id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
19725517|NCT04168190|42169189|FG000|Overall Study|Lost to Follow-up|0|||
19725518|NCT04168190|42169190|FG001|Overall Study|Lost to Follow-up|1|||
19725519|NCT04168190|42169191|FG002|Overall Study|Lost to Follow-up|0|||
19725520|NCT04168190|42169192|FG003|Overall Study|Lost to Follow-up|7|||
19725521|NCT04168190|42169193|FG004|Overall Study|Lost to Follow-up|5|||
19725522|NCT04168190|42169189|FG000|Overall Study|Withdrawal by Subject|1|||
19725523|NCT04168190|42169190|FG001|Overall Study|Withdrawal by Subject|0|||
19725524|NCT04168190|42169191|FG002|Overall Study|Withdrawal by Subject|0|||
19725525|NCT04168190|42169192|FG003|Overall Study|Withdrawal by Subject|2|||
19725526|NCT04168190|42169193|FG004|Overall Study|Withdrawal by Subject|4|||
19725527|NCT04168190|42169189|FG000|Overall Study|Death|0|||
19725528|NCT04168190|42169190|FG001|Overall Study|Death|0|||
19725529|NCT04168190|42169191|FG002|Overall Study|Death|0|||
19376144|NCT02262364|41618313|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
19376145|NCT00309985|41618319|FG000|Overall Study|Disease progression|12|||
19376146|NCT00309985|41618320|FG001|Overall Study|Disease progression|0|||
19376147|NCT00309985|41618319|FG000|Overall Study|Adverse Event|30|||
19376148|NCT00309985|41618320|FG001|Overall Study|Adverse Event|0|||
19376149|NCT00309985|41618319|FG000|Overall Study|Death|2|||
19551030|NCT01332227|41999868|FG000|Overall Study|Adverse Event|4|||
19551031|NCT01332227|41999869|FG001|Overall Study|Adverse Event|1|||
19551032|NCT01332227|41999868|FG000|Overall Study|Withdrawal by Subject|5|||
19551033|NCT01332227|41999869|FG001|Overall Study|Withdrawal by Subject|1|||
19551034|NCT01332227|41999868|FG000|Overall Study|Lost to Follow-up|2|||
19551035|NCT01332227|41999869|FG001|Overall Study|Lost to Follow-up|0|||
19551036|NCT01332227|41999868|FG000|Overall Study|Lack of Efficacy|3|||
19551037|NCT01332227|41999869|FG001|Overall Study|Lack of Efficacy|1|||
19551038|NCT01332227|41999868|FG000|Overall Study|Poor compliance/noncompliance|1|||
19551039|NCT01332227|41999869|FG001|Overall Study|Poor compliance/noncompliance|1|||
19638226|NCT00790751|42087623|FG000|Overall Study|Protocol non-compliance|16|||
19725530|NCT04168190|42169192|FG003|Overall Study|Death|1|||
19725531|NCT04168190|42169193|FG004|Overall Study|Death|0|||
19725532|NCT04476108|42169207|FG000|Overall Study|Adverse Event|4|||
19725533|NCT04476108|42169208|FG001|Overall Study|Adverse Event|1|||
19725534|NCT04476108|42169207|FG000|Overall Study|Lost to Follow-up|1|||
19725535|NCT04476108|42169208|FG001|Overall Study|Lost to Follow-up|0|||
19725536|NCT04476108|42169207|FG000|Overall Study|Inadvertent Enrollment|1|||
19725537|NCT04476108|42169208|FG001|Overall Study|Inadvertent Enrollment|0|||
19725538|NCT04476108|42169207|FG000|Overall Study|Protocol Violation|1|||
19725539|NCT04476108|42169208|FG001|Overall Study|Protocol Violation|1|||
19725540|NCT04476108|42169207|FG000|Overall Study|Withdrawal by Subject|1|||
19725541|NCT04476108|42169208|FG001|Overall Study|Withdrawal by Subject|1|||
19725542|NCT03529942|42169214|FG000|Overall Study|Withdrawal by Subject|13|||
19725543|NCT03529942|42169214|FG000|Overall Study|Physician Decision|1|||
19725544|NCT03529942|42169214|FG000|Overall Study|Lost to Follow-up|7|||
19725545|NCT03529942|42169214|FG000|Overall Study|Needle inserted but no drug administered|1|||
19725546|NCT03529942|42169214|FG000|Overall Study|Personal reasons|1|||
19725547|NCT04732338|42169223|FG000|Overall Study|Lost to Follow-up|3|||
19725548|NCT04732338|42169224|FG001|Overall Study|Lost to Follow-up|3|||
19725549|NCT04194008|42169230|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
19725550|NCT04194008|42169230|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
19725551|NCT04194008|42169230|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
19725552|NCT04194008|42169230|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
19725553|NCT04194008|42169230|FG000|Treatment Phase With Nerivio|Missing data|4|||
19725554|NCT04194008|42169230|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
19725555|NCT04189952|42169243|FG000|Follow-up Period|Death|1|||
19725556|NCT04189952|42169243|FG000|Follow-up Period|Withdrawal by Subject|1|||
19725557|NCT04716426|42169249|FG000|Overall Study|Vaccination|1|||
19725558|NCT04716426|42169250|FG001|Overall Study|Vaccination|1|||
19725559|NCT04716426|42169249|FG000|Overall Study|Contamination|1|||
19725560|NCT04716426|42169250|FG001|Overall Study|Contamination|0|||
19725561|NCT03694548|42169258|FG000|Part A Survey|Protocol Violation|3|||
19725562|NCT03694548|42169259|FG001|Part A Survey|Protocol Violation|3|||
19725563|NCT03694548|42169260|FG002|Part A Survey|Protocol Violation|0|||
19725564|NCT03694548|42169258|FG000|Part B Yoga Program|Protocol Violation|0|||
19725565|NCT03694548|42169259|FG001|Part B Yoga Program|Protocol Violation|0|||
19725566|NCT03694548|42169260|FG002|Part B Yoga Program|Protocol Violation|3|||
19725567|NCT03694548|42169258|FG000|Part B Yoga Program|Did not attend intervention|0|||
19725568|NCT03694548|42169259|FG001|Part B Yoga Program|Did not attend intervention|0|||
19725569|NCT03694548|42169260|FG002|Part B Yoga Program|Did not attend intervention|8|||
19725570|NCT04166630|42169272|FG000|Overall Study|Withdrawal by Subject|0|||
19725571|NCT04166630|42169273|FG001|Overall Study|Withdrawal by Subject|1|||
19725572|NCT04164758|42169282|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
19725573|NCT04164758|42169283|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
19725574|NCT04164758|42169284|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
19725575|NCT04164758|42169282|FG000|Overall Study|Adverse Event|0|||
19725576|NCT04164758|42169283|FG001|Overall Study|Adverse Event|1|||
19376150|NCT00309985|41618320|FG001|Overall Study|Death|0|||
19376151|NCT00309985|41618319|FG000|Overall Study|Withdrawal by Subject|5|||
19376152|NCT00309985|41618320|FG001|Overall Study|Withdrawal by Subject|1|||
19376153|NCT00309985|41618319|FG000|Overall Study|Physician Decision|3|||
19376154|NCT00309985|41618320|FG001|Overall Study|Physician Decision|0|||
19376155|NCT00309985|41618319|FG000|Overall Study|Never started treatment|7|||
19376156|NCT00309985|41618320|FG001|Overall Study|Never started treatment|0|||
19376157|NCT00309985|41618319|FG000|Overall Study|Complicating disease|1|||
19376158|NCT00309985|41618320|FG001|Overall Study|Complicating disease|0|||
19376159|NCT00309985|41618319|FG000|Overall Study|Non-compliance|1|||
19376160|NCT00309985|41618320|FG001|Overall Study|Non-compliance|0|||
19376161|NCT00309985|41618319|FG000|Overall Study|Chemotherapy discontinued only|1|||
19376162|NCT00309985|41618320|FG001|Overall Study|Chemotherapy discontinued only|0|||
19376163|NCT02261974|41618328|FG000|Overall Study|Withdrawal by Subject|3|||
19376164|NCT02261974|41618329|FG001|Overall Study|Withdrawal by Subject|2|||
19376165|NCT02261974|41618328|FG000|Overall Study|Pregnancy|0|||
19376166|NCT02261974|41618329|FG001|Overall Study|Pregnancy|1|||
19376167|NCT02261974|41618328|FG000|Overall Study|Missed treatment cut-off date|6|||
19376168|NCT02261974|41618329|FG001|Overall Study|Missed treatment cut-off date|3|||
19376169|NCT02261974|41618328|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
19376170|NCT02261974|41618329|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
19376171|NCT02261974|41618328|FG000|Overall Study|Lost to Follow-up|2|||
19376172|NCT02261974|41618329|FG001|Overall Study|Lost to Follow-up|0|||
19376173|NCT02261974|41618328|FG000|Overall Study|Adverse Event|1|||
19376174|NCT02261974|41618329|FG001|Overall Study|Adverse Event|0|||
19376175|NCT02356588|41618337|FG000|Overall Study|Lack of Efficacy|4|||
19376176|NCT02356588|41618338|FG001|Overall Study|Lack of Efficacy|10|||
19376177|NCT02356588|41618337|FG000|Overall Study|Adverse Event|0|||
19376178|NCT02356588|41618338|FG001|Overall Study|Adverse Event|2|||
19376179|NCT02356588|41618337|FG000|Overall Study|Withdrawal by Subject|1|||
19376180|NCT02356588|41618338|FG001|Overall Study|Withdrawal by Subject|0|||
19376181|NCT02356588|41618337|FG000|Overall Study|Protocol Violation|0|||
19376182|NCT02356588|41618338|FG001|Overall Study|Protocol Violation|1|||
19376183|NCT02355028|41618346|FG000|Overall Study|Adverse Event|2|||
19376184|NCT02355028|41618347|FG001|Overall Study|Adverse Event|0|||
19376185|NCT02355028|41618346|FG000|Overall Study|Withdrawal by Subject|1|||
19376186|NCT02355028|41618347|FG001|Overall Study|Withdrawal by Subject|1|||
19376187|NCT02355028|41618346|FG000|Overall Study|Deemed ineligible after randomization|8|||
19376188|NCT02355028|41618347|FG001|Overall Study|Deemed ineligible after randomization|4|||
19376189|NCT01643668|41618362|FG000|Overall Study|Death|1|||
19376190|NCT02260882|41618368|FG000|Overall Study|Protocol Violation|0|||
19376191|NCT02260882|41618369|FG001|Overall Study|Protocol Violation|1|||
19376192|NCT02260804|41618378|FG000|Induction Study Period|Protocol Violation|2|||
19376193|NCT02260804|41618379|FG001|Induction Study Period|Protocol Violation|0|||
19376194|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
19376195|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
19376196|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
19376197|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
19376198|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
19376199|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
19376200|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
19376201|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
19376202|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
19376203|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
19376204|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
19376205|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
19376206|NCT02260804|41618378|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
19376207|NCT02260804|41618379|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
19376208|NCT02260804|41618378|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
19376209|NCT02260804|41618379|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
19376210|NCT02260804|41618378|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
19376211|NCT02260804|41618379|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
19376212|NCT02260804|41618378|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
19376213|NCT02260804|41618379|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
19551040|NCT01332227|41999868|FG000|Overall Study|Patient moved from area|1|||
19376214|NCT02260648|41618388|FG000|Overall Study|Adverse Event|3|||
19376215|NCT02260648|41618389|FG001|Overall Study|Adverse Event|0|||
19376216|NCT02260648|41618390|FG002|Overall Study|Adverse Event|1|||
19376217|NCT02260648|41618388|FG000|Overall Study|Withdrawal by Subject|1|||
19376218|NCT02260648|41618389|FG001|Overall Study|Withdrawal by Subject|1|||
19376219|NCT02260648|41618390|FG002|Overall Study|Withdrawal by Subject|0|||
19551041|NCT01332227|41999869|FG001|Overall Study|Patient moved from area|0|||
19551042|NCT01332227|41999868|FG000|Overall Study|Patient began prohibited medication|0|||
19376220|NCT02260648|41618388|FG000|Overall Study|Protocol Violation|1|||
19376221|NCT02260648|41618389|FG001|Overall Study|Protocol Violation|0|||
19376222|NCT02260648|41618390|FG002|Overall Study|Protocol Violation|0|||
19376223|NCT02260648|41618388|FG000|Overall Study|Discontinue Due to Study Termination|13|||
19376224|NCT02260648|41618389|FG001|Overall Study|Discontinue Due to Study Termination|12|||
19376225|NCT02260648|41618390|FG002|Overall Study|Discontinue Due to Study Termination|7|||
19376226|NCT02260492|41618401|FG000|Overall Study|Adverse Event|6|||
19376227|NCT02260492|41618402|FG001|Overall Study|Adverse Event|1|||
19376228|NCT02260492|41618403|FG002|Overall Study|Adverse Event|2|||
19376229|NCT02260492|41618401|FG000|Overall Study|Death|0|||
19376230|NCT02260492|41618402|FG001|Overall Study|Death|1|||
19376231|NCT02260492|41618403|FG002|Overall Study|Death|0|||
19376232|NCT02260492|41618401|FG000|Overall Study|Lost to Follow-up|12|||
19376233|NCT02260492|41618402|FG001|Overall Study|Lost to Follow-up|9|||
19376234|NCT02260492|41618403|FG002|Overall Study|Lost to Follow-up|0|||
19376235|NCT02260492|41618401|FG000|Overall Study|Physician Decision|2|||
19376236|NCT02260492|41618402|FG001|Overall Study|Physician Decision|0|||
19376237|NCT02260492|41618403|FG002|Overall Study|Physician Decision|1|||
19376238|NCT02260492|41618401|FG000|Overall Study|Withdrawal by Subject|3|||
19376239|NCT02260492|41618402|FG001|Overall Study|Withdrawal by Subject|2|||
19376240|NCT02260492|41618403|FG002|Overall Study|Withdrawal by Subject|2|||
19376241|NCT02260258|41618413|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
19376242|NCT02260258|41618414|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
19376243|NCT02260180|41618424|FG000|Overall Study|Adverse Event|2|||
19376244|NCT02260180|41618425|FG001|Overall Study|Adverse Event|0|||
19376245|NCT02260180|41618426|FG002|Overall Study|Adverse Event|1|||
19376246|NCT02353468|41618434|FG000|Overall Study|Study terminated|3|||
19376247|NCT02349412|41618440|FG000|Overall Study|Withdrawal by Subject|7|||
19376248|NCT02349412|41618441|FG001|Overall Study|Withdrawal by Subject|7|||
19376249|NCT02259400|41618449|FG000|Overall Study|Death|0|||
19376250|NCT02259400|41618450|FG001|Overall Study|Death|2|||
19376251|NCT01530997|41618456|FG000|Overall Study|Physician Decision|1|||
19376252|NCT01530997|41618456|FG000|Overall Study|Withdrawal by Subject|1|||
19376253|NCT02259088|41618469|FG000|Overall Study|Adverse Event|6|||
19376254|NCT02259088|41618470|FG001|Overall Study|Adverse Event|4|||
19376255|NCT02259088|41618469|FG000|Overall Study|Lost to Follow-up|2|||
19376256|NCT02259088|41618470|FG001|Overall Study|Lost to Follow-up|0|||
19376257|NCT02259088|41618469|FG000|Overall Study|Death|2|||
19376258|NCT02259088|41618470|FG001|Overall Study|Death|0|||
19376259|NCT02259088|41618469|FG000|Overall Study|Physician Decision|5|||
19376260|NCT02259088|41618470|FG001|Overall Study|Physician Decision|2|||
19376261|NCT02259088|41618469|FG000|Overall Study|Protocol deviation|5|||
19376262|NCT02259088|41618470|FG001|Overall Study|Protocol deviation|0|||
19376263|NCT02259088|41618469|FG000|Overall Study|Subject/guardian decision|8|||
19376264|NCT02259088|41618470|FG001|Overall Study|Subject/guardian decision|8|||
19376265|NCT02880241|41618482|FG000|Overall Study|Lack of Efficacy|1|||
19376266|NCT02880241|41618483|FG001|Overall Study|Lack of Efficacy|0|||
19376267|NCT02880241|41618484|FG002|Overall Study|Lack of Efficacy|0|||
19376268|NCT02880241|41618485|FG003|Overall Study|Lack of Efficacy|0|||
19376269|NCT02880241|41618486|FG004|Overall Study|Lack of Efficacy|0|||
19376270|NCT02880241|41618487|FG005|Overall Study|Lack of Efficacy|0|||
19376271|NCT02259010|41618503|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
19376272|NCT02021773|41618512|FG000|Overall Study|Adverse Event|1|||
19376273|NCT02021773|41618513|FG001|Overall Study|Adverse Event|4|||
19376274|NCT02021773|41618514|FG002|Overall Study|Adverse Event|3|||
19376275|NCT02021773|41618512|FG000|Overall Study|Lack of Efficacy|2|||
19376276|NCT02021773|41618513|FG001|Overall Study|Lack of Efficacy|2|||
19376277|NCT02021773|41618514|FG002|Overall Study|Lack of Efficacy|2|||
19376278|NCT02021773|41618512|FG000|Overall Study|Protocol Violation|2|||
19376279|NCT02021773|41618513|FG001|Overall Study|Protocol Violation|3|||
19551043|NCT01332227|41999869|FG001|Overall Study|Patient began prohibited medication|1|||
19551044|NCT01332149|41999877|FG000|Overall Study|Adverse Event|11|||
19551045|NCT01332149|41999878|FG001|Overall Study|Adverse Event|9|||
19551046|NCT01332149|41999877|FG000|Overall Study|Other unspecified|5|||
19551047|NCT01332149|41999878|FG001|Overall Study|Other unspecified|7|||
19551048|NCT01332149|41999877|FG000|Overall Study|Protocol Violation|1|||
19551049|NCT01332149|41999878|FG001|Overall Study|Protocol Violation|3|||
19551050|NCT01332149|41999877|FG000|Overall Study|Withdrawal by Subject|4|||
19551051|NCT01332149|41999878|FG001|Overall Study|Withdrawal by Subject|5|||
19551052|NCT01332149|41999877|FG000|Overall Study|Lost to Follow-up|1|||
19551053|NCT01332149|41999878|FG001|Overall Study|Lost to Follow-up|1|||
19551054|NCT01332149|41999877|FG000|Overall Study|Insufficient clinical response|4|||
19551055|NCT01332149|41999878|FG001|Overall Study|Insufficient clinical response|7|||
19698908|NCT00313586|42143716|FG003|Overall Study|Physician Decision|0|||
19376280|NCT02021773|41618514|FG002|Overall Study|Protocol Violation|1|||
19376281|NCT02021773|41618512|FG000|Overall Study|Withdrawal by Subject|3|||
19376282|NCT02021773|41618513|FG001|Overall Study|Withdrawal by Subject|4|||
19376283|NCT02021773|41618514|FG002|Overall Study|Withdrawal by Subject|5|||
19376284|NCT02021773|41618512|FG000|Overall Study|Lost to Follow-up|1|||
19376285|NCT02021773|41618513|FG001|Overall Study|Lost to Follow-up|3|||
19376286|NCT02021773|41618514|FG002|Overall Study|Lost to Follow-up|0|||
19376287|NCT02021773|41618512|FG000|Overall Study|Reason not specified|3|||
19376288|NCT02021773|41618513|FG001|Overall Study|Reason not specified|0|||
19376289|NCT02021773|41618514|FG002|Overall Study|Reason not specified|0|||
19463209|NCT01703065|41720666|FG000|Overall Study|Lack of Efficacy|1|||
19376290|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
19376291|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
19376292|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376293|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376294|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376295|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376296|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376297|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376298|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376299|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376300|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376301|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
19376302|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
19376303|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376304|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376305|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376306|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376307|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376308|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
19376309|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376310|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376311|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376312|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
19376313|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
19376314|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376315|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
19376316|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376317|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376318|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19725577|NCT04164758|42169284|FG002|Overall Study|Adverse Event|0|||
19725578|NCT04178720|42169294|FG000|Overall Study|Withdrawal by Subject|2|||
19725579|NCT04178720|42169295|FG001|Overall Study|Withdrawal by Subject|0|||
19725580|NCT04178720|42169294|FG000|Overall Study|Relocation|0|||
19725581|NCT04178720|42169295|FG001|Overall Study|Relocation|1|||
19376319|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376320|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376321|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376322|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376323|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376324|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376325|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
19376326|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
19376327|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
19376328|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
19376329|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
19376330|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
19376331|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
19376332|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
19376333|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
19376334|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
19725582|NCT04177862|42169306|FG000|Overall Study|Protocol Violation|2|||
19376335|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
19376336|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
19376337|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
19376338|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376339|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376340|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376341|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19725583|NCT04177862|42169307|FG001|Overall Study|Protocol Violation|7|||
19725584|NCT04173572|42169316|FG000|Overall Study|Withdrawal by Subject|1|||
19376342|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19463210|NCT01703065|41720667|FG001|Overall Study|Lack of Efficacy|0|||
19725585|NCT04173572|42169317|FG001|Overall Study|Withdrawal by Subject|5|||
19725586|NCT04173572|42169316|FG000|Overall Study|Lost to Follow-up|3|||
19725587|NCT04173572|42169317|FG001|Overall Study|Lost to Follow-up|1|||
19725588|NCT04157738|42169325|FG000|Overall Study|Moved out of state|0|||
19725589|NCT04157738|42169326|FG001|Overall Study|Moved out of state|2|||
19725590|NCT04157738|42169325|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
19551056|NCT01332149|41999877|FG000|Overall Study|Did not meet entrance criteria|3|||
19551057|NCT01332149|41999878|FG001|Overall Study|Did not meet entrance criteria|4|||
19551058|NCT01332149|41999877|FG000|Overall Study|Randomized but not treated|1|||
19551059|NCT01332149|41999878|FG001|Overall Study|Randomized but not treated|2|||
19551060|NCT01330628|41999886|FG000|Overall Study|Death|2|||
19551061|NCT01330628|41999887|FG001|Overall Study|Death|3|||
19551062|NCT01330628|41999886|FG000|Overall Study|Lost to Follow-up|5|||
19551063|NCT01330628|41999887|FG001|Overall Study|Lost to Follow-up|6|||
19551064|NCT01330628|41999886|FG000|Overall Study|Adverse Event|44|||
19551065|NCT01330628|41999887|FG001|Overall Study|Adverse Event|25|||
19551066|NCT01330628|41999886|FG000|Overall Study|Withdrawn|18|||
19551067|NCT01330628|41999887|FG001|Overall Study|Withdrawn|6|||
19551068|NCT01330628|41999886|FG000|Overall Study|Didn't receive study treatment|1|||
19551069|NCT01330628|41999887|FG001|Overall Study|Didn't receive study treatment|0|||
19551070|NCT01330433|41999895|FG000|Overall Study|Death|1|||
19551071|NCT01330433|41999896|FG001|Overall Study|Death|3|||
19725591|NCT04157738|42169326|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
19725592|NCT04156646|42169334|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
19725593|NCT04156646|42169335|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
19725594|NCT04676412|42169346|FG000|Overall Study|Death|17|||
19725595|NCT04676412|42169347|FG001|Overall Study|Death|23|||
19725596|NCT04676412|42169346|FG000|Overall Study|Withdrawal by Subject|0|||
19725597|NCT04676412|42169347|FG001|Overall Study|Withdrawal by Subject|2|||
19725598|NCT04676412|42169346|FG000|Overall Study|Participants ongoing|32|||
19376343|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
19376344|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19551072|NCT01330433|41999895|FG000|Overall Study|Lost to Follow-up|1|||
19551073|NCT01330433|41999896|FG001|Overall Study|Lost to Follow-up|0|||
19551074|NCT01330316|41999904|FG000|Overall Study|Adverse Event|2|||
19551075|NCT01330316|41999905|FG001|Overall Study|Adverse Event|2|||
19551076|NCT01330316|41999904|FG000|Overall Study|Lack of Efficacy|0|||
19551077|NCT01330316|41999905|FG001|Overall Study|Lack of Efficacy|10|||
19551078|NCT01330316|41999904|FG000|Overall Study|Lost to Follow-up|0|||
19551079|NCT01330316|41999905|FG001|Overall Study|Lost to Follow-up|1|||
19551080|NCT01330316|41999904|FG000|Overall Study|Withdrawal by Subject|0|||
19551081|NCT01330316|41999905|FG001|Overall Study|Withdrawal by Subject|1|||
19551082|NCT01330316|41999904|FG000|Overall Study|other than above|0|||
19551083|NCT01330316|41999905|FG001|Overall Study|other than above|1|||
19551084|NCT01326702|41999918|FG000|Overall Study|Other|1|||
19551085|NCT01326702|41999919|FG001|Overall Study|Other|0|||
19551086|NCT01326702|41999920|FG002|Overall Study|Other|0|||
19376345|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376346|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376347|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376348|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376349|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
19376350|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376351|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376352|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376353|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376354|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376355|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
19376356|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376357|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376358|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376359|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19376360|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19551087|NCT01326702|41999921|FG003|Overall Study|Other|0|||
19551088|NCT01326702|41999922|FG004|Overall Study|Other|0|||
19551089|NCT01326702|41999923|FG005|Overall Study|Other|1|||
19551090|NCT01326702|41999924|FG006|Overall Study|Other|0|||
19551091|NCT01326702|41999918|FG000|Overall Study|progressive disease|1|||
19551092|NCT01326702|41999919|FG001|Overall Study|progressive disease|1|||
19551093|NCT01326702|41999920|FG002|Overall Study|progressive disease|3|||
19551094|NCT01326702|41999921|FG003|Overall Study|progressive disease|1|||
19725599|NCT04676412|42169347|FG001|Overall Study|Participants ongoing|33|||
19725600|NCT04150250|42169355|FG000|Overall Study|Lost to Follow-up|0|||
19551095|NCT01326702|41999922|FG004|Overall Study|progressive disease|3|||
19551096|NCT01326702|41999923|FG005|Overall Study|progressive disease|2|||
19551097|NCT01326702|41999924|FG006|Overall Study|progressive disease|3|||
19551098|NCT01326702|41999918|FG000|Overall Study|Death|0|||
19551099|NCT01326702|41999919|FG001|Overall Study|Death|1|||
19551100|NCT01326702|41999920|FG002|Overall Study|Death|0|||
19551101|NCT01326702|41999921|FG003|Overall Study|Death|0|||
19551102|NCT01326702|41999922|FG004|Overall Study|Death|0|||
19551103|NCT01326702|41999923|FG005|Overall Study|Death|0|||
19551104|NCT01326702|41999924|FG006|Overall Study|Death|0|||
19551105|NCT01326702|41999918|FG000|Overall Study|Adverse Event|0|||
19551106|NCT01326702|41999919|FG001|Overall Study|Adverse Event|0|||
19551107|NCT01326702|41999920|FG002|Overall Study|Adverse Event|1|||
19551108|NCT01326702|41999921|FG003|Overall Study|Adverse Event|1|||
19551109|NCT01326702|41999922|FG004|Overall Study|Adverse Event|0|||
19551110|NCT01326702|41999923|FG005|Overall Study|Adverse Event|3|||
19551111|NCT01326702|41999924|FG006|Overall Study|Adverse Event|1|||
19551112|NCT01326702|41999918|FG000|Overall Study|Withdrawal by Subject|0|||
19551113|NCT01326702|41999919|FG001|Overall Study|Withdrawal by Subject|0|||
19551114|NCT01326702|41999920|FG002|Overall Study|Withdrawal by Subject|1|||
19551115|NCT01326702|41999921|FG003|Overall Study|Withdrawal by Subject|0|||
19551116|NCT01326702|41999922|FG004|Overall Study|Withdrawal by Subject|1|||
19551117|NCT01326702|41999923|FG005|Overall Study|Withdrawal by Subject|1|||
19551118|NCT01326702|41999924|FG006|Overall Study|Withdrawal by Subject|3|||
19551119|NCT01326702|41999918|FG000|Overall Study|Not Treated|0|||
19551120|NCT01326702|41999919|FG001|Overall Study|Not Treated|0|||
19551121|NCT01326702|41999920|FG002|Overall Study|Not Treated|0|||
19551122|NCT01326702|41999921|FG003|Overall Study|Not Treated|1|||
19551123|NCT01326702|41999922|FG004|Overall Study|Not Treated|0|||
19551124|NCT01326702|41999923|FG005|Overall Study|Not Treated|1|||
19551125|NCT01326702|41999924|FG006|Overall Study|Not Treated|0|||
19551126|NCT01327703|41999943|FG000|Second Treatment Period|Adverse Event|1|||
19551127|NCT01327703|41999944|FG001|Second Treatment Period|Adverse Event|1|||
19551128|NCT01327703|41999943|FG000|Second Treatment Period|Protocol Violation|0|||
19551129|NCT01327703|41999944|FG001|Second Treatment Period|Protocol Violation|1|||
19551130|NCT01380080|41999955|FG000|Overall Study|Death|36|||
19551131|NCT01380080|41999956|FG001|Overall Study|Death|44|||
19551132|NCT01380080|41999955|FG000|Overall Study|Site is closing|28|||
19551133|NCT01380080|41999956|FG001|Overall Study|Site is closing|31|||
19551134|NCT01380080|41999955|FG000|Overall Study|Not able to get to clinic|7|||
19551135|NCT01380080|41999956|FG001|Overall Study|Not able to get to clinic|1|||
19551136|NCT01380080|41999955|FG000|Overall Study|Not willing to adhere to requirements|6|||
19551137|NCT01380080|41999956|FG001|Overall Study|Not willing to adhere to requirements|2|||
19551138|NCT01380080|41999955|FG000|Overall Study|Withdrawal by Subject|5|||
19551139|NCT01380080|41999956|FG001|Overall Study|Withdrawal by Subject|2|||
19551140|NCT01380080|41999955|FG000|Overall Study|Lost to Follow-up|3|||
19551141|NCT01380080|41999956|FG001|Overall Study|Lost to Follow-up|3|||
19551142|NCT01379768|41999965|FG000|Overall Study|Adverse Event|1|||
19551143|NCT01379768|41999966|FG001|Overall Study|Adverse Event|1|||
19551144|NCT01379768|41999967|FG002|Overall Study|Adverse Event|0|||
19551145|NCT01379768|41999965|FG000|Overall Study|Lost to Follow-up|2|||
19551146|NCT01379768|41999966|FG001|Overall Study|Lost to Follow-up|0|||
19551147|NCT01379768|41999967|FG002|Overall Study|Lost to Follow-up|0|||
19551148|NCT01379573|41999975|FG000|Overall Study|Lost to Follow-up|1|||
19551149|NCT01379573|41999975|FG000|Overall Study|Screen Failure|10|||
19551150|NCT01379534|41999981|FG000|Treatment Phase|Withdrawal by Subject|2|||
19551151|NCT01379534|41999982|FG001|Treatment Phase|Withdrawal by Subject|2|||
19551152|NCT01379534|41999981|FG000|Treatment Phase|Progressive disease|13|||
19551153|NCT01379534|41999982|FG001|Treatment Phase|Progressive disease|22|||
19551154|NCT01379534|41999981|FG000|Treatment Phase|Adverse Event|7|||
19551155|NCT01379534|41999982|FG001|Treatment Phase|Adverse Event|7|||
19551156|NCT01379534|41999981|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
19551157|NCT01379534|41999982|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
19551158|NCT01379534|41999981|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
19551159|NCT01379534|41999982|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
19551160|NCT01379534|41999981|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
19551161|NCT01379534|41999982|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
19551162|NCT01379534|41999981|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
19551163|NCT01379534|41999982|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
19551164|NCT01371851|41999990|FG000|Overall Study|Lost to Follow-up|5|||
19551165|NCT01371851|41999991|FG001|Overall Study|Lost to Follow-up|8|||
19551166|NCT01371851|41999990|FG000|Overall Study|was arrested and put in jail|0|||
19551167|NCT01371851|41999991|FG001|Overall Study|was arrested and put in jail|1|||
19551168|NCT01371851|41999990|FG000|Overall Study|non study related adverse event|1|||
19551169|NCT01371851|41999991|FG001|Overall Study|non study related adverse event|0|||
19551170|NCT01371851|41999990|FG000|Overall Study|Blood Pressure outside study parameters|2|||
19551171|NCT01371851|41999991|FG001|Overall Study|Blood Pressure outside study parameters|0|||
19551172|NCT01371734|42000000|FG000|Overall Study|Other|2|||
19551173|NCT01371734|42000001|FG001|Overall Study|Other|1|||
19551174|NCT01371734|42000002|FG002|Overall Study|Other|2|||
19725601|NCT04150250|42169356|FG001|Overall Study|Lost to Follow-up|2|||
19551175|NCT01371734|42000000|FG000|Overall Study|Withdrawal by Subject|3|||
19551176|NCT01371734|42000001|FG001|Overall Study|Withdrawal by Subject|4|||
19551177|NCT01371734|42000002|FG002|Overall Study|Withdrawal by Subject|9|||
19551178|NCT01371734|42000000|FG000|Overall Study|Lost to Follow-up|5|||
19551179|NCT01371734|42000001|FG001|Overall Study|Lost to Follow-up|3|||
19551180|NCT01371734|42000002|FG002|Overall Study|Lost to Follow-up|1|||
19551181|NCT01371734|42000000|FG000|Overall Study|Protocol Violation|3|||
19551182|NCT01371734|42000001|FG001|Overall Study|Protocol Violation|1|||
19551183|NCT01371734|42000002|FG002|Overall Study|Protocol Violation|2|||
19551184|NCT01371734|42000000|FG000|Overall Study|Adverse Event|8|||
19551185|NCT01371734|42000001|FG001|Overall Study|Adverse Event|8|||
19551186|NCT01371734|42000002|FG002|Overall Study|Adverse Event|3|||
19551187|NCT01371734|42000000|FG000|Overall Study|Lack of Efficacy|2|||
19551188|NCT01371734|42000001|FG001|Overall Study|Lack of Efficacy|2|||
19551189|NCT01371734|42000002|FG002|Overall Study|Lack of Efficacy|0|||
19551190|NCT01365494|42000012|FG000|Overall Study|Adverse Event|1|||
19551191|NCT01365494|42000013|FG001|Overall Study|Adverse Event|0|||
19551192|NCT01365494|42000012|FG000|Overall Study|Withdrawal by Subject|0|||
19551193|NCT01365494|42000013|FG001|Overall Study|Withdrawal by Subject|1|||
19551194|NCT01365494|42000012|FG000|Overall Study|Lost to Follow-up|1|||
19551195|NCT01365494|42000013|FG001|Overall Study|Lost to Follow-up|2|||
19551196|NCT01357889|42000022|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
19551197|NCT01357889|42000023|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
19551198|NCT01357889|42000022|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
19551199|NCT01357889|42000023|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
19551200|NCT01357889|42000022|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
19551201|NCT01357889|42000023|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
19551202|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
19551203|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
19551204|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
19551205|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
19551206|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
19551207|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
19551208|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
19551209|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
19551210|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
19551211|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
19551212|NCT01357889|42000022|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
19551213|NCT01357889|42000023|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
19551214|NCT01357889|42000022|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
19551215|NCT01357889|42000023|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
19551216|NCT01357889|42000022|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
19551217|NCT01357889|42000023|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
19551218|NCT01357889|42000022|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
19551219|NCT01357889|42000023|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
19551220|NCT01357889|42000022|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
19551221|NCT01357889|42000023|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
19551222|NCT01357850|42000035|FG000|Overall Study|Lost to Follow-up|1|||
19551223|NCT01357850|42000036|FG001|Overall Study|Lost to Follow-up|0|||
19551224|NCT01357850|42000037|FG002|Overall Study|Lost to Follow-up|0|||
19551225|NCT01357850|42000038|FG003|Overall Study|Lost to Follow-up|0|||
19551226|NCT01357655|42000051|FG000|Overall Study|Administrative Reason by Sponsor|45|||
19551227|NCT01357655|42000052|FG001|Overall Study|Administrative Reason by Sponsor|0|||
19551228|NCT01357655|42000051|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
19551229|NCT01357655|42000052|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19551230|NCT01357655|42000051|FG000|Overall Study|Disease Progression|1|||
19551231|NCT01357655|42000052|FG001|Overall Study|Disease Progression|0|||
19551232|NCT01357655|42000051|FG000|Overall Study|Lost to Follow-up|2|||
19551233|NCT01357655|42000052|FG001|Overall Study|Lost to Follow-up|0|||
19551234|NCT01357655|42000051|FG000|Overall Study|Maximum Clinical Benefit|2|||
19551235|NCT01357655|42000052|FG001|Overall Study|Maximum Clinical Benefit|0|||
19551236|NCT01357655|42000051|FG000|Overall Study|Reason Unspecified|1|||
19551237|NCT01357655|42000052|FG001|Overall Study|Reason Unspecified|0|||
19551238|NCT01357655|42000051|FG000|Overall Study|Study Drug Toxicity|11|||
19551239|NCT01357655|42000052|FG001|Overall Study|Study Drug Toxicity|0|||
19551240|NCT01357655|42000051|FG000|Overall Study|Subject Withdrew Consent|1|||
19551241|NCT01357655|42000052|FG001|Overall Study|Subject Withdrew Consent|0|||
19551242|NCT01357616|42000059|FG000|Overall Study|Adverse Event|1|||
19551243|NCT01357616|42000060|FG001|Overall Study|Adverse Event|1|||
19551244|NCT01357616|42000059|FG000|Overall Study|Lost to Follow-up|4|||
19551245|NCT01357616|42000060|FG001|Overall Study|Lost to Follow-up|3|||
19551246|NCT01357616|42000059|FG000|Overall Study|Protocol Violation|0|||
19551247|NCT01357616|42000060|FG001|Overall Study|Protocol Violation|2|||
19551248|NCT01357616|42000059|FG000|Overall Study|Inadequate Control of IOP|1|||
19551249|NCT01357616|42000060|FG001|Overall Study|Inadequate Control of IOP|2|||
19551250|NCT01357616|42000059|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
19551251|NCT01357616|42000060|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
19551252|NCT01357616|42000059|FG000|Overall Study|Withdrawal by Subject|1|||
19551253|NCT01357616|42000060|FG001|Overall Study|Withdrawal by Subject|0|||
19551254|NCT01357577|42000068|FG000|Overall Study|Lost to Follow-up|20|||
19551255|NCT01357577|42000069|FG001|Overall Study|Lost to Follow-up|16|||
19551256|NCT01357577|42000068|FG000|Overall Study|Withdrawal by Subject|16|||
19551257|NCT01357577|42000069|FG001|Overall Study|Withdrawal by Subject|8|||
19551258|NCT01357577|42000068|FG000|Overall Study|look at data in database?|1|||
19551259|NCT01357577|42000069|FG001|Overall Study|look at data in database?|2|||
19551260|NCT01351025|42000078|FG000|Week 0 - 20|Lost to Follow-up|2|||
19638227|NCT00790751|42087624|FG001|Overall Study|Protocol non-compliance|16|||
19638228|NCT00790751|42087625|FG002|Overall Study|Protocol non-compliance|10|||
19638229|NCT00790751|42087626|FG003|Overall Study|Protocol non-compliance|11|||
19638230|NCT00790751|42087623|FG000|Overall Study|Lost to Follow-up|4|||
19638231|NCT00790751|42087624|FG001|Overall Study|Lost to Follow-up|9|||
19638232|NCT00790751|42087625|FG002|Overall Study|Lost to Follow-up|4|||
19638233|NCT00790751|42087626|FG003|Overall Study|Lost to Follow-up|5|||
19638234|NCT00790751|42087623|FG000|Overall Study|Adverse Event|5|||
19638235|NCT00790751|42087624|FG001|Overall Study|Adverse Event|3|||
19638236|NCT00790751|42087625|FG002|Overall Study|Adverse Event|5|||
19638237|NCT00790751|42087626|FG003|Overall Study|Adverse Event|4|||
19638238|NCT00790751|42087623|FG000|Overall Study|Requirement for restricted medication|0|||
19638239|NCT00790751|42087624|FG001|Overall Study|Requirement for restricted medication|2|||
19638240|NCT00790751|42087625|FG002|Overall Study|Requirement for restricted medication|0|||
19638241|NCT00790751|42087626|FG003|Overall Study|Requirement for restricted medication|0|||
19638242|NCT00790751|42087623|FG000|Overall Study|Death|0|||
19638243|NCT00790751|42087624|FG001|Overall Study|Death|0|||
19638244|NCT00790751|42087625|FG002|Overall Study|Death|1|||
19638245|NCT00790751|42087626|FG003|Overall Study|Death|0|||
19638246|NCT00790751|42087623|FG000|Overall Study|Physician Decision|0|||
19638247|NCT00790751|42087624|FG001|Overall Study|Physician Decision|0|||
19638248|NCT00790751|42087625|FG002|Overall Study|Physician Decision|0|||
19638249|NCT00790751|42087626|FG003|Overall Study|Physician Decision|1|||
19638250|NCT00784979|42087636|FG000|Overall Study|incomplete data|6|||
19638251|NCT00738920|42087643|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
19638252|NCT00738920|42087644|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
19638253|NCT00738920|42087645|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
19638254|NCT00738920|42087643|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
19638255|NCT00738920|42087644|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
19638256|NCT00738920|42087645|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
19638257|NCT00738920|42087643|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
19638258|NCT00738920|42087644|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
19638259|NCT00738920|42087645|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
19638260|NCT00738920|42087643|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
19638261|NCT00738920|42087644|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
19638262|NCT00738920|42087645|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
19638263|NCT00738920|42087643|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
19638264|NCT00738920|42087644|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
19638265|NCT00738920|42087645|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
19638266|NCT00738920|42087643|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
19638267|NCT00738920|42087644|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
19638268|NCT00738920|42087645|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
19638269|NCT00738920|42087643|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
19638270|NCT00738920|42087644|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
19638271|NCT00738920|42087645|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
19638272|NCT00738920|42087643|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
19638273|NCT00738920|42087644|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
19638274|NCT00738920|42087645|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
19638275|NCT00738920|42087643|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
19638276|NCT00738920|42087644|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
19638277|NCT00738920|42087645|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
19638278|NCT00738920|42087643|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
19638279|NCT00738920|42087644|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
19638280|NCT00738920|42087645|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
19638281|NCT00582972|42087653|FG000|Overall Study|Protocol Violation|2|||
19638282|NCT04319718|42087660|FG000|Overall Study|Adverse Event|0|||
19638283|NCT04319718|42087661|FG001|Overall Study|Adverse Event|2|||
19638284|NCT04319718|42087660|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
19638285|NCT04319718|42087661|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
19638286|NCT04372602|42087669|FG000|Overall Study|Withdrawal by Subject|1|||
19638287|NCT04372602|42087670|FG001|Overall Study|Withdrawal by Subject|1|||
19638288|NCT04372602|42087669|FG000|Overall Study|Adverse Event|0|||
19638289|NCT04372602|42087670|FG001|Overall Study|Adverse Event|1|||
19638290|NCT04372602|42087669|FG000|Overall Study|Transitioned to comfort care|0|||
19638291|NCT04372602|42087670|FG001|Overall Study|Transitioned to comfort care|1|||
19638292|NCT00733304|42087679|FG000|Overall Study|Adverse Event|3|||
19638293|NCT00733304|42087680|FG001|Overall Study|Adverse Event|0|||
19638294|NCT00733304|42087681|FG002|Overall Study|Adverse Event|0|||
19638295|NCT00733304|42087679|FG000|Overall Study|Lack of Efficacy|0|||
19638296|NCT00733304|42087680|FG001|Overall Study|Lack of Efficacy|0|||
19638297|NCT00733304|42087681|FG002|Overall Study|Lack of Efficacy|2|||
19638298|NCT00733304|42087679|FG000|Overall Study|Lost to Follow-up|0|||
19638299|NCT00733304|42087680|FG001|Overall Study|Lost to Follow-up|1|||
19638300|NCT00733304|42087681|FG002|Overall Study|Lost to Follow-up|0|||
19638301|NCT00733304|42087679|FG000|Overall Study|Physician Decision|3|||
19638302|NCT00733304|42087680|FG001|Overall Study|Physician Decision|1|||
19638303|NCT00733304|42087681|FG002|Overall Study|Physician Decision|3|||
19638304|NCT00733304|42087679|FG000|Overall Study|Withdrawal by Subject|1|||
19638305|NCT00733304|42087680|FG001|Overall Study|Withdrawal by Subject|1|||
19638306|NCT00733304|42087681|FG002|Overall Study|Withdrawal by Subject|0|||
19638307|NCT00711243|42087695|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
19638308|NCT00711243|42087696|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
19638309|NCT00711243|42087697|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
19638310|NCT00711243|42087698|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
19638311|NCT00711243|42087699|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
19638312|NCT00711243|42087700|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
19638313|NCT00711243|42087695|FG000|Reached First Response/4 Cycles|Death|0|||
19638314|NCT00711243|42087696|FG001|Reached First Response/4 Cycles|Death|0|||
19638315|NCT00711243|42087697|FG002|Reached First Response/4 Cycles|Death|0|||
19638316|NCT00711243|42087698|FG003|Reached First Response/4 Cycles|Death|0|||
19638317|NCT00711243|42087699|FG004|Reached First Response/4 Cycles|Death|0|||
19638318|NCT00711243|42087700|FG005|Reached First Response/4 Cycles|Death|2|||
19638319|NCT00711243|42087695|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
19638320|NCT00711243|42087696|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
19638321|NCT00711243|42087697|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
19638322|NCT00711243|42087698|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
19638323|NCT00711243|42087699|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
19638324|NCT00711243|42087700|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
19638325|NCT00711243|42087695|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
19638326|NCT00711243|42087696|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
19638327|NCT00711243|42087697|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
19638328|NCT00711243|42087698|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
19638329|NCT00711243|42087699|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
19638330|NCT00711243|42087700|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
19638331|NCT00711243|42087695|FG000|Treated Cycle 5 After First Response|Death|0|||
19638332|NCT00711243|42087696|FG001|Treated Cycle 5 After First Response|Death|0|||
19638333|NCT00711243|42087697|FG002|Treated Cycle 5 After First Response|Death|0|||
19638334|NCT00711243|42087698|FG003|Treated Cycle 5 After First Response|Death|0|||
19638335|NCT00711243|42087699|FG004|Treated Cycle 5 After First Response|Death|0|||
19638336|NCT00711243|42087700|FG005|Treated Cycle 5 After First Response|Death|2|||
19638337|NCT00711243|42087695|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
19638338|NCT00711243|42087696|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
19638339|NCT00711243|42087697|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
19638340|NCT00711243|42087698|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
19638341|NCT00711243|42087699|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
19638342|NCT00711243|42087700|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
19638343|NCT00711243|42087695|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
19638344|NCT00711243|42087696|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
19638345|NCT00711243|42087697|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
19638346|NCT00711243|42087698|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
19638347|NCT00711243|42087699|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
19638348|NCT00711243|42087700|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
19638349|NCT00733226|42087718|FG000|Overall Study|Withdrawal by Subject|1|||
19638350|NCT00733226|42087719|FG001|Overall Study|Withdrawal by Subject|0|||
19638351|NCT00733226|42087718|FG000|Overall Study|Lost to Follow-up|2|||
19638352|NCT00733226|42087719|FG001|Overall Study|Lost to Follow-up|0|||
19638353|NCT00733226|42087718|FG000|Overall Study|moved to another place|2|||
19638354|NCT00733226|42087719|FG001|Overall Study|moved to another place|0|||
19638355|NCT00732992|42087727|FG000|Overall Study|Adverse Event|1|||
19638356|NCT00732992|42087728|FG001|Overall Study|Adverse Event|1|||
19638357|NCT00732992|42087727|FG000|Overall Study|Objective Progression or Relapse|3|||
19638358|NCT00732992|42087728|FG001|Overall Study|Objective Progression or Relapse|5|||
19638359|NCT00732992|42087727|FG000|Overall Study|Global Deterioration of Health Status|1|||
19638360|NCT00732992|42087728|FG001|Overall Study|Global Deterioration of Health Status|0|||
19638361|NCT00732992|42087727|FG000|Overall Study|Withdrawal by Subject|1|||
19638362|NCT00732992|42087728|FG001|Overall Study|Withdrawal by Subject|0|||
19638363|NCT00732758|42087737|FG000|Overall Study|Lost to Follow-up|8|||
19638364|NCT00732758|42087738|FG001|Overall Study|Lost to Follow-up|16|||
19638365|NCT00699153|42087746|FG000|Overall Study|Lost to Follow-up|1|||
19638366|NCT00699153|42087747|FG001|Overall Study|Lost to Follow-up|0|||
19638367|NCT00699153|42087746|FG000|Overall Study|Adverse Event|0|||
19638368|NCT00699153|42087747|FG001|Overall Study|Adverse Event|2|||
19638369|NCT00699153|42087746|FG000|Overall Study|Protocol Violation|1|||
19638370|NCT00699153|42087747|FG001|Overall Study|Protocol Violation|0|||
19638371|NCT00699153|42087746|FG000|Overall Study|Travel Problem|1|||
19638372|NCT00699153|42087747|FG001|Overall Study|Travel Problem|0|||
19638373|NCT00698997|42087755|FG000|Overall Study|Lost to Follow-up|3|||
19638374|NCT00698997|42087756|FG001|Overall Study|Lost to Follow-up|0|||
19638375|NCT00698997|42087755|FG000|Overall Study|Withdrawal by Subject|7|||
19638376|NCT00698997|42087756|FG001|Overall Study|Withdrawal by Subject|27|||
19638377|NCT00711087|42087765|FG000|Overall Study|Lost to Follow-up|1|||
19638378|NCT00711087|42087766|FG001|Overall Study|Lost to Follow-up|0|||
19638379|NCT00738530|42087774|FG000|Overall Study|Death|220|||
19638380|NCT00738530|42087775|FG001|Overall Study|Death|224|||
19638381|NCT00738530|42087774|FG000|Overall Study|Lost to Follow-up|8|||
19638382|NCT00738530|42087775|FG001|Overall Study|Lost to Follow-up|6|||
19638383|NCT00738530|42087774|FG000|Overall Study|Withdrawal by Subject|6|||
19638384|NCT00738530|42087775|FG001|Overall Study|Withdrawal by Subject|8|||
19638385|NCT00711009|42087783|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
19638386|NCT00711009|42087784|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
19638387|NCT00711009|42087783|FG000|Overall Study|Withdrawal by Subject|4|||
19638388|NCT00711009|42087784|FG001|Overall Study|Withdrawal by Subject|2|||
19638389|NCT00711009|42087783|FG000|Overall Study|Lost to Follow-up|3|||
19638390|NCT00711009|42087784|FG001|Overall Study|Lost to Follow-up|9|||
19638391|NCT00711009|42087783|FG000|Overall Study|Participant Noncompliant|0|||
19638392|NCT00711009|42087784|FG001|Overall Study|Participant Noncompliant|1|||
19638393|NCT00711009|42087783|FG000|Overall Study|Virologic Failure|2|||
19638394|NCT00711009|42087784|FG001|Overall Study|Virologic Failure|1|||
19638395|NCT00711009|42087783|FG000|Overall Study|Pregnancy|1|||
19638396|NCT00711009|42087784|FG001|Overall Study|Pregnancy|0|||
19638397|NCT00711009|42087783|FG000|Overall Study|Site closing|0|||
19638398|NCT00711009|42087784|FG001|Overall Study|Site closing|1|||
19638399|NCT00711009|42087783|FG000|Overall Study|Dose adjustment|1|||
19638400|NCT00711009|42087784|FG001|Overall Study|Dose adjustment|0|||
19638401|NCT00577005|42087792|FG000|Overall Study|Lost to Follow-up|3|||
19638402|NCT00577005|42087793|FG001|Overall Study|Lost to Follow-up|2|||
19638403|NCT00577005|42087792|FG000|Overall Study|Withdrawal by Subject|2|||
19638404|NCT00577005|42087793|FG001|Overall Study|Withdrawal by Subject|1|||
19638405|NCT00576927|42087804|FG000|Clinical Assessment|Lack of Efficacy|24|||
19638406|NCT00576927|42087804|FG000|Clinical Assessment|Death|1|||
19638407|NCT00576927|42087804|FG000|Clinical Assessment|Withdrawal by Subject|10|||
19638408|NCT00576927|42087804|FG000|Clinical Assessment|Physician Decision|1|||
19638409|NCT00576927|42087804|FG000|Baseline|Physician Decision|9|||
19638410|NCT00576927|42087804|FG000|Baseline|Medication Change by PCP of subject|1|||
19638411|NCT00576927|42087804|FG000|Baseline|Withdrawal by Subject|3|||
19638412|NCT00576927|42087804|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
19638413|NCT00576927|42087804|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
19638414|NCT00576927|42087804|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
19638415|NCT00576927|42087804|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
19638416|NCT00576927|42087804|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
19638417|NCT00698841|42087810|FG000|Overall Study|Withdrawal by Subject|2|||
19638418|NCT00698841|42087810|FG000|Overall Study|Adverse Event|3|||
19638419|NCT00698841|42087810|FG000|Overall Study|Disease progression|7|||
19638420|NCT00698841|42087810|FG000|Overall Study|Failure to meet eligibility criteria|2|||
19638421|NCT00698841|42087810|FG000|Overall Study|Study drug toxicity|2|||
19638422|NCT00698841|42087810|FG000|Overall Study|Other|2|||
19638423|NCT00577395|42087816|FG000|Overall Study|Study was terminated early by Sponsor|7|||
19638424|NCT00577395|42087817|FG001|Overall Study|Study was terminated early by Sponsor|6|||
19638425|NCT00738374|42087826|FG000|Induction Treatment Phase|Adverse Event|14|||
19638426|NCT00738374|42087827|FG001|Induction Treatment Phase|Adverse Event|0|||
19638427|NCT00738374|42087828|FG002|Induction Treatment Phase|Adverse Event|0|||
19638428|NCT00738374|42087829|FG003|Induction Treatment Phase|Adverse Event|0|||
19638429|NCT00738374|42087826|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
19638430|NCT00738374|42087827|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
19638431|NCT00738374|42087828|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
19638432|NCT00738374|42087829|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
19638433|NCT00738374|42087826|FG000|Induction Treatment Phase|Physician Decision|2|||
19638434|NCT00738374|42087827|FG001|Induction Treatment Phase|Physician Decision|0|||
19638435|NCT00738374|42087828|FG002|Induction Treatment Phase|Physician Decision|0|||
19638436|NCT00738374|42087829|FG003|Induction Treatment Phase|Physician Decision|0|||
19638437|NCT00738374|42087826|FG000|Induction Treatment Phase|Protocol Violation|2|||
19638438|NCT00738374|42087827|FG001|Induction Treatment Phase|Protocol Violation|0|||
19638439|NCT00738374|42087828|FG002|Induction Treatment Phase|Protocol Violation|0|||
19638440|NCT00738374|42087829|FG003|Induction Treatment Phase|Protocol Violation|0|||
19638441|NCT00738374|42087826|FG000|Induction Treatment Phase|Non-compliance|1|||
19638442|NCT00738374|42087827|FG001|Induction Treatment Phase|Non-compliance|0|||
19638443|NCT00738374|42087828|FG002|Induction Treatment Phase|Non-compliance|0|||
19638444|NCT00738374|42087829|FG003|Induction Treatment Phase|Non-compliance|0|||
19638445|NCT00738374|42087826|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
19638446|NCT00738374|42087827|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
19638447|NCT00738374|42087828|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
19638448|NCT00738374|42087829|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
19638449|NCT00738374|42087826|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
19638450|NCT00738374|42087827|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
19638451|NCT00738374|42087828|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
19638452|NCT00738374|42087829|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
19638453|NCT00738374|42087826|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
19638454|NCT00738374|42087827|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
19638455|NCT00738374|42087828|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
19638456|NCT00738374|42087829|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
19638457|NCT00738374|42087826|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
19638458|NCT00738374|42087827|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
19638459|NCT00738374|42087828|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
19638460|NCT00738374|42087829|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
19638461|NCT00738374|42087826|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
19638462|NCT00738374|42087827|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
19638463|NCT00738374|42087828|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
19638464|NCT00738374|42087829|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
19638465|NCT00738374|42087826|FG000|Maintenance Treatment/Observation Phase|Other|0|||
19638466|NCT00738374|42087827|FG001|Maintenance Treatment/Observation Phase|Other|1|||
19638467|NCT00738374|42087828|FG002|Maintenance Treatment/Observation Phase|Other|0|||
19638468|NCT00738374|42087829|FG003|Maintenance Treatment/Observation Phase|Other|0|||
19638469|NCT00697593|42087838|FG000|Overall Study|Adverse Event|3|||
19638470|NCT00697593|42087838|FG000|Overall Study|Protocol Violation|1|||
19638471|NCT00697593|42087838|FG000|Overall Study|Lack of Efficacy|3|||
19638472|NCT00697593|42087838|FG000|Overall Study|Suspension of the study by sponsor|12|||
19638473|NCT00697515|42087842|FG000|Dose Optimization Period|Adverse Event|4|||
19638474|NCT00697515|42087843|FG001|Dose Optimization Period|Adverse Event|0|||
19638475|NCT00697515|42087842|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
19638476|NCT00697515|42087843|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
19638477|NCT00697515|42087842|FG000|Dose Optimization Period|Lost to Follow-up|2|||
19638478|NCT00697515|42087843|FG001|Dose Optimization Period|Lost to Follow-up|0|||
19638479|NCT00697515|42087842|FG000|Dose Optimization Period|sponsor request|2|||
19638480|NCT00697515|42087843|FG001|Dose Optimization Period|sponsor request|0|||
19638481|NCT00697515|42087842|FG000|Dose Optimization Period|called to active duty|1|||
19638482|NCT00697515|42087843|FG001|Dose Optimization Period|called to active duty|0|||
19638483|NCT00697515|42087842|FG000|Dose Optimization Period|elevated QTc|1|||
19638484|NCT00697515|42087843|FG001|Dose Optimization Period|elevated QTc|0|||
19638485|NCT00697515|42087842|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
19638486|NCT00697515|42087843|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
19638487|NCT00697515|42087842|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
19638488|NCT00697515|42087843|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
19638489|NCT00697515|42087842|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
19638490|NCT00697515|42087843|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
19638491|NCT00697515|42087842|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
19638492|NCT00697515|42087843|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
19638493|NCT00738062|42087852|FG000|Open Label Treatment|Lack of Efficacy|5|||
19638494|NCT00738062|42087853|FG001|Open Label Treatment|Lack of Efficacy|0|||
19638495|NCT00738062|42087854|FG002|Open Label Treatment|Lack of Efficacy|0|||
19638496|NCT00738062|42087852|FG000|Open Label Treatment|Adverse Event|11|||
19638497|NCT00738062|42087853|FG001|Open Label Treatment|Adverse Event|0|||
19725602|NCT04537806|42169364|FG000|Overall Study|Randomized but not treated|1|||
19638498|NCT00738062|42087854|FG002|Open Label Treatment|Adverse Event|0|||
19638499|NCT00738062|42087852|FG000|Open Label Treatment|Protocol Violation|2|||
19638500|NCT00738062|42087853|FG001|Open Label Treatment|Protocol Violation|0|||
19638501|NCT00738062|42087854|FG002|Open Label Treatment|Protocol Violation|0|||
19638502|NCT00738062|42087852|FG000|Open Label Treatment|Withdrawal by Subject|9|||
19638503|NCT00738062|42087853|FG001|Open Label Treatment|Withdrawal by Subject|0|||
19638504|NCT00738062|42087854|FG002|Open Label Treatment|Withdrawal by Subject|0|||
19638505|NCT00738062|42087852|FG000|Open Label Treatment|Investigator Decision|1|||
19638506|NCT00738062|42087853|FG001|Open Label Treatment|Investigator Decision|0|||
19638507|NCT00738062|42087854|FG002|Open Label Treatment|Investigator Decision|0|||
19638508|NCT00738062|42087852|FG000|Open-Label Extension|Adverse Event|5|||
19638509|NCT00738062|42087853|FG001|Open-Label Extension|Adverse Event|0|||
19638510|NCT00738062|42087854|FG002|Open-Label Extension|Adverse Event|0|||
19638511|NCT00738062|42087852|FG000|Open-Label Extension|Physician Decision|1|||
19638512|NCT00738062|42087853|FG001|Open-Label Extension|Physician Decision|0|||
19638513|NCT00738062|42087854|FG002|Open-Label Extension|Physician Decision|0|||
19638514|NCT00738062|42087852|FG000|Open-Label Extension|Lack of Efficacy|2|||
19638515|NCT00738062|42087853|FG001|Open-Label Extension|Lack of Efficacy|0|||
19638516|NCT00738062|42087854|FG002|Open-Label Extension|Lack of Efficacy|0|||
19638517|NCT00738062|42087852|FG000|Open-Label Extension|Withdrawal by Subject|6|||
19638518|NCT00738062|42087853|FG001|Open-Label Extension|Withdrawal by Subject|0|||
19638519|NCT00738062|42087854|FG002|Open-Label Extension|Withdrawal by Subject|0|||
19638520|NCT00738062|42087852|FG000|Open-Label Extension|Protocol Violation|1|||
19638521|NCT00738062|42087853|FG001|Open-Label Extension|Protocol Violation|0|||
19638522|NCT00738062|42087854|FG002|Open-Label Extension|Protocol Violation|0|||
19638523|NCT00738062|42087852|FG000|Open-Label Extension|Study Terminated|2|||
19638524|NCT00738062|42087853|FG001|Open-Label Extension|Study Terminated|0|||
19638525|NCT00738062|42087854|FG002|Open-Label Extension|Study Terminated|0|||
19638526|NCT04245345|42087863|FG000|Overall Study|Death|1|||
19638527|NCT04245345|42087863|FG000|Overall Study|Exited prior to implant|5|||
19638528|NCT04245345|42087863|FG000|Overall Study|Exited prior to 1-month|9|||
19638529|NCT04245345|42087863|FG000|Overall Study|Missed 1-month visit|3|||
19638530|NCT04245345|42087863|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
19638531|NCT04245345|42087863|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
19638532|NCT00698685|42087869|FG000|Overall Study|Sister withdrew as donor|1|||
19638533|NCT00698685|42087869|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
19638534|NCT00737672|42087875|FG000|Overall Study|Graft Abandonment|48|||
19638535|NCT00737672|42087876|FG001|Overall Study|Graft Abandonment|56|||
19638536|NCT00737672|42087875|FG000|Overall Study|Death|23|||
19638537|NCT00737672|42087876|FG001|Overall Study|Death|22|||
19638538|NCT00737672|42087875|FG000|Overall Study|Withdrawal by Subject|1|||
19638539|NCT00737672|42087876|FG001|Overall Study|Withdrawal by Subject|2|||
19638540|NCT00737672|42087875|FG000|Overall Study|Lost to Follow-up|1|||
19638541|NCT00737672|42087876|FG001|Overall Study|Lost to Follow-up|0|||
19638542|NCT00737672|42087875|FG000|Overall Study|Miscellaneous|7|||
19638543|NCT00737672|42087876|FG001|Overall Study|Miscellaneous|1|||
19638544|NCT00737672|42087875|FG000|Overall Study|Physician Decision|0|||
19638545|NCT00737672|42087876|FG001|Overall Study|Physician Decision|2|||
19638546|NCT00737438|42087882|FG000|Overall Study|Withdrawal by Subject|2|||
19638547|NCT00737438|42087882|FG000|Overall Study|Patient ineligible|1|||
19638548|NCT00737282|42087888|FG000|Overall Study|Study prematurely terminated|175|||
19638549|NCT03884478|42087897|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
19638550|NCT03884478|42087898|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
19638551|NCT03884478|42087899|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
19638552|NCT03884478|42087897|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
19638553|NCT03884478|42087898|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
19638554|NCT03884478|42087899|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
19638555|NCT03884478|42087897|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
19638556|NCT03884478|42087898|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
19638557|NCT03884478|42087899|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
19638558|NCT03884478|42087897|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
19638559|NCT03884478|42087898|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
19638560|NCT03884478|42087899|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
19638561|NCT00582816|42087920|FG000|Overall Study|Engraftment Failure|3|||
19638562|NCT00737048|42087927|FG000|Overall Study|Physician Decision|0|||
19638563|NCT00737048|42087928|FG001|Overall Study|Physician Decision|0|||
19638564|NCT00737048|42087929|FG002|Overall Study|Physician Decision|1|||
19638565|NCT00737048|42087927|FG000|Overall Study|Adverse Event|0|||
19638566|NCT00737048|42087928|FG001|Overall Study|Adverse Event|1|||
19638567|NCT00737048|42087929|FG002|Overall Study|Adverse Event|0|||
19638568|NCT00737048|42087927|FG000|Overall Study|Worsening of the symptoms|3|||
19638569|NCT00737048|42087928|FG001|Overall Study|Worsening of the symptoms|5|||
19376361|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
19638570|NCT00737048|42087929|FG002|Overall Study|Worsening of the symptoms|3|||
19638571|NCT00731822|42087939|FG000|Overall Study|Adverse Event|2|||
19638572|NCT00731822|42087940|FG001|Overall Study|Adverse Event|1|||
19638573|NCT00731822|42087939|FG000|Overall Study|Protocol Violation|1|||
19638574|NCT00731822|42087940|FG001|Overall Study|Protocol Violation|0|||
19638575|NCT00731822|42087939|FG000|Overall Study|Lost to Follow-up|1|||
19638576|NCT00731822|42087940|FG001|Overall Study|Lost to Follow-up|0|||
19638577|NCT00731666|42087946|FG000|Overall Study|Adverse Event|2|||
19638578|NCT00731666|42087946|FG000|Overall Study|Lost to Follow-up|8|||
19638579|NCT00731666|42087946|FG000|Overall Study|Withdrawal by Subject|2|||
19638580|NCT00731120|42087953|FG000|Overall Study|Adverse Event|7|||
19638581|NCT00731120|42087954|FG001|Overall Study|Adverse Event|6|||
19638582|NCT00731120|42087955|FG002|Overall Study|Adverse Event|8|||
19638583|NCT00731120|42087953|FG000|Overall Study|Lack of Efficacy|4|||
19638584|NCT00731120|42087954|FG001|Overall Study|Lack of Efficacy|5|||
19638585|NCT00731120|42087955|FG002|Overall Study|Lack of Efficacy|4|||
19638586|NCT00731120|42087953|FG000|Overall Study|Noncompliance with Study Drug|3|||
19638587|NCT00731120|42087954|FG001|Overall Study|Noncompliance with Study Drug|3|||
19638588|NCT00731120|42087955|FG002|Overall Study|Noncompliance with Study Drug|1|||
19638589|NCT00731120|42087953|FG000|Overall Study|Protocol Deviations|1|||
19638590|NCT00731120|42087954|FG001|Overall Study|Protocol Deviations|6|||
19638591|NCT00731120|42087955|FG002|Overall Study|Protocol Deviations|1|||
19638592|NCT00731120|42087953|FG000|Overall Study|Withdrawal of Consent|13|||
19638593|NCT00731120|42087954|FG001|Overall Study|Withdrawal of Consent|8|||
19638594|NCT00731120|42087955|FG002|Overall Study|Withdrawal of Consent|4|||
19638595|NCT00731120|42087953|FG000|Overall Study|Lost to Follow-up|10|||
19638596|NCT00731120|42087954|FG001|Overall Study|Lost to Follow-up|15|||
19638597|NCT00731120|42087955|FG002|Overall Study|Lost to Follow-up|17|||
19638598|NCT00731120|42087953|FG000|Overall Study|Other|4|||
19638599|NCT00731120|42087954|FG001|Overall Study|Other|0|||
19638600|NCT00731120|42087955|FG002|Overall Study|Other|1|||
19638601|NCT00731042|42087965|FG000|Second Intervention|Did not meet inclusion criteria|0|||
19638602|NCT00731042|42087966|FG001|Second Intervention|Did not meet inclusion criteria|2|||
19638603|NCT00726986|42087972|FG000|Induction Phase|Adverse Event|4|||
19638604|NCT00726986|42087972|FG000|Induction Phase|Withdrawal by Subject|2|||
19638605|NCT00726986|42087972|FG000|Induction Phase|Death|2|||
19638606|NCT00726986|42087972|FG000|Induction Phase|Lack of Efficacy|5|||
19638607|NCT00726986|42087972|FG000|Induction Phase|Secondary Disease|2|||
19638608|NCT00726986|42087972|FG000|Maintenance Phase|Adverse Event|1|||
19638609|NCT00726986|42087972|FG000|Maintenance Phase|Lack of Efficacy|2|||
19638610|NCT00696657|42087985|FG000|Overall Study|Protocol Violation|0|||
19638611|NCT00696657|42087986|FG001|Overall Study|Protocol Violation|0|||
19638612|NCT00696657|42087987|FG002|Overall Study|Protocol Violation|0|||
19638613|NCT00696657|42087988|FG003|Overall Study|Protocol Violation|0|||
19638614|NCT00696657|42087989|FG004|Overall Study|Protocol Violation|0|||
19638615|NCT00696657|42087990|FG005|Overall Study|Protocol Violation|1|||
19638616|NCT00696657|42087991|FG006|Overall Study|Protocol Violation|0|||
19638617|NCT00696657|42087992|FG007|Overall Study|Protocol Violation|0|||
19638618|NCT00696657|42087993|FG008|Overall Study|Protocol Violation|1|||
19638619|NCT00696657|42087985|FG000|Overall Study|Lack of Efficacy|0|||
19638620|NCT00696657|42087986|FG001|Overall Study|Lack of Efficacy|1|||
19638621|NCT00696657|42087987|FG002|Overall Study|Lack of Efficacy|0|||
19638622|NCT00696657|42087988|FG003|Overall Study|Lack of Efficacy|0|||
19638623|NCT00696657|42087989|FG004|Overall Study|Lack of Efficacy|0|||
19638624|NCT00696657|42087990|FG005|Overall Study|Lack of Efficacy|0|||
19638625|NCT00696657|42087991|FG006|Overall Study|Lack of Efficacy|0|||
19638626|NCT00696657|42087992|FG007|Overall Study|Lack of Efficacy|0|||
19638627|NCT00696657|42087993|FG008|Overall Study|Lack of Efficacy|0|||
19638628|NCT00696657|42087985|FG000|Overall Study|Withdrawal criteria|1|||
19638629|NCT00696657|42087986|FG001|Overall Study|Withdrawal criteria|3|||
19638630|NCT00696657|42087987|FG002|Overall Study|Withdrawal criteria|2|||
19638631|NCT00696657|42087988|FG003|Overall Study|Withdrawal criteria|2|||
19638632|NCT00696657|42087989|FG004|Overall Study|Withdrawal criteria|0|||
19638633|NCT00696657|42087990|FG005|Overall Study|Withdrawal criteria|0|||
19638634|NCT00696657|42087991|FG006|Overall Study|Withdrawal criteria|1|||
19638635|NCT00696657|42087992|FG007|Overall Study|Withdrawal criteria|1|||
19638636|NCT00696657|42087993|FG008|Overall Study|Withdrawal criteria|2|||
19638637|NCT00696657|42087985|FG000|Overall Study|Unclassified|0|||
19725603|NCT04537806|42169365|FG001|Overall Study|Randomized but not treated|0|||
19725604|NCT04537806|42169364|FG000|Overall Study|Adverse Event|1|||
19725605|NCT04537806|42169365|FG001|Overall Study|Adverse Event|1|||
19390315|NCT01987960|41634111|FG001|Period 1|Adverse Event|0|||
19638638|NCT00696657|42087986|FG001|Overall Study|Unclassified|1|||
19638639|NCT00696657|42087987|FG002|Overall Study|Unclassified|3|||
19638640|NCT00696657|42087988|FG003|Overall Study|Unclassified|2|||
19638641|NCT00696657|42087989|FG004|Overall Study|Unclassified|4|||
19638642|NCT00696657|42087990|FG005|Overall Study|Unclassified|2|||
19638643|NCT00696657|42087991|FG006|Overall Study|Unclassified|0|||
19638644|NCT00696657|42087992|FG007|Overall Study|Unclassified|0|||
19638645|NCT00696657|42087993|FG008|Overall Study|Unclassified|1|||
19638646|NCT00696657|42087985|FG000|Overall Study|Adverse Event|0|||
19638647|NCT00696657|42087986|FG001|Overall Study|Adverse Event|0|||
19638648|NCT00696657|42087987|FG002|Overall Study|Adverse Event|3|||
19638649|NCT00696657|42087988|FG003|Overall Study|Adverse Event|7|||
19638650|NCT00696657|42087989|FG004|Overall Study|Adverse Event|6|||
19638651|NCT00696657|42087990|FG005|Overall Study|Adverse Event|9|||
19638652|NCT00696657|42087991|FG006|Overall Study|Adverse Event|14|||
19638653|NCT00696657|42087992|FG007|Overall Study|Adverse Event|2|||
19638654|NCT00696657|42087993|FG008|Overall Study|Adverse Event|5|||
19638655|NCT00730886|42088015|FG000|Overall Study|Lost to Follow-up|1|||
19638656|NCT00730886|42088016|FG001|Overall Study|Lost to Follow-up|0|||
19638657|NCT00730886|42088015|FG000|Overall Study|Physician Decision|1|||
19638658|NCT00730886|42088016|FG001|Overall Study|Physician Decision|0|||
19638659|NCT00726752|42088022|FG000|Overall Study|Lack of Efficacy|6|||
19638660|NCT00730028|42088040|FG000|Overall Study|Adverse Event|23|||
19638661|NCT00730028|42088041|FG001|Overall Study|Adverse Event|26|||
19638662|NCT00730028|42088042|FG002|Overall Study|Adverse Event|16|||
19638663|NCT00730028|42088043|FG003|Overall Study|Adverse Event|20|||
19638664|NCT00730028|42088044|FG004|Overall Study|Adverse Event|43|||
19638665|NCT00730028|42088040|FG000|Overall Study|Lost to Follow-up|13|||
19638666|NCT00730028|42088041|FG001|Overall Study|Lost to Follow-up|26|||
19638667|NCT00730028|42088042|FG002|Overall Study|Lost to Follow-up|22|||
19638668|NCT00730028|42088043|FG003|Overall Study|Lost to Follow-up|26|||
19638669|NCT00730028|42088044|FG004|Overall Study|Lost to Follow-up|25|||
19638670|NCT00730028|42088040|FG000|Overall Study|Protocol Violation|6|||
19638671|NCT00730028|42088041|FG001|Overall Study|Protocol Violation|1|||
19638672|NCT00730028|42088042|FG002|Overall Study|Protocol Violation|1|||
19638673|NCT00730028|42088043|FG003|Overall Study|Protocol Violation|2|||
19638674|NCT00730028|42088044|FG004|Overall Study|Protocol Violation|0|||
19638675|NCT00730028|42088040|FG000|Overall Study|Withdrawal by Subject|9|||
19638676|NCT00730028|42088041|FG001|Overall Study|Withdrawal by Subject|5|||
19638677|NCT00730028|42088042|FG002|Overall Study|Withdrawal by Subject|4|||
19638678|NCT00730028|42088043|FG003|Overall Study|Withdrawal by Subject|5|||
19638679|NCT00730028|42088044|FG004|Overall Study|Withdrawal by Subject|9|||
19638680|NCT00730028|42088040|FG000|Overall Study|Physician Decision|3|||
19638681|NCT00730028|42088041|FG001|Overall Study|Physician Decision|3|||
19638682|NCT00730028|42088042|FG002|Overall Study|Physician Decision|2|||
19638683|NCT00730028|42088043|FG003|Overall Study|Physician Decision|3|||
19638684|NCT00730028|42088044|FG004|Overall Study|Physician Decision|2|||
19638685|NCT00730028|42088040|FG000|Overall Study|Treatment Failure|5|||
19638686|NCT00730028|42088041|FG001|Overall Study|Treatment Failure|5|||
19638687|NCT00730028|42088042|FG002|Overall Study|Treatment Failure|0|||
19638688|NCT00730028|42088043|FG003|Overall Study|Treatment Failure|0|||
19638689|NCT00730028|42088044|FG004|Overall Study|Treatment Failure|1|||
19638690|NCT00730028|42088040|FG000|Overall Study|Randomization Error|1|||
19638691|NCT00730028|42088041|FG001|Overall Study|Randomization Error|0|||
19638692|NCT00730028|42088042|FG002|Overall Study|Randomization Error|0|||
19638693|NCT00730028|42088043|FG003|Overall Study|Randomization Error|0|||
19638694|NCT00730028|42088044|FG004|Overall Study|Randomization Error|2|||
19638695|NCT00736502|42088056|FG000|Overall Study|Adverse Event|22|||
19638696|NCT00736502|42088056|FG000|Overall Study|Lack of Efficacy|16|||
19638697|NCT00736502|42088056|FG000|Overall Study|Lost to Follow-up|27|||
19638698|NCT00729560|42088060|FG000|Overall Study|Withdrawal by Subject|3|||
19638699|NCT00736190|42088064|FG000|Overall Study|Pregnancy|1|||
19638700|NCT00736190|42088064|FG000|Overall Study|Withdrawal by Subject|1|||
19638701|NCT00736190|42088064|FG000|Overall Study|Adverse Event|1|||
19638702|NCT00729326|42088070|FG000|Overall Study|Lost to Follow-up|2|||
19638703|NCT00729326|42088071|FG001|Overall Study|Lost to Follow-up|0|||
19638704|NCT00729326|42088070|FG000|Overall Study|Physician Decision|0|||
19638705|NCT00729326|42088071|FG001|Overall Study|Physician Decision|1|||
19638706|NCT00729326|42088070|FG000|Overall Study|Protocol Violation|3|||
19638707|NCT00729326|42088071|FG001|Overall Study|Protocol Violation|2|||
19638708|NCT00729326|42088070|FG000|Overall Study|Subject Decision|4|||
19638709|NCT00729326|42088071|FG001|Overall Study|Subject Decision|4|||
19638710|NCT00729326|42088070|FG000|Overall Study|Sponsor Decision|1|||
19638711|NCT00729326|42088071|FG001|Overall Study|Sponsor Decision|2|||
19638712|NCT00729248|42088077|FG000|Overall Study|Physician Decision|2|||
19638713|NCT00696423|42088084|FG000|Overall Study|Lost to Follow-up|0|||
19638714|NCT00696423|42088085|FG001|Overall Study|Lost to Follow-up|5|||
19638715|NCT00736034|42088091|FG000|Overall Study|Adverse Event|2|||
19638716|NCT00576693|42088097|FG000|Overall Study|Lost to Follow-up|7|||
19638717|NCT00576693|42088098|FG001|Overall Study|Lost to Follow-up|11|||
19638718|NCT00576693|42088097|FG000|Overall Study|Withdrawal by Subject|3|||
19638719|NCT00576693|42088098|FG001|Overall Study|Withdrawal by Subject|13|||
19638720|NCT00698451|42088104|FG000|Overall Study|Adverse Event|22|||
19638721|NCT00698451|42088104|FG000|Overall Study|Physician Decision|2|||
19638722|NCT00698451|42088104|FG000|Overall Study|Protocol Violation|6|||
19638723|NCT00698451|42088104|FG000|Overall Study|Withdrawal by Subject|6|||
19638724|NCT00698451|42088104|FG000|Overall Study|Disease progression|3|||
19638725|NCT00697827|42088110|FG000|Overall Study|enrolled but not treated|2|||
19638726|NCT00697827|42088111|FG001|Overall Study|enrolled but not treated|1|||
19638727|NCT00728936|42088124|FG000|Overall Study|Withdrawal by Subject|0|||
19638728|NCT00728936|42088125|FG001|Overall Study|Withdrawal by Subject|0|||
19638729|NCT00728936|42088126|FG002|Overall Study|Withdrawal by Subject|0|||
19638730|NCT00728936|42088127|FG003|Overall Study|Withdrawal by Subject|0|||
19638731|NCT00728936|42088128|FG004|Overall Study|Withdrawal by Subject|0|||
19638732|NCT00728936|42088129|FG005|Overall Study|Withdrawal by Subject|1|||
19638733|NCT00728936|42088130|FG006|Overall Study|Withdrawal by Subject|0|||
19638734|NCT00693693|42088149|FG000|Overall Study|Lost to Follow-up|1|||
19638735|NCT00693693|42088150|FG001|Overall Study|Lost to Follow-up|1|||
19638736|NCT00693693|42088151|FG002|Overall Study|Lost to Follow-up|2|||
19638737|NCT00728468|42088159|FG000|Overall Study|Enrolled but not treated|1|||
19638738|NCT00728468|42088159|FG000|Overall Study|Death|1|||
19638739|NCT00728468|42088159|FG000|Overall Study|Protocol Violation|4|||
19638740|NCT00728468|42088159|FG000|Overall Study|Objective progression or relapse|9|||
19638741|NCT00728468|42088159|FG000|Overall Study|Study terminated by sponsor|1|||
19638742|NCT00727844|42088165|FG000|Initial Randomization|Physician Decision|2|||
19638743|NCT00727844|42088166|FG001|Initial Randomization|Physician Decision|0|||
19638744|NCT00727844|42088167|FG002|Initial Randomization|Physician Decision|0|||
19638745|NCT00727844|42088168|FG003|Initial Randomization|Physician Decision|0|||
19638746|NCT00735878|42088176|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
19638747|NCT00735878|42088177|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
19638748|NCT00735878|42088178|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
19638749|NCT00695955|42088189|FG000|Cohort 1|Adverse Event|26|||
19638750|NCT00695955|42088189|FG000|Cohort 1|Protocol Violation|2|||
19638751|NCT00695955|42088189|FG000|Cohort 1|Lost to Follow-up|30|||
19638752|NCT00695955|42088189|FG000|Cohort 1|Withdrawal by Subject|25|||
19638753|NCT00695955|42088189|FG000|Cohort 1|Lack of Efficacy|3|||
19638754|NCT00695955|42088189|FG000|Cohort 1|Other|16|||
19638755|NCT00695955|42088189|FG000|Cohort 2|Adverse Event|24|||
19638756|NCT00695955|42088189|FG000|Cohort 2|Protocol Violation|5|||
19638757|NCT00695955|42088189|FG000|Cohort 2|Lost to Follow-up|38|||
19638758|NCT00695955|42088189|FG000|Cohort 2|Withdrawal by Subject|28|||
19638759|NCT00695955|42088189|FG000|Cohort 2|Lack of Efficacy|4|||
19638760|NCT00695955|42088189|FG000|Cohort 2|Other|5|||
19638761|NCT00693225|42088197|FG000|Overall Study|Lost to Follow-up|1|||
19638762|NCT00693225|42088198|FG001|Overall Study|Lost to Follow-up|2|||
19638763|NCT00693225|42088197|FG000|Overall Study|Adverse Event|1|||
19638764|NCT00693225|42088198|FG001|Overall Study|Adverse Event|3|||
19638765|NCT00735644|42088209|FG000|Overall Study|Did not receive study vaccine|0|||
19638766|NCT00735644|42088210|FG001|Overall Study|Did not receive study vaccine|1|||
19638767|NCT00735644|42088211|FG002|Overall Study|Did not receive study vaccine|0|||
19638768|NCT00735644|42088212|FG003|Overall Study|Did not receive study vaccine|0|||
19638769|NCT00735644|42088213|FG004|Overall Study|Did not receive study vaccine|0|||
19638770|NCT00735644|42088209|FG000|Overall Study|Withdrawal by Subject|0|||
19638771|NCT00735644|42088210|FG001|Overall Study|Withdrawal by Subject|1|||
19638772|NCT00735644|42088211|FG002|Overall Study|Withdrawal by Subject|1|||
19638773|NCT00735644|42088212|FG003|Overall Study|Withdrawal by Subject|1|||
19638774|NCT00735644|42088213|FG004|Overall Study|Withdrawal by Subject|0|||
19638775|NCT03718299|42088232|FG000|Overall Study|Adverse Event|1|||
19638776|NCT03718299|42088232|FG000|Overall Study|Withdrawal by Subject|6|||
19638777|NCT03718299|42088232|FG000|Overall Study|Physician Decision|2|||
19638778|NCT03718299|42088232|FG000|Overall Study|Lost to Follow-up|1|||
19638779|NCT00724958|42088236|FG000|Overall Study|Adverse Event|28|||
19638780|NCT00724958|42088236|FG000|Overall Study|Loss of Response|40|||
19638781|NCT00724958|42088236|FG000|Overall Study|No Response|18|||
19638782|NCT00724958|42088236|FG000|Overall Study|Remission|7|||
19638783|NCT00724958|42088236|FG000|Overall Study|Other Reason|76|||
19638784|NCT00724958|42088236|FG000|Overall Study|No documentation for end of therapy|13|||
19638785|NCT00695565|42088242|FG000|Overall Study|Lost to Follow-up|4|||
19638786|NCT00695565|42088243|FG001|Overall Study|Lost to Follow-up|4|||
19638787|NCT00695565|42088242|FG000|Overall Study|Adverse Event|3|||
19638788|NCT00695565|42088243|FG001|Overall Study|Adverse Event|1|||
19638789|NCT00695565|42088242|FG000|Overall Study|Protocol Violation|3|||
19638790|NCT00695565|42088243|FG001|Overall Study|Protocol Violation|1|||
19638791|NCT00695565|42088242|FG000|Overall Study|Withdrawal by Subject|1|||
19638792|NCT00695565|42088243|FG001|Overall Study|Withdrawal by Subject|1|||
19638793|NCT00695565|42088242|FG000|Overall Study|Lack of Efficacy|1|||
19638794|NCT00695565|42088243|FG001|Overall Study|Lack of Efficacy|1|||
19638795|NCT00695565|42088242|FG000|Overall Study|Subject did not follow instructions|1|||
19638796|NCT00695565|42088243|FG001|Overall Study|Subject did not follow instructions|1|||
19638797|NCT00727532|42088249|FG000|Overall Study|Adverse Event|1|||
19638798|NCT00727532|42088249|FG000|Overall Study|Withdrawal by Subject|1|||
19638799|NCT00721214|42088253|FG000|Overall Study|Chose another center for transplant|1|||
19638800|NCT00721214|42088253|FG000|Overall Study|Death|3|||
19638801|NCT00720902|42088259|FG000|Overall Study|Withdrawal by Subject|1|||
19638802|NCT00720902|42088260|FG001|Overall Study|Withdrawal by Subject|0|||
19638803|NCT00720902|42088259|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
19638804|NCT00720902|42088260|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
19638805|NCT00695019|42088269|FG000|Overall Study|Withdrawal by Subject|8|||
19638806|NCT00695019|42088270|FG001|Overall Study|Withdrawal by Subject|6|||
19638807|NCT00695019|42088271|FG002|Overall Study|Withdrawal by Subject|4|||
19638808|NCT00695019|42088269|FG000|Overall Study|Protocol Violation|1|||
19638809|NCT00695019|42088270|FG001|Overall Study|Protocol Violation|3|||
19638810|NCT00695019|42088271|FG002|Overall Study|Protocol Violation|1|||
19638811|NCT00695019|42088269|FG000|Overall Study|Lack of Efficacy|0|||
19638812|NCT00695019|42088270|FG001|Overall Study|Lack of Efficacy|0|||
19638813|NCT00695019|42088271|FG002|Overall Study|Lack of Efficacy|1|||
19638814|NCT00695019|42088269|FG000|Overall Study|Various|4|||
19638815|NCT00695019|42088270|FG001|Overall Study|Various|5|||
19638816|NCT00695019|42088271|FG002|Overall Study|Various|4|||
19638817|NCT00694707|42088284|FG000|Overall Study|Did Not Receive Treatment|0|||
19638818|NCT00694707|42088285|FG001|Overall Study|Did Not Receive Treatment|0|||
19638819|NCT00694707|42088286|FG002|Overall Study|Did Not Receive Treatment|1|||
19638820|NCT00694707|42088287|FG003|Overall Study|Did Not Receive Treatment|1|||
19638821|NCT00694707|42088288|FG004|Overall Study|Did Not Receive Treatment|1|||
19638822|NCT00694707|42088284|FG000|Overall Study|Adverse Event|22|||
19638823|NCT00694707|42088285|FG001|Overall Study|Adverse Event|14|||
19638824|NCT00694707|42088286|FG002|Overall Study|Adverse Event|8|||
19638825|NCT00694707|42088287|FG003|Overall Study|Adverse Event|12|||
19638826|NCT00694707|42088288|FG004|Overall Study|Adverse Event|13|||
19638827|NCT00694707|42088284|FG000|Overall Study|Insufficient Therapeutic Response|33|||
19638828|NCT00694707|42088285|FG001|Overall Study|Insufficient Therapeutic Response|18|||
19638829|NCT00694707|42088286|FG002|Overall Study|Insufficient Therapeutic Response|17|||
19638830|NCT00694707|42088287|FG003|Overall Study|Insufficient Therapeutic Response|15|||
19638831|NCT00694707|42088288|FG004|Overall Study|Insufficient Therapeutic Response|10|||
19638832|NCT00694707|42088284|FG000|Overall Study|Protocol Violation|1|||
19638833|NCT00694707|42088285|FG001|Overall Study|Protocol Violation|2|||
19638834|NCT00694707|42088286|FG002|Overall Study|Protocol Violation|1|||
19638835|NCT00694707|42088287|FG003|Overall Study|Protocol Violation|3|||
19638836|NCT00694707|42088288|FG004|Overall Study|Protocol Violation|1|||
19638837|NCT00694707|42088284|FG000|Overall Study|Withdrawal of Consent|14|||
19638838|NCT00694707|42088285|FG001|Overall Study|Withdrawal of Consent|18|||
19638839|NCT00694707|42088286|FG002|Overall Study|Withdrawal of Consent|22|||
19638840|NCT00694707|42088287|FG003|Overall Study|Withdrawal of Consent|16|||
19638841|NCT00694707|42088288|FG004|Overall Study|Withdrawal of Consent|15|||
19638842|NCT00694707|42088284|FG000|Overall Study|Lost to Follow-up|0|||
19638843|NCT00694707|42088285|FG001|Overall Study|Lost to Follow-up|1|||
19638844|NCT00694707|42088286|FG002|Overall Study|Lost to Follow-up|2|||
19638845|NCT00694707|42088287|FG003|Overall Study|Lost to Follow-up|0|||
19638846|NCT00694707|42088288|FG004|Overall Study|Lost to Follow-up|0|||
19638847|NCT00694707|42088284|FG000|Overall Study|Jeopardizing Parole Status|1|||
19638848|NCT00694707|42088285|FG001|Overall Study|Jeopardizing Parole Status|0|||
19638849|NCT00694707|42088286|FG002|Overall Study|Jeopardizing Parole Status|0|||
19638850|NCT00694707|42088287|FG003|Overall Study|Jeopardizing Parole Status|0|||
19638851|NCT00694707|42088288|FG004|Overall Study|Jeopardizing Parole Status|0|||
19638852|NCT00694707|42088284|FG000|Overall Study|Death in the Family|1|||
19638853|NCT00694707|42088285|FG001|Overall Study|Death in the Family|0|||
19638854|NCT00694707|42088286|FG002|Overall Study|Death in the Family|0|||
19638855|NCT00694707|42088287|FG003|Overall Study|Death in the Family|0|||
19638856|NCT00694707|42088288|FG004|Overall Study|Death in the Family|0|||
19638857|NCT00694707|42088284|FG000|Overall Study|Arrest by Police|0|||
19638858|NCT00694707|42088285|FG001|Overall Study|Arrest by Police|1|||
19638859|NCT00694707|42088286|FG002|Overall Study|Arrest by Police|0|||
19638860|NCT00694707|42088287|FG003|Overall Study|Arrest by Police|0|||
19638861|NCT00694707|42088288|FG004|Overall Study|Arrest by Police|0|||
19638862|NCT00694707|42088284|FG000|Overall Study|Administrative Reasons|0|||
19638863|NCT00694707|42088285|FG001|Overall Study|Administrative Reasons|1|||
19638864|NCT00694707|42088286|FG002|Overall Study|Administrative Reasons|0|||
19638865|NCT00694707|42088287|FG003|Overall Study|Administrative Reasons|2|||
19638866|NCT00694707|42088288|FG004|Overall Study|Administrative Reasons|0|||
19638867|NCT00694707|42088284|FG000|Overall Study|Notification of Past Head Injury|0|||
19638868|NCT00694707|42088285|FG001|Overall Study|Notification of Past Head Injury|0|||
19638869|NCT00694707|42088286|FG002|Overall Study|Notification of Past Head Injury|0|||
19638870|NCT00694707|42088287|FG003|Overall Study|Notification of Past Head Injury|1|||
19638871|NCT00694707|42088288|FG004|Overall Study|Notification of Past Head Injury|0|||
19638872|NCT00692913|42088302|FG000|Overall Study|Adverse Event|8|||
19638873|NCT00692913|42088303|FG001|Overall Study|Adverse Event|4|||
19638874|NCT00692913|42088302|FG000|Overall Study|Lost to Follow-up|3|||
19638875|NCT00692913|42088303|FG001|Overall Study|Lost to Follow-up|5|||
19638876|NCT00692913|42088302|FG000|Overall Study|Physician Decision|2|||
19638877|NCT00692913|42088303|FG001|Overall Study|Physician Decision|0|||
19638878|NCT00692913|42088302|FG000|Overall Study|Protocol Violation|1|||
19638879|NCT00692913|42088303|FG001|Overall Study|Protocol Violation|1|||
19638880|NCT00692913|42088302|FG000|Overall Study|Withdrawal by Subject|15|||
19638881|NCT00692913|42088303|FG001|Overall Study|Withdrawal by Subject|20|||
19638882|NCT00694551|42088312|FG000|Overall Study|Disease Progression|1|||
19638883|NCT00694551|42088313|FG001|Overall Study|Disease Progression|0|||
19638884|NCT00694551|42088314|FG002|Overall Study|Disease Progression|1|||
19638885|NCT00689871|42088327|FG000|Overall Study|Lost to Follow-up|123|||
19638886|NCT00689871|42088328|FG001|Overall Study|Lost to Follow-up|13|||
19638887|NCT00689871|42088329|FG002|Overall Study|Lost to Follow-up|37|||
19638888|NCT00689871|42088330|FG003|Overall Study|Lost to Follow-up|1|||
19638889|NCT00689871|42088327|FG000|Overall Study|Explanted of All Study Devices|36|||
19638890|NCT00689871|42088328|FG001|Overall Study|Explanted of All Study Devices|25|||
19638891|NCT00689871|42088329|FG002|Overall Study|Explanted of All Study Devices|29|||
19638892|NCT00689871|42088330|FG003|Overall Study|Explanted of All Study Devices|3|||
19638893|NCT00689871|42088327|FG000|Overall Study|Withdrawal by Subject|13|||
19638894|NCT00689871|42088328|FG001|Overall Study|Withdrawal by Subject|3|||
19638895|NCT00689871|42088329|FG002|Overall Study|Withdrawal by Subject|4|||
19638896|NCT00689871|42088330|FG003|Overall Study|Withdrawal by Subject|1|||
19638897|NCT00689871|42088327|FG000|Overall Study|Death|1|||
19638898|NCT00689871|42088328|FG001|Overall Study|Death|10|||
19638899|NCT00689871|42088329|FG002|Overall Study|Death|2|||
19638900|NCT00689871|42088330|FG003|Overall Study|Death|2|||
19638901|NCT00689871|42088327|FG000|Overall Study|Physician Decision|2|||
19638902|NCT00689871|42088328|FG001|Overall Study|Physician Decision|1|||
19638903|NCT00689871|42088329|FG002|Overall Study|Physician Decision|1|||
19638904|NCT00689871|42088330|FG003|Overall Study|Physician Decision|0|||
19638905|NCT00793793|42088352|FG000|Overall Study|Adverse Event|0|||
19638906|NCT00793793|42088353|FG001|Overall Study|Adverse Event|0|||
19638907|NCT00793793|42088354|FG002|Overall Study|Adverse Event|1|||
19638908|NCT00793793|42088355|FG003|Overall Study|Adverse Event|1|||
19638909|NCT00793793|42088356|FG004|Overall Study|Adverse Event|0|||
19638910|NCT00793793|42088357|FG005|Overall Study|Adverse Event|1|||
19638911|NCT00793793|42088358|FG006|Overall Study|Adverse Event|2|||
19638912|NCT00793793|42088359|FG007|Overall Study|Adverse Event|0|||
19638913|NCT00793793|42088360|FG008|Overall Study|Adverse Event|0|||
19638914|NCT00793793|42088361|FG009|Overall Study|Adverse Event|0|||
19638915|NCT00793793|42088362|FG010|Overall Study|Adverse Event|0|||
19638916|NCT00793793|42088363|FG011|Overall Study|Adverse Event|2|||
19638917|NCT00793793|42088352|FG000|Overall Study|Protocol Violation|0|||
19638918|NCT00793793|42088353|FG001|Overall Study|Protocol Violation|0|||
19638919|NCT00793793|42088354|FG002|Overall Study|Protocol Violation|0|||
19638920|NCT00793793|42088355|FG003|Overall Study|Protocol Violation|1|||
19638921|NCT00793793|42088356|FG004|Overall Study|Protocol Violation|0|||
19638922|NCT00793793|42088357|FG005|Overall Study|Protocol Violation|0|||
19638923|NCT00793793|42088358|FG006|Overall Study|Protocol Violation|0|||
19638924|NCT00793793|42088359|FG007|Overall Study|Protocol Violation|0|||
19638925|NCT00793793|42088360|FG008|Overall Study|Protocol Violation|0|||
19638926|NCT00793793|42088361|FG009|Overall Study|Protocol Violation|0|||
19638927|NCT00793793|42088362|FG010|Overall Study|Protocol Violation|0|||
19638928|NCT00793793|42088363|FG011|Overall Study|Protocol Violation|0|||
19638929|NCT00793793|42088352|FG000|Overall Study|Lost to Follow-up|0|||
19638930|NCT00793793|42088353|FG001|Overall Study|Lost to Follow-up|0|||
19638931|NCT00793793|42088354|FG002|Overall Study|Lost to Follow-up|1|||
19638932|NCT00793793|42088355|FG003|Overall Study|Lost to Follow-up|0|||
19638933|NCT00793793|42088356|FG004|Overall Study|Lost to Follow-up|0|||
19638934|NCT00793793|42088357|FG005|Overall Study|Lost to Follow-up|0|||
19638935|NCT00793793|42088358|FG006|Overall Study|Lost to Follow-up|0|||
19638936|NCT00793793|42088359|FG007|Overall Study|Lost to Follow-up|0|||
19638937|NCT00793793|42088360|FG008|Overall Study|Lost to Follow-up|1|||
19638938|NCT00793793|42088361|FG009|Overall Study|Lost to Follow-up|3|||
19638939|NCT00793793|42088362|FG010|Overall Study|Lost to Follow-up|1|||
19638940|NCT00793793|42088363|FG011|Overall Study|Lost to Follow-up|0|||
19638941|NCT00793793|42088352|FG000|Overall Study|Withdrawal by Subject|0|||
19638942|NCT00793793|42088353|FG001|Overall Study|Withdrawal by Subject|0|||
19638943|NCT00793793|42088354|FG002|Overall Study|Withdrawal by Subject|0|||
19638944|NCT00793793|42088355|FG003|Overall Study|Withdrawal by Subject|0|||
19638945|NCT00793793|42088356|FG004|Overall Study|Withdrawal by Subject|1|||
19638946|NCT00793793|42088357|FG005|Overall Study|Withdrawal by Subject|0|||
19638947|NCT00793793|42088358|FG006|Overall Study|Withdrawal by Subject|0|||
19638948|NCT00793793|42088359|FG007|Overall Study|Withdrawal by Subject|0|||
19638949|NCT00793793|42088360|FG008|Overall Study|Withdrawal by Subject|1|||
19638950|NCT00793793|42088361|FG009|Overall Study|Withdrawal by Subject|0|||
19638951|NCT00793793|42088362|FG010|Overall Study|Withdrawal by Subject|0|||
19638952|NCT00793793|42088363|FG011|Overall Study|Withdrawal by Subject|0|||
19638953|NCT00793793|42088352|FG000|Overall Study|reason not specified|0|||
19638954|NCT00793793|42088353|FG001|Overall Study|reason not specified|1|||
19638955|NCT00793793|42088354|FG002|Overall Study|reason not specified|0|||
19638956|NCT00793793|42088355|FG003|Overall Study|reason not specified|1|||
19638957|NCT00793793|42088356|FG004|Overall Study|reason not specified|1|||
19638958|NCT00793793|42088357|FG005|Overall Study|reason not specified|1|||
19638959|NCT00793793|42088358|FG006|Overall Study|reason not specified|2|||
19638960|NCT00793793|42088359|FG007|Overall Study|reason not specified|0|||
19638961|NCT00793793|42088360|FG008|Overall Study|reason not specified|7|||
19638962|NCT00793793|42088361|FG009|Overall Study|reason not specified|6|||
19638963|NCT00793793|42088362|FG010|Overall Study|reason not specified|2|||
19638964|NCT00793793|42088363|FG011|Overall Study|reason not specified|4|||
19638965|NCT00776789|42088411|FG000|Overall Study|Consent refusal|2|||
19638966|NCT00776789|42088412|FG001|Overall Study|Consent refusal|2|||
19638967|NCT00776789|42088411|FG000|Overall Study|Poor quality video|1|||
19638968|NCT00776789|42088412|FG001|Overall Study|Poor quality video|1|||
19638969|NCT00776555|42088422|FG000|Overall Study|Study terminated|3|||
19638970|NCT00776555|42088423|FG001|Overall Study|Study terminated|0|||
19638971|NCT00720434|42088433|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
19638972|NCT00720434|42088434|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
19638973|NCT00720434|42088435|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
19638974|NCT00720434|42088436|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
19638975|NCT00720434|42088433|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
19638976|NCT00720434|42088434|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
19638977|NCT00720434|42088435|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
19638978|NCT00720434|42088436|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
19638979|NCT00720434|42088433|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
19638980|NCT00720434|42088434|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
19638981|NCT00720434|42088435|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
19638982|NCT00720434|42088436|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
19638983|NCT00720434|42088433|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
19638984|NCT00720434|42088434|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
19638985|NCT00720434|42088435|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
19638986|NCT00720434|42088436|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
19638987|NCT00720434|42088433|FG000|Open-Label Period (Week 5-72)|Other|4|||
19638988|NCT00720434|42088434|FG001|Open-Label Period (Week 5-72)|Other|3|||
19638989|NCT00720434|42088435|FG002|Open-Label Period (Week 5-72)|Other|3|||
19638990|NCT00720434|42088436|FG003|Open-Label Period (Week 5-72)|Other|2|||
19638991|NCT00776009|42088452|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
19638992|NCT00776009|42088453|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
19638993|NCT00776009|42088454|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
19638994|NCT00776009|42088455|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
19638995|NCT00776009|42088456|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
19638996|NCT00776009|42088457|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
19638997|NCT00776009|42088452|FG000|Period 1: First Intervention|Protocol Violation|0|||
19638998|NCT00776009|42088453|FG001|Period 1: First Intervention|Protocol Violation|1|||
19638999|NCT00776009|42088454|FG002|Period 1: First Intervention|Protocol Violation|0|||
19639000|NCT00776009|42088455|FG003|Period 1: First Intervention|Protocol Violation|0|||
19639001|NCT00776009|42088456|FG004|Period 1: First Intervention|Protocol Violation|1|||
19639002|NCT00776009|42088457|FG005|Period 1: First Intervention|Protocol Violation|0|||
19639003|NCT00776009|42088452|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
19639004|NCT00776009|42088453|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
19639005|NCT00776009|42088454|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
19639006|NCT00776009|42088455|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
19639007|NCT00776009|42088456|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
19639008|NCT00776009|42088457|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
19639009|NCT00776009|42088452|FG000|Period 2: Second Intervention|Protocol Violation|1|||
19639010|NCT00776009|42088453|FG001|Period 2: Second Intervention|Protocol Violation|0|||
19639011|NCT00776009|42088454|FG002|Period 2: Second Intervention|Protocol Violation|1|||
19639012|NCT00776009|42088455|FG003|Period 2: Second Intervention|Protocol Violation|0|||
19639013|NCT00776009|42088456|FG004|Period 2: Second Intervention|Protocol Violation|0|||
19639014|NCT00776009|42088457|FG005|Period 2: Second Intervention|Protocol Violation|0|||
19639015|NCT00776009|42088452|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
19639016|NCT00776009|42088453|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
19639017|NCT00776009|42088454|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
19639018|NCT00776009|42088455|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
19639019|NCT00776009|42088456|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
19639020|NCT00776009|42088457|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
19639021|NCT00694161|42088465|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
19639022|NCT00694161|42088465|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
19639023|NCT00694161|42088465|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
19639024|NCT00720356|42088469|FG000|Registration to Study|Determined to have methylated MGMT|67|||
19639025|NCT00720356|42088469|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
19639026|NCT00720356|42088469|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
19639027|NCT00720356|42088469|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
19639028|NCT00720356|42088469|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
19639029|NCT00720356|42088469|FG000|Follow up Until Death|Withdrawal by Subject|1|||
19639030|NCT00720356|42088469|FG000|Follow up Until Death|Alive at last data collection|4|||
19639031|NCT00720278|42088476|FG000|Overall Study|Adverse Event|5|||
19639032|NCT00720278|42088477|FG001|Overall Study|Adverse Event|3|||
19639033|NCT00720278|42088478|FG002|Overall Study|Adverse Event|4|||
19639034|NCT00720278|42088476|FG000|Overall Study|Withdrawal by Subject|0|||
19639035|NCT00720278|42088477|FG001|Overall Study|Withdrawal by Subject|1|||
19639036|NCT00720278|42088478|FG002|Overall Study|Withdrawal by Subject|0|||
19639037|NCT00720278|42088476|FG000|Overall Study|Lost to Follow-up|0|||
19639038|NCT00720278|42088477|FG001|Overall Study|Lost to Follow-up|0|||
19639039|NCT00720278|42088478|FG002|Overall Study|Lost to Follow-up|1|||
19639040|NCT00720278|42088476|FG000|Overall Study|Non-compliance|1|||
19639041|NCT00720278|42088477|FG001|Overall Study|Non-compliance|0|||
19639042|NCT00720278|42088478|FG002|Overall Study|Non-compliance|0|||
19639043|NCT00720278|42088476|FG000|Overall Study|eligibility criteria violation|1|||
19639044|NCT00720278|42088477|FG001|Overall Study|eligibility criteria violation|0|||
19639045|NCT00720278|42088478|FG002|Overall Study|eligibility criteria violation|1|||
19639046|NCT00720122|42088486|FG000|Overall Study|Lost to Follow-up|1|||
19639047|NCT00720122|42088486|FG000|Overall Study|Physician Decision|1|||
19639048|NCT00720122|42088486|FG000|Overall Study|Withdrawal by Subject|7|||
19639049|NCT00717860|42088492|FG000|Overall Study|Clinical adverse experience|5|||
19639050|NCT00717860|42088493|FG001|Overall Study|Clinical adverse experience|9|||
19639051|NCT00717860|42088492|FG000|Overall Study|Laboratory adverse experience|2|||
19639052|NCT00717860|42088493|FG001|Overall Study|Laboratory adverse experience|2|||
19639053|NCT00717860|42088492|FG000|Overall Study|Lack of Efficacy|7|||
19639054|NCT00717860|42088493|FG001|Overall Study|Lack of Efficacy|13|||
19639055|NCT00717860|42088492|FG000|Overall Study|Discontinued for other reason|6|||
19639056|NCT00717860|42088493|FG001|Overall Study|Discontinued for other reason|1|||
19639057|NCT00717860|42088492|FG000|Overall Study|Withdrew consent|7|||
19639058|NCT00717860|42088493|FG001|Overall Study|Withdrew consent|3|||
19639059|NCT00717314|42088501|FG000|Overall Study|Adverse Event|3|||
19639060|NCT00717314|42088502|FG001|Overall Study|Adverse Event|2|||
19639061|NCT00717314|42088501|FG000|Overall Study|Protocol Violation|1|||
19639062|NCT00717314|42088502|FG001|Overall Study|Protocol Violation|0|||
19639063|NCT00717314|42088501|FG000|Overall Study|Lost to Follow-up|1|||
19639064|NCT00717314|42088502|FG001|Overall Study|Lost to Follow-up|5|||
19639065|NCT00717314|42088501|FG000|Overall Study|Withdrawal by Subject|1|||
19639066|NCT00717314|42088502|FG001|Overall Study|Withdrawal by Subject|3|||
19639067|NCT00689793|42088510|FG000|Overall Study|Lost to Follow-up|4|||
19639068|NCT00689793|42088511|FG001|Overall Study|Lost to Follow-up|5|||
19639069|NCT00723944|42088521|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
19639070|NCT00723944|42088522|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
19639071|NCT00723944|42088521|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
19639072|NCT00723944|42088522|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
19639073|NCT00723944|42088521|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
19639074|NCT00723944|42088522|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
19639075|NCT00689481|42088530|FG000|Overall Study|Adverse Event|7|||
19639076|NCT00689481|42088531|FG001|Overall Study|Adverse Event|1|||
19639077|NCT00689481|42088530|FG000|Overall Study|Lost to Follow-up|4|||
19639078|NCT00689481|42088531|FG001|Overall Study|Lost to Follow-up|3|||
19639079|NCT00689481|42088530|FG000|Overall Study|Lack of Efficacy|4|||
19639080|NCT00689481|42088531|FG001|Overall Study|Lack of Efficacy|3|||
19725606|NCT04015232|42169373|FG000|Overall Study|Withdrawal by Subject|7|||
19725607|NCT04015232|42169374|FG001|Overall Study|Withdrawal by Subject|4|||
19725608|NCT04015232|42169373|FG000|Overall Study|Protocol Violation|1|||
19725609|NCT04015232|42169374|FG001|Overall Study|Protocol Violation|0|||
19725610|NCT04015232|42169373|FG000|Overall Study|Medical Grounds|3|||
19725611|NCT04015232|42169374|FG001|Overall Study|Medical Grounds|3|||
19725612|NCT04533204|42169386|FG000|Overall Study|Unable to understand training instructions|1|||
19725613|NCT04533204|42169387|FG001|Overall Study|Unable to understand training instructions|1|||
19725614|NCT04465422|42169395|FG000|Overall Study|Lost to Follow-up|0|||
19725615|NCT04465422|42169396|FG001|Overall Study|Lost to Follow-up|2|||
19725616|NCT04014062|42169406|FG000|Period I: Dosing|Medical Grounds|4|||
19725617|NCT04014062|42169407|FG001|Period I: Dosing|Medical Grounds|5|||
19725618|NCT04014062|42169406|FG000|Period I: Dosing|Withdrawal by Subject|3|||
19725619|NCT04014062|42169407|FG001|Period I: Dosing|Withdrawal by Subject|1|||
19725620|NCT04531098|42169421|FG000|Stage I|Adverse Event|0|||
19725621|NCT04531098|42169422|FG001|Stage I|Adverse Event|0|||
19725622|NCT04531098|42169423|FG002|Stage I|Adverse Event|3|||
19725623|NCT04531098|42169421|FG000|Stage I|Protocol Violation|0|||
19725624|NCT04531098|42169422|FG001|Stage I|Protocol Violation|0|||
19725625|NCT04531098|42169423|FG002|Stage I|Protocol Violation|5|||
19725626|NCT04531098|42169421|FG000|Stage I|Withdrawal by Subject|0|||
19390316|NCT01987960|41634112|FG002|Period 1|Adverse Event|0|||
19725627|NCT04531098|42169422|FG001|Stage I|Withdrawal by Subject|5|||
19639081|NCT00689481|42088530|FG000|Overall Study|Non-compliance with study treatment|1|||
19639082|NCT00689481|42088531|FG001|Overall Study|Non-compliance with study treatment|1|||
19725628|NCT04531098|42169423|FG002|Stage I|Withdrawal by Subject|10|||
19725629|NCT04531098|42169421|FG000|Stage II|Adverse Event|1|||
19725630|NCT04531098|42169422|FG001|Stage II|Adverse Event|2|||
19725631|NCT04531098|42169423|FG002|Stage II|Adverse Event|0|||
19725632|NCT04531098|42169421|FG000|Stage II|Protocol Violation|1|||
19725633|NCT04531098|42169422|FG001|Stage II|Protocol Violation|2|||
19725634|NCT04531098|42169423|FG002|Stage II|Protocol Violation|0|||
19725635|NCT04531098|42169421|FG000|Stage II|Withdrawal by Subject|3|||
19725636|NCT04531098|42169422|FG001|Stage II|Withdrawal by Subject|1|||
19725637|NCT04531098|42169423|FG002|Stage II|Withdrawal by Subject|0|||
19725638|NCT04531098|42169421|FG000|Stage II|Moved from study area|8|||
19725639|NCT04531098|42169422|FG001|Stage II|Moved from study area|5|||
19725640|NCT04531098|42169423|FG002|Stage II|Moved from study area|0|||
19725641|NCT04144166|42169431|FG000|Overall Study|Discharged before study start|1|||
19725642|NCT04144166|42169431|FG000|Overall Study|Pregnancy|1|||
19725643|NCT04144166|42169431|FG000|Overall Study|Nail polish could not be removed from finger|1|||
19725644|NCT04142450|42169440|FG000|Overall Study|Screen Failure|1|||
19725645|NCT04142450|42169440|FG000|Overall Study|Lost to Follow-up|1|||
19725646|NCT04529850|42169444|FG000|Overall Study|Death|2|||
19725647|NCT04529850|42169444|FG000|Overall Study|Physician Decision|1|||
19725648|NCT04529850|42169444|FG000|Overall Study|Withdrawal by Subject|2|||
19725649|NCT04225676|42169448|FG000|Overall Study|Physician Decision|1|||
19725650|NCT04225676|42169448|FG000|Overall Study|Lack of Efficacy|1|||
19725651|NCT04225676|42169448|FG000|Overall Study|Study terminated by sponsor|3|||
19725652|NCT04142216|42169456|FG000|Overall Study|Hospitalization|0|||
19725653|NCT04142216|42169457|FG001|Overall Study|Hospitalization|2|||
19725654|NCT04142216|42169456|FG000|Overall Study|Death|3|||
19725655|NCT04142216|42169457|FG001|Overall Study|Death|1|||
19725656|NCT04142216|42169456|FG000|Overall Study|Referral to another hemodialysis unit|3|||
19725657|NCT04142216|42169457|FG001|Overall Study|Referral to another hemodialysis unit|2|||
19725658|NCT04142216|42169456|FG000|Overall Study|Use of clove|0|||
19725659|NCT04142216|42169457|FG001|Overall Study|Use of clove|1|||
19725660|NCT04140890|42169465|FG000|Overall Study|Withdrawal by Subject|0|||
19725661|NCT04140890|42169466|FG001|Overall Study|Withdrawal by Subject|1|||
19725662|NCT03700320|42169477|FG000|Overall Study|Adverse Event|5|||
19725663|NCT03700320|42169478|FG001|Overall Study|Adverse Event|31|||
19725664|NCT03700320|42169477|FG000|Overall Study|Lack of Efficacy|2|||
19725665|NCT03700320|42169478|FG001|Overall Study|Lack of Efficacy|5|||
19725666|NCT03700320|42169477|FG000|Overall Study|Withdrawal by Subject|29|||
19725667|NCT03700320|42169478|FG001|Overall Study|Withdrawal by Subject|75|||
19725668|NCT03700320|42169477|FG000|Overall Study|Lost to Follow-up|16|||
19725669|NCT03700320|42169478|FG001|Overall Study|Lost to Follow-up|23|||
19725670|NCT03700320|42169477|FG000|Overall Study|Pregnancy|2|||
19725671|NCT03700320|42169478|FG001|Overall Study|Pregnancy|4|||
19725672|NCT03700320|42169477|FG000|Overall Study|Protocol Deviation|7|||
19725673|NCT03700320|42169478|FG001|Overall Study|Protocol Deviation|31|||
19725674|NCT03700320|42169477|FG000|Overall Study|Non-compliance with Study Drug|1|||
19725675|NCT03700320|42169478|FG001|Overall Study|Non-compliance with Study Drug|3|||
19725676|NCT03700320|42169477|FG000|Overall Study|Reason not Specified|0|||
19725677|NCT03700320|42169478|FG001|Overall Study|Reason not Specified|1|||
19725678|NCT04139018|42169486|FG000|Overall Study|Screen fail|1|||
19725679|NCT04139018|42169487|FG001|Overall Study|Screen fail|0|||
19725680|NCT04139018|42169486|FG000|Overall Study|Withdrawal by Subject|2|||
19725681|NCT04139018|42169487|FG001|Overall Study|Withdrawal by Subject|0|||
19725682|NCT04139018|42169486|FG000|Overall Study|Lost to Follow-up|0|||
19725683|NCT04139018|42169487|FG001|Overall Study|Lost to Follow-up|1|||
19725684|NCT04456686|42169495|FG000|Overall Study|Adverse Event|2|||
19725685|NCT04456686|42169496|FG001|Overall Study|Adverse Event|1|||
19725686|NCT04456686|42169495|FG000|Overall Study|Lack of Efficacy|3|||
19725687|NCT04456686|42169496|FG001|Overall Study|Lack of Efficacy|1|||
19725688|NCT04456686|42169495|FG000|Overall Study|Withdrew consent|3|||
19725689|NCT04456686|42169496|FG001|Overall Study|Withdrew consent|1|||
19725690|NCT04456686|42169495|FG000|Overall Study|Physician Decision|2|||
19725691|NCT04456686|42169496|FG001|Overall Study|Physician Decision|2|||
19376362|NCT00151775|41618527|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19725692|NCT04456686|42169495|FG000|Overall Study|Withdrawal by Subject|5|||
19725693|NCT04456686|42169496|FG001|Overall Study|Withdrawal by Subject|1|||
19725694|NCT04456686|42169495|FG000|Overall Study|Protocol Violation|0|||
19725695|NCT04456686|42169496|FG001|Overall Study|Protocol Violation|1|||
19725696|NCT04527978|42169504|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
19725697|NCT04527978|42169505|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
19725698|NCT04136444|42169516|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
19725699|NCT04136444|42169517|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
19725700|NCT04425252|42169531|FG000|Overall Study|Withdrawal by Subject|2|||
19725701|NCT04425252|42169532|FG001|Overall Study|Withdrawal by Subject|1|||
19725702|NCT04425252|42169531|FG000|Overall Study|Lost to Follow-up|1|||
19725703|NCT04425252|42169532|FG001|Overall Study|Lost to Follow-up|0|||
19725704|NCT04425252|42169531|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
19725705|NCT04425252|42169532|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
19725706|NCT03696576|42169543|FG000|Overall Study|Soreness of throat after therapy|1|||
19725707|NCT03696576|42169544|FG001|Overall Study|Soreness of throat after therapy|1|||
19725708|NCT03696576|42169543|FG000|Overall Study|Lost to Follow-up|2|||
19725709|NCT03696576|42169544|FG001|Overall Study|Lost to Follow-up|4|||
19725710|NCT04003610|42169553|FG000|Overall Study|Lost to Follow-up|0|||
19725711|NCT04003610|42169554|FG001|Overall Study|Lost to Follow-up|1|||
19725712|NCT04003610|42169555|FG002|Overall Study|Lost to Follow-up|0|||
19725713|NCT04003610|42169553|FG000|Overall Study|Death|0|||
19725714|NCT04003610|42169554|FG001|Overall Study|Death|0|||
19725715|NCT04003610|42169555|FG002|Overall Study|Death|3|||
19725716|NCT04003610|42169553|FG000|Overall Study|Study Terminated by Sponsor|0|||
19725717|NCT04003610|42169554|FG001|Overall Study|Study Terminated by Sponsor|0|||
19725718|NCT04003610|42169555|FG002|Overall Study|Study Terminated by Sponsor|3|||
19725719|NCT03999554|42169569|FG000|Overall Study|Lost to Follow-up|4|||
19725720|NCT03999554|42169570|FG001|Overall Study|Lost to Follow-up|5|||
19725721|NCT03999554|42169571|FG002|Overall Study|Lost to Follow-up|4|||
19725722|NCT03999554|42169572|FG003|Overall Study|Lost to Follow-up|5|||
19725723|NCT03999554|42169573|FG004|Overall Study|Lost to Follow-up|8|||
19725724|NCT03999554|42169569|FG000|Overall Study|Protocol Violation|0|||
19725725|NCT03999554|42169570|FG001|Overall Study|Protocol Violation|0|||
19725726|NCT03999554|42169571|FG002|Overall Study|Protocol Violation|5|||
19725727|NCT03999554|42169572|FG003|Overall Study|Protocol Violation|0|||
19725728|NCT03999554|42169573|FG004|Overall Study|Protocol Violation|0|||
19725729|NCT03999554|42169569|FG000|Overall Study|Pregnancy|0|||
19725730|NCT03999554|42169570|FG001|Overall Study|Pregnancy|0|||
19725731|NCT03999554|42169571|FG002|Overall Study|Pregnancy|1|||
19725732|NCT03999554|42169572|FG003|Overall Study|Pregnancy|0|||
19725733|NCT03999554|42169573|FG004|Overall Study|Pregnancy|0|||
19725734|NCT03999554|42169569|FG000|Overall Study|Withdrawal by Subject|2|||
19725735|NCT03999554|42169570|FG001|Overall Study|Withdrawal by Subject|2|||
19725736|NCT03999554|42169571|FG002|Overall Study|Withdrawal by Subject|2|||
19725737|NCT03999554|42169572|FG003|Overall Study|Withdrawal by Subject|1|||
19725738|NCT03999554|42169573|FG004|Overall Study|Withdrawal by Subject|1|||
19725739|NCT03999554|42169569|FG000|Overall Study|failure to comply with protocol requirements|0|||
19725740|NCT03999554|42169570|FG001|Overall Study|failure to comply with protocol requirements|0|||
19725741|NCT03999554|42169571|FG002|Overall Study|failure to comply with protocol requirements|0|||
19725742|NCT03999554|42169572|FG003|Overall Study|failure to comply with protocol requirements|1|||
19725743|NCT03999554|42169573|FG004|Overall Study|failure to comply with protocol requirements|0|||
19725744|NCT04129346|42169588|FG000|Overall Study|Death|1|||
19725745|NCT04129346|42169589|FG001|Overall Study|Death|0|||
19725746|NCT04526574|42169597|FG000|Overall Study|Protocol Violation|3|||
19725747|NCT04526574|42169598|FG001|Overall Study|Protocol Violation|1|||
19725748|NCT04526574|42169597|FG000|Overall Study|Withdrawal by Subject|12|||
19725749|NCT04526574|42169598|FG001|Overall Study|Withdrawal by Subject|9|||
19725750|NCT04526574|42169597|FG000|Overall Study|Other|1|||
19725751|NCT04526574|42169598|FG001|Overall Study|Other|2|||
19725752|NCT04526574|42169597|FG000|Overall Study|Adverse Event|1|||
19725753|NCT04526574|42169598|FG001|Overall Study|Adverse Event|1|||
19725754|NCT04526574|42169597|FG000|Overall Study|Death|2|||
19725755|NCT04526574|42169598|FG001|Overall Study|Death|3|||
19725756|NCT04526574|42169597|FG000|Overall Study|Lost to Follow-up|9|||
19725757|NCT04526574|42169598|FG001|Overall Study|Lost to Follow-up|9|||
19725758|NCT04526574|42169597|FG000|Overall Study|No longer meets eligibility criteria|8|||
19725759|NCT04526574|42169598|FG001|Overall Study|No longer meets eligibility criteria|8|||
19725760|NCT03993392|42169608|FG000|Overall Study|Withdrawal by Subject|3|||
19725761|NCT03993392|42169608|FG000|Overall Study|Lost to Follow-up|2|||
19725762|NCT03993392|42169608|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
19725763|NCT04422990|42169615|FG000|Overall Study|Withdrawal by Subject|0|||
19725764|NCT04422990|42169616|FG001|Overall Study|Withdrawal by Subject|1|||
19725765|NCT04422990|42169615|FG000|Overall Study|Travel|3|||
19725766|NCT04422990|42169616|FG001|Overall Study|Travel|0|||
19725767|NCT04377308|42169627|FG000|Overall Study|Withdrawal by Subject|0|||
19725768|NCT04377308|42169628|FG001|Overall Study|Withdrawal by Subject|1|||
19725769|NCT04447404|42169636|FG000|Overall Study|Death|2|||
19725770|NCT04447404|42169637|FG001|Overall Study|Death|0|||
19725771|NCT03988166|42169643|FG000|Overall Study|Lost to Follow-up|2|||
19725772|NCT03988166|42169643|FG000|Overall Study|Death|1|||
19725773|NCT03988088|42169652|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
19725774|NCT03988088|42169653|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
19725775|NCT03988088|42169654|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
19725776|NCT03988088|42169655|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
19725777|NCT03988088|42169652|FG000|Open-Label Addendum|Lost to Follow-up|0|||
19725778|NCT03988088|42169653|FG001|Open-Label Addendum|Lost to Follow-up|0|||
19725779|NCT03988088|42169654|FG002|Open-Label Addendum|Lost to Follow-up|1|||
19725780|NCT03988088|42169655|FG003|Open-Label Addendum|Lost to Follow-up|0|||
19725781|NCT03987932|42169666|FG000|Overall Study|Lost to Follow-up|2|||
19725782|NCT03987932|42169667|FG001|Overall Study|Lost to Follow-up|1|||
19725783|NCT03987932|42169668|FG002|Overall Study|Lost to Follow-up|1|||
19725784|NCT03987932|42169666|FG000|Overall Study|Non-study related elective surgery|0|||
19725785|NCT03987932|42169667|FG001|Overall Study|Non-study related elective surgery|0|||
19725786|NCT03987932|42169668|FG002|Overall Study|Non-study related elective surgery|1|||
19725787|NCT03987620|42169678|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
19725788|NCT03987620|42169679|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
19725789|NCT03987620|42169678|FG000|Overall Study|Adverse Event|3|||
19725790|NCT03987620|42169679|FG001|Overall Study|Adverse Event|0|||
19725791|NCT03987620|42169678|FG000|Overall Study|Lost to Follow-up|1|||
19725792|NCT03987620|42169679|FG001|Overall Study|Lost to Follow-up|2|||
19725793|NCT03987620|42169678|FG000|Overall Study|Physician Decision|0|||
19725794|NCT03987620|42169679|FG001|Overall Study|Physician Decision|1|||
19725795|NCT03987620|42169678|FG000|Overall Study|Pregnancy|1|||
19725796|NCT03987620|42169679|FG001|Overall Study|Pregnancy|0|||
19725797|NCT03987620|42169678|FG000|Overall Study|Withdrawal by Subject|7|||
19725798|NCT03987620|42169679|FG001|Overall Study|Withdrawal by Subject|1|||
19725799|NCT03987620|42169678|FG000|Overall Study|Other|2|||
19725800|NCT03987620|42169679|FG001|Overall Study|Other|5|||
19725801|NCT03069352|42169687|FG000|Overall Study|Ongoing|12|||
19725802|NCT03069352|42169688|FG001|Overall Study|Ongoing|40|||
19725803|NCT04376060|42169694|FG000|Overall Study|Physician Decision|1|||
19725804|NCT04413552|42169708|FG000|Overall Study|Adverse Event|0|||
19725805|NCT04413552|42169709|FG001|Overall Study|Adverse Event|0|||
19725806|NCT04413552|42169710|FG002|Overall Study|Adverse Event|0|||
19725807|NCT04413552|42169711|FG003|Overall Study|Adverse Event|0|||
19725808|NCT04413552|42169712|FG004|Overall Study|Adverse Event|0|||
19725809|NCT04413552|42169713|FG005|Overall Study|Adverse Event|0|||
19725810|NCT04413552|42169714|FG006|Overall Study|Adverse Event|1|||
19725811|NCT04413552|42169715|FG007|Overall Study|Adverse Event|0|||
19725812|NCT04413552|42169716|FG008|Overall Study|Adverse Event|0|||
19725813|NCT04413552|42169717|FG009|Overall Study|Adverse Event|0|||
19725814|NCT03987074|42169748|FG000|Overall Study|Withdrew Consent|1|||
19725815|NCT03987074|42169749|FG001|Overall Study|Withdrew Consent|1|||
19725816|NCT03987074|42169750|FG002|Overall Study|Withdrew Consent|0|||
19725817|NCT03987074|42169751|FG003|Overall Study|Withdrew Consent|2|||
19725818|NCT03987074|42169752|FG004|Overall Study|Withdrew Consent|1|||
19725819|NCT03987074|42169748|FG000|Overall Study|Adverse Event|2|||
19725820|NCT03987074|42169749|FG001|Overall Study|Adverse Event|1|||
19725821|NCT03987074|42169750|FG002|Overall Study|Adverse Event|0|||
19725822|NCT03987074|42169751|FG003|Overall Study|Adverse Event|0|||
19725823|NCT03987074|42169752|FG004|Overall Study|Adverse Event|1|||
19725824|NCT03987074|42169748|FG000|Overall Study|Lost to Follow-up|0|||
19725825|NCT03987074|42169749|FG001|Overall Study|Lost to Follow-up|0|||
19725826|NCT03987074|42169750|FG002|Overall Study|Lost to Follow-up|1|||
19725827|NCT03987074|42169751|FG003|Overall Study|Lost to Follow-up|1|||
19725828|NCT03987074|42169752|FG004|Overall Study|Lost to Follow-up|0|||
19725829|NCT03987074|42169748|FG000|Overall Study|Investigator's Discretion|0|||
19725830|NCT03987074|42169749|FG001|Overall Study|Investigator's Discretion|0|||
19725831|NCT03987074|42169750|FG002|Overall Study|Investigator's Discretion|0|||
19725832|NCT03987074|42169751|FG003|Overall Study|Investigator's Discretion|1|||
19725833|NCT03987074|42169752|FG004|Overall Study|Investigator's Discretion|0|||
19725834|NCT04439214|42169764|FG000|Overall Study|Adverse Event|13|||
19725835|NCT04439214|42169764|FG000|Overall Study|Disease progression|16|||
19725836|NCT04439214|42169764|FG000|Overall Study|Death|1|||
19725837|NCT04439214|42169764|FG000|Overall Study|Withdrawal by Subject|2|||
19725838|NCT04439214|42169764|FG000|Overall Study|Declining health|1|||
19725839|NCT04439214|42169764|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
19725840|NCT04439214|42169764|FG000|Overall Study|Ineligible|5|||
19725841|NCT03696342|42169770|FG000|Overall Study|Lost to Follow-up|1|||
19725842|NCT03696342|42169771|FG001|Overall Study|Lost to Follow-up|0|||
19725843|NCT04411680|42169779|FG000|Treatment Period|Adverse Event|3|||
19725844|NCT04411680|42169780|FG001|Treatment Period|Adverse Event|0|||
19725845|NCT04411680|42169779|FG000|Treatment Period|Discharged from hospital|18|||
19725846|NCT04411680|42169780|FG001|Treatment Period|Discharged from hospital|7|||
19725847|NCT04411680|42169779|FG000|Treatment Period|Missed 1 or more doses|8|||
19725848|NCT04411680|42169780|FG001|Treatment Period|Missed 1 or more doses|0|||
19725849|NCT04411680|42169779|FG000|Treatment Period|Transferred to another hospital|0|||
19725850|NCT04411680|42169780|FG001|Treatment Period|Transferred to another hospital|1|||
19725851|NCT04411680|42169779|FG000|Follow up Period|Withdrawal by Subject|2|||
19725852|NCT04411680|42169780|FG001|Follow up Period|Withdrawal by Subject|0|||
19725853|NCT04411680|42169779|FG000|Follow up Period|Lost to Follow-up|5|||
19725854|NCT04411680|42169780|FG001|Follow up Period|Lost to Follow-up|6|||
19725855|NCT04411680|42169779|FG000|Follow up Period|Death|11|||
19725856|NCT04411680|42169780|FG001|Follow up Period|Death|8|||
19725857|NCT04410198|42169786|FG000|Overall Study|Death|10|||
19725858|NCT04410198|42169786|FG000|Overall Study|Withdrawal by Subject|7|||
19725859|NCT04410198|42169786|FG000|Overall Study|Transferred/Relocation|4|||
19725860|NCT04410198|42169786|FG000|Overall Study|Kidney Transplant|9|||
19725861|NCT04410198|42169786|FG000|Overall Study|Adverse Event|4|||
19725862|NCT04410198|42169786|FG000|Overall Study|Physician Decision|2|||
19725863|NCT04410198|42169786|FG000|Overall Study|Other than specified|1|||
19725864|NCT04165824|42169790|FG000|Overall Study|Adverse Event|23|||
19725865|NCT04165824|42169790|FG000|Overall Study|Physician Decision|1|||
19725866|NCT04165824|42169790|FG000|Overall Study|Withdrawal by Subject|17|||
19725867|NCT04165824|42169790|FG000|Overall Study|Other|5|||
19725868|NCT04161144|42169796|FG000|Overall Study|Withdrawal by Subject|0|||
19725869|NCT04161144|42169797|FG001|Overall Study|Withdrawal by Subject|1|||
19725870|NCT04161144|42169796|FG000|Overall Study|Protocol Violation|1|||
19725871|NCT04161144|42169797|FG001|Overall Study|Protocol Violation|0|||
19725872|NCT03984812|42169814|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725873|NCT03984812|42169815|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725874|NCT03984812|42169816|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
19725875|NCT03984812|42169817|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725876|NCT03984812|42169818|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725877|NCT03984812|42169819|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725878|NCT03984812|42169820|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725879|NCT03984812|42169821|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725880|NCT03984812|42169822|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725881|NCT03984812|42169823|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725882|NCT03984812|42169824|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
19725883|NCT04160988|42169851|FG000|Overall Study|poor image quality|28|||
19725884|NCT04153188|42169872|FG000|Overall Study|Lost to Follow-up|1|||
19725885|NCT04153188|42169873|FG001|Overall Study|Lost to Follow-up|1|||
19376363|NCT00151775|41618528|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376364|NCT00151775|41618529|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19725886|NCT04153188|42169872|FG000|Overall Study|Withdrawal by Subject|2|||
19725887|NCT04153188|42169873|FG001|Overall Study|Withdrawal by Subject|0|||
19725888|NCT04153188|42169872|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
19725889|NCT04153188|42169873|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
19725890|NCT04113746|42169881|FG000|Overall Study|Lost to Follow-up|4|||
19725891|NCT04113746|42169882|FG001|Overall Study|Lost to Follow-up|4|||
19725892|NCT03611010|42169892|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
19376365|NCT00151775|41618530|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376366|NCT00151775|41618531|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376367|NCT00151775|41618532|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376368|NCT00151775|41618533|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
19376369|NCT00151775|41618534|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376370|NCT00151775|41618535|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376371|NCT00151775|41618536|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376372|NCT00151775|41618537|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376373|NCT00151775|41618538|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
19376374|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376375|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376376|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376377|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376378|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376379|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
19376380|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376381|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376382|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376383|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376384|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376385|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
19376386|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
19376387|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
19376388|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
19376389|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
19376390|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
19376391|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
19376392|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
19376393|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
19376394|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
19376395|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
19376396|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
19376397|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
19376398|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19725893|NCT03611010|42169893|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
19725894|NCT03611010|42169894|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
19725895|NCT03611010|42169895|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
19725896|NCT04357782|42169910|FG000|Overall Study|Discharged from hospital|1|||
19725897|NCT04357782|42169911|FG001|Overall Study|Discharged from hospital|0|||
19725898|NCT04357782|42169910|FG000|Overall Study|Death|0|||
19725899|NCT04357782|42169911|FG001|Overall Study|Death|2|||
19725900|NCT03980522|42169922|FG000|Treatment Period|Adverse Event|1|||
19725901|NCT03980522|42169923|FG001|Treatment Period|Adverse Event|0|||
19725902|NCT03980522|42169924|FG002|Treatment Period|Adverse Event|0|||
19725903|NCT03980522|42169925|FG003|Treatment Period|Adverse Event|0|||
19725904|NCT03980522|42169926|FG004|Treatment Period|Adverse Event|0|||
19725905|NCT04402866|42169944|FG000|Overall Study|Discontinued Prior to Treatment|0|||
19725906|NCT04402866|42169945|FG001|Overall Study|Discontinued Prior to Treatment|0|||
19725907|NCT04402866|42169946|FG002|Overall Study|Discontinued Prior to Treatment|0|||
19725908|NCT04402866|42169947|FG003|Overall Study|Discontinued Prior to Treatment|0|||
19725909|NCT04402866|42169948|FG004|Overall Study|Discontinued Prior to Treatment|2|||
19725910|NCT04402866|42169949|FG005|Overall Study|Discontinued Prior to Treatment|3|||
19725911|NCT04402866|42169944|FG000|Overall Study|Adverse Event|2|||
19725912|NCT04402866|42169945|FG001|Overall Study|Adverse Event|1|||
19725913|NCT04402866|42169946|FG002|Overall Study|Adverse Event|0|||
19725914|NCT04402866|42169947|FG003|Overall Study|Adverse Event|0|||
19725915|NCT04402866|42169948|FG004|Overall Study|Adverse Event|13|||
19725916|NCT04402866|42169949|FG005|Overall Study|Adverse Event|8|||
19725917|NCT04402866|42169944|FG000|Overall Study|Miscellaneous|0|||
19725918|NCT04402866|42169945|FG001|Overall Study|Miscellaneous|0|||
19725919|NCT04402866|42169946|FG002|Overall Study|Miscellaneous|1|||
19725920|NCT04402866|42169947|FG003|Overall Study|Miscellaneous|0|||
19725921|NCT04402866|42169948|FG004|Overall Study|Miscellaneous|0|||
19725922|NCT04402866|42169949|FG005|Overall Study|Miscellaneous|0|||
19725923|NCT04402866|42169944|FG000|Overall Study|Lost to Follow-up|0|||
19725924|NCT04402866|42169945|FG001|Overall Study|Lost to Follow-up|0|||
19725925|NCT04402866|42169946|FG002|Overall Study|Lost to Follow-up|0|||
19725926|NCT04402866|42169947|FG003|Overall Study|Lost to Follow-up|0|||
19725927|NCT04402866|42169948|FG004|Overall Study|Lost to Follow-up|0|||
19725928|NCT04402866|42169949|FG005|Overall Study|Lost to Follow-up|1|||
19725929|NCT04402866|42169944|FG000|Overall Study|Withdrawal by Subject|0|||
19725930|NCT04402866|42169945|FG001|Overall Study|Withdrawal by Subject|0|||
19725931|NCT04402866|42169946|FG002|Overall Study|Withdrawal by Subject|0|||
19725932|NCT04402866|42169947|FG003|Overall Study|Withdrawal by Subject|0|||
19725933|NCT04402866|42169948|FG004|Overall Study|Withdrawal by Subject|0|||
19725934|NCT04402866|42169949|FG005|Overall Study|Withdrawal by Subject|2|||
19725935|NCT04400682|42169961|FG000|Period 1|Withdrawal by Subject|1|||
19725936|NCT04400682|42169962|FG001|Period 1|Withdrawal by Subject|4|||
19725937|NCT03066778|42169970|FG000|Overall Study|Death|195|||
19725938|NCT03066778|42169971|FG001|Overall Study|Death|205|||
19725939|NCT03066778|42169970|FG000|Overall Study|Withdrawal by Subject|5|||
19725940|NCT03066778|42169971|FG001|Overall Study|Withdrawal by Subject|7|||
19725941|NCT04348656|42169980|FG000|Overall Study|Withdrawal by Subject|2|||
19725942|NCT04348656|42169981|FG001|Overall Study|Withdrawal by Subject|0|||
19725943|NCT04348656|42169980|FG000|Overall Study|Lost to Follow-up|11|||
19725944|NCT04348656|42169981|FG001|Overall Study|Lost to Follow-up|6|||
19725945|NCT04348500|42169996|FG000|Overall Study|Death|2|||
19725946|NCT04348500|42169997|FG001|Overall Study|Death|2|||
19725947|NCT04348500|42169996|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
19725948|NCT04348500|42169997|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
19725949|NCT04347954|42170006|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
19725950|NCT04347954|42170007|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
19725951|NCT04347954|42170008|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
19725952|NCT04347954|42170006|FG000|Overall Study|Lost to Follow-up|0|||
19725953|NCT04347954|42170007|FG001|Overall Study|Lost to Follow-up|1|||
19725954|NCT04347954|42170008|FG002|Overall Study|Lost to Follow-up|0|||
19725955|NCT03065530|42170020|FG000|Overall Study|Lack of Efficacy|1|||
19725956|NCT03065530|42170021|FG001|Overall Study|Lack of Efficacy|1|||
19725957|NCT03065530|42170022|FG002|Overall Study|Lack of Efficacy|0|||
19725958|NCT03065530|42170023|FG003|Overall Study|Lack of Efficacy|1|||
19725959|NCT03065530|42170020|FG000|Overall Study|Protocol Violation|1|||
19725960|NCT03065530|42170021|FG001|Overall Study|Protocol Violation|0|||
19725961|NCT03065530|42170022|FG002|Overall Study|Protocol Violation|1|||
19725962|NCT03065530|42170023|FG003|Overall Study|Protocol Violation|1|||
19725963|NCT03979820|42170045|FG000|Overall Study|Protocol Violation|1|||
19725964|NCT03979820|42170046|FG001|Overall Study|Protocol Violation|0|||
19725965|NCT03979820|42170047|FG002|Overall Study|Protocol Violation|0|||
19725966|NCT03979820|42170048|FG003|Overall Study|Protocol Violation|0|||
19725967|NCT03979820|42170045|FG000|Overall Study|Withdrawal by Subject|0|||
19725968|NCT03979820|42170046|FG001|Overall Study|Withdrawal by Subject|0|||
19725969|NCT03979820|42170047|FG002|Overall Study|Withdrawal by Subject|1|||
19725970|NCT03979820|42170048|FG003|Overall Study|Withdrawal by Subject|0|||
19725971|NCT03979820|42170045|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
19725972|NCT03979820|42170046|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
19725973|NCT03979820|42170047|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
19725974|NCT03979820|42170048|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
19725975|NCT03647488|42170065|FG000|Overall Study|Progressive disease|10|||
19725976|NCT03647488|42170066|FG001|Overall Study|Progressive disease|0|||
19725977|NCT03647488|42170067|FG002|Overall Study|Progressive disease|0|||
19725978|NCT03647488|42170065|FG000|Overall Study|Adverse Event|5|||
19725979|NCT03647488|42170066|FG001|Overall Study|Adverse Event|0|||
19725980|NCT03647488|42170067|FG002|Overall Study|Adverse Event|0|||
19725981|NCT03647488|42170065|FG000|Overall Study|Clinical progression|2|||
19725982|NCT03647488|42170066|FG001|Overall Study|Clinical progression|0|||
19725983|NCT03647488|42170067|FG002|Overall Study|Clinical progression|0|||
19725984|NCT03647488|42170065|FG000|Overall Study|Participant refused to take investigational product|1|||
19725985|NCT03647488|42170066|FG001|Overall Study|Participant refused to take investigational product|0|||
19725986|NCT03647488|42170067|FG002|Overall Study|Participant refused to take investigational product|0|||
19725987|NCT03693950|42170075|FG000|Overall Study|Withdrawal by Subject|1|||
19725988|NCT03693950|42170076|FG001|Overall Study|Withdrawal by Subject|0|||
19725989|NCT04110314|42170088|FG000|Overall Study|Did not meet inclusion criteria|35255|||
19725990|NCT04110314|42170089|FG001|Overall Study|Did not meet inclusion criteria|35104|||
19725991|NCT04110314|42170090|FG002|Overall Study|Did not meet inclusion criteria|35636|||
19725992|NCT04110314|42170091|FG003|Overall Study|Did not meet inclusion criteria|35135|||
19725993|NCT04110314|42170092|FG004|Overall Study|Did not meet inclusion criteria|35247|||
19725994|NCT04110314|42170093|FG005|Overall Study|Did not meet inclusion criteria|35727|||
19725995|NCT04109222|42170108|FG000|Overall Study|Adverse Event|1|||
19725996|NCT04109222|42170109|FG001|Overall Study|Adverse Event|0|||
19725997|NCT04109222|42170110|FG002|Overall Study|Adverse Event|0|||
19725998|NCT04098458|42170118|FG000|Overall Study|Death|1|||
19725999|NCT04098458|42170118|FG000|Overall Study|did not meet study inclusion criteria|3|||
19726000|NCT04128696|42170125|FG000|Overall Study|Lost to Follow-up|0|||
19726001|NCT04128696|42170126|FG001|Overall Study|Lost to Follow-up|1|||
19726002|NCT04128696|42170125|FG000|Overall Study|Withdrawal by Subject|8|||
19726003|NCT04128696|42170126|FG001|Overall Study|Withdrawal by Subject|5|||
19726004|NCT04128696|42170125|FG000|Overall Study|In Follow-up|47|||
19726005|NCT04128696|42170126|FG001|Overall Study|In Follow-up|51|||
19726006|NCT04128696|42170125|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
19726007|NCT04128696|42170126|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
19726008|NCT03447262|42170132|FG000|Overall Study|Adverse Event|7|||
19726009|NCT03447262|42170132|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
19726010|NCT03447262|42170132|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
19726011|NCT03447262|42170132|FG000|Overall Study|Death|2|||
19726012|NCT03447262|42170132|FG000|Overall Study|Study Termination by Sponsor|455|||
19726013|NCT03447262|42170132|FG000|Overall Study|Other|4|||
19726014|NCT04094870|42170141|FG000|Overall Study|Lost to Follow-up|1|||
19726015|NCT04094870|42170142|FG001|Overall Study|Lost to Follow-up|1|||
19726016|NCT04399356|42170157|FG000|Overall Study|Lost to Follow-up|1|||
19726017|NCT04399356|42170158|FG001|Overall Study|Lost to Follow-up|1|||
19726018|NCT04399356|42170157|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
19726019|NCT04399356|42170158|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
19726020|NCT04399356|42170157|FG000|Overall Study|Withdrawal by Subject|1|||
19726021|NCT04399356|42170158|FG001|Overall Study|Withdrawal by Subject|0|||
19726022|NCT03692676|42170168|FG000|Overall Study|exclude patients with prior use|4424|||
19726023|NCT03692676|42170169|FG001|Overall Study|exclude patients with prior use|24726|||
19726024|NCT03692676|42170170|FG002|Overall Study|exclude patients with prior use|0|||
19726025|NCT03692676|42170171|FG003|Overall Study|exclude patients with prior use|0|||
19726026|NCT03692676|42170168|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
19726027|NCT03692676|42170169|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
19726028|NCT03692676|42170170|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
19726029|NCT03692676|42170171|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
19726030|NCT03692676|42170168|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
19726031|NCT03692676|42170169|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
19726032|NCT03692676|42170170|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
19726033|NCT03692676|42170171|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
19726034|NCT03692676|42170168|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
19726035|NCT03692676|42170169|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
19726036|NCT03692676|42170170|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
19726037|NCT03692676|42170171|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
19726038|NCT03692676|42170168|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
19726039|NCT03692676|42170169|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
19726040|NCT03692676|42170170|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
19726041|NCT03692676|42170171|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
19726042|NCT03692676|42170168|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
19726043|NCT03692676|42170169|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
19726044|NCT03692676|42170170|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
19726045|NCT03692676|42170171|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
19726046|NCT03692676|42170168|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
19726047|NCT03692676|42170169|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
19726048|NCT03692676|42170170|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
19726049|NCT03692676|42170171|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
19726050|NCT03692676|42170168|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
19726051|NCT03692676|42170169|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
19726052|NCT03692676|42170170|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
19726053|NCT03692676|42170171|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
19726054|NCT03692676|42170168|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
19726055|NCT03692676|42170169|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
19726056|NCT03692676|42170170|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
19726057|NCT03692676|42170171|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
19726058|NCT03692676|42170168|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
19726059|NCT03692676|42170169|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
19726060|NCT03692676|42170170|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
19726061|NCT03692676|42170171|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
19726062|NCT03692676|42170168|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
19726063|NCT03692676|42170169|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
19726064|NCT03692676|42170170|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
19726065|NCT03692676|42170171|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
19726066|NCT03692676|42170168|FG000|Overall Study|Other|0|||
19726067|NCT03692676|42170169|FG001|Overall Study|Other|805|||
19726068|NCT03692676|42170170|FG002|Overall Study|Other|758|||
19726069|NCT03692676|42170171|FG003|Overall Study|Other|277|||
19726070|NCT03692676|42170168|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
19726071|NCT03692676|42170169|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
19726072|NCT03692676|42170170|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
19726073|NCT03692676|42170171|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
19726074|NCT03691428|42170183|FG000|Overall Study|Withdrawal by Subject|6|||
19726075|NCT03691428|42170184|FG001|Overall Study|Withdrawal by Subject|8|||
19726076|NCT04124952|42170190|FG000|Overall Study|Lost to Follow-up|1|||
19726077|NCT04122534|42170194|FG000|Overall Study|Lost to Follow-up|4|||
19726078|NCT04091360|42170204|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726079|NCT04091360|42170205|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726080|NCT04091360|42170206|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726081|NCT04091360|42170207|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726082|NCT04091360|42170208|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726083|NCT04091360|42170209|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726084|NCT04091360|42170210|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726085|NCT04091360|42170211|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
19726086|NCT04091360|42170212|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
19726087|NCT04091360|42170213|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
19726088|NCT04091360|42170204|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726089|NCT04091360|42170205|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726090|NCT04091360|42170206|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726091|NCT04091360|42170207|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726092|NCT04091360|42170208|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726093|NCT04091360|42170209|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726094|NCT04091360|42170210|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
19726095|NCT04091360|42170211|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
19726096|NCT04091360|42170212|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19726097|NCT04091360|42170213|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
19376399|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19726098|NCT04091360|42170204|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726099|NCT04091360|42170205|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726100|NCT04091360|42170206|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726101|NCT04091360|42170207|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726102|NCT04091360|42170208|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726103|NCT04091360|42170209|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726104|NCT04091360|42170210|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
19726105|NCT04091360|42170211|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726106|NCT04091360|42170212|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
19726107|NCT04091360|42170213|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
19726108|NCT04118166|42170235|FG000|Overall Study|Adverse Event|1|||
19726109|NCT04346628|42170242|FG000|Overall Study|Lost to Follow-up|4|||
19726110|NCT04346628|42170243|FG001|Overall Study|Lost to Follow-up|4|||
19726111|NCT04346628|42170242|FG000|Overall Study|Withdrew (had personal reasons)|2|||
19726112|NCT04346628|42170243|FG001|Overall Study|Withdrew (had personal reasons)|5|||
19726113|NCT04346628|42170242|FG000|Overall Study|Withdrew (medication intolerant)|0|||
19726114|NCT04346628|42170243|FG001|Overall Study|Withdrew (medication intolerant)|3|||
19726115|NCT04346628|42170242|FG000|Overall Study|Withdrew (declined intervention)|0|||
19726116|NCT04346628|42170243|FG001|Overall Study|Withdrew (declined intervention)|1|||
19726117|NCT03681470|42170249|FG000|Overall Study|Lack of Efficacy|3|||
19726118|NCT03681470|42170249|FG000|Overall Study|Lost to Follow-up|1|||
19726119|NCT03681470|42170249|FG000|Overall Study|Protocol Violation|3|||
19726120|NCT03681470|42170249|FG000|Overall Study|Withdrawal by Subject|1|||
19726121|NCT04343976|42170255|FG000|Overall Study|Withdrawal by Subject|0|||
19726122|NCT04343976|42170256|FG001|Overall Study|Withdrawal by Subject|1|||
19726123|NCT03322540|42170264|FG000|Overall Study|Death|21|||
19726124|NCT03322540|42170265|FG001|Overall Study|Death|28|||
19726125|NCT03322540|42170264|FG000|Overall Study|Lost to Follow-up|0|||
19726126|NCT03322540|42170265|FG001|Overall Study|Lost to Follow-up|1|||
19726127|NCT03322540|42170264|FG000|Overall Study|Physician Decision|7|||
19726128|NCT03322540|42170265|FG001|Overall Study|Physician Decision|6|||
19726129|NCT03322540|42170264|FG000|Overall Study|Withdrawal by Subject|3|||
19726130|NCT03322540|42170265|FG001|Overall Study|Withdrawal by Subject|1|||
19726131|NCT03322540|42170264|FG000|Overall Study|Study terminated by sponsor|0|||
19726132|NCT03322540|42170265|FG001|Overall Study|Study terminated by sponsor|1|||
19726133|NCT04339296|42170275|FG000|Overall Study|Refuse to participate after allocation|1|||
19726134|NCT04339296|42170276|FG001|Overall Study|Refuse to participate after allocation|1|||
19726135|NCT04339296|42170275|FG000|Overall Study|Withdrew after completion of baseline|2|||
19726136|NCT04339296|42170276|FG001|Overall Study|Withdrew after completion of baseline|1|||
19726137|NCT04339296|42170275|FG000|Overall Study|Lost to Follow-up|0|||
19726138|NCT04339296|42170276|FG001|Overall Study|Lost to Follow-up|4|||
19726139|NCT04339296|42170275|FG000|Overall Study|Discontinued intervention|5|||
19726140|NCT04339296|42170276|FG001|Overall Study|Discontinued intervention|3|||
19726141|NCT02025556|42170285|FG000|Overall Study|Adverse Event|0|||
19726142|NCT02025556|42170286|FG001|Overall Study|Adverse Event|4|||
19726143|NCT02025556|42170287|FG002|Overall Study|Adverse Event|2|||
19726144|NCT02025556|42170285|FG000|Overall Study|Lack of Efficacy|2|||
19726145|NCT02025556|42170286|FG001|Overall Study|Lack of Efficacy|1|||
19726146|NCT02025556|42170287|FG002|Overall Study|Lack of Efficacy|0|||
19726147|NCT02025556|42170285|FG000|Overall Study|Protocol Violation|2|||
19726148|NCT02025556|42170286|FG001|Overall Study|Protocol Violation|1|||
19726149|NCT02025556|42170287|FG002|Overall Study|Protocol Violation|0|||
19726150|NCT02025556|42170285|FG000|Overall Study|Withdrawal by Subject|0|||
19726151|NCT02025556|42170286|FG001|Overall Study|Withdrawal by Subject|3|||
19726152|NCT02025556|42170287|FG002|Overall Study|Withdrawal by Subject|6|||
19726153|NCT02025556|42170285|FG000|Overall Study|Lost to Follow-up|2|||
19726154|NCT02025556|42170286|FG001|Overall Study|Lost to Follow-up|4|||
19726155|NCT02025556|42170287|FG002|Overall Study|Lost to Follow-up|0|||
19726156|NCT02025556|42170285|FG000|Overall Study|Reason not reported|0|||
19726157|NCT02025556|42170286|FG001|Overall Study|Reason not reported|0|||
19726158|NCT02025556|42170287|FG002|Overall Study|Reason not reported|1|||
19726159|NCT04334460|42170297|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
19726160|NCT04334460|42170298|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
19726161|NCT04334460|42170297|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
19726162|NCT04334460|42170298|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
19726163|NCT04334148|42170307|FG000|Overall Study|positive nasal swab at baseline|0|||
19726164|NCT04334148|42170308|FG001|Overall Study|positive nasal swab at baseline|1|||
19726165|NCT04399122|42170316|FG000|Overall Study|Lost to Follow-up|2|||
19726166|NCT04399122|42170317|FG001|Overall Study|Lost to Follow-up|0|||
19726167|NCT04399122|42170316|FG000|Overall Study|Withdrawal by Subject|1|||
19726168|NCT04399122|42170317|FG001|Overall Study|Withdrawal by Subject|0|||
19726169|NCT04398732|42170338|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
19726170|NCT04398030|42170344|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
19726171|NCT04398030|42170345|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
19726172|NCT04398030|42170344|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
19726173|NCT04398030|42170345|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
19726174|NCT03064438|42170353|FG000|Overall Study|Lost to Follow-up|1|||
19726175|NCT03064438|42170354|FG001|Overall Study|Lost to Follow-up|0|||
19726176|NCT03064438|42170353|FG000|Overall Study|Withdrawal by Subject|0|||
19726177|NCT03064438|42170354|FG001|Overall Study|Withdrawal by Subject|1|||
19726178|NCT04327986|42170360|FG000|Overall Study|Physician Decision|2|||
19726179|NCT04327986|42170361|FG001|Overall Study|Physician Decision|0|||
19726180|NCT04327986|42170362|FG002|Overall Study|Physician Decision|0|||
19726181|NCT04327986|42170360|FG000|Overall Study|Death|1|||
19726182|NCT04327986|42170361|FG001|Overall Study|Death|0|||
19726183|NCT04327986|42170362|FG002|Overall Study|Death|0|||
19726184|NCT04322682|42170368|FG000|Overall Study|Withdrawal by Subject|33|||
19726185|NCT04322682|42170369|FG001|Overall Study|Withdrawal by Subject|47|||
19726186|NCT04322682|42170368|FG000|Overall Study|Death|5|||
19726187|NCT04322682|42170369|FG001|Overall Study|Death|9|||
19726188|NCT04322682|42170368|FG000|Overall Study|Lost to Follow-up|4|||
19726189|NCT04322682|42170369|FG001|Overall Study|Lost to Follow-up|8|||
19726190|NCT04322682|42170368|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
19726191|NCT04322682|42170369|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
19726192|NCT04322526|42170377|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
19726193|NCT04322526|42170378|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
19726194|NCT04322526|42170377|FG000|Washout (1 Week)|Lost to Follow-up|1|||
19726195|NCT04322526|42170378|FG001|Washout (1 Week)|Lost to Follow-up|2|||
19726196|NCT04115358|42170387|FG000|Overall Study|exfoliation|0|||
19726197|NCT04115358|42170388|FG001|Overall Study|exfoliation|0|||
19726198|NCT04115358|42170389|FG002|Overall Study|exfoliation|1|||
19726199|NCT04109118|42170398|FG000|Overall Study|Lost to Follow-up|3|||
19726200|NCT04105998|42170405|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
19726201|NCT04105998|42170406|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
19726202|NCT04397718|42170414|FG000|Overall Study|Death|7|||
19726203|NCT04397718|42170415|FG001|Overall Study|Death|11|||
19726204|NCT04397718|42170414|FG000|Overall Study|Lost to Follow-up|0|||
19726205|NCT04397718|42170415|FG001|Overall Study|Lost to Follow-up|4|||
19726206|NCT04105218|42170423|FG000|Overall Study|Withdrawal by Subject|3|||
19726207|NCT04105218|42170424|FG001|Overall Study|Withdrawal by Subject|2|||
19726208|NCT04105218|42170423|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
19726209|NCT04105218|42170424|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
19726210|NCT04105218|42170423|FG000|Overall Study|Failed screening tests|2|||
19726211|NCT04105218|42170424|FG001|Overall Study|Failed screening tests|1|||
19726212|NCT04317690|42170435|FG000|Overall Study|did not have complete information for primary outcome|0|||
19726213|NCT04317690|42170436|FG001|Overall Study|did not have complete information for primary outcome|4|||
19726214|NCT04317690|42170437|FG002|Overall Study|did not have complete information for primary outcome|0|||
19726215|NCT04317690|42170438|FG003|Overall Study|did not have complete information for primary outcome|2|||
19726216|NCT04317690|42170439|FG004|Overall Study|did not have complete information for primary outcome|0|||
19726217|NCT03721276|42170466|FG000|Overall Study|Lost to Follow-up|5|||
19726218|NCT03721276|42170467|FG001|Overall Study|Lost to Follow-up|3|||
19726219|NCT03721276|42170466|FG000|Overall Study|Adverse Event|0|||
19726220|NCT03721276|42170467|FG001|Overall Study|Adverse Event|1|||
19726221|NCT03269344|42170482|FG000|Overall Study|Protocol Violation|4|||
19726222|NCT03269344|42170483|FG001|Overall Study|Protocol Violation|3|||
19726223|NCT04389840|42170495|FG000|Overall Study|Adverse Event|0|||
19726224|NCT04389840|42170496|FG001|Overall Study|Adverse Event|0|||
19726225|NCT04389840|42170497|FG002|Overall Study|Adverse Event|0|||
19726226|NCT04389840|42170498|FG003|Overall Study|Adverse Event|1|||
19726227|NCT04389840|42170499|FG004|Overall Study|Adverse Event|0|||
19390317|NCT01987960|41634113|FG003|Period 1|Adverse Event|0|||
19376400|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376401|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376402|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376403|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376404|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
19376405|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376406|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376407|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376408|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376409|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
19376410|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376411|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376412|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
19376413|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376414|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376415|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376416|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376417|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376418|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376419|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376420|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376421|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
19376422|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376423|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376424|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
19376425|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376426|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376427|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376428|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376429|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376430|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376431|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376432|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376433|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
19376434|NCT00151775|41618527|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376435|NCT00151775|41618528|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376436|NCT00151775|41618529|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376437|NCT00151775|41618530|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376438|NCT00151775|41618531|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376439|NCT00151775|41618532|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376440|NCT00151775|41618533|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376441|NCT00151775|41618534|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376442|NCT00151775|41618535|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376443|NCT00151775|41618536|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376444|NCT00151775|41618537|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
19376445|NCT00151775|41618538|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
19376446|NCT00151775|41618527|FG000|Period 4: Open Label|Increased blood pressure|0|||
19376447|NCT00151775|41618528|FG001|Period 4: Open Label|Increased blood pressure|0|||
19376448|NCT00151775|41618529|FG002|Period 4: Open Label|Increased blood pressure|0|||
19376449|NCT00151775|41618530|FG003|Period 4: Open Label|Increased blood pressure|0|||
19376450|NCT00151775|41618531|FG004|Period 4: Open Label|Increased blood pressure|1|||
19376451|NCT00151775|41618532|FG005|Period 4: Open Label|Increased blood pressure|0|||
19376452|NCT00151775|41618533|FG006|Period 4: Open Label|Increased blood pressure|0|||
19376453|NCT00151775|41618534|FG007|Period 4: Open Label|Increased blood pressure|0|||
19376454|NCT00151775|41618535|FG008|Period 4: Open Label|Increased blood pressure|0|||
19376455|NCT00151775|41618536|FG009|Period 4: Open Label|Increased blood pressure|1|||
19376456|NCT00151775|41618537|FG010|Period 4: Open Label|Increased blood pressure|0|||
19376457|NCT00151775|41618538|FG011|Period 4: Open Label|Increased blood pressure|0|||
19376458|NCT00151775|41618527|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
19376459|NCT00151775|41618528|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
19376460|NCT00151775|41618529|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
19376461|NCT00151775|41618530|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
19376462|NCT00151775|41618531|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
19376463|NCT00151775|41618532|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
19376464|NCT00151775|41618533|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
19376465|NCT00151775|41618534|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
19376466|NCT00151775|41618535|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
19376467|NCT00151775|41618536|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
19376468|NCT00151775|41618537|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
19376469|NCT00151775|41618538|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
19376470|NCT00151775|41618527|FG000|Period 4: Open Label|Adverse Event|0|||
19376471|NCT00151775|41618528|FG001|Period 4: Open Label|Adverse Event|0|||
19376472|NCT00151775|41618529|FG002|Period 4: Open Label|Adverse Event|0|||
19376473|NCT00151775|41618530|FG003|Period 4: Open Label|Adverse Event|0|||
19376474|NCT00151775|41618531|FG004|Period 4: Open Label|Adverse Event|1|||
19376475|NCT00151775|41618532|FG005|Period 4: Open Label|Adverse Event|0|||
19376476|NCT00151775|41618533|FG006|Period 4: Open Label|Adverse Event|0|||
19376477|NCT00151775|41618534|FG007|Period 4: Open Label|Adverse Event|0|||
19376478|NCT00151775|41618535|FG008|Period 4: Open Label|Adverse Event|0|||
19376479|NCT00151775|41618536|FG009|Period 4: Open Label|Adverse Event|2|||
19376480|NCT00151775|41618537|FG010|Period 4: Open Label|Adverse Event|0|||
19376481|NCT00151775|41618538|FG011|Period 4: Open Label|Adverse Event|0|||
19376482|NCT00151775|41618527|FG000|Period 4: Open Label|Lost to Follow-up|0|||
19376483|NCT00151775|41618528|FG001|Period 4: Open Label|Lost to Follow-up|0|||
19376484|NCT00151775|41618529|FG002|Period 4: Open Label|Lost to Follow-up|0|||
19376485|NCT00151775|41618530|FG003|Period 4: Open Label|Lost to Follow-up|0|||
19376486|NCT00151775|41618531|FG004|Period 4: Open Label|Lost to Follow-up|17|||
19376487|NCT00151775|41618532|FG005|Period 4: Open Label|Lost to Follow-up|0|||
19376488|NCT00151775|41618533|FG006|Period 4: Open Label|Lost to Follow-up|0|||
19376489|NCT00151775|41618534|FG007|Period 4: Open Label|Lost to Follow-up|0|||
19376490|NCT00151775|41618535|FG008|Period 4: Open Label|Lost to Follow-up|0|||
19376491|NCT00151775|41618536|FG009|Period 4: Open Label|Lost to Follow-up|7|||
19376492|NCT00151775|41618537|FG010|Period 4: Open Label|Lost to Follow-up|0|||
19376493|NCT00151775|41618538|FG011|Period 4: Open Label|Lost to Follow-up|0|||
19376494|NCT00151775|41618527|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
19376495|NCT00151775|41618528|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
19376496|NCT00151775|41618529|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
19376497|NCT00151775|41618530|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
19376498|NCT00151775|41618531|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
19376499|NCT00151775|41618532|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
19376500|NCT00151775|41618533|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
19376501|NCT00151775|41618534|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
19376502|NCT00151775|41618535|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
19376503|NCT00151775|41618536|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
19376504|NCT00151775|41618537|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
19376505|NCT00151775|41618538|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
19376506|NCT00151775|41618527|FG000|Period 4: Open Label|Other|0|||
19376507|NCT00151775|41618528|FG001|Period 4: Open Label|Other|0|||
19376508|NCT00151775|41618529|FG002|Period 4: Open Label|Other|0|||
19376509|NCT00151775|41618530|FG003|Period 4: Open Label|Other|0|||
19376510|NCT00151775|41618531|FG004|Period 4: Open Label|Other|1|||
19376511|NCT00151775|41618532|FG005|Period 4: Open Label|Other|0|||
19376512|NCT00151775|41618533|FG006|Period 4: Open Label|Other|0|||
19376513|NCT00151775|41618534|FG007|Period 4: Open Label|Other|0|||
19376514|NCT00151775|41618535|FG008|Period 4: Open Label|Other|0|||
19376515|NCT00151775|41618536|FG009|Period 4: Open Label|Other|3|||
19376516|NCT00151775|41618537|FG010|Period 4: Open Label|Other|0|||
19376517|NCT00151775|41618538|FG011|Period 4: Open Label|Other|0|||
19376518|NCT00151775|41618527|FG000|Period 4: Open Label|Physician Decision|0|||
19376519|NCT00151775|41618528|FG001|Period 4: Open Label|Physician Decision|0|||
19376520|NCT00151775|41618529|FG002|Period 4: Open Label|Physician Decision|0|||
19376521|NCT00151775|41618530|FG003|Period 4: Open Label|Physician Decision|0|||
19376522|NCT00151775|41618531|FG004|Period 4: Open Label|Physician Decision|0|||
19376523|NCT00151775|41618532|FG005|Period 4: Open Label|Physician Decision|0|||
19376524|NCT00151775|41618533|FG006|Period 4: Open Label|Physician Decision|0|||
19376525|NCT00151775|41618534|FG007|Period 4: Open Label|Physician Decision|0|||
19376526|NCT00151775|41618535|FG008|Period 4: Open Label|Physician Decision|0|||
19376527|NCT00151775|41618536|FG009|Period 4: Open Label|Physician Decision|2|||
19376528|NCT00151775|41618537|FG010|Period 4: Open Label|Physician Decision|0|||
19376529|NCT00151775|41618538|FG011|Period 4: Open Label|Physician Decision|0|||
19376530|NCT00151775|41618527|FG000|Period 4: Open Label|Protocol Violation|0|||
19376531|NCT00151775|41618528|FG001|Period 4: Open Label|Protocol Violation|0|||
19376532|NCT00151775|41618529|FG002|Period 4: Open Label|Protocol Violation|0|||
19376533|NCT00151775|41618530|FG003|Period 4: Open Label|Protocol Violation|0|||
19376534|NCT00151775|41618531|FG004|Period 4: Open Label|Protocol Violation|1|||
19376535|NCT00151775|41618532|FG005|Period 4: Open Label|Protocol Violation|0|||
19376536|NCT00151775|41618533|FG006|Period 4: Open Label|Protocol Violation|0|||
19376537|NCT00151775|41618534|FG007|Period 4: Open Label|Protocol Violation|0|||
19376538|NCT00151775|41618535|FG008|Period 4: Open Label|Protocol Violation|0|||
19376539|NCT00151775|41618536|FG009|Period 4: Open Label|Protocol Violation|0|||
19376540|NCT00151775|41618537|FG010|Period 4: Open Label|Protocol Violation|0|||
19376541|NCT00151775|41618538|FG011|Period 4: Open Label|Protocol Violation|0|||
19376542|NCT02258464|41618581|FG000|Overall Study|Progressive disease (PD)|9|||
19376543|NCT02258464|41618582|FG001|Overall Study|Progressive disease (PD)|17|||
19376544|NCT02258464|41618581|FG000|Overall Study|Study drug never administered|1|||
19376545|NCT02258464|41618582|FG001|Overall Study|Study drug never administered|1|||
19376546|NCT02258464|41618581|FG000|Overall Study|AE not related to clinical PD|1|||
19376547|NCT02258464|41618582|FG001|Overall Study|AE not related to clinical PD|3|||
19376548|NCT02258464|41618581|FG000|Overall Study|Withdrawal by Subject|5|||
19376549|NCT02258464|41618582|FG001|Overall Study|Withdrawal by Subject|4|||
19376550|NCT02258464|41618581|FG000|Overall Study|AE related to clinical PD|1|||
19376551|NCT02258464|41618582|FG001|Overall Study|AE related to clinical PD|0|||
19376552|NCT02682901|41618590|FG000|Overall Study|Adverse Event|10|||
19376553|NCT02682901|41618591|FG001|Overall Study|Adverse Event|3|||
19376554|NCT02682901|41618590|FG000|Overall Study|Lack of Efficacy|0|||
19376555|NCT02682901|41618591|FG001|Overall Study|Lack of Efficacy|1|||
19376556|NCT02258074|41618601|FG000|Overall Study|Withdrawal by Subject|1|||
19376557|NCT02258074|41618602|FG001|Overall Study|Withdrawal by Subject|0|||
19376558|NCT02258074|41618603|FG002|Overall Study|Withdrawal by Subject|0|||
19376559|NCT02258074|41618604|FG003|Overall Study|Withdrawal by Subject|0|||
19376560|NCT02257684|41618614|FG000|Overall Study|Adverse Event|2|||
19376561|NCT02257684|41618614|FG000|Overall Study|Lack of Efficacy|1|||
19376562|NCT02257684|41618614|FG000|Overall Study|Sponsor's Decision|1|||
19376563|NCT01643044|41618620|FG000|Overall Study|Lost to Follow-up|1|||
19376564|NCT01643044|41618621|FG001|Overall Study|Lost to Follow-up|1|||
19376565|NCT01643044|41618620|FG000|Overall Study|Miscarried baby|2|||
19376566|NCT01643044|41618621|FG001|Overall Study|Miscarried baby|2|||
19376567|NCT01643044|41618620|FG000|Overall Study|Delivered outside of hospital|1|||
19376568|NCT01643044|41618621|FG001|Overall Study|Delivered outside of hospital|2|||
19376569|NCT01642732|41618627|FG000|Overall Study|Withdrawal by Subject|1|||
19376570|NCT02190721|41618634|FG000|Overall Study|Patient was out of the city|0|||
19376571|NCT02190721|41618635|FG001|Overall Study|Patient was out of the city|1|||
19376572|NCT02190721|41618636|FG002|Overall Study|Patient was out of the city|0|||
19376573|NCT00581477|41618644|FG000|Overall Study|Physician Decision|2|||
19376574|NCT02348008|41618660|FG000|Overall Study|Adverse Event|2|||
19376575|NCT02348008|41618661|FG001|Overall Study|Adverse Event|3|||
19376576|NCT02348008|41618662|FG002|Overall Study|Adverse Event|3|||
19376577|NCT02348008|41618660|FG000|Overall Study|Disease Progression|1|||
19376578|NCT02348008|41618661|FG001|Overall Study|Disease Progression|5|||
19376579|NCT02348008|41618662|FG002|Overall Study|Disease Progression|16|||
19376580|NCT02348008|41618660|FG000|Overall Study|Withdrawal by Subject|0|||
19376581|NCT02348008|41618661|FG001|Overall Study|Withdrawal by Subject|1|||
19376582|NCT02348008|41618662|FG002|Overall Study|Withdrawal by Subject|0|||
19376583|NCT02348008|41618660|FG000|Overall Study|Symptomatic Deterioration|0|||
19376584|NCT02348008|41618661|FG001|Overall Study|Symptomatic Deterioration|1|||
19376585|NCT02348008|41618662|FG002|Overall Study|Symptomatic Deterioration|0|||
19376586|NCT00495131|41618670|FG000|Overall Study|Adverse Event|6|||
19376587|NCT00495131|41618671|FG001|Overall Study|Adverse Event|2|||
19376588|NCT00495131|41618670|FG000|Overall Study|Lack of Efficacy|0|||
19376589|NCT00495131|41618671|FG001|Overall Study|Lack of Efficacy|2|||
19376590|NCT00495131|41618670|FG000|Overall Study|Lost to Follow-up|0|||
19376591|NCT00495131|41618671|FG001|Overall Study|Lost to Follow-up|2|||
19376592|NCT00495131|41618670|FG000|Overall Study|Withdrawal by Subject|1|||
19376593|NCT00495131|41618671|FG001|Overall Study|Withdrawal by Subject|0|||
19376594|NCT02257372|41618677|FG000|Overall Study|Adverse Event|3|||
19376595|NCT02257372|41618678|FG001|Overall Study|Adverse Event|7|||
19376596|NCT02257372|41618677|FG000|Overall Study|Lack of Efficacy|2|||
19376597|NCT02257372|41618678|FG001|Overall Study|Lack of Efficacy|1|||
19376598|NCT02257372|41618677|FG000|Overall Study|Protocol Violation|1|||
19376599|NCT02257372|41618678|FG001|Overall Study|Protocol Violation|1|||
19376600|NCT02257372|41618677|FG000|Overall Study|Lost to Follow-up|0|||
19376601|NCT02257372|41618678|FG001|Overall Study|Lost to Follow-up|1|||
19376602|NCT02257372|41618677|FG000|Overall Study|Withdrew consent|1|||
19376603|NCT02257372|41618678|FG001|Overall Study|Withdrew consent|0|||
19376604|NCT02256982|41618686|FG000|Overall Study|Disease Progression|0|||
19376605|NCT02256982|41618687|FG001|Overall Study|Disease Progression|1|||
19376606|NCT02736721|41618693|FG000|Overall Study|Adverse Event|8|||
19376607|NCT02736721|41618693|FG000|Overall Study|Lost to Follow-up|3|||
19376608|NCT02736721|41618693|FG000|Overall Study|Other|5|||
19376609|NCT04176445|41618697|FG000|Overall Study|Adverse Event|0|||
19376610|NCT04176445|41618698|FG001|Overall Study|Adverse Event|1|||
19376611|NCT04176445|41618697|FG000|Overall Study|change plans weaning after first intervention|0|||
19376612|NCT04176445|41618698|FG001|Overall Study|change plans weaning after first intervention|1|||
19376613|NCT02738203|41618706|FG000|Overall Study|Failed IUD Insertion|2|||
19376614|NCT02738203|41618707|FG001|Overall Study|Failed IUD Insertion|2|||
19376615|NCT02738203|41618706|FG000|Overall Study|Protocol Violation|0|||
19376616|NCT02738203|41618707|FG001|Overall Study|Protocol Violation|1|||
19376617|NCT02452034|41618719|FG000|Overall Study|Adverse Event|0|||
19376618|NCT02452034|41618720|FG001|Overall Study|Adverse Event|0|||
19376619|NCT02452034|41618721|FG002|Overall Study|Adverse Event|0|||
19376620|NCT02452034|41618722|FG003|Overall Study|Adverse Event|0|||
19376621|NCT02452034|41618723|FG004|Overall Study|Adverse Event|0|||
19376622|NCT02452034|41618724|FG005|Overall Study|Adverse Event|1|||
19376623|NCT02452034|41618719|FG000|Overall Study|Death|0|||
19376624|NCT02452034|41618720|FG001|Overall Study|Death|0|||
19376625|NCT02452034|41618721|FG002|Overall Study|Death|0|||
19376626|NCT02452034|41618722|FG003|Overall Study|Death|0|||
19376627|NCT02452034|41618723|FG004|Overall Study|Death|1|||
19376628|NCT02452034|41618724|FG005|Overall Study|Death|1|||
19376629|NCT02452034|41618719|FG000|Overall Study|Physician Decision|0|||
19376630|NCT02452034|41618720|FG001|Overall Study|Physician Decision|1|||
19376631|NCT02452034|41618721|FG002|Overall Study|Physician Decision|1|||
19376632|NCT02452034|41618722|FG003|Overall Study|Physician Decision|0|||
19376633|NCT02452034|41618723|FG004|Overall Study|Physician Decision|0|||
19376634|NCT02452034|41618724|FG005|Overall Study|Physician Decision|0|||
19376635|NCT02452034|41618719|FG000|Overall Study|Protocol Violation|0|||
19376636|NCT02452034|41618720|FG001|Overall Study|Protocol Violation|0|||
19376637|NCT02452034|41618721|FG002|Overall Study|Protocol Violation|0|||
19376638|NCT02452034|41618722|FG003|Overall Study|Protocol Violation|0|||
19376639|NCT02452034|41618723|FG004|Overall Study|Protocol Violation|0|||
19376640|NCT02452034|41618724|FG005|Overall Study|Protocol Violation|1|||
19376641|NCT02452034|41618719|FG000|Overall Study|Screen Failure|1|||
19376642|NCT02452034|41618720|FG001|Overall Study|Screen Failure|0|||
19376643|NCT02452034|41618721|FG002|Overall Study|Screen Failure|0|||
19376644|NCT02452034|41618722|FG003|Overall Study|Screen Failure|1|||
19376645|NCT02452034|41618723|FG004|Overall Study|Screen Failure|0|||
19376646|NCT02452034|41618724|FG005|Overall Study|Screen Failure|0|||
19376647|NCT02452034|41618719|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
19376648|NCT02452034|41618720|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
19376649|NCT02452034|41618721|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
19376650|NCT02452034|41618722|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
19376651|NCT02452034|41618723|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
19376652|NCT02452034|41618724|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
19376653|NCT02482298|41618751|FG000|Overall Study|Withdrawal by Subject|2|||
19376654|NCT02482298|41618752|FG001|Overall Study|Withdrawal by Subject|1|||
19376655|NCT02482298|41618753|FG002|Overall Study|Withdrawal by Subject|2|||
19376656|NCT02482298|41618751|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
19376657|NCT02482298|41618752|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
19376658|NCT02482298|41618753|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
19376659|NCT02482298|41618751|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
19376660|NCT02482298|41618752|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
19376661|NCT02482298|41618753|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
19376662|NCT02482298|41618751|FG000|Overall Study|Lost to Follow-up|0|||
19376663|NCT02482298|41618752|FG001|Overall Study|Lost to Follow-up|1|||
19376664|NCT02482298|41618753|FG002|Overall Study|Lost to Follow-up|0|||
19376665|NCT00440531|41618764|FG000|Overall Study|Adverse Event|1|||
19376666|NCT00440531|41618765|FG001|Overall Study|Adverse Event|0|||
19376667|NCT00440531|41618766|FG002|Overall Study|Adverse Event|2|||
19376668|NCT00440531|41618764|FG000|Overall Study|Withdrawal by Subject|2|||
19376669|NCT00440531|41618765|FG001|Overall Study|Withdrawal by Subject|0|||
19376670|NCT00440531|41618766|FG002|Overall Study|Withdrawal by Subject|0|||
19376671|NCT00440531|41618764|FG000|Overall Study|Protocol Violation|1|||
19376672|NCT00440531|41618765|FG001|Overall Study|Protocol Violation|2|||
19376673|NCT00440531|41618766|FG002|Overall Study|Protocol Violation|0|||
19376674|NCT00440531|41618764|FG000|Overall Study|Lost to Follow-up|4|||
19376675|NCT00440531|41618765|FG001|Overall Study|Lost to Follow-up|3|||
19376676|NCT00440531|41618766|FG002|Overall Study|Lost to Follow-up|5|||
19376677|NCT00440531|41618764|FG000|Overall Study|see pre-assignment details|2|||
19376678|NCT00440531|41618765|FG001|Overall Study|see pre-assignment details|0|||
19376679|NCT00440531|41618766|FG002|Overall Study|see pre-assignment details|0|||
19376680|NCT02513732|41618772|FG000|Overall Study|Lost to Follow-up|11|||
19376681|NCT02513732|41618772|FG000|Overall Study|Death|9|||
19376682|NCT02513732|41618772|FG000|Overall Study|Changing hospital|2|||
19376683|NCT00429923|41618779|FG000|Overall Study|Adverse Event|0|||
19376684|NCT00429923|41618780|FG001|Overall Study|Adverse Event|2|||
19376685|NCT00429923|41618781|FG002|Overall Study|Adverse Event|3|||
19376686|NCT00429923|41618779|FG000|Overall Study|Lack of Efficacy|4|||
19376687|NCT00429923|41618780|FG001|Overall Study|Lack of Efficacy|1|||
19376688|NCT00429923|41618781|FG002|Overall Study|Lack of Efficacy|33|||
19376689|NCT00429923|41618779|FG000|Overall Study|Lost to Follow-up|0|||
19376690|NCT00429923|41618780|FG001|Overall Study|Lost to Follow-up|0|||
19376691|NCT00429923|41618781|FG002|Overall Study|Lost to Follow-up|2|||
19376692|NCT00429923|41618779|FG000|Overall Study|Withdrew Consent|1|||
19376693|NCT00429923|41618780|FG001|Overall Study|Withdrew Consent|0|||
19376694|NCT00429923|41618781|FG002|Overall Study|Withdrew Consent|1|||
19376695|NCT00429923|41618779|FG000|Overall Study|Early Termination|0|||
19376696|NCT00429923|41618780|FG001|Overall Study|Early Termination|1|||
19376697|NCT00429923|41618781|FG002|Overall Study|Early Termination|0|||
19376698|NCT02256436|41618788|FG000|Overall Study|Adverse Event|9|||
19376699|NCT02256436|41618789|FG001|Overall Study|Adverse Event|14|||
19376700|NCT02256436|41618788|FG000|Overall Study|Death|216|||
19376701|NCT02256436|41618789|FG001|Overall Study|Death|208|||
19376702|NCT02256436|41618788|FG000|Overall Study|Lost to Follow-up|1|||
19376703|NCT02256436|41618789|FG001|Overall Study|Lost to Follow-up|2|||
19376704|NCT02256436|41618788|FG000|Overall Study|Physician Decision|1|||
19376705|NCT02256436|41618789|FG001|Overall Study|Physician Decision|0|||
19376706|NCT02256436|41618788|FG000|Overall Study|Protocol Violation|0|||
19376707|NCT02256436|41618789|FG001|Overall Study|Protocol Violation|1|||
19376708|NCT02256436|41618788|FG000|Overall Study|Withdrawal by Subject|26|||
19376709|NCT02256436|41618789|FG001|Overall Study|Withdrawal by Subject|10|||
19376710|NCT02256436|41618788|FG000|Overall Study|Transferred to Extension Study|11|||
19376711|NCT02256436|41618789|FG001|Overall Study|Transferred to Extension Study|23|||
19376712|NCT02256436|41618788|FG000|Overall Study|Did Not Continue on Extension Study|8|||
19376713|NCT02256436|41618789|FG001|Overall Study|Did Not Continue on Extension Study|12|||
19376714|NCT02481830|41618798|FG000|Overall Study|No longer meets Study Criteria|1|||
19376715|NCT02481830|41618799|FG001|Overall Study|No longer meets Study Criteria|4|||
19376716|NCT02481830|41618798|FG000|Overall Study|Withdrawal by Subject|0|||
19376717|NCT02481830|41618799|FG001|Overall Study|Withdrawal by Subject|14|||
19376718|NCT02481830|41618798|FG000|Overall Study|Disease Progression|1|||
19376719|NCT02481830|41618799|FG001|Overall Study|Disease Progression|1|||
19376720|NCT02481830|41618798|FG000|Overall Study|Participant not eligible for trial|0|||
19376721|NCT02481830|41618799|FG001|Overall Study|Participant not eligible for trial|1|||
19376722|NCT00326183|41618807|FG000|Overall Study|Lost to Follow-up|104|||
19376723|NCT00326183|41618808|FG001|Overall Study|Lost to Follow-up|56|||
19376724|NCT00326183|41618807|FG000|Overall Study|Protocol Violation|6|||
19376725|NCT00326183|41618808|FG001|Overall Study|Protocol Violation|3|||
19376726|NCT00326183|41618807|FG000|Overall Study|Withdrawal by Subject|35|||
19376727|NCT00326183|41618808|FG001|Overall Study|Withdrawal by Subject|7|||
19376728|NCT00326183|41618807|FG000|Overall Study|Subject Moved|7|||
19376729|NCT00326183|41618808|FG001|Overall Study|Subject Moved|4|||
19376730|NCT00326183|41618807|FG000|Overall Study|Other|47|||
19376731|NCT00326183|41618808|FG001|Overall Study|Other|13|||
19376732|NCT00326183|41618807|FG000|Overall Study|Adverse Event|1|||
19376733|NCT00326183|41618808|FG001|Overall Study|Adverse Event|0|||
19376734|NCT02481050|41618812|FG000|Overall Study|Adverse Event|1|||
19376735|NCT02481050|41618812|FG000|Overall Study|Disease Progression|47|||
19376736|NCT02481050|41618812|FG000|Overall Study|Withdrawal by Subject|7|||
19376737|NCT02481050|41618812|FG000|Overall Study|Other|3|||
19376738|NCT02511782|41618819|FG000|Overall Study|Withdrawal by Subject|1|||
19376739|NCT02511782|41618820|FG001|Overall Study|Withdrawal by Subject|0|||
19376740|NCT02511782|41618821|FG002|Overall Study|Withdrawal by Subject|0|||
19376741|NCT02480114|41618831|FG000|Overall Study|Not completing surveys|3|||
19376742|NCT02480114|41618832|FG001|Overall Study|Not completing surveys|2|||
19376743|NCT02480114|41618831|FG000|Overall Study|Withdrawal by Subject|2|||
19376744|NCT02480114|41618832|FG001|Overall Study|Withdrawal by Subject|4|||
19376745|NCT02480114|41618831|FG000|Overall Study|Disease progression|3|||
19376746|NCT02480114|41618832|FG001|Overall Study|Disease progression|0|||
19376747|NCT02480114|41618831|FG000|Overall Study|Improper completion of survey|1|||
19376748|NCT02480114|41618832|FG001|Overall Study|Improper completion of survey|1|||
19376749|NCT02480114|41618831|FG000|Overall Study|Not eligible|0|||
19376750|NCT02480114|41618832|FG001|Overall Study|Not eligible|1|||
19376751|NCT02479880|41618840|FG000|Overall Study|Study Terminated by Sponsor|13|||
19376752|NCT02479880|41618841|FG001|Overall Study|Study Terminated by Sponsor|12|||
19376753|NCT02479880|41618840|FG000|Overall Study|Pregnancy|0|||
19376754|NCT02479880|41618841|FG001|Overall Study|Pregnancy|1|||
19376755|NCT02479802|41618847|FG000|Overall Study|Lost to Follow-up|1|||
19376756|NCT02479802|41618847|FG000|Overall Study|Adverse Event|1|||
19376757|NCT02479412|41618860|FG000|Overall Study|Adverse Event|0|||
19376758|NCT02479412|41618861|FG001|Overall Study|Adverse Event|0|||
19376759|NCT02479412|41618862|FG002|Overall Study|Adverse Event|1|||
19376760|NCT02479412|41618863|FG003|Overall Study|Adverse Event|0|||
19376761|NCT02479412|41618864|FG004|Overall Study|Adverse Event|0|||
19376762|NCT02479412|41618865|FG005|Overall Study|Adverse Event|0|||
19376763|NCT02479412|41618866|FG006|Overall Study|Adverse Event|0|||
19376764|NCT02479412|41618867|FG007|Overall Study|Adverse Event|0|||
19376765|NCT02479412|41618868|FG008|Overall Study|Adverse Event|0|||
19376766|NCT02479412|41618860|FG000|Overall Study|Study-specific withdrawal criteria|0|||
19376767|NCT02479412|41618861|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19376768|NCT02479412|41618862|FG002|Overall Study|Study-specific withdrawal criteria|1|||
19376769|NCT02479412|41618863|FG003|Overall Study|Study-specific withdrawal criteria|1|||
19376770|NCT02479412|41618864|FG004|Overall Study|Study-specific withdrawal criteria|0|||
19376771|NCT02479412|41618865|FG005|Overall Study|Study-specific withdrawal criteria|0|||
19376772|NCT02479412|41618866|FG006|Overall Study|Study-specific withdrawal criteria|0|||
19376773|NCT02479412|41618867|FG007|Overall Study|Study-specific withdrawal criteria|1|||
19376774|NCT02479412|41618868|FG008|Overall Study|Study-specific withdrawal criteria|1|||
19376775|NCT02479412|41618860|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
19376776|NCT02479412|41618861|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
19376777|NCT02479412|41618862|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
19376778|NCT02479412|41618863|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
19376779|NCT02479412|41618864|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
19376780|NCT02479412|41618865|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
19376781|NCT02479412|41618866|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
19376782|NCT02479412|41618867|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
19376783|NCT02479412|41618868|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
19376784|NCT00224003|41618884|FG000|Overall Study|Adverse Event|1|||
19376785|NCT00224003|41618884|FG000|Overall Study|Protocol Violation|2|||
19376786|NCT00224003|41618884|FG000|Overall Study|Withdrawal by Subject|1|||
19376787|NCT00224003|41618884|FG000|Overall Study|unk|3|||
19376788|NCT02450552|41618890|FG000|Overall Study|Withdrawal by Subject|4|||
19376789|NCT02450552|41618891|FG001|Overall Study|Withdrawal by Subject|0|||
19376790|NCT02450552|41618892|FG002|Overall Study|Withdrawal by Subject|4|||
19376791|NCT02450552|41618890|FG000|Overall Study|Physician Decision|1|||
19376792|NCT02450552|41618891|FG001|Overall Study|Physician Decision|0|||
19376793|NCT02450552|41618892|FG002|Overall Study|Physician Decision|1|||
19376794|NCT02508428|41618902|FG000|Overall Study|Death|32|||
19376795|NCT02508428|41618903|FG001|Overall Study|Death|33|||
19376796|NCT02508428|41618902|FG000|Overall Study|Liner revised|3|||
19376797|NCT02508428|41618903|FG001|Overall Study|Liner revised|19|||
19376798|NCT02508428|41618902|FG000|Overall Study|Incomplete follow-up|17|||
19376799|NCT02508428|41618903|FG001|Overall Study|Incomplete follow-up|15|||
19376800|NCT02448680|41618911|FG000|Overall Study|Physician Decision|1|||
19376801|NCT02448680|41618912|FG001|Overall Study|Physician Decision|1|||
19376802|NCT02448680|41618911|FG000|Overall Study|Withdrawal by Subject|0|||
19376803|NCT02448680|41618912|FG001|Overall Study|Withdrawal by Subject|2|||
19376804|NCT02448446|41618922|FG000|Overall Study|Withdrawal by Subject|1|||
19376805|NCT02448446|41618923|FG001|Overall Study|Withdrawal by Subject|0|||
19376806|NCT02447744|41618931|FG000|Overall Study|Withdrawal by Subject|3|||
19376807|NCT02447744|41618932|FG001|Overall Study|Withdrawal by Subject|1|||
19376808|NCT02447744|41618931|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
19376809|NCT02447744|41618932|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
19376810|NCT02478632|41618940|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
19376811|NCT02478632|41618941|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
19376812|NCT02478632|41618940|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
19376813|NCT02478632|41618941|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
19376814|NCT02478632|41618940|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
19376815|NCT02478632|41618941|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
19376816|NCT02478398|41618952|FG000|Overall Study|Adverse Event|20|||
19376817|NCT02478398|41618953|FG001|Overall Study|Adverse Event|5|||
19376818|NCT02478398|41618952|FG000|Overall Study|Lost to Follow-up|5|||
19376819|NCT02478398|41618953|FG001|Overall Study|Lost to Follow-up|4|||
19376820|NCT02478398|41618952|FG000|Overall Study|Non-Compliance With Study Drug|5|||
19376821|NCT02478398|41618953|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19376822|NCT02478398|41618952|FG000|Overall Study|Protocol Violation|3|||
19376823|NCT02478398|41618953|FG001|Overall Study|Protocol Violation|1|||
19376824|NCT02478398|41618952|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
19376825|NCT02478398|41618953|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
19376826|NCT02478398|41618952|FG000|Overall Study|Withdrawal By Participant|10|||
19376827|NCT02478398|41618953|FG001|Overall Study|Withdrawal By Participant|4|||
19376828|NCT02478164|41618960|FG000|Overall Study|Lack of Efficacy|13|||
19376829|NCT02478164|41618960|FG000|Overall Study|Adverse Event|1|||
19376830|NCT02478164|41618960|FG000|Overall Study|Withdrawal by Subject|1|||
19376831|NCT02476994|41618966|FG000|Overall Study|Based on feedback from FDA|1|||
19376832|NCT02476994|41618967|FG001|Overall Study|Based on feedback from FDA|0|||
19376833|NCT02508194|41618975|FG000|Overall Study|Death|5|||
19376834|NCT02508194|41618976|FG001|Overall Study|Death|3|||
19376835|NCT02508194|41618975|FG000|Overall Study|Lost to Follow-up|25|||
19376836|NCT02508194|41618976|FG001|Overall Study|Lost to Follow-up|18|||
19376837|NCT02508194|41618975|FG000|Overall Study|Withdrawal by Subject|20|||
19376838|NCT02508194|41618976|FG001|Overall Study|Withdrawal by Subject|18|||
19376839|NCT02508194|41618975|FG000|Overall Study|Error in Randomization|1|||
19376840|NCT02508194|41618976|FG001|Overall Study|Error in Randomization|3|||
19376841|NCT02508194|41618975|FG000|Overall Study|Principal Investigator Decision|1|||
19376842|NCT02508194|41618976|FG001|Overall Study|Principal Investigator Decision|2|||
19376843|NCT02508116|41618984|FG000|Overall Study|Lost to Follow-up|2|||
19376844|NCT02508116|41618985|FG001|Overall Study|Lost to Follow-up|3|||
19376845|NCT02508116|41618984|FG000|Overall Study|Withdrawal by Subject|3|||
19376846|NCT02508116|41618985|FG001|Overall Study|Withdrawal by Subject|2|||
19376847|NCT02508116|41618984|FG000|Overall Study|Protocol Violation|1|||
19376848|NCT02508116|41618985|FG001|Overall Study|Protocol Violation|2|||
19376849|NCT02508116|41618984|FG000|Overall Study|Physician Decision|2|||
19376850|NCT02508116|41618985|FG001|Overall Study|Physician Decision|0|||
19376851|NCT01653782|41618994|FG000|Overall Study|Withdrawal by Subject|9|||
19376852|NCT01653782|41618995|FG001|Overall Study|Withdrawal by Subject|15|||
19376853|NCT01653782|41618996|FG002|Overall Study|Withdrawal by Subject|4|||
19376854|NCT01653782|41618994|FG000|Overall Study|Lost to Follow-up|7|||
19376855|NCT01653782|41618995|FG001|Overall Study|Lost to Follow-up|3|||
19376856|NCT01653782|41618996|FG002|Overall Study|Lost to Follow-up|2|||
19376857|NCT02318329|41619014|FG000|Overall Study|Progressive Disease|2|||
19376858|NCT02318329|41619015|FG001|Overall Study|Progressive Disease|3|||
19376859|NCT02318329|41619016|FG002|Overall Study|Progressive Disease|2|||
19376860|NCT02318329|41619017|FG003|Overall Study|Progressive Disease|3|||
19376861|NCT02318329|41619018|FG004|Overall Study|Progressive Disease|3|||
19376862|NCT02318329|41619019|FG005|Overall Study|Progressive Disease|3|||
19376863|NCT02318329|41619020|FG006|Overall Study|Progressive Disease|1|||
19376864|NCT02318329|41619021|FG007|Overall Study|Progressive Disease|1|||
19376865|NCT02318329|41619022|FG008|Overall Study|Progressive Disease|5|||
19376866|NCT02318329|41619023|FG009|Overall Study|Progressive Disease|39|||
19376867|NCT02318329|41619014|FG000|Overall Study|Death|0|||
19376868|NCT02318329|41619015|FG001|Overall Study|Death|0|||
19376869|NCT02318329|41619016|FG002|Overall Study|Death|0|||
19376870|NCT02318329|41619017|FG003|Overall Study|Death|0|||
19376871|NCT02318329|41619018|FG004|Overall Study|Death|0|||
19376872|NCT02318329|41619019|FG005|Overall Study|Death|0|||
19376873|NCT02318329|41619020|FG006|Overall Study|Death|0|||
19376874|NCT02318329|41619021|FG007|Overall Study|Death|0|||
19376875|NCT02318329|41619022|FG008|Overall Study|Death|0|||
19376876|NCT02318329|41619023|FG009|Overall Study|Death|5|||
19376877|NCT02318329|41619014|FG000|Overall Study|Lost to Follow-up|0|||
19376878|NCT02318329|41619015|FG001|Overall Study|Lost to Follow-up|0|||
19376879|NCT02318329|41619016|FG002|Overall Study|Lost to Follow-up|0|||
19376880|NCT02318329|41619017|FG003|Overall Study|Lost to Follow-up|0|||
19376881|NCT02318329|41619018|FG004|Overall Study|Lost to Follow-up|0|||
19376882|NCT02318329|41619019|FG005|Overall Study|Lost to Follow-up|0|||
19376883|NCT02318329|41619020|FG006|Overall Study|Lost to Follow-up|0|||
19376884|NCT02318329|41619021|FG007|Overall Study|Lost to Follow-up|0|||
19376885|NCT02318329|41619022|FG008|Overall Study|Lost to Follow-up|0|||
19376886|NCT02318329|41619023|FG009|Overall Study|Lost to Follow-up|1|||
19376887|NCT02318329|41619014|FG000|Overall Study|Withdrawal by Subject|0|||
19376888|NCT02318329|41619015|FG001|Overall Study|Withdrawal by Subject|0|||
19376889|NCT02318329|41619016|FG002|Overall Study|Withdrawal by Subject|0|||
19376890|NCT02318329|41619017|FG003|Overall Study|Withdrawal by Subject|0|||
19376891|NCT02318329|41619018|FG004|Overall Study|Withdrawal by Subject|0|||
19376892|NCT02318329|41619019|FG005|Overall Study|Withdrawal by Subject|0|||
19376893|NCT02318329|41619020|FG006|Overall Study|Withdrawal by Subject|0|||
19376894|NCT02318329|41619021|FG007|Overall Study|Withdrawal by Subject|0|||
19376895|NCT02318329|41619022|FG008|Overall Study|Withdrawal by Subject|0|||
19376896|NCT02318329|41619023|FG009|Overall Study|Withdrawal by Subject|6|||
19376897|NCT02318329|41619014|FG000|Overall Study|Other|1|||
19376898|NCT02318329|41619015|FG001|Overall Study|Other|1|||
19376899|NCT02318329|41619016|FG002|Overall Study|Other|1|||
19376900|NCT02318329|41619017|FG003|Overall Study|Other|0|||
19376901|NCT02318329|41619018|FG004|Overall Study|Other|0|||
19376902|NCT02318329|41619019|FG005|Overall Study|Other|0|||
19376903|NCT02318329|41619020|FG006|Overall Study|Other|0|||
19376904|NCT02318329|41619021|FG007|Overall Study|Other|0|||
19376905|NCT02318329|41619022|FG008|Overall Study|Other|1|||
19376906|NCT02318329|41619023|FG009|Overall Study|Other|1|||
19376907|NCT02255656|41619064|FG000|Overall Study|Adverse Event|11|||
19376908|NCT02255656|41619064|FG000|Overall Study|Poor compliance to protocol|3|||
19376909|NCT02255656|41619064|FG000|Overall Study|Lost to Follow-up|30|||
19376910|NCT02255656|41619064|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
19376911|NCT02255656|41619064|FG000|Overall Study|Other|126|||
19376912|NCT02255500|41619077|FG000|Overall Study|Withdrawal by Subject|1|||
19376913|NCT02255500|41619078|FG001|Overall Study|Withdrawal by Subject|0|||
19376914|NCT02505542|41619084|FG000|Part A: Open-Label Period|Adverse Event|31|||
19376915|NCT02505542|41619085|FG001|Part A: Open-Label Period|Adverse Event|0|||
19376916|NCT02505542|41619086|FG002|Part A: Open-Label Period|Adverse Event|0|||
19376917|NCT02505542|41619087|FG003|Part A: Open-Label Period|Adverse Event|0|||
19376918|NCT02505542|41619084|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
19376919|NCT02505542|41619085|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
19376920|NCT02505542|41619086|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
19376921|NCT02505542|41619087|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
19376922|NCT02505542|41619084|FG000|Part A: Open-Label Period|Protocol Violation|1|||
19376923|NCT02505542|41619085|FG001|Part A: Open-Label Period|Protocol Violation|0|||
19376924|NCT02505542|41619086|FG002|Part A: Open-Label Period|Protocol Violation|0|||
19376925|NCT02505542|41619087|FG003|Part A: Open-Label Period|Protocol Violation|0|||
19376926|NCT02505542|41619084|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
19376927|NCT02505542|41619085|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
19376928|NCT02505542|41619086|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
19376929|NCT02505542|41619087|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
19376930|NCT02505542|41619084|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
19376931|NCT02505542|41619085|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
19376932|NCT02505542|41619086|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
19376933|NCT02505542|41619087|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
19376934|NCT02505542|41619084|FG000|Part A: Open-Label Period|New medical history available|1|||
19376935|NCT02505542|41619085|FG001|Part A: Open-Label Period|New medical history available|0|||
19376936|NCT02505542|41619086|FG002|Part A: Open-Label Period|New medical history available|0|||
19376937|NCT02505542|41619087|FG003|Part A: Open-Label Period|New medical history available|0|||
19376938|NCT02505542|41619084|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
19376939|NCT02505542|41619085|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
19376940|NCT02505542|41619086|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
19376941|NCT02505542|41619087|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
19376942|NCT02505542|41619084|FG000|Part A: Open-Label Period|Pregnancy|2|||
19376943|NCT02505542|41619085|FG001|Part A: Open-Label Period|Pregnancy|0|||
19376944|NCT02505542|41619086|FG002|Part A: Open-Label Period|Pregnancy|0|||
19376945|NCT02505542|41619087|FG003|Part A: Open-Label Period|Pregnancy|0|||
19376946|NCT02505542|41619084|FG000|Part A: Open-Label Period|Sponsor directive|1|||
19376947|NCT02505542|41619085|FG001|Part A: Open-Label Period|Sponsor directive|0|||
19376948|NCT02505542|41619086|FG002|Part A: Open-Label Period|Sponsor directive|0|||
19376949|NCT02505542|41619087|FG003|Part A: Open-Label Period|Sponsor directive|0|||
19376950|NCT02505542|41619084|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
19376951|NCT02505542|41619085|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
19376952|NCT02505542|41619086|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
19376953|NCT02505542|41619087|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
19376954|NCT02505542|41619084|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
19376955|NCT02505542|41619085|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
19376956|NCT02505542|41619086|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
19376957|NCT02505542|41619087|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
19376958|NCT02505542|41619084|FG000|Part A: Open-Label Period|Non-compliance|1|||
19376959|NCT02505542|41619085|FG001|Part A: Open-Label Period|Non-compliance|0|||
19376960|NCT02505542|41619086|FG002|Part A: Open-Label Period|Non-compliance|0|||
19376961|NCT02505542|41619087|FG003|Part A: Open-Label Period|Non-compliance|0|||
19376962|NCT02505542|41619084|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
19376963|NCT02505542|41619085|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
19376964|NCT02505542|41619086|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
19376965|NCT02505542|41619087|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
19376966|NCT02505542|41619084|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
19376967|NCT02505542|41619085|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
19376968|NCT02505542|41619086|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
19376969|NCT02505542|41619087|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
19376970|NCT02505542|41619084|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
19376971|NCT02505542|41619085|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
19376972|NCT02505542|41619086|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
19376973|NCT02505542|41619087|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
19376974|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Adverse Event|0|||
19376975|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Adverse Event|0|||
19376976|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Adverse Event|1|||
19376977|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Adverse Event|3|||
19376978|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
19376979|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
19376980|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
19376981|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
19376982|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
19376983|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
19376984|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
19376985|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
19376986|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
19376987|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
19376988|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
19376989|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
19376990|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
19376991|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
19376992|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
19376993|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
19376994|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
19376995|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
19376996|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
19376997|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
19376998|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
19376999|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
19377000|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
19377001|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
19377002|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Miscalculation|0|||
19377003|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Miscalculation|1|||
19377004|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Miscalculation|0|||
19377005|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Miscalculation|0|||
19377006|NCT02505542|41619084|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
19377007|NCT02505542|41619085|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
19377008|NCT02505542|41619086|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
19377009|NCT02505542|41619087|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
19377010|NCT02475980|41619136|FG000|Overall Study|Lost to Follow-up|4|||
19377011|NCT02475980|41619136|FG000|Overall Study|Withdrawal by Subject|1|||
19377012|NCT02447432|41619142|FG000|Epoch 001|Adverse Event|1|||
19377013|NCT02447432|41619143|FG001|Epoch 001|Adverse Event|1|||
19377014|NCT02447432|41619142|FG000|Epoch 001|Withdrawal by Subject|0|||
19377015|NCT02447432|41619143|FG001|Epoch 001|Withdrawal by Subject|4|||
19377016|NCT02447432|41619142|FG000|Epoch 001|Migrated/moved from study area|3|||
19377017|NCT02447432|41619143|FG001|Epoch 001|Migrated/moved from study area|5|||
19377018|NCT02447432|41619142|FG000|Epoch 001|Lost to Follow-up|1|||
19377019|NCT02447432|41619143|FG001|Epoch 001|Lost to Follow-up|3|||
19377020|NCT02446886|41619151|FG000|Overall Study|Adverse Event|1|||
19377021|NCT02446886|41619152|FG001|Overall Study|Adverse Event|3|||
19377022|NCT02446886|41619151|FG000|Overall Study|Withdrawal by Subject|1|||
19377023|NCT02446886|41619152|FG001|Overall Study|Withdrawal by Subject|1|||
19377024|NCT03448939|41619170|FG000|Overall Study|Adverse Event|5|||
19377025|NCT03448939|41619171|FG001|Overall Study|Adverse Event|1|||
19377026|NCT03448939|41619170|FG000|Overall Study|Lost to Follow-up|6|||
19377027|NCT03448939|41619171|FG001|Overall Study|Lost to Follow-up|6|||
19377028|NCT03448939|41619170|FG000|Overall Study|Pregnancy|1|||
19377029|NCT03448939|41619171|FG001|Overall Study|Pregnancy|1|||
19377030|NCT03448939|41619170|FG000|Overall Study|Withdrawal by Subject|9|||
19377031|NCT03448939|41619171|FG001|Overall Study|Withdrawal by Subject|3|||
19377032|NCT02504294|41619189|FG000|Overall Study|Adverse Event|15|||
19377033|NCT02504294|41619190|FG001|Overall Study|Adverse Event|12|||
19390318|NCT01987960|41634110|FG000|Period 1|Lack of Efficacy|4|||
19377034|NCT02504294|41619189|FG000|Overall Study|Withdrawal by Subject|7|||
19377035|NCT02504294|41619190|FG001|Overall Study|Withdrawal by Subject|1|||
19377036|NCT02504294|41619189|FG000|Overall Study|Protocol Violation|27|||
19377037|NCT02504294|41619190|FG001|Overall Study|Protocol Violation|26|||
19377038|NCT02504294|41619189|FG000|Overall Study|Physician Decision|1|||
19377039|NCT02504294|41619190|FG001|Overall Study|Physician Decision|2|||
19377040|NCT02504294|41619189|FG000|Overall Study|Lost to Follow-up|6|||
19377041|NCT02504294|41619190|FG001|Overall Study|Lost to Follow-up|7|||
19377042|NCT02446418|41619198|FG000|Overall Study|Adverse Event|4|||
19377043|NCT02446418|41619199|FG001|Overall Study|Adverse Event|8|||
19377044|NCT02446418|41619198|FG000|Overall Study|Physician Decision|5|||
19377045|NCT02446418|41619199|FG001|Overall Study|Physician Decision|1|||
19377046|NCT02446418|41619198|FG000|Overall Study|Withdrawal by Subject|3|||
19377047|NCT02446418|41619199|FG001|Overall Study|Withdrawal by Subject|3|||
19377048|NCT02446418|41619198|FG000|Overall Study|Lost to Follow-up|2|||
19377049|NCT02446418|41619199|FG001|Overall Study|Lost to Follow-up|2|||
19377050|NCT02446418|41619198|FG000|Overall Study|Protocol Violation|1|||
19377051|NCT02446418|41619199|FG001|Overall Study|Protocol Violation|2|||
19377052|NCT02446418|41619198|FG000|Overall Study|Lack of Efficacy|2|||
19377053|NCT02446418|41619199|FG001|Overall Study|Lack of Efficacy|0|||
19377054|NCT02446418|41619198|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
19377055|NCT02446418|41619199|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
19377056|NCT02255422|41619212|FG000|Overall Study|Withdrawal by Subject|0|||
19377057|NCT02255422|41619213|FG001|Overall Study|Withdrawal by Subject|0|||
19377058|NCT02255422|41619214|FG002|Overall Study|Withdrawal by Subject|0|||
19377059|NCT02255422|41619215|FG003|Overall Study|Withdrawal by Subject|0|||
19377060|NCT02255422|41619216|FG004|Overall Study|Withdrawal by Subject|0|||
19377061|NCT02255422|41619217|FG005|Overall Study|Withdrawal by Subject|0|||
19377062|NCT02255422|41619218|FG006|Overall Study|Withdrawal by Subject|2|||
19377063|NCT02255422|41619212|FG000|Overall Study|Lost to Follow-up|0|||
19377064|NCT02255422|41619213|FG001|Overall Study|Lost to Follow-up|0|||
19377065|NCT02255422|41619214|FG002|Overall Study|Lost to Follow-up|1|||
19377066|NCT02255422|41619215|FG003|Overall Study|Lost to Follow-up|0|||
19377067|NCT02255422|41619216|FG004|Overall Study|Lost to Follow-up|0|||
19377068|NCT02255422|41619217|FG005|Overall Study|Lost to Follow-up|0|||
19377069|NCT02255422|41619218|FG006|Overall Study|Lost to Follow-up|0|||
19377070|NCT02445794|41619238|FG000|Overall Study|Adverse Event|0|||
19377071|NCT02445794|41619239|FG001|Overall Study|Adverse Event|0|||
19377072|NCT02445794|41619240|FG002|Overall Study|Adverse Event|2|||
19377073|NCT02445794|41619241|FG003|Overall Study|Adverse Event|0|||
19377074|NCT02475278|41619256|FG000|Overall Study|Lost to Follow-up|1|||
19377075|NCT02475278|41619256|FG000|Overall Study|Reason Not Specified|1|||
19377076|NCT02254486|41619262|FG000|Overall Study|Adverse Event|1|||
19377077|NCT02254486|41619263|FG001|Overall Study|Adverse Event|1|||
19377078|NCT02254486|41619262|FG000|Overall Study|Lack of Efficacy|1|||
19377079|NCT02254486|41619263|FG001|Overall Study|Lack of Efficacy|0|||
19377080|NCT02254486|41619262|FG000|Overall Study|Lost to Follow-up|2|||
19377081|NCT02254486|41619263|FG001|Overall Study|Lost to Follow-up|4|||
19377082|NCT02254486|41619262|FG000|Overall Study|Protocol Violation|1|||
19377083|NCT02254486|41619263|FG001|Overall Study|Protocol Violation|2|||
19377084|NCT02254486|41619262|FG000|Overall Study|Withdrawal by Subject|17|||
19377085|NCT02254486|41619263|FG001|Overall Study|Withdrawal by Subject|15|||
19377086|NCT02254486|41619262|FG000|Overall Study|GFR<60mL/min|16|||
19377087|NCT02254486|41619263|FG001|Overall Study|GFR<60mL/min|21|||
19377088|NCT02254486|41619262|FG000|Overall Study|Various|12|||
19377089|NCT02254486|41619263|FG001|Overall Study|Various|12|||
19377090|NCT01641640|41619269|FG000|Overall Study|Enrolled but not treated|1|||
19377091|NCT01641640|41619269|FG000|Overall Study|Efficacy failure|29|||
19377092|NCT01641640|41619269|FG000|Overall Study|Lost to Follow-up|3|||
19377093|NCT01641640|41619269|FG000|Overall Study|Withdrawal by Subject|2|||
19377094|NCT01641640|41619269|FG000|Overall Study|Adverse Event|1|||
19377095|NCT01639144|41619275|FG000|Overall Study|Withdrawal by Subject|4|||
19377096|NCT01639144|41619276|FG001|Overall Study|Withdrawal by Subject|2|||
19377097|NCT01639144|41619275|FG000|Overall Study|Physician Decision|2|||
19377098|NCT01639144|41619276|FG001|Overall Study|Physician Decision|0|||
19377099|NCT01639144|41619275|FG000|Overall Study|Met postoperative exclusion criteria|4|||
19377100|NCT01639144|41619276|FG001|Overall Study|Met postoperative exclusion criteria|3|||
19377101|NCT01601626|41619285|FG000|Overall Study|Death|1|||
19377102|NCT01601626|41619286|FG001|Overall Study|Death|1|||
19377103|NCT01601626|41619287|FG002|Overall Study|Death|1|||
19377104|NCT01601626|41619285|FG000|Overall Study|Lost to Follow-up|1|||
19377105|NCT01601626|41619286|FG001|Overall Study|Lost to Follow-up|2|||
19377106|NCT01601626|41619287|FG002|Overall Study|Lost to Follow-up|0|||
19377107|NCT01601626|41619285|FG000|Overall Study|Unable to Get to Clinic|0|||
19377108|NCT01601626|41619286|FG001|Overall Study|Unable to Get to Clinic|1|||
19377109|NCT01601626|41619287|FG002|Overall Study|Unable to Get to Clinic|0|||
19377110|NCT01601626|41619285|FG000|Overall Study|Withdrawal by Subject|0|||
19377111|NCT01601626|41619286|FG001|Overall Study|Withdrawal by Subject|1|||
19377112|NCT01601626|41619287|FG002|Overall Study|Withdrawal by Subject|1|||
19377113|NCT01601626|41619285|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
19377114|NCT01601626|41619286|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
19377115|NCT01601626|41619287|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
19377116|NCT02737501|41619297|FG000|Randomized Phase|Died|41|||
19377117|NCT02737501|41619298|FG001|Randomized Phase|Died|29|||
19377118|NCT02737501|41619299|FG002|Randomized Phase|Died|0|||
19377119|NCT02737501|41619297|FG000|Randomized Phase|Withdrawal by Subject|16|||
19377120|NCT02737501|41619298|FG001|Randomized Phase|Withdrawal by Subject|6|||
19377121|NCT02737501|41619299|FG002|Randomized Phase|Withdrawal by Subject|0|||
19377122|NCT02737501|41619297|FG000|Randomized Phase|Lost to Follow-up|0|||
19377123|NCT02737501|41619298|FG001|Randomized Phase|Lost to Follow-up|1|||
19377124|NCT02737501|41619299|FG002|Randomized Phase|Lost to Follow-up|0|||
19377125|NCT02737501|41619297|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
19377126|NCT02737501|41619298|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
19377127|NCT02737501|41619299|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
19377128|NCT02737501|41619297|FG000|Randomized Phase|Reason not Specified|1|||
19377129|NCT02737501|41619298|FG001|Randomized Phase|Reason not Specified|1|||
19377130|NCT02737501|41619299|FG002|Randomized Phase|Reason not Specified|0|||
19377131|NCT02737501|41619297|FG000|Randomized Phase|Never Treated|1|||
19377132|NCT02737501|41619298|FG001|Randomized Phase|Never Treated|1|||
19377133|NCT02737501|41619299|FG002|Randomized Phase|Never Treated|0|||
19377134|NCT02737501|41619297|FG000|Crossover Phase|Died|0|||
19377135|NCT02737501|41619298|FG001|Crossover Phase|Died|0|||
19377136|NCT02737501|41619299|FG002|Crossover Phase|Died|22|||
19377137|NCT02737501|41619297|FG000|Crossover Phase|Withdrew Consent|0|||
19377138|NCT02737501|41619298|FG001|Crossover Phase|Withdrew Consent|0|||
19377139|NCT02737501|41619299|FG002|Crossover Phase|Withdrew Consent|9|||
19377140|NCT02737501|41619297|FG000|Crossover Phase|Physician Decision|0|||
19377141|NCT02737501|41619298|FG001|Crossover Phase|Physician Decision|0|||
19377142|NCT02737501|41619299|FG002|Crossover Phase|Physician Decision|1|||
19377143|NCT02737501|41619297|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
19377144|NCT02737501|41619298|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
19377145|NCT02737501|41619299|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
19377146|NCT01640314|41619309|FG000|Overall Study|Protocol Violation|0|||
19377147|NCT01640314|41619310|FG001|Overall Study|Protocol Violation|1|||
19377148|NCT02740049|41619392|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
19377149|NCT01601704|41619398|FG000|Overall Study|Randomized but not dispensed study med|1|||
19377150|NCT01601704|41619399|FG001|Overall Study|Randomized but not dispensed study med|4|||
19377151|NCT04969276|41619408|FG000|Overall Study|Protocol Deviation|0|||
19377152|NCT04969276|41619409|FG001|Overall Study|Protocol Deviation|1|||
19377153|NCT04969276|41619410|FG002|Overall Study|Protocol Deviation|0|||
19377154|NCT04969276|41619408|FG000|Overall Study|Withdrawal by Subject|1|||
19377155|NCT04969276|41619409|FG001|Overall Study|Withdrawal by Subject|10|||
19377156|NCT04969276|41619410|FG002|Overall Study|Withdrawal by Subject|0|||
19377157|NCT04969276|41619408|FG000|Overall Study|Lost to Follow-up|0|||
19377158|NCT04969276|41619409|FG001|Overall Study|Lost to Follow-up|1|||
19377159|NCT04969276|41619410|FG002|Overall Study|Lost to Follow-up|0|||
19377160|NCT01601470|41619418|FG000|Period 2 - LCZ696|Physician Decision|1|||
19377161|NCT03275285|41619444|FG000|Overall Study|Ongoing|61|||
19377162|NCT03275285|41619445|FG001|Overall Study|Ongoing|105|||
19377163|NCT03248375|41619455|FG000|Overall Study|Lost to Follow-up|5|||
19726228|NCT04389840|42170500|FG005|Overall Study|Adverse Event|0|||
19377164|NCT01637272|41619459|FG000|Overall Study|Adverse Event|6|||
19377165|NCT01637272|41619459|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19377166|NCT01637272|41619459|FG000|Overall Study|Withdrawal by Subject|3|||
19377167|NCT01637272|41619459|FG000|Overall Study|Lost to Follow-up|2|||
19377168|NCT01637272|41619459|FG000|Overall Study|completed core, did not enter ext. phase|4|||
19377169|NCT01637272|41619459|FG000|Overall Study|Administrative problems|1|||
19377170|NCT01637272|41619459|FG000|Overall Study|Protocol Violation|2|||
19377171|NCT01636960|41619478|FG000|Induction Phase|Adverse Event|2|||
19377172|NCT01636960|41619478|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
19377173|NCT01636960|41619478|FG000|Maintenance Phase|Adverse Event|3|||
19377174|NCT01636960|41619478|FG000|Maintenance Phase|Progressive disease|1|||
19377175|NCT01636258|41619484|FG000|Overall Study|Lost to Follow-up|1|||
19377176|NCT01636258|41619485|FG001|Overall Study|Lost to Follow-up|0|||
19377177|NCT02504216|41619494|FG000|Overall Study|Lost to Follow-up|3|||
19377178|NCT02504216|41619495|FG001|Overall Study|Lost to Follow-up|3|||
19377179|NCT02504216|41619494|FG000|Overall Study|Withdrawal by Subject|8|||
19377180|NCT02504216|41619495|FG001|Overall Study|Withdrawal by Subject|12|||
19377181|NCT04354870|41619503|FG000|Overall Study|Lost to Follow-up|32|||
19377182|NCT04354870|41619504|FG001|Overall Study|Lost to Follow-up|12|||
19377183|NCT04354870|41619503|FG000|Overall Study|Withdrawal by Subject|10|||
19377184|NCT04354870|41619504|FG001|Overall Study|Withdrawal by Subject|16|||
19377185|NCT04354870|41619503|FG000|Overall Study|Did not complete all study visits|6|||
19377186|NCT04354870|41619504|FG001|Overall Study|Did not complete all study visits|5|||
19377187|NCT02473952|41619512|FG000|Overall Study|Adverse Event|2|||
19377188|NCT02473952|41619513|FG001|Overall Study|Adverse Event|2|||
19377189|NCT02473952|41619512|FG000|Overall Study|Withdrawal by Subject|0|||
19377190|NCT02473952|41619513|FG001|Overall Study|Withdrawal by Subject|6|||
19377191|NCT02473640|41619519|FG000|Treatment Period 1|Adverse Event|1|||
19377192|NCT01637584|41619528|FG000|Overall Study|Withdrawal by Subject|1|||
19377193|NCT01637584|41619529|FG001|Overall Study|Withdrawal by Subject|3|||
19377194|NCT03883906|41619536|FG000|Overall Study|Withdrawal by Subject|2|||
19377195|NCT03883906|41619536|FG000|Overall Study|Physician Decision|5|||
19377196|NCT03875092|41619542|FG000|Overall Study|Adverse Event|2|||
19377197|NCT03875092|41619543|FG001|Overall Study|Adverse Event|5|||
19377198|NCT03875092|41619542|FG000|Overall Study|Death|28|||
19377199|NCT03875092|41619543|FG001|Overall Study|Death|41|||
19377200|NCT03875092|41619542|FG000|Overall Study|Ongoing in Study|35|||
19377201|NCT03875092|41619543|FG001|Overall Study|Ongoing in Study|14|||
19377202|NCT02503202|41619554|FG000|Base Study: Up to Month 6|Death|1|||
19377203|NCT02503202|41619555|FG001|Base Study: Up to Month 6|Death|1|||
19377204|NCT02503202|41619556|FG002|Base Study: Up to Month 6|Death|0|||
19377205|NCT02503202|41619557|FG003|Base Study: Up to Month 6|Death|0|||
19377206|NCT02503202|41619558|FG004|Base Study: Up to Month 6|Death|0|||
19377207|NCT02503202|41619554|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
19377208|NCT02503202|41619555|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
19377209|NCT02503202|41619556|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
19377210|NCT02503202|41619557|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
19377211|NCT02503202|41619558|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
19377212|NCT02503202|41619554|FG000|Base Study: Up to Month 6|Physician Decision|0|||
19377213|NCT02503202|41619555|FG001|Base Study: Up to Month 6|Physician Decision|0|||
19377214|NCT02503202|41619556|FG002|Base Study: Up to Month 6|Physician Decision|0|||
19377215|NCT02503202|41619557|FG003|Base Study: Up to Month 6|Physician Decision|0|||
19377216|NCT02503202|41619558|FG004|Base Study: Up to Month 6|Physician Decision|1|||
19377217|NCT02503202|41619554|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
19377218|NCT02503202|41619555|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
19377219|NCT02503202|41619556|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
19377220|NCT02503202|41619557|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
19377221|NCT02503202|41619558|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
19377222|NCT02503202|41619554|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
19377223|NCT02503202|41619555|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
19377224|NCT02503202|41619556|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
19377225|NCT02503202|41619557|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
19377226|NCT02503202|41619558|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
19377227|NCT02503202|41619554|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
19377228|NCT02503202|41619555|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
19377229|NCT02503202|41619556|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
19377230|NCT02503202|41619557|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
19377231|NCT02503202|41619558|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
19377232|NCT02503202|41619554|FG000|Extension: Month 6 to 24|Death|1|||
19377233|NCT02503202|41619555|FG001|Extension: Month 6 to 24|Death|0|||
19377234|NCT02503202|41619556|FG002|Extension: Month 6 to 24|Death|0|||
19377235|NCT02503202|41619557|FG003|Extension: Month 6 to 24|Death|0|||
19377236|NCT02503202|41619558|FG004|Extension: Month 6 to 24|Death|0|||
19377237|NCT02503202|41619554|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
19377238|NCT02503202|41619555|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
19377239|NCT02503202|41619556|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
19377240|NCT02503202|41619557|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
19377241|NCT02503202|41619558|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
19377242|NCT02503202|41619554|FG000|Extension: Month 6 to 24|Physician Decision|1|||
19377243|NCT02503202|41619555|FG001|Extension: Month 6 to 24|Physician Decision|0|||
19377244|NCT02503202|41619556|FG002|Extension: Month 6 to 24|Physician Decision|1|||
19377245|NCT02503202|41619557|FG003|Extension: Month 6 to 24|Physician Decision|3|||
19377246|NCT02503202|41619558|FG004|Extension: Month 6 to 24|Physician Decision|0|||
19377247|NCT02503202|41619554|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
19377248|NCT02503202|41619555|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
19377249|NCT02503202|41619556|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
19377250|NCT02503202|41619557|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
19377251|NCT02503202|41619558|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
19377252|NCT02728102|41619573|FG000|Overall Study|Death|3|||
19377253|NCT02728102|41619574|FG001|Overall Study|Death|0|||
19377254|NCT02728102|41619575|FG002|Overall Study|Death|1|||
19377255|NCT02728102|41619573|FG000|Overall Study|Withdrawal by Subject|0|||
19377256|NCT02728102|41619574|FG001|Overall Study|Withdrawal by Subject|2|||
19377257|NCT02728102|41619575|FG002|Overall Study|Withdrawal by Subject|3|||
19377258|NCT02728102|41619573|FG000|Overall Study|Physician Decision|1|||
19377259|NCT02728102|41619574|FG001|Overall Study|Physician Decision|1|||
19377260|NCT02728102|41619575|FG002|Overall Study|Physician Decision|0|||
19377261|NCT02728102|41619573|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
19377262|NCT02728102|41619574|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
19377263|NCT02728102|41619575|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
19377264|NCT02728102|41619573|FG000|Overall Study|Covid|0|||
19377265|NCT02728102|41619574|FG001|Overall Study|Covid|0|||
19377266|NCT02728102|41619575|FG002|Overall Study|Covid|1|||
19377267|NCT02502734|41619584|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
19377268|NCT02502734|41619585|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
19377269|NCT02502734|41619584|FG000|Washout Period|Adverse Event|1|||
19377270|NCT02502734|41619585|FG001|Washout Period|Adverse Event|0|||
19377271|NCT02473250|41619593|FG000|Overall Study|Lost to Follow-up|10|||
19377272|NCT02473250|41619593|FG000|Overall Study|Physician Decision|5|||
19377273|NCT02473250|41619593|FG000|Overall Study|Did not tolerate medication washout|3|||
19377274|NCT02473250|41619593|FG000|Overall Study|Antidepressant effect of divalproex|2|||
19377275|NCT02501642|41619600|FG000|Overall Study|Lost to Follow-up|7|||
19377276|NCT02501642|41619601|FG001|Overall Study|Lost to Follow-up|11|||
19377277|NCT02706730|41619607|FG000|Overall Study|Adverse Event|3|||
19377278|NCT02706730|41619607|FG000|Overall Study|Lack of Efficacy|5|||
19377279|NCT02706730|41619607|FG000|Overall Study|Withdrawal by Subject|11|||
19377280|NCT02706730|41619607|FG000|Overall Study|Study Terminated by Sponsor|11|||
19377281|NCT02706730|41619607|FG000|Overall Study|Subject chose not to receive injection|3|||
19377282|NCT02443688|41619614|FG000|Overall Study|Adverse Event|2|||
19377283|NCT02443688|41619615|FG001|Overall Study|Adverse Event|3|||
19377284|NCT02443688|41619616|FG002|Overall Study|Adverse Event|2|||
19377285|NCT02443688|41619614|FG000|Overall Study|Lost to Follow-up|1|||
19377286|NCT02443688|41619615|FG001|Overall Study|Lost to Follow-up|0|||
19377287|NCT02443688|41619616|FG002|Overall Study|Lost to Follow-up|0|||
19377288|NCT02443688|41619614|FG000|Overall Study|Physician Decision|3|||
19377289|NCT02443688|41619615|FG001|Overall Study|Physician Decision|0|||
19377290|NCT02443688|41619616|FG002|Overall Study|Physician Decision|1|||
19377291|NCT02443688|41619614|FG000|Overall Study|Pregnancy|0|||
19377292|NCT02443688|41619615|FG001|Overall Study|Pregnancy|0|||
19377293|NCT02443688|41619616|FG002|Overall Study|Pregnancy|1|||
19377294|NCT02443688|41619614|FG000|Overall Study|Withdrawal by Subject|3|||
19377295|NCT02443688|41619615|FG001|Overall Study|Withdrawal by Subject|3|||
19377296|NCT02443688|41619616|FG002|Overall Study|Withdrawal by Subject|4|||
19377297|NCT02443688|41619614|FG000|Overall Study|Non-compliance with study drug|1|||
19377298|NCT02443688|41619615|FG001|Overall Study|Non-compliance with study drug|2|||
19377299|NCT02443688|41619616|FG002|Overall Study|Non-compliance with study drug|4|||
19377300|NCT02443688|41619614|FG000|Overall Study|Sponsor Request|2|||
19377301|NCT02443688|41619615|FG001|Overall Study|Sponsor Request|1|||
19377302|NCT02443688|41619616|FG002|Overall Study|Sponsor Request|0|||
19377303|NCT02443298|41619630|FG000|Overall Study|Adverse Event|3|||
19377304|NCT02443298|41619631|FG001|Overall Study|Adverse Event|3|||
19377305|NCT02443298|41619630|FG000|Overall Study|Withdrawal by Subject|1|||
19377306|NCT02443298|41619631|FG001|Overall Study|Withdrawal by Subject|2|||
19377307|NCT02500706|41619640|FG000|Overall Study|Adverse Event|0|||
19377308|NCT02500706|41619641|FG001|Overall Study|Adverse Event|0|||
19377309|NCT02500706|41619642|FG002|Overall Study|Adverse Event|1|||
19377310|NCT02500706|41619640|FG000|Overall Study|Lost to Follow-up|0|||
19377311|NCT02500706|41619641|FG001|Overall Study|Lost to Follow-up|1|||
19377312|NCT02500706|41619642|FG002|Overall Study|Lost to Follow-up|1|||
19377313|NCT02500706|41619640|FG000|Overall Study|Withdrawal by Subject|4|||
19377314|NCT02500706|41619641|FG001|Overall Study|Withdrawal by Subject|6|||
19377315|NCT02500706|41619642|FG002|Overall Study|Withdrawal by Subject|4|||
19377316|NCT02500706|41619640|FG000|Overall Study|Unclassified|0|||
19377317|NCT02500706|41619641|FG001|Overall Study|Unclassified|0|||
19377318|NCT02500706|41619642|FG002|Overall Study|Unclassified|1|||
19377319|NCT02442830|41619652|FG000|Overall Study|Technical Failure|0|||
19377320|NCT02442830|41619653|FG001|Overall Study|Technical Failure|1|||
19377321|NCT02471612|41619660|FG000|Overall Study|Lost to Follow-up|2|||
19377322|NCT02500550|41619677|FG000|Overall Study|Death|7|||
19377323|NCT02499770|41619683|FG000|Overall Study|Death|17|||
19377324|NCT02499770|41619684|FG001|Overall Study|Death|56|||
19377325|NCT02499770|41619683|FG000|Overall Study|Study completion|1|||
19377326|NCT02499770|41619684|FG001|Overall Study|Study completion|10|||
19377327|NCT02499770|41619683|FG000|Overall Study|Withdrawal by Subject|0|||
19377328|NCT02499770|41619684|FG001|Overall Study|Withdrawal by Subject|7|||
19377329|NCT02499770|41619683|FG000|Overall Study|Lost to Follow-up|0|||
19377330|NCT02499770|41619684|FG001|Overall Study|Lost to Follow-up|2|||
19377331|NCT02499770|41619683|FG000|Overall Study|Subject declined further treatment|1|||
19377332|NCT02499770|41619684|FG001|Overall Study|Subject declined further treatment|0|||
19377333|NCT02499770|41619683|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
19377334|NCT02499770|41619684|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
19377335|NCT02499770|41619683|FG000|Overall Study|Randomized but not enrolled|0|||
19377336|NCT02499770|41619684|FG001|Overall Study|Randomized but not enrolled|1|||
19377337|NCT02442284|41619696|FG000|Overall Study|Adverse Event|1|||
19377338|NCT02442284|41619696|FG000|Overall Study|Withdrew Consent|2|||
19377339|NCT02442284|41619696|FG000|Overall Study|Lost to Follow-up|3|||
19377340|NCT02442284|41619696|FG000|Overall Study|Other|1|||
19377341|NCT02442206|41619706|FG000|Period 1|Adverse Event|1|||
19377342|NCT02442206|41619707|FG001|Period 1|Adverse Event|1|||
19377343|NCT02442206|41619706|FG000|Period 1|withdrew consent|0|||
19377344|NCT02442206|41619707|FG001|Period 1|withdrew consent|1|||
19377345|NCT02442206|41619706|FG000|Period 1|COPD exacerbation|0|||
19377346|NCT02442206|41619707|FG001|Period 1|COPD exacerbation|1|||
19377347|NCT02442206|41619706|FG000|Period 2|Adverse Event|1|||
19377348|NCT02442206|41619707|FG001|Period 2|Adverse Event|0|||
19377349|NCT02499146|41619714|FG000|Overall Study|Lost to Follow-up|1|||
19377350|NCT02499146|41619714|FG000|Overall Study|Withdrawal by Subject|1|||
19377351|NCT02499146|41619714|FG000|Overall Study|Other|2|||
19377352|NCT02499146|41619714|FG000|Overall Study|Ongoing at date of cut-off|9|||
19377353|NCT02499146|41619714|FG000|Overall Study|Began other treatment/therapy|13|||
19377354|NCT03544138|41619718|FG000|Overall Study|Lost to Follow-up|29|||
19377355|NCT01634854|41619724|FG000|Overall Study|Cesarean delivery|2|||
19377356|NCT01634854|41619725|FG001|Overall Study|Cesarean delivery|7|||
19377357|NCT02469896|41619733|FG000|Overall Study|Withdrawal by Subject|2|||
19377358|NCT02469896|41619734|FG001|Overall Study|Withdrawal by Subject|0|||
19377359|NCT02441114|41619744|FG000|Washout2|Withdrawal by Subject|4|||
19377360|NCT02498678|41619750|FG000|Overall Study|interference from the surgical team|0|||
19377361|NCT02498678|41619751|FG001|Overall Study|interference from the surgical team|2|||
19377362|NCT02441036|41619762|FG000|Overall Study|No tissue resected|0|||
19377363|NCT02441036|41619763|FG001|Overall Study|No tissue resected|1|||
19377364|NCT02441036|41619764|FG002|Overall Study|No tissue resected|0|||
19377365|NCT02441036|41619765|FG003|Overall Study|No tissue resected|1|||
19377366|NCT02441036|41619766|FG004|Overall Study|No tissue resected|0|||
19377367|NCT02498444|41619781|FG000|Overall Study|Withdrawal by Subject|3|||
19377368|NCT02498444|41619782|FG001|Overall Study|Withdrawal by Subject|0|||
19377369|NCT02498444|41619781|FG000|Overall Study|Physician Decision|1|||
19377370|NCT02498444|41619782|FG001|Overall Study|Physician Decision|0|||
19377371|NCT02497976|41619790|FG000|Overall Study|Withdrawal by Subject|2|||
19377372|NCT02497976|41619791|FG001|Overall Study|Withdrawal by Subject|0|||
19377373|NCT02497976|41619790|FG000|Overall Study|Moved out of area|0|||
19377374|NCT02497976|41619791|FG001|Overall Study|Moved out of area|1|||
19377375|NCT03347188|41619799|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
19377376|NCT03347188|41619800|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
19377377|NCT03347188|41619799|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
19377378|NCT03347188|41619800|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
19377379|NCT03347188|41619799|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
19377380|NCT03347188|41619800|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
19377381|NCT03347188|41619799|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
19377382|NCT03347188|41619800|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
19377383|NCT03347188|41619799|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
19377384|NCT03347188|41619800|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
19377385|NCT03347188|41619799|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
19377386|NCT03347188|41619800|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
19377387|NCT03347188|41619799|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
19377388|NCT03347188|41619800|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
19377389|NCT03347188|41619799|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
19377390|NCT03347188|41619800|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
19377391|NCT02440568|41619810|FG000|Overall Study|Death|1|||
19377392|NCT02440568|41619811|FG001|Overall Study|Death|3|||
19377393|NCT02440568|41619812|FG002|Overall Study|Death|4|||
19377394|NCT02440568|41619813|FG003|Overall Study|Death|2|||
19377395|NCT02440568|41619810|FG000|Overall Study|Lack of Efficacy|2|||
19377396|NCT02440568|41619811|FG001|Overall Study|Lack of Efficacy|0|||
19377397|NCT02440568|41619812|FG002|Overall Study|Lack of Efficacy|1|||
19377398|NCT02440568|41619813|FG003|Overall Study|Lack of Efficacy|0|||
19377399|NCT02440568|41619810|FG000|Overall Study|Lost to Follow-up|1|||
19377400|NCT02440568|41619811|FG001|Overall Study|Lost to Follow-up|0|||
19377401|NCT02440568|41619812|FG002|Overall Study|Lost to Follow-up|0|||
19377402|NCT02440568|41619813|FG003|Overall Study|Lost to Follow-up|0|||
19377403|NCT01038778|41619826|FG000|Overall Study|Withdrawal by Subject|0|||
19377404|NCT01038778|41619827|FG001|Overall Study|Withdrawal by Subject|2|||
19377405|NCT01038778|41619828|FG002|Overall Study|Withdrawal by Subject|3|||
19377406|NCT03090191|41619837|FG000|Overall Study|Adverse Event|90|||
19377407|NCT03090191|41619838|FG001|Overall Study|Adverse Event|72|||
19377408|NCT03090191|41619837|FG000|Overall Study|Death|365|||
19377409|NCT03090191|41619838|FG001|Overall Study|Death|358|||
19377410|NCT03090191|41619837|FG000|Overall Study|Lost to Follow-up|382|||
19377411|NCT03090191|41619838|FG001|Overall Study|Lost to Follow-up|394|||
19377412|NCT03090191|41619837|FG000|Overall Study|Physician Decision|77|||
19377413|NCT03090191|41619838|FG001|Overall Study|Physician Decision|66|||
19377414|NCT03090191|41619837|FG000|Overall Study|Protocol Violation|43|||
19377415|NCT03090191|41619838|FG001|Overall Study|Protocol Violation|52|||
19377416|NCT03090191|41619837|FG000|Overall Study|Withdrawal by Subject|2160|||
19478074|NCT01693562|41757320|FG006|Exploration Phase|Other|2|||
19377417|NCT03090191|41619838|FG001|Overall Study|Withdrawal by Subject|2133|||
19377418|NCT03090191|41619837|FG000|Overall Study|Site terminated|7|||
19377419|NCT03090191|41619838|FG001|Overall Study|Site terminated|8|||
19377420|NCT03090191|41619837|FG000|Overall Study|Other|66|||
19377421|NCT03090191|41619838|FG001|Overall Study|Other|60|||
19377422|NCT03090191|41619837|FG000|Overall Study|Withdrawn before any study vaccination|43|||
19377423|NCT03090191|41619838|FG001|Overall Study|Withdrawn before any study vaccination|52|||
19377424|NCT00646204|41619846|FG000|Overall Study|Adverse Event|3|||
19377425|NCT00646204|41619847|FG001|Overall Study|Adverse Event|0|||
19377426|NCT00646204|41619846|FG000|Overall Study|Withdrawal by Subject|1|||
19377427|NCT00646204|41619847|FG001|Overall Study|Withdrawal by Subject|0|||
19377428|NCT02439320|41619870|FG000|Overall Study|Adverse Event|0|||
19377429|NCT02439320|41619871|FG001|Overall Study|Adverse Event|2|||
19377430|NCT02439320|41619872|FG002|Overall Study|Adverse Event|0|||
19377431|NCT02439320|41619870|FG000|Overall Study|Lost to Follow-up|37|||
19377432|NCT02439320|41619871|FG001|Overall Study|Lost to Follow-up|34|||
19377433|NCT02439320|41619872|FG002|Overall Study|Lost to Follow-up|42|||
19377434|NCT02439320|41619870|FG000|Overall Study|Death|0|||
19377435|NCT02439320|41619871|FG001|Overall Study|Death|1|||
19377436|NCT02439320|41619872|FG002|Overall Study|Death|0|||
19377437|NCT02439320|41619870|FG000|Overall Study|Noncompliance with Protocol|10|||
19377438|NCT02439320|41619871|FG001|Overall Study|Noncompliance with Protocol|11|||
19377439|NCT02439320|41619872|FG002|Overall Study|Noncompliance with Protocol|7|||
19377440|NCT02439320|41619870|FG000|Overall Study|Pregnancy|0|||
19377441|NCT02439320|41619871|FG001|Overall Study|Pregnancy|1|||
19377442|NCT02439320|41619872|FG002|Overall Study|Pregnancy|1|||
19377443|NCT02439320|41619870|FG000|Overall Study|Withdrawal by Subject|12|||
19377444|NCT02439320|41619871|FG001|Overall Study|Withdrawal by Subject|16|||
19377445|NCT02439320|41619872|FG002|Overall Study|Withdrawal by Subject|14|||
19377446|NCT02439320|41619870|FG000|Overall Study|Physician Decision|2|||
19377447|NCT02439320|41619871|FG001|Overall Study|Physician Decision|1|||
19377448|NCT02439320|41619872|FG002|Overall Study|Physician Decision|0|||
19377449|NCT02439320|41619870|FG000|Overall Study|Sponsor Request|0|||
19377450|NCT02439320|41619871|FG001|Overall Study|Sponsor Request|2|||
19377451|NCT02439320|41619872|FG002|Overall Study|Sponsor Request|1|||
19377452|NCT02439320|41619870|FG000|Overall Study|Randomization Failure|35|||
19377453|NCT02439320|41619871|FG001|Overall Study|Randomization Failure|46|||
19377454|NCT02439320|41619872|FG002|Overall Study|Randomization Failure|34|||
19377455|NCT02469038|41619888|FG000|Overall Study|Physician Decision|4|||
19377456|NCT02469038|41619889|FG001|Overall Study|Physician Decision|5|||
19377457|NCT02468648|41619895|FG000|Overall Study|Death|1|||
19377458|NCT02468414|41619901|FG000|Overall Study|Early Study Termination by Sponsor|1|||
19377459|NCT02468414|41619902|FG001|Overall Study|Early Study Termination by Sponsor|0|||
19377460|NCT02468414|41619901|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
19377461|NCT02468414|41619902|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
19377462|NCT02468414|41619901|FG000|Overall Study|Screen Failure|1|||
19377463|NCT02468414|41619902|FG001|Overall Study|Screen Failure|0|||
19377464|NCT02466386|41619908|FG000|Overall Study|Adverse Event|5|||
19377465|NCT02466386|41619908|FG000|Overall Study|Protocol Violation|2|||
19377466|NCT02466386|41619908|FG000|Overall Study|Withdrawal by Subject|14|||
19377467|NCT02466386|41619908|FG000|Overall Study|Lost to Follow-up|5|||
19377468|NCT02466386|41619908|FG000|Overall Study|Lack of Efficacy|8|||
19377469|NCT02466386|41619908|FG000|Overall Study|Other|10|||
19377470|NCT01633060|41619914|FG000|Randomization Phase|Protocol deviation|1|||
19377471|NCT01633060|41619915|FG001|Randomization Phase|Protocol deviation|2|||
19377472|NCT01633060|41619914|FG000|Randomization Phase|Technical problem|0|||
19377473|NCT01633060|41619915|FG001|Randomization Phase|Technical problem|1|||
19377474|NCT01633060|41619914|FG000|Treatment Phase|Adverse Event|24|||
19377475|NCT01633060|41619915|FG001|Treatment Phase|Adverse Event|3|||
19377476|NCT01633060|41619914|FG000|Treatment Phase|Lost to Follow-up|1|||
19377477|NCT01633060|41619915|FG001|Treatment Phase|Lost to Follow-up|0|||
19377478|NCT01633060|41619914|FG000|Treatment Phase|Physician Decision|16|||
19377479|NCT01633060|41619915|FG001|Treatment Phase|Physician Decision|7|||
19377480|NCT01633060|41619914|FG000|Treatment Phase|Progressive Disease|210|||
19377481|NCT01633060|41619915|FG001|Treatment Phase|Progressive Disease|120|||
19377482|NCT01633060|41619914|FG000|Treatment Phase|Protocol Deviation|1|||
19377483|NCT01633060|41619915|FG001|Treatment Phase|Protocol Deviation|0|||
19377484|NCT01633060|41619914|FG000|Treatment Phase|Study Terminated by sponsor|7|||
19377485|NCT01633060|41619915|FG001|Treatment Phase|Study Terminated by sponsor|3|||
19377486|NCT01633060|41619914|FG000|Treatment Phase|Subject/guardian decision|25|||
19377487|NCT01633060|41619915|FG001|Treatment Phase|Subject/guardian decision|4|||
19377488|NCT01633060|41619914|FG000|Treatment Phase|Death|4|||
19377489|NCT01633060|41619915|FG001|Treatment Phase|Death|3|||
19377490|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
19377491|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19377492|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
19377493|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
19390319|NCT01987960|41634111|FG001|Period 1|Lack of Efficacy|0|||
19377494|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
19377495|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
19377496|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
19377497|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
19377498|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
19377499|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
19377500|NCT01633060|41619914|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
19377501|NCT01633060|41619915|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
19377502|NCT01632904|41619924|FG000|Overall Study|Adverse Event|4|||
19377503|NCT01632904|41619925|FG001|Overall Study|Adverse Event|1|||
19377504|NCT01632904|41619924|FG000|Overall Study|Physician Decision|0|||
19377505|NCT01632904|41619925|FG001|Overall Study|Physician Decision|1|||
19377506|NCT01632904|41619924|FG000|Overall Study|Subject decision|3|||
19377507|NCT01632904|41619925|FG001|Overall Study|Subject decision|2|||
19377508|NCT01632904|41619924|FG000|Overall Study|Disease Progression|0|||
19377509|NCT01632904|41619925|FG001|Overall Study|Disease Progression|1|||
19377510|NCT01632904|41619924|FG000|Overall Study|Reason for discontinuation not available|0|||
19377511|NCT01632904|41619925|FG001|Overall Study|Reason for discontinuation not available|1|||
19377512|NCT03834779|41619933|FG000|Overall Study|Death|1|||
19377513|NCT03834779|41619934|FG001|Overall Study|Death|2|||
19377514|NCT03834779|41619933|FG000|Overall Study|Lost to Follow-up|6|||
19377515|NCT03834779|41619934|FG001|Overall Study|Lost to Follow-up|4|||
19377516|NCT03726437|41619943|FG000|Overall Study|Lost to Follow-up|85|||
19377517|NCT03726437|41619944|FG001|Overall Study|Lost to Follow-up|76|||
19377518|NCT02465528|41619954|FG000|Overall Study|Progressive disease|0|||
19377519|NCT02465528|41619955|FG001|Overall Study|Progressive disease|2|||
19377520|NCT02465528|41619956|FG002|Overall Study|Progressive disease|9|||
19377521|NCT02465528|41619957|FG003|Overall Study|Progressive disease|4|||
19377522|NCT02465528|41619954|FG000|Overall Study|Study terminated by sponsor|1|||
19377523|NCT02465528|41619955|FG001|Overall Study|Study terminated by sponsor|2|||
19377524|NCT02465528|41619956|FG002|Overall Study|Study terminated by sponsor|0|||
19377525|NCT02465528|41619957|FG003|Overall Study|Study terminated by sponsor|0|||
19377526|NCT02465528|41619954|FG000|Overall Study|Withdrawal by Subject|0|||
19377527|NCT02465528|41619955|FG001|Overall Study|Withdrawal by Subject|0|||
19377528|NCT02465528|41619956|FG002|Overall Study|Withdrawal by Subject|2|||
19377529|NCT02465528|41619957|FG003|Overall Study|Withdrawal by Subject|0|||
19377530|NCT02465528|41619954|FG000|Overall Study|Adverse Event|0|||
19377531|NCT02465528|41619955|FG001|Overall Study|Adverse Event|0|||
19377532|NCT02465528|41619956|FG002|Overall Study|Adverse Event|0|||
19377533|NCT02465528|41619957|FG003|Overall Study|Adverse Event|1|||
19377534|NCT02465528|41619954|FG000|Overall Study|Physician Decision|0|||
19377535|NCT02465528|41619955|FG001|Overall Study|Physician Decision|0|||
19377536|NCT02465528|41619956|FG002|Overall Study|Physician Decision|1|||
19377537|NCT02465528|41619957|FG003|Overall Study|Physician Decision|0|||
19377538|NCT02438384|41619972|FG000|Overall Study|Lost to Follow-up|8|||
19377539|NCT02438384|41619973|FG001|Overall Study|Lost to Follow-up|6|||
19377540|NCT02438384|41619974|FG002|Overall Study|Lost to Follow-up|4|||
19377541|NCT02463032|41619984|FG000|Overall Study|Lack of Efficacy|61|||
19377542|NCT02463032|41619985|FG001|Overall Study|Lack of Efficacy|50|||
19377543|NCT02463032|41619984|FG000|Overall Study|Death|8|||
19377544|NCT02463032|41619985|FG001|Overall Study|Death|8|||
19377545|NCT02463032|41619984|FG000|Overall Study|Adverse Event|2|||
19377546|NCT02463032|41619985|FG001|Overall Study|Adverse Event|6|||
19377547|NCT02496884|41619995|FG000|Overall Study|Counted twice as enrolled|2|||
19377548|NCT02496884|41619996|FG001|Overall Study|Counted twice as enrolled|0|||
19377549|NCT02496884|41619997|FG002|Overall Study|Counted twice as enrolled|0|||
19377550|NCT02496884|41619998|FG003|Overall Study|Counted twice as enrolled|0|||
19377551|NCT02496884|41619995|FG000|Overall Study|Withdrawal by Subject|0|||
19377552|NCT02496884|41619996|FG001|Overall Study|Withdrawal by Subject|3|||
19377553|NCT02496884|41619997|FG002|Overall Study|Withdrawal by Subject|0|||
19377554|NCT02496884|41619998|FG003|Overall Study|Withdrawal by Subject|0|||
19377555|NCT02462876|41620008|FG000|Overall Study|Death|3|||
19377556|NCT02462876|41620008|FG000|Overall Study|Lost to Follow-up|7|||
19377557|NCT02462876|41620008|FG000|Overall Study|Surgical Bypass|9|||
19377558|NCT02462876|41620008|FG000|Overall Study|Amputation Above the Metatarsals|1|||
19377559|NCT02462876|41620008|FG000|Overall Study|36 months follow-up visit missed|1|||
19377560|NCT02462876|41620008|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
19377561|NCT02462876|41620008|FG000|Overall Study|Patient did not come back to the vascular department|1|||
19377562|NCT02462876|41620008|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
19377563|NCT02462876|41620008|FG000|Overall Study|Patient refused to come back|1|||
19377564|NCT02462876|41620008|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
19377565|NCT02462876|41620008|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
19377566|NCT03386721|41620027|FG000|Overall Study|Death|12|||
19377567|NCT03386721|41620028|FG001|Overall Study|Death|21|||
19377568|NCT03386721|41620029|FG002|Overall Study|Death|2|||
19377569|NCT03386721|41620030|FG003|Overall Study|Death|5|||
19377570|NCT03386721|41620031|FG004|Overall Study|Death|1|||
19377571|NCT03386721|41620032|FG005|Overall Study|Death|12|||
19377572|NCT03386721|41620033|FG006|Overall Study|Death|1|||
19377573|NCT03386721|41620034|FG007|Overall Study|Death|1|||
19377574|NCT03386721|41620035|FG008|Overall Study|Death|12|||
19377575|NCT03386721|41620036|FG009|Overall Study|Death|20|||
19377576|NCT03386721|41620037|FG010|Overall Study|Death|21|||
19377577|NCT03386721|41620038|FG011|Overall Study|Death|21|||
19377578|NCT03386721|41620039|FG012|Overall Study|Death|14|||
19377579|NCT03386721|41620040|FG013|Overall Study|Death|2|||
19377580|NCT03386721|41620041|FG014|Overall Study|Death|1|||
19377581|NCT03386721|41620027|FG000|Overall Study|Lost to Follow-up|1|||
19377582|NCT03386721|41620028|FG001|Overall Study|Lost to Follow-up|3|||
19377583|NCT03386721|41620029|FG002|Overall Study|Lost to Follow-up|0|||
19377584|NCT03386721|41620030|FG003|Overall Study|Lost to Follow-up|0|||
19377585|NCT03386721|41620031|FG004|Overall Study|Lost to Follow-up|0|||
19377586|NCT03386721|41620032|FG005|Overall Study|Lost to Follow-up|2|||
19377587|NCT03386721|41620033|FG006|Overall Study|Lost to Follow-up|1|||
19377588|NCT03386721|41620034|FG007|Overall Study|Lost to Follow-up|0|||
19377589|NCT03386721|41620035|FG008|Overall Study|Lost to Follow-up|1|||
19377590|NCT03386721|41620036|FG009|Overall Study|Lost to Follow-up|2|||
19377591|NCT03386721|41620037|FG010|Overall Study|Lost to Follow-up|1|||
19377592|NCT03386721|41620038|FG011|Overall Study|Lost to Follow-up|0|||
19377593|NCT03386721|41620039|FG012|Overall Study|Lost to Follow-up|0|||
19377594|NCT03386721|41620040|FG013|Overall Study|Lost to Follow-up|0|||
19377595|NCT03386721|41620041|FG014|Overall Study|Lost to Follow-up|0|||
19377596|NCT03386721|41620027|FG000|Overall Study|Reason not specified|3|||
19377597|NCT03386721|41620028|FG001|Overall Study|Reason not specified|0|||
19377598|NCT03386721|41620029|FG002|Overall Study|Reason not specified|0|||
19377599|NCT03386721|41620030|FG003|Overall Study|Reason not specified|0|||
19377600|NCT03386721|41620031|FG004|Overall Study|Reason not specified|0|||
19377601|NCT03386721|41620032|FG005|Overall Study|Reason not specified|3|||
19377602|NCT03386721|41620033|FG006|Overall Study|Reason not specified|1|||
19377603|NCT03386721|41620034|FG007|Overall Study|Reason not specified|0|||
19377604|NCT03386721|41620035|FG008|Overall Study|Reason not specified|0|||
19377605|NCT03386721|41620036|FG009|Overall Study|Reason not specified|1|||
19377606|NCT03386721|41620037|FG010|Overall Study|Reason not specified|2|||
19377607|NCT03386721|41620038|FG011|Overall Study|Reason not specified|6|||
19377608|NCT03386721|41620039|FG012|Overall Study|Reason not specified|1|||
19377609|NCT03386721|41620040|FG013|Overall Study|Reason not specified|0|||
19377610|NCT03386721|41620041|FG014|Overall Study|Reason not specified|0|||
19377611|NCT03386721|41620027|FG000|Overall Study|Progressive Disease|0|||
19377612|NCT03386721|41620028|FG001|Overall Study|Progressive Disease|0|||
19377613|NCT03386721|41620029|FG002|Overall Study|Progressive Disease|1|||
19377614|NCT03386721|41620030|FG003|Overall Study|Progressive Disease|0|||
19463211|NCT01702987|41720680|FG000|Overall Study|Withdrawal by Subject|1|||
19463212|NCT01702987|41720681|FG001|Overall Study|Withdrawal by Subject|0|||
19463213|NCT01702519|41720702|FG000|Washout Period|Lost to Follow-up|1|||
19463214|NCT01702519|41720703|FG001|Washout Period|Lost to Follow-up|0|||
19463215|NCT01702519|41720702|FG000|Washout Period|Withdrawal by Subject|0|||
19463216|NCT01702519|41720703|FG001|Washout Period|Withdrawal by Subject|2|||
19463217|NCT01739803|41720715|FG000|Overall Study|Lost to Follow-up|9|||
19463218|NCT01739803|41720716|FG001|Overall Study|Lost to Follow-up|6|||
19463219|NCT01739335|41720728|FG000|Overall Study|Lost to Follow-up|7|||
19463220|NCT01739335|41720729|FG001|Overall Study|Lost to Follow-up|4|||
19463221|NCT01739335|41720728|FG000|Overall Study|Ineligible patient randomized|0|||
19463222|NCT01739335|41720729|FG001|Overall Study|Ineligible patient randomized|1|||
19463223|NCT01702363|41720754|FG000|Overall Study|Adverse Event|14|||
19463224|NCT01702363|41720754|FG000|Overall Study|Lack of Efficacy|4|||
19463225|NCT01702363|41720754|FG000|Overall Study|Withdrawal by Subject|2|||
19463226|NCT01722097|41720761|FG000|Overall Study|Patient sheets not returned|6|||
19463227|NCT01722097|41720762|FG001|Overall Study|Patient sheets not returned|5|||
19463228|NCT01701973|41720777|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463229|NCT01701973|41720778|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
19463230|NCT01701973|41720779|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463231|NCT01701973|41720780|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463232|NCT01701973|41720781|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463233|NCT01701973|41720782|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463234|NCT01701973|41720783|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463235|NCT01701973|41720784|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
19463236|NCT01721317|41720835|FG000|Overall Study|Study Closed / Terminated|2|||
19463237|NCT01721317|41720836|FG001|Overall Study|Study Closed / Terminated|2|||
19463238|NCT01721317|41720835|FG000|Overall Study|Physician Decision|0|||
19463239|NCT01721317|41720836|FG001|Overall Study|Physician Decision|1|||
19463240|NCT01721317|41720835|FG000|Overall Study|Withdrawal by Subject|0|||
19463241|NCT01721317|41720836|FG001|Overall Study|Withdrawal by Subject|1|||
19377615|NCT03386721|41620031|FG004|Overall Study|Progressive Disease|0|||
19463242|NCT01701193|41720846|FG000|Overall Study|Withdrawal by Subject|2|||
19463243|NCT01701193|41720847|FG001|Overall Study|Withdrawal by Subject|2|||
19463244|NCT01701193|41720848|FG002|Overall Study|Withdrawal by Subject|1|||
19463245|NCT01701193|41720849|FG003|Overall Study|Withdrawal by Subject|2|||
19463246|NCT01701193|41720846|FG000|Overall Study|Adverse Event|1|||
19463247|NCT01701193|41720847|FG001|Overall Study|Adverse Event|0|||
19463248|NCT01701193|41720848|FG002|Overall Study|Adverse Event|0|||
19463249|NCT01701193|41720849|FG003|Overall Study|Adverse Event|0|||
19463250|NCT01959347|41720897|FG000|Overall Study|Protocol Violation|9|||
19463251|NCT01959347|41720898|FG001|Overall Study|Protocol Violation|7|||
19463252|NCT01959035|41720924|FG000|Overall Study|Adverse Event|5|||
19463253|NCT01959035|41720924|FG000|Overall Study|Withdrawal by Subject|4|||
19463254|NCT01959035|41720924|FG000|Overall Study|Lost to Follow-up|1|||
19463255|NCT01959035|41720924|FG000|Overall Study|Other (no primary reason given)|1|||
19463256|NCT01700959|41720934|FG000|Overall Study|Adverse Event|0|||
19463257|NCT01700959|41720935|FG001|Overall Study|Adverse Event|1|||
19463258|NCT01700959|41720936|FG002|Overall Study|Adverse Event|1|||
19463259|NCT01700959|41720937|FG003|Overall Study|Adverse Event|2|||
19463260|NCT01700959|41720938|FG004|Overall Study|Adverse Event|0|||
19463261|NCT01700959|41720939|FG005|Overall Study|Adverse Event|2|||
19463262|NCT01700959|41720934|FG000|Overall Study|Withdrawal by Subject|15|||
19463263|NCT01700959|41720935|FG001|Overall Study|Withdrawal by Subject|9|||
19463264|NCT01700959|41720936|FG002|Overall Study|Withdrawal by Subject|12|||
19463265|NCT01700959|41720937|FG003|Overall Study|Withdrawal by Subject|11|||
19463266|NCT01700959|41720938|FG004|Overall Study|Withdrawal by Subject|8|||
19463267|NCT01700959|41720939|FG005|Overall Study|Withdrawal by Subject|12|||
19463268|NCT01700959|41720934|FG000|Overall Study|Ineligible|2|||
19463269|NCT01700959|41720935|FG001|Overall Study|Ineligible|1|||
19463270|NCT01700959|41720936|FG002|Overall Study|Ineligible|2|||
19463271|NCT01700959|41720937|FG003|Overall Study|Ineligible|0|||
19463272|NCT01700959|41720938|FG004|Overall Study|Ineligible|0|||
19463273|NCT01700959|41720939|FG005|Overall Study|Ineligible|1|||
19463274|NCT01700959|41720934|FG000|Overall Study|Noncompliant|9|||
19463275|NCT01700959|41720935|FG001|Overall Study|Noncompliant|9|||
19463276|NCT01700959|41720936|FG002|Overall Study|Noncompliant|17|||
19463277|NCT01700959|41720937|FG003|Overall Study|Noncompliant|18|||
19463278|NCT01700959|41720938|FG004|Overall Study|Noncompliant|15|||
19463279|NCT01700959|41720939|FG005|Overall Study|Noncompliant|9|||
19463280|NCT01700959|41720934|FG000|Overall Study|Side effects|1|||
19463281|NCT01700959|41720935|FG001|Overall Study|Side effects|4|||
19463282|NCT01700959|41720936|FG002|Overall Study|Side effects|8|||
19463283|NCT01700959|41720937|FG003|Overall Study|Side effects|4|||
19463284|NCT01700959|41720938|FG004|Overall Study|Side effects|4|||
19463285|NCT01700959|41720939|FG005|Overall Study|Side effects|1|||
19463286|NCT01738477|41720961|FG000|Overall Study|Lost to Follow-up|1|||
19463287|NCT01738477|41720962|FG001|Overall Study|Lost to Follow-up|4|||
19463288|NCT01737931|41720978|FG000|Overall Study|Withdrawal by Subject|0|||
19463289|NCT01737931|41720979|FG001|Overall Study|Withdrawal by Subject|1|||
19463290|NCT01737931|41720980|FG002|Overall Study|Withdrawal by Subject|1|||
19463291|NCT01737931|41720978|FG000|Overall Study|Physician Decision|0|||
19463292|NCT01737931|41720979|FG001|Overall Study|Physician Decision|1|||
19463293|NCT01737931|41720980|FG002|Overall Study|Physician Decision|0|||
19463294|NCT01958489|41720986|FG000|Period 2|Adverse Event|0|||
19463295|NCT01958489|41720987|FG001|Period 2|Adverse Event|1|||
19463296|NCT01721161|41721000|FG000|Overall Study|Adverse Event|2|||
19463297|NCT01721161|41721001|FG001|Overall Study|Adverse Event|3|||
19463298|NCT01721161|41721000|FG000|Overall Study|Lost to Follow-up|1|||
19463299|NCT01721161|41721001|FG001|Overall Study|Lost to Follow-up|2|||
19463300|NCT01721161|41721000|FG000|Overall Study|Withdrawal by Subject|1|||
19463301|NCT01721161|41721001|FG001|Overall Study|Withdrawal by Subject|1|||
19463302|NCT01721161|41721000|FG000|Overall Study|Other|0|||
19463303|NCT01721161|41721001|FG001|Overall Study|Other|1|||
19463304|NCT01700179|41721008|FG000|Overall Study|Physician Decision|2|||
19463305|NCT01699867|41721012|FG000|Overall Study|Screening Failure|3|||
19463306|NCT01699789|41721031|FG000|Overall Study|Withdrawal by Subject|18|||
19463307|NCT01699789|41721032|FG001|Overall Study|Withdrawal by Subject|23|||
19463308|NCT01699789|41721031|FG000|Overall Study|Death|1|||
19463309|NCT01699789|41721032|FG001|Overall Study|Death|2|||
19463310|NCT01699789|41721031|FG000|Overall Study|Lost to Follow-up|83|||
19463311|NCT01699789|41721032|FG001|Overall Study|Lost to Follow-up|101|||
19463312|NCT01944839|41721055|FG000|Overall Study|Physician Decision|2|||
19463313|NCT01944839|41721056|FG001|Overall Study|Physician Decision|2|||
19463314|NCT01944839|41721055|FG000|Overall Study|Protocol Violation|0|||
19463315|NCT01944839|41721056|FG001|Overall Study|Protocol Violation|1|||
19463316|NCT01944839|41721055|FG000|Overall Study|Adverse Event|10|||
19463317|NCT01944839|41721056|FG001|Overall Study|Adverse Event|5|||
19463318|NCT01944839|41721055|FG000|Overall Study|Withdrawal by Subject|9|||
19463319|NCT01944839|41721056|FG001|Overall Study|Withdrawal by Subject|17|||
19463320|NCT01944839|41721055|FG000|Overall Study|Lost to Follow-up|1|||
19463321|NCT01944839|41721056|FG001|Overall Study|Lost to Follow-up|0|||
19463322|NCT01944839|41721055|FG000|Overall Study|Subject non-compliance|0|||
19463323|NCT01944839|41721056|FG001|Overall Study|Subject non-compliance|3|||
19463324|NCT01944059|41721071|FG000|Overall Study|Lost to Follow-up|1|||
19463325|NCT01944059|41721071|FG000|Overall Study|Physician Decision|3|||
19463326|NCT01944059|41721071|FG000|Overall Study|Withdrawal by Subject|1|||
19463327|NCT01944059|41721071|FG000|Overall Study|Adverse Event|2|||
19463328|NCT01720225|41721078|FG000|Overall Study|Withdrawal by Subject|0|||
19463329|NCT01720225|41721079|FG001|Overall Study|Withdrawal by Subject|1|||
19463330|NCT01720225|41721078|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
19463331|NCT01720225|41721079|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
19463332|NCT01943591|41721087|FG000|Overall Study|Lost to Follow-up|3|||
19463333|NCT01943591|41721088|FG001|Overall Study|Lost to Follow-up|4|||
19463334|NCT01943591|41721087|FG000|Overall Study|Death|2|||
19463335|NCT01943591|41721088|FG001|Overall Study|Death|7|||
19463336|NCT01699087|41721094|FG000|Overall Study|Lost to Follow-up|7|||
19463337|NCT01699087|41721094|FG000|Overall Study|Screen failure (prior to treatment)|15|||
19463338|NCT01699087|41721094|FG000|Overall Study|Unable to make future visits|2|||
19463339|NCT01943435|41721102|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
19463340|NCT01943435|41721103|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
19463341|NCT01943435|41721104|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
19463342|NCT01943435|41721102|FG000|Intervention Period|Withdrawal by Subject|3|||
19463343|NCT01943435|41721103|FG001|Intervention Period|Withdrawal by Subject|3|||
19463344|NCT01943435|41721104|FG002|Intervention Period|Withdrawal by Subject|4|||
19463345|NCT01943435|41721102|FG000|2 Month Follow up|Lost to Follow-up|2|||
19463346|NCT01943435|41721103|FG001|2 Month Follow up|Lost to Follow-up|3|||
19463347|NCT01943435|41721104|FG002|2 Month Follow up|Lost to Follow-up|0|||
19463348|NCT01943435|41721102|FG000|6 Month Follow up|Lost to Follow-up|12|||
19463349|NCT01943435|41721103|FG001|6 Month Follow up|Lost to Follow-up|7|||
19463350|NCT01943435|41721104|FG002|6 Month Follow up|Lost to Follow-up|15|||
19463351|NCT01942733|41721122|FG000|Overall Study|Lost to Follow-up|1|||
19463352|NCT01942733|41721122|FG000|Overall Study|Non-compliance with IMP|1|||
19463353|NCT01942733|41721122|FG000|Overall Study|Administrative|1|||
19463354|NCT01957865|41721138|FG000|Overall Study|Found HIV negative|0|||
19463355|NCT01957865|41721139|FG001|Overall Study|Found HIV negative|0|||
19463356|NCT01957865|41721140|FG002|Overall Study|Found HIV negative|1|||
19463357|NCT01957865|41721138|FG000|Overall Study|Lost to Follow-up|0|||
19463358|NCT01957865|41721139|FG001|Overall Study|Lost to Follow-up|2|||
19463359|NCT01957865|41721140|FG002|Overall Study|Lost to Follow-up|2|||
19463360|NCT01957787|41721149|FG000|Overall Study|Death|18|||
19463361|NCT01957787|41721149|FG000|Overall Study|Lost to Follow-up|3|||
19463362|NCT01957787|41721149|FG000|Overall Study|Withdrawal by Subject|3|||
19463363|NCT01957787|41721149|FG000|Overall Study|Entered Hospice or Similar Program|2|||
19463364|NCT01957787|41721149|FG000|Overall Study|Index Tumor(s) Resected|2|||
19463365|NCT01957787|41721149|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
19463366|NCT01957787|41721149|FG000|Overall Study|Local therapy, not cryoablation|6|||
19463367|NCT01698775|41721155|FG000|Phase A|Adverse Event|2|||
19463368|NCT01698775|41721156|FG001|Phase A|Adverse Event|1|||
19463369|NCT01698775|41721155|FG000|Phase A|Death|1|||
19463370|NCT01698775|41721156|FG001|Phase A|Death|1|||
19463371|NCT01698775|41721155|FG000|Phase A|Lack of Efficacy|1|||
19463372|NCT01698775|41721156|FG001|Phase A|Lack of Efficacy|0|||
19463373|NCT01698775|41721155|FG000|Phase A|Lost to Follow-up|1|||
19463374|NCT01698775|41721156|FG001|Phase A|Lost to Follow-up|2|||
19463375|NCT01698775|41721155|FG000|Phase A|Protocol Violation|1|||
19463376|NCT01698775|41721156|FG001|Phase A|Protocol Violation|0|||
19463377|NCT01698775|41721155|FG000|Phase A|Withdrawal by Subject|3|||
19463378|NCT01698775|41721156|FG001|Phase A|Withdrawal by Subject|4|||
19463379|NCT01698775|41721155|FG000|Phase A|Kidney [transplant]|0|||
19463380|NCT01698775|41721156|FG001|Phase A|Kidney [transplant]|1|||
19463381|NCT01698775|41721155|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
19463382|NCT01698775|41721156|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
19463383|NCT01698775|41721155|FG000|Phase B|Adverse Event|6|||
19463384|NCT01698775|41721156|FG001|Phase B|Adverse Event|3|||
19463385|NCT01698775|41721155|FG000|Phase B|Death|0|||
19463386|NCT01698775|41721156|FG001|Phase B|Death|1|||
19463387|NCT01698775|41721155|FG000|Phase B|Lack of Efficacy|0|||
19463388|NCT01698775|41721156|FG001|Phase B|Lack of Efficacy|1|||
19463389|NCT01698775|41721155|FG000|Phase B|Lost to Follow-up|0|||
19463390|NCT01698775|41721156|FG001|Phase B|Lost to Follow-up|1|||
19463391|NCT01698775|41721155|FG000|Phase B|Physician Decision|1|||
19463392|NCT01698775|41721156|FG001|Phase B|Physician Decision|1|||
19463393|NCT01698775|41721155|FG000|Phase B|Protocol Violation|1|||
19463394|NCT01698775|41721156|FG001|Phase B|Protocol Violation|1|||
19463395|NCT01698775|41721155|FG000|Phase B|Withdrawal by Subject|6|||
19463396|NCT01698775|41721156|FG001|Phase B|Withdrawal by Subject|2|||
19463397|NCT01941095|41721166|FG000|Overall Study|Insufficient therapeutic response|13|||
19463398|NCT01941095|41721166|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
19463399|NCT01941095|41721166|FG000|Overall Study|Adverse Event|11|||
19463400|NCT01941095|41721166|FG000|Overall Study|Physician Decision|3|||
19463401|NCT01941095|41721166|FG000|Overall Study|Withdrawal by Subject|17|||
19463402|NCT01941095|41721166|FG000|Overall Study|Lost to Follow-up|10|||
19463403|NCT01957709|41721181|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
19463404|NCT01957553|41721198|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
19463405|NCT01957553|41721199|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
19463406|NCT01957553|41721198|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
19463407|NCT01957553|41721199|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
19463408|NCT01957553|41721198|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
19463409|NCT01957553|41721199|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
19463410|NCT01957553|41721198|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
19463411|NCT01957553|41721199|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
19463412|NCT01957553|41721198|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
19463413|NCT01957553|41721199|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
19463414|NCT01957553|41721198|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
19463415|NCT01957553|41721199|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
19463416|NCT01957553|41721198|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
19463417|NCT01957553|41721199|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
19463418|NCT01957553|41721198|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
19463419|NCT01957553|41721199|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
19463420|NCT01957553|41721198|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
19463421|NCT01957553|41721199|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
19463422|NCT01957475|41721224|FG000|Test Period 1|Withdrawal by Subject|1|||
19463423|NCT01957475|41721225|FG001|Test Period 1|Withdrawal by Subject|0|||
19463424|NCT01957475|41721224|FG000|Test Period 1|Other|1|||
19463425|NCT01957475|41721225|FG001|Test Period 1|Other|0|||
19463426|NCT01957475|41721224|FG000|Test Period 1|Lack of Efficacy|0|||
19463427|NCT01957475|41721225|FG001|Test Period 1|Lack of Efficacy|1|||
19463428|NCT01957475|41721224|FG000|Test Period 2|Adverse Event|1|||
19463429|NCT01957475|41721225|FG001|Test Period 2|Adverse Event|0|||
19463430|NCT01940939|41721233|FG000|Overall Study|Withdrawal by Subject|2|||
19463431|NCT01940939|41721234|FG001|Overall Study|Withdrawal by Subject|8|||
19463432|NCT01957397|41721240|FG000|Test Period 1|sudden leakage/small bag|1|||
19463433|NCT01957397|41721241|FG001|Test Period 1|sudden leakage/small bag|1|||
19463434|NCT01957397|41721240|FG000|Test Period 1|Withdrawal by Subject|1|||
19463435|NCT01957397|41721241|FG001|Test Period 1|Withdrawal by Subject|0|||
19463436|NCT01957397|41721240|FG000|Test Period 2|Adverse Event|0|||
19463437|NCT01957397|41721241|FG001|Test Period 2|Adverse Event|1|||
19463438|NCT01957397|41721240|FG000|Test Period 3|Adverse Event|1|||
19463439|NCT01957397|41721241|FG001|Test Period 3|Adverse Event|2|||
19463440|NCT01957397|41721240|FG000|Test Period 3|the adhesive did not work|1|||
19463441|NCT01957397|41721241|FG001|Test Period 3|the adhesive did not work|0|||
19463442|NCT01940705|41721255|FG000|Overall Study|Lost to Follow-up|1|||
19463443|NCT01940705|41721256|FG001|Overall Study|Lost to Follow-up|3|||
19463444|NCT01940705|41721257|FG002|Overall Study|Lost to Follow-up|2|||
19463445|NCT01940705|41721258|FG003|Overall Study|Lost to Follow-up|2|||
19463446|NCT01940705|41721255|FG000|Overall Study|Withdrawal by Subject|2|||
19463447|NCT01940705|41721256|FG001|Overall Study|Withdrawal by Subject|2|||
19463448|NCT01940705|41721257|FG002|Overall Study|Withdrawal by Subject|3|||
19463449|NCT01940705|41721258|FG003|Overall Study|Withdrawal by Subject|2|||
19463450|NCT01940705|41721255|FG000|Overall Study|Intervention not given|0|||
19463451|NCT01940705|41721256|FG001|Overall Study|Intervention not given|3|||
19463452|NCT01940705|41721257|FG002|Overall Study|Intervention not given|3|||
19463453|NCT01940705|41721258|FG003|Overall Study|Intervention not given|0|||
19463454|NCT01940705|41721255|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
19463455|NCT01940705|41721256|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
19463456|NCT01940705|41721257|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
19463457|NCT01940705|41721258|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
19463458|NCT01957163|41721283|FG000|Overall Study|Adverse Event|5|||
19463459|NCT01957163|41721284|FG001|Overall Study|Adverse Event|2|||
19463460|NCT01957163|41721285|FG002|Overall Study|Adverse Event|4|||
19463461|NCT01957163|41721283|FG000|Overall Study|Lack of Efficacy|5|||
19463462|NCT01957163|41721284|FG001|Overall Study|Lack of Efficacy|4|||
19463463|NCT01957163|41721285|FG002|Overall Study|Lack of Efficacy|9|||
19463464|NCT01957163|41721283|FG000|Overall Study|Protocol Violation|1|||
19463465|NCT01957163|41721284|FG001|Overall Study|Protocol Violation|2|||
19463466|NCT01957163|41721285|FG002|Overall Study|Protocol Violation|0|||
19463467|NCT01957163|41721283|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
19463468|NCT01957163|41721284|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
19463469|NCT01957163|41721285|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
19463470|NCT01957163|41721283|FG000|Overall Study|Lost to Follow-up|0|||
19463471|NCT01957163|41721284|FG001|Overall Study|Lost to Follow-up|1|||
19463472|NCT01957163|41721285|FG002|Overall Study|Lost to Follow-up|0|||
19463473|NCT01957163|41721283|FG000|Overall Study|Withdrawal by Subject|4|||
19463474|NCT01957163|41721284|FG001|Overall Study|Withdrawal by Subject|2|||
19478075|NCT01693562|41757321|FG007|Exploration Phase|Other|0|||
19463475|NCT01957163|41721285|FG002|Overall Study|Withdrawal by Subject|4|||
19463476|NCT01956773|41721308|FG000|Overall Study|Lost to Follow-up|628|||
19463477|NCT01956773|41721309|FG001|Overall Study|Lost to Follow-up|1|||
19463478|NCT01939223|41721348|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
19463479|NCT01939223|41721349|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
19463480|NCT01939223|41721348|FG000|Overall Study|Disease recurrence (radiological)|1|||
19463481|NCT01939223|41721349|FG001|Overall Study|Disease recurrence (radiological)|3|||
19463482|NCT01939223|41721348|FG000|Overall Study|Study stopped by Sponsor|5|||
19463483|NCT01939223|41721349|FG001|Overall Study|Study stopped by Sponsor|7|||
19463484|NCT01939223|41721348|FG000|Overall Study|Withdrawal by Subject|6|||
19463485|NCT01939223|41721349|FG001|Overall Study|Withdrawal by Subject|0|||
19463486|NCT01954745|41721394|FG000|Overall Study|Radiological Progression|11|||
19463487|NCT01954745|41721394|FG000|Overall Study|Clinical Progression|5|||
19463488|NCT01954745|41721394|FG000|Overall Study|Adverse Event|2|||
19463489|NCT01954745|41721394|FG000|Overall Study|Death|1|||
19463490|NCT01954121|41721409|FG000|Overall Study|Lack of Efficacy|94|||
19463491|NCT01954121|41721410|FG001|Overall Study|Lack of Efficacy|41|||
19463492|NCT01954121|41721409|FG000|Overall Study|Protocol Violation|0|||
19463493|NCT01954121|41721410|FG001|Overall Study|Protocol Violation|2|||
19463494|NCT01954121|41721409|FG000|Overall Study|Lost to Follow-up|5|||
19463495|NCT01954121|41721410|FG001|Overall Study|Lost to Follow-up|6|||
19463496|NCT01954121|41721409|FG000|Overall Study|Withdrawal by Subject|18|||
19463497|NCT01954121|41721410|FG001|Overall Study|Withdrawal by Subject|12|||
19463498|NCT01954121|41721409|FG000|Overall Study|Pregnancy|1|||
19463499|NCT01954121|41721410|FG001|Overall Study|Pregnancy|1|||
19463500|NCT01954121|41721409|FG000|Overall Study|AE, serious fatal|1|||
19463501|NCT01954121|41721410|FG001|Overall Study|AE, serious fatal|0|||
19463502|NCT01954121|41721409|FG000|Overall Study|AE, non-serious non-fatal|5|||
19463503|NCT01954121|41721410|FG001|Overall Study|AE, non-serious non-fatal|22|||
19463504|NCT01954121|41721409|FG000|Overall Study|SAE, non-fatal|1|||
19463505|NCT01954121|41721410|FG001|Overall Study|SAE, non-fatal|4|||
19463506|NCT01954121|41721409|FG000|Overall Study|Non-compliant with study procedures|1|||
19463507|NCT01954121|41721410|FG001|Overall Study|Non-compliant with study procedures|0|||
19463508|NCT01954121|41721409|FG000|Overall Study|Non-compliant patient|1|||
19463509|NCT01954121|41721410|FG001|Overall Study|Non-compliant patient|1|||
19463510|NCT01954121|41721409|FG000|Overall Study|Subject did not follow instructions|0|||
19463511|NCT01954121|41721410|FG001|Overall Study|Subject did not follow instructions|2|||
19463512|NCT01952015|41721445|FG000|Induction|Protocol Violation|1|||
19463513|NCT01952015|41721445|FG000|Maintenance|Adverse Event|2|||
19463514|NCT01952015|41721445|FG000|Treatment Period 3|Physician Decision|9|||
19463515|NCT01951703|41721478|FG000|First Intervention|Withdrawal by Subject|1|||
19463516|NCT01951703|41721479|FG001|First Intervention|Withdrawal by Subject|0|||
19463517|NCT01951703|41721478|FG000|First Intervention|Subject was not compliant|1|||
19463518|NCT01951703|41721479|FG001|First Intervention|Subject was not compliant|1|||
19463519|NCT01951703|41721478|FG000|First Intervention|Physician Decision|1|||
19463520|NCT01951703|41721479|FG001|First Intervention|Physician Decision|0|||
19463521|NCT01951703|41721478|FG000|Second Intervention|Protocol Violation|0|||
19463522|NCT01951703|41721479|FG001|Second Intervention|Protocol Violation|1|||
19463523|NCT01951703|41721478|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
19463524|NCT01951703|41721479|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
19463525|NCT01937351|41721505|FG000|Overall Study|Withdrawal by Subject|4|||
19463526|NCT01937351|41721506|FG001|Overall Study|Withdrawal by Subject|2|||
19463527|NCT01937351|41721505|FG000|Overall Study|Death|1|||
19463528|NCT01937351|41721506|FG001|Overall Study|Death|0|||
19463529|NCT01937351|41721505|FG000|Overall Study|Not treated w device, per protocol fail|4|||
19463530|NCT01937351|41721506|FG001|Overall Study|Not treated w device, per protocol fail|0|||
19463531|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463532|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
19463533|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463534|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
19463535|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
19463536|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463537|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463538|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463539|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463540|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463541|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463542|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463543|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463544|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463545|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
19463546|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
19463547|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
19463548|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
19463549|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463550|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463551|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463552|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463553|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463554|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463555|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463556|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463557|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463558|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463559|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463560|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
19463561|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463562|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463563|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463564|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
19463565|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463566|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463567|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463568|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463569|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463570|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463571|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463572|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463573|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463574|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463575|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
19463576|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463577|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
19463578|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463579|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463580|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463581|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463582|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463583|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463584|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463585|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463586|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463587|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463588|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463589|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463590|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
19463591|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463592|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463593|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463594|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463595|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
19463596|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463597|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463598|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463599|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463600|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463601|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463602|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463603|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463604|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463605|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
19463606|NCT01737697|41721539|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463607|NCT01737697|41721540|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
19463608|NCT01737697|41721541|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
19463609|NCT01737697|41721542|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
19463610|NCT01737697|41721543|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
19463611|NCT01737697|41721544|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19726229|NCT04389840|42170495|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
19463612|NCT01737697|41721545|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463613|NCT01737697|41721546|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463614|NCT01737697|41721547|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463615|NCT01737697|41721548|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463616|NCT01737697|41721549|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463617|NCT01737697|41721550|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463618|NCT01737697|41721551|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463619|NCT01737697|41721552|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463620|NCT01737697|41721553|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
19463621|NCT01737697|41721539|FG000|Subacute Phase|Adverse Event|0|||
19463622|NCT01737697|41721540|FG001|Subacute Phase|Adverse Event|0|||
19463623|NCT01737697|41721541|FG002|Subacute Phase|Adverse Event|0|||
19463624|NCT01737697|41721542|FG003|Subacute Phase|Adverse Event|0|||
19463625|NCT01737697|41721543|FG004|Subacute Phase|Adverse Event|0|||
19463626|NCT01737697|41721544|FG005|Subacute Phase|Adverse Event|1|||
19463627|NCT01737697|41721545|FG006|Subacute Phase|Adverse Event|1|||
19463628|NCT01737697|41721546|FG007|Subacute Phase|Adverse Event|1|||
19463629|NCT01737697|41721547|FG008|Subacute Phase|Adverse Event|1|||
19463630|NCT01737697|41721548|FG009|Subacute Phase|Adverse Event|1|||
19463631|NCT01737697|41721549|FG010|Subacute Phase|Adverse Event|4|||
19463632|NCT01737697|41721550|FG011|Subacute Phase|Adverse Event|1|||
19463633|NCT01737697|41721551|FG012|Subacute Phase|Adverse Event|1|||
19463634|NCT01737697|41721552|FG013|Subacute Phase|Adverse Event|0|||
19463635|NCT01737697|41721553|FG014|Subacute Phase|Adverse Event|0|||
19463636|NCT01737697|41721539|FG000|Subacute Phase|Withdrawal by Subject|0|||
19463637|NCT01737697|41721540|FG001|Subacute Phase|Withdrawal by Subject|0|||
19463638|NCT01737697|41721541|FG002|Subacute Phase|Withdrawal by Subject|0|||
19463639|NCT01737697|41721542|FG003|Subacute Phase|Withdrawal by Subject|0|||
19463640|NCT01737697|41721543|FG004|Subacute Phase|Withdrawal by Subject|0|||
19463641|NCT01737697|41721544|FG005|Subacute Phase|Withdrawal by Subject|1|||
19463642|NCT01737697|41721545|FG006|Subacute Phase|Withdrawal by Subject|0|||
19463643|NCT01737697|41721546|FG007|Subacute Phase|Withdrawal by Subject|2|||
19463644|NCT01737697|41721547|FG008|Subacute Phase|Withdrawal by Subject|0|||
19463645|NCT01737697|41721548|FG009|Subacute Phase|Withdrawal by Subject|1|||
19463646|NCT01737697|41721549|FG010|Subacute Phase|Withdrawal by Subject|0|||
19463647|NCT01737697|41721550|FG011|Subacute Phase|Withdrawal by Subject|1|||
19463648|NCT01737697|41721551|FG012|Subacute Phase|Withdrawal by Subject|1|||
19463649|NCT01737697|41721552|FG013|Subacute Phase|Withdrawal by Subject|1|||
19463650|NCT01737697|41721553|FG014|Subacute Phase|Withdrawal by Subject|0|||
19463651|NCT01737697|41721539|FG000|Subacute Phase|Lost to Follow-up|0|||
19463652|NCT01737697|41721540|FG001|Subacute Phase|Lost to Follow-up|0|||
19463653|NCT01737697|41721541|FG002|Subacute Phase|Lost to Follow-up|0|||
19463654|NCT01737697|41721542|FG003|Subacute Phase|Lost to Follow-up|0|||
19463655|NCT01737697|41721543|FG004|Subacute Phase|Lost to Follow-up|0|||
19463656|NCT01737697|41721544|FG005|Subacute Phase|Lost to Follow-up|0|||
19463657|NCT01737697|41721545|FG006|Subacute Phase|Lost to Follow-up|0|||
19463658|NCT01737697|41721546|FG007|Subacute Phase|Lost to Follow-up|0|||
19463659|NCT01737697|41721547|FG008|Subacute Phase|Lost to Follow-up|0|||
19463660|NCT01737697|41721548|FG009|Subacute Phase|Lost to Follow-up|0|||
19463661|NCT01737697|41721549|FG010|Subacute Phase|Lost to Follow-up|0|||
19463662|NCT01737697|41721550|FG011|Subacute Phase|Lost to Follow-up|0|||
19463663|NCT01737697|41721551|FG012|Subacute Phase|Lost to Follow-up|0|||
19463664|NCT01737697|41721552|FG013|Subacute Phase|Lost to Follow-up|0|||
19463665|NCT01737697|41721553|FG014|Subacute Phase|Lost to Follow-up|1|||
19463666|NCT01737697|41721539|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
19463667|NCT01737697|41721540|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
19463668|NCT01737697|41721541|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
19463669|NCT01737697|41721542|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
19463670|NCT01737697|41721543|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
19463671|NCT01737697|41721544|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
19463672|NCT01737697|41721545|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
19463673|NCT01737697|41721546|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
19463674|NCT01737697|41721547|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
19463675|NCT01737697|41721548|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
19463676|NCT01737697|41721549|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
19463677|NCT01737697|41721550|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
19463678|NCT01737697|41721551|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
19463679|NCT01737697|41721552|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
19463680|NCT01737697|41721553|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
19463681|NCT01737697|41721539|FG000|Subacute Phase|Protocol Violation|0|||
19463682|NCT01737697|41721540|FG001|Subacute Phase|Protocol Violation|0|||
19463683|NCT01737697|41721541|FG002|Subacute Phase|Protocol Violation|0|||
19463684|NCT01737697|41721542|FG003|Subacute Phase|Protocol Violation|0|||
19463685|NCT01737697|41721543|FG004|Subacute Phase|Protocol Violation|0|||
19463686|NCT01737697|41721544|FG005|Subacute Phase|Protocol Violation|1|||
19463687|NCT01737697|41721545|FG006|Subacute Phase|Protocol Violation|0|||
19463688|NCT01737697|41721546|FG007|Subacute Phase|Protocol Violation|0|||
19463689|NCT01737697|41721547|FG008|Subacute Phase|Protocol Violation|0|||
19463690|NCT01737697|41721548|FG009|Subacute Phase|Protocol Violation|0|||
19463691|NCT01737697|41721549|FG010|Subacute Phase|Protocol Violation|1|||
19463692|NCT01737697|41721550|FG011|Subacute Phase|Protocol Violation|0|||
19463693|NCT01737697|41721551|FG012|Subacute Phase|Protocol Violation|0|||
19463694|NCT01737697|41721552|FG013|Subacute Phase|Protocol Violation|0|||
19463695|NCT01737697|41721553|FG014|Subacute Phase|Protocol Violation|0|||
19463696|NCT01737697|41721539|FG000|Subacute Phase|Physician Decision|0|||
19463697|NCT01737697|41721540|FG001|Subacute Phase|Physician Decision|0|||
19463698|NCT01737697|41721541|FG002|Subacute Phase|Physician Decision|0|||
19463699|NCT01737697|41721542|FG003|Subacute Phase|Physician Decision|0|||
19463700|NCT01737697|41721543|FG004|Subacute Phase|Physician Decision|0|||
19463701|NCT01737697|41721544|FG005|Subacute Phase|Physician Decision|0|||
19463702|NCT01737697|41721545|FG006|Subacute Phase|Physician Decision|0|||
19463703|NCT01737697|41721546|FG007|Subacute Phase|Physician Decision|0|||
19463704|NCT01737697|41721547|FG008|Subacute Phase|Physician Decision|1|||
19463705|NCT01737697|41721548|FG009|Subacute Phase|Physician Decision|0|||
19463706|NCT01737697|41721549|FG010|Subacute Phase|Physician Decision|0|||
19463707|NCT01737697|41721550|FG011|Subacute Phase|Physician Decision|0|||
19463708|NCT01737697|41721551|FG012|Subacute Phase|Physician Decision|0|||
19463709|NCT01737697|41721552|FG013|Subacute Phase|Physician Decision|0|||
19463710|NCT01737697|41721553|FG014|Subacute Phase|Physician Decision|0|||
19463711|NCT01737697|41721539|FG000|Subacute Phase|Death|0|||
19463712|NCT01737697|41721540|FG001|Subacute Phase|Death|0|||
19463713|NCT01737697|41721541|FG002|Subacute Phase|Death|0|||
19463714|NCT01737697|41721542|FG003|Subacute Phase|Death|0|||
19463715|NCT01737697|41721543|FG004|Subacute Phase|Death|0|||
19463716|NCT01737697|41721544|FG005|Subacute Phase|Death|0|||
19463717|NCT01737697|41721545|FG006|Subacute Phase|Death|0|||
19463718|NCT01737697|41721546|FG007|Subacute Phase|Death|0|||
19463719|NCT01737697|41721547|FG008|Subacute Phase|Death|0|||
19463720|NCT01737697|41721548|FG009|Subacute Phase|Death|0|||
19463721|NCT01737697|41721549|FG010|Subacute Phase|Death|1|||
19463722|NCT01737697|41721550|FG011|Subacute Phase|Death|0|||
19463723|NCT01737697|41721551|FG012|Subacute Phase|Death|0|||
19463724|NCT01737697|41721552|FG013|Subacute Phase|Death|0|||
19463725|NCT01737697|41721553|FG014|Subacute Phase|Death|0|||
19463726|NCT01682863|41721709|FG000|Overall Study|Subject/guardian decision|19|||
19463727|NCT01682863|41721710|FG001|Overall Study|Subject/guardian decision|12|||
19463728|NCT01682863|41721711|FG002|Overall Study|Subject/guardian decision|10|||
19463729|NCT01682863|41721709|FG000|Overall Study|Lost to Follow-up|5|||
19463730|NCT01682863|41721710|FG001|Overall Study|Lost to Follow-up|1|||
19463731|NCT01682863|41721711|FG002|Overall Study|Lost to Follow-up|6|||
19463732|NCT01682863|41721709|FG000|Overall Study|Death|1|||
19463733|NCT01682863|41721710|FG001|Overall Study|Death|3|||
19463734|NCT01682863|41721711|FG002|Overall Study|Death|4|||
19463735|NCT01682863|41721709|FG000|Overall Study|Protocol deviation|1|||
19463736|NCT01682863|41721710|FG001|Overall Study|Protocol deviation|0|||
19463737|NCT01682863|41721711|FG002|Overall Study|Protocol deviation|1|||
19463738|NCT01682863|41721709|FG000|Overall Study|Technical problems|1|||
19463739|NCT01682863|41721710|FG001|Overall Study|Technical problems|0|||
19463740|NCT01682863|41721711|FG002|Overall Study|Technical problems|0|||
19463741|NCT01682863|41721709|FG000|Overall Study|Adverse Event|0|||
19463742|NCT01682863|41721710|FG001|Overall Study|Adverse Event|1|||
19463743|NCT01682863|41721711|FG002|Overall Study|Adverse Event|2|||
19463744|NCT01682863|41721709|FG000|Overall Study|Physician Decision|0|||
19463745|NCT01682863|41721710|FG001|Overall Study|Physician Decision|0|||
19463746|NCT01682863|41721711|FG002|Overall Study|Physician Decision|1|||
19463747|NCT01951625|41721724|FG000|Treatment Period|Protocol Violation|2|||
19463748|NCT01951625|41721725|FG001|Treatment Period|Protocol Violation|0|||
19463749|NCT01951625|41721726|FG002|Treatment Period|Protocol Violation|1|||
19463750|NCT01951625|41721727|FG003|Treatment Period|Protocol Violation|3|||
19463751|NCT01951625|41721728|FG004|Treatment Period|Protocol Violation|2|||
19463752|NCT01951625|41721724|FG000|Treatment Period|Physician Decision|0|||
19463753|NCT01951625|41721725|FG001|Treatment Period|Physician Decision|0|||
19463754|NCT01951625|41721726|FG002|Treatment Period|Physician Decision|0|||
19463755|NCT01951625|41721727|FG003|Treatment Period|Physician Decision|0|||
19463756|NCT01951625|41721728|FG004|Treatment Period|Physician Decision|1|||
19726230|NCT04389840|42170496|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
19463757|NCT01951625|41721724|FG000|Treatment Period|Protocol driven decision point|0|||
19463758|NCT01951625|41721725|FG001|Treatment Period|Protocol driven decision point|5|||
19463759|NCT01951625|41721726|FG002|Treatment Period|Protocol driven decision point|0|||
19463760|NCT01951625|41721727|FG003|Treatment Period|Protocol driven decision point|2|||
19463761|NCT01951625|41721728|FG004|Treatment Period|Protocol driven decision point|1|||
19463762|NCT01951625|41721724|FG000|Treatment Period|Non compliance with study drug|1|||
19463763|NCT01951625|41721725|FG001|Treatment Period|Non compliance with study drug|2|||
19463764|NCT01951625|41721726|FG002|Treatment Period|Non compliance with study drug|2|||
19463765|NCT01951625|41721727|FG003|Treatment Period|Non compliance with study drug|0|||
19463766|NCT01951625|41721728|FG004|Treatment Period|Non compliance with study drug|0|||
19463767|NCT01951625|41721724|FG000|Treatment Period|Death|3|||
19463768|NCT01951625|41721725|FG001|Treatment Period|Death|2|||
19463769|NCT01951625|41721726|FG002|Treatment Period|Death|2|||
19463770|NCT01951625|41721727|FG003|Treatment Period|Death|1|||
19463771|NCT01951625|41721728|FG004|Treatment Period|Death|2|||
19463772|NCT01951625|41721724|FG000|Treatment Period|Adverse Event|7|||
19463773|NCT01951625|41721725|FG001|Treatment Period|Adverse Event|10|||
19463774|NCT01951625|41721726|FG002|Treatment Period|Adverse Event|9|||
19463775|NCT01951625|41721727|FG003|Treatment Period|Adverse Event|8|||
19463776|NCT01951625|41721728|FG004|Treatment Period|Adverse Event|8|||
19463777|NCT01951625|41721724|FG000|Treatment Period|Withdrawal by Subject|5|||
19463778|NCT01951625|41721725|FG001|Treatment Period|Withdrawal by Subject|2|||
19463779|NCT01951625|41721726|FG002|Treatment Period|Withdrawal by Subject|1|||
19463780|NCT01951625|41721727|FG003|Treatment Period|Withdrawal by Subject|7|||
19463781|NCT01951625|41721728|FG004|Treatment Period|Withdrawal by Subject|3|||
19463782|NCT01951625|41721724|FG000|Treatment Period|Lost to Follow-up|1|||
19463783|NCT01951625|41721725|FG001|Treatment Period|Lost to Follow-up|0|||
19463784|NCT01951625|41721726|FG002|Treatment Period|Lost to Follow-up|0|||
19463785|NCT01951625|41721727|FG003|Treatment Period|Lost to Follow-up|1|||
19463786|NCT01951625|41721728|FG004|Treatment Period|Lost to Follow-up|0|||
19463787|NCT01951625|41721724|FG000|Follow Up Period|Non-compliance with study drug|1|||
19463788|NCT01951625|41721725|FG001|Follow Up Period|Non-compliance with study drug|0|||
19463789|NCT01951625|41721726|FG002|Follow Up Period|Non-compliance with study drug|0|||
19463790|NCT01951625|41721727|FG003|Follow Up Period|Non-compliance with study drug|0|||
19463791|NCT01951625|41721728|FG004|Follow Up Period|Non-compliance with study drug|0|||
19463792|NCT01951625|41721724|FG000|Follow Up Period|Death|1|||
19463793|NCT01951625|41721725|FG001|Follow Up Period|Death|3|||
19463794|NCT01951625|41721726|FG002|Follow Up Period|Death|2|||
19463795|NCT01951625|41721727|FG003|Follow Up Period|Death|2|||
19463796|NCT01951625|41721728|FG004|Follow Up Period|Death|1|||
19463797|NCT01951625|41721724|FG000|Follow Up Period|Logistical difficulties|1|||
19463798|NCT01951625|41721725|FG001|Follow Up Period|Logistical difficulties|2|||
19463799|NCT01951625|41721726|FG002|Follow Up Period|Logistical difficulties|0|||
19463800|NCT01951625|41721727|FG003|Follow Up Period|Logistical difficulties|0|||
19463801|NCT01951625|41721728|FG004|Follow Up Period|Logistical difficulties|0|||
19463802|NCT01951625|41721724|FG000|Follow Up Period|Adverse Event|0|||
19463803|NCT01951625|41721725|FG001|Follow Up Period|Adverse Event|3|||
19463804|NCT01951625|41721726|FG002|Follow Up Period|Adverse Event|2|||
19463805|NCT01951625|41721727|FG003|Follow Up Period|Adverse Event|3|||
19463806|NCT01951625|41721728|FG004|Follow Up Period|Adverse Event|5|||
19463807|NCT01951625|41721724|FG000|Follow Up Period|Withdrawal by Subject|4|||
19463808|NCT01951625|41721725|FG001|Follow Up Period|Withdrawal by Subject|1|||
19463809|NCT01951625|41721726|FG002|Follow Up Period|Withdrawal by Subject|0|||
19463810|NCT01951625|41721727|FG003|Follow Up Period|Withdrawal by Subject|5|||
19463811|NCT01951625|41721728|FG004|Follow Up Period|Withdrawal by Subject|3|||
19463812|NCT01951625|41721724|FG000|Follow Up Period|Lost to Follow-up|1|||
19463813|NCT01951625|41721725|FG001|Follow Up Period|Lost to Follow-up|0|||
19463814|NCT01951625|41721726|FG002|Follow Up Period|Lost to Follow-up|0|||
19463815|NCT01951625|41721727|FG003|Follow Up Period|Lost to Follow-up|1|||
19463816|NCT01951625|41721728|FG004|Follow Up Period|Lost to Follow-up|1|||
19463817|NCT04400890|41721743|FG000|Overall Study|Withdrawal by Subject|3|||
19463818|NCT04400890|41721744|FG001|Overall Study|Withdrawal by Subject|2|||
19463819|NCT01936649|41721750|FG000|Overall Study|Withdrawal by Subject|4|||
19463820|NCT01936649|41721750|FG000|Overall Study|Physician Decision|2|||
19463821|NCT01936649|41721750|FG000|Overall Study|Protocol Violation|2|||
19463822|NCT01936649|41721750|FG000|Overall Study|Other than specified above|5|||
19463823|NCT01720069|41721757|FG000|Overall Study|Could not use e-diary correctly|0|||
19463824|NCT01720069|41721758|FG001|Overall Study|Could not use e-diary correctly|1|||
19463825|NCT01720069|41721759|FG002|Overall Study|Could not use e-diary correctly|1|||
19463826|NCT01720069|41721757|FG000|Overall Study|Randomised without baseline values|0|||
19463827|NCT01720069|41721758|FG001|Overall Study|Randomised without baseline values|0|||
19463828|NCT01720069|41721759|FG002|Overall Study|Randomised without baseline values|1|||
19463829|NCT01720069|41721757|FG000|Overall Study|Adverse Event|0|||
19463830|NCT01720069|41721758|FG001|Overall Study|Adverse Event|0|||
19463831|NCT01720069|41721759|FG002|Overall Study|Adverse Event|1|||
19377616|NCT03386721|41620032|FG005|Overall Study|Progressive Disease|1|||
19377617|NCT03386721|41620033|FG006|Overall Study|Progressive Disease|0|||
19377618|NCT03386721|41620034|FG007|Overall Study|Progressive Disease|0|||
19377619|NCT03386721|41620035|FG008|Overall Study|Progressive Disease|2|||
19377620|NCT03386721|41620036|FG009|Overall Study|Progressive Disease|1|||
19377621|NCT03386721|41620037|FG010|Overall Study|Progressive Disease|1|||
19377622|NCT03386721|41620038|FG011|Overall Study|Progressive Disease|0|||
19377623|NCT03386721|41620039|FG012|Overall Study|Progressive Disease|1|||
19377624|NCT03386721|41620040|FG013|Overall Study|Progressive Disease|0|||
19377625|NCT03386721|41620041|FG014|Overall Study|Progressive Disease|0|||
19377626|NCT03386721|41620027|FG000|Overall Study|Site Terminated by Sponsor|5|||
19377627|NCT03386721|41620028|FG001|Overall Study|Site Terminated by Sponsor|5|||
19377628|NCT03386721|41620029|FG002|Overall Study|Site Terminated by Sponsor|0|||
19377629|NCT03386721|41620030|FG003|Overall Study|Site Terminated by Sponsor|0|||
19377630|NCT03386721|41620031|FG004|Overall Study|Site Terminated by Sponsor|1|||
19377631|NCT03386721|41620032|FG005|Overall Study|Site Terminated by Sponsor|3|||
19377632|NCT03386721|41620033|FG006|Overall Study|Site Terminated by Sponsor|0|||
19377633|NCT03386721|41620034|FG007|Overall Study|Site Terminated by Sponsor|1|||
19463832|NCT01720069|41721757|FG000|Overall Study|Lack of Efficacy|0|||
19463833|NCT01720069|41721758|FG001|Overall Study|Lack of Efficacy|4|||
19463834|NCT01720069|41721759|FG002|Overall Study|Lack of Efficacy|0|||
19463835|NCT01720069|41721757|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
19463836|NCT01720069|41721758|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
19463837|NCT01720069|41721759|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
19463838|NCT01720069|41721757|FG000|Overall Study|Withdrawal by Subject|0|||
19463839|NCT01720069|41721758|FG001|Overall Study|Withdrawal by Subject|2|||
19463840|NCT01720069|41721759|FG002|Overall Study|Withdrawal by Subject|1|||
19463841|NCT01720069|41721757|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
19463842|NCT01720069|41721758|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
19463843|NCT01720069|41721759|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
19463844|NCT01720069|41721757|FG000|Overall Study|Non-compliance on using e-diary|0|||
19463845|NCT01720069|41721758|FG001|Overall Study|Non-compliance on using e-diary|0|||
19463846|NCT01720069|41721759|FG002|Overall Study|Non-compliance on using e-diary|1|||
19463847|NCT01720069|41721757|FG000|Overall Study|Lost to Follow-up|0|||
19463848|NCT01720069|41721758|FG001|Overall Study|Lost to Follow-up|0|||
19463849|NCT01720069|41721759|FG002|Overall Study|Lost to Follow-up|1|||
19463850|NCT01719757|41721811|FG000|Overall Study|Adverse Event|38|||
19463851|NCT01719757|41721811|FG000|Overall Study|Withdrawal by Subject|15|||
19463852|NCT01719757|41721811|FG000|Overall Study|Lost to Follow-up|20|||
19463853|NCT01719757|41721811|FG000|Overall Study|Protocol Violation|1|||
19463854|NCT01719757|41721811|FG000|Overall Study|well controlled pain|27|||
19463855|NCT01718509|41721819|FG000|Overall Study|Lost to Follow-up|18|||
19463856|NCT01718509|41721820|FG001|Overall Study|Lost to Follow-up|15|||
19463857|NCT01718509|41721819|FG000|Overall Study|Withdrawal by Subject|7|||
19463858|NCT01718509|41721820|FG001|Overall Study|Withdrawal by Subject|13|||
19463859|NCT01718509|41721819|FG000|Overall Study|Adverse Event|5|||
19463860|NCT01718509|41721820|FG001|Overall Study|Adverse Event|7|||
19463861|NCT01718509|41721819|FG000|Overall Study|Other|13|||
19463862|NCT01718509|41721820|FG001|Overall Study|Other|11|||
19463863|NCT01718509|41721819|FG000|Overall Study|Protocol Violation|4|||
19463864|NCT01718509|41721820|FG001|Overall Study|Protocol Violation|2|||
19463865|NCT01718509|41721819|FG000|Overall Study|Lack of Efficacy|1|||
19463866|NCT01718509|41721820|FG001|Overall Study|Lack of Efficacy|0|||
19463867|NCT01857934|41721826|FG000|Overall Study|Relapse or progression|2|||
19463868|NCT01857934|41721826|FG000|Overall Study|Unacceptable toxicity|3|||
19463869|NCT01857934|41721826|FG000|Overall Study|Unwillingness or inability to comply|2|||
19463870|NCT01857934|41721826|FG000|Overall Study|Physician Decision|3|||
19463871|NCT01604941|41721867|FG000|Overall Study|Adverse Event|1|||
19463872|NCT01604941|41721868|FG001|Overall Study|Adverse Event|2|||
19463873|NCT01604941|41721869|FG002|Overall Study|Adverse Event|0|||
19463874|NCT01604941|41721870|FG003|Overall Study|Adverse Event|0|||
19463875|NCT01604941|41721871|FG004|Overall Study|Adverse Event|1|||
19463876|NCT01604941|41721872|FG005|Overall Study|Adverse Event|5|||
19463877|NCT01604941|41721867|FG000|Overall Study|Non-compliance|1|||
19463878|NCT01604941|41721868|FG001|Overall Study|Non-compliance|0|||
19463879|NCT01604941|41721869|FG002|Overall Study|Non-compliance|0|||
19463880|NCT01604941|41721870|FG003|Overall Study|Non-compliance|0|||
19463881|NCT01604941|41721871|FG004|Overall Study|Non-compliance|0|||
19463882|NCT01604941|41721872|FG005|Overall Study|Non-compliance|0|||
19463883|NCT01604941|41721867|FG000|Overall Study|Participant Decision|0|||
19463884|NCT01604941|41721868|FG001|Overall Study|Participant Decision|0|||
19463885|NCT01604941|41721869|FG002|Overall Study|Participant Decision|0|||
19463886|NCT01604941|41721870|FG003|Overall Study|Participant Decision|0|||
19463887|NCT01604941|41721871|FG004|Overall Study|Participant Decision|0|||
19463888|NCT01604941|41721872|FG005|Overall Study|Participant Decision|2|||
19463889|NCT01604941|41721867|FG000|Overall Study|Early Study Termination|9|||
19463890|NCT01604941|41721868|FG001|Overall Study|Early Study Termination|2|||
19463891|NCT01604941|41721869|FG002|Overall Study|Early Study Termination|3|||
19463892|NCT01604941|41721870|FG003|Overall Study|Early Study Termination|3|||
19463893|NCT01604941|41721871|FG004|Overall Study|Early Study Termination|0|||
19463894|NCT01604941|41721872|FG005|Overall Study|Early Study Termination|0|||
19463895|NCT01604785|41721880|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
19463896|NCT01604785|41721881|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
19463897|NCT01681849|41721890|FG000|Overall Study|Protocol Violation|2|||
19463898|NCT01681849|41721891|FG001|Overall Study|Protocol Violation|0|||
19463899|NCT01681849|41721892|FG002|Overall Study|Protocol Violation|0|||
19463900|NCT01681849|41721890|FG000|Overall Study|Withdrawal by Subject|3|||
19463901|NCT01681849|41721891|FG001|Overall Study|Withdrawal by Subject|5|||
19463902|NCT01681849|41721892|FG002|Overall Study|Withdrawal by Subject|33|||
19463903|NCT01681849|41721890|FG000|Overall Study|Lost to Follow-up|3|||
19463904|NCT01681849|41721891|FG001|Overall Study|Lost to Follow-up|2|||
19463905|NCT01681849|41721892|FG002|Overall Study|Lost to Follow-up|6|||
19463906|NCT01681771|41721901|FG000|Overall Study|Lost to Follow-up|4|||
19463907|NCT01681771|41721902|FG001|Overall Study|Lost to Follow-up|2|||
19463908|NCT04250350|41721908|FG000|Overall Study|Withdrawal by Subject|13|||
19463909|NCT04250350|41721908|FG000|Overall Study|Lost to Follow-up|8|||
19463910|NCT04250350|41721908|FG000|Overall Study|Adverse Event|5|||
19463911|NCT04250350|41721908|FG000|Overall Study|Lack of Efficacy|4|||
19463912|NCT04250350|41721908|FG000|Overall Study|Physician Decision|1|||
19463913|NCT04250350|41721908|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
19463914|NCT01718353|41721939|FG000|Overall Study|Lost to Follow-up|0|||
19463915|NCT01718353|41721940|FG001|Overall Study|Lost to Follow-up|1|||
19463916|NCT01718353|41721939|FG000|Overall Study|Principal Investigator's Decision|10|||
19463917|NCT01718353|41721940|FG001|Overall Study|Principal Investigator's Decision|4|||
19463918|NCT01718353|41721939|FG000|Overall Study|Randomized but not treated|2|||
19463919|NCT01718353|41721940|FG001|Overall Study|Randomized but not treated|0|||
19463920|NCT01716715|41721950|FG000|Overall Study|Never Treated|2|||
19463921|NCT01716715|41721951|FG001|Overall Study|Never Treated|4|||
19463922|NCT01697449|41721959|FG000|Overall Study|Disease progression|47|||
19463923|NCT01697449|41721959|FG000|Overall Study|Adverse Event|7|||
19463924|NCT01697449|41721959|FG000|Overall Study|Lost to Follow-up|5|||
19463925|NCT01697449|41721959|FG000|Overall Study|Withdrawal by Subject|2|||
19463926|NCT01697449|41721959|FG000|Overall Study|Physician Decision|1|||
19463927|NCT01697449|41721959|FG000|Overall Study|Death|2|||
19463928|NCT01697449|41721959|FG000|Overall Study|Other|1|||
19463929|NCT01697449|41721959|FG000|Overall Study|Missing|25|||
19463930|NCT01696981|41721968|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
19463931|NCT01696981|41721969|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
19463932|NCT01696981|41721968|FG000|Overall Study|Died Before Randomization|3|||
19463933|NCT01696981|41721969|FG001|Overall Study|Died Before Randomization|8|||
19463934|NCT01696981|41721968|FG000|Overall Study|Died Before ASU (Control)|278|||
19463935|NCT01696981|41721969|FG001|Overall Study|Died Before ASU (Control)|0|||
19463936|NCT01696981|41721968|FG000|Overall Study|Refused ASU (Control)|920|||
19463937|NCT01696981|41721969|FG001|Overall Study|Refused ASU (Control)|0|||
19463938|NCT01696981|41721968|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
19463939|NCT01696981|41721969|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
19463940|NCT01696279|41721975|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
19463941|NCT01696279|41721976|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
19463942|NCT01696279|41721977|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
19463943|NCT01696279|41721978|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
19463944|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
19463945|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
19463946|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
19463947|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
19463948|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
19463949|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
19463950|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
19463951|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
19463952|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
19463953|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
19463954|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
19463955|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
19463956|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
19463957|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
19463958|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
19463959|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
19463960|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
19463961|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
19463962|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
19463963|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
19463964|NCT01696279|41721975|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
19463965|NCT01696279|41721976|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
19463966|NCT01696279|41721977|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
19463967|NCT01696279|41721978|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
19463968|NCT01696279|41721975|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
19463969|NCT01696279|41721976|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
19463970|NCT01696279|41721977|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
19463971|NCT01696279|41721978|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
19463972|NCT01696279|41721975|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
19463973|NCT01696279|41721976|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
19463974|NCT01696279|41721977|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
19463975|NCT01696279|41721978|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
19463976|NCT01696279|41721975|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
19463977|NCT01696279|41721976|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
19726231|NCT04389840|42170497|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
19726232|NCT04389840|42170498|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
19726233|NCT04389840|42170499|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
19726234|NCT04389840|42170500|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
19726235|NCT04389840|42170495|FG000|Overall Study|Death|0|||
19726236|NCT04389840|42170496|FG001|Overall Study|Death|1|||
19726237|NCT04389840|42170497|FG002|Overall Study|Death|0|||
19726238|NCT04389840|42170498|FG003|Overall Study|Death|0|||
19726239|NCT04389840|42170499|FG004|Overall Study|Death|0|||
19726240|NCT04389840|42170500|FG005|Overall Study|Death|0|||
19726241|NCT04307940|42170523|FG000|Overall Study|Adverse Event|1|||
19463978|NCT01696279|41721977|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
19463979|NCT01696279|41721978|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
19463980|NCT01696279|41721975|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
19463981|NCT01696279|41721976|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
19463982|NCT01696279|41721977|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
19463983|NCT01696279|41721978|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
19463984|NCT01681069|41721989|FG000|Overall Study|Withdrawal by Subject|4|||
19463985|NCT01681069|41721990|FG001|Overall Study|Withdrawal by Subject|5|||
19463986|NCT01681069|41721989|FG000|Overall Study|Protocol Violation|1|||
19463987|NCT01681069|41721990|FG001|Overall Study|Protocol Violation|1|||
19463988|NCT01681069|41721989|FG000|Overall Study|Adverse Event|0|||
19463989|NCT01681069|41721990|FG001|Overall Study|Adverse Event|1|||
19463990|NCT01716559|41721996|FG000|Overall Study|Adverse Event|11|||
19463991|NCT01716559|41721996|FG000|Overall Study|Death|21|||
19463992|NCT01716559|41721996|FG000|Overall Study|Withdrawal by Subject|4|||
19463993|NCT01716559|41721996|FG000|Overall Study|Other withdrawal reason|75|||
19463994|NCT01936181|41722002|FG000|Randomised, Double-blind|Adverse Event|27|||
19463995|NCT01936181|41722003|FG001|Randomised, Double-blind|Adverse Event|21|||
19463996|NCT01936181|41722004|FG002|Randomised, Double-blind|Adverse Event|0|||
19463997|NCT01936181|41722005|FG003|Randomised, Double-blind|Adverse Event|0|||
19463998|NCT01936181|41722002|FG000|Randomised, Double-blind|Protocol Violation|1|||
19463999|NCT01936181|41722003|FG001|Randomised, Double-blind|Protocol Violation|5|||
19464000|NCT01936181|41722004|FG002|Randomised, Double-blind|Protocol Violation|0|||
19464001|NCT01936181|41722005|FG003|Randomised, Double-blind|Protocol Violation|0|||
19464002|NCT01936181|41722002|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
19464003|NCT01936181|41722003|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
19464004|NCT01936181|41722004|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
19464005|NCT01936181|41722005|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
19464006|NCT01936181|41722002|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
19464007|NCT01936181|41722003|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
19464008|NCT01936181|41722004|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
19464009|NCT01936181|41722005|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
19464010|NCT01936181|41722002|FG000|Randomised, Double-blind|Pregnancy|0|||
19464011|NCT01936181|41722003|FG001|Randomised, Double-blind|Pregnancy|1|||
19464012|NCT01936181|41722004|FG002|Randomised, Double-blind|Pregnancy|0|||
19464013|NCT01936181|41722005|FG003|Randomised, Double-blind|Pregnancy|0|||
19464014|NCT01936181|41722002|FG000|Randomised, Double-blind|Physician Decision|4|||
19464015|NCT01936181|41722003|FG001|Randomised, Double-blind|Physician Decision|4|||
19464016|NCT01936181|41722004|FG002|Randomised, Double-blind|Physician Decision|0|||
19464017|NCT01936181|41722005|FG003|Randomised, Double-blind|Physician Decision|0|||
19464018|NCT01936181|41722002|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
19464019|NCT01936181|41722003|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
19464020|NCT01936181|41722004|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
19464021|NCT01936181|41722005|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
19464022|NCT01936181|41722002|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
19464023|NCT01936181|41722003|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
19464024|NCT01936181|41722004|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
19464025|NCT01936181|41722005|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
19464026|NCT01936181|41722002|FG000|Transition-extension|Adverse Event|3|||
19464027|NCT01936181|41722003|FG001|Transition-extension|Adverse Event|0|||
19464028|NCT01936181|41722004|FG002|Transition-extension|Adverse Event|3|||
19464029|NCT01936181|41722005|FG003|Transition-extension|Adverse Event|1|||
19464030|NCT01936181|41722002|FG000|Transition-extension|Lost to Follow-up|3|||
19464031|NCT01936181|41722003|FG001|Transition-extension|Lost to Follow-up|0|||
19464032|NCT01936181|41722004|FG002|Transition-extension|Lost to Follow-up|1|||
19464033|NCT01936181|41722005|FG003|Transition-extension|Lost to Follow-up|2|||
19464034|NCT01936181|41722002|FG000|Transition-extension|Physician Decision|2|||
19726242|NCT04307940|42170524|FG001|Overall Study|Adverse Event|0|||
19726243|NCT04307940|42170525|FG002|Overall Study|Adverse Event|0|||
19464035|NCT01936181|41722003|FG001|Transition-extension|Physician Decision|0|||
19464036|NCT01936181|41722004|FG002|Transition-extension|Physician Decision|0|||
19464037|NCT01936181|41722005|FG003|Transition-extension|Physician Decision|1|||
19464038|NCT01936181|41722002|FG000|Transition-extension|Withdrawal by Subject|7|||
19464039|NCT01936181|41722003|FG001|Transition-extension|Withdrawal by Subject|0|||
19464040|NCT01936181|41722004|FG002|Transition-extension|Withdrawal by Subject|2|||
19464041|NCT01936181|41722005|FG003|Transition-extension|Withdrawal by Subject|1|||
19464042|NCT01696045|41722018|FG000|Overall Study|Study drug toxicity|1|||
19464043|NCT01696045|41722019|FG001|Overall Study|Study drug toxicity|5|||
19464044|NCT01696045|41722018|FG000|Overall Study|Disease progression|2|||
19464045|NCT01696045|41722019|FG001|Overall Study|Disease progression|2|||
19464046|NCT01716169|41722025|FG000|Overall Study|Adverse Event|1|||
19464047|NCT01716169|41722025|FG000|Overall Study|Lost to Follow-up|1|||
19464048|NCT01716169|41722025|FG000|Overall Study|Withdrawal by Subject|1|||
19464049|NCT01716169|41722025|FG000|Overall Study|inconsistent dressing application|1|||
19464050|NCT01935947|41722034|FG000|Overall Study|Adverse Event|0|||
19464051|NCT01935947|41722035|FG001|Overall Study|Adverse Event|2|||
19464052|NCT01935947|41722036|FG002|Overall Study|Adverse Event|0|||
19464053|NCT01935947|41722034|FG000|Overall Study|Diease Progression|2|||
19464054|NCT01935947|41722035|FG001|Overall Study|Diease Progression|2|||
19464055|NCT01935947|41722036|FG002|Overall Study|Diease Progression|2|||
19464056|NCT01935947|41722034|FG000|Overall Study|Death|1|||
19464057|NCT01935947|41722035|FG001|Overall Study|Death|0|||
19464058|NCT01935947|41722036|FG002|Overall Study|Death|0|||
19464059|NCT01618019|41722049|FG000|Overall Study|Withdrawal by Subject|14|||
19464060|NCT01618019|41722050|FG001|Overall Study|Withdrawal by Subject|14|||
19464061|NCT01593787|41722059|FG000|Overall Study|Adverse Event|1|||
19464062|NCT01593787|41722060|FG001|Overall Study|Adverse Event|0|||
19464063|NCT01593787|41722061|FG002|Overall Study|Adverse Event|0|||
19464064|NCT01951157|41722074|FG000|Overall Study|Progressive Disease|12|||
19464065|NCT01951157|41722075|FG001|Overall Study|Progressive Disease|13|||
19464066|NCT01951157|41722076|FG002|Overall Study|Progressive Disease|10|||
19464067|NCT01951157|41722074|FG000|Overall Study|Treatment-unrelated AE|1|||
19464068|NCT01951157|41722075|FG001|Overall Study|Treatment-unrelated AE|0|||
19464069|NCT01951157|41722076|FG002|Overall Study|Treatment-unrelated AE|3|||
19464070|NCT01951157|41722074|FG000|Overall Study|Study Termination|0|||
19464071|NCT01951157|41722075|FG001|Overall Study|Study Termination|0|||
19464072|NCT01951157|41722076|FG002|Overall Study|Study Termination|1|||
19464073|NCT01951157|41722074|FG000|Overall Study|Physician Decision|5|||
19464074|NCT01951157|41722075|FG001|Overall Study|Physician Decision|3|||
19464075|NCT01951157|41722076|FG002|Overall Study|Physician Decision|2|||
19464076|NCT01951157|41722074|FG000|Overall Study|Non-treatmentrelated death|2|||
19464077|NCT01951157|41722075|FG001|Overall Study|Non-treatmentrelated death|2|||
19464078|NCT01951157|41722076|FG002|Overall Study|Non-treatmentrelated death|2|||
19464079|NCT01951157|41722074|FG000|Overall Study|No treated|0|||
19464080|NCT01951157|41722075|FG001|Overall Study|No treated|1|||
19464081|NCT01951157|41722076|FG002|Overall Study|No treated|0|||
19464082|NCT01951157|41722074|FG000|Overall Study|Treatment-related AE|2|||
19464083|NCT01951157|41722075|FG001|Overall Study|Treatment-related AE|0|||
19464084|NCT01951157|41722076|FG002|Overall Study|Treatment-related AE|4|||
19464085|NCT01951157|41722074|FG000|Overall Study|Consent withdrawn by subject|0|||
19464086|NCT01951157|41722075|FG001|Overall Study|Consent withdrawn by subject|1|||
19464087|NCT01951157|41722076|FG002|Overall Study|Consent withdrawn by subject|3|||
19464088|NCT01951157|41722074|FG000|Overall Study|Treatment-related death|0|||
19464089|NCT01951157|41722075|FG001|Overall Study|Treatment-related death|2|||
19464090|NCT01951157|41722076|FG002|Overall Study|Treatment-related death|0|||
19464091|NCT01363349|41722087|FG000|Overall Study|Adverse Event|6|||
19464092|NCT01363349|41722088|FG001|Overall Study|Adverse Event|7|||
19464093|NCT01363349|41722087|FG000|Overall Study|Lack of Efficacy|3|||
19464094|NCT01363349|41722088|FG001|Overall Study|Lack of Efficacy|10|||
19464095|NCT01363349|41722087|FG000|Overall Study|Non compliance/Protocol deviations|2|||
19464096|NCT01363349|41722088|FG001|Overall Study|Non compliance/Protocol deviations|2|||
19464097|NCT01363349|41722087|FG000|Overall Study|Withdrawal by Subject|14|||
19464098|NCT01363349|41722088|FG001|Overall Study|Withdrawal by Subject|6|||
19464099|NCT01363349|41722087|FG000|Overall Study|Lost to Follow-up|5|||
19464100|NCT01363349|41722088|FG001|Overall Study|Lost to Follow-up|6|||
19464101|NCT01363349|41722087|FG000|Overall Study|Not reported|36|||
19464102|NCT01363349|41722088|FG001|Overall Study|Not reported|37|||
19464103|NCT01363349|41722087|FG000|Overall Study|missing|1|||
19464104|NCT01363349|41722088|FG001|Overall Study|missing|2|||
19464105|NCT01933919|41722179|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
19464106|NCT01933919|41722180|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
19464107|NCT01933919|41722179|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
19464108|NCT01933919|41722180|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
19464109|NCT01933919|41722179|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
19464110|NCT01933919|41722180|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
19464111|NCT01933919|41722179|FG000|Open-label Long-term Phase|Adverse Event|2|||
19464112|NCT01933919|41722180|FG001|Open-label Long-term Phase|Adverse Event|0|||
19464113|NCT01933919|41722179|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
19464114|NCT01933919|41722180|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
19464115|NCT01933919|41722179|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
19464116|NCT01933919|41722180|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
19464117|NCT01933919|41722179|FG000|Open-label Long-term Phase|Other|1|||
19464118|NCT01933919|41722180|FG001|Open-label Long-term Phase|Other|2|||
19464119|NCT01933217|41722209|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
19464120|NCT01933217|41722210|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
19464121|NCT01933217|41722209|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
19464122|NCT01933217|41722210|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
19464123|NCT01932437|41722220|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
19464124|NCT01932437|41722221|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
19464125|NCT01932437|41722222|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
19464126|NCT01932437|41722223|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
19464127|NCT01932437|41722224|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
19464128|NCT01932437|41722225|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
19390320|NCT01987960|41634112|FG002|Period 1|Lack of Efficacy|0|||
19464129|NCT01949051|41722246|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
19464130|NCT01949051|41722247|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
19464131|NCT01949051|41722248|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
19464132|NCT01949051|41722249|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
19464133|NCT01949051|41722250|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
19464134|NCT01949051|41722251|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
19464135|NCT01949051|41722246|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
19464136|NCT01949051|41722247|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19464137|NCT01949051|41722248|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19464138|NCT01949051|41722249|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19464139|NCT01949051|41722250|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19464140|NCT01949051|41722251|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19464141|NCT01949051|41722246|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
19464142|NCT01949051|41722247|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
19464143|NCT01949051|41722248|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
19464144|NCT01949051|41722249|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
19464145|NCT01949051|41722250|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
19464146|NCT01949051|41722251|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
19464147|NCT01949051|41722246|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
19464148|NCT01949051|41722247|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
19464149|NCT01949051|41722248|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
19464150|NCT01949051|41722249|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
19464151|NCT01949051|41722250|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
19464152|NCT01949051|41722251|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
19464153|NCT01949051|41722246|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
19464154|NCT01949051|41722247|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
19464155|NCT01949051|41722248|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
19464156|NCT01949051|41722249|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
19464157|NCT01949051|41722250|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
19464158|NCT01949051|41722251|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
19464159|NCT01948427|41722264|FG000|Overall Study|Serious Adverse Event|3|||
19464160|NCT01948427|41722265|FG001|Overall Study|Serious Adverse Event|0|||
19390321|NCT01987960|41634113|FG003|Period 1|Lack of Efficacy|0|||
19390322|NCT01987960|41634110|FG000|Period 1|Non-compliance with IMP|6|||
19390323|NCT01987960|41634111|FG001|Period 1|Non-compliance with IMP|0|||
19390324|NCT01987960|41634112|FG002|Period 1|Non-compliance with IMP|0|||
19390325|NCT01987960|41634113|FG003|Period 1|Non-compliance with IMP|0|||
19390326|NCT01987960|41634110|FG000|Period 1|Protocol Violation|12|||
19390327|NCT01987960|41634111|FG001|Period 1|Protocol Violation|0|||
19390328|NCT01987960|41634112|FG002|Period 1|Protocol Violation|0|||
19390329|NCT01987960|41634113|FG003|Period 1|Protocol Violation|0|||
19390330|NCT01987960|41634110|FG000|Period 1|Withdrawal by Subject|21|||
19390331|NCT01987960|41634111|FG001|Period 1|Withdrawal by Subject|0|||
19390332|NCT01987960|41634112|FG002|Period 1|Withdrawal by Subject|0|||
19390333|NCT01987960|41634113|FG003|Period 1|Withdrawal by Subject|0|||
19390334|NCT01987960|41634110|FG000|Period 1|Lost to Follow-up|40|||
19390335|NCT01987960|41634111|FG001|Period 1|Lost to Follow-up|0|||
19390336|NCT01987960|41634112|FG002|Period 1|Lost to Follow-up|0|||
19390337|NCT01987960|41634113|FG003|Period 1|Lost to Follow-up|0|||
19390338|NCT01987960|41634110|FG000|Period 1|administrative or other reason|75|||
19390339|NCT01987960|41634111|FG001|Period 1|administrative or other reason|0|||
19390340|NCT01987960|41634112|FG002|Period 1|administrative or other reason|0|||
19390341|NCT01987960|41634113|FG003|Period 1|administrative or other reason|0|||
19464161|NCT01948427|41722266|FG002|Overall Study|Serious Adverse Event|0|||
19464162|NCT01948427|41722267|FG003|Overall Study|Serious Adverse Event|0|||
19464163|NCT01948427|41722268|FG004|Overall Study|Serious Adverse Event|1|||
19464164|NCT01948427|41722264|FG000|Overall Study|Investigator Request|0|||
19464165|NCT01948427|41722265|FG001|Overall Study|Investigator Request|8|||
19464166|NCT01948427|41722266|FG002|Overall Study|Investigator Request|0|||
19464167|NCT01948427|41722267|FG003|Overall Study|Investigator Request|0|||
19464168|NCT01948427|41722268|FG004|Overall Study|Investigator Request|6|||
19464169|NCT01948427|41722264|FG000|Overall Study|Lost to Follow-up|1|||
19464170|NCT01948427|41722265|FG001|Overall Study|Lost to Follow-up|0|||
19464171|NCT01948427|41722266|FG002|Overall Study|Lost to Follow-up|0|||
19464172|NCT01948427|41722267|FG003|Overall Study|Lost to Follow-up|0|||
19464173|NCT01948427|41722268|FG004|Overall Study|Lost to Follow-up|4|||
19464174|NCT01948427|41722264|FG000|Overall Study|Withdrawal by Subject|2|||
19464175|NCT01948427|41722265|FG001|Overall Study|Withdrawal by Subject|0|||
19464176|NCT01948427|41722266|FG002|Overall Study|Withdrawal by Subject|0|||
19464177|NCT01948427|41722267|FG003|Overall Study|Withdrawal by Subject|0|||
19464178|NCT01948427|41722268|FG004|Overall Study|Withdrawal by Subject|1|||
19464179|NCT01948427|41722264|FG000|Overall Study|Other, Not Specified|1|||
19464180|NCT01948427|41722265|FG001|Overall Study|Other, Not Specified|9|||
19464181|NCT01948427|41722266|FG002|Overall Study|Other, Not Specified|0|||
19464182|NCT01948427|41722267|FG003|Overall Study|Other, Not Specified|0|||
19464183|NCT01948427|41722268|FG004|Overall Study|Other, Not Specified|2|||
19464184|NCT01948193|41722285|FG000|Overall Study|Serious event|2|||
19464185|NCT01948193|41722285|FG000|Overall Study|Lost to Follow-up|7|||
19464186|NCT01694485|41722295|FG000|Overall Study|Withdrawal by Subject|20|||
19464187|NCT01694485|41722296|FG001|Overall Study|Withdrawal by Subject|6|||
19464188|NCT01694485|41722297|FG002|Overall Study|Withdrawal by Subject|7|||
19464189|NCT01694485|41722298|FG003|Overall Study|Withdrawal by Subject|25|||
19464190|NCT01694485|41722299|FG004|Overall Study|Withdrawal by Subject|18|||
19464191|NCT01694485|41722295|FG000|Overall Study|Sponsor Decision|3|||
19464192|NCT01694485|41722296|FG001|Overall Study|Sponsor Decision|0|||
19464193|NCT01694485|41722297|FG002|Overall Study|Sponsor Decision|0|||
19464194|NCT01694485|41722298|FG003|Overall Study|Sponsor Decision|2|||
19464195|NCT01694485|41722299|FG004|Overall Study|Sponsor Decision|0|||
19464196|NCT01694485|41722295|FG000|Overall Study|Lost to Follow-up|9|||
19464197|NCT01694485|41722296|FG001|Overall Study|Lost to Follow-up|1|||
19464198|NCT01694485|41722297|FG002|Overall Study|Lost to Follow-up|6|||
19464199|NCT01694485|41722298|FG003|Overall Study|Lost to Follow-up|10|||
19464200|NCT01694485|41722299|FG004|Overall Study|Lost to Follow-up|7|||
19464201|NCT01694485|41722295|FG000|Overall Study|Death|1|||
19464202|NCT01694485|41722296|FG001|Overall Study|Death|0|||
19464203|NCT01694485|41722297|FG002|Overall Study|Death|0|||
19464204|NCT01694485|41722298|FG003|Overall Study|Death|1|||
19464205|NCT01694485|41722299|FG004|Overall Study|Death|0|||
19464206|NCT01931735|41722320|FG000|Randomized Phase|Lost to Follow-up|2|||
19464207|NCT01931735|41722321|FG001|Randomized Phase|Lost to Follow-up|2|||
19464208|NCT01931735|41722322|FG002|Randomized Phase|Lost to Follow-up|5|||
19464209|NCT01931735|41722323|FG003|Randomized Phase|Lost to Follow-up|0|||
19464210|NCT01931735|41722320|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
19464211|NCT01931735|41722321|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
19464212|NCT01931735|41722322|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
19464213|NCT01931735|41722323|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
19464214|NCT01931735|41722320|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
19464215|NCT01931735|41722321|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
19464216|NCT01931735|41722322|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
19464217|NCT01931735|41722323|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
19464218|NCT01930799|41722333|FG000|Overall Study|Withdrawal by Subject|3|||
19464219|NCT01930799|41722333|FG000|Overall Study|Lost to Follow-up|5|||
19464220|NCT01947491|41722341|FG000|Overall Study|Lost to Follow-up|5|||
19464221|NCT01947491|41722342|FG001|Overall Study|Lost to Follow-up|3|||
19464222|NCT01947491|41722343|FG002|Overall Study|Lost to Follow-up|1|||
19464223|NCT01947491|41722344|FG003|Overall Study|Lost to Follow-up|2|||
19464224|NCT01947491|41722341|FG000|Overall Study|Lack of Efficacy|1|||
19464225|NCT01947491|41722342|FG001|Overall Study|Lack of Efficacy|0|||
19464226|NCT01947491|41722343|FG002|Overall Study|Lack of Efficacy|0|||
19464227|NCT01947491|41722344|FG003|Overall Study|Lack of Efficacy|1|||
19464228|NCT01947491|41722341|FG000|Overall Study|Protocol Violation|1|||
19464229|NCT01947491|41722342|FG001|Overall Study|Protocol Violation|0|||
19464230|NCT01947491|41722343|FG002|Overall Study|Protocol Violation|0|||
19464231|NCT01947491|41722344|FG003|Overall Study|Protocol Violation|0|||
19464232|NCT01947491|41722341|FG000|Overall Study|Withdrawal by Subject|1|||
19464233|NCT01947491|41722342|FG001|Overall Study|Withdrawal by Subject|1|||
19464234|NCT01947491|41722343|FG002|Overall Study|Withdrawal by Subject|1|||
19464235|NCT01947491|41722344|FG003|Overall Study|Withdrawal by Subject|0|||
19464236|NCT01947491|41722341|FG000|Overall Study|Worsening of condition|0|||
19464237|NCT01947491|41722342|FG001|Overall Study|Worsening of condition|1|||
19464238|NCT01947491|41722343|FG002|Overall Study|Worsening of condition|0|||
19464239|NCT01947491|41722344|FG003|Overall Study|Worsening of condition|0|||
19464240|NCT01947491|41722341|FG000|Overall Study|Adverse Event|0|||
19464241|NCT01947491|41722342|FG001|Overall Study|Adverse Event|1|||
19464242|NCT01947491|41722343|FG002|Overall Study|Adverse Event|0|||
19464243|NCT01947491|41722344|FG003|Overall Study|Adverse Event|2|||
19464244|NCT01715857|41722354|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
19464245|NCT01692301|41722360|FG000|Overall Study|Adverse Event|15|||
19464246|NCT01692301|41722361|FG001|Overall Study|Adverse Event|12|||
19464247|NCT01692301|41722360|FG000|Overall Study|Death|1|||
19464248|NCT01692301|41722361|FG001|Overall Study|Death|2|||
19464249|NCT01692301|41722360|FG000|Overall Study|Lack of Efficacy|0|||
19464250|NCT01692301|41722361|FG001|Overall Study|Lack of Efficacy|5|||
19464251|NCT01692301|41722360|FG000|Overall Study|Non-compliance with study treatment|1|||
19464252|NCT01692301|41722361|FG001|Overall Study|Non-compliance with study treatment|2|||
19464253|NCT01692301|41722360|FG000|Overall Study|Protocol deviation|9|||
19464254|NCT01692301|41722361|FG001|Overall Study|Protocol deviation|2|||
19464255|NCT01692301|41722360|FG000|Overall Study|Patient/guardian decision|16|||
19464256|NCT01692301|41722361|FG001|Overall Study|Patient/guardian decision|15|||
19464257|NCT01692301|41722360|FG000|Overall Study|Technical problems|0|||
19464258|NCT01692301|41722361|FG001|Overall Study|Technical problems|1|||
19464259|NCT01692301|41722360|FG000|Overall Study|Physician Decision|2|||
19464260|NCT01692301|41722361|FG001|Overall Study|Physician Decision|2|||
19464261|NCT01692301|41722360|FG000|Overall Study|Lost to Follow-up|1|||
19464262|NCT01692301|41722361|FG001|Overall Study|Lost to Follow-up|1|||
19464263|NCT01592773|41722367|FG000|Overall Study|Study Terminated by Sponsor|582|||
19464264|NCT01592773|41722367|FG000|Overall Study|Withdrawal by Subject|35|||
19464265|NCT01592773|41722367|FG000|Overall Study|Lost to Follow-up|19|||
19464266|NCT01592773|41722367|FG000|Overall Study|Adverse Event|17|||
19464267|NCT01592773|41722367|FG000|Overall Study|Lack of Efficacy|9|||
19464268|NCT01592773|41722367|FG000|Overall Study|Protocol Violation|2|||
19464269|NCT01592773|41722367|FG000|Overall Study|Inclusion/exclusion not meet|1|||
19464270|NCT01592773|41722367|FG000|Overall Study|Other Reason|1|||
19464271|NCT01930175|41722374|FG000|Core Study|Lost to Follow-up|0|||
19464272|NCT01930175|41722375|FG001|Core Study|Lost to Follow-up|1|||
19464273|NCT01930175|41722376|FG002|Core Study|Lost to Follow-up|0|||
19464274|NCT01930175|41722374|FG000|Core Study|Adverse Event|0|||
19464275|NCT01930175|41722375|FG001|Core Study|Adverse Event|0|||
19464276|NCT01930175|41722376|FG002|Core Study|Adverse Event|1|||
19464277|NCT01592695|41722387|FG000|Overall Study|Lost to Follow-up|8|||
19464278|NCT01592695|41722388|FG001|Overall Study|Lost to Follow-up|4|||
19464279|NCT01929863|41722394|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
19464280|NCT01929863|41722395|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
19464281|NCT01929863|41722394|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
19464282|NCT01929863|41722395|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
19464283|NCT01929863|41722394|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
19464284|NCT01929863|41722395|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
19464285|NCT01918085|41722408|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
19464286|NCT01918085|41722409|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
19464287|NCT01714687|41722419|FG000|Overall Study|Withdrawal by Subject|1|||
19464288|NCT01714687|41722420|FG001|Overall Study|Withdrawal by Subject|0|||
19464289|NCT01714687|41722419|FG000|Overall Study|Lost to Follow-up|2|||
19464290|NCT01714687|41722420|FG001|Overall Study|Lost to Follow-up|4|||
19464291|NCT01714609|41722430|FG000|Overall Study|Protocol Violation|1|||
19464292|NCT01714609|41722431|FG001|Overall Study|Protocol Violation|0|||
19726244|NCT04307940|42170523|FG000|Overall Study|Withdrawal by Subject|2|||
19726245|NCT04307940|42170524|FG001|Overall Study|Withdrawal by Subject|3|||
19726246|NCT04307940|42170525|FG002|Overall Study|Withdrawal by Subject|1|||
19726247|NCT04307940|42170523|FG000|Overall Study|Lost to Follow-up|2|||
19726248|NCT04307940|42170524|FG001|Overall Study|Lost to Follow-up|0|||
19726249|NCT04307940|42170525|FG002|Overall Study|Lost to Follow-up|1|||
19726250|NCT02054104|42170535|FG000|Overall Study|Did not want to continue due to college classes|1|||
19726251|NCT02054104|42170536|FG001|Overall Study|Did not want to continue due to college classes|0|||
19726252|NCT02054104|42170535|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
19726253|NCT02054104|42170536|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
19726254|NCT02054104|42170535|FG000|Overall Study|No evidence of immunologic response|2|||
19726255|NCT02054104|42170536|FG001|Overall Study|No evidence of immunologic response|2|||
19726256|NCT02054104|42170535|FG000|Overall Study|Disease Progression On Study|4|||
19464293|NCT01929707|41722437|FG000|Intervention Period 1|Lost to Follow-up|0|||
19464294|NCT01929707|41722438|FG001|Intervention Period 1|Lost to Follow-up|0|||
19464295|NCT01929707|41722439|FG002|Intervention Period 1|Lost to Follow-up|0|||
19464296|NCT01929707|41722440|FG003|Intervention Period 1|Lost to Follow-up|1|||
19464297|NCT01929707|41722441|FG004|Intervention Period 1|Lost to Follow-up|0|||
19464298|NCT01929707|41722442|FG005|Intervention Period 1|Lost to Follow-up|0|||
19726257|NCT02054104|42170536|FG001|Overall Study|Disease Progression On Study|5|||
19726258|NCT02054104|42170535|FG000|Overall Study|Diagnosis of lymphoma|0|||
19726259|NCT02054104|42170536|FG001|Overall Study|Diagnosis of lymphoma|1|||
19726260|NCT02054104|42170535|FG000|Overall Study|Inconclusive response|0|||
19726261|NCT02054104|42170536|FG001|Overall Study|Inconclusive response|1|||
19726262|NCT04480710|42170546|FG000|Overall Study|Adverse Event|0|||
19726263|NCT04480710|42170547|FG001|Overall Study|Adverse Event|2|||
19726264|NCT04480710|42170548|FG002|Overall Study|Adverse Event|0|||
19726265|NCT04480710|42170549|FG003|Overall Study|Adverse Event|0|||
19726266|NCT04480710|42170546|FG000|Overall Study|Withdrawal by Subject|0|||
19726267|NCT04480710|42170547|FG001|Overall Study|Withdrawal by Subject|1|||
19726268|NCT04480710|42170548|FG002|Overall Study|Withdrawal by Subject|0|||
19726269|NCT04480710|42170549|FG003|Overall Study|Withdrawal by Subject|0|||
19726270|NCT04480710|42170546|FG000|Overall Study|Physician Decision|0|||
19726271|NCT04480710|42170547|FG001|Overall Study|Physician Decision|0|||
19726272|NCT04480710|42170548|FG002|Overall Study|Physician Decision|1|||
19726273|NCT04480710|42170549|FG003|Overall Study|Physician Decision|0|||
19726274|NCT04090242|42170567|FG000|Overall Study|Withdrawal by Subject|1|||
19726275|NCT04090242|42170568|FG001|Overall Study|Withdrawal by Subject|0|||
19726276|NCT04090164|42170577|FG000|Overall Study|incomplete data on file|245|||
19726277|NCT04090164|42170578|FG001|Overall Study|incomplete data on file|0|||
19726278|NCT04292730|42170607|FG000|Overall Study|Lost to Follow-up|8|||
19726279|NCT04292730|42170608|FG001|Overall Study|Lost to Follow-up|12|||
19726280|NCT04292730|42170609|FG002|Overall Study|Lost to Follow-up|12|||
19726281|NCT04292730|42170610|FG003|Overall Study|Lost to Follow-up|48|||
19726282|NCT04292730|42170607|FG000|Overall Study|Death|2|||
19726283|NCT04292730|42170608|FG001|Overall Study|Death|2|||
19726284|NCT04292730|42170609|FG002|Overall Study|Death|4|||
19726285|NCT04292730|42170610|FG003|Overall Study|Death|12|||
19726286|NCT04292730|42170607|FG000|Overall Study|Withdrew Consent|2|||
19726287|NCT04292730|42170608|FG001|Overall Study|Withdrew Consent|2|||
19726288|NCT04292730|42170609|FG002|Overall Study|Withdrew Consent|5|||
19726289|NCT04292730|42170610|FG003|Overall Study|Withdrew Consent|6|||
19726290|NCT04292730|42170607|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19726291|NCT04292730|42170608|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19726292|NCT04292730|42170609|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19726293|NCT04292730|42170610|FG003|Overall Study|Non-Compliance with Study Drug|0|||
19726294|NCT04292730|42170607|FG000|Overall Study|Protocol Violation|0|||
19726295|NCT04292730|42170608|FG001|Overall Study|Protocol Violation|0|||
19726296|NCT04292730|42170609|FG002|Overall Study|Protocol Violation|1|||
19726297|NCT04292730|42170610|FG003|Overall Study|Protocol Violation|0|||
19726298|NCT04292730|42170607|FG000|Overall Study|Randomized but not Treated|8|||
19726299|NCT04292730|42170608|FG001|Overall Study|Randomized but not Treated|4|||
19726300|NCT04292730|42170609|FG002|Overall Study|Randomized but not Treated|0|||
19726301|NCT04292730|42170610|FG003|Overall Study|Randomized but not Treated|14|||
19726302|NCT02861014|42170619|FG000|Primary Analysis|Adverse Event|7|||
19726303|NCT02861014|42170619|FG000|Primary Analysis|Death|1|||
19726304|NCT02861014|42170619|FG000|Primary Analysis|Lack of Efficacy|3|||
19726305|NCT02861014|42170619|FG000|Primary Analysis|Physician Decision|2|||
19726306|NCT02861014|42170619|FG000|Primary Analysis|Pregnancy|4|||
19726307|NCT02861014|42170619|FG000|Primary Analysis|Protocol Violation|2|||
19726308|NCT02861014|42170619|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
19726309|NCT02861014|42170619|FG000|Primary Analysis|Withdrawal by Subject|14|||
19726310|NCT02861014|42170619|FG000|Primary Analysis|Commercial ocrelizumab|3|||
19726311|NCT02861014|42170619|FG000|Safety Follow-up|Adverse Event|1|||
19726312|NCT02861014|42170619|FG000|Safety Follow-up|Pregnancy|1|||
19726313|NCT02861014|42170619|FG000|Safety Follow-up|Withdrawal by Subject|9|||
19726314|NCT02861014|42170619|FG000|Safety Follow-up|Study terminated by sponsor|1|||
19726315|NCT02861014|42170619|FG000|Safety Follow-up|Physician Decision|1|||
19726316|NCT02861014|42170619|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
19726317|NCT02861014|42170619|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
19726318|NCT04382586|42170627|FG000|Overall Study|Death|3|||
19726319|NCT04382586|42170628|FG001|Overall Study|Death|4|||
19726320|NCT04382586|42170627|FG000|Overall Study|Lost to Follow-up|11|||
19726321|NCT04382586|42170628|FG001|Overall Study|Lost to Follow-up|8|||
19726322|NCT04382586|42170627|FG000|Overall Study|Withdrawal by Subject|3|||
19726323|NCT04382586|42170628|FG001|Overall Study|Withdrawal by Subject|1|||
19726324|NCT04382586|42170627|FG000|Overall Study|Physician Decision|0|||
19726325|NCT04382586|42170628|FG001|Overall Study|Physician Decision|3|||
19726326|NCT04275336|42170637|FG000|Overall Study|First venipuncture failed|4|||
19726327|NCT04275336|42170638|FG001|Overall Study|First venipuncture failed|6|||
19726328|NCT04275336|42170639|FG002|Overall Study|First venipuncture failed|5|||
19726329|NCT04275336|42170637|FG000|Overall Study|Unscheduled venipuncture|9|||
19726330|NCT04275336|42170638|FG001|Overall Study|Unscheduled venipuncture|13|||
19726331|NCT04275336|42170639|FG002|Overall Study|Unscheduled venipuncture|7|||
19726332|NCT04275336|42170637|FG000|Overall Study|Failed specimen of saliva|4|||
19726333|NCT04275336|42170638|FG001|Overall Study|Failed specimen of saliva|3|||
19726334|NCT04275336|42170639|FG002|Overall Study|Failed specimen of saliva|4|||
19726335|NCT04268316|42170653|FG000|Overall Study|Withdrawal by Subject|2|||
19726336|NCT04268316|42170654|FG001|Overall Study|Withdrawal by Subject|1|||
19726337|NCT04268316|42170655|FG002|Overall Study|Withdrawal by Subject|0|||
19726338|NCT01971970|42170665|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
19726339|NCT01971970|42170666|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
19726340|NCT01971970|42170665|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
19726341|NCT01971970|42170666|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
19726342|NCT01971970|42170665|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
19726343|NCT01971970|42170666|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
19726344|NCT01971970|42170665|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
19726345|NCT01971970|42170666|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
19726346|NCT01971970|42170665|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
19726347|NCT01971970|42170666|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
19726348|NCT01971970|42170665|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
19726349|NCT01971970|42170666|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
19726350|NCT01971970|42170665|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
19726351|NCT01971970|42170666|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
19726352|NCT04079790|42170681|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
19726353|NCT04079790|42170682|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
19726354|NCT04079790|42170683|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
19726355|NCT04079790|42170684|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
19726356|NCT04079790|42170681|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
19726357|NCT04079790|42170682|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
19464299|NCT01929707|41722443|FG006|Intervention Period 1|Lost to Follow-up|0|||
19726358|NCT04079790|42170683|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
19726359|NCT04079790|42170684|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
19726360|NCT04079790|42170681|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
19726361|NCT04079790|42170682|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
19726362|NCT04079790|42170683|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
19726363|NCT04079790|42170684|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
19726364|NCT04259346|42170712|FG000|Overall Study|Lost to Follow-up|1|||
19726365|NCT04259346|42170713|FG001|Overall Study|Lost to Follow-up|3|||
19726366|NCT04259346|42170712|FG000|Overall Study|Protocol Violation|1|||
19726367|NCT04259346|42170713|FG001|Overall Study|Protocol Violation|0|||
19726368|NCT04259346|42170712|FG000|Overall Study|Withdrawal by Subject|1|||
19726369|NCT04259346|42170713|FG001|Overall Study|Withdrawal by Subject|0|||
19726370|NCT04259346|42170712|FG000|Overall Study|Adverse Event|1|||
19726371|NCT04259346|42170713|FG001|Overall Study|Adverse Event|1|||
19726372|NCT04230876|42170721|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
19726373|NCT04230876|42170722|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
19726374|NCT04228302|42170734|FG000|Overall Study|Adverse Event|0|||
19726375|NCT04228302|42170735|FG001|Overall Study|Adverse Event|0|||
19726376|NCT04228302|42170736|FG002|Overall Study|Adverse Event|0|||
19726377|NCT04228302|42170737|FG003|Overall Study|Adverse Event|0|||
19726378|NCT04228302|42170738|FG004|Overall Study|Adverse Event|1|||
19726379|NCT04228302|42170739|FG005|Overall Study|Adverse Event|0|||
19726380|NCT01348100|42170760|FG000|Overall Study|Subject Withdrew Consent|0|||
19726381|NCT01348100|42170761|FG001|Overall Study|Subject Withdrew Consent|0|||
19726382|NCT01348100|42170762|FG002|Overall Study|Subject Withdrew Consent|2|||
19726383|NCT01348100|42170763|FG003|Overall Study|Subject Withdrew Consent|0|||
19726384|NCT01348100|42170764|FG004|Overall Study|Subject Withdrew Consent|1|||
19726385|NCT01348100|42170765|FG005|Overall Study|Subject Withdrew Consent|0|||
19726386|NCT01348100|42170766|FG006|Overall Study|Subject Withdrew Consent|1|||
19726387|NCT01348100|42170760|FG000|Overall Study|Protocol Deviation|0|||
19726388|NCT01348100|42170761|FG001|Overall Study|Protocol Deviation|0|||
19726389|NCT01348100|42170762|FG002|Overall Study|Protocol Deviation|0|||
19726390|NCT01348100|42170763|FG003|Overall Study|Protocol Deviation|1|||
19726391|NCT01348100|42170764|FG004|Overall Study|Protocol Deviation|0|||
19726392|NCT01348100|42170765|FG005|Overall Study|Protocol Deviation|0|||
19726393|NCT01348100|42170766|FG006|Overall Study|Protocol Deviation|0|||
19726394|NCT01348100|42170760|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726395|NCT01348100|42170761|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726396|NCT01348100|42170762|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726397|NCT01348100|42170763|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726398|NCT01348100|42170764|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726399|NCT01348100|42170765|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
19726400|NCT01348100|42170766|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19726401|NCT01348100|42170760|FG000|Overall Study|Lost to Follow-up|0|||
19726402|NCT01348100|42170761|FG001|Overall Study|Lost to Follow-up|0|||
19726403|NCT01348100|42170762|FG002|Overall Study|Lost to Follow-up|0|||
19726404|NCT01348100|42170763|FG003|Overall Study|Lost to Follow-up|0|||
19726405|NCT01348100|42170764|FG004|Overall Study|Lost to Follow-up|0|||
19726406|NCT01348100|42170765|FG005|Overall Study|Lost to Follow-up|0|||
19726407|NCT01348100|42170766|FG006|Overall Study|Lost to Follow-up|1|||
19726408|NCT01348100|42170760|FG000|Overall Study|Administrative Problems|0|||
19726409|NCT01348100|42170761|FG001|Overall Study|Administrative Problems|0|||
19726410|NCT01348100|42170762|FG002|Overall Study|Administrative Problems|0|||
19726411|NCT01348100|42170763|FG003|Overall Study|Administrative Problems|0|||
19726412|NCT01348100|42170764|FG004|Overall Study|Administrative Problems|0|||
19726413|NCT01348100|42170765|FG005|Overall Study|Administrative Problems|1|||
19726414|NCT01348100|42170766|FG006|Overall Study|Administrative Problems|1|||
19726415|NCT03676634|42170787|FG000|Overall Study|Red blood cell loss|1|||
19726416|NCT03676634|42170787|FG000|Overall Study|Out-of-limit pulse|2|||
19726417|NCT03675776|42170794|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
19726418|NCT03675776|42170795|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
19726419|NCT03675776|42170796|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
19726420|NCT03675776|42170794|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
19726421|NCT03675776|42170795|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
19726422|NCT03675776|42170796|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
19726423|NCT03673670|42170810|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
19726424|NCT03673670|42170811|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
19726425|NCT03673670|42170812|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
19726426|NCT03673670|42170813|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
19726427|NCT03673670|42170814|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
19726428|NCT03673670|42170815|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
19726429|NCT03673670|42170810|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
19726430|NCT03673670|42170811|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
19726431|NCT03673670|42170812|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
19726432|NCT03673670|42170813|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
19726433|NCT03673670|42170814|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
19726434|NCT03673670|42170815|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
19726435|NCT03673670|42170810|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
19726436|NCT03673670|42170811|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
19726437|NCT03673670|42170812|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
19726438|NCT03673670|42170813|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
19726439|NCT03673670|42170814|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
19726440|NCT03673670|42170815|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
19726441|NCT03673670|42170810|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
19726442|NCT03673670|42170811|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
19726443|NCT03673670|42170812|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
19726444|NCT03673670|42170813|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
19726445|NCT03673670|42170814|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
19726446|NCT03673670|42170815|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
19726447|NCT03673670|42170810|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
19726448|NCT03673670|42170811|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
19726449|NCT03673670|42170812|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
19726450|NCT03673670|42170813|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
19726451|NCT03673670|42170814|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
19726452|NCT03673670|42170815|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
19726453|NCT03673670|42170810|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
19726454|NCT03673670|42170811|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
19726455|NCT03673670|42170812|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
19726456|NCT03673670|42170813|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
19726457|NCT03673670|42170814|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
19726458|NCT03673670|42170815|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
19726459|NCT03673670|42170810|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
19726460|NCT03673670|42170811|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
19726461|NCT03673670|42170812|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
19726462|NCT03673670|42170813|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
19726463|NCT03673670|42170814|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
19726464|NCT03673670|42170815|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
19726465|NCT04369742|42170834|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
19726466|NCT04369742|42170835|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
19726467|NCT04369742|42170834|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
19726468|NCT04369742|42170835|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
19726469|NCT04369430|42170843|FG000|Overall Study|Adverse Event|2|||
19726470|NCT04369430|42170844|FG001|Overall Study|Adverse Event|3|||
19726471|NCT04369430|42170843|FG000|Overall Study|Death|1|||
19726472|NCT04369430|42170844|FG001|Overall Study|Death|0|||
19726473|NCT04369430|42170843|FG000|Overall Study|Withdrawal by Subject|4|||
19726474|NCT04369430|42170844|FG001|Overall Study|Withdrawal by Subject|3|||
19726475|NCT04369430|42170843|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
19726476|NCT04369430|42170844|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
19726477|NCT04369430|42170843|FG000|Overall Study|Lost to Follow-up|0|||
19726478|NCT04369430|42170844|FG001|Overall Study|Lost to Follow-up|1|||
19726479|NCT04363736|42170852|FG000|Overall Study|Withdrawal by Subject|1|||
19726480|NCT04363736|42170853|FG001|Overall Study|Withdrawal by Subject|0|||
19726481|NCT04363736|42170852|FG000|Overall Study|Lost to Follow-up|10|||
19726482|NCT04363736|42170853|FG001|Overall Study|Lost to Follow-up|7|||
19726483|NCT04363736|42170852|FG000|Overall Study|Death|8|||
19726484|NCT04363736|42170853|FG001|Overall Study|Death|6|||
19726485|NCT04362176|42170861|FG000|Overall Study|Lost to Follow-up|5|||
19726486|NCT04362176|42170862|FG001|Overall Study|Lost to Follow-up|8|||
19726487|NCT04362176|42170861|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
19726488|NCT04362176|42170862|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
19726489|NCT04080752|42170870|FG000|Overall Study|Adverse Event|2|||
19726490|NCT04080752|42170871|FG001|Overall Study|Adverse Event|3|||
19726491|NCT04080752|42170870|FG000|Overall Study|Lack of Efficacy|1|||
19726492|NCT04080752|42170871|FG001|Overall Study|Lack of Efficacy|0|||
19726493|NCT04080752|42170870|FG000|Overall Study|Lost to Follow-up|1|||
19726494|NCT04080752|42170871|FG001|Overall Study|Lost to Follow-up|0|||
19726495|NCT04080752|42170870|FG000|Overall Study|Pregnancy|0|||
19726496|NCT04080752|42170871|FG001|Overall Study|Pregnancy|1|||
19726497|NCT04080752|42170870|FG000|Overall Study|Withdrawal by Subject|7|||
19726498|NCT04080752|42170871|FG001|Overall Study|Withdrawal by Subject|0|||
19726499|NCT04080752|42170870|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19726500|NCT04080752|42170871|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19726501|NCT04080752|42170870|FG000|Overall Study|Other|2|||
19726502|NCT04080752|42170871|FG001|Overall Study|Other|1|||
19726503|NCT04079816|42170878|FG000|Overall Study|Request of Subject|2|||
19726504|NCT04079816|42170878|FG000|Overall Study|Unable to draw samples|1|||
19726505|NCT04079114|42170882|FG000|Overall Study|Study prematuely terminated.|166|||
19726506|NCT03055936|42170890|FG000|Overall Study|Adverse Event|0|||
19726507|NCT03055936|42170891|FG001|Overall Study|Adverse Event|1|||
19726508|NCT03055936|42170892|FG002|Overall Study|Adverse Event|1|||
19726509|NCT03055936|42170893|FG003|Overall Study|Adverse Event|1|||
19726510|NCT03055936|42170890|FG000|Overall Study|Personal reason|2|||
19726511|NCT03055936|42170891|FG001|Overall Study|Personal reason|0|||
19726512|NCT03055936|42170892|FG002|Overall Study|Personal reason|1|||
19726513|NCT03055936|42170893|FG003|Overall Study|Personal reason|0|||
19726514|NCT03891524|42170935|FG000|Overall Study|Death|0|||
19726515|NCT03891524|42170936|FG001|Overall Study|Death|0|||
19726516|NCT03891524|42170937|FG002|Overall Study|Death|0|||
19726517|NCT03891524|42170938|FG003|Overall Study|Death|0|||
19726518|NCT03891524|42170939|FG004|Overall Study|Death|0|||
19726519|NCT03891524|42170940|FG005|Overall Study|Death|0|||
19726520|NCT03891524|42170941|FG006|Overall Study|Death|0|||
19726521|NCT03891524|42170942|FG007|Overall Study|Death|1|||
19726522|NCT03891524|42170935|FG000|Overall Study|Withdrawal by Subject|0|||
19726523|NCT03891524|42170936|FG001|Overall Study|Withdrawal by Subject|1|||
19726524|NCT03891524|42170937|FG002|Overall Study|Withdrawal by Subject|2|||
19726525|NCT03891524|42170938|FG003|Overall Study|Withdrawal by Subject|1|||
19726526|NCT03891524|42170939|FG004|Overall Study|Withdrawal by Subject|2|||
19726527|NCT03891524|42170940|FG005|Overall Study|Withdrawal by Subject|2|||
19726528|NCT03891524|42170941|FG006|Overall Study|Withdrawal by Subject|2|||
19726529|NCT03891524|42170942|FG007|Overall Study|Withdrawal by Subject|1|||
19726530|NCT03055624|42170977|FG000|Overall Study|Study closed|9|||
19726531|NCT01346176|42170984|FG000|Recruited|Protocol Violation|1|||
19726532|NCT01346176|42170985|FG001|Recruited|Protocol Violation|0|||
19726533|NCT01346176|42170986|FG002|Recruited|Protocol Violation|0|||
19726534|NCT01346176|42170984|FG000|Completed Advance Directive|Death|3|||
19726535|NCT01346176|42170985|FG001|Completed Advance Directive|Death|2|||
19726536|NCT01346176|42170986|FG002|Completed Advance Directive|Death|2|||
19726537|NCT01346176|42170984|FG000|Completed Advance Directive|Became Ineligible|3|||
19726538|NCT01346176|42170985|FG001|Completed Advance Directive|Became Ineligible|0|||
19726539|NCT01346176|42170986|FG002|Completed Advance Directive|Became Ineligible|1|||
19726540|NCT01346176|42170984|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
19726541|NCT01346176|42170985|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
19726542|NCT01346176|42170986|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
19726543|NCT01346176|42170984|FG000|Completed Satisfaction Survey|Death|3|||
19726544|NCT01346176|42170985|FG001|Completed Satisfaction Survey|Death|0|||
19726545|NCT01346176|42170986|FG002|Completed Satisfaction Survey|Death|2|||
19726546|NCT01346176|42170984|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
19726547|NCT01346176|42170985|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
19726548|NCT01346176|42170986|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
19726549|NCT04075604|42170997|FG000|Overall Study|Adverse Event|0|||
19726550|NCT04075604|42170998|FG001|Overall Study|Adverse Event|0|||
19726551|NCT04075604|42170999|FG002|Overall Study|Adverse Event|3|||
19726552|NCT04075604|42170997|FG000|Overall Study|Participant request to discontinue study treatment|0|||
19726553|NCT04075604|42170998|FG001|Overall Study|Participant request to discontinue study treatment|0|||
19726554|NCT04075604|42170999|FG002|Overall Study|Participant request to discontinue study treatment|1|||
19726555|NCT04075604|42170997|FG000|Overall Study|Participant withdrew consent|0|||
19726556|NCT04075604|42170998|FG001|Overall Study|Participant withdrew consent|0|||
19726557|NCT04075604|42170999|FG002|Overall Study|Participant withdrew consent|1|||
19726558|NCT04075604|42170997|FG000|Overall Study|Other reasons|1|||
19726559|NCT04075604|42170998|FG001|Overall Study|Other reasons|0|||
19726560|NCT04075604|42170999|FG002|Overall Study|Other reasons|0|||
19726561|NCT04075604|42170997|FG000|Overall Study|Disease progression|0|||
19726562|NCT04075604|42170998|FG001|Overall Study|Disease progression|1|||
19726563|NCT04075604|42170999|FG002|Overall Study|Disease progression|0|||
19726564|NCT04075604|42170997|FG000|Overall Study|Study drug toxicity|0|||
19726565|NCT04075604|42170998|FG001|Overall Study|Study drug toxicity|5|||
19726566|NCT04075604|42170999|FG002|Overall Study|Study drug toxicity|1|||
19726567|NCT03796208|42171018|FG000|Overall Study|Withdrawal by Subject|3|||
19478076|NCT01693562|41757322|FG008|Exploration Phase|Other|0|||
19726568|NCT03796208|42171019|FG001|Overall Study|Withdrawal by Subject|0|||
19726569|NCT03796208|42171018|FG000|Overall Study|Loss of pregnancy|1|||
19726570|NCT03796208|42171019|FG001|Overall Study|Loss of pregnancy|1|||
19726571|NCT03796208|42171018|FG000|Overall Study|Changed prenatal clinics|0|||
19726572|NCT03796208|42171019|FG001|Overall Study|Changed prenatal clinics|5|||
19726573|NCT03796208|42171018|FG000|Overall Study|Lost to Follow-up|20|||
19726574|NCT03796208|42171019|FG001|Overall Study|Lost to Follow-up|16|||
19726575|NCT01318876|42171025|FG000|Day 8 Survey|email address invalid|96|||
19726576|NCT01318876|42171025|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
19726577|NCT01318876|42171025|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
19726578|NCT03668600|42171029|FG000|Overall Study|Study Terminated by the Sponsor|157|||
19726579|NCT03668600|42171029|FG000|Overall Study|Protocol Violation|1|||
19726580|NCT03668600|42171029|FG000|Overall Study|Pregnancy|1|||
19726581|NCT03668600|42171029|FG000|Overall Study|Lost to Follow-up|7|||
19726582|NCT03668600|42171029|FG000|Overall Study|Withdrawal by Subject|56|||
19726583|NCT03668600|42171029|FG000|Overall Study|Lack of Efficacy|7|||
19726584|NCT03668600|42171029|FG000|Overall Study|Adverse Event|1|||
19726585|NCT04073186|42171033|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
19726586|NCT04073186|42171033|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
19726587|NCT04073186|42171033|FG000|First Wearing Cycle|Protocol Violation|1|||
19726588|NCT04073186|42171033|FG000|First Wearing Cycle|Lens Discomfort|2|||
19726589|NCT04073186|42171033|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
19726590|NCT04073186|42171033|FG000|Second Wearing Cycle|Adverse Event|1|||
19726591|NCT03054064|42171038|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
19726592|NCT03054064|42171038|FG000|Overall Study|Investigator Decision|2|||
19726593|NCT03054064|42171038|FG000|Overall Study|Bladder Issue|1|||
19726594|NCT03054064|42171038|FG000|Overall Study|High Blood Pressure|1|||
19726595|NCT03054064|42171038|FG000|Overall Study|Change in Status|1|||
19726596|NCT03053518|42171042|FG000|Overall Study|Withdrawal by Subject|3|||
19726597|NCT03053518|42171042|FG000|Overall Study|Lost to Follow-up|2|||
19726598|NCT03053518|42171042|FG000|Overall Study|Ineligible|5|||
19726599|NCT04015336|42171046|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
19726600|NCT04071158|42171069|FG000|Overall Study|Lost to Follow-up|1|||
19726601|NCT04071158|42171070|FG001|Overall Study|Lost to Follow-up|2|||
19726602|NCT04071158|42171071|FG002|Overall Study|Lost to Follow-up|3|||
19726603|NCT04071158|42171072|FG003|Overall Study|Lost to Follow-up|3|||
19726604|NCT04071158|42171073|FG004|Overall Study|Lost to Follow-up|5|||
19726605|NCT04071158|42171069|FG000|Overall Study|Randomized but not treated|2|||
19726606|NCT04071158|42171070|FG001|Overall Study|Randomized but not treated|2|||
19726607|NCT04071158|42171071|FG002|Overall Study|Randomized but not treated|0|||
19726608|NCT04071158|42171072|FG003|Overall Study|Randomized but not treated|0|||
19726609|NCT04071158|42171073|FG004|Overall Study|Randomized but not treated|0|||
19726610|NCT01317940|42171097|FG000|Overall Study|Death|1|||
19726611|NCT01317940|42171098|FG001|Overall Study|Death|0|||
19726612|NCT01317940|42171099|FG002|Overall Study|Death|1|||
19726613|NCT01317940|42171100|FG003|Overall Study|Death|0|||
19726614|NCT01317940|42171101|FG004|Overall Study|Death|0|||
19726615|NCT01317940|42171102|FG005|Overall Study|Death|0|||
19726616|NCT01317940|42171097|FG000|Overall Study|Lost to Follow-up|0|||
19726617|NCT01317940|42171098|FG001|Overall Study|Lost to Follow-up|0|||
19726618|NCT01317940|42171099|FG002|Overall Study|Lost to Follow-up|1|||
19726619|NCT01317940|42171100|FG003|Overall Study|Lost to Follow-up|1|||
19726620|NCT01317940|42171101|FG004|Overall Study|Lost to Follow-up|1|||
19726621|NCT01317940|42171102|FG005|Overall Study|Lost to Follow-up|0|||
19726622|NCT01317940|42171097|FG000|Overall Study|Change in therapy plan|0|||
19726623|NCT01317940|42171098|FG001|Overall Study|Change in therapy plan|0|||
19726624|NCT01317940|42171099|FG002|Overall Study|Change in therapy plan|3|||
19726625|NCT01317940|42171100|FG003|Overall Study|Change in therapy plan|0|||
19726626|NCT01317940|42171101|FG004|Overall Study|Change in therapy plan|0|||
19726627|NCT01317940|42171102|FG005|Overall Study|Change in therapy plan|0|||
19726628|NCT01345786|42171121|FG000|Overall Study|Adverse Event|0|||
19726629|NCT01345786|42171122|FG001|Overall Study|Adverse Event|1|||
19726630|NCT01345786|42171123|FG002|Overall Study|Adverse Event|3|||
19726631|NCT01345786|42171124|FG003|Overall Study|Adverse Event|1|||
19726632|NCT01345786|42171121|FG000|Overall Study|Subject withdrew consent|2|||
19726633|NCT01345786|42171122|FG001|Overall Study|Subject withdrew consent|2|||
19726634|NCT01345786|42171123|FG002|Overall Study|Subject withdrew consent|1|||
19726635|NCT01345786|42171124|FG003|Overall Study|Subject withdrew consent|0|||
19726636|NCT01345786|42171121|FG000|Overall Study|Noncompliance with protocol|1|||
19726637|NCT01345786|42171122|FG001|Overall Study|Noncompliance with protocol|0|||
19726638|NCT01345786|42171123|FG002|Overall Study|Noncompliance with protocol|1|||
19726639|NCT01345786|42171124|FG003|Overall Study|Noncompliance with protocol|0|||
19726640|NCT01345786|42171121|FG000|Overall Study|Administrative|3|||
19726641|NCT01345786|42171122|FG001|Overall Study|Administrative|5|||
19726642|NCT01345786|42171123|FG002|Overall Study|Administrative|0|||
19726643|NCT01345786|42171124|FG003|Overall Study|Administrative|0|||
19726644|NCT01345786|42171121|FG000|Overall Study|Lost to Follow-up|0|||
19726645|NCT01345786|42171122|FG001|Overall Study|Lost to Follow-up|0|||
19726646|NCT01345786|42171123|FG002|Overall Study|Lost to Follow-up|0|||
19726647|NCT01345786|42171124|FG003|Overall Study|Lost to Follow-up|2|||
19726648|NCT01317550|42171138|FG000|Overall Study|Withdrawal by Subject|1|||
19726649|NCT01317550|42171139|FG001|Overall Study|Withdrawal by Subject|0|||
19726650|NCT01317550|42171140|FG002|Overall Study|Withdrawal by Subject|0|||
19726651|NCT01317550|42171141|FG003|Overall Study|Withdrawal by Subject|0|||
19726652|NCT01317550|42171138|FG000|Overall Study|Lack of compliance study med|1|||
19726653|NCT01317550|42171139|FG001|Overall Study|Lack of compliance study med|0|||
19726654|NCT01317550|42171140|FG002|Overall Study|Lack of compliance study med|0|||
19726655|NCT01317550|42171141|FG003|Overall Study|Lack of compliance study med|0|||
19726656|NCT01317472|42171153|FG000|Overall Study|Withdrawal by Subject|1|||
19726657|NCT01317472|42171154|FG001|Overall Study|Withdrawal by Subject|0|||
19726658|NCT01317472|42171153|FG000|Overall Study|Unrelated hospitalization|1|||
19726659|NCT01317472|42171154|FG001|Overall Study|Unrelated hospitalization|0|||
19726660|NCT01345630|42171162|FG000|Overall Study|Adverse Event|22|||
19726661|NCT01345630|42171163|FG001|Overall Study|Adverse Event|23|||
19726662|NCT01345630|42171162|FG000|Overall Study|Lost to Follow-up|17|||
19726663|NCT01345630|42171163|FG001|Overall Study|Lost to Follow-up|16|||
19726664|NCT01345630|42171162|FG000|Overall Study|Protocol Violation|4|||
19726665|NCT01345630|42171163|FG001|Overall Study|Protocol Violation|1|||
19726666|NCT01345630|42171162|FG000|Overall Study|Medication error without associated AE|0|||
19726667|NCT01345630|42171163|FG001|Overall Study|Medication error without associated AE|1|||
19726668|NCT01345630|42171162|FG000|Overall Study|Study terminated by sponsor|254|||
19726669|NCT01345630|42171163|FG001|Overall Study|Study terminated by sponsor|285|||
19726670|NCT01345630|42171162|FG000|Overall Study|Other reasons|6|||
19726671|NCT01345630|42171163|FG001|Overall Study|Other reasons|8|||
19726672|NCT01345630|42171162|FG000|Overall Study|Withdrawn due to pregnancy|1|||
19726673|NCT01345630|42171163|FG001|Overall Study|Withdrawn due to pregnancy|2|||
19726674|NCT01345630|42171162|FG000|Overall Study|No longer willing to participate|9|||
19726675|NCT01345630|42171163|FG001|Overall Study|No longer willing to participate|12|||
19726676|NCT01345630|42171162|FG000|Overall Study|Insufficient clinical response|48|||
19726677|NCT01345630|42171163|FG001|Overall Study|Insufficient clinical response|11|||
19726678|NCT03693612|42171180|FG000|Overall Study|Lost to Follow-up|0|||
19726679|NCT03693612|42171181|FG001|Overall Study|Lost to Follow-up|0|||
19726680|NCT03693612|42171182|FG002|Overall Study|Lost to Follow-up|0|||
19726681|NCT03693612|42171183|FG003|Overall Study|Lost to Follow-up|0|||
19726682|NCT03693612|42171184|FG004|Overall Study|Lost to Follow-up|1|||
19726683|NCT03693612|42171185|FG005|Overall Study|Lost to Follow-up|0|||
19726684|NCT03693612|42171186|FG006|Overall Study|Lost to Follow-up|0|||
19726685|NCT03693612|42171180|FG000|Overall Study|Withdrawal by Subject|0|||
19726686|NCT03693612|42171181|FG001|Overall Study|Withdrawal by Subject|0|||
19726687|NCT03693612|42171182|FG002|Overall Study|Withdrawal by Subject|1|||
19726688|NCT03693612|42171183|FG003|Overall Study|Withdrawal by Subject|0|||
19726689|NCT03693612|42171184|FG004|Overall Study|Withdrawal by Subject|2|||
19726690|NCT03693612|42171185|FG005|Overall Study|Withdrawal by Subject|0|||
19726691|NCT03693612|42171186|FG006|Overall Study|Withdrawal by Subject|0|||
19726692|NCT03693612|42171180|FG000|Overall Study|Study Terminated by Sponsor|0|||
19726693|NCT03693612|42171181|FG001|Overall Study|Study Terminated by Sponsor|1|||
19726694|NCT03693612|42171182|FG002|Overall Study|Study Terminated by Sponsor|0|||
19726695|NCT03693612|42171183|FG003|Overall Study|Study Terminated by Sponsor|0|||
19726696|NCT03693612|42171184|FG004|Overall Study|Study Terminated by Sponsor|3|||
19726697|NCT03693612|42171185|FG005|Overall Study|Study Terminated by Sponsor|0|||
19726698|NCT03693612|42171186|FG006|Overall Study|Study Terminated by Sponsor|0|||
19726699|NCT03692910|42171202|FG000|Overall Study|Lost to Follow-up|4|||
19726700|NCT03692910|42171203|FG001|Overall Study|Lost to Follow-up|0|||
19726701|NCT03692910|42171204|FG002|Overall Study|Lost to Follow-up|0|||
19726702|NCT03692910|42171202|FG000|Overall Study|Withdrawal by Subject|2|||
19726703|NCT03692910|42171203|FG001|Overall Study|Withdrawal by Subject|0|||
19726704|NCT03692910|42171204|FG002|Overall Study|Withdrawal by Subject|0|||
19726705|NCT04223232|42171210|FG000|Overall Study|Withdrawal by Subject|1|||
19726706|NCT04206384|42171214|FG000|Overall Study|Withdrawal by Subject|8|||
19726707|NCT04206384|42171214|FG000|Overall Study|Adverse Event|2|||
19726708|NCT04051944|42171220|FG000|Overall Study|Study ending|1|||
19726709|NCT04051944|42171221|FG001|Overall Study|Study ending|1|||
19726710|NCT04051944|42171220|FG000|Overall Study|Early study termination by participant|1|||
19726711|NCT04051944|42171221|FG001|Overall Study|Early study termination by participant|0|||
19726712|NCT04051944|42171220|FG000|Overall Study|Withdrawal by Subject|2|||
19726713|NCT04051944|42171221|FG001|Overall Study|Withdrawal by Subject|2|||
19726714|NCT04051944|42171220|FG000|Overall Study|Lack of Efficacy|3|||
19726715|NCT04051944|42171221|FG001|Overall Study|Lack of Efficacy|0|||
19726716|NCT04051944|42171220|FG000|Overall Study|Adverse event, non- fatal|1|||
19726717|NCT04051944|42171221|FG001|Overall Study|Adverse event, non- fatal|1|||
19726718|NCT04050618|42171229|FG000|First Intervention|Withdrawal by Subject|2|||
19726719|NCT04050618|42171230|FG001|First Intervention|Withdrawal by Subject|0|||
19726720|NCT04050618|42171229|FG000|Second Intervention|Withdrawal by Subject|1|||
19726721|NCT04050618|42171230|FG001|Second Intervention|Withdrawal by Subject|0|||
19726722|NCT04067492|42171247|FG000|Overall Study|Lost to Follow-up|0|||
19726723|NCT04067492|42171248|FG001|Overall Study|Lost to Follow-up|0|||
19726724|NCT04067492|42171249|FG002|Overall Study|Lost to Follow-up|0|||
19726725|NCT04067492|42171250|FG003|Overall Study|Lost to Follow-up|0|||
19726726|NCT04067492|42171251|FG004|Overall Study|Lost to Follow-up|0|||
19726727|NCT04067492|42171252|FG005|Overall Study|Lost to Follow-up|1|||
19726728|NCT04067492|42171247|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
19726729|NCT04067492|42171248|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
19726730|NCT04067492|42171249|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
19726731|NCT04067492|42171250|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
19726732|NCT04067492|42171251|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
19726733|NCT04067492|42171252|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
19726734|NCT04067492|42171247|FG000|Overall Study|COVID-19 epidemiological situation|0|||
19726735|NCT04067492|42171248|FG001|Overall Study|COVID-19 epidemiological situation|0|||
19726736|NCT04067492|42171249|FG002|Overall Study|COVID-19 epidemiological situation|0|||
19726737|NCT04067492|42171250|FG003|Overall Study|COVID-19 epidemiological situation|1|||
19726738|NCT04067492|42171251|FG004|Overall Study|COVID-19 epidemiological situation|0|||
19726739|NCT04067492|42171252|FG005|Overall Study|COVID-19 epidemiological situation|0|||
19726740|NCT04046250|42171268|FG000|Overall Study|Death|0|||
19726741|NCT04046250|42171269|FG001|Overall Study|Death|1|||
19726742|NCT04046250|42171268|FG000|Overall Study|Withdrawal by Subject|3|||
19726743|NCT04046250|42171269|FG001|Overall Study|Withdrawal by Subject|3|||
19726744|NCT04375878|42171279|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
19726745|NCT04375878|42171280|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
19726746|NCT04375878|42171281|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
19726747|NCT04375878|42171282|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
19726748|NCT04375878|42171283|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
19726749|NCT04375878|42171284|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
19726750|NCT04375878|42171279|FG000|Crossover First and Second Interventions|Adverse Event|0|||
19726751|NCT04375878|42171280|FG001|Crossover First and Second Interventions|Adverse Event|0|||
19726752|NCT04375878|42171281|FG002|Crossover First and Second Interventions|Adverse Event|1|||
19726753|NCT04375878|42171282|FG003|Crossover First and Second Interventions|Adverse Event|0|||
19726754|NCT04375878|42171283|FG004|Crossover First and Second Interventions|Adverse Event|0|||
19726755|NCT04375878|42171284|FG005|Crossover First and Second Interventions|Adverse Event|0|||
19726756|NCT04375878|42171279|FG000|Extension Phase|Withdrawal by Subject|0|||
19726757|NCT04375878|42171280|FG001|Extension Phase|Withdrawal by Subject|0|||
19726758|NCT04375878|42171281|FG002|Extension Phase|Withdrawal by Subject|0|||
19726759|NCT04375878|42171282|FG003|Extension Phase|Withdrawal by Subject|0|||
19726760|NCT04375878|42171283|FG004|Extension Phase|Withdrawal by Subject|1|||
19726761|NCT04375878|42171284|FG005|Extension Phase|Withdrawal by Subject|0|||
19726762|NCT04189224|42171304|FG000|Period 2|Adverse Event|0|||
19726763|NCT04189224|42171305|FG001|Period 2|Adverse Event|1|||
19726764|NCT04186806|42171313|FG000|Period 1: 7 Days|Adverse Event|1|||
19726765|NCT04186806|42171314|FG001|Period 1: 7 Days|Adverse Event|0|||
19726766|NCT04041414|42171323|FG000|Overall Study|Lost to Follow-up|1|||
19726767|NCT04041414|42171324|FG001|Overall Study|Lost to Follow-up|2|||
19726768|NCT04370028|42171333|FG000|Overall Study|Withdrawal by Subject|695|||
19726769|NCT04370028|42171333|FG000|Overall Study|Protocol Violation|9|||
19726770|NCT04370028|42171333|FG000|Overall Study|Adverse Event|3|||
19726771|NCT04037748|42171346|FG000|Treatment Period 1|Withdrawal by Subject|3|||
19726772|NCT04037748|42171347|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19726773|NCT04037748|42171346|FG000|Treatment Period 1|Adverse Event|1|||
19726774|NCT04037748|42171347|FG001|Treatment Period 1|Adverse Event|1|||
19726775|NCT04037748|42171346|FG000|Treatment Period 1|Protocol Violation|4|||
19726776|NCT04037748|42171347|FG001|Treatment Period 1|Protocol Violation|5|||
19726777|NCT04037748|42171346|FG000|Treatment Period 2|Adverse Event|0|||
19726778|NCT04037748|42171347|FG001|Treatment Period 2|Adverse Event|1|||
19726779|NCT04037748|42171346|FG000|Treatment Period 2|Protocol Violation|2|||
19726780|NCT04037748|42171347|FG001|Treatment Period 2|Protocol Violation|0|||
19726781|NCT04036110|42171356|FG000|Overall Study|Lost to Follow-up|3|||
19726782|NCT04036110|42171357|FG001|Overall Study|Lost to Follow-up|2|||
19726783|NCT04036110|42171358|FG002|Overall Study|Lost to Follow-up|1|||
19726784|NCT04036110|42171356|FG000|Overall Study|Study Suspended|4|||
19726785|NCT04036110|42171357|FG001|Overall Study|Study Suspended|5|||
19726786|NCT04036110|42171358|FG002|Overall Study|Study Suspended|1|||
19726787|NCT03053050|42171369|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
19726788|NCT03053050|42171370|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
19726789|NCT03053050|42171371|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
19726790|NCT03053050|42171372|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
19726791|NCT03053050|42171369|FG000|Randomized Phase|Withdrew Consent|16|||
19726792|NCT03053050|42171370|FG001|Randomized Phase|Withdrew Consent|8|||
19726793|NCT03053050|42171371|FG002|Randomized Phase|Withdrew Consent|9|||
19726794|NCT03053050|42171372|FG003|Randomized Phase|Withdrew Consent|0|||
19726795|NCT03053050|42171369|FG000|Randomized Phase|Investigator's Discretion|6|||
19726796|NCT03053050|42171370|FG001|Randomized Phase|Investigator's Discretion|6|||
19726797|NCT03053050|42171371|FG002|Randomized Phase|Investigator's Discretion|3|||
19726798|NCT03053050|42171372|FG003|Randomized Phase|Investigator's Discretion|0|||
19726799|NCT03053050|42171369|FG000|Randomized Phase|Lost to Follow-up|5|||
19726800|NCT03053050|42171370|FG001|Randomized Phase|Lost to Follow-up|1|||
19726801|NCT03053050|42171371|FG002|Randomized Phase|Lost to Follow-up|1|||
19726802|NCT03053050|42171372|FG003|Randomized Phase|Lost to Follow-up|0|||
19726803|NCT03053050|42171369|FG000|Randomized Phase|Adverse Event|0|||
19726804|NCT03053050|42171370|FG001|Randomized Phase|Adverse Event|1|||
19726805|NCT03053050|42171371|FG002|Randomized Phase|Adverse Event|0|||
19726806|NCT03053050|42171372|FG003|Randomized Phase|Adverse Event|0|||
19726807|NCT03053050|42171369|FG000|Randomized Phase|Randomized but Never Treated|2|||
19726808|NCT03053050|42171370|FG001|Randomized Phase|Randomized but Never Treated|2|||
19726809|NCT03053050|42171371|FG002|Randomized Phase|Randomized but Never Treated|2|||
19726810|NCT03053050|42171372|FG003|Randomized Phase|Randomized but Never Treated|0|||
19726811|NCT03053050|42171369|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
19726812|NCT03053050|42171370|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
19726813|NCT03053050|42171371|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
19726814|NCT03053050|42171372|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
19726815|NCT03053050|42171369|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
19726816|NCT03053050|42171370|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
19726817|NCT03053050|42171371|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
19726818|NCT03053050|42171372|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
19726819|NCT03053050|42171369|FG000|Open-label Phase|Withdrew Consent|0|||
19726820|NCT03053050|42171370|FG001|Open-label Phase|Withdrew Consent|0|||
19726821|NCT03053050|42171371|FG002|Open-label Phase|Withdrew Consent|0|||
19726822|NCT03053050|42171372|FG003|Open-label Phase|Withdrew Consent|6|||
19726823|NCT03053050|42171369|FG000|Open-label Phase|Investigator's Discretion|0|||
19726824|NCT03053050|42171370|FG001|Open-label Phase|Investigator's Discretion|0|||
19726825|NCT03053050|42171371|FG002|Open-label Phase|Investigator's Discretion|0|||
19726826|NCT03053050|42171372|FG003|Open-label Phase|Investigator's Discretion|4|||
19726827|NCT04369950|42171383|FG000|Overall Study|Protocol Violation|2|||
19726828|NCT04369950|42171384|FG001|Overall Study|Protocol Violation|2|||
19726829|NCT04035564|42171392|FG000|Overall Study|Protocol Violation|1|||
19726830|NCT04035564|42171393|FG001|Overall Study|Protocol Violation|2|||
19726831|NCT04035564|42171392|FG000|Overall Study|No laboratory available|2|||
19726832|NCT04035564|42171393|FG001|Overall Study|No laboratory available|2|||
19726833|NCT04035564|42171392|FG000|Overall Study|Guardian declined consent|1|||
19726834|NCT04035564|42171393|FG001|Overall Study|Guardian declined consent|2|||
19726835|NCT02955602|42171402|FG000|Overall Study|Adverse Event|0|||
19726836|NCT02955602|42171403|FG001|Overall Study|Adverse Event|3|||
19726837|NCT02955602|42171404|FG002|Overall Study|Adverse Event|0|||
19726838|NCT02955602|42171402|FG000|Overall Study|Withdrawal of informed consent|1|||
19726839|NCT02955602|42171403|FG001|Overall Study|Withdrawal of informed consent|3|||
19726840|NCT02955602|42171404|FG002|Overall Study|Withdrawal of informed consent|2|||
19726841|NCT02955602|42171402|FG000|Overall Study|Lost to Follow-up|0|||
19726842|NCT02955602|42171403|FG001|Overall Study|Lost to Follow-up|0|||
19726843|NCT02955602|42171404|FG002|Overall Study|Lost to Follow-up|1|||
19726844|NCT02955602|42171402|FG000|Overall Study|Other|0|||
19726845|NCT02955602|42171403|FG001|Overall Study|Other|1|||
19726846|NCT02955602|42171404|FG002|Overall Study|Other|3|||
19726847|NCT04179786|42171412|FG000|Overall Study|Withdrawal by Subject|8|||
19726848|NCT03052816|42171418|FG000|Overall Study|Withdrawal by Subject|1|||
19726849|NCT03052816|42171419|FG001|Overall Study|Withdrawal by Subject|0|||
19726850|NCT03052816|42171418|FG000|Overall Study|Desired opioids|2|||
19726851|NCT03052816|42171419|FG001|Overall Study|Desired opioids|0|||
19726852|NCT04175808|42171427|FG000|Part A|Miscellaneous|2|||
19726853|NCT04175808|42171428|FG001|Part A|Miscellaneous|0|||
19726854|NCT04175808|42171429|FG002|Part A|Miscellaneous|0|||
19726855|NCT04175808|42171430|FG003|Part A|Miscellaneous|0|||
19726856|NCT04175808|42171431|FG004|Part A|Miscellaneous|0|||
19726857|NCT04175808|42171432|FG005|Part A|Miscellaneous|0|||
19726858|NCT04175808|42171433|FG006|Part A|Miscellaneous|0|||
19726859|NCT04057196|42171449|FG000|Overall Study|Withdrawal by Subject|3|||
19726860|NCT04057196|42171449|FG000|Overall Study|Death|3|||
19726861|NCT04027686|42171455|FG000|Overall Study|Lost to Follow-up|2|||
19726862|NCT04027686|42171456|FG001|Overall Study|Lost to Follow-up|0|||
19726863|NCT04027686|42171455|FG000|Overall Study|Withdrawal by Subject|0|||
19726864|NCT04027686|42171456|FG001|Overall Study|Withdrawal by Subject|1|||
19726865|NCT03052426|42171469|FG000|Overall Study|Withdrawal by Subject|0|||
19726866|NCT03052426|42171470|FG001|Overall Study|Withdrawal by Subject|1|||
19726867|NCT03052426|42171471|FG002|Overall Study|Withdrawal by Subject|0|||
19726868|NCT03052426|42171469|FG000|Overall Study|Lost to Follow-up|2|||
19726869|NCT03052426|42171470|FG001|Overall Study|Lost to Follow-up|0|||
19726870|NCT03052426|42171471|FG002|Overall Study|Lost to Follow-up|1|||
19726871|NCT03688880|42171486|FG000|Overall Study|Withdrawal by Subject|0|||
19726872|NCT03688880|42171487|FG001|Overall Study|Withdrawal by Subject|2|||
19726873|NCT03688880|42171486|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
19726874|NCT03688880|42171487|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
19726875|NCT03688880|42171486|FG000|Overall Study|Lost to Follow-up|4|||
19726876|NCT03688880|42171487|FG001|Overall Study|Lost to Follow-up|7|||
19726877|NCT03688880|42171486|FG000|Overall Study|Adverse Event|0|||
19726878|NCT03688880|42171487|FG001|Overall Study|Adverse Event|2|||
19726879|NCT03688880|42171486|FG000|Overall Study|Device deficiencies|0|||
19726880|NCT03688880|42171487|FG001|Overall Study|Device deficiencies|2|||
19726881|NCT03688880|42171486|FG000|Overall Study|Other|10|||
19726882|NCT03688880|42171487|FG001|Overall Study|Other|16|||
19726883|NCT03051178|42171493|FG000|Overall Study|Withdrawal by Subject|5|||
19726884|NCT03051100|42171499|FG000|Overall Study|Withdrawal by Subject|1|||
19726885|NCT03051100|42171500|FG001|Overall Study|Withdrawal by Subject|0|||
19726886|NCT01343368|42171508|FG000|Overall Study|Death|1|||
19726887|NCT01343368|42171509|FG001|Overall Study|Death|0|||
19726888|NCT01343368|42171508|FG000|Overall Study|Lost to Follow-up|1|||
19726889|NCT01343368|42171509|FG001|Overall Study|Lost to Follow-up|0|||
19726890|NCT02955212|42171517|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
19726891|NCT02955212|42171518|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
19726892|NCT02955212|42171517|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
19726893|NCT02955212|42171518|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
19726894|NCT02955212|42171517|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
19726895|NCT02955212|42171518|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
19726896|NCT02955212|42171517|FG000|Period 1: Double-blind Treatment Period|Other|3|||
19726897|NCT02955212|42171518|FG001|Period 1: Double-blind Treatment Period|Other|2|||
19726898|NCT02955212|42171517|FG000|Period 2: Open-label Extension|Adverse Event|11|||
19726899|NCT02955212|42171518|FG001|Period 2: Open-label Extension|Adverse Event|7|||
19726900|NCT02955212|42171517|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
19726901|NCT02955212|42171518|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
19726902|NCT02955212|42171517|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
19726903|NCT02955212|42171518|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
19726904|NCT02955212|42171517|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
19726905|NCT02955212|42171518|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
19726906|NCT02955212|42171517|FG000|Period 2: Open-label Extension|Other|2|||
19726907|NCT02955212|42171518|FG001|Period 2: Open-label Extension|Other|4|||
19726908|NCT03050398|42171525|FG000|Overall Study|Study terminated by sponsor|8|||
19726909|NCT03662750|42171529|FG000|Overall Study|Withdrawal by Subject|1|||
19726910|NCT04052204|42171533|FG000|Overall Study|Death|1|||
19726911|NCT04052204|42171534|FG001|Overall Study|Death|0|||
19726912|NCT04052204|42171535|FG002|Overall Study|Death|0|||
19726913|NCT04052204|42171533|FG000|Overall Study|Progressive disease|1|||
19726914|NCT04052204|42171534|FG001|Overall Study|Progressive disease|0|||
19726915|NCT04052204|42171535|FG002|Overall Study|Progressive disease|0|||
19726916|NCT04052204|42171533|FG000|Overall Study|Other|1|||
19726917|NCT04052204|42171534|FG001|Overall Study|Other|0|||
19726918|NCT04052204|42171535|FG002|Overall Study|Other|0|||
19726919|NCT04050722|42171541|FG000|Overall Study|Withdrawal by Subject|1|||
19726920|NCT04050722|42171542|FG001|Overall Study|Withdrawal by Subject|0|||
19726921|NCT04049552|42171548|FG000|Overall Study|Lost to Follow-up|1|||
19726922|NCT03048058|42171556|FG000|Overall Study|Lost to Follow-up|4|||
19726923|NCT03048058|42171557|FG001|Overall Study|Lost to Follow-up|0|||
19726924|NCT03048058|42171556|FG000|Overall Study|Withdrawal by Subject|0|||
19726925|NCT03048058|42171557|FG001|Overall Study|Withdrawal by Subject|4|||
19726926|NCT03047980|42171563|FG000|Overall Study|Adverse Event|1|||
19726927|NCT03631706|42171569|FG000|Overall Study|Randomized, not treated|1|||
19726928|NCT03631706|42171570|FG001|Overall Study|Randomized, not treated|0|||
19726929|NCT03631706|42171569|FG000|Overall Study|Treatment ongoing|26|||
19726930|NCT03631706|42171570|FG001|Overall Study|Treatment ongoing|57|||
19726931|NCT03631706|42171569|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
19726932|NCT03631706|42171570|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
19726933|NCT04048382|42171578|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
19726934|NCT04048382|42171579|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
19726935|NCT04048382|42171578|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
19726936|NCT04048382|42171579|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
19726937|NCT04048382|42171578|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
19726938|NCT04048382|42171579|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
19726939|NCT04047446|42171587|FG000|Overall Study|Physician Decision|1|||
19726940|NCT04047446|42171588|FG001|Overall Study|Physician Decision|0|||
19726941|NCT03655106|42171596|FG000|Overall Study|Withdrawal by Subject|3|||
19726942|NCT03655106|42171597|FG001|Overall Study|Withdrawal by Subject|2|||
19726943|NCT03655106|42171596|FG000|Overall Study|Lost to Follow-up|2|||
19726944|NCT03655106|42171597|FG001|Overall Study|Lost to Follow-up|1|||
19726945|NCT03655106|42171596|FG000|Overall Study|Duplicate Enrollment|1|||
19726946|NCT03655106|42171597|FG001|Overall Study|Duplicate Enrollment|1|||
19726947|NCT03655106|42171596|FG000|Overall Study|Protocol Violation|3|||
19726948|NCT03655106|42171597|FG001|Overall Study|Protocol Violation|0|||
19726949|NCT03630302|42171603|FG000|Surgery|hardware issue prevented LFP recordings|1|||
19726950|NCT03630302|42171603|FG000|3 Month Visit|Adverse Event|2|||
19726951|NCT03630302|42171603|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
19726952|NCT04041440|42171609|FG000|Overall Study|Withdrawal by Subject|0|||
19726953|NCT04041440|42171610|FG001|Overall Study|Withdrawal by Subject|1|||
19726954|NCT04041440|42171609|FG000|Overall Study|Lost to Follow-up|0|||
19726955|NCT04041440|42171610|FG001|Overall Study|Lost to Follow-up|1|||
19726956|NCT03654560|42171619|FG000|Overall Study|Death|3|||
19726957|NCT03654560|42171620|FG001|Overall Study|Death|1|||
19726958|NCT03654560|42171619|FG000|Overall Study|Lost to Follow-up|1|||
19726959|NCT03654560|42171620|FG001|Overall Study|Lost to Follow-up|0|||
19726960|NCT03629054|42171628|FG000|Period 2 (4 Days)|Not treated|0|||
19726961|NCT03629054|42171629|FG001|Period 2 (4 Days)|Not treated|1|||
19726962|NCT03628898|42171635|FG000|Overall Study|Device deficiency|1|||
19726963|NCT03628508|42171639|FG000|Overall Study|Lost to Follow-up|1|||
19726964|NCT03045328|42171643|FG000|Overall Study|Withdrawal by Subject|2|||
19726965|NCT02154490|42171649|FG000|Overall Study|No tissue submitted|23|||
19726966|NCT02154490|42171649|FG000|Overall Study|No biomarker results|167|||
19726967|NCT02154490|42171649|FG000|Overall Study|Not assigned to a sub-study|270|||
19726968|NCT02154490|42171649|FG000|Overall Study|Did not register to a sub-study|749|||
19726969|NCT01286272|42171655|FG000|Overall Study|Ineligible after beginning treatment|1|||
19726970|NCT01286272|42171656|FG001|Overall Study|Ineligible after beginning treatment|3|||
19726971|NCT03627494|42171674|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
19726972|NCT03627494|42171675|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726973|NCT03627494|42171676|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
19726974|NCT03627494|42171677|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726975|NCT03627494|42171678|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726976|NCT03627494|42171679|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726977|NCT03627494|42171680|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726978|NCT03627494|42171681|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726979|NCT03627494|42171682|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726980|NCT03627494|42171683|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726981|NCT03627494|42171684|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726982|NCT03627494|42171685|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
19726983|NCT03627494|42171674|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726984|NCT03627494|42171675|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726985|NCT03627494|42171676|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726986|NCT03627494|42171677|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726987|NCT03627494|42171678|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726988|NCT03627494|42171679|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726989|NCT03627494|42171680|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726990|NCT03627494|42171681|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726991|NCT03627494|42171682|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
19726992|NCT03627494|42171683|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726993|NCT03627494|42171684|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726994|NCT03627494|42171685|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
19726995|NCT03627494|42171674|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
19726996|NCT03627494|42171675|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
19726997|NCT03627494|42171676|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
19726998|NCT03627494|42171677|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
19726999|NCT03627494|42171678|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727000|NCT03627494|42171679|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727001|NCT03627494|42171680|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727002|NCT03627494|42171681|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727003|NCT03627494|42171682|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727004|NCT03627494|42171683|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
19727005|NCT03627494|42171684|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
19727006|NCT03627494|42171685|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
19727007|NCT03627416|42171726|FG000|Overall Study|Adverse Event|0|||
19727008|NCT03627416|42171727|FG001|Overall Study|Adverse Event|1|||
19727009|NCT00972478|42171735|FG000|Overall Study|Adverse Event|3|||
19727010|NCT00972478|42171736|FG001|Overall Study|Adverse Event|16|||
19727011|NCT00972478|42171735|FG000|Overall Study|Withdrawal by Subject|1|||
19727012|NCT00972478|42171736|FG001|Overall Study|Withdrawal by Subject|8|||
19727013|NCT00972478|42171735|FG000|Overall Study|Progression/Relapse|0|||
19727014|NCT00972478|42171736|FG001|Overall Study|Progression/Relapse|2|||
19727015|NCT00972478|42171735|FG000|Overall Study|Death|0|||
19727016|NCT00972478|42171736|FG001|Overall Study|Death|2|||
19727017|NCT00972478|42171735|FG000|Overall Study|Not protocol specified|1|||
19727018|NCT00972478|42171736|FG001|Overall Study|Not protocol specified|1|||
19727019|NCT00972478|42171735|FG000|Overall Study|Ineligible|1|||
19727020|NCT00972478|42171736|FG001|Overall Study|Ineligible|7|||
19727021|NCT00972478|42171735|FG000|Overall Study|Not start protocol treatment|1|||
19727022|NCT00972478|42171736|FG001|Overall Study|Not start protocol treatment|2|||
19727023|NCT00097539|42171750|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
19727024|NCT00097539|42171751|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
19727025|NCT00097539|42171752|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
19727026|NCT00097539|42171753|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
19727027|NCT00097539|42171754|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
19727028|NCT00097539|42171755|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
19727029|NCT00097539|42171756|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
19727030|NCT00097539|42171750|FG000|Overall Study|Withdrawal by Subject|925|||
19727031|NCT00097539|42171751|FG001|Overall Study|Withdrawal by Subject|323|||
19727032|NCT00097539|42171752|FG002|Overall Study|Withdrawal by Subject|346|||
19727033|NCT00097539|42171753|FG003|Overall Study|Withdrawal by Subject|217|||
19727034|NCT00097539|42171754|FG004|Overall Study|Withdrawal by Subject|68|||
19727035|NCT00097539|42171755|FG005|Overall Study|Withdrawal by Subject|229|||
19727036|NCT00097539|42171756|FG006|Overall Study|Withdrawal by Subject|3|||
19727037|NCT00097539|42171750|FG000|Overall Study|Participant Non-compliant|2140|||
19727038|NCT00097539|42171751|FG001|Overall Study|Participant Non-compliant|567|||
19727039|NCT00097539|42171752|FG002|Overall Study|Participant Non-compliant|1067|||
19727040|NCT00097539|42171753|FG003|Overall Study|Participant Non-compliant|353|||
19727041|NCT00097539|42171754|FG004|Overall Study|Participant Non-compliant|136|||
19727042|NCT00097539|42171755|FG005|Overall Study|Participant Non-compliant|543|||
19727043|NCT00097539|42171756|FG006|Overall Study|Participant Non-compliant|18|||
19727044|NCT00097539|42171750|FG000|Overall Study|Lack of Efficacy|249|||
19727045|NCT00097539|42171751|FG001|Overall Study|Lack of Efficacy|122|||
19727046|NCT00097539|42171752|FG002|Overall Study|Lack of Efficacy|202|||
19727047|NCT00097539|42171753|FG003|Overall Study|Lack of Efficacy|105|||
19727048|NCT00097539|42171754|FG004|Overall Study|Lack of Efficacy|45|||
19727049|NCT00097539|42171755|FG005|Overall Study|Lack of Efficacy|228|||
19727050|NCT00097539|42171756|FG006|Overall Study|Lack of Efficacy|5|||
19727051|NCT00097539|42171750|FG000|Overall Study|Adverse Event|78|||
19727052|NCT00097539|42171751|FG001|Overall Study|Adverse Event|133|||
19727053|NCT00097539|42171752|FG002|Overall Study|Adverse Event|37|||
19727054|NCT00097539|42171753|FG003|Overall Study|Adverse Event|27|||
19727055|NCT00097539|42171754|FG004|Overall Study|Adverse Event|30|||
19727056|NCT00097539|42171755|FG005|Overall Study|Adverse Event|59|||
19727057|NCT00097539|42171756|FG006|Overall Study|Adverse Event|1|||
19727058|NCT00097539|42171750|FG000|Overall Study|Death|2|||
19727059|NCT00097539|42171751|FG001|Overall Study|Death|7|||
19727060|NCT00097539|42171752|FG002|Overall Study|Death|0|||
19727061|NCT00097539|42171753|FG003|Overall Study|Death|0|||
19727062|NCT00097539|42171754|FG004|Overall Study|Death|1|||
19727063|NCT00097539|42171755|FG005|Overall Study|Death|3|||
19727064|NCT00097539|42171756|FG006|Overall Study|Death|0|||
19727065|NCT00097539|42171750|FG000|Overall Study|Reasons Other Than Above|3602|||
19727066|NCT00097539|42171751|FG001|Overall Study|Reasons Other Than Above|1382|||
19727067|NCT00097539|42171752|FG002|Overall Study|Reasons Other Than Above|1757|||
19727068|NCT00097539|42171753|FG003|Overall Study|Reasons Other Than Above|692|||
19727069|NCT00097539|42171754|FG004|Overall Study|Reasons Other Than Above|361|||
19727070|NCT00097539|42171755|FG005|Overall Study|Reasons Other Than Above|1244|||
19727071|NCT00097539|42171756|FG006|Overall Study|Reasons Other Than Above|34|||
19727072|NCT00097539|42171750|FG000|Overall Study|Reason not Specified|111|||
19727073|NCT00097539|42171751|FG001|Overall Study|Reason not Specified|49|||
19727074|NCT00097539|42171752|FG002|Overall Study|Reason not Specified|53|||
19727075|NCT00097539|42171753|FG003|Overall Study|Reason not Specified|21|||
19727076|NCT00097539|42171754|FG004|Overall Study|Reason not Specified|11|||
19727077|NCT00097539|42171755|FG005|Overall Study|Reason not Specified|40|||
19727078|NCT00097539|42171756|FG006|Overall Study|Reason not Specified|2|||
19727079|NCT03925324|42171774|FG000|Overall Study|Death|1|||
19727080|NCT03925324|42171775|FG001|Overall Study|Death|1|||
19727081|NCT03042910|42171781|FG000|Overall Study|Adverse Event|1|||
19464300|NCT01929707|41722444|FG007|Intervention Period 1|Lost to Follow-up|0|||
19727082|NCT03042910|42171781|FG000|Overall Study|Disease Progression|2|||
19727083|NCT03042910|42171781|FG000|Overall Study|Withdrawal by Subject|3|||
19727084|NCT03042910|42171781|FG000|Overall Study|Enrolled but not treated|1|||
19464301|NCT01929707|41722437|FG000|Intervention Period 1|Withdrawal by Subject|0|||
19727085|NCT03059446|42171785|FG000|Overall Study|Adverse Event|11|||
19727086|NCT03059446|42171785|FG000|Overall Study|Withdrawal of Consent|16|||
19727087|NCT03059446|42171785|FG000|Overall Study|Lost to Follow-up|3|||
19727088|NCT03059446|42171785|FG000|Overall Study|Protocol Violation|1|||
19727089|NCT03059446|42171785|FG000|Overall Study|Study Terminated by Sponsor|131|||
19727090|NCT03059446|42171785|FG000|Overall Study|Reason not Specified|5|||
19727091|NCT00090519|42171791|FG000|Overall Study|Adverse Event|5|||
19727092|NCT00090519|42171792|FG001|Overall Study|Adverse Event|4|||
19727093|NCT00090519|42171791|FG000|Overall Study|Death|9|||
19727094|NCT00090519|42171792|FG001|Overall Study|Death|9|||
19727095|NCT00090519|42171791|FG000|Overall Study|Lost to Follow-up|26|||
19727096|NCT00090519|42171792|FG001|Overall Study|Lost to Follow-up|29|||
19727097|NCT00090519|42171791|FG000|Overall Study|Withdrawal by Subject|28|||
19727098|NCT00090519|42171792|FG001|Overall Study|Withdrawal by Subject|29|||
19727099|NCT00090519|42171791|FG000|Overall Study|Physician Decision|2|||
19727100|NCT00090519|42171792|FG001|Overall Study|Physician Decision|3|||
19727101|NCT00090519|42171791|FG000|Overall Study|Sponsor Decision|3|||
19727102|NCT00090519|42171792|FG001|Overall Study|Sponsor Decision|1|||
19727103|NCT00096993|42171822|FG000|Overall Study|Death|1|||
19727104|NCT00096993|42171823|FG001|Overall Study|Death|0|||
19727105|NCT00096993|42171822|FG000|Overall Study|Disease progression|56|||
19727106|NCT00096993|42171823|FG001|Overall Study|Disease progression|53|||
19727107|NCT00096993|42171822|FG000|Overall Study|Adverse Event|2|||
19727108|NCT00096993|42171823|FG001|Overall Study|Adverse Event|8|||
19727109|NCT00096993|42171822|FG000|Overall Study|Subject's decision|3|||
19727110|NCT00096993|42171823|FG001|Overall Study|Subject's decision|1|||
19727111|NCT00096993|42171822|FG000|Overall Study|Physician Decision|2|||
19727112|NCT00096993|42171823|FG001|Overall Study|Physician Decision|1|||
19727113|NCT00096993|42171822|FG000|Overall Study|Non-compliance|0|||
19727114|NCT00096993|42171823|FG001|Overall Study|Non-compliance|1|||
19727115|NCT00096993|42171822|FG000|Overall Study|Other unspecified|1|||
19727116|NCT00096993|42171823|FG001|Overall Study|Other unspecified|1|||
19727117|NCT03040336|42171831|FG000|Overall Study|Death|1|||
19727118|NCT03040336|42171832|FG001|Overall Study|Death|0|||
19727119|NCT03040336|42171831|FG000|Overall Study|Withdrawal by Subject|2|||
19727120|NCT03040336|42171832|FG001|Overall Study|Withdrawal by Subject|3|||
19727121|NCT00072189|42171839|FG000|Overall Study|Withdrawal by Subject|1|||
19727122|NCT03040024|42171846|FG000|Overall Study|Adverse Event|0|||
19727123|NCT03040024|42171847|FG001|Overall Study|Adverse Event|1|||
19727124|NCT03040024|42171848|FG002|Overall Study|Adverse Event|0|||
19727125|NCT03040024|42171846|FG000|Overall Study|Death|0|||
19727126|NCT03040024|42171847|FG001|Overall Study|Death|1|||
19727127|NCT03040024|42171848|FG002|Overall Study|Death|0|||
19727128|NCT03040024|42171846|FG000|Overall Study|Physician Decision|0|||
19727129|NCT03040024|42171847|FG001|Overall Study|Physician Decision|0|||
19727130|NCT03040024|42171848|FG002|Overall Study|Physician Decision|1|||
19727131|NCT03039790|42171876|FG000|Overall Study|Lost to Follow-up|2|||
19727132|NCT03039790|42171877|FG001|Overall Study|Lost to Follow-up|0|||
19727133|NCT03039790|42171878|FG002|Overall Study|Lost to Follow-up|1|||
19727134|NCT03039790|42171879|FG003|Overall Study|Lost to Follow-up|1|||
19727135|NCT03039790|42171880|FG004|Overall Study|Lost to Follow-up|0|||
19727136|NCT03039790|42171881|FG005|Overall Study|Lost to Follow-up|1|||
19727137|NCT03039790|42171882|FG006|Overall Study|Lost to Follow-up|1|||
19727138|NCT03039790|42171883|FG007|Overall Study|Lost to Follow-up|1|||
19727139|NCT03039790|42171884|FG008|Overall Study|Lost to Follow-up|0|||
19727140|NCT03039790|42171885|FG009|Overall Study|Lost to Follow-up|1|||
19727141|NCT03039790|42171886|FG010|Overall Study|Lost to Follow-up|1|||
19727142|NCT03039790|42171887|FG011|Overall Study|Lost to Follow-up|0|||
19727143|NCT03039790|42171888|FG012|Overall Study|Lost to Follow-up|1|||
19727144|NCT03039790|42171889|FG013|Overall Study|Lost to Follow-up|0|||
19727145|NCT03039790|42171890|FG014|Overall Study|Lost to Follow-up|3|||
19727146|NCT03039790|42171891|FG015|Overall Study|Lost to Follow-up|1|||
19727147|NCT03039790|42171892|FG016|Overall Study|Lost to Follow-up|2|||
19727148|NCT03039790|42171893|FG017|Overall Study|Lost to Follow-up|2|||
19727149|NCT03039790|42171894|FG018|Overall Study|Lost to Follow-up|1|||
19727150|NCT03039790|42171895|FG019|Overall Study|Lost to Follow-up|3|||
19727151|NCT03039790|42171876|FG000|Overall Study|Withdrawal of Consent|1|||
19727152|NCT03039790|42171877|FG001|Overall Study|Withdrawal of Consent|0|||
19727153|NCT03039790|42171878|FG002|Overall Study|Withdrawal of Consent|0|||
19727154|NCT03039790|42171879|FG003|Overall Study|Withdrawal of Consent|1|||
19727155|NCT03039790|42171880|FG004|Overall Study|Withdrawal of Consent|0|||
19727156|NCT03039790|42171881|FG005|Overall Study|Withdrawal of Consent|0|||
19727157|NCT03039790|42171882|FG006|Overall Study|Withdrawal of Consent|0|||
19727158|NCT03039790|42171883|FG007|Overall Study|Withdrawal of Consent|0|||
19727159|NCT03039790|42171884|FG008|Overall Study|Withdrawal of Consent|0|||
19727160|NCT03039790|42171885|FG009|Overall Study|Withdrawal of Consent|1|||
19727161|NCT03039790|42171886|FG010|Overall Study|Withdrawal of Consent|0|||
19727162|NCT03039790|42171887|FG011|Overall Study|Withdrawal of Consent|0|||
19727163|NCT03039790|42171888|FG012|Overall Study|Withdrawal of Consent|2|||
19727164|NCT03039790|42171889|FG013|Overall Study|Withdrawal of Consent|0|||
19727165|NCT03039790|42171890|FG014|Overall Study|Withdrawal of Consent|1|||
19727166|NCT03039790|42171891|FG015|Overall Study|Withdrawal of Consent|5|||
19727167|NCT03039790|42171892|FG016|Overall Study|Withdrawal of Consent|3|||
19727168|NCT03039790|42171893|FG017|Overall Study|Withdrawal of Consent|0|||
19727169|NCT03039790|42171894|FG018|Overall Study|Withdrawal of Consent|2|||
19727170|NCT03039790|42171895|FG019|Overall Study|Withdrawal of Consent|5|||
19727171|NCT03039790|42171876|FG000|Overall Study|Death|0|||
19727172|NCT03039790|42171877|FG001|Overall Study|Death|0|||
19727173|NCT03039790|42171878|FG002|Overall Study|Death|0|||
19727174|NCT03039790|42171879|FG003|Overall Study|Death|0|||
19727175|NCT03039790|42171880|FG004|Overall Study|Death|0|||
19727176|NCT03039790|42171881|FG005|Overall Study|Death|0|||
19727177|NCT03039790|42171882|FG006|Overall Study|Death|0|||
19727178|NCT03039790|42171883|FG007|Overall Study|Death|0|||
19727179|NCT03039790|42171884|FG008|Overall Study|Death|0|||
19727180|NCT03039790|42171885|FG009|Overall Study|Death|0|||
19727181|NCT03039790|42171886|FG010|Overall Study|Death|0|||
19727182|NCT03039790|42171887|FG011|Overall Study|Death|0|||
19727183|NCT03039790|42171888|FG012|Overall Study|Death|0|||
19464302|NCT01929707|41722438|FG001|Intervention Period 1|Withdrawal by Subject|0|||
19464303|NCT01929707|41722439|FG002|Intervention Period 1|Withdrawal by Subject|0|||
19727184|NCT03039790|42171889|FG013|Overall Study|Death|0|||
19727185|NCT03039790|42171890|FG014|Overall Study|Death|0|||
19727186|NCT03039790|42171891|FG015|Overall Study|Death|1|||
19727187|NCT03039790|42171892|FG016|Overall Study|Death|3|||
19727188|NCT03039790|42171893|FG017|Overall Study|Death|0|||
19727189|NCT03039790|42171894|FG018|Overall Study|Death|2|||
19727190|NCT03039790|42171895|FG019|Overall Study|Death|0|||
19727191|NCT03039790|42171876|FG000|Overall Study|Reason, not Specified|1|||
19727192|NCT03039790|42171877|FG001|Overall Study|Reason, not Specified|0|||
19727193|NCT03039790|42171878|FG002|Overall Study|Reason, not Specified|0|||
19727194|NCT03039790|42171879|FG003|Overall Study|Reason, not Specified|0|||
19727195|NCT03039790|42171880|FG004|Overall Study|Reason, not Specified|0|||
19727196|NCT03039790|42171881|FG005|Overall Study|Reason, not Specified|0|||
19727197|NCT03039790|42171882|FG006|Overall Study|Reason, not Specified|0|||
19727198|NCT03039790|42171883|FG007|Overall Study|Reason, not Specified|0|||
19727199|NCT03039790|42171884|FG008|Overall Study|Reason, not Specified|0|||
19727200|NCT03039790|42171885|FG009|Overall Study|Reason, not Specified|0|||
19727201|NCT03039790|42171886|FG010|Overall Study|Reason, not Specified|0|||
19727202|NCT03039790|42171887|FG011|Overall Study|Reason, not Specified|0|||
19727203|NCT03039790|42171888|FG012|Overall Study|Reason, not Specified|0|||
19727204|NCT03039790|42171889|FG013|Overall Study|Reason, not Specified|0|||
19727205|NCT03039790|42171890|FG014|Overall Study|Reason, not Specified|0|||
19727206|NCT03039790|42171891|FG015|Overall Study|Reason, not Specified|0|||
19727207|NCT03039790|42171892|FG016|Overall Study|Reason, not Specified|2|||
19727208|NCT03039790|42171893|FG017|Overall Study|Reason, not Specified|0|||
19727209|NCT03039790|42171894|FG018|Overall Study|Reason, not Specified|1|||
19727210|NCT03039790|42171895|FG019|Overall Study|Reason, not Specified|0|||
19727211|NCT03038620|42171968|FG000|Overall Study|Lost to Follow-up|18|||
19727212|NCT03038620|42171969|FG001|Overall Study|Lost to Follow-up|23|||
19727213|NCT03038620|42171968|FG000|Overall Study|Withdrawal by Subject|0|||
19727214|NCT03038620|42171969|FG001|Overall Study|Withdrawal by Subject|15|||
19727215|NCT03038620|42171968|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
19727216|NCT03038620|42171969|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
19727217|NCT01350934|42171990|FG000|Base Study|Adverse Event|6|||
19727218|NCT01350934|42171991|FG001|Base Study|Adverse Event|0|||
19727219|NCT01350934|42171990|FG000|Base Study|Lost to Follow-up|1|||
19727220|NCT01350934|42171991|FG001|Base Study|Lost to Follow-up|0|||
19727221|NCT01350934|42171990|FG000|Base Study|Protocol Violation|1|||
19727222|NCT01350934|42171991|FG001|Base Study|Protocol Violation|1|||
19727223|NCT01350934|42171990|FG000|Base Study|Withdrawal by Subject|1|||
19727224|NCT01350934|42171991|FG001|Base Study|Withdrawal by Subject|2|||
19727225|NCT01350934|42171990|FG000|Base Study|Non-Compliance With Study Drug|2|||
19727226|NCT01350934|42171991|FG001|Base Study|Non-Compliance With Study Drug|0|||
19727227|NCT01350934|42171990|FG000|Extension Study|Adverse Event|2|||
19727228|NCT01350934|42171991|FG001|Extension Study|Adverse Event|1|||
19727229|NCT01350934|42171990|FG000|Extension Study|Lost to Follow-up|2|||
19727230|NCT01350934|42171991|FG001|Extension Study|Lost to Follow-up|0|||
19727231|NCT01350934|42171990|FG000|Extension Study|Protocol Violation|1|||
19727232|NCT01350934|42171991|FG001|Extension Study|Protocol Violation|1|||
19727233|NCT01350934|42171990|FG000|Extension Study|Lack of Efficacy|0|||
19727234|NCT01350934|42171991|FG001|Extension Study|Lack of Efficacy|1|||
19727235|NCT01350934|42171990|FG000|Extension Study|Withdrawal by Subject|0|||
19727236|NCT01350934|42171991|FG001|Extension Study|Withdrawal by Subject|1|||
19727237|NCT03622580|42172015|FG000|Overall Study|Death|16|||
19727238|NCT03622580|42172016|FG001|Overall Study|Death|21|||
19727239|NCT03622580|42172017|FG002|Overall Study|Death|13|||
19727240|NCT03622580|42172015|FG000|Overall Study|Adverse Event|6|||
19727241|NCT03622580|42172016|FG001|Overall Study|Adverse Event|6|||
19727242|NCT03622580|42172017|FG002|Overall Study|Adverse Event|5|||
19727243|NCT03622580|42172015|FG000|Overall Study|Withdrawal by Subject|12|||
19727244|NCT03622580|42172016|FG001|Overall Study|Withdrawal by Subject|7|||
19727245|NCT03622580|42172017|FG002|Overall Study|Withdrawal by Subject|19|||
19727246|NCT03622580|42172015|FG000|Overall Study|Lost to Follow-up|12|||
19727247|NCT03622580|42172016|FG001|Overall Study|Lost to Follow-up|9|||
19727248|NCT03622580|42172017|FG002|Overall Study|Lost to Follow-up|9|||
19727249|NCT03622580|42172015|FG000|Overall Study|Protocol Violation|1|||
19727250|NCT03622580|42172016|FG001|Overall Study|Protocol Violation|0|||
19727251|NCT03622580|42172017|FG002|Overall Study|Protocol Violation|1|||
19727252|NCT03622580|42172015|FG000|Overall Study|Physician Decision|3|||
19727253|NCT03622580|42172016|FG001|Overall Study|Physician Decision|0|||
19727254|NCT03622580|42172017|FG002|Overall Study|Physician Decision|1|||
19727255|NCT03622580|42172015|FG000|Overall Study|Pregnancy|0|||
19727256|NCT03622580|42172016|FG001|Overall Study|Pregnancy|1|||
19727257|NCT03622580|42172017|FG002|Overall Study|Pregnancy|0|||
19727258|NCT03622580|42172015|FG000|Overall Study|Lack of Efficacy|0|||
19727259|NCT03622580|42172016|FG001|Overall Study|Lack of Efficacy|0|||
19727260|NCT03622580|42172017|FG002|Overall Study|Lack of Efficacy|1|||
19727261|NCT03622580|42172015|FG000|Overall Study|Other|2|||
19727262|NCT03622580|42172016|FG001|Overall Study|Other|0|||
19727263|NCT03622580|42172017|FG002|Overall Study|Other|3|||
19727264|NCT00461032|42172028|FG000|Overall Study|Adverse Event|5|||
19727265|NCT00461032|42172029|FG001|Overall Study|Adverse Event|6|||
19727266|NCT00461032|42172028|FG000|Overall Study|Lack of Efficacy|5|||
19727267|NCT00461032|42172029|FG001|Overall Study|Lack of Efficacy|1|||
19727268|NCT00461032|42172028|FG000|Overall Study|Lost to Follow-up|7|||
19727269|NCT00461032|42172029|FG001|Overall Study|Lost to Follow-up|12|||
19727270|NCT00461032|42172028|FG000|Overall Study|Protocol Violation|4|||
19727271|NCT00461032|42172029|FG001|Overall Study|Protocol Violation|4|||
19727272|NCT00461032|42172028|FG000|Overall Study|Withdrawal by Subject|7|||
19727273|NCT00461032|42172029|FG001|Overall Study|Withdrawal by Subject|15|||
19727274|NCT00461032|42172028|FG000|Overall Study|Patient Moved or Relocated|2|||
19727275|NCT00461032|42172029|FG001|Overall Study|Patient Moved or Relocated|1|||
19373231|NCT02537522|41614217|FG003|Phase I - Contralateral|incorrect randomization|0|||
19727276|NCT00461032|42172028|FG000|Overall Study|Other|7|||
19727277|NCT00461032|42172029|FG001|Overall Study|Other|5|||
19727278|NCT00090142|42172035|FG000|Treatment Period I|Lost to Follow-up|1|||
19727279|NCT00090142|42172036|FG001|Treatment Period I|Lost to Follow-up|2|||
19727280|NCT00090142|42172035|FG000|Treatment Period I|Protocol Violation|2|||
19727281|NCT00090142|42172036|FG001|Treatment Period I|Protocol Violation|0|||
19727282|NCT00090142|42172035|FG000|Treatment Period I|Withdrawal by Subject|2|||
19727283|NCT00090142|42172036|FG001|Treatment Period I|Withdrawal by Subject|0|||
19727284|NCT00090142|42172035|FG000|Treatment Period I|Other|0|||
19727285|NCT00090142|42172036|FG001|Treatment Period I|Other|1|||
19727286|NCT00090142|42172035|FG000|Treatment Period II|Other|1|||
19727287|NCT00090142|42172036|FG001|Treatment Period II|Other|0|||
19727288|NCT03622112|42172053|FG000|Overall Study|Withdrawal by Subject|6|||
19727289|NCT03622112|42172054|FG001|Overall Study|Withdrawal by Subject|2|||
19727290|NCT03622112|42172055|FG002|Overall Study|Withdrawal by Subject|4|||
19727291|NCT03622112|42172056|FG003|Overall Study|Withdrawal by Subject|2|||
19727292|NCT03622112|42172057|FG004|Overall Study|Withdrawal by Subject|1|||
19727293|NCT03622112|42172058|FG005|Overall Study|Withdrawal by Subject|2|||
19727294|NCT03622112|42172059|FG006|Overall Study|Withdrawal by Subject|2|||
19727295|NCT03622112|42172053|FG000|Overall Study|Death|0|||
19727296|NCT03622112|42172054|FG001|Overall Study|Death|0|||
19727297|NCT03622112|42172055|FG002|Overall Study|Death|0|||
19727298|NCT03622112|42172056|FG003|Overall Study|Death|1|||
19727299|NCT03622112|42172057|FG004|Overall Study|Death|0|||
19727300|NCT03622112|42172058|FG005|Overall Study|Death|0|||
19727301|NCT03622112|42172059|FG006|Overall Study|Death|0|||
19727302|NCT03622112|42172053|FG000|Overall Study|Lost to Follow-up|1|||
19727303|NCT03622112|42172054|FG001|Overall Study|Lost to Follow-up|1|||
19727304|NCT03622112|42172055|FG002|Overall Study|Lost to Follow-up|0|||
19727305|NCT03622112|42172056|FG003|Overall Study|Lost to Follow-up|0|||
19727306|NCT03622112|42172057|FG004|Overall Study|Lost to Follow-up|0|||
19727307|NCT03622112|42172058|FG005|Overall Study|Lost to Follow-up|0|||
19727308|NCT03622112|42172059|FG006|Overall Study|Lost to Follow-up|0|||
19727309|NCT03622112|42172053|FG000|Overall Study|Study-specific withdrawal criteria|10|||
19727310|NCT03622112|42172054|FG001|Overall Study|Study-specific withdrawal criteria|8|||
19727311|NCT03622112|42172055|FG002|Overall Study|Study-specific withdrawal criteria|7|||
19727312|NCT03622112|42172056|FG003|Overall Study|Study-specific withdrawal criteria|6|||
19727313|NCT03622112|42172057|FG004|Overall Study|Study-specific withdrawal criteria|4|||
19727314|NCT03622112|42172058|FG005|Overall Study|Study-specific withdrawal criteria|18|||
19727315|NCT03622112|42172059|FG006|Overall Study|Study-specific withdrawal criteria|4|||
19727316|NCT03622112|42172053|FG000|Overall Study|Protocol Violation|2|||
19727317|NCT03622112|42172054|FG001|Overall Study|Protocol Violation|0|||
19727318|NCT03622112|42172055|FG002|Overall Study|Protocol Violation|1|||
19727319|NCT03622112|42172056|FG003|Overall Study|Protocol Violation|1|||
19727320|NCT03622112|42172057|FG004|Overall Study|Protocol Violation|0|||
19727321|NCT03622112|42172058|FG005|Overall Study|Protocol Violation|0|||
19727322|NCT03622112|42172059|FG006|Overall Study|Protocol Violation|0|||
19727323|NCT03622112|42172053|FG000|Overall Study|Adverse Event|6|||
19727324|NCT03622112|42172054|FG001|Overall Study|Adverse Event|8|||
19727325|NCT03622112|42172055|FG002|Overall Study|Adverse Event|4|||
19727326|NCT03622112|42172056|FG003|Overall Study|Adverse Event|11|||
19727327|NCT03622112|42172057|FG004|Overall Study|Adverse Event|4|||
19727328|NCT03622112|42172058|FG005|Overall Study|Adverse Event|20|||
19727329|NCT03622112|42172059|FG006|Overall Study|Adverse Event|2|||
19727330|NCT03622112|42172053|FG000|Overall Study|Reason not specified|0|||
19727331|NCT03622112|42172054|FG001|Overall Study|Reason not specified|1|||
19727332|NCT03622112|42172055|FG002|Overall Study|Reason not specified|0|||
19727333|NCT03622112|42172056|FG003|Overall Study|Reason not specified|1|||
19727334|NCT03622112|42172057|FG004|Overall Study|Reason not specified|1|||
19727335|NCT03622112|42172058|FG005|Overall Study|Reason not specified|2|||
19727336|NCT03622112|42172059|FG006|Overall Study|Reason not specified|1|||
19727337|NCT04032158|42172077|FG000|Overall Study|Study Termination|2|||
19727338|NCT04032158|42172078|FG001|Overall Study|Study Termination|1|||
19727339|NCT03654404|42172084|FG000|Overall Study|Death|1|||
19727340|NCT03654404|42172084|FG000|Overall Study|Lost to Follow-up|2|||
19727341|NCT03654404|42172084|FG000|Overall Study|Withdrawal by Subject|5|||
19727342|NCT03620708|42172091|FG000|Overall Study|Lost to Follow-up|1|||
19727343|NCT03620708|42172092|FG001|Overall Study|Lost to Follow-up|1|||
19727344|NCT03620708|42172093|FG002|Overall Study|Lost to Follow-up|2|||
19727345|NCT03620708|42172091|FG000|Overall Study|Withdrawal by Subject|0|||
19727346|NCT03620708|42172092|FG001|Overall Study|Withdrawal by Subject|0|||
19727347|NCT03620708|42172093|FG002|Overall Study|Withdrawal by Subject|1|||
19727348|NCT03654326|42172103|FG000|Overall Study|Withdrawal by Subject|5|||
19727349|NCT03654326|42172104|FG001|Overall Study|Withdrawal by Subject|3|||
19727350|NCT03654326|42172103|FG000|Overall Study|Physician Decision|0|||
19727351|NCT03654326|42172104|FG001|Overall Study|Physician Decision|1|||
19727352|NCT03654326|42172103|FG000|Overall Study|Unable to adhere to study schedule|0|||
19727353|NCT03654326|42172104|FG001|Overall Study|Unable to adhere to study schedule|1|||
19727354|NCT03654326|42172103|FG000|Overall Study|Lost to Follow-up|1|||
19727355|NCT03654326|42172104|FG001|Overall Study|Lost to Follow-up|1|||
19727356|NCT04025684|42172114|FG000|Overall Study|Withdrawal by Subject|1|||
19727357|NCT04025684|42172115|FG001|Overall Study|Withdrawal by Subject|1|||
19727358|NCT04025684|42172116|FG002|Overall Study|Withdrawal by Subject|0|||
19727359|NCT04025684|42172117|FG003|Overall Study|Withdrawal by Subject|0|||
19727360|NCT04025684|42172114|FG000|Overall Study|Multiple reasons|1|||
19727361|NCT04025684|42172115|FG001|Overall Study|Multiple reasons|3|||
19727362|NCT04025684|42172116|FG002|Overall Study|Multiple reasons|0|||
19727363|NCT04025684|42172117|FG003|Overall Study|Multiple reasons|1|||
19727364|NCT03617588|42172129|FG000|Overall Study|Withdrawal by Subject|1|||
19727365|NCT03617588|42172130|FG001|Overall Study|Withdrawal by Subject|0|||
19727366|NCT03616106|42172142|FG000|Overall Study|Removed by PI|6|||
19727367|NCT03616106|42172143|FG001|Overall Study|Removed by PI|0|||
19727368|NCT03616106|42172142|FG000|Overall Study|Withdrawal by Subject|1|||
19727369|NCT03616106|42172143|FG001|Overall Study|Withdrawal by Subject|1|||
19727370|NCT03616106|42172142|FG000|Overall Study|Lost to Follow-up|7|||
19727371|NCT03616106|42172143|FG001|Overall Study|Lost to Follow-up|0|||
19727372|NCT04019054|42172150|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
19727373|NCT04019054|42172151|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
19727374|NCT04019054|42172150|FG000|Overall Study|Withdrawal by Subject|3|||
19727375|NCT04019054|42172151|FG001|Overall Study|Withdrawal by Subject|1|||
19727376|NCT00071799|42172159|FG000|Overall Study|Adverse Event|19|||
19727377|NCT00071799|42172160|FG001|Overall Study|Adverse Event|10|||
19727378|NCT00071799|42172159|FG000|Overall Study|Protocol Violation|1|||
19727379|NCT00071799|42172160|FG001|Overall Study|Protocol Violation|7|||
19727380|NCT00071799|42172159|FG000|Overall Study|Lost to Follow-up|1|||
19727381|NCT00071799|42172160|FG001|Overall Study|Lost to Follow-up|1|||
19727382|NCT00071799|42172159|FG000|Overall Study|Withdrawal by Subject|15|||
19727383|NCT00071799|42172160|FG001|Overall Study|Withdrawal by Subject|37|||
19727384|NCT00071799|42172159|FG000|Overall Study|Physician Decision|0|||
19727385|NCT00071799|42172160|FG001|Overall Study|Physician Decision|2|||
19727386|NCT00071799|42172159|FG000|Overall Study|Lack of Efficacy|11|||
19727387|NCT00071799|42172160|FG001|Overall Study|Lack of Efficacy|18|||
19727388|NCT00071799|42172159|FG000|Overall Study|Disease Progression|23|||
19727389|NCT00071799|42172160|FG001|Overall Study|Disease Progression|20|||
19727390|NCT00071799|42172159|FG000|Overall Study|Different Central+Local Pathology Review|0|||
19727391|NCT00071799|42172160|FG001|Overall Study|Different Central+Local Pathology Review|1|||
19727392|NCT00071799|42172159|FG000|Overall Study|Not Documented|0|||
19727393|NCT00071799|42172160|FG001|Overall Study|Not Documented|2|||
19727394|NCT03615482|42172174|FG000|Overall Study|Death|1|||
19727395|NCT03615482|42172175|FG001|Overall Study|Death|0|||
19727396|NCT03615482|42172174|FG000|Overall Study|Lost to Follow-up|7|||
19727397|NCT03615482|42172175|FG001|Overall Study|Lost to Follow-up|7|||
19727398|NCT03615482|42172174|FG000|Overall Study|Physician Decision|2|||
19727399|NCT03615482|42172175|FG001|Overall Study|Physician Decision|3|||
19727400|NCT03615482|42172174|FG000|Overall Study|Withdrawal by Subject|7|||
19727401|NCT03615482|42172175|FG001|Overall Study|Withdrawal by Subject|7|||
19727402|NCT03688620|42172184|FG000|Overall Study|Other|0|||
19727403|NCT03688620|42172185|FG001|Overall Study|Other|0|||
19727404|NCT03688620|42172186|FG002|Overall Study|Other|1|||
19727405|NCT03688620|42172184|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
19727406|NCT03688620|42172185|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
19727407|NCT03688620|42172186|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
19727408|NCT03688620|42172184|FG000|Overall Study|Lost to Follow-up|16|||
19727409|NCT03688620|42172185|FG001|Overall Study|Lost to Follow-up|0|||
19727410|NCT03688620|42172186|FG002|Overall Study|Lost to Follow-up|1|||
19727411|NCT03688620|42172184|FG000|Overall Study|Withdrawal by Subject|0|||
19727412|NCT03688620|42172185|FG001|Overall Study|Withdrawal by Subject|0|||
19727413|NCT03688620|42172186|FG002|Overall Study|Withdrawal by Subject|6|||
19727414|NCT00090363|42172199|FG000|Overall Study|Lost to Follow-up|1|||
19727415|NCT00090363|42172200|FG001|Overall Study|Lost to Follow-up|2|||
19727416|NCT00090363|42172201|FG002|Overall Study|Lost to Follow-up|1|||
19727417|NCT00090363|42172199|FG000|Overall Study|Withdrawal by Subject|7|||
19727418|NCT00090363|42172200|FG001|Overall Study|Withdrawal by Subject|7|||
19727419|NCT00090363|42172201|FG002|Overall Study|Withdrawal by Subject|6|||
19727420|NCT00090363|42172199|FG000|Overall Study|Study-specific discontinuation criteria|75|||
19727421|NCT00090363|42172200|FG001|Overall Study|Study-specific discontinuation criteria|74|||
19727422|NCT00090363|42172201|FG002|Overall Study|Study-specific discontinuation criteria|62|||
19727423|NCT00090363|42172199|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19727424|NCT00090363|42172200|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19727425|NCT00090363|42172201|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
19727426|NCT00090363|42172199|FG000|Overall Study|Consent expired|7|||
19727427|NCT00090363|42172200|FG001|Overall Study|Consent expired|10|||
19727428|NCT00090363|42172201|FG002|Overall Study|Consent expired|9|||
19727429|NCT00090363|42172199|FG000|Overall Study|Reasons not specified|2|||
19727430|NCT00090363|42172200|FG001|Overall Study|Reasons not specified|1|||
19727431|NCT00090363|42172201|FG002|Overall Study|Reasons not specified|1|||
19727432|NCT00090363|42172199|FG000|Overall Study|Continuing on study off treatment|14|||
19727433|NCT00090363|42172200|FG001|Overall Study|Continuing on study off treatment|13|||
19727434|NCT00090363|42172201|FG002|Overall Study|Continuing on study off treatment|16|||
19727435|NCT03652610|42172211|FG000|Overall Study|Lost to Follow-up|1|||
19727436|NCT03652610|42172212|FG001|Overall Study|Lost to Follow-up|0|||
19727437|NCT03652610|42172211|FG000|Overall Study|Withdrawal by Subject|3|||
19727438|NCT03652610|42172212|FG001|Overall Study|Withdrawal by Subject|5|||
19727439|NCT03615404|42172218|FG000|Overall Study|Death|1|||
19727440|NCT03615404|42172218|FG000|Overall Study|vaccine did not pass quality assurance|1|||
19727441|NCT03614156|42172225|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
19727442|NCT03614156|42172226|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
19727443|NCT03614156|42172227|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
19464304|NCT01929707|41722440|FG003|Intervention Period 1|Withdrawal by Subject|2|||
19464305|NCT01929707|41722441|FG004|Intervention Period 1|Withdrawal by Subject|0|||
19464306|NCT01929707|41722442|FG005|Intervention Period 1|Withdrawal by Subject|0|||
19464307|NCT01929707|41722443|FG006|Intervention Period 1|Withdrawal by Subject|0|||
19464308|NCT01929707|41722444|FG007|Intervention Period 1|Withdrawal by Subject|0|||
19464309|NCT01929707|41722437|FG000|Intervention Period 2|Withdrawal by Subject|0|||
19464310|NCT01929707|41722438|FG001|Intervention Period 2|Withdrawal by Subject|0|||
19464311|NCT01929707|41722439|FG002|Intervention Period 2|Withdrawal by Subject|0|||
19464312|NCT01929707|41722440|FG003|Intervention Period 2|Withdrawal by Subject|0|||
19464313|NCT01929707|41722441|FG004|Intervention Period 2|Withdrawal by Subject|0|||
19464314|NCT01929707|41722442|FG005|Intervention Period 2|Withdrawal by Subject|2|||
19464315|NCT01929707|41722443|FG006|Intervention Period 2|Withdrawal by Subject|0|||
19464316|NCT01929707|41722444|FG007|Intervention Period 2|Withdrawal by Subject|0|||
19464317|NCT01714063|41722465|FG000|Overall Study|Equipment malfunction|2|||
19464318|NCT01929395|41722476|FG000|Overall Study|Did not complete - non-related toxicity|1|||
19464319|NCT01929395|41722477|FG001|Overall Study|Did not complete - non-related toxicity|0|||
19464320|NCT01929395|41722478|FG002|Overall Study|Did not complete - non-related toxicity|0|||
19464321|NCT01929395|41722476|FG000|Overall Study|Withdrawal by Subject|0|||
19464322|NCT01929395|41722477|FG001|Overall Study|Withdrawal by Subject|1|||
19464323|NCT01929395|41722478|FG002|Overall Study|Withdrawal by Subject|0|||
19464324|NCT01929395|41722476|FG000|Overall Study|Screen Fail|0|||
19727444|NCT03614156|42172228|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
19464325|NCT01929395|41722477|FG001|Overall Study|Screen Fail|0|||
19464326|NCT01929395|41722478|FG002|Overall Study|Screen Fail|1|||
19464327|NCT01713283|41722490|FG000|Overall Study|Lack of Efficacy|10|||
19464328|NCT01713283|41722491|FG001|Overall Study|Lack of Efficacy|2|||
19464329|NCT01713283|41722490|FG000|Overall Study|Lost to Follow-up|1|||
19464330|NCT01713283|41722491|FG001|Overall Study|Lost to Follow-up|1|||
19464331|NCT01592383|41722501|FG000|Overall Study|Adverse Event|1|||
19464332|NCT01691521|41722509|FG000|Overall Study|Adverse Event|4|||
19464333|NCT01691521|41722510|FG001|Overall Study|Adverse Event|0|||
19464334|NCT01691521|41722511|FG002|Overall Study|Adverse Event|1|||
19464335|NCT01691521|41722509|FG000|Overall Study|Lack of Efficacy|1|||
19464336|NCT01691521|41722510|FG001|Overall Study|Lack of Efficacy|1|||
19464337|NCT01691521|41722511|FG002|Overall Study|Lack of Efficacy|2|||
19464338|NCT01691521|41722509|FG000|Overall Study|Protocol Violation|0|||
19464339|NCT01691521|41722510|FG001|Overall Study|Protocol Violation|3|||
19464340|NCT01691521|41722511|FG002|Overall Study|Protocol Violation|0|||
19464341|NCT01691521|41722509|FG000|Overall Study|Lost to Follow-up|0|||
19464342|NCT01691521|41722510|FG001|Overall Study|Lost to Follow-up|2|||
19464343|NCT01691521|41722511|FG002|Overall Study|Lost to Follow-up|2|||
19464344|NCT01691521|41722509|FG000|Overall Study|Physician Decision|2|||
19464345|NCT01691521|41722510|FG001|Overall Study|Physician Decision|1|||
19464346|NCT01691521|41722511|FG002|Overall Study|Physician Decision|0|||
19464347|NCT01691521|41722509|FG000|Overall Study|Withdrawal by Subject|5|||
19464348|NCT01691521|41722510|FG001|Overall Study|Withdrawal by Subject|9|||
19464349|NCT01691521|41722511|FG002|Overall Study|Withdrawal by Subject|4|||
19464350|NCT01929317|41722522|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
19464351|NCT01929317|41722523|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
19464352|NCT01929317|41722522|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
19464353|NCT01929317|41722523|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
19464354|NCT01929317|41722522|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
19464355|NCT01929317|41722523|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
19464356|NCT01929317|41722522|FG000|Long-term Phase|Adverse Event|5|||
19464357|NCT01929317|41722523|FG001|Long-term Phase|Adverse Event|1|||
19464358|NCT01929317|41722522|FG000|Long-term Phase|Physician Decision|3|||
19464359|NCT01929317|41722523|FG001|Long-term Phase|Physician Decision|0|||
19464360|NCT01929317|41722522|FG000|Long-term Phase|Withdrawal by Subject|4|||
19464361|NCT01929317|41722523|FG001|Long-term Phase|Withdrawal by Subject|0|||
19464362|NCT01929317|41722522|FG000|Long-term Phase|Protocol Violation|1|||
19464363|NCT01929317|41722523|FG001|Long-term Phase|Protocol Violation|0|||
19464364|NCT01929317|41722522|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
19464365|NCT01929317|41722523|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
19464366|NCT01929317|41722522|FG000|Long-term Phase|Study Closed/Terminated|5|||
19464367|NCT01929317|41722523|FG001|Long-term Phase|Study Closed/Terminated|3|||
19464368|NCT01711879|41722537|FG000|Overall Study|Death|1|||
19464369|NCT01711879|41722538|FG001|Overall Study|Death|0|||
19464370|NCT01689649|41722561|FG000|Overall Study|Lack of Efficacy|3|||
19464371|NCT01689649|41722561|FG000|Overall Study|Non-compliance|11|||
19464372|NCT01689649|41722561|FG000|Overall Study|Protocol Violation|3|||
19464373|NCT01689649|41722561|FG000|Overall Study|Lost to Follow-up|5|||
19464374|NCT01929083|41722565|FG000|Intervention 1|Lost to Follow-up|2|||
19464375|NCT01929083|41722566|FG001|Intervention 1|Lost to Follow-up|0|||
19464376|NCT01929083|41722565|FG000|Intervention 1|Nonadherent to study medications|1|||
19464377|NCT01929083|41722566|FG001|Intervention 1|Nonadherent to study medications|0|||
19464378|NCT01929083|41722565|FG000|Intervention 2|Adverse Event|0|||
19464379|NCT01929083|41722566|FG001|Intervention 2|Adverse Event|1|||
19464380|NCT01689337|41722572|FG000|Overall Study|Study Discontinuation|1|||
19464381|NCT01688635|41722578|FG000|Washout 1|Withdrawal by Subject|1|||
19464382|NCT01688635|41722579|FG001|Washout 1|Withdrawal by Subject|0|||
19464383|NCT01688635|41722578|FG000|Washout 1|Adverse Event|0|||
19464384|NCT01688635|41722579|FG001|Washout 1|Adverse Event|1|||
19464385|NCT01688635|41722578|FG000|Washout 1|Physician Decision|0|||
19464386|NCT01688635|41722579|FG001|Washout 1|Physician Decision|1|||
19464387|NCT01688635|41722578|FG000|Washout 2|Physician Decision|1|||
19464388|NCT01688635|41722579|FG001|Washout 2|Physician Decision|0|||
19464389|NCT01688635|41722578|FG000|Washout 2|Withdrawal by Subject|1|||
19464390|NCT01688635|41722579|FG001|Washout 2|Withdrawal by Subject|0|||
19464391|NCT01688635|41722578|FG000|Washout 2|Sponsor Decision|1|||
19464392|NCT01688635|41722579|FG001|Washout 2|Sponsor Decision|2|||
19464393|NCT01688635|41722578|FG000|Washout 3|Withdrawal by Subject|1|||
19464394|NCT01688635|41722579|FG001|Washout 3|Withdrawal by Subject|0|||
19464395|NCT01591681|41722586|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
19464396|NCT01591681|41722586|FG000|Overall Study|Failed to use system during run-in|1|||
19464397|NCT01711645|41722601|FG000|Overall Study|Withdrawal by Subject|8|||
19464398|NCT01711645|41722601|FG000|Overall Study|Lost to Follow-up|6|||
19464399|NCT01711645|41722601|FG000|Overall Study|Physician Decision|5|||
19464400|NCT01590433|41722616|FG000|Overall Study|Lost to Follow-up|20|||
19464401|NCT01590433|41722617|FG001|Overall Study|Lost to Follow-up|8|||
19464402|NCT01590433|41722616|FG000|Overall Study|Withdrawal by Subject|21|||
19464403|NCT01590433|41722617|FG001|Overall Study|Withdrawal by Subject|11|||
19464404|NCT01590433|41722616|FG000|Overall Study|Adverse Event|11|||
19464405|NCT01590433|41722617|FG001|Overall Study|Adverse Event|3|||
19377634|NCT03386721|41620035|FG008|Overall Study|Site Terminated by Sponsor|4|||
19464406|NCT01928927|41722634|FG000|Overall Study|Lost to Follow-up|1|||
19464407|NCT01928927|41722635|FG001|Overall Study|Lost to Follow-up|0|||
19464408|NCT01928927|41722634|FG000|Overall Study|Withdrawal by Subject|1|||
19464409|NCT01928927|41722635|FG001|Overall Study|Withdrawal by Subject|1|||
19464410|NCT01710709|41722656|FG000|Overall Study|Lost to Follow-up|29|||
19551261|NCT01351025|42000079|FG001|Week 0 - 20|Lost to Follow-up|1|||
19551262|NCT01351025|42000078|FG000|Week 0 - 20|Withdrawal by Subject|1|||
19551263|NCT01351025|42000079|FG001|Week 0 - 20|Withdrawal by Subject|0|||
19551264|NCT01351025|42000078|FG000|Week 24 - 44|Lost to Follow-up|0|||
19551265|NCT01351025|42000079|FG001|Week 24 - 44|Lost to Follow-up|2|||
19551266|NCT01351025|42000078|FG000|Week 24 - 44|Site closed|0|||
19551267|NCT01351025|42000079|FG001|Week 24 - 44|Site closed|1|||
19551268|NCT01351025|42000078|FG000|Week 24 - 44|unable to get to clinic|1|||
19551269|NCT01351025|42000079|FG001|Week 24 - 44|unable to get to clinic|1|||
19551270|NCT01349036|42000093|FG000|Overall Study|Disease progression|13|||
19551271|NCT01349036|42000094|FG001|Overall Study|Disease progression|22|||
19551272|NCT01349036|42000093|FG000|Overall Study|Other|1|||
19551273|NCT01349036|42000094|FG001|Overall Study|Other|0|||
19551274|NCT01349036|42000093|FG000|Overall Study|Withdrawal by Subject|0|||
19551275|NCT01349036|42000094|FG001|Overall Study|Withdrawal by Subject|2|||
19551276|NCT01348763|42000104|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
19551277|NCT01348763|42000104|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
19551278|NCT01346969|42000112|FG000|Overall Study|Withdrawal by Subject|0|||
19551279|NCT01346969|42000113|FG001|Overall Study|Withdrawal by Subject|0|||
19551280|NCT01346969|42000114|FG002|Overall Study|Withdrawal by Subject|1|||
19551281|NCT01346969|42000115|FG003|Overall Study|Withdrawal by Subject|0|||
19551282|NCT01346969|42000112|FG000|Overall Study|Lost to Follow-up|1|||
19551283|NCT01346969|42000113|FG001|Overall Study|Lost to Follow-up|0|||
19551284|NCT01346969|42000114|FG002|Overall Study|Lost to Follow-up|2|||
19551285|NCT01346969|42000115|FG003|Overall Study|Lost to Follow-up|0|||
19551286|NCT01346969|42000112|FG000|Overall Study|Physician Decision|0|||
19464411|NCT01710709|41722656|FG000|Overall Study|Adverse Event|48|||
19464412|NCT01710709|41722656|FG000|Overall Study|Participant met withdrawal criteria|33|||
19464413|NCT01710709|41722656|FG000|Overall Study|Participant withdrawn by investigator|2|||
19464414|NCT01710709|41722656|FG000|Overall Study|Withdrawal by Subject|53|||
19464415|NCT01710709|41722656|FG000|Overall Study|Protocol Violation|5|||
19464416|NCT01710709|41722656|FG000|Overall Study|Lack of Efficacy|3|||
19464417|NCT01617629|41722661|FG000|Overall Study|Death|2|||
19478077|NCT01693562|41757323|FG009|Exploration Phase|Other|0|||
19478078|NCT01693562|41757324|FG010|Exploration Phase|Other|0|||
19377635|NCT03386721|41620036|FG009|Overall Study|Site Terminated by Sponsor|5|||
19377636|NCT03386721|41620037|FG010|Overall Study|Site Terminated by Sponsor|3|||
19377637|NCT03386721|41620038|FG011|Overall Study|Site Terminated by Sponsor|11|||
19377638|NCT03386721|41620039|FG012|Overall Study|Site Terminated by Sponsor|6|||
19377639|NCT03386721|41620040|FG013|Overall Study|Site Terminated by Sponsor|0|||
19377640|NCT03386721|41620041|FG014|Overall Study|Site Terminated by Sponsor|0|||
19377641|NCT03386721|41620027|FG000|Overall Study|Symptomatic Deterioration|0|||
19377642|NCT03386721|41620028|FG001|Overall Study|Symptomatic Deterioration|0|||
19377643|NCT03386721|41620029|FG002|Overall Study|Symptomatic Deterioration|0|||
19377644|NCT03386721|41620030|FG003|Overall Study|Symptomatic Deterioration|0|||
19377645|NCT03386721|41620031|FG004|Overall Study|Symptomatic Deterioration|0|||
19377646|NCT03386721|41620032|FG005|Overall Study|Symptomatic Deterioration|0|||
19377647|NCT03386721|41620033|FG006|Overall Study|Symptomatic Deterioration|0|||
19377648|NCT03386721|41620034|FG007|Overall Study|Symptomatic Deterioration|0|||
19377649|NCT03386721|41620035|FG008|Overall Study|Symptomatic Deterioration|1|||
19377650|NCT03386721|41620036|FG009|Overall Study|Symptomatic Deterioration|0|||
19377651|NCT03386721|41620037|FG010|Overall Study|Symptomatic Deterioration|0|||
19377652|NCT03386721|41620038|FG011|Overall Study|Symptomatic Deterioration|1|||
19377653|NCT03386721|41620039|FG012|Overall Study|Symptomatic Deterioration|0|||
19377654|NCT03386721|41620040|FG013|Overall Study|Symptomatic Deterioration|0|||
19377655|NCT03386721|41620041|FG014|Overall Study|Symptomatic Deterioration|0|||
19377656|NCT03386721|41620027|FG000|Overall Study|Withdrawal by Subject|1|||
19377657|NCT03386721|41620028|FG001|Overall Study|Withdrawal by Subject|2|||
19377658|NCT03386721|41620029|FG002|Overall Study|Withdrawal by Subject|0|||
19377659|NCT03386721|41620030|FG003|Overall Study|Withdrawal by Subject|0|||
19377660|NCT03386721|41620031|FG004|Overall Study|Withdrawal by Subject|0|||
19377661|NCT03386721|41620032|FG005|Overall Study|Withdrawal by Subject|0|||
19377662|NCT03386721|41620033|FG006|Overall Study|Withdrawal by Subject|0|||
19377663|NCT03386721|41620034|FG007|Overall Study|Withdrawal by Subject|0|||
19377664|NCT03386721|41620035|FG008|Overall Study|Withdrawal by Subject|2|||
19377665|NCT03386721|41620036|FG009|Overall Study|Withdrawal by Subject|1|||
19377666|NCT03386721|41620037|FG010|Overall Study|Withdrawal by Subject|3|||
19377667|NCT03386721|41620038|FG011|Overall Study|Withdrawal by Subject|2|||
19377668|NCT03386721|41620039|FG012|Overall Study|Withdrawal by Subject|3|||
19377669|NCT03386721|41620040|FG013|Overall Study|Withdrawal by Subject|0|||
19377670|NCT03386721|41620041|FG014|Overall Study|Withdrawal by Subject|0|||
19377671|NCT02462720|41620073|FG000|Part 2|Withdrawal by Subject|1|||
19377672|NCT02462720|41620074|FG001|Part 2|Withdrawal by Subject|0|||
19377673|NCT02462720|41620073|FG000|Part 2|Protocol Violation|0|||
19377674|NCT02462720|41620074|FG001|Part 2|Protocol Violation|1|||
19377675|NCT02246218|41620084|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19377676|NCT02246218|41620085|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19377677|NCT02246218|41620084|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
19377678|NCT02246218|41620085|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
19377679|NCT02246218|41620084|FG000|Overall Study|Adverse Event|1|||
19377680|NCT02246218|41620085|FG001|Overall Study|Adverse Event|1|||
19377681|NCT02246218|41620084|FG000|Overall Study|Lost to Follow-up|1|||
19377682|NCT02246218|41620085|FG001|Overall Study|Lost to Follow-up|0|||
19377683|NCT02244580|41620091|FG000|Overall Study|No cancer tissues available|241|||
19377684|NCT02244424|41620101|FG000|Overall Study|Lost to Follow-up|20|||
19377685|NCT02244424|41620102|FG001|Overall Study|Lost to Follow-up|10|||
19377686|NCT00159783|41620111|FG000|Overall Study|Adverse Event|5|||
19377687|NCT00159783|41620112|FG001|Overall Study|Adverse Event|7|||
19377688|NCT00159783|41620113|FG002|Overall Study|Adverse Event|9|||
19377689|NCT00159783|41620111|FG000|Overall Study|Lack of Efficacy|1|||
19377690|NCT00159783|41620112|FG001|Overall Study|Lack of Efficacy|2|||
19377691|NCT00159783|41620113|FG002|Overall Study|Lack of Efficacy|3|||
19377692|NCT00159783|41620111|FG000|Overall Study|Withdrawal by Subject|7|||
19377693|NCT00159783|41620112|FG001|Overall Study|Withdrawal by Subject|11|||
19377694|NCT00159783|41620113|FG002|Overall Study|Withdrawal by Subject|12|||
19377695|NCT00159783|41620111|FG000|Overall Study|Lost to Follow-up|6|||
19377696|NCT00159783|41620112|FG001|Overall Study|Lost to Follow-up|5|||
19377697|NCT00159783|41620113|FG002|Overall Study|Lost to Follow-up|11|||
19377698|NCT00159783|41620111|FG000|Overall Study|Other|0|||
19377699|NCT00159783|41620112|FG001|Overall Study|Other|2|||
19377700|NCT00159783|41620113|FG002|Overall Study|Other|4|||
19377701|NCT02936323|41620132|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377702|NCT02936323|41620133|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
19377703|NCT02936323|41620134|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377704|NCT02936323|41620135|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
19377705|NCT02936323|41620136|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
19377706|NCT02936323|41620137|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
19377707|NCT02936323|41620138|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377708|NCT02936323|41620139|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377709|NCT02936323|41620140|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377710|NCT02936323|41620141|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
19377711|NCT02936323|41620132|FG000|Phase 1 Dose Escalation|Death|2|||
19377712|NCT02936323|41620133|FG001|Phase 1 Dose Escalation|Death|1|||
19377713|NCT02936323|41620134|FG002|Phase 1 Dose Escalation|Death|3|||
19377714|NCT02936323|41620135|FG003|Phase 1 Dose Escalation|Death|1|||
19377715|NCT02936323|41620136|FG004|Phase 1 Dose Escalation|Death|2|||
19377716|NCT02936323|41620137|FG005|Phase 1 Dose Escalation|Death|3|||
19377717|NCT02936323|41620138|FG006|Phase 1 Dose Escalation|Death|3|||
19377718|NCT02936323|41620139|FG007|Phase 1 Dose Escalation|Death|0|||
19377719|NCT02936323|41620140|FG008|Phase 1 Dose Escalation|Death|0|||
19377720|NCT02936323|41620141|FG009|Phase 1 Dose Escalation|Death|0|||
19377721|NCT02936323|41620132|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377722|NCT02936323|41620133|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377723|NCT02936323|41620134|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377724|NCT02936323|41620135|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377725|NCT02936323|41620136|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377726|NCT02936323|41620137|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
19377727|NCT02936323|41620138|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377728|NCT02936323|41620139|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377729|NCT02936323|41620140|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377730|NCT02936323|41620141|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
19377731|NCT02936323|41620132|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19464418|NCT01617629|41722661|FG000|Overall Study|Investigator's Clinical Judgement|1|||
19377732|NCT02936323|41620133|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377733|NCT02936323|41620134|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377734|NCT02936323|41620135|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377735|NCT02936323|41620136|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377736|NCT02936323|41620137|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377737|NCT02936323|41620138|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
19377738|NCT02936323|41620139|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
19377739|NCT02936323|41620140|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
19464419|NCT01617629|41722661|FG000|Overall Study|Reason Not Specified|1|||
19377740|NCT02936323|41620141|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
19377741|NCT02936323|41620132|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
19377742|NCT02936323|41620133|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
19377743|NCT02936323|41620134|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
19377744|NCT02936323|41620135|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
19377745|NCT02936323|41620136|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
19377746|NCT02936323|41620137|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
19377747|NCT02936323|41620138|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
19377748|NCT02936323|41620139|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
19377749|NCT02936323|41620140|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
19377750|NCT02936323|41620141|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
19377751|NCT02936323|41620132|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377752|NCT02936323|41620133|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377753|NCT02936323|41620134|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377754|NCT02936323|41620135|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377755|NCT02936323|41620136|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377756|NCT02936323|41620137|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377757|NCT02936323|41620138|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377758|NCT02936323|41620139|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
19377759|NCT02936323|41620140|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
19377760|NCT02936323|41620141|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
19377761|NCT02936323|41620132|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377762|NCT02936323|41620133|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377763|NCT02936323|41620134|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377764|NCT02936323|41620135|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377765|NCT02936323|41620136|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377766|NCT02936323|41620137|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377767|NCT02936323|41620138|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377768|NCT02936323|41620139|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377769|NCT02936323|41620140|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
19377770|NCT02936323|41620141|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
19377771|NCT02936323|41620132|FG000|Phase 2a Dose Expansion|Death|0|||
19377772|NCT02936323|41620133|FG001|Phase 2a Dose Expansion|Death|0|||
19377773|NCT02936323|41620134|FG002|Phase 2a Dose Expansion|Death|0|||
19377774|NCT02936323|41620135|FG003|Phase 2a Dose Expansion|Death|0|||
19377775|NCT02936323|41620136|FG004|Phase 2a Dose Expansion|Death|0|||
19377776|NCT02936323|41620137|FG005|Phase 2a Dose Expansion|Death|0|||
19377777|NCT02936323|41620138|FG006|Phase 2a Dose Expansion|Death|0|||
19377778|NCT02936323|41620139|FG007|Phase 2a Dose Expansion|Death|4|||
19377779|NCT02936323|41620140|FG008|Phase 2a Dose Expansion|Death|8|||
19377780|NCT02936323|41620141|FG009|Phase 2a Dose Expansion|Death|10|||
19377781|NCT02243176|41620175|FG000|Overall Study|Other reason|1|||
19377782|NCT02243176|41620176|FG001|Overall Study|Other reason|2|||
19377783|NCT02243176|41620175|FG000|Overall Study|protocol specified withdrawal critera|1|||
19377784|NCT02243176|41620176|FG001|Overall Study|protocol specified withdrawal critera|3|||
19377785|NCT02243176|41620175|FG000|Overall Study|Protocol Violation|2|||
19377786|NCT02243176|41620176|FG001|Overall Study|Protocol Violation|1|||
19377787|NCT02243176|41620175|FG000|Overall Study|Withdrawal by Subject|8|||
19377788|NCT02243176|41620176|FG001|Overall Study|Withdrawal by Subject|7|||
19377789|NCT02243176|41620175|FG000|Overall Study|Adverse Event|2|||
19377790|NCT02243176|41620176|FG001|Overall Study|Adverse Event|2|||
19377791|NCT00002663|41620187|FG000|Overall Study|Death|4|||
19377792|NCT00002663|41620188|FG001|Overall Study|Death|1|||
19377793|NCT00002663|41620189|FG002|Overall Study|Death|1|||
19377794|NCT00002663|41620190|FG003|Overall Study|Death|0|||
19377795|NCT00002663|41620191|FG004|Overall Study|Death|0|||
19377796|NCT00002663|41620192|FG005|Overall Study|Death|13|||
19377797|NCT00002663|41620193|FG006|Overall Study|Death|0|||
19377798|NCT00002663|41620194|FG007|Overall Study|Death|1|||
19377799|NCT00002663|41620195|FG008|Overall Study|Death|1|||
19377800|NCT00002663|41620196|FG009|Overall Study|Death|1|||
19377801|NCT00002663|41620187|FG000|Overall Study|Lost to Follow-up|3|||
19377802|NCT00002663|41620188|FG001|Overall Study|Lost to Follow-up|0|||
19377803|NCT00002663|41620189|FG002|Overall Study|Lost to Follow-up|0|||
19377804|NCT00002663|41620190|FG003|Overall Study|Lost to Follow-up|1|||
19377805|NCT00002663|41620191|FG004|Overall Study|Lost to Follow-up|0|||
19377806|NCT00002663|41620192|FG005|Overall Study|Lost to Follow-up|1|||
19377807|NCT00002663|41620193|FG006|Overall Study|Lost to Follow-up|0|||
19377808|NCT00002663|41620194|FG007|Overall Study|Lost to Follow-up|0|||
19377809|NCT00002663|41620195|FG008|Overall Study|Lost to Follow-up|0|||
19377810|NCT00002663|41620196|FG009|Overall Study|Lost to Follow-up|0|||
19377811|NCT00002663|41620187|FG000|Overall Study|Other|0|||
19377812|NCT00002663|41620188|FG001|Overall Study|Other|1|||
19377813|NCT00002663|41620189|FG002|Overall Study|Other|0|||
19377814|NCT00002663|41620190|FG003|Overall Study|Other|0|||
19377815|NCT00002663|41620191|FG004|Overall Study|Other|0|||
19377816|NCT00002663|41620192|FG005|Overall Study|Other|1|||
19377817|NCT00002663|41620193|FG006|Overall Study|Other|1|||
19377818|NCT00002663|41620194|FG007|Overall Study|Other|0|||
19377819|NCT00002663|41620195|FG008|Overall Study|Other|0|||
19377820|NCT00002663|41620196|FG009|Overall Study|Other|0|||
19377821|NCT00002663|41620187|FG000|Overall Study|Physician Decision|0|||
19377822|NCT00002663|41620188|FG001|Overall Study|Physician Decision|0|||
19377823|NCT00002663|41620189|FG002|Overall Study|Physician Decision|0|||
19377824|NCT00002663|41620190|FG003|Overall Study|Physician Decision|0|||
19377825|NCT00002663|41620191|FG004|Overall Study|Physician Decision|1|||
19377826|NCT00002663|41620192|FG005|Overall Study|Physician Decision|0|||
19377827|NCT00002663|41620193|FG006|Overall Study|Physician Decision|0|||
19377828|NCT00002663|41620194|FG007|Overall Study|Physician Decision|0|||
19377829|NCT00002663|41620195|FG008|Overall Study|Physician Decision|1|||
19377830|NCT00002663|41620196|FG009|Overall Study|Physician Decision|1|||
19377831|NCT00002663|41620187|FG000|Overall Study|Adverse Event|0|||
19377832|NCT00002663|41620188|FG001|Overall Study|Adverse Event|0|||
19377833|NCT00002663|41620189|FG002|Overall Study|Adverse Event|0|||
19377834|NCT00002663|41620190|FG003|Overall Study|Adverse Event|1|||
19377835|NCT00002663|41620191|FG004|Overall Study|Adverse Event|0|||
19377836|NCT00002663|41620192|FG005|Overall Study|Adverse Event|0|||
19377837|NCT00002663|41620193|FG006|Overall Study|Adverse Event|0|||
19377838|NCT00002663|41620194|FG007|Overall Study|Adverse Event|1|||
19377839|NCT00002663|41620195|FG008|Overall Study|Adverse Event|0|||
19377840|NCT00002663|41620196|FG009|Overall Study|Adverse Event|0|||
19377841|NCT02240680|41620207|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
19377842|NCT02240680|41620208|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
19377843|NCT02240680|41620209|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
19377844|NCT02240680|41620210|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
19377845|NCT02240680|41620207|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
19377846|NCT02240680|41620208|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
19377847|NCT02240680|41620209|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
19377848|NCT02240680|41620210|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
19377849|NCT02240680|41620207|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
19377850|NCT02240680|41620208|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
19377851|NCT02240680|41620209|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
19377852|NCT02240680|41620210|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
19377853|NCT02240680|41620207|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
19377854|NCT02240680|41620208|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
19377855|NCT02240680|41620209|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
19464420|NCT01617629|41722661|FG000|Overall Study|Participant Withdrew Consent|2|||
19464421|NCT01686373|41722676|FG000|Overall Study|Lost to Follow-up|3|||
19377856|NCT02240680|41620210|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
19377857|NCT02240680|41620207|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
19377858|NCT02240680|41620208|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
19377859|NCT02240680|41620209|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
19377860|NCT02240680|41620210|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
19377861|NCT02240680|41620207|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
19464422|NCT01686373|41722677|FG001|Overall Study|Lost to Follow-up|0|||
19377862|NCT02240680|41620208|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
19377863|NCT02240680|41620209|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
19377864|NCT02240680|41620210|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
19377865|NCT02240680|41620207|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
19377866|NCT02240680|41620208|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
19377867|NCT02240680|41620209|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
19377868|NCT02240680|41620210|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
19377869|NCT02240680|41620207|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
19377870|NCT02240680|41620208|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
19377871|NCT02240680|41620209|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
19377872|NCT02240680|41620210|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
19377873|NCT02240368|41620221|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
19377874|NCT02240368|41620222|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
19377875|NCT02240368|41620223|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
19377876|NCT02240368|41620221|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
19377877|NCT02240368|41620222|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
19377878|NCT02240368|41620223|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
19377879|NCT02239978|41620233|FG000|Overall Study|Withdrawal by Subject|2|||
19377880|NCT02239978|41620234|FG001|Overall Study|Withdrawal by Subject|0|||
19377881|NCT02239510|41620244|FG000|Overall Study|Lost to Follow-up|2|||
19377882|NCT02239510|41620245|FG001|Overall Study|Lost to Follow-up|1|||
19377883|NCT02462486|41620254|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
19377884|NCT02462486|41620255|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
19377885|NCT02462486|41620256|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
19377886|NCT02462486|41620254|FG000|Overall Study|Adverse Event|53|||
19377887|NCT02462486|41620255|FG001|Overall Study|Adverse Event|48|||
19377888|NCT02462486|41620256|FG002|Overall Study|Adverse Event|21|||
19377889|NCT02462486|41620254|FG000|Overall Study|Lack of Efficacy|6|||
19464423|NCT01686373|41722676|FG000|Overall Study|Withdrawal by Subject|0|||
19464424|NCT01686373|41722677|FG001|Overall Study|Withdrawal by Subject|1|||
19464425|NCT01686373|41722676|FG000|Overall Study|Adverse Event|0|||
19464426|NCT01686373|41722677|FG001|Overall Study|Adverse Event|1|||
19464427|NCT01709695|41722685|FG000|Overall Study|Withdrawal by Subject|1|||
19464428|NCT01709695|41722686|FG001|Overall Study|Withdrawal by Subject|1|||
19464429|NCT01685983|41722696|FG000|Overall Study|Adverse Event|7|||
19464430|NCT01685983|41722696|FG000|Overall Study|Death|1|||
19464431|NCT01685983|41722696|FG000|Overall Study|Withdrawal by Subject|19|||
19464432|NCT01685983|41722696|FG000|Overall Study|Protocol Violation|2|||
19464433|NCT01685983|41722696|FG000|Overall Study|Physician Decision|13|||
19464434|NCT01685983|41722696|FG000|Overall Study|Other|7|||
19464435|NCT01685983|41722696|FG000|Overall Study|Progressive Disease|32|||
19464436|NCT01685983|41722696|FG000|Overall Study|Noncompliance with Study Drug|1|||
19464437|NCT01685437|41722708|FG000|Overall Study|Withdrawal by Subject|22|||
19464438|NCT01685437|41722708|FG000|Overall Study|Lost to Follow-up|3|||
19464439|NCT01685437|41722708|FG000|Overall Study|Adverse Event|1|||
19464440|NCT01685437|41722708|FG000|Overall Study|Protocol Violation|4|||
19464441|NCT01685437|41722708|FG000|Overall Study|Unable to make visits due to work|1|||
19464442|NCT01685203|41722748|FG000|Overall Study|Lost to Follow-up|3|||
19464443|NCT01685203|41722749|FG001|Overall Study|Lost to Follow-up|3|||
19464444|NCT01685203|41722750|FG002|Overall Study|Lost to Follow-up|0|||
19464445|NCT01685203|41722751|FG003|Overall Study|Lost to Follow-up|1|||
19464446|NCT01685203|41722752|FG004|Overall Study|Lost to Follow-up|0|||
19464447|NCT01685203|41722753|FG005|Overall Study|Lost to Follow-up|0|||
19464448|NCT01685203|41722754|FG006|Overall Study|Lost to Follow-up|0|||
19464449|NCT01685203|41722748|FG000|Overall Study|Adverse Event|0|||
19464450|NCT01685203|41722749|FG001|Overall Study|Adverse Event|0|||
19464451|NCT01685203|41722750|FG002|Overall Study|Adverse Event|0|||
19464452|NCT01685203|41722751|FG003|Overall Study|Adverse Event|0|||
19464453|NCT01685203|41722752|FG004|Overall Study|Adverse Event|0|||
19464454|NCT01685203|41722753|FG005|Overall Study|Adverse Event|2|||
19464455|NCT01685203|41722754|FG006|Overall Study|Adverse Event|0|||
19464456|NCT01685203|41722748|FG000|Overall Study|Adverse event and withdrew consent|1|||
19464457|NCT01685203|41722749|FG001|Overall Study|Adverse event and withdrew consent|0|||
19464458|NCT01685203|41722750|FG002|Overall Study|Adverse event and withdrew consent|0|||
19464459|NCT01685203|41722751|FG003|Overall Study|Adverse event and withdrew consent|0|||
19464460|NCT01685203|41722752|FG004|Overall Study|Adverse event and withdrew consent|0|||
19377890|NCT02462486|41620255|FG001|Overall Study|Lack of Efficacy|12|||
19377891|NCT02462486|41620256|FG002|Overall Study|Lack of Efficacy|3|||
19377892|NCT02462486|41620254|FG000|Overall Study|Lost to Follow-up|3|||
19377893|NCT02462486|41620255|FG001|Overall Study|Lost to Follow-up|4|||
19377894|NCT02462486|41620256|FG002|Overall Study|Lost to Follow-up|2|||
19377895|NCT02462486|41620254|FG000|Overall Study|Withdrawal by Subject|25|||
19377896|NCT02462486|41620255|FG001|Overall Study|Withdrawal by Subject|22|||
19377897|NCT02462486|41620256|FG002|Overall Study|Withdrawal by Subject|19|||
19377898|NCT02462486|41620254|FG000|Overall Study|Protocol Violation|3|||
19377899|NCT02462486|41620255|FG001|Overall Study|Protocol Violation|1|||
19377900|NCT02462486|41620256|FG002|Overall Study|Protocol Violation|1|||
19377901|NCT02462486|41620254|FG000|Overall Study|Reason not Specified|3|||
19377902|NCT02462486|41620255|FG001|Overall Study|Reason not Specified|4|||
19377903|NCT02462486|41620256|FG002|Overall Study|Reason not Specified|3|||
19377904|NCT02495948|41620264|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
19377905|NCT02495948|41620265|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
19377906|NCT02495948|41620264|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
19377907|NCT02495948|41620265|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
19377908|NCT02461628|41620274|FG000|Overall Study|Refused to complete survey|4|||
19377909|NCT02461628|41620275|FG001|Overall Study|Refused to complete survey|7|||
19377910|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
19377911|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
19377912|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
19377913|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
19377914|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
19377915|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
19377916|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
19377917|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
19377918|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
19377919|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
19377920|NCT02429791|41620283|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
19377921|NCT02429791|41620284|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
19377922|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
19377923|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
19377924|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
19377925|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
19377926|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
19377927|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
19377928|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
19377929|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
19377930|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
19377931|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
19377932|NCT02429791|41620283|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
19377933|NCT02429791|41620284|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
19377934|NCT02132611|41620297|FG000|Overall Study|Death|2|||
19377935|NCT02461160|41620314|FG000|Overall Study|Lost to Follow-up|0|||
19377936|NCT02461160|41620315|FG001|Overall Study|Lost to Follow-up|0|||
19377937|NCT02461160|41620316|FG002|Overall Study|Lost to Follow-up|0|||
19377938|NCT02461160|41620317|FG003|Overall Study|Lost to Follow-up|0|||
19377939|NCT02461160|41620318|FG004|Overall Study|Lost to Follow-up|0|||
19377940|NCT02461160|41620319|FG005|Overall Study|Lost to Follow-up|0|||
19377941|NCT02461160|41620320|FG006|Overall Study|Lost to Follow-up|0|||
19377942|NCT02461160|41620321|FG007|Overall Study|Lost to Follow-up|1|||
19377943|NCT02461160|41620322|FG008|Overall Study|Lost to Follow-up|0|||
19377944|NCT02461160|41620323|FG009|Overall Study|Lost to Follow-up|0|||
19377945|NCT02461160|41620324|FG010|Overall Study|Lost to Follow-up|0|||
19377946|NCT02461160|41620325|FG011|Overall Study|Lost to Follow-up|0|||
19377947|NCT02461160|41620326|FG012|Overall Study|Lost to Follow-up|0|||
19377948|NCT01653704|41620377|FG000|Overall Study|Technical failure during recording|1|||
19377949|NCT01653704|41620378|FG001|Overall Study|Technical failure during recording|1|||
19377950|NCT01653704|41620377|FG000|Overall Study|Performance not reflective of training|1|||
19377951|NCT01653704|41620378|FG001|Overall Study|Performance not reflective of training|0|||
19377952|NCT02495168|41620387|FG000|Overall Study|Other than Specified|18|||
19377953|NCT02495168|41620388|FG001|Overall Study|Other than Specified|22|||
19377954|NCT02495168|41620389|FG002|Overall Study|Other than Specified|5|||
19377955|NCT02495168|41620387|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
19377956|NCT02495168|41620388|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
19377957|NCT02495168|41620389|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
19377958|NCT02495168|41620387|FG000|Overall Study|Physician Decision|1|||
19377959|NCT02495168|41620388|FG001|Overall Study|Physician Decision|1|||
19377960|NCT02495168|41620389|FG002|Overall Study|Physician Decision|0|||
19377961|NCT02495168|41620387|FG000|Overall Study|Lost to Follow-up|10|||
19377962|NCT02495168|41620388|FG001|Overall Study|Lost to Follow-up|6|||
19377963|NCT02495168|41620389|FG002|Overall Study|Lost to Follow-up|1|||
19377964|NCT02495168|41620387|FG000|Overall Study|Withdrawal by Subject|1|||
19377965|NCT02495168|41620388|FG001|Overall Study|Withdrawal by Subject|4|||
19377966|NCT02495168|41620389|FG002|Overall Study|Withdrawal by Subject|2|||
19377967|NCT02495168|41620387|FG000|Overall Study|Protocol Violation|0|||
19377968|NCT02495168|41620388|FG001|Overall Study|Protocol Violation|10|||
19377969|NCT02495168|41620389|FG002|Overall Study|Protocol Violation|1|||
19377970|NCT02495168|41620387|FG000|Overall Study|Adverse Event|4|||
19377971|NCT02495168|41620388|FG001|Overall Study|Adverse Event|8|||
19377972|NCT02495168|41620389|FG002|Overall Study|Adverse Event|3|||
19377973|NCT02495168|41620387|FG000|Overall Study|Lack of Efficacy|0|||
19377974|NCT02495168|41620388|FG001|Overall Study|Lack of Efficacy|0|||
19377975|NCT02495168|41620389|FG002|Overall Study|Lack of Efficacy|3|||
19377976|NCT02494778|41620397|FG000|Overall Study|Death|3|||
19377977|NCT02494778|41620397|FG000|Overall Study|Other|173|||
19377978|NCT02494778|41620397|FG000|Overall Study|Lack of Efficacy|4|||
19377979|NCT02494778|41620397|FG000|Overall Study|Adverse Event|18|||
19377980|NCT02494778|41620397|FG000|Overall Study|Withdrawal by Subject|20|||
19377981|NCT02494778|41620397|FG000|Overall Study|Lost to Follow-up|2|||
19377982|NCT02494778|41620397|FG000|Overall Study|Noncompliant with study drug admin.|1|||
19377983|NCT02493764|41620403|FG000|Overall Study|Adverse Event|2|||
19377984|NCT02493764|41620404|FG001|Overall Study|Adverse Event|2|||
19377985|NCT02493764|41620403|FG000|Overall Study|Death|44|||
19377986|NCT02493764|41620404|FG001|Overall Study|Death|58|||
19377987|NCT02493764|41620403|FG000|Overall Study|Lost to Follow-up|2|||
19377988|NCT02493764|41620404|FG001|Overall Study|Lost to Follow-up|1|||
19377989|NCT02493764|41620403|FG000|Overall Study|Protocol Violation|6|||
19377990|NCT02493764|41620404|FG001|Overall Study|Protocol Violation|7|||
19377991|NCT02493764|41620403|FG000|Overall Study|Physician Decision|1|||
19377992|NCT02493764|41620404|FG001|Overall Study|Physician Decision|1|||
19377993|NCT02493764|41620403|FG000|Overall Study|Participant moved|17|||
19377994|NCT02493764|41620404|FG001|Overall Study|Participant moved|5|||
19377995|NCT02493764|41620403|FG000|Overall Study|Withdrawal parent/guardian|0|||
19377996|NCT02493764|41620404|FG001|Overall Study|Withdrawal parent/guardian|1|||
19377997|NCT02493764|41620403|FG000|Overall Study|Withdrawal by Subject|11|||
19377998|NCT02493764|41620404|FG001|Overall Study|Withdrawal by Subject|7|||
19377999|NCT02460380|41620412|FG000|Overall Study|Withdrawal by Subject|10|||
19378000|NCT02460380|41620413|FG001|Overall Study|Withdrawal by Subject|5|||
19378001|NCT02493062|41620420|FG000|Overall Study|Physician Decision|12|||
19378002|NCT02492984|41620426|FG000|Overall Study|Adverse Event|1|||
19378003|NCT02492984|41620427|FG001|Overall Study|Adverse Event|0|||
19378004|NCT02492984|41620426|FG000|Overall Study|Protocol Violation|1|||
19378005|NCT02492984|41620427|FG001|Overall Study|Protocol Violation|0|||
19378006|NCT02492984|41620426|FG000|Overall Study|Withdrawal by Subject|1|||
19378007|NCT02492984|41620427|FG001|Overall Study|Withdrawal by Subject|0|||
19378008|NCT01680159|41620440|FG000|Screening Period|Not meet criteria for dose-up period|7|||
19378009|NCT01680159|41620440|FG000|Increased Dose Period|Adverse Event|6|||
19378010|NCT01680159|41620440|FG000|Increased Dose Period|Withdrawal by Subject|2|||
19378011|NCT02491892|41620462|FG000|Overall Study|Adverse Event|1|||
19378012|NCT02491892|41620463|FG001|Overall Study|Adverse Event|1|||
19378013|NCT02491892|41620462|FG000|Overall Study|Death|1|||
19378014|NCT02491892|41620463|FG001|Overall Study|Death|1|||
19378015|NCT02491892|41620462|FG000|Overall Study|Lack of Efficacy|37|||
19378016|NCT02491892|41620463|FG001|Overall Study|Lack of Efficacy|36|||
19378017|NCT02491892|41620462|FG000|Overall Study|Refused Treatment|1|||
19378018|NCT02491892|41620463|FG001|Overall Study|Refused Treatment|0|||
19378019|NCT02491892|41620462|FG000|Overall Study|Lost to Follow-up|1|||
19378020|NCT02491892|41620463|FG001|Overall Study|Lost to Follow-up|0|||
19378021|NCT02436356|41620479|FG000|Overall Study|Excluded by MRI Screening|0|||
19378022|NCT02436356|41620480|FG001|Overall Study|Excluded by MRI Screening|0|||
19378023|NCT02436356|41620481|FG002|Overall Study|Excluded by MRI Screening|2|||
19378024|NCT02436356|41620479|FG000|Overall Study|Lost to Follow-up|0|||
19378025|NCT02436356|41620480|FG001|Overall Study|Lost to Follow-up|1|||
19378026|NCT02436356|41620481|FG002|Overall Study|Lost to Follow-up|0|||
19378027|NCT02436356|41620479|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
19378028|NCT02436356|41620480|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
19378029|NCT02436356|41620481|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
19378030|NCT02436356|41620479|FG000|Overall Study|Excluded due to other medical conditions|3|||
19378031|NCT02436356|41620480|FG001|Overall Study|Excluded due to other medical conditions|0|||
19378032|NCT02436356|41620481|FG002|Overall Study|Excluded due to other medical conditions|0|||
19378033|NCT02436356|41620479|FG000|Overall Study|Withdrawal by Subject|1|||
19378034|NCT02436356|41620480|FG001|Overall Study|Withdrawal by Subject|0|||
19378035|NCT02436356|41620481|FG002|Overall Study|Withdrawal by Subject|0|||
19378036|NCT02436200|41620494|FG000|Overall Study|Significant outlier|1|||
19378037|NCT01679613|41620498|FG000|Overall Study|other than stated above|0|||
19378038|NCT01679613|41620499|FG001|Overall Study|other than stated above|1|||
19378039|NCT01679613|41620500|FG002|Overall Study|other than stated above|2|||
19378040|NCT01679613|41620501|FG003|Overall Study|other than stated above|2|||
19378041|NCT02489630|41620510|FG000|Overall Study|Oversedation|1|||
19378042|NCT02489630|41620511|FG001|Overall Study|Oversedation|1|||
19378043|NCT02489630|41620510|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
19378044|NCT02489630|41620511|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
19378045|NCT02739347|41620519|FG000|Overall Study|Adverse Event|3|||
19378046|NCT02739347|41620520|FG001|Overall Study|Adverse Event|0|||
19378047|NCT02739347|41620519|FG000|Overall Study|Protocol Violation|0|||
19378048|NCT02739347|41620520|FG001|Overall Study|Protocol Violation|1|||
19378049|NCT02739347|41620519|FG000|Overall Study|Lost to Follow-up|0|||
19378050|NCT02739347|41620520|FG001|Overall Study|Lost to Follow-up|2|||
19378051|NCT02435966|41620529|FG000|Overall Study|Withdrawal by Subject|0|||
19378052|NCT02435966|41620530|FG001|Overall Study|Withdrawal by Subject|1|||
19378053|NCT02435966|41620531|FG002|Overall Study|Withdrawal by Subject|0|||
19378054|NCT01679301|41620539|FG000|Screening Period|screen failure|3|||
19378055|NCT01679301|41620540|FG001|Screening Period|screen failure|0|||
19378056|NCT01679301|41620541|FG002|Screening Period|screen failure|0|||
19378057|NCT01678911|41620547|FG000|Second Intervention|Lost to Follow-up|2|||
19378058|NCT01678911|41620548|FG001|Second Intervention|Lost to Follow-up|0|||
19378059|NCT02487446|41620554|FG000|Period 1|Physician Decision|0|||
19378060|NCT02487446|41620555|FG001|Period 1|Physician Decision|1|||
19378061|NCT02487446|41620554|FG000|Period 1|Lack of Efficacy|1|||
19378062|NCT02487446|41620555|FG001|Period 1|Lack of Efficacy|0|||
19378063|NCT02487446|41620554|FG000|Period 1|Protocol deviation|3|||
19378064|NCT02487446|41620555|FG001|Period 1|Protocol deviation|2|||
19378065|NCT02487446|41620554|FG000|Period 1|Lost to Follow-up|2|||
19378066|NCT02487446|41620555|FG001|Period 1|Lost to Follow-up|0|||
19378067|NCT02487446|41620554|FG000|Period 1|Withdrawal by Subject|2|||
19378068|NCT02487446|41620555|FG001|Period 1|Withdrawal by Subject|0|||
19378069|NCT02487446|41620554|FG000|Period 1|Adverse Event|5|||
19378070|NCT02487446|41620555|FG001|Period 1|Adverse Event|5|||
19378071|NCT02487446|41620554|FG000|Washout|Lost to Follow-up|0|||
19378072|NCT02487446|41620555|FG001|Washout|Lost to Follow-up|2|||
19378073|NCT02487446|41620554|FG000|Washout|Withdrawal by Subject|1|||
19378074|NCT02487446|41620555|FG001|Washout|Withdrawal by Subject|4|||
19378075|NCT02487446|41620554|FG000|Washout|Adverse Event|2|||
19378076|NCT02487446|41620555|FG001|Washout|Adverse Event|2|||
19378077|NCT02487446|41620554|FG000|Period 2|Protocol deviation|0|||
19378078|NCT02487446|41620555|FG001|Period 2|Protocol deviation|1|||
19378079|NCT02487446|41620554|FG000|Period 2|Lost to Follow-up|1|||
19378080|NCT02487446|41620555|FG001|Period 2|Lost to Follow-up|1|||
19378081|NCT02487446|41620554|FG000|Period 2|Withdrawal by Subject|1|||
19378082|NCT02487446|41620555|FG001|Period 2|Withdrawal by Subject|1|||
19378083|NCT02487446|41620554|FG000|Period 2|Adverse Event|6|||
19378084|NCT02487446|41620555|FG001|Period 2|Adverse Event|2|||
19378085|NCT02739269|41620564|FG000|Overall Study|Protocol Violation|5|||
19378086|NCT02739269|41620565|FG001|Overall Study|Protocol Violation|0|||
19378087|NCT02739269|41620564|FG000|Overall Study|Cycle cancellation|2|||
19378088|NCT02739269|41620565|FG001|Overall Study|Cycle cancellation|2|||
19378089|NCT02739269|41620564|FG000|Overall Study|Withdrawal by Subject|0|||
19378090|NCT02739269|41620565|FG001|Overall Study|Withdrawal by Subject|2|||
19378091|NCT03318523|41620575|FG000|PC Period: Up to Year 1|Adverse Event|1|||
19378092|NCT03318523|41620576|FG001|PC Period: Up to Year 1|Adverse Event|0|||
19378093|NCT03318523|41620577|FG002|PC Period: Up to Year 1|Adverse Event|2|||
19378094|NCT03318523|41620578|FG003|PC Period: Up to Year 1|Adverse Event|0|||
19464461|NCT01685203|41722753|FG005|Overall Study|Adverse event and withdrew consent|0|||
19378095|NCT03318523|41620579|FG004|PC Period: Up to Year 1|Adverse Event|0|||
19378096|NCT03318523|41620580|FG005|PC Period: Up to Year 1|Adverse Event|0|||
19378097|NCT03318523|41620581|FG006|PC Period: Up to Year 1|Adverse Event|0|||
19378098|NCT03318523|41620582|FG007|PC Period: Up to Year 1|Adverse Event|0|||
19378099|NCT03318523|41620583|FG008|PC Period: Up to Year 1|Adverse Event|0|||
19378100|NCT03318523|41620584|FG009|PC Period: Up to Year 1|Adverse Event|0|||
19378101|NCT03318523|41620575|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
19378102|NCT03318523|41620576|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
19378103|NCT03318523|41620577|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378104|NCT03318523|41620578|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
19378105|NCT03318523|41620579|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378106|NCT03318523|41620580|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378107|NCT03318523|41620581|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378108|NCT03318523|41620582|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378109|NCT03318523|41620583|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
19464462|NCT01685203|41722754|FG006|Overall Study|Adverse event and withdrew consent|0|||
19378110|NCT03318523|41620584|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
19378111|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378112|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378113|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378114|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378115|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
19378116|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378117|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378118|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
19378119|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
19378120|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
19378121|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378122|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378123|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378124|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378125|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
19464463|NCT01685203|41722748|FG000|Overall Study|Patient's decision|0|||
19464464|NCT01685203|41722749|FG001|Overall Study|Patient's decision|0|||
19464465|NCT01685203|41722750|FG002|Overall Study|Patient's decision|0|||
19464466|NCT01685203|41722751|FG003|Overall Study|Patient's decision|0|||
19464467|NCT01685203|41722752|FG004|Overall Study|Patient's decision|0|||
19464468|NCT01685203|41722753|FG005|Overall Study|Patient's decision|1|||
19464469|NCT01685203|41722754|FG006|Overall Study|Patient's decision|0|||
19464470|NCT01928771|41722773|FG000|Overall Study|Adverse Event|6|||
19464471|NCT01928771|41722774|FG001|Overall Study|Adverse Event|5|||
19464472|NCT01928771|41722775|FG002|Overall Study|Adverse Event|1|||
19464473|NCT01928771|41722773|FG000|Overall Study|Death|2|||
19464474|NCT01928771|41722774|FG001|Overall Study|Death|2|||
19464475|NCT01928771|41722775|FG002|Overall Study|Death|2|||
19464476|NCT01928771|41722773|FG000|Overall Study|Lost to Follow-up|5|||
19464477|NCT01928771|41722774|FG001|Overall Study|Lost to Follow-up|6|||
19378126|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378127|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
19378128|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
19378129|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
19378130|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
19378131|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378132|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378133|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378134|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378135|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378136|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
19378137|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378138|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378139|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378140|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
19378141|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378142|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378143|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378144|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378145|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378146|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378147|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378148|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378149|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
19378150|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
19378151|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
19378152|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
19378153|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
19378154|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
19378155|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
19378156|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
19378157|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
19378158|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
19378159|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
19378160|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
19378161|NCT03318523|41620575|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378162|NCT03318523|41620576|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378163|NCT03318523|41620577|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378164|NCT03318523|41620578|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378165|NCT03318523|41620579|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
19378166|NCT03318523|41620580|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378167|NCT03318523|41620581|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378168|NCT03318523|41620582|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
19378169|NCT03318523|41620583|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
19378170|NCT03318523|41620584|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
19378171|NCT01678209|41620611|FG000|Overall Study|could not scan twice|1|||
19378172|NCT01678209|41620612|FG001|Overall Study|could not scan twice|1|||
19378173|NCT01678209|41620613|FG002|Overall Study|could not scan twice|1|||
19378174|NCT01678209|41620611|FG000|Overall Study|scheduling conflicts|0|||
19378175|NCT01678209|41620612|FG001|Overall Study|scheduling conflicts|0|||
19378176|NCT01678209|41620613|FG002|Overall Study|scheduling conflicts|1|||
19378177|NCT01678209|41620611|FG000|Overall Study|screen fail|16|||
19378178|NCT01678209|41620612|FG001|Overall Study|screen fail|17|||
19378179|NCT01678209|41620613|FG002|Overall Study|screen fail|16|||
19378180|NCT02239120|41620623|FG000|Overall Study|Death|56|||
19378181|NCT02239120|41620624|FG001|Overall Study|Death|58|||
19378182|NCT02239120|41620623|FG000|Overall Study|Lost to Follow-up|19|||
19378183|NCT02239120|41620624|FG001|Overall Study|Lost to Follow-up|14|||
19378184|NCT01603407|41620633|FG000|Overall Study|Adverse Event|1|||
19378185|NCT01603407|41620634|FG001|Overall Study|Adverse Event|1|||
19378186|NCT01603407|41620635|FG002|Overall Study|Adverse Event|1|||
19378187|NCT01603407|41620633|FG000|Overall Study|Protocol Violation|2|||
19464478|NCT01928771|41722775|FG002|Overall Study|Lost to Follow-up|3|||
19378188|NCT01603407|41620634|FG001|Overall Study|Protocol Violation|2|||
19378189|NCT01603407|41620635|FG002|Overall Study|Protocol Violation|0|||
19378190|NCT01603407|41620633|FG000|Overall Study|Withdrawal by Subject|8|||
19378191|NCT01603407|41620634|FG001|Overall Study|Withdrawal by Subject|5|||
19378192|NCT01603407|41620635|FG002|Overall Study|Withdrawal by Subject|7|||
19464479|NCT01928771|41722773|FG000|Overall Study|Withdrawal by Subject|20|||
19378193|NCT01603407|41620633|FG000|Overall Study|Lost to Follow-up|0|||
19378194|NCT01603407|41620634|FG001|Overall Study|Lost to Follow-up|3|||
19378195|NCT01603407|41620635|FG002|Overall Study|Lost to Follow-up|2|||
19378196|NCT02235454|41620665|FG000|Overall Study|Withdrawal by Subject|2|||
19378197|NCT02235298|41620671|FG000|Overall Study|Lost to Follow-up|6|||
19378198|NCT02235298|41620672|FG001|Overall Study|Lost to Follow-up|5|||
19378199|NCT02235298|41620671|FG000|Overall Study|Adverse Event|2|||
19378200|NCT02235298|41620672|FG001|Overall Study|Adverse Event|2|||
19378201|NCT02235298|41620671|FG000|Overall Study|Withdrawal by Subject|0|||
19378202|NCT02235298|41620672|FG001|Overall Study|Withdrawal by Subject|1|||
19378203|NCT02234596|41620678|FG000|Overall Study|Participant not treated|2|||
19378204|NCT02234362|41620682|FG000|Overall Study|Not eligible after first screening visit|17|||
19378205|NCT02234362|41620682|FG000|Overall Study|Lost to Follow-up|6|||
19378206|NCT02234362|41620682|FG000|Overall Study|Withdrawal by Subject|3|||
19378207|NCT02234284|41620688|FG000|Overall Study|Death|4|||
19378208|NCT02234284|41620689|FG001|Overall Study|Death|2|||
19378209|NCT02234284|41620688|FG000|Overall Study|Withdrawal by Subject|1|||
19378210|NCT02234284|41620689|FG001|Overall Study|Withdrawal by Subject|0|||
19378211|NCT02234284|41620688|FG000|Overall Study|Lost to Follow-up|20|||
19378212|NCT02234284|41620689|FG001|Overall Study|Lost to Follow-up|7|||
19378213|NCT02233738|41620701|FG000|Overall Study|Lost to Follow-up|5|||
19378214|NCT02233738|41620702|FG001|Overall Study|Lost to Follow-up|12|||
19464480|NCT01928771|41722774|FG001|Overall Study|Withdrawal by Subject|15|||
19378215|NCT02233738|41620701|FG000|Overall Study|Death|0|||
19378216|NCT02233738|41620702|FG001|Overall Study|Death|1|||
19378217|NCT02233738|41620701|FG000|Overall Study|Withdrawal by Subject|0|||
19378218|NCT02233738|41620702|FG001|Overall Study|Withdrawal by Subject|1|||
19378219|NCT02233738|41620701|FG000|Overall Study|Did not return after Baseline|3|||
19378220|NCT02233738|41620702|FG001|Overall Study|Did not return after Baseline|2|||
19378221|NCT02232880|41620870|FG000|Overall Study|study stopped prior to randomization|1|||
19378222|NCT02896855|41620876|FG000|Overall Study|Death|50|||
19378223|NCT02896855|41620877|FG001|Overall Study|Death|40|||
19378224|NCT02896855|41620876|FG000|Overall Study|Lost to Follow-up|15|||
19378225|NCT02896855|41620877|FG001|Overall Study|Lost to Follow-up|9|||
19378226|NCT02896855|41620876|FG000|Overall Study|Withdrawal by Subject|7|||
19378227|NCT02896855|41620877|FG001|Overall Study|Withdrawal by Subject|4|||
19378228|NCT02232802|41620888|FG000|Period 1|Sponsor request|1|||
19378229|NCT02232802|41620889|FG001|Period 1|Sponsor request|0|||
19378230|NCT02232802|41620888|FG000|Period 1|Adverse Event|1|||
19378231|NCT02232802|41620889|FG001|Period 1|Adverse Event|1|||
19378232|NCT00821587|41620897|FG000|Overall Study|Physician Decision|0|||
19378233|NCT00821587|41620898|FG001|Overall Study|Physician Decision|1|||
19378234|NCT02434328|41620906|FG000|Overall Study|Adverse Event|9|||
19464481|NCT01928771|41722775|FG002|Overall Study|Withdrawal by Subject|17|||
19464482|NCT01928771|41722773|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
19464483|NCT01928771|41722774|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
19378235|NCT02434328|41620907|FG001|Overall Study|Adverse Event|4|||
19378236|NCT02434328|41620906|FG000|Overall Study|Lack of Efficacy|0|||
19378237|NCT02434328|41620907|FG001|Overall Study|Lack of Efficacy|2|||
19378238|NCT02434328|41620906|FG000|Overall Study|Physician Decision|0|||
19378239|NCT02434328|41620907|FG001|Overall Study|Physician Decision|1|||
19378240|NCT02434328|41620906|FG000|Overall Study|Withdrawal by Subject|12|||
19378241|NCT02434328|41620907|FG001|Overall Study|Withdrawal by Subject|21|||
19378242|NCT02434328|41620906|FG000|Overall Study|Death|4|||
19378243|NCT02434328|41620907|FG001|Overall Study|Death|7|||
19378244|NCT02434328|41620906|FG000|Overall Study|Lost to Follow-up|1|||
19378245|NCT02434328|41620907|FG001|Overall Study|Lost to Follow-up|6|||
19378246|NCT02434328|41620906|FG000|Overall Study|Other|4|||
19378247|NCT02434328|41620907|FG001|Overall Study|Other|1|||
19378248|NCT02660229|41620916|FG000|Overall Study|Adverse Event|2|||
19378249|NCT02660229|41620917|FG001|Overall Study|Adverse Event|0|||
19378250|NCT02660229|41620916|FG000|Overall Study|Withdrawal by Subject|0|||
19378251|NCT02660229|41620917|FG001|Overall Study|Withdrawal by Subject|1|||
19378252|NCT02232178|41620926|FG000|Overall Study|Lost to Follow-up|0|||
19378253|NCT02232178|41620927|FG001|Overall Study|Lost to Follow-up|1|||
19378254|NCT02232178|41620928|FG002|Overall Study|Lost to Follow-up|0|||
19378255|NCT02232178|41620926|FG000|Overall Study|ineligibility|0|||
19378256|NCT02232178|41620927|FG001|Overall Study|ineligibility|0|||
19378257|NCT02232178|41620928|FG002|Overall Study|ineligibility|1|||
19378258|NCT02232178|41620926|FG000|Overall Study|surgical complication|1|||
19378259|NCT02232178|41620927|FG001|Overall Study|surgical complication|0|||
19378260|NCT02232178|41620928|FG002|Overall Study|surgical complication|0|||
19378261|NCT01678131|41620939|FG000|Overall Study|Adverse Event|0|||
19378262|NCT01678131|41620940|FG001|Overall Study|Adverse Event|1|||
19378263|NCT01678131|41620941|FG002|Overall Study|Adverse Event|0|||
19378264|NCT01678131|41620939|FG000|Overall Study|Withdrawal by Subject|0|||
19378265|NCT01678131|41620940|FG001|Overall Study|Withdrawal by Subject|0|||
19378266|NCT01678131|41620941|FG002|Overall Study|Withdrawal by Subject|2|||
19378267|NCT02231164|41620951|FG000|Overall Study|Adverse Event|1|||
19378268|NCT02231164|41620952|FG001|Overall Study|Adverse Event|1|||
19378269|NCT02231164|41620951|FG000|Overall Study|Lack of Efficacy|4|||
19464484|NCT01928771|41722775|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
19464485|NCT01928771|41722773|FG000|Overall Study|Other Reasons|9|||
19464486|NCT01928771|41722774|FG001|Overall Study|Other Reasons|9|||
19378270|NCT02231164|41620952|FG001|Overall Study|Lack of Efficacy|3|||
19727445|NCT03614156|42172225|FG000|Open-Label Treatment Period|Adverse Event|7|||
19378271|NCT02231164|41620951|FG000|Overall Study|Withdrawal by Subject|1|||
19378272|NCT02231164|41620952|FG001|Overall Study|Withdrawal by Subject|2|||
19378273|NCT02457182|41620960|FG000|Overall Study|Lost to Follow-up|1|||
19378274|NCT02457182|41620961|FG001|Overall Study|Lost to Follow-up|0|||
19378275|NCT02230384|41620969|FG000|Phase 1|Lost to Follow-up|1|||
19378276|NCT02230384|41620970|FG001|Phase 1|Lost to Follow-up|0|||
19378277|NCT02230384|41620969|FG000|Phase 1|Physician Decision|0|||
19464487|NCT01928771|41722775|FG002|Overall Study|Other Reasons|14|||
19464488|NCT01928771|41722773|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
19478079|NCT01693562|41757325|FG011|Exploration Phase|Other|0|||
19378278|NCT02230384|41620970|FG001|Phase 1|Physician Decision|1|||
19478080|NCT01693562|41757326|FG012|Exploration Phase|Other|0|||
19378279|NCT02230384|41620969|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
19378280|NCT02230384|41620970|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
19378281|NCT02230384|41620969|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
19378282|NCT02230384|41620970|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
19378283|NCT02230384|41620969|FG000|Phase 2 - Switch|Adverse Event|2|||
19378284|NCT02230384|41620970|FG001|Phase 2 - Switch|Adverse Event|0|||
19378285|NCT02738801|41620986|FG000|Overall Study|Adverse Event|1|||
19378286|NCT02738801|41620987|FG001|Overall Study|Adverse Event|1|||
19378287|NCT02738801|41620986|FG000|Overall Study|Withdrawal by Subject|0|||
19378288|NCT02738801|41620987|FG001|Overall Study|Withdrawal by Subject|1|||
19378289|NCT02230306|41621003|FG000|Overall Study|Did not receive study treatment|1|||
19378290|NCT01680861|41621009|FG000|Early Post-transplant Period|Protocol Violation|1|||
19478081|NCT01693562|41757327|FG013|Exploration Phase|Other|0|||
19378291|NCT01680861|41621010|FG001|Early Post-transplant Period|Protocol Violation|1|||
19378292|NCT02229214|41621020|FG000|Overall Study|Adverse Event|2|||
19378293|NCT02229214|41621021|FG001|Overall Study|Adverse Event|0|||
19378294|NCT02229214|41621020|FG000|Overall Study|Withdrawal by Subject|4|||
19378295|NCT02229214|41621021|FG001|Overall Study|Withdrawal by Subject|0|||
19378296|NCT02228980|41621033|FG000|Overall Study|Adverse Event|14|||
19378297|NCT02228980|41621034|FG001|Overall Study|Adverse Event|0|||
19378298|NCT02228980|41621035|FG002|Overall Study|Adverse Event|0|||
19378299|NCT02228980|41621036|FG003|Overall Study|Adverse Event|0|||
19378300|NCT02228980|41621033|FG000|Overall Study|Protocol Violation|7|||
19378301|NCT02228980|41621034|FG001|Overall Study|Protocol Violation|0|||
19378302|NCT02228980|41621035|FG002|Overall Study|Protocol Violation|0|||
19378303|NCT02228980|41621036|FG003|Overall Study|Protocol Violation|0|||
19378304|NCT02228980|41621033|FG000|Overall Study|Withdrawal by Subject|3|||
19378305|NCT02228980|41621034|FG001|Overall Study|Withdrawal by Subject|3|||
19378306|NCT02228980|41621035|FG002|Overall Study|Withdrawal by Subject|2|||
19378307|NCT02228980|41621036|FG003|Overall Study|Withdrawal by Subject|3|||
19378308|NCT02228590|41621050|FG000|Overall Study|Withdrawal by Subject|1|||
19378309|NCT02227108|41621055|FG000|Overall Study|Did not receive treatment|2|||
19378310|NCT02227108|41621055|FG000|Overall Study|Other|3|||
19378311|NCT02227108|41621055|FG000|Overall Study|Progressive disease|17|||
19378312|NCT02227108|41621055|FG000|Overall Study|Initiation of alternative therapy|2|||
19378313|NCT02227108|41621055|FG000|Overall Study|Investigator discretion|1|||
19464489|NCT01928771|41722774|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
19478082|NCT01693562|41757328|FG014|Exploration Phase|Other|0|||
19378314|NCT02227108|41621055|FG000|Overall Study|Adverse Event|6|||
19378315|NCT03564145|41621059|FG000|Overall Study|Adverse Event|4|||
19378316|NCT03564145|41621059|FG000|Overall Study|Lost to Follow-up|21|||
19378317|NCT03564145|41621059|FG000|Overall Study|Protocol Violation|2|||
19378318|NCT03564145|41621059|FG000|Overall Study|Withdrawal by Subject|48|||
19551287|NCT01346969|42000113|FG001|Overall Study|Physician Decision|0|||
19551288|NCT01346969|42000114|FG002|Overall Study|Physician Decision|0|||
19551289|NCT01346969|42000115|FG003|Overall Study|Physician Decision|1|||
19378319|NCT03564145|41621059|FG000|Overall Study|Study Terminated by Sponsor|146|||
19378320|NCT03564145|41621059|FG000|Overall Study|Physician Decision|1|||
19378321|NCT03564145|41621059|FG000|Overall Study|Other Than Specified|1|||
19378322|NCT03564145|41621059|FG000|Overall Study|Pregnancy|1|||
19378323|NCT02226562|41621065|FG000|Overall Study|Lost to Follow-up|0|||
19378324|NCT02226562|41621066|FG001|Overall Study|Lost to Follow-up|1|||
19378325|NCT02456636|41621100|FG000|Overall Study|Death|0|||
19378326|NCT02456636|41621101|FG001|Overall Study|Death|3|||
19378327|NCT02456636|41621102|FG002|Overall Study|Death|0|||
19378328|NCT02456636|41621100|FG000|Overall Study|Pregnancy|1|||
19378329|NCT02456636|41621101|FG001|Overall Study|Pregnancy|3|||
19378330|NCT02456636|41621102|FG002|Overall Study|Pregnancy|5|||
19378331|NCT02456636|41621100|FG000|Overall Study|Physician Decision|4|||
19378332|NCT02456636|41621101|FG001|Overall Study|Physician Decision|5|||
19378333|NCT02456636|41621102|FG002|Overall Study|Physician Decision|4|||
19378334|NCT02456636|41621100|FG000|Overall Study|Withdrawal by Subject|13|||
19464490|NCT01928771|41722775|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
19378335|NCT02456636|41621101|FG001|Overall Study|Withdrawal by Subject|14|||
19378336|NCT02456636|41621102|FG002|Overall Study|Withdrawal by Subject|16|||
19378337|NCT02456636|41621100|FG000|Overall Study|Lost to Follow-up|50|||
19378338|NCT02456636|41621101|FG001|Overall Study|Lost to Follow-up|44|||
19378339|NCT02456636|41621102|FG002|Overall Study|Lost to Follow-up|50|||
19378340|NCT02226172|41621110|FG000|Overall Study|Participant refused further follow-up|4|||
19378341|NCT02226172|41621110|FG000|Overall Study|Other|5|||
19378342|NCT02226172|41621110|FG000|Overall Study|Death|1|||
19378343|NCT02226172|41621110|FG000|Overall Study|Study terminated by sponsor|1|||
19378344|NCT02226172|41621110|FG000|Overall Study|Adverse Event|6|||
19378345|NCT01676961|41621114|FG000|Overall Study|Death|3|||
19378346|NCT01676961|41621114|FG000|Overall Study|Lost to Follow-up|1|||
19378347|NCT01676961|41621114|FG000|Overall Study|Withdrawal by Subject|1|||
19378348|NCT01676727|41621136|FG000|Overall Study|Death|18|||
19378349|NCT01676727|41621136|FG000|Overall Study|Withdrawal by Subject|6|||
19378350|NCT01676727|41621136|FG000|Overall Study|Screening failure|5|||
19378351|NCT01676727|41621136|FG000|Overall Study|Not willing to attend 1-year visit|2|||
19378352|NCT01676727|41621136|FG000|Overall Study|Valve explanted|1|||
19378353|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
19378354|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
19378355|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19378356|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19378357|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19378358|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19378359|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19378360|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
19378361|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
19378362|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
19378363|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19378364|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19378365|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19378366|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19378367|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
19378368|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19378369|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
19378370|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19378371|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19378372|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19378373|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19378374|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378375|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
19378376|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378377|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378378|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378379|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378380|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19378381|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
19378382|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
19378383|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
19378384|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19378385|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19378386|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19378387|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19378388|NCT03745651|41621144|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
19378389|NCT03745651|41621145|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
19378390|NCT03745651|41621146|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
19378391|NCT03745651|41621147|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
19378392|NCT03745651|41621148|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
19378393|NCT03745651|41621149|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
19378394|NCT03745651|41621150|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
19378395|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378396|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378397|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378398|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378399|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378400|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
19378401|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19378402|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19378403|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19378404|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19378405|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
19378406|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19378407|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
19378408|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
19378409|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19378410|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19378411|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19378412|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
19378413|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
19378414|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
19378415|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
19378416|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19378417|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19378418|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19378419|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
19378420|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19378421|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
19378422|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
19378423|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
19378424|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
19378425|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
19378426|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
19378427|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
19378428|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
19378429|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
19378430|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19378431|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19464491|NCT01589653|41722785|FG000|Overall Study|Protocol Violation|3|||
19378432|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19378433|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19378434|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19378435|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
19378436|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19378437|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19378438|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19378439|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19378440|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
19378441|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
19378442|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
19378443|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
19378444|NCT03745651|41621144|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
19378445|NCT03745651|41621145|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
19378446|NCT03745651|41621146|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
19378447|NCT03745651|41621147|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
19378448|NCT03745651|41621148|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
19378449|NCT03745651|41621149|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
19378450|NCT03745651|41621150|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
19378451|NCT02738879|41621168|FG000|Overall Study|Adverse Event|1|||
19378452|NCT02738879|41621169|FG001|Overall Study|Adverse Event|1|||
19378453|NCT02738879|41621168|FG000|Overall Study|Death|0|||
19378454|NCT02738879|41621169|FG001|Overall Study|Death|2|||
19378455|NCT02738879|41621168|FG000|Overall Study|Lost to Follow-up|1|||
19378456|NCT02738879|41621169|FG001|Overall Study|Lost to Follow-up|5|||
19378457|NCT02738879|41621168|FG000|Overall Study|Protocol Violation|1|||
19378458|NCT02738879|41621169|FG001|Overall Study|Protocol Violation|3|||
19378459|NCT02738879|41621168|FG000|Overall Study|Physician Decision|3|||
19378460|NCT02738879|41621169|FG001|Overall Study|Physician Decision|4|||
19378461|NCT02738879|41621168|FG000|Overall Study|Pregnancy|0|||
19378462|NCT02738879|41621169|FG001|Overall Study|Pregnancy|1|||
19378463|NCT02738879|41621168|FG000|Overall Study|Screen Failure|1|||
19378464|NCT02738879|41621169|FG001|Overall Study|Screen Failure|2|||
19378465|NCT02738879|41621168|FG000|Overall Study|Site Discontinued Study Participation|1|||
19378466|NCT02738879|41621169|FG001|Overall Study|Site Discontinued Study Participation|0|||
19378467|NCT02738879|41621168|FG000|Overall Study|Withdrawal by Subject|5|||
19378468|NCT02738879|41621169|FG001|Overall Study|Withdrawal by Subject|7|||
19378469|NCT03502811|41621175|FG000|Overall Study|Death|157|||
19378470|NCT03502811|41621175|FG000|Overall Study|Withdrawal by Subject|105|||
19378471|NCT03502811|41621175|FG000|Overall Study|Lost to Follow-up|26|||
19378472|NCT03502811|41621175|FG000|Overall Study|No Visits (Missed)|31|||
19378473|NCT00515671|41621187|FG000|Overall Study|Lost to Follow-up|13|||
19378474|NCT00515671|41621188|FG001|Overall Study|Lost to Follow-up|10|||
19378475|NCT00515671|41621187|FG000|Overall Study|Withdrawal by Subject|3|||
19378476|NCT00515671|41621188|FG001|Overall Study|Withdrawal by Subject|5|||
19378477|NCT00515671|41621187|FG000|Overall Study|incarcerated|1|||
19378478|NCT00515671|41621188|FG001|Overall Study|incarcerated|2|||
19378479|NCT01677195|41621197|FG000|Overall Study|Lost to Follow-up|14|||
19378480|NCT01677195|41621198|FG001|Overall Study|Lost to Follow-up|22|||
19378481|NCT01677195|41621199|FG002|Overall Study|Lost to Follow-up|22|||
19378482|NCT01677195|41621197|FG000|Overall Study|Withdrawal by Subject|1|||
19378483|NCT01677195|41621198|FG001|Overall Study|Withdrawal by Subject|0|||
19378484|NCT01677195|41621199|FG002|Overall Study|Withdrawal by Subject|1|||
19378485|NCT01677195|41621197|FG000|Overall Study|Adverse Event|6|||
19378486|NCT01677195|41621198|FG001|Overall Study|Adverse Event|4|||
19378487|NCT01677195|41621199|FG002|Overall Study|Adverse Event|1|||
19378488|NCT01677195|41621197|FG000|Overall Study|Physician Decision|1|||
19378489|NCT01677195|41621198|FG001|Overall Study|Physician Decision|2|||
19378490|NCT01677195|41621199|FG002|Overall Study|Physician Decision|2|||
19378491|NCT01677195|41621197|FG000|Overall Study|Pregnancy|0|||
19378492|NCT01677195|41621198|FG001|Overall Study|Pregnancy|1|||
19378493|NCT01677195|41621199|FG002|Overall Study|Pregnancy|0|||
19378494|NCT01677195|41621197|FG000|Overall Study|Protocol Violation|7|||
19378495|NCT01677195|41621198|FG001|Overall Study|Protocol Violation|3|||
19378496|NCT01677195|41621199|FG002|Overall Study|Protocol Violation|4|||
19378497|NCT00928447|41621211|FG000|Overall Study|Withdrawal by Subject|1|||
19378498|NCT00928447|41621211|FG000|Overall Study|Investigator's decision|1|||
19378499|NCT02224846|41621217|FG000|Period 1 (Month 3)|Adverse Event|2|||
19378500|NCT02224846|41621218|FG001|Period 1 (Month 3)|Adverse Event|1|||
19378501|NCT02224846|41621217|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
19378502|NCT02224846|41621218|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
19378503|NCT02224846|41621217|FG000|Period 1 (Month 3)|Protocol Violation|4|||
19378504|NCT02224846|41621218|FG001|Period 1 (Month 3)|Protocol Violation|8|||
19378505|NCT02224846|41621217|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
19378506|NCT02224846|41621218|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
19378507|NCT02224846|41621217|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
19378508|NCT02224846|41621218|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
19378509|NCT02224846|41621217|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
19378510|NCT02224846|41621218|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
19378511|NCT02224846|41621217|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
19378512|NCT02224846|41621218|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
19378513|NCT02224846|41621217|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
19378514|NCT02224846|41621218|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
19378515|NCT02224846|41621217|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
19378516|NCT02224846|41621218|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
19378517|NCT02224846|41621217|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
19378518|NCT02224846|41621218|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
19378519|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
19378520|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
19464492|NCT01589653|41722786|FG001|Overall Study|Protocol Violation|1|||
19378521|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
19378522|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
19378523|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
19378524|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
19378525|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
19378526|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
19378527|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
19464493|NCT01589653|41722785|FG000|Overall Study|Withdrawal criteria|4|||
19464494|NCT01589653|41722786|FG001|Overall Study|Withdrawal criteria|7|||
19464495|NCT01589653|41722785|FG000|Overall Study|Unclassified|0|||
19464496|NCT01589653|41722786|FG001|Overall Study|Unclassified|3|||
19478083|NCT01693562|41757329|FG015|Exploration Phase|Other|0|||
19378528|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
19378529|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
19378530|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
19378531|NCT02224846|41621217|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
19378532|NCT02224846|41621218|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
19464497|NCT01928615|41722792|FG000|Overall Study|Study Terminated by Sponsor|2|||
19464498|NCT01589497|41722801|FG000|Overall Study|Withdrawal by Subject|0|||
19464499|NCT01589497|41722802|FG001|Overall Study|Withdrawal by Subject|1|||
19464500|NCT01589497|41722803|FG002|Overall Study|Withdrawal by Subject|0|||
19464501|NCT01589497|41722804|FG003|Overall Study|Withdrawal by Subject|1|||
19464502|NCT01589497|41722801|FG000|Overall Study|Death|1|||
19378533|NCT01632280|41621226|FG000|Overall Study|Withdrawal by Subject|1|||
19378534|NCT01632280|41621227|FG001|Overall Study|Withdrawal by Subject|0|||
19378535|NCT02224690|41621235|FG000|Overall Study|Adverse Event|8|||
19378536|NCT02224690|41621236|FG001|Overall Study|Adverse Event|1|||
19378537|NCT02224690|41621235|FG000|Overall Study|Met Withdrawal Criteria|4|||
19378538|NCT02224690|41621236|FG001|Overall Study|Met Withdrawal Criteria|0|||
19378539|NCT02224690|41621235|FG000|Overall Study|Use of G-tube|1|||
19378540|NCT02224690|41621236|FG001|Overall Study|Use of G-tube|0|||
19378541|NCT02224690|41621235|FG000|Overall Study|Did not meet eligibility criteria|1|||
19378542|NCT02224690|41621236|FG001|Overall Study|Did not meet eligibility criteria|0|||
19378543|NCT01634152|41621245|FG000|Overall Study|Adverse Event|2|||
19378544|NCT01634152|41621246|FG001|Overall Study|Adverse Event|0|||
19378545|NCT01634152|41621247|FG002|Overall Study|Adverse Event|2|||
19464503|NCT01589497|41722802|FG001|Overall Study|Death|0|||
19464504|NCT01589497|41722803|FG002|Overall Study|Death|0|||
19378546|NCT01634152|41621245|FG000|Overall Study|Consent withdrawn not due to AE|1|||
19378547|NCT01634152|41621246|FG001|Overall Study|Consent withdrawn not due to AE|0|||
19378548|NCT01634152|41621247|FG002|Overall Study|Consent withdrawn not due to AE|1|||
19378549|NCT01634152|41621245|FG000|Overall Study|Not treated|0|||
19378550|NCT01634152|41621246|FG001|Overall Study|Not treated|1|||
19378551|NCT01634152|41621247|FG002|Overall Study|Not treated|0|||
19378552|NCT01634152|41621245|FG000|Overall Study|Other reason not defined above|1|||
19378553|NCT01634152|41621246|FG001|Overall Study|Other reason not defined above|0|||
19464505|NCT01589497|41722804|FG003|Overall Study|Death|0|||
19464506|NCT01589497|41722801|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
19464507|NCT01589497|41722802|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
19464508|NCT01589497|41722803|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
19464509|NCT01589497|41722804|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
19464510|NCT01928381|41722819|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
19378554|NCT01634152|41621247|FG002|Overall Study|Other reason not defined above|1|||
19378555|NCT03862807|41621255|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
19378556|NCT01378429|41621279|FG000|Overall Study|Noncompliance with study drug|1|||
19464511|NCT01928381|41722820|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19464512|NCT01928381|41722821|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19378557|NCT01378429|41621280|FG001|Overall Study|Noncompliance with study drug|0|||
19378558|NCT01599754|41621291|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
19378559|NCT01599754|41621292|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
19378560|NCT01599754|41621291|FG000|Overall Study|Participant noncompliance|4|||
19378561|NCT01599754|41621292|FG001|Overall Study|Participant noncompliance|4|||
19378562|NCT01599754|41621291|FG000|Overall Study|Lost to Follow-up|13|||
19378563|NCT01599754|41621292|FG001|Overall Study|Lost to Follow-up|6|||
19378564|NCT01599754|41621291|FG000|Overall Study|Death|31|||
19378565|NCT01599754|41621292|FG001|Overall Study|Death|33|||
19378566|NCT01599754|41621291|FG000|Overall Study|Adverse Event|3|||
19378567|NCT01599754|41621292|FG001|Overall Study|Adverse Event|2|||
19378568|NCT01599754|41621291|FG000|Overall Study|Investigator decision|1|||
19378569|NCT01599754|41621292|FG001|Overall Study|Investigator decision|3|||
19378570|NCT01599754|41621291|FG000|Overall Study|Withdrawal by Subject|24|||
19378571|NCT01599754|41621292|FG001|Overall Study|Withdrawal by Subject|25|||
19464513|NCT01928381|41722822|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19464514|NCT01928381|41722823|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19378572|NCT01599754|41621291|FG000|Overall Study|Study terminated by sponsor|282|||
19464515|NCT01928381|41722824|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19464516|NCT01928381|41722825|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
19464517|NCT01928381|41722819|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
19464518|NCT01928381|41722820|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
19464519|NCT01928381|41722821|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
19464520|NCT01928381|41722822|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
19378573|NCT01599754|41621292|FG001|Overall Study|Study terminated by sponsor|285|||
19378574|NCT02138110|41621298|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
19378575|NCT02138110|41621298|FG000|Overall Scaffold Implantation|Death|3|||
19378576|NCT02223754|41621304|FG000|Period 1|Adverse Event|1|||
19464521|NCT01928381|41722823|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
19464522|NCT01928381|41722824|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
19464523|NCT01928381|41722825|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
19464524|NCT01928381|41722819|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
19464525|NCT01928381|41722820|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
19464526|NCT01928381|41722821|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
19378577|NCT02223754|41621305|FG001|Period 1|Adverse Event|0|||
19464527|NCT01928381|41722822|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
19464528|NCT01928381|41722823|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
19464529|NCT01928381|41722824|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
19378578|NCT02223754|41621304|FG000|Period 1|Lost to Follow-up|0|||
19378579|NCT02223754|41621305|FG001|Period 1|Lost to Follow-up|1|||
19378580|NCT02223754|41621304|FG000|Period 1|Protocol Violation|2|||
19378581|NCT02223754|41621305|FG001|Period 1|Protocol Violation|4|||
19378582|NCT02223754|41621304|FG000|Period 1|Withdrawal by Subject|0|||
19378583|NCT02223754|41621305|FG001|Period 1|Withdrawal by Subject|4|||
19378584|NCT02223754|41621304|FG000|Period 1|Test Article No Longer Available|1|||
19378585|NCT02223754|41621305|FG001|Period 1|Test Article No Longer Available|5|||
19378586|NCT02223754|41621304|FG000|Period 1|Unsatisfactory Visual Response|0|||
19378587|NCT02223754|41621305|FG001|Period 1|Unsatisfactory Visual Response|1|||
19378588|NCT02223754|41621304|FG000|Period 2|Adverse Event|0|||
19378589|NCT02223754|41621305|FG001|Period 2|Adverse Event|1|||
19378590|NCT02223754|41621304|FG000|Period 2|Protocol Violation|1|||
19378591|NCT02223754|41621305|FG001|Period 2|Protocol Violation|0|||
19378592|NCT02223754|41621304|FG000|Period 2|Lens Discomfort|1|||
19378593|NCT02223754|41621305|FG001|Period 2|Lens Discomfort|1|||
19378594|NCT02223754|41621304|FG000|Period 2|Lost to Follow-up|1|||
19478084|NCT01693562|41757330|FG016|Exploration Phase|Other|0|||
19378595|NCT02223754|41621305|FG001|Period 2|Lost to Follow-up|0|||
19378596|NCT02223754|41621304|FG000|Period 2|Test Article No Longer Available|0|||
19378597|NCT02223754|41621305|FG001|Period 2|Test Article No Longer Available|1|||
19378598|NCT02223364|41621315|FG000|Overall Study|Protocol Violation|3|||
19378599|NCT02223364|41621316|FG001|Overall Study|Protocol Violation|0|||
19378600|NCT02223364|41621317|FG002|Overall Study|Protocol Violation|3|||
19378601|NCT02223364|41621315|FG000|Overall Study|subject expired before surgery|1|||
19378602|NCT02223364|41621316|FG001|Overall Study|subject expired before surgery|0|||
19378603|NCT02223364|41621317|FG002|Overall Study|subject expired before surgery|0|||
19378604|NCT02223364|41621315|FG000|Overall Study|Physician Decision|1|||
19378605|NCT02223364|41621316|FG001|Overall Study|Physician Decision|0|||
19378606|NCT02223364|41621317|FG002|Overall Study|Physician Decision|0|||
19378607|NCT01378975|41621327|FG000|Overall Study|Death|77|||
19378608|NCT01378975|41621328|FG001|Overall Study|Death|46|||
19378609|NCT01378975|41621327|FG000|Overall Study|Investigator Request|1|||
19378610|NCT01378975|41621328|FG001|Overall Study|Investigator Request|0|||
19378611|NCT01378975|41621327|FG000|Overall Study|Lost to Follow-up|4|||
19378612|NCT01378975|41621328|FG001|Overall Study|Lost to Follow-up|1|||
19378613|NCT01378975|41621327|FG000|Overall Study|Withdrew Consent|4|||
19378614|NCT01378975|41621328|FG001|Overall Study|Withdrew Consent|3|||
19378615|NCT02222896|41621335|FG000|Abdomen|Did not qualify|34|||
19378616|NCT02222896|41621336|FG001|Abdomen|Did not qualify|10|||
19378617|NCT02222896|41621337|FG002|Abdomen|Did not qualify|32|||
19378618|NCT02222896|41621335|FG000|Groin|Did not qualify|43|||
19378619|NCT02222896|41621336|FG001|Groin|Did not qualify|9|||
19378620|NCT02222896|41621337|FG002|Groin|Did not qualify|40|||
19378621|NCT02222818|41621350|FG000|Period 1|Eligibility criteria not met|0|||
19378622|NCT02222818|41621351|FG001|Period 1|Eligibility criteria not met|3|||
19378623|NCT01378195|41621362|FG000|Overall Study|Lost to Follow-up|29|||
19378624|NCT01378195|41621363|FG001|Overall Study|Lost to Follow-up|18|||
19378625|NCT01378117|41621372|FG000|Overall Study|withdrawal|2|||
19378626|NCT01378117|41621373|FG001|Overall Study|withdrawal|1|||
19378627|NCT01378117|41621374|FG002|Overall Study|withdrawal|2|||
19378628|NCT01378117|41621372|FG000|Overall Study|discharged before med given|2|||
19378629|NCT01378117|41621373|FG001|Overall Study|discharged before med given|0|||
19378630|NCT01378117|41621374|FG002|Overall Study|discharged before med given|1|||
19378631|NCT04254809|41621409|FG000|Overall Study|Lost to Follow-up|5|||
19378632|NCT04254809|41621410|FG001|Overall Study|Lost to Follow-up|10|||
19378633|NCT02717611|41621416|FG000|Overall Study|Death|13|||
19378634|NCT02717611|41621416|FG000|Overall Study|Withdrawal by Subject|6|||
19378635|NCT02717611|41621416|FG000|Overall Study|Active, not recruiting|40|||
19378636|NCT02717611|41621416|FG000|Overall Study|Complicating disease|1|||
19378637|NCT02736409|41621424|FG000|Overall Study|Withdrawal by Subject|4|||
19378638|NCT02736409|41621425|FG001|Overall Study|Withdrawal by Subject|2|||
19378639|NCT02736409|41621426|FG002|Overall Study|Withdrawal by Subject|17|||
19378640|NCT02736409|41621427|FG003|Overall Study|Withdrawal by Subject|3|||
19378641|NCT02736409|41621424|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19378642|NCT02736409|41621425|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19378643|NCT02736409|41621426|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19378644|NCT02736409|41621427|FG003|Overall Study|Non-Compliance with Study Drug|1|||
19378645|NCT02736409|41621424|FG000|Overall Study|Adverse Event|0|||
19378646|NCT02736409|41621425|FG001|Overall Study|Adverse Event|1|||
19378647|NCT02736409|41621426|FG002|Overall Study|Adverse Event|5|||
19378648|NCT02736409|41621427|FG003|Overall Study|Adverse Event|4|||
19378649|NCT02736409|41621424|FG000|Overall Study|Other|0|||
19378650|NCT02736409|41621425|FG001|Overall Study|Other|0|||
19378651|NCT02736409|41621426|FG002|Overall Study|Other|1|||
19378652|NCT02736409|41621427|FG003|Overall Study|Other|1|||
19378653|NCT02736409|41621424|FG000|Overall Study|Pregnancy|0|||
19378654|NCT02736409|41621425|FG001|Overall Study|Pregnancy|0|||
19378655|NCT02736409|41621426|FG002|Overall Study|Pregnancy|1|||
19378656|NCT02736409|41621427|FG003|Overall Study|Pregnancy|0|||
19378657|NCT02736409|41621424|FG000|Overall Study|Lost to Follow-up|0|||
19378658|NCT02736409|41621425|FG001|Overall Study|Lost to Follow-up|0|||
19378659|NCT02736409|41621426|FG002|Overall Study|Lost to Follow-up|2|||
19378660|NCT02736409|41621427|FG003|Overall Study|Lost to Follow-up|1|||
19378661|NCT02736409|41621424|FG000|Overall Study|Physician Decision|0|||
19378662|NCT02736409|41621425|FG001|Overall Study|Physician Decision|0|||
19378663|NCT02736409|41621426|FG002|Overall Study|Physician Decision|0|||
19378664|NCT02736409|41621427|FG003|Overall Study|Physician Decision|2|||
19378665|NCT03099707|41621440|FG000|Overall Study|Withdrawal by Subject|0|||
19378666|NCT03099707|41621441|FG001|Overall Study|Withdrawal by Subject|3|||
19378667|NCT03099707|41621440|FG000|Overall Study|Lost to Follow-up|0|||
19378668|NCT03099707|41621441|FG001|Overall Study|Lost to Follow-up|1|||
19378669|NCT02906033|41621449|FG000|Baseline|Protocol Violation|37|||
19378670|NCT02906033|41621450|FG001|Baseline|Protocol Violation|33|||
19378671|NCT02906033|41621449|FG000|Follow-up|Lost to Follow-up|46|||
19378672|NCT02906033|41621450|FG001|Follow-up|Lost to Follow-up|62|||
19378673|NCT02221882|41621462|FG000|Overall Study|Withdrawal by Subject|0|||
19378674|NCT02221882|41621463|FG001|Overall Study|Withdrawal by Subject|0|||
19378675|NCT02221882|41621464|FG002|Overall Study|Withdrawal by Subject|4|||
19378676|NCT02221882|41621465|FG003|Overall Study|Withdrawal by Subject|2|||
19378677|NCT02221882|41621466|FG004|Overall Study|Withdrawal by Subject|2|||
19378678|NCT02221882|41621467|FG005|Overall Study|Withdrawal by Subject|2|||
19378679|NCT02221882|41621462|FG000|Overall Study|Death|0|||
19378680|NCT02221882|41621463|FG001|Overall Study|Death|1|||
19378681|NCT02221882|41621464|FG002|Overall Study|Death|0|||
19378682|NCT02221882|41621465|FG003|Overall Study|Death|0|||
19378683|NCT02221882|41621466|FG004|Overall Study|Death|0|||
19378684|NCT02221882|41621467|FG005|Overall Study|Death|0|||
19378685|NCT02837783|41621488|FG000|Overall Study|Adverse Event|1|||
19378686|NCT02837783|41621489|FG001|Overall Study|Adverse Event|0|||
19378687|NCT02837783|41621488|FG000|Overall Study|Other, Not Specified|1|||
19378688|NCT02837783|41621489|FG001|Overall Study|Other, Not Specified|2|||
19378689|NCT02221648|41621497|FG000|Overall Study|Withdrawal by Subject|3|||
19378690|NCT02221648|41621498|FG001|Overall Study|Withdrawal by Subject|3|||
19378691|NCT02220712|41621508|FG000|Overall Study|Adverse Event|1|||
19378692|NCT02220712|41621508|FG000|Overall Study|Withdrawal by Subject|2|||
19378693|NCT02220712|41621508|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
19378694|NCT02219932|41621518|FG000|Overall Study|Other|5|||
19378695|NCT02219932|41621519|FG001|Overall Study|Other|11|||
19378696|NCT02219932|41621518|FG000|Overall Study|Death|1|||
19378697|NCT02219932|41621519|FG001|Overall Study|Death|1|||
19378698|NCT02219932|41621518|FG000|Overall Study|Investigator Decision|0|||
19378699|NCT02219932|41621519|FG001|Overall Study|Investigator Decision|1|||
19378700|NCT02219932|41621518|FG000|Overall Study|Consent Withdrawn|11|||
19378701|NCT02219932|41621519|FG001|Overall Study|Consent Withdrawn|7|||
19378702|NCT02219932|41621518|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
19378703|NCT02219932|41621519|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
19378704|NCT02219932|41621518|FG000|Overall Study|Protocol Violation|10|||
19378705|NCT02219932|41621519|FG001|Overall Study|Protocol Violation|6|||
19378706|NCT02219932|41621518|FG000|Overall Study|Pregnancy|1|||
19378707|NCT02219932|41621519|FG001|Overall Study|Pregnancy|0|||
19378708|NCT02219932|41621518|FG000|Overall Study|Lost to Follow-up|4|||
19378709|NCT02219932|41621519|FG001|Overall Study|Lost to Follow-up|2|||
19378710|NCT02219932|41621518|FG000|Overall Study|Adverse Event|23|||
19378711|NCT02219932|41621519|FG001|Overall Study|Adverse Event|21|||
19378712|NCT02219464|41621527|FG000|Overall Study|Withdrawal by Subject|1|||
19378713|NCT02219464|41621528|FG001|Overall Study|Withdrawal by Subject|0|||
19378714|NCT02219464|41621527|FG000|Overall Study|case cancelled|1|||
19378715|NCT02219464|41621528|FG001|Overall Study|case cancelled|0|||
19378716|NCT02219464|41621527|FG000|Overall Study|catheter malfunction|1|||
19378717|NCT02219464|41621528|FG001|Overall Study|catheter malfunction|0|||
19378718|NCT02219308|41621536|FG000|Overall Study|Withdrawal by Subject|1|||
19378719|NCT02219308|41621537|FG001|Overall Study|Withdrawal by Subject|2|||
19378720|NCT02218372|41621545|FG000|Overall Study|Adverse Event|1|||
19378721|NCT02218372|41621546|FG001|Overall Study|Adverse Event|1|||
19378722|NCT02218372|41621545|FG000|Overall Study|Miscellaneous|2|||
19378723|NCT02218372|41621546|FG001|Overall Study|Miscellaneous|1|||
19378724|NCT02218372|41621545|FG000|Overall Study|Randomized but did not receive treatment|2|||
19378725|NCT02218372|41621546|FG001|Overall Study|Randomized but did not receive treatment|3|||
19378726|NCT02218372|41621545|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19378727|NCT02218372|41621546|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19378728|NCT02218216|41621559|FG000|Overall Study|Study terminated before completed|6|||
19378729|NCT02218216|41621560|FG001|Overall Study|Study terminated before completed|0|||
19378730|NCT02218216|41621561|FG002|Overall Study|Study terminated before completed|0|||
19378731|NCT02217982|41621571|FG000|Overall Study|Trial discontinued|1|||
19378732|NCT02217982|41621572|FG001|Overall Study|Trial discontinued|0|||
19378733|NCT02217982|41621571|FG000|Overall Study|Adverse Event|0|||
19378734|NCT02217982|41621572|FG001|Overall Study|Adverse Event|1|||
19378735|NCT02254408|41621580|FG000|Overall Study|Randomized But Not Treated|1|||
19378736|NCT02254408|41621581|FG001|Overall Study|Randomized But Not Treated|3|||
19378737|NCT02254408|41621580|FG000|Overall Study|Adverse Event|1|||
19378738|NCT02254408|41621581|FG001|Overall Study|Adverse Event|0|||
19378739|NCT02254408|41621580|FG000|Overall Study|Death|2|||
19378740|NCT02254408|41621581|FG001|Overall Study|Death|3|||
19378741|NCT02254408|41621580|FG000|Overall Study|Investigator's Discretion|0|||
19378742|NCT02254408|41621581|FG001|Overall Study|Investigator's Discretion|1|||
19378743|NCT02254408|41621580|FG000|Overall Study|Withdrawal by Subject|3|||
19378744|NCT02254408|41621581|FG001|Overall Study|Withdrawal by Subject|3|||
19378745|NCT02254408|41621580|FG000|Overall Study|Lost to Follow-up|1|||
19378746|NCT02254408|41621581|FG001|Overall Study|Lost to Follow-up|0|||
19378747|NCT02207608|41621589|FG000|Overall Study|Adverse Event|1|||
19378748|NCT02207608|41621590|FG001|Overall Study|Adverse Event|0|||
19378749|NCT03530995|41621598|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
19378750|NCT03530995|41621599|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
19378751|NCT03530995|41621598|FG000|Part 1 Period 3|Protocol Violation|1|||
19378752|NCT03530995|41621599|FG001|Part 1 Period 3|Protocol Violation|0|||
19378753|NCT03530995|41621598|FG000|Part 1 Period 4|Physician Decision|1|||
19378754|NCT03530995|41621599|FG001|Part 1 Period 4|Physician Decision|0|||
19378755|NCT03530995|41621598|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
19378756|NCT03530995|41621599|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
19378757|NCT02217436|41621623|FG000|Overall Study|Protocol Violation|1|||
19378758|NCT02217436|41621624|FG001|Overall Study|Protocol Violation|1|||
19378759|NCT02217436|41621623|FG000|Overall Study|Incomplete data|0|||
19378760|NCT02217436|41621624|FG001|Overall Study|Incomplete data|1|||
19378761|NCT02207530|41621630|FG000|Overall Study|Worsening condition under investigation|78|||
19378762|NCT02207530|41621630|FG000|Overall Study|Patient decision to stop study treatment|5|||
19378763|NCT02207530|41621630|FG000|Overall Study|Adverse Event|8|||
19378764|NCT02207374|41621637|FG000|Overall Study|Withdrawal by Subject|5|||
19378765|NCT02207374|41621638|FG001|Overall Study|Withdrawal by Subject|9|||
19378766|NCT02207374|41621639|FG002|Overall Study|Withdrawal by Subject|4|||
19378767|NCT02207374|41621637|FG000|Overall Study|Death|1|||
19378768|NCT02207374|41621638|FG001|Overall Study|Death|0|||
19378769|NCT02207374|41621639|FG002|Overall Study|Death|1|||
19378770|NCT02207374|41621637|FG000|Overall Study|Missing follow-up information|0|||
19378771|NCT02207374|41621638|FG001|Overall Study|Missing follow-up information|1|||
19378772|NCT02207374|41621639|FG002|Overall Study|Missing follow-up information|1|||
19378773|NCT02217280|41621647|FG000|Overall Study|Withdrawal by Subject|2|||
19378774|NCT02217280|41621647|FG000|Overall Study|Post-consent sceen fail|2|||
19378775|NCT02786537|41621658|FG000|As Randomized|Adverse Event|0|||
19378776|NCT02786537|41621659|FG001|As Randomized|Adverse Event|11|||
19378777|NCT02786537|41621660|FG002|As Randomized|Adverse Event|0|||
19378778|NCT02786537|41621661|FG003|As Randomized|Adverse Event|4|||
19378779|NCT02786537|41621662|FG004|As Randomized|Adverse Event|6|||
19378780|NCT02786537|41621663|FG005|As Randomized|Adverse Event|2|||
19378781|NCT02786537|41621658|FG000|As Randomized|Lack of Efficacy|0|||
19378782|NCT02786537|41621659|FG001|As Randomized|Lack of Efficacy|0|||
19378783|NCT02786537|41621660|FG002|As Randomized|Lack of Efficacy|0|||
19378784|NCT02786537|41621661|FG003|As Randomized|Lack of Efficacy|1|||
19378785|NCT02786537|41621662|FG004|As Randomized|Lack of Efficacy|0|||
19378786|NCT02786537|41621663|FG005|As Randomized|Lack of Efficacy|0|||
19378787|NCT02786537|41621658|FG000|As Randomized|Withdrawal by Subject|1|||
19378788|NCT02786537|41621659|FG001|As Randomized|Withdrawal by Subject|2|||
19378789|NCT02786537|41621660|FG002|As Randomized|Withdrawal by Subject|0|||
19378790|NCT02786537|41621661|FG003|As Randomized|Withdrawal by Subject|1|||
19378791|NCT02786537|41621662|FG004|As Randomized|Withdrawal by Subject|1|||
19378792|NCT02786537|41621663|FG005|As Randomized|Withdrawal by Subject|0|||
19378793|NCT02786537|41621658|FG000|As Randomized|Death|0|||
19378794|NCT02786537|41621659|FG001|As Randomized|Death|2|||
19378795|NCT02786537|41621660|FG002|As Randomized|Death|0|||
19378796|NCT02786537|41621661|FG003|As Randomized|Death|3|||
19378797|NCT02786537|41621662|FG004|As Randomized|Death|1|||
19378798|NCT02786537|41621663|FG005|As Randomized|Death|0|||
19378799|NCT02786537|41621658|FG000|As Randomized|Non-compliance with study drug|1|||
19378800|NCT02786537|41621659|FG001|As Randomized|Non-compliance with study drug|11|||
19378801|NCT02786537|41621660|FG002|As Randomized|Non-compliance with study drug|0|||
19378802|NCT02786537|41621661|FG003|As Randomized|Non-compliance with study drug|1|||
19378803|NCT02786537|41621662|FG004|As Randomized|Non-compliance with study drug|0|||
19378804|NCT02786537|41621663|FG005|As Randomized|Non-compliance with study drug|1|||
19378805|NCT02786537|41621658|FG000|As Randomized|Lost to treatment follow-up|4|||
19378806|NCT02786537|41621659|FG001|As Randomized|Lost to treatment follow-up|32|||
19378807|NCT02786537|41621660|FG002|As Randomized|Lost to treatment follow-up|0|||
19378808|NCT02786537|41621661|FG003|As Randomized|Lost to treatment follow-up|24|||
19378809|NCT02786537|41621662|FG004|As Randomized|Lost to treatment follow-up|4|||
19378810|NCT02786537|41621663|FG005|As Randomized|Lost to treatment follow-up|4|||
19378811|NCT02786537|41621658|FG000|As Randomized|Incarceration|0|||
19378812|NCT02786537|41621659|FG001|As Randomized|Incarceration|1|||
19378813|NCT02786537|41621660|FG002|As Randomized|Incarceration|0|||
19378814|NCT02786537|41621661|FG003|As Randomized|Incarceration|0|||
19378815|NCT02786537|41621662|FG004|As Randomized|Incarceration|0|||
19378816|NCT02786537|41621663|FG005|As Randomized|Incarceration|0|||
19378817|NCT02786537|41621658|FG000|As Randomized|Opiate Dependency Relapse|0|||
19378818|NCT02786537|41621659|FG001|As Randomized|Opiate Dependency Relapse|1|||
19378819|NCT02786537|41621660|FG002|As Randomized|Opiate Dependency Relapse|0|||
19378820|NCT02786537|41621661|FG003|As Randomized|Opiate Dependency Relapse|0|||
19378821|NCT02786537|41621662|FG004|As Randomized|Opiate Dependency Relapse|0|||
19378822|NCT02786537|41621663|FG005|As Randomized|Opiate Dependency Relapse|0|||
19378823|NCT02786537|41621658|FG000|As Randomized|HCV drugs stolen from pt|0|||
19378824|NCT02786537|41621659|FG001|As Randomized|HCV drugs stolen from pt|1|||
19378825|NCT02786537|41621660|FG002|As Randomized|HCV drugs stolen from pt|0|||
19378826|NCT02786537|41621661|FG003|As Randomized|HCV drugs stolen from pt|0|||
19378827|NCT02786537|41621662|FG004|As Randomized|HCV drugs stolen from pt|0|||
19378828|NCT02786537|41621663|FG005|As Randomized|HCV drugs stolen from pt|0|||
19378829|NCT02786537|41621658|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
19378830|NCT02786537|41621659|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
19378831|NCT02786537|41621660|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
19378832|NCT02786537|41621661|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
19378833|NCT02786537|41621662|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
19378834|NCT02786537|41621663|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
19378835|NCT02786537|41621658|FG000|As Randomized|Subject lost insurance|0|||
19378836|NCT02786537|41621659|FG001|As Randomized|Subject lost insurance|0|||
19378837|NCT02786537|41621660|FG002|As Randomized|Subject lost insurance|0|||
19378838|NCT02786537|41621661|FG003|As Randomized|Subject lost insurance|1|||
19378839|NCT02786537|41621662|FG004|As Randomized|Subject lost insurance|0|||
19378840|NCT02786537|41621663|FG005|As Randomized|Subject lost insurance|0|||
19378841|NCT02786537|41621658|FG000|As Treated|Adverse Event|0|||
19378842|NCT02786537|41621659|FG001|As Treated|Adverse Event|11|||
19378843|NCT02786537|41621660|FG002|As Treated|Adverse Event|0|||
19378844|NCT02786537|41621661|FG003|As Treated|Adverse Event|4|||
19378845|NCT02786537|41621662|FG004|As Treated|Adverse Event|6|||
19378846|NCT02786537|41621663|FG005|As Treated|Adverse Event|2|||
19378847|NCT02786537|41621658|FG000|As Treated|Death|0|||
19378848|NCT02786537|41621659|FG001|As Treated|Death|2|||
19378849|NCT02786537|41621660|FG002|As Treated|Death|0|||
19378850|NCT02786537|41621661|FG003|As Treated|Death|3|||
19378851|NCT02786537|41621662|FG004|As Treated|Death|1|||
19378852|NCT02786537|41621663|FG005|As Treated|Death|0|||
19378853|NCT02786537|41621658|FG000|As Treated|Lack of Efficacy|0|||
19378854|NCT02786537|41621659|FG001|As Treated|Lack of Efficacy|0|||
19378855|NCT02786537|41621660|FG002|As Treated|Lack of Efficacy|0|||
19378856|NCT02786537|41621661|FG003|As Treated|Lack of Efficacy|1|||
19378857|NCT02786537|41621662|FG004|As Treated|Lack of Efficacy|0|||
19378858|NCT02786537|41621663|FG005|As Treated|Lack of Efficacy|0|||
19378859|NCT02786537|41621658|FG000|As Treated|Lost to Follow-up|4|||
19378860|NCT02786537|41621659|FG001|As Treated|Lost to Follow-up|32|||
19378861|NCT02786537|41621660|FG002|As Treated|Lost to Follow-up|0|||
19378862|NCT02786537|41621661|FG003|As Treated|Lost to Follow-up|25|||
19378863|NCT02786537|41621662|FG004|As Treated|Lost to Follow-up|4|||
19378864|NCT02786537|41621663|FG005|As Treated|Lost to Follow-up|4|||
19378865|NCT02786537|41621658|FG000|As Treated|Non-compliance with study drug|1|||
19378866|NCT02786537|41621659|FG001|As Treated|Non-compliance with study drug|11|||
19378867|NCT02786537|41621660|FG002|As Treated|Non-compliance with study drug|0|||
19378868|NCT02786537|41621661|FG003|As Treated|Non-compliance with study drug|1|||
19378869|NCT02786537|41621662|FG004|As Treated|Non-compliance with study drug|0|||
19378870|NCT02786537|41621663|FG005|As Treated|Non-compliance with study drug|1|||
19378871|NCT02786537|41621658|FG000|As Treated|Lost insurance|0|||
19378872|NCT02786537|41621659|FG001|As Treated|Lost insurance|0|||
19378873|NCT02786537|41621660|FG002|As Treated|Lost insurance|0|||
19378874|NCT02786537|41621661|FG003|As Treated|Lost insurance|1|||
19378875|NCT02786537|41621662|FG004|As Treated|Lost insurance|0|||
19378876|NCT02786537|41621663|FG005|As Treated|Lost insurance|0|||
19378877|NCT02786537|41621658|FG000|As Treated|Withdrawal by Subject|1|||
19378878|NCT02786537|41621659|FG001|As Treated|Withdrawal by Subject|2|||
19378879|NCT02786537|41621660|FG002|As Treated|Withdrawal by Subject|0|||
19378880|NCT02786537|41621661|FG003|As Treated|Withdrawal by Subject|0|||
19378881|NCT02786537|41621662|FG004|As Treated|Withdrawal by Subject|1|||
19378882|NCT02786537|41621663|FG005|As Treated|Withdrawal by Subject|0|||
19378883|NCT02786537|41621658|FG000|As Treated|Incarceration|0|||
19378884|NCT02786537|41621659|FG001|As Treated|Incarceration|1|||
19378885|NCT02786537|41621660|FG002|As Treated|Incarceration|0|||
19378886|NCT02786537|41621661|FG003|As Treated|Incarceration|0|||
19378887|NCT02786537|41621662|FG004|As Treated|Incarceration|0|||
19378888|NCT02786537|41621663|FG005|As Treated|Incarceration|0|||
19378889|NCT02786537|41621658|FG000|As Treated|Opiate dependency relapse|0|||
19378890|NCT02786537|41621659|FG001|As Treated|Opiate dependency relapse|1|||
19378891|NCT02786537|41621660|FG002|As Treated|Opiate dependency relapse|0|||
19378892|NCT02786537|41621661|FG003|As Treated|Opiate dependency relapse|0|||
19378893|NCT02786537|41621662|FG004|As Treated|Opiate dependency relapse|0|||
19378894|NCT02786537|41621663|FG005|As Treated|Opiate dependency relapse|0|||
19378895|NCT02786537|41621658|FG000|As Treated|Drugs stolen from patient|0|||
19378896|NCT02786537|41621659|FG001|As Treated|Drugs stolen from patient|1|||
19378897|NCT02786537|41621660|FG002|As Treated|Drugs stolen from patient|0|||
19378898|NCT02786537|41621661|FG003|As Treated|Drugs stolen from patient|0|||
19378899|NCT02786537|41621662|FG004|As Treated|Drugs stolen from patient|0|||
19378900|NCT02786537|41621663|FG005|As Treated|Drugs stolen from patient|0|||
19378901|NCT02786537|41621658|FG000|As Treated|Advised to stop tx after loss of meds|0|||
19378902|NCT02786537|41621659|FG001|As Treated|Advised to stop tx after loss of meds|1|||
19378903|NCT02786537|41621660|FG002|As Treated|Advised to stop tx after loss of meds|0|||
19378904|NCT02786537|41621661|FG003|As Treated|Advised to stop tx after loss of meds|0|||
19378905|NCT02786537|41621662|FG004|As Treated|Advised to stop tx after loss of meds|0|||
19378906|NCT02786537|41621663|FG005|As Treated|Advised to stop tx after loss of meds|0|||
19378907|NCT02216812|41621771|FG000|Overall Study|Lost to Follow-up|10|||
19378908|NCT02216812|41621772|FG001|Overall Study|Lost to Follow-up|5|||
19378909|NCT02252536|41621780|FG000|Overall Study|Lost to Follow-up|5|||
19378910|NCT02252536|41621781|FG001|Overall Study|Lost to Follow-up|3|||
19378911|NCT02206828|41621787|FG000|Overall Study|Lost to Follow-up|7|||
19378912|NCT01209767|41621814|FG000|Overall Study|Withdrawal by Subject|1|||
19378913|NCT01209767|41621814|FG000|Overall Study|Lost to Follow-up|3|||
19378914|NCT02252146|41621822|FG000|Overall Study|Lack of Efficacy|4|||
19378915|NCT02252146|41621822|FG000|Overall Study|Entered hospice care|1|||
19378916|NCT02252146|41621822|FG000|Overall Study|Inability to travel to study site|1|||
19378917|NCT02500589|41621828|FG000|Overall Study|Withdrawal by Subject|11|||
19378918|NCT02500589|41621829|FG001|Overall Study|Withdrawal by Subject|14|||
19378919|NCT02500589|41621828|FG000|Overall Study|Lost to Follow-up|10|||
19378920|NCT02500589|41621829|FG001|Overall Study|Lost to Follow-up|12|||
19378921|NCT02500589|41621828|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
19378922|NCT02500589|41621829|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
19378923|NCT02500589|41621828|FG000|Overall Study|Death|7|||
19378924|NCT02500589|41621829|FG001|Overall Study|Death|5|||
19378925|NCT02251990|41621841|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
19378926|NCT02251990|41621842|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
19378927|NCT02251990|41621841|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
19378928|NCT02251990|41621842|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
19378929|NCT02251990|41621841|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
19378930|NCT02251990|41621842|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
19378931|NCT02251990|41621841|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
19378932|NCT02251990|41621842|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
19378933|NCT02251990|41621841|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
19378934|NCT02251990|41621842|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
19378935|NCT02251990|41621841|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
19378936|NCT02251990|41621842|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
19378937|NCT02251912|41621851|FG000|Overall Study|Withdrawal by Subject|2|||
19378938|NCT02251912|41621852|FG001|Overall Study|Withdrawal by Subject|3|||
19378939|NCT02251912|41621851|FG000|Overall Study|Adverse Event|0|||
19378940|NCT02251912|41621852|FG001|Overall Study|Adverse Event|2|||
19378941|NCT02206048|41621867|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
19378942|NCT02205814|41621879|FG000|Overall Study|Lost to Follow-up|0|||
19378943|NCT02205814|41621880|FG001|Overall Study|Lost to Follow-up|0|||
19378944|NCT02205814|41621881|FG002|Overall Study|Lost to Follow-up|0|||
19464530|NCT01928381|41722825|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
19378945|NCT02205814|41621882|FG003|Overall Study|Lost to Follow-up|1|||
19378946|NCT02205814|41621879|FG000|Overall Study|Lack of Efficacy|1|||
19378947|NCT02205814|41621880|FG001|Overall Study|Lack of Efficacy|0|||
19378948|NCT02205814|41621881|FG002|Overall Study|Lack of Efficacy|1|||
19378949|NCT02205814|41621882|FG003|Overall Study|Lack of Efficacy|1|||
19378950|NCT02205814|41621879|FG000|Overall Study|Physician Decision|0|||
19378951|NCT02205814|41621880|FG001|Overall Study|Physician Decision|0|||
19378952|NCT02205814|41621881|FG002|Overall Study|Physician Decision|1|||
19378953|NCT02205814|41621882|FG003|Overall Study|Physician Decision|0|||
19378954|NCT02205814|41621879|FG000|Overall Study|Protocol Violation|1|||
19378955|NCT02205814|41621880|FG001|Overall Study|Protocol Violation|0|||
19378956|NCT02205814|41621881|FG002|Overall Study|Protocol Violation|0|||
19378957|NCT02205814|41621882|FG003|Overall Study|Protocol Violation|1|||
19378958|NCT02205814|41621879|FG000|Overall Study|Withdrawal by Subject|0|||
19378959|NCT02205814|41621880|FG001|Overall Study|Withdrawal by Subject|1|||
19378960|NCT02205814|41621881|FG002|Overall Study|Withdrawal by Subject|2|||
19378961|NCT02205814|41621882|FG003|Overall Study|Withdrawal by Subject|1|||
19378962|NCT02205814|41621879|FG000|Overall Study|not compliant with study procedures|0|||
19378963|NCT02205814|41621880|FG001|Overall Study|not compliant with study procedures|0|||
19378964|NCT02205814|41621881|FG002|Overall Study|not compliant with study procedures|1|||
19378965|NCT02205814|41621882|FG003|Overall Study|not compliant with study procedures|0|||
19378966|NCT02662985|41621894|FG000|Treatment Period 1|Adverse Event|0|||
19378967|NCT02662985|41621895|FG001|Treatment Period 1|Adverse Event|2|||
19378968|NCT02662985|41621894|FG000|Treatment Period 1|Protocol Violation|0|||
19378969|NCT02662985|41621895|FG001|Treatment Period 1|Protocol Violation|1|||
19378970|NCT02662985|41621894|FG000|Treatment Period 1|Physician Decision|1|||
19378971|NCT02662985|41621895|FG001|Treatment Period 1|Physician Decision|0|||
19378972|NCT02662985|41621894|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19378973|NCT02662985|41621895|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19378974|NCT02662985|41621894|FG000|Treatment Period 2|Lack of Efficacy|0|||
19378975|NCT02662985|41621895|FG001|Treatment Period 2|Lack of Efficacy|1|||
19378976|NCT02662985|41621894|FG000|Treatment Period 2|Lost to Follow-up|1|||
19378977|NCT02662985|41621895|FG001|Treatment Period 2|Lost to Follow-up|0|||
19378978|NCT02662985|41621894|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
19378979|NCT02662985|41621895|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
19378980|NCT02662985|41621894|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
19378981|NCT02662985|41621895|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
19378982|NCT02662985|41621894|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
19378983|NCT02662985|41621895|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
19378984|NCT02662985|41621894|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
19378985|NCT02662985|41621895|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
19378986|NCT02662985|41621894|FG000|Treatment Period 3 (Extension Period)|Death|0|||
19378987|NCT02662985|41621895|FG001|Treatment Period 3 (Extension Period)|Death|1|||
19378988|NCT01631812|41621901|FG000|Overall Study|Adverse Event|25|||
19378989|NCT01631812|41621901|FG000|Overall Study|Lack of Efficacy|5|||
19378990|NCT01631812|41621901|FG000|Overall Study|Withdrawal by Subject|4|||
19378991|NCT01631812|41621901|FG000|Overall Study|Physician Decision|3|||
19378992|NCT02323295|41621907|FG000|Overall Study|Adverse Event|0|||
19378993|NCT02323295|41621908|FG001|Overall Study|Adverse Event|1|||
19378994|NCT02323295|41621907|FG000|Overall Study|Withdrawal by Subject|0|||
19378995|NCT02323295|41621908|FG001|Overall Study|Withdrawal by Subject|1|||
19378996|NCT02323295|41621907|FG000|Overall Study|Patient did not have surgery as planned.|0|||
19378997|NCT02323295|41621908|FG001|Overall Study|Patient did not have surgery as planned.|1|||
19378998|NCT02215954|41621917|FG000|Overall Study|Adverse Event|0|||
19378999|NCT02215954|41621918|FG001|Overall Study|Adverse Event|0|||
19379000|NCT02215954|41621919|FG002|Overall Study|Adverse Event|1|||
19379001|NCT02215954|41621917|FG000|Overall Study|Withdrawal by Subject|0|||
19379002|NCT02215954|41621918|FG001|Overall Study|Withdrawal by Subject|0|||
19464531|NCT01928381|41722819|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
19464532|NCT01928381|41722820|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
19464533|NCT01928381|41722821|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
19379003|NCT02215954|41621919|FG002|Overall Study|Withdrawal by Subject|2|||
19379004|NCT02215954|41621917|FG000|Overall Study|Not exposed|1|||
19379005|NCT02215954|41621918|FG001|Overall Study|Not exposed|1|||
19379006|NCT02215954|41621919|FG002|Overall Study|Not exposed|3|||
19379007|NCT01941719|41621930|FG000|Overall Study|Lost to Follow-up|20|||
19379008|NCT01941719|41621931|FG001|Overall Study|Lost to Follow-up|19|||
19379009|NCT02215252|41621941|FG000|Overall Study|Adverse Event|1|||
19379010|NCT02215252|41621942|FG001|Overall Study|Adverse Event|5|||
19379011|NCT02215252|41621943|FG002|Overall Study|Adverse Event|2|||
19379012|NCT02215252|41621941|FG000|Overall Study|Lost to Follow-up|0|||
19379013|NCT02215252|41621942|FG001|Overall Study|Lost to Follow-up|0|||
19379014|NCT02215252|41621943|FG002|Overall Study|Lost to Follow-up|1|||
19379015|NCT02215252|41621941|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
19379016|NCT02215252|41621942|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
19379017|NCT02215252|41621943|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
19379018|NCT02215252|41621941|FG000|Overall Study|Protocol Violation|0|||
19379019|NCT02215252|41621942|FG001|Overall Study|Protocol Violation|1|||
19379020|NCT02215252|41621943|FG002|Overall Study|Protocol Violation|0|||
19379021|NCT02215252|41621941|FG000|Overall Study|Withdrawal by Subject|1|||
19379022|NCT02215252|41621942|FG001|Overall Study|Withdrawal by Subject|0|||
19379023|NCT02215252|41621943|FG002|Overall Study|Withdrawal by Subject|0|||
19379024|NCT02215252|41621941|FG000|Overall Study|Other|0|||
19379025|NCT02215252|41621942|FG001|Overall Study|Other|1|||
19379026|NCT02215252|41621943|FG002|Overall Study|Other|1|||
19379027|NCT02204410|41621951|FG000|Overall Study|Lost to Follow-up|5|||
19379028|NCT02204410|41621951|FG000|Overall Study|Physician Decision|2|||
19379029|NCT02204410|41621951|FG000|Overall Study|Protocol Violation|1|||
19379030|NCT02204410|41621951|FG000|Overall Study|Withdrawal by Subject|3|||
19379031|NCT02250274|41621957|FG000|Overall Study|Insufficient blood draw amount|7|||
19379032|NCT02250274|41621958|FG001|Overall Study|Insufficient blood draw amount|6|||
19379033|NCT02213458|41621972|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
19379034|NCT02213458|41621973|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
19379035|NCT02213458|41621972|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
19379036|NCT02213458|41621973|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
19379037|NCT02213458|41621972|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
19379038|NCT02213458|41621973|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
19379039|NCT02213458|41621972|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
19379040|NCT02213458|41621973|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
19379041|NCT02213458|41621972|FG000|Overall Study|Refused re-consent|6|||
19379042|NCT02213458|41621973|FG001|Overall Study|Refused re-consent|0|||
19379043|NCT02213458|41621972|FG000|Overall Study|Lost to Follow-up|2|||
19379044|NCT02213458|41621973|FG001|Overall Study|Lost to Follow-up|2|||
19379045|NCT02213458|41621972|FG000|Overall Study|Withdrawal by Subject|26|||
19379046|NCT02213458|41621973|FG001|Overall Study|Withdrawal by Subject|8|||
19379047|NCT02213380|41621981|FG000|Underwent Randomization|Withdrawal by Subject|2|||
19379048|NCT02213380|41621982|FG001|Underwent Randomization|Withdrawal by Subject|0|||
19379049|NCT02213380|41621981|FG000|Underwent Randomization|Not treated|3|||
19379050|NCT02213380|41621982|FG001|Underwent Randomization|Not treated|3|||
19379051|NCT02213380|41621981|FG000|Per-protocol Analysis|Protocol Violation|32|||
19379052|NCT02213380|41621982|FG001|Per-protocol Analysis|Protocol Violation|36|||
19379053|NCT02202850|41621990|FG000|Overall Study|Other|2|||
19379054|NCT02202850|41621991|FG001|Overall Study|Other|2|||
19379055|NCT02202850|41621990|FG000|Overall Study|Enbrel treatment discontinued|15|||
19379056|NCT02202850|41621991|FG001|Overall Study|Enbrel treatment discontinued|3|||
19379057|NCT02202850|41621990|FG000|Overall Study|Lost to Follow-up|7|||
19379058|NCT02202850|41621991|FG001|Overall Study|Lost to Follow-up|1|||
19379059|NCT02212678|41621997|FG000|Overall Study|Adverse Event|1|||
19379060|NCT03104075|41622003|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
19379061|NCT03104075|41622004|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
19379062|NCT03038087|41622011|FG000|Overall Study|lost data|1|||
19379063|NCT02249182|41622022|FG000|Treatment Phase|Lost to Follow-up|4|||
19379064|NCT02249182|41622023|FG001|Treatment Phase|Lost to Follow-up|0|||
19379065|NCT02249182|41622024|FG002|Treatment Phase|Lost to Follow-up|0|||
19379066|NCT02249182|41622025|FG003|Treatment Phase|Lost to Follow-up|0|||
19379067|NCT02249182|41622026|FG004|Treatment Phase|Lost to Follow-up|0|||
19379068|NCT03641339|41622066|FG000|Overall Study|Physician Decision|1|||
19379069|NCT03641339|41622067|FG001|Overall Study|Physician Decision|0|||
19379070|NCT03641339|41622068|FG002|Overall Study|Physician Decision|0|||
19379071|NCT03641339|41622069|FG003|Overall Study|Physician Decision|0|||
19379072|NCT03641339|41622070|FG004|Overall Study|Physician Decision|0|||
19379073|NCT03641339|41622071|FG005|Overall Study|Physician Decision|0|||
19379074|NCT03641339|41622066|FG000|Overall Study|Withdrawal by Subject|0|||
19379075|NCT03641339|41622067|FG001|Overall Study|Withdrawal by Subject|2|||
19379076|NCT03641339|41622068|FG002|Overall Study|Withdrawal by Subject|0|||
19379077|NCT03641339|41622069|FG003|Overall Study|Withdrawal by Subject|2|||
19379078|NCT03641339|41622070|FG004|Overall Study|Withdrawal by Subject|0|||
19379079|NCT03641339|41622071|FG005|Overall Study|Withdrawal by Subject|1|||
19379080|NCT02248480|41622087|FG000|Overall Study|Lack of Efficacy|4|||
19379081|NCT02248480|41622088|FG001|Overall Study|Lack of Efficacy|6|||
19379082|NCT02248480|41622087|FG000|Overall Study|Adverse Event|11|||
19379083|NCT02248480|41622088|FG001|Overall Study|Adverse Event|2|||
19379084|NCT02248480|41622087|FG000|Overall Study|Withdrawal by Subject|2|||
19379085|NCT02248480|41622088|FG001|Overall Study|Withdrawal by Subject|4|||
19379086|NCT02248480|41622087|FG000|Overall Study|Entry Criteria Not Met|0|||
19379087|NCT02248480|41622088|FG001|Overall Study|Entry Criteria Not Met|1|||
19379088|NCT02248480|41622087|FG000|Overall Study|Other:Physician Decision|0|||
19379089|NCT02248480|41622088|FG001|Overall Study|Other:Physician Decision|1|||
19379090|NCT01653158|41622095|FG000|Overall Study|Death|0|||
19379091|NCT01653158|41622096|FG001|Overall Study|Death|0|||
19379092|NCT01653158|41622097|FG002|Overall Study|Death|0|||
19379093|NCT01653158|41622098|FG003|Overall Study|Death|1|||
19379094|NCT01653158|41622099|FG004|Overall Study|Death|0|||
19379095|NCT01653158|41622100|FG005|Overall Study|Death|0|||
19379096|NCT01653158|41622101|FG006|Overall Study|Death|0|||
19379097|NCT01653158|41622102|FG007|Overall Study|Death|2|||
19379098|NCT01653158|41622095|FG000|Overall Study|Adverse Event|0|||
19379099|NCT01653158|41622096|FG001|Overall Study|Adverse Event|0|||
19379100|NCT01653158|41622097|FG002|Overall Study|Adverse Event|0|||
19379101|NCT01653158|41622098|FG003|Overall Study|Adverse Event|1|||
19379102|NCT01653158|41622099|FG004|Overall Study|Adverse Event|0|||
19379103|NCT01653158|41622100|FG005|Overall Study|Adverse Event|0|||
19379104|NCT01653158|41622101|FG006|Overall Study|Adverse Event|0|||
19379105|NCT01653158|41622102|FG007|Overall Study|Adverse Event|3|||
19379106|NCT01653158|41622095|FG000|Overall Study|Other|0|||
19379107|NCT01653158|41622096|FG001|Overall Study|Other|0|||
19379108|NCT01653158|41622097|FG002|Overall Study|Other|0|||
19379109|NCT01653158|41622098|FG003|Overall Study|Other|0|||
19379110|NCT01653158|41622099|FG004|Overall Study|Other|0|||
19379111|NCT01653158|41622100|FG005|Overall Study|Other|0|||
19379112|NCT01653158|41622101|FG006|Overall Study|Other|0|||
19379113|NCT01653158|41622102|FG007|Overall Study|Other|1|||
19379114|NCT01653158|41622095|FG000|Overall Study|Progressive disease|0|||
19379115|NCT01653158|41622096|FG001|Overall Study|Progressive disease|0|||
19379116|NCT01653158|41622097|FG002|Overall Study|Progressive disease|0|||
19379117|NCT01653158|41622098|FG003|Overall Study|Progressive disease|0|||
19379118|NCT01653158|41622099|FG004|Overall Study|Progressive disease|1|||
19379119|NCT01653158|41622100|FG005|Overall Study|Progressive disease|1|||
19379120|NCT01653158|41622101|FG006|Overall Study|Progressive disease|2|||
19379121|NCT01653158|41622102|FG007|Overall Study|Progressive disease|9|||
19379122|NCT01653158|41622095|FG000|Overall Study|Withdrawal by Subject|1|||
19379123|NCT01653158|41622096|FG001|Overall Study|Withdrawal by Subject|0|||
19379124|NCT01653158|41622097|FG002|Overall Study|Withdrawal by Subject|0|||
19379125|NCT01653158|41622098|FG003|Overall Study|Withdrawal by Subject|0|||
19379126|NCT01653158|41622099|FG004|Overall Study|Withdrawal by Subject|0|||
19379127|NCT01653158|41622100|FG005|Overall Study|Withdrawal by Subject|0|||
19379128|NCT01653158|41622101|FG006|Overall Study|Withdrawal by Subject|0|||
19379129|NCT01653158|41622102|FG007|Overall Study|Withdrawal by Subject|0|||
19379130|NCT02247466|41622127|FG000|Overall Study|Procedure changed to open surgery|0|||
19379131|NCT02247466|41622128|FG001|Overall Study|Procedure changed to open surgery|3|||
19379132|NCT03317795|41622136|FG000|Overall Study|IUD Expulsion|1|||
19379133|NCT03317795|41622137|FG001|Overall Study|IUD Expulsion|0|||
19379134|NCT03317795|41622136|FG000|Overall Study|Lost to Follow-up|1|||
19379135|NCT03317795|41622137|FG001|Overall Study|Lost to Follow-up|3|||
19379136|NCT03317795|41622136|FG000|Overall Study|Treatment change|0|||
19379137|NCT03317795|41622137|FG001|Overall Study|Treatment change|3|||
19379138|NCT03317795|41622136|FG000|Overall Study|Intolerance of medication|0|||
19379139|NCT03317795|41622137|FG001|Overall Study|Intolerance of medication|1|||
19379140|NCT02202616|41622143|FG000|Overall Study|Screen failed|24|||
19379141|NCT02202616|41622143|FG000|Overall Study|Adverse Event|32|||
19379142|NCT02202616|41622143|FG000|Overall Study|Protocol deviation|18|||
19379143|NCT02202616|41622143|FG000|Overall Study|Patient withdrew consent|12|||
19379144|NCT02202616|41622143|FG000|Overall Study|Lost to Follow-up|6|||
19379145|NCT02202616|41622143|FG000|Overall Study|Administrative problems|6|||
19379146|NCT02202616|41622143|FG000|Overall Study|Abnormal test procedure result|1|||
19379147|NCT02202616|41622143|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19379148|NCT02455388|41622150|FG000|Overall Study|Protocol Violation|1|||
19379149|NCT02455388|41622151|FG001|Overall Study|Protocol Violation|0|||
19379150|NCT02455388|41622152|FG002|Overall Study|Protocol Violation|4|||
19379151|NCT02455388|41622150|FG000|Overall Study|Withdrawal by Subject|0|||
19379152|NCT02455388|41622151|FG001|Overall Study|Withdrawal by Subject|0|||
19379153|NCT02455388|41622152|FG002|Overall Study|Withdrawal by Subject|7|||
19379154|NCT02455076|41622165|FG000|Inpatient|Withdrawal by Subject|1|||
19379155|NCT02455076|41622166|FG001|Inpatient|Withdrawal by Subject|0|||
19464534|NCT01928381|41722822|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
19464535|NCT01928381|41722823|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
19464536|NCT01928381|41722824|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
19464537|NCT01928381|41722825|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
19464538|NCT01928381|41722819|FG000|Part 1 - Pain Training|Protocol Violation|1|||
19464539|NCT01928381|41722820|FG001|Part 1 - Pain Training|Protocol Violation|0|||
19464540|NCT01928381|41722821|FG002|Part 1 - Pain Training|Protocol Violation|0|||
19464541|NCT01928381|41722822|FG003|Part 1 - Pain Training|Protocol Violation|0|||
19464542|NCT01928381|41722823|FG004|Part 1 - Pain Training|Protocol Violation|0|||
19464543|NCT01928381|41722824|FG005|Part 1 - Pain Training|Protocol Violation|0|||
19464544|NCT01928381|41722825|FG006|Part 1 - Pain Training|Protocol Violation|0|||
19464545|NCT01928381|41722819|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
19464546|NCT01928381|41722820|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19464547|NCT01928381|41722821|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19464548|NCT01928381|41722822|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19379156|NCT02455076|41622167|FG002|Inpatient|Withdrawal by Subject|0|||
19379157|NCT02455076|41622168|FG003|Inpatient|Withdrawal by Subject|0|||
19464549|NCT01928381|41722823|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19478085|NCT01693562|41757331|FG017|Exploration Phase|Other|0|||
19379158|NCT02455076|41622169|FG004|Inpatient|Withdrawal by Subject|0|||
19379159|NCT02455076|41622165|FG000|Inpatient|Discharged <24 h after admission|0|||
19379160|NCT02455076|41622166|FG001|Inpatient|Discharged <24 h after admission|1|||
19379161|NCT02455076|41622167|FG002|Inpatient|Discharged <24 h after admission|0|||
19379162|NCT02455076|41622168|FG003|Inpatient|Discharged <24 h after admission|0|||
19379163|NCT02455076|41622169|FG004|Inpatient|Discharged <24 h after admission|0|||
19379164|NCT02455076|41622165|FG000|Inpatient|Adverse Event|3|||
19379165|NCT02455076|41622166|FG001|Inpatient|Adverse Event|0|||
19379166|NCT02455076|41622167|FG002|Inpatient|Adverse Event|0|||
19379167|NCT02455076|41622168|FG003|Inpatient|Adverse Event|0|||
19379168|NCT02455076|41622169|FG004|Inpatient|Adverse Event|0|||
19379169|NCT02455076|41622165|FG000|Outpatient|Adverse Event|0|||
19379170|NCT02455076|41622166|FG001|Outpatient|Adverse Event|0|||
19379171|NCT02455076|41622167|FG002|Outpatient|Adverse Event|0|||
19379172|NCT02455076|41622168|FG003|Outpatient|Adverse Event|5|||
19379173|NCT02455076|41622169|FG004|Outpatient|Adverse Event|0|||
19379174|NCT02455076|41622165|FG000|Outpatient|Lost to Follow-up|0|||
19379175|NCT02455076|41622166|FG001|Outpatient|Lost to Follow-up|0|||
19379176|NCT02455076|41622167|FG002|Outpatient|Lost to Follow-up|0|||
19379177|NCT02455076|41622168|FG003|Outpatient|Lost to Follow-up|1|||
19379178|NCT02455076|41622169|FG004|Outpatient|Lost to Follow-up|12|||
19379179|NCT02433080|41622183|FG000|Overall Study|Lost to Follow-up|1|||
19379180|NCT02433080|41622184|FG001|Overall Study|Lost to Follow-up|2|||
19464550|NCT01928381|41722824|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19464551|NCT01928381|41722825|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
19464552|NCT01928381|41722819|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
19464553|NCT01928381|41722820|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464554|NCT01928381|41722821|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464555|NCT01928381|41722822|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464556|NCT01928381|41722823|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464557|NCT01928381|41722824|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464558|NCT01928381|41722825|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
19464559|NCT01928381|41722819|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
19464560|NCT01928381|41722820|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464561|NCT01928381|41722821|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464562|NCT01928381|41722822|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464563|NCT01928381|41722823|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464564|NCT01928381|41722824|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464565|NCT01928381|41722825|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
19464566|NCT01928381|41722819|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
19464567|NCT01928381|41722820|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464568|NCT01928381|41722821|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464569|NCT01928381|41722822|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464570|NCT01928381|41722823|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464571|NCT01928381|41722824|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464572|NCT01928381|41722825|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
19464573|NCT01928381|41722819|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464574|NCT01928381|41722820|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464575|NCT01928381|41722821|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
19464576|NCT01928381|41722822|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464577|NCT01928381|41722823|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464578|NCT01928381|41722824|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464579|NCT01928381|41722825|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
19464580|NCT01928381|41722819|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19379181|NCT02433080|41622183|FG000|Overall Study|Withdrawal by Subject|0|||
19379182|NCT02433080|41622184|FG001|Overall Study|Withdrawal by Subject|2|||
19379183|NCT03092219|41622193|FG000|Overall Study|Protocol Violation|7|||
19379184|NCT03092219|41622194|FG001|Overall Study|Protocol Violation|4|||
19379185|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Death|3|||
19379186|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Death|2|||
19379187|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Death|4|||
19379188|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Death|3|||
19379189|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Death|0|||
19379190|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Death|0|||
19379191|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
19379192|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
19379193|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
19379194|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
19379195|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
19379196|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
19379197|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
19379198|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
19379199|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
19379200|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
19379201|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
19379202|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
19379203|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
19379204|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
19379205|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
19379206|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
19379207|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
19379208|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
19379209|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
19379210|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
19379211|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
19379212|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
19379213|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
19379214|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
19379215|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
19379216|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
19379217|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
19379218|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
19379219|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
19379220|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
19379221|NCT02432846|41622209|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
19379222|NCT02432846|41622210|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
19379223|NCT02432846|41622211|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
19379224|NCT02432846|41622212|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
19379225|NCT02432846|41622213|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
19379226|NCT02432846|41622214|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
19379227|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
19379228|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
19379229|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
19379230|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
19379231|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
19379232|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
19379233|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
19379234|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
19379235|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
19379236|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
19379237|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
19379238|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
19379239|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
19379240|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
19379241|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
19379242|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
19379243|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
19379244|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
19379245|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
19379246|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
19379247|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
19379248|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
19478086|NCT01693562|41757332|FG018|Exploration Phase|Other|0|||
19379249|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
19379250|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
19379251|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
19379252|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
19379253|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
19379254|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
19379255|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
19464581|NCT01928381|41722820|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19464582|NCT01928381|41722821|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
19464583|NCT01928381|41722822|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19464584|NCT01928381|41722823|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19464585|NCT01928381|41722824|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19464586|NCT01928381|41722825|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
19464587|NCT01928381|41722819|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
19464588|NCT01928381|41722820|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
19464589|NCT01928381|41722821|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
19464590|NCT01928381|41722822|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
19464591|NCT01928381|41722823|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
19464592|NCT01928381|41722824|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
19464593|NCT01928381|41722825|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
19464594|NCT01928381|41722819|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
19464595|NCT01928381|41722820|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
19464596|NCT01928381|41722821|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
19464597|NCT01928381|41722822|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
19464598|NCT01928381|41722823|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
19464599|NCT01928381|41722824|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
19464600|NCT01928381|41722825|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
19464601|NCT01928381|41722819|FG000|Washout First Intervention|Protocol Violation|0|||
19464602|NCT01928381|41722820|FG001|Washout First Intervention|Protocol Violation|0|||
19464603|NCT01928381|41722821|FG002|Washout First Intervention|Protocol Violation|0|||
19464604|NCT01928381|41722822|FG003|Washout First Intervention|Protocol Violation|0|||
19464605|NCT01928381|41722823|FG004|Washout First Intervention|Protocol Violation|1|||
19464606|NCT01928381|41722824|FG005|Washout First Intervention|Protocol Violation|0|||
19464607|NCT01928381|41722825|FG006|Washout First Intervention|Protocol Violation|0|||
19464608|NCT01928381|41722819|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
19464609|NCT01928381|41722820|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
19464610|NCT01928381|41722821|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
19464611|NCT01928381|41722822|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
19464612|NCT01928381|41722823|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
19464613|NCT01928381|41722824|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
19464614|NCT01928381|41722825|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
19464615|NCT01928381|41722819|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464616|NCT01928381|41722820|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464617|NCT01928381|41722821|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
19464618|NCT01928381|41722822|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464619|NCT01928381|41722823|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464620|NCT01928381|41722824|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464621|NCT01928381|41722825|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
19464622|NCT01928225|41722837|FG000|Overall Study|Pregnancy|1|||
19464623|NCT01928225|41722838|FG001|Overall Study|Pregnancy|0|||
19464624|NCT01928225|41722837|FG000|Overall Study|basaloid cervical cancer|1|||
19464625|NCT01928225|41722838|FG001|Overall Study|basaloid cervical cancer|0|||
19464626|NCT01928225|41722837|FG000|Overall Study|Lost to Follow-up|1|||
19464627|NCT01928225|41722838|FG001|Overall Study|Lost to Follow-up|3|||
19464628|NCT01927757|41722845|FG000|Overall Study|Withdrawal by Subject|14|||
19464629|NCT01927757|41722845|FG000|Overall Study|Lost to Follow-up|2|||
19464630|NCT01927757|41722845|FG000|Overall Study|Decision by Sponsor|2|||
19464631|NCT01927757|41722845|FG000|Overall Study|Other|1|||
19464632|NCT01927757|41722845|FG000|Overall Study|Ethical Reasons|4|||
19464633|NCT01927367|41722855|FG000|Overall Study|Withdrawal by Subject|7|||
19464634|NCT01927367|41722856|FG001|Overall Study|Withdrawal by Subject|4|||
19464635|NCT01927367|41722855|FG000|Overall Study|No baseline data|0|||
19379256|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
19379257|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
19379258|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
19464636|NCT01927367|41722856|FG001|Overall Study|No baseline data|1|||
19464637|NCT01913639|41722862|FG000|Overall Study|Not Eligible|3|||
19464638|NCT01913483|41722868|FG000|Overall Study|Withdrawal by Subject|1|||
19464639|NCT01913483|41722869|FG001|Overall Study|Withdrawal by Subject|2|||
19464640|NCT01913483|41722868|FG000|Overall Study|Lost to Follow-up|6|||
19379259|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
19379260|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
19379261|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
19379262|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
19379263|NCT02432846|41622209|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
19379264|NCT02432846|41622210|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
19379265|NCT02432846|41622211|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
19379266|NCT02432846|41622212|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
19379267|NCT02432846|41622213|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
19379268|NCT02432846|41622214|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
19379269|NCT02432144|41622227|FG000|Overall Study|Participant Non-Compliance|1|||
19379270|NCT02246998|41622235|FG000|Overall Study|Adverse Event|0|||
19379271|NCT02246998|41622236|FG001|Overall Study|Adverse Event|1|||
19379272|NCT02246998|41622237|FG002|Overall Study|Adverse Event|1|||
19379273|NCT02246998|41622238|FG003|Overall Study|Adverse Event|0|||
19379274|NCT02246998|41622235|FG000|Overall Study|Lost to Follow-up|1|||
19379275|NCT02246998|41622236|FG001|Overall Study|Lost to Follow-up|0|||
19379276|NCT02246998|41622237|FG002|Overall Study|Lost to Follow-up|0|||
19379277|NCT02246998|41622238|FG003|Overall Study|Lost to Follow-up|1|||
19379278|NCT02246998|41622235|FG000|Overall Study|Randomized but Never Dosed|1|||
19379279|NCT02246998|41622236|FG001|Overall Study|Randomized but Never Dosed|2|||
19379280|NCT02246998|41622237|FG002|Overall Study|Randomized but Never Dosed|2|||
19379281|NCT02246998|41622238|FG003|Overall Study|Randomized but Never Dosed|1|||
19379282|NCT02486588|41622257|FG000|Overall Study|Randomized in error- ineligible|738|||
19379283|NCT02486588|41622258|FG001|Overall Study|Randomized in error- ineligible|750|||
19379284|NCT02486588|41622259|FG002|Overall Study|Randomized in error- ineligible|755|||
19379285|NCT02486588|41622260|FG003|Overall Study|Randomized in error- ineligible|738|||
19379286|NCT02486588|41622261|FG004|Overall Study|Randomized in error- ineligible|746|||
19379287|NCT02486588|41622262|FG005|Overall Study|Randomized in error- ineligible|746|||
19379288|NCT00805961|41622281|FG000|Modality Therapy|Withdrawal by Subject|1|||
19379289|NCT00805961|41622281|FG000|Modality Therapy|Adverse Event|1|||
19379290|NCT00805961|41622281|FG000|Modality Therapy|Disease Progression|2|||
19379291|NCT00805961|41622281|FG000|Treatment-Free Interval|Adverse Event|3|||
19379292|NCT00805961|41622281|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
19379293|NCT00805961|41622281|FG000|Treatment-Free Interval|Physician Decision|1|||
19379294|NCT00805961|41622281|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
19379295|NCT00805961|41622281|FG000|Maintenance Treatment|Lack of Efficacy|13|||
19379296|NCT00805961|41622281|FG000|Maintenance Treatment|Intercurrent Illness|7|||
19379297|NCT00805961|41622281|FG000|Maintenance Treatment|Adverse Event|6|||
19379298|NCT00805961|41622281|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
19379299|NCT00805961|41622281|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
19379300|NCT00805961|41622281|FG000|Maintenance Treatment|Withdrawn Consent|1|||
19379301|NCT02202538|41622285|FG000|Overall Study|Withdrawal by Subject|5|||
19379302|NCT02202538|41622285|FG000|Overall Study|Did not meet all inclusion criteria|2|||
19379303|NCT02202538|41622285|FG000|Overall Study|Investigator Decision|1|||
19379304|NCT02454608|41622292|FG000|Double-Blind Period|Lack of Efficacy|0|||
19379305|NCT02454608|41622293|FG001|Double-Blind Period|Lack of Efficacy|2|||
19379306|NCT02454608|41622294|FG002|Double-Blind Period|Lack of Efficacy|0|||
19379307|NCT02454608|41622292|FG000|Open Label Period|Lost to Follow-up|0|||
19379308|NCT02454608|41622293|FG001|Open Label Period|Lost to Follow-up|0|||
19379309|NCT02454608|41622294|FG002|Open Label Period|Lost to Follow-up|11|||
19379310|NCT02454608|41622292|FG000|Open Label Period|Withdrawal by Subject|0|||
19379311|NCT02454608|41622293|FG001|Open Label Period|Withdrawal by Subject|0|||
19379312|NCT02454608|41622294|FG002|Open Label Period|Withdrawal by Subject|8|||
19379313|NCT02246764|41622305|FG000|Overall Study|Adverse Event|15|||
19379314|NCT02246764|41622306|FG001|Overall Study|Adverse Event|29|||
19379315|NCT02246764|41622307|FG002|Overall Study|Adverse Event|1|||
19379316|NCT02246764|41622305|FG000|Overall Study|Withdrawal by Subject|0|||
19379317|NCT02246764|41622306|FG001|Overall Study|Withdrawal by Subject|0|||
19379318|NCT02246764|41622307|FG002|Overall Study|Withdrawal by Subject|1|||
19379319|NCT02246764|41622305|FG000|Overall Study|Disallowed Concomitant Medication|1|||
19379320|NCT02246764|41622306|FG001|Overall Study|Disallowed Concomitant Medication|0|||
19379321|NCT02246764|41622307|FG002|Overall Study|Disallowed Concomitant Medication|0|||
19379322|NCT02246764|41622305|FG000|Overall Study|Physician Decision|0|||
19379323|NCT02246764|41622306|FG001|Overall Study|Physician Decision|2|||
19379324|NCT02246764|41622307|FG002|Overall Study|Physician Decision|1|||
19379325|NCT02246764|41622305|FG000|Overall Study|Protocol Violation|2|||
19379326|NCT02246764|41622306|FG001|Overall Study|Protocol Violation|1|||
19379327|NCT02246764|41622307|FG002|Overall Study|Protocol Violation|1|||
19379328|NCT02454530|41622317|FG000|Overall Study|Other|8|||
19379329|NCT02454530|41622318|FG001|Overall Study|Other|13|||
19379330|NCT02454530|41622317|FG000|Overall Study|Missing information|56|||
19379331|NCT02454530|41622318|FG001|Overall Study|Missing information|69|||
19379332|NCT02454530|41622317|FG000|Overall Study|Death|2|||
19379333|NCT02454530|41622318|FG001|Overall Study|Death|41|||
19379334|NCT02454530|41622317|FG000|Overall Study|Lost to Follow-up|4|||
19379335|NCT02454530|41622318|FG001|Overall Study|Lost to Follow-up|4|||
19379336|NCT02431676|41622328|FG000|Overall Study|no lab obtained|0|||
19379337|NCT02431676|41622329|FG001|Overall Study|no lab obtained|1|||
19379338|NCT02431676|41622330|FG002|Overall Study|no lab obtained|2|||
19379339|NCT01654250|41622340|FG000|Overall Study|Lost to Follow-up|1|||
19379340|NCT01654250|41622341|FG001|Overall Study|Lost to Follow-up|0|||
19379341|NCT01652690|41622350|FG000|Overall Study|Withdrawal by Subject|16|||
19379342|NCT01652690|41622351|FG001|Overall Study|Withdrawal by Subject|4|||
19379343|NCT01652690|41622350|FG000|Overall Study|Other|8|||
19379344|NCT01652690|41622351|FG001|Overall Study|Other|9|||
19379345|NCT01652690|41622350|FG000|Overall Study|Lost to Follow-up|6|||
19379346|NCT01652690|41622351|FG001|Overall Study|Lost to Follow-up|6|||
19379347|NCT01652690|41622350|FG000|Overall Study|Death|5|||
19379348|NCT01652690|41622351|FG001|Overall Study|Death|2|||
19379349|NCT02429414|41622359|FG000|Overall Study|Physician Decision|0|||
19379350|NCT02429414|41622360|FG001|Overall Study|Physician Decision|1|||
19379351|NCT02429258|41622368|FG000|Overall Study|Withdrawal by Subject|2|||
19379352|NCT02429258|41622369|FG001|Overall Study|Withdrawal by Subject|0|||
19379353|NCT02429258|41622368|FG000|Overall Study|Protocol Violation|0|||
19379354|NCT02429258|41622369|FG001|Overall Study|Protocol Violation|1|||
19379355|NCT02201524|41622379|FG000|Overall Study|Adverse Event|0|||
19379356|NCT02201524|41622380|FG001|Overall Study|Adverse Event|2|||
19379357|NCT02201524|41622381|FG002|Overall Study|Adverse Event|1|||
19379358|NCT02201524|41622382|FG003|Overall Study|Adverse Event|0|||
19379359|NCT02201524|41622379|FG000|Overall Study|Insufficient clinical response|1|||
19379360|NCT02201524|41622380|FG001|Overall Study|Insufficient clinical response|0|||
19379361|NCT02201524|41622381|FG002|Overall Study|Insufficient clinical response|0|||
19379362|NCT02201524|41622382|FG003|Overall Study|Insufficient clinical response|0|||
19379363|NCT02201524|41622379|FG000|Overall Study|Lost to Follow-up|0|||
19379364|NCT02201524|41622380|FG001|Overall Study|Lost to Follow-up|0|||
19379365|NCT02201524|41622381|FG002|Overall Study|Lost to Follow-up|2|||
19379366|NCT02201524|41622382|FG003|Overall Study|Lost to Follow-up|0|||
19379367|NCT02201524|41622379|FG000|Overall Study|No longer meets eligibility criteria|0|||
19379368|NCT02201524|41622380|FG001|Overall Study|No longer meets eligibility criteria|0|||
19379369|NCT02201524|41622381|FG002|Overall Study|No longer meets eligibility criteria|0|||
19379370|NCT02201524|41622382|FG003|Overall Study|No longer meets eligibility criteria|2|||
19379371|NCT02201524|41622379|FG000|Overall Study|Protocol Violation|0|||
19379372|NCT02201524|41622380|FG001|Overall Study|Protocol Violation|0|||
19379373|NCT02201524|41622381|FG002|Overall Study|Protocol Violation|0|||
19379374|NCT02201524|41622382|FG003|Overall Study|Protocol Violation|1|||
19379375|NCT02201524|41622379|FG000|Overall Study|Withdrawal by Subject|0|||
19379376|NCT02201524|41622380|FG001|Overall Study|Withdrawal by Subject|0|||
19379377|NCT02201524|41622381|FG002|Overall Study|Withdrawal by Subject|1|||
19379378|NCT02201524|41622382|FG003|Overall Study|Withdrawal by Subject|1|||
19379379|NCT02201524|41622379|FG000|Overall Study|Other|1|||
19379380|NCT02201524|41622380|FG001|Overall Study|Other|1|||
19379381|NCT02201524|41622381|FG002|Overall Study|Other|0|||
19379382|NCT02201524|41622382|FG003|Overall Study|Other|0|||
19379383|NCT02453048|41622397|FG000|Overall Study|Only part of initial 6 mo. study|0|||
19464641|NCT01913483|41722869|FG001|Overall Study|Lost to Follow-up|3|||
19379384|NCT02453048|41622398|FG001|Overall Study|Only part of initial 6 mo. study|0|||
19379385|NCT02453048|41622399|FG002|Overall Study|Only part of initial 6 mo. study|0|||
19379386|NCT02453048|41622400|FG003|Overall Study|Only part of initial 6 mo. study|0|||
19379387|NCT02453048|41622401|FG004|Overall Study|Only part of initial 6 mo. study|6|||
19379388|NCT02453048|41622397|FG000|Overall Study|Lost to Follow-up|0|||
19379389|NCT02453048|41622398|FG001|Overall Study|Lost to Follow-up|1|||
19379390|NCT02453048|41622399|FG002|Overall Study|Lost to Follow-up|2|||
19379391|NCT02453048|41622400|FG003|Overall Study|Lost to Follow-up|0|||
19379392|NCT02453048|41622401|FG004|Overall Study|Lost to Follow-up|0|||
19379393|NCT02137252|41622415|FG000|Overall Study|trial terminated early|2|||
19464642|NCT01913483|41722868|FG000|Overall Study|Death|14|||
19379394|NCT02137252|41622416|FG001|Overall Study|trial terminated early|1|||
19379395|NCT02201290|41622422|FG000|Overall Study|Withdrawal by Subject|2|||
19379396|NCT02201290|41622422|FG000|Overall Study|Lack of Efficacy|2|||
19379397|NCT02201290|41622422|FG000|Overall Study|Adverse Event|1|||
19379398|NCT02200510|41622428|FG000|Overall Study|Death|1|||
19379399|NCT02200510|41622429|FG001|Overall Study|Death|1|||
19379400|NCT02200510|41622428|FG000|Overall Study|Protocol Violation|0|||
19379401|NCT02200510|41622429|FG001|Overall Study|Protocol Violation|1|||
19379402|NCT02200510|41622428|FG000|Overall Study|Lost to Follow-up|7|||
19379403|NCT02200510|41622429|FG001|Overall Study|Lost to Follow-up|1|||
19379404|NCT02200510|41622428|FG000|Overall Study|potential COI - joined study team|1|||
19379405|NCT02200510|41622429|FG001|Overall Study|potential COI - joined study team|0|||
19379406|NCT02452892|41622439|FG000|Week 1 Initial Randommization|Adverse Event|1|||
19379407|NCT02452892|41622440|FG001|Week 1 Initial Randommization|Adverse Event|0|||
19379408|NCT02452892|41622441|FG002|Week 1 Initial Randommization|Adverse Event|0|||
19379409|NCT02452892|41622442|FG003|Week 1 Initial Randommization|Adverse Event|0|||
19379410|NCT02452892|41622439|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
19379411|NCT02452892|41622440|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
19379412|NCT02452892|41622441|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
19379413|NCT02452892|41622442|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
19379414|NCT02452892|41622439|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
19379415|NCT02452892|41622440|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
19379416|NCT02452892|41622441|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
19379417|NCT02452892|41622442|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
19379418|NCT02452892|41622439|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
19379419|NCT02452892|41622440|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
19379420|NCT02452892|41622441|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
19379421|NCT02452892|41622442|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
19379422|NCT02452892|41622439|FG000|Follow-up|Withdrawal by Subject|0|||
19379423|NCT02452892|41622440|FG001|Follow-up|Withdrawal by Subject|0|||
19379424|NCT02452892|41622441|FG002|Follow-up|Withdrawal by Subject|0|||
19379425|NCT02452892|41622442|FG003|Follow-up|Withdrawal by Subject|1|||
19379426|NCT02452892|41622439|FG000|Follow-up|Subject left town on Day 42|1|||
19379427|NCT02452892|41622440|FG001|Follow-up|Subject left town on Day 42|0|||
19379428|NCT02452892|41622441|FG002|Follow-up|Subject left town on Day 42|0|||
19379429|NCT02452892|41622442|FG003|Follow-up|Subject left town on Day 42|0|||
19379430|NCT02135848|41622457|FG000|Overall Study|Adverse Event|2|||
19379431|NCT02135848|41622458|FG001|Overall Study|Adverse Event|0|||
19379432|NCT02135848|41622457|FG000|Overall Study|Withdrawal by Subject|1|||
19379433|NCT02135848|41622458|FG001|Overall Study|Withdrawal by Subject|1|||
19379434|NCT02738333|41622478|FG000|Overall Study|Death|1|||
19379435|NCT02738333|41622479|FG001|Overall Study|Death|0|||
19379436|NCT02738333|41622480|FG002|Overall Study|Death|0|||
19379437|NCT02738333|41622478|FG000|Overall Study|Lost to Follow-up|1|||
19379438|NCT02738333|41622479|FG001|Overall Study|Lost to Follow-up|0|||
19379439|NCT02738333|41622480|FG002|Overall Study|Lost to Follow-up|0|||
19379440|NCT02135692|41622488|FG000|Overall Study|Adverse Event|3|||
19379441|NCT02135692|41622488|FG000|Overall Study|Lack of Efficacy|2|||
19379442|NCT02135692|41622488|FG000|Overall Study|Protocol Violation|2|||
19379443|NCT02135692|41622488|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
19379444|NCT02135692|41622488|FG000|Overall Study|Product commercially available|159|||
19379445|NCT02135692|41622488|FG000|Overall Study|Study closed/terminated|153|||
19379446|NCT02135692|41622488|FG000|Overall Study|Lost to Follow-up|4|||
19379447|NCT02135692|41622488|FG000|Overall Study|Withdrawal by Subject|15|||
19379448|NCT02135614|41622494|FG000|Overall Study|Randomized but Not Treated|2|||
19379449|NCT02135614|41622495|FG001|Overall Study|Randomized but Not Treated|1|||
19464643|NCT01913483|41722869|FG001|Overall Study|Death|17|||
19464644|NCT01913405|41722875|FG000|Overall Study|Withdrawal by Subject|1|||
19379450|NCT02135614|41622494|FG000|Overall Study|Adverse Event|0|||
19379451|NCT02135614|41622495|FG001|Overall Study|Adverse Event|1|||
19379452|NCT02135614|41622494|FG000|Overall Study|Death|1|||
19379453|NCT02135614|41622495|FG001|Overall Study|Death|0|||
19379454|NCT02135614|41622494|FG000|Overall Study|Investigator's Discretion|0|||
19379455|NCT02135614|41622495|FG001|Overall Study|Investigator's Discretion|1|||
19379456|NCT02135614|41622494|FG000|Overall Study|Withdrew Consent|2|||
19379457|NCT02135614|41622495|FG001|Overall Study|Withdrew Consent|2|||
19379458|NCT02135614|41622494|FG000|Overall Study|Lost to Follow-up|3|||
19379459|NCT02135614|41622495|FG001|Overall Study|Lost to Follow-up|0|||
19379460|NCT02168842|41622503|FG000|Overall Study|Withdrawal by Subject|5|||
19379461|NCT02168842|41622504|FG001|Overall Study|Withdrawal by Subject|3|||
19379462|NCT02168842|41622503|FG000|Overall Study|Lost to Follow-up|0|||
19379463|NCT02168842|41622504|FG001|Overall Study|Lost to Follow-up|2|||
19379464|NCT02168842|41622503|FG000|Overall Study|Death|2|||
19379465|NCT02168842|41622504|FG001|Overall Study|Death|1|||
19379466|NCT02168842|41622503|FG000|Overall Study|Physician Decision|1|||
19379467|NCT02168842|41622504|FG001|Overall Study|Physician Decision|2|||
19379468|NCT02200042|41622514|FG000|Overall Study|Withdrawal by Subject|0|||
19379469|NCT02200042|41622515|FG001|Overall Study|Withdrawal by Subject|1|||
19379470|NCT02199028|41622523|FG000|Week 1|Adverse Event|1|||
19379471|NCT02199028|41622524|FG001|Week 1|Adverse Event|0|||
19379472|NCT02199028|41622523|FG000|Week 3|Adverse Event|1|||
19379473|NCT02199028|41622524|FG001|Week 3|Adverse Event|0|||
19464645|NCT01913405|41722875|FG000|Overall Study|Adverse Event|1|||
19379474|NCT03347123|41622533|FG000|Overall Study|Death|1|||
19379475|NCT03347123|41622534|FG001|Overall Study|Death|2|||
19379476|NCT03347123|41622535|FG002|Overall Study|Death|0|||
19379477|NCT03347123|41622536|FG003|Overall Study|Death|0|||
19379478|NCT03347123|41622537|FG004|Overall Study|Death|0|||
19379479|NCT03347123|41622538|FG005|Overall Study|Death|0|||
19379480|NCT03347123|41622539|FG006|Overall Study|Death|0|||
19379481|NCT03347123|41622533|FG000|Overall Study|Withdrawal by Subject|1|||
19379482|NCT03347123|41622534|FG001|Overall Study|Withdrawal by Subject|0|||
19379483|NCT03347123|41622535|FG002|Overall Study|Withdrawal by Subject|0|||
19379484|NCT03347123|41622536|FG003|Overall Study|Withdrawal by Subject|0|||
19379485|NCT03347123|41622537|FG004|Overall Study|Withdrawal by Subject|0|||
19379486|NCT03347123|41622538|FG005|Overall Study|Withdrawal by Subject|0|||
19379487|NCT03347123|41622539|FG006|Overall Study|Withdrawal by Subject|0|||
19379488|NCT03347123|41622533|FG000|Overall Study|Reason not Specified|3|||
19379489|NCT03347123|41622534|FG001|Overall Study|Reason not Specified|4|||
19379490|NCT03347123|41622535|FG002|Overall Study|Reason not Specified|0|||
19379491|NCT03347123|41622536|FG003|Overall Study|Reason not Specified|0|||
19379492|NCT03347123|41622537|FG004|Overall Study|Reason not Specified|0|||
19379493|NCT03347123|41622538|FG005|Overall Study|Reason not Specified|0|||
19379494|NCT03347123|41622539|FG006|Overall Study|Reason not Specified|0|||
19379495|NCT02133742|41622550|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
19379496|NCT02133742|41622550|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
19379497|NCT02133742|41622550|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
19379498|NCT02133742|41622550|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
19379499|NCT02133742|41622550|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
19379500|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
19379501|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
19379502|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
19379503|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
19379504|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
19379505|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
19379506|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
19379507|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
19379508|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
19379509|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
19379510|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
19379511|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
19379512|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
19379513|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
19379514|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
19379515|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
19379516|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
19379517|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
19464646|NCT01927055|41722895|FG000|Open-label|Adverse Event|6|||
19379518|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
19379519|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
19379520|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
19379521|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
19379522|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
19379523|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
19379524|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
19379525|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
19379526|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
19379527|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
19379528|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
19379529|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
19379530|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
19379531|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
19379532|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
19379533|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
19379534|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
19379535|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
19379536|NCT02198794|41622556|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
19379537|NCT02198794|41622557|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
19379538|NCT02198794|41622558|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
19379539|NCT02198794|41622559|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
19379540|NCT02198794|41622556|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
19379541|NCT02198794|41622557|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
19379542|NCT02198794|41622558|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
19379543|NCT02198794|41622559|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
19379544|NCT02198794|41622556|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
19379545|NCT02198794|41622557|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
19379546|NCT02198794|41622558|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
19379547|NCT02198794|41622559|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
19379548|NCT02198794|41622556|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
19379549|NCT02198794|41622557|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
19379550|NCT02198794|41622558|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
19379551|NCT02198794|41622559|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
19379552|NCT02198794|41622556|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
19379553|NCT02198794|41622557|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
19379554|NCT02198794|41622558|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
19379555|NCT02198794|41622559|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
19379556|NCT02198794|41622556|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
19379557|NCT02198794|41622557|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
19379558|NCT02198794|41622558|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
19379559|NCT02198794|41622559|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
19379560|NCT02133664|41622570|FG000|Overall Study|Lost to Follow-up|2|||
19379561|NCT02133664|41622571|FG001|Overall Study|Lost to Follow-up|1|||
19379562|NCT02133664|41622570|FG000|Overall Study|Adverse Event|3|||
19379563|NCT02133664|41622571|FG001|Overall Study|Adverse Event|6|||
19379564|NCT02133508|41622577|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
19379565|NCT02133508|41622577|FG000|Overall Study|Death|12|||
19379566|NCT02133508|41622577|FG000|Overall Study|Lost to Follow-up|2|||
19379567|NCT02133352|41622581|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
19379568|NCT02167594|41622588|FG000|Overall Study|Withdrawal by Subject|2|||
19379569|NCT02167594|41622589|FG001|Overall Study|Withdrawal by Subject|0|||
19379570|NCT02167594|41622590|FG002|Overall Study|Withdrawal by Subject|0|||
19379571|NCT02167594|41622588|FG000|Overall Study|Death|0|||
19379572|NCT02167594|41622589|FG001|Overall Study|Death|1|||
19379573|NCT02167594|41622590|FG002|Overall Study|Death|0|||
19379574|NCT02555657|41622601|FG000|Overall Study|Death|274|||
19379575|NCT02555657|41622602|FG001|Overall Study|Death|262|||
19379576|NCT02555657|41622601|FG000|Overall Study|Physician Decision|0|||
19379577|NCT02555657|41622602|FG001|Overall Study|Physician Decision|1|||
19379578|NCT02555657|41622601|FG000|Overall Study|Sponsor Decision|27|||
19379579|NCT02555657|41622602|FG001|Overall Study|Sponsor Decision|15|||
19379580|NCT02555657|41622601|FG000|Overall Study|Withdrawal by Subject|11|||
19379581|NCT02555657|41622602|FG001|Overall Study|Withdrawal by Subject|32|||
19379582|NCT02195518|41622634|FG000|Overall Study|Adverse Event|1|||
19379583|NCT02195518|41622634|FG000|Overall Study|Protocol Violation|4|||
19379584|NCT02195518|41622634|FG000|Overall Study|Pregnancy|2|||
19379585|NCT02195518|41622634|FG000|Overall Study|Withdrawal by Subject|1|||
19379586|NCT02195518|41622634|FG000|Overall Study|Lost to Follow-up|1|||
19379587|NCT03032705|41622657|FG000|Overall Study|Lost to Follow-up|16|||
19379588|NCT03032705|41622658|FG001|Overall Study|Lost to Follow-up|17|||
19379589|NCT03032705|41622657|FG000|Overall Study|did not quality|6|||
19379590|NCT03032705|41622658|FG001|Overall Study|did not quality|6|||
19379591|NCT04476251|41622664|FG000|Overall Study|Not treated|1|||
19379592|NCT03795233|41622670|FG000|Overall Study|Withdrawal by Subject|2|||
19379593|NCT03795233|41622671|FG001|Overall Study|Withdrawal by Subject|1|||
19379594|NCT03795233|41622670|FG000|Overall Study|Lost to Follow-up|1|||
19379595|NCT03795233|41622671|FG001|Overall Study|Lost to Follow-up|0|||
19379596|NCT03795233|41622670|FG000|Overall Study|Death|1|||
19379597|NCT03795233|41622671|FG001|Overall Study|Death|0|||
19379598|NCT03645863|41622680|FG000|Overall Study|Withdrawal by Subject|1|||
19379599|NCT03645863|41622681|FG001|Overall Study|Withdrawal by Subject|0|||
19379600|NCT03645863|41622682|FG002|Overall Study|Withdrawal by Subject|0|||
19379601|NCT03564119|41622692|FG000|Overall Study|Adverse Event|4|||
19379602|NCT03564119|41622693|FG001|Overall Study|Adverse Event|0|||
19379603|NCT03564119|41622692|FG000|Overall Study|Lost to Follow-up|1|||
19379604|NCT03564119|41622693|FG001|Overall Study|Lost to Follow-up|4|||
19379605|NCT03564119|41622692|FG000|Overall Study|Protocol Violation|1|||
19379606|NCT03564119|41622693|FG001|Overall Study|Protocol Violation|0|||
19379607|NCT03564119|41622692|FG000|Overall Study|Withdrawal by Subject|9|||
19379608|NCT03564119|41622693|FG001|Overall Study|Withdrawal by Subject|4|||
19464647|NCT01927055|41722896|FG001|Open-label|Adverse Event|0|||
19464648|NCT01927055|41722897|FG002|Open-label|Adverse Event|0|||
19379609|NCT03564119|41622692|FG000|Overall Study|Other Than Specified|0|||
19379610|NCT03564119|41622693|FG001|Overall Study|Other Than Specified|1|||
19379611|NCT04531241|41622699|FG000|Period 1|Withdrawal by Subject|2|||
19379612|NCT04531241|41622700|FG001|Period 1|Withdrawal by Subject|0|||
19379613|NCT04531241|41622699|FG000|Period 1|Dispesed incorrect lens power|1|||
19379614|NCT04531241|41622700|FG001|Period 1|Dispesed incorrect lens power|0|||
19379615|NCT04531241|41622699|FG000|Period 1|Protocol Violation|1|||
19379616|NCT04531241|41622700|FG001|Period 1|Protocol Violation|0|||
19379617|NCT04531241|41622699|FG000|Period 1|No longer eligible|0|||
19379618|NCT04531241|41622700|FG001|Period 1|No longer eligible|1|||
19379619|NCT04531241|41622699|FG000|Period 1|Lens Discomfort|0|||
19379620|NCT04531241|41622700|FG001|Period 1|Lens Discomfort|1|||
19379621|NCT04531241|41622699|FG000|Period 2|Covid-19 Related|1|||
19379622|NCT04531241|41622700|FG001|Period 2|Covid-19 Related|1|||
19379623|NCT03181529|41622708|FG000|Overall Study|Withdrawal by Subject|1|||
19379624|NCT03181529|41622709|FG001|Overall Study|Withdrawal by Subject|1|||
19379625|NCT03181529|41622708|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
19379626|NCT03181529|41622709|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
19379627|NCT03470441|41622723|FG000|Overall Study|Death|0|||
19379628|NCT03470441|41622724|FG001|Overall Study|Death|1|||
19379629|NCT03470441|41622725|FG002|Overall Study|Death|1|||
19379630|NCT03470441|41622726|FG003|Overall Study|Death|0|||
19379631|NCT03470441|41622723|FG000|Overall Study|Adverse Event|0|||
19379632|NCT03470441|41622724|FG001|Overall Study|Adverse Event|0|||
19379633|NCT03470441|41622725|FG002|Overall Study|Adverse Event|0|||
19379634|NCT03470441|41622726|FG003|Overall Study|Adverse Event|1|||
19379635|NCT03470441|41622723|FG000|Overall Study|Withdrawal by Subject|1|||
19379636|NCT03470441|41622724|FG001|Overall Study|Withdrawal by Subject|4|||
19379637|NCT03470441|41622725|FG002|Overall Study|Withdrawal by Subject|1|||
19379638|NCT03470441|41622726|FG003|Overall Study|Withdrawal by Subject|3|||
19379639|NCT03361865|41622738|FG000|Overall Study|Death|17|||
19379640|NCT03361865|41622739|FG001|Overall Study|Death|18|||
19379641|NCT03361865|41622738|FG000|Overall Study|Physician Decision|1|||
19379642|NCT03361865|41622739|FG001|Overall Study|Physician Decision|9|||
19379643|NCT03361865|41622738|FG000|Overall Study|Withdrawal by Subject|1|||
19379644|NCT03361865|41622739|FG001|Overall Study|Withdrawal by Subject|0|||
19379645|NCT02149121|41622753|FG000|Main Study Period|Lack of Efficacy|2|||
19379646|NCT02149121|41622754|FG001|Main Study Period|Lack of Efficacy|2|||
19379647|NCT02149121|41622755|FG002|Main Study Period|Lack of Efficacy|1|||
19379648|NCT02149121|41622756|FG003|Main Study Period|Lack of Efficacy|0|||
19379649|NCT02149121|41622757|FG004|Main Study Period|Lack of Efficacy|0|||
19379650|NCT02149121|41622758|FG005|Main Study Period|Lack of Efficacy|0|||
19379651|NCT02149121|41622759|FG006|Main Study Period|Lack of Efficacy|0|||
19379652|NCT02149121|41622753|FG000|Main Study Period|Withdrawal by Subject|9|||
19379653|NCT02149121|41622754|FG001|Main Study Period|Withdrawal by Subject|5|||
19379654|NCT02149121|41622755|FG002|Main Study Period|Withdrawal by Subject|1|||
19379655|NCT02149121|41622756|FG003|Main Study Period|Withdrawal by Subject|0|||
19379656|NCT02149121|41622757|FG004|Main Study Period|Withdrawal by Subject|0|||
19379657|NCT02149121|41622758|FG005|Main Study Period|Withdrawal by Subject|0|||
19379658|NCT02149121|41622759|FG006|Main Study Period|Withdrawal by Subject|0|||
19379659|NCT02149121|41622753|FG000|Main Study Period|Adverse Event|2|||
19379660|NCT02149121|41622754|FG001|Main Study Period|Adverse Event|5|||
19379661|NCT02149121|41622755|FG002|Main Study Period|Adverse Event|1|||
19379662|NCT02149121|41622756|FG003|Main Study Period|Adverse Event|0|||
19379663|NCT02149121|41622757|FG004|Main Study Period|Adverse Event|0|||
19379664|NCT02149121|41622758|FG005|Main Study Period|Adverse Event|0|||
19379665|NCT02149121|41622759|FG006|Main Study Period|Adverse Event|0|||
19379666|NCT02149121|41622753|FG000|Main Study Period|Protocol Violation|2|||
19379667|NCT02149121|41622754|FG001|Main Study Period|Protocol Violation|0|||
19379668|NCT02149121|41622755|FG002|Main Study Period|Protocol Violation|0|||
19379669|NCT02149121|41622756|FG003|Main Study Period|Protocol Violation|0|||
19379670|NCT02149121|41622757|FG004|Main Study Period|Protocol Violation|0|||
19379671|NCT02149121|41622758|FG005|Main Study Period|Protocol Violation|0|||
19379672|NCT02149121|41622759|FG006|Main Study Period|Protocol Violation|0|||
19379673|NCT02149121|41622753|FG000|Main Study Period|Lost to Follow-up|2|||
19379674|NCT02149121|41622754|FG001|Main Study Period|Lost to Follow-up|1|||
19379675|NCT02149121|41622755|FG002|Main Study Period|Lost to Follow-up|0|||
19379676|NCT02149121|41622756|FG003|Main Study Period|Lost to Follow-up|0|||
19379677|NCT02149121|41622757|FG004|Main Study Period|Lost to Follow-up|0|||
19379678|NCT02149121|41622758|FG005|Main Study Period|Lost to Follow-up|0|||
19379679|NCT02149121|41622759|FG006|Main Study Period|Lost to Follow-up|0|||
19379680|NCT02149121|41622753|FG000|Main Study Period|Death|1|||
19379681|NCT02149121|41622754|FG001|Main Study Period|Death|0|||
19379682|NCT02149121|41622755|FG002|Main Study Period|Death|0|||
19379683|NCT02149121|41622756|FG003|Main Study Period|Death|0|||
19379684|NCT02149121|41622757|FG004|Main Study Period|Death|0|||
19379685|NCT02149121|41622758|FG005|Main Study Period|Death|0|||
19379686|NCT02149121|41622759|FG006|Main Study Period|Death|0|||
19379687|NCT02149121|41622753|FG000|Main Study Period|Physician Decision|1|||
19379688|NCT02149121|41622754|FG001|Main Study Period|Physician Decision|0|||
19379689|NCT02149121|41622755|FG002|Main Study Period|Physician Decision|0|||
19379690|NCT02149121|41622756|FG003|Main Study Period|Physician Decision|0|||
19379691|NCT02149121|41622757|FG004|Main Study Period|Physician Decision|0|||
19379692|NCT02149121|41622758|FG005|Main Study Period|Physician Decision|0|||
19379693|NCT02149121|41622759|FG006|Main Study Period|Physician Decision|0|||
19379694|NCT02149121|41622753|FG000|Main Study Period|Developed any malignancy|0|||
19379695|NCT02149121|41622754|FG001|Main Study Period|Developed any malignancy|1|||
19379696|NCT02149121|41622755|FG002|Main Study Period|Developed any malignancy|1|||
19379697|NCT02149121|41622756|FG003|Main Study Period|Developed any malignancy|0|||
19379698|NCT02149121|41622757|FG004|Main Study Period|Developed any malignancy|0|||
19379699|NCT02149121|41622758|FG005|Main Study Period|Developed any malignancy|0|||
19379700|NCT02149121|41622759|FG006|Main Study Period|Developed any malignancy|0|||
19379701|NCT02149121|41622753|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
19379702|NCT02149121|41622754|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
19379703|NCT02149121|41622755|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
19379704|NCT02149121|41622756|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
19379705|NCT02149121|41622757|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
19379706|NCT02149121|41622758|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
19379707|NCT02149121|41622759|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
19379708|NCT02149121|41622753|FG000|Main Study Period|Disease progression|0|||
19379709|NCT02149121|41622754|FG001|Main Study Period|Disease progression|1|||
19379710|NCT02149121|41622755|FG002|Main Study Period|Disease progression|0|||
19379711|NCT02149121|41622756|FG003|Main Study Period|Disease progression|0|||
19379712|NCT02149121|41622757|FG004|Main Study Period|Disease progression|0|||
19464649|NCT01927055|41722895|FG000|Open-label|Withdrawal by Subject|1|||
19464650|NCT01927055|41722896|FG001|Open-label|Withdrawal by Subject|0|||
19464651|NCT01927055|41722897|FG002|Open-label|Withdrawal by Subject|0|||
19373232|NCT02537522|41614214|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
19373233|NCT02537522|41614215|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
19373234|NCT02537522|41614216|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
19373235|NCT02537522|41614217|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
19373236|NCT02537522|41614214|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
19373237|NCT02537522|41614215|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
19373238|NCT02537522|41614216|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
19373239|NCT02537522|41614217|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
19373240|NCT02536976|41614225|FG000|Overall Study|Physician Decision|0|||
19373241|NCT02536976|41614226|FG001|Overall Study|Physician Decision|1|||
19373242|NCT02672553|41614236|FG000|Overall Study|Death|3|||
19373243|NCT02672553|41614237|FG001|Overall Study|Death|5|||
19373244|NCT02672553|41614236|FG000|Overall Study|Valve Explant|1|||
19373245|NCT02672553|41614237|FG001|Overall Study|Valve Explant|0|||
19373246|NCT02672553|41614236|FG000|Overall Study|Conversion to Commercial Valve|3|||
19373247|NCT02672553|41614237|FG001|Overall Study|Conversion to Commercial Valve|0|||
19373248|NCT02672553|41614236|FG000|Overall Study|Withdrawal by Subject|3|||
19373249|NCT02672553|41614237|FG001|Overall Study|Withdrawal by Subject|3|||
19373250|NCT02672553|41614236|FG000|Overall Study|Intraoperative screen failure|2|||
19373251|NCT02672553|41614237|FG001|Overall Study|Intraoperative screen failure|0|||
19373252|NCT01373229|41614244|FG000|Overall Study|Death|3|||
19373253|NCT01373229|41614244|FG000|Overall Study|Physician Decision|3|||
19373254|NCT02671461|41614251|FG000|Treatment|Adverse Event|0|||
19373255|NCT02671461|41614252|FG001|Treatment|Adverse Event|0|||
19373256|NCT02671461|41614253|FG002|Treatment|Adverse Event|1|||
19373257|NCT02671461|41614251|FG000|Treatment|Administrative Reason by Sponsor|1|||
19373258|NCT02671461|41614252|FG001|Treatment|Administrative Reason by Sponsor|3|||
19373259|NCT02671461|41614253|FG002|Treatment|Administrative Reason by Sponsor|4|||
19373260|NCT02671461|41614251|FG000|Treatment|Randomized, not treated|1|||
19373261|NCT02671461|41614252|FG001|Treatment|Randomized, not treated|0|||
19373262|NCT02671461|41614253|FG002|Treatment|Randomized, not treated|0|||
19373263|NCT02671461|41614251|FG000|Follow-up|Withdrawal by Subject|1|||
19373264|NCT02671461|41614252|FG001|Follow-up|Withdrawal by Subject|0|||
19373265|NCT02671461|41614253|FG002|Follow-up|Withdrawal by Subject|0|||
19373266|NCT02671461|41614251|FG000|Follow-up|Lost to Follow-up|0|||
19373267|NCT02671461|41614252|FG001|Follow-up|Lost to Follow-up|0|||
19373268|NCT02671461|41614253|FG002|Follow-up|Lost to Follow-up|1|||
19373269|NCT02671461|41614251|FG000|Follow-up|Administrative Reason by Sponsor|0|||
19373270|NCT02671461|41614252|FG001|Follow-up|Administrative Reason by Sponsor|1|||
19373271|NCT02671461|41614253|FG002|Follow-up|Administrative Reason by Sponsor|0|||
19373272|NCT02535416|41614270|FG000|Overall Study|Family bereavement overseas|1|||
19373273|NCT02535416|41614271|FG001|Overall Study|Family bereavement overseas|0|||
19373274|NCT02535416|41614272|FG002|Overall Study|Family bereavement overseas|0|||
19373275|NCT02535416|41614273|FG003|Overall Study|Family bereavement overseas|0|||
19373276|NCT02535416|41614274|FG004|Overall Study|Family bereavement overseas|0|||
19373277|NCT02535416|41614275|FG005|Overall Study|Family bereavement overseas|0|||
19373278|NCT02535416|41614276|FG006|Overall Study|Family bereavement overseas|0|||
19373279|NCT02535416|41614277|FG007|Overall Study|Family bereavement overseas|0|||
19373280|NCT02535416|41614278|FG008|Overall Study|Family bereavement overseas|0|||
19373281|NCT02670915|41614328|FG000|Overall Study|Withdrawal by Subject|0|||
19373282|NCT02670915|41614329|FG001|Overall Study|Withdrawal by Subject|1|||
19373283|NCT02670915|41614330|FG002|Overall Study|Withdrawal by Subject|4|||
19373284|NCT02670915|41614328|FG000|Overall Study|Withdrawal by parent/guardian|4|||
19373285|NCT02670915|41614329|FG001|Overall Study|Withdrawal by parent/guardian|4|||
19373286|NCT02670915|41614330|FG002|Overall Study|Withdrawal by parent/guardian|1|||
19373287|NCT02670915|41614328|FG000|Overall Study|Unclassified|0|||
19379713|NCT02149121|41622758|FG005|Main Study Period|Disease progression|0|||
19379714|NCT02149121|41622759|FG006|Main Study Period|Disease progression|0|||
19379715|NCT02149121|41622753|FG000|Extension Study Period|Withdrawal by Subject|0|||
19379716|NCT02149121|41622754|FG001|Extension Study Period|Withdrawal by Subject|0|||
19379717|NCT02149121|41622755|FG002|Extension Study Period|Withdrawal by Subject|0|||
19379718|NCT02149121|41622756|FG003|Extension Study Period|Withdrawal by Subject|1|||
19379719|NCT02149121|41622757|FG004|Extension Study Period|Withdrawal by Subject|0|||
19379720|NCT02149121|41622758|FG005|Extension Study Period|Withdrawal by Subject|2|||
19379721|NCT02149121|41622759|FG006|Extension Study Period|Withdrawal by Subject|0|||
19379722|NCT01865617|41622811|FG000|Overall Study|Death|27|||
19379723|NCT01865617|41622812|FG001|Overall Study|Death|3|||
19379724|NCT01865617|41622813|FG002|Overall Study|Death|1|||
19379725|NCT01865617|41622814|FG003|Overall Study|Death|1|||
19379726|NCT01865617|41622815|FG004|Overall Study|Death|5|||
19379727|NCT01865617|41622816|FG005|Overall Study|Death|1|||
19379728|NCT01865617|41622817|FG006|Overall Study|Death|11|||
19379729|NCT01865617|41622818|FG007|Overall Study|Death|1|||
19379730|NCT01865617|41622819|FG008|Overall Study|Death|11|||
19379731|NCT01865617|41622820|FG009|Overall Study|Death|3|||
19379732|NCT01865617|41622821|FG010|Overall Study|Death|32|||
19379733|NCT01865617|41622822|FG011|Overall Study|Death|6|||
19379734|NCT01865617|41622823|FG012|Overall Study|Death|13|||
19379735|NCT01865617|41622811|FG000|Overall Study|Lost to Follow-up|2|||
19379736|NCT01865617|41622812|FG001|Overall Study|Lost to Follow-up|0|||
19379737|NCT01865617|41622813|FG002|Overall Study|Lost to Follow-up|0|||
19379738|NCT01865617|41622814|FG003|Overall Study|Lost to Follow-up|0|||
19379739|NCT01865617|41622815|FG004|Overall Study|Lost to Follow-up|0|||
19379740|NCT01865617|41622816|FG005|Overall Study|Lost to Follow-up|0|||
19379741|NCT01865617|41622817|FG006|Overall Study|Lost to Follow-up|0|||
19379742|NCT01865617|41622818|FG007|Overall Study|Lost to Follow-up|0|||
19379743|NCT01865617|41622819|FG008|Overall Study|Lost to Follow-up|0|||
19379744|NCT01865617|41622820|FG009|Overall Study|Lost to Follow-up|0|||
19379745|NCT01865617|41622821|FG010|Overall Study|Lost to Follow-up|0|||
19379746|NCT01865617|41622822|FG011|Overall Study|Lost to Follow-up|0|||
19379747|NCT01865617|41622823|FG012|Overall Study|Lost to Follow-up|0|||
19379748|NCT01865617|41622811|FG000|Overall Study|Withdrawal by Subject|1|||
19379749|NCT01865617|41622812|FG001|Overall Study|Withdrawal by Subject|0|||
19379750|NCT01865617|41622813|FG002|Overall Study|Withdrawal by Subject|0|||
19379751|NCT01865617|41622814|FG003|Overall Study|Withdrawal by Subject|0|||
19379752|NCT01865617|41622815|FG004|Overall Study|Withdrawal by Subject|0|||
19379753|NCT01865617|41622816|FG005|Overall Study|Withdrawal by Subject|0|||
19379754|NCT01865617|41622817|FG006|Overall Study|Withdrawal by Subject|0|||
19379755|NCT01865617|41622818|FG007|Overall Study|Withdrawal by Subject|0|||
19379756|NCT01865617|41622819|FG008|Overall Study|Withdrawal by Subject|0|||
19379757|NCT01865617|41622820|FG009|Overall Study|Withdrawal by Subject|0|||
19379758|NCT01865617|41622821|FG010|Overall Study|Withdrawal by Subject|0|||
19379759|NCT01865617|41622822|FG011|Overall Study|Withdrawal by Subject|0|||
19379760|NCT01865617|41622823|FG012|Overall Study|Withdrawal by Subject|0|||
19379761|NCT01865617|41622811|FG000|Overall Study|Patient proceeded to new therapy|0|||
19379762|NCT01865617|41622812|FG001|Overall Study|Patient proceeded to new therapy|0|||
19379763|NCT01865617|41622813|FG002|Overall Study|Patient proceeded to new therapy|0|||
19379764|NCT01865617|41622814|FG003|Overall Study|Patient proceeded to new therapy|0|||
19379765|NCT01865617|41622815|FG004|Overall Study|Patient proceeded to new therapy|2|||
19379766|NCT01865617|41622816|FG005|Overall Study|Patient proceeded to new therapy|0|||
19379767|NCT01865617|41622817|FG006|Overall Study|Patient proceeded to new therapy|0|||
19379768|NCT01865617|41622818|FG007|Overall Study|Patient proceeded to new therapy|0|||
19379769|NCT01865617|41622819|FG008|Overall Study|Patient proceeded to new therapy|0|||
19379770|NCT01865617|41622820|FG009|Overall Study|Patient proceeded to new therapy|0|||
19379771|NCT01865617|41622821|FG010|Overall Study|Patient proceeded to new therapy|0|||
19379772|NCT01865617|41622822|FG011|Overall Study|Patient proceeded to new therapy|0|||
19379773|NCT01865617|41622823|FG012|Overall Study|Patient proceeded to new therapy|0|||
19379774|NCT01865617|41622811|FG000|Overall Study|Other|0|||
19379775|NCT01865617|41622812|FG001|Overall Study|Other|0|||
19379776|NCT01865617|41622813|FG002|Overall Study|Other|0|||
19379777|NCT01865617|41622814|FG003|Overall Study|Other|0|||
19379778|NCT01865617|41622815|FG004|Overall Study|Other|0|||
19379779|NCT01865617|41622816|FG005|Overall Study|Other|0|||
19379780|NCT01865617|41622817|FG006|Overall Study|Other|1|||
19379781|NCT01865617|41622818|FG007|Overall Study|Other|0|||
19379782|NCT01865617|41622819|FG008|Overall Study|Other|0|||
19379783|NCT01865617|41622820|FG009|Overall Study|Other|0|||
19379784|NCT01865617|41622821|FG010|Overall Study|Other|0|||
19379785|NCT01865617|41622822|FG011|Overall Study|Other|0|||
19379786|NCT01865617|41622823|FG012|Overall Study|Other|0|||
19379787|NCT01328431|41622865|FG000|Baseline|Protocol Violation|0|||
19379788|NCT01328431|41622866|FG001|Baseline|Protocol Violation|2|||
19379789|NCT01328431|41622865|FG000|1 Month (1M)|Lost to Follow-up|55|||
19379790|NCT01328431|41622866|FG001|1 Month (1M)|Lost to Follow-up|58|||
19379791|NCT01328431|41622865|FG000|3 Month (3M)|Death|2|||
19379792|NCT01328431|41622866|FG001|3 Month (3M)|Death|2|||
19379793|NCT01328431|41622865|FG000|3 Month (3M)|Lost to Follow-up|75|||
19379794|NCT01328431|41622866|FG001|3 Month (3M)|Lost to Follow-up|70|||
19379795|NCT01328431|41622865|FG000|12 Month (12M)|Death|2|||
19379796|NCT01328431|41622866|FG001|12 Month (12M)|Death|6|||
19379797|NCT01328431|41622865|FG000|12 Month (12M)|Lost to Follow-up|82|||
19379798|NCT01328431|41622866|FG001|12 Month (12M)|Lost to Follow-up|91|||
19379799|NCT00893789|41622876|FG000|Overall Study|Withdrawal by Subject|3|||
19379800|NCT00893789|41622877|FG001|Overall Study|Withdrawal by Subject|1|||
19379801|NCT00893789|41622878|FG002|Overall Study|Withdrawal by Subject|3|||
19379802|NCT00893789|41622879|FG003|Overall Study|Withdrawal by Subject|1|||
19379803|NCT00893789|41622876|FG000|Overall Study|Noncompliance With Study Drug|1|||
19379804|NCT00893789|41622877|FG001|Overall Study|Noncompliance With Study Drug|0|||
19379805|NCT00893789|41622878|FG002|Overall Study|Noncompliance With Study Drug|1|||
19379806|NCT00893789|41622879|FG003|Overall Study|Noncompliance With Study Drug|2|||
19379807|NCT00893789|41622876|FG000|Overall Study|Noncompliance With Study Procedures|1|||
19379808|NCT00893789|41622877|FG001|Overall Study|Noncompliance With Study Procedures|0|||
19379809|NCT00893789|41622878|FG002|Overall Study|Noncompliance With Study Procedures|0|||
19379810|NCT00893789|41622879|FG003|Overall Study|Noncompliance With Study Procedures|0|||
19379811|NCT00893789|41622876|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
19379812|NCT00893789|41622877|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
19379813|NCT00893789|41622878|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
19379814|NCT00893789|41622879|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
19379815|NCT00893789|41622876|FG000|Overall Study|Adverse Event|0|||
19379816|NCT00893789|41622877|FG001|Overall Study|Adverse Event|2|||
19379817|NCT00893789|41622878|FG002|Overall Study|Adverse Event|1|||
19379818|NCT00893789|41622879|FG003|Overall Study|Adverse Event|5|||
19379819|NCT00893789|41622876|FG000|Overall Study|Protocol Violation|0|||
19379820|NCT00893789|41622877|FG001|Overall Study|Protocol Violation|1|||
19379821|NCT00893789|41622878|FG002|Overall Study|Protocol Violation|1|||
19379822|NCT00893789|41622879|FG003|Overall Study|Protocol Violation|4|||
19379823|NCT00893789|41622876|FG000|Overall Study|Lost to Follow-up|0|||
19379824|NCT00893789|41622877|FG001|Overall Study|Lost to Follow-up|0|||
19379825|NCT00893789|41622878|FG002|Overall Study|Lost to Follow-up|0|||
19379826|NCT00893789|41622879|FG003|Overall Study|Lost to Follow-up|1|||
19379827|NCT02164864|41622892|FG000|Overall Study|Trial disease worsening|7|||
19379828|NCT02164864|41622893|FG001|Overall Study|Trial disease worsening|5|||
19379829|NCT02164864|41622894|FG002|Overall Study|Trial disease worsening|1|||
19379830|NCT02164864|41622892|FG000|Overall Study|Other pre-existing disease worsening|6|||
19379831|NCT02164864|41622893|FG001|Overall Study|Other pre-existing disease worsening|4|||
19379832|NCT02164864|41622894|FG002|Overall Study|Other pre-existing disease worsening|9|||
19379833|NCT02164864|41622892|FG000|Overall Study|Other Adverse Event (AE)|52|||
19379834|NCT02164864|41622893|FG001|Overall Study|Other Adverse Event (AE)|32|||
19379835|NCT02164864|41622894|FG002|Overall Study|Other Adverse Event (AE)|49|||
19379836|NCT02164864|41622892|FG000|Overall Study|Protocol Violation|2|||
19379837|NCT02164864|41622893|FG001|Overall Study|Protocol Violation|4|||
19379838|NCT02164864|41622894|FG002|Overall Study|Protocol Violation|1|||
19379839|NCT02164864|41622892|FG000|Overall Study|Lost to Follow-up|4|||
19379840|NCT02164864|41622893|FG001|Overall Study|Lost to Follow-up|3|||
19379841|NCT02164864|41622894|FG002|Overall Study|Lost to Follow-up|2|||
19379842|NCT02164864|41622892|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
19379843|NCT02164864|41622893|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
19379844|NCT02164864|41622894|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
19379845|NCT02164864|41622892|FG000|Overall Study|Other than stated|3|||
19379846|NCT02164864|41622893|FG001|Overall Study|Other than stated|4|||
19379847|NCT02164864|41622894|FG002|Overall Study|Other than stated|14|||
19379848|NCT02419807|41622905|FG000|Overall Study|Withdrawal by Subject|4|||
19379849|NCT02419807|41622905|FG000|Overall Study|Physician Decision|1|||
19379850|NCT02419807|41622905|FG000|Overall Study|Protocol Violation|5|||
19379851|NCT03857867|41622909|FG000|Overall Study|Physician Decision|1|||
19379852|NCT01628926|41622917|FG000|Overall Study|Adverse Event|13|||
19379853|NCT01628926|41622918|FG001|Overall Study|Adverse Event|11|||
19379854|NCT01628926|41622919|FG002|Overall Study|Adverse Event|9|||
19379855|NCT01628926|41622917|FG000|Overall Study|Lack of Efficacy|2|||
19379856|NCT01628926|41622918|FG001|Overall Study|Lack of Efficacy|1|||
19379857|NCT01628926|41622919|FG002|Overall Study|Lack of Efficacy|5|||
19379858|NCT01628926|41622917|FG000|Overall Study|Withdrawal by Subject|6|||
19379859|NCT01628926|41622918|FG001|Overall Study|Withdrawal by Subject|4|||
19379860|NCT01628926|41622919|FG002|Overall Study|Withdrawal by Subject|2|||
19379861|NCT01628926|41622917|FG000|Overall Study|Protocol Violation|0|||
19379862|NCT01628926|41622918|FG001|Overall Study|Protocol Violation|1|||
19379863|NCT01628926|41622919|FG002|Overall Study|Protocol Violation|0|||
19379864|NCT01628926|41622917|FG000|Overall Study|Discontinuation criteria|3|||
19379865|NCT01628926|41622918|FG001|Overall Study|Discontinuation criteria|4|||
19379866|NCT01628926|41622919|FG002|Overall Study|Discontinuation criteria|0|||
19379867|NCT01628926|41622917|FG000|Overall Study|Physician Decision|2|||
19379868|NCT01628926|41622918|FG001|Overall Study|Physician Decision|2|||
19379869|NCT01628926|41622919|FG002|Overall Study|Physician Decision|1|||
19379870|NCT01628848|41622930|FG000|Overall Study|Adverse Event|9|||
19379871|NCT01628848|41622931|FG001|Overall Study|Adverse Event|7|||
19464652|NCT01927055|41722895|FG000|Open-label|Study Stopped|4|||
19379872|NCT01628848|41622930|FG000|Overall Study|Lack of Efficacy|0|||
19379873|NCT01628848|41622931|FG001|Overall Study|Lack of Efficacy|4|||
19379874|NCT01628848|41622930|FG000|Overall Study|Withdrawal by Subject|0|||
19379875|NCT01628848|41622931|FG001|Overall Study|Withdrawal by Subject|2|||
19379876|NCT01628848|41622930|FG000|Overall Study|Physician Decision|3|||
19379877|NCT01628848|41622931|FG001|Overall Study|Physician Decision|1|||
19379878|NCT02164318|41622941|FG000|Overall Study|Withdrawal by Subject|0|||
19379879|NCT02164318|41622942|FG001|Overall Study|Withdrawal by Subject|1|||
19379880|NCT02164318|41622943|FG002|Overall Study|Withdrawal by Subject|0|||
19379881|NCT02164318|41622944|FG003|Overall Study|Withdrawal by Subject|1|||
19379882|NCT03436199|41622957|FG000|Overall Study|Adverse Event|15|||
19379883|NCT03436199|41622958|FG001|Overall Study|Adverse Event|40|||
19379884|NCT03436199|41622959|FG002|Overall Study|Adverse Event|7|||
19379885|NCT03436199|41622957|FG000|Overall Study|Withdrawal by Subject|4|||
19379886|NCT03436199|41622958|FG001|Overall Study|Withdrawal by Subject|10|||
19379887|NCT03436199|41622959|FG002|Overall Study|Withdrawal by Subject|3|||
19379888|NCT03436199|41622957|FG000|Overall Study|Lost to Follow-up|1|||
19379889|NCT03436199|41622958|FG001|Overall Study|Lost to Follow-up|0|||
19379890|NCT03436199|41622959|FG002|Overall Study|Lost to Follow-up|2|||
19379891|NCT03436199|41622957|FG000|Overall Study|Protocol Violation|1|||
19379892|NCT03436199|41622958|FG001|Overall Study|Protocol Violation|1|||
19379893|NCT03436199|41622959|FG002|Overall Study|Protocol Violation|0|||
19379894|NCT03436199|41622957|FG000|Overall Study|Physician Decision|0|||
19379895|NCT03436199|41622958|FG001|Overall Study|Physician Decision|1|||
19379896|NCT03436199|41622959|FG002|Overall Study|Physician Decision|0|||
19379897|NCT03436199|41622957|FG000|Overall Study|Could not return to clinic|1|||
19379898|NCT03436199|41622958|FG001|Overall Study|Could not return to clinic|0|||
19379899|NCT03436199|41622959|FG002|Overall Study|Could not return to clinic|0|||
19379900|NCT03436199|41622957|FG000|Overall Study|Withdrawn per physician|0|||
19379901|NCT03436199|41622958|FG001|Overall Study|Withdrawn per physician|1|||
19379902|NCT03436199|41622959|FG002|Overall Study|Withdrawn per physician|0|||
19379903|NCT02131636|41622969|FG000|Overall Study|Personal Reasons|4|||
19379904|NCT02131636|41622970|FG001|Overall Study|Personal Reasons|4|||
19379905|NCT02131636|41622969|FG000|Overall Study|Lost to Follow-up|4|||
19379906|NCT02131636|41622970|FG001|Overall Study|Lost to Follow-up|0|||
19379907|NCT02131636|41622969|FG000|Overall Study|Adverse Event|4|||
19379908|NCT02131636|41622970|FG001|Overall Study|Adverse Event|1|||
19379909|NCT02131324|41622978|FG000|Overall Study|Withdrawal by Subject|1|||
19379910|NCT02131324|41622979|FG001|Overall Study|Withdrawal by Subject|2|||
19379911|NCT02131324|41622978|FG000|Overall Study|Lost to Follow-up|1|||
19379912|NCT02131324|41622979|FG001|Overall Study|Lost to Follow-up|1|||
19379913|NCT02734693|41622988|FG000|Overall Study|Adverse Event|1|||
19379914|NCT02734693|41622989|FG001|Overall Study|Adverse Event|3|||
19379915|NCT02734693|41622990|FG002|Overall Study|Adverse Event|3|||
19379916|NCT02734693|41622988|FG000|Overall Study|Lack of Efficacy|1|||
19379917|NCT02734693|41622989|FG001|Overall Study|Lack of Efficacy|0|||
19379918|NCT02734693|41622990|FG002|Overall Study|Lack of Efficacy|0|||
19379919|NCT02734693|41622988|FG000|Overall Study|Lost to Follow-up|2|||
19379920|NCT02734693|41622989|FG001|Overall Study|Lost to Follow-up|0|||
19379921|NCT02734693|41622990|FG002|Overall Study|Lost to Follow-up|0|||
19379922|NCT02734693|41622988|FG000|Overall Study|Protocol Violation|1|||
19379923|NCT02734693|41622989|FG001|Overall Study|Protocol Violation|0|||
19379924|NCT02734693|41622990|FG002|Overall Study|Protocol Violation|0|||
19379925|NCT02734693|41622988|FG000|Overall Study|Withdrawal by Subject|1|||
19379926|NCT02734693|41622989|FG001|Overall Study|Withdrawal by Subject|0|||
19379927|NCT02734693|41622990|FG002|Overall Study|Withdrawal by Subject|0|||
19379928|NCT02193880|41622998|FG000|Overall Study|patients did not collect enough HPC|3|||
19379929|NCT03846427|41623002|FG000|Overall Study|Death|7|||
19379930|NCT03846427|41623002|FG000|Overall Study|Withdrawal by Subject|2|||
19379931|NCT03846427|41623002|FG000|Overall Study|Remaining in study|59|||
19379932|NCT01378325|41623008|FG000|Overall Study|Protocol Violation|0|||
19379933|NCT01378325|41623009|FG001|Overall Study|Protocol Violation|1|||
19379934|NCT01093573|41623018|FG000|Overall Study|Physician Decision|0|||
19379935|NCT01093573|41623019|FG001|Overall Study|Physician Decision|0|||
19379936|NCT01093573|41623020|FG002|Overall Study|Physician Decision|1|||
19379937|NCT01093573|41623018|FG000|Overall Study|Insurance Denied|0|||
19379938|NCT01093573|41623019|FG001|Overall Study|Insurance Denied|0|||
19379939|NCT01093573|41623020|FG002|Overall Study|Insurance Denied|1|||
19379940|NCT02733367|41623048|FG000|Overall Study|Withdrawal by Subject|6|||
19379941|NCT02087423|41623056|FG000|Overall Study|Withdrawal by Subject|20|||
19379942|NCT02087423|41623057|FG001|Overall Study|Withdrawal by Subject|20|||
19379943|NCT02087423|41623058|FG002|Overall Study|Withdrawal by Subject|3|||
19379944|NCT02087423|41623056|FG000|Overall Study|Death|68|||
19379945|NCT02087423|41623057|FG001|Overall Study|Death|207|||
19379946|NCT02087423|41623058|FG002|Overall Study|Death|40|||
19379947|NCT02087423|41623056|FG000|Overall Study|Lost to Follow-up|0|||
19379948|NCT02087423|41623057|FG001|Overall Study|Lost to Follow-up|2|||
19379949|NCT02087423|41623058|FG002|Overall Study|Lost to Follow-up|0|||
19379950|NCT02087423|41623056|FG000|Overall Study|Terminated from study at final DCO|23|||
19379951|NCT02087423|41623057|FG001|Overall Study|Terminated from study at final DCO|36|||
19379952|NCT02087423|41623058|FG002|Overall Study|Terminated from study at final DCO|25|||
19379953|NCT03688555|41623070|FG000|Treatment Period|Adverse Event|0|||
19379954|NCT03688555|41623071|FG001|Treatment Period|Adverse Event|0|||
19379955|NCT03688555|41623072|FG002|Treatment Period|Adverse Event|1|||
19379956|NCT03443869|41623081|FG000|Overall Study|Death|3|||
19379957|NCT03443869|41623082|FG001|Overall Study|Death|3|||
19379958|NCT03443869|41623081|FG000|Overall Study|Withdrawal by Subject|34|||
19379959|NCT03443869|41623082|FG001|Overall Study|Withdrawal by Subject|22|||
19379960|NCT03443869|41623081|FG000|Overall Study|Lost to Follow-up|1|||
19379961|NCT03443869|41623082|FG001|Overall Study|Lost to Follow-up|2|||
19379962|NCT03443869|41623081|FG000|Overall Study|Physician Decision|3|||
19379963|NCT03443869|41623082|FG001|Overall Study|Physician Decision|3|||
19379964|NCT03443869|41623081|FG000|Overall Study|Other|4|||
19379965|NCT03443869|41623082|FG001|Overall Study|Other|4|||
19379966|NCT01328951|41623123|FG000|Overall Study|Disease Progression|17|||
19379967|NCT01328951|41623124|FG001|Overall Study|Disease Progression|14|||
19379968|NCT01328951|41623123|FG000|Overall Study|Adverse Event|2|||
19379969|NCT01328951|41623124|FG001|Overall Study|Adverse Event|0|||
19379970|NCT01328951|41623123|FG000|Overall Study|Death|243|||
19379971|NCT01328951|41623124|FG001|Overall Study|Death|258|||
19379972|NCT01328951|41623123|FG000|Overall Study|Lost to Follow-up|6|||
19379973|NCT01328951|41623124|FG001|Overall Study|Lost to Follow-up|7|||
19379974|NCT01328951|41623123|FG000|Overall Study|Withdrawal by Subject|6|||
19379975|NCT01328951|41623124|FG001|Overall Study|Withdrawal by Subject|6|||
19379976|NCT01328951|41623123|FG000|Overall Study|Study Closed by the Sponsor|36|||
19379977|NCT01328951|41623124|FG001|Overall Study|Study Closed by the Sponsor|31|||
19379978|NCT01328951|41623123|FG000|Overall Study|Other|11|||
19379979|NCT01328951|41623124|FG001|Overall Study|Other|6|||
19379980|NCT02611817|41623137|FG000|Open-label Induction Phase|Reason not Specified|9|||
19379981|NCT02611817|41623138|FG001|Open-label Induction Phase|Reason not Specified|0|||
19379982|NCT02611817|41623139|FG002|Open-label Induction Phase|Reason not Specified|0|||
19379983|NCT02611817|41623137|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
19379984|NCT02611817|41623138|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
19379985|NCT02611817|41623139|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
19379986|NCT02611817|41623137|FG000|Open-label Induction Phase|Pregnancy|1|||
19379987|NCT02611817|41623138|FG001|Open-label Induction Phase|Pregnancy|0|||
19379988|NCT02611817|41623139|FG002|Open-label Induction Phase|Pregnancy|0|||
19379989|NCT02611817|41623137|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
19379990|NCT02611817|41623138|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
19379991|NCT02611817|41623139|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
19379992|NCT02611817|41623137|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
19379993|NCT02611817|41623138|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
19379994|NCT02611817|41623139|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
19379995|NCT02611817|41623137|FG000|Open-label Induction Phase|Protocol Violation|5|||
19379996|NCT02611817|41623138|FG001|Open-label Induction Phase|Protocol Violation|0|||
19379997|NCT02611817|41623139|FG002|Open-label Induction Phase|Protocol Violation|0|||
19379998|NCT02611817|41623137|FG000|Open-label Induction Phase|Adverse Event|16|||
19379999|NCT02611817|41623138|FG001|Open-label Induction Phase|Adverse Event|0|||
19380000|NCT02611817|41623139|FG002|Open-label Induction Phase|Adverse Event|0|||
19380001|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
19380002|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
19380003|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
19380004|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
19380005|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
19380006|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
19380007|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
19380008|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
19380009|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
19380010|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
19380011|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
19380012|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
19464653|NCT01927055|41722896|FG001|Open-label|Study Stopped|0|||
19464654|NCT01927055|41722897|FG002|Open-label|Study Stopped|0|||
19464655|NCT01927055|41722895|FG000|Open-label|Supine Hypertension|4|||
19464656|NCT01927055|41722896|FG001|Open-label|Supine Hypertension|0|||
19464657|NCT01927055|41722897|FG002|Open-label|Supine Hypertension|0|||
19464658|NCT01927055|41722895|FG000|Open-label|Difficulty attending study visits|1|||
19464659|NCT01927055|41722896|FG001|Open-label|Difficulty attending study visits|0|||
19464660|NCT01927055|41722897|FG002|Open-label|Difficulty attending study visits|0|||
19464661|NCT01927055|41722895|FG000|Double-Blind|Adverse Event|0|||
19464662|NCT01927055|41722896|FG001|Double-Blind|Adverse Event|1|||
19464663|NCT01927055|41722897|FG002|Double-Blind|Adverse Event|1|||
19464664|NCT01927055|41722895|FG000|Double-Blind|Protocol Violation|0|||
19464665|NCT01927055|41722896|FG001|Double-Blind|Protocol Violation|0|||
19464666|NCT01927055|41722897|FG002|Double-Blind|Protocol Violation|1|||
19464667|NCT01927055|41722895|FG000|Double-Blind|Withdrawal by Subject|0|||
19464668|NCT01927055|41722896|FG001|Double-Blind|Withdrawal by Subject|2|||
19464669|NCT01927055|41722897|FG002|Double-Blind|Withdrawal by Subject|3|||
19464670|NCT01927055|41722895|FG000|Double-Blind|Study Stopped|0|||
19464671|NCT01927055|41722896|FG001|Double-Blind|Study Stopped|7|||
19464672|NCT01927055|41722897|FG002|Double-Blind|Study Stopped|7|||
19464673|NCT01927055|41722895|FG000|Double-Blind|Supine Hypertension|0|||
19464674|NCT01927055|41722896|FG001|Double-Blind|Supine Hypertension|0|||
19464675|NCT01927055|41722897|FG002|Double-Blind|Supine Hypertension|1|||
19464676|NCT01927055|41722895|FG000|Double-Blind|Extended Vacation|0|||
19464677|NCT01927055|41722896|FG001|Double-Blind|Extended Vacation|1|||
19464678|NCT01927055|41722897|FG002|Double-Blind|Extended Vacation|0|||
19464679|NCT01913327|41722906|FG000|Overall Study|Withdrawal by Subject|0|||
19464680|NCT01913327|41722907|FG001|Overall Study|Withdrawal by Subject|1|||
19464681|NCT01926509|41722917|FG000|Overall Study|vital sign met discontinuation criteria|1|||
19464682|NCT01926509|41722918|FG001|Overall Study|vital sign met discontinuation criteria|0|||
19464683|NCT01926509|41722919|FG002|Overall Study|vital sign met discontinuation criteria|0|||
19464684|NCT01926509|41722920|FG003|Overall Study|vital sign met discontinuation criteria|0|||
19464685|NCT01926119|41722930|FG000|Overall Study|Withdrawal by Subject|1|||
19464686|NCT01912781|41722936|FG000|Overall Study|Withdrawal by Subject|2|||
19464687|NCT01912781|41722937|FG001|Overall Study|Withdrawal by Subject|0|||
19464688|NCT01925417|41722944|FG000|Overall Study|Withdrawal by Subject|2|||
19464689|NCT01925417|41722944|FG000|Overall Study|Death|1|||
19464690|NCT01911845|41722949|FG000|Overall Study|Adverse Event|2|||
19464691|NCT01911845|41722949|FG000|Overall Study|Lost to Follow-up|1|||
19464692|NCT01911845|41722949|FG000|Overall Study|Other (not specified)|3|||
19464693|NCT01925339|41722957|FG000|Overall Study|Adverse Event|2|||
19464694|NCT01925339|41722958|FG001|Overall Study|Adverse Event|0|||
19464695|NCT01925183|41722966|FG000|Overall Study|Adverse Event|1|||
19464696|NCT01925183|41722967|FG001|Overall Study|Adverse Event|0|||
19464697|NCT01910519|41722975|FG000|Overall Study|Withdrawal by Subject|2|||
19464698|NCT01910519|41722976|FG001|Overall Study|Withdrawal by Subject|0|||
19464699|NCT01910519|41722975|FG000|Overall Study|Adverse Event|2|||
19464700|NCT01910519|41722976|FG001|Overall Study|Adverse Event|0|||
19464701|NCT01910441|41722984|FG000|Overall Study|Sponsor decision|0|||
19464702|NCT01910441|41722985|FG001|Overall Study|Sponsor decision|2|||
19464703|NCT01910441|41722984|FG000|Overall Study|Lost to Follow-up|6|||
19464704|NCT01910441|41722985|FG001|Overall Study|Lost to Follow-up|5|||
19380013|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
19380014|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
19380015|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
19380016|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
19380017|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
19380018|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
19380019|NCT02611817|41623137|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
19380020|NCT02611817|41623138|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
19380021|NCT02611817|41623139|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
19380022|NCT02735915|41623146|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
19380023|NCT02735915|41623146|FG000|Overall Study|Withdrawal following SAE|2|||
19380024|NCT02735915|41623146|FG000|Overall Study|Withdrawal by Subject|1|||
19380025|NCT02557139|41623155|FG000|Overall Study|Significant liver elevation|1|||
19380026|NCT02557139|41623156|FG001|Overall Study|Significant liver elevation|0|||
19380027|NCT02557139|41623157|FG002|Overall Study|Significant liver elevation|1|||
19380028|NCT02557139|41623155|FG000|Overall Study|Withdrawal by Subject|1|||
19380029|NCT02557139|41623156|FG001|Overall Study|Withdrawal by Subject|0|||
19380030|NCT02557139|41623157|FG002|Overall Study|Withdrawal by Subject|0|||
19380031|NCT02557139|41623155|FG000|Overall Study|Illness of prohibited medication|0|||
19380032|NCT02557139|41623156|FG001|Overall Study|Illness of prohibited medication|0|||
19380033|NCT02557139|41623157|FG002|Overall Study|Illness of prohibited medication|1|||
19380034|NCT01328717|41623174|FG000|Overall Study|Adverse Event|1|||
19380035|NCT01677741|41623186|FG000|Overall Study|Death|0|||
19380036|NCT01677741|41623187|FG001|Overall Study|Death|0|||
19380037|NCT01677741|41623188|FG002|Overall Study|Death|0|||
19380038|NCT01677741|41623189|FG003|Overall Study|Death|1|||
19380039|NCT01677741|41623190|FG004|Overall Study|Death|0|||
19380040|NCT01677741|41623191|FG005|Overall Study|Death|1|||
19380041|NCT01677741|41623192|FG006|Overall Study|Death|0|||
19380042|NCT01677741|41623193|FG007|Overall Study|Death|0|||
19380043|NCT01677741|41623186|FG000|Overall Study|Withdrawal by Subject|2|||
19380044|NCT01677741|41623187|FG001|Overall Study|Withdrawal by Subject|7|||
19380045|NCT01677741|41623188|FG002|Overall Study|Withdrawal by Subject|5|||
19380046|NCT01677741|41623189|FG003|Overall Study|Withdrawal by Subject|4|||
19380047|NCT01677741|41623190|FG004|Overall Study|Withdrawal by Subject|11|||
19380048|NCT01677741|41623191|FG005|Overall Study|Withdrawal by Subject|20|||
19380049|NCT01677741|41623192|FG006|Overall Study|Withdrawal by Subject|4|||
19380050|NCT01677741|41623193|FG007|Overall Study|Withdrawal by Subject|2|||
19380051|NCT01677741|41623186|FG000|Overall Study|Enrolled in a rollover study|0|||
19380052|NCT01677741|41623187|FG001|Overall Study|Enrolled in a rollover study|3|||
19380053|NCT01677741|41623188|FG002|Overall Study|Enrolled in a rollover study|2|||
19380054|NCT01677741|41623189|FG003|Overall Study|Enrolled in a rollover study|1|||
19380055|NCT01677741|41623190|FG004|Overall Study|Enrolled in a rollover study|6|||
19380056|NCT01677741|41623191|FG005|Overall Study|Enrolled in a rollover study|6|||
19380057|NCT01677741|41623192|FG006|Overall Study|Enrolled in a rollover study|7|||
19380058|NCT01677741|41623193|FG007|Overall Study|Enrolled in a rollover study|0|||
19380059|NCT01677741|41623186|FG000|Overall Study|Progressive disease|1|||
19380060|NCT01677741|41623187|FG001|Overall Study|Progressive disease|0|||
19380061|NCT01677741|41623188|FG002|Overall Study|Progressive disease|1|||
19380062|NCT01677741|41623189|FG003|Overall Study|Progressive disease|0|||
19380063|NCT01677741|41623190|FG004|Overall Study|Progressive disease|0|||
19380064|NCT01677741|41623191|FG005|Overall Study|Progressive disease|1|||
19380065|NCT01677741|41623192|FG006|Overall Study|Progressive disease|0|||
19380066|NCT01677741|41623193|FG007|Overall Study|Progressive disease|0|||
19380067|NCT01677507|41623245|FG000|Initial Assignment|Adverse Event|0|||
19380068|NCT01677507|41623246|FG001|Initial Assignment|Adverse Event|1|||
19380069|NCT01677507|41623245|FG000|Initial Assignment|Protocol Violation|0|||
19380070|NCT01677507|41623246|FG001|Initial Assignment|Protocol Violation|1|||
19380071|NCT01677507|41623245|FG000|Second Assigment|Withdrawal by Subject|2|||
19380072|NCT01677507|41623246|FG001|Second Assigment|Withdrawal by Subject|2|||
19380073|NCT01677507|41623245|FG000|Second Assigment|Adverse Event|1|||
19380074|NCT01677507|41623246|FG001|Second Assigment|Adverse Event|3|||
19380075|NCT03126539|41623256|FG000|Overall Study|Lost to Follow-up|1|||
19380076|NCT03126539|41623257|FG001|Overall Study|Lost to Follow-up|1|||
19380077|NCT03126539|41623258|FG002|Overall Study|Lost to Follow-up|1|||
19380078|NCT03126539|41623259|FG003|Overall Study|Lost to Follow-up|0|||
19380079|NCT03126539|41623260|FG004|Overall Study|Lost to Follow-up|0|||
19380080|NCT02732951|41623275|FG000|Overall Study|Other than listed|1|||
19380081|NCT02732951|41623276|FG001|Overall Study|Other than listed|0|||
19380082|NCT02732951|41623275|FG000|Overall Study|Lost to Follow-up|0|||
19380083|NCT02732951|41623276|FG001|Overall Study|Lost to Follow-up|1|||
19380084|NCT02732951|41623275|FG000|Overall Study|Adverse Event|4|||
19380085|NCT02732951|41623276|FG001|Overall Study|Adverse Event|4|||
19380086|NCT02732951|41623275|FG000|Overall Study|Protocol Violation|0|||
19380087|NCT02732951|41623276|FG001|Overall Study|Protocol Violation|1|||
19464705|NCT01910441|41722984|FG000|Overall Study|Withdrawal by Subject|0|||
19464706|NCT01910441|41722985|FG001|Overall Study|Withdrawal by Subject|1|||
19464707|NCT01910441|41722984|FG000|Overall Study|Non-compliance|0|||
19464708|NCT01910441|41722985|FG001|Overall Study|Non-compliance|1|||
19464709|NCT01910441|41722984|FG000|Overall Study|Adverse Event|1|||
19464710|NCT01910441|41722985|FG001|Overall Study|Adverse Event|0|||
19464711|NCT01910441|41722984|FG000|Overall Study|Physician Decision|0|||
19464712|NCT01910441|41722985|FG001|Overall Study|Physician Decision|1|||
19464713|NCT01923467|41722991|FG000|Overall Study|Lost to Follow-up|62|||
19464714|NCT01923467|41722991|FG000|Overall Study|Subject non-interest|479|||
19464715|NCT01910129|41722997|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
19464716|NCT01910129|41722998|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
19464717|NCT01910129|41722999|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
19464718|NCT01910129|41722997|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
19464719|NCT01910129|41722998|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
19464720|NCT01910129|41722999|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
19464721|NCT01909973|41723019|FG000|Overall Study|Lost to Follow-up|1|||
19464722|NCT01909973|41723020|FG001|Overall Study|Lost to Follow-up|0|||
19464723|NCT01617005|41723026|FG000|Overall Study|Pregnancy|1|||
19464724|NCT01617005|41723026|FG000|Overall Study|Lack of motivation for treatment|1|||
19380088|NCT01377233|41623287|FG000|Open-label|Adverse Event|1|||
19380089|NCT01377233|41623288|FG001|Open-label|Adverse Event|0|||
19380090|NCT01377233|41623289|FG002|Open-label|Adverse Event|0|||
19380091|NCT01377233|41623290|FG003|Open-label|Adverse Event|0|||
19380092|NCT01377233|41623291|FG004|Open-label|Adverse Event|0|||
19380093|NCT01377233|41623287|FG000|Open-label|Withdrawal by Subject|3|||
19380094|NCT01377233|41623288|FG001|Open-label|Withdrawal by Subject|0|||
19380095|NCT01377233|41623289|FG002|Open-label|Withdrawal by Subject|0|||
19380096|NCT01377233|41623290|FG003|Open-label|Withdrawal by Subject|0|||
19380097|NCT01377233|41623291|FG004|Open-label|Withdrawal by Subject|0|||
19380098|NCT01377233|41623287|FG000|Double-blind|Adverse Event|0|||
19464725|NCT01908803|41723032|FG000|Overall Study|Adverse Event|1|||
19464726|NCT01908803|41723033|FG001|Overall Study|Adverse Event|0|||
19464727|NCT01908803|41723032|FG000|Overall Study|Physician Decision|0|||
19464728|NCT01908803|41723033|FG001|Overall Study|Physician Decision|1|||
19464729|NCT01908803|41723032|FG000|Overall Study|Withdrawal by Subject|1|||
19464730|NCT01908803|41723033|FG001|Overall Study|Withdrawal by Subject|0|||
19464731|NCT01908803|41723032|FG000|Overall Study|Randomization Error|1|||
19373288|NCT02670915|41614329|FG001|Overall Study|Unclassified|3|||
19373289|NCT02670915|41614330|FG002|Overall Study|Unclassified|0|||
19373290|NCT02545868|41614341|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
19373291|NCT02545868|41614342|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
19373292|NCT02545868|41614343|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
19373293|NCT02764151|41614360|FG000|Overall Study|Subject refused further follow-up|0|||
19373294|NCT02764151|41614361|FG001|Overall Study|Subject refused further follow-up|0|||
19373295|NCT02764151|41614362|FG002|Overall Study|Subject refused further follow-up|0|||
19373296|NCT02764151|41614363|FG003|Overall Study|Subject refused further follow-up|1|||
19373297|NCT02764151|41614360|FG000|Overall Study|Other|0|||
19373298|NCT02764151|41614361|FG001|Overall Study|Other|0|||
19373299|NCT02764151|41614362|FG002|Overall Study|Other|0|||
19373300|NCT02764151|41614363|FG003|Overall Study|Other|2|||
19373301|NCT02545322|41614373|FG000|Overall Study|Withdrawal by Subject|3|||
19373302|NCT02763215|41614377|FG000|Overall Study|Participants withdrew from study|3|||
19373303|NCT02763215|41614377|FG000|Overall Study|Missed visit|1|||
19373304|NCT02763215|41614377|FG000|Overall Study|Visit outside visit-window|1|||
19373305|NCT02763215|41614377|FG000|Overall Study|Death|1|||
19373306|NCT02763215|41614377|FG000|Overall Study|Lost to Follow-up|1|||
19373307|NCT02770547|41614396|FG000|Overall Study|Patient non-compliant|1|||
19373308|NCT02770547|41614397|FG001|Overall Study|Patient non-compliant|0|||
19373309|NCT02770547|41614396|FG000|Overall Study|Adverse Event|0|||
19373310|NCT02770547|41614397|FG001|Overall Study|Adverse Event|1|||
19373311|NCT01661972|41614405|FG000|Overall Study|Adverse Event|1|||
19373312|NCT01661972|41614406|FG001|Overall Study|Adverse Event|2|||
19373313|NCT01661972|41614405|FG000|Overall Study|Death during Treatment period|1|||
19373314|NCT01661972|41614406|FG001|Overall Study|Death during Treatment period|1|||
19373315|NCT01661972|41614405|FG000|Overall Study|Withdrawal by Subject|0|||
19373316|NCT01661972|41614406|FG001|Overall Study|Withdrawal by Subject|1|||
19373317|NCT00888355|41614418|FG000|Overall Study|Adverse Event|10|||
19373318|NCT00888355|41614419|FG001|Overall Study|Adverse Event|0|||
19373319|NCT00888355|41614420|FG002|Overall Study|Adverse Event|3|||
19373320|NCT00888355|41614421|FG003|Overall Study|Adverse Event|3|||
19373321|NCT00888355|41614418|FG000|Overall Study|Lack of Efficacy|9|||
19373322|NCT00888355|41614419|FG001|Overall Study|Lack of Efficacy|2|||
19373323|NCT00888355|41614420|FG002|Overall Study|Lack of Efficacy|5|||
19373324|NCT00888355|41614421|FG003|Overall Study|Lack of Efficacy|2|||
19373325|NCT00888355|41614418|FG000|Overall Study|Lost to Follow-up|0|||
19373326|NCT00888355|41614419|FG001|Overall Study|Lost to Follow-up|2|||
19373327|NCT00888355|41614420|FG002|Overall Study|Lost to Follow-up|2|||
19373328|NCT00888355|41614421|FG003|Overall Study|Lost to Follow-up|0|||
19373329|NCT00888355|41614418|FG000|Overall Study|Protocol Violation|3|||
19373330|NCT00888355|41614419|FG001|Overall Study|Protocol Violation|2|||
19373331|NCT00888355|41614420|FG002|Overall Study|Protocol Violation|1|||
19373332|NCT00888355|41614421|FG003|Overall Study|Protocol Violation|2|||
19373333|NCT00888355|41614418|FG000|Overall Study|Withdrawal by Subject|0|||
19373334|NCT00888355|41614419|FG001|Overall Study|Withdrawal by Subject|3|||
19373335|NCT00888355|41614420|FG002|Overall Study|Withdrawal by Subject|1|||
19373336|NCT00888355|41614421|FG003|Overall Study|Withdrawal by Subject|3|||
19373337|NCT00794677|41614429|FG000|First Intervention|Withdrawal by Subject|2|||
19373338|NCT00794677|41614430|FG001|First Intervention|Withdrawal by Subject|0|||
19380099|NCT01377233|41623288|FG001|Double-blind|Adverse Event|1|||
19380100|NCT01377233|41623289|FG002|Double-blind|Adverse Event|2|||
19380101|NCT01377233|41623290|FG003|Double-blind|Adverse Event|2|||
19380102|NCT01377233|41623291|FG004|Double-blind|Adverse Event|0|||
19380103|NCT01377233|41623287|FG000|Double-blind|Protocol Violation|0|||
19380104|NCT01377233|41623288|FG001|Double-blind|Protocol Violation|0|||
19380105|NCT01377233|41623289|FG002|Double-blind|Protocol Violation|0|||
19380106|NCT01377233|41623290|FG003|Double-blind|Protocol Violation|0|||
19380107|NCT01377233|41623291|FG004|Double-blind|Protocol Violation|1|||
19380108|NCT01377233|41623287|FG000|Double-blind|Withdrawal by Subject|0|||
19380109|NCT01377233|41623288|FG001|Double-blind|Withdrawal by Subject|0|||
19380110|NCT01377233|41623289|FG002|Double-blind|Withdrawal by Subject|0|||
19380111|NCT01377233|41623290|FG003|Double-blind|Withdrawal by Subject|1|||
19380112|NCT01377233|41623291|FG004|Double-blind|Withdrawal by Subject|0|||
19380113|NCT01377233|41623287|FG000|Double-blind|Administrative or other|0|||
19380114|NCT01377233|41623288|FG001|Double-blind|Administrative or other|0|||
19380115|NCT01377233|41623289|FG002|Double-blind|Administrative or other|0|||
19380116|NCT01377233|41623290|FG003|Double-blind|Administrative or other|1|||
19380117|NCT01377233|41623291|FG004|Double-blind|Administrative or other|1|||
19380118|NCT03248531|41623310|FG000|Overall Study|Adverse Event|0|||
19380119|NCT03248531|41623311|FG001|Overall Study|Adverse Event|0|||
19380120|NCT03248531|41623312|FG002|Overall Study|Adverse Event|1|||
19380121|NCT03248531|41623310|FG000|Overall Study|Lost to Follow-up|1|||
19380122|NCT03248531|41623311|FG001|Overall Study|Lost to Follow-up|0|||
19380123|NCT03248531|41623312|FG002|Overall Study|Lost to Follow-up|5|||
19380124|NCT03248531|41623310|FG000|Overall Study|Withdrawal by Subject|3|||
19380125|NCT03248531|41623311|FG001|Overall Study|Withdrawal by Subject|3|||
19380126|NCT03248531|41623312|FG002|Overall Study|Withdrawal by Subject|2|||
19380127|NCT03248531|41623310|FG000|Overall Study|Sponsor Request|0|||
19380128|NCT03248531|41623311|FG001|Overall Study|Sponsor Request|2|||
19380129|NCT03248531|41623312|FG002|Overall Study|Sponsor Request|0|||
19380130|NCT02656329|41623329|FG000|Overall Study|Lost to Follow-up|2|||
19380131|NCT02656329|41623330|FG001|Overall Study|Lost to Follow-up|3|||
19380132|NCT02656329|41623329|FG000|Overall Study|Withdrawal by Subject|7|||
19380133|NCT02656329|41623330|FG001|Overall Study|Withdrawal by Subject|6|||
19380134|NCT02656329|41623329|FG000|Overall Study|Study termination by Sponsor|150|||
19380135|NCT02656329|41623330|FG001|Overall Study|Study termination by Sponsor|142|||
19380136|NCT02656329|41623329|FG000|Overall Study|Other than specified above|5|||
19380137|NCT02656329|41623330|FG001|Overall Study|Other than specified above|6|||
19380138|NCT03776357|41623337|FG000|Overall Study|Lost to Follow-up|3|||
19380139|NCT04520997|41623343|FG000|Overall Study|Lost to Follow-up|1|||
19380140|NCT04520997|41623344|FG001|Overall Study|Lost to Follow-up|1|||
19380141|NCT04520997|41623343|FG000|Overall Study|Withdrawal by Subject|1|||
19380142|NCT04520997|41623344|FG001|Overall Study|Withdrawal by Subject|0|||
19380143|NCT04520997|41623343|FG000|Overall Study|Not Treated|0|||
19380144|NCT04520997|41623344|FG001|Overall Study|Not Treated|1|||
19380145|NCT02181413|41623355|FG000|Overall Study|Adverse Event|7|||
19380146|NCT02181413|41623356|FG001|Overall Study|Adverse Event|24|||
19380147|NCT02181413|41623355|FG000|Overall Study|Progressive Disease|121|||
19380148|NCT02181413|41623356|FG001|Overall Study|Progressive Disease|143|||
19380149|NCT02181413|41623355|FG000|Overall Study|Withdrawal by Subject|5|||
19380150|NCT02181413|41623356|FG001|Overall Study|Withdrawal by Subject|8|||
19380151|NCT02181413|41623355|FG000|Overall Study|Reason Not Specified|19|||
19380152|NCT02181413|41623356|FG001|Overall Study|Reason Not Specified|20|||
19380153|NCT02181413|41623355|FG000|Overall Study|Ongoing Study Treatment|0|||
19380154|NCT02181413|41623356|FG001|Overall Study|Ongoing Study Treatment|1|||
19380155|NCT02181413|41623355|FG000|Overall Study|Lost to Follow-up|0|||
19380156|NCT02181413|41623356|FG001|Overall Study|Lost to Follow-up|1|||
19380157|NCT02734433|41623364|FG000|Overall Study|Disease progression|1|||
19380158|NCT02734433|41623365|FG001|Overall Study|Disease progression|5|||
19380159|NCT02734433|41623364|FG000|Overall Study|Clinical progression|0|||
19380160|NCT02734433|41623365|FG001|Overall Study|Clinical progression|1|||
19380161|NCT02734433|41623364|FG000|Overall Study|Withdrawal by Subject|1|||
19380162|NCT02734433|41623365|FG001|Overall Study|Withdrawal by Subject|2|||
19380163|NCT02452424|41623391|FG000|Overall Study|Death|2|||
19380164|NCT02452424|41623392|FG001|Overall Study|Death|2|||
19380165|NCT02452424|41623393|FG002|Overall Study|Death|2|||
19380166|NCT02452424|41623394|FG003|Overall Study|Death|6|||
19380167|NCT02452424|41623395|FG004|Overall Study|Death|2|||
19380168|NCT02452424|41623396|FG005|Overall Study|Death|0|||
19380169|NCT02452424|41623397|FG006|Overall Study|Death|5|||
19380170|NCT02452424|41623398|FG007|Overall Study|Death|1|||
19380171|NCT02452424|41623399|FG008|Overall Study|Death|3|||
19380172|NCT02452424|41623400|FG009|Overall Study|Death|1|||
19380173|NCT02452424|41623401|FG010|Overall Study|Death|0|||
19380174|NCT02452424|41623391|FG000|Overall Study|Lost to Follow-up|0|||
19380175|NCT02452424|41623392|FG001|Overall Study|Lost to Follow-up|1|||
19380176|NCT02452424|41623393|FG002|Overall Study|Lost to Follow-up|1|||
19380177|NCT02452424|41623394|FG003|Overall Study|Lost to Follow-up|0|||
19380178|NCT02452424|41623395|FG004|Overall Study|Lost to Follow-up|0|||
19380179|NCT02452424|41623396|FG005|Overall Study|Lost to Follow-up|0|||
19380180|NCT02452424|41623397|FG006|Overall Study|Lost to Follow-up|0|||
19380181|NCT02452424|41623398|FG007|Overall Study|Lost to Follow-up|0|||
19380182|NCT02452424|41623399|FG008|Overall Study|Lost to Follow-up|0|||
19380183|NCT02452424|41623400|FG009|Overall Study|Lost to Follow-up|0|||
19380184|NCT02452424|41623401|FG010|Overall Study|Lost to Follow-up|0|||
19380185|NCT02452424|41623391|FG000|Overall Study|Withdrawal by Subject|0|||
19380186|NCT02452424|41623392|FG001|Overall Study|Withdrawal by Subject|0|||
19380187|NCT02452424|41623393|FG002|Overall Study|Withdrawal by Subject|3|||
19380188|NCT02452424|41623394|FG003|Overall Study|Withdrawal by Subject|2|||
19380189|NCT02452424|41623395|FG004|Overall Study|Withdrawal by Subject|0|||
19380190|NCT02452424|41623396|FG005|Overall Study|Withdrawal by Subject|0|||
19380191|NCT02452424|41623397|FG006|Overall Study|Withdrawal by Subject|1|||
19380192|NCT02452424|41623398|FG007|Overall Study|Withdrawal by Subject|0|||
19380193|NCT02452424|41623399|FG008|Overall Study|Withdrawal by Subject|1|||
19380194|NCT02452424|41623400|FG009|Overall Study|Withdrawal by Subject|1|||
19380195|NCT02452424|41623401|FG010|Overall Study|Withdrawal by Subject|0|||
19380196|NCT02452424|41623391|FG000|Overall Study|Other|0|||
19380197|NCT02452424|41623392|FG001|Overall Study|Other|0|||
19380198|NCT02452424|41623393|FG002|Overall Study|Other|1|||
19380199|NCT02452424|41623394|FG003|Overall Study|Other|0|||
19380200|NCT02452424|41623395|FG004|Overall Study|Other|0|||
19380201|NCT02452424|41623396|FG005|Overall Study|Other|1|||
19380202|NCT02452424|41623397|FG006|Overall Study|Other|4|||
19380203|NCT02452424|41623398|FG007|Overall Study|Other|3|||
19380204|NCT02452424|41623399|FG008|Overall Study|Other|0|||
19380205|NCT02452424|41623400|FG009|Overall Study|Other|0|||
19380206|NCT02452424|41623401|FG010|Overall Study|Other|1|||
19380207|NCT02452424|41623391|FG000|Overall Study|Progressive disease (per RECIST)|0|||
19380208|NCT02452424|41623392|FG001|Overall Study|Progressive disease (per RECIST)|0|||
19380209|NCT02452424|41623393|FG002|Overall Study|Progressive disease (per RECIST)|0|||
19380210|NCT02452424|41623394|FG003|Overall Study|Progressive disease (per RECIST)|0|||
19380211|NCT02452424|41623395|FG004|Overall Study|Progressive disease (per RECIST)|0|||
19380212|NCT02452424|41623396|FG005|Overall Study|Progressive disease (per RECIST)|0|||
19380213|NCT02452424|41623397|FG006|Overall Study|Progressive disease (per RECIST)|0|||
19380214|NCT02452424|41623398|FG007|Overall Study|Progressive disease (per RECIST)|0|||
19380215|NCT02452424|41623399|FG008|Overall Study|Progressive disease (per RECIST)|2|||
19380216|NCT02452424|41623400|FG009|Overall Study|Progressive disease (per RECIST)|0|||
19380217|NCT02452424|41623401|FG010|Overall Study|Progressive disease (per RECIST)|0|||
19380218|NCT02452424|41623391|FG000|Overall Study|Adverse Event|0|||
19380219|NCT02452424|41623392|FG001|Overall Study|Adverse Event|0|||
19380220|NCT02452424|41623393|FG002|Overall Study|Adverse Event|0|||
19380221|NCT02452424|41623394|FG003|Overall Study|Adverse Event|0|||
19380222|NCT02452424|41623395|FG004|Overall Study|Adverse Event|0|||
19380223|NCT02452424|41623396|FG005|Overall Study|Adverse Event|0|||
19380224|NCT02452424|41623397|FG006|Overall Study|Adverse Event|0|||
19380225|NCT02452424|41623398|FG007|Overall Study|Adverse Event|0|||
19380226|NCT02452424|41623399|FG008|Overall Study|Adverse Event|0|||
19380227|NCT02452424|41623400|FG009|Overall Study|Adverse Event|0|||
19380228|NCT02452424|41623401|FG010|Overall Study|Adverse Event|1|||
19380229|NCT02419508|41623429|FG000|Overall Study|Adverse Event|9|||
19380230|NCT02419508|41623430|FG001|Overall Study|Adverse Event|3|||
19380231|NCT02419508|41623429|FG000|Overall Study|Withdrawal by Subject|1|||
19380232|NCT02419508|41623430|FG001|Overall Study|Withdrawal by Subject|0|||
19380233|NCT02419508|41623429|FG000|Overall Study|Other - Reason not specified|0|||
19380234|NCT02419508|41623430|FG001|Overall Study|Other - Reason not specified|1|||
19380235|NCT01328249|41623438|FG000|Overall Study|Adverse Event|3|||
19380236|NCT01328249|41623439|FG001|Overall Study|Adverse Event|0|||
19380237|NCT01328249|41623438|FG000|Overall Study|Disease progression|1|||
19380238|NCT01328249|41623439|FG001|Overall Study|Disease progression|0|||
19380239|NCT01328249|41623438|FG000|Overall Study|Withdrawal by Subject|1|||
19380240|NCT01328249|41623439|FG001|Overall Study|Withdrawal by Subject|1|||
19380241|NCT01328249|41623438|FG000|Overall Study|Moved before end of treatment visit|1|||
19380242|NCT01328249|41623439|FG001|Overall Study|Moved before end of treatment visit|0|||
19380243|NCT01328249|41623438|FG000|Overall Study|Subject choice|1|||
19380244|NCT01328249|41623439|FG001|Overall Study|Subject choice|1|||
19380245|NCT01328249|41623438|FG000|Overall Study|Protocol Violation|0|||
19380246|NCT01328249|41623439|FG001|Overall Study|Protocol Violation|1|||
19380247|NCT01651052|41623447|FG000|Overall Study|Death|21|||
19380248|NCT01651052|41623447|FG000|Overall Study|Explant|1|||
19380249|NCT01651052|41623447|FG000|Overall Study|Withdrawal by Subject|1|||
19380250|NCT01651052|41623447|FG000|Overall Study|Lost to Follow-up|3|||
19380251|NCT02388074|41623451|FG000|Overall Study|Lost in Transit|2|||
19380252|NCT02388074|41623451|FG000|Overall Study|Sample Not Returned|1|||
19464732|NCT01908803|41723033|FG001|Overall Study|Randomization Error|0|||
19380253|NCT01602549|41623457|FG000|Overall Study|Protocol Violation|0|||
19380254|NCT01602549|41623458|FG001|Overall Study|Protocol Violation|1|||
19380255|NCT01602549|41623457|FG000|Overall Study|Withdrawal by Subject|1|||
19380256|NCT01602549|41623458|FG001|Overall Study|Withdrawal by Subject|0|||
19380257|NCT02427464|41623468|FG000|Overall Study|Adverse Event|6|||
19380258|NCT02427464|41623469|FG001|Overall Study|Adverse Event|1|||
19380259|NCT02427464|41623468|FG000|Overall Study|Lost to Follow-up|16|||
19380260|NCT02427464|41623469|FG001|Overall Study|Lost to Follow-up|5|||
19380261|NCT02427464|41623468|FG000|Overall Study|Physician Decision|2|||
19380262|NCT02427464|41623469|FG001|Overall Study|Physician Decision|0|||
19380263|NCT02427464|41623468|FG000|Overall Study|Withdrawal by Subject|10|||
19380264|NCT02427464|41623469|FG001|Overall Study|Withdrawal by Subject|8|||
19380265|NCT02427464|41623468|FG000|Overall Study|Noncompliance|16|||
19380266|NCT02427464|41623469|FG001|Overall Study|Noncompliance|10|||
19380267|NCT02426918|41623478|FG000|Overall Study|Adverse Event|2|||
19380268|NCT02426918|41623479|FG001|Overall Study|Adverse Event|2|||
19380269|NCT02426918|41623480|FG002|Overall Study|Adverse Event|0|||
19380270|NCT02426918|41623478|FG000|Overall Study|Physician Decision|1|||
19380271|NCT02426918|41623479|FG001|Overall Study|Physician Decision|1|||
19380272|NCT02426918|41623480|FG002|Overall Study|Physician Decision|1|||
19380273|NCT02426918|41623478|FG000|Overall Study|Withdrawal by Subject|5|||
19380274|NCT02426918|41623479|FG001|Overall Study|Withdrawal by Subject|5|||
19380275|NCT02426918|41623480|FG002|Overall Study|Withdrawal by Subject|4|||
19380276|NCT02426918|41623478|FG000|Overall Study|Other|9|||
19380277|NCT02426918|41623479|FG001|Overall Study|Other|11|||
19380278|NCT02426918|41623480|FG002|Overall Study|Other|9|||
19380279|NCT02387840|41623494|FG000|Overall Study|Death|0|||
19380280|NCT02387840|41623495|FG001|Overall Study|Death|0|||
19380281|NCT02387840|41623496|FG002|Overall Study|Death|0|||
19380282|NCT02387840|41623497|FG003|Overall Study|Death|0|||
19380283|NCT02387840|41623498|FG004|Overall Study|Death|0|||
19380284|NCT02387840|41623499|FG005|Overall Study|Death|1|||
19380285|NCT02426684|41623519|FG000|Overall Study|Physician Decision|1|||
19380286|NCT02387762|41623525|FG000|Overall Study|Withdrawal by Subject|1|||
19380287|NCT02387762|41623526|FG001|Overall Study|Withdrawal by Subject|0|||
19380288|NCT02418182|41623534|FG000|Overall Study|Unable to re-consent|18|||
19380289|NCT02418182|41623535|FG001|Overall Study|Unable to re-consent|15|||
19380290|NCT02418182|41623534|FG000|Overall Study|Lost to Follow-up|0|||
19380291|NCT02418182|41623535|FG001|Overall Study|Lost to Follow-up|2|||
19380292|NCT02387372|41623556|FG000|Overall Study|Not Treated|1|||
19380293|NCT02387372|41623557|FG001|Overall Study|Not Treated|0|||
19464733|NCT01908803|41723032|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
19464734|NCT01908803|41723033|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
19464735|NCT01908101|41723040|FG000|Overall Study|Physician Decision|1|||
19464736|NCT01908101|41723040|FG000|Overall Study|Withdrawal by Subject|1|||
19464737|NCT01908101|41723040|FG000|Overall Study|Incorrect Diagnosis|2|||
19464738|NCT01908101|41723040|FG000|Overall Study|Incorrect Starting Dose|1|||
19464739|NCT01908101|41723040|FG000|Overall Study|Did not complete the first cycle|4|||
19464740|NCT01923389|41723046|FG000|Overall Study|Protocol Violation|1|||
19464741|NCT01923389|41723047|FG001|Overall Study|Protocol Violation|0|||
19464742|NCT01907087|41723054|FG000|Overall Study|Withdrawal by Subject|1|||
19464743|NCT01616771|41723058|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
19464744|NCT01589185|41723072|FG000|Overall Study|Death|1|||
19464745|NCT01589185|41723073|FG001|Overall Study|Death|2|||
19464746|NCT01589185|41723074|FG002|Overall Study|Death|2|||
19464747|NCT01589185|41723075|FG003|Overall Study|Death|0|||
19464748|NCT01589185|41723076|FG004|Overall Study|Death|1|||
19464749|NCT01589185|41723072|FG000|Overall Study|Lost to Follow-up|1|||
19464750|NCT01589185|41723073|FG001|Overall Study|Lost to Follow-up|0|||
19464751|NCT01589185|41723074|FG002|Overall Study|Lost to Follow-up|2|||
19464752|NCT01589185|41723075|FG003|Overall Study|Lost to Follow-up|3|||
19464753|NCT01589185|41723076|FG004|Overall Study|Lost to Follow-up|0|||
19464754|NCT01588951|41723092|FG000|Overall Study|Ineligible in retrospect|0|||
19464755|NCT01588951|41723093|FG001|Overall Study|Ineligible in retrospect|0|||
19464756|NCT01588951|41723094|FG002|Overall Study|Ineligible in retrospect|1|||
19464757|NCT01709383|41723104|FG000|Overall Study|Lost to Follow-up|1|||
19464758|NCT01709383|41723105|FG001|Overall Study|Lost to Follow-up|0|||
19464759|NCT01588405|41723113|FG000|Overall Study|Adverse Event|1|||
19464760|NCT01588405|41723113|FG000|Overall Study|Clinical Worsening|1|||
19464761|NCT01923311|41723122|FG000|Overall Study|Pregnancy|1|||
19464762|NCT01923311|41723123|FG001|Overall Study|Pregnancy|0|||
19464763|NCT01923311|41723122|FG000|Overall Study|Investigator's Discretion|1|||
19464764|NCT01923311|41723123|FG001|Overall Study|Investigator's Discretion|0|||
19464765|NCT01923311|41723122|FG000|Overall Study|Non-Compliance with Study Drug|2|||
19464766|NCT01923311|41723123|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19380294|NCT02426138|41623573|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
19380295|NCT02426138|41623574|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
19380296|NCT02657343|41623593|FG000|Overall Study|Death|0|||
19380297|NCT02657343|41623594|FG001|Overall Study|Death|2|||
19464767|NCT01923311|41723122|FG000|Overall Study|Withdrew Consent|1|||
19464768|NCT01923311|41723123|FG001|Overall Study|Withdrew Consent|0|||
19464769|NCT01923311|41723122|FG000|Overall Study|Study Terminated by Sponsor|12|||
19464770|NCT01923311|41723123|FG001|Overall Study|Study Terminated by Sponsor|0|||
19373339|NCT02770391|41614434|FG000|Overall Study|Lost to Follow-up|2|||
19373340|NCT02770391|41614434|FG000|Overall Study|Withdrawal by Subject|1|||
19373341|NCT02770391|41614434|FG000|Overall Study|Surgery delayed unevaluable|2|||
19373342|NCT02770391|41614434|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
19373343|NCT02536508|41614441|FG000|Overall Study|Withdrawal by Subject|18|||
19373344|NCT02536508|41614442|FG001|Overall Study|Withdrawal by Subject|13|||
19373345|NCT02536508|41614443|FG002|Overall Study|Withdrawal by Subject|7|||
19373346|NCT02536508|41614441|FG000|Overall Study|Adverse Event|14|||
19373347|NCT02536508|41614442|FG001|Overall Study|Adverse Event|13|||
19373348|NCT02536508|41614443|FG002|Overall Study|Adverse Event|6|||
19373349|NCT02536508|41614441|FG000|Overall Study|Lost to Follow-up|12|||
19373350|NCT02536508|41614442|FG001|Overall Study|Lost to Follow-up|4|||
19373351|NCT02536508|41614443|FG002|Overall Study|Lost to Follow-up|0|||
19373352|NCT02536508|41614441|FG000|Overall Study|Lack of Efficacy|3|||
19373353|NCT02536508|41614442|FG001|Overall Study|Lack of Efficacy|5|||
19373354|NCT02536508|41614443|FG002|Overall Study|Lack of Efficacy|4|||
19373355|NCT02536508|41614441|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
19373356|NCT02536508|41614442|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
19373357|NCT02536508|41614443|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
19373358|NCT02536508|41614441|FG000|Overall Study|Physician Decision|0|||
19373359|NCT02536508|41614442|FG001|Overall Study|Physician Decision|4|||
19373360|NCT02536508|41614443|FG002|Overall Study|Physician Decision|2|||
19373361|NCT02536508|41614441|FG000|Overall Study|Major Protocol Deviation|2|||
19373362|NCT02536508|41614442|FG001|Overall Study|Major Protocol Deviation|2|||
19373363|NCT02536508|41614443|FG002|Overall Study|Major Protocol Deviation|2|||
19373364|NCT02536508|41614441|FG000|Overall Study|Administrative Reasons|0|||
19373365|NCT02536508|41614442|FG001|Overall Study|Administrative Reasons|1|||
19373366|NCT02536508|41614443|FG002|Overall Study|Administrative Reasons|0|||
19373367|NCT00103259|41614460|FG000|Overall Study|Death|3|||
19373368|NCT00103259|41614461|FG001|Overall Study|Death|2|||
19373369|NCT00103259|41614460|FG000|Overall Study|Withdrawal by Subject|2|||
19373370|NCT00103259|41614461|FG001|Overall Study|Withdrawal by Subject|3|||
19373371|NCT00103259|41614460|FG000|Overall Study|alternative therapy|1|||
19373372|NCT00103259|41614461|FG001|Overall Study|alternative therapy|0|||
19373373|NCT00103259|41614460|FG000|Overall Study|other (reasons were not specified)|2|||
19373374|NCT00103259|41614461|FG001|Overall Study|other (reasons were not specified)|1|||
19373375|NCT00103259|41614460|FG000|Overall Study|ineligible/no protocol therapy|4|||
19373376|NCT00103259|41614461|FG001|Overall Study|ineligible/no protocol therapy|6|||
19373377|NCT02544152|41614471|FG000|Overall Study|Adverse Event|0|||
19373378|NCT02544152|41614472|FG001|Overall Study|Adverse Event|4|||
19373379|NCT02544152|41614471|FG000|Overall Study|Withdrawal by Subject|0|||
19373380|NCT02544152|41614472|FG001|Overall Study|Withdrawal by Subject|3|||
19373381|NCT02544152|41614471|FG000|Overall Study|Other|1|||
19373382|NCT02544152|41614472|FG001|Overall Study|Other|0|||
19373383|NCT02534324|41614480|FG000|Overall Study|Protocol Violation|4|||
19373384|NCT02534324|41614481|FG001|Overall Study|Protocol Violation|1|||
19373385|NCT02534324|41614480|FG000|Overall Study|Lost to Follow-up|20|||
19373386|NCT02534324|41614481|FG001|Overall Study|Lost to Follow-up|7|||
19373387|NCT02534324|41614480|FG000|Overall Study|Adverse Event|1|||
19373388|NCT02534324|41614481|FG001|Overall Study|Adverse Event|0|||
19373389|NCT02761733|41614491|FG000|Overall Study|Death|3|||
19373390|NCT02761733|41614492|FG001|Overall Study|Death|5|||
19373391|NCT02761733|41614493|FG002|Overall Study|Death|1|||
19373392|NCT02761733|41614494|FG003|Overall Study|Death|1|||
19373393|NCT02761733|41614491|FG000|Overall Study|Lost to Follow-up|6|||
19373394|NCT02761733|41614492|FG001|Overall Study|Lost to Follow-up|7|||
19373395|NCT02761733|41614493|FG002|Overall Study|Lost to Follow-up|0|||
19373396|NCT02761733|41614494|FG003|Overall Study|Lost to Follow-up|3|||
19373397|NCT02761733|41614491|FG000|Overall Study|Physician Decision|4|||
19373398|NCT02761733|41614492|FG001|Overall Study|Physician Decision|0|||
19373399|NCT02761733|41614493|FG002|Overall Study|Physician Decision|0|||
19373400|NCT02761733|41614494|FG003|Overall Study|Physician Decision|0|||
19373401|NCT02761733|41614491|FG000|Overall Study|Withdrawal by Subject|2|||
19373402|NCT02761733|41614492|FG001|Overall Study|Withdrawal by Subject|0|||
19373403|NCT02761733|41614493|FG002|Overall Study|Withdrawal by Subject|0|||
19373404|NCT02761733|41614494|FG003|Overall Study|Withdrawal by Subject|0|||
19380298|NCT02657343|41623595|FG002|Overall Study|Death|0|||
19380299|NCT02657343|41623596|FG003|Overall Study|Death|0|||
19380300|NCT02657343|41623597|FG004|Overall Study|Death|0|||
19380301|NCT02657343|41623598|FG005|Overall Study|Death|0|||
19380302|NCT02657343|41623593|FG000|Overall Study|Patient went to hospice|1|||
19380303|NCT02657343|41623594|FG001|Overall Study|Patient went to hospice|0|||
19380304|NCT02657343|41623595|FG002|Overall Study|Patient went to hospice|0|||
19380305|NCT02657343|41623596|FG003|Overall Study|Patient went to hospice|0|||
19380306|NCT02657343|41623597|FG004|Overall Study|Patient went to hospice|0|||
19380307|NCT02657343|41623598|FG005|Overall Study|Patient went to hospice|0|||
19380308|NCT02657343|41623593|FG000|Overall Study|Withdrawal by Subject|0|||
19380309|NCT02657343|41623594|FG001|Overall Study|Withdrawal by Subject|0|||
19380310|NCT02657343|41623595|FG002|Overall Study|Withdrawal by Subject|0|||
19380311|NCT02657343|41623596|FG003|Overall Study|Withdrawal by Subject|0|||
19380312|NCT02657343|41623597|FG004|Overall Study|Withdrawal by Subject|1|||
19380313|NCT02657343|41623598|FG005|Overall Study|Withdrawal by Subject|0|||
19380314|NCT02425826|41623614|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
19380315|NCT02425826|41623615|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
19380316|NCT02425826|41623616|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
19380317|NCT02425826|41623614|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
19380318|NCT02425826|41623615|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
19380319|NCT02425826|41623616|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
19380320|NCT02425826|41623614|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
19380321|NCT02425826|41623615|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
19380322|NCT02425826|41623616|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
19551290|NCT01346969|42000112|FG000|Overall Study|Randomized but not treated|1|||
19380323|NCT02425826|41623614|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
19380324|NCT02425826|41623615|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
19380325|NCT02425826|41623616|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
19380326|NCT02425826|41623614|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
19380327|NCT02425826|41623615|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
19380328|NCT02425826|41623616|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
19380329|NCT02425826|41623614|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
19380330|NCT02425826|41623615|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
19380331|NCT02425826|41623616|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
19380332|NCT02425826|41623614|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
19380333|NCT02425826|41623615|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
19380334|NCT02425826|41623616|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
19380335|NCT02425826|41623614|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
19380336|NCT02425826|41623615|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
19380337|NCT02425826|41623616|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
19380338|NCT02425826|41623614|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
19380339|NCT02425826|41623615|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
19380340|NCT02425826|41623616|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
19380341|NCT02425826|41623614|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
19380342|NCT02425826|41623615|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
19380343|NCT02425826|41623616|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
19380344|NCT02656173|41623628|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
19380345|NCT02656173|41623629|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
19380346|NCT02656173|41623628|FG000|Overall Study|Adverse Event|7|||
19380347|NCT02656173|41623629|FG001|Overall Study|Adverse Event|5|||
19380348|NCT02656173|41623628|FG000|Overall Study|Withdrawal by Subject|1|||
19380349|NCT02656173|41623629|FG001|Overall Study|Withdrawal by Subject|3|||
19380350|NCT02656173|41623628|FG000|Overall Study|Protocol Violation|0|||
19380351|NCT02656173|41623629|FG001|Overall Study|Protocol Violation|1|||
19380352|NCT02656173|41623628|FG000|Overall Study|Miscellaneous|2|||
19380353|NCT02656173|41623629|FG001|Overall Study|Miscellaneous|0|||
19380354|NCT02656017|41623639|FG000|Overall Study|Study burden|3|||
19380355|NCT02656017|41623640|FG001|Overall Study|Study burden|3|||
19380356|NCT02656017|41623639|FG000|Overall Study|Adverse Event|2|||
19380357|NCT02656017|41623640|FG001|Overall Study|Adverse Event|1|||
19380358|NCT02656017|41623639|FG000|Overall Study|Unable/unwilling to take study medication|2|||
19380359|NCT02656017|41623640|FG001|Overall Study|Unable/unwilling to take study medication|1|||
19380360|NCT02656017|41623639|FG000|Overall Study|Began Tolvaptan|1|||
19380361|NCT02656017|41623640|FG001|Overall Study|Began Tolvaptan|1|||
19380362|NCT02656017|41623639|FG000|Overall Study|Withdrawal by Subject|1|||
19380363|NCT02656017|41623640|FG001|Overall Study|Withdrawal by Subject|0|||
19380364|NCT02655237|41623648|FG000|Overall Study|Adverse Event|10|||
19380365|NCT02655237|41623649|FG001|Overall Study|Adverse Event|7|||
19380366|NCT02655237|41623648|FG000|Overall Study|Protocol Deviation|2|||
19380367|NCT02655237|41623649|FG001|Overall Study|Protocol Deviation|0|||
19380368|NCT02655237|41623648|FG000|Overall Study|Withdrawal by Participant|1|||
19380369|NCT02655237|41623649|FG001|Overall Study|Withdrawal by Participant|2|||
19380370|NCT02655237|41623648|FG000|Overall Study|Lack of Efficacy|0|||
19380371|NCT02655237|41623649|FG001|Overall Study|Lack of Efficacy|1|||
19380372|NCT02655237|41623648|FG000|Overall Study|Recovery Leading to Surgery|2|||
19380373|NCT02655237|41623649|FG001|Overall Study|Recovery Leading to Surgery|1|||
19380374|NCT02655237|41623648|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
19380375|NCT02655237|41623649|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
19380376|NCT02655237|41623648|FG000|Overall Study|Randomized but Not Treated|1|||
19380377|NCT02655237|41623649|FG001|Overall Study|Randomized but Not Treated|0|||
19380378|NCT02657031|41623657|FG000|Overall Study|Adverse Event|1|||
19380379|NCT02657031|41623658|FG001|Overall Study|Adverse Event|2|||
19380380|NCT04375397|41623686|FG000|Overall Study|Death|1|||
19380381|NCT04375397|41623687|FG001|Overall Study|Death|1|||
19380382|NCT04375397|41623686|FG000|Overall Study|Withdrew consent|2|||
19380383|NCT04375397|41623687|FG001|Overall Study|Withdrew consent|0|||
19380384|NCT04375397|41623686|FG000|Overall Study|Lost to Follow-up|6|||
19380385|NCT04375397|41623687|FG001|Overall Study|Lost to Follow-up|4|||
19380386|NCT04375397|41623686|FG000|Overall Study|Other, not specified|0|||
19380387|NCT04375397|41623687|FG001|Overall Study|Other, not specified|1|||
19380388|NCT02387216|41623695|FG000|Overall Study|Progressive disease|2|||
19380389|NCT02387216|41623696|FG001|Overall Study|Progressive disease|0|||
19380390|NCT02387216|41623695|FG000|Overall Study|Withdrawal by Subject|3|||
19380391|NCT02387216|41623696|FG001|Overall Study|Withdrawal by Subject|5|||
19380392|NCT02387216|41623695|FG000|Overall Study|Physician Decision|2|||
19380393|NCT02387216|41623696|FG001|Overall Study|Physician Decision|0|||
19380394|NCT02387216|41623695|FG000|Overall Study|Sponsor Decision|28|||
19380395|NCT02387216|41623696|FG001|Overall Study|Sponsor Decision|12|||
19380396|NCT02387216|41623695|FG000|Overall Study|Death|60|||
19380397|NCT02387216|41623696|FG001|Overall Study|Death|23|||
19380398|NCT02387216|41623695|FG000|Overall Study|Other|5|||
19380399|NCT02387216|41623696|FG001|Overall Study|Other|4|||
19380400|NCT02387216|41623695|FG000|Overall Study|Lost to Follow-up|0|||
19380401|NCT02387216|41623696|FG001|Overall Study|Lost to Follow-up|3|||
19380402|NCT02417246|41623704|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
19380403|NCT02417246|41623705|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
19380404|NCT02417246|41623704|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
19380405|NCT02417246|41623705|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
19380406|NCT02417246|41623704|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
19380407|NCT02417246|41623705|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
19380408|NCT02417246|41623704|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
19380409|NCT02417246|41623705|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
19380410|NCT02424734|41623716|FG000|Overall Study|Treatment stopped to be discharged home|2|||
19380411|NCT02424734|41623717|FG001|Overall Study|Treatment stopped to be discharged home|2|||
19380412|NCT02424734|41623718|FG002|Overall Study|Treatment stopped to be discharged home|0|||
19380413|NCT02424578|41623729|FG000|Overall Study|Withdrawal by Subject|0|||
19380414|NCT02424578|41623730|FG001|Overall Study|Withdrawal by Subject|1|||
19380415|NCT02416934|41623738|FG000|Overall Study|given steroids|1|||
19380416|NCT02416934|41623739|FG001|Overall Study|given steroids|2|||
19380417|NCT02416934|41623738|FG000|Overall Study|Lost to Follow-up|0|||
19380418|NCT02416934|41623739|FG001|Overall Study|Lost to Follow-up|2|||
19380419|NCT02416934|41623738|FG000|Overall Study|Withdrawal by Subject|1|||
19380420|NCT02416934|41623739|FG001|Overall Study|Withdrawal by Subject|0|||
19380421|NCT02416934|41623738|FG000|Overall Study|recruited during continuing renewal proc|0|||
19380422|NCT02416934|41623739|FG001|Overall Study|recruited during continuing renewal proc|1|||
19380423|NCT02416934|41623738|FG000|Overall Study|Protocol Violation|0|||
19380424|NCT02416934|41623739|FG001|Overall Study|Protocol Violation|1|||
19380425|NCT02416934|41623738|FG000|Overall Study|surgery started late|0|||
19380426|NCT02416934|41623739|FG001|Overall Study|surgery started late|1|||
19380427|NCT02416934|41623738|FG000|Overall Study|re-operation|1|||
19380428|NCT02416934|41623739|FG001|Overall Study|re-operation|0|||
19380429|NCT02819635|41623759|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
19380430|NCT02819635|41623760|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
19380431|NCT02819635|41623761|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
19380432|NCT02819635|41623762|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
19380433|NCT02819635|41623763|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
19380434|NCT02819635|41623764|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
19380435|NCT02819635|41623765|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
19380436|NCT02819635|41623766|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
19380437|NCT02819635|41623767|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
19380438|NCT02819635|41623768|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
19380439|NCT02819635|41623769|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
19380440|NCT02819635|41623770|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
19380441|NCT02819635|41623759|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380442|NCT02819635|41623760|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380443|NCT02819635|41623761|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380444|NCT02819635|41623762|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380445|NCT02819635|41623763|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
19380446|NCT02819635|41623764|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
19380447|NCT02819635|41623765|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
19380448|NCT02819635|41623766|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380449|NCT02819635|41623767|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380450|NCT02819635|41623768|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380451|NCT02819635|41623769|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380452|NCT02819635|41623770|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
19380453|NCT02819635|41623759|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380454|NCT02819635|41623760|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380455|NCT02819635|41623761|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380456|NCT02819635|41623762|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380457|NCT02819635|41623763|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19478087|NCT01693562|41757333|FG019|Exploration Phase|Other|0|||
19380458|NCT02819635|41623764|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
19380459|NCT02819635|41623765|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
19380460|NCT02819635|41623766|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380461|NCT02819635|41623767|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380462|NCT02819635|41623768|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380463|NCT02819635|41623769|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380464|NCT02819635|41623770|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
19380465|NCT02819635|41623759|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380466|NCT02819635|41623760|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380467|NCT02819635|41623761|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380468|NCT02819635|41623762|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380469|NCT02819635|41623763|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380470|NCT02819635|41623764|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380471|NCT02819635|41623765|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
19380472|NCT02819635|41623766|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380473|NCT02819635|41623767|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380474|NCT02819635|41623768|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380475|NCT02819635|41623769|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380476|NCT02819635|41623770|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
19380477|NCT02819635|41623759|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
19380478|NCT02819635|41623760|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
19380479|NCT02819635|41623761|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
19380480|NCT02819635|41623762|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
19380481|NCT02819635|41623763|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
19380482|NCT02819635|41623764|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
19380483|NCT02819635|41623765|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
19380484|NCT02819635|41623766|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
19380485|NCT02819635|41623767|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
19380486|NCT02819635|41623768|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
19380487|NCT02819635|41623769|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
19380488|NCT02819635|41623770|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
19380489|NCT02819635|41623759|FG000|Substudy 2, Part 2|Adverse Event|0|||
19380490|NCT02819635|41623760|FG001|Substudy 2, Part 2|Adverse Event|0|||
19380491|NCT02819635|41623761|FG002|Substudy 2, Part 2|Adverse Event|0|||
19380492|NCT02819635|41623762|FG003|Substudy 2, Part 2|Adverse Event|0|||
19380493|NCT02819635|41623763|FG004|Substudy 2, Part 2|Adverse Event|0|||
19380494|NCT02819635|41623764|FG005|Substudy 2, Part 2|Adverse Event|4|||
19380495|NCT02819635|41623765|FG006|Substudy 2, Part 2|Adverse Event|0|||
19380496|NCT02819635|41623766|FG007|Substudy 2, Part 2|Adverse Event|0|||
19380497|NCT02819635|41623767|FG008|Substudy 2, Part 2|Adverse Event|0|||
19380498|NCT02819635|41623768|FG009|Substudy 2, Part 2|Adverse Event|0|||
19380499|NCT02819635|41623769|FG010|Substudy 2, Part 2|Adverse Event|0|||
19380500|NCT02819635|41623770|FG011|Substudy 2, Part 2|Adverse Event|0|||
19380501|NCT02819635|41623759|FG000|Substudy 2, Part 2|Withdrew consent|0|||
19380502|NCT02819635|41623760|FG001|Substudy 2, Part 2|Withdrew consent|0|||
19380503|NCT02819635|41623761|FG002|Substudy 2, Part 2|Withdrew consent|0|||
19380504|NCT02819635|41623762|FG003|Substudy 2, Part 2|Withdrew consent|0|||
19380505|NCT02819635|41623763|FG004|Substudy 2, Part 2|Withdrew consent|0|||
19380506|NCT02819635|41623764|FG005|Substudy 2, Part 2|Withdrew consent|3|||
19380507|NCT02819635|41623765|FG006|Substudy 2, Part 2|Withdrew consent|1|||
19380508|NCT02819635|41623766|FG007|Substudy 2, Part 2|Withdrew consent|0|||
19380509|NCT02819635|41623767|FG008|Substudy 2, Part 2|Withdrew consent|0|||
19380510|NCT02819635|41623768|FG009|Substudy 2, Part 2|Withdrew consent|0|||
19380511|NCT02819635|41623769|FG010|Substudy 2, Part 2|Withdrew consent|0|||
19380512|NCT02819635|41623770|FG011|Substudy 2, Part 2|Withdrew consent|0|||
19380513|NCT02819635|41623759|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
19380514|NCT02819635|41623760|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
19380515|NCT02819635|41623761|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
19380516|NCT02819635|41623762|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
19380517|NCT02819635|41623763|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
19380518|NCT02819635|41623764|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
19380519|NCT02819635|41623765|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
19380520|NCT02819635|41623766|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
19380521|NCT02819635|41623767|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
19380522|NCT02819635|41623768|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
19380523|NCT02819635|41623769|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
19380524|NCT02819635|41623770|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
19380525|NCT02819635|41623759|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380526|NCT02819635|41623760|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380527|NCT02819635|41623761|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380528|NCT02819635|41623762|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380529|NCT02819635|41623763|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380530|NCT02819635|41623764|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380531|NCT02819635|41623765|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
19380532|NCT02819635|41623766|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380533|NCT02819635|41623767|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380534|NCT02819635|41623768|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380535|NCT02819635|41623769|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380536|NCT02819635|41623770|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
19380537|NCT02819635|41623759|FG000|Substudy 2, Part 2|Other, not specified|0|||
19380538|NCT02819635|41623760|FG001|Substudy 2, Part 2|Other, not specified|0|||
19380539|NCT02819635|41623761|FG002|Substudy 2, Part 2|Other, not specified|0|||
19380540|NCT02819635|41623762|FG003|Substudy 2, Part 2|Other, not specified|0|||
19380541|NCT02819635|41623763|FG004|Substudy 2, Part 2|Other, not specified|0|||
19380542|NCT02819635|41623764|FG005|Substudy 2, Part 2|Other, not specified|4|||
19380543|NCT02819635|41623765|FG006|Substudy 2, Part 2|Other, not specified|8|||
19380544|NCT02819635|41623766|FG007|Substudy 2, Part 2|Other, not specified|0|||
19380545|NCT02819635|41623767|FG008|Substudy 2, Part 2|Other, not specified|0|||
19380546|NCT02819635|41623768|FG009|Substudy 2, Part 2|Other, not specified|0|||
19380547|NCT02819635|41623769|FG010|Substudy 2, Part 2|Other, not specified|0|||
19380548|NCT02819635|41623770|FG011|Substudy 2, Part 2|Other, not specified|0|||
19380549|NCT02819635|41623759|FG000|Substudy 3|Adverse Event|0|||
19380550|NCT02819635|41623760|FG001|Substudy 3|Adverse Event|0|||
19380551|NCT02819635|41623761|FG002|Substudy 3|Adverse Event|0|||
19380552|NCT02819635|41623762|FG003|Substudy 3|Adverse Event|0|||
19380553|NCT02819635|41623763|FG004|Substudy 3|Adverse Event|0|||
19380554|NCT02819635|41623764|FG005|Substudy 3|Adverse Event|0|||
19380555|NCT02819635|41623765|FG006|Substudy 3|Adverse Event|0|||
19380556|NCT02819635|41623766|FG007|Substudy 3|Adverse Event|0|||
19380557|NCT02819635|41623767|FG008|Substudy 3|Adverse Event|32|||
19380558|NCT02819635|41623768|FG009|Substudy 3|Adverse Event|3|||
19380559|NCT02819635|41623769|FG010|Substudy 3|Adverse Event|12|||
19380560|NCT02819635|41623770|FG011|Substudy 3|Adverse Event|18|||
19380561|NCT02819635|41623759|FG000|Substudy 3|Withdrew consent|0|||
19380562|NCT02819635|41623760|FG001|Substudy 3|Withdrew consent|0|||
19380563|NCT02819635|41623761|FG002|Substudy 3|Withdrew consent|0|||
19380564|NCT02819635|41623762|FG003|Substudy 3|Withdrew consent|0|||
19380565|NCT02819635|41623763|FG004|Substudy 3|Withdrew consent|0|||
19380566|NCT02819635|41623764|FG005|Substudy 3|Withdrew consent|0|||
19380567|NCT02819635|41623765|FG006|Substudy 3|Withdrew consent|0|||
19380568|NCT02819635|41623766|FG007|Substudy 3|Withdrew consent|0|||
19380569|NCT02819635|41623767|FG008|Substudy 3|Withdrew consent|11|||
19380570|NCT02819635|41623768|FG009|Substudy 3|Withdrew consent|1|||
19380571|NCT02819635|41623769|FG010|Substudy 3|Withdrew consent|4|||
19380572|NCT02819635|41623770|FG011|Substudy 3|Withdrew consent|9|||
19380573|NCT02819635|41623759|FG000|Substudy 3|Lost to Follow-up|0|||
19380574|NCT02819635|41623760|FG001|Substudy 3|Lost to Follow-up|0|||
19380575|NCT02819635|41623761|FG002|Substudy 3|Lost to Follow-up|0|||
19380576|NCT02819635|41623762|FG003|Substudy 3|Lost to Follow-up|0|||
19380577|NCT02819635|41623763|FG004|Substudy 3|Lost to Follow-up|0|||
19380578|NCT02819635|41623764|FG005|Substudy 3|Lost to Follow-up|0|||
19380579|NCT02819635|41623765|FG006|Substudy 3|Lost to Follow-up|0|||
19380580|NCT02819635|41623766|FG007|Substudy 3|Lost to Follow-up|0|||
19380581|NCT02819635|41623767|FG008|Substudy 3|Lost to Follow-up|1|||
19380582|NCT02819635|41623768|FG009|Substudy 3|Lost to Follow-up|0|||
19380583|NCT02819635|41623769|FG010|Substudy 3|Lost to Follow-up|1|||
19380584|NCT02819635|41623770|FG011|Substudy 3|Lost to Follow-up|1|||
19380585|NCT02819635|41623759|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380586|NCT02819635|41623760|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380587|NCT02819635|41623761|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380588|NCT02819635|41623762|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380589|NCT02819635|41623763|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380590|NCT02819635|41623764|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380591|NCT02819635|41623765|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380592|NCT02819635|41623766|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380593|NCT02819635|41623767|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380594|NCT02819635|41623768|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380595|NCT02819635|41623769|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
19380596|NCT02819635|41623770|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
19380597|NCT02819635|41623759|FG000|Substudy 3|Other, not specified|0|||
19380598|NCT02819635|41623760|FG001|Substudy 3|Other, not specified|0|||
19380599|NCT02819635|41623761|FG002|Substudy 3|Other, not specified|0|||
19380600|NCT02819635|41623762|FG003|Substudy 3|Other, not specified|0|||
19380601|NCT02819635|41623763|FG004|Substudy 3|Other, not specified|0|||
19380602|NCT02819635|41623764|FG005|Substudy 3|Other, not specified|0|||
19380603|NCT02819635|41623765|FG006|Substudy 3|Other, not specified|0|||
19380604|NCT02819635|41623766|FG007|Substudy 3|Other, not specified|0|||
19380605|NCT02819635|41623767|FG008|Substudy 3|Other, not specified|202|||
19380606|NCT02819635|41623768|FG009|Substudy 3|Other, not specified|5|||
19380607|NCT02819635|41623769|FG010|Substudy 3|Other, not specified|89|||
19380608|NCT02819635|41623770|FG011|Substudy 3|Other, not specified|39|||
19380609|NCT02424344|41623805|FG000|Overall Study|Lack of Efficacy|0|||
19380610|NCT02424344|41623806|FG001|Overall Study|Lack of Efficacy|1|||
19380611|NCT02424344|41623805|FG000|Overall Study|Withdrawal by Subject|2|||
19380612|NCT02424344|41623806|FG001|Overall Study|Withdrawal by Subject|1|||
19380613|NCT02424344|41623805|FG000|Overall Study|Lost to Follow-up|1|||
19380614|NCT02424344|41623806|FG001|Overall Study|Lost to Follow-up|0|||
19380615|NCT02424344|41623805|FG000|Overall Study|Adverse Event|4|||
19380616|NCT02424344|41623806|FG001|Overall Study|Adverse Event|8|||
19380617|NCT02423798|41623812|FG000|Overall Study|Withdrawal by Subject|3|||
19380618|NCT01651208|41623835|FG000|Overall Study|Lost to Follow-up|14|||
19380619|NCT01651208|41623836|FG001|Overall Study|Lost to Follow-up|16|||
19380620|NCT02383940|41623845|FG000|Overall Study|Adverse Event|1|||
19380621|NCT02383940|41623846|FG001|Overall Study|Adverse Event|0|||
19380622|NCT02383940|41623845|FG000|Overall Study|Lost to Follow-up|2|||
19380623|NCT02383940|41623846|FG001|Overall Study|Lost to Follow-up|2|||
19380624|NCT02383940|41623845|FG000|Overall Study|Physician Decision|2|||
19380625|NCT02383940|41623846|FG001|Overall Study|Physician Decision|0|||
19380626|NCT02383940|41623845|FG000|Overall Study|Withdrawal by Subject|1|||
19380627|NCT02383940|41623846|FG001|Overall Study|Withdrawal by Subject|1|||
19380628|NCT02383940|41623845|FG000|Overall Study|Randomized but not treated|2|||
19380629|NCT02383940|41623846|FG001|Overall Study|Randomized but not treated|0|||
19380630|NCT02383940|41623845|FG000|Overall Study|Other than specified above|1|||
19380631|NCT02383940|41623846|FG001|Overall Study|Other than specified above|0|||
19380632|NCT02383862|41623854|FG000|3 Month Follow up|Lost to Follow-up|23|||
19380633|NCT02383862|41623855|FG001|3 Month Follow up|Lost to Follow-up|21|||
19380634|NCT02383472|41623870|FG000|Overall Study|Withdrawal by Subject|1|||
19380635|NCT02383472|41623871|FG001|Overall Study|Withdrawal by Subject|1|||
19380636|NCT02234323|41623879|FG000|All Enrolled|Not Treated: Completed study in database|2|||
19380637|NCT02234323|41623879|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
19380638|NCT02234323|41623879|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
19380639|NCT02234323|41623879|FG000|All Treated|Death|1|||
19380640|NCT02234323|41623879|FG000|All Treated|Physician Decision|5|||
19380641|NCT02234323|41623879|FG000|All Treated|Lack of Efficacy|3|||
19380642|NCT02234323|41623879|FG000|All Treated|Exceeded lab value limit|2|||
19380643|NCT02234323|41623879|FG000|All Treated|Other|7|||
19380644|NCT02414828|41623889|FG000|Overall Study|Lost to Follow-up|0|||
19380645|NCT02414828|41623890|FG001|Overall Study|Lost to Follow-up|1|||
19380646|NCT02414828|41623891|FG002|Overall Study|Lost to Follow-up|1|||
19380647|NCT02414828|41623892|FG003|Overall Study|Lost to Follow-up|2|||
19380648|NCT02413346|41623905|FG000|Overall Study|Adverse Event|6|||
19380649|NCT02413346|41623906|FG001|Overall Study|Adverse Event|6|||
19380650|NCT02413346|41623905|FG000|Overall Study|Withdrawal by Subject|30|||
19380651|NCT02413346|41623906|FG001|Overall Study|Withdrawal by Subject|40|||
19639083|NCT00689481|42088530|FG000|Overall Study|Withdrawal by Subject|8|||
19727446|NCT03614156|42172226|FG001|Open-Label Treatment Period|Adverse Event|0|||
19380652|NCT02413346|41623905|FG000|Overall Study|Lost to Follow-up|17|||
19380653|NCT02413346|41623906|FG001|Overall Study|Lost to Follow-up|21|||
19380654|NCT02413346|41623905|FG000|Overall Study|Protocol Violation|2|||
19380655|NCT02413346|41623906|FG001|Overall Study|Protocol Violation|0|||
19380656|NCT02413346|41623905|FG000|Overall Study|Other Miscellaneous Reasons|4|||
19380657|NCT02413346|41623906|FG001|Overall Study|Other Miscellaneous Reasons|3|||
19380658|NCT03390101|41623919|FG000|Weeks 0-12|Withdrawal by Subject|0|||
19380659|NCT03390101|41623920|FG001|Weeks 0-12|Withdrawal by Subject|1|||
19380660|NCT03390101|41623921|FG002|Weeks 0-12|Withdrawal by Subject|1|||
19380661|NCT03390101|41623919|FG000|Weeks 0-12|Lost to Follow-up|0|||
19380662|NCT03390101|41623920|FG001|Weeks 0-12|Lost to Follow-up|1|||
19380663|NCT03390101|41623921|FG002|Weeks 0-12|Lost to Follow-up|0|||
19380664|NCT03390101|41623919|FG000|Weeks 12-54|Withdrawal by Subject|0|||
19380665|NCT03390101|41623920|FG001|Weeks 12-54|Withdrawal by Subject|3|||
19380666|NCT03390101|41623921|FG002|Weeks 12-54|Withdrawal by Subject|1|||
19380667|NCT03390101|41623919|FG000|Weeks 12-54|Pregnancy|1|||
19380668|NCT03390101|41623920|FG001|Weeks 12-54|Pregnancy|0|||
19380669|NCT03390101|41623921|FG002|Weeks 12-54|Pregnancy|0|||
19380670|NCT03390101|41623919|FG000|Weeks 12-54|Adverse Event|2|||
19380671|NCT03390101|41623920|FG001|Weeks 12-54|Adverse Event|1|||
19380672|NCT03390101|41623921|FG002|Weeks 12-54|Adverse Event|1|||
19380673|NCT02732639|41623929|FG000|Overall Study|Lost to Follow-up|1|||
19380674|NCT02732561|41623935|FG000|Overall Study|Lost to Follow-up|1|||
19380675|NCT02732561|41623936|FG001|Overall Study|Lost to Follow-up|1|||
19464771|NCT01603615|41723130|FG000|Overall Study|Did not Receive Treatment|7|||
19464772|NCT01603615|41723130|FG000|Overall Study|Lost to Follow-up|9|||
19464773|NCT01603615|41723130|FG000|Overall Study|Personal Reasons|17|||
19464774|NCT01603615|41723130|FG000|Overall Study|Other Miscellaneous|1|||
19464775|NCT01685047|41723134|FG000|Overall Study|Withdrawal by Subject|20|||
19464776|NCT01685047|41723134|FG000|Overall Study|Death|26|||
19464777|NCT01685047|41723134|FG000|Overall Study|Lost to Follow-up|8|||
19464778|NCT01685047|41723134|FG000|Overall Study|Physician Decision|25|||
19464779|NCT01685047|41723134|FG000|Overall Study|Adverse Event|5|||
19464780|NCT01685047|41723134|FG000|Overall Study|patient withdrawn by sponsor|1|||
19464781|NCT01905683|41723138|FG000|Overall Study|Protocol Violation|1|||
19464782|NCT01905683|41723138|FG000|Overall Study|Re-injection criteria not met; others|13|||
19464783|NCT01905683|41723138|FG000|Overall Study|Physician Decision|1|||
19464784|NCT01905683|41723138|FG000|Overall Study|Lack of Efficacy|8|||
19464785|NCT01905683|41723138|FG000|Overall Study|Withdrawal by Subject|20|||
19464786|NCT01905683|41723138|FG000|Overall Study|Adverse Event|4|||
19464787|NCT01905683|41723138|FG000|Overall Study|Lost to Follow-up|4|||
19464788|NCT01921829|41723144|FG000|Overall Study|Withdrawal by Subject|0|||
19464789|NCT01921829|41723145|FG001|Overall Study|Withdrawal by Subject|1|||
19464790|NCT01904903|41723151|FG000|Overall Study|Withdrawal by Subject|1|||
19464791|NCT01921517|41723157|FG000|Overall Study|Lost to Follow-up|5|||
19464792|NCT01921517|41723158|FG001|Overall Study|Lost to Follow-up|0|||
19464793|NCT01921517|41723157|FG000|Overall Study|Newly diagnosed health concern|2|||
19464794|NCT01921517|41723158|FG001|Overall Study|Newly diagnosed health concern|0|||
19464795|NCT01921517|41723157|FG000|Overall Study|Physician Decision|0|||
19464796|NCT01921517|41723158|FG001|Overall Study|Physician Decision|2|||
19464797|NCT01921517|41723157|FG000|Overall Study|Withdrawal by Subject|7|||
19464798|NCT01921517|41723158|FG001|Overall Study|Withdrawal by Subject|3|||
19464799|NCT01921517|41723157|FG000|Overall Study|Subject missed final imaging|1|||
19464800|NCT01921517|41723158|FG001|Overall Study|Subject missed final imaging|4|||
19464801|NCT01921205|41723166|FG000|Overall Study|Adverse Event|12|||
19464802|NCT01921205|41723167|FG001|Overall Study|Adverse Event|7|||
19464803|NCT01921205|41723166|FG000|Overall Study|Lack of Efficacy|1|||
19464804|NCT01921205|41723167|FG001|Overall Study|Lack of Efficacy|0|||
19464805|NCT01921205|41723166|FG000|Overall Study|Protocol Violation|1|||
19464806|NCT01921205|41723167|FG001|Overall Study|Protocol Violation|3|||
19464807|NCT01921205|41723166|FG000|Overall Study|Lost to Follow-up|1|||
19464808|NCT01921205|41723167|FG001|Overall Study|Lost to Follow-up|1|||
19464809|NCT01921205|41723166|FG000|Overall Study|Withdrawal by Subject|6|||
19464810|NCT01921205|41723167|FG001|Overall Study|Withdrawal by Subject|5|||
19464811|NCT01921205|41723166|FG000|Overall Study|Use Of Prohibited Medication|0|||
19464812|NCT01921205|41723167|FG001|Overall Study|Use Of Prohibited Medication|1|||
19464813|NCT01921205|41723166|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
19464814|NCT01921205|41723167|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
19464815|NCT01921205|41723166|FG000|Overall Study|Non Compliance Of The Parent|0|||
19464816|NCT01921205|41723167|FG001|Overall Study|Non Compliance Of The Parent|1|||
19464817|NCT01921205|41723166|FG000|Overall Study|Non Compliance Of Child|0|||
19639084|NCT00689481|42088531|FG001|Overall Study|Withdrawal by Subject|4|||
19727447|NCT03614156|42172227|FG002|Open-Label Treatment Period|Adverse Event|0|||
19380676|NCT02732561|41623935|FG000|Overall Study|Withdrawal by Subject|1|||
19380677|NCT02732561|41623936|FG001|Overall Study|Withdrawal by Subject|0|||
19380678|NCT02412878|41623944|FG000|Overall Study|Withdrawal by Subject|19|||
19380679|NCT02412878|41623945|FG001|Overall Study|Withdrawal by Subject|10|||
19380680|NCT02412878|41623944|FG000|Overall Study|Lost to Follow-up|2|||
19464818|NCT01921205|41723167|FG001|Overall Study|Non Compliance Of Child|1|||
19464819|NCT01920893|41723175|FG000|Overall Study|Adverse Event|5|||
19464820|NCT01920893|41723176|FG001|Overall Study|Adverse Event|2|||
19464821|NCT01920893|41723175|FG000|Overall Study|Lack of Efficacy|2|||
19464822|NCT01920893|41723176|FG001|Overall Study|Lack of Efficacy|0|||
19464823|NCT01709305|41723183|FG000|Phase 1|Clinical Adverse Event|80|||
19464824|NCT01709305|41723184|FG001|Phase 1|Clinical Adverse Event|0|||
19464825|NCT01709305|41723185|FG002|Phase 1|Clinical Adverse Event|0|||
19464826|NCT01709305|41723186|FG003|Phase 1|Clinical Adverse Event|0|||
19464827|NCT01709305|41723187|FG004|Phase 1|Clinical Adverse Event|0|||
19464828|NCT01709305|41723183|FG000|Phase 1|Death|2|||
19464829|NCT01709305|41723184|FG001|Phase 1|Death|0|||
19464830|NCT01709305|41723185|FG002|Phase 1|Death|0|||
19464831|NCT01709305|41723186|FG003|Phase 1|Death|0|||
19464832|NCT01709305|41723187|FG004|Phase 1|Death|0|||
19464833|NCT01709305|41723183|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
19464834|NCT01709305|41723184|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
19464835|NCT01709305|41723185|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
19464836|NCT01709305|41723186|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
19464837|NCT01709305|41723187|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
19464838|NCT01709305|41723183|FG000|Phase 1|Laboratory Adverse Event|16|||
19464839|NCT01709305|41723184|FG001|Phase 1|Laboratory Adverse Event|0|||
19464840|NCT01709305|41723185|FG002|Phase 1|Laboratory Adverse Event|0|||
19464841|NCT01709305|41723186|FG003|Phase 1|Laboratory Adverse Event|0|||
19464842|NCT01709305|41723187|FG004|Phase 1|Laboratory Adverse Event|0|||
19464843|NCT01709305|41723183|FG000|Phase 1|Lost to Follow-up|147|||
19464844|NCT01709305|41723184|FG001|Phase 1|Lost to Follow-up|0|||
19464845|NCT01709305|41723185|FG002|Phase 1|Lost to Follow-up|0|||
19464846|NCT01709305|41723186|FG003|Phase 1|Lost to Follow-up|0|||
19464847|NCT01709305|41723187|FG004|Phase 1|Lost to Follow-up|0|||
19464848|NCT01709305|41723183|FG000|Phase 1|Travel, moving, etc.|30|||
19464849|NCT01709305|41723184|FG001|Phase 1|Travel, moving, etc.|0|||
19464850|NCT01709305|41723185|FG002|Phase 1|Travel, moving, etc.|0|||
19464851|NCT01709305|41723186|FG003|Phase 1|Travel, moving, etc.|0|||
19464852|NCT01709305|41723187|FG004|Phase 1|Travel, moving, etc.|0|||
19464853|NCT01709305|41723183|FG000|Phase 1|Physician Decision|13|||
19464854|NCT01709305|41723184|FG001|Phase 1|Physician Decision|0|||
19464855|NCT01709305|41723185|FG002|Phase 1|Physician Decision|0|||
19464856|NCT01709305|41723186|FG003|Phase 1|Physician Decision|0|||
19464857|NCT01709305|41723187|FG004|Phase 1|Physician Decision|0|||
19464858|NCT01709305|41723183|FG000|Phase 1|Protocol Violation|118|||
19464859|NCT01709305|41723184|FG001|Phase 1|Protocol Violation|0|||
19464860|NCT01709305|41723185|FG002|Phase 1|Protocol Violation|0|||
19464861|NCT01709305|41723186|FG003|Phase 1|Protocol Violation|0|||
19464862|NCT01709305|41723187|FG004|Phase 1|Protocol Violation|0|||
19464863|NCT01709305|41723183|FG000|Phase 1|Withdrawal by Subject|218|||
19464864|NCT01709305|41723184|FG001|Phase 1|Withdrawal by Subject|0|||
19464865|NCT01709305|41723185|FG002|Phase 1|Withdrawal by Subject|0|||
19464866|NCT01709305|41723186|FG003|Phase 1|Withdrawal by Subject|0|||
19464867|NCT01709305|41723187|FG004|Phase 1|Withdrawal by Subject|0|||
19464868|NCT01709305|41723183|FG000|Phase 2|Clinical Adverse Event|0|||
19464869|NCT01709305|41723184|FG001|Phase 2|Clinical Adverse Event|10|||
19464870|NCT01709305|41723185|FG002|Phase 2|Clinical Adverse Event|10|||
19464871|NCT01709305|41723186|FG003|Phase 2|Clinical Adverse Event|6|||
19464872|NCT01709305|41723187|FG004|Phase 2|Clinical Adverse Event|11|||
19464873|NCT01709305|41723183|FG000|Phase 2|Death|0|||
19464874|NCT01709305|41723184|FG001|Phase 2|Death|0|||
19464875|NCT01709305|41723185|FG002|Phase 2|Death|1|||
19464876|NCT01709305|41723186|FG003|Phase 2|Death|0|||
19464877|NCT01709305|41723187|FG004|Phase 2|Death|0|||
19464878|NCT01709305|41723183|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
19464879|NCT01709305|41723184|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
19464880|NCT01709305|41723185|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
19464881|NCT01709305|41723186|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
19464882|NCT01709305|41723187|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
19464883|NCT01709305|41723183|FG000|Phase 2|Laboratory Adverse Event|0|||
19464884|NCT01709305|41723184|FG001|Phase 2|Laboratory Adverse Event|1|||
19464885|NCT01709305|41723185|FG002|Phase 2|Laboratory Adverse Event|0|||
19464886|NCT01709305|41723186|FG003|Phase 2|Laboratory Adverse Event|1|||
19464887|NCT01709305|41723187|FG004|Phase 2|Laboratory Adverse Event|1|||
19464888|NCT01709305|41723183|FG000|Phase 2|Lost to Follow-up|0|||
19464889|NCT01709305|41723184|FG001|Phase 2|Lost to Follow-up|10|||
19464890|NCT01709305|41723185|FG002|Phase 2|Lost to Follow-up|6|||
19464891|NCT01709305|41723186|FG003|Phase 2|Lost to Follow-up|9|||
19464892|NCT01709305|41723187|FG004|Phase 2|Lost to Follow-up|5|||
19464893|NCT01709305|41723183|FG000|Phase 2|Travel, moving, etc.|0|||
19464894|NCT01709305|41723184|FG001|Phase 2|Travel, moving, etc.|2|||
19464895|NCT01709305|41723185|FG002|Phase 2|Travel, moving, etc.|3|||
19464896|NCT01709305|41723186|FG003|Phase 2|Travel, moving, etc.|3|||
19464897|NCT01709305|41723187|FG004|Phase 2|Travel, moving, etc.|5|||
19464898|NCT01709305|41723183|FG000|Phase 2|Physician Decision|0|||
19464899|NCT01709305|41723184|FG001|Phase 2|Physician Decision|2|||
19464900|NCT01709305|41723185|FG002|Phase 2|Physician Decision|0|||
19464901|NCT01709305|41723186|FG003|Phase 2|Physician Decision|1|||
19464902|NCT01709305|41723187|FG004|Phase 2|Physician Decision|2|||
19464903|NCT01709305|41723183|FG000|Phase 2|Protocol Violation|0|||
19464904|NCT01709305|41723184|FG001|Phase 2|Protocol Violation|19|||
19464905|NCT01709305|41723185|FG002|Phase 2|Protocol Violation|19|||
19464906|NCT01709305|41723186|FG003|Phase 2|Protocol Violation|13|||
19464907|NCT01709305|41723187|FG004|Phase 2|Protocol Violation|9|||
19464908|NCT01709305|41723183|FG000|Phase 2|Withdrawal by Subject|0|||
19464909|NCT01709305|41723184|FG001|Phase 2|Withdrawal by Subject|8|||
19464910|NCT01709305|41723185|FG002|Phase 2|Withdrawal by Subject|6|||
19464911|NCT01709305|41723186|FG003|Phase 2|Withdrawal by Subject|15|||
19464912|NCT01709305|41723187|FG004|Phase 2|Withdrawal by Subject|12|||
19464913|NCT01684423|41723207|FG000|Overall Study|Withdrawal by Subject|0|||
19464914|NCT01684423|41723208|FG001|Overall Study|Withdrawal by Subject|0|||
19464915|NCT01684423|41723209|FG002|Overall Study|Withdrawal by Subject|1|||
19464916|NCT01684423|41723210|FG003|Overall Study|Withdrawal by Subject|0|||
19464917|NCT01684423|41723211|FG004|Overall Study|Withdrawal by Subject|0|||
19464918|NCT01709227|41723227|FG000|Overall Study|Physician Decision|1|||
19464919|NCT01709227|41723228|FG001|Overall Study|Physician Decision|0|||
19464920|NCT01709227|41723227|FG000|Overall Study|Pleural Peritoneal communication|0|||
19464921|NCT01709227|41723228|FG001|Overall Study|Pleural Peritoneal communication|9|||
19464922|NCT01684033|41723235|FG000|Period 1, First 30 Days|Adverse Event|1|||
19464923|NCT01684033|41723236|FG001|Period 1, First 30 Days|Adverse Event|1|||
19464924|NCT01684033|41723235|FG000|Period 1, First 30 Days|Noncompliance|1|||
19464925|NCT01684033|41723236|FG001|Period 1, First 30 Days|Noncompliance|0|||
19464926|NCT01684033|41723235|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
19464927|NCT01684033|41723236|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
19464928|NCT01684033|41723235|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
19464929|NCT01684033|41723236|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
19464930|NCT01684033|41723235|FG000|Period 2, Second 30 Days|Adverse Event|1|||
19464931|NCT01684033|41723236|FG001|Period 2, Second 30 Days|Adverse Event|0|||
19464932|NCT01903811|41723277|FG000|Overall Study|No measurable disease|1|||
19464933|NCT01903811|41723278|FG001|Overall Study|No measurable disease|1|||
19464934|NCT01903811|41723277|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
19464935|NCT01903811|41723278|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
19464936|NCT01903811|41723277|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
19464937|NCT01903811|41723278|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
19464938|NCT01903811|41723277|FG000|Overall Study|Withdrawal by Subject|0|||
19464939|NCT01903811|41723278|FG001|Overall Study|Withdrawal by Subject|1|||
19464940|NCT01709149|41723295|FG000|Open-label Lead-in Phase|Adverse Event|109|||
19464941|NCT01709149|41723296|FG001|Open-label Lead-in Phase|Adverse Event|0|||
19464942|NCT01709149|41723297|FG002|Open-label Lead-in Phase|Adverse Event|0|||
19464943|NCT01709149|41723295|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
19464944|NCT01709149|41723296|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
19464945|NCT01709149|41723297|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
19464946|NCT01709149|41723295|FG000|Open-label Lead-in Phase|Death|1|||
19464947|NCT01709149|41723296|FG001|Open-label Lead-in Phase|Death|0|||
19464948|NCT01709149|41723297|FG002|Open-label Lead-in Phase|Death|0|||
19464949|NCT01709149|41723295|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
19464950|NCT01709149|41723296|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
19464951|NCT01709149|41723297|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
19464952|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
19464953|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
19464954|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
19464955|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19464956|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
19464957|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
19464958|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19464959|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
19464960|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
19464961|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
19464962|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
19464963|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
19464964|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
19464965|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
19464966|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
19464967|NCT01709149|41723295|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19464968|NCT01709149|41723296|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
19464969|NCT01709149|41723297|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19464970|NCT01568593|41723306|FG000|Overall Study|Lack of Efficacy|4|||
19464971|NCT01568593|41723307|FG001|Overall Study|Lack of Efficacy|1|||
19464972|NCT01568593|41723306|FG000|Overall Study|Adverse Event|3|||
19464973|NCT01568593|41723307|FG001|Overall Study|Adverse Event|2|||
19464974|NCT01683565|41723315|FG000|Overall Study|Lost to Follow-up|2|||
19464975|NCT01683565|41723316|FG001|Overall Study|Lost to Follow-up|0|||
19464976|NCT01683565|41723315|FG000|Overall Study|Discontinued Intervention|1|||
19464977|NCT01683565|41723316|FG001|Overall Study|Discontinued Intervention|1|||
19464978|NCT01903031|41723340|FG000|Overall Study|Not Able to Attend Clinic|1|||
19464979|NCT01903031|41723341|FG001|Overall Study|Not Able to Attend Clinic|1|||
19464980|NCT01903031|41723342|FG002|Overall Study|Not Able to Attend Clinic|0|||
19464981|NCT01903031|41723340|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
19464982|NCT01903031|41723341|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
19464983|NCT01903031|41723342|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
19464984|NCT01903031|41723340|FG000|Overall Study|Adverse Event|0|||
19464985|NCT01903031|41723341|FG001|Overall Study|Adverse Event|1|||
19464986|NCT01903031|41723342|FG002|Overall Study|Adverse Event|0|||
19464987|NCT01903031|41723340|FG000|Overall Study|Withdrawal by Subject|0|||
19464988|NCT01903031|41723341|FG001|Overall Study|Withdrawal by Subject|1|||
19464989|NCT01903031|41723342|FG002|Overall Study|Withdrawal by Subject|1|||
19464990|NCT01903031|41723340|FG000|Overall Study|Protocol Violation|0|||
19464991|NCT01903031|41723341|FG001|Overall Study|Protocol Violation|0|||
19464992|NCT01903031|41723342|FG002|Overall Study|Protocol Violation|2|||
19464993|NCT01903031|41723340|FG000|Overall Study|Lost to Follow-up|0|||
19464994|NCT01903031|41723341|FG001|Overall Study|Lost to Follow-up|0|||
19464995|NCT01903031|41723342|FG002|Overall Study|Lost to Follow-up|1|||
19464996|NCT01903031|41723340|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
19464997|NCT01903031|41723341|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
19464998|NCT01903031|41723342|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
19464999|NCT01616693|41723374|FG000|Evaluated for Safety|Physician Decision|1|||
19465000|NCT01616693|41723375|FG001|Evaluated for Safety|Physician Decision|0|||
19465001|NCT01616693|41723376|FG002|Evaluated for Safety|Physician Decision|1|||
19465002|NCT01616693|41723377|FG003|Evaluated for Safety|Physician Decision|0|||
19465003|NCT01616693|41723374|FG000|Received Both Vaccines|Adverse Event|2|||
19465004|NCT01616693|41723375|FG001|Received Both Vaccines|Adverse Event|0|||
19465005|NCT01616693|41723376|FG002|Received Both Vaccines|Adverse Event|0|||
19465006|NCT01616693|41723377|FG003|Received Both Vaccines|Adverse Event|0|||
19465007|NCT01616693|41723374|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
19465008|NCT01616693|41723375|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
19465009|NCT01616693|41723376|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
19465010|NCT01616693|41723377|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
19465011|NCT01616693|41723374|FG000|Received Both Vaccines|Lost to Follow-up|4|||
19465012|NCT01616693|41723375|FG001|Received Both Vaccines|Lost to Follow-up|3|||
19465013|NCT01616693|41723376|FG002|Received Both Vaccines|Lost to Follow-up|4|||
19465014|NCT01616693|41723377|FG003|Received Both Vaccines|Lost to Follow-up|4|||
19465015|NCT01616693|41723374|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
19465016|NCT01616693|41723375|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
19465017|NCT01616693|41723376|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
19465018|NCT01616693|41723377|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
19465019|NCT01616459|41723484|FG000|Overall Study|Adverse Event|1|||
19465020|NCT01616459|41723485|FG001|Overall Study|Adverse Event|1|||
19465021|NCT01616459|41723486|FG002|Overall Study|Adverse Event|2|||
19465022|NCT01616459|41723487|FG003|Overall Study|Adverse Event|0|||
19465023|NCT01616459|41723484|FG000|Overall Study|Lost to Follow-up|1|||
19465024|NCT01616459|41723485|FG001|Overall Study|Lost to Follow-up|11|||
19465025|NCT01616459|41723486|FG002|Overall Study|Lost to Follow-up|3|||
19465026|NCT01616459|41723487|FG003|Overall Study|Lost to Follow-up|2|||
19465027|NCT01616459|41723484|FG000|Overall Study|Protocol Violation|0|||
19465028|NCT01616459|41723485|FG001|Overall Study|Protocol Violation|0|||
19465029|NCT01616459|41723486|FG002|Overall Study|Protocol Violation|0|||
19465030|NCT01616459|41723487|FG003|Overall Study|Protocol Violation|2|||
19465031|NCT01616459|41723484|FG000|Overall Study|Withdrawal by Subject|2|||
19465032|NCT01616459|41723485|FG001|Overall Study|Withdrawal by Subject|4|||
19465033|NCT01616459|41723486|FG002|Overall Study|Withdrawal by Subject|4|||
19465034|NCT01616459|41723487|FG003|Overall Study|Withdrawal by Subject|4|||
19465035|NCT01616459|41723484|FG000|Overall Study|Other reason|0|||
19465036|NCT01616459|41723485|FG001|Overall Study|Other reason|1|||
19465037|NCT01616459|41723486|FG002|Overall Study|Other reason|1|||
19465038|NCT01616459|41723487|FG003|Overall Study|Other reason|0|||
19465039|NCT01919801|41723504|FG000|Overall Study|Withdrawal by Subject|1|||
19465040|NCT01919801|41723505|FG001|Overall Study|Withdrawal by Subject|0|||
19465041|NCT01919801|41723504|FG000|Overall Study|Physician Decision|0|||
19465042|NCT01919801|41723505|FG001|Overall Study|Physician Decision|1|||
19465043|NCT01919801|41723504|FG000|Overall Study|Lost to Follow-up|0|||
19465044|NCT01919801|41723505|FG001|Overall Study|Lost to Follow-up|1|||
19465045|NCT01919801|41723504|FG000|Overall Study|Other|0|||
19465046|NCT01919801|41723505|FG001|Overall Study|Other|1|||
19465047|NCT01919723|41723513|FG000|Overall Study|Blood Samples Hemolyzed|2|||
19465048|NCT01919723|41723514|FG001|Overall Study|Blood Samples Hemolyzed|2|||
19465049|NCT01919489|41723522|FG000|Overall Study|Rejected the need of injections|4|||
19465050|NCT01919489|41723523|FG001|Overall Study|Rejected the need of injections|7|||
19465051|NCT01919489|41723522|FG000|Overall Study|Adverse Event|10|||
19465052|NCT01919489|41723523|FG001|Overall Study|Adverse Event|0|||
19465053|NCT01919489|41723522|FG000|Overall Study|Hospital readmission|2|||
19465054|NCT01919489|41723523|FG001|Overall Study|Hospital readmission|9|||
19465055|NCT01919489|41723522|FG000|Overall Study|Death|2|||
19465056|NCT01919489|41723523|FG001|Overall Study|Death|1|||
19465057|NCT01919489|41723522|FG000|Overall Study|Lost to Follow-up|38|||
19465058|NCT01919489|41723523|FG001|Overall Study|Lost to Follow-up|27|||
19465059|NCT01919411|41723531|FG000|Overall Study|Lost to Follow-up|2|||
19465060|NCT01919411|41723532|FG001|Overall Study|Lost to Follow-up|4|||
19465061|NCT01919411|41723531|FG000|Overall Study|Physician Decision|1|||
19465062|NCT01919411|41723532|FG001|Overall Study|Physician Decision|0|||
19465063|NCT01919411|41723531|FG000|Overall Study|Protocol Violation|2|||
19465064|NCT01919411|41723532|FG001|Overall Study|Protocol Violation|1|||
19465065|NCT01901393|41723540|FG000|Overall Study|Adverse Event|1|||
19465066|NCT01901393|41723541|FG001|Overall Study|Adverse Event|0|||
19465067|NCT01890707|41723549|FG000|Overall Study|Lost to Follow-up|1|||
19465068|NCT01890707|41723550|FG001|Overall Study|Lost to Follow-up|1|||
19465069|NCT01900691|41723556|FG000|Overall Study|Death|7|||
19465070|NCT01900691|41723556|FG000|Overall Study|Lost to Follow-up|4|||
19465071|NCT01900691|41723556|FG000|Overall Study|Study Device Not Placed|3|||
19465072|NCT01900691|41723556|FG000|Overall Study|Non study stent placed|2|||
19465073|NCT01900691|41723556|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
19465074|NCT01900691|41723556|FG000|Overall Study|Complete stent migration through digestive tract|1|||
19465075|NCT01890473|41723563|FG000|Overall Study|Lost to Follow-up|1|||
19465076|NCT01890473|41723564|FG001|Overall Study|Lost to Follow-up|0|||
19465077|NCT01890473|41723563|FG000|Overall Study|Poor/non-compliance|1|||
19465078|NCT01890473|41723564|FG001|Overall Study|Poor/non-compliance|0|||
19465079|NCT01889069|41723574|FG000|Overall Study|Death|18|||
19465080|NCT01889069|41723574|FG000|Overall Study|Progression of Disease|14|||
19465081|NCT01889069|41723574|FG000|Overall Study|Lost to Follow-up|6|||
19465082|NCT01889069|41723574|FG000|Overall Study|Other|4|||
19465083|NCT01889069|41723574|FG000|Overall Study|Consent Withdrawal|3|||
19465084|NCT02533180|41723586|FG000|Overall Study|Death|0|||
19465085|NCT02533180|41723587|FG001|Overall Study|Death|1|||
19465086|NCT02533180|41723586|FG000|Overall Study|Lost to Follow-up|0|||
19465087|NCT02533180|41723587|FG001|Overall Study|Lost to Follow-up|1|||
19465088|NCT02533180|41723586|FG000|Overall Study|Physician Decision|0|||
19465089|NCT02533180|41723587|FG001|Overall Study|Physician Decision|1|||
19465090|NCT02533180|41723586|FG000|Overall Study|Withdrawal by Subject|2|||
19465091|NCT02533180|41723587|FG001|Overall Study|Withdrawal by Subject|4|||
19465092|NCT02533180|41723586|FG000|Overall Study|Screen Failure|37|||
19465093|NCT02533180|41723587|FG001|Overall Study|Screen Failure|0|||
19465094|NCT02533180|41723586|FG000|Overall Study|Protocol Deviation|0|||
19465095|NCT02533180|41723587|FG001|Overall Study|Protocol Deviation|1|||
19465096|NCT02533180|41723586|FG000|Overall Study|On Study|0|||
19465097|NCT02533180|41723587|FG001|Overall Study|On Study|39|||
19465098|NCT01739348|41723618|FG000|Part I (Base Study)|Adverse Event|41|||
19465099|NCT01739348|41723619|FG001|Part I (Base Study)|Adverse Event|52|||
19465100|NCT01739348|41723620|FG002|Part I (Base Study)|Adverse Event|8|||
19465101|NCT01739348|41723621|FG003|Part I (Base Study)|Adverse Event|33|||
19465102|NCT01739348|41723618|FG000|Part I (Base Study)|Death|10|||
19465103|NCT01739348|41723619|FG001|Part I (Base Study)|Death|7|||
19465104|NCT01739348|41723620|FG002|Part I (Base Study)|Death|2|||
19465105|NCT01739348|41723621|FG003|Part I (Base Study)|Death|8|||
19465106|NCT01739348|41723618|FG000|Part I (Base Study)|Lack of Efficacy|3|||
19465107|NCT01739348|41723619|FG001|Part I (Base Study)|Lack of Efficacy|8|||
19465108|NCT01739348|41723620|FG002|Part I (Base Study)|Lack of Efficacy|0|||
19465109|NCT01739348|41723621|FG003|Part I (Base Study)|Lack of Efficacy|7|||
19465110|NCT01739348|41723618|FG000|Part I (Base Study)|Lost to Follow-up|4|||
19465111|NCT01739348|41723619|FG001|Part I (Base Study)|Lost to Follow-up|2|||
19465112|NCT01739348|41723620|FG002|Part I (Base Study)|Lost to Follow-up|4|||
19465113|NCT01739348|41723621|FG003|Part I (Base Study)|Lost to Follow-up|4|||
19465114|NCT01739348|41723618|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
19465115|NCT01739348|41723619|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
19465116|NCT01739348|41723620|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
19465117|NCT01739348|41723621|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
19465118|NCT01739348|41723618|FG000|Part I (Base Study)|Physician Decision|10|||
19465119|NCT01739348|41723619|FG001|Part I (Base Study)|Physician Decision|7|||
19465120|NCT01739348|41723620|FG002|Part I (Base Study)|Physician Decision|1|||
19465121|NCT01739348|41723621|FG003|Part I (Base Study)|Physician Decision|4|||
19465122|NCT01739348|41723618|FG000|Part I (Base Study)|Protocol Violation|2|||
19380681|NCT02412878|41623945|FG001|Overall Study|Lost to Follow-up|3|||
19465123|NCT01739348|41723619|FG001|Part I (Base Study)|Protocol Violation|0|||
19465124|NCT01739348|41723620|FG002|Part I (Base Study)|Protocol Violation|1|||
19465125|NCT01739348|41723621|FG003|Part I (Base Study)|Protocol Violation|2|||
19465126|NCT01739348|41723618|FG000|Part I (Base Study)|Screen Failure|2|||
19465127|NCT01739348|41723619|FG001|Part I (Base Study)|Screen Failure|0|||
19465128|NCT01739348|41723620|FG002|Part I (Base Study)|Screen Failure|0|||
19465129|NCT01739348|41723621|FG003|Part I (Base Study)|Screen Failure|0|||
19465130|NCT01739348|41723618|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
19465131|NCT01739348|41723619|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
19465132|NCT01739348|41723620|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
19465133|NCT01739348|41723621|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
19465134|NCT01739348|41723618|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
19465135|NCT01739348|41723619|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
19465136|NCT01739348|41723620|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
19465137|NCT01739348|41723621|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
19465138|NCT01739348|41723618|FG000|Part I (Base Study)|Participant Moved|4|||
19465139|NCT01739348|41723619|FG001|Part I (Base Study)|Participant Moved|3|||
19465140|NCT01739348|41723620|FG002|Part I (Base Study)|Participant Moved|1|||
19465141|NCT01739348|41723621|FG003|Part I (Base Study)|Participant Moved|7|||
19465142|NCT01739348|41723618|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
19465143|NCT01739348|41723619|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
19465144|NCT01739348|41723620|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
19465145|NCT01739348|41723621|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
19465146|NCT01739348|41723618|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
19465147|NCT01739348|41723619|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
19465148|NCT01739348|41723620|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
19465149|NCT01739348|41723621|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
19465150|NCT01739348|41723618|FG000|Part II (Extension Study)|Adverse Event|10|||
19465151|NCT01739348|41723619|FG001|Part II (Extension Study)|Adverse Event|11|||
19465152|NCT01739348|41723620|FG002|Part II (Extension Study)|Adverse Event|7|||
19465153|NCT01739348|41723621|FG003|Part II (Extension Study)|Adverse Event|26|||
19465154|NCT01739348|41723618|FG000|Part II (Extension Study)|Death|3|||
19465155|NCT01739348|41723619|FG001|Part II (Extension Study)|Death|3|||
19465156|NCT01739348|41723620|FG002|Part II (Extension Study)|Death|2|||
19465157|NCT01739348|41723621|FG003|Part II (Extension Study)|Death|6|||
19465158|NCT01739348|41723618|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
19465159|NCT01739348|41723619|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
19465160|NCT01739348|41723620|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
19465161|NCT01739348|41723621|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
19465162|NCT01739348|41723618|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
19465163|NCT01739348|41723619|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
19465164|NCT01739348|41723620|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
19465165|NCT01739348|41723621|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
19465166|NCT01739348|41723618|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
19465167|NCT01739348|41723619|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
19465168|NCT01739348|41723620|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
19465169|NCT01739348|41723621|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
19465170|NCT01739348|41723618|FG000|Part II (Extension Study)|Physician Decision|7|||
19465171|NCT01739348|41723619|FG001|Part II (Extension Study)|Physician Decision|11|||
19465172|NCT01739348|41723620|FG002|Part II (Extension Study)|Physician Decision|6|||
19465173|NCT01739348|41723621|FG003|Part II (Extension Study)|Physician Decision|12|||
19465174|NCT01739348|41723618|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
19465175|NCT01739348|41723619|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
19465176|NCT01739348|41723620|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
19465177|NCT01739348|41723621|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
19465178|NCT01739348|41723618|FG000|Part II (Extension Study)|Participant Moved|3|||
19465179|NCT01739348|41723619|FG001|Part II (Extension Study)|Participant Moved|3|||
19465180|NCT01739348|41723620|FG002|Part II (Extension Study)|Participant Moved|0|||
19465181|NCT01739348|41723621|FG003|Part II (Extension Study)|Participant Moved|3|||
19465182|NCT01739348|41723618|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
19465183|NCT01739348|41723619|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
19465184|NCT01739348|41723620|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
19465185|NCT01739348|41723621|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
19465186|NCT01739348|41723618|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
19465187|NCT01739348|41723619|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
19465188|NCT01739348|41723620|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
19465189|NCT01739348|41723621|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
19465190|NCT01738646|41723653|FG000|Overall Study|Still Receiving Treatment|2|||
19465191|NCT01716104|41723660|FG000|Overall Study|Do not meet inclusion criteria|6|||
19465192|NCT01716104|41723661|FG001|Overall Study|Do not meet inclusion criteria|7|||
19465193|NCT04426695|41723741|FG000|Overall Study|Death|2|||
19465194|NCT04426695|41723742|FG001|Overall Study|Death|0|||
19465195|NCT04426695|41723743|FG002|Overall Study|Death|1|||
19465196|NCT04426695|41723744|FG003|Overall Study|Death|27|||
19465197|NCT04426695|41723745|FG004|Overall Study|Death|25|||
19465198|NCT04426695|41723746|FG005|Overall Study|Death|21|||
19465199|NCT04426695|41723747|FG006|Overall Study|Death|42|||
19465200|NCT04426695|41723748|FG007|Overall Study|Death|23|||
19465201|NCT04426695|41723749|FG008|Overall Study|Death|37|||
19465202|NCT04426695|41723750|FG009|Overall Study|Death|14|||
19465203|NCT04426695|41723751|FG010|Overall Study|Death|8|||
19465204|NCT04426695|41723752|FG011|Overall Study|Death|7|||
19465205|NCT04426695|41723753|FG012|Overall Study|Death|13|||
19465206|NCT04426695|41723754|FG013|Overall Study|Death|25|||
19465207|NCT04426695|41723755|FG014|Overall Study|Death|19|||
19465208|NCT04426695|41723756|FG015|Overall Study|Death|7|||
19465209|NCT04426695|41723757|FG016|Overall Study|Death|8|||
19465210|NCT04426695|41723758|FG017|Overall Study|Death|4|||
19465211|NCT04426695|41723741|FG000|Overall Study|Lost to Follow-up|2|||
19465212|NCT04426695|41723742|FG001|Overall Study|Lost to Follow-up|4|||
19639085|NCT00689481|42088530|FG000|Overall Study|Excluded medication started during study|0|||
19639086|NCT00689481|42088531|FG001|Overall Study|Excluded medication started during study|1|||
19639087|NCT00689481|42088530|FG000|Overall Study|Subject early term, left on vacation|0|||
19639088|NCT00689481|42088531|FG001|Overall Study|Subject early term, left on vacation|1|||
19639089|NCT00688701|42088540|FG000|Overall Study|Adverse Event|1|||
19639090|NCT00688701|42088541|FG001|Overall Study|Adverse Event|0|||
19639091|NCT00688701|42088542|FG002|Overall Study|Adverse Event|5|||
19639092|NCT00688701|42088543|FG003|Overall Study|Adverse Event|3|||
19639093|NCT00688701|42088540|FG000|Overall Study|Lack of Efficacy|0|||
19639094|NCT00688701|42088541|FG001|Overall Study|Lack of Efficacy|1|||
19639095|NCT00688701|42088542|FG002|Overall Study|Lack of Efficacy|0|||
19639096|NCT00688701|42088543|FG003|Overall Study|Lack of Efficacy|0|||
19639097|NCT00688701|42088540|FG000|Overall Study|Withdrawal by Subject|3|||
19639098|NCT00688701|42088541|FG001|Overall Study|Withdrawal by Subject|3|||
19639099|NCT00688701|42088542|FG002|Overall Study|Withdrawal by Subject|4|||
19639100|NCT00688701|42088543|FG003|Overall Study|Withdrawal by Subject|8|||
19639101|NCT00688701|42088540|FG000|Overall Study|Poor compliance to protocol|0|||
19639102|NCT00688701|42088541|FG001|Overall Study|Poor compliance to protocol|1|||
19639103|NCT00688701|42088542|FG002|Overall Study|Poor compliance to protocol|1|||
19639104|NCT00688701|42088543|FG003|Overall Study|Poor compliance to protocol|0|||
19639105|NCT00688623|42088563|FG000|Overall Study|Adverse Event|22|||
19639106|NCT00688623|42088563|FG000|Overall Study|abnormal lab value|1|||
19639107|NCT00688623|42088563|FG000|Overall Study|Withdrawal by Subject|4|||
19639108|NCT00688623|42088563|FG000|Overall Study|Death|3|||
19639109|NCT00688623|42088563|FG000|Overall Study|disease progression|23|||
19639110|NCT00688623|42088563|FG000|Overall Study|Protocol Violation|2|||
19639111|NCT00717236|42088569|FG000|Double-Blind Period|Adverse Event|33|||
19639112|NCT00717236|42088570|FG001|Double-Blind Period|Adverse Event|6|||
19639113|NCT00717236|42088569|FG000|Double-Blind Period|Lack of Efficacy|6|||
19639114|NCT00717236|42088570|FG001|Double-Blind Period|Lack of Efficacy|6|||
19639115|NCT00717236|42088569|FG000|Double-Blind Period|Lost to Follow-up|3|||
19639116|NCT00717236|42088570|FG001|Double-Blind Period|Lost to Follow-up|5|||
19639117|NCT00717236|42088569|FG000|Double-Blind Period|Withdrawal by Subject|10|||
19639118|NCT00717236|42088570|FG001|Double-Blind Period|Withdrawal by Subject|2|||
19639119|NCT00717236|42088569|FG000|Double-Blind Period|Loss of efficacy|3|||
19639120|NCT00717236|42088570|FG001|Double-Blind Period|Loss of efficacy|0|||
19727448|NCT03614156|42172228|FG003|Open-Label Treatment Period|Adverse Event|0|||
19727449|NCT03614156|42172225|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
19727450|NCT03614156|42172226|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
19727451|NCT03614156|42172227|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
19727452|NCT03614156|42172228|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
19727453|NCT03614156|42172225|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
19727454|NCT03614156|42172226|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
19727455|NCT03614156|42172227|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
19727456|NCT03614156|42172228|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
19727457|NCT03614156|42172225|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
19727458|NCT03614156|42172226|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
19727459|NCT03614156|42172227|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
19727460|NCT03614156|42172228|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
19727461|NCT03614156|42172225|FG000|Open-Label Treatment Period|Protocol Violation|2|||
19727462|NCT03614156|42172226|FG001|Open-Label Treatment Period|Protocol Violation|0|||
19727463|NCT03614156|42172227|FG002|Open-Label Treatment Period|Protocol Violation|0|||
19727464|NCT03614156|42172228|FG003|Open-Label Treatment Period|Protocol Violation|0|||
19727465|NCT03614156|42172225|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
19727466|NCT03614156|42172226|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
19380682|NCT02380742|41623953|FG000|Overall Study|Withdrawal by Subject|1|||
19380683|NCT02380742|41623954|FG001|Overall Study|Withdrawal by Subject|0|||
19465213|NCT04426695|41723743|FG002|Overall Study|Lost to Follow-up|1|||
19465214|NCT04426695|41723744|FG003|Overall Study|Lost to Follow-up|19|||
19639121|NCT00717236|42088569|FG000|Double-Blind Period|Other: Death|1|||
19639122|NCT00717236|42088570|FG001|Double-Blind Period|Other: Death|0|||
19639123|NCT00717236|42088569|FG000|Double-Blind Period|Other: Pregnancy|1|||
19639124|NCT00717236|42088570|FG001|Double-Blind Period|Other: Pregnancy|0|||
19639125|NCT00717236|42088569|FG000|Double-Blind Period|Other: Protocol Violation|2|||
19639126|NCT00717236|42088570|FG001|Double-Blind Period|Other: Protocol Violation|0|||
19727467|NCT03614156|42172227|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
19727468|NCT03614156|42172228|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
19727469|NCT03614156|42172225|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
19727470|NCT03614156|42172226|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
19727471|NCT03614156|42172227|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
19727472|NCT03614156|42172228|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
19727473|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
19727474|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
19727475|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
19727476|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
19727477|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19727478|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
19727479|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19727480|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19727481|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19727482|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19727483|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
19727484|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
19727485|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
19727486|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
19727487|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
19727488|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
19727489|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
19727490|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
19727491|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
19727492|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
19727493|NCT03614156|42172225|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
19727494|NCT03614156|42172226|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
19727495|NCT03614156|42172227|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
19727496|NCT03614156|42172228|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
19727497|NCT03614156|42172225|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
19727498|NCT03614156|42172226|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
19727499|NCT03614156|42172227|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
19727500|NCT03614156|42172228|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
19727501|NCT03614156|42172225|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
19727502|NCT03614156|42172226|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
19727503|NCT03614156|42172227|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
19727504|NCT03614156|42172228|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
19727505|NCT03614156|42172225|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
19727506|NCT03614156|42172226|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
19727507|NCT03614156|42172227|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
19727508|NCT03614156|42172228|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
19727509|NCT03614078|42172240|FG000|Overall Study|Withdrawal by Subject|2|||
19727510|NCT03614078|42172241|FG001|Overall Study|Withdrawal by Subject|2|||
19727511|NCT03614078|42172242|FG002|Overall Study|Withdrawal by Subject|3|||
19727512|NCT03614078|42172240|FG000|Overall Study|Participant Did Not Return for Visit|0|||
19727513|NCT03614078|42172241|FG001|Overall Study|Participant Did Not Return for Visit|1|||
19727514|NCT03614078|42172242|FG002|Overall Study|Participant Did Not Return for Visit|0|||
19727515|NCT03614078|42172240|FG000|Overall Study|High Neutrophils|0|||
19727516|NCT03614078|42172241|FG001|Overall Study|High Neutrophils|0|||
19727517|NCT03614078|42172242|FG002|Overall Study|High Neutrophils|2|||
19727518|NCT03614078|42172240|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
19727519|NCT03614078|42172241|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
19727520|NCT03614078|42172242|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
19727521|NCT03614078|42172240|FG000|Overall Study|Exacerbation of Psoriasis|0|||
19727522|NCT03614078|42172241|FG001|Overall Study|Exacerbation of Psoriasis|1|||
19727523|NCT03614078|42172242|FG002|Overall Study|Exacerbation of Psoriasis|0|||
19727524|NCT03614078|42172240|FG000|Overall Study|Adverse Event|0|||
19727525|NCT03614078|42172241|FG001|Overall Study|Adverse Event|2|||
19727526|NCT03614078|42172242|FG002|Overall Study|Adverse Event|0|||
19727527|NCT03614078|42172240|FG000|Overall Study|Dizziness and Rash|0|||
19727528|NCT03614078|42172241|FG001|Overall Study|Dizziness and Rash|1|||
19380684|NCT02922725|41623963|FG000|Overall Study|Withdrawal by Subject|1|||
19380685|NCT02922725|41623964|FG001|Overall Study|Withdrawal by Subject|0|||
19380686|NCT02922725|41623965|FG002|Overall Study|Withdrawal by Subject|0|||
19380687|NCT02805257|41623974|FG000|Overall Study|Lost to Follow-up|7|||
19380688|NCT02805257|41623975|FG001|Overall Study|Lost to Follow-up|6|||
19380689|NCT02805257|41623974|FG000|Overall Study|Death|0|||
19380690|NCT02805257|41623975|FG001|Overall Study|Death|1|||
19727529|NCT03614078|42172242|FG002|Overall Study|Dizziness and Rash|0|||
19727530|NCT03613454|42172252|FG000|Overall Study|Protocol Violation|1|||
19727531|NCT03613454|42172253|FG001|Overall Study|Protocol Violation|0|||
19727532|NCT03613454|42172252|FG000|Overall Study|Protocol Violation|0|||
19727533|NCT03613454|42172253|FG001|Overall Study|Protocol Violation|1|||
19727534|NCT03581786|42172261|FG000|Overall Study|Death|17|||
19727535|NCT03581786|42172262|FG001|Overall Study|Death|12|||
19727536|NCT03581786|42172261|FG000|Overall Study|Withdrawal by Subject|2|||
19727537|NCT03581786|42172262|FG001|Overall Study|Withdrawal by Subject|4|||
19727538|NCT03581786|42172261|FG000|Overall Study|Lost to Follow-up|1|||
19727539|NCT03581786|42172262|FG001|Overall Study|Lost to Follow-up|0|||
19727540|NCT03581786|42172261|FG000|Overall Study|reason other than specified above|0|||
19727541|NCT03581786|42172262|FG001|Overall Study|reason other than specified above|1|||
19727542|NCT03581786|42172261|FG000|Overall Study|Ongoing in the study|123|||
19727543|NCT03581786|42172262|FG001|Overall Study|Ongoing in the study|129|||
19727544|NCT03580382|42172270|FG000|Overall Study|Early Termination of Study|0|||
19727545|NCT03580382|42172271|FG001|Overall Study|Early Termination of Study|3|||
19727546|NCT03579290|42172276|FG000|Overall Study|Lost to Follow-up|9|||
19727547|NCT03611582|42172282|FG000|Overall Study|Adverse Event|26|||
19727548|NCT03611582|42172283|FG001|Overall Study|Adverse Event|6|||
19727549|NCT03611582|42172282|FG000|Overall Study|Protocol Violation|0|||
19727550|NCT03611582|42172283|FG001|Overall Study|Protocol Violation|1|||
19727551|NCT03611582|42172282|FG000|Overall Study|Pregnancy|1|||
19727552|NCT03611582|42172283|FG001|Overall Study|Pregnancy|2|||
19727553|NCT03611582|42172282|FG000|Overall Study|Lack of Efficacy|0|||
19727554|NCT03611582|42172283|FG001|Overall Study|Lack of Efficacy|1|||
19727555|NCT03611582|42172282|FG000|Overall Study|At the discretion of the investigator|1|||
19727556|NCT03611582|42172283|FG001|Overall Study|At the discretion of the investigator|0|||
19727557|NCT03611582|42172282|FG000|Overall Study|Safety concern as judged by the investigator|1|||
19727558|NCT03611582|42172283|FG001|Overall Study|Safety concern as judged by the investigator|2|||
19727559|NCT03611582|42172282|FG000|Overall Study|Withdrawal by Subject|4|||
19727560|NCT03611582|42172283|FG001|Overall Study|Withdrawal by Subject|3|||
19727561|NCT03611582|42172282|FG000|Overall Study|Lost to Follow-up|18|||
19727562|NCT03611582|42172283|FG001|Overall Study|Lost to Follow-up|7|||
19727563|NCT03611582|42172282|FG000|Overall Study|other|17|||
19727564|NCT03611582|42172283|FG001|Overall Study|other|16|||
19727565|NCT04015518|42172294|FG000|Overall Study|Adverse Event|6|||
19727566|NCT04015518|42172295|FG001|Overall Study|Adverse Event|1|||
19727567|NCT04015518|42172296|FG002|Overall Study|Adverse Event|1|||
19727568|NCT04015518|42172297|FG003|Overall Study|Adverse Event|3|||
19727569|NCT04015518|42172298|FG004|Overall Study|Adverse Event|3|||
19727570|NCT04015518|42172294|FG000|Overall Study|Lack of Efficacy|1|||
19727571|NCT04015518|42172295|FG001|Overall Study|Lack of Efficacy|0|||
19727572|NCT04015518|42172296|FG002|Overall Study|Lack of Efficacy|1|||
19727573|NCT04015518|42172297|FG003|Overall Study|Lack of Efficacy|0|||
19727574|NCT04015518|42172298|FG004|Overall Study|Lack of Efficacy|4|||
19727575|NCT04015518|42172294|FG000|Overall Study|Lost to Follow-up|0|||
19727576|NCT04015518|42172295|FG001|Overall Study|Lost to Follow-up|0|||
19727577|NCT04015518|42172296|FG002|Overall Study|Lost to Follow-up|0|||
19727578|NCT04015518|42172297|FG003|Overall Study|Lost to Follow-up|0|||
19727579|NCT04015518|42172298|FG004|Overall Study|Lost to Follow-up|1|||
19727580|NCT04015518|42172294|FG000|Overall Study|Withdrawal by Subject|0|||
19727581|NCT04015518|42172295|FG001|Overall Study|Withdrawal by Subject|1|||
19727582|NCT04015518|42172296|FG002|Overall Study|Withdrawal by Subject|0|||
19727583|NCT04015518|42172297|FG003|Overall Study|Withdrawal by Subject|1|||
19727584|NCT04015518|42172298|FG004|Overall Study|Withdrawal by Subject|1|||
19727585|NCT04015518|42172294|FG000|Overall Study|Patient did not come for consecutive visits|0|||
19727586|NCT04015518|42172295|FG001|Overall Study|Patient did not come for consecutive visits|1|||
19727587|NCT04015518|42172296|FG002|Overall Study|Patient did not come for consecutive visits|0|||
19727588|NCT04015518|42172297|FG003|Overall Study|Patient did not come for consecutive visits|0|||
19727589|NCT04015518|42172298|FG004|Overall Study|Patient did not come for consecutive visits|0|||
19727590|NCT04015518|42172294|FG000|Overall Study|not willing to travel due to Covid-19|0|||
19727591|NCT04015518|42172295|FG001|Overall Study|not willing to travel due to Covid-19|0|||
19727592|NCT04015518|42172296|FG002|Overall Study|not willing to travel due to Covid-19|1|||
19727593|NCT04015518|42172297|FG003|Overall Study|not willing to travel due to Covid-19|0|||
19727594|NCT04015518|42172298|FG004|Overall Study|not willing to travel due to Covid-19|0|||
19727595|NCT04015518|42172294|FG000|Overall Study|Patient wants to discontinue treatment|0|||
19465215|NCT04426695|41723745|FG004|Overall Study|Lost to Follow-up|10|||
19727596|NCT04015518|42172295|FG001|Overall Study|Patient wants to discontinue treatment|0|||
19727597|NCT04015518|42172296|FG002|Overall Study|Patient wants to discontinue treatment|0|||
19727598|NCT04015518|42172297|FG003|Overall Study|Patient wants to discontinue treatment|1|||
19727599|NCT04015518|42172298|FG004|Overall Study|Patient wants to discontinue treatment|0|||
19727600|NCT04015518|42172294|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
19727601|NCT04015518|42172295|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
19727602|NCT04015518|42172296|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
19727603|NCT04015518|42172297|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
19727604|NCT04015518|42172298|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
19727605|NCT04015518|42172294|FG000|Overall Study|Pregnancy|0|||
19727606|NCT04015518|42172295|FG001|Overall Study|Pregnancy|0|||
19380691|NCT04794803|41623983|FG000|Overall Study|Death|1|||
19727607|NCT04015518|42172296|FG002|Overall Study|Pregnancy|0|||
19727608|NCT04015518|42172297|FG003|Overall Study|Pregnancy|0|||
19727609|NCT04015518|42172298|FG004|Overall Study|Pregnancy|1|||
19727610|NCT04015518|42172294|FG000|Overall Study|Personal reasons|1|||
19727611|NCT04015518|42172295|FG001|Overall Study|Personal reasons|0|||
19727612|NCT04015518|42172296|FG002|Overall Study|Personal reasons|0|||
19727613|NCT04015518|42172297|FG003|Overall Study|Personal reasons|0|||
19727614|NCT04015518|42172298|FG004|Overall Study|Personal reasons|1|||
19380692|NCT04794803|41623984|FG001|Overall Study|Death|3|||
19380693|NCT04794803|41623983|FG000|Overall Study|Lost to Follow-up|2|||
19380694|NCT04794803|41623984|FG001|Overall Study|Lost to Follow-up|2|||
19380695|NCT04794803|41623983|FG000|Overall Study|Withdrawal by Subject|1|||
19380696|NCT04794803|41623984|FG001|Overall Study|Withdrawal by Subject|0|||
19380697|NCT04794803|41623983|FG000|Overall Study|Physician Decision|1|||
19727615|NCT04015518|42172294|FG000|Overall Study|Withdrew consent|1|||
19727616|NCT04015518|42172295|FG001|Overall Study|Withdrew consent|0|||
19727617|NCT04015518|42172296|FG002|Overall Study|Withdrew consent|0|||
19727618|NCT04015518|42172297|FG003|Overall Study|Withdrew consent|0|||
19727619|NCT04015518|42172298|FG004|Overall Study|Withdrew consent|0|||
19727620|NCT04015518|42172294|FG000|Overall Study|Prostate carcinoma|1|||
19727621|NCT04015518|42172295|FG001|Overall Study|Prostate carcinoma|0|||
19727622|NCT04015518|42172296|FG002|Overall Study|Prostate carcinoma|0|||
19727623|NCT04015518|42172297|FG003|Overall Study|Prostate carcinoma|0|||
19727624|NCT04015518|42172298|FG004|Overall Study|Prostate carcinoma|0|||
19727625|NCT04015518|42172294|FG000|Overall Study|Could not keep appointments due to work|1|||
19727626|NCT04015518|42172295|FG001|Overall Study|Could not keep appointments due to work|0|||
19727627|NCT04015518|42172296|FG002|Overall Study|Could not keep appointments due to work|0|||
19727628|NCT04015518|42172297|FG003|Overall Study|Could not keep appointments due to work|0|||
19727629|NCT04015518|42172298|FG004|Overall Study|Could not keep appointments due to work|0|||
19727630|NCT03577730|42172315|FG000|Overall Study|Physician Decision|3|||
19727631|NCT03577730|42172316|FG001|Overall Study|Physician Decision|1|||
19727632|NCT03577730|42172315|FG000|Overall Study|Did not receive allocated intervention|1|||
19727633|NCT03577730|42172316|FG001|Overall Study|Did not receive allocated intervention|0|||
19727634|NCT03608774|42172324|FG000|Overall Study|Lost to Follow-up|5|||
19727635|NCT03608774|42172325|FG001|Overall Study|Lost to Follow-up|5|||
19727636|NCT03608774|42172324|FG000|Overall Study|Withdrawal by Subject|1|||
19727637|NCT03608774|42172325|FG001|Overall Study|Withdrawal by Subject|0|||
19727638|NCT03608774|42172324|FG000|Overall Study|Protocol Violation|1|||
19727639|NCT03608774|42172325|FG001|Overall Study|Protocol Violation|0|||
19727640|NCT03608774|42172324|FG000|Overall Study|Not eligible at enrollment|0|||
19727641|NCT03608774|42172325|FG001|Overall Study|Not eligible at enrollment|1|||
19727642|NCT03608774|42172324|FG000|Overall Study|Health related event|0|||
19727643|NCT03608774|42172325|FG001|Overall Study|Health related event|1|||
19727644|NCT04021524|42172333|FG000|Overall Study|Change in surgical intervention|0|||
19727645|NCT04021524|42172334|FG001|Overall Study|Change in surgical intervention|1|||
19727646|NCT03607682|42172340|FG000|Overall Study|Withdrawal by Subject|1|||
19727647|NCT03607682|42172340|FG000|Overall Study|Disease progression|1|||
19727648|NCT03606668|42172344|FG000|Overall Study|Screen Failure|1|||
19727649|NCT03606668|42172344|FG000|Overall Study|Lost to Follow-up|1|||
19727650|NCT03601052|42172348|FG000|Overall Study|Lost to Follow-up|2|||
19727651|NCT03600740|42172357|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
19727652|NCT03600428|42172363|FG000|Overall Study|Not eligible|0|||
19727653|NCT03600428|42172364|FG001|Overall Study|Not eligible|1|||
19727654|NCT03600428|42172363|FG000|Overall Study|Lost to Follow-up|5|||
19727655|NCT03600428|42172364|FG001|Overall Study|Lost to Follow-up|4|||
19727656|NCT03575702|42172372|FG000|Overall Study|Withdrawal by Subject|1|||
19380698|NCT04794803|41623984|FG001|Overall Study|Physician Decision|1|||
19380699|NCT04794803|41623983|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
19465216|NCT04426695|41723746|FG005|Overall Study|Lost to Follow-up|14|||
19465217|NCT04426695|41723747|FG006|Overall Study|Lost to Follow-up|5|||
19727657|NCT03575702|42172373|FG001|Overall Study|Withdrawal by Subject|1|||
19727658|NCT03575702|42172372|FG000|Overall Study|Lost to Follow-up|1|||
19727659|NCT03575702|42172373|FG001|Overall Study|Lost to Follow-up|2|||
19727660|NCT03575702|42172372|FG000|Overall Study|Protocol Violation|0|||
19727661|NCT03575702|42172373|FG001|Overall Study|Protocol Violation|1|||
19727662|NCT03575702|42172372|FG000|Overall Study|Patient non compliance|4|||
19727663|NCT03575702|42172373|FG001|Overall Study|Patient non compliance|0|||
19727664|NCT03575468|42172381|FG000|Overall Study|Withdrawal by Subject|3|||
19727665|NCT03575468|42172382|FG001|Overall Study|Withdrawal by Subject|0|||
19727666|NCT03575468|42172381|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
19465218|NCT04426695|41723748|FG007|Overall Study|Lost to Follow-up|14|||
19727667|NCT03575468|42172382|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
19727668|NCT03575468|42172381|FG000|Overall Study|Lost to Follow-up|13|||
19727669|NCT03575468|42172382|FG001|Overall Study|Lost to Follow-up|17|||
19727670|NCT03573908|42172390|FG000|Treatment Period|Adverse Event|4|||
19727671|NCT03573908|42172391|FG001|Treatment Period|Adverse Event|9|||
19727672|NCT03573908|42172392|FG002|Treatment Period|Adverse Event|0|||
19727673|NCT03573908|42172393|FG003|Treatment Period|Adverse Event|0|||
19727674|NCT03573908|42172394|FG004|Treatment Period|Adverse Event|0|||
19727675|NCT03573908|42172390|FG000|Treatment Period|Protocol Violation|1|||
19727676|NCT03573908|42172391|FG001|Treatment Period|Protocol Violation|0|||
19727677|NCT03573908|42172392|FG002|Treatment Period|Protocol Violation|0|||
19727678|NCT03573908|42172393|FG003|Treatment Period|Protocol Violation|0|||
19727679|NCT03573908|42172394|FG004|Treatment Period|Protocol Violation|0|||
19727680|NCT03573908|42172390|FG000|Treatment Period|Withdrawal by Subject|7|||
19727681|NCT03573908|42172391|FG001|Treatment Period|Withdrawal by Subject|5|||
19727682|NCT03573908|42172392|FG002|Treatment Period|Withdrawal by Subject|0|||
19727683|NCT03573908|42172393|FG003|Treatment Period|Withdrawal by Subject|0|||
19727684|NCT03573908|42172394|FG004|Treatment Period|Withdrawal by Subject|0|||
19727685|NCT03573908|42172390|FG000|Treatment Period|Lost to Follow-up|7|||
19727686|NCT03573908|42172391|FG001|Treatment Period|Lost to Follow-up|6|||
19727687|NCT03573908|42172392|FG002|Treatment Period|Lost to Follow-up|0|||
19727688|NCT03573908|42172393|FG003|Treatment Period|Lost to Follow-up|0|||
19727689|NCT03573908|42172394|FG004|Treatment Period|Lost to Follow-up|0|||
19727690|NCT03573908|42172390|FG000|Treatment Period|Pregnancy|1|||
19727691|NCT03573908|42172391|FG001|Treatment Period|Pregnancy|0|||
19727692|NCT03573908|42172392|FG002|Treatment Period|Pregnancy|0|||
19727693|NCT03573908|42172393|FG003|Treatment Period|Pregnancy|0|||
19727694|NCT03573908|42172394|FG004|Treatment Period|Pregnancy|0|||
19727695|NCT03573908|42172390|FG000|Treatment Period|Other, Not Specified|4|||
19727696|NCT03573908|42172391|FG001|Treatment Period|Other, Not Specified|6|||
19727697|NCT03573908|42172392|FG002|Treatment Period|Other, Not Specified|0|||
19727698|NCT03573908|42172393|FG003|Treatment Period|Other, Not Specified|0|||
19727699|NCT03573908|42172394|FG004|Treatment Period|Other, Not Specified|0|||
19727700|NCT03573908|42172390|FG000|Randomized Withdrawal Period|Adverse Event|0|||
19727701|NCT03573908|42172391|FG001|Randomized Withdrawal Period|Adverse Event|0|||
19727702|NCT03573908|42172392|FG002|Randomized Withdrawal Period|Adverse Event|3|||
19727703|NCT03573908|42172393|FG003|Randomized Withdrawal Period|Adverse Event|0|||
19727704|NCT03573908|42172394|FG004|Randomized Withdrawal Period|Adverse Event|0|||
19727705|NCT03573908|42172390|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19727706|NCT03573908|42172391|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19727707|NCT03573908|42172392|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19727708|NCT03573908|42172393|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19727709|NCT03573908|42172394|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
19727710|NCT03573908|42172390|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
19727711|NCT03573908|42172391|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
19727712|NCT03573908|42172392|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
19727713|NCT03573908|42172393|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
19727714|NCT03573908|42172394|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
19727715|NCT03573908|42172390|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
19727716|NCT03573908|42172391|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
19727717|NCT03573908|42172392|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
19727718|NCT03573908|42172393|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
19727719|NCT03573908|42172394|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
19727720|NCT03573830|42172405|FG000|Overall Study|Dropped without completing treatment|0|||
19727721|NCT03573830|42172406|FG001|Overall Study|Dropped without completing treatment|7|||
19727722|NCT03573830|42172405|FG000|Overall Study|Lost to Follow-up|4|||
19727723|NCT03573830|42172406|FG001|Overall Study|Lost to Follow-up|0|||
19727724|NCT03595904|42172413|FG000|Overall Study|Protocol Violation|3|||
19727725|NCT03595904|42172414|FG001|Overall Study|Protocol Violation|1|||
19727726|NCT03595904|42172413|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
19727727|NCT03595904|42172414|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
19727728|NCT03595904|42172413|FG000|Overall Study|Insurance complications|1|||
19727729|NCT03595904|42172414|FG001|Overall Study|Insurance complications|0|||
19727730|NCT03595904|42172413|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
19727731|NCT03595904|42172414|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
19727732|NCT03595280|42172423|FG000|Overall Study|Lost to Follow-up|6|||
19727733|NCT03595280|42172424|FG001|Overall Study|Lost to Follow-up|9|||
19727734|NCT03595280|42172425|FG002|Overall Study|Lost to Follow-up|15|||
19727735|NCT03593876|42172433|FG000|Overall Study|Withdrawal by Subject|1|||
19727736|NCT03593876|42172433|FG000|Overall Study|Discharged home before intervention completion|2|||
19727737|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Adverse Event|5|||
19727738|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Adverse Event|8|||
19727739|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Adverse Event|4|||
19727740|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Adverse Event|8|||
19727741|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
19727742|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
19727743|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
19727744|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
19727745|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
19727746|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
19727747|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
19727748|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
19727749|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Physician Decision|1|||
19727750|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Physician Decision|0|||
19727751|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Physician Decision|0|||
19727752|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Physician Decision|0|||
19727753|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
19727754|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
19727755|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
19727756|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
19727757|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Pregnancy|0|||
19727758|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Pregnancy|1|||
19727759|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Pregnancy|0|||
19380700|NCT04794803|41623984|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
19380701|NCT04794803|41623983|FG000|Overall Study|Refused to continue the treatment|1|||
19380702|NCT04794803|41623984|FG001|Overall Study|Refused to continue the treatment|0|||
19465219|NCT04426695|41723749|FG008|Overall Study|Lost to Follow-up|10|||
19465220|NCT04426695|41723750|FG009|Overall Study|Lost to Follow-up|11|||
19727760|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Pregnancy|0|||
19380703|NCT04794803|41623983|FG000|Overall Study|Patient admitted to ICU|0|||
19380704|NCT04794803|41623984|FG001|Overall Study|Patient admitted to ICU|1|||
19380705|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
19380706|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380707|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380708|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380709|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380710|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380711|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
19380712|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
19380713|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380714|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380715|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380716|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380717|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380718|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
19380719|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19465221|NCT04426695|41723751|FG010|Overall Study|Lost to Follow-up|12|||
19465222|NCT04426695|41723752|FG011|Overall Study|Lost to Follow-up|6|||
19727761|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
19727762|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
19727763|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
19727764|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
19727765|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Death|0|||
19727766|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Death|1|||
19727767|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Death|0|||
19727768|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Death|0|||
19727769|NCT00071487|42172441|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
19727770|NCT00071487|42172442|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
19727771|NCT00071487|42172443|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
19727772|NCT00071487|42172444|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
19727773|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
19727774|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
19727775|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
19727776|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
19727777|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19727778|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19727779|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19727780|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
19727781|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19727782|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19727783|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19727784|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
19727785|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
19727786|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
19727787|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
19727788|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
19727789|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19727790|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19727791|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19727792|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
19727793|NCT00071487|42172441|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
19727794|NCT00071487|42172442|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
19727795|NCT00071487|42172443|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
19727796|NCT00071487|42172444|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
19727797|NCT03591146|42172461|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
19727798|NCT03591146|42172462|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
19727799|NCT03591146|42172463|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
19727800|NCT03591146|42172464|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
19727801|NCT03591146|42172465|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
19727802|NCT03591146|42172461|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
19727803|NCT03591146|42172462|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
19727804|NCT03591146|42172463|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
19727805|NCT03591146|42172464|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
19727806|NCT03591146|42172465|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
19727807|NCT03591146|42172461|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
19727808|NCT03591146|42172462|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
19727809|NCT03591146|42172463|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
19727810|NCT03591146|42172464|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
19727811|NCT03591146|42172465|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
19727812|NCT03591146|42172461|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
19727813|NCT03591146|42172462|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
19727814|NCT03591146|42172463|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
19727815|NCT03591146|42172464|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
19727816|NCT03591146|42172465|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
19727817|NCT00096447|42172477|FG000|Overall Study|Never treated|1|||
19727818|NCT03590366|42172488|FG000|Overall Study|Adverse Event|0|||
19727819|NCT03590366|42172489|FG001|Overall Study|Adverse Event|3|||
19727820|NCT03590366|42172488|FG000|Overall Study|Lost to Follow-up|3|||
19727821|NCT03590366|42172489|FG001|Overall Study|Lost to Follow-up|3|||
19727822|NCT03590366|42172488|FG000|Overall Study|Withdrawal by Subject|0|||
19727823|NCT03590366|42172489|FG001|Overall Study|Withdrawal by Subject|2|||
19727824|NCT03588572|42172497|FG000|Visitation 1|Lack of Efficacy|1|||
19727825|NCT03588572|42172498|FG001|Visitation 1|Lack of Efficacy|1|||
19727826|NCT03588572|42172497|FG000|Visitation 2|Lost to Follow-up|1|||
19727827|NCT03588572|42172498|FG001|Visitation 2|Lost to Follow-up|1|||
19727828|NCT03588572|42172497|FG000|Visitation 2|Lack of Efficacy|0|||
19727829|NCT03588572|42172498|FG001|Visitation 2|Lack of Efficacy|1|||
19727830|NCT03588572|42172497|FG000|Visitation 2|Withdrawal by Subject|1|||
19727831|NCT03588572|42172498|FG001|Visitation 2|Withdrawal by Subject|0|||
19727832|NCT03588572|42172497|FG000|Visitation 3|Lost to Follow-up|1|||
19727833|NCT03588572|42172498|FG001|Visitation 3|Lost to Follow-up|1|||
19727834|NCT03588572|42172497|FG000|Visitation 3|Physician Decision|1|||
19727835|NCT03588572|42172498|FG001|Visitation 3|Physician Decision|1|||
19727836|NCT03588572|42172497|FG000|Visitation 3|Withdrawal by Subject|1|||
19727837|NCT03588572|42172498|FG001|Visitation 3|Withdrawal by Subject|0|||
19727838|NCT00090285|42172506|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
19727839|NCT00090285|42172507|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
19727840|NCT00090285|42172508|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19727841|NCT00090285|42172509|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19727842|NCT00090285|42172510|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19727843|NCT00090285|42172511|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19727844|NCT00090285|42172506|FG000|Base Study Vaccination Period|Adverse Event|2|||
19727845|NCT00090285|42172507|FG001|Base Study Vaccination Period|Adverse Event|4|||
19727846|NCT00090285|42172508|FG002|Base Study Vaccination Period|Adverse Event|0|||
19380720|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
19380721|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19380722|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19380723|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19380724|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19380725|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
19380726|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380727|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380728|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
19380729|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380730|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380731|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380732|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
19380733|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380734|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380735|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
19380736|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380737|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380738|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380739|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
19380740|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380741|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380742|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
19727847|NCT00090285|42172509|FG003|Base Study Vaccination Period|Adverse Event|0|||
19727848|NCT00090285|42172510|FG004|Base Study Vaccination Period|Adverse Event|0|||
19727849|NCT00090285|42172511|FG005|Base Study Vaccination Period|Adverse Event|0|||
19727850|NCT00090285|42172506|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
19727851|NCT00090285|42172507|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
19727852|NCT00090285|42172508|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
19727853|NCT00090285|42172509|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
19727854|NCT00090285|42172510|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
19727855|NCT00090285|42172511|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
19727856|NCT00090285|42172506|FG000|Base Study Vaccination Period|Protocol Violation|2|||
19727857|NCT00090285|42172507|FG001|Base Study Vaccination Period|Protocol Violation|3|||
19727858|NCT00090285|42172508|FG002|Base Study Vaccination Period|Protocol Violation|0|||
19727859|NCT00090285|42172509|FG003|Base Study Vaccination Period|Protocol Violation|0|||
19727860|NCT00090285|42172510|FG004|Base Study Vaccination Period|Protocol Violation|0|||
19727861|NCT00090285|42172511|FG005|Base Study Vaccination Period|Protocol Violation|0|||
19727862|NCT00090285|42172506|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
19727863|NCT00090285|42172507|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
19727864|NCT00090285|42172508|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
19727865|NCT00090285|42172509|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
19727866|NCT00090285|42172510|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
19727867|NCT00090285|42172511|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
19727868|NCT00090285|42172506|FG000|Base Study Vaccination Period|Uncooperative|2|||
19727869|NCT00090285|42172507|FG001|Base Study Vaccination Period|Uncooperative|2|||
19380743|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380744|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380745|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380746|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
19380747|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19727870|NCT00090285|42172508|FG002|Base Study Vaccination Period|Uncooperative|0|||
19727871|NCT00090285|42172509|FG003|Base Study Vaccination Period|Uncooperative|0|||
19727872|NCT00090285|42172510|FG004|Base Study Vaccination Period|Uncooperative|0|||
19380748|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19380749|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19380750|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
19380751|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19380752|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19380753|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
19380754|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380755|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380756|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380757|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
19380758|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380759|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380760|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
19380761|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19380762|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19380763|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19727873|NCT00090285|42172511|FG005|Base Study Vaccination Period|Uncooperative|0|||
19727874|NCT00090285|42172506|FG000|Base Study Vaccination Period|Moved|20|||
19727875|NCT00090285|42172507|FG001|Base Study Vaccination Period|Moved|21|||
19727876|NCT00090285|42172508|FG002|Base Study Vaccination Period|Moved|0|||
19727877|NCT00090285|42172509|FG003|Base Study Vaccination Period|Moved|0|||
19727878|NCT00090285|42172510|FG004|Base Study Vaccination Period|Moved|0|||
19727879|NCT00090285|42172511|FG005|Base Study Vaccination Period|Moved|0|||
19727880|NCT00090285|42172506|FG000|Base Study Vaccination Period|Site Terminated|1|||
19727881|NCT00090285|42172507|FG001|Base Study Vaccination Period|Site Terminated|0|||
19727882|NCT00090285|42172508|FG002|Base Study Vaccination Period|Site Terminated|0|||
19727883|NCT00090285|42172509|FG003|Base Study Vaccination Period|Site Terminated|0|||
19727884|NCT00090285|42172510|FG004|Base Study Vaccination Period|Site Terminated|0|||
19727885|NCT00090285|42172511|FG005|Base Study Vaccination Period|Site Terminated|0|||
19727886|NCT00090285|42172506|FG000|Base Study Vaccination Period|Other|2|||
19727887|NCT00090285|42172507|FG001|Base Study Vaccination Period|Other|2|||
19727888|NCT00090285|42172508|FG002|Base Study Vaccination Period|Other|0|||
19727889|NCT00090285|42172509|FG003|Base Study Vaccination Period|Other|0|||
19727890|NCT00090285|42172510|FG004|Base Study Vaccination Period|Other|0|||
19727891|NCT00090285|42172511|FG005|Base Study Vaccination Period|Other|0|||
19727892|NCT00090285|42172506|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
19727893|NCT00090285|42172507|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
19727894|NCT00090285|42172508|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
19727895|NCT00090285|42172509|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
19727896|NCT00090285|42172510|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
19727897|NCT00090285|42172511|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
19727898|NCT00090285|42172506|FG000|Base Study Vaccination Period|HIV positive|1|||
19727899|NCT00090285|42172507|FG001|Base Study Vaccination Period|HIV positive|1|||
19727900|NCT00090285|42172508|FG002|Base Study Vaccination Period|HIV positive|0|||
19727901|NCT00090285|42172509|FG003|Base Study Vaccination Period|HIV positive|0|||
19727902|NCT00090285|42172510|FG004|Base Study Vaccination Period|HIV positive|0|||
19727903|NCT00090285|42172511|FG005|Base Study Vaccination Period|HIV positive|0|||
19727904|NCT00090285|42172506|FG000|Base Study Follow-up Period|Adverse Event|3|||
19727905|NCT00090285|42172507|FG001|Base Study Follow-up Period|Adverse Event|10|||
19727906|NCT00090285|42172508|FG002|Base Study Follow-up Period|Adverse Event|0|||
19727907|NCT00090285|42172509|FG003|Base Study Follow-up Period|Adverse Event|0|||
19727908|NCT00090285|42172510|FG004|Base Study Follow-up Period|Adverse Event|0|||
19727909|NCT00090285|42172511|FG005|Base Study Follow-up Period|Adverse Event|0|||
19727910|NCT00090285|42172506|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
19727911|NCT00090285|42172507|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
19727912|NCT00090285|42172508|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
19380764|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19727913|NCT00090285|42172509|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
19727914|NCT00090285|42172510|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
19727915|NCT00090285|42172511|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
19727916|NCT00090285|42172506|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
19727917|NCT00090285|42172507|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
19727918|NCT00090285|42172508|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
19727919|NCT00090285|42172509|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
19727920|NCT00090285|42172510|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
19727921|NCT00090285|42172511|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
19727922|NCT00090285|42172506|FG000|Base Study Follow-up Period|Moved|41|||
19465223|NCT04426695|41723753|FG012|Overall Study|Lost to Follow-up|2|||
19465224|NCT04426695|41723754|FG013|Overall Study|Lost to Follow-up|2|||
19727923|NCT00090285|42172507|FG001|Base Study Follow-up Period|Moved|36|||
19727924|NCT00090285|42172508|FG002|Base Study Follow-up Period|Moved|0|||
19727925|NCT00090285|42172509|FG003|Base Study Follow-up Period|Moved|0|||
19727926|NCT00090285|42172510|FG004|Base Study Follow-up Period|Moved|0|||
19727927|NCT00090285|42172511|FG005|Base Study Follow-up Period|Moved|0|||
19727928|NCT00090285|42172506|FG000|Base Study Follow-up Period|Other|2|||
19727929|NCT00090285|42172507|FG001|Base Study Follow-up Period|Other|0|||
19727930|NCT00090285|42172508|FG002|Base Study Follow-up Period|Other|0|||
19727931|NCT00090285|42172509|FG003|Base Study Follow-up Period|Other|0|||
19727932|NCT00090285|42172510|FG004|Base Study Follow-up Period|Other|0|||
19727933|NCT00090285|42172511|FG005|Base Study Follow-up Period|Other|0|||
19727934|NCT00090285|42172506|FG000|Base Study Follow-up Period|Protocol Violation|1|||
19727935|NCT00090285|42172507|FG001|Base Study Follow-up Period|Protocol Violation|0|||
19727936|NCT00090285|42172508|FG002|Base Study Follow-up Period|Protocol Violation|0|||
19727937|NCT00090285|42172509|FG003|Base Study Follow-up Period|Protocol Violation|0|||
19727938|NCT00090285|42172510|FG004|Base Study Follow-up Period|Protocol Violation|0|||
19727939|NCT00090285|42172511|FG005|Base Study Follow-up Period|Protocol Violation|0|||
19727940|NCT00090285|42172506|FG000|Base Study Follow-up Period|Uncooperative|3|||
19727941|NCT00090285|42172507|FG001|Base Study Follow-up Period|Uncooperative|4|||
19727942|NCT00090285|42172508|FG002|Base Study Follow-up Period|Uncooperative|0|||
19727943|NCT00090285|42172509|FG003|Base Study Follow-up Period|Uncooperative|0|||
19727944|NCT00090285|42172510|FG004|Base Study Follow-up Period|Uncooperative|0|||
19727945|NCT00090285|42172511|FG005|Base Study Follow-up Period|Uncooperative|0|||
19727946|NCT00090285|42172506|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
19727947|NCT00090285|42172507|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
19727948|NCT00090285|42172508|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
19727949|NCT00090285|42172509|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
19727950|NCT00090285|42172510|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
19727951|NCT00090285|42172511|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
19727952|NCT00090285|42172506|FG000|Extension 1|Adverse Event|0|||
19727953|NCT00090285|42172507|FG001|Extension 1|Adverse Event|0|||
19727954|NCT00090285|42172508|FG002|Extension 1|Adverse Event|2|||
19727955|NCT00090285|42172509|FG003|Extension 1|Adverse Event|0|||
19727956|NCT00090285|42172510|FG004|Extension 1|Adverse Event|0|||
19727957|NCT00090285|42172511|FG005|Extension 1|Adverse Event|0|||
19727958|NCT00090285|42172506|FG000|Extension 1|Lost to Follow-up|0|||
19727959|NCT00090285|42172507|FG001|Extension 1|Lost to Follow-up|0|||
19727960|NCT00090285|42172508|FG002|Extension 1|Lost to Follow-up|35|||
19727961|NCT00090285|42172509|FG003|Extension 1|Lost to Follow-up|0|||
19727962|NCT00090285|42172510|FG004|Extension 1|Lost to Follow-up|0|||
19727963|NCT00090285|42172511|FG005|Extension 1|Lost to Follow-up|0|||
19727964|NCT00090285|42172506|FG000|Extension 1|Withdrawal by Subject|0|||
19727965|NCT00090285|42172507|FG001|Extension 1|Withdrawal by Subject|0|||
19727966|NCT00090285|42172508|FG002|Extension 1|Withdrawal by Subject|13|||
19727967|NCT00090285|42172509|FG003|Extension 1|Withdrawal by Subject|1|||
19727968|NCT00090285|42172510|FG004|Extension 1|Withdrawal by Subject|0|||
19727969|NCT00090285|42172511|FG005|Extension 1|Withdrawal by Subject|0|||
19727970|NCT00090285|42172506|FG000|Extension 1|Other|0|||
19727971|NCT00090285|42172507|FG001|Extension 1|Other|0|||
19727972|NCT00090285|42172508|FG002|Extension 1|Other|4|||
19727973|NCT00090285|42172509|FG003|Extension 1|Other|0|||
19727974|NCT00090285|42172510|FG004|Extension 1|Other|0|||
19727975|NCT00090285|42172511|FG005|Extension 1|Other|0|||
19727976|NCT00090285|42172506|FG000|Extension 1|Moved|0|||
19727977|NCT00090285|42172507|FG001|Extension 1|Moved|0|||
19727978|NCT00090285|42172508|FG002|Extension 1|Moved|3|||
19727979|NCT00090285|42172509|FG003|Extension 1|Moved|0|||
19727980|NCT00090285|42172510|FG004|Extension 1|Moved|0|||
19727981|NCT00090285|42172511|FG005|Extension 1|Moved|0|||
19727982|NCT00090285|42172506|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
19727983|NCT00090285|42172507|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
19727984|NCT00090285|42172508|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
19727985|NCT00090285|42172509|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
19727986|NCT00090285|42172510|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
19727987|NCT00090285|42172511|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
19727988|NCT00090285|42172506|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19727989|NCT00090285|42172507|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19727990|NCT00090285|42172508|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19727991|NCT00090285|42172509|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19727992|NCT00090285|42172510|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
19727993|NCT00090285|42172511|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
19727994|NCT00090285|42172506|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19727995|NCT00090285|42172507|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19727996|NCT00090285|42172508|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19727997|NCT00090285|42172509|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19727998|NCT00090285|42172510|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
19727999|NCT00090285|42172511|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
19728000|NCT00090285|42172506|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
19728001|NCT00090285|42172507|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
19728002|NCT00090285|42172508|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
19728003|NCT00090285|42172509|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
19728004|NCT00090285|42172510|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
19728005|NCT00090285|42172511|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
19728006|NCT00070941|42172529|FG000|Overall Study|Adverse Event|10|||
19728007|NCT00070941|42172530|FG001|Overall Study|Adverse Event|8|||
19728008|NCT00070941|42172531|FG002|Overall Study|Adverse Event|4|||
19728009|NCT00070707|42172541|FG000|Overall Study|Adverse Event|1|||
19728010|NCT00070707|42172542|FG001|Overall Study|Adverse Event|2|||
19728011|NCT00070707|42172541|FG000|Overall Study|Lack of Efficacy|4|||
19728012|NCT00070707|42172542|FG001|Overall Study|Lack of Efficacy|1|||
19728013|NCT00070707|42172541|FG000|Overall Study|Protocol Violation|8|||
19728014|NCT00070707|42172542|FG001|Overall Study|Protocol Violation|4|||
19728015|NCT00070707|42172541|FG000|Overall Study|Unrelated to Study Medication|1|||
19728016|NCT00070707|42172542|FG001|Overall Study|Unrelated to Study Medication|0|||
19728017|NCT03036124|42172550|FG000|Overall Study|Lost to Follow-up|0|||
19728018|NCT03036124|42172551|FG001|Overall Study|Lost to Follow-up|2|||
19728019|NCT03036124|42172550|FG000|Overall Study|Withdrawal by Subject|5|||
19728020|NCT03036124|42172551|FG001|Overall Study|Withdrawal by Subject|4|||
19728021|NCT00070317|42172557|FG000|Overall Study|Inevaluable (Never Treated)|1|||
19728022|NCT00070317|42172557|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
19728023|NCT00070317|42172557|FG000|Overall Study|Ineligible required test not done|1|||
19728024|NCT00070317|42172557|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
19728025|NCT00070317|42172557|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
19728026|NCT03649412|42172563|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
19728027|NCT03649412|42172564|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
19728028|NCT03649412|42172563|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
19728029|NCT03649412|42172564|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
19728030|NCT03649412|42172563|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
19728031|NCT03649412|42172564|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19728032|NCT03649412|42172563|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
19728033|NCT03649412|42172564|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
19728034|NCT03649412|42172563|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
19728035|NCT03649412|42172564|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
19728036|NCT03649412|42172563|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
19728037|NCT03649412|42172564|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
19728038|NCT03587636|42172609|FG000|Overall Study|Lost to Follow-up|2|||
19728039|NCT03587636|42172610|FG001|Overall Study|Lost to Follow-up|5|||
19728040|NCT04021290|42172628|FG000|Overall Study|Adverse Event|4|||
19728041|NCT04021290|42172629|FG001|Overall Study|Adverse Event|3|||
19728042|NCT04021290|42172628|FG000|Overall Study|Lack of Efficacy|0|||
19728043|NCT04021290|42172629|FG001|Overall Study|Lack of Efficacy|3|||
19728044|NCT04021290|42172628|FG000|Overall Study|Lost to Follow-up|2|||
19728045|NCT04021290|42172629|FG001|Overall Study|Lost to Follow-up|1|||
19728046|NCT04021290|42172628|FG000|Overall Study|Death|1|||
19728047|NCT04021290|42172629|FG001|Overall Study|Death|0|||
19728048|NCT04021290|42172628|FG000|Overall Study|Physician Decision|1|||
19728049|NCT04021290|42172629|FG001|Overall Study|Physician Decision|2|||
19728050|NCT04021290|42172628|FG000|Overall Study|Withdrawal by Subject|1|||
19728051|NCT04021290|42172629|FG001|Overall Study|Withdrawal by Subject|5|||
19728052|NCT04021290|42172628|FG000|Overall Study|Ongoing|89|||
19728053|NCT04021290|42172629|FG001|Overall Study|Ongoing|0|||
19728054|NCT04021290|42172628|FG000|Overall Study|Protocol Deviation|5|||
19728055|NCT04021290|42172629|FG001|Overall Study|Protocol Deviation|4|||
19728056|NCT03586544|42172637|FG000|First Intervention|Adverse Event|0|||
19728057|NCT03586544|42172638|FG001|First Intervention|Adverse Event|1|||
19728058|NCT03586544|42172637|FG000|Second Intervention|Withdrawal by Subject|0|||
19728059|NCT03586544|42172638|FG001|Second Intervention|Withdrawal by Subject|1|||
19728060|NCT03585296|42172644|FG000|Overall Study|Adverse Event|1|||
19728061|NCT03585296|42172644|FG000|Overall Study|Lost to Follow-up|2|||
19728062|NCT03585296|42172644|FG000|Overall Study|Withdrawal by Subject|2|||
19728063|NCT03589768|42172652|FG000|Overall Study|Death|1|||
19728064|NCT03589768|42172653|FG001|Overall Study|Death|0|||
19728065|NCT03589768|42172654|FG002|Overall Study|Death|8|||
19728066|NCT03589768|42172655|FG003|Overall Study|Death|3|||
19728067|NCT03589768|42172652|FG000|Overall Study|Withdrawal by Subject|2|||
19728068|NCT03589768|42172653|FG001|Overall Study|Withdrawal by Subject|0|||
19728069|NCT03589768|42172654|FG002|Overall Study|Withdrawal by Subject|0|||
19728070|NCT03589768|42172655|FG003|Overall Study|Withdrawal by Subject|0|||
19728071|NCT03589768|42172652|FG000|Overall Study|Protocol Violation|1|||
19728072|NCT03589768|42172653|FG001|Overall Study|Protocol Violation|0|||
19728073|NCT03589768|42172654|FG002|Overall Study|Protocol Violation|0|||
19728074|NCT03589768|42172655|FG003|Overall Study|Protocol Violation|0|||
19728075|NCT02892422|42172665|FG000|Overall Study|Enrolled not treated|4|||
19728076|NCT02892422|42172665|FG000|Overall Study|Adverse Event|38|||
19728077|NCT02892422|42172665|FG000|Overall Study|Lack of Efficacy|32|||
19728078|NCT02892422|42172665|FG000|Overall Study|Non-compliance with study drug|11|||
19728079|NCT02892422|42172665|FG000|Overall Study|Protocol Violation|4|||
19728080|NCT02892422|42172665|FG000|Overall Study|Withdrawal by Subject|56|||
19728081|NCT02892422|42172665|FG000|Overall Study|Lost to Follow-up|5|||
19728082|NCT02892422|42172665|FG000|Overall Study|sponsor information 16159A results|21|||
19728083|NCT02892422|42172665|FG000|Overall Study|withdrawal of consent|13|||
19728084|NCT02892422|42172665|FG000|Overall Study|exclusion criteria met|3|||
19728085|NCT02892422|42172665|FG000|Overall Study|moving elsewhere|4|||
19728086|NCT02892422|42172665|FG000|Overall Study|non-compliance|10|||
19728087|NCT02892422|42172665|FG000|Overall Study|patient legally incapable|1|||
19728088|NCT02892422|42172665|FG000|Overall Study|patient decision|7|||
19728089|NCT02892422|42172665|FG000|Overall Study|Investigator decision|1|||
19728090|NCT03571646|42172671|FG000|Overall Study|Adverse Event|1|||
19728091|NCT03571646|42172672|FG001|Overall Study|Adverse Event|0|||
19728092|NCT03571646|42172671|FG000|Overall Study|Withdrawal by Subject|1|||
19728093|NCT03571646|42172672|FG001|Overall Study|Withdrawal by Subject|1|||
19728094|NCT03645434|42172678|FG000|Period 1|Adverse Event|0|||
19728095|NCT03645434|42172679|FG001|Period 1|Adverse Event|0|||
19728096|NCT03645434|42172680|FG002|Period 1|Adverse Event|0|||
19728097|NCT03645434|42172681|FG003|Period 1|Adverse Event|1|||
19728098|NCT03645434|42172682|FG004|Period 1|Adverse Event|0|||
19728099|NCT03645434|42172683|FG005|Period 1|Adverse Event|0|||
19728100|NCT03645434|42172678|FG000|Period 1|COPD exacerbation|0|||
19728101|NCT03645434|42172679|FG001|Period 1|COPD exacerbation|0|||
19728102|NCT03645434|42172680|FG002|Period 1|COPD exacerbation|0|||
19728103|NCT03645434|42172681|FG003|Period 1|COPD exacerbation|0|||
19728104|NCT03645434|42172682|FG004|Period 1|COPD exacerbation|1|||
19728105|NCT03645434|42172683|FG005|Period 1|COPD exacerbation|0|||
19728106|NCT00089505|42172695|FG000|Overall Study|Death|4|||
19728107|NCT00089505|42172696|FG001|Overall Study|Death|1|||
19728108|NCT00089505|42172697|FG002|Overall Study|Death|5|||
19728109|NCT00089505|42172698|FG003|Overall Study|Death|8|||
19728110|NCT00089505|42172695|FG000|Overall Study|Withdrawal by Subject|3|||
19728111|NCT00089505|42172696|FG001|Overall Study|Withdrawal by Subject|0|||
19728112|NCT00089505|42172697|FG002|Overall Study|Withdrawal by Subject|6|||
19728113|NCT00089505|42172698|FG003|Overall Study|Withdrawal by Subject|6|||
19728114|NCT00089505|42172695|FG000|Overall Study|Lost to Follow-up|1|||
19728115|NCT00089505|42172696|FG001|Overall Study|Lost to Follow-up|1|||
19728116|NCT00089505|42172697|FG002|Overall Study|Lost to Follow-up|9|||
19728117|NCT00089505|42172698|FG003|Overall Study|Lost to Follow-up|7|||
19728118|NCT00089505|42172695|FG000|Overall Study|Physician Decision|1|||
19728119|NCT00089505|42172696|FG001|Overall Study|Physician Decision|0|||
19728120|NCT00089505|42172697|FG002|Overall Study|Physician Decision|0|||
19728121|NCT00089505|42172698|FG003|Overall Study|Physician Decision|0|||
19728122|NCT00089505|42172695|FG000|Overall Study|Protocol Violation|0|||
19728123|NCT00089505|42172696|FG001|Overall Study|Protocol Violation|0|||
19728124|NCT00089505|42172697|FG002|Overall Study|Protocol Violation|1|||
19728125|NCT00089505|42172698|FG003|Overall Study|Protocol Violation|0|||
19728126|NCT04009824|42172713|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
19728127|NCT04009824|42172714|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
19728128|NCT04009824|42172715|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
19728129|NCT04009824|42172716|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
19728130|NCT04009824|42172717|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
19728131|NCT03555890|42172733|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19728132|NCT03555890|42172734|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19728133|NCT03555890|42172735|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19728134|NCT03555890|42172736|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
19728135|NCT03688074|42172748|FG000|Overall Study|Adverse Event|0|||
19728136|NCT03688074|42172749|FG001|Overall Study|Adverse Event|1|||
19728137|NCT03688074|42172748|FG000|Overall Study|Other|1|||
19728138|NCT03688074|42172749|FG001|Overall Study|Other|0|||
19728139|NCT03630120|42172759|FG000|Overall Study|Disease progression|0|||
19728140|NCT03630120|42172760|FG001|Overall Study|Disease progression|1|||
19728141|NCT03630120|42172761|FG002|Overall Study|Disease progression|1|||
19728142|NCT03630120|42172762|FG003|Overall Study|Disease progression|1|||
19728143|NCT03555266|42172774|FG000|Overall Study|Protocol Violation|6|||
19728144|NCT03555266|42172775|FG001|Overall Study|Protocol Violation|4|||
19728145|NCT03629886|42172783|FG000|Overall Study|Migrated / moved from the study area|0|||
19728146|NCT03629886|42172784|FG001|Overall Study|Migrated / moved from the study area|55|||
19728147|NCT03629886|42172783|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
19728148|NCT03629886|42172784|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
19728149|NCT03629886|42172783|FG000|Overall Study|Study vaccine not administrated|0|||
19728150|NCT03629886|42172784|FG001|Overall Study|Study vaccine not administrated|3|||
19728151|NCT03629886|42172783|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
19728152|NCT03629886|42172784|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
19728153|NCT03629886|42172783|FG000|Overall Study|Refused vaccination step of the study|0|||
19728154|NCT03629886|42172784|FG001|Overall Study|Refused vaccination step of the study|44|||
19728155|NCT03656874|42172793|FG000|Overall Study|Lost to Follow-up|3|||
19728156|NCT03656874|42172794|FG001|Overall Study|Lost to Follow-up|17|||
19728157|NCT03554486|42172802|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
19728158|NCT03554486|42172803|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
19728159|NCT03554486|42172804|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
19728160|NCT03554486|42172802|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
19728161|NCT03554486|42172803|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
19728162|NCT03554486|42172804|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
19728163|NCT03554486|42172802|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19728164|NCT03554486|42172803|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
19728165|NCT03554486|42172804|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
19728166|NCT03520036|42172814|FG000|Overall Study|Adverse Event|1|||
19728167|NCT03520036|42172815|FG001|Overall Study|Adverse Event|2|||
19728168|NCT03520036|42172816|FG002|Overall Study|Adverse Event|0|||
19728169|NCT03520036|42172814|FG000|Overall Study|Protocol Violation|1|||
19728170|NCT03520036|42172815|FG001|Overall Study|Protocol Violation|0|||
19728171|NCT03520036|42172816|FG002|Overall Study|Protocol Violation|0|||
19728172|NCT03520036|42172814|FG000|Overall Study|Withdrawal by Subject|0|||
19728173|NCT03520036|42172815|FG001|Overall Study|Withdrawal by Subject|1|||
19728174|NCT03520036|42172816|FG002|Overall Study|Withdrawal by Subject|4|||
19728175|NCT03520036|42172814|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
19728176|NCT03520036|42172815|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
19728177|NCT03520036|42172816|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
19728178|NCT03554018|42172826|FG000|Overall Study|Lost to Follow-up|3|||
19728179|NCT03554018|42172827|FG001|Overall Study|Lost to Follow-up|7|||
19728180|NCT03571256|42172836|FG000|Overall Study|Adverse Event|3|||
19728181|NCT03571256|42172837|FG001|Overall Study|Adverse Event|0|||
19728182|NCT03571256|42172838|FG002|Overall Study|Adverse Event|1|||
19728183|NCT03571256|42172836|FG000|Overall Study|Withdrawal by Subject|3|||
19728184|NCT03571256|42172837|FG001|Overall Study|Withdrawal by Subject|1|||
19728185|NCT03571256|42172838|FG002|Overall Study|Withdrawal by Subject|1|||
19728186|NCT03571256|42172836|FG000|Overall Study|Other than specified|0|||
19728187|NCT03571256|42172837|FG001|Overall Study|Other than specified|1|||
19728188|NCT03571256|42172838|FG002|Overall Study|Other than specified|1|||
19728189|NCT03571256|42172836|FG000|Overall Study|Protocol Violation|0|||
19728190|NCT03571256|42172837|FG001|Overall Study|Protocol Violation|1|||
19728191|NCT03571256|42172838|FG002|Overall Study|Protocol Violation|1|||
19728192|NCT03570554|42172852|FG000|Overall Study|Non-compliance with study drug|0|||
19728193|NCT03570554|42172853|FG001|Overall Study|Non-compliance with study drug|0|||
19728194|NCT03570554|42172854|FG002|Overall Study|Non-compliance with study drug|1|||
19728195|NCT03570554|42172855|FG003|Overall Study|Non-compliance with study drug|0|||
19728196|NCT03570554|42172852|FG000|Overall Study|Adverse Event|0|||
19728197|NCT03570554|42172853|FG001|Overall Study|Adverse Event|0|||
19728198|NCT03570554|42172854|FG002|Overall Study|Adverse Event|0|||
19728199|NCT03570554|42172855|FG003|Overall Study|Adverse Event|1|||
19728200|NCT04004208|42172867|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19728201|NCT04004208|42172868|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19728202|NCT04004208|42172867|FG000|Overall Study|Death|3|||
19728203|NCT04004208|42172868|FG001|Overall Study|Death|0|||
19728204|NCT04004208|42172867|FG000|Overall Study|COVID-19 pandemic|1|||
19728205|NCT04004208|42172868|FG001|Overall Study|COVID-19 pandemic|0|||
19728206|NCT04004208|42172867|FG000|Overall Study|Physician Decision|1|||
19728207|NCT04004208|42172868|FG001|Overall Study|Physician Decision|0|||
19728208|NCT04004208|42172867|FG000|Overall Study|Adverse Event|1|||
19728209|NCT04004208|42172868|FG001|Overall Study|Adverse Event|1|||
19728210|NCT03643952|42172874|FG000|Overall Study|Lack of Efficacy|1|||
19728211|NCT03035032|42172886|FG000|Overall Study|Adverse Event|2|||
19728212|NCT03035032|42172886|FG000|Overall Study|Death|9|||
19728213|NCT03035032|42172886|FG000|Overall Study|Lost to Follow-up|1|||
19728214|NCT03035032|42172886|FG000|Overall Study|Progressive Disease|22|||
19728215|NCT03035032|42172886|FG000|Overall Study|Protocol Violation|2|||
19728216|NCT03035032|42172886|FG000|Overall Study|Withdrawal by Subject|2|||
19728217|NCT03035032|42172886|FG000|Overall Study|Physician Decision|5|||
19728218|NCT03629184|42172892|FG000|Overall Study|Withdrawal by Subject|2|||
19728219|NCT03629184|42172893|FG001|Overall Study|Withdrawal by Subject|1|||
19728220|NCT03629184|42172892|FG000|Overall Study|Physician Decision|1|||
19728221|NCT03629184|42172893|FG001|Overall Study|Physician Decision|0|||
19728222|NCT03549338|42172911|FG000|Overall Study|Progressive Disease|1|||
19728223|NCT03549338|42172912|FG001|Overall Study|Progressive Disease|0|||
19728224|NCT03549338|42172913|FG002|Overall Study|Progressive Disease|0|||
19728225|NCT03549338|42172911|FG000|Overall Study|Clinical Progression|0|||
19728226|NCT03549338|42172912|FG001|Overall Study|Clinical Progression|1|||
19728227|NCT03549338|42172913|FG002|Overall Study|Clinical Progression|0|||
19728228|NCT03629028|42172921|FG000|Overall Study|Lost to Follow-up|26|||
19728229|NCT03629028|42172922|FG001|Overall Study|Lost to Follow-up|23|||
19728230|NCT03629028|42172921|FG000|Overall Study|Pregnancy|4|||
19728231|NCT03629028|42172922|FG001|Overall Study|Pregnancy|2|||
19728232|NCT03629028|42172921|FG000|Overall Study|intolerance to examination|2|||
19728233|NCT03629028|42172922|FG001|Overall Study|intolerance to examination|0|||
19728234|NCT03549104|42172940|FG000|Overall Study|Physician Decision|2|||
19728235|NCT03549104|42172941|FG001|Overall Study|Physician Decision|0|||
19728236|NCT03549104|42172940|FG000|Overall Study|Withdrawal by Subject|5|||
19728237|NCT03549104|42172941|FG001|Overall Study|Withdrawal by Subject|2|||
19728238|NCT03549104|42172940|FG000|Overall Study|Covid shelter in place|1|||
19728239|NCT03549104|42172941|FG001|Overall Study|Covid shelter in place|2|||
19728240|NCT02892344|42172949|FG000|Overall Study|Protocol deviation|3|||
19728241|NCT02892344|42172950|FG001|Overall Study|Protocol deviation|4|||
19728242|NCT02892344|42172949|FG000|Overall Study|Adverse Event|1|||
19728243|NCT02892344|42172950|FG001|Overall Study|Adverse Event|8|||
19728244|NCT02892344|42172949|FG000|Overall Study|Lost to Follow-up|0|||
19728245|NCT02892344|42172950|FG001|Overall Study|Lost to Follow-up|1|||
19728246|NCT02892344|42172949|FG000|Overall Study|Non-compliance with study treatment|0|||
19728247|NCT02892344|42172950|FG001|Overall Study|Non-compliance with study treatment|1|||
19728248|NCT02892344|42172949|FG000|Overall Study|Physician Decision|0|||
19728249|NCT02892344|42172950|FG001|Overall Study|Physician Decision|2|||
19728250|NCT02892344|42172949|FG000|Overall Study|Subject/guardian decision|0|||
19728251|NCT02892344|42172950|FG001|Overall Study|Subject/guardian decision|4|||
19728252|NCT02892344|42172949|FG000|Overall Study|Technical problems|0|||
19728253|NCT02892344|42172950|FG001|Overall Study|Technical problems|1|||
19728254|NCT03567980|42172956|FG000|Overall Study|Adverse Event|1|||
19728255|NCT02894840|42172964|FG000|Overall Study|Lost to Follow-up|1|||
19728256|NCT02894840|42172965|FG001|Overall Study|Lost to Follow-up|0|||
19728257|NCT02894840|42172966|FG002|Overall Study|Lost to Follow-up|3|||
19728258|NCT02894840|42172967|FG003|Overall Study|Lost to Follow-up|0|||
19728259|NCT03358030|42172986|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
19728260|NCT03358030|42172987|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
19728261|NCT03358030|42172988|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
19728262|NCT03358030|42172989|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
19728263|NCT03358030|42172986|FG000|Overall Study|Ineligibility|0|||
19728264|NCT03358030|42172987|FG001|Overall Study|Ineligibility|0|||
19728265|NCT03358030|42172988|FG002|Overall Study|Ineligibility|0|||
19728266|NCT03358030|42172989|FG003|Overall Study|Ineligibility|2|||
19728267|NCT03358030|42172986|FG000|Overall Study|Voluntary Withdrawal|1|||
19728268|NCT03358030|42172987|FG001|Overall Study|Voluntary Withdrawal|1|||
19728269|NCT03358030|42172988|FG002|Overall Study|Voluntary Withdrawal|3|||
19728270|NCT03358030|42172989|FG003|Overall Study|Voluntary Withdrawal|1|||
19728271|NCT03358030|42172986|FG000|Overall Study|Other|0|||
19728272|NCT03358030|42172987|FG001|Overall Study|Other|0|||
19728273|NCT03358030|42172988|FG002|Overall Study|Other|1|||
19728274|NCT03358030|42172989|FG003|Overall Study|Other|0|||
19728275|NCT03566810|42173003|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
19728276|NCT03566810|42173004|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
19728277|NCT03566810|42173005|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
19728278|NCT03566810|42173006|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
19728279|NCT03628716|42173029|FG000|Overall Study|Adverse Event|1|||
19728280|NCT03628716|42173030|FG001|Overall Study|Adverse Event|1|||
19728281|NCT03628716|42173029|FG000|Overall Study|Death|1|||
19728282|NCT03628716|42173030|FG001|Overall Study|Death|0|||
19728283|NCT03628716|42173029|FG000|Overall Study|Lack of Efficacy|15|||
19728284|NCT03628716|42173030|FG001|Overall Study|Lack of Efficacy|20|||
19728285|NCT03628716|42173029|FG000|Overall Study|Withdrawal by Subject|1|||
19728286|NCT03628716|42173030|FG001|Overall Study|Withdrawal by Subject|2|||
19728287|NCT03628716|42173029|FG000|Overall Study|Study Terminated by Sponsor|1|||
19728288|NCT03628716|42173030|FG001|Overall Study|Study Terminated by Sponsor|0|||
19728289|NCT04002960|42173038|FG000|Overall Study|Withdrawn prior to Completion|2|||
19728290|NCT04002648|42173044|FG000|Overall Study|Lost to Follow-up|2|||
19728291|NCT04002648|42173045|FG001|Overall Study|Lost to Follow-up|0|||
19728292|NCT00088413|42173066|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
19728293|NCT00088413|42173067|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
19728294|NCT00088413|42173068|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
19728295|NCT00088413|42173069|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
19728296|NCT00088413|42173066|FG000|Overall Study|Adverse Events/Side Effects|0|||
19728297|NCT00088413|42173067|FG001|Overall Study|Adverse Events/Side Effects|1|||
19728298|NCT00088413|42173068|FG002|Overall Study|Adverse Events/Side Effects|1|||
19728299|NCT00088413|42173069|FG003|Overall Study|Adverse Events/Side Effects|0|||
19728300|NCT00088413|42173066|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
19728301|NCT00088413|42173067|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
19728302|NCT00088413|42173068|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
19728303|NCT00088413|42173069|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
19728304|NCT00088413|42173066|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
19728305|NCT00088413|42173067|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
19728306|NCT00088413|42173068|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
19728307|NCT00088413|42173069|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
19728308|NCT00088413|42173066|FG000|Overall Study|Death|0|||
19728309|NCT00088413|42173067|FG001|Overall Study|Death|1|||
19728310|NCT00088413|42173068|FG002|Overall Study|Death|0|||
19728311|NCT00088413|42173069|FG003|Overall Study|Death|0|||
19728312|NCT00088413|42173066|FG000|Overall Study|Progressive disease|9|||
19728313|NCT00088413|42173067|FG001|Overall Study|Progressive disease|11|||
19728314|NCT00088413|42173068|FG002|Overall Study|Progressive disease|8|||
19728315|NCT00088413|42173069|FG003|Overall Study|Progressive disease|14|||
19728316|NCT00088413|42173066|FG000|Overall Study|Other|0|||
19728317|NCT00088413|42173067|FG001|Overall Study|Other|1|||
19728318|NCT00088413|42173068|FG002|Overall Study|Other|0|||
19728319|NCT00088413|42173069|FG003|Overall Study|Other|0|||
19728320|NCT00088413|42173066|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
19728321|NCT00088413|42173067|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
19728322|NCT00088413|42173068|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
19728323|NCT00088413|42173069|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
19728324|NCT03995784|42173081|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
19728325|NCT00086385|42173096|FG000|Overall Study|Death|2|||
19728326|NCT00086385|42173097|FG001|Overall Study|Death|2|||
19728327|NCT00086385|42173098|FG002|Overall Study|Death|1|||
19728328|NCT00086385|42173099|FG003|Overall Study|Death|1|||
19465225|NCT04426695|41723755|FG014|Overall Study|Lost to Follow-up|2|||
19728329|NCT03993288|42173111|FG000|Overall Study|Lost to Follow-up|2|||
19728330|NCT03993288|42173112|FG001|Overall Study|Lost to Follow-up|1|||
19728331|NCT03993288|42173111|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
19728332|NCT03993288|42173112|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
19728333|NCT03993288|42173111|FG000|Overall Study|wrong randomization|0|||
19728334|NCT03993288|42173112|FG001|Overall Study|wrong randomization|1|||
19728335|NCT03993288|42173111|FG000|Overall Study|improper enrollment|0|||
19728336|NCT03993288|42173112|FG001|Overall Study|improper enrollment|1|||
19728337|NCT03993288|42173111|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
19728338|NCT03993288|42173112|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
19728339|NCT03993288|42173111|FG000|Overall Study|developed SAE|2|||
19728340|NCT03993288|42173112|FG001|Overall Study|developed SAE|0|||
19728341|NCT03993288|42173111|FG000|Overall Study|consent withdrawal|1|||
19728342|NCT03993288|42173112|FG001|Overall Study|consent withdrawal|0|||
19728343|NCT03993288|42173111|FG000|Overall Study|did not follow the treatment schedule|1|||
19728344|NCT03993288|42173112|FG001|Overall Study|did not follow the treatment schedule|0|||
19728345|NCT03993288|42173111|FG000|Overall Study|did not follow the treatment regimen|1|||
19728346|NCT03993288|42173112|FG001|Overall Study|did not follow the treatment regimen|0|||
19728347|NCT03993288|42173111|FG000|Overall Study|Adverse Event|1|||
19728348|NCT03993288|42173112|FG001|Overall Study|Adverse Event|0|||
19728349|NCT03993288|42173111|FG000|Overall Study|Withdrawal by Subject|1|||
19728350|NCT03993288|42173112|FG001|Overall Study|Withdrawal by Subject|1|||
19728351|NCT03991494|42173118|FG000|Overall Study|Progressive Disease|4|||
19728352|NCT00086307|42173136|FG000|Overall Study|Lack of Efficacy|1|||
19728353|NCT00086307|42173137|FG001|Overall Study|Lack of Efficacy|1|||
19728354|NCT00086307|42173138|FG002|Overall Study|Lack of Efficacy|2|||
19728355|NCT00086307|42173136|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
19728356|NCT00086307|42173137|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
19728357|NCT00086307|42173138|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
19728358|NCT00086307|42173136|FG000|Overall Study|Nausea and headaches|0|||
19728359|NCT00086307|42173137|FG001|Overall Study|Nausea and headaches|0|||
19728360|NCT00086307|42173138|FG002|Overall Study|Nausea and headaches|1|||
19728361|NCT00086307|42173136|FG000|Overall Study|Constipation and sleepiness|0|||
19728362|NCT00086307|42173137|FG001|Overall Study|Constipation and sleepiness|0|||
19728363|NCT00086307|42173138|FG002|Overall Study|Constipation and sleepiness|1|||
19728364|NCT00086307|42173136|FG000|Overall Study|Suicidal ideation|0|||
19728365|NCT00086307|42173137|FG001|Overall Study|Suicidal ideation|0|||
19728366|NCT00086307|42173138|FG002|Overall Study|Suicidal ideation|1|||
19728367|NCT00086307|42173136|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
19728368|NCT00086307|42173137|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
19728369|NCT00086307|42173138|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
19728370|NCT00086307|42173136|FG000|Overall Study|Withdrawal by Subject|0|||
19728371|NCT00086307|42173137|FG001|Overall Study|Withdrawal by Subject|0|||
19728372|NCT00086307|42173138|FG002|Overall Study|Withdrawal by Subject|2|||
19728373|NCT03624972|42173149|FG000|Overall Study|Lost to Follow-up|2|||
19728374|NCT03624972|42173150|FG001|Overall Study|Lost to Follow-up|0|||
19728375|NCT03624972|42173151|FG002|Overall Study|Lost to Follow-up|0|||
19728376|NCT03624972|42173149|FG000|Overall Study|Withdrawal by Subject|0|||
19728377|NCT03624972|42173150|FG001|Overall Study|Withdrawal by Subject|2|||
19728378|NCT03624972|42173151|FG002|Overall Study|Withdrawal by Subject|0|||
19728379|NCT03988842|42173160|FG000|Overall Study|Death|1|||
19728380|NCT02668822|42173167|FG000|Overall Study|Protocol Violation|2|||
19728381|NCT02668822|42173168|FG001|Overall Study|Protocol Violation|0|||
19728382|NCT02668822|42173167|FG000|Overall Study|Study Terminated by Sponsor|7|||
19728383|NCT02668822|42173168|FG001|Overall Study|Study Terminated by Sponsor|9|||
19728384|NCT02524288|42173174|FG000|Overall Study|Adverse Event|115|||
19728385|NCT02524288|42173174|FG000|Overall Study|Lost to Follow-up|216|||
19728386|NCT02524288|42173174|FG000|Overall Study|Non-Compliance With Protocol|32|||
19728387|NCT02524288|42173174|FG000|Overall Study|Non-Compliance With Study Drug|14|||
19728388|NCT02524288|42173174|FG000|Overall Study|Pregnancy Wish|6|||
19728389|NCT02524288|42173174|FG000|Overall Study|Protocol Violation|6|||
19728390|NCT02524288|42173174|FG000|Overall Study|Screen Failure|2|||
19728391|NCT02524288|42173174|FG000|Overall Study|Site Discontinued Study Participation|1|||
19728392|NCT02524288|42173174|FG000|Overall Study|Study Terminated By Sponsor|1417|||
19728393|NCT02524288|42173174|FG000|Overall Study|Subject Moved|32|||
19728394|NCT02524288|42173174|FG000|Overall Study|Withdrawal by Subject|76|||
19728395|NCT02524288|42173174|FG000|Overall Study|Pregnancy|22|||
19728396|NCT02524288|42173174|FG000|Overall Study|Physician Decision|2|||
19728397|NCT03624504|42173178|FG000|Overall Study|Unsuccessful Implant|1|||
19728398|NCT02954952|42173185|FG000|Overall Study|Withdrawal by Subject|1|||
19728399|NCT02954952|42173186|FG001|Overall Study|Withdrawal by Subject|0|||
19728400|NCT02954952|42173187|FG002|Overall Study|Withdrawal by Subject|0|||
19728401|NCT02954952|42173185|FG000|Overall Study|No data collected|0|||
19728402|NCT02954952|42173186|FG001|Overall Study|No data collected|1|||
19728403|NCT02954952|42173187|FG002|Overall Study|No data collected|0|||
19728404|NCT03547154|42173197|FG000|Overall Study|Disease Progression/Recurrence|6|||
19728405|NCT03547154|42173198|FG001|Overall Study|Disease Progression/Recurrence|14|||
19728406|NCT03547154|42173197|FG000|Overall Study|Adverse Event|26|||
19728407|NCT03547154|42173198|FG001|Overall Study|Adverse Event|31|||
19728408|NCT03547154|42173197|FG000|Overall Study|Protocol Violation|6|||
19728409|NCT03547154|42173198|FG001|Overall Study|Protocol Violation|1|||
19728410|NCT03547154|42173197|FG000|Overall Study|Physician Decision|4|||
19728411|NCT03547154|42173198|FG001|Overall Study|Physician Decision|3|||
19728412|NCT03547154|42173197|FG000|Overall Study|Insufficient Therapeutic Response|13|||
19728413|NCT03547154|42173198|FG001|Overall Study|Insufficient Therapeutic Response|10|||
19728414|NCT03547154|42173197|FG000|Overall Study|Withdrawal by Subject|10|||
19728415|NCT03547154|42173198|FG001|Overall Study|Withdrawal by Subject|6|||
19728416|NCT03547154|42173197|FG000|Overall Study|Not Selected|0|||
19728417|NCT03547154|42173198|FG001|Overall Study|Not Selected|1|||
19728418|NCT03547154|42173197|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
19728419|NCT03547154|42173198|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
19728420|NCT02275546|42173204|FG000|Treatment Period 2|Withdrawal by Subject|2|||
19728421|NCT02275546|42173205|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19728422|NCT02275546|42173204|FG000|Treatment Period 2|Protocol Violation|0|||
19728423|NCT02275546|42173205|FG001|Treatment Period 2|Protocol Violation|1|||
19728424|NCT03624192|42173211|FG000|Overall Study|Lost to Follow-up|1|||
19728425|NCT03624192|42173212|FG001|Overall Study|Lost to Follow-up|1|||
19728426|NCT03034954|42173222|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
19728427|NCT03034954|42173223|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
19728428|NCT00057837|42173231|FG000|Overall Study|Progression/relapse|12|||
19728429|NCT00057837|42173232|FG001|Overall Study|Progression/relapse|14|||
19728430|NCT00057837|42173231|FG000|Overall Study|Adverse Event|2|||
19728431|NCT00057837|42173232|FG001|Overall Study|Adverse Event|12|||
19728432|NCT00057837|42173231|FG000|Overall Study|Death|5|||
19728433|NCT00057837|42173232|FG001|Overall Study|Death|4|||
19728434|NCT00057837|42173231|FG000|Overall Study|Withdrawal by Subject|5|||
19728435|NCT00057837|42173232|FG001|Overall Study|Withdrawal by Subject|3|||
19728436|NCT00057837|42173231|FG000|Overall Study|Alternative therapy|0|||
19728437|NCT00057837|42173232|FG001|Overall Study|Alternative therapy|1|||
19728438|NCT00057837|42173231|FG000|Overall Study|Other complicating disease|2|||
19728439|NCT00057837|42173232|FG001|Overall Study|Other complicating disease|1|||
19728440|NCT00057837|42173231|FG000|Overall Study|Physician Decision|1|||
19728441|NCT00057837|42173232|FG001|Overall Study|Physician Decision|0|||
19728442|NCT00057837|42173231|FG000|Overall Study|Ineligible|3|||
19728443|NCT00057837|42173232|FG001|Overall Study|Ineligible|3|||
19728444|NCT00057837|42173231|FG000|Overall Study|Never started treatment|1|||
19728445|NCT00057837|42173232|FG001|Overall Study|Never started treatment|1|||
19728446|NCT03546842|42173238|FG000|Overall Study|Protocol Violation|1|||
19728447|NCT03546842|42173238|FG000|Overall Study|Withdrawal by Subject|2|||
19728448|NCT03640052|42173242|FG000|Overall Study|Lost to Follow-up|0|||
19728449|NCT03640052|42173243|FG001|Overall Study|Lost to Follow-up|1|||
19728450|NCT03640052|42173244|FG002|Overall Study|Lost to Follow-up|0|||
19728451|NCT03640052|42173245|FG003|Overall Study|Lost to Follow-up|0|||
19728452|NCT03640052|42173246|FG004|Overall Study|Lost to Follow-up|0|||
19728453|NCT00068601|42173260|FG000|Overall Study|Ineligible|11|||
19728454|NCT00068601|42173261|FG001|Overall Study|Ineligible|13|||
19728455|NCT00068601|42173260|FG000|Overall Study|Not evaluable: withdrew consent|5|||
19728456|NCT00068601|42173261|FG001|Overall Study|Not evaluable: withdrew consent|4|||
19728457|NCT00068601|42173260|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
19728458|NCT00068601|42173261|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
19728459|NCT00068601|42173260|FG000|Overall Study|Death|11|||
19728460|NCT00068601|42173261|FG001|Overall Study|Death|3|||
19728461|NCT00068601|42173260|FG000|Overall Study|Lost to Follow-up|3|||
19728462|NCT00068601|42173261|FG001|Overall Study|Lost to Follow-up|2|||
19728463|NCT00068601|42173260|FG000|Overall Study|Missing primary outcome data|30|||
19728464|NCT00068601|42173261|FG001|Overall Study|Missing primary outcome data|34|||
19728465|NCT03638258|42173270|FG000|Overall Study|Adverse Event|1|||
19728466|NCT03638258|42173271|FG001|Overall Study|Adverse Event|0|||
19728467|NCT03638258|42173272|FG002|Overall Study|Adverse Event|2|||
19728468|NCT03638258|42173270|FG000|Overall Study|Lost to Follow-up|2|||
19728469|NCT03638258|42173271|FG001|Overall Study|Lost to Follow-up|4|||
19728470|NCT03638258|42173272|FG002|Overall Study|Lost to Follow-up|5|||
19728471|NCT03638258|42173270|FG000|Overall Study|Pregnancy|0|||
19728472|NCT03638258|42173271|FG001|Overall Study|Pregnancy|0|||
19728473|NCT03638258|42173272|FG002|Overall Study|Pregnancy|1|||
19728474|NCT03638258|42173270|FG000|Overall Study|Protocol Violation|0|||
19728475|NCT03638258|42173271|FG001|Overall Study|Protocol Violation|0|||
19728476|NCT03638258|42173272|FG002|Overall Study|Protocol Violation|1|||
19728477|NCT03638258|42173270|FG000|Overall Study|Withdrawal by Subject|4|||
19728478|NCT03638258|42173271|FG001|Overall Study|Withdrawal by Subject|5|||
19728479|NCT03638258|42173272|FG002|Overall Study|Withdrawal by Subject|12|||
19728480|NCT03638258|42173270|FG000|Overall Study|Lack of Efficacy|0|||
19728481|NCT03638258|42173271|FG001|Overall Study|Lack of Efficacy|0|||
19728482|NCT03638258|42173272|FG002|Overall Study|Lack of Efficacy|2|||
19728483|NCT01670656|42173286|FG000|Overall Study|Non-compliance with study drug|0|||
19728484|NCT01670656|42173287|FG001|Overall Study|Non-compliance with study drug|0|||
19728485|NCT01670656|42173288|FG002|Overall Study|Non-compliance with study drug|3|||
19728486|NCT01670656|42173289|FG003|Overall Study|Non-compliance with study drug|0|||
19728487|NCT01670656|42173290|FG004|Overall Study|Non-compliance with study drug|1|||
19728488|NCT01670656|42173286|FG000|Overall Study|Pregnancy|0|||
19728489|NCT01670656|42173287|FG001|Overall Study|Pregnancy|0|||
19728490|NCT01670656|42173288|FG002|Overall Study|Pregnancy|0|||
19728491|NCT01670656|42173289|FG003|Overall Study|Pregnancy|0|||
19728492|NCT01670656|42173290|FG004|Overall Study|Pregnancy|1|||
19728493|NCT01670656|42173286|FG000|Overall Study|Withdrawal by Subject|1|||
19728494|NCT01670656|42173287|FG001|Overall Study|Withdrawal by Subject|1|||
19728495|NCT01670656|42173288|FG002|Overall Study|Withdrawal by Subject|0|||
19728496|NCT01670656|42173289|FG003|Overall Study|Withdrawal by Subject|0|||
19728497|NCT01670656|42173290|FG004|Overall Study|Withdrawal by Subject|0|||
19728498|NCT01670656|42173286|FG000|Overall Study|Non-compliance with protocol|0|||
19728499|NCT01670656|42173287|FG001|Overall Study|Non-compliance with protocol|3|||
19728500|NCT01670656|42173288|FG002|Overall Study|Non-compliance with protocol|1|||
19728501|NCT01670656|42173289|FG003|Overall Study|Non-compliance with protocol|1|||
19728502|NCT01670656|42173290|FG004|Overall Study|Non-compliance with protocol|2|||
19728503|NCT01670656|42173286|FG000|Overall Study|Adverse Event|2|||
19728504|NCT01670656|42173287|FG001|Overall Study|Adverse Event|2|||
19728505|NCT01670656|42173288|FG002|Overall Study|Adverse Event|2|||
19728506|NCT01670656|42173289|FG003|Overall Study|Adverse Event|3|||
19728507|NCT01670656|42173290|FG004|Overall Study|Adverse Event|3|||
19728508|NCT01670656|42173286|FG000|Overall Study|Subject withdrew consent|0|||
19728509|NCT01670656|42173287|FG001|Overall Study|Subject withdrew consent|1|||
19728510|NCT01670656|42173288|FG002|Overall Study|Subject withdrew consent|2|||
19728511|NCT01670656|42173289|FG003|Overall Study|Subject withdrew consent|1|||
19728512|NCT01670656|42173290|FG004|Overall Study|Subject withdrew consent|1|||
19728513|NCT01670656|42173286|FG000|Overall Study|Lost to Follow-up|0|||
19728514|NCT01670656|42173287|FG001|Overall Study|Lost to Follow-up|0|||
19728515|NCT01670656|42173288|FG002|Overall Study|Lost to Follow-up|0|||
19728516|NCT01670656|42173289|FG003|Overall Study|Lost to Follow-up|0|||
19728517|NCT01670656|42173290|FG004|Overall Study|Lost to Follow-up|3|||
19728518|NCT01670656|42173286|FG000|Overall Study|Subject moved|0|||
19728519|NCT01670656|42173287|FG001|Overall Study|Subject moved|0|||
19728520|NCT01670656|42173288|FG002|Overall Study|Subject moved|0|||
19728521|NCT01670656|42173289|FG003|Overall Study|Subject moved|1|||
19728522|NCT01670656|42173290|FG004|Overall Study|Subject moved|0|||
19728523|NCT03621696|42173306|FG000|Overall Study|Not eligible|0|||
19728524|NCT03621696|42173307|FG001|Overall Study|Not eligible|0|||
19728525|NCT03621696|42173308|FG002|Overall Study|Not eligible|0|||
19728526|NCT03621696|42173309|FG003|Overall Study|Not eligible|5|||
19728527|NCT03621696|42173306|FG000|Overall Study|Withdrawal by Subject|1|||
19728528|NCT03621696|42173307|FG001|Overall Study|Withdrawal by Subject|1|||
19728529|NCT03621696|42173308|FG002|Overall Study|Withdrawal by Subject|1|||
19728530|NCT03621696|42173309|FG003|Overall Study|Withdrawal by Subject|0|||
19728531|NCT03621696|42173306|FG000|Overall Study|Physician Decision|0|||
19728532|NCT03621696|42173307|FG001|Overall Study|Physician Decision|0|||
19728533|NCT03621696|42173308|FG002|Overall Study|Physician Decision|1|||
19728534|NCT03621696|42173309|FG003|Overall Study|Physician Decision|0|||
19728535|NCT00068445|42173319|FG000|Randomization|Cancel|1|||
19728536|NCT00068445|42173320|FG001|Randomization|Cancel|3|||
19728537|NCT00068445|42173319|FG000|Randomization|Ineligible|1|||
19728538|NCT00068445|42173320|FG001|Randomization|Ineligible|1|||
19728539|NCT00068445|42173319|FG000|Treatment|Refused Further Treatment|13|||
19728540|NCT00068445|42173320|FG001|Treatment|Refused Further Treatment|10|||
19728541|NCT00068445|42173319|FG000|Treatment|Adverse Event|7|||
19728542|NCT00068445|42173320|FG001|Treatment|Adverse Event|1|||
19728543|NCT00068445|42173319|FG000|Treatment|Other (Specifics not available)|9|||
19728544|NCT00068445|42173320|FG001|Treatment|Other (Specifics not available)|5|||
19728545|NCT03653208|42173335|FG000|Overall Study|Withdrawal by Subject|0|||
19728546|NCT03653208|42173336|FG001|Overall Study|Withdrawal by Subject|0|||
19728547|NCT03653208|42173337|FG002|Overall Study|Withdrawal by Subject|0|||
19728548|NCT03653208|42173338|FG003|Overall Study|Withdrawal by Subject|0|||
19728549|NCT03653208|42173339|FG004|Overall Study|Withdrawal by Subject|1|||
19728550|NCT03653208|42173340|FG005|Overall Study|Withdrawal by Subject|0|||
19728551|NCT03653208|42173341|FG006|Overall Study|Withdrawal by Subject|0|||
19728552|NCT03653208|42173342|FG007|Overall Study|Withdrawal by Subject|1|||
19728553|NCT03653208|42173343|FG008|Overall Study|Withdrawal by Subject|1|||
19728554|NCT03545984|42173365|FG000|Overall Study|CSF cases not present during rotation|11|||
19728555|NCT03545984|42173366|FG001|Overall Study|CSF cases not present during rotation|9|||
19728556|NCT03033784|42173374|FG000|Overall Study|Anxiety related to MRI scanner|0|||
19728557|NCT03033784|42173375|FG001|Overall Study|Anxiety related to MRI scanner|1|||
19728558|NCT03033784|42173376|FG002|Overall Study|Anxiety related to MRI scanner|0|||
19728559|NCT03033784|42173377|FG003|Overall Study|Anxiety related to MRI scanner|0|||
19728560|NCT03033784|42173378|FG004|Overall Study|Anxiety related to MRI scanner|0|||
19728561|NCT03033784|42173379|FG005|Overall Study|Anxiety related to MRI scanner|0|||
19728562|NCT03033784|42173380|FG006|Overall Study|Anxiety related to MRI scanner|0|||
19728563|NCT03033784|42173381|FG007|Overall Study|Anxiety related to MRI scanner|0|||
19728564|NCT03033784|42173382|FG008|Overall Study|Anxiety related to MRI scanner|0|||
19728565|NCT03033784|42173383|FG009|Overall Study|Anxiety related to MRI scanner|0|||
19728566|NCT03033784|42173384|FG010|Overall Study|Anxiety related to MRI scanner|0|||
19728567|NCT03033784|42173385|FG011|Overall Study|Anxiety related to MRI scanner|0|||
19728568|NCT03033784|42173386|FG012|Overall Study|Anxiety related to MRI scanner|0|||
19728569|NCT03033784|42173374|FG000|Overall Study|Withdrawal by Subject|0|||
19728570|NCT03033784|42173375|FG001|Overall Study|Withdrawal by Subject|0|||
19728571|NCT03033784|42173376|FG002|Overall Study|Withdrawal by Subject|0|||
19728572|NCT03033784|42173377|FG003|Overall Study|Withdrawal by Subject|0|||
19728573|NCT03033784|42173378|FG004|Overall Study|Withdrawal by Subject|0|||
19728574|NCT03033784|42173379|FG005|Overall Study|Withdrawal by Subject|0|||
19728575|NCT03033784|42173380|FG006|Overall Study|Withdrawal by Subject|0|||
19728576|NCT03033784|42173381|FG007|Overall Study|Withdrawal by Subject|0|||
19728577|NCT03033784|42173382|FG008|Overall Study|Withdrawal by Subject|0|||
19728578|NCT03033784|42173383|FG009|Overall Study|Withdrawal by Subject|0|||
19728579|NCT03033784|42173384|FG010|Overall Study|Withdrawal by Subject|0|||
19728580|NCT03033784|42173385|FG011|Overall Study|Withdrawal by Subject|0|||
19728581|NCT03033784|42173386|FG012|Overall Study|Withdrawal by Subject|2|||
19728582|NCT00038649|42173397|FG000|Overall Study|Adverse Event|9|||
19728583|NCT03544268|42173403|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
19728584|NCT03544268|42173404|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
19728585|NCT03652818|42173415|FG000|Overall Study|Adverse Event|1|||
19728586|NCT03652818|42173416|FG001|Overall Study|Adverse Event|0|||
19728587|NCT03652818|42173417|FG002|Overall Study|Adverse Event|0|||
19728588|NCT03652818|42173418|FG003|Overall Study|Adverse Event|0|||
19728589|NCT03652818|42173419|FG004|Overall Study|Adverse Event|0|||
19728590|NCT03652818|42173415|FG000|Overall Study|Physician Decision|1|||
19728591|NCT03652818|42173416|FG001|Overall Study|Physician Decision|0|||
19728592|NCT03652818|42173417|FG002|Overall Study|Physician Decision|0|||
19728593|NCT03652818|42173418|FG003|Overall Study|Physician Decision|0|||
19728594|NCT03652818|42173419|FG004|Overall Study|Physician Decision|0|||
19728595|NCT03652818|42173415|FG000|Overall Study|Lost to Follow-up|0|||
19728596|NCT03652818|42173416|FG001|Overall Study|Lost to Follow-up|1|||
19728597|NCT03652818|42173417|FG002|Overall Study|Lost to Follow-up|2|||
19728598|NCT03652818|42173418|FG003|Overall Study|Lost to Follow-up|1|||
19728599|NCT03652818|42173419|FG004|Overall Study|Lost to Follow-up|1|||
19728600|NCT03619902|42173431|FG000|Overall Study|Termination of Study by Investigator|1|||
19728601|NCT03619902|42173431|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
19728602|NCT00620464|42173437|FG000|Overall Study|Adverse Event|15|||
19728603|NCT00620464|42173438|FG001|Overall Study|Adverse Event|17|||
19728604|NCT00620464|42173437|FG000|Overall Study|Lost to Follow-up|1|||
19728605|NCT00620464|42173438|FG001|Overall Study|Lost to Follow-up|1|||
19728606|NCT00620464|42173437|FG000|Overall Study|Planning Pregnancy|1|||
19728607|NCT00620464|42173438|FG001|Overall Study|Planning Pregnancy|4|||
19728608|NCT00620464|42173437|FG000|Overall Study|Personal|2|||
19728609|NCT00620464|42173438|FG001|Overall Study|Personal|2|||
19728610|NCT00620464|42173437|FG000|Overall Study|Used prohibited medication|1|||
19728611|NCT00620464|42173438|FG001|Overall Study|Used prohibited medication|0|||
19728612|NCT03652662|42173446|FG000|Overall Study|Withdrawal by Subject|2|||
19728613|NCT03652662|42173447|FG001|Overall Study|Withdrawal by Subject|1|||
19728614|NCT03652662|42173446|FG000|Overall Study|Lost to Follow-up|1|||
19728615|NCT03652662|42173447|FG001|Overall Study|Lost to Follow-up|0|||
19728616|NCT03560258|42173456|FG000|Overall Study|Lost to Follow-up|3|||
19728617|NCT03560258|42173457|FG001|Overall Study|Lost to Follow-up|0|||
19728618|NCT03560258|42173458|FG002|Overall Study|Lost to Follow-up|0|||
19728619|NCT03560258|42173456|FG000|Overall Study|Protocol Violation|0|||
19728620|NCT03560258|42173457|FG001|Overall Study|Protocol Violation|1|||
19728621|NCT03560258|42173458|FG002|Overall Study|Protocol Violation|0|||
19728622|NCT03560258|42173456|FG000|Overall Study|Withdrawal by Subject|0|||
19728623|NCT03560258|42173457|FG001|Overall Study|Withdrawal by Subject|0|||
19728624|NCT03560258|42173458|FG002|Overall Study|Withdrawal by Subject|1|||
19728625|NCT02768662|42173466|FG000|Overall Study|Adverse Event|1|||
19728626|NCT02768662|42173466|FG000|Overall Study|Lost to Follow-up|4|||
19728627|NCT02768662|42173466|FG000|Overall Study|Withdrawal by Subject|3|||
19728628|NCT02768662|42173466|FG000|Overall Study|Study terminated by Sponsor|78|||
19728629|NCT03539432|42173472|FG000|Overall Study|Lost to Follow-up|0|||
19728630|NCT03539432|42173473|FG001|Overall Study|Lost to Follow-up|1|||
19728631|NCT03615924|42173481|FG000|Overall Study|Withdrawal by Subject|2|||
19728632|NCT03615924|42173482|FG001|Overall Study|Withdrawal by Subject|5|||
19728633|NCT03615924|42173481|FG000|Overall Study|Death|3|||
19728634|NCT03615924|42173482|FG001|Overall Study|Death|1|||
19728635|NCT03615924|42173481|FG000|Overall Study|Lost to Follow-up|1|||
19728636|NCT03615924|42173482|FG001|Overall Study|Lost to Follow-up|0|||
19728637|NCT03615924|42173481|FG000|Overall Study|Randomized in error|1|||
19728638|NCT03615924|42173482|FG001|Overall Study|Randomized in error|0|||
19728639|NCT03615924|42173481|FG000|Overall Study|Study termination by Sponsor|94|||
19728640|NCT03615924|42173482|FG001|Overall Study|Study termination by Sponsor|86|||
19728641|NCT03535844|42173490|FG000|Overall Study|Withdrawal by Subject|0|||
19728642|NCT03535844|42173491|FG001|Overall Study|Withdrawal by Subject|1|||
19728643|NCT03533114|42173508|FG000|Overall|Adverse Event|16|||
19728644|NCT03533114|42173509|FG001|Overall|Adverse Event|11|||
19728645|NCT03533114|42173508|FG000|Overall|Consent Withdrawal by Participant|7|||
19728646|NCT03533114|42173509|FG001|Overall|Consent Withdrawal by Participant|6|||
19728647|NCT03533114|42173508|FG000|Overall|Lack of Efficacy|5|||
19728648|NCT03533114|42173509|FG001|Overall|Lack of Efficacy|3|||
19728649|NCT03533114|42173508|FG000|Overall|Lost to Follow-up|1|||
19728650|NCT03533114|42173509|FG001|Overall|Lost to Follow-up|1|||
19728651|NCT03533114|42173508|FG000|Overall|Physician Decision|0|||
19728652|NCT03533114|42173509|FG001|Overall|Physician Decision|2|||
19728653|NCT03533114|42173508|FG000|Overall|Protocol deviation|1|||
19728654|NCT03533114|42173509|FG001|Overall|Protocol deviation|1|||
19728655|NCT03533114|42173508|FG000|Overall|Failure to meet randomization criteria|1|||
19728656|NCT03533114|42173509|FG001|Overall|Failure to meet randomization criteria|2|||
19728657|NCT03533114|42173508|FG000|Overall|Non-Compliance with study drug|0|||
19728658|NCT03533114|42173509|FG001|Overall|Non-Compliance with study drug|1|||
19728659|NCT03533114|42173508|FG000|Overall|Other|0|||
19728660|NCT03533114|42173509|FG001|Overall|Other|1|||
19728661|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Adverse Event|11|||
19728662|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Adverse Event|8|||
19728663|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
19728664|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
19728665|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
19728666|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
19728667|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
19728668|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
19728669|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
19728670|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
19728671|NCT03533114|42173508|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
19728672|NCT03533114|42173509|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
19728673|NCT03533114|42173508|FG000|Stable Dose|Adverse Event|0|||
19728674|NCT03533114|42173509|FG001|Stable Dose|Adverse Event|2|||
19728675|NCT03533114|42173508|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
19728676|NCT03533114|42173509|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
19728677|NCT03533114|42173508|FG000|Stable Dose|Lack of Efficacy|1|||
19728678|NCT03533114|42173509|FG001|Stable Dose|Lack of Efficacy|0|||
19728679|NCT03533114|42173508|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
19728680|NCT03533114|42173509|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
19728681|NCT03533114|42173508|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
19728682|NCT03533114|42173509|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
19728683|NCT03533114|42173508|FG000|Open-Label Safety Extension|Adverse Event|3|||
19728684|NCT03533114|42173509|FG001|Open-Label Safety Extension|Adverse Event|0|||
19728685|NCT03533114|42173508|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
19728686|NCT03533114|42173509|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
19728687|NCT03533114|42173508|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
19728688|NCT03533114|42173509|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
19728689|NCT03533114|42173508|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
19728690|NCT03533114|42173509|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
19728691|NCT03533114|42173508|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
19728692|NCT03533114|42173509|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
19728693|NCT03033394|42173517|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
19728694|NCT03033394|42173517|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
19728695|NCT03033394|42173517|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
19728696|NCT03033394|42173517|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
19728697|NCT03033394|42173517|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
19728698|NCT03981822|42173534|FG000|Overall Study|Lost to Follow-up|0|||
19728699|NCT03981822|42173535|FG001|Overall Study|Lost to Follow-up|1|||
19728700|NCT03981822|42173536|FG002|Overall Study|Lost to Follow-up|1|||
19728701|NCT03981822|42173537|FG003|Overall Study|Lost to Follow-up|0|||
19728702|NCT03981822|42173538|FG004|Overall Study|Lost to Follow-up|6|||
19728703|NCT03981822|42173539|FG005|Overall Study|Lost to Follow-up|4|||
19728704|NCT03981822|42173540|FG006|Overall Study|Lost to Follow-up|4|||
19728705|NCT03981822|42173541|FG007|Overall Study|Lost to Follow-up|2|||
19728706|NCT03981822|42173534|FG000|Overall Study|Withdrawal by Subject|0|||
19728707|NCT03981822|42173535|FG001|Overall Study|Withdrawal by Subject|1|||
19728708|NCT03981822|42173536|FG002|Overall Study|Withdrawal by Subject|0|||
19728709|NCT03981822|42173537|FG003|Overall Study|Withdrawal by Subject|0|||
19728710|NCT03981822|42173538|FG004|Overall Study|Withdrawal by Subject|0|||
19728711|NCT03981822|42173539|FG005|Overall Study|Withdrawal by Subject|1|||
19728712|NCT03981822|42173540|FG006|Overall Study|Withdrawal by Subject|0|||
19728713|NCT03981822|42173541|FG007|Overall Study|Withdrawal by Subject|2|||
19728714|NCT03981822|42173534|FG000|Overall Study|COVID-19 Related|0|||
19728715|NCT03981822|42173535|FG001|Overall Study|COVID-19 Related|0|||
19728716|NCT03981822|42173536|FG002|Overall Study|COVID-19 Related|0|||
19728717|NCT03981822|42173537|FG003|Overall Study|COVID-19 Related|0|||
19728718|NCT03981822|42173538|FG004|Overall Study|COVID-19 Related|2|||
19728719|NCT03981822|42173539|FG005|Overall Study|COVID-19 Related|1|||
19728720|NCT03981822|42173540|FG006|Overall Study|COVID-19 Related|2|||
19728721|NCT03981822|42173541|FG007|Overall Study|COVID-19 Related|1|||
19728722|NCT03980808|42173555|FG000|Overall Study|Lost to Follow-up|2|||
19728723|NCT03980808|42173556|FG001|Overall Study|Lost to Follow-up|2|||
19728724|NCT03650556|42173562|FG000|Overall Study|Death|2|||
19728725|NCT03650556|42173562|FG000|Overall Study|Withdrawal by Subject|20|||
19728726|NCT03650556|42173562|FG000|Overall Study|Physician Decision|2|||
19728727|NCT03650556|42173562|FG000|Overall Study|Lost to Follow-up|8|||
19728728|NCT03650556|42173562|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
19728729|NCT03650556|42173562|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
19728730|NCT03531632|42173570|FG000|Overall Study|Adverse Event|0|||
19728731|NCT03531632|42173571|FG001|Overall Study|Adverse Event|0|||
19728732|NCT03531632|42173572|FG002|Overall Study|Adverse Event|1|||
19728733|NCT03531632|42173570|FG000|Overall Study|Death|4|||
19728734|NCT03531632|42173571|FG001|Overall Study|Death|0|||
19728735|NCT03531632|42173572|FG002|Overall Study|Death|14|||
19728736|NCT03531632|42173570|FG000|Overall Study|Study Terminated|1|||
19728737|NCT03531632|42173571|FG001|Overall Study|Study Terminated|3|||
19728738|NCT03531632|42173572|FG002|Overall Study|Study Terminated|11|||
19728739|NCT03979638|42173583|FG000|Period 1|Physician Decision|1|||
19728740|NCT03979638|42173584|FG001|Period 1|Physician Decision|1|||
19728741|NCT03979638|42173583|FG000|Period 1|Withdrawal by Subject|4|||
19728742|NCT03979638|42173584|FG001|Period 1|Withdrawal by Subject|3|||
19728743|NCT03979638|42173583|FG000|Period 1|Study terminated by Sponsor|1|||
19728744|NCT03979638|42173584|FG001|Period 1|Study terminated by Sponsor|3|||
19728745|NCT03979638|42173583|FG000|Period 1|Protocol Violation|1|||
19728746|NCT03979638|42173584|FG001|Period 1|Protocol Violation|0|||
19728747|NCT03979638|42173583|FG000|Period 2|Study terminated by Sponsor|1|||
19728748|NCT03979638|42173584|FG001|Period 2|Study terminated by Sponsor|1|||
19728749|NCT03655054|42173599|FG000|Overall Study|Lost to Follow-up|1|||
19728750|NCT03615144|42173605|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
19728751|NCT03615144|42173606|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
19728752|NCT03682302|42173616|FG000|Overall Study|Lost to Follow-up|1|||
19728753|NCT03682302|42173617|FG001|Overall Study|Lost to Follow-up|2|||
19728754|NCT03682302|42173618|FG002|Overall Study|Lost to Follow-up|0|||
19728755|NCT03682302|42173619|FG003|Overall Study|Lost to Follow-up|1|||
19728756|NCT03682302|42173616|FG000|Overall Study|Study drug was not administered|0|||
19728757|NCT03682302|42173617|FG001|Overall Study|Study drug was not administered|0|||
19728758|NCT03682302|42173618|FG002|Overall Study|Study drug was not administered|1|||
19728759|NCT03682302|42173619|FG003|Overall Study|Study drug was not administered|1|||
19728760|NCT03522506|42173633|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19728761|NCT03522506|42173634|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19728762|NCT03522506|42173635|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19728763|NCT03522506|42173636|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19728764|NCT03522506|42173633|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19728765|NCT03522506|42173634|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19728766|NCT03522506|42173635|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19728767|NCT03522506|42173636|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
19728768|NCT02892734|42173667|FG000|Treatment on Study|Progressive Disease|2|||
19728769|NCT02892734|42173667|FG000|Follow up for 2 Years|Death|2|||
19728770|NCT02892734|42173667|FG000|Follow up for 2 Years|Study closed early|1|||
19728771|NCT00055497|42173675|FG000|Overall Study|Adverse Event|1|||
19728772|NCT00055497|42173676|FG001|Overall Study|Adverse Event|1|||
19728773|NCT00055497|42173677|FG002|Overall Study|Adverse Event|1|||
19728774|NCT00055497|42173678|FG003|Overall Study|Adverse Event|28|||
19728775|NCT00055497|42173675|FG000|Overall Study|Withdrawal by Subject|3|||
19728776|NCT00055497|42173676|FG001|Overall Study|Withdrawal by Subject|1|||
19728777|NCT00055497|42173677|FG002|Overall Study|Withdrawal by Subject|1|||
19728778|NCT00055497|42173678|FG003|Overall Study|Withdrawal by Subject|15|||
19728779|NCT00055497|42173675|FG000|Overall Study|Lost to Follow-up|0|||
19728780|NCT00055497|42173676|FG001|Overall Study|Lost to Follow-up|1|||
19728781|NCT00055497|42173677|FG002|Overall Study|Lost to Follow-up|0|||
19728782|NCT00055497|42173678|FG003|Overall Study|Lost to Follow-up|5|||
19728783|NCT00055497|42173675|FG000|Overall Study|Protocol Violation|0|||
19728784|NCT00055497|42173676|FG001|Overall Study|Protocol Violation|0|||
19728785|NCT00055497|42173677|FG002|Overall Study|Protocol Violation|0|||
19728786|NCT00055497|42173678|FG003|Overall Study|Protocol Violation|3|||
19728787|NCT00055497|42173675|FG000|Overall Study|Lack of Efficacy|1|||
19728788|NCT00055497|42173676|FG001|Overall Study|Lack of Efficacy|0|||
19728789|NCT00055497|42173677|FG002|Overall Study|Lack of Efficacy|0|||
19728790|NCT00055497|42173678|FG003|Overall Study|Lack of Efficacy|27|||
19728791|NCT00055497|42173675|FG000|Overall Study|Administrative Reasons|0|||
19728792|NCT00055497|42173676|FG001|Overall Study|Administrative Reasons|0|||
19728793|NCT00055497|42173677|FG002|Overall Study|Administrative Reasons|0|||
19728794|NCT00055497|42173678|FG003|Overall Study|Administrative Reasons|1|||
19728795|NCT00055497|42173675|FG000|Overall Study|Other|0|||
19728796|NCT00055497|42173676|FG001|Overall Study|Other|0|||
19728797|NCT00055497|42173677|FG002|Overall Study|Other|0|||
19728798|NCT00055497|42173678|FG003|Overall Study|Other|11|||
19728799|NCT03520400|42173695|FG000|Overall Study|Physician Decision|15|||
19728800|NCT03520400|42173696|FG001|Overall Study|Physician Decision|7|||
19728801|NCT03615066|42173705|FG000|Main Study|Withdrew Consent|0|||
19728802|NCT03615066|42173706|FG001|Main Study|Withdrew Consent|1|||
19728803|NCT03615066|42173707|FG002|Main Study|Withdrew Consent|1|||
19728804|NCT03615066|42173705|FG000|Main Study|Lost to Follow-up|0|||
19728805|NCT03615066|42173706|FG001|Main Study|Lost to Follow-up|0|||
19728806|NCT03615066|42173707|FG002|Main Study|Lost to Follow-up|1|||
19728807|NCT03615066|42173705|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
19728808|NCT03615066|42173706|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
19728809|NCT03615066|42173707|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
19728810|NCT03615066|42173705|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
19728811|NCT03615066|42173706|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
19728812|NCT03615066|42173707|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
19728813|NCT03615066|42173705|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
19728814|NCT03615066|42173706|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
19728815|NCT03615066|42173707|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
19728816|NCT03527966|42173721|FG000|Overall Study|Lost to Follow-up|3|||
19728817|NCT03527966|42173722|FG001|Overall Study|Lost to Follow-up|0|||
19728818|NCT03808545|42173730|FG000|Overall Study|Withdrawal by Subject|1|||
19728819|NCT03808545|42173731|FG001|Overall Study|Withdrawal by Subject|1|||
19728820|NCT03807843|42173740|FG000|Overall Study|Lost to Follow-up|1|||
19728821|NCT03807843|42173741|FG001|Overall Study|Lost to Follow-up|0|||
19728822|NCT03519932|42173747|FG000|First Intervention|Adverse Event|1|||
19728823|NCT03519932|42173748|FG001|First Intervention|Adverse Event|3|||
19728824|NCT03806127|42173761|FG000|Overall Study|Withdrawal by Subject|4|||
19728825|NCT03806127|42173762|FG001|Overall Study|Withdrawal by Subject|5|||
19728826|NCT03806127|42173761|FG000|Overall Study|Protocol Violation|3|||
19728827|NCT03806127|42173762|FG001|Overall Study|Protocol Violation|1|||
19728828|NCT03806127|42173761|FG000|Overall Study|Adverse Event|3|||
19728829|NCT03806127|42173762|FG001|Overall Study|Adverse Event|0|||
19728830|NCT03806127|42173761|FG000|Overall Study|Unable to Complete Procedures|0|||
19728831|NCT03806127|42173762|FG001|Overall Study|Unable to Complete Procedures|1|||
19728832|NCT03806127|42173761|FG000|Overall Study|Pregnancy|0|||
19728833|NCT03806127|42173762|FG001|Overall Study|Pregnancy|1|||
19728834|NCT03806127|42173761|FG000|Overall Study|Lost to Follow-up|5|||
19728835|NCT03806127|42173762|FG001|Overall Study|Lost to Follow-up|1|||
19728836|NCT03806127|42173761|FG000|Overall Study|Physician Decision|1|||
19728837|NCT03806127|42173762|FG001|Overall Study|Physician Decision|1|||
19728838|NCT03806127|42173761|FG000|Overall Study|Could Not Come Due to Covid|1|||
19728839|NCT03806127|42173762|FG001|Overall Study|Could Not Come Due to Covid|0|||
19728840|NCT03806127|42173761|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
19728841|NCT03806127|42173762|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
19728842|NCT03806127|42173761|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
19728843|NCT03806127|42173762|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
19728844|NCT03806127|42173761|FG000|Overall Study|Covid 19 Restrictions|2|||
19728845|NCT03806127|42173762|FG001|Overall Study|Covid 19 Restrictions|0|||
19728846|NCT03806127|42173761|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
19728847|NCT03806127|42173762|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
19728848|NCT03806127|42173761|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
19728849|NCT03806127|42173762|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
19728850|NCT02843074|42173768|FG000|Overall Study|Withdrawal by Subject|5|||
19728851|NCT02843074|42173768|FG000|Overall Study|Progressive disease|1|||
19728852|NCT02843074|42173768|FG000|Overall Study|Physician Decision|1|||
19728853|NCT02843074|42173768|FG000|Overall Study|Lost to Follow-up|1|||
19728854|NCT02843074|42173768|FG000|Overall Study|Death|9|||
19465226|NCT04426695|41723756|FG015|Overall Study|Lost to Follow-up|0|||
19728855|NCT03607422|42173778|FG000|Overall Study|Adverse Event|7|||
19728856|NCT03607422|42173779|FG001|Overall Study|Adverse Event|3|||
19728857|NCT03607422|42173780|FG002|Overall Study|Adverse Event|2|||
19465227|NCT04426695|41723757|FG016|Overall Study|Lost to Follow-up|0|||
19728858|NCT03607422|42173781|FG003|Overall Study|Adverse Event|0|||
19728859|NCT03607422|42173782|FG004|Overall Study|Adverse Event|2|||
19728860|NCT03607422|42173783|FG005|Overall Study|Adverse Event|0|||
19728861|NCT03607422|42173778|FG000|Overall Study|Withdrawal by Subject|11|||
19728862|NCT03607422|42173779|FG001|Overall Study|Withdrawal by Subject|3|||
19728863|NCT03607422|42173780|FG002|Overall Study|Withdrawal by Subject|6|||
19728864|NCT03607422|42173781|FG003|Overall Study|Withdrawal by Subject|2|||
19728865|NCT03607422|42173782|FG004|Overall Study|Withdrawal by Subject|0|||
19728866|NCT03607422|42173783|FG005|Overall Study|Withdrawal by Subject|0|||
19728867|NCT03607422|42173778|FG000|Overall Study|Lost to Follow-up|0|||
19728868|NCT03607422|42173779|FG001|Overall Study|Lost to Follow-up|0|||
19728869|NCT03607422|42173780|FG002|Overall Study|Lost to Follow-up|1|||
19728870|NCT03607422|42173781|FG003|Overall Study|Lost to Follow-up|0|||
19728871|NCT03607422|42173782|FG004|Overall Study|Lost to Follow-up|0|||
19728872|NCT03607422|42173783|FG005|Overall Study|Lost to Follow-up|0|||
19728873|NCT03607422|42173778|FG000|Overall Study|Other|12|||
19728874|NCT03607422|42173779|FG001|Overall Study|Other|4|||
19728875|NCT03607422|42173780|FG002|Overall Study|Other|1|||
19728876|NCT03607422|42173781|FG003|Overall Study|Other|2|||
19728877|NCT03607422|42173782|FG004|Overall Study|Other|0|||
19728878|NCT03607422|42173783|FG005|Overall Study|Other|2|||
19728879|NCT03607422|42173778|FG000|Overall Study|Ongoing at Time of Analysis|8|||
19728880|NCT03607422|42173779|FG001|Overall Study|Ongoing at Time of Analysis|0|||
19728881|NCT03607422|42173780|FG002|Overall Study|Ongoing at Time of Analysis|2|||
19728882|NCT03607422|42173781|FG003|Overall Study|Ongoing at Time of Analysis|1|||
19728883|NCT03607422|42173782|FG004|Overall Study|Ongoing at Time of Analysis|1|||
19728884|NCT03607422|42173783|FG005|Overall Study|Ongoing at Time of Analysis|1|||
19728885|NCT03650400|42173799|FG000|Overall Study|Study terminated by sponsor|0|||
19728886|NCT03650400|42173800|FG001|Overall Study|Study terminated by sponsor|5|||
19728887|NCT00038103|42173808|FG000|Overall Study|Adverse Event|5|||
19728888|NCT00038103|42173809|FG001|Overall Study|Adverse Event|6|||
19728889|NCT00038103|42173808|FG000|Overall Study|Lack of Efficacy|48|||
19728890|NCT00038103|42173809|FG001|Overall Study|Lack of Efficacy|41|||
19728891|NCT00038103|42173808|FG000|Overall Study|Withdrawal by Subject|0|||
19728892|NCT00038103|42173809|FG001|Overall Study|Withdrawal by Subject|3|||
19728893|NCT00038103|42173808|FG000|Overall Study|Lost to Follow-up|0|||
19728894|NCT00038103|42173809|FG001|Overall Study|Lost to Follow-up|3|||
19728895|NCT00038103|42173808|FG000|Overall Study|Protocol Violation|0|||
19728896|NCT00038103|42173809|FG001|Overall Study|Protocol Violation|2|||
19728897|NCT00038103|42173808|FG000|Overall Study|Sponsor Decision|0|||
19728898|NCT00038103|42173809|FG001|Overall Study|Sponsor Decision|1|||
19728899|NCT00038103|42173808|FG000|Overall Study|Randomized/never treated|2|||
19728900|NCT00038103|42173809|FG001|Overall Study|Randomized/never treated|0|||
19728901|NCT03680742|42173815|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
19728902|NCT03678870|42173821|FG000|Overall Study|prescribed non- protocol medications|10|||
19728903|NCT03678870|42173822|FG001|Overall Study|prescribed non- protocol medications|6|||
19728904|NCT03678870|42173821|FG000|Overall Study|Lost to Follow-up|3|||
19728905|NCT03678870|42173822|FG001|Overall Study|Lost to Follow-up|2|||
19728906|NCT03805971|42173828|FG000|Overall Study|Withdrawal by Subject|1|||
19728907|NCT03805971|42173828|FG000|Overall Study|Protocol Violation|2|||
19728908|NCT03032380|42173835|FG000|Overall Study|Adverse Event|0|||
19728909|NCT03032380|42173836|FG001|Overall Study|Adverse Event|1|||
19728910|NCT03032380|42173835|FG000|Overall Study|Lack of Efficacy|1|||
19728911|NCT03032380|42173836|FG001|Overall Study|Lack of Efficacy|0|||
19728912|NCT03032380|42173835|FG000|Overall Study|Withdrawal by Subject|2|||
19728913|NCT03032380|42173836|FG001|Overall Study|Withdrawal by Subject|3|||
19728914|NCT03032380|42173835|FG000|Overall Study|Recovery|0|||
19728915|NCT03032380|42173836|FG001|Overall Study|Recovery|1|||
19728916|NCT03032380|42173835|FG000|Overall Study|Death|39|||
19728917|NCT03032380|42173836|FG001|Overall Study|Death|34|||
19728918|NCT03032380|42173835|FG000|Overall Study|Other - Miscellaneous|0|||
19728919|NCT03032380|42173836|FG001|Overall Study|Other - Miscellaneous|1|||
19728920|NCT03519854|42173860|FG000|Overall Study|Technical Error|0|||
19728921|NCT03519854|42173861|FG001|Overall Study|Technical Error|0|||
19728922|NCT03519854|42173862|FG002|Overall Study|Technical Error|1|||
19728923|NCT03519854|42173863|FG003|Overall Study|Technical Error|0|||
19728924|NCT03519854|42173864|FG004|Overall Study|Technical Error|0|||
19728925|NCT03519854|42173865|FG005|Overall Study|Technical Error|0|||
19728926|NCT03519854|42173866|FG006|Overall Study|Technical Error|0|||
19728927|NCT03519854|42173867|FG007|Overall Study|Technical Error|0|||
19728928|NCT03519854|42173868|FG008|Overall Study|Technical Error|0|||
19728929|NCT03519854|42173869|FG009|Overall Study|Technical Error|0|||
19728930|NCT03519854|42173870|FG010|Overall Study|Technical Error|0|||
19728931|NCT03519854|42173871|FG011|Overall Study|Technical Error|0|||
19728932|NCT03519854|42173872|FG012|Overall Study|Technical Error|0|||
19728933|NCT03519854|42173873|FG013|Overall Study|Technical Error|0|||
19728934|NCT03519854|42173874|FG014|Overall Study|Technical Error|0|||
19728935|NCT03519854|42173875|FG015|Overall Study|Technical Error|0|||
19728936|NCT03519854|42173876|FG016|Overall Study|Technical Error|0|||
19728937|NCT03519854|42173877|FG017|Overall Study|Technical Error|0|||
19728938|NCT03479216|42173917|FG000|Overall Study|Withdrawal by Subject|3|||
19728939|NCT03479216|42173918|FG001|Overall Study|Withdrawal by Subject|2|||
19728940|NCT03479216|42173917|FG000|Overall Study|Physician Decision|2|||
19728941|NCT03479216|42173918|FG001|Overall Study|Physician Decision|3|||
19728942|NCT03518840|42173924|FG000|Overall Study|Lost to Follow-up|6|||
19728943|NCT03436082|42173933|FG000|Overall Study|Did not undergo procedure|1|||
19728944|NCT03436082|42173934|FG001|Overall Study|Did not undergo procedure|0|||
19728945|NCT03677934|42173942|FG000|Overall Study|Adverse Event|1|||
19728946|NCT03677934|42173943|FG001|Overall Study|Adverse Event|1|||
19728947|NCT03677934|42173942|FG000|Overall Study|Death|8|||
19728948|NCT03677934|42173943|FG001|Overall Study|Death|4|||
19728949|NCT03677934|42173942|FG000|Overall Study|Lost to Follow-up|3|||
19728950|NCT03677934|42173943|FG001|Overall Study|Lost to Follow-up|0|||
19728951|NCT03677934|42173942|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19728952|NCT03677934|42173943|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19728953|NCT03677934|42173942|FG000|Overall Study|Physician Decision|0|||
19728954|NCT03677934|42173943|FG001|Overall Study|Physician Decision|1|||
19728955|NCT03677934|42173942|FG000|Overall Study|Withdrawal by Subject|1|||
19728956|NCT03677934|42173943|FG001|Overall Study|Withdrawal by Subject|7|||
19728957|NCT03435692|42173955|FG000|Overall Study|Lack of Efficacy|2|||
19728958|NCT03435692|42173956|FG001|Overall Study|Lack of Efficacy|2|||
19728959|NCT03435692|42173957|FG002|Overall Study|Lack of Efficacy|0|||
19728960|NCT03475316|42173971|FG000|6 Month Intervention|Adverse Event|2|||
19728961|NCT03475316|42173972|FG001|6 Month Intervention|Adverse Event|1|||
19728962|NCT03475316|42173971|FG000|6 Month Intervention|Withdrawal by Subject|2|||
19728963|NCT03475316|42173972|FG001|6 Month Intervention|Withdrawal by Subject|0|||
19728964|NCT03475316|42173971|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
19728965|NCT03475316|42173972|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
19728966|NCT03475316|42173971|FG000|9 Months|Study stopped due to COVID pandemic|3|||
19728967|NCT03475316|42173972|FG001|9 Months|Study stopped due to COVID pandemic|4|||
19728968|NCT03673956|42173982|FG000|Overall Study|Lost to Follow-up|1|||
19728969|NCT03673956|42173983|FG001|Overall Study|Lost to Follow-up|0|||
19728970|NCT03673956|42173984|FG002|Overall Study|Lost to Follow-up|0|||
19728971|NCT03673956|42173985|FG003|Overall Study|Lost to Follow-up|0|||
19728972|NCT03673956|42173982|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
19728973|NCT03673956|42173983|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
19728974|NCT03673956|42173984|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
19728975|NCT03673956|42173985|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
19728976|NCT03517436|42173995|FG000|Overall Study|Death|3|||
19728977|NCT03517436|42173995|FG000|Overall Study|Withdrawal by Subject|4|||
19728978|NCT03517436|42173995|FG000|Overall Study|Did not receive study valve.|1|||
19728979|NCT03673098|42174001|FG000|Overall Study|Lost to Follow-up|2|||
19728980|NCT03673098|42174002|FG001|Overall Study|Lost to Follow-up|3|||
19728981|NCT03673098|42174001|FG000|Overall Study|Withdrawal by Subject|6|||
19728982|NCT03673098|42174002|FG001|Overall Study|Withdrawal by Subject|1|||
19728983|NCT03673098|42174001|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
19728984|NCT03673098|42174002|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
19728985|NCT03435224|42174015|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
19728986|NCT03672396|42174019|FG000|Overall Study|Withdrawal by Subject|4|||
19728987|NCT03672396|42174019|FG000|Overall Study|Physician Decision|1|||
19728988|NCT03672396|42174019|FG000|Overall Study|Adverse Event|1|||
19728989|NCT03434834|42174023|FG000|Overall Study|unable to swallow OCT probe|16|||
19728990|NCT03605862|42174029|FG000|Overall Study|Withdrawal by Subject|12|||
19728991|NCT03605862|42174030|FG001|Overall Study|Withdrawal by Subject|9|||
19728992|NCT03605862|42174029|FG000|Overall Study|Adverse Event|2|||
19728993|NCT03605862|42174030|FG001|Overall Study|Adverse Event|1|||
19728994|NCT03605862|42174029|FG000|Overall Study|Physician Decision|3|||
19728995|NCT03605862|42174030|FG001|Overall Study|Physician Decision|1|||
19728996|NCT03605862|42174029|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
19728997|NCT03605862|42174030|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
19728998|NCT03672006|42174039|FG000|Overall Study|exclusion criteria met|0|||
19728999|NCT03672006|42174040|FG001|Overall Study|exclusion criteria met|1|||
19729000|NCT03512288|42174050|FG000|Overall Study|Adverse Event|1|||
19729001|NCT03512288|42174051|FG001|Overall Study|Adverse Event|0|||
19729002|NCT03512288|42174050|FG000|Overall Study|Lost to Follow-up|12|||
19729003|NCT03512288|42174051|FG001|Overall Study|Lost to Follow-up|15|||
19729004|NCT03512288|42174050|FG000|Overall Study|Physician Decision|0|||
19729005|NCT03512288|42174051|FG001|Overall Study|Physician Decision|2|||
19729006|NCT03512288|42174050|FG000|Overall Study|Protocol Violation|6|||
19729007|NCT03512288|42174051|FG001|Overall Study|Protocol Violation|4|||
19729008|NCT03512288|42174050|FG000|Overall Study|Medication error without associated adverse event|1|||
19729009|NCT03512288|42174051|FG001|Overall Study|Medication error without associated adverse event|0|||
19729010|NCT03512288|42174050|FG000|Overall Study|No longer met eligibility criteria|5|||
19729011|NCT03512288|42174051|FG001|Overall Study|No longer met eligibility criteria|2|||
19729012|NCT03512288|42174050|FG000|Overall Study|Withdrawal by parent/guardian|14|||
19729013|NCT03512288|42174051|FG001|Overall Study|Withdrawal by parent/guardian|18|||
19729014|NCT03512288|42174050|FG000|Overall Study|Other|1|||
19729015|NCT03512288|42174051|FG001|Overall Study|Other|1|||
19729016|NCT03512288|42174050|FG000|Overall Study|Randomized but not treated|1|||
19729017|NCT03512288|42174051|FG001|Overall Study|Randomized but not treated|1|||
19729018|NCT03031678|42174057|FG000|Overall Study|Study closed prior to completion|1|||
19729019|NCT03669588|42174067|FG000|Overall Study|Adverse Event|1|||
19729020|NCT03669588|42174068|FG001|Overall Study|Adverse Event|0|||
19729021|NCT03669588|42174067|FG000|Overall Study|Physician Decision|0|||
19729022|NCT03669588|42174068|FG001|Overall Study|Physician Decision|1|||
19729023|NCT03669588|42174067|FG000|Overall Study|Protocol Violation|1|||
19729024|NCT03669588|42174068|FG001|Overall Study|Protocol Violation|0|||
19729025|NCT03669588|42174067|FG000|Overall Study|Sponsor Decision|1|||
19729026|NCT03669588|42174068|FG001|Overall Study|Sponsor Decision|1|||
19729027|NCT03669588|42174067|FG000|Overall Study|Withdrawal by Subject|1|||
19729028|NCT03669588|42174068|FG001|Overall Study|Withdrawal by Subject|4|||
19729029|NCT03669588|42174067|FG000|Overall Study|Rescue Therapy Needed|0|||
19729030|NCT03669588|42174068|FG001|Overall Study|Rescue Therapy Needed|1|||
19729031|NCT03646656|42174094|FG000|Overall Study|Lost to Follow-up|1|||
19729032|NCT03646656|42174095|FG001|Overall Study|Lost to Follow-up|0|||
19729033|NCT03646656|42174094|FG000|Overall Study|Withdrawal by Subject|2|||
19729034|NCT03646656|42174095|FG001|Overall Study|Withdrawal by Subject|0|||
19729035|NCT03598140|42174107|FG000|Overall Study|enrolled but didn't start|1|||
19729036|NCT03598140|42174108|FG001|Overall Study|enrolled but didn't start|0|||
19729037|NCT03644550|42174114|FG000|Overall Study|Withdrawal by Subject|3|||
19729038|NCT03644550|42174114|FG000|Overall Study|Progressive disease|15|||
19729039|NCT03511664|42174121|FG000|Overall Study|Treatment ongoing|49|||
19729040|NCT03511664|42174122|FG001|Overall Study|Treatment ongoing|5|||
19729041|NCT03511664|42174121|FG000|Overall Study|Entered long-term follow-up|140|||
19729042|NCT03511664|42174122|FG001|Overall Study|Entered long-term follow-up|50|||
19729043|NCT03511664|42174121|FG000|Overall Study|Withdrawal by Subject|29|||
19729044|NCT03511664|42174122|FG001|Overall Study|Withdrawal by Subject|53|||
19729045|NCT03511664|42174121|FG000|Overall Study|Lost to Follow-up|4|||
19729046|NCT03511664|42174122|FG001|Overall Study|Lost to Follow-up|4|||
19729047|NCT03511664|42174121|FG000|Overall Study|Physician Decision|0|||
19729048|NCT03511664|42174122|FG001|Overall Study|Physician Decision|1|||
19729049|NCT00054717|42174130|FG000|Overall Study|Randomized but not treated|2|||
19729050|NCT00054717|42174131|FG001|Overall Study|Randomized but not treated|8|||
19729051|NCT00054717|42174130|FG000|Overall Study|Adverse Event|70|||
19729052|NCT00054717|42174131|FG001|Overall Study|Adverse Event|22|||
19729053|NCT00054717|42174130|FG000|Overall Study|Protocol Violation|18|||
19729054|NCT00054717|42174131|FG001|Overall Study|Protocol Violation|19|||
19729055|NCT00054717|42174130|FG000|Overall Study|Lost to Follow-up|23|||
19729056|NCT00054717|42174131|FG001|Overall Study|Lost to Follow-up|13|||
19729057|NCT00054717|42174130|FG000|Overall Study|Withdrawal by Subject|32|||
19729058|NCT00054717|42174131|FG001|Overall Study|Withdrawal by Subject|20|||
19729059|NCT00054717|42174130|FG000|Overall Study|Other reason not defined above|117|||
19729060|NCT00054717|42174131|FG001|Overall Study|Other reason not defined above|217|||
19729061|NCT03430856|42174140|FG000|Overall Study|Adverse Event|0|||
19729062|NCT03430856|42174141|FG001|Overall Study|Adverse Event|1|||
19729063|NCT03430856|42174142|FG002|Overall Study|Adverse Event|0|||
19729064|NCT03430856|42174140|FG000|Overall Study|Rescue criteria|1|||
19729065|NCT03430856|42174141|FG001|Overall Study|Rescue criteria|1|||
19729066|NCT03430856|42174142|FG002|Overall Study|Rescue criteria|0|||
19729067|NCT03430856|42174140|FG000|Overall Study|Voluntary withdrawal of consent|1|||
19729068|NCT03430856|42174141|FG001|Overall Study|Voluntary withdrawal of consent|1|||
19729069|NCT03430856|42174142|FG002|Overall Study|Voluntary withdrawal of consent|1|||
19729070|NCT03731364|42174158|FG000|Overall Study|Adverse Event|0|||
19729071|NCT03731364|42174159|FG001|Overall Study|Adverse Event|0|||
19729072|NCT03731364|42174160|FG002|Overall Study|Adverse Event|1|||
19729073|NCT03731364|42174161|FG003|Overall Study|Adverse Event|2|||
19729074|NCT03731364|42174162|FG004|Overall Study|Adverse Event|1|||
19729075|NCT03510182|42174174|FG000|Overall Study|Withdrawal by Subject|2|||
19729076|NCT00066807|42174180|FG000|Overall Study|Study was terminated early|14|||
19729077|NCT00066807|42174181|FG001|Overall Study|Study was terminated early|15|||
19729078|NCT03428750|42174189|FG000|Overall Study|Withdrawal by Subject|11|||
19729079|NCT03428750|42174190|FG001|Overall Study|Withdrawal by Subject|10|||
19729080|NCT03428750|42174189|FG000|Overall Study|Lost to Follow-up|3|||
19729081|NCT03428750|42174190|FG001|Overall Study|Lost to Follow-up|9|||
19729082|NCT03428750|42174189|FG000|Overall Study|Adverse Event|9|||
19729083|NCT03428750|42174190|FG001|Overall Study|Adverse Event|1|||
19729084|NCT03428750|42174189|FG000|Overall Study|Protocol Violation|1|||
19729085|NCT03428750|42174190|FG001|Overall Study|Protocol Violation|0|||
19465228|NCT04426695|41723758|FG017|Overall Study|Lost to Follow-up|0|||
19729086|NCT03428750|42174189|FG000|Overall Study|Administrative|0|||
19729087|NCT03428750|42174190|FG001|Overall Study|Administrative|1|||
19729088|NCT03666858|42174219|FG000|Cohort 1|Adverse Event|1|||
19729089|NCT03666858|42174220|FG001|Cohort 1|Adverse Event|0|||
19729090|NCT03666858|42174219|FG000|Cohort 2|Adverse Event|0|||
19729091|NCT03666858|42174220|FG001|Cohort 2|Adverse Event|1|||
19729092|NCT00054639|42174226|FG000|Overall Study|Lack of Efficacy|1|||
19729093|NCT00054639|42174226|FG000|Overall Study|Physician Decision|1|||
19729094|NCT03428360|42174230|FG000|Overall Study|Informed consent withdrawn|5|||
19729095|NCT03428360|42174230|FG000|Overall Study|Withdrawal by Subject|4|||
19729096|NCT03428360|42174230|FG000|Overall Study|Lost to Follow-up|5|||
19729097|NCT03428360|42174230|FG000|Overall Study|Physician Decision|2|||
19729098|NCT03428360|42174230|FG000|Overall Study|Informed consent withdrawn|5|||
19729099|NCT03428360|42174230|FG000|Overall Study|Study terminated by sponsor|10|||
19729100|NCT03428360|42174230|FG000|Overall Study|Non-compliant with study|1|||
19729101|NCT03428360|42174230|FG000|Overall Study|Non-compliant with study drug|3|||
19729102|NCT03428360|42174230|FG000|Overall Study|Death|3|||
19729103|NCT03428360|42174230|FG000|Overall Study|Adverse Event|1|||
19729104|NCT03428360|42174230|FG000|Overall Study|Not on antiepileptic drug|1|||
19729105|NCT03427892|42174238|FG000|Overall Study|Lost to Follow-up|2|||
19729106|NCT03595332|42174244|FG000|Overall Study|Lost to Follow-up|16|||
19729107|NCT03595332|42174245|FG001|Overall Study|Lost to Follow-up|22|||
19729108|NCT03595332|42174244|FG000|Overall Study|Unable to retrieve ID from school|0|||
19729109|NCT03595332|42174245|FG001|Overall Study|Unable to retrieve ID from school|2|||
19729110|NCT03427268|42174254|FG000|Overall Study|Progressive disease|25|||
19729111|NCT03427268|42174254|FG000|Overall Study|Never treated|2|||
19729112|NCT03427268|42174254|FG000|Overall Study|Compassionate use|1|||
19729113|NCT03427268|42174254|FG000|Overall Study|Withdrawal by Subject|1|||
19729114|NCT03427268|42174254|FG000|Overall Study|Adverse Event|3|||
19729115|NCT03509948|42174258|FG000|Overall Study|Protocol Violation|0|||
19729116|NCT03509948|42174259|FG001|Overall Study|Protocol Violation|1|||
19729117|NCT03466658|42174265|FG000|Overall Study|Withdrawal by Subject|3|||
19729118|NCT03425396|42174276|FG000|Overall Study|Lost to Follow-up|2|||
19729119|NCT03425396|42174277|FG001|Overall Study|Lost to Follow-up|5|||
19729120|NCT03425396|42174278|FG002|Overall Study|Lost to Follow-up|2|||
19729121|NCT03425396|42174279|FG003|Overall Study|Lost to Follow-up|0|||
19729122|NCT03425396|42174280|FG004|Overall Study|Lost to Follow-up|0|||
19729123|NCT03425396|42174276|FG000|Overall Study|Withdrawal by Subject|0|||
19729124|NCT03425396|42174277|FG001|Overall Study|Withdrawal by Subject|1|||
19729125|NCT03425396|42174278|FG002|Overall Study|Withdrawal by Subject|0|||
19729126|NCT03425396|42174279|FG003|Overall Study|Withdrawal by Subject|1|||
19729127|NCT03425396|42174280|FG004|Overall Study|Withdrawal by Subject|0|||
19729128|NCT03425396|42174276|FG000|Overall Study|Other|0|||
19729129|NCT03425396|42174277|FG001|Overall Study|Other|1|||
19729130|NCT03425396|42174278|FG002|Overall Study|Other|1|||
19729131|NCT03425396|42174279|FG003|Overall Study|Other|0|||
19729132|NCT03425396|42174280|FG004|Overall Study|Other|1|||
19729133|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
19729134|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
19729135|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
19729136|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
19729137|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Death|1|||
19729138|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Death|1|||
19729139|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
19729140|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
19729141|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
19729142|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
19729143|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
19729144|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
19729145|NCT00033657|42174294|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
19729146|NCT00033657|42174295|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
19729147|NCT00033657|42174294|FG000|Surgical Resection|not complete resection|0|||
19729148|NCT00033657|42174295|FG001|Surgical Resection|not complete resection|3|||
19729149|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
19729150|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
19729151|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
19729152|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
19729153|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|Death|2|||
19729154|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|Death|1|||
19729155|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
19729156|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
19729157|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
19729158|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
19729159|NCT00033657|42174294|FG000|Adjuvant Chemotherapy|Other|0|||
19729160|NCT00033657|42174295|FG001|Adjuvant Chemotherapy|Other|2|||
19729161|NCT00066729|42174303|FG000|Overall Study|Lost to Follow-up|1|||
19729162|NCT00066729|42174303|FG000|Overall Study|Disease progression|1|||
19729163|NCT00032487|42174309|FG000|Overall Study|Withdrawal by Subject|67|||
19729164|NCT00032487|42174310|FG001|Overall Study|Withdrawal by Subject|43|||
19729165|NCT00032487|42174309|FG000|Overall Study|Adverse Event|3|||
19729166|NCT00032487|42174310|FG001|Overall Study|Adverse Event|7|||
19729167|NCT00032487|42174309|FG000|Overall Study|Lost to Follow-up|57|||
19729168|NCT00032487|42174310|FG001|Overall Study|Lost to Follow-up|58|||
19729169|NCT00032487|42174309|FG000|Overall Study|Had other reason|12|||
19729170|NCT00032487|42174310|FG001|Overall Study|Had other reason|12|||
19729171|NCT03595176|42174318|FG000|Overall Study|Death|0|||
19729172|NCT03595176|42174319|FG001|Overall Study|Death|2|||
19729173|NCT03595176|42174318|FG000|Overall Study|Lost to Follow-up|0|||
19729174|NCT03595176|42174319|FG001|Overall Study|Lost to Follow-up|1|||
19729175|NCT03641508|42174327|FG000|First Injection|Lost to Follow-up|2|||
19729176|NCT03641508|42174328|FG001|First Injection|Lost to Follow-up|0|||
19729177|NCT00066573|42174336|FG000|Overall Study|Did not received protocol treatment|28|||
19729178|NCT00066573|42174337|FG001|Overall Study|Did not received protocol treatment|28|||
19729179|NCT03465878|42174345|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
19729180|NCT03465878|42174346|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
19729181|NCT03465878|42174347|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
19729182|NCT03465878|42174348|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
19729183|NCT03465878|42174345|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
19729184|NCT03465878|42174346|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
19729185|NCT03465878|42174347|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
19729186|NCT03465878|42174348|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
19729187|NCT03465878|42174345|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
19729188|NCT03465878|42174346|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
19729189|NCT03465878|42174347|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
19729190|NCT03465878|42174348|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
19729191|NCT03637374|42174376|FG000|Overall Study|Death|2|||
19729192|NCT03637374|42174377|FG001|Overall Study|Death|0|||
19729193|NCT03421730|42174383|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729194|NCT03421730|42174384|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
19729195|NCT03421730|42174385|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729196|NCT03421730|42174386|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729197|NCT03421730|42174387|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729198|NCT03421730|42174388|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729199|NCT03421730|42174389|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729200|NCT03421730|42174390|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729201|NCT03421730|42174391|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729202|NCT03421730|42174392|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729203|NCT03421730|42174393|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729204|NCT03421730|42174394|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
19729205|NCT03421730|42174383|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729206|NCT03421730|42174384|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729207|NCT03421730|42174385|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729208|NCT03421730|42174386|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729209|NCT03421730|42174387|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
19729210|NCT03421730|42174388|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729211|NCT03421730|42174389|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729212|NCT03421730|42174390|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729213|NCT03421730|42174391|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729214|NCT03421730|42174392|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729215|NCT03421730|42174393|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729216|NCT03421730|42174394|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
19729217|NCT00054327|42174414|FG000|Overall Study|Engraftment failure|1|||
19729218|NCT00054327|42174415|FG001|Overall Study|Engraftment failure|0|||
19729219|NCT00054327|42174416|FG002|Overall Study|Engraftment failure|0|||
19729220|NCT00054327|42174417|FG003|Overall Study|Engraftment failure|0|||
19729221|NCT00054327|42174418|FG004|Overall Study|Engraftment failure|0|||
19729222|NCT00054327|42174419|FG005|Overall Study|Engraftment failure|0|||
19729223|NCT03503162|42174433|FG000|Overall Study|did not meet eligibility|1|||
19729224|NCT03029650|42174437|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
19729225|NCT03029650|42174438|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
19729226|NCT03029650|42174437|FG000|Washout (1 Week)|Physician Decision|0|||
19729227|NCT03029650|42174438|FG001|Washout (1 Week)|Physician Decision|1|||
19729228|NCT03462680|42174450|FG000|Overall Study|Withdrawal by Subject|3|||
19729229|NCT03462680|42174451|FG001|Overall Study|Withdrawal by Subject|5|||
19729230|NCT03636906|42174460|FG000|Overall Study|Adverse Event|0|||
19729231|NCT03636906|42174461|FG001|Overall Study|Adverse Event|0|||
19729232|NCT03636906|42174462|FG002|Overall Study|Adverse Event|1|||
19729233|NCT03636906|42174460|FG000|Overall Study|Lost to Follow-up|1|||
19729234|NCT03636906|42174461|FG001|Overall Study|Lost to Follow-up|0|||
19729235|NCT03636906|42174462|FG002|Overall Study|Lost to Follow-up|0|||
19729236|NCT03636906|42174460|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
19729237|NCT03636906|42174461|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
19729238|NCT03636906|42174462|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
19729239|NCT03636906|42174460|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
19729240|NCT03636906|42174461|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19729241|NCT03636906|42174462|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
19729242|NCT03636906|42174460|FG000|Overall Study|Other|0|||
19729243|NCT03636906|42174461|FG001|Overall Study|Other|0|||
19729244|NCT03636906|42174462|FG002|Overall Study|Other|1|||
19729245|NCT03028870|42174480|FG000|Overall Study|Adverse Event|7|||
19729246|NCT03028870|42174481|FG001|Overall Study|Adverse Event|4|||
19729247|NCT03028870|42174482|FG002|Overall Study|Adverse Event|3|||
19729248|NCT03028870|42174483|FG003|Overall Study|Adverse Event|3|||
19729249|NCT03028870|42174480|FG000|Overall Study|Withdrawal by Subject|1|||
19729250|NCT03028870|42174481|FG001|Overall Study|Withdrawal by Subject|1|||
19729251|NCT03028870|42174482|FG002|Overall Study|Withdrawal by Subject|1|||
19729252|NCT03028870|42174483|FG003|Overall Study|Withdrawal by Subject|2|||
19729253|NCT03028870|42174480|FG000|Overall Study|Lost to Follow-up|1|||
19729254|NCT03028870|42174481|FG001|Overall Study|Lost to Follow-up|0|||
19729255|NCT03028870|42174482|FG002|Overall Study|Lost to Follow-up|0|||
19729256|NCT03028870|42174483|FG003|Overall Study|Lost to Follow-up|0|||
19729257|NCT03028870|42174480|FG000|Overall Study|Lack of Efficacy|3|||
19729258|NCT03028870|42174481|FG001|Overall Study|Lack of Efficacy|0|||
19729259|NCT03028870|42174482|FG002|Overall Study|Lack of Efficacy|0|||
19729260|NCT03028870|42174483|FG003|Overall Study|Lack of Efficacy|0|||
19729261|NCT03028870|42174480|FG000|Overall Study|Administrative|5|||
19729262|NCT03028870|42174481|FG001|Overall Study|Administrative|5|||
19729263|NCT03028870|42174482|FG002|Overall Study|Administrative|12|||
19729264|NCT03028870|42174483|FG003|Overall Study|Administrative|4|||
19729265|NCT03663582|42174493|FG000|Overall Study|Physician Decision|1|||
19729266|NCT03502616|42174499|FG000|Up to Week 16|Withdrawal by Subject|1|||
19380765|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
19380766|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19380767|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
19380768|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19380769|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19380770|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19465229|NCT04426695|41723741|FG000|Overall Study|Participant Decision|1|||
19729267|NCT03502616|42174500|FG001|Up to Week 16|Withdrawal by Subject|2|||
19729268|NCT03502616|42174499|FG000|Up to Week 16|Lost to Follow-up|0|||
19729269|NCT03502616|42174500|FG001|Up to Week 16|Lost to Follow-up|1|||
19729270|NCT03502616|42174499|FG000|Up to Week 16|Randomized, but not treated|1|||
19729271|NCT03502616|42174500|FG001|Up to Week 16|Randomized, but not treated|0|||
19729272|NCT03502616|42174499|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
19729273|NCT03502616|42174500|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
19729274|NCT03502616|42174499|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
19729275|NCT03502616|42174500|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
19729276|NCT03028012|42174521|FG000|Overall Study|Lost to Follow-up|2|||
19729277|NCT03028012|42174522|FG001|Overall Study|Lost to Follow-up|3|||
19729278|NCT03028012|42174523|FG002|Overall Study|Lost to Follow-up|3|||
19729279|NCT03635190|42174532|FG000|Overall Study|Lost to Follow-up|4|||
19729280|NCT03635190|42174532|FG000|Overall Study|Death|3|||
19729281|NCT03635190|42174532|FG000|Overall Study|Withdrawal by Subject|1|||
19465230|NCT04426695|41723742|FG001|Overall Study|Participant Decision|2|||
19729282|NCT03635190|42174532|FG000|Overall Study|Patient moved and did not return for follow up|1|||
19729283|NCT03634800|42174539|FG000|Overall Study|Adverse Event|1|||
19729284|NCT03634800|42174539|FG000|Overall Study|Disease Progression|4|||
19729285|NCT03634800|42174539|FG000|Overall Study|Withdrawal by Subject|1|||
19729286|NCT03027466|42174547|FG000|Overall Study|Opting out of the app|1869|||
19729287|NCT03027466|42174548|FG001|Overall Study|Opting out of the app|1819|||
19729288|NCT03027466|42174549|FG002|Overall Study|Opting out of the app|1743|||
19729289|NCT03027466|42174550|FG003|Overall Study|Opting out of the app|1821|||
19729290|NCT03662334|42174562|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
19729291|NCT03662334|42174563|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
19729292|NCT02955186|42174571|FG000|Overall Study|Withdrawal by Subject|6|||
19729293|NCT02955186|42174572|FG001|Overall Study|Withdrawal by Subject|2|||
19729294|NCT02955186|42174571|FG000|Overall Study|Protocol Violation|1|||
19729295|NCT02955186|42174572|FG001|Overall Study|Protocol Violation|0|||
19729296|NCT03502070|42174578|FG000|Overall Study|Withdrawal by Subject|1|||
19729297|NCT03502070|42174578|FG000|Overall Study|Screen Failure|1|||
19729298|NCT03586830|42174586|FG000|Overall Study|Site terminated by Sponsor|1|||
19729299|NCT03586830|42174587|FG001|Overall Study|Site terminated by Sponsor|4|||
19729300|NCT03586830|42174588|FG002|Overall Study|Site terminated by Sponsor|3|||
19729301|NCT03586830|42174589|FG003|Overall Study|Site terminated by Sponsor|3|||
19729302|NCT03586830|42174586|FG000|Overall Study|Lost to Follow-up|0|||
19729303|NCT03586830|42174587|FG001|Overall Study|Lost to Follow-up|2|||
19729304|NCT03586830|42174588|FG002|Overall Study|Lost to Follow-up|2|||
19729305|NCT03586830|42174589|FG003|Overall Study|Lost to Follow-up|1|||
19729306|NCT03586830|42174586|FG000|Overall Study|Withdrawal by Subject|1|||
19729307|NCT03586830|42174587|FG001|Overall Study|Withdrawal by Subject|0|||
19729308|NCT03586830|42174588|FG002|Overall Study|Withdrawal by Subject|3|||
19729309|NCT03586830|42174589|FG003|Overall Study|Withdrawal by Subject|1|||
19729310|NCT03026530|42174601|FG000|Overall Study|Lost to Follow-up|19|||
19729311|NCT03026530|42174602|FG001|Overall Study|Lost to Follow-up|24|||
19729312|NCT03026530|42174601|FG000|Overall Study|Protocol Violation|2|||
19729313|NCT03026530|42174602|FG001|Overall Study|Protocol Violation|5|||
19729314|NCT03418376|42174612|FG000|Overall Study|Musculoskeletal injury|1|||
19729315|NCT03418376|42174613|FG001|Overall Study|Musculoskeletal injury|2|||
19729316|NCT03418376|42174614|FG002|Overall Study|Musculoskeletal injury|1|||
19729317|NCT03418376|42174615|FG003|Overall Study|Musculoskeletal injury|0|||
19729318|NCT03418376|42174612|FG000|Overall Study|Personal reasons|0|||
19729319|NCT03418376|42174613|FG001|Overall Study|Personal reasons|2|||
19729320|NCT03418376|42174614|FG002|Overall Study|Personal reasons|2|||
19729321|NCT03418376|42174615|FG003|Overall Study|Personal reasons|1|||
19729322|NCT03418376|42174612|FG000|Overall Study|Exacerbation|0|||
19729323|NCT03418376|42174613|FG001|Overall Study|Exacerbation|1|||
19729324|NCT03418376|42174614|FG002|Overall Study|Exacerbation|0|||
19729325|NCT03418376|42174615|FG003|Overall Study|Exacerbation|0|||
19729326|NCT03585504|42174627|FG000|Overall Study|Lost to Follow-up|26|||
19729327|NCT03585504|42174628|FG001|Overall Study|Lost to Follow-up|29|||
19729328|NCT03417830|42174636|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
19729329|NCT03417830|42174637|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
19729330|NCT03576768|42174648|FG000|Overall Study|Lost to Follow-up|3|||
19729331|NCT03576768|42174649|FG001|Overall Study|Lost to Follow-up|3|||
19729332|NCT03576768|42174650|FG002|Overall Study|Lost to Follow-up|0|||
19729333|NCT03576768|42174651|FG003|Overall Study|Lost to Follow-up|0|||
19729334|NCT03576066|42174663|FG000|Overall Study|Noncompliance with study drug|0|||
19729335|NCT03576066|42174664|FG001|Overall Study|Noncompliance with study drug|1|||
19729336|NCT03557034|42174676|FG000|Overall Study|Withdrawal by Subject|1|||
19729337|NCT03557034|42174677|FG001|Overall Study|Withdrawal by Subject|0|||
19729338|NCT03583554|42174683|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
19729339|NCT03583554|42174684|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
19729340|NCT03583554|42174685|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
19729341|NCT03948178|42174696|FG000|Overall Study|Protocol Violation|1|||
19729342|NCT03948178|42174696|FG000|Overall Study|Lost to Follow-up|2|||
19729343|NCT03948178|42174696|FG000|Overall Study|Withdrawal by Subject|2|||
19729344|NCT03948178|42174696|FG000|Overall Study|Reason not known|2|||
19729345|NCT03948178|42174696|FG000|Overall Study|Personal reason|14|||
19729346|NCT03948178|42174696|FG000|Overall Study|Disease progression|30|||
19729347|NCT03948178|42174696|FG000|Overall Study|Adverse Event|12|||
19729348|NCT03948178|42174696|FG000|Overall Study|Sponsor terminated study|164|||
19729349|NCT03520920|42174703|FG000|Overall Study|Death|13|||
19729350|NCT03520920|42174704|FG001|Overall Study|Death|1|||
19729351|NCT03520920|42174705|FG002|Overall Study|Death|0|||
19729352|NCT03520920|42174703|FG000|Overall Study|Withdrawal by Subject|2|||
19729353|NCT03520920|42174704|FG001|Overall Study|Withdrawal by Subject|1|||
19729354|NCT03520920|42174705|FG002|Overall Study|Withdrawal by Subject|0|||
19729355|NCT03520920|42174703|FG000|Overall Study|Study Terminated by the Sponsor|5|||
19729356|NCT03520920|42174704|FG001|Overall Study|Study Terminated by the Sponsor|14|||
19729357|NCT03520920|42174705|FG002|Overall Study|Study Terminated by the Sponsor|5|||
19729358|NCT02953340|42174721|FG000|Overall Study|Death|0|||
19729359|NCT02953340|42174722|FG001|Overall Study|Death|1|||
19729360|NCT02953340|42174721|FG000|Overall Study|Investigator Decision|3|||
19729361|NCT02953340|42174722|FG001|Overall Study|Investigator Decision|3|||
19729362|NCT02953340|42174721|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
19729363|NCT02953340|42174722|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
19729364|NCT02953340|42174721|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
19729365|NCT02953340|42174722|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
19729366|NCT02953340|42174721|FG000|Overall Study|Withdrawal by Subject|9|||
19729367|NCT02953340|42174722|FG001|Overall Study|Withdrawal by Subject|9|||
19729368|NCT02953340|42174721|FG000|Overall Study|Sponsor decision|0|||
19729369|NCT02953340|42174722|FG001|Overall Study|Sponsor decision|2|||
19729370|NCT02953340|42174721|FG000|Overall Study|Lost to Follow-up|3|||
19729371|NCT02953340|42174722|FG001|Overall Study|Lost to Follow-up|2|||
19729372|NCT02953340|42174721|FG000|Overall Study|Reason not specified|2|||
19729373|NCT02953340|42174722|FG001|Overall Study|Reason not specified|2|||
19729374|NCT03554772|42174738|FG000|Overall Study|Lost to Follow-up|0|||
19729375|NCT03554772|42174739|FG001|Overall Study|Lost to Follow-up|0|||
19729376|NCT03554772|42174740|FG002|Overall Study|Lost to Follow-up|0|||
19729377|NCT03554772|42174741|FG003|Overall Study|Lost to Follow-up|2|||
19729378|NCT03573804|42174751|FG000|Overall Study|claustrophobia or MRI table problems|10|||
19729379|NCT03417440|42174769|FG000|Overall Study|Lost to Follow-up|0|||
19729380|NCT03417440|42174770|FG001|Overall Study|Lost to Follow-up|1|||
19729381|NCT03417440|42174771|FG002|Overall Study|Lost to Follow-up|0|||
19729382|NCT03417440|42174772|FG003|Overall Study|Lost to Follow-up|0|||
19729383|NCT03417440|42174773|FG004|Overall Study|Lost to Follow-up|1|||
19729384|NCT03417440|42174774|FG005|Overall Study|Lost to Follow-up|0|||
19729385|NCT03417440|42174775|FG006|Overall Study|Lost to Follow-up|0|||
19729386|NCT03417440|42174776|FG007|Overall Study|Lost to Follow-up|0|||
19729387|NCT03417440|42174769|FG000|Overall Study|Withdrawal by Subject|2|||
19729388|NCT03417440|42174770|FG001|Overall Study|Withdrawal by Subject|0|||
19729389|NCT03417440|42174771|FG002|Overall Study|Withdrawal by Subject|2|||
19729390|NCT03417440|42174772|FG003|Overall Study|Withdrawal by Subject|1|||
19729391|NCT03417440|42174773|FG004|Overall Study|Withdrawal by Subject|1|||
19729392|NCT03417440|42174774|FG005|Overall Study|Withdrawal by Subject|0|||
19729393|NCT03417440|42174775|FG006|Overall Study|Withdrawal by Subject|0|||
19729394|NCT03417440|42174776|FG007|Overall Study|Withdrawal by Subject|1|||
19729395|NCT03458702|42174799|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
19729396|NCT03458702|42174800|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
19729397|NCT03458702|42174799|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
19729398|NCT03458702|42174800|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
19729399|NCT03454412|42174806|FG000|Baseline Assesment|Physician Decision|12|||
19729400|NCT03452540|42174810|FG000|Overall Study|Adverse Event|1|||
19729401|NCT03452540|42174810|FG000|Overall Study|Withdrawal by Subject|1|||
19729402|NCT03452540|42174810|FG000|Overall Study|Other SAE and AE|2|||
19729403|NCT03573336|42174817|FG000|Overall Study|Study terminated|2|||
19729404|NCT03573336|42174818|FG001|Overall Study|Study terminated|4|||
19729405|NCT03573336|42174819|FG002|Overall Study|Study terminated|2|||
19729406|NCT03500198|42174829|FG000|Overall Study|Lost to Follow-up|0|||
19729407|NCT03500198|42174830|FG001|Overall Study|Lost to Follow-up|1|||
19729408|NCT03553758|42174838|FG000|Overall Study|Lost to Follow-up|1|||
19729409|NCT03552198|42174848|FG000|Overall Study|Lost to Follow-up|42|||
19729410|NCT03552198|42174849|FG001|Overall Study|Lost to Follow-up|48|||
19729411|NCT03552198|42174850|FG002|Overall Study|Lost to Follow-up|15|||
19729412|NCT03552198|42174851|FG003|Overall Study|Lost to Follow-up|19|||
19729413|NCT03552198|42174848|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
19729414|NCT03552198|42174849|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
19729415|NCT03552198|42174850|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
19729416|NCT03552198|42174851|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
19729417|NCT03552198|42174848|FG000|Overall Study|Did not receive air alerts|1|||
19729418|NCT03552198|42174849|FG001|Overall Study|Did not receive air alerts|0|||
19729419|NCT03552198|42174850|FG002|Overall Study|Did not receive air alerts|0|||
19729420|NCT03552198|42174851|FG003|Overall Study|Did not receive air alerts|1|||
19729421|NCT02954354|42174864|FG000|Overall Study|Adverse Event|2|||
19729422|NCT02954354|42174865|FG001|Overall Study|Adverse Event|2|||
19729423|NCT02954354|42174866|FG002|Overall Study|Adverse Event|4|||
19729424|NCT02954354|42174864|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
19729425|NCT02954354|42174865|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
19729426|NCT02954354|42174866|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
19729427|NCT02954354|42174864|FG000|Overall Study|Lack of Efficacy|0|||
19729428|NCT02954354|42174865|FG001|Overall Study|Lack of Efficacy|2|||
19729429|NCT02954354|42174866|FG002|Overall Study|Lack of Efficacy|0|||
19729430|NCT02954354|42174864|FG000|Overall Study|Withdrawal by Subject|17|||
19729431|NCT02954354|42174865|FG001|Overall Study|Withdrawal by Subject|9|||
19729432|NCT02954354|42174866|FG002|Overall Study|Withdrawal by Subject|11|||
19729433|NCT02954354|42174864|FG000|Overall Study|Lost to Follow-up|12|||
19729434|NCT02954354|42174865|FG001|Overall Study|Lost to Follow-up|5|||
19729435|NCT02954354|42174866|FG002|Overall Study|Lost to Follow-up|0|||
19729436|NCT02954354|42174864|FG000|Overall Study|Miscellaneous|2|||
19729437|NCT02954354|42174865|FG001|Overall Study|Miscellaneous|2|||
19729438|NCT02954354|42174866|FG002|Overall Study|Miscellaneous|1|||
19729439|NCT03519516|42174878|FG000|Overall Study|Adverse Event|0|||
19729440|NCT03519516|42174879|FG001|Overall Study|Adverse Event|1|||
19729441|NCT03519204|42174887|FG000|Overall Study|Lost to Follow-up|3|||
19729442|NCT03519204|42174888|FG001|Overall Study|Lost to Follow-up|8|||
19729443|NCT03519204|42174887|FG000|Overall Study|Withdrawal by Subject|9|||
19729444|NCT03519204|42174888|FG001|Overall Study|Withdrawal by Subject|7|||
19729445|NCT03519204|42174887|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19729446|NCT03519204|42174888|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19729447|NCT03518658|42174900|FG000|Overall Study|Other|51|||
19729448|NCT03518658|42174901|FG001|Overall Study|Other|0|||
19729449|NCT03518112|42174909|FG000|Overall Study|Withdrawal by Subject|1|||
19729450|NCT03706456|42174913|FG000|Overall Study|Lack of Efficacy|1|||
19729451|NCT03706456|42174913|FG000|Overall Study|Ongoing|21|||
19729452|NCT03517566|42174922|FG000|Overall Study|Adverse Event|5|||
19729453|NCT03517566|42174923|FG001|Overall Study|Adverse Event|2|||
19729454|NCT03517566|42174924|FG002|Overall Study|Adverse Event|2|||
19729455|NCT03517566|42174925|FG003|Overall Study|Adverse Event|8|||
19729456|NCT03517566|42174926|FG004|Overall Study|Adverse Event|7|||
19729457|NCT03517566|42174922|FG000|Overall Study|Lack of Efficacy|3|||
19729458|NCT03517566|42174923|FG001|Overall Study|Lack of Efficacy|2|||
19729459|NCT03517566|42174924|FG002|Overall Study|Lack of Efficacy|1|||
19729460|NCT03517566|42174925|FG003|Overall Study|Lack of Efficacy|1|||
19729461|NCT03517566|42174926|FG004|Overall Study|Lack of Efficacy|4|||
19729462|NCT03517566|42174922|FG000|Overall Study|Lost to Follow-up|3|||
19729463|NCT03517566|42174923|FG001|Overall Study|Lost to Follow-up|1|||
19729464|NCT03517566|42174924|FG002|Overall Study|Lost to Follow-up|1|||
19729465|NCT03517566|42174925|FG003|Overall Study|Lost to Follow-up|1|||
19729466|NCT03517566|42174926|FG004|Overall Study|Lost to Follow-up|0|||
19729467|NCT03517566|42174922|FG000|Overall Study|Physician Decision|1|||
19729468|NCT03517566|42174923|FG001|Overall Study|Physician Decision|1|||
19729469|NCT03517566|42174924|FG002|Overall Study|Physician Decision|0|||
19729470|NCT03517566|42174925|FG003|Overall Study|Physician Decision|1|||
19729471|NCT03517566|42174926|FG004|Overall Study|Physician Decision|0|||
19729472|NCT03517566|42174922|FG000|Overall Study|Pregnancy|0|||
19729473|NCT03517566|42174923|FG001|Overall Study|Pregnancy|1|||
19729474|NCT03517566|42174924|FG002|Overall Study|Pregnancy|0|||
19729475|NCT03517566|42174925|FG003|Overall Study|Pregnancy|0|||
19729476|NCT03517566|42174926|FG004|Overall Study|Pregnancy|0|||
19729477|NCT03517566|42174922|FG000|Overall Study|Protocol Deviation|0|||
19729478|NCT03517566|42174923|FG001|Overall Study|Protocol Deviation|1|||
19729479|NCT03517566|42174924|FG002|Overall Study|Protocol Deviation|0|||
19729480|NCT03517566|42174925|FG003|Overall Study|Protocol Deviation|1|||
19729481|NCT03517566|42174926|FG004|Overall Study|Protocol Deviation|1|||
19729482|NCT03517566|42174922|FG000|Overall Study|Study terminated by Sponsor|11|||
19729483|NCT03517566|42174923|FG001|Overall Study|Study terminated by Sponsor|5|||
19729484|NCT03517566|42174924|FG002|Overall Study|Study terminated by Sponsor|6|||
19729485|NCT03517566|42174925|FG003|Overall Study|Study terminated by Sponsor|14|||
19729486|NCT03517566|42174926|FG004|Overall Study|Study terminated by Sponsor|12|||
19729487|NCT03517566|42174922|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
19729488|NCT03517566|42174923|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
19729489|NCT03517566|42174924|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
19729490|NCT03517566|42174925|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
19729491|NCT03517566|42174926|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
19729492|NCT03916744|42174942|FG000|Overall Study|Withdrawal by Subject|0|||
19729493|NCT03916744|42174943|FG001|Overall Study|Withdrawal by Subject|1|||
19729494|NCT03916744|42174944|FG002|Overall Study|Withdrawal by Subject|2|||
19729495|NCT03639610|42174959|FG000|Overall Study|Adverse Event|7|||
19729496|NCT03639610|42174960|FG001|Overall Study|Adverse Event|1|||
19729497|NCT03639610|42174961|FG002|Overall Study|Adverse Event|0|||
19729498|NCT03639610|42174959|FG000|Overall Study|Physician Decision|3|||
19729499|NCT03639610|42174960|FG001|Overall Study|Physician Decision|1|||
19729500|NCT03639610|42174961|FG002|Overall Study|Physician Decision|0|||
19729501|NCT03639610|42174959|FG000|Overall Study|Disease progression|8|||
19729502|NCT03639610|42174960|FG001|Overall Study|Disease progression|5|||
19729503|NCT03639610|42174961|FG002|Overall Study|Disease progression|3|||
19729504|NCT03639610|42174959|FG000|Overall Study|Study terminated by sponsor|2|||
19729505|NCT03639610|42174960|FG001|Overall Study|Study terminated by sponsor|1|||
19729506|NCT03639610|42174961|FG002|Overall Study|Study terminated by sponsor|1|||
19729507|NCT03639610|42174959|FG000|Overall Study|Patient request to stop treatment|1|||
19729508|NCT03639610|42174960|FG001|Overall Study|Patient request to stop treatment|2|||
19729509|NCT03639610|42174961|FG002|Overall Study|Patient request to stop treatment|0|||
19729510|NCT02954406|42174979|FG000|Overall Study|Adverse Event|0|||
19729511|NCT02954406|42174980|FG001|Overall Study|Adverse Event|1|||
19729512|NCT02954406|42174981|FG002|Overall Study|Adverse Event|0|||
19729513|NCT02954406|42174982|FG003|Overall Study|Adverse Event|0|||
19729514|NCT02954406|42174983|FG004|Overall Study|Adverse Event|1|||
19729515|NCT02954406|42174984|FG005|Overall Study|Adverse Event|0|||
19729516|NCT02954406|42174985|FG006|Overall Study|Adverse Event|0|||
19729517|NCT02954406|42174986|FG007|Overall Study|Adverse Event|0|||
19729518|NCT02954406|42174987|FG008|Overall Study|Adverse Event|1|||
19729519|NCT02954406|42174988|FG009|Overall Study|Adverse Event|1|||
19729520|NCT02954406|42174989|FG010|Overall Study|Adverse Event|0|||
19729521|NCT02954406|42174979|FG000|Overall Study|Progressive Disease|3|||
19729522|NCT02954406|42174980|FG001|Overall Study|Progressive Disease|4|||
19729523|NCT02954406|42174981|FG002|Overall Study|Progressive Disease|3|||
19729524|NCT02954406|42174982|FG003|Overall Study|Progressive Disease|4|||
19729525|NCT02954406|42174983|FG004|Overall Study|Progressive Disease|3|||
19729526|NCT02954406|42174984|FG005|Overall Study|Progressive Disease|3|||
19729527|NCT02954406|42174985|FG006|Overall Study|Progressive Disease|2|||
19729528|NCT02954406|42174986|FG007|Overall Study|Progressive Disease|2|||
19729529|NCT02954406|42174987|FG008|Overall Study|Progressive Disease|1|||
19729530|NCT02954406|42174988|FG009|Overall Study|Progressive Disease|1|||
19729531|NCT02954406|42174989|FG010|Overall Study|Progressive Disease|0|||
19729532|NCT02954406|42174979|FG000|Overall Study|Symptomatic Deterioration|0|||
19729533|NCT02954406|42174980|FG001|Overall Study|Symptomatic Deterioration|1|||
19729534|NCT02954406|42174981|FG002|Overall Study|Symptomatic Deterioration|0|||
19729535|NCT02954406|42174982|FG003|Overall Study|Symptomatic Deterioration|0|||
19729536|NCT02954406|42174983|FG004|Overall Study|Symptomatic Deterioration|0|||
19729537|NCT02954406|42174984|FG005|Overall Study|Symptomatic Deterioration|0|||
19729538|NCT02954406|42174985|FG006|Overall Study|Symptomatic Deterioration|0|||
19729539|NCT02954406|42174986|FG007|Overall Study|Symptomatic Deterioration|0|||
19729540|NCT02954406|42174987|FG008|Overall Study|Symptomatic Deterioration|0|||
19729541|NCT02954406|42174988|FG009|Overall Study|Symptomatic Deterioration|0|||
19729542|NCT02954406|42174989|FG010|Overall Study|Symptomatic Deterioration|0|||
19729543|NCT02954406|42174979|FG000|Overall Study|Death|0|||
19729544|NCT02954406|42174980|FG001|Overall Study|Death|0|||
19729545|NCT02954406|42174981|FG002|Overall Study|Death|0|||
19729546|NCT02954406|42174982|FG003|Overall Study|Death|0|||
19729547|NCT02954406|42174983|FG004|Overall Study|Death|1|||
19729548|NCT02954406|42174984|FG005|Overall Study|Death|0|||
19729549|NCT02954406|42174985|FG006|Overall Study|Death|0|||
19729550|NCT02954406|42174986|FG007|Overall Study|Death|0|||
19729551|NCT02954406|42174987|FG008|Overall Study|Death|1|||
19729552|NCT02954406|42174988|FG009|Overall Study|Death|1|||
19729553|NCT02954406|42174989|FG010|Overall Study|Death|0|||
19729554|NCT02954406|42174979|FG000|Overall Study|Reason Not Specified|0|||
19729555|NCT02954406|42174980|FG001|Overall Study|Reason Not Specified|0|||
19729556|NCT02954406|42174981|FG002|Overall Study|Reason Not Specified|3|||
19729557|NCT02954406|42174982|FG003|Overall Study|Reason Not Specified|2|||
19729558|NCT02954406|42174983|FG004|Overall Study|Reason Not Specified|2|||
19729559|NCT02954406|42174984|FG005|Overall Study|Reason Not Specified|0|||
19729560|NCT02954406|42174985|FG006|Overall Study|Reason Not Specified|1|||
19729561|NCT02954406|42174986|FG007|Overall Study|Reason Not Specified|0|||
19729562|NCT02954406|42174987|FG008|Overall Study|Reason Not Specified|1|||
19729563|NCT02954406|42174988|FG009|Overall Study|Reason Not Specified|0|||
19729564|NCT02954406|42174989|FG010|Overall Study|Reason Not Specified|0|||
19729565|NCT03514914|42175019|FG000|Overall Study|Death|3|||
19729566|NCT03514914|42175020|FG001|Overall Study|Death|3|||
19729567|NCT03514914|42175019|FG000|Overall Study|Lost to Follow-up|117|||
19729568|NCT03514914|42175020|FG001|Overall Study|Lost to Follow-up|89|||
19729569|NCT03513588|42175029|FG000|Overall Study|Lost to Follow-up|0|||
19729570|NCT03513588|42175030|FG001|Overall Study|Lost to Follow-up|1|||
19729571|NCT03513588|42175031|FG002|Overall Study|Lost to Follow-up|1|||
19729572|NCT03513588|42175029|FG000|Overall Study|Study dosing paused by sponsor|1|||
19729573|NCT03513588|42175030|FG001|Overall Study|Study dosing paused by sponsor|1|||
19729574|NCT03513588|42175031|FG002|Overall Study|Study dosing paused by sponsor|0|||
19729575|NCT03513588|42175029|FG000|Overall Study|Death|0|||
19465231|NCT04426695|41723743|FG002|Overall Study|Participant Decision|2|||
19729576|NCT03513588|42175030|FG001|Overall Study|Death|0|||
19729577|NCT03513588|42175031|FG002|Overall Study|Death|1|||
19729578|NCT03512028|42175043|FG000|Overall Study|Withdrawal by Subject|2|||
19729579|NCT03512028|42175044|FG001|Overall Study|Withdrawal by Subject|0|||
19729580|NCT03512028|42175043|FG000|Overall Study|Protocol Violation|2|||
19729581|NCT03512028|42175044|FG001|Overall Study|Protocol Violation|0|||
19729582|NCT03511326|42175050|FG000|Overall Study|Withdrawal by Subject|1|||
19729583|NCT03508830|42175056|FG000|Overall Study|Withdrawal by Subject|3|||
19729584|NCT03508830|42175057|FG001|Overall Study|Withdrawal by Subject|4|||
19729585|NCT03508830|42175056|FG000|Overall Study|Physician Decision|2|||
19729586|NCT03508830|42175057|FG001|Overall Study|Physician Decision|2|||
19729587|NCT03508050|42175065|FG000|Overall Study|Pleural adhesions|1|||
19729588|NCT03508050|42175066|FG001|Overall Study|Pleural adhesions|0|||
19729589|NCT03508050|42175065|FG000|Overall Study|Mucus plug|1|||
19729590|NCT03508050|42175066|FG001|Overall Study|Mucus plug|0|||
19729591|NCT03508050|42175065|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
19729592|NCT03508050|42175066|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
19729593|NCT03508050|42175065|FG000|Overall Study|Sustained desaturation|0|||
19729594|NCT03508050|42175066|FG001|Overall Study|Sustained desaturation|1|||
19729595|NCT03381274|42175078|FG000|Overall Study|Death|2|||
19729596|NCT03381274|42175079|FG001|Overall Study|Death|9|||
19729597|NCT03381274|42175080|FG002|Overall Study|Death|3|||
19729598|NCT03381274|42175081|FG003|Overall Study|Death|2|||
19729599|NCT03381274|42175082|FG004|Overall Study|Death|3|||
19729600|NCT03381274|42175078|FG000|Overall Study|Lost to Follow-up|0|||
19729601|NCT03381274|42175079|FG001|Overall Study|Lost to Follow-up|0|||
19729602|NCT03381274|42175080|FG002|Overall Study|Lost to Follow-up|0|||
19729603|NCT03381274|42175081|FG003|Overall Study|Lost to Follow-up|1|||
19729604|NCT03381274|42175082|FG004|Overall Study|Lost to Follow-up|0|||
19729605|NCT03381274|42175078|FG000|Overall Study|Withdrawal by Subject|2|||
19729606|NCT03381274|42175079|FG001|Overall Study|Withdrawal by Subject|1|||
19729607|NCT03381274|42175080|FG002|Overall Study|Withdrawal by Subject|3|||
19729608|NCT03381274|42175081|FG003|Overall Study|Withdrawal by Subject|1|||
19729609|NCT03381274|42175082|FG004|Overall Study|Withdrawal by Subject|0|||
19729610|NCT03381274|42175078|FG000|Overall Study|Other|1|||
19729611|NCT03381274|42175079|FG001|Overall Study|Other|11|||
19729612|NCT03381274|42175080|FG002|Overall Study|Other|0|||
19729613|NCT03381274|42175081|FG003|Overall Study|Other|2|||
19729614|NCT03381274|42175082|FG004|Overall Study|Other|2|||
19729615|NCT03569202|42175100|FG000|Part 3|Physician Decision|1|||
19729616|NCT03569202|42175101|FG001|Part 3|Physician Decision|0|||
19729617|NCT03569202|42175100|FG000|Part 3|Other|1|||
19729618|NCT03569202|42175101|FG001|Part 3|Other|1|||
19729619|NCT03568500|42175110|FG000|Overall Study|Lost to Follow-up|1|||
19729620|NCT03568500|42175111|FG001|Overall Study|Lost to Follow-up|1|||
19729621|NCT03568500|42175112|FG002|Overall Study|Lost to Follow-up|2|||
19729622|NCT03568500|42175110|FG000|Overall Study|Adverse Event|1|||
19729623|NCT03568500|42175111|FG001|Overall Study|Adverse Event|1|||
19729624|NCT03568500|42175112|FG002|Overall Study|Adverse Event|2|||
19729625|NCT03568500|42175110|FG000|Overall Study|Physician Decision|1|||
19729626|NCT03568500|42175111|FG001|Overall Study|Physician Decision|0|||
19729627|NCT03568500|42175112|FG002|Overall Study|Physician Decision|0|||
19729628|NCT03568500|42175110|FG000|Overall Study|Withdrawal by Subject|4|||
19729629|NCT03568500|42175111|FG001|Overall Study|Withdrawal by Subject|2|||
19729630|NCT03568500|42175112|FG002|Overall Study|Withdrawal by Subject|0|||
19729631|NCT03568500|42175110|FG000|Overall Study|Technical Problems|2|||
19729632|NCT03568500|42175111|FG001|Overall Study|Technical Problems|1|||
19729633|NCT03568500|42175112|FG002|Overall Study|Technical Problems|0|||
19729634|NCT03568500|42175110|FG000|Overall Study|Participant Noncompliance|1|||
19729635|NCT03568500|42175111|FG001|Overall Study|Participant Noncompliance|1|||
19729636|NCT03568500|42175112|FG002|Overall Study|Participant Noncompliance|0|||
19729637|NCT03504852|42175137|FG000|Overall Study|Withdrawal of informed consent|2|||
19729638|NCT03504852|42175138|FG001|Overall Study|Withdrawal of informed consent|1|||
19729639|NCT03504852|42175139|FG002|Overall Study|Withdrawal of informed consent|0|||
19729640|NCT03504852|42175137|FG000|Overall Study|Withdrawal by Subject|5|||
19729641|NCT03504852|42175138|FG001|Overall Study|Withdrawal by Subject|5|||
19729642|NCT03504852|42175139|FG002|Overall Study|Withdrawal by Subject|1|||
19729643|NCT03504852|42175137|FG000|Overall Study|Lost to Follow-up|4|||
19729644|NCT03504852|42175138|FG001|Overall Study|Lost to Follow-up|1|||
19729645|NCT03504852|42175139|FG002|Overall Study|Lost to Follow-up|0|||
19729646|NCT03504852|42175137|FG000|Overall Study|New therapy for study indication|1|||
19729647|NCT03504852|42175138|FG001|Overall Study|New therapy for study indication|0|||
19729648|NCT03504852|42175139|FG002|Overall Study|New therapy for study indication|0|||
19729649|NCT03504852|42175137|FG000|Overall Study|Lack of Efficacy|1|||
19729650|NCT03504852|42175138|FG001|Overall Study|Lack of Efficacy|2|||
19729651|NCT03504852|42175139|FG002|Overall Study|Lack of Efficacy|0|||
19729652|NCT03504852|42175137|FG000|Overall Study|Death|0|||
19729653|NCT03504852|42175138|FG001|Overall Study|Death|1|||
19729654|NCT03504852|42175139|FG002|Overall Study|Death|0|||
19729655|NCT03504852|42175137|FG000|Overall Study|Adverse Event|4|||
19729656|NCT03504852|42175138|FG001|Overall Study|Adverse Event|8|||
19729657|NCT03504852|42175139|FG002|Overall Study|Adverse Event|2|||
19729658|NCT03025828|42175149|FG000|Overall Study|Lost to Follow-up|1|||
19729659|NCT03546816|42175155|FG000|Overall Study|Adverse Event|5|||
19729660|NCT03546816|42175156|FG001|Overall Study|Adverse Event|3|||
19729661|NCT03546816|42175155|FG000|Overall Study|Lack of Efficacy|2|||
19729662|NCT03546816|42175156|FG001|Overall Study|Lack of Efficacy|4|||
19729663|NCT03546816|42175155|FG000|Overall Study|Pregnancy|1|||
19729664|NCT03546816|42175156|FG001|Overall Study|Pregnancy|0|||
19729665|NCT03546816|42175155|FG000|Overall Study|Physician Decision|2|||
19729666|NCT03546816|42175156|FG001|Overall Study|Physician Decision|0|||
19729667|NCT03546816|42175155|FG000|Overall Study|Withdrawal by Subject|8|||
19729668|NCT03546816|42175156|FG001|Overall Study|Withdrawal by Subject|10|||
19729669|NCT03546816|42175155|FG000|Overall Study|Lost to Follow-up|3|||
19729670|NCT03546816|42175156|FG001|Overall Study|Lost to Follow-up|2|||
19729671|NCT03024970|42175164|FG000|First Intervention|Adverse Event|1|||
19729672|NCT03024970|42175165|FG001|First Intervention|Adverse Event|0|||
19729673|NCT03024970|42175164|FG000|Second Intervention|Lost to Follow-up|1|||
19729674|NCT03024970|42175165|FG001|Second Intervention|Lost to Follow-up|0|||
19729675|NCT03500094|42175171|FG000|Overall Study|Withdrawal by Subject|1|||
19729676|NCT03500094|42175171|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
19729677|NCT03500094|42175171|FG000|Overall Study|Lost to Follow-up|1|||
19729678|NCT03566550|42175179|FG000|Overall Study|Withdrawal by Subject|0|||
19729679|NCT03566550|42175180|FG001|Overall Study|Withdrawal by Subject|1|||
19729680|NCT03563716|42175188|FG000|Overall Study|Death|20|||
19729681|NCT03563716|42175189|FG001|Overall Study|Death|14|||
19729682|NCT03563716|42175188|FG000|Overall Study|Withdrawal by Subject|3|||
19729683|NCT03563716|42175189|FG001|Overall Study|Withdrawal by Subject|3|||
19729684|NCT03563716|42175188|FG000|Overall Study|Still on Study|45|||
19729685|NCT03563716|42175189|FG001|Overall Study|Still on Study|50|||
19729686|NCT03566238|42175198|FG000|Overall Study|Adverse Event|0|||
19729687|NCT03566238|42175199|FG001|Overall Study|Adverse Event|1|||
19729688|NCT03566238|42175200|FG002|Overall Study|Adverse Event|0|||
19729689|NCT03566238|42175198|FG000|Overall Study|Lack of Efficacy|4|||
19729690|NCT03566238|42175199|FG001|Overall Study|Lack of Efficacy|2|||
19729691|NCT03566238|42175200|FG002|Overall Study|Lack of Efficacy|5|||
19729692|NCT03566238|42175198|FG000|Overall Study|Other|1|||
19729693|NCT03566238|42175199|FG001|Overall Study|Other|0|||
19729694|NCT03566238|42175200|FG002|Overall Study|Other|0|||
19729695|NCT02894502|42175211|FG000|Baseline|Withdrawal by Subject|24|||
19729696|NCT02894502|42175212|FG001|Baseline|Withdrawal by Subject|31|||
19729697|NCT02894502|42175213|FG002|Baseline|Withdrawal by Subject|36|||
19729698|NCT02894502|42175211|FG000|Baseline|Death|3|||
19729699|NCT02894502|42175212|FG001|Baseline|Death|1|||
19729700|NCT02894502|42175213|FG002|Baseline|Death|9|||
19729701|NCT02894502|42175211|FG000|First Follow up|Withdrawal by Subject|32|||
19729702|NCT02894502|42175212|FG001|First Follow up|Withdrawal by Subject|29|||
19729703|NCT02894502|42175213|FG002|First Follow up|Withdrawal by Subject|37|||
19729704|NCT02894502|42175211|FG000|First Follow up|Death|2|||
19729705|NCT02894502|42175212|FG001|First Follow up|Death|2|||
19729706|NCT02894502|42175213|FG002|First Follow up|Death|3|||
19729707|NCT02894502|42175211|FG000|Second Follow up|Withdrawal by Subject|13|||
19729708|NCT02894502|42175212|FG001|Second Follow up|Withdrawal by Subject|15|||
19729709|NCT02894502|42175213|FG002|Second Follow up|Withdrawal by Subject|13|||
19729710|NCT02894502|42175211|FG000|Second Follow up|Death|2|||
19729711|NCT02894502|42175212|FG001|Second Follow up|Death|3|||
19729712|NCT02894502|42175213|FG002|Second Follow up|Death|1|||
19729713|NCT02894502|42175211|FG000|Third Follow up|Withdrawal by Subject|5|||
19729714|NCT02894502|42175212|FG001|Third Follow up|Withdrawal by Subject|6|||
19729715|NCT02894502|42175213|FG002|Third Follow up|Withdrawal by Subject|3|||
19729716|NCT02894502|42175211|FG000|Third Follow up|Death|1|||
19729717|NCT02894502|42175212|FG001|Third Follow up|Death|1|||
19729718|NCT02894502|42175213|FG002|Third Follow up|Death|0|||
19729719|NCT03449030|42175234|FG000|Overall Study|Withdrawal by Subject|0|||
19729720|NCT03449030|42175235|FG001|Overall Study|Withdrawal by Subject|0|||
19729721|NCT03449030|42175236|FG002|Overall Study|Withdrawal by Subject|0|||
19729722|NCT03449030|42175237|FG003|Overall Study|Withdrawal by Subject|1|||
19729723|NCT03449030|42175238|FG004|Overall Study|Withdrawal by Subject|1|||
19729724|NCT03449030|42175239|FG005|Overall Study|Withdrawal by Subject|1|||
19729725|NCT03449030|42175240|FG006|Overall Study|Withdrawal by Subject|1|||
19729726|NCT03449030|42175241|FG007|Overall Study|Withdrawal by Subject|2|||
19729727|NCT03449030|42175242|FG008|Overall Study|Withdrawal by Subject|0|||
19729728|NCT03449030|42175243|FG009|Overall Study|Withdrawal by Subject|0|||
19729729|NCT03449030|42175234|FG000|Overall Study|Symptomatic Deterioration|0|||
19729730|NCT03449030|42175235|FG001|Overall Study|Symptomatic Deterioration|1|||
19729731|NCT03449030|42175236|FG002|Overall Study|Symptomatic Deterioration|0|||
19729732|NCT03449030|42175237|FG003|Overall Study|Symptomatic Deterioration|0|||
19729733|NCT03449030|42175238|FG004|Overall Study|Symptomatic Deterioration|0|||
19729734|NCT03449030|42175239|FG005|Overall Study|Symptomatic Deterioration|1|||
19729735|NCT03449030|42175240|FG006|Overall Study|Symptomatic Deterioration|1|||
19729736|NCT03449030|42175241|FG007|Overall Study|Symptomatic Deterioration|0|||
19729737|NCT03449030|42175242|FG008|Overall Study|Symptomatic Deterioration|2|||
19729738|NCT03449030|42175243|FG009|Overall Study|Symptomatic Deterioration|0|||
19729739|NCT03449030|42175234|FG000|Overall Study|Progressive Disease|1|||
19729740|NCT03449030|42175235|FG001|Overall Study|Progressive Disease|0|||
19729741|NCT03449030|42175236|FG002|Overall Study|Progressive Disease|1|||
19729742|NCT03449030|42175237|FG003|Overall Study|Progressive Disease|4|||
19729743|NCT03449030|42175238|FG004|Overall Study|Progressive Disease|5|||
19729744|NCT03449030|42175239|FG005|Overall Study|Progressive Disease|3|||
19729745|NCT03449030|42175240|FG006|Overall Study|Progressive Disease|0|||
19729746|NCT03449030|42175241|FG007|Overall Study|Progressive Disease|1|||
19729747|NCT03449030|42175242|FG008|Overall Study|Progressive Disease|1|||
19729748|NCT03449030|42175243|FG009|Overall Study|Progressive Disease|1|||
19729749|NCT03449030|42175234|FG000|Overall Study|Adverse Event|0|||
19729750|NCT03449030|42175235|FG001|Overall Study|Adverse Event|0|||
19729751|NCT03449030|42175236|FG002|Overall Study|Adverse Event|0|||
19729752|NCT03449030|42175237|FG003|Overall Study|Adverse Event|0|||
19729753|NCT03449030|42175238|FG004|Overall Study|Adverse Event|0|||
19729754|NCT03449030|42175239|FG005|Overall Study|Adverse Event|2|||
19729755|NCT03449030|42175240|FG006|Overall Study|Adverse Event|0|||
19729756|NCT03449030|42175241|FG007|Overall Study|Adverse Event|0|||
19729757|NCT03449030|42175242|FG008|Overall Study|Adverse Event|0|||
19729758|NCT03449030|42175243|FG009|Overall Study|Adverse Event|0|||
19729759|NCT03449030|42175234|FG000|Overall Study|Death|0|||
19729760|NCT03449030|42175235|FG001|Overall Study|Death|0|||
19729761|NCT03449030|42175236|FG002|Overall Study|Death|0|||
19729762|NCT03449030|42175237|FG003|Overall Study|Death|0|||
19729763|NCT03449030|42175238|FG004|Overall Study|Death|1|||
19729764|NCT03449030|42175239|FG005|Overall Study|Death|0|||
19729765|NCT03449030|42175240|FG006|Overall Study|Death|0|||
19729766|NCT03449030|42175241|FG007|Overall Study|Death|0|||
19729767|NCT03449030|42175242|FG008|Overall Study|Death|0|||
19729768|NCT03449030|42175243|FG009|Overall Study|Death|0|||
19729769|NCT03448406|42175268|FG000|Overall Study|Noncompliance of scheduled visits|1|||
19729770|NCT03448406|42175269|FG001|Overall Study|Noncompliance of scheduled visits|2|||
19729771|NCT03448406|42175268|FG000|Overall Study|Withdrawal by Subject|1|||
19729772|NCT03448406|42175269|FG001|Overall Study|Withdrawal by Subject|2|||
19729773|NCT03448406|42175268|FG000|Overall Study|Protocol Violation|1|||
19729774|NCT03448406|42175269|FG001|Overall Study|Protocol Violation|0|||
19729775|NCT03448406|42175268|FG000|Overall Study|Adverse Event|8|||
19729776|NCT03448406|42175269|FG001|Overall Study|Adverse Event|9|||
19729777|NCT03499028|42175277|FG000|Overall Study|Lost to Follow-up|12|||
19729778|NCT03499028|42175278|FG001|Overall Study|Lost to Follow-up|9|||
19729779|NCT03499028|42175277|FG000|Overall Study|Withdrawal by Subject|5|||
19729780|NCT03499028|42175278|FG001|Overall Study|Withdrawal by Subject|8|||
19729781|NCT03499028|42175277|FG000|Overall Study|Unplanned SNF discharge|5|||
19729782|NCT03499028|42175278|FG001|Overall Study|Unplanned SNF discharge|8|||
19729783|NCT03498560|42175286|FG000|Overall Study|Found Ineligible|2|||
19729784|NCT03498560|42175286|FG000|Overall Study|Withdrawal by Subject|14|||
19729785|NCT03498560|42175286|FG000|Overall Study|Lost to Follow-up|4|||
19729786|NCT03498560|42175286|FG000|Overall Study|Death|1|||
19729787|NCT00064701|42175294|FG000|One Year Post-transplant|Did not receive study drug|7|||
19729788|NCT00064701|42175295|FG001|One Year Post-transplant|Did not receive study drug|12|||
19729789|NCT00064701|42175296|FG002|One Year Post-transplant|Did not receive study drug|11|||
19729790|NCT00064701|42175294|FG000|One Year Post-transplant|Adverse Event|23|||
19729791|NCT00064701|42175295|FG001|One Year Post-transplant|Adverse Event|19|||
19729792|NCT00064701|42175296|FG002|One Year Post-transplant|Adverse Event|37|||
19729793|NCT00064701|42175294|FG000|One Year Post-transplant|Rejection|0|||
19729794|NCT00064701|42175295|FG001|One Year Post-transplant|Rejection|1|||
19729795|NCT00064701|42175296|FG002|One Year Post-transplant|Rejection|16|||
19729796|NCT00064701|42175294|FG000|One Year Post-transplant|Non-compliance|4|||
19729797|NCT00064701|42175295|FG001|One Year Post-transplant|Non-compliance|2|||
19729798|NCT00064701|42175296|FG002|One Year Post-transplant|Non-compliance|5|||
19729799|NCT00064701|42175294|FG000|One Year Post-transplant|Graft Failure|3|||
19729800|NCT00064701|42175295|FG001|One Year Post-transplant|Graft Failure|2|||
19729801|NCT00064701|42175296|FG002|One Year Post-transplant|Graft Failure|1|||
19729802|NCT00064701|42175294|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
19729803|NCT00064701|42175295|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
19729804|NCT00064701|42175296|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
19729805|NCT00064701|42175294|FG000|One Year Post-transplant|Lost to Follow-up|1|||
19729806|NCT00064701|42175295|FG001|One Year Post-transplant|Lost to Follow-up|0|||
19729807|NCT00064701|42175296|FG002|One Year Post-transplant|Lost to Follow-up|0|||
19729808|NCT00064701|42175294|FG000|One Year Post-transplant|Converted to rapamycin|1|||
19729809|NCT00064701|42175295|FG001|One Year Post-transplant|Converted to rapamycin|0|||
19729810|NCT00064701|42175296|FG002|One Year Post-transplant|Converted to rapamycin|0|||
19729811|NCT00064701|42175294|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
19729812|NCT00064701|42175295|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
19729813|NCT00064701|42175296|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
19729814|NCT00064701|42175294|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
19729815|NCT00064701|42175295|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
19729816|NCT00064701|42175296|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
19729817|NCT00064701|42175294|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
19729818|NCT00064701|42175295|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
19729819|NCT00064701|42175296|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
19729820|NCT00064701|42175294|FG000|One Year Post-transplant|Poor absorption|0|||
19729821|NCT00064701|42175295|FG001|One Year Post-transplant|Poor absorption|1|||
19729822|NCT00064701|42175296|FG002|One Year Post-transplant|Poor absorption|0|||
19729823|NCT00064701|42175294|FG000|One Year Post-transplant|Pancreas transplant|0|||
19729824|NCT00064701|42175295|FG001|One Year Post-transplant|Pancreas transplant|0|||
19729825|NCT00064701|42175296|FG002|One Year Post-transplant|Pancreas transplant|1|||
19729826|NCT00064701|42175294|FG000|Clinical Continuation Phase|Adverse Event|12|||
19729827|NCT00064701|42175295|FG001|Clinical Continuation Phase|Adverse Event|21|||
19729828|NCT00064701|42175296|FG002|Clinical Continuation Phase|Adverse Event|14|||
19729829|NCT00064701|42175294|FG000|Clinical Continuation Phase|Non-compliance|8|||
19729830|NCT00064701|42175295|FG001|Clinical Continuation Phase|Non-compliance|6|||
19729831|NCT00064701|42175296|FG002|Clinical Continuation Phase|Non-compliance|7|||
19729832|NCT00064701|42175294|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
19729833|NCT00064701|42175295|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
19729834|NCT00064701|42175296|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
19729835|NCT00064701|42175294|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
19729836|NCT00064701|42175295|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
19729837|NCT00064701|42175296|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
19729838|NCT00064701|42175294|FG000|Clinical Continuation Phase|Graft Failure|5|||
19729839|NCT00064701|42175295|FG001|Clinical Continuation Phase|Graft Failure|5|||
19729840|NCT00064701|42175296|FG002|Clinical Continuation Phase|Graft Failure|2|||
19729841|NCT00064701|42175294|FG000|Clinical Continuation Phase|Rejection|1|||
19729842|NCT00064701|42175295|FG001|Clinical Continuation Phase|Rejection|2|||
19729843|NCT00064701|42175296|FG002|Clinical Continuation Phase|Rejection|2|||
19729844|NCT00064701|42175294|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
19729845|NCT00064701|42175295|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
19729846|NCT00064701|42175296|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
19729847|NCT00064701|42175294|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
19729848|NCT00064701|42175295|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
19729849|NCT00064701|42175296|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
19729850|NCT00064701|42175294|FG000|Clinical Continuation Phase|Physician Decision|1|||
19729851|NCT00064701|42175295|FG001|Clinical Continuation Phase|Physician Decision|3|||
19729852|NCT00064701|42175296|FG002|Clinical Continuation Phase|Physician Decision|0|||
19729853|NCT00064701|42175294|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
19729854|NCT00064701|42175295|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
19729855|NCT00064701|42175296|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
19729856|NCT00064701|42175294|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
19729857|NCT00064701|42175295|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
19729858|NCT00064701|42175296|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
19729859|NCT00064701|42175294|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
19729860|NCT00064701|42175295|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
19729861|NCT00064701|42175296|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
19729862|NCT00064701|42175294|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
19729863|NCT00064701|42175295|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
19729864|NCT00064701|42175296|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
19729865|NCT00064701|42175294|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
19729866|NCT00064701|42175295|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
19729867|NCT00064701|42175296|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
19729868|NCT00064701|42175294|FG000|Clinical Continuation Phase|Patient opted out|0|||
19729869|NCT00064701|42175295|FG001|Clinical Continuation Phase|Patient opted out|0|||
19729870|NCT00064701|42175296|FG002|Clinical Continuation Phase|Patient opted out|1|||
19729871|NCT00064077|42175308|FG000|Overall Study|Improper prior treatment|1|||
19729872|NCT00064077|42175309|FG001|Overall Study|Improper prior treatment|0|||
19729873|NCT00064077|42175310|FG002|Overall Study|Improper prior treatment|0|||
19729874|NCT00064077|42175311|FG003|Overall Study|Improper prior treatment|0|||
19729875|NCT00064077|42175308|FG000|Overall Study|Poor risk|2|||
19729876|NCT00064077|42175309|FG001|Overall Study|Poor risk|0|||
19729877|NCT00064077|42175310|FG002|Overall Study|Poor risk|1|||
19729878|NCT00064077|42175311|FG003|Overall Study|Poor risk|1|||
19729879|NCT00064077|42175308|FG000|Overall Study|Pathology|10|||
19729880|NCT00064077|42175309|FG001|Overall Study|Pathology|7|||
19729881|NCT00064077|42175310|FG002|Overall Study|Pathology|3|||
19729882|NCT00064077|42175311|FG003|Overall Study|Pathology|4|||
19729883|NCT00064077|42175308|FG000|Overall Study|No surgery|0|||
19729884|NCT00064077|42175309|FG001|Overall Study|No surgery|0|||
19729885|NCT00064077|42175310|FG002|Overall Study|No surgery|1|||
19729886|NCT00064077|42175311|FG003|Overall Study|No surgery|0|||
19729887|NCT00064077|42175308|FG000|Overall Study|No tumor|0|||
19729888|NCT00064077|42175309|FG001|Overall Study|No tumor|0|||
19729889|NCT00064077|42175310|FG002|Overall Study|No tumor|1|||
19729890|NCT00064077|42175311|FG003|Overall Study|No tumor|0|||
19729891|NCT00064077|42175308|FG000|Overall Study|Other reasons|2|||
19729892|NCT00064077|42175309|FG001|Overall Study|Other reasons|2|||
19729893|NCT00064077|42175310|FG002|Overall Study|Other reasons|1|||
19729894|NCT00064077|42175311|FG003|Overall Study|Other reasons|2|||
19729895|NCT00063999|42175323|FG000|Overall Study|Withdrawal by Subject|1|||
19729896|NCT00063999|42175324|FG001|Overall Study|Withdrawal by Subject|0|||
19729897|NCT00063999|42175323|FG000|Overall Study|Ineligible|44|||
19729898|NCT00063999|42175324|FG001|Overall Study|Ineligible|24|||
19729899|NCT03131440|42175369|FG000|Overall Study|Withdrawal by Subject|1|||
19729900|NCT03131440|42175370|FG001|Overall Study|Withdrawal by Subject|3|||
19729901|NCT03131440|42175371|FG002|Overall Study|Withdrawal by Subject|0|||
19729902|NCT03131440|42175372|FG003|Overall Study|Withdrawal by Subject|0|||
19729903|NCT03131440|42175373|FG004|Overall Study|Withdrawal by Subject|1|||
19729904|NCT03131440|42175374|FG005|Overall Study|Withdrawal by Subject|0|||
19729905|NCT03131440|42175375|FG006|Overall Study|Withdrawal by Subject|0|||
19729906|NCT03131440|42175376|FG007|Overall Study|Withdrawal by Subject|1|||
19729907|NCT03131440|42175377|FG008|Overall Study|Withdrawal by Subject|1|||
19729908|NCT03131440|42175378|FG009|Overall Study|Withdrawal by Subject|1|||
19729909|NCT03131440|42175379|FG010|Overall Study|Withdrawal by Subject|0|||
19729910|NCT03131440|42175380|FG011|Overall Study|Withdrawal by Subject|1|||
19729911|NCT03131440|42175381|FG012|Overall Study|Withdrawal by Subject|1|||
19729912|NCT03131440|42175382|FG013|Overall Study|Withdrawal by Subject|0|||
19729913|NCT03131440|42175383|FG014|Overall Study|Withdrawal by Subject|1|||
19729914|NCT03131440|42175384|FG015|Overall Study|Withdrawal by Subject|0|||
19729915|NCT03131440|42175385|FG016|Overall Study|Withdrawal by Subject|0|||
19729916|NCT03131440|42175386|FG017|Overall Study|Withdrawal by Subject|0|||
19729917|NCT03131440|42175387|FG018|Overall Study|Withdrawal by Subject|1|||
19729918|NCT03131440|42175388|FG019|Overall Study|Withdrawal by Subject|0|||
19729919|NCT03131440|42175389|FG020|Overall Study|Withdrawal by Subject|1|||
19729920|NCT03131440|42175390|FG021|Overall Study|Withdrawal by Subject|1|||
19729921|NCT03131440|42175391|FG022|Overall Study|Withdrawal by Subject|1|||
19729922|NCT03131440|42175392|FG023|Overall Study|Withdrawal by Subject|0|||
19729923|NCT03131440|42175393|FG024|Overall Study|Withdrawal by Subject|0|||
19729924|NCT03131440|42175394|FG025|Overall Study|Withdrawal by Subject|0|||
19729925|NCT03131440|42175395|FG026|Overall Study|Withdrawal by Subject|0|||
19729926|NCT03131440|42175396|FG027|Overall Study|Withdrawal by Subject|0|||
19729927|NCT03131440|42175397|FG028|Overall Study|Withdrawal by Subject|0|||
19729928|NCT03131440|42175398|FG029|Overall Study|Withdrawal by Subject|0|||
19729929|NCT03131440|42175399|FG030|Overall Study|Withdrawal by Subject|1|||
19729930|NCT03131440|42175400|FG031|Overall Study|Withdrawal by Subject|0|||
19729931|NCT03131440|42175369|FG000|Overall Study|Lost to Follow-up|0|||
19729932|NCT03131440|42175370|FG001|Overall Study|Lost to Follow-up|0|||
19729933|NCT03131440|42175371|FG002|Overall Study|Lost to Follow-up|0|||
19729934|NCT03131440|42175372|FG003|Overall Study|Lost to Follow-up|0|||
19729935|NCT03131440|42175373|FG004|Overall Study|Lost to Follow-up|0|||
19729936|NCT03131440|42175374|FG005|Overall Study|Lost to Follow-up|1|||
19729937|NCT03131440|42175375|FG006|Overall Study|Lost to Follow-up|0|||
19729938|NCT03131440|42175376|FG007|Overall Study|Lost to Follow-up|0|||
19729939|NCT03131440|42175377|FG008|Overall Study|Lost to Follow-up|0|||
19729940|NCT03131440|42175378|FG009|Overall Study|Lost to Follow-up|0|||
19729941|NCT03131440|42175379|FG010|Overall Study|Lost to Follow-up|0|||
19729942|NCT03131440|42175380|FG011|Overall Study|Lost to Follow-up|0|||
19729943|NCT03131440|42175381|FG012|Overall Study|Lost to Follow-up|0|||
19729944|NCT03131440|42175382|FG013|Overall Study|Lost to Follow-up|0|||
19729945|NCT03131440|42175383|FG014|Overall Study|Lost to Follow-up|0|||
19729946|NCT03131440|42175384|FG015|Overall Study|Lost to Follow-up|0|||
19729947|NCT03131440|42175385|FG016|Overall Study|Lost to Follow-up|0|||
19729948|NCT03131440|42175386|FG017|Overall Study|Lost to Follow-up|0|||
19729949|NCT03131440|42175387|FG018|Overall Study|Lost to Follow-up|0|||
19729950|NCT03131440|42175388|FG019|Overall Study|Lost to Follow-up|2|||
19729951|NCT03131440|42175389|FG020|Overall Study|Lost to Follow-up|1|||
19729952|NCT03131440|42175390|FG021|Overall Study|Lost to Follow-up|0|||
19729953|NCT03131440|42175391|FG022|Overall Study|Lost to Follow-up|1|||
19729954|NCT03131440|42175392|FG023|Overall Study|Lost to Follow-up|0|||
19729955|NCT03131440|42175393|FG024|Overall Study|Lost to Follow-up|1|||
19729956|NCT03131440|42175394|FG025|Overall Study|Lost to Follow-up|0|||
19729957|NCT03131440|42175395|FG026|Overall Study|Lost to Follow-up|0|||
19729958|NCT03131440|42175396|FG027|Overall Study|Lost to Follow-up|2|||
19729959|NCT03131440|42175397|FG028|Overall Study|Lost to Follow-up|0|||
19729960|NCT03131440|42175398|FG029|Overall Study|Lost to Follow-up|2|||
19729961|NCT03131440|42175399|FG030|Overall Study|Lost to Follow-up|0|||
19729962|NCT03131440|42175400|FG031|Overall Study|Lost to Follow-up|0|||
19729963|NCT03131440|42175369|FG000|Overall Study|Death|0|||
19729964|NCT03131440|42175370|FG001|Overall Study|Death|0|||
19729965|NCT03131440|42175371|FG002|Overall Study|Death|0|||
19729966|NCT03131440|42175372|FG003|Overall Study|Death|0|||
19729967|NCT03131440|42175373|FG004|Overall Study|Death|0|||
19729968|NCT03131440|42175374|FG005|Overall Study|Death|0|||
19729969|NCT03131440|42175375|FG006|Overall Study|Death|0|||
19729970|NCT03131440|42175376|FG007|Overall Study|Death|0|||
19729971|NCT03131440|42175377|FG008|Overall Study|Death|0|||
19729972|NCT03131440|42175378|FG009|Overall Study|Death|0|||
19729973|NCT03131440|42175379|FG010|Overall Study|Death|0|||
19729974|NCT03131440|42175380|FG011|Overall Study|Death|0|||
19729975|NCT03131440|42175381|FG012|Overall Study|Death|0|||
19729976|NCT03131440|42175382|FG013|Overall Study|Death|0|||
19729977|NCT03131440|42175383|FG014|Overall Study|Death|0|||
19729978|NCT03131440|42175384|FG015|Overall Study|Death|0|||
19729979|NCT03131440|42175385|FG016|Overall Study|Death|0|||
19729980|NCT03131440|42175386|FG017|Overall Study|Death|0|||
19729981|NCT03131440|42175387|FG018|Overall Study|Death|0|||
19729982|NCT03131440|42175388|FG019|Overall Study|Death|0|||
19729983|NCT03131440|42175389|FG020|Overall Study|Death|0|||
19729984|NCT03131440|42175390|FG021|Overall Study|Death|0|||
19729985|NCT03131440|42175391|FG022|Overall Study|Death|0|||
19729986|NCT03131440|42175392|FG023|Overall Study|Death|0|||
19729987|NCT03131440|42175393|FG024|Overall Study|Death|0|||
19729988|NCT03131440|42175394|FG025|Overall Study|Death|1|||
19729989|NCT03131440|42175395|FG026|Overall Study|Death|0|||
19729990|NCT03131440|42175396|FG027|Overall Study|Death|0|||
19729991|NCT03131440|42175397|FG028|Overall Study|Death|0|||
19729992|NCT03131440|42175398|FG029|Overall Study|Death|0|||
19729993|NCT03131440|42175399|FG030|Overall Study|Death|0|||
19729994|NCT03131440|42175400|FG031|Overall Study|Death|0|||
19729995|NCT02915302|42175445|FG000|Overall Study|Adverse Event|3|||
19729996|NCT02915302|42175446|FG001|Overall Study|Adverse Event|0|||
19729997|NCT02915302|42175445|FG000|Overall Study|Protocol Violation|20|||
19729998|NCT02915302|42175446|FG001|Overall Study|Protocol Violation|27|||
19729999|NCT02915302|42175445|FG000|Overall Study|Lost to Follow-up|19|||
19730000|NCT02915302|42175446|FG001|Overall Study|Lost to Follow-up|22|||
19730001|NCT02915302|42175445|FG000|Overall Study|Withdrawal by Subject|22|||
19730002|NCT02915302|42175446|FG001|Overall Study|Withdrawal by Subject|29|||
19730003|NCT02915302|42175445|FG000|Overall Study|Other|1|||
19730004|NCT02915302|42175446|FG001|Overall Study|Other|0|||
19730005|NCT03023878|42175452|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
19730006|NCT03023878|42175452|FG000|Pre-Study Run-In Period|Death|1|||
19730007|NCT03023878|42175452|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
19730008|NCT03023878|42175452|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
19730009|NCT03023878|42175452|FG000|Treatment Period|Disease Progression|1|||
19730010|NCT03023878|42175452|FG000|Treatment Period|Withdrawal by Subject|1|||
19730011|NCT03023878|42175452|FG000|Treatment Period|Adverse Event|1|||
19730012|NCT03023878|42175452|FG000|Long Term Follow-Up Period|Death|2|||
19730013|NCT03022630|42175458|FG000|Overall Study|Death|9|||
19730014|NCT03022630|42175459|FG001|Overall Study|Death|7|||
19730015|NCT03022630|42175458|FG000|Overall Study|Withdrawal by Subject|0|||
19730016|NCT03022630|42175459|FG001|Overall Study|Withdrawal by Subject|5|||
19730017|NCT03023722|42175470|FG000|Overall Study|No follow-up assessment|4|||
19730018|NCT03022084|42175476|FG000|Overall Study|Lost to Follow-up|2|||
19730019|NCT03022084|42175477|FG001|Overall Study|Lost to Follow-up|3|||
19730020|NCT03021304|42175483|FG000|Overall Study|Lack of Efficacy|1|||
19730021|NCT01979536|42175489|FG000|Overall Study|Physician Decision|2|||
19730022|NCT01979536|42175490|FG001|Overall Study|Physician Decision|3|||
19730023|NCT01979536|42175489|FG000|Overall Study|Withdrawal by Subject|0|||
19730024|NCT01979536|42175490|FG001|Overall Study|Withdrawal by Subject|1|||
19730025|NCT01979536|42175489|FG000|Overall Study|Refusal|0|||
19730026|NCT01979536|42175490|FG001|Overall Study|Refusal|1|||
19730027|NCT01979536|42175489|FG000|Overall Study|Relapse|0|||
19730028|NCT01979536|42175490|FG001|Overall Study|Relapse|1|||
19730029|NCT01979536|42175489|FG000|Overall Study|Study terminated by Sponsor|0|||
19730030|NCT01979536|42175490|FG001|Overall Study|Study terminated by Sponsor|1|||
19730031|NCT01979536|42175489|FG000|Overall Study|Did not start treatment|0|||
19730032|NCT01979536|42175490|FG001|Overall Study|Did not start treatment|1|||
19730033|NCT03496298|42175512|FG000|Overall Study|Adverse Event|49|||
19730034|NCT03496298|42175513|FG001|Overall Study|Adverse Event|68|||
19730035|NCT03496298|42175514|FG002|Overall Study|Adverse Event|79|||
19730036|NCT03496298|42175512|FG000|Overall Study|Study terminated by Sponsor|1050|||
19730037|NCT03496298|42175513|FG001|Overall Study|Study terminated by Sponsor|1063|||
19730038|NCT03496298|42175514|FG002|Overall Study|Study terminated by Sponsor|1071|||
19730039|NCT03496298|42175512|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
19730040|NCT03496298|42175513|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
19380771|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19380772|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
19380773|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19380774|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
19380775|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19380776|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19380777|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19380778|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19380779|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
19730041|NCT03496298|42175514|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
19730042|NCT03496298|42175512|FG000|Overall Study|Withdrawal by Subject|176|||
19730043|NCT03496298|42175513|FG001|Overall Study|Withdrawal by Subject|154|||
19730044|NCT03496298|42175514|FG002|Overall Study|Withdrawal by Subject|151|||
19730045|NCT03496298|42175512|FG000|Overall Study|Other|29|||
19730046|NCT03496298|42175513|FG001|Overall Study|Other|20|||
19730047|NCT03496298|42175514|FG002|Overall Study|Other|23|||
19730048|NCT03496298|42175512|FG000|Overall Study|Randomized and not treated|1|||
19730049|NCT03496298|42175513|FG001|Overall Study|Randomized and not treated|1|||
19730050|NCT03496298|42175514|FG002|Overall Study|Randomized and not treated|1|||
19730051|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
19730052|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
19730053|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
19730054|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
19730055|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
19730056|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
19730057|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
19730058|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
19730059|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
19730060|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
19730061|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
19730062|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
19730063|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
19730064|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
19730065|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
19730066|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
19730067|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
19730068|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
19730069|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
19730070|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
19730071|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
19730072|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
19730073|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
19730074|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
19730075|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
19730076|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
19730077|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
19730078|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
19730079|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
19730080|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
19730081|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
19730082|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
19730083|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
19730084|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730085|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
19730086|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
19730087|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
19730088|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730089|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730090|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730091|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730092|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730093|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730094|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
19730095|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730096|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730097|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19380780|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19730098|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730099|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
19730100|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730101|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730102|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730103|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730104|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730105|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
19730106|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
19730107|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730108|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730109|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730110|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730111|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730112|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730113|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730114|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730115|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730116|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
19730117|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
19730118|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
19730119|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
19730120|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
19730121|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
19730122|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
19730123|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
19730124|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
19730125|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
19730126|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
19730127|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
19730128|NCT02914522|42175527|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730129|NCT02914522|42175528|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
19730130|NCT02914522|42175529|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730131|NCT02914522|42175530|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730132|NCT02914522|42175531|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
19730133|NCT02914522|42175532|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
19730134|NCT02914522|42175533|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730135|NCT02914522|42175534|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730136|NCT02914522|42175535|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730137|NCT02914522|42175536|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730138|NCT02914522|42175537|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
19730139|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730140|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730141|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730142|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730143|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730144|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
19730145|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
19730146|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
19730147|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
19730148|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
19730149|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
19730150|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730151|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730152|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730153|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730154|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730155|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
19730156|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
19730157|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
19730158|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
19730159|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
19730160|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
19730161|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730162|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730163|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730164|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730165|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730166|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730167|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
19730168|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
19730169|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
19730170|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
19730171|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
19730172|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730173|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730174|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730175|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730176|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730177|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
19730178|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
19730179|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
19730180|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
19730181|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
19730182|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
19730183|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
19730184|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
19730185|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
19730186|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
19730187|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
19730188|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
19730189|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
19730190|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
19730191|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
19730192|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
19730193|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
19730194|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730195|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730196|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730197|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730198|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730199|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730200|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730201|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
19730202|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
19730203|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730204|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
19730205|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730206|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730207|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730208|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730209|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730210|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730211|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730212|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730213|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
19730214|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
19730215|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
19730216|NCT02914522|42175527|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730217|NCT02914522|42175528|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730218|NCT02914522|42175529|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730219|NCT02914522|42175530|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730220|NCT02914522|42175531|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730221|NCT02914522|42175532|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730222|NCT02914522|42175533|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730223|NCT02914522|42175534|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730224|NCT02914522|42175535|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19465232|NCT04426695|41723744|FG003|Overall Study|Participant Decision|12|||
19465233|NCT04426695|41723745|FG004|Overall Study|Participant Decision|18|||
19730225|NCT02914522|42175536|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
19730226|NCT02914522|42175537|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
19730227|NCT02924428|42175566|FG000|Overall Study|Adverse Event|1|||
19730228|NCT02924428|42175567|FG001|Overall Study|Adverse Event|0|||
19730229|NCT02924428|42175566|FG000|Overall Study|Physician Decision|1|||
19730230|NCT02924428|42175567|FG001|Overall Study|Physician Decision|0|||
19730231|NCT02924428|42175566|FG000|Overall Study|Lost to Follow-up|2|||
19730232|NCT02924428|42175567|FG001|Overall Study|Lost to Follow-up|4|||
19730233|NCT02924428|42175566|FG000|Overall Study|Pregnancy|0|||
19730234|NCT02924428|42175567|FG001|Overall Study|Pregnancy|1|||
19730235|NCT00062751|42175578|FG000|Overall Study|Disease progression|24|||
19730236|NCT00062751|42175579|FG001|Overall Study|Disease progression|17|||
19730237|NCT00062751|42175580|FG002|Overall Study|Disease progression|24|||
19730238|NCT00062751|42175581|FG003|Overall Study|Disease progression|2|||
19730239|NCT00062751|42175582|FG004|Overall Study|Disease progression|2|||
19730240|NCT00062751|42175578|FG000|Overall Study|Adverse Event|4|||
19730241|NCT00062751|42175579|FG001|Overall Study|Adverse Event|7|||
19730242|NCT00062751|42175580|FG002|Overall Study|Adverse Event|2|||
19730243|NCT00062751|42175581|FG003|Overall Study|Adverse Event|2|||
19730244|NCT00062751|42175582|FG004|Overall Study|Adverse Event|2|||
19730245|NCT00062751|42175578|FG000|Overall Study|Other|2|||
19730246|NCT00062751|42175579|FG001|Overall Study|Other|3|||
19730247|NCT00062751|42175580|FG002|Overall Study|Other|1|||
19730248|NCT00062751|42175581|FG003|Overall Study|Other|0|||
19730249|NCT00062751|42175582|FG004|Overall Study|Other|1|||
19730250|NCT00062751|42175578|FG000|Overall Study|Withdrawal by Subject|1|||
19730251|NCT00062751|42175579|FG001|Overall Study|Withdrawal by Subject|2|||
19730252|NCT00062751|42175580|FG002|Overall Study|Withdrawal by Subject|2|||
19730253|NCT00062751|42175581|FG003|Overall Study|Withdrawal by Subject|1|||
19730254|NCT00062751|42175582|FG004|Overall Study|Withdrawal by Subject|0|||
19730255|NCT00062751|42175578|FG000|Overall Study|Symptomatic deterioration|1|||
19730256|NCT00062751|42175579|FG001|Overall Study|Symptomatic deterioration|1|||
19730257|NCT00062751|42175580|FG002|Overall Study|Symptomatic deterioration|0|||
19730258|NCT00062751|42175581|FG003|Overall Study|Symptomatic deterioration|0|||
19730259|NCT00062751|42175582|FG004|Overall Study|Symptomatic deterioration|1|||
19730260|NCT00062751|42175578|FG000|Overall Study|Death|1|||
19730261|NCT00062751|42175579|FG001|Overall Study|Death|0|||
19730262|NCT00062751|42175580|FG002|Overall Study|Death|1|||
19730263|NCT00062751|42175581|FG003|Overall Study|Death|0|||
19730264|NCT00062751|42175582|FG004|Overall Study|Death|0|||
19730265|NCT00062439|42175599|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
19730266|NCT00062439|42175599|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
19730267|NCT00062439|42175599|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
19730268|NCT00062439|42175599|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
19730269|NCT00062439|42175599|FG000|Post Chemoradiation Assessment|Death|1|||
19730270|NCT00062439|42175599|FG000|Post Chemoradiation Assessment|Disease progression|2|||
19730271|NCT00062439|42175599|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
19730272|NCT00062439|42175599|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
19730273|NCT00062439|42175599|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
19730274|NCT00062439|42175599|FG000|Surgery|Physician Decision|4|||
19730275|NCT00062439|42175599|FG000|Surgery|Death|1|||
19730276|NCT00062439|42175599|FG000|Surgery|Adverse Event|2|||
19730277|NCT00062439|42175599|FG000|Consolidation Chemotherapy|Adverse Event|2|||
19730278|NCT00051363|42175610|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
19730279|NCT00051363|42175611|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
19730280|NCT00051363|42175610|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
19730281|NCT00051363|42175611|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
19730282|NCT00051363|42175610|FG000|Overall Study|Death|2|||
19730283|NCT00051363|42175611|FG001|Overall Study|Death|2|||
19730284|NCT00051363|42175610|FG000|Overall Study|Excluded Pre-Randomization|2|||
19730285|NCT00051363|42175611|FG001|Overall Study|Excluded Pre-Randomization|5|||
19730286|NCT00031551|42175619|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
19730287|NCT00031551|42175620|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
19730288|NCT00049257|42175630|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
19730289|NCT00049257|42175630|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
19730290|NCT00049257|42175630|FG000|Carboplatin, Paclitaxel|Death|2|||
19730291|NCT00049257|42175630|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
19730292|NCT00601900|42175636|FG000|Overall Study|Withdrawal by Subject|0|||
19730293|NCT00601900|42175637|FG001|Overall Study|Withdrawal by Subject|3|||
19730294|NCT03020992|42175643|FG000|Overall Study|Adverse Event|5|||
19730295|NCT03020992|42175643|FG000|Overall Study|Withdrawal by Subject|1|||
19730296|NCT03020914|42175650|FG000|Overall Study|Surgery Cancelled|1|||
19730297|NCT03020914|42175651|FG001|Overall Study|Surgery Cancelled|0|||
19730298|NCT03018340|42175659|FG000|Overall Study|Adverse Event|1|||
19730299|NCT03018340|42175660|FG001|Overall Study|Adverse Event|2|||
19730300|NCT03018340|42175659|FG000|Overall Study|Withdrawal by Subject|0|||
19730301|NCT03018340|42175660|FG001|Overall Study|Withdrawal by Subject|8|||
19730302|NCT03018340|42175659|FG000|Overall Study|Lack of Efficacy|0|||
19730303|NCT03018340|42175660|FG001|Overall Study|Lack of Efficacy|1|||
19730304|NCT03018340|42175659|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
19730305|NCT03018340|42175660|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
19730306|NCT03018340|42175659|FG000|Overall Study|Lost to Follow-up|1|||
19730307|NCT03018340|42175660|FG001|Overall Study|Lost to Follow-up|7|||
19730308|NCT03018340|42175659|FG000|Overall Study|Protocol Violation|3|||
19730309|NCT03018340|42175660|FG001|Overall Study|Protocol Violation|7|||
19730310|NCT03018340|42175659|FG000|Overall Study|Not further specified|0|||
19730311|NCT03018340|42175660|FG001|Overall Study|Not further specified|1|||
19730312|NCT03016078|42175670|FG000|Overall Study|Protocol Violation|1|||
19730313|NCT03016078|42175670|FG000|Overall Study|Protocol Violation|1|||
19730314|NCT00048165|42175676|FG000|Completed 6 Months Study|Administration/Other|8|||
19730315|NCT00048165|42175677|FG001|Completed 6 Months Study|Administration/Other|8|||
19730316|NCT00048165|42175676|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
19730317|NCT00048165|42175677|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
19730318|NCT00048165|42175676|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
19730319|NCT00048165|42175677|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
19730320|NCT00048165|42175676|FG000|Completed 6 Months Study|Death|12|||
19730321|NCT00048165|42175677|FG001|Completed 6 Months Study|Death|6|||
19730322|NCT00048165|42175676|FG000|Completed 6 Months Study|Insufficient therapy|1|||
19730323|NCT00048165|42175677|FG001|Completed 6 Months Study|Insufficient therapy|4|||
19730324|NCT00048165|42175676|FG000|Completed 6 Months Study|Other violation|4|||
19730325|NCT00048165|42175677|FG001|Completed 6 Months Study|Other violation|6|||
19730326|NCT00048165|42175676|FG000|Completed 6 Months Study|Refused treatment|5|||
19730327|NCT00048165|42175677|FG001|Completed 6 Months Study|Refused treatment|5|||
19730328|NCT00048165|42175676|FG000|Completed 6 Months Study|Violation criteria|0|||
19730329|NCT00048165|42175677|FG001|Completed 6 Months Study|Violation criteria|2|||
19730330|NCT00048165|42175676|FG000|Completed 6 Months Study|Did not receive study drug|6|||
19730331|NCT00048165|42175677|FG001|Completed 6 Months Study|Did not receive study drug|6|||
19730332|NCT00048165|42175676|FG000|Completed 12 Months Study|Administration/Other|0|||
19730333|NCT00048165|42175677|FG001|Completed 12 Months Study|Administration/Other|2|||
19730334|NCT00048165|42175676|FG000|Completed 12 Months Study|Death|2|||
19730335|NCT00048165|42175677|FG001|Completed 12 Months Study|Death|1|||
19730336|NCT00048165|42175676|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
19730337|NCT00048165|42175677|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
19730338|NCT00059787|42175685|FG000|Overall Study|Adverse Event|13|||
19730339|NCT00059787|42175685|FG000|Overall Study|disease progression|2|||
19730340|NCT00059787|42175685|FG000|Overall Study|ineligible|1|||
19730341|NCT00059787|42175685|FG000|Overall Study|Other|4|||
19730342|NCT00058539|42175690|FG000|Overall Study|Disease progression|24|||
19730343|NCT00058539|42175690|FG000|Overall Study|Adverse Event|3|||
19730344|NCT00058539|42175690|FG000|Overall Study|Withdrawal by Subject|5|||
19730345|NCT00058539|42175690|FG000|Overall Study|Physician Decision|9|||
19730346|NCT00058539|42175690|FG000|Overall Study|Death|1|||
19730347|NCT03015532|42175702|FG000|Overall Study|Adverse Event|0|||
19730348|NCT03015532|42175703|FG001|Overall Study|Adverse Event|0|||
19730349|NCT03015532|42175704|FG002|Overall Study|Adverse Event|0|||
19730350|NCT03015532|42175705|FG003|Overall Study|Adverse Event|0|||
19730351|NCT03015532|42175706|FG004|Overall Study|Adverse Event|0|||
19730352|NCT03015532|42175707|FG005|Overall Study|Adverse Event|2|||
19730353|NCT03015532|42175708|FG006|Overall Study|Adverse Event|1|||
19730354|NCT03015532|42175709|FG007|Overall Study|Adverse Event|0|||
19730355|NCT03015532|42175702|FG000|Overall Study|Withdrawal by Subject|0|||
19730356|NCT03015532|42175703|FG001|Overall Study|Withdrawal by Subject|0|||
19730357|NCT03015532|42175704|FG002|Overall Study|Withdrawal by Subject|0|||
19730358|NCT03015532|42175705|FG003|Overall Study|Withdrawal by Subject|0|||
19730359|NCT03015532|42175706|FG004|Overall Study|Withdrawal by Subject|0|||
19730360|NCT03015532|42175707|FG005|Overall Study|Withdrawal by Subject|0|||
19730361|NCT03015532|42175708|FG006|Overall Study|Withdrawal by Subject|1|||
19730362|NCT03015532|42175709|FG007|Overall Study|Withdrawal by Subject|0|||
19730363|NCT00047463|42175731|FG000|Overall Study|Withdrawal by Subject|0|||
19730364|NCT00047463|42175732|FG001|Overall Study|Withdrawal by Subject|3|||
19730365|NCT03015220|42175745|FG000|Overall Study|Withdrawal by Subject|3|||
19465234|NCT04426695|41723746|FG005|Overall Study|Participant Decision|22|||
19730366|NCT03015220|42175746|FG001|Overall Study|Withdrawal by Subject|2|||
19730367|NCT03015220|42175747|FG002|Overall Study|Withdrawal by Subject|2|||
19730368|NCT03015220|42175748|FG003|Overall Study|Withdrawal by Subject|2|||
19730369|NCT03015220|42175745|FG000|Overall Study|Lost to Follow-up|0|||
19730370|NCT03015220|42175746|FG001|Overall Study|Lost to Follow-up|0|||
19465235|NCT04426695|41723747|FG006|Overall Study|Participant Decision|13|||
19730371|NCT03015220|42175747|FG002|Overall Study|Lost to Follow-up|1|||
19730372|NCT03015220|42175748|FG003|Overall Study|Lost to Follow-up|0|||
19730373|NCT00022659|42175758|FG000|Overall Study|Ineligible: wrong primary|1|||
19730374|NCT00022659|42175758|FG000|Overall Study|Never treated|1|||
19730375|NCT03014674|42175769|FG000|Overall Study|Withdrawal by Subject|1|||
19730376|NCT03014674|42175770|FG001|Overall Study|Withdrawal by Subject|0|||
19730377|NCT03014674|42175771|FG002|Overall Study|Withdrawal by Subject|0|||
19730378|NCT03018106|42175781|FG000|Overall Study|Lost to Follow-up|0|||
19730379|NCT03018106|42175782|FG001|Overall Study|Lost to Follow-up|1|||
19730380|NCT03018028|42175791|FG000|Overall Study|Withdrawal by Subject|3|||
19730381|NCT03018028|42175792|FG001|Overall Study|Withdrawal by Subject|0|||
19730382|NCT03018028|42175793|FG002|Overall Study|Withdrawal by Subject|1|||
19730383|NCT03018028|42175794|FG003|Overall Study|Withdrawal by Subject|2|||
19730384|NCT03018028|42175795|FG004|Overall Study|Withdrawal by Subject|0|||
19730385|NCT03014206|42175807|FG000|Overall Study|Registration Violation|12|||
19730386|NCT03010462|42175813|FG000|Overall Study|Withdrawal by Subject|3|||
19730387|NCT03010462|42175814|FG001|Overall Study|Withdrawal by Subject|1|||
19730388|NCT00021255|42175823|FG000|Overall Study|Death|1|||
19730389|NCT00021255|42175824|FG001|Overall Study|Death|0|||
19730390|NCT00021255|42175825|FG002|Overall Study|Death|2|||
19730391|NCT00021255|42175823|FG000|Overall Study|Breast cancer relapse|5|||
19730392|NCT00021255|42175824|FG001|Overall Study|Breast cancer relapse|18|||
19730393|NCT00021255|42175825|FG002|Overall Study|Breast cancer relapse|11|||
19730394|NCT00021255|42175823|FG000|Overall Study|Second primary malignancy|0|||
19730395|NCT00021255|42175824|FG001|Overall Study|Second primary malignancy|4|||
19730396|NCT00021255|42175825|FG002|Overall Study|Second primary malignancy|1|||
19730397|NCT00021255|42175823|FG000|Overall Study|Withdrawal by Subject|41|||
19730398|NCT00021255|42175824|FG001|Overall Study|Withdrawal by Subject|64|||
19730399|NCT00021255|42175825|FG002|Overall Study|Withdrawal by Subject|26|||
19730400|NCT00021255|42175823|FG000|Overall Study|Lost to Follow-up|0|||
19730401|NCT00021255|42175824|FG001|Overall Study|Lost to Follow-up|2|||
19730402|NCT00021255|42175825|FG002|Overall Study|Lost to Follow-up|3|||
19730403|NCT00021255|42175823|FG000|Overall Study|Cardiac toxicity|0|||
19730404|NCT00021255|42175824|FG001|Overall Study|Cardiac toxicity|61|||
19730405|NCT00021255|42175825|FG002|Overall Study|Cardiac toxicity|32|||
19730406|NCT00021255|42175823|FG000|Overall Study|Herceptin toxicity|0|||
19730407|NCT00021255|42175824|FG001|Overall Study|Herceptin toxicity|22|||
19730408|NCT00021255|42175825|FG002|Overall Study|Herceptin toxicity|6|||
19730409|NCT00021255|42175823|FG000|Overall Study|Adverse Event|46|||
19730410|NCT00021255|42175824|FG001|Overall Study|Adverse Event|30|||
19730411|NCT00021255|42175825|FG002|Overall Study|Adverse Event|18|||
19730412|NCT00021255|42175823|FG000|Overall Study|Protocol Violation|0|||
19730413|NCT00021255|42175824|FG001|Overall Study|Protocol Violation|2|||
19730414|NCT00021255|42175825|FG002|Overall Study|Protocol Violation|0|||
19730415|NCT00021255|42175823|FG000|Overall Study|Other than specified above|0|||
19730416|NCT00021255|42175824|FG001|Overall Study|Other than specified above|38|||
19730417|NCT00021255|42175825|FG002|Overall Study|Other than specified above|19|||
19730418|NCT00021255|42175823|FG000|Overall Study|Missing|0|||
19730419|NCT00021255|42175824|FG001|Overall Study|Missing|27|||
19730420|NCT00021255|42175825|FG002|Overall Study|Missing|13|||
19730421|NCT00021255|42175823|FG000|Overall Study|Randomized but not treated|28|||
19730422|NCT00021255|42175824|FG001|Overall Study|Randomized but not treated|2|||
19730423|NCT00021255|42175825|FG002|Overall Study|Randomized but not treated|18|||
19730424|NCT03012334|42175843|FG000|Period 1|Withdrawal by Subject|0|||
19730425|NCT03012334|42175844|FG001|Period 1|Withdrawal by Subject|0|||
19730426|NCT03012334|42175845|FG002|Period 1|Withdrawal by Subject|0|||
19730427|NCT03012334|42175846|FG003|Period 1|Withdrawal by Subject|0|||
19730428|NCT03012334|42175847|FG004|Period 1|Withdrawal by Subject|0|||
19730429|NCT03012334|42175848|FG005|Period 1|Withdrawal by Subject|0|||
19730430|NCT03012334|42175849|FG006|Period 1|Withdrawal by Subject|0|||
19730431|NCT03012334|42175850|FG007|Period 1|Withdrawal by Subject|0|||
19730432|NCT03012334|42175851|FG008|Period 1|Withdrawal by Subject|0|||
19730433|NCT03012334|42175852|FG009|Period 1|Withdrawal by Subject|1|||
19730434|NCT03012334|42175843|FG000|Period 2|Withdrawal by Subject|0|||
19730435|NCT03012334|42175844|FG001|Period 2|Withdrawal by Subject|1|||
19730436|NCT03012334|42175845|FG002|Period 2|Withdrawal by Subject|0|||
19730437|NCT03012334|42175846|FG003|Period 2|Withdrawal by Subject|0|||
19730438|NCT03012334|42175847|FG004|Period 2|Withdrawal by Subject|0|||
19730439|NCT03012334|42175848|FG005|Period 2|Withdrawal by Subject|0|||
19730440|NCT03012334|42175849|FG006|Period 2|Withdrawal by Subject|0|||
19730441|NCT03012334|42175850|FG007|Period 2|Withdrawal by Subject|0|||
19730442|NCT03012334|42175851|FG008|Period 2|Withdrawal by Subject|0|||
19730443|NCT03012334|42175852|FG009|Period 2|Withdrawal by Subject|0|||
19730444|NCT03012334|42175843|FG000|Period 2|Protocol Violation|0|||
19730445|NCT03012334|42175844|FG001|Period 2|Protocol Violation|0|||
19730446|NCT03012334|42175845|FG002|Period 2|Protocol Violation|1|||
19730447|NCT03012334|42175846|FG003|Period 2|Protocol Violation|0|||
19730448|NCT03012334|42175847|FG004|Period 2|Protocol Violation|0|||
19730449|NCT03012334|42175848|FG005|Period 2|Protocol Violation|0|||
19730450|NCT03012334|42175849|FG006|Period 2|Protocol Violation|0|||
19730451|NCT03012334|42175850|FG007|Period 2|Protocol Violation|1|||
19730452|NCT03012334|42175851|FG008|Period 2|Protocol Violation|0|||
19730453|NCT03012334|42175852|FG009|Period 2|Protocol Violation|0|||
19730454|NCT03012334|42175843|FG000|Period 4|Non-Compliance|0|||
19730455|NCT03012334|42175844|FG001|Period 4|Non-Compliance|0|||
19730456|NCT03012334|42175845|FG002|Period 4|Non-Compliance|0|||
19730457|NCT03012334|42175846|FG003|Period 4|Non-Compliance|0|||
19730458|NCT03012334|42175847|FG004|Period 4|Non-Compliance|0|||
19730459|NCT03012334|42175848|FG005|Period 4|Non-Compliance|0|||
19730460|NCT03012334|42175849|FG006|Period 4|Non-Compliance|1|||
19730461|NCT03012334|42175850|FG007|Period 4|Non-Compliance|0|||
19730462|NCT03012334|42175851|FG008|Period 4|Non-Compliance|0|||
19730463|NCT03012334|42175852|FG009|Period 4|Non-Compliance|0|||
19730464|NCT03012334|42175843|FG000|Period 4|Adverse Event|0|||
19730465|NCT03012334|42175844|FG001|Period 4|Adverse Event|0|||
19730466|NCT03012334|42175845|FG002|Period 4|Adverse Event|0|||
19730467|NCT03012334|42175846|FG003|Period 4|Adverse Event|0|||
19730468|NCT03012334|42175847|FG004|Period 4|Adverse Event|0|||
19730469|NCT03012334|42175848|FG005|Period 4|Adverse Event|0|||
19730470|NCT03012334|42175849|FG006|Period 4|Adverse Event|0|||
19730471|NCT03012334|42175850|FG007|Period 4|Adverse Event|0|||
19730472|NCT03012334|42175851|FG008|Period 4|Adverse Event|1|||
19730473|NCT03012334|42175852|FG009|Period 4|Adverse Event|0|||
19730474|NCT03565068|42175874|FG000|Overall Study|Protocol Violation|0|||
19730475|NCT03565068|42175875|FG001|Overall Study|Protocol Violation|0|||
19730476|NCT03565068|42175876|FG002|Overall Study|Protocol Violation|0|||
19730477|NCT03565068|42175877|FG003|Overall Study|Protocol Violation|0|||
19730478|NCT03565068|42175878|FG004|Overall Study|Protocol Violation|1|||
19730479|NCT03565068|42175879|FG005|Overall Study|Protocol Violation|0|||
19730480|NCT03565068|42175880|FG006|Overall Study|Protocol Violation|0|||
19730481|NCT03565068|42175881|FG007|Overall Study|Protocol Violation|1|||
19730482|NCT03565068|42175882|FG008|Overall Study|Protocol Violation|0|||
19730483|NCT03565068|42175874|FG000|Overall Study|Sponsor decision|0|||
19730484|NCT03565068|42175875|FG001|Overall Study|Sponsor decision|0|||
19730485|NCT03565068|42175876|FG002|Overall Study|Sponsor decision|0|||
19730486|NCT03565068|42175877|FG003|Overall Study|Sponsor decision|0|||
19730487|NCT03565068|42175878|FG004|Overall Study|Sponsor decision|1|||
19730488|NCT03565068|42175879|FG005|Overall Study|Sponsor decision|1|||
19730489|NCT03565068|42175880|FG006|Overall Study|Sponsor decision|0|||
19730490|NCT03565068|42175881|FG007|Overall Study|Sponsor decision|0|||
19730491|NCT03565068|42175882|FG008|Overall Study|Sponsor decision|0|||
19730492|NCT03565068|42175874|FG000|Overall Study|Withdrawal by Subject|0|||
19730493|NCT03565068|42175875|FG001|Overall Study|Withdrawal by Subject|0|||
19730494|NCT03565068|42175876|FG002|Overall Study|Withdrawal by Subject|1|||
19730495|NCT03565068|42175877|FG003|Overall Study|Withdrawal by Subject|0|||
19730496|NCT03565068|42175878|FG004|Overall Study|Withdrawal by Subject|2|||
19730497|NCT03565068|42175879|FG005|Overall Study|Withdrawal by Subject|0|||
19730498|NCT03565068|42175880|FG006|Overall Study|Withdrawal by Subject|1|||
19730499|NCT03565068|42175881|FG007|Overall Study|Withdrawal by Subject|5|||
19730500|NCT03565068|42175882|FG008|Overall Study|Withdrawal by Subject|1|||
19730501|NCT03565068|42175874|FG000|Overall Study|Physician Decision|0|||
19730502|NCT03565068|42175875|FG001|Overall Study|Physician Decision|0|||
19730503|NCT03565068|42175876|FG002|Overall Study|Physician Decision|0|||
19730504|NCT03565068|42175877|FG003|Overall Study|Physician Decision|0|||
19730505|NCT03565068|42175878|FG004|Overall Study|Physician Decision|0|||
19730506|NCT03565068|42175879|FG005|Overall Study|Physician Decision|0|||
19730507|NCT03565068|42175880|FG006|Overall Study|Physician Decision|0|||
19730508|NCT03565068|42175881|FG007|Overall Study|Physician Decision|1|||
19730509|NCT03565068|42175882|FG008|Overall Study|Physician Decision|0|||
19730510|NCT03565068|42175874|FG000|Overall Study|Lost to Follow-up|0|||
19730511|NCT03565068|42175875|FG001|Overall Study|Lost to Follow-up|0|||
19730512|NCT03565068|42175876|FG002|Overall Study|Lost to Follow-up|0|||
19730513|NCT03565068|42175877|FG003|Overall Study|Lost to Follow-up|0|||
19730514|NCT03565068|42175878|FG004|Overall Study|Lost to Follow-up|0|||
19730515|NCT03565068|42175879|FG005|Overall Study|Lost to Follow-up|0|||
19730516|NCT03565068|42175880|FG006|Overall Study|Lost to Follow-up|0|||
19730517|NCT03565068|42175881|FG007|Overall Study|Lost to Follow-up|1|||
19730518|NCT03565068|42175882|FG008|Overall Study|Lost to Follow-up|0|||
19730519|NCT00010803|42175941|FG000|Overall Study|Withdrawal by Subject|97|||
19730520|NCT00010803|42175942|FG001|Overall Study|Withdrawal by Subject|98|||
19730521|NCT02914834|42175950|FG000|Overall Study|Study halted due to COVID|1|||
19730522|NCT02914834|42175951|FG001|Overall Study|Study halted due to COVID|1|||
19730523|NCT02914834|42175950|FG000|Overall Study|1 subject withdrew|0|||
19730524|NCT02914834|42175951|FG001|Overall Study|1 subject withdrew|1|||
19730525|NCT03497130|42175959|FG000|Overall Study|Lost to Follow-up|1|||
19730526|NCT03497130|42175960|FG001|Overall Study|Lost to Follow-up|1|||
19730527|NCT03006562|42175968|FG000|Overall Study|Lost to Follow-up|0|||
19730528|NCT03006562|42175969|FG001|Overall Study|Lost to Follow-up|1|||
19730529|NCT03007966|42175977|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
19730530|NCT03007966|42175978|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
19730531|NCT03541200|42175985|FG000|Overall Study|Adverse Event|19|||
19730532|NCT03541200|42175985|FG000|Overall Study|Death|1|||
19730533|NCT03541200|42175985|FG000|Overall Study|Lost to Follow-up|10|||
19730534|NCT03541200|42175985|FG000|Overall Study|Physician Decision|1|||
19730535|NCT03541200|42175985|FG000|Overall Study|Protocol Violation|51|||
19730536|NCT03541200|42175985|FG000|Overall Study|Withdrawal by Subject|23|||
19730537|NCT03541200|42175985|FG000|Overall Study|other|8|||
19730538|NCT03007888|42175989|FG000|First Intervention (14 Days)|Adverse Event|1|||
19730539|NCT03007888|42175990|FG001|First Intervention (14 Days)|Adverse Event|0|||
19730540|NCT03541044|42175999|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
19730541|NCT03541044|42176000|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
19730542|NCT03541044|42175999|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
19730543|NCT03541044|42176000|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
19730544|NCT00009945|42176010|FG000|Overall Study|no follow up data|7|||
19730545|NCT00009945|42176011|FG001|Overall Study|no follow up data|5|||
19730546|NCT03540030|42176019|FG000|Overall Study|Withdrawal by Subject|2|||
19730547|NCT03540030|42176020|FG001|Overall Study|Withdrawal by Subject|1|||
19730548|NCT03540030|42176019|FG000|Overall Study|screen fail|7|||
19730549|NCT03540030|42176020|FG001|Overall Study|screen fail|1|||
19730550|NCT03540030|42176019|FG000|Overall Study|never had surgery after signing consent|9|||
19730551|NCT03540030|42176020|FG001|Overall Study|never had surgery after signing consent|1|||
19730552|NCT00008385|42176028|FG000|Overall Study|Off treatment reasons not reported|79|||
19730553|NCT00008385|42176029|FG001|Overall Study|Off treatment reasons not reported|70|||
19730554|NCT00008385|42176028|FG000|Overall Study|Progressive disease|52|||
19730555|NCT00008385|42176029|FG001|Overall Study|Progressive disease|117|||
19730556|NCT00008385|42176028|FG000|Overall Study|Adverse Event|8|||
19730557|NCT00008385|42176029|FG001|Overall Study|Adverse Event|20|||
19730558|NCT00008385|42176028|FG000|Overall Study|Death|12|||
19730559|NCT00008385|42176029|FG001|Overall Study|Death|18|||
19730560|NCT00008385|42176028|FG000|Overall Study|Withdrawal by Subject|67|||
19730561|NCT00008385|42176029|FG001|Overall Study|Withdrawal by Subject|157|||
19730562|NCT00008385|42176028|FG000|Overall Study|Start non-protocol therapy|3|||
19730563|NCT00008385|42176029|FG001|Overall Study|Start non-protocol therapy|1|||
19730564|NCT00008385|42176028|FG000|Overall Study|Other complicating disease|17|||
19730565|NCT00008385|42176029|FG001|Overall Study|Other complicating disease|30|||
19730566|NCT00008385|42176028|FG000|Overall Study|Maximum dose reached|0|||
19730567|NCT00008385|42176029|FG001|Overall Study|Maximum dose reached|2|||
19730568|NCT00008385|42176028|FG000|Overall Study|Other|105|||
19730569|NCT00008385|42176029|FG001|Overall Study|Other|212|||
19730570|NCT00008385|42176028|FG000|Overall Study|Not start protocol therapy|44|||
19730571|NCT00008385|42176029|FG001|Overall Study|Not start protocol therapy|175|||
19730572|NCT03003676|42176037|FG000|Overall Study|Lack of Efficacy|5|||
19730573|NCT03003676|42176038|FG001|Overall Study|Lack of Efficacy|7|||
19730574|NCT03003676|42176037|FG000|Overall Study|Withdrawal by Subject|0|||
19730575|NCT03003676|42176038|FG001|Overall Study|Withdrawal by Subject|1|||
19730576|NCT03003676|42176037|FG000|Overall Study|Hepatitis B infection|1|||
19730577|NCT03003676|42176038|FG001|Overall Study|Hepatitis B infection|0|||
19730578|NCT00047385|42176048|FG000|Overall Study|Death before any screening|2|||
19730579|NCT00047385|42176049|FG001|Overall Study|Death before any screening|5|||
19730580|NCT00047385|42176048|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
19730581|NCT00047385|42176049|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
19730582|NCT00047385|42176048|FG000|Overall Study|Eligible for screening but had no screen|260|||
19730583|NCT00047385|42176049|FG001|Overall Study|Eligible for screening but had no screen|492|||
19730584|NCT03003520|42176057|FG000|Induction|Ongoing|1|||
19730585|NCT03003520|42176058|FG001|Induction|Ongoing|0|||
19730586|NCT03003520|42176057|FG000|Induction|Adverse Event|4|||
19730587|NCT03003520|42176058|FG001|Induction|Adverse Event|0|||
19730588|NCT03003520|42176057|FG000|Induction|Death|1|||
19730589|NCT03003520|42176058|FG001|Induction|Death|0|||
19730590|NCT03003520|42176057|FG000|Induction|Palliative care|1|||
19730591|NCT03003520|42176058|FG001|Induction|Palliative care|0|||
19730592|NCT03003520|42176057|FG000|Induction|Physician Decision|2|||
19730593|NCT03003520|42176058|FG001|Induction|Physician Decision|0|||
19730594|NCT03003520|42176057|FG000|Induction|Withdrawal by Subject|3|||
19730595|NCT03003520|42176058|FG001|Induction|Withdrawal by Subject|0|||
19730596|NCT03003520|42176057|FG000|Induction|Progressive disease|1|||
19730597|NCT03003520|42176058|FG001|Induction|Progressive disease|0|||
19730598|NCT03003520|42176057|FG000|Consolidation|Ongoing|18|||
19730599|NCT03003520|42176058|FG001|Consolidation|Ongoing|0|||
19730600|NCT03003520|42176057|FG000|Consolidation|Adverse Event|2|||
19730601|NCT03003520|42176058|FG001|Consolidation|Adverse Event|0|||
19730602|NCT03003520|42176057|FG000|Consolidation|Progressive disease|3|||
19730603|NCT03003520|42176058|FG001|Consolidation|Progressive disease|1|||
19730604|NCT03003520|42176057|FG000|Consolidation|Withdrawal by Subject|1|||
19730605|NCT03003520|42176058|FG001|Consolidation|Withdrawal by Subject|0|||
19730606|NCT03003520|42176057|FG000|Follow-up|Death|1|||
19730607|NCT03003520|42176058|FG001|Follow-up|Death|1|||
19730608|NCT03003520|42176057|FG000|Follow-up|Ongoing|12|||
19730609|NCT03003520|42176058|FG001|Follow-up|Ongoing|2|||
19730610|NCT03003520|42176057|FG000|Follow-up|Withdrawal by Subject|1|||
19730611|NCT03003520|42176058|FG001|Follow-up|Withdrawal by Subject|0|||
19730612|NCT03002818|42176072|FG000|Overall Study|Decision of the investigator|1|||
19730613|NCT03002194|42176076|FG000|Overall Study|Lost to Follow-up|6|||
19730614|NCT03002194|42176076|FG000|Overall Study|Adverse Event|1|||
19730615|NCT03002194|42176076|FG000|Overall Study|Lack of Efficacy|1|||
19730616|NCT03002194|42176076|FG000|Overall Study|Withdrawal by Subject|2|||
19730617|NCT02912650|42176084|FG000|Overall Study|Withdrawal by Subject|1|||
19730618|NCT02912650|42176085|FG001|Overall Study|Withdrawal by Subject|0|||
19730619|NCT02912650|42176086|FG002|Overall Study|Withdrawal by Subject|1|||
19730620|NCT02912650|42176087|FG003|Overall Study|Withdrawal by Subject|5|||
19730621|NCT02912650|42176084|FG000|Overall Study|Adverse Event|0|||
19730622|NCT02912650|42176085|FG001|Overall Study|Adverse Event|0|||
19730623|NCT02912650|42176086|FG002|Overall Study|Adverse Event|1|||
19730624|NCT02912650|42176087|FG003|Overall Study|Adverse Event|0|||
19730625|NCT03004924|42176100|FG000|Overall Study|Adverse Event|6|||
19730626|NCT03004924|42176101|FG001|Overall Study|Adverse Event|5|||
19730627|NCT03004924|42176102|FG002|Overall Study|Adverse Event|10|||
19730628|NCT03004924|42176100|FG000|Overall Study|Protocol Violation|4|||
19730629|NCT03004924|42176101|FG001|Overall Study|Protocol Violation|0|||
19730630|NCT03004924|42176102|FG002|Overall Study|Protocol Violation|1|||
19730631|NCT03004924|42176100|FG000|Overall Study|Withdrawal by Subject|5|||
19730632|NCT03004924|42176101|FG001|Overall Study|Withdrawal by Subject|3|||
19730633|NCT03004924|42176102|FG002|Overall Study|Withdrawal by Subject|5|||
19730634|NCT03004924|42176100|FG000|Overall Study|Lost to Follow-up|6|||
19730635|NCT03004924|42176101|FG001|Overall Study|Lost to Follow-up|1|||
19730636|NCT03004924|42176102|FG002|Overall Study|Lost to Follow-up|4|||
19730637|NCT03004924|42176100|FG000|Overall Study|Lack of Efficacy|2|||
19730638|NCT03004924|42176101|FG001|Overall Study|Lack of Efficacy|4|||
19730639|NCT03004924|42176102|FG002|Overall Study|Lack of Efficacy|2|||
19730640|NCT03004924|42176100|FG000|Overall Study|Physician Decision|1|||
19730641|NCT03004924|42176101|FG001|Overall Study|Physician Decision|0|||
19730642|NCT03004924|42176102|FG002|Overall Study|Physician Decision|1|||
19730643|NCT03004924|42176100|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19730644|NCT03004924|42176101|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19730645|NCT03004924|42176102|FG002|Overall Study|Withdrawal by parent/guardian|2|||
19730646|NCT03004924|42176100|FG000|Overall Study|Screen Failure|1|||
19730647|NCT03004924|42176101|FG001|Overall Study|Screen Failure|0|||
19730648|NCT03004924|42176102|FG002|Overall Study|Screen Failure|0|||
19730649|NCT03004924|42176100|FG000|Overall Study|Pregnancy|0|||
19730650|NCT03004924|42176101|FG001|Overall Study|Pregnancy|1|||
19730651|NCT03004924|42176102|FG002|Overall Study|Pregnancy|0|||
19730652|NCT03004924|42176100|FG000|Overall Study|Terminated by Sponsor|0|||
19730653|NCT03004924|42176101|FG001|Overall Study|Terminated by Sponsor|0|||
19730654|NCT03004924|42176102|FG002|Overall Study|Terminated by Sponsor|1|||
19730655|NCT03004924|42176100|FG000|Overall Study|Missed Study Visit|0|||
19730656|NCT03004924|42176101|FG001|Overall Study|Missed Study Visit|0|||
19730657|NCT03004924|42176102|FG002|Overall Study|Missed Study Visit|2|||
19730658|NCT03004924|42176100|FG000|Overall Study|HSV1 Positive|1|||
19730659|NCT03004924|42176101|FG001|Overall Study|HSV1 Positive|0|||
19730660|NCT03004924|42176102|FG002|Overall Study|HSV1 Positive|0|||
19730661|NCT03002038|42176113|FG000|Overall Study|Adverse Event|3|||
19730662|NCT03002038|42176114|FG001|Overall Study|Adverse Event|1|||
19730663|NCT03002038|42176113|FG000|Overall Study|Withdrawal by Subject|8|||
19730664|NCT03002038|42176114|FG001|Overall Study|Withdrawal by Subject|4|||
19730665|NCT03002038|42176113|FG000|Overall Study|Immigration to another region|0|||
19730666|NCT03002038|42176114|FG001|Overall Study|Immigration to another region|2|||
19730667|NCT02911948|42176122|FG000|Overall Study|Protocol Violation|0|||
19730668|NCT02911948|42176123|FG001|Overall Study|Protocol Violation|1|||
19730669|NCT02911948|42176122|FG000|Overall Study|Withdrawal by Subject|0|||
19730670|NCT02911948|42176123|FG001|Overall Study|Withdrawal by Subject|2|||
19730671|NCT02911948|42176122|FG000|Overall Study|Lack of Efficacy|0|||
19730672|NCT02911948|42176123|FG001|Overall Study|Lack of Efficacy|1|||
19730673|NCT02911948|42176122|FG000|Overall Study|Unclassified|0|||
19730674|NCT02911948|42176123|FG001|Overall Study|Unclassified|3|||
19730675|NCT02996968|42176131|FG000|Overall Study|Withdrawal by Subject|1|||
19730676|NCT02996968|42176132|FG001|Overall Study|Withdrawal by Subject|0|||
19730677|NCT00027027|42176143|FG000|Overall Study|Adverse Event|0|||
19730678|NCT00027027|42176144|FG001|Overall Study|Adverse Event|0|||
19730679|NCT00027027|42176145|FG002|Overall Study|Adverse Event|1|||
19730680|NCT00027027|42176146|FG003|Overall Study|Adverse Event|0|||
19730681|NCT00027027|42176147|FG004|Overall Study|Adverse Event|1|||
19730682|NCT00027027|42176143|FG000|Overall Study|Admitted for Signs of PD|0|||
19730683|NCT00027027|42176144|FG001|Overall Study|Admitted for Signs of PD|0|||
19730684|NCT00027027|42176145|FG002|Overall Study|Admitted for Signs of PD|0|||
19730685|NCT00027027|42176146|FG003|Overall Study|Admitted for Signs of PD|0|||
19730686|NCT00027027|42176147|FG004|Overall Study|Admitted for Signs of PD|1|||
19730687|NCT00027027|42176143|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
19730688|NCT00027027|42176144|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
19730689|NCT00027027|42176145|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
19730690|NCT00027027|42176146|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
19730691|NCT00027027|42176147|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
19730692|NCT00027027|42176143|FG000|Overall Study|PD Requiring Surgery|0|||
19730693|NCT00027027|42176144|FG001|Overall Study|PD Requiring Surgery|0|||
19730694|NCT00027027|42176145|FG002|Overall Study|PD Requiring Surgery|1|||
19730695|NCT00027027|42176146|FG003|Overall Study|PD Requiring Surgery|0|||
19730696|NCT00027027|42176147|FG004|Overall Study|PD Requiring Surgery|0|||
19730697|NCT00027027|42176143|FG000|Overall Study|Physician Decision Due To PD|2|||
19730698|NCT00027027|42176144|FG001|Overall Study|Physician Decision Due To PD|3|||
19730699|NCT00027027|42176145|FG002|Overall Study|Physician Decision Due To PD|2|||
19730700|NCT00027027|42176146|FG003|Overall Study|Physician Decision Due To PD|3|||
19730701|NCT00027027|42176147|FG004|Overall Study|Physician Decision Due To PD|5|||
19730702|NCT00027027|42176143|FG000|Overall Study|Withdrawal by Subject|0|||
19730703|NCT00027027|42176144|FG001|Overall Study|Withdrawal by Subject|0|||
19730704|NCT00027027|42176145|FG002|Overall Study|Withdrawal by Subject|0|||
19730705|NCT00027027|42176146|FG003|Overall Study|Withdrawal by Subject|0|||
19730706|NCT00027027|42176147|FG004|Overall Study|Withdrawal by Subject|1|||
19730707|NCT00046839|42176165|FG000|Overall Study|Ineligible / No protocol treatment|0|||
19730708|NCT00046839|42176166|FG001|Overall Study|Ineligible / No protocol treatment|2|||
19730709|NCT00046839|42176165|FG000|Overall Study|Withdrawal of consent|1|||
19730710|NCT00046839|42176166|FG001|Overall Study|Withdrawal of consent|0|||
19730711|NCT00006903|42176175|FG000|Overall Study|Still receiving treatment|0|||
19730712|NCT00006903|42176176|FG001|Overall Study|Still receiving treatment|0|||
19730713|NCT00006903|42176177|FG002|Overall Study|Still receiving treatment|1|||
19730714|NCT00006903|42176175|FG000|Overall Study|Refused further treatment|0|||
19730715|NCT00006903|42176176|FG001|Overall Study|Refused further treatment|2|||
19730716|NCT00006903|42176177|FG002|Overall Study|Refused further treatment|1|||
19730717|NCT00006903|42176175|FG000|Overall Study|Adverse Event|0|||
19730718|NCT00006903|42176176|FG001|Overall Study|Adverse Event|0|||
19730719|NCT00006903|42176177|FG002|Overall Study|Adverse Event|1|||
19730720|NCT00006903|42176175|FG000|Overall Study|Death|0|||
19730721|NCT00006903|42176176|FG001|Overall Study|Death|1|||
19730722|NCT00006903|42176177|FG002|Overall Study|Death|0|||
19730723|NCT00006903|42176175|FG000|Overall Study|Patient never treated|0|||
19730724|NCT00006903|42176176|FG001|Overall Study|Patient never treated|0|||
19730725|NCT00006903|42176177|FG002|Overall Study|Patient never treated|1|||
19730726|NCT00006903|42176175|FG000|Overall Study|Ineligible|10|||
19730727|NCT00006903|42176176|FG001|Overall Study|Ineligible|1|||
19730728|NCT00006903|42176177|FG002|Overall Study|Ineligible|2|||
19730729|NCT00026793|42176185|FG000|Overall Study|Death on study due to underlying disease|4|||
19730730|NCT00026793|42176185|FG000|Overall Study|Physician Decision|2|||
19730731|NCT00026793|42176185|FG000|Overall Study|Off study|2|||
19730732|NCT03539484|42176196|FG000|Overall Study|Death|1|||
19730733|NCT03539484|42176197|FG001|Overall Study|Death|0|||
19730734|NCT03539484|42176198|FG002|Overall Study|Death|0|||
19730735|NCT03539484|42176199|FG003|Overall Study|Death|2|||
19730736|NCT03539484|42176200|FG004|Overall Study|Death|8|||
19730737|NCT03539484|42176201|FG005|Overall Study|Death|3|||
19730738|NCT03539484|42176202|FG006|Overall Study|Death|0|||
19730739|NCT03539484|42176196|FG000|Overall Study|Lost to Follow-up|0|||
19730740|NCT03539484|42176197|FG001|Overall Study|Lost to Follow-up|1|||
19730741|NCT03539484|42176198|FG002|Overall Study|Lost to Follow-up|0|||
19730742|NCT03539484|42176199|FG003|Overall Study|Lost to Follow-up|0|||
19730743|NCT03539484|42176200|FG004|Overall Study|Lost to Follow-up|1|||
19730744|NCT03539484|42176201|FG005|Overall Study|Lost to Follow-up|0|||
19730745|NCT03539484|42176202|FG006|Overall Study|Lost to Follow-up|0|||
19730746|NCT03539484|42176196|FG000|Overall Study|Withdrawal by Subject|0|||
19730747|NCT03539484|42176197|FG001|Overall Study|Withdrawal by Subject|0|||
19730748|NCT03539484|42176198|FG002|Overall Study|Withdrawal by Subject|0|||
19730749|NCT03539484|42176199|FG003|Overall Study|Withdrawal by Subject|0|||
19730750|NCT03539484|42176200|FG004|Overall Study|Withdrawal by Subject|2|||
19730751|NCT03539484|42176201|FG005|Overall Study|Withdrawal by Subject|0|||
19730752|NCT03539484|42176202|FG006|Overall Study|Withdrawal by Subject|1|||
19730753|NCT03539484|42176196|FG000|Overall Study|Study Terminated by Sponsor|0|||
19730754|NCT03539484|42176197|FG001|Overall Study|Study Terminated by Sponsor|0|||
19730755|NCT03539484|42176198|FG002|Overall Study|Study Terminated by Sponsor|1|||
19730756|NCT03539484|42176199|FG003|Overall Study|Study Terminated by Sponsor|1|||
19730757|NCT03539484|42176200|FG004|Overall Study|Study Terminated by Sponsor|2|||
19730758|NCT03539484|42176201|FG005|Overall Study|Study Terminated by Sponsor|2|||
19730759|NCT03539484|42176202|FG006|Overall Study|Study Terminated by Sponsor|1|||
19730760|NCT03561090|42176225|FG000|Overall Study|Adverse Event|11|||
19730761|NCT03561090|42176226|FG001|Overall Study|Adverse Event|7|||
19730762|NCT03561090|42176225|FG000|Overall Study|Non-Compliance With Study Drug|2|||
19730763|NCT03561090|42176226|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19730764|NCT03561090|42176225|FG000|Overall Study|Protocol Violation|2|||
19730765|NCT03561090|42176226|FG001|Overall Study|Protocol Violation|2|||
19730766|NCT03561090|42176225|FG000|Overall Study|Withdrawal by Subject|7|||
19730767|NCT03561090|42176226|FG001|Overall Study|Withdrawal by Subject|7|||
19730768|NCT03561090|42176225|FG000|Overall Study|Lost to Follow-up|7|||
19730769|NCT03561090|42176226|FG001|Overall Study|Lost to Follow-up|2|||
19730770|NCT03561090|42176225|FG000|Overall Study|Study Terminated by Sponsor|10|||
19730771|NCT03561090|42176226|FG001|Overall Study|Study Terminated by Sponsor|15|||
19730772|NCT03561090|42176225|FG000|Overall Study|Randomized by Mistake|1|||
19730773|NCT03561090|42176226|FG001|Overall Study|Randomized by Mistake|1|||
19730774|NCT03561090|42176225|FG000|Overall Study|Other Not Specified|0|||
19730775|NCT03561090|42176226|FG001|Overall Study|Other Not Specified|2|||
19730776|NCT02996500|42176240|FG000|Overall Study|Adverse Event|1|||
19730777|NCT02996500|42176241|FG001|Overall Study|Adverse Event|1|||
19730778|NCT02996500|42176242|FG002|Overall Study|Adverse Event|4|||
19730779|NCT02996500|42176243|FG003|Overall Study|Adverse Event|3|||
19730780|NCT02996500|42176244|FG004|Overall Study|Adverse Event|1|||
19730781|NCT02996500|42176245|FG005|Overall Study|Adverse Event|2|||
19730782|NCT02996500|42176240|FG000|Overall Study|Lack of Efficacy|0|||
19730783|NCT02996500|42176241|FG001|Overall Study|Lack of Efficacy|0|||
19730784|NCT02996500|42176242|FG002|Overall Study|Lack of Efficacy|0|||
19730785|NCT02996500|42176243|FG003|Overall Study|Lack of Efficacy|0|||
19730786|NCT02996500|42176244|FG004|Overall Study|Lack of Efficacy|2|||
19730787|NCT02996500|42176245|FG005|Overall Study|Lack of Efficacy|0|||
19730788|NCT02996500|42176240|FG000|Overall Study|Lost to Follow-up|1|||
19730789|NCT02996500|42176241|FG001|Overall Study|Lost to Follow-up|0|||
19730790|NCT02996500|42176242|FG002|Overall Study|Lost to Follow-up|0|||
19730791|NCT02996500|42176243|FG003|Overall Study|Lost to Follow-up|0|||
19730792|NCT02996500|42176244|FG004|Overall Study|Lost to Follow-up|0|||
19730793|NCT02996500|42176245|FG005|Overall Study|Lost to Follow-up|1|||
19730794|NCT02996500|42176240|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19730795|NCT02996500|42176241|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19730796|NCT02996500|42176242|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
19730797|NCT02996500|42176243|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
19730798|NCT02996500|42176244|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
19730799|NCT02996500|42176245|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
19730800|NCT02996500|42176240|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19730801|NCT02996500|42176241|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19730802|NCT02996500|42176242|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19730803|NCT02996500|42176243|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19730804|NCT02996500|42176244|FG004|Overall Study|Non-Compliance With Study Drug|0|||
19730805|NCT02996500|42176245|FG005|Overall Study|Non-Compliance With Study Drug|1|||
19730806|NCT02996500|42176240|FG000|Overall Study|Progressive Disease|1|||
19730807|NCT02996500|42176241|FG001|Overall Study|Progressive Disease|0|||
19730808|NCT02996500|42176242|FG002|Overall Study|Progressive Disease|0|||
19730809|NCT02996500|42176243|FG003|Overall Study|Progressive Disease|0|||
19730810|NCT02996500|42176244|FG004|Overall Study|Progressive Disease|0|||
19730811|NCT02996500|42176245|FG005|Overall Study|Progressive Disease|0|||
19730812|NCT02996500|42176240|FG000|Overall Study|Other|2|||
19730813|NCT02996500|42176241|FG001|Overall Study|Other|0|||
19730814|NCT02996500|42176242|FG002|Overall Study|Other|2|||
19730815|NCT02996500|42176243|FG003|Overall Study|Other|0|||
19730816|NCT02996500|42176244|FG004|Overall Study|Other|0|||
19730817|NCT02996500|42176245|FG005|Overall Study|Other|0|||
19730818|NCT02996500|42176240|FG000|Overall Study|Protocol Violation|0|||
19730819|NCT02996500|42176241|FG001|Overall Study|Protocol Violation|0|||
19730820|NCT02996500|42176242|FG002|Overall Study|Protocol Violation|0|||
19730821|NCT02996500|42176243|FG003|Overall Study|Protocol Violation|1|||
19730822|NCT02996500|42176244|FG004|Overall Study|Protocol Violation|0|||
19730823|NCT02996500|42176245|FG005|Overall Study|Protocol Violation|0|||
19730824|NCT02996500|42176240|FG000|Overall Study|Withdrawal by Subject|3|||
19730825|NCT02996500|42176241|FG001|Overall Study|Withdrawal by Subject|0|||
19730826|NCT02996500|42176242|FG002|Overall Study|Withdrawal by Subject|3|||
19730827|NCT02996500|42176243|FG003|Overall Study|Withdrawal by Subject|0|||
19730828|NCT02996500|42176244|FG004|Overall Study|Withdrawal by Subject|2|||
19730829|NCT02996500|42176245|FG005|Overall Study|Withdrawal by Subject|0|||
19730830|NCT00006489|42176267|FG000|Overall Study|Adverse Event|3|||
19730831|NCT00006489|42176268|FG001|Overall Study|Adverse Event|2|||
19730832|NCT00006489|42176269|FG002|Overall Study|Adverse Event|4|||
19730833|NCT00006489|42176270|FG003|Overall Study|Adverse Event|3|||
19730834|NCT00006489|42176267|FG000|Overall Study|Withdrawal by Subject|10|||
19730835|NCT00006489|42176268|FG001|Overall Study|Withdrawal by Subject|9|||
19730836|NCT00006489|42176269|FG002|Overall Study|Withdrawal by Subject|9|||
19730837|NCT00006489|42176270|FG003|Overall Study|Withdrawal by Subject|6|||
19730838|NCT00006489|42176267|FG000|Overall Study|Scheduling Conflict|0|||
19730839|NCT00006489|42176268|FG001|Overall Study|Scheduling Conflict|3|||
19730840|NCT00006489|42176269|FG002|Overall Study|Scheduling Conflict|2|||
19730841|NCT00006489|42176270|FG003|Overall Study|Scheduling Conflict|1|||
19730842|NCT00006489|42176267|FG000|Overall Study|Death|0|||
19730843|NCT00006489|42176268|FG001|Overall Study|Death|0|||
19730844|NCT00006489|42176269|FG002|Overall Study|Death|0|||
19730845|NCT00006489|42176270|FG003|Overall Study|Death|1|||
19730846|NCT03535974|42176283|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
19730847|NCT03535974|42176284|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
19730848|NCT03535974|42176285|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
19730849|NCT03535974|42176283|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
19730850|NCT03535974|42176284|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
19730851|NCT03535974|42176285|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
19730852|NCT00025233|42176293|FG000|Overall Study|Ineligible: wrong cell type|1|||
19730853|NCT00025233|42176293|FG000|Overall Study|Ineligible: wrong primary|1|||
19730854|NCT00025233|42176293|FG000|Overall Study|Ineligible: improper prior treatment|1|||
19730855|NCT00025233|42176293|FG000|Overall Study|Never treated|1|||
19730856|NCT03535740|42176303|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
19730857|NCT03535740|42176303|FG000|Overall Study|Death|34|||
19730858|NCT03535740|42176303|FG000|Overall Study|Lost to Follow-up|1|||
19730859|NCT03535740|42176303|FG000|Overall Study|Withdrawal by Subject|13|||
19730860|NCT00025155|42176308|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
19730861|NCT00025155|42176308|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
19730862|NCT02998996|42176323|FG000|Overall Study|Lost to Follow-up|0|||
19730863|NCT02998996|42176324|FG001|Overall Study|Lost to Follow-up|0|||
19730864|NCT02998996|42176325|FG002|Overall Study|Lost to Follow-up|1|||
19730865|NCT02998996|42176326|FG003|Overall Study|Lost to Follow-up|0|||
19730866|NCT02998996|42176327|FG004|Overall Study|Lost to Follow-up|0|||
19730867|NCT02998996|42176328|FG005|Overall Study|Lost to Follow-up|0|||
19730868|NCT02998996|42176323|FG000|Overall Study|Pregnancy|0|||
19730869|NCT02998996|42176324|FG001|Overall Study|Pregnancy|1|||
19730870|NCT02998996|42176325|FG002|Overall Study|Pregnancy|0|||
19730871|NCT02998996|42176326|FG003|Overall Study|Pregnancy|0|||
19730872|NCT02998996|42176327|FG004|Overall Study|Pregnancy|0|||
19730873|NCT02998996|42176328|FG005|Overall Study|Pregnancy|0|||
19730874|NCT02998996|42176323|FG000|Overall Study|Family reasons|0|||
19730875|NCT02998996|42176324|FG001|Overall Study|Family reasons|0|||
19730876|NCT02998996|42176325|FG002|Overall Study|Family reasons|0|||
19730877|NCT02998996|42176326|FG003|Overall Study|Family reasons|0|||
19730878|NCT02998996|42176327|FG004|Overall Study|Family reasons|1|||
19730879|NCT02998996|42176328|FG005|Overall Study|Family reasons|0|||
19730880|NCT02994940|42176344|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
19730881|NCT02994940|42176345|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
19730882|NCT02994940|42176344|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
19730883|NCT02994940|42176345|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
19730884|NCT02994940|42176344|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
19730885|NCT02994940|42176345|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
19730886|NCT02994394|42176353|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
19730887|NCT02994394|42176354|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
19730888|NCT02994394|42176355|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
19730889|NCT02994394|42176356|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
19730890|NCT02994394|42176357|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
19730891|NCT02994394|42176358|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
19730892|NCT02994394|42176353|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
19730893|NCT02994394|42176354|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
19730894|NCT02994394|42176355|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
19730895|NCT02994394|42176356|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
19730896|NCT02994394|42176357|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
19730897|NCT02994394|42176358|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
19730898|NCT02998840|42176376|FG000|Overall Study|Lost to Follow-up|1|||
19730899|NCT02998840|42176377|FG001|Overall Study|Lost to Follow-up|1|||
19730900|NCT02998840|42176378|FG002|Overall Study|Lost to Follow-up|2|||
19730901|NCT02998840|42176379|FG003|Overall Study|Lost to Follow-up|3|||
19730902|NCT02998840|42176376|FG000|Overall Study|Withdrawal by Subject|1|||
19730903|NCT02998840|42176377|FG001|Overall Study|Withdrawal by Subject|1|||
19730904|NCT02998840|42176378|FG002|Overall Study|Withdrawal by Subject|0|||
19730905|NCT02998840|42176379|FG003|Overall Study|Withdrawal by Subject|1|||
19730906|NCT02998840|42176376|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
19730907|NCT02998840|42176377|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
19730908|NCT02998840|42176378|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
19730909|NCT02998840|42176379|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
19730910|NCT00023673|42176390|FG000|Overall Study|Ineligible / no protocol treatment|0|||
19730911|NCT00023673|42176391|FG001|Overall Study|Ineligible / no protocol treatment|0|||
19730912|NCT00023673|42176392|FG002|Overall Study|Ineligible / no protocol treatment|0|||
19730913|NCT00023673|42176393|FG003|Overall Study|Ineligible / no protocol treatment|1|||
19730914|NCT00023673|42176390|FG000|Overall Study|Patient withdrew consent|0|||
19730915|NCT00023673|42176391|FG001|Overall Study|Patient withdrew consent|0|||
19730916|NCT00023673|42176392|FG002|Overall Study|Patient withdrew consent|0|||
19730917|NCT00023673|42176393|FG003|Overall Study|Patient withdrew consent|1|||
19730918|NCT01069900|42176405|FG000|Overall Study|Technical problems|0|||
19730919|NCT01069900|42176406|FG001|Overall Study|Technical problems|1|||
19730920|NCT01069900|42176405|FG000|Overall Study|Lost to Follow-up|7|||
19730921|NCT01069900|42176406|FG001|Overall Study|Lost to Follow-up|1|||
19730922|NCT01069900|42176405|FG000|Overall Study|Withdrawal by Subject|6|||
19730923|NCT01069900|42176406|FG001|Overall Study|Withdrawal by Subject|1|||
19730924|NCT01069900|42176405|FG000|Overall Study|Protocol Violation|4|||
19730925|NCT01069900|42176406|FG001|Overall Study|Protocol Violation|1|||
19730926|NCT01069900|42176405|FG000|Overall Study|Insufficient Therapeutic effect|1|||
19730927|NCT01069900|42176406|FG001|Overall Study|Insufficient Therapeutic effect|0|||
19730928|NCT01069120|42176414|FG000|Overall Study|Study prematurely terminated|27|||
19730929|NCT00006237|42176422|FG000|Overall Study|Adverse Event|39|||
19730930|NCT00006237|42176423|FG001|Overall Study|Adverse Event|29|||
19730931|NCT00006237|42176422|FG000|Overall Study|Death|1|||
19730932|NCT00006237|42176423|FG001|Overall Study|Death|0|||
19730933|NCT00006237|42176422|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
19730934|NCT00006237|42176423|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
19730935|NCT00006237|42176422|FG000|Overall Study|Progression/relapse|54|||
19730936|NCT00006237|42176423|FG001|Overall Study|Progression/relapse|2|||
19730937|NCT00006237|42176422|FG000|Overall Study|Not eligible|9|||
19730938|NCT00006237|42176423|FG001|Overall Study|Not eligible|20|||
19730939|NCT00006237|42176422|FG000|Overall Study|Withdrawal by Subject|0|||
19730940|NCT00006237|42176423|FG001|Overall Study|Withdrawal by Subject|1|||
19730941|NCT00006237|42176422|FG000|Overall Study|Not protocol specified|14|||
19730942|NCT00006237|42176423|FG001|Overall Study|Not protocol specified|5|||
19730943|NCT02993926|42176432|FG000|Enantone Treatment Phase|Adverse Event|1|||
19730944|NCT02993926|42176433|FG001|Enantone Treatment Phase|Adverse Event|0|||
19730945|NCT02993926|42176434|FG002|Enantone Treatment Phase|Adverse Event|0|||
19730946|NCT02993926|42176432|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
19730947|NCT02993926|42176433|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
19730948|NCT02993926|42176434|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
19730949|NCT02993926|42176432|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
19730950|NCT02993926|42176433|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
19730951|NCT02993926|42176434|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
19730952|NCT02993926|42176432|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
19730953|NCT02993926|42176433|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
19730954|NCT02993926|42176434|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
19730955|NCT02993224|42176444|FG000|Core Phase - Period 1|Adverse Event|4|||
19730956|NCT02993224|42176444|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
19730957|NCT02993224|42176444|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
19730958|NCT02993224|42176444|FG000|Core Phase- Period 2|Adverse Event|1|||
19730959|NCT02993224|42176444|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
19730960|NCT02993224|42176444|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
19730961|NCT02993224|42176444|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
19730962|NCT02993224|42176444|FG000|Extension Phase|Adverse Event|3|||
19730963|NCT02993224|42176444|FG000|Extension Phase|Withdrawal by Subject|3|||
19730964|NCT02993224|42176444|FG000|Extension Phase|Lost to Follow-up|2|||
19730965|NCT02993224|42176444|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
19730966|NCT03447314|42176468|FG000|Part 1 (Up to 27 Months)|Death|6|||
19730967|NCT03447314|42176469|FG001|Part 1 (Up to 27 Months)|Death|5|||
19730968|NCT03447314|42176470|FG002|Part 1 (Up to 27 Months)|Death|3|||
19730969|NCT03447314|42176471|FG003|Part 1 (Up to 27 Months)|Death|3|||
19730970|NCT03447314|42176472|FG004|Part 1 (Up to 27 Months)|Death|0|||
19730971|NCT03447314|42176473|FG005|Part 1 (Up to 27 Months)|Death|4|||
19730972|NCT03447314|42176474|FG006|Part 1 (Up to 27 Months)|Death|3|||
19730973|NCT03447314|42176475|FG007|Part 1 (Up to 27 Months)|Death|0|||
19730974|NCT03447314|42176476|FG008|Part 1 (Up to 27 Months)|Death|0|||
19730975|NCT03447314|42176477|FG009|Part 1 (Up to 27 Months)|Death|0|||
19730976|NCT03447314|42176478|FG010|Part 1 (Up to 27 Months)|Death|4|||
19730977|NCT03447314|42176479|FG011|Part 1 (Up to 27 Months)|Death|2|||
19730978|NCT03447314|42176480|FG012|Part 1 (Up to 27 Months)|Death|0|||
19730979|NCT03447314|42176481|FG013|Part 1 (Up to 27 Months)|Death|0|||
19730980|NCT03447314|42176482|FG014|Part 1 (Up to 27 Months)|Death|0|||
19730981|NCT03447314|42176483|FG015|Part 1 (Up to 27 Months)|Death|0|||
19730982|NCT03447314|42176484|FG016|Part 1 (Up to 27 Months)|Death|0|||
19730983|NCT03447314|42176485|FG017|Part 1 (Up to 27 Months)|Death|0|||
19730984|NCT03447314|42176468|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
19730985|NCT03447314|42176469|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
19730986|NCT03447314|42176470|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
19730987|NCT03447314|42176471|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
19730988|NCT03447314|42176472|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
19730989|NCT03447314|42176473|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
19730990|NCT03447314|42176474|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
19730991|NCT03447314|42176475|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730992|NCT03447314|42176476|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730993|NCT03447314|42176477|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730994|NCT03447314|42176478|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
19730995|NCT03447314|42176479|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4|||
19730996|NCT03447314|42176480|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730997|NCT03447314|42176481|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730998|NCT03447314|42176482|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19730999|NCT03447314|42176483|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19731000|NCT03447314|42176484|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19731001|NCT03447314|42176485|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
19731002|NCT03447314|42176468|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
19731003|NCT03447314|42176469|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731004|NCT03447314|42176470|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
19731005|NCT03447314|42176471|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731006|NCT03447314|42176472|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731007|NCT03447314|42176473|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
19731008|NCT03447314|42176474|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731009|NCT03447314|42176475|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731010|NCT03447314|42176476|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731011|NCT03447314|42176477|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731012|NCT03447314|42176478|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731013|NCT03447314|42176479|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731014|NCT03447314|42176480|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731015|NCT03447314|42176481|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731016|NCT03447314|42176482|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731017|NCT03447314|42176483|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731018|NCT03447314|42176484|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731019|NCT03447314|42176485|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
19731020|NCT03447314|42176468|FG000|Part 1 (Up to 27 Months)|Disease progression|0|||
19731021|NCT03447314|42176469|FG001|Part 1 (Up to 27 Months)|Disease progression|0|||
19731022|NCT03447314|42176470|FG002|Part 1 (Up to 27 Months)|Disease progression|1|||
19731023|NCT03447314|42176471|FG003|Part 1 (Up to 27 Months)|Disease progression|0|||
19731024|NCT03447314|42176472|FG004|Part 1 (Up to 27 Months)|Disease progression|0|||
19731025|NCT03447314|42176473|FG005|Part 1 (Up to 27 Months)|Disease progression|0|||
19731026|NCT03447314|42176474|FG006|Part 1 (Up to 27 Months)|Disease progression|0|||
19731027|NCT03447314|42176475|FG007|Part 1 (Up to 27 Months)|Disease progression|0|||
19731028|NCT03447314|42176476|FG008|Part 1 (Up to 27 Months)|Disease progression|0|||
19731029|NCT03447314|42176477|FG009|Part 1 (Up to 27 Months)|Disease progression|0|||
19731030|NCT03447314|42176478|FG010|Part 1 (Up to 27 Months)|Disease progression|0|||
19731031|NCT03447314|42176479|FG011|Part 1 (Up to 27 Months)|Disease progression|0|||
19731032|NCT03447314|42176480|FG012|Part 1 (Up to 27 Months)|Disease progression|0|||
19731033|NCT03447314|42176481|FG013|Part 1 (Up to 27 Months)|Disease progression|0|||
19731034|NCT03447314|42176482|FG014|Part 1 (Up to 27 Months)|Disease progression|0|||
19731035|NCT03447314|42176483|FG015|Part 1 (Up to 27 Months)|Disease progression|0|||
19731036|NCT03447314|42176484|FG016|Part 1 (Up to 27 Months)|Disease progression|0|||
19731037|NCT03447314|42176485|FG017|Part 1 (Up to 27 Months)|Disease progression|0|||
19731038|NCT03447314|42176468|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731039|NCT03447314|42176469|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731040|NCT03447314|42176470|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1|||
19731041|NCT03447314|42176471|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731042|NCT03447314|42176472|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731043|NCT03447314|42176473|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731044|NCT03447314|42176474|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731045|NCT03447314|42176475|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731046|NCT03447314|42176476|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731047|NCT03447314|42176477|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731048|NCT03447314|42176478|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731049|NCT03447314|42176479|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731050|NCT03447314|42176480|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731051|NCT03447314|42176481|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731052|NCT03447314|42176482|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731053|NCT03447314|42176483|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731054|NCT03447314|42176484|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731055|NCT03447314|42176485|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
19731056|NCT03495908|42176528|FG000|Overall Study|Withdrawal by Subject|3|||
19731057|NCT03495908|42176529|FG001|Overall Study|Withdrawal by Subject|1|||
19731058|NCT03495908|42176528|FG000|Overall Study|Lost to Follow-up|1|||
19731059|NCT03495908|42176529|FG001|Overall Study|Lost to Follow-up|4|||
19731060|NCT03495908|42176528|FG000|Overall Study|Adverse Event|0|||
19731061|NCT03495908|42176529|FG001|Overall Study|Adverse Event|2|||
19731062|NCT03495908|42176528|FG000|Overall Study|Death|1|||
19731063|NCT03495908|42176529|FG001|Overall Study|Death|0|||
19731064|NCT03495908|42176528|FG000|Overall Study|Physician Decision|5|||
19731065|NCT03495908|42176529|FG001|Overall Study|Physician Decision|4|||
19731066|NCT03495908|42176528|FG000|Overall Study|No documented reason|0|||
19731067|NCT03495908|42176529|FG001|Overall Study|No documented reason|2|||
19731068|NCT02992288|42176541|FG000|Overall Study|Adverse Event|8|||
19731069|NCT02992288|42176542|FG001|Overall Study|Adverse Event|2|||
19731070|NCT02992288|42176543|FG002|Overall Study|Adverse Event|2|||
19731071|NCT02992288|42176544|FG003|Overall Study|Adverse Event|2|||
19731072|NCT02992288|42176545|FG004|Overall Study|Adverse Event|2|||
19731073|NCT02992288|42176546|FG005|Overall Study|Adverse Event|7|||
19731074|NCT02992288|42176541|FG000|Overall Study|Non-compliance with study drug|0|||
19731075|NCT02992288|42176542|FG001|Overall Study|Non-compliance with study drug|1|||
19731076|NCT02992288|42176543|FG002|Overall Study|Non-compliance with study drug|1|||
19731077|NCT02992288|42176544|FG003|Overall Study|Non-compliance with study drug|0|||
19731078|NCT02992288|42176545|FG004|Overall Study|Non-compliance with study drug|1|||
19731079|NCT02992288|42176546|FG005|Overall Study|Non-compliance with study drug|0|||
19731080|NCT02992288|42176541|FG000|Overall Study|Physician Decision|3|||
19731081|NCT02992288|42176542|FG001|Overall Study|Physician Decision|0|||
19731082|NCT02992288|42176543|FG002|Overall Study|Physician Decision|1|||
19731083|NCT02992288|42176544|FG003|Overall Study|Physician Decision|0|||
19731084|NCT02992288|42176545|FG004|Overall Study|Physician Decision|0|||
19731085|NCT02992288|42176546|FG005|Overall Study|Physician Decision|1|||
19731086|NCT02992288|42176541|FG000|Overall Study|Death|2|||
19731087|NCT02992288|42176542|FG001|Overall Study|Death|0|||
19731088|NCT02992288|42176543|FG002|Overall Study|Death|2|||
19731089|NCT02992288|42176544|FG003|Overall Study|Death|1|||
19731090|NCT02992288|42176545|FG004|Overall Study|Death|2|||
19731091|NCT02992288|42176546|FG005|Overall Study|Death|0|||
19731092|NCT02992288|42176541|FG000|Overall Study|Lost to Follow-up|0|||
19731093|NCT02992288|42176542|FG001|Overall Study|Lost to Follow-up|0|||
19731094|NCT02992288|42176543|FG002|Overall Study|Lost to Follow-up|0|||
19731095|NCT02992288|42176544|FG003|Overall Study|Lost to Follow-up|1|||
19731096|NCT02992288|42176545|FG004|Overall Study|Lost to Follow-up|0|||
19731097|NCT02992288|42176546|FG005|Overall Study|Lost to Follow-up|0|||
19731098|NCT02992288|42176541|FG000|Overall Study|Protocol Violation|0|||
19731099|NCT02992288|42176542|FG001|Overall Study|Protocol Violation|0|||
19731100|NCT02992288|42176543|FG002|Overall Study|Protocol Violation|0|||
19731101|NCT02992288|42176544|FG003|Overall Study|Protocol Violation|0|||
19731102|NCT02992288|42176545|FG004|Overall Study|Protocol Violation|0|||
19731103|NCT02992288|42176546|FG005|Overall Study|Protocol Violation|1|||
19731104|NCT02992288|42176541|FG000|Overall Study|Withdrawal by Subject|4|||
19731105|NCT02992288|42176542|FG001|Overall Study|Withdrawal by Subject|2|||
19731106|NCT02992288|42176543|FG002|Overall Study|Withdrawal by Subject|1|||
19731107|NCT02992288|42176544|FG003|Overall Study|Withdrawal by Subject|5|||
19731108|NCT02992288|42176545|FG004|Overall Study|Withdrawal by Subject|3|||
19731109|NCT02992288|42176546|FG005|Overall Study|Withdrawal by Subject|4|||
19731110|NCT02953262|42176564|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
19731111|NCT02953262|42176565|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
19731112|NCT02953262|42176566|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
19731113|NCT02953262|42176567|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
19731114|NCT03415178|42176583|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
19465236|NCT04426695|41723748|FG007|Overall Study|Participant Decision|13|||
19465237|NCT04426695|41723749|FG008|Overall Study|Participant Decision|10|||
19465238|NCT04426695|41723750|FG009|Overall Study|Participant Decision|15|||
19465239|NCT04426695|41723751|FG010|Overall Study|Participant Decision|16|||
19465240|NCT04426695|41723752|FG011|Overall Study|Participant Decision|17|||
19465241|NCT04426695|41723753|FG012|Overall Study|Participant Decision|2|||
19465242|NCT04426695|41723754|FG013|Overall Study|Participant Decision|1|||
19465243|NCT04426695|41723755|FG014|Overall Study|Participant Decision|2|||
19465244|NCT04426695|41723756|FG015|Overall Study|Participant Decision|0|||
19465245|NCT04426695|41723757|FG016|Overall Study|Participant Decision|0|||
19465246|NCT04426695|41723758|FG017|Overall Study|Participant Decision|0|||
19465247|NCT04426695|41723741|FG000|Overall Study|Adverse Event|0|||
19465248|NCT04426695|41723742|FG001|Overall Study|Adverse Event|0|||
19465249|NCT04426695|41723743|FG002|Overall Study|Adverse Event|0|||
19465250|NCT04426695|41723744|FG003|Overall Study|Adverse Event|0|||
19465251|NCT04426695|41723745|FG004|Overall Study|Adverse Event|0|||
19465252|NCT04426695|41723746|FG005|Overall Study|Adverse Event|0|||
19465253|NCT04426695|41723747|FG006|Overall Study|Adverse Event|0|||
19465254|NCT04426695|41723748|FG007|Overall Study|Adverse Event|1|||
19731115|NCT03415178|42176584|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
19731116|NCT03415178|42176583|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
19731117|NCT03415178|42176584|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
19731118|NCT02992132|42176597|FG000|Overall Study|Adverse Event|4|||
19731119|NCT02992132|42176598|FG001|Overall Study|Adverse Event|1|||
19731120|NCT02992132|42176599|FG002|Overall Study|Adverse Event|3|||
19731121|NCT02992132|42176597|FG000|Overall Study|Lack of Efficacy|2|||
19731122|NCT02992132|42176598|FG001|Overall Study|Lack of Efficacy|0|||
19731123|NCT02992132|42176599|FG002|Overall Study|Lack of Efficacy|0|||
19731124|NCT02992132|42176597|FG000|Overall Study|Non-compliance with study drug|2|||
19731125|NCT02992132|42176598|FG001|Overall Study|Non-compliance with study drug|0|||
19731126|NCT02992132|42176599|FG002|Overall Study|Non-compliance with study drug|0|||
19731127|NCT02992132|42176597|FG000|Overall Study|Progressive disease|1|||
19731128|NCT02992132|42176598|FG001|Overall Study|Progressive disease|0|||
19731129|NCT02992132|42176599|FG002|Overall Study|Progressive disease|0|||
19731130|NCT02992132|42176597|FG000|Overall Study|Protocol Violation|2|||
19731131|NCT02992132|42176598|FG001|Overall Study|Protocol Violation|2|||
19731132|NCT02992132|42176599|FG002|Overall Study|Protocol Violation|0|||
19731133|NCT02992132|42176597|FG000|Overall Study|Caregiver withdrew consent|2|||
19731134|NCT02992132|42176598|FG001|Overall Study|Caregiver withdrew consent|3|||
19731135|NCT02992132|42176599|FG002|Overall Study|Caregiver withdrew consent|2|||
19731136|NCT02992132|42176597|FG000|Overall Study|Withdrawal by Subject|0|||
19731137|NCT02992132|42176598|FG001|Overall Study|Withdrawal by Subject|2|||
19731138|NCT02992132|42176599|FG002|Overall Study|Withdrawal by Subject|1|||
19731139|NCT02992132|42176597|FG000|Overall Study|Physician Decision|0|||
19731140|NCT02992132|42176598|FG001|Overall Study|Physician Decision|0|||
19731141|NCT02992132|42176599|FG002|Overall Study|Physician Decision|1|||
19731142|NCT03444584|42176609|FG000|Overall Study|Withdrawal by Subject|0|||
19731143|NCT03444584|42176610|FG001|Overall Study|Withdrawal by Subject|1|||
19731144|NCT03444584|42176609|FG000|Overall Study|Other|0|||
19731145|NCT03444584|42176610|FG001|Overall Study|Other|1|||
19731146|NCT02989168|42176619|FG000|Overall Study|Withdrawal by Subject|2|||
19731147|NCT02989168|42176620|FG001|Overall Study|Withdrawal by Subject|0|||
19731148|NCT02989168|42176619|FG000|Overall Study|Physician Decision|0|||
19731149|NCT02989168|42176620|FG001|Overall Study|Physician Decision|1|||
19731150|NCT02989168|42176619|FG000|Overall Study|Adverse Event|1|||
19731151|NCT02989168|42176620|FG001|Overall Study|Adverse Event|2|||
19731152|NCT02989168|42176619|FG000|Overall Study|Sponsor stopped study.|1|||
19731153|NCT02989168|42176620|FG001|Overall Study|Sponsor stopped study.|0|||
19731154|NCT02988622|42176628|FG000|Overall Study|Lost to Follow-up|17|||
19731155|NCT03412604|42176634|FG000|Overall Study|Withdrawal by Subject|1|||
19731156|NCT02991430|42176641|FG000|Treatment Period 1|Adverse Event|1|||
19731157|NCT02991430|42176642|FG001|Treatment Period 1|Adverse Event|0|||
19731158|NCT02991430|42176643|FG002|Treatment Period 1|Adverse Event|2|||
19731159|NCT02991430|42176641|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19731160|NCT02991430|42176642|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19731161|NCT02991430|42176643|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19731162|NCT02991430|42176641|FG000|Treatment Period 2|Study Termination|6|||
19731163|NCT02991430|42176642|FG001|Treatment Period 2|Study Termination|3|||
19731164|NCT02991430|42176643|FG002|Treatment Period 2|Study Termination|3|||
19731165|NCT02991430|42176641|FG000|Treatment Period 2|Lost to Follow-up|0|||
19731166|NCT02991430|42176642|FG001|Treatment Period 2|Lost to Follow-up|0|||
19731167|NCT02991430|42176643|FG002|Treatment Period 2|Lost to Follow-up|1|||
19731168|NCT02991430|42176641|FG000|Post-treatment Observation Period|Study Termination|3|||
19731169|NCT02991430|42176642|FG001|Post-treatment Observation Period|Study Termination|6|||
19731170|NCT02991430|42176643|FG002|Post-treatment Observation Period|Study Termination|5|||
19731171|NCT03411902|42176653|FG000|Overall Study|Lost to Follow-up|3|||
19731172|NCT03411902|42176654|FG001|Overall Study|Lost to Follow-up|0|||
19731173|NCT03494816|42176660|FG000|Overall Study|Protocol Violation|2|||
19731174|NCT03494816|42176660|FG000|Overall Study|Physician Decision|2|||
19731175|NCT03494816|42176660|FG000|Overall Study|Did not start trial treatment|1|||
19731176|NCT03494816|42176660|FG000|Overall Study|Adverse Event|1|||
19731177|NCT03492554|42176670|FG000|Overall Study|Protocol Violation|0|||
19731178|NCT03492554|42176671|FG001|Overall Study|Protocol Violation|14|||
19731179|NCT03443414|42176683|FG000|Overall Study|Adverse Event|6|||
19731180|NCT03443414|42176684|FG001|Overall Study|Adverse Event|0|||
19731181|NCT03443414|42176685|FG002|Overall Study|Adverse Event|4|||
19731182|NCT03443414|42176686|FG003|Overall Study|Adverse Event|2|||
19731183|NCT03443414|42176687|FG004|Overall Study|Adverse Event|3|||
19731184|NCT03443414|42176683|FG000|Overall Study|Withdrawal by Subject|3|||
19731185|NCT03443414|42176684|FG001|Overall Study|Withdrawal by Subject|2|||
19731186|NCT03443414|42176685|FG002|Overall Study|Withdrawal by Subject|2|||
19731187|NCT03443414|42176686|FG003|Overall Study|Withdrawal by Subject|2|||
19731188|NCT03443414|42176687|FG004|Overall Study|Withdrawal by Subject|1|||
19731189|NCT03443414|42176683|FG000|Overall Study|Death|0|||
19731190|NCT03443414|42176684|FG001|Overall Study|Death|1|||
19731191|NCT03443414|42176685|FG002|Overall Study|Death|0|||
19731192|NCT03443414|42176686|FG003|Overall Study|Death|1|||
19731193|NCT03443414|42176687|FG004|Overall Study|Death|0|||
19731194|NCT03443414|42176683|FG000|Overall Study|Reason not specified|2|||
19731195|NCT03443414|42176684|FG001|Overall Study|Reason not specified|0|||
19731196|NCT03443414|42176685|FG002|Overall Study|Reason not specified|0|||
19731197|NCT03443414|42176686|FG003|Overall Study|Reason not specified|0|||
19731198|NCT03443414|42176687|FG004|Overall Study|Reason not specified|1|||
19731199|NCT02991118|42176701|FG000|Overall Study|Death|3|||
19731200|NCT02991118|42176702|FG001|Overall Study|Death|8|||
19731201|NCT02991118|42176701|FG000|Overall Study|Protocol Violation|0|||
19731202|NCT02991118|42176702|FG001|Overall Study|Protocol Violation|3|||
19731203|NCT02991118|42176701|FG000|Overall Study|Physician Decision|0|||
19731204|NCT02991118|42176702|FG001|Overall Study|Physician Decision|1|||
19731205|NCT02991118|42176701|FG000|Overall Study|Moved out of the country|0|||
19731206|NCT02991118|42176702|FG001|Overall Study|Moved out of the country|1|||
19731207|NCT02991118|42176701|FG000|Overall Study|Adverse Event|2|||
19731208|NCT02991118|42176702|FG001|Overall Study|Adverse Event|2|||
19731209|NCT02991118|42176701|FG000|Overall Study|Withdrawal by Subject|1|||
19731210|NCT02991118|42176702|FG001|Overall Study|Withdrawal by Subject|7|||
19731211|NCT02991118|42176701|FG000|Overall Study|Could not attend study visits|0|||
19731212|NCT02991118|42176702|FG001|Overall Study|Could not attend study visits|1|||
19731213|NCT02991118|42176701|FG000|Overall Study|Lost to Follow-up|1|||
19731214|NCT02991118|42176702|FG001|Overall Study|Lost to Follow-up|9|||
19731215|NCT03491150|42176710|FG000|Overall Study|Adverse Event|1|||
19731216|NCT03491150|42176711|FG001|Overall Study|Adverse Event|0|||
19731217|NCT03491150|42176710|FG000|Overall Study|Study Terminated by Sponsor|74|||
19731218|NCT03491150|42176711|FG001|Overall Study|Study Terminated by Sponsor|70|||
19731219|NCT03491150|42176710|FG000|Overall Study|Other|0|||
19731220|NCT03491150|42176711|FG001|Overall Study|Other|1|||
19731221|NCT03491150|42176710|FG000|Overall Study|Withdrawal by Subject|1|||
19731222|NCT03491150|42176711|FG001|Overall Study|Withdrawal by Subject|2|||
19731223|NCT02991040|42176717|FG000|Overall Study|Withdrawal by Subject|2|||
19731224|NCT02991040|42176717|FG000|Overall Study|Lost to Follow-up|2|||
19731225|NCT02910466|42176723|FG000|Overall Study|Adverse Event|1|||
19731226|NCT02910466|42176723|FG000|Overall Study|Withdrawal by Subject|3|||
19731227|NCT02910466|42176723|FG000|Overall Study|Lost to Follow-up|5|||
19731228|NCT02910466|42176723|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
19731229|NCT02910466|42176723|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
19731230|NCT01068730|42176727|FG000|Period 3|Personal reason|1|||
19731231|NCT01068730|42176728|FG001|Period 3|Personal reason|0|||
19731232|NCT01068730|42176729|FG002|Period 3|Personal reason|0|||
19731233|NCT01068730|42176730|FG003|Period 3|Personal reason|0|||
19731234|NCT01068730|42176727|FG000|Period 4|Family emergency|0|||
19731235|NCT01068730|42176728|FG001|Period 4|Family emergency|1|||
19731236|NCT01068730|42176729|FG002|Period 4|Family emergency|0|||
19731237|NCT01068730|42176730|FG003|Period 4|Family emergency|0|||
19731238|NCT01068652|42176749|FG000|Overall Study|Adverse Event|4|||
19731239|NCT01068652|42176750|FG001|Overall Study|Adverse Event|0|||
19731240|NCT01068652|42176749|FG000|Overall Study|Lack of Efficacy|0|||
19731241|NCT01068652|42176750|FG001|Overall Study|Lack of Efficacy|2|||
19731242|NCT01068652|42176749|FG000|Overall Study|Lost to Follow-up|2|||
19731243|NCT01068652|42176750|FG001|Overall Study|Lost to Follow-up|1|||
19731244|NCT01068652|42176749|FG000|Overall Study|Protocol Violation|3|||
19731245|NCT01068652|42176750|FG001|Overall Study|Protocol Violation|6|||
19731246|NCT01068652|42176749|FG000|Overall Study|Withdrawal criteria|1|||
19731247|NCT01068652|42176750|FG001|Overall Study|Withdrawal criteria|2|||
19731248|NCT01068652|42176749|FG000|Overall Study|Patient was not eligible|1|||
19731249|NCT01068652|42176750|FG001|Overall Study|Patient was not eligible|0|||
19731250|NCT01068652|42176749|FG000|Overall Study|Unclassified|7|||
19731251|NCT01068652|42176750|FG001|Overall Study|Unclassified|4|||
19731252|NCT02921776|42176762|FG000|Overall Study|patient deterioration, fatigue|2|||
19731253|NCT02921776|42176763|FG001|Overall Study|patient deterioration, fatigue|6|||
19731254|NCT02921776|42176764|FG002|Overall Study|patient deterioration, fatigue|0|||
19731255|NCT02921776|42176765|FG003|Overall Study|patient deterioration, fatigue|0|||
19731256|NCT02921776|42176766|FG004|Overall Study|patient deterioration, fatigue|0|||
19731257|NCT02921776|42176767|FG005|Overall Study|patient deterioration, fatigue|0|||
19731258|NCT02921776|42176768|FG006|Overall Study|patient deterioration, fatigue|0|||
19731259|NCT02921776|42176769|FG007|Overall Study|patient deterioration, fatigue|0|||
19731260|NCT02921776|42176762|FG000|Overall Study|Withdrawal by Subject|0|||
19731261|NCT02921776|42176763|FG001|Overall Study|Withdrawal by Subject|2|||
19731262|NCT02921776|42176764|FG002|Overall Study|Withdrawal by Subject|0|||
19731263|NCT02921776|42176765|FG003|Overall Study|Withdrawal by Subject|1|||
19731264|NCT02921776|42176766|FG004|Overall Study|Withdrawal by Subject|1|||
19731265|NCT02921776|42176767|FG005|Overall Study|Withdrawal by Subject|0|||
19731266|NCT02921776|42176768|FG006|Overall Study|Withdrawal by Subject|8|||
19731267|NCT02921776|42176769|FG007|Overall Study|Withdrawal by Subject|1|||
19731268|NCT02921776|42176762|FG000|Overall Study|Death|0|||
19731269|NCT02921776|42176763|FG001|Overall Study|Death|0|||
19731270|NCT02921776|42176764|FG002|Overall Study|Death|0|||
19465255|NCT04426695|41723749|FG008|Overall Study|Adverse Event|0|||
19731271|NCT02921776|42176765|FG003|Overall Study|Death|2|||
19731272|NCT02921776|42176766|FG004|Overall Study|Death|0|||
19731273|NCT02921776|42176767|FG005|Overall Study|Death|0|||
19731274|NCT02921776|42176768|FG006|Overall Study|Death|0|||
19731275|NCT02921776|42176769|FG007|Overall Study|Death|0|||
19731276|NCT02921776|42176762|FG000|Overall Study|extubation or early discharge|0|||
19731277|NCT02921776|42176763|FG001|Overall Study|extubation or early discharge|0|||
19731278|NCT02921776|42176764|FG002|Overall Study|extubation or early discharge|0|||
19731279|NCT02921776|42176765|FG003|Overall Study|extubation or early discharge|5|||
19731280|NCT02921776|42176766|FG004|Overall Study|extubation or early discharge|5|||
19731281|NCT02921776|42176767|FG005|Overall Study|extubation or early discharge|0|||
19731282|NCT02921776|42176768|FG006|Overall Study|extubation or early discharge|0|||
19731283|NCT02921776|42176769|FG007|Overall Study|extubation or early discharge|0|||
19731284|NCT02921776|42176762|FG000|Overall Study|Lost to Follow-up|0|||
19731285|NCT02921776|42176763|FG001|Overall Study|Lost to Follow-up|0|||
19731286|NCT02921776|42176764|FG002|Overall Study|Lost to Follow-up|0|||
19731287|NCT02921776|42176765|FG003|Overall Study|Lost to Follow-up|0|||
19731288|NCT02921776|42176766|FG004|Overall Study|Lost to Follow-up|0|||
19731289|NCT02921776|42176767|FG005|Overall Study|Lost to Follow-up|2|||
19731290|NCT02921776|42176768|FG006|Overall Study|Lost to Follow-up|3|||
19731291|NCT02921776|42176769|FG007|Overall Study|Lost to Follow-up|6|||
19731292|NCT02922634|42176793|FG000|Overall Study|Withdrawal by Subject|5|||
19731293|NCT02922634|42176793|FG000|Overall Study|Did not have their surgery|5|||
19731294|NCT00023595|42176809|FG000|5 Year Follow up|Lost to Follow-up|2|||
19731295|NCT00023595|42176810|FG001|5 Year Follow up|Lost to Follow-up|2|||
19731296|NCT00023595|42176811|FG002|5 Year Follow up|Lost to Follow-up|1|||
19731297|NCT00023595|42176812|FG003|5 Year Follow up|Lost to Follow-up|7|||
19731298|NCT00023595|42176813|FG004|5 Year Follow up|Lost to Follow-up|3|||
19731299|NCT00023595|42176809|FG000|10 Year Follow up|Lost to Follow-up|12|||
19731300|NCT00023595|42176810|FG001|10 Year Follow up|Lost to Follow-up|10|||
19465256|NCT04426695|41723750|FG009|Overall Study|Adverse Event|0|||
19465257|NCT04426695|41723751|FG010|Overall Study|Adverse Event|1|||
19465258|NCT04426695|41723752|FG011|Overall Study|Adverse Event|1|||
19731301|NCT00023595|42176811|FG002|10 Year Follow up|Lost to Follow-up|3|||
19731302|NCT00023595|42176812|FG003|10 Year Follow up|Lost to Follow-up|0|||
19731303|NCT00023595|42176813|FG004|10 Year Follow up|Lost to Follow-up|0|||
19731304|NCT02920528|42176839|FG000|Overall Study|Incomplete Data|1|||
19731305|NCT02920528|42176840|FG001|Overall Study|Incomplete Data|1|||
19731306|NCT02920528|42176841|FG002|Overall Study|Incomplete Data|1|||
19731307|NCT02920528|42176839|FG000|Overall Study|Adverse Event|0|||
19731308|NCT02920528|42176840|FG001|Overall Study|Adverse Event|0|||
19731309|NCT02920528|42176841|FG002|Overall Study|Adverse Event|3|||
19731310|NCT02920528|42176839|FG000|Overall Study|Did not meet inclusion criteria|2|||
19731311|NCT02920528|42176840|FG001|Overall Study|Did not meet inclusion criteria|0|||
19731312|NCT02920528|42176841|FG002|Overall Study|Did not meet inclusion criteria|1|||
19731313|NCT01068418|42176849|FG000|Overall Study|Physician Decision|12|||
19731314|NCT01068262|42176857|FG000|Overall Study|Adverse Event|2|||
19731315|NCT01068262|42176858|FG001|Overall Study|Adverse Event|0|||
19731316|NCT01068262|42176859|FG002|Overall Study|Adverse Event|1|||
19731317|NCT01068262|42176860|FG003|Overall Study|Adverse Event|0|||
19731318|NCT01068262|42176857|FG000|Overall Study|Protocol Violation|1|||
19731319|NCT01068262|42176858|FG001|Overall Study|Protocol Violation|0|||
19731320|NCT01068262|42176859|FG002|Overall Study|Protocol Violation|0|||
19731321|NCT01068262|42176860|FG003|Overall Study|Protocol Violation|0|||
19731322|NCT01068262|42176857|FG000|Overall Study|Withdrawal by Subject|0|||
19731323|NCT01068262|42176858|FG001|Overall Study|Withdrawal by Subject|1|||
19731324|NCT01068262|42176859|FG002|Overall Study|Withdrawal by Subject|0|||
19731325|NCT01068262|42176860|FG003|Overall Study|Withdrawal by Subject|0|||
19731326|NCT02920450|42176873|FG000|Overall Study|Death|1|||
19731327|NCT02920450|42176874|FG001|Overall Study|Death|0|||
19731328|NCT02920450|42176875|FG002|Overall Study|Death|0|||
19731329|NCT02920450|42176876|FG003|Overall Study|Death|0|||
19731330|NCT02920450|42176873|FG000|Overall Study|Withdrawal by Subject|1|||
19731331|NCT02920450|42176874|FG001|Overall Study|Withdrawal by Subject|0|||
19731332|NCT02920450|42176875|FG002|Overall Study|Withdrawal by Subject|0|||
19731333|NCT02920450|42176876|FG003|Overall Study|Withdrawal by Subject|0|||
19731334|NCT01066936|42176887|FG000|Overall Study|Death|2|||
19731335|NCT01066936|42176887|FG000|Overall Study|Device revised/removed|1|||
19731336|NCT01066936|42176887|FG000|Overall Study|Lost to Follow-up|3|||
19731337|NCT01066936|42176887|FG000|Overall Study|Withdrawal by Subject|4|||
19731338|NCT02919436|42176895|FG000|Overall Study|Did not undergo surgery|16|||
19731339|NCT02919436|42176896|FG001|Overall Study|Did not undergo surgery|20|||
19731340|NCT02919436|42176895|FG000|Overall Study|Enrolled before trial registration|44|||
19731341|NCT02919436|42176896|FG001|Overall Study|Enrolled before trial registration|33|||
19731342|NCT03804879|42176906|FG000|Overall Study|Adverse Event|3|||
19731343|NCT03804879|42176907|FG001|Overall Study|Adverse Event|0|||
19465259|NCT04426695|41723753|FG012|Overall Study|Adverse Event|0|||
19465260|NCT04426695|41723754|FG013|Overall Study|Adverse Event|0|||
19465261|NCT04426695|41723755|FG014|Overall Study|Adverse Event|0|||
19465262|NCT04426695|41723756|FG015|Overall Study|Adverse Event|0|||
19731344|NCT03804879|42176906|FG000|Overall Study|Study Terminated By Sponsor|10|||
19731345|NCT03804879|42176907|FG001|Overall Study|Study Terminated By Sponsor|12|||
19731346|NCT03804879|42176906|FG000|Overall Study|Withdrawal by Subject|3|||
19731347|NCT03804879|42176907|FG001|Overall Study|Withdrawal by Subject|1|||
19731348|NCT03803475|42176914|FG000|Overall Study|Physician Decision|1|||
19731349|NCT00005937|42176918|FG000|Overall Study|Lack of Efficacy|5|||
19731350|NCT03443024|42176926|FG000|Overall Study|Adverse Event|2|||
19731351|NCT03443024|42176927|FG001|Overall Study|Adverse Event|4|||
19731352|NCT03443024|42176928|FG002|Overall Study|Adverse Event|3|||
19731353|NCT03443024|42176929|FG003|Overall Study|Adverse Event|1|||
19731354|NCT03443024|42176926|FG000|Overall Study|Lost to Follow-up|9|||
19731355|NCT03443024|42176927|FG001|Overall Study|Lost to Follow-up|9|||
19731356|NCT03443024|42176928|FG002|Overall Study|Lost to Follow-up|7|||
19731357|NCT03443024|42176929|FG003|Overall Study|Lost to Follow-up|5|||
19731358|NCT03443024|42176926|FG000|Overall Study|Withdrawal by Subject|8|||
19731359|NCT03443024|42176927|FG001|Overall Study|Withdrawal by Subject|15|||
19731360|NCT03443024|42176928|FG002|Overall Study|Withdrawal by Subject|9|||
19731361|NCT03443024|42176929|FG003|Overall Study|Withdrawal by Subject|23|||
19731362|NCT03443024|42176926|FG000|Overall Study|Physician Decision|1|||
19731363|NCT03443024|42176927|FG001|Overall Study|Physician Decision|2|||
19731364|NCT03443024|42176928|FG002|Overall Study|Physician Decision|0|||
19731365|NCT03443024|42176929|FG003|Overall Study|Physician Decision|1|||
19731366|NCT03443024|42176926|FG000|Overall Study|Sponsor Decision|1|||
19731367|NCT03443024|42176927|FG001|Overall Study|Sponsor Decision|1|||
19731368|NCT03443024|42176928|FG002|Overall Study|Sponsor Decision|0|||
19731369|NCT03443024|42176929|FG003|Overall Study|Sponsor Decision|0|||
19731370|NCT03443024|42176926|FG000|Overall Study|Protocol Deviation|0|||
19731371|NCT03443024|42176927|FG001|Overall Study|Protocol Deviation|0|||
19731372|NCT03443024|42176928|FG002|Overall Study|Protocol Deviation|0|||
19731373|NCT03443024|42176929|FG003|Overall Study|Protocol Deviation|2|||
19731374|NCT02908516|42176941|FG000|Overall Study|Study Terminated|3|||
19731375|NCT02908516|42176942|FG001|Overall Study|Study Terminated|3|||
19731376|NCT02907892|42176950|FG000|Overall Study|Lost to Follow-up|27|||
19731377|NCT02907892|42176951|FG001|Overall Study|Lost to Follow-up|40|||
19731378|NCT02906644|42176959|FG000|First 2 Weeks|Withdrawal by Subject|0|||
19731379|NCT02906644|42176960|FG001|First 2 Weeks|Withdrawal by Subject|2|||
19731380|NCT02906644|42176959|FG000|First 2 Weeks|Physician Decision|1|||
19731381|NCT02906644|42176960|FG001|First 2 Weeks|Physician Decision|1|||
19731382|NCT02906644|42176959|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
19731383|NCT02906644|42176960|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
19731384|NCT02906644|42176959|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
19731385|NCT02906644|42176960|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
19731386|NCT03410108|42176967|FG000|Overall Study|Ongoing|41|||
19731387|NCT03410108|42176967|FG000|Overall Study|Adverse Event|4|||
19731388|NCT03410108|42176967|FG000|Overall Study|Progressive Disease|58|||
19731389|NCT03410108|42176967|FG000|Overall Study|Withdrawal by Subject|1|||
19731390|NCT02982772|42176976|FG000|Intervention|Lost to Follow-up|19|||
19731391|NCT02982772|42176977|FG001|Intervention|Lost to Follow-up|13|||
19731392|NCT02982772|42176976|FG000|1M Follow-Up|Lost to Follow-up|21|||
19731393|NCT02982772|42176977|FG001|1M Follow-Up|Lost to Follow-up|18|||
19731394|NCT02982772|42176976|FG000|3M Follow-Up|Lost to Follow-up|17|||
19731395|NCT02982772|42176977|FG001|3M Follow-Up|Lost to Follow-up|11|||
19731396|NCT02982772|42176976|FG000|6M Follow-Up|Lost to Follow-up|11|||
19731397|NCT02982772|42176977|FG001|6M Follow-Up|Lost to Follow-up|9|||
19731398|NCT02982772|42176976|FG000|12M Follow-Up|Lost to Follow-up|11|||
19731399|NCT02982772|42176977|FG001|12M Follow-Up|Lost to Follow-up|5|||
19731400|NCT03488108|42176987|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
19731401|NCT03488108|42176988|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
19731402|NCT03488108|42176987|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
19731403|NCT03488108|42176988|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
19731404|NCT03440918|42176998|FG000|Overall Study|Protocol Violation|0|||
19731405|NCT03440918|42176999|FG001|Overall Study|Protocol Violation|16|||
19731406|NCT03486392|42177010|FG000|Overall Study|Lost to Follow-up|0|||
19731407|NCT03486392|42177011|FG001|Overall Study|Lost to Follow-up|0|||
19731408|NCT03486392|42177012|FG002|Overall Study|Lost to Follow-up|8|||
19731409|NCT03486392|42177013|FG003|Overall Study|Lost to Follow-up|5|||
19731410|NCT03486392|42177014|FG004|Overall Study|Lost to Follow-up|2|||
19731411|NCT03486392|42177010|FG000|Overall Study|Withdrawal by Subject|3|||
19731412|NCT03486392|42177011|FG001|Overall Study|Withdrawal by Subject|0|||
19731413|NCT03486392|42177012|FG002|Overall Study|Withdrawal by Subject|6|||
19731414|NCT03486392|42177013|FG003|Overall Study|Withdrawal by Subject|4|||
19731415|NCT03486392|42177014|FG004|Overall Study|Withdrawal by Subject|1|||
19731416|NCT03486392|42177010|FG000|Overall Study|Death|0|||
19731417|NCT03486392|42177011|FG001|Overall Study|Death|0|||
19731418|NCT03486392|42177012|FG002|Overall Study|Death|0|||
19731419|NCT03486392|42177013|FG003|Overall Study|Death|0|||
19731420|NCT03486392|42177014|FG004|Overall Study|Death|1|||
19731421|NCT02981602|42177031|FG000|Overall Study|Adverse Event|0|||
19731422|NCT02981602|42177032|FG001|Overall Study|Adverse Event|0|||
19731423|NCT02981602|42177033|FG002|Overall Study|Adverse Event|0|||
19731424|NCT02981602|42177034|FG003|Overall Study|Adverse Event|1|||
19731425|NCT02981602|42177035|FG004|Overall Study|Adverse Event|0|||
19731426|NCT02981524|42177048|FG000|Overall Study|Progressive Disease|14|||
19731427|NCT02981524|42177048|FG000|Overall Study|Death (unrelated)|1|||
19731428|NCT02981524|42177048|FG000|Overall Study|Treatment Related Toxicity|1|||
19731429|NCT02981524|42177048|FG000|Overall Study|Withdrawal by Subject|1|||
19731430|NCT03486314|42177052|FG000|Part A|Adverse Event|1|||
19731431|NCT03486314|42177053|FG001|Part A|Adverse Event|0|||
19731432|NCT03486314|42177054|FG002|Part A|Adverse Event|0|||
19731433|NCT03486314|42177052|FG000|Part A|Symptomatic Deterioration|2|||
19731434|NCT03486314|42177053|FG001|Part A|Symptomatic Deterioration|0|||
19731435|NCT03486314|42177054|FG002|Part A|Symptomatic Deterioration|0|||
19731436|NCT02905006|42177068|FG000|Overall Study|Adverse Event|1|||
19731437|NCT02905006|42177069|FG001|Overall Study|Adverse Event|1|||
19731438|NCT02905006|42177070|FG002|Overall Study|Adverse Event|1|||
19731439|NCT02905006|42177071|FG003|Overall Study|Adverse Event|1|||
19731440|NCT02905006|42177072|FG004|Overall Study|Adverse Event|0|||
19731441|NCT02905006|42177073|FG005|Overall Study|Adverse Event|1|||
19731442|NCT02905006|42177068|FG000|Overall Study|Lack of Efficacy|1|||
19731443|NCT02905006|42177069|FG001|Overall Study|Lack of Efficacy|0|||
19731444|NCT02905006|42177070|FG002|Overall Study|Lack of Efficacy|0|||
19731445|NCT02905006|42177071|FG003|Overall Study|Lack of Efficacy|0|||
19731446|NCT02905006|42177072|FG004|Overall Study|Lack of Efficacy|0|||
19731447|NCT02905006|42177073|FG005|Overall Study|Lack of Efficacy|0|||
19731448|NCT02905006|42177068|FG000|Overall Study|Protocol Violation|2|||
19731449|NCT02905006|42177069|FG001|Overall Study|Protocol Violation|0|||
19731450|NCT02905006|42177070|FG002|Overall Study|Protocol Violation|0|||
19731451|NCT02905006|42177071|FG003|Overall Study|Protocol Violation|0|||
19731452|NCT02905006|42177072|FG004|Overall Study|Protocol Violation|0|||
19731453|NCT02905006|42177073|FG005|Overall Study|Protocol Violation|0|||
19731454|NCT02905006|42177068|FG000|Overall Study|Lost to Follow-up|0|||
19731455|NCT02905006|42177069|FG001|Overall Study|Lost to Follow-up|0|||
19731456|NCT02905006|42177070|FG002|Overall Study|Lost to Follow-up|0|||
19731457|NCT02905006|42177071|FG003|Overall Study|Lost to Follow-up|1|||
19731458|NCT02905006|42177072|FG004|Overall Study|Lost to Follow-up|1|||
19731459|NCT02905006|42177073|FG005|Overall Study|Lost to Follow-up|0|||
19731460|NCT02905006|42177068|FG000|Overall Study|Withdrawal by Subject|0|||
19731461|NCT02905006|42177069|FG001|Overall Study|Withdrawal by Subject|0|||
19731462|NCT02905006|42177070|FG002|Overall Study|Withdrawal by Subject|1|||
19731463|NCT02905006|42177071|FG003|Overall Study|Withdrawal by Subject|1|||
19731464|NCT02905006|42177072|FG004|Overall Study|Withdrawal by Subject|0|||
19731465|NCT02905006|42177073|FG005|Overall Study|Withdrawal by Subject|1|||
19731466|NCT02905006|42177068|FG000|Overall Study|Screening exclusion criteria met|1|||
19731467|NCT02905006|42177069|FG001|Overall Study|Screening exclusion criteria met|0|||
19731468|NCT02905006|42177070|FG002|Overall Study|Screening exclusion criteria met|0|||
19731469|NCT02905006|42177071|FG003|Overall Study|Screening exclusion criteria met|0|||
19731470|NCT02905006|42177072|FG004|Overall Study|Screening exclusion criteria met|0|||
19731471|NCT02905006|42177073|FG005|Overall Study|Screening exclusion criteria met|0|||
19731472|NCT02905006|42177068|FG000|Overall Study|Lab withdrawal criterion met|0|||
19731473|NCT02905006|42177069|FG001|Overall Study|Lab withdrawal criterion met|1|||
19731474|NCT02905006|42177070|FG002|Overall Study|Lab withdrawal criterion met|2|||
19731475|NCT02905006|42177071|FG003|Overall Study|Lab withdrawal criterion met|2|||
19731476|NCT02905006|42177072|FG004|Overall Study|Lab withdrawal criterion met|2|||
19731477|NCT02905006|42177073|FG005|Overall Study|Lab withdrawal criterion met|1|||
19731478|NCT02905006|42177068|FG000|Overall Study|Positive for Tuberculosis|0|||
19731479|NCT02905006|42177069|FG001|Overall Study|Positive for Tuberculosis|1|||
19731480|NCT02905006|42177070|FG002|Overall Study|Positive for Tuberculosis|0|||
19731481|NCT02905006|42177071|FG003|Overall Study|Positive for Tuberculosis|0|||
19731482|NCT02905006|42177072|FG004|Overall Study|Positive for Tuberculosis|0|||
19731483|NCT02905006|42177073|FG005|Overall Study|Positive for Tuberculosis|0|||
19731484|NCT02905006|42177068|FG000|Overall Study|Subject positive for Hep B|0|||
19731485|NCT02905006|42177069|FG001|Overall Study|Subject positive for Hep B|0|||
19731486|NCT02905006|42177070|FG002|Overall Study|Subject positive for Hep B|1|||
19731487|NCT02905006|42177071|FG003|Overall Study|Subject positive for Hep B|0|||
19731488|NCT02905006|42177072|FG004|Overall Study|Subject positive for Hep B|0|||
19731489|NCT02905006|42177073|FG005|Overall Study|Subject positive for Hep B|0|||
19731490|NCT02905006|42177068|FG000|Overall Study|Patient moved abroad|0|||
19731491|NCT02905006|42177069|FG001|Overall Study|Patient moved abroad|0|||
19731492|NCT02905006|42177070|FG002|Overall Study|Patient moved abroad|0|||
19731493|NCT02905006|42177071|FG003|Overall Study|Patient moved abroad|1|||
19731494|NCT02905006|42177072|FG004|Overall Study|Patient moved abroad|0|||
19731495|NCT02905006|42177073|FG005|Overall Study|Patient moved abroad|0|||
19731496|NCT02905006|42177068|FG000|Overall Study|Patient randomized by mistake|0|||
19731497|NCT02905006|42177069|FG001|Overall Study|Patient randomized by mistake|0|||
19731498|NCT02905006|42177070|FG002|Overall Study|Patient randomized by mistake|0|||
19731499|NCT02905006|42177071|FG003|Overall Study|Patient randomized by mistake|0|||
19731500|NCT02905006|42177072|FG004|Overall Study|Patient randomized by mistake|0|||
19731501|NCT02905006|42177073|FG005|Overall Study|Patient randomized by mistake|1|||
19731502|NCT01066780|42177111|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
19731503|NCT01066780|42177112|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
19731504|NCT02975206|42177119|FG000|Overall Study|Withdrawal by Subject|14|||
19731505|NCT02975206|42177120|FG001|Overall Study|Withdrawal by Subject|11|||
19731506|NCT02975206|42177121|FG002|Overall Study|Withdrawal by Subject|11|||
19731507|NCT02975206|42177119|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
19731508|NCT02975206|42177120|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
19731509|NCT02975206|42177121|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
19731510|NCT01066156|42177129|FG000|Overall Study|ineligible|2|||
19731511|NCT01066156|42177129|FG000|Overall Study|Lost to Follow-up|7|||
19731512|NCT01066156|42177129|FG000|Overall Study|Withdrawal by Subject|1|||
19731513|NCT02980042|42177135|FG000|Overall Study|Lost to Follow-up|5|||
19731514|NCT02980042|42177136|FG001|Overall Study|Lost to Follow-up|0|||
19731515|NCT02980042|42177135|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
19731516|NCT02980042|42177136|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
19731517|NCT01066000|42177154|FG000|Overall Study|Protocol Violation|4|||
19731518|NCT01066000|42177154|FG000|Overall Study|Death|3|||
19731519|NCT01066000|42177154|FG000|Overall Study|Withdrawal by Subject|1|||
19731520|NCT01066000|42177154|FG000|Overall Study|Adverse Event|1|||
19731521|NCT01065844|42177158|FG000|Overall Study|Adverse Event|5|||
19731522|NCT00004635|42177164|FG000|Period One|refused|2|||
19731523|NCT00004635|42177165|FG001|Period One|refused|1|||
19731524|NCT00004635|42177164|FG000|Period One|Withdrawal by Subject|1|||
19731525|NCT00004635|42177165|FG001|Period One|Withdrawal by Subject|1|||
19731526|NCT00004635|42177164|FG000|Period One|Protocol Violation|1|||
19731527|NCT00004635|42177165|FG001|Period One|Protocol Violation|0|||
19731528|NCT00004635|42177164|FG000|Period One|PSA did not go <5 ng/mL|1|||
19731529|NCT00004635|42177165|FG001|Period One|PSA did not go <5 ng/mL|0|||
19731530|NCT00004635|42177164|FG000|Period One|second malignancy|1|||
19731531|NCT00004635|42177165|FG001|Period One|second malignancy|0|||
19731532|NCT00004635|42177164|FG000|Period One|progressed|0|||
19731533|NCT00004635|42177165|FG001|Period One|progressed|2|||
19731534|NCT00004635|42177164|FG000|Period One|health problem|0|||
19731535|NCT00004635|42177165|FG001|Period One|health problem|1|||
19731536|NCT00004635|42177164|FG000|Period One|discrepancy in data entry|0|||
19731537|NCT00004635|42177165|FG001|Period One|discrepancy in data entry|1|||
19731538|NCT00004635|42177164|FG000|Period Two|progression|2|||
19731539|NCT00004635|42177165|FG001|Period Two|progression|3|||
19731540|NCT00004635|42177164|FG000|Period Two|Adverse Event|1|||
19731541|NCT00004635|42177165|FG001|Period Two|Adverse Event|0|||
19731542|NCT00004635|42177164|FG000|Period Two|refused|0|||
19731543|NCT00004635|42177165|FG001|Period Two|refused|2|||
19731544|NCT00004635|42177164|FG000|Period Two|health problem|1|||
19731545|NCT00004635|42177165|FG001|Period Two|health problem|1|||
19731546|NCT00004635|42177164|FG000|Period Two|travel issues|0|||
19731547|NCT00004635|42177165|FG001|Period Two|travel issues|1|||
19731548|NCT00004635|42177164|FG000|Period Two|secondary malignancy|1|||
19731549|NCT00004635|42177165|FG001|Period Two|secondary malignancy|1|||
19731550|NCT00004635|42177164|FG000|Period Two|Lost to Follow-up|1|||
19731551|NCT00004635|42177165|FG001|Period Two|Lost to Follow-up|0|||
19731552|NCT00004635|42177164|FG000|Period Two|discrepancy in data entry|0|||
19731553|NCT00004635|42177165|FG001|Period Two|discrepancy in data entry|1|||
19731554|NCT00004563|42177176|FG000|Overall Study|Withdrawal by Subject|20|||
19731555|NCT00004563|42177177|FG001|Overall Study|Withdrawal by Subject|16|||
19731556|NCT00004563|42177176|FG000|Overall Study|Lack of Efficacy|3|||
19731557|NCT00004563|42177177|FG001|Overall Study|Lack of Efficacy|5|||
19731558|NCT00004563|42177176|FG000|Overall Study|Death|2|||
19731559|NCT00004563|42177177|FG001|Overall Study|Death|3|||
19731560|NCT00003645|42177185|FG000|Overall Study|Death|4|||
19731561|NCT00003645|42177186|FG001|Overall Study|Death|1|||
19731562|NCT00003645|42177185|FG000|Overall Study|Lost to Follow-up|7|||
19731563|NCT00003645|42177186|FG001|Overall Study|Lost to Follow-up|8|||
19731564|NCT00003645|42177185|FG000|Overall Study|Withdrawal by Subject|1|||
19731565|NCT00003645|42177186|FG001|Overall Study|Withdrawal by Subject|3|||
19731566|NCT00003537|42177194|FG000|Overall Study|Not evalauable|1|||
19731567|NCT00003531|42177198|FG000|Overall Study|Not evaluable|10|||
19465263|NCT04426695|41723757|FG016|Overall Study|Adverse Event|0|||
19465264|NCT04426695|41723758|FG017|Overall Study|Adverse Event|0|||
19465265|NCT04426695|41723741|FG000|Overall Study|Sponsor Request|0|||
19731568|NCT02918968|42177204|FG000|1st Line AAT|Progressive disease|9|||
19731569|NCT02918968|42177205|FG001|1st Line AAT|Progressive disease|4|||
19731570|NCT02918968|42177204|FG000|1st Line AAT|Adverse Event|12|||
19731571|NCT02918968|42177205|FG001|1st Line AAT|Adverse Event|3|||
19731572|NCT02918968|42177204|FG000|1st Line AAT|Physician Decision|4|||
19731573|NCT02918968|42177205|FG001|1st Line AAT|Physician Decision|2|||
19731574|NCT02918968|42177204|FG000|1st Line AAT|Withdrawal by Subject|2|||
19731575|NCT02918968|42177205|FG001|1st Line AAT|Withdrawal by Subject|1|||
19731576|NCT02918968|42177204|FG000|1st Line AAT|Lost to Follow-up|0|||
19731577|NCT02918968|42177205|FG001|1st Line AAT|Lost to Follow-up|1|||
19731578|NCT02918968|42177204|FG000|1st Line AAT|Death|1|||
19731579|NCT02918968|42177205|FG001|1st Line AAT|Death|0|||
19731580|NCT02918968|42177204|FG000|1st Line AAT|Miscellaneous|1|||
19731581|NCT02918968|42177205|FG001|1st Line AAT|Miscellaneous|0|||
19731582|NCT02918968|42177204|FG000|2nd Line AAT|Progressive disease|21|||
19731583|NCT02918968|42177205|FG001|2nd Line AAT|Progressive disease|3|||
19731584|NCT02918968|42177204|FG000|2nd Line AAT|Adverse Event|2|||
19731585|NCT02918968|42177205|FG001|2nd Line AAT|Adverse Event|5|||
19731586|NCT02918968|42177204|FG000|2nd Line AAT|Physician Decision|0|||
19380781|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
19380782|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380783|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380784|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380785|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380786|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
19380787|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380788|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
19380789|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380790|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380791|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380792|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380793|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380794|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
19380795|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
19380796|NCT01791595|41623997|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380797|NCT01791595|41623998|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380798|NCT01791595|41623999|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380799|NCT01791595|41624000|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380800|NCT01791595|41624001|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380801|NCT01791595|41624002|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
19380802|NCT01791595|41624003|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
19380803|NCT01791595|41623997|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380804|NCT01791595|41623998|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380805|NCT01791595|41623999|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380806|NCT01791595|41624000|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380807|NCT01791595|41624001|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380808|NCT01791595|41624002|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
19380809|NCT01791595|41624003|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
19731587|NCT02918968|42177205|FG001|2nd Line AAT|Physician Decision|1|||
19731588|NCT02918968|42177204|FG000|2nd Line AAT|Withdrawal by Subject|2|||
19731589|NCT02918968|42177205|FG001|2nd Line AAT|Withdrawal by Subject|2|||
19731590|NCT02918968|42177204|FG000|2nd Line AAT|Death|0|||
19731591|NCT02918968|42177205|FG001|2nd Line AAT|Death|1|||
19731592|NCT01065766|42177213|FG000|Overall Study|Assessed before the contracted date|1|||
19731593|NCT01065766|42177213|FG000|Overall Study|Contraindication to administration|6|||
19731594|NCT01065766|42177213|FG000|Overall Study|Violated dosage/administration|25|||
19731595|NCT01063972|42177219|FG000|Overall Study|Death|12|||
19731596|NCT01063972|42177220|FG001|Overall Study|Death|11|||
19731597|NCT01063972|42177219|FG000|Overall Study|Incarcerated|2|||
19731598|NCT01063972|42177220|FG001|Overall Study|Incarcerated|1|||
19731599|NCT00042939|42177228|FG000|Overall Study|Adverse Event|6|||
19731600|NCT00042939|42177229|FG001|Overall Study|Adverse Event|7|||
19731601|NCT00042939|42177228|FG000|Overall Study|Death|3|||
19731602|NCT00042939|42177229|FG001|Overall Study|Death|2|||
19731603|NCT00042939|42177228|FG000|Overall Study|Withdrawal by Subject|3|||
19731604|NCT00042939|42177229|FG001|Overall Study|Withdrawal by Subject|4|||
19731605|NCT00042939|42177228|FG000|Overall Study|Other disease|1|||
19731606|NCT00042939|42177229|FG001|Overall Study|Other disease|0|||
19731607|NCT00042939|42177228|FG000|Overall Study|Ineligible|2|||
19731608|NCT00042939|42177229|FG001|Overall Study|Ineligible|2|||
19731609|NCT00042939|42177228|FG000|Overall Study|Deterioration of health|3|||
19731610|NCT00042939|42177229|FG001|Overall Study|Deterioration of health|4|||
19731611|NCT00042939|42177228|FG000|Overall Study|QOL diminished|1|||
19731612|NCT00042939|42177229|FG001|Overall Study|QOL diminished|0|||
19731613|NCT00042939|42177228|FG000|Overall Study|Rising ca 19-9|1|||
19731614|NCT00042939|42177229|FG001|Overall Study|Rising ca 19-9|0|||
19731615|NCT00042939|42177228|FG000|Overall Study|Patient non-compliance|1|||
19731616|NCT00042939|42177229|FG001|Overall Study|Patient non-compliance|0|||
19731617|NCT00042939|42177228|FG000|Overall Study|Still on treatment|1|||
19731618|NCT00042939|42177229|FG001|Overall Study|Still on treatment|0|||
19731619|NCT00042939|42177228|FG000|Overall Study|Treatment break > 4 weeks|0|||
19731620|NCT00042939|42177229|FG001|Overall Study|Treatment break > 4 weeks|1|||
19731621|NCT00042939|42177228|FG000|Overall Study|Did not start treatment|2|||
19731622|NCT00042939|42177229|FG001|Overall Study|Did not start treatment|1|||
19731623|NCT00003483|42177235|FG000|Overall Study|Not evaluable|1|||
19731624|NCT00003477|42177239|FG000|Overall Study|Not evalauable|4|||
19731625|NCT00003471|42177243|FG000|Overall Study|Not evaluable|4|||
19731626|NCT04185220|42177249|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
19731627|NCT04185220|42177250|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
19731628|NCT04185220|42177249|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
19731629|NCT04185220|42177250|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
19731630|NCT00002931|42177257|FG000|Overall Study|rapidly progressing disease during|2|||
19731631|NCT02918266|42177272|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
19731632|NCT02918266|42177273|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731633|NCT02918266|42177274|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731634|NCT02918266|42177275|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731635|NCT02918266|42177276|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731636|NCT02918266|42177277|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731637|NCT02918266|42177278|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
19731638|NCT02918266|42177279|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731639|NCT02918266|42177280|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
19731640|NCT02918266|42177281|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731641|NCT02918266|42177282|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
19731642|NCT00041067|42177302|FG000|Overall Study|Adverse Event|20|||
19731643|NCT00041067|42177302|FG000|Overall Study|Progression|19|||
19731644|NCT00041067|42177302|FG000|Overall Study|Patient refusal|12|||
19731645|NCT00041067|42177302|FG000|Overall Study|Other reasons|23|||
19731646|NCT00041067|42177302|FG000|Overall Study|Ineligible|2|||
19731647|NCT01063036|42177307|FG000|Participants Treated With Study Drug|Adverse Event|1|||
19731648|NCT01063036|42177307|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
19731649|NCT01063036|42177307|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
19731650|NCT01063036|42177307|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
19731651|NCT01063036|42177307|FG000|Participants Treated With Study Drug|Pregnancy|1|||
19731652|NCT01063036|42177307|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
19731653|NCT01063036|42177307|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
19731654|NCT01063036|42177307|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
19731655|NCT00040365|42177311|FG000|Overall Study|Death|1|||
19731656|NCT00040365|42177311|FG000|Overall Study|Progressive disease|7|||
19731657|NCT00040365|42177311|FG000|Overall Study|Lost to Follow-up|3|||
19731658|NCT02974114|42177318|FG000|Overall Study|Other (Not specified)|0|||
19731659|NCT02974114|42177319|FG001|Overall Study|Other (Not specified)|1|||
19731660|NCT02974114|42177320|FG002|Overall Study|Other (Not specified)|2|||
19731661|NCT00001959|42177330|FG000|Overall Study|newly diagnosed colon cancer|1|||
19731662|NCT00001959|42177330|FG000|Overall Study|disabling sedation|1|||
19731663|NCT00001959|42177330|FG000|Overall Study|non-compliance|1|||
19731664|NCT00001941|42177334|FG000|Overall Study|not treated- rapidly progressing disease|0|||
19731665|NCT00001941|42177335|FG001|Overall Study|not treated- rapidly progressing disease|0|||
19731666|NCT00001941|42177336|FG002|Overall Study|not treated- rapidly progressing disease|0|||
19731667|NCT00001941|42177337|FG003|Overall Study|not treated- rapidly progressing disease|0|||
19731668|NCT00001941|42177338|FG004|Overall Study|not treated- rapidly progressing disease|1|||
19731669|NCT02978326|42177346|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
19731670|NCT02978326|42177347|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
19731671|NCT02978326|42177348|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
19731672|NCT02978326|42177346|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
19731673|NCT02978326|42177347|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
19731674|NCT02978326|42177348|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
19731675|NCT02978326|42177346|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
19731676|NCT02978326|42177347|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
19731677|NCT02978326|42177348|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
19731678|NCT02978326|42177346|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
19731679|NCT02978326|42177347|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
19731680|NCT02978326|42177348|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
19731681|NCT01061866|42177358|FG000|Overall Study|Adverse Event|2|||
19731682|NCT01061008|42177364|FG000|Overall Study|Badiocephalic fistula failed|3|||
19731683|NCT01061008|42177365|FG001|Overall Study|Badiocephalic fistula failed|2|||
19731684|NCT01061008|42177364|FG000|Overall Study|Death|1|||
19731685|NCT01061008|42177365|FG001|Overall Study|Death|0|||
19731686|NCT01061008|42177364|FG000|Overall Study|Withdrawal by Subject|1|||
19731687|NCT01061008|42177365|FG001|Overall Study|Withdrawal by Subject|3|||
19731688|NCT01061008|42177364|FG000|Overall Study|Unable to exercise following surgery|1|||
19731689|NCT01061008|42177365|FG001|Overall Study|Unable to exercise following surgery|0|||
19731690|NCT01061008|42177364|FG000|Overall Study|Adverse Event|0|||
19731691|NCT01061008|42177365|FG001|Overall Study|Adverse Event|1|||
19731692|NCT00039741|42177375|FG000|Overall Study|Death|0|||
19731693|NCT00039741|42177376|FG001|Overall Study|Death|1|||
19731694|NCT00039741|42177377|FG002|Overall Study|Death|0|||
19731695|NCT00039741|42177378|FG003|Overall Study|Death|0|||
19731696|NCT00039741|42177375|FG000|Overall Study|Lost to Follow-up|3|||
19731697|NCT00039741|42177376|FG001|Overall Study|Lost to Follow-up|1|||
19731698|NCT00039741|42177377|FG002|Overall Study|Lost to Follow-up|5|||
19731699|NCT00039741|42177378|FG003|Overall Study|Lost to Follow-up|2|||
19731700|NCT00039741|42177375|FG000|Overall Study|Confounding medical condition|1|||
19731701|NCT00039741|42177376|FG001|Overall Study|Confounding medical condition|0|||
19731702|NCT00039741|42177377|FG002|Overall Study|Confounding medical condition|0|||
19731703|NCT00039741|42177378|FG003|Overall Study|Confounding medical condition|0|||
19731704|NCT00039741|42177375|FG000|Overall Study|Not able to get to clinic|5|||
19731705|NCT00039741|42177376|FG001|Overall Study|Not able to get to clinic|2|||
19731706|NCT00039741|42177377|FG002|Overall Study|Not able to get to clinic|0|||
19731707|NCT00039741|42177378|FG003|Overall Study|Not able to get to clinic|3|||
19731708|NCT00039741|42177375|FG000|Overall Study|Moved|3|||
19731709|NCT00039741|42177376|FG001|Overall Study|Moved|2|||
19731710|NCT00039741|42177377|FG002|Overall Study|Moved|3|||
19731711|NCT00039741|42177378|FG003|Overall Study|Moved|6|||
19731712|NCT00039741|42177375|FG000|Overall Study|Non-compliance with protocol|1|||
19731713|NCT00039741|42177376|FG001|Overall Study|Non-compliance with protocol|0|||
19731714|NCT00039741|42177377|FG002|Overall Study|Non-compliance with protocol|1|||
19731715|NCT00039741|42177378|FG003|Overall Study|Non-compliance with protocol|0|||
19731716|NCT00039741|42177375|FG000|Overall Study|Withdrew consent|0|||
19731717|NCT00039741|42177376|FG001|Overall Study|Withdrew consent|5|||
19731718|NCT00039741|42177377|FG002|Overall Study|Withdrew consent|0|||
19731719|NCT00039741|42177378|FG003|Overall Study|Withdrew consent|1|||
19731720|NCT00039741|42177375|FG000|Overall Study|Missed final visit|2|||
19731721|NCT00039741|42177376|FG001|Overall Study|Missed final visit|1|||
19731722|NCT00039741|42177377|FG002|Overall Study|Missed final visit|2|||
19731723|NCT00039741|42177378|FG003|Overall Study|Missed final visit|2|||
19731724|NCT02973802|42177388|FG000|Overall Study|Lost to Follow-up|1|||
19731725|NCT02973802|42177388|FG000|Overall Study|Withdrawal by Subject|1|||
19731726|NCT02973100|42177397|FG000|Overall Study|Adverse Event|1|||
19731727|NCT02973100|42177398|FG001|Overall Study|Adverse Event|2|||
19731728|NCT02973100|42177399|FG002|Overall Study|Adverse Event|1|||
19731729|NCT02973100|42177400|FG003|Overall Study|Adverse Event|2|||
19731730|NCT02973100|42177397|FG000|Overall Study|Lost to Follow-up|3|||
19731731|NCT02973100|42177398|FG001|Overall Study|Lost to Follow-up|1|||
19731732|NCT02973100|42177399|FG002|Overall Study|Lost to Follow-up|1|||
19731733|NCT02973100|42177400|FG003|Overall Study|Lost to Follow-up|0|||
19731734|NCT02973100|42177397|FG000|Overall Study|Withdrawal by Subject|3|||
19731735|NCT02973100|42177398|FG001|Overall Study|Withdrawal by Subject|5|||
19731736|NCT02973100|42177399|FG002|Overall Study|Withdrawal by Subject|1|||
19731737|NCT02973100|42177400|FG003|Overall Study|Withdrawal by Subject|4|||
19731738|NCT02973100|42177397|FG000|Overall Study|Notification of change in address|0|||
19731739|NCT02973100|42177398|FG001|Overall Study|Notification of change in address|0|||
19731740|NCT02973100|42177399|FG002|Overall Study|Notification of change in address|0|||
19731741|NCT02973100|42177400|FG003|Overall Study|Notification of change in address|1|||
19731742|NCT02973100|42177397|FG000|Overall Study|Failed to attend Safety followup period|0|||
19731743|NCT02973100|42177398|FG001|Overall Study|Failed to attend Safety followup period|0|||
19731744|NCT02973100|42177399|FG002|Overall Study|Failed to attend Safety followup period|1|||
19731745|NCT02973100|42177400|FG003|Overall Study|Failed to attend Safety followup period|0|||
19731746|NCT01060540|42177415|FG000|Overall Study|Withdrawal by Subject|10|||
19731747|NCT01060540|42177416|FG001|Overall Study|Withdrawal by Subject|20|||
19731748|NCT01060540|42177415|FG000|Overall Study|Lost to Follow-up|52|||
19731749|NCT01060540|42177416|FG001|Overall Study|Lost to Follow-up|43|||
19731750|NCT01060540|42177415|FG000|Overall Study|Death|2|||
19731751|NCT01060540|42177416|FG001|Overall Study|Death|1|||
19731752|NCT01060540|42177415|FG000|Overall Study|Physician Decision|0|||
19731753|NCT01060540|42177416|FG001|Overall Study|Physician Decision|1|||
19731754|NCT02972632|42177441|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
19731755|NCT02972632|42177441|FG000|Overall Study|Lost to Follow-up|4|||
19731756|NCT02972632|42177441|FG000|Overall Study|Voluntary Withdrawal|10|||
19731757|NCT01060384|42177445|FG000|Overall Study|Withdrawal by Subject|0|||
19731758|NCT01060384|42177446|FG001|Overall Study|Withdrawal by Subject|1|||
19731759|NCT01060384|42177447|FG002|Overall Study|Withdrawal by Subject|0|||
19731760|NCT01060384|42177448|FG003|Overall Study|Withdrawal by Subject|0|||
19731761|NCT01060384|42177449|FG004|Overall Study|Withdrawal by Subject|0|||
19731762|NCT01060384|42177445|FG000|Overall Study|Death|0|||
19731763|NCT01060384|42177446|FG001|Overall Study|Death|0|||
19731764|NCT01060384|42177447|FG002|Overall Study|Death|0|||
19731765|NCT01060384|42177448|FG003|Overall Study|Death|0|||
19731766|NCT01060384|42177449|FG004|Overall Study|Death|1|||
19731767|NCT01060384|42177445|FG000|Overall Study|Intercurrent illness|0|||
19731768|NCT01060384|42177446|FG001|Overall Study|Intercurrent illness|0|||
19731769|NCT01060384|42177447|FG002|Overall Study|Intercurrent illness|0|||
19731770|NCT01060384|42177448|FG003|Overall Study|Intercurrent illness|0|||
19731771|NCT01060384|42177449|FG004|Overall Study|Intercurrent illness|1|||
19731772|NCT01060150|42177458|FG000|Overall Study|Adverse Event|6|||
19731773|NCT01060150|42177458|FG000|Overall Study|Lost to Follow-up|1|||
19731774|NCT01060150|42177458|FG000|Overall Study|Protocol Violation|6|||
19731775|NCT01060150|42177458|FG000|Overall Study|Withdrawal by Subject|8|||
19731776|NCT01060150|42177458|FG000|Overall Study|Enrolled, but not treated|2|||
19731777|NCT02972242|42177464|FG000|Overall Study|Withdrawal by Subject|1|||
19731778|NCT02972242|42177465|FG001|Overall Study|Withdrawal by Subject|0|||
19731779|NCT02970292|42177473|FG000|Overall Study|Physician Decision|1|||
19731780|NCT02970292|42177474|FG001|Overall Study|Physician Decision|1|||
19731781|NCT02970292|42177473|FG000|Overall Study|Withdrawal by Subject|11|||
19731782|NCT02970292|42177474|FG001|Overall Study|Withdrawal by Subject|5|||
19731783|NCT02970292|42177473|FG000|Overall Study|Noncompliance with study drug|2|||
19731784|NCT02970292|42177474|FG001|Overall Study|Noncompliance with study drug|2|||
19731785|NCT02970292|42177473|FG000|Overall Study|Adverse Event|5|||
19731786|NCT02970292|42177474|FG001|Overall Study|Adverse Event|0|||
19731787|NCT02970292|42177473|FG000|Overall Study|Lack of Efficacy|1|||
19731788|NCT02970292|42177474|FG001|Overall Study|Lack of Efficacy|0|||
19731789|NCT02970292|42177473|FG000|Overall Study|Lost to Follow-up|1|||
19731790|NCT02970292|42177474|FG001|Overall Study|Lost to Follow-up|0|||
19731791|NCT02970292|42177473|FG000|Overall Study|Protocol Violation|2|||
19731792|NCT02970292|42177474|FG001|Overall Study|Protocol Violation|0|||
19731793|NCT02970292|42177473|FG000|Overall Study|Other|1|||
19731794|NCT02970292|42177474|FG001|Overall Study|Other|0|||
19731795|NCT02971228|42177480|FG000|Overall Study|Withdrawal by Subject|1|||
19731796|NCT02971228|42177481|FG001|Overall Study|Withdrawal by Subject|1|||
19731797|NCT02971228|42177482|FG002|Overall Study|Withdrawal by Subject|0|||
19731798|NCT02971228|42177483|FG003|Overall Study|Withdrawal by Subject|0|||
19731799|NCT02971228|42177484|FG004|Overall Study|Withdrawal by Subject|0|||
19731800|NCT02971228|42177480|FG000|Overall Study|Logistical challenges|0|||
19731801|NCT02971228|42177481|FG001|Overall Study|Logistical challenges|1|||
19731802|NCT02971228|42177482|FG002|Overall Study|Logistical challenges|0|||
19731803|NCT02971228|42177483|FG003|Overall Study|Logistical challenges|0|||
19731804|NCT02971228|42177484|FG004|Overall Study|Logistical challenges|0|||
19731805|NCT01060072|42177497|FG000|Overall Study|Adverse Event|1|||
19731806|NCT01060072|42177498|FG001|Overall Study|Adverse Event|1|||
19731807|NCT01060072|42177497|FG000|Overall Study|Physician Decision|0|||
19731808|NCT01060072|42177498|FG001|Overall Study|Physician Decision|2|||
19731809|NCT01060072|42177497|FG000|Overall Study|Protocol Violation|0|||
19380810|NCT01791595|41623997|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19731810|NCT01060072|42177498|FG001|Overall Study|Protocol Violation|1|||
19731811|NCT01060072|42177497|FG000|Overall Study|Acute cholecystitis|1|||
19731812|NCT01060072|42177498|FG001|Overall Study|Acute cholecystitis|0|||
19731813|NCT01060072|42177497|FG000|Overall Study|Excluded Medications|0|||
19731814|NCT01060072|42177498|FG001|Overall Study|Excluded Medications|1|||
19731815|NCT02969590|42177506|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
19731816|NCT02969590|42177507|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
19731817|NCT02969590|42177508|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
19731818|NCT03345849|42177520|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
19731819|NCT03345849|42177521|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
19731820|NCT03345849|42177522|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
19731821|NCT03345849|42177523|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
19731822|NCT03345849|42177520|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
19731823|NCT03345849|42177521|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
19731824|NCT03345849|42177522|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
19731825|NCT03345849|42177523|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
19731826|NCT03345849|42177520|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
19731827|NCT03345849|42177521|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
19731828|NCT03345849|42177522|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
19731829|NCT03345849|42177523|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
19731830|NCT03345849|42177520|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
19731831|NCT03345849|42177521|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
19731832|NCT03345849|42177522|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
19731833|NCT03345849|42177523|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
19731834|NCT03345849|42177520|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
19731835|NCT03345849|42177521|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
19731836|NCT03345849|42177522|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
19731837|NCT03345849|42177523|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
19731838|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
19731839|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
19731840|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
19731841|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
19731842|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
19731843|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
19731844|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
19731845|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
19731846|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
19731847|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
19731848|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
19731849|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
19731850|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
19731851|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
19731852|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
19731853|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
19731854|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
19731855|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
19731856|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
19731857|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
19731858|NCT03345849|42177520|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
19731859|NCT03345849|42177521|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
19731860|NCT03345849|42177522|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
19731861|NCT03345849|42177523|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
19731862|NCT03011307|42177533|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
19731863|NCT03011307|42177534|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
19731864|NCT03011307|42177533|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
19731865|NCT03011307|42177534|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
19731866|NCT03011307|42177533|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
19731867|NCT03011307|42177534|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
19731868|NCT03798717|42177546|FG000|Overall Study|Failed Screening|0|||
19731869|NCT03798717|42177547|FG001|Overall Study|Failed Screening|0|||
19731870|NCT03798717|42177548|FG002|Overall Study|Failed Screening|0|||
19731871|NCT03798717|42177549|FG003|Overall Study|Failed Screening|0|||
19731872|NCT03798717|42177550|FG004|Overall Study|Failed Screening|0|||
19731873|NCT03798717|42177551|FG005|Overall Study|Failed Screening|1|||
19731874|NCT03798717|42177546|FG000|Overall Study|Physician Decision|1|||
19731875|NCT03798717|42177547|FG001|Overall Study|Physician Decision|0|||
19731876|NCT03798717|42177548|FG002|Overall Study|Physician Decision|1|||
19731877|NCT03798717|42177549|FG003|Overall Study|Physician Decision|0|||
19731878|NCT03798717|42177550|FG004|Overall Study|Physician Decision|0|||
19731879|NCT03798717|42177551|FG005|Overall Study|Physician Decision|0|||
19731880|NCT03798717|42177546|FG000|Overall Study|Withdrawal by Subject|0|||
19731881|NCT03798717|42177547|FG001|Overall Study|Withdrawal by Subject|0|||
19731882|NCT03798717|42177548|FG002|Overall Study|Withdrawal by Subject|0|||
19731883|NCT03798717|42177549|FG003|Overall Study|Withdrawal by Subject|1|||
19731884|NCT03798717|42177550|FG004|Overall Study|Withdrawal by Subject|0|||
19731885|NCT03798717|42177551|FG005|Overall Study|Withdrawal by Subject|0|||
19731886|NCT03798717|42177546|FG000|Overall Study|Lost to Follow-up|1|||
19731887|NCT03798717|42177547|FG001|Overall Study|Lost to Follow-up|0|||
19731888|NCT03798717|42177548|FG002|Overall Study|Lost to Follow-up|0|||
19731889|NCT03798717|42177549|FG003|Overall Study|Lost to Follow-up|1|||
19731890|NCT03798717|42177550|FG004|Overall Study|Lost to Follow-up|0|||
19731891|NCT03798717|42177551|FG005|Overall Study|Lost to Follow-up|0|||
19731892|NCT03798717|42177546|FG000|Overall Study|Adverse Event|0|||
19731893|NCT03798717|42177547|FG001|Overall Study|Adverse Event|1|||
19731894|NCT03798717|42177548|FG002|Overall Study|Adverse Event|0|||
19731895|NCT03798717|42177549|FG003|Overall Study|Adverse Event|0|||
19731896|NCT03798717|42177550|FG004|Overall Study|Adverse Event|0|||
19731897|NCT03798717|42177551|FG005|Overall Study|Adverse Event|0|||
19731898|NCT03798717|42177546|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
19731899|NCT03798717|42177547|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
19731900|NCT03798717|42177548|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
19731901|NCT03798717|42177549|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
19731902|NCT03798717|42177550|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
19731903|NCT03798717|42177551|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
19731904|NCT03798483|42177560|FG000|Overall Study|Lost to Follow-up|2|||
19731905|NCT03792477|42177573|FG000|Overall Study|Adverse Event|0|||
19731906|NCT03792477|42177574|FG001|Overall Study|Adverse Event|0|||
19731907|NCT03792477|42177575|FG002|Overall Study|Adverse Event|0|||
19731908|NCT03792477|42177576|FG003|Overall Study|Adverse Event|1|||
19731909|NCT03792477|42177577|FG004|Overall Study|Adverse Event|0|||
19731910|NCT03792477|42177573|FG000|Overall Study|Lost to Follow-up|0|||
19731911|NCT03792477|42177574|FG001|Overall Study|Lost to Follow-up|0|||
19731912|NCT03792477|42177575|FG002|Overall Study|Lost to Follow-up|2|||
19731913|NCT03792477|42177576|FG003|Overall Study|Lost to Follow-up|0|||
19731914|NCT03792477|42177577|FG004|Overall Study|Lost to Follow-up|0|||
19731915|NCT03792477|42177573|FG000|Overall Study|Other|0|||
19731916|NCT03792477|42177574|FG001|Overall Study|Other|0|||
19731917|NCT03792477|42177575|FG002|Overall Study|Other|0|||
19731918|NCT03792477|42177576|FG003|Overall Study|Other|0|||
19731919|NCT03792477|42177577|FG004|Overall Study|Other|1|||
19731920|NCT03790917|42177583|FG000|Overall Study|Death|1|||
19731921|NCT03788967|42177590|FG000|Overall Study|Lost to Follow-up|14|||
19731922|NCT03788967|42177591|FG001|Overall Study|Lost to Follow-up|10|||
19731923|NCT03788967|42177590|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
19731924|NCT03788967|42177591|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
19731925|NCT03788967|42177590|FG000|Overall Study|Participant Withdrawal of Consent|13|||
19731926|NCT03788967|42177591|FG001|Overall Study|Participant Withdrawal of Consent|5|||
19731927|NCT03788967|42177590|FG000|Overall Study|Adverse Event|1|||
19731928|NCT03788967|42177591|FG001|Overall Study|Adverse Event|1|||
19731929|NCT03788967|42177590|FG000|Overall Study|COVID-19|1|||
19731930|NCT03788967|42177591|FG001|Overall Study|COVID-19|2|||
19731931|NCT03782571|42177599|FG000|Period 1|Withdrawal by Subject|1|||
19731932|NCT03782571|42177600|FG001|Period 1|Withdrawal by Subject|0|||
19731933|NCT03782571|42177601|FG002|Period 1|Withdrawal by Subject|0|||
19731934|NCT03782571|42177602|FG003|Period 1|Withdrawal by Subject|0|||
19731935|NCT03782571|42177599|FG000|Period 3|Subject Unable to Attend V5|1|||
19731936|NCT03782571|42177600|FG001|Period 3|Subject Unable to Attend V5|0|||
19731937|NCT03782571|42177601|FG002|Period 3|Subject Unable to Attend V5|0|||
19731938|NCT03782571|42177602|FG003|Period 3|Subject Unable to Attend V5|0|||
19731939|NCT03782571|42177599|FG000|Period 3|Adverse Event|1|||
19731940|NCT03782571|42177600|FG001|Period 3|Adverse Event|0|||
19731941|NCT03782571|42177601|FG002|Period 3|Adverse Event|0|||
19731942|NCT03782571|42177602|FG003|Period 3|Adverse Event|0|||
19731943|NCT03783039|42177616|FG000|Overall Study|Death|2|||
19731944|NCT03783039|42177617|FG001|Overall Study|Death|1|||
19731945|NCT03776175|42177627|FG000|Treatment Period (42 Days)|Adverse Event|0|||
19731946|NCT03776175|42177628|FG001|Treatment Period (42 Days)|Adverse Event|1|||
19731947|NCT03776175|42177629|FG002|Treatment Period (42 Days)|Adverse Event|1|||
19731948|NCT03776175|42177630|FG003|Treatment Period (42 Days)|Adverse Event|0|||
19731949|NCT03776175|42177627|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
19731950|NCT03776175|42177628|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
19731951|NCT03776175|42177629|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
19731952|NCT03776175|42177630|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
19731953|NCT03776175|42177627|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
19731954|NCT03776175|42177628|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
19731955|NCT03776175|42177629|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
19731956|NCT03776175|42177630|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
19731957|NCT03776175|42177627|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
19731958|NCT03776175|42177628|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
19731959|NCT03776175|42177629|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
19731960|NCT03776175|42177630|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
19731961|NCT03776175|42177627|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
19731962|NCT03776175|42177628|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
19731963|NCT03776175|42177629|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
19731964|NCT03776175|42177630|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
19731965|NCT03776175|42177627|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
19731966|NCT03776175|42177628|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
19731967|NCT03776175|42177629|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
19731968|NCT03776175|42177630|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
19731969|NCT02903914|42177648|FG000|Overall Study|Adverse Event|0|||
19731970|NCT02903914|42177649|FG001|Overall Study|Adverse Event|0|||
19731971|NCT02903914|42177650|FG002|Overall Study|Adverse Event|1|||
19731972|NCT02903914|42177651|FG003|Overall Study|Adverse Event|0|||
19731973|NCT02903914|42177652|FG004|Overall Study|Adverse Event|0|||
19731974|NCT02903914|42177653|FG005|Overall Study|Adverse Event|1|||
19731975|NCT02903914|42177654|FG006|Overall Study|Adverse Event|2|||
19731976|NCT02903914|42177655|FG007|Overall Study|Adverse Event|1|||
19731977|NCT02903914|42177648|FG000|Overall Study|Withdrawal by Subject|3|||
19731978|NCT02903914|42177649|FG001|Overall Study|Withdrawal by Subject|1|||
19731979|NCT02903914|42177650|FG002|Overall Study|Withdrawal by Subject|28|||
19731980|NCT02903914|42177651|FG003|Overall Study|Withdrawal by Subject|0|||
19731981|NCT02903914|42177652|FG004|Overall Study|Withdrawal by Subject|1|||
19731982|NCT02903914|42177653|FG005|Overall Study|Withdrawal by Subject|1|||
19731983|NCT02903914|42177654|FG006|Overall Study|Withdrawal by Subject|12|||
19731984|NCT02903914|42177655|FG007|Overall Study|Withdrawal by Subject|0|||
19731985|NCT02903914|42177648|FG000|Overall Study|Progressive Disease|1|||
19731986|NCT02903914|42177649|FG001|Overall Study|Progressive Disease|0|||
19731987|NCT02903914|42177650|FG002|Overall Study|Progressive Disease|4|||
19731988|NCT02903914|42177651|FG003|Overall Study|Progressive Disease|0|||
19731989|NCT02903914|42177652|FG004|Overall Study|Progressive Disease|0|||
19731990|NCT02903914|42177653|FG005|Overall Study|Progressive Disease|0|||
19731991|NCT02903914|42177654|FG006|Overall Study|Progressive Disease|2|||
19731992|NCT02903914|42177655|FG007|Overall Study|Progressive Disease|4|||
19731993|NCT02903914|42177648|FG000|Overall Study|Death|0|||
19731994|NCT02903914|42177649|FG001|Overall Study|Death|0|||
19731995|NCT02903914|42177650|FG002|Overall Study|Death|9|||
19731996|NCT02903914|42177651|FG003|Overall Study|Death|0|||
19731997|NCT02903914|42177652|FG004|Overall Study|Death|1|||
19731998|NCT02903914|42177653|FG005|Overall Study|Death|3|||
19731999|NCT02903914|42177654|FG006|Overall Study|Death|24|||
19732000|NCT02903914|42177655|FG007|Overall Study|Death|0|||
19732001|NCT02903914|42177648|FG000|Overall Study|Lost to Follow-up|0|||
19732002|NCT02903914|42177649|FG001|Overall Study|Lost to Follow-up|1|||
19732003|NCT02903914|42177650|FG002|Overall Study|Lost to Follow-up|0|||
19732004|NCT02903914|42177651|FG003|Overall Study|Lost to Follow-up|0|||
19732005|NCT02903914|42177652|FG004|Overall Study|Lost to Follow-up|2|||
19732006|NCT02903914|42177653|FG005|Overall Study|Lost to Follow-up|0|||
19732007|NCT02903914|42177654|FG006|Overall Study|Lost to Follow-up|1|||
19732008|NCT02903914|42177655|FG007|Overall Study|Lost to Follow-up|0|||
19732009|NCT02903914|42177648|FG000|Overall Study|Physician Decision|0|||
19732010|NCT02903914|42177649|FG001|Overall Study|Physician Decision|0|||
19732011|NCT02903914|42177650|FG002|Overall Study|Physician Decision|1|||
19732012|NCT02903914|42177651|FG003|Overall Study|Physician Decision|0|||
19732013|NCT02903914|42177652|FG004|Overall Study|Physician Decision|0|||
19732014|NCT02903914|42177653|FG005|Overall Study|Physician Decision|0|||
19732015|NCT02903914|42177654|FG006|Overall Study|Physician Decision|1|||
19732016|NCT02903914|42177655|FG007|Overall Study|Physician Decision|0|||
19732017|NCT02903914|42177648|FG000|Overall Study|Symptomatic Deterioration|0|||
19732018|NCT02903914|42177649|FG001|Overall Study|Symptomatic Deterioration|0|||
19732019|NCT02903914|42177650|FG002|Overall Study|Symptomatic Deterioration|1|||
19732020|NCT02903914|42177651|FG003|Overall Study|Symptomatic Deterioration|0|||
19732021|NCT02903914|42177652|FG004|Overall Study|Symptomatic Deterioration|0|||
19732022|NCT02903914|42177653|FG005|Overall Study|Symptomatic Deterioration|0|||
19732023|NCT02903914|42177654|FG006|Overall Study|Symptomatic Deterioration|0|||
19732024|NCT02903914|42177655|FG007|Overall Study|Symptomatic Deterioration|0|||
19732025|NCT02903914|42177648|FG000|Overall Study|New Cancer Therapy|2|||
19732026|NCT02903914|42177649|FG001|Overall Study|New Cancer Therapy|2|||
19732027|NCT02903914|42177650|FG002|Overall Study|New Cancer Therapy|21|||
19732028|NCT02903914|42177651|FG003|Overall Study|New Cancer Therapy|4|||
19732029|NCT02903914|42177652|FG004|Overall Study|New Cancer Therapy|3|||
19732030|NCT02903914|42177653|FG005|Overall Study|New Cancer Therapy|6|||
19732031|NCT02903914|42177654|FG006|Overall Study|New Cancer Therapy|55|||
19732032|NCT02903914|42177655|FG007|Overall Study|New Cancer Therapy|0|||
19732033|NCT02903914|42177648|FG000|Overall Study|Reasoning not specified|2|||
19732034|NCT02903914|42177649|FG001|Overall Study|Reasoning not specified|3|||
19732035|NCT02903914|42177650|FG002|Overall Study|Reasoning not specified|20|||
19732036|NCT02903914|42177651|FG003|Overall Study|Reasoning not specified|3|||
19732037|NCT02903914|42177652|FG004|Overall Study|Reasoning not specified|3|||
19732038|NCT02903914|42177653|FG005|Overall Study|Reasoning not specified|3|||
19732039|NCT02903914|42177654|FG006|Overall Study|Reasoning not specified|20|||
19732040|NCT02903914|42177655|FG007|Overall Study|Reasoning not specified|0|||
19732041|NCT02969044|42177677|FG000|Overall Study|Withdrawal by Subject|2|||
19732042|NCT02969044|42177678|FG001|Overall Study|Withdrawal by Subject|6|||
19732043|NCT02969044|42177677|FG000|Overall Study|Adverse Event|3|||
19732044|NCT02969044|42177678|FG001|Overall Study|Adverse Event|0|||
19732045|NCT02967562|42177686|FG000|Overall Study|Consent not obtained|1|||
19732046|NCT02967562|42177687|FG001|Overall Study|Consent not obtained|0|||
19732047|NCT02967562|42177686|FG000|Overall Study|High leak precluding analysis|1|||
19732048|NCT02967562|42177687|FG001|Overall Study|High leak precluding analysis|1|||
19732049|NCT02968576|42177693|FG000|Overall Study|Pregnancy|0|||
19732050|NCT02968576|42177694|FG001|Overall Study|Pregnancy|1|||
19732051|NCT02966002|42177698|FG000|Overall Study|Withdrawal by Subject|2|||
19732052|NCT02966002|42177698|FG000|Overall Study|Adverse Event|1|||
19732053|NCT02966002|42177698|FG000|Overall Study|Lost to Follow-up|1|||
19732054|NCT02965846|42177705|FG000|Overall Study|Lost to Follow-up|1|||
19732055|NCT02965846|42177706|FG001|Overall Study|Lost to Follow-up|0|||
19732056|NCT02965846|42177707|FG002|Overall Study|Lost to Follow-up|0|||
19732057|NCT02965846|42177705|FG000|Overall Study|Withdrawal by Subject|0|||
19732058|NCT02965846|42177706|FG001|Overall Study|Withdrawal by Subject|1|||
19732059|NCT02965846|42177707|FG002|Overall Study|Withdrawal by Subject|0|||
19732060|NCT02965846|42177705|FG000|Overall Study|Study Terminated By Sponsor|4|||
19732061|NCT02965846|42177706|FG001|Overall Study|Study Terminated By Sponsor|4|||
19732062|NCT02965846|42177707|FG002|Overall Study|Study Terminated By Sponsor|0|||
19732063|NCT02965846|42177705|FG000|Overall Study|Participants not randomized|0|||
19732064|NCT02965846|42177706|FG001|Overall Study|Participants not randomized|0|||
19732065|NCT02965846|42177707|FG002|Overall Study|Participants not randomized|33|||
19732066|NCT02900170|42177713|FG000|Overall Study|Lost to Follow-up|8|||
19732067|NCT02900092|42177717|FG000|Overall Study|Adverse Event|1|||
19732068|NCT02902120|42177725|FG000|Overall Study|Lack of Efficacy|1|||
19732069|NCT02965456|42177731|FG000|Overall Study|Lost to Follow-up|40|||
19732070|NCT02965456|42177732|FG001|Overall Study|Lost to Follow-up|18|||
19732071|NCT02965456|42177731|FG000|Overall Study|Subject Request|22|||
19732072|NCT02965456|42177732|FG001|Overall Study|Subject Request|13|||
19732073|NCT02965456|42177731|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
19732074|NCT02965456|42177732|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
19732075|NCT02965456|42177731|FG000|Overall Study|Adverse Event|3|||
19732076|NCT02965456|42177732|FG001|Overall Study|Adverse Event|0|||
19732077|NCT02965456|42177731|FG000|Overall Study|Noncompliance with Study Drug|1|||
19732078|NCT02965456|42177732|FG001|Overall Study|Noncompliance with Study Drug|1|||
19732079|NCT02965456|42177731|FG000|Overall Study|Worsening Condition|0|||
19732080|NCT02965456|42177732|FG001|Overall Study|Worsening Condition|2|||
19732081|NCT02965456|42177731|FG000|Overall Study|Lack of Efficacy|1|||
19732082|NCT02965456|42177732|FG001|Overall Study|Lack of Efficacy|0|||
19732083|NCT02965456|42177731|FG000|Overall Study|Physician Decision|0|||
19732084|NCT02965456|42177732|FG001|Overall Study|Physician Decision|1|||
19732085|NCT02965456|42177731|FG000|Overall Study|Pregnancy|1|||
19732086|NCT02965456|42177732|FG001|Overall Study|Pregnancy|0|||
19732087|NCT02965456|42177731|FG000|Overall Study|Protocol Violation|0|||
19732088|NCT02965456|42177732|FG001|Overall Study|Protocol Violation|1|||
19732089|NCT02965456|42177731|FG000|Overall Study|Participant ran out of study drug|0|||
19732090|NCT02965456|42177732|FG001|Overall Study|Participant ran out of study drug|1|||
19732091|NCT02965378|42177740|FG000|Overall Study|Progression|16|||
19732092|NCT02965378|42177741|FG001|Overall Study|Progression|4|||
19732093|NCT02965378|42177740|FG000|Overall Study|Adverse Event|5|||
19732094|NCT02965378|42177741|FG001|Overall Study|Adverse Event|2|||
19732095|NCT02965378|42177740|FG000|Overall Study|Death|2|||
19732096|NCT02965378|42177741|FG001|Overall Study|Death|0|||
19732097|NCT02965378|42177740|FG000|Overall Study|Refusal|2|||
19732098|NCT02965378|42177741|FG001|Overall Study|Refusal|1|||
19732099|NCT02965378|42177740|FG000|Overall Study|Not protocol specified|0|||
19732100|NCT02965378|42177741|FG001|Overall Study|Not protocol specified|2|||
19732101|NCT03772041|42177749|FG000|Overall Study|Adverse Event|8|||
19732102|NCT03772041|42177750|FG001|Overall Study|Adverse Event|3|||
19732103|NCT03772041|42177749|FG000|Overall Study|Withdrawal by Subject|0|||
19732104|NCT03772041|42177750|FG001|Overall Study|Withdrawal by Subject|2|||
19732105|NCT03772041|42177749|FG000|Overall Study|Protocol Violation|4|||
19732106|NCT03772041|42177750|FG001|Overall Study|Protocol Violation|2|||
19732107|NCT03772041|42177749|FG000|Overall Study|Physician Decision|2|||
19732108|NCT03772041|42177750|FG001|Overall Study|Physician Decision|3|||
19732109|NCT02899156|42177758|FG000|Overall Study|Death|1|||
19732110|NCT02899156|42177759|FG001|Overall Study|Death|0|||
19732111|NCT02899156|42177758|FG000|Overall Study|Physician Decision|0|||
19732112|NCT02899156|42177759|FG001|Overall Study|Physician Decision|1|||
19732113|NCT03773133|42177765|FG000|Overall Study|Screen Failure|8|||
19732114|NCT02969356|42177770|FG000|Overall Study|Adverse Event|7|||
19732115|NCT02969356|42177770|FG000|Overall Study|Consent withdrawn|2|||
19732116|NCT02969356|42177770|FG000|Overall Study|Lost to Follow-up|3|||
19732117|NCT02969356|42177770|FG000|Overall Study|Did not need to be reinjected|6|||
19732118|NCT02969356|42177770|FG000|Overall Study|Personal reasons|5|||
19732119|NCT02898454|42177777|FG000|Overall Study|Adverse Event|4|||
19732120|NCT02898454|42177778|FG001|Overall Study|Adverse Event|1|||
19732121|NCT02898454|42177779|FG002|Overall Study|Adverse Event|2|||
19732122|NCT02898454|42177777|FG000|Overall Study|Protocol Violation|1|||
19732123|NCT02898454|42177778|FG001|Overall Study|Protocol Violation|0|||
19732124|NCT02898454|42177779|FG002|Overall Study|Protocol Violation|1|||
19732125|NCT02898454|42177777|FG000|Overall Study|Lack of Efficacy|4|||
19732126|NCT02898454|42177778|FG001|Overall Study|Lack of Efficacy|1|||
19732127|NCT02898454|42177779|FG002|Overall Study|Lack of Efficacy|0|||
19732128|NCT02898454|42177777|FG000|Overall Study|Withdrawal by Subject|6|||
19732129|NCT02898454|42177778|FG001|Overall Study|Withdrawal by Subject|3|||
19732130|NCT02898454|42177779|FG002|Overall Study|Withdrawal by Subject|3|||
19732131|NCT02898454|42177777|FG000|Overall Study|Lost to Follow-up|1|||
19732132|NCT02898454|42177778|FG001|Overall Study|Lost to Follow-up|0|||
19732133|NCT02898454|42177779|FG002|Overall Study|Lost to Follow-up|0|||
19732134|NCT02898454|42177777|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
19732135|NCT02898454|42177778|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
19732136|NCT02898454|42177779|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
19732137|NCT03772587|42177797|FG000|Overall Study|COVID-19|0|||
19732138|NCT03772587|42177798|FG001|Overall Study|COVID-19|0|||
19732139|NCT03772587|42177799|FG002|Overall Study|COVID-19|1|||
19732140|NCT03772587|42177800|FG003|Overall Study|COVID-19|1|||
19732141|NCT03772587|42177801|FG004|Overall Study|COVID-19|0|||
19732142|NCT03772587|42177797|FG000|Overall Study|Withdrawal by Subject|1|||
19732143|NCT03772587|42177798|FG001|Overall Study|Withdrawal by Subject|0|||
19732144|NCT03772587|42177799|FG002|Overall Study|Withdrawal by Subject|0|||
19732145|NCT03772587|42177800|FG003|Overall Study|Withdrawal by Subject|0|||
19732146|NCT03772587|42177801|FG004|Overall Study|Withdrawal by Subject|0|||
19732147|NCT02963506|42177828|FG000|Double-Blind Period|Adverse Event|0|||
19732148|NCT02963506|42177829|FG001|Double-Blind Period|Adverse Event|0|||
19732149|NCT02963506|42177830|FG002|Double-Blind Period|Adverse Event|1|||
19732150|NCT02963506|42177831|FG003|Double-Blind Period|Adverse Event|0|||
19732151|NCT02963506|42177832|FG004|Double-Blind Period|Adverse Event|0|||
19732152|NCT02963506|42177833|FG005|Double-Blind Period|Adverse Event|0|||
19732153|NCT02963506|42177834|FG006|Double-Blind Period|Adverse Event|0|||
19732154|NCT02963506|42177835|FG007|Double-Blind Period|Adverse Event|0|||
19732155|NCT02963506|42177836|FG008|Double-Blind Period|Adverse Event|0|||
19732156|NCT02963506|42177837|FG009|Double-Blind Period|Adverse Event|0|||
19732157|NCT02963506|42177838|FG010|Double-Blind Period|Adverse Event|0|||
19732158|NCT02963506|42177839|FG011|Double-Blind Period|Adverse Event|0|||
19732159|NCT02963506|42177840|FG012|Double-Blind Period|Adverse Event|0|||
19732160|NCT02963506|42177828|FG000|Double-Blind Period|Death|0|||
19732161|NCT02963506|42177829|FG001|Double-Blind Period|Death|0|||
19732162|NCT02963506|42177830|FG002|Double-Blind Period|Death|0|||
19732163|NCT02963506|42177831|FG003|Double-Blind Period|Death|1|||
19732164|NCT02963506|42177832|FG004|Double-Blind Period|Death|0|||
19732165|NCT02963506|42177833|FG005|Double-Blind Period|Death|0|||
19732166|NCT02963506|42177834|FG006|Double-Blind Period|Death|0|||
19732167|NCT02963506|42177835|FG007|Double-Blind Period|Death|0|||
19732168|NCT02963506|42177836|FG008|Double-Blind Period|Death|0|||
19732169|NCT02963506|42177837|FG009|Double-Blind Period|Death|0|||
19732170|NCT02963506|42177838|FG010|Double-Blind Period|Death|0|||
19732171|NCT02963506|42177839|FG011|Double-Blind Period|Death|0|||
19732172|NCT02963506|42177840|FG012|Double-Blind Period|Death|0|||
19732173|NCT02963506|42177828|FG000|Double-Blind Period|Lost to Follow-up|0|||
19732174|NCT02963506|42177829|FG001|Double-Blind Period|Lost to Follow-up|1|||
19732175|NCT02963506|42177830|FG002|Double-Blind Period|Lost to Follow-up|0|||
19732176|NCT02963506|42177831|FG003|Double-Blind Period|Lost to Follow-up|0|||
19732177|NCT02963506|42177832|FG004|Double-Blind Period|Lost to Follow-up|0|||
19732178|NCT02963506|42177833|FG005|Double-Blind Period|Lost to Follow-up|0|||
19732179|NCT02963506|42177834|FG006|Double-Blind Period|Lost to Follow-up|0|||
19732180|NCT02963506|42177835|FG007|Double-Blind Period|Lost to Follow-up|0|||
19732181|NCT02963506|42177836|FG008|Double-Blind Period|Lost to Follow-up|0|||
19732182|NCT02963506|42177837|FG009|Double-Blind Period|Lost to Follow-up|0|||
19732183|NCT02963506|42177838|FG010|Double-Blind Period|Lost to Follow-up|0|||
19732184|NCT02963506|42177839|FG011|Double-Blind Period|Lost to Follow-up|0|||
19732185|NCT02963506|42177840|FG012|Double-Blind Period|Lost to Follow-up|0|||
19732186|NCT02963506|42177828|FG000|Double-Blind Period|Withdrawal by Subject|0|||
19732187|NCT02963506|42177829|FG001|Double-Blind Period|Withdrawal by Subject|0|||
19732188|NCT02963506|42177830|FG002|Double-Blind Period|Withdrawal by Subject|1|||
19732189|NCT02963506|42177831|FG003|Double-Blind Period|Withdrawal by Subject|1|||
19732190|NCT02963506|42177832|FG004|Double-Blind Period|Withdrawal by Subject|0|||
19732191|NCT02963506|42177833|FG005|Double-Blind Period|Withdrawal by Subject|0|||
19732192|NCT02963506|42177834|FG006|Double-Blind Period|Withdrawal by Subject|0|||
19732193|NCT02963506|42177835|FG007|Double-Blind Period|Withdrawal by Subject|0|||
19732194|NCT02963506|42177836|FG008|Double-Blind Period|Withdrawal by Subject|0|||
19732195|NCT02963506|42177837|FG009|Double-Blind Period|Withdrawal by Subject|0|||
19732196|NCT02963506|42177838|FG010|Double-Blind Period|Withdrawal by Subject|0|||
19732197|NCT02963506|42177839|FG011|Double-Blind Period|Withdrawal by Subject|0|||
19732198|NCT02963506|42177840|FG012|Double-Blind Period|Withdrawal by Subject|0|||
19732199|NCT02963506|42177828|FG000|Double-Blind Period|No compliance|0|||
19732200|NCT02963506|42177829|FG001|Double-Blind Period|No compliance|1|||
19732201|NCT02963506|42177830|FG002|Double-Blind Period|No compliance|0|||
19732202|NCT02963506|42177831|FG003|Double-Blind Period|No compliance|0|||
19732203|NCT02963506|42177832|FG004|Double-Blind Period|No compliance|0|||
19732204|NCT02963506|42177833|FG005|Double-Blind Period|No compliance|0|||
19732205|NCT02963506|42177834|FG006|Double-Blind Period|No compliance|0|||
19732206|NCT02963506|42177835|FG007|Double-Blind Period|No compliance|0|||
19732207|NCT02963506|42177836|FG008|Double-Blind Period|No compliance|0|||
19732208|NCT02963506|42177837|FG009|Double-Blind Period|No compliance|0|||
19732209|NCT02963506|42177838|FG010|Double-Blind Period|No compliance|0|||
19732210|NCT02963506|42177839|FG011|Double-Blind Period|No compliance|0|||
19732211|NCT02963506|42177840|FG012|Double-Blind Period|No compliance|0|||
19732212|NCT02963506|42177828|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732213|NCT02963506|42177829|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
19732214|NCT02963506|42177830|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732215|NCT02963506|42177831|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732216|NCT02963506|42177832|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732217|NCT02963506|42177833|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732218|NCT02963506|42177834|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732219|NCT02963506|42177835|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732220|NCT02963506|42177836|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732221|NCT02963506|42177837|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732222|NCT02963506|42177838|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732223|NCT02963506|42177839|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732224|NCT02963506|42177840|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
19732225|NCT02963506|42177828|FG000|Dose-Blind Period|Adverse Event|0|||
19732226|NCT02963506|42177829|FG001|Dose-Blind Period|Adverse Event|0|||
19380811|NCT01791595|41623998|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19380812|NCT01791595|41623999|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19732227|NCT02963506|42177830|FG002|Dose-Blind Period|Adverse Event|0|||
19732228|NCT02963506|42177831|FG003|Dose-Blind Period|Adverse Event|0|||
19732229|NCT02963506|42177832|FG004|Dose-Blind Period|Adverse Event|0|||
19732230|NCT02963506|42177833|FG005|Dose-Blind Period|Adverse Event|1|||
19732231|NCT02963506|42177834|FG006|Dose-Blind Period|Adverse Event|3|||
19732232|NCT02963506|42177835|FG007|Dose-Blind Period|Adverse Event|2|||
19732233|NCT02963506|42177836|FG008|Dose-Blind Period|Adverse Event|2|||
19732234|NCT02963506|42177837|FG009|Dose-Blind Period|Adverse Event|2|||
19732235|NCT02963506|42177838|FG010|Dose-Blind Period|Adverse Event|1|||
19732236|NCT02963506|42177839|FG011|Dose-Blind Period|Adverse Event|1|||
19732237|NCT02963506|42177840|FG012|Dose-Blind Period|Adverse Event|6|||
19732238|NCT02963506|42177828|FG000|Dose-Blind Period|Lack of Efficacy|0|||
19732239|NCT02963506|42177829|FG001|Dose-Blind Period|Lack of Efficacy|0|||
19732240|NCT02963506|42177830|FG002|Dose-Blind Period|Lack of Efficacy|0|||
19732241|NCT02963506|42177831|FG003|Dose-Blind Period|Lack of Efficacy|0|||
19732242|NCT02963506|42177832|FG004|Dose-Blind Period|Lack of Efficacy|0|||
19732243|NCT02963506|42177833|FG005|Dose-Blind Period|Lack of Efficacy|0|||
19732244|NCT02963506|42177834|FG006|Dose-Blind Period|Lack of Efficacy|0|||
19732245|NCT02963506|42177835|FG007|Dose-Blind Period|Lack of Efficacy|1|||
19380813|NCT01791595|41624000|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19380814|NCT01791595|41624001|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19380815|NCT01791595|41624002|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
19380816|NCT01791595|41624003|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
19380817|NCT01791595|41623997|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19380818|NCT01791595|41623998|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19732246|NCT02963506|42177836|FG008|Dose-Blind Period|Lack of Efficacy|0|||
19732247|NCT02963506|42177837|FG009|Dose-Blind Period|Lack of Efficacy|1|||
19732248|NCT02963506|42177838|FG010|Dose-Blind Period|Lack of Efficacy|0|||
19732249|NCT02963506|42177839|FG011|Dose-Blind Period|Lack of Efficacy|0|||
19732250|NCT02963506|42177840|FG012|Dose-Blind Period|Lack of Efficacy|0|||
19732251|NCT02963506|42177828|FG000|Dose-Blind Period|Lost to Follow-up|0|||
19732252|NCT02963506|42177829|FG001|Dose-Blind Period|Lost to Follow-up|0|||
19732253|NCT02963506|42177830|FG002|Dose-Blind Period|Lost to Follow-up|0|||
19732254|NCT02963506|42177831|FG003|Dose-Blind Period|Lost to Follow-up|0|||
19732255|NCT02963506|42177832|FG004|Dose-Blind Period|Lost to Follow-up|0|||
19732256|NCT02963506|42177833|FG005|Dose-Blind Period|Lost to Follow-up|1|||
19732257|NCT02963506|42177834|FG006|Dose-Blind Period|Lost to Follow-up|0|||
19732258|NCT02963506|42177835|FG007|Dose-Blind Period|Lost to Follow-up|0|||
19732259|NCT02963506|42177836|FG008|Dose-Blind Period|Lost to Follow-up|1|||
19732260|NCT02963506|42177837|FG009|Dose-Blind Period|Lost to Follow-up|0|||
19732261|NCT02963506|42177838|FG010|Dose-Blind Period|Lost to Follow-up|0|||
19732262|NCT02963506|42177839|FG011|Dose-Blind Period|Lost to Follow-up|1|||
19732263|NCT02963506|42177840|FG012|Dose-Blind Period|Lost to Follow-up|0|||
19732264|NCT02963506|42177828|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
19732265|NCT02963506|42177829|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
19732266|NCT02963506|42177830|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
19732267|NCT02963506|42177831|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
19732268|NCT02963506|42177832|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
19732269|NCT02963506|42177833|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
19732270|NCT02963506|42177834|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
19732271|NCT02963506|42177835|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
19732272|NCT02963506|42177836|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
19732273|NCT02963506|42177837|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
19732274|NCT02963506|42177838|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
19732275|NCT02963506|42177839|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
19732276|NCT02963506|42177840|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
19732277|NCT02963506|42177828|FG000|Dose-Blind Period|Sponsor decision|0|||
19732278|NCT02963506|42177829|FG001|Dose-Blind Period|Sponsor decision|0|||
19380819|NCT01791595|41623999|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19380820|NCT01791595|41624000|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19380821|NCT01791595|41624001|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19380822|NCT01791595|41624002|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
19380823|NCT01791595|41624003|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
19380824|NCT01791595|41623997|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380825|NCT01791595|41623998|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380826|NCT01791595|41623999|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380827|NCT01791595|41624000|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380828|NCT01791595|41624001|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380829|NCT01791595|41624002|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
19380830|NCT01791595|41624003|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
19380831|NCT01559363|41624056|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
19380832|NCT01559363|41624057|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
19380833|NCT01559363|41624058|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
19380834|NCT01559363|41624059|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
19380835|NCT01559363|41624060|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
19380836|NCT01559363|41624061|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
19380837|NCT01559363|41624056|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
19380838|NCT01559363|41624057|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
19380839|NCT01559363|41624058|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
19380840|NCT01559363|41624059|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
19380841|NCT01559363|41624060|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
19380842|NCT01559363|41624061|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
19380843|NCT01559363|41624056|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
19380844|NCT01559363|41624057|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
19380845|NCT01559363|41624058|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
19380846|NCT01559363|41624059|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
19380847|NCT01559363|41624060|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
19380848|NCT01559363|41624061|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
19380849|NCT01559363|41624056|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
19380850|NCT01559363|41624057|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
19380851|NCT01559363|41624058|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
19380852|NCT01559363|41624059|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
19380853|NCT01559363|41624060|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
19380854|NCT01559363|41624061|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
19380855|NCT01559363|41624056|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
19465266|NCT04426695|41723742|FG001|Overall Study|Sponsor Request|0|||
19732279|NCT02963506|42177830|FG002|Dose-Blind Period|Sponsor decision|0|||
19732280|NCT02963506|42177831|FG003|Dose-Blind Period|Sponsor decision|0|||
19732281|NCT02963506|42177832|FG004|Dose-Blind Period|Sponsor decision|0|||
19732282|NCT02963506|42177833|FG005|Dose-Blind Period|Sponsor decision|1|||
19380856|NCT01559363|41624057|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
19380857|NCT01559363|41624058|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
19732283|NCT02963506|42177834|FG006|Dose-Blind Period|Sponsor decision|0|||
19732284|NCT02963506|42177835|FG007|Dose-Blind Period|Sponsor decision|0|||
19732285|NCT02963506|42177836|FG008|Dose-Blind Period|Sponsor decision|0|||
19732286|NCT02963506|42177837|FG009|Dose-Blind Period|Sponsor decision|0|||
19732287|NCT02963506|42177838|FG010|Dose-Blind Period|Sponsor decision|0|||
19732288|NCT02963506|42177839|FG011|Dose-Blind Period|Sponsor decision|0|||
19732289|NCT02963506|42177840|FG012|Dose-Blind Period|Sponsor decision|0|||
19732290|NCT02963506|42177828|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732291|NCT02963506|42177829|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732292|NCT02963506|42177830|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732293|NCT02963506|42177831|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732294|NCT02963506|42177832|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732295|NCT02963506|42177833|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732296|NCT02963506|42177834|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732297|NCT02963506|42177835|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732298|NCT02963506|42177836|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732299|NCT02963506|42177837|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732300|NCT02963506|42177838|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732301|NCT02963506|42177839|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
19732302|NCT02963506|42177840|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
19732303|NCT01345162|42177859|FG000|Overall Study|Protocol Violation|2|||
19732304|NCT01345162|42177860|FG001|Overall Study|Protocol Violation|4|||
19799320|NCT02901431|42257300|FG003|Open Label Part|Study Terminated By Sponsor|0|||
19799321|NCT02901431|42257301|FG004|Open Label Part|Study Terminated By Sponsor|0|||
19799322|NCT02901431|42257302|FG005|Open Label Part|Study Terminated By Sponsor|0|||
19799323|NCT02901431|42257303|FG006|Open Label Part|Study Terminated By Sponsor|0|||
19799324|NCT02901431|42257304|FG007|Open Label Part|Study Terminated By Sponsor|0|||
19799325|NCT02901431|42257305|FG008|Open Label Part|Study Terminated By Sponsor|35|||
19799326|NCT02901431|42257306|FG009|Open Label Part|Study Terminated By Sponsor|12|||
19799327|NCT02901431|42257307|FG010|Open Label Part|Study Terminated By Sponsor|21|||
19799328|NCT02901431|42257308|FG011|Open Label Part|Study Terminated By Sponsor|31|||
19799329|NCT02901431|42257309|FG012|Open Label Part|Study Terminated By Sponsor|0|||
19799330|NCT02901431|42257297|FG000|Open Label Part|Withdrawal by Subject|0|||
19799331|NCT02901431|42257298|FG001|Open Label Part|Withdrawal by Subject|0|||
19799332|NCT02901431|42257299|FG002|Open Label Part|Withdrawal by Subject|0|||
19799333|NCT02901431|42257300|FG003|Open Label Part|Withdrawal by Subject|0|||
19799334|NCT02901431|42257301|FG004|Open Label Part|Withdrawal by Subject|0|||
19799335|NCT02901431|42257302|FG005|Open Label Part|Withdrawal by Subject|0|||
19799336|NCT02901431|42257303|FG006|Open Label Part|Withdrawal by Subject|0|||
19799337|NCT02901431|42257304|FG007|Open Label Part|Withdrawal by Subject|0|||
19799338|NCT02901431|42257305|FG008|Open Label Part|Withdrawal by Subject|6|||
19799339|NCT02901431|42257306|FG009|Open Label Part|Withdrawal by Subject|5|||
19799340|NCT02901431|42257307|FG010|Open Label Part|Withdrawal by Subject|7|||
19799341|NCT02901431|42257308|FG011|Open Label Part|Withdrawal by Subject|3|||
19799342|NCT02901431|42257309|FG012|Open Label Part|Withdrawal by Subject|1|||
19799343|NCT02873377|42257336|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
19799344|NCT02873377|42257337|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
19799345|NCT02873377|42257336|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
19799346|NCT02873377|42257337|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
19799347|NCT02966795|42257346|FG000|Overall Study|Patient Left the Country|0|||
19799348|NCT02966795|42257347|FG001|Overall Study|Patient Left the Country|1|||
19799349|NCT02873221|42257355|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
19799350|NCT02873221|42257356|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
19799351|NCT02873221|42257357|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
19799352|NCT02873221|42257355|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
19799353|NCT02873221|42257356|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
19799354|NCT02873221|42257357|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
19799355|NCT02873221|42257355|FG000|Treatment Period|Protocol Violation|2|||
19799356|NCT02873221|42257356|FG001|Treatment Period|Protocol Violation|5|||
19799357|NCT02873221|42257357|FG002|Treatment Period|Protocol Violation|8|||
19799358|NCT02873221|42257355|FG000|Treatment Period|Pregnancy|4|||
19799359|NCT02873221|42257356|FG001|Treatment Period|Pregnancy|6|||
19799360|NCT02873221|42257357|FG002|Treatment Period|Pregnancy|3|||
19799361|NCT02873221|42257355|FG000|Treatment Period|Lack of Qualifying Event|0|||
19799362|NCT02873221|42257356|FG001|Treatment Period|Lack of Qualifying Event|3|||
19799363|NCT02873221|42257357|FG002|Treatment Period|Lack of Qualifying Event|1|||
19799364|NCT02873221|42257355|FG000|Treatment Period|Withdrawal of Consent|52|||
19799365|NCT02873221|42257356|FG001|Treatment Period|Withdrawal of Consent|51|||
19799366|NCT02873221|42257357|FG002|Treatment Period|Withdrawal of Consent|41|||
19799367|NCT02873221|42257355|FG000|Treatment Period|Lack of Efficacy|0|||
19799368|NCT02873221|42257356|FG001|Treatment Period|Lack of Efficacy|17|||
19799369|NCT02873221|42257357|FG002|Treatment Period|Lack of Efficacy|12|||
19799370|NCT02873221|42257355|FG000|Treatment Period|Adverse Event|4|||
19799371|NCT02873221|42257356|FG001|Treatment Period|Adverse Event|9|||
19799372|NCT02873221|42257357|FG002|Treatment Period|Adverse Event|11|||
19799373|NCT02873221|42257355|FG000|Treatment Period|Lost to Follow-up|26|||
19799374|NCT02873221|42257356|FG001|Treatment Period|Lost to Follow-up|30|||
19732305|NCT01345318|42177866|FG000|Overall Study|Adverse Event|16|||
19732306|NCT01345318|42177866|FG000|Overall Study|Lack of Efficacy|17|||
19732307|NCT01345318|42177866|FG000|Overall Study|Lost to Follow-up|2|||
19732308|NCT01345318|42177866|FG000|Overall Study|Protocol Violation|1|||
19732309|NCT01345318|42177866|FG000|Overall Study|Withdrawal by Subject|41|||
19732310|NCT01345318|42177866|FG000|Overall Study|Other|3|||
19732311|NCT02961244|42177873|FG000|Overall Study|Protocol Violation|0|||
19732312|NCT02961244|42177874|FG001|Overall Study|Protocol Violation|1|||
19732313|NCT02961244|42177873|FG000|Overall Study|Withdrawal by Subject|1|||
19732314|NCT02961244|42177874|FG001|Overall Study|Withdrawal by Subject|2|||
19732315|NCT02961244|42177873|FG000|Overall Study|Surgery plan change after study approval|0|||
19732316|NCT02961244|42177874|FG001|Overall Study|Surgery plan change after study approval|2|||
19732317|NCT02961244|42177873|FG000|Overall Study|Lost to Follow-up|0|||
19732318|NCT02961244|42177874|FG001|Overall Study|Lost to Follow-up|2|||
19732319|NCT02961244|42177873|FG000|Overall Study|İnadequate data|0|||
19732320|NCT02961244|42177874|FG001|Overall Study|İnadequate data|2|||
19732321|NCT03771963|42177880|FG000|Overall Study|Lost to Follow-up|22|||
19732322|NCT03771963|42177880|FG000|Overall Study|Withdrawal of Consent|10|||
19732323|NCT02962648|42177884|FG000|Overall Study|Withdrawal by Subject|3|||
19732324|NCT02962648|42177884|FG000|Overall Study|Lost to Follow-up|3|||
19732325|NCT02962648|42177884|FG000|Overall Study|Physician Decision|1|||
19732326|NCT02962648|42177884|FG000|Overall Study|Subject had problems with transportation|2|||
19732327|NCT02962882|42177888|FG000|Overall Study|Adverse Event|2|||
19732328|NCT02962882|42177888|FG000|Overall Study|Withdrawal by Subject|2|||
19732329|NCT02962882|42177888|FG000|Overall Study|Transfer from ICU|32|||
19732330|NCT02961790|42177897|FG000|Overall Study|Canceled|4|||
19732331|NCT02961790|42177898|FG001|Overall Study|Canceled|5|||
19732332|NCT02961790|42177899|FG002|Overall Study|Canceled|1|||
19732333|NCT02961790|42177900|FG003|Overall Study|Canceled|4|||
19732334|NCT02961790|42177897|FG000|Overall Study|without baseline data|4|||
19732335|NCT02961790|42177898|FG001|Overall Study|without baseline data|0|||
19732336|NCT02961790|42177899|FG002|Overall Study|without baseline data|1|||
19732337|NCT02961790|42177900|FG003|Overall Study|without baseline data|0|||
19732338|NCT02961790|42177897|FG000|Overall Study|without post baseline data|7|||
19732339|NCT02961790|42177898|FG001|Overall Study|without post baseline data|6|||
19732340|NCT02961790|42177899|FG002|Overall Study|without post baseline data|4|||
19732341|NCT02961790|42177900|FG003|Overall Study|without post baseline data|1|||
19732342|NCT02960854|42177922|FG000|Overall Study|Not Disclosed|2|||
19732343|NCT02960854|42177923|FG001|Overall Study|Not Disclosed|2|||
19732344|NCT02960854|42177922|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
19732345|NCT02960854|42177923|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
19732346|NCT02960854|42177922|FG000|Overall Study|Subject Withdrew Consent|0|||
19732347|NCT02960854|42177923|FG001|Overall Study|Subject Withdrew Consent|1|||
19732348|NCT02960854|42177922|FG000|Overall Study|Death|4|||
19732349|NCT02960854|42177923|FG001|Overall Study|Death|6|||
19732350|NCT01344538|42177931|FG000|Overall Study|Adverse Event|1|||
19732351|NCT01344538|42177932|FG001|Overall Study|Adverse Event|1|||
19732352|NCT01344538|42177931|FG000|Overall Study|Lost to Follow-up|1|||
19732353|NCT01344538|42177932|FG001|Overall Study|Lost to Follow-up|0|||
19732354|NCT01344460|42177938|FG000|Overall Study|Withdrawal by Subject|1|||
19732355|NCT01344460|42177938|FG000|Overall Study|Lost to Follow-up|2|||
19732356|NCT03764631|42177948|FG000|Overall Study|Personal Reasons|3|||
19732357|NCT03764631|42177949|FG001|Overall Study|Personal Reasons|2|||
19732358|NCT03764631|42177948|FG000|Overall Study|Switching Therapy|3|||
19732359|NCT03764631|42177949|FG001|Overall Study|Switching Therapy|3|||
19732360|NCT03764631|42177948|FG000|Overall Study|Adverse Event|0|||
19732361|NCT03764631|42177949|FG001|Overall Study|Adverse Event|1|||
19732362|NCT03764631|42177948|FG000|Overall Study|Lost to Follow-up|33|||
19732363|NCT03764631|42177949|FG001|Overall Study|Lost to Follow-up|41|||
19732364|NCT03764631|42177948|FG000|Overall Study|No data as study site was closed|2|||
19732365|NCT03764631|42177949|FG001|Overall Study|No data as study site was closed|6|||
19732366|NCT02956486|42177968|FG000|Core Phase|Adverse Event|51|||
19732367|NCT02956486|42177969|FG001|Core Phase|Adverse Event|88|||
19732368|NCT02956486|42177970|FG002|Core Phase|Adverse Event|0|||
19732369|NCT02956486|42177968|FG000|Core Phase|Lost to Follow-up|8|||
19732370|NCT02956486|42177969|FG001|Core Phase|Lost to Follow-up|6|||
19732371|NCT02956486|42177970|FG002|Core Phase|Lost to Follow-up|0|||
19732372|NCT02956486|42177968|FG000|Core Phase|Inadequate therapeutic effect|4|||
19732373|NCT02956486|42177969|FG001|Core Phase|Inadequate therapeutic effect|5|||
19732374|NCT02956486|42177970|FG002|Core Phase|Inadequate therapeutic effect|0|||
19732375|NCT02956486|42177968|FG000|Core Phase|Withdrawal by Subject|101|||
19732376|NCT02956486|42177969|FG001|Core Phase|Withdrawal by Subject|104|||
19732377|NCT02956486|42177970|FG002|Core Phase|Withdrawal by Subject|0|||
19732378|NCT02956486|42177968|FG000|Core Phase|Study terminated by sponsor|888|||
19732379|NCT02956486|42177969|FG001|Core Phase|Study terminated by sponsor|848|||
19732380|NCT02956486|42177970|FG002|Core Phase|Study terminated by sponsor|0|||
19732381|NCT02956486|42177968|FG000|Core Phase|Other|27|||
19732382|NCT02956486|42177969|FG001|Core Phase|Other|18|||
19732383|NCT02956486|42177970|FG002|Core Phase|Other|0|||
19732384|NCT02956486|42177968|FG000|Core Phase|Not treated|0|||
19732385|NCT02956486|42177969|FG001|Core Phase|Not treated|3|||
19732386|NCT02956486|42177970|FG002|Core Phase|Not treated|0|||
19732387|NCT02956486|42177968|FG000|Extension Phase|Adverse Event|0|||
19732388|NCT02956486|42177969|FG001|Extension Phase|Adverse Event|0|||
19732389|NCT02956486|42177970|FG002|Extension Phase|Adverse Event|2|||
19732390|NCT02956486|42177968|FG000|Extension Phase|Study terminated by sponsor|0|||
19732391|NCT02956486|42177969|FG001|Extension Phase|Study terminated by sponsor|0|||
19732392|NCT02956486|42177970|FG002|Extension Phase|Study terminated by sponsor|16|||
19732393|NCT02956486|42177968|FG000|Extension Phase|Not Treated|0|||
19732394|NCT02956486|42177969|FG001|Extension Phase|Not Treated|0|||
19732395|NCT02956486|42177970|FG002|Extension Phase|Not Treated|1|||
19732396|NCT03445533|42177985|FG000|Overall Study|Progressive Disease|48|||
19732397|NCT03445533|42177986|FG001|Overall Study|Progressive Disease|81|||
19732398|NCT03445533|42177985|FG000|Overall Study|Adverse Event|60|||
19732399|NCT03445533|42177986|FG001|Overall Study|Adverse Event|64|||
19732400|NCT03445533|42177985|FG000|Overall Study|Death|9|||
19732401|NCT03445533|42177986|FG001|Overall Study|Death|19|||
19732402|NCT03445533|42177985|FG000|Overall Study|Miscellaneous|0|||
19732403|NCT03445533|42177986|FG001|Overall Study|Miscellaneous|16|||
19732404|NCT03445533|42177985|FG000|Overall Study|Withdrawal by Subject|3|||
19732405|NCT03445533|42177986|FG001|Overall Study|Withdrawal by Subject|4|||
19732406|NCT03445533|42177985|FG000|Overall Study|Physician Decision|1|||
19732407|NCT03445533|42177986|FG001|Overall Study|Physician Decision|3|||
19732408|NCT03445533|42177985|FG000|Overall Study|Sponsor Decision|0|||
19732409|NCT03445533|42177986|FG001|Overall Study|Sponsor Decision|1|||
19732410|NCT03445533|42177985|FG000|Overall Study|Lost to Follow-up|0|||
19732411|NCT03445533|42177986|FG001|Overall Study|Lost to Follow-up|1|||
19732412|NCT03445533|42177985|FG000|Overall Study|Never Received any Study Treatment|7|||
19732413|NCT03445533|42177986|FG001|Overall Study|Never Received any Study Treatment|4|||
19732414|NCT01337050|42177995|FG000|Overall Study|Death|0|||
19732415|NCT01337050|42177996|FG001|Overall Study|Death|0|||
19732416|NCT01337050|42177997|FG002|Overall Study|Death|4|||
19732417|NCT01337050|42177995|FG000|Overall Study|Other|4|||
19732418|NCT01337050|42177996|FG001|Overall Study|Other|6|||
19732419|NCT01337050|42177997|FG002|Overall Study|Other|8|||
19732420|NCT01337050|42177995|FG000|Overall Study|Participants refused further follow-up|0|||
19732421|NCT01337050|42177996|FG001|Overall Study|Participants refused further follow-up|7|||
19732422|NCT01337050|42177997|FG002|Overall Study|Participants refused further follow-up|7|||
19732423|NCT01336972|42178009|FG000|Overall Study|Adverse Event|1|||
19732424|NCT01336972|42178010|FG001|Overall Study|Adverse Event|1|||
19732425|NCT01336972|42178011|FG002|Overall Study|Adverse Event|0|||
19732426|NCT03762681|42178028|FG000|Part 1|Withdrawal by Subject|0|||
19732427|NCT03762681|42178029|FG001|Part 1|Withdrawal by Subject|0|||
19732428|NCT03762681|42178030|FG002|Part 1|Withdrawal by Subject|0|||
19732429|NCT03762681|42178031|FG003|Part 1|Withdrawal by Subject|1|||
19732430|NCT03762681|42178032|FG004|Part 1|Withdrawal by Subject|0|||
19732431|NCT03762681|42178033|FG005|Part 1|Withdrawal by Subject|0|||
19732432|NCT03762681|42178034|FG006|Part 1|Withdrawal by Subject|0|||
19732433|NCT03762681|42178035|FG007|Part 1|Withdrawal by Subject|0|||
19732434|NCT03762681|42178028|FG000|Part 2a|Pandemic Travel Restrictions|0|||
19732435|NCT03762681|42178029|FG001|Part 2a|Pandemic Travel Restrictions|0|||
19732436|NCT03762681|42178030|FG002|Part 2a|Pandemic Travel Restrictions|0|||
19732437|NCT03762681|42178031|FG003|Part 2a|Pandemic Travel Restrictions|0|||
19732438|NCT03762681|42178032|FG004|Part 2a|Pandemic Travel Restrictions|0|||
19732439|NCT03762681|42178033|FG005|Part 2a|Pandemic Travel Restrictions|0|||
19732440|NCT03762681|42178034|FG006|Part 2a|Pandemic Travel Restrictions|0|||
19732441|NCT03762681|42178035|FG007|Part 2a|Pandemic Travel Restrictions|1|||
19732442|NCT03764475|42178064|FG000|Overall Study|Adverse Event|11|||
19732443|NCT03764475|42178065|FG001|Overall Study|Adverse Event|2|||
19732444|NCT03764475|42178064|FG000|Overall Study|Lost to Follow-up|24|||
19732445|NCT03764475|42178065|FG001|Overall Study|Lost to Follow-up|10|||
19732446|NCT03764475|42178064|FG000|Overall Study|Withdrawal by Subject|26|||
19732447|NCT03764475|42178065|FG001|Overall Study|Withdrawal by Subject|10|||
19732448|NCT03764475|42178064|FG000|Overall Study|Lack of Efficacy|3|||
19732449|NCT03764475|42178065|FG001|Overall Study|Lack of Efficacy|0|||
19732450|NCT03764475|42178064|FG000|Overall Study|COVID-19 Disruption|2|||
19732451|NCT03764475|42178065|FG001|Overall Study|COVID-19 Disruption|0|||
19732452|NCT03370276|42178078|FG000|Overall Study|Death|0|||
19732453|NCT03370276|42178079|FG001|Overall Study|Death|2|||
19732454|NCT03370276|42178080|FG002|Overall Study|Death|5|||
19732455|NCT02873338|42178091|FG000|Overall Study|Adverse Event|0|||
19732456|NCT02873338|42178092|FG001|Overall Study|Adverse Event|2|||
19732457|NCT02873338|42178093|FG002|Overall Study|Adverse Event|1|||
19732458|NCT02873338|42178091|FG000|Overall Study|Death|2|||
19732459|NCT02873338|42178092|FG001|Overall Study|Death|1|||
19732460|NCT02873338|42178093|FG002|Overall Study|Death|1|||
19732461|NCT02873338|42178091|FG000|Overall Study|Withdrawal by Subject|2|||
19732462|NCT02873338|42178092|FG001|Overall Study|Withdrawal by Subject|1|||
19732463|NCT02873338|42178093|FG002|Overall Study|Withdrawal by Subject|3|||
19732464|NCT02873338|42178091|FG000|Overall Study|Lack of Efficacy|0|||
19732465|NCT02873338|42178092|FG001|Overall Study|Lack of Efficacy|2|||
19732466|NCT02873338|42178093|FG002|Overall Study|Lack of Efficacy|0|||
19732467|NCT02873338|42178091|FG000|Overall Study|Other or Missing|14|||
19732468|NCT02873338|42178092|FG001|Overall Study|Other or Missing|15|||
19732469|NCT02873338|42178093|FG002|Overall Study|Other or Missing|13|||
19732470|NCT02872012|42178106|FG000|Overall Study|Withdrawal by Subject|1|||
19732471|NCT02872012|42178107|FG001|Overall Study|Withdrawal by Subject|0|||
19732472|NCT02872012|42178108|FG002|Overall Study|Withdrawal by Subject|0|||
19732473|NCT02872012|42178109|FG003|Overall Study|Withdrawal by Subject|0|||
19732474|NCT02872012|42178110|FG004|Overall Study|Withdrawal by Subject|0|||
19732475|NCT02959138|42178127|FG000|Overall Study|Enrolled but Never Treated|0|||
19732476|NCT02959138|42178128|FG001|Overall Study|Enrolled but Never Treated|1|||
19732477|NCT02959138|42178129|FG002|Overall Study|Enrolled but Never Treated|0|||
19732478|NCT01344226|42178141|FG000|Overall Study|Protocol Violation|2|||
19732479|NCT01344226|42178141|FG000|Overall Study|Withdrawal by Subject|3|||
19732480|NCT01344226|42178141|FG000|Overall Study|Lack of Efficacy|3|||
19732481|NCT02869438|42178147|FG000|Overall Study|Lost to Follow-up|1|||
19732482|NCT02869438|42178148|FG001|Overall Study|Lost to Follow-up|0|||
19732483|NCT02869438|42178147|FG000|Overall Study|Adverse Event|1|||
19732484|NCT02869438|42178148|FG001|Overall Study|Adverse Event|0|||
19732485|NCT02869438|42178147|FG000|Overall Study|Withdrawal by Subject|1|||
19732486|NCT02869438|42178148|FG001|Overall Study|Withdrawal by Subject|2|||
19732487|NCT02868892|42178154|FG000|Overall Study|Investigator left site and no follow-up|6|||
19732488|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Death|1|||
19732489|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Death|1|||
19732490|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Death|0|||
19732491|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Death|0|||
19732492|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Death|1|||
19732493|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Death|0|||
19732494|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Death|0|||
19732495|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Death|0|||
19732496|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Death|0|||
19732497|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Death|0|||
19732498|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
19732499|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
19732500|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
19732501|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732502|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
19732503|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732504|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732505|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732506|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732507|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
19732508|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732509|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732510|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732511|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732512|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
19732513|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732514|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732515|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732516|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732517|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
19732518|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
19732519|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732520|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732521|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732522|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732523|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732524|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732525|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732526|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732527|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
19732528|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
19732529|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732530|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732531|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
19732532|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
19732533|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19465267|NCT04426695|41723743|FG002|Overall Study|Sponsor Request|0|||
19732534|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732535|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732536|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732537|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
19732538|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
19732539|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732540|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732541|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
19732542|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732543|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732544|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732545|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732546|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732547|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
19732548|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
19732549|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
19732550|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
19732551|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
19732552|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
19732553|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
19732554|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
19732555|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
19732556|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
19732557|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
19732558|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
19732559|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
19732560|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
19732561|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732562|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
19732563|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732564|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732565|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732566|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732567|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732568|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
19732569|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732570|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732571|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
19732572|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
19732573|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732574|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732575|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732576|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732577|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
19732578|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732579|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732580|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732581|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732582|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732583|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732584|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732585|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732586|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732587|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732588|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732589|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19799375|NCT02873221|42257357|FG002|Treatment Period|Lost to Follow-up|26|||
19465268|NCT04426695|41723744|FG003|Overall Study|Sponsor Request|0|||
19732590|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
19732591|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732592|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
19551291|NCT01346969|42000113|FG001|Overall Study|Randomized but not treated|0|||
19551292|NCT01346969|42000114|FG002|Overall Study|Randomized but not treated|0|||
19551293|NCT01346969|42000115|FG003|Overall Study|Randomized but not treated|0|||
19732593|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732594|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732595|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732596|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732597|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732598|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
19732599|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
19732600|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
19732601|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
19732602|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
19732603|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
19732604|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
19732605|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
19732606|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
19732607|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
19732608|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732609|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732610|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732611|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
19732612|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
19732613|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732614|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732615|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732616|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732617|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732618|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
19732619|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732620|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
19732621|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
19732622|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
19732623|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732624|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732625|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732626|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732627|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732628|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
19732629|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732630|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732631|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732632|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
19732633|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732634|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732635|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732636|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732637|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
19732638|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732639|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732640|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732641|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732642|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
19732643|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732644|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732645|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732646|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732647|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732648|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732649|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
19732650|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732651|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732652|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
19732653|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732654|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732655|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732656|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732657|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
19732658|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
19732659|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732660|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732661|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732662|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
19732663|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732664|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732665|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732666|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732667|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
19732668|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
19732669|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732670|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
19732671|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732672|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
19732673|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732674|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732675|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732676|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732677|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
19732678|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Other|5|||
19732679|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Other|1|||
19732680|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Other|0|||
19732681|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Other|3|||
19732682|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Other|0|||
19732683|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Other|0|||
19732684|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Other|0|||
19732685|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Other|0|||
19732686|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Other|0|||
19732687|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Other|0|||
19732688|NCT03352557|42178163|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732689|NCT03352557|42178164|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732690|NCT03352557|42178165|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732691|NCT03352557|42178166|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
19380858|NCT01559363|41624059|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
19380859|NCT01559363|41624060|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
19380860|NCT01559363|41624061|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
19380861|NCT01559363|41624056|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
19732692|NCT03352557|42178167|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
19732693|NCT03352557|42178168|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732694|NCT03352557|42178169|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732695|NCT03352557|42178170|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732696|NCT03352557|42178171|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732697|NCT03352557|42178172|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
19732698|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Death|0|||
19732699|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Death|0|||
19732700|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Death|0|||
19732701|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Death|0|||
19732702|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Death|0|||
19732703|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Death|1|||
19732704|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Death|0|||
19732705|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Death|1|||
19732706|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Death|1|||
19732707|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Death|1|||
19732708|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732709|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732710|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732711|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732712|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732713|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
19732714|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732715|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732716|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732717|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
19732718|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732719|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732720|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732721|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732722|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732723|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732724|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732725|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732726|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
19732727|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
19732728|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
19732729|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
19732730|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
19732731|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
19732732|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
19732733|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
19732734|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
19380862|NCT01559363|41624057|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
19380863|NCT01559363|41624058|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
19380864|NCT01559363|41624059|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
19380865|NCT01559363|41624060|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
19380866|NCT01559363|41624061|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
19380867|NCT01559363|41624056|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
19380868|NCT01559363|41624057|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
19380869|NCT01559363|41624058|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
19380870|NCT01559363|41624059|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
19380871|NCT01559363|41624060|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
19380872|NCT01559363|41624061|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
19380873|NCT02732327|41624083|FG000|Overall Study|Protocol Violation|0|||
19380874|NCT02732327|41624084|FG001|Overall Study|Protocol Violation|1|||
19380875|NCT03179605|41624090|FG000|Overall Study|Withdrawal by Subject|1|||
19732735|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
19732736|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
19732737|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
19732738|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732739|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732740|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732741|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732742|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732743|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
19732744|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
19732745|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
19732746|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
19732747|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
19732748|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732749|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732750|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732751|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732752|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732753|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732754|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732755|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732756|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
19732757|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
19732758|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732759|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732760|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732761|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732762|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732763|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
19732764|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
19732765|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
19732766|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
19732767|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
19732768|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732769|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732770|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732771|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732772|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732773|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732774|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732775|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
19732776|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
19732777|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
19732778|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732779|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732780|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732781|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732782|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732783|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732784|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732785|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
19732786|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19732787|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
19799376|NCT02873221|42257355|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
19732788|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732789|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732790|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732791|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732792|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732793|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732794|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732795|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
19732796|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732797|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
19732798|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732799|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732800|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732801|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732802|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732803|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732804|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732805|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
19732806|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
19732807|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
19732808|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732809|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732810|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732811|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732812|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732813|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
19732814|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732815|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732816|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
19732817|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
19732818|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732819|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732820|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732821|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732822|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732823|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732824|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732825|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732826|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
19732827|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
19732828|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732829|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732830|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732831|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732832|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732833|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732834|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732835|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
19732836|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
19732837|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
19732838|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732839|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732840|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732841|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732842|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732843|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732844|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732845|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
19732846|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
19732847|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
19732848|NCT03352557|42178163|FG000|LTE Period: Week 80 to Week 173|Other|0|||
19732849|NCT03352557|42178164|FG001|LTE Period: Week 80 to Week 173|Other|0|||
19732850|NCT03352557|42178165|FG002|LTE Period: Week 80 to Week 173|Other|0|||
19732851|NCT03352557|42178166|FG003|LTE Period: Week 80 to Week 173|Other|0|||
19732852|NCT03352557|42178167|FG004|LTE Period: Week 80 to Week 173|Other|0|||
19732853|NCT03352557|42178168|FG005|LTE Period: Week 80 to Week 173|Other|0|||
19732854|NCT03352557|42178169|FG006|LTE Period: Week 80 to Week 173|Other|0|||
19732855|NCT03352557|42178170|FG007|LTE Period: Week 80 to Week 173|Other|1|||
19732856|NCT03352557|42178171|FG008|LTE Period: Week 80 to Week 173|Other|0|||
19732857|NCT03352557|42178172|FG009|LTE Period: Week 80 to Week 173|Other|0|||
19732858|NCT02866942|42178197|FG000|Overall Study|Invalid consent|1|||
19732859|NCT02908672|42178251|FG000|Overall Study|Death|112|||
19732860|NCT02908672|42178252|FG001|Overall Study|Death|93|||
19732861|NCT02908672|42178251|FG000|Overall Study|Lost to Follow-up|3|||
19732862|NCT02908672|42178252|FG001|Overall Study|Lost to Follow-up|3|||
19732863|NCT02908672|42178251|FG000|Overall Study|Other|2|||
19732864|NCT02908672|42178252|FG001|Overall Study|Other|0|||
19732865|NCT02908672|42178251|FG000|Overall Study|Protocol Violation|1|||
19732866|NCT02908672|42178252|FG001|Overall Study|Protocol Violation|1|||
19732867|NCT02908672|42178251|FG000|Overall Study|Withdrawal by Subject|13|||
19732868|NCT02908672|42178252|FG001|Overall Study|Withdrawal by Subject|18|||
19732869|NCT02908672|42178251|FG000|Overall Study|Study is ongoing|124|||
19732870|NCT02908672|42178252|FG001|Overall Study|Study is ongoing|141|||
19732871|NCT02908672|42178251|FG000|Overall Study|Discontinued the study during run-in|3|||
19732872|NCT02908672|42178252|FG001|Overall Study|Discontinued the study during run-in|0|||
19732873|NCT01336894|42178260|FG000|Follow-up|Study terminated prematurely|2|||
19732874|NCT01336894|42178261|FG001|Follow-up|Study terminated prematurely|7|||
19732875|NCT02572167|42178270|FG000|Overall Study|Withdrawal by Subject|0|||
19732876|NCT02572167|42178271|FG001|Overall Study|Withdrawal by Subject|3|||
19732877|NCT02572167|42178272|FG002|Overall Study|Withdrawal by Subject|0|||
19732878|NCT02572167|42178270|FG000|Overall Study|Lost to Follow-up|2|||
19732879|NCT02572167|42178271|FG001|Overall Study|Lost to Follow-up|5|||
19732880|NCT02572167|42178272|FG002|Overall Study|Lost to Follow-up|3|||
19732881|NCT02572167|42178270|FG000|Overall Study|Death|0|||
19732882|NCT02572167|42178271|FG001|Overall Study|Death|8|||
19732883|NCT02572167|42178272|FG002|Overall Study|Death|3|||
19732884|NCT02572167|42178270|FG000|Overall Study|Did not meet inclusion criteria|0|||
19732885|NCT02572167|42178271|FG001|Overall Study|Did not meet inclusion criteria|0|||
19732886|NCT02572167|42178272|FG002|Overall Study|Did not meet inclusion criteria|1|||
19732887|NCT02572167|42178270|FG000|Overall Study|Study closure by Sponsor|4|||
19732888|NCT02572167|42178271|FG001|Overall Study|Study closure by Sponsor|40|||
19732889|NCT02572167|42178272|FG002|Overall Study|Study closure by Sponsor|24|||
19732890|NCT01336738|42178286|FG000|Overall Study|Adverse Event|0|||
19732891|NCT01336738|42178287|FG001|Overall Study|Adverse Event|3|||
19732892|NCT01336738|42178288|FG002|Overall Study|Adverse Event|2|||
19732893|NCT01336738|42178289|FG003|Overall Study|Adverse Event|1|||
19732894|NCT01336738|42178290|FG004|Overall Study|Adverse Event|3|||
19732895|NCT01336738|42178286|FG000|Overall Study|Lost to Follow-up|2|||
19732896|NCT01336738|42178287|FG001|Overall Study|Lost to Follow-up|1|||
19732897|NCT01336738|42178288|FG002|Overall Study|Lost to Follow-up|2|||
19732898|NCT01336738|42178289|FG003|Overall Study|Lost to Follow-up|2|||
19732899|NCT01336738|42178290|FG004|Overall Study|Lost to Follow-up|2|||
19732900|NCT01336738|42178286|FG000|Overall Study|Did not meet entrance criteria|0|||
19732901|NCT01336738|42178287|FG001|Overall Study|Did not meet entrance criteria|1|||
19732902|NCT01336738|42178288|FG002|Overall Study|Did not meet entrance criteria|0|||
19732903|NCT01336738|42178289|FG003|Overall Study|Did not meet entrance criteria|0|||
19732904|NCT01336738|42178290|FG004|Overall Study|Did not meet entrance criteria|0|||
19732905|NCT01336738|42178286|FG000|Overall Study|Protocol Violation|0|||
19732906|NCT01336738|42178287|FG001|Overall Study|Protocol Violation|1|||
19732907|NCT01336738|42178288|FG002|Overall Study|Protocol Violation|0|||
19732908|NCT01336738|42178289|FG003|Overall Study|Protocol Violation|0|||
19732909|NCT01336738|42178290|FG004|Overall Study|Protocol Violation|0|||
19732910|NCT01336738|42178286|FG000|Overall Study|Withdrawal by Subject|2|||
19732911|NCT01336738|42178287|FG001|Overall Study|Withdrawal by Subject|0|||
19732912|NCT01336738|42178288|FG002|Overall Study|Withdrawal by Subject|2|||
19732913|NCT01336738|42178289|FG003|Overall Study|Withdrawal by Subject|1|||
19732914|NCT01336738|42178290|FG004|Overall Study|Withdrawal by Subject|1|||
19732915|NCT01336738|42178286|FG000|Overall Study|Other|3|||
19732916|NCT01336738|42178287|FG001|Overall Study|Other|3|||
19732917|NCT01336738|42178288|FG002|Overall Study|Other|2|||
19732918|NCT01336738|42178289|FG003|Overall Study|Other|3|||
19732919|NCT01336738|42178290|FG004|Overall Study|Other|4|||
19732920|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
19732921|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
19732922|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
19732923|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
19732924|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
19732925|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
19732926|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
19732927|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
19732928|NCT02258451|42178304|FG000|Overall Study|Death|4|||
19732929|NCT02258451|42178305|FG001|Overall Study|Death|3|||
19732930|NCT02258451|42178304|FG000|Overall Study|Withdrawal by Subject|21|||
19732931|NCT02258451|42178305|FG001|Overall Study|Withdrawal by Subject|12|||
19732932|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
19732933|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
19732934|NCT02258451|42178304|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
19732935|NCT02258451|42178305|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
19732936|NCT02258451|42178304|FG000|Overall Study|Physician Decision|0|||
19732937|NCT02258451|42178305|FG001|Overall Study|Physician Decision|2|||
19732938|NCT02258451|42178304|FG000|Overall Study|Never treated|2|||
19732939|NCT02258451|42178305|FG001|Overall Study|Never treated|3|||
19732940|NCT02258451|42178304|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
19732941|NCT02258451|42178305|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
19732942|NCT02865538|42178318|FG000|Overall Study|Withdrawal by Subject|0|||
19732943|NCT02865538|42178319|FG001|Overall Study|Withdrawal by Subject|0|||
19732944|NCT02865538|42178320|FG002|Overall Study|Withdrawal by Subject|1|||
19732945|NCT02865538|42178321|FG003|Overall Study|Withdrawal by Subject|0|||
19732946|NCT02865538|42178322|FG004|Overall Study|Withdrawal by Subject|0|||
19732947|NCT02865538|42178318|FG000|Overall Study|Lost to Follow-up|1|||
19732948|NCT02865538|42178319|FG001|Overall Study|Lost to Follow-up|0|||
19732949|NCT02865538|42178320|FG002|Overall Study|Lost to Follow-up|0|||
19732950|NCT02865538|42178321|FG003|Overall Study|Lost to Follow-up|0|||
19732951|NCT02865538|42178322|FG004|Overall Study|Lost to Follow-up|0|||
19732952|NCT02860546|42178334|FG000|Overall Study|Clinical Progression|6|||
19732953|NCT02860546|42178334|FG000|Overall Study|Radiological Progression|12|||
19732954|NCT01982955|42178343|FG000|Overall Study|Randomized but not treated|0|||
19732955|NCT01982955|42178344|FG001|Overall Study|Randomized but not treated|0|||
19732956|NCT01982955|42178345|FG002|Overall Study|Randomized but not treated|0|||
19732957|NCT01982955|42178346|FG003|Overall Study|Randomized but not treated|1|||
19732958|NCT01982955|42178347|FG004|Overall Study|Randomized but not treated|0|||
19732959|NCT00396279|42178360|FG000|Overall Study|Ongoing in study|26|||
19732960|NCT00396279|42178360|FG000|Overall Study|Disease progression|2|||
19732961|NCT00396279|42178360|FG000|Overall Study|Withdrawal by Subject|1|||
19732962|NCT00396279|42178360|FG000|Overall Study|Physician Decision|1|||
19732963|NCT01347866|42178381|FG000|Overall Study|Death|0|||
19732964|NCT01347866|42178382|FG001|Overall Study|Death|0|||
19732965|NCT01347866|42178383|FG002|Overall Study|Death|0|||
19732966|NCT01347866|42178384|FG003|Overall Study|Death|1|||
19732967|NCT01347866|42178385|FG004|Overall Study|Death|2|||
19732968|NCT01347866|42178386|FG005|Overall Study|Death|2|||
19732969|NCT01347866|42178387|FG006|Overall Study|Death|1|||
19732970|NCT01347866|42178388|FG007|Overall Study|Death|0|||
19732971|NCT01347866|42178389|FG008|Overall Study|Death|4|||
19732972|NCT01347866|42178390|FG009|Overall Study|Death|1|||
19732973|NCT01347866|42178391|FG010|Overall Study|Death|3|||
19732974|NCT01347866|42178392|FG011|Overall Study|Death|1|||
19732975|NCT01347866|42178393|FG012|Overall Study|Death|2|||
19732976|NCT01347866|42178394|FG013|Overall Study|Death|0|||
19732977|NCT01347866|42178395|FG014|Overall Study|Death|0|||
19732978|NCT01347866|42178396|FG015|Overall Study|Death|1|||
19732979|NCT01347866|42178397|FG016|Overall Study|Death|0|||
19732980|NCT01347866|42178381|FG000|Overall Study|Lost to Follow-up|0|||
19732981|NCT01347866|42178382|FG001|Overall Study|Lost to Follow-up|0|||
19732982|NCT01347866|42178383|FG002|Overall Study|Lost to Follow-up|0|||
19732983|NCT01347866|42178384|FG003|Overall Study|Lost to Follow-up|0|||
19732984|NCT01347866|42178385|FG004|Overall Study|Lost to Follow-up|0|||
19732985|NCT01347866|42178386|FG005|Overall Study|Lost to Follow-up|0|||
19732986|NCT01347866|42178387|FG006|Overall Study|Lost to Follow-up|0|||
19732987|NCT01347866|42178388|FG007|Overall Study|Lost to Follow-up|1|||
19732988|NCT01347866|42178389|FG008|Overall Study|Lost to Follow-up|1|||
19732989|NCT01347866|42178390|FG009|Overall Study|Lost to Follow-up|0|||
19732990|NCT01347866|42178391|FG010|Overall Study|Lost to Follow-up|0|||
19732991|NCT01347866|42178392|FG011|Overall Study|Lost to Follow-up|0|||
19732992|NCT01347866|42178393|FG012|Overall Study|Lost to Follow-up|0|||
19732993|NCT01347866|42178394|FG013|Overall Study|Lost to Follow-up|0|||
19732994|NCT01347866|42178395|FG014|Overall Study|Lost to Follow-up|0|||
19732995|NCT01347866|42178396|FG015|Overall Study|Lost to Follow-up|0|||
19551294|NCT01346774|42000127|FG000|Overall Study|Did not take a single dose|6|||
19732996|NCT01347866|42178397|FG016|Overall Study|Lost to Follow-up|0|||
19732997|NCT01347866|42178381|FG000|Overall Study|Other|3|||
19732998|NCT01347866|42178382|FG001|Overall Study|Other|1|||
19732999|NCT01347866|42178383|FG002|Overall Study|Other|1|||
19733000|NCT01347866|42178384|FG003|Overall Study|Other|4|||
19733001|NCT01347866|42178385|FG004|Overall Study|Other|5|||
19733002|NCT01347866|42178386|FG005|Overall Study|Other|0|||
19733003|NCT01347866|42178387|FG006|Overall Study|Other|5|||
19733004|NCT01347866|42178388|FG007|Overall Study|Other|3|||
19733005|NCT01347866|42178389|FG008|Overall Study|Other|22|||
19733006|NCT01347866|42178390|FG009|Overall Study|Other|5|||
19733007|NCT01347866|42178391|FG010|Overall Study|Other|0|||
19733008|NCT01347866|42178392|FG011|Overall Study|Other|3|||
19733009|NCT01347866|42178393|FG012|Overall Study|Other|4|||
19733010|NCT01347866|42178394|FG013|Overall Study|Other|4|||
19733011|NCT01347866|42178395|FG014|Overall Study|Other|2|||
19733012|NCT01347866|42178396|FG015|Overall Study|Other|3|||
19733013|NCT01347866|42178397|FG016|Overall Study|Other|0|||
19733014|NCT01347866|42178381|FG000|Overall Study|Subject refused further follow-up|2|||
19733015|NCT01347866|42178382|FG001|Overall Study|Subject refused further follow-up|0|||
19733016|NCT01347866|42178383|FG002|Overall Study|Subject refused further follow-up|0|||
19733017|NCT01347866|42178384|FG003|Overall Study|Subject refused further follow-up|2|||
19733018|NCT01347866|42178385|FG004|Overall Study|Subject refused further follow-up|0|||
19733019|NCT01347866|42178386|FG005|Overall Study|Subject refused further follow-up|1|||
19733020|NCT01347866|42178387|FG006|Overall Study|Subject refused further follow-up|0|||
19733021|NCT01347866|42178388|FG007|Overall Study|Subject refused further follow-up|0|||
19733022|NCT01347866|42178389|FG008|Overall Study|Subject refused further follow-up|4|||
19733023|NCT01347866|42178390|FG009|Overall Study|Subject refused further follow-up|1|||
19733024|NCT01347866|42178391|FG010|Overall Study|Subject refused further follow-up|0|||
19733025|NCT01347866|42178392|FG011|Overall Study|Subject refused further follow-up|0|||
19733026|NCT01347866|42178393|FG012|Overall Study|Subject refused further follow-up|1|||
19733027|NCT01347866|42178394|FG013|Overall Study|Subject refused further follow-up|3|||
19733028|NCT01347866|42178395|FG014|Overall Study|Subject refused further follow-up|1|||
19733029|NCT01347866|42178396|FG015|Overall Study|Subject refused further follow-up|0|||
19733030|NCT01347866|42178397|FG016|Overall Study|Subject refused further follow-up|2|||
19733031|NCT01347710|42178468|FG000|Overall Study|Withdrawal by Subject|2|||
19733032|NCT01347710|42178468|FG000|Overall Study|Adverse Event|4|||
19733033|NCT01347710|42178468|FG000|Overall Study|Angio or SPECT not completed|18|||
19733034|NCT01347710|42178468|FG000|Overall Study|issue with vitals prior to dosing|1|||
19733035|NCT01347710|42178468|FG000|Overall Study|Lost to Follow-up|1|||
19733036|NCT01347710|42178468|FG000|Overall Study|Physician Decision|2|||
19733037|NCT01347710|42178468|FG000|Overall Study|Other|3|||
19733038|NCT03485222|42178478|FG000|Overall Study|Death|0|||
19733039|NCT03485222|42178479|FG001|Overall Study|Death|1|||
19733040|NCT03485222|42178478|FG000|Overall Study|Lost to Follow-up|2|||
19733041|NCT03485222|42178479|FG001|Overall Study|Lost to Follow-up|1|||
19733042|NCT01347554|42178487|FG000|Overall Study|Lack of Efficacy|7|||
19733043|NCT01347554|42178488|FG001|Overall Study|Lack of Efficacy|11|||
19733044|NCT03482882|42178494|FG000|Overall Study|Adverse Event|3|||
19733045|NCT03482882|42178494|FG000|Overall Study|Lost to Follow-up|1|||
19733046|NCT03482882|42178494|FG000|Overall Study|Protocol Violation|2|||
19733047|NCT03482882|42178494|FG000|Overall Study|Not further specified|1|||
19733048|NCT03480932|42178501|FG000|Overall Study|Death|1|||
19733049|NCT03480932|42178502|FG001|Overall Study|Death|1|||
19733050|NCT03480932|42178503|FG002|Overall Study|Death|0|||
19733051|NCT03480932|42178501|FG000|Overall Study|Lost to Follow-up|0|||
19733052|NCT03480932|42178502|FG001|Overall Study|Lost to Follow-up|2|||
19733053|NCT03480932|42178503|FG002|Overall Study|Lost to Follow-up|3|||
19733054|NCT03480932|42178501|FG000|Overall Study|Incarcerated|2|||
19733055|NCT03480932|42178502|FG001|Overall Study|Incarcerated|2|||
19733056|NCT03480932|42178503|FG002|Overall Study|Incarcerated|2|||
19733057|NCT03387020|42178514|FG000|Overall Study|Adverse Event|0|||
19733058|NCT03387020|42178515|FG001|Overall Study|Adverse Event|2|||
19733059|NCT03387020|42178516|FG002|Overall Study|Adverse Event|0|||
19733060|NCT03387020|42178514|FG000|Overall Study|Withdrawal by Subject|2|||
19733061|NCT03387020|42178515|FG001|Overall Study|Withdrawal by Subject|0|||
19733062|NCT03387020|42178516|FG002|Overall Study|Withdrawal by Subject|0|||
19733063|NCT03386474|42178536|FG000|Overall Study|Death|1|||
19733064|NCT03386474|42178537|FG001|Overall Study|Death|0|||
19733065|NCT03386474|42178536|FG000|Overall Study|Adverse Event|0|||
19733066|NCT03386474|42178537|FG001|Overall Study|Adverse Event|1|||
19733067|NCT02446600|42178552|FG000|Overall Study|Never treated|20|||
19733068|NCT02446600|42178553|FG001|Overall Study|Never treated|2|||
19733069|NCT02446600|42178554|FG002|Overall Study|Never treated|6|||
19733070|NCT02446600|42178555|FG003|Overall Study|Never treated|0|||
19733071|NCT02446600|42178552|FG000|Overall Study|Withdrawal by Subject|19|||
19733072|NCT02446600|42178553|FG001|Overall Study|Withdrawal by Subject|5|||
19733073|NCT02446600|42178554|FG002|Overall Study|Withdrawal by Subject|17|||
19733074|NCT02446600|42178555|FG003|Overall Study|Withdrawal by Subject|0|||
19733075|NCT02446600|42178552|FG000|Overall Study|Ineligible|1|||
19733076|NCT02446600|42178553|FG001|Overall Study|Ineligible|4|||
19733077|NCT02446600|42178554|FG002|Overall Study|Ineligible|4|||
19733078|NCT02446600|42178555|FG003|Overall Study|Ineligible|1|||
19733079|NCT02446600|42178552|FG000|Overall Study|Duplicate Enrollment|0|||
19733080|NCT02446600|42178553|FG001|Overall Study|Duplicate Enrollment|1|||
19733081|NCT02446600|42178554|FG002|Overall Study|Duplicate Enrollment|0|||
19733082|NCT02446600|42178555|FG003|Overall Study|Duplicate Enrollment|0|||
19733083|NCT03405818|42178565|FG000|Overall Study|Withdrawal by Subject|4|||
19733084|NCT03405818|42178565|FG000|Overall Study|Lost to Follow-up|4|||
19733085|NCT03403634|42178569|FG000|Overall Study|Disease progression|3|||
19733086|NCT03403634|42178569|FG000|Overall Study|Did not meet eligibility criteria|4|||
19733087|NCT03403400|42178576|FG000|Overall Study|Lost to Follow-up|1|||
19733088|NCT03403400|42178577|FG001|Overall Study|Lost to Follow-up|0|||
19733089|NCT03403400|42178578|FG002|Overall Study|Lost to Follow-up|1|||
19733090|NCT03403400|42178576|FG000|Overall Study|Hospitalization|1|||
19733091|NCT03403400|42178577|FG001|Overall Study|Hospitalization|0|||
19733092|NCT03403400|42178578|FG002|Overall Study|Hospitalization|0|||
19733093|NCT03403400|42178576|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
19733094|NCT03403400|42178577|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
19733095|NCT03403400|42178578|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
19733096|NCT02863354|42178603|FG000|Year 1|Lost to Follow-up|1|||
19733097|NCT02863354|42178604|FG001|Year 1|Lost to Follow-up|1|||
19733098|NCT02863354|42178603|FG000|Year 1|Withdrawal by Subject|3|||
19733099|NCT02863354|42178604|FG001|Year 1|Withdrawal by Subject|0|||
19733100|NCT02863354|42178603|FG000|Year 1|Death|0|||
19733101|NCT02863354|42178604|FG001|Year 1|Death|1|||
19733102|NCT02863354|42178603|FG000|Year 2|Lost to Follow-up|2|||
19733103|NCT02863354|42178604|FG001|Year 2|Lost to Follow-up|2|||
19733104|NCT03480152|42178612|FG000|Phase I|Signed consent. Died before treatment.|1|||
19733105|NCT03480152|42178613|FG001|Phase I|Signed consent. Died before treatment.|0|||
19733106|NCT03480152|42178614|FG002|Phase I|Signed consent. Died before treatment.|0|||
19733107|NCT02859454|42178622|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
19733108|NCT02862730|42178629|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733109|NCT02862730|42178630|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733110|NCT02862730|42178631|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
19733111|NCT02862730|42178632|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733112|NCT02862730|42178633|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733113|NCT02862730|42178634|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733114|NCT02862730|42178635|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
19733115|NCT02862730|42178629|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
19733116|NCT02862730|42178630|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733117|NCT02862730|42178631|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733118|NCT02862730|42178632|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733119|NCT02862730|42178633|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733120|NCT02862730|42178634|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733121|NCT02862730|42178635|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
19733122|NCT02862730|42178629|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
19733123|NCT02862730|42178630|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
19733124|NCT02862730|42178631|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
19733125|NCT02862730|42178632|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
19733126|NCT02862730|42178633|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
19733127|NCT02862730|42178634|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
19733128|NCT02862730|42178635|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
19733129|NCT02862730|42178629|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19733130|NCT02862730|42178630|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19733131|NCT02862730|42178631|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19733132|NCT02862730|42178632|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
19733133|NCT02862730|42178633|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19380876|NCT02412722|41624100|FG000|Overall Study|Adverse Event|0|||
19380877|NCT02412722|41624101|FG001|Overall Study|Adverse Event|2|||
19380878|NCT02412722|41624102|FG002|Overall Study|Adverse Event|0|||
19380879|NCT02412722|41624103|FG003|Overall Study|Adverse Event|3|||
19380880|NCT02412722|41624104|FG004|Overall Study|Adverse Event|0|||
19380881|NCT02412722|41624105|FG005|Overall Study|Adverse Event|3|||
19380882|NCT02412722|41624100|FG000|Overall Study|Progressive Disease|6|||
19380883|NCT02412722|41624101|FG001|Overall Study|Progressive Disease|4|||
19380884|NCT02412722|41624102|FG002|Overall Study|Progressive Disease|4|||
19380885|NCT02412722|41624103|FG003|Overall Study|Progressive Disease|9|||
19380886|NCT02412722|41624104|FG004|Overall Study|Progressive Disease|3|||
19380887|NCT02412722|41624105|FG005|Overall Study|Progressive Disease|3|||
19380888|NCT02412722|41624100|FG000|Overall Study|Withdrawal by Subject|2|||
19733134|NCT02862730|42178634|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19733135|NCT02862730|42178635|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
19733136|NCT03402386|42178650|FG000|Overall Study|Adverse Event|3|||
19733137|NCT03402386|42178650|FG000|Overall Study|Physician Decision|1|||
19380889|NCT02412722|41624101|FG001|Overall Study|Withdrawal by Subject|0|||
19380890|NCT02412722|41624102|FG002|Overall Study|Withdrawal by Subject|1|||
19380891|NCT02412722|41624103|FG003|Overall Study|Withdrawal by Subject|2|||
19380892|NCT02412722|41624104|FG004|Overall Study|Withdrawal by Subject|1|||
19380893|NCT02412722|41624105|FG005|Overall Study|Withdrawal by Subject|1|||
19733138|NCT03402386|42178650|FG000|Overall Study|Difficult to control Hb|2|||
19733139|NCT03401450|42178656|FG000|Overall Study|Lost to Follow-up|4|||
19733140|NCT03401450|42178657|FG001|Overall Study|Lost to Follow-up|6|||
19733141|NCT03401450|42178656|FG000|Overall Study|Anesthesia plan changed|2|||
19733142|NCT03401450|42178657|FG001|Overall Study|Anesthesia plan changed|2|||
19733143|NCT03401450|42178656|FG000|Overall Study|Did not complete medication diary|4|||
19733144|NCT03401450|42178657|FG001|Overall Study|Did not complete medication diary|2|||
19733145|NCT03401450|42178656|FG000|Overall Study|post surgery medication change|2|||
19733146|NCT03401450|42178657|FG001|Overall Study|post surgery medication change|1|||
19733147|NCT03401450|42178656|FG000|Overall Study|Cancelled surgery|0|||
19733148|NCT03401450|42178657|FG001|Overall Study|Cancelled surgery|2|||
19733149|NCT03353792|42178665|FG000|Overall Study|Lost to Follow-up|1|||
19733150|NCT03353792|42178666|FG001|Overall Study|Lost to Follow-up|0|||
19733151|NCT03353792|42178665|FG000|Overall Study|Participant Unable to Manage Device|1|||
19733152|NCT03353792|42178666|FG001|Overall Study|Participant Unable to Manage Device|0|||
19733153|NCT02862574|42178675|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19733154|NCT02862574|42178676|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19733155|NCT02862574|42178677|FG002|Double-Blind Treatment Period|Adverse Event|0|||
19733156|NCT02862574|42178675|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
19733157|NCT02862574|42178676|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
19733158|NCT02862574|42178677|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
19733159|NCT02862574|42178675|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
19733160|NCT02862574|42178676|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
19733161|NCT02862574|42178677|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
19733162|NCT02862106|42178692|FG000|Overall Study|Adverse Event|4|||
19733163|NCT02862106|42178693|FG001|Overall Study|Adverse Event|0|||
19733164|NCT02862106|42178692|FG000|Overall Study|Protocol Violation|16|||
19733165|NCT02862106|42178693|FG001|Overall Study|Protocol Violation|1|||
19733166|NCT02862106|42178692|FG000|Overall Study|Lost to Follow-up|15|||
19733167|NCT02862106|42178693|FG001|Overall Study|Lost to Follow-up|5|||
19733168|NCT02862106|42178692|FG000|Overall Study|Withdrawal by Subject|2|||
19733169|NCT02862106|42178693|FG001|Overall Study|Withdrawal by Subject|0|||
19733170|NCT02862106|42178692|FG000|Overall Study|Subjects moved to other city|1|||
19733171|NCT02862106|42178693|FG001|Overall Study|Subjects moved to other city|0|||
19733172|NCT04157296|42178708|FG000|Overall Study|Withdrawal by Subject|0|||
19733173|NCT04157296|42178709|FG001|Overall Study|Withdrawal by Subject|1|||
19733174|NCT04157296|42178708|FG000|Overall Study|Did not obtain second fMRI.|0|||
19733175|NCT04157296|42178709|FG001|Overall Study|Did not obtain second fMRI.|1|||
19733176|NCT04157296|42178708|FG000|Overall Study|MRI failed/no second fMRI|0|||
19733177|NCT04157296|42178709|FG001|Overall Study|MRI failed/no second fMRI|1|||
19733178|NCT02859142|42178717|FG000|Overall Study|Adverse Event|1|||
19733179|NCT02859142|42178718|FG001|Overall Study|Adverse Event|2|||
19733180|NCT02859142|42178717|FG000|Overall Study|Lost to Follow-up|1|||
19733181|NCT02859142|42178718|FG001|Overall Study|Lost to Follow-up|4|||
19733182|NCT02859142|42178717|FG000|Overall Study|Withdrawal by Subject|2|||
19733183|NCT02859142|42178718|FG001|Overall Study|Withdrawal by Subject|0|||
19733184|NCT02859142|42178717|FG000|Overall Study|Scheduling difficulties|0|||
19733185|NCT02859142|42178718|FG001|Overall Study|Scheduling difficulties|3|||
19733186|NCT03351608|42178729|FG000|Overall Study|Lost to Follow-up|0|||
19733187|NCT03351608|42178730|FG001|Overall Study|Lost to Follow-up|1|||
19733188|NCT03351608|42178731|FG002|Overall Study|Lost to Follow-up|1|||
19733189|NCT03351608|42178732|FG003|Overall Study|Lost to Follow-up|1|||
19733190|NCT03351608|42178733|FG004|Overall Study|Lost to Follow-up|1|||
19733191|NCT03351608|42178729|FG000|Overall Study|Physician Decision|1|||
19733192|NCT03351608|42178730|FG001|Overall Study|Physician Decision|0|||
19733193|NCT03351608|42178731|FG002|Overall Study|Physician Decision|0|||
19733194|NCT03351608|42178732|FG003|Overall Study|Physician Decision|2|||
19733195|NCT03351608|42178733|FG004|Overall Study|Physician Decision|1|||
19733196|NCT03351608|42178729|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
19733197|NCT03351608|42178730|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
19733198|NCT03351608|42178731|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
19733199|NCT03351608|42178732|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
19380894|NCT02412722|41624100|FG000|Overall Study|Lost to Follow-up|0|||
19733200|NCT03351608|42178733|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
19733201|NCT03351608|42178729|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19733202|NCT03351608|42178730|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19733203|NCT03351608|42178731|FG002|Overall Study|Withdrawal by parent/guardian|1|||
19733204|NCT03351608|42178732|FG003|Overall Study|Withdrawal by parent/guardian|1|||
19733205|NCT03351608|42178733|FG004|Overall Study|Withdrawal by parent/guardian|0|||
19733206|NCT03351608|42178729|FG000|Overall Study|Other|0|||
19733207|NCT03351608|42178730|FG001|Overall Study|Other|1|||
19733208|NCT03351608|42178731|FG002|Overall Study|Other|1|||
19733209|NCT03351608|42178732|FG003|Overall Study|Other|3|||
19733210|NCT03351608|42178733|FG004|Overall Study|Other|0|||
19733211|NCT02857816|42178756|FG000|Overall Study|Screen Failure|33|||
19733212|NCT02857816|42178756|FG000|Overall Study|Withdrawal by Subject|4|||
19733213|NCT02857816|42178756|FG000|Overall Study|Lost to Follow-up|1|||
19733214|NCT02858440|42178761|FG000|Overall Study|Lost to Follow-up|3|||
19733215|NCT02858440|42178761|FG000|Overall Study|Protocol Violation|2|||
19733216|NCT02858440|42178761|FG000|Overall Study|Consent withdrawal|3|||
19733217|NCT02858440|42178761|FG000|Overall Study|Migrated/moved from study area|4|||
19733218|NCT03382418|42178768|FG000|Overall Study|Withdrawal by Subject|1|||
19733219|NCT03382418|42178769|FG001|Overall Study|Withdrawal by Subject|0|||
19733220|NCT03382418|42178770|FG002|Overall Study|Withdrawal by Subject|0|||
19733221|NCT03382418|42178768|FG000|Overall Study|Lost to Follow-up|2|||
19733222|NCT03382418|42178769|FG001|Overall Study|Lost to Follow-up|3|||
19733223|NCT03382418|42178770|FG002|Overall Study|Lost to Follow-up|0|||
19733224|NCT02858362|42178782|FG000|Overall Study|Protocol Violation|0|||
19733225|NCT02858362|42178783|FG001|Overall Study|Protocol Violation|1|||
19733226|NCT02858362|42178784|FG002|Overall Study|Protocol Violation|0|||
19733227|NCT02858362|42178782|FG000|Overall Study|Withdrawal by Subject|1|||
19733228|NCT02858362|42178783|FG001|Overall Study|Withdrawal by Subject|0|||
19733229|NCT02858362|42178784|FG002|Overall Study|Withdrawal by Subject|0|||
19733230|NCT02858362|42178782|FG000|Overall Study|Early Study Termination|0|||
19733231|NCT02858362|42178783|FG001|Overall Study|Early Study Termination|0|||
19733232|NCT02858362|42178784|FG002|Overall Study|Early Study Termination|3|||
19733233|NCT02858362|42178782|FG000|Overall Study|Lost to Follow-up|1|||
19733234|NCT02858362|42178783|FG001|Overall Study|Lost to Follow-up|0|||
19733235|NCT02858362|42178784|FG002|Overall Study|Lost to Follow-up|0|||
19733236|NCT03382262|42178801|FG000|Overall Study|Physician Decision|0|||
19733237|NCT03382262|42178802|FG001|Overall Study|Physician Decision|0|||
19733238|NCT03382262|42178803|FG002|Overall Study|Physician Decision|1|||
19733239|NCT03382262|42178804|FG003|Overall Study|Physician Decision|0|||
19733240|NCT03382262|42178801|FG000|Overall Study|Withdrawal by Subject|0|||
19733241|NCT03382262|42178802|FG001|Overall Study|Withdrawal by Subject|0|||
19733242|NCT03382262|42178803|FG002|Overall Study|Withdrawal by Subject|0|||
19733243|NCT03382262|42178804|FG003|Overall Study|Withdrawal by Subject|1|||
19733244|NCT03350750|42178816|FG000|Overall Study|Death|1|||
19733245|NCT03350750|42178817|FG001|Overall Study|Death|1|||
19733246|NCT03394508|42178827|FG000|Overall Study|Protocol Violation|0|||
19733247|NCT03394508|42178828|FG001|Overall Study|Protocol Violation|3|||
19733248|NCT03394508|42178827|FG000|Overall Study|Lost to Follow-up|1|||
19733249|NCT03394508|42178828|FG001|Overall Study|Lost to Follow-up|0|||
19733250|NCT02856880|42178838|FG000|Overall Study|Withdrawal of consent|1|||
19733251|NCT03393806|42178859|FG000|Overall Study|Physician Decision|1|||
19733252|NCT03393806|42178860|FG001|Overall Study|Physician Decision|0|||
19733253|NCT02856802|42178869|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
19733254|NCT02856802|42178870|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
19733255|NCT02856802|42178869|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
19733256|NCT02856802|42178870|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
19733257|NCT02856802|42178869|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
19733258|NCT02856802|42178870|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
19733259|NCT02856802|42178869|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
19733260|NCT02856802|42178870|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
19733261|NCT02856802|42178869|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
19733262|NCT02856802|42178870|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
19733263|NCT02856802|42178869|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
19733264|NCT02856802|42178870|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
19733265|NCT03381248|42178882|FG000|Overall Study|Withdrawal by Subject|5|||
19733266|NCT03381248|42178883|FG001|Overall Study|Withdrawal by Subject|3|||
19733267|NCT03381248|42178882|FG000|Overall Study|Lost to Follow-up|3|||
19733268|NCT03381248|42178883|FG001|Overall Study|Lost to Follow-up|2|||
19733269|NCT03381248|42178882|FG000|Overall Study|Lack of Efficacy|1|||
19733270|NCT03381248|42178883|FG001|Overall Study|Lack of Efficacy|0|||
19733271|NCT03381248|42178882|FG000|Overall Study|Adverse Event|2|||
19465269|NCT04426695|41723745|FG004|Overall Study|Sponsor Request|0|||
19733272|NCT03381248|42178883|FG001|Overall Study|Adverse Event|0|||
19733273|NCT03381248|42178882|FG000|Overall Study|Protocol Violation|2|||
19733274|NCT03381248|42178883|FG001|Overall Study|Protocol Violation|1|||
19733275|NCT03380390|42178889|FG000|Overall Study|Adverse Event|3|||
19733276|NCT03350672|42178896|FG000|Overall Study|Withdrawal by Subject|7|||
19733277|NCT03350672|42178897|FG001|Overall Study|Withdrawal by Subject|0|||
19733278|NCT03350672|42178898|FG002|Overall Study|Withdrawal by Subject|0|||
19733279|NCT03392168|42178910|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
19733280|NCT03392168|42178911|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
19733281|NCT03392168|42178912|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
19733282|NCT03392168|42178913|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
19733283|NCT03392168|42178910|FG000|Period 2: Cohort 2|Other|0|||
19733284|NCT03392168|42178911|FG001|Period 2: Cohort 2|Other|1|||
19733285|NCT03392168|42178912|FG002|Period 2: Cohort 2|Other|0|||
19733286|NCT03392168|42178913|FG003|Period 2: Cohort 2|Other|0|||
19733287|NCT03391232|42178924|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
19733288|NCT03391232|42178925|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
19733289|NCT03391232|42178924|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
19733290|NCT03391232|42178925|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
19733291|NCT03379376|42178933|FG000|Overall Study|Lost to Follow-up|2|||
19733292|NCT03379376|42178933|FG000|Overall Study|Did not wish to complete follow up|1|||
19733293|NCT03379376|42178933|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
19733294|NCT03379376|42178933|FG000|Overall Study|Death|1|||
19733295|NCT03349034|42178939|FG000|Overall Study|catheters dislodged during transport|2|||
19733296|NCT03349034|42178940|FG001|Overall Study|catheters dislodged during transport|0|||
19733297|NCT03349034|42178939|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
19733298|NCT03349034|42178940|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
19733299|NCT03349034|42178939|FG000|Overall Study|soft tissue flap used|1|||
19733300|NCT03349034|42178940|FG001|Overall Study|soft tissue flap used|0|||
19733301|NCT03349034|42178939|FG000|Overall Study|Other|0|||
19733302|NCT03349034|42178940|FG001|Overall Study|Other|1|||
19733303|NCT00358215|42178950|FG000|Overall Study|Ineligibility determined|4|||
19733304|NCT00358215|42178951|FG001|Overall Study|Ineligibility determined|3|||
19733305|NCT00358215|42178950|FG000|Overall Study|Adverse Event|83|||
19733306|NCT00358215|42178951|FG001|Overall Study|Adverse Event|65|||
19733307|NCT00358215|42178950|FG000|Overall Study|Withdrawal by Subject|111|||
19733308|NCT00358215|42178951|FG001|Overall Study|Withdrawal by Subject|102|||
19733309|NCT00358215|42178950|FG000|Overall Study|Participant request|65|||
19733310|NCT00358215|42178951|FG001|Overall Study|Participant request|64|||
19733311|NCT00358215|42178950|FG000|Overall Study|Physician Decision|47|||
19733312|NCT00358215|42178951|FG001|Overall Study|Physician Decision|39|||
19733313|NCT00358215|42178950|FG000|Overall Study|Lost to Follow-up|16|||
19733314|NCT00358215|42178951|FG001|Overall Study|Lost to Follow-up|22|||
19733315|NCT00358215|42178950|FG000|Overall Study|Death|265|||
19733316|NCT00358215|42178951|FG001|Overall Study|Death|281|||
19733317|NCT00358215|42178950|FG000|Overall Study|Protocol Violation|64|||
19733318|NCT00358215|42178951|FG001|Overall Study|Protocol Violation|59|||
19733319|NCT00358215|42178950|FG000|Overall Study|Pregnancy|1|||
19733320|NCT00358215|42178951|FG001|Overall Study|Pregnancy|0|||
19733321|NCT00358215|42178950|FG000|Overall Study|Other|21|||
19733322|NCT00358215|42178951|FG001|Overall Study|Other|14|||
19733323|NCT00358215|42178950|FG000|Overall Study|Did not receive investigational product|2|||
19733324|NCT00358215|42178951|FG001|Overall Study|Did not receive investigational product|3|||
19733325|NCT02855164|42178965|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
19733326|NCT02855164|42178966|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
19733327|NCT02855164|42178967|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
19733328|NCT02855164|42178968|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
19733329|NCT02855164|42178969|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
19733330|NCT02855164|42178970|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
19733331|NCT02855164|42178971|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
19733332|NCT02855164|42178972|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
19733333|NCT02855164|42178965|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
19733334|NCT02855164|42178966|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
19733335|NCT02855164|42178967|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
19733336|NCT02855164|42178968|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
19733337|NCT02855164|42178969|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
19733338|NCT02855164|42178970|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
19733339|NCT02855164|42178971|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
19733340|NCT02855164|42178972|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
19733341|NCT02855164|42178965|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
19733342|NCT02855164|42178966|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
19733343|NCT02855164|42178967|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
19733344|NCT02855164|42178968|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
19733345|NCT02855164|42178969|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
19733346|NCT02855164|42178970|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
19733347|NCT02855164|42178971|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
19733348|NCT02855164|42178972|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
19733349|NCT02855164|42178965|FG000|Part C (Randomized Set)|Adverse Event|0|||
19733350|NCT02855164|42178966|FG001|Part C (Randomized Set)|Adverse Event|0|||
19733351|NCT02855164|42178967|FG002|Part C (Randomized Set)|Adverse Event|0|||
19733352|NCT02855164|42178968|FG003|Part C (Randomized Set)|Adverse Event|0|||
19733353|NCT02855164|42178969|FG004|Part C (Randomized Set)|Adverse Event|0|||
19733354|NCT02855164|42178970|FG005|Part C (Randomized Set)|Adverse Event|5|||
19733355|NCT02855164|42178971|FG006|Part C (Randomized Set)|Adverse Event|9|||
19733356|NCT02855164|42178972|FG007|Part C (Randomized Set)|Adverse Event|2|||
19733357|NCT02855164|42178965|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
19733358|NCT02855164|42178966|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
19733359|NCT02855164|42178967|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
19733360|NCT02855164|42178968|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
19733361|NCT02855164|42178969|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
19733362|NCT02855164|42178970|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
19733363|NCT02855164|42178971|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
19733364|NCT02855164|42178972|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
19733365|NCT02855164|42178965|FG000|Part C (Randomized Set)|Physician Decision|0|||
19733366|NCT02855164|42178966|FG001|Part C (Randomized Set)|Physician Decision|0|||
19733367|NCT02855164|42178967|FG002|Part C (Randomized Set)|Physician Decision|0|||
19733368|NCT02855164|42178968|FG003|Part C (Randomized Set)|Physician Decision|0|||
19733369|NCT02855164|42178969|FG004|Part C (Randomized Set)|Physician Decision|0|||
19733370|NCT02855164|42178970|FG005|Part C (Randomized Set)|Physician Decision|1|||
19733371|NCT02855164|42178971|FG006|Part C (Randomized Set)|Physician Decision|0|||
19733372|NCT02855164|42178972|FG007|Part C (Randomized Set)|Physician Decision|1|||
19733373|NCT02855164|42178965|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
19733374|NCT02855164|42178966|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
19733375|NCT02855164|42178967|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
19733376|NCT02855164|42178968|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
19733377|NCT02855164|42178969|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
19733378|NCT02855164|42178970|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
19733379|NCT02855164|42178971|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
19733380|NCT02855164|42178972|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
19733381|NCT01002742|42179012|FG000|Overall Study|Determined to be ineligible|0|||
19733382|NCT01002742|42179013|FG001|Overall Study|Determined to be ineligible|1|||
19733383|NCT02853760|42179019|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
19733384|NCT02853760|42179020|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
19733385|NCT02853760|42179021|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
19733386|NCT02853760|42179022|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
19733387|NCT02853760|42179023|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
19733388|NCT02853760|42179024|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
19733389|NCT02852434|42179034|FG000|Overall Study|Withdrawal by Subject|0|||
19733390|NCT02852434|42179035|FG001|Overall Study|Withdrawal by Subject|1|||
19733391|NCT02852434|42179034|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
19733392|NCT02852434|42179035|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
19733393|NCT02903368|42179043|FG000|Overall Study|Adverse Event|3|||
19733394|NCT02903368|42179044|FG001|Overall Study|Adverse Event|0|||
19733395|NCT02903368|42179043|FG000|Overall Study|Withdrawal by Subject|1|||
19733396|NCT02903368|42179044|FG001|Overall Study|Withdrawal by Subject|0|||
19733397|NCT02850016|42179052|FG000|Overall Study|Withdrawal by Subject|1|||
19733398|NCT02850016|42179053|FG001|Overall Study|Withdrawal by Subject|2|||
19733399|NCT02849704|42179061|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
19733400|NCT02849704|42179062|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
19733401|NCT02849704|42179061|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
19733402|NCT02849704|42179062|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
19733403|NCT02849704|42179061|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
19733404|NCT02849704|42179062|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
19733405|NCT03347396|42179083|FG000|Part A (26 Weeks)|Adverse Event|1|||
19733406|NCT03347396|42179084|FG001|Part A (26 Weeks)|Adverse Event|0|||
19733407|NCT03347396|42179083|FG000|Part A (26 Weeks)|Death|0|||
19733408|NCT03347396|42179084|FG001|Part A (26 Weeks)|Death|1|||
19733409|NCT03347396|42179083|FG000|Part B (149 Weeks)|Adverse Event|1|||
19733410|NCT03347396|42179084|FG001|Part B (149 Weeks)|Adverse Event|1|||
19733411|NCT03347396|42179083|FG000|Part B (149 Weeks)|Death|1|||
19733412|NCT03347396|42179084|FG001|Part B (149 Weeks)|Death|0|||
19733413|NCT03373760|42179095|FG000|Overall Study|Adverse Event|8|||
19733414|NCT03373760|42179095|FG000|Overall Study|Disease Progression|46|||
19733415|NCT03373760|42179095|FG000|Overall Study|Death|4|||
19733416|NCT03335150|42179104|FG000|Overall Study|Withdrawal by Subject|10|||
19733417|NCT03335150|42179105|FG001|Overall Study|Withdrawal by Subject|4|||
19733418|NCT03335150|42179104|FG000|Overall Study|Adverse Event|0|||
19733419|NCT03335150|42179105|FG001|Overall Study|Adverse Event|1|||
19733420|NCT03334448|42179111|FG000|Washout|Personal Reason|0|||
19733421|NCT03334448|42179112|FG001|Washout|Personal Reason|1|||
19733422|NCT03334448|42179113|FG002|Washout|Personal Reason|0|||
19733423|NCT03334448|42179114|FG003|Washout|Personal Reason|0|||
19733424|NCT03334448|42179111|FG000|Washout|Protocol Violation|0|||
19733425|NCT03334448|42179112|FG001|Washout|Protocol Violation|0|||
19733426|NCT03334448|42179113|FG002|Washout|Protocol Violation|0|||
19733427|NCT03334448|42179114|FG003|Washout|Protocol Violation|1|||
19733428|NCT02849080|42179122|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
19733429|NCT02849080|42179123|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
19733430|NCT02849080|42179124|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
19733431|NCT02849080|42179125|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
19733432|NCT02849080|42179122|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
19733433|NCT02849080|42179123|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
19733434|NCT02849080|42179124|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
19733435|NCT02849080|42179125|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
19733436|NCT02849080|42179122|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
19733437|NCT02849080|42179123|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
19733438|NCT02849080|42179124|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
19733439|NCT02849080|42179125|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
19733440|NCT02849080|42179122|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
19733441|NCT02849080|42179123|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
19733442|NCT02849080|42179124|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
19733443|NCT02849080|42179125|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
19733444|NCT02849080|42179122|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
19733445|NCT02849080|42179123|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
19733446|NCT02849080|42179124|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
19733447|NCT02849080|42179125|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
19733448|NCT02849080|42179122|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
19733449|NCT02849080|42179123|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
19733450|NCT02849080|42179124|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
19733451|NCT02849080|42179125|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
19733452|NCT03346070|42179142|FG000|Overall Study|Death|0|||
19733453|NCT03346070|42179143|FG001|Overall Study|Death|0|||
19733454|NCT03346070|42179144|FG002|Overall Study|Death|0|||
19733455|NCT03346070|42179145|FG003|Overall Study|Death|0|||
19733456|NCT03346070|42179146|FG004|Overall Study|Death|1|||
19733457|NCT03346070|42179142|FG000|Overall Study|Lost to Follow-up|0|||
19733458|NCT03346070|42179143|FG001|Overall Study|Lost to Follow-up|1|||
19733459|NCT03346070|42179144|FG002|Overall Study|Lost to Follow-up|2|||
19733460|NCT03346070|42179145|FG003|Overall Study|Lost to Follow-up|0|||
19733461|NCT03346070|42179146|FG004|Overall Study|Lost to Follow-up|0|||
19733462|NCT03346070|42179142|FG000|Overall Study|Physician Decision|0|||
19733463|NCT03346070|42179143|FG001|Overall Study|Physician Decision|0|||
19733464|NCT03346070|42179144|FG002|Overall Study|Physician Decision|0|||
19733465|NCT03346070|42179145|FG003|Overall Study|Physician Decision|1|||
19733466|NCT03346070|42179146|FG004|Overall Study|Physician Decision|1|||
19733467|NCT03346070|42179142|FG000|Overall Study|Withdrawal by Subject|1|||
19733468|NCT03346070|42179143|FG001|Overall Study|Withdrawal by Subject|0|||
19733469|NCT03346070|42179144|FG002|Overall Study|Withdrawal by Subject|0|||
19733470|NCT03346070|42179145|FG003|Overall Study|Withdrawal by Subject|1|||
19733471|NCT03346070|42179146|FG004|Overall Study|Withdrawal by Subject|0|||
19733472|NCT03346070|42179142|FG000|Overall Study|Study medication not received as planned|2|||
19733473|NCT03346070|42179143|FG001|Overall Study|Study medication not received as planned|3|||
19733474|NCT03346070|42179144|FG002|Overall Study|Study medication not received as planned|2|||
19733475|NCT03346070|42179145|FG003|Overall Study|Study medication not received as planned|3|||
19733476|NCT03346070|42179146|FG004|Overall Study|Study medication not received as planned|2|||
19733477|NCT03346070|42179142|FG000|Overall Study|Screen Failure|0|||
19733478|NCT03346070|42179143|FG001|Overall Study|Screen Failure|0|||
19733479|NCT03346070|42179144|FG002|Overall Study|Screen Failure|0|||
19733480|NCT03346070|42179145|FG003|Overall Study|Screen Failure|1|||
19733481|NCT03346070|42179146|FG004|Overall Study|Screen Failure|1|||
19733482|NCT02951780|42179169|FG000|Period 1|Adverse Event|0|||
19733483|NCT02951780|42179170|FG001|Period 1|Adverse Event|0|||
19733484|NCT02951780|42179171|FG002|Period 1|Adverse Event|0|||
19733485|NCT02951780|42179172|FG003|Period 1|Adverse Event|1|||
19733486|NCT02951780|42179173|FG004|Period 1|Adverse Event|0|||
19733487|NCT02951780|42179174|FG005|Period 1|Adverse Event|0|||
19733488|NCT02951780|42179175|FG006|Period 1|Adverse Event|0|||
19733489|NCT02951780|42179176|FG007|Period 1|Adverse Event|0|||
19733490|NCT02951780|42179177|FG008|Period 1|Adverse Event|0|||
19733491|NCT02951780|42179169|FG000|Period 1|Scheduling Conflicts|0|||
19733492|NCT02951780|42179170|FG001|Period 1|Scheduling Conflicts|0|||
19733493|NCT02951780|42179171|FG002|Period 1|Scheduling Conflicts|0|||
19733494|NCT02951780|42179172|FG003|Period 1|Scheduling Conflicts|0|||
19733495|NCT02951780|42179173|FG004|Period 1|Scheduling Conflicts|0|||
19465270|NCT04426695|41723746|FG005|Overall Study|Sponsor Request|0|||
19465271|NCT04426695|41723747|FG006|Overall Study|Sponsor Request|1|||
19465272|NCT04426695|41723748|FG007|Overall Study|Sponsor Request|0|||
19733496|NCT02951780|42179174|FG005|Period 1|Scheduling Conflicts|0|||
19733497|NCT02951780|42179175|FG006|Period 1|Scheduling Conflicts|0|||
19733498|NCT02951780|42179176|FG007|Period 1|Scheduling Conflicts|1|||
19733499|NCT02951780|42179177|FG008|Period 1|Scheduling Conflicts|0|||
19733500|NCT02951780|42179169|FG000|Period 2|Scheduling Conflicts|0|||
19733501|NCT02951780|42179170|FG001|Period 2|Scheduling Conflicts|0|||
19733502|NCT02951780|42179171|FG002|Period 2|Scheduling Conflicts|0|||
19733503|NCT02951780|42179172|FG003|Period 2|Scheduling Conflicts|0|||
19733504|NCT02951780|42179173|FG004|Period 2|Scheduling Conflicts|0|||
19733505|NCT02951780|42179174|FG005|Period 2|Scheduling Conflicts|0|||
19733506|NCT02951780|42179175|FG006|Period 2|Scheduling Conflicts|0|||
19733507|NCT02951780|42179176|FG007|Period 2|Scheduling Conflicts|1|||
19733508|NCT02951780|42179177|FG008|Period 2|Scheduling Conflicts|0|||
19733509|NCT03334214|42179199|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
19733510|NCT03334214|42179200|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
19733511|NCT03334214|42179199|FG000|Overall Study|Withdrawal by Subject|0|||
19733512|NCT03334214|42179200|FG001|Overall Study|Withdrawal by Subject|1|||
19733513|NCT03334214|42179199|FG000|Overall Study|Other|1|||
19733514|NCT03334214|42179200|FG001|Overall Study|Other|0|||
19733515|NCT02250664|42179210|FG000|Overall Study|Lost to Follow-up|18|||
19733516|NCT02250664|42179211|FG001|Overall Study|Lost to Follow-up|28|||
19733517|NCT02250664|42179212|FG002|Overall Study|Lost to Follow-up|33|||
19733518|NCT02250664|42179210|FG000|Overall Study|Personal Reasons|7|||
19733519|NCT02250664|42179211|FG001|Overall Study|Personal Reasons|8|||
19733520|NCT02250664|42179212|FG002|Overall Study|Personal Reasons|14|||
19733521|NCT02250664|42179210|FG000|Overall Study|Adverse Event|6|||
19733522|NCT02250664|42179211|FG001|Overall Study|Adverse Event|3|||
19733523|NCT02250664|42179212|FG002|Overall Study|Adverse Event|8|||
19733524|NCT02250664|42179210|FG000|Overall Study|Incarcerated|2|||
19733525|NCT02250664|42179211|FG001|Overall Study|Incarcerated|1|||
19733526|NCT02250664|42179212|FG002|Overall Study|Incarcerated|2|||
19733527|NCT02250664|42179210|FG000|Overall Study|Withdrawal by Subject|0|||
19733528|NCT02250664|42179211|FG001|Overall Study|Withdrawal by Subject|1|||
19733529|NCT02250664|42179212|FG002|Overall Study|Withdrawal by Subject|2|||
19733530|NCT02250664|42179210|FG000|Overall Study|Death|0|||
19733531|NCT02250664|42179211|FG001|Overall Study|Death|1|||
19733532|NCT02250664|42179212|FG002|Overall Study|Death|1|||
19733533|NCT02250664|42179210|FG000|Overall Study|Physician Decision|1|||
19733534|NCT02250664|42179211|FG001|Overall Study|Physician Decision|3|||
19733535|NCT02250664|42179212|FG002|Overall Study|Physician Decision|1|||
19733536|NCT02250664|42179210|FG000|Overall Study|Protocol Violation|1|||
19733537|NCT02250664|42179211|FG001|Overall Study|Protocol Violation|0|||
19733538|NCT02250664|42179212|FG002|Overall Study|Protocol Violation|1|||
19733539|NCT02250664|42179210|FG000|Overall Study|Reason unknown|1|||
19733540|NCT02250664|42179211|FG001|Overall Study|Reason unknown|0|||
19733541|NCT02250664|42179212|FG002|Overall Study|Reason unknown|0|||
19733542|NCT02646982|42179222|FG000|Overall Study|Adverse Event|1|||
19733543|NCT02646982|42179223|FG001|Overall Study|Adverse Event|1|||
19733544|NCT02646982|42179222|FG000|Overall Study|Withdrawal by Subject|2|||
19733545|NCT02646982|42179223|FG001|Overall Study|Withdrawal by Subject|1|||
19733546|NCT02845336|42179231|FG000|Overall Study|Lost to Follow-up|3|||
19733547|NCT02845336|42179232|FG001|Overall Study|Lost to Follow-up|1|||
19733548|NCT02845336|42179231|FG000|Overall Study|Inability to get medication|2|||
19733549|NCT02845336|42179232|FG001|Overall Study|Inability to get medication|0|||
19733550|NCT02844946|42179240|FG000|Overall Study|Lost to Follow-up|7|||
19733551|NCT02844946|42179241|FG001|Overall Study|Lost to Follow-up|0|||
19733552|NCT02951156|42179250|FG000|Overall Study|Death|3|||
19733553|NCT02951156|42179251|FG001|Overall Study|Death|8|||
19733554|NCT02951156|42179252|FG002|Overall Study|Death|5|||
19733555|NCT02951156|42179250|FG000|Overall Study|Progressive disease|1|||
19733556|NCT02951156|42179251|FG001|Overall Study|Progressive disease|0|||
19733557|NCT02951156|42179252|FG002|Overall Study|Progressive disease|1|||
19733558|NCT02951156|42179250|FG000|Overall Study|Withdrawal by Subject|0|||
19733559|NCT02951156|42179251|FG001|Overall Study|Withdrawal by Subject|0|||
19733560|NCT02951156|42179252|FG002|Overall Study|Withdrawal by Subject|1|||
19733561|NCT02951156|42179250|FG000|Overall Study|Study terminated by sponsor|0|||
19733562|NCT02951156|42179251|FG001|Overall Study|Study terminated by sponsor|0|||
19733563|NCT02951156|42179252|FG002|Overall Study|Study terminated by sponsor|1|||
19733564|NCT02951156|42179250|FG000|Overall Study|Other|5|||
19733565|NCT02951156|42179251|FG001|Overall Study|Other|1|||
19733566|NCT02951156|42179252|FG002|Overall Study|Other|2|||
19733567|NCT03345914|42179264|FG000|Overall Study|Transition to another study at week 16|80|||
19733568|NCT03345914|42179265|FG001|Overall Study|Transition to another study at week 16|86|||
19733569|NCT03345914|42179266|FG002|Overall Study|Transition to another study at week 16|78|||
19733570|NCT03345914|42179264|FG000|Overall Study|Transition to OLE during follow-up|37|||
19733571|NCT03345914|42179265|FG001|Overall Study|Transition to OLE during follow-up|33|||
19733572|NCT03345914|42179266|FG002|Overall Study|Transition to OLE during follow-up|39|||
19733573|NCT03345914|42179264|FG000|Overall Study|Physician Decision|0|||
19733574|NCT03345914|42179265|FG001|Overall Study|Physician Decision|1|||
19733575|NCT03345914|42179266|FG002|Overall Study|Physician Decision|1|||
19733576|NCT03345914|42179264|FG000|Overall Study|Withdrawal by Subject|5|||
19733577|NCT03345914|42179265|FG001|Overall Study|Withdrawal by Subject|1|||
19733578|NCT03345914|42179266|FG002|Overall Study|Withdrawal by Subject|2|||
19733579|NCT03345914|42179264|FG000|Overall Study|Other|1|||
19733580|NCT03345914|42179265|FG001|Overall Study|Other|1|||
19733581|NCT03345914|42179266|FG002|Overall Study|Other|1|||
19733582|NCT03345914|42179264|FG000|Overall Study|Ongoing|0|||
19733583|NCT03345914|42179265|FG001|Overall Study|Ongoing|0|||
19733584|NCT03345914|42179266|FG002|Overall Study|Ongoing|1|||
19733585|NCT03369704|42179276|FG000|Treatment Epoch|technical problems|1|||
19733586|NCT03369704|42179277|FG001|Treatment Epoch|technical problems|0|||
19733587|NCT03369704|42179276|FG000|Treatment Epoch|Protocol Violation|1|||
19733588|NCT03369704|42179277|FG001|Treatment Epoch|Protocol Violation|0|||
19733589|NCT03369704|42179276|FG000|Treatment Epoch|Lost to Follow-up|0|||
19733590|NCT03369704|42179277|FG001|Treatment Epoch|Lost to Follow-up|1|||
19733591|NCT03369704|42179276|FG000|Treatment Epoch|Lack of Efficacy|0|||
19733592|NCT03369704|42179277|FG001|Treatment Epoch|Lack of Efficacy|2|||
19733593|NCT03369704|42179276|FG000|Treatment Epoch|Adverse Event|2|||
19733594|NCT03369704|42179277|FG001|Treatment Epoch|Adverse Event|0|||
19733595|NCT03369704|42179276|FG000|Follow-up Epoch|Lost to Follow-up|1|||
19733596|NCT03369704|42179277|FG001|Follow-up Epoch|Lost to Follow-up|0|||
19733597|NCT03366428|42179283|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
19733598|NCT03366428|42179283|FG000|Overall Study|Adverse Event|12|||
19733599|NCT03366428|42179283|FG000|Overall Study|Clinical progression|2|||
19733600|NCT03366428|42179283|FG000|Overall Study|Withdrawal by Subject|4|||
19733601|NCT02839876|42179291|FG000|Overall Study|Protocol Violation|10|||
19733602|NCT02839876|42179292|FG001|Overall Study|Protocol Violation|11|||
19733603|NCT03366194|42179298|FG000|Overall Study|Lost to Follow-up|2|||
19733604|NCT02839798|42179303|FG000|Overall Study|Withdrawal by Subject|2|||
19733605|NCT03345836|42179310|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
19733606|NCT03345836|42179311|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
19733607|NCT03345836|42179312|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
19733608|NCT03345836|42179313|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
19733609|NCT03345836|42179314|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
19733610|NCT03345836|42179315|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
19733611|NCT03345836|42179310|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
19733612|NCT03345836|42179311|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
19733613|NCT03345836|42179312|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
19733614|NCT03345836|42179313|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
19733615|NCT03345836|42179314|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
19733616|NCT03345836|42179315|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
19733617|NCT03345836|42179310|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
19733618|NCT03345836|42179311|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
19733619|NCT03345836|42179312|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
19733620|NCT03345836|42179313|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
19733621|NCT03345836|42179314|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
19733622|NCT03345836|42179315|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
19733623|NCT03345836|42179310|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
19733624|NCT03345836|42179311|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
19733625|NCT03345836|42179312|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
19733626|NCT03345836|42179313|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
19733627|NCT03345836|42179314|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
19733628|NCT03345836|42179315|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
19733629|NCT03345836|42179310|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
19733630|NCT03345836|42179311|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
19733631|NCT03345836|42179312|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
19733632|NCT03345836|42179313|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
19733633|NCT03345836|42179314|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
19733634|NCT03345836|42179315|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
19733635|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
19733636|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
19733637|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
19733638|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
19733639|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
19733640|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
19733641|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
19733642|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
19733643|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
19733644|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
19733645|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
19733646|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
19733647|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
19733648|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
19733649|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
19380895|NCT02412722|41624101|FG001|Overall Study|Lost to Follow-up|0|||
19380896|NCT02412722|41624102|FG002|Overall Study|Lost to Follow-up|0|||
19733650|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
19733651|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
19733652|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
19733653|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
19733654|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
19733655|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
19733656|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
19733657|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
19733658|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
19733659|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
19733660|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
19733661|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
19733662|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
19733663|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
19733664|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
19733665|NCT03345836|42179310|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
19733666|NCT03345836|42179311|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
19733667|NCT03345836|42179312|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
19733668|NCT03345836|42179313|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
19733669|NCT03345836|42179314|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
19733670|NCT03345836|42179315|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
19733671|NCT02839330|42179335|FG000|Overall Study|Adverse Event|0|||
19733672|NCT02839330|42179336|FG001|Overall Study|Adverse Event|1|||
19733673|NCT02839330|42179337|FG002|Overall Study|Adverse Event|2|||
19733674|NCT02839330|42179338|FG003|Overall Study|Adverse Event|2|||
19733675|NCT02839330|42179335|FG000|Overall Study|Death|4|||
19733676|NCT02839330|42179336|FG001|Overall Study|Death|6|||
19733677|NCT02839330|42179337|FG002|Overall Study|Death|1|||
19733678|NCT02839330|42179338|FG003|Overall Study|Death|1|||
19733679|NCT02839330|42179335|FG000|Overall Study|Withdrawal by Subject|27|||
19733680|NCT02839330|42179336|FG001|Overall Study|Withdrawal by Subject|19|||
19733681|NCT02839330|42179337|FG002|Overall Study|Withdrawal by Subject|11|||
19733682|NCT02839330|42179338|FG003|Overall Study|Withdrawal by Subject|13|||
19733683|NCT02839330|42179335|FG000|Overall Study|Lost to Follow-up|22|||
19733684|NCT02839330|42179336|FG001|Overall Study|Lost to Follow-up|27|||
19733685|NCT02839330|42179337|FG002|Overall Study|Lost to Follow-up|29|||
19733686|NCT02839330|42179338|FG003|Overall Study|Lost to Follow-up|25|||
19733687|NCT02839330|42179335|FG000|Overall Study|Administrative Reason|0|||
19733688|NCT02839330|42179336|FG001|Overall Study|Administrative Reason|0|||
19733689|NCT02839330|42179337|FG002|Overall Study|Administrative Reason|0|||
19733690|NCT02839330|42179338|FG003|Overall Study|Administrative Reason|1|||
19733691|NCT02839330|42179335|FG000|Overall Study|Protocol Violation|1|||
19733692|NCT02839330|42179336|FG001|Overall Study|Protocol Violation|2|||
19733693|NCT02839330|42179337|FG002|Overall Study|Protocol Violation|2|||
19733694|NCT02839330|42179338|FG003|Overall Study|Protocol Violation|3|||
19733695|NCT02839330|42179335|FG000|Overall Study|Other reason, not specified|4|||
19733696|NCT02839330|42179336|FG001|Overall Study|Other reason, not specified|3|||
19733697|NCT02839330|42179337|FG002|Overall Study|Other reason, not specified|3|||
19733698|NCT02839330|42179338|FG003|Overall Study|Other reason, not specified|6|||
19733699|NCT03363776|42179352|FG000|Overall Study|Progressive disease|2|||
19733700|NCT03363776|42179353|FG001|Overall Study|Progressive disease|3|||
19733701|NCT03363776|42179354|FG002|Overall Study|Progressive disease|1|||
19733702|NCT03363776|42179352|FG000|Overall Study|Study drug toxicity|0|||
19733703|NCT03363776|42179353|FG001|Overall Study|Study drug toxicity|0|||
19733704|NCT03363776|42179354|FG002|Overall Study|Study drug toxicity|1|||
19733705|NCT03363776|42179352|FG000|Overall Study|Death|1|||
19733706|NCT03363776|42179353|FG001|Overall Study|Death|0|||
19733707|NCT03363776|42179354|FG002|Overall Study|Death|0|||
19733708|NCT03360344|42179365|FG000|Overall Study|Withdrawal by Subject|0|||
19733709|NCT03360344|42179366|FG001|Overall Study|Withdrawal by Subject|1|||
19733710|NCT03360344|42179367|FG002|Overall Study|Withdrawal by Subject|1|||
19733711|NCT02838628|42179377|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
19733712|NCT02838628|42179378|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
19733713|NCT02838628|42179377|FG000|Recurrence Follow-up Period|Adverse Event|1|||
19733714|NCT02838628|42179378|FG001|Recurrence Follow-up Period|Adverse Event|0|||
19733715|NCT02838628|42179377|FG000|Recurrence Follow-up Period|Non-compliance|0|||
19733716|NCT02838628|42179378|FG001|Recurrence Follow-up Period|Non-compliance|1|||
19733717|NCT02838628|42179377|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
19733718|NCT02838628|42179378|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
19733719|NCT02838628|42179377|FG000|Recurrence Follow-up Period|Other un-specified|1|||
19733720|NCT02838628|42179378|FG001|Recurrence Follow-up Period|Other un-specified|1|||
19733721|NCT02835820|42179387|FG000|Overall Study|Baseline Screen Failure|0|||
19733722|NCT02835820|42179388|FG001|Overall Study|Baseline Screen Failure|3|||
19733723|NCT03359174|42179394|FG000|Overall Study|Adverse Event|1|||
19733724|NCT02832622|42179398|FG000|Overall Study|MPP not programmed|1259|||
19733725|NCT02832622|42179398|FG000|Overall Study|Withdrawal by Subject|123|||
19733726|NCT02832622|42179398|FG000|Overall Study|Death|119|||
19733727|NCT02832622|42179398|FG000|Overall Study|Unsuccessful CRT implant|93|||
19733728|NCT02832622|42179398|FG000|Overall Study|Lost to Follow-up|45|||
19733729|NCT02832622|42179398|FG000|Overall Study|Patient non-compliance|42|||
19733730|NCT02832622|42179398|FG000|Overall Study|Withdrawal by other reasons|25|||
19733731|NCT02832622|42179398|FG000|Overall Study|System explant|24|||
19733732|NCT02832622|42179398|FG000|Overall Study|Physician Decision|6|||
19733733|NCT00093015|42179405|FG000|Overall Study|Withdrawal by Subject|194|||
19733734|NCT00093015|42179406|FG001|Overall Study|Withdrawal by Subject|171|||
19733735|NCT00093015|42179405|FG000|Overall Study|Lost to Follow-up|96|||
19733736|NCT00093015|42179406|FG001|Overall Study|Lost to Follow-up|108|||
19733737|NCT00093015|42179405|FG000|Overall Study|Death|375|||
19733738|NCT00093015|42179406|FG001|Overall Study|Death|385|||
19733739|NCT03358472|42179415|FG000|Overall Study|Death|6|||
19733740|NCT03358472|42179416|FG001|Overall Study|Death|3|||
19733741|NCT03358472|42179417|FG002|Overall Study|Death|10|||
19733742|NCT03358472|42179415|FG000|Overall Study|Physician Decision|0|||
19733743|NCT03358472|42179416|FG001|Overall Study|Physician Decision|1|||
19733744|NCT03358472|42179417|FG002|Overall Study|Physician Decision|0|||
19733745|NCT03358472|42179415|FG000|Overall Study|Withdrawal by Subject|0|||
19733746|NCT03358472|42179416|FG001|Overall Study|Withdrawal by Subject|0|||
19733747|NCT03358472|42179417|FG002|Overall Study|Withdrawal by Subject|1|||
19733748|NCT03358472|42179415|FG000|Overall Study|On-going at clinical cut off date|9|||
19733749|NCT03358472|42179416|FG001|Overall Study|On-going at clinical cut off date|6|||
19733750|NCT03358472|42179417|FG002|Overall Study|On-going at clinical cut off date|5|||
19733751|NCT03358238|42179427|FG000|Overall Study|Withdrawal by Subject|0|||
19733752|NCT03358238|42179428|FG001|Overall Study|Withdrawal by Subject|1|||
19733753|NCT03342638|42179440|FG000|Overall Study|Withdrawal by Subject|1|||
19733754|NCT03342638|42179441|FG001|Overall Study|Withdrawal by Subject|0|||
19733755|NCT03342638|42179440|FG000|Overall Study|Physician Decision|0|||
19733756|NCT03342638|42179441|FG001|Overall Study|Physician Decision|1|||
19733757|NCT03342560|42179447|FG000|Overall Study|Lost to Follow-up|2|||
19733758|NCT03355742|42179464|FG000|Overall Study|Lost to Follow-up|4|||
19733759|NCT03355742|42179464|FG000|Overall Study|Withdrawal by Subject|29|||
19733760|NCT03355742|42179464|FG000|Overall Study|Physician Decision|6|||
19733761|NCT03355742|42179464|FG000|Overall Study|Death|55|||
19733762|NCT03355742|42179464|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
19733763|NCT03341312|42179468|FG000|Period 1|Withdrawal by Subject|0|||
19733764|NCT03341312|42179469|FG001|Period 1|Withdrawal by Subject|1|||
19733765|NCT03341312|42179470|FG002|Period 1|Withdrawal by Subject|0|||
19733766|NCT03341312|42179471|FG003|Period 1|Withdrawal by Subject|0|||
19733767|NCT02949908|42179483|FG000|Overall Study|Study termination|2|||
19733768|NCT01358734|42179490|FG000|Overall Study|Adverse Event|4|||
19733769|NCT01358734|42179491|FG001|Overall Study|Adverse Event|7|||
19733770|NCT01358734|42179492|FG002|Overall Study|Adverse Event|3|||
19733771|NCT01358734|42179490|FG000|Overall Study|Lack of Efficacy|0|||
19733772|NCT01358734|42179491|FG001|Overall Study|Lack of Efficacy|1|||
19733773|NCT01358734|42179492|FG002|Overall Study|Lack of Efficacy|3|||
19733774|NCT01358734|42179490|FG000|Overall Study|Withdrawal by Subject|1|||
19733775|NCT01358734|42179491|FG001|Overall Study|Withdrawal by Subject|6|||
19733776|NCT01358734|42179492|FG002|Overall Study|Withdrawal by Subject|3|||
19733777|NCT01358734|42179490|FG000|Overall Study|Death|3|||
19733778|NCT01358734|42179491|FG001|Overall Study|Death|7|||
19733779|NCT01358734|42179492|FG002|Overall Study|Death|2|||
19733780|NCT01358734|42179490|FG000|Overall Study|Progressive Disease|5|||
19733781|NCT01358734|42179491|FG001|Overall Study|Progressive Disease|13|||
19733782|NCT01358734|42179492|FG002|Overall Study|Progressive Disease|16|||
19733783|NCT01358734|42179490|FG000|Overall Study|Non-compliance with study drug|0|||
19733784|NCT01358734|42179491|FG001|Overall Study|Non-compliance with study drug|0|||
19733785|NCT01358734|42179492|FG002|Overall Study|Non-compliance with study drug|1|||
19733786|NCT01358734|42179490|FG000|Overall Study|Other|2|||
19733787|NCT01358734|42179491|FG001|Overall Study|Other|5|||
19733788|NCT01358734|42179492|FG002|Overall Study|Other|4|||
19733789|NCT01358734|42179490|FG000|Overall Study|Protocol Violation|0|||
19733790|NCT01358734|42179491|FG001|Overall Study|Protocol Violation|0|||
19733791|NCT01358734|42179492|FG002|Overall Study|Protocol Violation|2|||
19733792|NCT01341652|42179502|FG000|Overall Study|Incorrect Random Assignment|0|||
19733793|NCT01341652|42179503|FG001|Overall Study|Incorrect Random Assignment|1|||
19733794|NCT01341652|42179502|FG000|Overall Study|ineligible; presence metastatic disease|0|||
19733795|NCT01341652|42179503|FG001|Overall Study|ineligible; presence metastatic disease|1|||
19733796|NCT02828644|42179511|FG000|Overall Study|Lost to Follow-up|23|||
19733797|NCT02828644|42179512|FG001|Overall Study|Lost to Follow-up|22|||
19733798|NCT02949362|42179521|FG000|Retrospective Period|Inform consent not signed by participant|4|||
19733799|NCT02949362|42179522|FG001|Retrospective Period|Inform consent not signed by participant|1|||
19733800|NCT02949362|42179523|FG002|Retrospective Period|Inform consent not signed by participant|0|||
19733801|NCT02949362|42179524|FG003|Retrospective Period|Inform consent not signed by participant|0|||
19733802|NCT02949362|42179521|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
19733803|NCT02949362|42179522|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
19733804|NCT02949362|42179523|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
19733805|NCT02949362|42179524|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
19733806|NCT02949362|42179521|FG000|Prospective Period|Other|0|||
19733807|NCT02949362|42179522|FG001|Prospective Period|Other|0|||
19733808|NCT02949362|42179523|FG002|Prospective Period|Other|0|||
19733809|NCT02949362|42179524|FG003|Prospective Period|Other|4|||
19733810|NCT02947022|42179536|FG000|Overall Study|Study Stopped|1|||
19733811|NCT03338972|42179547|FG000|Overall Study|Death|1|||
19733812|NCT03338972|42179548|FG001|Overall Study|Death|1|||
19733813|NCT03338972|42179549|FG002|Overall Study|Death|0|||
19733814|NCT03338972|42179550|FG003|Overall Study|Death|0|||
19733815|NCT03338972|42179547|FG000|Overall Study|Withdrawal by Subject|1|||
19733816|NCT03338972|42179548|FG001|Overall Study|Withdrawal by Subject|0|||
19733817|NCT03338972|42179549|FG002|Overall Study|Withdrawal by Subject|0|||
19733818|NCT03338972|42179550|FG003|Overall Study|Withdrawal by Subject|0|||
19733819|NCT03338894|42179560|FG000|Overall Study|not able able to attend 9 or more classes|10|||
19733820|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
19733821|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
19733822|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
19733823|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
19733824|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
19733825|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
19733826|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
19733827|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
19733828|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
19733829|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
19733830|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
19733831|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
19733832|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
19733833|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
19733834|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
19733835|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
19733836|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
19733837|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
19733838|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
19733839|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
19733840|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
19733841|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
19733842|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
19733843|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
19733844|NCT03338816|42179566|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
19733845|NCT03338816|42179567|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
19733846|NCT03338816|42179568|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
19733847|NCT03338816|42179569|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
19733848|NCT03337490|42179581|FG000|Overall Study|Withdrawal by Subject|1|||
19733849|NCT03337490|42179582|FG001|Overall Study|Withdrawal by Subject|0|||
19733850|NCT03337490|42179583|FG002|Overall Study|Withdrawal by Subject|0|||
19733851|NCT03337490|42179581|FG000|Overall Study|Lack of Efficacy|10|||
19733852|NCT03337490|42179582|FG001|Overall Study|Lack of Efficacy|12|||
19733853|NCT03337490|42179583|FG002|Overall Study|Lack of Efficacy|35|||
19733854|NCT03337490|42179581|FG000|Overall Study|Physician Decision|0|||
19733855|NCT03337490|42179582|FG001|Overall Study|Physician Decision|1|||
19733856|NCT03337490|42179583|FG002|Overall Study|Physician Decision|0|||
19733857|NCT03337490|42179581|FG000|Overall Study|Lost to Follow-up|0|||
19733858|NCT03337490|42179582|FG001|Overall Study|Lost to Follow-up|1|||
19733859|NCT03337490|42179583|FG002|Overall Study|Lost to Follow-up|0|||
19733860|NCT02944448|42179593|FG000|Overall Study|Adverse Event|37|||
19733861|NCT02944448|42179594|FG001|Overall Study|Adverse Event|6|||
19733862|NCT02944448|42179593|FG000|Overall Study|Lack of Efficacy|8|||
19733863|NCT02944448|42179594|FG001|Overall Study|Lack of Efficacy|5|||
19733864|NCT02944448|42179593|FG000|Overall Study|Lost to Follow-up|3|||
19733865|NCT02944448|42179594|FG001|Overall Study|Lost to Follow-up|1|||
19733866|NCT02944448|42179593|FG000|Overall Study|Protocol Violation|25|||
19733867|NCT02944448|42179594|FG001|Overall Study|Protocol Violation|7|||
19733868|NCT02944448|42179593|FG000|Overall Study|Withdrawal by Subject|14|||
19733869|NCT02944448|42179594|FG001|Overall Study|Withdrawal by Subject|4|||
19733870|NCT02944448|42179593|FG000|Overall Study|Sponsor did not supply drug in time|0|||
19733871|NCT02944448|42179594|FG001|Overall Study|Sponsor did not supply drug in time|1|||
19733872|NCT02944448|42179593|FG000|Overall Study|Noncompliant with dosing|1|||
19733873|NCT02944448|42179594|FG001|Overall Study|Noncompliant with dosing|0|||
19733874|NCT02944448|42179593|FG000|Overall Study|Abnormal laboratory values|1|||
19733875|NCT02944448|42179594|FG001|Overall Study|Abnormal laboratory values|0|||
19733876|NCT02943668|42179601|FG000|Overall Study|Disease Progression|1|||
19733877|NCT02891408|42179636|FG000|Overall Study|Lost to Follow-up|0|||
19733878|NCT02891408|42179637|FG001|Overall Study|Lost to Follow-up|0|||
19733879|NCT02891408|42179638|FG002|Overall Study|Lost to Follow-up|1|||
19733880|NCT02891408|42179639|FG003|Overall Study|Lost to Follow-up|0|||
19733881|NCT02891408|42179640|FG004|Overall Study|Lost to Follow-up|0|||
19733882|NCT02891408|42179641|FG005|Overall Study|Lost to Follow-up|0|||
19733883|NCT02891408|42179642|FG006|Overall Study|Lost to Follow-up|0|||
19733884|NCT03283670|42179668|FG000|Placebo Gas|Withdrawal by Subject|2|||
19733885|NCT03283670|42179668|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
19733886|NCT03283670|42179668|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
19733887|NCT01358578|42179689|FG000|Induction Period|Adverse Event|2|||
19733888|NCT01358578|42179690|FG001|Induction Period|Adverse Event|4|||
19733889|NCT01358578|42179691|FG002|Induction Period|Adverse Event|2|||
19733890|NCT01358578|42179692|FG003|Induction Period|Adverse Event|6|||
19733891|NCT01358578|42179693|FG004|Induction Period|Adverse Event|0|||
19733892|NCT01358578|42179694|FG005|Induction Period|Adverse Event|0|||
19733893|NCT01358578|42179689|FG000|Induction Period|Lack of Efficacy|0|||
19733894|NCT01358578|42179690|FG001|Induction Period|Lack of Efficacy|0|||
19733895|NCT01358578|42179691|FG002|Induction Period|Lack of Efficacy|9|||
19733896|NCT01358578|42179692|FG003|Induction Period|Lack of Efficacy|1|||
19733897|NCT01358578|42179693|FG004|Induction Period|Lack of Efficacy|0|||
19733898|NCT01358578|42179694|FG005|Induction Period|Lack of Efficacy|0|||
19733899|NCT01358578|42179689|FG000|Induction Period|Lost to Follow-up|0|||
19733900|NCT01358578|42179690|FG001|Induction Period|Lost to Follow-up|0|||
19733901|NCT01358578|42179691|FG002|Induction Period|Lost to Follow-up|1|||
19733902|NCT01358578|42179692|FG003|Induction Period|Lost to Follow-up|4|||
19733903|NCT01358578|42179693|FG004|Induction Period|Lost to Follow-up|0|||
19733904|NCT01358578|42179694|FG005|Induction Period|Lost to Follow-up|0|||
19733905|NCT01358578|42179689|FG000|Induction Period|Physician Decision|2|||
19733906|NCT01358578|42179690|FG001|Induction Period|Physician Decision|1|||
19733907|NCT01358578|42179691|FG002|Induction Period|Physician Decision|2|||
19733908|NCT01358578|42179692|FG003|Induction Period|Physician Decision|0|||
19733909|NCT01358578|42179693|FG004|Induction Period|Physician Decision|0|||
19733910|NCT01358578|42179694|FG005|Induction Period|Physician Decision|0|||
19733911|NCT01358578|42179689|FG000|Induction Period|Protocol Deviation|3|||
19733912|NCT01358578|42179690|FG001|Induction Period|Protocol Deviation|5|||
19733913|NCT01358578|42179691|FG002|Induction Period|Protocol Deviation|0|||
19733914|NCT01358578|42179692|FG003|Induction Period|Protocol Deviation|3|||
19733915|NCT01358578|42179693|FG004|Induction Period|Protocol Deviation|0|||
19733916|NCT01358578|42179694|FG005|Induction Period|Protocol Deviation|0|||
19733917|NCT01358578|42179689|FG000|Induction Period|technical problems|0|||
19733918|NCT01358578|42179690|FG001|Induction Period|technical problems|0|||
19733919|NCT01358578|42179691|FG002|Induction Period|technical problems|1|||
19733920|NCT01358578|42179692|FG003|Induction Period|technical problems|1|||
19733921|NCT01358578|42179693|FG004|Induction Period|technical problems|0|||
19733922|NCT01358578|42179694|FG005|Induction Period|technical problems|0|||
19733923|NCT01358578|42179689|FG000|Induction Period|Withdrawal by Subject|5|||
19733924|NCT01358578|42179690|FG001|Induction Period|Withdrawal by Subject|5|||
19733925|NCT01358578|42179691|FG002|Induction Period|Withdrawal by Subject|10|||
19733926|NCT01358578|42179692|FG003|Induction Period|Withdrawal by Subject|6|||
19733927|NCT01358578|42179693|FG004|Induction Period|Withdrawal by Subject|0|||
19733928|NCT01358578|42179694|FG005|Induction Period|Withdrawal by Subject|0|||
19733929|NCT01358578|42179689|FG000|Maintenance Period|Adverse Event|2|||
19733930|NCT01358578|42179690|FG001|Maintenance Period|Adverse Event|7|||
19733931|NCT01358578|42179691|FG002|Maintenance Period|Adverse Event|0|||
19733932|NCT01358578|42179692|FG003|Maintenance Period|Adverse Event|6|||
19733933|NCT01358578|42179693|FG004|Maintenance Period|Adverse Event|4|||
19733934|NCT01358578|42179694|FG005|Maintenance Period|Adverse Event|3|||
19733935|NCT01358578|42179689|FG000|Maintenance Period|Lack of Efficacy|10|||
19733936|NCT01358578|42179690|FG001|Maintenance Period|Lack of Efficacy|2|||
19733937|NCT01358578|42179691|FG002|Maintenance Period|Lack of Efficacy|0|||
19733938|NCT01358578|42179692|FG003|Maintenance Period|Lack of Efficacy|11|||
19733939|NCT01358578|42179693|FG004|Maintenance Period|Lack of Efficacy|3|||
19733940|NCT01358578|42179694|FG005|Maintenance Period|Lack of Efficacy|0|||
19733941|NCT01358578|42179689|FG000|Maintenance Period|Lost to Follow-up|4|||
19733942|NCT01358578|42179690|FG001|Maintenance Period|Lost to Follow-up|0|||
19733943|NCT01358578|42179691|FG002|Maintenance Period|Lost to Follow-up|0|||
19733944|NCT01358578|42179692|FG003|Maintenance Period|Lost to Follow-up|5|||
19733945|NCT01358578|42179693|FG004|Maintenance Period|Lost to Follow-up|1|||
19380897|NCT02412722|41624103|FG003|Overall Study|Lost to Follow-up|0|||
19733946|NCT01358578|42179694|FG005|Maintenance Period|Lost to Follow-up|1|||
19733947|NCT01358578|42179689|FG000|Maintenance Period|Non-compliance with study treatment|3|||
19733948|NCT01358578|42179690|FG001|Maintenance Period|Non-compliance with study treatment|1|||
19733949|NCT01358578|42179691|FG002|Maintenance Period|Non-compliance with study treatment|0|||
19733950|NCT01358578|42179692|FG003|Maintenance Period|Non-compliance with study treatment|2|||
19733951|NCT01358578|42179693|FG004|Maintenance Period|Non-compliance with study treatment|1|||
19733952|NCT01358578|42179694|FG005|Maintenance Period|Non-compliance with study treatment|2|||
19733953|NCT01358578|42179689|FG000|Maintenance Period|Physician Decision|0|||
19733954|NCT01358578|42179690|FG001|Maintenance Period|Physician Decision|1|||
19733955|NCT01358578|42179691|FG002|Maintenance Period|Physician Decision|0|||
19733956|NCT01358578|42179692|FG003|Maintenance Period|Physician Decision|1|||
19733957|NCT01358578|42179693|FG004|Maintenance Period|Physician Decision|0|||
19733958|NCT01358578|42179694|FG005|Maintenance Period|Physician Decision|0|||
19733959|NCT01358578|42179689|FG000|Maintenance Period|Pregnancy|1|||
19733960|NCT01358578|42179690|FG001|Maintenance Period|Pregnancy|0|||
19733961|NCT01358578|42179691|FG002|Maintenance Period|Pregnancy|0|||
19733962|NCT01358578|42179692|FG003|Maintenance Period|Pregnancy|0|||
19733963|NCT01358578|42179693|FG004|Maintenance Period|Pregnancy|0|||
19733964|NCT01358578|42179694|FG005|Maintenance Period|Pregnancy|0|||
19733965|NCT01358578|42179689|FG000|Maintenance Period|Protocol deviation|7|||
19733966|NCT01358578|42179690|FG001|Maintenance Period|Protocol deviation|4|||
19733967|NCT01358578|42179691|FG002|Maintenance Period|Protocol deviation|0|||
19733968|NCT01358578|42179692|FG003|Maintenance Period|Protocol deviation|2|||
19733969|NCT01358578|42179693|FG004|Maintenance Period|Protocol deviation|2|||
19733970|NCT01358578|42179694|FG005|Maintenance Period|Protocol deviation|2|||
19733971|NCT01358578|42179689|FG000|Maintenance Period|Withdrawal by Subject|12|||
19733972|NCT01358578|42179690|FG001|Maintenance Period|Withdrawal by Subject|7|||
19733973|NCT01358578|42179691|FG002|Maintenance Period|Withdrawal by Subject|2|||
19733974|NCT01358578|42179692|FG003|Maintenance Period|Withdrawal by Subject|15|||
19733975|NCT01358578|42179693|FG004|Maintenance Period|Withdrawal by Subject|6|||
19733976|NCT01358578|42179694|FG005|Maintenance Period|Withdrawal by Subject|3|||
19733977|NCT01358578|42179689|FG000|Follow-up Period|Adverse Event|1|||
19733978|NCT01358578|42179690|FG001|Follow-up Period|Adverse Event|1|||
19733979|NCT01358578|42179691|FG002|Follow-up Period|Adverse Event|0|||
19733980|NCT01358578|42179692|FG003|Follow-up Period|Adverse Event|0|||
19733981|NCT01358578|42179693|FG004|Follow-up Period|Adverse Event|0|||
19733982|NCT01358578|42179694|FG005|Follow-up Period|Adverse Event|0|||
19733983|NCT01358578|42179689|FG000|Follow-up Period|Lack of Efficacy|3|||
19733984|NCT01358578|42179690|FG001|Follow-up Period|Lack of Efficacy|0|||
19733985|NCT01358578|42179691|FG002|Follow-up Period|Lack of Efficacy|4|||
19733986|NCT01358578|42179692|FG003|Follow-up Period|Lack of Efficacy|1|||
19733987|NCT01358578|42179693|FG004|Follow-up Period|Lack of Efficacy|0|||
19733988|NCT01358578|42179694|FG005|Follow-up Period|Lack of Efficacy|0|||
19733989|NCT01358578|42179689|FG000|Follow-up Period|Lost to Follow-up|0|||
19733990|NCT01358578|42179690|FG001|Follow-up Period|Lost to Follow-up|1|||
19733991|NCT01358578|42179691|FG002|Follow-up Period|Lost to Follow-up|0|||
19733992|NCT01358578|42179692|FG003|Follow-up Period|Lost to Follow-up|4|||
19733993|NCT01358578|42179693|FG004|Follow-up Period|Lost to Follow-up|0|||
19733994|NCT01358578|42179694|FG005|Follow-up Period|Lost to Follow-up|0|||
19733995|NCT01358578|42179689|FG000|Follow-up Period|non- compliance with study treatment|1|||
19733996|NCT01358578|42179690|FG001|Follow-up Period|non- compliance with study treatment|0|||
19733997|NCT01358578|42179691|FG002|Follow-up Period|non- compliance with study treatment|0|||
19733998|NCT01358578|42179692|FG003|Follow-up Period|non- compliance with study treatment|0|||
19733999|NCT01358578|42179693|FG004|Follow-up Period|non- compliance with study treatment|0|||
19734000|NCT01358578|42179694|FG005|Follow-up Period|non- compliance with study treatment|0|||
19734001|NCT01358578|42179689|FG000|Follow-up Period|Pregnancy|1|||
19734002|NCT01358578|42179690|FG001|Follow-up Period|Pregnancy|0|||
19734003|NCT01358578|42179691|FG002|Follow-up Period|Pregnancy|0|||
19734004|NCT01358578|42179692|FG003|Follow-up Period|Pregnancy|0|||
19734005|NCT01358578|42179693|FG004|Follow-up Period|Pregnancy|0|||
19734006|NCT01358578|42179694|FG005|Follow-up Period|Pregnancy|0|||
19734007|NCT01358578|42179689|FG000|Follow-up Period|Withdrawal by Subject|3|||
19734008|NCT01358578|42179690|FG001|Follow-up Period|Withdrawal by Subject|3|||
19734009|NCT01358578|42179691|FG002|Follow-up Period|Withdrawal by Subject|1|||
19734010|NCT01358578|42179692|FG003|Follow-up Period|Withdrawal by Subject|12|||
19734011|NCT01358578|42179693|FG004|Follow-up Period|Withdrawal by Subject|0|||
19734012|NCT01358578|42179694|FG005|Follow-up Period|Withdrawal by Subject|0|||
19734013|NCT01358578|42179689|FG000|Follow-up Period|Physician Decision|1|||
19734014|NCT01358578|42179690|FG001|Follow-up Period|Physician Decision|1|||
19734015|NCT01358578|42179691|FG002|Follow-up Period|Physician Decision|0|||
19734016|NCT01358578|42179692|FG003|Follow-up Period|Physician Decision|2|||
19734017|NCT01358578|42179693|FG004|Follow-up Period|Physician Decision|0|||
19734018|NCT01358578|42179694|FG005|Follow-up Period|Physician Decision|0|||
19734019|NCT02833948|42179724|FG000|Overall Study|Death|2|||
19734020|NCT02833948|42179725|FG001|Overall Study|Death|3|||
19734021|NCT02833948|42179724|FG000|Overall Study|were not scanned|8|||
19734022|NCT02833948|42179725|FG001|Overall Study|were not scanned|13|||
19734023|NCT02833948|42179724|FG000|Overall Study|scans could not be evaluated|5|||
19734024|NCT02833948|42179725|FG001|Overall Study|scans could not be evaluated|2|||
19734025|NCT02828020|42179738|FG000|Treatment Period|Adverse Event|3|||
19734026|NCT02828020|42179739|FG001|Treatment Period|Adverse Event|1|||
19734027|NCT02828020|42179740|FG002|Treatment Period|Adverse Event|1|||
19734028|NCT02828020|42179738|FG000|Treatment Period|Withdrawal of Consent|10|||
19734029|NCT02828020|42179739|FG001|Treatment Period|Withdrawal of Consent|14|||
19734030|NCT02828020|42179740|FG002|Treatment Period|Withdrawal of Consent|9|||
19734031|NCT02828020|42179738|FG000|Treatment Period|Lost to Follow-up|21|||
19734032|NCT02828020|42179739|FG001|Treatment Period|Lost to Follow-up|24|||
19734033|NCT02828020|42179740|FG002|Treatment Period|Lost to Follow-up|18|||
19734034|NCT02828020|42179738|FG000|Treatment Period|Lack of Qualifying Event|44|||
19734035|NCT02828020|42179739|FG001|Treatment Period|Lack of Qualifying Event|53|||
19734036|NCT02828020|42179740|FG002|Treatment Period|Lack of Qualifying Event|43|||
19734037|NCT02828020|42179738|FG000|Treatment Period|Pregnancy|0|||
19734038|NCT02828020|42179739|FG001|Treatment Period|Pregnancy|2|||
19734039|NCT02828020|42179740|FG002|Treatment Period|Pregnancy|0|||
19734040|NCT02828020|42179738|FG000|Treatment Period|Protocol Violation|2|||
19734041|NCT02828020|42179739|FG001|Treatment Period|Protocol Violation|4|||
19734042|NCT02828020|42179740|FG002|Treatment Period|Protocol Violation|7|||
19734043|NCT02828020|42179738|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
19734044|NCT02828020|42179739|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
19734045|NCT02828020|42179740|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
19734046|NCT02828020|42179738|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
19734047|NCT02828020|42179739|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
19734048|NCT02828020|42179740|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
19734049|NCT02828020|42179738|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
19734050|NCT02828020|42179739|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
19734051|NCT02828020|42179740|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
19734052|NCT02828020|42179738|FG000|Safety Follow-up Period|Protocol Violation|0|||
19734053|NCT02828020|42179739|FG001|Safety Follow-up Period|Protocol Violation|2|||
19734054|NCT02828020|42179740|FG002|Safety Follow-up Period|Protocol Violation|1|||
19734055|NCT02828020|42179738|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
19734056|NCT02828020|42179739|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
19734057|NCT02828020|42179740|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
19734058|NCT02827708|42179759|FG000|Overall Study|Lost to Follow-up|3|||
19734059|NCT02827708|42179760|FG001|Overall Study|Lost to Follow-up|1|||
19734060|NCT02827708|42179759|FG000|Overall Study|Withdrawal by Subject|1|||
19734061|NCT02827708|42179760|FG001|Overall Study|Withdrawal by Subject|2|||
19734062|NCT02827708|42179759|FG000|Overall Study|Death|1|||
19734063|NCT02827708|42179760|FG001|Overall Study|Death|2|||
19734064|NCT03760185|42179766|FG000|Overall Study|Lost to Follow-up|1|||
19734065|NCT03760185|42179767|FG001|Overall Study|Lost to Follow-up|1|||
19734066|NCT02891174|42179777|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
19734067|NCT02891174|42179778|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
19734068|NCT02891174|42179777|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
19734069|NCT02891174|42179778|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
19734070|NCT02891174|42179777|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
19734071|NCT02891174|42179778|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
19734072|NCT02891174|42179777|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
19734073|NCT02891174|42179778|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
19734074|NCT02891174|42179777|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
19734075|NCT02891174|42179778|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
19734076|NCT02891174|42179777|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
19734077|NCT02891174|42179778|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
19734078|NCT02891174|42179777|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
19734079|NCT02891174|42179778|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
19734080|NCT01751984|42179799|FG000|Overall Study|Adverse Event|5|||
19734081|NCT01751984|42179800|FG001|Overall Study|Adverse Event|3|||
19734082|NCT01751984|42179799|FG000|Overall Study|Withdrawal by Subject|0|||
19734083|NCT01751984|42179800|FG001|Overall Study|Withdrawal by Subject|1|||
19734084|NCT01751984|42179799|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
19734085|NCT01751984|42179800|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
19734086|NCT03330236|42179808|FG000|Overall Study|Death|2|||
19734087|NCT03330236|42179809|FG001|Overall Study|Death|1|||
19734088|NCT03330236|42179808|FG000|Overall Study|Withdrawal by Subject|2|||
19734089|NCT03330236|42179809|FG001|Overall Study|Withdrawal by Subject|4|||
19734090|NCT03330236|42179808|FG000|Overall Study|Lost to Follow-up|0|||
19734091|NCT03330236|42179809|FG001|Overall Study|Lost to Follow-up|2|||
19734092|NCT03330236|42179808|FG000|Overall Study|Physician Decision|2|||
19734093|NCT03330236|42179809|FG001|Overall Study|Physician Decision|0|||
19734094|NCT03330236|42179808|FG000|Overall Study|Protocol Violation|4|||
19734095|NCT03330236|42179809|FG001|Overall Study|Protocol Violation|3|||
19734096|NCT03330236|42179808|FG000|Overall Study|SedLine malfunction/blinding|19|||
19734097|NCT03330236|42179809|FG001|Overall Study|SedLine malfunction/blinding|14|||
19734098|NCT03330236|42179808|FG000|Overall Study|Volatile anesthetics used|11|||
19734099|NCT03330236|42179809|FG001|Overall Study|Volatile anesthetics used|8|||
19734100|NCT03330236|42179808|FG000|Overall Study|Surgery aborted/converted to open|60|||
19734101|NCT03330236|42179809|FG001|Overall Study|Surgery aborted/converted to open|52|||
19734102|NCT02831764|42179817|FG000|Overall Study|Protocol specific withdrawal criteria|0|||
19734103|NCT02831764|42179818|FG001|Overall Study|Protocol specific withdrawal criteria|2|||
19734104|NCT02831764|42179817|FG000|Overall Study|Withdrawal by Subject|7|||
19734105|NCT02831764|42179818|FG001|Overall Study|Withdrawal by Subject|6|||
19734106|NCT02831764|42179817|FG000|Overall Study|Physician Decision|2|||
19734107|NCT02831764|42179818|FG001|Overall Study|Physician Decision|2|||
19734108|NCT02831764|42179817|FG000|Overall Study|Lost to Follow-up|6|||
19734109|NCT02831764|42179818|FG001|Overall Study|Lost to Follow-up|5|||
19734110|NCT02831764|42179817|FG000|Overall Study|Adverse Event|8|||
19734111|NCT02831764|42179818|FG001|Overall Study|Adverse Event|5|||
19734112|NCT02831764|42179817|FG000|Overall Study|Lack of Efficacy|2|||
19734113|NCT02831764|42179818|FG001|Overall Study|Lack of Efficacy|2|||
19734114|NCT02831764|42179817|FG000|Overall Study|Protocol Violation|5|||
19734115|NCT02831764|42179818|FG001|Overall Study|Protocol Violation|2|||
19734116|NCT02831764|42179817|FG000|Overall Study|Ongoing at the time of the analysis|330|||
19734117|NCT02831764|42179818|FG001|Overall Study|Ongoing at the time of the analysis|335|||
19734118|NCT03330002|42179824|FG000|Overall Study|Lost to Follow-up|15|||
19734119|NCT03330002|42179824|FG000|Overall Study|Death|7|||
19734120|NCT02948582|42179828|FG000|Washout Period 1|Adverse Event|0|||
19734121|NCT02948582|42179829|FG001|Washout Period 1|Adverse Event|2|||
19734122|NCT02948582|42179830|FG002|Washout Period 1|Adverse Event|0|||
19734123|NCT02948582|42179831|FG003|Washout Period 1|Adverse Event|0|||
19734124|NCT02948582|42179832|FG004|Washout Period 1|Adverse Event|0|||
19734125|NCT02948582|42179833|FG005|Washout Period 1|Adverse Event|0|||
19734126|NCT02948582|42179828|FG000|Washout Period 1|Protocol Violation|0|||
19734127|NCT02948582|42179829|FG001|Washout Period 1|Protocol Violation|0|||
19734128|NCT02948582|42179830|FG002|Washout Period 1|Protocol Violation|0|||
19734129|NCT02948582|42179831|FG003|Washout Period 1|Protocol Violation|0|||
19734130|NCT02948582|42179832|FG004|Washout Period 1|Protocol Violation|0|||
19734131|NCT02948582|42179833|FG005|Washout Period 1|Protocol Violation|1|||
19734132|NCT02948582|42179828|FG000|Washout Period 2|Adverse Event|0|||
19734133|NCT02948582|42179829|FG001|Washout Period 2|Adverse Event|1|||
19734134|NCT02948582|42179830|FG002|Washout Period 2|Adverse Event|0|||
19734135|NCT02948582|42179831|FG003|Washout Period 2|Adverse Event|0|||
19734136|NCT02948582|42179832|FG004|Washout Period 2|Adverse Event|0|||
19734137|NCT02948582|42179833|FG005|Washout Period 2|Adverse Event|0|||
19734138|NCT02948582|42179828|FG000|Washout Period 2|personal reasons|0|||
19734139|NCT02948582|42179829|FG001|Washout Period 2|personal reasons|0|||
19734140|NCT02948582|42179830|FG002|Washout Period 2|personal reasons|0|||
19734141|NCT02948582|42179831|FG003|Washout Period 2|personal reasons|1|||
19734142|NCT02948582|42179832|FG004|Washout Period 2|personal reasons|0|||
19734143|NCT02948582|42179833|FG005|Washout Period 2|personal reasons|0|||
19734144|NCT02948582|42179828|FG000|Washout Period 4|Adverse Event|1|||
19734145|NCT02948582|42179829|FG001|Washout Period 4|Adverse Event|0|||
19734146|NCT02948582|42179830|FG002|Washout Period 4|Adverse Event|1|||
19734147|NCT02948582|42179831|FG003|Washout Period 4|Adverse Event|0|||
19734148|NCT02948582|42179832|FG004|Washout Period 4|Adverse Event|0|||
19734149|NCT02948582|42179833|FG005|Washout Period 4|Adverse Event|0|||
19734150|NCT03756285|42179849|FG000|Overall Study|Lost to Follow-up|0|||
19734151|NCT03756285|42179850|FG001|Overall Study|Lost to Follow-up|1|||
19734152|NCT03756285|42179849|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
19734153|NCT03756285|42179850|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
19734154|NCT03756285|42179849|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
19734155|NCT03756285|42179850|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
19734156|NCT02825992|42179876|FG000|Overall Study|Withdrawal by Subject|4|||
19734157|NCT02825992|42179876|FG000|Overall Study|Lost to Follow-up|2|||
19734158|NCT02825992|42179876|FG000|Overall Study|Procedure terminated|2|||
19734159|NCT01339000|42179888|FG000|Overall Study|study closed due to lack of drug supply|1|||
19734160|NCT01339000|42179889|FG001|Overall Study|study closed due to lack of drug supply|0|||
19734161|NCT03755661|42179900|FG000|Overall Study|Lost to Follow-up|1|||
19734162|NCT03755661|42179901|FG001|Overall Study|Lost to Follow-up|0|||
19734163|NCT03752151|42179907|FG000|Overall Study|Withdrawal by Subject|1|||
19734164|NCT03752151|42179907|FG000|Overall Study|Protocol Violation|1|||
19734165|NCT01336634|42179915|FG000|Overall Study|Study closed/terminated|5|||
19734166|NCT01336634|42179916|FG001|Overall Study|Study closed/terminated|6|||
19734167|NCT01336634|42179917|FG002|Overall Study|Study closed/terminated|6|||
19734168|NCT01336634|42179915|FG000|Overall Study|Lost to Follow-up|2|||
19734169|NCT01336634|42179916|FG001|Overall Study|Lost to Follow-up|1|||
19734170|NCT01336634|42179917|FG002|Overall Study|Lost to Follow-up|1|||
19734171|NCT01336634|42179915|FG000|Overall Study|Physician Decision|1|||
19734172|NCT01336634|42179916|FG001|Overall Study|Physician Decision|1|||
19734173|NCT01336634|42179917|FG002|Overall Study|Physician Decision|0|||
19734174|NCT01336634|42179915|FG000|Overall Study|Withdrawal by Subject|6|||
19734175|NCT01336634|42179916|FG001|Overall Study|Withdrawal by Subject|0|||
19734176|NCT01336634|42179917|FG002|Overall Study|Withdrawal by Subject|2|||
19734177|NCT02947100|42179932|FG000|Overall Study|study terminated early|3|||
19734178|NCT02947100|42179932|FG000|Overall Study|did not meet inclusion criteria|1|||
19734179|NCT03329846|42179938|FG000|Overall Study|Disease progression|4|||
19734180|NCT03329846|42179939|FG001|Overall Study|Disease progression|6|||
19734181|NCT03329846|42179938|FG000|Overall Study|Study drug toxicity|1|||
19734182|NCT03329846|42179939|FG001|Overall Study|Study drug toxicity|0|||
19734183|NCT03329846|42179938|FG000|Overall Study|Participant request to discontinue treatment|0|||
19734184|NCT03329846|42179939|FG001|Overall Study|Participant request to discontinue treatment|1|||
19734185|NCT03329846|42179938|FG000|Overall Study|Participant withdrew consent|1|||
19734186|NCT03329846|42179939|FG001|Overall Study|Participant withdrew consent|0|||
19734187|NCT03329846|42179938|FG000|Overall Study|Other reasons|2|||
19734188|NCT03329846|42179939|FG001|Overall Study|Other reasons|2|||
19734189|NCT03325010|42179947|FG000|Overall Study|Adverse Event|3|||
19734190|NCT03325010|42179948|FG001|Overall Study|Adverse Event|8|||
19734191|NCT03325010|42179947|FG000|Overall Study|Protocol Violation|1|||
19734192|NCT03325010|42179948|FG001|Overall Study|Protocol Violation|8|||
19734193|NCT03325010|42179947|FG000|Overall Study|Withdrawal by Subject|1|||
19734194|NCT03325010|42179948|FG001|Overall Study|Withdrawal by Subject|3|||
19734195|NCT03325010|42179947|FG000|Overall Study|Lost to Follow-up|1|||
19734196|NCT03325010|42179948|FG001|Overall Study|Lost to Follow-up|0|||
19734197|NCT03325010|42179947|FG000|Overall Study|Physician Decision|1|||
19734198|NCT03325010|42179948|FG001|Overall Study|Physician Decision|1|||
19734199|NCT03325010|42179947|FG000|Overall Study|Lack of Efficacy|2|||
19734200|NCT03325010|42179948|FG001|Overall Study|Lack of Efficacy|0|||
19734201|NCT02823574|42179958|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1|||
19734202|NCT02823574|42179959|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
19734203|NCT02823574|42179960|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
19734204|NCT02823574|42179961|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
19734205|NCT02823574|42179958|FG000|Pre-Treatment Period|Disease progression|0|||
19734206|NCT02823574|42179959|FG001|Pre-Treatment Period|Disease progression|0|||
19734207|NCT02823574|42179960|FG002|Pre-Treatment Period|Disease progression|1|||
19734208|NCT02823574|42179961|FG003|Pre-Treatment Period|Disease progression|0|||
19734209|NCT02823574|42179958|FG000|Treatment Period|Poor/Non Compliance|1|||
19734210|NCT02823574|42179959|FG001|Treatment Period|Poor/Non Compliance|0|||
19734211|NCT02823574|42179960|FG002|Treatment Period|Poor/Non Compliance|0|||
19734212|NCT02823574|42179961|FG003|Treatment Period|Poor/Non Compliance|1|||
19734213|NCT02823574|42179958|FG000|Treatment Period|Maximum Clinical Benefit|1|||
19734214|NCT02823574|42179959|FG001|Treatment Period|Maximum Clinical Benefit|0|||
19734215|NCT02823574|42179960|FG002|Treatment Period|Maximum Clinical Benefit|2|||
19734216|NCT02823574|42179961|FG003|Treatment Period|Maximum Clinical Benefit|0|||
19734217|NCT02823574|42179958|FG000|Treatment Period|Lost to Follow-up|1|||
19734218|NCT02823574|42179959|FG001|Treatment Period|Lost to Follow-up|0|||
19734219|NCT02823574|42179960|FG002|Treatment Period|Lost to Follow-up|0|||
19734220|NCT02823574|42179961|FG003|Treatment Period|Lost to Follow-up|0|||
19734221|NCT02823574|42179958|FG000|Treatment Period|Participant withdrew consent|2|||
19380898|NCT02412722|41624104|FG004|Overall Study|Lost to Follow-up|1|||
19465273|NCT04426695|41723749|FG008|Overall Study|Sponsor Request|0|||
19465274|NCT04426695|41723750|FG009|Overall Study|Sponsor Request|0|||
19551295|NCT01346774|42000128|FG001|Overall Study|Did not take a single dose|4|||
19734222|NCT02823574|42179959|FG001|Treatment Period|Participant withdrew consent|0|||
19380899|NCT02412722|41624105|FG005|Overall Study|Lost to Follow-up|0|||
19380900|NCT02412722|41624100|FG000|Overall Study|Received drug in run-in and discontinued|0|||
19380901|NCT02412722|41624101|FG001|Overall Study|Received drug in run-in and discontinued|2|||
19380902|NCT02412722|41624102|FG002|Overall Study|Received drug in run-in and discontinued|0|||
19380903|NCT02412722|41624103|FG003|Overall Study|Received drug in run-in and discontinued|0|||
19380904|NCT02412722|41624104|FG004|Overall Study|Received drug in run-in and discontinued|0|||
19380905|NCT02412722|41624105|FG005|Overall Study|Received drug in run-in and discontinued|0|||
19380906|NCT02412722|41624100|FG000|Overall Study|Reason not Specified|3|||
19380907|NCT02412722|41624101|FG001|Overall Study|Reason not Specified|0|||
19380908|NCT02412722|41624102|FG002|Overall Study|Reason not Specified|2|||
19380909|NCT02412722|41624103|FG003|Overall Study|Reason not Specified|1|||
19380910|NCT02412722|41624104|FG004|Overall Study|Reason not Specified|2|||
19380911|NCT02412722|41624105|FG005|Overall Study|Reason not Specified|6|||
19734223|NCT02823574|42179960|FG002|Treatment Period|Participant withdrew consent|0|||
19734224|NCT02823574|42179961|FG003|Treatment Period|Participant withdrew consent|0|||
19734225|NCT02823574|42179958|FG000|Treatment Period|Participant request to discontinue|4|||
19734226|NCT02823574|42179959|FG001|Treatment Period|Participant request to discontinue|0|||
19734227|NCT02823574|42179960|FG002|Treatment Period|Participant request to discontinue|2|||
19734228|NCT02823574|42179961|FG003|Treatment Period|Participant request to discontinue|3|||
19734229|NCT02823574|42179958|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
19734230|NCT02823574|42179959|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
19734231|NCT02823574|42179960|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8|||
19734232|NCT02823574|42179961|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1|||
19734233|NCT02823574|42179958|FG000|Treatment Period|Study Drug Toxicity|7|||
19734234|NCT02823574|42179959|FG001|Treatment Period|Study Drug Toxicity|2|||
19734235|NCT02823574|42179960|FG002|Treatment Period|Study Drug Toxicity|13|||
19734236|NCT02823574|42179961|FG003|Treatment Period|Study Drug Toxicity|3|||
19734237|NCT02823574|42179958|FG000|Treatment Period|Disease Progression|112|||
19734238|NCT02823574|42179959|FG001|Treatment Period|Disease Progression|60|||
19734239|NCT02823574|42179960|FG002|Treatment Period|Disease Progression|80|||
19734240|NCT02823574|42179961|FG003|Treatment Period|Disease Progression|41|||
19734241|NCT02823574|42179958|FG000|Treatment Period|participant no longer meets study criteria|0|||
19734242|NCT02823574|42179959|FG001|Treatment Period|participant no longer meets study criteria|0|||
19734243|NCT02823574|42179960|FG002|Treatment Period|participant no longer meets study criteria|1|||
19734244|NCT02823574|42179961|FG003|Treatment Period|participant no longer meets study criteria|0|||
19734245|NCT02823574|42179958|FG000|Treatment Period|Death|0|||
19734246|NCT02823574|42179959|FG001|Treatment Period|Death|0|||
19734247|NCT02823574|42179960|FG002|Treatment Period|Death|2|||
19734248|NCT02823574|42179961|FG003|Treatment Period|Death|1|||
19734249|NCT02823574|42179958|FG000|Treatment Period|Other reasons|1|||
19734250|NCT02823574|42179959|FG001|Treatment Period|Other reasons|2|||
19734251|NCT02823574|42179960|FG002|Treatment Period|Other reasons|0|||
19734252|NCT02823574|42179961|FG003|Treatment Period|Other reasons|1|||
19734253|NCT02824432|42179976|FG000|Overall Study|Major Protocol Deviation|1|||
19734254|NCT02824432|42179977|FG001|Overall Study|Major Protocol Deviation|0|||
19734255|NCT02823964|42179983|FG000|Overall Study|Adverse Event|2|||
19734256|NCT02823964|42179983|FG000|Overall Study|Physician Decision|1|||
19734257|NCT02823964|42179983|FG000|Overall Study|Lack of Efficacy|1|||
19734258|NCT02823964|42179983|FG000|Overall Study|Withdrawal by Subject|1|||
19734259|NCT01338610|42179990|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
19734260|NCT01338610|42179991|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
19734261|NCT01338610|42179992|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
19734262|NCT01338610|42179990|FG000|Overall Study|Protocol Violation|1|||
19734263|NCT01338610|42179991|FG001|Overall Study|Protocol Violation|0|||
19734264|NCT01338610|42179992|FG002|Overall Study|Protocol Violation|1|||
19734265|NCT01338610|42179990|FG000|Overall Study|Adverse Event|3|||
19734266|NCT01338610|42179991|FG001|Overall Study|Adverse Event|0|||
19734267|NCT01338610|42179992|FG002|Overall Study|Adverse Event|0|||
19734268|NCT01355302|42179999|FG000|Phase 1b|Death|4|||
19734269|NCT01355302|42180000|FG001|Phase 1b|Death|0|||
19734270|NCT01355302|42180001|FG002|Phase 1b|Death|0|||
19734271|NCT01355302|42179999|FG000|Phase 1b|Study terminated by sponsor|2|||
19734272|NCT01355302|42180000|FG001|Phase 1b|Study terminated by sponsor|0|||
19734273|NCT01355302|42180001|FG002|Phase 1b|Study terminated by sponsor|0|||
19734274|NCT01355068|42180009|FG000|First Intervention Period|Adverse Event|0|||
19734275|NCT01355068|42180010|FG001|First Intervention Period|Adverse Event|1|||
19734276|NCT01355068|42180009|FG000|First Intervention Period|Withdrawal by Subject|0|||
19734277|NCT01355068|42180010|FG001|First Intervention Period|Withdrawal by Subject|1|||
19734278|NCT03756129|42180022|FG000|Overall Study|Adverse Event|1|||
19734279|NCT03756129|42180023|FG001|Overall Study|Adverse Event|1|||
19734280|NCT03756129|42180024|FG002|Overall Study|Adverse Event|0|||
19734281|NCT03756129|42180025|FG003|Overall Study|Adverse Event|2|||
19734282|NCT03756129|42180026|FG004|Overall Study|Adverse Event|0|||
19734283|NCT03756129|42180027|FG005|Overall Study|Adverse Event|0|||
19734284|NCT03756129|42180022|FG000|Overall Study|Withdrawal by Subject|2|||
19734285|NCT03756129|42180023|FG001|Overall Study|Withdrawal by Subject|1|||
19734286|NCT03756129|42180024|FG002|Overall Study|Withdrawal by Subject|3|||
19734287|NCT03756129|42180025|FG003|Overall Study|Withdrawal by Subject|1|||
19734288|NCT03756129|42180026|FG004|Overall Study|Withdrawal by Subject|1|||
19734289|NCT03756129|42180027|FG005|Overall Study|Withdrawal by Subject|3|||
19734290|NCT03756129|42180022|FG000|Overall Study|Lost to Follow-up|0|||
19734291|NCT03756129|42180023|FG001|Overall Study|Lost to Follow-up|0|||
19734292|NCT03756129|42180024|FG002|Overall Study|Lost to Follow-up|0|||
19734293|NCT03756129|42180025|FG003|Overall Study|Lost to Follow-up|0|||
19734294|NCT03756129|42180026|FG004|Overall Study|Lost to Follow-up|0|||
19734295|NCT03756129|42180027|FG005|Overall Study|Lost to Follow-up|1|||
19734296|NCT03756129|42180022|FG000|Overall Study|Physician Decision|0|||
19734297|NCT03756129|42180023|FG001|Overall Study|Physician Decision|0|||
19734298|NCT03756129|42180024|FG002|Overall Study|Physician Decision|0|||
19734299|NCT03756129|42180025|FG003|Overall Study|Physician Decision|0|||
19734300|NCT03756129|42180026|FG004|Overall Study|Physician Decision|0|||
19734301|NCT03756129|42180027|FG005|Overall Study|Physician Decision|1|||
19734302|NCT02822794|42180053|FG000|Overall Study|Withdrew Consent|1|||
19734303|NCT02822794|42180054|FG001|Overall Study|Withdrew Consent|0|||
19734304|NCT01338298|42180069|FG000|Overall Study|Withdrawal by Subject|1|||
19734305|NCT01338298|42180070|FG001|Overall Study|Withdrawal by Subject|1|||
19734306|NCT01338298|42180069|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
19734307|NCT01338298|42180070|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
19734308|NCT01338298|42180069|FG000|Overall Study|Administrative error|0|||
19734309|NCT01338298|42180070|FG001|Overall Study|Administrative error|1|||
19734310|NCT01338298|42180069|FG000|Overall Study|Positive symptom worsening|1|||
19734311|NCT01338298|42180070|FG001|Overall Study|Positive symptom worsening|0|||
19734312|NCT01338298|42180069|FG000|Overall Study|Depressive symptoms and nausea|1|||
19734313|NCT01338298|42180070|FG001|Overall Study|Depressive symptoms and nausea|0|||
19734314|NCT01338298|42180069|FG000|Overall Study|Non-adherence|1|||
19734315|NCT01338298|42180070|FG001|Overall Study|Non-adherence|0|||
19734316|NCT01354132|42180078|FG000|Randomization|Physician Decision|1|||
19734317|NCT01354132|42180079|FG001|Randomization|Physician Decision|0|||
19734318|NCT01354132|42180078|FG000|Randomization|Withdrawal by Subject|0|||
19734319|NCT01354132|42180079|FG001|Randomization|Withdrawal by Subject|1|||
19734320|NCT01354132|42180078|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
19734321|NCT01354132|42180079|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
19734322|NCT01354132|42180078|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
19734323|NCT01354132|42180079|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
19734324|NCT01354132|42180078|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
19734325|NCT01354132|42180079|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
19734326|NCT01353898|42180094|FG000|Overall Study|Study site terminated|0|||
19734327|NCT01353898|42180095|FG001|Overall Study|Study site terminated|0|||
19734328|NCT01353898|42180096|FG002|Overall Study|Study site terminated|0|||
19734329|NCT01353898|42180097|FG003|Overall Study|Study site terminated|0|||
19734330|NCT01353898|42180098|FG004|Overall Study|Study site terminated|0|||
19734331|NCT01353898|42180099|FG005|Overall Study|Study site terminated|1|||
19734332|NCT01372150|42180116|FG000|Overall Study|Lack of Efficacy|3|||
19734333|NCT01372150|42180117|FG001|Overall Study|Lack of Efficacy|0|||
19734334|NCT01372150|42180118|FG002|Overall Study|Lack of Efficacy|1|||
19734335|NCT01372150|42180116|FG000|Overall Study|Lost to Follow-up|4|||
19734336|NCT01372150|42180117|FG001|Overall Study|Lost to Follow-up|5|||
19734337|NCT01372150|42180118|FG002|Overall Study|Lost to Follow-up|6|||
19734338|NCT01372150|42180116|FG000|Overall Study|Protocol Violation|1|||
19734339|NCT01372150|42180117|FG001|Overall Study|Protocol Violation|0|||
19734340|NCT01372150|42180118|FG002|Overall Study|Protocol Violation|3|||
19734341|NCT01372150|42180116|FG000|Overall Study|Withdrawal by Subject|2|||
19734342|NCT01372150|42180117|FG001|Overall Study|Withdrawal by Subject|7|||
19734343|NCT01372150|42180118|FG002|Overall Study|Withdrawal by Subject|2|||
19734344|NCT01372150|42180116|FG000|Overall Study|Other|1|||
19734345|NCT01372150|42180117|FG001|Overall Study|Other|0|||
19734346|NCT01372150|42180118|FG002|Overall Study|Other|2|||
19734347|NCT01372150|42180116|FG000|Overall Study|Adverse Event|2|||
19734348|NCT01372150|42180117|FG001|Overall Study|Adverse Event|1|||
19734349|NCT01372150|42180118|FG002|Overall Study|Adverse Event|2|||
19734350|NCT01372150|42180116|FG000|Overall Study|Randomized but not treated|0|||
19734351|NCT01372150|42180117|FG001|Overall Study|Randomized but not treated|1|||
19734352|NCT01372150|42180118|FG002|Overall Study|Randomized but not treated|0|||
19734353|NCT03749109|42180128|FG000|Overall Study|Adverse Event|2|||
19734354|NCT03749109|42180129|FG001|Overall Study|Adverse Event|0|||
19734355|NCT03329690|42180141|FG000|Overall Study|Progressive disease per RECIST|85|||
19734356|NCT03329690|42180142|FG001|Overall Study|Progressive disease per RECIST|44|||
19734357|NCT03329690|42180143|FG002|Overall Study|Progressive disease per RECIST|6|||
19734358|NCT03329690|42180144|FG003|Overall Study|Progressive disease per RECIST|16|||
19734359|NCT03329690|42180145|FG004|Overall Study|Progressive disease per RECIST|20|||
19734360|NCT03329690|42180141|FG000|Overall Study|Clinical progression|7|||
19734361|NCT03329690|42180142|FG001|Overall Study|Clinical progression|4|||
19734362|NCT03329690|42180143|FG002|Overall Study|Clinical progression|1|||
19734363|NCT03329690|42180144|FG003|Overall Study|Clinical progression|1|||
19734364|NCT03329690|42180145|FG004|Overall Study|Clinical progression|1|||
19734365|NCT03329690|42180141|FG000|Overall Study|Adverse Event|22|||
19734366|NCT03329690|42180142|FG001|Overall Study|Adverse Event|4|||
19734367|NCT03329690|42180143|FG002|Overall Study|Adverse Event|0|||
19734368|NCT03329690|42180144|FG003|Overall Study|Adverse Event|1|||
19734369|NCT03329690|42180145|FG004|Overall Study|Adverse Event|2|||
19734370|NCT03329690|42180141|FG000|Overall Study|Death|2|||
19734371|NCT03329690|42180142|FG001|Overall Study|Death|0|||
19734372|NCT03329690|42180143|FG002|Overall Study|Death|0|||
19734373|NCT03329690|42180144|FG003|Overall Study|Death|1|||
19734374|NCT03329690|42180145|FG004|Overall Study|Death|0|||
19734375|NCT03329690|42180141|FG000|Overall Study|Withdrawal by Subject|2|||
19734376|NCT03329690|42180142|FG001|Overall Study|Withdrawal by Subject|3|||
19734377|NCT03329690|42180143|FG002|Overall Study|Withdrawal by Subject|0|||
19734378|NCT03329690|42180144|FG003|Overall Study|Withdrawal by Subject|1|||
19734379|NCT03329690|42180145|FG004|Overall Study|Withdrawal by Subject|0|||
19734380|NCT03329690|42180141|FG000|Overall Study|Physician Decision|1|||
19734381|NCT03329690|42180142|FG001|Overall Study|Physician Decision|0|||
19734382|NCT03329690|42180143|FG002|Overall Study|Physician Decision|0|||
19734383|NCT03329690|42180144|FG003|Overall Study|Physician Decision|0|||
19734384|NCT03329690|42180145|FG004|Overall Study|Physician Decision|1|||
19734385|NCT03329690|42180141|FG000|Overall Study|Miscellaneous|6|||
19734386|NCT03329690|42180142|FG001|Overall Study|Miscellaneous|0|||
19734387|NCT03329690|42180143|FG002|Overall Study|Miscellaneous|0|||
19734388|NCT03329690|42180144|FG003|Overall Study|Miscellaneous|0|||
19734389|NCT03329690|42180145|FG004|Overall Study|Miscellaneous|0|||
19734390|NCT03329690|42180141|FG000|Overall Study|Did not receive treatment|1|||
19734391|NCT03329690|42180142|FG001|Overall Study|Did not receive treatment|0|||
19734392|NCT03329690|42180143|FG002|Overall Study|Did not receive treatment|0|||
19734393|NCT03329690|42180144|FG003|Overall Study|Did not receive treatment|1|||
19734394|NCT03329690|42180145|FG004|Overall Study|Did not receive treatment|0|||
19734395|NCT03328832|42180165|FG000|Overall Study|Lost to Follow-up|0|||
19734396|NCT03328832|42180166|FG001|Overall Study|Lost to Follow-up|1|||
19734397|NCT02820844|42180174|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
19734398|NCT02820844|42180175|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
19734399|NCT02820844|42180176|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
19734400|NCT02820844|42180177|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
19734401|NCT02820844|42180178|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
19734402|NCT02820844|42180179|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
19734403|NCT02820844|42180174|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
19734404|NCT02820844|42180175|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
19734405|NCT02820844|42180176|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
19734406|NCT02820844|42180177|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
19734407|NCT02820844|42180178|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
19734408|NCT02820844|42180179|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
19734409|NCT02820844|42180174|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
19734410|NCT02820844|42180175|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
19734411|NCT02820844|42180176|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
19734412|NCT02820844|42180177|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
19734413|NCT02820844|42180178|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
19734414|NCT02820844|42180179|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
19734415|NCT02820844|42180174|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
19734416|NCT02820844|42180175|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
19734417|NCT02820844|42180176|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
19734418|NCT02820844|42180177|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
19734419|NCT02820844|42180178|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
19734420|NCT02820844|42180179|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
19734421|NCT02820844|42180174|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
19734422|NCT02820844|42180175|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
19734423|NCT02820844|42180176|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
19734424|NCT02820844|42180177|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
19734425|NCT02820844|42180178|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
19734426|NCT02820844|42180179|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
19734427|NCT02820844|42180174|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
19734428|NCT02820844|42180175|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
19734429|NCT02820844|42180176|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
19734430|NCT02820844|42180177|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
19734431|NCT02820844|42180178|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
19734432|NCT02820844|42180179|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
19734433|NCT02820844|42180174|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
19734434|NCT02820844|42180175|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
19734435|NCT02820844|42180176|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
19734436|NCT02820844|42180177|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
19734437|NCT02820844|42180178|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
19734438|NCT02820844|42180179|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
19734439|NCT02820844|42180174|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734440|NCT02820844|42180175|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734441|NCT02820844|42180176|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
19734442|NCT02820844|42180177|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
19734443|NCT02820844|42180178|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734444|NCT02820844|42180179|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734445|NCT02820844|42180174|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
19380912|NCT03074695|41624141|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
19734446|NCT02820844|42180175|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
19734447|NCT02820844|42180176|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
19734448|NCT02820844|42180177|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
19734449|NCT02820844|42180178|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
19734450|NCT02820844|42180179|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
19734451|NCT02820844|42180174|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734452|NCT02820844|42180175|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734453|NCT02820844|42180176|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734454|NCT02820844|42180177|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734455|NCT02820844|42180178|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
19734456|NCT02820844|42180179|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
19734457|NCT02942576|42180198|FG000|Overall Study|Adverse Event|28|||
19734458|NCT02942576|42180199|FG001|Overall Study|Adverse Event|6|||
19734459|NCT02942576|42180198|FG000|Overall Study|Withdrawal by Subject|7|||
19734460|NCT02942576|42180199|FG001|Overall Study|Withdrawal by Subject|5|||
19734461|NCT02942576|42180198|FG000|Overall Study|Physician Decision|1|||
19734462|NCT02942576|42180199|FG001|Overall Study|Physician Decision|4|||
19734463|NCT02942576|42180198|FG000|Overall Study|Other|10|||
19734464|NCT02942576|42180199|FG001|Overall Study|Other|8|||
19734465|NCT02820298|42180207|FG000|Overall Study|Withdrawal by Subject|0|||
19734466|NCT02820298|42180208|FG001|Overall Study|Withdrawal by Subject|1|||
19734467|NCT02820298|42180207|FG000|Overall Study|Physician Decision|1|||
19734468|NCT02820298|42180208|FG001|Overall Study|Physician Decision|0|||
19734469|NCT02820298|42180207|FG000|Overall Study|Protocol Violation|0|||
19734470|NCT02820298|42180208|FG001|Overall Study|Protocol Violation|1|||
19734471|NCT02819440|42180222|FG000|Overall Study|Adverse Event|3|||
19734472|NCT02819440|42180223|FG001|Overall Study|Adverse Event|1|||
19734473|NCT02819440|42180222|FG000|Overall Study|Lost to Follow-up|1|||
19734474|NCT02819440|42180223|FG001|Overall Study|Lost to Follow-up|3|||
19734475|NCT02819440|42180222|FG000|Overall Study|Withdrawal by Subject|9|||
19734476|NCT02819440|42180223|FG001|Overall Study|Withdrawal by Subject|8|||
19734477|NCT03814720|42180234|FG000|Overall Study|Lost to Follow-up|0|||
19734478|NCT03814720|42180235|FG001|Overall Study|Lost to Follow-up|1|||
19734479|NCT03814720|42180236|FG002|Overall Study|Lost to Follow-up|0|||
19734480|NCT03814720|42180237|FG003|Overall Study|Lost to Follow-up|0|||
19734481|NCT03814720|42180238|FG004|Overall Study|Lost to Follow-up|0|||
19734482|NCT02818036|42180254|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
19734483|NCT02818036|42180255|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
19734484|NCT02818036|42180254|FG000|Overall Study|Withdrawal by Subject|1|||
19734485|NCT02818036|42180255|FG001|Overall Study|Withdrawal by Subject|0|||
19734486|NCT01287741|42180263|FG000|Overall Study|Withdrawal by Subject|35|||
19734487|NCT01287741|42180264|FG001|Overall Study|Withdrawal by Subject|38|||
19734488|NCT01287741|42180263|FG000|Overall Study|Protocol Violation|2|||
19734489|NCT01287741|42180264|FG001|Overall Study|Protocol Violation|0|||
19734490|NCT01287741|42180263|FG000|Overall Study|Physician Decision|15|||
19734491|NCT01287741|42180264|FG001|Overall Study|Physician Decision|23|||
19734492|NCT01287741|42180263|FG000|Overall Study|Non-compliance|8|||
19734493|NCT01287741|42180264|FG001|Overall Study|Non-compliance|6|||
19734494|NCT01287741|42180263|FG000|Overall Study|Lost to Follow-up|10|||
19734495|NCT01287741|42180264|FG001|Overall Study|Lost to Follow-up|8|||
19734496|NCT01287741|42180263|FG000|Overall Study|Death|32|||
19734497|NCT01287741|42180264|FG001|Overall Study|Death|44|||
19734498|NCT01287741|42180263|FG000|Overall Study|Adverse Event|4|||
19734499|NCT01287741|42180264|FG001|Overall Study|Adverse Event|6|||
19734500|NCT01287741|42180263|FG000|Overall Study|Study terminated by Sponsor|307|||
19734501|NCT01287741|42180264|FG001|Overall Study|Study terminated by Sponsor|315|||
19734502|NCT01287741|42180263|FG000|Overall Study|Progressive disease|190|||
19734503|NCT01287741|42180264|FG001|Overall Study|Progressive disease|166|||
19734504|NCT01287741|42180263|FG000|Overall Study|Reason not specified|23|||
19734505|NCT01287741|42180264|FG001|Overall Study|Reason not specified|9|||
19734506|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
19734507|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
19734508|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
19734509|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
19734510|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19734511|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
19734512|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
19734513|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
19734514|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
19734515|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
19734516|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
19734517|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
19734518|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
19734519|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
19734520|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
19734521|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
19734522|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
19734523|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
19734524|NCT03739203|42180278|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
19734525|NCT03739203|42180279|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
19734526|NCT03739203|42180280|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
19734527|NCT03739203|42180278|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
19734528|NCT03739203|42180279|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
19734529|NCT03739203|42180280|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
19734530|NCT03739203|42180278|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
19734531|NCT03739203|42180279|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
19734532|NCT03739203|42180280|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
19734533|NCT03739203|42180278|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
19734534|NCT03739203|42180279|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
19734535|NCT03739203|42180280|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
19734536|NCT03739203|42180278|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
19734537|NCT03739203|42180279|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
19734538|NCT03739203|42180280|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
19734539|NCT02942264|42180297|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734540|NCT02942264|42180298|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
19734541|NCT02942264|42180299|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734542|NCT02942264|42180300|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734543|NCT02942264|42180301|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734544|NCT02942264|42180302|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734545|NCT02942264|42180303|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
19734546|NCT02942264|42180304|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734547|NCT02942264|42180305|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
19734548|NCT02942264|42180297|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734549|NCT02942264|42180298|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734550|NCT02942264|42180299|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734551|NCT02942264|42180300|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734552|NCT02942264|42180301|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734553|NCT02942264|42180302|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734554|NCT02942264|42180303|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734555|NCT02942264|42180304|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
19734556|NCT02942264|42180305|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
19734557|NCT03322514|42180332|FG000|Overall Study|Withdrawal by Subject|1|||
19734558|NCT03322514|42180333|FG001|Overall Study|Withdrawal by Subject|1|||
19734559|NCT03325712|42180347|FG000|Overall Study|Protocol Violation|0|||
19734560|NCT03325712|42180348|FG001|Overall Study|Protocol Violation|0|||
19734561|NCT03325712|42180349|FG002|Overall Study|Protocol Violation|0|||
19734562|NCT03325712|42180350|FG003|Overall Study|Protocol Violation|0|||
19734563|NCT03325712|42180351|FG004|Overall Study|Protocol Violation|1|||
19734564|NCT03325712|42180352|FG005|Overall Study|Protocol Violation|0|||
19734565|NCT03325712|42180353|FG006|Overall Study|Protocol Violation|0|||
19734566|NCT03325712|42180354|FG007|Overall Study|Protocol Violation|0|||
19734567|NCT03325712|42180347|FG000|Overall Study|Adverse Event|0|||
19734568|NCT03325712|42180348|FG001|Overall Study|Adverse Event|0|||
19734569|NCT03325712|42180349|FG002|Overall Study|Adverse Event|0|||
19734570|NCT03325712|42180350|FG003|Overall Study|Adverse Event|0|||
19734571|NCT03325712|42180351|FG004|Overall Study|Adverse Event|1|||
19734572|NCT03325712|42180352|FG005|Overall Study|Adverse Event|0|||
19734573|NCT03325712|42180353|FG006|Overall Study|Adverse Event|0|||
19734574|NCT03325712|42180354|FG007|Overall Study|Adverse Event|0|||
19734575|NCT03734679|42180382|FG000|Overall Study|Missed Visit|1|||
19734576|NCT03325556|42180386|FG000|Open-label Period|Lack of Response in OL period|70|||
19734577|NCT03325556|42180387|FG001|Open-label Period|Lack of Response in OL period|0|||
19734578|NCT03325556|42180388|FG002|Open-label Period|Lack of Response in OL period|0|||
19734579|NCT03325556|42180386|FG000|Open-label Period|Adverse Event|27|||
19734580|NCT03325556|42180387|FG001|Open-label Period|Adverse Event|0|||
19734581|NCT03325556|42180388|FG002|Open-label Period|Adverse Event|0|||
19734582|NCT03325556|42180386|FG000|Open-label Period|Death|1|||
19734583|NCT03325556|42180387|FG001|Open-label Period|Death|0|||
19734584|NCT03325556|42180388|FG002|Open-label Period|Death|0|||
19734585|NCT03325556|42180386|FG000|Open-label Period|Lost to Follow-up|1|||
19734586|NCT03325556|42180387|FG001|Open-label Period|Lost to Follow-up|0|||
19734587|NCT03325556|42180388|FG002|Open-label Period|Lost to Follow-up|0|||
19465275|NCT04426695|41723751|FG010|Overall Study|Sponsor Request|0|||
19465276|NCT04426695|41723752|FG011|Overall Study|Sponsor Request|0|||
19734588|NCT03325556|42180386|FG000|Open-label Period|Non-compliance with study drug|5|||
19734589|NCT03325556|42180387|FG001|Open-label Period|Non-compliance with study drug|0|||
19734590|NCT03325556|42180388|FG002|Open-label Period|Non-compliance with study drug|0|||
19734591|NCT03325556|42180386|FG000|Open-label Period|Use of prohibited medication|1|||
19734592|NCT03325556|42180387|FG001|Open-label Period|Use of prohibited medication|0|||
19734593|NCT03325556|42180388|FG002|Open-label Period|Use of prohibited medication|0|||
19734594|NCT03325556|42180386|FG000|Open-label Period|Protocol Violation|4|||
19734595|NCT03325556|42180387|FG001|Open-label Period|Protocol Violation|0|||
19734596|NCT03325556|42180388|FG002|Open-label Period|Protocol Violation|0|||
19734597|NCT03325556|42180386|FG000|Open-label Period|Withdrawal by Subject|17|||
19734598|NCT03325556|42180387|FG001|Open-label Period|Withdrawal by Subject|0|||
19734599|NCT03325556|42180388|FG002|Open-label Period|Withdrawal by Subject|0|||
19734600|NCT03325556|42180386|FG000|Open-label Period|Not otherwise specified|8|||
19734601|NCT03325556|42180387|FG001|Open-label Period|Not otherwise specified|0|||
19734602|NCT03325556|42180388|FG002|Open-label Period|Not otherwise specified|0|||
19734603|NCT03325556|42180386|FG000|Open-label Period|Administrative discont. at study termination|41|||
19734604|NCT03325556|42180387|FG001|Open-label Period|Administrative discont. at study termination|0|||
19734605|NCT03325556|42180388|FG002|Open-label Period|Administrative discont. at study termination|0|||
19734606|NCT03325556|42180386|FG000|Double-blind Period|Relapse|0|||
19734607|NCT03325556|42180387|FG001|Double-blind Period|Relapse|15|||
19734608|NCT03325556|42180388|FG002|Double-blind Period|Relapse|34|||
19734609|NCT03325556|42180386|FG000|Double-blind Period|Adverse Event|0|||
19734610|NCT03325556|42180387|FG001|Double-blind Period|Adverse Event|3|||
19734611|NCT03325556|42180388|FG002|Double-blind Period|Adverse Event|1|||
19734612|NCT03325556|42180386|FG000|Double-blind Period|Noncompliance with study drug|0|||
19734613|NCT03325556|42180387|FG001|Double-blind Period|Noncompliance with study drug|0|||
19734614|NCT03325556|42180388|FG002|Double-blind Period|Noncompliance with study drug|1|||
19734615|NCT03325556|42180386|FG000|Double-blind Period|Use of prohibited medication|0|||
19734616|NCT03325556|42180387|FG001|Double-blind Period|Use of prohibited medication|1|||
19734617|NCT03325556|42180388|FG002|Double-blind Period|Use of prohibited medication|0|||
19734618|NCT03325556|42180386|FG000|Double-blind Period|Physician Decision|0|||
19734619|NCT03325556|42180387|FG001|Double-blind Period|Physician Decision|0|||
19734620|NCT03325556|42180388|FG002|Double-blind Period|Physician Decision|1|||
19734621|NCT03325556|42180386|FG000|Double-blind Period|Withdrawal by Subject|0|||
19734622|NCT03325556|42180387|FG001|Double-blind Period|Withdrawal by Subject|6|||
19734623|NCT03325556|42180388|FG002|Double-blind Period|Withdrawal by Subject|4|||
19734624|NCT03325556|42180386|FG000|Double-blind Period|Not otherwise specified|0|||
19734625|NCT03325556|42180387|FG001|Double-blind Period|Not otherwise specified|1|||
19734626|NCT03325556|42180388|FG002|Double-blind Period|Not otherwise specified|5|||
19734627|NCT03325556|42180386|FG000|Double-blind Period|Administrative discont. at study termination|0|||
19734628|NCT03325556|42180387|FG001|Double-blind Period|Administrative discont. at study termination|35|||
19734629|NCT03325556|42180388|FG002|Double-blind Period|Administrative discont. at study termination|31|||
19734630|NCT03320564|42180395|FG000|Overall Study|Protocol Violation|1|||
19734631|NCT03325166|42180399|FG000|Overall Study|Adverse Event|1|||
19734632|NCT02888756|42180406|FG000|Analytical Treatment Interruption|Physician Decision|10|||
19734633|NCT02888756|42180407|FG001|Analytical Treatment Interruption|Physician Decision|6|||
19734634|NCT02888756|42180408|FG002|Analytical Treatment Interruption|Physician Decision|5|||
19734635|NCT03305666|42180418|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
19734636|NCT03305666|42180419|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
19734637|NCT03304184|42180427|FG000|Overall Study|Withdrawal by Subject|1|||
19734638|NCT03304184|42180428|FG001|Overall Study|Withdrawal by Subject|2|||
19734639|NCT03736785|42180438|FG000|Overall Study|Adverse Event|1|||
19734640|NCT03736785|42180439|FG001|Overall Study|Adverse Event|1|||
19734641|NCT03736785|42180440|FG002|Overall Study|Adverse Event|1|||
19734642|NCT03736785|42180438|FG000|Overall Study|Death|1|||
19734643|NCT03736785|42180439|FG001|Overall Study|Death|0|||
19734644|NCT03736785|42180440|FG002|Overall Study|Death|1|||
19734645|NCT03736785|42180438|FG000|Overall Study|Lost to Follow-up|0|||
19734646|NCT03736785|42180439|FG001|Overall Study|Lost to Follow-up|2|||
19380913|NCT03074695|41624142|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
19380914|NCT03074695|41624141|FG000|Overall Study|Research staff not available|1|||
19380915|NCT03074695|41624142|FG001|Overall Study|Research staff not available|2|||
19380916|NCT03074695|41624141|FG000|Overall Study|Did not receive neuraxial block|2|||
19380917|NCT03074695|41624142|FG001|Overall Study|Did not receive neuraxial block|2|||
19380918|NCT03469999|41624148|FG000|Overall Study|Lost to Follow-up|2|||
19380919|NCT02379728|41624155|FG000|Overall Study|Lost to Follow-up|1|||
19380920|NCT02379728|41624156|FG001|Overall Study|Lost to Follow-up|0|||
19380921|NCT02379728|41624157|FG002|Overall Study|Lost to Follow-up|3|||
19734647|NCT03736785|42180440|FG002|Overall Study|Lost to Follow-up|3|||
19734648|NCT03736785|42180438|FG000|Overall Study|Non compliance with study drug|1|||
19734649|NCT03736785|42180439|FG001|Overall Study|Non compliance with study drug|1|||
19380922|NCT02379728|41624158|FG003|Overall Study|Lost to Follow-up|0|||
19380923|NCT02379728|41624155|FG000|Overall Study|Withdrawal by Subject|5|||
19734650|NCT03736785|42180440|FG002|Overall Study|Non compliance with study drug|0|||
19734651|NCT03736785|42180438|FG000|Overall Study|Physician Decision|0|||
19734652|NCT03736785|42180439|FG001|Overall Study|Physician Decision|1|||
19734653|NCT03736785|42180440|FG002|Overall Study|Physician Decision|1|||
19734654|NCT03736785|42180438|FG000|Overall Study|Protocol Violation|1|||
19734655|NCT03736785|42180439|FG001|Overall Study|Protocol Violation|4|||
19734656|NCT03736785|42180440|FG002|Overall Study|Protocol Violation|3|||
19734657|NCT03736785|42180438|FG000|Overall Study|Sponsor Decision|1|||
19734658|NCT03736785|42180439|FG001|Overall Study|Sponsor Decision|0|||
19734659|NCT03736785|42180440|FG002|Overall Study|Sponsor Decision|0|||
19734660|NCT03736785|42180438|FG000|Overall Study|Unknown/Missing data|3|||
19734661|NCT03736785|42180439|FG001|Overall Study|Unknown/Missing data|2|||
19734662|NCT03736785|42180440|FG002|Overall Study|Unknown/Missing data|1|||
19734663|NCT03736785|42180438|FG000|Overall Study|Withdrawal by Subject|9|||
19734664|NCT03736785|42180439|FG001|Overall Study|Withdrawal by Subject|6|||
19734665|NCT03736785|42180440|FG002|Overall Study|Withdrawal by Subject|4|||
19734666|NCT03734991|42180451|FG000|Overall Study|Adverse Event|4|||
19734667|NCT03734991|42180452|FG001|Overall Study|Adverse Event|0|||
19734668|NCT03734991|42180451|FG000|Overall Study|Lost to Follow-up|4|||
19734669|NCT03734991|42180452|FG001|Overall Study|Lost to Follow-up|0|||
19734670|NCT03734991|42180451|FG000|Overall Study|Physician Decision|0|||
19734671|NCT03734991|42180452|FG001|Overall Study|Physician Decision|1|||
19734672|NCT03734991|42180451|FG000|Overall Study|Pregnancy|1|||
19734673|NCT03734991|42180452|FG001|Overall Study|Pregnancy|0|||
19734674|NCT03734991|42180451|FG000|Overall Study|Withdrawal by Subject|6|||
19734675|NCT03734991|42180452|FG001|Overall Study|Withdrawal by Subject|3|||
19734676|NCT03734991|42180451|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
19734677|NCT03734991|42180452|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
19734678|NCT03734991|42180451|FG000|Overall Study|Other|2|||
19734679|NCT03734991|42180452|FG001|Overall Study|Other|2|||
19734680|NCT03303092|42180461|FG000|Overall Study|Adverse Event|1|||
19734681|NCT03303092|42180462|FG001|Overall Study|Adverse Event|0|||
19734682|NCT03303092|42180463|FG002|Overall Study|Adverse Event|1|||
19734683|NCT03303092|42180461|FG000|Overall Study|Protocol Violation|1|||
19734684|NCT03303092|42180462|FG001|Overall Study|Protocol Violation|5|||
19734685|NCT03303092|42180463|FG002|Overall Study|Protocol Violation|1|||
19734686|NCT03303092|42180461|FG000|Overall Study|Withdrawal by Subject|1|||
19734687|NCT03303092|42180462|FG001|Overall Study|Withdrawal by Subject|1|||
19734688|NCT03303092|42180463|FG002|Overall Study|Withdrawal by Subject|3|||
19734689|NCT04517864|42180473|FG000|Placebo-Controlled Phase|Adverse Event|1|||
19734690|NCT04517864|42180474|FG001|Placebo-Controlled Phase|Adverse Event|0|||
19734691|NCT04517864|42180473|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
19734692|NCT04517864|42180474|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
19734693|NCT04517864|42180473|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
19734694|NCT04517864|42180474|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
19734695|NCT04517864|42180473|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
19734696|NCT04517864|42180474|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
19734697|NCT04517864|42180473|FG000|Active Therapy Extension Phase|Adverse Event|1|||
19734698|NCT04517864|42180474|FG001|Active Therapy Extension Phase|Adverse Event|0|||
19734699|NCT03302936|42180495|FG000|Overall Study|Protocol Violation|3|||
19734700|NCT03302936|42180496|FG001|Overall Study|Protocol Violation|4|||
19734701|NCT03733899|42180506|FG000|Period 1|Protocol Violation|0|||
19734702|NCT03733899|42180507|FG001|Period 1|Protocol Violation|0|||
19734703|NCT03733899|42180508|FG002|Period 1|Protocol Violation|0|||
19734704|NCT03733899|42180509|FG003|Period 1|Protocol Violation|0|||
19734705|NCT03733899|42180510|FG004|Period 1|Protocol Violation|0|||
19734706|NCT03733899|42180511|FG005|Period 1|Protocol Violation|1|||
19734707|NCT03733899|42180506|FG000|Period 2|Unscuccessful Treatment|0|||
19734708|NCT03733899|42180507|FG001|Period 2|Unscuccessful Treatment|1|||
19734709|NCT03733899|42180508|FG002|Period 2|Unscuccessful Treatment|0|||
19734710|NCT03733899|42180509|FG003|Period 2|Unscuccessful Treatment|0|||
19734711|NCT03733899|42180510|FG004|Period 2|Unscuccessful Treatment|0|||
19734712|NCT03733899|42180511|FG005|Period 2|Unscuccessful Treatment|0|||
19734713|NCT03733899|42180506|FG000|Period 3|Withdrawal by Subject|1|||
19639127|NCT00717236|42088569|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
19639128|NCT00717236|42088570|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
19639129|NCT00717236|42088569|FG000|Double-Blind Period|Other: Site withdrew|2|||
19639130|NCT00717236|42088570|FG001|Double-Blind Period|Other: Site withdrew|0|||
19639131|NCT00717236|42088569|FG000|Double-Blind Period|Other: Screening failure|1|||
19639132|NCT00717236|42088570|FG001|Double-Blind Period|Other: Screening failure|0|||
19639133|NCT00717236|42088569|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
19639134|NCT00717236|42088570|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
19639135|NCT00717236|42088569|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
19639136|NCT00717236|42088570|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
19639137|NCT00717236|42088569|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
19639138|NCT00717236|42088570|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
19734714|NCT03733899|42180507|FG001|Period 3|Withdrawal by Subject|0|||
19734715|NCT03733899|42180508|FG002|Period 3|Withdrawal by Subject|0|||
19734716|NCT03733899|42180509|FG003|Period 3|Withdrawal by Subject|0|||
19734717|NCT03733899|42180510|FG004|Period 3|Withdrawal by Subject|0|||
19734718|NCT03733899|42180511|FG005|Period 3|Withdrawal by Subject|0|||
19734719|NCT03727347|42180524|FG000|Overall Study|Withdrawal by Subject|2|||
19734720|NCT03727347|42180524|FG000|Overall Study|Lost to Follow-up|1|||
19734721|NCT03302234|42180539|FG000|Overall Study|Death|137|||
19734722|NCT03302234|42180540|FG001|Overall Study|Death|135|||
19734723|NCT03302234|42180539|FG000|Overall Study|Withdrawal by Subject|1|||
19734724|NCT03302234|42180540|FG001|Overall Study|Withdrawal by Subject|1|||
19734725|NCT03302234|42180539|FG000|Overall Study|Laryngeal carcinoma|0|||
19734726|NCT03302234|42180540|FG001|Overall Study|Laryngeal carcinoma|1|||
19734727|NCT03915626|42180547|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
19734728|NCT03301844|42180559|FG000|Overall Study|suspected colon cancer|1|||
19734729|NCT03301844|42180560|FG001|Overall Study|suspected colon cancer|1|||
19734730|NCT03313310|42180568|FG000|Phase 2|Lost to Follow-up|4|||
19734731|NCT03313310|42180569|FG001|Phase 2|Lost to Follow-up|0|||
19734732|NCT03313310|42180568|FG000|Phase 3|Lost to Follow-up|0|||
19734733|NCT03313310|42180569|FG001|Phase 3|Lost to Follow-up|1|||
19734734|NCT03313076|42180579|FG000|Overall Study|Withdrawal by Subject|2|||
19734735|NCT03313076|42180580|FG001|Overall Study|Withdrawal by Subject|0|||
19734736|NCT03313076|42180581|FG002|Overall Study|Withdrawal by Subject|0|||
19734737|NCT03313076|42180582|FG003|Overall Study|Withdrawal by Subject|0|||
19734738|NCT03313076|42180579|FG000|Overall Study|Lost to Follow-up|0|||
19734739|NCT03313076|42180580|FG001|Overall Study|Lost to Follow-up|2|||
19734740|NCT03313076|42180581|FG002|Overall Study|Lost to Follow-up|2|||
19734741|NCT03313076|42180582|FG003|Overall Study|Lost to Follow-up|2|||
19734742|NCT02940626|42180600|FG000|Overall Study|Death|40|||
19734743|NCT02940626|42180601|FG001|Overall Study|Death|32|||
19734744|NCT02940626|42180600|FG000|Overall Study|Lost to Follow-up|5|||
19734745|NCT02940626|42180601|FG001|Overall Study|Lost to Follow-up|2|||
19734746|NCT02940626|42180600|FG000|Overall Study|Withdrawal by Subject|1|||
19734747|NCT02940626|42180601|FG001|Overall Study|Withdrawal by Subject|0|||
19734748|NCT02940626|42180600|FG000|Overall Study|Transfer to Hospice Care|1|||
19734749|NCT02940626|42180601|FG001|Overall Study|Transfer to Hospice Care|0|||
19734750|NCT02940626|42180600|FG000|Overall Study|Prohibited Concomitant Medication|0|||
19734751|NCT02940626|42180601|FG001|Overall Study|Prohibited Concomitant Medication|1|||
19734752|NCT03300050|42180614|FG000|Overall Study|Lost to Follow-up|2|||
19734753|NCT03300050|42180615|FG001|Overall Study|Lost to Follow-up|1|||
19734754|NCT03300050|42180616|FG002|Overall Study|Lost to Follow-up|0|||
19734755|NCT03300050|42180617|FG003|Overall Study|Lost to Follow-up|0|||
19734756|NCT03300050|42180618|FG004|Overall Study|Lost to Follow-up|1|||
19734757|NCT03300050|42180614|FG000|Overall Study|Withdrawal by Subject|1|||
19734758|NCT03300050|42180615|FG001|Overall Study|Withdrawal by Subject|1|||
19734759|NCT03300050|42180616|FG002|Overall Study|Withdrawal by Subject|1|||
19734760|NCT03300050|42180617|FG003|Overall Study|Withdrawal by Subject|0|||
19734761|NCT03300050|42180618|FG004|Overall Study|Withdrawal by Subject|0|||
19734762|NCT03300050|42180614|FG000|Overall Study|Death|0|||
19734763|NCT03300050|42180615|FG001|Overall Study|Death|0|||
19734764|NCT03300050|42180616|FG002|Overall Study|Death|1|||
19734765|NCT03300050|42180617|FG003|Overall Study|Death|0|||
19734766|NCT03300050|42180618|FG004|Overall Study|Death|0|||
19734767|NCT03300050|42180614|FG000|Overall Study|Not Eligible at Randomization|0|||
19734768|NCT03300050|42180615|FG001|Overall Study|Not Eligible at Randomization|0|||
19734769|NCT03300050|42180616|FG002|Overall Study|Not Eligible at Randomization|1|||
19734770|NCT03300050|42180617|FG003|Overall Study|Not Eligible at Randomization|1|||
19734771|NCT03300050|42180618|FG004|Overall Study|Not Eligible at Randomization|0|||
19734772|NCT03725085|42180630|FG000|Overall Study|Lost to Follow-up|2|||
19734773|NCT02940392|42180635|FG000|Overall Study|Lost to Follow-up|3|||
19734774|NCT02940392|42180635|FG000|Overall Study|Retreatment|3|||
19734775|NCT02940392|42180635|FG000|Overall Study|Death|2|||
19734776|NCT03298412|42180648|FG000|Run-in Period|Other, Not Specified|1|||
19734777|NCT03298412|42180648|FG000|Run-in Period|Disease Progression|1|||
19734778|NCT03298412|42180648|FG000|Run-in Period|Ineligibility Determined|1|||
19734779|NCT03298412|42180648|FG000|Run-in Period|Decision by Sponsor|6|||
19734780|NCT03297398|42180655|FG000|Overall Study|Sponsor's decision|6|||
19734781|NCT03297398|42180656|FG001|Overall Study|Sponsor's decision|9|||
19734782|NCT03297398|42180657|FG002|Overall Study|Sponsor's decision|7|||
19380924|NCT02379728|41624156|FG001|Overall Study|Withdrawal by Subject|0|||
19380925|NCT02379728|41624157|FG002|Overall Study|Withdrawal by Subject|5|||
19734783|NCT03297398|42180655|FG000|Overall Study|Adverse Event|1|||
19734784|NCT03297398|42180656|FG001|Overall Study|Adverse Event|4|||
19734785|NCT03297398|42180657|FG002|Overall Study|Adverse Event|4|||
19734786|NCT03297398|42180655|FG000|Overall Study|Withdrawal by Subject|1|||
19734787|NCT03297398|42180656|FG001|Overall Study|Withdrawal by Subject|2|||
19734788|NCT03297398|42180657|FG002|Overall Study|Withdrawal by Subject|2|||
19734789|NCT03297398|42180655|FG000|Overall Study|Protocol Violation|0|||
19734790|NCT03297398|42180656|FG001|Overall Study|Protocol Violation|2|||
19734791|NCT03297398|42180657|FG002|Overall Study|Protocol Violation|0|||
19734792|NCT03297398|42180655|FG000|Overall Study|Physician Decision|0|||
19734793|NCT03297398|42180656|FG001|Overall Study|Physician Decision|0|||
19734794|NCT03297398|42180657|FG002|Overall Study|Physician Decision|1|||
19734795|NCT03297398|42180655|FG000|Overall Study|Lost to Follow-up|0|||
19734796|NCT03297398|42180656|FG001|Overall Study|Lost to Follow-up|0|||
19734797|NCT03297398|42180657|FG002|Overall Study|Lost to Follow-up|1|||
19734798|NCT03293654|42180668|FG000|Overall Study|Lost to Follow-up|0|||
19734799|NCT03293654|42180669|FG001|Overall Study|Lost to Follow-up|1|||
19734800|NCT03293654|42180670|FG002|Overall Study|Lost to Follow-up|0|||
19734801|NCT03312218|42180680|FG000|Overall Study|Never signed in to access the app|54|||
19734802|NCT03312218|42180681|FG001|Overall Study|Never signed in to access the app|58|||
19734803|NCT03930615|42180689|FG000|Overall Study|Death|9|||
19734804|NCT03930615|42180690|FG001|Overall Study|Death|3|||
19734805|NCT03930615|42180689|FG000|Overall Study|Lost to Follow-up|1|||
19734806|NCT03930615|42180690|FG001|Overall Study|Lost to Follow-up|2|||
19734807|NCT03930615|42180689|FG000|Overall Study|Physician Decision|3|||
19734808|NCT03930615|42180690|FG001|Overall Study|Physician Decision|4|||
19734809|NCT03930615|42180689|FG000|Overall Study|Withdrawal by Subject|13|||
19734810|NCT03930615|42180690|FG001|Overall Study|Withdrawal by Subject|2|||
19734811|NCT03930615|42180689|FG000|Overall Study|Not treated|1|||
19734812|NCT03930615|42180690|FG001|Overall Study|Not treated|1|||
19734813|NCT03292640|42180698|FG000|Overall Study|Withdrawal by Subject|17|||
19734814|NCT03292640|42180699|FG001|Overall Study|Withdrawal by Subject|16|||
19734815|NCT03292640|42180698|FG000|Overall Study|Adverse Event|20|||
19734816|NCT03292640|42180699|FG001|Overall Study|Adverse Event|2|||
19734817|NCT03292640|42180698|FG000|Overall Study|Lost to Follow-up|24|||
19734818|NCT03292640|42180699|FG001|Overall Study|Lost to Follow-up|24|||
19734819|NCT03292406|42180721|FG000|Overall Study|Progressive Disease|6|||
19734820|NCT03292406|42180722|FG001|Overall Study|Progressive Disease|3|||
19734821|NCT03292406|42180723|FG002|Overall Study|Progressive Disease|4|||
19734822|NCT03292406|42180721|FG000|Overall Study|Adverse Event|7|||
19734823|NCT03292406|42180722|FG001|Overall Study|Adverse Event|1|||
19734824|NCT03292406|42180723|FG002|Overall Study|Adverse Event|4|||
19734825|NCT03292406|42180721|FG000|Overall Study|Withdrawal by Subject|0|||
19734826|NCT03292406|42180722|FG001|Overall Study|Withdrawal by Subject|7|||
19734827|NCT03292406|42180723|FG002|Overall Study|Withdrawal by Subject|2|||
19734828|NCT03292406|42180721|FG000|Overall Study|Protocol Violation|0|||
19734829|NCT03292406|42180722|FG001|Overall Study|Protocol Violation|1|||
19734830|NCT03292406|42180723|FG002|Overall Study|Protocol Violation|1|||
19734831|NCT03292406|42180721|FG000|Overall Study|Other|0|||
19734832|NCT03292406|42180722|FG001|Overall Study|Other|1|||
19734833|NCT03292406|42180723|FG002|Overall Study|Other|2|||
19734834|NCT03292016|42180743|FG000|Second Washout|Adverse Event|0|||
19734835|NCT03292016|42180744|FG001|Second Washout|Adverse Event|1|||
19734836|NCT03292016|42180745|FG002|Second Washout|Adverse Event|0|||
19734837|NCT03292016|42180746|FG003|Second Washout|Adverse Event|0|||
19734838|NCT03292016|42180747|FG004|Second Washout|Adverse Event|0|||
19734839|NCT03292016|42180748|FG005|Second Washout|Adverse Event|0|||
19734840|NCT03290300|42180756|FG000|Overall Study|Lost to Follow-up|3|||
19734841|NCT03289676|42180769|FG000|Overall Study|Withdrawal by Subject|2|||
19734842|NCT03289676|42180770|FG001|Overall Study|Withdrawal by Subject|0|||
19734843|NCT03289676|42180769|FG000|Overall Study|Protocol Violation|2|||
19734844|NCT03289676|42180770|FG001|Overall Study|Protocol Violation|0|||
19734845|NCT03289676|42180769|FG000|Overall Study|Lost to Follow-up|0|||
19734846|NCT03289676|42180770|FG001|Overall Study|Lost to Follow-up|1|||
19734847|NCT03287804|42180786|FG000|Overall Study|Death|1|||
19734848|NCT03287804|42180786|FG000|Overall Study|Physician Decision|2|||
19734849|NCT03287804|42180786|FG000|Overall Study|Progressive disease|8|||
19734850|NCT03286400|42180791|FG000|Overall Study|Death|10|||
19734851|NCT03286400|42180791|FG000|Overall Study|Lost to Follow-up|10|||
19734852|NCT03286400|42180791|FG000|Overall Study|Physician Decision|1|||
19734853|NCT03286400|42180791|FG000|Overall Study|Scheduling difficulty|4|||
19734854|NCT03310970|42180795|FG000|Overall Study|Withdrawal by Subject|0|||
19734855|NCT03310970|42180796|FG001|Overall Study|Withdrawal by Subject|1|||
19734856|NCT03285308|42180805|FG000|Overall Study|Adverse Event|3|||
19734857|NCT03285308|42180806|FG001|Overall Study|Adverse Event|7|||
19734858|NCT03285308|42180805|FG000|Overall Study|Withdrawal by Subject|8|||
19734859|NCT03285308|42180806|FG001|Overall Study|Withdrawal by Subject|9|||
19734860|NCT03285308|42180805|FG000|Overall Study|Lost to Follow-up|3|||
19734861|NCT03285308|42180806|FG001|Overall Study|Lost to Follow-up|1|||
19734862|NCT03285308|42180805|FG000|Overall Study|Protocol Deviation|6|||
19734863|NCT03285308|42180806|FG001|Overall Study|Protocol Deviation|5|||
19465277|NCT04426695|41723753|FG012|Overall Study|Sponsor Request|0|||
19734864|NCT03285308|42180805|FG000|Overall Study|Reason not Specified|0|||
19734865|NCT03285308|42180806|FG001|Overall Study|Reason not Specified|1|||
19734866|NCT03537651|42180813|FG000|Overall Study|Adverse Event|2|||
19734867|NCT03537651|42180813|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
19734868|NCT03537651|42180813|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
19734869|NCT03537651|42180813|FG000|Overall Study|Other|1|||
19734870|NCT03723915|42180820|FG000|Screening|Failed to meet screening requirements.|2|||
19734871|NCT03723915|42180820|FG000|On Treatment|Failed to meet treatment requirements|2|||
19734872|NCT03281876|42180826|FG000|Overall Study|Adverse Event|4|||
19734873|NCT03281876|42180827|FG001|Overall Study|Adverse Event|15|||
19734874|NCT03281876|42180826|FG000|Overall Study|Lost to Follow-up|1|||
19734875|NCT03281876|42180827|FG001|Overall Study|Lost to Follow-up|4|||
19734876|NCT03281876|42180826|FG000|Overall Study|Withdrawal by Subject|11|||
19734877|NCT03281876|42180827|FG001|Overall Study|Withdrawal by Subject|15|||
19734878|NCT03281876|42180826|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
19734879|NCT03281876|42180827|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19734880|NCT03281876|42180826|FG000|Overall Study|OTHER|5|||
19734881|NCT03281876|42180827|FG001|Overall Study|OTHER|5|||
19734882|NCT02819518|42180838|FG000|Overall Study|Death|9|||
19734883|NCT02819518|42180839|FG001|Overall Study|Death|11|||
19734884|NCT02819518|42180840|FG002|Overall Study|Death|9|||
19734885|NCT02819518|42180841|FG003|Overall Study|Death|447|||
19734886|NCT02819518|42180842|FG004|Overall Study|Death|233|||
19734887|NCT02819518|42180838|FG000|Overall Study|Withdrawal by Subject|0|||
19734888|NCT02819518|42180839|FG001|Overall Study|Withdrawal by Subject|0|||
19734889|NCT02819518|42180840|FG002|Overall Study|Withdrawal by Subject|0|||
19734890|NCT02819518|42180841|FG003|Overall Study|Withdrawal by Subject|21|||
19734891|NCT02819518|42180842|FG004|Overall Study|Withdrawal by Subject|6|||
19734892|NCT02819518|42180838|FG000|Overall Study|Ongoing in Study|2|||
19734893|NCT02819518|42180839|FG001|Overall Study|Ongoing in Study|3|||
19734894|NCT02819518|42180840|FG002|Overall Study|Ongoing in Study|1|||
19734895|NCT02819518|42180841|FG003|Overall Study|Ongoing in Study|98|||
19734896|NCT02819518|42180842|FG004|Overall Study|Ongoing in Study|42|||
19734897|NCT03310580|42180859|FG000|Overall Study|Adverse Event|0|||
19734898|NCT03310580|42180860|FG001|Overall Study|Adverse Event|1|||
19734899|NCT03310580|42180861|FG002|Overall Study|Adverse Event|0|||
19734900|NCT03415022|42180884|FG000|Overall Study|Withdrawal by Subject|1|||
19734901|NCT03415022|42180885|FG001|Overall Study|Withdrawal by Subject|2|||
19734902|NCT03415022|42180884|FG000|Overall Study|COVID-19 Suspension|2|||
19734903|NCT03415022|42180885|FG001|Overall Study|COVID-19 Suspension|3|||
19734904|NCT03415022|42180884|FG000|Overall Study|Lost to Follow-up|2|||
19734905|NCT03415022|42180885|FG001|Overall Study|Lost to Follow-up|0|||
19734906|NCT02816398|42180891|FG000|Overall Study|Death|5|||
19734907|NCT02816398|42180891|FG000|Overall Study|Lack of Efficacy|8|||
19734908|NCT02816398|42180891|FG000|Overall Study|Lost to Follow-up|1|||
19734909|NCT02812186|42180897|FG000|Period 1|Post randomization screen failure|5|||
19734910|NCT02812186|42180898|FG001|Period 1|Post randomization screen failure|9|||
19734911|NCT02812186|42180897|FG000|Period 1|nonevaluable data sets|6|||
19734912|NCT02812186|42180898|FG001|Period 1|nonevaluable data sets|6|||
19734913|NCT02811640|42180907|FG000|Overall Study|Technology malfunction|2|||
19734914|NCT03310268|42180914|FG000|Overall Study|(Not specified)|1|||
19734915|NCT03310268|42180915|FG001|Overall Study|(Not specified)|5|||
19734916|NCT03310268|42180916|FG002|Overall Study|(Not specified)|0|||
19734917|NCT02810392|42180926|FG000|Overall Study|Subject too ill to continue|1|||
19734918|NCT02810392|42180927|FG001|Overall Study|Subject too ill to continue|0|||
19734919|NCT02810392|42180926|FG000|Overall Study|COVID 19 research restrictions|0|||
19734920|NCT02810392|42180927|FG001|Overall Study|COVID 19 research restrictions|1|||
19734921|NCT02815540|42180933|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
19734922|NCT03280550|42180939|FG000|Overall Study|Withdrawal by Subject|2|||
19734923|NCT03280550|42180940|FG001|Overall Study|Withdrawal by Subject|2|||
19734924|NCT03280550|42180939|FG000|Overall Study|Physician Decision|0|||
19734925|NCT03280550|42180940|FG001|Overall Study|Physician Decision|1|||
19734926|NCT03276026|42180948|FG000|Overall Study|Protocol Violation|1|||
19734927|NCT03276026|42180949|FG001|Overall Study|Protocol Violation|0|||
19734928|NCT01589523|42180955|FG000|Overall Study|Withdrawal by Subject|1|||
19734929|NCT03277352|42180961|FG000|Overall Study|Study Terminated By Sponsor|2|||
19734930|NCT03277352|42180961|FG000|Overall Study|Withdrawal by Subject|4|||
19734931|NCT03277352|42180961|FG000|Overall Study|Death|4|||
19734932|NCT02814838|42180968|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
19734933|NCT02814838|42180969|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
19734934|NCT02814838|42180968|FG000|Overall Study|Consent withdrawal|1|||
19734935|NCT02814838|42180969|FG001|Overall Study|Consent withdrawal|1|||
19734936|NCT03276728|42180983|FG000|Overall Study|Lost to Follow-up|0|||
19734937|NCT03276728|42180984|FG001|Overall Study|Lost to Follow-up|0|||
19734938|NCT03276728|42180985|FG002|Overall Study|Lost to Follow-up|2|||
19734939|NCT03276728|42180986|FG003|Overall Study|Lost to Follow-up|2|||
19734940|NCT03276728|42180987|FG004|Overall Study|Lost to Follow-up|0|||
19734941|NCT03276728|42180988|FG005|Overall Study|Lost to Follow-up|0|||
19734942|NCT03276728|42180989|FG006|Overall Study|Lost to Follow-up|0|||
19734943|NCT03276728|42180990|FG007|Overall Study|Lost to Follow-up|0|||
19734944|NCT03276728|42180983|FG000|Overall Study|Withdrawal by Subject|0|||
19734945|NCT03276728|42180984|FG001|Overall Study|Withdrawal by Subject|0|||
19734946|NCT03276728|42180985|FG002|Overall Study|Withdrawal by Subject|0|||
19734947|NCT03276728|42180986|FG003|Overall Study|Withdrawal by Subject|3|||
19734948|NCT03276728|42180987|FG004|Overall Study|Withdrawal by Subject|0|||
19734949|NCT03276728|42180988|FG005|Overall Study|Withdrawal by Subject|0|||
19734950|NCT03276728|42180989|FG006|Overall Study|Withdrawal by Subject|0|||
19734951|NCT03276728|42180990|FG007|Overall Study|Withdrawal by Subject|0|||
19734952|NCT03276728|42180983|FG000|Overall Study|Decision by sponsor|0|||
19734953|NCT03276728|42180984|FG001|Overall Study|Decision by sponsor|0|||
19734954|NCT03276728|42180985|FG002|Overall Study|Decision by sponsor|0|||
19734955|NCT03276728|42180986|FG003|Overall Study|Decision by sponsor|0|||
19734956|NCT03276728|42180987|FG004|Overall Study|Decision by sponsor|1|||
19734957|NCT03276728|42180988|FG005|Overall Study|Decision by sponsor|0|||
19734958|NCT03276728|42180989|FG006|Overall Study|Decision by sponsor|2|||
19734959|NCT03276728|42180990|FG007|Overall Study|Decision by sponsor|1|||
19734960|NCT03275246|42181010|FG000|Overall Study|Protocol Violation|5|||
19734961|NCT03275246|42181010|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
19734962|NCT02940860|42181016|FG000|Overall Study|Non-serious AE|1|||
19734963|NCT02940860|42181017|FG001|Overall Study|Non-serious AE|2|||
19734964|NCT02940860|42181016|FG000|Overall Study|Serious AE|7|||
19734965|NCT02940860|42181017|FG001|Overall Study|Serious AE|3|||
19734966|NCT02940860|42181016|FG000|Overall Study|Withdrawal by Subject|19|||
19734967|NCT02940860|42181017|FG001|Overall Study|Withdrawal by Subject|9|||
19734968|NCT02940860|42181016|FG000|Overall Study|Lost to Follow-up|13|||
19734969|NCT02940860|42181017|FG001|Overall Study|Lost to Follow-up|7|||
19734970|NCT02940860|42181016|FG000|Overall Study|Physician Decision|5|||
19734971|NCT02940860|42181017|FG001|Overall Study|Physician Decision|3|||
19734972|NCT02940860|42181016|FG000|Overall Study|Sponsor Decision|0|||
19734973|NCT02940860|42181017|FG001|Overall Study|Sponsor Decision|1|||
19734974|NCT02940860|42181016|FG000|Overall Study|Protocol Violation|0|||
19734975|NCT02940860|42181017|FG001|Overall Study|Protocol Violation|2|||
19734976|NCT02940860|42181016|FG000|Overall Study|Death|3|||
19734977|NCT02940860|42181017|FG001|Overall Study|Death|2|||
19734978|NCT02940860|42181016|FG000|Overall Study|Moved, poor venous access, transport|6|||
19734979|NCT02940860|42181017|FG001|Overall Study|Moved, poor venous access, transport|4|||
19734980|NCT02940860|42181016|FG000|Overall Study|Not treated|2|||
19734981|NCT02940860|42181017|FG001|Overall Study|Not treated|2|||
19734982|NCT03309020|42181027|FG000|Overall Study|Death|1|||
19734983|NCT03309020|42181028|FG001|Overall Study|Death|0|||
19734984|NCT03309020|42181027|FG000|Overall Study|Did not undergo surgery|2|||
19734985|NCT03309020|42181028|FG001|Overall Study|Did not undergo surgery|1|||
19734986|NCT02806960|42181036|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
19734987|NCT02806960|42181037|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
19734988|NCT02806960|42181038|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
19734989|NCT02806960|42181039|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
19734990|NCT03718143|42181049|FG000|Overall Study|Death|1|||
19734991|NCT03718143|42181050|FG001|Overall Study|Death|0|||
19734992|NCT03718143|42181051|FG002|Overall Study|Death|0|||
19734993|NCT03718143|42181049|FG000|Overall Study|Progression of Disease|1|||
19734994|NCT03718143|42181050|FG001|Overall Study|Progression of Disease|0|||
19734995|NCT03718143|42181051|FG002|Overall Study|Progression of Disease|0|||
19734996|NCT03718143|42181049|FG000|Overall Study|Withdrawal of Informed Consent|1|||
19734997|NCT03718143|42181050|FG001|Overall Study|Withdrawal of Informed Consent|2|||
19734998|NCT03718143|42181051|FG002|Overall Study|Withdrawal of Informed Consent|1|||
19734999|NCT03274466|42181061|FG000|Overall Study|Withdrawal by Subject|7|||
19735000|NCT03274466|42181062|FG001|Overall Study|Withdrawal by Subject|3|||
19735001|NCT03274466|42181061|FG000|Overall Study|Protocol Specified Withdrawal|5|||
19735002|NCT03274466|42181062|FG001|Overall Study|Protocol Specified Withdrawal|11|||
19735003|NCT03274466|42181061|FG000|Overall Study|Lost to Follow-up|5|||
19735004|NCT03274466|42181062|FG001|Overall Study|Lost to Follow-up|7|||
19735005|NCT03274466|42181061|FG000|Overall Study|Subject Non-compliance|0|||
19735006|NCT03274466|42181062|FG001|Overall Study|Subject Non-compliance|1|||
19735007|NCT03274466|42181061|FG000|Overall Study|Adverse Event|3|||
19735008|NCT03274466|42181062|FG001|Overall Study|Adverse Event|3|||
19735009|NCT03274466|42181061|FG000|Overall Study|Physician Decision|0|||
19735010|NCT03274466|42181062|FG001|Overall Study|Physician Decision|1|||
19735011|NCT03274466|42181061|FG000|Overall Study|Protocol Violation|3|||
19735012|NCT03274466|42181062|FG001|Overall Study|Protocol Violation|3|||
19735013|NCT02806726|42181068|FG000|Overall Study|Lost to Follow-up|1|||
19735014|NCT02806414|42181073|FG000|Overall Study|Lost to Follow-up|2|||
19735015|NCT02806024|42181079|FG000|Overall Study|Night Delivery|1|||
19735016|NCT02806024|42181080|FG001|Overall Study|Night Delivery|1|||
19735017|NCT02806024|42181079|FG000|Overall Study|DVT during antepartum admission|0|||
19735018|NCT02806024|42181080|FG001|Overall Study|DVT during antepartum admission|1|||
19735019|NCT02805790|42181088|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
19735020|NCT02805790|42181089|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
19735021|NCT02802592|42181095|FG000|Overall Study|Study terminated due to loss of funding|4|||
19735022|NCT02803138|42181100|FG000|Overall Study|Failure to return|38|||
19735023|NCT02803138|42181100|FG000|Overall Study|Insufficient virological response|2|||
19735024|NCT02803138|42181100|FG000|Overall Study|Withdrawn consent|1|||
19735025|NCT02803138|42181100|FG000|Overall Study|Death|1|||
19735026|NCT02803138|42181100|FG000|Overall Study|Other, not specified|28|||
19735027|NCT02801578|42181106|FG000|Overall Study|Adverse Event|2|||
19735028|NCT02799472|42181112|FG000|Overall Study|Withdrawal by Subject|2|||
19735029|NCT02799472|42181113|FG001|Overall Study|Withdrawal by Subject|4|||
19735030|NCT02799472|42181112|FG000|Overall Study|Lack of Efficacy|2|||
19735031|NCT02799472|42181113|FG001|Overall Study|Lack of Efficacy|0|||
19735032|NCT02799472|42181112|FG000|Overall Study|Lost to Follow-up|0|||
19735033|NCT02799472|42181113|FG001|Overall Study|Lost to Follow-up|1|||
19735034|NCT03245450|42181126|FG000|Overall Study|Radiological disease progression|3|||
19735035|NCT03245450|42181127|FG001|Overall Study|Radiological disease progression|3|||
19735036|NCT03245450|42181128|FG002|Overall Study|Radiological disease progression|2|||
19735037|NCT03245450|42181129|FG003|Overall Study|Radiological disease progression|2|||
19735038|NCT03245450|42181130|FG004|Overall Study|Radiological disease progression|7|||
19735039|NCT03245450|42181131|FG005|Overall Study|Radiological disease progression|6|||
19735040|NCT03245450|42181132|FG006|Overall Study|Radiological disease progression|6|||
19735041|NCT03245450|42181126|FG000|Overall Study|Clinical disease progression|0|||
19735042|NCT03245450|42181127|FG001|Overall Study|Clinical disease progression|0|||
19735043|NCT03245450|42181128|FG002|Overall Study|Clinical disease progression|1|||
19735044|NCT03245450|42181129|FG003|Overall Study|Clinical disease progression|0|||
19735045|NCT03245450|42181130|FG004|Overall Study|Clinical disease progression|0|||
19735046|NCT03245450|42181131|FG005|Overall Study|Clinical disease progression|2|||
19735047|NCT03245450|42181132|FG006|Overall Study|Clinical disease progression|0|||
19735048|NCT03245450|42181126|FG000|Overall Study|Other|0|||
19735049|NCT03245450|42181127|FG001|Overall Study|Other|0|||
19735050|NCT03245450|42181128|FG002|Overall Study|Other|0|||
19735051|NCT03245450|42181129|FG003|Overall Study|Other|1|||
19735052|NCT03245450|42181130|FG004|Overall Study|Other|1|||
19735053|NCT03245450|42181131|FG005|Overall Study|Other|1|||
19735054|NCT03245450|42181132|FG006|Overall Study|Other|1|||
19735055|NCT03245450|42181126|FG000|Overall Study|Withdrawal by Subject|0|||
19735056|NCT03245450|42181127|FG001|Overall Study|Withdrawal by Subject|1|||
19735057|NCT03245450|42181128|FG002|Overall Study|Withdrawal by Subject|0|||
19735058|NCT03245450|42181129|FG003|Overall Study|Withdrawal by Subject|0|||
19735059|NCT03245450|42181130|FG004|Overall Study|Withdrawal by Subject|0|||
19735060|NCT03245450|42181131|FG005|Overall Study|Withdrawal by Subject|0|||
19735061|NCT03245450|42181132|FG006|Overall Study|Withdrawal by Subject|0|||
19735062|NCT03245450|42181126|FG000|Overall Study|Adverse Event|0|||
19735063|NCT03245450|42181127|FG001|Overall Study|Adverse Event|0|||
19735064|NCT03245450|42181128|FG002|Overall Study|Adverse Event|0|||
19735065|NCT03245450|42181129|FG003|Overall Study|Adverse Event|0|||
19735066|NCT03245450|42181130|FG004|Overall Study|Adverse Event|1|||
19735067|NCT03245450|42181131|FG005|Overall Study|Adverse Event|0|||
19735068|NCT03245450|42181132|FG006|Overall Study|Adverse Event|2|||
19735069|NCT03712917|42181157|FG000|Overall Study|Pregnancy|0|||
19735070|NCT03712917|42181158|FG001|Overall Study|Pregnancy|0|||
19735071|NCT03712917|42181159|FG002|Overall Study|Pregnancy|1|||
19735072|NCT03712917|42181157|FG000|Overall Study|Adverse Event|0|||
19735073|NCT03712917|42181158|FG001|Overall Study|Adverse Event|4|||
19735074|NCT03712917|42181159|FG002|Overall Study|Adverse Event|3|||
19735075|NCT03712917|42181157|FG000|Overall Study|Lost to Follow-up|9|||
19735076|NCT03712917|42181158|FG001|Overall Study|Lost to Follow-up|4|||
19735077|NCT03712917|42181159|FG002|Overall Study|Lost to Follow-up|5|||
19735078|NCT02748694|42181182|FG000|Overall Study|Voluntary Withdrawal|0|||
19735079|NCT02748694|42181183|FG001|Overall Study|Voluntary Withdrawal|0|||
19735080|NCT02748694|42181184|FG002|Overall Study|Voluntary Withdrawal|0|||
19735081|NCT02748694|42181185|FG003|Overall Study|Voluntary Withdrawal|0|||
19735082|NCT02748694|42181186|FG004|Overall Study|Voluntary Withdrawal|0|||
19735083|NCT02748694|42181187|FG005|Overall Study|Voluntary Withdrawal|0|||
19735084|NCT02748694|42181188|FG006|Overall Study|Voluntary Withdrawal|0|||
19735085|NCT02748694|42181189|FG007|Overall Study|Voluntary Withdrawal|0|||
19735086|NCT02748694|42181190|FG008|Overall Study|Voluntary Withdrawal|0|||
19735087|NCT02748694|42181191|FG009|Overall Study|Voluntary Withdrawal|0|||
19735088|NCT02748694|42181192|FG010|Overall Study|Voluntary Withdrawal|0|||
19735089|NCT02748694|42181193|FG011|Overall Study|Voluntary Withdrawal|0|||
19735090|NCT02748694|42181194|FG012|Overall Study|Voluntary Withdrawal|0|||
19735091|NCT02748694|42181195|FG013|Overall Study|Voluntary Withdrawal|0|||
19735092|NCT02748694|42181196|FG014|Overall Study|Voluntary Withdrawal|2|||
19735093|NCT02800642|42181252|FG000|Overall Study|Death|3|||
19735094|NCT02800642|42181252|FG000|Overall Study|Other|10|||
19465278|NCT04426695|41723754|FG013|Overall Study|Sponsor Request|0|||
19735095|NCT02800642|42181252|FG000|Overall Study|Physician Decision|2|||
19735096|NCT02800642|42181252|FG000|Overall Study|Adverse Event|6|||
19735097|NCT02800642|42181252|FG000|Overall Study|Withdrawal by Subject|3|||
19735098|NCT02800642|42181252|FG000|Overall Study|Lost to Follow-up|1|||
19735099|NCT02799784|42181256|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
19735100|NCT02799784|42181257|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
19735101|NCT02799784|42181256|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
19735102|NCT02799784|42181257|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
19735103|NCT02799784|42181256|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
19735104|NCT02799784|42181257|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
19735105|NCT02799784|42181256|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
19735106|NCT02799784|42181257|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
19735107|NCT02799784|42181256|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
19735108|NCT02799784|42181257|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
19735109|NCT02799784|42181256|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
19735110|NCT02799784|42181257|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
19735111|NCT01333072|42181265|FG000|Overall Study|Lost to Follow-up|3|||
19735112|NCT01333072|42181266|FG001|Overall Study|Lost to Follow-up|0|||
19735113|NCT01333072|42181265|FG000|Overall Study|Adverse Event|2|||
19735114|NCT01333072|42181266|FG001|Overall Study|Adverse Event|4|||
19735115|NCT01333072|42181265|FG000|Overall Study|Physician Decision|1|||
19735116|NCT01333072|42181266|FG001|Overall Study|Physician Decision|0|||
19735117|NCT01315353|42181275|FG000|Overall Study|Death|2|||
19735118|NCT01315353|42181276|FG001|Overall Study|Death|1|||
19735119|NCT01315353|42181277|FG002|Overall Study|Death|0|||
19735120|NCT01315353|42181275|FG000|Overall Study|Withdrawal by Subject|2|||
19735121|NCT01315353|42181276|FG001|Overall Study|Withdrawal by Subject|6|||
19735122|NCT01315353|42181277|FG002|Overall Study|Withdrawal by Subject|1|||
19735123|NCT01315353|42181275|FG000|Overall Study|Lost to Follow-up|13|||
19735124|NCT01315353|42181276|FG001|Overall Study|Lost to Follow-up|6|||
19735125|NCT01315353|42181277|FG002|Overall Study|Lost to Follow-up|6|||
19735126|NCT01315353|42181275|FG000|Overall Study|Unwilling to adhere to requirements|5|||
19735127|NCT01315353|42181276|FG001|Overall Study|Unwilling to adhere to requirements|5|||
19735128|NCT01315353|42181277|FG002|Overall Study|Unwilling to adhere to requirements|4|||
19735129|NCT01315353|42181275|FG000|Overall Study|Site closing|7|||
19735130|NCT01315353|42181276|FG001|Overall Study|Site closing|4|||
19735131|NCT01315353|42181277|FG002|Overall Study|Site closing|0|||
19735132|NCT01315353|42181275|FG000|Overall Study|Taken off study by site in error|0|||
19735133|NCT01315353|42181276|FG001|Overall Study|Taken off study by site in error|1|||
19735134|NCT01315353|42181277|FG002|Overall Study|Taken off study by site in error|0|||
19735135|NCT01315353|42181275|FG000|Overall Study|Inadvertent randomization/assignment|0|||
19735136|NCT01315353|42181276|FG001|Overall Study|Inadvertent randomization/assignment|0|||
19735137|NCT01315353|42181277|FG002|Overall Study|Inadvertent randomization/assignment|2|||
19735138|NCT03712449|42181287|FG000|Overall Study|Withdraw Consent|0|||
19735139|NCT03712449|42181288|FG001|Overall Study|Withdraw Consent|1|||
19735140|NCT03517540|42181298|FG000|Overall Study|Protocol Violation|2|||
19735141|NCT03517540|42181299|FG001|Overall Study|Protocol Violation|0|||
19735142|NCT03517540|42181300|FG002|Overall Study|Protocol Violation|0|||
19735143|NCT03517540|42181301|FG003|Overall Study|Protocol Violation|1|||
19735144|NCT03517540|42181298|FG000|Overall Study|Adverse Event|9|||
19735145|NCT03517540|42181299|FG001|Overall Study|Adverse Event|3|||
19735146|NCT03517540|42181300|FG002|Overall Study|Adverse Event|8|||
19735147|NCT03517540|42181301|FG003|Overall Study|Adverse Event|1|||
19735148|NCT03517540|42181298|FG000|Overall Study|Withdrawal by Subject|3|||
19735149|NCT03517540|42181299|FG001|Overall Study|Withdrawal by Subject|4|||
19735150|NCT03517540|42181300|FG002|Overall Study|Withdrawal by Subject|1|||
19735151|NCT03517540|42181301|FG003|Overall Study|Withdrawal by Subject|3|||
19735152|NCT02799082|42181313|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
19735153|NCT02799082|42181314|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
19735154|NCT02799082|42181313|FG000|Overall Study|Protocol Violation|0|||
19735155|NCT02799082|42181314|FG001|Overall Study|Protocol Violation|1|||
19735156|NCT03710889|42181320|FG000|Overall Study|Adverse Event|2|||
19735157|NCT03710889|42181320|FG000|Overall Study|Protocol Deviation|1|||
19735158|NCT02797678|42181324|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
19735159|NCT02797678|42181325|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
19735160|NCT02797678|42181326|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
19735161|NCT02797678|42181327|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
19735162|NCT02797678|42181324|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
19735163|NCT02797678|42181325|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
19735164|NCT02797678|42181326|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
19735165|NCT02797678|42181327|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
19735166|NCT02797678|42181324|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
19735167|NCT02797678|42181325|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
19735168|NCT02797678|42181326|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
19735169|NCT02797678|42181327|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
19735170|NCT03308942|42181345|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
19735171|NCT03308942|42181346|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
19735172|NCT03308942|42181347|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
19735173|NCT03308942|42181348|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
19735174|NCT03308942|42181349|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
19735175|NCT03308942|42181345|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
19735176|NCT03308942|42181346|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
19735177|NCT03308942|42181347|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
19735178|NCT03308942|42181348|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
19735179|NCT03308942|42181349|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
19735180|NCT03308942|42181345|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
19735181|NCT03308942|42181346|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
19735182|NCT03308942|42181347|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
19735183|NCT03308942|42181348|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
19735184|NCT03308942|42181349|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
19735185|NCT03308942|42181345|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
19735186|NCT03308942|42181346|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
19735187|NCT03308942|42181347|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
19735188|NCT03308942|42181348|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
19735189|NCT03308942|42181349|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
19735190|NCT03308942|42181345|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
19735191|NCT03308942|42181346|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
19735192|NCT03308942|42181347|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
19735193|NCT03308942|42181348|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
19735194|NCT03308942|42181349|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
19735195|NCT03308942|42181345|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
19735196|NCT03308942|42181346|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
19735197|NCT03308942|42181347|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
19735198|NCT03308942|42181348|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
19735199|NCT03308942|42181349|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
19735200|NCT03308942|42181345|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
19735201|NCT03308942|42181346|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
19735202|NCT03308942|42181347|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
19735203|NCT03308942|42181348|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
19735204|NCT03308942|42181349|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
19735205|NCT03308786|42181362|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
19735206|NCT03274076|42181369|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
19735207|NCT03274076|42181370|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
19735208|NCT03274076|42181371|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
19735209|NCT03274076|42181372|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
19735210|NCT03274076|42181369|FG000|24 Weeks Open Label|Adverse Event|0|||
19735211|NCT03274076|42181370|FG001|24 Weeks Open Label|Adverse Event|0|||
19735212|NCT03274076|42181371|FG002|24 Weeks Open Label|Adverse Event|2|||
19735213|NCT03274076|42181372|FG003|24 Weeks Open Label|Adverse Event|0|||
19735214|NCT03274076|42181369|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
19735215|NCT03274076|42181370|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
19735216|NCT03274076|42181371|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
19735217|NCT03274076|42181372|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
19735218|NCT02797522|42181402|FG000|Overall Study|Study Terminated by Sponsor|0|||
19735219|NCT02797522|42181403|FG001|Overall Study|Study Terminated by Sponsor|0|||
19735220|NCT02797522|42181404|FG002|Overall Study|Study Terminated by Sponsor|0|||
19735221|NCT02797522|42181405|FG003|Overall Study|Study Terminated by Sponsor|0|||
19735222|NCT02797522|42181406|FG004|Overall Study|Study Terminated by Sponsor|0|||
19735223|NCT02797522|42181407|FG005|Overall Study|Study Terminated by Sponsor|0|||
19735224|NCT02797522|42181408|FG006|Overall Study|Study Terminated by Sponsor|0|||
19735225|NCT02797522|42181409|FG007|Overall Study|Study Terminated by Sponsor|4|||
19735226|NCT02797522|42181410|FG008|Overall Study|Study Terminated by Sponsor|2|||
19735227|NCT02797522|42181411|FG009|Overall Study|Study Terminated by Sponsor|4|||
19735228|NCT02797522|42181412|FG010|Overall Study|Study Terminated by Sponsor|1|||
19735229|NCT02659514|42181451|FG000|Overall Study|Adverse Event|3|||
19735230|NCT02659514|42181452|FG001|Overall Study|Adverse Event|12|||
19735231|NCT02659514|42181451|FG000|Overall Study|Disease Progression|23|||
19735232|NCT02659514|42181452|FG001|Overall Study|Disease Progression|13|||
19735233|NCT02659514|42181451|FG000|Overall Study|Withdrawal by Subject|0|||
19735234|NCT02659514|42181452|FG001|Overall Study|Withdrawal by Subject|4|||
19735235|NCT02659514|42181451|FG000|Overall Study|Lost to Follow-up|0|||
19735236|NCT02659514|42181452|FG001|Overall Study|Lost to Follow-up|1|||
19735237|NCT02659514|42181451|FG000|Overall Study|Death|6|||
19735238|NCT02659514|42181452|FG001|Overall Study|Death|1|||
19735239|NCT02659514|42181451|FG000|Overall Study|Reason Unspecified|0|||
19735240|NCT02659514|42181452|FG001|Overall Study|Reason Unspecified|3|||
19735241|NCT04570670|42181460|FG000|Overall Study|Withdrawal by Subject|1|||
19735242|NCT04570670|42181461|FG001|Overall Study|Withdrawal by Subject|0|||
19735243|NCT02797132|42181467|FG000|Part A (15 Days)|Adverse Event|1|||
19735244|NCT02797132|42181467|FG000|Part B (24 Weeks)|Adverse Event|3|||
19735245|NCT03270644|42181480|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
19735246|NCT03270644|42181480|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
19735247|NCT03269552|42181491|FG000|Overall Study|Adverse Event|2|||
19735248|NCT02796664|42181498|FG000|Overall Study|Withdrawal by Subject|0|||
19735249|NCT02796664|42181499|FG001|Overall Study|Withdrawal by Subject|3|||
19735250|NCT02796664|42181498|FG000|Overall Study|Noncompliance|1|||
19735251|NCT02796664|42181499|FG001|Overall Study|Noncompliance|1|||
19735252|NCT02796664|42181498|FG000|Overall Study|Death|0|||
19735253|NCT02796664|42181499|FG001|Overall Study|Death|1|||
19735254|NCT01370356|42181509|FG000|Overall Study|Death|1|||
19735255|NCT01370356|42181510|FG001|Overall Study|Death|0|||
19735256|NCT01370356|42181509|FG000|Overall Study|Lack of Efficacy|6|||
19735257|NCT01370356|42181510|FG001|Overall Study|Lack of Efficacy|28|||
19735258|NCT01370356|42181509|FG000|Overall Study|Lost to Follow-up|76|||
19735259|NCT01370356|42181510|FG001|Overall Study|Lost to Follow-up|81|||
19735260|NCT01370356|42181509|FG000|Overall Study|Withdrawal by Subject|54|||
19735261|NCT01370356|42181510|FG001|Overall Study|Withdrawal by Subject|59|||
19735262|NCT01370356|42181509|FG000|Overall Study|Reason not specified|39|||
19735263|NCT01370356|42181510|FG001|Overall Study|Reason not specified|43|||
19735264|NCT01370356|42181509|FG000|Overall Study|Protocol Violation|3|||
19735265|NCT01370356|42181510|FG001|Overall Study|Protocol Violation|3|||
19735266|NCT01370356|42181509|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
19735267|NCT01370356|42181510|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
19735268|NCT01370356|42181509|FG000|Overall Study|AE Not Related to Study Drug|1|||
19735269|NCT01370356|42181510|FG001|Overall Study|AE Not Related to Study Drug|4|||
19735270|NCT02794870|42181518|FG000|Overall Study|Withdrawal by Subject|2|||
19735271|NCT02794870|42181519|FG001|Overall Study|Withdrawal by Subject|0|||
19735272|NCT01370590|42181527|FG000|Period 1|Adverse Event|8|||
19735273|NCT01370590|42181528|FG001|Period 1|Adverse Event|4|||
19735274|NCT01370590|42181527|FG000|Period 1|Lost to Follow-up|2|||
19735275|NCT01370590|42181528|FG001|Period 1|Lost to Follow-up|2|||
19735276|NCT01370590|42181527|FG000|Period 1|Protocol Violation|2|||
19735277|NCT01370590|42181528|FG001|Period 1|Protocol Violation|2|||
19735278|NCT01370590|42181527|FG000|Period 1|Withdrawal by Subject|4|||
19735279|NCT01370590|42181528|FG001|Period 1|Withdrawal by Subject|2|||
19735280|NCT01370590|42181527|FG000|Period 1|Could not access randomization system|0|||
19735281|NCT01370590|42181528|FG001|Period 1|Could not access randomization system|1|||
19735282|NCT01370590|42181527|FG000|Crossover Washout Period|Adverse Event|1|||
19735283|NCT01370590|42181528|FG001|Crossover Washout Period|Adverse Event|4|||
19735284|NCT01370590|42181527|FG000|Crossover Washout Period|Lost to Follow-up|2|||
19735285|NCT01370590|42181528|FG001|Crossover Washout Period|Lost to Follow-up|0|||
19735286|NCT01370590|42181527|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
19735287|NCT01370590|42181528|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
19735288|NCT01370590|42181527|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
19735289|NCT01370590|42181528|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
19735290|NCT01370590|42181527|FG000|Period 2|Adverse Event|0|||
19735291|NCT01370590|42181528|FG001|Period 2|Adverse Event|1|||
19735292|NCT01370590|42181527|FG000|Period 2|Withdrawal by Subject|1|||
19735293|NCT01370590|42181528|FG001|Period 2|Withdrawal by Subject|1|||
19735294|NCT05200455|42181539|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
19735295|NCT04646109|42181546|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
19735296|NCT04646109|42181547|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
19735297|NCT04601103|42181557|FG000|Overall Study|Needed crown & cleaning|0|||
19735298|NCT04601103|42181558|FG001|Overall Study|Needed crown & cleaning|0|||
19735299|NCT04601103|42181559|FG002|Overall Study|Needed crown & cleaning|1|||
19735300|NCT04601103|42181557|FG000|Overall Study|study was terminated|18|||
19735301|NCT04601103|42181558|FG001|Overall Study|study was terminated|18|||
19735302|NCT04601103|42181559|FG002|Overall Study|study was terminated|16|||
19735303|NCT04502979|42181569|FG000|Overall Study|Lost to Follow-up|1|||
19735304|NCT04502979|42181570|FG001|Overall Study|Lost to Follow-up|3|||
19735305|NCT04502979|42181569|FG000|Overall Study|Withdrawal by Subject|2|||
19735306|NCT04502979|42181570|FG001|Overall Study|Withdrawal by Subject|1|||
19735307|NCT04590027|42181578|FG000|Overall Study|Lost to Follow-up|17|||
19735308|NCT04590027|42181579|FG001|Overall Study|Lost to Follow-up|14|||
19735309|NCT04590027|42181578|FG000|Overall Study|Protocol Violation|0|||
19735310|NCT04590027|42181579|FG001|Overall Study|Protocol Violation|3|||
19735311|NCT04587453|42181591|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
19735312|NCT04587453|42181592|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
19735313|NCT02793232|42181609|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735314|NCT02793232|42181610|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735315|NCT02793232|42181611|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735316|NCT02793232|42181612|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735317|NCT02793232|42181613|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
19735318|NCT02793232|42181614|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735319|NCT02793232|42181615|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
19735320|NCT02793232|42181616|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735321|NCT02793232|42181617|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
19735322|NCT04584645|42181653|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
19735323|NCT04584645|42181654|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
19735324|NCT03695367|42181680|FG000|Overall Study|Missed the Day 28 visit.|1|||
19735325|NCT03695367|42181681|FG001|Overall Study|Missed the Day 28 visit.|0|||
19735326|NCT03695367|42181680|FG000|Overall Study|Lost to Follow-up|0|||
19735327|NCT03695367|42181681|FG001|Overall Study|Lost to Follow-up|1|||
19735328|NCT03695367|42181680|FG000|Overall Study|Withdrawal by Subject|0|||
19735329|NCT03695367|42181681|FG001|Overall Study|Withdrawal by Subject|1|||
19735330|NCT03695367|42181680|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
19735331|NCT03695367|42181681|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
19735332|NCT02794480|42181689|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
19735333|NCT02794480|42181690|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
19735334|NCT02794480|42181691|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
19735335|NCT02794480|42181692|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
19735336|NCT02794480|42181689|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
19735337|NCT02794480|42181690|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
19735338|NCT02794480|42181691|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
19735339|NCT02794480|42181692|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
19735340|NCT02794480|42181689|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19735341|NCT02794480|42181690|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19735342|NCT02794480|42181691|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19735343|NCT02794480|42181692|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
19735344|NCT02794480|42181689|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19735345|NCT02794480|42181690|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
19735346|NCT02794480|42181691|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19735347|NCT02794480|42181692|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
19735348|NCT02794480|42181689|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
19735349|NCT02794480|42181690|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19735350|NCT02794480|42181691|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19735351|NCT02794480|42181692|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
19735352|NCT04558125|42181700|FG000|Overall Study|Death|1|||
19735353|NCT02793622|42181706|FG000|Overall Study|Lost to Follow-up|31|||
19735354|NCT02793622|42181707|FG001|Overall Study|Lost to Follow-up|19|||
19735355|NCT02793622|42181706|FG000|Overall Study|Withdrawal by Subject|21|||
19735356|NCT02793622|42181707|FG001|Overall Study|Withdrawal by Subject|17|||
19735357|NCT02793622|42181706|FG000|Overall Study|Adverse Event|0|||
19735358|NCT02793622|42181707|FG001|Overall Study|Adverse Event|1|||
19735359|NCT02793622|42181706|FG000|Overall Study|Protocol Violation|1|||
19735360|NCT02793622|42181707|FG001|Overall Study|Protocol Violation|5|||
19735361|NCT04493931|42181720|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
19735362|NCT04493931|42181721|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735363|NCT04493931|42181722|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735364|NCT04493931|42181723|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735365|NCT04493931|42181724|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735366|NCT04493931|42181725|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735367|NCT04493931|42181726|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
19735368|NCT04493931|42181720|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735369|NCT04493931|42181721|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
19735370|NCT04493931|42181722|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735371|NCT04493931|42181723|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735372|NCT04493931|42181724|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735373|NCT04493931|42181725|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735374|NCT04493931|42181726|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
19735375|NCT04493931|42181720|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735376|NCT04493931|42181721|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
19735377|NCT04493931|42181722|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735378|NCT04493931|42181723|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735379|NCT04493931|42181724|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735380|NCT04493931|42181725|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735381|NCT04493931|42181726|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
19735382|NCT04493931|42181720|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735383|NCT04493931|42181721|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735384|NCT04493931|42181722|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
19735385|NCT04493931|42181723|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735386|NCT04493931|42181724|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735387|NCT04493931|42181725|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735388|NCT04493931|42181726|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
19735389|NCT03437278|42181759|FG000|Overall Study|Adverse Event|0|||
19735390|NCT03437278|42181760|FG001|Overall Study|Adverse Event|0|||
19735391|NCT03437278|42181761|FG002|Overall Study|Adverse Event|1|||
19735392|NCT03437278|42181759|FG000|Overall Study|Progressive disease|1|||
19735393|NCT03437278|42181760|FG001|Overall Study|Progressive disease|0|||
19735394|NCT03437278|42181761|FG002|Overall Study|Progressive disease|0|||
19735395|NCT03437278|42181759|FG000|Overall Study|Physician Decision|1|||
19735396|NCT03437278|42181760|FG001|Overall Study|Physician Decision|0|||
19735397|NCT03437278|42181761|FG002|Overall Study|Physician Decision|1|||
19735398|NCT04553913|42181771|FG000|Overall Study|patient's block resolved prior to PACU|1|||
19735399|NCT04553913|42181771|FG000|Overall Study|did not use the device properly|5|||
19735400|NCT04490499|42181776|FG000|Overall Study|Withdrawal by Subject|2|||
19735401|NCT01332994|42181780|FG000|Overall Study|Adverse Event|34|||
19735402|NCT01332994|42181780|FG000|Overall Study|Death|1|||
19735403|NCT01332994|42181780|FG000|Overall Study|Lack of Efficacy|1|||
19735404|NCT01332994|42181780|FG000|Overall Study|Lost to Follow-up|4|||
19735405|NCT01332994|42181780|FG000|Overall Study|Protocol Violation|6|||
19735406|NCT01332994|42181780|FG000|Overall Study|Withdrawal by Subject|15|||
19735407|NCT01332994|42181780|FG000|Overall Study|Administrative Problem|2|||
19735408|NCT01332994|42181780|FG000|Overall Study|Other|8|||
19735409|NCT03698331|42181786|FG000|Overall Study|Adverse Event|2|||
19735410|NCT03698331|42181787|FG001|Overall Study|Adverse Event|3|||
19735411|NCT03698331|42181786|FG000|Overall Study|Withdrawal by Subject|1|||
19735412|NCT03698331|42181787|FG001|Overall Study|Withdrawal by Subject|1|||
19735413|NCT03698331|42181786|FG000|Overall Study|Lost to Follow-up|0|||
19735414|NCT03698331|42181787|FG001|Overall Study|Lost to Follow-up|2|||
19735415|NCT03698331|42181786|FG000|Overall Study|Non-compliance with study drug|1|||
19735416|NCT03698331|42181787|FG001|Overall Study|Non-compliance with study drug|0|||
19735417|NCT04889625|42181793|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
19735418|NCT04889625|42181794|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
19735419|NCT04889625|42181793|FG000|Period 1|Subject out of window|0|||
19735420|NCT04889625|42181794|FG001|Period 1|Subject out of window|1|||
19735421|NCT04889625|42181793|FG000|Period 1|Wrong add power dispensed|0|||
19735422|NCT04889625|42181794|FG001|Period 1|Wrong add power dispensed|1|||
19735423|NCT04889625|42181793|FG000|Period 1|Discontinued due to fitting guide error|1|||
19735424|NCT04889625|42181794|FG001|Period 1|Discontinued due to fitting guide error|1|||
19735425|NCT04889625|42181793|FG000|Period 2|Test article no longer available|1|||
19735426|NCT04889625|42181794|FG001|Period 2|Test article no longer available|0|||
19735427|NCT04889625|42181793|FG000|Period 2|Incorrect lens dispensed|1|||
19735428|NCT04889625|42181794|FG001|Period 2|Incorrect lens dispensed|0|||
19735429|NCT04889625|42181793|FG000|Period 2|Wrong add power dispensed|0|||
19735430|NCT04889625|42181794|FG001|Period 2|Wrong add power dispensed|1|||
19735431|NCT04883541|42181802|FG000|Overall Study|Not attending regular yoga class|16|||
19735432|NCT04883541|42181803|FG001|Overall Study|Not attending regular yoga class|0|||
19735433|NCT04883541|42181802|FG000|Overall Study|Not attending the pregnancy school|0|||
19735434|NCT04883541|42181803|FG001|Overall Study|Not attending the pregnancy school|9|||
19735435|NCT04882995|42181811|FG000|Overall Study|Withdrawal by Subject|1|||
19735436|NCT04882995|42181812|FG001|Overall Study|Withdrawal by Subject|2|||
19735437|NCT04882995|42181811|FG000|Overall Study|Protocol Violation|4|||
19735438|NCT04882995|42181812|FG001|Overall Study|Protocol Violation|4|||
19735439|NCT04882995|42181811|FG000|Overall Study|Surgery postponed due to COVID|1|||
19735440|NCT04882995|42181812|FG001|Overall Study|Surgery postponed due to COVID|1|||
19735441|NCT04483011|42181820|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
19735442|NCT04483011|42181821|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
19735443|NCT04545567|42181831|FG000|Overall Study|tested positive for SARS-co-V2|1|||
19735444|NCT04545567|42181832|FG001|Overall Study|tested positive for SARS-co-V2|1|||
19735445|NCT04545567|42181831|FG000|Overall Study|Withdrawal by Subject|0|||
19735446|NCT04545567|42181832|FG001|Overall Study|Withdrawal by Subject|1|||
19735447|NCT04534491|42181838|FG000|Overall Study|Not completed end-of-study interview|24|||
19735448|NCT04534491|42181838|FG000|Overall Study|Non-users|70|||
19735449|NCT04534491|42181838|FG000|Overall Study|Non-verifiable users|58|||
19735450|NCT03694821|42181845|FG000|Overall Study|Study terminated|4|||
19735451|NCT03694821|42181846|FG001|Overall Study|Study terminated|8|||
19465279|NCT04426695|41723755|FG014|Overall Study|Sponsor Request|0|||
19735452|NCT03694821|42181847|FG002|Overall Study|Study terminated|4|||
19465280|NCT04426695|41723756|FG015|Overall Study|Sponsor Request|0|||
19735453|NCT04531527|42181855|FG000|Overall Study|Found to be Ineligible|3|||
19735454|NCT04474197|42181863|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
19735455|NCT04474197|42181864|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
19735456|NCT04474197|42181865|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
19735457|NCT04474197|42181866|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
19735458|NCT02079766|42181883|FG000|Overall Study|Physician Decision|1|||
19735459|NCT02079766|42181884|FG001|Overall Study|Physician Decision|0|||
19735460|NCT02079766|42181883|FG000|Overall Study|Withdrawal by Subject|1|||
19735461|NCT02079766|42181884|FG001|Overall Study|Withdrawal by Subject|0|||
19735462|NCT04841577|42181892|FG000|Overall Study|Adverse Event|5|||
19735463|NCT04841577|42181893|FG001|Overall Study|Adverse Event|10|||
19735464|NCT04841577|42181892|FG000|Overall Study|Lost to Follow-up|8|||
19735465|NCT04841577|42181893|FG001|Overall Study|Lost to Follow-up|7|||
19735466|NCT04841577|42181892|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
19735467|NCT04841577|42181893|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
19735468|NCT04841577|42181892|FG000|Overall Study|Other|0|||
19735469|NCT04841577|42181893|FG001|Overall Study|Other|1|||
19735470|NCT04529109|42181899|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
19735471|NCT04529109|42181900|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
19735472|NCT04528641|42181912|FG000|Overall Study|Withdrawal by Subject|0|||
19735473|NCT04528641|42181913|FG001|Overall Study|Withdrawal by Subject|0|||
19735474|NCT04528641|42181914|FG002|Overall Study|Withdrawal by Subject|0|||
19735475|NCT04528641|42181915|FG003|Overall Study|Withdrawal by Subject|1|||
19735476|NCT04528641|42181916|FG004|Overall Study|Withdrawal by Subject|0|||
19735477|NCT04528641|42181917|FG005|Overall Study|Withdrawal by Subject|1|||
19735478|NCT04527471|42181936|FG000|Overall Study|Adverse Event|1|||
19735479|NCT04527471|42181937|FG001|Overall Study|Adverse Event|0|||
19735480|NCT04527471|42181936|FG000|Overall Study|Lost to Follow-up|1|||
19735481|NCT04527471|42181937|FG001|Overall Study|Lost to Follow-up|0|||
19735482|NCT04471935|42181943|FG000|Overall Study|Withdrawal by Subject|1|||
19735483|NCT04471935|42181943|FG000|Overall Study|Deemed ineligible to participate|1|||
19735484|NCT04468347|42181951|FG000|Overall Study|Withdrawal by Subject|0|||
19735485|NCT04468347|42181952|FG001|Overall Study|Withdrawal by Subject|1|||
19735486|NCT04468347|42181953|FG002|Overall Study|Withdrawal by Subject|3|||
19735487|NCT04468347|42181954|FG003|Overall Study|Withdrawal by Subject|3|||
19735488|NCT04468347|42181951|FG000|Overall Study|Lost to Follow-up|0|||
19735489|NCT04468347|42181952|FG001|Overall Study|Lost to Follow-up|0|||
19735490|NCT04468347|42181953|FG002|Overall Study|Lost to Follow-up|1|||
19735491|NCT04468347|42181954|FG003|Overall Study|Lost to Follow-up|1|||
19735492|NCT04468347|42181951|FG000|Overall Study|Physician Decision|1|||
19735493|NCT04468347|42181952|FG001|Overall Study|Physician Decision|0|||
19735494|NCT04468347|42181953|FG002|Overall Study|Physician Decision|2|||
19735495|NCT04468347|42181954|FG003|Overall Study|Physician Decision|0|||
19735496|NCT04468347|42181951|FG000|Overall Study|Protocol Violation|1|||
19735497|NCT04468347|42181952|FG001|Overall Study|Protocol Violation|0|||
19735498|NCT04468347|42181953|FG002|Overall Study|Protocol Violation|0|||
19735499|NCT04468347|42181954|FG003|Overall Study|Protocol Violation|0|||
19735500|NCT04822701|42181970|FG000|Overall Study|Not treated|2|||
19735501|NCT04822701|42181971|FG001|Overall Study|Not treated|0|||
19735502|NCT04822701|42181970|FG000|Overall Study|Lost to Follow-up|1|||
19735503|NCT04822701|42181971|FG001|Overall Study|Lost to Follow-up|0|||
19735504|NCT04822701|42181970|FG000|Overall Study|Withdrawal by Subject|1|||
19735505|NCT04822701|42181971|FG001|Overall Study|Withdrawal by Subject|0|||
19735506|NCT04461795|42181977|FG000|Overall Study|Lost to Follow-up|2|||
19735507|NCT04461795|42181977|FG000|Overall Study|Withdrawal by Subject|2|||
19735508|NCT04461795|42181977|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
19735509|NCT04461015|42181984|FG000|Overall Study|IV access lost during the study|0|||
19735510|NCT04461015|42181985|FG001|Overall Study|IV access lost during the study|1|||
19735511|NCT04461015|42181984|FG000|Overall Study|Withdrawal by Subject|0|||
19735512|NCT04461015|42181985|FG001|Overall Study|Withdrawal by Subject|1|||
19735513|NCT04810221|42181991|FG000|Overall Study|Physician Decision|3|||
19735514|NCT03694353|42181995|FG000|Overall Study|Withdrawal by Subject|1|||
19735515|NCT03694353|42181995|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
19735516|NCT04521777|42181999|FG000|Overall Study|Death|2|||
19735517|NCT04521777|42181999|FG000|Overall Study|Withdrawal by Subject|2|||
19735518|NCT03700671|42182005|FG000|Overall Study|Lack of Efficacy|1|||
19735519|NCT03700671|42182006|FG001|Overall Study|Lack of Efficacy|2|||
19735520|NCT04779879|42182020|FG000|Part A: Up to Day 29|ongoing in the study|8|||
19735521|NCT04779879|42182021|FG001|Part A: Up to Day 29|ongoing in the study|22|||
19735522|NCT04779879|42182022|FG002|Part A: Up to Day 29|ongoing in the study|0|||
19735523|NCT04779879|42182023|FG003|Part A: Up to Day 29|ongoing in the study|0|||
19735524|NCT04779879|42182024|FG004|Part A: Up to Day 29|ongoing in the study|0|||
19735525|NCT04779879|42182025|FG005|Part A: Up to Day 29|ongoing in the study|0|||
19735526|NCT04779879|42182020|FG000|Part B: Up to Day 29|Ongoing in the study|0|||
19735527|NCT04779879|42182021|FG001|Part B: Up to Day 29|Ongoing in the study|0|||
19735528|NCT04779879|42182022|FG002|Part B: Up to Day 29|Ongoing in the study|84|||
19735529|NCT04779879|42182023|FG003|Part B: Up to Day 29|Ongoing in the study|82|||
19735530|NCT04779879|42182024|FG004|Part B: Up to Day 29|Ongoing in the study|0|||
19735531|NCT04779879|42182025|FG005|Part B: Up to Day 29|Ongoing in the study|0|||
19735532|NCT04779879|42182020|FG000|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
19735533|NCT04779879|42182021|FG001|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
19735534|NCT04779879|42182022|FG002|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
19735535|NCT04779879|42182023|FG003|Part B: Up to Day 29|Randomized, but did not receive treatment|1|||
19735536|NCT04779879|42182024|FG004|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
19735537|NCT04779879|42182025|FG005|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
19735538|NCT04779879|42182020|FG000|Part C: Up to Day 29|Ongoing in the study|0|||
19735539|NCT04779879|42182021|FG001|Part C: Up to Day 29|Ongoing in the study|0|||
19735540|NCT04779879|42182022|FG002|Part C: Up to Day 29|Ongoing in the study|0|||
19735541|NCT04779879|42182023|FG003|Part C: Up to Day 29|Ongoing in the study|0|||
19735542|NCT04779879|42182024|FG004|Part C: Up to Day 29|Ongoing in the study|78|||
19735543|NCT04779879|42182025|FG005|Part C: Up to Day 29|Ongoing in the study|77|||
19735544|NCT04779879|42182020|FG000|Part C: Up to Day 29|Death|0|||
19735545|NCT04779879|42182021|FG001|Part C: Up to Day 29|Death|0|||
19735546|NCT04779879|42182022|FG002|Part C: Up to Day 29|Death|0|||
19735547|NCT04779879|42182023|FG003|Part C: Up to Day 29|Death|0|||
19735548|NCT04779879|42182024|FG004|Part C: Up to Day 29|Death|0|||
19735549|NCT04779879|42182025|FG005|Part C: Up to Day 29|Death|1|||
19735550|NCT04779879|42182020|FG000|Part C: Up to Day 29|Withdrawal by Subject|0|||
19735551|NCT04779879|42182021|FG001|Part C: Up to Day 29|Withdrawal by Subject|0|||
19735552|NCT04779879|42182022|FG002|Part C: Up to Day 29|Withdrawal by Subject|0|||
19735553|NCT04779879|42182023|FG003|Part C: Up to Day 29|Withdrawal by Subject|0|||
19735554|NCT04779879|42182024|FG004|Part C: Up to Day 29|Withdrawal by Subject|1|||
19735555|NCT04779879|42182025|FG005|Part C: Up to Day 29|Withdrawal by Subject|0|||
19735556|NCT04764669|42182045|FG000|Overall Study|Adverse Event|1|||
19735557|NCT04764669|42182046|FG001|Overall Study|Adverse Event|0|||
19735558|NCT04764669|42182047|FG002|Overall Study|Adverse Event|1|||
19735559|NCT04764669|42182048|FG003|Overall Study|Adverse Event|0|||
19735560|NCT04764669|42182045|FG000|Overall Study|Subject Choice|0|||
19735561|NCT04764669|42182046|FG001|Overall Study|Subject Choice|0|||
19735562|NCT04764669|42182047|FG002|Overall Study|Subject Choice|1|||
19735563|NCT04764669|42182048|FG003|Overall Study|Subject Choice|0|||
19735564|NCT04764669|42182045|FG000|Overall Study|Withdrawal by Subject|2|||
19735565|NCT04764669|42182046|FG001|Overall Study|Withdrawal by Subject|0|||
19735566|NCT04764669|42182047|FG002|Overall Study|Withdrawal by Subject|0|||
19735567|NCT04764669|42182048|FG003|Overall Study|Withdrawal by Subject|0|||
19735568|NCT04439253|42182058|FG000|Overall Study|Adverse Event|1|||
19735569|NCT04439253|42182058|FG000|Overall Study|Disease progression|2|||
19735570|NCT04439253|42182058|FG000|Overall Study|Complicating disease|1|||
19735571|NCT04438785|42182064|FG000|Overall Study|change of weight, give up intervention|2|||
19735572|NCT04438785|42182065|FG001|Overall Study|change of weight, give up intervention|10|||
19735573|NCT04741503|42182073|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
19735574|NCT04741503|42182074|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
19735575|NCT04741503|42182075|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
19735576|NCT04741503|42182073|FG000|Initial Enrollment|Overquotas removed|0|||
19735577|NCT04741503|42182074|FG001|Initial Enrollment|Overquotas removed|0|||
19735578|NCT04741503|42182075|FG002|Initial Enrollment|Overquotas removed|186|||
19735579|NCT04741503|42182073|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
19735580|NCT04741503|42182074|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
19735581|NCT04741503|42182075|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
19735582|NCT04734873|42182084|FG000|Overall Study|Lost to Follow-up|1|||
19735583|NCT04734873|42182085|FG001|Overall Study|Lost to Follow-up|3|||
19735584|NCT04734873|42182086|FG002|Overall Study|Lost to Follow-up|2|||
19735585|NCT04734873|42182084|FG000|Overall Study|Randomized but not dosed|1|||
19735586|NCT04734873|42182085|FG001|Overall Study|Randomized but not dosed|0|||
19735587|NCT04734873|42182086|FG002|Overall Study|Randomized but not dosed|1|||
19735588|NCT04435665|42182098|FG000|Overall Study|Lost to Follow-up|0|||
19735589|NCT04435665|42182099|FG001|Overall Study|Lost to Follow-up|0|||
19735590|NCT04435665|42182100|FG002|Overall Study|Lost to Follow-up|0|||
19735591|NCT04435665|42182101|FG003|Overall Study|Lost to Follow-up|1|||
19735592|NCT04428411|42182111|FG000|Overall Study|Lost to Follow-up|114|||
19735593|NCT04422561|42182120|FG000|Overall Study|Lost to Follow-up|25|||
19735594|NCT04422561|42182121|FG001|Overall Study|Lost to Follow-up|11|||
19735595|NCT01369498|42182131|FG000|Overall Study|Lack of Efficacy|9|||
19735596|NCT01369498|42182132|FG001|Overall Study|Lack of Efficacy|9|||
19735597|NCT01369498|42182133|FG002|Overall Study|Lack of Efficacy|1|||
19735598|NCT01369498|42182134|FG003|Overall Study|Lack of Efficacy|3|||
19735599|NCT01369498|42182131|FG000|Overall Study|Adverse Event|1|||
19735600|NCT01369498|42182132|FG001|Overall Study|Adverse Event|2|||
19735601|NCT01369498|42182133|FG002|Overall Study|Adverse Event|0|||
19735602|NCT01369498|42182134|FG003|Overall Study|Adverse Event|1|||
19735603|NCT01369498|42182131|FG000|Overall Study|Withdrawal of Consent|0|||
19735604|NCT01369498|42182132|FG001|Overall Study|Withdrawal of Consent|1|||
19735605|NCT01369498|42182133|FG002|Overall Study|Withdrawal of Consent|1|||
19735606|NCT01369498|42182134|FG003|Overall Study|Withdrawal of Consent|1|||
19735607|NCT01369498|42182131|FG000|Overall Study|Death|0|||
19735608|NCT01369498|42182132|FG001|Overall Study|Death|0|||
19735609|NCT01369498|42182133|FG002|Overall Study|Death|1|||
19735610|NCT01369498|42182134|FG003|Overall Study|Death|0|||
19735611|NCT01369498|42182131|FG000|Overall Study|Investigator's Discretion|1|||
19735612|NCT01369498|42182132|FG001|Overall Study|Investigator's Discretion|0|||
19735613|NCT01369498|42182133|FG002|Overall Study|Investigator's Discretion|1|||
19735614|NCT01369498|42182134|FG003|Overall Study|Investigator's Discretion|3|||
19735615|NCT01369498|42182131|FG000|Overall Study|Unknown Reason|1|||
19735616|NCT01369498|42182132|FG001|Overall Study|Unknown Reason|0|||
19735617|NCT01369498|42182133|FG002|Overall Study|Unknown Reason|11|||
19735618|NCT01369498|42182134|FG003|Overall Study|Unknown Reason|6|||
19735619|NCT01369498|42182131|FG000|Overall Study|Disease Progression|0|||
19735620|NCT01369498|42182132|FG001|Overall Study|Disease Progression|0|||
19735621|NCT01369498|42182133|FG002|Overall Study|Disease Progression|0|||
19735622|NCT01369498|42182134|FG003|Overall Study|Disease Progression|1|||
19735623|NCT04709835|42182148|FG000|Overall Study|Withdrawal by Subject|0|||
19735624|NCT04709835|42182149|FG001|Overall Study|Withdrawal by Subject|1|||
19735625|NCT04709835|42182150|FG002|Overall Study|Withdrawal by Subject|0|||
19735626|NCT04407507|42182164|FG000|Overall Study|Withdrawal by Subject|0|||
19735627|NCT04407507|42182165|FG001|Overall Study|Withdrawal by Subject|1|||
19735628|NCT04698993|42182173|FG000|Overall Study|PCR results not accessible|2|||
19735629|NCT04698993|42182174|FG001|Overall Study|PCR results not accessible|7|||
19735630|NCT04698993|42182173|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
19735631|NCT04698993|42182174|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
19735632|NCT04359771|42182182|FG000|Overall Study|Lack of Efficacy|2|||
19735633|NCT04359771|42182183|FG001|Overall Study|Lack of Efficacy|2|||
19735634|NCT04356573|42182191|FG000|Overall Study|Didn't Qualify|1|||
19735635|NCT04356573|42182192|FG001|Overall Study|Didn't Qualify|0|||
19735636|NCT04352127|42182208|FG000|Overall Study|Unable to obtain readings|4|||
19735637|NCT04352127|42182209|FG001|Overall Study|Unable to obtain readings|1|||
19735638|NCT04351269|42182218|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
19735639|NCT04351269|42182219|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
19735640|NCT04351269|42182220|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
19735641|NCT04351269|42182218|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
19735642|NCT04351269|42182219|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
19735643|NCT04351269|42182220|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
19735644|NCT04351269|42182218|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
19735645|NCT04351269|42182219|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
19735646|NCT04351269|42182220|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
19735647|NCT04351269|42182218|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
19735648|NCT04351269|42182219|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
19735649|NCT04351269|42182220|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
19735650|NCT04351269|42182218|FG000|Overall Study|Lost to Follow-up|1|||
19735651|NCT04351269|42182219|FG001|Overall Study|Lost to Follow-up|3|||
19735652|NCT04351269|42182220|FG002|Overall Study|Lost to Follow-up|0|||
19735653|NCT04348851|42182235|FG000|Post-Test 1|Withdrawal by Subject|0|||
19735654|NCT04348851|42182236|FG001|Post-Test 1|Withdrawal by Subject|1|||
19735655|NCT04348851|42182237|FG002|Post-Test 1|Withdrawal by Subject|0|||
19735656|NCT04348851|42182238|FG003|Post-Test 1|Withdrawal by Subject|0|||
19735657|NCT04348851|42182235|FG000|Post-Test 1|Lost to Follow-up|0|||
19735658|NCT04348851|42182236|FG001|Post-Test 1|Lost to Follow-up|1|||
19735659|NCT04348851|42182237|FG002|Post-Test 1|Lost to Follow-up|0|||
19735660|NCT04348851|42182238|FG003|Post-Test 1|Lost to Follow-up|0|||
19735661|NCT04348851|42182235|FG000|Post-Test 2|Stroke survivor death|0|||
19735662|NCT04348851|42182236|FG001|Post-Test 2|Stroke survivor death|1|||
19735663|NCT04348851|42182237|FG002|Post-Test 2|Stroke survivor death|0|||
19735664|NCT04348851|42182238|FG003|Post-Test 2|Stroke survivor death|1|||
19735665|NCT04346199|42182250|FG000|Overall Study|Death|8|||
19735666|NCT04346199|42182251|FG001|Overall Study|Death|9|||
19735667|NCT04346199|42182250|FG000|Overall Study|Lost to Follow-up|0|||
19735668|NCT04346199|42182251|FG001|Overall Study|Lost to Follow-up|1|||
19735669|NCT04346199|42182250|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
19735670|NCT04346199|42182251|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
19735671|NCT04346199|42182250|FG000|Overall Study|Withdrawal by Subject|5|||
19735672|NCT04346199|42182251|FG001|Overall Study|Withdrawal by Subject|1|||
19735673|NCT04345653|42182257|FG000|Overall Study|Withdrawal by Subject|2|||
19735674|NCT04342689|42182264|FG000|Overall Study|Withdrawal by Subject|32|||
19735675|NCT04342689|42182265|FG001|Overall Study|Withdrawal by Subject|33|||
19735676|NCT04342689|42182264|FG000|Overall Study|Lost to Follow-up|10|||
19735677|NCT04342689|42182265|FG001|Overall Study|Lost to Follow-up|12|||
19735678|NCT04169061|42182273|FG000|Overall Study|Adverse Event|2|||
19735679|NCT04169061|42182273|FG000|Overall Study|Death|1|||
19735680|NCT04169061|42182273|FG000|Overall Study|Withdrawal by Subject|1|||
19735681|NCT04169061|42182273|FG000|Overall Study|Protocol Violation|1|||
19735682|NCT02792218|42182279|FG000|Overall Study|Patient/guardian decision|15|||
19735683|NCT02792218|42182280|FG001|Overall Study|Patient/guardian decision|42|||
19735684|NCT02792218|42182279|FG000|Overall Study|Adverse Event|15|||
19735685|NCT02792218|42182280|FG001|Overall Study|Adverse Event|14|||
19735686|NCT02792218|42182279|FG000|Overall Study|Lost to Follow-up|10|||
19735687|NCT02792218|42182280|FG001|Overall Study|Lost to Follow-up|5|||
19735688|NCT02792218|42182279|FG000|Overall Study|Lack of Efficacy|1|||
19735689|NCT02792218|42182280|FG001|Overall Study|Lack of Efficacy|12|||
19735690|NCT02792218|42182279|FG000|Overall Study|Physician Decision|4|||
19735691|NCT02792218|42182280|FG001|Overall Study|Physician Decision|4|||
19735692|NCT02792218|42182279|FG000|Overall Study|Protocol deviation|3|||
19735693|NCT02792218|42182280|FG001|Overall Study|Protocol deviation|2|||
19735694|NCT02792218|42182279|FG000|Overall Study|New therapy for study indication|0|||
19735695|NCT02792218|42182280|FG001|Overall Study|New therapy for study indication|1|||
19735696|NCT02792218|42182279|FG000|Overall Study|Non-compliance with study treatment|0|||
19735697|NCT02792218|42182280|FG001|Overall Study|Non-compliance with study treatment|1|||
19735698|NCT02792218|42182279|FG000|Overall Study|Pregnancy|1|||
19735699|NCT02792218|42182280|FG001|Overall Study|Pregnancy|0|||
19735700|NCT00153101|42182291|FG000|Overall Study|Lost to Follow-up|14|||
19735701|NCT00153101|42182292|FG001|Overall Study|Lost to Follow-up|14|||
19735702|NCT00153101|42182293|FG002|Overall Study|Lost to Follow-up|12|||
19735703|NCT00153101|42182294|FG003|Overall Study|Lost to Follow-up|5|||
19735704|NCT00153101|42182295|FG004|Overall Study|Lost to Follow-up|5|||
19735705|NCT00153101|42182291|FG000|Overall Study|Withdrawal by Subject|3|||
19735706|NCT00153101|42182292|FG001|Overall Study|Withdrawal by Subject|4|||
19735707|NCT00153101|42182293|FG002|Overall Study|Withdrawal by Subject|3|||
19735708|NCT00153101|42182294|FG003|Overall Study|Withdrawal by Subject|3|||
19735709|NCT00153101|42182295|FG004|Overall Study|Withdrawal by Subject|5|||
19735710|NCT04401579|42182311|FG000|Overall Study|Death|23|||
19735711|NCT04401579|42182312|FG001|Overall Study|Death|36|||
19735712|NCT04401579|42182311|FG000|Overall Study|Lost to Follow-up|40|||
19735713|NCT04401579|42182312|FG001|Overall Study|Lost to Follow-up|41|||
19735714|NCT04401579|42182311|FG000|Overall Study|Withdrawal by Subject|8|||
19735715|NCT04401579|42182312|FG001|Overall Study|Withdrawal by Subject|16|||
19735716|NCT04401579|42182311|FG000|Overall Study|Physician Decision|1|||
19735717|NCT04401579|42182312|FG001|Overall Study|Physician Decision|2|||
19735718|NCT04401579|42182311|FG000|Overall Study|Became ineligible after enrollment|1|||
19735719|NCT04401579|42182312|FG001|Overall Study|Became ineligible after enrollment|1|||
19735720|NCT04401579|42182311|FG000|Overall Study|Enrolled but treatment not administered|7|||
19735721|NCT04401579|42182312|FG001|Overall Study|Enrolled but treatment not administered|9|||
19735722|NCT04401579|42182311|FG000|Overall Study|Adverse Event|2|||
19735723|NCT04401579|42182312|FG001|Overall Study|Adverse Event|1|||
19735724|NCT04401579|42182311|FG000|Overall Study|Scheduling error|1|||
19735725|NCT04401579|42182312|FG001|Overall Study|Scheduling error|2|||
19735726|NCT04401579|42182311|FG000|Overall Study|Transferred to another hospital|1|||
19735727|NCT04401579|42182312|FG001|Overall Study|Transferred to another hospital|2|||
19735728|NCT04161807|42182318|FG000|Overall Study|Withdrawal by Subject|2|||
19735729|NCT04161807|42182318|FG000|Overall Study|Performed only 1 treatment|2|||
19735730|NCT04401423|42182324|FG000|Overall Study|Withdrawal by Subject|3|||
19735731|NCT04401423|42182325|FG001|Overall Study|Withdrawal by Subject|1|||
19735732|NCT04401423|42182324|FG000|Overall Study|Physician Decision|2|||
19735733|NCT04401423|42182325|FG001|Overall Study|Physician Decision|1|||
19735734|NCT04399161|42182336|FG000|Overall Study|Withdrawal by Subject|1|||
19735735|NCT04399161|42182337|FG001|Overall Study|Withdrawal by Subject|0|||
19735736|NCT04399161|42182338|FG002|Overall Study|Withdrawal by Subject|2|||
19735737|NCT04399161|42182336|FG000|Overall Study|Protocol Violation|1|||
19735738|NCT04399161|42182337|FG001|Overall Study|Protocol Violation|2|||
19735739|NCT04399161|42182338|FG002|Overall Study|Protocol Violation|0|||
19735740|NCT02076178|42182348|FG000|Oral Phase|Adverse Event|0|||
19735741|NCT02076178|42182349|FG001|Oral Phase|Adverse Event|7|||
19735742|NCT02076178|42182348|FG000|Oral Phase|Withdrawal by Subject|0|||
19735743|NCT02076178|42182349|FG001|Oral Phase|Withdrawal by Subject|4|||
19735744|NCT02076178|42182348|FG000|Oral Phase|Physician Decision|0|||
19735745|NCT02076178|42182349|FG001|Oral Phase|Physician Decision|1|||
19735746|NCT02076178|42182348|FG000|Injection Phase|Protocol defined stopping criteria|1|||
19735747|NCT02076178|42182349|FG001|Injection Phase|Protocol defined stopping criteria|0|||
19735748|NCT02076178|42182348|FG000|Injection Phase|Withdrawal by Subject|0|||
19735749|NCT02076178|42182349|FG001|Injection Phase|Withdrawal by Subject|3|||
19735750|NCT02076178|42182348|FG000|Injection Phase|Physician Decision|0|||
19735751|NCT02076178|42182349|FG001|Injection Phase|Physician Decision|3|||
19735752|NCT02076178|42182348|FG000|Injection Phase|Lost to Follow-up|0|||
19735753|NCT02076178|42182349|FG001|Injection Phase|Lost to Follow-up|1|||
19735754|NCT04160091|42182361|FG000|Overall Study|Terminated by Sponsor|7|||
19735755|NCT04160091|42182362|FG001|Overall Study|Terminated by Sponsor|3|||
19735756|NCT04160091|42182363|FG002|Overall Study|Terminated by Sponsor|5|||
19735757|NCT04160091|42182364|FG003|Overall Study|Terminated by Sponsor|2|||
19735758|NCT04160091|42182361|FG000|Overall Study|Noncompliance|0|||
19735759|NCT04160091|42182362|FG001|Overall Study|Noncompliance|0|||
19735760|NCT04160091|42182363|FG002|Overall Study|Noncompliance|0|||
19735761|NCT04160091|42182364|FG003|Overall Study|Noncompliance|1|||
19735762|NCT04160091|42182361|FG000|Overall Study|Withdrawal by Subject|0|||
19735763|NCT04160091|42182362|FG001|Overall Study|Withdrawal by Subject|0|||
19735764|NCT04160091|42182363|FG002|Overall Study|Withdrawal by Subject|0|||
19735765|NCT04160091|42182364|FG003|Overall Study|Withdrawal by Subject|1|||
19735766|NCT00149825|42182376|FG000|Overall Study|Intolerance to medication side effects|1|||
19735767|NCT00149825|42182377|FG001|Overall Study|Intolerance to medication side effects|2|||
19735768|NCT00149825|42182376|FG000|Overall Study|Time commitments|2|||
19735769|NCT00149825|42182377|FG001|Overall Study|Time commitments|1|||
19735770|NCT00149825|42182376|FG000|Overall Study|Not liking insomnia therapy|1|||
19735771|NCT00149825|42182377|FG001|Overall Study|Not liking insomnia therapy|0|||
19735772|NCT00149825|42182376|FG000|Overall Study|Other|1|||
19735773|NCT00149825|42182377|FG001|Overall Study|Other|0|||
19735774|NCT04397757|42182385|FG000|Overall Study|Death|3|||
19735775|NCT04397757|42182386|FG001|Overall Study|Death|11|||
19735776|NCT04397757|42182385|FG000|Overall Study|Withdrawal by Subject|2|||
19735777|NCT04397757|42182386|FG001|Overall Study|Withdrawal by Subject|0|||
19735778|NCT04397757|42182385|FG000|Overall Study|Lost to Follow-up|4|||
19735779|NCT04397757|42182386|FG001|Overall Study|Lost to Follow-up|3|||
19735780|NCT02792062|42182403|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
19735781|NCT02792062|42182404|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
19735782|NCT02792062|42182405|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
19735783|NCT02792062|42182406|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
19735784|NCT02792062|42182407|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
19735785|NCT02792062|42182408|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
19735786|NCT00196937|42182419|FG000|Overall Study|Serious Adverse Event|1|||
19735787|NCT00196937|42182420|FG001|Overall Study|Serious Adverse Event|0|||
19735788|NCT00196937|42182421|FG002|Overall Study|Serious Adverse Event|0|||
19735789|NCT00196937|42182419|FG000|Overall Study|Non-serious adverse event|1|||
19735790|NCT00196937|42182420|FG001|Overall Study|Non-serious adverse event|1|||
19735791|NCT00196937|42182421|FG002|Overall Study|Non-serious adverse event|1|||
19735792|NCT00196937|42182419|FG000|Overall Study|Withdrawal by Subject|0|||
19735793|NCT00196937|42182420|FG001|Overall Study|Withdrawal by Subject|0|||
19735794|NCT00196937|42182421|FG002|Overall Study|Withdrawal by Subject|2|||
19735795|NCT00196937|42182419|FG000|Overall Study|Lost to Follow-up|4|||
19735796|NCT00196937|42182420|FG001|Overall Study|Lost to Follow-up|3|||
19735797|NCT00196937|42182421|FG002|Overall Study|Lost to Follow-up|3|||
19735798|NCT00196937|42182419|FG000|Overall Study|Other|3|||
19735799|NCT00196937|42182420|FG001|Overall Study|Other|1|||
19735800|NCT00196937|42182421|FG002|Overall Study|Other|1|||
19735801|NCT04397445|42182430|FG000|Overall Study|Withdrawal by Subject|1|||
19735802|NCT04397445|42182431|FG001|Overall Study|Withdrawal by Subject|0|||
19735803|NCT04397445|42182432|FG002|Overall Study|Withdrawal by Subject|0|||
19735804|NCT04397445|42182433|FG003|Overall Study|Withdrawal by Subject|0|||
19735805|NCT00191945|42182450|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
19735806|NCT00191945|42182451|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
19735807|NCT00191945|42182450|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
19735808|NCT00191945|42182451|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
19735809|NCT00191945|42182450|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
19735810|NCT00191945|42182451|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
19735811|NCT00191945|42182450|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
19735812|NCT00191945|42182451|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
19735813|NCT01369342|42182461|FG000|Overall Study|Withdrawal by Subject|7|||
19735814|NCT01369342|42182462|FG001|Overall Study|Withdrawal by Subject|7|||
19735815|NCT01369342|42182463|FG002|Overall Study|Withdrawal by Subject|2|||
19735816|NCT01369342|42182461|FG000|Overall Study|Lost to Follow-up|5|||
19735817|NCT01369342|42182462|FG001|Overall Study|Lost to Follow-up|2|||
19735818|NCT01369342|42182463|FG002|Overall Study|Lost to Follow-up|1|||
19735819|NCT01369342|42182461|FG000|Overall Study|Not Treated|1|||
19735820|NCT01369342|42182462|FG001|Overall Study|Not Treated|0|||
19735821|NCT01369342|42182463|FG002|Overall Study|Not Treated|0|||
19735822|NCT00191477|42182473|FG000|Overall Study|Tumor Recurrence|49|||
19735823|NCT00191477|42182474|FG001|Overall Study|Tumor Recurrence|48|||
19735824|NCT00191477|42182473|FG000|Overall Study|Death, Study Disease|1|||
19735825|NCT00191477|42182474|FG001|Overall Study|Death, Study Disease|1|||
19735826|NCT00191477|42182473|FG000|Overall Study|Death, Other Cause|3|||
19735827|NCT00191477|42182474|FG001|Overall Study|Death, Other Cause|6|||
19735828|NCT00191477|42182473|FG000|Overall Study|Lost to Follow-up|23|||
19735829|NCT00191477|42182474|FG001|Overall Study|Lost to Follow-up|21|||
19735830|NCT00191477|42182473|FG000|Overall Study|Protocol Violation|1|||
19735831|NCT00191477|42182474|FG001|Overall Study|Protocol Violation|1|||
19735832|NCT00191477|42182473|FG000|Overall Study|Treatment Change|2|||
19735833|NCT00191477|42182474|FG001|Overall Study|Treatment Change|0|||
19735834|NCT00191477|42182473|FG000|Overall Study|Withdrawal by Subject|2|||
19735835|NCT00191477|42182474|FG001|Overall Study|Withdrawal by Subject|0|||
19735836|NCT00191477|42182473|FG000|Overall Study|Other|2|||
19735837|NCT00191477|42182474|FG001|Overall Study|Other|0|||
19735838|NCT00191477|42182473|FG000|Overall Study|Not Eligible|41|||
19735839|NCT00191477|42182474|FG001|Overall Study|Not Eligible|38|||
19735840|NCT00191477|42182473|FG000|Overall Study|Pathological Specimen Lost|1|||
19735841|NCT00191477|42182474|FG001|Overall Study|Pathological Specimen Lost|0|||
19735842|NCT00191477|42182473|FG000|Overall Study|Discontinued Prior to Instillation|13|||
19735843|NCT00191477|42182474|FG001|Overall Study|Discontinued Prior to Instillation|14|||
19735844|NCT04320615|42182482|FG000|Overall Study|Withdrawal by Subject|4|||
19735845|NCT04320615|42182483|FG001|Overall Study|Withdrawal by Subject|10|||
19735846|NCT04320615|42182482|FG000|Overall Study|Physician Decision|2|||
19735847|NCT04320615|42182483|FG001|Overall Study|Physician Decision|0|||
19735848|NCT04320615|42182482|FG000|Overall Study|Other|2|||
19735849|NCT04320615|42182483|FG001|Overall Study|Other|0|||
19735850|NCT04320615|42182482|FG000|Overall Study|Lost to Follow-up|5|||
19735851|NCT04320615|42182483|FG001|Overall Study|Lost to Follow-up|23|||
19735852|NCT04320615|42182482|FG000|Overall Study|Death|35|||
19735853|NCT04320615|42182483|FG001|Overall Study|Death|71|||
19735854|NCT00149747|42182495|FG000|Overall Study|Death|1|||
19735855|NCT00149747|42182496|FG001|Overall Study|Death|0|||
19735856|NCT00149747|42182495|FG000|Overall Study|Withdrawal by Subject|3|||
19735857|NCT00149747|42182496|FG001|Overall Study|Withdrawal by Subject|3|||
19735858|NCT00187889|42182504|FG000|Overall Study|Withdrawal by Subject|6|||
19735859|NCT00187889|42182505|FG001|Overall Study|Withdrawal by Subject|4|||
19735860|NCT00148343|42182514|FG000|Overall Study|Withdrawal by Subject|12|||
19735861|NCT00148343|42182515|FG001|Overall Study|Withdrawal by Subject|7|||
19735862|NCT00148343|42182514|FG000|Overall Study|Physician Decision|3|||
19735863|NCT00148343|42182515|FG001|Overall Study|Physician Decision|4|||
19735864|NCT04150341|42182521|FG000|Overall Study|Physician Decision|0|||
19735865|NCT04150341|42182522|FG001|Overall Study|Physician Decision|0|||
19735866|NCT04150341|42182523|FG002|Overall Study|Physician Decision|1|||
19735867|NCT04150341|42182524|FG003|Overall Study|Physician Decision|0|||
19735868|NCT04150341|42182525|FG004|Overall Study|Physician Decision|0|||
19735869|NCT04150341|42182526|FG005|Overall Study|Physician Decision|0|||
19735870|NCT04150341|42182521|FG000|Overall Study|Adverse Event|0|||
19735871|NCT04150341|42182522|FG001|Overall Study|Adverse Event|0|||
19735872|NCT04150341|42182523|FG002|Overall Study|Adverse Event|0|||
19735873|NCT04150341|42182524|FG003|Overall Study|Adverse Event|0|||
19735874|NCT04150341|42182525|FG004|Overall Study|Adverse Event|1|||
19735875|NCT04150341|42182526|FG005|Overall Study|Adverse Event|0|||
19735876|NCT00148109|42182538|FG000|Overall Study|Lack of Efficacy|10|||
19735877|NCT00148109|42182539|FG001|Overall Study|Lack of Efficacy|18|||
19735878|NCT00148109|42182538|FG000|Overall Study|Adverse Event|0|||
19735879|NCT00148109|42182539|FG001|Overall Study|Adverse Event|2|||
19735880|NCT00148109|42182538|FG000|Overall Study|Withdrawal by Subject|2|||
19735881|NCT00148109|42182539|FG001|Overall Study|Withdrawal by Subject|0|||
19735882|NCT00186485|42182545|FG000|Overall Study|Lost to Follow-up|3|||
19735883|NCT00147251|42182551|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
19735884|NCT00147251|42182552|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
19735885|NCT04390191|42182562|FG000|Overall Study|Withdrawal by Subject|1|||
19735886|NCT04390191|42182563|FG001|Overall Study|Withdrawal by Subject|0|||
19735887|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
19735888|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
19735889|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
19735890|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735891|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735892|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735893|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735894|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735895|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
19735896|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Physician Decision|1|||
19735897|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Physician Decision|2|||
19735898|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Physician Decision|0|||
19735899|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Physician Decision|0|||
19735900|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Physician Decision|0|||
19380926|NCT02379728|41624158|FG003|Overall Study|Withdrawal by Subject|3|||
19465281|NCT04426695|41723757|FG016|Overall Study|Sponsor Request|0|||
19735901|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Physician Decision|0|||
19465282|NCT04426695|41723758|FG017|Overall Study|Sponsor Request|0|||
19735902|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Physician Decision|0|||
19735903|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Physician Decision|0|||
19735904|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Physician Decision|0|||
19735905|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
19735906|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
19735907|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
19735908|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
19735909|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
19735910|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
19735911|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
19735912|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
19735913|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
19735914|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
19735915|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735916|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735917|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735918|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735919|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735920|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735921|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735922|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
19735923|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
19735924|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
19735925|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735926|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735927|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735928|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735929|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735930|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735931|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
19735932|NCT04405076|42182575|FG000|Part A (Blinded Phase)|Other than Specified|0|||
19735933|NCT04405076|42182576|FG001|Part A (Blinded Phase)|Other than Specified|0|||
19735934|NCT04405076|42182577|FG002|Part A (Blinded Phase)|Other than Specified|3|||
19735935|NCT04405076|42182578|FG003|Part A (Blinded Phase)|Other than Specified|0|||
19735936|NCT04405076|42182579|FG004|Part A (Blinded Phase)|Other than Specified|0|||
19735937|NCT04405076|42182580|FG005|Part A (Blinded Phase)|Other than Specified|0|||
19735938|NCT04405076|42182581|FG006|Part A (Blinded Phase)|Other than Specified|0|||
19735939|NCT04405076|42182582|FG007|Part A (Blinded Phase)|Other than Specified|0|||
19735940|NCT04405076|42182583|FG008|Part A (Blinded Phase)|Other than Specified|0|||
19735941|NCT04405076|42182575|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735942|NCT04405076|42182576|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735943|NCT04405076|42182577|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735944|NCT04405076|42182578|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
19735945|NCT04405076|42182579|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
19735946|NCT04405076|42182580|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
19735947|NCT04405076|42182581|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735948|NCT04405076|42182582|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735949|NCT04405076|42182583|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
19735950|NCT04405076|42182575|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735951|NCT04405076|42182576|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735952|NCT04405076|42182577|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735953|NCT04405076|42182578|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735954|NCT04405076|42182579|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
19735955|NCT04405076|42182580|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735956|NCT04405076|42182581|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735957|NCT04405076|42182582|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735958|NCT04405076|42182583|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
19735959|NCT04405076|42182575|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735960|NCT04405076|42182576|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735961|NCT04405076|42182577|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735962|NCT04405076|42182578|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
19735963|NCT04405076|42182579|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
19735964|NCT04405076|42182580|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
19735965|NCT04405076|42182581|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735966|NCT04405076|42182582|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735967|NCT04405076|42182583|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
19735968|NCT04405076|42182575|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735969|NCT04405076|42182576|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735970|NCT04405076|42182577|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735971|NCT04405076|42182578|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735972|NCT04405076|42182579|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735973|NCT04405076|42182580|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735974|NCT04405076|42182581|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
19735975|NCT04405076|42182582|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
19735976|NCT04405076|42182583|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
19735977|NCT04405076|42182575|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735978|NCT04405076|42182576|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735979|NCT04405076|42182577|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735980|NCT04405076|42182578|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735981|NCT04405076|42182579|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735982|NCT04405076|42182580|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735983|NCT04405076|42182581|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
19735984|NCT04405076|42182582|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735985|NCT04405076|42182583|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
19735986|NCT04311177|42182611|FG000|Overall Study|Adverse Event|3|||
19735987|NCT04311177|42182612|FG001|Overall Study|Adverse Event|1|||
19735988|NCT04311177|42182611|FG000|Overall Study|Physician Decision|4|||
19735989|NCT04311177|42182612|FG001|Overall Study|Physician Decision|3|||
19735990|NCT04311177|42182611|FG000|Overall Study|Withdrawal by Subject|1|||
19735991|NCT04311177|42182612|FG001|Overall Study|Withdrawal by Subject|0|||
19735992|NCT03267212|42182618|FG000|First Intervention|Lost to Follow-up|0|||
19735993|NCT03267212|42182619|FG001|First Intervention|Lost to Follow-up|2|||
19735994|NCT03267212|42182618|FG000|First Intervention|Withdrawal by Subject|1|||
19735995|NCT03267212|42182619|FG001|First Intervention|Withdrawal by Subject|1|||
19735996|NCT03267212|42182618|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
19735997|NCT03267212|42182619|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
19735998|NCT04292535|42182639|FG000|Overall Study|Withdrawal by Subject|0|||
19735999|NCT04292535|42182640|FG001|Overall Study|Withdrawal by Subject|0|||
19736000|NCT04292535|42182641|FG002|Overall Study|Withdrawal by Subject|0|||
19736001|NCT04292535|42182642|FG003|Overall Study|Withdrawal by Subject|0|||
19736002|NCT04292535|42182643|FG004|Overall Study|Withdrawal by Subject|0|||
19736003|NCT04292535|42182644|FG005|Overall Study|Withdrawal by Subject|0|||
19736004|NCT04292535|42182645|FG006|Overall Study|Withdrawal by Subject|0|||
19736005|NCT04292535|42182646|FG007|Overall Study|Withdrawal by Subject|1|||
19736006|NCT04292535|42182647|FG008|Overall Study|Withdrawal by Subject|0|||
19736007|NCT04292535|42182648|FG009|Overall Study|Withdrawal by Subject|0|||
19736008|NCT04292535|42182649|FG010|Overall Study|Withdrawal by Subject|0|||
19736009|NCT04292535|42182650|FG011|Overall Study|Withdrawal by Subject|0|||
19736010|NCT04292535|42182651|FG012|Overall Study|Withdrawal by Subject|0|||
19736011|NCT04292535|42182652|FG013|Overall Study|Withdrawal by Subject|0|||
19736012|NCT04292535|42182639|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736013|NCT04292535|42182640|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736014|NCT04292535|42182641|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736015|NCT04292535|42182642|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736016|NCT04292535|42182643|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736017|NCT04292535|42182644|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736018|NCT04292535|42182645|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736019|NCT04292535|42182646|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
19736020|NCT04292535|42182647|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736021|NCT04292535|42182648|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736022|NCT04292535|42182649|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736023|NCT04292535|42182650|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
19736024|NCT04292535|42182651|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
19736025|NCT04292535|42182652|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
19736026|NCT04292535|42182639|FG000|Overall Study|Report of Dizziness|0|||
19736027|NCT04292535|42182640|FG001|Overall Study|Report of Dizziness|0|||
19551296|NCT01346774|42000127|FG000|Overall Study|Lost to Follow-up|3|||
19736028|NCT04292535|42182641|FG002|Overall Study|Report of Dizziness|0|||
19736029|NCT04292535|42182642|FG003|Overall Study|Report of Dizziness|0|||
19736030|NCT04292535|42182643|FG004|Overall Study|Report of Dizziness|0|||
19736031|NCT04292535|42182644|FG005|Overall Study|Report of Dizziness|0|||
19736032|NCT04292535|42182645|FG006|Overall Study|Report of Dizziness|0|||
19736033|NCT04292535|42182646|FG007|Overall Study|Report of Dizziness|0|||
19736034|NCT04292535|42182647|FG008|Overall Study|Report of Dizziness|0|||
19736035|NCT04292535|42182648|FG009|Overall Study|Report of Dizziness|0|||
19736036|NCT04292535|42182649|FG010|Overall Study|Report of Dizziness|0|||
19736037|NCT04292535|42182650|FG011|Overall Study|Report of Dizziness|0|||
19736038|NCT04292535|42182651|FG012|Overall Study|Report of Dizziness|0|||
19736039|NCT04292535|42182652|FG013|Overall Study|Report of Dizziness|1|||
19736040|NCT04292535|42182639|FG000|Overall Study|Equipment Failure|0|||
19736041|NCT04292535|42182640|FG001|Overall Study|Equipment Failure|0|||
19736042|NCT04292535|42182641|FG002|Overall Study|Equipment Failure|0|||
19736043|NCT04292535|42182642|FG003|Overall Study|Equipment Failure|0|||
19736044|NCT04292535|42182643|FG004|Overall Study|Equipment Failure|0|||
19736045|NCT04292535|42182644|FG005|Overall Study|Equipment Failure|0|||
19736046|NCT04292535|42182645|FG006|Overall Study|Equipment Failure|0|||
19736047|NCT04292535|42182646|FG007|Overall Study|Equipment Failure|0|||
19736048|NCT04292535|42182647|FG008|Overall Study|Equipment Failure|0|||
19736049|NCT04292535|42182648|FG009|Overall Study|Equipment Failure|0|||
19736050|NCT04292535|42182649|FG010|Overall Study|Equipment Failure|0|||
19736051|NCT04292535|42182650|FG011|Overall Study|Equipment Failure|1|||
19736052|NCT04292535|42182651|FG012|Overall Study|Equipment Failure|0|||
19736053|NCT04292535|42182652|FG013|Overall Study|Equipment Failure|0|||
19736054|NCT04385199|42182684|FG000|Overall Study|Withdrawal by Subject|1|||
19736055|NCT04385199|42182685|FG001|Overall Study|Withdrawal by Subject|0|||
19736056|NCT04284813|42182691|FG000|Overall Study|Withdrawal by Subject|1|||
19736057|NCT03263780|42182695|FG000|Overall Study|Withdrawal by Subject|3|||
19736058|NCT03263780|42182695|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
19736059|NCT02791438|42182701|FG000|Treatment Period|Adverse Event|1|||
19736060|NCT02791438|42182702|FG001|Treatment Period|Adverse Event|0|||
19736061|NCT02791438|42182701|FG000|Treatment Period|Withdrawal by Subject|0|||
19736062|NCT02791438|42182702|FG001|Treatment Period|Withdrawal by Subject|1|||
19736063|NCT02791438|42182701|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
19736064|NCT02791438|42182702|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
19736065|NCT03712124|42182710|FG000|Overall Study|Protocol Violation|1|||
19736066|NCT03712124|42182711|FG001|Overall Study|Protocol Violation|0|||
19736067|NCT02791516|42182725|FG000|Overall Study|Withdrawal by Subject|1|||
19736068|NCT02791516|42182726|FG001|Overall Study|Withdrawal by Subject|1|||
19736069|NCT03263702|42182734|FG000|Overall Study|Lost to Follow-up|2|||
19736070|NCT03263702|42182735|FG001|Overall Study|Lost to Follow-up|2|||
19736071|NCT03263702|42182734|FG000|Overall Study|Withdrawal by Subject|1|||
19736072|NCT03263702|42182735|FG001|Overall Study|Withdrawal by Subject|2|||
19736073|NCT03692871|42182743|FG000|Overall Study|Death|1|||
19736074|NCT03692871|42182744|FG001|Overall Study|Death|1|||
19736075|NCT03692871|42182743|FG000|Overall Study|Lost to Follow-up|24|||
19736076|NCT03692871|42182744|FG001|Overall Study|Lost to Follow-up|9|||
19736077|NCT03692871|42182743|FG000|Overall Study|Physician Decision|22|||
19736078|NCT03692871|42182744|FG001|Overall Study|Physician Decision|7|||
19736079|NCT03692871|42182743|FG000|Overall Study|Protocol Deviation|1|||
19736080|NCT03692871|42182744|FG001|Overall Study|Protocol Deviation|0|||
19736081|NCT03692871|42182743|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
19736082|NCT03692871|42182744|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
19736083|NCT04384107|42182752|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
19736084|NCT04384107|42182753|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
19736085|NCT04384107|42182752|FG000|Overall Study|Lost to Follow-up|1|||
19736086|NCT04384107|42182753|FG001|Overall Study|Lost to Follow-up|0|||
19736087|NCT04130919|42182762|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
19736088|NCT04130919|42182763|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
19736089|NCT04130919|42182764|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
19736090|NCT04130919|42182765|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
19736091|NCT04130919|42182766|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
19736092|NCT04130919|42182767|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
19736093|NCT04130919|42182762|FG000|Blinded Treatment Phase|Adverse Event|0|||
19736094|NCT04130919|42182763|FG001|Blinded Treatment Phase|Adverse Event|0|||
19736095|NCT04130919|42182764|FG002|Blinded Treatment Phase|Adverse Event|1|||
19736096|NCT04130919|42182765|FG003|Blinded Treatment Phase|Adverse Event|0|||
19736097|NCT04130919|42182766|FG004|Blinded Treatment Phase|Adverse Event|0|||
19736098|NCT04130919|42182767|FG005|Blinded Treatment Phase|Adverse Event|0|||
19736099|NCT04130919|42182762|FG000|Blinded Treatment Phase|Disease worsening|0|||
19736100|NCT04130919|42182763|FG001|Blinded Treatment Phase|Disease worsening|0|||
19736101|NCT04130919|42182764|FG002|Blinded Treatment Phase|Disease worsening|1|||
19736102|NCT04130919|42182765|FG003|Blinded Treatment Phase|Disease worsening|0|||
19736103|NCT04130919|42182766|FG004|Blinded Treatment Phase|Disease worsening|0|||
19736104|NCT04130919|42182767|FG005|Blinded Treatment Phase|Disease worsening|0|||
19736105|NCT04130919|42182762|FG000|Blinded Treatment Phase|Investigator's decision|0|||
19736106|NCT04130919|42182763|FG001|Blinded Treatment Phase|Investigator's decision|1|||
19736107|NCT04130919|42182764|FG002|Blinded Treatment Phase|Investigator's decision|0|||
19736108|NCT04130919|42182765|FG003|Blinded Treatment Phase|Investigator's decision|0|||
19736109|NCT04130919|42182766|FG004|Blinded Treatment Phase|Investigator's decision|0|||
19736110|NCT04130919|42182767|FG005|Blinded Treatment Phase|Investigator's decision|0|||
19736111|NCT04130919|42182762|FG000|Blinded Treatment Phase|Withdrew consent|1|||
19736112|NCT04130919|42182763|FG001|Blinded Treatment Phase|Withdrew consent|0|||
19736113|NCT04130919|42182764|FG002|Blinded Treatment Phase|Withdrew consent|0|||
19736114|NCT04130919|42182765|FG003|Blinded Treatment Phase|Withdrew consent|0|||
19736115|NCT04130919|42182766|FG004|Blinded Treatment Phase|Withdrew consent|0|||
19736116|NCT04130919|42182767|FG005|Blinded Treatment Phase|Withdrew consent|0|||
19736117|NCT04130919|42182762|FG000|Open-label Treatment Phase|Withdrew consent|0|||
19736118|NCT04130919|42182763|FG001|Open-label Treatment Phase|Withdrew consent|0|||
19736119|NCT04130919|42182764|FG002|Open-label Treatment Phase|Withdrew consent|0|||
19736120|NCT04130919|42182765|FG003|Open-label Treatment Phase|Withdrew consent|1|||
19736121|NCT04130919|42182766|FG004|Open-label Treatment Phase|Withdrew consent|1|||
19736122|NCT04130919|42182767|FG005|Open-label Treatment Phase|Withdrew consent|1|||
19736123|NCT04130919|42182762|FG000|Open-label Treatment Phase|Disease worsening|0|||
19736124|NCT04130919|42182763|FG001|Open-label Treatment Phase|Disease worsening|0|||
19736125|NCT04130919|42182764|FG002|Open-label Treatment Phase|Disease worsening|0|||
19736126|NCT04130919|42182765|FG003|Open-label Treatment Phase|Disease worsening|1|||
19736127|NCT04130919|42182766|FG004|Open-label Treatment Phase|Disease worsening|0|||
19736128|NCT04130919|42182767|FG005|Open-label Treatment Phase|Disease worsening|1|||
19736129|NCT04130919|42182762|FG000|Open-label Treatment Phase|Investigator's decision|0|||
19736130|NCT04130919|42182763|FG001|Open-label Treatment Phase|Investigator's decision|0|||
19736131|NCT04130919|42182764|FG002|Open-label Treatment Phase|Investigator's decision|0|||
19736132|NCT04130919|42182765|FG003|Open-label Treatment Phase|Investigator's decision|1|||
19736133|NCT04130919|42182766|FG004|Open-label Treatment Phase|Investigator's decision|0|||
19736134|NCT04130919|42182767|FG005|Open-label Treatment Phase|Investigator's decision|0|||
19736135|NCT04130919|42182762|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
19736136|NCT04130919|42182763|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
19736137|NCT04130919|42182764|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
19736138|NCT04130919|42182765|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
19736139|NCT04130919|42182766|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
19736140|NCT04130919|42182767|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
19736141|NCT04130919|42182762|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
19736142|NCT04130919|42182763|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
19736143|NCT04130919|42182764|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
19736144|NCT04130919|42182765|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
19736145|NCT04130919|42182766|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
19736146|NCT04130919|42182767|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
19736147|NCT04128267|42182781|FG000|Overall Study|Withdrawal by Subject|6|||
19736148|NCT04128267|42182781|FG000|Overall Study|Death|2|||
19736149|NCT04128267|42182781|FG000|Overall Study|Disease progression|1|||
19736150|NCT04128267|42182781|FG000|Overall Study|Participant had other medical issues|4|||
19736151|NCT04128267|42182781|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
19736152|NCT03691779|42182785|FG000|Part B (24 Weeks)|Adverse Event|0|||
19736153|NCT03691779|42182786|FG001|Part B (24 Weeks)|Adverse Event|1|||
19736154|NCT03691779|42182785|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
19736155|NCT03691779|42182786|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
19736156|NCT04258995|42182795|FG000|Overall Study|Lost to Follow-up|1|||
19736157|NCT04258995|42182796|FG001|Overall Study|Lost to Follow-up|1|||
19736158|NCT04247061|42182802|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
19736159|NCT04247061|42182802|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
19736160|NCT04247061|42182802|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
19736161|NCT04241133|42182808|FG000|Overall Study|COVID19 Precautions|14|||
19736162|NCT04241133|42182809|FG001|Overall Study|COVID19 Precautions|34|||
19736163|NCT04123665|42182817|FG000|Overall Study|Withdrawal by Subject|7|||
19736164|NCT04123665|42182818|FG001|Overall Study|Withdrawal by Subject|0|||
19736165|NCT04123665|42182817|FG000|Overall Study|Lost to Follow-up|1|||
19736166|NCT04123665|42182818|FG001|Overall Study|Lost to Follow-up|0|||
19736167|NCT03981614|42182827|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
19736168|NCT03981614|42182828|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
19736169|NCT03981614|42182829|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
19736170|NCT04232943|42182843|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
19736171|NCT04232943|42182844|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
19736172|NCT04232943|42182845|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
19736173|NCT04232943|42182843|FG000|Overall Study|Withdrawal by Subject|1|||
19736174|NCT04232943|42182844|FG001|Overall Study|Withdrawal by Subject|1|||
19736175|NCT04232943|42182845|FG002|Overall Study|Withdrawal by Subject|0|||
19736176|NCT03694275|42182856|FG000|Overall Study|Adverse Event|0|||
19736177|NCT03694275|42182857|FG001|Overall Study|Adverse Event|1|||
19736178|NCT03694275|42182856|FG000|Overall Study|Reason not Specified|0|||
19465283|NCT04426695|41723741|FG000|Overall Study|Physician Decision|0|||
19551297|NCT01346774|42000128|FG001|Overall Study|Lost to Follow-up|4|||
19736179|NCT03694275|42182857|FG001|Overall Study|Reason not Specified|1|||
19736180|NCT04230213|42182864|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
19736181|NCT04230213|42182865|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
19736182|NCT04230213|42182866|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
19736183|NCT04230213|42182864|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
19736184|NCT04230213|42182865|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
19736185|NCT04230213|42182866|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
19736186|NCT04230213|42182864|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
19736187|NCT04230213|42182865|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
19736188|NCT04230213|42182866|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
19736189|NCT04230213|42182864|FG000|TP2: Week 10 to Week 16|Other|0|||
19736190|NCT04230213|42182865|FG001|TP2: Week 10 to Week 16|Other|2|||
19736191|NCT04230213|42182866|FG002|TP2: Week 10 to Week 16|Other|1|||
19736192|NCT04230213|42182864|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
19736193|NCT04230213|42182865|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
19736194|NCT04230213|42182866|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
19736195|NCT04230213|42182864|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
19736196|NCT04230213|42182865|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
19736197|NCT04230213|42182866|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
19736198|NCT04230213|42182864|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
19736199|NCT04230213|42182865|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
19736200|NCT04230213|42182866|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
19736201|NCT04230213|42182864|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
19736202|NCT04230213|42182865|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
19736203|NCT04230213|42182866|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
19736204|NCT04230213|42182864|FG000|TP3: Week 16 to Week 22|Other|0|||
19736205|NCT04230213|42182865|FG001|TP3: Week 16 to Week 22|Other|1|||
19736206|NCT04230213|42182866|FG002|TP3: Week 16 to Week 22|Other|3|||
19736207|NCT04230213|42182864|FG000|TP4: Week 22 to Week 32|Other|0|||
19736208|NCT04230213|42182865|FG001|TP4: Week 22 to Week 32|Other|5|||
19736209|NCT04230213|42182866|FG002|TP4: Week 22 to Week 32|Other|5|||
19736210|NCT04230213|42182864|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
19639139|NCT00717236|42088569|FG000|Double-Blind Period|Other: History of cancer|1|||
19639140|NCT00717236|42088570|FG001|Double-Blind Period|Other: History of cancer|0|||
19639141|NCT00717236|42088569|FG000|Double-Blind Period|Other: Sponsor request|1|||
19639142|NCT00717236|42088570|FG001|Double-Blind Period|Other: Sponsor request|0|||
19639143|NCT00717236|42088569|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
19639144|NCT00717236|42088570|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
19639145|NCT00717236|42088569|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
19639146|NCT00717236|42088570|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
19639147|NCT00717236|42088569|FG000|Double-Blind Period|Other: Subject moved|1|||
19639148|NCT00717236|42088570|FG001|Double-Blind Period|Other: Subject moved|1|||
19736211|NCT04230213|42182865|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
19736212|NCT04230213|42182866|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
19736213|NCT04230213|42182864|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
19736214|NCT04230213|42182865|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
19736215|NCT04230213|42182866|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
19736216|NCT04230213|42182864|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
19736217|NCT04230213|42182865|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
19736218|NCT04230213|42182866|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
19736219|NCT04230213|42182864|FG000|Follow up: Week 32 to Week 36|Other|0|||
19736220|NCT04230213|42182865|FG001|Follow up: Week 32 to Week 36|Other|1|||
19736221|NCT04230213|42182866|FG002|Follow up: Week 32 to Week 36|Other|1|||
19736222|NCT04222725|42182878|FG000|Overall Study|Adverse Event|0|||
19736223|NCT04222725|42182879|FG001|Overall Study|Adverse Event|1|||
19736224|NCT04222725|42182880|FG002|Overall Study|Adverse Event|0|||
19736225|NCT04222725|42182881|FG003|Overall Study|Adverse Event|0|||
19465284|NCT04426695|41723742|FG001|Overall Study|Physician Decision|0|||
19465285|NCT04426695|41723743|FG002|Overall Study|Physician Decision|0|||
19465286|NCT04426695|41723744|FG003|Overall Study|Physician Decision|0|||
19465287|NCT04426695|41723745|FG004|Overall Study|Physician Decision|0|||
19465288|NCT04426695|41723746|FG005|Overall Study|Physician Decision|0|||
19465289|NCT04426695|41723747|FG006|Overall Study|Physician Decision|0|||
19465290|NCT04426695|41723748|FG007|Overall Study|Physician Decision|0|||
19465291|NCT04426695|41723749|FG008|Overall Study|Physician Decision|0|||
19736226|NCT04213989|42182893|FG000|Overall Study|Withdrawal by Subject|3|||
19736227|NCT04213989|42182894|FG001|Overall Study|Withdrawal by Subject|2|||
19736228|NCT04213989|42182893|FG000|Overall Study|Physician Decision|1|||
19736229|NCT04213989|42182894|FG001|Overall Study|Physician Decision|0|||
19736230|NCT04213989|42182893|FG000|Overall Study|Lost to Follow-up|0|||
19736231|NCT04213989|42182894|FG001|Overall Study|Lost to Follow-up|4|||
19736232|NCT03242252|42182903|FG000|Overall Study|At the Participant's own Request|18|||
19465292|NCT04426695|41723750|FG009|Overall Study|Physician Decision|1|||
19465293|NCT04426695|41723751|FG010|Overall Study|Physician Decision|0|||
19736233|NCT03242252|42182904|FG001|Overall Study|At the Participant's own Request|10|||
19736234|NCT03242252|42182905|FG002|Overall Study|At the Participant's own Request|15|||
19736235|NCT03242252|42182903|FG000|Overall Study|Adverse Event|8|||
19736236|NCT03242252|42182904|FG001|Overall Study|Adverse Event|6|||
19736237|NCT03242252|42182905|FG002|Overall Study|Adverse Event|9|||
19736238|NCT03242252|42182903|FG000|Overall Study|Poor Compliance to Protocol|0|||
19736239|NCT03242252|42182904|FG001|Overall Study|Poor Compliance to Protocol|2|||
19736240|NCT03242252|42182905|FG002|Overall Study|Poor Compliance to Protocol|3|||
19736241|NCT03242252|42182903|FG000|Overall Study|Study Terminated by Sponsor|1|||
19736242|NCT03242252|42182904|FG001|Overall Study|Study Terminated by Sponsor|0|||
19736243|NCT03242252|42182905|FG002|Overall Study|Study Terminated by Sponsor|0|||
19736244|NCT03242252|42182903|FG000|Overall Study|Reason not Specified|4|||
19736245|NCT03242252|42182904|FG001|Overall Study|Reason not Specified|4|||
19736246|NCT03242252|42182905|FG002|Overall Study|Reason not Specified|1|||
19736247|NCT03242252|42182903|FG000|Overall Study|Lost to Follow-up|5|||
19736248|NCT03242252|42182904|FG001|Overall Study|Lost to Follow-up|1|||
19736249|NCT03242252|42182905|FG002|Overall Study|Lost to Follow-up|4|||
19736250|NCT04109391|42182922|FG000|Overall Study|Adverse Event|2|||
19736251|NCT04109391|42182923|FG001|Overall Study|Adverse Event|2|||
19736252|NCT04109391|42182924|FG002|Overall Study|Adverse Event|0|||
19736253|NCT04109391|42182922|FG000|Overall Study|Withdrawal by Subject|2|||
19736254|NCT04109391|42182923|FG001|Overall Study|Withdrawal by Subject|0|||
19736255|NCT04109391|42182924|FG002|Overall Study|Withdrawal by Subject|0|||
19736256|NCT04109391|42182922|FG000|Overall Study|Pregnancy|1|||
19736257|NCT04109391|42182923|FG001|Overall Study|Pregnancy|0|||
19736258|NCT04109391|42182924|FG002|Overall Study|Pregnancy|0|||
19736259|NCT04109391|42182922|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
19736260|NCT04109391|42182923|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
19736261|NCT04109391|42182924|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
19736262|NCT04109391|42182922|FG000|Overall Study|Lost to Follow-up|0|||
19736263|NCT04109391|42182923|FG001|Overall Study|Lost to Follow-up|0|||
19736264|NCT04109391|42182924|FG002|Overall Study|Lost to Follow-up|1|||
19736265|NCT04109391|42182922|FG000|Overall Study|Lack of Efficacy|2|||
19736266|NCT04109391|42182923|FG001|Overall Study|Lack of Efficacy|2|||
19736267|NCT04109391|42182924|FG002|Overall Study|Lack of Efficacy|3|||
19736268|NCT04106817|42182935|FG000|Overall Study|Lost to Follow-up|1|||
19736269|NCT04106817|42182936|FG001|Overall Study|Lost to Follow-up|0|||
19736270|NCT04106817|42182937|FG002|Overall Study|Lost to Follow-up|0|||
19736271|NCT04097925|42182945|FG000|Overall Study|Withdrawal by Subject|1|||
19736272|NCT04195893|42182949|FG000|Second Intervention|Withdrawal by Subject|1|||
19736273|NCT04195893|42182950|FG001|Second Intervention|Withdrawal by Subject|0|||
19736274|NCT04195581|42182956|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
19736275|NCT04195581|42182956|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
19736276|NCT04195581|42182956|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
19736277|NCT04195581|42182956|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
19736278|NCT04195581|42182956|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
19736279|NCT04195581|42182956|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
19736280|NCT04096365|42182974|FG000|Overall Study|Adverse Event|1|||
19736281|NCT04194489|42182978|FG000|Overall Study|Withdrawal by Subject|5|||
19736282|NCT04194489|42182978|FG000|Overall Study|Lost to Follow-up|48|||
19736283|NCT03260894|42182984|FG000|Overall Study|Death|6|||
19736284|NCT03260894|42182985|FG001|Overall Study|Death|8|||
19736285|NCT03260894|42182984|FG000|Overall Study|Withdrawal by Subject|4|||
19736286|NCT03260894|42182985|FG001|Overall Study|Withdrawal by Subject|11|||
19736287|NCT03260894|42182984|FG000|Overall Study|On-going at clinical cut off date|36|||
19736288|NCT03260894|42182985|FG001|Overall Study|On-going at clinical cut off date|31|||
19736289|NCT04094883|42182991|FG000|Overall Study|Withdrawal by Subject|1|||
19736290|NCT01368562|42182995|FG000|Overall Study|Adverse Event|1|||
19736291|NCT01368562|42182995|FG000|Overall Study|Disease progression|1|||
19736292|NCT01368562|42182995|FG000|Overall Study|Lost to Follow-up|1|||
19736293|NCT01368562|42182995|FG000|Overall Study|Death|6|||
19736294|NCT01368562|42182995|FG000|Overall Study|Unresponsive to treatment|5|||
19736295|NCT01368562|42182995|FG000|Overall Study|Other|3|||
19736296|NCT01368562|42182995|FG000|Overall Study|Other than specified|2|||
19736297|NCT03242018|42183002|FG000|Overall Study|Adverse Event|7|||
19736298|NCT03242018|42183003|FG001|Overall Study|Adverse Event|7|||
19736299|NCT03242018|42183004|FG002|Overall Study|Adverse Event|6|||
19736300|NCT03242018|42183002|FG000|Overall Study|Lost to Follow-up|2|||
19736301|NCT03242018|42183003|FG001|Overall Study|Lost to Follow-up|2|||
19736302|NCT03242018|42183004|FG002|Overall Study|Lost to Follow-up|2|||
19736303|NCT03242018|42183002|FG000|Overall Study|At the Participant's Own Request|5|||
19736304|NCT03242018|42183003|FG001|Overall Study|At the Participant's Own Request|1|||
19736305|NCT03242018|42183004|FG002|Overall Study|At the Participant's Own Request|4|||
19736306|NCT03242018|42183002|FG000|Overall Study|Reason Not Specified|3|||
19736307|NCT03242018|42183003|FG001|Overall Study|Reason Not Specified|4|||
19736308|NCT03242018|42183004|FG002|Overall Study|Reason Not Specified|1|||
19736309|NCT03242018|42183002|FG000|Overall Study|Study Terminated by Sponsor|1|||
19736310|NCT03242018|42183003|FG001|Overall Study|Study Terminated by Sponsor|0|||
19736311|NCT03242018|42183004|FG002|Overall Study|Study Terminated by Sponsor|1|||
19736312|NCT02789176|42183017|FG000|Overall Study|Death|0|||
19736313|NCT02789176|42183018|FG001|Overall Study|Death|0|||
19736314|NCT02789176|42183019|FG002|Overall Study|Death|3|||
19736315|NCT02789176|42183020|FG003|Overall Study|Death|0|||
19736316|NCT02789176|42183017|FG000|Overall Study|Withdrawal by Subject|0|||
19736317|NCT02789176|42183018|FG001|Overall Study|Withdrawal by Subject|0|||
19736318|NCT02789176|42183019|FG002|Overall Study|Withdrawal by Subject|1|||
19736319|NCT02789176|42183020|FG003|Overall Study|Withdrawal by Subject|0|||
19736320|NCT02789176|42183017|FG000|Overall Study|Lost to Follow-up|8|||
19736321|NCT02789176|42183018|FG001|Overall Study|Lost to Follow-up|2|||
19736322|NCT02789176|42183019|FG002|Overall Study|Lost to Follow-up|6|||
19736323|NCT02789176|42183020|FG003|Overall Study|Lost to Follow-up|1|||
19736324|NCT03259490|42183032|FG000|Period 1|Withdrawal by Subject|0|||
19736325|NCT03259490|42183033|FG001|Period 1|Withdrawal by Subject|1|||
19736326|NCT03259490|42183032|FG000|Period 2|Protocol Violation|1|||
19736327|NCT03259490|42183033|FG001|Period 2|Protocol Violation|0|||
19736328|NCT03259334|42183042|FG000|Overall Study|Adverse Event|3|||
19736329|NCT03259334|42183043|FG001|Overall Study|Adverse Event|8|||
19736330|NCT03259334|42183044|FG002|Overall Study|Adverse Event|5|||
19736331|NCT03259334|42183042|FG000|Overall Study|Withdrawal by Subject|4|||
19736332|NCT03259334|42183043|FG001|Overall Study|Withdrawal by Subject|2|||
19736333|NCT03259334|42183044|FG002|Overall Study|Withdrawal by Subject|4|||
19736334|NCT03259334|42183042|FG000|Overall Study|Physician Decision|1|||
19736335|NCT03259334|42183043|FG001|Overall Study|Physician Decision|0|||
19736336|NCT03259334|42183044|FG002|Overall Study|Physician Decision|0|||
19736337|NCT03259334|42183042|FG000|Overall Study|Lost to Follow-up|0|||
19736338|NCT03259334|42183043|FG001|Overall Study|Lost to Follow-up|2|||
19736339|NCT03259334|42183044|FG002|Overall Study|Lost to Follow-up|1|||
19736340|NCT03259334|42183042|FG000|Overall Study|Protocol Deviation|0|||
19736341|NCT03259334|42183043|FG001|Overall Study|Protocol Deviation|3|||
19736342|NCT03259334|42183044|FG002|Overall Study|Protocol Deviation|2|||
19736343|NCT03259334|42183042|FG000|Overall Study|Lack of Efficacy|2|||
19736344|NCT03259334|42183043|FG001|Overall Study|Lack of Efficacy|0|||
19736345|NCT03259334|42183044|FG002|Overall Study|Lack of Efficacy|1|||
19736346|NCT03259334|42183042|FG000|Overall Study|Randomized but never treated|0|||
19736347|NCT03259334|42183043|FG001|Overall Study|Randomized but never treated|2|||
19736348|NCT03259334|42183044|FG002|Overall Study|Randomized but never treated|0|||
19736349|NCT01331824|42183052|FG000|Overall Study|Adverse Event|2|||
19736350|NCT01331824|42183052|FG000|Overall Study|Death|1|||
19736351|NCT01331824|42183052|FG000|Overall Study|Disease Progression|9|||
19736352|NCT01331824|42183052|FG000|Overall Study|Withdrawal by Subject|1|||
19736353|NCT03258710|42183056|FG000|Overall Study|Adverse Event|1|||
19736354|NCT03258710|42183056|FG000|Overall Study|Protocol-defined stopping criteria|1|||
19736355|NCT03258710|42183056|FG000|Overall Study|Physician Decision|1|||
19736356|NCT03240692|42183060|FG000|Overall Study|Physician Decision|1|||
19736357|NCT03240692|42183060|FG000|Overall Study|Withdrawal by Subject|1|||
19736358|NCT03233048|42183064|FG000|Overall Study|Withdrawal by Subject|1|||
19736359|NCT04178967|42183070|FG000|Overall Study|Adverse Event|4|||
19736360|NCT04178967|42183071|FG001|Overall Study|Adverse Event|6|||
19736361|NCT04178967|42183070|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
19736362|NCT04178967|42183071|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
19736363|NCT04178967|42183070|FG000|Overall Study|Lack of Efficacy|3|||
19736364|NCT04178967|42183071|FG001|Overall Study|Lack of Efficacy|1|||
19736365|NCT04178967|42183070|FG000|Overall Study|Protocol Violation|0|||
19736366|NCT04178967|42183071|FG001|Overall Study|Protocol Violation|7|||
19736367|NCT04178967|42183070|FG000|Overall Study|Withdrawal by Subject|8|||
19736368|NCT04178967|42183071|FG001|Overall Study|Withdrawal by Subject|7|||
19736369|NCT04178967|42183070|FG000|Overall Study|Lost to Follow-up|2|||
19736370|NCT04178967|42183071|FG001|Overall Study|Lost to Follow-up|0|||
19736371|NCT02937740|42183079|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
19736372|NCT02937740|42183080|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
19736373|NCT02937740|42183079|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
19736374|NCT02937740|42183080|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
19736375|NCT02937740|42183079|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
19736376|NCT02937740|42183080|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
19736377|NCT02937740|42183079|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
19736378|NCT02937740|42183080|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
19736379|NCT02937740|42183079|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
19736380|NCT02937740|42183080|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
19736381|NCT02937740|42183079|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
19736382|NCT02937740|42183080|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
19736383|NCT04173741|42183103|FG000|Overall Study|IVC measurement cannot be done|1|||
19736384|NCT04173741|42183104|FG001|Overall Study|IVC measurement cannot be done|1|||
19736385|NCT03231800|42183112|FG000|Overall Study|Lost to Follow-up|0|||
19736386|NCT03231800|42183113|FG001|Overall Study|Lost to Follow-up|2|||
19736387|NCT03231800|42183112|FG000|Overall Study|Protocol Violation|1|||
19736388|NCT03231800|42183113|FG001|Overall Study|Protocol Violation|1|||
19736389|NCT03231800|42183112|FG000|Overall Study|reason not provided|2|||
19736390|NCT03231800|42183113|FG001|Overall Study|reason not provided|0|||
19736391|NCT04085601|42183121|FG000|Overall Study|Lost to Follow-up|1|||
19736392|NCT04085601|42183122|FG001|Overall Study|Lost to Follow-up|0|||
19736393|NCT04085601|42183121|FG000|Overall Study|Death|1|||
19736394|NCT04085601|42183122|FG001|Overall Study|Death|1|||
19736395|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
19736396|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
19736397|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
19736398|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
19736399|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19736400|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
19736401|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19736402|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19736403|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
19736404|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
19736405|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
19736406|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
19736407|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
19736408|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
19736409|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
19736410|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
19736411|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
19736412|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
19736413|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
19736414|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
19736415|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
19736416|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
19736417|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
19736418|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
19736419|NCT03230864|42183131|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
19736420|NCT03230864|42183132|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
19736421|NCT03230864|42183133|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
19736422|NCT03230864|42183134|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
19736423|NCT03230864|42183131|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
19736424|NCT03230864|42183132|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
19736425|NCT03230864|42183133|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
19736426|NCT03230864|42183134|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
19736427|NCT03230864|42183131|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
19736428|NCT03230864|42183132|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
19736429|NCT03230864|42183133|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
19736430|NCT03230864|42183134|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
19736431|NCT03230864|42183131|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
19736432|NCT03230864|42183132|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
19736433|NCT03230864|42183133|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
19736434|NCT03230864|42183134|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
19736435|NCT04085367|42183146|FG000|Overall Study|Adverse Event|1|||
19736436|NCT04085367|42183147|FG001|Overall Study|Adverse Event|1|||
19736437|NCT04085367|42183146|FG000|Overall Study|Withdrawal by Subject|13|||
19736438|NCT04085367|42183147|FG001|Overall Study|Withdrawal by Subject|4|||
19736439|NCT04085367|42183146|FG000|Overall Study|Lost to Follow-up|3|||
19736440|NCT04085367|42183147|FG001|Overall Study|Lost to Follow-up|1|||
19736441|NCT04085367|42183146|FG000|Overall Study|Other unspecified|2|||
19736442|NCT04085367|42183147|FG001|Overall Study|Other unspecified|1|||
19736443|NCT04085367|42183146|FG000|Overall Study|Status Unknown|1|||
19736444|NCT04085367|42183147|FG001|Overall Study|Status Unknown|1|||
19736445|NCT03228836|42183153|FG000|Overall Study|Adverse Event|3|||
19736446|NCT03228836|42183153|FG000|Overall Study|Withdrawal by Subject|1|||
19736447|NCT03228836|42183153|FG000|Overall Study|Death|1|||
19380927|NCT02379728|41624155|FG000|Overall Study|Protocol Violation|0|||
19736448|NCT03228836|42183153|FG000|Overall Study|Physician Decision|1|||
19736449|NCT03228836|42183153|FG000|Overall Study|Disease Progression|7|||
19736450|NCT03228836|42183153|FG000|Overall Study|Other|4|||
19736451|NCT02937350|42183160|FG000|Overall Study|Withdrawal by Subject|0|||
19736452|NCT02937350|42183161|FG001|Overall Study|Withdrawal by Subject|1|||
19736453|NCT02937350|42183162|FG002|Overall Study|Withdrawal by Subject|0|||
19736454|NCT04085289|42183171|FG000|Overall Study|Withdrawal by Subject|0|||
19736455|NCT04085289|42183172|FG001|Overall Study|Withdrawal by Subject|0|||
19736456|NCT04085289|42183173|FG002|Overall Study|Withdrawal by Subject|1|||
19736457|NCT04080297|42183182|FG000|Overall Study|Adverse Event|1|||
19736458|NCT04080297|42183183|FG001|Overall Study|Adverse Event|3|||
19736459|NCT04080297|42183182|FG000|Overall Study|concurrent illness|1|||
19736460|NCT04080297|42183183|FG001|Overall Study|concurrent illness|0|||
19736461|NCT04014075|42183189|FG000|Overall Study|Progressive Disease|39|||
19736462|NCT04014075|42183189|FG000|Overall Study|Adverse Event|9|||
19736463|NCT04014075|42183189|FG000|Overall Study|Clinical Progression|2|||
19736464|NCT04014075|42183189|FG000|Overall Study|Death|2|||
19736465|NCT04014075|42183189|FG000|Overall Study|Withdrawal by Subject|2|||
19736466|NCT04014075|42183189|FG000|Overall Study|Miscellaneous|1|||
19736467|NCT04014075|42183189|FG000|Overall Study|Physician Decision|1|||
19736468|NCT04013529|42183195|FG000|Overall Study|Withdrawal by Subject|1|||
19736469|NCT04013529|42183196|FG001|Overall Study|Withdrawal by Subject|1|||
19736470|NCT04011735|42183205|FG000|Overall Study|Withdrawal by Subject|1|||
19736471|NCT04011735|42183206|FG001|Overall Study|Withdrawal by Subject|0|||
19736472|NCT04011735|42183207|FG002|Overall Study|Withdrawal by Subject|1|||
19736473|NCT04011735|42183205|FG000|Overall Study|Met exclusion criteria after study entry|0|||
19736474|NCT04011735|42183206|FG001|Overall Study|Met exclusion criteria after study entry|1|||
19736475|NCT04011735|42183207|FG002|Overall Study|Met exclusion criteria after study entry|0|||
19736476|NCT04009629|42183219|FG000|Overall Study|Withdrawal by Subject|2|||
19736477|NCT04009629|42183220|FG001|Overall Study|Withdrawal by Subject|0|||
19736478|NCT04007367|42183229|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
19736479|NCT04007367|42183230|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
19736480|NCT04007367|42183231|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
19736481|NCT04007367|42183229|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
19736482|NCT04007367|42183230|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
19736483|NCT04007367|42183231|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
19736484|NCT04007367|42183229|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
19736485|NCT04007367|42183230|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
19736486|NCT04007367|42183231|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
19736487|NCT04007367|42183229|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
19736488|NCT04007367|42183230|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
19736489|NCT04007367|42183231|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
19736490|NCT04007367|42183229|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
19736491|NCT04007367|42183230|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
19736492|NCT04007367|42183231|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
19736493|NCT03694197|42183241|FG000|Overall Study|Adverse Event|9|||
19736494|NCT03694197|42183241|FG000|Overall Study|Protocol became inconvenient to participate|1|||
19736495|NCT03694197|42183241|FG000|Overall Study|Physician Decision|4|||
19736496|NCT03694197|42183241|FG000|Overall Study|Study terminated by sponsor|1350|||
19736497|NCT03694197|42183241|FG000|Overall Study|Participant moved|5|||
19736498|NCT03694197|42183241|FG000|Overall Study|Participant withdrew consent|10|||
19736499|NCT03694197|42183241|FG000|Overall Study|Related to IMP administration|1|||
19736500|NCT03694197|42183241|FG000|Overall Study|Not disclosed|5|||
19736501|NCT04365699|42183248|FG000|Overall Study|Death|2|||
19736502|NCT04365699|42183249|FG001|Overall Study|Death|5|||
19736503|NCT04365699|42183250|FG002|Overall Study|Death|15|||
19736504|NCT04005885|42183258|FG000|First Intervention|Withdrawal by Subject|1|||
19736505|NCT04005885|42183259|FG001|First Intervention|Withdrawal by Subject|1|||
19736506|NCT04005885|42183258|FG000|Second Intervention|Withdrawal by Subject|0|||
19736507|NCT04005885|42183259|FG001|Second Intervention|Withdrawal by Subject|2|||
19736508|NCT04003623|42183272|FG000|Overall Study|Withdrawal by Subject|1|||
19736509|NCT04003623|42183273|FG001|Overall Study|Withdrawal by Subject|0|||
19736510|NCT04480424|42183281|FG000|Overall Study|Withdrawal by Subject|0|||
19736511|NCT04480424|42183282|FG001|Overall Study|Withdrawal by Subject|2|||
19736512|NCT04480424|42183281|FG000|Overall Study|Lost to Follow-up|3|||
19736513|NCT04480424|42183282|FG001|Overall Study|Lost to Follow-up|3|||
19736514|NCT04480424|42183281|FG000|Overall Study|Death|14|||
19736515|NCT04480424|42183282|FG001|Overall Study|Death|16|||
19736516|NCT04480424|42183281|FG000|Overall Study|Reason not Specified|5|||
19736517|NCT04480424|42183282|FG001|Overall Study|Reason not Specified|5|||
19736518|NCT03256526|42183291|FG000|Overall Study|Adverse Event|1|||
19736519|NCT03256526|42183292|FG001|Overall Study|Adverse Event|0|||
19736520|NCT03256526|42183293|FG002|Overall Study|Adverse Event|1|||
19736521|NCT03256526|42183291|FG000|Overall Study|Lost to Follow-up|1|||
19736522|NCT03256526|42183292|FG001|Overall Study|Lost to Follow-up|0|||
19736523|NCT03256526|42183293|FG002|Overall Study|Lost to Follow-up|2|||
19736524|NCT03255980|42183305|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
19736525|NCT03255980|42183306|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
19736526|NCT03255980|42183307|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
19736527|NCT03255980|42183308|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
19736528|NCT03255980|42183305|FG000|Overall Study|Adverse Event|1|||
19736529|NCT03255980|42183306|FG001|Overall Study|Adverse Event|1|||
19736530|NCT03255980|42183307|FG002|Overall Study|Adverse Event|0|||
19736531|NCT03255980|42183308|FG003|Overall Study|Adverse Event|1|||
19736532|NCT03255980|42183305|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
19736533|NCT03255980|42183306|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
19736534|NCT03255980|42183307|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
19736535|NCT03255980|42183308|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
19736536|NCT03255980|42183305|FG000|Overall Study|Lost to Follow-up|1|||
19736537|NCT03255980|42183306|FG001|Overall Study|Lost to Follow-up|1|||
19736538|NCT03255980|42183307|FG002|Overall Study|Lost to Follow-up|0|||
19736539|NCT03255980|42183308|FG003|Overall Study|Lost to Follow-up|3|||
19736540|NCT03255980|42183305|FG000|Overall Study|Withdrawal by Subject|0|||
19736541|NCT03255980|42183306|FG001|Overall Study|Withdrawal by Subject|1|||
19736542|NCT03255980|42183307|FG002|Overall Study|Withdrawal by Subject|0|||
19736543|NCT03255980|42183308|FG003|Overall Study|Withdrawal by Subject|3|||
19736544|NCT03228212|42183318|FG000|Period 1|Adverse Event|1|||
19736545|NCT03228212|42183319|FG001|Period 1|Adverse Event|0|||
19736546|NCT03228212|42183318|FG000|Period 1|no longer meets eligibility criteria|0|||
19736547|NCT03228212|42183319|FG001|Period 1|no longer meets eligibility criteria|1|||
19736548|NCT03228212|42183318|FG000|Period 2|Lost to Follow-up|1|||
19736549|NCT03228212|42183319|FG001|Period 2|Lost to Follow-up|0|||
19736550|NCT04003155|42183328|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
19736551|NCT04003155|42183329|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
19736552|NCT04003155|42183330|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
19736553|NCT04003155|42183331|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
19736554|NCT04003155|42183332|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
19736555|NCT04003155|42183328|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
19736556|NCT04003155|42183329|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
19736557|NCT04003155|42183330|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
19736558|NCT04003155|42183331|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
19736559|NCT04003155|42183332|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
19736560|NCT04003155|42183328|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
19736561|NCT04003155|42183329|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
19736562|NCT04003155|42183330|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
19736563|NCT04003155|42183331|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
19736564|NCT04003155|42183332|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
19736565|NCT04003155|42183328|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
19736566|NCT04003155|42183329|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
19736567|NCT04003155|42183330|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
19736568|NCT04003155|42183331|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
19736569|NCT04003155|42183332|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
19736570|NCT04003155|42183328|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
19736571|NCT04003155|42183329|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
19736572|NCT04003155|42183330|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
19736573|NCT04003155|42183331|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
19736574|NCT04003155|42183332|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
19736575|NCT04003155|42183328|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
19736576|NCT04003155|42183329|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
19736577|NCT04003155|42183330|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
19736578|NCT04003155|42183331|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
19736579|NCT04003155|42183332|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
19736580|NCT04003155|42183328|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
19736581|NCT04003155|42183329|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
19736582|NCT04003155|42183330|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
19736583|NCT04003155|42183331|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
19736584|NCT04003155|42183332|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
19736585|NCT04003155|42183328|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
19736586|NCT04003155|42183329|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
19736587|NCT04003155|42183330|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
19736588|NCT04003155|42183331|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
19736589|NCT04003155|42183332|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
19736590|NCT04003155|42183328|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
19736591|NCT04003155|42183329|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
19465294|NCT04426695|41723752|FG011|Overall Study|Physician Decision|0|||
19736592|NCT04003155|42183330|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
19736593|NCT04003155|42183331|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
19736594|NCT04003155|42183332|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
19736595|NCT04000815|42183353|FG000|Overall Study|Lost to Follow-up|9|||
19736596|NCT04000815|42183354|FG001|Overall Study|Lost to Follow-up|2|||
19736597|NCT04000815|42183355|FG002|Overall Study|Lost to Follow-up|3|||
19736598|NCT04000815|42183353|FG000|Overall Study|Withdrawal by Subject|4|||
19736599|NCT04000815|42183354|FG001|Overall Study|Withdrawal by Subject|3|||
19736600|NCT04000815|42183355|FG002|Overall Study|Withdrawal by Subject|2|||
19736601|NCT04000815|42183353|FG000|Overall Study|Right ovarian cyst occured|1|||
19736602|NCT04000815|42183354|FG001|Overall Study|Right ovarian cyst occured|0|||
19736603|NCT04000815|42183355|FG002|Overall Study|Right ovarian cyst occured|0|||
19736604|NCT04000815|42183353|FG000|Overall Study|Hypertension occured on follow up|0|||
19736605|NCT04000815|42183354|FG001|Overall Study|Hypertension occured on follow up|0|||
19736606|NCT04000815|42183355|FG002|Overall Study|Hypertension occured on follow up|2|||
19736607|NCT04000581|42183365|FG000|Overall Study|Withdrawal by Subject|0|||
19736608|NCT04000581|42183366|FG001|Overall Study|Withdrawal by Subject|1|||
19736609|NCT03848403|42183372|FG000|Period 2 (Day 8)|Adverse Event|1|||
19736610|NCT03848403|42183373|FG001|Period 2 (Day 8)|Adverse Event|2|||
19736611|NCT03848403|42183374|FG002|Period 2 (Day 8)|Adverse Event|2|||
19736612|NCT03848403|42183372|FG000|Period 2 (Day 8)|Physician Decision|0|||
19736613|NCT03848403|42183373|FG001|Period 2 (Day 8)|Physician Decision|1|||
19736614|NCT03848403|42183374|FG002|Period 2 (Day 8)|Physician Decision|0|||
19736615|NCT03848403|42183372|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
19736616|NCT03848403|42183373|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
19736617|NCT03848403|42183374|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
19736618|NCT03995355|42183384|FG000|Overall Study|Adverse Event|1|||
19736619|NCT03995355|42183385|FG001|Overall Study|Adverse Event|0|||
19736620|NCT03995355|42183384|FG000|Overall Study|Withdrawal by Subject|1|||
19736621|NCT03995355|42183385|FG001|Overall Study|Withdrawal by Subject|0|||
19736622|NCT03995355|42183384|FG000|Overall Study|Scheduling Issues|0|||
19736623|NCT03995355|42183385|FG001|Overall Study|Scheduling Issues|1|||
19736624|NCT04054011|42183391|FG000|Overall Study|COVID|3|||
19736625|NCT04053465|42183399|FG000|Overall Study|Withdrawal by Subject|4|||
19736626|NCT04053465|42183400|FG001|Overall Study|Withdrawal by Subject|4|||
19736627|NCT00143507|42183408|FG000|Overall Study|Death|572|||
19736628|NCT00143507|42183409|FG001|Overall Study|Death|547|||
19736629|NCT00143507|42183408|FG000|Overall Study|Withdrawal by Subject|114|||
19736630|NCT00143507|42183409|FG001|Overall Study|Withdrawal by Subject|102|||
19736631|NCT00143507|42183408|FG000|Overall Study|Lost to Follow-up|1|||
19736632|NCT00143507|42183409|FG001|Overall Study|Lost to Follow-up|0|||
19736633|NCT00143507|42183408|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
19736634|NCT00143507|42183409|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
19736635|NCT03988803|42183415|FG000|Period 2|Prematurely discontinued from medication|2|||
19736636|NCT03988803|42183415|FG000|Period 2|Adverse Event|1|||
19736637|NCT00181883|42183423|FG000|Overall Study|Lack of Efficacy|2|||
19736638|NCT00181883|42183423|FG000|Overall Study|Treatment Limiting AEs|3|||
19736639|NCT00181883|42183423|FG000|Overall Study|Withdrawal by Subject|4|||
19736640|NCT00181883|42183423|FG000|Overall Study|Lost to Follow-up|1|||
19736641|NCT00180713|42183429|FG000|Overall Study|Withdrawal by Subject|2|||
19736642|NCT00180713|42183430|FG001|Overall Study|Withdrawal by Subject|0|||
19736643|NCT00180713|42183429|FG000|Overall Study|Adverse Event|3|||
19736644|NCT00180713|42183430|FG001|Overall Study|Adverse Event|3|||
19736645|NCT03988023|42183438|FG000|Overall Study|Non-compliance|3|||
19736646|NCT03988023|42183439|FG001|Overall Study|Non-compliance|0|||
19736647|NCT03988023|42183438|FG000|Overall Study|Withdrawal by Subject|39|||
19736648|NCT03988023|42183439|FG001|Overall Study|Withdrawal by Subject|37|||
19736649|NCT03988023|42183438|FG000|Overall Study|Adverse Event|0|||
19736650|NCT03988023|42183439|FG001|Overall Study|Adverse Event|2|||
19736651|NCT03988023|42183438|FG000|Overall Study|Physician Decision|0|||
19736652|NCT03988023|42183439|FG001|Overall Study|Physician Decision|1|||
19736653|NCT03988023|42183438|FG000|Overall Study|Lost to Follow-up|5|||
19736654|NCT03988023|42183439|FG001|Overall Study|Lost to Follow-up|8|||
19736655|NCT03988023|42183438|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
19736656|NCT03988023|42183439|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
19736657|NCT03988023|42183438|FG000|Overall Study|Lack of Efficacy|3|||
19736658|NCT03988023|42183439|FG001|Overall Study|Lack of Efficacy|1|||
19736659|NCT03988023|42183438|FG000|Overall Study|COVID-19 pandemic|225|||
19736660|NCT03988023|42183439|FG001|Overall Study|COVID-19 pandemic|227|||
19736661|NCT04052139|42183448|FG000|Overall Study|Lost to Follow-up|2|||
19736662|NCT04052139|42183449|FG001|Overall Study|Lost to Follow-up|0|||
19736663|NCT04052139|42183450|FG002|Overall Study|Lost to Follow-up|0|||
19736664|NCT04052139|42183448|FG000|Overall Study|Withdrawal by Subject|1|||
19736665|NCT04052139|42183449|FG001|Overall Study|Withdrawal by Subject|0|||
19736666|NCT04052139|42183450|FG002|Overall Study|Withdrawal by Subject|0|||
19736667|NCT03984825|42183458|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
19736668|NCT03984825|42183458|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
19736669|NCT03984825|42183458|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
19736670|NCT03981861|42183467|FG000|Overall Study|Withdrawal by Subject|3|||
19736671|NCT01332266|42183476|FG000|Phase 1b|Death|3|||
19736672|NCT01332266|42183477|FG001|Phase 1b|Death|3|||
19736673|NCT01332266|42183478|FG002|Phase 1b|Death|2|||
19736674|NCT01332266|42183479|FG003|Phase 1b|Death|0|||
19736675|NCT01332266|42183480|FG004|Phase 1b|Death|0|||
19736676|NCT01332266|42183476|FG000|Phase 1b|Lost to Follow-up|0|||
19736677|NCT01332266|42183477|FG001|Phase 1b|Lost to Follow-up|1|||
19736678|NCT01332266|42183478|FG002|Phase 1b|Lost to Follow-up|0|||
19736679|NCT01332266|42183479|FG003|Phase 1b|Lost to Follow-up|0|||
19736680|NCT01332266|42183480|FG004|Phase 1b|Lost to Follow-up|0|||
19736681|NCT01332266|42183476|FG000|Phase 1b|Withdrawal by Subject|1|||
19736682|NCT01332266|42183477|FG001|Phase 1b|Withdrawal by Subject|1|||
19736683|NCT01332266|42183478|FG002|Phase 1b|Withdrawal by Subject|1|||
19736684|NCT01332266|42183479|FG003|Phase 1b|Withdrawal by Subject|0|||
19736685|NCT01332266|42183480|FG004|Phase 1b|Withdrawal by Subject|0|||
19736686|NCT01332266|42183476|FG000|Phase 2|Death|0|||
19736687|NCT01332266|42183477|FG001|Phase 2|Death|0|||
19736688|NCT01332266|42183478|FG002|Phase 2|Death|0|||
19736689|NCT01332266|42183479|FG003|Phase 2|Death|33|||
19736690|NCT01332266|42183480|FG004|Phase 2|Death|36|||
19736691|NCT01332266|42183476|FG000|Phase 2|Lost to Follow-up|0|||
19736692|NCT01332266|42183477|FG001|Phase 2|Lost to Follow-up|0|||
19736693|NCT01332266|42183478|FG002|Phase 2|Lost to Follow-up|0|||
19736694|NCT01332266|42183479|FG003|Phase 2|Lost to Follow-up|2|||
19736695|NCT01332266|42183480|FG004|Phase 2|Lost to Follow-up|0|||
19736696|NCT01332266|42183476|FG000|Phase 2|Physician Decision|0|||
19736697|NCT01332266|42183477|FG001|Phase 2|Physician Decision|0|||
19736698|NCT01332266|42183478|FG002|Phase 2|Physician Decision|0|||
19736699|NCT01332266|42183479|FG003|Phase 2|Physician Decision|3|||
19736700|NCT01332266|42183480|FG004|Phase 2|Physician Decision|1|||
19736701|NCT01332266|42183476|FG000|Phase 2|Symptomatic deterioration|0|||
19736702|NCT01332266|42183477|FG001|Phase 2|Symptomatic deterioration|0|||
19736703|NCT01332266|42183478|FG002|Phase 2|Symptomatic deterioration|0|||
19736704|NCT01332266|42183479|FG003|Phase 2|Symptomatic deterioration|0|||
19736705|NCT01332266|42183480|FG004|Phase 2|Symptomatic deterioration|1|||
19736706|NCT01332266|42183476|FG000|Phase 2|Progression Disease|0|||
19736707|NCT01332266|42183477|FG001|Phase 2|Progression Disease|0|||
19736708|NCT01332266|42183478|FG002|Phase 2|Progression Disease|0|||
19736709|NCT01332266|42183479|FG003|Phase 2|Progression Disease|2|||
19736710|NCT01332266|42183480|FG004|Phase 2|Progression Disease|1|||
19736711|NCT01332266|42183476|FG000|Phase 2|Withdrawal by Subject|0|||
19736712|NCT01332266|42183477|FG001|Phase 2|Withdrawal by Subject|0|||
19736713|NCT01332266|42183478|FG002|Phase 2|Withdrawal by Subject|0|||
19736714|NCT01332266|42183479|FG003|Phase 2|Withdrawal by Subject|2|||
19736715|NCT01332266|42183480|FG004|Phase 2|Withdrawal by Subject|2|||
19736716|NCT03255824|42183495|FG000|Overall Study|Under-sedation|2|||
19736717|NCT03255824|42183496|FG001|Overall Study|Under-sedation|1|||
19736718|NCT03238352|42183505|FG000|Overall Study|Lost to Follow-up|0|||
19736719|NCT03238352|42183506|FG001|Overall Study|Lost to Follow-up|2|||
19736720|NCT03238352|42183507|FG002|Overall Study|Lost to Follow-up|1|||
19736721|NCT03238352|42183505|FG000|Overall Study|Withdrawal by Subject|0|||
19736722|NCT03238352|42183506|FG001|Overall Study|Withdrawal by Subject|1|||
19736723|NCT03238352|42183507|FG002|Overall Study|Withdrawal by Subject|0|||
19736724|NCT00180479|42183517|FG000|Overall Study|Death|4|||
19736725|NCT00180479|42183518|FG001|Overall Study|Death|2|||
19736726|NCT00180479|42183517|FG000|Overall Study|Lost to Follow-up|9|||
19736727|NCT00180479|42183518|FG001|Overall Study|Lost to Follow-up|7|||
19736728|NCT00180479|42183517|FG000|Overall Study|Withdrawal by Subject|3|||
19736729|NCT00180479|42183518|FG001|Overall Study|Withdrawal by Subject|3|||
19736730|NCT00180479|42183517|FG000|Overall Study|Informed consent not signed|0|||
19736731|NCT00180479|42183518|FG001|Overall Study|Informed consent not signed|1|||
19736732|NCT03224234|42183528|FG000|Main Study|Lost to Follow-up|5|||
19736733|NCT03224234|42183529|FG001|Main Study|Lost to Follow-up|5|||
19736734|NCT02955069|42183543|FG000|Overall Study|Adverse Event|7|||
19736735|NCT02955069|42183544|FG001|Overall Study|Adverse Event|2|||
19736736|NCT02955069|42183543|FG000|Overall Study|Death|7|||
19736737|NCT02955069|42183544|FG001|Overall Study|Death|3|||
19736738|NCT02955069|42183543|FG000|Overall Study|Physician Decision|10|||
19736739|NCT02955069|42183544|FG001|Overall Study|Physician Decision|2|||
19736740|NCT02955069|42183543|FG000|Overall Study|Progressive disease|64|||
19736741|NCT02955069|42183544|FG001|Overall Study|Progressive disease|13|||
19736742|NCT02955069|42183543|FG000|Overall Study|Study terminated by sponsor|4|||
19736743|NCT02955069|42183544|FG001|Overall Study|Study terminated by sponsor|0|||
19736744|NCT02955069|42183543|FG000|Overall Study|Subject/Guardian decision|3|||
19736745|NCT02955069|42183544|FG001|Overall Study|Subject/Guardian decision|1|||
19736746|NCT03254108|42183557|FG000|Overall Study|Adverse Event|0|||
19736747|NCT03254108|42183558|FG001|Overall Study|Adverse Event|2|||
19736748|NCT03254108|42183559|FG002|Overall Study|Adverse Event|0|||
19736749|NCT03254108|42183560|FG003|Overall Study|Adverse Event|1|||
19736750|NCT03254108|42183561|FG004|Overall Study|Adverse Event|1|||
19736751|NCT03254108|42183557|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
19736752|NCT03254108|42183558|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
19736753|NCT03254108|42183559|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
19736754|NCT03254108|42183560|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
19799377|NCT02873221|42257356|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
19736755|NCT03254108|42183561|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
19736756|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
19736757|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
19736758|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
19736759|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
19736760|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
19736761|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
19736762|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
19736763|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
19736764|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
19736765|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
19736766|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
19736767|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
19736768|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
19736769|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
19736770|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
19736771|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
19736772|NCT03773978|42183585|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
19736773|NCT03773978|42183586|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
19736774|NCT03773978|42183585|FG000|DBW Period|Adverse Event|2|||
19736775|NCT03773978|42183586|FG001|DBW Period|Adverse Event|2|||
19736776|NCT03773978|42183585|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
19736777|NCT03773978|42183586|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
19736778|NCT03773978|42183585|FG000|DBW Period|Withdrawal by Subject|2|||
19736779|NCT03773978|42183586|FG001|DBW Period|Withdrawal by Subject|1|||
19736780|NCT03773978|42183585|FG000|DBW Period|Due to epidemic or pandemic|5|||
19736781|NCT03773978|42183586|FG001|DBW Period|Due to epidemic or pandemic|6|||
19736782|NCT03773978|42183585|FG000|DBW Period|Study team decision|1|||
19736783|NCT03773978|42183586|FG001|DBW Period|Study team decision|0|||
19736784|NCT03253796|42183602|FG000|Period 1: Run-In|Adverse Event|4|||
19736785|NCT03253796|42183603|FG001|Period 1: Run-In|Adverse Event|0|||
19736786|NCT03253796|42183604|FG002|Period 1: Run-In|Adverse Event|0|||
19736787|NCT03253796|42183605|FG003|Period 1: Run-In|Adverse Event|0|||
19736788|NCT03253796|42183606|FG004|Period 1: Run-In|Adverse Event|0|||
19736789|NCT03253796|42183602|FG000|Period 1: Run-In|Lack of Efficacy|1|||
19736790|NCT03253796|42183603|FG001|Period 1: Run-In|Lack of Efficacy|0|||
19736791|NCT03253796|42183604|FG002|Period 1: Run-In|Lack of Efficacy|0|||
19736792|NCT03253796|42183605|FG003|Period 1: Run-In|Lack of Efficacy|0|||
19736793|NCT03253796|42183606|FG004|Period 1: Run-In|Lack of Efficacy|0|||
19736794|NCT03253796|42183602|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
19736795|NCT03253796|42183603|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
19736796|NCT03253796|42183604|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
19736797|NCT03253796|42183605|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
19736798|NCT03253796|42183606|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
19736799|NCT03253796|42183602|FG000|Period 1: Run-In|Protocol Violation|5|||
19736800|NCT03253796|42183603|FG001|Period 1: Run-In|Protocol Violation|0|||
19736801|NCT03253796|42183604|FG002|Period 1: Run-In|Protocol Violation|0|||
19736802|NCT03253796|42183605|FG003|Period 1: Run-In|Protocol Violation|0|||
19736803|NCT03253796|42183606|FG004|Period 1: Run-In|Protocol Violation|0|||
19736804|NCT03253796|42183602|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
19736805|NCT03253796|42183603|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
19736806|NCT03253796|42183604|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
19736807|NCT03253796|42183605|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
19736808|NCT03253796|42183606|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
19736809|NCT03253796|42183602|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
19736810|NCT03253796|42183603|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
19736811|NCT03253796|42183604|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
19736812|NCT03253796|42183605|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
19736813|NCT03253796|42183606|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
19736814|NCT03253796|42183602|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
19736815|NCT03253796|42183603|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
19736816|NCT03253796|42183604|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
19736817|NCT03253796|42183605|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
19736818|NCT03253796|42183606|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
19736819|NCT03253796|42183602|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
19736820|NCT03253796|42183603|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
19736821|NCT03253796|42183604|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
19736822|NCT03253796|42183605|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
19736823|NCT03253796|42183606|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
19736824|NCT03253796|42183602|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
19736825|NCT03253796|42183603|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
19736826|NCT03253796|42183604|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
19736827|NCT03253796|42183605|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
19736828|NCT03253796|42183606|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
19736829|NCT03253796|42183602|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
19736830|NCT03253796|42183603|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
19736831|NCT03253796|42183604|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
19736832|NCT03253796|42183605|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
19736833|NCT03253796|42183606|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
19736834|NCT03253796|42183602|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
19736835|NCT03253796|42183603|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
19736836|NCT03253796|42183604|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
19736837|NCT03253796|42183605|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
19736838|NCT03253796|42183606|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
19736839|NCT03682107|42183626|FG000|Overall Study|Withdrawal by Subject|0|||
19736840|NCT03682107|42183627|FG001|Overall Study|Withdrawal by Subject|1|||
19736841|NCT03682107|42183628|FG002|Overall Study|Withdrawal by Subject|0|||
19736842|NCT03682107|42183629|FG003|Overall Study|Withdrawal by Subject|0|||
19736843|NCT03682107|42183630|FG004|Overall Study|Withdrawal by Subject|0|||
19736844|NCT03673046|42183644|FG000|Overall Study|Adverse Event|1|||
19736845|NCT03673046|42183645|FG001|Overall Study|Adverse Event|1|||
19736846|NCT03673046|42183644|FG000|Overall Study|Withdrawal by Subject|8|||
19736847|NCT03673046|42183645|FG001|Overall Study|Withdrawal by Subject|2|||
19736848|NCT02956005|42183651|FG000|Overall Study|Not eligible|1|||
19736849|NCT02956005|42183651|FG000|Overall Study|Withdrawal by Subject|3|||
19736850|NCT02956005|42183651|FG000|Overall Study|Physician Decision|12|||
19736851|NCT03253094|42183661|FG000|Overall Study|Adverse Event|2|||
19736852|NCT03253094|42183662|FG001|Overall Study|Adverse Event|0|||
19736853|NCT03253094|42183663|FG002|Overall Study|Adverse Event|0|||
19736854|NCT03253094|42183664|FG003|Overall Study|Adverse Event|0|||
19736855|NCT03253094|42183665|FG004|Overall Study|Adverse Event|0|||
19736856|NCT03253094|42183666|FG005|Overall Study|Adverse Event|0|||
19736857|NCT03253094|42183661|FG000|Overall Study|Lack of Efficacy|0|||
19736858|NCT03253094|42183662|FG001|Overall Study|Lack of Efficacy|0|||
19736859|NCT03253094|42183663|FG002|Overall Study|Lack of Efficacy|2|||
19736860|NCT03253094|42183664|FG003|Overall Study|Lack of Efficacy|1|||
19736861|NCT03253094|42183665|FG004|Overall Study|Lack of Efficacy|2|||
19736862|NCT03253094|42183666|FG005|Overall Study|Lack of Efficacy|1|||
19736863|NCT03253094|42183661|FG000|Overall Study|Lost to Follow-up|0|||
19736864|NCT03253094|42183662|FG001|Overall Study|Lost to Follow-up|0|||
19736865|NCT03253094|42183663|FG002|Overall Study|Lost to Follow-up|1|||
19736866|NCT03253094|42183664|FG003|Overall Study|Lost to Follow-up|1|||
19736867|NCT03253094|42183665|FG004|Overall Study|Lost to Follow-up|0|||
19736868|NCT03253094|42183666|FG005|Overall Study|Lost to Follow-up|1|||
19736869|NCT03253094|42183661|FG000|Overall Study|Physician Decision|1|||
19736870|NCT03253094|42183662|FG001|Overall Study|Physician Decision|0|||
19736871|NCT03253094|42183663|FG002|Overall Study|Physician Decision|0|||
19736872|NCT03253094|42183664|FG003|Overall Study|Physician Decision|1|||
19736873|NCT03253094|42183665|FG004|Overall Study|Physician Decision|0|||
19736874|NCT03253094|42183666|FG005|Overall Study|Physician Decision|2|||
19736875|NCT03253094|42183661|FG000|Overall Study|Withdrawal by Subject|1|||
19736876|NCT03253094|42183662|FG001|Overall Study|Withdrawal by Subject|2|||
19736877|NCT03253094|42183663|FG002|Overall Study|Withdrawal by Subject|1|||
19380928|NCT02379728|41624156|FG001|Overall Study|Protocol Violation|0|||
19736878|NCT03253094|42183664|FG003|Overall Study|Withdrawal by Subject|0|||
19736879|NCT03253094|42183665|FG004|Overall Study|Withdrawal by Subject|3|||
19736880|NCT03253094|42183666|FG005|Overall Study|Withdrawal by Subject|0|||
19736881|NCT03253094|42183661|FG000|Overall Study|Other|0|||
19736882|NCT03253094|42183662|FG001|Overall Study|Other|1|||
19736883|NCT03253094|42183663|FG002|Overall Study|Other|2|||
19736884|NCT03253094|42183664|FG003|Overall Study|Other|1|||
19736885|NCT03253094|42183665|FG004|Overall Study|Other|0|||
19736886|NCT03253094|42183666|FG005|Overall Study|Other|0|||
19736887|NCT03654885|42183682|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
19736888|NCT03654885|42183683|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
19736889|NCT03654885|42183682|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
19736890|NCT03654885|42183683|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
19736891|NCT03654885|42183682|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
19736892|NCT03654885|42183683|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
19736893|NCT03654885|42183682|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
19380929|NCT02379728|41624157|FG002|Overall Study|Protocol Violation|2|||
19736894|NCT03654885|42183683|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
19736895|NCT03654885|42183682|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
19736896|NCT03654885|42183683|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
19736897|NCT03654885|42183682|FG000|Overall Study|Adverse Event in Study Eye|3|||
19736898|NCT03654885|42183683|FG001|Overall Study|Adverse Event in Study Eye|0|||
19736899|NCT03654885|42183682|FG000|Overall Study|Consent Withdrawn|1|||
19736900|NCT03654885|42183683|FG001|Overall Study|Consent Withdrawn|0|||
19736901|NCT03654885|42183682|FG000|Overall Study|Death|3|||
19736902|NCT03654885|42183683|FG001|Overall Study|Death|1|||
19736903|NCT03654885|42183682|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
19736904|NCT03654885|42183683|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
19736905|NCT03654885|42183682|FG000|Overall Study|Lost to Follow-up|3|||
19736906|NCT03654885|42183683|FG001|Overall Study|Lost to Follow-up|3|||
19736907|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
19736908|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
19736909|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
19736910|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
19736911|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
19736912|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
19736913|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
19736914|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
19736915|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
19736916|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
19736917|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
19736918|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
19736919|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Death|3|||
19736920|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Death|1|||
19736921|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
19736922|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
19736923|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Adverse Event|7|||
19736924|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Adverse Event|8|||
19736925|NCT03236246|42183691|FG000|24-Week Dose Titration Period|Captured as Other|1|||
19736926|NCT03236246|42183692|FG001|24-Week Dose Titration Period|Captured as Other|2|||
19736927|NCT03236246|42183691|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
19736928|NCT03236246|42183692|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
19736929|NCT03236246|42183691|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
19736930|NCT03236246|42183692|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
19736931|NCT03236246|42183691|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
19736932|NCT03236246|42183692|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
19736933|NCT03236246|42183691|FG000|24-Week Dose Maintenance Period|Death|0|||
19736934|NCT03236246|42183692|FG001|24-Week Dose Maintenance Period|Death|1|||
19736935|NCT03236246|42183691|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
19736936|NCT03236246|42183692|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
19736937|NCT02937584|42183698|FG000|Period 1|Adverse Event|1|||
19736938|NCT02937584|42183699|FG001|Period 1|Adverse Event|2|||
19736939|NCT02937584|42183698|FG000|Washout|Adverse Event|0|||
19736940|NCT02937584|42183699|FG001|Washout|Adverse Event|1|||
19736941|NCT00179621|42183708|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
19736942|NCT00179621|42183709|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
19736943|NCT00179621|42183710|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
19736944|NCT00179621|42183711|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
19736945|NCT00179621|42183708|FG000|Double-Blind Period|Adverse Event|2|||
19736946|NCT00179621|42183709|FG001|Double-Blind Period|Adverse Event|7|||
19736947|NCT00179621|42183710|FG002|Double-Blind Period|Adverse Event|4|||
19736948|NCT00179621|42183711|FG003|Double-Blind Period|Adverse Event|0|||
19736949|NCT00179621|42183708|FG000|Double-Blind Period|Withdrawal by Subject|2|||
19736950|NCT00179621|42183709|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19736951|NCT00179621|42183710|FG002|Double-Blind Period|Withdrawal by Subject|3|||
19736952|NCT00179621|42183711|FG003|Double-Blind Period|Withdrawal by Subject|0|||
19736953|NCT00179621|42183708|FG000|Double-Blind Period|Death|0|||
19736954|NCT00179621|42183709|FG001|Double-Blind Period|Death|1|||
19736955|NCT00179621|42183710|FG002|Double-Blind Period|Death|2|||
19380930|NCT02379728|41624158|FG003|Overall Study|Protocol Violation|0|||
19380931|NCT03463993|41624169|FG000|Overall Study|Lost to Follow-up|7|||
19736956|NCT00179621|42183711|FG003|Double-Blind Period|Death|0|||
19736957|NCT00179621|42183708|FG000|Double-Blind Period|Protocol Violation|1|||
19736958|NCT00179621|42183709|FG001|Double-Blind Period|Protocol Violation|0|||
19736959|NCT00179621|42183710|FG002|Double-Blind Period|Protocol Violation|0|||
19736960|NCT00179621|42183711|FG003|Double-Blind Period|Protocol Violation|0|||
19736961|NCT00179621|42183708|FG000|Double-Blind Period|Other|0|||
19736962|NCT00179621|42183709|FG001|Double-Blind Period|Other|2|||
19736963|NCT00179621|42183710|FG002|Double-Blind Period|Other|2|||
19736964|NCT00179621|42183711|FG003|Double-Blind Period|Other|0|||
19736965|NCT00179621|42183708|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
19736966|NCT00179621|42183709|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
19736967|NCT00179621|42183710|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
19736968|NCT00179621|42183711|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
19736969|NCT00179621|42183708|FG000|Open-Label Period|Adverse Event|0|||
19736970|NCT00179621|42183709|FG001|Open-Label Period|Adverse Event|6|||
19736971|NCT00179621|42183710|FG002|Open-Label Period|Adverse Event|5|||
19736972|NCT00179621|42183711|FG003|Open-Label Period|Adverse Event|6|||
19736973|NCT00179621|42183708|FG000|Open-Label Period|Withdrawal by Subject|0|||
19736974|NCT00179621|42183709|FG001|Open-Label Period|Withdrawal by Subject|2|||
19736975|NCT00179621|42183710|FG002|Open-Label Period|Withdrawal by Subject|2|||
19736976|NCT00179621|42183711|FG003|Open-Label Period|Withdrawal by Subject|2|||
19736977|NCT00179621|42183708|FG000|Open-Label Period|Death|0|||
19736978|NCT00179621|42183709|FG001|Open-Label Period|Death|0|||
19736979|NCT00179621|42183710|FG002|Open-Label Period|Death|1|||
19736980|NCT00179621|42183711|FG003|Open-Label Period|Death|2|||
19736981|NCT00179621|42183708|FG000|Open-Label Period|Other|0|||
19736982|NCT00179621|42183709|FG001|Open-Label Period|Other|1|||
19736983|NCT00179621|42183710|FG002|Open-Label Period|Other|1|||
19736984|NCT00179621|42183711|FG003|Open-Label Period|Other|2|||
19736985|NCT03235544|42183724|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
19736986|NCT03235544|42183725|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
19736987|NCT03235544|42183726|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
19736988|NCT03235544|42183727|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
19736989|NCT03235544|42183724|FG000|Overall Study|Death|11|||
19736990|NCT03235544|42183725|FG001|Overall Study|Death|23|||
19736991|NCT03235544|42183726|FG002|Overall Study|Death|11|||
19736992|NCT03235544|42183727|FG003|Overall Study|Death|20|||
19736993|NCT03235544|42183724|FG000|Overall Study|Lost to Follow-up|0|||
19736994|NCT03235544|42183725|FG001|Overall Study|Lost to Follow-up|1|||
19736995|NCT03235544|42183726|FG002|Overall Study|Lost to Follow-up|0|||
19736996|NCT03235544|42183727|FG003|Overall Study|Lost to Follow-up|1|||
19736997|NCT03235544|42183724|FG000|Overall Study|Withdrawal by Participant|0|||
19736998|NCT03235544|42183725|FG001|Overall Study|Withdrawal by Participant|0|||
19736999|NCT03235544|42183726|FG002|Overall Study|Withdrawal by Participant|1|||
19737000|NCT03235544|42183727|FG003|Overall Study|Withdrawal by Participant|0|||
19737001|NCT03235544|42183724|FG000|Overall Study|Reason not Specified|0|||
19737002|NCT03235544|42183725|FG001|Overall Study|Reason not Specified|4|||
19737003|NCT03235544|42183726|FG002|Overall Study|Reason not Specified|0|||
19737004|NCT03235544|42183727|FG003|Overall Study|Reason not Specified|1|||
19737005|NCT00179309|42183740|FG000|Treatment|Toxicity|2|||
19737006|NCT00179309|42183741|FG001|Treatment|Toxicity|3|||
19737007|NCT00179309|42183740|FG000|Treatment|Withdrawal by Subject|1|||
19737008|NCT00179309|42183741|FG001|Treatment|Withdrawal by Subject|2|||
19737009|NCT00179309|42183740|FG000|Treatment|Allergy|1|||
19737010|NCT00179309|42183741|FG001|Treatment|Allergy|0|||
19737011|NCT00178685|42183762|FG000|Overall Study|Death|3|||
19737012|NCT00178685|42183763|FG001|Overall Study|Death|3|||
19737013|NCT00178685|42183764|FG002|Overall Study|Death|6|||
19737014|NCT00178685|42183762|FG000|Overall Study|Lost to Follow-up|100|||
19737015|NCT00178685|42183763|FG001|Overall Study|Lost to Follow-up|187|||
19737016|NCT00178685|42183764|FG002|Overall Study|Lost to Follow-up|183|||
19737017|NCT00178685|42183762|FG000|Overall Study|Withdrawal by Subject|8|||
19737018|NCT00178685|42183763|FG001|Overall Study|Withdrawal by Subject|14|||
19737019|NCT00178685|42183764|FG002|Overall Study|Withdrawal by Subject|7|||
19737020|NCT02933528|42183772|FG000|Overall Study|Lost to Follow-up|2|||
19737021|NCT00177671|42183778|FG000|Overall Study|Withdrawal by Subject|5|||
19737022|NCT00177671|42183779|FG001|Overall Study|Withdrawal by Subject|6|||
19737023|NCT00177671|42183778|FG000|Overall Study|medical complications|2|||
19737024|NCT00177671|42183779|FG001|Overall Study|medical complications|0|||
19737025|NCT00177671|42183778|FG000|Overall Study|Adverse Event|6|||
19737026|NCT00177671|42183779|FG001|Overall Study|Adverse Event|0|||
19737027|NCT00177671|42183778|FG000|Overall Study|Physician Decision|12|||
19737028|NCT00177671|42183779|FG001|Overall Study|Physician Decision|8|||
19737029|NCT02933060|42183787|FG000|Overall Study|Withdrawal by Subject|0|||
19737030|NCT02933060|42183788|FG001|Overall Study|Withdrawal by Subject|1|||
19737031|NCT03235154|42183794|FG000|Overall Study|Withdrawal by Subject|1|||
19737032|NCT03235154|42183794|FG000|Overall Study|Adverse Event|1|||
19737033|NCT03235154|42183794|FG000|Overall Study|Lost to Follow-up|2|||
19737034|NCT03234608|42183802|FG000|Overall Study|Lost to Follow-up|23|||
19737035|NCT03234608|42183803|FG001|Overall Study|Lost to Follow-up|21|||
19737036|NCT03248882|42183814|FG000|Overall Study|Adverse Event|3|||
19737037|NCT03248882|42183815|FG001|Overall Study|Adverse Event|3|||
19737038|NCT03248882|42183816|FG002|Overall Study|Adverse Event|2|||
19737039|NCT03248882|42183817|FG003|Overall Study|Adverse Event|6|||
19737040|NCT03248882|42183818|FG004|Overall Study|Adverse Event|9|||
19737041|NCT03248882|42183814|FG000|Overall Study|Lost to Follow-up|0|||
19737042|NCT03248882|42183815|FG001|Overall Study|Lost to Follow-up|0|||
19737043|NCT03248882|42183816|FG002|Overall Study|Lost to Follow-up|0|||
19737044|NCT03248882|42183817|FG003|Overall Study|Lost to Follow-up|0|||
19737045|NCT03248882|42183818|FG004|Overall Study|Lost to Follow-up|1|||
19737046|NCT03248882|42183814|FG000|Overall Study|Protocol Violation|2|||
19737047|NCT03248882|42183815|FG001|Overall Study|Protocol Violation|0|||
19737048|NCT03248882|42183816|FG002|Overall Study|Protocol Violation|2|||
19737049|NCT03248882|42183817|FG003|Overall Study|Protocol Violation|0|||
19737050|NCT03248882|42183818|FG004|Overall Study|Protocol Violation|1|||
19737051|NCT03248882|42183814|FG000|Overall Study|Withdrawal by Subject|2|||
19737052|NCT03248882|42183815|FG001|Overall Study|Withdrawal by Subject|2|||
19737053|NCT03248882|42183816|FG002|Overall Study|Withdrawal by Subject|3|||
19737054|NCT03248882|42183817|FG003|Overall Study|Withdrawal by Subject|4|||
19737055|NCT03248882|42183818|FG004|Overall Study|Withdrawal by Subject|2|||
19737056|NCT03233438|42183832|FG000|Overall Study|Lost to Follow-up|4|||
19737057|NCT03233438|42183833|FG001|Overall Study|Lost to Follow-up|9|||
19737058|NCT03233438|42183832|FG000|Overall Study|Withdrawal by Subject|2|||
19737059|NCT03233438|42183833|FG001|Overall Study|Withdrawal by Subject|1|||
19737060|NCT03233438|42183832|FG000|Overall Study|No recording of dalbavancin|0|||
19737061|NCT03233438|42183833|FG001|Overall Study|No recording of dalbavancin|1|||
19737062|NCT01368406|42183841|FG000|Overall Study|Lost to Follow-up|8|||
19737063|NCT01368406|42183842|FG001|Overall Study|Lost to Follow-up|4|||
19737064|NCT01368406|42183841|FG000|Overall Study|Withdrawal by Subject|8|||
19737065|NCT01368406|42183842|FG001|Overall Study|Withdrawal by Subject|4|||
19737066|NCT01368406|42183841|FG000|Overall Study|relapse of the disease|3|||
19737067|NCT01368406|42183842|FG001|Overall Study|relapse of the disease|2|||
19737068|NCT01368406|42183841|FG000|Overall Study|started working|2|||
19737069|NCT01368406|42183842|FG001|Overall Study|started working|3|||
19737070|NCT00175877|42183848|FG000|Overall Study|Adverse Event|136|||
19737071|NCT00175877|42183848|FG000|Overall Study|Withdrawal by Subject|141|||
19737072|NCT00175877|42183848|FG000|Overall Study|Lost to Follow-up|9|||
19737073|NCT00175877|42183848|FG000|Overall Study|Lack of Efficacy|26|||
19737074|NCT00175877|42183848|FG000|Overall Study|Protocol Violation|15|||
19737075|NCT00175877|42183848|FG000|Overall Study|Other Reason|20|||
19737076|NCT00175877|42183848|FG000|Overall Study|AE & Other|1|||
19737077|NCT00175877|42183848|FG000|Overall Study|Withdrawal by subject & Other|1|||
19737078|NCT02788474|42183854|FG000|Double Blind Treatment Period|Not treated|1|||
19737079|NCT02788474|42183855|FG001|Double Blind Treatment Period|Not treated|0|||
19737080|NCT02788474|42183854|FG000|Double Blind Treatment Period|Patient's refusal|3|||
19737081|NCT02788474|42183855|FG001|Double Blind Treatment Period|Patient's refusal|0|||
19737082|NCT02788474|42183854|FG000|Double Blind Treatment Period|Adverse Event|6|||
19737083|NCT02788474|42183855|FG001|Double Blind Treatment Period|Adverse Event|4|||
19737084|NCT02788474|42183854|FG000|Open Label Treatment Period|Adverse Event|29|||
19737085|NCT02788474|42183855|FG001|Open Label Treatment Period|Adverse Event|9|||
19737086|NCT02788474|42183854|FG000|Open Label Treatment Period|Other than reason specified|1|||
19737087|NCT02788474|42183855|FG001|Open Label Treatment Period|Other than reason specified|0|||
19737088|NCT02788474|42183854|FG000|Open Label Treatment Period|Patient's refusal|1|||
19737089|NCT02788474|42183855|FG001|Open Label Treatment Period|Patient's refusal|3|||
19737090|NCT02788474|42183854|FG000|Open Label Treatment Period|Non-compliance|1|||
19737091|NCT02788474|42183855|FG001|Open Label Treatment Period|Non-compliance|0|||
19737092|NCT03248492|42183867|FG000|Overall Study|Ongoing|23|||
19737093|NCT03248492|42183868|FG001|Overall Study|Ongoing|26|||
19737094|NCT03248492|42183869|FG002|Overall Study|Ongoing|3|||
19737095|NCT03248492|42183870|FG003|Overall Study|Ongoing|85|||
19737096|NCT03248492|42183871|FG004|Overall Study|Ongoing|2|||
19737097|NCT03248492|42183867|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
19737098|NCT03248492|42183868|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
19737099|NCT03248492|42183869|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
19737100|NCT03248492|42183870|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
19737101|NCT03248492|42183871|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
19737102|NCT03248492|42183867|FG000|Overall Study|Adverse Event|6|||
19737103|NCT03248492|42183868|FG001|Overall Study|Adverse Event|6|||
19737104|NCT03248492|42183869|FG002|Overall Study|Adverse Event|8|||
19737105|NCT03248492|42183870|FG003|Overall Study|Adverse Event|8|||
19737106|NCT03248492|42183871|FG004|Overall Study|Adverse Event|1|||
19737107|NCT03248492|42183867|FG000|Overall Study|Withdrawal by Subject|3|||
19737108|NCT03248492|42183868|FG001|Overall Study|Withdrawal by Subject|3|||
19737109|NCT03248492|42183869|FG002|Overall Study|Withdrawal by Subject|0|||
19737110|NCT03248492|42183870|FG003|Overall Study|Withdrawal by Subject|3|||
19737111|NCT03248492|42183871|FG004|Overall Study|Withdrawal by Subject|1|||
19737112|NCT03248492|42183867|FG000|Overall Study|Physician Decision|1|||
19737113|NCT03248492|42183868|FG001|Overall Study|Physician Decision|0|||
19737114|NCT03248492|42183869|FG002|Overall Study|Physician Decision|1|||
19737115|NCT03248492|42183870|FG003|Overall Study|Physician Decision|2|||
19737116|NCT03248492|42183871|FG004|Overall Study|Physician Decision|0|||
19737117|NCT03248492|42183867|FG000|Overall Study|Death|1|||
19737118|NCT03248492|42183868|FG001|Overall Study|Death|0|||
19737119|NCT03248492|42183869|FG002|Overall Study|Death|0|||
19737120|NCT03248492|42183870|FG003|Overall Study|Death|6|||
19737121|NCT03248492|42183871|FG004|Overall Study|Death|0|||
19737122|NCT03248492|42183867|FG000|Overall Study|Other|0|||
19737123|NCT03248492|42183868|FG001|Overall Study|Other|1|||
19737124|NCT03248492|42183869|FG002|Overall Study|Other|0|||
19737125|NCT03248492|42183870|FG003|Overall Study|Other|4|||
19737126|NCT03248492|42183871|FG004|Overall Study|Other|0|||
19737127|NCT03247556|42183894|FG000|Overall Study|Adverse Event|1|||
19737128|NCT03247556|42183895|FG001|Overall Study|Adverse Event|4|||
19737129|NCT03247556|42183896|FG002|Overall Study|Adverse Event|5|||
19737130|NCT03247556|42183894|FG000|Overall Study|Lost to Follow-up|5|||
19737131|NCT03247556|42183895|FG001|Overall Study|Lost to Follow-up|5|||
19737132|NCT03247556|42183896|FG002|Overall Study|Lost to Follow-up|4|||
19737133|NCT03247556|42183894|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
19737134|NCT03247556|42183895|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
19737135|NCT03247556|42183896|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
19737136|NCT03247556|42183894|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
19737137|NCT03247556|42183895|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
19737138|NCT03247556|42183896|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
19737139|NCT03247556|42183894|FG000|Overall Study|Protocol Violation|2|||
19737140|NCT03247556|42183895|FG001|Overall Study|Protocol Violation|0|||
19737141|NCT03247556|42183896|FG002|Overall Study|Protocol Violation|1|||
19737142|NCT03247556|42183894|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
19737143|NCT03247556|42183895|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
19737144|NCT03247556|42183896|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
19737145|NCT03216746|42183908|FG000|Overall Study|Lost to Follow-up|6|||
19737146|NCT03216746|42183909|FG001|Overall Study|Lost to Follow-up|8|||
19737147|NCT03216746|42183910|FG002|Overall Study|Lost to Follow-up|5|||
19737148|NCT03216746|42183911|FG003|Overall Study|Lost to Follow-up|6|||
19737149|NCT02787304|42183925|FG000|Overall Study|Adverse Event|9|||
19737150|NCT02787304|42183926|FG001|Overall Study|Adverse Event|3|||
19737151|NCT02787304|42183927|FG002|Overall Study|Adverse Event|8|||
19737152|NCT02787304|42183928|FG003|Overall Study|Adverse Event|1|||
19737153|NCT02787304|42183925|FG000|Overall Study|Withdrawal by Subject|1|||
19737154|NCT02787304|42183926|FG001|Overall Study|Withdrawal by Subject|4|||
19737155|NCT02787304|42183927|FG002|Overall Study|Withdrawal by Subject|0|||
19737156|NCT02787304|42183928|FG003|Overall Study|Withdrawal by Subject|0|||
19737157|NCT02787304|42183925|FG000|Overall Study|Lost to Follow-up|1|||
19737158|NCT02787304|42183926|FG001|Overall Study|Lost to Follow-up|0|||
19737159|NCT02787304|42183927|FG002|Overall Study|Lost to Follow-up|0|||
19737160|NCT02787304|42183928|FG003|Overall Study|Lost to Follow-up|1|||
19737161|NCT02787304|42183925|FG000|Overall Study|Noncompliance with study drug|0|||
19737162|NCT02787304|42183926|FG001|Overall Study|Noncompliance with study drug|0|||
19737163|NCT02787304|42183927|FG002|Overall Study|Noncompliance with study drug|1|||
19737164|NCT02787304|42183928|FG003|Overall Study|Noncompliance with study drug|0|||
19737165|NCT02787304|42183925|FG000|Overall Study|Physician Decision|0|||
19737166|NCT02787304|42183926|FG001|Overall Study|Physician Decision|0|||
19737167|NCT02787304|42183927|FG002|Overall Study|Physician Decision|1|||
19737168|NCT02787304|42183928|FG003|Overall Study|Physician Decision|0|||
19737169|NCT02787304|42183925|FG000|Overall Study|Study terminated by sponsor|25|||
19737170|NCT02787304|42183926|FG001|Overall Study|Study terminated by sponsor|31|||
19737171|NCT02787304|42183927|FG002|Overall Study|Study terminated by sponsor|31|||
19737172|NCT02787304|42183928|FG003|Overall Study|Study terminated by sponsor|32|||
19737173|NCT02932904|42183942|FG000|Overall Study|Reason not Specified|1|||
19737174|NCT02932904|42183943|FG001|Overall Study|Reason not Specified|0|||
19737175|NCT02932904|42183944|FG002|Overall Study|Reason not Specified|2|||
19737176|NCT02932904|42183945|FG003|Overall Study|Reason not Specified|2|||
19737177|NCT02932904|42183942|FG000|Overall Study|Noncompliance with Study Drug|2|||
19737178|NCT02932904|42183943|FG001|Overall Study|Noncompliance with Study Drug|3|||
19737179|NCT02932904|42183944|FG002|Overall Study|Noncompliance with Study Drug|3|||
19737180|NCT02932904|42183945|FG003|Overall Study|Noncompliance with Study Drug|4|||
19737181|NCT02932904|42183942|FG000|Overall Study|Pregnancy|0|||
19737182|NCT02932904|42183943|FG001|Overall Study|Pregnancy|1|||
19737183|NCT02932904|42183944|FG002|Overall Study|Pregnancy|1|||
19737184|NCT02932904|42183945|FG003|Overall Study|Pregnancy|0|||
19737185|NCT02932904|42183942|FG000|Overall Study|Study Termination|0|||
19737186|NCT02932904|42183943|FG001|Overall Study|Study Termination|1|||
19737187|NCT02932904|42183944|FG002|Overall Study|Study Termination|0|||
19737188|NCT02932904|42183945|FG003|Overall Study|Study Termination|0|||
19737189|NCT02932904|42183942|FG000|Overall Study|Voluntary Withdrawal|2|||
19737190|NCT02932904|42183943|FG001|Overall Study|Voluntary Withdrawal|1|||
19737191|NCT02932904|42183944|FG002|Overall Study|Voluntary Withdrawal|4|||
19465295|NCT04426695|41723753|FG012|Overall Study|Physician Decision|1|||
19465296|NCT04426695|41723754|FG013|Overall Study|Physician Decision|0|||
19737192|NCT02932904|42183945|FG003|Overall Study|Voluntary Withdrawal|2|||
19737193|NCT02932904|42183942|FG000|Overall Study|Lost to Follow-up|5|||
19737194|NCT02932904|42183943|FG001|Overall Study|Lost to Follow-up|3|||
19737195|NCT02932904|42183944|FG002|Overall Study|Lost to Follow-up|6|||
19737196|NCT02932904|42183945|FG003|Overall Study|Lost to Follow-up|0|||
19737197|NCT02932904|42183942|FG000|Overall Study|Significant Protocol Deviation|2|||
19737198|NCT02932904|42183943|FG001|Overall Study|Significant Protocol Deviation|3|||
19737199|NCT02932904|42183944|FG002|Overall Study|Significant Protocol Deviation|6|||
19737200|NCT02932904|42183945|FG003|Overall Study|Significant Protocol Deviation|1|||
19737201|NCT02932904|42183942|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
19737202|NCT02932904|42183943|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
19737203|NCT02932904|42183944|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
19737204|NCT02932904|42183945|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
19737205|NCT02932904|42183942|FG000|Overall Study|Randomized But Not Treated|1|||
19737206|NCT02932904|42183943|FG001|Overall Study|Randomized But Not Treated|1|||
19737207|NCT02932904|42183944|FG002|Overall Study|Randomized But Not Treated|0|||
19737208|NCT02932904|42183945|FG003|Overall Study|Randomized But Not Treated|2|||
19737209|NCT02542293|42183960|FG000|Overall Study|Death|367|||
19737210|NCT02542293|42183961|FG001|Overall Study|Death|377|||
19737211|NCT02542293|42183960|FG000|Overall Study|Withdrawal by Subject|8|||
19737212|NCT02542293|42183961|FG001|Overall Study|Withdrawal by Subject|19|||
19737213|NCT00688376|42183976|FG000|Double-Blind Phase|Adverse Event|4|||
19737214|NCT00688376|42183977|FG001|Double-Blind Phase|Adverse Event|4|||
19737215|NCT00688376|42183976|FG000|Double-Blind Phase|Protocol Violation|1|||
19737216|NCT00688376|42183977|FG001|Double-Blind Phase|Protocol Violation|2|||
19737217|NCT00688376|42183976|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
19737218|NCT00688376|42183977|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
19737219|NCT00688376|42183976|FG000|Double-Blind Phase|Not treated|0|||
19737220|NCT00688376|42183977|FG001|Double-Blind Phase|Not treated|1|||
19737221|NCT00688376|42183976|FG000|Blinded Extension Phase|Adverse Event|3|||
19737222|NCT00688376|42183977|FG001|Blinded Extension Phase|Adverse Event|4|||
19737223|NCT00688376|42183976|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
19737224|NCT00688376|42183977|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
19737225|NCT00688376|42183976|FG000|Blinded Extension Phase|Physician Decision|1|||
19737226|NCT00688376|42183977|FG001|Blinded Extension Phase|Physician Decision|0|||
19737227|NCT00688376|42183976|FG000|Blinded Extension Phase|Other|1|||
19737228|NCT00688376|42183977|FG001|Blinded Extension Phase|Other|0|||
19737229|NCT03214952|42183985|FG000|Overall Study|Protocol Deviation|45|||
19737230|NCT03214952|42183985|FG000|Overall Study|Case Report Forms Uncollected|13|||
19737231|NCT01367704|42183991|FG000|Overall Study|Lost to Follow-up|47|||
19737232|NCT01367704|42183992|FG001|Overall Study|Lost to Follow-up|161|||
19737233|NCT03214094|42183998|FG000|Overall Study|Case Report Forms Uncollected|14|||
19737234|NCT03214094|42183998|FG000|Overall Study|Protocol Deviation|46|||
19737235|NCT01367236|42184004|FG000|Overall Study|Withdrawal by Subject|3|||
19737236|NCT01367236|42184005|FG001|Overall Study|Withdrawal by Subject|1|||
19737237|NCT03681951|42184019|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
19737238|NCT03681951|42184020|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737239|NCT03681951|42184021|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737240|NCT03681951|42184022|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737241|NCT03681951|42184023|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737242|NCT03681951|42184024|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737243|NCT03681951|42184025|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737244|NCT03681951|42184026|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
19737245|NCT03681951|42184019|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
19737246|NCT03681951|42184020|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737247|NCT03681951|42184021|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737248|NCT03681951|42184022|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737249|NCT03681951|42184023|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737250|NCT03681951|42184024|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737251|NCT03681951|42184025|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737252|NCT03681951|42184026|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
19737253|NCT03681951|42184019|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
19737254|NCT03681951|42184020|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737255|NCT03681951|42184021|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737256|NCT03681951|42184022|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737257|NCT03681951|42184023|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737258|NCT03681951|42184024|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737259|NCT03681951|42184025|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19465297|NCT04426695|41723755|FG014|Overall Study|Physician Decision|0|||
19737260|NCT03681951|42184026|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
19737261|NCT03681405|42184051|FG000|Overall Study|Found to be ineligible after randomized|1|||
19737262|NCT03681405|42184052|FG001|Overall Study|Found to be ineligible after randomized|0|||
19737263|NCT00174785|42184062|FG000|Overall Study|Adverse Event|293|||
19465298|NCT04426695|41723756|FG015|Overall Study|Physician Decision|0|||
19465299|NCT04426695|41723757|FG016|Overall Study|Physician Decision|0|||
19737264|NCT00174785|42184063|FG001|Overall Study|Adverse Event|191|||
19737265|NCT00174785|42184062|FG000|Overall Study|Protocol Violation|14|||
19737266|NCT00174785|42184063|FG001|Overall Study|Protocol Violation|14|||
19737267|NCT00174785|42184062|FG000|Overall Study|Withdrawal by Subject|173|||
19737268|NCT00174785|42184063|FG001|Overall Study|Withdrawal by Subject|175|||
19737269|NCT00174785|42184062|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
19737270|NCT00174785|42184063|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
19737271|NCT00174785|42184062|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
19737272|NCT00174785|42184063|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
19737273|NCT00174785|42184062|FG000|Overall Study|Other prohibited medication|5|||
19737274|NCT00174785|42184063|FG001|Overall Study|Other prohibited medication|3|||
19737275|NCT00174785|42184062|FG000|Overall Study|Family request|6|||
19737276|NCT00174785|42184063|FG001|Overall Study|Family request|8|||
19737277|NCT00174785|42184062|FG000|Overall Study|Not pre-specified/Not coded|56|||
19737278|NCT00174785|42184063|FG001|Overall Study|Not pre-specified/Not coded|70|||
19737279|NCT03681093|42184072|FG000|Overall Study|Subject decision|0|||
19737280|NCT03681093|42184073|FG001|Overall Study|Subject decision|2|||
19737281|NCT03681093|42184074|FG002|Overall Study|Subject decision|1|||
19737282|NCT00166517|42184084|FG000|Overall Study|Lost to Follow-up|1|||
19737283|NCT00166517|42184085|FG001|Overall Study|Lost to Follow-up|0|||
19737284|NCT00166517|42184084|FG000|Overall Study|Protocol Violation|4|||
19737285|NCT00166517|42184085|FG001|Overall Study|Protocol Violation|1|||
19737286|NCT00166517|42184084|FG000|Overall Study|Withdrawal by Subject|0|||
19737287|NCT00166517|42184085|FG001|Overall Study|Withdrawal by Subject|1|||
19737288|NCT00166439|42184091|FG000|Overall Study|Ineligible|5|||
19737289|NCT00138671|42184097|FG000|Overall Study|Death|0|||
19737290|NCT00138671|42184098|FG001|Overall Study|Death|3|||
19737291|NCT00138671|42184097|FG000|Overall Study|Adverse Event|6|||
19737292|NCT00138671|42184098|FG001|Overall Study|Adverse Event|3|||
19737293|NCT00138671|42184097|FG000|Overall Study|Lost to Follow-up|1|||
19737294|NCT00138671|42184098|FG001|Overall Study|Lost to Follow-up|2|||
19737295|NCT00138671|42184097|FG000|Overall Study|Withdrawal by Subject|3|||
19737296|NCT00138671|42184098|FG001|Overall Study|Withdrawal by Subject|5|||
19737297|NCT00138671|42184097|FG000|Overall Study|Other|3|||
19737298|NCT00138671|42184098|FG001|Overall Study|Other|3|||
19737299|NCT01367158|42184117|FG000|Overall Study|Withdrew consent|0|||
19737300|NCT01367158|42184118|FG001|Overall Study|Withdrew consent|2|||
19737301|NCT01367158|42184119|FG002|Overall Study|Withdrew consent|1|||
19737302|NCT01367158|42184120|FG003|Overall Study|Withdrew consent|0|||
19737303|NCT01367158|42184121|FG004|Overall Study|Withdrew consent|2|||
19737304|NCT01367158|42184122|FG005|Overall Study|Withdrew consent|0|||
19737305|NCT01367158|42184123|FG006|Overall Study|Withdrew consent|0|||
19737306|NCT01367158|42184124|FG007|Overall Study|Withdrew consent|1|||
19737307|NCT01367158|42184125|FG008|Overall Study|Withdrew consent|0|||
19737308|NCT01367158|42184126|FG009|Overall Study|Withdrew consent|0|||
19737309|NCT01367158|42184127|FG010|Overall Study|Withdrew consent|0|||
19737310|NCT01367158|42184117|FG000|Overall Study|Lost to Follow-up|0|||
19737311|NCT01367158|42184118|FG001|Overall Study|Lost to Follow-up|0|||
19737312|NCT01367158|42184119|FG002|Overall Study|Lost to Follow-up|0|||
19737313|NCT01367158|42184120|FG003|Overall Study|Lost to Follow-up|1|||
19737314|NCT01367158|42184121|FG004|Overall Study|Lost to Follow-up|0|||
19737315|NCT01367158|42184122|FG005|Overall Study|Lost to Follow-up|2|||
19737316|NCT01367158|42184123|FG006|Overall Study|Lost to Follow-up|0|||
19737317|NCT01367158|42184124|FG007|Overall Study|Lost to Follow-up|1|||
19737318|NCT01367158|42184125|FG008|Overall Study|Lost to Follow-up|0|||
19737319|NCT01367158|42184126|FG009|Overall Study|Lost to Follow-up|0|||
19737320|NCT01367158|42184127|FG010|Overall Study|Lost to Follow-up|1|||
19737321|NCT01367158|42184117|FG000|Overall Study|Protocol Violation|0|||
19737322|NCT01367158|42184118|FG001|Overall Study|Protocol Violation|1|||
19737323|NCT01367158|42184119|FG002|Overall Study|Protocol Violation|0|||
19737324|NCT01367158|42184120|FG003|Overall Study|Protocol Violation|0|||
19737325|NCT01367158|42184121|FG004|Overall Study|Protocol Violation|0|||
19737326|NCT01367158|42184122|FG005|Overall Study|Protocol Violation|0|||
19737327|NCT01367158|42184123|FG006|Overall Study|Protocol Violation|0|||
19737328|NCT01367158|42184124|FG007|Overall Study|Protocol Violation|0|||
19737329|NCT01367158|42184125|FG008|Overall Study|Protocol Violation|0|||
19737330|NCT01367158|42184126|FG009|Overall Study|Protocol Violation|0|||
19737331|NCT01367158|42184127|FG010|Overall Study|Protocol Violation|0|||
19737332|NCT00130637|42184162|FG000|Overall Study|Adverse Event|2|||
19737333|NCT00130637|42184162|FG000|Overall Study|Withdrawal by Subject|1|||
19737334|NCT03679767|42184170|FG000|Overall Study|Death|16|||
19737335|NCT03679767|42184171|FG001|Overall Study|Death|10|||
19737336|NCT03679767|42184172|FG002|Overall Study|Death|16|||
19737337|NCT03679767|42184173|FG003|Overall Study|Death|10|||
19737338|NCT03679767|42184170|FG000|Overall Study|Lost to Follow-up|1|||
19737339|NCT03679767|42184171|FG001|Overall Study|Lost to Follow-up|0|||
19737340|NCT03679767|42184172|FG002|Overall Study|Lost to Follow-up|1|||
19737341|NCT03679767|42184173|FG003|Overall Study|Lost to Follow-up|1|||
19737342|NCT03679767|42184170|FG000|Overall Study|Withdrawal by Subject|0|||
19737343|NCT03679767|42184171|FG001|Overall Study|Withdrawal by Subject|0|||
19737344|NCT03679767|42184172|FG002|Overall Study|Withdrawal by Subject|0|||
19737345|NCT03679767|42184173|FG003|Overall Study|Withdrawal by Subject|1|||
19737346|NCT03679767|42184170|FG000|Overall Study|Follow-up Completed|4|||
19737347|NCT03679767|42184171|FG001|Overall Study|Follow-up Completed|1|||
19737348|NCT03679767|42184172|FG002|Overall Study|Follow-up Completed|3|||
19737349|NCT03679767|42184173|FG003|Overall Study|Follow-up Completed|5|||
19737350|NCT03679767|42184170|FG000|Overall Study|Ongoing|14|||
19737351|NCT03679767|42184171|FG001|Overall Study|Ongoing|12|||
19737352|NCT03679767|42184172|FG002|Overall Study|Ongoing|9|||
19737353|NCT03679767|42184173|FG003|Overall Study|Ongoing|17|||
19737354|NCT00130247|42184187|FG000|Overall Study|Pregnancy|1|||
19737355|NCT00130247|42184188|FG001|Overall Study|Pregnancy|0|||
19737356|NCT00130247|42184187|FG000|Overall Study|Post-randomization exclusion|1|||
19737357|NCT00130247|42184188|FG001|Overall Study|Post-randomization exclusion|2|||
19737358|NCT00130247|42184187|FG000|Overall Study|Not compliant with DOT|0|||
19737359|NCT00130247|42184188|FG001|Overall Study|Not compliant with DOT|2|||
19737360|NCT03678285|42184194|FG000|Overall Study|Adverse Event|2|||
19737361|NCT03678285|42184194|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
19737362|NCT03678285|42184194|FG000|Overall Study|Dehydrated prior to start of workout|1|||
19737363|NCT04032171|42184200|FG000|Overall Study|Study Termination|1|||
19737364|NCT04032171|42184201|FG001|Overall Study|Study Termination|0|||
19737365|NCT00137423|42184209|FG000|Overall Study|Adverse Event|7|||
19737366|NCT00137423|42184210|FG001|Overall Study|Adverse Event|9|||
19737367|NCT00137423|42184209|FG000|Overall Study|consent withdrawn|1|||
19737368|NCT00137423|42184210|FG001|Overall Study|consent withdrawn|1|||
19737369|NCT00137423|42184209|FG000|Overall Study|Lack of Efficacy|31|||
19737370|NCT00137423|42184210|FG001|Overall Study|Lack of Efficacy|33|||
19737371|NCT00137423|42184209|FG000|Overall Study|Death|0|||
19737372|NCT00137423|42184210|FG001|Overall Study|Death|1|||
19737373|NCT02786836|42184220|FG000|Overall Study|Death|1|||
19737374|NCT02786836|42184220|FG000|Overall Study|Lack of Efficacy|2|||
19737375|NCT02786836|42184220|FG000|Overall Study|Protocol Violation|3|||
19737376|NCT02786836|42184220|FG000|Overall Study|Withdrawal by Subject|3|||
19737377|NCT02786836|42184220|FG000|Overall Study|Liver Transplantation|2|||
19737378|NCT02786836|42184220|FG000|Overall Study|Device or Pharmacy Issues|3|||
19737379|NCT00137267|42184227|FG000|Overall Study|Lost to Follow-up|15|||
19737380|NCT00137267|42184228|FG001|Overall Study|Lost to Follow-up|21|||
19737381|NCT00137111|42184238|FG000|Total Therapy|Death|35|||
19737382|NCT00137111|42184239|FG001|Total Therapy|Death|0|||
19737383|NCT00137111|42184240|FG002|Total Therapy|Death|0|||
19737384|NCT00137111|42184241|FG003|Total Therapy|Death|0|||
19737385|NCT00137111|42184238|FG000|Total Therapy|Non Compliance|5|||
19737386|NCT00137111|42184239|FG001|Total Therapy|Non Compliance|0|||
19737387|NCT00137111|42184240|FG002|Total Therapy|Non Compliance|0|||
19737388|NCT00137111|42184241|FG003|Total Therapy|Non Compliance|0|||
19737389|NCT00136955|42184248|FG000|Overall Study|Adverse Event|8|||
19737390|NCT00136955|42184248|FG000|Overall Study|Lost to Follow-up|1|||
19737391|NCT00136955|42184248|FG000|Overall Study|Withdrawal by Subject|2|||
19737392|NCT00136955|42184248|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
19737393|NCT00135707|42184254|FG000|Overall Study|Lost to Follow-up|94|||
19737394|NCT00135707|42184255|FG001|Overall Study|Lost to Follow-up|89|||
19737395|NCT00135707|42184254|FG000|Overall Study|Withdrawal by Subject|0|||
19737396|NCT00135707|42184255|FG001|Overall Study|Withdrawal by Subject|1|||
19737397|NCT00135707|42184254|FG000|Overall Study|Institutional review board request|1|||
19737398|NCT00135707|42184255|FG001|Overall Study|Institutional review board request|0|||
19737399|NCT00129701|42184265|FG000|Overall Study|Withdrawal by Subject|33|||
19737400|NCT00129623|42184274|FG000|Overall Study|Adverse Event|3|||
19737401|NCT00129623|42184275|FG001|Overall Study|Adverse Event|7|||
19737402|NCT00129623|42184274|FG000|Overall Study|Refused Treatment|5|||
19737403|NCT00129623|42184275|FG001|Overall Study|Refused Treatment|3|||
19465300|NCT04426695|41723758|FG017|Overall Study|Physician Decision|0|||
19465301|NCT04426695|41723741|FG000|Overall Study|Randomized but Never Treated|3|||
19737404|NCT00129623|42184274|FG000|Overall Study|Failure to Return|1|||
19737405|NCT00129623|42184275|FG001|Overall Study|Failure to Return|1|||
19737406|NCT00129623|42184274|FG000|Overall Study|Relocated job out of state|1|||
19737407|NCT00129623|42184275|FG001|Overall Study|Relocated job out of state|0|||
19737408|NCT00129623|42184274|FG000|Overall Study|Uncertainty to return|0|||
19737409|NCT00129623|42184275|FG001|Overall Study|Uncertainty to return|1|||
19737410|NCT00129545|42184286|FG000|Overall Study|Death|5|||
19737411|NCT00129545|42184287|FG001|Overall Study|Death|60|||
19737412|NCT00129545|42184288|FG002|Overall Study|Death|44|||
19737413|NCT00129545|42184286|FG000|Overall Study|Withdrawal by Subject|3|||
19737414|NCT00129545|42184287|FG001|Overall Study|Withdrawal by Subject|18|||
19737415|NCT00129545|42184288|FG002|Overall Study|Withdrawal by Subject|44|||
19737416|NCT00129545|42184286|FG000|Overall Study|Lost to Follow-up|2|||
19737417|NCT00129545|42184287|FG001|Overall Study|Lost to Follow-up|22|||
19737418|NCT00129545|42184288|FG002|Overall Study|Lost to Follow-up|13|||
19737419|NCT00129545|42184286|FG000|Overall Study|Physician Decision|0|||
19737420|NCT00129545|42184287|FG001|Overall Study|Physician Decision|3|||
19737421|NCT00129545|42184288|FG002|Overall Study|Physician Decision|10|||
19737422|NCT00129545|42184286|FG000|Overall Study|Device not implanted|16|||
19737423|NCT00129545|42184287|FG001|Overall Study|Device not implanted|61|||
19737424|NCT00129545|42184288|FG002|Overall Study|Device not implanted|0|||
19737425|NCT00129467|42184298|FG000|Received Intervention|Death|1|||
19737426|NCT00129467|42184299|FG001|Received Intervention|Death|1|||
19737427|NCT00129467|42184298|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
19737428|NCT00129467|42184299|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
19737429|NCT00129467|42184298|FG000|Received Intervention|Delirium|2|||
19737430|NCT00129467|42184299|FG001|Received Intervention|Delirium|0|||
19737431|NCT00129467|42184298|FG000|Received Intervention|Withdrawal by Subject|1|||
19737432|NCT00129467|42184299|FG001|Received Intervention|Withdrawal by Subject|0|||
19737433|NCT00129467|42184298|FG000|Received Intervention|Nausea|1|||
19737434|NCT00129467|42184299|FG001|Received Intervention|Nausea|0|||
19737435|NCT00129467|42184298|FG000|Received Intervention|Intolerance to citalopram|0|||
19737436|NCT00129467|42184299|FG001|Received Intervention|Intolerance to citalopram|1|||
19737437|NCT00129467|42184298|FG000|Received Intervention|Dizzyness, fatigue|0|||
19737438|NCT00129467|42184299|FG001|Received Intervention|Dizzyness, fatigue|1|||
19737439|NCT00129467|42184298|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
19737440|NCT00129467|42184299|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
19737441|NCT00129467|42184298|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
19737442|NCT00129467|42184299|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
19737443|NCT00129311|42184307|FG000|Overall Study|Withdrawal by Subject|12|||
19737444|NCT00129311|42184308|FG001|Overall Study|Withdrawal by Subject|19|||
19737445|NCT00133991|42184314|FG000|Overall Study|Death|4|||
19737446|NCT02784106|42184320|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
19737447|NCT02784106|42184321|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
19737448|NCT02784106|42184322|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
19737449|NCT02784106|42184323|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
19737450|NCT02784106|42184320|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
19737451|NCT02784106|42184321|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
19737452|NCT02784106|42184322|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19737453|NCT02784106|42184323|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19737454|NCT02784106|42184320|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
19737455|NCT02784106|42184321|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
19737456|NCT02784106|42184322|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
19737457|NCT02784106|42184323|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
19737458|NCT02784106|42184320|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
19737459|NCT02784106|42184321|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
19737460|NCT02784106|42184322|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
19737461|NCT02784106|42184323|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
19737462|NCT02784106|42184320|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
19737463|NCT02784106|42184321|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
19737464|NCT02784106|42184322|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
19737465|NCT02784106|42184323|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
19737466|NCT02784106|42184320|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
19737467|NCT02784106|42184321|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
19737468|NCT02784106|42184322|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
19737469|NCT02784106|42184323|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
19737470|NCT02785900|42184334|FG000|Overall Study|Study Termination by Sponsor|64|||
19737471|NCT02785900|42184335|FG001|Overall Study|Study Termination by Sponsor|81|||
19737472|NCT02785900|42184334|FG000|Overall Study|Death|46|||
19737473|NCT02785900|42184335|FG001|Overall Study|Death|32|||
19737474|NCT02785900|42184334|FG000|Overall Study|Withdrawal by Subject|4|||
19737475|NCT02785900|42184335|FG001|Overall Study|Withdrawal by Subject|8|||
19737476|NCT02785900|42184334|FG000|Overall Study|Physician Decision|3|||
19737477|NCT02785900|42184335|FG001|Overall Study|Physician Decision|2|||
19737478|NCT00127205|42184344|FG000|Overall Study|Adverse Event|228|||
19737479|NCT00127205|42184345|FG001|Overall Study|Adverse Event|387|||
19737480|NCT00127205|42184346|FG002|Overall Study|Adverse Event|273|||
19737481|NCT00127205|42184344|FG000|Overall Study|Death|8|||
19737482|NCT00127205|42184345|FG001|Overall Study|Death|6|||
19737483|NCT00127205|42184346|FG002|Overall Study|Death|5|||
19737484|NCT00127205|42184344|FG000|Overall Study|Withdrawal by Subject|318|||
19465302|NCT04426695|41723742|FG001|Overall Study|Randomized but Never Treated|1|||
19737485|NCT00127205|42184345|FG001|Overall Study|Withdrawal by Subject|310|||
19737486|NCT00127205|42184346|FG002|Overall Study|Withdrawal by Subject|172|||
19737487|NCT00127205|42184344|FG000|Overall Study|Other-non protocol specified|142|||
19737488|NCT00127205|42184345|FG001|Overall Study|Other-non protocol specified|129|||
19737489|NCT00127205|42184346|FG002|Overall Study|Other-non protocol specified|77|||
19737490|NCT00127205|42184344|FG000|Overall Study|Data not reported|6|||
19465303|NCT04426695|41723743|FG002|Overall Study|Randomized but Never Treated|0|||
19737491|NCT00127205|42184345|FG001|Overall Study|Data not reported|10|||
19737492|NCT00127205|42184346|FG002|Overall Study|Data not reported|1|||
19737493|NCT00127205|42184344|FG000|Overall Study|Progression|127|||
19737494|NCT00127205|42184345|FG001|Overall Study|Progression|131|||
19380932|NCT03463993|41624170|FG001|Overall Study|Lost to Follow-up|8|||
19737495|NCT00127205|42184346|FG002|Overall Study|Progression|84|||
19737496|NCT02785588|42184356|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
19737497|NCT02785588|42184356|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
19737498|NCT03670641|42184360|FG000|Overall Study|Lost to Follow-up|3|||
19737499|NCT04029519|42184367|FG000|Overall Study|Protocol Violation|1|||
19737500|NCT04029519|42184367|FG000|Overall Study|Withdrawal by Subject|3|||
19737501|NCT04029519|42184367|FG000|Overall Study|Lost to Follow-up|1|||
19737502|NCT03669861|42184371|FG000|Overall Study|Disease Flare|5|||
19737503|NCT03669861|42184371|FG000|Overall Study|Lack of Efficacy|2|||
19737504|NCT00127127|42184379|FG000|Overall Study|Adverse Event|0|||
19737505|NCT00127127|42184380|FG001|Overall Study|Adverse Event|2|||
19737506|NCT00127127|42184381|FG002|Overall Study|Adverse Event|0|||
19737507|NCT00127127|42184382|FG003|Overall Study|Adverse Event|1|||
19737508|NCT00127127|42184379|FG000|Overall Study|Lack of Efficacy|1|||
19737509|NCT00127127|42184380|FG001|Overall Study|Lack of Efficacy|3|||
19737510|NCT00127127|42184381|FG002|Overall Study|Lack of Efficacy|0|||
19737511|NCT00127127|42184382|FG003|Overall Study|Lack of Efficacy|2|||
19737512|NCT03669549|42184419|FG000|Overall Study|Adverse Event|4|||
19737513|NCT03669549|42184419|FG000|Overall Study|Withdrawal by Subject|1|||
19737514|NCT03669549|42184419|FG000|Overall Study|Study terminated by the Sponsor|1|||
19737515|NCT00126659|42184430|FG000|Overall Study|Adverse Event|0|||
19737516|NCT00126659|42184431|FG001|Overall Study|Adverse Event|0|||
19737517|NCT00126659|42184432|FG002|Overall Study|Adverse Event|2|||
19737518|NCT04022733|42184440|FG000|Overall Study|conversion to open surgery|3|||
19737519|NCT04022733|42184441|FG001|Overall Study|conversion to open surgery|2|||
19737520|NCT04022733|42184440|FG000|Overall Study|bradycardia|0|||
19737521|NCT04022733|42184441|FG001|Overall Study|bradycardia|1|||
19737522|NCT03669081|42184449|FG000|Overall Study|Data could not be validated|1|||
19737523|NCT03669081|42184450|FG001|Overall Study|Data could not be validated|1|||
19737524|NCT03667053|42184459|FG000|Overall Study|Withdrawal by Subject|1|||
19737525|NCT03667053|42184460|FG001|Overall Study|Withdrawal by Subject|0|||
19737526|NCT03667053|42184461|FG002|Overall Study|Withdrawal by Subject|0|||
19737527|NCT03631407|42184478|FG000|Overall Study|Withdrawal by Subject|3|||
19737528|NCT03631407|42184479|FG001|Overall Study|Withdrawal by Subject|2|||
19737529|NCT03631407|42184478|FG000|Overall Study|Sponsor Decision|0|||
19737530|NCT03631407|42184479|FG001|Overall Study|Sponsor Decision|2|||
19737531|NCT03631407|42184478|FG000|Overall Study|Death|16|||
19737532|NCT03631407|42184479|FG001|Overall Study|Death|16|||
19737533|NCT03631407|42184478|FG000|Overall Study|Randomized by mistake without study treatment|1|||
19737534|NCT03631407|42184479|FG001|Overall Study|Randomized by mistake without study treatment|0|||
19737535|NCT03630393|42184496|FG000|Overall Study|Death|1|||
19737536|NCT03630393|42184497|FG001|Overall Study|Death|0|||
19737537|NCT03628599|42184514|FG000|Overall Study|Adverse Event|0|||
19737538|NCT03628599|42184515|FG001|Overall Study|Adverse Event|1|||
19737539|NCT03627195|42184541|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
19737540|NCT03627195|42184542|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
19737541|NCT03627195|42184543|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
19737542|NCT03627195|42184544|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
19737543|NCT03627195|42184545|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
19737544|NCT03627195|42184546|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
19737545|NCT00126581|42184562|FG000|Overall Study|Adverse Event|3|||
19737546|NCT00126581|42184563|FG001|Overall Study|Adverse Event|7|||
19737547|NCT00126581|42184562|FG000|Overall Study|Death|3|||
19737548|NCT00126581|42184563|FG001|Overall Study|Death|2|||
19737549|NCT00126581|42184562|FG000|Overall Study|Withdrawal by Subject|1|||
19737550|NCT00126581|42184563|FG001|Overall Study|Withdrawal by Subject|4|||
19737551|NCT00126581|42184562|FG000|Overall Study|Alternative therapy|3|||
19737552|NCT00126581|42184563|FG001|Overall Study|Alternative therapy|3|||
19737553|NCT00126581|42184562|FG000|Overall Study|Other illness/MD discretion|3|||
19737554|NCT00126581|42184563|FG001|Overall Study|Other illness/MD discretion|4|||
19737555|NCT03704584|42184573|FG000|Overall Study|Withdrawal by Subject|1|||
19737556|NCT03704584|42184574|FG001|Overall Study|Withdrawal by Subject|0|||
19737557|NCT03662997|42184584|FG000|Overall Study|Adverse Event|0|||
19737558|NCT03662997|42184585|FG001|Overall Study|Adverse Event|2|||
19737559|NCT03662997|42184586|FG002|Overall Study|Adverse Event|0|||
19737560|NCT03662997|42184587|FG003|Overall Study|Adverse Event|0|||
19737561|NCT03648879|42184599|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
19737562|NCT03647709|42184603|FG000|Overall Study|Lost to Follow-up|5|||
19737563|NCT03647709|42184603|FG000|Overall Study|Physician Decision|6|||
19737564|NCT03647709|42184603|FG000|Overall Study|Withdrawal by Subject|3|||
19737565|NCT03661983|42184609|FG000|Open Label Stabilization Phase|Adverse Event|5|||
19737566|NCT03661983|42184610|FG001|Open Label Stabilization Phase|Adverse Event|0|||
19737567|NCT03661983|42184611|FG002|Open Label Stabilization Phase|Adverse Event|0|||
19737568|NCT03661983|42184612|FG003|Open Label Stabilization Phase|Adverse Event|0|||
19737569|NCT03661983|42184609|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
19737570|NCT03661983|42184610|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
19737571|NCT03661983|42184611|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
19737572|NCT03661983|42184612|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
19737573|NCT03661983|42184609|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
19737574|NCT03661983|42184610|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
19737575|NCT03661983|42184611|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
19737576|NCT03661983|42184612|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
19737577|NCT03661983|42184609|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
19737578|NCT03661983|42184610|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
19737579|NCT03661983|42184611|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
19737580|NCT03661983|42184612|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
19737581|NCT03661983|42184609|FG000|Double-blind Randomized Phase|Adverse Event|0|||
19737582|NCT03661983|42184610|FG001|Double-blind Randomized Phase|Adverse Event|1|||
19737583|NCT03661983|42184611|FG002|Double-blind Randomized Phase|Adverse Event|0|||
19737584|NCT03661983|42184612|FG003|Double-blind Randomized Phase|Adverse Event|0|||
19737585|NCT03661983|42184609|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
19737586|NCT03661983|42184610|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
19737587|NCT03661983|42184611|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
19737588|NCT03661983|42184612|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
19737589|NCT03661983|42184609|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
19737590|NCT03661983|42184610|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
19737591|NCT03661983|42184611|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
19737592|NCT03661983|42184612|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
19737593|NCT03661983|42184609|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
19737594|NCT03661983|42184610|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
19737595|NCT03661983|42184611|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
19737596|NCT03661983|42184612|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
19737597|NCT02783170|42184623|FG000|Overall Study|Randomized but not Vaccinated|1|||
19737598|NCT02783170|42184624|FG001|Overall Study|Randomized but not Vaccinated|0|||
19737599|NCT03646305|42184635|FG000|Overall Study|Lost to Follow-up|4|||
19737600|NCT03646305|42184636|FG001|Overall Study|Lost to Follow-up|2|||
19737601|NCT03646305|42184637|FG002|Overall Study|Lost to Follow-up|2|||
19737602|NCT03646305|42184638|FG003|Overall Study|Lost to Follow-up|1|||
19737603|NCT03646305|42184635|FG000|Overall Study|Withdrawal by Subject|1|||
19737604|NCT03646305|42184636|FG001|Overall Study|Withdrawal by Subject|0|||
19737605|NCT03646305|42184637|FG002|Overall Study|Withdrawal by Subject|0|||
19737606|NCT03646305|42184638|FG003|Overall Study|Withdrawal by Subject|1|||
19737607|NCT02782780|42184654|FG000|Overall Study|dropped out after randomization.|7|||
19737608|NCT02782780|42184655|FG001|Overall Study|dropped out after randomization.|5|||
19737609|NCT02782780|42184654|FG000|Overall Study|Protocol Violation|0|||
19737610|NCT02782780|42184655|FG001|Overall Study|Protocol Violation|2|||
19737611|NCT00126503|42184667|FG000|Overall Study|disease progression|23|||
19737612|NCT00126503|42184668|FG001|Overall Study|disease progression|14|||
19737613|NCT00126503|42184667|FG000|Overall Study|Withdrawal by Subject|0|||
19737614|NCT00126503|42184668|FG001|Overall Study|Withdrawal by Subject|1|||
19737615|NCT00126503|42184667|FG000|Overall Study|alternative therapy|1|||
19737616|NCT00126503|42184668|FG001|Overall Study|alternative therapy|1|||
19737617|NCT00126503|42184667|FG000|Overall Study|other complicating disease|4|||
19737618|NCT00126503|42184668|FG001|Overall Study|other complicating disease|1|||
19737619|NCT00126503|42184667|FG000|Overall Study|Death|3|||
19737620|NCT00126503|42184668|FG001|Overall Study|Death|0|||
19737621|NCT00126503|42184667|FG000|Overall Study|Adverse Event|13|||
19737622|NCT00126503|42184668|FG001|Overall Study|Adverse Event|3|||
19737623|NCT00126503|42184667|FG000|Overall Study|non-compliant|1|||
19737624|NCT00126503|42184668|FG001|Overall Study|non-compliant|0|||
19737625|NCT00126503|42184667|FG000|Overall Study|Physician Decision|2|||
19737626|NCT00126503|42184668|FG001|Overall Study|Physician Decision|1|||
19737627|NCT00126425|42184680|FG000|Overall Study|Withdrawal by Subject|17|||
19737628|NCT00126425|42184681|FG001|Overall Study|Withdrawal by Subject|1|||
19737629|NCT00126425|42184680|FG000|Overall Study|Lost to Follow-up|8|||
19737630|NCT00126425|42184681|FG001|Overall Study|Lost to Follow-up|4|||
19737631|NCT00126425|42184680|FG000|Overall Study|Protocol Violation|9|||
19737632|NCT00126425|42184681|FG001|Overall Study|Protocol Violation|6|||
19737633|NCT00126425|42184680|FG000|Overall Study|Adverse Event|1|||
19737634|NCT00126425|42184681|FG001|Overall Study|Adverse Event|0|||
19737635|NCT00126425|42184680|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
19737636|NCT00126425|42184681|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
19737637|NCT00126425|42184680|FG000|Overall Study|Other|5|||
19737638|NCT00126425|42184681|FG001|Overall Study|Other|0|||
19737639|NCT00126191|42184689|FG000|Overall Study|Physician Decision|0|||
19737640|NCT00126191|42184690|FG001|Overall Study|Physician Decision|1|||
19737641|NCT00126191|42184689|FG000|Overall Study|Death|0|||
19737642|NCT00126191|42184690|FG001|Overall Study|Death|1|||
19737643|NCT03248128|42184698|FG000|Overall Study|Lost to Follow-up|1|||
19737644|NCT03248128|42184699|FG001|Overall Study|Lost to Follow-up|0|||
19737645|NCT03248128|42184698|FG000|Overall Study|Withdrawal by Subject|16|||
19737646|NCT03248128|42184699|FG001|Overall Study|Withdrawal by Subject|14|||
19737647|NCT03248128|42184698|FG000|Overall Study|Site Closed|4|||
19737648|NCT03248128|42184699|FG001|Overall Study|Site Closed|3|||
19737649|NCT03248128|42184698|FG000|Overall Study|Randomized, but did not receive treatment|1|||
19737650|NCT03248128|42184699|FG001|Overall Study|Randomized, but did not receive treatment|3|||
19380933|NCT03463993|41624169|FG000|Overall Study|Withdrawal by Subject|2|||
19380934|NCT03463993|41624170|FG001|Overall Study|Withdrawal by Subject|0|||
19380935|NCT03463993|41624169|FG000|Overall Study|Protocol Violation|4|||
19380936|NCT03463993|41624170|FG001|Overall Study|Protocol Violation|1|||
19380937|NCT03463993|41624169|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
19380938|NCT03463993|41624170|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
19380939|NCT03463993|41624169|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
19380940|NCT03463993|41624170|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
19465304|NCT04426695|41723744|FG003|Overall Study|Randomized but Never Treated|4|||
19737651|NCT00124943|42184712|FG000|Phase II|Adverse Event|0|||
19737652|NCT00124943|42184713|FG001|Phase II|Adverse Event|2|||
19737653|NCT00124943|42184714|FG002|Phase II|Adverse Event|0|||
19737654|NCT00124943|42184715|FG003|Phase II|Adverse Event|1|||
19737655|NCT00124943|42184712|FG000|Phase II|Protocol Violation|0|||
19737656|NCT00124943|42184713|FG001|Phase II|Protocol Violation|0|||
19737657|NCT00124943|42184714|FG002|Phase II|Protocol Violation|0|||
19737658|NCT00124943|42184715|FG003|Phase II|Protocol Violation|1|||
19737659|NCT00124943|42184712|FG000|Phase II|Lost to Follow-up|0|||
19737660|NCT00124943|42184713|FG001|Phase II|Lost to Follow-up|0|||
19737661|NCT00124943|42184714|FG002|Phase II|Lost to Follow-up|0|||
19737662|NCT00124943|42184715|FG003|Phase II|Lost to Follow-up|1|||
19737663|NCT00124943|42184712|FG000|Phase II|Withdrawal by Subject|0|||
19737664|NCT00124943|42184713|FG001|Phase II|Withdrawal by Subject|0|||
19737665|NCT00124943|42184714|FG002|Phase II|Withdrawal by Subject|0|||
19737666|NCT00124943|42184715|FG003|Phase II|Withdrawal by Subject|2|||
19737667|NCT00124709|42184727|FG000|Overall Study|Randomized but did not take medication|3|||
19737668|NCT00124709|42184728|FG001|Overall Study|Randomized but did not take medication|1|||
19737669|NCT00124709|42184727|FG000|Overall Study|Adverse Event|3|||
19737670|NCT00124709|42184728|FG001|Overall Study|Adverse Event|0|||
19737671|NCT00124709|42184727|FG000|Overall Study|Lack of Efficacy|5|||
19737672|NCT00124709|42184728|FG001|Overall Study|Lack of Efficacy|10|||
19737673|NCT00124709|42184727|FG000|Overall Study|Protocol Violation|3|||
19737674|NCT00124709|42184728|FG001|Overall Study|Protocol Violation|5|||
19737675|NCT00124709|42184727|FG000|Overall Study|Withdrawal by Subject|127|||
19737676|NCT00124709|42184728|FG001|Overall Study|Withdrawal by Subject|136|||
19737677|NCT00124709|42184727|FG000|Overall Study|Lost to Follow-up|114|||
19737678|NCT00124709|42184728|FG001|Overall Study|Lost to Follow-up|120|||
19737679|NCT00108862|42184736|FG000|Overall Study|Death|31|||
19737680|NCT00108862|42184737|FG001|Overall Study|Death|37|||
19737681|NCT00108862|42184736|FG000|Overall Study|Withdrawal by Subject|10|||
19737682|NCT00108862|42184737|FG001|Overall Study|Withdrawal by Subject|6|||
19737683|NCT00108862|42184736|FG000|Overall Study|Lost to Follow-up|27|||
19737684|NCT00108862|42184737|FG001|Overall Study|Lost to Follow-up|19|||
19737685|NCT00564850|42184743|FG000|Overall Study|Protocol Violation|2|||
19737686|NCT00561340|42184749|FG000|Overall Study|refused to drink pediasure|6|||
19737687|NCT00561340|42184750|FG001|Overall Study|refused to drink pediasure|0|||
19737688|NCT00108628|42184758|FG000|Overall Study|Withdrawal by Subject|17|||
19737689|NCT00108628|42184759|FG001|Overall Study|Withdrawal by Subject|9|||
19737690|NCT00108628|42184758|FG000|Overall Study|Lack of Efficacy|2|||
19737691|NCT00108628|42184759|FG001|Overall Study|Lack of Efficacy|1|||
19737692|NCT00108628|42184758|FG000|Overall Study|Death|1|||
19737693|NCT00108628|42184759|FG001|Overall Study|Death|0|||
19737694|NCT02715856|42184767|FG000|Overall Study|Software Issues|12|||
19737695|NCT02715856|42184768|FG001|Overall Study|Software Issues|7|||
19737696|NCT02715856|42184767|FG000|Overall Study|Death|6|||
19737697|NCT02715856|42184768|FG001|Overall Study|Death|5|||
19737698|NCT02715856|42184767|FG000|Overall Study|Non- Compliant|0|||
19737699|NCT02715856|42184768|FG001|Overall Study|Non- Compliant|40|||
19737700|NCT00108160|42184776|FG000|Overall Study|Lost to Follow-up|25|||
19737701|NCT00108160|42184777|FG001|Overall Study|Lost to Follow-up|12|||
19737702|NCT00108160|42184776|FG000|Overall Study|Death|1|||
19737703|NCT00108160|42184777|FG001|Overall Study|Death|2|||
19737704|NCT00108160|42184776|FG000|Overall Study|Withdrawal by Subject|4|||
19737705|NCT00108160|42184777|FG001|Overall Study|Withdrawal by Subject|2|||
19737706|NCT00108160|42184776|FG000|Overall Study|Protocol Violation|9|||
19737707|NCT00108160|42184777|FG001|Overall Study|Protocol Violation|5|||
19737708|NCT01366846|42184789|FG000|Overall Study|Withdrawal by Subject|2|||
19737709|NCT01366846|42184790|FG001|Overall Study|Withdrawal by Subject|0|||
19737710|NCT01366846|42184791|FG002|Overall Study|Withdrawal by Subject|0|||
19737711|NCT01366846|42184792|FG003|Overall Study|Withdrawal by Subject|0|||
19737712|NCT01366846|42184789|FG000|Overall Study|Communication Difficulties|1|||
19737713|NCT01366846|42184790|FG001|Overall Study|Communication Difficulties|4|||
19737714|NCT01366846|42184791|FG002|Overall Study|Communication Difficulties|0|||
19737715|NCT01366846|42184792|FG003|Overall Study|Communication Difficulties|1|||
19737716|NCT01366846|42184789|FG000|Overall Study|Scheduling Conflicts|0|||
19737717|NCT01366846|42184790|FG001|Overall Study|Scheduling Conflicts|0|||
19737718|NCT01366846|42184791|FG002|Overall Study|Scheduling Conflicts|1|||
19737719|NCT01366846|42184792|FG003|Overall Study|Scheduling Conflicts|0|||
19737720|NCT00108082|42184808|FG000|Overall Study|Adverse Event|14|||
19737721|NCT00108082|42184809|FG001|Overall Study|Adverse Event|12|||
19737722|NCT00108082|42184810|FG002|Overall Study|Adverse Event|17|||
19737723|NCT00108082|42184808|FG000|Overall Study|Lost to Follow-up|6|||
19737724|NCT00108082|42184809|FG001|Overall Study|Lost to Follow-up|3|||
19737725|NCT00108082|42184810|FG002|Overall Study|Lost to Follow-up|7|||
19737726|NCT00108082|42184808|FG000|Overall Study|Consent Withdrawn|3|||
19737727|NCT00108082|42184809|FG001|Overall Study|Consent Withdrawn|3|||
19737728|NCT00108082|42184810|FG002|Overall Study|Consent Withdrawn|5|||
19737729|NCT00108082|42184808|FG000|Overall Study|Protocol Violation|1|||
19737730|NCT00108082|42184809|FG001|Overall Study|Protocol Violation|2|||
19737731|NCT00108082|42184810|FG002|Overall Study|Protocol Violation|0|||
19737732|NCT00108082|42184808|FG000|Overall Study|Lack of Efficacy|3|||
19737733|NCT00108082|42184809|FG001|Overall Study|Lack of Efficacy|1|||
19737734|NCT00108082|42184810|FG002|Overall Study|Lack of Efficacy|2|||
19737735|NCT00108082|42184808|FG000|Overall Study|Amendment 4: > Month 12|5|||
19737736|NCT00108082|42184809|FG001|Overall Study|Amendment 4: > Month 12|7|||
19737737|NCT00108082|42184810|FG002|Overall Study|Amendment 4: > Month 12|5|||
19737738|NCT00108082|42184808|FG000|Overall Study|Woman of Child-bearing Potential|2|||
19737739|NCT00108082|42184809|FG001|Overall Study|Woman of Child-bearing Potential|0|||
19737740|NCT00108082|42184810|FG002|Overall Study|Woman of Child-bearing Potential|2|||
19737741|NCT00108082|42184808|FG000|Overall Study|Incorrectly Randomized|0|||
19737742|NCT00108082|42184809|FG001|Overall Study|Incorrectly Randomized|0|||
19737743|NCT00108082|42184810|FG002|Overall Study|Incorrectly Randomized|2|||
19737744|NCT00108082|42184808|FG000|Overall Study|Non-compliance|1|||
19380941|NCT02412488|41624185|FG000|Overall Study|Lost to Follow-up|10|||
19478088|NCT01693562|41757334|FG020|Exploration Phase|Other|0|||
19737745|NCT00108082|42184809|FG001|Overall Study|Non-compliance|0|||
19737746|NCT00108082|42184810|FG002|Overall Study|Non-compliance|2|||
19737747|NCT00108082|42184808|FG000|Overall Study|Stopped Study Medication|0|||
19737748|NCT00108082|42184809|FG001|Overall Study|Stopped Study Medication|0|||
19737749|NCT00108082|42184810|FG002|Overall Study|Stopped Study Medication|1|||
19737750|NCT00108082|42184808|FG000|Overall Study|Site Closed Study|0|||
19737751|NCT00108082|42184809|FG001|Overall Study|Site Closed Study|2|||
19737752|NCT00108082|42184810|FG002|Overall Study|Site Closed Study|0|||
19737753|NCT00108082|42184808|FG000|Overall Study|Protocol Amendment|0|||
19737754|NCT00108082|42184809|FG001|Overall Study|Protocol Amendment|1|||
19737755|NCT00108082|42184810|FG002|Overall Study|Protocol Amendment|0|||
19737756|NCT00108082|42184808|FG000|Overall Study|Study Medication Not Tapered|0|||
19737757|NCT00108082|42184809|FG001|Overall Study|Study Medication Not Tapered|1|||
19737758|NCT00108082|42184810|FG002|Overall Study|Study Medication Not Tapered|0|||
19737759|NCT00108082|42184808|FG000|Overall Study|Subject Left Site Location|1|||
19737760|NCT00108082|42184809|FG001|Overall Study|Subject Left Site Location|0|||
19737761|NCT00108082|42184810|FG002|Overall Study|Subject Left Site Location|0|||
19737762|NCT00108082|42184808|FG000|Overall Study|Investigator Not at Site|1|||
19737763|NCT00108082|42184809|FG001|Overall Study|Investigator Not at Site|0|||
19737764|NCT00108082|42184810|FG002|Overall Study|Investigator Not at Site|0|||
19737765|NCT00108082|42184808|FG000|Overall Study|Blood Pressure Not Controlled|1|||
19737766|NCT00108082|42184809|FG001|Overall Study|Blood Pressure Not Controlled|0|||
19737767|NCT00108082|42184810|FG002|Overall Study|Blood Pressure Not Controlled|0|||
19737768|NCT00104884|42184818|FG000|Overall Study|Disease progression|4|||
19737769|NCT00104728|42184826|FG000|Overall Study|screen failures|19|||
19737770|NCT02781844|42184834|FG000|Treatment Period 1|Adverse Event|0|||
19737771|NCT02781844|42184835|FG001|Treatment Period 1|Adverse Event|0|||
19737772|NCT02781844|42184836|FG002|Treatment Period 1|Adverse Event|0|||
19737773|NCT02781844|42184837|FG003|Treatment Period 1|Adverse Event|0|||
19737774|NCT02781844|42184838|FG004|Treatment Period 1|Adverse Event|0|||
19737775|NCT02781844|42184839|FG005|Treatment Period 1|Adverse Event|1|||
19737776|NCT02781844|42184840|FG006|Treatment Period 1|Adverse Event|0|||
19737777|NCT02781844|42184841|FG007|Treatment Period 1|Adverse Event|0|||
19737778|NCT02775916|42184859|FG000|Overall Study|Adverse Event|1|||
19737779|NCT02775916|42184860|FG001|Overall Study|Adverse Event|0|||
19737780|NCT02775916|42184859|FG000|Overall Study|Subject/Guardian Decision|2|||
19737781|NCT02775916|42184860|FG001|Overall Study|Subject/Guardian Decision|0|||
19737782|NCT03622593|42184869|FG000|Overall Study|Withdrawal by Subject|11|||
19737783|NCT03622593|42184870|FG001|Overall Study|Withdrawal by Subject|9|||
19737784|NCT03622593|42184871|FG002|Overall Study|Withdrawal by Subject|13|||
19737785|NCT03622593|42184869|FG000|Overall Study|Death|12|||
19737786|NCT03622593|42184870|FG001|Overall Study|Death|9|||
19737787|NCT03622593|42184871|FG002|Overall Study|Death|10|||
19737788|NCT03622593|42184869|FG000|Overall Study|Lost to Follow-up|11|||
19737789|NCT03622593|42184870|FG001|Overall Study|Lost to Follow-up|5|||
19737790|NCT03622593|42184871|FG002|Overall Study|Lost to Follow-up|8|||
19737791|NCT03622593|42184869|FG000|Overall Study|Adverse Event|4|||
19737792|NCT03622593|42184870|FG001|Overall Study|Adverse Event|5|||
19737793|NCT03622593|42184871|FG002|Overall Study|Adverse Event|6|||
19737794|NCT03622593|42184869|FG000|Overall Study|Physician Decision|2|||
19737795|NCT03622593|42184870|FG001|Overall Study|Physician Decision|1|||
19737796|NCT03622593|42184871|FG002|Overall Study|Physician Decision|6|||
19737797|NCT03622593|42184869|FG000|Overall Study|Other|2|||
19737798|NCT03622593|42184870|FG001|Overall Study|Other|2|||
19737799|NCT03622593|42184871|FG002|Overall Study|Other|3|||
19737800|NCT03622593|42184869|FG000|Overall Study|Protocol Violation|0|||
19737801|NCT03622593|42184870|FG001|Overall Study|Protocol Violation|0|||
19737802|NCT03622593|42184871|FG002|Overall Study|Protocol Violation|1|||
19737803|NCT03622593|42184869|FG000|Overall Study|Pregnancy|0|||
19737804|NCT03622593|42184870|FG001|Overall Study|Pregnancy|0|||
19737805|NCT03622593|42184871|FG002|Overall Study|Pregnancy|1|||
19737806|NCT00122681|42184882|FG000|Overall Study|Adverse Event|20|||
19737807|NCT00122681|42184883|FG001|Overall Study|Adverse Event|16|||
19737808|NCT00122681|42184882|FG000|Overall Study|Lost to Follow-up|1080|||
19737809|NCT00122681|42184883|FG001|Overall Study|Lost to Follow-up|1097|||
19737810|NCT00122681|42184882|FG000|Overall Study|Protocol Violation|7|||
19737811|NCT00122681|42184883|FG001|Overall Study|Protocol Violation|10|||
19737812|NCT00122681|42184882|FG000|Overall Study|Withdrawal by Subject|257|||
19737813|NCT00122681|42184883|FG001|Overall Study|Withdrawal by Subject|251|||
19737814|NCT00122681|42184882|FG000|Overall Study|Personal reasons|150|||
19737815|NCT00122681|42184883|FG001|Overall Study|Personal reasons|147|||
19737816|NCT02774278|42184897|FG000|Overall Study|Lack of Efficacy|199|||
19737817|NCT02774278|42184897|FG000|Overall Study|Death|29|||
19737818|NCT02774278|42184897|FG000|Overall Study|Adverse event/intercurrent illness|16|||
19737819|NCT02774278|42184897|FG000|Overall Study|Refused treatment/did not cooperate|9|||
19737820|NCT02774278|42184897|FG000|Overall Study|Administrative reasons|6|||
19737821|NCT02774278|42184897|FG000|Overall Study|Withdrawal by Subject|3|||
19737822|NCT02774278|42184897|FG000|Overall Study|Protocol Violation|2|||
19737823|NCT03621189|42184903|FG000|Overall Study|Withdrawal by Subject|0|||
19465305|NCT04426695|41723745|FG004|Overall Study|Randomized but Never Treated|5|||
19737824|NCT03621189|42184904|FG001|Overall Study|Withdrawal by Subject|3|||
19737825|NCT03621189|42184903|FG000|Overall Study|Physician Decision|0|||
19737826|NCT03621189|42184904|FG001|Overall Study|Physician Decision|2|||
19737827|NCT00122135|42184913|FG000|Overall Study|Withdrawal by Subject|3|||
19737828|NCT00122135|42184914|FG001|Overall Study|Withdrawal by Subject|0|||
19380942|NCT02412488|41624185|FG000|Overall Study|Withdrawal by Subject|5|||
19737829|NCT03645057|42184924|FG000|Randomization to Baseline|Lost to Follow-up|1|||
19737830|NCT03645057|42184925|FG001|Randomization to Baseline|Lost to Follow-up|0|||
19737831|NCT03645057|42184926|FG002|Randomization to Baseline|Lost to Follow-up|1|||
19737832|NCT03645057|42184927|FG003|Randomization to Baseline|Lost to Follow-up|0|||
19737833|NCT03645057|42184924|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
19737834|NCT03645057|42184925|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
19737835|NCT03645057|42184926|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
19737836|NCT03645057|42184927|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
19737837|NCT03645057|42184924|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
19737838|NCT03645057|42184925|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
19737839|NCT03645057|42184926|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
19737840|NCT03645057|42184927|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
19737841|NCT03645057|42184924|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
19737842|NCT03645057|42184925|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
19737843|NCT03645057|42184926|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
19737844|NCT03645057|42184927|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
19737845|NCT00132041|42184933|FG000|Baseline|Ineligible|6|||
19737846|NCT00132041|42184933|FG000|3 Months Post Ablation|Transplant|1|||
19737847|NCT00132041|42184933|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
19737848|NCT00132041|42184933|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
19737849|NCT00132041|42184933|FG000|6 Months Post Ablation|Death|2|||
19737850|NCT00132041|42184933|FG000|6 Months Post Ablation|Transplant|6|||
19737851|NCT00132041|42184933|FG000|9 Months Post Ablation|Death|1|||
19737852|NCT00132041|42184933|FG000|9 Months Post Ablation|Transplant|1|||
19737853|NCT00132041|42184933|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
19737854|NCT00132041|42184933|FG000|12 Months Post Ablation|Death|1|||
19737855|NCT00132041|42184933|FG000|12 Months Post Ablation|Transplant|1|||
19737856|NCT00132041|42184933|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
19737857|NCT00132041|42184933|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
19737858|NCT00132041|42184933|FG000|15 Months Post Ablation|Death|1|||
19737859|NCT00132041|42184933|FG000|15 Months Post Ablation|Transplant|5|||
19737860|NCT00132041|42184933|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
19737861|NCT00132041|42184933|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
19737862|NCT00132041|42184933|FG000|18 Months Post Ablation|Transplant|1|||
19737863|NCT00132041|42184933|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
19737864|NCT00132041|42184933|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
19737865|NCT03643575|42184943|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
19737866|NCT03643575|42184944|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
19737867|NCT03643575|42184945|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
19737868|NCT03643575|42184946|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
19737869|NCT03643575|42184947|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
19737870|NCT03643575|42184948|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
19737871|NCT03643575|42184943|FG000|Washout: 7 Days|Adverse Event|1|||
19737872|NCT03643575|42184944|FG001|Washout: 7 Days|Adverse Event|0|||
19737873|NCT03643575|42184945|FG002|Washout: 7 Days|Adverse Event|0|||
19737874|NCT03643575|42184946|FG003|Washout: 7 Days|Adverse Event|0|||
19737875|NCT03643575|42184947|FG004|Washout: 7 Days|Adverse Event|0|||
19737876|NCT03643575|42184948|FG005|Washout: 7 Days|Adverse Event|0|||
19737877|NCT03643575|42184943|FG000|Washout: 7 Days|Non compliance check in|0|||
19737878|NCT03643575|42184944|FG001|Washout: 7 Days|Non compliance check in|1|||
19737879|NCT03643575|42184945|FG002|Washout: 7 Days|Non compliance check in|0|||
19737880|NCT03643575|42184946|FG003|Washout: 7 Days|Non compliance check in|0|||
19737881|NCT03643575|42184947|FG004|Washout: 7 Days|Non compliance check in|0|||
19737882|NCT03643575|42184948|FG005|Washout: 7 Days|Non compliance check in|0|||
19737883|NCT02768194|42184956|FG000|Period 1|Adverse Event|0|||
19737884|NCT02768194|42184957|FG001|Period 1|Adverse Event|0|||
19737885|NCT02768194|42184958|FG002|Period 1|Adverse Event|0|||
19737886|NCT02768194|42184959|FG003|Period 1|Adverse Event|1|||
19737887|NCT02768194|42184960|FG004|Period 1|Adverse Event|0|||
19737888|NCT02768194|42184961|FG005|Period 1|Adverse Event|0|||
19737889|NCT02768194|42184956|FG000|Period 2|Other (Reason not specified)|1|||
19737890|NCT02768194|42184957|FG001|Period 2|Other (Reason not specified)|0|||
19737891|NCT02768194|42184958|FG002|Period 2|Other (Reason not specified)|0|||
19737892|NCT02768194|42184959|FG003|Period 2|Other (Reason not specified)|0|||
19737893|NCT02768194|42184960|FG004|Period 2|Other (Reason not specified)|0|||
19737894|NCT02768194|42184961|FG005|Period 2|Other (Reason not specified)|0|||
19737895|NCT02768194|42184956|FG000|Period 3|Other (Reason not specified)|0|||
19737896|NCT02768194|42184957|FG001|Period 3|Other (Reason not specified)|1|||
19737897|NCT02768194|42184958|FG002|Period 3|Other (Reason not specified)|0|||
19737898|NCT02768194|42184959|FG003|Period 3|Other (Reason not specified)|0|||
19737899|NCT02768194|42184960|FG004|Period 3|Other (Reason not specified)|0|||
19737900|NCT02768194|42184961|FG005|Period 3|Other (Reason not specified)|0|||
19737901|NCT00130793|42184971|FG000|Overall Study|Lost to Follow-up|1|||
19737902|NCT00130793|42184972|FG001|Overall Study|Lost to Follow-up|4|||
19737903|NCT00130793|42184971|FG000|Overall Study|Withdrew consent|2|||
19737904|NCT00130793|42184972|FG001|Overall Study|Withdrew consent|0|||
19737905|NCT03818399|42184979|FG000|Overall Study|Lost to Follow-up|11|||
19737906|NCT03818399|42184979|FG000|Overall Study|Withdrawal by Subject|1|||
19737907|NCT03818399|42184979|FG000|Overall Study|Protocol Violation|2|||
19737908|NCT03642873|42184983|FG000|Third Intervention (1 Day)|Screen failure|0|||
19737909|NCT03642873|42184984|FG001|Third Intervention (1 Day)|Screen failure|0|||
19737910|NCT03642873|42184985|FG002|Third Intervention (1 Day)|Screen failure|0|||
19737911|NCT03642873|42184986|FG003|Third Intervention (1 Day)|Screen failure|0|||
19737912|NCT03642873|42184987|FG004|Third Intervention (1 Day)|Screen failure|1|||
19737913|NCT03642873|42184988|FG005|Third Intervention (1 Day)|Screen failure|0|||
19737914|NCT03818321|42185002|FG000|Overall Study|Withdrawal by Subject|1|||
19737915|NCT03818321|42185003|FG001|Overall Study|Withdrawal by Subject|2|||
19737916|NCT03616977|42185009|FG000|Period 1|Physician Decision|0|||
19737917|NCT03616977|42185010|FG001|Period 1|Physician Decision|1|||
19737918|NCT03616977|42185009|FG000|Period 3|Adverse Event|1|||
19737919|NCT03616977|42185010|FG001|Period 3|Adverse Event|1|||
19737920|NCT02767570|42185019|FG000|Overall Study|Lost to Follow-up|3|||
19737921|NCT02767570|42185020|FG001|Overall Study|Lost to Follow-up|0|||
19737922|NCT02767570|42185019|FG000|Overall Study|COVID shutdown|2|||
19737923|NCT02767570|42185020|FG001|Overall Study|COVID shutdown|5|||
19737924|NCT02767570|42185019|FG000|Overall Study|Increased pain|2|||
19737925|NCT02767570|42185020|FG001|Overall Study|Increased pain|0|||
19737926|NCT02767570|42185019|FG000|Overall Study|Withdrawal by Subject|1|||
19737927|NCT02767570|42185020|FG001|Overall Study|Withdrawal by Subject|3|||
19737928|NCT02767570|42185019|FG000|Overall Study|Unrelated medical issue|1|||
19737929|NCT02767570|42185020|FG001|Overall Study|Unrelated medical issue|1|||
19737930|NCT02767570|42185019|FG000|Overall Study|Received intra-articular injection|0|||
19737931|NCT02767570|42185020|FG001|Overall Study|Received intra-articular injection|1|||
19737932|NCT03816761|42185029|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
19737933|NCT03816761|42185030|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
19737934|NCT03816761|42185031|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
19737935|NCT03816761|42185032|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
19737936|NCT03816761|42185033|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
19737937|NCT03816761|42185034|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
19737938|NCT03816761|42185029|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
19737939|NCT03816761|42185030|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
19737940|NCT03816761|42185031|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
19737941|NCT03816761|42185032|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
19737942|NCT03816761|42185033|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
19737943|NCT03816761|42185034|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
19737944|NCT02770612|42185056|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
19737945|NCT03575871|42185063|FG000|Overall Study|Adverse Event|5|||
19737946|NCT03575871|42185064|FG001|Overall Study|Adverse Event|5|||
19737947|NCT03575871|42185065|FG002|Overall Study|Adverse Event|8|||
19737948|NCT03575871|42185063|FG000|Overall Study|Death|1|||
19737949|NCT03575871|42185064|FG001|Overall Study|Death|0|||
19737950|NCT03575871|42185065|FG002|Overall Study|Death|0|||
19737951|NCT03575871|42185063|FG000|Overall Study|Lack of Efficacy|5|||
19737952|NCT03575871|42185064|FG001|Overall Study|Lack of Efficacy|4|||
19737953|NCT03575871|42185065|FG002|Overall Study|Lack of Efficacy|7|||
19737954|NCT03575871|42185063|FG000|Overall Study|Lost to Follow-up|1|||
19737955|NCT03575871|42185064|FG001|Overall Study|Lost to Follow-up|1|||
19737956|NCT03575871|42185065|FG002|Overall Study|Lost to Follow-up|1|||
19737957|NCT03575871|42185063|FG000|Overall Study|Protocol Deviation|1|||
19737958|NCT03575871|42185064|FG001|Overall Study|Protocol Deviation|1|||
19737959|NCT03575871|42185065|FG002|Overall Study|Protocol Deviation|1|||
19737960|NCT03575871|42185063|FG000|Overall Study|Withdrawal by Subject|6|||
19737961|NCT03575871|42185064|FG001|Overall Study|Withdrawal by Subject|1|||
19737962|NCT03575871|42185065|FG002|Overall Study|Withdrawal by Subject|9|||
19737963|NCT03575871|42185063|FG000|Overall Study|Other than specified|2|||
19737964|NCT03575871|42185064|FG001|Overall Study|Other than specified|2|||
19737965|NCT03575871|42185065|FG002|Overall Study|Other than specified|0|||
19737966|NCT03642717|42185073|FG000|Overall Study|Lost to Follow-up|2|||
19737967|NCT03642717|42185073|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
19737968|NCT03642717|42185073|FG000|Overall Study|Taken study drug prior to contract date|3|||
19737969|NCT02766478|42185080|FG000|Overall Study|Withdrawal by Subject|1|||
19737970|NCT02766478|42185081|FG001|Overall Study|Withdrawal by Subject|1|||
19737971|NCT02766400|42185089|FG000|Overall Study|Death|1|||
19737972|NCT02766400|42185090|FG001|Overall Study|Death|2|||
19737973|NCT02766400|42185089|FG000|Overall Study|Withdrawal by Subject|1|||
19737974|NCT02766400|42185090|FG001|Overall Study|Withdrawal by Subject|0|||
19737975|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
19737976|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
19737977|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
19737978|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
19737979|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
19737980|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
19737981|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Death|7|||
19737982|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Death|5|||
19737983|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Death|6|||
19737984|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
19737985|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
19737986|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
19737987|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
19737988|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
19737989|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
19737990|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Other|1|||
19737991|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Other|0|||
19737992|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Other|0|||
19737993|NCT00104650|42185099|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
19737994|NCT00104650|42185100|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
19737995|NCT00104650|42185101|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
19737996|NCT00104650|42185099|FG000|Follow-up Period|Physician Decision|1|||
19737997|NCT00104650|42185100|FG001|Follow-up Period|Physician Decision|1|||
19737998|NCT00104650|42185101|FG002|Follow-up Period|Physician Decision|0|||
19737999|NCT00104650|42185099|FG000|Follow-up Period|Adverse Event|1|||
19738000|NCT00104650|42185100|FG001|Follow-up Period|Adverse Event|0|||
19738001|NCT00104650|42185101|FG002|Follow-up Period|Adverse Event|1|||
19738002|NCT00104650|42185099|FG000|Follow-up Period|Withdrawal by Subject|0|||
19738003|NCT00104650|42185100|FG001|Follow-up Period|Withdrawal by Subject|3|||
19738004|NCT00104650|42185101|FG002|Follow-up Period|Withdrawal by Subject|3|||
19738005|NCT00104650|42185099|FG000|Follow-up Period|Death|6|||
19738006|NCT00104650|42185100|FG001|Follow-up Period|Death|6|||
19738007|NCT00104650|42185101|FG002|Follow-up Period|Death|4|||
19738008|NCT00104650|42185099|FG000|Follow-up Period|Disease progression|3|||
19738009|NCT00104650|42185100|FG001|Follow-up Period|Disease progression|1|||
19738010|NCT00104650|42185101|FG002|Follow-up Period|Disease progression|0|||
19738011|NCT00104650|42185099|FG000|Follow-up Period|Lost to Follow-up|0|||
19738012|NCT00104650|42185100|FG001|Follow-up Period|Lost to Follow-up|1|||
19738013|NCT00104650|42185101|FG002|Follow-up Period|Lost to Follow-up|2|||
19738014|NCT00104650|42185099|FG000|Follow-up Period|Other|0|||
19738015|NCT00104650|42185100|FG001|Follow-up Period|Other|1|||
19738016|NCT00104650|42185101|FG002|Follow-up Period|Other|0|||
19738017|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
19738018|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
19738019|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
19738020|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
19738021|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
19738022|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
19738023|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
19738024|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
19738025|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
19738026|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
19738027|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
19738028|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
19738029|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
19738030|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
19738031|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
19738032|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
19738033|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
19738034|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
19738035|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
19738036|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
19738037|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
19738038|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
19738039|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
19738040|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
19738041|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
19738042|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
19738043|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
19738044|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
19738045|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
19738046|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
19738047|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
19738048|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
19738049|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
19738050|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
19738051|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
19738052|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
19738053|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
19738054|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
19738055|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
19738056|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
19738057|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
19738058|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
19738059|NCT03732807|42185116|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738060|NCT03732807|42185117|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738061|NCT03732807|42185118|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738062|NCT03732807|42185119|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738063|NCT03732807|42185120|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738064|NCT03732807|42185121|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
19738065|NCT03732807|42185122|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19738066|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
19738067|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
19738068|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
19738069|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
19738070|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
19738071|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
19738072|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
19738073|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
19738074|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
19738075|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
19738076|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
19738077|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
19738078|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
19738079|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
19738080|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
19738081|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
19738082|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
19738083|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
19738084|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
19738085|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
19738086|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
19738087|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738088|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
19738089|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738090|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738091|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738092|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738093|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
19738094|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
19738095|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
19738096|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
19738097|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
19738098|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
19738099|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
19738100|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
19738101|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
19738102|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
19738103|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
19738104|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
19738105|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
19738106|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
19738107|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
19738108|NCT03732807|42185116|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
19738109|NCT03732807|42185117|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
19738110|NCT03732807|42185118|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
19738111|NCT03732807|42185119|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
19738112|NCT03732807|42185120|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
19738113|NCT03732807|42185121|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
19738114|NCT03732807|42185122|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
19738115|NCT00104416|42185141|FG000|Double-Blind Phase|Adverse Event|2|||
19738116|NCT00104416|42185142|FG001|Double-Blind Phase|Adverse Event|1|||
19738117|NCT00104416|42185143|FG002|Double-Blind Phase|Adverse Event|0|||
19738118|NCT00104416|42185144|FG003|Double-Blind Phase|Adverse Event|0|||
19465306|NCT04426695|41723746|FG005|Overall Study|Randomized but Never Treated|5|||
19738119|NCT00104416|42185145|FG004|Double-Blind Phase|Adverse Event|0|||
19738120|NCT00104416|42185141|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19738121|NCT00104416|42185142|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19738122|NCT00104416|42185143|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19738123|NCT00104416|42185144|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19738124|NCT00104416|42185145|FG004|Double-Blind Phase|Lost to Follow-up|0|||
19738125|NCT00104416|42185141|FG000|Double-Blind Phase|Protocol Violation|0|||
19738126|NCT00104416|42185142|FG001|Double-Blind Phase|Protocol Violation|1|||
19738127|NCT00104416|42185143|FG002|Double-Blind Phase|Protocol Violation|0|||
19738128|NCT00104416|42185144|FG003|Double-Blind Phase|Protocol Violation|0|||
19738129|NCT00104416|42185145|FG004|Double-Blind Phase|Protocol Violation|0|||
19738130|NCT00104416|42185141|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
19738131|NCT00104416|42185142|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
19738132|NCT00104416|42185143|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19738133|NCT00104416|42185144|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19738134|NCT00104416|42185145|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
19738135|NCT00104416|42185141|FG000|Double-Blind Phase|Pregnancy|1|||
19738136|NCT00104416|42185142|FG001|Double-Blind Phase|Pregnancy|0|||
19738137|NCT00104416|42185143|FG002|Double-Blind Phase|Pregnancy|0|||
19738138|NCT00104416|42185144|FG003|Double-Blind Phase|Pregnancy|0|||
19738139|NCT00104416|42185145|FG004|Double-Blind Phase|Pregnancy|0|||
19738140|NCT00104416|42185141|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
19738141|NCT00104416|42185142|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
19738142|NCT00104416|42185143|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
19738143|NCT00104416|42185144|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
19738144|NCT00104416|42185145|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
19478089|NCT01693562|41757335|FG021|Exploration Phase|Other|0|||
19465307|NCT04426695|41723747|FG006|Overall Study|Randomized but Never Treated|4|||
19380943|NCT02412488|41624185|FG000|Overall Study|Physician Decision|1|||
19478090|NCT01693562|41757336|FG022|Exploration Phase|Other|0|||
19465308|NCT04426695|41723748|FG007|Overall Study|Randomized but Never Treated|6|||
19465309|NCT04426695|41723749|FG008|Overall Study|Randomized but Never Treated|6|||
19465310|NCT04426695|41723750|FG009|Overall Study|Randomized but Never Treated|3|||
19738145|NCT00104416|42185141|FG000|Continuation Phase|Adverse Event|0|||
19738146|NCT00104416|42185142|FG001|Continuation Phase|Adverse Event|0|||
19738147|NCT00104416|42185143|FG002|Continuation Phase|Adverse Event|2|||
19738148|NCT00104416|42185144|FG003|Continuation Phase|Adverse Event|0|||
19738149|NCT00104416|42185145|FG004|Continuation Phase|Adverse Event|2|||
19738150|NCT00104416|42185141|FG000|Continuation Phase|Lost to Follow-up|0|||
19738151|NCT00104416|42185142|FG001|Continuation Phase|Lost to Follow-up|0|||
19738152|NCT00104416|42185143|FG002|Continuation Phase|Lost to Follow-up|1|||
19738153|NCT00104416|42185144|FG003|Continuation Phase|Lost to Follow-up|0|||
19465311|NCT04426695|41723751|FG010|Overall Study|Randomized but Never Treated|3|||
19465312|NCT04426695|41723752|FG011|Overall Study|Randomized but Never Treated|6|||
19465313|NCT04426695|41723753|FG012|Overall Study|Randomized but Never Treated|1|||
19465314|NCT04426695|41723754|FG013|Overall Study|Randomized but Never Treated|2|||
19465315|NCT04426695|41723755|FG014|Overall Study|Randomized but Never Treated|0|||
19465316|NCT04426695|41723756|FG015|Overall Study|Randomized but Never Treated|0|||
19465317|NCT04426695|41723757|FG016|Overall Study|Randomized but Never Treated|0|||
19465318|NCT04426695|41723758|FG017|Overall Study|Randomized but Never Treated|0|||
19465319|NCT01838200|41723835|FG000|Overall Study|Adverse Event|0|||
19465320|NCT01838200|41723836|FG001|Overall Study|Adverse Event|2|||
19465321|NCT01838200|41723835|FG000|Overall Study|Progressive disease|3|||
19465322|NCT01838200|41723836|FG001|Overall Study|Progressive disease|0|||
19465323|NCT03219034|41723879|FG000|Overall Study|Lost to Follow-up|9|||
19380944|NCT02412488|41624185|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
19465324|NCT03219034|41723880|FG001|Overall Study|Lost to Follow-up|13|||
19551298|NCT01346774|42000127|FG000|Overall Study|Withdrawal by Subject|1|||
19380945|NCT02412488|41624185|FG000|Overall Study|Reveal LINQ explant|1|||
19738154|NCT00104416|42185145|FG004|Continuation Phase|Lost to Follow-up|1|||
19738155|NCT00104416|42185141|FG000|Continuation Phase|Withdrawal by Subject|0|||
19738156|NCT00104416|42185142|FG001|Continuation Phase|Withdrawal by Subject|0|||
19738157|NCT00104416|42185143|FG002|Continuation Phase|Withdrawal by Subject|2|||
19738158|NCT00104416|42185144|FG003|Continuation Phase|Withdrawal by Subject|1|||
19738159|NCT00104416|42185145|FG004|Continuation Phase|Withdrawal by Subject|1|||
19738160|NCT00104416|42185141|FG000|Continuation Phase|Pregnancy|0|||
19738161|NCT00104416|42185142|FG001|Continuation Phase|Pregnancy|0|||
19738162|NCT00104416|42185143|FG002|Continuation Phase|Pregnancy|1|||
19738163|NCT00104416|42185144|FG003|Continuation Phase|Pregnancy|1|||
19738164|NCT00104416|42185145|FG004|Continuation Phase|Pregnancy|0|||
19738165|NCT00104416|42185141|FG000|Continuation Phase|Non-compliance|0|||
19738166|NCT00104416|42185142|FG001|Continuation Phase|Non-compliance|0|||
19380946|NCT02378480|41624191|FG000|Overall Study|Physician Decision|1|||
19380947|NCT02378480|41624192|FG001|Overall Study|Physician Decision|1|||
19738167|NCT00104416|42185143|FG002|Continuation Phase|Non-compliance|0|||
19738168|NCT00104416|42185144|FG003|Continuation Phase|Non-compliance|0|||
19738169|NCT00104416|42185145|FG004|Continuation Phase|Non-compliance|1|||
19738170|NCT03639987|42185159|FG000|Overall Study|Study terminated by sponsor|26|||
19738171|NCT03639987|42185160|FG001|Overall Study|Study terminated by sponsor|25|||
19738172|NCT03639987|42185159|FG000|Overall Study|Lost to Follow-up|0|||
19738173|NCT03639987|42185160|FG001|Overall Study|Lost to Follow-up|1|||
19738174|NCT02766088|42185166|FG000|Overall Study|Sponsor study termination|498|||
19738175|NCT02766088|42185166|FG000|Overall Study|Migrated/moved from the study area|1|||
19738176|NCT02766088|42185166|FG000|Overall Study|Lost to Follow-up|5|||
19738177|NCT02766088|42185166|FG000|Overall Study|Other|1|||
19738178|NCT02766088|42185166|FG000|Overall Study|Death|1|||
19738179|NCT03639675|42185170|FG000|Overall Study|Withdrawal by Subject|1|||
19738180|NCT03635775|42185178|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
19738181|NCT03635775|42185179|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
19738182|NCT03635775|42185180|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
19738183|NCT03635775|42185181|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
19738184|NCT03610581|42185193|FG000|Overall Study|Study terminated by sponsor|2|||
19738185|NCT03610581|42185194|FG001|Overall Study|Study terminated by sponsor|0|||
19738186|NCT03610581|42185193|FG000|Overall Study|Other|0|||
19738187|NCT03610581|42185194|FG001|Overall Study|Other|1|||
19738188|NCT03610581|42185193|FG000|Overall Study|Withdrawal by Subject|1|||
19738189|NCT03610581|42185194|FG001|Overall Study|Withdrawal by Subject|0|||
19738190|NCT03610269|42185200|FG000|Overall Study|Physician Decision|10|||
19738191|NCT03610269|42185200|FG000|Overall Study|Protocol Violation|1|||
19738192|NCT03610269|42185200|FG000|Overall Study|Unable to draw blood|1|||
19738193|NCT03610269|42185200|FG000|Overall Study|Screen fail|4|||
19738194|NCT00121667|42185208|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
19738195|NCT00121667|42185209|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
19738196|NCT00121667|42185210|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
19738197|NCT00121667|42185211|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
19738198|NCT00121667|42185208|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
19738199|NCT00121667|42185209|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
19738200|NCT00121667|42185210|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
19738201|NCT00121667|42185211|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
19738202|NCT00121667|42185208|FG000|Short Term (ST) Period|Adverse Event|5|||
19738203|NCT00121667|42185209|FG001|Short Term (ST) Period|Adverse Event|6|||
19738204|NCT00121667|42185210|FG002|Short Term (ST) Period|Adverse Event|5|||
19738205|NCT00121667|42185211|FG003|Short Term (ST) Period|Adverse Event|3|||
19380948|NCT02378480|41624191|FG000|Overall Study|Death|1|||
19380949|NCT02378480|41624192|FG001|Overall Study|Death|2|||
19380950|NCT02378480|41624191|FG000|Overall Study|Randomized, but Not Treated|6|||
19380951|NCT02378480|41624192|FG001|Overall Study|Randomized, but Not Treated|4|||
19380952|NCT02378480|41624191|FG000|Overall Study|Adverse Event|0|||
19380953|NCT02378480|41624192|FG001|Overall Study|Adverse Event|1|||
19380954|NCT02378480|41624191|FG000|Overall Study|Missed EOT/PTE Visit|1|||
19380955|NCT02378480|41624192|FG001|Overall Study|Missed EOT/PTE Visit|2|||
19380956|NCT02378480|41624191|FG000|Overall Study|Withdrawal by Subject|9|||
19639149|NCT00717236|42088569|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
19639150|NCT00717236|42088570|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
19639151|NCT00717236|42088569|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
19380957|NCT02378480|41624192|FG001|Overall Study|Withdrawal by Subject|4|||
19639152|NCT00717236|42088570|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
19465325|NCT03219034|41723879|FG000|Overall Study|Additional dental work needed|1|||
19639153|NCT00717236|42088569|FG000|Double-Blind Period|Other: Transportation problems|0|||
19639154|NCT00717236|42088570|FG001|Double-Blind Period|Other: Transportation problems|1|||
19380958|NCT02378480|41624191|FG000|Overall Study|Lost to Follow-up|10|||
19380959|NCT02378480|41624192|FG001|Overall Study|Lost to Follow-up|18|||
19380960|NCT02345330|41624198|FG000|Overall Study|Death|1|||
19380961|NCT02345330|41624198|FG000|Overall Study|Progressive Disease|2|||
19380962|NCT02411396|41624202|FG000|Overall Study|Lost to Follow-up|31|||
19738206|NCT00121667|42185208|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
19738207|NCT00121667|42185209|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
19738208|NCT00121667|42185210|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
19738209|NCT00121667|42185211|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
19738210|NCT00121667|42185208|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
19738211|NCT00121667|42185209|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
19738212|NCT00121667|42185210|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
19738213|NCT00121667|42185211|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
19738214|NCT00121667|42185208|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
19738215|NCT00121667|42185209|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
19738216|NCT00121667|42185210|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
19738217|NCT00121667|42185211|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
19738218|NCT00121667|42185208|FG000|Short Term (ST) Period|Other Reason|3|||
19738219|NCT00121667|42185209|FG001|Short Term (ST) Period|Other Reason|0|||
19738220|NCT00121667|42185210|FG002|Short Term (ST) Period|Other Reason|0|||
19738221|NCT00121667|42185211|FG003|Short Term (ST) Period|Other Reason|0|||
19738222|NCT00121667|42185208|FG000|Short Term (ST) Period|Death|0|||
19738223|NCT00121667|42185209|FG001|Short Term (ST) Period|Death|0|||
19738224|NCT00121667|42185210|FG002|Short Term (ST) Period|Death|0|||
19738225|NCT00121667|42185211|FG003|Short Term (ST) Period|Death|1|||
19380963|NCT02411396|41624202|FG000|Overall Study|Death|10|||
19465326|NCT03219034|41723880|FG001|Overall Study|Additional dental work needed|0|||
19465327|NCT03219034|41723879|FG000|Overall Study|UPPP Surgery|1|||
19380964|NCT02345252|41624223|FG000|Double-Blind Phase|Adverse Event|2|||
19380965|NCT02345252|41624224|FG001|Double-Blind Phase|Adverse Event|3|||
19380966|NCT02345252|41624223|FG000|Double-Blind Phase|Death|1|||
19380967|NCT02345252|41624224|FG001|Double-Blind Phase|Death|2|||
19380968|NCT02345252|41624223|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19380969|NCT02345252|41624224|FG001|Double-Blind Phase|Lack of Efficacy|0|||
19380970|NCT02345252|41624223|FG000|Double-Blind Phase|Investigator's Discretion|4|||
19380971|NCT02345252|41624224|FG001|Double-Blind Phase|Investigator's Discretion|6|||
19380972|NCT02345252|41624223|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19380973|NCT02345252|41624224|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
19380974|NCT02345252|41624223|FG000|Double-Blind Phase|Protocol Violation|2|||
19738226|NCT00121667|42185208|FG000|Short Term (ST) Period|Pregnancy|0|||
19738227|NCT00121667|42185209|FG001|Short Term (ST) Period|Pregnancy|0|||
19738228|NCT00121667|42185210|FG002|Short Term (ST) Period|Pregnancy|0|||
19738229|NCT00121667|42185211|FG003|Short Term (ST) Period|Pregnancy|1|||
19738230|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
19738231|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
19738232|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
19738233|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
19738234|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
19738235|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
19738236|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
19738237|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
19738238|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
19738239|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
19738240|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
19738241|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
19738242|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
19738243|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
19738244|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
19738245|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
19738246|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
19738247|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
19738248|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
19738249|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
19738250|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
19738251|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
19738252|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
19738253|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
19738254|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
19738255|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
19738256|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
19738257|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
19738258|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
19738259|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
19738260|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
19738261|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
19738262|NCT00121667|42185208|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
19738263|NCT00121667|42185209|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
19738264|NCT00121667|42185210|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
19738265|NCT00121667|42185211|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
19738266|NCT02954601|42185225|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
19738267|NCT02954601|42185226|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
19738268|NCT02954601|42185227|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
19738269|NCT02954601|42185228|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
19738270|NCT03633903|42185240|FG000|Overall Study|Withdrawal by Subject|1|||
19738271|NCT03633903|42185241|FG001|Overall Study|Withdrawal by Subject|2|||
19738272|NCT03633903|42185240|FG000|Overall Study|Lost to Follow-up|5|||
19738273|NCT03633903|42185241|FG001|Overall Study|Lost to Follow-up|5|||
19738274|NCT03607695|42185247|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
19738275|NCT03607695|42185247|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
19738276|NCT03557775|42185254|FG000|Overall Study|Withdrawal by Subject|1|||
19738277|NCT03557775|42185255|FG001|Overall Study|Withdrawal by Subject|2|||
19738278|NCT03557775|42185256|FG002|Overall Study|Withdrawal by Subject|4|||
19738279|NCT03557775|42185254|FG000|Overall Study|Physician Decision|0|||
19738280|NCT03557775|42185255|FG001|Overall Study|Physician Decision|1|||
19738281|NCT03557775|42185256|FG002|Overall Study|Physician Decision|0|||
19738282|NCT00121199|42185264|FG000|Overall Study|Adverse Event|11|||
19738283|NCT00121199|42185264|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
19738284|NCT00121199|42185264|FG000|Overall Study|Progression/Relapse|1|||
19738285|NCT00121199|42185264|FG000|Overall Study|Death|3|||
19465328|NCT03219034|41723880|FG001|Overall Study|UPPP Surgery|0|||
19465329|NCT03219034|41723879|FG000|Overall Study|Dental sensitivity|0|||
19738286|NCT00121199|42185264|FG000|Overall Study|Other - Not Protocol Specified|3|||
19738287|NCT00121199|42185264|FG000|Overall Study|Ineligible|9|||
19738288|NCT00119405|42185268|FG000|Overall Study|Withdrawal by Subject|1|||
19738289|NCT00119015|42185274|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
19738290|NCT00119015|42185275|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
19738291|NCT00119015|42185276|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
19738292|NCT01981850|42185289|FG000|Main Phase Stage 1|Death|2|||
19738293|NCT01981850|42185290|FG001|Main Phase Stage 1|Death|0|||
19738294|NCT01981850|42185291|FG002|Main Phase Stage 1|Death|0|||
19738295|NCT01981850|42185292|FG003|Main Phase Stage 1|Death|0|||
19738296|NCT01981850|42185293|FG004|Main Phase Stage 1|Death|0|||
19738297|NCT01981850|42185294|FG005|Main Phase Stage 1|Death|0|||
19738298|NCT01981850|42185295|FG006|Main Phase Stage 1|Death|0|||
19738299|NCT01981850|42185296|FG007|Main Phase Stage 1|Death|0|||
19551299|NCT01346774|42000128|FG001|Overall Study|Withdrawal by Subject|4|||
19551300|NCT01346774|42000127|FG000|Overall Study|Protocol Violation|2|||
19551301|NCT01346774|42000128|FG001|Overall Study|Protocol Violation|3|||
19551302|NCT01346774|42000127|FG000|Overall Study|Adverse Event|1|||
19551303|NCT01346774|42000128|FG001|Overall Study|Adverse Event|2|||
19551304|NCT01346696|42000134|FG000|Overall Study|Death|1|||
19551305|NCT01346540|42000140|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
19551306|NCT01346540|42000141|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
19551307|NCT01346540|42000140|FG000|Overall Study|Adverse Event|0|||
19551308|NCT01346540|42000141|FG001|Overall Study|Adverse Event|4|||
19551309|NCT01342913|42000150|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
19551310|NCT01342913|42000151|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19551311|NCT01342913|42000152|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19551312|NCT01342913|42000150|FG000|2-week Run-in Period|Physician Decision|6|||
19551313|NCT01342913|42000151|FG001|2-week Run-in Period|Physician Decision|0|||
19551314|NCT01342913|42000152|FG002|2-week Run-in Period|Physician Decision|0|||
19551315|NCT01342913|42000150|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
19551316|NCT01342913|42000151|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19551317|NCT01342913|42000152|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19551318|NCT01342913|42000150|FG000|2-week Run-in Period|Adverse Event|2|||
19551319|NCT01342913|42000151|FG001|2-week Run-in Period|Adverse Event|0|||
19738300|NCT01981850|42185297|FG008|Main Phase Stage 1|Death|0|||
19738301|NCT01981850|42185298|FG009|Main Phase Stage 1|Death|0|||
19738302|NCT01981850|42185289|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
19738303|NCT01981850|42185290|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738304|NCT01981850|42185291|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738305|NCT01981850|42185292|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738306|NCT01981850|42185293|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738307|NCT01981850|42185294|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738308|NCT01981850|42185295|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738309|NCT01981850|42185296|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738310|NCT01981850|42185297|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738311|NCT01981850|42185298|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
19738312|NCT01981850|42185289|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
19738313|NCT01981850|42185290|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
19738314|NCT01981850|42185291|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
19738315|NCT01981850|42185292|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
19738316|NCT01981850|42185293|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
19738317|NCT01981850|42185294|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
19738318|NCT01981850|42185295|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
19738319|NCT01981850|42185296|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
19738320|NCT01981850|42185297|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
19738321|NCT01981850|42185298|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
19551320|NCT01342913|42000152|FG002|2-week Run-in Period|Adverse Event|0|||
19551321|NCT01342913|42000150|FG000|2-week Run-in Period|Protocol Violation|5|||
19380975|NCT02345252|41624224|FG001|Double-Blind Phase|Protocol Violation|1|||
19465330|NCT03219034|41723880|FG001|Overall Study|Dental sensitivity|1|||
19738322|NCT01981850|42185289|FG000|Main Phase Stage 1|Various reasons|0|||
19738323|NCT01981850|42185290|FG001|Main Phase Stage 1|Various reasons|0|||
19738324|NCT01981850|42185291|FG002|Main Phase Stage 1|Various reasons|2|||
19738325|NCT01981850|42185292|FG003|Main Phase Stage 1|Various reasons|0|||
19738326|NCT01981850|42185293|FG004|Main Phase Stage 1|Various reasons|0|||
19738327|NCT01981850|42185294|FG005|Main Phase Stage 1|Various reasons|0|||
19738328|NCT01981850|42185295|FG006|Main Phase Stage 1|Various reasons|0|||
19738329|NCT01981850|42185296|FG007|Main Phase Stage 1|Various reasons|0|||
19738330|NCT01981850|42185297|FG008|Main Phase Stage 1|Various reasons|0|||
19738331|NCT01981850|42185298|FG009|Main Phase Stage 1|Various reasons|0|||
19738332|NCT01981850|42185289|FG000|Main Phase Stage 2|Adverse Event|0|||
19738333|NCT01981850|42185290|FG001|Main Phase Stage 2|Adverse Event|0|||
19738334|NCT01981850|42185291|FG002|Main Phase Stage 2|Adverse Event|0|||
19738335|NCT01981850|42185292|FG003|Main Phase Stage 2|Adverse Event|0|||
19738336|NCT01981850|42185293|FG004|Main Phase Stage 2|Adverse Event|6|||
19738337|NCT01981850|42185294|FG005|Main Phase Stage 2|Adverse Event|5|||
19738338|NCT01981850|42185295|FG006|Main Phase Stage 2|Adverse Event|7|||
19738339|NCT01981850|42185296|FG007|Main Phase Stage 2|Adverse Event|0|||
19738340|NCT01981850|42185297|FG008|Main Phase Stage 2|Adverse Event|0|||
19738341|NCT01981850|42185298|FG009|Main Phase Stage 2|Adverse Event|0|||
19738342|NCT01981850|42185289|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738343|NCT01981850|42185290|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738344|NCT01981850|42185291|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738345|NCT01981850|42185292|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738346|NCT01981850|42185293|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
19738347|NCT01981850|42185294|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
19738348|NCT01981850|42185295|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
19738349|NCT01981850|42185296|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738350|NCT01981850|42185297|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738351|NCT01981850|42185298|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
19738352|NCT01981850|42185289|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
19738353|NCT01981850|42185290|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
19738354|NCT01981850|42185291|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
19738355|NCT01981850|42185292|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
19738356|NCT01981850|42185293|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
19738357|NCT01981850|42185294|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
19738358|NCT01981850|42185295|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
19738359|NCT01981850|42185296|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
19738360|NCT01981850|42185297|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
19738361|NCT01981850|42185298|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
19738362|NCT01981850|42185289|FG000|Main Phase Stage 2|Various reasons|0|||
19738363|NCT01981850|42185290|FG001|Main Phase Stage 2|Various reasons|0|||
19738364|NCT01981850|42185291|FG002|Main Phase Stage 2|Various reasons|0|||
19738365|NCT01981850|42185292|FG003|Main Phase Stage 2|Various reasons|0|||
19738366|NCT01981850|42185293|FG004|Main Phase Stage 2|Various reasons|2|||
19738367|NCT01981850|42185294|FG005|Main Phase Stage 2|Various reasons|0|||
19738368|NCT01981850|42185295|FG006|Main Phase Stage 2|Various reasons|1|||
19738369|NCT01981850|42185296|FG007|Main Phase Stage 2|Various reasons|0|||
19738370|NCT01981850|42185297|FG008|Main Phase Stage 2|Various reasons|0|||
19738371|NCT01981850|42185298|FG009|Main Phase Stage 2|Various reasons|0|||
19738372|NCT01981850|42185289|FG000|Main Phase Stage 2|Progressive Disease|0|||
19738373|NCT01981850|42185290|FG001|Main Phase Stage 2|Progressive Disease|0|||
19738374|NCT01981850|42185291|FG002|Main Phase Stage 2|Progressive Disease|0|||
19738375|NCT01981850|42185292|FG003|Main Phase Stage 2|Progressive Disease|0|||
19738376|NCT01981850|42185293|FG004|Main Phase Stage 2|Progressive Disease|0|||
19738377|NCT01981850|42185294|FG005|Main Phase Stage 2|Progressive Disease|6|||
19738378|NCT01981850|42185295|FG006|Main Phase Stage 2|Progressive Disease|6|||
19738379|NCT01981850|42185296|FG007|Main Phase Stage 2|Progressive Disease|0|||
19738380|NCT01981850|42185297|FG008|Main Phase Stage 2|Progressive Disease|0|||
19738381|NCT01981850|42185298|FG009|Main Phase Stage 2|Progressive Disease|0|||
19738382|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Adverse Event|0|||
19738383|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Adverse Event|0|||
19738384|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Adverse Event|0|||
19738385|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Adverse Event|0|||
19738386|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Adverse Event|0|||
19738387|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Adverse Event|0|||
19738388|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Adverse Event|0|||
19738389|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Adverse Event|2|||
19738390|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Adverse Event|1|||
19738391|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Adverse Event|8|||
19738392|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738393|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738394|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738395|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738396|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738397|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738398|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
19738399|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
19738400|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
19738401|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
19738402|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Various reasons|0|||
19738403|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Various reasons|0|||
19380976|NCT02345252|41624223|FG000|Double-Blind Phase|Withdrew Consent|21|||
19380977|NCT02345252|41624224|FG001|Double-Blind Phase|Withdrew Consent|23|||
19465331|NCT03219034|41723879|FG000|Overall Study|Death in family|0|||
19465332|NCT03219034|41723880|FG001|Overall Study|Death in family|1|||
19380978|NCT02345252|41624223|FG000|Double-Blind Phase|Lost to Follow-up|8|||
19465333|NCT01706198|41723904|FG000|Overall Study|Adverse Event|12|||
19465334|NCT01706198|41723905|FG001|Overall Study|Adverse Event|15|||
19465335|NCT01706198|41723904|FG000|Overall Study|Protocol Violation|7|||
19738404|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Various reasons|0|||
19738405|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Various reasons|0|||
19738406|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Various reasons|0|||
19738407|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Various reasons|0|||
19738408|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Various reasons|0|||
19738409|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Various reasons|3|||
19738410|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Various reasons|1|||
19738411|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Various reasons|3|||
19738412|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
19738413|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
19738414|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
19738415|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
19738416|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
19738417|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
19738418|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
19738419|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
19738420|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
19738421|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
19738422|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738423|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738424|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738425|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19465336|NCT01706198|41723905|FG001|Overall Study|Protocol Violation|5|||
19465337|NCT01706198|41723904|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
19738426|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738427|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738428|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738429|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738430|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
19738431|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
19738432|NCT01981850|42185289|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738433|NCT01981850|42185290|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738434|NCT01981850|42185291|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738435|NCT01981850|42185292|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738436|NCT01981850|42185293|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738437|NCT01981850|42185294|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738438|NCT01981850|42185295|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738439|NCT01981850|42185296|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738440|NCT01981850|42185297|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
19738441|NCT01981850|42185298|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
19738442|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10|||
19738443|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Adverse Event|7|||
19738444|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Protocol Violation|6|||
19738445|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5|||
19738446|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|other|3|||
19738447|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Death|2|||
19738448|NCT03557307|42185330|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
19738449|NCT03557307|42185330|FG000|Maintenance Phase|Adverse Event|4|||
19738450|NCT03557307|42185330|FG000|Maintenance Phase|Death|3|||
19738451|NCT03557307|42185330|FG000|Maintenance Phase|Lost to Follow-up|2|||
19738452|NCT03557307|42185330|FG000|Maintenance Phase|Pregnancy|2|||
19738453|NCT03557307|42185330|FG000|Maintenance Phase|Protocol Violation|11|||
19738454|NCT03557307|42185330|FG000|Maintenance Phase|Withdrawal by Subject|2|||
19738455|NCT03557307|42185330|FG000|Maintenance Phase|other|3|||
19738456|NCT00118703|42185336|FG000|Overall Study|Protocol Violation|1|||
19738457|NCT00118703|42185337|FG001|Overall Study|Protocol Violation|0|||
19738458|NCT00118703|42185336|FG000|Overall Study|Adverse Event|1|||
19738459|NCT00118703|42185337|FG001|Overall Study|Adverse Event|1|||
19738460|NCT00118703|42185336|FG000|Overall Study|Participant took two different treatment|0|||
19738461|NCT00118703|42185337|FG001|Overall Study|Participant took two different treatment|1|||
19738462|NCT00118703|42185336|FG000|Overall Study|Withdrawal by Subject|2|||
19738463|NCT00118703|42185337|FG001|Overall Study|Withdrawal by Subject|5|||
19738464|NCT00118703|42185336|FG000|Overall Study|Lost to Follow-up|1|||
19738465|NCT00118703|42185337|FG001|Overall Study|Lost to Follow-up|2|||
19738466|NCT00104104|42185345|FG000|Overall Study|Adverse Event|8|||
19380979|NCT02345252|41624224|FG001|Double-Blind Phase|Lost to Follow-up|10|||
19380980|NCT02345252|41624223|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
19380981|NCT02345252|41624224|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
19738467|NCT00104104|42185346|FG001|Overall Study|Adverse Event|8|||
19738468|NCT00104104|42185345|FG000|Overall Study|Abnormal laboratory value(s)|20|||
19738469|NCT00104104|42185346|FG001|Overall Study|Abnormal laboratory value(s)|14|||
19738470|NCT00104104|42185345|FG000|Overall Study|Lack of Efficacy|0|||
19738471|NCT00104104|42185346|FG001|Overall Study|Lack of Efficacy|3|||
19738472|NCT00104104|42185345|FG000|Overall Study|Condition no longer requires study drug|7|||
19738473|NCT00104104|42185346|FG001|Overall Study|Condition no longer requires study drug|4|||
19738474|NCT00104104|42185345|FG000|Overall Study|Protocol Violation|5|||
19738475|NCT00104104|42185346|FG001|Overall Study|Protocol Violation|2|||
19738476|NCT00104104|42185345|FG000|Overall Study|Withdrawal by Subject|11|||
19738477|NCT00104104|42185346|FG001|Overall Study|Withdrawal by Subject|15|||
19738478|NCT00104104|42185345|FG000|Overall Study|Lost to Follow-up|3|||
19738479|NCT00104104|42185346|FG001|Overall Study|Lost to Follow-up|7|||
19738480|NCT00104104|42185345|FG000|Overall Study|Administrative problems|12|||
19738481|NCT00104104|42185346|FG001|Overall Study|Administrative problems|13|||
19738482|NCT00104104|42185345|FG000|Overall Study|Death|9|||
19738483|NCT00104104|42185346|FG001|Overall Study|Death|6|||
19738484|NCT03557151|42185354|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
19738485|NCT03557151|42185355|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
19738486|NCT03557151|42185354|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
19738487|NCT03557151|42185355|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
19738488|NCT03557151|42185354|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
19738489|NCT03557151|42185355|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
19738490|NCT00115739|42185363|FG000|Overall Study|Lost to Follow-up|3|||
19738491|NCT01347086|42185379|FG000|Overall Study|failed screening visit|0|||
19738492|NCT01347086|42185380|FG001|Overall Study|failed screening visit|0|||
19738493|NCT01347086|42185381|FG002|Overall Study|failed screening visit|1|||
19738494|NCT01347086|42185382|FG003|Overall Study|failed screening visit|0|||
19738495|NCT01347086|42185383|FG004|Overall Study|failed screening visit|0|||
19738496|NCT01347086|42185384|FG005|Overall Study|failed screening visit|0|||
19738497|NCT01347086|42185385|FG006|Overall Study|failed screening visit|1|||
19738498|NCT01347086|42185386|FG007|Overall Study|failed screening visit|1|||
19738499|NCT01347086|42185387|FG008|Overall Study|failed screening visit|0|||
19738500|NCT01347086|42185388|FG009|Overall Study|failed screening visit|1|||
19738501|NCT03605745|42185420|FG000|Overall Study|Study was terminated for business reasons|47|||
19738502|NCT03246152|42185424|FG000|Overall Study|Lost to Follow-up|2|||
19738503|NCT03246152|42185424|FG000|Overall Study|Protocol Violation|1|||
19738504|NCT03571581|42185428|FG000|Overall Study|Death|2|||
19738505|NCT03571581|42185428|FG000|Overall Study|Withdrawal by Subject|2|||
19738506|NCT00115349|42185437|FG000|Overall Study|Study closed due to low enrollment.|11|||
19738507|NCT00115349|42185438|FG001|Overall Study|Study closed due to low enrollment.|9|||
19738508|NCT00115037|42185446|FG000|Phase1|Lost to Follow-up|16|||
19738509|NCT00115037|42185447|FG001|Phase1|Lost to Follow-up|23|||
19738510|NCT00115037|42185448|FG002|Phase1|Lost to Follow-up|0|||
19738511|NCT00115037|42185449|FG003|Phase1|Lost to Follow-up|0|||
19738512|NCT00115037|42185450|FG004|Phase1|Lost to Follow-up|0|||
19738513|NCT00115037|42185451|FG005|Phase1|Lost to Follow-up|0|||
19738514|NCT00115037|42185446|FG000|Phase1|Withdrawal by Subject|9|||
19738515|NCT00115037|42185447|FG001|Phase1|Withdrawal by Subject|4|||
19738516|NCT00115037|42185448|FG002|Phase1|Withdrawal by Subject|0|||
19738517|NCT00115037|42185449|FG003|Phase1|Withdrawal by Subject|0|||
19738518|NCT00115037|42185450|FG004|Phase1|Withdrawal by Subject|0|||
19738519|NCT00115037|42185451|FG005|Phase1|Withdrawal by Subject|0|||
19738520|NCT00115037|42185446|FG000|Phase2|Death|0|||
19738521|NCT00115037|42185447|FG001|Phase2|Death|0|||
19738522|NCT00115037|42185448|FG002|Phase2|Death|1|||
19465338|NCT01706198|41723905|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
19465339|NCT01706198|41723904|FG000|Overall Study|Lost to Follow-up|97|||
19465340|NCT01706198|41723905|FG001|Overall Study|Lost to Follow-up|93|||
19465341|NCT01706198|41723904|FG000|Overall Study|Physician Decision|23|||
19465342|NCT01706198|41723905|FG001|Overall Study|Physician Decision|37|||
19465343|NCT01706198|41723904|FG000|Overall Study|Withdrawal by Subject|23|||
19465344|NCT01706198|41723905|FG001|Overall Study|Withdrawal by Subject|31|||
19465345|NCT01705730|41723911|FG000|Overall Study|Lack of Efficacy|1|||
19465346|NCT01705730|41723911|FG000|Overall Study|Adverse Event|3|||
19465347|NCT01705730|41723911|FG000|Overall Study|Lost to Follow-up|1|||
19465348|NCT01705730|41723911|FG000|Overall Study|Reason not Specified|4|||
19465349|NCT01705652|41723917|FG000|Overall Study|Adverse Event|1|||
19465350|NCT01705652|41723918|FG001|Overall Study|Adverse Event|0|||
19465351|NCT01705652|41723917|FG000|Overall Study|Withdrawal by Subject|1|||
19465352|NCT01705652|41723918|FG001|Overall Study|Withdrawal by Subject|2|||
19465353|NCT01705652|41723917|FG000|Overall Study|non-compliance|1|||
19465354|NCT01705652|41723918|FG001|Overall Study|non-compliance|1|||
19465355|NCT01705574|41723946|FG000|Double-Blind Phase|Lost to Follow-up|12|||
19465356|NCT01705574|41723947|FG001|Double-Blind Phase|Lost to Follow-up|16|||
19465357|NCT01705574|41723948|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19465358|NCT01705574|41723949|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19465359|NCT01705574|41723946|FG000|Double-Blind Phase|Adverse Event|3|||
19465360|NCT01705574|41723947|FG001|Double-Blind Phase|Adverse Event|10|||
19465361|NCT01705574|41723948|FG002|Double-Blind Phase|Adverse Event|0|||
19465362|NCT01705574|41723949|FG003|Double-Blind Phase|Adverse Event|0|||
19465363|NCT01705574|41723946|FG000|Double-Blind Phase|Withdrew Consent|8|||
19465364|NCT01705574|41723947|FG001|Double-Blind Phase|Withdrew Consent|5|||
19465365|NCT01705574|41723948|FG002|Double-Blind Phase|Withdrew Consent|0|||
19465366|NCT01705574|41723949|FG003|Double-Blind Phase|Withdrew Consent|0|||
19465367|NCT01705574|41723946|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
19465368|NCT01705574|41723947|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
19465369|NCT01705574|41723948|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
19465370|NCT01705574|41723949|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
19465371|NCT01705574|41723946|FG000|Double-Blind Phase|Pregnancy|1|||
19465372|NCT01705574|41723947|FG001|Double-Blind Phase|Pregnancy|1|||
19465373|NCT01705574|41723948|FG002|Double-Blind Phase|Pregnancy|0|||
19465374|NCT01705574|41723949|FG003|Double-Blind Phase|Pregnancy|0|||
19465375|NCT01705574|41723946|FG000|Double-Blind Phase|Protocol Violation|1|||
19465376|NCT01705574|41723947|FG001|Double-Blind Phase|Protocol Violation|0|||
19465377|NCT01705574|41723948|FG002|Double-Blind Phase|Protocol Violation|0|||
19465378|NCT01705574|41723949|FG003|Double-Blind Phase|Protocol Violation|0|||
19465379|NCT01705574|41723946|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
19465380|NCT01705574|41723947|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
19465381|NCT01705574|41723948|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
19465382|NCT01705574|41723949|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
19465383|NCT01705574|41723946|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
19465384|NCT01705574|41723947|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
19465385|NCT01705574|41723948|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
19380982|NCT01239797|41624234|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
19738523|NCT00115037|42185449|FG003|Phase2|Death|0|||
19738524|NCT00115037|42185450|FG004|Phase2|Death|0|||
19390342|NCT01987960|41634110|FG000|Period 1|Withdrawal of consent before treatment|4|||
19465386|NCT01705574|41723949|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
19465387|NCT01705574|41723946|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
19380983|NCT01239797|41624235|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
19380984|NCT01239797|41624234|FG000|Randomized Participants|Participant withdrew consent|1|||
19380985|NCT01239797|41624235|FG001|Randomized Participants|Participant withdrew consent|7|||
19465388|NCT01705574|41723947|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
19465389|NCT01705574|41723948|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
19465390|NCT01705574|41723949|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
19465391|NCT01705574|41723946|FG000|Open-Label Extension Phase|Adverse Event|3|||
19465392|NCT01705574|41723947|FG001|Open-Label Extension Phase|Adverse Event|0|||
19465393|NCT01705574|41723948|FG002|Open-Label Extension Phase|Adverse Event|0|||
19465394|NCT01705574|41723949|FG003|Open-Label Extension Phase|Adverse Event|1|||
19465395|NCT01705574|41723946|FG000|Open-Label Extension Phase|Death|2|||
19465396|NCT01705574|41723947|FG001|Open-Label Extension Phase|Death|0|||
19465397|NCT01705574|41723948|FG002|Open-Label Extension Phase|Death|1|||
19465398|NCT01705574|41723949|FG003|Open-Label Extension Phase|Death|0|||
19465399|NCT01705574|41723946|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
19465400|NCT01705574|41723947|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
19465401|NCT01705574|41723948|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
19465402|NCT01705574|41723949|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
19465403|NCT01705574|41723946|FG000|Open-Label Extension Phase|Physician Decision|0|||
19465404|NCT01705574|41723947|FG001|Open-Label Extension Phase|Physician Decision|0|||
19465405|NCT01705574|41723948|FG002|Open-Label Extension Phase|Physician Decision|2|||
19465406|NCT01705574|41723949|FG003|Open-Label Extension Phase|Physician Decision|0|||
19465407|NCT01705574|41723946|FG000|Open-Label Extension Phase|Pregnancy|0|||
19465408|NCT01705574|41723947|FG001|Open-Label Extension Phase|Pregnancy|0|||
19465409|NCT01705574|41723948|FG002|Open-Label Extension Phase|Pregnancy|1|||
19465410|NCT01705574|41723949|FG003|Open-Label Extension Phase|Pregnancy|1|||
19465411|NCT01737710|41723970|FG000|Overall Study|Lost to Follow-up|0|||
19465412|NCT01737710|41723971|FG001|Overall Study|Lost to Follow-up|2|||
19465413|NCT01737710|41723972|FG002|Overall Study|Lost to Follow-up|2|||
19380986|NCT01239797|41624234|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
19380987|NCT01239797|41624235|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
19738525|NCT00115037|42185451|FG005|Phase2|Death|1|||
19738526|NCT00115037|42185446|FG000|Phase2|Withdrawal by Subject|0|||
19738527|NCT00115037|42185447|FG001|Phase2|Withdrawal by Subject|0|||
19738528|NCT00115037|42185448|FG002|Phase2|Withdrawal by Subject|2|||
19738529|NCT00115037|42185449|FG003|Phase2|Withdrawal by Subject|1|||
19738530|NCT00115037|42185450|FG004|Phase2|Withdrawal by Subject|2|||
19738531|NCT00115037|42185451|FG005|Phase2|Withdrawal by Subject|1|||
19738532|NCT00115037|42185446|FG000|Phase2|Lost to Follow-up|0|||
19738533|NCT00115037|42185447|FG001|Phase2|Lost to Follow-up|0|||
19738534|NCT00115037|42185448|FG002|Phase2|Lost to Follow-up|12|||
19738535|NCT00115037|42185449|FG003|Phase2|Lost to Follow-up|14|||
19738536|NCT00115037|42185450|FG004|Phase2|Lost to Follow-up|4|||
19738537|NCT00115037|42185451|FG005|Phase2|Lost to Follow-up|10|||
19738538|NCT03555435|42185468|FG000|Overall Study|Lost to Follow-up|17|||
19738539|NCT03555435|42185469|FG001|Overall Study|Lost to Follow-up|19|||
19738540|NCT03555435|42185470|FG002|Overall Study|Lost to Follow-up|8|||
19738541|NCT03214640|42185482|FG000|Overall Study|Protocol Violation|1|||
19738542|NCT03214640|42185483|FG001|Overall Study|Protocol Violation|2|||
19738543|NCT03214640|42185484|FG002|Overall Study|Protocol Violation|1|||
19738544|NCT03214640|42185485|FG003|Overall Study|Protocol Violation|4|||
19738545|NCT03214406|42185497|FG000|Overall Study|did not meet enrollment criteria|9|||
19738546|NCT03214406|42185498|FG001|Overall Study|did not meet enrollment criteria|13|||
19738547|NCT03214406|42185497|FG000|Overall Study|Withdrawal by Subject|1|||
19738548|NCT03214406|42185498|FG001|Overall Study|Withdrawal by Subject|0|||
19738549|NCT03214406|42185497|FG000|Overall Study|Lost to Follow-up|0|||
19738550|NCT03214406|42185498|FG001|Overall Study|Lost to Follow-up|2|||
19738551|NCT03213938|42185506|FG000|Overall Study|Lost to Follow-up|4|||
19738552|NCT03213938|42185507|FG001|Overall Study|Lost to Follow-up|3|||
19738553|NCT03213938|42185506|FG000|Overall Study|Lack of Efficacy|1|||
19738554|NCT03213938|42185507|FG001|Overall Study|Lack of Efficacy|0|||
19738555|NCT03213938|42185506|FG000|Overall Study|Decline to participate|5|||
19738556|NCT03213938|42185507|FG001|Overall Study|Decline to participate|4|||
19738557|NCT03213938|42185506|FG000|Overall Study|Without reason|4|||
19738558|NCT03213938|42185507|FG001|Overall Study|Without reason|5|||
19738559|NCT03604497|42185513|FG000|Overall Study|Protocol Violation|52|||
19738560|NCT03213626|42185521|FG000|Overall Study|Adverse Event|1|||
19738561|NCT03213626|42185521|FG000|Overall Study|Progressive Disease|6|||
19738562|NCT03604341|42185527|FG000|Overall Study|Withdrawal by Subject|1|||
19738563|NCT03604341|42185528|FG001|Overall Study|Withdrawal by Subject|1|||
19738564|NCT03604341|42185527|FG000|Overall Study|Adverse Event|1|||
19738565|NCT03604341|42185528|FG001|Overall Study|Adverse Event|0|||
19738566|NCT03604341|42185527|FG000|Overall Study|Protocol Violation|0|||
19738567|NCT03604341|42185528|FG001|Overall Study|Protocol Violation|1|||
19738568|NCT03603639|42185534|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
19738569|NCT03603639|42185535|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
19738570|NCT03603639|42185536|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
19738571|NCT03603639|42185537|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
19738572|NCT03603639|42185538|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
19738573|NCT03603639|42185539|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
19738574|NCT03603639|42185534|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
19738575|NCT03603639|42185535|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
19738576|NCT03603639|42185536|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
19738577|NCT03603639|42185537|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
19465414|NCT01737710|41723973|FG003|Overall Study|Lost to Follow-up|0|||
19465415|NCT01737710|41723974|FG004|Overall Study|Lost to Follow-up|0|||
19465416|NCT01737710|41723970|FG000|Overall Study|Withdrawal by Subject|1|||
19465417|NCT01737710|41723971|FG001|Overall Study|Withdrawal by Subject|1|||
19465418|NCT01737710|41723972|FG002|Overall Study|Withdrawal by Subject|1|||
19465419|NCT01737710|41723973|FG003|Overall Study|Withdrawal by Subject|0|||
19465420|NCT01737710|41723974|FG004|Overall Study|Withdrawal by Subject|0|||
19738578|NCT03603639|42185538|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
19738579|NCT03603639|42185539|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
19738580|NCT00114959|42185553|FG000|Overall Study|Lack of Efficacy|6|||
19738581|NCT00114959|42185553|FG000|Overall Study|Physician Decision|1|||
19738582|NCT00114959|42185553|FG000|Overall Study|Death|1|||
19738583|NCT02778100|42185559|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
19738584|NCT02778100|42185560|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
19738585|NCT00118157|42185568|FG000|Overall Study|Adverse Event|2|||
19738586|NCT00118157|42185568|FG000|Overall Study|Death|8|||
19738587|NCT00118157|42185568|FG000|Overall Study|Withdrawal by Subject|2|||
19738588|NCT02762500|42185575|FG000|Overall Study|Lack of Efficacy|1|||
19738589|NCT02762500|42185576|FG001|Overall Study|Lack of Efficacy|0|||
19738590|NCT02762500|42185575|FG000|Overall Study|Withdrawal by Subject|1|||
19738591|NCT02762500|42185576|FG001|Overall Study|Withdrawal by Subject|1|||
19738592|NCT02762500|42185575|FG000|Overall Study|Adverse Event|0|||
19738593|NCT02762500|42185576|FG001|Overall Study|Adverse Event|2|||
19738594|NCT03552549|42185584|FG000|Overall Study|Disease progression|25|||
19738595|NCT03552549|42185585|FG001|Overall Study|Disease progression|17|||
19738596|NCT03552549|42185584|FG000|Overall Study|Adverse event in first 12 months|12|||
19738597|NCT03552549|42185585|FG001|Overall Study|Adverse event in first 12 months|8|||
19738598|NCT03552549|42185584|FG000|Overall Study|Withdrawal by Subject|7|||
19738599|NCT03552549|42185585|FG001|Overall Study|Withdrawal by Subject|7|||
19738600|NCT03552549|42185584|FG000|Overall Study|Unknown (no reason provided)|4|||
19738601|NCT03552549|42185585|FG001|Overall Study|Unknown (no reason provided)|2|||
19738602|NCT03552549|42185584|FG000|Overall Study|Not in participant's best interest|2|||
19738603|NCT03552549|42185585|FG001|Overall Study|Not in participant's best interest|1|||
19738604|NCT03552549|42185584|FG000|Overall Study|Did not complete study treatment|2|||
19738605|NCT03552549|42185585|FG001|Overall Study|Did not complete study treatment|3|||
19738606|NCT03552549|42185584|FG000|Overall Study|Did not meet eligibility criteria|1|||
19738607|NCT03552549|42185585|FG001|Overall Study|Did not meet eligibility criteria|0|||
19738608|NCT03552549|42185584|FG000|Overall Study|Administrative|0|||
19738609|NCT03552549|42185585|FG001|Overall Study|Administrative|14|||
19738610|NCT00117845|42185591|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
19738611|NCT02761642|42185595|FG000|Overall Study|Did not Receive Study Treatment|3|||
19738612|NCT02761642|42185595|FG000|Overall Study|Adverse Event|13|||
19738613|NCT02761642|42185595|FG000|Overall Study|Withdrawal by Subject|2|||
19738614|NCT02761642|42185595|FG000|Overall Study|Non-compliant|7|||
19738615|NCT02761642|42185595|FG000|Overall Study|Death|3|||
19738616|NCT02761642|42185595|FG000|Overall Study|Lack of Efficacy|20|||
19738617|NCT02761642|42185595|FG000|Overall Study|Physician Decision|1|||
19738618|NCT02761642|42185595|FG000|Overall Study|Reason Unspecified|21|||
19738619|NCT00113555|42185599|FG000|Overall Study|Baseline Failure|59|||
19738620|NCT00113555|42185599|FG000|Overall Study|Permanently Explanted|7|||
19738621|NCT00113555|42185599|FG000|Overall Study|Death|1|||
19738622|NCT00113555|42185599|FG000|Overall Study|Missed Followup|4|||
19738623|NCT00113555|42185599|FG000|Overall Study|Lost to Follow-up|8|||
19380988|NCT01239797|41624234|FG000|Treated Participants|Disease progression|185|||
19380989|NCT01239797|41624235|FG001|Treated Participants|Disease progression|185|||
19380990|NCT01239797|41624234|FG000|Treated Participants|Study drug toxicity|39|||
19380991|NCT01239797|41624235|FG001|Treated Participants|Study drug toxicity|45|||
19380992|NCT01239797|41624234|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
19380993|NCT01239797|41624235|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
19738624|NCT03189524|42185607|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
19465421|NCT01737710|41723970|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
19465422|NCT01737710|41723971|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
19465423|NCT01737710|41723972|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
19465424|NCT01737710|41723973|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
19465425|NCT01737710|41723974|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
19465426|NCT01682876|41723989|FG000|Overall Study|Administrative reason|4|||
19465427|NCT01682876|41723990|FG001|Overall Study|Administrative reason|4|||
19465428|NCT01682876|41723991|FG002|Overall Study|Administrative reason|0|||
19465429|NCT01682876|41723992|FG003|Overall Study|Administrative reason|3|||
19465430|NCT01682876|41723989|FG000|Overall Study|Adverse Event|0|||
19465431|NCT01682876|41723990|FG001|Overall Study|Adverse Event|0|||
19465432|NCT01682876|41723991|FG002|Overall Study|Adverse Event|0|||
19465433|NCT01682876|41723992|FG003|Overall Study|Adverse Event|1|||
19465434|NCT01682876|41723989|FG000|Overall Study|Lost to Follow-up|11|||
19465435|NCT01682876|41723990|FG001|Overall Study|Lost to Follow-up|15|||
19465436|NCT01682876|41723991|FG002|Overall Study|Lost to Follow-up|9|||
19465437|NCT01682876|41723992|FG003|Overall Study|Lost to Follow-up|11|||
19465438|NCT01682876|41723989|FG000|Overall Study|Protocol Violation|1|||
19465439|NCT01682876|41723990|FG001|Overall Study|Protocol Violation|1|||
19465440|NCT01682876|41723991|FG002|Overall Study|Protocol Violation|1|||
19465441|NCT01682876|41723992|FG003|Overall Study|Protocol Violation|1|||
19465442|NCT01682876|41723989|FG000|Overall Study|Withdrawal by Subject|4|||
19465443|NCT01682876|41723990|FG001|Overall Study|Withdrawal by Subject|0|||
19465444|NCT01682876|41723991|FG002|Overall Study|Withdrawal by Subject|0|||
19465445|NCT01682876|41723992|FG003|Overall Study|Withdrawal by Subject|2|||
19465446|NCT01682876|41723989|FG000|Overall Study|Other|1|||
19465447|NCT01682876|41723990|FG001|Overall Study|Other|0|||
19465448|NCT01682876|41723991|FG002|Overall Study|Other|1|||
19465449|NCT01682876|41723992|FG003|Overall Study|Other|1|||
19465450|NCT01682720|41724009|FG000|Overall Study|Randomized but Not Treated|0|||
19465451|NCT01682720|41724010|FG001|Overall Study|Randomized but Not Treated|1|||
19465452|NCT01682720|41724011|FG002|Overall Study|Randomized but Not Treated|1|||
19465453|NCT01682720|41724012|FG003|Overall Study|Randomized but Not Treated|0|||
19465454|NCT01682720|41724009|FG000|Overall Study|Terminated by Sponsor|83|||
19465455|NCT01682720|41724010|FG001|Overall Study|Terminated by Sponsor|0|||
19465456|NCT01682720|41724011|FG002|Overall Study|Terminated by Sponsor|0|||
19465457|NCT01682720|41724012|FG003|Overall Study|Terminated by Sponsor|0|||
19465458|NCT01682720|41724009|FG000|Overall Study|Efficacy Failure|0|||
19465459|NCT01682720|41724010|FG001|Overall Study|Efficacy Failure|3|||
19465460|NCT01682720|41724011|FG002|Overall Study|Efficacy Failure|3|||
19465461|NCT01682720|41724012|FG003|Overall Study|Efficacy Failure|30|||
19465462|NCT01682720|41724009|FG000|Overall Study|Lost to Follow-up|1|||
19465463|NCT01682720|41724010|FG001|Overall Study|Lost to Follow-up|1|||
19465464|NCT01682720|41724011|FG002|Overall Study|Lost to Follow-up|0|||
19465465|NCT01682720|41724012|FG003|Overall Study|Lost to Follow-up|6|||
19465466|NCT01682720|41724009|FG000|Overall Study|Subject Withdrew Consent|0|||
19465467|NCT01682720|41724010|FG001|Overall Study|Subject Withdrew Consent|0|||
19465468|NCT01682720|41724011|FG002|Overall Study|Subject Withdrew Consent|2|||
19738625|NCT03189524|42185608|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
19465469|NCT01682720|41724012|FG003|Overall Study|Subject Withdrew Consent|2|||
19465470|NCT01682720|41724009|FG000|Overall Study|Adverse Event|1|||
19465471|NCT01682720|41724010|FG001|Overall Study|Adverse Event|0|||
19465472|NCT01682720|41724011|FG002|Overall Study|Adverse Event|1|||
19465473|NCT01682720|41724012|FG003|Overall Study|Adverse Event|1|||
19465474|NCT01714544|41724031|FG000|Overall Study|Lost to Follow-up|1|||
19465475|NCT01714544|41724031|FG000|Overall Study|Physician Decision|1|||
19465476|NCT01714544|41724031|FG000|Overall Study|Withdrawal by Subject|1|||
19465477|NCT01703858|41724038|FG000|Overall Study|Withdrawal by Subject|0|||
19465478|NCT01703858|41724039|FG001|Overall Study|Withdrawal by Subject|1|||
19465479|NCT01703858|41724040|FG002|Overall Study|Withdrawal by Subject|0|||
19465480|NCT01714310|41724056|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
19465481|NCT01714310|41724057|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
19465482|NCT01714310|41724058|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
19465483|NCT01714310|41724056|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
19465484|NCT01714310|41724057|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
19465485|NCT01714310|41724058|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
19465486|NCT01714310|41724056|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
19465487|NCT01714310|41724057|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
19465488|NCT01714310|41724058|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
19465489|NCT01714310|41724056|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
19465490|NCT01714310|41724057|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
19465491|NCT01714310|41724058|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
19465492|NCT01713998|41724079|FG000|Overall Study|Lost to Follow-up|2|||
19465493|NCT01713998|41724080|FG001|Overall Study|Lost to Follow-up|0|||
19738626|NCT03189524|42185609|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
19738627|NCT03189524|42185607|FG000|Overall Study|Death|2|||
19738628|NCT03189524|42185608|FG001|Overall Study|Death|2|||
19738629|NCT03189524|42185609|FG002|Overall Study|Death|1|||
19738630|NCT03189524|42185607|FG000|Overall Study|Lost to Follow-up|1|||
19738631|NCT03189524|42185608|FG001|Overall Study|Lost to Follow-up|0|||
19738632|NCT03189524|42185609|FG002|Overall Study|Lost to Follow-up|8|||
19738633|NCT03189524|42185607|FG000|Overall Study|Withdrawal by Subject|1|||
19738634|NCT03189524|42185608|FG001|Overall Study|Withdrawal by Subject|1|||
19738635|NCT03189524|42185609|FG002|Overall Study|Withdrawal by Subject|3|||
19738636|NCT03189524|42185607|FG000|Overall Study|Progressive Disease|0|||
19738637|NCT03189524|42185608|FG001|Overall Study|Progressive Disease|2|||
19738638|NCT03189524|42185609|FG002|Overall Study|Progressive Disease|0|||
19738639|NCT03600909|42185624|FG000|Overall Study|Not treated|0|||
19738640|NCT03600909|42185625|FG001|Overall Study|Not treated|3|||
19738641|NCT03600909|42185626|FG002|Overall Study|Not treated|0|||
19738642|NCT03189446|42185634|FG000|Overall Study|Adverse Event|2|||
19738643|NCT03189446|42185634|FG000|Overall Study|Withdrawal by Subject|2|||
19738644|NCT03189446|42185634|FG000|Overall Study|Physician Decision|1|||
19380994|NCT01239797|41624234|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
19465494|NCT01713998|41724081|FG002|Overall Study|Lost to Follow-up|2|||
19380995|NCT01239797|41624235|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
19738645|NCT03212690|42185638|FG000|Overall Study|Protocol Violation|1|||
19380996|NCT01239797|41624234|FG000|Treated Participants|Administrative reason by sponsor|13|||
19465495|NCT01713998|41724079|FG000|Overall Study|Withdrawal by Subject|1|||
19738646|NCT03568461|42185642|FG000|Overall Study|Death|7|||
19738647|NCT03568461|42185642|FG000|Overall Study|Physician Decision|5|||
19380997|NCT01239797|41624235|FG001|Treated Participants|Administrative reason by sponsor|4|||
19465496|NCT01713998|41724080|FG001|Overall Study|Withdrawal by Subject|0|||
19465497|NCT01713998|41724081|FG002|Overall Study|Withdrawal by Subject|0|||
19465498|NCT01681628|41724091|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
19738648|NCT03568461|42185642|FG000|Overall Study|Subject decision|5|||
19465499|NCT01681628|41724092|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
19465500|NCT01681628|41724091|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
19738649|NCT03568461|42185642|FG000|Overall Study|Lost to Follow-up|1|||
19380998|NCT01239797|41624234|FG000|Treated Participants|Other reasons|14|||
19380999|NCT01239797|41624235|FG001|Treated Participants|Other reasons|14|||
19738650|NCT03188120|42185646|FG000|Overall Study|Adverse Event|4|||
19381000|NCT01239797|41624234|FG000|Treated Participants|Participant withdrew consent|6|||
19381001|NCT01239797|41624235|FG001|Treated Participants|Participant withdrew consent|11|||
19381002|NCT01239797|41624234|FG000|Treated Participants|Death|1|||
19381003|NCT01239797|41624235|FG001|Treated Participants|Death|1|||
19381004|NCT01239797|41624234|FG000|Treated Participants|Participant no longer meets study criteria|1|||
19381005|NCT01239797|41624235|FG001|Treated Participants|Participant no longer meets study criteria|1|||
19381006|NCT01239797|41624234|FG000|Treated Participants|Poor/non-compliance|0|||
19381007|NCT01239797|41624235|FG001|Treated Participants|Poor/non-compliance|1|||
19381008|NCT02639065|41624241|FG000|Study Treatment|Disease Progression|11|||
19381009|NCT02639065|41624241|FG000|Study Treatment|Adverse Event|8|||
19381010|NCT02639065|41624241|FG000|Study Treatment|Withdrawal by Subject|1|||
19381011|NCT02639065|41624241|FG000|Follow up|Withdrawal by Subject|1|||
19381012|NCT02639065|41624241|FG000|Follow up|Symptomatic Deterioration|2|||
19381013|NCT02639065|41624241|FG000|Follow up|Death|2|||
19381014|NCT02639065|41624241|FG000|Follow up|Study Terminated|1|||
19381015|NCT02639065|41624241|FG000|Follow up|Disease Progression|3|||
19381016|NCT01236521|41624247|FG000|Overall Study|Withdrawal by Subject|12|||
19381017|NCT01236521|41624248|FG001|Overall Study|Withdrawal by Subject|17|||
19381018|NCT01236521|41624247|FG000|Overall Study|Death|2|||
19381019|NCT01236521|41624248|FG001|Overall Study|Death|1|||
19381020|NCT01236521|41624247|FG000|Overall Study|Lost to Follow-up|9|||
19381021|NCT01236521|41624248|FG001|Overall Study|Lost to Follow-up|7|||
19381022|NCT01092143|41624259|FG000|Overall Study|Adverse Event|10|||
19381023|NCT01092143|41624260|FG001|Overall Study|Adverse Event|5|||
19381024|NCT01092143|41624261|FG002|Overall Study|Adverse Event|1|||
19381025|NCT01092143|41624262|FG003|Overall Study|Adverse Event|4|||
19381026|NCT01092143|41624263|FG004|Overall Study|Adverse Event|3|||
19381027|NCT01092143|41624259|FG000|Overall Study|Lost to Follow-up|1|||
19381028|NCT01092143|41624260|FG001|Overall Study|Lost to Follow-up|0|||
19381029|NCT01092143|41624261|FG002|Overall Study|Lost to Follow-up|1|||
19381030|NCT01092143|41624262|FG003|Overall Study|Lost to Follow-up|0|||
19381031|NCT01092143|41624263|FG004|Overall Study|Lost to Follow-up|0|||
19381032|NCT01092143|41624259|FG000|Overall Study|Consent withdrawn|2|||
19381033|NCT01092143|41624260|FG001|Overall Study|Consent withdrawn|1|||
19381034|NCT01092143|41624261|FG002|Overall Study|Consent withdrawn|0|||
19381035|NCT01092143|41624262|FG003|Overall Study|Consent withdrawn|1|||
19381036|NCT01092143|41624263|FG004|Overall Study|Consent withdrawn|3|||
19381037|NCT01092143|41624259|FG000|Overall Study|Not treated|0|||
19381038|NCT01092143|41624260|FG001|Overall Study|Not treated|0|||
19381039|NCT01092143|41624261|FG002|Overall Study|Not treated|1|||
19381040|NCT01092143|41624262|FG003|Overall Study|Not treated|0|||
19381041|NCT01092143|41624263|FG004|Overall Study|Not treated|0|||
19381042|NCT01092143|41624259|FG000|Overall Study|did not reversibility criteria|0|||
19381043|NCT01092143|41624260|FG001|Overall Study|did not reversibility criteria|0|||
19381044|NCT01092143|41624261|FG002|Overall Study|did not reversibility criteria|1|||
19381045|NCT01092143|41624262|FG003|Overall Study|did not reversibility criteria|0|||
19381046|NCT01092143|41624263|FG004|Overall Study|did not reversibility criteria|0|||
19381047|NCT01092143|41624259|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
19381048|NCT01092143|41624260|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
19381049|NCT01092143|41624261|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
19381050|NCT01092143|41624262|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
19381051|NCT01092143|41624263|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
19381052|NCT01092143|41624259|FG000|Overall Study|Ineligible patient|1|||
19381053|NCT01092143|41624260|FG001|Overall Study|Ineligible patient|0|||
19381054|NCT01092143|41624261|FG002|Overall Study|Ineligible patient|0|||
19381055|NCT01092143|41624262|FG003|Overall Study|Ineligible patient|0|||
19381056|NCT01092143|41624263|FG004|Overall Study|Ineligible patient|0|||
19381057|NCT01092143|41624259|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
19381058|NCT01092143|41624260|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
19381059|NCT01092143|41624261|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
19381060|NCT01092143|41624262|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
19381061|NCT01092143|41624263|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
19381062|NCT01092143|41624259|FG000|Overall Study|Patient travel|0|||
19381063|NCT01092143|41624260|FG001|Overall Study|Patient travel|0|||
19381064|NCT01092143|41624261|FG002|Overall Study|Patient travel|0|||
19381065|NCT01092143|41624262|FG003|Overall Study|Patient travel|0|||
19381066|NCT01092143|41624263|FG004|Overall Study|Patient travel|1|||
19465501|NCT01681628|41724092|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
19465502|NCT01681628|41724091|FG000|19 Months Follow-up|Death|1|||
19465503|NCT01681628|41724092|FG001|19 Months Follow-up|Death|0|||
19465504|NCT01681628|41724091|FG000|19 Months Follow-up|Lost to Follow-up|61|||
19465505|NCT01681628|41724092|FG001|19 Months Follow-up|Lost to Follow-up|43|||
19465506|NCT00016354|41724114|FG000|Overall Study|Lack of Efficacy|0|||
19465507|NCT00016354|41724115|FG001|Overall Study|Lack of Efficacy|0|||
19465508|NCT00016354|41724116|FG002|Overall Study|Lack of Efficacy|0|||
19465509|NCT00016354|41724117|FG003|Overall Study|Lack of Efficacy|0|||
19465510|NCT00016354|41724118|FG004|Overall Study|Lack of Efficacy|0|||
19465511|NCT00016354|41724119|FG005|Overall Study|Lack of Efficacy|0|||
19465512|NCT00016354|41724120|FG006|Overall Study|Lack of Efficacy|0|||
19465513|NCT00016354|41724121|FG007|Overall Study|Lack of Efficacy|1|||
19465514|NCT01681472|41724129|FG000|Overall Study|Adverse Event|0|||
19465515|NCT01681472|41724130|FG001|Overall Study|Adverse Event|1|||
19465516|NCT01681472|41724131|FG002|Overall Study|Adverse Event|0|||
19465517|NCT01681472|41724132|FG003|Overall Study|Adverse Event|0|||
19465518|NCT01049308|41724161|FG000|Pill Counts|Withdrawal by Subject|83|||
19465519|NCT01713686|41724168|FG000|Overall Study|Lost to Follow-up|9|||
19381067|NCT01092143|41624259|FG000|Overall Study|Non compliance with study medication|0|||
19381068|NCT01092143|41624260|FG001|Overall Study|Non compliance with study medication|0|||
19738651|NCT03188120|42185646|FG000|Overall Study|Insufficient Effectiveness|8|||
19465520|NCT01713686|41724168|FG000|Overall Study|Withdrawal by Subject|6|||
19465521|NCT01047436|41724174|FG000|Overall Study|Protocol Violation|1|||
19381069|NCT01092143|41624261|FG002|Overall Study|Non compliance with study medication|0|||
19465522|NCT01047436|41724175|FG001|Overall Study|Protocol Violation|0|||
19465523|NCT01681004|41724183|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
19381070|NCT01092143|41624262|FG003|Overall Study|Non compliance with study medication|0|||
19465524|NCT01681004|41724184|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
19465525|NCT01681004|41724183|FG000|Study Completion|Lost to Follow-up|8|||
19381071|NCT01092143|41624263|FG004|Overall Study|Non compliance with study medication|1|||
19551322|NCT01342913|42000151|FG001|2-week Run-in Period|Protocol Violation|0|||
19551323|NCT01342913|42000152|FG002|2-week Run-in Period|Protocol Violation|0|||
19551324|NCT01342913|42000150|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
19551325|NCT01342913|42000151|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
19551326|NCT01342913|42000152|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
19551327|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19551328|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Adverse Event|3|||
19551329|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Adverse Event|6|||
19551330|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
19551331|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
19551332|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
19551333|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
19551334|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
19551335|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
19465526|NCT01681004|41724184|FG001|Study Completion|Lost to Follow-up|3|||
19465527|NCT01681004|41724183|FG000|Study Completion|Physician Decision|1|||
19465528|NCT01681004|41724184|FG001|Study Completion|Physician Decision|3|||
19381072|NCT01092143|41624259|FG000|Overall Study|Randomized by mistake|0|||
19465529|NCT01681004|41724183|FG000|Study Completion|Site Termination|2|||
19465530|NCT01681004|41724184|FG001|Study Completion|Site Termination|1|||
19465531|NCT01681004|41724183|FG000|Study Completion|Death|1|||
19465532|NCT01681004|41724184|FG001|Study Completion|Death|1|||
19381073|NCT01092143|41624260|FG001|Overall Study|Randomized by mistake|0|||
19381074|NCT01092143|41624261|FG002|Overall Study|Randomized by mistake|0|||
19465533|NCT01046110|41724196|FG000|Overall Study|Adverse Event|9|||
19381075|NCT01092143|41624262|FG003|Overall Study|Randomized by mistake|1|||
19465534|NCT01046110|41724197|FG001|Overall Study|Adverse Event|2|||
19465535|NCT01046110|41724196|FG000|Overall Study|Lack of Efficacy|0|||
19465536|NCT01046110|41724197|FG001|Overall Study|Lack of Efficacy|1|||
19465537|NCT01046110|41724196|FG000|Overall Study|Protocol Violation|7|||
19465538|NCT01046110|41724197|FG001|Overall Study|Protocol Violation|12|||
19465539|NCT01046110|41724196|FG000|Overall Study|Withdrawal Criteria|3|||
19381076|NCT01092143|41624263|FG004|Overall Study|Randomized by mistake|0|||
19465540|NCT01046110|41724197|FG001|Overall Study|Withdrawal Criteria|5|||
19465541|NCT01046110|41724196|FG000|Overall Study|Unclassified|36|||
19465542|NCT01046110|41724197|FG001|Overall Study|Unclassified|35|||
19738652|NCT03188120|42185646|FG000|Overall Study|Improved|12|||
19738653|NCT03188120|42185646|FG000|Overall Study|Lost to Follow-up|7|||
19738654|NCT03188120|42185646|FG000|Overall Study|Other than specified|3|||
19738655|NCT03188120|42185646|FG000|Overall Study|No visit after the first visit|13|||
19738656|NCT02895945|42185652|FG000|Overall Study|Physician Decision|2|||
19738657|NCT02895945|42185653|FG001|Overall Study|Physician Decision|1|||
19738658|NCT02777554|42185661|FG000|Overall Study|Adverse Event|4|||
19738659|NCT02777554|42185662|FG001|Overall Study|Adverse Event|4|||
19738660|NCT02777554|42185663|FG002|Overall Study|Adverse Event|0|||
19738661|NCT02777554|42185664|FG003|Overall Study|Adverse Event|1|||
19381077|NCT01092143|41624259|FG000|Overall Study|Pregnancy|0|||
19381078|NCT01092143|41624260|FG001|Overall Study|Pregnancy|0|||
19381079|NCT01092143|41624261|FG002|Overall Study|Pregnancy|0|||
19381080|NCT01092143|41624262|FG003|Overall Study|Pregnancy|1|||
19381081|NCT01092143|41624263|FG004|Overall Study|Pregnancy|0|||
19381082|NCT02377466|41624277|FG000|Overall Study|Other: Randomized and not treated|0|||
19381083|NCT02377466|41624278|FG001|Overall Study|Other: Randomized and not treated|2|||
19465543|NCT01713530|41724205|FG000|Overall Study|Adverse Event|0|||
19381084|NCT00950989|41624295|FG000|Overall Study|Death|0|||
19738662|NCT02777554|42185665|FG004|Overall Study|Adverse Event|0|||
19381085|NCT00950989|41624296|FG001|Overall Study|Death|0|||
19465544|NCT01713530|41724206|FG001|Overall Study|Adverse Event|5|||
19465545|NCT01713530|41724205|FG000|Overall Study|Withdrawal criteria|21|||
19465546|NCT01713530|41724206|FG001|Overall Study|Withdrawal criteria|12|||
19465547|NCT01713530|41724205|FG000|Overall Study|Unclassified|4|||
19465548|NCT01713530|41724206|FG001|Overall Study|Unclassified|2|||
19465549|NCT01045798|41724214|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
19465550|NCT01045798|41724215|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
19465551|NCT01045798|41724214|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
19465552|NCT01045798|41724215|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
19465553|NCT01045798|41724214|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
19465554|NCT01045798|41724215|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
19465555|NCT01045798|41724214|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
19465556|NCT01045798|41724215|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
19465557|NCT01712984|41724228|FG000|Overall Study|Adverse Event|0|||
19465558|NCT01712984|41724229|FG001|Overall Study|Adverse Event|0|||
19465559|NCT01712984|41724230|FG002|Overall Study|Adverse Event|1|||
19465560|NCT01712984|41724228|FG000|Overall Study|Protocol Violation|2|||
19465561|NCT01712984|41724229|FG001|Overall Study|Protocol Violation|0|||
19465562|NCT01712984|41724230|FG002|Overall Study|Protocol Violation|1|||
19465563|NCT01712984|41724228|FG000|Overall Study|Lost to Follow-up|8|||
19465564|NCT01712984|41724229|FG001|Overall Study|Lost to Follow-up|10|||
19465565|NCT01712984|41724230|FG002|Overall Study|Lost to Follow-up|1|||
19465566|NCT01712984|41724228|FG000|Overall Study|Withdrawal by Subject|6|||
19465567|NCT01712984|41724229|FG001|Overall Study|Withdrawal by Subject|6|||
19465568|NCT01712984|41724230|FG002|Overall Study|Withdrawal by Subject|7|||
19738663|NCT02777554|42185666|FG005|Overall Study|Adverse Event|0|||
19738664|NCT02777554|42185661|FG000|Overall Study|Withdrawal by Subject|3|||
19738665|NCT02777554|42185662|FG001|Overall Study|Withdrawal by Subject|1|||
19738666|NCT02777554|42185663|FG002|Overall Study|Withdrawal by Subject|1|||
19738667|NCT02777554|42185664|FG003|Overall Study|Withdrawal by Subject|0|||
19738668|NCT02777554|42185665|FG004|Overall Study|Withdrawal by Subject|0|||
19738669|NCT02777554|42185666|FG005|Overall Study|Withdrawal by Subject|0|||
19738670|NCT02777554|42185661|FG000|Overall Study|Discharged early due to hurricane|22|||
19738671|NCT02777554|42185662|FG001|Overall Study|Discharged early due to hurricane|20|||
19738672|NCT02777554|42185663|FG002|Overall Study|Discharged early due to hurricane|0|||
19738673|NCT02777554|42185664|FG003|Overall Study|Discharged early due to hurricane|0|||
19738674|NCT02777554|42185665|FG004|Overall Study|Discharged early due to hurricane|0|||
19738675|NCT02777554|42185666|FG005|Overall Study|Discharged early due to hurricane|0|||
19738676|NCT02777554|42185661|FG000|Overall Study|Other - Miscellaneous|1|||
19738677|NCT02777554|42185662|FG001|Overall Study|Other - Miscellaneous|0|||
19738678|NCT02777554|42185663|FG002|Overall Study|Other - Miscellaneous|0|||
19381086|NCT00950989|41624297|FG002|Overall Study|Death|1|||
19738679|NCT02777554|42185664|FG003|Overall Study|Other - Miscellaneous|0|||
19738680|NCT02777554|42185665|FG004|Overall Study|Other - Miscellaneous|0|||
19381087|NCT00950989|41624298|FG003|Overall Study|Death|0|||
19551336|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19551337|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
19551338|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
19465569|NCT01042678|41724241|FG000|Overall Study|Physician Decision|1|||
19465570|NCT01042678|41724242|FG001|Overall Study|Physician Decision|0|||
19465571|NCT01042678|41724243|FG002|Overall Study|Physician Decision|0|||
19465572|NCT01042678|41724244|FG003|Overall Study|Physician Decision|0|||
19465573|NCT01042678|41724245|FG004|Overall Study|Physician Decision|0|||
19465574|NCT01042678|41724246|FG005|Overall Study|Physician Decision|0|||
19465575|NCT01042600|41724256|FG000|Overall Study|Ineligible|1|||
19465576|NCT01042600|41724257|FG001|Overall Study|Ineligible|0|||
19465577|NCT01041976|41724266|FG000|Overall Study|Withdrawal by Subject|3|||
19465578|NCT01041976|41724267|FG001|Overall Study|Withdrawal by Subject|0|||
19465579|NCT01041976|41724266|FG000|Overall Study|Incarceration|2|||
19465580|NCT01041976|41724267|FG001|Overall Study|Incarceration|0|||
19465581|NCT01041976|41724266|FG000|Overall Study|Death|0|||
19465582|NCT01041976|41724267|FG001|Overall Study|Death|4|||
19465583|NCT01712516|41724293|FG000|Overall Study|Technical problems|0|||
19465584|NCT01712516|41724294|FG001|Overall Study|Technical problems|0|||
19465585|NCT01712516|41724295|FG002|Overall Study|Technical problems|0|||
19738681|NCT02777554|42185666|FG005|Overall Study|Other - Miscellaneous|0|||
19465586|NCT01712516|41724296|FG003|Overall Study|Technical problems|2|||
19465587|NCT01712516|41724293|FG000|Overall Study|Lost to Follow-up|0|||
19465588|NCT01712516|41724294|FG001|Overall Study|Lost to Follow-up|0|||
19465589|NCT01712516|41724295|FG002|Overall Study|Lost to Follow-up|2|||
19465590|NCT01712516|41724296|FG003|Overall Study|Lost to Follow-up|1|||
19465591|NCT01712516|41724293|FG000|Overall Study|Death|0|||
19465592|NCT01712516|41724294|FG001|Overall Study|Death|1|||
19465593|NCT01712516|41724295|FG002|Overall Study|Death|0|||
19465594|NCT01712516|41724296|FG003|Overall Study|Death|0|||
19465595|NCT01712516|41724293|FG000|Overall Study|Protocol deviation|1|||
19465596|NCT01712516|41724294|FG001|Overall Study|Protocol deviation|0|||
19465597|NCT01712516|41724295|FG002|Overall Study|Protocol deviation|1|||
19465598|NCT01712516|41724296|FG003|Overall Study|Protocol deviation|0|||
19465599|NCT01712516|41724293|FG000|Overall Study|Physician Decision|2|||
19465600|NCT01712516|41724294|FG001|Overall Study|Physician Decision|0|||
19381088|NCT00950989|41624295|FG000|Overall Study|Administrative Decision|0|||
19381089|NCT00950989|41624296|FG001|Overall Study|Administrative Decision|1|||
19381090|NCT00950989|41624297|FG002|Overall Study|Administrative Decision|0|||
19465601|NCT01712516|41724295|FG002|Overall Study|Physician Decision|0|||
19465602|NCT01712516|41724296|FG003|Overall Study|Physician Decision|1|||
19465603|NCT01712516|41724293|FG000|Overall Study|Withdrawal by Subject|3|||
19738682|NCT03550209|42185690|FG000|Overall Study|Lost to Follow-up|1|||
19738683|NCT03550209|42185691|FG001|Overall Study|Lost to Follow-up|0|||
19465604|NCT01712516|41724294|FG001|Overall Study|Withdrawal by Subject|9|||
19465605|NCT01712516|41724295|FG002|Overall Study|Withdrawal by Subject|3|||
19465606|NCT01712516|41724296|FG003|Overall Study|Withdrawal by Subject|9|||
19465607|NCT01703000|41724306|FG000|Overall Study|Death|1|||
19465608|NCT01040728|41724310|FG000|Overall Study|Adverse Event|4|||
19465609|NCT01040728|41724311|FG001|Overall Study|Adverse Event|8|||
19373405|NCT02761733|41614491|FG000|Overall Study|Discharged from Study Site|10|||
19373406|NCT02761733|41614492|FG001|Overall Study|Discharged from Study Site|9|||
19373407|NCT02761733|41614493|FG002|Overall Study|Discharged from Study Site|25|||
19373408|NCT02761733|41614494|FG003|Overall Study|Discharged from Study Site|11|||
19373409|NCT02761733|41614491|FG000|Overall Study|Cognitive Impairment|5|||
19373410|NCT02761733|41614492|FG001|Overall Study|Cognitive Impairment|0|||
19373411|NCT02761733|41614493|FG002|Overall Study|Cognitive Impairment|1|||
19373412|NCT02761733|41614494|FG003|Overall Study|Cognitive Impairment|0|||
19373413|NCT03715465|41614506|FG000|Overall Study|Withdrawal by Subject|1|||
19373414|NCT03715465|41614507|FG001|Overall Study|Withdrawal by Subject|2|||
19373415|NCT00840073|41614515|FG000|Second Intervention|Missed 72 hour blood draw|1|||
19373416|NCT00840073|41614516|FG001|Second Intervention|Missed 72 hour blood draw|1|||
19373417|NCT00838279|41614522|FG000|Washout|Protocol Violation|1|||
19373418|NCT00838279|41614523|FG001|Washout|Protocol Violation|0|||
19373419|NCT00838279|41614522|FG000|Washout|Withdrawal by Subject|0|||
19373420|NCT00838279|41614523|FG001|Washout|Withdrawal by Subject|1|||
19373421|NCT02759939|41614531|FG000|Overall Study|Missing data on first outcome assessed|11|||
19373422|NCT02759939|41614532|FG001|Overall Study|Missing data on first outcome assessed|2|||
19373423|NCT02759939|41614533|FG002|Overall Study|Missing data on first outcome assessed|5|||
19373424|NCT02759939|41614534|FG003|Overall Study|Missing data on first outcome assessed|2|||
19373425|NCT02759939|41614531|FG000|Overall Study|Ineligible for T2 and T3|310|||
19373426|NCT02759939|41614532|FG001|Overall Study|Ineligible for T2 and T3|179|||
19373427|NCT02759939|41614533|FG002|Overall Study|Ineligible for T2 and T3|366|||
19373428|NCT02759939|41614534|FG003|Overall Study|Ineligible for T2 and T3|391|||
19373429|NCT02759939|41614531|FG000|Overall Study|Lost to Follow-up|735|||
19373430|NCT02759939|41614532|FG001|Overall Study|Lost to Follow-up|791|||
19373431|NCT02759939|41614533|FG002|Overall Study|Lost to Follow-up|783|||
19373432|NCT02759939|41614534|FG003|Overall Study|Lost to Follow-up|650|||
19373433|NCT00835705|41614553|FG000|First Intervention|Difficulty with vein|1|||
19373434|NCT00835705|41614554|FG001|First Intervention|Difficulty with vein|0|||
19373435|NCT00835705|41614553|FG000|Second Intervention|Difficulty with vein|1|||
19373436|NCT00835705|41614554|FG001|Second Intervention|Difficulty with vein|0|||
19373437|NCT02938520|41614560|FG000|Overall Study|On-going at the time of analysis|258|||
19373438|NCT02938520|41614561|FG001|Overall Study|On-going at the time of analysis|261|||
19373439|NCT02938520|41614560|FG000|Overall Study|Physician Decision|2|||
19373440|NCT02938520|41614561|FG001|Overall Study|Physician Decision|5|||
19373441|NCT02938520|41614560|FG000|Overall Study|Lost to Follow-up|2|||
19373442|NCT02938520|41614561|FG001|Overall Study|Lost to Follow-up|2|||
19373443|NCT02938520|41614560|FG000|Overall Study|Withdrawal by Subject|7|||
19373444|NCT02938520|41614561|FG001|Overall Study|Withdrawal by Subject|7|||
19373445|NCT02938520|41614560|FG000|Overall Study|Protocol Violation|0|||
19373446|NCT02938520|41614561|FG001|Overall Study|Protocol Violation|1|||
19373447|NCT02938520|41614560|FG000|Overall Study|Lack of Efficacy|5|||
19373448|NCT02938520|41614561|FG001|Overall Study|Lack of Efficacy|3|||
19373449|NCT02938520|41614560|FG000|Overall Study|Adverse Event|9|||
19373450|NCT02938520|41614561|FG001|Overall Study|Adverse Event|4|||
19373451|NCT02759471|41614570|FG000|Overall Study|discomfort|2|||
19373452|NCT00835549|41614578|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
19373453|NCT00835549|41614579|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19373454|NCT03945825|41614589|FG000|Overall Study|Enrolled but treatment not administered|0|||
19373455|NCT03945825|41614590|FG001|Overall Study|Enrolled but treatment not administered|0|||
19373456|NCT03945825|41614591|FG002|Overall Study|Enrolled but treatment not administered|0|||
19373457|NCT03945825|41614592|FG003|Overall Study|Enrolled but treatment not administered|0|||
19373458|NCT03945825|41614593|FG004|Overall Study|Enrolled but treatment not administered|1|||
19373459|NCT03945825|41614594|FG005|Overall Study|Enrolled but treatment not administered|0|||
19373460|NCT03945825|41614589|FG000|Overall Study|Lost to Follow-up|1|||
19373461|NCT03945825|41614590|FG001|Overall Study|Lost to Follow-up|5|||
19373462|NCT03945825|41614591|FG002|Overall Study|Lost to Follow-up|0|||
19381091|NCT00950989|41624298|FG003|Overall Study|Administrative Decision|0|||
19381092|NCT00950989|41624295|FG000|Overall Study|Disease Progression|0|||
19381093|NCT00950989|41624296|FG001|Overall Study|Disease Progression|0|||
19381094|NCT00950989|41624297|FG002|Overall Study|Disease Progression|1|||
19381095|NCT00950989|41624298|FG003|Overall Study|Disease Progression|0|||
19381096|NCT00950989|41624295|FG000|Overall Study|Withdrawal by Subject|2|||
19381097|NCT00950989|41624296|FG001|Overall Study|Withdrawal by Subject|1|||
19381098|NCT00950989|41624297|FG002|Overall Study|Withdrawal by Subject|0|||
19381099|NCT00950989|41624298|FG003|Overall Study|Withdrawal by Subject|0|||
19381100|NCT00950989|41624295|FG000|Overall Study|Adverse Event|2|||
19381101|NCT00950989|41624296|FG001|Overall Study|Adverse Event|1|||
19381102|NCT00950989|41624297|FG002|Overall Study|Adverse Event|1|||
19381103|NCT00950989|41624298|FG003|Overall Study|Adverse Event|0|||
19381104|NCT00593567|41624313|FG000|Overall Study|Adverse Event|2|||
19381105|NCT00593567|41624314|FG001|Overall Study|Adverse Event|0|||
19381106|NCT00593567|41624313|FG000|Overall Study|Physician Decision|2|||
19381107|NCT00593567|41624314|FG001|Overall Study|Physician Decision|0|||
19381108|NCT00593567|41624313|FG000|Overall Study|Protocol Violation|13|||
19381109|NCT00593567|41624314|FG001|Overall Study|Protocol Violation|7|||
19381110|NCT00593567|41624313|FG000|Overall Study|Lack of Efficacy|2|||
19381111|NCT00593567|41624314|FG001|Overall Study|Lack of Efficacy|1|||
19381112|NCT00593567|41624313|FG000|Overall Study|Withdrawal by Subject|1|||
19381113|NCT00593567|41624314|FG001|Overall Study|Withdrawal by Subject|2|||
19381114|NCT02411084|41624322|FG000|Overall Study|Lack of Efficacy|6|||
19381115|NCT02411084|41624323|FG001|Overall Study|Lack of Efficacy|3|||
19381116|NCT02411084|41624322|FG000|Overall Study|Death|5|||
19381117|NCT02411084|41624323|FG001|Overall Study|Death|4|||
19381118|NCT02411084|41624322|FG000|Overall Study|Adverse Event|2|||
19381119|NCT02411084|41624323|FG001|Overall Study|Adverse Event|1|||
19381120|NCT02411084|41624322|FG000|Overall Study|Other reasons|0|||
19381121|NCT02411084|41624323|FG001|Overall Study|Other reasons|5|||
19381122|NCT01602315|41624336|FG000|Overall Study|Protocol Violation|0|||
19381123|NCT01602315|41624337|FG001|Overall Study|Protocol Violation|0|||
19381124|NCT01602315|41624338|FG002|Overall Study|Protocol Violation|0|||
19381125|NCT01602315|41624339|FG003|Overall Study|Protocol Violation|0|||
19381126|NCT01602315|41624340|FG004|Overall Study|Protocol Violation|0|||
19381127|NCT01602315|41624341|FG005|Overall Study|Protocol Violation|1|||
19381128|NCT01602315|41624342|FG006|Overall Study|Protocol Violation|0|||
19381129|NCT01602315|41624336|FG000|Overall Study|Physician Decision|2|||
19381130|NCT01602315|41624337|FG001|Overall Study|Physician Decision|0|||
19381131|NCT01602315|41624338|FG002|Overall Study|Physician Decision|0|||
19381132|NCT01602315|41624339|FG003|Overall Study|Physician Decision|0|||
19381133|NCT01602315|41624340|FG004|Overall Study|Physician Decision|2|||
19381134|NCT01602315|41624341|FG005|Overall Study|Physician Decision|1|||
19381135|NCT01602315|41624342|FG006|Overall Study|Physician Decision|1|||
19381136|NCT01602315|41624336|FG000|Overall Study|Disease progression|6|||
19381137|NCT01602315|41624337|FG001|Overall Study|Disease progression|3|||
19381138|NCT01602315|41624338|FG002|Overall Study|Disease progression|10|||
19381139|NCT01602315|41624339|FG003|Overall Study|Disease progression|1|||
19381140|NCT01602315|41624340|FG004|Overall Study|Disease progression|41|||
19381141|NCT01602315|41624341|FG005|Overall Study|Disease progression|12|||
19738684|NCT03550209|42185692|FG002|Overall Study|Lost to Follow-up|1|||
19373463|NCT03945825|41614592|FG003|Overall Study|Lost to Follow-up|1|||
19465610|NCT01040728|41724312|FG002|Overall Study|Adverse Event|0|||
19465611|NCT01040728|41724313|FG003|Overall Study|Adverse Event|4|||
19465612|NCT01040728|41724310|FG000|Overall Study|Withdrawal by Subject|0|||
19465613|NCT01040728|41724311|FG001|Overall Study|Withdrawal by Subject|1|||
19373464|NCT03945825|41614593|FG004|Overall Study|Lost to Follow-up|2|||
19465614|NCT01040728|41724312|FG002|Overall Study|Withdrawal by Subject|1|||
19465615|NCT01040728|41724313|FG003|Overall Study|Withdrawal by Subject|0|||
19465616|NCT01040728|41724310|FG000|Overall Study|Protocol Violation|0|||
19381142|NCT01602315|41624342|FG006|Overall Study|Disease progression|15|||
19381143|NCT01602315|41624336|FG000|Overall Study|Death|1|||
19465617|NCT01040728|41724311|FG001|Overall Study|Protocol Violation|0|||
19465618|NCT01040728|41724312|FG002|Overall Study|Protocol Violation|0|||
19465619|NCT01040728|41724313|FG003|Overall Study|Protocol Violation|1|||
19465620|NCT01040728|41724310|FG000|Overall Study|Lack of Efficacy|0|||
19465621|NCT01040728|41724311|FG001|Overall Study|Lack of Efficacy|1|||
19465622|NCT01040728|41724312|FG002|Overall Study|Lack of Efficacy|0|||
19465623|NCT01040728|41724313|FG003|Overall Study|Lack of Efficacy|1|||
19465624|NCT01040728|41724310|FG000|Overall Study|Other reasons not listed above|0|||
19465625|NCT01040728|41724311|FG001|Overall Study|Other reasons not listed above|1|||
19465626|NCT01040728|41724312|FG002|Overall Study|Other reasons not listed above|0|||
19465627|NCT01040728|41724313|FG003|Overall Study|Other reasons not listed above|0|||
19465628|NCT01593020|41724331|FG000|Overall Study|Adverse Event|1|||
19465629|NCT01593020|41724332|FG001|Overall Study|Adverse Event|1|||
19465630|NCT01593020|41724331|FG000|Overall Study|Death|0|||
19465631|NCT01593020|41724332|FG001|Overall Study|Death|1|||
19465632|NCT01593020|41724331|FG000|Overall Study|Ineligible|1|||
19465633|NCT01593020|41724332|FG001|Overall Study|Ineligible|0|||
19465634|NCT01040260|41724340|FG000|Overall Study|Withdrawal by Subject|12|||
19465635|NCT01040260|41724341|FG001|Overall Study|Withdrawal by Subject|6|||
19465636|NCT01040260|41724340|FG000|Overall Study|Lost to Follow-up|3|||
19465637|NCT01040260|41724341|FG001|Overall Study|Lost to Follow-up|5|||
19465638|NCT01712438|41724347|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
19465639|NCT01712438|41724347|FG000|Overall Study|Ongoing ITI treatment|6|||
19465640|NCT01712438|41724347|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
19465641|NCT01712438|41724347|FG000|Overall Study|Prematurely Discontinued|25|||
19465642|NCT01712204|41724358|FG000|Overall Study|Adverse Event|3|||
19465643|NCT01712204|41724359|FG001|Overall Study|Adverse Event|1|||
19465644|NCT01712204|41724358|FG000|Overall Study|Withdrawal by Subject|3|||
19465645|NCT01712204|41724359|FG001|Overall Study|Withdrawal by Subject|3|||
19465646|NCT01712204|41724358|FG000|Overall Study|Lost to Follow-up|1|||
19465647|NCT01712204|41724359|FG001|Overall Study|Lost to Follow-up|0|||
19465648|NCT01712204|41724358|FG000|Overall Study|Protocol Violation|1|||
19465649|NCT01712204|41724359|FG001|Overall Study|Protocol Violation|1|||
19738685|NCT03550209|42185693|FG003|Overall Study|Lost to Follow-up|0|||
19373465|NCT03945825|41614594|FG005|Overall Study|Lost to Follow-up|2|||
19465650|NCT01592864|41724367|FG000|Overall Study|Withdrawal by Subject|0|||
19465651|NCT01592864|41724368|FG001|Overall Study|Withdrawal by Subject|1|||
19465652|NCT01592786|41724374|FG000|Overall Study|Adverse Event|60|||
19465653|NCT01592786|41724374|FG000|Overall Study|Lack of Efficacy|19|||
19465654|NCT01592786|41724374|FG000|Overall Study|Protocol Violation|14|||
19465655|NCT01592786|41724374|FG000|Overall Study|Withdrawal by Subject|23|||
19465656|NCT01592786|41724374|FG000|Overall Study|Lost to Follow-up|19|||
19465657|NCT01592786|41724374|FG000|Overall Study|Other|3|||
19465658|NCT01711736|41724380|FG000|Overall Study|Lost to Follow-up|4|||
19465659|NCT01711736|41724381|FG001|Overall Study|Lost to Follow-up|1|||
19465660|NCT01711736|41724380|FG000|Overall Study|Withdrawal by Subject|6|||
19465661|NCT01711736|41724381|FG001|Overall Study|Withdrawal by Subject|6|||
19465662|NCT01711736|41724380|FG000|Overall Study|Migrated/moved from study area|2|||
19465663|NCT01711736|41724381|FG001|Overall Study|Migrated/moved from study area|1|||
19465664|NCT01592708|41724390|FG000|Overall Study|Protocol Violation|3|||
19381144|NCT01602315|41624337|FG001|Overall Study|Death|1|||
19465665|NCT01592708|41724391|FG001|Overall Study|Protocol Violation|0|||
19465666|NCT01042522|41724402|FG000|Overall Study|Adverse Event|1|||
19465667|NCT01042522|41724403|FG001|Overall Study|Adverse Event|2|||
19373466|NCT03945825|41614589|FG000|Overall Study|Withdrawal by Subject|1|||
19465668|NCT01042522|41724402|FG000|Overall Study|Disease Progression|5|||
19465669|NCT01042522|41724403|FG001|Overall Study|Disease Progression|0|||
19381145|NCT01602315|41624338|FG002|Overall Study|Death|1|||
19381146|NCT01602315|41624339|FG003|Overall Study|Death|1|||
19381147|NCT01602315|41624340|FG004|Overall Study|Death|7|||
19465670|NCT01042522|41724402|FG000|Overall Study|Death|1|||
19465671|NCT01042522|41724403|FG001|Overall Study|Death|0|||
19465672|NCT01042522|41724402|FG000|Overall Study|Patient Refused|0|||
19465673|NCT01042522|41724403|FG001|Overall Study|Patient Refused|3|||
19465674|NCT01042522|41724402|FG000|Overall Study|Withdrawal by Subject|1|||
19465675|NCT01042522|41724403|FG001|Overall Study|Withdrawal by Subject|1|||
19465676|NCT01702844|41724409|FG000|Overall Study|Adverse Event|9|||
19465677|NCT01702844|41724409|FG000|Overall Study|Death|1|||
19465678|NCT01702844|41724409|FG000|Overall Study|Withdrawal by Subject|3|||
19465679|NCT01702844|41724409|FG000|Overall Study|Physician Decision|6|||
19465680|NCT01702532|41724415|FG000|Overall Study|Adverse Event|0|||
19465681|NCT01702532|41724416|FG001|Overall Study|Adverse Event|1|||
19465682|NCT01702454|41724425|FG000|Overall Study|Consent withdrawal|0|||
19465683|NCT01702454|41724426|FG001|Overall Study|Consent withdrawal|1|||
19465684|NCT01702454|41724425|FG000|Overall Study|Migrated/moved from study area|0|||
19381148|NCT01602315|41624341|FG005|Overall Study|Death|2|||
19381149|NCT01602315|41624342|FG006|Overall Study|Death|2|||
19465685|NCT01702454|41724426|FG001|Overall Study|Migrated/moved from study area|1|||
19465686|NCT01702454|41724425|FG000|Overall Study|Lost to Follow-up|3|||
19465687|NCT01702454|41724426|FG001|Overall Study|Lost to Follow-up|6|||
19465688|NCT01702298|41724439|FG000|Overall Study|Withdrawal by Subject|1|||
19738686|NCT03550209|42185690|FG000|Overall Study|Withdrawal by Subject|0|||
19381150|NCT01602315|41624336|FG000|Overall Study|Withdrawal by Subject|2|||
19465689|NCT02993523|41724448|FG000|Overall Study|Withdrew Consent|0|||
19465690|NCT02993523|41724449|FG001|Overall Study|Withdrew Consent|0|||
19381151|NCT01602315|41624337|FG001|Overall Study|Withdrawal by Subject|0|||
19381152|NCT01602315|41624338|FG002|Overall Study|Withdrawal by Subject|2|||
19381153|NCT01602315|41624339|FG003|Overall Study|Withdrawal by Subject|0|||
19381154|NCT01602315|41624340|FG004|Overall Study|Withdrawal by Subject|6|||
19381155|NCT01602315|41624341|FG005|Overall Study|Withdrawal by Subject|0|||
19381156|NCT01602315|41624342|FG006|Overall Study|Withdrawal by Subject|1|||
19381157|NCT01602315|41624336|FG000|Overall Study|Adverse Event|5|||
19738687|NCT03550209|42185691|FG001|Overall Study|Withdrawal by Subject|3|||
19738688|NCT03550209|42185692|FG002|Overall Study|Withdrawal by Subject|1|||
19738689|NCT03550209|42185693|FG003|Overall Study|Withdrawal by Subject|2|||
19738690|NCT03550209|42185690|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
19738691|NCT03550209|42185691|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
19738692|NCT03550209|42185692|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
19738693|NCT03550209|42185693|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
19738694|NCT02764762|42185703|FG000|Overall Study|Adverse Event|5|||
19738695|NCT02764762|42185703|FG000|Overall Study|Voluntary Withdrawal|3|||
19738696|NCT02764762|42185703|FG000|Overall Study|Significant Deviation|1|||
19738697|NCT03032510|42185709|FG000|Overall Study|Adverse Event|5|||
19738698|NCT03032510|42185710|FG001|Overall Study|Adverse Event|2|||
19738699|NCT03032510|42185709|FG000|Overall Study|Lost to Follow-up|8|||
19738700|NCT03032510|42185710|FG001|Overall Study|Lost to Follow-up|7|||
19738701|NCT03032510|42185709|FG000|Overall Study|Withdrawal by Subject|8|||
19738702|NCT03032510|42185710|FG001|Overall Study|Withdrawal by Subject|7|||
19738703|NCT03032510|42185709|FG000|Overall Study|Subject noncompliance|4|||
19738704|NCT03032510|42185710|FG001|Overall Study|Subject noncompliance|2|||
19738705|NCT03032510|42185709|FG000|Overall Study|Physician Decision|2|||
19738706|NCT03032510|42185710|FG001|Overall Study|Physician Decision|0|||
19738707|NCT03599349|42185720|FG000|Overall Study|Lost to Follow-up|1|||
19738708|NCT03599193|42185730|FG000|Overall Study|Adverse Event|0|||
19738709|NCT03599193|42185731|FG001|Overall Study|Adverse Event|2|||
19738710|NCT03599193|42185730|FG000|Overall Study|Withdrawal by Subject|1|||
19738711|NCT03599193|42185731|FG001|Overall Study|Withdrawal by Subject|0|||
19738712|NCT03599193|42185730|FG000|Overall Study|Protocol Violation|1|||
19738713|NCT03599193|42185731|FG001|Overall Study|Protocol Violation|0|||
19738714|NCT03599193|42185730|FG000|Overall Study|Lost to Follow-up|0|||
19738715|NCT03599193|42185731|FG001|Overall Study|Lost to Follow-up|1|||
19738716|NCT03166124|42185740|FG000|Treatment Period 1|Adverse Event|0|||
19738717|NCT03166124|42185741|FG001|Treatment Period 1|Adverse Event|0|||
19738718|NCT03166124|42185742|FG002|Treatment Period 1|Adverse Event|1|||
19738719|NCT03166124|42185743|FG003|Treatment Period 1|Adverse Event|0|||
19738720|NCT03166124|42185740|FG000|Wash-out Period|Withdrawal by Subject|0|||
19738721|NCT03166124|42185741|FG001|Wash-out Period|Withdrawal by Subject|1|||
19738722|NCT03166124|42185742|FG002|Wash-out Period|Withdrawal by Subject|0|||
19738723|NCT03166124|42185743|FG003|Wash-out Period|Withdrawal by Subject|1|||
19738724|NCT03166124|42185740|FG000|Wash-out Period|Adverse Event|0|||
19738725|NCT03166124|42185741|FG001|Wash-out Period|Adverse Event|1|||
19465691|NCT02993523|41724450|FG002|Overall Study|Withdrew Consent|2|||
19465692|NCT02993523|41724451|FG003|Overall Study|Withdrew Consent|9|||
19465693|NCT02993523|41724452|FG004|Overall Study|Withdrew Consent|0|||
19465694|NCT02993523|41724448|FG000|Overall Study|Lost to Follow-up|0|||
19465695|NCT02993523|41724449|FG001|Overall Study|Lost to Follow-up|0|||
19465696|NCT02993523|41724450|FG002|Overall Study|Lost to Follow-up|3|||
19465697|NCT02993523|41724451|FG003|Overall Study|Lost to Follow-up|6|||
19465698|NCT02993523|41724452|FG004|Overall Study|Lost to Follow-up|0|||
19465699|NCT02993523|41724448|FG000|Overall Study|Death|1|||
19465700|NCT02993523|41724449|FG001|Overall Study|Death|1|||
19465701|NCT02993523|41724450|FG002|Overall Study|Death|138|||
19465702|NCT02993523|41724451|FG003|Overall Study|Death|222|||
19465703|NCT02993523|41724452|FG004|Overall Study|Death|6|||
19465704|NCT02993523|41724448|FG000|Overall Study|Reason not Specified|0|||
19465705|NCT02993523|41724449|FG001|Overall Study|Reason not Specified|0|||
19465706|NCT02993523|41724450|FG002|Overall Study|Reason not Specified|1|||
19465707|NCT02993523|41724451|FG003|Overall Study|Reason not Specified|1|||
19465708|NCT02993523|41724452|FG004|Overall Study|Reason not Specified|0|||
19465709|NCT01701362|41724462|FG000|Overall Study|Adverse events not related to study drug|1|||
19465710|NCT01701362|41724463|FG001|Overall Study|Adverse events not related to study drug|6|||
19465711|NCT01701362|41724462|FG000|Overall Study|Adverse events related to study drug|12|||
19465712|NCT01701362|41724463|FG001|Overall Study|Adverse events related to study drug|10|||
19465713|NCT01701362|41724462|FG000|Overall Study|Protocol Violation|5|||
19465714|NCT01701362|41724463|FG001|Overall Study|Protocol Violation|3|||
19465715|NCT01701362|41724462|FG000|Overall Study|No longer willing to participate|8|||
19465716|NCT01701362|41724463|FG001|Overall Study|No longer willing to participate|14|||
19465717|NCT01701362|41724462|FG000|Overall Study|Lost to Follow-up|6|||
19465718|NCT01701362|41724463|FG001|Overall Study|Lost to Follow-up|9|||
19465719|NCT01701362|41724462|FG000|Overall Study|Insufficient clinical response|6|||
19465720|NCT01701362|41724463|FG001|Overall Study|Insufficient clinical response|6|||
19465721|NCT01701362|41724462|FG000|Overall Study|Death|0|||
19465722|NCT01701362|41724463|FG001|Overall Study|Death|1|||
19465723|NCT01701362|41724462|FG000|Overall Study|Randomized but not treated|1|||
19465724|NCT01701362|41724463|FG001|Overall Study|Randomized but not treated|2|||
19465725|NCT01701362|41724462|FG000|Overall Study|Reasons other than those mentioned above|3|||
19465726|NCT01701362|41724463|FG001|Overall Study|Reasons other than those mentioned above|5|||
19465727|NCT01710800|41724492|FG000|Overall Study|Withdrawal by Subject|21|||
19465728|NCT01710800|41724492|FG000|Overall Study|Protocol Violation|1|||
19465729|NCT01710020|41724498|FG000|Period 1|Protocol Violation|1|||
19465730|NCT01700348|41724504|FG000|Overall Study|Withdrawal by Subject|22|||
19738726|NCT03166124|42185742|FG002|Wash-out Period|Adverse Event|1|||
19738727|NCT03166124|42185743|FG003|Wash-out Period|Adverse Event|0|||
19738728|NCT03567291|42185754|FG000|Period I|Adverse Event|14|||
19738729|NCT03567291|42185755|FG001|Period I|Adverse Event|0|||
19738730|NCT03567291|42185756|FG002|Period I|Adverse Event|0|||
19738731|NCT03567291|42185757|FG003|Period I|Adverse Event|0|||
19738732|NCT03567291|42185754|FG000|Period I|Protocol Violation|1|||
19381158|NCT01602315|41624337|FG001|Overall Study|Adverse Event|1|||
19381159|NCT01602315|41624338|FG002|Overall Study|Adverse Event|5|||
19381160|NCT01602315|41624339|FG003|Overall Study|Adverse Event|4|||
19465731|NCT01700348|41724504|FG000|Overall Study|Lost to Follow-up|1|||
19465732|NCT01700192|41724512|FG000|Overall Study|Adverse Event|73|||
19465733|NCT01700192|41724513|FG001|Overall Study|Adverse Event|18|||
19465734|NCT01700192|41724512|FG000|Overall Study|Lack of Efficacy|1|||
19465735|NCT01700192|41724513|FG001|Overall Study|Lack of Efficacy|0|||
19465736|NCT01700192|41724512|FG000|Overall Study|Lost to Follow-up|42|||
19465737|NCT01700192|41724513|FG001|Overall Study|Lost to Follow-up|29|||
19738733|NCT03567291|42185755|FG001|Period I|Protocol Violation|0|||
19381161|NCT01602315|41624340|FG004|Overall Study|Adverse Event|15|||
19381162|NCT01602315|41624341|FG005|Overall Study|Adverse Event|3|||
19381163|NCT01602315|41624342|FG006|Overall Study|Adverse Event|9|||
19381164|NCT01602315|41624336|FG000|Overall Study|Subject/guardian decision|0|||
19381165|NCT01602315|41624337|FG001|Overall Study|Subject/guardian decision|0|||
19381166|NCT01602315|41624338|FG002|Overall Study|Subject/guardian decision|0|||
19381167|NCT01602315|41624339|FG003|Overall Study|Subject/guardian decision|0|||
19381168|NCT01602315|41624340|FG004|Overall Study|Subject/guardian decision|0|||
19381169|NCT01602315|41624341|FG005|Overall Study|Subject/guardian decision|0|||
19381170|NCT01602315|41624342|FG006|Overall Study|Subject/guardian decision|1|||
19381171|NCT01602315|41624336|FG000|Overall Study|Cross-over patients to combo treatment|0|||
19465738|NCT01700192|41724512|FG000|Overall Study|Noncompliance with study drug|0|||
19465739|NCT01700192|41724513|FG001|Overall Study|Noncompliance with study drug|5|||
19465740|NCT01700192|41724512|FG000|Overall Study|Physician Decision|2|||
19465741|NCT01700192|41724513|FG001|Overall Study|Physician Decision|3|||
19738734|NCT03567291|42185756|FG002|Period I|Protocol Violation|0|||
19738735|NCT03567291|42185757|FG003|Period I|Protocol Violation|0|||
19738736|NCT03567291|42185754|FG000|Period I|Withdrawal by Subject|23|||
19738737|NCT03567291|42185755|FG001|Period I|Withdrawal by Subject|0|||
19738738|NCT03567291|42185756|FG002|Period I|Withdrawal by Subject|0|||
19738739|NCT03567291|42185757|FG003|Period I|Withdrawal by Subject|0|||
19738740|NCT03567291|42185754|FG000|Period I|Lost to Follow-up|2|||
19738741|NCT03567291|42185755|FG001|Period I|Lost to Follow-up|0|||
19738742|NCT03567291|42185756|FG002|Period I|Lost to Follow-up|0|||
19738743|NCT03567291|42185757|FG003|Period I|Lost to Follow-up|0|||
19738744|NCT03567291|42185754|FG000|Period I|Terminated by sponsor|44|||
19738745|NCT03567291|42185755|FG001|Period I|Terminated by sponsor|0|||
19738746|NCT03567291|42185756|FG002|Period I|Terminated by sponsor|0|||
19738747|NCT03567291|42185757|FG003|Period I|Terminated by sponsor|0|||
19738748|NCT03567291|42185754|FG000|Period I|Missing or unknown|7|||
19738749|NCT03567291|42185755|FG001|Period I|Missing or unknown|0|||
19738750|NCT03567291|42185756|FG002|Period I|Missing or unknown|0|||
19738751|NCT03567291|42185757|FG003|Period I|Missing or unknown|0|||
19738752|NCT03567291|42185754|FG000|Period II|Adverse Event|0|||
19738753|NCT03567291|42185755|FG001|Period II|Adverse Event|1|||
19738754|NCT03567291|42185756|FG002|Period II|Adverse Event|0|||
19738755|NCT03567291|42185757|FG003|Period II|Adverse Event|0|||
19738756|NCT03567291|42185754|FG000|Period II|Missing or unknown|0|||
19738757|NCT03567291|42185755|FG001|Period II|Missing or unknown|2|||
19738758|NCT03567291|42185756|FG002|Period II|Missing or unknown|1|||
19738759|NCT03567291|42185757|FG003|Period II|Missing or unknown|0|||
19738760|NCT03567291|42185754|FG000|Period III|Adverse Event|0|||
19738761|NCT03567291|42185755|FG001|Period III|Adverse Event|0|||
19738762|NCT03567291|42185756|FG002|Period III|Adverse Event|0|||
19738763|NCT03567291|42185757|FG003|Period III|Adverse Event|4|||
19738764|NCT03567291|42185754|FG000|Period III|Withdrawal by Subject|0|||
19738765|NCT03567291|42185755|FG001|Period III|Withdrawal by Subject|0|||
19738766|NCT03567291|42185756|FG002|Period III|Withdrawal by Subject|0|||
19738767|NCT03567291|42185757|FG003|Period III|Withdrawal by Subject|4|||
19738768|NCT03567291|42185754|FG000|Period III|Lost to Follow-up|0|||
19738769|NCT03567291|42185755|FG001|Period III|Lost to Follow-up|0|||
19738770|NCT03567291|42185756|FG002|Period III|Lost to Follow-up|0|||
19738771|NCT03567291|42185757|FG003|Period III|Lost to Follow-up|1|||
19738772|NCT03567291|42185754|FG000|Period III|Terminated by sponsor|0|||
19738773|NCT03567291|42185755|FG001|Period III|Terminated by sponsor|0|||
19738774|NCT03567291|42185756|FG002|Period III|Terminated by sponsor|0|||
19738775|NCT03567291|42185757|FG003|Period III|Terminated by sponsor|68|||
19738776|NCT03567291|42185754|FG000|Period III|Missing or unknown|0|||
19738777|NCT03567291|42185755|FG001|Period III|Missing or unknown|0|||
19738778|NCT03567291|42185756|FG002|Period III|Missing or unknown|0|||
19738779|NCT03567291|42185757|FG003|Period III|Missing or unknown|8|||
19738780|NCT02777242|42185763|FG000|Overall Study|Other|2|||
19738781|NCT02777242|42185763|FG000|Overall Study|Lost to Follow-up|1|||
19738782|NCT02777242|42185763|FG000|Overall Study|Multiple|1|||
19738783|NCT02777242|42185763|FG000|Overall Study|Sponsor's request|1|||
19738784|NCT02777242|42185763|FG000|Overall Study|Withdrawal by Subject|1|||
19738785|NCT03212144|42185769|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
19738786|NCT03212144|42185770|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
19738787|NCT03212144|42185769|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
19738788|NCT03212144|42185770|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
19738789|NCT03566979|42185780|FG000|Overall Study|Withdrawal by Subject|2|||
19738790|NCT03566979|42185781|FG001|Overall Study|Withdrawal by Subject|0|||
19738791|NCT03566979|42185782|FG002|Overall Study|Withdrawal by Subject|1|||
19738792|NCT03566979|42185783|FG003|Overall Study|Withdrawal by Subject|1|||
19738793|NCT03566979|42185780|FG000|Overall Study|Lost to Follow-up|2|||
19738794|NCT03566979|42185781|FG001|Overall Study|Lost to Follow-up|7|||
19738795|NCT03566979|42185782|FG002|Overall Study|Lost to Follow-up|9|||
19738796|NCT03566979|42185783|FG003|Overall Study|Lost to Follow-up|5|||
19738797|NCT03566979|42185780|FG000|Overall Study|Adverse Event|1|||
19738798|NCT03566979|42185781|FG001|Overall Study|Adverse Event|0|||
19738799|NCT03566979|42185782|FG002|Overall Study|Adverse Event|0|||
19738800|NCT03566979|42185783|FG003|Overall Study|Adverse Event|0|||
19738801|NCT00116831|42185795|FG000|Overall Study|Adverse Event|14|||
19738802|NCT00116831|42185796|FG001|Overall Study|Adverse Event|16|||
19738803|NCT00116831|42185795|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
19738804|NCT00116831|42185796|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
19738805|NCT00116831|42185795|FG000|Overall Study|Lost to Follow-up|8|||
19738806|NCT00116831|42185796|FG001|Overall Study|Lost to Follow-up|6|||
19738807|NCT00116831|42185795|FG000|Overall Study|Protocol Violation|3|||
19738808|NCT00116831|42185796|FG001|Overall Study|Protocol Violation|6|||
19738809|NCT00116831|42185795|FG000|Overall Study|Hypoglycaemic events|1|||
19738810|NCT00116831|42185796|FG001|Overall Study|Hypoglycaemic events|0|||
19738811|NCT00116831|42185795|FG000|Overall Study|Low haemoglobin on screening|1|||
19738812|NCT00116831|42185796|FG001|Overall Study|Low haemoglobin on screening|0|||
19738813|NCT00116831|42185795|FG000|Overall Study|Withdrawn investigational product|1|||
19738814|NCT00116831|42185796|FG001|Overall Study|Withdrawn investigational product|0|||
19738815|NCT00116831|42185795|FG000|Overall Study|Withdrawal by Subject|32|||
19738816|NCT00116831|42185796|FG001|Overall Study|Withdrawal by Subject|32|||
19738817|NCT00116831|42185795|FG000|Overall Study|Insufficient therapeutic effect|0|||
19738818|NCT00116831|42185796|FG001|Overall Study|Insufficient therapeutic effect|1|||
19738819|NCT00116831|42185795|FG000|Overall Study|Missing data for participant|1|||
19738820|NCT00116831|42185796|FG001|Overall Study|Missing data for participant|0|||
19738821|NCT02777086|42185804|FG000|Overall Study|Lost to Follow-up|96|||
19738822|NCT02777086|42185805|FG001|Overall Study|Lost to Follow-up|99|||
19738823|NCT03549429|42185813|FG000|Overall Study|Protocol Violation|5|||
19738824|NCT03549429|42185814|FG001|Overall Study|Protocol Violation|3|||
19738825|NCT02784704|42185824|FG000|Overall Study|Adverse Event|4|||
19738826|NCT02784704|42185825|FG001|Overall Study|Adverse Event|2|||
19738827|NCT02784704|42185824|FG000|Overall Study|Lost to Follow-up|6|||
19738828|NCT02784704|42185825|FG001|Overall Study|Lost to Follow-up|4|||
19738829|NCT02784704|42185824|FG000|Overall Study|Withdrawal by Subject|1|||
19738830|NCT02784704|42185825|FG001|Overall Study|Withdrawal by Subject|3|||
19738831|NCT02784704|42185824|FG000|Overall Study|Subject Non Compliance|2|||
19738832|NCT02784704|42185825|FG001|Overall Study|Subject Non Compliance|0|||
19738833|NCT03566823|42185836|FG000|Overall Study|Lack of Efficacy|0|||
19738834|NCT03566823|42185837|FG001|Overall Study|Lack of Efficacy|1|||
19738835|NCT03566823|42185838|FG002|Overall Study|Lack of Efficacy|0|||
19738836|NCT03566823|42185836|FG000|Overall Study|Withdrawal by Subject|1|||
19738837|NCT03566823|42185837|FG001|Overall Study|Withdrawal by Subject|2|||
19738838|NCT03566823|42185838|FG002|Overall Study|Withdrawal by Subject|0|||
19738839|NCT03566823|42185836|FG000|Overall Study|Adverse Event|1|||
19738840|NCT03566823|42185837|FG001|Overall Study|Adverse Event|0|||
19738841|NCT03566823|42185838|FG002|Overall Study|Adverse Event|2|||
19738842|NCT03549117|42185848|FG000|Overall Study|Withdrawal by Subject|1|||
19738843|NCT03549117|42185849|FG001|Overall Study|Withdrawal by Subject|0|||
19738844|NCT03183908|42185857|FG000|Overall Study|Missing Symptom Diary Data|0|||
19738845|NCT03183908|42185858|FG001|Overall Study|Missing Symptom Diary Data|2|||
19738846|NCT03565887|42185870|FG000|Overall Study|Adverse Event|1|||
19738847|NCT03565887|42185871|FG001|Overall Study|Adverse Event|0|||
19738848|NCT03565887|42185870|FG000|Overall Study|Withdrawal by Subject|0|||
19738849|NCT03565887|42185871|FG001|Overall Study|Withdrawal by Subject|2|||
19738850|NCT03183518|42185877|FG000|Overall Study|Other (Not specified)|2|||
19738851|NCT03183518|42185877|FG000|Overall Study|Other (Withdrawal of consent)|1|||
19738852|NCT00116753|42185885|FG000|Overall Study|Adverse Event|16|||
19738853|NCT00116753|42185886|FG001|Overall Study|Adverse Event|10|||
19738854|NCT00116753|42185887|FG002|Overall Study|Adverse Event|7|||
19738855|NCT00116753|42185885|FG000|Overall Study|Withdrawal by Subject|11|||
19738856|NCT00116753|42185886|FG001|Overall Study|Withdrawal by Subject|12|||
19738857|NCT00116753|42185887|FG002|Overall Study|Withdrawal by Subject|8|||
19738858|NCT00116753|42185885|FG000|Overall Study|Lost to Follow-up|0|||
19738859|NCT00116753|42185886|FG001|Overall Study|Lost to Follow-up|2|||
19738860|NCT00116753|42185887|FG002|Overall Study|Lost to Follow-up|1|||
19738861|NCT00116753|42185885|FG000|Overall Study|Protocol Violation|0|||
19738862|NCT00116753|42185886|FG001|Overall Study|Protocol Violation|0|||
19738863|NCT00116753|42185887|FG002|Overall Study|Protocol Violation|1|||
19738864|NCT00116753|42185885|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
19738865|NCT00116753|42185886|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
19738866|NCT00116753|42185887|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
19738867|NCT00116753|42185885|FG000|Overall Study|Disease Progression|3|||
19738868|NCT00116753|42185886|FG001|Overall Study|Disease Progression|4|||
19738869|NCT00116753|42185887|FG002|Overall Study|Disease Progression|3|||
19738870|NCT00116753|42185885|FG000|Overall Study|Abnormal Echocardiogram|0|||
19738871|NCT00116753|42185886|FG001|Overall Study|Abnormal Echocardiogram|0|||
19738872|NCT00116753|42185887|FG002|Overall Study|Abnormal Echocardiogram|1|||
19738873|NCT00116753|42185885|FG000|Overall Study|Progressive Parkinson's Disease|1|||
19738874|NCT00116753|42185886|FG001|Overall Study|Progressive Parkinson's Disease|0|||
19738875|NCT00116753|42185887|FG002|Overall Study|Progressive Parkinson's Disease|0|||
19738876|NCT00116753|42185885|FG000|Overall Study|Dosing Error|0|||
19738877|NCT00116753|42185886|FG001|Overall Study|Dosing Error|1|||
19738878|NCT00116753|42185887|FG002|Overall Study|Dosing Error|0|||
19738879|NCT00113399|42185906|FG000|Overall Study|Death|1|||
19738880|NCT00113399|42185907|FG001|Overall Study|Death|1|||
19738881|NCT00113399|42185906|FG000|Overall Study|Withdrawal by Subject|1|||
19738882|NCT00113399|42185907|FG001|Overall Study|Withdrawal by Subject|2|||
19738883|NCT00113399|42185906|FG000|Overall Study|Complete Response|0|||
19738884|NCT00113399|42185907|FG001|Overall Study|Complete Response|1|||
19738885|NCT00113399|42185906|FG000|Overall Study|Other|0|||
19738886|NCT00113399|42185907|FG001|Overall Study|Other|1|||
19738887|NCT00113087|42185915|FG000|Overall Study|Death or Transplant|14|||
19738888|NCT00113087|42185916|FG001|Overall Study|Death or Transplant|16|||
19738889|NCT00113087|42185915|FG000|Overall Study|Family or MD withdrew subject|10|||
19738890|NCT00113087|42185916|FG001|Overall Study|Family or MD withdrew subject|5|||
19738891|NCT00112463|42185922|FG000|Overall Study|Physician Decision|1|||
19738892|NCT00112463|42185922|FG000|Overall Study|Progression|30|||
19738893|NCT00112463|42185922|FG000|Overall Study|Second Primary|1|||
19738894|NCT00112463|42185922|FG000|Overall Study|Toxicity|3|||
19738895|NCT00112463|42185922|FG000|Overall Study|Withdrawal by Subject|2|||
19738896|NCT00112463|42185922|FG000|Overall Study|Never started treatment|2|||
19738897|NCT03548415|42185932|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
19738898|NCT03548415|42185933|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
19738899|NCT03548415|42185934|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
19738900|NCT03548415|42185935|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
19738901|NCT03548415|42185936|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
19738902|NCT00112385|42185952|FG000|Overall Study|Lost to Follow-up|1|||
19738903|NCT00112385|42185953|FG001|Overall Study|Lost to Follow-up|0|||
19738904|NCT00112385|42185952|FG000|Overall Study|Withdrawal by Subject|0|||
19738905|NCT00112385|42185953|FG001|Overall Study|Withdrawal by Subject|1|||
19738906|NCT03548337|42185961|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
19738907|NCT03548337|42185962|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
19738908|NCT03548337|42185961|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
19738909|NCT03548337|42185962|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
19738910|NCT03548337|42185961|FG000|Infant Series|Lost to Follow-up|2|||
19738911|NCT03548337|42185962|FG001|Infant Series|Lost to Follow-up|1|||
19738912|NCT03548337|42185961|FG000|Infant Series|Adverse Event|0|||
19738913|NCT03548337|42185962|FG001|Infant Series|Adverse Event|2|||
19738914|NCT03548337|42185961|FG000|Infant Series|Randomized but Not Vaccinated|1|||
19738915|NCT03548337|42185962|FG001|Infant Series|Randomized but Not Vaccinated|0|||
19738916|NCT03548337|42185961|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
19738917|NCT03548337|42185962|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
19738918|NCT03596151|42185974|FG000|Overall Study|Withdrawal by Subject|1|||
19738919|NCT03547635|42185981|FG000|Overall Study|Adverse Event|5|||
19738920|NCT03547635|42185982|FG001|Overall Study|Adverse Event|2|||
19738921|NCT03547635|42185983|FG002|Overall Study|Adverse Event|3|||
19738922|NCT03547635|42185981|FG000|Overall Study|Lost to Follow-up|1|||
19738923|NCT03547635|42185982|FG001|Overall Study|Lost to Follow-up|3|||
19738924|NCT03547635|42185983|FG002|Overall Study|Lost to Follow-up|4|||
19738925|NCT03547635|42185981|FG000|Overall Study|Withdrawal by Subject|1|||
19738926|NCT03547635|42185982|FG001|Overall Study|Withdrawal by Subject|0|||
19738927|NCT03547635|42185983|FG002|Overall Study|Withdrawal by Subject|0|||
19738928|NCT03547635|42185981|FG000|Overall Study|Withdrawal By PI|0|||
19738929|NCT03547635|42185982|FG001|Overall Study|Withdrawal By PI|1|||
19738930|NCT03547635|42185983|FG002|Overall Study|Withdrawal By PI|0|||
19738931|NCT03547635|42185981|FG000|Overall Study|Withdrawal by Sponsor|0|||
19738932|NCT03547635|42185982|FG001|Overall Study|Withdrawal by Sponsor|0|||
19738933|NCT03547635|42185983|FG002|Overall Study|Withdrawal by Sponsor|1|||
19738934|NCT03547635|42185981|FG000|Overall Study|Errant Randomization before Treatment|0|||
19738935|NCT03547635|42185982|FG001|Overall Study|Errant Randomization before Treatment|1|||
19738936|NCT03547635|42185983|FG002|Overall Study|Errant Randomization before Treatment|0|||
19738937|NCT03547635|42185981|FG000|Overall Study|Withdrawal by Subject|1|||
19738938|NCT03547635|42185982|FG001|Overall Study|Withdrawal by Subject|0|||
19738939|NCT03547635|42185983|FG002|Overall Study|Withdrawal by Subject|0|||
19738940|NCT03182738|42186037|FG000|Overall Study|Lost to Follow-up|9|||
19738941|NCT03182738|42186038|FG001|Overall Study|Lost to Follow-up|3|||
19738942|NCT03182738|42186037|FG000|Overall Study|Pregnancy|0|||
19738943|NCT03182738|42186038|FG001|Overall Study|Pregnancy|1|||
19738944|NCT03182738|42186037|FG000|Overall Study|Withdrawal by Subject|0|||
19738945|NCT03182738|42186038|FG001|Overall Study|Withdrawal by Subject|1|||
19738946|NCT03547167|42186046|FG000|Overall Study|Withdrawal by Subject|34|||
19738947|NCT03547167|42186047|FG001|Overall Study|Withdrawal by Subject|12|||
19738948|NCT03547167|42186046|FG000|Overall Study|Screen Failure|0|||
19738949|NCT03547167|42186047|FG001|Overall Study|Screen Failure|1|||
19738950|NCT03547167|42186046|FG000|Overall Study|Lost to Follow-up|59|||
19738951|NCT03547167|42186047|FG001|Overall Study|Lost to Follow-up|15|||
19738952|NCT03547167|42186046|FG000|Overall Study|Death|4|||
19738953|NCT03547167|42186047|FG001|Overall Study|Death|2|||
19738954|NCT03560739|42186061|FG000|Overall Study|Adverse Event|0|||
19738955|NCT03560739|42186062|FG001|Overall Study|Adverse Event|1|||
19738956|NCT03560739|42186063|FG002|Overall Study|Adverse Event|0|||
19738957|NCT03560739|42186064|FG003|Overall Study|Adverse Event|0|||
19738958|NCT00101686|42186084|FG000|Overall Study|Progressive Disease|37|||
19738959|NCT00101686|42186085|FG001|Overall Study|Progressive Disease|28|||
19738960|NCT00101686|42186086|FG002|Overall Study|Progressive Disease|37|||
19738961|NCT00101686|42186087|FG003|Overall Study|Progressive Disease|38|||
19738962|NCT00101686|42186088|FG004|Overall Study|Progressive Disease|28|||
19738963|NCT00101686|42186089|FG005|Overall Study|Progressive Disease|25|||
19738964|NCT00101686|42186090|FG006|Overall Study|Progressive Disease|5|||
19738965|NCT00101686|42186091|FG007|Overall Study|Progressive Disease|7|||
19738966|NCT00101686|42186092|FG008|Overall Study|Progressive Disease|10|||
19738967|NCT00101686|42186093|FG009|Overall Study|Progressive Disease|8|||
19738968|NCT00101686|42186084|FG000|Overall Study|initiation other anti-cancer treatment|4|||
19465742|NCT01700192|41724512|FG000|Overall Study|Pregnancy|1|||
19465743|NCT01700192|41724513|FG001|Overall Study|Pregnancy|4|||
19465744|NCT01700192|41724512|FG000|Overall Study|Progressive disease|1|||
19465745|NCT01700192|41724513|FG001|Overall Study|Progressive disease|0|||
19465746|NCT01700192|41724512|FG000|Overall Study|Protocol Violation|3|||
19465747|NCT01700192|41724513|FG001|Overall Study|Protocol Violation|4|||
19465748|NCT01700192|41724512|FG000|Overall Study|Technical problems|0|||
19465749|NCT01700192|41724513|FG001|Overall Study|Technical problems|1|||
19465750|NCT01700192|41724512|FG000|Overall Study|Withdrawal by Subject|56|||
19465751|NCT01700192|41724513|FG001|Overall Study|Withdrawal by Subject|64|||
19465752|NCT01700192|41724512|FG000|Overall Study|Never received study drug|1|||
19465753|NCT01700192|41724513|FG001|Overall Study|Never received study drug|0|||
19465754|NCT03153111|41724530|FG000|Overall Study|Death|2|||
19465755|NCT03153111|41724531|FG001|Overall Study|Death|5|||
19465756|NCT03153111|41724530|FG000|Overall Study|Lost to Follow-up|1|||
19465757|NCT03153111|41724531|FG001|Overall Study|Lost to Follow-up|0|||
19465758|NCT03153111|41724530|FG000|Overall Study|Physician Decision|5|||
19465759|NCT03153111|41724531|FG001|Overall Study|Physician Decision|1|||
19465760|NCT03153111|41724530|FG000|Overall Study|Withdrawal by Subject|3|||
19465761|NCT03153111|41724531|FG001|Overall Study|Withdrawal by Subject|3|||
19465762|NCT01709864|41724539|FG000|Overall Study|Physician Decision|0|||
19465763|NCT01709864|41724540|FG001|Overall Study|Physician Decision|1|||
19465764|NCT01709864|41724539|FG000|Overall Study|subject/guardian decision|5|||
19465765|NCT01709864|41724540|FG001|Overall Study|subject/guardian decision|6|||
19465766|NCT01709864|41724539|FG000|Overall Study|Lost to Follow-up|1|||
19465767|NCT01709864|41724540|FG001|Overall Study|Lost to Follow-up|0|||
19465768|NCT01709864|41724539|FG000|Overall Study|non-compliance with study treatment|1|||
19465769|NCT01709864|41724540|FG001|Overall Study|non-compliance with study treatment|1|||
19465770|NCT01709864|41724539|FG000|Overall Study|Adverse Event|0|||
19465771|NCT01709864|41724540|FG001|Overall Study|Adverse Event|2|||
19465772|NCT01709864|41724539|FG000|Overall Study|Death|0|||
19465773|NCT01709864|41724540|FG001|Overall Study|Death|1|||
19465774|NCT01709708|41724548|FG000|Overall Study|Protocol Violation|1|||
19465775|NCT01709708|41724549|FG001|Overall Study|Protocol Violation|2|||
19465776|NCT01709318|41724572|FG000|Overall Study|Adverse Event|3|||
19465777|NCT01709318|41724573|FG001|Overall Study|Adverse Event|4|||
19465778|NCT01709318|41724574|FG002|Overall Study|Adverse Event|2|||
19465779|NCT01709318|41724575|FG003|Overall Study|Adverse Event|2|||
19465780|NCT01709318|41724576|FG004|Overall Study|Adverse Event|0|||
19465781|NCT01709318|41724577|FG005|Overall Study|Adverse Event|1|||
19465782|NCT01709318|41724578|FG006|Overall Study|Adverse Event|2|||
19381172|NCT01602315|41624337|FG001|Overall Study|Cross-over patients to combo treatment|0|||
19381173|NCT01602315|41624338|FG002|Overall Study|Cross-over patients to combo treatment|0|||
19381174|NCT01602315|41624339|FG003|Overall Study|Cross-over patients to combo treatment|0|||
19465783|NCT01709318|41724572|FG000|Overall Study|Lost to Follow-up|2|||
19381175|NCT01602315|41624340|FG004|Overall Study|Cross-over patients to combo treatment|0|||
19381176|NCT01602315|41624341|FG005|Overall Study|Cross-over patients to combo treatment|16|||
19381177|NCT01602315|41624342|FG006|Overall Study|Cross-over patients to combo treatment|0|||
19381178|NCT02344004|41624380|FG000|Overall Study|Adverse Event|11|||
19381179|NCT02344004|41624381|FG001|Overall Study|Adverse Event|1|||
19465784|NCT01709318|41724573|FG001|Overall Study|Lost to Follow-up|0|||
19465785|NCT01709318|41724574|FG002|Overall Study|Lost to Follow-up|0|||
19465786|NCT01709318|41724575|FG003|Overall Study|Lost to Follow-up|0|||
19465787|NCT01709318|41724576|FG004|Overall Study|Lost to Follow-up|1|||
19465788|NCT01709318|41724577|FG005|Overall Study|Lost to Follow-up|1|||
19465789|NCT01709318|41724578|FG006|Overall Study|Lost to Follow-up|1|||
19465790|NCT01709318|41724572|FG000|Overall Study|Non-compliance with Study Drug|0|||
19465791|NCT01709318|41724573|FG001|Overall Study|Non-compliance with Study Drug|2|||
19465792|NCT01709318|41724574|FG002|Overall Study|Non-compliance with Study Drug|1|||
19465793|NCT01709318|41724575|FG003|Overall Study|Non-compliance with Study Drug|1|||
19465794|NCT01709318|41724576|FG004|Overall Study|Non-compliance with Study Drug|0|||
19465795|NCT01709318|41724577|FG005|Overall Study|Non-compliance with Study Drug|0|||
19465796|NCT01709318|41724578|FG006|Overall Study|Non-compliance with Study Drug|2|||
19465797|NCT01709318|41724572|FG000|Overall Study|Physician Decision|0|||
19465798|NCT01709318|41724573|FG001|Overall Study|Physician Decision|0|||
19465799|NCT01709318|41724574|FG002|Overall Study|Physician Decision|0|||
19465800|NCT01709318|41724575|FG003|Overall Study|Physician Decision|0|||
19465801|NCT01709318|41724576|FG004|Overall Study|Physician Decision|0|||
19465802|NCT01709318|41724577|FG005|Overall Study|Physician Decision|0|||
19465803|NCT01709318|41724578|FG006|Overall Study|Physician Decision|1|||
19465804|NCT01709318|41724572|FG000|Overall Study|Pregnancy|0|||
19465805|NCT01709318|41724573|FG001|Overall Study|Pregnancy|0|||
19465806|NCT01709318|41724574|FG002|Overall Study|Pregnancy|0|||
19465807|NCT01709318|41724575|FG003|Overall Study|Pregnancy|0|||
19465808|NCT01709318|41724576|FG004|Overall Study|Pregnancy|1|||
19465809|NCT01709318|41724577|FG005|Overall Study|Pregnancy|0|||
19465810|NCT01709318|41724578|FG006|Overall Study|Pregnancy|0|||
19465811|NCT01709318|41724572|FG000|Overall Study|Protocol Violation|0|||
19465812|NCT01709318|41724573|FG001|Overall Study|Protocol Violation|0|||
19465813|NCT01709318|41724574|FG002|Overall Study|Protocol Violation|0|||
19465814|NCT01709318|41724575|FG003|Overall Study|Protocol Violation|0|||
19465815|NCT01709318|41724576|FG004|Overall Study|Protocol Violation|2|||
19465816|NCT01709318|41724577|FG005|Overall Study|Protocol Violation|0|||
19465817|NCT01709318|41724578|FG006|Overall Study|Protocol Violation|1|||
19465818|NCT01709318|41724572|FG000|Overall Study|Technical Problems|1|||
19465819|NCT01709318|41724573|FG001|Overall Study|Technical Problems|0|||
19465820|NCT01709318|41724574|FG002|Overall Study|Technical Problems|0|||
19465821|NCT01709318|41724575|FG003|Overall Study|Technical Problems|0|||
19465822|NCT01709318|41724576|FG004|Overall Study|Technical Problems|0|||
19465823|NCT01709318|41724577|FG005|Overall Study|Technical Problems|0|||
19465824|NCT01709318|41724578|FG006|Overall Study|Technical Problems|0|||
19465825|NCT01709318|41724572|FG000|Overall Study|Withdrawal by Subject|3|||
19465826|NCT01709318|41724573|FG001|Overall Study|Withdrawal by Subject|0|||
19465827|NCT01709318|41724574|FG002|Overall Study|Withdrawal by Subject|3|||
19465828|NCT01709318|41724575|FG003|Overall Study|Withdrawal by Subject|3|||
19465829|NCT01709318|41724576|FG004|Overall Study|Withdrawal by Subject|0|||
19465830|NCT01709318|41724577|FG005|Overall Study|Withdrawal by Subject|2|||
19465831|NCT01709318|41724578|FG006|Overall Study|Withdrawal by Subject|4|||
19465832|NCT01709318|41724572|FG000|Overall Study|Other Protocol Specified Criteria|0|||
19465833|NCT01709318|41724573|FG001|Overall Study|Other Protocol Specified Criteria|1|||
19465834|NCT01709318|41724574|FG002|Overall Study|Other Protocol Specified Criteria|0|||
19465835|NCT01709318|41724575|FG003|Overall Study|Other Protocol Specified Criteria|0|||
19465836|NCT01709318|41724576|FG004|Overall Study|Other Protocol Specified Criteria|0|||
19465837|NCT01709318|41724577|FG005|Overall Study|Other Protocol Specified Criteria|0|||
19465838|NCT01709318|41724578|FG006|Overall Study|Other Protocol Specified Criteria|0|||
19465839|NCT01699178|41724596|FG000|Overall Study|Adverse Event|1|||
19381180|NCT02344004|41624380|FG000|Overall Study|Death|9|||
19381181|NCT02344004|41624381|FG001|Overall Study|Death|7|||
19381182|NCT02344004|41624380|FG000|Overall Study|Physician Decision|4|||
19551339|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Physician Decision|0|||
19551340|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Physician Decision|2|||
19738969|NCT00101686|42186085|FG001|Overall Study|initiation other anti-cancer treatment|3|||
19738970|NCT00101686|42186086|FG002|Overall Study|initiation other anti-cancer treatment|4|||
19738971|NCT00101686|42186087|FG003|Overall Study|initiation other anti-cancer treatment|3|||
19738972|NCT00101686|42186088|FG004|Overall Study|initiation other anti-cancer treatment|1|||
19738973|NCT00101686|42186089|FG005|Overall Study|initiation other anti-cancer treatment|1|||
19738974|NCT00101686|42186090|FG006|Overall Study|initiation other anti-cancer treatment|2|||
19738975|NCT00101686|42186091|FG007|Overall Study|initiation other anti-cancer treatment|2|||
19738976|NCT00101686|42186092|FG008|Overall Study|initiation other anti-cancer treatment|3|||
19738977|NCT00101686|42186093|FG009|Overall Study|initiation other anti-cancer treatment|3|||
19738978|NCT00101686|42186084|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
19738979|NCT00101686|42186085|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
19738980|NCT00101686|42186086|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
19738981|NCT00101686|42186087|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
19738982|NCT00101686|42186088|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
19738983|NCT00101686|42186089|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
19738984|NCT00101686|42186090|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
19738985|NCT00101686|42186091|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
19738986|NCT00101686|42186092|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
19738987|NCT00101686|42186093|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
19738988|NCT00101686|42186084|FG000|Overall Study|unacceptable toxicity|3|||
19738989|NCT00101686|42186085|FG001|Overall Study|unacceptable toxicity|9|||
19738990|NCT00101686|42186086|FG002|Overall Study|unacceptable toxicity|10|||
19738991|NCT00101686|42186087|FG003|Overall Study|unacceptable toxicity|6|||
19738992|NCT00101686|42186088|FG004|Overall Study|unacceptable toxicity|16|||
19738993|NCT00101686|42186089|FG005|Overall Study|unacceptable toxicity|10|||
19738994|NCT00101686|42186090|FG006|Overall Study|unacceptable toxicity|4|||
19738995|NCT00101686|42186091|FG007|Overall Study|unacceptable toxicity|2|||
19738996|NCT00101686|42186092|FG008|Overall Study|unacceptable toxicity|1|||
19738997|NCT00101686|42186093|FG009|Overall Study|unacceptable toxicity|4|||
19738998|NCT00101686|42186084|FG000|Overall Study|Randomized but did not receive treament|1|||
19738999|NCT00101686|42186085|FG001|Overall Study|Randomized but did not receive treament|6|||
19381183|NCT02344004|41624381|FG001|Overall Study|Physician Decision|1|||
19465840|NCT01699178|41724597|FG001|Overall Study|Adverse Event|5|||
19465841|NCT01699178|41724596|FG000|Overall Study|Lost to Follow-up|1|||
19465842|NCT01699178|41724597|FG001|Overall Study|Lost to Follow-up|6|||
19465843|NCT01699178|41724596|FG000|Overall Study|Non-compliance with Study Drug|3|||
19465844|NCT01699178|41724597|FG001|Overall Study|Non-compliance with Study Drug|1|||
19465845|NCT01699178|41724596|FG000|Overall Study|Physician Decision|1|||
19465846|NCT01699178|41724597|FG001|Overall Study|Physician Decision|0|||
19465847|NCT01699178|41724596|FG000|Overall Study|Withdrawal by Subject|4|||
19465848|NCT01699178|41724597|FG001|Overall Study|Withdrawal by Subject|12|||
19465849|NCT01699178|41724596|FG000|Overall Study|Hematocrit >54%|1|||
19465850|NCT01699178|41724597|FG001|Overall Study|Hematocrit >54%|1|||
19465851|NCT01699178|41724596|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
19465852|NCT01699178|41724597|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
19465853|NCT01699178|41724596|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
19465854|NCT01699178|41724597|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
19465855|NCT01683409|41724608|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
19465856|NCT01683409|41724609|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
19381184|NCT02344004|41624380|FG000|Overall Study|Withdrawal by Subject|22|||
19465857|NCT01683409|41724610|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
19465858|NCT01683409|41724611|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
19739000|NCT00101686|42186086|FG002|Overall Study|Randomized but did not receive treament|2|||
19739001|NCT00101686|42186087|FG003|Overall Study|Randomized but did not receive treament|2|||
19381185|NCT02344004|41624381|FG001|Overall Study|Withdrawal by Subject|5|||
19739002|NCT00101686|42186088|FG004|Overall Study|Randomized but did not receive treament|2|||
19373467|NCT03945825|41614590|FG001|Overall Study|Withdrawal by Subject|0|||
19381186|NCT02344004|41624380|FG000|Overall Study|Rescue Medication|2|||
19381187|NCT02344004|41624381|FG001|Overall Study|Rescue Medication|0|||
19739003|NCT00101686|42186089|FG005|Overall Study|Randomized but did not receive treament|2|||
19739004|NCT00101686|42186090|FG006|Overall Study|Randomized but did not receive treament|0|||
19739005|NCT00101686|42186091|FG007|Overall Study|Randomized but did not receive treament|1|||
19465859|NCT01683409|41724612|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
19465860|NCT01683409|41724608|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
19465861|NCT01683409|41724609|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
19465862|NCT01683409|41724610|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
19465863|NCT01683409|41724611|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
19465864|NCT01683409|41724612|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
19465865|NCT01683409|41724608|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
19465866|NCT01683409|41724609|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
19465867|NCT01683409|41724610|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
19465868|NCT01683409|41724611|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
19465869|NCT01683409|41724612|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
19465870|NCT01683409|41724608|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
19465871|NCT01683409|41724609|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
19465872|NCT01683409|41724610|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
19465873|NCT01683409|41724611|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
19465874|NCT01683409|41724612|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
19465875|NCT01683409|41724608|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
19465876|NCT01683409|41724609|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
19465877|NCT01683409|41724610|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
19465878|NCT01683409|41724611|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
19465879|NCT01683409|41724612|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
19465880|NCT01683409|41724608|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
19465881|NCT01683409|41724609|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
19465882|NCT01683409|41724610|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
19465883|NCT01683409|41724611|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
19465884|NCT01683409|41724612|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
19465885|NCT01683409|41724608|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
19465886|NCT01683409|41724609|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
19465887|NCT01683409|41724610|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
19465888|NCT01683409|41724611|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
19465889|NCT01683409|41724612|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
19465890|NCT01683409|41724608|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
19465891|NCT01683409|41724609|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
19465892|NCT01683409|41724610|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
19465893|NCT01683409|41724611|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
19465894|NCT01683409|41724612|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
19465895|NCT01683409|41724608|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
19465896|NCT01683409|41724609|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
19465897|NCT01683409|41724610|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
19465898|NCT01683409|41724611|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
19465899|NCT01683409|41724612|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
19465900|NCT01683409|41724608|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
19465901|NCT01683409|41724609|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
19465902|NCT01683409|41724610|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
19465903|NCT01683409|41724611|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
19465904|NCT01683409|41724612|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
19465905|NCT01683409|41724608|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
19465906|NCT01683409|41724609|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
19465907|NCT01683409|41724610|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
19465908|NCT01683409|41724611|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
19465909|NCT01683409|41724612|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
19465910|NCT01699022|41724638|FG000|Overall Study|Early discontinuation from the study|3|||
19465911|NCT01683019|41724646|FG000|Overall Study|Withdrawal by Subject|2|||
19465912|NCT01683019|41724647|FG001|Overall Study|Withdrawal by Subject|1|||
19465913|NCT01683019|41724648|FG002|Overall Study|Withdrawal by Subject|4|||
19739006|NCT00101686|42186092|FG008|Overall Study|Randomized but did not receive treament|0|||
19465914|NCT01709162|41724658|FG000|Overall Study|Disease progression|3|||
19465915|NCT01709162|41724659|FG001|Overall Study|Disease progression|3|||
19465916|NCT01709162|41724658|FG000|Overall Study|Study drug toxicity|2|||
19465917|NCT01709162|41724659|FG001|Overall Study|Study drug toxicity|0|||
19465918|NCT01709162|41724658|FG000|Overall Study|Administrative reason by sponsor|0|||
19381188|NCT02344004|41624380|FG000|Overall Study|Other Not Specified|12|||
19381189|NCT02344004|41624381|FG001|Overall Study|Other Not Specified|0|||
19639155|NCT00717236|42088569|FG000|Double-Blind Period|Other: Investigator Decision|0|||
19639156|NCT00717236|42088570|FG001|Double-Blind Period|Other: Investigator Decision|1|||
19639157|NCT00717236|42088569|FG000|Open-Label Period|Adverse Event|29|||
19639158|NCT00717236|42088570|FG001|Open-Label Period|Adverse Event|4|||
19639159|NCT00717236|42088569|FG000|Open-Label Period|Lack of Efficacy|30|||
19639160|NCT00717236|42088570|FG001|Open-Label Period|Lack of Efficacy|8|||
19639161|NCT00717236|42088569|FG000|Open-Label Period|Lost to Follow-up|28|||
19639162|NCT00717236|42088570|FG001|Open-Label Period|Lost to Follow-up|4|||
19639163|NCT00717236|42088569|FG000|Open-Label Period|Withdrawal by Subject|20|||
19639164|NCT00717236|42088570|FG001|Open-Label Period|Withdrawal by Subject|2|||
19639165|NCT00717236|42088569|FG000|Open-Label Period|Loss of Efficacy|6|||
19639166|NCT00717236|42088570|FG001|Open-Label Period|Loss of Efficacy|1|||
19465919|NCT01709162|41724659|FG001|Overall Study|Administrative reason by sponsor|1|||
19465920|NCT01709162|41724658|FG000|Overall Study|Other|1|||
19465921|NCT01709162|41724659|FG001|Overall Study|Other|0|||
19465922|NCT01709162|41724658|FG000|Overall Study|Withdrawal by Subject|0|||
19465923|NCT01709162|41724659|FG001|Overall Study|Withdrawal by Subject|1|||
19465924|NCT01698554|41724669|FG000|Overall Study|Adverse Event|2|||
19465925|NCT01698554|41724670|FG001|Overall Study|Adverse Event|5|||
19465926|NCT01698554|41724671|FG002|Overall Study|Adverse Event|0|||
19465927|NCT01698554|41724672|FG003|Overall Study|Adverse Event|1|||
19381190|NCT02344004|41624380|FG000|Overall Study|Protocol Violation|1|||
19381191|NCT02344004|41624381|FG001|Overall Study|Protocol Violation|0|||
19381192|NCT01328093|41624390|FG000|Double-Blind Phase|Adverse Event|78|||
19381193|NCT01328093|41624391|FG001|Double-Blind Phase|Adverse Event|15|||
19381194|NCT01328093|41624390|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
19381195|NCT01328093|41624391|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
19381196|NCT01328093|41624390|FG000|Double-Blind Phase|Lost to Follow-up|39|||
19465928|NCT01698554|41724669|FG000|Overall Study|Lost to Follow-up|1|||
19465929|NCT01698554|41724670|FG001|Overall Study|Lost to Follow-up|0|||
19465930|NCT01698554|41724671|FG002|Overall Study|Lost to Follow-up|0|||
19381197|NCT01328093|41624391|FG001|Double-Blind Phase|Lost to Follow-up|14|||
19465931|NCT01698554|41724672|FG003|Overall Study|Lost to Follow-up|0|||
19465932|NCT01698554|41724669|FG000|Overall Study|Personal Reasons|0|||
19465933|NCT01698554|41724670|FG001|Overall Study|Personal Reasons|5|||
19465934|NCT01698554|41724671|FG002|Overall Study|Personal Reasons|1|||
19465935|NCT01698554|41724672|FG003|Overall Study|Personal Reasons|1|||
19465936|NCT01698554|41724669|FG000|Overall Study|Protocol Violation|2|||
19465937|NCT01698554|41724670|FG001|Overall Study|Protocol Violation|0|||
19465938|NCT01698554|41724671|FG002|Overall Study|Protocol Violation|1|||
19465939|NCT01698554|41724672|FG003|Overall Study|Protocol Violation|0|||
19465940|NCT01698554|41724669|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19465941|NCT01698554|41724670|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19465942|NCT01698554|41724671|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19465943|NCT01698554|41724672|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19739007|NCT00101686|42186093|FG009|Overall Study|Randomized but did not receive treament|1|||
19465944|NCT01698320|41724684|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
19551341|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Physician Decision|0|||
19551342|NCT01342913|42000150|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19465945|NCT01698320|41724685|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
19465946|NCT01698320|41724686|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
19465947|NCT01698320|41724684|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
19465948|NCT01698320|41724685|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
19465949|NCT01698320|41724686|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
19465950|NCT01698320|41724684|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
19465951|NCT01698320|41724685|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
19465952|NCT01698320|41724686|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
19465953|NCT01698320|41724684|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
19465954|NCT01698320|41724685|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
19465955|NCT01698320|41724686|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
19465956|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Adverse Event|0|||
19465957|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Adverse Event|1|||
19465958|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Adverse Event|1|||
19465959|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
19465960|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
19465961|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
19465962|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
19465963|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
19465964|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
19465965|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Pregnancy|0|||
19465966|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Pregnancy|1|||
19465967|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Pregnancy|1|||
19465968|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
19465969|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
19465970|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
19465971|NCT01698320|41724684|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
19465972|NCT01698320|41724685|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
19465973|NCT01698320|41724686|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
19465974|NCT01698320|41724684|FG000|40-Week Open-Label Period|Adverse Event|0|||
19465975|NCT01698320|41724685|FG001|40-Week Open-Label Period|Adverse Event|3|||
19465976|NCT01698320|41724686|FG002|40-Week Open-Label Period|Adverse Event|2|||
19465977|NCT01698320|41724684|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
19465978|NCT01698320|41724685|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
19465979|NCT01698320|41724686|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
19465980|NCT01698320|41724684|FG000|40-Week Open-Label Period|Pregnancy|0|||
19465981|NCT01698320|41724685|FG001|40-Week Open-Label Period|Pregnancy|2|||
19465982|NCT01698320|41724686|FG002|40-Week Open-Label Period|Pregnancy|1|||
19465983|NCT01698320|41724684|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
19465984|NCT01698320|41724685|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
19465985|NCT01698320|41724686|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
19465986|NCT01698320|41724684|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
19465987|NCT01698320|41724685|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
19465988|NCT01698320|41724686|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
19465989|NCT01698008|41724696|FG000|Overall Study|Withdrawal by Subject|1|||
19465990|NCT01698008|41724697|FG001|Overall Study|Withdrawal by Subject|2|||
19465991|NCT01697696|41724713|FG000|Overall Study|Study terminated by sponsor|0|||
19465992|NCT01697696|41724714|FG001|Overall Study|Study terminated by sponsor|3|||
19465993|NCT01697696|41724713|FG000|Overall Study|Protocol deviation|1|||
19465994|NCT01697696|41724714|FG001|Overall Study|Protocol deviation|0|||
19465995|NCT01697696|41724713|FG000|Overall Study|Physician Decision|1|||
19465996|NCT01697696|41724714|FG001|Overall Study|Physician Decision|0|||
19465997|NCT01697696|41724713|FG000|Overall Study|Death|4|||
19465998|NCT01697696|41724714|FG001|Overall Study|Death|2|||
19465999|NCT01697696|41724713|FG000|Overall Study|Lost to Follow-up|10|||
19466000|NCT01697696|41724714|FG001|Overall Study|Lost to Follow-up|7|||
19466001|NCT01697696|41724713|FG000|Overall Study|Subject/guardian decision|31|||
19466002|NCT01697696|41724714|FG001|Overall Study|Subject/guardian decision|35|||
19466003|NCT01569152|41724722|FG000|Phase IIa, Period 1|Early Escape|5|||
19466004|NCT01569152|41724723|FG001|Phase IIa, Period 1|Early Escape|22|||
19466005|NCT01569152|41724724|FG002|Phase IIa, Period 1|Early Escape|0|||
19466006|NCT01569152|41724722|FG000|Phase IIa, Period 1|Adverse Event|4|||
19466007|NCT01569152|41724723|FG001|Phase IIa, Period 1|Adverse Event|0|||
19466008|NCT01569152|41724724|FG002|Phase IIa, Period 1|Adverse Event|0|||
19466009|NCT01569152|41724722|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
19466010|NCT01569152|41724723|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
19466011|NCT01569152|41724724|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
19466012|NCT01569152|41724722|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
19466013|NCT01569152|41724723|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
19466014|NCT01569152|41724724|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
19466015|NCT01569152|41724722|FG000|Phase IIa, Period 1|Protocol Violation|0|||
19466016|NCT01569152|41724723|FG001|Phase IIa, Period 1|Protocol Violation|1|||
19466017|NCT01569152|41724724|FG002|Phase IIa, Period 1|Protocol Violation|0|||
19466018|NCT01569152|41724722|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
19466019|NCT01569152|41724723|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
19466020|NCT01569152|41724724|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
19466021|NCT01569152|41724722|FG000|Safety Extension, Period 3|Adverse Event|0|||
19466022|NCT01569152|41724723|FG001|Safety Extension, Period 3|Adverse Event|0|||
19466023|NCT01569152|41724724|FG002|Safety Extension, Period 3|Adverse Event|4|||
19466024|NCT01569152|41724722|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
19466025|NCT01569152|41724723|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
19466026|NCT01569152|41724724|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
19466027|NCT01569152|41724722|FG000|Safety Extension, Period 3|Physician Decision|0|||
19466028|NCT01569152|41724723|FG001|Safety Extension, Period 3|Physician Decision|0|||
19739008|NCT00101686|42186084|FG000|Overall Study|intercurrent non-cancer related illness|0|||
19466029|NCT01569152|41724724|FG002|Safety Extension, Period 3|Physician Decision|2|||
19466030|NCT01569152|41724722|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
19466031|NCT01569152|41724723|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
19466032|NCT01569152|41724724|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
19466033|NCT01569074|41724749|FG000|Overall Study|Study stopped|6|||
19466034|NCT01569074|41724750|FG001|Overall Study|Study stopped|6|||
19466035|NCT01569074|41724751|FG002|Overall Study|Study stopped|8|||
19466036|NCT01569074|41724752|FG003|Overall Study|Study stopped|7|||
19466037|NCT01569074|41724753|FG004|Overall Study|Study stopped|7|||
19466038|NCT01569074|41724749|FG000|Overall Study|Study-specific discontinuation criteria|0|||
19466039|NCT01569074|41724750|FG001|Overall Study|Study-specific discontinuation criteria|1|||
19466040|NCT01569074|41724751|FG002|Overall Study|Study-specific discontinuation criteria|0|||
19466041|NCT01569074|41724752|FG003|Overall Study|Study-specific discontinuation criteria|0|||
19466042|NCT01569074|41724753|FG004|Overall Study|Study-specific discontinuation criteria|0|||
19466043|NCT01569074|41724749|FG000|Overall Study|Severe non-compliance to protocol|0|||
19466044|NCT01569074|41724750|FG001|Overall Study|Severe non-compliance to protocol|0|||
19466045|NCT01569074|41724751|FG002|Overall Study|Severe non-compliance to protocol|1|||
19466046|NCT01569074|41724752|FG003|Overall Study|Severe non-compliance to protocol|0|||
19466047|NCT01569074|41724753|FG004|Overall Study|Severe non-compliance to protocol|0|||
19466048|NCT01569074|41724749|FG000|Overall Study|eg change in circumstances|0|||
19466049|NCT01569074|41724750|FG001|Overall Study|eg change in circumstances|2|||
19466050|NCT01569074|41724751|FG002|Overall Study|eg change in circumstances|0|||
19466051|NCT01569074|41724752|FG003|Overall Study|eg change in circumstances|1|||
19466052|NCT01569074|41724753|FG004|Overall Study|eg change in circumstances|1|||
19466053|NCT01569074|41724749|FG000|Overall Study|Adverse Event|1|||
19466054|NCT01569074|41724750|FG001|Overall Study|Adverse Event|0|||
19466055|NCT01569074|41724751|FG002|Overall Study|Adverse Event|3|||
19739009|NCT00101686|42186085|FG001|Overall Study|intercurrent non-cancer related illness|0|||
19466056|NCT01569074|41724752|FG003|Overall Study|Adverse Event|0|||
19639167|NCT00717236|42088569|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
19466057|NCT01569074|41724753|FG004|Overall Study|Adverse Event|0|||
19466058|NCT01604408|41724771|FG000|Treatment Period 1|Protocol Violation|0|||
19466059|NCT01604408|41724772|FG001|Treatment Period 1|Protocol Violation|1|||
19466060|NCT01604408|41724771|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19466061|NCT01604408|41724772|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19466062|NCT01604408|41724771|FG000|Treatment Period 2|Protocol Violation|1|||
19466063|NCT01604408|41724772|FG001|Treatment Period 2|Protocol Violation|0|||
19466064|NCT01604408|41724771|FG000|Treatment Period 2|Adverse Event|0|||
19466065|NCT01604408|41724772|FG001|Treatment Period 2|Adverse Event|1|||
19381198|NCT01328093|41624390|FG000|Double-Blind Phase|Protocol Violation|30|||
19466066|NCT01604408|41724771|FG000|Treatment Period 3|Protocol Violation|1|||
19466067|NCT01604408|41724772|FG001|Treatment Period 3|Protocol Violation|1|||
19466068|NCT01604408|41724771|FG000|Treatment Period 3|Adverse Event|0|||
19466069|NCT01604408|41724772|FG001|Treatment Period 3|Adverse Event|3|||
19466070|NCT01604408|41724771|FG000|Treatment Period 3|Withdrawal by Subject|3|||
19466071|NCT01604408|41724772|FG001|Treatment Period 3|Withdrawal by Subject|1|||
19466072|NCT01604408|41724771|FG000|Treatment Period 3|Sponsor Decision|1|||
19466073|NCT01604408|41724772|FG001|Treatment Period 3|Sponsor Decision|0|||
19466074|NCT01604408|41724771|FG000|Treatment Period 4|Death|1|||
19466075|NCT01604408|41724772|FG001|Treatment Period 4|Death|0|||
19466076|NCT01604408|41724771|FG000|Treatment Period 4|Withdrawal by Subject|2|||
19466077|NCT01604408|41724772|FG001|Treatment Period 4|Withdrawal by Subject|1|||
19466078|NCT01604408|41724771|FG000|Treatment Period 4|Adverse Event|0|||
19466079|NCT01604408|41724772|FG001|Treatment Period 4|Adverse Event|1|||
19466080|NCT01604408|41724771|FG000|Treatment Period 5|Adverse Event|4|||
19466081|NCT01604408|41724772|FG001|Treatment Period 5|Adverse Event|0|||
19466082|NCT01604408|41724771|FG000|Treatment Period 6|Lost to Follow-up|0|||
19466083|NCT01604408|41724772|FG001|Treatment Period 6|Lost to Follow-up|1|||
19466084|NCT01604408|41724771|FG000|Treatment Period 6|Adverse Event|2|||
19466085|NCT01604408|41724772|FG001|Treatment Period 6|Adverse Event|0|||
19466086|NCT01604408|41724771|FG000|Treatment Period 6|Sponsor decision|0|||
19466087|NCT01604408|41724772|FG001|Treatment Period 6|Sponsor decision|1|||
19466088|NCT01604408|41724771|FG000|Observation Period|Adverse Event|1|||
19466089|NCT01604408|41724772|FG001|Observation Period|Adverse Event|1|||
19466090|NCT01604408|41724771|FG000|Observation Period|Withdrawal by Subject|0|||
19466091|NCT01604408|41724772|FG001|Observation Period|Withdrawal by Subject|2|||
19466092|NCT01567826|41724780|FG000|Overall Study|Lost to Follow-up|3|||
19466093|NCT01567826|41724781|FG001|Overall Study|Lost to Follow-up|2|||
19739010|NCT00101686|42186086|FG002|Overall Study|intercurrent non-cancer related illness|2|||
19381199|NCT01328093|41624391|FG001|Double-Blind Phase|Protocol Violation|10|||
19381200|NCT01328093|41624390|FG000|Double-Blind Phase|Lack of Efficacy|55|||
19381201|NCT01328093|41624391|FG001|Double-Blind Phase|Lack of Efficacy|13|||
19381202|NCT01328093|41624390|FG000|Double-Blind Phase|Sponsor Decision|17|||
19381203|NCT01328093|41624391|FG001|Double-Blind Phase|Sponsor Decision|3|||
19381204|NCT01328093|41624390|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
19381205|NCT01328093|41624391|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
19466094|NCT01697462|41724789|FG000|Overall Study|Disease Progression|1|||
19466095|NCT01697462|41724789|FG000|Overall Study|Adverse Event|6|||
19466096|NCT01697462|41724789|FG000|Overall Study|Lost to Follow-up|21|||
19466097|NCT01697462|41724789|FG000|Overall Study|Withdrawal by Subject|12|||
19466098|NCT01697462|41724789|FG000|Overall Study|Investigator Decision|21|||
19466099|NCT01697462|41724789|FG000|Overall Study|Death|1|||
19466100|NCT01697462|41724789|FG000|Overall Study|Other|10|||
19466101|NCT01697462|41724789|FG000|Overall Study|Missing|5|||
19466102|NCT01696994|41724795|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
19466103|NCT01696994|41724796|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
19466104|NCT01696994|41724795|FG000|Overall Study|Died Before Randomization|1|||
19466105|NCT01696994|41724796|FG001|Overall Study|Died Before Randomization|2|||
19466106|NCT01696994|41724795|FG000|Overall Study|Died Before ASU (Control)|73|||
19466107|NCT01696994|41724796|FG001|Overall Study|Died Before ASU (Control)|0|||
19466108|NCT01696994|41724795|FG000|Overall Study|No Ovaries at Baseline|4807|||
19466109|NCT01696994|41724796|FG001|Overall Study|No Ovaries at Baseline|4851|||
19466110|NCT01696994|41724795|FG000|Overall Study|Refused ASU (Control)|311|||
19466111|NCT01696994|41724796|FG001|Overall Study|Refused ASU (Control)|0|||
19466112|NCT01696994|41724795|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
19466113|NCT01696994|41724796|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
19466114|NCT01592240|41724975|FG000|Overall Study|Adverse Event|1|||
19466115|NCT01592240|41724976|FG001|Overall Study|Adverse Event|0|||
19466116|NCT01592240|41724977|FG002|Overall Study|Adverse Event|0|||
19466117|NCT01592240|41724978|FG003|Overall Study|Adverse Event|1|||
19466118|NCT01592240|41724979|FG004|Overall Study|Adverse Event|1|||
19466119|NCT01592240|41724980|FG005|Overall Study|Adverse Event|0|||
19466120|NCT01592240|41724981|FG006|Overall Study|Adverse Event|0|||
19466121|NCT01592240|41724975|FG000|Overall Study|Death|0|||
19466122|NCT01592240|41724976|FG001|Overall Study|Death|1|||
19466123|NCT01592240|41724977|FG002|Overall Study|Death|0|||
19466124|NCT01592240|41724978|FG003|Overall Study|Death|0|||
19466125|NCT01592240|41724979|FG004|Overall Study|Death|0|||
19466126|NCT01592240|41724980|FG005|Overall Study|Death|0|||
19466127|NCT01592240|41724981|FG006|Overall Study|Death|0|||
19466128|NCT01592240|41724975|FG000|Overall Study|Lost to Follow-up|1|||
19466129|NCT01592240|41724976|FG001|Overall Study|Lost to Follow-up|3|||
19466130|NCT01592240|41724977|FG002|Overall Study|Lost to Follow-up|1|||
19466131|NCT01592240|41724978|FG003|Overall Study|Lost to Follow-up|0|||
19466132|NCT01592240|41724979|FG004|Overall Study|Lost to Follow-up|3|||
19466133|NCT01592240|41724980|FG005|Overall Study|Lost to Follow-up|2|||
19466134|NCT01592240|41724981|FG006|Overall Study|Lost to Follow-up|0|||
19466135|NCT01592240|41724975|FG000|Overall Study|Protocol Violation|0|||
19466136|NCT01592240|41724976|FG001|Overall Study|Protocol Violation|0|||
19466137|NCT01592240|41724977|FG002|Overall Study|Protocol Violation|0|||
19466138|NCT01592240|41724978|FG003|Overall Study|Protocol Violation|0|||
19466139|NCT01592240|41724979|FG004|Overall Study|Protocol Violation|0|||
19466140|NCT01592240|41724980|FG005|Overall Study|Protocol Violation|1|||
19466141|NCT01592240|41724981|FG006|Overall Study|Protocol Violation|0|||
19466142|NCT01592240|41724975|FG000|Overall Study|Withdrawal by Subject|0|||
19466143|NCT01592240|41724976|FG001|Overall Study|Withdrawal by Subject|4|||
19466144|NCT01592240|41724977|FG002|Overall Study|Withdrawal by Subject|4|||
19466145|NCT01592240|41724978|FG003|Overall Study|Withdrawal by Subject|1|||
19466146|NCT01592240|41724979|FG004|Overall Study|Withdrawal by Subject|3|||
19466147|NCT01592240|41724980|FG005|Overall Study|Withdrawal by Subject|0|||
19466148|NCT01592240|41724981|FG006|Overall Study|Withdrawal by Subject|2|||
19466149|NCT01592240|41724975|FG000|Overall Study|Other|0|||
19466150|NCT01592240|41724976|FG001|Overall Study|Other|3|||
19466151|NCT01592240|41724977|FG002|Overall Study|Other|1|||
19466152|NCT01592240|41724978|FG003|Overall Study|Other|1|||
19466153|NCT01592240|41724979|FG004|Overall Study|Other|0|||
19466154|NCT01592240|41724980|FG005|Overall Study|Other|0|||
19466155|NCT01592240|41724981|FG006|Overall Study|Other|1|||
19466156|NCT01592240|41724975|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
19466157|NCT01592240|41724976|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
19466158|NCT01592240|41724977|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
19466159|NCT01592240|41724978|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
19466160|NCT01592240|41724979|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
19466161|NCT01592240|41724980|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
19466162|NCT01592240|41724981|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
19466163|NCT01591616|41725024|FG000|Overall Study|Withdrawal by Subject|1|||
19466164|NCT01591460|41725180|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
19466165|NCT01591460|41725180|FG000|Overall Study|Futility Rule (Week 12)|7|||
19466166|NCT01591460|41725180|FG000|Overall Study|Futility Rule (Week 24)|3|||
19466167|NCT01591460|41725180|FG000|Overall Study|Rebound or Breakthrough|3|||
19466168|NCT01591460|41725180|FG000|Overall Study|Treatment Discontinued by Error|1|||
19466169|NCT01591460|41725180|FG000|Overall Study|Lost to Follow-up|1|||
19466170|NCT01591460|41725180|FG000|Overall Study|Noncompliance|1|||
19466171|NCT01591460|41725180|FG000|Overall Study|Participant Refusal|3|||
19466172|NCT01591460|41725180|FG000|Overall Study|Withdrawal by Subject|1|||
19466173|NCT01591460|41725180|FG000|Overall Study|Protocol Violation|1|||
19466174|NCT01591382|41725203|FG000|Overall Study|Discharged Prior to Study Completion|2|||
19466175|NCT01591382|41725204|FG001|Overall Study|Discharged Prior to Study Completion|1|||
19466176|NCT01591382|41725203|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
19466177|NCT01591382|41725204|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
19466178|NCT01696214|41725222|FG000|Overall Study|Lost to Follow-up|1|||
19466179|NCT01696214|41725223|FG001|Overall Study|Lost to Follow-up|0|||
19466180|NCT01696214|41725224|FG002|Overall Study|Lost to Follow-up|0|||
19466181|NCT01696214|41725225|FG003|Overall Study|Lost to Follow-up|0|||
19466182|NCT01543087|41725258|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
19466183|NCT01543087|41725259|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
19466184|NCT01543087|41725260|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
19466185|NCT01543087|41725261|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
19466186|NCT01543087|41725262|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
19466187|NCT01543087|41725263|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
19466188|NCT01543087|41725258|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
19466189|NCT01543087|41725259|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
19466190|NCT01543087|41725260|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
19466191|NCT01543087|41725261|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
19466192|NCT01543087|41725262|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
19466193|NCT01543087|41725263|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
19466194|NCT01543087|41725258|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
19466195|NCT01543087|41725259|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
19466196|NCT01543087|41725260|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
19466197|NCT01543087|41725261|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
19466198|NCT01543087|41725262|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
19466199|NCT01543087|41725263|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
19466200|NCT01543087|41725258|FG000|Stage 1 (48 Months)|Other than specified|5|||
19466201|NCT01543087|41725259|FG001|Stage 1 (48 Months)|Other than specified|0|||
19466202|NCT01543087|41725260|FG002|Stage 1 (48 Months)|Other than specified|9|||
19466203|NCT01543087|41725261|FG003|Stage 1 (48 Months)|Other than specified|0|||
19466204|NCT01543087|41725262|FG004|Stage 1 (48 Months)|Other than specified|0|||
19466205|NCT01543087|41725263|FG005|Stage 1 (48 Months)|Other than specified|0|||
19466206|NCT01543087|41725258|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
19466207|NCT01543087|41725259|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
19466208|NCT01543087|41725260|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
19466209|NCT01543087|41725261|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
19466210|NCT01543087|41725262|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
19466211|NCT01543087|41725263|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
19466212|NCT01543087|41725258|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
19466213|NCT01543087|41725259|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
19466214|NCT01543087|41725260|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
19466215|NCT01543087|41725261|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
19466216|NCT01543087|41725262|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
19466217|NCT01543087|41725263|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
19466218|NCT01543087|41725258|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
19466219|NCT01543087|41725259|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
19466220|NCT01543087|41725260|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
19466221|NCT01543087|41725261|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
19466222|NCT01543087|41725262|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
19466223|NCT01543087|41725263|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
19466224|NCT01696058|41725301|FG000|Overall Study|Adverse Event|21|||
19466225|NCT01696058|41725302|FG001|Overall Study|Adverse Event|11|||
19466226|NCT01696058|41725301|FG000|Overall Study|Lack of Efficacy|2|||
19466227|NCT01696058|41725302|FG001|Overall Study|Lack of Efficacy|3|||
19466228|NCT01696058|41725301|FG000|Overall Study|Protocol Violation|9|||
19466229|NCT01696058|41725302|FG001|Overall Study|Protocol Violation|3|||
19466230|NCT01696058|41725301|FG000|Overall Study|Lost to Follow-up|2|||
19466231|NCT01696058|41725302|FG001|Overall Study|Lost to Follow-up|5|||
19466232|NCT01696058|41725301|FG000|Overall Study|Withdrawal by Subject|4|||
19466233|NCT01696058|41725302|FG001|Overall Study|Withdrawal by Subject|6|||
19466234|NCT01696058|41725301|FG000|Overall Study|Other reason prematurely discontinued|5|||
19466235|NCT01696058|41725302|FG001|Overall Study|Other reason prematurely discontinued|3|||
19466236|NCT01695746|41725308|FG000|Overall Study|Adverse Event|1|||
19466237|NCT01695746|41725308|FG000|Overall Study|Non-compliance by the participant|3|||
19466238|NCT01695746|41725308|FG000|Overall Study|Protocol Violation|5|||
19466239|NCT01695746|41725308|FG000|Overall Study|Participant not willing to participate|3|||
19466240|NCT01694420|41725319|FG000|Overall Study|Lost to Follow-up|3|||
19466241|NCT01675479|41725490|FG000|Overall Study|Lost to Follow-up|11|||
19466242|NCT02406027|41725615|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
19466243|NCT02406027|41725616|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
19466244|NCT02406027|41725617|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
19466245|NCT02406027|41725618|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
19466246|NCT02406027|41725619|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
19466247|NCT02406027|41725620|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
19466248|NCT02406027|41725621|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
19466249|NCT02406027|41725615|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
19466250|NCT02406027|41725616|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
19466251|NCT02406027|41725617|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
19466252|NCT02406027|41725618|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
19466253|NCT02406027|41725619|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
19466254|NCT02406027|41725620|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
19466255|NCT02406027|41725621|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
19466256|NCT02406027|41725615|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
19466257|NCT02406027|41725616|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
19466258|NCT02406027|41725617|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
19466259|NCT02406027|41725618|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
19466260|NCT02406027|41725619|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
19466261|NCT02406027|41725620|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
19466262|NCT02406027|41725621|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
19466263|NCT02406027|41725615|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
19466264|NCT02406027|41725616|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
19466265|NCT02406027|41725617|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
19466266|NCT02406027|41725618|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
19466267|NCT02406027|41725619|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
19466268|NCT02406027|41725620|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
19466269|NCT02406027|41725621|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
19466270|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
19466271|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
19466272|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
19466273|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
19466274|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
19466275|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
19466276|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
19466277|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
19466278|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
19466279|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
19466280|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
19466281|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
19466282|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
19466283|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
19466284|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
19466285|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
19466286|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
19466287|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
19466288|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
19466289|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
19466290|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
19466291|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
19466292|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
19466293|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
19466294|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
19466295|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
19466296|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
19466297|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
19466298|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466299|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466300|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466301|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466302|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466303|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
19466304|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
19466305|NCT02406027|41725615|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466306|NCT02406027|41725616|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466307|NCT02406027|41725617|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466308|NCT02406027|41725618|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466309|NCT02406027|41725619|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
19466310|NCT02406027|41725620|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466311|NCT02406027|41725621|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
19466312|NCT00089973|41725637|FG000|Overall Study|Adverse Event|3|||
19466313|NCT00089973|41725637|FG000|Overall Study|Withdrawal by Subject|1|||
19466314|NCT00089973|41725637|FG000|Overall Study|Disease progression|45|||
19466315|NCT00089973|41725637|FG000|Overall Study|Death|1|||
19466316|NCT00089661|41725655|FG000|Overall Study|Adverse Event|0|||
19466317|NCT00089661|41725656|FG001|Overall Study|Adverse Event|2|||
19466318|NCT00089661|41725655|FG000|Overall Study|Death|1|||
19466319|NCT00089661|41725656|FG001|Overall Study|Death|0|||
19466320|NCT00089661|41725655|FG000|Overall Study|Lost to Follow-up|0|||
19466321|NCT00089661|41725656|FG001|Overall Study|Lost to Follow-up|3|||
19466322|NCT00089661|41725655|FG000|Overall Study|Withdrawal by Subject|11|||
19466323|NCT00089661|41725656|FG001|Overall Study|Withdrawal by Subject|9|||
19466324|NCT00089661|41725655|FG000|Overall Study|Disease progression|1|||
19466325|NCT00089661|41725656|FG001|Overall Study|Disease progression|3|||
19466326|NCT00089661|41725655|FG000|Overall Study|Ineligibility determined|4|||
19466327|NCT00089661|41725656|FG001|Overall Study|Ineligibility determined|4|||
19466328|NCT00089661|41725655|FG000|Overall Study|Noncompliance|2|||
19466329|NCT00089661|41725656|FG001|Overall Study|Noncompliance|4|||
19466330|NCT00089661|41725655|FG000|Overall Study|Other|2|||
19466331|NCT00089661|41725656|FG001|Overall Study|Other|1|||
19466332|NCT00089583|41725677|FG000|Overall Study|Adverse Event|0|||
19466333|NCT00089583|41725678|FG001|Overall Study|Adverse Event|3|||
19466334|NCT00089583|41725677|FG000|Overall Study|Insufficient Viral Load Response|5|||
19466335|NCT00089583|41725678|FG001|Overall Study|Insufficient Viral Load Response|5|||
19466336|NCT00089583|41725677|FG000|Overall Study|Withdrawal by Subject|0|||
19466337|NCT00089583|41725678|FG001|Overall Study|Withdrawal by Subject|4|||
19466338|NCT00089583|41725677|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
19466339|NCT00089583|41725678|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
19466340|NCT00089583|41725677|FG000|Overall Study|Participant Refused Study Medication|0|||
19466341|NCT00089583|41725678|FG001|Overall Study|Participant Refused Study Medication|2|||
19739011|NCT00101686|42186087|FG003|Overall Study|intercurrent non-cancer related illness|0|||
19739012|NCT00101686|42186088|FG004|Overall Study|intercurrent non-cancer related illness|1|||
19466342|NCT00089583|41725677|FG000|Overall Study|Non-Compliance|0|||
19466343|NCT00089583|41725678|FG001|Overall Study|Non-Compliance|4|||
19466344|NCT00089583|41725677|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
19466345|NCT00089583|41725678|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
19466346|NCT00089583|41725677|FG000|Overall Study|Participant Management Criteria Met|0|||
19466347|NCT00089583|41725678|FG001|Overall Study|Participant Management Criteria Met|1|||
19466348|NCT00089583|41725677|FG000|Overall Study|Reason Not Provided|0|||
19466349|NCT00089583|41725678|FG001|Overall Study|Reason Not Provided|1|||
19466350|NCT00089583|41725677|FG000|Overall Study|Protocol Violation|0|||
19466351|NCT00089583|41725678|FG001|Overall Study|Protocol Violation|3|||
19466352|NCT00089583|41725677|FG000|Overall Study|Principal Investigator Decision|0|||
19466353|NCT00089583|41725678|FG001|Overall Study|Principal Investigator Decision|10|||
19466354|NCT00089583|41725677|FG000|Overall Study|Start of Disallowed Medication|0|||
19466355|NCT00089583|41725678|FG001|Overall Study|Start of Disallowed Medication|1|||
19466356|NCT00089583|41725677|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
19466357|NCT00089583|41725678|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
19466358|NCT00089583|41725677|FG000|Overall Study|Participant Incarcerated|0|||
19466359|NCT00089583|41725678|FG001|Overall Study|Participant Incarcerated|1|||
19466360|NCT00088881|41725690|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
19466361|NCT00088881|41725690|FG000|Step 1 - R-CHOP|Adverse Event|1|||
19466362|NCT00088881|41725690|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
19466363|NCT00088881|41725690|FG000|Step 1 - R-CHOP|Physician Decision|1|||
19466364|NCT00088881|41725690|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
19466365|NCT00088881|41725690|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
19466366|NCT00088881|41725690|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
19466367|NCT00087555|41725738|FG000|Overall Study|Adverse Event|3|||
19466368|NCT00087555|41725739|FG001|Overall Study|Adverse Event|6|||
19466369|NCT00087555|41725740|FG002|Overall Study|Adverse Event|14|||
19466370|NCT00087555|41725738|FG000|Overall Study|Lost to Follow-up|0|||
19466371|NCT00087555|41725739|FG001|Overall Study|Lost to Follow-up|1|||
19466372|NCT00087555|41725740|FG002|Overall Study|Lost to Follow-up|1|||
19466373|NCT00087555|41725738|FG000|Overall Study|Non - Compliance|1|||
19466374|NCT00087555|41725739|FG001|Overall Study|Non - Compliance|0|||
19466375|NCT00087555|41725740|FG002|Overall Study|Non - Compliance|0|||
19466376|NCT00087555|41725738|FG000|Overall Study|Protocol Violation|0|||
19466377|NCT00087555|41725739|FG001|Overall Study|Protocol Violation|0|||
19466378|NCT00087555|41725740|FG002|Overall Study|Protocol Violation|2|||
19466379|NCT00087555|41725738|FG000|Overall Study|Screen Failure|1|||
19466380|NCT00087555|41725739|FG001|Overall Study|Screen Failure|1|||
19466381|NCT00087555|41725740|FG002|Overall Study|Screen Failure|0|||
19466382|NCT00087555|41725738|FG000|Overall Study|Pregnancy|0|||
19466383|NCT00087555|41725739|FG001|Overall Study|Pregnancy|1|||
19466384|NCT00087555|41725740|FG002|Overall Study|Pregnancy|1|||
19466385|NCT00087555|41725738|FG000|Overall Study|Withdrawal by Subject|3|||
19466386|NCT00087555|41725739|FG001|Overall Study|Withdrawal by Subject|2|||
19466387|NCT00087555|41725740|FG002|Overall Study|Withdrawal by Subject|1|||
19466388|NCT00087555|41725738|FG000|Overall Study|Lack of Efficacy|2|||
19466389|NCT00087555|41725739|FG001|Overall Study|Lack of Efficacy|0|||
19466390|NCT00087555|41725740|FG002|Overall Study|Lack of Efficacy|1|||
19466391|NCT00087555|41725738|FG000|Overall Study|Non Compliance|0|||
19466392|NCT00087555|41725739|FG001|Overall Study|Non Compliance|0|||
19466393|NCT00087555|41725740|FG002|Overall Study|Non Compliance|1|||
19466394|NCT00087555|41725738|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
19466395|NCT00087555|41725739|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
19466396|NCT00087555|41725740|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
19466397|NCT00087555|41725738|FG000|Overall Study|Patient wanted to go back on Med|1|||
19466398|NCT00087555|41725739|FG001|Overall Study|Patient wanted to go back on Med|0|||
19466399|NCT00087555|41725740|FG002|Overall Study|Patient wanted to go back on Med|0|||
19466400|NCT00086619|41725763|FG000|Overall Study|Withdrawal by Subject|6|||
19466401|NCT00086619|41725764|FG001|Overall Study|Withdrawal by Subject|6|||
19466402|NCT00086619|41725763|FG000|Overall Study|Adverse Event|8|||
19466403|NCT00086619|41725764|FG001|Overall Study|Adverse Event|10|||
19466404|NCT00086619|41725763|FG000|Overall Study|Protocol Violation|1|||
19466405|NCT00086619|41725764|FG001|Overall Study|Protocol Violation|1|||
19466406|NCT00085917|41725777|FG000|Overall Study|Adverse Event|4|||
19466407|NCT00085917|41725778|FG001|Overall Study|Adverse Event|3|||
19466408|NCT00084747|41725784|FG000|Overall Study|Relapsed|8|||
19466409|NCT00084747|41725784|FG000|Overall Study|Death|3|||
19466410|NCT00084747|41725784|FG000|Overall Study|Withdrawal by Subject|2|||
19466411|NCT00081159|41725819|FG000|Overall Study|Withdrawal by Subject|0|||
19466412|NCT00081159|41725820|FG001|Overall Study|Withdrawal by Subject|3|||
19466413|NCT00081159|41725819|FG000|Overall Study|Myelosuppression prior to treatment|0|||
19466414|NCT00081159|41725820|FG001|Overall Study|Myelosuppression prior to treatment|1|||
19466415|NCT00081159|41725819|FG000|Overall Study|Lost to Follow-up|2|||
19466416|NCT00081159|41725820|FG001|Overall Study|Lost to Follow-up|1|||
19466417|NCT00080223|41725835|FG000|Overall Study|Adverse Event|23|||
19466418|NCT00080223|41725835|FG000|Overall Study|Death|21|||
19466419|NCT00080223|41725835|FG000|Overall Study|Withdrawal by Subject|13|||
19466420|NCT00080223|41725835|FG000|Overall Study|Lung Transplantation|9|||
19551343|NCT01342913|42000151|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
19551344|NCT01342913|42000152|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
19551345|NCT01342796|42000160|FG000|Overall Study|Withdrawal by Subject|2|||
19551346|NCT01342796|42000161|FG001|Overall Study|Withdrawal by Subject|0|||
19551347|NCT01342796|42000160|FG000|Overall Study|Lost to Follow-up|0|||
19551348|NCT01342796|42000161|FG001|Overall Study|Lost to Follow-up|3|||
19551349|NCT01342796|42000160|FG000|Overall Study|Inappropriate enrollment|1|||
19551350|NCT01342796|42000161|FG001|Overall Study|Inappropriate enrollment|0|||
19551351|NCT01342640|42000167|FG000|Overall Study|Adverse Event|3|||
19551352|NCT01342640|42000167|FG000|Overall Study|Protocol Violation|16|||
19551353|NCT01342640|42000167|FG000|Overall Study|Lost to Follow-up|21|||
19551354|NCT01342640|42000167|FG000|Overall Study|Other|1|||
19551355|NCT01342484|42000174|FG000|Overall Study|Other Reasons|1|||
19551356|NCT01342484|42000175|FG001|Overall Study|Other Reasons|0|||
19551357|NCT01342484|42000176|FG002|Overall Study|Other Reasons|0|||
19551358|NCT01342484|42000174|FG000|Overall Study|Protocol Violation|0|||
19551359|NCT01342484|42000175|FG001|Overall Study|Protocol Violation|0|||
19551360|NCT01342484|42000176|FG002|Overall Study|Protocol Violation|1|||
19551361|NCT01342484|42000174|FG000|Overall Study|Withdrawal by Subject|1|||
19551362|NCT01342484|42000175|FG001|Overall Study|Withdrawal by Subject|0|||
19551363|NCT01342484|42000176|FG002|Overall Study|Withdrawal by Subject|0|||
19551364|NCT01342445|42000186|FG000|Overall Study|Experienced side effects|0|||
19551365|NCT01342445|42000187|FG001|Overall Study|Experienced side effects|2|||
19551366|NCT01342367|42000199|FG000|Overall Study|Death|1|||
19551367|NCT01342367|42000200|FG001|Overall Study|Death|0|||
19551368|NCT01342367|42000199|FG000|Overall Study|Withdrawal by Subject|1|||
19551369|NCT01342367|42000200|FG001|Overall Study|Withdrawal by Subject|2|||
19466421|NCT00080223|41725835|FG000|Overall Study|Non-compliance With Study Treatment|7|||
19466422|NCT00080223|41725835|FG000|Overall Study|Participant unwilling to continue|2|||
19466423|NCT00080223|41725835|FG000|Overall Study|Physician Decision|1|||
19466424|NCT01899053|41726473|FG000|Overall Study|Progressive Disease|4|||
19551370|NCT01342211|42000211|FG000|Overall Study|Lost to Follow-up|0|||
19551371|NCT01342211|42000212|FG001|Overall Study|Lost to Follow-up|0|||
19551372|NCT01342211|42000213|FG002|Overall Study|Lost to Follow-up|0|||
19551373|NCT01342211|42000214|FG003|Overall Study|Lost to Follow-up|1|||
19551374|NCT01342211|42000215|FG004|Overall Study|Lost to Follow-up|0|||
19551375|NCT01342211|42000211|FG000|Overall Study|Adverse Event|0|||
19466425|NCT01899053|41726474|FG001|Overall Study|Progressive Disease|0|||
19466426|NCT01899053|41726475|FG002|Overall Study|Progressive Disease|3|||
19466427|NCT01899053|41726476|FG003|Overall Study|Progressive Disease|0|||
19466428|NCT01899053|41726477|FG004|Overall Study|Progressive Disease|3|||
19466429|NCT01899053|41726478|FG005|Overall Study|Progressive Disease|1|||
19466430|NCT01899053|41726479|FG006|Overall Study|Progressive Disease|1|||
19466431|NCT01899053|41726480|FG007|Overall Study|Progressive Disease|1|||
19466432|NCT01899053|41726481|FG008|Overall Study|Progressive Disease|4|||
19466433|NCT01899053|41726482|FG009|Overall Study|Progressive Disease|3|||
19466434|NCT01899053|41726483|FG010|Overall Study|Progressive Disease|12|||
19466435|NCT01899053|41726484|FG011|Overall Study|Progressive Disease|5|||
19466436|NCT01899053|41726485|FG012|Overall Study|Progressive Disease|8|||
19466437|NCT01899053|41726486|FG013|Overall Study|Progressive Disease|17|||
19466438|NCT01899053|41726473|FG000|Overall Study|Adverse Event|1|||
19466439|NCT01899053|41726474|FG001|Overall Study|Adverse Event|1|||
19466440|NCT01899053|41726475|FG002|Overall Study|Adverse Event|1|||
19466441|NCT01899053|41726476|FG003|Overall Study|Adverse Event|3|||
19466442|NCT01899053|41726477|FG004|Overall Study|Adverse Event|1|||
19466443|NCT01899053|41726478|FG005|Overall Study|Adverse Event|1|||
19466444|NCT01899053|41726479|FG006|Overall Study|Adverse Event|1|||
19466445|NCT01899053|41726480|FG007|Overall Study|Adverse Event|0|||
19466446|NCT01899053|41726481|FG008|Overall Study|Adverse Event|2|||
19466447|NCT01899053|41726482|FG009|Overall Study|Adverse Event|0|||
19466448|NCT01899053|41726483|FG010|Overall Study|Adverse Event|3|||
19466449|NCT01899053|41726484|FG011|Overall Study|Adverse Event|1|||
19466450|NCT01899053|41726485|FG012|Overall Study|Adverse Event|2|||
19466451|NCT01899053|41726486|FG013|Overall Study|Adverse Event|2|||
19466452|NCT01899053|41726473|FG000|Overall Study|Reason Not Specified|0|||
19466453|NCT01899053|41726474|FG001|Overall Study|Reason Not Specified|0|||
19466454|NCT01899053|41726475|FG002|Overall Study|Reason Not Specified|0|||
19466455|NCT01899053|41726476|FG003|Overall Study|Reason Not Specified|0|||
19466456|NCT01899053|41726477|FG004|Overall Study|Reason Not Specified|0|||
19466457|NCT01899053|41726478|FG005|Overall Study|Reason Not Specified|0|||
19466458|NCT01899053|41726479|FG006|Overall Study|Reason Not Specified|1|||
19466459|NCT01899053|41726480|FG007|Overall Study|Reason Not Specified|0|||
19466460|NCT01899053|41726481|FG008|Overall Study|Reason Not Specified|0|||
19466461|NCT01899053|41726482|FG009|Overall Study|Reason Not Specified|0|||
19466462|NCT01899053|41726483|FG010|Overall Study|Reason Not Specified|0|||
19466463|NCT01899053|41726484|FG011|Overall Study|Reason Not Specified|0|||
19466464|NCT01899053|41726485|FG012|Overall Study|Reason Not Specified|1|||
19466465|NCT01899053|41726486|FG013|Overall Study|Reason Not Specified|0|||
19466466|NCT01899053|41726473|FG000|Overall Study|Withdrawal by Subject|1|||
19466467|NCT01899053|41726474|FG001|Overall Study|Withdrawal by Subject|1|||
19466468|NCT01899053|41726475|FG002|Overall Study|Withdrawal by Subject|2|||
19466469|NCT01899053|41726476|FG003|Overall Study|Withdrawal by Subject|0|||
19466470|NCT01899053|41726477|FG004|Overall Study|Withdrawal by Subject|2|||
19466471|NCT01899053|41726478|FG005|Overall Study|Withdrawal by Subject|0|||
19466472|NCT01899053|41726479|FG006|Overall Study|Withdrawal by Subject|0|||
19466473|NCT01899053|41726480|FG007|Overall Study|Withdrawal by Subject|1|||
19466474|NCT01899053|41726481|FG008|Overall Study|Withdrawal by Subject|0|||
19466475|NCT01899053|41726482|FG009|Overall Study|Withdrawal by Subject|0|||
19466476|NCT01899053|41726483|FG010|Overall Study|Withdrawal by Subject|0|||
19466477|NCT01899053|41726484|FG011|Overall Study|Withdrawal by Subject|0|||
19466478|NCT01899053|41726485|FG012|Overall Study|Withdrawal by Subject|1|||
19466479|NCT01899053|41726486|FG013|Overall Study|Withdrawal by Subject|1|||
19466480|NCT01899053|41726473|FG000|Overall Study|Protocol Violation|0|||
19466481|NCT01899053|41726474|FG001|Overall Study|Protocol Violation|0|||
19466482|NCT01899053|41726475|FG002|Overall Study|Protocol Violation|1|||
19466483|NCT01899053|41726476|FG003|Overall Study|Protocol Violation|0|||
19466484|NCT01899053|41726477|FG004|Overall Study|Protocol Violation|0|||
19466485|NCT01899053|41726478|FG005|Overall Study|Protocol Violation|0|||
19466486|NCT01899053|41726479|FG006|Overall Study|Protocol Violation|0|||
19466487|NCT01899053|41726480|FG007|Overall Study|Protocol Violation|0|||
19466488|NCT01899053|41726481|FG008|Overall Study|Protocol Violation|0|||
19466489|NCT01899053|41726482|FG009|Overall Study|Protocol Violation|0|||
19466490|NCT01899053|41726483|FG010|Overall Study|Protocol Violation|0|||
19466491|NCT01899053|41726484|FG011|Overall Study|Protocol Violation|0|||
19466492|NCT01899053|41726485|FG012|Overall Study|Protocol Violation|0|||
19466493|NCT01899053|41726486|FG013|Overall Study|Protocol Violation|0|||
19466494|NCT01899053|41726473|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
19466495|NCT01899053|41726474|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
19466496|NCT01899053|41726475|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466497|NCT01899053|41726476|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466498|NCT01899053|41726477|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466499|NCT01899053|41726478|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466500|NCT01899053|41726479|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466501|NCT01899053|41726480|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466502|NCT01899053|41726481|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466503|NCT01899053|41726482|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466504|NCT01899053|41726483|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
19466505|NCT01899053|41726484|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466506|NCT01899053|41726485|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466507|NCT01899053|41726486|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
19466508|NCT01899053|41726473|FG000|Overall Study|Symptomatic Deterioration|0|||
19466509|NCT01899053|41726474|FG001|Overall Study|Symptomatic Deterioration|0|||
19466510|NCT01899053|41726475|FG002|Overall Study|Symptomatic Deterioration|0|||
19466511|NCT01899053|41726476|FG003|Overall Study|Symptomatic Deterioration|0|||
19466512|NCT01899053|41726477|FG004|Overall Study|Symptomatic Deterioration|0|||
19551376|NCT01342211|42000212|FG001|Overall Study|Adverse Event|0|||
19551377|NCT01342211|42000213|FG002|Overall Study|Adverse Event|0|||
19551378|NCT01342211|42000214|FG003|Overall Study|Adverse Event|0|||
19551379|NCT01342211|42000215|FG004|Overall Study|Adverse Event|1|||
19551380|NCT01342211|42000211|FG000|Overall Study|Withdrawal by Subject|0|||
19551381|NCT01342211|42000212|FG001|Overall Study|Withdrawal by Subject|0|||
19551382|NCT01342211|42000213|FG002|Overall Study|Withdrawal by Subject|0|||
19551383|NCT01342211|42000214|FG003|Overall Study|Withdrawal by Subject|1|||
19739013|NCT00101686|42186089|FG005|Overall Study|intercurrent non-cancer related illness|3|||
19466513|NCT01899053|41726478|FG005|Overall Study|Symptomatic Deterioration|1|||
19466514|NCT01899053|41726479|FG006|Overall Study|Symptomatic Deterioration|0|||
19466515|NCT01899053|41726480|FG007|Overall Study|Symptomatic Deterioration|1|||
19466516|NCT01899053|41726481|FG008|Overall Study|Symptomatic Deterioration|0|||
19466517|NCT01899053|41726482|FG009|Overall Study|Symptomatic Deterioration|0|||
19466518|NCT01899053|41726483|FG010|Overall Study|Symptomatic Deterioration|0|||
19466519|NCT01899053|41726484|FG011|Overall Study|Symptomatic Deterioration|1|||
19466520|NCT01899053|41726485|FG012|Overall Study|Symptomatic Deterioration|2|||
19466521|NCT01899053|41726486|FG013|Overall Study|Symptomatic Deterioration|0|||
19466522|NCT01888367|41726591|FG000|Overall Study|Physician Decision|3|||
19466523|NCT01888367|41726592|FG001|Overall Study|Physician Decision|4|||
19466524|NCT01888367|41726593|FG002|Overall Study|Physician Decision|2|||
19466525|NCT01888367|41726591|FG000|Overall Study|Death|2|||
19466526|NCT01888367|41726592|FG001|Overall Study|Death|0|||
19551384|NCT01342211|42000215|FG004|Overall Study|Withdrawal by Subject|0|||
19551385|NCT01342211|42000211|FG000|Overall Study|Randomized, but not Treated|0|||
19551386|NCT01342211|42000212|FG001|Overall Study|Randomized, but not Treated|2|||
19551387|NCT01342211|42000213|FG002|Overall Study|Randomized, but not Treated|0|||
19551388|NCT01342211|42000214|FG003|Overall Study|Randomized, but not Treated|0|||
19739014|NCT00101686|42186090|FG006|Overall Study|intercurrent non-cancer related illness|1|||
19466527|NCT01888367|41726593|FG002|Overall Study|Death|1|||
19466528|NCT01888367|41726591|FG000|Overall Study|Withdrawal by Subject|1|||
19466529|NCT01888367|41726592|FG001|Overall Study|Withdrawal by Subject|0|||
19466530|NCT01888367|41726593|FG002|Overall Study|Withdrawal by Subject|1|||
19466531|NCT01888367|41726591|FG000|Overall Study|Lost to Follow-up|1|||
19466532|NCT01888367|41726592|FG001|Overall Study|Lost to Follow-up|1|||
19466533|NCT01888367|41726593|FG002|Overall Study|Lost to Follow-up|0|||
19466534|NCT01888367|41726591|FG000|Overall Study|Protocol Violation|0|||
19466535|NCT01888367|41726592|FG001|Overall Study|Protocol Violation|0|||
19466536|NCT01888367|41726593|FG002|Overall Study|Protocol Violation|1|||
19466537|NCT01888367|41726591|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
19466538|NCT01888367|41726592|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
19466539|NCT01888367|41726593|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
19466540|NCT01898195|41726619|FG000|Smoking Abstinence|Did not have good measurements|35|||
19466541|NCT01898195|41726620|FG001|Smoking Abstinence|Did not have good measurements|38|||
19466542|NCT01898195|41726621|FG002|Smoking Abstinence|Did not have good measurements|36|||
19466543|NCT01897727|41726635|FG000|Overall Study|Exclusion: central sleep apnea|0|||
19466544|NCT01897727|41726636|FG001|Overall Study|Exclusion: central sleep apnea|1|||
19466545|NCT01897493|41726642|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
19466546|NCT01887353|41726651|FG000|Overall Study|Study stopped early|4|||
19466547|NCT01887353|41726652|FG001|Overall Study|Study stopped early|3|||
19466548|NCT01896869|41726674|FG000|Overall Study|Withdrawal by Subject|0|||
19466549|NCT01896869|41726675|FG001|Overall Study|Withdrawal by Subject|6|||
19466550|NCT01896869|41726674|FG000|Overall Study|Lost to Follow-up|1|||
19466551|NCT01896869|41726675|FG001|Overall Study|Lost to Follow-up|0|||
19466552|NCT01896557|41726685|FG000|Clopidogrel Alone|Adverse Event|1|||
19466553|NCT01896557|41726686|FG001|Clopidogrel Alone|Adverse Event|0|||
19466554|NCT01896557|41726685|FG000|Clopidogrel + GI Protector|low adherence|1|||
19466555|NCT01896557|41726686|FG001|Clopidogrel + GI Protector|low adherence|1|||
19466556|NCT01896557|41726685|FG000|Clopidogrel + GI Protector|Reading error|1|||
19466557|NCT01896557|41726686|FG001|Clopidogrel + GI Protector|Reading error|3|||
19551389|NCT01342211|42000215|FG004|Overall Study|Randomized, but not Treated|1|||
19551390|NCT01342094|42000233|FG000|Overall Study|Adverse Event|5|||
19551391|NCT01342094|42000234|FG001|Overall Study|Adverse Event|0|||
19466558|NCT01886105|41726701|FG000|Overall Study|Lack of Efficacy|3|||
19466559|NCT01895777|41726730|FG000|Overall Study|Adverse Event|1|||
19466560|NCT01895777|41726731|FG001|Overall Study|Adverse Event|2|||
19551392|NCT01342094|42000233|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
19551393|NCT01342094|42000234|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
19551394|NCT01342094|42000233|FG000|Overall Study|Withdrawal by Subject|0|||
19551395|NCT01342094|42000234|FG001|Overall Study|Withdrawal by Subject|2|||
19551396|NCT01340768|42000242|FG000|Overall Study|Lost to Follow-up|10|||
19551397|NCT01340768|42000243|FG001|Overall Study|Lost to Follow-up|4|||
19551398|NCT01340768|42000242|FG000|Overall Study|Withdrawal by Subject|5|||
19551399|NCT01340768|42000243|FG001|Overall Study|Withdrawal by Subject|1|||
19551400|NCT01340768|42000242|FG000|Overall Study|Other|2|||
19551401|NCT01340768|42000243|FG001|Overall Study|Other|0|||
19551402|NCT01340651|42000249|FG000|Overall Study|Adverse Event|3|||
19551403|NCT01340651|42000249|FG000|Overall Study|Consent Withdrawn|2|||
19551404|NCT01340651|42000249|FG000|Overall Study|Commercial Supply per Sponsor|12|||
19551405|NCT01340495|42000255|FG000|Overall Study|Withdrawal by Subject|1|||
19551406|NCT01340300|42000263|FG000|Overall Study|Lost to Follow-up|3|||
19551407|NCT01340300|42000264|FG001|Overall Study|Lost to Follow-up|0|||
19551408|NCT01340300|42000265|FG002|Overall Study|Lost to Follow-up|5|||
19551409|NCT01340300|42000266|FG003|Overall Study|Lost to Follow-up|10|||
19551410|NCT01340300|42000263|FG000|Overall Study|Withdrawal by Subject|5|||
19551411|NCT01340300|42000264|FG001|Overall Study|Withdrawal by Subject|6|||
19551412|NCT01340300|42000265|FG002|Overall Study|Withdrawal by Subject|6|||
19551413|NCT01340300|42000266|FG003|Overall Study|Withdrawal by Subject|3|||
19551414|NCT01340300|42000263|FG000|Overall Study|Adverse Event|1|||
19551415|NCT01340300|42000264|FG001|Overall Study|Adverse Event|0|||
19551416|NCT01340300|42000265|FG002|Overall Study|Adverse Event|4|||
19551417|NCT01340300|42000266|FG003|Overall Study|Adverse Event|0|||
19551418|NCT01340300|42000263|FG000|Overall Study|Physician Decision|0|||
19551419|NCT01340300|42000264|FG001|Overall Study|Physician Decision|1|||
19551420|NCT01340300|42000265|FG002|Overall Study|Physician Decision|0|||
19551421|NCT01340300|42000266|FG003|Overall Study|Physician Decision|0|||
19551422|NCT01340300|42000263|FG000|Overall Study|Unrelated sickness|0|||
19551423|NCT01340300|42000264|FG001|Overall Study|Unrelated sickness|2|||
19551424|NCT01340300|42000265|FG002|Overall Study|Unrelated sickness|0|||
19551425|NCT01340300|42000266|FG003|Overall Study|Unrelated sickness|1|||
19551426|NCT01340066|42000278|FG000|Placebo Run in Period|Screen Failures|27|||
19551427|NCT01340066|42000279|FG001|Placebo Run in Period|Screen Failures|0|||
19551428|NCT01340066|42000280|FG002|Placebo Run in Period|Screen Failures|0|||
19551429|NCT01340066|42000278|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
19551430|NCT01340066|42000279|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
19551431|NCT01340066|42000280|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
19551432|NCT01340066|42000278|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
19551433|NCT01340066|42000279|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
19551434|NCT01340066|42000280|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
19551435|NCT01340066|42000278|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
19551436|NCT01340066|42000279|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
19551437|NCT01340066|42000280|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
19551438|NCT01107535|42000287|FG000|Overall Study|Death|5|||
19551439|NCT01326546|42000293|FG000|Overall Study|Lost to Follow-up|8|||
19551440|NCT01326546|42000294|FG001|Overall Study|Lost to Follow-up|7|||
19551441|NCT01326546|42000293|FG000|Overall Study|Protocol Violation|3|||
19551442|NCT01326546|42000294|FG001|Overall Study|Protocol Violation|4|||
19551443|NCT01326546|42000293|FG000|Overall Study|Pregnancy|0|||
19551444|NCT01326546|42000294|FG001|Overall Study|Pregnancy|1|||
19551445|NCT01326546|42000293|FG000|Overall Study|Adverse Event|1|||
19551446|NCT01326546|42000294|FG001|Overall Study|Adverse Event|0|||
19551447|NCT01326546|42000293|FG000|Overall Study|Withdrawal by Subject|5|||
19551448|NCT01326546|42000294|FG001|Overall Study|Withdrawal by Subject|1|||
19551449|NCT01325532|42000302|FG000|Overall Study|Withdrawal by Subject|2|||
19551450|NCT01325532|42000303|FG001|Overall Study|Withdrawal by Subject|0|||
19551451|NCT01171963|42000311|FG000|Overall Study|Adverse Event|10|||
19551452|NCT01171963|42000312|FG001|Overall Study|Adverse Event|15|||
19551453|NCT01171963|42000311|FG000|Overall Study|Lost to Follow-up|23|||
19551454|NCT01171963|42000312|FG001|Overall Study|Lost to Follow-up|24|||
19551455|NCT01171963|42000311|FG000|Overall Study|Other - diarrhoea|1|||
19381206|NCT01328093|41624390|FG000|Double-Blind Phase|Scheduling conflict|8|||
19551456|NCT01171963|42000312|FG001|Overall Study|Other - diarrhoea|0|||
19551457|NCT01171963|42000311|FG000|Overall Study|Withdrawal by Subject|114|||
19551458|NCT01171963|42000312|FG001|Overall Study|Withdrawal by Subject|129|||
19551459|NCT01171183|42000323|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
19551460|NCT01171183|42000324|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
19551461|NCT01171183|42000323|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
19551462|NCT01171183|42000324|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
19739015|NCT00101686|42186091|FG007|Overall Study|intercurrent non-cancer related illness|0|||
19551463|NCT01171183|42000323|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
19551464|NCT01171183|42000324|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
19551465|NCT01171183|42000323|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
19551466|NCT01171183|42000324|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
19551467|NCT01171183|42000323|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
19551468|NCT01171183|42000324|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
19551469|NCT01171183|42000323|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
19551470|NCT01171183|42000324|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
19551471|NCT01170091|42000330|FG000|Overall Study|Missing efficacy evaluation|3|||
19551472|NCT01170091|42000330|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
19551473|NCT01169779|42000336|FG000|Overall Study|Adverse Event|3|||
19551474|NCT01169779|42000337|FG001|Overall Study|Adverse Event|11|||
19551475|NCT01169779|42000336|FG000|Overall Study|Lack of Efficacy|1|||
19551476|NCT01169779|42000337|FG001|Overall Study|Lack of Efficacy|0|||
19551477|NCT01169779|42000336|FG000|Overall Study|Protocol Violation|1|||
19551478|NCT01169779|42000337|FG001|Overall Study|Protocol Violation|1|||
19551479|NCT01169779|42000336|FG000|Overall Study|Withdrawal by Subject|3|||
19551480|NCT01169779|42000337|FG001|Overall Study|Withdrawal by Subject|2|||
19551481|NCT01169779|42000336|FG000|Overall Study|Familial and personal reasons|3|||
19551482|NCT01169779|42000337|FG001|Overall Study|Familial and personal reasons|3|||
19551483|NCT01169701|42000345|FG000|Overall Study|Lost to Follow-up|1|||
19551484|NCT01169701|42000346|FG001|Overall Study|Lost to Follow-up|1|||
19551485|NCT01169701|42000345|FG000|Overall Study|Withdrawal by Subject|1|||
19551486|NCT01169701|42000346|FG001|Overall Study|Withdrawal by Subject|3|||
19551487|NCT01169701|42000345|FG000|Overall Study|Adverse Event|1|||
19551488|NCT01169701|42000346|FG001|Overall Study|Adverse Event|2|||
19551489|NCT01169701|42000345|FG000|Overall Study|Exclusion criteria|2|||
19551490|NCT01169701|42000346|FG001|Overall Study|Exclusion criteria|0|||
19551491|NCT01169701|42000345|FG000|Overall Study|Death|0|||
19551492|NCT01169701|42000346|FG001|Overall Study|Death|1|||
19551493|NCT01169701|42000345|FG000|Overall Study|Administrative problems|0|||
19551494|NCT01169701|42000346|FG001|Overall Study|Administrative problems|1|||
19551495|NCT01169701|42000345|FG000|Overall Study|Serious adverse event|0|||
19551496|NCT01169701|42000346|FG001|Overall Study|Serious adverse event|1|||
19551497|NCT01169701|42000345|FG000|Overall Study|Sponsor decision|0|||
19551498|NCT01169701|42000346|FG001|Overall Study|Sponsor decision|1|||
19551499|NCT01168999|42000356|FG000|Overall Study|Lost to Follow-up|2|||
19551500|NCT01168999|42000357|FG001|Overall Study|Lost to Follow-up|1|||
19551501|NCT01168999|42000358|FG002|Overall Study|Lost to Follow-up|0|||
19551502|NCT01168999|42000359|FG003|Overall Study|Lost to Follow-up|0|||
19551503|NCT01167907|42000371|FG000|Overall Study|Protocol Violation|1|||
19551504|NCT01167907|42000372|FG001|Overall Study|Protocol Violation|0|||
19551505|NCT01167907|42000371|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
19551506|NCT01167907|42000372|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
19551507|NCT01166659|42000378|FG000|Overall Study|Subject Decision|8|||
19551508|NCT01166659|42000378|FG000|Overall Study|Investigator Decision|2|||
19551509|NCT01166659|42000378|FG000|Overall Study|Death|1|||
19551510|NCT01166659|42000378|FG000|Overall Study|Lost to Follow-up|1|||
19551511|NCT01166659|42000378|FG000|Overall Study|Study Closed at Site|1|||
19551512|NCT01115491|42000383|FG000|Overall Study|Death|22|||
19551513|NCT01115491|42000383|FG000|Overall Study|Adverse Event|3|||
19551514|NCT01115491|42000383|FG000|Overall Study|Lost to Follow-up|3|||
19551515|NCT01115491|42000383|FG000|Overall Study|Withdrawal by Subject|1|||
19551516|NCT01115491|42000383|FG000|Overall Study|Physician Decision|1|||
19551517|NCT01113931|42000389|FG000|Overall Study|Adverse Event|2|||
19551518|NCT01113931|42000390|FG001|Overall Study|Adverse Event|2|||
19551519|NCT01113931|42000389|FG000|Overall Study|Physician Decision|0|||
19551520|NCT01113931|42000390|FG001|Overall Study|Physician Decision|2|||
19551521|NCT01113931|42000389|FG000|Overall Study|Lost to Follow-up|12|||
19551522|NCT01113931|42000390|FG001|Overall Study|Lost to Follow-up|9|||
19551523|NCT01113931|42000389|FG000|Overall Study|Various|2|||
19551524|NCT01113931|42000390|FG001|Overall Study|Various|4|||
19551525|NCT01113931|42000389|FG000|Overall Study|Withdrawal by Subject|3|||
19551526|NCT01113931|42000390|FG001|Overall Study|Withdrawal by Subject|0|||
19551527|NCT01107379|42000396|FG000|Overall Study|Withdrawal by Subject|18|||
19551528|NCT01107379|42000396|FG000|Overall Study|Lost to Follow-up|3|||
19551529|NCT01106911|42000400|FG000|Overall Study|Physician Decision|2|||
19551530|NCT01106911|42000400|FG000|Overall Study|deemed ineligible after screening|3|||
19466561|NCT01895777|41726730|FG000|Overall Study|Lost to Follow-up|2|||
19466562|NCT01895777|41726731|FG001|Overall Study|Lost to Follow-up|0|||
19466563|NCT01895777|41726730|FG000|Overall Study|Not treated|1|||
19466564|NCT01895777|41726731|FG001|Overall Study|Not treated|0|||
19466565|NCT01895777|41726730|FG000|Overall Study|Other reasons|3|||
19466566|NCT01895777|41726731|FG001|Overall Study|Other reasons|2|||
19466567|NCT01895777|41726730|FG000|Overall Study|Non-compliance with the CTP|2|||
19466568|NCT01895777|41726731|FG001|Overall Study|Non-compliance with the CTP|1|||
19466569|NCT01885559|41726759|FG000|Overall Study|Lost to Follow-up|15|||
19466570|NCT01885559|41726760|FG001|Overall Study|Lost to Follow-up|16|||
19466571|NCT01885559|41726759|FG000|Overall Study|Less than full participation|9|||
19466572|NCT01885559|41726760|FG001|Overall Study|Less than full participation|19|||
19466573|NCT01885559|41726759|FG000|Overall Study|Protocol Violation|0|||
19466574|NCT01885559|41726760|FG001|Overall Study|Protocol Violation|1|||
19466575|NCT01884545|41726770|FG000|Overall Study|Lost to Follow-up|6|||
19466576|NCT01884545|41726771|FG001|Overall Study|Lost to Follow-up|4|||
19466577|NCT01884545|41726772|FG002|Overall Study|Lost to Follow-up|9|||
19466578|NCT01884545|41726773|FG003|Overall Study|Lost to Follow-up|4|||
19466579|NCT01884545|41726770|FG000|Overall Study|Patient withdrawn|7|||
19466580|NCT01884545|41726771|FG001|Overall Study|Patient withdrawn|12|||
19466581|NCT01884545|41726772|FG002|Overall Study|Patient withdrawn|5|||
19466582|NCT01884545|41726773|FG003|Overall Study|Patient withdrawn|5|||
19466583|NCT01884545|41726770|FG000|Overall Study|Non-adherence|0|||
19466584|NCT01884545|41726771|FG001|Overall Study|Non-adherence|2|||
19466585|NCT01884545|41726772|FG002|Overall Study|Non-adherence|0|||
19466586|NCT01884545|41726773|FG003|Overall Study|Non-adherence|0|||
19466587|NCT01895543|41726783|FG000|Overall Study|Withdrawal by Subject|43|||
19466588|NCT01895543|41726783|FG000|Overall Study|Lost to Follow-up|25|||
19466589|NCT01895543|41726783|FG000|Overall Study|Adverse Event|28|||
19466590|NCT01895543|41726783|FG000|Overall Study|Subject's substantial non-compliance|6|||
19466591|NCT01895543|41726783|FG000|Overall Study|Protocol Violation|1|||
19466592|NCT01895543|41726783|FG000|Overall Study|Physician Decision|2|||
19466593|NCT01895543|41726783|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
19466594|NCT04828161|41726880|FG000|Overall Study|Withdrawal by Subject|0|||
19466595|NCT04828161|41726881|FG001|Overall Study|Withdrawal by Subject|3|||
19466596|NCT04828161|41726882|FG002|Overall Study|Withdrawal by Subject|3|||
19466597|NCT04828161|41726883|FG003|Overall Study|Withdrawal by Subject|4|||
19466598|NCT04828161|41726880|FG000|Overall Study|Lost to Follow-up|1|||
19466599|NCT04828161|41726881|FG001|Overall Study|Lost to Follow-up|4|||
19466600|NCT04828161|41726882|FG002|Overall Study|Lost to Follow-up|2|||
19466601|NCT04828161|41726883|FG003|Overall Study|Lost to Follow-up|2|||
19466602|NCT04828161|41726880|FG000|Overall Study|Other|2|||
19466603|NCT04828161|41726881|FG001|Overall Study|Other|0|||
19466604|NCT04828161|41726882|FG002|Overall Study|Other|2|||
19466605|NCT04828161|41726883|FG003|Overall Study|Other|0|||
19466606|NCT04828161|41726880|FG000|Overall Study|Death|0|||
19466607|NCT04828161|41726881|FG001|Overall Study|Death|0|||
19466608|NCT04828161|41726882|FG002|Overall Study|Death|0|||
19466609|NCT04828161|41726883|FG003|Overall Study|Death|2|||
19466610|NCT01895309|41726981|FG000|Overall Study|Adverse Event|13|||
19466611|NCT01895309|41726982|FG001|Overall Study|Adverse Event|17|||
19466612|NCT01895309|41726981|FG000|Overall Study|Protocol Violation|1|||
19466613|NCT01895309|41726982|FG001|Overall Study|Protocol Violation|0|||
19466614|NCT01895309|41726981|FG000|Overall Study|Lack of Efficacy|1|||
19466615|NCT01895309|41726982|FG001|Overall Study|Lack of Efficacy|3|||
19466616|NCT01895309|41726981|FG000|Overall Study|Lost to Follow-up|1|||
19466617|NCT01895309|41726982|FG001|Overall Study|Lost to Follow-up|3|||
19466618|NCT01895309|41726981|FG000|Overall Study|Physician Decision|15|||
19466619|NCT01895309|41726982|FG001|Overall Study|Physician Decision|10|||
19466620|NCT01895309|41726981|FG000|Overall Study|Withdrawal by Subject|9|||
19466621|NCT01895309|41726982|FG001|Overall Study|Withdrawal by Subject|18|||
19466622|NCT01884311|41726992|FG000|Overall Study|Withdrawal by Subject|3|||
19466623|NCT01884311|41726992|FG000|Overall Study|withdrew consent due to AEs|1|||
19466624|NCT01884311|41726992|FG000|Overall Study|Precautionary measure|1|||
19466625|NCT01884077|41727032|FG000|Overall Study|screen fail|0|||
19466626|NCT01884077|41727033|FG001|Overall Study|screen fail|2|||
19466627|NCT01884077|41727032|FG000|Overall Study|canceled surgery|2|||
19466628|NCT01884077|41727033|FG001|Overall Study|canceled surgery|0|||
19466629|NCT01884077|41727032|FG000|Overall Study|Lost to Follow-up|0|||
19466630|NCT01884077|41727033|FG001|Overall Study|Lost to Follow-up|4|||
19466631|NCT01884077|41727032|FG000|Overall Study|study closed|6|||
19466632|NCT01884077|41727033|FG001|Overall Study|study closed|4|||
19466633|NCT01894919|41727052|FG000|Overall Study|Withdrawal by Subject|1|||
19466634|NCT01894919|41727053|FG001|Overall Study|Withdrawal by Subject|0|||
19466635|NCT01894919|41727054|FG002|Overall Study|Withdrawal by Subject|0|||
19466636|NCT01894919|41727055|FG003|Overall Study|Withdrawal by Subject|0|||
19466637|NCT01894919|41727056|FG004|Overall Study|Withdrawal by Subject|1|||
19466638|NCT01894919|41727057|FG005|Overall Study|Withdrawal by Subject|0|||
19466639|NCT01894919|41727058|FG006|Overall Study|Withdrawal by Subject|0|||
19466640|NCT01894919|41727059|FG007|Overall Study|Withdrawal by Subject|0|||
19466641|NCT01894919|41727060|FG008|Overall Study|Withdrawal by Subject|0|||
19466642|NCT01894919|41727061|FG009|Overall Study|Withdrawal by Subject|1|||
19466643|NCT01894919|41727062|FG010|Overall Study|Withdrawal by Subject|1|||
19466644|NCT01894919|41727063|FG011|Overall Study|Withdrawal by Subject|0|||
19466645|NCT01894919|41727064|FG012|Overall Study|Withdrawal by Subject|0|||
19551531|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
19466646|NCT01894919|41727052|FG000|Overall Study|Adverse Event|0|||
19466647|NCT01894919|41727053|FG001|Overall Study|Adverse Event|0|||
19551532|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
19739016|NCT00101686|42186092|FG008|Overall Study|intercurrent non-cancer related illness|1|||
19466648|NCT01894919|41727054|FG002|Overall Study|Adverse Event|0|||
19466649|NCT01894919|41727055|FG003|Overall Study|Adverse Event|0|||
19466650|NCT01894919|41727056|FG004|Overall Study|Adverse Event|0|||
19466651|NCT01894919|41727057|FG005|Overall Study|Adverse Event|0|||
19466652|NCT01894919|41727058|FG006|Overall Study|Adverse Event|0|||
19466653|NCT01894919|41727059|FG007|Overall Study|Adverse Event|0|||
19466654|NCT01894919|41727060|FG008|Overall Study|Adverse Event|0|||
19466655|NCT01894919|41727061|FG009|Overall Study|Adverse Event|0|||
19466656|NCT01894919|41727062|FG010|Overall Study|Adverse Event|1|||
19466657|NCT01894919|41727063|FG011|Overall Study|Adverse Event|0|||
19466658|NCT01894919|41727064|FG012|Overall Study|Adverse Event|0|||
19466659|NCT01894919|41727052|FG000|Overall Study|Other-Unspecified|1|||
19466660|NCT01894919|41727053|FG001|Overall Study|Other-Unspecified|0|||
19466661|NCT01894919|41727054|FG002|Overall Study|Other-Unspecified|0|||
19466662|NCT01894919|41727055|FG003|Overall Study|Other-Unspecified|0|||
19466663|NCT01894919|41727056|FG004|Overall Study|Other-Unspecified|0|||
19466664|NCT01894919|41727057|FG005|Overall Study|Other-Unspecified|0|||
19466665|NCT01894919|41727058|FG006|Overall Study|Other-Unspecified|0|||
19466666|NCT01894919|41727059|FG007|Overall Study|Other-Unspecified|0|||
19466667|NCT01894919|41727060|FG008|Overall Study|Other-Unspecified|0|||
19466668|NCT01894919|41727061|FG009|Overall Study|Other-Unspecified|0|||
19466669|NCT01894919|41727062|FG010|Overall Study|Other-Unspecified|0|||
19466670|NCT01894919|41727063|FG011|Overall Study|Other-Unspecified|0|||
19466671|NCT01894919|41727064|FG012|Overall Study|Other-Unspecified|0|||
19466672|NCT01894919|41727052|FG000|Overall Study|Lost to Follow-up|0|||
19466673|NCT01894919|41727053|FG001|Overall Study|Lost to Follow-up|0|||
19466674|NCT01894919|41727054|FG002|Overall Study|Lost to Follow-up|0|||
19466675|NCT01894919|41727055|FG003|Overall Study|Lost to Follow-up|0|||
19466676|NCT01894919|41727056|FG004|Overall Study|Lost to Follow-up|2|||
19466677|NCT01894919|41727057|FG005|Overall Study|Lost to Follow-up|0|||
19466678|NCT01894919|41727058|FG006|Overall Study|Lost to Follow-up|0|||
19466679|NCT01894919|41727059|FG007|Overall Study|Lost to Follow-up|0|||
19466680|NCT01894919|41727060|FG008|Overall Study|Lost to Follow-up|0|||
19466681|NCT01894919|41727061|FG009|Overall Study|Lost to Follow-up|0|||
19466682|NCT01894919|41727062|FG010|Overall Study|Lost to Follow-up|0|||
19466683|NCT01894919|41727063|FG011|Overall Study|Lost to Follow-up|0|||
19551533|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
19551534|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
19551535|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Death|0|||
19551536|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Death|0|||
19551537|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Death|1|||
19551538|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Death|0|||
19551539|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
19551540|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
19551541|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
19551542|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
19551543|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
19551544|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
19551545|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
19551546|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
19551547|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
19551548|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
19551549|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
19551550|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
19551551|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
19551552|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
19551553|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
19551554|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
19551555|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
19551556|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
19551557|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
19551558|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
19551559|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
19551560|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
19466684|NCT01894919|41727064|FG012|Overall Study|Lost to Follow-up|0|||
19466685|NCT01894841|41727108|FG000|Overall Study|Withdrawal by Subject|9|||
19466686|NCT01894841|41727109|FG001|Overall Study|Withdrawal by Subject|4|||
19466687|NCT01894841|41727108|FG000|Overall Study|Withdrawn by investigator|2|||
19466688|NCT01894841|41727109|FG001|Overall Study|Withdrawn by investigator|2|||
19466689|NCT01894841|41727108|FG000|Overall Study|Lost to Follow-up|7|||
19466690|NCT01894841|41727109|FG001|Overall Study|Lost to Follow-up|3|||
19466691|NCT01894607|41727119|FG000|Overall Study|Ineligible|1|||
19466692|NCT01883453|41727125|FG000|Overall Study|No episode of common cold|25|||
19466693|NCT01883453|41727126|FG001|Overall Study|No episode of common cold|23|||
19466694|NCT01882985|41727160|FG000|Overall Study|Lost to Follow-up|1|||
19551561|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
19551562|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
19551563|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
19551564|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
19466695|NCT01882985|41727160|FG000|Overall Study|Withdrawal by Subject|1|||
19466696|NCT01893905|41727173|FG000|Overall Study|Withdrawal by Subject|1|||
19466697|NCT01893905|41727174|FG001|Overall Study|Withdrawal by Subject|0|||
19466698|NCT01893905|41727173|FG000|Overall Study|Adverse Event|9|||
19466699|NCT01893905|41727174|FG001|Overall Study|Adverse Event|3|||
19466700|NCT01893905|41727173|FG000|Overall Study|Lack of Efficacy|5|||
19466701|NCT01893905|41727174|FG001|Overall Study|Lack of Efficacy|7|||
19466702|NCT01893905|41727173|FG000|Overall Study|Lost to Follow-up|1|||
19466703|NCT01893905|41727174|FG001|Overall Study|Lost to Follow-up|0|||
19466704|NCT01893905|41727173|FG000|Overall Study|Protocol Violation|6|||
19466705|NCT01893905|41727174|FG001|Overall Study|Protocol Violation|1|||
19466706|NCT01893905|41727173|FG000|Overall Study|Lack of adherence to treatment|2|||
19466707|NCT01893905|41727174|FG001|Overall Study|Lack of adherence to treatment|0|||
19466708|NCT01893905|41727173|FG000|Overall Study|Other reason|1|||
19466709|NCT01893905|41727174|FG001|Overall Study|Other reason|3|||
19466710|NCT01893827|41727187|FG000|Overall Study|Lost to Follow-up|19|||
19466711|NCT01893827|41727188|FG001|Overall Study|Lost to Follow-up|26|||
19466712|NCT01882907|41727196|FG000|Overall Study|Adverse Event|3|||
19466713|NCT01882907|41727197|FG001|Overall Study|Adverse Event|1|||
19466714|NCT01882907|41727196|FG000|Overall Study|Lack of Efficacy|0|||
19466715|NCT01882907|41727197|FG001|Overall Study|Lack of Efficacy|3|||
19466716|NCT01882907|41727196|FG000|Overall Study|Lost to Follow-up|1|||
19466717|NCT01882907|41727197|FG001|Overall Study|Lost to Follow-up|4|||
19466718|NCT01882907|41727196|FG000|Overall Study|Protocol Violation|10|||
19466719|NCT01882907|41727197|FG001|Overall Study|Protocol Violation|14|||
19466720|NCT01882907|41727196|FG000|Overall Study|Withdrawal by Subject|0|||
19466721|NCT01882907|41727197|FG001|Overall Study|Withdrawal by Subject|6|||
19466722|NCT01893281|41727219|FG000|Overall Study|Adverse Event|1|||
19466723|NCT01893281|41727219|FG000|Overall Study|Protocol Violation|1|||
19466724|NCT01893281|41727219|FG000|Overall Study|Withdrawal by Subject|1|||
19466725|NCT01893203|41727223|FG000|Overall Study|Withdrawal by Subject|1|||
19466726|NCT01882829|41727227|FG000|Overall Study|Adverse Event|4|||
19466727|NCT01882829|41727227|FG000|Overall Study|Protocol Violation|1|||
19466728|NCT01882829|41727227|FG000|Overall Study|Withdrawal by Subject|1|||
19466729|NCT01882439|41727311|FG000|Overall Study|Adverse event related to study drug|3|||
19466730|NCT01882439|41727312|FG001|Overall Study|Adverse event related to study drug|8|||
19466731|NCT01882439|41727313|FG002|Overall Study|Adverse event related to study drug|1|||
19466732|NCT01882439|41727314|FG003|Overall Study|Adverse event related to study drug|2|||
19466733|NCT01882439|41727311|FG000|Overall Study|Pregnancy|0|||
19466734|NCT01882439|41727312|FG001|Overall Study|Pregnancy|1|||
19466735|NCT01882439|41727313|FG002|Overall Study|Pregnancy|0|||
19466736|NCT01882439|41727314|FG003|Overall Study|Pregnancy|0|||
19466737|NCT01882439|41727311|FG000|Overall Study|Protocol Violation|2|||
19466738|NCT01882439|41727312|FG001|Overall Study|Protocol Violation|2|||
19466739|NCT01882439|41727313|FG002|Overall Study|Protocol Violation|0|||
19466740|NCT01882439|41727314|FG003|Overall Study|Protocol Violation|1|||
19466741|NCT01882439|41727311|FG000|Overall Study|No longer willing to participate|1|||
19466742|NCT01882439|41727312|FG001|Overall Study|No longer willing to participate|4|||
19466743|NCT01882439|41727313|FG002|Overall Study|No longer willing to participate|2|||
19466744|NCT01882439|41727314|FG003|Overall Study|No longer willing to participate|3|||
19466745|NCT01882439|41727311|FG000|Overall Study|Medication error with no associated AE|0|||
19466746|NCT01882439|41727312|FG001|Overall Study|Medication error with no associated AE|0|||
19466747|NCT01882439|41727313|FG002|Overall Study|Medication error with no associated AE|2|||
19466748|NCT01882439|41727314|FG003|Overall Study|Medication error with no associated AE|0|||
19466749|NCT01882439|41727311|FG000|Overall Study|Insufficient clinical response|1|||
19466750|NCT01882439|41727312|FG001|Overall Study|Insufficient clinical response|4|||
19466751|NCT01882439|41727313|FG002|Overall Study|Insufficient clinical response|4|||
19466752|NCT01882439|41727314|FG003|Overall Study|Insufficient clinical response|2|||
19466753|NCT01882439|41727311|FG000|Overall Study|Adverse event unrelated to study drug|2|||
19466754|NCT01882439|41727312|FG001|Overall Study|Adverse event unrelated to study drug|2|||
19466755|NCT01882439|41727313|FG002|Overall Study|Adverse event unrelated to study drug|1|||
19466756|NCT01882439|41727314|FG003|Overall Study|Adverse event unrelated to study drug|1|||
19466757|NCT01892657|41727361|FG000|Overall Study|Withdrawal by Subject|6|||
19466758|NCT01892657|41727361|FG000|Overall Study|Protocol Violation|12|||
19466759|NCT01881737|41727388|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
19466760|NCT01881737|41727388|FG000|Overall Study|Withdrawal by Subject|1|||
19466761|NCT01881737|41727388|FG000|Overall Study|Worsening of baseline behavior|1|||
19466762|NCT01892501|41727424|FG000|Overall Study|Protocol Violation|2|||
19466763|NCT01892501|41727424|FG000|Overall Study|Puncture not carried out|9|||
19466764|NCT01892501|41727424|FG000|Overall Study|Radiological monitoring not carried out|5|||
19466765|NCT01892501|41727424|FG000|Overall Study|Non-contributory histological result|12|||
19466766|NCT01892345|41727439|FG000|Overall Study|Adverse Event|0|||
19466767|NCT01892345|41727440|FG001|Overall Study|Adverse Event|2|||
19466768|NCT01892345|41727439|FG000|Overall Study|Death|1|||
19466769|NCT01892345|41727440|FG001|Overall Study|Death|0|||
19466770|NCT01892345|41727439|FG000|Overall Study|Lost to Follow-up|3|||
19466771|NCT01892345|41727440|FG001|Overall Study|Lost to Follow-up|0|||
19466772|NCT01892345|41727439|FG000|Overall Study|Withdrawal by Subject|12|||
19466773|NCT01892345|41727440|FG001|Overall Study|Withdrawal by Subject|1|||
19466774|NCT01892189|41727517|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
19466775|NCT01892189|41727518|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
19466776|NCT01892189|41727519|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
19466777|NCT01892189|41727520|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
19466778|NCT01892189|41727521|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
19466779|NCT01892189|41727522|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
19466780|NCT01892189|41727523|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
19466781|NCT01892189|41727524|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
19466782|NCT01892189|41727525|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
19466783|NCT01892189|41727517|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19551565|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19551566|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19551567|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
19551568|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
19551569|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
19551570|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
19551571|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
19551572|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
19551573|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
19551574|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
19551575|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Other|8|||
19551576|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Other|14|||
19551577|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Other|8|||
19551578|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Other|23|||
19551579|NCT01106677|42000408|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
19551580|NCT01106677|42000409|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
19551581|NCT01106677|42000410|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
19551582|NCT01106677|42000411|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
19551583|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19551584|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19551585|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
19551586|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
19551587|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Death|0|||
19551588|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Death|0|||
19551589|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Death|0|||
19551590|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Death|1|||
19551591|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
19551592|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
19551593|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
19551594|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
19551595|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19551596|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
19551597|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
19551598|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
19551599|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
19551600|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
19381207|NCT01328093|41624391|FG001|Double-Blind Phase|Scheduling conflict|3|||
19381208|NCT01328093|41624390|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
19381209|NCT01328093|41624391|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
19381210|NCT01328093|41624390|FG000|Double-Blind Phase|Death|1|||
19381211|NCT01328093|41624391|FG001|Double-Blind Phase|Death|0|||
19381212|NCT01328093|41624390|FG000|Open-Label Phase|Sponsor Decision|98|||
19381213|NCT01328093|41624391|FG001|Open-Label Phase|Sponsor Decision|34|||
19381214|NCT01328093|41624390|FG000|Open-Label Phase|Protocol Violation|8|||
19381215|NCT01328093|41624391|FG001|Open-Label Phase|Protocol Violation|3|||
19381216|NCT01328093|41624390|FG000|Open-Label Phase|Lost to Follow-up|10|||
19381217|NCT01328093|41624391|FG001|Open-Label Phase|Lost to Follow-up|1|||
19381218|NCT01328093|41624390|FG000|Open-Label Phase|Adverse Event|10|||
19381219|NCT01328093|41624391|FG001|Open-Label Phase|Adverse Event|4|||
19381220|NCT01328093|41624390|FG000|Open-Label Phase|Lack of Efficacy|5|||
19381221|NCT01328093|41624391|FG001|Open-Label Phase|Lack of Efficacy|6|||
19466784|NCT01892189|41727518|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19466785|NCT01892189|41727519|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
19466786|NCT01892189|41727520|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19466787|NCT01892189|41727521|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19466788|NCT01892189|41727522|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19466789|NCT01892189|41727523|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19551601|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
19551602|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
19551603|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19551604|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19551605|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19551606|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19551607|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19551608|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
19551609|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
19551610|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19551611|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
19551612|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
19466790|NCT01892189|41727524|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19466791|NCT01892189|41727525|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19466792|NCT01892189|41727517|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466793|NCT01892189|41727518|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466794|NCT01892189|41727519|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466795|NCT01892189|41727520|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466796|NCT01892189|41727521|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466797|NCT01892189|41727522|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
19466798|NCT01892189|41727523|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19551613|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
19551614|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
19551615|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19551616|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19551617|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19551618|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
19551619|NCT01106677|42000408|FG000|Extension Period: Week 26 to Week 52|Other|6|||
19551620|NCT01106677|42000409|FG001|Extension Period: Week 26 to Week 52|Other|5|||
19466799|NCT01892189|41727524|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19466800|NCT01892189|41727525|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
19551621|NCT01106677|42000410|FG002|Extension Period: Week 26 to Week 52|Other|8|||
19551622|NCT01106677|42000411|FG003|Extension Period: Week 26 to Week 52|Other|5|||
19551623|NCT01106287|42000432|FG000|Overall Study|Adverse Event|1|||
19551624|NCT01106287|42000433|FG001|Overall Study|Adverse Event|0|||
19551625|NCT01106287|42000434|FG002|Overall Study|Adverse Event|0|||
19551626|NCT01106287|42000435|FG003|Overall Study|Adverse Event|0|||
19739017|NCT00101686|42186093|FG009|Overall Study|intercurrent non-cancer related illness|1|||
19551627|NCT01104493|42000451|FG000|Overall Study|Lost to Follow-up|0|||
19551628|NCT01104493|42000452|FG001|Overall Study|Lost to Follow-up|2|||
19551629|NCT01104415|42000458|FG000|Core Phase|Consent withdrawn by subjects|1|||
19551630|NCT01104415|42000459|FG001|Core Phase|Consent withdrawn by subjects|0|||
19551631|NCT01104415|42000458|FG000|Extension Period|Progressive disease|0|||
19466801|NCT01881425|41727556|FG000|Overall Study|Death|5|||
19466802|NCT01881425|41727557|FG001|Overall Study|Death|1|||
19466803|NCT01881425|41727556|FG000|Overall Study|Withdrawal by Subject|8|||
19466804|NCT01881425|41727557|FG001|Overall Study|Withdrawal by Subject|3|||
19466805|NCT01881425|41727556|FG000|Overall Study|Physician Decision|2|||
19466806|NCT01881425|41727557|FG001|Overall Study|Physician Decision|1|||
19466807|NCT01881425|41727556|FG000|Overall Study|Adverse Event|3|||
19466808|NCT01881425|41727557|FG001|Overall Study|Adverse Event|0|||
19466809|NCT01881425|41727556|FG000|Overall Study|General Anesthesia panic attack|0|||
19466810|NCT01881425|41727557|FG001|Overall Study|General Anesthesia panic attack|1|||
19466811|NCT01881425|41727556|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
19466812|NCT01881425|41727557|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
19466813|NCT01881425|41727556|FG000|Overall Study|Lost to Follow-up|7|||
19466814|NCT01881425|41727557|FG001|Overall Study|Lost to Follow-up|2|||
19466815|NCT01891721|41727576|FG000|Overall Study|Lost to Follow-up|10|||
19466816|NCT01891721|41727577|FG001|Overall Study|Lost to Follow-up|5|||
19466817|NCT01891721|41727578|FG002|Overall Study|Lost to Follow-up|1|||
19466818|NCT01880957|41727597|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
19466819|NCT01880957|41727598|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
19466820|NCT01880957|41727597|FG000|Overall Study|Lost to Follow-up|11|||
19466821|NCT01880957|41727598|FG001|Overall Study|Lost to Follow-up|0|||
19466822|NCT01880957|41727597|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
19466823|NCT01880957|41727598|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
19466824|NCT04152837|41727613|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
19466825|NCT04152837|41727613|FG000|Maintenance Period|Adverse Event|1|||
19551632|NCT01104415|42000459|FG001|Extension Period|Progressive disease|4|||
19551633|NCT01104415|42000458|FG000|Extension Period|Death|0|||
19551634|NCT01104415|42000459|FG001|Extension Period|Death|1|||
19551635|NCT01104415|42000458|FG000|Extension Period|Physician Decision|0|||
19551636|NCT01104415|42000459|FG001|Extension Period|Physician Decision|1|||
19551637|NCT01104415|42000458|FG000|Extension Period|Transition to Study LX1606.302|0|||
19551638|NCT01104415|42000459|FG001|Extension Period|Transition to Study LX1606.302|4|||
19551639|NCT01104415|42000458|FG000|Extension Period|Heart surgery/feeling miserable|0|||
19551640|NCT01104415|42000459|FG001|Extension Period|Heart surgery/feeling miserable|1|||
19551641|NCT01099579|42000469|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
19551642|NCT01099579|42000470|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
19551643|NCT01099579|42000471|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
19551644|NCT01099579|42000469|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
19551645|NCT01099579|42000470|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
19551646|NCT01099579|42000471|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
19551647|NCT01099579|42000469|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
19551648|NCT01099579|42000470|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
19551649|NCT01099579|42000471|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
19551650|NCT01099579|42000469|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
19551651|NCT01099579|42000470|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
19739018|NCT00101686|42186084|FG000|Overall Study|Physician Decision|10|||
19466826|NCT04152837|41727613|FG000|Maintenance Period|Withdrawal by Subject|1|||
19466827|NCT04152837|41727613|FG000|Maintenance Period|Sponsor Termination of Study|2|||
19466828|NCT01879553|41727632|FG000|Overall Study|Withdrawal by Subject|1|||
19466829|NCT01879553|41727633|FG001|Overall Study|Withdrawal by Subject|0|||
19466830|NCT01890785|41727654|FG000|Third Intervention|Withdrawal by Subject|0|||
19466831|NCT01890785|41727655|FG001|Third Intervention|Withdrawal by Subject|1|||
19466832|NCT01890785|41727656|FG002|Third Intervention|Withdrawal by Subject|0|||
19466833|NCT01890785|41727657|FG003|Third Intervention|Withdrawal by Subject|0|||
19466834|NCT01890785|41727658|FG004|Third Intervention|Withdrawal by Subject|0|||
19466835|NCT01890785|41727659|FG005|Third Intervention|Withdrawal by Subject|0|||
19466836|NCT01878383|41727683|FG000|Overall Study|Lost to Follow-up|0|||
19551652|NCT01099579|42000471|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
19739019|NCT00101686|42186085|FG001|Overall Study|Physician Decision|13|||
19466837|NCT01878383|41727684|FG001|Overall Study|Lost to Follow-up|1499|||
19466838|NCT01878149|41727692|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
19466839|NCT01878149|41727693|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
19466840|NCT01863953|41727715|FG000|Overall Study|Adverse Event|0|||
19466841|NCT01863953|41727716|FG001|Overall Study|Adverse Event|0|||
19466842|NCT01863953|41727717|FG002|Overall Study|Adverse Event|1|||
19466843|NCT03049449|41727993|FG000|Overall Study|Did not receive treatment.|0|||
19466844|NCT03049449|41727994|FG001|Overall Study|Did not receive treatment.|0|||
19466845|NCT03049449|41727995|FG002|Overall Study|Did not receive treatment.|0|||
19466846|NCT03049449|41727996|FG003|Overall Study|Did not receive treatment.|0|||
19466847|NCT03049449|41727997|FG004|Overall Study|Did not receive treatment.|0|||
19466848|NCT03049449|41727998|FG005|Overall Study|Did not receive treatment.|0|||
19466849|NCT03049449|41727999|FG006|Overall Study|Did not receive treatment.|0|||
19466850|NCT03049449|41728000|FG007|Overall Study|Did not receive treatment.|0|||
19466851|NCT03049449|41728001|FG008|Overall Study|Did not receive treatment.|1|||
19466852|NCT03049449|41728002|FG009|Overall Study|Did not receive treatment.|0|||
19466853|NCT03049449|41727993|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
19466854|NCT03049449|41727994|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
19466855|NCT03049449|41727995|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
19466856|NCT03049449|41727996|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
19466857|NCT03049449|41727997|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
19466858|NCT03049449|41727998|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
19466859|NCT03049449|41727999|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
19466860|NCT03049449|41728000|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
19466861|NCT03049449|41728001|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
19466862|NCT03049449|41728002|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
19466863|NCT03049449|41727993|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466864|NCT03049449|41727994|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466865|NCT03049449|41727995|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466866|NCT03049449|41727996|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466867|NCT03049449|41727997|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466868|NCT03049449|41727998|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466869|NCT03049449|41727999|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466870|NCT03049449|41728000|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
19466871|NCT03049449|41728001|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
19466872|NCT03049449|41728002|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
19466873|NCT02989857|41728135|FG000|Randomization Phase|Not Treated|3|||
19466874|NCT02989857|41728136|FG001|Randomization Phase|Not Treated|2|||
19466875|NCT02989857|41728137|FG002|Randomization Phase|Not Treated|0|||
19466876|NCT01877915|41728148|FG000|Overall Study|Lost to Follow-up|10|||
19466877|NCT01877915|41728149|FG001|Overall Study|Lost to Follow-up|9|||
19466878|NCT01877915|41728148|FG000|Overall Study|Withdrawal by Subject|42|||
19466879|NCT01877915|41728149|FG001|Overall Study|Withdrawal by Subject|55|||
19466880|NCT01877915|41728148|FG000|Overall Study|Other|2|||
19466881|NCT01877915|41728149|FG001|Overall Study|Other|4|||
19466882|NCT01876979|41728157|FG000|Overall Study|Physician Decision|2|||
19466883|NCT01876979|41728158|FG001|Overall Study|Physician Decision|3|||
19466884|NCT01860989|41728164|FG000|Overall Study|Unsatisfactory therapeutic|5|||
19466885|NCT01860677|41728180|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
19466886|NCT01860677|41728181|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
19466887|NCT01876901|41728199|FG000|Overall Study|Protocol Violation|10|||
19466888|NCT01876901|41728200|FG001|Overall Study|Protocol Violation|2|||
19466889|NCT01876901|41728199|FG000|Overall Study|No or other surgical intervention|7|||
19466890|NCT01876901|41728200|FG001|Overall Study|No or other surgical intervention|5|||
19466891|NCT01876823|41728207|FG000|Overall Study|Withdrawal by Subject|5|||
19466892|NCT01876823|41728207|FG000|Overall Study|Physician Decision|2|||
19466893|NCT01876823|41728207|FG000|Overall Study|Patients moved|2|||
19466894|NCT01876511|41728214|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
19466895|NCT01876511|41728215|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
19466896|NCT01876511|41728216|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
19466897|NCT01876511|41728214|FG000|Overall Study|Death (unrelated)|3|||
19466898|NCT01876511|41728215|FG001|Overall Study|Death (unrelated)|0|||
19466899|NCT01876511|41728216|FG002|Overall Study|Death (unrelated)|2|||
19466900|NCT01876511|41728214|FG000|Overall Study|Drug-related Toxicity|5|||
19466901|NCT01876511|41728215|FG001|Overall Study|Drug-related Toxicity|1|||
19466902|NCT01876511|41728216|FG002|Overall Study|Drug-related Toxicity|6|||
19466903|NCT01876511|41728214|FG000|Overall Study|Patient Decision|3|||
19466904|NCT01876511|41728215|FG001|Overall Study|Patient Decision|0|||
19466905|NCT01876511|41728216|FG002|Overall Study|Patient Decision|6|||
19551653|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
19551654|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
19551655|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
19551656|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
19551657|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
19551658|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
19551659|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
19551660|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
19551661|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
19551662|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
19551663|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
19551664|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
19551665|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
19466906|NCT01876511|41728214|FG000|Overall Study|Physician Decision|1|||
19466907|NCT01876511|41728215|FG001|Overall Study|Physician Decision|0|||
19466908|NCT01876511|41728216|FG002|Overall Study|Physician Decision|1|||
19466909|NCT01993719|41728231|FG000|First Drug Administration|Not treated|1|||
19466910|NCT01993719|41728232|FG001|First Drug Administration|Not treated|0|||
19466911|NCT01993719|41728233|FG002|First Drug Administration|Not treated|0|||
19466912|NCT01993719|41728234|FG003|First Drug Administration|Not treated|0|||
19466913|NCT01993719|41728235|FG004|First Drug Administration|Not treated|0|||
19466914|NCT00638235|41728277|FG000|Overall Study|Lost to Follow-up|31|||
19466915|NCT00638235|41728278|FG001|Overall Study|Lost to Follow-up|3|||
19466916|NCT00638235|41728279|FG002|Overall Study|Lost to Follow-up|18|||
19466917|NCT00638235|41728280|FG003|Overall Study|Lost to Follow-up|10|||
19466918|NCT00638235|41728281|FG004|Overall Study|Lost to Follow-up|13|||
19466919|NCT00638235|41728282|FG005|Overall Study|Lost to Follow-up|26|||
19466920|NCT00638235|41728283|FG006|Overall Study|Lost to Follow-up|0|||
19466921|NCT00638235|41728284|FG007|Overall Study|Lost to Follow-up|1|||
19466922|NCT00638235|41728285|FG008|Overall Study|Lost to Follow-up|18|||
19466923|NCT00638157|41728323|FG000|Overall Study|Adverse Event|0|||
19466924|NCT00638157|41728324|FG001|Overall Study|Adverse Event|1|||
19466925|NCT00638157|41728323|FG000|Overall Study|Clinical (symptomatic) failure|1|||
19466926|NCT00638157|41728324|FG001|Overall Study|Clinical (symptomatic) failure|1|||
19466927|NCT00638157|41728323|FG000|Overall Study|Microbiological failure|1|||
19466928|NCT00638157|41728324|FG001|Overall Study|Microbiological failure|0|||
19466929|NCT00638157|41728323|FG000|Overall Study|Lost to Follow-up|1|||
19466930|NCT00638157|41728324|FG001|Overall Study|Lost to Follow-up|0|||
19466931|NCT00638157|41728323|FG000|Overall Study|Physician Decision|1|||
19466932|NCT00638157|41728324|FG001|Overall Study|Physician Decision|0|||
19466933|NCT00638157|41728323|FG000|Overall Study|Other|1|||
19466934|NCT00638157|41728324|FG001|Overall Study|Other|2|||
19466935|NCT00638157|41728323|FG000|Overall Study|Randomized, not treated|2|||
19466936|NCT00638157|41728324|FG001|Overall Study|Randomized, not treated|0|||
19466937|NCT00637377|41728335|FG000|Overall Study|Adverse Event|2|||
19466938|NCT00637377|41728336|FG001|Overall Study|Adverse Event|6|||
19466939|NCT00637377|41728337|FG002|Overall Study|Adverse Event|8|||
19466940|NCT00637377|41728338|FG003|Overall Study|Adverse Event|9|||
19466941|NCT00637377|41728335|FG000|Overall Study|Death|1|||
19466942|NCT00637377|41728336|FG001|Overall Study|Death|3|||
19466943|NCT00637377|41728337|FG002|Overall Study|Death|2|||
19466944|NCT00637377|41728338|FG003|Overall Study|Death|1|||
19466945|NCT00637377|41728335|FG000|Overall Study|Lack of Efficacy|0|||
19466946|NCT00637377|41728336|FG001|Overall Study|Lack of Efficacy|0|||
19466947|NCT00637377|41728337|FG002|Overall Study|Lack of Efficacy|1|||
19466948|NCT00637377|41728338|FG003|Overall Study|Lack of Efficacy|1|||
19466949|NCT00637377|41728335|FG000|Overall Study|Lost to Follow-up|4|||
19466950|NCT00637377|41728336|FG001|Overall Study|Lost to Follow-up|1|||
19466951|NCT00637377|41728337|FG002|Overall Study|Lost to Follow-up|2|||
19466952|NCT00637377|41728338|FG003|Overall Study|Lost to Follow-up|2|||
19466953|NCT00637377|41728335|FG000|Overall Study|Protocol Violation|2|||
19466954|NCT00637377|41728336|FG001|Overall Study|Protocol Violation|1|||
19466955|NCT00637377|41728337|FG002|Overall Study|Protocol Violation|1|||
19466956|NCT00637377|41728338|FG003|Overall Study|Protocol Violation|0|||
19466957|NCT00637377|41728335|FG000|Overall Study|Withdrawal by Subject|11|||
19551666|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
19551667|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
19551668|NCT01099579|42000469|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
19551669|NCT01099579|42000470|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
19466958|NCT00637377|41728336|FG001|Overall Study|Withdrawal by Subject|15|||
19466959|NCT00637377|41728337|FG002|Overall Study|Withdrawal by Subject|13|||
19466960|NCT00637377|41728338|FG003|Overall Study|Withdrawal by Subject|11|||
19466961|NCT00637377|41728335|FG000|Overall Study|Other (no further information available)|7|||
19466962|NCT00637377|41728336|FG001|Overall Study|Other (no further information available)|6|||
19466963|NCT00637377|41728337|FG002|Overall Study|Other (no further information available)|10|||
19739020|NCT00101686|42186086|FG002|Overall Study|Physician Decision|6|||
19466964|NCT00637377|41728338|FG003|Overall Study|Other (no further information available)|5|||
19466965|NCT00636987|41728348|FG000|Overall Study|Death|44|||
19466966|NCT00636987|41728348|FG000|Overall Study|Explanted|13|||
19466967|NCT00636987|41728348|FG000|Overall Study|Lost to Follow-up|63|||
19466968|NCT00636987|41728348|FG000|Overall Study|5 year visit window not complete|69|||
19466969|NCT00636441|41728503|FG000|Overall Study|Adverse Event|0|||
19466970|NCT00636441|41728504|FG001|Overall Study|Adverse Event|1|||
19466971|NCT00636441|41728505|FG002|Overall Study|Adverse Event|1|||
19466972|NCT00636441|41728506|FG003|Overall Study|Adverse Event|0|||
19466973|NCT00636441|41728507|FG004|Overall Study|Adverse Event|0|||
19551670|NCT01099579|42000471|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
19551671|NCT01103713|42000481|FG000|Overall Study|Lost to Follow-up|2|||
19551672|NCT01103713|42000481|FG000|Overall Study|Withdrawal by Subject|8|||
19466974|NCT00636441|41728508|FG005|Overall Study|Adverse Event|1|||
19466975|NCT00636441|41728509|FG006|Overall Study|Adverse Event|0|||
19466976|NCT00636441|41728503|FG000|Overall Study|Late, ineligible|0|||
19466977|NCT00636441|41728504|FG001|Overall Study|Late, ineligible|0|||
19466978|NCT00636441|41728505|FG002|Overall Study|Late, ineligible|0|||
19466979|NCT00636441|41728506|FG003|Overall Study|Late, ineligible|0|||
19466980|NCT00636441|41728507|FG004|Overall Study|Late, ineligible|0|||
19466981|NCT00636441|41728508|FG005|Overall Study|Late, ineligible|0|||
19466982|NCT00636441|41728509|FG006|Overall Study|Late, ineligible|1|||
19466983|NCT00636441|41728503|FG000|Overall Study|Screen Failure|0|||
19466984|NCT00636441|41728504|FG001|Overall Study|Screen Failure|0|||
19466985|NCT00636441|41728505|FG002|Overall Study|Screen Failure|0|||
19466986|NCT00636441|41728506|FG003|Overall Study|Screen Failure|0|||
19466987|NCT00636441|41728507|FG004|Overall Study|Screen Failure|0|||
19466988|NCT00636441|41728508|FG005|Overall Study|Screen Failure|0|||
19466989|NCT00636441|41728509|FG006|Overall Study|Screen Failure|17|||
19466990|NCT00636363|41728532|FG000|Overall Study|Conjunctivitis|0|||
19466991|NCT00636363|41728533|FG001|Overall Study|Conjunctivitis|0|||
19466992|NCT00636363|41728534|FG002|Overall Study|Conjunctivitis|1|||
19466993|NCT00636363|41728532|FG000|Overall Study|Adverse Event|0|||
19466994|NCT00636363|41728533|FG001|Overall Study|Adverse Event|0|||
19466995|NCT00636363|41728534|FG002|Overall Study|Adverse Event|1|||
19466996|NCT00636363|41728532|FG000|Overall Study|Positive slit lamp finding|0|||
19466997|NCT00636363|41728533|FG001|Overall Study|Positive slit lamp finding|2|||
19466998|NCT00636363|41728534|FG002|Overall Study|Positive slit lamp finding|1|||
19466999|NCT00636363|41728532|FG000|Overall Study|Study related symptoms/complaints|8|||
19467000|NCT00636363|41728533|FG001|Overall Study|Study related symptoms/complaints|7|||
19467001|NCT00636363|41728534|FG002|Overall Study|Study related symptoms/complaints|4|||
19467002|NCT00636363|41728532|FG000|Overall Study|Met ineligibility criteria|0|||
19467003|NCT00636363|41728533|FG001|Overall Study|Met ineligibility criteria|0|||
19467004|NCT00636363|41728534|FG002|Overall Study|Met ineligibility criteria|3|||
19467005|NCT00636363|41728532|FG000|Overall Study|Missed > 1 visit|0|||
19467006|NCT00636363|41728533|FG001|Overall Study|Missed > 1 visit|1|||
19467007|NCT00636363|41728534|FG002|Overall Study|Missed > 1 visit|3|||
19467008|NCT00636363|41728532|FG000|Overall Study|Lack of motivation|1|||
19467009|NCT00636363|41728533|FG001|Overall Study|Lack of motivation|0|||
19467010|NCT00636363|41728534|FG002|Overall Study|Lack of motivation|1|||
19467011|NCT00636363|41728532|FG000|Overall Study|Protocol Violation|0|||
19467012|NCT00636363|41728533|FG001|Overall Study|Protocol Violation|3|||
19467013|NCT00636363|41728534|FG002|Overall Study|Protocol Violation|0|||
19467014|NCT00636363|41728532|FG000|Overall Study|Lost to Follow-up|3|||
19467015|NCT00636363|41728533|FG001|Overall Study|Lost to Follow-up|4|||
19467016|NCT00636363|41728534|FG002|Overall Study|Lost to Follow-up|2|||
19467017|NCT00636363|41728532|FG000|Overall Study|Withdrawal by Subject|1|||
19467018|NCT00636363|41728533|FG001|Overall Study|Withdrawal by Subject|3|||
19467019|NCT00636363|41728534|FG002|Overall Study|Withdrawal by Subject|2|||
19467020|NCT00636207|41728576|FG000|Overall Study|Adverse Event|1|||
19467021|NCT00636207|41728577|FG001|Overall Study|Adverse Event|0|||
19467022|NCT00636207|41728578|FG002|Overall Study|Adverse Event|0|||
19467023|NCT00636207|41728579|FG003|Overall Study|Adverse Event|0|||
19467024|NCT00636207|41728580|FG004|Overall Study|Adverse Event|0|||
19467025|NCT00636207|41728581|FG005|Overall Study|Adverse Event|0|||
19467026|NCT00636207|41728582|FG006|Overall Study|Adverse Event|0|||
19467027|NCT00636207|41728576|FG000|Overall Study|Withdrawal by Subject|0|||
19467028|NCT00636207|41728577|FG001|Overall Study|Withdrawal by Subject|1|||
19467029|NCT00636207|41728578|FG002|Overall Study|Withdrawal by Subject|0|||
19467030|NCT00636207|41728579|FG003|Overall Study|Withdrawal by Subject|0|||
19467031|NCT00636207|41728580|FG004|Overall Study|Withdrawal by Subject|1|||
19467032|NCT00636207|41728581|FG005|Overall Study|Withdrawal by Subject|0|||
19467033|NCT00636207|41728582|FG006|Overall Study|Withdrawal by Subject|0|||
19467034|NCT00635661|41728603|FG000|Overall Study|Withdrawal by Subject|4|||
19467035|NCT00635427|41728692|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
19467036|NCT00635427|41728693|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
19467037|NCT00635427|41728694|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
19467038|NCT00635427|41728695|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
19467039|NCT00635427|41728696|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
19467040|NCT00635427|41728692|FG000|Overall Study|Death|0|||
19467041|NCT00635427|41728693|FG001|Overall Study|Death|0|||
19467042|NCT00635427|41728694|FG002|Overall Study|Death|0|||
19467043|NCT00635427|41728695|FG003|Overall Study|Death|1|||
19467044|NCT00635427|41728696|FG004|Overall Study|Death|0|||
19467045|NCT00635427|41728692|FG000|Overall Study|Termination Of Study By Sponsor|12|||
19467046|NCT00635427|41728693|FG001|Overall Study|Termination Of Study By Sponsor|6|||
19467047|NCT00635427|41728694|FG002|Overall Study|Termination Of Study By Sponsor|10|||
19467048|NCT00635427|41728695|FG003|Overall Study|Termination Of Study By Sponsor|6|||
19467049|NCT00635427|41728696|FG004|Overall Study|Termination Of Study By Sponsor|6|||
19467050|NCT00635427|41728692|FG000|Overall Study|Withdrawal Of Consent|0|||
19467051|NCT00635427|41728693|FG001|Overall Study|Withdrawal Of Consent|0|||
19467052|NCT00635427|41728694|FG002|Overall Study|Withdrawal Of Consent|0|||
19467053|NCT00635427|41728695|FG003|Overall Study|Withdrawal Of Consent|2|||
19467054|NCT00635427|41728696|FG004|Overall Study|Withdrawal Of Consent|2|||
19467055|NCT00635349|41728708|FG000|Overall Study|Other|8|||
19467056|NCT00635349|41728709|FG001|Overall Study|Other|6|||
19467057|NCT00635349|41728708|FG000|Overall Study|Protocol Violation|18|||
19467058|NCT00635349|41728709|FG001|Overall Study|Protocol Violation|22|||
19467059|NCT00635349|41728708|FG000|Overall Study|Withdrawal by Subject|3|||
19467060|NCT00635349|41728709|FG001|Overall Study|Withdrawal by Subject|8|||
19467061|NCT00635349|41728708|FG000|Overall Study|Lost to Follow-up|4|||
19467062|NCT00635349|41728709|FG001|Overall Study|Lost to Follow-up|3|||
19467063|NCT00635349|41728708|FG000|Overall Study|Adverse Event|11|||
19467064|NCT00635349|41728709|FG001|Overall Study|Adverse Event|9|||
19467065|NCT00634803|41728718|FG000|Overall Study|Lost to Follow-up|6|||
19467066|NCT00634803|41728719|FG001|Overall Study|Lost to Follow-up|7|||
19467067|NCT00634803|41728720|FG002|Overall Study|Lost to Follow-up|7|||
19467068|NCT01217385|41728736|FG000|Overall Study|Withdrawal by Subject|3|||
19467069|NCT01217385|41728736|FG000|Overall Study|DOSI not performed/not eval|12|||
19467070|NCT01217385|41728736|FG000|Overall Study|Central Path not Available|1|||
19467071|NCT01217385|41728736|FG000|Overall Study|Normal Breast TOI not available|10|||
19551673|NCT01103713|42000481|FG000|Overall Study|Study terminated by sponsor|2|||
19551674|NCT01103713|42000481|FG000|Overall Study|Other|1|||
19551675|NCT01103479|42000491|FG000|Overall Study|Up to date with CRC screening|1|||
19551676|NCT01103479|42000492|FG001|Overall Study|Up to date with CRC screening|9|||
19551677|NCT01103479|42000493|FG002|Overall Study|Up to date with CRC screening|12|||
19551678|NCT01103479|42000491|FG000|Overall Study|Family history of CRC|1|||
19551679|NCT01103479|42000492|FG001|Overall Study|Family history of CRC|0|||
19551680|NCT01103479|42000493|FG002|Overall Study|Family history of CRC|2|||
19551681|NCT01103479|42000491|FG000|Overall Study|Active cancer|1|||
19551682|NCT01103479|42000492|FG001|Overall Study|Active cancer|0|||
19551683|NCT01103479|42000493|FG002|Overall Study|Active cancer|0|||
19551684|NCT01103479|42000491|FG000|Overall Study|Saw non-study physician|2|||
19551685|NCT01103479|42000492|FG001|Overall Study|Saw non-study physician|0|||
19551686|NCT01103479|42000493|FG002|Overall Study|Saw non-study physician|0|||
19551687|NCT01103323|42000504|FG000|Without/Before Drug Switch|Adverse Event|50|||
19551688|NCT01103323|42000505|FG001|Without/Before Drug Switch|Adverse Event|7|||
19551689|NCT01103323|42000504|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
19467072|NCT01378104|41729088|FG000|Overall Study|Adverse Event|8|||
19467073|NCT01378104|41729089|FG001|Overall Study|Adverse Event|8|||
19467074|NCT01378104|41729088|FG000|Overall Study|Lack of Efficacy|7|||
19467075|NCT01378104|41729089|FG001|Overall Study|Lack of Efficacy|5|||
19467076|NCT01378104|41729088|FG000|Overall Study|Withdrawal by Subject|12|||
19467077|NCT01378104|41729089|FG001|Overall Study|Withdrawal by Subject|13|||
19467078|NCT01379274|41729130|FG000|Overall Study|funding withdrawn|1|||
19467079|NCT01216683|41729332|FG000|Induction|Never started treatment|0|||
19467080|NCT01216683|41729333|FG001|Induction|Never started treatment|6|||
19467081|NCT01216683|41729334|FG002|Induction|Never started treatment|3|||
19467082|NCT01216683|41729332|FG000|Induction|Lack of Efficacy|4|||
19467083|NCT01216683|41729333|FG001|Induction|Lack of Efficacy|3|||
19467084|NCT01216683|41729334|FG002|Induction|Lack of Efficacy|7|||
19467085|NCT01216683|41729332|FG000|Induction|Adverse Event|0|||
19467086|NCT01216683|41729333|FG001|Induction|Adverse Event|5|||
19467087|NCT01216683|41729334|FG002|Induction|Adverse Event|5|||
19467088|NCT01216683|41729332|FG000|Induction|Death|0|||
19467089|NCT01216683|41729333|FG001|Induction|Death|0|||
19467090|NCT01216683|41729334|FG002|Induction|Death|2|||
19467091|NCT01216683|41729332|FG000|Induction|Withdrawal by Subject|0|||
19467092|NCT01216683|41729333|FG001|Induction|Withdrawal by Subject|4|||
19467093|NCT01216683|41729334|FG002|Induction|Withdrawal by Subject|2|||
19467094|NCT01216683|41729332|FG000|Induction|Other disease|0|||
19467095|NCT01216683|41729333|FG001|Induction|Other disease|1|||
19467096|NCT01216683|41729334|FG002|Induction|Other disease|2|||
19467097|NCT01216683|41729332|FG000|Continuation|Lack of Efficacy|3|||
19467098|NCT01216683|41729333|FG001|Continuation|Lack of Efficacy|2|||
19467099|NCT01216683|41729334|FG002|Continuation|Lack of Efficacy|7|||
19467100|NCT01216683|41729332|FG000|Continuation|Adverse Event|5|||
19467101|NCT01216683|41729333|FG001|Continuation|Adverse Event|3|||
19467102|NCT01216683|41729334|FG002|Continuation|Adverse Event|16|||
19467103|NCT01216683|41729332|FG000|Continuation|Death|1|||
19467104|NCT01216683|41729333|FG001|Continuation|Death|0|||
19467105|NCT01216683|41729334|FG002|Continuation|Death|2|||
19467106|NCT01216683|41729332|FG000|Continuation|Withdrawal by Subject|4|||
19467107|NCT01216683|41729333|FG001|Continuation|Withdrawal by Subject|5|||
19467108|NCT01216683|41729334|FG002|Continuation|Withdrawal by Subject|9|||
19467109|NCT01216683|41729332|FG000|Continuation|Other diseases|0|||
19467110|NCT01216683|41729333|FG001|Continuation|Other diseases|2|||
19467111|NCT01216683|41729334|FG002|Continuation|Other diseases|1|||
19467112|NCT01216683|41729332|FG000|Continuation|Physician Decision|1|||
19467113|NCT01216683|41729333|FG001|Continuation|Physician Decision|0|||
19467114|NCT01216683|41729334|FG002|Continuation|Physician Decision|1|||
19467115|NCT01216683|41729332|FG000|Continuation|Non-compliance|1|||
19467116|NCT01216683|41729333|FG001|Continuation|Non-compliance|0|||
19467117|NCT01216683|41729334|FG002|Continuation|Non-compliance|1|||
19467118|NCT01216683|41729332|FG000|Continuation|Insurance change|0|||
19467119|NCT01216683|41729333|FG001|Continuation|Insurance change|1|||
19467120|NCT01216683|41729334|FG002|Continuation|Insurance change|0|||
19467121|NCT01216683|41729332|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
19467122|NCT01216683|41729333|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
19467123|NCT01216683|41729334|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
19467124|NCT01216683|41729332|FG000|Continuation|Not reported|0|||
19467125|NCT01216683|41729333|FG001|Continuation|Not reported|0|||
19551690|NCT01103323|42000505|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
19467126|NCT01216683|41729334|FG002|Continuation|Not reported|1|||
19467127|NCT01216683|41729332|FG000|Continuation|Never started treatment|0|||
19551691|NCT01103323|42000504|FG000|Without/Before Drug Switch|Protocol Violation|2|||
19467128|NCT01216683|41729333|FG001|Continuation|Never started treatment|1|||
19467129|NCT01216683|41729334|FG002|Continuation|Never started treatment|5|||
19467130|NCT00634569|41729357|FG000|Overall Study|Withdrawal by Subject|0|||
19467131|NCT00634569|41729358|FG001|Overall Study|Withdrawal by Subject|4|||
19467132|NCT00634569|41729357|FG000|Overall Study|Physician Decision|0|||
19467133|NCT00634569|41729358|FG001|Overall Study|Physician Decision|1|||
19467134|NCT00634179|41729403|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
19467135|NCT03877926|41729478|FG000|Overall Study|Adverse Event|1|||
19467136|NCT03877926|41729479|FG001|Overall Study|Adverse Event|0|||
19467137|NCT03877926|41729480|FG002|Overall Study|Adverse Event|0|||
19467138|NCT03877926|41729481|FG003|Overall Study|Adverse Event|0|||
19467139|NCT03877926|41729478|FG000|Overall Study|Death|2|||
19467140|NCT03877926|41729479|FG001|Overall Study|Death|2|||
19467141|NCT03877926|41729480|FG002|Overall Study|Death|2|||
19467142|NCT03877926|41729481|FG003|Overall Study|Death|0|||
19467143|NCT03877926|41729478|FG000|Overall Study|Lost to Follow-up|41|||
19467144|NCT03877926|41729479|FG001|Overall Study|Lost to Follow-up|52|||
19467145|NCT03877926|41729480|FG002|Overall Study|Lost to Follow-up|45|||
19551692|NCT01103323|42000505|FG001|Without/Before Drug Switch|Protocol Violation|0|||
19551693|NCT01103323|42000504|FG000|Without/Before Drug Switch|Physician Decision|2|||
19551694|NCT01103323|42000505|FG001|Without/Before Drug Switch|Physician Decision|0|||
19551695|NCT01103323|42000504|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
19551696|NCT01103323|42000505|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
19551697|NCT01103323|42000504|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
19551698|NCT01103323|42000505|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
19551699|NCT01103323|42000504|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
19551700|NCT01103323|42000505|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
19551701|NCT01103245|42000516|FG000|Overall Study|Withdrawal by Subject|1|||
19551702|NCT01103245|42000517|FG001|Overall Study|Withdrawal by Subject|0|||
19551703|NCT01103245|42000518|FG002|Overall Study|Withdrawal by Subject|3|||
19551704|NCT01103245|42000519|FG003|Overall Study|Withdrawal by Subject|0|||
19551705|NCT01103245|42000516|FG000|Overall Study|Inadequate IV access|1|||
19551706|NCT01103245|42000517|FG001|Overall Study|Inadequate IV access|0|||
19551707|NCT01103245|42000518|FG002|Overall Study|Inadequate IV access|0|||
19551708|NCT01103245|42000519|FG003|Overall Study|Inadequate IV access|0|||
19467146|NCT03877926|41729481|FG003|Overall Study|Lost to Follow-up|17|||
19467147|NCT03877926|41729478|FG000|Overall Study|Physician Decision|2|||
19467148|NCT03877926|41729479|FG001|Overall Study|Physician Decision|0|||
19467149|NCT03877926|41729480|FG002|Overall Study|Physician Decision|2|||
19467150|NCT03877926|41729481|FG003|Overall Study|Physician Decision|0|||
19551709|NCT01103245|42000516|FG000|Overall Study|Adverse Event|0|||
19551710|NCT01103245|42000517|FG001|Overall Study|Adverse Event|2|||
19551711|NCT01103245|42000518|FG002|Overall Study|Adverse Event|1|||
19551712|NCT01103245|42000519|FG003|Overall Study|Adverse Event|0|||
19551713|NCT01103245|42000516|FG000|Overall Study|Physician Decision|1|||
19551714|NCT01103245|42000517|FG001|Overall Study|Physician Decision|0|||
19551715|NCT01103245|42000518|FG002|Overall Study|Physician Decision|0|||
19551716|NCT01103245|42000519|FG003|Overall Study|Physician Decision|0|||
19551717|NCT01099267|42000529|FG000|MDS-003 Study|Adverse Event|37|||
19551718|NCT01099267|42000529|FG000|MDS-003 Study|Lack of Efficacy|52|||
19551719|NCT01099267|42000529|FG000|MDS-003 Study|Withdrawal by Subject|8|||
19551720|NCT01099267|42000529|FG000|MDS-003 Study|Lost to Follow-up|1|||
19551721|NCT01099267|42000529|FG000|MDS-003 Study|Death|11|||
19551722|NCT01099267|42000529|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
19551723|NCT01099267|42000529|FG000|MDS-003 Study|Disease Progression|7|||
19551724|NCT01099267|42000529|FG000|MDS-003 Study|Investigator Decision|2|||
19551725|NCT01099267|42000529|FG000|MDS-003 Study|Non-Compliance|2|||
19551726|NCT01099267|42000529|FG000|MDS-003 Study|Loss of Response|1|||
19551727|NCT01099267|42000529|FG000|MDS-003 Study|Secondary Malign Disease|1|||
19551728|NCT01098487|42000533|FG000|Overall Study|Adverse Event|22|||
19551729|NCT01098487|42000533|FG000|Overall Study|Lack of Efficacy|11|||
19551730|NCT01098487|42000533|FG000|Overall Study|Withdrawal by Subject|7|||
19551731|NCT01098487|42000533|FG000|Overall Study|Lost to Follow-up|3|||
19551732|NCT01098487|42000533|FG000|Overall Study|Physician Decision|1|||
19551733|NCT01098097|42000537|FG000|Overall Study|Adverse Event|17|||
19551734|NCT01098097|42000537|FG000|Overall Study|Lost to Follow-up|18|||
19551735|NCT01098097|42000537|FG000|Overall Study|Status unknown|16|||
19551736|NCT01098097|42000537|FG000|Overall Study|No reason reported|31|||
19551737|NCT01097863|42000544|FG000|Overall Study|Discomfort|1|||
19551738|NCT01097863|42000545|FG001|Overall Study|Discomfort|0|||
19551739|NCT01097863|42000546|FG002|Overall Study|Discomfort|1|||
19551740|NCT01097863|42000544|FG000|Overall Study|Did not return for final visit|0|||
19551741|NCT01097863|42000545|FG001|Overall Study|Did not return for final visit|0|||
19551742|NCT01097863|42000546|FG002|Overall Study|Did not return for final visit|1|||
19551743|NCT01326962|42000554|FG000|Overall Study|Adverse Event|1|||
19551744|NCT01326962|42000554|FG000|Overall Study|Withdrawal by Subject|1|||
19551745|NCT01326962|42000554|FG000|Overall Study|Lost to Follow-up|3|||
19551746|NCT01326962|42000554|FG000|Overall Study|Other|2|||
19551747|NCT01326728|42000560|FG000|Overall Study|Death|13|||
19551748|NCT01326728|42000561|FG001|Overall Study|Death|0|||
19551749|NCT01326728|42000560|FG000|Overall Study|Early closure of study|34|||
19551750|NCT01326728|42000561|FG001|Overall Study|Early closure of study|9|||
19551751|NCT01097707|42000571|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19551752|NCT01097707|42000572|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19551753|NCT01097707|42000573|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19551754|NCT01097707|42000574|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19551755|NCT01097707|42000575|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19551756|NCT01097707|42000571|FG000|Overall Study|Adverse Event|4|||
19551757|NCT01097707|42000572|FG001|Overall Study|Adverse Event|2|||
19551758|NCT01097707|42000573|FG002|Overall Study|Adverse Event|3|||
19551759|NCT01097707|42000574|FG003|Overall Study|Adverse Event|1|||
19551760|NCT01097707|42000575|FG004|Overall Study|Adverse Event|3|||
19551761|NCT01097707|42000571|FG000|Overall Study|Entry Criteria Not Met|2|||
19551762|NCT01097707|42000572|FG001|Overall Study|Entry Criteria Not Met|1|||
19551763|NCT01097707|42000573|FG002|Overall Study|Entry Criteria Not Met|1|||
19551764|NCT01097707|42000574|FG003|Overall Study|Entry Criteria Not Met|0|||
19551765|NCT01097707|42000575|FG004|Overall Study|Entry Criteria Not Met|1|||
19551766|NCT01097707|42000571|FG000|Overall Study|Lack of Efficacy|1|||
19551767|NCT01097707|42000572|FG001|Overall Study|Lack of Efficacy|0|||
19551768|NCT01097707|42000573|FG002|Overall Study|Lack of Efficacy|0|||
19551769|NCT01097707|42000574|FG003|Overall Study|Lack of Efficacy|1|||
19551770|NCT01097707|42000575|FG004|Overall Study|Lack of Efficacy|0|||
19551771|NCT01097707|42000571|FG000|Overall Study|Lost to Follow-up|1|||
19551772|NCT01097707|42000572|FG001|Overall Study|Lost to Follow-up|1|||
19551773|NCT01097707|42000573|FG002|Overall Study|Lost to Follow-up|2|||
19551774|NCT01097707|42000574|FG003|Overall Study|Lost to Follow-up|0|||
19551775|NCT01097707|42000575|FG004|Overall Study|Lost to Follow-up|3|||
19551776|NCT01097707|42000571|FG000|Overall Study|Protocol Violation|2|||
19551777|NCT01097707|42000572|FG001|Overall Study|Protocol Violation|2|||
19551778|NCT01097707|42000573|FG002|Overall Study|Protocol Violation|3|||
19551779|NCT01097707|42000574|FG003|Overall Study|Protocol Violation|2|||
19551780|NCT01097707|42000575|FG004|Overall Study|Protocol Violation|2|||
19551781|NCT01097707|42000571|FG000|Overall Study|Sponsor Decision|31|||
19551782|NCT01097707|42000572|FG001|Overall Study|Sponsor Decision|31|||
19551783|NCT01097707|42000573|FG002|Overall Study|Sponsor Decision|34|||
19551784|NCT01097707|42000574|FG003|Overall Study|Sponsor Decision|35|||
19551785|NCT01097707|42000575|FG004|Overall Study|Sponsor Decision|36|||
19551786|NCT01097707|42000571|FG000|Overall Study|Withdrawal by Subject|3|||
19551787|NCT01097707|42000572|FG001|Overall Study|Withdrawal by Subject|6|||
19551788|NCT01097707|42000573|FG002|Overall Study|Withdrawal by Subject|1|||
19551789|NCT01097707|42000574|FG003|Overall Study|Withdrawal by Subject|4|||
19551790|NCT01097707|42000575|FG004|Overall Study|Withdrawal by Subject|3|||
19551791|NCT01097707|42000571|FG000|Overall Study|Reason unknown|0|||
19551792|NCT01097707|42000572|FG001|Overall Study|Reason unknown|0|||
19551793|NCT01097707|42000573|FG002|Overall Study|Reason unknown|0|||
19551794|NCT01097707|42000574|FG003|Overall Study|Reason unknown|0|||
19467151|NCT03877926|41729478|FG000|Overall Study|Withdrawal by Subject|18|||
19467152|NCT03877926|41729479|FG001|Overall Study|Withdrawal by Subject|21|||
19467153|NCT03877926|41729480|FG002|Overall Study|Withdrawal by Subject|12|||
19467154|NCT03877926|41729481|FG003|Overall Study|Withdrawal by Subject|4|||
19467155|NCT03877926|41729478|FG000|Overall Study|Other - Various|4|||
19467156|NCT03877926|41729479|FG001|Overall Study|Other - Various|1|||
19467157|NCT03877926|41729480|FG002|Overall Study|Other - Various|1|||
19467158|NCT03877926|41729481|FG003|Overall Study|Other - Various|0|||
19467159|NCT03877926|41729478|FG000|Overall Study|Not Treated|3|||
19467160|NCT03877926|41729479|FG001|Overall Study|Not Treated|1|||
19467161|NCT03877926|41729480|FG002|Overall Study|Not Treated|1|||
19467162|NCT03877926|41729481|FG003|Overall Study|Not Treated|0|||
19551795|NCT01097707|42000575|FG004|Overall Study|Reason unknown|1|||
19551796|NCT01326104|42000589|FG000|Overall Study|progressed prior to vaccine|0|||
19551797|NCT01326104|42000590|FG001|Overall Study|progressed prior to vaccine|2|||
19551798|NCT01326104|42000589|FG000|Overall Study|unable to make vaccine|0|||
19551799|NCT01326104|42000590|FG001|Overall Study|unable to make vaccine|2|||
19467163|NCT02874144|41729704|FG000|Overall Study|Lost to Follow-up|3|||
19467164|NCT02874144|41729705|FG001|Overall Study|Lost to Follow-up|5|||
19467165|NCT02611830|41729735|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
19467166|NCT02611830|41729736|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
19467167|NCT02611830|41729737|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
19467168|NCT02611830|41729738|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
19467169|NCT02611830|41729735|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
19551800|NCT01326026|42000598|FG000|Overall Study|Adverse Event|4|||
19739021|NCT00101686|42186087|FG003|Overall Study|Physician Decision|7|||
19739022|NCT00101686|42186088|FG004|Overall Study|Physician Decision|8|||
19467170|NCT02611830|41729736|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
19467171|NCT02611830|41729737|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
19467172|NCT02611830|41729738|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
19467173|NCT02611830|41729735|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
19467174|NCT02611830|41729736|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
19467175|NCT02611830|41729737|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
19467176|NCT02611830|41729738|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
19467177|NCT02611830|41729735|FG000|OL Induction Phase|Lack of Efficacy|9|||
19467178|NCT02611830|41729736|FG001|OL Induction Phase|Lack of Efficacy|0|||
19467179|NCT02611830|41729737|FG002|OL Induction Phase|Lack of Efficacy|0|||
19467180|NCT02611830|41729738|FG003|OL Induction Phase|Lack of Efficacy|0|||
19467181|NCT02611830|41729735|FG000|OL Induction Phase|Reason not specified|3|||
19467182|NCT02611830|41729736|FG001|OL Induction Phase|Reason not specified|0|||
19467183|NCT02611830|41729737|FG002|OL Induction Phase|Reason not specified|0|||
19467184|NCT02611830|41729738|FG003|OL Induction Phase|Reason not specified|0|||
19467185|NCT02611830|41729735|FG000|Maintenance Phase|Lack of Efficacy|0|||
19467186|NCT02611830|41729736|FG001|Maintenance Phase|Lack of Efficacy|29|||
19467187|NCT02611830|41729737|FG002|Maintenance Phase|Lack of Efficacy|18|||
19467188|NCT02611830|41729738|FG003|Maintenance Phase|Lack of Efficacy|6|||
19467189|NCT02611830|41729735|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
19467190|NCT02611830|41729736|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
19467191|NCT02611830|41729737|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
19467192|NCT02611830|41729738|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
19467193|NCT02611830|41729735|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
19467194|NCT02611830|41729736|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
19467195|NCT02611830|41729737|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
19467196|NCT02611830|41729738|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
19467197|NCT02611830|41729735|FG000|Maintenance Phase|Lost to Follow-up|0|||
19467198|NCT02611830|41729736|FG001|Maintenance Phase|Lost to Follow-up|0|||
19467199|NCT02611830|41729737|FG002|Maintenance Phase|Lost to Follow-up|0|||
19467200|NCT02611830|41729738|FG003|Maintenance Phase|Lost to Follow-up|1|||
19467201|NCT02611830|41729735|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
19467202|NCT02611830|41729736|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
19467203|NCT02611830|41729737|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
19467204|NCT02611830|41729738|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
19467205|NCT02611830|41729735|FG000|Maintenance Phase|Pregnancy|0|||
19467206|NCT02611830|41729736|FG001|Maintenance Phase|Pregnancy|0|||
19467207|NCT02611830|41729737|FG002|Maintenance Phase|Pregnancy|1|||
19467208|NCT02611830|41729738|FG003|Maintenance Phase|Pregnancy|0|||
19467209|NCT02611830|41729735|FG000|Maintenance Phase|Reason not specified|0|||
19467210|NCT02611830|41729736|FG001|Maintenance Phase|Reason not specified|1|||
19467211|NCT02611830|41729737|FG002|Maintenance Phase|Reason not specified|4|||
19467212|NCT02611830|41729738|FG003|Maintenance Phase|Reason not specified|0|||
19467213|NCT01328574|41729924|FG000|Overall Study|Refused further treatment|1|||
19467214|NCT01328496|41730046|FG000|Overall Study|Significant Change in Health Status|1|||
19467215|NCT01328496|41730047|FG001|Overall Study|Significant Change in Health Status|0|||
19467216|NCT02734212|41730167|FG000|Overall Study|Lost to Follow-up|5|||
19467217|NCT02734212|41730168|FG001|Overall Study|Lost to Follow-up|10|||
19467218|NCT04604184|41730245|FG000|Overall Study|Adverse Event|5|||
19467219|NCT04604184|41730246|FG001|Overall Study|Adverse Event|5|||
19467220|NCT04604184|41730245|FG000|Overall Study|Death|2|||
19467221|NCT04604184|41730246|FG001|Overall Study|Death|1|||
19467222|NCT04604184|41730245|FG000|Overall Study|Withdrawal by Subject|1|||
19467223|NCT04604184|41730246|FG001|Overall Study|Withdrawal by Subject|3|||
19467224|NCT04604184|41730245|FG000|Overall Study|Not treated|2|||
19467225|NCT04604184|41730246|FG001|Overall Study|Not treated|2|||
19467226|NCT04604184|41730245|FG000|Overall Study|Due to sponsor decision|9|||
19467227|NCT04604184|41730246|FG001|Overall Study|Due to sponsor decision|7|||
19467228|NCT04604184|41730245|FG000|Overall Study|Physician Decision|0|||
19467229|NCT04604184|41730246|FG001|Overall Study|Physician Decision|1|||
19467230|NCT04604184|41730245|FG000|Overall Study|Transfer to healthcare|1|||
19467231|NCT04604184|41730246|FG001|Overall Study|Transfer to healthcare|0|||
19467232|NCT01859741|41730417|FG000|Overall Study|Death|3|||
19467233|NCT01859741|41730418|FG001|Overall Study|Death|2|||
19467234|NCT01859741|41730419|FG002|Overall Study|Death|4|||
19551801|NCT01326026|42000599|FG001|Overall Study|Adverse Event|3|||
19467235|NCT01859741|41730420|FG003|Overall Study|Death|3|||
19467236|NCT01859741|41730421|FG004|Overall Study|Death|5|||
19467237|NCT01859741|41730422|FG005|Overall Study|Death|4|||
19467238|NCT01859741|41730423|FG006|Overall Study|Death|51|||
19467239|NCT01859741|41730424|FG007|Overall Study|Death|51|||
19467240|NCT01859741|41730417|FG000|Overall Study|Lost to Follow-up|0|||
19467241|NCT01859741|41730418|FG001|Overall Study|Lost to Follow-up|0|||
19467242|NCT01859741|41730419|FG002|Overall Study|Lost to Follow-up|0|||
19467243|NCT01859741|41730420|FG003|Overall Study|Lost to Follow-up|0|||
19467244|NCT01859741|41730421|FG004|Overall Study|Lost to Follow-up|0|||
19551802|NCT01326026|42000598|FG000|Overall Study|Withdrawal Criteria|5|||
19467245|NCT01859741|41730422|FG005|Overall Study|Lost to Follow-up|1|||
19467246|NCT01859741|41730423|FG006|Overall Study|Lost to Follow-up|0|||
19467247|NCT01859741|41730424|FG007|Overall Study|Lost to Follow-up|4|||
19467248|NCT01859741|41730417|FG000|Overall Study|Withdrawal by Subject|0|||
19467249|NCT01859741|41730418|FG001|Overall Study|Withdrawal by Subject|1|||
19467250|NCT01859741|41730419|FG002|Overall Study|Withdrawal by Subject|2|||
19467251|NCT01859741|41730420|FG003|Overall Study|Withdrawal by Subject|0|||
19467252|NCT01859741|41730421|FG004|Overall Study|Withdrawal by Subject|0|||
19467253|NCT01859741|41730422|FG005|Overall Study|Withdrawal by Subject|1|||
19467254|NCT01859741|41730423|FG006|Overall Study|Withdrawal by Subject|1|||
19467255|NCT01859741|41730424|FG007|Overall Study|Withdrawal by Subject|1|||
19467256|NCT01859741|41730417|FG000|Overall Study|Study Terminated by Sponsor|0|||
19467257|NCT01859741|41730418|FG001|Overall Study|Study Terminated by Sponsor|0|||
19467258|NCT01859741|41730419|FG002|Overall Study|Study Terminated by Sponsor|0|||
19467259|NCT01859741|41730420|FG003|Overall Study|Study Terminated by Sponsor|0|||
19467260|NCT01859741|41730421|FG004|Overall Study|Study Terminated by Sponsor|1|||
19467261|NCT01859741|41730422|FG005|Overall Study|Study Terminated by Sponsor|0|||
19467262|NCT01859741|41730423|FG006|Overall Study|Study Terminated by Sponsor|16|||
19467263|NCT01859741|41730424|FG007|Overall Study|Study Terminated by Sponsor|14|||
19467264|NCT01859741|41730417|FG000|Overall Study|Other|0|||
19467265|NCT01859741|41730418|FG001|Overall Study|Other|0|||
19467266|NCT01859741|41730419|FG002|Overall Study|Other|0|||
19467267|NCT01859741|41730420|FG003|Overall Study|Other|0|||
19467268|NCT01859741|41730421|FG004|Overall Study|Other|0|||
19467269|NCT01859741|41730422|FG005|Overall Study|Other|0|||
19551803|NCT01326026|42000599|FG001|Overall Study|Withdrawal Criteria|7|||
19551804|NCT01326026|42000598|FG000|Overall Study|Other|3|||
19551805|NCT01326026|42000599|FG001|Overall Study|Other|3|||
19551806|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
19551807|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
19551808|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
19551809|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19551810|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19551811|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19551812|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19551813|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19551814|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
19551815|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
19551816|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
19551817|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19551818|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19551819|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19551820|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19551821|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19551822|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
19551823|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
19551824|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
19551825|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19551826|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19551827|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19551828|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19551829|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19551830|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
19551831|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
19551832|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
19551833|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19551834|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19551835|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19551836|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19551837|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19551838|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
19551839|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
19551840|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
19551841|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19739023|NCT00101686|42186089|FG005|Overall Study|Physician Decision|9|||
19467270|NCT01859741|41730423|FG006|Overall Study|Other|2|||
19467271|NCT01859741|41730424|FG007|Overall Study|Other|0|||
19467272|NCT01859507|41730470|FG000|Overall Study|left the country|4|||
19467273|NCT01876043|41730475|FG000|Overall Study|Death|1|||
19467274|NCT01876043|41730475|FG000|Overall Study|Withdrawal by Subject|1|||
19467275|NCT01875731|41730481|FG000|Overall Study|Fail to obtain lab sample|1|||
19467276|NCT01875731|41730482|FG001|Overall Study|Fail to obtain lab sample|0|||
19467277|NCT01873859|41730490|FG000|Overall Study|Withdrawal by Subject|0|||
19467278|NCT01873859|41730491|FG001|Overall Study|Withdrawal by Subject|4|||
19467279|NCT01857869|41730508|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
19467280|NCT01857869|41730509|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
19467281|NCT01857869|41730510|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
19467282|NCT01857869|41730511|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
19467283|NCT01857869|41730512|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
19467284|NCT01857869|41730513|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
19467285|NCT01857869|41730514|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
19467286|NCT01857869|41730515|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
19467287|NCT01857869|41730516|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
19467288|NCT01857869|41730517|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
19467289|NCT01857869|41730508|FG000|Primary/Challenge Phase|Pregnancy|1|||
19467290|NCT01857869|41730509|FG001|Primary/Challenge Phase|Pregnancy|0|||
19467291|NCT01857869|41730510|FG002|Primary/Challenge Phase|Pregnancy|0|||
19467292|NCT01857869|41730511|FG003|Primary/Challenge Phase|Pregnancy|0|||
19467293|NCT01857869|41730512|FG004|Primary/Challenge Phase|Pregnancy|0|||
19467294|NCT01857869|41730513|FG005|Primary/Challenge Phase|Pregnancy|0|||
19467295|NCT01857869|41730514|FG006|Primary/Challenge Phase|Pregnancy|0|||
19467296|NCT01857869|41730515|FG007|Primary/Challenge Phase|Pregnancy|0|||
19467297|NCT01857869|41730516|FG008|Primary/Challenge Phase|Pregnancy|0|||
19467298|NCT01857869|41730517|FG009|Primary/Challenge Phase|Pregnancy|0|||
19467299|NCT01857869|41730508|FG000|Primary/Challenge Phase|Protocol Violation|1|||
19467300|NCT01857869|41730509|FG001|Primary/Challenge Phase|Protocol Violation|0|||
19467301|NCT01857869|41730510|FG002|Primary/Challenge Phase|Protocol Violation|0|||
19467302|NCT01857869|41730511|FG003|Primary/Challenge Phase|Protocol Violation|0|||
19467303|NCT01857869|41730512|FG004|Primary/Challenge Phase|Protocol Violation|0|||
19467304|NCT01857869|41730513|FG005|Primary/Challenge Phase|Protocol Violation|0|||
19467305|NCT01857869|41730514|FG006|Primary/Challenge Phase|Protocol Violation|0|||
19467306|NCT01857869|41730515|FG007|Primary/Challenge Phase|Protocol Violation|0|||
19467307|NCT01857869|41730516|FG008|Primary/Challenge Phase|Protocol Violation|0|||
19467308|NCT01857869|41730517|FG009|Primary/Challenge Phase|Protocol Violation|0|||
19467309|NCT01857869|41730508|FG000|Primary/Challenge Phase|Other|1|||
19551842|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19551843|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19551844|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19551845|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19551846|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
19551847|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
19551848|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551849|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551850|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551851|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551852|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551853|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19551854|NCT01097629|42000608|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
19551855|NCT01097629|42000609|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
19551856|NCT01097629|42000610|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
19551857|NCT01097629|42000611|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19551858|NCT01097629|42000612|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19551859|NCT01097629|42000613|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19551860|NCT01097629|42000614|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19739024|NCT00101686|42186090|FG006|Overall Study|Physician Decision|5|||
19551861|NCT01097629|42000615|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19551862|NCT01097629|42000608|FG000|DB RO Phase|Withdrawal by Subject|0|||
19551863|NCT01097629|42000609|FG001|DB RO Phase|Withdrawal by Subject|0|||
19551864|NCT01097629|42000610|FG002|DB RO Phase|Withdrawal by Subject|0|||
19551865|NCT01097629|42000611|FG003|DB RO Phase|Withdrawal by Subject|0|||
19551866|NCT01097629|42000612|FG004|DB RO Phase|Withdrawal by Subject|0|||
19551867|NCT01097629|42000613|FG005|DB RO Phase|Withdrawal by Subject|0|||
19551868|NCT01097629|42000614|FG006|DB RO Phase|Withdrawal by Subject|0|||
19551869|NCT01097629|42000615|FG007|DB RO Phase|Withdrawal by Subject|1|||
19551870|NCT01097629|42000608|FG000|DB RO Phase|Protocol Violation|0|||
19551871|NCT01097629|42000609|FG001|DB RO Phase|Protocol Violation|0|||
19551872|NCT01097629|42000610|FG002|DB RO Phase|Protocol Violation|0|||
19467310|NCT01857869|41730509|FG001|Primary/Challenge Phase|Other|1|||
19467311|NCT01857869|41730510|FG002|Primary/Challenge Phase|Other|0|||
19467312|NCT01857869|41730511|FG003|Primary/Challenge Phase|Other|0|||
19467313|NCT01857869|41730512|FG004|Primary/Challenge Phase|Other|0|||
19467314|NCT01857869|41730513|FG005|Primary/Challenge Phase|Other|0|||
19467315|NCT01857869|41730514|FG006|Primary/Challenge Phase|Other|0|||
19467316|NCT01857869|41730515|FG007|Primary/Challenge Phase|Other|0|||
19467317|NCT01857869|41730516|FG008|Primary/Challenge Phase|Other|0|||
19551873|NCT01097629|42000611|FG003|DB RO Phase|Protocol Violation|1|||
19551874|NCT01097629|42000612|FG004|DB RO Phase|Protocol Violation|0|||
19551875|NCT01097629|42000613|FG005|DB RO Phase|Protocol Violation|1|||
19551876|NCT01097629|42000614|FG006|DB RO Phase|Protocol Violation|1|||
19551877|NCT01097629|42000615|FG007|DB RO Phase|Protocol Violation|0|||
19551878|NCT01097629|42000608|FG000|DB RO Phase|Lost to Follow-up|0|||
19551879|NCT01097629|42000609|FG001|DB RO Phase|Lost to Follow-up|0|||
19551880|NCT01097629|42000610|FG002|DB RO Phase|Lost to Follow-up|0|||
19551881|NCT01097629|42000611|FG003|DB RO Phase|Lost to Follow-up|0|||
19551882|NCT01097629|42000612|FG004|DB RO Phase|Lost to Follow-up|0|||
19551883|NCT01097629|42000613|FG005|DB RO Phase|Lost to Follow-up|0|||
19551884|NCT01097629|42000614|FG006|DB RO Phase|Lost to Follow-up|2|||
19551885|NCT01097629|42000615|FG007|DB RO Phase|Lost to Follow-up|0|||
19551886|NCT01324622|42000640|FG000|Overall Study|Lost to Follow-up|7|||
19551887|NCT01324622|42000641|FG001|Overall Study|Lost to Follow-up|7|||
19467318|NCT01857869|41730517|FG009|Primary/Challenge Phase|Other|0|||
19467319|NCT01857869|41730508|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467320|NCT01857869|41730509|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467321|NCT01857869|41730510|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467322|NCT01857869|41730511|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
19467323|NCT01857869|41730512|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467324|NCT01857869|41730513|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467325|NCT01857869|41730514|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467326|NCT01857869|41730515|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467327|NCT01857869|41730516|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467328|NCT01857869|41730517|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
19467329|NCT01857869|41730508|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467330|NCT01857869|41730509|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467331|NCT01857869|41730510|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467332|NCT01857869|41730511|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
19467333|NCT01857869|41730512|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467334|NCT01857869|41730513|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467335|NCT01857869|41730514|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467336|NCT01857869|41730515|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19551888|NCT01324622|42000640|FG000|Overall Study|Death|1|||
19551889|NCT01324622|42000641|FG001|Overall Study|Death|0|||
19467337|NCT01857869|41730516|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467338|NCT01857869|41730517|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
19467339|NCT00861705|41730676|FG000|Overall Study|Never Began Treatment|7|||
19467340|NCT00861705|41730677|FG001|Overall Study|Never Began Treatment|3|||
19467341|NCT00861705|41730678|FG002|Overall Study|Never Began Treatment|0|||
19467342|NCT00861705|41730679|FG003|Overall Study|Never Began Treatment|1|||
19467343|NCT00634101|41730779|FG000|Overall Study|Study Terminated|3|||
19467344|NCT00634101|41730780|FG001|Overall Study|Study Terminated|3|||
19467345|NCT00634101|41730779|FG000|Overall Study|Lost to Follow-up|2|||
19467346|NCT00634101|41730780|FG001|Overall Study|Lost to Follow-up|0|||
19467347|NCT00633477|41730797|FG000|Overall Study|Death|1|||
19467348|NCT00633477|41730798|FG001|Overall Study|Death|0|||
19467349|NCT00633477|41730797|FG000|Overall Study|Randomized but not treated|1|||
19467350|NCT00633477|41730798|FG001|Overall Study|Randomized but not treated|0|||
19467351|NCT00331773|41730823|FG000|Overall Study|Withdrawal by Subject|6|||
19467352|NCT00331773|41730824|FG001|Overall Study|Withdrawal by Subject|4|||
19467353|NCT00331773|41730823|FG000|Overall Study|Protocol Violation|10|||
19467354|NCT00331773|41730824|FG001|Overall Study|Protocol Violation|3|||
19467355|NCT00633243|41730857|FG000|Overall Study|Withdrawal by Subject|0|||
19467356|NCT00633243|41730858|FG001|Overall Study|Withdrawal by Subject|1|||
19467357|NCT00633243|41730857|FG000|Overall Study|incarceration|0|||
19467358|NCT00633243|41730858|FG001|Overall Study|incarceration|2|||
19467359|NCT00633243|41730857|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
19467360|NCT00633243|41730858|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
19467361|NCT00633243|41730857|FG000|Overall Study|Not comfortable with self-injecting|0|||
19467362|NCT00633243|41730858|FG001|Overall Study|Not comfortable with self-injecting|1|||
19467363|NCT00633243|41730857|FG000|Overall Study|Mental Health--Depression|0|||
19467364|NCT00633243|41730858|FG001|Overall Study|Mental Health--Depression|1|||
19467365|NCT00633243|41730857|FG000|Overall Study|Couldn't tolerate side-effects|1|||
19467366|NCT00633243|41730858|FG001|Overall Study|Couldn't tolerate side-effects|1|||
19551890|NCT01324622|42000640|FG000|Overall Study|Lack of Efficacy|1|||
19551891|NCT01324622|42000641|FG001|Overall Study|Lack of Efficacy|0|||
19551892|NCT01097005|42000648|FG000|Overall Study|Case Report Form not collected|18|||
19467367|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
19467368|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
19551893|NCT01097005|42000648|FG000|Overall Study|Subjects cannot visit the hospital|1|||
19467369|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
19467370|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
19467371|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
19467372|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
19467373|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
19467374|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
19467375|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
19467376|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
19467377|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
19467378|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
19467379|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
19467380|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
19467381|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
19467382|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
19467383|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
19467384|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
19467385|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
19467386|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
19467387|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
19467388|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
19467389|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
19467390|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
19467391|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
19551894|NCT01097005|42000648|FG000|Overall Study|Poor medication compliance|1|||
19551895|NCT01097005|42000648|FG000|Overall Study|No examination data available|244|||
19551896|NCT01097005|42000648|FG000|Overall Study|Deviation from exclusion criteria|37|||
19551897|NCT01097005|42000648|FG000|Overall Study|Adverse Event|14|||
19467392|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
19467393|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
19467394|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
19467395|NCT01872689|41730868|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
19467396|NCT01872689|41730869|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
19467397|NCT01872689|41730870|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
19467398|NCT01872689|41730871|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
19467399|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
19467400|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
19467401|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
19467402|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
19467403|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
19467404|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
19467405|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
19467406|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
19467407|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
19467408|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
19551898|NCT01097005|42000648|FG000|Overall Study|Discontinuance by complication|50|||
19551899|NCT01096849|42000657|FG000|Overall Study|Consent Withdrawn|1|||
19551900|NCT01096849|42000658|FG001|Overall Study|Consent Withdrawn|4|||
19551901|NCT01096849|42000659|FG002|Overall Study|Consent Withdrawn|2|||
19551902|NCT01096849|42000657|FG000|Overall Study|Lack of Efficacy|0|||
19551903|NCT01096849|42000658|FG001|Overall Study|Lack of Efficacy|2|||
19551904|NCT01096849|42000659|FG002|Overall Study|Lack of Efficacy|0|||
19551905|NCT01096849|42000657|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
19551906|NCT01096849|42000658|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
19551907|NCT01096849|42000659|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
19551908|NCT01096849|42000657|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
19551909|NCT01096849|42000658|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
19551910|NCT01096849|42000659|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
19551911|NCT01096849|42000657|FG000|Overall Study|Administrative Reasons|0|||
19551912|NCT01096849|42000658|FG001|Overall Study|Administrative Reasons|1|||
19551913|NCT01096849|42000659|FG002|Overall Study|Administrative Reasons|2|||
19551914|NCT01096849|42000657|FG000|Overall Study|Lost to Follow-up|1|||
19551915|NCT01096849|42000658|FG001|Overall Study|Lost to Follow-up|3|||
19551916|NCT01096849|42000659|FG002|Overall Study|Lost to Follow-up|1|||
19551917|NCT01324388|42000670|FG000|Part 1 of Study|Adverse Event|2|||
19551918|NCT01324388|42000671|FG001|Part 1 of Study|Adverse Event|0|||
19551919|NCT01324388|42000672|FG002|Part 1 of Study|Adverse Event|0|||
19551920|NCT01324388|42000673|FG003|Part 1 of Study|Adverse Event|0|||
19551921|NCT01324388|42000670|FG000|Part 1 of Study|Protocol Violation|1|||
19551922|NCT01324388|42000671|FG001|Part 1 of Study|Protocol Violation|2|||
19551923|NCT01324388|42000672|FG002|Part 1 of Study|Protocol Violation|0|||
19551924|NCT01324388|42000673|FG003|Part 1 of Study|Protocol Violation|0|||
19551925|NCT01324388|42000670|FG000|Part 1 of Study|Physician Decision|1|||
19551926|NCT01324388|42000671|FG001|Part 1 of Study|Physician Decision|0|||
19551927|NCT01324388|42000672|FG002|Part 1 of Study|Physician Decision|0|||
19551928|NCT01324388|42000673|FG003|Part 1 of Study|Physician Decision|0|||
19551929|NCT01324388|42000670|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
19551930|NCT01324388|42000671|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
19551931|NCT01324388|42000672|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
19551932|NCT01324388|42000673|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
19551933|NCT01324388|42000670|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
19551934|NCT01324388|42000671|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
19551935|NCT01324388|42000672|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
19551936|NCT01324388|42000673|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
19551937|NCT01102777|42000687|FG000|Overall Study|Death|2|||
19551938|NCT01102777|42000688|FG001|Overall Study|Death|6|||
19551939|NCT01102777|42000687|FG000|Overall Study|Lost to Follow-up|7|||
19551940|NCT01102777|42000688|FG001|Overall Study|Lost to Follow-up|10|||
19551941|NCT01324310|42000695|FG000|Overall Study|Adverse Event|1|||
19739025|NCT00101686|42186091|FG007|Overall Study|Physician Decision|5|||
19467409|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
19467410|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
19467411|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
19467412|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
19467413|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
19467414|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
19467415|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
19467416|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
19467417|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
19467418|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
19467419|NCT01872689|41730868|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
19467420|NCT01872689|41730869|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
19467421|NCT01872689|41730870|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
19467422|NCT01872689|41730871|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
19467423|NCT00632931|41730884|FG000|Part 1, Period 1|Protocol Violation|1|||
19467424|NCT00632931|41730885|FG001|Part 1, Period 1|Protocol Violation|0|||
19467425|NCT00632931|41730886|FG002|Part 1, Period 1|Protocol Violation|0|||
19467426|NCT00632931|41730884|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
19467427|NCT00632931|41730885|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
19467428|NCT00632931|41730886|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
19467429|NCT00632931|41730884|FG000|Part 2|Adverse Event|0|||
19467430|NCT00632931|41730885|FG001|Part 2|Adverse Event|0|||
19467431|NCT00632931|41730886|FG002|Part 2|Adverse Event|3|||
19467432|NCT00632931|41730884|FG000|Part 2|Death|0|||
19467433|NCT00632931|41730885|FG001|Part 2|Death|0|||
19467434|NCT00632931|41730886|FG002|Part 2|Death|1|||
19467435|NCT00632931|41730884|FG000|Part 2|Lack of Efficacy|0|||
19467436|NCT00632931|41730885|FG001|Part 2|Lack of Efficacy|0|||
19467437|NCT00632931|41730886|FG002|Part 2|Lack of Efficacy|17|||
19467438|NCT00632931|41730884|FG000|Part 2|Withdrawal by Subject|0|||
19467439|NCT00632931|41730885|FG001|Part 2|Withdrawal by Subject|0|||
19467440|NCT00632931|41730886|FG002|Part 2|Withdrawal by Subject|3|||
19467441|NCT01857323|41730891|FG000|Overall Study|Adverse Event|1|||
19467442|NCT01857323|41730891|FG000|Overall Study|Withdrawal by Subject|3|||
19467443|NCT01857323|41730891|FG000|Overall Study|Non-compliance|1|||
19467444|NCT01857323|41730891|FG000|Overall Study|Protocol Violation|6|||
19467445|NCT01857323|41730891|FG000|Overall Study|Lost to Follow-up|1|||
19551942|NCT01324310|42000695|FG000|Overall Study|Disease Progression|1|||
19551943|NCT01102231|42000701|FG000|Overall Study|Protocol Violation|3|||
19739026|NCT00101686|42186092|FG008|Overall Study|Physician Decision|1|||
19739027|NCT00101686|42186093|FG009|Overall Study|Physician Decision|1|||
19467446|NCT01857323|41730891|FG000|Overall Study|Other|4|||
19467447|NCT01857323|41730891|FG000|Overall Study|Did not complete 180 doses|48|||
19467448|NCT00632541|41730895|FG000|Overall Study|Adverse Event|7|||
19467449|NCT01872611|41730901|FG000|Overall Study|Adverse Event|3|||
19467450|NCT01872611|41730902|FG001|Overall Study|Adverse Event|1|||
19467451|NCT01872611|41730901|FG000|Overall Study|Adverse Event, prior to treatment|0|||
19467452|NCT01872611|41730902|FG001|Overall Study|Adverse Event, prior to treatment|1|||
19467453|NCT01872611|41730901|FG000|Overall Study|Death|0|||
19467454|NCT01872611|41730902|FG001|Overall Study|Death|1|||
19467455|NCT01872611|41730901|FG000|Overall Study|Death, prior to treatment|0|||
19467456|NCT01872611|41730902|FG001|Overall Study|Death, prior to treatment|1|||
19467457|NCT01872611|41730901|FG000|Overall Study|Lost to Follow-up|8|||
19467458|NCT01872611|41730902|FG001|Overall Study|Lost to Follow-up|1|||
19467459|NCT01872611|41730901|FG000|Overall Study|Physician Decision|1|||
19467460|NCT01872611|41730902|FG001|Overall Study|Physician Decision|0|||
19467461|NCT01872611|41730901|FG000|Overall Study|Withdrawal by Subject|6|||
19467462|NCT01872611|41730902|FG001|Overall Study|Withdrawal by Subject|1|||
19467463|NCT01872611|41730901|FG000|Overall Study|Reason not provided|6|||
19467464|NCT01872611|41730902|FG001|Overall Study|Reason not provided|6|||
19467465|NCT03089853|41730912|FG000|Overall Study|Lost to Follow-up|2|||
19467466|NCT03089853|41730913|FG001|Overall Study|Lost to Follow-up|1|||
19467467|NCT03086967|41730921|FG000|Overall Study|Screen Failure|2|||
19467468|NCT03086967|41730922|FG001|Overall Study|Screen Failure|2|||
19467469|NCT01856543|41730930|FG000|Overall Study|Treatment discontinued|6|||
19467470|NCT01856543|41730931|FG001|Overall Study|Treatment discontinued|3|||
19467471|NCT01856543|41730930|FG000|Overall Study|Withdrawn before start|7|||
19467472|NCT01856543|41730931|FG001|Overall Study|Withdrawn before start|3|||
19467473|NCT00632463|41730941|FG000|Overall Study|Adverse Event|0|||
19467474|NCT00632463|41730942|FG001|Overall Study|Adverse Event|1|||
19467475|NCT00632463|41730943|FG002|Overall Study|Adverse Event|0|||
19467476|NCT00632229|41730953|FG000|Overall Study|Adverse Event|6|||
19467477|NCT00632229|41730954|FG001|Overall Study|Adverse Event|0|||
19467478|NCT00632229|41730953|FG000|Overall Study|Lost to Follow-up|0|||
19467479|NCT00632229|41730954|FG001|Overall Study|Lost to Follow-up|3|||
19467480|NCT00632229|41730953|FG000|Overall Study|Lack of Efficacy|0|||
19467481|NCT00632229|41730954|FG001|Overall Study|Lack of Efficacy|2|||
19467482|NCT00632229|41730953|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
19467483|NCT00632229|41730954|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
19467484|NCT00631137|41730962|FG000|Overall Study|Withdrawal by Subject|1|||
19467485|NCT00631137|41730963|FG001|Overall Study|Withdrawal by Subject|0|||
19467486|NCT03086343|41730971|FG000|Overall Study|Adverse Event|7|||
19467487|NCT03086343|41730972|FG001|Overall Study|Adverse Event|7|||
19467488|NCT03086343|41730971|FG000|Overall Study|Withdrawal by Subject|10|||
19467489|NCT03086343|41730972|FG001|Overall Study|Withdrawal by Subject|6|||
19467490|NCT03086343|41730971|FG000|Overall Study|Lost to Follow-up|3|||
19467491|NCT03086343|41730972|FG001|Overall Study|Lost to Follow-up|1|||
19467492|NCT03086343|41730971|FG000|Overall Study|Lack of Efficacy|4|||
19467493|NCT03086343|41730972|FG001|Overall Study|Lack of Efficacy|6|||
19467494|NCT03086343|41730971|FG000|Overall Study|Other, not specified|8|||
19467495|NCT03086343|41730972|FG001|Overall Study|Other, not specified|4|||
19467496|NCT03086343|41730971|FG000|Overall Study|Missing|0|||
19467497|NCT03086343|41730972|FG001|Overall Study|Missing|1|||
19467498|NCT00630825|41730991|FG000|Overall Study|Adverse Event|4|||
19467499|NCT00630825|41730992|FG001|Overall Study|Adverse Event|4|||
19467500|NCT00630825|41730993|FG002|Overall Study|Adverse Event|3|||
19467501|NCT00630825|41730994|FG003|Overall Study|Adverse Event|1|||
19467502|NCT00630825|41730991|FG000|Overall Study|Entry Criteria Not Met|1|||
19467503|NCT00630825|41730992|FG001|Overall Study|Entry Criteria Not Met|0|||
19467504|NCT00630825|41730993|FG002|Overall Study|Entry Criteria Not Met|2|||
19467505|NCT00630825|41730994|FG003|Overall Study|Entry Criteria Not Met|1|||
19467506|NCT00630825|41730991|FG000|Overall Study|Lost to Follow-up|1|||
19467507|NCT00630825|41730992|FG001|Overall Study|Lost to Follow-up|1|||
19467508|NCT00630825|41730993|FG002|Overall Study|Lost to Follow-up|1|||
19467509|NCT00630825|41730994|FG003|Overall Study|Lost to Follow-up|1|||
19467510|NCT00630825|41730991|FG000|Overall Study|Physician Decision|1|||
19467511|NCT00630825|41730992|FG001|Overall Study|Physician Decision|0|||
19467512|NCT00630825|41730993|FG002|Overall Study|Physician Decision|0|||
19467513|NCT00630825|41730994|FG003|Overall Study|Physician Decision|0|||
19467514|NCT00630825|41730991|FG000|Overall Study|Withdrawal by Subject|2|||
19467515|NCT00630825|41730992|FG001|Overall Study|Withdrawal by Subject|2|||
19467516|NCT00630825|41730993|FG002|Overall Study|Withdrawal by Subject|2|||
19467517|NCT00630825|41730994|FG003|Overall Study|Withdrawal by Subject|3|||
19467518|NCT03052608|41731269|FG000|Treatment Phase|Adverse Event|10|||
19467519|NCT03052608|41731270|FG001|Treatment Phase|Adverse Event|12|||
19467520|NCT03052608|41731269|FG000|Treatment Phase|Death|6|||
19467521|NCT03052608|41731270|FG001|Treatment Phase|Death|4|||
19467522|NCT03052608|41731269|FG000|Treatment Phase|Withdrawal by Subject|4|||
19467523|NCT03052608|41731270|FG001|Treatment Phase|Withdrawal by Subject|12|||
19467524|NCT03052608|41731269|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
19551944|NCT01102231|42000701|FG000|Overall Study|Lack of Efficacy|2|||
19551945|NCT01102231|42000701|FG000|Overall Study|Death|2|||
19551946|NCT01102231|42000701|FG000|Overall Study|Adverse Event|3|||
19551947|NCT01102231|42000701|FG000|Overall Study|Withdrawal by Subject|1|||
19551948|NCT01102231|42000701|FG000|Overall Study|Did not received the treatment|4|||
19551949|NCT01094743|42000706|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
19551950|NCT01095835|42000714|FG000|Overall Study|Adverse Event|8|||
19551951|NCT01095835|42000715|FG001|Overall Study|Adverse Event|6|||
19551952|NCT01095835|42000716|FG002|Overall Study|Adverse Event|6|||
19551953|NCT01095835|42000714|FG000|Overall Study|Lack of Efficacy|0|||
19551954|NCT01095835|42000715|FG001|Overall Study|Lack of Efficacy|1|||
19551955|NCT01095835|42000716|FG002|Overall Study|Lack of Efficacy|0|||
19551956|NCT01095835|42000714|FG000|Overall Study|Physician Decision|0|||
19467525|NCT03052608|41731270|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
19551957|NCT01095835|42000715|FG001|Overall Study|Physician Decision|0|||
19551958|NCT01095835|42000716|FG002|Overall Study|Physician Decision|1|||
19551959|NCT01095835|42000714|FG000|Overall Study|Withdrawal by Subject|1|||
19551960|NCT01095835|42000715|FG001|Overall Study|Withdrawal by Subject|3|||
19551961|NCT01095835|42000716|FG002|Overall Study|Withdrawal by Subject|0|||
19551962|NCT01095835|42000714|FG000|Overall Study|Non study compliance|0|||
19551963|NCT01095835|42000715|FG001|Overall Study|Non study compliance|0|||
19551964|NCT01095835|42000716|FG002|Overall Study|Non study compliance|1|||
19551965|NCT01095835|42000714|FG000|Overall Study|Protocol Violation|1|||
19551966|NCT01095835|42000715|FG001|Overall Study|Protocol Violation|2|||
19551967|NCT01095835|42000716|FG002|Overall Study|Protocol Violation|0|||
19551968|NCT01324232|42000729|FG000|Overall Study|Protocol Violation|0|||
19551969|NCT01324232|42000730|FG001|Overall Study|Protocol Violation|0|||
19551970|NCT01324232|42000731|FG002|Overall Study|Protocol Violation|0|||
19551971|NCT01324232|42000732|FG003|Overall Study|Protocol Violation|2|||
19467526|NCT03052608|41731269|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
19467527|NCT03052608|41731270|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
19467528|NCT03052608|41731269|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
19467529|NCT03052608|41731270|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
19467530|NCT03052608|41731269|FG000|Treatment Phase|Ongoing|103|||
19467531|NCT03052608|41731270|FG001|Treatment Phase|Ongoing|31|||
19467532|NCT03052608|41731269|FG000|Long-Term Follow-up Phase|Death|23|||
19467533|NCT03052608|41731270|FG001|Long-Term Follow-up Phase|Death|28|||
19467534|NCT03052608|41731269|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
19467535|NCT03052608|41731270|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
19467536|NCT03052608|41731269|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
19467537|NCT03052608|41731270|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
19467538|NCT03052608|41731269|FG000|Long-Term Follow-up Phase|Ongoing|122|||
19467539|NCT03052608|41731270|FG001|Long-Term Follow-up Phase|Ongoing|99|||
19467540|NCT04075734|41731309|FG000|Overall Study|Lost to Follow-up|1|||
19467541|NCT04075734|41731310|FG001|Overall Study|Lost to Follow-up|1|||
19467542|NCT04075734|41731311|FG002|Overall Study|Lost to Follow-up|0|||
19467543|NCT04075734|41731309|FG000|Overall Study|Withdrawal by Subject|3|||
19467544|NCT04075734|41731310|FG001|Overall Study|Withdrawal by Subject|0|||
19467545|NCT04075734|41731311|FG002|Overall Study|Withdrawal by Subject|0|||
19467546|NCT00989781|41731356|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
19467547|NCT00989781|41731357|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
19467548|NCT00989235|41731398|FG000|Overall Study|Death|0|||
19467549|NCT00989235|41731399|FG001|Overall Study|Death|1|||
19467550|NCT00989235|41731398|FG000|Overall Study|Adverse Event|0|||
19467551|NCT00989235|41731399|FG001|Overall Study|Adverse Event|1|||
19467552|NCT00989235|41731398|FG000|Overall Study|Lack of Efficacy|1|||
19467553|NCT00989235|41731399|FG001|Overall Study|Lack of Efficacy|0|||
19467554|NCT00989235|41731398|FG000|Overall Study|Withdrawal of Consent|1|||
19467555|NCT00989235|41731399|FG001|Overall Study|Withdrawal of Consent|1|||
19467556|NCT00989235|41731398|FG000|Overall Study|Desire to Become Pregnant|1|||
19467557|NCT00989235|41731399|FG001|Overall Study|Desire to Become Pregnant|0|||
19467558|NCT00989235|41731398|FG000|Overall Study|Randomized by Mistake|0|||
19467559|NCT00989235|41731399|FG001|Overall Study|Randomized by Mistake|2|||
19467560|NCT00989235|41731398|FG000|Overall Study|Lost to Follow-up|0|||
19467561|NCT00989235|41731399|FG001|Overall Study|Lost to Follow-up|1|||
19467562|NCT00988533|41731439|FG000|Overall Study|Lost to Follow-up|3|||
19551972|NCT01324232|42000729|FG000|Overall Study|Missing|0|||
19551973|NCT01324232|42000730|FG001|Overall Study|Missing|0|||
19551974|NCT01324232|42000731|FG002|Overall Study|Missing|1|||
19467563|NCT03633396|41731471|FG000|Overall Study|Withdrawal by Subject|4|||
19467564|NCT03633396|41731472|FG001|Overall Study|Withdrawal by Subject|4|||
19467565|NCT03633396|41731471|FG000|Overall Study|Adverse Event|1|||
19467566|NCT03633396|41731472|FG001|Overall Study|Adverse Event|1|||
19467567|NCT03633396|41731471|FG000|Overall Study|Lack of Efficacy|1|||
19467568|NCT03633396|41731472|FG001|Overall Study|Lack of Efficacy|0|||
19467569|NCT03633396|41731471|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
19551975|NCT01324232|42000732|FG003|Overall Study|Missing|0|||
19551976|NCT01324232|42000729|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
19467570|NCT03633396|41731472|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
19467571|NCT00988065|41731485|FG000|Overall Study|Adverse Event|4|||
19467572|NCT00988065|41731486|FG001|Overall Study|Adverse Event|10|||
19467573|NCT00988065|41731487|FG002|Overall Study|Adverse Event|2|||
19467574|NCT00988065|41731485|FG000|Overall Study|Lost to Follow-up|1|||
19467575|NCT00988065|41731486|FG001|Overall Study|Lost to Follow-up|2|||
19467576|NCT00988065|41731487|FG002|Overall Study|Lost to Follow-up|2|||
19467577|NCT00988065|41731485|FG000|Overall Study|Subject withdrew consent|3|||
19467578|NCT00988065|41731486|FG001|Overall Study|Subject withdrew consent|5|||
19467579|NCT00988065|41731487|FG002|Overall Study|Subject withdrew consent|2|||
19467580|NCT00988065|41731485|FG000|Overall Study|Noncompliance with protocol|5|||
19467581|NCT00988065|41731486|FG001|Overall Study|Noncompliance with protocol|6|||
19467582|NCT00988065|41731487|FG002|Overall Study|Noncompliance with protocol|9|||
19467583|NCT00987831|41731511|FG000|Overall Study|Never flared in 12 months|1|||
19467584|NCT00987831|41731512|FG001|Overall Study|Never flared in 12 months|0|||
19467585|NCT00987831|41731513|FG002|Overall Study|Never flared in 12 months|0|||
19467586|NCT00987831|41731511|FG000|Overall Study|Lost to Follow-up|0|||
19467587|NCT00987831|41731512|FG001|Overall Study|Lost to Follow-up|3|||
19467588|NCT00987831|41731513|FG002|Overall Study|Lost to Follow-up|0|||
19467589|NCT00986973|41731544|FG000|Overall Study|Withdrawn by study team|1|||
19467590|NCT00986427|41731551|FG000|Overall Study|Lost to Follow-up|2|||
19467591|NCT00986427|41731552|FG001|Overall Study|Lost to Follow-up|0|||
19467592|NCT00986427|41731551|FG000|Overall Study|Lack of Efficacy|1|||
19467593|NCT00986427|41731552|FG001|Overall Study|Lack of Efficacy|0|||
19467594|NCT00986427|41731551|FG000|Overall Study|Withdrawal by Subject|1|||
19467595|NCT00986427|41731552|FG001|Overall Study|Withdrawal by Subject|0|||
19467596|NCT00986349|41731562|FG000|Overall Study|Unsuccessful implant procedure|3|||
19467597|NCT00986349|41731562|FG000|Overall Study|Adverse Event|2|||
19551977|NCT01324232|42000730|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
19551978|NCT01324232|42000731|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
19551979|NCT01324232|42000732|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
19551980|NCT01324232|42000729|FG000|Overall Study|Lack of Efficacy|2|||
19551981|NCT01324232|42000730|FG001|Overall Study|Lack of Efficacy|1|||
19551982|NCT01324232|42000731|FG002|Overall Study|Lack of Efficacy|2|||
19551983|NCT01324232|42000732|FG003|Overall Study|Lack of Efficacy|2|||
19551984|NCT01324232|42000729|FG000|Overall Study|Participant Refused Medication|0|||
19551985|NCT01324232|42000730|FG001|Overall Study|Participant Refused Medication|1|||
19551986|NCT01324232|42000731|FG002|Overall Study|Participant Refused Medication|0|||
19551987|NCT01324232|42000732|FG003|Overall Study|Participant Refused Medication|0|||
19551988|NCT01324232|42000729|FG000|Overall Study|Intercurrent illness|0|||
19551989|NCT01324232|42000730|FG001|Overall Study|Intercurrent illness|0|||
19551990|NCT01324232|42000731|FG002|Overall Study|Intercurrent illness|0|||
19551991|NCT01324232|42000732|FG003|Overall Study|Intercurrent illness|1|||
19551992|NCT01324232|42000729|FG000|Overall Study|Adverse Event|2|||
19551993|NCT01324232|42000730|FG001|Overall Study|Adverse Event|5|||
19551994|NCT01324232|42000731|FG002|Overall Study|Adverse Event|6|||
19551995|NCT01324232|42000732|FG003|Overall Study|Adverse Event|6|||
19551996|NCT01324232|42000729|FG000|Overall Study|Withdrawal by Subject|0|||
19551997|NCT01324232|42000730|FG001|Overall Study|Withdrawal by Subject|3|||
19551998|NCT01324232|42000731|FG002|Overall Study|Withdrawal by Subject|4|||
19551999|NCT01324232|42000732|FG003|Overall Study|Withdrawal by Subject|0|||
19739028|NCT00101686|42186084|FG000|Overall Study|Other|1|||
19739029|NCT00101686|42186085|FG001|Overall Study|Other|4|||
19739030|NCT00101686|42186086|FG002|Overall Study|Other|1|||
19739031|NCT00101686|42186087|FG003|Overall Study|Other|6|||
19739032|NCT00101686|42186088|FG004|Overall Study|Other|2|||
19739033|NCT00101686|42186089|FG005|Overall Study|Other|12|||
19739034|NCT00101686|42186090|FG006|Overall Study|Other|1|||
19739035|NCT00101686|42186091|FG007|Overall Study|Other|5|||
19739036|NCT00101686|42186092|FG008|Overall Study|Other|3|||
19739037|NCT00101686|42186093|FG009|Overall Study|Other|3|||
19739038|NCT00101686|42186084|FG000|Overall Study|Withdrawal by Subject|9|||
19552000|NCT01324232|42000729|FG000|Overall Study|Lost to Follow-up|1|||
19552001|NCT01324232|42000730|FG001|Overall Study|Lost to Follow-up|0|||
19552002|NCT01324232|42000731|FG002|Overall Study|Lost to Follow-up|0|||
19552003|NCT01324232|42000732|FG003|Overall Study|Lost to Follow-up|0|||
19552004|NCT01094119|42000749|FG000|Overall Study|Lack of Efficacy|2|||
19552005|NCT01094119|42000750|FG001|Overall Study|Lack of Efficacy|4|||
19552006|NCT01323920|42000756|FG000|Overall Study|Death|5|||
19552007|NCT01323920|42000756|FG000|Overall Study|Withdrawal by Subject|1|||
19552008|NCT01093885|42000760|FG000|Overall Study|Adverse Event|4|||
19552009|NCT01093885|42000760|FG000|Overall Study|Lost to Follow-up|1|||
19552010|NCT01101997|42000765|FG000|Overall Study|Withdrawal by Subject|2|||
19552011|NCT01324830|42000790|FG000|Overall Study|Progressive Disease|3|||
19552012|NCT01324830|42000791|FG001|Overall Study|Progressive Disease|2|||
19467598|NCT00986349|41731562|FG000|Overall Study|Physician Decision|1|||
19467599|NCT00986349|41731562|FG000|Overall Study|device migration|1|||
19467600|NCT00985959|41731585|FG000|Overall Study|Adverse Event|0|||
19552013|NCT01324830|42000792|FG002|Overall Study|Progressive Disease|3|||
19552014|NCT01324830|42000793|FG003|Overall Study|Progressive Disease|3|||
19552015|NCT01324830|42000794|FG004|Overall Study|Progressive Disease|6|||
19552016|NCT01324830|42000795|FG005|Overall Study|Progressive Disease|6|||
19552017|NCT01324830|42000796|FG006|Overall Study|Progressive Disease|3|||
19552018|NCT01324830|42000797|FG007|Overall Study|Progressive Disease|3|||
19552019|NCT01324830|42000798|FG008|Overall Study|Progressive Disease|3|||
19552020|NCT01324830|42000799|FG009|Overall Study|Progressive Disease|6|||
19552021|NCT01324830|42000800|FG010|Overall Study|Progressive Disease|2|||
19552022|NCT01324830|42000801|FG011|Overall Study|Progressive Disease|1|||
19552023|NCT01324830|42000802|FG012|Overall Study|Progressive Disease|1|||
19552024|NCT01324830|42000803|FG013|Overall Study|Progressive Disease|1|||
19552025|NCT01324830|42000804|FG014|Overall Study|Progressive Disease|1|||
19552026|NCT01324830|42000805|FG015|Overall Study|Progressive Disease|3|||
19552027|NCT01324830|42000806|FG016|Overall Study|Progressive Disease|2|||
19552028|NCT01324830|42000807|FG017|Overall Study|Progressive Disease|3|||
19552029|NCT01324830|42000808|FG018|Overall Study|Progressive Disease|4|||
19552030|NCT01324830|42000790|FG000|Overall Study|Dose limiting toxicity|0|||
19552031|NCT01324830|42000791|FG001|Overall Study|Dose limiting toxicity|0|||
19552032|NCT01324830|42000792|FG002|Overall Study|Dose limiting toxicity|0|||
19552033|NCT01324830|42000793|FG003|Overall Study|Dose limiting toxicity|0|||
19552034|NCT01324830|42000794|FG004|Overall Study|Dose limiting toxicity|1|||
19552035|NCT01324830|42000795|FG005|Overall Study|Dose limiting toxicity|0|||
19552036|NCT01324830|42000796|FG006|Overall Study|Dose limiting toxicity|0|||
19552037|NCT01324830|42000797|FG007|Overall Study|Dose limiting toxicity|0|||
19552038|NCT01324830|42000798|FG008|Overall Study|Dose limiting toxicity|0|||
19552039|NCT01324830|42000799|FG009|Overall Study|Dose limiting toxicity|0|||
19552040|NCT01324830|42000800|FG010|Overall Study|Dose limiting toxicity|0|||
19552041|NCT01324830|42000801|FG011|Overall Study|Dose limiting toxicity|0|||
19552042|NCT01324830|42000802|FG012|Overall Study|Dose limiting toxicity|0|||
19552043|NCT01324830|42000803|FG013|Overall Study|Dose limiting toxicity|0|||
19552044|NCT01324830|42000804|FG014|Overall Study|Dose limiting toxicity|0|||
19552045|NCT01324830|42000805|FG015|Overall Study|Dose limiting toxicity|0|||
19552046|NCT01324830|42000806|FG016|Overall Study|Dose limiting toxicity|1|||
19552047|NCT01324830|42000807|FG017|Overall Study|Dose limiting toxicity|1|||
19552048|NCT01324830|42000808|FG018|Overall Study|Dose limiting toxicity|1|||
19552049|NCT01324830|42000790|FG000|Overall Study|Reason not mentioned above|0|||
19552050|NCT01324830|42000791|FG001|Overall Study|Reason not mentioned above|0|||
19552051|NCT01324830|42000792|FG002|Overall Study|Reason not mentioned above|0|||
19552052|NCT01324830|42000793|FG003|Overall Study|Reason not mentioned above|0|||
19552053|NCT01324830|42000794|FG004|Overall Study|Reason not mentioned above|0|||
19552054|NCT01324830|42000795|FG005|Overall Study|Reason not mentioned above|0|||
19552055|NCT01324830|42000796|FG006|Overall Study|Reason not mentioned above|0|||
19552056|NCT01324830|42000797|FG007|Overall Study|Reason not mentioned above|0|||
19552057|NCT01324830|42000798|FG008|Overall Study|Reason not mentioned above|0|||
19552058|NCT01324830|42000799|FG009|Overall Study|Reason not mentioned above|0|||
19552059|NCT01324830|42000800|FG010|Overall Study|Reason not mentioned above|0|||
19552060|NCT01324830|42000801|FG011|Overall Study|Reason not mentioned above|0|||
19552061|NCT01324830|42000802|FG012|Overall Study|Reason not mentioned above|0|||
19552062|NCT01324830|42000803|FG013|Overall Study|Reason not mentioned above|0|||
19552063|NCT01324830|42000804|FG014|Overall Study|Reason not mentioned above|0|||
19552064|NCT01324830|42000805|FG015|Overall Study|Reason not mentioned above|0|||
19552065|NCT01324830|42000806|FG016|Overall Study|Reason not mentioned above|0|||
19552066|NCT01324830|42000807|FG017|Overall Study|Reason not mentioned above|1|||
19552067|NCT01324830|42000808|FG018|Overall Study|Reason not mentioned above|0|||
19552068|NCT01324830|42000790|FG000|Overall Study|Adverse Event, serious fatal|0|||
19552069|NCT01324830|42000791|FG001|Overall Study|Adverse Event, serious fatal|1|||
19467601|NCT00985959|41731586|FG001|Overall Study|Adverse Event|0|||
19467602|NCT00985959|41731587|FG002|Overall Study|Adverse Event|19|||
19467603|NCT00985959|41731585|FG000|Overall Study|Withdrawal by Subject|0|||
19467604|NCT00985959|41731586|FG001|Overall Study|Withdrawal by Subject|0|||
19467605|NCT00985959|41731587|FG002|Overall Study|Withdrawal by Subject|8|||
19467606|NCT00985959|41731585|FG000|Overall Study|Progressive disease|1|||
19467607|NCT00985959|41731586|FG001|Overall Study|Progressive disease|2|||
19467608|NCT00985959|41731587|FG002|Overall Study|Progressive disease|8|||
19552070|NCT01324830|42000792|FG002|Overall Study|Adverse Event, serious fatal|0|||
19552071|NCT01324830|42000793|FG003|Overall Study|Adverse Event, serious fatal|0|||
19467609|NCT00985959|41731585|FG000|Overall Study|Unrecovered toxicity|0|||
19552072|NCT01324830|42000794|FG004|Overall Study|Adverse Event, serious fatal|0|||
19552073|NCT01324830|42000795|FG005|Overall Study|Adverse Event, serious fatal|0|||
19552074|NCT01324830|42000796|FG006|Overall Study|Adverse Event, serious fatal|0|||
19552075|NCT01324830|42000797|FG007|Overall Study|Adverse Event, serious fatal|0|||
19552076|NCT01324830|42000798|FG008|Overall Study|Adverse Event, serious fatal|0|||
19552077|NCT01324830|42000799|FG009|Overall Study|Adverse Event, serious fatal|0|||
19552078|NCT01324830|42000800|FG010|Overall Study|Adverse Event, serious fatal|0|||
19552079|NCT01324830|42000801|FG011|Overall Study|Adverse Event, serious fatal|0|||
19467610|NCT00985959|41731586|FG001|Overall Study|Unrecovered toxicity|0|||
19467611|NCT00985959|41731587|FG002|Overall Study|Unrecovered toxicity|7|||
19467612|NCT00985959|41731585|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
19467613|NCT00985959|41731586|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
19467614|NCT00985959|41731587|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
19467615|NCT00985959|41731585|FG000|Overall Study|Complete response observed over 2 cycles|0|||
19467616|NCT00985959|41731586|FG001|Overall Study|Complete response observed over 2 cycles|1|||
19467617|NCT00985959|41731587|FG002|Overall Study|Complete response observed over 2 cycles|4|||
19467618|NCT00985959|41731585|FG000|Overall Study|Other|0|||
19467619|NCT00985959|41731586|FG001|Overall Study|Other|0|||
19467620|NCT00985959|41731587|FG002|Overall Study|Other|11|||
19467621|NCT00985725|41731603|FG000|Overall Study|Adverse Event|4|||
19467622|NCT00985725|41731604|FG001|Overall Study|Adverse Event|1|||
19467623|NCT00985725|41731603|FG000|Overall Study|Protocol Violation|1|||
19467624|NCT00985725|41731604|FG001|Overall Study|Protocol Violation|3|||
19467625|NCT00985725|41731603|FG000|Overall Study|Withdrawal by Subject|4|||
19467626|NCT00985725|41731604|FG001|Overall Study|Withdrawal by Subject|4|||
19467627|NCT00985725|41731603|FG000|Overall Study|Lost to Follow-up|1|||
19467628|NCT00985725|41731604|FG001|Overall Study|Lost to Follow-up|1|||
19467629|NCT00985725|41731603|FG000|Overall Study|Lack of Efficacy|0|||
19467630|NCT00985725|41731604|FG001|Overall Study|Lack of Efficacy|1|||
19467631|NCT00985725|41731603|FG000|Overall Study|Non-compliance|1|||
19467632|NCT00985725|41731604|FG001|Overall Study|Non-compliance|2|||
19467633|NCT00985725|41731603|FG000|Overall Study|Out-of-window visits|0|||
19467634|NCT00985725|41731604|FG001|Overall Study|Out-of-window visits|1|||
19467635|NCT00985491|41731619|FG000|Overall Study|Adverse Event|8|||
19467636|NCT00985491|41731619|FG000|Overall Study|device migration|7|||
19467637|NCT00985491|41731619|FG000|Overall Study|Withdrawal by Subject|1|||
19467638|NCT00985491|41731619|FG000|Overall Study|implant failure|3|||
19467639|NCT00984867|41731654|FG000|Overall Study|Adverse Event|3|||
19467640|NCT00984867|41731655|FG001|Overall Study|Adverse Event|7|||
19467641|NCT00984867|41731654|FG000|Overall Study|Death|1|||
19467642|NCT00984867|41731655|FG001|Overall Study|Death|0|||
19467643|NCT00984867|41731654|FG000|Overall Study|Withdrawal by Subject|13|||
19467644|NCT00984867|41731655|FG001|Overall Study|Withdrawal by Subject|4|||
19467645|NCT00984867|41731654|FG000|Overall Study|Lost to Follow-up|3|||
19467646|NCT00984867|41731655|FG001|Overall Study|Lost to Follow-up|4|||
19467647|NCT00984867|41731654|FG000|Overall Study|Poor/non-compliance|0|||
19467648|NCT00984867|41731655|FG001|Overall Study|Poor/non-compliance|1|||
19467649|NCT00984867|41731654|FG000|Overall Study|Subject no longer meets study criteria|1|||
19467650|NCT00984867|41731655|FG001|Overall Study|Subject no longer meets study criteria|1|||
19467651|NCT00984867|41731654|FG000|Overall Study|site closing|1|||
19467652|NCT00984867|41731655|FG001|Overall Study|site closing|0|||
19467653|NCT00984867|41731654|FG000|Overall Study|lack of efficacy and subject compliance|1|||
19467654|NCT00984867|41731655|FG001|Overall Study|lack of efficacy and subject compliance|0|||
19467655|NCT00984009|41731695|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
19467656|NCT00983931|41731702|FG000|14 Day Washout Period|Physician Decision|1|||
19467657|NCT00983853|41731714|FG000|Overall Study|Lost to Follow-up|1|||
19467658|NCT00983853|41731715|FG001|Overall Study|Lost to Follow-up|1|||
19467659|NCT00983853|41731716|FG002|Overall Study|Lost to Follow-up|2|||
19467660|NCT00983853|41731717|FG003|Overall Study|Lost to Follow-up|2|||
19467661|NCT00983853|41731718|FG004|Overall Study|Lost to Follow-up|2|||
19467662|NCT00983853|41731719|FG005|Overall Study|Lost to Follow-up|1|||
19467663|NCT00983853|41731714|FG000|Overall Study|Withdrawal by Subject|0|||
19467664|NCT00983853|41731715|FG001|Overall Study|Withdrawal by Subject|0|||
19467665|NCT00983853|41731716|FG002|Overall Study|Withdrawal by Subject|1|||
19467666|NCT00983853|41731717|FG003|Overall Study|Withdrawal by Subject|0|||
19467667|NCT00983853|41731718|FG004|Overall Study|Withdrawal by Subject|1|||
19467668|NCT00983853|41731719|FG005|Overall Study|Withdrawal by Subject|0|||
19467669|NCT00983853|41731714|FG000|Overall Study|Unable to come to study follow-up visits|0|||
19467670|NCT00983853|41731715|FG001|Overall Study|Unable to come to study follow-up visits|1|||
19467671|NCT00983853|41731716|FG002|Overall Study|Unable to come to study follow-up visits|0|||
19467672|NCT00983853|41731717|FG003|Overall Study|Unable to come to study follow-up visits|0|||
19467673|NCT00983853|41731718|FG004|Overall Study|Unable to come to study follow-up visits|0|||
19467674|NCT00983853|41731719|FG005|Overall Study|Unable to come to study follow-up visits|0|||
19467675|NCT00983073|41731735|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
19467676|NCT00983073|41731735|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
19467677|NCT00983073|41731735|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
19467678|NCT00983073|41731735|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
19467679|NCT00983073|41731735|FG000|Titration and Optimal Dose Period|Other reason|4|||
19467680|NCT00983073|41731735|FG000|Maintenance Period|Adverse Event|5|||
19467681|NCT00983073|41731735|FG000|Maintenance Period|Withdrawal by Subject|2|||
19467682|NCT00983073|41731735|FG000|Maintenance Period|Lack of Efficacy|2|||
19467683|NCT00983073|41731735|FG000|Maintenance Period|Other Reason|7|||
19467684|NCT00982137|41731744|FG000|Overall Study|Lost to Follow-up|0|||
19552080|NCT01324830|42000802|FG012|Overall Study|Adverse Event, serious fatal|0|||
19467685|NCT00982137|41731745|FG001|Overall Study|Lost to Follow-up|0|||
19467686|NCT00982137|41731746|FG002|Overall Study|Lost to Follow-up|0|||
19467687|NCT00982137|41731747|FG003|Overall Study|Lost to Follow-up|1|||
19467688|NCT00982137|41731744|FG000|Overall Study|Withdrawal by Subject|0|||
19552081|NCT01324830|42000803|FG013|Overall Study|Adverse Event, serious fatal|0|||
19552082|NCT01324830|42000804|FG014|Overall Study|Adverse Event, serious fatal|0|||
19552083|NCT01324830|42000805|FG015|Overall Study|Adverse Event, serious fatal|0|||
19552084|NCT01324830|42000806|FG016|Overall Study|Adverse Event, serious fatal|0|||
19552085|NCT01324830|42000807|FG017|Overall Study|Adverse Event, serious fatal|0|||
19552086|NCT01324830|42000808|FG018|Overall Study|Adverse Event, serious fatal|0|||
19467689|NCT00982137|41731745|FG001|Overall Study|Withdrawal by Subject|1|||
19467690|NCT00982137|41731746|FG002|Overall Study|Withdrawal by Subject|0|||
19467691|NCT00982137|41731747|FG003|Overall Study|Withdrawal by Subject|0|||
19467692|NCT00981747|41731764|FG000|Losartan|Withdrawal by Subject|1|||
19467693|NCT00981747|41731764|FG000|Losartan|Death|1|||
19467694|NCT00981747|41731764|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
19467695|NCT01856309|41731919|FG000|Overall Study|Death|4|||
19467696|NCT01856309|41731920|FG001|Overall Study|Death|6|||
19467697|NCT01856309|41731921|FG002|Overall Study|Death|11|||
19467698|NCT01856309|41731922|FG003|Overall Study|Death|6|||
19467699|NCT01856309|41731919|FG000|Overall Study|Lost to Follow-up|6|||
19467700|NCT01856309|41731920|FG001|Overall Study|Lost to Follow-up|2|||
19467701|NCT01856309|41731921|FG002|Overall Study|Lost to Follow-up|4|||
19467702|NCT01856309|41731922|FG003|Overall Study|Lost to Follow-up|8|||
19467703|NCT01856309|41731919|FG000|Overall Study|Withdrawal by Subject|11|||
19467704|NCT01856309|41731920|FG001|Overall Study|Withdrawal by Subject|13|||
19467705|NCT01856309|41731921|FG002|Overall Study|Withdrawal by Subject|28|||
19467706|NCT01856309|41731922|FG003|Overall Study|Withdrawal by Subject|26|||
19467707|NCT01856309|41731919|FG000|Overall Study|Other|227|||
19467708|NCT01856309|41731920|FG001|Overall Study|Other|225|||
19467709|NCT01856309|41731921|FG002|Overall Study|Other|447|||
19467710|NCT01856309|41731922|FG003|Overall Study|Other|469|||
19467711|NCT01856309|41731919|FG000|Overall Study|Lack of Efficacy|14|||
19467712|NCT01856309|41731920|FG001|Overall Study|Lack of Efficacy|9|||
19467713|NCT01856309|41731921|FG002|Overall Study|Lack of Efficacy|40|||
19467714|NCT01856309|41731922|FG003|Overall Study|Lack of Efficacy|25|||
19467715|NCT01856309|41731919|FG000|Overall Study|Adverse Event|31|||
19467716|NCT01856309|41731920|FG001|Overall Study|Adverse Event|31|||
19467717|NCT01856309|41731921|FG002|Overall Study|Adverse Event|55|||
19467718|NCT01856309|41731922|FG003|Overall Study|Adverse Event|65|||
19467719|NCT01856309|41731919|FG000|Overall Study|Pregnancy|0|||
19467720|NCT01856309|41731920|FG001|Overall Study|Pregnancy|0|||
19467721|NCT01856309|41731921|FG002|Overall Study|Pregnancy|0|||
19467722|NCT01856309|41731922|FG003|Overall Study|Pregnancy|1|||
19467723|NCT01856309|41731919|FG000|Overall Study|Physician Decision|6|||
19552087|NCT01324830|42000790|FG000|Overall Study|Adverse Event, non-fatal|0|||
19552088|NCT01324830|42000791|FG001|Overall Study|Adverse Event, non-fatal|0|||
19552089|NCT01324830|42000792|FG002|Overall Study|Adverse Event, non-fatal|0|||
19552090|NCT01324830|42000793|FG003|Overall Study|Adverse Event, non-fatal|0|||
19552091|NCT01324830|42000794|FG004|Overall Study|Adverse Event, non-fatal|0|||
19552092|NCT01324830|42000795|FG005|Overall Study|Adverse Event, non-fatal|0|||
19552093|NCT01324830|42000796|FG006|Overall Study|Adverse Event, non-fatal|0|||
19552094|NCT01324830|42000797|FG007|Overall Study|Adverse Event, non-fatal|0|||
19552095|NCT01324830|42000798|FG008|Overall Study|Adverse Event, non-fatal|2|||
19552096|NCT01324830|42000799|FG009|Overall Study|Adverse Event, non-fatal|0|||
19552097|NCT01324830|42000800|FG010|Overall Study|Adverse Event, non-fatal|1|||
19552098|NCT01324830|42000801|FG011|Overall Study|Adverse Event, non-fatal|0|||
19552099|NCT01324830|42000802|FG012|Overall Study|Adverse Event, non-fatal|0|||
19552100|NCT01324830|42000803|FG013|Overall Study|Adverse Event, non-fatal|0|||
19552101|NCT01324830|42000804|FG014|Overall Study|Adverse Event, non-fatal|0|||
19552102|NCT01324830|42000805|FG015|Overall Study|Adverse Event, non-fatal|0|||
19552103|NCT01324830|42000806|FG016|Overall Study|Adverse Event, non-fatal|0|||
19552104|NCT01324830|42000807|FG017|Overall Study|Adverse Event, non-fatal|1|||
19552105|NCT01324830|42000808|FG018|Overall Study|Adverse Event, non-fatal|0|||
19467724|NCT01856309|41731920|FG001|Overall Study|Physician Decision|1|||
19467725|NCT01856309|41731921|FG002|Overall Study|Physician Decision|6|||
19467726|NCT01856309|41731922|FG003|Overall Study|Physician Decision|8|||
19467727|NCT01856309|41731919|FG000|Overall Study|Noncompliance With Study Drug|0|||
19467728|NCT01856309|41731920|FG001|Overall Study|Noncompliance With Study Drug|1|||
19467729|NCT01856309|41731921|FG002|Overall Study|Noncompliance With Study Drug|4|||
19552106|NCT01324830|42000790|FG000|Overall Study|Withdrawal by Subject|0|||
19552107|NCT01324830|42000791|FG001|Overall Study|Withdrawal by Subject|0|||
19552108|NCT01324830|42000792|FG002|Overall Study|Withdrawal by Subject|0|||
19552109|NCT01324830|42000793|FG003|Overall Study|Withdrawal by Subject|0|||
19467730|NCT01856309|41731922|FG003|Overall Study|Noncompliance With Study Drug|1|||
19467731|NCT01855919|41732120|FG000|Overall Study|Adverse Event|16|||
19552110|NCT01324830|42000794|FG004|Overall Study|Withdrawal by Subject|0|||
19467732|NCT01855919|41732121|FG001|Overall Study|Adverse Event|8|||
19467733|NCT01855919|41732120|FG000|Overall Study|Lack of Efficacy|1|||
19467734|NCT01855919|41732121|FG001|Overall Study|Lack of Efficacy|3|||
19467735|NCT01855919|41732120|FG000|Overall Study|Withdrawal by Subject|4|||
19467736|NCT01855919|41732121|FG001|Overall Study|Withdrawal by Subject|10|||
19467737|NCT01855919|41732120|FG000|Overall Study|Entry Criteria Not Met|1|||
19552111|NCT01324830|42000795|FG005|Overall Study|Withdrawal by Subject|1|||
19467738|NCT01855919|41732121|FG001|Overall Study|Entry Criteria Not Met|1|||
19467739|NCT01855919|41732120|FG000|Overall Study|Protocol Violation|1|||
19467740|NCT01855919|41732121|FG001|Overall Study|Protocol Violation|4|||
19467741|NCT01871519|41732137|FG000|Overall Study|Death|26|||
19467742|NCT01871519|41732137|FG000|Overall Study|Lost to Follow-up|15|||
19467743|NCT01871519|41732137|FG000|Overall Study|Withdrawal by Subject|49|||
19467744|NCT01871285|41732144|FG000|First Intervention (1 Day)|Adverse Event|1|||
19467745|NCT01871285|41732145|FG001|First Intervention (1 Day)|Adverse Event|0|||
19467746|NCT01871285|41732146|FG002|First Intervention (1 Day)|Adverse Event|0|||
19467747|NCT01871285|41732147|FG003|First Intervention (1 Day)|Adverse Event|0|||
19467748|NCT01871285|41732144|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
19467749|NCT01871285|41732145|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
19467750|NCT01871285|41732146|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
19467751|NCT01871285|41732147|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
19467752|NCT01870973|41732173|FG000|Overall Study|Lost to Follow-up|10|||
19467753|NCT01870973|41732174|FG001|Overall Study|Lost to Follow-up|3|||
19467754|NCT01854827|41732193|FG000|Overall Study|Death|1|||
19467755|NCT01854047|41732336|FG000|Overall Study|Lack of Efficacy|1|||
19467756|NCT01854047|41732337|FG001|Overall Study|Lack of Efficacy|0|||
19467757|NCT01854047|41732338|FG002|Overall Study|Lack of Efficacy|0|||
19467758|NCT01854047|41732339|FG003|Overall Study|Lack of Efficacy|0|||
19552112|NCT01324830|42000796|FG006|Overall Study|Withdrawal by Subject|0|||
19552113|NCT01324830|42000797|FG007|Overall Study|Withdrawal by Subject|0|||
19552114|NCT01324830|42000798|FG008|Overall Study|Withdrawal by Subject|0|||
19552115|NCT01324830|42000799|FG009|Overall Study|Withdrawal by Subject|0|||
19552116|NCT01324830|42000800|FG010|Overall Study|Withdrawal by Subject|1|||
19552117|NCT01324830|42000801|FG011|Overall Study|Withdrawal by Subject|0|||
19552118|NCT01324830|42000802|FG012|Overall Study|Withdrawal by Subject|0|||
19552119|NCT01324830|42000803|FG013|Overall Study|Withdrawal by Subject|0|||
19467759|NCT01854047|41732340|FG004|Overall Study|Lack of Efficacy|0|||
19467760|NCT01854047|41732336|FG000|Overall Study|Poor compliance to protocol|3|||
19467761|NCT01854047|41732337|FG001|Overall Study|Poor compliance to protocol|0|||
19467762|NCT01854047|41732338|FG002|Overall Study|Poor compliance to protocol|2|||
19467763|NCT01854047|41732339|FG003|Overall Study|Poor compliance to protocol|0|||
19552120|NCT01324830|42000804|FG014|Overall Study|Withdrawal by Subject|0|||
19552121|NCT01324830|42000805|FG015|Overall Study|Withdrawal by Subject|0|||
19467764|NCT01854047|41732340|FG004|Overall Study|Poor compliance to protocol|0|||
19467765|NCT01854047|41732336|FG000|Overall Study|Adverse Event|5|||
19467766|NCT01854047|41732337|FG001|Overall Study|Adverse Event|4|||
19552122|NCT01324830|42000806|FG016|Overall Study|Withdrawal by Subject|0|||
19467767|NCT01854047|41732338|FG002|Overall Study|Adverse Event|6|||
19467768|NCT01854047|41732339|FG003|Overall Study|Adverse Event|10|||
19467769|NCT01854047|41732340|FG004|Overall Study|Adverse Event|7|||
19467770|NCT01854047|41732336|FG000|Overall Study|Randomized but not treated|0|||
19467771|NCT01854047|41732337|FG001|Overall Study|Randomized but not treated|1|||
19467772|NCT01854047|41732338|FG002|Overall Study|Randomized but not treated|2|||
19467773|NCT01854047|41732339|FG003|Overall Study|Randomized but not treated|0|||
19467774|NCT01854047|41732340|FG004|Overall Study|Randomized but not treated|4|||
19467775|NCT01854047|41732336|FG000|Overall Study|Other than specified above|3|||
19467776|NCT01854047|41732337|FG001|Overall Study|Other than specified above|3|||
19467777|NCT01854047|41732338|FG002|Overall Study|Other than specified above|3|||
19467778|NCT01854047|41732339|FG003|Overall Study|Other than specified above|5|||
19467779|NCT01854047|41732340|FG004|Overall Study|Other than specified above|8|||
19467780|NCT01870739|41732390|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
19467781|NCT01870739|41732391|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
19467782|NCT01870739|41732390|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
19467783|NCT01870739|41732391|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
19467784|NCT01870739|41732390|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
19467785|NCT01870739|41732391|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
19467786|NCT01870739|41732390|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
19467787|NCT01870739|41732391|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
19467788|NCT01870739|41732390|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
19467789|NCT01870739|41732391|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
19467790|NCT01870739|41732390|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
19467791|NCT01870739|41732391|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
19467792|NCT01870739|41732390|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
19467793|NCT01870739|41732391|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
19467794|NCT01613417|41732429|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
19467795|NCT01613417|41732430|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
19467796|NCT01870583|41732458|FG000|Overall Study|Protocol Violation|0|||
19552123|NCT01324830|42000807|FG017|Overall Study|Withdrawal by Subject|0|||
19552124|NCT01324830|42000808|FG018|Overall Study|Withdrawal by Subject|1|||
19552125|NCT01324440|42000856|FG000|Overall Study|Subject moved|0|||
19552126|NCT01324440|42000857|FG001|Overall Study|Subject moved|1|||
19552127|NCT01325493|42000865|FG000|Overall Study|Protocol Violation|0|||
19552128|NCT01325493|42000866|FG001|Overall Study|Protocol Violation|1|||
19467797|NCT01870583|41732459|FG001|Overall Study|Protocol Violation|5|||
19467798|NCT01870583|41732460|FG002|Overall Study|Protocol Violation|3|||
19552129|NCT01325493|42000865|FG000|Overall Study|loss of neuromonitoring signals|0|||
19552130|NCT01325493|42000866|FG001|Overall Study|loss of neuromonitoring signals|2|||
19467799|NCT01870583|41732458|FG000|Overall Study|Lost to Follow-up|11|||
19467800|NCT01870583|41732459|FG001|Overall Study|Lost to Follow-up|13|||
19467801|NCT01870583|41732460|FG002|Overall Study|Lost to Follow-up|5|||
19467802|NCT01869959|41732518|FG000|Randomization Period|Physician Decision|0|||
19467803|NCT01869959|41732519|FG001|Randomization Period|Physician Decision|0|||
19467804|NCT01869959|41732520|FG002|Randomization Period|Physician Decision|0|||
19467805|NCT01869959|41732521|FG003|Randomization Period|Physician Decision|0|||
19467806|NCT01869959|41732522|FG004|Randomization Period|Physician Decision|1|||
19467807|NCT01869959|41732518|FG000|Treatment Period|Adverse Event|1|||
19467808|NCT01869959|41732519|FG001|Treatment Period|Adverse Event|0|||
19467809|NCT01869959|41732520|FG002|Treatment Period|Adverse Event|3|||
19467810|NCT01869959|41732521|FG003|Treatment Period|Adverse Event|1|||
19467811|NCT01869959|41732522|FG004|Treatment Period|Adverse Event|0|||
19467812|NCT01869959|41732518|FG000|Treatment Period|Sponsor decision|0|||
19467813|NCT01869959|41732519|FG001|Treatment Period|Sponsor decision|1|||
19467814|NCT01869959|41732520|FG002|Treatment Period|Sponsor decision|0|||
19467815|NCT01869959|41732521|FG003|Treatment Period|Sponsor decision|1|||
19467816|NCT01869959|41732522|FG004|Treatment Period|Sponsor decision|0|||
19467817|NCT01869959|41732518|FG000|Treatment Period|Withdrawal by Subject|0|||
19467818|NCT01869959|41732519|FG001|Treatment Period|Withdrawal by Subject|1|||
19467819|NCT01869959|41732520|FG002|Treatment Period|Withdrawal by Subject|0|||
19467820|NCT01869959|41732521|FG003|Treatment Period|Withdrawal by Subject|0|||
19467821|NCT01869959|41732522|FG004|Treatment Period|Withdrawal by Subject|0|||
19467822|NCT01613027|41732583|FG000|Overall Study|Lost to Follow-up|5|||
19467823|NCT01613027|41732583|FG000|Overall Study|Switched Physician|1|||
19467824|NCT01613027|41732583|FG000|Overall Study|Lack of Efficacy|1|||
19467825|NCT01613027|41732583|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
19552131|NCT01325493|42000865|FG000|Overall Study|Allergy|1|||
19552132|NCT01325493|42000866|FG001|Overall Study|Allergy|0|||
19552133|NCT01323972|42000876|FG000|Overall Study|Withdrawal by Subject|1|||
19467826|NCT01869725|41732601|FG000|Overall Study|ineligible after registration|1|||
19467827|NCT01869725|41732601|FG000|Overall Study|Death|1|||
19467828|NCT01869725|41732601|FG000|Overall Study|Lost to Follow-up|2|||
19467829|NCT01851863|41732622|FG000|Overall Study|Did not receive study medication|2|||
19467830|NCT01851863|41732623|FG001|Overall Study|Did not receive study medication|5|||
19467831|NCT01851863|41732624|FG002|Overall Study|Did not receive study medication|3|||
19467832|NCT01851863|41732625|FG003|Overall Study|Did not receive study medication|0|||
19467833|NCT01851863|41732622|FG000|Overall Study|Lost to Follow-up|3|||
19467834|NCT01851863|41732623|FG001|Overall Study|Lost to Follow-up|4|||
19467835|NCT01851863|41732624|FG002|Overall Study|Lost to Follow-up|2|||
19467836|NCT01851863|41732625|FG003|Overall Study|Lost to Follow-up|3|||
19467837|NCT01850615|41732653|FG000|Overall Study|Protocol Violation|4|||
19467838|NCT01850615|41732654|FG001|Overall Study|Protocol Violation|1|||
19467839|NCT01850615|41732653|FG000|Overall Study|Adverse Event|2|||
19467840|NCT01850615|41732654|FG001|Overall Study|Adverse Event|1|||
19467841|NCT01850615|41732653|FG000|Overall Study|Withdrawal by Subject|3|||
19467842|NCT01850615|41732654|FG001|Overall Study|Withdrawal by Subject|1|||
19467843|NCT01850615|41732653|FG000|Overall Study|Lost to Follow-up|0|||
19467844|NCT01850615|41732654|FG001|Overall Study|Lost to Follow-up|1|||
19467845|NCT01850615|41732653|FG000|Overall Study|Unclassified|0|||
19467846|NCT01850615|41732654|FG001|Overall Study|Unclassified|1|||
19467847|NCT01868477|41732739|FG000|Overall Study|Adverse Event|2|||
19467848|NCT01868477|41732740|FG001|Overall Study|Adverse Event|4|||
19467849|NCT01868477|41732739|FG000|Overall Study|Disease progression|1|||
19467850|NCT01868477|41732740|FG001|Overall Study|Disease progression|1|||
19467851|NCT01868477|41732739|FG000|Overall Study|Withdrawal by Subject|1|||
19467852|NCT01868477|41732740|FG001|Overall Study|Withdrawal by Subject|0|||
19467853|NCT01849289|41732755|FG000|Overall Study|Adverse Event|3|||
19467854|NCT01849289|41732756|FG001|Overall Study|Adverse Event|3|||
19467855|NCT01849289|41732755|FG000|Overall Study|Protocol Violation|3|||
19467856|NCT01849289|41732756|FG001|Overall Study|Protocol Violation|3|||
19467857|NCT01849289|41732755|FG000|Overall Study|Withdrawal criteria|1|||
19467858|NCT01849289|41732756|FG001|Overall Study|Withdrawal criteria|0|||
19467859|NCT01849289|41732755|FG000|Overall Study|Unclassified|25|||
19467860|NCT01849289|41732756|FG001|Overall Study|Unclassified|18|||
19467861|NCT01868243|41732764|FG000|Overall Study|Death|0|||
19467862|NCT01868243|41732765|FG001|Overall Study|Death|1|||
19467863|NCT01611935|41732773|FG000|Overall Study|Family Declined Participation|1|||
19467864|NCT01611935|41732774|FG001|Overall Study|Family Declined Participation|0|||
19467865|NCT01868165|41732780|FG000|Overall Study|Withdrawal by Subject|36|||
19467866|NCT01868165|41732780|FG000|Overall Study|Physician Decision|2|||
19467867|NCT01868165|41732780|FG000|Overall Study|Lost to Follow-up|3|||
19467868|NCT01868165|41732780|FG000|Overall Study|Death|4|||
19467869|NCT01868009|41732819|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
19467870|NCT01868009|41732820|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
19467871|NCT01868009|41732819|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
19467872|NCT01868009|41732820|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
19552134|NCT01323972|42000877|FG001|Overall Study|Withdrawal by Subject|0|||
19552135|NCT01323972|42000878|FG002|Overall Study|Withdrawal by Subject|1|||
19552136|NCT01323972|42000879|FG003|Overall Study|Withdrawal by Subject|0|||
19552137|NCT01323972|42000876|FG000|Overall Study|Migrated/moved from study area|1|||
19552138|NCT01323972|42000877|FG001|Overall Study|Migrated/moved from study area|2|||
19552139|NCT01323972|42000878|FG002|Overall Study|Migrated/moved from study area|0|||
19552140|NCT01323972|42000879|FG003|Overall Study|Migrated/moved from study area|0|||
19552141|NCT01323972|42000876|FG000|Overall Study|Lost to Follow-up|0|||
19552142|NCT01323972|42000877|FG001|Overall Study|Lost to Follow-up|1|||
19552143|NCT01323972|42000878|FG002|Overall Study|Lost to Follow-up|1|||
19552144|NCT01323972|42000879|FG003|Overall Study|Lost to Follow-up|1|||
19552145|NCT01325337|42000896|FG000|Overall Study|Adverse Event|0|||
19552146|NCT01325337|42000897|FG001|Overall Study|Adverse Event|2|||
19552147|NCT01325337|42000898|FG002|Overall Study|Adverse Event|2|||
19552148|NCT01325337|42000899|FG003|Overall Study|Adverse Event|1|||
19552149|NCT01325337|42000900|FG004|Overall Study|Adverse Event|2|||
19552150|NCT01325337|42000896|FG000|Overall Study|Lost to Follow-up|2|||
19552151|NCT01325337|42000897|FG001|Overall Study|Lost to Follow-up|2|||
19552152|NCT01325337|42000898|FG002|Overall Study|Lost to Follow-up|2|||
19552153|NCT01325337|42000899|FG003|Overall Study|Lost to Follow-up|1|||
19552154|NCT01325337|42000900|FG004|Overall Study|Lost to Follow-up|2|||
19552155|NCT01325337|42000896|FG000|Overall Study|Personal Reasons|2|||
19552156|NCT01325337|42000897|FG001|Overall Study|Personal Reasons|5|||
19552157|NCT01325337|42000898|FG002|Overall Study|Personal Reasons|4|||
19552158|NCT01325337|42000899|FG003|Overall Study|Personal Reasons|8|||
19552159|NCT01325337|42000900|FG004|Overall Study|Personal Reasons|3|||
19552160|NCT01325337|42000896|FG000|Overall Study|Withdrawal by Subject|1|||
19552161|NCT01325337|42000897|FG001|Overall Study|Withdrawal by Subject|0|||
19552162|NCT01325337|42000898|FG002|Overall Study|Withdrawal by Subject|1|||
19467873|NCT01868009|41732819|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
19467874|NCT01868009|41732820|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
19467875|NCT01849055|41732874|FG000|Overall Study|Withdrawal by Subject|0|||
19467876|NCT01849055|41732875|FG001|Overall Study|Withdrawal by Subject|0|||
19467877|NCT01849055|41732876|FG002|Overall Study|Withdrawal by Subject|1|||
19467878|NCT01849055|41732877|FG003|Overall Study|Withdrawal by Subject|0|||
19467879|NCT01849055|41732878|FG004|Overall Study|Withdrawal by Subject|0|||
19552163|NCT01325337|42000899|FG003|Overall Study|Withdrawal by Subject|0|||
19552164|NCT01325337|42000900|FG004|Overall Study|Withdrawal by Subject|1|||
19552165|NCT01324947|42000912|FG000|Overall Study|Adverse Event|7|||
19552166|NCT01324947|42000912|FG000|Overall Study|Death|10|||
19552167|NCT01324947|42000912|FG000|Overall Study|Other|3|||
19552168|NCT01324947|42000912|FG000|Overall Study|Progressive Disease|50|||
19552169|NCT01324947|42000912|FG000|Overall Study|Withdrawal by Subject|3|||
19552170|NCT01324947|42000912|FG000|Overall Study|1 discontinued before starting drug|1|||
19552171|NCT01101841|42000920|FG000|Overall Study|Adverse Event|15|||
19552172|NCT01101841|42000921|FG001|Overall Study|Adverse Event|15|||
19552173|NCT01101841|42000920|FG000|Overall Study|Lost to Follow-up|9|||
19552174|NCT01101841|42000921|FG001|Overall Study|Lost to Follow-up|3|||
19552175|NCT01101841|42000920|FG000|Overall Study|Withdrawal by Subject|21|||
19552176|NCT01101841|42000921|FG001|Overall Study|Withdrawal by Subject|40|||
19552177|NCT01101841|42000920|FG000|Overall Study|Protocol Violation|1|||
19552178|NCT01101841|42000921|FG001|Overall Study|Protocol Violation|1|||
19552179|NCT01101841|42000920|FG000|Overall Study|Physician Decision|0|||
19552180|NCT01101841|42000921|FG001|Overall Study|Physician Decision|2|||
19552181|NCT01101841|42000920|FG000|Overall Study|Lack of Efficacy|0|||
19552182|NCT01101841|42000921|FG001|Overall Study|Lack of Efficacy|2|||
19552183|NCT01101841|42000920|FG000|Overall Study|Other|0|||
19552184|NCT01101841|42000921|FG001|Overall Study|Other|1|||
19552185|NCT01101841|42000920|FG000|Overall Study|Suicidality Tracking Scale|3|||
19552186|NCT01101841|42000921|FG001|Overall Study|Suicidality Tracking Scale|1|||
19552187|NCT01101841|42000920|FG000|Overall Study|Eligibility Criteria|1|||
19552188|NCT01101841|42000921|FG001|Overall Study|Eligibility Criteria|2|||
19552189|NCT01324401|42000930|FG000|Overall Study|Withdrawn before any treatment|0|||
19552190|NCT01324401|42000931|FG001|Overall Study|Withdrawn before any treatment|3|||
19552191|NCT01324401|42000930|FG000|Overall Study|Adverse Event|1|||
19552192|NCT01324401|42000931|FG001|Overall Study|Adverse Event|3|||
19552193|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
19552194|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
19552195|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
19552196|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
19552197|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
19552198|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
19552199|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
19552200|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
19552201|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
19739039|NCT00101686|42186085|FG001|Overall Study|Withdrawal by Subject|8|||
19739040|NCT00101686|42186086|FG002|Overall Study|Withdrawal by Subject|6|||
19467880|NCT01849055|41732879|FG005|Overall Study|Withdrawal by Subject|0|||
19467881|NCT01848353|41732905|FG000|Phase 1|Withdrawal by Subject|3|||
19467882|NCT01848353|41732906|FG001|Phase 1|Withdrawal by Subject|1|||
19467883|NCT01848353|41732907|FG002|Phase 1|Withdrawal by Subject|0|||
19467884|NCT01848353|41732908|FG003|Phase 1|Withdrawal by Subject|0|||
19467885|NCT01848353|41732905|FG000|Phase 2|Withdrawal by Subject|3|||
19467886|NCT01848353|41732906|FG001|Phase 2|Withdrawal by Subject|2|||
19467887|NCT01848353|41732907|FG002|Phase 2|Withdrawal by Subject|0|||
19467888|NCT01848353|41732908|FG003|Phase 2|Withdrawal by Subject|0|||
19467889|NCT01848353|41732905|FG000|Phase 3|Withdrawal by Subject|1|||
19467890|NCT01848353|41732906|FG001|Phase 3|Withdrawal by Subject|1|||
19467891|NCT01848353|41732907|FG002|Phase 3|Withdrawal by Subject|0|||
19552202|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
19552203|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
19552204|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
19552205|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
19467892|NCT01848353|41732908|FG003|Phase 3|Withdrawal by Subject|0|||
19739041|NCT00101686|42186087|FG003|Overall Study|Withdrawal by Subject|8|||
19552206|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
19739042|NCT00101686|42186088|FG004|Overall Study|Withdrawal by Subject|8|||
19467895|NCT01847885|41732948|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
19467896|NCT01847885|41732949|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
19467897|NCT01847885|41732950|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
19467898|NCT01847885|41732948|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
19467899|NCT01847885|41732949|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
19467900|NCT01847885|41732950|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
19467901|NCT01847885|41732948|FG000|Initial Enrollment (Consented)|Screen failure|39|||
19467902|NCT01847885|41732949|FG001|Initial Enrollment (Consented)|Screen failure|0|||
19467903|NCT01847885|41732950|FG002|Initial Enrollment (Consented)|Screen failure|0|||
19467904|NCT01847885|41732948|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
19467905|NCT01847885|41732949|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
19467906|NCT01847885|41732950|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
19467907|NCT01847885|41732948|FG000|Randomization|Protocol Violation|0|||
19467908|NCT01847885|41732949|FG001|Randomization|Protocol Violation|1|||
19467909|NCT01847885|41732950|FG002|Randomization|Protocol Violation|0|||
19467910|NCT01847885|41732948|FG000|Randomization|Withdrawal by Subject|0|||
19467911|NCT01847885|41732949|FG001|Randomization|Withdrawal by Subject|0|||
19467912|NCT01847885|41732950|FG002|Randomization|Withdrawal by Subject|2|||
19467913|NCT01847885|41732948|FG000|Randomization|Screen Failure|0|||
19467914|NCT01847885|41732949|FG001|Randomization|Screen Failure|3|||
19467915|NCT01847885|41732950|FG002|Randomization|Screen Failure|0|||
19467916|NCT01867307|41732988|FG000|Overall Study|Protocol Violation|2|||
19467917|NCT01867307|41732989|FG001|Overall Study|Protocol Violation|0|||
19467918|NCT01867307|41732988|FG000|Overall Study|Other Adverse Event|1|||
19467919|NCT01867307|41732989|FG001|Overall Study|Other Adverse Event|3|||
19739043|NCT00101686|42186089|FG005|Overall Study|Withdrawal by Subject|7|||
19552207|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
19552208|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
19552209|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
19552210|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
19552211|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19552212|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19552213|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19552214|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19552215|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
19552216|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19552217|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19552218|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19552219|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19552220|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19552221|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19552222|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19552223|NCT01323660|42000937|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
19552224|NCT01323660|42000938|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19552225|NCT01323660|42000939|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
19552226|NCT01323660|42000940|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
19552227|NCT01323660|42000941|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
19552228|NCT01323660|42000942|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19552229|NCT01323660|42000937|FG000|Washout Period (14 Days)|Adverse Event|0|||
19552230|NCT01323660|42000938|FG001|Washout Period (14 Days)|Adverse Event|0|||
19552231|NCT01323660|42000939|FG002|Washout Period (14 Days)|Adverse Event|0|||
19552232|NCT01323660|42000940|FG003|Washout Period (14 Days)|Adverse Event|0|||
19552233|NCT01323660|42000941|FG004|Washout Period (14 Days)|Adverse Event|1|||
19552234|NCT01323660|42000942|FG005|Washout Period (14 Days)|Adverse Event|0|||
19552235|NCT01323660|42000937|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
19552236|NCT01323660|42000938|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
19552237|NCT01323660|42000939|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
19552238|NCT01323660|42000940|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
19552239|NCT01323660|42000941|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
19552240|NCT01323660|42000942|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
19552241|NCT01323660|42000937|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19552242|NCT01323660|42000938|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19552243|NCT01323660|42000939|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19552244|NCT01323660|42000940|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19552245|NCT01323660|42000941|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19552246|NCT01323660|42000942|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
19552247|NCT01323660|42000937|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
19552248|NCT01323660|42000938|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
19552249|NCT01323660|42000939|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
19552250|NCT01323660|42000940|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
19552251|NCT01323660|42000941|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
19552252|NCT01323660|42000942|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
19552253|NCT01323660|42000937|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
19552254|NCT01323660|42000938|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
19552255|NCT01323660|42000939|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
19552256|NCT01323660|42000940|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
19552257|NCT01323660|42000941|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
19552258|NCT01323660|42000942|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
19552259|NCT01323660|42000937|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
19552260|NCT01323660|42000938|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19552261|NCT01323660|42000939|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19552262|NCT01323660|42000940|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19552263|NCT01323660|42000941|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19552264|NCT01323660|42000942|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
19552265|NCT01323660|42000937|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19552266|NCT01323660|42000938|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19552267|NCT01323660|42000939|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19552268|NCT01323660|42000940|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19552269|NCT01323660|42000941|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
19552270|NCT01323660|42000942|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19552271|NCT01092637|42000958|FG000|Overall Study|Death|47|||
19552272|NCT01092637|42000959|FG001|Overall Study|Death|49|||
19552273|NCT01324323|42000966|FG000|Overall Study|Withdrawal by Subject|1|||
19552274|NCT01323582|42000980|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
19552275|NCT01323582|42000981|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
19552276|NCT01323582|42000980|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
19552277|NCT01323582|42000981|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
19552278|NCT01323582|42000980|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
19552279|NCT01323582|42000981|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
19552280|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
19552281|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
19552282|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
19552283|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
19552284|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
19552285|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
19552286|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
19552287|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
19552288|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
19552289|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
19739044|NCT00101686|42186090|FG006|Overall Study|Withdrawal by Subject|7|||
19739045|NCT00101686|42186091|FG007|Overall Study|Withdrawal by Subject|7|||
19739046|NCT00101686|42186092|FG008|Overall Study|Withdrawal by Subject|8|||
19739047|NCT00101686|42186093|FG009|Overall Study|Withdrawal by Subject|9|||
19739048|NCT00101452|42186113|FG000|Overall Study|Adverse Event|2|||
19739049|NCT00101452|42186114|FG001|Overall Study|Adverse Event|0|||
19739050|NCT00101452|42186115|FG002|Overall Study|Adverse Event|1|||
19739051|NCT00101452|42186113|FG000|Overall Study|Lost to Follow-up|13|||
19739052|NCT00101452|42186114|FG001|Overall Study|Lost to Follow-up|8|||
19739053|NCT00101452|42186115|FG002|Overall Study|Lost to Follow-up|14|||
19739054|NCT00101452|42186113|FG000|Overall Study|Withdrawal by Subject|10|||
19739055|NCT00101452|42186114|FG001|Overall Study|Withdrawal by Subject|14|||
19467920|NCT01845077|41732998|FG000|Washout Period|Lost to Follow-up|0|||
19467921|NCT01845077|41732999|FG001|Washout Period|Lost to Follow-up|1|||
19467922|NCT01845077|41733000|FG002|Washout Period|Lost to Follow-up|0|||
19467923|NCT01845077|41733001|FG003|Washout Period|Lost to Follow-up|1|||
19467924|NCT01845077|41733002|FG004|Washout Period|Lost to Follow-up|0|||
19467925|NCT01845077|41733003|FG005|Washout Period|Lost to Follow-up|1|||
19467926|NCT01845077|41732998|FG000|Washout Period|Adverse Event|1|||
19467927|NCT01845077|41732999|FG001|Washout Period|Adverse Event|0|||
19467928|NCT01845077|41733000|FG002|Washout Period|Adverse Event|0|||
19467929|NCT01845077|41733001|FG003|Washout Period|Adverse Event|0|||
19467930|NCT01845077|41733002|FG004|Washout Period|Adverse Event|0|||
19467931|NCT01845077|41733003|FG005|Washout Period|Adverse Event|0|||
19467932|NCT01845077|41732998|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
19467933|NCT01845077|41732999|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
19467934|NCT01845077|41733000|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
19467935|NCT01845077|41733001|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
19467936|NCT01845077|41733002|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
19467937|NCT01845077|41733003|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
19467938|NCT01845077|41732998|FG000|Washout Period|Protocol Violation|0|||
19467939|NCT01845077|41732999|FG001|Washout Period|Protocol Violation|0|||
19467940|NCT01845077|41733000|FG002|Washout Period|Protocol Violation|0|||
19467941|NCT01845077|41733001|FG003|Washout Period|Protocol Violation|1|||
19467942|NCT01845077|41733002|FG004|Washout Period|Protocol Violation|1|||
19467943|NCT01845077|41733003|FG005|Washout Period|Protocol Violation|0|||
19467944|NCT01866917|41733020|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
19467945|NCT01866917|41733021|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
19467946|NCT01844765|41733156|FG000|Overall Study|Adverse Event|6|||
19467947|NCT01844765|41733157|FG001|Overall Study|Adverse Event|8|||
19467948|NCT01844765|41733156|FG000|Overall Study|Withdrawal by Subject|2|||
19467949|NCT01844765|41733157|FG001|Overall Study|Withdrawal by Subject|3|||
19467950|NCT01844765|41733156|FG000|Overall Study|Disease progression|1|||
19467951|NCT01844765|41733157|FG001|Overall Study|Disease progression|0|||
19467952|NCT01844765|41733156|FG000|Overall Study|Administrative problems|3|||
19467953|NCT01844765|41733157|FG001|Overall Study|Administrative problems|4|||
19467954|NCT01844765|41733156|FG000|Overall Study|Protocol deviation|2|||
19467955|NCT01844765|41733157|FG001|Overall Study|Protocol deviation|0|||
19467956|NCT01844765|41733156|FG000|Overall Study|Untreated|1|||
19467957|NCT01844765|41733157|FG001|Overall Study|Untreated|0|||
19467958|NCT01866293|41733172|FG000|Overall Study|Adverse Event|2|||
19467959|NCT01844687|41733176|FG000|Visit 1|Protocol Violation|3|||
19467960|NCT01844687|41733176|FG000|Visit 1|Lost to Follow-up|5|||
19467961|NCT01844687|41733176|FG000|Visit 2|Withdrawal by Subject|1|||
19467962|NCT01844687|41733176|FG000|Visit 2|Protocol Violation|1|||
19467963|NCT01844687|41733176|FG000|Visit 3|Lost to Follow-up|1|||
19467964|NCT01844687|41733176|FG000|Visit 3|Withdrawal by Subject|3|||
19467965|NCT01844687|41733176|FG000|Visit 3|child care problems|1|||
19467966|NCT01844687|41733176|FG000|Visit 4|Pregnancy|1|||
19467967|NCT01844687|41733176|FG000|Visit 4|Lost to Follow-up|1|||
19467968|NCT01844687|41733176|FG000|Visit 4|Withdrawal by Subject|2|||
19467969|NCT01844531|41733202|FG000|Overall Study|Withdrawal by Subject|0|||
19467970|NCT01844531|41733203|FG001|Overall Study|Withdrawal by Subject|1|||
19467971|NCT01844531|41733204|FG002|Overall Study|Withdrawal by Subject|0|||
19467972|NCT01844531|41733205|FG003|Overall Study|Withdrawal by Subject|0|||
19467973|NCT01844375|41733217|FG000|Overall Study|Protocol Violation|1|||
19467974|NCT01844375|41733218|FG001|Overall Study|Protocol Violation|1|||
19467975|NCT02367456|41733227|FG000|Overall Study|Death|8|||
19467976|NCT02367456|41733228|FG001|Overall Study|Death|21|||
19467977|NCT02367456|41733229|FG002|Overall Study|Death|14|||
19467978|NCT02367456|41733227|FG000|Overall Study|Lost to Follow-up|1|||
19467979|NCT02367456|41733228|FG001|Overall Study|Lost to Follow-up|3|||
19467980|NCT02367456|41733229|FG002|Overall Study|Lost to Follow-up|1|||
19467981|NCT02367456|41733227|FG000|Overall Study|Ongoing|0|||
19467982|NCT02367456|41733228|FG001|Overall Study|Ongoing|6|||
19467983|NCT02367456|41733229|FG002|Overall Study|Ongoing|15|||
19467984|NCT02367456|41733227|FG000|Overall Study|Other reason|3|||
19467985|NCT02367456|41733228|FG001|Overall Study|Other reason|0|||
19467986|NCT02367456|41733229|FG002|Overall Study|Other reason|0|||
19467987|NCT01865747|41733260|FG000|Overall Study (ITT)|Adverse Event|32|||
19467988|NCT01865747|41733261|FG001|Overall Study (ITT)|Adverse Event|31|||
19467989|NCT01865747|41733260|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
19467990|NCT01865747|41733261|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
19467991|NCT01865747|41733260|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
19467992|NCT01865747|41733261|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
19467993|NCT01865747|41733260|FG000|Overall Study (ITT)|Protocol Violation|1|||
19467994|NCT01865747|41733261|FG001|Overall Study (ITT)|Protocol Violation|1|||
19467995|NCT01865747|41733260|FG000|Overall Study (ITT)|Physician Decision|5|||
19467996|NCT01865747|41733261|FG001|Overall Study (ITT)|Physician Decision|2|||
19467997|NCT01865747|41733260|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
19467998|NCT01865747|41733261|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
19467999|NCT01865747|41733260|FG000|Overall Study (ITT)|Sponsor Decision|0|||
19468000|NCT01865747|41733261|FG001|Overall Study (ITT)|Sponsor Decision|1|||
19468001|NCT01865747|41733260|FG000|Overall Study (ITT)|Progressive Disease|122|||
19468002|NCT01865747|41733261|FG001|Overall Study (ITT)|Progressive Disease|158|||
19468003|NCT01865747|41733260|FG000|Overall Study (ITT)|Reason Not Provided|0|||
19468004|NCT01865747|41733261|FG001|Overall Study (ITT)|Reason Not Provided|1|||
19468005|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
19468006|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
19468007|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
19468008|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
19468009|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
19468010|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
19468011|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
19468012|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
19468013|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
19468014|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
19468015|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
19468016|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
19468017|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
19468018|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
19468019|NCT01865747|41733260|FG000|Primary Intent to Treat (PITT)|Other|0|||
19468020|NCT01865747|41733261|FG001|Primary Intent to Treat (PITT)|Other|1|||
19468021|NCT01843673|41733302|FG000|Overall Study|Lack of Efficacy|2|||
19468022|NCT01843673|41733302|FG000|Overall Study|Withdrawal by Subject|4|||
19468023|NCT01843205|41733321|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
19468024|NCT01843205|41733322|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
19468025|NCT01835015|41733409|FG000|Overall Study|Adverse Event|0|||
19468026|NCT01835015|41733410|FG001|Overall Study|Adverse Event|0|||
19468027|NCT01835015|41733411|FG002|Overall Study|Adverse Event|1|||
19468028|NCT01835015|41733412|FG003|Overall Study|Adverse Event|0|||
19468029|NCT01835015|41733413|FG004|Overall Study|Adverse Event|0|||
19468030|NCT01842581|41733441|FG000|Overall Study|Adverse Event|6|||
19468031|NCT01842581|41733442|FG001|Overall Study|Adverse Event|4|||
19468032|NCT01842581|41733441|FG000|Overall Study|HE breakthrough|26|||
19468033|NCT01842581|41733442|FG001|Overall Study|HE breakthrough|13|||
19468034|NCT01842581|41733441|FG000|Overall Study|Liver transplant|2|||
19468035|NCT01842581|41733442|FG001|Overall Study|Liver transplant|0|||
19468036|NCT01842581|41733441|FG000|Overall Study|Lost to Follow-up|2|||
19468037|NCT01842581|41733442|FG001|Overall Study|Lost to Follow-up|5|||
19468038|NCT01842581|41733441|FG000|Overall Study|Withdrawal by Subject|5|||
19468039|NCT01842581|41733442|FG001|Overall Study|Withdrawal by Subject|7|||
19468040|NCT01842581|41733441|FG000|Overall Study|Other than specified|3|||
19468041|NCT01842581|41733442|FG001|Overall Study|Other than specified|1|||
19468042|NCT01833533|41733450|FG000|Overall Study|Adverse Event|0|||
19468043|NCT01833533|41733451|FG001|Overall Study|Adverse Event|1|||
19468044|NCT01833533|41733450|FG000|Overall Study|Lost to Follow-up|4|||
19468045|NCT01833533|41733451|FG001|Overall Study|Lost to Follow-up|9|||
19468046|NCT01833533|41733450|FG000|Overall Study|To Enter an Extension Study|0|||
19468047|NCT01833533|41733451|FG001|Overall Study|To Enter an Extension Study|4|||
19468048|NCT01833533|41733450|FG000|Overall Study|Other|2|||
19468049|NCT01833533|41733451|FG001|Overall Study|Other|7|||
19468050|NCT01833455|41733459|FG000|Overall Study|Withdrawal by Subject|1|||
19468051|NCT01833455|41733460|FG001|Overall Study|Withdrawal by Subject|0|||
19468052|NCT01833143|41733478|FG000|Overall Study|Not Treated|1|||
19468053|NCT01841567|41733482|FG000|Overall Study|Adverse Event|3|||
19468054|NCT01833065|41733489|FG000|Overall Study|Adverse Event|6|||
19468055|NCT01833065|41733490|FG001|Overall Study|Adverse Event|1|||
19468056|NCT01833065|41733491|FG002|Overall Study|Adverse Event|0|||
19468057|NCT01833065|41733492|FG003|Overall Study|Adverse Event|2|||
19468058|NCT01833065|41733493|FG004|Overall Study|Adverse Event|3|||
19468059|NCT01833065|41733489|FG000|Overall Study|Protocol Violation|1|||
19468060|NCT01833065|41733490|FG001|Overall Study|Protocol Violation|0|||
19468061|NCT01833065|41733491|FG002|Overall Study|Protocol Violation|0|||
19468062|NCT01833065|41733492|FG003|Overall Study|Protocol Violation|0|||
19468063|NCT01833065|41733493|FG004|Overall Study|Protocol Violation|2|||
19468064|NCT01833065|41733489|FG000|Overall Study|Lost to Follow-up|1|||
19468065|NCT01833065|41733490|FG001|Overall Study|Lost to Follow-up|0|||
19468066|NCT01833065|41733491|FG002|Overall Study|Lost to Follow-up|0|||
19468067|NCT01833065|41733492|FG003|Overall Study|Lost to Follow-up|0|||
19468068|NCT01833065|41733493|FG004|Overall Study|Lost to Follow-up|3|||
19468069|NCT01833065|41733489|FG000|Overall Study|Withdrawal by Subject|6|||
19468070|NCT01833065|41733490|FG001|Overall Study|Withdrawal by Subject|2|||
19468071|NCT01833065|41733491|FG002|Overall Study|Withdrawal by Subject|4|||
19468072|NCT01833065|41733492|FG003|Overall Study|Withdrawal by Subject|3|||
19468073|NCT01833065|41733493|FG004|Overall Study|Withdrawal by Subject|11|||
19468074|NCT01833065|41733489|FG000|Overall Study|Subject's substantial non-compliance|0|||
19468075|NCT01833065|41733490|FG001|Overall Study|Subject's substantial non-compliance|1|||
19468076|NCT01833065|41733491|FG002|Overall Study|Subject's substantial non-compliance|0|||
19468077|NCT01833065|41733492|FG003|Overall Study|Subject's substantial non-compliance|0|||
19468078|NCT01833065|41733493|FG004|Overall Study|Subject's substantial non-compliance|0|||
19468079|NCT01833065|41733489|FG000|Overall Study|Trial terminated by sponsor|8|||
19468080|NCT01833065|41733490|FG001|Overall Study|Trial terminated by sponsor|8|||
19468081|NCT01833065|41733491|FG002|Overall Study|Trial terminated by sponsor|7|||
19468082|NCT01833065|41733492|FG003|Overall Study|Trial terminated by sponsor|3|||
19468083|NCT01833065|41733493|FG004|Overall Study|Trial terminated by sponsor|13|||
19468084|NCT01833065|41733489|FG000|Overall Study|Others|2|||
19468085|NCT01833065|41733490|FG001|Overall Study|Others|1|||
19468086|NCT01833065|41733491|FG002|Overall Study|Others|1|||
19468087|NCT01833065|41733492|FG003|Overall Study|Others|1|||
19552290|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
19552291|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
19552292|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
19552293|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
19552294|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
19552295|NCT01323621|42000991|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
19552296|NCT01323621|42000992|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
19552297|NCT01323621|42000993|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
19552298|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
19552299|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
19552300|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
19552301|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
19552302|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
19552303|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
19552304|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
19552305|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
19552306|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
19552307|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19468088|NCT01833065|41733493|FG004|Overall Study|Others|4|||
19468089|NCT01831817|41733507|FG000|Overall Study|Lost to Follow-up|1|||
19468090|NCT01831817|41733508|FG001|Overall Study|Lost to Follow-up|0|||
19468091|NCT01831817|41733509|FG002|Overall Study|Lost to Follow-up|0|||
19468092|NCT01831817|41733510|FG003|Overall Study|Lost to Follow-up|0|||
19468093|NCT01831817|41733507|FG000|Overall Study|Withdrawl of Consent|3|||
19468094|NCT01831817|41733508|FG001|Overall Study|Withdrawl of Consent|0|||
19468095|NCT01831817|41733509|FG002|Overall Study|Withdrawl of Consent|0|||
19468096|NCT01831817|41733510|FG003|Overall Study|Withdrawl of Consent|0|||
19468097|NCT01840943|41733535|FG000|Overall Study|Withdrawal by Subject|5|||
19552308|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
19552309|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19552310|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
19552311|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
19552312|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
19468098|NCT01840943|41733536|FG001|Overall Study|Withdrawal by Subject|6|||
19468099|NCT01840943|41733535|FG000|Overall Study|Physician Decision|4|||
19468100|NCT01840943|41733536|FG001|Overall Study|Physician Decision|2|||
19468101|NCT01840943|41733535|FG000|Overall Study|Lost to Follow-up|4|||
19468102|NCT01840943|41733536|FG001|Overall Study|Lost to Follow-up|4|||
19468103|NCT01840163|41733544|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
19468104|NCT01840163|41733545|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
19468105|NCT01840163|41733544|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
19468106|NCT01840163|41733545|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
19468107|NCT01840163|41733544|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
19468108|NCT01840163|41733545|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
19468109|NCT01831427|41733708|FG000|Overall Study|Adverse Event|0|||
19468110|NCT01831427|41733709|FG001|Overall Study|Adverse Event|1|||
19468111|NCT01831427|41733710|FG002|Overall Study|Adverse Event|0|||
19468112|NCT01831427|41733711|FG003|Overall Study|Adverse Event|0|||
19468113|NCT01831427|41733712|FG004|Overall Study|Adverse Event|0|||
19468114|NCT01831427|41733713|FG005|Overall Study|Adverse Event|1|||
19468115|NCT01831427|41733714|FG006|Overall Study|Adverse Event|0|||
19468116|NCT01831427|41733715|FG007|Overall Study|Adverse Event|1|||
19468117|NCT01831427|41733716|FG008|Overall Study|Adverse Event|0|||
19468118|NCT01831427|41733717|FG009|Overall Study|Adverse Event|0|||
19468119|NCT01831427|41733718|FG010|Overall Study|Adverse Event|2|||
19468120|NCT01831427|41733708|FG000|Overall Study|Investigator's Discretion|0|||
19468121|NCT01831427|41733709|FG001|Overall Study|Investigator's Discretion|0|||
19468122|NCT01831427|41733710|FG002|Overall Study|Investigator's Discretion|0|||
19468123|NCT01831427|41733711|FG003|Overall Study|Investigator's Discretion|1|||
19468124|NCT01831427|41733712|FG004|Overall Study|Investigator's Discretion|0|||
19468125|NCT01831427|41733713|FG005|Overall Study|Investigator's Discretion|0|||
19468126|NCT01831427|41733714|FG006|Overall Study|Investigator's Discretion|0|||
19468127|NCT01831427|41733715|FG007|Overall Study|Investigator's Discretion|0|||
19468128|NCT01831427|41733716|FG008|Overall Study|Investigator's Discretion|0|||
19468129|NCT01831427|41733717|FG009|Overall Study|Investigator's Discretion|0|||
19468130|NCT01831427|41733718|FG010|Overall Study|Investigator's Discretion|0|||
19468131|NCT01831427|41733708|FG000|Overall Study|Withdrew Consent|0|||
19468132|NCT01831427|41733709|FG001|Overall Study|Withdrew Consent|0|||
19468133|NCT01831427|41733710|FG002|Overall Study|Withdrew Consent|0|||
19468134|NCT01831427|41733711|FG003|Overall Study|Withdrew Consent|0|||
19468135|NCT01831427|41733712|FG004|Overall Study|Withdrew Consent|0|||
19468136|NCT01831427|41733713|FG005|Overall Study|Withdrew Consent|0|||
19468137|NCT01831427|41733714|FG006|Overall Study|Withdrew Consent|2|||
19552313|NCT01323621|42000991|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19552314|NCT01323621|42000992|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
19552315|NCT01323621|42000993|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
19552316|NCT01323192|42001001|FG000|Overall Study|Adverse Event|6|||
19552317|NCT01323192|42001002|FG001|Overall Study|Adverse Event|1|||
19552318|NCT01323192|42001001|FG000|Overall Study|Withdrawal by Subject|3|||
19552319|NCT01323192|42001002|FG001|Overall Study|Withdrawal by Subject|1|||
19552320|NCT01323192|42001001|FG000|Overall Study|Noncompliance with study medication|0|||
19552321|NCT01323192|42001002|FG001|Overall Study|Noncompliance with study medication|3|||
19552322|NCT01323192|42001001|FG000|Overall Study|Nonmedical reasons|0|||
19552323|NCT01323192|42001002|FG001|Overall Study|Nonmedical reasons|1|||
19552324|NCT01323387|42001008|FG000|Overall Study|Withdrawal by Subject|41|||
19552325|NCT01323387|42001008|FG000|Overall Study|Radiographic Data Unavailable|1|||
19552326|NCT01323387|42001008|FG000|Overall Study|Revision|14|||
19552327|NCT01323387|42001008|FG000|Overall Study|Protocol Violation|12|||
19552328|NCT01323387|42001008|FG000|Overall Study|Randomized but Never Treated|16|||
19552329|NCT01321749|42001016|FG000|Overall Study|Lost to Follow-up|4|||
19552330|NCT01321749|42001017|FG001|Overall Study|Lost to Follow-up|11|||
19552331|NCT01321749|42001016|FG000|Overall Study|Protocol Violation|4|||
19552332|NCT01321749|42001017|FG001|Overall Study|Protocol Violation|7|||
19552333|NCT01321749|42001016|FG000|Overall Study|Withdrawal by Subject|5|||
19552334|NCT01321749|42001017|FG001|Overall Study|Withdrawal by Subject|4|||
19552335|NCT01320735|42001023|FG000|Overall Study|Adverse Event|3|||
19552336|NCT01320735|42001023|FG000|Overall Study|Withdrawal by Subject|3|||
19552337|NCT01320735|42001023|FG000|Overall Study|Lost to Follow-up|13|||
19552338|NCT01320735|42001023|FG000|Overall Study|Administrative Reason|6|||
19552339|NCT01320735|42001023|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
19552340|NCT01320735|42001023|FG000|Overall Study|Protocol Violation|1|||
19552341|NCT01320735|42001023|FG000|Overall Study|Other|1|||
19552342|NCT01320735|42001023|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
19552343|NCT01320735|42001023|FG000|Overall Study|Investigator Unable to be Contacted|17|||
19552344|NCT01320033|42001030|FG000|Overall Study|Lack of Efficacy|0|||
19552345|NCT01320033|42001031|FG001|Overall Study|Lack of Efficacy|0|||
19552346|NCT01320033|42001032|FG002|Overall Study|Lack of Efficacy|1|||
19552347|NCT01320033|42001030|FG000|Overall Study|Adverse Event|9|||
19552348|NCT01320033|42001031|FG001|Overall Study|Adverse Event|7|||
19552349|NCT01320033|42001032|FG002|Overall Study|Adverse Event|8|||
19552350|NCT01320033|42001030|FG000|Overall Study|Withdrawal by Subject|22|||
19552351|NCT01320033|42001031|FG001|Overall Study|Withdrawal by Subject|23|||
19552352|NCT01320033|42001032|FG002|Overall Study|Withdrawal by Subject|23|||
19552353|NCT01320033|42001030|FG000|Overall Study|Protocol Violation|3|||
19552354|NCT01320033|42001031|FG001|Overall Study|Protocol Violation|5|||
19552355|NCT01320033|42001032|FG002|Overall Study|Protocol Violation|3|||
19552356|NCT01320033|42001030|FG000|Overall Study|Lost to Follow-up|22|||
19552357|NCT01320033|42001031|FG001|Overall Study|Lost to Follow-up|26|||
19552358|NCT01320033|42001032|FG002|Overall Study|Lost to Follow-up|17|||
19552359|NCT01320033|42001030|FG000|Overall Study|Other|2|||
19552360|NCT01320033|42001031|FG001|Overall Study|Other|3|||
19552361|NCT01320033|42001032|FG002|Overall Study|Other|1|||
19552362|NCT01101061|42001046|FG000|Overall Study|Adverse Event|0|||
19552363|NCT01101061|42001047|FG001|Overall Study|Adverse Event|0|||
19552364|NCT01101061|42001048|FG002|Overall Study|Adverse Event|1|||
19552365|NCT01101061|42001049|FG003|Overall Study|Adverse Event|0|||
19552366|NCT01101061|42001050|FG004|Overall Study|Adverse Event|0|||
19552367|NCT01101061|42001051|FG005|Overall Study|Adverse Event|0|||
19552368|NCT01317615|42001069|FG000|Overall Study|Disease progression|25|||
19552369|NCT01317615|42001069|FG000|Overall Study|New cancer therapy|5|||
19552370|NCT01317615|42001069|FG000|Overall Study|Death|6|||
19552371|NCT01317615|42001069|FG000|Overall Study|Withdrawal by Subject|5|||
19552372|NCT01317615|42001069|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19552373|NCT01317615|42001069|FG000|Overall Study|Adverse Event|7|||
19552374|NCT01078675|42001075|FG000|Overall Study|Withdrawal by Subject|7|||
19552375|NCT01078675|42001076|FG001|Overall Study|Withdrawal by Subject|3|||
19552376|NCT01078675|42001075|FG000|Overall Study|Protocol Violation|56|||
19552377|NCT01078675|42001076|FG001|Overall Study|Protocol Violation|0|||
19552378|NCT01078675|42001075|FG000|Overall Study|Provided in CRF for specific reasons|2|||
19552379|NCT01078675|42001076|FG001|Overall Study|Provided in CRF for specific reasons|3|||
19552380|NCT01078675|42001075|FG000|Overall Study|Adverse Event|3|||
19552381|NCT01078675|42001076|FG001|Overall Study|Adverse Event|0|||
19552382|NCT01100437|42001082|FG000|Titration/Stabilization|Adverse Event|0|||
19552383|NCT01100437|42001083|FG001|Titration/Stabilization|Adverse Event|0|||
19552384|NCT01100437|42001084|FG002|Titration/Stabilization|Adverse Event|4|||
19552385|NCT01100437|42001082|FG000|Titration/Stabilization|Non-compliance|0|||
19552386|NCT01100437|42001083|FG001|Titration/Stabilization|Non-compliance|0|||
19552387|NCT01100437|42001084|FG002|Titration/Stabilization|Non-compliance|1|||
19552388|NCT01100437|42001082|FG000|Titration/Stabilization|Sponsor canceled study|0|||
19552389|NCT01100437|42001083|FG001|Titration/Stabilization|Sponsor canceled study|0|||
19552390|NCT01100437|42001084|FG002|Titration/Stabilization|Sponsor canceled study|1|||
19552391|NCT01100437|42001082|FG000|Maintenance|Withdrawal by Subject|0|||
19552392|NCT01100437|42001083|FG001|Maintenance|Withdrawal by Subject|0|||
19552393|NCT01100437|42001084|FG002|Maintenance|Withdrawal by Subject|1|||
19552394|NCT01100437|42001082|FG000|Maintenance|Sponsor termination of study|0|||
19552395|NCT01100437|42001083|FG001|Maintenance|Sponsor termination of study|0|||
19552396|NCT01100437|42001084|FG002|Maintenance|Sponsor termination of study|1|||
19552397|NCT01322490|42001096|FG000|Treatment Period|Adverse Event|12|||
19552398|NCT01322490|42001097|FG001|Treatment Period|Adverse Event|18|||
19552399|NCT01322490|42001098|FG002|Treatment Period|Adverse Event|15|||
19552400|NCT01322490|42001096|FG000|Treatment Period|Death|5|||
19552401|NCT01322490|42001097|FG001|Treatment Period|Death|7|||
19552402|NCT01322490|42001098|FG002|Treatment Period|Death|3|||
19552403|NCT01322490|42001096|FG000|Treatment Period|Lack of Efficacy|89|||
19552404|NCT01322490|42001097|FG001|Treatment Period|Lack of Efficacy|100|||
19552405|NCT01322490|42001098|FG002|Treatment Period|Lack of Efficacy|112|||
19552406|NCT01322490|42001096|FG000|Treatment Period|Physician Decision|0|||
19552407|NCT01322490|42001097|FG001|Treatment Period|Physician Decision|2|||
19552408|NCT01322490|42001098|FG002|Treatment Period|Physician Decision|1|||
19552409|NCT01322490|42001096|FG000|Treatment Period|Protocol Violation|7|||
19468138|NCT01831427|41733715|FG007|Overall Study|Withdrew Consent|0|||
19468139|NCT01831427|41733716|FG008|Overall Study|Withdrew Consent|0|||
19468140|NCT01831427|41733717|FG009|Overall Study|Withdrew Consent|1|||
19468141|NCT01831427|41733718|FG010|Overall Study|Withdrew Consent|1|||
19468142|NCT01830881|41733764|FG000|Overall Study|Changed decision to have an abortion|0|||
19468143|NCT01830881|41733765|FG001|Overall Study|Changed decision to have an abortion|1|||
19468144|NCT01838681|41733801|FG000|Period A|Adverse Event|39|||
19468145|NCT01838681|41733802|FG001|Period A|Adverse Event|0|||
19552410|NCT01322490|42001097|FG001|Treatment Period|Protocol Violation|5|||
19552411|NCT01322490|42001098|FG002|Treatment Period|Protocol Violation|4|||
19552412|NCT01322490|42001096|FG000|Treatment Period|Withdrawal by Subject|14|||
19468146|NCT01838681|41733803|FG002|Period A|Adverse Event|0|||
19468147|NCT01838681|41733804|FG003|Period A|Adverse Event|0|||
19468148|NCT01838681|41733801|FG000|Period A|Lack of Efficacy|21|||
19468149|NCT01838681|41733802|FG001|Period A|Lack of Efficacy|0|||
19552413|NCT01322490|42001097|FG001|Treatment Period|Withdrawal by Subject|16|||
19552414|NCT01322490|42001098|FG002|Treatment Period|Withdrawal by Subject|11|||
19552415|NCT01322490|42001096|FG000|Treatment Period|Non-compliance with study drug|0|||
19552416|NCT01322490|42001097|FG001|Treatment Period|Non-compliance with study drug|0|||
19468150|NCT01838681|41733803|FG002|Period A|Lack of Efficacy|0|||
19468151|NCT01838681|41733804|FG003|Period A|Lack of Efficacy|0|||
19468152|NCT01838681|41733801|FG000|Period A|Early response|148|||
19468153|NCT01838681|41733802|FG001|Period A|Early response|0|||
19468154|NCT01838681|41733803|FG002|Period A|Early response|0|||
19468155|NCT01838681|41733804|FG003|Period A|Early response|0|||
19468156|NCT01838681|41733801|FG000|Period A|Withdrawal by Subject|70|||
19468157|NCT01838681|41733802|FG001|Period A|Withdrawal by Subject|0|||
19468158|NCT01838681|41733803|FG002|Period A|Withdrawal by Subject|0|||
19468159|NCT01838681|41733804|FG003|Period A|Withdrawal by Subject|0|||
19468160|NCT01838681|41733801|FG000|Period A|Protocol Violation|16|||
19468161|NCT01838681|41733802|FG001|Period A|Protocol Violation|0|||
19468162|NCT01838681|41733803|FG002|Period A|Protocol Violation|0|||
19468163|NCT01838681|41733804|FG003|Period A|Protocol Violation|0|||
19468164|NCT01838681|41733801|FG000|Period A|Non-compliance with IMP|6|||
19468165|NCT01838681|41733802|FG001|Period A|Non-compliance with IMP|0|||
19468166|NCT01838681|41733803|FG002|Period A|Non-compliance with IMP|0|||
19468167|NCT01838681|41733804|FG003|Period A|Non-compliance with IMP|0|||
19468168|NCT01838681|41733801|FG000|Period A|Lost to Follow-up|4|||
19468169|NCT01838681|41733802|FG001|Period A|Lost to Follow-up|0|||
19552417|NCT01322490|42001098|FG002|Treatment Period|Non-compliance with study drug|1|||
19552418|NCT01322490|42001096|FG000|Treatment Period|Other per report|2|||
19552419|NCT01322490|42001097|FG001|Treatment Period|Other per report|2|||
19552420|NCT01322490|42001098|FG002|Treatment Period|Other per report|1|||
19552421|NCT01322490|42001096|FG000|Treatment Period|Randomized but Not Treated|3|||
19552422|NCT01322490|42001097|FG001|Treatment Period|Randomized but Not Treated|3|||
19552423|NCT01322490|42001098|FG002|Treatment Period|Randomized but Not Treated|5|||
19552424|NCT01322490|42001096|FG000|Long Term Follow-up Period|Death|235|||
19552425|NCT01322490|42001097|FG001|Long Term Follow-up Period|Death|239|||
19552426|NCT01322490|42001098|FG002|Long Term Follow-up Period|Death|236|||
19552427|NCT01322490|42001096|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
19552428|NCT01322490|42001097|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
19552429|NCT01322490|42001098|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
19552430|NCT01322490|42001096|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
19552431|NCT01322490|42001097|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
19552432|NCT01322490|42001098|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
19552433|NCT01322490|42001096|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
19552434|NCT01322490|42001097|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
19552435|NCT01322490|42001098|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
19468170|NCT01838681|41733803|FG002|Period A|Lost to Follow-up|0|||
19468171|NCT01838681|41733804|FG003|Period A|Lost to Follow-up|0|||
19468172|NCT01838681|41733801|FG000|Period A|Withdrawal before treatment|4|||
19468173|NCT01838681|41733802|FG001|Period A|Withdrawal before treatment|0|||
19468174|NCT01838681|41733803|FG002|Period A|Withdrawal before treatment|0|||
19468175|NCT01838681|41733804|FG003|Period A|Withdrawal before treatment|0|||
19468176|NCT01838681|41733801|FG000|Period A|Administrative or other reasons|17|||
19468177|NCT01838681|41733802|FG001|Period A|Administrative or other reasons|0|||
19468178|NCT01838681|41733803|FG002|Period A|Administrative or other reasons|0|||
19468179|NCT01838681|41733804|FG003|Period A|Administrative or other reasons|0|||
19468180|NCT01838681|41733801|FG000|Period B/A+|Adverse Event|0|||
19468181|NCT01838681|41733802|FG001|Period B/A+|Adverse Event|13|||
19468182|NCT01838681|41733803|FG002|Period B/A+|Adverse Event|27|||
19468183|NCT01838681|41733804|FG003|Period B/A+|Adverse Event|16|||
19468184|NCT01838681|41733801|FG000|Period B/A+|Lack of Efficacy|0|||
19468185|NCT01838681|41733802|FG001|Period B/A+|Lack of Efficacy|9|||
19468186|NCT01838681|41733803|FG002|Period B/A+|Lack of Efficacy|11|||
19468187|NCT01838681|41733804|FG003|Period B/A+|Lack of Efficacy|6|||
19468188|NCT01838681|41733801|FG000|Period B/A+|Withdrawal by Subject|0|||
19468189|NCT01838681|41733802|FG001|Period B/A+|Withdrawal by Subject|28|||
19468190|NCT01838681|41733803|FG002|Period B/A+|Withdrawal by Subject|35|||
19468191|NCT01838681|41733804|FG003|Period B/A+|Withdrawal by Subject|47|||
19468192|NCT01838681|41733801|FG000|Period B/A+|Protocol Violation|0|||
19468193|NCT01838681|41733802|FG001|Period B/A+|Protocol Violation|1|||
19468194|NCT01838681|41733803|FG002|Period B/A+|Protocol Violation|4|||
19468195|NCT01838681|41733804|FG003|Period B/A+|Protocol Violation|6|||
19468196|NCT01838681|41733801|FG000|Period B/A+|Non-compliance with IMP|0|||
19468197|NCT01838681|41733802|FG001|Period B/A+|Non-compliance with IMP|2|||
19468198|NCT01838681|41733803|FG002|Period B/A+|Non-compliance with IMP|3|||
19468199|NCT01838681|41733804|FG003|Period B/A+|Non-compliance with IMP|3|||
19468200|NCT01838681|41733801|FG000|Period B/A+|Lost to Follow-up|0|||
19552436|NCT01322490|42001096|FG000|Long Term Follow-up Period|Other per report|3|||
19552437|NCT01322490|42001097|FG001|Long Term Follow-up Period|Other per report|2|||
19552438|NCT01322490|42001098|FG002|Long Term Follow-up Period|Other per report|2|||
19552439|NCT01322490|42001096|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
19552440|NCT01322490|42001097|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
19552441|NCT01322490|42001098|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
19552442|NCT01314261|42001110|FG000|Overall Study|Adverse Event|1|||
19552443|NCT01314261|42001111|FG001|Overall Study|Adverse Event|0|||
19552444|NCT01314261|42001112|FG002|Overall Study|Adverse Event|0|||
19468201|NCT01838681|41733802|FG001|Period B/A+|Lost to Follow-up|2|||
19468202|NCT01838681|41733803|FG002|Period B/A+|Lost to Follow-up|5|||
19468203|NCT01838681|41733804|FG003|Period B/A+|Lost to Follow-up|11|||
19468204|NCT01838681|41733801|FG000|Period B/A+|Withdrawal before treatment|0|||
19468205|NCT01838681|41733802|FG001|Period B/A+|Withdrawal before treatment|1|||
19468206|NCT01838681|41733803|FG002|Period B/A+|Withdrawal before treatment|0|||
19468207|NCT01838681|41733804|FG003|Period B/A+|Withdrawal before treatment|0|||
19468208|NCT01838681|41733801|FG000|Period B/A+|Administrative or other reasons|0|||
19468209|NCT01838681|41733802|FG001|Period B/A+|Administrative or other reasons|6|||
19468210|NCT01838681|41733803|FG002|Period B/A+|Administrative or other reasons|10|||
19468211|NCT01838681|41733804|FG003|Period B/A+|Administrative or other reasons|28|||
19468212|NCT01611857|41733862|FG000|Overall Study|Withdrawal by Subject|0|||
19468213|NCT01611857|41733863|FG001|Overall Study|Withdrawal by Subject|2|||
19468214|NCT01829477|41733886|FG000|Overall Study|Study Terminated by Sponsor|15|||
19468215|NCT01829477|41733887|FG001|Overall Study|Study Terminated by Sponsor|15|||
19468216|NCT01829477|41733886|FG000|Overall Study|Withdrawal by Subject|1|||
19468217|NCT01829477|41733887|FG001|Overall Study|Withdrawal by Subject|0|||
19468218|NCT01611155|41733903|FG000|Overall Study|Adverse Event|1|||
19468219|NCT01611155|41733904|FG001|Overall Study|Adverse Event|1|||
19468220|NCT01611155|41733903|FG000|Overall Study|Refused further treatment|6|||
19468221|NCT01611155|41733904|FG001|Overall Study|Refused further treatment|4|||
19468222|NCT01611155|41733903|FG000|Overall Study|Disease progression|1|||
19468223|NCT01611155|41733904|FG001|Overall Study|Disease progression|0|||
19468224|NCT01611155|41733903|FG000|Overall Study|Withdrawal by Subject|1|||
19468225|NCT01611155|41733904|FG001|Overall Study|Withdrawal by Subject|0|||
19468226|NCT01611155|41733903|FG000|Overall Study|Alternative treatment|0|||
19468227|NCT01611155|41733904|FG001|Overall Study|Alternative treatment|1|||
19468228|NCT01611155|41733903|FG000|Overall Study|Ineligible patient|0|||
19468229|NCT01611155|41733904|FG001|Overall Study|Ineligible patient|1|||
19468230|NCT01829243|41733919|FG000|First Intervention|Screen Failure|4|||
19468231|NCT01829243|41733920|FG001|First Intervention|Screen Failure|2|||
19468232|NCT01838447|41733930|FG000|Overall Study|Change in surgical plan|1|||
19468233|NCT01838447|41733931|FG001|Overall Study|Change in surgical plan|2|||
19468234|NCT01838447|41733930|FG000|Overall Study|Withdrawal by Subject|1|||
19468235|NCT01838447|41733931|FG001|Overall Study|Withdrawal by Subject|1|||
19468236|NCT01829165|41733939|FG000|Overall Study|Did not complete intervention|2|||
19468237|NCT01829165|41733940|FG001|Overall Study|Did not complete intervention|0|||
19468238|NCT01838213|41733948|FG000|Overall Study|Ineligible|166|||
19468239|NCT01838213|41733949|FG001|Overall Study|Ineligible|191|||
19468240|NCT01837823|41733955|FG000|Overall Study|Lost to Follow-up|6|||
19468241|NCT01828073|41733965|FG000|Overall Study|Lost to Follow-up|1|||
19468242|NCT01828073|41733966|FG001|Overall Study|Lost to Follow-up|2|||
19468243|NCT03819114|41733986|FG000|Overall Study|Protocol Violation|0|||
19468244|NCT03819114|41733987|FG001|Overall Study|Protocol Violation|1|||
19468245|NCT03819114|41733988|FG002|Overall Study|Protocol Violation|1|||
19468246|NCT03819114|41733989|FG003|Overall Study|Protocol Violation|0|||
19468247|NCT03819114|41733986|FG000|Overall Study|Lost to Follow-up|0|||
19468248|NCT03819114|41733987|FG001|Overall Study|Lost to Follow-up|0|||
19468249|NCT03819114|41733988|FG002|Overall Study|Lost to Follow-up|1|||
19468250|NCT03819114|41733989|FG003|Overall Study|Lost to Follow-up|0|||
19552445|NCT01314261|42001113|FG003|Overall Study|Adverse Event|0|||
19552446|NCT01314261|42001110|FG000|Overall Study|Withdrawal by Subject|0|||
19468251|NCT01827839|41734001|FG000|Overall Study|Adverse Event|1|||
19468252|NCT01827839|41734001|FG000|Overall Study|Consent Withdrawal|2|||
19468253|NCT01827371|41734016|FG000|Overall Study|Adverse Event|0|||
19468254|NCT01827371|41734017|FG001|Overall Study|Adverse Event|0|||
19468255|NCT01827371|41734018|FG002|Overall Study|Adverse Event|4|||
19468256|NCT01827371|41734019|FG003|Overall Study|Adverse Event|2|||
19468257|NCT01827371|41734016|FG000|Overall Study|Lost to Follow-up|0|||
19468258|NCT01827371|41734017|FG001|Overall Study|Lost to Follow-up|2|||
19468259|NCT01827371|41734018|FG002|Overall Study|Lost to Follow-up|0|||
19468260|NCT01827371|41734019|FG003|Overall Study|Lost to Follow-up|4|||
19739056|NCT00101452|42186115|FG002|Overall Study|Withdrawal by Subject|9|||
19739057|NCT00101452|42186113|FG000|Overall Study|Baseline Fail|2|||
19739058|NCT00101452|42186114|FG001|Overall Study|Baseline Fail|1|||
19739059|NCT00101452|42186115|FG002|Overall Study|Baseline Fail|2|||
19739060|NCT00101452|42186113|FG000|Overall Study|Physician Decision|0|||
19739061|NCT00101452|42186114|FG001|Overall Study|Physician Decision|3|||
19739062|NCT00101452|42186115|FG002|Overall Study|Physician Decision|2|||
19739063|NCT00101452|42186113|FG000|Overall Study|Protocol Violation|2|||
19739064|NCT00101452|42186114|FG001|Overall Study|Protocol Violation|1|||
19739065|NCT00101452|42186115|FG002|Overall Study|Protocol Violation|3|||
19739066|NCT00101452|42186113|FG000|Overall Study|Other|15|||
19739067|NCT00101452|42186114|FG001|Overall Study|Other|16|||
19739068|NCT00101452|42186115|FG002|Overall Study|Other|12|||
19739069|NCT03546621|42186131|FG000|Overall Study|Withdrawal by Subject|0|||
19739070|NCT03546621|42186132|FG001|Overall Study|Withdrawal by Subject|1|||
19739071|NCT03546621|42186133|FG002|Overall Study|Withdrawal by Subject|2|||
19739072|NCT03546621|42186134|FG003|Overall Study|Withdrawal by Subject|1|||
19739073|NCT03546621|42186131|FG000|Overall Study|Lost to Follow-up|0|||
19739074|NCT03546621|42186132|FG001|Overall Study|Lost to Follow-up|1|||
19739075|NCT03546621|42186133|FG002|Overall Study|Lost to Follow-up|0|||
19739076|NCT03546621|42186134|FG003|Overall Study|Lost to Follow-up|0|||
19739077|NCT03546621|42186131|FG000|Overall Study|Adverse Event|0|||
19468261|NCT01827371|41734016|FG000|Overall Study|Protocol Violation|1|||
19468262|NCT01827371|41734017|FG001|Overall Study|Protocol Violation|0|||
19468263|NCT01827371|41734018|FG002|Overall Study|Protocol Violation|0|||
19468264|NCT01827371|41734019|FG003|Overall Study|Protocol Violation|0|||
19468265|NCT01827371|41734016|FG000|Overall Study|Withdrawal by Subject|1|||
19468266|NCT01827371|41734017|FG001|Overall Study|Withdrawal by Subject|2|||
19552447|NCT01314261|42001111|FG001|Overall Study|Withdrawal by Subject|3|||
19552448|NCT01314261|42001112|FG002|Overall Study|Withdrawal by Subject|1|||
19552449|NCT01314261|42001113|FG003|Overall Study|Withdrawal by Subject|0|||
19552450|NCT01314261|42001110|FG000|Overall Study|Lost to Follow-up|1|||
19552451|NCT01314261|42001111|FG001|Overall Study|Lost to Follow-up|0|||
19552452|NCT01314261|42001112|FG002|Overall Study|Lost to Follow-up|2|||
19552453|NCT01314261|42001113|FG003|Overall Study|Lost to Follow-up|2|||
19552454|NCT01314261|42001110|FG000|Overall Study|Virologic Failure|0|||
19552455|NCT01314261|42001111|FG001|Overall Study|Virologic Failure|1|||
19552456|NCT01314261|42001112|FG002|Overall Study|Virologic Failure|0|||
19552457|NCT01314261|42001113|FG003|Overall Study|Virologic Failure|1|||
19552458|NCT01321710|42001126|FG000|Overall Study|Lost to Follow-up|4|||
19552459|NCT01321710|42001127|FG001|Overall Study|Lost to Follow-up|5|||
19552460|NCT01321710|42001128|FG002|Overall Study|Lost to Follow-up|0|||
19552461|NCT01321008|42001138|FG000|Overall Study|Early Study Termination|1|||
19552462|NCT01320150|42001144|FG000|Overall Study|Protocol Violation|15|||
19552463|NCT01320150|42001144|FG000|Overall Study|Withdrawal by Subject|5|||
19552464|NCT01320150|42001144|FG000|Overall Study|Death|2|||
19552465|NCT01320150|42001144|FG000|Overall Study|Lost to Follow-up|44|||
19552466|NCT01323530|42001155|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
19552467|NCT01323530|42001156|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
19552468|NCT01323530|42001157|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
19552469|NCT01323530|42001158|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
19468267|NCT01827371|41734018|FG002|Overall Study|Withdrawal by Subject|2|||
19468268|NCT01827371|41734019|FG003|Overall Study|Withdrawal by Subject|3|||
19552470|NCT01323530|42001159|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
19552471|NCT01323530|42001160|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
19552472|NCT01323530|42001161|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
19552473|NCT01323530|42001155|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
19552474|NCT01323530|42001156|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
19552475|NCT01323530|42001157|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
19552476|NCT01323530|42001158|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
19552477|NCT01323530|42001159|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
19552478|NCT01323530|42001160|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
19739078|NCT03546621|42186132|FG001|Overall Study|Adverse Event|1|||
19739079|NCT03546621|42186133|FG002|Overall Study|Adverse Event|0|||
19739080|NCT03546621|42186134|FG003|Overall Study|Adverse Event|1|||
19468269|NCT01827371|41734016|FG000|Overall Study|Physician Decision|0|||
19468270|NCT01827371|41734017|FG001|Overall Study|Physician Decision|1|||
19468271|NCT01827371|41734018|FG002|Overall Study|Physician Decision|0|||
19468272|NCT01827371|41734019|FG003|Overall Study|Physician Decision|1|||
19468273|NCT01827371|41734016|FG000|Overall Study|Temporary study halt to vaccinations|11|||
19468274|NCT01827371|41734017|FG001|Overall Study|Temporary study halt to vaccinations|2|||
19468275|NCT01827371|41734018|FG002|Overall Study|Temporary study halt to vaccinations|5|||
19552479|NCT01323530|42001161|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
19552480|NCT01323530|42001155|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
19739081|NCT03546621|42186131|FG000|Overall Study|Progressive disease|0|||
19739082|NCT03546621|42186132|FG001|Overall Study|Progressive disease|0|||
19739083|NCT03546621|42186133|FG002|Overall Study|Progressive disease|0|||
19552481|NCT01323530|42001156|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
19552482|NCT01323530|42001157|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
19552483|NCT01323530|42001158|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
19552484|NCT01323530|42001159|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
19552485|NCT01323530|42001160|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
19552486|NCT01323530|42001161|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
19552487|NCT01323530|42001155|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552488|NCT01323530|42001156|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552489|NCT01323530|42001157|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552490|NCT01323530|42001158|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552491|NCT01323530|42001159|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552492|NCT01323530|42001160|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
19552493|NCT01323530|42001161|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
19552494|NCT01323530|42001155|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19552495|NCT01323530|42001156|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19552496|NCT01323530|42001157|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19552497|NCT01323530|42001158|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19468276|NCT01827371|41734019|FG003|Overall Study|Temporary study halt to vaccinations|13|||
19468277|NCT04409262|41734208|FG000|Overall Study|Adverse Event|0|||
19468278|NCT04409262|41734209|FG001|Overall Study|Adverse Event|2|||
19468279|NCT04409262|41734208|FG000|Overall Study|Death|55|||
19468280|NCT04409262|41734209|FG001|Overall Study|Death|97|||
19468281|NCT04409262|41734208|FG000|Overall Study|Lost to Follow-up|12|||
19468282|NCT04409262|41734209|FG001|Overall Study|Lost to Follow-up|23|||
19468283|NCT04409262|41734208|FG000|Overall Study|Lack of Staff|0|||
19468284|NCT04409262|41734209|FG001|Overall Study|Lack of Staff|1|||
19468285|NCT04409262|41734208|FG000|Overall Study|Protocol Violation|3|||
19468286|NCT04409262|41734209|FG001|Overall Study|Protocol Violation|1|||
19468287|NCT04409262|41734208|FG000|Overall Study|Withdrawal by Subject|5|||
19468288|NCT04409262|41734209|FG001|Overall Study|Withdrawal by Subject|10|||
19468289|NCT04305912|41734253|FG000|First Intervention|COVID-19 Suspension|2|||
19468290|NCT04305912|41734254|FG001|First Intervention|COVID-19 Suspension|0|||
19468291|NCT04305912|41734253|FG000|First Intervention|Withdrawal by Subject|0|||
19468292|NCT04305912|41734254|FG001|First Intervention|Withdrawal by Subject|1|||
19468293|NCT04305912|41734253|FG000|Second Intervention|Adverse Event|0|||
19468294|NCT04305912|41734254|FG001|Second Intervention|Adverse Event|1|||
19468295|NCT00782184|41734483|FG000|Overall Study|Adverse Event|1|||
19468296|NCT00782184|41734484|FG001|Overall Study|Adverse Event|2|||
19468297|NCT00782184|41734483|FG000|Overall Study|Protocol Violation|0|||
19468298|NCT00782184|41734484|FG001|Overall Study|Protocol Violation|1|||
19468299|NCT00782184|41734483|FG000|Overall Study|Withdrawal by Subject|3|||
19468300|NCT00782184|41734484|FG001|Overall Study|Withdrawal by Subject|2|||
19468301|NCT02731638|41734520|FG000|Overall Study|Lost to Follow-up|6|||
19468302|NCT02731638|41734521|FG001|Overall Study|Lost to Follow-up|9|||
19468303|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
19468304|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
19468305|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
19468306|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
19468307|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
19468308|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
19468309|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
19552498|NCT01323530|42001159|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19552499|NCT01323530|42001160|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
19552500|NCT01323530|42001161|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
19552501|NCT01323530|42001155|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552502|NCT01323530|42001156|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552503|NCT01323530|42001157|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552504|NCT01323530|42001158|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552505|NCT01323530|42001159|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552506|NCT01323530|42001160|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
19552507|NCT01323530|42001161|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
19552508|NCT01323530|42001155|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552509|NCT01323530|42001156|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552510|NCT01323530|42001157|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552511|NCT01323530|42001158|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552512|NCT01323530|42001159|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552513|NCT01323530|42001160|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
19552514|NCT01323530|42001161|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
19552515|NCT01323530|42001155|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552516|NCT01323530|42001156|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552517|NCT01323530|42001157|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552518|NCT01323530|42001158|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552519|NCT01323530|42001159|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552520|NCT01323530|42001160|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
19552521|NCT01323530|42001161|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
19552522|NCT01313637|42001182|FG000|Overall Study|Adverse Event|17|||
19739084|NCT03546621|42186134|FG003|Overall Study|Progressive disease|1|||
19739085|NCT02761330|42186144|FG000|Treatment Week 1|Withdrawal by Subject|0|||
19468310|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
19468311|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Death|6|||
19468312|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Death|2|||
19468313|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Death|2|||
19468314|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Death|9|||
19468315|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
19468316|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
19468317|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
19552523|NCT01313637|42001183|FG001|Overall Study|Adverse Event|24|||
19552524|NCT01313637|42001184|FG002|Overall Study|Adverse Event|25|||
19552525|NCT01313637|42001185|FG003|Overall Study|Adverse Event|18|||
19552526|NCT01313637|42001182|FG000|Overall Study|Lack of Efficacy|44|||
19552527|NCT01313637|42001183|FG001|Overall Study|Lack of Efficacy|38|||
19552528|NCT01313637|42001184|FG002|Overall Study|Lack of Efficacy|37|||
19552529|NCT01313637|42001185|FG003|Overall Study|Lack of Efficacy|24|||
19552530|NCT01313637|42001182|FG000|Overall Study|Protocol Violation|4|||
19552531|NCT01313637|42001183|FG001|Overall Study|Protocol Violation|3|||
19552532|NCT01313637|42001184|FG002|Overall Study|Protocol Violation|11|||
19552533|NCT01313637|42001185|FG003|Overall Study|Protocol Violation|5|||
19552534|NCT01313637|42001182|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
19552535|NCT01313637|42001183|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
19552536|NCT01313637|42001184|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
19552537|NCT01313637|42001185|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
19552538|NCT01313637|42001182|FG000|Overall Study|Lost to Follow-up|0|||
19552539|NCT01313637|42001183|FG001|Overall Study|Lost to Follow-up|2|||
19552540|NCT01313637|42001184|FG002|Overall Study|Lost to Follow-up|1|||
19552541|NCT01313637|42001185|FG003|Overall Study|Lost to Follow-up|3|||
19552542|NCT01313637|42001182|FG000|Overall Study|Withdrawal by Subject|11|||
19552543|NCT01313637|42001183|FG001|Overall Study|Withdrawal by Subject|13|||
19552544|NCT01313637|42001184|FG002|Overall Study|Withdrawal by Subject|18|||
19552545|NCT01313637|42001185|FG003|Overall Study|Withdrawal by Subject|15|||
19552546|NCT01320722|42001200|FG000|Overall Study|Did not Receive Intervention|3|||
19552547|NCT01320722|42001201|FG001|Overall Study|Did not Receive Intervention|2|||
19552548|NCT01320722|42001202|FG002|Overall Study|Did not Receive Intervention|1|||
19552549|NCT01320722|42001203|FG003|Overall Study|Did not Receive Intervention|1|||
19552550|NCT01320722|42001204|FG004|Overall Study|Did not Receive Intervention|2|||
19552551|NCT01320722|42001200|FG000|Overall Study|Lost to Follow-up|0|||
19552552|NCT01320722|42001201|FG001|Overall Study|Lost to Follow-up|1|||
19552553|NCT01320722|42001202|FG002|Overall Study|Lost to Follow-up|0|||
19552554|NCT01320722|42001203|FG003|Overall Study|Lost to Follow-up|1|||
19552555|NCT01320722|42001204|FG004|Overall Study|Lost to Follow-up|3|||
19552556|NCT01320722|42001200|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
19552557|NCT01320722|42001201|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
19552558|NCT01320722|42001202|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
19552559|NCT01320722|42001203|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
19552560|NCT01320722|42001204|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
19552561|NCT01320722|42001200|FG000|Overall Study|Participant Developed a Rash|0|||
19552562|NCT01320722|42001201|FG001|Overall Study|Participant Developed a Rash|0|||
19552563|NCT01320722|42001202|FG002|Overall Study|Participant Developed a Rash|2|||
19552564|NCT01320722|42001203|FG003|Overall Study|Participant Developed a Rash|1|||
19552565|NCT01320722|42001204|FG004|Overall Study|Participant Developed a Rash|1|||
19552566|NCT01320722|42001200|FG000|Overall Study|Non-compliant with Medication|0|||
19552567|NCT01320722|42001201|FG001|Overall Study|Non-compliant with Medication|0|||
19552568|NCT01320722|42001202|FG002|Overall Study|Non-compliant with Medication|1|||
19552569|NCT01320722|42001203|FG003|Overall Study|Non-compliant with Medication|0|||
19552570|NCT01320722|42001204|FG004|Overall Study|Non-compliant with Medication|0|||
19552571|NCT01320722|42001200|FG000|Overall Study|Adverse Event|0|||
19552572|NCT01320722|42001201|FG001|Overall Study|Adverse Event|0|||
19552573|NCT01320722|42001202|FG002|Overall Study|Adverse Event|3|||
19552574|NCT01320722|42001203|FG003|Overall Study|Adverse Event|6|||
19552575|NCT01320722|42001204|FG004|Overall Study|Adverse Event|0|||
19552576|NCT01320722|42001200|FG000|Overall Study|Not Compliant with Study Procedures|0|||
19552577|NCT01320722|42001201|FG001|Overall Study|Not Compliant with Study Procedures|0|||
19552578|NCT01320722|42001202|FG002|Overall Study|Not Compliant with Study Procedures|0|||
19552579|NCT01320722|42001203|FG003|Overall Study|Not Compliant with Study Procedures|4|||
19552580|NCT01320722|42001204|FG004|Overall Study|Not Compliant with Study Procedures|0|||
19552581|NCT01320722|42001200|FG000|Overall Study|Pregnancy|0|||
19552582|NCT01320722|42001201|FG001|Overall Study|Pregnancy|0|||
19552583|NCT01320722|42001202|FG002|Overall Study|Pregnancy|0|||
19552584|NCT01320722|42001203|FG003|Overall Study|Pregnancy|1|||
19552585|NCT01320722|42001204|FG004|Overall Study|Pregnancy|0|||
19552586|NCT01320722|42001200|FG000|Overall Study|Started an Exclusionary Medication|0|||
19552587|NCT01320722|42001201|FG001|Overall Study|Started an Exclusionary Medication|0|||
19552588|NCT01320722|42001202|FG002|Overall Study|Started an Exclusionary Medication|0|||
19552589|NCT01320722|42001203|FG003|Overall Study|Started an Exclusionary Medication|0|||
19552590|NCT01320722|42001204|FG004|Overall Study|Started an Exclusionary Medication|1|||
19552591|NCT01320722|42001200|FG000|Overall Study|Withdrew due to Health Condition|0|||
19552592|NCT01320722|42001201|FG001|Overall Study|Withdrew due to Health Condition|0|||
19552593|NCT01320722|42001202|FG002|Overall Study|Withdrew due to Health Condition|0|||
19552594|NCT01320722|42001203|FG003|Overall Study|Withdrew due to Health Condition|0|||
19552595|NCT01320722|42001204|FG004|Overall Study|Withdrew due to Health Condition|1|||
19552596|NCT01313559|42001221|FG000|Overall Study|Withdrawal by Subject|1|||
19552597|NCT01313559|42001222|FG001|Overall Study|Withdrawal by Subject|2|||
19552598|NCT01313559|42001221|FG000|Overall Study|Disease progression|1|||
19552599|NCT01313559|42001222|FG001|Overall Study|Disease progression|0|||
19552600|NCT01313559|42001221|FG000|Overall Study|Rising PSA|2|||
19552601|NCT01313559|42001222|FG001|Overall Study|Rising PSA|0|||
19552602|NCT01312779|42001228|FG000|Overall Study|Withdrawal by Subject|2|||
19552603|NCT01312779|42001228|FG000|Overall Study|Death|3|||
19552604|NCT01312779|42001228|FG000|Overall Study|Not Implanted with Device|27|||
19552605|NCT01312467|42001241|FG000|Overall Study|Adverse Event|4|||
19552606|NCT01312467|42001241|FG000|Overall Study|Lost to Follow-up|1|||
19552607|NCT01312467|42001241|FG000|Overall Study|Withdrawal by Subject|2|||
19552608|NCT01312467|42001241|FG000|Overall Study|Deported to country of origin|1|||
19552609|NCT01312467|42001241|FG000|Overall Study|Another medical condition|1|||
19552610|NCT01312467|42001241|FG000|Overall Study|Ineligible|4|||
19552611|NCT01310127|42001248|FG000|Overall Study|Protocol Violation|1|||
19552612|NCT01310127|42001249|FG001|Overall Study|Protocol Violation|1|||
19552613|NCT01310127|42001248|FG000|Overall Study|advanced psc cataract outlier|1|||
19552614|NCT01310127|42001249|FG001|Overall Study|advanced psc cataract outlier|0|||
19552615|NCT01309893|42001255|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
19552616|NCT01309893|42001256|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
19552617|NCT01309893|42001255|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
19552618|NCT01309893|42001256|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
19552619|NCT01318902|42001266|FG000|Overall Study|Symptomatic Deterioration|0|||
19552620|NCT01318902|42001267|FG001|Overall Study|Symptomatic Deterioration|1|||
19552621|NCT01318902|42001268|FG002|Overall Study|Symptomatic Deterioration|1|||
19552622|NCT01318902|42001269|FG003|Overall Study|Symptomatic Deterioration|2|||
19552623|NCT01318902|42001266|FG000|Overall Study|Withdrawal by Patient|0|||
19552624|NCT01318902|42001267|FG001|Overall Study|Withdrawal by Patient|1|||
19552625|NCT01318902|42001268|FG002|Overall Study|Withdrawal by Patient|0|||
19552626|NCT01318902|42001269|FG003|Overall Study|Withdrawal by Patient|3|||
19552627|NCT01318902|42001266|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
19552628|NCT01318902|42001267|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
19552629|NCT01318902|42001268|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
19552630|NCT01318902|42001269|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
19552631|NCT01318902|42001266|FG000|Overall Study|Adverse Event|0|||
19552632|NCT01318902|42001267|FG001|Overall Study|Adverse Event|1|||
19552633|NCT01318902|42001268|FG002|Overall Study|Adverse Event|0|||
19552634|NCT01318902|42001269|FG003|Overall Study|Adverse Event|0|||
19552635|NCT01318902|42001266|FG000|Overall Study|Terminated by Sponsor|0|||
19552636|NCT01318902|42001267|FG001|Overall Study|Terminated by Sponsor|0|||
19552637|NCT01318902|42001268|FG002|Overall Study|Terminated by Sponsor|1|||
19552638|NCT01318902|42001269|FG003|Overall Study|Terminated by Sponsor|0|||
19552639|NCT01313858|42001284|FG000|Overall Study|Premature Treatment Termination|251|||
19552640|NCT01313858|42001285|FG001|Overall Study|Premature Treatment Termination|219|||
19552641|NCT01313858|42001286|FG002|Overall Study|Premature Treatment Termination|191|||
19552642|NCT01313858|42001284|FG000|Overall Study|Lost to Follow-up|35|||
19552643|NCT01313858|42001285|FG001|Overall Study|Lost to Follow-up|51|||
19552644|NCT01313858|42001286|FG002|Overall Study|Lost to Follow-up|47|||
19552645|NCT01090765|42001298|FG000|Overall Study|Patient withdrew consent|0|||
19552646|NCT01090765|42001299|FG001|Overall Study|Patient withdrew consent|0|||
19552647|NCT01090765|42001300|FG002|Overall Study|Patient withdrew consent|0|||
19552648|NCT01090765|42001301|FG003|Overall Study|Patient withdrew consent|0|||
19552649|NCT01090765|42001302|FG004|Overall Study|Patient withdrew consent|1|||
19552650|NCT01090765|42001303|FG005|Overall Study|Patient withdrew consent|1|||
19552651|NCT01090765|42001298|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
19552652|NCT01090765|42001299|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
19552653|NCT01090765|42001300|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
19552654|NCT01090765|42001301|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
19552655|NCT01090765|42001302|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
19739086|NCT02761330|42186145|FG001|Treatment Week 1|Withdrawal by Subject|0|||
19739087|NCT02761330|42186146|FG002|Treatment Week 1|Withdrawal by Subject|0|||
19468318|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
19468319|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
19468320|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
19552656|NCT01090765|42001303|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
19552657|NCT01090765|42001298|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
19552658|NCT01090765|42001299|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
19552659|NCT01090765|42001300|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
19552660|NCT01090765|42001301|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
19552661|NCT01090765|42001302|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
19552662|NCT01090765|42001303|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
19552663|NCT01313780|42001320|FG000|Overall Study|Lack of Efficacy|4|||
19552664|NCT01313780|42001321|FG001|Overall Study|Lack of Efficacy|2|||
19552665|NCT01313780|42001320|FG000|Overall Study|Adverse Event|6|||
19552666|NCT01313780|42001321|FG001|Overall Study|Adverse Event|11|||
19552667|NCT01313780|42001320|FG000|Overall Study|Withdrawal by Subject|2|||
19552668|NCT01313780|42001321|FG001|Overall Study|Withdrawal by Subject|8|||
19468321|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
19468322|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
19468323|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
19468324|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
19468325|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
19468326|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
19552669|NCT01313780|42001320|FG000|Overall Study|Protocol Violation|10|||
19552670|NCT01313780|42001321|FG001|Overall Study|Protocol Violation|4|||
19552671|NCT01313780|42001320|FG000|Overall Study|missing data|3|||
19552672|NCT01313780|42001321|FG001|Overall Study|missing data|3|||
19552673|NCT01090453|42001329|FG000|Overall Study|Withdrawal by Subject|1|||
19552674|NCT01090453|42001330|FG001|Overall Study|Withdrawal by Subject|2|||
19552675|NCT01090453|42001329|FG000|Overall Study|Lost to Follow-up|7|||
19552676|NCT01090453|42001330|FG001|Overall Study|Lost to Follow-up|7|||
19552677|NCT01090453|42001329|FG000|Overall Study|Non serious AEs|1|||
19552678|NCT01090453|42001330|FG001|Overall Study|Non serious AEs|0|||
19552679|NCT01090453|42001329|FG000|Overall Study|Protocol Violation|2|||
19552680|NCT01090453|42001330|FG001|Overall Study|Protocol Violation|0|||
19552681|NCT01090453|42001329|FG000|Overall Study|Other|2|||
19552682|NCT01090453|42001330|FG001|Overall Study|Other|4|||
19552683|NCT01090453|42001329|FG000|Overall Study|Eligibility Criteria|0|||
19552684|NCT01090453|42001330|FG001|Overall Study|Eligibility Criteria|1|||
19552685|NCT01171612|42001336|FG000|Overall Study|Lost to Follow-up|51|||
19468327|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
19468328|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
19468329|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
19468330|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
19468331|NCT03730662|41734968|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
19468332|NCT03730662|41734969|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
19468333|NCT03730662|41734970|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
19468334|NCT03730662|41734971|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
19468335|NCT03730662|41734968|FG000|Variable Treatment Period|Adverse Event|1|||
19468336|NCT03730662|41734969|FG001|Variable Treatment Period|Adverse Event|2|||
19468337|NCT03730662|41734970|FG002|Variable Treatment Period|Adverse Event|0|||
19468338|NCT03730662|41734971|FG003|Variable Treatment Period|Adverse Event|7|||
19552686|NCT01171534|42001345|FG000|Overall Study|Lost to Follow-up|0|||
19552687|NCT01171534|42001346|FG001|Overall Study|Lost to Follow-up|2|||
19552688|NCT01171534|42001345|FG000|Overall Study|screen failure|0|||
19552689|NCT01171534|42001346|FG001|Overall Study|screen failure|1|||
19552690|NCT01170598|42001352|FG000|Overall Study|Withdrawal by Subject|1|||
19552691|NCT01170598|42001352|FG000|Overall Study|Death|3|||
19552692|NCT01170598|42001352|FG000|Overall Study|Lost to Follow-up|1|||
19552693|NCT01170598|42001352|FG000|Overall Study|Refused|1|||
19552694|NCT01170364|42001358|FG000|Overall Study|Protocol Violation|4|||
19552695|NCT01170364|42001359|FG001|Overall Study|Protocol Violation|1|||
19468339|NCT03730662|41734968|FG000|Variable Treatment Period|Death|9|||
19468340|NCT03730662|41734969|FG001|Variable Treatment Period|Death|0|||
19468341|NCT03730662|41734970|FG002|Variable Treatment Period|Death|6|||
19552696|NCT01076179|42001365|FG000|Overall Study|Withdrawal by Subject|1|||
19552697|NCT01170208|42001373|FG000|Overall Study|Withdrawal by Subject|5|||
19552698|NCT01170208|42001374|FG001|Overall Study|Withdrawal by Subject|0|||
19552699|NCT01170208|42001375|FG002|Overall Study|Withdrawal by Subject|1|||
19552700|NCT01170208|42001373|FG000|Overall Study|Protocol Violation|1|||
19552701|NCT01170208|42001374|FG001|Overall Study|Protocol Violation|0|||
19552702|NCT01170208|42001375|FG002|Overall Study|Protocol Violation|1|||
19552703|NCT01313624|42001388|FG000|Double-Blind Phase|Adverse Event|27|||
19552704|NCT01313624|42001389|FG001|Double-Blind Phase|Adverse Event|4|||
19552705|NCT01313624|42001388|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
19552706|NCT01313624|42001389|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
19468342|NCT03730662|41734971|FG003|Variable Treatment Period|Death|26|||
19468343|NCT03730662|41734968|FG000|Variable Treatment Period|Lost to Follow-up|2|||
19468344|NCT03730662|41734969|FG001|Variable Treatment Period|Lost to Follow-up|1|||
19468345|NCT03730662|41734970|FG002|Variable Treatment Period|Lost to Follow-up|4|||
19468346|NCT03730662|41734971|FG003|Variable Treatment Period|Lost to Follow-up|11|||
19468347|NCT03730662|41734968|FG000|Variable Treatment Period|Personal Reason|0|||
19468348|NCT03730662|41734969|FG001|Variable Treatment Period|Personal Reason|2|||
19468349|NCT03730662|41734970|FG002|Variable Treatment Period|Personal Reason|1|||
19468350|NCT03730662|41734971|FG003|Variable Treatment Period|Personal Reason|6|||
19468351|NCT03730662|41734968|FG000|Variable Treatment Period|Physician Decision|0|||
19468352|NCT03730662|41734969|FG001|Variable Treatment Period|Physician Decision|0|||
19468353|NCT03730662|41734970|FG002|Variable Treatment Period|Physician Decision|0|||
19468354|NCT03730662|41734971|FG003|Variable Treatment Period|Physician Decision|3|||
19468355|NCT03730662|41734968|FG000|Variable Treatment Period|Protocol Violation|0|||
19468356|NCT03730662|41734969|FG001|Variable Treatment Period|Protocol Violation|1|||
19468357|NCT03730662|41734970|FG002|Variable Treatment Period|Protocol Violation|1|||
19468358|NCT03730662|41734971|FG003|Variable Treatment Period|Protocol Violation|1|||
19552707|NCT01313624|42001388|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19552708|NCT01313624|42001389|FG001|Double-Blind Phase|Lost to Follow-up|2|||
19552709|NCT01313624|42001388|FG000|Double-Blind Phase|Physician Decision|1|||
19552710|NCT01313624|42001389|FG001|Double-Blind Phase|Physician Decision|0|||
19552711|NCT01313624|42001388|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19552712|NCT01313624|42001389|FG001|Double-Blind Phase|Lack of Efficacy|0|||
19468359|NCT03730662|41734968|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
19552713|NCT01313624|42001388|FG000|Open-Label Phase|Adverse Event|1|||
19552714|NCT01313624|42001389|FG001|Open-Label Phase|Adverse Event|10|||
19552715|NCT01313624|42001388|FG000|Open-Label Phase|Withdrawal by Subject|2|||
19552716|NCT01313624|42001389|FG001|Open-Label Phase|Withdrawal by Subject|2|||
19552717|NCT01313624|42001388|FG000|Open-Label Phase|Lost to Follow-up|1|||
19552718|NCT01313624|42001389|FG001|Open-Label Phase|Lost to Follow-up|1|||
19552719|NCT01169350|42001397|FG000|Overall Study|Physician Decision|3|||
19552720|NCT01169350|42001397|FG000|Overall Study|Lost to Follow-up|2|||
19739088|NCT02761330|42186147|FG003|Treatment Week 1|Withdrawal by Subject|1|||
19739089|NCT02761330|42186148|FG004|Treatment Week 1|Withdrawal by Subject|0|||
19739090|NCT02761330|42186149|FG005|Treatment Week 1|Withdrawal by Subject|1|||
19739091|NCT03559257|42186165|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
19739092|NCT03559257|42186166|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
19739093|NCT03559257|42186165|FG000|Double Blind Treatment Period|Protocol Violation|1|||
19468360|NCT03730662|41734969|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
19468361|NCT03730662|41734970|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
19468362|NCT03730662|41734971|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
19468363|NCT03185832|41735086|FG000|Overall Study|Death|9|||
19468364|NCT03185832|41735087|FG001|Overall Study|Death|14|||
19468365|NCT03185832|41735088|FG002|Overall Study|Death|9|||
19468366|NCT03185832|41735089|FG003|Overall Study|Death|7|||
19468367|NCT03185832|41735086|FG000|Overall Study|Withdrawn - vital status available|0|||
19552721|NCT01169038|42001401|FG000|Overall Study|Death|1|||
19552722|NCT01169038|42001401|FG000|Overall Study|Adverse Event|5|||
19552723|NCT01169038|42001401|FG000|Overall Study|Required antibiotic administration|1|||
19552724|NCT01167634|42001409|FG000|Overall Study|Lost to Follow-up|1|||
19552725|NCT01167634|42001410|FG001|Overall Study|Lost to Follow-up|3|||
19552726|NCT01167634|42001411|FG002|Overall Study|Lost to Follow-up|3|||
19468368|NCT03185832|41735087|FG001|Overall Study|Withdrawn - vital status available|1|||
19468369|NCT03185832|41735088|FG002|Overall Study|Withdrawn - vital status available|1|||
19468370|NCT03185832|41735089|FG003|Overall Study|Withdrawn - vital status available|4|||
19468371|NCT04569786|41735141|FG000|Overall Study|Lost to Follow-up|1|||
19552727|NCT01167634|42001412|FG003|Overall Study|Lost to Follow-up|4|||
19552728|NCT01167634|42001409|FG000|Overall Study|Withdrawal by Subject|1|||
19739094|NCT03559257|42186166|FG001|Double Blind Treatment Period|Protocol Violation|4|||
19739095|NCT03559257|42186165|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
19739096|NCT03559257|42186166|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
19739097|NCT03559257|42186165|FG000|Double Blind Treatment Period|Adverse Event|0|||
19739098|NCT03559257|42186166|FG001|Double Blind Treatment Period|Adverse Event|1|||
19468372|NCT04569786|41735142|FG001|Overall Study|Lost to Follow-up|0|||
19468373|NCT04569786|41735143|FG002|Overall Study|Lost to Follow-up|4|||
19468374|NCT04569786|41735144|FG003|Overall Study|Lost to Follow-up|1|||
19468375|NCT04569786|41735145|FG004|Overall Study|Lost to Follow-up|0|||
19552729|NCT01167634|42001410|FG001|Overall Study|Withdrawal by Subject|1|||
19552730|NCT01167634|42001411|FG002|Overall Study|Withdrawal by Subject|0|||
19552731|NCT01167634|42001412|FG003|Overall Study|Withdrawal by Subject|0|||
19468376|NCT04569786|41735141|FG000|Overall Study|Withdrawal by Subject|0|||
19552732|NCT01166386|42001424|FG000|Overall Study|Withdrawal by Subject|3|||
19552733|NCT01166386|42001425|FG001|Overall Study|Withdrawal by Subject|5|||
19552734|NCT01114828|42001433|FG000|Overall Study|Adverse Event|1|||
19739099|NCT03559257|42186165|FG000|Double Blind Treatment Period|Screen Failure|0|||
19468377|NCT04569786|41735142|FG001|Overall Study|Withdrawal by Subject|0|||
19552735|NCT01114828|42001434|FG001|Overall Study|Adverse Event|1|||
19552736|NCT01114828|42001433|FG000|Overall Study|Lack of Efficacy|0|||
19552737|NCT01114828|42001434|FG001|Overall Study|Lack of Efficacy|2|||
19552738|NCT01114828|42001433|FG000|Overall Study|Protocol Violation|2|||
19552739|NCT01114828|42001434|FG001|Overall Study|Protocol Violation|0|||
19552740|NCT01114828|42001433|FG000|Overall Study|Withdrawal by Subject|0|||
19552741|NCT01114828|42001434|FG001|Overall Study|Withdrawal by Subject|1|||
19552742|NCT01313312|42001440|FG000|Overall Study|Adverse Event|5|||
19552743|NCT01313312|42001440|FG000|Overall Study|Withdrawal by Subject|18|||
19552744|NCT01313312|42001440|FG000|Overall Study|Lack of Efficacy|3|||
19552745|NCT01313312|42001440|FG000|Overall Study|Investigator Decision|1|||
19552746|NCT01313312|42001440|FG000|Overall Study|Observational Phase|1|||
19552747|NCT01313312|42001440|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
19552748|NCT01313312|42001440|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
19552749|NCT01114672|42001446|FG000|Overall Study|Death|0|||
19552750|NCT01114672|42001447|FG001|Overall Study|Death|1|||
19552751|NCT01114672|42001446|FG000|Overall Study|Withdrawal by Subject|2|||
19552752|NCT01114672|42001447|FG001|Overall Study|Withdrawal by Subject|1|||
19552753|NCT01114672|42001446|FG000|Overall Study|Lost to Follow-up|1|||
19552754|NCT01114672|42001447|FG001|Overall Study|Lost to Follow-up|0|||
19552755|NCT01114672|42001446|FG000|Overall Study|transplanted|1|||
19552756|NCT01114672|42001447|FG001|Overall Study|transplanted|0|||
19552757|NCT01114516|42001455|FG000|Overall Study|Lost to Follow-up|2|||
19552758|NCT01114516|42001456|FG001|Overall Study|Lost to Follow-up|1|||
19552759|NCT01114438|42001462|FG000|Overall Study|Adverse Event|10|||
19552760|NCT01114438|42001462|FG000|Overall Study|concomitant medication|1|||
19552761|NCT01114438|42001462|FG000|Overall Study|Physician Decision|1|||
19552762|NCT01114438|42001462|FG000|Overall Study|Withdrawal by Subject|2|||
19552763|NCT01313078|42001471|FG000|Overall Study|Death|1|||
19552764|NCT01313078|42001471|FG000|Overall Study|Discontinued study drug|1|||
19552765|NCT01313078|42001471|FG000|Overall Study|Withdrawal by Subject|1|||
19552766|NCT01114360|42001475|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
19552767|NCT01114360|42001476|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
19552768|NCT01310036|42001496|FG000|Overall Study|Administrative/other|10|||
19739100|NCT03559257|42186166|FG001|Double Blind Treatment Period|Screen Failure|1|||
19739101|NCT03559257|42186165|FG000|Open-label Treatment Period|Adverse Event|1|||
19739102|NCT03559257|42186166|FG001|Open-label Treatment Period|Adverse Event|4|||
19739103|NCT03559257|42186165|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
19739104|NCT03559257|42186166|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
19739105|NCT03559257|42186165|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
19739106|NCT03559257|42186166|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
19739107|NCT03559257|42186165|FG000|Open-label Treatment Period|Protocol Violation|2|||
19739108|NCT03559257|42186166|FG001|Open-label Treatment Period|Protocol Violation|0|||
19739109|NCT03559257|42186165|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
19739110|NCT03559257|42186166|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
19739111|NCT03559257|42186165|FG000|Open-label Treatment Period|Physician Decision|0|||
19739112|NCT03559257|42186166|FG001|Open-label Treatment Period|Physician Decision|1|||
19739113|NCT02892513|42186177|FG000|Overall Study|Withdrawal by Subject|0|||
19739114|NCT02892513|42186178|FG001|Overall Study|Withdrawal by Subject|1|||
19739115|NCT03558555|42186186|FG000|Overall Study|Lost to Follow-up|2|||
19739116|NCT03558555|42186187|FG001|Overall Study|Lost to Follow-up|1|||
19739117|NCT03541317|42186195|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
19739118|NCT03541317|42186196|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
19739119|NCT03541317|42186197|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
19739120|NCT03541317|42186198|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
19468378|NCT04569786|41735143|FG002|Overall Study|Withdrawal by Subject|0|||
19552769|NCT01310036|42001496|FG000|Overall Study|Withdrew Consent|11|||
19552770|NCT01310036|42001496|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
19552771|NCT01310036|42001496|FG000|Overall Study|Progression of Disease|164|||
19468379|NCT04569786|41735144|FG003|Overall Study|Withdrawal by Subject|5|||
19552772|NCT01310036|42001496|FG000|Overall Study|Death|1|||
19552773|NCT01310036|42001496|FG000|Overall Study|Adverse event or intercurrent illness|12|||
19739121|NCT03541317|42186199|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
19739122|NCT03541317|42186200|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
19468380|NCT04569786|41735145|FG004|Overall Study|Withdrawal by Subject|1|||
19468381|NCT04569786|41735141|FG000|Overall Study|Physician Decision|0|||
19468382|NCT04569786|41735142|FG001|Overall Study|Physician Decision|0|||
19468383|NCT04569786|41735143|FG002|Overall Study|Physician Decision|0|||
19468384|NCT04569786|41735144|FG003|Overall Study|Physician Decision|1|||
19468385|NCT04569786|41735145|FG004|Overall Study|Physician Decision|0|||
19468386|NCT01826981|41735321|FG000|Overall Study|Lack of Efficacy|0|||
19468387|NCT01826981|41735322|FG001|Overall Study|Lack of Efficacy|1|||
19468388|NCT01826981|41735323|FG002|Overall Study|Lack of Efficacy|0|||
19468389|NCT01826981|41735324|FG003|Overall Study|Lack of Efficacy|0|||
19468390|NCT01826981|41735325|FG004|Overall Study|Lack of Efficacy|5|||
19468391|NCT01826981|41735326|FG005|Overall Study|Lack of Efficacy|0|||
19468392|NCT01826981|41735327|FG006|Overall Study|Lack of Efficacy|0|||
19468393|NCT01826981|41735328|FG007|Overall Study|Lack of Efficacy|8|||
19468394|NCT01826981|41735329|FG008|Overall Study|Lack of Efficacy|7|||
19468395|NCT01826981|41735330|FG009|Overall Study|Lack of Efficacy|0|||
19468396|NCT01826981|41735331|FG010|Overall Study|Lack of Efficacy|1|||
19468397|NCT01826981|41735332|FG011|Overall Study|Lack of Efficacy|0|||
19468398|NCT01826981|41735333|FG012|Overall Study|Lack of Efficacy|0|||
19468399|NCT01826981|41735334|FG013|Overall Study|Lack of Efficacy|3|||
19468400|NCT01826981|41735335|FG014|Overall Study|Lack of Efficacy|0|||
19468401|NCT01826981|41735321|FG000|Overall Study|Lost to Follow-up|0|||
19468402|NCT01826981|41735322|FG001|Overall Study|Lost to Follow-up|0|||
19468403|NCT01826981|41735323|FG002|Overall Study|Lost to Follow-up|0|||
19468404|NCT01826981|41735324|FG003|Overall Study|Lost to Follow-up|0|||
19468405|NCT01826981|41735325|FG004|Overall Study|Lost to Follow-up|1|||
19468406|NCT01826981|41735326|FG005|Overall Study|Lost to Follow-up|1|||
19468407|NCT01826981|41735327|FG006|Overall Study|Lost to Follow-up|0|||
19468408|NCT01826981|41735328|FG007|Overall Study|Lost to Follow-up|1|||
19468409|NCT01826981|41735329|FG008|Overall Study|Lost to Follow-up|0|||
19468410|NCT01826981|41735330|FG009|Overall Study|Lost to Follow-up|1|||
19468411|NCT01826981|41735331|FG010|Overall Study|Lost to Follow-up|1|||
19468412|NCT01826981|41735332|FG011|Overall Study|Lost to Follow-up|1|||
19468413|NCT01826981|41735333|FG012|Overall Study|Lost to Follow-up|1|||
19468414|NCT01826981|41735334|FG013|Overall Study|Lost to Follow-up|0|||
19468415|NCT01826981|41735335|FG014|Overall Study|Lost to Follow-up|0|||
19468416|NCT01826981|41735321|FG000|Overall Study|Withdrew Consent|0|||
19468417|NCT01826981|41735322|FG001|Overall Study|Withdrew Consent|0|||
19468418|NCT01826981|41735323|FG002|Overall Study|Withdrew Consent|0|||
19468419|NCT01826981|41735324|FG003|Overall Study|Withdrew Consent|0|||
19468420|NCT01826981|41735325|FG004|Overall Study|Withdrew Consent|0|||
19468421|NCT01826981|41735326|FG005|Overall Study|Withdrew Consent|0|||
19468422|NCT01826981|41735327|FG006|Overall Study|Withdrew Consent|1|||
19468423|NCT01826981|41735328|FG007|Overall Study|Withdrew Consent|1|||
19468424|NCT01826981|41735329|FG008|Overall Study|Withdrew Consent|0|||
19468425|NCT01826981|41735330|FG009|Overall Study|Withdrew Consent|0|||
19468426|NCT01826981|41735331|FG010|Overall Study|Withdrew Consent|0|||
19468427|NCT01826981|41735332|FG011|Overall Study|Withdrew Consent|1|||
19468428|NCT01826981|41735333|FG012|Overall Study|Withdrew Consent|0|||
19468429|NCT01826981|41735334|FG013|Overall Study|Withdrew Consent|1|||
19468430|NCT01826981|41735335|FG014|Overall Study|Withdrew Consent|0|||
19468431|NCT01826981|41735321|FG000|Overall Study|Adverse Event|0|||
19468432|NCT01826981|41735322|FG001|Overall Study|Adverse Event|0|||
19468433|NCT01826981|41735323|FG002|Overall Study|Adverse Event|0|||
19468434|NCT01826981|41735324|FG003|Overall Study|Adverse Event|0|||
19468435|NCT01826981|41735325|FG004|Overall Study|Adverse Event|1|||
19468436|NCT01826981|41735326|FG005|Overall Study|Adverse Event|0|||
19468437|NCT01826981|41735327|FG006|Overall Study|Adverse Event|0|||
19468438|NCT01826981|41735328|FG007|Overall Study|Adverse Event|0|||
19552774|NCT01309100|42001500|FG000|Overall Study|Protocol Violation|1|||
19552775|NCT01309100|42001500|FG000|Overall Study|Positive Slit lamp finding|1|||
19552776|NCT01308788|42001509|FG000|2-year Treatment|medication change by treating physician|4|||
19552777|NCT01308788|42001510|FG001|2-year Treatment|medication change by treating physician|11|||
19552778|NCT01075321|42001516|FG000|Overall Study|Withdrawal by Subject|0|||
19552779|NCT01075321|42001517|FG001|Overall Study|Withdrawal by Subject|0|||
19552780|NCT01075321|42001518|FG002|Overall Study|Withdrawal by Subject|1|||
19552781|NCT01075321|42001519|FG003|Overall Study|Withdrawal by Subject|1|||
19552782|NCT01075321|42001516|FG000|Overall Study|Protocol Violation|0|||
19552783|NCT01075321|42001517|FG001|Overall Study|Protocol Violation|0|||
19552784|NCT01075321|42001518|FG002|Overall Study|Protocol Violation|1|||
19552785|NCT01075321|42001519|FG003|Overall Study|Protocol Violation|0|||
19552786|NCT01075321|42001516|FG000|Overall Study|Treatment Incomplete due to progression|1|||
19552787|NCT01075321|42001517|FG001|Overall Study|Treatment Incomplete due to progression|0|||
19552788|NCT01075321|42001518|FG002|Overall Study|Treatment Incomplete due to progression|0|||
19552789|NCT01075321|42001519|FG003|Overall Study|Treatment Incomplete due to progression|0|||
19739123|NCT03590613|42186212|FG000|Period 2, 4 Days|Physician Decision|0|||
19739124|NCT03590613|42186213|FG001|Period 2, 4 Days|Physician Decision|0|||
19739125|NCT03590613|42186214|FG002|Period 2, 4 Days|Physician Decision|0|||
19739126|NCT03590613|42186215|FG003|Period 2, 4 Days|Physician Decision|1|||
19739127|NCT03557931|42186231|FG000|Overall Study|Adverse Event|4|||
19739128|NCT03557931|42186232|FG001|Overall Study|Adverse Event|6|||
19739129|NCT03557931|42186233|FG002|Overall Study|Adverse Event|1|||
19739130|NCT03557931|42186231|FG000|Overall Study|Lost to Follow-up|4|||
19739131|NCT03557931|42186232|FG001|Overall Study|Lost to Follow-up|4|||
19739132|NCT03557931|42186233|FG002|Overall Study|Lost to Follow-up|1|||
19739133|NCT03557931|42186231|FG000|Overall Study|Protocol Violation|1|||
19552790|NCT01075321|42001516|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
19552791|NCT01075321|42001517|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
19552792|NCT01075321|42001518|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
19552793|NCT01075321|42001519|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
19552794|NCT01114204|42001533|FG000|Overall Study|Adverse Event|3|||
19552795|NCT01114204|42001534|FG001|Overall Study|Adverse Event|2|||
19552796|NCT01114204|42001533|FG000|Overall Study|Lost to Follow-up|1|||
19552797|NCT01114204|42001534|FG001|Overall Study|Lost to Follow-up|0|||
19552798|NCT01114204|42001533|FG000|Overall Study|Withdrawal by Subject|10|||
19552799|NCT01114204|42001534|FG001|Overall Study|Withdrawal by Subject|6|||
19552800|NCT01114204|42001533|FG000|Overall Study|Death|1|||
19552801|NCT01114204|42001534|FG001|Overall Study|Death|0|||
19552802|NCT01114204|42001533|FG000|Overall Study|Other-Personal reasons|2|||
19552803|NCT01114204|42001534|FG001|Overall Study|Other-Personal reasons|0|||
19552804|NCT01114204|42001533|FG000|Overall Study|Other-Medical monitor request|1|||
19552805|NCT01114204|42001534|FG001|Overall Study|Other-Medical monitor request|0|||
19552806|NCT01114204|42001533|FG000|Overall Study|Other-Participant request|2|||
19552807|NCT01114204|42001534|FG001|Overall Study|Other-Participant request|0|||
19552808|NCT01114204|42001533|FG000|Overall Study|Other-Protocol Violation|1|||
19552809|NCT01114204|42001534|FG001|Overall Study|Other-Protocol Violation|0|||
19552810|NCT01075243|42001543|FG000|Overall Study|Lost to Follow-up|5|||
19552811|NCT01075243|42001544|FG001|Overall Study|Lost to Follow-up|2|||
19552812|NCT01075243|42001545|FG002|Overall Study|Lost to Follow-up|0|||
19552813|NCT01075243|42001543|FG000|Overall Study|Withdrawal by Subject|1|||
19552814|NCT01075243|42001544|FG001|Overall Study|Withdrawal by Subject|1|||
19739134|NCT03557931|42186232|FG001|Overall Study|Protocol Violation|4|||
19739135|NCT03557931|42186233|FG002|Overall Study|Protocol Violation|1|||
19468439|NCT01826981|41735329|FG008|Overall Study|Adverse Event|0|||
19739136|NCT03557931|42186231|FG000|Overall Study|Withdrawal by Subject|14|||
19468440|NCT01826981|41735330|FG009|Overall Study|Adverse Event|0|||
19468441|NCT01826981|41735331|FG010|Overall Study|Adverse Event|0|||
19468442|NCT01826981|41735332|FG011|Overall Study|Adverse Event|0|||
19552815|NCT01075243|42001545|FG002|Overall Study|Withdrawal by Subject|0|||
19552816|NCT01308476|42001557|FG000|Overall Study|Lost to Follow-up|2|||
19552817|NCT01308476|42001558|FG001|Overall Study|Lost to Follow-up|2|||
19552818|NCT01308476|42001557|FG000|Overall Study|Other|1|||
19552819|NCT01308476|42001558|FG001|Overall Study|Other|0|||
19552820|NCT01078441|42001564|FG000|Overall Study|Withdrawal by Subject|1|||
19552821|NCT01308008|42001570|FG000|4 Weeks|Illness, disinterest, time|9|||
19552822|NCT01308008|42001571|FG001|4 Weeks|Illness, disinterest, time|2|||
19552823|NCT01113892|42001579|FG000|Overall Study|Lost to Follow-up|2|||
19552824|NCT01113892|42001580|FG001|Overall Study|Lost to Follow-up|2|||
19552825|NCT01113892|42001579|FG000|Overall Study|Withdrawal by Subject|1|||
19552826|NCT01113892|42001580|FG001|Overall Study|Withdrawal by Subject|1|||
19552827|NCT01113892|42001579|FG000|Overall Study|Death|2|||
19552828|NCT01113892|42001580|FG001|Overall Study|Death|4|||
19552829|NCT01113892|42001579|FG000|Overall Study|Graft no longer evaluable|9|||
19552830|NCT01113892|42001580|FG001|Overall Study|Graft no longer evaluable|9|||
19552831|NCT01090063|42001586|FG000|Screen|Screen Failed|4|||
19552832|NCT01090063|42001586|FG000|Treatment|Withdrawal by Subject|4|||
19552833|NCT01113580|42001602|FG000|Overall Study|Protocol Violation|1|||
19468443|NCT01826981|41735333|FG012|Overall Study|Adverse Event|0|||
19468444|NCT01826981|41735334|FG013|Overall Study|Adverse Event|0|||
19468445|NCT01826981|41735335|FG014|Overall Study|Adverse Event|0|||
19468446|NCT01826981|41735321|FG000|Overall Study|Upper G-I Haemorrhage|0|||
19468447|NCT01826981|41735322|FG001|Overall Study|Upper G-I Haemorrhage|0|||
19468448|NCT01826981|41735323|FG002|Overall Study|Upper G-I Haemorrhage|0|||
19468449|NCT01826981|41735324|FG003|Overall Study|Upper G-I Haemorrhage|0|||
19468450|NCT01826981|41735325|FG004|Overall Study|Upper G-I Haemorrhage|0|||
19468451|NCT01826981|41735326|FG005|Overall Study|Upper G-I Haemorrhage|0|||
19468452|NCT01826981|41735327|FG006|Overall Study|Upper G-I Haemorrhage|0|||
19468453|NCT01826981|41735328|FG007|Overall Study|Upper G-I Haemorrhage|0|||
19468454|NCT01826981|41735329|FG008|Overall Study|Upper G-I Haemorrhage|0|||
19468455|NCT01826981|41735330|FG009|Overall Study|Upper G-I Haemorrhage|0|||
19468456|NCT01826981|41735331|FG010|Overall Study|Upper G-I Haemorrhage|0|||
19468457|NCT01826981|41735332|FG011|Overall Study|Upper G-I Haemorrhage|0|||
19468458|NCT01826981|41735333|FG012|Overall Study|Upper G-I Haemorrhage|0|||
19468459|NCT01826981|41735334|FG013|Overall Study|Upper G-I Haemorrhage|1|||
19468460|NCT01826981|41735335|FG014|Overall Study|Upper G-I Haemorrhage|0|||
19468461|NCT01826981|41735321|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468462|NCT01826981|41735322|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468463|NCT01826981|41735323|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468464|NCT01826981|41735324|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468465|NCT01826981|41735325|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468466|NCT01826981|41735326|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468467|NCT01826981|41735327|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468468|NCT01826981|41735328|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
19468469|NCT01826981|41735329|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468470|NCT01826981|41735330|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468471|NCT01826981|41735331|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468472|NCT01826981|41735332|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468473|NCT01826981|41735333|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468474|NCT01826981|41735334|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468475|NCT01826981|41735335|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
19468476|NCT01804049|41735407|FG000|Overall Study|Adverse Event|2|||
19468477|NCT01804049|41735408|FG001|Overall Study|Adverse Event|10|||
19468478|NCT01804049|41735407|FG000|Overall Study|Lost to Follow-up|2|||
19468479|NCT01804049|41735408|FG001|Overall Study|Lost to Follow-up|1|||
19468480|NCT01804049|41735407|FG000|Overall Study|Decreased interest/personal|4|||
19468481|NCT01804049|41735408|FG001|Overall Study|Decreased interest/personal|5|||
19468482|NCT01804049|41735407|FG000|Overall Study|Other health concerns|2|||
19468483|NCT01804049|41735408|FG001|Overall Study|Other health concerns|7|||
19468484|NCT01804049|41735407|FG000|Overall Study|Moved out of area|0|||
19468485|NCT01804049|41735408|FG001|Overall Study|Moved out of area|7|||
19468486|NCT01804049|41735407|FG000|Overall Study|other MD recommended|1|||
19468487|NCT01804049|41735408|FG001|Overall Study|other MD recommended|1|||
19468488|NCT01804049|41735407|FG000|Overall Study|Enrollment in dual studies|0|||
19468489|NCT01804049|41735408|FG001|Overall Study|Enrollment in dual studies|1|||
19468490|NCT01826825|41735418|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
19468491|NCT01826825|41735419|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
19468492|NCT01803737|41735429|FG000|Overall Study|Lack of Time|1|||
19552834|NCT01113580|42001603|FG001|Overall Study|Protocol Violation|0|||
19468493|NCT01803737|41735430|FG001|Overall Study|Lack of Time|0|||
19468494|NCT01803737|41735429|FG000|Overall Study|Medical Reason|0|||
19468495|NCT01803737|41735430|FG001|Overall Study|Medical Reason|1|||
19468496|NCT01803737|41735429|FG000|Overall Study|Lost to Follow-up|0|||
19468497|NCT01803737|41735430|FG001|Overall Study|Lost to Follow-up|2|||
19468498|NCT01826201|41735436|FG000|Overall Study|Non compliance with protocol|4|||
19468499|NCT01803269|41735467|FG000|Overall Study|Withdrawal by Subject|3|||
19468500|NCT01803269|41735468|FG001|Overall Study|Withdrawal by Subject|0|||
19468501|NCT01803269|41735469|FG002|Overall Study|Withdrawal by Subject|0|||
19468502|NCT01802879|41735477|FG000|Overall Study|Administrative problems|2|||
19468503|NCT01802879|41735477|FG000|Overall Study|Disease progression|6|||
19468504|NCT01825577|41735481|FG000|Overall Study|Physician Decision|2|||
19468505|NCT01825577|41735481|FG000|Overall Study|Withdrawal by Subject|1|||
19468506|NCT01825577|41735481|FG000|Overall Study|Withdrawn by family members|2|||
19468507|NCT01825577|41735481|FG000|Overall Study|Lack of Efficacy|3|||
19552835|NCT01306214|42001612|FG000|Overall Study|Death|0|||
19552836|NCT01306214|42001613|FG001|Overall Study|Death|0|||
19552837|NCT01306214|42001614|FG002|Overall Study|Death|1|||
19552838|NCT01306214|42001612|FG000|Overall Study|Lost to Follow-up|3|||
19552839|NCT01306214|42001613|FG001|Overall Study|Lost to Follow-up|5|||
19552840|NCT01306214|42001614|FG002|Overall Study|Lost to Follow-up|4|||
19552841|NCT01306214|42001612|FG000|Overall Study|Withdrawal by Subject|24|||
19552842|NCT01306214|42001613|FG001|Overall Study|Withdrawal by Subject|22|||
19552843|NCT01306214|42001614|FG002|Overall Study|Withdrawal by Subject|16|||
19552844|NCT01306214|42001612|FG000|Overall Study|Not treated|1|||
19552845|NCT01306214|42001613|FG001|Overall Study|Not treated|1|||
19552846|NCT01306214|42001614|FG002|Overall Study|Not treated|1|||
19552847|NCT01077739|42001624|FG000|Overall Study|Premature withdrawal|1|||
19552848|NCT01077739|42001625|FG001|Overall Study|Premature withdrawal|3|||
19552849|NCT01077739|42001624|FG000|Overall Study|Withdrawal by Subject|1|||
19552850|NCT01077739|42001625|FG001|Overall Study|Withdrawal by Subject|0|||
19552851|NCT01077739|42001624|FG000|Overall Study|Death|0|||
19552852|NCT01077739|42001625|FG001|Overall Study|Death|3|||
19552853|NCT01077739|42001624|FG000|Overall Study|Unacceptable toxicity|1|||
19552854|NCT01077739|42001625|FG001|Overall Study|Unacceptable toxicity|2|||
19552855|NCT01077739|42001624|FG000|Overall Study|Other|2|||
19552856|NCT01077739|42001625|FG001|Overall Study|Other|2|||
19552857|NCT01306058|42001631|FG000|Overall Study|Death|1|||
19552858|NCT01306058|42001631|FG000|Overall Study|Enrolled but did not get treatment|1|||
19552859|NCT01305200|42001638|FG000|Overall Study|Physician Decision|4|||
19552860|NCT01305200|42001639|FG001|Overall Study|Physician Decision|6|||
19552861|NCT01305200|42001640|FG002|Overall Study|Physician Decision|1|||
19552862|NCT01305200|42001638|FG000|Overall Study|Withdrawal by Subject|24|||
19552863|NCT01305200|42001639|FG001|Overall Study|Withdrawal by Subject|21|||
19552864|NCT01305200|42001640|FG002|Overall Study|Withdrawal by Subject|1|||
19552865|NCT01305200|42001638|FG000|Overall Study|Ineligible|1|||
19552866|NCT01305200|42001639|FG001|Overall Study|Ineligible|2|||
19552867|NCT01305200|42001640|FG002|Overall Study|Ineligible|1|||
19552868|NCT01305200|42001638|FG000|Overall Study|Death|0|||
19552869|NCT01305200|42001639|FG001|Overall Study|Death|2|||
19552870|NCT01305200|42001640|FG002|Overall Study|Death|0|||
19552871|NCT01077271|42001650|FG000|Overall Study|Parental desire|8|||
19552872|NCT01077271|42001650|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
19552873|NCT01077271|42001650|FG000|Overall Study|Noncompliance|2|||
19552874|NCT01077271|42001650|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
19552875|NCT01077271|42001650|FG000|Overall Study|Changed doctors|2|||
19552876|NCT01077271|42001650|FG000|Overall Study|Parents thought too many injections|2|||
19552877|NCT01077271|42001650|FG000|Overall Study|End of RSV season nearly reached|1|||
19468508|NCT01802411|41735487|FG000|Overall Study|Death|2|||
19552878|NCT01077271|42001650|FG000|Overall Study|Mother unconvinced of the necessity|1|||
19552879|NCT01305044|42001664|FG000|Overall Study|Withdrawal by Subject|3|||
19552880|NCT01305044|42001665|FG001|Overall Study|Withdrawal by Subject|6|||
19552881|NCT01304498|42001673|FG000|Overall Study|Adverse Event|1|||
19552882|NCT01304498|42001674|FG001|Overall Study|Adverse Event|1|||
19552883|NCT01304498|42001673|FG000|Overall Study|Withdrawal by Subject|2|||
19552884|NCT01304498|42001674|FG001|Overall Study|Withdrawal by Subject|3|||
19552885|NCT01304498|42001673|FG000|Overall Study|Protocol Violation|1|||
19552886|NCT01304498|42001674|FG001|Overall Study|Protocol Violation|0|||
19552887|NCT01304498|42001673|FG000|Overall Study|Lost to Follow-up|2|||
19552888|NCT01304498|42001674|FG001|Overall Study|Lost to Follow-up|1|||
19552889|NCT01077193|42001680|FG000|Overall Study|Lost to Follow-up|1|||
19552890|NCT01077193|42001680|FG000|Overall Study|Withdrawal by Subject|2|||
19552891|NCT01077193|42001680|FG000|Overall Study|Lack of Efficacy|1|||
19552892|NCT01077193|42001680|FG000|Overall Study|Study Terminated by Sponsor|40|||
19552893|NCT01074931|42001684|FG000|Overall Study|Economic reasons|1|||
19552894|NCT01074931|42001684|FG000|Overall Study|Death|5|||
19552895|NCT01303172|42001694|FG000|Overall Study|Physician Decision|9|||
19552896|NCT01303172|42001695|FG001|Overall Study|Physician Decision|6|||
19552897|NCT01303172|42001694|FG000|Overall Study|Adverse Event|5|||
19552898|NCT01303172|42001695|FG001|Overall Study|Adverse Event|2|||
19468509|NCT01802411|41735488|FG001|Overall Study|Death|1|||
19468510|NCT01802411|41735487|FG000|Overall Study|Adverse Event|2|||
19552899|NCT01303172|42001694|FG000|Overall Study|Withdrawal by Subject|4|||
19552900|NCT01303172|42001695|FG001|Overall Study|Withdrawal by Subject|2|||
19552901|NCT01303172|42001694|FG000|Overall Study|Death|20|||
19552902|NCT01303172|42001695|FG001|Overall Study|Death|7|||
19552903|NCT01303172|42001694|FG000|Overall Study|Lack of Efficacy|25|||
19552904|NCT01303172|42001695|FG001|Overall Study|Lack of Efficacy|17|||
19552905|NCT01302938|42001704|FG000|Overall Study|Withdrawal by Subject|1|||
19552906|NCT01302938|42001705|FG001|Overall Study|Withdrawal by Subject|0|||
19552907|NCT01302938|42001704|FG000|Overall Study|Adverse Event|1|||
19552908|NCT01302938|42001705|FG001|Overall Study|Adverse Event|0|||
19552909|NCT01302548|42001714|FG000|Overall Study|Lost to Follow-up|2|||
19552910|NCT01302548|42001715|FG001|Overall Study|Lost to Follow-up|1|||
19552911|NCT01076959|42001721|FG000|Overall Study|Adverse Event|767|||
19468511|NCT01802411|41735488|FG001|Overall Study|Adverse Event|7|||
19468512|NCT01802411|41735487|FG000|Overall Study|Lack of Efficacy|8|||
19468513|NCT01802411|41735488|FG001|Overall Study|Lack of Efficacy|10|||
19468514|NCT01802411|41735487|FG000|Overall Study|Withdrawal by Subject|0|||
19468515|NCT01802411|41735488|FG001|Overall Study|Withdrawal by Subject|2|||
19468516|NCT01802411|41735487|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
19468517|NCT01802411|41735488|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
19468518|NCT01802411|41735487|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
19468519|NCT01802411|41735488|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
19552912|NCT01076959|42001721|FG000|Overall Study|Lack of Efficacy|849|||
19552913|NCT01076959|42001721|FG000|Overall Study|Non-compliance|274|||
19552914|NCT01076959|42001721|FG000|Overall Study|Lost to Follow-up|241|||
19552915|NCT01076959|42001721|FG000|Overall Study|Other|119|||
19552916|NCT01302392|42001740|FG000|Overall Study|Lost to Follow-up|1|||
19552917|NCT01302392|42001741|FG001|Overall Study|Lost to Follow-up|0|||
19552918|NCT01302392|42001740|FG000|Overall Study|Withdrawal by Subject|6|||
19552919|NCT01302392|42001741|FG001|Overall Study|Withdrawal by Subject|1|||
19552920|NCT01076647|42001749|FG000|Overall Study|Adverse Event|4|||
19552921|NCT01076647|42001750|FG001|Overall Study|Adverse Event|1|||
19552922|NCT01076647|42001749|FG000|Overall Study|Lack of Efficacy|0|||
19552923|NCT01076647|42001750|FG001|Overall Study|Lack of Efficacy|1|||
19552924|NCT01076647|42001749|FG000|Overall Study|Protocol Violation|7|||
19552925|NCT01076647|42001750|FG001|Overall Study|Protocol Violation|9|||
19552926|NCT01076647|42001749|FG000|Overall Study|Withdrawal criteria|2|||
19552927|NCT01076647|42001750|FG001|Overall Study|Withdrawal criteria|2|||
19552928|NCT01076647|42001749|FG000|Overall Study|Unclassified|12|||
19552929|NCT01076647|42001750|FG001|Overall Study|Unclassified|12|||
19552930|NCT01074307|42001758|FG000|Overall Study|No primary endpoint evaluation|14|||
19552931|NCT01074307|42001759|FG001|Overall Study|No primary endpoint evaluation|6|||
19552932|NCT01074307|42001758|FG000|Overall Study|Exclusion criterion|0|||
19552933|NCT01074307|42001759|FG001|Overall Study|Exclusion criterion|1|||
19552934|NCT01074307|42001758|FG000|Overall Study|Protocol Violation|8|||
19552935|NCT01074307|42001759|FG001|Overall Study|Protocol Violation|5|||
19552936|NCT01076335|42001765|FG000|Overall Study|Withdrawal by Subject|3|||
19552937|NCT01076335|42001765|FG000|Overall Study|Withdrawal without treatment|1|||
19552938|NCT01309737|42001772|FG000|Week 0 to 16|Death|1|||
19552939|NCT01309737|42001773|FG001|Week 0 to 16|Death|0|||
19552940|NCT01309737|42001774|FG002|Week 0 to 16|Death|1|||
19552941|NCT01309737|42001775|FG003|Week 0 to 16|Death|0|||
19552942|NCT01309737|42001776|FG004|Week 0 to 16|Death|0|||
19552943|NCT01309737|42001772|FG000|Week 0 to 16|Adverse Event|11|||
19552944|NCT01309737|42001773|FG001|Week 0 to 16|Adverse Event|10|||
19552945|NCT01309737|42001774|FG002|Week 0 to 16|Adverse Event|5|||
19552946|NCT01309737|42001775|FG003|Week 0 to 16|Adverse Event|0|||
19552947|NCT01309737|42001776|FG004|Week 0 to 16|Adverse Event|0|||
19552948|NCT01309737|42001772|FG000|Week 0 to 16|Lack of Efficacy|15|||
19552949|NCT01309737|42001773|FG001|Week 0 to 16|Lack of Efficacy|2|||
19552950|NCT01309737|42001774|FG002|Week 0 to 16|Lack of Efficacy|24|||
19552951|NCT01309737|42001775|FG003|Week 0 to 16|Lack of Efficacy|0|||
19552952|NCT01309737|42001776|FG004|Week 0 to 16|Lack of Efficacy|0|||
19552953|NCT01309737|42001772|FG000|Week 0 to 16|Lost to Follow-up|7|||
19552954|NCT01309737|42001773|FG001|Week 0 to 16|Lost to Follow-up|8|||
19552955|NCT01309737|42001774|FG002|Week 0 to 16|Lost to Follow-up|3|||
19552956|NCT01309737|42001775|FG003|Week 0 to 16|Lost to Follow-up|0|||
19552957|NCT01309737|42001776|FG004|Week 0 to 16|Lost to Follow-up|0|||
19552958|NCT01309737|42001772|FG000|Week 0 to 16|Withdrawal by Subject|7|||
19552959|NCT01309737|42001773|FG001|Week 0 to 16|Withdrawal by Subject|6|||
19552960|NCT01309737|42001774|FG002|Week 0 to 16|Withdrawal by Subject|7|||
19552961|NCT01309737|42001775|FG003|Week 0 to 16|Withdrawal by Subject|0|||
19552962|NCT01309737|42001776|FG004|Week 0 to 16|Withdrawal by Subject|0|||
19552963|NCT01309737|42001772|FG000|Week 0 to 16|Other|10|||
19552964|NCT01309737|42001773|FG001|Week 0 to 16|Other|14|||
19552965|NCT01309737|42001774|FG002|Week 0 to 16|Other|4|||
19552966|NCT01309737|42001775|FG003|Week 0 to 16|Other|0|||
19552967|NCT01309737|42001776|FG004|Week 0 to 16|Other|0|||
19552968|NCT01309737|42001772|FG000|Week 0 to 16|Randomized, but not treated|1|||
19552969|NCT01309737|42001773|FG001|Week 0 to 16|Randomized, but not treated|0|||
19552970|NCT01309737|42001774|FG002|Week 0 to 16|Randomized, but not treated|0|||
19468520|NCT01802411|41735487|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
19468521|NCT01802411|41735488|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
19468522|NCT02963610|41735529|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
19468523|NCT02606136|41735611|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
19468524|NCT02606136|41735611|FG000|Overall Study|Withdrawal by Subject|1|||
19468525|NCT01802333|41735754|FG000|Overall Study|Ineligible|2|||
19468526|NCT01802333|41735755|FG001|Overall Study|Ineligible|6|||
19468527|NCT01802333|41735756|FG002|Overall Study|Ineligible|8|||
19468528|NCT01802333|41735754|FG000|Overall Study|Adverse Event|1|||
19468529|NCT01802333|41735755|FG001|Overall Study|Adverse Event|8|||
19468530|NCT01802333|41735756|FG002|Overall Study|Adverse Event|8|||
19468531|NCT01802333|41735754|FG000|Overall Study|Withdrawal by Subject|6|||
19468532|NCT01802333|41735755|FG001|Overall Study|Withdrawal by Subject|6|||
19552971|NCT01309737|42001775|FG003|Week 0 to 16|Randomized, but not treated|0|||
19552972|NCT01309737|42001776|FG004|Week 0 to 16|Randomized, but not treated|0|||
19552973|NCT01309737|42001772|FG000|Week 16 to 52|Death|0|||
19468533|NCT01802333|41735756|FG002|Overall Study|Withdrawal by Subject|5|||
19468534|NCT01802333|41735754|FG000|Overall Study|Progression/relapse|1|||
19552974|NCT01309737|42001773|FG001|Week 16 to 52|Death|0|||
19552975|NCT01309737|42001774|FG002|Week 16 to 52|Death|0|||
19552976|NCT01309737|42001775|FG003|Week 16 to 52|Death|0|||
19552977|NCT01309737|42001776|FG004|Week 16 to 52|Death|1|||
19552978|NCT01309737|42001772|FG000|Week 16 to 52|Adverse Event|7|||
19552979|NCT01309737|42001773|FG001|Week 16 to 52|Adverse Event|7|||
19468535|NCT01802333|41735755|FG001|Overall Study|Progression/relapse|3|||
19468536|NCT01802333|41735756|FG002|Overall Study|Progression/relapse|0|||
19468537|NCT01802333|41735754|FG000|Overall Study|Death|7|||
19468538|NCT01802333|41735755|FG001|Overall Study|Death|14|||
19468539|NCT01802333|41735756|FG002|Overall Study|Death|13|||
19468540|NCT01802333|41735754|FG000|Overall Study|Other - not protocol specified|32|||
19468541|NCT01802333|41735755|FG001|Overall Study|Other - not protocol specified|22|||
19552980|NCT01309737|42001774|FG002|Week 16 to 52|Adverse Event|0|||
19552981|NCT01309737|42001775|FG003|Week 16 to 52|Adverse Event|6|||
19552982|NCT01309737|42001776|FG004|Week 16 to 52|Adverse Event|5|||
19468542|NCT01802333|41735756|FG002|Overall Study|Other - not protocol specified|24|||
19552983|NCT01309737|42001772|FG000|Week 16 to 52|Lack of Efficacy|107|||
19552984|NCT01309737|42001773|FG001|Week 16 to 52|Lack of Efficacy|76|||
19468543|NCT01802333|41735754|FG000|Overall Study|Did not start treatment|0|||
19468544|NCT01802333|41735755|FG001|Overall Study|Did not start treatment|2|||
19468545|NCT01802333|41735756|FG002|Overall Study|Did not start treatment|5|||
19552985|NCT01309737|42001774|FG002|Week 16 to 52|Lack of Efficacy|0|||
19552986|NCT01309737|42001775|FG003|Week 16 to 52|Lack of Efficacy|25|||
19552987|NCT01309737|42001776|FG004|Week 16 to 52|Lack of Efficacy|21|||
19552988|NCT01309737|42001772|FG000|Week 16 to 52|Lost to Follow-up|4|||
19552989|NCT01309737|42001773|FG001|Week 16 to 52|Lost to Follow-up|2|||
19552990|NCT01309737|42001774|FG002|Week 16 to 52|Lost to Follow-up|0|||
19552991|NCT01309737|42001775|FG003|Week 16 to 52|Lost to Follow-up|1|||
19552992|NCT01309737|42001776|FG004|Week 16 to 52|Lost to Follow-up|4|||
19552993|NCT01309737|42001772|FG000|Week 16 to 52|Withdrawal by Subject|5|||
19552994|NCT01309737|42001773|FG001|Week 16 to 52|Withdrawal by Subject|6|||
19552995|NCT01309737|42001774|FG002|Week 16 to 52|Withdrawal by Subject|0|||
19552996|NCT01309737|42001775|FG003|Week 16 to 52|Withdrawal by Subject|0|||
19552997|NCT01309737|42001776|FG004|Week 16 to 52|Withdrawal by Subject|2|||
19552998|NCT01309737|42001772|FG000|Week 16 to 52|Other|10|||
19552999|NCT01309737|42001773|FG001|Week 16 to 52|Other|12|||
19553000|NCT01309737|42001774|FG002|Week 16 to 52|Other|0|||
19553001|NCT01309737|42001775|FG003|Week 16 to 52|Other|2|||
19553002|NCT01309737|42001776|FG004|Week 16 to 52|Other|0|||
19553003|NCT01074229|42001802|FG000|Overall Study|Lost to Follow-up|1|||
19553004|NCT01074229|42001803|FG001|Overall Study|Lost to Follow-up|0|||
19553005|NCT01074229|42001804|FG002|Overall Study|Lost to Follow-up|0|||
19553006|NCT01074229|42001802|FG000|Overall Study|Change to open surgical procedure|1|||
19553007|NCT01074229|42001803|FG001|Overall Study|Change to open surgical procedure|3|||
19553008|NCT01074229|42001804|FG002|Overall Study|Change to open surgical procedure|4|||
19553009|NCT01106014|42001816|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
19553010|NCT01106014|42001817|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
19553011|NCT01106014|42001816|FG000|Overall Study|Adverse Event|78|||
19553012|NCT01106014|42001817|FG001|Overall Study|Adverse Event|42|||
19553013|NCT01106014|42001816|FG000|Overall Study|Withdrawal by Subject|43|||
19553014|NCT01106014|42001817|FG001|Overall Study|Withdrawal by Subject|37|||
19553015|NCT01106014|42001816|FG000|Overall Study|Administrative reason|7|||
19553016|NCT01106014|42001817|FG001|Overall Study|Administrative reason|6|||
19553017|NCT01106014|42001816|FG000|Overall Study|Lost to Follow-up|2|||
19553018|NCT01106014|42001817|FG001|Overall Study|Lost to Follow-up|3|||
19553019|NCT01073605|42001826|FG000|Overall Study|Ongoing at Cutoff Date|1|||
19553020|NCT01073605|42001827|FG001|Overall Study|Ongoing at Cutoff Date|1|||
19553021|NCT01073605|42001828|FG002|Overall Study|Ongoing at Cutoff Date|0|||
19553022|NCT01073605|42001826|FG000|Overall Study|Adverse Event|2|||
19553023|NCT01073605|42001827|FG001|Overall Study|Adverse Event|1|||
19553024|NCT01073605|42001828|FG002|Overall Study|Adverse Event|0|||
19553025|NCT01073605|42001826|FG000|Overall Study|Lost to Follow-up|3|||
19553026|NCT01073605|42001827|FG001|Overall Study|Lost to Follow-up|4|||
19553027|NCT01073605|42001828|FG002|Overall Study|Lost to Follow-up|9|||
19553028|NCT01073605|42001826|FG000|Overall Study|Other|25|||
19553029|NCT01073605|42001827|FG001|Overall Study|Other|21|||
19553030|NCT01073605|42001828|FG002|Overall Study|Other|29|||
19553031|NCT01073605|42001826|FG000|Overall Study|Withdrawal by Subject|31|||
19553032|NCT01073605|42001827|FG001|Overall Study|Withdrawal by Subject|39|||
19553033|NCT01073605|42001828|FG002|Overall Study|Withdrawal by Subject|22|||
19553034|NCT01073605|42001826|FG000|Overall Study|Randomized But Not Treated|0|||
19553035|NCT01073605|42001827|FG001|Overall Study|Randomized But Not Treated|1|||
19553036|NCT01073605|42001828|FG002|Overall Study|Randomized But Not Treated|1|||
19553037|NCT01073293|42001838|FG000|Overall Study|Lost to Follow-up|0|||
19553038|NCT01073293|42001839|FG001|Overall Study|Lost to Follow-up|1|||
19553039|NCT01073293|42001838|FG000|Overall Study|Withdrawal by Subject|5|||
19553040|NCT01073293|42001839|FG001|Overall Study|Withdrawal by Subject|10|||
19553041|NCT01105936|42001845|FG000|Period 1|Adverse Event|0|||
19553042|NCT01105936|42001846|FG001|Period 1|Adverse Event|0|||
19553043|NCT01105936|42001847|FG002|Period 1|Adverse Event|0|||
19553044|NCT01105936|42001848|FG003|Period 1|Adverse Event|1|||
19553045|NCT01105936|42001845|FG000|Period 2|Adverse Event|1|||
19553046|NCT01105936|42001846|FG001|Period 2|Adverse Event|0|||
19553047|NCT01105936|42001847|FG002|Period 2|Adverse Event|0|||
19553048|NCT01105936|42001848|FG003|Period 2|Adverse Event|0|||
19553049|NCT01105936|42001845|FG000|Period 3|Protocol Violation|0|||
19553050|NCT01105936|42001846|FG001|Period 3|Protocol Violation|2|||
19553051|NCT01105936|42001847|FG002|Period 3|Protocol Violation|0|||
19553052|NCT01105936|42001848|FG003|Period 3|Protocol Violation|0|||
19553053|NCT01309659|42001859|FG000|Overall Study|Protocol Violation|0|||
19553054|NCT01309659|42001860|FG001|Overall Study|Protocol Violation|1|||
19553055|NCT01104766|42001870|FG000|Overall Study|Did not meet inc/exc criteria|1|||
19553056|NCT01104766|42001871|FG001|Overall Study|Did not meet inc/exc criteria|0|||
19553057|NCT01104766|42001872|FG002|Overall Study|Did not meet inc/exc criteria|0|||
19553058|NCT01104766|42001873|FG003|Overall Study|Did not meet inc/exc criteria|0|||
19553059|NCT01104766|42001870|FG000|Overall Study|Adverse Event|17|||
19553060|NCT01104766|42001871|FG001|Overall Study|Adverse Event|15|||
19553061|NCT01104766|42001872|FG002|Overall Study|Adverse Event|20|||
19553062|NCT01104766|42001873|FG003|Overall Study|Adverse Event|14|||
19553063|NCT01104766|42001870|FG000|Overall Study|Lack of Efficacy|20|||
19553064|NCT01104766|42001871|FG001|Overall Study|Lack of Efficacy|15|||
19553065|NCT01104766|42001872|FG002|Overall Study|Lack of Efficacy|14|||
19553066|NCT01104766|42001873|FG003|Overall Study|Lack of Efficacy|8|||
19553067|NCT01104766|42001870|FG000|Overall Study|Protocol Violation|2|||
19553068|NCT01104766|42001871|FG001|Overall Study|Protocol Violation|0|||
19553069|NCT01104766|42001872|FG002|Overall Study|Protocol Violation|0|||
19553070|NCT01104766|42001873|FG003|Overall Study|Protocol Violation|0|||
19553071|NCT01104766|42001870|FG000|Overall Study|Withdrawal by Subject|17|||
19553072|NCT01104766|42001871|FG001|Overall Study|Withdrawal by Subject|19|||
19553073|NCT01104766|42001872|FG002|Overall Study|Withdrawal by Subject|25|||
19553074|NCT01104766|42001873|FG003|Overall Study|Withdrawal by Subject|15|||
19553075|NCT01104766|42001870|FG000|Overall Study|Lost to Follow-up|1|||
19553076|NCT01104766|42001871|FG001|Overall Study|Lost to Follow-up|2|||
19553077|NCT01104766|42001872|FG002|Overall Study|Lost to Follow-up|1|||
19553078|NCT01104766|42001873|FG003|Overall Study|Lost to Follow-up|1|||
19553079|NCT01104376|42001883|FG000|Overall Study|Withdrawal by Subject|15|||
19553080|NCT01104376|42001883|FG000|Overall Study|Consented but excluded after labs|13|||
19553081|NCT01072357|42001889|FG000|Overall Study|Lost to Follow-up|0|||
19468546|NCT00980655|41735801|FG000|Overall Study|Adverse Event|13|||
19468547|NCT00980655|41735802|FG001|Overall Study|Adverse Event|31|||
19468548|NCT00980655|41735801|FG000|Overall Study|Death|0|||
19468549|NCT00980655|41735802|FG001|Overall Study|Death|7|||
19468550|NCT00980655|41735801|FG000|Overall Study|Protocol Violation|2|||
19468551|NCT00980655|41735802|FG001|Overall Study|Protocol Violation|7|||
19468552|NCT00980655|41735801|FG000|Overall Study|Withdrawal by Subject|0|||
19468553|NCT00980655|41735802|FG001|Overall Study|Withdrawal by Subject|4|||
19468554|NCT00980655|41735801|FG000|Overall Study|Lost to Follow-up|0|||
19468555|NCT00980655|41735802|FG001|Overall Study|Lost to Follow-up|1|||
19468556|NCT00980655|41735801|FG000|Overall Study|Parent/legal guardian request|1|||
19468557|NCT00980655|41735802|FG001|Overall Study|Parent/legal guardian request|0|||
19468558|NCT00980655|41735801|FG000|Overall Study|Other|0|||
19468559|NCT00980655|41735802|FG001|Overall Study|Other|1|||
19468560|NCT01824875|41735815|FG000|Overall Study|Disease progression|22|||
19468561|NCT01824875|41735816|FG001|Overall Study|Disease progression|15|||
19468562|NCT01824875|41735815|FG000|Overall Study|Withdrawal by Subject|5|||
19468563|NCT01824875|41735816|FG001|Overall Study|Withdrawal by Subject|4|||
19468564|NCT01824875|41735815|FG000|Overall Study|Adverse Event|4|||
19468565|NCT01824875|41735816|FG001|Overall Study|Adverse Event|10|||
19468566|NCT01824875|41735815|FG000|Overall Study|Alternative therapy|3|||
19468567|NCT01824875|41735816|FG001|Overall Study|Alternative therapy|0|||
19468568|NCT01824875|41735815|FG000|Overall Study|Complicating disease|1|||
19468569|NCT01824875|41735816|FG001|Overall Study|Complicating disease|0|||
19468570|NCT01824875|41735815|FG000|Overall Study|Physician Decision|0|||
19468571|NCT01824875|41735816|FG001|Overall Study|Physician Decision|1|||
19468572|NCT01824875|41735815|FG000|Overall Study|Non-compliance|1|||
19468573|NCT01824875|41735816|FG001|Overall Study|Non-compliance|1|||
19468574|NCT01824875|41735815|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
19468575|NCT01824875|41735816|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
19468576|NCT01824875|41735815|FG000|Overall Study|Administrative issues|0|||
19468577|NCT01824875|41735816|FG001|Overall Study|Administrative issues|2|||
19468578|NCT01824875|41735815|FG000|Overall Study|Ineligible or never started treatment|9|||
19468579|NCT01824875|41735816|FG001|Overall Study|Ineligible or never started treatment|5|||
19468580|NCT01824875|41735815|FG000|Overall Study|Other|0|||
19468581|NCT01824875|41735816|FG001|Overall Study|Other|2|||
19468582|NCT01801865|41735857|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
19468583|NCT01801865|41735857|FG000|Overall Study|Physician Decision|7|||
19468584|NCT00980343|41735867|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
19468585|NCT00980343|41735868|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
19468586|NCT01801475|41735878|FG000|Overall Study|Withdrawal by Subject|0|||
19468587|NCT01801475|41735879|FG001|Overall Study|Withdrawal by Subject|0|||
19468588|NCT01801475|41735880|FG002|Overall Study|Withdrawal by Subject|0|||
19468589|NCT01801475|41735881|FG003|Overall Study|Withdrawal by Subject|0|||
19468590|NCT01801475|41735882|FG004|Overall Study|Withdrawal by Subject|1|||
19553082|NCT01072357|42001890|FG001|Overall Study|Lost to Follow-up|1|||
19553083|NCT01072201|42001898|FG000|Overall Study|Lost to Follow-up|0|||
19553084|NCT01072201|42001899|FG001|Overall Study|Lost to Follow-up|1|||
19553085|NCT01103362|42001905|FG000|Overall Study|study terminated|596|||
19553086|NCT01103284|42001911|FG000|Overall Study|Death|2|||
19553087|NCT01103284|42001912|FG001|Overall Study|Death|0|||
19468591|NCT01822925|41735941|FG000|Overall Study|Adverse Event|1|||
19468592|NCT01822925|41735942|FG001|Overall Study|Adverse Event|1|||
19468593|NCT01822925|41735943|FG002|Overall Study|Adverse Event|1|||
19468594|NCT01822925|41735944|FG003|Overall Study|Adverse Event|1|||
19468595|NCT01822925|41735941|FG000|Overall Study|Lost to Follow-up|0|||
19468596|NCT01822925|41735942|FG001|Overall Study|Lost to Follow-up|1|||
19468597|NCT01822925|41735943|FG002|Overall Study|Lost to Follow-up|0|||
19468598|NCT01822925|41735944|FG003|Overall Study|Lost to Follow-up|0|||
19468599|NCT01822925|41735941|FG000|Overall Study|Protocol Violation|1|||
19553088|NCT01103284|42001911|FG000|Overall Study|Lost to Follow-up|9|||
19553089|NCT01103284|42001912|FG001|Overall Study|Lost to Follow-up|10|||
19553090|NCT01103284|42001911|FG000|Overall Study|Pregnancy|3|||
19553091|NCT01103284|42001912|FG001|Overall Study|Pregnancy|1|||
19553092|NCT01103284|42001911|FG000|Overall Study|Protocol Violation|12|||
19553093|NCT01103284|42001912|FG001|Overall Study|Protocol Violation|5|||
19553094|NCT01103284|42001911|FG000|Overall Study|Adverse Event|0|||
19553095|NCT01103284|42001912|FG001|Overall Study|Adverse Event|5|||
19553096|NCT01103284|42001911|FG000|Overall Study|Withdrawal by Subject|14|||
19553097|NCT01103284|42001912|FG001|Overall Study|Withdrawal by Subject|18|||
19553098|NCT01103284|42001911|FG000|Overall Study|Dermal Hypersensitivity|0|||
19553099|NCT01103284|42001912|FG001|Overall Study|Dermal Hypersensitivity|1|||
19553100|NCT01103284|42001911|FG000|Overall Study|Termination by the Sponsor|0|||
19639168|NCT00717236|42088570|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
19639169|NCT00717236|42088569|FG000|Open-Label Period|Other: Lack of Compliance|1|||
19739137|NCT03557931|42186232|FG001|Overall Study|Withdrawal by Subject|0|||
19553101|NCT01103284|42001912|FG001|Overall Study|Termination by the Sponsor|1|||
19553102|NCT01103284|42001911|FG000|Overall Study|Not described|2|||
19553103|NCT01103284|42001912|FG001|Overall Study|Not described|1|||
19553104|NCT01103284|42001911|FG000|Overall Study|Missing CRF entries for study completion|0|||
19553105|NCT01103284|42001912|FG001|Overall Study|Missing CRF entries for study completion|2|||
19553106|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
19553107|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Off-label use|283|||
19553108|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
19553109|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
19553110|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
19553111|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
19553112|NCT01070953|42001918|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
19553113|NCT01070953|42001918|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
19553114|NCT01070953|42001918|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
19553115|NCT01070953|42001918|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
19553116|NCT01089361|42001930|FG000|Overall Study|Death|1|||
19553117|NCT01089361|42001931|FG001|Overall Study|Death|0|||
19468600|NCT01822925|41735942|FG001|Overall Study|Protocol Violation|0|||
19468601|NCT01822925|41735943|FG002|Overall Study|Protocol Violation|0|||
19468602|NCT01822925|41735944|FG003|Overall Study|Protocol Violation|1|||
19553118|NCT01102972|42001941|FG000|Overall Study|Adverse Event|8|||
19739138|NCT03557931|42186233|FG002|Overall Study|Withdrawal by Subject|7|||
19739139|NCT03557931|42186231|FG000|Overall Study|Miscellaneous|8|||
19739140|NCT03557931|42186232|FG001|Overall Study|Miscellaneous|5|||
19739141|NCT03557931|42186233|FG002|Overall Study|Miscellaneous|3|||
19739142|NCT03522675|42186243|FG000|Overall Study|Screen fail|1|||
19468603|NCT01822925|41735941|FG000|Overall Study|Withdrawal by Subject|2|||
19468604|NCT01822925|41735942|FG001|Overall Study|Withdrawal by Subject|0|||
19739143|NCT03522675|42186243|FG000|Overall Study|Non-reactive to histamine|1|||
19739144|NCT00294047|42186253|FG000|Month 48|Adverse Event|28|||
19739145|NCT00294047|42186254|FG001|Month 48|Adverse Event|13|||
19739146|NCT00294047|42186253|FG000|Month 48|Protocol Violation|4|||
19468605|NCT01822925|41735943|FG002|Overall Study|Withdrawal by Subject|2|||
19468606|NCT01822925|41735944|FG003|Overall Study|Withdrawal by Subject|2|||
19468607|NCT01822925|41735941|FG000|Overall Study|Taking prohibited medication|2|||
19468608|NCT01822925|41735942|FG001|Overall Study|Taking prohibited medication|0|||
19468609|NCT01822925|41735943|FG002|Overall Study|Taking prohibited medication|0|||
19468610|NCT01822925|41735944|FG003|Overall Study|Taking prohibited medication|1|||
19468611|NCT01801007|41735977|FG000|Overall Study|Adverse Event|2|||
19553119|NCT01102972|42001942|FG001|Overall Study|Adverse Event|2|||
19739147|NCT00294047|42186254|FG001|Month 48|Protocol Violation|4|||
19739148|NCT00294047|42186253|FG000|Month 48|Withdrawal by Subject|111|||
19739149|NCT00294047|42186254|FG001|Month 48|Withdrawal by Subject|115|||
19739150|NCT00294047|42186253|FG000|Month 48|Lost to Follow-up|272|||
19739151|NCT00294047|42186254|FG001|Month 48|Lost to Follow-up|287|||
19553120|NCT01102972|42001941|FG000|Overall Study|Lack of Efficacy|2|||
19553121|NCT01102972|42001942|FG001|Overall Study|Lack of Efficacy|1|||
19553122|NCT01102972|42001941|FG000|Overall Study|Protocol Violation|1|||
19553123|NCT01102972|42001942|FG001|Overall Study|Protocol Violation|0|||
19553124|NCT01102972|42001941|FG000|Overall Study|Lost to Follow-up|10|||
19553125|NCT01102972|42001942|FG001|Overall Study|Lost to Follow-up|5|||
19553126|NCT01102972|42001941|FG000|Overall Study|Investigator Discretion|2|||
19553127|NCT01102972|42001942|FG001|Overall Study|Investigator Discretion|0|||
19739152|NCT00294047|42186253|FG000|Month 48|Other|10|||
19739153|NCT00294047|42186254|FG001|Month 48|Other|14|||
19553128|NCT01102972|42001941|FG000|Overall Study|Withdrawal by Subject|6|||
19553129|NCT01102972|42001942|FG001|Overall Study|Withdrawal by Subject|6|||
19639170|NCT00717236|42088570|FG001|Open-Label Period|Other: Lack of Compliance|1|||
19468612|NCT01801007|41735977|FG000|Overall Study|Lost to Follow-up|4|||
19468613|NCT01801007|41735977|FG000|Overall Study|Withdrawal by Subject|5|||
19739154|NCT00294047|42186253|FG000|Month 84|Adverse Event|4|||
19739155|NCT00294047|42186254|FG001|Month 84|Adverse Event|2|||
19739156|NCT00294047|42186253|FG000|Month 84|Protocol Violation|1|||
19739157|NCT00294047|42186254|FG001|Month 84|Protocol Violation|1|||
19739158|NCT00294047|42186253|FG000|Month 84|Withdrawal by Subject|33|||
19739159|NCT00294047|42186254|FG001|Month 84|Withdrawal by Subject|31|||
19739160|NCT00294047|42186253|FG000|Month 84|Lost to Follow-up|187|||
19739161|NCT00294047|42186254|FG001|Month 84|Lost to Follow-up|190|||
19553130|NCT01309269|42001948|FG000|Overall Study|Adverse Event|56|||
19553131|NCT01309269|42001948|FG000|Overall Study|Withdrawal by Subject|25|||
19553132|NCT01309269|42001948|FG000|Overall Study|Lack of Acceptance|15|||
19553133|NCT01309269|42001948|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
19553134|NCT01309269|42001948|FG000|Overall Study|Kidney Transplant|25|||
19553135|NCT01309269|42001948|FG000|Overall Study|Administrative Problems|141|||
19553136|NCT01309269|42001948|FG000|Overall Study|Other|256|||
19553137|NCT01309269|42001948|FG000|Overall Study|Other|1|||
19553138|NCT01309269|42001948|FG000|Overall Study|Study Completion Data Not Recorded|95|||
19553139|NCT01309269|42001948|FG000|Overall Study|Enrolled but not Treated|107|||
19553140|NCT01088503|42001955|FG000|Overall Study|Withdrawal by Subject|118|||
19553141|NCT01088503|42001956|FG001|Overall Study|Withdrawal by Subject|327|||
19553142|NCT01088503|42001957|FG002|Overall Study|Withdrawal by Subject|10|||
19553143|NCT01088503|42001955|FG000|Overall Study|Death|64|||
19553144|NCT01088503|42001956|FG001|Overall Study|Death|358|||
19553145|NCT01088503|42001957|FG002|Overall Study|Death|7|||
19553146|NCT01087489|42001963|FG000|Overall Study|enrolled in another VA study|0|||
19553147|NCT01087489|42001964|FG001|Overall Study|enrolled in another VA study|1|||
19553148|NCT01087489|42001963|FG000|Overall Study|Death|0|||
19553149|NCT01087489|42001964|FG001|Overall Study|Death|1|||
19553150|NCT01087489|42001963|FG000|Overall Study|unable to survey by telephone|0|||
19553151|NCT01087489|42001964|FG001|Overall Study|unable to survey by telephone|1|||
19553152|NCT01082965|42001972|FG000|Overall Study|Protocol Violation|0|||
19553153|NCT01082965|42001973|FG001|Overall Study|Protocol Violation|1|||
19553154|NCT01082965|42001972|FG000|Overall Study|Other|1|||
19553155|NCT01082965|42001973|FG001|Overall Study|Other|1|||
19553156|NCT01102426|42001981|FG000|Overall Study|Randomized but not treated|4|||
19553157|NCT01102426|42001982|FG001|Overall Study|Randomized but not treated|1|||
19553158|NCT01102426|42001981|FG000|Overall Study|Adverse Events (treatment-related)|15|||
19553159|NCT01102426|42001982|FG001|Overall Study|Adverse Events (treatment-related)|8|||
19553160|NCT01102426|42001981|FG000|Overall Study|Physician Decision|9|||
19553161|NCT01102426|42001982|FG001|Overall Study|Physician Decision|6|||
19553162|NCT01102426|42001981|FG000|Overall Study|Progressive Disease|85|||
19739162|NCT00294047|42186253|FG000|Month 84|Absent Cervix|2|||
19739163|NCT00294047|42186254|FG001|Month 84|Absent Cervix|0|||
19739164|NCT00294047|42186253|FG000|Month 84|Work related reasons|4|||
19739165|NCT00294047|42186254|FG001|Month 84|Work related reasons|2|||
19739166|NCT00294047|42186253|FG000|Month 84|Center closed, subject did not transfer|1|||
19739167|NCT00294047|42186254|FG001|Month 84|Center closed, subject did not transfer|0|||
19739168|NCT00294047|42186253|FG000|Month 84|Family problems|2|||
19739169|NCT00294047|42186254|FG001|Month 84|Family problems|2|||
19739170|NCT00294047|42186253|FG000|Month 84|Lack of time|3|||
19739171|NCT00294047|42186254|FG001|Month 84|Lack of time|1|||
19739172|NCT00294047|42186253|FG000|Month 84|Personal reason|2|||
19739173|NCT00294047|42186254|FG001|Month 84|Personal reason|4|||
19739174|NCT00294047|42186253|FG000|Month 84|Subject does not want male physician|1|||
19739175|NCT00294047|42186254|FG001|Month 84|Subject does not want male physician|0|||
19739176|NCT00294047|42186253|FG000|Month 84|Transport reimbursement delayed|0|||
19739177|NCT00294047|42186254|FG001|Month 84|Transport reimbursement delayed|1|||
19739178|NCT00294047|42186253|FG000|Month 84|Unable to reach study site|1|||
19739179|NCT00294047|42186254|FG001|Month 84|Unable to reach study site|0|||
19739180|NCT00294047|42186253|FG000|Month 84|Under investigation locally|1|||
19739181|NCT00294047|42186254|FG001|Month 84|Under investigation locally|0|||
19739182|NCT00294047|42186253|FG000|Month 84|Visit missed|0|||
19739183|NCT00294047|42186254|FG001|Month 84|Visit missed|1|||
19739184|NCT00294047|42186253|FG000|Month 84|No consent for Month 84 Follow-up|731|||
19739185|NCT00294047|42186254|FG001|Month 84|No consent for Month 84 Follow-up|754|||
19553163|NCT01102426|42001982|FG001|Overall Study|Progressive Disease|44|||
19553164|NCT01102426|42001981|FG000|Overall Study|Adverse Events (unrelated to|9|||
19739186|NCT00293813|42186264|FG000|Overall Study|Physician Decision|0|||
19553165|NCT01102426|42001982|FG001|Overall Study|Adverse Events (unrelated to|1|||
19553166|NCT01102426|42001981|FG000|Overall Study|Patient Refusal|24|||
19553167|NCT01102426|42001982|FG001|Overall Study|Patient Refusal|12|||
19553168|NCT01102426|42001981|FG000|Overall Study|Death (due to adverse events|0|||
19553169|NCT01102426|42001982|FG001|Overall Study|Death (due to adverse events|1|||
19739187|NCT00293813|42186265|FG001|Overall Study|Physician Decision|1|||
19739188|NCT00293813|42186266|FG002|Overall Study|Physician Decision|0|||
19739189|NCT00293813|42186264|FG000|Overall Study|Adverse Event|3|||
19739190|NCT00293813|42186265|FG001|Overall Study|Adverse Event|1|||
19739191|NCT00293813|42186266|FG002|Overall Study|Adverse Event|1|||
19739192|NCT00293813|42186264|FG000|Overall Study|Withdrawal by Subject|7|||
19739193|NCT00293813|42186265|FG001|Overall Study|Withdrawal by Subject|4|||
19739194|NCT00293813|42186266|FG002|Overall Study|Withdrawal by Subject|4|||
19739195|NCT00293813|42186264|FG000|Overall Study|Lost to Follow-up|3|||
19739196|NCT00293813|42186265|FG001|Overall Study|Lost to Follow-up|2|||
19739197|NCT00293813|42186266|FG002|Overall Study|Lost to Follow-up|3|||
19739198|NCT00293813|42186264|FG000|Overall Study|Noncompliance|0|||
19739199|NCT00293813|42186265|FG001|Overall Study|Noncompliance|1|||
19739200|NCT00293813|42186266|FG002|Overall Study|Noncompliance|0|||
19739201|NCT00293579|42186274|FG000|Overall Study|Withdrawal by Subject|1|||
19739202|NCT00293423|42186281|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
19739203|NCT00293423|42186282|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
19739204|NCT00293423|42186281|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
19739205|NCT00293423|42186282|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
19739206|NCT00293423|42186281|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
19739207|NCT00293423|42186282|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
19739208|NCT00293423|42186281|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
19739209|NCT00293423|42186282|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
19739210|NCT00293423|42186281|FG000|Surgical Resection|processing error during surgical resection|1|||
19739211|NCT00293423|42186282|FG001|Surgical Resection|processing error during surgical resection|0|||
19739212|NCT00293423|42186281|FG000|Surgical Resection|Withdrawal by Subject|4|||
19739213|NCT00293423|42186282|FG001|Surgical Resection|Withdrawal by Subject|0|||
19739214|NCT00293423|42186281|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
19739215|NCT00293423|42186282|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
19739216|NCT03538743|42186297|FG000|Overall Study|Adverse Event|0|||
19739217|NCT03538743|42186298|FG001|Overall Study|Adverse Event|0|||
19739218|NCT03538743|42186299|FG002|Overall Study|Adverse Event|1|||
19739219|NCT03538743|42186300|FG003|Overall Study|Adverse Event|1|||
19739220|NCT03538743|42186301|FG004|Overall Study|Adverse Event|0|||
19739221|NCT03538743|42186302|FG005|Overall Study|Adverse Event|0|||
19739222|NCT03538743|42186303|FG006|Overall Study|Adverse Event|0|||
19739223|NCT03538743|42186304|FG007|Overall Study|Adverse Event|0|||
19739224|NCT03538743|42186305|FG008|Overall Study|Adverse Event|0|||
19739225|NCT03538743|42186297|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
19739226|NCT03538743|42186298|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
19468614|NCT01822691|41735981|FG000|Overall Study|Withdrawal by Subject|2|||
19468615|NCT01822535|41735987|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
19553170|NCT01102426|42001981|FG000|Overall Study|Death (non-related to the study|19|||
19553171|NCT01102426|42001982|FG001|Overall Study|Death (non-related to the study|8|||
19553172|NCT01101334|42001990|FG000|Overall Study|Adverse Event|9|||
19553173|NCT01101334|42001991|FG001|Overall Study|Adverse Event|4|||
19553174|NCT01101334|42001990|FG000|Overall Study|Death|7|||
19553175|NCT01101334|42001991|FG001|Overall Study|Death|1|||
19553176|NCT01101334|42001990|FG000|Overall Study|Withdrawal by Subject|4|||
19739227|NCT03538743|42186299|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
19739228|NCT03538743|42186300|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
19739229|NCT03538743|42186301|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
19739230|NCT03538743|42186302|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
19739231|NCT03538743|42186303|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
19739232|NCT03538743|42186304|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
19739233|NCT03538743|42186305|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
19468616|NCT01822535|41735988|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
19468617|NCT01822535|41735987|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
19468618|NCT01822535|41735988|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
19468619|NCT01822535|41735987|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
19468620|NCT01822535|41735988|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
19468621|NCT01799993|41736074|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
19468622|NCT01799993|41736075|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
19468623|NCT01799993|41736074|FG000|Overall Study|Death|61|||
19468624|NCT01799993|41736075|FG001|Overall Study|Death|45|||
19468625|NCT01799993|41736074|FG000|Overall Study|Withdrawal by Subject|23|||
19468626|NCT01799993|41736075|FG001|Overall Study|Withdrawal by Subject|24|||
19468627|NCT01799993|41736074|FG000|Overall Study|Lost to Follow-up|5|||
19468628|NCT01799993|41736075|FG001|Overall Study|Lost to Follow-up|8|||
19468629|NCT01799993|41736074|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
19468630|NCT01799993|41736075|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
19468631|NCT01799993|41736074|FG000|Overall Study|Protocol driven decision point|0|||
19468632|NCT01799993|41736075|FG001|Overall Study|Protocol driven decision point|3|||
19468633|NCT01799993|41736074|FG000|Overall Study|Protocol Violation|1|||
19468634|NCT01799993|41736075|FG001|Overall Study|Protocol Violation|1|||
19468635|NCT01799993|41736074|FG000|Overall Study|Deterioration of general conditions|2|||
19468636|NCT01799993|41736075|FG001|Overall Study|Deterioration of general conditions|0|||
19468637|NCT01799993|41736074|FG000|Overall Study|Screen failure|0|||
19468638|NCT01799993|41736075|FG001|Overall Study|Screen failure|1|||
19468639|NCT01799993|41736074|FG000|Overall Study|Adverse Event|1|||
19468640|NCT01799993|41736075|FG001|Overall Study|Adverse Event|0|||
19468641|NCT01799993|41736074|FG000|Overall Study|Lack of Efficacy|1|||
19468642|NCT01799993|41736075|FG001|Overall Study|Lack of Efficacy|0|||
19468643|NCT01799993|41736074|FG000|Overall Study|Recovery|0|||
19468644|NCT01799993|41736075|FG001|Overall Study|Recovery|1|||
19468645|NCT01799993|41736074|FG000|Overall Study|Logistical difficulties|1|||
19468646|NCT01799993|41736075|FG001|Overall Study|Logistical difficulties|0|||
19468647|NCT01799993|41736074|FG000|Overall Study|Protocol deviation|1|||
19468648|NCT01799993|41736075|FG001|Overall Study|Protocol deviation|0|||
19468649|NCT01799993|41736074|FG000|Overall Study|Non-compliance with medical device|1|||
19468650|NCT01799993|41736075|FG001|Overall Study|Non-compliance with medical device|0|||
19468651|NCT01799993|41736074|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19468652|NCT01799993|41736075|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19468653|NCT01799993|41736074|FG000|Overall Study|Other|1|||
19468654|NCT01799993|41736075|FG001|Overall Study|Other|0|||
19468655|NCT01799993|41736074|FG000|Overall Study|Subject didn't return for follow-up|0|||
19468656|NCT01799993|41736075|FG001|Overall Study|Subject didn't return for follow-up|1|||
19468657|NCT01822223|41736092|FG000|Overall Study|Death|0|||
19468658|NCT01822223|41736093|FG001|Overall Study|Death|1|||
19468659|NCT02228382|41736179|FG000|Overall Study|Death|5|||
19468660|NCT02228382|41736180|FG001|Overall Study|Death|7|||
19468661|NCT02228382|41736181|FG002|Overall Study|Death|5|||
19468662|NCT02228382|41736182|FG003|Overall Study|Death|0|||
19468663|NCT02228382|41736183|FG004|Overall Study|Death|2|||
19468664|NCT02228382|41736179|FG000|Overall Study|Participant refused further follow-up|0|||
19468665|NCT02228382|41736180|FG001|Overall Study|Participant refused further follow-up|0|||
19468666|NCT02228382|41736181|FG002|Overall Study|Participant refused further follow-up|1|||
19468667|NCT02228382|41736182|FG003|Overall Study|Participant refused further follow-up|0|||
19468668|NCT02228382|41736183|FG004|Overall Study|Participant refused further follow-up|0|||
19468669|NCT02228382|41736179|FG000|Overall Study|Study terminated by sponsor|3|||
19468670|NCT02228382|41736180|FG001|Overall Study|Study terminated by sponsor|5|||
19468671|NCT02228382|41736181|FG002|Overall Study|Study terminated by sponsor|7|||
19468672|NCT02228382|41736182|FG003|Overall Study|Study terminated by sponsor|0|||
19468673|NCT02228382|41736183|FG004|Overall Study|Study terminated by sponsor|0|||
19468674|NCT02228382|41736179|FG000|Overall Study|Lost to Follow-up|0|||
19468675|NCT02228382|41736180|FG001|Overall Study|Lost to Follow-up|0|||
19468676|NCT02228382|41736181|FG002|Overall Study|Lost to Follow-up|3|||
19468677|NCT02228382|41736182|FG003|Overall Study|Lost to Follow-up|1|||
19468678|NCT02228382|41736183|FG004|Overall Study|Lost to Follow-up|0|||
19468679|NCT02228382|41736179|FG000|Overall Study|Withdrawal by Subject|0|||
19468680|NCT02228382|41736180|FG001|Overall Study|Withdrawal by Subject|3|||
19468681|NCT02228382|41736181|FG002|Overall Study|Withdrawal by Subject|2|||
19468682|NCT02228382|41736182|FG003|Overall Study|Withdrawal by Subject|1|||
19468683|NCT02228382|41736183|FG004|Overall Study|Withdrawal by Subject|0|||
19468684|NCT02228382|41736179|FG000|Overall Study|Other|2|||
19468685|NCT02228382|41736180|FG001|Overall Study|Other|3|||
19468686|NCT02228382|41736181|FG002|Overall Study|Other|3|||
19468687|NCT02228382|41736182|FG003|Overall Study|Other|0|||
19468688|NCT02228382|41736183|FG004|Overall Study|Other|0|||
19468689|NCT01900002|41736227|FG000|Overall Study|Withdrawal by Subject|2|||
19468690|NCT01900002|41736227|FG000|Overall Study|ineligible for Y-90|4|||
19468691|NCT01377012|41736257|FG000|Core Study|Study terminated by Sponsor|47|||
19468692|NCT01377012|41736258|FG001|Core Study|Study terminated by Sponsor|54|||
19468693|NCT01377012|41736259|FG002|Core Study|Study terminated by Sponsor|46|||
19468694|NCT01377012|41736257|FG000|Core Study|Technical problems|1|||
19468695|NCT01377012|41736258|FG001|Core Study|Technical problems|0|||
19468696|NCT01377012|41736259|FG002|Core Study|Technical problems|0|||
19468697|NCT01377012|41736257|FG000|Core Study|Withdrawal by Subject|15|||
19468698|NCT01377012|41736258|FG001|Core Study|Withdrawal by Subject|23|||
19468699|NCT01377012|41736259|FG002|Core Study|Withdrawal by Subject|18|||
19468700|NCT01377012|41736257|FG000|Core Study|Protocol Violation|7|||
19468701|NCT01377012|41736258|FG001|Core Study|Protocol Violation|3|||
19468702|NCT01377012|41736259|FG002|Core Study|Protocol Violation|2|||
19468703|NCT01377012|41736257|FG000|Core Study|Pregnancy|0|||
19468704|NCT01377012|41736258|FG001|Core Study|Pregnancy|0|||
19468705|NCT01377012|41736259|FG002|Core Study|Pregnancy|1|||
19468706|NCT01377012|41736257|FG000|Core Study|Physician Decision|5|||
19468707|NCT01377012|41736258|FG001|Core Study|Physician Decision|4|||
19468708|NCT01377012|41736259|FG002|Core Study|Physician Decision|10|||
19468709|NCT01377012|41736257|FG000|Core Study|Non-Compliant with study treatment|0|||
19468710|NCT01377012|41736258|FG001|Core Study|Non-Compliant with study treatment|0|||
19468711|NCT01377012|41736259|FG002|Core Study|Non-Compliant with study treatment|1|||
19468712|NCT01377012|41736257|FG000|Core Study|No Longer require treatment|0|||
19468713|NCT01377012|41736258|FG001|Core Study|No Longer require treatment|0|||
19468714|NCT01377012|41736259|FG002|Core Study|No Longer require treatment|1|||
19468715|NCT01377012|41736257|FG000|Core Study|Lost to Follow-up|7|||
19468716|NCT01377012|41736258|FG001|Core Study|Lost to Follow-up|5|||
19468717|NCT01377012|41736259|FG002|Core Study|Lost to Follow-up|4|||
19468718|NCT01377012|41736257|FG000|Core Study|Lack of Efficacy|41|||
19468719|NCT01377012|41736258|FG001|Core Study|Lack of Efficacy|28|||
19468720|NCT01377012|41736259|FG002|Core Study|Lack of Efficacy|37|||
19468721|NCT01377012|41736257|FG000|Core Study|Death|1|||
19468722|NCT01377012|41736258|FG001|Core Study|Death|1|||
19468723|NCT01377012|41736259|FG002|Core Study|Death|1|||
19468724|NCT01377012|41736257|FG000|Core Study|Adverse Event|10|||
19468725|NCT01377012|41736258|FG001|Core Study|Adverse Event|14|||
19468726|NCT01377012|41736259|FG002|Core Study|Adverse Event|13|||
19468727|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
19468728|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
19468729|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
19468730|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
19468731|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
19468732|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
19468733|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
19468734|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
19468735|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
19468736|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
19468737|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
19468738|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
19468739|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
19468740|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
19468741|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
19468742|NCT01377012|41736257|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
19468743|NCT01377012|41736258|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
19468744|NCT01377012|41736259|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
19468745|NCT01376310|41736508|FG000|Overall Study|Study closed/terminated|1|||
19468746|NCT01376310|41736509|FG001|Overall Study|Study closed/terminated|2|||
19468747|NCT01376310|41736508|FG000|Overall Study|Withdrawal by Subject|8|||
19468748|NCT01376310|41736509|FG001|Overall Study|Withdrawal by Subject|2|||
19468749|NCT01376310|41736508|FG000|Overall Study|Physician Decision|26|||
19468750|NCT01376310|41736509|FG001|Overall Study|Physician Decision|7|||
19468751|NCT01376310|41736508|FG000|Overall Study|Lost to Follow-up|1|||
19468752|NCT01376310|41736509|FG001|Overall Study|Lost to Follow-up|0|||
19468753|NCT01949506|41736515|FG000|Overall Study|Physician Decision|1|||
19468754|NCT00709098|41736612|FG000|Double-blind Period|Withdrawal of consent|3|||
19468755|NCT00709098|41736613|FG001|Double-blind Period|Withdrawal of consent|3|||
19468756|NCT00709098|41736614|FG002|Double-blind Period|Withdrawal of consent|0|||
19468757|NCT00709098|41736612|FG000|Double-blind Period|Administrative reason|1|||
19468758|NCT00709098|41736613|FG001|Double-blind Period|Administrative reason|3|||
19468759|NCT00709098|41736614|FG002|Double-blind Period|Administrative reason|0|||
19468760|NCT00709098|41736612|FG000|Double-blind Period|Death|1|||
19468761|NCT00709098|41736613|FG001|Double-blind Period|Death|1|||
19468762|NCT00709098|41736614|FG002|Double-blind Period|Death|0|||
19468763|NCT00709098|41736612|FG000|Double-blind Period|Lost to Follow-up|1|||
19468764|NCT00709098|41736613|FG001|Double-blind Period|Lost to Follow-up|1|||
19468765|NCT00709098|41736614|FG002|Double-blind Period|Lost to Follow-up|0|||
19468766|NCT00709098|41736612|FG000|Open-label Period|Withdrawal of consent|0|||
19468767|NCT00709098|41736613|FG001|Open-label Period|Withdrawal of consent|0|||
19468768|NCT00709098|41736614|FG002|Open-label Period|Withdrawal of consent|7|||
19468769|NCT00709098|41736612|FG000|Open-label Period|Administrative reason|0|||
19468770|NCT00709098|41736613|FG001|Open-label Period|Administrative reason|0|||
19468771|NCT00709098|41736614|FG002|Open-label Period|Administrative reason|5|||
19468772|NCT00709098|41736612|FG000|Open-label Period|Death|0|||
19468773|NCT00709098|41736613|FG001|Open-label Period|Death|0|||
19468774|NCT00709098|41736614|FG002|Open-label Period|Death|1|||
19468775|NCT00709098|41736612|FG000|Open-label Period|Lost to Follow-up|0|||
19468776|NCT00709098|41736613|FG001|Open-label Period|Lost to Follow-up|0|||
19468777|NCT00709098|41736614|FG002|Open-label Period|Lost to Follow-up|1|||
19468778|NCT01376700|41736623|FG000|Overall Study|Sponsor terminated study early|8|||
19468779|NCT01376700|41736623|FG000|Overall Study|Low or high titer inhibitor|8|||
19468780|NCT01797965|41736634|FG000|Overall Study|Adverse Event|104|||
19468781|NCT01797965|41736635|FG001|Overall Study|Adverse Event|129|||
19468782|NCT01797965|41736636|FG002|Overall Study|Adverse Event|4|||
19468783|NCT01797965|41736637|FG003|Overall Study|Adverse Event|21|||
19468784|NCT01797965|41736634|FG000|Overall Study|Lost to Follow-up|9|||
19468785|NCT01797965|41736635|FG001|Overall Study|Lost to Follow-up|8|||
19468786|NCT01797965|41736636|FG002|Overall Study|Lost to Follow-up|1|||
19468787|NCT01797965|41736637|FG003|Overall Study|Lost to Follow-up|2|||
19468788|NCT01797965|41736634|FG000|Overall Study|Consent withdrawn|130|||
19468789|NCT01797965|41736635|FG001|Overall Study|Consent withdrawn|117|||
19468790|NCT01797965|41736636|FG002|Overall Study|Consent withdrawn|3|||
19468791|NCT01797965|41736637|FG003|Overall Study|Consent withdrawn|35|||
19468792|NCT01797965|41736634|FG000|Overall Study|Investigator decision|21|||
19468793|NCT01797965|41736635|FG001|Overall Study|Investigator decision|15|||
19468794|NCT01797965|41736636|FG002|Overall Study|Investigator decision|0|||
19468795|NCT01797965|41736637|FG003|Overall Study|Investigator decision|0|||
19468796|NCT01797965|41736634|FG000|Overall Study|Death|2|||
19468797|NCT01797965|41736635|FG001|Overall Study|Death|4|||
19468798|NCT01797965|41736636|FG002|Overall Study|Death|0|||
19468799|NCT01797965|41736637|FG003|Overall Study|Death|0|||
19468800|NCT01797965|41736634|FG000|Overall Study|Disease progression, defined by protocol|3|||
19468801|NCT01797965|41736635|FG001|Overall Study|Disease progression, defined by protocol|1|||
19468802|NCT01797965|41736636|FG002|Overall Study|Disease progression, defined by protocol|0|||
19468803|NCT01797965|41736637|FG003|Overall Study|Disease progression, defined by protocol|0|||
19468804|NCT01797965|41736634|FG000|Overall Study|Reason Not Specified|280|||
19468805|NCT01797965|41736635|FG001|Overall Study|Reason Not Specified|295|||
19468806|NCT01797965|41736636|FG002|Overall Study|Reason Not Specified|0|||
19468807|NCT01797965|41736637|FG003|Overall Study|Reason Not Specified|15|||
19468808|NCT01376388|41736682|FG000|Overall Study|Adverse Event|13|||
19468809|NCT01376388|41736682|FG000|Overall Study|Lack of Efficacy|2|||
19468810|NCT01376388|41736682|FG000|Overall Study|Withdrawal by Subject|3|||
19468811|NCT01821677|41736703|FG000|Overall Study|Adverse Event|4|||
19468812|NCT01821677|41736704|FG001|Overall Study|Adverse Event|6|||
19468813|NCT01821677|41736705|FG002|Overall Study|Adverse Event|5|||
19468814|NCT01821677|41736703|FG000|Overall Study|Physician Decision|1|||
19468815|NCT01821677|41736704|FG001|Overall Study|Physician Decision|4|||
19468816|NCT01821677|41736705|FG002|Overall Study|Physician Decision|1|||
19468817|NCT01821677|41736703|FG000|Overall Study|Non-compliance|0|||
19468818|NCT01821677|41736704|FG001|Overall Study|Non-compliance|1|||
19468819|NCT01821677|41736705|FG002|Overall Study|Non-compliance|2|||
19468820|NCT01821677|41736703|FG000|Overall Study|Lost to Follow-up|2|||
19468821|NCT01821677|41736704|FG001|Overall Study|Lost to Follow-up|1|||
19468822|NCT01821677|41736705|FG002|Overall Study|Lost to Follow-up|3|||
19468823|NCT01821677|41736703|FG000|Overall Study|Protocol Violation|0|||
19468824|NCT01821677|41736704|FG001|Overall Study|Protocol Violation|0|||
19468825|NCT01821677|41736705|FG002|Overall Study|Protocol Violation|2|||
19468826|NCT01821677|41736703|FG000|Overall Study|Withdrawal by Subject|7|||
19468827|NCT01821677|41736704|FG001|Overall Study|Withdrawal by Subject|3|||
19468828|NCT01821677|41736705|FG002|Overall Study|Withdrawal by Subject|2|||
19468829|NCT01821677|41736703|FG000|Overall Study|Other|9|||
19468830|NCT01821677|41736704|FG001|Overall Study|Other|0|||
19468831|NCT01821677|41736705|FG002|Overall Study|Other|0|||
19468832|NCT01797731|41736716|FG000|Overall Study|Didn't have proper radiographs required|3|||
19468833|NCT01797731|41736717|FG001|Overall Study|Didn't have proper radiographs required|3|||
19468834|NCT00709722|41736723|FG000|Overall Study|Adverse Event|1|||
19468835|NCT01820585|41736744|FG000|Overall Study|Adverse Event|9|||
19468836|NCT01820585|41736745|FG001|Overall Study|Adverse Event|13|||
19468837|NCT01820585|41736746|FG002|Overall Study|Adverse Event|23|||
19468838|NCT01820585|41736747|FG003|Overall Study|Adverse Event|34|||
19553177|NCT01101334|42001991|FG001|Overall Study|Withdrawal by Subject|3|||
19553178|NCT01101334|42001990|FG000|Overall Study|Withdrawal by Sponsor|1|||
19553179|NCT01101334|42001991|FG001|Overall Study|Withdrawal by Sponsor|1|||
19553180|NCT01101334|42001990|FG000|Overall Study|Progressive Disease|22|||
19553181|NCT01101334|42001991|FG001|Overall Study|Progressive Disease|35|||
19553182|NCT01101334|42001990|FG000|Overall Study|Other|2|||
19553183|NCT01101334|42001991|FG001|Overall Study|Other|1|||
19553184|NCT01327547|42001999|FG000|Overall Study|Adverse Event|4|||
19553185|NCT01327547|42002000|FG001|Overall Study|Adverse Event|1|||
19553186|NCT01327547|42001999|FG000|Overall Study|Death|1|||
19553187|NCT01327547|42002000|FG001|Overall Study|Death|2|||
19553188|NCT01327547|42001999|FG000|Overall Study|Lost to Follow-up|6|||
19553189|NCT01327547|42002000|FG001|Overall Study|Lost to Follow-up|6|||
19553190|NCT01327547|42001999|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
19553191|NCT01327547|42002000|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
19553192|NCT01327547|42001999|FG000|Overall Study|Withdrawal by Subject|3|||
19553193|NCT01327547|42002000|FG001|Overall Study|Withdrawal by Subject|7|||
19468839|NCT01820585|41736744|FG000|Overall Study|Lack of Efficacy|9|||
19468840|NCT01820585|41736745|FG001|Overall Study|Lack of Efficacy|7|||
19468841|NCT01820585|41736746|FG002|Overall Study|Lack of Efficacy|5|||
19468842|NCT01820585|41736747|FG003|Overall Study|Lack of Efficacy|1|||
19468843|NCT01820585|41736744|FG000|Overall Study|Withdrawal by Subject|3|||
19468844|NCT01820585|41736745|FG001|Overall Study|Withdrawal by Subject|7|||
19468845|NCT01820585|41736746|FG002|Overall Study|Withdrawal by Subject|3|||
19553194|NCT01327547|42001999|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
19468846|NCT01820585|41736747|FG003|Overall Study|Withdrawal by Subject|8|||
19468847|NCT01820585|41736744|FG000|Overall Study|Lost to Follow-up|3|||
19553195|NCT01327547|42002000|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
19553196|NCT01327547|42001999|FG000|Overall Study|Protocol Violation|1|||
19553197|NCT01327547|42002000|FG001|Overall Study|Protocol Violation|0|||
19553198|NCT01327547|42001999|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
19553199|NCT01327547|42002000|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
19553200|NCT01327547|42001999|FG000|Overall Study|Required prohibited medication|2|||
19553201|NCT01327547|42002000|FG001|Overall Study|Required prohibited medication|0|||
19553202|NCT01327547|42001999|FG000|Overall Study|Non-compliance with study procedures|1|||
19553203|NCT01327547|42002000|FG001|Overall Study|Non-compliance with study procedures|0|||
19553204|NCT01327547|42001999|FG000|Overall Study|By investigator in subject's interest|0|||
19553205|NCT01327547|42002000|FG001|Overall Study|By investigator in subject's interest|1|||
19553206|NCT01308567|42002022|FG000|Overall Study|Lost to Follow-up|2|||
19553207|NCT01308567|42002023|FG001|Overall Study|Lost to Follow-up|4|||
19553208|NCT01308567|42002024|FG002|Overall Study|Lost to Follow-up|4|||
19553209|NCT01307319|42002035|FG000|Overall Study|Adverse Event|2|||
19553210|NCT01307319|42002036|FG001|Overall Study|Adverse Event|2|||
19553211|NCT01307319|42002037|FG002|Overall Study|Adverse Event|1|||
19553212|NCT01307319|42002035|FG000|Overall Study|Lost to Follow-up|1|||
19553213|NCT01307319|42002036|FG001|Overall Study|Lost to Follow-up|0|||
19468848|NCT01820585|41736745|FG001|Overall Study|Lost to Follow-up|3|||
19553214|NCT01307319|42002037|FG002|Overall Study|Lost to Follow-up|1|||
19553215|NCT01307319|42002035|FG000|Overall Study|Protocol Violation|1|||
19553216|NCT01307319|42002036|FG001|Overall Study|Protocol Violation|1|||
19553217|NCT01307319|42002037|FG002|Overall Study|Protocol Violation|0|||
19553218|NCT01307319|42002035|FG000|Overall Study|Withdrawal by Subject|0|||
19553219|NCT01307319|42002036|FG001|Overall Study|Withdrawal by Subject|1|||
19553220|NCT01307319|42002037|FG002|Overall Study|Withdrawal by Subject|2|||
19553221|NCT01307319|42002035|FG000|Overall Study|Other|0|||
19739234|NCT03538743|42186297|FG000|Overall Study|Withdrawal by Subject|0|||
19739235|NCT03538743|42186298|FG001|Overall Study|Withdrawal by Subject|0|||
19739236|NCT03538743|42186299|FG002|Overall Study|Withdrawal by Subject|0|||
19739237|NCT03538743|42186300|FG003|Overall Study|Withdrawal by Subject|1|||
19553222|NCT01307319|42002036|FG001|Overall Study|Other|4|||
19553223|NCT01307319|42002037|FG002|Overall Study|Other|3|||
19553224|NCT01080391|42002047|FG000|Overall Study|Randomized but not treated|7|||
19553225|NCT01080391|42002048|FG001|Overall Study|Randomized but not treated|4|||
19553226|NCT01070329|42002056|FG000|Overall Study|Adverse Event|13|||
19553227|NCT01070329|42002057|FG001|Overall Study|Adverse Event|10|||
19553228|NCT01070329|42002056|FG000|Overall Study|Lost to Follow-up|22|||
19553229|NCT01070329|42002057|FG001|Overall Study|Lost to Follow-up|12|||
19553230|NCT01070329|42002056|FG000|Overall Study|Withdrawal by Subject|9|||
19553231|NCT01070329|42002057|FG001|Overall Study|Withdrawal by Subject|11|||
19553232|NCT01070329|42002056|FG000|Overall Study|Protocol Violation|3|||
19553233|NCT01070329|42002057|FG001|Overall Study|Protocol Violation|8|||
19553234|NCT01070329|42002056|FG000|Overall Study|Lack of Efficacy|2|||
19553235|NCT01070329|42002057|FG001|Overall Study|Lack of Efficacy|6|||
19553236|NCT01070329|42002056|FG000|Overall Study|Physician Decision|2|||
19553237|NCT01070329|42002057|FG001|Overall Study|Physician Decision|1|||
19553238|NCT01070329|42002056|FG000|Overall Study|Entry Criteria Not Met|1|||
19553239|NCT01070329|42002057|FG001|Overall Study|Entry Criteria Not Met|0|||
19553240|NCT01070329|42002056|FG000|Overall Study|Sponsor Decision|0|||
19553241|NCT01070329|42002057|FG001|Overall Study|Sponsor Decision|1|||
19553242|NCT01069861|42002063|FG000|Overall Study|Death|1|||
19553243|NCT01069861|42002063|FG000|Overall Study|Adverse Event|1|||
19553244|NCT01069861|42002063|FG000|Overall Study|Did not meet entrance criteria|1|||
19468849|NCT01820585|41736746|FG002|Overall Study|Lost to Follow-up|0|||
19468850|NCT01820585|41736747|FG003|Overall Study|Lost to Follow-up|3|||
19468851|NCT01820585|41736744|FG000|Overall Study|Protocol Violation|3|||
19468852|NCT01820585|41736745|FG001|Overall Study|Protocol Violation|1|||
19468853|NCT01820585|41736746|FG002|Overall Study|Protocol Violation|1|||
19468854|NCT01820585|41736747|FG003|Overall Study|Protocol Violation|1|||
19468855|NCT01820585|41736744|FG000|Overall Study|Subject non-compliance|0|||
19468856|NCT01820585|41736745|FG001|Overall Study|Subject non-compliance|0|||
19468857|NCT01820585|41736746|FG002|Overall Study|Subject non-compliance|1|||
19468858|NCT01820585|41736747|FG003|Overall Study|Subject non-compliance|2|||
19468859|NCT01820585|41736744|FG000|Overall Study|at sponsor request|0|||
19468860|NCT01820585|41736745|FG001|Overall Study|at sponsor request|0|||
19468861|NCT01820585|41736746|FG002|Overall Study|at sponsor request|1|||
19468862|NCT01820585|41736747|FG003|Overall Study|at sponsor request|0|||
19468863|NCT01820585|41736744|FG000|Overall Study|Pregnancy|0|||
19468864|NCT01820585|41736745|FG001|Overall Study|Pregnancy|1|||
19468865|NCT01820585|41736746|FG002|Overall Study|Pregnancy|0|||
19468866|NCT01820585|41736747|FG003|Overall Study|Pregnancy|0|||
19468867|NCT01797263|41736759|FG000|Overall Study|Withdrawal by Subject|21|||
19468868|NCT01797263|41736760|FG001|Overall Study|Withdrawal by Subject|25|||
19468869|NCT01797263|41736759|FG000|Overall Study|Death|1|||
19468870|NCT01797263|41736760|FG001|Overall Study|Death|0|||
19468871|NCT01797263|41736759|FG000|Overall Study|Lost to Follow-up|15|||
19553245|NCT01306929|42002067|FG000|Overall Study|Withdrawal by Subject|23|||
19553246|NCT01306929|42002067|FG000|Overall Study|Adverse Event|21|||
19553247|NCT01306929|42002067|FG000|Overall Study|Physician Decision|13|||
19553248|NCT01306929|42002067|FG000|Overall Study|Death|8|||
19553249|NCT01306929|42002067|FG000|Overall Study|Withdrawal by parent/guardian|5|||
19553250|NCT01306929|42002067|FG000|Overall Study|Protocol Violation|3|||
19553251|NCT01306929|42002067|FG000|Overall Study|Non-compliance with study drug|2|||
19553252|NCT01306929|42002067|FG000|Overall Study|Lost to Follow-up|2|||
19553253|NCT01306929|42002067|FG000|Overall Study|Various|17|||
19553254|NCT01064401|42002073|FG000|Overall Study|Adverse Event|47|||
19553255|NCT01064401|42002074|FG001|Overall Study|Adverse Event|56|||
19553256|NCT01064401|42002073|FG000|Overall Study|Lack of Efficacy|46|||
19553257|NCT01064401|42002074|FG001|Overall Study|Lack of Efficacy|23|||
19553258|NCT01064401|42002073|FG000|Overall Study|Lost to Follow-up|12|||
19553259|NCT01064401|42002074|FG001|Overall Study|Lost to Follow-up|9|||
19553260|NCT01064401|42002073|FG000|Overall Study|Consent Withdrawn|98|||
19553261|NCT01064401|42002074|FG001|Overall Study|Consent Withdrawn|80|||
19553262|NCT01064401|42002073|FG000|Overall Study|Investigator Decision|4|||
19553263|NCT01064401|42002074|FG001|Overall Study|Investigator Decision|6|||
19553264|NCT01064401|42002073|FG000|Overall Study|Death|4|||
19553265|NCT01064401|42002074|FG001|Overall Study|Death|0|||
19553266|NCT01064401|42002073|FG000|Overall Study|Pregnancy|4|||
19553267|NCT01064401|42002074|FG001|Overall Study|Pregnancy|7|||
19553268|NCT01064401|42002073|FG000|Overall Study|Noncompliance|7|||
19553269|NCT01064401|42002074|FG001|Overall Study|Noncompliance|8|||
19553270|NCT01064401|42002073|FG000|Overall Study|Site Closure|4|||
19553271|NCT01064401|42002074|FG001|Overall Study|Site Closure|5|||
19553272|NCT01064401|42002073|FG000|Overall Study|Other|2|||
19553273|NCT01064401|42002074|FG001|Overall Study|Other|1|||
19553274|NCT01306617|42002084|FG000|Overall Study|Adverse Event|1|||
19553275|NCT01306617|42002085|FG001|Overall Study|Adverse Event|0|||
19553276|NCT01306617|42002086|FG002|Overall Study|Adverse Event|0|||
19553277|NCT01306617|42002084|FG000|Overall Study|Virologic Failure|0|||
19553278|NCT01306617|42002085|FG001|Overall Study|Virologic Failure|0|||
19553279|NCT01306617|42002086|FG002|Overall Study|Virologic Failure|5|||
19553280|NCT01306617|42002084|FG000|Overall Study|Non-compliance|0|||
19553281|NCT01306617|42002085|FG001|Overall Study|Non-compliance|1|||
19553282|NCT01306617|42002086|FG002|Overall Study|Non-compliance|0|||
19553283|NCT01306305|42002096|FG000|Overall Study|Lost to Follow-up|1|||
19553284|NCT01306305|42002097|FG001|Overall Study|Lost to Follow-up|0|||
19553285|NCT01306305|42002096|FG000|Overall Study|Withdrew consent|1|||
19553286|NCT01306305|42002097|FG001|Overall Study|Withdrew consent|0|||
19553287|NCT01038427|42002106|FG000|Overall Study|Lost to follow up|1|||
19553288|NCT01038427|42002107|FG001|Overall Study|Lost to follow up|1|||
19553289|NCT01038427|42002108|FG002|Overall Study|Lost to follow up|0|||
19468872|NCT01797263|41736760|FG001|Overall Study|Lost to Follow-up|15|||
19553290|NCT01038427|42002106|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
19553291|NCT01038427|42002107|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
19553292|NCT01038427|42002108|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
19553293|NCT01038427|42002106|FG000|Overall Study|Withdrew consent|0|||
19553294|NCT01038427|42002107|FG001|Overall Study|Withdrew consent|0|||
19553295|NCT01038427|42002108|FG002|Overall Study|Withdrew consent|1|||
19553296|NCT01038427|42002106|FG000|Overall Study|Adverse Event|2|||
19553297|NCT01038427|42002107|FG001|Overall Study|Adverse Event|2|||
19553298|NCT01038427|42002108|FG002|Overall Study|Adverse Event|1|||
19553299|NCT01038427|42002106|FG000|Overall Study|Enrolled in error|0|||
19553300|NCT01038427|42002107|FG001|Overall Study|Enrolled in error|1|||
19553301|NCT01038427|42002108|FG002|Overall Study|Enrolled in error|1|||
19553302|NCT01038427|42002106|FG000|Overall Study|Other|0|||
19553303|NCT01038427|42002107|FG001|Overall Study|Other|2|||
19553304|NCT01038427|42002108|FG002|Overall Study|Other|0|||
19553305|NCT01037413|42002116|FG000|Part A: Skin Testing|Adverse Event|1|||
19553306|NCT01037413|42002117|FG001|Part A: Skin Testing|Adverse Event|0|||
19553307|NCT01037413|42002116|FG000|Part A: Skin Testing|Protocol Violation|1|||
19553308|NCT01037413|42002117|FG001|Part A: Skin Testing|Protocol Violation|0|||
19553309|NCT01037413|42002116|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
19553310|NCT01037413|42002117|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
19553311|NCT01037413|42002116|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
19553312|NCT01037413|42002117|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
19553313|NCT01326845|42002132|FG000|Overall Study|Administrative Problems|5|||
19553314|NCT01326845|42002133|FG001|Overall Study|Administrative Problems|2|||
19553315|NCT01326845|42002132|FG000|Overall Study|Adverse Event|1|||
19553316|NCT01326845|42002133|FG001|Overall Study|Adverse Event|0|||
19553317|NCT01326845|42002132|FG000|Overall Study|Misisng|1|||
19553318|NCT01326845|42002133|FG001|Overall Study|Misisng|3|||
19553319|NCT01062763|42002141|FG000|Overall Study|Adverse Event|3|||
19553320|NCT01062763|42002142|FG001|Overall Study|Adverse Event|4|||
19553321|NCT01048099|42002148|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
19553322|NCT01048099|42002148|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
19553323|NCT01303965|42002156|FG000|Overall Study|Adverse Event|1|||
19553324|NCT01303965|42002157|FG001|Overall Study|Adverse Event|1|||
19553325|NCT01303965|42002156|FG000|Overall Study|Death|0|||
19553326|NCT01303965|42002157|FG001|Overall Study|Death|3|||
19553327|NCT01303965|42002156|FG000|Overall Study|Withdrawal by Subject|1|||
19553328|NCT01303965|42002157|FG001|Overall Study|Withdrawal by Subject|0|||
19553329|NCT01303965|42002156|FG000|Overall Study|Disease Progression|1|||
19553330|NCT01303965|42002157|FG001|Overall Study|Disease Progression|6|||
19553331|NCT01045993|42002167|FG000|Overall Study|Treated-later found eligibility not met|0|||
19553332|NCT01045993|42002168|FG001|Overall Study|Treated-later found eligibility not met|1|||
19553333|NCT01045993|42002169|FG002|Overall Study|Treated-later found eligibility not met|0|||
19553334|NCT01045993|42002170|FG003|Overall Study|Treated-later found eligibility not met|0|||
19553335|NCT01303419|42002180|FG000|Overall Study|Discontinuation of study|60|||
19553336|NCT01303419|42002180|FG000|Overall Study|Did not complete both imaging methods|5|||
19553337|NCT01303419|42002180|FG000|Overall Study|Did not meet all I/E after screening|31|||
19553338|NCT01326533|42002186|FG000|Overall Study|Lost to Follow-up|2|||
19553339|NCT01326533|42002187|FG001|Overall Study|Lost to Follow-up|0|||
19553340|NCT01326533|42002186|FG000|Overall Study|Withdrawal by Subject|1|||
19553341|NCT01326533|42002187|FG001|Overall Study|Withdrawal by Subject|0|||
19553342|NCT01326533|42002186|FG000|Overall Study|Adverse Event|1|||
19553343|NCT01326533|42002187|FG001|Overall Study|Adverse Event|0|||
19553344|NCT01045447|42002195|FG000|Overall Study|Adverse Event|0|||
19553345|NCT01045447|42002196|FG001|Overall Study|Adverse Event|1|||
19553346|NCT01045447|42002195|FG000|Overall Study|Lack of Efficacy|3|||
19553347|NCT01045447|42002196|FG001|Overall Study|Lack of Efficacy|1|||
19553348|NCT01045447|42002195|FG000|Overall Study|Protocol Violation|6|||
19553349|NCT01045447|42002196|FG001|Overall Study|Protocol Violation|3|||
19553350|NCT01045447|42002195|FG000|Overall Study|Withdrawal Criteria|10|||
19553351|NCT01045447|42002196|FG001|Overall Study|Withdrawal Criteria|10|||
19553352|NCT01045447|42002195|FG000|Overall Study|Unclassified|17|||
19553353|NCT01045447|42002196|FG001|Overall Study|Unclassified|13|||
19553354|NCT01301625|42002202|FG000|Overall Study|Death|5|||
19553355|NCT01301625|42002202|FG000|Overall Study|Not Due|21|||
19553356|NCT01301625|42002202|FG000|Overall Study|Expected|8|||
19553357|NCT01301625|42002202|FG000|Overall Study|Lost to Follow-up|1|||
19553358|NCT01301391|42002206|FG000|Overall Study|Death|13|||
19553359|NCT01301391|42002206|FG000|Overall Study|Lost to Follow-up|3|||
19553360|NCT01301391|42002206|FG000|Overall Study|Physician Decision|2|||
19553361|NCT01301391|42002206|FG000|Overall Study|Sponsor's decision|8|||
19553362|NCT01036321|42002212|FG000|Overall Study|Ineligible after randomization|0|||
19553363|NCT01036321|42002213|FG001|Overall Study|Ineligible after randomization|1|||
19553364|NCT01036321|42002212|FG000|Overall Study|Withdrawal by Subject|3|||
19553365|NCT01036321|42002213|FG001|Overall Study|Withdrawal by Subject|2|||
19553366|NCT01036321|42002212|FG000|Overall Study|Adverse Event|2|||
19553367|NCT01036321|42002213|FG001|Overall Study|Adverse Event|1|||
19553368|NCT01061359|42002219|FG000|Overall Study|Death|32|||
19553369|NCT01061359|42002219|FG000|Overall Study|Lost to Follow-up|1072|||
19553370|NCT01061359|42002219|FG000|Overall Study|Relapse|187|||
19553371|NCT01061359|42002219|FG000|Overall Study|Secondary neoplasm|11|||
19553372|NCT01301079|42002225|FG000|Overall Study|Lost to Follow-up|2|||
19553373|NCT01301079|42002226|FG001|Overall Study|Lost to Follow-up|2|||
19553374|NCT01036165|42002236|FG000|Overall Study|Adverse Event|6|||
19553375|NCT01036165|42002236|FG000|Overall Study|Lost to Follow-up|2|||
19553376|NCT01036165|42002236|FG000|Overall Study|Withdrawal by Subject|3|||
19553377|NCT01036165|42002236|FG000|Overall Study|Device Related Issues|3|||
19553378|NCT01036165|42002236|FG000|Overall Study|Problems finding proper area to inject|1|||
19553379|NCT01301001|42002240|FG000|First Intervention|Lost to Follow-up|4|||
19553380|NCT01301001|42002241|FG001|First Intervention|Lost to Follow-up|4|||
19553381|NCT01301001|42002240|FG000|First Intervention|Withdrawal by Subject|1|||
19553382|NCT01301001|42002241|FG001|First Intervention|Withdrawal by Subject|4|||
19553383|NCT01301001|42002240|FG000|First Intervention|Adverse Event|5|||
19553384|NCT01301001|42002241|FG001|First Intervention|Adverse Event|0|||
19468873|NCT01797185|41736815|FG000|Overall Study|Adverse Event|5|||
19468874|NCT01797185|41736816|FG001|Overall Study|Adverse Event|15|||
19468875|NCT01797185|41736817|FG002|Overall Study|Adverse Event|6|||
19468876|NCT01797185|41736815|FG000|Overall Study|Withdrawal by Subject|6|||
19468877|NCT01797185|41736816|FG001|Overall Study|Withdrawal by Subject|9|||
19468878|NCT01797185|41736817|FG002|Overall Study|Withdrawal by Subject|5|||
19553385|NCT01301001|42002240|FG000|First Intervention|Protocol Violation|0|||
19553386|NCT01301001|42002241|FG001|First Intervention|Protocol Violation|1|||
19553387|NCT01301001|42002240|FG000|Second Intervention|Adverse Event|2|||
19553388|NCT01301001|42002241|FG001|Second Intervention|Adverse Event|0|||
19553389|NCT01301001|42002240|FG000|Second Intervention|Withdrawal by Subject|2|||
19553390|NCT01301001|42002241|FG001|Second Intervention|Withdrawal by Subject|0|||
19553391|NCT01035463|42002250|FG000|Overall Study|Adverse Event|0|||
19553392|NCT01035463|42002251|FG001|Overall Study|Adverse Event|0|||
19468879|NCT01797185|41736815|FG000|Overall Study|Site terminated|8|||
19468880|NCT01797185|41736816|FG001|Overall Study|Site terminated|4|||
19468881|NCT01797185|41736817|FG002|Overall Study|Site terminated|0|||
19468882|NCT01797185|41736815|FG000|Overall Study|Lost to Follow-up|2|||
19468883|NCT01797185|41736816|FG001|Overall Study|Lost to Follow-up|6|||
19468884|NCT01797185|41736817|FG002|Overall Study|Lost to Follow-up|1|||
19468885|NCT01797185|41736815|FG000|Overall Study|Withdrawn per sponsor|5|||
19468886|NCT01797185|41736816|FG001|Overall Study|Withdrawn per sponsor|0|||
19468887|NCT01797185|41736817|FG002|Overall Study|Withdrawn per sponsor|0|||
19468888|NCT01797185|41736815|FG000|Overall Study|Physician Decision|1|||
19468889|NCT01797185|41736816|FG001|Overall Study|Physician Decision|3|||
19468890|NCT01797185|41736817|FG002|Overall Study|Physician Decision|0|||
19468891|NCT01797185|41736815|FG000|Overall Study|Protocol Violation|1|||
19468892|NCT01797185|41736816|FG001|Overall Study|Protocol Violation|1|||
19468893|NCT01797185|41736817|FG002|Overall Study|Protocol Violation|0|||
19468894|NCT01819727|41736873|FG000|Overall Study|Adverse Event|8|||
19468895|NCT01819727|41736874|FG001|Overall Study|Adverse Event|9|||
19468896|NCT01819727|41736873|FG000|Overall Study|Death|1|||
19468897|NCT01819727|41736874|FG001|Overall Study|Death|0|||
19468898|NCT01819727|41736873|FG000|Overall Study|Lost to Follow-up|1|||
19468899|NCT01819727|41736874|FG001|Overall Study|Lost to Follow-up|1|||
19468900|NCT01819727|41736873|FG000|Overall Study|Physician Decision|3|||
19468901|NCT01819727|41736874|FG001|Overall Study|Physician Decision|2|||
19468902|NCT01819727|41736873|FG000|Overall Study|Pregnancy|1|||
19468903|NCT01819727|41736874|FG001|Overall Study|Pregnancy|0|||
19468904|NCT01819727|41736873|FG000|Overall Study|Protocol Violation|0|||
19468905|NCT01819727|41736874|FG001|Overall Study|Protocol Violation|2|||
19468906|NCT01819727|41736873|FG000|Overall Study|Study Terminated by Sponsor|0|||
19468907|NCT01819727|41736874|FG001|Overall Study|Study Terminated by Sponsor|1|||
19468908|NCT01819727|41736873|FG000|Overall Study|Withdrawal by Subject|6|||
19468909|NCT01819727|41736874|FG001|Overall Study|Withdrawal by Subject|11|||
19468910|NCT01819727|41736873|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
19468911|NCT01819727|41736874|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
19468912|NCT01819727|41736873|FG000|Overall Study|Quit due to lack of health benifits|0|||
19468913|NCT01819727|41736874|FG001|Overall Study|Quit due to lack of health benifits|1|||
19468914|NCT01795937|41736933|FG000|Overall Study|Withdrawal by Subject|1|||
19468915|NCT01795937|41736934|FG001|Overall Study|Withdrawal by Subject|0|||
19468916|NCT01795937|41736935|FG002|Overall Study|Withdrawal by Subject|0|||
19468917|NCT01795937|41736933|FG000|Overall Study|Physician Decision|0|||
19553393|NCT01035463|42002252|FG002|Overall Study|Adverse Event|4|||
19468918|NCT01795937|41736934|FG001|Overall Study|Physician Decision|1|||
19468919|NCT01795937|41736935|FG002|Overall Study|Physician Decision|0|||
19553394|NCT01035463|42002253|FG003|Overall Study|Adverse Event|1|||
19553395|NCT01035463|42002254|FG004|Overall Study|Adverse Event|5|||
19553396|NCT01035463|42002255|FG005|Overall Study|Adverse Event|7|||
19553397|NCT01035463|42002250|FG000|Overall Study|Withdrawal by Subject|0|||
19468920|NCT01817777|41736977|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
19468921|NCT01817777|41736978|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
19468922|NCT01817777|41736979|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
19468923|NCT01817777|41736977|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
19468924|NCT01817777|41736978|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
19468925|NCT01817777|41736979|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
19468926|NCT01817777|41736977|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
19468927|NCT01817777|41736978|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
19468928|NCT01817777|41736979|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
19468929|NCT01817777|41736977|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
19468930|NCT01817777|41736978|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
19468931|NCT01817777|41736979|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
19468932|NCT01817777|41736977|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
19468933|NCT01817777|41736978|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
19553398|NCT01035463|42002251|FG001|Overall Study|Withdrawal by Subject|2|||
19553399|NCT01035463|42002252|FG002|Overall Study|Withdrawal by Subject|1|||
19553400|NCT01035463|42002253|FG003|Overall Study|Withdrawal by Subject|0|||
19553401|NCT01035463|42002254|FG004|Overall Study|Withdrawal by Subject|1|||
19553402|NCT01035463|42002255|FG005|Overall Study|Withdrawal by Subject|4|||
19553403|NCT01035463|42002250|FG000|Overall Study|Disease progression|0|||
19553404|NCT01035463|42002251|FG001|Overall Study|Disease progression|0|||
19553405|NCT01035463|42002252|FG002|Overall Study|Disease progression|0|||
19553406|NCT01035463|42002253|FG003|Overall Study|Disease progression|0|||
19553407|NCT01035463|42002254|FG004|Overall Study|Disease progression|0|||
19553408|NCT01035463|42002255|FG005|Overall Study|Disease progression|3|||
19553409|NCT01035463|42002250|FG000|Overall Study|Other Malignancy|0|||
19553410|NCT01035463|42002251|FG001|Overall Study|Other Malignancy|0|||
19553411|NCT01035463|42002252|FG002|Overall Study|Other Malignancy|0|||
19468934|NCT01817777|41736979|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
19468935|NCT01795547|41737005|FG000|Overall Study|Adverse Event|16|||
19468936|NCT01795547|41737006|FG001|Overall Study|Adverse Event|27|||
19468937|NCT01795547|41737005|FG000|Overall Study|Lack of Efficacy|8|||
19468938|NCT01795547|41737006|FG001|Overall Study|Lack of Efficacy|3|||
19468939|NCT01795547|41737005|FG000|Overall Study|Protocol Violation|6|||
19468940|NCT01795547|41737006|FG001|Overall Study|Protocol Violation|4|||
19468941|NCT01795547|41737005|FG000|Overall Study|Lost to Follow-up|2|||
19468942|NCT01795547|41737006|FG001|Overall Study|Lost to Follow-up|5|||
19468943|NCT01795547|41737005|FG000|Overall Study|Withdrawal of consent|7|||
19468944|NCT01795547|41737006|FG001|Overall Study|Withdrawal of consent|12|||
19468945|NCT01795547|41737005|FG000|Overall Study|Not Treated|4|||
19468946|NCT01795547|41737006|FG001|Overall Study|Not Treated|10|||
19468947|NCT01795547|41737005|FG000|Overall Study|Non-compliance with IMP|1|||
19468948|NCT01795547|41737006|FG001|Overall Study|Non-compliance with IMP|1|||
19468949|NCT01795547|41737005|FG000|Overall Study|Others|4|||
19468950|NCT01795547|41737006|FG001|Overall Study|Others|1|||
19468951|NCT01795547|41737005|FG000|Overall Study|Not stated|0|||
19468952|NCT01795547|41737006|FG001|Overall Study|Not stated|1|||
19468953|NCT01794923|41737032|FG000|Overall Study|Adverse Event|0|||
19468954|NCT01794923|41737033|FG001|Overall Study|Adverse Event|0|||
19468955|NCT01794923|41737034|FG002|Overall Study|Adverse Event|1|||
19468956|NCT01794845|41737042|FG000|Overall Study|Withdrawal by Subject|1|||
19468957|NCT01794689|41737050|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
19468958|NCT01794689|41737051|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
19468959|NCT01794689|41737052|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
19468960|NCT01794689|41737053|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
19468961|NCT01794689|41737050|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
19468962|NCT01794689|41737051|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
19468963|NCT01794689|41737052|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
19553412|NCT01035463|42002253|FG003|Overall Study|Other Malignancy|0|||
19553413|NCT01035463|42002254|FG004|Overall Study|Other Malignancy|0|||
19553414|NCT01035463|42002255|FG005|Overall Study|Other Malignancy|2|||
19553415|NCT01035463|42002250|FG000|Overall Study|Other|0|||
19553416|NCT01035463|42002251|FG001|Overall Study|Other|0|||
19553417|NCT01035463|42002252|FG002|Overall Study|Other|0|||
19553418|NCT01035463|42002253|FG003|Overall Study|Other|1|||
19553419|NCT01035463|42002254|FG004|Overall Study|Other|0|||
19553420|NCT01035463|42002255|FG005|Overall Study|Other|2|||
19553421|NCT01300923|42002262|FG000|Overall Study|Physician Decision|0|||
19468964|NCT01794689|41737053|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
19468965|NCT01794689|41737050|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
19468966|NCT01794689|41737051|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
19553422|NCT01300923|42002263|FG001|Overall Study|Physician Decision|2|||
19553423|NCT01300767|42002268|FG000|Overall Study|Discomfort|2|||
19553424|NCT01300767|42002268|FG000|Overall Study|Biomicroscopy|1|||
19553425|NCT01300767|42002268|FG000|Overall Study|Unacceptable fit|1|||
19553426|NCT01300455|42002276|FG000|Washout|Withdrawal by Subject|1|||
19553427|NCT01300455|42002277|FG001|Washout|Withdrawal by Subject|0|||
19468967|NCT01794689|41737052|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
19468968|NCT01794689|41737053|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
19468969|NCT01794689|41737050|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
19468970|NCT01794689|41737051|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
19468971|NCT01794689|41737052|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
19468972|NCT01794689|41737053|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
19468973|NCT01794299|41737069|FG000|Overall Study|ATIR manufacturing not possible|1|||
19468974|NCT01794299|41737069|FG000|Overall Study|Death|14|||
19468975|NCT01794299|41737069|FG000|Overall Study|Graft failure|1|||
19468976|NCT01794299|41737069|FG000|Overall Study|ATIR batch rejected|2|||
19468977|NCT01794299|41737069|FG000|Overall Study|Relapse|2|||
19468978|NCT01794299|41737069|FG000|Overall Study|Discontinued from active follow-up|1|||
19468979|NCT01794299|41737069|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
19468980|NCT01817075|41737075|FG000|Overall Study|Adverse Event|7|||
19468981|NCT01817075|41737076|FG001|Overall Study|Adverse Event|5|||
19468982|NCT01817075|41737075|FG000|Overall Study|Physician Decision|9|||
19468983|NCT01817075|41737076|FG001|Overall Study|Physician Decision|12|||
19468984|NCT01817075|41737075|FG000|Overall Study|Withdrawal by Subject|31|||
19468985|NCT01817075|41737076|FG001|Overall Study|Withdrawal by Subject|15|||
19468986|NCT01817075|41737075|FG000|Overall Study|Received Sorafenib after enrollment|0|||
19468987|NCT01817075|41737076|FG001|Overall Study|Received Sorafenib after enrollment|1|||
19468988|NCT01817075|41737075|FG000|Overall Study|Ineligible|0|||
19468989|NCT01817075|41737076|FG001|Overall Study|Ineligible|2|||
19553428|NCT01107418|42002287|FG000|Overall Study|Disease Progression|45|||
19553429|NCT01107418|42002287|FG000|Overall Study|Adverse Event|3|||
19553430|NCT01107418|42002287|FG000|Overall Study|Withdrawal by Subject|1|||
19553431|NCT01107418|42002287|FG000|Overall Study|Study Closing|1|||
19553432|NCT01107418|42002287|FG000|Overall Study|Started Other Therapy|1|||
19553433|NCT01107418|42002287|FG000|Overall Study|Entered Extension Study|1|||
19553434|NCT01101178|42002302|FG000|Period 1|Withdrawal by Subject|1|||
19553435|NCT01101178|42002303|FG001|Period 1|Withdrawal by Subject|2|||
19553436|NCT01101178|42002302|FG000|Period 1|Positive drug screen|1|||
19553437|NCT01101178|42002303|FG001|Period 1|Positive drug screen|1|||
19553438|NCT01101178|42002302|FG000|Period 1|Adverse Event|2|||
19553439|NCT01101178|42002303|FG001|Period 1|Adverse Event|1|||
19553440|NCT01101178|42002302|FG000|Period 2|Withdrawal by Subject|0|||
19553441|NCT01101178|42002303|FG001|Period 2|Withdrawal by Subject|1|||
19553442|NCT01101022|42002312|FG000|Overall Study|Adverse Event|6|||
19553443|NCT01101022|42002313|FG001|Overall Study|Adverse Event|2|||
19553444|NCT01101022|42002312|FG000|Overall Study|Protocol Violation|4|||
19553445|NCT01101022|42002313|FG001|Overall Study|Protocol Violation|3|||
19553446|NCT01101022|42002312|FG000|Overall Study|Withdrawal by Subject|3|||
19553447|NCT01101022|42002313|FG001|Overall Study|Withdrawal by Subject|8|||
19553448|NCT01101022|42002312|FG000|Overall Study|Lost to Follow-up|1|||
19553449|NCT01101022|42002313|FG001|Overall Study|Lost to Follow-up|4|||
19553450|NCT01101022|42002312|FG000|Overall Study|Lack of Efficacy|0|||
19553451|NCT01101022|42002313|FG001|Overall Study|Lack of Efficacy|7|||
19553452|NCT01101022|42002312|FG000|Overall Study|Sponsor decision|1|||
19553453|NCT01101022|42002313|FG001|Overall Study|Sponsor decision|1|||
19553454|NCT01101022|42002312|FG000|Overall Study|Non-compliance|1|||
19553455|NCT01101022|42002313|FG001|Overall Study|Non-compliance|0|||
19553456|NCT01101022|42002312|FG000|Overall Study|Work schedule|1|||
19553457|NCT01101022|42002313|FG001|Overall Study|Work schedule|1|||
19553458|NCT01101022|42002312|FG000|Overall Study|Vacation|0|||
19553459|NCT01101022|42002313|FG001|Overall Study|Vacation|1|||
19553460|NCT01299909|42002322|FG000|Overall Study|Lost to Follow-up|22|||
19553461|NCT01299909|42002323|FG001|Overall Study|Lost to Follow-up|18|||
19553462|NCT01299909|42002324|FG002|Overall Study|Lost to Follow-up|17|||
19553463|NCT01298661|42002334|FG000|Overall Study|Withdrawal by Subject|2|||
19468990|NCT01816763|41737085|FG000|Overall Study|The main reason for an incomplete survey|4|||
19468991|NCT01816763|41737086|FG001|Overall Study|The main reason for an incomplete survey|15|||
19553464|NCT01298661|42002335|FG001|Overall Study|Withdrawal by Subject|0|||
19553465|NCT01298661|42002336|FG002|Overall Study|Withdrawal by Subject|2|||
19553466|NCT01100944|42002345|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
19553467|NCT01100944|42002346|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
19553468|NCT01100944|42002347|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
19553469|NCT01100944|42002345|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
19553470|NCT01100944|42002346|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
19553471|NCT01100944|42002347|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
19553472|NCT01100944|42002345|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
19553473|NCT01100944|42002346|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
19553474|NCT01100944|42002347|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
19553475|NCT01100944|42002345|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
19553476|NCT01100944|42002346|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
19553477|NCT01100944|42002347|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
19553478|NCT01100320|42002368|FG000|Period 1|Withdrawal by Subject|2|||
19553479|NCT01100320|42002369|FG001|Period 1|Withdrawal by Subject|4|||
19553480|NCT01100320|42002368|FG000|Period 1|Positive Drug Screen|1|||
19553481|NCT01100320|42002369|FG001|Period 1|Positive Drug Screen|1|||
19553482|NCT01100320|42002368|FG000|Period 1|Adverse Event|2|||
19553483|NCT01100320|42002369|FG001|Period 1|Adverse Event|2|||
19553484|NCT01100320|42002368|FG000|Period 2|Withdrawal by Subject|1|||
19553485|NCT01100320|42002369|FG001|Period 2|Withdrawal by Subject|1|||
19553486|NCT01100086|42002375|FG000|Period 1|Withdrawal by Subject|1|||
19553487|NCT01100086|42002376|FG001|Period 1|Withdrawal by Subject|0|||
19553488|NCT01297959|42002384|FG000|Overall Study|Adverse Event|0|||
19553489|NCT01297959|42002385|FG001|Overall Study|Adverse Event|1|||
19553490|NCT01297959|42002384|FG000|Overall Study|Protocol Violation|2|||
19553491|NCT01297959|42002385|FG001|Overall Study|Protocol Violation|1|||
19553492|NCT01297959|42002384|FG000|Overall Study|Withdrawal by Subject|5|||
19468992|NCT01816763|41737087|FG002|Overall Study|The main reason for an incomplete survey|11|||
19468993|NCT01816685|41737100|FG000|Overall Study|Lost to Follow-up|7|||
19468994|NCT01816685|41737101|FG001|Overall Study|Lost to Follow-up|9|||
19468995|NCT01816685|41737100|FG000|Overall Study|Surgery Cancelled|3|||
19468996|NCT01816685|41737101|FG001|Overall Study|Surgery Cancelled|2|||
19468997|NCT00708552|41737132|FG000|Overall Study|Adverse Event|10|||
19468998|NCT00708552|41737133|FG001|Overall Study|Adverse Event|3|||
19468999|NCT00708552|41737134|FG002|Overall Study|Adverse Event|4|||
19469000|NCT00708552|41737135|FG003|Overall Study|Adverse Event|6|||
19469001|NCT00708552|41737132|FG000|Overall Study|Lack of Efficacy|0|||
19469002|NCT00708552|41737133|FG001|Overall Study|Lack of Efficacy|4|||
19469003|NCT00708552|41737134|FG002|Overall Study|Lack of Efficacy|1|||
19469004|NCT00708552|41737135|FG003|Overall Study|Lack of Efficacy|0|||
19469005|NCT00708552|41737132|FG000|Overall Study|Protocol Violation|0|||
19469006|NCT00708552|41737133|FG001|Overall Study|Protocol Violation|0|||
19469007|NCT00708552|41737134|FG002|Overall Study|Protocol Violation|2|||
19469008|NCT00708552|41737135|FG003|Overall Study|Protocol Violation|4|||
19469009|NCT00708552|41737132|FG000|Overall Study|Lost to Follow-up|4|||
19469010|NCT00708552|41737133|FG001|Overall Study|Lost to Follow-up|2|||
19469011|NCT00708552|41737134|FG002|Overall Study|Lost to Follow-up|0|||
19469012|NCT00708552|41737135|FG003|Overall Study|Lost to Follow-up|1|||
19469013|NCT00708552|41737132|FG000|Overall Study|Physician Decision|1|||
19469014|NCT00708552|41737133|FG001|Overall Study|Physician Decision|2|||
19469015|NCT00708552|41737134|FG002|Overall Study|Physician Decision|0|||
19469016|NCT00708552|41737135|FG003|Overall Study|Physician Decision|0|||
19469017|NCT00708552|41737132|FG000|Overall Study|Withdrawal by Subject|12|||
19469018|NCT00708552|41737133|FG001|Overall Study|Withdrawal by Subject|7|||
19469019|NCT00708552|41737134|FG002|Overall Study|Withdrawal by Subject|8|||
19469020|NCT00708552|41737135|FG003|Overall Study|Withdrawal by Subject|10|||
19469021|NCT01816295|41737265|FG000|Double Blind Phase|Adverse Event|11|||
19469022|NCT01816295|41737266|FG001|Double Blind Phase|Adverse Event|8|||
19469023|NCT01816295|41737265|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
19469024|NCT01816295|41737266|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
19469025|NCT01816295|41737265|FG000|Double Blind Phase|Lost to Follow-up|3|||
19469026|NCT01816295|41737266|FG001|Double Blind Phase|Lost to Follow-up|5|||
19469027|NCT01816295|41737265|FG000|Double Blind Phase|Physician Decision|2|||
19553493|NCT01297959|42002385|FG001|Overall Study|Withdrawal by Subject|4|||
19469028|NCT01816295|41737266|FG001|Double Blind Phase|Physician Decision|2|||
19469029|NCT01816295|41737265|FG000|Double Blind Phase|Protocol Violation|17|||
19469030|NCT01816295|41737266|FG001|Double Blind Phase|Protocol Violation|11|||
19469031|NCT01816295|41737265|FG000|Double Blind Phase|Sponsor Decision|8|||
19469032|NCT01816295|41737266|FG001|Double Blind Phase|Sponsor Decision|8|||
19469033|NCT01816295|41737265|FG000|Double Blind Phase|Withdrawal by Subject|22|||
19469034|NCT01816295|41737266|FG001|Double Blind Phase|Withdrawal by Subject|20|||
19469035|NCT01816295|41737265|FG000|OLE Phase|Adverse Event|17|||
19469036|NCT01816295|41737266|FG001|OLE Phase|Adverse Event|15|||
19469037|NCT01816295|41737265|FG000|OLE Phase|Death|1|||
19469038|NCT01816295|41737266|FG001|OLE Phase|Death|0|||
19469039|NCT01816295|41737265|FG000|OLE Phase|Entry Criteria Not Met|3|||
19469040|NCT01816295|41737266|FG001|OLE Phase|Entry Criteria Not Met|5|||
19469041|NCT01816295|41737265|FG000|OLE Phase|Lost to Follow-up|5|||
19469042|NCT01816295|41737266|FG001|OLE Phase|Lost to Follow-up|5|||
19469043|NCT01816295|41737265|FG000|OLE Phase|Physician Decision|3|||
19469044|NCT01816295|41737266|FG001|OLE Phase|Physician Decision|1|||
19469045|NCT01816295|41737265|FG000|OLE Phase|Protocol Violation|4|||
19469046|NCT01816295|41737266|FG001|OLE Phase|Protocol Violation|4|||
19469047|NCT01816295|41737265|FG000|OLE Phase|Sponsor Decision|7|||
19469048|NCT01816295|41737266|FG001|OLE Phase|Sponsor Decision|9|||
19469049|NCT01816295|41737265|FG000|OLE Phase|Withdrawal by Subject|10|||
19469050|NCT01816295|41737266|FG001|OLE Phase|Withdrawal by Subject|10|||
19469051|NCT01816295|41737265|FG000|OLE Phase|Lack of Efficacy|3|||
19469052|NCT01816295|41737266|FG001|OLE Phase|Lack of Efficacy|7|||
19469053|NCT01610297|41737291|FG000|Overall Study|Lost to Follow-up|1|||
19469054|NCT01793051|41737302|FG000|Overall Study|Withdrawal by Subject|6|||
19469055|NCT01793051|41737303|FG001|Overall Study|Withdrawal by Subject|4|||
19469056|NCT01793051|41737302|FG000|Overall Study|Adverse Event|0|||
19469057|NCT01793051|41737303|FG001|Overall Study|Adverse Event|2|||
19469058|NCT01793051|41737302|FG000|Overall Study|Too ill to continue|1|||
19469059|NCT01793051|41737303|FG001|Overall Study|Too ill to continue|0|||
19469060|NCT01793051|41737302|FG000|Overall Study|Switched chemo|1|||
19469061|NCT01793051|41737303|FG001|Overall Study|Switched chemo|1|||
19469062|NCT01793051|41737302|FG000|Overall Study|Lack of compliance|1|||
19739238|NCT03538743|42186301|FG004|Overall Study|Withdrawal by Subject|0|||
19739239|NCT03538743|42186302|FG005|Overall Study|Withdrawal by Subject|0|||
19739240|NCT03538743|42186303|FG006|Overall Study|Withdrawal by Subject|0|||
19739241|NCT03538743|42186304|FG007|Overall Study|Withdrawal by Subject|0|||
19739242|NCT03538743|42186305|FG008|Overall Study|Withdrawal by Subject|0|||
19739243|NCT03521817|42186335|FG000|Overall Study|Protocol Violation|0|||
19739244|NCT03521817|42186336|FG001|Overall Study|Protocol Violation|1|||
19739245|NCT03538431|42186342|FG000|Overall Study|Physician Decision|0|||
19739246|NCT03538431|42186343|FG001|Overall Study|Physician Decision|1|||
19739247|NCT03538431|42186342|FG000|Overall Study|Withdrawal by Subject|1|||
19739248|NCT03538431|42186343|FG001|Overall Study|Withdrawal by Subject|0|||
19739249|NCT03521193|42186353|FG000|Overall Study|Withdrawal by Subject|8|||
19739250|NCT03521193|42186354|FG001|Overall Study|Withdrawal by Subject|0|||
19739251|NCT03521193|42186353|FG000|Overall Study|non compliant to ASA treatment|8|||
19739252|NCT03521193|42186354|FG001|Overall Study|non compliant to ASA treatment|0|||
19469063|NCT01793051|41737303|FG001|Overall Study|Lack of compliance|0|||
19469064|NCT01793051|41737302|FG000|Overall Study|Requested to be removed from the study|1|||
19469065|NCT01793051|41737303|FG001|Overall Study|Requested to be removed from the study|1|||
19469066|NCT01816061|41737336|FG000|Overall Study|Lost to Follow-up|13|||
19469067|NCT01816061|41737337|FG001|Overall Study|Lost to Follow-up|24|||
19469068|NCT01792115|41737363|FG000|Overall Study|Lost to Follow-up|0|||
19469069|NCT01792115|41737364|FG001|Overall Study|Lost to Follow-up|1|||
19469070|NCT01792115|41737365|FG002|Overall Study|Lost to Follow-up|0|||
19469071|NCT01791803|41737377|FG000|Overall Study|Withdrawal by Subject|0|||
19469072|NCT01791803|41737378|FG001|Overall Study|Withdrawal by Subject|0|||
19469073|NCT01791803|41737379|FG002|Overall Study|Withdrawal by Subject|0|||
19469074|NCT01791803|41737380|FG003|Overall Study|Withdrawal by Subject|2|||
19469075|NCT01791803|41737377|FG000|Overall Study|Physician Decision|0|||
19469076|NCT01791803|41737378|FG001|Overall Study|Physician Decision|2|||
19469077|NCT01791803|41737379|FG002|Overall Study|Physician Decision|0|||
19469078|NCT01791803|41737380|FG003|Overall Study|Physician Decision|1|||
19469079|NCT01791803|41737377|FG000|Overall Study|Death|0|||
19469080|NCT01791803|41737378|FG001|Overall Study|Death|0|||
19469081|NCT01791803|41737379|FG002|Overall Study|Death|2|||
19469082|NCT01791803|41737380|FG003|Overall Study|Death|2|||
19469083|NCT01791725|41737405|FG000|Overall Study|Withdrawal by Subject|0|||
19469084|NCT01791725|41737406|FG001|Overall Study|Withdrawal by Subject|1|||
19469085|NCT01791725|41737407|FG002|Overall Study|Withdrawal by Subject|0|||
19469086|NCT01791413|41737417|FG000|Overall Study|Lost to Follow-up|5|||
19469087|NCT01791413|41737418|FG001|Overall Study|Lost to Follow-up|1|||
19469088|NCT01610063|41737431|FG000|Overall Study|Lost to Follow-up|42|||
19469089|NCT01610063|41737432|FG001|Overall Study|Lost to Follow-up|20|||
19469090|NCT01813721|41737438|FG000|Overall Study|Ineligibility determined|63|||
19469091|NCT01813721|41737438|FG000|Overall Study|Withdrawal by Subject|1|||
19469092|NCT01790633|41737462|FG000|Overall Study|Protocol Violation|1|||
19469093|NCT01790633|41737463|FG001|Overall Study|Protocol Violation|2|||
19469094|NCT01790633|41737462|FG000|Overall Study|Did not have serology performed|47|||
19469095|NCT01790633|41737463|FG001|Overall Study|Did not have serology performed|0|||
19469096|NCT01790633|41737462|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
19469097|NCT01790633|41737463|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
19469098|NCT01788215|41737472|FG000|Overall Study|Withdrawal by Subject|0|||
19469099|NCT01788215|41737473|FG001|Overall Study|Withdrawal by Subject|1|||
19469100|NCT01788215|41737472|FG000|Overall Study|Lost to Follow-up|2|||
19469101|NCT01788215|41737473|FG001|Overall Study|Lost to Follow-up|0|||
19469102|NCT01787825|41737479|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
19469103|NCT01787825|41737480|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
19469104|NCT01787825|41737479|FG000|Overall Study|Data Not Analyzable|5|||
19469105|NCT01787825|41737480|FG001|Overall Study|Data Not Analyzable|1|||
19469106|NCT01813019|41737489|FG000|Overall Study|Adverse Event|0|||
19469107|NCT01813019|41737490|FG001|Overall Study|Adverse Event|3|||
19469108|NCT01813019|41737489|FG000|Overall Study|Withdrawal by Subject|3|||
19469109|NCT01813019|41737490|FG001|Overall Study|Withdrawal by Subject|2|||
19469110|NCT01813019|41737489|FG000|Overall Study|administrative problems|2|||
19469111|NCT01813019|41737490|FG001|Overall Study|administrative problems|0|||
19469112|NCT01813019|41737489|FG000|Overall Study|Protocol Deviation|2|||
19469113|NCT01813019|41737490|FG001|Overall Study|Protocol Deviation|1|||
19469114|NCT01787591|41737498|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
19469115|NCT01787591|41737499|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
19469116|NCT01787591|41737500|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
19469117|NCT01787591|41737501|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
19469118|NCT01812707|41737516|FG000|Overall Study|Adverse Event|0|||
19469119|NCT01812707|41737517|FG001|Overall Study|Adverse Event|0|||
19469120|NCT01812707|41737518|FG002|Overall Study|Adverse Event|0|||
19469121|NCT01812707|41737519|FG003|Overall Study|Adverse Event|2|||
19469122|NCT01812707|41737516|FG000|Overall Study|Poor compliance to protocol|1|||
19739253|NCT03538041|42186363|FG000|12-Week Treatment Period|Adverse Event|1|||
19739254|NCT03538041|42186364|FG001|12-Week Treatment Period|Adverse Event|1|||
19469123|NCT01812707|41737517|FG001|Overall Study|Poor compliance to protocol|0|||
19469124|NCT01812707|41737518|FG002|Overall Study|Poor compliance to protocol|0|||
19469125|NCT01812707|41737519|FG003|Overall Study|Poor compliance to protocol|0|||
19469126|NCT01812707|41737516|FG000|Overall Study|Consent withdrawn by participant|1|||
19469127|NCT01812707|41737517|FG001|Overall Study|Consent withdrawn by participant|0|||
19469128|NCT01812707|41737518|FG002|Overall Study|Consent withdrawn by participant|0|||
19469129|NCT01812707|41737519|FG003|Overall Study|Consent withdrawn by participant|0|||
19469130|NCT01787279|41737530|FG000|Overall Study|Lost to Follow-up|2|||
19469131|NCT01787279|41737530|FG000|Overall Study|Lack of Efficacy|1|||
19469132|NCT02728206|41737534|FG000|Overall Study|Death|1|||
19469133|NCT01811225|41737538|FG000|Treatment Period 1|Adverse Event|2|||
19469134|NCT01811225|41737539|FG001|Treatment Period 1|Adverse Event|3|||
19469135|NCT01811225|41737538|FG000|Treatment Period 1|Lost to Follow-up|12|||
19469136|NCT01811225|41737539|FG001|Treatment Period 1|Lost to Follow-up|8|||
19469137|NCT01811225|41737538|FG000|Treatment Period 1|transporation|1|||
19469138|NCT01811225|41737539|FG001|Treatment Period 1|transporation|0|||
19469139|NCT01811225|41737538|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
19553494|NCT01297959|42002384|FG000|Overall Study|Physician Decision|0|||
19553495|NCT01297959|42002385|FG001|Overall Study|Physician Decision|1|||
19553496|NCT01297959|42002384|FG000|Overall Study|Unrelated medical illness / complication|0|||
19553497|NCT01297959|42002385|FG001|Overall Study|Unrelated medical illness / complication|2|||
19553498|NCT01297959|42002384|FG000|Overall Study|Other|13|||
19553499|NCT01297959|42002385|FG001|Overall Study|Other|7|||
19553500|NCT01035229|42002393|FG000|Overall Study|Adverse Event|61|||
19553501|NCT01035229|42002394|FG001|Overall Study|Adverse Event|14|||
19553502|NCT01035229|42002393|FG000|Overall Study|Withdrawal by Subject|20|||
19553503|NCT01035229|42002394|FG001|Overall Study|Withdrawal by Subject|7|||
19739255|NCT03538041|42186363|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
19553504|NCT01035229|42002393|FG000|Overall Study|Lost to Follow-up|1|||
19553505|NCT01035229|42002394|FG001|Overall Study|Lost to Follow-up|0|||
19553506|NCT01035229|42002393|FG000|Overall Study|Administrative problems|1|||
19553507|NCT01035229|42002394|FG001|Overall Study|Administrative problems|1|||
19553508|NCT01035229|42002393|FG000|Overall Study|Death|13|||
19553509|NCT01035229|42002394|FG001|Overall Study|Death|5|||
19553510|NCT01035229|42002393|FG000|Overall Study|New cancer therapy|2|||
19553511|NCT01035229|42002394|FG001|Overall Study|New cancer therapy|0|||
19553512|NCT01035229|42002393|FG000|Overall Study|Protocol Violation|0|||
19553513|NCT01035229|42002394|FG001|Overall Study|Protocol Violation|2|||
19553514|NCT01035229|42002393|FG000|Overall Study|Sponsor's decision to end study|3|||
19553515|NCT01035229|42002394|FG001|Overall Study|Sponsor's decision to end study|3|||
19553516|NCT01035229|42002393|FG000|Overall Study|Disease Progression|261|||
19553517|NCT01035229|42002394|FG001|Overall Study|Disease Progression|152|||
19553518|NCT01106404|42002404|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
19553519|NCT01106404|42002405|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
19553520|NCT01106404|42002404|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
19553521|NCT01106404|42002405|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
19739256|NCT03538041|42186364|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
19739257|NCT03538041|42186363|FG000|Treatment Extension Period|Adverse Event|4|||
19739258|NCT03538041|42186364|FG001|Treatment Extension Period|Adverse Event|0|||
19739259|NCT03538041|42186363|FG000|Treatment Extension Period|Physician Decision|1|||
19739260|NCT03538041|42186364|FG001|Treatment Extension Period|Physician Decision|0|||
19739261|NCT03538041|42186363|FG000|Treatment Extension Period|Lack of Efficacy|1|||
19739262|NCT03538041|42186364|FG001|Treatment Extension Period|Lack of Efficacy|3|||
19739263|NCT03538041|42186363|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
19739264|NCT03538041|42186364|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
19739265|NCT03521115|42186375|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
19739266|NCT03521115|42186376|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
19739267|NCT03521115|42186375|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
19739268|NCT03521115|42186376|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
19739269|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
19739270|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
19739271|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
19739272|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
19739273|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
19739274|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
19739275|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
19739276|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
19553522|NCT01106404|42002404|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
19553523|NCT01106404|42002405|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
19553524|NCT01106404|42002404|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
19469140|NCT01811225|41737539|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
19469141|NCT01811225|41737538|FG000|Treatment Period 2|Lost to Follow-up|1|||
19469142|NCT01811225|41737539|FG001|Treatment Period 2|Lost to Follow-up|2|||
19739277|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
19739278|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
19739279|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
19739280|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
19739281|NCT00293267|42186390|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
19553525|NCT01106404|42002405|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
19553526|NCT01059799|42002419|FG000|Overall Study|Adverse Event|2|||
19553527|NCT01059799|42002420|FG001|Overall Study|Adverse Event|3|||
19553528|NCT01059799|42002419|FG000|Overall Study|Lack of Efficacy|1|||
19553529|NCT01059799|42002420|FG001|Overall Study|Lack of Efficacy|0|||
19553530|NCT01059799|42002419|FG000|Overall Study|Protocol Violation|3|||
19553531|NCT01059799|42002420|FG001|Overall Study|Protocol Violation|2|||
19553532|NCT01059799|42002419|FG000|Overall Study|Withdrawal criteria|13|||
19553533|NCT01059799|42002420|FG001|Overall Study|Withdrawal criteria|2|||
19553534|NCT01059799|42002419|FG000|Overall Study|Other|12|||
19553535|NCT01059799|42002420|FG001|Overall Study|Other|3|||
19553536|NCT01106248|42002426|FG000|Overall Study|Adverse Event|1|||
19553537|NCT01106248|42002426|FG000|Overall Study|Administrative|2|||
19553538|NCT01059175|42002432|FG000|Overall Study|Death|17|||
19553539|NCT01059175|42002433|FG001|Overall Study|Death|17|||
19553540|NCT01059175|42002432|FG000|Overall Study|Adverse Event|4|||
19553541|NCT01059175|42002433|FG001|Overall Study|Adverse Event|2|||
19553542|NCT01059175|42002432|FG000|Overall Study|Lost to Follow-up|0|||
19553543|NCT01059175|42002433|FG001|Overall Study|Lost to Follow-up|1|||
19553544|NCT01297491|42002441|FG000|Overall Study|Adverse Event|11|||
19553545|NCT01297491|42002442|FG001|Overall Study|Adverse Event|6|||
19553546|NCT01297491|42002441|FG000|Overall Study|Physician Decision|3|||
19553547|NCT01297491|42002442|FG001|Overall Study|Physician Decision|2|||
19553548|NCT01297491|42002441|FG000|Overall Study|Progressive disease|11|||
19553549|NCT01297491|42002442|FG001|Overall Study|Progressive disease|20|||
19553550|NCT01297491|42002441|FG000|Overall Study|Patient/Guardian decision|3|||
19553551|NCT01297491|42002442|FG001|Overall Study|Patient/Guardian decision|4|||
19553552|NCT01297491|42002441|FG000|Overall Study|Death|2|||
19553553|NCT01297491|42002442|FG001|Overall Study|Death|1|||
19553554|NCT01106092|42002452|FG000|Overall Study|Withdrawal by Subject|0|||
19553555|NCT01106092|42002453|FG001|Overall Study|Withdrawal by Subject|0|||
19553556|NCT01106092|42002454|FG002|Overall Study|Withdrawal by Subject|0|||
19553557|NCT01106092|42002455|FG003|Overall Study|Withdrawal by Subject|1|||
19553558|NCT01097668|42002467|FG000|Overall Study|Withdrawal by Subject|1|||
19553559|NCT01097668|42002468|FG001|Overall Study|Withdrawal by Subject|2|||
19553560|NCT01097668|42002467|FG000|Overall Study|Lost to Follow-up|1|||
19553561|NCT01097668|42002468|FG001|Overall Study|Lost to Follow-up|0|||
19553562|NCT01325207|42002484|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
19553563|NCT01325207|42002485|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
19553564|NCT01325207|42002486|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
19553565|NCT01325207|42002487|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
19553566|NCT01325207|42002488|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
19553567|NCT01325207|42002489|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
19553568|NCT01325207|42002484|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
19553569|NCT01325207|42002485|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
19553570|NCT01325207|42002486|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
19553571|NCT01325207|42002487|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
19553572|NCT01325207|42002488|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
19553573|NCT01325207|42002489|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
19553574|NCT01325207|42002484|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
19553575|NCT01325207|42002485|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
19553576|NCT01325207|42002486|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
19553577|NCT01325207|42002487|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
19553578|NCT01325207|42002488|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
19553579|NCT01325207|42002489|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
19553580|NCT01325207|42002484|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
19553581|NCT01325207|42002485|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
19553582|NCT01325207|42002486|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
19553583|NCT01325207|42002487|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
19553584|NCT01325207|42002488|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
19553585|NCT01325207|42002489|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
19553586|NCT01325207|42002484|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
19553587|NCT01325207|42002485|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
19553588|NCT01325207|42002486|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
19553589|NCT01325207|42002487|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
19553590|NCT01325207|42002488|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
19553591|NCT01325207|42002489|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
19553592|NCT01325207|42002484|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
19553593|NCT01325207|42002485|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
19553594|NCT01325207|42002486|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
19553595|NCT01325207|42002487|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
19553596|NCT01325207|42002488|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
19553597|NCT01325207|42002489|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
19553598|NCT01325207|42002484|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
19553599|NCT01325207|42002485|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
19553600|NCT01325207|42002486|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
19553601|NCT01325207|42002487|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
19469143|NCT01811225|41737538|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
19469144|NCT01811225|41737539|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
19469145|NCT01809197|41737547|FG000|Overall Study|Lost to Follow-up|4|||
19469146|NCT01809197|41737548|FG001|Overall Study|Lost to Follow-up|2|||
19469147|NCT01809197|41737547|FG000|Overall Study|Adverse Event|2|||
19469148|NCT01809197|41737548|FG001|Overall Study|Adverse Event|3|||
19469149|NCT01809197|41737547|FG000|Overall Study|Failed slit lamp exam|1|||
19469150|NCT01809197|41737548|FG001|Overall Study|Failed slit lamp exam|0|||
19469151|NCT01809197|41737547|FG000|Overall Study|Non-Compliance|1|||
19469152|NCT01809197|41737548|FG001|Overall Study|Non-Compliance|1|||
19469153|NCT01809197|41737547|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
19469154|NCT01809197|41737548|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
19469155|NCT01809197|41737547|FG000|Overall Study|Withdrawal by Subject|1|||
19469156|NCT01809197|41737548|FG001|Overall Study|Withdrawal by Subject|1|||
19469157|NCT01809197|41737547|FG000|Overall Study|Product not available|0|||
19469158|NCT01809197|41737548|FG001|Overall Study|Product not available|1|||
19469159|NCT01786109|41737557|FG000|Overall Study|fail manometry barostat tube placement|1|||
19469160|NCT01786109|41737558|FG001|Overall Study|fail manometry barostat tube placement|0|||
19469161|NCT01786109|41737559|FG002|Overall Study|fail manometry barostat tube placement|0|||
19469162|NCT01786109|41737557|FG000|Overall Study|unrelated illness|0|||
19469163|NCT01786109|41737558|FG001|Overall Study|unrelated illness|0|||
19553602|NCT01325207|42002488|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
19553603|NCT01325207|42002489|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
19553604|NCT01324349|42002506|FG000|Overall Study|Death|1|||
19553605|NCT01324349|42002507|FG001|Overall Study|Death|1|||
19553606|NCT01324349|42002506|FG000|Overall Study|Withdrawal by Subject|0|||
19553607|NCT01324349|42002507|FG001|Overall Study|Withdrawal by Subject|1|||
19553608|NCT01095250|42002517|FG000|Overall Study|administrative reasons|8|||
19553609|NCT01095250|42002518|FG001|Overall Study|administrative reasons|10|||
19553610|NCT01095250|42002519|FG002|Overall Study|administrative reasons|7|||
19553611|NCT01095250|42002520|FG003|Overall Study|administrative reasons|5|||
19553612|NCT01095250|42002517|FG000|Overall Study|Withdrawal by Subject|0|||
19553613|NCT01095250|42002518|FG001|Overall Study|Withdrawal by Subject|0|||
19553614|NCT01095250|42002519|FG002|Overall Study|Withdrawal by Subject|1|||
19553615|NCT01095250|42002520|FG003|Overall Study|Withdrawal by Subject|0|||
19553616|NCT01324271|42002530|FG000|Overall Study|Lost to Follow-up|3|||
19553617|NCT01324271|42002531|FG001|Overall Study|Lost to Follow-up|0|||
19553618|NCT01324271|42002530|FG000|Overall Study|Physician Decision|1|||
19553619|NCT01324271|42002531|FG001|Overall Study|Physician Decision|0|||
19553620|NCT01095094|42002537|FG000|Overall Study|Withdrawal by Subject|1|||
19553621|NCT01095094|42002537|FG000|Overall Study|Death|1|||
19553622|NCT01095094|42002537|FG000|Overall Study|Physician Decision|1|||
19553623|NCT01323647|42002543|FG000|Overall Study|Migrated/moved from study area|2|||
19553624|NCT01323647|42002544|FG001|Overall Study|Migrated/moved from study area|0|||
19739282|NCT00293267|42186391|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
19469164|NCT01786109|41737559|FG002|Overall Study|unrelated illness|1|||
19469165|NCT01786109|41737557|FG000|Overall Study|adverse effects colon preparation|0|||
19469166|NCT01786109|41737558|FG001|Overall Study|adverse effects colon preparation|0|||
19469167|NCT01786109|41737559|FG002|Overall Study|adverse effects colon preparation|1|||
19469168|NCT02728830|41737643|FG000|Overall Study|Exclusionary Surgery|9|||
19469169|NCT02728830|41737643|FG000|Overall Study|Exclusionary Pathology|6|||
19469170|NCT02728830|41737643|FG000|Overall Study|Physician Decision|3|||
19469171|NCT02728830|41737643|FG000|Overall Study|Withdrawal by Subject|2|||
19469172|NCT02728830|41737643|FG000|Overall Study|Lost to Follow-up|1|||
19469173|NCT02728830|41737643|FG000|Overall Study|Exclusionary Lab Values|1|||
19469174|NCT02728830|41737643|FG000|Overall Study|Contraindicated Illness|1|||
19469175|NCT02728830|41737643|FG000|Overall Study|Language Barrier|1|||
19469176|NCT02728596|41737697|FG000|Overall Study|Refusal unrelated to adverse event|3|||
19469177|NCT02728596|41737698|FG001|Overall Study|Refusal unrelated to adverse event|6|||
19469178|NCT02728596|41737699|FG002|Overall Study|Refusal unrelated to adverse event|7|||
19469179|NCT02728596|41737700|FG003|Overall Study|Refusal unrelated to adverse event|7|||
19469180|NCT02728596|41737697|FG000|Overall Study|Death|44|||
19469181|NCT02728596|41737698|FG001|Overall Study|Death|42|||
19469182|NCT02728596|41737699|FG002|Overall Study|Death|123|||
19469183|NCT02728596|41737700|FG003|Overall Study|Death|68|||
19469184|NCT00708162|41738083|FG000|Randomized Phase|Randomized but Not Treated|7|||
19469185|NCT00708162|41738084|FG001|Randomized Phase|Randomized but Not Treated|5|||
19469186|NCT00708162|41738083|FG000|Randomized Phase|Participant Noncompliance|40|||
19469187|NCT00708162|41738084|FG001|Randomized Phase|Participant Noncompliance|32|||
19469188|NCT00708162|41738083|FG000|Randomized Phase|Lost to Follow-up|34|||
19469189|NCT00708162|41738084|FG001|Randomized Phase|Lost to Follow-up|34|||
19469190|NCT00708162|41738083|FG000|Randomized Phase|Withdrew Consent|31|||
19469191|NCT00708162|41738084|FG001|Randomized Phase|Withdrew Consent|22|||
19469192|NCT00708162|41738083|FG000|Randomized Phase|Lack of Efficacy|14|||
19469193|NCT00708162|41738084|FG001|Randomized Phase|Lack of Efficacy|19|||
19469194|NCT00708162|41738083|FG000|Randomized Phase|Protocol Violation|10|||
19469195|NCT00708162|41738084|FG001|Randomized Phase|Protocol Violation|11|||
19469196|NCT00708162|41738083|FG000|Randomized Phase|Adverse Event|8|||
19469197|NCT00708162|41738084|FG001|Randomized Phase|Adverse Event|12|||
19469198|NCT00708162|41738083|FG000|Randomized Phase|Investigator's Discretion|7|||
19469199|NCT00708162|41738084|FG001|Randomized Phase|Investigator's Discretion|10|||
19469200|NCT00708162|41738083|FG000|Randomized Phase|Death|2|||
19469201|NCT00708162|41738084|FG001|Randomized Phase|Death|9|||
19469202|NCT00708162|41738083|FG000|Randomized Phase|Pregnancy|3|||
19469203|NCT00708162|41738084|FG001|Randomized Phase|Pregnancy|0|||
19469204|NCT00708162|41738083|FG000|Open-Label Phase|Lost to Follow-up|10|||
19469205|NCT00708162|41738084|FG001|Open-Label Phase|Lost to Follow-up|8|||
19469206|NCT00708162|41738083|FG000|Open-Label Phase|Withdrew Consent|12|||
19469207|NCT00708162|41738084|FG001|Open-Label Phase|Withdrew Consent|6|||
19469208|NCT00708162|41738083|FG000|Open-Label Phase|Participant Noncompliance|7|||
19469209|NCT00708162|41738084|FG001|Open-Label Phase|Participant Noncompliance|7|||
19469210|NCT00708162|41738083|FG000|Open-Label Phase|Lack of Efficacy|7|||
19553625|NCT01323647|42002543|FG000|Overall Study|Withdrawal by Subject|5|||
19553626|NCT01323647|42002544|FG001|Overall Study|Withdrawal by Subject|0|||
19553627|NCT01323647|42002543|FG000|Overall Study|Lost to Follow-up|2|||
19553628|NCT01323647|42002544|FG001|Overall Study|Lost to Follow-up|0|||
19553629|NCT01094782|42002556|FG000|Overall Study|Withdrawal by Subject|5|||
19469211|NCT00708162|41738084|FG001|Open-Label Phase|Lack of Efficacy|4|||
19469212|NCT00708162|41738083|FG000|Open-Label Phase|Investigator's Discretion|3|||
19553630|NCT01094782|42002557|FG001|Overall Study|Withdrawal by Subject|5|||
19553631|NCT01094782|42002558|FG002|Overall Study|Withdrawal by Subject|1|||
19553632|NCT01094782|42002559|FG003|Overall Study|Withdrawal by Subject|5|||
19553633|NCT01094782|42002560|FG004|Overall Study|Withdrawal by Subject|5|||
19553634|NCT01094782|42002561|FG005|Overall Study|Withdrawal by Subject|0|||
19553635|NCT01094782|42002556|FG000|Overall Study|Lost to Follow-up|1|||
19553636|NCT01094782|42002557|FG001|Overall Study|Lost to Follow-up|0|||
19553637|NCT01094782|42002558|FG002|Overall Study|Lost to Follow-up|0|||
19553638|NCT01094782|42002559|FG003|Overall Study|Lost to Follow-up|2|||
19553639|NCT01094782|42002560|FG004|Overall Study|Lost to Follow-up|1|||
19553640|NCT01094782|42002561|FG005|Overall Study|Lost to Follow-up|4|||
19553641|NCT01094782|42002556|FG000|Overall Study|Positive Drug Screen|2|||
19553642|NCT01094782|42002557|FG001|Overall Study|Positive Drug Screen|2|||
19553643|NCT01094782|42002558|FG002|Overall Study|Positive Drug Screen|1|||
19553644|NCT01094782|42002559|FG003|Overall Study|Positive Drug Screen|1|||
19553645|NCT01094782|42002560|FG004|Overall Study|Positive Drug Screen|3|||
19553646|NCT01094782|42002561|FG005|Overall Study|Positive Drug Screen|2|||
19553647|NCT01094782|42002556|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
19553648|NCT01094782|42002557|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
19553649|NCT01094782|42002558|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
19553650|NCT01094782|42002559|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
19553651|NCT01094782|42002560|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
19553652|NCT01094782|42002561|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
19553653|NCT01094782|42002556|FG000|Overall Study|Unable to Complete Questionnaires|0|||
19553654|NCT01094782|42002557|FG001|Overall Study|Unable to Complete Questionnaires|1|||
19553655|NCT01094782|42002558|FG002|Overall Study|Unable to Complete Questionnaires|0|||
19553656|NCT01094782|42002559|FG003|Overall Study|Unable to Complete Questionnaires|0|||
19553657|NCT01094782|42002560|FG004|Overall Study|Unable to Complete Questionnaires|0|||
19553658|NCT01094782|42002561|FG005|Overall Study|Unable to Complete Questionnaires|0|||
19553659|NCT01094782|42002556|FG000|Overall Study|Healthy Subject Had Pain|0|||
19553660|NCT01094782|42002557|FG001|Overall Study|Healthy Subject Had Pain|1|||
19553661|NCT01094782|42002558|FG002|Overall Study|Healthy Subject Had Pain|0|||
19553662|NCT01094782|42002559|FG003|Overall Study|Healthy Subject Had Pain|0|||
19553663|NCT01094782|42002560|FG004|Overall Study|Healthy Subject Had Pain|0|||
19553664|NCT01094782|42002561|FG005|Overall Study|Healthy Subject Had Pain|0|||
19469213|NCT00708162|41738084|FG001|Open-Label Phase|Investigator's Discretion|2|||
19469214|NCT00708162|41738083|FG000|Open-Label Phase|Death|3|||
19469215|NCT00708162|41738084|FG001|Open-Label Phase|Death|1|||
19469216|NCT00708162|41738083|FG000|Open-Label Phase|Adverse Event|1|||
19469217|NCT00708162|41738084|FG001|Open-Label Phase|Adverse Event|2|||
19469218|NCT00708162|41738083|FG000|Open-Label Phase|Other|1|||
19739283|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
19739284|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
19469219|NCT00708162|41738084|FG001|Open-Label Phase|Other|0|||
19553665|NCT01094782|42002556|FG000|Overall Study|Hypertension|0|||
19553666|NCT01094782|42002557|FG001|Overall Study|Hypertension|0|||
19553667|NCT01094782|42002558|FG002|Overall Study|Hypertension|1|||
19553668|NCT01094782|42002559|FG003|Overall Study|Hypertension|0|||
19553669|NCT01094782|42002560|FG004|Overall Study|Hypertension|0|||
19553670|NCT01094782|42002561|FG005|Overall Study|Hypertension|0|||
19553671|NCT01094782|42002556|FG000|Overall Study|Wrong Pain Condition|0|||
19553672|NCT01094782|42002557|FG001|Overall Study|Wrong Pain Condition|0|||
19553673|NCT01094782|42002558|FG002|Overall Study|Wrong Pain Condition|0|||
19553674|NCT01094782|42002559|FG003|Overall Study|Wrong Pain Condition|2|||
19553675|NCT01094782|42002560|FG004|Overall Study|Wrong Pain Condition|1|||
19553676|NCT01094782|42002561|FG005|Overall Study|Wrong Pain Condition|1|||
19553677|NCT01094782|42002556|FG000|Overall Study|Recent Interventional Injection|0|||
19553678|NCT01094782|42002557|FG001|Overall Study|Recent Interventional Injection|0|||
19553679|NCT01094782|42002558|FG002|Overall Study|Recent Interventional Injection|0|||
19553680|NCT01094782|42002559|FG003|Overall Study|Recent Interventional Injection|0|||
19553681|NCT01094782|42002560|FG004|Overall Study|Recent Interventional Injection|0|||
19553682|NCT01094782|42002561|FG005|Overall Study|Recent Interventional Injection|1|||
19553683|NCT01094782|42002556|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
19553684|NCT01094782|42002557|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
19553685|NCT01094782|42002558|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
19553686|NCT01094782|42002559|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
19553687|NCT01094782|42002560|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
19553688|NCT01094782|42002561|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
19553689|NCT01094782|42002556|FG000|Overall Study|Noncompliance With Study Schedule|0|||
19553690|NCT01094782|42002557|FG001|Overall Study|Noncompliance With Study Schedule|0|||
19553691|NCT01094782|42002558|FG002|Overall Study|Noncompliance With Study Schedule|0|||
19469220|NCT02245672|41738160|FG000|Overall Study|Adverse Event|4|||
19553692|NCT01094782|42002559|FG003|Overall Study|Noncompliance With Study Schedule|1|||
19739285|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
19739286|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
19739287|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
19553693|NCT01094782|42002560|FG004|Overall Study|Noncompliance With Study Schedule|0|||
19553694|NCT01094782|42002561|FG005|Overall Study|Noncompliance With Study Schedule|0|||
19553695|NCT01097044|42002577|FG000|Overall Study|Withdrawal by Subject|4|||
19553696|NCT01097044|42002578|FG001|Overall Study|Withdrawal by Subject|4|||
19553697|NCT01097044|42002577|FG000|Overall Study|Lost to Follow-up|1|||
19553698|NCT01097044|42002578|FG001|Overall Study|Lost to Follow-up|0|||
19553699|NCT01097044|42002577|FG000|Overall Study|Withdrawal by Sponsor|0|||
19553700|NCT01097044|42002578|FG001|Overall Study|Withdrawal by Sponsor|1|||
19553701|NCT01322009|42002588|FG000|Overall Study|Death|0|||
19553702|NCT01322009|42002589|FG001|Overall Study|Death|1|||
19553703|NCT01322009|42002588|FG000|Overall Study|Adverse Event|0|||
19553704|NCT01322009|42002589|FG001|Overall Study|Adverse Event|1|||
19553705|NCT01322009|42002588|FG000|Overall Study|ng tube discontinued|0|||
19553706|NCT01322009|42002589|FG001|Overall Study|ng tube discontinued|1|||
19553707|NCT01321697|42002595|FG000|Overall Study|Study Terminated|7|||
19553708|NCT01320683|42002599|FG000|Overall Study|Positive antibody response|1|||
19553709|NCT01320293|42002603|FG000|Overall Study|Lack of Efficacy|1|||
19553710|NCT01320293|42002603|FG000|Overall Study|Adverse Event|1|||
19553711|NCT01318811|42002609|FG000|Overall Study|Physician Decision|1|||
19553712|NCT01318811|42002610|FG001|Overall Study|Physician Decision|1|||
19553713|NCT01318811|42002609|FG000|Overall Study|CRRT stopped for head CT|0|||
19553714|NCT01318811|42002610|FG001|Overall Study|CRRT stopped for head CT|1|||
19553715|NCT01318811|42002609|FG000|Overall Study|Death|0|||
19553716|NCT01318811|42002610|FG001|Overall Study|Death|1|||
19553717|NCT01318811|42002609|FG000|Overall Study|CRRT stopped for head MRI|0|||
19553718|NCT01318811|42002610|FG001|Overall Study|CRRT stopped for head MRI|1|||
19553719|NCT01093846|42002619|FG000|Overall Study|Adverse Event|0|||
19553720|NCT01093846|42002620|FG001|Overall Study|Adverse Event|0|||
19553721|NCT01093846|42002621|FG002|Overall Study|Adverse Event|1|||
19553722|NCT01093846|42002619|FG000|Overall Study|Lack of Efficacy|0|||
19553723|NCT01093846|42002620|FG001|Overall Study|Lack of Efficacy|0|||
19553724|NCT01093846|42002621|FG002|Overall Study|Lack of Efficacy|4|||
19553725|NCT01093846|42002619|FG000|Overall Study|Condition no longer required study drug|1|||
19553726|NCT01093846|42002620|FG001|Overall Study|Condition no longer required study drug|1|||
19553727|NCT01093846|42002621|FG002|Overall Study|Condition no longer required study drug|1|||
19553728|NCT01093846|42002619|FG000|Overall Study|Administrative Problems|18|||
19553729|NCT01093846|42002620|FG001|Overall Study|Administrative Problems|17|||
19553730|NCT01093846|42002621|FG002|Overall Study|Administrative Problems|15|||
19553731|NCT01315847|42002629|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
19553732|NCT01315847|42002630|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
19553733|NCT01315847|42002629|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
19553734|NCT01315847|42002630|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
19553735|NCT01093534|42002639|FG000|Overall Study|Adverse Event|2|||
19553736|NCT01093534|42002640|FG001|Overall Study|Adverse Event|5|||
19553737|NCT01093534|42002641|FG002|Overall Study|Adverse Event|2|||
19553738|NCT01093534|42002639|FG000|Overall Study|Lack of Efficacy|2|||
19553739|NCT01093534|42002640|FG001|Overall Study|Lack of Efficacy|1|||
19553740|NCT01093534|42002641|FG002|Overall Study|Lack of Efficacy|1|||
19553741|NCT01093534|42002639|FG000|Overall Study|Withdrawal by Subject|5|||
19553742|NCT01093534|42002640|FG001|Overall Study|Withdrawal by Subject|7|||
19553743|NCT01093534|42002641|FG002|Overall Study|Withdrawal by Subject|2|||
19553744|NCT01093534|42002639|FG000|Overall Study|Other|1|||
19553745|NCT01093534|42002640|FG001|Overall Study|Other|3|||
19553746|NCT01093534|42002641|FG002|Overall Study|Other|4|||
19553747|NCT01314911|42002652|FG000|Overall Study|Lost to Follow-up|3|||
19553748|NCT01314911|42002653|FG001|Overall Study|Lost to Follow-up|2|||
19553749|NCT01314911|42002652|FG000|Overall Study|Withdrawal by Subject|1|||
19553750|NCT01314911|42002653|FG001|Overall Study|Withdrawal by Subject|3|||
19553751|NCT01314911|42002652|FG000|Overall Study|Received Non-randomized Study Drug|0|||
19553752|NCT01314911|42002653|FG001|Overall Study|Received Non-randomized Study Drug|1|||
19553753|NCT01314911|42002652|FG000|Overall Study|Never Started Treatment|1|||
19553754|NCT01314911|42002653|FG001|Overall Study|Never Started Treatment|0|||
19553755|NCT01093222|42002659|FG000|Overall Study|Ineligible|6|||
19553756|NCT01093222|42002659|FG000|Overall Study|Adverse Event|7|||
19553757|NCT01093222|42002659|FG000|Overall Study|Progression/relapse|24|||
19553758|NCT01093222|42002659|FG000|Overall Study|Death|2|||
19553759|NCT01093222|42002659|FG000|Overall Study|Not protocol specified|1|||
19553760|NCT01313663|42002665|FG000|Overall Study|Study Closed/Terminated|2|||
19553761|NCT01313663|42002666|FG001|Overall Study|Study Closed/Terminated|4|||
19553762|NCT01313663|42002665|FG000|Overall Study|Lost to Follow-up|0|||
19553763|NCT01313663|42002666|FG001|Overall Study|Lost to Follow-up|1|||
19553764|NCT01313663|42002665|FG000|Overall Study|Physician Decision|0|||
19739288|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
19553765|NCT01313663|42002666|FG001|Overall Study|Physician Decision|2|||
19553766|NCT01313663|42002665|FG000|Overall Study|Withdrawal by Subject|2|||
19553767|NCT01313663|42002666|FG001|Overall Study|Withdrawal by Subject|1|||
19553768|NCT01092832|42002674|FG000|Overall Study|Other|1|||
19553769|NCT01092832|42002675|FG001|Overall Study|Other|0|||
19553770|NCT01313273|42002683|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
19553771|NCT01313273|42002684|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
19553772|NCT01313273|42002683|FG000|Overall Study|Withdrawal by Subject|1|||
19553773|NCT01313273|42002684|FG001|Overall Study|Withdrawal by Subject|0|||
19553774|NCT01313273|42002683|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
19469221|NCT02245672|41738161|FG001|Overall Study|Adverse Event|4|||
19469222|NCT02245672|41738162|FG002|Overall Study|Adverse Event|4|||
19469223|NCT02245672|41738160|FG000|Overall Study|Lost to Follow-up|3|||
19469224|NCT02245672|41738161|FG001|Overall Study|Lost to Follow-up|5|||
19469225|NCT02245672|41738162|FG002|Overall Study|Lost to Follow-up|1|||
19469226|NCT02245672|41738160|FG000|Overall Study|Withdrawal by Subject|6|||
19469227|NCT02245672|41738161|FG001|Overall Study|Withdrawal by Subject|3|||
19469228|NCT02245672|41738162|FG002|Overall Study|Withdrawal by Subject|0|||
19469229|NCT02245672|41738160|FG000|Overall Study|Randomized in error (not treated)|0|||
19469230|NCT02245672|41738161|FG001|Overall Study|Randomized in error (not treated)|1|||
19469231|NCT02245672|41738162|FG002|Overall Study|Randomized in error (not treated)|0|||
19469232|NCT00706992|41738307|FG000|Overall Study|Study termination|5|||
19469233|NCT00706992|41738308|FG001|Overall Study|Study termination|5|||
19469234|NCT00706992|41738309|FG002|Overall Study|Study termination|6|||
19469235|NCT00706992|41738310|FG003|Overall Study|Study termination|2|||
19469236|NCT00706992|41738311|FG004|Overall Study|Study termination|3|||
19469237|NCT00706992|41738312|FG005|Overall Study|Study termination|2|||
19469238|NCT00706992|41738313|FG006|Overall Study|Study termination|3|||
19469239|NCT00706992|41738307|FG000|Overall Study|Disease progression before treatment|0|||
19469240|NCT00706992|41738308|FG001|Overall Study|Disease progression before treatment|0|||
19469241|NCT00706992|41738309|FG002|Overall Study|Disease progression before treatment|0|||
19469242|NCT00706992|41738310|FG003|Overall Study|Disease progression before treatment|0|||
19469243|NCT00706992|41738311|FG004|Overall Study|Disease progression before treatment|1|||
19469244|NCT00706992|41738312|FG005|Overall Study|Disease progression before treatment|0|||
19469245|NCT00706992|41738313|FG006|Overall Study|Disease progression before treatment|0|||
19469246|NCT01785875|41738366|FG000|Overall Study|Withdrawal by Subject|41|||
19469247|NCT01785875|41738367|FG001|Overall Study|Withdrawal by Subject|34|||
19469248|NCT01785875|41738368|FG002|Overall Study|Withdrawal by Subject|36|||
19469249|NCT01785875|41738366|FG000|Overall Study|Lost to Follow-up|19|||
19469250|NCT01785875|41738367|FG001|Overall Study|Lost to Follow-up|22|||
19469251|NCT01785875|41738368|FG002|Overall Study|Lost to Follow-up|6|||
19469252|NCT01785875|41738366|FG000|Overall Study|Death|27|||
19469253|NCT01785875|41738367|FG001|Overall Study|Death|16|||
19469254|NCT01785875|41738368|FG002|Overall Study|Death|7|||
19469255|NCT01785875|41738366|FG000|Overall Study|Sponsor Decision|0|||
19469256|NCT01785875|41738367|FG001|Overall Study|Sponsor Decision|2|||
19469257|NCT01785875|41738368|FG002|Overall Study|Sponsor Decision|0|||
19469258|NCT01785875|41738366|FG000|Overall Study|Protocol Specified Criteria|207|||
19469259|NCT01785875|41738367|FG001|Overall Study|Protocol Specified Criteria|214|||
19469260|NCT01785875|41738368|FG002|Overall Study|Protocol Specified Criteria|55|||
19469261|NCT01785875|41738366|FG000|Overall Study|Missing|0|||
19469262|NCT01785875|41738367|FG001|Overall Study|Missing|1|||
19469263|NCT01785875|41738368|FG002|Overall Study|Missing|3|||
19469264|NCT00706914|41738430|FG000|Overall Study|Lack of Efficacy|0|||
19469265|NCT00706914|41738431|FG001|Overall Study|Lack of Efficacy|1|||
19469266|NCT00706914|41738432|FG002|Overall Study|Lack of Efficacy|0|||
19469267|NCT00706914|41738430|FG000|Overall Study|Lost to Follow-up|1|||
19469268|NCT00706914|41738431|FG001|Overall Study|Lost to Follow-up|0|||
19469269|NCT00706914|41738432|FG002|Overall Study|Lost to Follow-up|0|||
19469270|NCT00706914|41738430|FG000|Overall Study|Adverse Event|2|||
19469271|NCT00706914|41738431|FG001|Overall Study|Adverse Event|2|||
19469272|NCT00706914|41738432|FG002|Overall Study|Adverse Event|0|||
19469273|NCT00706914|41738430|FG000|Overall Study|Protocol Violation|3|||
19469274|NCT00706914|41738431|FG001|Overall Study|Protocol Violation|1|||
19469275|NCT00706914|41738432|FG002|Overall Study|Protocol Violation|1|||
19469276|NCT01808651|41738539|FG000|Study Period 1|Lost to Follow-up|1|||
19469277|NCT01808651|41738540|FG001|Study Period 1|Lost to Follow-up|3|||
19469278|NCT01808651|41738541|FG002|Study Period 1|Lost to Follow-up|0|||
19469279|NCT01808651|41738539|FG000|Study Period 1|Protocol Violation|1|||
19469280|NCT01808651|41738540|FG001|Study Period 1|Protocol Violation|0|||
19469281|NCT01808651|41738541|FG002|Study Period 1|Protocol Violation|1|||
19469282|NCT01808651|41738539|FG000|Study Period 1|Physician Decision|3|||
19469283|NCT01808651|41738540|FG001|Study Period 1|Physician Decision|2|||
19469284|NCT01808651|41738541|FG002|Study Period 1|Physician Decision|0|||
19469285|NCT01808651|41738539|FG000|Study Period 1|Lack of Efficacy|2|||
19553775|NCT01313273|42002684|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
19553776|NCT01091974|42002694|FG000|Overall Study|Did not start intervention|3|||
19469286|NCT01808651|41738540|FG001|Study Period 1|Lack of Efficacy|1|||
19739289|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
19739290|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
19739291|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Death|3|||
19739292|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Death|0|||
19469287|NCT01808651|41738541|FG002|Study Period 1|Lack of Efficacy|0|||
19469288|NCT01808651|41738539|FG000|Study Period 1|Adverse Event|10|||
19469289|NCT01808651|41738540|FG001|Study Period 1|Adverse Event|4|||
19469290|NCT01808651|41738541|FG002|Study Period 1|Adverse Event|1|||
19469291|NCT01808651|41738539|FG000|Study Period 1|Participant Decision|9|||
19469292|NCT01808651|41738540|FG001|Study Period 1|Participant Decision|7|||
19469293|NCT01808651|41738541|FG002|Study Period 1|Participant Decision|3|||
19469294|NCT00706134|41738606|FG000|Overall Study|Adverse Event|8|||
19469295|NCT00706134|41738607|FG001|Overall Study|Adverse Event|7|||
19469296|NCT00706134|41738608|FG002|Overall Study|Adverse Event|2|||
19469297|NCT00706134|41738609|FG003|Overall Study|Adverse Event|3|||
19469298|NCT00706134|41738606|FG000|Overall Study|Lost to Follow-up|0|||
19469299|NCT00706134|41738607|FG001|Overall Study|Lost to Follow-up|1|||
19469300|NCT00706134|41738608|FG002|Overall Study|Lost to Follow-up|0|||
19469301|NCT00706134|41738609|FG003|Overall Study|Lost to Follow-up|0|||
19469302|NCT00706134|41738606|FG000|Overall Study|Protocol Violation|0|||
19469303|NCT00706134|41738607|FG001|Overall Study|Protocol Violation|6|||
19469304|NCT00706134|41738608|FG002|Overall Study|Protocol Violation|0|||
19469305|NCT00706134|41738609|FG003|Overall Study|Protocol Violation|3|||
19469306|NCT00706134|41738606|FG000|Overall Study|Withdrawal by Subject|1|||
19469307|NCT00706134|41738607|FG001|Overall Study|Withdrawal by Subject|2|||
19469308|NCT00706134|41738608|FG002|Overall Study|Withdrawal by Subject|1|||
19469309|NCT00706134|41738609|FG003|Overall Study|Withdrawal by Subject|0|||
19469310|NCT00706134|41738606|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
19469311|NCT00706134|41738607|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19469312|NCT00706134|41738608|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
19469313|NCT00706134|41738609|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
19469314|NCT00706134|41738606|FG000|Overall Study|Did not meet study criteria|2|||
19469315|NCT00706134|41738607|FG001|Overall Study|Did not meet study criteria|0|||
19469316|NCT00706134|41738608|FG002|Overall Study|Did not meet study criteria|0|||
19469317|NCT00706134|41738609|FG003|Overall Study|Did not meet study criteria|0|||
19469318|NCT01808573|41738621|FG000|Overall Study|Death|212|||
19469319|NCT01808573|41738622|FG001|Overall Study|Death|240|||
19469320|NCT01808573|41738621|FG000|Overall Study|Withdrawal by Subject|12|||
19469321|NCT01808573|41738622|FG001|Overall Study|Withdrawal by Subject|10|||
19469322|NCT01808573|41738621|FG000|Overall Study|Lost to Follow-up|3|||
19469323|NCT01808573|41738622|FG001|Overall Study|Lost to Follow-up|0|||
19469324|NCT01808573|41738621|FG000|Overall Study|Discontinuation of study by sponsor|79|||
19469325|NCT01808573|41738622|FG001|Overall Study|Discontinuation of study by sponsor|64|||
19469326|NCT01808573|41738621|FG000|Overall Study|Randomized in Error|1|||
19469327|NCT01808573|41738622|FG001|Overall Study|Randomized in Error|0|||
19469328|NCT02246530|41738649|FG000|Overall Study|Lost to Follow-up|4|||
19469329|NCT02246530|41738650|FG001|Overall Study|Lost to Follow-up|0|||
19469330|NCT01808339|41738656|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469331|NCT01808339|41738657|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469332|NCT01808339|41738658|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469333|NCT01808339|41738659|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
19469334|NCT01808339|41738660|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
19469335|NCT01808339|41738661|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
19469336|NCT01808339|41738656|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19469337|NCT01808339|41738657|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19553777|NCT01091974|42002695|FG001|Overall Study|Did not start intervention|1|||
19553778|NCT01091974|42002696|FG002|Overall Study|Did not start intervention|3|||
19469338|NCT01808339|41738658|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19469339|NCT01808339|41738659|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19469340|NCT01808339|41738660|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19469341|NCT01808339|41738661|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19469342|NCT01808339|41738656|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469343|NCT01808339|41738657|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469344|NCT01808339|41738658|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
19469345|NCT01808339|41738659|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469346|NCT01808339|41738660|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469347|NCT01808339|41738661|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
19469348|NCT02727660|41738711|FG000|Overall Study|Lack of Efficacy|40|||
19469349|NCT02727660|41738712|FG001|Overall Study|Lack of Efficacy|40|||
19469350|NCT02727660|41738713|FG002|Overall Study|Lack of Efficacy|70|||
19469351|NCT02727660|41738711|FG000|Overall Study|Adverse Event|28|||
19469352|NCT02727660|41738712|FG001|Overall Study|Adverse Event|21|||
19469353|NCT02727660|41738713|FG002|Overall Study|Adverse Event|32|||
19469354|NCT02727660|41738711|FG000|Overall Study|Withdrawal by Subject|26|||
19469355|NCT02727660|41738712|FG001|Overall Study|Withdrawal by Subject|25|||
19469356|NCT02727660|41738713|FG002|Overall Study|Withdrawal by Subject|30|||
19469357|NCT02727660|41738711|FG000|Overall Study|Physician Decision|3|||
19469358|NCT02727660|41738712|FG001|Overall Study|Physician Decision|8|||
19553779|NCT01091974|42002697|FG003|Overall Study|Did not start intervention|1|||
19553780|NCT01091974|42002694|FG000|Overall Study|resumed sleep medication|0|||
19553781|NCT01091974|42002695|FG001|Overall Study|resumed sleep medication|0|||
19553782|NCT01091974|42002696|FG002|Overall Study|resumed sleep medication|1|||
19553783|NCT01091974|42002697|FG003|Overall Study|resumed sleep medication|2|||
19553784|NCT01091974|42002694|FG000|Overall Study|Withdrawal by Subject|1|||
19553785|NCT01091974|42002695|FG001|Overall Study|Withdrawal by Subject|3|||
19553786|NCT01091974|42002696|FG002|Overall Study|Withdrawal by Subject|2|||
19553787|NCT01091974|42002697|FG003|Overall Study|Withdrawal by Subject|2|||
19739293|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
19469359|NCT02727660|41738713|FG002|Overall Study|Physician Decision|14|||
19469360|NCT02727660|41738711|FG000|Overall Study|Lost to Follow-up|5|||
19469361|NCT02727660|41738712|FG001|Overall Study|Lost to Follow-up|9|||
19469362|NCT02727660|41738713|FG002|Overall Study|Lost to Follow-up|8|||
19469363|NCT02727660|41738711|FG000|Overall Study|Protocol Violation|7|||
19469364|NCT02727660|41738712|FG001|Overall Study|Protocol Violation|5|||
19469365|NCT02727660|41738713|FG002|Overall Study|Protocol Violation|5|||
19469366|NCT02727660|41738711|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
19739294|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
19469367|NCT02727660|41738712|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
19381222|NCT01328093|41624390|FG000|Open-Label Phase|Withdrawal by Subject|4|||
19381223|NCT01328093|41624391|FG001|Open-Label Phase|Withdrawal by Subject|1|||
19381224|NCT01328093|41624390|FG000|Open-Label Phase|Scheduling conflict|2|||
19381225|NCT01328093|41624391|FG001|Open-Label Phase|Scheduling conflict|1|||
19381226|NCT01328093|41624390|FG000|Open-Label Phase|Subject is moving or has moved|2|||
19381227|NCT01328093|41624391|FG001|Open-Label Phase|Subject is moving or has moved|0|||
19381228|NCT01328093|41624390|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
19381229|NCT01328093|41624391|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
19381230|NCT02654145|41624398|FG000|Overall Study|Lack of Efficacy|1|||
19381231|NCT02654145|41624398|FG000|Overall Study|Protocol Violation|1|||
19381232|NCT02654145|41624398|FG000|Overall Study|Withdrawal by Subject|5|||
19469368|NCT02727660|41738713|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
19381233|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
19381234|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
19381235|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
19381236|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
19381237|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
19381238|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
19381239|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
19381240|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
19469369|NCT02727660|41738711|FG000|Overall Study|Administrative Reasons|2|||
19469370|NCT02727660|41738712|FG001|Overall Study|Administrative Reasons|3|||
19469371|NCT02727660|41738713|FG002|Overall Study|Administrative Reasons|4|||
19469372|NCT01784861|41738727|FG000|Overall Study|Adverse Event|0|||
19469373|NCT01784861|41738728|FG001|Overall Study|Adverse Event|0|||
19469374|NCT01784861|41738729|FG002|Overall Study|Adverse Event|1|||
19469375|NCT01784861|41738730|FG003|Overall Study|Adverse Event|2|||
19469376|NCT01784861|41738731|FG004|Overall Study|Adverse Event|1|||
19469377|NCT01784861|41738732|FG005|Overall Study|Adverse Event|0|||
19469378|NCT01784861|41738727|FG000|Overall Study|Withdrawal by Subject|0|||
19469379|NCT01784861|41738728|FG001|Overall Study|Withdrawal by Subject|0|||
19469380|NCT01784861|41738729|FG002|Overall Study|Withdrawal by Subject|0|||
19469381|NCT01784861|41738730|FG003|Overall Study|Withdrawal by Subject|1|||
19469382|NCT01784861|41738731|FG004|Overall Study|Withdrawal by Subject|0|||
19469383|NCT01784861|41738732|FG005|Overall Study|Withdrawal by Subject|0|||
19469384|NCT01784861|41738727|FG000|Overall Study|Physician Decision|0|||
19469385|NCT01784861|41738728|FG001|Overall Study|Physician Decision|0|||
19469386|NCT01784861|41738729|FG002|Overall Study|Physician Decision|0|||
19469387|NCT01784861|41738730|FG003|Overall Study|Physician Decision|2|||
19469388|NCT01784861|41738731|FG004|Overall Study|Physician Decision|0|||
19469389|NCT01784861|41738732|FG005|Overall Study|Physician Decision|1|||
19478091|NCT01693562|41757314|FG000|Expansion Phase|Withdrawal by Subject|0|||
19478092|NCT01693562|41757315|FG001|Expansion Phase|Withdrawal by Subject|0|||
19478093|NCT01693562|41757316|FG002|Expansion Phase|Withdrawal by Subject|0|||
19478094|NCT01693562|41757317|FG003|Expansion Phase|Withdrawal by Subject|0|||
19478095|NCT01693562|41757318|FG004|Expansion Phase|Withdrawal by Subject|0|||
19478096|NCT01693562|41757319|FG005|Expansion Phase|Withdrawal by Subject|0|||
19478097|NCT01693562|41757320|FG006|Expansion Phase|Withdrawal by Subject|0|||
19553788|NCT01091974|42002694|FG000|Overall Study|side-effects|1|||
19478098|NCT01693562|41757321|FG007|Expansion Phase|Withdrawal by Subject|16|||
19478099|NCT01693562|41757322|FG008|Expansion Phase|Withdrawal by Subject|2|||
19478100|NCT01693562|41757323|FG009|Expansion Phase|Withdrawal by Subject|54|||
19478101|NCT01693562|41757324|FG010|Expansion Phase|Withdrawal by Subject|2|||
19478102|NCT01693562|41757325|FG011|Expansion Phase|Withdrawal by Subject|2|||
19381241|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
19381242|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
19381243|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
19381244|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
19381245|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
19381246|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
19381247|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
19381248|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
19381249|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
19381250|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
19381251|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
19381252|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
19381253|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
19381254|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
19381255|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
19381256|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
19381257|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
19381258|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
19381259|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
19381260|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
19381261|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
19381262|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
19381263|NCT01111565|41624402|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
19381264|NCT01111565|41624403|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
19381265|NCT01111565|41624404|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
19381266|NCT01111565|41624405|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
19381267|NCT01111565|41624406|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
19469390|NCT02727192|41738806|FG000|Overall Study|Lost to Follow-up|1|||
19469391|NCT02727192|41738807|FG001|Overall Study|Lost to Follow-up|0|||
19469392|NCT02727192|41738808|FG002|Overall Study|Lost to Follow-up|0|||
19469393|NCT00705666|41738828|FG000|Overall Study|No post-treatment questionnaire|279|||
19469394|NCT00705666|41738828|FG000|Overall Study|Withdrawal by Subject|21|||
19469395|NCT00705666|41738828|FG000|Overall Study|Physician Decision|7|||
19469396|NCT00705666|41738828|FG000|Overall Study|Lost to Follow-up|5|||
19469397|NCT00705666|41738828|FG000|Overall Study|Death|1|||
19469398|NCT00705666|41738828|FG000|Overall Study|Adverse Event|4|||
19469399|NCT00705666|41738828|FG000|Overall Study|Other|12|||
19469400|NCT00705666|41738828|FG000|Overall Study|Other|2|||
19469401|NCT00705666|41738828|FG000|Overall Study|Lack of data|3|||
19469402|NCT00705666|41738828|FG000|Overall Study|Untreated|5|||
19469403|NCT02725866|41738987|FG000|Overall Study|Failure to return|6|||
19469404|NCT02725866|41738987|FG000|Overall Study|Withdrew consent|3|||
19469405|NCT02725866|41738987|FG000|Overall Study|Insufficient virological response|1|||
19469406|NCT02725866|41738987|FG000|Overall Study|Other, not specified|4|||
19469407|NCT02726022|41739023|FG000|Overall Study|Adverse Event|14|||
19469408|NCT02726022|41739023|FG000|Overall Study|Treatment Failure|8|||
19469409|NCT02726022|41739023|FG000|Overall Study|Poor Compliance|13|||
19373468|NCT03945825|41614591|FG002|Overall Study|Withdrawal by Subject|1|||
19373469|NCT03945825|41614592|FG003|Overall Study|Withdrawal by Subject|1|||
19373470|NCT03945825|41614593|FG004|Overall Study|Withdrawal by Subject|0|||
19373471|NCT03945825|41614594|FG005|Overall Study|Withdrawal by Subject|1|||
19373472|NCT02759315|41614622|FG000|Overall Study|Adverse Event|0|||
19373473|NCT02759315|41614623|FG001|Overall Study|Adverse Event|0|||
19373474|NCT02759315|41614624|FG002|Overall Study|Adverse Event|0|||
19373475|NCT02759315|41614625|FG003|Overall Study|Adverse Event|1|||
19373476|NCT02759315|41614626|FG004|Overall Study|Adverse Event|0|||
19373477|NCT02759315|41614622|FG000|Overall Study|Death|0|||
19373478|NCT02759315|41614623|FG001|Overall Study|Death|0|||
19373479|NCT02759315|41614624|FG002|Overall Study|Death|1|||
19373480|NCT02759315|41614625|FG003|Overall Study|Death|0|||
19373481|NCT02759315|41614626|FG004|Overall Study|Death|0|||
19373482|NCT02759315|41614622|FG000|Overall Study|Lost to Follow-up|2|||
19373483|NCT02759315|41614623|FG001|Overall Study|Lost to Follow-up|0|||
19373484|NCT02759315|41614624|FG002|Overall Study|Lost to Follow-up|4|||
19373485|NCT02759315|41614625|FG003|Overall Study|Lost to Follow-up|0|||
19373486|NCT02759315|41614626|FG004|Overall Study|Lost to Follow-up|0|||
19373487|NCT02759315|41614622|FG000|Overall Study|Protocol Violation|0|||
19373488|NCT02759315|41614623|FG001|Overall Study|Protocol Violation|1|||
19373489|NCT02759315|41614624|FG002|Overall Study|Protocol Violation|0|||
19373490|NCT02759315|41614625|FG003|Overall Study|Protocol Violation|0|||
19373491|NCT02759315|41614626|FG004|Overall Study|Protocol Violation|0|||
19373492|NCT02759315|41614622|FG000|Overall Study|Study terminated prior to completion|2|||
19373493|NCT02759315|41614623|FG001|Overall Study|Study terminated prior to completion|0|||
19373494|NCT02759315|41614624|FG002|Overall Study|Study terminated prior to completion|5|||
19373495|NCT02759315|41614625|FG003|Overall Study|Study terminated prior to completion|0|||
19373496|NCT02759315|41614626|FG004|Overall Study|Study terminated prior to completion|1|||
19373497|NCT00835081|41614642|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19373498|NCT00835081|41614643|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19373499|NCT02543918|41614649|FG000|Overall Study|Never treated|0|||
19373500|NCT02543918|41614650|FG001|Overall Study|Never treated|1|||
19373501|NCT02543918|41614649|FG000|Overall Study|Lost to Follow-up|1|||
19373502|NCT02543918|41614650|FG001|Overall Study|Lost to Follow-up|1|||
19373503|NCT02543918|41614649|FG000|Overall Study|Withdrawal by Subject|1|||
19373504|NCT02543918|41614650|FG001|Overall Study|Withdrawal by Subject|1|||
19373505|NCT02543918|41614649|FG000|Overall Study|Adverse Event|1|||
19373506|NCT02543918|41614650|FG001|Overall Study|Adverse Event|1|||
19373507|NCT01372995|41614659|FG000|Overall Study|Spouse withdrew participant from study|0|||
19373508|NCT01372995|41614660|FG001|Overall Study|Spouse withdrew participant from study|1|||
19373509|NCT01372995|41614661|FG002|Overall Study|Spouse withdrew participant from study|0|||
19373510|NCT01372995|41614659|FG000|Overall Study|Physician Decision|0|||
19381268|NCT01111565|41624402|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19381269|NCT01111565|41624403|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19381270|NCT01111565|41624404|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19381271|NCT01111565|41624405|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
19381272|NCT01111565|41624406|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19381273|NCT01111565|41624402|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19381274|NCT01111565|41624403|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19381275|NCT01111565|41624404|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
19381276|NCT01111565|41624405|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19381277|NCT01111565|41624406|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19381278|NCT01111565|41624402|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
19381279|NCT01111565|41624403|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
19381280|NCT01111565|41624404|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
19381281|NCT01111565|41624405|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
19381282|NCT01111565|41624406|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
19381283|NCT01111565|41624402|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
19381284|NCT01111565|41624403|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
19381285|NCT01111565|41624404|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
19381286|NCT01111565|41624405|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
19381287|NCT01111565|41624406|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
19381288|NCT01111565|41624402|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
19381289|NCT01111565|41624403|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
19381290|NCT01111565|41624404|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
19381291|NCT01111565|41624405|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
19381292|NCT01111565|41624406|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
19381293|NCT02343458|41624420|FG000|Overall Study|Adverse Event|15|||
19381294|NCT02343458|41624421|FG001|Overall Study|Adverse Event|14|||
19381295|NCT02343458|41624422|FG002|Overall Study|Adverse Event|15|||
19381296|NCT02343458|41624423|FG003|Overall Study|Adverse Event|3|||
19381297|NCT02343458|41624420|FG000|Overall Study|Lack of Efficacy|3|||
19381298|NCT02343458|41624421|FG001|Overall Study|Lack of Efficacy|8|||
19381299|NCT02343458|41624422|FG002|Overall Study|Lack of Efficacy|4|||
19381300|NCT02343458|41624423|FG003|Overall Study|Lack of Efficacy|8|||
19381301|NCT02343458|41624420|FG000|Overall Study|Withdrawal by Subject|18|||
19381302|NCT02343458|41624421|FG001|Overall Study|Withdrawal by Subject|17|||
19381303|NCT02343458|41624422|FG002|Overall Study|Withdrawal by Subject|23|||
19381304|NCT02343458|41624423|FG003|Overall Study|Withdrawal by Subject|14|||
19381305|NCT02343458|41624420|FG000|Overall Study|Physician Decision|1|||
19381306|NCT02343458|41624421|FG001|Overall Study|Physician Decision|4|||
19381307|NCT02343458|41624422|FG002|Overall Study|Physician Decision|2|||
19381308|NCT02343458|41624423|FG003|Overall Study|Physician Decision|2|||
19381309|NCT02343458|41624420|FG000|Overall Study|Lost to Follow-up|5|||
19381310|NCT02343458|41624421|FG001|Overall Study|Lost to Follow-up|5|||
19381311|NCT02343458|41624422|FG002|Overall Study|Lost to Follow-up|3|||
19381312|NCT02343458|41624423|FG003|Overall Study|Lost to Follow-up|1|||
19381313|NCT02343458|41624420|FG000|Overall Study|Protocol Violation|2|||
19381314|NCT02343458|41624421|FG001|Overall Study|Protocol Violation|5|||
19381315|NCT02343458|41624422|FG002|Overall Study|Protocol Violation|2|||
19381316|NCT02343458|41624423|FG003|Overall Study|Protocol Violation|2|||
19381317|NCT02343458|41624420|FG000|Overall Study|Protocol Specified Criteria|17|||
19381318|NCT02343458|41624421|FG001|Overall Study|Protocol Specified Criteria|13|||
19381319|NCT02343458|41624422|FG002|Overall Study|Protocol Specified Criteria|14|||
19381320|NCT02343458|41624423|FG003|Overall Study|Protocol Specified Criteria|8|||
19381321|NCT01328041|41624446|FG000|Overall Study|Adverse Event|7|||
19381322|NCT01328041|41624446|FG000|Overall Study|Lack of Efficacy|27|||
19381323|NCT01328041|41624446|FG000|Overall Study|Protocol Violation|7|||
19381324|NCT01328041|41624446|FG000|Overall Study|Lost to Follow-up|7|||
19381325|NCT01328041|41624446|FG000|Overall Study|Physician Decision|2|||
19381326|NCT01328041|41624446|FG000|Overall Study|Withdrawal by Subject|7|||
19381327|NCT02410772|41624453|FG000|Overall Study|Death|3|||
19381328|NCT02410772|41624454|FG001|Overall Study|Death|4|||
19381329|NCT02410772|41624455|FG002|Overall Study|Death|8|||
19381330|NCT02410772|41624453|FG000|Overall Study|Lost to Follow-up|31|||
19381331|NCT02410772|41624454|FG001|Overall Study|Lost to Follow-up|23|||
19381332|NCT02410772|41624455|FG002|Overall Study|Lost to Follow-up|22|||
19381333|NCT02410772|41624453|FG000|Overall Study|Pregnancy|8|||
19381334|NCT02410772|41624454|FG001|Overall Study|Pregnancy|4|||
19381335|NCT02410772|41624455|FG002|Overall Study|Pregnancy|5|||
19381336|NCT02410772|41624453|FG000|Overall Study|Protocol Violation|8|||
19381337|NCT02410772|41624454|FG001|Overall Study|Protocol Violation|8|||
19381338|NCT02410772|41624455|FG002|Overall Study|Protocol Violation|4|||
19381339|NCT02410772|41624453|FG000|Overall Study|Baseline Drug Resistance|49|||
19381340|NCT02410772|41624454|FG001|Overall Study|Baseline Drug Resistance|40|||
19381341|NCT02410772|41624455|FG002|Overall Study|Baseline Drug Resistance|51|||
19381342|NCT02410772|41624453|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
19381343|NCT02410772|41624454|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
19381344|NCT02410772|41624455|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
19381345|NCT02410772|41624453|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
19381346|NCT02410772|41624454|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
19381347|NCT02410772|41624455|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
19381348|NCT01648790|41624472|FG000|Treatment 3|Withdrawal by Subject|0|||
19381349|NCT01648790|41624473|FG001|Treatment 3|Withdrawal by Subject|0|||
19381350|NCT01648790|41624474|FG002|Treatment 3|Withdrawal by Subject|0|||
19381351|NCT01648790|41624475|FG003|Treatment 3|Withdrawal by Subject|1|||
19381352|NCT01648790|41624476|FG004|Treatment 3|Withdrawal by Subject|0|||
19381353|NCT01936857|41624499|FG000|Overall Study|Sent to prison or 06 center|11|||
19381354|NCT01936857|41624500|FG001|Overall Study|Sent to prison or 06 center|12|||
19381355|NCT01936857|41624499|FG000|Overall Study|Lost to Follow-up|10|||
19381356|NCT01936857|41624500|FG001|Overall Study|Lost to Follow-up|7|||
19381357|NCT01936857|41624499|FG000|Overall Study|Death|7|||
19381358|NCT01936857|41624500|FG001|Overall Study|Death|3|||
19381359|NCT01936857|41624499|FG000|Overall Study|Moved|2|||
19381360|NCT01936857|41624500|FG001|Overall Study|Moved|1|||
19381361|NCT01936857|41624499|FG000|Overall Study|Withdrawal by Subject|1|||
19381362|NCT01936857|41624500|FG001|Overall Study|Withdrawal by Subject|0|||
19381363|NCT01936857|41624499|FG000|Overall Study|Side effect of medication|1|||
19381364|NCT01936857|41624500|FG001|Overall Study|Side effect of medication|0|||
19381365|NCT01936857|41624499|FG000|Overall Study|Other|2|||
19381366|NCT01936857|41624500|FG001|Overall Study|Other|2|||
19381367|NCT01602224|41624509|FG000|Overall Study|Adverse Event|0|||
19381368|NCT01602224|41624510|FG001|Overall Study|Adverse Event|1|||
19381369|NCT01602224|41624511|FG002|Overall Study|Adverse Event|0|||
19381370|NCT01602224|41624509|FG000|Overall Study|Investigator Decison|1|||
19381371|NCT01602224|41624510|FG001|Overall Study|Investigator Decison|0|||
19381372|NCT01602224|41624511|FG002|Overall Study|Investigator Decison|0|||
19639171|NCT00717236|42088569|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
19639172|NCT00717236|42088570|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
19381373|NCT01602224|41624509|FG000|Overall Study|Lost to Follow-up|0|||
19381374|NCT01602224|41624510|FG001|Overall Study|Lost to Follow-up|0|||
19381375|NCT01602224|41624511|FG002|Overall Study|Lost to Follow-up|1|||
19381376|NCT01602224|41624509|FG000|Overall Study|Protocol Violation|0|||
19381377|NCT01602224|41624510|FG001|Overall Study|Protocol Violation|1|||
19381378|NCT01602224|41624511|FG002|Overall Study|Protocol Violation|0|||
19381379|NCT01602224|41624509|FG000|Overall Study|Sponsor Decision|2|||
19381380|NCT01602224|41624510|FG001|Overall Study|Sponsor Decision|3|||
19381381|NCT01602224|41624511|FG002|Overall Study|Sponsor Decision|2|||
19381382|NCT01602224|41624509|FG000|Overall Study|Withdrawal by Subject|5|||
19381383|NCT01602224|41624510|FG001|Overall Study|Withdrawal by Subject|3|||
19381384|NCT01602224|41624511|FG002|Overall Study|Withdrawal by Subject|3|||
19381385|NCT04498247|41624529|FG000|Overall Study|Lost to Follow-up|0|||
19381386|NCT04498247|41624530|FG001|Overall Study|Lost to Follow-up|0|||
19381387|NCT04498247|41624531|FG002|Overall Study|Lost to Follow-up|0|||
19381388|NCT04498247|41624532|FG003|Overall Study|Lost to Follow-up|1|||
19381389|NCT04498247|41624533|FG004|Overall Study|Lost to Follow-up|0|||
19381390|NCT04498247|41624534|FG005|Overall Study|Lost to Follow-up|0|||
19381391|NCT04498247|41624535|FG006|Overall Study|Lost to Follow-up|0|||
19381392|NCT04498247|41624536|FG007|Overall Study|Lost to Follow-up|0|||
19381393|NCT04498247|41624529|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
19381394|NCT04498247|41624530|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381395|NCT04498247|41624531|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381396|NCT04498247|41624532|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381397|NCT04498247|41624533|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381398|NCT04498247|41624534|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381399|NCT04498247|41624535|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381400|NCT04498247|41624536|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
19381401|NCT04498247|41624529|FG000|Overall Study|Withdrawal by Subject|0|||
19381402|NCT04498247|41624530|FG001|Overall Study|Withdrawal by Subject|8|||
19381403|NCT04498247|41624531|FG002|Overall Study|Withdrawal by Subject|0|||
19381404|NCT04498247|41624532|FG003|Overall Study|Withdrawal by Subject|7|||
19381405|NCT04498247|41624533|FG004|Overall Study|Withdrawal by Subject|0|||
19381406|NCT04498247|41624534|FG005|Overall Study|Withdrawal by Subject|0|||
19381407|NCT04498247|41624535|FG006|Overall Study|Withdrawal by Subject|1|||
19381408|NCT04498247|41624536|FG007|Overall Study|Withdrawal by Subject|0|||
19381409|NCT04498247|41624529|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
19381410|NCT04498247|41624530|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
19381411|NCT04498247|41624531|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
19381412|NCT04498247|41624532|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
19381413|NCT04498247|41624533|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
19381414|NCT04498247|41624534|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
19381415|NCT04498247|41624535|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
19381416|NCT04498247|41624536|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
19381417|NCT03887117|41624564|FG000|Overall Study|Discontinued prematurely|0|||
19381418|NCT03887117|41624565|FG001|Overall Study|Discontinued prematurely|1|||
19381419|NCT03887117|41624566|FG002|Overall Study|Discontinued prematurely|1|||
19381420|NCT03887117|41624567|FG003|Overall Study|Discontinued prematurely|2|||
19381421|NCT04038385|41624588|FG000|Overall Study|Completed baseline assessment only|7|||
19381422|NCT04038385|41624589|FG001|Overall Study|Completed baseline assessment only|4|||
19381423|NCT04038385|41624588|FG000|Overall Study|Moved out of area|4|||
19381424|NCT04038385|41624589|FG001|Overall Study|Moved out of area|2|||
19381425|NCT04038385|41624588|FG000|Overall Study|Discontinued study involvement|6|||
19381426|NCT04038385|41624589|FG001|Overall Study|Discontinued study involvement|1|||
19381427|NCT00783263|41624599|FG000|Overall Study|Adverse Event|3|||
19381428|NCT00783263|41624600|FG001|Overall Study|Adverse Event|0|||
19381429|NCT00783263|41624601|FG002|Overall Study|Adverse Event|2|||
19381430|NCT00783263|41624602|FG003|Overall Study|Adverse Event|1|||
19381431|NCT00783263|41624599|FG000|Overall Study|Lost to Follow-up|1|||
19381432|NCT00783263|41624600|FG001|Overall Study|Lost to Follow-up|1|||
19381433|NCT00783263|41624601|FG002|Overall Study|Lost to Follow-up|0|||
19381434|NCT00783263|41624602|FG003|Overall Study|Lost to Follow-up|0|||
19381435|NCT00783263|41624599|FG000|Overall Study|Withdrawal by Subject|0|||
19381436|NCT00783263|41624600|FG001|Overall Study|Withdrawal by Subject|1|||
19381437|NCT00783263|41624601|FG002|Overall Study|Withdrawal by Subject|1|||
19381438|NCT00783263|41624602|FG003|Overall Study|Withdrawal by Subject|2|||
19381439|NCT03987919|41624629|FG000|Overall Study|Adverse Event|1|||
19381440|NCT03987919|41624630|FG001|Overall Study|Adverse Event|4|||
19381441|NCT03987919|41624631|FG002|Overall Study|Adverse Event|1|||
19381442|NCT03987919|41624632|FG003|Overall Study|Adverse Event|3|||
19381443|NCT03987919|41624629|FG000|Overall Study|Death|4|||
19381444|NCT03987919|41624630|FG001|Overall Study|Death|4|||
19381445|NCT03987919|41624631|FG002|Overall Study|Death|4|||
19381446|NCT03987919|41624632|FG003|Overall Study|Death|1|||
19381447|NCT03987919|41624629|FG000|Overall Study|Lost to Follow-up|5|||
19381448|NCT03987919|41624630|FG001|Overall Study|Lost to Follow-up|6|||
19381449|NCT03987919|41624631|FG002|Overall Study|Lost to Follow-up|8|||
19381450|NCT03987919|41624632|FG003|Overall Study|Lost to Follow-up|12|||
19381451|NCT03987919|41624629|FG000|Overall Study|Physician Decision|0|||
19381452|NCT03987919|41624630|FG001|Overall Study|Physician Decision|2|||
19381453|NCT03987919|41624631|FG002|Overall Study|Physician Decision|0|||
19381454|NCT03987919|41624632|FG003|Overall Study|Physician Decision|4|||
19381455|NCT03987919|41624629|FG000|Overall Study|Pregnancy|1|||
19381456|NCT03987919|41624630|FG001|Overall Study|Pregnancy|0|||
19381457|NCT03987919|41624631|FG002|Overall Study|Pregnancy|1|||
19381458|NCT03987919|41624632|FG003|Overall Study|Pregnancy|1|||
19381459|NCT03987919|41624629|FG000|Overall Study|Protocol Violation|0|||
19381460|NCT03987919|41624630|FG001|Overall Study|Protocol Violation|1|||
19381461|NCT03987919|41624631|FG002|Overall Study|Protocol Violation|0|||
19381462|NCT03987919|41624632|FG003|Overall Study|Protocol Violation|0|||
19469410|NCT02726022|41739023|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
19469411|NCT02725788|41739038|FG000|Overall Study|Lost to Follow-up|1|||
19469412|NCT02725788|41739039|FG001|Overall Study|Lost to Follow-up|1|||
19469413|NCT02725788|41739038|FG000|Overall Study|Protocol Violation|0|||
19469414|NCT02725788|41739039|FG001|Overall Study|Protocol Violation|1|||
19469415|NCT02725710|41739178|FG000|Overall Study|Lost to Follow-up|1|||
19469416|NCT02725710|41739179|FG001|Overall Study|Lost to Follow-up|0|||
19469417|NCT02724462|41739210|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
19469418|NCT02724462|41739211|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
19469419|NCT02724462|41739210|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
19469420|NCT02724462|41739211|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
19469421|NCT02724462|41739210|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
19469422|NCT02724462|41739211|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
19469423|NCT02724462|41739210|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
19469424|NCT02724462|41739211|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
19469425|NCT02724462|41739210|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
19469426|NCT02724462|41739211|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
19469427|NCT02724462|41739210|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
19469428|NCT02724462|41739211|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
19469429|NCT02725476|41739268|FG000|Overall Study|Physician Decision|2|||
19469430|NCT02725476|41739269|FG001|Overall Study|Physician Decision|0|||
19469431|NCT02725476|41739268|FG000|Overall Study|Adverse Event|1|||
19469432|NCT02725476|41739269|FG001|Overall Study|Adverse Event|1|||
19469433|NCT02725008|41739374|FG000|Overall Study|Lost to Follow-up|7|||
19469434|NCT02725008|41739375|FG001|Overall Study|Lost to Follow-up|9|||
19469435|NCT02725008|41739374|FG000|Overall Study|Withdrawal by Subject|2|||
19469436|NCT02725008|41739375|FG001|Overall Study|Withdrawal by Subject|2|||
19469437|NCT02725008|41739374|FG000|Overall Study|Admitted to hospital|0|||
19469438|NCT02725008|41739375|FG001|Overall Study|Admitted to hospital|1|||
19469439|NCT01807949|41739647|FG000|Overall Study|Adverse Event|1|||
19469440|NCT01807949|41739648|FG001|Overall Study|Adverse Event|2|||
19469441|NCT01807949|41739649|FG002|Overall Study|Adverse Event|2|||
19469442|NCT01807949|41739647|FG000|Overall Study|Withdrawal by Subject|1|||
19469443|NCT01807949|41739648|FG001|Overall Study|Withdrawal by Subject|2|||
19469444|NCT01807949|41739649|FG002|Overall Study|Withdrawal by Subject|2|||
19469445|NCT01807949|41739647|FG000|Overall Study|Non-Compliance|0|||
19469446|NCT01807949|41739648|FG001|Overall Study|Non-Compliance|0|||
19469447|NCT01807949|41739649|FG002|Overall Study|Non-Compliance|1|||
19469448|NCT01807949|41739647|FG000|Overall Study|Undefined|0|||
19469449|NCT01807949|41739648|FG001|Overall Study|Undefined|1|||
19469450|NCT01807949|41739649|FG002|Overall Study|Undefined|2|||
19469451|NCT01807949|41739647|FG000|Overall Study|Randomized But Not Treated|0|||
19469452|NCT01807949|41739648|FG001|Overall Study|Randomized But Not Treated|2|||
19469453|NCT01807949|41739649|FG002|Overall Study|Randomized But Not Treated|2|||
19469454|NCT01806779|41739661|FG000|Overall Study|Physician Decision|2|||
19469455|NCT01806779|41739662|FG001|Overall Study|Physician Decision|0|||
19469456|NCT01806779|41739663|FG002|Overall Study|Physician Decision|1|||
19469457|NCT01806779|41739661|FG000|Overall Study|Lack of Efficacy|1|||
19381463|NCT03987919|41624629|FG000|Overall Study|Site terminated by Sponsor|0|||
19381464|NCT03987919|41624630|FG001|Overall Study|Site terminated by Sponsor|0|||
19381465|NCT03987919|41624631|FG002|Overall Study|Site terminated by Sponsor|0|||
19381466|NCT03987919|41624632|FG003|Overall Study|Site terminated by Sponsor|1|||
19381467|NCT03987919|41624629|FG000|Overall Study|Withdrawal by Subject|7|||
19381468|NCT03987919|41624630|FG001|Overall Study|Withdrawal by Subject|7|||
19381469|NCT03987919|41624631|FG002|Overall Study|Withdrawal by Subject|8|||
19381470|NCT03987919|41624632|FG003|Overall Study|Withdrawal by Subject|4|||
19381471|NCT03987919|41624629|FG000|Overall Study|Other - as reported by the investigator|1|||
19381472|NCT03987919|41624630|FG001|Overall Study|Other - as reported by the investigator|3|||
19381473|NCT03987919|41624631|FG002|Overall Study|Other - as reported by the investigator|2|||
19381474|NCT03987919|41624632|FG003|Overall Study|Other - as reported by the investigator|0|||
19381475|NCT00535405|41624652|FG000|Overall Study|Adverse Event|6|||
19381476|NCT00535405|41624653|FG001|Overall Study|Adverse Event|8|||
19381477|NCT00535405|41624654|FG002|Overall Study|Adverse Event|3|||
19469458|NCT01806779|41739662|FG001|Overall Study|Lack of Efficacy|1|||
19469459|NCT01806779|41739663|FG002|Overall Study|Lack of Efficacy|0|||
19381478|NCT00535405|41624655|FG003|Overall Study|Adverse Event|8|||
19469460|NCT01806779|41739661|FG000|Overall Study|Lost to Follow-up|19|||
19469461|NCT01806779|41739662|FG001|Overall Study|Lost to Follow-up|20|||
19469462|NCT01806779|41739663|FG002|Overall Study|Lost to Follow-up|0|||
19469463|NCT01806779|41739661|FG000|Overall Study|Withdrawal by Subject|20|||
19469464|NCT01806779|41739662|FG001|Overall Study|Withdrawal by Subject|23|||
19469465|NCT01806779|41739663|FG002|Overall Study|Withdrawal by Subject|22|||
19469466|NCT01607957|41739737|FG000|Overall Study|Not treated|1|||
19469467|NCT01607957|41739738|FG001|Overall Study|Not treated|1|||
19469468|NCT01607957|41739737|FG000|Overall Study|Death|367|||
19469469|NCT01607957|41739738|FG001|Overall Study|Death|211|||
19469470|NCT01607957|41739737|FG000|Overall Study|Lost to Follow-up|3|||
19469471|NCT01607957|41739738|FG001|Overall Study|Lost to Follow-up|3|||
19469472|NCT01607957|41739737|FG000|Overall Study|Participant refusal|1|||
19469473|NCT01607957|41739738|FG001|Overall Study|Participant refusal|0|||
19469474|NCT01806623|41739758|FG000|Overall Study|Withdrawal by Subject|1|||
19469475|NCT01806623|41739758|FG000|Overall Study|Adverse Event|1|||
19469476|NCT01806623|41739758|FG000|Overall Study|Did not meet the inclusion criteria|56|||
19469477|NCT01806545|41739764|FG000|Overall Study|Adverse Event|2|||
19469478|NCT01806545|41739765|FG001|Overall Study|Adverse Event|3|||
19469479|NCT01806545|41739764|FG000|Overall Study|Lost to Follow-up|1|||
19381479|NCT00535405|41624656|FG004|Overall Study|Adverse Event|6|||
19381480|NCT00535405|41624652|FG000|Overall Study|Lost to Follow-up|1|||
19381481|NCT00535405|41624653|FG001|Overall Study|Lost to Follow-up|3|||
19381482|NCT00535405|41624654|FG002|Overall Study|Lost to Follow-up|3|||
19381483|NCT00535405|41624655|FG003|Overall Study|Lost to Follow-up|2|||
19381484|NCT00535405|41624656|FG004|Overall Study|Lost to Follow-up|1|||
19381485|NCT00535405|41624652|FG000|Overall Study|Physician Decision|3|||
19381486|NCT00535405|41624653|FG001|Overall Study|Physician Decision|2|||
19381487|NCT00535405|41624654|FG002|Overall Study|Physician Decision|0|||
19381488|NCT00535405|41624655|FG003|Overall Study|Physician Decision|1|||
19381489|NCT00535405|41624656|FG004|Overall Study|Physician Decision|1|||
19381490|NCT00535405|41624652|FG000|Overall Study|Protocol Violation|2|||
19381491|NCT00535405|41624653|FG001|Overall Study|Protocol Violation|2|||
19381492|NCT00535405|41624654|FG002|Overall Study|Protocol Violation|2|||
19381493|NCT00535405|41624655|FG003|Overall Study|Protocol Violation|1|||
19381494|NCT00535405|41624656|FG004|Overall Study|Protocol Violation|0|||
19381495|NCT00535405|41624652|FG000|Overall Study|Withdrawal by Subject|5|||
19381496|NCT00535405|41624653|FG001|Overall Study|Withdrawal by Subject|11|||
19381497|NCT00535405|41624654|FG002|Overall Study|Withdrawal by Subject|10|||
19381498|NCT00535405|41624655|FG003|Overall Study|Withdrawal by Subject|10|||
19381499|NCT00535405|41624656|FG004|Overall Study|Withdrawal by Subject|8|||
19381500|NCT00271817|41624671|FG000|Part 1|Adverse Event|68|||
19381501|NCT00271817|41624672|FG001|Part 1|Adverse Event|25|||
19381502|NCT00271817|41624673|FG002|Part 1|Adverse Event|156|||
19381503|NCT00271817|41624671|FG000|Part 1|Lost to Follow-up|6|||
19381504|NCT00271817|41624672|FG001|Part 1|Lost to Follow-up|8|||
19381505|NCT00271817|41624673|FG002|Part 1|Lost to Follow-up|24|||
19381506|NCT00271817|41624671|FG000|Part 1|Protocol Violation|5|||
19381507|NCT00271817|41624672|FG001|Part 1|Protocol Violation|4|||
19381508|NCT00271817|41624673|FG002|Part 1|Protocol Violation|7|||
19381509|NCT00271817|41624671|FG000|Part 1|Patient Moved|3|||
19381510|NCT00271817|41624672|FG001|Part 1|Patient Moved|1|||
19381511|NCT00271817|41624673|FG002|Part 1|Patient Moved|5|||
19381512|NCT00271817|41624671|FG000|Part 1|Withdrawal by Subject|23|||
19381513|NCT00271817|41624672|FG001|Part 1|Withdrawal by Subject|17|||
19381514|NCT00271817|41624673|FG002|Part 1|Withdrawal by Subject|45|||
19381515|NCT00271817|41624671|FG000|Part 1|LDL < 50 mg/dL|1|||
19381516|NCT00271817|41624672|FG001|Part 1|LDL < 50 mg/dL|4|||
19381517|NCT00271817|41624673|FG002|Part 1|LDL < 50 mg/dL|48|||
19381518|NCT00271817|41624671|FG000|Part 2|Adverse Event|0|||
19381519|NCT00271817|41624672|FG001|Part 2|Adverse Event|17|||
19381520|NCT00271817|41624673|FG002|Part 2|Adverse Event|33|||
19381521|NCT00271817|41624671|FG000|Part 2|Lack of Efficacy|0|||
19381522|NCT00271817|41624672|FG001|Part 2|Lack of Efficacy|1|||
19469480|NCT01806545|41739765|FG001|Overall Study|Lost to Follow-up|0|||
19469481|NCT01806545|41739764|FG000|Overall Study|Withdrawal by Subject|3|||
19469482|NCT01806545|41739765|FG001|Overall Study|Withdrawal by Subject|2|||
19469483|NCT01806389|41739771|FG000|Overall Study|Withdrawal by Subject|4|||
19469484|NCT01782131|41740027|FG000|Overall Study|Death|93|||
19469485|NCT01782131|41740028|FG001|Overall Study|Death|96|||
19381523|NCT00271817|41624673|FG002|Part 2|Lack of Efficacy|6|||
19381524|NCT00271817|41624671|FG000|Part 2|Lost to Follow-up|0|||
19381525|NCT00271817|41624672|FG001|Part 2|Lost to Follow-up|6|||
19381526|NCT00271817|41624673|FG002|Part 2|Lost to Follow-up|18|||
19469486|NCT01782131|41740027|FG000|Overall Study|Lost to Follow-up|1|||
19469487|NCT01782131|41740028|FG001|Overall Study|Lost to Follow-up|3|||
19469488|NCT01782131|41740027|FG000|Overall Study|Withdrawal by Subject|10|||
19469489|NCT01782131|41740028|FG001|Overall Study|Withdrawal by Subject|10|||
19469490|NCT01782131|41740027|FG000|Overall Study|Randomized but not treated|5|||
19469491|NCT01782131|41740028|FG001|Overall Study|Randomized but not treated|5|||
19469492|NCT01782131|41740027|FG000|Overall Study|Reason not provided|0|||
19469493|NCT01782131|41740028|FG001|Overall Study|Reason not provided|1|||
19469494|NCT01781975|41740049|FG000|Overall Study|Death|1|||
19469495|NCT01781975|41740050|FG001|Overall Study|Death|0|||
19469496|NCT01781975|41740049|FG000|Overall Study|Withdrawal by Subject|1|||
19469497|NCT01781975|41740050|FG001|Overall Study|Withdrawal by Subject|1|||
19469498|NCT01804673|41740071|FG000|Overall Study|Adverse Event|4|||
19469499|NCT01804673|41740071|FG000|Overall Study|Withdrawal by Subject|1|||
19469500|NCT01804673|41740071|FG000|Overall Study|Lack of Efficacy|9|||
19469501|NCT01804673|41740071|FG000|Overall Study|Change to Oral Therapy|37|||
19469502|NCT01804673|41740071|FG000|Overall Study|No Further Therapy Required|84|||
19469503|NCT01804673|41740071|FG000|Overall Study|Use of Prohibited Medication|1|||
19469504|NCT01804673|41740071|FG000|Overall Study|Other|4|||
19469505|NCT01774097|41740081|FG000|Overall Study|Withdrawal by Subject|1|||
19469506|NCT01774097|41740082|FG001|Overall Study|Withdrawal by Subject|1|||
19469507|NCT01774097|41740081|FG000|Overall Study|Adverse Event|1|||
19469508|NCT01774097|41740082|FG001|Overall Study|Adverse Event|1|||
19469509|NCT02859558|41740156|FG000|Step 1|Not Eligible|0|||
19469510|NCT02859558|41740157|FG001|Step 1|Not Eligible|0|||
19469511|NCT02859558|41740158|FG002|Step 1|Not Eligible|0|||
19469512|NCT02859558|41740159|FG003|Step 1|Not Eligible|0|||
19469513|NCT02859558|41740160|FG004|Step 1|Not Eligible|3|||
19469514|NCT02859558|41740156|FG000|Step 1|Lost to Follow-up|1|||
19469515|NCT02859558|41740157|FG001|Step 1|Lost to Follow-up|3|||
19469516|NCT02859558|41740158|FG002|Step 1|Lost to Follow-up|3|||
19469517|NCT02859558|41740159|FG003|Step 1|Lost to Follow-up|0|||
19469518|NCT02859558|41740160|FG004|Step 1|Lost to Follow-up|0|||
19469519|NCT02859558|41740156|FG000|Step 1|Did Not Return to Clinic|2|||
19469520|NCT02859558|41740157|FG001|Step 1|Did Not Return to Clinic|3|||
19469521|NCT02859558|41740158|FG002|Step 1|Did Not Return to Clinic|4|||
19469522|NCT02859558|41740159|FG003|Step 1|Did Not Return to Clinic|0|||
19469523|NCT02859558|41740160|FG004|Step 1|Did Not Return to Clinic|0|||
19469524|NCT02859558|41740156|FG000|Step 1|Moved|0|||
19469525|NCT02859558|41740157|FG001|Step 1|Moved|1|||
19469526|NCT02859558|41740158|FG002|Step 1|Moved|1|||
19469527|NCT02859558|41740159|FG003|Step 1|Moved|0|||
19469528|NCT02859558|41740160|FG004|Step 1|Moved|0|||
19469529|NCT02859558|41740156|FG000|Step 1|Withdrawal By Participant|1|||
19469530|NCT02859558|41740157|FG001|Step 1|Withdrawal By Participant|2|||
19469531|NCT02859558|41740158|FG002|Step 1|Withdrawal By Participant|1|||
19469532|NCT02859558|41740159|FG003|Step 1|Withdrawal By Participant|0|||
19469533|NCT02859558|41740160|FG004|Step 1|Withdrawal By Participant|0|||
19469534|NCT02859558|41740156|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
19469535|NCT02859558|41740157|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
19469536|NCT02859558|41740158|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
19469537|NCT02859558|41740159|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
19469538|NCT02859558|41740160|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
19469539|NCT02859558|41740156|FG000|Step 1|Incarceration|0|||
19469540|NCT02859558|41740157|FG001|Step 1|Incarceration|1|||
19469541|NCT02859558|41740158|FG002|Step 1|Incarceration|0|||
19469542|NCT02859558|41740159|FG003|Step 1|Incarceration|0|||
19469543|NCT02859558|41740160|FG004|Step 1|Incarceration|0|||
19469544|NCT02859558|41740156|FG000|Step 1|Non-Adherence to Study Drug|2|||
19469545|NCT02859558|41740157|FG001|Step 1|Non-Adherence to Study Drug|0|||
19373511|NCT01372995|41614660|FG001|Overall Study|Physician Decision|0|||
19373512|NCT01372995|41614661|FG002|Overall Study|Physician Decision|1|||
19381527|NCT00271817|41624671|FG000|Part 2|Protocol Violation|0|||
19381528|NCT00271817|41624672|FG001|Part 2|Protocol Violation|3|||
19381529|NCT00271817|41624673|FG002|Part 2|Protocol Violation|5|||
19381530|NCT00271817|41624671|FG000|Part 2|Patient Moved|0|||
19381531|NCT00271817|41624672|FG001|Part 2|Patient Moved|0|||
19381532|NCT00271817|41624673|FG002|Part 2|Patient Moved|5|||
19381533|NCT00271817|41624671|FG000|Part 2|Withdrawal by Subject|0|||
19381534|NCT00271817|41624672|FG001|Part 2|Withdrawal by Subject|2|||
19381535|NCT00271817|41624673|FG002|Part 2|Withdrawal by Subject|13|||
19381536|NCT00271817|41624671|FG000|Part 2|LDL < 50 mg/dL|0|||
19381537|NCT00271817|41624672|FG001|Part 2|LDL < 50 mg/dL|3|||
19381538|NCT00271817|41624673|FG002|Part 2|LDL < 50 mg/dL|4|||
19381539|NCT02731157|41624685|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
19381540|NCT03268811|41624693|FG000|Overall Study|Adverse Event|0|||
19469546|NCT02859558|41740158|FG002|Step 1|Non-Adherence to Study Drug|1|||
19469547|NCT02859558|41740159|FG003|Step 1|Non-Adherence to Study Drug|0|||
19469548|NCT02859558|41740160|FG004|Step 1|Non-Adherence to Study Drug|0|||
19469549|NCT02859558|41740156|FG000|Step 1|Non-Adherence to Study Requirements|3|||
19469550|NCT02859558|41740157|FG001|Step 1|Non-Adherence to Study Requirements|1|||
19373513|NCT02757521|41614671|FG000|Overall Study|Adverse Event|1|||
19373514|NCT02757521|41614672|FG001|Overall Study|Adverse Event|0|||
19373515|NCT00834613|41614680|FG000|First Intervention|Protocol Violation|1|||
19373516|NCT00834613|41614681|FG001|First Intervention|Protocol Violation|0|||
19373517|NCT00834067|41614698|FG000|Washout of 21 Days|Protocol Violation|0|||
19373518|NCT00834067|41614699|FG001|Washout of 21 Days|Protocol Violation|1|||
19373519|NCT02758613|41614707|FG000|Treatment|Physician and Sponsor Decision|1|||
19469551|NCT02859558|41740158|FG002|Step 1|Non-Adherence to Study Requirements|0|||
19469552|NCT02859558|41740159|FG003|Step 1|Non-Adherence to Study Requirements|0|||
19469553|NCT02859558|41740160|FG004|Step 1|Non-Adherence to Study Requirements|0|||
19469554|NCT02859558|41740156|FG000|Step 1|Virologic Failure|2|||
19469555|NCT02859558|41740157|FG001|Step 1|Virologic Failure|1|||
19469556|NCT02859558|41740158|FG002|Step 1|Virologic Failure|1|||
19469557|NCT02859558|41740159|FG003|Step 1|Virologic Failure|0|||
19469558|NCT02859558|41740160|FG004|Step 1|Virologic Failure|0|||
19469559|NCT02859558|41740156|FG000|Step 2|Active On Study|23|||
19469560|NCT02859558|41740157|FG001|Step 2|Active On Study|38|||
19469561|NCT02859558|41740158|FG002|Step 2|Active On Study|20|||
19469562|NCT02859558|41740159|FG003|Step 2|Active On Study|0|||
19469563|NCT02859558|41740160|FG004|Step 2|Active On Study|0|||
19469564|NCT02859558|41740156|FG000|Step 2|Did Not Return to Clinic|2|||
19469565|NCT02859558|41740157|FG001|Step 2|Did Not Return to Clinic|0|||
19469566|NCT02859558|41740158|FG002|Step 2|Did Not Return to Clinic|0|||
19469567|NCT02859558|41740159|FG003|Step 2|Did Not Return to Clinic|0|||
19469568|NCT02859558|41740160|FG004|Step 2|Did Not Return to Clinic|0|||
19469569|NCT02859558|41740156|FG000|Step 2|Unexpected Closure of Site|0|||
19469570|NCT02859558|41740157|FG001|Step 2|Unexpected Closure of Site|1|||
19469571|NCT02859558|41740158|FG002|Step 2|Unexpected Closure of Site|1|||
19469572|NCT02859558|41740159|FG003|Step 2|Unexpected Closure of Site|0|||
19469573|NCT02859558|41740160|FG004|Step 2|Unexpected Closure of Site|0|||
19469574|NCT00705432|41740211|FG000|Treatment Period|Adverse Event|45|||
19469575|NCT00705432|41740212|FG001|Treatment Period|Adverse Event|37|||
19469576|NCT00705432|41740213|FG002|Treatment Period|Adverse Event|51|||
19469577|NCT00705432|41740214|FG003|Treatment Period|Adverse Event|12|||
19469578|NCT00705432|41740215|FG004|Treatment Period|Adverse Event|8|||
19469579|NCT00705432|41740216|FG005|Treatment Period|Adverse Event|9|||
19469580|NCT00705432|41740211|FG000|Treatment Period|Treatment failure|92|||
19469581|NCT00705432|41740212|FG001|Treatment Period|Treatment failure|42|||
19469582|NCT00705432|41740213|FG002|Treatment Period|Treatment failure|33|||
19469583|NCT00705432|41740214|FG003|Treatment Period|Treatment failure|25|||
19469584|NCT00705432|41740215|FG004|Treatment Period|Treatment failure|13|||
19469585|NCT00705432|41740216|FG005|Treatment Period|Treatment failure|14|||
19469586|NCT00705432|41740211|FG000|Treatment Period|Non medical reason|26|||
19469587|NCT00705432|41740212|FG001|Treatment Period|Non medical reason|32|||
19469588|NCT00705432|41740213|FG002|Treatment Period|Non medical reason|37|||
19469589|NCT00705432|41740214|FG003|Treatment Period|Non medical reason|4|||
19469590|NCT00705432|41740215|FG004|Treatment Period|Non medical reason|7|||
19469591|NCT00705432|41740216|FG005|Treatment Period|Non medical reason|7|||
19469592|NCT00705432|41740211|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
19469593|NCT00705432|41740212|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
19469594|NCT00705432|41740213|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
19469595|NCT00705432|41740214|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
19469596|NCT00705432|41740215|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
19469597|NCT00705432|41740216|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
19469598|NCT00705432|41740211|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
19469599|NCT00705432|41740212|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
19469600|NCT00705432|41740213|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
19469601|NCT00705432|41740214|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
19469602|NCT00705432|41740215|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
19469603|NCT00705432|41740216|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
19469604|NCT00704964|41740227|FG000|Overall Study|Not completed on time|328|||
19469605|NCT00704808|41740243|FG000|Overall Study|Discontinued prior to starting treatment|14|||
19469606|NCT00704808|41740243|FG000|Overall Study|Death|7|||
19469607|NCT00704808|41740243|FG000|Overall Study|Tumor progression|80|||
19469608|NCT00704808|41740243|FG000|Overall Study|Patient's decision|11|||
19469609|NCT00704808|41740243|FG000|Overall Study|Early therapy discontinuation|16|||
19469610|NCT00704808|41740243|FG000|Overall Study|Adverse Event|1|||
19469611|NCT00704808|41740243|FG000|Overall Study|Lost to Follow-up|1|||
19469612|NCT00704808|41740243|FG000|Overall Study|Treatment change|1|||
19469613|NCT05166876|41740277|FG000|Overall Study|Withdrawal by Subject|1|||
19469614|NCT05166876|41740278|FG001|Overall Study|Withdrawal by Subject|0|||
19469615|NCT05166876|41740279|FG002|Overall Study|Withdrawal by Subject|0|||
19469616|NCT01375608|41740291|FG000|Overall Study|Withdrawal by Subject|2|||
19469617|NCT00704418|41740306|FG000|Overall Study|Withdrawal by Subject|2|||
19469618|NCT00704418|41740307|FG001|Overall Study|Withdrawal by Subject|0|||
19469619|NCT00704418|41740306|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
19469620|NCT00704418|41740307|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
19469621|NCT00704340|41740376|FG000|Overall Study|Lost to Follow-up|2|||
19469622|NCT00704340|41740377|FG001|Overall Study|Lost to Follow-up|1|||
19469623|NCT00704340|41740376|FG000|Overall Study|Death|0|||
19469624|NCT00704340|41740377|FG001|Overall Study|Death|1|||
19469625|NCT00552058|41740385|FG000|Overall Study|Adverse Event|8|||
19469626|NCT00552058|41740386|FG001|Overall Study|Adverse Event|7|||
19469627|NCT00552058|41740385|FG000|Overall Study|Lack of Efficacy|1|||
19469628|NCT00552058|41740386|FG001|Overall Study|Lack of Efficacy|5|||
19469629|NCT00552058|41740385|FG000|Overall Study|Lost to Follow-up|1|||
19469630|NCT00552058|41740386|FG001|Overall Study|Lost to Follow-up|0|||
19469631|NCT00552058|41740385|FG000|Overall Study|Withdrawal by Subject|4|||
19469632|NCT00552058|41740386|FG001|Overall Study|Withdrawal by Subject|4|||
19469633|NCT00552058|41740385|FG000|Overall Study|Other: Protocol Violation|0|||
19469634|NCT00552058|41740386|FG001|Overall Study|Other: Protocol Violation|1|||
19469635|NCT00552058|41740385|FG000|Overall Study|Other: Non Compliance|1|||
19469636|NCT00552058|41740386|FG001|Overall Study|Other: Non Compliance|2|||
19469637|NCT00552058|41740385|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
19469638|NCT00552058|41740386|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
19469639|NCT00552058|41740385|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
19469640|NCT00552058|41740386|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
19469641|NCT00552058|41740385|FG000|Overall Study|Other: Positive Stool Result|0|||
19469642|NCT00552058|41740386|FG001|Overall Study|Other: Positive Stool Result|1|||
19469643|NCT00552058|41740385|FG000|Overall Study|Other: Randomized in error|0|||
19469644|NCT00552058|41740386|FG001|Overall Study|Other: Randomized in error|1|||
19469645|NCT00552058|41740385|FG000|Overall Study|Other: Sponsors Decision|0|||
19469646|NCT00552058|41740386|FG001|Overall Study|Other: Sponsors Decision|1|||
19469647|NCT00552058|41740385|FG000|Overall Study|Other: Early Roll Over|1|||
19469648|NCT00552058|41740386|FG001|Overall Study|Other: Early Roll Over|0|||
19469649|NCT00550732|41740415|FG000|Overall Study|Death|4|||
19469650|NCT00550732|41740415|FG000|Overall Study|Withdrawal by Subject|2|||
19469651|NCT00550732|41740415|FG000|Overall Study|Physician Decision|2|||
19469652|NCT00550732|41740415|FG000|Overall Study|Lost to Follow-up|1|||
19469653|NCT00550732|41740415|FG000|Overall Study|Palliative care|1|||
19469654|NCT00550732|41740415|FG000|Overall Study|Adverse Event|1|||
19469655|NCT00550420|41740429|FG000|Overall Study|Adverse Event|28|||
19469656|NCT00550420|41740429|FG000|Overall Study|Lost to Follow-up|8|||
19469657|NCT00550420|41740429|FG000|Overall Study|Protocol Violation|11|||
19469658|NCT00550420|41740429|FG000|Overall Study|Withdrawal by Subject|30|||
19469659|NCT00550420|41740429|FG000|Overall Study|Still in study at termination|206|||
19469660|NCT00550420|41740429|FG000|Overall Study|Missing|2|||
19469661|NCT00550420|41740429|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
19469662|NCT00550420|41740429|FG000|Overall Study|Investigators opinion|1|||
19469663|NCT00550420|41740429|FG000|Overall Study|Lack of curative effect|1|||
19469664|NCT00550420|41740429|FG000|Overall Study|Unethical stop of enrollment|2|||
19469665|NCT00550420|41740429|FG000|Overall Study|Caregiver's decision to withdraw|1|||
19469666|NCT00550420|41740429|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
19469667|NCT00550420|41740429|FG000|Overall Study|Exclusion criteria|1|||
19469668|NCT00550420|41740429|FG000|Overall Study|Prohibited medicine|1|||
19469669|NCT00558064|41740441|FG000|Overall Study|Adverse Event|3|||
19469670|NCT00558064|41740442|FG001|Overall Study|Adverse Event|2|||
19469671|NCT00558064|41740441|FG000|Overall Study|Lack of Efficacy|0|||
19469672|NCT00558064|41740442|FG001|Overall Study|Lack of Efficacy|1|||
19381541|NCT03268811|41624694|FG001|Overall Study|Adverse Event|1|||
19381542|NCT02732015|41624703|FG000|Overall Study|Lost to Follow-up|0|||
19381543|NCT02732015|41624704|FG001|Overall Study|Lost to Follow-up|1|||
19381544|NCT01441115|41624724|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
19381545|NCT02006147|41624735|FG000|Overall Study|Protocol Violation|1|||
19469673|NCT00558064|41740441|FG000|Overall Study|Protocol Violation|1|||
19469674|NCT00558064|41740442|FG001|Overall Study|Protocol Violation|0|||
19469675|NCT00558064|41740441|FG000|Overall Study|Lost to Follow-up|0|||
19469676|NCT00558064|41740442|FG001|Overall Study|Lost to Follow-up|1|||
19469677|NCT00558064|41740441|FG000|Overall Study|Withdrawal by Subject|0|||
19469678|NCT00558064|41740442|FG001|Overall Study|Withdrawal by Subject|1|||
19469679|NCT00558064|41740441|FG000|Overall Study|No visit within allowance period|1|||
19469680|NCT00558064|41740442|FG001|Overall Study|No visit within allowance period|0|||
19469681|NCT00557830|41740451|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
19469682|NCT00557830|41740452|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
19381546|NCT02006147|41624736|FG001|Overall Study|Protocol Violation|1|||
19381547|NCT02006147|41624737|FG002|Overall Study|Protocol Violation|0|||
19381548|NCT02006147|41624738|FG003|Overall Study|Protocol Violation|0|||
19381549|NCT02006147|41624735|FG000|Overall Study|Withdrawal by Subject|0|||
19381550|NCT02006147|41624736|FG001|Overall Study|Withdrawal by Subject|1|||
19469683|NCT00557830|41740453|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
19469684|NCT00557830|41740451|FG000|Screening Treatment Phase|Adverse Event|2|||
19381551|NCT02006147|41624737|FG002|Overall Study|Withdrawal by Subject|0|||
19381552|NCT02006147|41624738|FG003|Overall Study|Withdrawal by Subject|0|||
19469685|NCT00557830|41740452|FG001|Screening Treatment Phase|Adverse Event|0|||
19469686|NCT00557830|41740453|FG002|Screening Treatment Phase|Adverse Event|0|||
19469687|NCT00557830|41740451|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
19469688|NCT00557830|41740452|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
19469689|NCT00557830|41740453|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
19469690|NCT00557440|41740464|FG000|Treatment Period 1|Adverse Event|0|||
19469691|NCT00557440|41740465|FG001|Treatment Period 1|Adverse Event|0|||
19469692|NCT00557440|41740466|FG002|Treatment Period 1|Adverse Event|1|||
19469693|NCT00556894|41740477|FG000|Overall Study|Adverse Event|2|||
19469694|NCT00556894|41740478|FG001|Overall Study|Adverse Event|3|||
19381553|NCT02006147|41624735|FG000|Overall Study|Withdrawal by Sponsor|1|||
19381554|NCT02006147|41624736|FG001|Overall Study|Withdrawal by Sponsor|0|||
19381555|NCT02006147|41624737|FG002|Overall Study|Withdrawal by Sponsor|0|||
19381556|NCT02006147|41624738|FG003|Overall Study|Withdrawal by Sponsor|0|||
19381557|NCT02732119|41624749|FG000|Phase I|Adverse Event|1|||
19381558|NCT02732119|41624750|FG001|Phase I|Adverse Event|3|||
19469695|NCT00556894|41740479|FG002|Overall Study|Adverse Event|3|||
19469696|NCT00556894|41740477|FG000|Overall Study|Death|1|||
19469697|NCT00556894|41740478|FG001|Overall Study|Death|0|||
19469698|NCT00556894|41740479|FG002|Overall Study|Death|0|||
19469699|NCT00556894|41740477|FG000|Overall Study|regulatory decision in Bulgaria|10|||
19469700|NCT00556894|41740478|FG001|Overall Study|regulatory decision in Bulgaria|14|||
19469701|NCT00556894|41740479|FG002|Overall Study|regulatory decision in Bulgaria|13|||
19469702|NCT00556894|41740477|FG000|Overall Study|Change in therapy|2|||
19469703|NCT00556894|41740478|FG001|Overall Study|Change in therapy|1|||
19469704|NCT00556894|41740479|FG002|Overall Study|Change in therapy|2|||
19469705|NCT00556894|41740477|FG000|Overall Study|Withdrawal by Subject|1|||
19469706|NCT00556894|41740478|FG001|Overall Study|Withdrawal by Subject|1|||
19469707|NCT00556894|41740479|FG002|Overall Study|Withdrawal by Subject|1|||
19469708|NCT02722044|41740487|FG000|Overall Study|Adverse Event|2|||
19469709|NCT02722044|41740487|FG000|Overall Study|Physician Decision|1|||
19469710|NCT02722044|41740487|FG000|Overall Study|Withdrawal by Subject|1|||
19469711|NCT02722044|41740487|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
19469712|NCT00556426|41740492|FG000|Overall Study|Withdrawal by Subject|3|||
19469713|NCT00556426|41740492|FG000|Overall Study|Death|6|||
19469714|NCT00555568|41740500|FG000|Overall Study|Lost to Follow-up|26|||
19469715|NCT00555568|41740501|FG001|Overall Study|Lost to Follow-up|16|||
19469716|NCT00555568|41740502|FG002|Overall Study|Lost to Follow-up|16|||
19469717|NCT00702702|41740513|FG000|Overall Study|Study prematurely terminated|56|||
19469718|NCT02721966|41740524|FG000|Overall Study|Protocol Violation|1|||
19469719|NCT02721966|41740525|FG001|Overall Study|Protocol Violation|0|||
19469720|NCT02721966|41740526|FG002|Overall Study|Protocol Violation|0|||
19381559|NCT02732119|41624751|FG002|Phase I|Adverse Event|1|||
19381560|NCT02732119|41624752|FG003|Phase I|Adverse Event|0|||
19381561|NCT02732119|41624753|FG004|Phase I|Adverse Event|0|||
19381562|NCT02732119|41624749|FG000|Phase I|Progressive disease|7|||
19381563|NCT02732119|41624750|FG001|Phase I|Progressive disease|3|||
19381564|NCT02732119|41624751|FG002|Phase I|Progressive disease|2|||
19381565|NCT02732119|41624752|FG003|Phase I|Progressive disease|0|||
19381566|NCT02732119|41624753|FG004|Phase I|Progressive disease|0|||
19381567|NCT02732119|41624749|FG000|Phase I|Protocol deviation|0|||
19381568|NCT02732119|41624750|FG001|Phase I|Protocol deviation|1|||
19381569|NCT02732119|41624751|FG002|Phase I|Protocol deviation|0|||
19381570|NCT02732119|41624752|FG003|Phase I|Protocol deviation|0|||
19381571|NCT02732119|41624753|FG004|Phase I|Protocol deviation|0|||
19469721|NCT02721966|41740527|FG003|Overall Study|Protocol Violation|0|||
19381572|NCT02732119|41624749|FG000|Phase I|Physician Decision|0|||
19469722|NCT02721966|41740528|FG004|Overall Study|Protocol Violation|0|||
19469723|NCT02721966|41740524|FG000|Overall Study|Withdrawal by Subject|9|||
19469724|NCT02721966|41740525|FG001|Overall Study|Withdrawal by Subject|2|||
19469725|NCT02721966|41740526|FG002|Overall Study|Withdrawal by Subject|3|||
19469726|NCT02721966|41740527|FG003|Overall Study|Withdrawal by Subject|7|||
19469727|NCT02721966|41740528|FG004|Overall Study|Withdrawal by Subject|0|||
19469728|NCT02721966|41740524|FG000|Overall Study|Adverse Event|4|||
19469729|NCT02721966|41740525|FG001|Overall Study|Adverse Event|4|||
19469730|NCT02721966|41740526|FG002|Overall Study|Adverse Event|3|||
19469731|NCT02721966|41740527|FG003|Overall Study|Adverse Event|0|||
19469732|NCT02721966|41740528|FG004|Overall Study|Adverse Event|0|||
19469733|NCT02721966|41740524|FG000|Overall Study|Death|1|||
19469734|NCT02721966|41740525|FG001|Overall Study|Death|0|||
19469735|NCT02721966|41740526|FG002|Overall Study|Death|0|||
19469736|NCT02721966|41740527|FG003|Overall Study|Death|0|||
19469737|NCT02721966|41740528|FG004|Overall Study|Death|0|||
19381573|NCT02732119|41624750|FG001|Phase I|Physician Decision|3|||
19381574|NCT02732119|41624751|FG002|Phase I|Physician Decision|4|||
19469738|NCT02721966|41740524|FG000|Overall Study|Lack of Efficacy|7|||
19469739|NCT02721966|41740525|FG001|Overall Study|Lack of Efficacy|4|||
19469740|NCT02721966|41740526|FG002|Overall Study|Lack of Efficacy|0|||
19469741|NCT02721966|41740527|FG003|Overall Study|Lack of Efficacy|0|||
19469742|NCT02721966|41740528|FG004|Overall Study|Lack of Efficacy|0|||
19469743|NCT02721966|41740524|FG000|Overall Study|Lost to Follow-up|0|||
19469744|NCT02721966|41740525|FG001|Overall Study|Lost to Follow-up|0|||
19469745|NCT02721966|41740526|FG002|Overall Study|Lost to Follow-up|3|||
19469746|NCT02721966|41740527|FG003|Overall Study|Lost to Follow-up|0|||
19469747|NCT02721966|41740528|FG004|Overall Study|Lost to Follow-up|0|||
19469748|NCT02721966|41740524|FG000|Overall Study|Physician Decision|1|||
19469749|NCT02721966|41740525|FG001|Overall Study|Physician Decision|1|||
19469750|NCT02721966|41740526|FG002|Overall Study|Physician Decision|0|||
19469751|NCT02721966|41740527|FG003|Overall Study|Physician Decision|0|||
19469752|NCT02721966|41740528|FG004|Overall Study|Physician Decision|0|||
19469753|NCT02721966|41740524|FG000|Overall Study|Pregnancy|1|||
19469754|NCT02721966|41740525|FG001|Overall Study|Pregnancy|0|||
19469755|NCT02721966|41740526|FG002|Overall Study|Pregnancy|0|||
19469756|NCT02721966|41740527|FG003|Overall Study|Pregnancy|0|||
19469757|NCT02721966|41740528|FG004|Overall Study|Pregnancy|0|||
19469758|NCT02721966|41740524|FG000|Overall Study|Did not continue to period 2|5|||
19469759|NCT02721966|41740525|FG001|Overall Study|Did not continue to period 2|12|||
19469760|NCT02721966|41740526|FG002|Overall Study|Did not continue to period 2|0|||
19469761|NCT02721966|41740527|FG003|Overall Study|Did not continue to period 2|0|||
19469762|NCT02721966|41740528|FG004|Overall Study|Did not continue to period 2|5|||
19469763|NCT00553462|41740536|FG000|Overall Study|Adverse Event|4|||
19469764|NCT00553462|41740536|FG000|Overall Study|Progression|4|||
19469765|NCT00553462|41740536|FG000|Overall Study|Withdrawal by Subject|5|||
19469766|NCT00553462|41740536|FG000|Overall Study|Physician Decision|1|||
19469767|NCT00553150|41740542|FG000|Overall Study|Withdrawal by Subject|0|||
19469768|NCT00553150|41740543|FG001|Overall Study|Withdrawal by Subject|0|||
19469769|NCT00553150|41740544|FG002|Overall Study|Withdrawal by Subject|0|||
19469770|NCT00553150|41740545|FG003|Overall Study|Withdrawal by Subject|2|||
19469771|NCT00553150|41740542|FG000|Overall Study|Protocol Violation|0|||
19469772|NCT00553150|41740543|FG001|Overall Study|Protocol Violation|0|||
19469773|NCT00553150|41740544|FG002|Overall Study|Protocol Violation|0|||
19469774|NCT00553150|41740545|FG003|Overall Study|Protocol Violation|1|||
19469775|NCT00553150|41740542|FG000|Overall Study|Ineligible|0|||
19469776|NCT00553150|41740543|FG001|Overall Study|Ineligible|0|||
19469777|NCT00553150|41740544|FG002|Overall Study|Ineligible|0|||
19469778|NCT00553150|41740545|FG003|Overall Study|Ineligible|1|||
19469779|NCT03301350|41740553|FG000|Overall Study|Withdrawal by Subject|4|||
19469780|NCT03301350|41740553|FG000|Overall Study|Adverse Event|1|||
19469781|NCT03301350|41740553|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
19469782|NCT03301350|41740553|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
19469783|NCT03301350|41740553|FG000|Overall Study|no detail provided|1|||
19469784|NCT04735432|41740560|FG000|Overall Study|Other - due to personal reason|1|||
19469785|NCT04735432|41740561|FG001|Overall Study|Other - due to personal reason|0|||
19469786|NCT04735432|41740560|FG000|Overall Study|Adverse Event|2|||
19469787|NCT04735432|41740561|FG001|Overall Study|Adverse Event|0|||
19469788|NCT02722278|41740570|FG000|Overall Study|Withdrawal by Subject|5|||
19469789|NCT02722278|41740571|FG001|Overall Study|Withdrawal by Subject|3|||
19469790|NCT02722278|41740570|FG000|Overall Study|Adverse Event|4|||
19469791|NCT02722278|41740571|FG001|Overall Study|Adverse Event|1|||
19469792|NCT02722278|41740570|FG000|Overall Study|Lost to Follow-up|2|||
19469793|NCT02722278|41740571|FG001|Overall Study|Lost to Follow-up|0|||
19469794|NCT02722278|41740570|FG000|Overall Study|Protocol Violation|1|||
19469795|NCT02722278|41740571|FG001|Overall Study|Protocol Violation|0|||
19469796|NCT02722278|41740570|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
19469797|NCT02722278|41740571|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
19469798|NCT02722278|41740570|FG000|Overall Study|Subject declined after tx assignment|0|||
19469799|NCT02722278|41740571|FG001|Overall Study|Subject declined after tx assignment|1|||
19469800|NCT02722278|41740570|FG000|Overall Study|Site closure not study related|0|||
19469801|NCT02722278|41740571|FG001|Overall Study|Site closure not study related|1|||
19469802|NCT00703092|41740579|FG000|Overall Study|Withdrawal by Subject|2|||
19469803|NCT02720484|41740583|FG000|Treatment on Study|Adverse Event|1|||
19469804|NCT02720484|41740583|FG000|Treatment on Study|Withdrawal by Subject|1|||
19469805|NCT02720484|41740583|FG000|Treatment on Study|Progressive Disease|4|||
19469806|NCT02720484|41740583|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
19469807|NCT02720484|41740583|FG000|Follow Up for 2 Years|Death|3|||
19469808|NCT02720484|41740583|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
19469809|NCT02715804|41740589|FG000|Overall Study|Death|222|||
19469810|NCT02715804|41740590|FG001|Overall Study|Death|106|||
19469811|NCT02715804|41740589|FG000|Overall Study|Withdrawal by Subject|5|||
19469812|NCT02715804|41740590|FG001|Overall Study|Withdrawal by Subject|4|||
19469813|NCT02715804|41740589|FG000|Overall Study|Other than specified|2|||
19553789|NCT01091974|42002695|FG001|Overall Study|side-effects|1|||
19553790|NCT01091974|42002696|FG002|Overall Study|side-effects|0|||
19381575|NCT02732119|41624752|FG003|Phase I|Physician Decision|0|||
19381576|NCT02732119|41624753|FG004|Phase I|Physician Decision|0|||
19381577|NCT02732119|41624749|FG000|Phase II|Adverse Event|0|||
19381578|NCT02732119|41624750|FG001|Phase II|Adverse Event|0|||
19381579|NCT02732119|41624751|FG002|Phase II|Adverse Event|0|||
19381580|NCT02732119|41624752|FG003|Phase II|Adverse Event|3|||
19381581|NCT02732119|41624753|FG004|Phase II|Adverse Event|3|||
19381582|NCT02732119|41624749|FG000|Phase II|Death|0|||
19381583|NCT02732119|41624750|FG001|Phase II|Death|0|||
19381584|NCT02732119|41624751|FG002|Phase II|Death|0|||
19381585|NCT02732119|41624752|FG003|Phase II|Death|1|||
19381586|NCT02732119|41624753|FG004|Phase II|Death|0|||
19381587|NCT02732119|41624749|FG000|Phase II|Progressive dissease|0|||
19381588|NCT02732119|41624750|FG001|Phase II|Progressive dissease|0|||
19381589|NCT02732119|41624751|FG002|Phase II|Progressive dissease|0|||
19381590|NCT02732119|41624752|FG003|Phase II|Progressive dissease|30|||
19381591|NCT02732119|41624753|FG004|Phase II|Progressive dissease|23|||
19381592|NCT02732119|41624749|FG000|Phase II|Study terminated by sponsor|0|||
19381593|NCT02732119|41624750|FG001|Phase II|Study terminated by sponsor|0|||
19381594|NCT02732119|41624751|FG002|Phase II|Study terminated by sponsor|0|||
19381595|NCT02732119|41624752|FG003|Phase II|Study terminated by sponsor|2|||
19381596|NCT02732119|41624753|FG004|Phase II|Study terminated by sponsor|2|||
19381597|NCT02732119|41624749|FG000|Phase II|Other|0|||
19381598|NCT02732119|41624750|FG001|Phase II|Other|0|||
19381599|NCT02732119|41624751|FG002|Phase II|Other|0|||
19381600|NCT02732119|41624752|FG003|Phase II|Other|2|||
19381601|NCT02732119|41624753|FG004|Phase II|Other|0|||
19381602|NCT02732119|41624749|FG000|Phase II|Physician Decision|0|||
19381603|NCT02732119|41624750|FG001|Phase II|Physician Decision|0|||
19381604|NCT02732119|41624751|FG002|Phase II|Physician Decision|0|||
19381605|NCT02732119|41624752|FG003|Phase II|Physician Decision|8|||
19381606|NCT02732119|41624753|FG004|Phase II|Physician Decision|5|||
19381607|NCT03252925|41624776|FG000|Overall Study|Withdrawal by Subject|1|||
19381608|NCT03252925|41624777|FG001|Overall Study|Withdrawal by Subject|0|||
19381609|NCT03252925|41624776|FG000|Overall Study|Protocol Violation|6|||
19381610|NCT03252925|41624777|FG001|Overall Study|Protocol Violation|0|||
19381611|NCT03252925|41624776|FG000|Overall Study|Adverse Event|1|||
19381612|NCT03252925|41624777|FG001|Overall Study|Adverse Event|0|||
19381613|NCT03252925|41624776|FG000|Overall Study|Lost to Follow-up|6|||
19381614|NCT03252925|41624777|FG001|Overall Study|Lost to Follow-up|6|||
19381615|NCT01327885|41624785|FG000|Overall Study|Disease progression-according to RECIST|173|||
19381616|NCT01327885|41624786|FG001|Overall Study|Disease progression-according to RECIST|165|||
19381617|NCT01327885|41624785|FG000|Overall Study|Clinical progression|24|||
19381618|NCT01327885|41624786|FG001|Overall Study|Clinical progression|27|||
19381619|NCT01327885|41624785|FG000|Overall Study|Adverse Event|14|||
19381620|NCT01327885|41624786|FG001|Overall Study|Adverse Event|10|||
19381621|NCT01327885|41624785|FG000|Overall Study|Subject choice|5|||
19381622|NCT01327885|41624786|FG001|Overall Study|Subject choice|10|||
19381623|NCT01327885|41624785|FG000|Overall Study|Other|8|||
19381624|NCT01327885|41624786|FG001|Overall Study|Other|6|||
19381625|NCT01327885|41624785|FG000|Overall Study|Withdrawal of consent from study|3|||
19381626|NCT01327885|41624786|FG001|Overall Study|Withdrawal of consent from study|4|||
19381627|NCT01327885|41624785|FG000|Overall Study|Not treated|1|||
19381628|NCT01327885|41624786|FG001|Overall Study|Not treated|1|||
19381629|NCT01327885|41624785|FG000|Overall Study|Administrative decision|0|||
19381630|NCT01327885|41624786|FG001|Overall Study|Administrative decision|1|||
19381631|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
19381632|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
19381633|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
19381634|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
19381635|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
19381636|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
19381637|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
19381638|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
19381639|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
19381640|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
19381641|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
19381642|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
19381643|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
19381644|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
19381645|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
19381646|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
19381647|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
19381648|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19469814|NCT02715804|41740590|FG001|Overall Study|Other than specified|3|||
19469815|NCT02717832|41740596|FG000|Overall Study|Inability to place IV|3|||
19469816|NCT02717754|41740607|FG000|Overall Study|Incorrect Infusion Duration|0|||
19469817|NCT02717754|41740608|FG001|Overall Study|Incorrect Infusion Duration|0|||
19469818|NCT02717754|41740609|FG002|Overall Study|Incorrect Infusion Duration|0|||
19469819|NCT02717754|41740610|FG003|Overall Study|Incorrect Infusion Duration|10|||
19469820|NCT02717754|41740611|FG004|Overall Study|Incorrect Infusion Duration|20|||
19469821|NCT02717754|41740612|FG005|Overall Study|Incorrect Infusion Duration|20|||
19469822|NCT02927262|41740624|FG000|Overall Study|Adverse Event|7|||
19469823|NCT02927262|41740625|FG001|Overall Study|Adverse Event|1|||
19469824|NCT02927262|41740624|FG000|Overall Study|Death|1|||
19469825|NCT02927262|41740625|FG001|Overall Study|Death|0|||
19469826|NCT02927262|41740624|FG000|Overall Study|Withdrawal by Subject|3|||
19469827|NCT02927262|41740625|FG001|Overall Study|Withdrawal by Subject|0|||
19469828|NCT02927262|41740624|FG000|Overall Study|Disease Relapse|23|||
19469829|NCT02927262|41740625|FG001|Overall Study|Disease Relapse|18|||
19469830|NCT02927262|41740624|FG000|Overall Study|Miscellaneous|5|||
19469831|NCT02927262|41740625|FG001|Overall Study|Miscellaneous|4|||
19469832|NCT02927262|41740624|FG000|Overall Study|Ongoing|4|||
19469833|NCT02927262|41740625|FG001|Overall Study|Ongoing|0|||
19469834|NCT02717130|41740631|FG000|Overall Study|Withdrawal by Subject|1|||
19469835|NCT02717130|41740631|FG000|Overall Study|Adverse Event|1|||
19469836|NCT02717130|41740631|FG000|Overall Study|Physician Decision|1|||
19469837|NCT02717130|41740631|FG000|Overall Study|Study Closure|4|||
19469838|NCT02192502|41740637|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
19469839|NCT02192502|41740638|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
19469840|NCT02192502|41740637|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
19469841|NCT02192502|41740638|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
19469842|NCT02192502|41740637|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
19469843|NCT02192502|41740638|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
19469844|NCT01781429|41740659|FG000|Overall Study|Death|0|||
19469845|NCT01781429|41740660|FG001|Overall Study|Death|0|||
19469846|NCT01781429|41740661|FG002|Overall Study|Death|0|||
19469847|NCT01781429|41740662|FG003|Overall Study|Death|0|||
19469848|NCT01781429|41740663|FG004|Overall Study|Death|0|||
19469849|NCT01781429|41740664|FG005|Overall Study|Death|0|||
19469850|NCT01781429|41740665|FG006|Overall Study|Death|0|||
19469851|NCT01781429|41740666|FG007|Overall Study|Death|0|||
19469852|NCT01781429|41740667|FG008|Overall Study|Death|0|||
19469853|NCT01781429|41740668|FG009|Overall Study|Death|1|||
19469854|NCT01781429|41740669|FG010|Overall Study|Death|0|||
19469855|NCT01781429|41740670|FG011|Overall Study|Death|0|||
19469856|NCT01781429|41740671|FG012|Overall Study|Death|1|||
19469857|NCT01781429|41740672|FG013|Overall Study|Death|0|||
19469858|NCT01781429|41740673|FG014|Overall Study|Death|1|||
19469859|NCT01781429|41740674|FG015|Overall Study|Death|0|||
19469860|NCT01781429|41740659|FG000|Overall Study|Withdrawal by Subject|0|||
19469861|NCT01781429|41740660|FG001|Overall Study|Withdrawal by Subject|0|||
19469862|NCT01781429|41740661|FG002|Overall Study|Withdrawal by Subject|0|||
19469863|NCT01781429|41740662|FG003|Overall Study|Withdrawal by Subject|0|||
19469864|NCT01781429|41740663|FG004|Overall Study|Withdrawal by Subject|0|||
19469865|NCT01781429|41740664|FG005|Overall Study|Withdrawal by Subject|0|||
19469866|NCT01781429|41740665|FG006|Overall Study|Withdrawal by Subject|0|||
19469867|NCT01781429|41740666|FG007|Overall Study|Withdrawal by Subject|0|||
19469868|NCT01781429|41740667|FG008|Overall Study|Withdrawal by Subject|1|||
19469869|NCT01781429|41740668|FG009|Overall Study|Withdrawal by Subject|3|||
19469870|NCT01781429|41740669|FG010|Overall Study|Withdrawal by Subject|1|||
19469871|NCT01781429|41740670|FG011|Overall Study|Withdrawal by Subject|1|||
19469872|NCT01781429|41740671|FG012|Overall Study|Withdrawal by Subject|5|||
19469873|NCT01781429|41740672|FG013|Overall Study|Withdrawal by Subject|2|||
19469874|NCT01781429|41740673|FG014|Overall Study|Withdrawal by Subject|3|||
19469875|NCT01781429|41740674|FG015|Overall Study|Withdrawal by Subject|0|||
19469876|NCT01781429|41740659|FG000|Overall Study|Disease Progression|1|||
19469877|NCT01781429|41740660|FG001|Overall Study|Disease Progression|0|||
19469878|NCT01781429|41740661|FG002|Overall Study|Disease Progression|1|||
19469879|NCT01781429|41740662|FG003|Overall Study|Disease Progression|1|||
19469880|NCT01781429|41740663|FG004|Overall Study|Disease Progression|1|||
19469881|NCT01781429|41740664|FG005|Overall Study|Disease Progression|4|||
19469882|NCT01781429|41740665|FG006|Overall Study|Disease Progression|7|||
19469883|NCT01781429|41740666|FG007|Overall Study|Disease Progression|4|||
19469884|NCT01781429|41740667|FG008|Overall Study|Disease Progression|6|||
19469885|NCT01781429|41740668|FG009|Overall Study|Disease Progression|15|||
19469886|NCT01781429|41740669|FG010|Overall Study|Disease Progression|15|||
19469887|NCT01781429|41740670|FG011|Overall Study|Disease Progression|15|||
19469888|NCT01781429|41740671|FG012|Overall Study|Disease Progression|15|||
19469889|NCT01781429|41740672|FG013|Overall Study|Disease Progression|4|||
19469890|NCT01781429|41740673|FG014|Overall Study|Disease Progression|11|||
19469891|NCT01781429|41740674|FG015|Overall Study|Disease Progression|0|||
19469892|NCT01781429|41740659|FG000|Overall Study|Unacceptable Toxicity|0|||
19469893|NCT01781429|41740660|FG001|Overall Study|Unacceptable Toxicity|0|||
19469894|NCT01781429|41740661|FG002|Overall Study|Unacceptable Toxicity|0|||
19469895|NCT01781429|41740662|FG003|Overall Study|Unacceptable Toxicity|0|||
19469896|NCT01781429|41740663|FG004|Overall Study|Unacceptable Toxicity|0|||
19469897|NCT01781429|41740664|FG005|Overall Study|Unacceptable Toxicity|0|||
19469898|NCT01781429|41740665|FG006|Overall Study|Unacceptable Toxicity|0|||
19469899|NCT01781429|41740666|FG007|Overall Study|Unacceptable Toxicity|0|||
19469900|NCT01781429|41740667|FG008|Overall Study|Unacceptable Toxicity|0|||
19469901|NCT01781429|41740668|FG009|Overall Study|Unacceptable Toxicity|0|||
19469902|NCT01781429|41740669|FG010|Overall Study|Unacceptable Toxicity|0|||
19469903|NCT01781429|41740670|FG011|Overall Study|Unacceptable Toxicity|2|||
19469904|NCT01781429|41740671|FG012|Overall Study|Unacceptable Toxicity|0|||
19469905|NCT01781429|41740672|FG013|Overall Study|Unacceptable Toxicity|0|||
19469906|NCT01781429|41740673|FG014|Overall Study|Unacceptable Toxicity|0|||
19469907|NCT01781429|41740674|FG015|Overall Study|Unacceptable Toxicity|0|||
19469908|NCT01781429|41740659|FG000|Overall Study|Patient Condition Changed|0|||
19469909|NCT01781429|41740660|FG001|Overall Study|Patient Condition Changed|0|||
19469910|NCT01781429|41740661|FG002|Overall Study|Patient Condition Changed|0|||
19469911|NCT01781429|41740662|FG003|Overall Study|Patient Condition Changed|0|||
19469912|NCT01781429|41740663|FG004|Overall Study|Patient Condition Changed|0|||
19469913|NCT01781429|41740664|FG005|Overall Study|Patient Condition Changed|0|||
19469914|NCT01781429|41740665|FG006|Overall Study|Patient Condition Changed|0|||
19469915|NCT01781429|41740666|FG007|Overall Study|Patient Condition Changed|0|||
19469916|NCT01781429|41740667|FG008|Overall Study|Patient Condition Changed|0|||
19469917|NCT01781429|41740668|FG009|Overall Study|Patient Condition Changed|4|||
19469918|NCT01781429|41740669|FG010|Overall Study|Patient Condition Changed|0|||
19469919|NCT01781429|41740670|FG011|Overall Study|Patient Condition Changed|1|||
19469920|NCT01781429|41740671|FG012|Overall Study|Patient Condition Changed|0|||
19469921|NCT01781429|41740672|FG013|Overall Study|Patient Condition Changed|1|||
19469922|NCT01781429|41740673|FG014|Overall Study|Patient Condition Changed|0|||
19469923|NCT01781429|41740674|FG015|Overall Study|Patient Condition Changed|0|||
19469924|NCT01781429|41740659|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
19469925|NCT01781429|41740660|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
19381649|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19381650|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19381651|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Death|2|||
19381652|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Death|2|||
19381653|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Death|0|||
19381654|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Death|0|||
19381655|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Death|0|||
19381656|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
19381657|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
19381658|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
19381659|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
19469926|NCT01781429|41740661|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
19469927|NCT01781429|41740662|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
19469928|NCT01781429|41740663|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
19469929|NCT01781429|41740664|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
19469930|NCT01781429|41740665|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
19469931|NCT01781429|41740666|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
19469932|NCT01781429|41740667|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
19469933|NCT01781429|41740668|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
19469934|NCT01781429|41740669|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
19469935|NCT01781429|41740670|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
19469936|NCT01781429|41740671|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
19381660|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
19381661|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
19381662|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
19381663|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
19381664|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
19381665|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
19381666|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
19381667|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
19381668|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
19381669|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
19381670|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
19381671|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
19381672|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
19381673|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
19381674|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
19381675|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
19381676|NCT03420781|41624804|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
19381677|NCT03420781|41624805|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
19381678|NCT03420781|41624806|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
19381679|NCT03420781|41624807|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
19381680|NCT03420781|41624808|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
19381681|NCT03420781|41624804|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
19381682|NCT03420781|41624805|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
19381683|NCT03420781|41624806|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
19381684|NCT03420781|41624807|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
19381685|NCT03420781|41624808|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
19381686|NCT03420781|41624804|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
19381687|NCT03420781|41624805|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
19381688|NCT03420781|41624806|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
19469937|NCT01781429|41740672|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
19469938|NCT01781429|41740673|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
19469939|NCT01781429|41740674|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
19469940|NCT01781429|41740659|FG000|Overall Study|Enrolled, but not treated|0|||
19469941|NCT01781429|41740660|FG001|Overall Study|Enrolled, but not treated|0|||
19469942|NCT01781429|41740661|FG002|Overall Study|Enrolled, but not treated|0|||
19469943|NCT01781429|41740662|FG003|Overall Study|Enrolled, but not treated|0|||
19469944|NCT01781429|41740663|FG004|Overall Study|Enrolled, but not treated|0|||
19469945|NCT01781429|41740664|FG005|Overall Study|Enrolled, but not treated|0|||
19469946|NCT01781429|41740665|FG006|Overall Study|Enrolled, but not treated|0|||
19469947|NCT01781429|41740666|FG007|Overall Study|Enrolled, but not treated|0|||
19469948|NCT01781429|41740667|FG008|Overall Study|Enrolled, but not treated|0|||
19469949|NCT01781429|41740668|FG009|Overall Study|Enrolled, but not treated|0|||
19469950|NCT01781429|41740669|FG010|Overall Study|Enrolled, but not treated|1|||
19469951|NCT01781429|41740670|FG011|Overall Study|Enrolled, but not treated|0|||
19469952|NCT01781429|41740671|FG012|Overall Study|Enrolled, but not treated|0|||
19469953|NCT01781429|41740672|FG013|Overall Study|Enrolled, but not treated|0|||
19469954|NCT01781429|41740673|FG014|Overall Study|Enrolled, but not treated|0|||
19469955|NCT01781429|41740674|FG015|Overall Study|Enrolled, but not treated|0|||
19469956|NCT01773473|41740709|FG000|Overall Study|Adverse Event|3|||
19469957|NCT01773473|41740710|FG001|Overall Study|Adverse Event|2|||
19469958|NCT01773473|41740709|FG000|Overall Study|Protocol Violation|0|||
19469959|NCT01773473|41740710|FG001|Overall Study|Protocol Violation|4|||
19469960|NCT01773473|41740709|FG000|Overall Study|Physician Decision|3|||
19469961|NCT01773473|41740710|FG001|Overall Study|Physician Decision|5|||
19469962|NCT01773473|41740709|FG000|Overall Study|Sponsor Decision|2|||
19469963|NCT01773473|41740710|FG001|Overall Study|Sponsor Decision|0|||
19469964|NCT01773473|41740709|FG000|Overall Study|Lack of Efficacy|0|||
19469965|NCT01773473|41740710|FG001|Overall Study|Lack of Efficacy|1|||
19469966|NCT01773473|41740709|FG000|Overall Study|Non-Compliance with study drug|1|||
19469967|NCT01773473|41740710|FG001|Overall Study|Non-Compliance with study drug|4|||
19469968|NCT01773473|41740709|FG000|Overall Study|Withdrawal by Subject|5|||
19469969|NCT01773473|41740710|FG001|Overall Study|Withdrawal by Subject|3|||
19469970|NCT01773473|41740709|FG000|Overall Study|Lost to Follow-up|2|||
19469971|NCT01773473|41740710|FG001|Overall Study|Lost to Follow-up|0|||
19469972|NCT01772693|41740718|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
19469973|NCT01772693|41740719|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
19469974|NCT01772693|41740718|FG000|Overall Study|Withdrawal by Subject|2|||
19469975|NCT01772693|41740719|FG001|Overall Study|Withdrawal by Subject|0|||
19469976|NCT01772693|41740718|FG000|Overall Study|Alternative Treatment|2|||
19469977|NCT01772693|41740719|FG001|Overall Study|Alternative Treatment|0|||
19469978|NCT01779869|41740725|FG000|Overall Study|Physician Decision|2|||
19469979|NCT01772537|41740732|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
19469980|NCT01772537|41740733|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
19469981|NCT01772537|41740734|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
19469982|NCT01772147|41740747|FG000|Overall Study|Adverse Event|13|||
19469983|NCT01772147|41740748|FG001|Overall Study|Adverse Event|10|||
19469984|NCT01772147|41740749|FG002|Overall Study|Adverse Event|6|||
19469985|NCT01772147|41740747|FG000|Overall Study|Withdrew Consent|7|||
19469986|NCT01772147|41740748|FG001|Overall Study|Withdrew Consent|8|||
19469987|NCT01772147|41740749|FG002|Overall Study|Withdrew Consent|4|||
19469988|NCT01772147|41740747|FG000|Overall Study|Lost to Follow-up|1|||
19469989|NCT01772147|41740748|FG001|Overall Study|Lost to Follow-up|0|||
19469990|NCT01772147|41740749|FG002|Overall Study|Lost to Follow-up|1|||
19469991|NCT01772147|41740747|FG000|Overall Study|Protocol Deviation|2|||
19469992|NCT01772147|41740748|FG001|Overall Study|Protocol Deviation|1|||
19469993|NCT01772147|41740749|FG002|Overall Study|Protocol Deviation|1|||
19469994|NCT01772147|41740747|FG000|Overall Study|Lack of Efficacy|8|||
19469995|NCT01772147|41740748|FG001|Overall Study|Lack of Efficacy|6|||
19469996|NCT01772147|41740749|FG002|Overall Study|Lack of Efficacy|6|||
19381689|NCT03420781|41624807|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
19381690|NCT03420781|41624808|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
19381691|NCT03420781|41624804|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
19381692|NCT03420781|41624805|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
19381693|NCT03420781|41624806|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
19381694|NCT03420781|41624807|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
19381695|NCT03420781|41624808|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
19381696|NCT03269695|41624826|FG000|Overall Study|Adverse Event|2|||
19381697|NCT03269695|41624827|FG001|Overall Study|Adverse Event|1|||
19381698|NCT03269695|41624826|FG000|Overall Study|Lack of Efficacy|0|||
19381699|NCT03269695|41624827|FG001|Overall Study|Lack of Efficacy|1|||
19381700|NCT03269695|41624826|FG000|Overall Study|Withdrawal by Subject|0|||
19381701|NCT03269695|41624827|FG001|Overall Study|Withdrawal by Subject|1|||
19381702|NCT02766335|41624836|FG000|Initial Registration|Adverse Event|6|||
19381703|NCT02766335|41624837|FG001|Initial Registration|Adverse Event|3|||
19381704|NCT02766335|41624838|FG002|Initial Registration|Adverse Event|0|||
19381705|NCT02766335|41624836|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
19381706|NCT02766335|41624837|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
19381707|NCT02766335|41624838|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
19381708|NCT02766335|41624836|FG000|Initial Registration|Progression/relapse|49|||
19381709|NCT02766335|41624837|FG001|Initial Registration|Progression/relapse|15|||
19381710|NCT02766335|41624838|FG002|Initial Registration|Progression/relapse|0|||
19381711|NCT02766335|41624836|FG000|Initial Registration|Death|1|||
19381712|NCT02766335|41624837|FG001|Initial Registration|Death|3|||
19381713|NCT02766335|41624838|FG002|Initial Registration|Death|0|||
19381714|NCT02766335|41624836|FG000|Initial Registration|not protocol specified|1|||
19381715|NCT02766335|41624837|FG001|Initial Registration|not protocol specified|9|||
19381716|NCT02766335|41624838|FG002|Initial Registration|not protocol specified|0|||
19381717|NCT02766335|41624836|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
19381718|NCT02766335|41624837|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
19381719|NCT02766335|41624838|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
19381720|NCT02766335|41624836|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
19381721|NCT02766335|41624837|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
19381722|NCT02766335|41624838|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
19381723|NCT00462943|41624847|FG000|Overall Study|Failure to achieve a response|5|||
19381724|NCT00462943|41624848|FG001|Overall Study|Failure to achieve a response|5|||
19381725|NCT00462943|41624849|FG002|Overall Study|Failure to achieve a response|1|||
19381726|NCT00462943|41624847|FG000|Overall Study|Adverse Event|6|||
19381727|NCT00462943|41624848|FG001|Overall Study|Adverse Event|4|||
19381728|NCT00462943|41624849|FG002|Overall Study|Adverse Event|1|||
19381729|NCT00462943|41624847|FG000|Overall Study|Protocol Violation|1|||
19381730|NCT00462943|41624848|FG001|Overall Study|Protocol Violation|0|||
19381731|NCT00462943|41624849|FG002|Overall Study|Protocol Violation|0|||
19381732|NCT00462943|41624847|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
19381733|NCT00462943|41624848|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
19381734|NCT00462943|41624849|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
19381735|NCT00462943|41624847|FG000|Overall Study|Disease Progression|15|||
19381736|NCT00462943|41624848|FG001|Overall Study|Disease Progression|15|||
19381737|NCT00462943|41624849|FG002|Overall Study|Disease Progression|9|||
19381738|NCT00462943|41624847|FG000|Overall Study|Death|5|||
19381739|NCT00462943|41624848|FG001|Overall Study|Death|2|||
19381740|NCT00462943|41624849|FG002|Overall Study|Death|7|||
19381741|NCT00462943|41624847|FG000|Overall Study|Stem Cell Transplant|1|||
19381742|NCT00462943|41624848|FG001|Overall Study|Stem Cell Transplant|1|||
19381743|NCT00462943|41624849|FG002|Overall Study|Stem Cell Transplant|0|||
19381744|NCT00462943|41624847|FG000|Overall Study|Bone Marrow Transplant|1|||
19381745|NCT00462943|41624848|FG001|Overall Study|Bone Marrow Transplant|0|||
19381746|NCT00462943|41624849|FG002|Overall Study|Bone Marrow Transplant|0|||
19381747|NCT00462943|41624847|FG000|Overall Study|Required Lymphocyte Infusion|1|||
19381748|NCT00462943|41624848|FG001|Overall Study|Required Lymphocyte Infusion|0|||
19381749|NCT00462943|41624849|FG002|Overall Study|Required Lymphocyte Infusion|0|||
19381750|NCT00462943|41624847|FG000|Overall Study|Transplant - not specified|1|||
19381751|NCT00462943|41624848|FG001|Overall Study|Transplant - not specified|0|||
19381752|NCT00462943|41624849|FG002|Overall Study|Transplant - not specified|1|||
19381753|NCT00462943|41624847|FG000|Overall Study|Physician Decision|1|||
19381754|NCT00462943|41624848|FG001|Overall Study|Physician Decision|0|||
19381755|NCT00462943|41624849|FG002|Overall Study|Physician Decision|0|||
19381756|NCT00462943|41624847|FG000|Overall Study|Withdrawal by Subject|0|||
19381757|NCT00462943|41624848|FG001|Overall Study|Withdrawal by Subject|1|||
19381758|NCT00462943|41624849|FG002|Overall Study|Withdrawal by Subject|0|||
19381759|NCT02730793|41624873|FG000|Overall Study|Physician Decision|0|||
19381760|NCT02730793|41624874|FG001|Overall Study|Physician Decision|1|||
19381761|NCT02730793|41624873|FG000|Overall Study|Withdrawal by Subject|0|||
19381762|NCT02730793|41624874|FG001|Overall Study|Withdrawal by Subject|1|||
19381763|NCT02855125|41624882|FG000|Overall Study|Withdrawal by Subject|2|||
19381764|NCT02855125|41624883|FG001|Overall Study|Withdrawal by Subject|2|||
19381765|NCT02855125|41624882|FG000|Overall Study|Clinical Disease Progression|5|||
19381766|NCT02855125|41624883|FG001|Overall Study|Clinical Disease Progression|4|||
19381767|NCT02855125|41624882|FG000|Overall Study|Radiologic Disease Progression|36|||
19381768|NCT02855125|41624883|FG001|Overall Study|Radiologic Disease Progression|39|||
19381769|NCT02855125|41624882|FG000|Overall Study|Adverse Event|11|||
19469997|NCT01771913|41740759|FG000|Overall Study|Withdrawal by Subject|1|||
19469998|NCT01771913|41740760|FG001|Overall Study|Withdrawal by Subject|0|||
19469999|NCT01606787|41740768|FG000|Overall Study|Withdrawal by Subject|4|||
19470000|NCT01606787|41740769|FG001|Overall Study|Withdrawal by Subject|5|||
19470001|NCT01606787|41740768|FG000|Overall Study|Surgery canceled|0|||
19470002|NCT01606787|41740769|FG001|Overall Study|Surgery canceled|2|||
19470003|NCT01778855|41740777|FG000|Overall Study|Death|0|||
19470004|NCT01778855|41740778|FG001|Overall Study|Death|1|||
19470005|NCT01770743|41740789|FG000|Overall Study|Adverse Event|1|||
19470006|NCT01770743|41740790|FG001|Overall Study|Adverse Event|0|||
19470007|NCT01770743|41740791|FG002|Overall Study|Adverse Event|0|||
19470008|NCT01770743|41740792|FG003|Overall Study|Adverse Event|0|||
19470009|NCT01770743|41740793|FG004|Overall Study|Adverse Event|0|||
19470010|NCT01770743|41740789|FG000|Overall Study|Withdrawal by Subject|0|||
19470011|NCT01770743|41740790|FG001|Overall Study|Withdrawal by Subject|0|||
19470012|NCT01770743|41740791|FG002|Overall Study|Withdrawal by Subject|1|||
19470013|NCT01770743|41740792|FG003|Overall Study|Withdrawal by Subject|1|||
19470014|NCT01770743|41740793|FG004|Overall Study|Withdrawal by Subject|1|||
19470015|NCT01770743|41740789|FG000|Overall Study|Lost to Follow-up|0|||
19470016|NCT01770743|41740790|FG001|Overall Study|Lost to Follow-up|2|||
19470017|NCT01770743|41740791|FG002|Overall Study|Lost to Follow-up|0|||
19470018|NCT01770743|41740792|FG003|Overall Study|Lost to Follow-up|0|||
19470019|NCT01770743|41740793|FG004|Overall Study|Lost to Follow-up|1|||
19470020|NCT01770743|41740789|FG000|Overall Study|Sponsor Terminated Subject|1|||
19470021|NCT01770743|41740790|FG001|Overall Study|Sponsor Terminated Subject|0|||
19470022|NCT01770743|41740791|FG002|Overall Study|Sponsor Terminated Subject|0|||
19470023|NCT01770743|41740792|FG003|Overall Study|Sponsor Terminated Subject|1|||
19470024|NCT01770743|41740793|FG004|Overall Study|Sponsor Terminated Subject|0|||
19470025|NCT01770743|41740789|FG000|Overall Study|Moving Out of State|0|||
19470026|NCT01770743|41740790|FG001|Overall Study|Moving Out of State|1|||
19470027|NCT01770743|41740791|FG002|Overall Study|Moving Out of State|0|||
19470028|NCT01770743|41740792|FG003|Overall Study|Moving Out of State|0|||
19470029|NCT01770743|41740793|FG004|Overall Study|Moving Out of State|0|||
19470030|NCT01777997|41740805|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
19470031|NCT01777997|41740805|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
19470032|NCT01777997|41740805|FG000|Weeks 48 to 72/96 on ART|Death|1|||
19470033|NCT01777997|41740805|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
19470034|NCT01770509|41740811|FG000|Overall Study|Injury|0|||
19470035|NCT01770509|41740812|FG001|Overall Study|Injury|1|||
19470036|NCT01770509|41740811|FG000|Overall Study|Lost to Follow-up|1|||
19470037|NCT01770509|41740812|FG001|Overall Study|Lost to Follow-up|2|||
19470038|NCT01770353|41740820|FG000|Overall Study|Progressive disease|2|||
19470039|NCT01770353|41740821|FG001|Overall Study|Progressive disease|1|||
19470040|NCT01770353|41740820|FG000|Overall Study|Adverse Event|0|||
19470041|NCT01770353|41740821|FG001|Overall Study|Adverse Event|1|||
19470042|NCT01770353|41740820|FG000|Overall Study|Protocol Violation|1|||
19470043|NCT01770353|41740821|FG001|Overall Study|Protocol Violation|0|||
19470044|NCT01770353|41740820|FG000|Overall Study|Physician Decision|0|||
19470045|NCT01770353|41740821|FG001|Overall Study|Physician Decision|3|||
19470046|NCT01770353|41740820|FG000|Overall Study|Clinical deterioration|3|||
19470047|NCT01770353|41740821|FG001|Overall Study|Clinical deterioration|6|||
19470048|NCT01770353|41740820|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
19381770|NCT02855125|41624883|FG001|Overall Study|Adverse Event|7|||
19381771|NCT02855125|41624882|FG000|Overall Study|Physician Decision|1|||
19381772|NCT02855125|41624883|FG001|Overall Study|Physician Decision|0|||
19470049|NCT01770353|41740821|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
19470050|NCT01777763|41740837|FG000|Overall Study|Adverse Event|2|||
19470051|NCT01777763|41740838|FG001|Overall Study|Adverse Event|32|||
19470052|NCT01777763|41740837|FG000|Overall Study|Protocol Violation|1|||
19470053|NCT01777763|41740838|FG001|Overall Study|Protocol Violation|7|||
19470054|NCT01777763|41740837|FG000|Overall Study|Withdrawal by Subject|0|||
19470055|NCT01777763|41740838|FG001|Overall Study|Withdrawal by Subject|2|||
19470056|NCT01777763|41740837|FG000|Overall Study|Treatment Failure|1|||
19470057|NCT01777763|41740838|FG001|Overall Study|Treatment Failure|6|||
19470058|NCT01769339|41740844|FG000|Overall Study|Lost to Follow-up|42|||
19470059|NCT01769339|41740844|FG000|Overall Study|Adverse Event|1|||
19470060|NCT01769105|41740850|FG000|First Intervention|Protocol Violation|2|||
19470061|NCT01769105|41740851|FG001|First Intervention|Protocol Violation|2|||
19470062|NCT01769105|41740850|FG000|Cross-over|Lost to Follow-up|5|||
19470063|NCT01769105|41740851|FG001|Cross-over|Lost to Follow-up|0|||
19470064|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
19470065|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
19470066|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
19470067|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
19470068|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
19470069|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
19470070|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
19470071|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
19470072|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
19470073|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
19470074|NCT01777139|41740859|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
19470075|NCT01777139|41740860|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
19470076|NCT01777139|41740859|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
19470077|NCT01777139|41740860|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
19470078|NCT01777139|41740859|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
19470079|NCT01777139|41740860|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
19470080|NCT01768637|41740869|FG000|Overall Study|Lost to Follow-up|2|||
19470081|NCT01768637|41740870|FG001|Overall Study|Lost to Follow-up|7|||
19470082|NCT01768637|41740869|FG000|Overall Study|Difficult blood draw|1|||
19470083|NCT01768637|41740870|FG001|Overall Study|Difficult blood draw|0|||
19470084|NCT01886872|41740879|FG000|Overall Study|Ineligible|7|||
19470085|NCT01886872|41740880|FG001|Overall Study|Ineligible|4|||
19470086|NCT01886872|41740881|FG002|Overall Study|Ineligible|12|||
19470087|NCT01768559|41740893|FG000|Overall Study|Randomized but not treated|0|||
19470088|NCT01768559|41740894|FG001|Overall Study|Randomized but not treated|0|||
19470089|NCT01768559|41740895|FG002|Overall Study|Randomized but not treated|1|||
19470090|NCT01768559|41740893|FG000|Overall Study|Adverse Event|15|||
19470091|NCT01768559|41740894|FG001|Overall Study|Adverse Event|2|||
19470092|NCT01768559|41740895|FG002|Overall Study|Adverse Event|5|||
19470093|NCT01768559|41740893|FG000|Overall Study|Lack of Efficacy|6|||
19470094|NCT01768559|41740894|FG001|Overall Study|Lack of Efficacy|4|||
19470095|NCT01768559|41740895|FG002|Overall Study|Lack of Efficacy|0|||
19470096|NCT01768559|41740893|FG000|Overall Study|Poor compliance to protocol|0|||
19470097|NCT01768559|41740894|FG001|Overall Study|Poor compliance to protocol|3|||
19470098|NCT01768559|41740895|FG002|Overall Study|Poor compliance to protocol|2|||
19470099|NCT01768559|41740893|FG000|Overall Study|Other than specified|9|||
19470100|NCT01768559|41740894|FG001|Overall Study|Other than specified|8|||
19470101|NCT01768559|41740895|FG002|Overall Study|Other than specified|5|||
19470102|NCT00983619|41740919|FG000|Overall Study|Lost to Follow-up|0|||
19470103|NCT00983619|41740920|FG001|Overall Study|Lost to Follow-up|1|||
19470104|NCT00983619|41740921|FG002|Overall Study|Lost to Follow-up|0|||
19470105|NCT00983619|41740922|FG003|Overall Study|Lost to Follow-up|0|||
19470106|NCT00983619|41740923|FG004|Overall Study|Lost to Follow-up|0|||
19470107|NCT00983619|41740924|FG005|Overall Study|Lost to Follow-up|2|||
19470108|NCT00983619|41740925|FG006|Overall Study|Lost to Follow-up|0|||
19470109|NCT00983619|41740926|FG007|Overall Study|Lost to Follow-up|0|||
19470110|NCT00983619|41740927|FG008|Overall Study|Lost to Follow-up|0|||
19470111|NCT00983619|41740928|FG009|Overall Study|Lost to Follow-up|0|||
19470112|NCT00983619|41740929|FG010|Overall Study|Lost to Follow-up|0|||
19470113|NCT00983619|41740930|FG011|Overall Study|Lost to Follow-up|2|||
19470114|NCT00983619|41740919|FG000|Overall Study|Withdrawal by Subject|2|||
19470115|NCT00983619|41740920|FG001|Overall Study|Withdrawal by Subject|1|||
19470116|NCT00983619|41740921|FG002|Overall Study|Withdrawal by Subject|1|||
19470117|NCT00983619|41740922|FG003|Overall Study|Withdrawal by Subject|3|||
19470118|NCT00983619|41740923|FG004|Overall Study|Withdrawal by Subject|1|||
19470119|NCT00983619|41740924|FG005|Overall Study|Withdrawal by Subject|23|||
19470120|NCT00983619|41740925|FG006|Overall Study|Withdrawal by Subject|0|||
19470121|NCT00983619|41740926|FG007|Overall Study|Withdrawal by Subject|0|||
19470122|NCT00983619|41740927|FG008|Overall Study|Withdrawal by Subject|0|||
19470123|NCT00983619|41740928|FG009|Overall Study|Withdrawal by Subject|0|||
19470124|NCT00983619|41740929|FG010|Overall Study|Withdrawal by Subject|1|||
19470125|NCT00983619|41740930|FG011|Overall Study|Withdrawal by Subject|1|||
19470126|NCT00983619|41740919|FG000|Overall Study|Death|0|||
19470127|NCT00983619|41740920|FG001|Overall Study|Death|2|||
19470128|NCT00983619|41740921|FG002|Overall Study|Death|2|||
19470129|NCT00983619|41740922|FG003|Overall Study|Death|1|||
19470130|NCT00983619|41740923|FG004|Overall Study|Death|2|||
19470131|NCT00983619|41740924|FG005|Overall Study|Death|30|||
19470132|NCT00983619|41740925|FG006|Overall Study|Death|1|||
19470133|NCT00983619|41740926|FG007|Overall Study|Death|0|||
19470134|NCT00983619|41740927|FG008|Overall Study|Death|1|||
19470135|NCT00983619|41740928|FG009|Overall Study|Death|2|||
19470136|NCT00983619|41740929|FG010|Overall Study|Death|9|||
19470137|NCT00983619|41740930|FG011|Overall Study|Death|8|||
19470138|NCT00983619|41740919|FG000|Overall Study|Other|1|||
19470139|NCT00983619|41740920|FG001|Overall Study|Other|0|||
19470140|NCT00983619|41740921|FG002|Overall Study|Other|0|||
19470141|NCT00983619|41740922|FG003|Overall Study|Other|1|||
19470142|NCT00983619|41740923|FG004|Overall Study|Other|0|||
19470143|NCT00983619|41740924|FG005|Overall Study|Other|12|||
19470144|NCT00983619|41740925|FG006|Overall Study|Other|2|||
19470145|NCT00983619|41740926|FG007|Overall Study|Other|2|||
19381773|NCT02855125|41624882|FG000|Overall Study|On Treatment|9|||
19381774|NCT02855125|41624883|FG001|Overall Study|On Treatment|11|||
19381775|NCT02855125|41624882|FG000|Overall Study|Randomized but not treated|0|||
19381776|NCT02855125|41624883|FG001|Overall Study|Randomized but not treated|1|||
19381777|NCT02730871|41624906|FG000|Overall Study|Adverse Event|6|||
19381778|NCT02730871|41624907|FG001|Overall Study|Adverse Event|0|||
19381779|NCT03376789|41624915|FG000|Overall Study|Withdrawal by Subject|3|||
19381780|NCT03376789|41624916|FG001|Overall Study|Withdrawal by Subject|5|||
19381781|NCT03376789|41624915|FG000|Overall Study|Protocol Violation|0|||
19381782|NCT03376789|41624916|FG001|Overall Study|Protocol Violation|1|||
19381783|NCT03376789|41624915|FG000|Overall Study|Adverse Event|0|||
19381784|NCT03376789|41624916|FG001|Overall Study|Adverse Event|1|||
19381785|NCT03376789|41624915|FG000|Overall Study|Lost to Follow-up|1|||
19381786|NCT03376789|41624916|FG001|Overall Study|Lost to Follow-up|1|||
19381787|NCT03376789|41624915|FG000|Overall Study|Per sponsor due to noncompliance|1|||
19381788|NCT03376789|41624916|FG001|Overall Study|Per sponsor due to noncompliance|0|||
19381789|NCT03376789|41624915|FG000|Overall Study|Subject off study medication|0|||
19381790|NCT03376789|41624916|FG001|Overall Study|Subject off study medication|1|||
19381791|NCT04032093|41624932|FG000|Overall Study|Lost to Follow-up|7|||
19381792|NCT04032093|41624933|FG001|Overall Study|Lost to Follow-up|7|||
19381793|NCT04032093|41624934|FG002|Overall Study|Lost to Follow-up|6|||
19381794|NCT04032093|41624935|FG003|Overall Study|Lost to Follow-up|10|||
19381795|NCT04032093|41624936|FG004|Overall Study|Lost to Follow-up|13|||
19381796|NCT04032093|41624937|FG005|Overall Study|Lost to Follow-up|7|||
19381797|NCT04032093|41624938|FG006|Overall Study|Lost to Follow-up|7|||
19381798|NCT04032093|41624939|FG007|Overall Study|Lost to Follow-up|5|||
19381799|NCT04032093|41624940|FG008|Overall Study|Lost to Follow-up|9|||
19381800|NCT04032093|41624941|FG009|Overall Study|Lost to Follow-up|12|||
19381801|NCT04032093|41624932|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19381802|NCT04032093|41624933|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19470146|NCT00983619|41740927|FG008|Overall Study|Other|0|||
19470147|NCT00983619|41740928|FG009|Overall Study|Other|1|||
19470148|NCT00983619|41740929|FG010|Overall Study|Other|1|||
19470149|NCT00983619|41740930|FG011|Overall Study|Other|0|||
19470150|NCT00653068|41740980|FG000|Overall Study|Death|9|||
19470151|NCT00653068|41740980|FG000|Overall Study|Lack of Efficacy|34|||
19470152|NCT00653068|41740980|FG000|Overall Study|Physician Decision|4|||
19470153|NCT00653068|41740980|FG000|Overall Study|Withdrawal by Subject|1|||
19470154|NCT00653068|41740980|FG000|Overall Study|Ineligible|2|||
19470155|NCT01767857|41740989|FG000|Overall Study|Adverse Event|27|||
19470156|NCT01767857|41740990|FG001|Overall Study|Adverse Event|7|||
19470157|NCT01767857|41740989|FG000|Overall Study|Death|28|||
19470158|NCT01767857|41740990|FG001|Overall Study|Death|13|||
19470159|NCT01767857|41740989|FG000|Overall Study|Lack of Efficacy|299|||
19470160|NCT01767857|41740990|FG001|Overall Study|Lack of Efficacy|151|||
19470161|NCT01767857|41740989|FG000|Overall Study|Lost to Follow-up|1|||
19470162|NCT01767857|41740990|FG001|Overall Study|Lost to Follow-up|1|||
19470163|NCT01767857|41740989|FG000|Overall Study|Withdrawal by Subject|38|||
19381803|NCT04032093|41624934|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
19381804|NCT04032093|41624935|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
19381805|NCT04032093|41624936|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
19381806|NCT04032093|41624937|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
19470164|NCT01767857|41740990|FG001|Overall Study|Withdrawal by Subject|18|||
19470165|NCT01767857|41740989|FG000|Overall Study|Physician Decision|17|||
19470166|NCT01767857|41740990|FG001|Overall Study|Physician Decision|10|||
19470167|NCT01767857|41740989|FG000|Overall Study|Protocol Terminated|1|||
19470168|NCT01767857|41740990|FG001|Overall Study|Protocol Terminated|0|||
19553791|NCT01091974|42002697|FG003|Overall Study|side-effects|2|||
19470169|NCT01767857|41740989|FG000|Overall Study|Randomized But Never Treated|19|||
19470170|NCT01767857|41740990|FG001|Overall Study|Randomized But Never Treated|13|||
19470171|NCT01775501|41740997|FG000|Overall Study|Discontinued prior to treatment|1|||
19470172|NCT01775189|41741026|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470173|NCT01775189|41741027|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
19470174|NCT01775189|41741028|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470175|NCT01775189|41741029|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470176|NCT01775189|41741030|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470177|NCT01775189|41741031|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470178|NCT01775189|41741032|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19470179|NCT01775189|41741026|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470180|NCT01775189|41741027|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
19470181|NCT01775189|41741028|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470182|NCT01775189|41741029|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470183|NCT01775189|41741030|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470184|NCT01775189|41741031|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470185|NCT01775189|41741032|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19470186|NCT01775189|41741026|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
19470187|NCT01775189|41741027|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
19470188|NCT01775189|41741028|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
19470189|NCT01775189|41741029|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
19470190|NCT01775189|41741030|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
19470191|NCT01775189|41741031|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
19470192|NCT01775189|41741032|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
19470193|NCT01775189|41741026|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19470194|NCT01775189|41741027|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19470195|NCT01775189|41741028|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19470196|NCT01775189|41741029|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19470197|NCT01775189|41741030|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19470198|NCT01775189|41741031|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
19470199|NCT01775189|41741032|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
19639173|NCT00717236|42088569|FG000|Open-Label Period|Other: Moved|1|||
19470200|NCT01775189|41741026|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470201|NCT01775189|41741027|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470202|NCT01775189|41741028|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470203|NCT01775189|41741029|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
19470204|NCT01775189|41741030|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470205|NCT01775189|41741031|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470206|NCT01775189|41741032|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
19470207|NCT01775189|41741026|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
19470208|NCT01775189|41741027|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
19470209|NCT01775189|41741028|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
19470210|NCT01775189|41741029|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
19470211|NCT01775189|41741030|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
19470212|NCT01775189|41741031|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
19470213|NCT01775189|41741032|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
19470214|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
19470215|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
19470216|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
19470217|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
19470218|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
19470219|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
19470220|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
19470221|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
19470222|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
19470223|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
19470224|NCT01767467|41741182|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
19470225|NCT01767467|41741183|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
19470226|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
19470227|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
19470228|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
19470229|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
19470230|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
19470231|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
19470232|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
19470233|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
19470234|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
19470235|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
19470236|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
19470237|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
19470238|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
19470239|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
19470240|NCT01767467|41741182|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
19470241|NCT01767467|41741183|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
19470242|NCT04126083|41741256|FG000|Overall Study|Withdrawal by Subject|1|||
19470243|NCT01766921|41741296|FG000|Overall Study|Administrative Reason|5|||
19470244|NCT01766921|41741297|FG001|Overall Study|Administrative Reason|5|||
19381807|NCT04032093|41624938|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
19381808|NCT04032093|41624939|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
19381809|NCT04032093|41624940|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
19381810|NCT04032093|41624941|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
19381811|NCT04032093|41624932|FG000|Overall Study|Other|1|||
19381812|NCT04032093|41624933|FG001|Overall Study|Other|0|||
19381813|NCT04032093|41624934|FG002|Overall Study|Other|0|||
19381814|NCT04032093|41624935|FG003|Overall Study|Other|1|||
19470245|NCT01766921|41741296|FG000|Overall Study|Death|1|||
19470246|NCT01766921|41741297|FG001|Overall Study|Death|1|||
19470247|NCT01766921|41741296|FG000|Overall Study|Lost to Follow-up|1|||
19470248|NCT01766921|41741297|FG001|Overall Study|Lost to Follow-up|3|||
19470249|NCT01766921|41741296|FG000|Overall Study|Unclassified|2|||
19470250|NCT01766921|41741297|FG001|Overall Study|Unclassified|2|||
19381815|NCT04032093|41624936|FG004|Overall Study|Other|1|||
19381816|NCT04032093|41624937|FG005|Overall Study|Other|0|||
19381817|NCT04032093|41624938|FG006|Overall Study|Other|0|||
19381818|NCT04032093|41624939|FG007|Overall Study|Other|0|||
19381819|NCT04032093|41624940|FG008|Overall Study|Other|0|||
19470251|NCT01766921|41741296|FG000|Overall Study|Protocol Violation|1|||
19470252|NCT01766921|41741297|FG001|Overall Study|Protocol Violation|1|||
19470253|NCT01766921|41741296|FG000|Overall Study|Withdrawal by Subject|14|||
19470254|NCT01766921|41741297|FG001|Overall Study|Withdrawal by Subject|5|||
19470255|NCT01774799|41741315|FG000|Overall Study|Lost to Follow-up|1|||
19470256|NCT01774799|41741316|FG001|Overall Study|Lost to Follow-up|1|||
19470257|NCT01774799|41741317|FG002|Overall Study|Lost to Follow-up|0|||
19470258|NCT01774799|41741318|FG003|Overall Study|Lost to Follow-up|0|||
19470259|NCT01774253|41741324|FG000|Overall Study|Lack of Efficacy|4|||
19470260|NCT01774253|41741324|FG000|Overall Study|Physician Decision|2|||
19470261|NCT01774253|41741324|FG000|Overall Study|Withdrawal by Subject|2|||
19470262|NCT01774253|41741324|FG000|Overall Study|Death|1|||
19470263|NCT01765751|41741364|FG000|Overall Study|Lost to Follow-up|0|||
19470264|NCT01765751|41741365|FG001|Overall Study|Lost to Follow-up|2|||
19470265|NCT01765751|41741366|FG002|Overall Study|Lost to Follow-up|1|||
19470266|NCT01736657|41741386|FG000|Overall Study|insufficient vascular access|1|||
19470267|NCT01736579|41741401|FG000|Overall Study|Termination of Study by Sponsor|2|||
19470268|NCT01736579|41741402|FG001|Overall Study|Termination of Study by Sponsor|2|||
19470269|NCT01765673|41741433|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
19470270|NCT01764659|41741440|FG000|Overall Study|Death|1|||
19470271|NCT01764659|41741440|FG000|Overall Study|Physician Decision|1|||
19470272|NCT01736189|41741446|FG000|Overall Study|Violation of registration criteria|41|||
19470273|NCT01736189|41741446|FG000|Overall Study|Protocol Violation|4|||
19470274|NCT01736189|41741446|FG000|Overall Study|Criteria and protocol violations|1|||
19470275|NCT01735175|41741478|FG000|Overall Study|Withdrawal by Subject|9|||
19470276|NCT01735175|41741479|FG001|Overall Study|Withdrawal by Subject|2|||
19470277|NCT01735175|41741478|FG000|Overall Study|Lost to Follow-up|4|||
19470278|NCT01735175|41741479|FG001|Overall Study|Lost to Follow-up|2|||
19470279|NCT01735175|41741478|FG000|Overall Study|Death|3|||
19470280|NCT01735175|41741479|FG001|Overall Study|Death|2|||
19470281|NCT01735175|41741478|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
19470282|NCT01735175|41741479|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
19470283|NCT01762943|41741491|FG000|Overall Study|Physician Decision|1|||
19470284|NCT01762943|41741492|FG001|Overall Study|Physician Decision|1|||
19470285|NCT01762943|41741491|FG000|Overall Study|Protocol Violation|1|||
19470286|NCT01762943|41741492|FG001|Overall Study|Protocol Violation|0|||
19470287|NCT01762943|41741491|FG000|Overall Study|Withdrawal by Subject|2|||
19470288|NCT01762943|41741492|FG001|Overall Study|Withdrawal by Subject|1|||
19470289|NCT01734785|41741555|FG000|Open-Label Period|Adverse Event|0|||
19470290|NCT01734785|41741556|FG001|Open-Label Period|Adverse Event|0|||
19470291|NCT01734785|41741557|FG002|Open-Label Period|Adverse Event|0|||
19470292|NCT01734785|41741558|FG003|Open-Label Period|Adverse Event|9|||
19470293|NCT01734785|41741555|FG000|Open-Label Period|Lack of Efficacy|0|||
19470294|NCT01734785|41741556|FG001|Open-Label Period|Lack of Efficacy|0|||
19470295|NCT01734785|41741557|FG002|Open-Label Period|Lack of Efficacy|0|||
19470296|NCT01734785|41741558|FG003|Open-Label Period|Lack of Efficacy|1|||
19470297|NCT01734785|41741555|FG000|Open-Label Period|Protocol Violation|0|||
19470298|NCT01734785|41741556|FG001|Open-Label Period|Protocol Violation|0|||
19470299|NCT01734785|41741557|FG002|Open-Label Period|Protocol Violation|0|||
19470300|NCT01734785|41741558|FG003|Open-Label Period|Protocol Violation|13|||
19470301|NCT01734785|41741555|FG000|Open-Label Period|Lost to Follow-up|0|||
19553792|NCT01313117|42002707|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
19381820|NCT04032093|41624941|FG009|Overall Study|Other|1|||
19381821|NCT04032093|41624932|FG000|Overall Study|Withdrawal by Subject|1|||
19381822|NCT04032093|41624933|FG001|Overall Study|Withdrawal by Subject|3|||
19381823|NCT04032093|41624934|FG002|Overall Study|Withdrawal by Subject|2|||
19381824|NCT04032093|41624935|FG003|Overall Study|Withdrawal by Subject|2|||
19381825|NCT04032093|41624936|FG004|Overall Study|Withdrawal by Subject|3|||
19381826|NCT04032093|41624937|FG005|Overall Study|Withdrawal by Subject|0|||
19381827|NCT04032093|41624938|FG006|Overall Study|Withdrawal by Subject|0|||
19381828|NCT04032093|41624939|FG007|Overall Study|Withdrawal by Subject|0|||
19470302|NCT01734785|41741556|FG001|Open-Label Period|Lost to Follow-up|0|||
19470303|NCT01734785|41741557|FG002|Open-Label Period|Lost to Follow-up|0|||
19470304|NCT01734785|41741558|FG003|Open-Label Period|Lost to Follow-up|14|||
19470305|NCT01734785|41741555|FG000|Open-Label Period|Withdrawal by Subject|0|||
19470306|NCT01734785|41741556|FG001|Open-Label Period|Withdrawal by Subject|0|||
19470307|NCT01734785|41741557|FG002|Open-Label Period|Withdrawal by Subject|0|||
19470308|NCT01734785|41741558|FG003|Open-Label Period|Withdrawal by Subject|12|||
19470309|NCT01734785|41741555|FG000|Open-Label Period|Other Reasons|0|||
19470310|NCT01734785|41741556|FG001|Open-Label Period|Other Reasons|0|||
19470311|NCT01734785|41741557|FG002|Open-Label Period|Other Reasons|0|||
19470312|NCT01734785|41741558|FG003|Open-Label Period|Other Reasons|224|||
19470313|NCT01734785|41741555|FG000|Double-Blind Period|Adverse Event|0|||
19470314|NCT01734785|41741556|FG001|Double-Blind Period|Adverse Event|3|||
19470315|NCT01734785|41741557|FG002|Double-Blind Period|Adverse Event|2|||
19470316|NCT01734785|41741558|FG003|Double-Blind Period|Adverse Event|0|||
19470317|NCT01734785|41741555|FG000|Double-Blind Period|Lack of Efficacy|0|||
19470318|NCT01734785|41741556|FG001|Double-Blind Period|Lack of Efficacy|1|||
19381829|NCT04032093|41624940|FG008|Overall Study|Withdrawal by Subject|0|||
19470319|NCT01734785|41741557|FG002|Double-Blind Period|Lack of Efficacy|0|||
19470320|NCT01734785|41741558|FG003|Double-Blind Period|Lack of Efficacy|0|||
19470321|NCT01734785|41741555|FG000|Double-Blind Period|Protocol Violation|0|||
19381830|NCT04032093|41624941|FG009|Overall Study|Withdrawal by Subject|0|||
19470322|NCT01734785|41741556|FG001|Double-Blind Period|Protocol Violation|1|||
19553793|NCT01313117|42002707|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
19553794|NCT01313039|42002712|FG000|Overall Study|Physician Decision|1|||
19553795|NCT01313039|42002712|FG000|Overall Study|Adverse Event|1|||
19553796|NCT01091662|42002718|FG000|Overall Study|Adverse Event|1|||
19553797|NCT01091662|42002719|FG001|Overall Study|Adverse Event|9|||
19553798|NCT01091662|42002718|FG000|Overall Study|Physician Decision|1|||
19553799|NCT01091662|42002719|FG001|Overall Study|Physician Decision|1|||
19470323|NCT01734785|41741557|FG002|Double-Blind Period|Protocol Violation|1|||
19470324|NCT01734785|41741558|FG003|Double-Blind Period|Protocol Violation|0|||
19470325|NCT01734785|41741555|FG000|Double-Blind Period|Lost to Follow-up|2|||
19470326|NCT01734785|41741556|FG001|Double-Blind Period|Lost to Follow-up|4|||
19470327|NCT01734785|41741557|FG002|Double-Blind Period|Lost to Follow-up|2|||
19470328|NCT01734785|41741558|FG003|Double-Blind Period|Lost to Follow-up|0|||
19470329|NCT01734785|41741555|FG000|Double-Blind Period|Withdrawal by Subject|2|||
19470330|NCT01734785|41741556|FG001|Double-Blind Period|Withdrawal by Subject|0|||
19470331|NCT01734785|41741557|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19470332|NCT01734785|41741558|FG003|Double-Blind Period|Withdrawal by Subject|0|||
19470333|NCT01734785|41741555|FG000|Double-Blind Period|Not treated|1|||
19470334|NCT01734785|41741556|FG001|Double-Blind Period|Not treated|0|||
19470335|NCT01734785|41741557|FG002|Double-Blind Period|Not treated|0|||
19470336|NCT01734785|41741558|FG003|Double-Blind Period|Not treated|0|||
19470337|NCT01734395|41741567|FG000|Overall Study|Other|65|||
19470338|NCT01734395|41741567|FG000|Overall Study|Lost to Follow-up|287|||
19470339|NCT01734395|41741567|FG000|Overall Study|Lack of Efficacy|5|||
19470340|NCT01734395|41741567|FG000|Overall Study|Adverse Event|40|||
19470341|NCT01734395|41741567|FG000|Overall Study|Withdrawal by Subject|10|||
19470342|NCT01734395|41741567|FG000|Overall Study|Missing the reasons for not completed|3|||
19470343|NCT01597505|41741606|FG000|Overall Study|Physician Decision|5|||
19470344|NCT01597505|41741607|FG001|Overall Study|Physician Decision|0|||
19470345|NCT01597505|41741606|FG000|Overall Study|Adverse Event|19|||
19470346|NCT01597505|41741607|FG001|Overall Study|Adverse Event|7|||
19470347|NCT01597505|41741606|FG000|Overall Study|Lost to Follow-up|4|||
19470348|NCT01597505|41741607|FG001|Overall Study|Lost to Follow-up|2|||
19470349|NCT01597505|41741606|FG000|Overall Study|Withdrawal by Subject|10|||
19470350|NCT01597505|41741607|FG001|Overall Study|Withdrawal by Subject|18|||
19470351|NCT01597505|41741606|FG000|Overall Study|Other|5|||
19470352|NCT01597505|41741607|FG001|Overall Study|Other|6|||
19470353|NCT01597505|41741606|FG000|Overall Study|Missing|1|||
19470354|NCT01597505|41741607|FG001|Overall Study|Missing|0|||
19470355|NCT01760447|41741646|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
19470356|NCT01760447|41741647|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
19470357|NCT01760447|41741648|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
19470358|NCT01760447|41741649|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
19470359|NCT01760447|41741646|FG000|Weeks 0-20|Withdrawal by Subject|2|||
19470360|NCT01760447|41741647|FG001|Weeks 0-20|Withdrawal by Subject|0|||
19470361|NCT01760447|41741648|FG002|Weeks 0-20|Withdrawal by Subject|1|||
19470362|NCT01760447|41741649|FG003|Weeks 0-20|Withdrawal by Subject|0|||
19470363|NCT01760447|41741646|FG000|Weeks 0-20|Lost to Follow-up|1|||
19470364|NCT01760447|41741647|FG001|Weeks 0-20|Lost to Follow-up|0|||
19470365|NCT01760447|41741648|FG002|Weeks 0-20|Lost to Follow-up|1|||
19470366|NCT01760447|41741649|FG003|Weeks 0-20|Lost to Follow-up|1|||
19470367|NCT01760447|41741646|FG000|Weeks 0-20|Randomized but not treated|0|||
19470368|NCT01760447|41741647|FG001|Weeks 0-20|Randomized but not treated|0|||
19470369|NCT01760447|41741648|FG002|Weeks 0-20|Randomized but not treated|2|||
19470370|NCT01760447|41741649|FG003|Weeks 0-20|Randomized but not treated|0|||
19470371|NCT01760447|41741646|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
19470372|NCT01760447|41741647|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
19470373|NCT01760447|41741648|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
19470374|NCT01760447|41741649|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
19470375|NCT01760447|41741646|FG000|Weeks 20-54|Withdrawal by Subject|2|||
19470376|NCT01760447|41741647|FG001|Weeks 20-54|Withdrawal by Subject|1|||
19470377|NCT01760447|41741648|FG002|Weeks 20-54|Withdrawal by Subject|1|||
19470378|NCT01760447|41741649|FG003|Weeks 20-54|Withdrawal by Subject|2|||
19470379|NCT01760447|41741646|FG000|Weeks 20-54|Lost to Follow-up|0|||
19470380|NCT01760447|41741647|FG001|Weeks 20-54|Lost to Follow-up|0|||
19470381|NCT01760447|41741648|FG002|Weeks 20-54|Lost to Follow-up|1|||
19553800|NCT01091662|42002718|FG000|Overall Study|Withdrawal by Subject|7|||
19470382|NCT01760447|41741649|FG003|Weeks 20-54|Lost to Follow-up|2|||
19470383|NCT01732913|41741738|FG000|Overall Study|Study Terminated by Sponsor|105|||
19470384|NCT01732913|41741739|FG001|Overall Study|Study Terminated by Sponsor|55|||
19470385|NCT01732913|41741738|FG000|Overall Study|Withdrawal by Subject|27|||
19470386|NCT01732913|41741739|FG001|Overall Study|Withdrawal by Subject|4|||
19470387|NCT01732913|41741738|FG000|Overall Study|Physician Decision|14|||
19470388|NCT01732913|41741739|FG001|Overall Study|Physician Decision|7|||
19470389|NCT01732913|41741738|FG000|Overall Study|Other|7|||
19470390|NCT01732913|41741739|FG001|Overall Study|Other|1|||
19470391|NCT01732913|41741738|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
19470392|NCT01732913|41741739|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
19470393|NCT01732835|41741770|FG000|6-month Primary Endpoint|Did not receive device|19|||
19470394|NCT01732835|41741770|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
19470395|NCT01732835|41741770|FG000|6-month Primary Endpoint|Adverse Event|3|||
19470396|NCT01732835|41741770|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
19470397|NCT01732835|41741770|FG000|2-year Extended Follow-up|Adverse Event|3|||
19470398|NCT01732835|41741770|FG000|2-year Extended Follow-up|Death|1|||
19470399|NCT01759511|41741824|FG000|Overall Study|Adverse Event|4|||
19470400|NCT01759511|41741824|FG000|Overall Study|Death|2|||
19470401|NCT01759511|41741824|FG000|Overall Study|Lack of Efficacy|2|||
19470402|NCT01759511|41741824|FG000|Overall Study|Physician Decision|1|||
19470403|NCT01759511|41741824|FG000|Overall Study|Progressive Disease|5|||
19470404|NCT01759511|41741824|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
19470405|NCT01759511|41741824|FG000|Overall Study|Study Terminated by Sponsor|13|||
19470406|NCT01759511|41741824|FG000|Overall Study|Withdrawal by Subject|3|||
19470407|NCT01732757|41741842|FG000|Overall Study|Lost to Follow-up|1|||
19470408|NCT01732757|41741843|FG001|Overall Study|Lost to Follow-up|0|||
19470409|NCT01732757|41741844|FG002|Overall Study|Lost to Follow-up|0|||
19470410|NCT01758731|41741852|FG000|Overall Study|Physician Decision|1|||
19470411|NCT01606319|41741862|FG000|Overall Study|Lost to Follow-up|17|||
19470412|NCT01606319|41741863|FG001|Overall Study|Lost to Follow-up|14|||
19470413|NCT01606319|41741862|FG000|Overall Study|Withdrawal by Subject|9|||
19470414|NCT01606319|41741863|FG001|Overall Study|Withdrawal by Subject|12|||
19470415|NCT01606319|41741862|FG000|Overall Study|Physician Decision|1|||
19470416|NCT01606319|41741863|FG001|Overall Study|Physician Decision|2|||
19470417|NCT01606319|41741862|FG000|Overall Study|Lack of Efficacy|6|||
19470418|NCT01606319|41741863|FG001|Overall Study|Lack of Efficacy|8|||
19470419|NCT01606319|41741862|FG000|Overall Study|Adverse Event|1|||
19470420|NCT01606319|41741863|FG001|Overall Study|Adverse Event|4|||
19470421|NCT01757405|41741871|FG000|Overall Study|Lost to Follow-up|1|||
19470422|NCT01757405|41741872|FG001|Overall Study|Lost to Follow-up|1|||
19470423|NCT01757405|41741871|FG000|Overall Study|Withdrawal by Subject|0|||
19470424|NCT01757405|41741872|FG001|Overall Study|Withdrawal by Subject|1|||
19470425|NCT01455597|41741878|FG000|Overall Study|Adverse Event|7|||
19470426|NCT01455597|41741879|FG001|Overall Study|Adverse Event|0|||
19470427|NCT01455597|41741880|FG002|Overall Study|Adverse Event|5|||
19470428|NCT01455597|41741881|FG003|Overall Study|Adverse Event|1|||
19470429|NCT01455597|41741878|FG000|Overall Study|Lack of Efficacy|0|||
19470430|NCT01455597|41741879|FG001|Overall Study|Lack of Efficacy|1|||
19470431|NCT01455597|41741880|FG002|Overall Study|Lack of Efficacy|2|||
19470432|NCT01455597|41741881|FG003|Overall Study|Lack of Efficacy|0|||
19470433|NCT01455597|41741878|FG000|Overall Study|Lost to Follow-up|3|||
19470434|NCT01455597|41741879|FG001|Overall Study|Lost to Follow-up|0|||
19470435|NCT01455597|41741880|FG002|Overall Study|Lost to Follow-up|2|||
19470436|NCT01455597|41741881|FG003|Overall Study|Lost to Follow-up|1|||
19470437|NCT01455597|41741878|FG000|Overall Study|Withdrew Consent|6|||
19470438|NCT01455597|41741879|FG001|Overall Study|Withdrew Consent|5|||
19470439|NCT01455597|41741880|FG002|Overall Study|Withdrew Consent|8|||
19470440|NCT01455597|41741881|FG003|Overall Study|Withdrew Consent|5|||
19470441|NCT01455597|41741878|FG000|Overall Study|Reason not Specified|1|||
19470442|NCT01455597|41741879|FG001|Overall Study|Reason not Specified|2|||
19470443|NCT01455597|41741880|FG002|Overall Study|Reason not Specified|3|||
19470444|NCT01455597|41741881|FG003|Overall Study|Reason not Specified|3|||
19470445|NCT01757171|41741904|FG000|Overall Study|Adverse Event|5|||
19470446|NCT01757171|41741905|FG001|Overall Study|Adverse Event|1|||
19470447|NCT01757171|41741904|FG000|Overall Study|Disease Progression|1|||
19470448|NCT01757171|41741905|FG001|Overall Study|Disease Progression|0|||
19470449|NCT01757171|41741904|FG000|Overall Study|Hospitalization|1|||
19470450|NCT01757171|41741905|FG001|Overall Study|Hospitalization|0|||
19470451|NCT01757171|41741904|FG000|Overall Study|ECOG decline|1|||
19470452|NCT01757171|41741905|FG001|Overall Study|ECOG decline|0|||
19470453|NCT01756235|41741911|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
19470454|NCT01730729|41741915|FG000|Overall Study|Adverse Event|1|||
19470455|NCT01730729|41741915|FG000|Overall Study|Death|1|||
19470456|NCT01730729|41741915|FG000|Overall Study|Progressive Disease|12|||
19470457|NCT01756157|41741919|FG000|First Intervention Period|Withdrawal by Subject|1|||
19470458|NCT01756157|41741920|FG001|First Intervention Period|Withdrawal by Subject|0|||
19470459|NCT01756157|41741919|FG000|First Intervention Period|Lost to Follow-up|0|||
19470460|NCT01756157|41741920|FG001|First Intervention Period|Lost to Follow-up|2|||
19470461|NCT01756079|41741926|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
19470462|NCT01756079|41741926|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
19470463|NCT01756079|41741926|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
19470464|NCT01756079|41741926|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
19470465|NCT01756079|41741926|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
19470466|NCT04967885|41741933|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
19470467|NCT04967885|41741934|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
19470468|NCT04967885|41741933|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
19470469|NCT04967885|41741934|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
19470470|NCT04967885|41741933|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
19470471|NCT04967885|41741934|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
19470472|NCT04967885|41741933|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
19470473|NCT04967885|41741934|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
19470474|NCT04967885|41741933|FG000|EMI-II Intervention|Lost to Follow-up|14|||
19470475|NCT04967885|41741934|FG001|EMI-II Intervention|Lost to Follow-up|10|||
19470476|NCT04571060|41741951|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
19470477|NCT04571060|41741952|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
19470478|NCT04571060|41741951|FG000|Overall Study|Never treated migraine|47|||
19470479|NCT04571060|41741952|FG001|Overall Study|Never treated migraine|36|||
19470480|NCT04571060|41741951|FG000|Overall Study|Protocol Violation|4|||
19470481|NCT04571060|41741952|FG001|Overall Study|Protocol Violation|2|||
19470482|NCT04571060|41741951|FG000|Overall Study|Withdrawal by Subject|6|||
19470483|NCT04571060|41741952|FG001|Overall Study|Withdrawal by Subject|2|||
19470484|NCT04571060|41741951|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
19470485|NCT04571060|41741952|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
19470486|NCT04426318|41741960|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
19470487|NCT04426318|41741961|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
19470488|NCT04356963|41741976|FG000|First Session|Withdrawal by Subject|1|||
19470489|NCT04356963|41741976|FG000|Second Session|Withdrawal by Subject|3|||
19470490|NCT04356963|41741976|FG000|Second Session|Lost to Follow-up|1|||
19470491|NCT04356963|41741976|FG000|Third Session|Lost to Follow-up|6|||
19470492|NCT04356963|41741976|FG000|Third Session|Withdrawal by Subject|1|||
19470493|NCT04184622|41741990|FG000|Overall Study|Adverse Event|7|||
19470494|NCT04184622|41741991|FG001|Overall Study|Adverse Event|7|||
19470495|NCT04184622|41741992|FG002|Overall Study|Adverse Event|11|||
19470496|NCT04184622|41741993|FG003|Overall Study|Adverse Event|8|||
19470497|NCT04184622|41741990|FG000|Overall Study|Death|4|||
19470498|NCT04184622|41741991|FG001|Overall Study|Death|4|||
19470499|NCT04184622|41741992|FG002|Overall Study|Death|2|||
19470500|NCT04184622|41741993|FG003|Overall Study|Death|1|||
19381831|NCT04032093|41624932|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19639174|NCT00717236|42088570|FG001|Open-Label Period|Other: Moved|0|||
19639175|NCT00717236|42088569|FG000|Open-Label Period|Other: Investigator Decision|1|||
19470501|NCT04184622|41741990|FG000|Overall Study|Lost to Follow-up|41|||
19470502|NCT04184622|41741991|FG001|Overall Study|Lost to Follow-up|19|||
19470503|NCT04184622|41741992|FG002|Overall Study|Lost to Follow-up|20|||
19470504|NCT04184622|41741993|FG003|Overall Study|Lost to Follow-up|15|||
19470505|NCT04184622|41741990|FG000|Overall Study|Missing Weight at Week 72|1|||
19639176|NCT00717236|42088570|FG001|Open-Label Period|Other: Investigator Decision|0|||
19470506|NCT04184622|41741991|FG001|Overall Study|Missing Weight at Week 72|0|||
19639177|NCT00717236|42088569|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
19639178|NCT00717236|42088570|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
19639179|NCT00717236|42088569|FG000|Open-Label Period|Other: Sponsor Request|3|||
19639180|NCT00717236|42088570|FG001|Open-Label Period|Other: Sponsor Request|0|||
19639181|NCT00717236|42088569|FG000|Open-Label Period|Other: Cataract Surgery|1|||
19639182|NCT00717236|42088570|FG001|Open-Label Period|Other: Cataract Surgery|0|||
19639183|NCT00717236|42088569|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
19470507|NCT04184622|41741992|FG002|Overall Study|Missing Weight at Week 72|1|||
19470508|NCT04184622|41741993|FG003|Overall Study|Missing Weight at Week 72|0|||
19470509|NCT04184622|41741990|FG000|Overall Study|Other - as reported by the investigator|22|||
19470510|NCT04184622|41741991|FG001|Overall Study|Other - as reported by the investigator|7|||
19470511|NCT04184622|41741992|FG002|Overall Study|Other - as reported by the investigator|5|||
19470512|NCT04184622|41741993|FG003|Overall Study|Other - as reported by the investigator|12|||
19470513|NCT04184622|41741990|FG000|Overall Study|Physician Decision|0|||
19470514|NCT04184622|41741991|FG001|Overall Study|Physician Decision|0|||
19470515|NCT04184622|41741992|FG002|Overall Study|Physician Decision|3|||
19470516|NCT04184622|41741993|FG003|Overall Study|Physician Decision|1|||
19470517|NCT04184622|41741990|FG000|Overall Study|Pregnancy|4|||
19470518|NCT04184622|41741991|FG001|Overall Study|Pregnancy|4|||
19470519|NCT04184622|41741992|FG002|Overall Study|Pregnancy|3|||
19470520|NCT04184622|41741993|FG003|Overall Study|Pregnancy|5|||
19470521|NCT04184622|41741990|FG000|Overall Study|Protocol Deviation|1|||
19470522|NCT04184622|41741991|FG001|Overall Study|Protocol Deviation|0|||
19470523|NCT04184622|41741992|FG002|Overall Study|Protocol Deviation|0|||
19470524|NCT04184622|41741993|FG003|Overall Study|Protocol Deviation|0|||
19470525|NCT04184622|41741990|FG000|Overall Study|Withdrawal by Subject|68|||
19470526|NCT04184622|41741991|FG001|Overall Study|Withdrawal by Subject|28|||
19470527|NCT04184622|41741992|FG002|Overall Study|Withdrawal by Subject|29|||
19470528|NCT04184622|41741993|FG003|Overall Study|Withdrawal by Subject|22|||
19470529|NCT03941483|41742011|FG000|Overall Study|Miscellaneous|2|||
19470530|NCT03941483|41742012|FG001|Overall Study|Miscellaneous|3|||
19470531|NCT03941483|41742013|FG002|Overall Study|Miscellaneous|0|||
19470532|NCT03941483|41742011|FG000|Overall Study|Study Terminated by Sponsor|1|||
19470533|NCT03941483|41742012|FG001|Overall Study|Study Terminated by Sponsor|0|||
19470534|NCT03941483|41742013|FG002|Overall Study|Study Terminated by Sponsor|0|||
19470535|NCT03941483|41742011|FG000|Overall Study|Withdrawal by Subject|1|||
19470536|NCT03941483|41742012|FG001|Overall Study|Withdrawal by Subject|4|||
19470537|NCT03941483|41742013|FG002|Overall Study|Withdrawal by Subject|1|||
19470538|NCT03941483|41742011|FG000|Overall Study|Lost to Follow-up|2|||
19470539|NCT03941483|41742012|FG001|Overall Study|Lost to Follow-up|1|||
19470540|NCT03941483|41742013|FG002|Overall Study|Lost to Follow-up|8|||
19470541|NCT03941483|41742011|FG000|Overall Study|Death|3|||
19470542|NCT03941483|41742012|FG001|Overall Study|Death|2|||
19470543|NCT03941483|41742013|FG002|Overall Study|Death|6|||
19470544|NCT03689855|41742049|FG000|Overall Study|Adverse Event|3|||
19470545|NCT03689855|41742049|FG000|Overall Study|Withdrawal by Subject|1|||
19470546|NCT03635996|41742053|FG000|Overall Study|Study terminated by Sponsor|94|||
19470547|NCT03635996|41742053|FG000|Overall Study|Withdrawal by Subject|20|||
19470548|NCT03635996|41742053|FG000|Overall Study|Ablation|26|||
19470549|NCT03635996|41742053|FG000|Overall Study|Adverse Event|7|||
19470550|NCT03635996|41742053|FG000|Overall Study|Physician Decision|3|||
19470551|NCT03635996|41742053|FG000|Overall Study|Prohibited medication|5|||
19470552|NCT03635996|41742053|FG000|Overall Study|Did not meet eligibility criteria|5|||
19470553|NCT03635996|41742053|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
19470554|NCT03635996|41742053|FG000|Overall Study|Protocol Violation|1|||
19470555|NCT03635996|41742053|FG000|Overall Study|Lost to Follow-up|1|||
19470556|NCT03595878|41742060|FG000|Overall Study|Death|2|||
19470557|NCT03595878|41742061|FG001|Overall Study|Death|1|||
19470558|NCT03595878|41742062|FG002|Overall Study|Death|0|||
19470559|NCT03595878|41742060|FG000|Overall Study|Disease progression|2|||
19470560|NCT03595878|41742061|FG001|Overall Study|Disease progression|1|||
19470561|NCT03595878|41742062|FG002|Overall Study|Disease progression|2|||
19470562|NCT03168464|41742108|FG000|Overall Study|Death|9|||
19470563|NCT03168464|41742108|FG000|Overall Study|Progression of disease|6|||
19470564|NCT02985957|41742119|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19470565|NCT02985957|41742120|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19470566|NCT02985957|41742121|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19639184|NCT00717236|42088570|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
19470567|NCT02985957|41742122|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19470568|NCT02985957|41742123|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19470569|NCT02985957|41742124|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19470570|NCT02985957|41742125|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19470571|NCT02985957|41742119|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
19639185|NCT00717236|42088569|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
19470572|NCT02985957|41742120|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
19470573|NCT02985957|41742121|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
19470574|NCT02985957|41742122|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
19470575|NCT02985957|41742123|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
19470576|NCT02985957|41742124|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
19470577|NCT02985957|41742125|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
19470578|NCT02985957|41742119|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470579|NCT02985957|41742120|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470580|NCT02985957|41742121|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470581|NCT02985957|41742122|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470582|NCT02985957|41742123|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470583|NCT02985957|41742124|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19470584|NCT02985957|41742125|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
19470585|NCT02985957|41742119|FG000|Treatment Period|Death|0|||
19470586|NCT02985957|41742120|FG001|Treatment Period|Death|0|||
19470587|NCT02985957|41742121|FG002|Treatment Period|Death|0|||
19470588|NCT02985957|41742122|FG003|Treatment Period|Death|0|||
19470589|NCT02985957|41742123|FG004|Treatment Period|Death|1|||
19470590|NCT02985957|41742124|FG005|Treatment Period|Death|0|||
19470591|NCT02985957|41742125|FG006|Treatment Period|Death|0|||
19470592|NCT02985957|41742119|FG000|Treatment Period|Participant withdrew consent|0|||
19470593|NCT02985957|41742120|FG001|Treatment Period|Participant withdrew consent|0|||
19470594|NCT02985957|41742121|FG002|Treatment Period|Participant withdrew consent|0|||
19470595|NCT02985957|41742122|FG003|Treatment Period|Participant withdrew consent|1|||
19470596|NCT02985957|41742123|FG004|Treatment Period|Participant withdrew consent|3|||
19470597|NCT02985957|41742124|FG005|Treatment Period|Participant withdrew consent|0|||
19470598|NCT02985957|41742125|FG006|Treatment Period|Participant withdrew consent|1|||
19470599|NCT02985957|41742119|FG000|Treatment Period|Lost to Follow-up|0|||
19639186|NCT00717236|42088570|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
19639187|NCT00717236|42088569|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
19470600|NCT02985957|41742120|FG001|Treatment Period|Lost to Follow-up|0|||
19470601|NCT02985957|41742121|FG002|Treatment Period|Lost to Follow-up|0|||
19470602|NCT02985957|41742122|FG003|Treatment Period|Lost to Follow-up|0|||
19470603|NCT02985957|41742123|FG004|Treatment Period|Lost to Follow-up|1|||
19470604|NCT02985957|41742124|FG005|Treatment Period|Lost to Follow-up|0|||
19470605|NCT02985957|41742125|FG006|Treatment Period|Lost to Follow-up|0|||
19470606|NCT02985957|41742119|FG000|Treatment Period|Other reasons|0|||
19470607|NCT02985957|41742120|FG001|Treatment Period|Other reasons|0|||
19470608|NCT02985957|41742121|FG002|Treatment Period|Other reasons|1|||
19470609|NCT02985957|41742122|FG003|Treatment Period|Other reasons|3|||
19470610|NCT02985957|41742123|FG004|Treatment Period|Other reasons|6|||
19470611|NCT02985957|41742124|FG005|Treatment Period|Other reasons|0|||
19470612|NCT02985957|41742125|FG006|Treatment Period|Other reasons|1|||
19470613|NCT02985957|41742119|FG000|Treatment Period|Not reported|0|||
19470614|NCT02985957|41742120|FG001|Treatment Period|Not reported|1|||
19470615|NCT02985957|41742121|FG002|Treatment Period|Not reported|2|||
19470616|NCT02985957|41742122|FG003|Treatment Period|Not reported|5|||
19470617|NCT02985957|41742123|FG004|Treatment Period|Not reported|0|||
19470618|NCT02985957|41742124|FG005|Treatment Period|Not reported|0|||
19470619|NCT02985957|41742125|FG006|Treatment Period|Not reported|0|||
19470620|NCT02985957|41742119|FG000|Treatment Period|Maximum clinical benefit|0|||
19470621|NCT02985957|41742120|FG001|Treatment Period|Maximum clinical benefit|0|||
19470622|NCT02985957|41742121|FG002|Treatment Period|Maximum clinical benefit|1|||
19470623|NCT02985957|41742122|FG003|Treatment Period|Maximum clinical benefit|1|||
19470624|NCT02985957|41742123|FG004|Treatment Period|Maximum clinical benefit|0|||
19470625|NCT02985957|41742124|FG005|Treatment Period|Maximum clinical benefit|0|||
19470626|NCT02985957|41742125|FG006|Treatment Period|Maximum clinical benefit|2|||
19470627|NCT02985957|41742119|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
19470628|NCT02985957|41742120|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
19470629|NCT02985957|41742121|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
19470630|NCT02985957|41742122|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
19470631|NCT02985957|41742123|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
19470632|NCT02985957|41742124|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
19470633|NCT02985957|41742125|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
19470634|NCT02985957|41742119|FG000|Treatment Period|Study drug toxicity|1|||
19470635|NCT02985957|41742120|FG001|Treatment Period|Study drug toxicity|23|||
19470636|NCT02985957|41742121|FG002|Treatment Period|Study drug toxicity|20|||
19470637|NCT02985957|41742122|FG003|Treatment Period|Study drug toxicity|11|||
19470638|NCT02985957|41742123|FG004|Treatment Period|Study drug toxicity|19|||
19470639|NCT02985957|41742124|FG005|Treatment Period|Study drug toxicity|3|||
19470640|NCT02985957|41742125|FG006|Treatment Period|Study drug toxicity|5|||
19470641|NCT02985957|41742119|FG000|Treatment Period|Disease progression|0|||
19470642|NCT02985957|41742120|FG001|Treatment Period|Disease progression|16|||
19470643|NCT02985957|41742121|FG002|Treatment Period|Disease progression|20|||
19470644|NCT02985957|41742122|FG003|Treatment Period|Disease progression|39|||
19470645|NCT02985957|41742123|FG004|Treatment Period|Disease progression|29|||
19470646|NCT02985957|41742124|FG005|Treatment Period|Disease progression|11|||
19470647|NCT02985957|41742125|FG006|Treatment Period|Disease progression|28|||
19470648|NCT02985957|41742119|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
19470649|NCT02985957|41742120|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
19470650|NCT02985957|41742121|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
19470651|NCT02985957|41742122|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
19470652|NCT02985957|41742123|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
19470653|NCT02985957|41742124|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
19470654|NCT02985957|41742125|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
19470655|NCT02985957|41742119|FG000|Treatment Period|Poor/Non-Compliance|0|||
19470656|NCT02985957|41742120|FG001|Treatment Period|Poor/Non-Compliance|0|||
19470657|NCT02985957|41742121|FG002|Treatment Period|Poor/Non-Compliance|0|||
19470658|NCT02985957|41742122|FG003|Treatment Period|Poor/Non-Compliance|0|||
19470659|NCT02985957|41742123|FG004|Treatment Period|Poor/Non-Compliance|1|||
19470660|NCT02985957|41742124|FG005|Treatment Period|Poor/Non-Compliance|1|||
19470661|NCT02985957|41742125|FG006|Treatment Period|Poor/Non-Compliance|0|||
19470662|NCT02985957|41742119|FG000|Treatment Period|Continuing in Treatment Period|0|||
19470663|NCT02985957|41742120|FG001|Treatment Period|Continuing in Treatment Period|1|||
19470664|NCT02985957|41742121|FG002|Treatment Period|Continuing in Treatment Period|0|||
19470665|NCT02985957|41742122|FG003|Treatment Period|Continuing in Treatment Period|4|||
19470666|NCT02985957|41742123|FG004|Treatment Period|Continuing in Treatment Period|4|||
19470667|NCT02985957|41742124|FG005|Treatment Period|Continuing in Treatment Period|0|||
19470668|NCT02985957|41742125|FG006|Treatment Period|Continuing in Treatment Period|0|||
19470669|NCT02818920|41742147|FG000|Overall Study|Unresectable|4|||
19470670|NCT02818920|41742147|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
19470671|NCT02818920|41742147|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
19470672|NCT02818920|41742147|FG000|Overall Study|Adverse Event|3|||
19470673|NCT02818920|41742147|FG000|Overall Study|Developed Other Disease|1|||
19470674|NCT02818920|41742147|FG000|Overall Study|Refused Further Treatment|1|||
19470675|NCT01909453|41742178|FG000|Overall Study|Ongoing|118|||
19470676|NCT01909453|41742179|FG001|Overall Study|Ongoing|103|||
19470677|NCT01909453|41742180|FG002|Overall Study|Ongoing|83|||
19470678|NCT01909453|41742181|FG003|Overall Study|Ongoing|164|||
19470679|NCT01909453|41742182|FG004|Overall Study|Ongoing|50|||
19470680|NCT01909453|41742178|FG000|Overall Study|Death|69|||
19470681|NCT01909453|41742179|FG001|Overall Study|Death|74|||
19470682|NCT01909453|41742180|FG002|Overall Study|Death|88|||
19470683|NCT01909453|41742181|FG003|Overall Study|Death|86|||
19470684|NCT01909453|41742182|FG004|Overall Study|Death|29|||
19470685|NCT01909453|41742178|FG000|Overall Study|Lost to Follow-up|3|||
19470686|NCT01909453|41742179|FG001|Overall Study|Lost to Follow-up|4|||
19470687|NCT01909453|41742180|FG002|Overall Study|Lost to Follow-up|4|||
19470688|NCT01909453|41742181|FG003|Overall Study|Lost to Follow-up|3|||
19470689|NCT01909453|41742182|FG004|Overall Study|Lost to Follow-up|3|||
19470690|NCT01909453|41742178|FG000|Overall Study|Withdrawal by Subject|2|||
19470691|NCT01909453|41742179|FG001|Overall Study|Withdrawal by Subject|13|||
19470692|NCT01909453|41742180|FG002|Overall Study|Withdrawal by Subject|16|||
19470693|NCT01909453|41742181|FG003|Overall Study|Withdrawal by Subject|5|||
19470694|NCT01909453|41742182|FG004|Overall Study|Withdrawal by Subject|4|||
19470695|NCT01454401|41742200|FG000|Overall Study|Death|1|||
19470696|NCT01454401|41742200|FG000|Overall Study|hospitalised|1|||
19470697|NCT01454401|41742200|FG000|Overall Study|osteomyelitis|2|||
19470698|NCT01454401|41742200|FG000|Overall Study|non-adherence|1|||
19470699|NCT01344018|41742206|FG000|Overall Study|Death|22|||
19470700|NCT01344018|41742207|FG001|Overall Study|Death|25|||
19470701|NCT01344018|41742206|FG000|Overall Study|Lost to Follow-up|4|||
19470702|NCT01344018|41742207|FG001|Overall Study|Lost to Follow-up|7|||
19470703|NCT01320085|41742216|FG000|Overall Study|Treatment Ongoing|0|||
19470704|NCT01320085|41742217|FG001|Overall Study|Treatment Ongoing|13|||
19470705|NCT01320085|41742218|FG002|Overall Study|Treatment Ongoing|2|||
19470706|NCT01320085|41742216|FG000|Overall Study|Disease Progression|26|||
19470707|NCT01320085|41742217|FG001|Overall Study|Disease Progression|86|||
19470708|NCT01320085|41742218|FG002|Overall Study|Disease Progression|16|||
19470709|NCT01320085|41742216|FG000|Overall Study|Adverse Event|12|||
19470710|NCT01320085|41742217|FG001|Overall Study|Adverse Event|14|||
19470711|NCT01320085|41742218|FG002|Overall Study|Adverse Event|5|||
19470712|NCT01320085|41742216|FG000|Overall Study|Withdrawal by Subject|2|||
19470713|NCT01320085|41742217|FG001|Overall Study|Withdrawal by Subject|4|||
19470714|NCT01320085|41742218|FG002|Overall Study|Withdrawal by Subject|1|||
19470715|NCT01320085|41742216|FG000|Overall Study|Protocol Deviation|1|||
19470716|NCT01320085|41742217|FG001|Overall Study|Protocol Deviation|0|||
19470717|NCT01320085|41742218|FG002|Overall Study|Protocol Deviation|1|||
19478103|NCT01693562|41757326|FG012|Expansion Phase|Withdrawal by Subject|3|||
19478104|NCT01693562|41757327|FG013|Expansion Phase|Withdrawal by Subject|5|||
19478105|NCT01693562|41757328|FG014|Expansion Phase|Withdrawal by Subject|16|||
19478106|NCT01693562|41757329|FG015|Expansion Phase|Withdrawal by Subject|7|||
19478107|NCT01693562|41757330|FG016|Expansion Phase|Withdrawal by Subject|40|||
19478108|NCT01693562|41757331|FG017|Expansion Phase|Withdrawal by Subject|4|||
19478109|NCT01693562|41757332|FG018|Expansion Phase|Withdrawal by Subject|8|||
19478110|NCT01693562|41757333|FG019|Expansion Phase|Withdrawal by Subject|3|||
19478111|NCT01693562|41757334|FG020|Expansion Phase|Withdrawal by Subject|1|||
19478112|NCT01693562|41757335|FG021|Expansion Phase|Withdrawal by Subject|8|||
19478113|NCT01693562|41757336|FG022|Expansion Phase|Withdrawal by Subject|1|||
19478114|NCT01693562|41757314|FG000|Expansion Phase|Death|0|||
19478115|NCT01693562|41757315|FG001|Expansion Phase|Death|0|||
19478116|NCT01693562|41757316|FG002|Expansion Phase|Death|0|||
19478117|NCT01693562|41757317|FG003|Expansion Phase|Death|0|||
19478118|NCT01693562|41757318|FG004|Expansion Phase|Death|0|||
19478119|NCT01693562|41757319|FG005|Expansion Phase|Death|0|||
19478120|NCT01693562|41757320|FG006|Expansion Phase|Death|0|||
19478121|NCT01693562|41757321|FG007|Expansion Phase|Death|42|||
19478122|NCT01693562|41757322|FG008|Expansion Phase|Death|17|||
19478123|NCT01693562|41757323|FG009|Expansion Phase|Death|208|||
19478124|NCT01693562|41757324|FG010|Expansion Phase|Death|30|||
19478125|NCT01693562|41757325|FG011|Expansion Phase|Death|8|||
19478126|NCT01693562|41757326|FG012|Expansion Phase|Death|19|||
19478127|NCT01693562|41757327|FG013|Expansion Phase|Death|42|||
19478128|NCT01693562|41757328|FG014|Expansion Phase|Death|23|||
19478129|NCT01693562|41757329|FG015|Expansion Phase|Death|23|||
19478130|NCT01693562|41757330|FG016|Expansion Phase|Death|128|||
19478131|NCT01693562|41757331|FG017|Expansion Phase|Death|16|||
19478132|NCT01693562|41757332|FG018|Expansion Phase|Death|36|||
19478133|NCT01693562|41757333|FG019|Expansion Phase|Death|16|||
19478134|NCT01693562|41757334|FG020|Expansion Phase|Death|17|||
19553801|NCT01091662|42002719|FG001|Overall Study|Withdrawal by Subject|6|||
19553802|NCT01091662|42002718|FG000|Overall Study|met exit criteria|7|||
19553803|NCT01091662|42002719|FG001|Overall Study|met exit criteria|13|||
19553804|NCT01091662|42002718|FG000|Overall Study|met exclusion criteria|1|||
19478135|NCT01693562|41757335|FG021|Expansion Phase|Death|35|||
19478136|NCT01693562|41757336|FG022|Expansion Phase|Death|7|||
19478137|NCT01693562|41757314|FG000|Expansion Phase|Lost to Follow-up|0|||
19478138|NCT01693562|41757315|FG001|Expansion Phase|Lost to Follow-up|0|||
19478139|NCT01693562|41757316|FG002|Expansion Phase|Lost to Follow-up|0|||
19478140|NCT01693562|41757317|FG003|Expansion Phase|Lost to Follow-up|0|||
19478141|NCT01693562|41757318|FG004|Expansion Phase|Lost to Follow-up|0|||
19478142|NCT01693562|41757319|FG005|Expansion Phase|Lost to Follow-up|0|||
19478143|NCT01693562|41757320|FG006|Expansion Phase|Lost to Follow-up|0|||
19478144|NCT01693562|41757321|FG007|Expansion Phase|Lost to Follow-up|1|||
19478145|NCT01693562|41757322|FG008|Expansion Phase|Lost to Follow-up|2|||
19478146|NCT01693562|41757323|FG009|Expansion Phase|Lost to Follow-up|10|||
19478147|NCT01693562|41757324|FG010|Expansion Phase|Lost to Follow-up|4|||
19478148|NCT01693562|41757325|FG011|Expansion Phase|Lost to Follow-up|4|||
19478149|NCT01693562|41757326|FG012|Expansion Phase|Lost to Follow-up|1|||
19478150|NCT01693562|41757327|FG013|Expansion Phase|Lost to Follow-up|3|||
19478151|NCT01693562|41757328|FG014|Expansion Phase|Lost to Follow-up|0|||
19478152|NCT01693562|41757329|FG015|Expansion Phase|Lost to Follow-up|1|||
19553805|NCT01091662|42002719|FG001|Overall Study|met exclusion criteria|0|||
19478153|NCT01693562|41757330|FG016|Expansion Phase|Lost to Follow-up|1|||
19478154|NCT01693562|41757331|FG017|Expansion Phase|Lost to Follow-up|0|||
19478155|NCT01693562|41757332|FG018|Expansion Phase|Lost to Follow-up|2|||
19478156|NCT01693562|41757333|FG019|Expansion Phase|Lost to Follow-up|1|||
19478157|NCT01693562|41757334|FG020|Expansion Phase|Lost to Follow-up|2|||
19478158|NCT01693562|41757335|FG021|Expansion Phase|Lost to Follow-up|2|||
19478159|NCT01693562|41757336|FG022|Expansion Phase|Lost to Follow-up|1|||
19478160|NCT01693562|41757314|FG000|Expansion Phase|Other|0|||
19478161|NCT01693562|41757315|FG001|Expansion Phase|Other|0|||
19478162|NCT01693562|41757316|FG002|Expansion Phase|Other|0|||
19478163|NCT01693562|41757317|FG003|Expansion Phase|Other|0|||
19478164|NCT01693562|41757318|FG004|Expansion Phase|Other|0|||
19470718|NCT01755767|41742253|FG000|Overall Study|Progressive Disease|8|||
19470719|NCT01755767|41742254|FG001|Overall Study|Progressive Disease|7|||
19470720|NCT01755767|41742255|FG002|Overall Study|Progressive Disease|91|||
19470721|NCT01755767|41742256|FG003|Overall Study|Progressive Disease|43|||
19470722|NCT01755767|41742253|FG000|Overall Study|Clinical Disease Progression|4|||
19470723|NCT01755767|41742254|FG001|Overall Study|Clinical Disease Progression|2|||
19470724|NCT01755767|41742255|FG002|Overall Study|Clinical Disease Progression|29|||
19470725|NCT01755767|41742256|FG003|Overall Study|Clinical Disease Progression|20|||
19470726|NCT01755767|41742253|FG000|Overall Study|Radiographic Disease Progression|9|||
19470727|NCT01755767|41742254|FG001|Overall Study|Radiographic Disease Progression|4|||
19470728|NCT01755767|41742255|FG002|Overall Study|Radiographic Disease Progression|44|||
19470729|NCT01755767|41742256|FG003|Overall Study|Radiographic Disease Progression|27|||
19470730|NCT01755767|41742253|FG000|Overall Study|Adverse Event|6|||
19470731|NCT01755767|41742254|FG001|Overall Study|Adverse Event|0|||
19470732|NCT01755767|41742255|FG002|Overall Study|Adverse Event|28|||
19470733|NCT01755767|41742256|FG003|Overall Study|Adverse Event|11|||
19470734|NCT01755767|41742253|FG000|Overall Study|Death|1|||
19470735|NCT01755767|41742254|FG001|Overall Study|Death|2|||
19470736|NCT01755767|41742255|FG002|Overall Study|Death|15|||
19470737|NCT01755767|41742256|FG003|Overall Study|Death|4|||
19470738|NCT01755767|41742253|FG000|Overall Study|Subject Decision|0|||
19470739|NCT01755767|41742254|FG001|Overall Study|Subject Decision|0|||
19470740|NCT01755767|41742255|FG002|Overall Study|Subject Decision|10|||
19553806|NCT01091662|42002718|FG000|Overall Study|Lost to Follow-up|0|||
19553807|NCT01091662|42002719|FG001|Overall Study|Lost to Follow-up|1|||
19553808|NCT01091662|42002718|FG000|Overall Study|Pregnancy|0|||
19553809|NCT01091662|42002719|FG001|Overall Study|Pregnancy|1|||
19553810|NCT01091662|42002718|FG000|Overall Study|Protocol Violation|0|||
19553811|NCT01091662|42002719|FG001|Overall Study|Protocol Violation|2|||
19470741|NCT01755767|41742256|FG003|Overall Study|Subject Decision|3|||
19553812|NCT01091662|42002718|FG000|Overall Study|unable to swallow capsule|0|||
19553813|NCT01091662|42002719|FG001|Overall Study|unable to swallow capsule|1|||
19553814|NCT01312961|42002732|FG000|Overall Study|Adverse Event|3|||
19553815|NCT01312961|42002733|FG001|Overall Study|Adverse Event|3|||
19553816|NCT01312961|42002732|FG000|Overall Study|Lack of Efficacy|11|||
19553817|NCT01312961|42002733|FG001|Overall Study|Lack of Efficacy|1|||
19553818|NCT01312961|42002732|FG000|Overall Study|Poor compliance to protocol|1|||
19553819|NCT01312961|42002733|FG001|Overall Study|Poor compliance to protocol|0|||
19470742|NCT01755767|41742253|FG000|Overall Study|Withdrawal by Subject|0|||
19470743|NCT01755767|41742254|FG001|Overall Study|Withdrawal by Subject|0|||
19470744|NCT01755767|41742255|FG002|Overall Study|Withdrawal by Subject|2|||
19553820|NCT01312961|42002732|FG000|Overall Study|Other than specified above|2|||
19553821|NCT01312961|42002733|FG001|Overall Study|Other than specified above|3|||
19553822|NCT01311557|42002742|FG000|Overall Study|Serious adverse event|0|||
19553823|NCT01311557|42002743|FG001|Overall Study|Serious adverse event|1|||
19553824|NCT01311557|42002742|FG000|Overall Study|Protocol Violation|4|||
19553825|NCT01311557|42002743|FG001|Overall Study|Protocol Violation|2|||
19470745|NCT01755767|41742256|FG003|Overall Study|Withdrawal by Subject|1|||
19470746|NCT01755767|41742253|FG000|Overall Study|Other|0|||
19470747|NCT01755767|41742254|FG001|Overall Study|Other|0|||
19470748|NCT01755767|41742255|FG002|Overall Study|Other|2|||
19470749|NCT01755767|41742256|FG003|Overall Study|Other|3|||
19470750|NCT01755767|41742253|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
19470751|NCT01755767|41742254|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
19470752|NCT01755767|41742255|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
19470753|NCT01755767|41742256|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
19470754|NCT01730339|41742352|FG000|Overall Study|Withdrawal by Subject|3|||
19470755|NCT01730339|41742353|FG001|Overall Study|Withdrawal by Subject|2|||
19470756|NCT01730339|41742352|FG000|Overall Study|Lost to Follow-up|1|||
19470757|NCT01730339|41742353|FG001|Overall Study|Lost to Follow-up|1|||
19470758|NCT01730339|41742352|FG000|Overall Study|Un-specified|1|||
19470759|NCT01730339|41742353|FG001|Overall Study|Un-specified|0|||
19470760|NCT01754753|41742410|FG000|Overall Study|Study close|43|||
19470761|NCT01754753|41742411|FG001|Overall Study|Study close|44|||
19470762|NCT01754753|41742410|FG000|Overall Study|Lost to Follow-up|9|||
19470763|NCT01754753|41742411|FG001|Overall Study|Lost to Follow-up|5|||
19470764|NCT01729871|41742419|FG000|Overall Study|Adverse Event|7|||
19470765|NCT01729871|41742420|FG001|Overall Study|Adverse Event|7|||
19470766|NCT01729871|41742419|FG000|Overall Study|Death|0|||
19470767|NCT01729871|41742420|FG001|Overall Study|Death|1|||
19470768|NCT01729871|41742419|FG000|Overall Study|Lack of Efficacy|0|||
19470769|NCT01729871|41742420|FG001|Overall Study|Lack of Efficacy|1|||
19470770|NCT01729871|41742419|FG000|Overall Study|Physician Decision|0|||
19470771|NCT01729871|41742420|FG001|Overall Study|Physician Decision|2|||
19470772|NCT01729871|41742419|FG000|Overall Study|Protocol Violation|1|||
19470773|NCT01729871|41742420|FG001|Overall Study|Protocol Violation|0|||
19470774|NCT01729871|41742419|FG000|Overall Study|Withdrawal by Subject|0|||
19470775|NCT01729871|41742420|FG001|Overall Study|Withdrawal by Subject|3|||
19470776|NCT01729871|41742419|FG000|Overall Study|Other|4|||
19470777|NCT01729871|41742420|FG001|Overall Study|Other|9|||
19470778|NCT01729559|41742428|FG000|Overall Study|Protocol Violation|31|||
19470779|NCT01729559|41742429|FG001|Overall Study|Protocol Violation|28|||
19470780|NCT01728779|41742448|FG000|Overall Study|Withdrawal by Subject|1|||
19470781|NCT01728623|41742459|FG000|Overall Study|Disease progression|26|||
19470782|NCT01728623|41742459|FG000|Overall Study|Adverse Event|1|||
19470783|NCT01728623|41742459|FG000|Overall Study|Withdrawal by Subject|1|||
19470784|NCT01754129|41742466|FG000|Overall Study|Death|13|||
19470785|NCT01754129|41742466|FG000|Overall Study|Duodopa discontinuation|9|||
19470786|NCT01754129|41742466|FG000|Overall Study|Lost to Follow-up|7|||
19470787|NCT01754129|41742466|FG000|Overall Study|Withdrew consent|1|||
19470788|NCT01754129|41742466|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
19470789|NCT01728077|41742479|FG000|Overall Study|Lack of Efficacy|3|||
19470790|NCT01728077|41742480|FG001|Overall Study|Lack of Efficacy|1|||
19470791|NCT01728077|41742479|FG000|Overall Study|Lost to Follow-up|1|||
19470792|NCT01728077|41742480|FG001|Overall Study|Lost to Follow-up|0|||
19470793|NCT01728077|41742479|FG000|Overall Study|Subject choice|2|||
19470794|NCT01728077|41742480|FG001|Overall Study|Subject choice|3|||
19470795|NCT01728077|41742479|FG000|Overall Study|Death|0|||
19470796|NCT01728077|41742480|FG001|Overall Study|Death|1|||
19470797|NCT01728077|41742479|FG000|Overall Study|Patient moving|1|||
19470798|NCT01728077|41742480|FG001|Overall Study|Patient moving|0|||
19470799|NCT01728077|41742479|FG000|Overall Study|Non compliance|1|||
19470800|NCT01728077|41742480|FG001|Overall Study|Non compliance|0|||
19470801|NCT01606007|41742499|FG000|Overall Study|Reason 'Other' in the protocol|0|||
19470802|NCT01606007|41742500|FG001|Overall Study|Reason 'Other' in the protocol|1|||
19470803|NCT01606007|41742501|FG002|Overall Study|Reason 'Other' in the protocol|1|||
19470804|NCT01606007|41742499|FG000|Overall Study|Pregnancy|0|||
19553826|NCT01311557|42002742|FG000|Overall Study|Lost to Follow-up|0|||
19553827|NCT01311557|42002743|FG001|Overall Study|Lost to Follow-up|1|||
19470805|NCT01606007|41742500|FG001|Overall Study|Pregnancy|1|||
19470806|NCT01606007|41742501|FG002|Overall Study|Pregnancy|1|||
19470807|NCT01606007|41742499|FG000|Overall Study|Withdrawal by Subject|8|||
19470808|NCT01606007|41742500|FG001|Overall Study|Withdrawal by Subject|6|||
19470809|NCT01606007|41742501|FG002|Overall Study|Withdrawal by Subject|1|||
19470810|NCT01606007|41742499|FG000|Overall Study|Adverse Event|0|||
19470811|NCT01606007|41742500|FG001|Overall Study|Adverse Event|1|||
19470812|NCT01606007|41742501|FG002|Overall Study|Adverse Event|1|||
19470813|NCT01606007|41742499|FG000|Overall Study|discontinue study treatment|0|||
19470814|NCT01606007|41742500|FG001|Overall Study|discontinue study treatment|2|||
19470815|NCT01606007|41742501|FG002|Overall Study|discontinue study treatment|1|||
19470816|NCT01606007|41742499|FG000|Overall Study|Lost to Follow-up|6|||
19470817|NCT01606007|41742500|FG001|Overall Study|Lost to Follow-up|8|||
19470818|NCT01606007|41742501|FG002|Overall Study|Lost to Follow-up|5|||
19470819|NCT01606007|41742499|FG000|Overall Study|Poor/Non-compliance|1|||
19470820|NCT01606007|41742500|FG001|Overall Study|Poor/Non-compliance|0|||
19470821|NCT01606007|41742501|FG002|Overall Study|Poor/Non-compliance|0|||
19470822|NCT01753193|41742580|FG000|Overall Study|Withdrawal by Subject|23|||
19470823|NCT01753193|41742580|FG000|Overall Study|Lost to Follow-up|6|||
19470824|NCT01753193|41742580|FG000|Overall Study|Death|1|||
19470825|NCT01753193|41742580|FG000|Overall Study|Other|16|||
19470826|NCT01727297|41742627|FG000|Overall Study|Death|13|||
19470827|NCT01727297|41742628|FG001|Overall Study|Death|0|||
19470828|NCT01727297|41742627|FG000|Overall Study|Protocol Violation|1|||
19470829|NCT01727297|41742628|FG001|Overall Study|Protocol Violation|10|||
19470830|NCT01727297|41742627|FG000|Overall Study|Adverse Event|3|||
19470831|NCT01727297|41742628|FG001|Overall Study|Adverse Event|1|||
19470832|NCT01727297|41742627|FG000|Overall Study|Lost to Follow-up|11|||
19470833|NCT01727297|41742628|FG001|Overall Study|Lost to Follow-up|0|||
19470834|NCT01727297|41742627|FG000|Overall Study|Withdrawal by Subject|26|||
19470835|NCT01727297|41742628|FG001|Overall Study|Withdrawal by Subject|27|||
19470836|NCT01727297|41742627|FG000|Overall Study|Physician Decision|19|||
19470837|NCT01727297|41742628|FG001|Overall Study|Physician Decision|5|||
19470838|NCT01727297|41742627|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
19470839|NCT01727297|41742628|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
19470840|NCT01753115|41742644|FG000|Overall Study|Lost to Follow-up|3|||
19470841|NCT01753115|41742645|FG001|Overall Study|Lost to Follow-up|6|||
19470842|NCT01753115|41742646|FG002|Overall Study|Lost to Follow-up|8|||
19470843|NCT01753115|41742644|FG000|Overall Study|Withdrawal by Subject|6|||
19470844|NCT01753115|41742645|FG001|Overall Study|Withdrawal by Subject|5|||
19470845|NCT01753115|41742646|FG002|Overall Study|Withdrawal by Subject|6|||
19470846|NCT01753115|41742644|FG000|Overall Study|Subject non-compliant|3|||
19470847|NCT01753115|41742645|FG001|Overall Study|Subject non-compliant|3|||
19470848|NCT01753115|41742646|FG002|Overall Study|Subject non-compliant|0|||
19470849|NCT01753115|41742644|FG000|Overall Study|Used excluded drug|0|||
19470850|NCT01753115|41742645|FG001|Overall Study|Used excluded drug|1|||
19470851|NCT01753115|41742646|FG002|Overall Study|Used excluded drug|0|||
19470852|NCT01727141|41742667|FG000|Overall Study|Physician Decision|0|||
19470853|NCT01727141|41742668|FG001|Overall Study|Physician Decision|1|||
19470854|NCT01727141|41742669|FG002|Overall Study|Physician Decision|0|||
19470855|NCT01727141|41742670|FG003|Overall Study|Physician Decision|2|||
19470856|NCT01727141|41742667|FG000|Overall Study|Lost to Follow-up|0|||
19470857|NCT01727141|41742668|FG001|Overall Study|Lost to Follow-up|2|||
19470858|NCT01727141|41742669|FG002|Overall Study|Lost to Follow-up|0|||
19470859|NCT01727141|41742670|FG003|Overall Study|Lost to Follow-up|0|||
19470860|NCT01727141|41742667|FG000|Overall Study|Death|0|||
19470861|NCT01727141|41742668|FG001|Overall Study|Death|1|||
19470862|NCT01727141|41742669|FG002|Overall Study|Death|1|||
19470863|NCT01727141|41742670|FG003|Overall Study|Death|1|||
19470864|NCT01727141|41742667|FG000|Overall Study|Protocol deviation|1|||
19470865|NCT01727141|41742668|FG001|Overall Study|Protocol deviation|1|||
19470866|NCT01727141|41742669|FG002|Overall Study|Protocol deviation|0|||
19470867|NCT01727141|41742670|FG003|Overall Study|Protocol deviation|1|||
19470868|NCT01727141|41742667|FG000|Overall Study|Withdrawal by Subject|4|||
19470869|NCT01727141|41742668|FG001|Overall Study|Withdrawal by Subject|4|||
19470870|NCT01727141|41742669|FG002|Overall Study|Withdrawal by Subject|2|||
19470871|NCT01727141|41742670|FG003|Overall Study|Withdrawal by Subject|11|||
19470872|NCT01726517|41742694|FG000|Overall Study|Withdrawal by Subject|0|||
19470873|NCT01726517|41742695|FG001|Overall Study|Withdrawal by Subject|0|||
19470874|NCT01726517|41742696|FG002|Overall Study|Withdrawal by Subject|1|||
19470875|NCT01726517|41742697|FG003|Overall Study|Withdrawal by Subject|0|||
19470876|NCT01726517|41742698|FG004|Overall Study|Withdrawal by Subject|0|||
19470877|NCT01752023|41742712|FG000|Overall Study|Physician Decision|2|||
19470878|NCT01752023|41742713|FG001|Overall Study|Physician Decision|1|||
19470879|NCT01726049|41742725|FG000|Overall Study|Death|1|||
19470880|NCT01726049|41742726|FG001|Overall Study|Death|1|||
19470881|NCT01726049|41742725|FG000|Overall Study|Adverse Event|4|||
19470882|NCT01726049|41742726|FG001|Overall Study|Adverse Event|1|||
19470883|NCT01726049|41742725|FG000|Overall Study|refused second HC|0|||
19470884|NCT01726049|41742726|FG001|Overall Study|refused second HC|2|||
19470885|NCT01605617|41742747|FG000|First Intervention|Adverse Event|0|||
19470886|NCT01605617|41742748|FG001|First Intervention|Adverse Event|1|||
19470887|NCT01605617|41742747|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
19470888|NCT01605617|41742748|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
19470889|NCT01751867|41742765|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
19470890|NCT01751867|41742766|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
19470891|NCT01751867|41742765|FG000|Overall Study|Diease Progression|4|||
19470892|NCT01751867|41742766|FG001|Overall Study|Diease Progression|18|||
19470893|NCT01751867|41742765|FG000|Overall Study|Adverse Event|8|||
19470894|NCT01751867|41742766|FG001|Overall Study|Adverse Event|15|||
19470895|NCT01751867|41742765|FG000|Overall Study|Poor Compliance|0|||
19470896|NCT01751867|41742766|FG001|Overall Study|Poor Compliance|5|||
19470897|NCT01751867|41742765|FG000|Overall Study|Withdrawal by Subject|3|||
19470898|NCT01751867|41742766|FG001|Overall Study|Withdrawal by Subject|1|||
19470899|NCT01751867|41742765|FG000|Overall Study|Physician Decision|4|||
19470900|NCT01751867|41742766|FG001|Overall Study|Physician Decision|7|||
19470901|NCT01751867|41742765|FG000|Overall Study|Protocol Violation|0|||
19470902|NCT01751867|41742766|FG001|Overall Study|Protocol Violation|2|||
19470903|NCT01751867|41742765|FG000|Overall Study|Death|0|||
19470904|NCT01751867|41742766|FG001|Overall Study|Death|5|||
19470905|NCT01751867|41742765|FG000|Overall Study|Other|11|||
19470906|NCT01751867|41742766|FG001|Overall Study|Other|37|||
19470907|NCT01751867|41742765|FG000|Overall Study|Randomized but not treated.|2|||
19470908|NCT01751867|41742766|FG001|Overall Study|Randomized but not treated.|1|||
19470909|NCT01751165|41742792|FG000|Overall Study|Adverse event, serious fatal|1|||
19470910|NCT01751165|41742793|FG001|Overall Study|Adverse event, serious fatal|0|||
19470911|NCT01751165|41742794|FG002|Overall Study|Adverse event, serious fatal|1|||
19470912|NCT01751165|41742792|FG000|Overall Study|Withdrawal by Subject|0|||
19470913|NCT01751165|41742793|FG001|Overall Study|Withdrawal by Subject|0|||
19470914|NCT01751165|41742794|FG002|Overall Study|Withdrawal by Subject|1|||
19470915|NCT01751165|41742792|FG000|Overall Study|Serious adverse event|0|||
19470916|NCT01751165|41742793|FG001|Overall Study|Serious adverse event|2|||
19470917|NCT01751165|41742794|FG002|Overall Study|Serious adverse event|0|||
19470918|NCT01751165|41742792|FG000|Overall Study|Lost to Follow-up|1|||
19470919|NCT01751165|41742793|FG001|Overall Study|Lost to Follow-up|1|||
19470920|NCT01751165|41742794|FG002|Overall Study|Lost to Follow-up|1|||
19470921|NCT01751087|41742819|FG000|Overall Study|Withdrawal by Subject|1|||
19470922|NCT01751087|41742820|FG001|Overall Study|Withdrawal by Subject|0|||
19470923|NCT01751087|41742821|FG002|Overall Study|Withdrawal by Subject|0|||
19470924|NCT01751087|41742819|FG000|Overall Study|Physician Decision|0|||
19470925|NCT01751087|41742820|FG001|Overall Study|Physician Decision|0|||
19470926|NCT01751087|41742821|FG002|Overall Study|Physician Decision|1|||
19470927|NCT01750697|41742829|FG000|Overall Study|Transferred Back to Local Hospital|1|||
19470928|NCT01750697|41742829|FG000|Overall Study|Physician and Family Decision|1|||
19470929|NCT01750697|41742829|FG000|Overall Study|Transferred to Adult Services|5|||
19470930|NCT01750697|41742829|FG000|Overall Study|Physician Decision|1|||
19470931|NCT01750697|41742829|FG000|Overall Study|Withdrawal by Subject|1|||
19470932|NCT01750229|41742840|FG000|Randomized Crossover Phase|Adverse Event|1|||
19470933|NCT01750229|41742840|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
19470934|NCT01750229|41742840|FG000|Long-term Follow-up Phase|Adverse Event|2|||
19470935|NCT01750229|41742840|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
19470936|NCT01724489|41742852|FG000|Overall Study|Adverse Event|8|||
19470937|NCT01724489|41742853|FG001|Overall Study|Adverse Event|3|||
19470938|NCT01724489|41742852|FG000|Overall Study|Surgery, medication|1|||
19470939|NCT01724489|41742853|FG001|Overall Study|Surgery, medication|1|||
19470940|NCT01724489|41742852|FG000|Overall Study|Lost to Follow-up|1|||
19470941|NCT01724489|41742853|FG001|Overall Study|Lost to Follow-up|2|||
19470942|NCT01724489|41742852|FG000|Overall Study|Withdrawal by Subject|6|||
19470943|NCT01724489|41742853|FG001|Overall Study|Withdrawal by Subject|6|||
19470944|NCT01724177|41742868|FG000|Overall Study|Adverse Event|8|||
19470945|NCT01724177|41742868|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
19470946|NCT01724177|41742868|FG000|Overall Study|Nervous participant|1|||
19470947|NCT01724177|41742868|FG000|Overall Study|Serious Adverse Event Related|1|||
19470948|NCT04378270|41742900|FG000|Overall Study|Lack of Efficacy|1|||
19470949|NCT04378270|41742900|FG000|Overall Study|Withdrawal by Subject|1|||
19381832|NCT04032093|41624933|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19381833|NCT04032093|41624934|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
19381834|NCT04032093|41624935|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
19470950|NCT04378270|41742900|FG000|Overall Study|Screen Failure|1|||
19470951|NCT04378270|41742900|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
19470952|NCT01724021|41742906|FG000|Overall Study|Adverse Event|11|||
19470953|NCT01724021|41742907|FG001|Overall Study|Adverse Event|6|||
19470954|NCT01724021|41742906|FG000|Overall Study|Death|46|||
19470955|NCT01724021|41742907|FG001|Overall Study|Death|58|||
19470956|NCT01724021|41742906|FG000|Overall Study|Participant request/ Withdrew consent|18|||
19381835|NCT04032093|41624936|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
19470957|NCT01724021|41742907|FG001|Overall Study|Participant request/ Withdrew consent|14|||
19470958|NCT01724021|41742906|FG000|Overall Study|Lost to Follow-up|15|||
19470959|NCT01724021|41742907|FG001|Overall Study|Lost to Follow-up|15|||
19470960|NCT01724021|41742906|FG000|Overall Study|Reason Not Specified|36|||
19470961|NCT01724021|41742907|FG001|Overall Study|Reason Not Specified|39|||
19470962|NCT01724021|41742906|FG000|Overall Study|Missing|1|||
19470963|NCT01724021|41742907|FG001|Overall Study|Missing|1|||
19470964|NCT01723397|41742921|FG000|Study Period 1|Protocol Violation|0|||
19470965|NCT01723397|41742922|FG001|Study Period 1|Protocol Violation|1|||
19470966|NCT01723397|41742921|FG000|Study Period 2|Protocol Violation|0|||
19470967|NCT01723397|41742922|FG001|Study Period 2|Protocol Violation|1|||
19470968|NCT01723163|41742930|FG000|Treatment Phase|Withdrawal by Subject|14|||
19470969|NCT01723163|41742931|FG001|Treatment Phase|Withdrawal by Subject|6|||
19470970|NCT01723163|41742930|FG000|Treatment Phase|Withdrawal by PI|5|||
19470971|NCT01723163|41742931|FG001|Treatment Phase|Withdrawal by PI|1|||
19470972|NCT01723163|41742930|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
19470973|NCT01723163|41742931|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
19470974|NCT01723163|41742930|FG000|3-Month Follow-up|Unable to Contact|12|||
19470975|NCT01723163|41742931|FG001|3-Month Follow-up|Unable to Contact|19|||
19470976|NCT01723163|41742930|FG000|6-Month Follow-up|Death|1|||
19470977|NCT01723163|41742931|FG001|6-Month Follow-up|Death|0|||
19470978|NCT01723163|41742930|FG000|6-Month Follow-up|Unable to Contact|17|||
19470979|NCT01723163|41742931|FG001|6-Month Follow-up|Unable to Contact|15|||
19470980|NCT01723163|41742930|FG000|12-Month Follow-up|Death|1|||
19470981|NCT01723163|41742931|FG001|12-Month Follow-up|Death|0|||
19470982|NCT01723163|41742930|FG000|12-Month Follow-up|Unable to Contact|23|||
19470983|NCT01723163|41742931|FG001|12-Month Follow-up|Unable to Contact|28|||
19470984|NCT01722071|41742941|FG000|Overall Study|Protocol Violation|1|||
19470985|NCT01722071|41742942|FG001|Overall Study|Protocol Violation|0|||
19470986|NCT01721759|41742948|FG000|Treatment Period|Disease Progression|85|||
19470987|NCT01721759|41742948|FG000|Treatment Period|Study drug toxicity|14|||
19470988|NCT01721759|41742948|FG000|Treatment Period|Death|1|||
19470989|NCT01721759|41742948|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
19470990|NCT01721759|41742948|FG000|Treatment Period|Participant request to withdraw|3|||
19470991|NCT01721759|41742948|FG000|Treatment Period|Other Reasons|3|||
19470992|NCT01721759|41742948|FG000|End of Study Period|Participant Withdrew Consent|5|||
19470993|NCT01721759|41742948|FG000|End of Study Period|Death|101|||
19470994|NCT01721759|41742948|FG000|End of Study Period|Lost to Follow-up|1|||
19470995|NCT01721759|41742948|FG000|End of Study Period|Other Reasons|10|||
19470996|NCT01721369|41742957|FG000|Overall Study|Not initial etiological diagnosis|12|||
19470997|NCT01721057|41743019|FG000|Treatment Period|Withdrawal by Subject|11|||
19470998|NCT01721057|41743020|FG001|Treatment Period|Withdrawal by Subject|5|||
19470999|NCT01721057|41743021|FG002|Treatment Period|Withdrawal by Subject|8|||
19471000|NCT01721057|41743022|FG003|Treatment Period|Withdrawal by Subject|0|||
19471001|NCT01721057|41743023|FG004|Treatment Period|Withdrawal by Subject|0|||
19471002|NCT01721057|41743024|FG005|Treatment Period|Withdrawal by Subject|0|||
19471003|NCT01721057|41743025|FG006|Treatment Period|Withdrawal by Subject|0|||
19471004|NCT01721057|41743019|FG000|Treatment Period|Adverse Event|7|||
19471005|NCT01721057|41743020|FG001|Treatment Period|Adverse Event|10|||
19471006|NCT01721057|41743021|FG002|Treatment Period|Adverse Event|12|||
19471007|NCT01721057|41743022|FG003|Treatment Period|Adverse Event|0|||
19471008|NCT01721057|41743023|FG004|Treatment Period|Adverse Event|0|||
19471009|NCT01721057|41743024|FG005|Treatment Period|Adverse Event|0|||
19471010|NCT01721057|41743025|FG006|Treatment Period|Adverse Event|0|||
19471011|NCT01721057|41743019|FG000|Treatment Period|Lack of Efficacy|7|||
19471012|NCT01721057|41743020|FG001|Treatment Period|Lack of Efficacy|3|||
19471013|NCT01721057|41743021|FG002|Treatment Period|Lack of Efficacy|0|||
19471014|NCT01721057|41743022|FG003|Treatment Period|Lack of Efficacy|0|||
19471015|NCT01721057|41743023|FG004|Treatment Period|Lack of Efficacy|0|||
19471016|NCT01721057|41743024|FG005|Treatment Period|Lack of Efficacy|0|||
19471017|NCT01721057|41743025|FG006|Treatment Period|Lack of Efficacy|0|||
19471018|NCT01721057|41743019|FG000|Treatment Period|Lost to Follow-up|1|||
19471019|NCT01721057|41743020|FG001|Treatment Period|Lost to Follow-up|0|||
19471020|NCT01721057|41743021|FG002|Treatment Period|Lost to Follow-up|0|||
19471021|NCT01721057|41743022|FG003|Treatment Period|Lost to Follow-up|0|||
19471022|NCT01721057|41743023|FG004|Treatment Period|Lost to Follow-up|0|||
19471023|NCT01721057|41743024|FG005|Treatment Period|Lost to Follow-up|0|||
19471024|NCT01721057|41743025|FG006|Treatment Period|Lost to Follow-up|0|||
19471025|NCT01721057|41743019|FG000|Treatment Period|Physician Decision|0|||
19471026|NCT01721057|41743020|FG001|Treatment Period|Physician Decision|1|||
19471027|NCT01721057|41743021|FG002|Treatment Period|Physician Decision|3|||
19471028|NCT01721057|41743022|FG003|Treatment Period|Physician Decision|0|||
19471029|NCT01721057|41743023|FG004|Treatment Period|Physician Decision|0|||
19471030|NCT01721057|41743024|FG005|Treatment Period|Physician Decision|0|||
19471031|NCT01721057|41743025|FG006|Treatment Period|Physician Decision|0|||
19471032|NCT01721057|41743019|FG000|Treatment Period|Death|2|||
19471033|NCT01721057|41743020|FG001|Treatment Period|Death|0|||
19471034|NCT01721057|41743021|FG002|Treatment Period|Death|0|||
19471035|NCT01721057|41743022|FG003|Treatment Period|Death|0|||
19471036|NCT01721057|41743023|FG004|Treatment Period|Death|0|||
19471037|NCT01721057|41743024|FG005|Treatment Period|Death|0|||
19471038|NCT01721057|41743025|FG006|Treatment Period|Death|0|||
19471039|NCT01721057|41743019|FG000|Rescue Period|Adverse Event|0|||
19471040|NCT01721057|41743020|FG001|Rescue Period|Adverse Event|0|||
19471041|NCT01721057|41743021|FG002|Rescue Period|Adverse Event|0|||
19471042|NCT01721057|41743022|FG003|Rescue Period|Adverse Event|1|||
19471043|NCT01721057|41743023|FG004|Rescue Period|Adverse Event|0|||
19471044|NCT01721057|41743024|FG005|Rescue Period|Adverse Event|0|||
19471045|NCT01721057|41743025|FG006|Rescue Period|Adverse Event|0|||
19471046|NCT01721057|41743019|FG000|Rescue Period|Lack of Efficacy|0|||
19471047|NCT01721057|41743020|FG001|Rescue Period|Lack of Efficacy|0|||
19471048|NCT01721057|41743021|FG002|Rescue Period|Lack of Efficacy|0|||
19471049|NCT01721057|41743022|FG003|Rescue Period|Lack of Efficacy|2|||
19471050|NCT01721057|41743023|FG004|Rescue Period|Lack of Efficacy|0|||
19471051|NCT01721057|41743024|FG005|Rescue Period|Lack of Efficacy|0|||
19471052|NCT01721057|41743025|FG006|Rescue Period|Lack of Efficacy|0|||
19471053|NCT04570384|41743054|FG000|Overall Study|Adverse Event|2|||
19471054|NCT04570384|41743055|FG001|Overall Study|Adverse Event|1|||
19471055|NCT04570384|41743054|FG000|Overall Study|Death|2|||
19471056|NCT04570384|41743055|FG001|Overall Study|Death|5|||
19471057|NCT04570384|41743054|FG000|Overall Study|Lost to Follow-up|1|||
19471058|NCT04570384|41743055|FG001|Overall Study|Lost to Follow-up|0|||
19471059|NCT04570384|41743054|FG000|Overall Study|Other|1|||
19471060|NCT04570384|41743055|FG001|Overall Study|Other|0|||
19471061|NCT04570384|41743054|FG000|Overall Study|Protocol Violation|0|||
19471062|NCT04570384|41743055|FG001|Overall Study|Protocol Violation|1|||
19471063|NCT04570384|41743054|FG000|Overall Study|Sponsor Decision|1|||
19471064|NCT04570384|41743055|FG001|Overall Study|Sponsor Decision|0|||
19471065|NCT04570384|41743054|FG000|Overall Study|Withdrawal by Subject|4|||
19471066|NCT04570384|41743055|FG001|Overall Study|Withdrawal by Subject|2|||
19471067|NCT02563522|41743108|FG000|Overall Study|Adverse Event|2|||
19471068|NCT02563522|41743109|FG001|Overall Study|Adverse Event|3|||
19471069|NCT02563522|41743108|FG000|Overall Study|Lost to Follow-up|1|||
19471070|NCT02563522|41743109|FG001|Overall Study|Lost to Follow-up|0|||
19471071|NCT02563522|41743108|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
19471072|NCT02563522|41743109|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
19471073|NCT02180724|41743117|FG000|Overall Study|Death|26|||
19471074|NCT02180724|41743118|FG001|Overall Study|Death|1|||
19471075|NCT02180724|41743117|FG000|Overall Study|Lost to Follow-up|3|||
19471076|NCT02180724|41743118|FG001|Overall Study|Lost to Follow-up|1|||
19471077|NCT02180724|41743117|FG000|Overall Study|Withdrawal by Subject|4|||
19471078|NCT02180724|41743118|FG001|Overall Study|Withdrawal by Subject|2|||
19471079|NCT02180724|41743117|FG000|Overall Study|PI Decision|5|||
19471080|NCT02180724|41743118|FG001|Overall Study|PI Decision|2|||
19471081|NCT02180724|41743117|FG000|Overall Study|Study terminated by sponsor|54|||
19471082|NCT02180724|41743118|FG001|Overall Study|Study terminated by sponsor|8|||
19471083|NCT03578146|41743145|FG000|Overall Study|Did Not Receive Treatment|1|||
19471084|NCT03578146|41743146|FG001|Overall Study|Did Not Receive Treatment|0|||
19471085|NCT03578146|41743147|FG002|Overall Study|Did Not Receive Treatment|0|||
19471086|NCT03578146|41743148|FG003|Overall Study|Did Not Receive Treatment|0|||
19471087|NCT03578146|41743149|FG004|Overall Study|Did Not Receive Treatment|0|||
19471088|NCT03578146|41743150|FG005|Overall Study|Did Not Receive Treatment|2|||
19471089|NCT03578146|41743145|FG000|Overall Study|Lost to Follow-up|0|||
19471090|NCT03578146|41743146|FG001|Overall Study|Lost to Follow-up|1|||
19471091|NCT03578146|41743147|FG002|Overall Study|Lost to Follow-up|1|||
19471092|NCT03578146|41743148|FG003|Overall Study|Lost to Follow-up|0|||
19471093|NCT03578146|41743149|FG004|Overall Study|Lost to Follow-up|0|||
19471094|NCT03578146|41743150|FG005|Overall Study|Lost to Follow-up|1|||
19471095|NCT02716896|41743166|FG000|Overall Study|Physician Decision|0|||
19471096|NCT02716896|41743167|FG001|Overall Study|Physician Decision|1|||
19471097|NCT02715726|41743235|FG000|Overall Study|Adverse Event|2|||
19471098|NCT02715726|41743236|FG001|Overall Study|Adverse Event|6|||
19471099|NCT02715726|41743235|FG000|Overall Study|Protocol Violation|1|||
19471100|NCT02715726|41743236|FG001|Overall Study|Protocol Violation|0|||
19471101|NCT02715726|41743235|FG000|Overall Study|Death|2|||
19471102|NCT02715726|41743236|FG001|Overall Study|Death|1|||
19471103|NCT02715726|41743235|FG000|Overall Study|Participant moved|1|||
19471104|NCT02715726|41743236|FG001|Overall Study|Participant moved|3|||
19471105|NCT02715726|41743235|FG000|Overall Study|Other than specified above|11|||
19471106|NCT02715726|41743236|FG001|Overall Study|Other than specified above|15|||
19471107|NCT02715726|41743235|FG000|Overall Study|Randomized but not treated|1|||
19471108|NCT02715726|41743236|FG001|Overall Study|Randomized but not treated|2|||
19471109|NCT04248816|41743249|FG000|Overall Study|Ineligible post-randomization|7|||
19471110|NCT04248816|41743250|FG001|Overall Study|Ineligible post-randomization|21|||
19471111|NCT04248816|41743251|FG002|Overall Study|Ineligible post-randomization|25|||
19471112|NCT02314156|41743288|FG000|Overall Study|Adverse Event|1|||
19471113|NCT02314156|41743289|FG001|Overall Study|Adverse Event|0|||
19471114|NCT02314156|41743288|FG000|Overall Study|Withdrawal by Subject|1|||
19471115|NCT02314156|41743289|FG001|Overall Study|Withdrawal by Subject|0|||
19471116|NCT02716584|41743371|FG000|Overall Study|Lost to Follow-up|8|||
19471117|NCT02716584|41743372|FG001|Overall Study|Lost to Follow-up|5|||
19471118|NCT04034238|41743480|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
19471119|NCT04034238|41743481|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
19471120|NCT04034238|41743482|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
19471121|NCT04034238|41743483|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19471122|NCT04034238|41743480|FG000|Dose Escalation Phase|Screen failures|0|||
19471123|NCT04034238|41743481|FG001|Dose Escalation Phase|Screen failures|0|||
19471124|NCT04034238|41743482|FG002|Dose Escalation Phase|Screen failures|0|||
19471125|NCT04034238|41743483|FG003|Dose Escalation Phase|Screen failures|2|||
19471126|NCT04034238|41743480|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
19471127|NCT04034238|41743481|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
19471128|NCT04034238|41743482|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
19471129|NCT04034238|41743483|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
19471130|NCT04034238|41743480|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
19471131|NCT04034238|41743481|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
19471132|NCT04034238|41743482|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
19471133|NCT04034238|41743483|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
19471134|NCT02716194|41743595|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
19471135|NCT02716194|41743596|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
19471136|NCT02716194|41743597|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
19471137|NCT03773484|41743667|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
19471138|NCT02715258|41743860|FG000|Overall Study|Withdrawal by Subject|6|||
19471139|NCT02715258|41743861|FG001|Overall Study|Withdrawal by Subject|1|||
19471140|NCT02715258|41743860|FG000|Overall Study|Lost to Follow-up|7|||
19471141|NCT02715258|41743861|FG001|Overall Study|Lost to Follow-up|1|||
19471142|NCT02715258|41743860|FG000|Overall Study|Terminated by Sponsor|0|||
19471143|NCT02715258|41743861|FG001|Overall Study|Terminated by Sponsor|1|||
19471144|NCT02715258|41743860|FG000|Overall Study|Death|0|||
19553828|NCT01311557|42002742|FG000|Overall Study|Withdrawal by Subject|1|||
19553829|NCT01311557|42002743|FG001|Overall Study|Withdrawal by Subject|2|||
19553830|NCT01310777|42002752|FG000|Overall Study|Adverse Event|23|||
19553831|NCT01310777|42002753|FG001|Overall Study|Adverse Event|1|||
19553832|NCT01310777|42002754|FG002|Overall Study|Adverse Event|15|||
19471145|NCT02715258|41743861|FG001|Overall Study|Death|1|||
19471146|NCT02715258|41743860|FG000|Overall Study|Subject non-compliant|1|||
19471147|NCT02715258|41743861|FG001|Overall Study|Subject non-compliant|1|||
19471148|NCT02715258|41743860|FG000|Overall Study|GCP violation|2|||
19471149|NCT02715258|41743861|FG001|Overall Study|GCP violation|1|||
19471150|NCT02714868|41743886|FG000|Overall Study|Withdrawal by Subject|3|||
19471151|NCT02714868|41743887|FG001|Overall Study|Withdrawal by Subject|0|||
19471152|NCT02714868|41743886|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
19471153|NCT02714868|41743887|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
19471154|NCT02714868|41743886|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
19471155|NCT02714868|41743887|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
19471156|NCT02713542|41744211|FG000|Overall Study|Use of prohibited medication|14|||
19471157|NCT02713542|41744212|FG001|Overall Study|Use of prohibited medication|5|||
19471158|NCT02713542|41744211|FG000|Overall Study|Withdrawal by Subject|4|||
19471159|NCT02713542|41744212|FG001|Overall Study|Withdrawal by Subject|1|||
19471160|NCT03548220|41744296|FG000|Overall Study|Lost to Follow-up|1|||
19471161|NCT03548220|41744297|FG001|Overall Study|Lost to Follow-up|0|||
19471162|NCT03548220|41744298|FG002|Overall Study|Lost to Follow-up|0|||
19471163|NCT03548220|41744299|FG003|Overall Study|Lost to Follow-up|0|||
19471164|NCT02712996|41744334|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
19471165|NCT02712996|41744335|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
19471166|NCT00701064|41744442|FG000|Overall Study|Protocol Violation|1|||
19471167|NCT00701064|41744443|FG001|Overall Study|Protocol Violation|1|||
19471168|NCT00701064|41744442|FG000|Overall Study|Withdrawal by Subject|1|||
19471169|NCT00701064|41744443|FG001|Overall Study|Withdrawal by Subject|1|||
19471170|NCT00701064|41744442|FG000|Overall Study|initiated other PTSD treatment|2|||
19471171|NCT00701064|41744443|FG001|Overall Study|initiated other PTSD treatment|2|||
19471172|NCT01748825|41744582|FG000|Dose Escalation|Refused further treatment|2|||
19471173|NCT01748825|41744583|FG001|Dose Escalation|Refused further treatment|2|||
19471174|NCT01748825|41744584|FG002|Dose Escalation|Refused further treatment|0|||
19471175|NCT01748825|41744585|FG003|Dose Escalation|Refused further treatment|0|||
19471176|NCT01748825|41744586|FG004|Dose Escalation|Refused further treatment|1|||
19471177|NCT01748825|41744587|FG005|Dose Escalation|Refused further treatment|2|||
19471178|NCT01748825|41744588|FG006|Dose Escalation|Refused further treatment|0|||
19471179|NCT01748825|41744589|FG007|Dose Escalation|Refused further treatment|0|||
19471180|NCT01748825|41744590|FG008|Dose Escalation|Refused further treatment|0|||
19471181|NCT01748825|41744591|FG009|Dose Escalation|Refused further treatment|0|||
19471182|NCT01748825|41744582|FG000|Dose Escalation|Switched to alternative treatment|0|||
19471183|NCT01748825|41744583|FG001|Dose Escalation|Switched to alternative treatment|0|||
19471184|NCT01748825|41744584|FG002|Dose Escalation|Switched to alternative treatment|0|||
19471185|NCT01748825|41744585|FG003|Dose Escalation|Switched to alternative treatment|1|||
19471186|NCT01748825|41744586|FG004|Dose Escalation|Switched to alternative treatment|0|||
19471187|NCT01748825|41744587|FG005|Dose Escalation|Switched to alternative treatment|0|||
19553833|NCT01310777|42002752|FG000|Overall Study|Lost to Follow-up|0|||
19553834|NCT01310777|42002753|FG001|Overall Study|Lost to Follow-up|4|||
19553835|NCT01310777|42002754|FG002|Overall Study|Lost to Follow-up|1|||
19553836|NCT01310777|42002752|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
19553837|NCT01310777|42002753|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
19553838|NCT01310777|42002754|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
19553839|NCT01310777|42002752|FG000|Overall Study|Inadequate Control of IOP|5|||
19553840|NCT01310777|42002753|FG001|Overall Study|Inadequate Control of IOP|7|||
19553841|NCT01310777|42002754|FG002|Overall Study|Inadequate Control of IOP|10|||
19553842|NCT01310777|42002752|FG000|Overall Study|Other|4|||
19553843|NCT01310777|42002753|FG001|Overall Study|Other|1|||
19553844|NCT01310777|42002754|FG002|Overall Study|Other|2|||
19471188|NCT01748825|41744588|FG006|Dose Escalation|Switched to alternative treatment|0|||
19471189|NCT01748825|41744589|FG007|Dose Escalation|Switched to alternative treatment|0|||
19471190|NCT01748825|41744590|FG008|Dose Escalation|Switched to alternative treatment|0|||
19471191|NCT01748825|41744591|FG009|Dose Escalation|Switched to alternative treatment|0|||
19471192|NCT01748825|41744582|FG000|Dose Escalation|Adverse Event|0|||
19471193|NCT01748825|41744583|FG001|Dose Escalation|Adverse Event|0|||
19471194|NCT01748825|41744584|FG002|Dose Escalation|Adverse Event|0|||
19471195|NCT01748825|41744585|FG003|Dose Escalation|Adverse Event|0|||
19471196|NCT01748825|41744586|FG004|Dose Escalation|Adverse Event|0|||
19471197|NCT01748825|41744587|FG005|Dose Escalation|Adverse Event|0|||
19471198|NCT01748825|41744588|FG006|Dose Escalation|Adverse Event|1|||
19471199|NCT01748825|41744589|FG007|Dose Escalation|Adverse Event|0|||
19471200|NCT01748825|41744590|FG008|Dose Escalation|Adverse Event|0|||
19471201|NCT01748825|41744591|FG009|Dose Escalation|Adverse Event|0|||
19471202|NCT01748825|41744582|FG000|Dose Expansion|Refused further treatment|0|||
19471203|NCT01748825|41744583|FG001|Dose Expansion|Refused further treatment|0|||
19471204|NCT01748825|41744584|FG002|Dose Expansion|Refused further treatment|0|||
19471205|NCT01748825|41744585|FG003|Dose Expansion|Refused further treatment|0|||
19471206|NCT01748825|41744586|FG004|Dose Expansion|Refused further treatment|0|||
19471207|NCT01748825|41744587|FG005|Dose Expansion|Refused further treatment|0|||
19471208|NCT01748825|41744588|FG006|Dose Expansion|Refused further treatment|0|||
19471209|NCT01748825|41744589|FG007|Dose Expansion|Refused further treatment|0|||
19471210|NCT01748825|41744590|FG008|Dose Expansion|Refused further treatment|1|||
19471211|NCT01748825|41744591|FG009|Dose Expansion|Refused further treatment|1|||
19471212|NCT01748825|41744582|FG000|Dose Expansion|Switched to alternative treatment|0|||
19471213|NCT01748825|41744583|FG001|Dose Expansion|Switched to alternative treatment|0|||
19471214|NCT01748825|41744584|FG002|Dose Expansion|Switched to alternative treatment|0|||
19471215|NCT01748825|41744585|FG003|Dose Expansion|Switched to alternative treatment|0|||
19471216|NCT01748825|41744586|FG004|Dose Expansion|Switched to alternative treatment|0|||
19471217|NCT01748825|41744587|FG005|Dose Expansion|Switched to alternative treatment|0|||
19471218|NCT01748825|41744588|FG006|Dose Expansion|Switched to alternative treatment|0|||
19471219|NCT01748825|41744589|FG007|Dose Expansion|Switched to alternative treatment|0|||
19471220|NCT01748825|41744590|FG008|Dose Expansion|Switched to alternative treatment|0|||
19471221|NCT01748825|41744591|FG009|Dose Expansion|Switched to alternative treatment|1|||
19471222|NCT01748825|41744582|FG000|Dose Expansion|Adverse Event|0|||
19471223|NCT01748825|41744583|FG001|Dose Expansion|Adverse Event|0|||
19471224|NCT01748825|41744584|FG002|Dose Expansion|Adverse Event|0|||
19471225|NCT01748825|41744585|FG003|Dose Expansion|Adverse Event|0|||
19471226|NCT01748825|41744586|FG004|Dose Expansion|Adverse Event|0|||
19471227|NCT01748825|41744587|FG005|Dose Expansion|Adverse Event|0|||
19471228|NCT01748825|41744588|FG006|Dose Expansion|Adverse Event|0|||
19471229|NCT01748825|41744589|FG007|Dose Expansion|Adverse Event|0|||
19471230|NCT01748825|41744590|FG008|Dose Expansion|Adverse Event|0|||
19471231|NCT01748825|41744591|FG009|Dose Expansion|Adverse Event|3|||
19471232|NCT01748825|41744582|FG000|Dose Expansion|Physician Decision|0|||
19471233|NCT01748825|41744583|FG001|Dose Expansion|Physician Decision|0|||
19471234|NCT01748825|41744584|FG002|Dose Expansion|Physician Decision|0|||
19471235|NCT01748825|41744585|FG003|Dose Expansion|Physician Decision|0|||
19471236|NCT01748825|41744586|FG004|Dose Expansion|Physician Decision|0|||
19471237|NCT01748825|41744587|FG005|Dose Expansion|Physician Decision|0|||
19471238|NCT01748825|41744588|FG006|Dose Expansion|Physician Decision|0|||
19471239|NCT01748825|41744589|FG007|Dose Expansion|Physician Decision|0|||
19471240|NCT01748825|41744590|FG008|Dose Expansion|Physician Decision|1|||
19471241|NCT01748825|41744591|FG009|Dose Expansion|Physician Decision|0|||
19471242|NCT01720667|41744653|FG000|Overall Study|Adverse Event|1|||
19471243|NCT01720667|41744654|FG001|Overall Study|Adverse Event|1|||
19471244|NCT01720667|41744653|FG000|Overall Study|Withdrawal by Subject|3|||
19471245|NCT01720667|41744654|FG001|Overall Study|Withdrawal by Subject|0|||
19471246|NCT01720043|41744662|FG000|Overall Study|Withdrawal by Subject|1|||
19471247|NCT00700752|41744666|FG000|First Intervention|Withdrawal by Subject|0|||
19471248|NCT00700752|41744667|FG001|First Intervention|Withdrawal by Subject|2|||
19471249|NCT01747811|41744684|FG000|Overall Study|Lack of Efficacy|2|||
19471250|NCT01747811|41744685|FG001|Overall Study|Lack of Efficacy|4|||
19471251|NCT01747655|41744693|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
19471252|NCT01747655|41744694|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
19471253|NCT01747655|41744693|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
19471254|NCT01747655|41744694|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
19471255|NCT01747655|41744693|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
19471256|NCT01747655|41744694|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
19471257|NCT01718483|41744702|FG000|Overall Study|Withdrawal by Subject|14|||
19471258|NCT01718483|41744703|FG001|Overall Study|Withdrawal by Subject|12|||
19471259|NCT01718483|41744702|FG000|Overall Study|Adverse Event|5|||
19471260|NCT01718483|41744703|FG001|Overall Study|Adverse Event|12|||
19471261|NCT01718483|41744702|FG000|Overall Study|Lost to Follow-up|8|||
19471262|NCT01718483|41744703|FG001|Overall Study|Lost to Follow-up|3|||
19471263|NCT01718483|41744702|FG000|Overall Study|Protocol Violation|4|||
19471264|NCT01718483|41744703|FG001|Overall Study|Protocol Violation|2|||
19471265|NCT01718483|41744702|FG000|Overall Study|Other|1|||
19471266|NCT01718483|41744703|FG001|Overall Study|Other|4|||
19471267|NCT01718483|41744702|FG000|Overall Study|Pregnancy|1|||
19471268|NCT01718483|41744703|FG001|Overall Study|Pregnancy|1|||
19471269|NCT01718483|41744702|FG000|Overall Study|Lack of Efficacy|1|||
19471270|NCT01718483|41744703|FG001|Overall Study|Lack of Efficacy|0|||
19471271|NCT01717859|41744709|FG000|Overall Study|Adverse Event|5|||
19471272|NCT01717859|41744709|FG000|Overall Study|Moved out of state|1|||
19471273|NCT01717859|41744709|FG000|Overall Study|Patient concerned about mental health|1|||
19471274|NCT01717859|41744709|FG000|Overall Study|Lost to Follow-up|1|||
19471275|NCT01717859|41744709|FG000|Overall Study|Withdrawal by Subject|2|||
19471276|NCT01747499|41745002|FG000|Overall Study|Steroid refractory aGvHD|1|||
19471277|NCT01747499|41745003|FG001|Overall Study|Steroid refractory aGvHD|0|||
19471278|NCT01747499|41745004|FG002|Overall Study|Steroid refractory aGvHD|0|||
19471279|NCT01747499|41745005|FG003|Overall Study|Steroid refractory aGvHD|1|||
19471280|NCT01747499|41745006|FG004|Overall Study|Steroid refractory aGvHD|4|||
19471281|NCT01747499|41745002|FG000|Overall Study|Physician Decision|0|||
19471282|NCT01747499|41745003|FG001|Overall Study|Physician Decision|1|||
19471283|NCT01747499|41745004|FG002|Overall Study|Physician Decision|0|||
19471284|NCT01747499|41745005|FG003|Overall Study|Physician Decision|0|||
19471285|NCT01747499|41745006|FG004|Overall Study|Physician Decision|2|||
19471286|NCT01747499|41745002|FG000|Overall Study|Death|0|||
19471287|NCT01747499|41745003|FG001|Overall Study|Death|0|||
19471288|NCT01747499|41745004|FG002|Overall Study|Death|0|||
19471289|NCT01747499|41745005|FG003|Overall Study|Death|1|||
19471290|NCT01747499|41745006|FG004|Overall Study|Death|1|||
19471291|NCT01747499|41745002|FG000|Overall Study|Withdrawal by Subject|0|||
19471292|NCT01747499|41745003|FG001|Overall Study|Withdrawal by Subject|0|||
19471293|NCT01747499|41745004|FG002|Overall Study|Withdrawal by Subject|0|||
19471294|NCT01747499|41745005|FG003|Overall Study|Withdrawal by Subject|0|||
19471295|NCT01747499|41745006|FG004|Overall Study|Withdrawal by Subject|6|||
19471296|NCT01747499|41745002|FG000|Overall Study|Developed AML and death|0|||
19471297|NCT01747499|41745003|FG001|Overall Study|Developed AML and death|0|||
19471298|NCT01747499|41745004|FG002|Overall Study|Developed AML and death|0|||
19471299|NCT01747499|41745005|FG003|Overall Study|Developed AML and death|0|||
19471300|NCT01747499|41745006|FG004|Overall Study|Developed AML and death|1|||
19471301|NCT01747499|41745002|FG000|Overall Study|Determined not to be eligible|0|||
19471302|NCT01747499|41745003|FG001|Overall Study|Determined not to be eligible|0|||
19471303|NCT01747499|41745004|FG002|Overall Study|Determined not to be eligible|0|||
19471304|NCT01747499|41745005|FG003|Overall Study|Determined not to be eligible|0|||
19471305|NCT01747499|41745006|FG004|Overall Study|Determined not to be eligible|1|||
19471306|NCT01717391|41745038|FG000|Overall Study|Withdrawal by Subject|5|||
19471307|NCT01717391|41745038|FG000|Overall Study|Physician Decision|1|||
19471308|NCT01717391|41745038|FG000|Overall Study|FLT technical failure|3|||
19471309|NCT01746017|41745181|FG000|Period 1|Withdrawal by Subject|0|||
19471310|NCT01746017|41745182|FG001|Period 1|Withdrawal by Subject|0|||
19471311|NCT01746017|41745183|FG002|Period 1|Withdrawal by Subject|0|||
19471312|NCT01746017|41745184|FG003|Period 1|Withdrawal by Subject|0|||
19471313|NCT01746017|41745185|FG004|Period 1|Withdrawal by Subject|0|||
19471314|NCT01746017|41745186|FG005|Period 1|Withdrawal by Subject|0|||
19471315|NCT01746017|41745187|FG006|Period 1|Withdrawal by Subject|1|||
19471316|NCT01746017|41745188|FG007|Period 1|Withdrawal by Subject|0|||
19471317|NCT01746017|41745189|FG008|Period 1|Withdrawal by Subject|0|||
19471318|NCT01746017|41745190|FG009|Period 1|Withdrawal by Subject|0|||
19471319|NCT01746017|41745191|FG010|Period 1|Withdrawal by Subject|0|||
19471320|NCT01746017|41745181|FG000|Period 3|Withdrawal by Subject|0|||
19471321|NCT01746017|41745182|FG001|Period 3|Withdrawal by Subject|0|||
19471322|NCT01746017|41745183|FG002|Period 3|Withdrawal by Subject|0|||
19471323|NCT01746017|41745184|FG003|Period 3|Withdrawal by Subject|0|||
19471324|NCT01746017|41745185|FG004|Period 3|Withdrawal by Subject|0|||
19471325|NCT01746017|41745186|FG005|Period 3|Withdrawal by Subject|1|||
19471326|NCT01746017|41745187|FG006|Period 3|Withdrawal by Subject|0|||
19471327|NCT01746017|41745188|FG007|Period 3|Withdrawal by Subject|0|||
19471328|NCT01746017|41745189|FG008|Period 3|Withdrawal by Subject|0|||
19471329|NCT01746017|41745190|FG009|Period 3|Withdrawal by Subject|0|||
19471330|NCT01746017|41745191|FG010|Period 3|Withdrawal by Subject|0|||
19471331|NCT01717313|41745253|FG000|Phase A (Weeks 0 to 24)|Death|0|||
19471332|NCT01717313|41745254|FG001|Phase A (Weeks 0 to 24)|Death|1|||
19471333|NCT01717313|41745253|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
19471334|NCT01717313|41745254|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
19471335|NCT01717313|41745253|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
19471336|NCT01717313|41745254|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
19471337|NCT01717313|41745253|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
19471338|NCT01717313|41745254|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
19471339|NCT01717313|41745253|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
19471340|NCT01717313|41745254|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
19471341|NCT01717313|41745253|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
19471342|NCT01717313|41745254|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
19471343|NCT01717313|41745253|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
19471344|NCT01717313|41745254|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
19471345|NCT01717313|41745253|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
19471346|NCT01717313|41745254|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
19471347|NCT01717313|41745253|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
19471348|NCT01717313|41745254|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
19471349|NCT01745393|41745266|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
19471350|NCT01745393|41745267|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
19471351|NCT01745393|41745266|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
19471352|NCT01745393|41745267|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
19471353|NCT01745393|41745266|FG000|12-month Follow-up|Lost to Follow-up|6|||
19471354|NCT01745393|41745267|FG001|12-month Follow-up|Lost to Follow-up|5|||
19471355|NCT01744691|41745298|FG000|Overall Study|Progressive Disease|18|||
19471356|NCT01744691|41745298|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
19471357|NCT01744691|41745298|FG000|Overall Study|Withdrawal of consent for treatment|3|||
19471358|NCT01744691|41745298|FG000|Overall Study|Physician Decision|4|||
19471359|NCT01716533|41745333|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
19471360|NCT01716533|41745334|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
19471361|NCT01716533|41745335|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
19471362|NCT01716533|41745336|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
19471363|NCT01716533|41745333|FG000|Overall Study|Withdrawal by Subject|0|||
19471364|NCT01716533|41745334|FG001|Overall Study|Withdrawal by Subject|0|||
19471365|NCT01716533|41745335|FG002|Overall Study|Withdrawal by Subject|0|||
19471366|NCT01716533|41745336|FG003|Overall Study|Withdrawal by Subject|5|||
19471367|NCT01716533|41745333|FG000|Overall Study|Death|0|||
19471368|NCT01716533|41745334|FG001|Overall Study|Death|0|||
19471369|NCT01716533|41745335|FG002|Overall Study|Death|0|||
19471370|NCT01716533|41745336|FG003|Overall Study|Death|2|||
19471371|NCT01716533|41745333|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
19471372|NCT01716533|41745334|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
19471373|NCT01716533|41745335|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
19471374|NCT01716533|41745336|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
19471375|NCT01375374|41745350|FG000|Overall Study|Adverse Event|1|||
19471376|NCT01743989|41745962|FG000|Treatment Phase|Unstable MR4.0|0|||
19471377|NCT01743989|41745963|FG001|Treatment Phase|Unstable MR4.0|6|||
19471378|NCT01743989|41745964|FG002|Treatment Phase|Unstable MR4.0|263|||
19471379|NCT01743989|41745962|FG000|Treatment Phase|Adverse Event|0|||
19471380|NCT01743989|41745963|FG001|Treatment Phase|Adverse Event|4|||
19471381|NCT01743989|41745964|FG002|Treatment Phase|Adverse Event|67|||
19471382|NCT01743989|41745962|FG000|Treatment Phase|Withdrawal by Subject|1|||
19471383|NCT01743989|41745963|FG001|Treatment Phase|Withdrawal by Subject|3|||
19471384|NCT01743989|41745964|FG002|Treatment Phase|Withdrawal by Subject|28|||
19471385|NCT01743989|41745962|FG000|Treatment Phase|Death|0|||
19471386|NCT01743989|41745963|FG001|Treatment Phase|Death|1|||
19471387|NCT01743989|41745964|FG002|Treatment Phase|Death|3|||
19471388|NCT01743989|41745962|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
19471389|NCT01743989|41745963|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
19471390|NCT01743989|41745964|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
19471391|NCT01743989|41745962|FG000|Treatment Phase|Protocol deviation|0|||
19471392|NCT01743989|41745963|FG001|Treatment Phase|Protocol deviation|0|||
19471393|NCT01743989|41745964|FG002|Treatment Phase|Protocol deviation|3|||
19471394|NCT01743989|41745962|FG000|Treatment Phase|Pregnancy|0|||
19471395|NCT01743989|41745963|FG001|Treatment Phase|Pregnancy|0|||
19471396|NCT01743989|41745964|FG002|Treatment Phase|Pregnancy|2|||
19471397|NCT01743989|41745962|FG000|Treatment Phase|Lost to Follow-up|0|||
19471398|NCT01743989|41745963|FG001|Treatment Phase|Lost to Follow-up|0|||
19471399|NCT01743989|41745964|FG002|Treatment Phase|Lost to Follow-up|2|||
19471400|NCT01743989|41745962|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
19471401|NCT01743989|41745963|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
19471402|NCT01743989|41745964|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
19471403|NCT01743989|41745962|FG000|Treatment Phase|Administrative problems|0|||
19471404|NCT01743989|41745963|FG001|Treatment Phase|Administrative problems|0|||
19471405|NCT01743989|41745964|FG002|Treatment Phase|Administrative problems|1|||
19471406|NCT01743989|41745962|FG000|Treatment Phase|New cancer (CML) therapy|0|||
19471407|NCT01743989|41745963|FG001|Treatment Phase|New cancer (CML) therapy|1|||
19471408|NCT01743989|41745964|FG002|Treatment Phase|New cancer (CML) therapy|0|||
19471409|NCT01743989|41745962|FG000|Treatment Phase|Physician Decision|0|||
19471410|NCT01743989|41745963|FG001|Treatment Phase|Physician Decision|0|||
19553845|NCT01310699|42002764|FG000|Overall Study|Patients did not complete tandem.|4|||
19471411|NCT01743989|41745964|FG002|Treatment Phase|Physician Decision|3|||
19471412|NCT01743989|41745962|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
19471413|NCT01743989|41745963|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
19471414|NCT01743989|41745964|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
19471415|NCT01743989|41745962|FG000|Treatment Phase|Not randomized by mistake|0|||
19471416|NCT01743989|41745963|FG001|Treatment Phase|Not randomized by mistake|0|||
19471417|NCT01743989|41745964|FG002|Treatment Phase|Not randomized by mistake|1|||
19471418|NCT01743989|41745962|FG000|Treatment Phase|Included by mistake|0|||
19471419|NCT01743989|41745963|FG001|Treatment Phase|Included by mistake|0|||
19471420|NCT01743989|41745964|FG002|Treatment Phase|Included by mistake|1|||
19471421|NCT01743989|41745962|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
19471422|NCT01743989|41745963|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
19471423|NCT01743989|41745964|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
19471424|NCT01743989|41745962|FG000|TFR Phase|Adverse Event|0|||
19471425|NCT01743989|41745963|FG001|TFR Phase|Adverse Event|1|||
19471426|NCT01743989|41745964|FG002|TFR Phase|Adverse Event|0|||
19471427|NCT01743989|41745962|FG000|TFR Phase|Lost to Follow-up|0|||
19471428|NCT01743989|41745963|FG001|TFR Phase|Lost to Follow-up|2|||
19471429|NCT01743989|41745964|FG002|TFR Phase|Lost to Follow-up|0|||
19471430|NCT01743989|41745962|FG000|TFR Phase|Physician Decision|0|||
19471431|NCT01743989|41745963|FG001|TFR Phase|Physician Decision|1|||
19471432|NCT01743989|41745964|FG002|TFR Phase|Physician Decision|0|||
19471433|NCT01743989|41745962|FG000|TFR Phase|Logistical problems|0|||
19471434|NCT01743989|41745963|FG001|TFR Phase|Logistical problems|2|||
19471435|NCT01743989|41745964|FG002|TFR Phase|Logistical problems|0|||
19471436|NCT01743989|41745962|FG000|TFR Phase|Protocol deviation|0|||
19471437|NCT01743989|41745963|FG001|TFR Phase|Protocol deviation|1|||
19471438|NCT01743989|41745964|FG002|TFR Phase|Protocol deviation|0|||
19471439|NCT01743989|41745962|FG000|TFR Phase|Withdrawal by Subject|0|||
19471440|NCT01743989|41745963|FG001|TFR Phase|Withdrawal by Subject|2|||
19471441|NCT01743989|41745964|FG002|TFR Phase|Withdrawal by Subject|0|||
19471442|NCT01743989|41745962|FG000|Re-treatment Phase|Adverse Event|8|||
19471443|NCT01743989|41745963|FG001|Re-treatment Phase|Adverse Event|4|||
19471444|NCT01743989|41745964|FG002|Re-treatment Phase|Adverse Event|0|||
19471445|NCT01743989|41745962|FG000|Re-treatment Phase|Death|1|||
19471446|NCT01743989|41745963|FG001|Re-treatment Phase|Death|1|||
19471447|NCT01743989|41745964|FG002|Re-treatment Phase|Death|0|||
19471448|NCT01743989|41745962|FG000|Re-treatment Phase|Administrative problems|1|||
19471449|NCT01743989|41745963|FG001|Re-treatment Phase|Administrative problems|1|||
19471450|NCT01743989|41745964|FG002|Re-treatment Phase|Administrative problems|0|||
19471451|NCT01743989|41745962|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
19471452|NCT01743989|41745963|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
19471453|NCT01743989|41745964|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
19471454|NCT01743989|41745962|FG000|Re-treatment Phase|Unstable MR|1|||
19471455|NCT01743989|41745963|FG001|Re-treatment Phase|Unstable MR|0|||
19471456|NCT01743989|41745964|FG002|Re-treatment Phase|Unstable MR|0|||
19471457|NCT01743989|41745962|FG000|Re-treatment Phase|Physician Decision|0|||
19471458|NCT01743989|41745963|FG001|Re-treatment Phase|Physician Decision|1|||
19471459|NCT01743989|41745964|FG002|Re-treatment Phase|Physician Decision|0|||
19471460|NCT01743989|41745962|FG000|Re-treatment Phase|Lost to Follow-up|0|||
19471461|NCT01743989|41745963|FG001|Re-treatment Phase|Lost to Follow-up|1|||
19471462|NCT01743989|41745964|FG002|Re-treatment Phase|Lost to Follow-up|0|||
19471463|NCT01605461|41745997|FG000|Overall Study|Lost to Follow-up|3|||
19471464|NCT01605461|41745997|FG000|Overall Study|Withdrawal by Subject|1|||
19471465|NCT01742897|41746001|FG000|Overall Study|Adverse Event|3|||
19471466|NCT01742897|41746001|FG000|Overall Study|Withdrawal by Subject|1|||
19471467|NCT01742897|41746001|FG000|Overall Study|Other|1|||
19471468|NCT01715831|41746005|FG000|Overall Study|Adverse Event|1|||
19471469|NCT01741259|41746011|FG000|Overall Study|Protocol Violation|6|||
19471470|NCT01741259|41746012|FG001|Overall Study|Protocol Violation|4|||
19471471|NCT01741259|41746011|FG000|Overall Study|Withdrawal by Subject|0|||
19471472|NCT01741259|41746012|FG001|Overall Study|Withdrawal by Subject|2|||
19471473|NCT01715129|41746018|FG000|Overall Study|Adverse Event, fatal|1|||
19381836|NCT04032093|41624937|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
19471474|NCT01715129|41746018|FG000|Overall Study|Lack of Efficacy|3|||
19471475|NCT01715129|41746018|FG000|Overall Study|Protocol Violation|1|||
19471476|NCT01715129|41746018|FG000|Overall Study|Consent Withdrawn|2|||
19471477|NCT01715129|41746018|FG000|Overall Study|Lost to Follow-up|1|||
19471478|NCT01715129|41746018|FG000|Overall Study|Other|1|||
19471479|NCT01740791|41746111|FG000|Overall Study|Randomized but never treated|5|||
19471480|NCT01740791|41746112|FG001|Overall Study|Randomized but never treated|3|||
19471481|NCT01740791|41746113|FG002|Overall Study|Randomized but never treated|2|||
19471482|NCT01740791|41746114|FG003|Overall Study|Randomized but never treated|2|||
19471483|NCT01740791|41746115|FG004|Overall Study|Randomized but never treated|1|||
19471484|NCT01740791|41746116|FG005|Overall Study|Randomized but never treated|3|||
19471485|NCT01740791|41746111|FG000|Overall Study|Lost to Follow-up|2|||
19471486|NCT01740791|41746112|FG001|Overall Study|Lost to Follow-up|0|||
19471487|NCT01740791|41746113|FG002|Overall Study|Lost to Follow-up|2|||
19471488|NCT01740791|41746114|FG003|Overall Study|Lost to Follow-up|3|||
19471489|NCT01740791|41746115|FG004|Overall Study|Lost to Follow-up|2|||
19471490|NCT01740791|41746116|FG005|Overall Study|Lost to Follow-up|3|||
19471491|NCT01740791|41746111|FG000|Overall Study|Withdrew Consent|4|||
19471492|NCT01740791|41746112|FG001|Overall Study|Withdrew Consent|0|||
19471493|NCT01740791|41746113|FG002|Overall Study|Withdrew Consent|1|||
19471494|NCT01740791|41746114|FG003|Overall Study|Withdrew Consent|2|||
19471495|NCT01740791|41746115|FG004|Overall Study|Withdrew Consent|0|||
19471496|NCT01740791|41746116|FG005|Overall Study|Withdrew Consent|3|||
19471497|NCT01740791|41746111|FG000|Overall Study|Investigator's discretion|1|||
19471498|NCT01740791|41746112|FG001|Overall Study|Investigator's discretion|0|||
19471499|NCT01740791|41746113|FG002|Overall Study|Investigator's discretion|1|||
19471500|NCT01740791|41746114|FG003|Overall Study|Investigator's discretion|0|||
19471501|NCT01740791|41746115|FG004|Overall Study|Investigator's discretion|0|||
19471502|NCT01740791|41746116|FG005|Overall Study|Investigator's discretion|1|||
19471503|NCT01740791|41746111|FG000|Overall Study|Adverse Event|0|||
19471504|NCT01740791|41746112|FG001|Overall Study|Adverse Event|0|||
19471505|NCT01740791|41746113|FG002|Overall Study|Adverse Event|0|||
19471506|NCT01740791|41746114|FG003|Overall Study|Adverse Event|0|||
19471507|NCT01740791|41746115|FG004|Overall Study|Adverse Event|0|||
19471508|NCT01740791|41746116|FG005|Overall Study|Adverse Event|1|||
19471509|NCT01740401|41746171|FG000|Overall Study|Progression of disease|6|||
19471510|NCT01740401|41746171|FG000|Overall Study|Adverse Event|2|||
19471511|NCT01740401|41746171|FG000|Overall Study|Did not reach primary endpoint|2|||
19471512|NCT01740323|41746177|FG000|Overall Study|Adverse Event|1|||
19471513|NCT01740323|41746178|FG001|Overall Study|Adverse Event|0|||
19471514|NCT01740323|41746177|FG000|Overall Study|Randomized but did not take study drug|1|||
19471515|NCT01740323|41746178|FG001|Overall Study|Randomized but did not take study drug|0|||
19471516|NCT01740089|41746196|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
19471517|NCT01740089|41746197|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
19471518|NCT01740089|41746198|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
19471519|NCT01740089|41746196|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
19471520|NCT01740089|41746197|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
19471521|NCT01740089|41746198|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
19471522|NCT01740089|41746196|FG000|After 12 Weeks|Lack of Efficacy|3|||
19471523|NCT01740089|41746197|FG001|After 12 Weeks|Lack of Efficacy|1|||
19471524|NCT01740089|41746198|FG002|After 12 Weeks|Lack of Efficacy|4|||
19471525|NCT01740089|41746196|FG000|After 12 Weeks|Adverse Event|2|||
19471526|NCT01740089|41746197|FG001|After 12 Weeks|Adverse Event|0|||
19471527|NCT01740089|41746198|FG002|After 12 Weeks|Adverse Event|5|||
19471528|NCT01740089|41746196|FG000|After 12 Weeks|Protocol Violation|1|||
19471529|NCT01740089|41746197|FG001|After 12 Weeks|Protocol Violation|1|||
19471530|NCT01740089|41746198|FG002|After 12 Weeks|Protocol Violation|1|||
19471531|NCT01740089|41746196|FG000|After 12 Weeks|Withdrawal by Subject|1|||
19471532|NCT01740089|41746197|FG001|After 12 Weeks|Withdrawal by Subject|1|||
19471533|NCT01740089|41746198|FG002|After 12 Weeks|Withdrawal by Subject|1|||
19471534|NCT01739933|41746209|FG000|Overall Study|Death|89|||
19471535|NCT01739933|41746210|FG001|Overall Study|Death|86|||
19471536|NCT01739933|41746209|FG000|Overall Study|Withdrawal by Subject|10|||
19471537|NCT01739933|41746210|FG001|Overall Study|Withdrawal by Subject|8|||
19471538|NCT01739933|41746209|FG000|Overall Study|Lost to Follow-up|3|||
19471539|NCT01739933|41746210|FG001|Overall Study|Lost to Follow-up|10|||
19471540|NCT01739933|41746209|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
19471541|NCT01739933|41746210|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
19471542|NCT01738919|41746227|FG000|Overall Study|Lost to Follow-up|1|||
19471543|NCT01738919|41746228|FG001|Overall Study|Lost to Follow-up|0|||
19471544|NCT01738919|41746227|FG000|Overall Study|Immigrated|0|||
19471545|NCT01738919|41746228|FG001|Overall Study|Immigrated|1|||
19471546|NCT01738919|41746227|FG000|Overall Study|Withdrawal by Subject|0|||
19471547|NCT01738919|41746228|FG001|Overall Study|Withdrawal by Subject|1|||
19471548|NCT01738919|41746227|FG000|Overall Study|Not treated in accordance to guidelines|0|||
19471549|NCT01738919|41746228|FG001|Overall Study|Not treated in accordance to guidelines|1|||
19471550|NCT01712399|41746249|FG000|Overall Study|Lost to Follow-up|1|||
19471551|NCT01712399|41746249|FG000|Overall Study|Withdrawal by Subject|39|||
19471552|NCT01712399|41746249|FG000|Overall Study|Death|1|||
19471553|NCT01712399|41746249|FG000|Overall Study|Adverse Event|11|||
19471554|NCT01712399|41746249|FG000|Overall Study|Study closure|345|||
19471555|NCT03225846|41746360|FG000|Overall Study|Adverse Event|0|||
19471556|NCT03225846|41746361|FG001|Overall Study|Adverse Event|0|||
19471557|NCT03225846|41746362|FG002|Overall Study|Adverse Event|0|||
19471558|NCT03225846|41746363|FG003|Overall Study|Adverse Event|0|||
19471559|NCT03225846|41746364|FG004|Overall Study|Adverse Event|0|||
19471560|NCT03225846|41746365|FG005|Overall Study|Adverse Event|0|||
19471561|NCT03225846|41746366|FG006|Overall Study|Adverse Event|6|||
19471562|NCT03225846|41746360|FG000|Overall Study|Withdrawal by Subject|0|||
19471563|NCT03225846|41746361|FG001|Overall Study|Withdrawal by Subject|1|||
19471564|NCT03225846|41746362|FG002|Overall Study|Withdrawal by Subject|0|||
19471565|NCT03225846|41746363|FG003|Overall Study|Withdrawal by Subject|0|||
19471566|NCT03225846|41746364|FG004|Overall Study|Withdrawal by Subject|0|||
19471567|NCT03225846|41746365|FG005|Overall Study|Withdrawal by Subject|0|||
19471568|NCT03225846|41746366|FG006|Overall Study|Withdrawal by Subject|0|||
19471569|NCT03225846|41746360|FG000|Overall Study|Death|0|||
19471570|NCT03225846|41746361|FG001|Overall Study|Death|1|||
19471571|NCT03225846|41746362|FG002|Overall Study|Death|0|||
19471572|NCT03225846|41746363|FG003|Overall Study|Death|0|||
19471573|NCT03225846|41746364|FG004|Overall Study|Death|0|||
19471574|NCT03225846|41746365|FG005|Overall Study|Death|0|||
19471575|NCT03225846|41746366|FG006|Overall Study|Death|0|||
19553846|NCT01310699|42002765|FG001|Overall Study|Patients did not complete tandem.|6|||
19471576|NCT03225846|41746360|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471577|NCT03225846|41746361|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471578|NCT03225846|41746362|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
19471579|NCT03225846|41746363|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471580|NCT03225846|41746364|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471581|NCT03225846|41746365|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471582|NCT03225846|41746366|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
19471583|NCT03225846|41746360|FG000|Overall Study|Patient decision|0|||
19471584|NCT03225846|41746361|FG001|Overall Study|Patient decision|0|||
19471585|NCT03225846|41746362|FG002|Overall Study|Patient decision|0|||
19471586|NCT03225846|41746363|FG003|Overall Study|Patient decision|0|||
19471587|NCT03225846|41746364|FG004|Overall Study|Patient decision|0|||
19471588|NCT03225846|41746365|FG005|Overall Study|Patient decision|0|||
19471589|NCT03225846|41746366|FG006|Overall Study|Patient decision|1|||
19471590|NCT01712009|41746431|FG000|Overall Study|Withdrawal by Subject|24|||
19471591|NCT01712009|41746432|FG001|Overall Study|Withdrawal by Subject|15|||
19471592|NCT01712009|41746433|FG002|Overall Study|Withdrawal by Subject|8|||
19471593|NCT01712009|41746431|FG000|Overall Study|Lost to Follow-up|2|||
19471594|NCT01712009|41746432|FG001|Overall Study|Lost to Follow-up|0|||
19471595|NCT01712009|41746433|FG002|Overall Study|Lost to Follow-up|1|||
19471596|NCT01712009|41746431|FG000|Overall Study|Decision by Sponsor|12|||
19471597|NCT01712009|41746432|FG001|Overall Study|Decision by Sponsor|14|||
19471598|NCT01712009|41746433|FG002|Overall Study|Decision by Sponsor|12|||
19471599|NCT01711853|41746462|FG000|Overall Study|Not treated|3|||
19471600|NCT01708187|41746468|FG000|Overall Study|Lost to Follow-up|0|||
19471601|NCT01708187|41746469|FG001|Overall Study|Lost to Follow-up|1|||
19471602|NCT01711619|41746558|FG000|Overall Study|Early study termination|10|||
19471603|NCT01711619|41746559|FG001|Overall Study|Early study termination|14|||
19471604|NCT01711619|41746558|FG000|Overall Study|Withdrawal by Subject|3|||
19471605|NCT01711619|41746559|FG001|Overall Study|Withdrawal by Subject|7|||
19739295|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
19739296|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
19739297|NCT00293267|42186390|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
19739298|NCT00293267|42186391|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
19739299|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
19739300|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
19739301|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
19739302|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
19739303|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
19739304|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
19739305|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
19739306|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
19739307|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
19739308|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
19739309|NCT00293267|42186390|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
19471606|NCT01711619|41746558|FG000|Overall Study|Protocol Violation|2|||
19471607|NCT01711619|41746559|FG001|Overall Study|Protocol Violation|3|||
19471608|NCT01711619|41746558|FG000|Overall Study|Adverse Event|2|||
19471609|NCT01711619|41746559|FG001|Overall Study|Adverse Event|0|||
19471610|NCT01711619|41746558|FG000|Overall Study|Lost to Follow-up|1|||
19471611|NCT01711619|41746559|FG001|Overall Study|Lost to Follow-up|0|||
19471612|NCT01710527|41746574|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
19471613|NCT01710527|41746575|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
19471614|NCT01706939|41746583|FG000|Pre Randomization|Screen Failure|1|||
19471615|NCT01706939|41746584|FG001|Pre Randomization|Screen Failure|0|||
19471616|NCT01706939|41746585|FG002|Pre Randomization|Screen Failure|0|||
19471617|NCT01706939|41746583|FG000|Pre Randomization|Ineligible for Randomization|1|||
19471618|NCT01706939|41746584|FG001|Pre Randomization|Ineligible for Randomization|0|||
19471619|NCT01706939|41746585|FG002|Pre Randomization|Ineligible for Randomization|0|||
19471620|NCT01706939|41746583|FG000|Pre Randomization|Withdrawal by Subject|1|||
19471621|NCT01706939|41746584|FG001|Pre Randomization|Withdrawal by Subject|0|||
19471622|NCT01706939|41746585|FG002|Pre Randomization|Withdrawal by Subject|0|||
19471623|NCT01706939|41746583|FG000|Randomization|Insufficient QoL survey compliance|0|||
19471624|NCT01706939|41746584|FG001|Randomization|Insufficient QoL survey compliance|1|||
19471625|NCT01706939|41746585|FG002|Randomization|Insufficient QoL survey compliance|1|||
19471626|NCT01706939|41746583|FG000|Randomization|Progression of disease|0|||
19471627|NCT01706939|41746584|FG001|Randomization|Progression of disease|2|||
19471628|NCT01706939|41746585|FG002|Randomization|Progression of disease|1|||
19471629|NCT01709903|41746594|FG000|Overall Study|administrative problems|2|||
19471630|NCT01709903|41746595|FG001|Overall Study|administrative problems|6|||
19471631|NCT01709903|41746594|FG000|Overall Study|Abnormal test procedure results|1|||
19471632|NCT01709903|41746595|FG001|Overall Study|Abnormal test procedure results|0|||
19471633|NCT01709903|41746594|FG000|Overall Study|In ability to use device|1|||
19471634|NCT01709903|41746595|FG001|Overall Study|In ability to use device|1|||
19471635|NCT01709903|41746594|FG000|Overall Study|no longer needed study drug|0|||
19471636|NCT01709903|41746595|FG001|Overall Study|no longer needed study drug|1|||
19471637|NCT01709903|41746594|FG000|Overall Study|Lost to Follow-up|0|||
19471638|NCT01709903|41746595|FG001|Overall Study|Lost to Follow-up|2|||
19471639|NCT01709903|41746594|FG000|Overall Study|Death|2|||
19471640|NCT01709903|41746595|FG001|Overall Study|Death|0|||
19471641|NCT01709903|41746594|FG000|Overall Study|Protocol Violation|3|||
19471642|NCT01709903|41746595|FG001|Overall Study|Protocol Violation|2|||
19471643|NCT01709903|41746594|FG000|Overall Study|Lack of Efficacy|3|||
19471644|NCT01709903|41746595|FG001|Overall Study|Lack of Efficacy|3|||
19471645|NCT01709903|41746594|FG000|Overall Study|Withdrawal by Subject|6|||
19471646|NCT01709903|41746595|FG001|Overall Study|Withdrawal by Subject|6|||
19471647|NCT01709903|41746594|FG000|Overall Study|Adverse Event|11|||
19471648|NCT01709903|41746595|FG001|Overall Study|Adverse Event|18|||
19471649|NCT04492618|41746601|FG000|Overall Study|Withdrawal by Subject|1|||
19471650|NCT01605227|41746607|FG000|Overall Study|Did not receive study treatment|2|||
19471651|NCT01605227|41746608|FG001|Overall Study|Did not receive study treatment|3|||
19471652|NCT01605227|41746607|FG000|Overall Study|Adverse Event|228|||
19471653|NCT01605227|41746608|FG001|Overall Study|Adverse Event|42|||
19471654|NCT01605227|41746607|FG000|Overall Study|Progressive Disease|132|||
19471655|NCT01605227|41746608|FG001|Overall Study|Progressive Disease|128|||
19471656|NCT01605227|41746607|FG000|Overall Study|Clinical Deterioration|227|||
19471657|NCT01605227|41746608|FG001|Overall Study|Clinical Deterioration|133|||
19471658|NCT01605227|41746607|FG000|Overall Study|Lost to Follow-up|1|||
19471659|NCT01605227|41746608|FG001|Overall Study|Lost to Follow-up|0|||
19471660|NCT01605227|41746607|FG000|Overall Study|Protocol Violation|1|||
19471661|NCT01605227|41746608|FG001|Overall Study|Protocol Violation|0|||
19471662|NCT01605227|41746607|FG000|Overall Study|Physician Decision|9|||
19471663|NCT01605227|41746608|FG001|Overall Study|Physician Decision|7|||
19471664|NCT01605227|41746607|FG000|Overall Study|Withdrawal by Subject|18|||
19471665|NCT01605227|41746608|FG001|Overall Study|Withdrawal by Subject|14|||
19471666|NCT01605227|41746607|FG000|Overall Study|Sponsor Decision|2|||
19471667|NCT01605227|41746608|FG001|Overall Study|Sponsor Decision|0|||
19471668|NCT01605227|41746607|FG000|Overall Study|Started New Therapy|1|||
19471669|NCT01605227|41746608|FG001|Overall Study|Started New Therapy|0|||
19471670|NCT01605227|41746607|FG000|Overall Study|Subject Decision|0|||
19471671|NCT01605227|41746608|FG001|Overall Study|Subject Decision|1|||
19471672|NCT01605227|41746607|FG000|Overall Study|Dose Held >6 weeks|0|||
19471673|NCT01605227|41746608|FG001|Overall Study|Dose Held >6 weeks|1|||
19471674|NCT01709513|41746617|FG000|Overall Study|Randomized but not treated|0|||
19471675|NCT01709513|41746618|FG001|Overall Study|Randomized but not treated|1|||
19471676|NCT01709513|41746619|FG002|Overall Study|Randomized but not treated|0|||
19471677|NCT01709513|41746617|FG000|Overall Study|Adverse Event|16|||
19471678|NCT01709513|41746618|FG001|Overall Study|Adverse Event|31|||
19471679|NCT01709513|41746619|FG002|Overall Study|Adverse Event|23|||
19471680|NCT01709513|41746617|FG000|Overall Study|Poor compliance to protocol|2|||
19471681|NCT01709513|41746618|FG001|Overall Study|Poor compliance to protocol|0|||
19471682|NCT01709513|41746619|FG002|Overall Study|Poor compliance to protocol|0|||
19471683|NCT01709513|41746617|FG000|Overall Study|Other|3|||
19471684|NCT01709513|41746618|FG001|Overall Study|Other|11|||
19471685|NCT01709513|41746619|FG002|Overall Study|Other|7|||
19471686|NCT01605071|41746632|FG000|Overall Study|Withdrawal by Subject|3|||
19471687|NCT01605071|41746633|FG001|Overall Study|Withdrawal by Subject|2|||
19471688|NCT02710422|41746643|FG000|Overall Study|Termination of study|9|||
19471689|NCT02710422|41746644|FG001|Overall Study|Termination of study|9|||
19471690|NCT01706159|41746654|FG000|Overall Study|Withdrawal Criteria|2|||
19471691|NCT01706159|41746655|FG001|Overall Study|Withdrawal Criteria|1|||
19471692|NCT01706159|41746654|FG000|Overall Study|Unclassified|6|||
19471693|NCT01706159|41746655|FG001|Overall Study|Unclassified|1|||
19471694|NCT01706003|41746663|FG000|Overall Study|Withdrawal by Subject|2|||
19471695|NCT01706003|41746664|FG001|Overall Study|Withdrawal by Subject|0|||
19471696|NCT01706003|41746663|FG000|Overall Study|Not scheduled|3|||
19471697|NCT01706003|41746664|FG001|Overall Study|Not scheduled|0|||
19471698|NCT01706003|41746663|FG000|Overall Study|Lost to Follow-up|6|||
19471699|NCT01706003|41746664|FG001|Overall Study|Lost to Follow-up|4|||
19471700|NCT01705691|41746672|FG000|Overall Study|Death|1|||
19471701|NCT01705691|41746673|FG001|Overall Study|Death|2|||
19471702|NCT01705691|41746672|FG000|Overall Study|Withdrawal by Subject|1|||
19471703|NCT01705691|41746673|FG001|Overall Study|Withdrawal by Subject|2|||
19381837|NCT04032093|41624938|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
19471704|NCT01705691|41746672|FG000|Overall Study|Lost to Follow-up|1|||
19471705|NCT01705691|41746673|FG001|Overall Study|Lost to Follow-up|1|||
19471706|NCT01705691|41746672|FG000|Overall Study|Other|0|||
19471707|NCT01705691|41746673|FG001|Overall Study|Other|1|||
19471708|NCT03766906|41746679|FG000|Overall Study|Withdrawal by Subject|6|||
19471709|NCT01705145|41746683|FG000|Part B|Adverse Event|1|||
19471710|NCT01704755|41746701|FG000|Overall Study|Adverse Event|4|||
19471711|NCT01704755|41746702|FG001|Overall Study|Adverse Event|1|||
19471712|NCT01704755|41746701|FG000|Overall Study|Lost to Follow-up|3|||
19471713|NCT01704755|41746702|FG001|Overall Study|Lost to Follow-up|4|||
19471714|NCT01704755|41746701|FG000|Overall Study|Withdrew consent|1|||
19471715|NCT01704755|41746702|FG001|Overall Study|Withdrew consent|1|||
19471716|NCT01704755|41746701|FG000|Overall Study|Other (not specified)|3|||
19471717|NCT01704755|41746702|FG001|Overall Study|Other (not specified)|1|||
19471718|NCT01704755|41746701|FG000|Overall Study|Withdrew consent and personal issues|1|||
19471719|NCT01704755|41746702|FG001|Overall Study|Withdrew consent and personal issues|0|||
19471720|NCT01704599|41746708|FG000|Overall Study|Adverse Event|1|||
19471721|NCT03599518|41746740|FG000|Overall Study|Clinical progression|0|||
19471722|NCT03599518|41746741|FG001|Overall Study|Clinical progression|0|||
19471723|NCT03599518|41746742|FG002|Overall Study|Clinical progression|0|||
19471724|NCT03599518|41746743|FG003|Overall Study|Clinical progression|0|||
19471725|NCT03599518|41746744|FG004|Overall Study|Clinical progression|1|||
19471726|NCT03599518|41746740|FG000|Overall Study|Adverse Event|0|||
19471727|NCT03599518|41746741|FG001|Overall Study|Adverse Event|0|||
19471728|NCT03599518|41746742|FG002|Overall Study|Adverse Event|0|||
19471729|NCT03599518|41746743|FG003|Overall Study|Adverse Event|0|||
19471730|NCT03599518|41746744|FG004|Overall Study|Adverse Event|1|||
19471731|NCT03599518|41746740|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
19471732|NCT03599518|41746741|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
19471733|NCT03599518|41746742|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
19471734|NCT03599518|41746743|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
19471735|NCT03599518|41746744|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
19471736|NCT03599518|41746740|FG000|Overall Study|Participant withdrawal from study treatment|0|||
19471737|NCT03599518|41746741|FG001|Overall Study|Participant withdrawal from study treatment|0|||
19471738|NCT03599518|41746742|FG002|Overall Study|Participant withdrawal from study treatment|1|||
19471739|NCT03599518|41746743|FG003|Overall Study|Participant withdrawal from study treatment|0|||
19471740|NCT03599518|41746744|FG004|Overall Study|Participant withdrawal from study treatment|0|||
19471741|NCT02709486|41746821|FG000|Overall Study|Adverse Event|2|||
19471742|NCT02709486|41746822|FG001|Overall Study|Adverse Event|5|||
19471743|NCT02709486|41746823|FG002|Overall Study|Adverse Event|3|||
19471744|NCT02709486|41746821|FG000|Overall Study|Death|0|||
19471745|NCT02709486|41746822|FG001|Overall Study|Death|0|||
19471746|NCT02709486|41746823|FG002|Overall Study|Death|2|||
19471747|NCT02709486|41746821|FG000|Overall Study|Insufficient clinical response|7|||
19471748|NCT02709486|41746822|FG001|Overall Study|Insufficient clinical response|3|||
19471749|NCT02709486|41746823|FG002|Overall Study|Insufficient clinical response|3|||
19471750|NCT02709486|41746821|FG000|Overall Study|Lost to Follow-up|3|||
19471751|NCT02709486|41746822|FG001|Overall Study|Lost to Follow-up|2|||
19471752|NCT02709486|41746823|FG002|Overall Study|Lost to Follow-up|2|||
19471753|NCT02709486|41746821|FG000|Overall Study|Other|0|||
19471754|NCT02709486|41746822|FG001|Overall Study|Other|2|||
19471755|NCT02709486|41746823|FG002|Overall Study|Other|3|||
19471756|NCT02709486|41746821|FG000|Overall Study|Withdrawal by Subject|32|||
19471757|NCT02709486|41746822|FG001|Overall Study|Withdrawal by Subject|22|||
19471758|NCT02709486|41746823|FG002|Overall Study|Withdrawal by Subject|32|||
19471759|NCT03110770|41746840|FG000|Overall Study|Death|1|||
19471760|NCT03110770|41746841|FG001|Overall Study|Death|0|||
19471761|NCT03110770|41746842|FG002|Overall Study|Death|0|||
19471762|NCT03110770|41746843|FG003|Overall Study|Death|1|||
19471763|NCT03110770|41746844|FG004|Overall Study|Death|0|||
19471764|NCT03110770|41746840|FG000|Overall Study|Enrolled but did not receive product|0|||
19471765|NCT03110770|41746841|FG001|Overall Study|Enrolled but did not receive product|0|||
19471766|NCT03110770|41746842|FG002|Overall Study|Enrolled but did not receive product|0|||
19471767|NCT03110770|41746843|FG003|Overall Study|Enrolled but did not receive product|8|||
19471768|NCT03110770|41746844|FG004|Overall Study|Enrolled but did not receive product|7|||
19471769|NCT03110770|41746840|FG000|Overall Study|Lost to Follow-up|0|||
19471770|NCT03110770|41746841|FG001|Overall Study|Lost to Follow-up|0|||
19471771|NCT03110770|41746842|FG002|Overall Study|Lost to Follow-up|0|||
19471772|NCT03110770|41746843|FG003|Overall Study|Lost to Follow-up|53|||
19471773|NCT03110770|41746844|FG004|Overall Study|Lost to Follow-up|45|||
19471774|NCT03110770|41746840|FG000|Overall Study|Investigator Decision|0|||
19471775|NCT03110770|41746841|FG001|Overall Study|Investigator Decision|0|||
19471776|NCT03110770|41746842|FG002|Overall Study|Investigator Decision|0|||
19471777|NCT03110770|41746843|FG003|Overall Study|Investigator Decision|5|||
19471778|NCT03110770|41746844|FG004|Overall Study|Investigator Decision|3|||
19471779|NCT03110770|41746840|FG000|Overall Study|Withdrawal by Subject|0|||
19471780|NCT03110770|41746841|FG001|Overall Study|Withdrawal by Subject|0|||
19471781|NCT03110770|41746842|FG002|Overall Study|Withdrawal by Subject|0|||
19471782|NCT03110770|41746843|FG003|Overall Study|Withdrawal by Subject|24|||
19471783|NCT03110770|41746844|FG004|Overall Study|Withdrawal by Subject|24|||
19471784|NCT03110770|41746840|FG000|Overall Study|Moved from area|5|||
19471785|NCT03110770|41746841|FG001|Overall Study|Moved from area|0|||
19471786|NCT03110770|41746842|FG002|Overall Study|Moved from area|2|||
19471787|NCT03110770|41746843|FG003|Overall Study|Moved from area|42|||
19471788|NCT03110770|41746844|FG004|Overall Study|Moved from area|43|||
19471789|NCT03110770|41746840|FG000|Overall Study|Illness/Injury unrelated to product|0|||
19471790|NCT03110770|41746841|FG001|Overall Study|Illness/Injury unrelated to product|0|||
19471791|NCT03110770|41746842|FG002|Overall Study|Illness/Injury unrelated to product|0|||
19471792|NCT03110770|41746843|FG003|Overall Study|Illness/Injury unrelated to product|0|||
19471793|NCT03110770|41746844|FG004|Overall Study|Illness/Injury unrelated to product|1|||
19471794|NCT00703326|41747050|FG000|Overall Study|Lost to Follow-up|47|||
19471795|NCT00703326|41747051|FG001|Overall Study|Lost to Follow-up|18|||
19471796|NCT00703326|41747050|FG000|Overall Study|Withdrawal by Subject|54|||
19471797|NCT00703326|41747051|FG001|Overall Study|Withdrawal by Subject|20|||
19471798|NCT00703326|41747050|FG000|Overall Study|Adverse Event|1|||
19471799|NCT00703326|41747051|FG001|Overall Study|Adverse Event|0|||
19471800|NCT04868500|41747104|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
19471801|NCT04868500|41747105|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
19471802|NCT04868500|41747104|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
19471803|NCT04868500|41747105|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
19471804|NCT04372186|41747113|FG000|Overall Study|Death|24|||
19471805|NCT04372186|41747114|FG001|Overall Study|Death|11|||
19471806|NCT04372186|41747113|FG000|Overall Study|Transferred to a different facility for care|0|||
19471807|NCT04372186|41747114|FG001|Overall Study|Transferred to a different facility for care|2|||
19471808|NCT04317040|41747144|FG000|Overall Study|Lost to Follow-up|2|||
19471809|NCT04317040|41747145|FG001|Overall Study|Lost to Follow-up|0|||
19471810|NCT04317040|41747144|FG000|Overall Study|Death|16|||
19471811|NCT04317040|41747145|FG001|Overall Study|Death|18|||
19471812|NCT04317040|41747144|FG000|Overall Study|Withdrawal by Subject|0|||
19471813|NCT04317040|41747145|FG001|Overall Study|Withdrawal by Subject|1|||
19471814|NCT04317040|41747144|FG000|Overall Study|Incomplete assessments|0|||
19471815|NCT04317040|41747145|FG001|Overall Study|Incomplete assessments|1|||
19471816|NCT00703014|41747225|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
19471817|NCT00703014|41747226|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
19471818|NCT00703014|41747227|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
19471819|NCT00703014|41747228|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
19471820|NCT00703014|41747225|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
19471821|NCT00703014|41747226|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
19471822|NCT00703014|41747227|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
19471823|NCT00703014|41747228|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
19471824|NCT03915496|41747280|FG000|Overall Study|Adverse Event|2|||
19471825|NCT03915496|41747281|FG001|Overall Study|Adverse Event|1|||
19471826|NCT03915496|41747282|FG002|Overall Study|Adverse Event|2|||
19471827|NCT02709330|41747299|FG000|Overall Study|Death|5|||
19471828|NCT02709330|41747300|FG001|Overall Study|Death|0|||
19471829|NCT02709330|41747299|FG000|Overall Study|Lost to Follow-up|2|||
19471830|NCT02709330|41747300|FG001|Overall Study|Lost to Follow-up|0|||
19471831|NCT02709330|41747299|FG000|Overall Study|Physician Decision|2|||
19471832|NCT02709330|41747300|FG001|Overall Study|Physician Decision|0|||
19471833|NCT02709330|41747299|FG000|Overall Study|Withdrawal by Subject|4|||
19471834|NCT02709330|41747300|FG001|Overall Study|Withdrawal by Subject|0|||
19471835|NCT02709096|41747308|FG000|Overall Study|non-compliance|1|||
19471836|NCT02709096|41747309|FG001|Overall Study|non-compliance|1|||
19471837|NCT01372410|41747315|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
19471838|NCT01372410|41747316|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
19471839|NCT01372410|41747317|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
19471840|NCT01372410|41747318|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
19471841|NCT01372410|41747319|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
19471842|NCT01372410|41747320|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
19471843|NCT01372410|41747321|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
19471844|NCT01372410|41747322|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
19471845|NCT01372410|41747315|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471846|NCT01372410|41747316|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
19471847|NCT01372410|41747317|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471848|NCT01372410|41747318|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471849|NCT01372410|41747319|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471850|NCT01372410|41747320|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471851|NCT01372410|41747321|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
19471852|NCT01372410|41747322|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
19471853|NCT01372410|41747315|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471854|NCT01372410|41747316|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471855|NCT01372410|41747317|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471856|NCT01372410|41747318|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471857|NCT01372410|41747319|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
19471858|NCT01372410|41747320|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471859|NCT01372410|41747321|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471860|NCT01372410|41747322|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
19471861|NCT01372410|41747315|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471862|NCT01372410|41747316|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471863|NCT01372410|41747317|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471864|NCT01372410|41747318|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471865|NCT01372410|41747319|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471866|NCT01372410|41747320|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471867|NCT01372410|41747321|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
19471868|NCT01372410|41747322|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
19471869|NCT01372410|41747315|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
19471870|NCT01372410|41747316|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471871|NCT01372410|41747317|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471872|NCT01372410|41747318|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471873|NCT01372410|41747319|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471874|NCT01372410|41747320|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471875|NCT01372410|41747321|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
19471876|NCT01372410|41747322|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
19471877|NCT01372410|41747315|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471878|NCT01372410|41747316|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471879|NCT01372410|41747317|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471880|NCT01372410|41747318|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471881|NCT01372410|41747319|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
19471882|NCT01372410|41747320|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471883|NCT01372410|41747321|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471884|NCT01372410|41747322|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
19471885|NCT01372410|41747315|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
19471886|NCT01372410|41747316|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
19471887|NCT01372410|41747317|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
19471888|NCT01372410|41747318|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
19471889|NCT01372410|41747319|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
19471890|NCT01372410|41747320|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
19471891|NCT01372410|41747321|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
19471892|NCT01372410|41747322|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
19471893|NCT01372410|41747315|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471894|NCT01372410|41747316|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471895|NCT01372410|41747317|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471896|NCT01372410|41747318|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471897|NCT01372410|41747319|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471898|NCT01372410|41747320|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471899|NCT01372410|41747321|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
19471900|NCT01372410|41747322|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
19471901|NCT01372410|41747315|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471902|NCT01372410|41747316|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471903|NCT01372410|41747317|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
19471904|NCT01372410|41747318|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471905|NCT01372410|41747319|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471906|NCT01372410|41747320|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471907|NCT01372410|41747321|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471908|NCT01372410|41747322|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
19471909|NCT01372410|41747315|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471910|NCT01372410|41747316|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471911|NCT01372410|41747317|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471912|NCT01372410|41747318|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471913|NCT01372410|41747319|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471914|NCT01372410|41747320|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
19471915|NCT01372410|41747321|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471916|NCT01372410|41747322|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
19471917|NCT04624672|41747343|FG000|Overall Study|Early Study Closure|2|||
19471918|NCT04624672|41747344|FG001|Overall Study|Early Study Closure|1|||
19471919|NCT01704287|41747369|FG000|Initial Treatment Period|Death|139|||
19471920|NCT01704287|41747370|FG001|Initial Treatment Period|Death|129|||
19553847|NCT01310075|42002775|FG000|Overall Study|Lost to Follow-up|1|||
19553848|NCT01310075|42002776|FG001|Overall Study|Lost to Follow-up|0|||
19471921|NCT01704287|41747371|FG002|Initial Treatment Period|Death|71|||
19471922|NCT01704287|41747372|FG003|Initial Treatment Period|Death|0|||
19471923|NCT01704287|41747373|FG004|Initial Treatment Period|Death|0|||
19471924|NCT01704287|41747369|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
19471925|NCT01704287|41747370|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
19471926|NCT01704287|41747371|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
19471927|NCT01704287|41747372|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
19471928|NCT01704287|41747373|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
19471929|NCT01704287|41747369|FG000|Initial Treatment Period|Lost to Follow-up|5|||
19471930|NCT01704287|41747370|FG001|Initial Treatment Period|Lost to Follow-up|3|||
19471931|NCT01704287|41747371|FG002|Initial Treatment Period|Lost to Follow-up|0|||
19471932|NCT01704287|41747372|FG003|Initial Treatment Period|Lost to Follow-up|0|||
19471933|NCT01704287|41747373|FG004|Initial Treatment Period|Lost to Follow-up|0|||
19471934|NCT01704287|41747369|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
19471935|NCT01704287|41747370|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
19471936|NCT01704287|41747371|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
19471937|NCT01704287|41747372|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
19471938|NCT01704287|41747373|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
19471939|NCT01704287|41747369|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
19471940|NCT01704287|41747370|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
19471941|NCT01704287|41747371|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
19471942|NCT01704287|41747372|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
19471943|NCT01704287|41747373|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
19471944|NCT01704287|41747369|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
19471945|NCT01704287|41747370|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
19471946|NCT01704287|41747371|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
19471947|NCT01704287|41747372|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
19471948|NCT01704287|41747373|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
19471949|NCT01704287|41747369|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
19471950|NCT01704287|41747370|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
19471951|NCT01704287|41747371|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
19471952|NCT01704287|41747372|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
19471953|NCT01704287|41747373|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
19471954|NCT01682837|41747401|FG000|Baseline|Withdrawal by Subject|5|||
19471955|NCT01703819|41747438|FG000|Overall Study|Adverse Event|0|||
19471956|NCT01703819|41747439|FG001|Overall Study|Adverse Event|1|||
19471957|NCT01703819|41747438|FG000|Overall Study|Withdrawal by Subject|0|||
19471958|NCT01703819|41747439|FG001|Overall Study|Withdrawal by Subject|1|||
19471959|NCT01682759|41747451|FG000|Overall Study|Death|2|||
19471960|NCT01682759|41747452|FG001|Overall Study|Death|1|||
19471961|NCT01682759|41747451|FG000|Overall Study|Lost to Follow-up|10|||
19471962|NCT01682759|41747452|FG001|Overall Study|Lost to Follow-up|13|||
19471963|NCT01682759|41747451|FG000|Overall Study|Physician Decision|1|||
19471964|NCT01682759|41747452|FG001|Overall Study|Physician Decision|1|||
19471965|NCT01682759|41747451|FG000|Overall Study|Withdrawal by Subject|56|||
19471966|NCT01682759|41747452|FG001|Overall Study|Withdrawal by Subject|55|||
19471967|NCT01682681|41747462|FG000|Overall Study|Lack of Efficacy|62|||
19471968|NCT01682681|41747462|FG000|Overall Study|Withdrawal by Subject|1|||
19471969|NCT01682681|41747462|FG000|Overall Study|Moved to other hospital|10|||
19471970|NCT01682681|41747462|FG000|Overall Study|Lost to Follow-up|174|||
19471971|NCT01682681|41747462|FG000|Overall Study|Adverse Event|46|||
19471972|NCT01682681|41747462|FG000|Overall Study|tapering of topiramate|5|||
19471973|NCT01682681|41747462|FG000|Overall Study|Other|21|||
19471974|NCT01682681|41747462|FG000|Overall Study|Low compliance|13|||
19471975|NCT01682603|41747466|FG000|Overall Study|Lost to Follow-up|3|||
19471976|NCT01682213|41747482|FG000|Overall Study|Withdrawal by Subject|2|||
19471977|NCT01703741|41747491|FG000|Overall Study|Withdrawal by Subject|6|||
19471978|NCT01703741|41747491|FG000|Overall Study|Adverse Event|2|||
19471979|NCT01703741|41747491|FG000|Overall Study|Physician Decision|2|||
19471980|NCT01703741|41747491|FG000|Overall Study|Protocol Violation|1|||
19471981|NCT01703741|41747491|FG000|Overall Study|Lost to Follow-up|3|||
19471982|NCT01703741|41747491|FG000|Overall Study|Subject did not want to continue|2|||
19471983|NCT01703741|41747491|FG000|Overall Study|Subject cannot comply with study visits|1|||
19471984|NCT01703741|41747491|FG000|Overall Study|Subject started testosterone injections|1|||
19471985|NCT01681511|41747497|FG000|Overall Study|No Treatment Received|1|||
19471986|NCT01681511|41747498|FG001|Overall Study|No Treatment Received|3|||
19471987|NCT01681511|41747497|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
19471988|NCT01681511|41747498|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
19553849|NCT01310075|42002775|FG000|Overall Study|Physician Decision|10|||
19553850|NCT01310075|42002776|FG001|Overall Study|Physician Decision|7|||
19471989|NCT01681511|41747497|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
19478165|NCT01693562|41757319|FG005|Expansion Phase|Other|0|||
19471990|NCT01681511|41747498|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
19471991|NCT01681511|41747497|FG000|Overall Study|No Daily Urine Sample Collected|0|||
19471992|NCT01681511|41747498|FG001|Overall Study|No Daily Urine Sample Collected|1|||
19471993|NCT01681511|41747497|FG000|Overall Study|No post-catheter sample collected|11|||
19471994|NCT01681511|41747498|FG001|Overall Study|No post-catheter sample collected|4|||
19471995|NCT02175004|41747506|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
19471996|NCT02175004|41747507|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
19471997|NCT02175004|41747506|FG000|Overall Study|Investigator Judgment|1|||
19471998|NCT02175004|41747507|FG001|Overall Study|Investigator Judgment|4|||
19471999|NCT02175004|41747506|FG000|Overall Study|Voluntary Withdrawal|6|||
19472000|NCT02175004|41747507|FG001|Overall Study|Voluntary Withdrawal|19|||
19472001|NCT02175004|41747506|FG000|Overall Study|Liver Transplant|1|||
19472002|NCT02175004|41747507|FG001|Overall Study|Liver Transplant|0|||
19472003|NCT02175004|41747506|FG000|Overall Study|Disease Progression|1|||
19472004|NCT02175004|41747507|FG001|Overall Study|Disease Progression|0|||
19472005|NCT02175004|41747506|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
19472006|NCT02175004|41747507|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
19472007|NCT01681433|41747515|FG000|Overall Study|Lack of Efficacy|23|||
19472008|NCT01681433|41747516|FG001|Overall Study|Lack of Efficacy|23|||
19472009|NCT01681433|41747515|FG000|Overall Study|Withdrawal by Subject|5|||
19472010|NCT01681433|41747516|FG001|Overall Study|Withdrawal by Subject|5|||
19472011|NCT01681433|41747515|FG000|Overall Study|Protocol Violation|2|||
19472012|NCT01681433|41747516|FG001|Overall Study|Protocol Violation|0|||
19472013|NCT01681433|41747515|FG000|Overall Study|Adverse Event|2|||
19472014|NCT01681433|41747516|FG001|Overall Study|Adverse Event|4|||
19472015|NCT01681433|41747515|FG000|Overall Study|Lost to Follow-up|0|||
19472016|NCT01681433|41747516|FG001|Overall Study|Lost to Follow-up|1|||
19472017|NCT01681277|41747527|FG000|Overall Study|Adverse Event|1|||
19472018|NCT01681277|41747528|FG001|Overall Study|Adverse Event|0|||
19472019|NCT01681277|41747529|FG002|Overall Study|Adverse Event|0|||
19472020|NCT01681277|41747530|FG003|Overall Study|Adverse Event|0|||
19472021|NCT01681277|41747531|FG004|Overall Study|Adverse Event|0|||
19472022|NCT01703117|41747549|FG000|Overall Study|Adverse Event|4|||
19472023|NCT01703117|41747550|FG001|Overall Study|Adverse Event|3|||
19472024|NCT01703117|41747549|FG000|Overall Study|Withdrawal by Subject|0|||
19472025|NCT01703117|41747550|FG001|Overall Study|Withdrawal by Subject|1|||
19472026|NCT01702961|41747558|FG000|Overall Study|Additional treatment|3|||
19472027|NCT01702961|41747558|FG000|Overall Study|Progressive disease|5|||
19472028|NCT01702961|41747558|FG000|Overall Study|Relapse|20|||
19472029|NCT01702961|41747558|FG000|Overall Study|Death|6|||
19472030|NCT01702961|41747558|FG000|Overall Study|Lost to Follow-up|2|||
19472031|NCT01702961|41747558|FG000|Overall Study|Ongoing|11|||
19472032|NCT01593917|41747562|FG000|Overall Study|Death|67|||
19472033|NCT01593917|41747562|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
19472034|NCT01593917|41747562|FG000|Overall Study|Withdrawal by Subject|23|||
19472035|NCT01593917|41747562|FG000|Overall Study|Lost to Follow-up|12|||
19472036|NCT01593917|41747562|FG000|Overall Study|Protocol Violation|5|||
19472037|NCT01593917|41747562|FG000|Overall Study|Physician Decision|3|||
19472038|NCT01593761|41747566|FG000|Overall Study|Lost to Follow-up|1|||
19472039|NCT01593761|41747566|FG000|Overall Study|culture negative for MRSA at baseline|5|||
19472040|NCT01593761|41747566|FG000|Overall Study|positive for hepatitis C virus|1|||
19472041|NCT01593761|41747566|FG000|Overall Study|secondary cellulitis|1|||
19472042|NCT02706834|41747587|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19472043|NCT02706834|41747588|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
19472044|NCT02706834|41747589|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19472045|NCT02706834|41747590|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
19472046|NCT02706834|41747591|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
19472047|NCT02706834|41747592|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
19472048|NCT02706834|41747593|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
19472049|NCT02706834|41747594|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
19472050|NCT02706834|41747595|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
19472051|NCT02706834|41747596|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
19472052|NCT02706834|41747597|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
19472053|NCT02706834|41747587|FG000|Overall Study|Lost to Follow-up|0|||
19472054|NCT02706834|41747588|FG001|Overall Study|Lost to Follow-up|0|||
19472055|NCT02706834|41747589|FG002|Overall Study|Lost to Follow-up|1|||
19472056|NCT02706834|41747590|FG003|Overall Study|Lost to Follow-up|0|||
19472057|NCT02706834|41747591|FG004|Overall Study|Lost to Follow-up|0|||
19472058|NCT02706834|41747592|FG005|Overall Study|Lost to Follow-up|0|||
19472059|NCT02706834|41747593|FG006|Overall Study|Lost to Follow-up|0|||
19472060|NCT02706834|41747594|FG007|Overall Study|Lost to Follow-up|0|||
19472061|NCT02706834|41747595|FG008|Overall Study|Lost to Follow-up|0|||
19472062|NCT02706834|41747596|FG009|Overall Study|Lost to Follow-up|0|||
19472063|NCT02706834|41747597|FG010|Overall Study|Lost to Follow-up|0|||
19472064|NCT02706834|41747587|FG000|Overall Study|Voluntary Withdrawal|1|||
19472065|NCT02706834|41747588|FG001|Overall Study|Voluntary Withdrawal|0|||
19472066|NCT02706834|41747589|FG002|Overall Study|Voluntary Withdrawal|0|||
19472067|NCT02706834|41747590|FG003|Overall Study|Voluntary Withdrawal|0|||
19472068|NCT02706834|41747591|FG004|Overall Study|Voluntary Withdrawal|0|||
19472069|NCT02706834|41747592|FG005|Overall Study|Voluntary Withdrawal|0|||
19472070|NCT02706834|41747593|FG006|Overall Study|Voluntary Withdrawal|0|||
19472071|NCT02706834|41747594|FG007|Overall Study|Voluntary Withdrawal|0|||
19472072|NCT02706834|41747595|FG008|Overall Study|Voluntary Withdrawal|0|||
19472073|NCT02706834|41747596|FG009|Overall Study|Voluntary Withdrawal|1|||
19472074|NCT02706834|41747597|FG010|Overall Study|Voluntary Withdrawal|0|||
19472075|NCT02706834|41747587|FG000|Overall Study|Other Reason Not Specified|1|||
19472076|NCT02706834|41747588|FG001|Overall Study|Other Reason Not Specified|0|||
19472077|NCT02706834|41747589|FG002|Overall Study|Other Reason Not Specified|0|||
19472078|NCT02706834|41747590|FG003|Overall Study|Other Reason Not Specified|0|||
19472079|NCT02706834|41747591|FG004|Overall Study|Other Reason Not Specified|1|||
19472080|NCT02706834|41747592|FG005|Overall Study|Other Reason Not Specified|0|||
19472081|NCT02706834|41747593|FG006|Overall Study|Other Reason Not Specified|0|||
19472082|NCT02706834|41747594|FG007|Overall Study|Other Reason Not Specified|0|||
19472083|NCT02706834|41747595|FG008|Overall Study|Other Reason Not Specified|0|||
19472084|NCT02706834|41747596|FG009|Overall Study|Other Reason Not Specified|0|||
19472085|NCT02706834|41747597|FG010|Overall Study|Other Reason Not Specified|0|||
19472086|NCT01702025|41747646|FG000|Overall Study|Equipment failure|1|||
19472087|NCT01702025|41747647|FG001|Overall Study|Equipment failure|0|||
19472088|NCT01702025|41747648|FG002|Overall Study|Equipment failure|0|||
19472089|NCT01702025|41747649|FG003|Overall Study|Equipment failure|0|||
19472090|NCT01702025|41747646|FG000|Overall Study|Adverse Event|1|||
19472091|NCT01702025|41747647|FG001|Overall Study|Adverse Event|1|||
19472092|NCT01702025|41747648|FG002|Overall Study|Adverse Event|1|||
19472093|NCT01702025|41747649|FG003|Overall Study|Adverse Event|0|||
19472094|NCT01592747|41747666|FG000|Overall Study|Loss of Therapeutic Response|107|||
19472095|NCT01592747|41747667|FG001|Overall Study|Loss of Therapeutic Response|108|||
19472096|NCT01592747|41747668|FG002|Overall Study|Loss of Therapeutic Response|100|||
19472097|NCT01592747|41747666|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
19472098|NCT01592747|41747667|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
19472099|NCT01592747|41747668|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
19472100|NCT01592747|41747666|FG000|Overall Study|Adverse Event|1|||
19472101|NCT01592747|41747667|FG001|Overall Study|Adverse Event|0|||
19472102|NCT01592747|41747668|FG002|Overall Study|Adverse Event|0|||
19472103|NCT01592747|41747666|FG000|Overall Study|Protocol Violation|4|||
19472104|NCT01592747|41747667|FG001|Overall Study|Protocol Violation|0|||
19472105|NCT01592747|41747668|FG002|Overall Study|Protocol Violation|4|||
19472106|NCT01592747|41747666|FG000|Overall Study|Lack of Efficacy|0|||
19472107|NCT01592747|41747667|FG001|Overall Study|Lack of Efficacy|1|||
19472108|NCT01592747|41747668|FG002|Overall Study|Lack of Efficacy|0|||
19472109|NCT01592747|41747666|FG000|Overall Study|Withdrawal by Subject|2|||
19472110|NCT01592747|41747667|FG001|Overall Study|Withdrawal by Subject|0|||
19472111|NCT01592747|41747668|FG002|Overall Study|Withdrawal by Subject|2|||
19472112|NCT01592747|41747666|FG000|Overall Study|Lost to Follow-up|1|||
19472113|NCT01592747|41747667|FG001|Overall Study|Lost to Follow-up|0|||
19472114|NCT01592747|41747668|FG002|Overall Study|Lost to Follow-up|1|||
19472115|NCT01592747|41747666|FG000|Overall Study|Other Reasons|1|||
19472116|NCT01592747|41747667|FG001|Overall Study|Other Reasons|1|||
19472117|NCT01592747|41747668|FG002|Overall Study|Other Reasons|0|||
19472118|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Death|3|||
19472119|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Death|3|||
19472120|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Death|0|||
19472121|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Death|0|||
19472122|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
19472123|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
19472124|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
19472125|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
19472126|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
19472127|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
19472128|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
19472129|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
19472130|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
19472131|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
19472132|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
19472133|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
19472134|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
19472135|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
19472136|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
19472137|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
19472138|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
19472139|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
19472140|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
19472141|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
19472142|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
19472143|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
19472144|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
19472145|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
19472146|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Other|6|||
19472147|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Other|3|||
19472148|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Other|0|||
19472149|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Other|0|||
19472150|NCT02051608|41747681|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
19472151|NCT02051608|41747682|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
19472152|NCT02051608|41747683|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
19472153|NCT02051608|41747684|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
19472154|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Adverse Event|0|||
19472155|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Adverse Event|0|||
19472156|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Adverse Event|6|||
19472157|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Adverse Event|8|||
19472158|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Death|0|||
19472159|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Death|0|||
19472160|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Death|7|||
19472161|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Death|4|||
19472162|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
19472163|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
19472164|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
19472165|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
19472166|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
19472167|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
19472168|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
19472169|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
19472170|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
19472171|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
19472172|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
19472173|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
19472174|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
19472175|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
19472176|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
19472177|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
19472178|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Physician Decision|0|||
19472179|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Physician Decision|0|||
19472180|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Physician Decision|8|||
19553851|NCT01310075|42002775|FG000|Overall Study|Protocol Violation|2|||
19553852|NCT01310075|42002776|FG001|Overall Study|Protocol Violation|2|||
19553853|NCT01310075|42002775|FG000|Overall Study|Withdrawal by Subject|1|||
19553854|NCT01310075|42002776|FG001|Overall Study|Withdrawal by Subject|1|||
19553855|NCT01309997|42002784|FG000|Overall Study|Adverse Event|1|||
19472181|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Physician Decision|5|||
19472182|NCT02051608|41747681|FG000|Part 2: Open-label Extension|Other|0|||
19472183|NCT02051608|41747682|FG001|Part 2: Open-label Extension|Other|0|||
19472184|NCT02051608|41747683|FG002|Part 2: Open-label Extension|Other|9|||
19472185|NCT02051608|41747684|FG003|Part 2: Open-label Extension|Other|9|||
19472186|NCT02705586|41747697|FG000|Overall Study|Health Issues|2|||
19472187|NCT02705586|41747697|FG000|Overall Study|Transportation Difficulties|5|||
19472188|NCT02705586|41747697|FG000|Overall Study|Vacation/Planned Absence|1|||
19472189|NCT01592045|41747703|FG000|Overall Study|Disease Progression|1|||
19472190|NCT01592045|41747704|FG001|Overall Study|Disease Progression|1|||
19472191|NCT01592045|41747703|FG000|Overall Study|Adverse Event|1|||
19472192|NCT01592045|41747704|FG001|Overall Study|Adverse Event|1|||
19472193|NCT01592045|41747703|FG000|Overall Study|Withdrawal by Subject|1|||
19472194|NCT01592045|41747704|FG001|Overall Study|Withdrawal by Subject|0|||
19472195|NCT01592045|41747703|FG000|Overall Study|Moved out of country|2|||
19472196|NCT01592045|41747704|FG001|Overall Study|Moved out of country|0|||
19472197|NCT01591499|41747712|FG000|Baseline Visit|Withdrawal by Subject|0|||
19472198|NCT01591499|41747713|FG001|Baseline Visit|Withdrawal by Subject|2|||
19472199|NCT01591499|41747714|FG002|Baseline Visit|Withdrawal by Subject|0|||
19472200|NCT01591499|41747715|FG003|Baseline Visit|Withdrawal by Subject|2|||
19472201|NCT01591499|41747712|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
19472202|NCT01591499|41747713|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
19472203|NCT01591499|41747714|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
19472204|NCT01591499|41747715|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
19472205|NCT01591499|41747712|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
19472206|NCT01591499|41747713|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
19472207|NCT01591499|41747714|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
19472208|NCT01591499|41747715|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
19472209|NCT01981720|41747739|FG000|Overall Study|Adverse Event|1|||
19472210|NCT01981720|41747739|FG000|Overall Study|Withdrawal by Subject|3|||
19472211|NCT01981720|41747739|FG000|Overall Study|Pregnancy|1|||
19472212|NCT01590797|41747749|FG000|Overall Study|Adverse Event|4|||
19472213|NCT01590797|41747750|FG001|Overall Study|Adverse Event|3|||
19472214|NCT01590797|41747749|FG000|Overall Study|Lack of Efficacy|0|||
19472215|NCT01590797|41747750|FG001|Overall Study|Lack of Efficacy|2|||
19472216|NCT01590797|41747749|FG000|Overall Study|Lost to Follow-up|0|||
19472217|NCT01590797|41747750|FG001|Overall Study|Lost to Follow-up|1|||
19472218|NCT01590797|41747749|FG000|Overall Study|Protocol Violation|4|||
19472219|NCT01590797|41747750|FG001|Overall Study|Protocol Violation|1|||
19472220|NCT01590797|41747749|FG000|Overall Study|Withdrawal by Subject|7|||
19472221|NCT01590797|41747750|FG001|Overall Study|Withdrawal by Subject|5|||
19472222|NCT01590797|41747749|FG000|Overall Study|Other Protocol Specified Criteria|2|||
19472223|NCT01590797|41747750|FG001|Overall Study|Other Protocol Specified Criteria|4|||
19472224|NCT01590563|41747756|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
19472225|NCT01867606|41747763|FG000|Overall Study|Withdrawal by Subject|10|||
19553856|NCT01309997|42002785|FG001|Overall Study|Adverse Event|0|||
19553857|NCT01309997|42002784|FG000|Overall Study|Death|1|||
19553858|NCT01309997|42002785|FG001|Overall Study|Death|3|||
19553859|NCT01309997|42002784|FG000|Overall Study|Lack of Efficacy|2|||
19472226|NCT01867606|41747764|FG001|Overall Study|Withdrawal by Subject|14|||
19472227|NCT01867606|41747763|FG000|Overall Study|Protocol Violation|0|||
19472228|NCT01867606|41747764|FG001|Overall Study|Protocol Violation|1|||
19472229|NCT01701401|41747780|FG000|Overall Study|Randomized But Not Treated|3|||
19472230|NCT01701401|41747781|FG001|Overall Study|Randomized But Not Treated|1|||
19472231|NCT01701401|41747782|FG002|Overall Study|Randomized But Not Treated|0|||
19472232|NCT01701401|41747783|FG003|Overall Study|Randomized But Not Treated|1|||
19472233|NCT01701401|41747780|FG000|Overall Study|Lost to Follow-up|5|||
19739310|NCT00293267|42186391|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
19739311|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
19739312|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
19739313|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
19739314|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
19739315|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
19739316|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
19739317|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
19739318|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
19739319|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
19739320|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
19739321|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
19739322|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
19739323|NCT00293267|42186390|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
19739324|NCT00293267|42186391|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
19739325|NCT03520959|42186401|FG000|Overall Study|Study terminated by Sponsor|0|||
19739326|NCT03520959|42186402|FG001|Overall Study|Study terminated by Sponsor|1|||
19739327|NCT03537261|42186410|FG000|Overall Study|Lost to Follow-up|4|||
19739328|NCT03537261|42186411|FG001|Overall Study|Lost to Follow-up|5|||
19739329|NCT03537261|42186410|FG000|Overall Study|Withdrawal by Subject|4|||
19739330|NCT03537261|42186411|FG001|Overall Study|Withdrawal by Subject|6|||
19739331|NCT03537261|42186410|FG000|Overall Study|Did not return study questionnaires|0|||
19739332|NCT03537261|42186411|FG001|Overall Study|Did not return study questionnaires|1|||
19739333|NCT03536949|42186419|FG000|Overall Study|Adverse Event|4|||
19739334|NCT03536949|42186420|FG001|Overall Study|Adverse Event|0|||
19739335|NCT03536949|42186419|FG000|Overall Study|Lost to Follow-up|2|||
19739336|NCT03536949|42186420|FG001|Overall Study|Lost to Follow-up|1|||
19739337|NCT03536949|42186419|FG000|Overall Study|Withdrawal by Subject|6|||
19472234|NCT01701401|41747781|FG001|Overall Study|Lost to Follow-up|5|||
19472235|NCT01701401|41747782|FG002|Overall Study|Lost to Follow-up|1|||
19472236|NCT01701401|41747783|FG003|Overall Study|Lost to Follow-up|3|||
19472237|NCT01701401|41747780|FG000|Overall Study|Withdrew Consent|0|||
19472238|NCT01701401|41747781|FG001|Overall Study|Withdrew Consent|3|||
19472239|NCT01701401|41747782|FG002|Overall Study|Withdrew Consent|1|||
19472240|NCT01701401|41747783|FG003|Overall Study|Withdrew Consent|2|||
19472241|NCT01701401|41747780|FG000|Overall Study|Lack of Efficacy|1|||
19472242|NCT01701401|41747781|FG001|Overall Study|Lack of Efficacy|0|||
19472243|NCT01701401|41747782|FG002|Overall Study|Lack of Efficacy|2|||
19472244|NCT01701401|41747783|FG003|Overall Study|Lack of Efficacy|0|||
19472245|NCT01701401|41747780|FG000|Overall Study|Adverse Event|1|||
19472246|NCT01701401|41747781|FG001|Overall Study|Adverse Event|0|||
19472247|NCT01701401|41747782|FG002|Overall Study|Adverse Event|0|||
19472248|NCT01701401|41747783|FG003|Overall Study|Adverse Event|0|||
19472249|NCT01701401|41747780|FG000|Overall Study|Protocol Violation|0|||
19472250|NCT01701401|41747781|FG001|Overall Study|Protocol Violation|0|||
19472251|NCT01701401|41747782|FG002|Overall Study|Protocol Violation|1|||
19472252|NCT01701401|41747783|FG003|Overall Study|Protocol Violation|0|||
19472253|NCT01701245|41747795|FG000|Overall Study|Protocol Violation|1|||
19472254|NCT01701245|41747796|FG001|Overall Study|Protocol Violation|3|||
19472255|NCT01701245|41747795|FG000|Overall Study|Did not complete the open label period|11|||
19472256|NCT01701245|41747796|FG001|Overall Study|Did not complete the open label period|12|||
19472257|NCT01590017|41747802|FG000|Overall Study|Adverse Event|1|||
19472258|NCT01590017|41747802|FG000|Overall Study|Withdrawal by Subject|1|||
19472259|NCT01590017|41747802|FG000|Overall Study|Lack of Efficacy|1|||
19472260|NCT01590017|41747802|FG000|Overall Study|Physician Decision|1|||
19472261|NCT01700621|41747808|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
19472262|NCT01700621|41747809|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
19472263|NCT01700621|41747808|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
19472264|NCT01700621|41747809|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
19472265|NCT01700621|41747808|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
19472266|NCT01700621|41747809|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
19472267|NCT01589237|41747820|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
19472268|NCT01589237|41747821|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
19472269|NCT01589237|41747822|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
19381838|NCT04032093|41624939|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
19381839|NCT04032093|41624940|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
19478166|NCT01693562|41757320|FG006|Expansion Phase|Other|0|||
19472270|NCT01589237|41747823|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
19472271|NCT01589237|41747820|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
19472272|NCT01589237|41747821|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
19472273|NCT01589237|41747822|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
19472274|NCT01589237|41747823|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
19472275|NCT01589237|41747820|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
19472276|NCT01589237|41747821|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
19472277|NCT01589237|41747822|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
19472278|NCT01589237|41747823|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
19472279|NCT01589237|41747820|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
19472280|NCT01589237|41747821|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
19472281|NCT01589237|41747822|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
19472282|NCT01589237|41747823|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
19472283|NCT01700387|41747839|FG000|Overall Study|Withdrawal by Subject|1|||
19472284|NCT01700387|41747840|FG001|Overall Study|Withdrawal by Subject|2|||
19472285|NCT01700387|41747839|FG000|Overall Study|Adverse Event|1|||
19472286|NCT01700387|41747840|FG001|Overall Study|Adverse Event|1|||
19472287|NCT01700387|41747839|FG000|Overall Study|Lost to Follow-up|2|||
19472288|NCT01700387|41747840|FG001|Overall Study|Lost to Follow-up|1|||
19472289|NCT01699685|41747852|FG000|Period 1|Adverse Event|1|||
19472290|NCT01699685|41747853|FG001|Period 1|Adverse Event|1|||
19472291|NCT01699685|41747852|FG000|Period 1|Medical or ethical, noncompliance|2|||
19472292|NCT01699685|41747853|FG001|Period 1|Medical or ethical, noncompliance|0|||
19472293|NCT01699685|41747852|FG000|Period 1|Other|0|||
19472294|NCT01699685|41747853|FG001|Period 1|Other|1|||
19472295|NCT01699685|41747852|FG000|Period 1|Patient request|0|||
19472296|NCT01699685|41747853|FG001|Period 1|Patient request|1|||
19472297|NCT01699685|41747852|FG000|Period 2|Lost to Follow-up|1|||
19472298|NCT01699685|41747853|FG001|Period 2|Lost to Follow-up|0|||
19472299|NCT01587989|41747861|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
19472300|NCT01587989|41747862|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
19472301|NCT01587989|41747863|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
19472302|NCT01587989|41747861|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
19472303|NCT01587989|41747862|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
19472304|NCT01587989|41747863|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
19472305|NCT01587989|41747861|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
19472306|NCT01587989|41747862|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
19472307|NCT01587989|41747863|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
19472308|NCT01587989|41747861|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
19472309|NCT01587989|41747862|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
19472310|NCT01587989|41747863|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
19472311|NCT01587989|41747861|FG000|Randomized Study Treatment|Screening failure|0|||
19472312|NCT01587989|41747862|FG001|Randomized Study Treatment|Screening failure|1|||
19472313|NCT01587989|41747863|FG002|Randomized Study Treatment|Screening failure|0|||
19472314|NCT01587989|41747861|FG000|Randomized Study Treatment|Physician Decision|0|||
19472315|NCT01587989|41747862|FG001|Randomized Study Treatment|Physician Decision|0|||
19472316|NCT01587989|41747863|FG002|Randomized Study Treatment|Physician Decision|1|||
19472317|NCT01697969|41747869|FG000|Overall Study|Did not meet inc/exc criteria|3|||
19472318|NCT01586819|41747876|FG000|Overall Study|Withdrawal by Subject|1|||
19472319|NCT01586819|41747877|FG001|Overall Study|Withdrawal by Subject|0|||
19472320|NCT01697579|41747888|FG000|Base Study-Cycle 1|Adverse Event|1|||
19472321|NCT01697579|41747889|FG001|Base Study-Cycle 1|Adverse Event|0|||
19472322|NCT01697579|41747890|FG002|Base Study-Cycle 1|Adverse Event|0|||
19472323|NCT01697579|41747891|FG003|Base Study-Cycle 1|Adverse Event|0|||
19472324|NCT01697579|41747892|FG004|Base Study-Cycle 1|Adverse Event|0|||
19472325|NCT01697579|41747893|FG005|Base Study-Cycle 1|Adverse Event|0|||
19472326|NCT01697579|41747894|FG006|Base Study-Cycle 1|Adverse Event|0|||
19472327|NCT01697579|41747888|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
19472328|NCT01697579|41747889|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472329|NCT01697579|41747890|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472330|NCT01697579|41747891|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472331|NCT01697579|41747892|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472332|NCT01697579|41747893|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472333|NCT01697579|41747894|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
19472334|NCT01697579|41747888|FG000|Base Study-Cycle 1|Protocol Violation|0|||
19472335|NCT01697579|41747889|FG001|Base Study-Cycle 1|Protocol Violation|0|||
19472336|NCT01697579|41747890|FG002|Base Study-Cycle 1|Protocol Violation|0|||
19472337|NCT01697579|41747891|FG003|Base Study-Cycle 1|Protocol Violation|0|||
19472338|NCT01697579|41747892|FG004|Base Study-Cycle 1|Protocol Violation|3|||
19472339|NCT01697579|41747893|FG005|Base Study-Cycle 1|Protocol Violation|0|||
19472340|NCT01697579|41747894|FG006|Base Study-Cycle 1|Protocol Violation|0|||
19472341|NCT01697579|41747888|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19472342|NCT01697579|41747889|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
19472343|NCT01697579|41747890|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19739338|NCT03536949|42186420|FG001|Overall Study|Withdrawal by Subject|0|||
19739339|NCT03536949|42186419|FG000|Overall Study|Non-compliance|2|||
19472344|NCT01697579|41747891|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19472345|NCT01697579|41747892|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19472346|NCT01697579|41747893|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19472347|NCT01697579|41747894|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
19472348|NCT01697579|41747888|FG000|Base Study-Cycle 1|Technical Problems|0|||
19472349|NCT01697579|41747889|FG001|Base Study-Cycle 1|Technical Problems|0|||
19472350|NCT01697579|41747890|FG002|Base Study-Cycle 1|Technical Problems|1|||
19472351|NCT01697579|41747891|FG003|Base Study-Cycle 1|Technical Problems|1|||
19472352|NCT01697579|41747892|FG004|Base Study-Cycle 1|Technical Problems|0|||
19472353|NCT01697579|41747893|FG005|Base Study-Cycle 1|Technical Problems|0|||
19472354|NCT01697579|41747894|FG006|Base Study-Cycle 1|Technical Problems|0|||
19472355|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Death|0|||
19739340|NCT03536949|42186420|FG001|Overall Study|Non-compliance|1|||
19739341|NCT03588741|42186426|FG000|Overall Study|Withdrawal by Subject|1|||
19739342|NCT00111917|42186432|FG000|Overall Study|Withdrawal by Subject|1|||
19739343|NCT00111917|42186433|FG001|Overall Study|Withdrawal by Subject|1|||
19739344|NCT03520569|42186443|FG000|Overall Study|Withdrawal by Subject|1|||
19739345|NCT00111839|42186456|FG000|Overall Study|Disease Progression|30|||
19739346|NCT00111839|42186457|FG001|Overall Study|Disease Progression|33|||
19739347|NCT00111839|42186458|FG002|Overall Study|Disease Progression|33|||
19739348|NCT00111839|42186456|FG000|Overall Study|Adverse Event|5|||
19739349|NCT00111839|42186457|FG001|Overall Study|Adverse Event|3|||
19739350|NCT00111839|42186458|FG002|Overall Study|Adverse Event|1|||
19739351|NCT00111839|42186456|FG000|Overall Study|Protocol Violation|2|||
19739352|NCT00111839|42186457|FG001|Overall Study|Protocol Violation|4|||
19739353|NCT00111839|42186458|FG002|Overall Study|Protocol Violation|2|||
19739354|NCT00111839|42186456|FG000|Overall Study|Death|1|||
19739355|NCT00111839|42186457|FG001|Overall Study|Death|1|||
19739356|NCT00111839|42186458|FG002|Overall Study|Death|6|||
19739357|NCT00111839|42186456|FG000|Overall Study|Withdrawal by Subject|2|||
19739358|NCT00111839|42186457|FG001|Overall Study|Withdrawal by Subject|2|||
19739359|NCT00111839|42186458|FG002|Overall Study|Withdrawal by Subject|2|||
19739360|NCT00111839|42186456|FG000|Overall Study|Lost to Follow-up|1|||
19739361|NCT00111839|42186457|FG001|Overall Study|Lost to Follow-up|0|||
19739362|NCT00111839|42186458|FG002|Overall Study|Lost to Follow-up|0|||
19739363|NCT00111839|42186456|FG000|Overall Study|Logistical Constraint|1|||
19739364|NCT00111839|42186457|FG001|Overall Study|Logistical Constraint|0|||
19739365|NCT00111839|42186458|FG002|Overall Study|Logistical Constraint|0|||
19472356|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Death|0|||
19472357|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Death|0|||
19472358|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Death|0|||
19472359|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Death|0|||
19472360|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Death|0|||
19472361|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Death|2|||
19472362|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19472363|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19472364|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19472365|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19472366|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19472367|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
19472368|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
19472369|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
19472370|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
19472371|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
19472372|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
19472373|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
19472374|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
19472375|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
19472376|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472377|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472378|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472379|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472380|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472381|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
19472382|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
19472383|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
19472384|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
19739366|NCT00111839|42186456|FG000|Overall Study|Other|6|||
19739367|NCT00111839|42186457|FG001|Overall Study|Other|3|||
19739368|NCT00111839|42186458|FG002|Overall Study|Other|3|||
19739369|NCT00111839|42186456|FG000|Overall Study|Randomized but Not Treated|0|||
19739370|NCT00111839|42186457|FG001|Overall Study|Randomized but Not Treated|0|||
19739371|NCT00111839|42186458|FG002|Overall Study|Randomized but Not Treated|2|||
19739372|NCT00111761|42186468|FG000|Part 1|Physician Decision|0|||
19472385|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
19472386|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
19472387|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
19472388|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
19472389|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
19472390|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472391|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472392|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472393|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472394|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472395|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
19472396|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
19472397|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
19472398|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
19472399|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
19472400|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
19472401|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
19472402|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
19472403|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
19472404|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
19472405|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
19472406|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
19472407|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
19472408|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
19472409|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
19472410|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
19472411|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472412|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472413|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472414|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472415|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472416|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
19472417|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
19472418|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472419|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472420|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472421|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472422|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472423|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
19472424|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
19472425|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
19553860|NCT01309997|42002785|FG001|Overall Study|Lack of Efficacy|2|||
19472426|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
19472427|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
19472428|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
19472429|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
19472430|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
19472431|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
19472432|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
19472433|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
19472434|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
19472435|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
19472436|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
19472437|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
19472438|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
19472439|NCT01697579|41747888|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472440|NCT01697579|41747889|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472441|NCT01697579|41747890|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472442|NCT01697579|41747891|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472443|NCT01697579|41747892|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472444|NCT01697579|41747893|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
19472445|NCT01697579|41747894|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
19472446|NCT01586195|41747922|FG000|Overall Study|Death|11|||
19472447|NCT01586195|41747922|FG000|Overall Study|Withdrawal of Consent|5|||
19472448|NCT01586195|41747922|FG000|Overall Study|Started new anti-melanoma therapy|1|||
19472449|NCT01586195|41747922|FG000|Overall Study|Reason not specified|9|||
19472450|NCT01585961|41747926|FG000|Overall Study|Death|6|||
19472451|NCT01585961|41747926|FG000|Overall Study|Physician Decision|1|||
19472452|NCT01585961|41747926|FG000|Overall Study|Decision to use non-study catheter|1|||
19472453|NCT01585961|41747926|FG000|Overall Study|Withdrawal by Subject|1|||
19472454|NCT01585961|41747926|FG000|Overall Study|Lost to Follow-up|23|||
19472455|NCT01585961|41747926|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
19472456|NCT01697501|41747930|FG000|Overall Study|Protocol Violation|2|||
19472457|NCT01697345|41747943|FG000|Overall Study|Withdrawal by Subject|1|||
19472458|NCT01802632|41747968|FG000|Overall Study|Death|28|||
19472459|NCT01802632|41747969|FG001|Overall Study|Death|1|||
19472460|NCT01802632|41747970|FG002|Overall Study|Death|38|||
19472461|NCT01802632|41747971|FG003|Overall Study|Death|0|||
19472462|NCT01802632|41747972|FG004|Overall Study|Death|2|||
19472463|NCT01802632|41747973|FG005|Overall Study|Death|0|||
19472464|NCT01802632|41747968|FG000|Overall Study|Withdrawal by Subject|4|||
19472465|NCT01802632|41747969|FG001|Overall Study|Withdrawal by Subject|2|||
19472466|NCT01802632|41747970|FG002|Overall Study|Withdrawal by Subject|7|||
19472467|NCT01802632|41747971|FG003|Overall Study|Withdrawal by Subject|3|||
19472468|NCT01802632|41747972|FG004|Overall Study|Withdrawal by Subject|0|||
19472469|NCT01802632|41747973|FG005|Overall Study|Withdrawal by Subject|1|||
19472470|NCT01802632|41747968|FG000|Overall Study|Objective Disease Progression|1|||
19472471|NCT01802632|41747969|FG001|Overall Study|Objective Disease Progression|12|||
19472472|NCT01802632|41747970|FG002|Overall Study|Objective Disease Progression|104|||
19472473|NCT01802632|41747971|FG003|Overall Study|Objective Disease Progression|6|||
19472474|NCT01802632|41747972|FG004|Overall Study|Objective Disease Progression|4|||
19472475|NCT01802632|41747973|FG005|Overall Study|Objective Disease Progression|4|||
19472476|NCT01802632|41747968|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
19472477|NCT01802632|41747969|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
19472478|NCT01802632|41747970|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
19472479|NCT01802632|41747971|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
19472480|NCT01802632|41747972|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
19472481|NCT01802632|41747973|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
19472482|NCT01802632|41747968|FG000|Overall Study|Other (not specified)|0|||
19472483|NCT01802632|41747969|FG001|Overall Study|Other (not specified)|0|||
19472484|NCT01802632|41747970|FG002|Overall Study|Other (not specified)|7|||
19472485|NCT01802632|41747971|FG003|Overall Study|Other (not specified)|1|||
19472486|NCT01802632|41747972|FG004|Overall Study|Other (not specified)|0|||
19472487|NCT01802632|41747973|FG005|Overall Study|Other (not specified)|1|||
19472488|NCT01697267|41748035|FG000|Overall Study|Death|3|||
19472489|NCT01697267|41748036|FG001|Overall Study|Death|1|||
19472490|NCT01697267|41748035|FG000|Overall Study|Withdrawal by Subject|5|||
19472491|NCT01697267|41748036|FG001|Overall Study|Withdrawal by Subject|5|||
19472492|NCT01697267|41748035|FG000|Overall Study|Adverse Event|2|||
19472493|NCT01697267|41748036|FG001|Overall Study|Adverse Event|1|||
19472494|NCT01697267|41748035|FG000|Overall Study|Lost to Follow-up|2|||
19472495|NCT01697267|41748036|FG001|Overall Study|Lost to Follow-up|4|||
19472496|NCT01697267|41748035|FG000|Overall Study|Physician Decision|2|||
19472497|NCT01697267|41748036|FG001|Overall Study|Physician Decision|4|||
19472498|NCT01696955|41748098|FG000|Main Study|Protocol Violation|1|||
19472499|NCT01696955|41748099|FG001|Main Study|Protocol Violation|0|||
19472500|NCT01696955|41748098|FG000|Main Study|Withdrawal by Subject|1|||
19472501|NCT01696955|41748099|FG001|Main Study|Withdrawal by Subject|1|||
19472502|NCT02702388|41748123|FG000|Overall Study|Disease Progression|18|||
19472503|NCT02702388|41748124|FG001|Overall Study|Disease Progression|25|||
19472504|NCT02702388|41748123|FG000|Overall Study|Withdrawal by Subject|9|||
19472505|NCT02702388|41748124|FG001|Overall Study|Withdrawal by Subject|7|||
19472506|NCT02702388|41748123|FG000|Overall Study|Adverse Event|11|||
19472507|NCT02702388|41748124|FG001|Overall Study|Adverse Event|15|||
19472508|NCT02702388|41748123|FG000|Overall Study|Other|2|||
19472509|NCT02702388|41748124|FG001|Overall Study|Other|4|||
19472510|NCT01696877|41748150|FG000|Overall Study|Adverse Event|0|||
19472511|NCT01696877|41748151|FG001|Overall Study|Adverse Event|1|||
19472512|NCT02703636|41748347|FG000|Overall Study|Adverse Event|14|||
19472513|NCT02703636|41748347|FG000|Overall Study|Study stopped by sponsor|1|||
19472514|NCT02703636|41748347|FG000|Overall Study|Withdrawal by Subject|1|||
19472515|NCT02703324|41748575|FG000|Period Two|Withdrawal by Subject|0|||
19472516|NCT02703324|41748576|FG001|Period Two|Withdrawal by Subject|0|||
19472517|NCT02703324|41748577|FG002|Period Two|Withdrawal by Subject|1|||
19472518|NCT02703324|41748578|FG003|Period Two|Withdrawal by Subject|0|||
19472519|NCT02703324|41748579|FG004|Period Two|Withdrawal by Subject|0|||
19472520|NCT02703324|41748580|FG005|Period Two|Withdrawal by Subject|0|||
19472521|NCT02701764|41748591|FG000|Overall Study|Lost to Follow-up|0|||
19472522|NCT02701764|41748592|FG001|Overall Study|Lost to Follow-up|1|||
19472523|NCT01696643|41748773|FG000|Overall Study|Adverse Event|15|||
19472524|NCT01696643|41748774|FG001|Overall Study|Adverse Event|7|||
19472525|NCT01696643|41748773|FG000|Overall Study|Death|1|||
19472526|NCT01696643|41748774|FG001|Overall Study|Death|2|||
19472527|NCT01696643|41748773|FG000|Overall Study|Lack of Efficacy|3|||
19472528|NCT01696643|41748774|FG001|Overall Study|Lack of Efficacy|0|||
19472529|NCT01696643|41748773|FG000|Overall Study|Lost to Follow-up|67|||
19472530|NCT01696643|41748774|FG001|Overall Study|Lost to Follow-up|67|||
19472531|NCT01696643|41748773|FG000|Overall Study|Physician Decision|3|||
19472532|NCT01696643|41748774|FG001|Overall Study|Physician Decision|2|||
19472533|NCT01696643|41748773|FG000|Overall Study|Pregnancy|0|||
19472534|NCT01696643|41748774|FG001|Overall Study|Pregnancy|1|||
19472535|NCT01696643|41748773|FG000|Overall Study|Protocol Violation|7|||
19472536|NCT01696643|41748774|FG001|Overall Study|Protocol Violation|7|||
19472537|NCT01696643|41748773|FG000|Overall Study|Study Terminated by Sponsor|286|||
19472538|NCT01696643|41748774|FG001|Overall Study|Study Terminated by Sponsor|294|||
19472539|NCT01696643|41748773|FG000|Overall Study|Withdrawal by Subject|142|||
19472540|NCT01696643|41748774|FG001|Overall Study|Withdrawal by Subject|149|||
19472541|NCT01696643|41748773|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
19472542|NCT01696643|41748774|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
19472543|NCT01696643|41748773|FG000|Overall Study|Site Error|2|||
19472544|NCT01696643|41748774|FG001|Overall Study|Site Error|1|||
19472545|NCT01696643|41748773|FG000|Overall Study|Participant Incarcerated|0|||
19472546|NCT01696643|41748774|FG001|Overall Study|Participant Incarcerated|1|||
19472547|NCT01696643|41748773|FG000|Overall Study|Medical Monitor Decision|0|||
19472548|NCT01696643|41748774|FG001|Overall Study|Medical Monitor Decision|2|||
19472549|NCT01696643|41748773|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
19472550|NCT01696643|41748774|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
19472551|NCT01695317|41748786|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
19472552|NCT01695317|41748787|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
19472553|NCT01695317|41748786|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
19472554|NCT01695317|41748787|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
19472555|NCT02701296|41748843|FG000|Overall Study|Incomplete Data|0|||
19472556|NCT02701296|41748844|FG001|Overall Study|Incomplete Data|2|||
19472557|NCT01582451|41748861|FG000|Overall Study|Adverse Event|1|||
19472558|NCT01582451|41748862|FG001|Overall Study|Adverse Event|3|||
19553861|NCT01309997|42002784|FG000|Overall Study|Withdrawal by Subject|1|||
19553862|NCT01309997|42002785|FG001|Overall Study|Withdrawal by Subject|1|||
19553863|NCT01309919|42002804|FG000|Overall Study|Did not receive a postpartum IUD|17|||
19472559|NCT01582451|41748861|FG000|Overall Study|Death|3|||
19472560|NCT01582451|41748862|FG001|Overall Study|Death|3|||
19472561|NCT01582451|41748861|FG000|Overall Study|Lost to Follow-up|0|||
19472562|NCT01582451|41748862|FG001|Overall Study|Lost to Follow-up|2|||
19472563|NCT01582451|41748861|FG000|Overall Study|Protocol Violation|11|||
19472564|NCT01582451|41748862|FG001|Overall Study|Protocol Violation|3|||
19472565|NCT01582451|41748861|FG000|Overall Study|Withdrawal by Subject|13|||
19472566|NCT01582451|41748862|FG001|Overall Study|Withdrawal by Subject|9|||
19472567|NCT01582451|41748861|FG000|Overall Study|Physician Decision|3|||
19472568|NCT01582451|41748862|FG001|Overall Study|Physician Decision|0|||
19739373|NCT00111761|42186469|FG001|Part 1|Physician Decision|1|||
19472569|NCT01582451|41748861|FG000|Overall Study|Sponsor Decision|1|||
19472570|NCT01582451|41748862|FG001|Overall Study|Sponsor Decision|0|||
19472571|NCT02700984|41748955|FG000|Overall Study|Death|2|||
19739374|NCT00111761|42186468|FG000|Part 1|Death|0|||
19472572|NCT02700984|41748956|FG001|Overall Study|Death|1|||
19739375|NCT00111761|42186469|FG001|Part 1|Death|2|||
19472573|NCT02700984|41748955|FG000|Overall Study|Lost to Follow-up|2|||
19472574|NCT02700984|41748956|FG001|Overall Study|Lost to Follow-up|1|||
19472575|NCT02700984|41748955|FG000|Overall Study|Physician Decision|0|||
19472576|NCT02700984|41748956|FG001|Overall Study|Physician Decision|1|||
19472577|NCT02700984|41748955|FG000|Overall Study|Withdrawal by Subject|8|||
19472578|NCT02700984|41748956|FG001|Overall Study|Withdrawal by Subject|9|||
19472579|NCT02700984|41748955|FG000|Overall Study|Reason not specified|3|||
19472580|NCT02700984|41748956|FG001|Overall Study|Reason not specified|2|||
19472581|NCT02696850|41749030|FG000|Overall Study|Withdrawal by Subject|3|||
19472582|NCT02696850|41749031|FG001|Overall Study|Withdrawal by Subject|3|||
19472583|NCT02696850|41749030|FG000|Overall Study|Lost to Follow-up|8|||
19472584|NCT02696850|41749031|FG001|Overall Study|Lost to Follow-up|5|||
19472585|NCT02698410|41749194|FG000|Overall Study|Adverse Event|2|||
19472586|NCT02698410|41749194|FG000|Overall Study|Withdrawal by Subject|1|||
19472587|NCT02698410|41749194|FG000|Overall Study|Other|1|||
19472588|NCT02699892|41749198|FG000|Overall Study|Other|36|||
19472589|NCT02698176|41749205|FG000|Overall Study|Progressive disease|4|||
19472590|NCT02698176|41749206|FG001|Overall Study|Progressive disease|3|||
19472591|NCT02698176|41749207|FG002|Overall Study|Progressive disease|1|||
19472592|NCT02698176|41749208|FG003|Overall Study|Progressive disease|0|||
19472593|NCT02698176|41749205|FG000|Overall Study|Adverse Event|2|||
19472594|NCT02698176|41749206|FG001|Overall Study|Adverse Event|0|||
19472595|NCT02698176|41749207|FG002|Overall Study|Adverse Event|0|||
19472596|NCT02698176|41749208|FG003|Overall Study|Adverse Event|0|||
19472597|NCT02698176|41749205|FG000|Overall Study|Clinical progression|3|||
19472598|NCT02698176|41749206|FG001|Overall Study|Clinical progression|0|||
19472599|NCT02698176|41749207|FG002|Overall Study|Clinical progression|0|||
19472600|NCT02698176|41749208|FG003|Overall Study|Clinical progression|0|||
19472601|NCT02693418|41749224|FG000|Overall Study|Lost to Follow-up|1|||
19472602|NCT02693418|41749225|FG001|Overall Study|Lost to Follow-up|2|||
19472603|NCT02693418|41749226|FG002|Overall Study|Lost to Follow-up|0|||
19472604|NCT02693418|41749227|FG003|Overall Study|Lost to Follow-up|0|||
19472605|NCT02693418|41749228|FG004|Overall Study|Lost to Follow-up|0|||
19472606|NCT02693418|41749224|FG000|Overall Study|Menses during study period|0|||
19472607|NCT02693418|41749225|FG001|Overall Study|Menses during study period|0|||
19472608|NCT02693418|41749226|FG002|Overall Study|Menses during study period|2|||
19472609|NCT02693418|41749227|FG003|Overall Study|Menses during study period|0|||
19472610|NCT02693418|41749228|FG004|Overall Study|Menses during study period|0|||
19472611|NCT02693106|41749261|FG000|Overall Study|No time|3|||
19472612|NCT02546986|41749273|FG000|Treatment Period|Progressive Disease|20|||
19553864|NCT01309919|42002805|FG001|Overall Study|Did not receive a postpartum IUD|48|||
19553865|NCT01309841|42002814|FG000|Overall Study|Other|0|||
19553866|NCT01309841|42002815|FG001|Overall Study|Other|1|||
19553867|NCT01309841|42002816|FG002|Overall Study|Other|1|||
19472613|NCT02546986|41749274|FG001|Treatment Period|Progressive Disease|22|||
19472614|NCT02546986|41749273|FG000|Treatment Period|Adverse Event|14|||
19472615|NCT02546986|41749274|FG001|Treatment Period|Adverse Event|6|||
19472616|NCT02546986|41749273|FG000|Treatment Period|Symptomatic Deterioration|4|||
19472617|NCT02546986|41749274|FG001|Treatment Period|Symptomatic Deterioration|3|||
19472618|NCT02546986|41749273|FG000|Treatment Period|Death|3|||
19472619|NCT02546986|41749274|FG001|Treatment Period|Death|4|||
19472620|NCT02546986|41749273|FG000|Treatment Period|Physician Decision|1|||
19472621|NCT02546986|41749274|FG001|Treatment Period|Physician Decision|2|||
19553868|NCT01309841|42002814|FG000|Overall Study|Lost to Follow-up|7|||
19472622|NCT02546986|41749273|FG000|Treatment Period|Protocol Violation|1|||
19472623|NCT02546986|41749274|FG001|Treatment Period|Protocol Violation|0|||
19472624|NCT02546986|41749273|FG000|Treatment Period|Withdrawal by Subject|1|||
19472625|NCT02546986|41749274|FG001|Treatment Period|Withdrawal by Subject|1|||
19472626|NCT02546986|41749273|FG000|Treatment Period|Non-compliance with Study Drug|0|||
19472627|NCT02546986|41749274|FG001|Treatment Period|Non-compliance with Study Drug|1|||
19472628|NCT02546986|41749273|FG000|Treatment Period|Study Terminated by Sponsor|0|||
19472629|NCT02546986|41749274|FG001|Treatment Period|Study Terminated by Sponsor|1|||
19472630|NCT02546986|41749273|FG000|Treatment Period|Miscellaneous|7|||
19472631|NCT02546986|41749274|FG001|Treatment Period|Miscellaneous|9|||
19472632|NCT02546986|41749273|FG000|Survival Follow-Up Phase|Missing Status|3|||
19472633|NCT02546986|41749274|FG001|Survival Follow-Up Phase|Missing Status|5|||
19472634|NCT02546986|41749273|FG000|Survival Follow-Up Phase|Death|18|||
19472635|NCT02546986|41749274|FG001|Survival Follow-Up Phase|Death|12|||
19472636|NCT02546986|41749273|FG000|Survival Follow-Up Phase|Alive|13|||
19472637|NCT02546986|41749274|FG001|Survival Follow-Up Phase|Alive|16|||
19472638|NCT02546986|41749273|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
19472639|NCT02546986|41749274|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
19472640|NCT02689206|41749285|FG000|Overall Study|Adverse Event|0|||
19472641|NCT02689206|41749286|FG001|Overall Study|Adverse Event|0|||
19472642|NCT02689206|41749287|FG002|Overall Study|Adverse Event|1|||
19472643|NCT02689206|41749288|FG003|Overall Study|Adverse Event|0|||
19472644|NCT02689206|41749289|FG004|Overall Study|Adverse Event|2|||
19472645|NCT02689206|41749285|FG000|Overall Study|Protocol Violation|1|||
19472646|NCT02689206|41749286|FG001|Overall Study|Protocol Violation|0|||
19472647|NCT02689206|41749287|FG002|Overall Study|Protocol Violation|0|||
19472648|NCT02689206|41749288|FG003|Overall Study|Protocol Violation|1|||
19472649|NCT02689206|41749289|FG004|Overall Study|Protocol Violation|2|||
19472650|NCT02689206|41749285|FG000|Overall Study|Other: Reached stopping criteria|0|||
19472651|NCT02689206|41749286|FG001|Overall Study|Other: Reached stopping criteria|1|||
19472652|NCT02689206|41749287|FG002|Overall Study|Other: Reached stopping criteria|2|||
19472653|NCT02689206|41749288|FG003|Overall Study|Other: Reached stopping criteria|3|||
19472654|NCT02689206|41749289|FG004|Overall Study|Other: Reached stopping criteria|4|||
19472655|NCT02689206|41749285|FG000|Overall Study|Physician Decision|1|||
19472656|NCT02689206|41749286|FG001|Overall Study|Physician Decision|0|||
19472657|NCT02689206|41749287|FG002|Overall Study|Physician Decision|0|||
19472658|NCT02689206|41749288|FG003|Overall Study|Physician Decision|0|||
19472659|NCT02689206|41749289|FG004|Overall Study|Physician Decision|0|||
19472660|NCT02689206|41749285|FG000|Overall Study|Withdrawal by Subject|1|||
19472661|NCT02689206|41749286|FG001|Overall Study|Withdrawal by Subject|0|||
19472662|NCT02689206|41749287|FG002|Overall Study|Withdrawal by Subject|1|||
19472663|NCT02689206|41749288|FG003|Overall Study|Withdrawal by Subject|0|||
19472664|NCT02689206|41749289|FG004|Overall Study|Withdrawal by Subject|0|||
19472665|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
19472666|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
19472667|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
19472668|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
19472669|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472670|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472671|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472672|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472673|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472674|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472675|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472676|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472677|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472678|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
19472679|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
19472680|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
19472681|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
19472682|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
19472683|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472684|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472685|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472686|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472687|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472688|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472689|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19739376|NCT00111761|42186468|FG000|Part 1|Other|0|||
19381840|NCT04032093|41624941|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
19472690|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472691|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472692|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19472693|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
19472694|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472695|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
19472696|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472697|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472698|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472699|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472700|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472701|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472702|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472703|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472704|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472705|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472706|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19472707|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
19472708|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
19472709|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
19472710|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472711|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472712|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472713|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472714|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472715|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472716|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472717|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472718|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472719|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472720|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19472721|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
19472722|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472723|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
19472724|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472725|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472726|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472727|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472728|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472729|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472730|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472731|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472732|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472733|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472734|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
19472735|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
19472736|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472737|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
19472738|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472739|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472740|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472741|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472742|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19739377|NCT00111761|42186469|FG001|Part 1|Other|1|||
19472743|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472744|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472745|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472746|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472747|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472748|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19472749|NCT01695239|41749309|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
19472750|NCT01695239|41749310|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472751|NCT01695239|41749311|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472752|NCT01695239|41749312|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472753|NCT01695239|41749313|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472754|NCT01695239|41749314|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472755|NCT01695239|41749315|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472756|NCT01695239|41749316|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472757|NCT01695239|41749317|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472758|NCT01695239|41749318|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472759|NCT01695239|41749319|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472760|NCT01695239|41749320|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472761|NCT01695239|41749321|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472762|NCT01695239|41749322|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19472763|NCT01695239|41749309|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472764|NCT01695239|41749310|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472765|NCT01695239|41749311|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472766|NCT01695239|41749312|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472767|NCT01695239|41749313|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472768|NCT01695239|41749314|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472769|NCT01695239|41749315|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472770|NCT01695239|41749316|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
19472771|NCT01695239|41749317|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472772|NCT01695239|41749318|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472773|NCT01695239|41749319|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472774|NCT01695239|41749320|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472775|NCT01695239|41749321|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472776|NCT01695239|41749322|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
19472777|NCT01695239|41749309|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472778|NCT01695239|41749310|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472779|NCT01695239|41749311|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472780|NCT01695239|41749312|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472781|NCT01695239|41749313|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472782|NCT01695239|41749314|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472783|NCT01695239|41749315|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472784|NCT01695239|41749316|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
19472785|NCT01695239|41749317|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472786|NCT01695239|41749318|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472787|NCT01695239|41749319|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472788|NCT01695239|41749320|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472789|NCT01695239|41749321|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472790|NCT01695239|41749322|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
19472791|NCT01695239|41749309|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472792|NCT01695239|41749310|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472793|NCT01695239|41749311|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472794|NCT01695239|41749312|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472795|NCT01695239|41749313|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472796|NCT01695239|41749314|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472797|NCT01695239|41749315|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472798|NCT01695239|41749316|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
19472799|NCT01695239|41749317|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472800|NCT01695239|41749318|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472801|NCT01695239|41749319|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472802|NCT01695239|41749320|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472803|NCT01695239|41749321|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472804|NCT01695239|41749322|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
19472805|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472806|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472807|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472808|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472809|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472810|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472811|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472812|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472813|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
19472814|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
19472815|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472816|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472817|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472818|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
19472819|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
19472820|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
19472821|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
19472822|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
19472823|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
19472824|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
19472825|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
19472826|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
19472827|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
19472828|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
19472829|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
19472830|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
19472831|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
19472832|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
19472833|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472834|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472835|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472836|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472837|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472838|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472839|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472840|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472841|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
19472842|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
19472843|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472844|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472845|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472846|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
19472847|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
19472848|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
19472849|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
19472850|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
19472851|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
19472852|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
19472853|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
19472854|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
19472855|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
19472856|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
19472857|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
19472858|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
19472859|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
19472860|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
19472861|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472862|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472863|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472864|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472865|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472866|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472867|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472868|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472869|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
19472870|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
19472871|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472872|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472873|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472874|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
19472875|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472876|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472877|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472878|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472879|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472880|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472881|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472882|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472883|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
19472884|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
19472885|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472886|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472887|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472888|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
19472889|NCT01695239|41749309|FG000|Extension Long-Term Extension Periods|Death|0|||
19472890|NCT01695239|41749310|FG001|Extension Long-Term Extension Periods|Death|0|||
19472891|NCT01695239|41749311|FG002|Extension Long-Term Extension Periods|Death|0|||
19472892|NCT01695239|41749312|FG003|Extension Long-Term Extension Periods|Death|0|||
19472893|NCT01695239|41749313|FG004|Extension Long-Term Extension Periods|Death|0|||
19472894|NCT01695239|41749314|FG005|Extension Long-Term Extension Periods|Death|0|||
19472895|NCT01695239|41749315|FG006|Extension Long-Term Extension Periods|Death|0|||
19472896|NCT01695239|41749316|FG007|Extension Long-Term Extension Periods|Death|0|||
19472897|NCT01695239|41749317|FG008|Extension Long-Term Extension Periods|Death|1|||
19472898|NCT01695239|41749318|FG009|Extension Long-Term Extension Periods|Death|0|||
19472899|NCT01695239|41749319|FG010|Extension Long-Term Extension Periods|Death|0|||
19472900|NCT01695239|41749320|FG011|Extension Long-Term Extension Periods|Death|0|||
19472901|NCT01695239|41749321|FG012|Extension Long-Term Extension Periods|Death|0|||
19472902|NCT01695239|41749322|FG013|Extension Long-Term Extension Periods|Death|0|||
19472903|NCT01695239|41749309|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472904|NCT01695239|41749310|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472905|NCT01695239|41749311|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472906|NCT01695239|41749312|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472907|NCT01695239|41749313|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472908|NCT01695239|41749314|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472909|NCT01695239|41749315|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472910|NCT01695239|41749316|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472911|NCT01695239|41749317|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472912|NCT01695239|41749318|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472913|NCT01695239|41749319|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19472914|NCT01695239|41749320|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
19472915|NCT01695239|41749321|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
19472916|NCT01695239|41749322|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
19472917|NCT01695239|41749309|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472918|NCT01695239|41749310|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472919|NCT01695239|41749311|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472920|NCT01695239|41749312|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472921|NCT01695239|41749313|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472922|NCT01695239|41749314|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472923|NCT01695239|41749315|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472924|NCT01695239|41749316|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472925|NCT01695239|41749317|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472926|NCT01695239|41749318|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472927|NCT01695239|41749319|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472928|NCT01695239|41749320|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19472929|NCT01695239|41749321|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
19472930|NCT01695239|41749322|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
19472931|NCT01695239|41749309|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472932|NCT01695239|41749310|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472933|NCT01695239|41749311|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472934|NCT01695239|41749312|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472935|NCT01695239|41749313|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472936|NCT01695239|41749314|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472937|NCT01695239|41749315|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472938|NCT01695239|41749316|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472939|NCT01695239|41749317|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472940|NCT01695239|41749318|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472941|NCT01695239|41749319|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472942|NCT01695239|41749320|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472943|NCT01695239|41749321|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
19472944|NCT01695239|41749322|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
19472945|NCT01695239|41749309|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472946|NCT01695239|41749310|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472947|NCT01695239|41749311|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472948|NCT01695239|41749312|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19381841|NCT04032093|41624932|FG000|Overall Study|Adverse Event|0|||
19381842|NCT04032093|41624933|FG001|Overall Study|Adverse Event|0|||
19381843|NCT04032093|41624934|FG002|Overall Study|Adverse Event|0|||
19381844|NCT04032093|41624935|FG003|Overall Study|Adverse Event|0|||
19381845|NCT04032093|41624936|FG004|Overall Study|Adverse Event|0|||
19381846|NCT04032093|41624937|FG005|Overall Study|Adverse Event|0|||
19381847|NCT04032093|41624938|FG006|Overall Study|Adverse Event|0|||
19381848|NCT04032093|41624939|FG007|Overall Study|Adverse Event|0|||
19381849|NCT04032093|41624940|FG008|Overall Study|Adverse Event|0|||
19381850|NCT04032093|41624941|FG009|Overall Study|Adverse Event|1|||
19472949|NCT01695239|41749313|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472950|NCT01695239|41749314|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19553869|NCT01309841|42002815|FG001|Overall Study|Lost to Follow-up|6|||
19381851|NCT04032093|41624932|FG000|Overall Study|Physician Decision|0|||
19472951|NCT01695239|41749315|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472952|NCT01695239|41749316|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472953|NCT01695239|41749317|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472954|NCT01695239|41749318|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472955|NCT01695239|41749319|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472956|NCT01695239|41749320|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472957|NCT01695239|41749321|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19472958|NCT01695239|41749322|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
19472959|NCT02163694|41749346|FG000|Overall Study|Adverse event- related to progression|3|||
19472960|NCT02163694|41749347|FG001|Overall Study|Adverse event- related to progression|8|||
19472961|NCT02163694|41749346|FG000|Overall Study|Adverse event- not related to progression|7|||
19472962|NCT02163694|41749347|FG001|Overall Study|Adverse event- not related to progression|17|||
19472963|NCT02163694|41749346|FG000|Overall Study|Withdrew consent|8|||
19472964|NCT02163694|41749347|FG001|Overall Study|Withdrew consent|21|||
19472965|NCT02163694|41749346|FG000|Overall Study|Lost to Follow-up|1|||
19472966|NCT02163694|41749347|FG001|Overall Study|Lost to Follow-up|2|||
19472967|NCT02163694|41749346|FG000|Overall Study|Progressive disease per protocol|122|||
19472968|NCT02163694|41749347|FG001|Overall Study|Progressive disease per protocol|197|||
19472969|NCT02163694|41749346|FG000|Overall Study|Other, not specified|13|||
19472970|NCT02163694|41749347|FG001|Overall Study|Other, not specified|22|||
19472971|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
19472972|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
19472973|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
19472974|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
19472975|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
19472976|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
19472977|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
19472978|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
19472979|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
19472980|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
19472981|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
19472982|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
19472983|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
19472984|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
19472985|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
19472986|NCT01694849|41749381|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
19472987|NCT01694849|41749382|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
19472988|NCT01694849|41749383|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
19472989|NCT01694849|41749381|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
19472990|NCT01694849|41749382|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
19472991|NCT01694849|41749383|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
19472992|NCT01694849|41749381|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
19472993|NCT01694849|41749382|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
19472994|NCT01694849|41749383|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
19472995|NCT01694771|41749432|FG000|Overall Study|Adverse Event|18|||
19472996|NCT01694771|41749433|FG001|Overall Study|Adverse Event|16|||
19472997|NCT01694771|41749432|FG000|Overall Study|Lack of Efficacy|1|||
19472998|NCT01694771|41749433|FG001|Overall Study|Lack of Efficacy|0|||
19472999|NCT01694771|41749432|FG000|Overall Study|Non compliance protocol|7|||
19381852|NCT04032093|41624933|FG001|Overall Study|Physician Decision|0|||
19473000|NCT01694771|41749433|FG001|Overall Study|Non compliance protocol|6|||
19473001|NCT01694771|41749432|FG000|Overall Study|Lost to Follow-up|2|||
19473002|NCT01694771|41749433|FG001|Overall Study|Lost to Follow-up|3|||
19473003|NCT01694771|41749432|FG000|Overall Study|Consent withdrawn|7|||
19553870|NCT01309841|42002816|FG002|Overall Study|Lost to Follow-up|4|||
19473004|NCT01694771|41749433|FG001|Overall Study|Consent withdrawn|9|||
19473005|NCT01694771|41749432|FG000|Overall Study|Other reasons|5|||
19473006|NCT01694771|41749433|FG001|Overall Study|Other reasons|6|||
19473007|NCT01582061|41749462|FG000|Overall Study|Lack of Efficacy|3|||
19473008|NCT01582061|41749463|FG001|Overall Study|Lack of Efficacy|23|||
19473009|NCT01582061|41749462|FG000|Overall Study|Adverse Event|12|||
19473010|NCT01582061|41749463|FG001|Overall Study|Adverse Event|8|||
19381853|NCT04032093|41624934|FG002|Overall Study|Physician Decision|0|||
19473011|NCT01582061|41749462|FG000|Overall Study|Withdrawal by Subject|10|||
19473012|NCT01582061|41749463|FG001|Overall Study|Withdrawal by Subject|4|||
19473013|NCT01582061|41749462|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19473014|NCT01582061|41749463|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19473015|NCT01582061|41749462|FG000|Overall Study|Death|0|||
19473016|NCT01582061|41749463|FG001|Overall Study|Death|1|||
19473017|NCT01582061|41749462|FG000|Overall Study|condition no longer requires study drug|1|||
19473018|NCT01582061|41749463|FG001|Overall Study|condition no longer requires study drug|0|||
19473019|NCT01582061|41749462|FG000|Overall Study|Lost to Follow-up|1|||
19473020|NCT01582061|41749463|FG001|Overall Study|Lost to Follow-up|0|||
19473021|NCT01693523|41749482|FG000|Overall Study|Adverse Event|2|||
19473022|NCT01693523|41749483|FG001|Overall Study|Adverse Event|1|||
19473023|NCT01693523|41749484|FG002|Overall Study|Adverse Event|0|||
19473024|NCT01693523|41749482|FG000|Overall Study|Death|0|||
19473025|NCT01693523|41749483|FG001|Overall Study|Death|1|||
19473026|NCT01693523|41749484|FG002|Overall Study|Death|1|||
19473027|NCT01693523|41749482|FG000|Overall Study|Lost to Follow-up|0|||
19473028|NCT01693523|41749483|FG001|Overall Study|Lost to Follow-up|0|||
19473029|NCT01693523|41749484|FG002|Overall Study|Lost to Follow-up|4|||
19473030|NCT01693523|41749482|FG000|Overall Study|Physician Decision|0|||
19473031|NCT01693523|41749483|FG001|Overall Study|Physician Decision|0|||
19473032|NCT01693523|41749484|FG002|Overall Study|Physician Decision|1|||
19473033|NCT01693523|41749482|FG000|Overall Study|Withdrawal by Subject|1|||
19473034|NCT01693523|41749483|FG001|Overall Study|Withdrawal by Subject|2|||
19473035|NCT01693523|41749484|FG002|Overall Study|Withdrawal by Subject|2|||
19473036|NCT01693523|41749482|FG000|Overall Study|Lack of compliance study medication|1|||
19473037|NCT01693523|41749483|FG001|Overall Study|Lack of compliance study medication|2|||
19473038|NCT01693523|41749484|FG002|Overall Study|Lack of compliance study medication|0|||
19473039|NCT01693523|41749482|FG000|Overall Study|Chemotherapy was held|1|||
19473040|NCT01693523|41749483|FG001|Overall Study|Chemotherapy was held|2|||
19473041|NCT01693523|41749484|FG002|Overall Study|Chemotherapy was held|0|||
19553871|NCT01309841|42002814|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
19473042|NCT01581593|41749500|FG000|Overall Study|Withdrawal by Subject|1|||
19473043|NCT01581281|41749511|FG000|Overall Study|Early Study Closure|15|||
19473044|NCT01581281|41749512|FG001|Overall Study|Early Study Closure|6|||
19473045|NCT01581281|41749513|FG002|Overall Study|Early Study Closure|12|||
19473046|NCT02692716|41749524|FG000|Overall Study|Lost to Follow-up|2|||
19473047|NCT02692716|41749525|FG001|Overall Study|Lost to Follow-up|5|||
19473048|NCT02692716|41749524|FG000|Overall Study|Withdrawal by Subject|3|||
19473049|NCT02692716|41749525|FG001|Overall Study|Withdrawal by Subject|1|||
19473050|NCT01580969|41749534|FG000|Overall Study|Physician Decision|3|||
19473051|NCT01580969|41749535|FG001|Overall Study|Physician Decision|0|||
19473052|NCT01580969|41749536|FG002|Overall Study|Physician Decision|0|||
19473053|NCT01693367|41749546|FG000|Overall Study|Withdrawal by Subject|1|||
19473054|NCT01693367|41749547|FG001|Overall Study|Withdrawal by Subject|1|||
19473055|NCT01693367|41749546|FG000|Overall Study|Physician Decision|0|||
19473056|NCT01693367|41749547|FG001|Overall Study|Physician Decision|1|||
19473057|NCT02696226|41749557|FG000|Overall Study|Study terminated - lack of enrollment|1|||
19473058|NCT02696226|41749558|FG001|Overall Study|Study terminated - lack of enrollment|0|||
19473059|NCT02696226|41749559|FG002|Overall Study|Study terminated - lack of enrollment|2|||
19473060|NCT02696226|41749560|FG003|Overall Study|Study terminated - lack of enrollment|0|||
19473061|NCT01692275|41749576|FG000|Overall Study|Lost to Follow-up|57|||
19473062|NCT01692275|41749577|FG001|Overall Study|Lost to Follow-up|48|||
19473063|NCT01692275|41749576|FG000|Overall Study|Withdrawal by Subject|9|||
19473064|NCT01692275|41749577|FG001|Overall Study|Withdrawal by Subject|11|||
19473065|NCT02692560|41749597|FG000|Overall Study|Withdrawal by Subject|0|||
19473066|NCT02692560|41749598|FG001|Overall Study|Withdrawal by Subject|6|||
19473067|NCT02688192|41749606|FG000|Overall Study|Lost to Follow-up|11|||
19473068|NCT02688192|41749607|FG001|Overall Study|Lost to Follow-up|5|||
19473069|NCT02688192|41749606|FG000|Overall Study|Physician Decision|1|||
19473070|NCT02688192|41749607|FG001|Overall Study|Physician Decision|0|||
19473071|NCT01579565|41749616|FG000|Randomized|Adverse Event|1|||
19473072|NCT01579565|41749617|FG001|Randomized|Adverse Event|3|||
19473073|NCT01579565|41749616|FG000|Randomized|Withdrawal by Subject|3|||
19473074|NCT01579565|41749617|FG001|Randomized|Withdrawal by Subject|0|||
19473075|NCT01579565|41749616|FG000|Randomized|inadequate preoperative pupil dilation|0|||
19473076|NCT01579565|41749617|FG001|Randomized|inadequate preoperative pupil dilation|1|||
19473077|NCT01579565|41749616|FG000|Randomized|prohibited preoperative eating|1|||
19473078|NCT01579565|41749617|FG001|Randomized|prohibited preoperative eating|0|||
19473079|NCT01579565|41749616|FG000|Randomized|prohibited preoperative medication|0|||
19473080|NCT01579565|41749617|FG001|Randomized|prohibited preoperative medication|1|||
19473081|NCT01579565|41749616|FG000|Treated|Physician Decision|0|||
19473082|NCT01579565|41749617|FG001|Treated|Physician Decision|1|||
19473083|NCT01579565|41749616|FG000|Treated|Lost to Follow-up|2|||
19473084|NCT01579565|41749617|FG001|Treated|Lost to Follow-up|1|||
19473085|NCT01579565|41749616|FG000|Treated|declined to return for final visit|0|||
19473086|NCT01579565|41749617|FG001|Treated|declined to return for final visit|1|||
19473087|NCT01578785|41749627|FG000|Overall Study|Withdrawal by Subject|0|||
19473088|NCT01578785|41749628|FG001|Overall Study|Withdrawal by Subject|1|||
19473089|NCT01578785|41749627|FG000|Overall Study|Study terminated by sponsor|59|||
19473090|NCT01578785|41749628|FG001|Overall Study|Study terminated by sponsor|118|||
19473091|NCT02692482|41749636|FG000|Overall Study|Death|2|||
19473092|NCT02692482|41749637|FG001|Overall Study|Death|2|||
19473093|NCT02692482|41749636|FG000|Overall Study|Withdrawal by Subject|1|||
19473094|NCT02692482|41749637|FG001|Overall Study|Withdrawal by Subject|2|||
19473095|NCT01578551|41749646|FG000|Overall Study|Adverse Event|1|||
19473096|NCT01578551|41749647|FG001|Overall Study|Adverse Event|0|||
19473097|NCT01692197|41749654|FG000|Overall Study|Failed Screening|3|||
19473098|NCT01692119|41749661|FG000|Overall Study|Protocol Violation|3|||
19473099|NCT01692119|41749662|FG001|Overall Study|Protocol Violation|1|||
19473100|NCT01692119|41749661|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
19473101|NCT01692119|41749662|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
19473102|NCT01691885|41749668|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
19473103|NCT01691885|41749669|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
19473104|NCT01691885|41749668|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
19473105|NCT01691885|41749669|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
19473106|NCT01587703|41749702|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
19473107|NCT01587703|41749703|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473108|NCT01587703|41749704|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473109|NCT01587703|41749705|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473110|NCT01587703|41749706|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473111|NCT01587703|41749707|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473112|NCT01587703|41749708|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473113|NCT01587703|41749709|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473114|NCT01587703|41749710|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473115|NCT01587703|41749711|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473116|NCT01587703|41749712|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473117|NCT01587703|41749713|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473118|NCT01587703|41749714|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473119|NCT01587703|41749715|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473120|NCT01587703|41749716|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473121|NCT01587703|41749717|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473122|NCT01587703|41749718|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473123|NCT01587703|41749719|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473124|NCT01587703|41749720|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
19473125|NCT01587703|41749702|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473126|NCT01587703|41749703|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473127|NCT01587703|41749704|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473128|NCT01587703|41749705|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473129|NCT01587703|41749706|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473130|NCT01587703|41749707|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
19473131|NCT01587703|41749708|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473132|NCT01587703|41749709|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
19473133|NCT01587703|41749710|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473134|NCT01587703|41749711|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473135|NCT01587703|41749712|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473136|NCT01587703|41749713|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473137|NCT01587703|41749714|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473138|NCT01587703|41749715|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473139|NCT01587703|41749716|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473140|NCT01587703|41749717|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473141|NCT01587703|41749718|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473142|NCT01587703|41749719|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473143|NCT01587703|41749720|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
19473144|NCT01587703|41749702|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473145|NCT01587703|41749703|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473146|NCT01587703|41749704|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473147|NCT01587703|41749705|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473148|NCT01587703|41749706|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473149|NCT01587703|41749707|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473150|NCT01587703|41749708|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
19473151|NCT01587703|41749709|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473152|NCT01587703|41749710|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473153|NCT01587703|41749711|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473154|NCT01587703|41749712|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473155|NCT01587703|41749713|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473156|NCT01587703|41749714|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473157|NCT01587703|41749715|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473158|NCT01587703|41749716|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473159|NCT01587703|41749717|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473160|NCT01587703|41749718|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473161|NCT01587703|41749719|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473162|NCT01587703|41749720|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
19473163|NCT01587703|41749702|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
19473164|NCT01587703|41749703|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
19473165|NCT01587703|41749704|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
19473166|NCT01587703|41749705|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
19473167|NCT01587703|41749706|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
19473168|NCT01587703|41749707|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
19473169|NCT01587703|41749708|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
19473170|NCT01587703|41749709|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
19473171|NCT01587703|41749710|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473172|NCT01587703|41749711|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473173|NCT01587703|41749712|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473174|NCT01587703|41749713|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473175|NCT01587703|41749714|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473176|NCT01587703|41749715|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473177|NCT01587703|41749716|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473178|NCT01587703|41749717|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473179|NCT01587703|41749718|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473180|NCT01587703|41749719|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473181|NCT01587703|41749720|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
19473182|NCT01587703|41749702|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473183|NCT01587703|41749703|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473184|NCT01587703|41749704|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473185|NCT01587703|41749705|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473186|NCT01587703|41749706|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473187|NCT01587703|41749707|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473188|NCT01587703|41749708|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473189|NCT01587703|41749709|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473190|NCT01587703|41749710|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
19473191|NCT01587703|41749711|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
19473192|NCT01587703|41749712|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
19473193|NCT01587703|41749713|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473194|NCT01587703|41749714|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473195|NCT01587703|41749715|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473196|NCT01587703|41749716|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473197|NCT01587703|41749717|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473198|NCT01587703|41749718|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473199|NCT01587703|41749719|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473200|NCT01587703|41749720|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
19473201|NCT01587703|41749702|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473202|NCT01587703|41749703|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473203|NCT01587703|41749704|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473204|NCT01587703|41749705|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473205|NCT01587703|41749706|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473206|NCT01587703|41749707|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19381854|NCT04032093|41624935|FG003|Overall Study|Physician Decision|0|||
19473207|NCT01587703|41749708|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473208|NCT01587703|41749709|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473209|NCT01587703|41749710|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
19473210|NCT01587703|41749711|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473211|NCT01587703|41749712|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
19473212|NCT01587703|41749713|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473213|NCT01587703|41749714|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473214|NCT01587703|41749715|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473215|NCT01587703|41749716|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473216|NCT01587703|41749717|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19381855|NCT04032093|41624936|FG004|Overall Study|Physician Decision|0|||
19473217|NCT01587703|41749718|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473218|NCT01587703|41749719|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473219|NCT01587703|41749720|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
19473220|NCT01587703|41749702|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473221|NCT01587703|41749703|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473222|NCT01587703|41749704|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473223|NCT01587703|41749705|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473224|NCT01587703|41749706|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473225|NCT01587703|41749707|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473226|NCT01587703|41749708|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473227|NCT01587703|41749709|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473228|NCT01587703|41749710|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473229|NCT01587703|41749711|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
19473230|NCT01587703|41749712|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
19473231|NCT01587703|41749713|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473232|NCT01587703|41749714|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473233|NCT01587703|41749715|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473234|NCT01587703|41749716|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473235|NCT01587703|41749717|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473236|NCT01587703|41749718|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473237|NCT01587703|41749719|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473238|NCT01587703|41749720|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
19473239|NCT01587703|41749702|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473240|NCT01587703|41749703|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473241|NCT01587703|41749704|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473242|NCT01587703|41749705|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473243|NCT01587703|41749706|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473244|NCT01587703|41749707|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473245|NCT01587703|41749708|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473246|NCT01587703|41749709|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473247|NCT01587703|41749710|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
19473248|NCT01587703|41749711|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473249|NCT01587703|41749712|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473250|NCT01587703|41749713|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473251|NCT01587703|41749714|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473252|NCT01587703|41749715|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473253|NCT01587703|41749716|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473254|NCT01587703|41749717|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473255|NCT01587703|41749718|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473256|NCT01587703|41749719|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473257|NCT01587703|41749720|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
19473258|NCT01587703|41749702|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473259|NCT01587703|41749703|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473260|NCT01587703|41749704|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19739378|NCT00111761|42186468|FG000|Part 1|Withdrawal by Subject|0|||
19739379|NCT00111761|42186469|FG001|Part 1|Withdrawal by Subject|1|||
19739380|NCT00111761|42186468|FG000|Part 2|Adverse Event|1|||
19739381|NCT00111761|42186469|FG001|Part 2|Adverse Event|0|||
19739382|NCT00111761|42186468|FG000|Part 2|Physician Decision|1|||
19739383|NCT00111761|42186469|FG001|Part 2|Physician Decision|0|||
19739384|NCT00111761|42186468|FG000|Part 2|Death|1|||
19739385|NCT00111761|42186469|FG001|Part 2|Death|0|||
19739386|NCT00111761|42186468|FG000|Part 2|Disease progression|3|||
19739387|NCT00111761|42186469|FG001|Part 2|Disease progression|0|||
19739388|NCT00111761|42186468|FG000|Part 2|Protocol-specified criteria|1|||
19739389|NCT00111761|42186469|FG001|Part 2|Protocol-specified criteria|0|||
19739390|NCT00111761|42186468|FG000|Part 2|Other|1|||
19739391|NCT00111761|42186469|FG001|Part 2|Other|0|||
19739392|NCT03519867|42186485|FG000|Overall Study|Adverse Event|1|||
19739393|NCT03519867|42186486|FG001|Overall Study|Adverse Event|1|||
19739394|NCT03519867|42186487|FG002|Overall Study|Adverse Event|0|||
19739395|NCT03519867|42186488|FG003|Overall Study|Adverse Event|0|||
19473261|NCT01587703|41749705|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473262|NCT01587703|41749706|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473263|NCT01587703|41749707|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473264|NCT01587703|41749708|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473265|NCT01587703|41749709|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473266|NCT01587703|41749710|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473267|NCT01587703|41749711|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473268|NCT01587703|41749712|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473269|NCT01587703|41749713|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473270|NCT01587703|41749714|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473271|NCT01587703|41749715|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473272|NCT01587703|41749716|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473273|NCT01587703|41749717|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473274|NCT01587703|41749718|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473275|NCT01587703|41749719|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
19473276|NCT01587703|41749720|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
19473277|NCT01587703|41749702|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473278|NCT01587703|41749703|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473279|NCT01587703|41749704|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473280|NCT01587703|41749705|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473281|NCT01587703|41749706|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473282|NCT01587703|41749707|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473283|NCT01587703|41749708|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473284|NCT01587703|41749709|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473285|NCT01587703|41749710|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473286|NCT01587703|41749711|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473287|NCT01587703|41749712|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473288|NCT01587703|41749713|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473289|NCT01587703|41749714|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473290|NCT01587703|41749715|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473291|NCT01587703|41749716|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473292|NCT01587703|41749717|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473293|NCT01587703|41749718|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
19473294|NCT01587703|41749719|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
19473295|NCT01587703|41749720|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
19473296|NCT01587703|41749702|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473297|NCT01587703|41749703|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473298|NCT01587703|41749704|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473299|NCT01587703|41749705|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473300|NCT01587703|41749706|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473301|NCT01587703|41749707|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473302|NCT01587703|41749708|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473303|NCT01587703|41749709|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473304|NCT01587703|41749710|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473305|NCT01587703|41749711|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473306|NCT01587703|41749712|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473307|NCT01587703|41749713|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473308|NCT01587703|41749714|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473309|NCT01587703|41749715|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473310|NCT01587703|41749716|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473311|NCT01587703|41749717|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
19473312|NCT01587703|41749718|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473313|NCT01587703|41749719|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473314|NCT01587703|41749720|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
19473315|NCT01587703|41749702|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473316|NCT01587703|41749703|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19739396|NCT03519867|42186489|FG004|Overall Study|Adverse Event|0|||
19739397|NCT03519867|42186490|FG005|Overall Study|Adverse Event|0|||
19473317|NCT01587703|41749704|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473318|NCT01587703|41749705|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473319|NCT01587703|41749706|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473320|NCT01587703|41749707|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473321|NCT01587703|41749708|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473322|NCT01587703|41749709|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473323|NCT01587703|41749710|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473324|NCT01587703|41749711|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473325|NCT01587703|41749712|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473326|NCT01587703|41749713|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
19473327|NCT01587703|41749714|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473328|NCT01587703|41749715|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473329|NCT01587703|41749716|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
19473330|NCT01587703|41749717|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473331|NCT01587703|41749718|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473332|NCT01587703|41749719|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473333|NCT01587703|41749720|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
19473334|NCT01587703|41749702|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473335|NCT01587703|41749703|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473336|NCT01587703|41749704|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473337|NCT01587703|41749705|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473338|NCT01587703|41749706|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473339|NCT01587703|41749707|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473340|NCT01587703|41749708|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473341|NCT01587703|41749709|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473342|NCT01587703|41749710|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473343|NCT01587703|41749711|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473344|NCT01587703|41749712|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473345|NCT01587703|41749713|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
19473346|NCT01587703|41749714|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
19473347|NCT01587703|41749715|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
19473348|NCT01587703|41749716|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
19473349|NCT01587703|41749717|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
19473350|NCT01587703|41749718|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
19473351|NCT01587703|41749719|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473352|NCT01587703|41749720|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
19473353|NCT01587703|41749702|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473354|NCT01587703|41749703|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473355|NCT01587703|41749704|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473356|NCT01587703|41749705|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473357|NCT01587703|41749706|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473358|NCT01587703|41749707|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473359|NCT01587703|41749708|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473360|NCT01587703|41749709|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473361|NCT01587703|41749710|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473362|NCT01587703|41749711|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473363|NCT01587703|41749712|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473364|NCT01587703|41749713|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
19473365|NCT01587703|41749714|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
19473366|NCT01587703|41749715|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
19473367|NCT01587703|41749716|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
19473368|NCT01587703|41749717|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
19473369|NCT01587703|41749718|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
19473370|NCT01587703|41749719|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473371|NCT01587703|41749720|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
19473372|NCT01587703|41749702|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473373|NCT01587703|41749703|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473374|NCT01587703|41749704|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473375|NCT01587703|41749705|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473376|NCT01587703|41749706|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473377|NCT01587703|41749707|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473378|NCT01587703|41749708|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19739398|NCT03519867|42186491|FG006|Overall Study|Adverse Event|0|||
19473379|NCT01587703|41749709|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473380|NCT01587703|41749710|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473381|NCT01587703|41749711|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473382|NCT01587703|41749712|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473383|NCT01587703|41749713|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
19473384|NCT01587703|41749714|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473385|NCT01587703|41749715|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473386|NCT01587703|41749716|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473387|NCT01587703|41749717|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473388|NCT01587703|41749718|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473389|NCT01587703|41749719|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473390|NCT01587703|41749720|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
19473391|NCT01577381|41749783|FG000|Overall Study|Discontinued|2|||
19473392|NCT01577381|41749784|FG001|Overall Study|Discontinued|1|||
19473393|NCT01577381|41749785|FG002|Overall Study|Discontinued|2|||
19473394|NCT01577381|41749786|FG003|Overall Study|Discontinued|2|||
19473395|NCT01577381|41749783|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
19473396|NCT01577381|41749784|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
19473397|NCT01577381|41749785|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
19473398|NCT01577381|41749786|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
19473399|NCT02686164|41749796|FG000|Overall Study|Adverse Event|1|||
19473400|NCT02686164|41749796|FG000|Overall Study|Withdrawal of consent|1|||
19473401|NCT02686164|41749796|FG000|Overall Study|Clinical progression|1|||
19473402|NCT01691105|41749817|FG000|1 Month Follow-up|Lost to Follow-up|41|||
19473403|NCT01691105|41749818|FG001|1 Month Follow-up|Lost to Follow-up|38|||
19473404|NCT01691105|41749817|FG000|1 Month Follow-up|Death|2|||
19473405|NCT01691105|41749818|FG001|1 Month Follow-up|Death|3|||
19473406|NCT01691105|41749817|FG000|6 Month Follow-up|Lost to Follow-up|39|||
19473407|NCT01691105|41749818|FG001|6 Month Follow-up|Lost to Follow-up|58|||
19473408|NCT01691105|41749817|FG000|6 Month Follow-up|Death|13|||
19473409|NCT01691105|41749818|FG001|6 Month Follow-up|Death|13|||
19473410|NCT01691105|41749817|FG000|12 Month Follow-up|Lost to Follow-up|50|||
19473411|NCT01691105|41749818|FG001|12 Month Follow-up|Lost to Follow-up|71|||
19473412|NCT01691105|41749817|FG000|12 Month Follow-up|Death|22|||
19473413|NCT01691105|41749818|FG001|12 Month Follow-up|Death|30|||
19473414|NCT01691105|41749817|FG000|12 Month Biochemical Verification|Death|22|||
19473415|NCT01691105|41749818|FG001|12 Month Biochemical Verification|Death|30|||
19473416|NCT01691105|41749817|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
19473417|NCT01691105|41749818|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
19473418|NCT01691105|41749817|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
19473419|NCT01691105|41749818|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
19473420|NCT02685072|41749826|FG000|Treatment Period|Lost to Follow-up|12|||
19473421|NCT02685072|41749827|FG001|Treatment Period|Lost to Follow-up|6|||
19739399|NCT03519867|42186492|FG007|Overall Study|Adverse Event|0|||
19473422|NCT02685072|41749826|FG000|Treatment Period|Withdrawal by Subject|1|||
19473423|NCT02685072|41749827|FG001|Treatment Period|Withdrawal by Subject|3|||
19473424|NCT02685072|41749826|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
19473425|NCT02685072|41749827|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
19473426|NCT02695524|41749897|FG000|Overall Study|Lost to Follow-up|3|||
19473427|NCT02695524|41749898|FG001|Overall Study|Lost to Follow-up|2|||
19473428|NCT02695524|41749897|FG000|Overall Study|Death|0|||
19473429|NCT02695524|41749898|FG001|Overall Study|Death|1|||
19473430|NCT01576367|41749904|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19473431|NCT01576367|41749904|FG000|Overall Study|Moved to commercial use after 6 months|1|||
19473432|NCT01689857|41749915|FG000|Overall Study|Lost to Follow-up|5|||
19473433|NCT01689857|41749916|FG001|Overall Study|Lost to Follow-up|2|||
19473434|NCT01587079|41749931|FG000|Overall Study|Protocol-specified criteria|9|||
19473435|NCT01587079|41749931|FG000|Overall Study|Protocol Violation|5|||
19473436|NCT01587079|41749931|FG000|Overall Study|Lost to Follow-up|2|||
19473437|NCT01587079|41749931|FG000|Overall Study|Physician Decision|2|||
19473438|NCT01587079|41749931|FG000|Overall Study|Withdrawal by Subject|7|||
19473439|NCT01587079|41749931|FG000|Overall Study|Adverse Event|14|||
19473440|NCT01587001|41749984|FG000|Overall Study|Lost to Follow-up|2|||
19473441|NCT01587001|41749985|FG001|Overall Study|Lost to Follow-up|0|||
19473442|NCT01587001|41749984|FG000|Overall Study|Insufficient samples to complete testing|4|||
19473443|NCT01587001|41749985|FG001|Overall Study|Insufficient samples to complete testing|1|||
19473444|NCT01568047|41750015|FG000|Overall Study|Ineligibility|1|||
19473445|NCT01568047|41750016|FG001|Overall Study|Ineligibility|0|||
19473446|NCT01568047|41750017|FG002|Overall Study|Ineligibility|0|||
19473447|NCT01568047|41750018|FG003|Overall Study|Ineligibility|0|||
19473448|NCT01568047|41750015|FG000|Overall Study|Withdrawal by Subject|0|||
19473449|NCT01568047|41750016|FG001|Overall Study|Withdrawal by Subject|1|||
19473450|NCT01568047|41750017|FG002|Overall Study|Withdrawal by Subject|0|||
19473451|NCT01568047|41750018|FG003|Overall Study|Withdrawal by Subject|0|||
19473452|NCT01568047|41750015|FG000|Overall Study|Adverse Event|0|||
19473453|NCT01568047|41750016|FG001|Overall Study|Adverse Event|0|||
19473454|NCT01568047|41750017|FG002|Overall Study|Adverse Event|1|||
19473455|NCT01568047|41750018|FG003|Overall Study|Adverse Event|1|||
19473456|NCT02694978|41750030|FG000|Overall Study|Adverse Event|10|||
19473457|NCT02694978|41750031|FG001|Overall Study|Adverse Event|9|||
19473458|NCT02694978|41750030|FG000|Overall Study|Withdrawal by Subject|22|||
19473459|NCT02694978|41750031|FG001|Overall Study|Withdrawal by Subject|19|||
19473460|NCT02694978|41750030|FG000|Overall Study|Lost to Follow-up|14|||
19473461|NCT02694978|41750031|FG001|Overall Study|Lost to Follow-up|17|||
19473462|NCT02694978|41750030|FG000|Overall Study|Death|4|||
19473463|NCT02694978|41750031|FG001|Overall Study|Death|1|||
19473464|NCT02694978|41750030|FG000|Overall Study|Other-Decision of Participant|6|||
19473465|NCT02694978|41750031|FG001|Overall Study|Other-Decision of Participant|1|||
19473466|NCT02694978|41750030|FG000|Overall Study|Other-Investigator's decision|1|||
19473467|NCT02694978|41750031|FG001|Overall Study|Other-Investigator's decision|0|||
19473468|NCT02694978|41750030|FG000|Overall Study|Other-Unable to be reached|0|||
19473469|NCT02694978|41750031|FG001|Overall Study|Other-Unable to be reached|1|||
19473470|NCT02694978|41750030|FG000|Overall Study|Other-Protocol noncompliant|2|||
19473471|NCT02694978|41750031|FG001|Overall Study|Other-Protocol noncompliant|1|||
19473472|NCT02694978|41750030|FG000|Overall Study|Other-Personal reasons|3|||
19473473|NCT02694978|41750031|FG001|Overall Study|Other-Personal reasons|3|||
19473474|NCT02694978|41750030|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
19473475|NCT02694978|41750031|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
19473476|NCT01688999|41750040|FG000|Overall Study|Withdrawal by Subject|5|||
19473477|NCT01688999|41750041|FG001|Overall Study|Withdrawal by Subject|1|||
19473478|NCT01688999|41750042|FG002|Overall Study|Withdrawal by Subject|1|||
19473479|NCT01688999|41750040|FG000|Overall Study|Adverse Event|2|||
19473480|NCT01688999|41750041|FG001|Overall Study|Adverse Event|0|||
19473481|NCT01688999|41750042|FG002|Overall Study|Adverse Event|2|||
19473482|NCT01688999|41750040|FG000|Overall Study|Ineligible/Not treated|1|||
19473483|NCT01688999|41750041|FG001|Overall Study|Ineligible/Not treated|0|||
19473484|NCT01688999|41750042|FG002|Overall Study|Ineligible/Not treated|0|||
19473485|NCT01541917|41750066|FG000|Overall Study|Lost to Follow-up|2|||
19473486|NCT01541917|41750067|FG001|Overall Study|Lost to Follow-up|2|||
19473487|NCT01541917|41750066|FG000|Overall Study|Withdrawal by Subject|13|||
19473488|NCT01541917|41750067|FG001|Overall Study|Withdrawal by Subject|7|||
19473489|NCT01688921|41750087|FG000|Overall Study|Lost to Follow-up|7|||
19473490|NCT01688921|41750088|FG001|Overall Study|Lost to Follow-up|13|||
19473491|NCT01688921|41750087|FG000|Overall Study|Physician Decision|6|||
19473492|NCT01688921|41750088|FG001|Overall Study|Physician Decision|1|||
19473493|NCT01688921|41750087|FG000|Overall Study|Protocol Violation|0|||
19473494|NCT01688921|41750088|FG001|Overall Study|Protocol Violation|1|||
19473495|NCT01688921|41750087|FG000|Overall Study|informed consent|3|||
19473496|NCT01688921|41750088|FG001|Overall Study|informed consent|0|||
19473497|NCT01541371|41750110|FG000|Overall Study|Withdrawal by Subject|14|||
19473498|NCT01541371|41750110|FG000|Overall Study|Lost to Follow-up|21|||
19473499|NCT01541371|41750110|FG000|Overall Study|Adverse Event|15|||
19473500|NCT01541371|41750110|FG000|Overall Study|Lack of Efficacy|12|||
19473501|NCT01541371|41750110|FG000|Overall Study|Protocol Violation|6|||
19473502|NCT01541371|41750110|FG000|Overall Study|Study medication non-compliance|3|||
19739400|NCT03519867|42186493|FG008|Overall Study|Adverse Event|0|||
19381856|NCT04032093|41624937|FG005|Overall Study|Physician Decision|1|||
19473503|NCT01541371|41750110|FG000|Overall Study|Other|6|||
19473504|NCT01687673|41750143|FG000|Overall Study|Physician Decision|1|||
19473505|NCT01687595|41750232|FG000|Overall Study|Withdrawal by Subject|8|||
19473506|NCT01687595|41750233|FG001|Overall Study|Withdrawal by Subject|0|||
19473507|NCT01687595|41750232|FG000|Overall Study|Lost to Follow-up|3|||
19473508|NCT01687595|41750233|FG001|Overall Study|Lost to Follow-up|1|||
19473509|NCT01687595|41750232|FG000|Overall Study|Investigator's decision|1|||
19473510|NCT01687595|41750233|FG001|Overall Study|Investigator's decision|0|||
19473511|NCT01687595|41750232|FG000|Overall Study|Sponsor's decision|1|||
19473512|NCT01687595|41750233|FG001|Overall Study|Sponsor's decision|0|||
19473513|NCT01687595|41750232|FG000|Overall Study|Noncompliance|1|||
19473514|NCT01687595|41750233|FG001|Overall Study|Noncompliance|2|||
19473515|NCT01687595|41750232|FG000|Overall Study|Other than specified|56|||
19473516|NCT01687595|41750233|FG001|Overall Study|Other than specified|7|||
19473517|NCT01687283|41750241|FG000|Overall Study|Adverse Event|11|||
19473518|NCT01687283|41750242|FG001|Overall Study|Adverse Event|4|||
19473519|NCT01687283|41750241|FG000|Overall Study|Lack of Efficacy|3|||
19473520|NCT01687283|41750242|FG001|Overall Study|Lack of Efficacy|1|||
19473521|NCT01687283|41750241|FG000|Overall Study|Protocol Violation|1|||
19473522|NCT01687283|41750242|FG001|Overall Study|Protocol Violation|3|||
19473523|NCT01687283|41750241|FG000|Overall Study|protocol defined stopping criteria|8|||
19473524|NCT01687283|41750242|FG001|Overall Study|protocol defined stopping criteria|10|||
19473525|NCT01687283|41750241|FG000|Overall Study|Lost to Follow-up|1|||
19473526|NCT01687283|41750242|FG001|Overall Study|Lost to Follow-up|1|||
19473527|NCT01687283|41750241|FG000|Overall Study|Investigator discretion|2|||
19473528|NCT01687283|41750242|FG001|Overall Study|Investigator discretion|0|||
19473529|NCT01687283|41750241|FG000|Overall Study|Withdrawal by Subject|9|||
19473530|NCT01687283|41750242|FG001|Overall Study|Withdrawal by Subject|8|||
19473531|NCT02684370|41750251|FG000|Part A|Adverse Event|2|||
19473532|NCT02684370|41750252|FG001|Part A|Adverse Event|0|||
19381857|NCT04032093|41624938|FG006|Overall Study|Physician Decision|0|||
19473533|NCT02684370|41750253|FG002|Part A|Adverse Event|1|||
19473534|NCT02684370|41750254|FG003|Part A|Adverse Event|0|||
19473535|NCT02684370|41750255|FG004|Part A|Adverse Event|0|||
19473536|NCT02684370|41750256|FG005|Part A|Adverse Event|0|||
19473537|NCT02684370|41750251|FG000|Part A|Lost to Follow-up|1|||
19473538|NCT02684370|41750252|FG001|Part A|Lost to Follow-up|1|||
19473539|NCT02684370|41750253|FG002|Part A|Lost to Follow-up|0|||
19473540|NCT02684370|41750254|FG003|Part A|Lost to Follow-up|0|||
19473541|NCT02684370|41750255|FG004|Part A|Lost to Follow-up|0|||
19473542|NCT02684370|41750256|FG005|Part A|Lost to Follow-up|0|||
19473543|NCT02684370|41750251|FG000|Part A|Subject Withdrawal|1|||
19473544|NCT02684370|41750252|FG001|Part A|Subject Withdrawal|0|||
19473545|NCT02684370|41750253|FG002|Part A|Subject Withdrawal|3|||
19473546|NCT02684370|41750254|FG003|Part A|Subject Withdrawal|0|||
19473547|NCT02684370|41750255|FG004|Part A|Subject Withdrawal|0|||
19473548|NCT02684370|41750256|FG005|Part A|Subject Withdrawal|0|||
19473549|NCT02684370|41750251|FG000|Part A|Other|0|||
19473550|NCT02684370|41750252|FG001|Part A|Other|0|||
19473551|NCT02684370|41750253|FG002|Part A|Other|1|||
19473552|NCT02684370|41750254|FG003|Part A|Other|0|||
19473553|NCT02684370|41750255|FG004|Part A|Other|0|||
19473554|NCT02684370|41750256|FG005|Part A|Other|0|||
19473555|NCT02684370|41750251|FG000|Part B|Adverse Event|0|||
19473556|NCT02684370|41750252|FG001|Part B|Adverse Event|0|||
19473557|NCT02684370|41750253|FG002|Part B|Adverse Event|0|||
19473558|NCT02684370|41750254|FG003|Part B|Adverse Event|0|||
19473559|NCT02684370|41750255|FG004|Part B|Adverse Event|2|||
19473560|NCT02684370|41750256|FG005|Part B|Adverse Event|1|||
19473561|NCT02684370|41750251|FG000|Part B|Lost to Follow-up|0|||
19473562|NCT02684370|41750252|FG001|Part B|Lost to Follow-up|0|||
19473563|NCT02684370|41750253|FG002|Part B|Lost to Follow-up|0|||
19473564|NCT02684370|41750254|FG003|Part B|Lost to Follow-up|1|||
19473565|NCT02684370|41750255|FG004|Part B|Lost to Follow-up|2|||
19473566|NCT02684370|41750256|FG005|Part B|Lost to Follow-up|5|||
19473567|NCT02684370|41750251|FG000|Part B|Subject Withdrawal|0|||
19473568|NCT02684370|41750252|FG001|Part B|Subject Withdrawal|0|||
19473569|NCT02684370|41750253|FG002|Part B|Subject Withdrawal|0|||
19473570|NCT02684370|41750254|FG003|Part B|Subject Withdrawal|1|||
19473571|NCT02684370|41750255|FG004|Part B|Subject Withdrawal|1|||
19473572|NCT02684370|41750256|FG005|Part B|Subject Withdrawal|2|||
19473573|NCT01686581|41750283|FG000|Overall Study|Side-effects or Health Problems|15|||
19473574|NCT01686581|41750283|FG000|Overall Study|Lack of Efficacy|90|||
19473575|NCT01686581|41750283|FG000|Overall Study|Participant Concerned about Risks|6|||
19473576|NCT01686581|41750283|FG000|Overall Study|Thinks Injections Too Painful|8|||
19473577|NCT01686581|41750283|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
19473578|NCT01686581|41750283|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
19473579|NCT01686581|41750283|FG000|Overall Study|Thinks it is Inconvenient|17|||
19473580|NCT01686581|41750283|FG000|Overall Study|Other Miscellaneous Reasons|36|||
19473581|NCT01686581|41750283|FG000|Overall Study|Reason Missing|1|||
19473582|NCT02691936|41750301|FG000|Overall Study|Withdrawal by Subject|2|||
19473583|NCT02691936|41750302|FG001|Overall Study|Withdrawal by Subject|5|||
19473584|NCT01685801|41750349|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
19473585|NCT01685801|41750350|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
19473586|NCT01685801|41750351|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
19473587|NCT01685801|41750352|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
19473588|NCT01685801|41750349|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
19473589|NCT01685801|41750350|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
19473590|NCT01685801|41750351|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
19473591|NCT01685801|41750352|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
19473592|NCT01353222|41750371|FG000|Overall Study|Death|30|||
19473593|NCT01353222|41750372|FG001|Overall Study|Death|30|||
19473594|NCT01353222|41750371|FG000|Overall Study|Withdrawal by Subject|8|||
19473595|NCT01353222|41750372|FG001|Overall Study|Withdrawal by Subject|5|||
19473596|NCT01353222|41750371|FG000|Overall Study|Study Terminated|31|||
19473597|NCT01353222|41750372|FG001|Overall Study|Study Terminated|37|||
19473598|NCT01353222|41750371|FG000|Overall Study|Site closed research department|1|||
19473599|NCT01353222|41750372|FG001|Overall Study|Site closed research department|0|||
19473600|NCT01684943|41750402|FG000|Overall Study|Inadequate Venous Access|3|||
19473601|NCT01684943|41750403|FG001|Overall Study|Inadequate Venous Access|0|||
19473602|NCT01684943|41750404|FG002|Overall Study|Inadequate Venous Access|0|||
19473603|NCT01684943|41750402|FG000|Overall Study|Principal Investigator Determination|1|||
19473604|NCT01684943|41750403|FG001|Overall Study|Principal Investigator Determination|0|||
19473605|NCT01684943|41750404|FG002|Overall Study|Principal Investigator Determination|0|||
19473606|NCT01684943|41750402|FG000|Overall Study|Excluded from Analysis|1|||
19473607|NCT01684943|41750403|FG001|Overall Study|Excluded from Analysis|1|||
19473608|NCT01684943|41750404|FG002|Overall Study|Excluded from Analysis|1|||
19473609|NCT01684943|41750402|FG000|Overall Study|Lost to Follow-up|3|||
19473610|NCT01684943|41750403|FG001|Overall Study|Lost to Follow-up|0|||
19473611|NCT01684943|41750404|FG002|Overall Study|Lost to Follow-up|0|||
19473612|NCT01684943|41750402|FG000|Overall Study|Planning Pregnancy|1|||
19473613|NCT01684943|41750403|FG001|Overall Study|Planning Pregnancy|0|||
19473614|NCT01684943|41750404|FG002|Overall Study|Planning Pregnancy|0|||
19473615|NCT01683383|41750419|FG000|Overall Study|Infant was not transported|1|||
19473616|NCT01683383|41750420|FG001|Overall Study|Infant was not transported|0|||
19473617|NCT02694744|41750428|FG000|Overall Study|Adverse Event|2|||
19473618|NCT02694744|41750429|FG001|Overall Study|Adverse Event|1|||
19473619|NCT02694744|41750428|FG000|Overall Study|Withdrawal by Subject|2|||
19473620|NCT02694744|41750429|FG001|Overall Study|Withdrawal by Subject|1|||
19473621|NCT02694744|41750428|FG000|Overall Study|Physician Decision|1|||
19473622|NCT02694744|41750429|FG001|Overall Study|Physician Decision|2|||
19473623|NCT02694744|41750428|FG000|Overall Study|Lost to Follow-up|1|||
19473624|NCT02694744|41750429|FG001|Overall Study|Lost to Follow-up|0|||
19473625|NCT02694744|41750428|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
19473626|NCT02694744|41750429|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
19473627|NCT01683071|41750443|FG000|Part 1|Lack of Efficacy|1|||
19473628|NCT01683071|41750444|FG001|Part 1|Lack of Efficacy|0|||
19473629|NCT01683071|41750445|FG002|Part 1|Lack of Efficacy|0|||
19473630|NCT01683071|41750446|FG003|Part 1|Lack of Efficacy|3|||
19473631|NCT01683071|41750447|FG004|Part 1|Lack of Efficacy|0|||
19473632|NCT01683071|41750448|FG005|Part 1|Lack of Efficacy|0|||
19473633|NCT01683071|41750443|FG000|Part 1|Withdrawal by Subject|1|||
19473634|NCT01683071|41750444|FG001|Part 1|Withdrawal by Subject|2|||
19473635|NCT01683071|41750445|FG002|Part 1|Withdrawal by Subject|2|||
19473636|NCT01683071|41750446|FG003|Part 1|Withdrawal by Subject|1|||
19473637|NCT01683071|41750447|FG004|Part 1|Withdrawal by Subject|0|||
19473638|NCT01683071|41750448|FG005|Part 1|Withdrawal by Subject|0|||
19473639|NCT01683071|41750443|FG000|Part 1|Surgery Cancelled|1|||
19473640|NCT01683071|41750444|FG001|Part 1|Surgery Cancelled|0|||
19473641|NCT01683071|41750445|FG002|Part 1|Surgery Cancelled|0|||
19473642|NCT01683071|41750446|FG003|Part 1|Surgery Cancelled|0|||
19473643|NCT01683071|41750447|FG004|Part 1|Surgery Cancelled|0|||
19473644|NCT01683071|41750448|FG005|Part 1|Surgery Cancelled|0|||
19473645|NCT01683071|41750443|FG000|Part 1|Did not receive study drug|1|||
19473646|NCT01683071|41750444|FG001|Part 1|Did not receive study drug|0|||
19473647|NCT01683071|41750445|FG002|Part 1|Did not receive study drug|0|||
19473648|NCT01683071|41750446|FG003|Part 1|Did not receive study drug|1|||
19473649|NCT01683071|41750447|FG004|Part 1|Did not receive study drug|0|||
19473650|NCT01683071|41750448|FG005|Part 1|Did not receive study drug|0|||
19473651|NCT01683071|41750443|FG000|Part 1|Early termination; met exclusion criteria|0|||
19473652|NCT01683071|41750444|FG001|Part 1|Early termination; met exclusion criteria|2|||
19473653|NCT01683071|41750445|FG002|Part 1|Early termination; met exclusion criteria|1|||
19473654|NCT01683071|41750446|FG003|Part 1|Early termination; met exclusion criteria|0|||
19473655|NCT01683071|41750447|FG004|Part 1|Early termination; met exclusion criteria|0|||
19473656|NCT01683071|41750448|FG005|Part 1|Early termination; met exclusion criteria|0|||
19473657|NCT01683071|41750443|FG000|Part 2|Lack of Efficacy|0|||
19473658|NCT01683071|41750444|FG001|Part 2|Lack of Efficacy|0|||
19473659|NCT01683071|41750445|FG002|Part 2|Lack of Efficacy|0|||
19473660|NCT01683071|41750446|FG003|Part 2|Lack of Efficacy|0|||
19473661|NCT01683071|41750447|FG004|Part 2|Lack of Efficacy|3|||
19473662|NCT01683071|41750448|FG005|Part 2|Lack of Efficacy|4|||
19473663|NCT01683071|41750443|FG000|Part 2|Lost to Follow-up|0|||
19473664|NCT01683071|41750444|FG001|Part 2|Lost to Follow-up|0|||
19473665|NCT01683071|41750445|FG002|Part 2|Lost to Follow-up|0|||
19473666|NCT01683071|41750446|FG003|Part 2|Lost to Follow-up|0|||
19473667|NCT01683071|41750447|FG004|Part 2|Lost to Follow-up|2|||
19473668|NCT01683071|41750448|FG005|Part 2|Lost to Follow-up|0|||
19473669|NCT01683071|41750443|FG000|Part 2|Withdrawal by Subject|0|||
19473670|NCT01683071|41750444|FG001|Part 2|Withdrawal by Subject|0|||
19473671|NCT01683071|41750445|FG002|Part 2|Withdrawal by Subject|0|||
19473672|NCT01683071|41750446|FG003|Part 2|Withdrawal by Subject|0|||
19473673|NCT01683071|41750447|FG004|Part 2|Withdrawal by Subject|3|||
19473674|NCT01683071|41750448|FG005|Part 2|Withdrawal by Subject|3|||
19473675|NCT01683071|41750443|FG000|Part 2|Surgery cancelled|0|||
19473676|NCT01683071|41750444|FG001|Part 2|Surgery cancelled|0|||
19473677|NCT01683071|41750445|FG002|Part 2|Surgery cancelled|0|||
19473678|NCT01683071|41750446|FG003|Part 2|Surgery cancelled|0|||
19473679|NCT01683071|41750447|FG004|Part 2|Surgery cancelled|4|||
19473680|NCT01683071|41750448|FG005|Part 2|Surgery cancelled|2|||
19473681|NCT01683071|41750443|FG000|Part 2|Did not receive study drug|0|||
19473682|NCT01683071|41750444|FG001|Part 2|Did not receive study drug|0|||
19473683|NCT01683071|41750445|FG002|Part 2|Did not receive study drug|0|||
19473684|NCT01683071|41750446|FG003|Part 2|Did not receive study drug|0|||
19473685|NCT01683071|41750447|FG004|Part 2|Did not receive study drug|2|||
19473686|NCT01683071|41750448|FG005|Part 2|Did not receive study drug|1|||
19473687|NCT01683071|41750443|FG000|Part 2|Met exclusion criterion|0|||
19473688|NCT01683071|41750444|FG001|Part 2|Met exclusion criterion|0|||
19473689|NCT01683071|41750445|FG002|Part 2|Met exclusion criterion|0|||
19473690|NCT01683071|41750446|FG003|Part 2|Met exclusion criterion|0|||
19473691|NCT01683071|41750447|FG004|Part 2|Met exclusion criterion|1|||
19473692|NCT01683071|41750448|FG005|Part 2|Met exclusion criterion|1|||
19473693|NCT01683071|41750443|FG000|Part 2|Protocol deviation|0|||
19473694|NCT01683071|41750444|FG001|Part 2|Protocol deviation|0|||
19473695|NCT01683071|41750445|FG002|Part 2|Protocol deviation|0|||
19473696|NCT01683071|41750446|FG003|Part 2|Protocol deviation|0|||
19473697|NCT01683071|41750447|FG004|Part 2|Protocol deviation|1|||
19473698|NCT01683071|41750448|FG005|Part 2|Protocol deviation|2|||
19473699|NCT01683071|41750443|FG000|Part 2|Withdrawal by investigator decision|0|||
19473700|NCT01683071|41750444|FG001|Part 2|Withdrawal by investigator decision|0|||
19473701|NCT01683071|41750445|FG002|Part 2|Withdrawal by investigator decision|0|||
19473702|NCT01683071|41750446|FG003|Part 2|Withdrawal by investigator decision|0|||
19473703|NCT01683071|41750447|FG004|Part 2|Withdrawal by investigator decision|1|||
19473704|NCT01683071|41750448|FG005|Part 2|Withdrawal by investigator decision|2|||
19473705|NCT01567865|41750472|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
19473706|NCT01567865|41750473|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
19473707|NCT01567865|41750474|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
19473708|NCT01567865|41750475|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
19473709|NCT01567865|41750472|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
19473710|NCT01567865|41750473|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
19473711|NCT01567865|41750474|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
19473712|NCT01567865|41750475|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
19473713|NCT01567163|41750486|FG000|Overall Study|Progressive Disease|2|||
19473714|NCT01567163|41750486|FG000|Overall Study|Lost to Follow-up|2|||
19473715|NCT01567085|41750495|FG000|Overall Study|Death|6|||
19473716|NCT01567085|41750495|FG000|Overall Study|Adverse Event|6|||
19473717|NCT01567085|41750495|FG000|Overall Study|Lost to Follow-up|3|||
19473718|NCT01567085|41750495|FG000|Overall Study|Graft loss|2|||
19473719|NCT01567085|41750495|FG000|Overall Study|Renal transplantectomy|1|||
19473720|NCT01567085|41750495|FG000|Overall Study|Returned to chronic dialysis|1|||
19473721|NCT01567085|41750495|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
19473722|NCT01566773|41750499|FG000|Overall Study|Protocol specified criteria|4|||
19473723|NCT01566773|41750499|FG000|Overall Study|Protocol Violation|4|||
19473724|NCT01566773|41750499|FG000|Overall Study|Withdrawal by Subject|9|||
19473725|NCT01566773|41750499|FG000|Overall Study|Administrative reason|1|||
19473726|NCT01566773|41750499|FG000|Overall Study|Adverse Event|10|||
19473727|NCT01566773|41750499|FG000|Overall Study|Physician Decision|2|||
19473728|NCT01566149|41750521|FG000|Overall Study|Adverse Event|0|||
19473729|NCT01566149|41750522|FG001|Overall Study|Adverse Event|1|||
19473730|NCT01566149|41750521|FG000|Overall Study|Non-compliance with study medication|2|||
19473731|NCT01566149|41750522|FG001|Overall Study|Non-compliance with study medication|0|||
19473732|NCT01566149|41750521|FG000|Overall Study|Protocol Violation|0|||
19473733|NCT01566149|41750522|FG001|Overall Study|Protocol Violation|1|||
19473734|NCT01566149|41750521|FG000|Overall Study|Withdrawal by Subject|1|||
19473735|NCT01566149|41750522|FG001|Overall Study|Withdrawal by Subject|0|||
19473736|NCT01565993|41750530|FG000|Overall Study|Physician Decision|0|||
19473737|NCT01565993|41750531|FG001|Overall Study|Physician Decision|3|||
19473738|NCT01565291|41750539|FG000|Overall Study|Withdrawal by Subject|1|||
19473739|NCT01565291|41750540|FG001|Overall Study|Withdrawal by Subject|0|||
19473740|NCT03382834|41750548|FG000|Overall Study|Lost to Follow-up|1|||
19473741|NCT03382834|41750549|FG001|Overall Study|Lost to Follow-up|0|||
19473742|NCT03382834|41750548|FG000|Overall Study|Withdrawal by Subject|0|||
19473743|NCT03382834|41750549|FG001|Overall Study|Withdrawal by Subject|1|||
19473744|NCT02691702|41750566|FG000|Overall Study|Adverse Event|1|||
19473745|NCT02691702|41750567|FG001|Overall Study|Adverse Event|0|||
19473746|NCT02691702|41750568|FG002|Overall Study|Adverse Event|0|||
19473747|NCT02691702|41750569|FG003|Overall Study|Adverse Event|0|||
19473748|NCT02691702|41750570|FG004|Overall Study|Adverse Event|0|||
19473749|NCT02691702|41750571|FG005|Overall Study|Adverse Event|0|||
19473750|NCT02691702|41750572|FG006|Overall Study|Adverse Event|0|||
19473751|NCT02691702|41750573|FG007|Overall Study|Adverse Event|0|||
19473752|NCT02691702|41750574|FG008|Overall Study|Adverse Event|1|||
19473753|NCT02691702|41750575|FG009|Overall Study|Adverse Event|0|||
19473754|NCT02691702|41750576|FG010|Overall Study|Adverse Event|1|||
19473755|NCT02691702|41750566|FG000|Overall Study|Lost to Follow-up|0|||
19473756|NCT02691702|41750567|FG001|Overall Study|Lost to Follow-up|0|||
19473757|NCT02691702|41750568|FG002|Overall Study|Lost to Follow-up|1|||
19473758|NCT02691702|41750569|FG003|Overall Study|Lost to Follow-up|0|||
19473759|NCT02691702|41750570|FG004|Overall Study|Lost to Follow-up|0|||
19473760|NCT02691702|41750571|FG005|Overall Study|Lost to Follow-up|2|||
19473761|NCT02691702|41750572|FG006|Overall Study|Lost to Follow-up|0|||
19473762|NCT02691702|41750573|FG007|Overall Study|Lost to Follow-up|0|||
19473763|NCT02691702|41750574|FG008|Overall Study|Lost to Follow-up|0|||
19473764|NCT02691702|41750575|FG009|Overall Study|Lost to Follow-up|0|||
19473765|NCT02691702|41750576|FG010|Overall Study|Lost to Follow-up|1|||
19473766|NCT02691702|41750566|FG000|Overall Study|Withdrawal by Subject|1|||
19473767|NCT02691702|41750567|FG001|Overall Study|Withdrawal by Subject|1|||
19473768|NCT02691702|41750568|FG002|Overall Study|Withdrawal by Subject|0|||
19473769|NCT02691702|41750569|FG003|Overall Study|Withdrawal by Subject|0|||
19473770|NCT02691702|41750570|FG004|Overall Study|Withdrawal by Subject|0|||
19473771|NCT02691702|41750571|FG005|Overall Study|Withdrawal by Subject|1|||
19473772|NCT02691702|41750572|FG006|Overall Study|Withdrawal by Subject|2|||
19473773|NCT02691702|41750573|FG007|Overall Study|Withdrawal by Subject|0|||
19473774|NCT02691702|41750574|FG008|Overall Study|Withdrawal by Subject|0|||
19473775|NCT02691702|41750575|FG009|Overall Study|Withdrawal by Subject|0|||
19473776|NCT02691702|41750576|FG010|Overall Study|Withdrawal by Subject|0|||
19473777|NCT02691702|41750566|FG000|Overall Study|Other|0|||
19473778|NCT02691702|41750567|FG001|Overall Study|Other|0|||
19473779|NCT02691702|41750568|FG002|Overall Study|Other|0|||
19473780|NCT02691702|41750569|FG003|Overall Study|Other|0|||
19473781|NCT02691702|41750570|FG004|Overall Study|Other|0|||
19473782|NCT02691702|41750571|FG005|Overall Study|Other|0|||
19473783|NCT02691702|41750572|FG006|Overall Study|Other|1|||
19473784|NCT02691702|41750573|FG007|Overall Study|Other|0|||
19473785|NCT02691702|41750574|FG008|Overall Study|Other|1|||
19473786|NCT02691702|41750575|FG009|Overall Study|Other|0|||
19473787|NCT02691702|41750576|FG010|Overall Study|Other|0|||
19473788|NCT02691702|41750566|FG000|Overall Study|Protocol Violation|0|||
19473789|NCT02691702|41750567|FG001|Overall Study|Protocol Violation|0|||
19473790|NCT02691702|41750568|FG002|Overall Study|Protocol Violation|0|||
19473791|NCT02691702|41750569|FG003|Overall Study|Protocol Violation|0|||
19473792|NCT02691702|41750570|FG004|Overall Study|Protocol Violation|0|||
19473793|NCT02691702|41750571|FG005|Overall Study|Protocol Violation|0|||
19473794|NCT02691702|41750572|FG006|Overall Study|Protocol Violation|0|||
19473795|NCT02691702|41750573|FG007|Overall Study|Protocol Violation|0|||
19473796|NCT02691702|41750574|FG008|Overall Study|Protocol Violation|0|||
19473797|NCT02691702|41750575|FG009|Overall Study|Protocol Violation|2|||
19473798|NCT02691702|41750576|FG010|Overall Study|Protocol Violation|0|||
19473799|NCT01564277|41750610|FG000|Overall Study|Protocol Violation|0|||
19473800|NCT01564277|41750611|FG001|Overall Study|Protocol Violation|1|||
19473801|NCT01564277|41750610|FG000|Overall Study|Physician Decision|1|||
19473802|NCT01564277|41750611|FG001|Overall Study|Physician Decision|0|||
19473803|NCT03361306|41750617|FG000|Overall Study|Death|5|||
19473804|NCT03361306|41750617|FG000|Overall Study|Still On Study (on study treatment)|3|||
19473805|NCT03361306|41750617|FG000|Overall Study|Still On Study (in follow up)|7|||
19473806|NCT02679222|41750621|FG000|Overall Study|No time for project|1|||
19473807|NCT01563185|41750633|FG000|Overall Study|Withdrawal by Subject|1|||
19473808|NCT01563185|41750633|FG000|Overall Study|Non-Compliance with study drug|1|||
19473809|NCT03305848|41750637|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
19473810|NCT03305848|41750637|FG000|Overall Study|Physician Decision|2|||
19473811|NCT01563029|41750646|FG000|Overall Study|Adverse Event|1|||
19473812|NCT01563029|41750647|FG001|Overall Study|Adverse Event|0|||
19473813|NCT01563029|41750648|FG002|Overall Study|Adverse Event|1|||
19473814|NCT01563029|41750649|FG003|Overall Study|Adverse Event|2|||
19473815|NCT01563029|41750650|FG004|Overall Study|Adverse Event|1|||
19473816|NCT01563029|41750646|FG000|Overall Study|Lack of Efficacy|42|||
19473817|NCT01563029|41750647|FG001|Overall Study|Lack of Efficacy|16|||
19473818|NCT01563029|41750648|FG002|Overall Study|Lack of Efficacy|23|||
19473819|NCT01563029|41750649|FG003|Overall Study|Lack of Efficacy|21|||
19473820|NCT01563029|41750650|FG004|Overall Study|Lack of Efficacy|19|||
19473821|NCT01563029|41750646|FG000|Overall Study|Protocol Violation|1|||
19473822|NCT01563029|41750647|FG001|Overall Study|Protocol Violation|2|||
19473823|NCT01563029|41750648|FG002|Overall Study|Protocol Violation|3|||
19473824|NCT01563029|41750649|FG003|Overall Study|Protocol Violation|1|||
19553872|NCT01309841|42002815|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
19381858|NCT04032093|41624939|FG007|Overall Study|Physician Decision|0|||
19381859|NCT04032093|41624940|FG008|Overall Study|Physician Decision|0|||
19473825|NCT01563029|41750650|FG004|Overall Study|Protocol Violation|3|||
19473826|NCT01563029|41750646|FG000|Overall Study|Protocol defined stopping criteria|1|||
19473827|NCT01563029|41750647|FG001|Overall Study|Protocol defined stopping criteria|0|||
19473828|NCT01563029|41750648|FG002|Overall Study|Protocol defined stopping criteria|0|||
19473829|NCT01563029|41750649|FG003|Overall Study|Protocol defined stopping criteria|0|||
19473830|NCT01563029|41750650|FG004|Overall Study|Protocol defined stopping criteria|0|||
19473831|NCT01563029|41750646|FG000|Overall Study|Lost to Follow-up|1|||
19473832|NCT01563029|41750647|FG001|Overall Study|Lost to Follow-up|0|||
19473833|NCT01563029|41750648|FG002|Overall Study|Lost to Follow-up|1|||
19473834|NCT01563029|41750649|FG003|Overall Study|Lost to Follow-up|1|||
19473835|NCT01563029|41750650|FG004|Overall Study|Lost to Follow-up|1|||
19473836|NCT01563029|41750646|FG000|Overall Study|Physician Decision|3|||
19473837|NCT01563029|41750647|FG001|Overall Study|Physician Decision|5|||
19473838|NCT01563029|41750648|FG002|Overall Study|Physician Decision|2|||
19473839|NCT01563029|41750649|FG003|Overall Study|Physician Decision|4|||
19473840|NCT01563029|41750650|FG004|Overall Study|Physician Decision|2|||
19473841|NCT01563029|41750646|FG000|Overall Study|Withdrawal by Subject|4|||
19473842|NCT01563029|41750647|FG001|Overall Study|Withdrawal by Subject|1|||
19473843|NCT01563029|41750648|FG002|Overall Study|Withdrawal by Subject|3|||
19473844|NCT01563029|41750649|FG003|Overall Study|Withdrawal by Subject|4|||
19473845|NCT01563029|41750650|FG004|Overall Study|Withdrawal by Subject|3|||
19473846|NCT01562873|41750663|FG000|Overall Study|Disease Progression per RECIST|10|||
19473847|NCT01562873|41750664|FG001|Overall Study|Disease Progression per RECIST|0|||
19473848|NCT01562873|41750663|FG000|Overall Study|Adverse Event|1|||
19473849|NCT01562873|41750664|FG001|Overall Study|Adverse Event|0|||
19473850|NCT01562873|41750663|FG000|Overall Study|Clinical Disease Progression|9|||
19473851|NCT01562873|41750664|FG001|Overall Study|Clinical Disease Progression|0|||
19473852|NCT01562873|41750663|FG000|Overall Study|Clinical PD and adverse event|1|||
19473853|NCT01562873|41750664|FG001|Overall Study|Clinical PD and adverse event|0|||
19473854|NCT03273712|41750668|FG000|Overall Study|Death|5|||
19473855|NCT03273712|41750668|FG000|Overall Study|Adverse Event|1|||
19473856|NCT03273712|41750668|FG000|Overall Study|Disease Progression|1|||
19473857|NCT01562327|41750673|FG000|Overall Study|Adverse Event|2|||
19473858|NCT01562327|41750673|FG000|Overall Study|Lack of Efficacy|1|||
19473859|NCT01562327|41750673|FG000|Overall Study|Participant drop-out|1|||
19473860|NCT01562327|41750673|FG000|Overall Study|Infusion not received at 6 month window|4|||
19473861|NCT01561313|41750680|FG000|Overall Study|Withdrawal by Subject|1|||
19473862|NCT01561313|41750681|FG001|Overall Study|Withdrawal by Subject|0|||
19473863|NCT01561313|41750680|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
19473864|NCT01561313|41750681|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
19473865|NCT01561079|41750687|FG000|Overall Study|Physician Decision|17|||
19473866|NCT01561079|41750687|FG000|Overall Study|Withdrawal by Subject|59|||
19473867|NCT01561079|41750687|FG000|Overall Study|Protocol Violation|2|||
19473868|NCT01559675|41750732|FG000|Overall Study|Protocol Violation|1|||
19473869|NCT01559675|41750733|FG001|Overall Study|Protocol Violation|2|||
19473870|NCT01559675|41750732|FG000|Overall Study|2nd operation on same patient excluded|14|||
19473871|NCT01559675|41750733|FG001|Overall Study|2nd operation on same patient excluded|12|||
19473872|NCT01374906|41750741|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19473873|NCT01374906|41750742|FG001|Overall Study|Abnormal laboratory value(s)|3|||
19473874|NCT01374906|41750741|FG000|Overall Study|Administrative problems|2|||
19473875|NCT01374906|41750742|FG001|Overall Study|Administrative problems|2|||
19473876|NCT01374906|41750741|FG000|Overall Study|Adverse Event|10|||
19473877|NCT01374906|41750742|FG001|Overall Study|Adverse Event|11|||
19473878|NCT01374906|41750741|FG000|Overall Study|Death|0|||
19473879|NCT01374906|41750742|FG001|Overall Study|Death|2|||
19473880|NCT01374906|41750741|FG000|Overall Study|Protocol Violation|2|||
19473881|NCT01374906|41750742|FG001|Overall Study|Protocol Violation|2|||
19473882|NCT01374906|41750741|FG000|Overall Study|Withdrawal by Subject|15|||
19473883|NCT01374906|41750742|FG001|Overall Study|Withdrawal by Subject|9|||
19473884|NCT01374906|41750741|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
19473885|NCT01374906|41750742|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
19473886|NCT03228394|41750760|FG000|Overall Study|Lost to Follow-up|0|||
19473887|NCT03228394|41750761|FG001|Overall Study|Lost to Follow-up|0|||
19473888|NCT03228394|41750762|FG002|Overall Study|Lost to Follow-up|1|||
19473889|NCT03228394|41750763|FG003|Overall Study|Lost to Follow-up|1|||
19473890|NCT03228394|41750764|FG004|Overall Study|Lost to Follow-up|0|||
19473891|NCT03228394|41750765|FG005|Overall Study|Lost to Follow-up|0|||
19473892|NCT03228394|41750766|FG006|Overall Study|Lost to Follow-up|2|||
19473893|NCT03228394|41750767|FG007|Overall Study|Lost to Follow-up|0|||
19473894|NCT03228394|41750760|FG000|Overall Study|Withdrawal by Subject|0|||
19473895|NCT03228394|41750761|FG001|Overall Study|Withdrawal by Subject|0|||
19473896|NCT03228394|41750762|FG002|Overall Study|Withdrawal by Subject|1|||
19473897|NCT03228394|41750763|FG003|Overall Study|Withdrawal by Subject|0|||
19473898|NCT03228394|41750764|FG004|Overall Study|Withdrawal by Subject|0|||
19473899|NCT03228394|41750765|FG005|Overall Study|Withdrawal by Subject|0|||
19473900|NCT03228394|41750766|FG006|Overall Study|Withdrawal by Subject|1|||
19473901|NCT03228394|41750767|FG007|Overall Study|Withdrawal by Subject|3|||
19473902|NCT03228394|41750760|FG000|Overall Study|Protocol Violation|0|||
19473903|NCT03228394|41750761|FG001|Overall Study|Protocol Violation|0|||
19473904|NCT03228394|41750762|FG002|Overall Study|Protocol Violation|0|||
19473905|NCT03228394|41750763|FG003|Overall Study|Protocol Violation|1|||
19473906|NCT03228394|41750764|FG004|Overall Study|Protocol Violation|0|||
19473907|NCT03228394|41750765|FG005|Overall Study|Protocol Violation|0|||
19473908|NCT03228394|41750766|FG006|Overall Study|Protocol Violation|0|||
19473909|NCT03228394|41750767|FG007|Overall Study|Protocol Violation|0|||
19473910|NCT03228394|41750760|FG000|Overall Study|Physician Decision|0|||
19473911|NCT03228394|41750761|FG001|Overall Study|Physician Decision|0|||
19473912|NCT03228394|41750762|FG002|Overall Study|Physician Decision|0|||
19473913|NCT03228394|41750763|FG003|Overall Study|Physician Decision|0|||
19473914|NCT03228394|41750764|FG004|Overall Study|Physician Decision|0|||
19473915|NCT03228394|41750765|FG005|Overall Study|Physician Decision|0|||
19473916|NCT03228394|41750766|FG006|Overall Study|Physician Decision|1|||
19473917|NCT03228394|41750767|FG007|Overall Study|Physician Decision|0|||
19473918|NCT03228394|41750760|FG000|Overall Study|Noncompliance|0|||
19473919|NCT03228394|41750761|FG001|Overall Study|Noncompliance|0|||
19473920|NCT03228394|41750762|FG002|Overall Study|Noncompliance|0|||
19473921|NCT03228394|41750763|FG003|Overall Study|Noncompliance|0|||
19473922|NCT03228394|41750764|FG004|Overall Study|Noncompliance|0|||
19473923|NCT03228394|41750765|FG005|Overall Study|Noncompliance|0|||
19473924|NCT03228394|41750766|FG006|Overall Study|Noncompliance|1|||
19473925|NCT03228394|41750767|FG007|Overall Study|Noncompliance|0|||
19473926|NCT02683746|41750806|FG000|Overall Study|Adverse Event|3|||
19473927|NCT02683746|41750807|FG001|Overall Study|Adverse Event|2|||
19473928|NCT02683746|41750806|FG000|Overall Study|Lost to Follow-up|5|||
19473929|NCT02683746|41750807|FG001|Overall Study|Lost to Follow-up|6|||
19473930|NCT02683746|41750806|FG000|Overall Study|Withdrawal by Subject|6|||
19473931|NCT02683746|41750807|FG001|Overall Study|Withdrawal by Subject|5|||
19473932|NCT02683746|41750806|FG000|Overall Study|Physician Decision|2|||
19473933|NCT02683746|41750807|FG001|Overall Study|Physician Decision|1|||
19473934|NCT01559129|41750815|FG000|Treatment Phase|Adverse Event|0|||
19473935|NCT01559129|41750816|FG001|Treatment Phase|Adverse Event|2|||
19473936|NCT01559129|41750815|FG000|Treatment Phase|Progressive Disease|1|||
19473937|NCT01559129|41750816|FG001|Treatment Phase|Progressive Disease|1|||
19473938|NCT01559129|41750815|FG000|Treatment Phase|Lack of Efficacy|0|||
19473939|NCT01559129|41750816|FG001|Treatment Phase|Lack of Efficacy|1|||
19473940|NCT01559129|41750815|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
19473941|NCT01559129|41750816|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
19473942|NCT01559129|41750815|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
19473943|NCT01559129|41750816|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
19473944|NCT01559129|41750815|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
19473945|NCT01559129|41750816|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
19473946|NCT01559129|41750815|FG000|Open-label Extension Period|Adverse Event|1|||
19473947|NCT01559129|41750816|FG001|Open-label Extension Period|Adverse Event|0|||
19473948|NCT01559129|41750815|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
19473949|NCT01559129|41750816|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
19473950|NCT02691468|41750830|FG000|Overall Study|Bronchial blocker use|2|||
19473951|NCT02691468|41750831|FG001|Overall Study|Bronchial blocker use|1|||
19473952|NCT02691468|41750830|FG000|Overall Study|Lost to Follow-up|2|||
19473953|NCT02691468|41750831|FG001|Overall Study|Lost to Follow-up|1|||
19553873|NCT01309841|42002816|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
19739401|NCT03519867|42186494|FG009|Overall Study|Adverse Event|0|||
19739402|NCT03519867|42186485|FG000|Overall Study|Protocol Violation|0|||
19739403|NCT03519867|42186486|FG001|Overall Study|Protocol Violation|0|||
19739404|NCT03519867|42186487|FG002|Overall Study|Protocol Violation|0|||
19739405|NCT03519867|42186488|FG003|Overall Study|Protocol Violation|0|||
19553874|NCT01309841|42002814|FG000|Overall Study|Lack of Efficacy|0|||
19553875|NCT01309841|42002815|FG001|Overall Study|Lack of Efficacy|0|||
19553876|NCT01309841|42002816|FG002|Overall Study|Lack of Efficacy|2|||
19553877|NCT01309841|42002814|FG000|Overall Study|Adverse Event|9|||
19553878|NCT01309841|42002815|FG001|Overall Study|Adverse Event|22|||
19553879|NCT01309841|42002816|FG002|Overall Study|Adverse Event|11|||
19553880|NCT01309841|42002814|FG000|Overall Study|Death|1|||
19553881|NCT01309841|42002815|FG001|Overall Study|Death|0|||
19553882|NCT01309841|42002816|FG002|Overall Study|Death|0|||
19473954|NCT02691468|41750830|FG000|Overall Study|Failure to advance FOB|2|||
19473955|NCT02691468|41750831|FG001|Overall Study|Failure to advance FOB|0|||
19473956|NCT02678676|41750839|FG000|Overall Study|Death|619|||
19473957|NCT02678676|41750840|FG001|Overall Study|Death|649|||
19473958|NCT02678676|41750839|FG000|Overall Study|Withdrawal by Subject|13|||
19473959|NCT02678676|41750840|FG001|Overall Study|Withdrawal by Subject|5|||
19473960|NCT02678676|41750839|FG000|Overall Study|Lost to Follow-up|171|||
19473961|NCT02678676|41750840|FG001|Overall Study|Lost to Follow-up|151|||
19473962|NCT02678676|41750839|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
19473963|NCT02678676|41750840|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
19473964|NCT01558739|41750846|FG000|Overall Study|Adverse Event|7|||
19473965|NCT01558739|41750846|FG000|Overall Study|Withdrawal by Subject|2|||
19473966|NCT01558739|41750846|FG000|Overall Study|Death|3|||
19553883|NCT01309841|42002814|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19553884|NCT01309841|42002815|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19553885|NCT01309841|42002816|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
19553886|NCT01309841|42002814|FG000|Overall Study|Withdrawal by Subject|17|||
19381860|NCT04032093|41624941|FG009|Overall Study|Physician Decision|0|||
19473967|NCT01558739|41750846|FG000|Overall Study|Disease Progression|4|||
19473968|NCT01558739|41750846|FG000|Overall Study|Protocol Violation|1|||
19553887|NCT01309841|42002815|FG001|Overall Study|Withdrawal by Subject|6|||
19553888|NCT01309841|42002816|FG002|Overall Study|Withdrawal by Subject|13|||
19739406|NCT03519867|42186489|FG004|Overall Study|Protocol Violation|0|||
19473969|NCT02683668|41750850|FG000|Period 2|Withdrawal by Subject|0|||
19473970|NCT02683668|41750851|FG001|Period 2|Withdrawal by Subject|1|||
19473971|NCT02683668|41750852|FG002|Period 2|Withdrawal by Subject|0|||
19473972|NCT02678286|41750860|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
19473973|NCT02678286|41750861|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
19473974|NCT02678286|41750860|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
19473975|NCT02678286|41750861|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
19473976|NCT02678286|41750860|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
19473977|NCT02678286|41750861|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
19473978|NCT02678286|41750860|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
19473979|NCT02678286|41750861|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
19473980|NCT02678286|41750860|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
19473981|NCT02678286|41750861|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
19473982|NCT02682264|41750869|FG000|Overall Study|Withdrawal by Subject|56|||
19473983|NCT02682264|41750870|FG001|Overall Study|Withdrawal by Subject|45|||
19473984|NCT02682264|41750869|FG000|Overall Study|Lost to Follow-up|49|||
19473985|NCT02682264|41750870|FG001|Overall Study|Lost to Follow-up|41|||
19473986|NCT02682264|41750869|FG000|Overall Study|Lack of Efficacy|14|||
19473987|NCT02682264|41750870|FG001|Overall Study|Lack of Efficacy|16|||
19473988|NCT02682264|41750869|FG000|Overall Study|Withdrawal by Parent|6|||
19473989|NCT02682264|41750870|FG001|Overall Study|Withdrawal by Parent|7|||
19473990|NCT02682264|41750869|FG000|Overall Study|Adverse Event|9|||
19473991|NCT02682264|41750870|FG001|Overall Study|Adverse Event|0|||
19473992|NCT02682264|41750869|FG000|Overall Study|Noncompliance with study drug|1|||
19473993|NCT02682264|41750870|FG001|Overall Study|Noncompliance with study drug|4|||
19473994|NCT02682264|41750869|FG000|Overall Study|Pregnancy|1|||
19473995|NCT02682264|41750870|FG001|Overall Study|Pregnancy|2|||
19473996|NCT02682264|41750869|FG000|Overall Study|Recovery|1|||
19473997|NCT02682264|41750870|FG001|Overall Study|Recovery|2|||
19473998|NCT02682264|41750869|FG000|Overall Study|Progressive Disease|1|||
19381861|NCT01675167|41624965|FG000|Open-label Titration Phase|Adverse Event|81|||
19473999|NCT02682264|41750870|FG001|Overall Study|Progressive Disease|0|||
19474000|NCT02682264|41750869|FG000|Overall Study|Technical Problems|0|||
19474001|NCT02682264|41750870|FG001|Overall Study|Technical Problems|1|||
19478167|NCT01693562|41757321|FG007|Expansion Phase|Other|3|||
19474002|NCT02682264|41750869|FG000|Overall Study|Moved abroad and unable to continue|0|||
19474003|NCT02682264|41750870|FG001|Overall Study|Moved abroad and unable to continue|3|||
19474004|NCT02682264|41750869|FG000|Overall Study|Stopped test article application|0|||
19474005|NCT02682264|41750870|FG001|Overall Study|Stopped test article application|1|||
19474006|NCT01566721|41750878|FG000|Treatment Period|Withdrawal by Subject|35|||
19474007|NCT01566721|41750879|FG001|Treatment Period|Withdrawal by Subject|9|||
19474008|NCT01566721|41750878|FG000|Treatment Period|Disease Progression/Recurrence|37|||
19474009|NCT01566721|41750879|FG001|Treatment Period|Disease Progression/Recurrence|13|||
19474010|NCT01566721|41750878|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
19474011|NCT01566721|41750879|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
19474012|NCT01566721|41750878|FG000|Treatment Period|Other|13|||
19474013|NCT01566721|41750879|FG001|Treatment Period|Other|2|||
19474014|NCT01566721|41750878|FG000|Treatment Period|Lack of Compliance|5|||
19474015|NCT01566721|41750879|FG001|Treatment Period|Lack of Compliance|1|||
19474016|NCT01566721|41750878|FG000|Treatment Period|Adverse Event|100|||
19474017|NCT01566721|41750879|FG001|Treatment Period|Adverse Event|30|||
19474018|NCT01566721|41750878|FG000|Treatment Period|Pregnancy|1|||
19474019|NCT01566721|41750879|FG001|Treatment Period|Pregnancy|0|||
19474020|NCT01566721|41750878|FG000|Safety Follow-up|Physician Decision|6|||
19474021|NCT01566721|41750879|FG001|Safety Follow-up|Physician Decision|4|||
19474022|NCT01566721|41750878|FG000|Safety Follow-up|Lost to Follow-up|101|||
19474023|NCT01566721|41750879|FG001|Safety Follow-up|Lost to Follow-up|48|||
19474024|NCT01566721|41750878|FG000|Safety Follow-up|Withdrawal by Subject|155|||
19474025|NCT01566721|41750879|FG001|Safety Follow-up|Withdrawal by Subject|49|||
19553889|NCT01309841|42002814|FG000|Overall Study|Did Not Receive Treatment|2|||
19553890|NCT01309841|42002815|FG001|Overall Study|Did Not Receive Treatment|0|||
19553891|NCT01309841|42002816|FG002|Overall Study|Did Not Receive Treatment|1|||
19553892|NCT01309841|42002814|FG000|Overall Study|Severe non-compliance with protocol|0|||
19553893|NCT01309841|42002815|FG001|Overall Study|Severe non-compliance with protocol|5|||
19553894|NCT01309841|42002816|FG002|Overall Study|Severe non-compliance with protocol|2|||
19381862|NCT01675167|41624966|FG001|Open-label Titration Phase|Adverse Event|0|||
19474026|NCT01566721|41750878|FG000|Safety Follow-up|Death|28|||
19474027|NCT01566721|41750879|FG001|Safety Follow-up|Death|4|||
19474028|NCT01566721|41750878|FG000|Safety Follow-up|Non-compliance|7|||
19474029|NCT01566721|41750879|FG001|Safety Follow-up|Non-compliance|3|||
19474030|NCT01566721|41750878|FG000|Safety Follow-up|Protocol Violation|7|||
19474031|NCT01566721|41750879|FG001|Safety Follow-up|Protocol Violation|0|||
19474032|NCT01566721|41750878|FG000|Safety Follow-up|Site closure|2|||
19474033|NCT01566721|41750879|FG001|Safety Follow-up|Site closure|3|||
19474034|NCT01566721|41750878|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
19474035|NCT01566721|41750879|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
19474036|NCT01566721|41750878|FG000|Safety Follow-up|Missing|7|||
19474037|NCT01566721|41750879|FG001|Safety Follow-up|Missing|2|||
19474038|NCT01566721|41750878|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
19474039|NCT01566721|41750879|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
19474040|NCT01566721|41750878|FG000|Safety Follow-up|Sponsor decision|1|||
19474041|NCT01566721|41750879|FG001|Safety Follow-up|Sponsor decision|0|||
19474042|NCT01566721|41750878|FG000|Safety Follow-up|Adverse Event|8|||
19474043|NCT01566721|41750879|FG001|Safety Follow-up|Adverse Event|4|||
19474044|NCT01541215|41750894|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
19474045|NCT01541215|41750895|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
19474046|NCT01541215|41750894|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
19474047|NCT01541215|41750895|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
19474048|NCT01541215|41750894|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
19474049|NCT01541215|41750895|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
19474050|NCT01541215|41750894|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
19474051|NCT01541215|41750895|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
19474052|NCT01541215|41750894|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
19474053|NCT01541215|41750895|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
19474054|NCT01541215|41750894|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
19474055|NCT01541215|41750895|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
19474056|NCT01540981|41750907|FG000|Overall Study|Withdrawal by Subject|1|||
19474057|NCT01540981|41750908|FG001|Overall Study|Withdrawal by Subject|0|||
19474058|NCT01585987|41750916|FG000|Randomized|Withdrawal by Subject|0|||
19474059|NCT01585987|41750917|FG001|Randomized|Withdrawal by Subject|4|||
19474060|NCT01585987|41750916|FG000|Randomized|No longer met criteria|0|||
19474061|NCT01585987|41750917|FG001|Randomized|No longer met criteria|2|||
19474062|NCT01585987|41750916|FG000|Treated|Disease Progression|39|||
19474063|NCT01585987|41750917|FG001|Treated|Disease Progression|36|||
19474064|NCT01585987|41750916|FG000|Treated|Study Drug Toxicity|9|||
19474065|NCT01585987|41750917|FG001|Treated|Study Drug Toxicity|5|||
19474066|NCT01585987|41750916|FG000|Treated|Adverse Event|3|||
19474067|NCT01585987|41750917|FG001|Treated|Adverse Event|0|||
19474068|NCT01585987|41750916|FG000|Treated|Withdrawal by Subject|1|||
19474069|NCT01585987|41750917|FG001|Treated|Withdrawal by Subject|2|||
19474070|NCT01585987|41750916|FG000|Treated|Death|1|||
19474071|NCT01585987|41750917|FG001|Treated|Death|0|||
19474072|NCT01585987|41750916|FG000|Treated|Lost to Follow-up|0|||
19474073|NCT01585987|41750917|FG001|Treated|Lost to Follow-up|1|||
19474074|NCT01585987|41750916|FG000|Treated|Maximum Clinical Benefit|0|||
19474075|NCT01585987|41750917|FG001|Treated|Maximum Clinical Benefit|1|||
19474076|NCT01585987|41750916|FG000|Treated|Non-Specified|1|||
19474077|NCT01585987|41750917|FG001|Treated|Non-Specified|2|||
19474078|NCT01585987|41750916|FG000|Treated|Subject Request|0|||
19474079|NCT01585987|41750917|FG001|Treated|Subject Request|1|||
19474080|NCT01585987|41750916|FG000|Treated|Poor/Non-Compliance|0|||
19474081|NCT01585987|41750917|FG001|Treated|Poor/Non-Compliance|1|||
19474082|NCT01585831|41750926|FG000|Overall Study|Physician Decision|0|||
19474083|NCT01585831|41750927|FG001|Overall Study|Physician Decision|1|||
19474084|NCT01585831|41750926|FG000|Overall Study|Withdrawal by Subject|2|||
19474085|NCT01585831|41750927|FG001|Overall Study|Withdrawal by Subject|1|||
19474086|NCT01565941|41750935|FG000|Overall Study|Withdrawn by parent/guardian|3|||
19474087|NCT01565941|41750936|FG001|Overall Study|Withdrawn by parent/guardian|2|||
19474088|NCT01565941|41750935|FG000|Overall Study|Randomized; did not receive intevention|8|||
19474089|NCT01565941|41750936|FG001|Overall Study|Randomized; did not receive intevention|2|||
19474090|NCT01558271|41750951|FG000|Overall Study|Adverse Event|6|||
19474091|NCT01558271|41750952|FG001|Overall Study|Adverse Event|3|||
19474092|NCT01558271|41750953|FG002|Overall Study|Adverse Event|4|||
19474093|NCT01558271|41750951|FG000|Overall Study|Lost to Follow-up|1|||
19474094|NCT01558271|41750952|FG001|Overall Study|Lost to Follow-up|0|||
19474095|NCT01558271|41750953|FG002|Overall Study|Lost to Follow-up|0|||
19474096|NCT01558271|41750951|FG000|Overall Study|Protocol Violation|1|||
19474097|NCT01558271|41750952|FG001|Overall Study|Protocol Violation|0|||
19474098|NCT01558271|41750953|FG002|Overall Study|Protocol Violation|0|||
19474099|NCT01558271|41750951|FG000|Overall Study|Withdrawal by Subject|10|||
19474100|NCT01558271|41750952|FG001|Overall Study|Withdrawal by Subject|6|||
19474101|NCT01558271|41750953|FG002|Overall Study|Withdrawal by Subject|12|||
19474102|NCT01558271|41750951|FG000|Overall Study|Physician Decision|0|||
19474103|NCT01558271|41750952|FG001|Overall Study|Physician Decision|2|||
19474104|NCT01558271|41750953|FG002|Overall Study|Physician Decision|1|||
19474105|NCT01565707|41750969|FG000|Overall Study|Adverse Event|1|||
19474106|NCT01565707|41750970|FG001|Overall Study|Adverse Event|6|||
19474107|NCT01565707|41750971|FG002|Overall Study|Adverse Event|2|||
19474108|NCT01565707|41750972|FG003|Overall Study|Adverse Event|1|||
19474109|NCT01565707|41750969|FG000|Overall Study|Lost to Follow-up|1|||
19474110|NCT01565707|41750970|FG001|Overall Study|Lost to Follow-up|0|||
19474111|NCT01565707|41750971|FG002|Overall Study|Lost to Follow-up|0|||
19474112|NCT01565707|41750972|FG003|Overall Study|Lost to Follow-up|0|||
19474113|NCT01565707|41750969|FG000|Overall Study|Protocol Violation|1|||
19474114|NCT01565707|41750970|FG001|Overall Study|Protocol Violation|0|||
19474115|NCT01565707|41750971|FG002|Overall Study|Protocol Violation|0|||
19474116|NCT01565707|41750972|FG003|Overall Study|Protocol Violation|1|||
19474117|NCT01565707|41750969|FG000|Overall Study|Withdrawal by Subject|3|||
19474118|NCT01565707|41750970|FG001|Overall Study|Withdrawal by Subject|1|||
19474119|NCT01565707|41750971|FG002|Overall Study|Withdrawal by Subject|1|||
19474120|NCT01565707|41750972|FG003|Overall Study|Withdrawal by Subject|1|||
19474121|NCT01565707|41750969|FG000|Overall Study|Randomized but not evaluable|2|||
19474122|NCT01565707|41750970|FG001|Overall Study|Randomized but not evaluable|0|||
19474123|NCT01565707|41750971|FG002|Overall Study|Randomized but not evaluable|0|||
19474124|NCT01565707|41750972|FG003|Overall Study|Randomized but not evaluable|0|||
19474125|NCT01565707|41750969|FG000|Overall Study|Miscellaneous|1|||
19474126|NCT01565707|41750970|FG001|Overall Study|Miscellaneous|1|||
19474127|NCT01565707|41750971|FG002|Overall Study|Miscellaneous|0|||
19474128|NCT01565707|41750972|FG003|Overall Study|Miscellaneous|2|||
19474129|NCT01557569|41750991|FG000|Overall Study|Adverse Event|2|||
19474130|NCT01557569|41750992|FG001|Overall Study|Adverse Event|0|||
19474131|NCT01557569|41750991|FG000|Overall Study|high blood pressure|0|||
19474132|NCT01557569|41750992|FG001|Overall Study|high blood pressure|1|||
19553895|NCT01308749|42002826|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
19474133|NCT01557569|41750991|FG000|Overall Study|Withdrawal by Subject|3|||
19474134|NCT01557569|41750992|FG001|Overall Study|Withdrawal by Subject|5|||
19474135|NCT01557569|41750991|FG000|Overall Study|noncompliance with rules of residential|0|||
19474136|NCT01557569|41750992|FG001|Overall Study|noncompliance with rules of residential|1|||
19474137|NCT01538719|41751000|FG000|Overall Study|Lost to Follow-up|2|||
19474138|NCT01538719|41751001|FG001|Overall Study|Lost to Follow-up|0|||
19474139|NCT01537783|41751009|FG000|Overall Study|Lost to Follow-up|11|||
19474140|NCT01537783|41751010|FG001|Overall Study|Lost to Follow-up|2|||
19474141|NCT01556165|41751018|FG000|Overall Study|Adverse Event|5|||
19474142|NCT01556165|41751019|FG001|Overall Study|Adverse Event|3|||
19474143|NCT01556165|41751018|FG000|Overall Study|Protocol Violation|0|||
19474144|NCT01556165|41751019|FG001|Overall Study|Protocol Violation|3|||
19474145|NCT01556165|41751018|FG000|Overall Study|Withdrawal of Consent|7|||
19474146|NCT01556165|41751019|FG001|Overall Study|Withdrawal of Consent|1|||
19474147|NCT01537549|41751025|FG000|Overall Study|Lost to Follow-up|1|||
19474148|NCT01537549|41751025|FG000|Overall Study|Withdrawal by Subject|2|||
19474149|NCT01555931|41751033|FG000|Overall Study|Lost to Follow-up|2|||
19474150|NCT01555931|41751034|FG001|Overall Study|Lost to Follow-up|5|||
19474151|NCT01583179|41751042|FG000|Overall Study|Screen failure|1|||
19474152|NCT01583179|41751043|FG001|Overall Study|Screen failure|2|||
19474153|NCT01582945|41751049|FG000|Overall Study|Intolerable side-effects|1|||
19474154|NCT01582945|41751049|FG000|Overall Study|Scheduling conflicts|1|||
19474155|NCT01565083|41751055|FG000|Overall Study|Withdrawal by Subject|6|||
19474156|NCT01565083|41751056|FG001|Overall Study|Withdrawal by Subject|4|||
19474157|NCT01565083|41751055|FG000|Overall Study|Lost to Follow-up|2|||
19474158|NCT01565083|41751056|FG001|Overall Study|Lost to Follow-up|7|||
19474159|NCT01565083|41751055|FG000|Overall Study|Death|22|||
19474160|NCT01565083|41751056|FG001|Overall Study|Death|23|||
19474161|NCT01565083|41751055|FG000|Overall Study|Other|3|||
19474162|NCT01565083|41751056|FG001|Overall Study|Other|5|||
19474163|NCT01555463|41751064|FG000|Treatment|Adverse Event|6|||
19474164|NCT01555463|41751065|FG001|Treatment|Adverse Event|12|||
19474165|NCT01555463|41751064|FG000|Treatment|Withdrawal by Subject|24|||
19474166|NCT01555463|41751065|FG001|Treatment|Withdrawal by Subject|36|||
19474167|NCT01555463|41751064|FG000|Treatment|Lost to Follow-up|28|||
19474168|NCT01555463|41751065|FG001|Treatment|Lost to Follow-up|23|||
19474169|NCT01555463|41751064|FG000|Treatment|Protocol Violation|4|||
19474170|NCT01555463|41751065|FG001|Treatment|Protocol Violation|5|||
19474171|NCT01555463|41751064|FG000|Treatment|Other reason|2|||
19474172|NCT01555463|41751065|FG001|Treatment|Other reason|3|||
19474173|NCT01555463|41751064|FG000|Follow up|Adverse Event|2|||
19474174|NCT01555463|41751065|FG001|Follow up|Adverse Event|5|||
19474175|NCT01555463|41751064|FG000|Follow up|Death|0|||
19474176|NCT01555463|41751065|FG001|Follow up|Death|1|||
19553896|NCT01308749|42002827|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
19553897|NCT01308749|42002826|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
19553898|NCT01308749|42002827|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
19553899|NCT01308749|42002826|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
19553900|NCT01308749|42002827|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
19553901|NCT01307891|42002849|FG000|Overall Study|Progressive Disease|3|||
19553902|NCT01307891|42002850|FG001|Overall Study|Progressive Disease|1|||
19474177|NCT01555463|41751064|FG000|Follow up|Withdrawal by Subject|22|||
19553903|NCT01307579|42002858|FG000|Overall Study|Death|3|||
19474178|NCT01555463|41751065|FG001|Follow up|Withdrawal by Subject|22|||
19474179|NCT01555463|41751064|FG000|Follow up|Lost to Follow-up|9|||
19474180|NCT01555463|41751065|FG001|Follow up|Lost to Follow-up|10|||
19474181|NCT01555463|41751064|FG000|Follow up|Protocol Violation|2|||
19474182|NCT01555463|41751065|FG001|Follow up|Protocol Violation|4|||
19474183|NCT01555463|41751064|FG000|Follow up|Other reason|3|||
19474184|NCT01555463|41751065|FG001|Follow up|Other reason|3|||
19474185|NCT01582789|41751071|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
19474186|NCT01582789|41751072|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
19474187|NCT01537393|41751082|FG000|Overall Study|Exclude prior to study|32|||
19474188|NCT01537393|41751083|FG001|Overall Study|Exclude prior to study|44|||
19474189|NCT01537393|41751082|FG000|Overall Study|Death|20|||
19474190|NCT01537393|41751083|FG001|Overall Study|Death|32|||
19553904|NCT01307579|42002859|FG001|Overall Study|Death|6|||
19474191|NCT01537393|41751082|FG000|Overall Study|Withdrawal by Subject|18|||
19474192|NCT01537393|41751083|FG001|Overall Study|Withdrawal by Subject|17|||
19474193|NCT01537393|41751082|FG000|Overall Study|Lost to Follow-up|53|||
19474194|NCT01537393|41751083|FG001|Overall Study|Lost to Follow-up|48|||
19474195|NCT01537393|41751082|FG000|Overall Study|Failure - Regrafted|28|||
19474196|NCT01537393|41751083|FG001|Overall Study|Failure - Regrafted|43|||
19474197|NCT01537393|41751082|FG000|Overall Study|Failure - Not regrafted|2|||
19474198|NCT01537393|41751083|FG001|Overall Study|Failure - Not regrafted|6|||
19474199|NCT01537393|41751082|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
19474200|NCT01537393|41751083|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
19474201|NCT01555151|41751093|FG000|Overall Study|Withdrawal by Subject|6|||
19474202|NCT01555151|41751094|FG001|Overall Study|Withdrawal by Subject|2|||
19474203|NCT01555151|41751095|FG002|Overall Study|Withdrawal by Subject|0|||
19474204|NCT01555151|41751096|FG003|Overall Study|Withdrawal by Subject|2|||
19474205|NCT01555151|41751093|FG000|Overall Study|Administrative|3|||
19474206|NCT01555151|41751094|FG001|Overall Study|Administrative|1|||
19474207|NCT01555151|41751095|FG002|Overall Study|Administrative|2|||
19474208|NCT01555151|41751096|FG003|Overall Study|Administrative|0|||
19474209|NCT01555151|41751093|FG000|Overall Study|Protocol Violation|3|||
19474210|NCT01555151|41751094|FG001|Overall Study|Protocol Violation|3|||
19474211|NCT01555151|41751095|FG002|Overall Study|Protocol Violation|3|||
19474212|NCT01555151|41751096|FG003|Overall Study|Protocol Violation|5|||
19474213|NCT01555151|41751093|FG000|Overall Study|Adverse Event|1|||
19474214|NCT01555151|41751094|FG001|Overall Study|Adverse Event|2|||
19474215|NCT01555151|41751095|FG002|Overall Study|Adverse Event|1|||
19474216|NCT01555151|41751096|FG003|Overall Study|Adverse Event|2|||
19474217|NCT01555151|41751093|FG000|Overall Study|Lost to Follow-up|0|||
19474218|NCT01555151|41751094|FG001|Overall Study|Lost to Follow-up|0|||
19474219|NCT01555151|41751095|FG002|Overall Study|Lost to Follow-up|0|||
19474220|NCT01555151|41751096|FG003|Overall Study|Lost to Follow-up|1|||
19474221|NCT01537081|41751110|FG000|Overall Study|Adverse Event|5|||
19474222|NCT01537081|41751111|FG001|Overall Study|Adverse Event|2|||
19474223|NCT01537081|41751112|FG002|Overall Study|Adverse Event|2|||
19474224|NCT01537081|41751110|FG000|Overall Study|Lack of Efficacy|2|||
19474225|NCT01537081|41751111|FG001|Overall Study|Lack of Efficacy|1|||
19474226|NCT01537081|41751112|FG002|Overall Study|Lack of Efficacy|0|||
19474227|NCT01537081|41751110|FG000|Overall Study|Lost to Follow-up|17|||
19474228|NCT01537081|41751111|FG001|Overall Study|Lost to Follow-up|15|||
19474229|NCT01537081|41751112|FG002|Overall Study|Lost to Follow-up|9|||
19474230|NCT01537081|41751110|FG000|Overall Study|Protocol Violation|3|||
19474231|NCT01537081|41751111|FG001|Overall Study|Protocol Violation|2|||
19474232|NCT01537081|41751112|FG002|Overall Study|Protocol Violation|2|||
19474233|NCT01537081|41751110|FG000|Overall Study|Withdrawal by Subject|6|||
19474234|NCT01537081|41751111|FG001|Overall Study|Withdrawal by Subject|11|||
19474235|NCT01537081|41751112|FG002|Overall Study|Withdrawal by Subject|3|||
19474236|NCT01537081|41751110|FG000|Overall Study|Physician Decision|5|||
19474237|NCT01537081|41751111|FG001|Overall Study|Physician Decision|6|||
19474238|NCT01537081|41751112|FG002|Overall Study|Physician Decision|0|||
19474239|NCT01537081|41751110|FG000|Overall Study|Sponsor decision|0|||
19474240|NCT01537081|41751111|FG001|Overall Study|Sponsor decision|1|||
19474241|NCT01537081|41751112|FG002|Overall Study|Sponsor decision|0|||
19474242|NCT01537081|41751110|FG000|Overall Study|Assigned but never dosed|1|||
19474243|NCT01537081|41751111|FG001|Overall Study|Assigned but never dosed|0|||
19474244|NCT01537081|41751112|FG002|Overall Study|Assigned but never dosed|0|||
19474245|NCT01564459|41751124|FG000|Run-In|Adverse Event|7|||
19474246|NCT01564459|41751125|FG001|Run-In|Adverse Event|0|||
19474247|NCT01564459|41751126|FG002|Run-In|Adverse Event|0|||
19474248|NCT01564459|41751124|FG000|Run-In|Lost to Follow-up|1|||
19474249|NCT01564459|41751125|FG001|Run-In|Lost to Follow-up|0|||
19474250|NCT01564459|41751126|FG002|Run-In|Lost to Follow-up|0|||
19474251|NCT01564459|41751124|FG000|Run-In|Non-compliance with study drug|2|||
19474252|NCT01564459|41751125|FG001|Run-In|Non-compliance with study drug|0|||
19474253|NCT01564459|41751126|FG002|Run-In|Non-compliance with study drug|0|||
19474254|NCT01564459|41751124|FG000|Run-In|Protocol Violation|1|||
19474255|NCT01564459|41751125|FG001|Run-In|Protocol Violation|0|||
19474256|NCT01564459|41751126|FG002|Run-In|Protocol Violation|0|||
19474257|NCT01564459|41751124|FG000|Run-In|Withdrawal by Subject|1|||
19474258|NCT01564459|41751125|FG001|Run-In|Withdrawal by Subject|0|||
19474259|NCT01564459|41751126|FG002|Run-In|Withdrawal by Subject|0|||
19474260|NCT01564459|41751124|FG000|Double-blind Treatment|Adverse Event|0|||
19474261|NCT01564459|41751125|FG001|Double-blind Treatment|Adverse Event|0|||
19474262|NCT01564459|41751126|FG002|Double-blind Treatment|Adverse Event|1|||
19474263|NCT01555073|41751141|FG000|Overall Study|Lost to Follow-up|1|||
19474264|NCT01555073|41751142|FG001|Overall Study|Lost to Follow-up|2|||
19474265|NCT01555073|41751143|FG002|Overall Study|Lost to Follow-up|0|||
19474266|NCT01555073|41751144|FG003|Overall Study|Lost to Follow-up|5|||
19474267|NCT01582243|41751154|FG000|Overall Study|Withdrawal by Subject|1|||
19474268|NCT01582243|41751154|FG000|Overall Study|Adverse Event|1|||
19474269|NCT01582243|41751154|FG000|Overall Study|Lost to Follow-up|1|||
19474270|NCT01536535|41751160|FG000|Overall Study|Withdrawal by Subject|10|||
19474271|NCT01536535|41751161|FG001|Overall Study|Withdrawal by Subject|5|||
19474272|NCT01536535|41751160|FG000|Overall Study|Lost to Follow-up|4|||
19474273|NCT01536535|41751161|FG001|Overall Study|Lost to Follow-up|6|||
19474274|NCT01536535|41751160|FG000|Overall Study|Physician Decision|1|||
19474275|NCT01536535|41751161|FG001|Overall Study|Physician Decision|1|||
19474276|NCT01536535|41751160|FG000|Overall Study|Participant moved|0|||
19474277|NCT01536535|41751161|FG001|Overall Study|Participant moved|1|||
19474278|NCT01554527|41751171|FG000|Overall Study|Withdrawal by Subject|1|||
19474279|NCT01554527|41751172|FG001|Overall Study|Withdrawal by Subject|0|||
19474280|NCT01554527|41751173|FG002|Overall Study|Withdrawal by Subject|3|||
19474281|NCT01554527|41751171|FG000|Overall Study|Lost to Follow-up|0|||
19474282|NCT01554527|41751172|FG001|Overall Study|Lost to Follow-up|0|||
19474283|NCT01554527|41751173|FG002|Overall Study|Lost to Follow-up|4|||
19474284|NCT01554527|41751171|FG000|Overall Study|Physician Decision|0|||
19474285|NCT01554527|41751172|FG001|Overall Study|Physician Decision|0|||
19474286|NCT01554527|41751173|FG002|Overall Study|Physician Decision|1|||
19474287|NCT01563913|41751184|FG000|Overall Study|Physician Decision|1|||
19474288|NCT01563913|41751185|FG001|Overall Study|Physician Decision|0|||
19474289|NCT01563913|41751184|FG000|Overall Study|Spouse Passed Away|1|||
19474290|NCT01563913|41751185|FG001|Overall Study|Spouse Passed Away|0|||
19474291|NCT01553747|41751194|FG000|Overall Study|Protocol Violation|0|||
19474292|NCT01553747|41751195|FG001|Overall Study|Protocol Violation|2|||
19474293|NCT01553747|41751196|FG002|Overall Study|Protocol Violation|0|||
19474294|NCT01553747|41751194|FG000|Overall Study|Voluntarily withdrew|70|||
19474295|NCT01553747|41751195|FG001|Overall Study|Voluntarily withdrew|66|||
19474296|NCT01553747|41751196|FG002|Overall Study|Voluntarily withdrew|74|||
19474297|NCT01553747|41751194|FG000|Overall Study|Adverse event or SAE|32|||
19474298|NCT01553747|41751195|FG001|Overall Study|Adverse event or SAE|28|||
19474299|NCT01553747|41751196|FG002|Overall Study|Adverse event or SAE|19|||
19474300|NCT01553747|41751194|FG000|Overall Study|Physician decision: other|10|||
19474301|NCT01553747|41751195|FG001|Overall Study|Physician decision: other|8|||
19474302|NCT01553747|41751196|FG002|Overall Study|Physician decision: other|7|||
19474303|NCT01553747|41751194|FG000|Overall Study|Lost to Follow-up|11|||
19474304|NCT01553747|41751195|FG001|Overall Study|Lost to Follow-up|5|||
19474305|NCT01553747|41751196|FG002|Overall Study|Lost to Follow-up|6|||
19474306|NCT01553747|41751194|FG000|Overall Study|Sponsor decision, specify|7|||
19474307|NCT01553747|41751195|FG001|Overall Study|Sponsor decision, specify|5|||
19474308|NCT01553747|41751196|FG002|Overall Study|Sponsor decision, specify|0|||
19474309|NCT01553747|41751194|FG000|Overall Study|Physician decision: lack of efficacy|1|||
19474310|NCT01553747|41751195|FG001|Overall Study|Physician decision: lack of efficacy|5|||
19474311|NCT01553747|41751196|FG002|Overall Study|Physician decision: lack of efficacy|3|||
19474312|NCT01536379|41751209|FG000|Overall Study|Adverse Event|1|||
19474313|NCT01536379|41751210|FG001|Overall Study|Adverse Event|2|||
19474314|NCT01536379|41751209|FG000|Overall Study|Withdrawal by Subject|1|||
19474315|NCT01536379|41751210|FG001|Overall Study|Withdrawal by Subject|1|||
19474316|NCT01536145|41751216|FG000|Overall Study|Progressive disease|3|||
19474317|NCT01536145|41751217|FG001|Overall Study|Progressive disease|4|||
19474318|NCT01536145|41751218|FG002|Overall Study|Progressive disease|1|||
19474319|NCT01536145|41751219|FG003|Overall Study|Progressive disease|2|||
19474320|NCT01536145|41751220|FG004|Overall Study|Progressive disease|1|||
19474321|NCT01536145|41751221|FG005|Overall Study|Progressive disease|2|||
19474322|NCT01536145|41751222|FG006|Overall Study|Progressive disease|1|||
19474323|NCT01536145|41751223|FG007|Overall Study|Progressive disease|2|||
19474324|NCT01536145|41751224|FG008|Overall Study|Progressive disease|1|||
19474325|NCT01536145|41751225|FG009|Overall Study|Progressive disease|3|||
19474326|NCT01536145|41751226|FG010|Overall Study|Progressive disease|3|||
19474327|NCT01536145|41751216|FG000|Overall Study|Withdrawal by Subject|0|||
19474328|NCT01536145|41751217|FG001|Overall Study|Withdrawal by Subject|0|||
19474329|NCT01536145|41751218|FG002|Overall Study|Withdrawal by Subject|1|||
19474330|NCT01536145|41751219|FG003|Overall Study|Withdrawal by Subject|0|||
19474331|NCT01536145|41751220|FG004|Overall Study|Withdrawal by Subject|0|||
19474332|NCT01536145|41751221|FG005|Overall Study|Withdrawal by Subject|1|||
19474333|NCT01536145|41751222|FG006|Overall Study|Withdrawal by Subject|0|||
19474334|NCT01536145|41751223|FG007|Overall Study|Withdrawal by Subject|0|||
19474335|NCT01536145|41751224|FG008|Overall Study|Withdrawal by Subject|2|||
19474336|NCT01536145|41751225|FG009|Overall Study|Withdrawal by Subject|0|||
19474337|NCT01536145|41751226|FG010|Overall Study|Withdrawal by Subject|2|||
19474338|NCT01536145|41751216|FG000|Overall Study|Other|0|||
19474339|NCT01536145|41751217|FG001|Overall Study|Other|0|||
19474340|NCT01536145|41751218|FG002|Overall Study|Other|0|||
19474341|NCT01536145|41751219|FG003|Overall Study|Other|0|||
19474342|NCT01536145|41751220|FG004|Overall Study|Other|1|||
19474343|NCT01536145|41751221|FG005|Overall Study|Other|0|||
19474344|NCT01536145|41751222|FG006|Overall Study|Other|0|||
19474345|NCT01536145|41751223|FG007|Overall Study|Other|0|||
19474346|NCT01536145|41751224|FG008|Overall Study|Other|0|||
19474347|NCT01536145|41751225|FG009|Overall Study|Other|3|||
19474348|NCT01536145|41751226|FG010|Overall Study|Other|2|||
19474349|NCT01536145|41751216|FG000|Overall Study|Death|0|||
19474350|NCT01536145|41751217|FG001|Overall Study|Death|0|||
19474351|NCT01536145|41751218|FG002|Overall Study|Death|0|||
19474352|NCT01536145|41751219|FG003|Overall Study|Death|0|||
19474353|NCT01536145|41751220|FG004|Overall Study|Death|0|||
19474354|NCT01536145|41751221|FG005|Overall Study|Death|0|||
19474355|NCT01536145|41751222|FG006|Overall Study|Death|1|||
19474356|NCT01536145|41751223|FG007|Overall Study|Death|0|||
19474357|NCT01536145|41751224|FG008|Overall Study|Death|0|||
19474358|NCT01536145|41751225|FG009|Overall Study|Death|0|||
19474359|NCT01536145|41751226|FG010|Overall Study|Death|0|||
19474360|NCT01536145|41751216|FG000|Overall Study|Adverse Event|0|||
19474361|NCT01536145|41751217|FG001|Overall Study|Adverse Event|0|||
19474362|NCT01536145|41751218|FG002|Overall Study|Adverse Event|0|||
19474363|NCT01536145|41751219|FG003|Overall Study|Adverse Event|0|||
19474364|NCT01536145|41751220|FG004|Overall Study|Adverse Event|0|||
19474365|NCT01536145|41751221|FG005|Overall Study|Adverse Event|0|||
19474366|NCT01536145|41751222|FG006|Overall Study|Adverse Event|0|||
19474367|NCT01536145|41751223|FG007|Overall Study|Adverse Event|2|||
19474368|NCT01536145|41751224|FG008|Overall Study|Adverse Event|0|||
19474369|NCT01536145|41751225|FG009|Overall Study|Adverse Event|0|||
19474370|NCT01536145|41751226|FG010|Overall Study|Adverse Event|3|||
19474371|NCT01536067|41751257|FG000|Overall Study|Disease Progression|1|||
19474372|NCT01582009|41751261|FG000|Overall Study|Withdrawal by Subject|1|||
19474373|NCT01582009|41751261|FG000|Overall Study|Physician Decision|1|||
19474374|NCT01553591|41751268|FG000|Overall Study|Voluntarily withdrew|94|||
19474375|NCT01553591|41751269|FG001|Overall Study|Voluntarily withdrew|79|||
19474376|NCT01553591|41751270|FG002|Overall Study|Voluntarily withdrew|96|||
19474377|NCT01553591|41751268|FG000|Overall Study|Adverse Event|36|||
19474378|NCT01553591|41751269|FG001|Overall Study|Adverse Event|45|||
19474379|NCT01553591|41751270|FG002|Overall Study|Adverse Event|16|||
19474380|NCT01553591|41751268|FG000|Overall Study|Lost to Follow-up|25|||
19474381|NCT01553591|41751269|FG001|Overall Study|Lost to Follow-up|23|||
19474382|NCT01553591|41751270|FG002|Overall Study|Lost to Follow-up|16|||
19474383|NCT01553591|41751268|FG000|Overall Study|Physician decision: other|11|||
19474384|NCT01553591|41751269|FG001|Overall Study|Physician decision: other|14|||
19474385|NCT01553591|41751270|FG002|Overall Study|Physician decision: other|16|||
19474386|NCT01553591|41751268|FG000|Overall Study|Physician decision: lack of efficacy|2|||
19474387|NCT01553591|41751269|FG001|Overall Study|Physician decision: lack of efficacy|3|||
19474388|NCT01553591|41751270|FG002|Overall Study|Physician decision: lack of efficacy|7|||
19474389|NCT01553591|41751268|FG000|Overall Study|Protocol Violation|3|||
19474390|NCT01553591|41751269|FG001|Overall Study|Protocol Violation|4|||
19474391|NCT01553591|41751270|FG002|Overall Study|Protocol Violation|4|||
19474392|NCT01553591|41751268|FG000|Overall Study|Sponsor decision|1|||
19474393|NCT01553591|41751269|FG001|Overall Study|Sponsor decision|0|||
19474394|NCT01553591|41751270|FG002|Overall Study|Sponsor decision|3|||
19474395|NCT01553591|41751268|FG000|Overall Study|Randomized and never dispensed drug|0|||
19474396|NCT01553591|41751269|FG001|Overall Study|Randomized and never dispensed drug|1|||
19474397|NCT01553591|41751270|FG002|Overall Study|Randomized and never dispensed drug|0|||
19474398|NCT01581931|41751278|FG000|Washout|Adverse Event|0|||
19474399|NCT01581931|41751279|FG001|Washout|Adverse Event|1|||
19474400|NCT01581619|41751285|FG000|Overall Study|Withdrawal by Subject|1|||
19474401|NCT01581619|41751285|FG000|Overall Study|Lost to Follow-up|1|||
19474402|NCT01581307|41751291|FG000|Overall Study|Withdrawal by Subject|1|||
19474403|NCT01580995|41751297|FG000|Overall Study|Lost to Follow-up|2|||
19474404|NCT01580995|41751298|FG001|Overall Study|Lost to Follow-up|2|||
19474405|NCT01535599|41751306|FG000|Overall Study|Adverse Event|6|||
19474406|NCT01535599|41751307|FG001|Overall Study|Adverse Event|15|||
19474407|NCT01535599|41751306|FG000|Overall Study|Lost to Follow-up|3|||
19474408|NCT01535599|41751307|FG001|Overall Study|Lost to Follow-up|4|||
19474409|NCT01535599|41751306|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
19474410|NCT01535599|41751307|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
19474411|NCT01535599|41751306|FG000|Overall Study|Treatment Failure|33|||
19474412|NCT01535599|41751307|FG001|Overall Study|Treatment Failure|66|||
19474413|NCT01535599|41751306|FG000|Overall Study|BL Culture + for Group A Strep|0|||
19474414|NCT01535599|41751307|FG001|Overall Study|BL Culture + for Group A Strep|1|||
19474415|NCT01535599|41751306|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
19474416|NCT01535599|41751307|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
19474417|NCT01535599|41751306|FG000|Overall Study|Randomized in Error|2|||
19474418|NCT01535599|41751307|FG001|Overall Study|Randomized in Error|4|||
19474419|NCT01535599|41751306|FG000|Overall Study|Did not use product|1|||
19474420|NCT01535599|41751307|FG001|Overall Study|Did not use product|0|||
19474421|NCT01535599|41751306|FG000|Overall Study|Other|1|||
19474422|NCT01535599|41751307|FG001|Overall Study|Other|0|||
19474423|NCT01535599|41751306|FG000|Overall Study|Stopped medication|0|||
19474424|NCT01535599|41751307|FG001|Overall Study|Stopped medication|1|||
19474425|NCT01535599|41751306|FG000|Overall Study|Noncompliance|0|||
19474426|NCT01535599|41751307|FG001|Overall Study|Noncompliance|1|||
19474427|NCT01553279|41751315|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
19474428|NCT01553279|41751316|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
19474429|NCT01553279|41751315|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
19474430|NCT01553279|41751316|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
19474431|NCT01553279|41751315|FG000|Interim Period|Withdrawal by Subject|2|||
19474432|NCT01553279|41751316|FG001|Interim Period|Withdrawal by Subject|2|||
19474433|NCT01553279|41751315|FG000|Interim Period|Lost to Follow-up|1|||
19474434|NCT01553279|41751316|FG001|Interim Period|Lost to Follow-up|0|||
19474435|NCT01553279|41751315|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
19474436|NCT01553279|41751316|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
19474437|NCT01553279|41751315|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
19474438|NCT01553279|41751316|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
19474439|NCT01562743|41751323|FG000|Overall Study|Adverse Event|29|||
19474440|NCT01562743|41751323|FG000|Overall Study|Lack of Efficacy|3|||
19474441|NCT01562743|41751323|FG000|Overall Study|Withdrawal by Subject|13|||
19474442|NCT01562743|41751323|FG000|Overall Study|Protocol Violation|1|||
19474443|NCT01562743|41751323|FG000|Overall Study|Discontinuation criteria|2|||
19474444|NCT01562743|41751323|FG000|Overall Study|Lost to Follow-up|2|||
19474445|NCT01562743|41751323|FG000|Overall Study|Physician Decision|2|||
19474446|NCT01535443|41751327|FG000|Overall Study|Physician Decision|3|||
19474447|NCT01535287|41751334|FG000|Overall Study|drug not prepared in time|5|||
19474448|NCT01535287|41751335|FG001|Overall Study|drug not prepared in time|6|||
19474449|NCT01551173|41751343|FG000|Overall Study|Withdrawal by Subject|11|||
19474450|NCT01551173|41751344|FG001|Overall Study|Withdrawal by Subject|16|||
19474451|NCT01551173|41751343|FG000|Overall Study|Adverse Event|7|||
19474452|NCT01551173|41751344|FG001|Overall Study|Adverse Event|6|||
19474453|NCT01551173|41751343|FG000|Overall Study|Lost to Follow-up|5|||
19474454|NCT01551173|41751344|FG001|Overall Study|Lost to Follow-up|7|||
19474455|NCT01551173|41751343|FG000|Overall Study|Other|5|||
19474456|NCT01551173|41751344|FG001|Overall Study|Other|3|||
19474457|NCT01549613|41751353|FG000|Overall Study|Lost to Follow-up|11|||
19474458|NCT01549613|41751354|FG001|Overall Study|Lost to Follow-up|11|||
19474459|NCT01548599|41751362|FG000|Overall Study|Lost to Follow-up|0|||
19474460|NCT01548599|41751363|FG001|Overall Study|Lost to Follow-up|1|||
19474461|NCT01548599|41751362|FG000|Overall Study|Withdrawal by Subject|4|||
19474462|NCT01548599|41751363|FG001|Overall Study|Withdrawal by Subject|0|||
19474463|NCT01548599|41751362|FG000|Overall Study|Death|2|||
19474464|NCT01548599|41751363|FG001|Overall Study|Death|1|||
19474465|NCT01548287|41751376|FG000|Screening|No reason provided|0|||
19474466|NCT01548287|41751377|FG001|Screening|No reason provided|0|||
19474467|NCT01548287|41751378|FG002|Screening|No reason provided|0|||
19474468|NCT01548287|41751379|FG003|Screening|No reason provided|0|||
19474469|NCT01548287|41751380|FG004|Screening|No reason provided|9|||
19474470|NCT01548287|41751376|FG000|Screening|Did not meet eligibility criteria|0|||
19474471|NCT01548287|41751377|FG001|Screening|Did not meet eligibility criteria|0|||
19474472|NCT01548287|41751378|FG002|Screening|Did not meet eligibility criteria|0|||
19474473|NCT01548287|41751379|FG003|Screening|Did not meet eligibility criteria|0|||
19474474|NCT01548287|41751380|FG004|Screening|Did not meet eligibility criteria|74|||
19474475|NCT01548287|41751376|FG000|Randomized Period|Did not meet inclusion criteria|0|||
19474476|NCT01548287|41751377|FG001|Randomized Period|Did not meet inclusion criteria|0|||
19474477|NCT01548287|41751378|FG002|Randomized Period|Did not meet inclusion criteria|2|||
19474478|NCT01548287|41751379|FG003|Randomized Period|Did not meet inclusion criteria|0|||
19474479|NCT01548287|41751380|FG004|Randomized Period|Did not meet inclusion criteria|0|||
19474480|NCT01548287|41751376|FG000|Randomized Period|Adverse Event|0|||
19474481|NCT01548287|41751377|FG001|Randomized Period|Adverse Event|2|||
19474482|NCT01548287|41751378|FG002|Randomized Period|Adverse Event|5|||
19474483|NCT01548287|41751379|FG003|Randomized Period|Adverse Event|0|||
19474484|NCT01548287|41751380|FG004|Randomized Period|Adverse Event|0|||
19474485|NCT01546883|41751390|FG000|Overall Study|Withdrawal by Subject|3|||
19474486|NCT01546883|41751390|FG000|Overall Study|Adverse Event|4|||
19474487|NCT01546883|41751390|FG000|Overall Study|Lost to Follow-up|2|||
19474488|NCT01546883|41751390|FG000|Overall Study|early closure of study|2|||
19474489|NCT01546883|41751390|FG000|Overall Study|other unrelated illness|1|||
19474490|NCT01580293|41751401|FG000|Part A_Main Trial|Adverse Event|0|||
19474491|NCT01580293|41751402|FG001|Part A_Main Trial|Adverse Event|2|||
19474492|NCT01580293|41751403|FG002|Part A_Main Trial|Adverse Event|0|||
19474493|NCT01580293|41751401|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
19474494|NCT01580293|41751402|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
19474495|NCT01580293|41751403|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
19474496|NCT01580293|41751401|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
19474497|NCT01580293|41751402|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
19474498|NCT01580293|41751403|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
19474499|NCT01580293|41751401|FG000|Part A_Extension|Adverse Event|0|||
19474500|NCT01580293|41751402|FG001|Part A_Extension|Adverse Event|2|||
19474501|NCT01580293|41751403|FG002|Part A_Extension|Adverse Event|0|||
19474502|NCT01580293|41751401|FG000|Part A_Extension|Withdrawal by Subject|0|||
19474503|NCT01580293|41751402|FG001|Part A_Extension|Withdrawal by Subject|3|||
19474504|NCT01580293|41751403|FG002|Part A_Extension|Withdrawal by Subject|0|||
19474505|NCT01580293|41751401|FG000|Part A_Extension|Lost to Follow-up|0|||
19474506|NCT01580293|41751402|FG001|Part A_Extension|Lost to Follow-up|1|||
19474507|NCT01580293|41751403|FG002|Part A_Extension|Lost to Follow-up|0|||
19474508|NCT01580293|41751401|FG000|Part A_Extension|Other Reason|0|||
19474509|NCT01580293|41751402|FG001|Part A_Extension|Other Reason|1|||
19474510|NCT01580293|41751403|FG002|Part A_Extension|Other Reason|0|||
19474511|NCT01580293|41751401|FG000|Part A_Extension|Completed Japan only|0|||
19474512|NCT01580293|41751402|FG001|Part A_Extension|Completed Japan only|5|||
19474513|NCT01580293|41751403|FG002|Part A_Extension|Completed Japan only|0|||
19474514|NCT01580293|41751401|FG000|Part B|Withdrawal by Subject|0|||
19474515|NCT01580293|41751402|FG001|Part B|Withdrawal by Subject|0|||
19474516|NCT01580293|41751403|FG002|Part B|Withdrawal by Subject|1|||
19474517|NCT01580293|41751401|FG000|Part B|Other reason|0|||
19474518|NCT01580293|41751402|FG001|Part B|Other reason|0|||
19474519|NCT01580293|41751403|FG002|Part B|Other reason|1|||
19474520|NCT01546649|41751432|FG000|Overall Study|Adverse Event|4|||
19474521|NCT01546649|41751433|FG001|Overall Study|Adverse Event|5|||
19474522|NCT01546649|41751432|FG000|Overall Study|Protocol Violation|1|||
19474523|NCT01546649|41751433|FG001|Overall Study|Protocol Violation|0|||
19474524|NCT01546649|41751432|FG000|Overall Study|Lack of Efficacy|1|||
19474525|NCT01546649|41751433|FG001|Overall Study|Lack of Efficacy|0|||
19474526|NCT01546649|41751432|FG000|Overall Study|Recurrence|1|||
19474527|NCT01546649|41751433|FG001|Overall Study|Recurrence|1|||
19474528|NCT01546649|41751432|FG000|Overall Study|Discovery of secondary cancer|0|||
19474529|NCT01546649|41751433|FG001|Overall Study|Discovery of secondary cancer|1|||
19474530|NCT01546649|41751432|FG000|Overall Study|Withdrawal by Subject|1|||
19474531|NCT01546649|41751433|FG001|Overall Study|Withdrawal by Subject|2|||
19474532|NCT01544309|41751441|FG000|Overall Study|Withdrawal by Subject|12|||
19474533|NCT01544309|41751442|FG001|Overall Study|Withdrawal by Subject|7|||
19474534|NCT01544309|41751441|FG000|Overall Study|Protocol Violation|2|||
19474535|NCT01544309|41751442|FG001|Overall Study|Protocol Violation|1|||
19474536|NCT01544309|41751441|FG000|Overall Study|Physician Decision|4|||
19474537|NCT01544309|41751442|FG001|Overall Study|Physician Decision|1|||
19474538|NCT01544309|41751441|FG000|Overall Study|Not performed pre-dose examination|1|||
19474539|NCT01544309|41751442|FG001|Overall Study|Not performed pre-dose examination|2|||
19474540|NCT01544309|41751441|FG000|Overall Study|Administered prohibit prior medication|1|||
19474541|NCT01544309|41751442|FG001|Overall Study|Administered prohibit prior medication|0|||
19474542|NCT01544153|41751454|FG000|Overall Study|Under 18|0|||
19474543|NCT01544153|41751455|FG001|Overall Study|Under 18|1|||
19474544|NCT01544153|41751456|FG002|Overall Study|Under 18|0|||
19474545|NCT01544153|41751457|FG003|Overall Study|Under 18|0|||
19474546|NCT01544153|41751454|FG000|Overall Study|Non-smoker|0|||
19474547|NCT01544153|41751455|FG001|Overall Study|Non-smoker|0|||
19474548|NCT01544153|41751456|FG002|Overall Study|Non-smoker|1|||
19474549|NCT01544153|41751457|FG003|Overall Study|Non-smoker|0|||
19474550|NCT01543685|41751472|FG000|Overall Study|Lack of Efficacy|1|||
19474551|NCT01543685|41751473|FG001|Overall Study|Lack of Efficacy|2|||
19474552|NCT01543685|41751474|FG002|Overall Study|Lack of Efficacy|2|||
19474553|NCT01543685|41751475|FG003|Overall Study|Lack of Efficacy|0|||
19474554|NCT01543685|41751476|FG004|Overall Study|Lack of Efficacy|2|||
19474555|NCT01543685|41751472|FG000|Overall Study|Adverse Event|2|||
19474556|NCT01543685|41751473|FG001|Overall Study|Adverse Event|1|||
19474557|NCT01543685|41751474|FG002|Overall Study|Adverse Event|0|||
19474558|NCT01543685|41751475|FG003|Overall Study|Adverse Event|0|||
19474559|NCT01543685|41751476|FG004|Overall Study|Adverse Event|2|||
19474560|NCT01541969|41751490|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
19474561|NCT01541969|41751491|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
19474562|NCT01541969|41751490|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
19474563|NCT01541969|41751491|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
19474564|NCT01541969|41751490|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
19474565|NCT01541969|41751491|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
19474566|NCT01541969|41751490|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
19474567|NCT01541969|41751491|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
19474568|NCT01541969|41751490|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
19474569|NCT01541969|41751491|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
19474570|NCT01541969|41751490|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
19474571|NCT01541969|41751491|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
19474572|NCT01541969|41751490|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
19474573|NCT01541969|41751491|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
19474574|NCT01541969|41751490|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
19474575|NCT01541969|41751491|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
19474576|NCT01541969|41751490|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
19474577|NCT01541969|41751491|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
19474578|NCT01541969|41751490|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
19474579|NCT01541969|41751491|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
19474580|NCT01540565|41751500|FG000|Overall Study|Ineligible|2|||
19474581|NCT01540487|41751506|FG000|Overall Study|Protocol Violation|1|||
19474582|NCT01540487|41751507|FG001|Overall Study|Protocol Violation|0|||
19474583|NCT01539863|41751519|FG000|Overall Study|Lost to Follow-up|5|||
19474584|NCT01539863|41751520|FG001|Overall Study|Lost to Follow-up|4|||
19474585|NCT01539317|41751528|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
19474586|NCT01539317|41751529|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
19474587|NCT01539239|41751540|FG000|Overall Study|Death|5|||
19474588|NCT01539239|41751541|FG001|Overall Study|Death|5|||
19474589|NCT01539239|41751540|FG000|Overall Study|Lost to Follow-up|7|||
19474590|NCT01539239|41751541|FG001|Overall Study|Lost to Follow-up|12|||
19474591|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
19474592|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
19474593|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
19474594|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
19474595|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
19474596|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
19474597|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Death|6|||
19474598|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Death|0|||
19474599|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Death|0|||
19474600|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
19474601|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
19474602|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
19474603|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
19474604|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
19474605|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
19474606|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
19474607|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
19474608|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
19474609|NCT01539083|41751547|FG000|Before Randomization (VCD Induction)|Other|5|||
19474610|NCT01539083|41751548|FG001|Before Randomization (VCD Induction)|Other|0|||
19474611|NCT01539083|41751549|FG002|Before Randomization (VCD Induction)|Other|0|||
19474612|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
19474613|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
19474614|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
19474615|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Other|0|||
19474616|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Other|1|||
19474617|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Other|1|||
19474618|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
19474619|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
19553905|NCT01307579|42002858|FG000|Overall Study|Physician Decision|26|||
19474620|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
19474621|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
19474622|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
19474623|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
19474624|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
19474625|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
19474626|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
19474627|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
19474628|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
19474629|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
19474630|NCT01539083|41751547|FG000|After Randomization (TP and VTP)|Death|0|||
19474631|NCT01539083|41751548|FG001|After Randomization (TP and VTP)|Death|6|||
19474632|NCT01539083|41751549|FG002|After Randomization (TP and VTP)|Death|11|||
19474633|NCT01537211|41751558|FG000|Overall Study|Lost to Follow-up|0|||
19474634|NCT01537211|41751559|FG001|Overall Study|Lost to Follow-up|1|||
19474635|NCT01537133|41751573|FG000|Overall Study|Withdrawal by Subject|2|||
19474636|NCT01537133|41751574|FG001|Overall Study|Withdrawal by Subject|0|||
19474637|NCT01537133|41751575|FG002|Overall Study|Withdrawal by Subject|0|||
19474638|NCT01537133|41751576|FG003|Overall Study|Withdrawal by Subject|0|||
19474639|NCT01537133|41751573|FG000|Overall Study|Lost to Follow-up|1|||
19474640|NCT01537133|41751574|FG001|Overall Study|Lost to Follow-up|0|||
19474641|NCT01537133|41751575|FG002|Overall Study|Lost to Follow-up|0|||
19381863|NCT01675167|41624967|FG002|Open-label Titration Phase|Adverse Event|0|||
19381864|NCT01675167|41624965|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
19474642|NCT01537133|41751576|FG003|Overall Study|Lost to Follow-up|0|||
19474643|NCT01536587|41751584|FG000|Overall Study|Adverse Event|2|||
19474644|NCT01536119|41751590|FG000|Overall Study|Lost to Follow-up|17|||
19553906|NCT01307579|42002859|FG001|Overall Study|Physician Decision|29|||
19474645|NCT01536119|41751591|FG001|Overall Study|Lost to Follow-up|14|||
19474646|NCT01535729|41751597|FG000|Overall Study|Withdrawal by Subject|2|||
19474647|NCT01535729|41751597|FG000|Overall Study|Disease progression|230|||
19474648|NCT01535729|41751597|FG000|Overall Study|Discontinued treatment|25|||
19474649|NCT01535729|41751597|FG000|Overall Study|Lost to Follow-up|8|||
19474650|NCT01535729|41751597|FG000|Overall Study|Death|52|||
19474651|NCT01535729|41751597|FG000|Overall Study|Other|19|||
19474652|NCT01535729|41751597|FG000|Overall Study|Did not sign informed consent|1|||
19474653|NCT01535729|41751597|FG000|Overall Study|No previous chemotherapy|33|||
19474654|NCT01535729|41751597|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
19474655|NCT01535729|41751597|FG000|Overall Study|Protocol Violation|11|||
19474656|NCT01535729|41751597|FG000|Overall Study|Screening failure|1|||
19474657|NCT01535729|41751597|FG000|Overall Study|Not treated|9|||
19474658|NCT01535729|41751597|FG000|Overall Study|No participant record available|5|||
19474659|NCT01535261|41751601|FG000|Overall Study|Physician Decision|8|||
19474660|NCT01535261|41751601|FG000|Overall Study|Protocol Violation|3|||
19474661|NCT01535261|41751601|FG000|Overall Study|Death|5|||
19474662|NCT01535261|41751601|FG000|Overall Study|Lost to Follow-up|8|||
19474663|NCT01535261|41751601|FG000|Overall Study|Withdrawal by Subject|14|||
19474664|NCT01535261|41751601|FG000|Overall Study|Adverse Event|12|||
19474665|NCT01534637|41751605|FG000|Overall Study|Physician Decision|3|||
19474666|NCT01534637|41751605|FG000|Overall Study|Lack of Efficacy|3|||
19474667|NCT01534637|41751605|FG000|Overall Study|Withdrawal by Subject|1|||
19381865|NCT01675167|41624966|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
19474668|NCT01534637|41751605|FG000|Overall Study|Adverse Event|1|||
19474669|NCT01534637|41751605|FG000|Overall Study|Liver Mets before treatment|1|||
19474670|NCT02655016|41751611|FG000|Overall Study|Disease progression|6|||
19474671|NCT02655016|41751612|FG001|Overall Study|Disease progression|4|||
19474672|NCT02655016|41751611|FG000|Overall Study|Site closed|0|||
19474673|NCT02655016|41751612|FG001|Overall Study|Site closed|1|||
19474674|NCT02655016|41751611|FG000|Overall Study|Death|30|||
19474675|NCT02655016|41751612|FG001|Overall Study|Death|48|||
19474676|NCT02655016|41751611|FG000|Overall Study|Lost to Follow-up|1|||
19474677|NCT02655016|41751612|FG001|Overall Study|Lost to Follow-up|1|||
19474678|NCT02655016|41751611|FG000|Overall Study|Withdrawal by Subject|18|||
19474679|NCT02655016|41751612|FG001|Overall Study|Withdrawal by Subject|36|||
19474680|NCT01533935|41751619|FG000|Overall Study|Adverse Event|5|||
19553907|NCT01307579|42002858|FG000|Overall Study|Withdrawal by Subject|7|||
19474681|NCT01533935|41751620|FG001|Overall Study|Adverse Event|7|||
19474682|NCT01533935|41751621|FG002|Overall Study|Adverse Event|1|||
19474683|NCT01533935|41751622|FG003|Overall Study|Adverse Event|5|||
19474684|NCT01533935|41751623|FG004|Overall Study|Adverse Event|3|||
19474685|NCT01533935|41751619|FG000|Overall Study|Protocol Violation|0|||
19474686|NCT01533935|41751620|FG001|Overall Study|Protocol Violation|2|||
19474687|NCT01533935|41751621|FG002|Overall Study|Protocol Violation|0|||
19474688|NCT01533935|41751622|FG003|Overall Study|Protocol Violation|0|||
19474689|NCT01533935|41751623|FG004|Overall Study|Protocol Violation|0|||
19474690|NCT01533935|41751619|FG000|Overall Study|Lost to Follow-up|0|||
19474691|NCT01533935|41751620|FG001|Overall Study|Lost to Follow-up|0|||
19474692|NCT01533935|41751621|FG002|Overall Study|Lost to Follow-up|1|||
19474693|NCT01533935|41751622|FG003|Overall Study|Lost to Follow-up|0|||
19474694|NCT01533935|41751623|FG004|Overall Study|Lost to Follow-up|0|||
19474695|NCT01533935|41751619|FG000|Overall Study|Withdrawal by Subject|0|||
19474696|NCT01533935|41751620|FG001|Overall Study|Withdrawal by Subject|4|||
19474697|NCT01533935|41751621|FG002|Overall Study|Withdrawal by Subject|5|||
19474698|NCT01533935|41751622|FG003|Overall Study|Withdrawal by Subject|2|||
19474699|NCT01533935|41751623|FG004|Overall Study|Withdrawal by Subject|4|||
19474700|NCT01533935|41751619|FG000|Overall Study|Other reason not defined above|1|||
19474701|NCT01533935|41751620|FG001|Overall Study|Other reason not defined above|0|||
19474702|NCT01533935|41751621|FG002|Overall Study|Other reason not defined above|1|||
19474703|NCT01533935|41751622|FG003|Overall Study|Other reason not defined above|0|||
19474704|NCT01533935|41751623|FG004|Overall Study|Other reason not defined above|1|||
19474705|NCT01532999|41751637|FG000|Overall Study|Lost to Follow-up|14|||
19474706|NCT01532999|41751638|FG001|Overall Study|Lost to Follow-up|8|||
19474707|NCT01532999|41751637|FG000|Overall Study|Physician Decision|1|||
19474708|NCT01532999|41751638|FG001|Overall Study|Physician Decision|2|||
19474709|NCT01532999|41751637|FG000|Overall Study|Withdrawal by Subject|5|||
19474710|NCT01532999|41751638|FG001|Overall Study|Withdrawal by Subject|0|||
19474711|NCT01532999|41751637|FG000|Overall Study|Relocated|2|||
19474712|NCT01532999|41751638|FG001|Overall Study|Relocated|0|||
19474713|NCT01532999|41751637|FG000|Overall Study|should not have been randomized|1|||
19474714|NCT01532999|41751638|FG001|Overall Study|should not have been randomized|0|||
19474715|NCT01532999|41751637|FG000|Overall Study|substantial noncompliance|2|||
19474716|NCT01532999|41751638|FG001|Overall Study|substantial noncompliance|0|||
19474717|NCT01532999|41751637|FG000|Overall Study|no show for week 9 assessments|6|||
19553908|NCT01307579|42002859|FG001|Overall Study|Withdrawal by Subject|3|||
19474718|NCT01532999|41751638|FG001|Overall Study|no show for week 9 assessments|4|||
19474719|NCT01532999|41751637|FG000|Overall Study|Adverse Event|0|||
19474720|NCT01532999|41751638|FG001|Overall Study|Adverse Event|1|||
19739407|NCT03519867|42186490|FG005|Overall Study|Protocol Violation|1|||
19474721|NCT01532999|41751637|FG000|Overall Study|incarcerated|0|||
19474722|NCT01532999|41751638|FG001|Overall Study|incarcerated|1|||
19474723|NCT01532999|41751637|FG000|Overall Study|New job|0|||
19474724|NCT01532999|41751638|FG001|Overall Study|New job|2|||
19474725|NCT01532921|41751644|FG000|Overall Study|Death|3|||
19474726|NCT01532921|41751644|FG000|Overall Study|Withdrawal by Subject|2|||
19474727|NCT01532921|41751644|FG000|Overall Study|Lost to Follow-up|3|||
19474728|NCT01532921|41751644|FG000|Overall Study|Physician Decision|7|||
19474729|NCT01532921|41751644|FG000|Overall Study|Device was explanted during procedure|1|||
19474730|NCT01532687|41751654|FG000|Overall Study|Death|2|||
19474731|NCT01532687|41751655|FG001|Overall Study|Death|0|||
19474732|NCT01532687|41751654|FG000|Overall Study|Adverse Event|6|||
19474733|NCT01532687|41751655|FG001|Overall Study|Adverse Event|1|||
19474734|NCT01532687|41751654|FG000|Overall Study|Withdrawal by Subject|1|||
19474735|NCT01532687|41751655|FG001|Overall Study|Withdrawal by Subject|0|||
19474736|NCT01532687|41751654|FG000|Overall Study|Physician Decision|2|||
19474737|NCT01532687|41751655|FG001|Overall Study|Physician Decision|1|||
19474738|NCT01532687|41751654|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
19474739|NCT01532687|41751655|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
19474740|NCT02677116|41751672|FG000|Overall Study|Adverse Event|0|||
19474741|NCT02677116|41751673|FG001|Overall Study|Adverse Event|1|||
19474742|NCT02677116|41751674|FG002|Overall Study|Adverse Event|0|||
19474743|NCT02677116|41751675|FG003|Overall Study|Adverse Event|0|||
19474744|NCT02677116|41751676|FG004|Overall Study|Adverse Event|0|||
19474745|NCT02677116|41751677|FG005|Overall Study|Adverse Event|1|||
19474746|NCT02677116|41751678|FG006|Overall Study|Adverse Event|1|||
19474747|NCT02677116|41751679|FG007|Overall Study|Adverse Event|0|||
19474748|NCT02677116|41751680|FG008|Overall Study|Adverse Event|0|||
19474749|NCT02677116|41751672|FG000|Overall Study|Physician Decision|0|||
19474750|NCT02677116|41751673|FG001|Overall Study|Physician Decision|2|||
19474751|NCT02677116|41751674|FG002|Overall Study|Physician Decision|3|||
19474752|NCT02677116|41751675|FG003|Overall Study|Physician Decision|2|||
19474753|NCT02677116|41751676|FG004|Overall Study|Physician Decision|1|||
19474754|NCT02677116|41751677|FG005|Overall Study|Physician Decision|3|||
19474755|NCT02677116|41751678|FG006|Overall Study|Physician Decision|1|||
19474756|NCT02677116|41751679|FG007|Overall Study|Physician Decision|1|||
19474757|NCT02677116|41751680|FG008|Overall Study|Physician Decision|2|||
19474758|NCT02677116|41751672|FG000|Overall Study|Withdrawal by parent or guardian|2|||
19474759|NCT02677116|41751673|FG001|Overall Study|Withdrawal by parent or guardian|1|||
19474760|NCT02677116|41751674|FG002|Overall Study|Withdrawal by parent or guardian|0|||
19474761|NCT02677116|41751675|FG003|Overall Study|Withdrawal by parent or guardian|1|||
19474762|NCT02677116|41751676|FG004|Overall Study|Withdrawal by parent or guardian|0|||
19474763|NCT02677116|41751677|FG005|Overall Study|Withdrawal by parent or guardian|0|||
19474764|NCT02677116|41751678|FG006|Overall Study|Withdrawal by parent or guardian|2|||
19474765|NCT02677116|41751679|FG007|Overall Study|Withdrawal by parent or guardian|1|||
19474766|NCT02677116|41751680|FG008|Overall Study|Withdrawal by parent or guardian|0|||
19474767|NCT02677116|41751672|FG000|Overall Study|Withdrawal by Subject|1|||
19474768|NCT02677116|41751673|FG001|Overall Study|Withdrawal by Subject|0|||
19474769|NCT02677116|41751674|FG002|Overall Study|Withdrawal by Subject|0|||
19474770|NCT02677116|41751675|FG003|Overall Study|Withdrawal by Subject|0|||
19474771|NCT02677116|41751676|FG004|Overall Study|Withdrawal by Subject|0|||
19474772|NCT02677116|41751677|FG005|Overall Study|Withdrawal by Subject|0|||
19474773|NCT02677116|41751678|FG006|Overall Study|Withdrawal by Subject|0|||
19474774|NCT02677116|41751679|FG007|Overall Study|Withdrawal by Subject|0|||
19474775|NCT02677116|41751680|FG008|Overall Study|Withdrawal by Subject|0|||
19474776|NCT02689518|41751723|FG000|Overall Study|Withdrawal by Subject|3|||
19474777|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
19474778|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
19474779|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
19474780|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
19474781|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
19474782|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
19474783|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
19474784|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
19474785|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
19474786|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
19474787|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
19474788|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
19474789|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
19474790|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
19474791|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
19474792|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|Other|6|||
19474793|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|Other|6|||
19474794|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|Other|7|||
19474795|NCT02681094|41751730|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
19474796|NCT02681094|41751731|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
19474797|NCT02681094|41751732|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
19474798|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Participant decision|7|||
19474799|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Participant decision|10|||
19474800|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Participant decision|9|||
19474801|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
19474802|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
19474803|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
19474804|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
19474805|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
19474806|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
19474807|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
19474808|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
19474809|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
19474810|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
19474811|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
19474812|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
19474813|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|Other|6|||
19474814|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|Other|6|||
19474815|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|Other|7|||
19474816|NCT02681094|41751730|FG000|2 - Enrolled Participants Set|No treatment given|0|||
19474817|NCT02681094|41751731|FG001|2 - Enrolled Participants Set|No treatment given|1|||
19474818|NCT02681094|41751732|FG002|2 - Enrolled Participants Set|No treatment given|1|||
19474819|NCT02689284|41751743|FG000|Overall Study|Adverse Event|1|||
19474820|NCT02689284|41751744|FG001|Overall Study|Adverse Event|8|||
19474821|NCT02689284|41751743|FG000|Overall Study|Death|0|||
19474822|NCT02689284|41751744|FG001|Overall Study|Death|1|||
19474823|NCT02689284|41751743|FG000|Overall Study|Physician Decision|1|||
19474824|NCT02689284|41751744|FG001|Overall Study|Physician Decision|2|||
19474825|NCT02689284|41751743|FG000|Overall Study|Withdrawal by Subject|0|||
19474826|NCT02689284|41751744|FG001|Overall Study|Withdrawal by Subject|1|||
19474827|NCT02689284|41751743|FG000|Overall Study|progression of cancer|1|||
19474828|NCT02689284|41751744|FG001|Overall Study|progression of cancer|72|||
19474829|NCT02689284|41751743|FG000|Overall Study|decreased heart function|0|||
19474830|NCT02689284|41751744|FG001|Overall Study|decreased heart function|1|||
19474831|NCT02689284|41751743|FG000|Overall Study|concern for anemia|0|||
19474832|NCT02689284|41751744|FG001|Overall Study|concern for anemia|1|||
19474833|NCT02689284|41751743|FG000|Overall Study|no measurable cancer for evaluation|0|||
19474834|NCT02689284|41751744|FG001|Overall Study|no measurable cancer for evaluation|1|||
19474835|NCT02676882|41751753|FG000|Overall Study|Adverse Event|1|||
19474836|NCT02676882|41751754|FG001|Overall Study|Adverse Event|0|||
19474837|NCT02676882|41751753|FG000|Overall Study|Lost to Follow-up|1|||
19474838|NCT02676882|41751754|FG001|Overall Study|Lost to Follow-up|0|||
19474839|NCT02676882|41751753|FG000|Overall Study|Withdrawal by Subject|1|||
19474840|NCT02676882|41751754|FG001|Overall Study|Withdrawal by Subject|2|||
19474841|NCT02674386|41751763|FG000|Overall Study|Lost to Follow-up|0|||
19474842|NCT02674386|41751764|FG001|Overall Study|Lost to Follow-up|1|||
19474843|NCT02674386|41751765|FG002|Overall Study|Lost to Follow-up|1|||
19474844|NCT02674386|41751763|FG000|Overall Study|Withdrawal by Subject|0|||
19474845|NCT02674386|41751764|FG001|Overall Study|Withdrawal by Subject|4|||
19474846|NCT02674386|41751765|FG002|Overall Study|Withdrawal by Subject|0|||
19474847|NCT02674386|41751763|FG000|Overall Study|Other|0|||
19474848|NCT02674386|41751764|FG001|Overall Study|Other|1|||
19474849|NCT02674386|41751765|FG002|Overall Study|Other|0|||
19474850|NCT02674386|41751763|FG000|Overall Study|Enrolled but not evaluated|0|||
19474851|NCT02674386|41751764|FG001|Overall Study|Enrolled but not evaluated|4|||
19474852|NCT02674386|41751765|FG002|Overall Study|Enrolled but not evaluated|0|||
19474853|NCT02680002|41751784|FG000|Overall Study|Lost to Follow-up|5|||
19474854|NCT02680002|41751785|FG001|Overall Study|Lost to Follow-up|1|||
19474855|NCT02680002|41751786|FG002|Overall Study|Lost to Follow-up|4|||
19474856|NCT02680002|41751787|FG003|Overall Study|Lost to Follow-up|2|||
19474857|NCT02680002|41751788|FG004|Overall Study|Lost to Follow-up|0|||
19474858|NCT02680002|41751789|FG005|Overall Study|Lost to Follow-up|2|||
19474859|NCT02680002|41751784|FG000|Overall Study|Physician Decision|5|||
19474860|NCT02680002|41751785|FG001|Overall Study|Physician Decision|1|||
19474861|NCT02680002|41751786|FG002|Overall Study|Physician Decision|1|||
19474862|NCT02680002|41751787|FG003|Overall Study|Physician Decision|1|||
19474863|NCT02680002|41751788|FG004|Overall Study|Physician Decision|1|||
19474864|NCT02680002|41751789|FG005|Overall Study|Physician Decision|1|||
19474865|NCT02680002|41751784|FG000|Overall Study|Protocol Violation|1|||
19474866|NCT02680002|41751785|FG001|Overall Study|Protocol Violation|0|||
19474867|NCT02680002|41751786|FG002|Overall Study|Protocol Violation|1|||
19474868|NCT02680002|41751787|FG003|Overall Study|Protocol Violation|0|||
19474869|NCT02680002|41751788|FG004|Overall Study|Protocol Violation|1|||
19474870|NCT02680002|41751789|FG005|Overall Study|Protocol Violation|2|||
19474871|NCT02680002|41751784|FG000|Overall Study|Withdrawal by Subject|0|||
19474872|NCT02680002|41751785|FG001|Overall Study|Withdrawal by Subject|0|||
19474873|NCT02680002|41751786|FG002|Overall Study|Withdrawal by Subject|1|||
19474874|NCT02680002|41751787|FG003|Overall Study|Withdrawal by Subject|0|||
19474875|NCT02680002|41751788|FG004|Overall Study|Withdrawal by Subject|2|||
19474876|NCT02680002|41751789|FG005|Overall Study|Withdrawal by Subject|2|||
19474877|NCT02680002|41751784|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
19474878|NCT02680002|41751785|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
19474879|NCT02680002|41751786|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
19474880|NCT02680002|41751787|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
19474881|NCT02680002|41751788|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
19474882|NCT02680002|41751789|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
19474883|NCT02680002|41751784|FG000|Overall Study|Other|0|||
19474884|NCT02680002|41751785|FG001|Overall Study|Other|1|||
19474885|NCT02680002|41751786|FG002|Overall Study|Other|0|||
19474886|NCT02680002|41751787|FG003|Overall Study|Other|0|||
19474887|NCT02680002|41751788|FG004|Overall Study|Other|1|||
19474888|NCT02680002|41751789|FG005|Overall Study|Other|0|||
19474889|NCT02680002|41751784|FG000|Overall Study|Adverse Event|0|||
19474890|NCT02680002|41751785|FG001|Overall Study|Adverse Event|0|||
19474891|NCT02680002|41751786|FG002|Overall Study|Adverse Event|0|||
19474892|NCT02680002|41751787|FG003|Overall Study|Adverse Event|0|||
19474893|NCT02680002|41751788|FG004|Overall Study|Adverse Event|1|||
19474894|NCT02680002|41751789|FG005|Overall Study|Adverse Event|2|||
19474895|NCT04557384|41751806|FG000|Overall Study|Study Terminated by Sponsor|1|||
19474896|NCT04557384|41751806|FG000|Overall Study|Death|1|||
19474897|NCT02673684|41751812|FG000|Overall Study|Study not completed d/t loss of funding|9|||
19474898|NCT02673684|41751813|FG001|Overall Study|Study not completed d/t loss of funding|8|||
19474899|NCT02675634|41751821|FG000|Test Period 1|Adverse Event|0|||
19474900|NCT02675634|41751822|FG001|Test Period 1|Adverse Event|1|||
19474901|NCT02675634|41751823|FG002|Test Period 1|Adverse Event|0|||
19474902|NCT02675634|41751824|FG003|Test Period 1|Adverse Event|1|||
19474903|NCT02675634|41751825|FG004|Test Period 1|Adverse Event|0|||
19474904|NCT02675634|41751826|FG005|Test Period 1|Adverse Event|0|||
19474905|NCT02675634|41751821|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
19474906|NCT02675634|41751822|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
19474907|NCT02675634|41751823|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
19474908|NCT02675634|41751824|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
19474909|NCT02675634|41751825|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
19474910|NCT02675634|41751826|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
19474911|NCT02675634|41751821|FG000|Test Period 2|Lack of Efficacy|1|||
19474912|NCT02675634|41751822|FG001|Test Period 2|Lack of Efficacy|0|||
19474913|NCT02675634|41751823|FG002|Test Period 2|Lack of Efficacy|0|||
19474914|NCT02675634|41751824|FG003|Test Period 2|Lack of Efficacy|0|||
19474915|NCT02675634|41751825|FG004|Test Period 2|Lack of Efficacy|0|||
19474916|NCT02675634|41751826|FG005|Test Period 2|Lack of Efficacy|0|||
19474917|NCT02675634|41751821|FG000|Test Period 2|Adverse Event|0|||
19474918|NCT02675634|41751822|FG001|Test Period 2|Adverse Event|0|||
19474919|NCT02675634|41751823|FG002|Test Period 2|Adverse Event|0|||
19474920|NCT02675634|41751824|FG003|Test Period 2|Adverse Event|0|||
19474921|NCT02675634|41751825|FG004|Test Period 2|Adverse Event|0|||
19474922|NCT02675634|41751826|FG005|Test Period 2|Adverse Event|1|||
19474923|NCT02671500|41751834|FG000|Overall Study|Lack of Efficacy|12|||
19474924|NCT02671500|41751834|FG000|Overall Study|Lost to Follow-up|2|||
19474925|NCT02671422|41751842|FG000|Overall Study|Lost to Follow-up|1|||
19474926|NCT02671422|41751842|FG000|Overall Study|Adverse Event|68|||
19474927|NCT02671422|41751842|FG000|Overall Study|Lack of Efficacy|1|||
19474928|NCT02671422|41751842|FG000|Overall Study|Lost to Follow-up|4|||
19474929|NCT02671422|41751842|FG000|Overall Study|Withdrawal by Subject|7|||
19474930|NCT02671422|41751842|FG000|Overall Study|Progressive Disease|156|||
19474931|NCT02671422|41751842|FG000|Overall Study|Worsening of Disease|4|||
19474932|NCT02671422|41751842|FG000|Overall Study|Sponsor decision|5|||
19474933|NCT02671422|41751842|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
19474934|NCT02671422|41751842|FG000|Overall Study|Not treated with Vargatef®|3|||
19474935|NCT02671422|41751842|FG000|Overall Study|Other not defined above|3|||
19474936|NCT02671266|41751848|FG000|Overall Study|Withdrawal by Subject|1|||
19474937|NCT02671266|41751849|FG001|Overall Study|Withdrawal by Subject|1|||
19474938|NCT03320070|41751857|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
19474939|NCT03320070|41751858|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
19474940|NCT03320070|41751857|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
19474941|NCT03320070|41751858|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
19474942|NCT03320070|41751857|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
19474943|NCT03320070|41751858|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
19474944|NCT03320070|41751857|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
19474945|NCT03320070|41751858|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
19474946|NCT03320070|41751857|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
19474947|NCT03320070|41751858|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
19474948|NCT03320070|41751857|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
19474949|NCT03320070|41751858|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
19474950|NCT02667912|41751869|FG000|Overall Study|Death|3|||
19474951|NCT02667912|41751870|FG001|Overall Study|Death|1|||
19474952|NCT02667912|41751869|FG000|Overall Study|Withdrawal by Subject|1|||
19474953|NCT02667912|41751870|FG001|Overall Study|Withdrawal by Subject|2|||
19474954|NCT02667912|41751869|FG000|Overall Study|Withdrawal by Subject|1|||
19474955|NCT02667912|41751870|FG001|Overall Study|Withdrawal by Subject|0|||
19474956|NCT01373346|41751876|FG000|Overall Study|Death|1|||
19474957|NCT03284424|41751887|FG000|Overall Study|Death|56|||
19474958|NCT03284424|41751888|FG001|Overall Study|Death|13|||
19474959|NCT03284424|41751887|FG000|Overall Study|Lost to Follow-up|1|||
19474960|NCT03284424|41751888|FG001|Overall Study|Lost to Follow-up|0|||
19474961|NCT03284424|41751887|FG000|Overall Study|Physician Decision|1|||
19474962|NCT03284424|41751888|FG001|Overall Study|Physician Decision|0|||
19474963|NCT03284424|41751887|FG000|Overall Study|Withdrawal by Subject|3|||
19474964|NCT03284424|41751888|FG001|Overall Study|Withdrawal by Subject|2|||
19474965|NCT03284424|41751887|FG000|Overall Study|Ongoing in study|44|||
19474966|NCT03284424|41751888|FG001|Overall Study|Ongoing in study|39|||
19474967|NCT02674854|41751896|FG000|Overall Study|Adverse Event|17|||
19474968|NCT02674854|41751897|FG001|Overall Study|Adverse Event|15|||
19474969|NCT02674854|41751898|FG002|Overall Study|Adverse Event|5|||
19474970|NCT02674854|41751896|FG000|Overall Study|Withdrawal by Subject|1|||
19474971|NCT02674854|41751897|FG001|Overall Study|Withdrawal by Subject|5|||
19474972|NCT02674854|41751898|FG002|Overall Study|Withdrawal by Subject|4|||
19474973|NCT02674854|41751896|FG000|Overall Study|No-compliant subject|1|||
19474974|NCT02674854|41751897|FG001|Overall Study|No-compliant subject|0|||
19474975|NCT02674854|41751898|FG002|Overall Study|No-compliant subject|1|||
19474976|NCT02674854|41751896|FG000|Overall Study|Lost to Follow-up|1|||
19474977|NCT02674854|41751897|FG001|Overall Study|Lost to Follow-up|0|||
19474978|NCT02674854|41751898|FG002|Overall Study|Lost to Follow-up|2|||
19474979|NCT02674854|41751896|FG000|Overall Study|Lack of Efficacy|0|||
19474980|NCT02674854|41751897|FG001|Overall Study|Lack of Efficacy|3|||
19474981|NCT02674854|41751898|FG002|Overall Study|Lack of Efficacy|0|||
19474982|NCT02674854|41751896|FG000|Overall Study|Disallowed Concurrent Medication|2|||
19474983|NCT02674854|41751897|FG001|Overall Study|Disallowed Concurrent Medication|2|||
19474984|NCT02674854|41751898|FG002|Overall Study|Disallowed Concurrent Medication|0|||
19474985|NCT02674854|41751896|FG000|Overall Study|Protocol Violation|1|||
19474986|NCT02674854|41751897|FG001|Overall Study|Protocol Violation|1|||
19474987|NCT02674854|41751898|FG002|Overall Study|Protocol Violation|2|||
19474988|NCT02674854|41751896|FG000|Overall Study|Death|0|||
19474989|NCT02674854|41751897|FG001|Overall Study|Death|1|||
19474990|NCT02674854|41751898|FG002|Overall Study|Death|0|||
19474991|NCT02674854|41751896|FG000|Overall Study|Subject missed V6.2|1|||
19474992|NCT02674854|41751897|FG001|Overall Study|Subject missed V6.2|0|||
19474993|NCT02674854|41751898|FG002|Overall Study|Subject missed V6.2|0|||
19474994|NCT02667288|41751906|FG000|Overall Study|Protocol Violation|5|||
19474995|NCT02667288|41751906|FG000|Overall Study|Lost to Follow-up|3|||
19474996|NCT02667288|41751906|FG000|Overall Study|Withdrawal by Subject|5|||
19474997|NCT02670330|41751912|FG000|Overall Study|Protocol Deviation|1|||
19474998|NCT02670330|41751913|FG001|Overall Study|Protocol Deviation|0|||
19474999|NCT02670330|41751912|FG000|Overall Study|Study Terminated By Sponsor|36|||
19475000|NCT02670330|41751913|FG001|Overall Study|Study Terminated By Sponsor|43|||
19475001|NCT02670330|41751912|FG000|Overall Study|Adverse Event|1|||
19475002|NCT02670330|41751913|FG001|Overall Study|Adverse Event|3|||
19475003|NCT02670330|41751912|FG000|Overall Study|Withdrawal by Subject|34|||
19475004|NCT02670330|41751913|FG001|Overall Study|Withdrawal by Subject|29|||
19475005|NCT02670330|41751912|FG000|Overall Study|Lost to Follow-up|3|||
19475006|NCT02670330|41751913|FG001|Overall Study|Lost to Follow-up|2|||
19475007|NCT02669940|41751921|FG000|Overall Study|Failure to return|0|||
19475008|NCT02669940|41751922|FG001|Overall Study|Failure to return|3|||
19475009|NCT02669940|41751921|FG000|Overall Study|Insufficient follow-up data|1|||
19475010|NCT02669940|41751922|FG001|Overall Study|Insufficient follow-up data|0|||
19475011|NCT02669862|41751938|FG000|Overall Study|Lost to Follow-up|0|||
19475012|NCT02669862|41751939|FG001|Overall Study|Lost to Follow-up|2|||
19475013|NCT02669862|41751940|FG002|Overall Study|Lost to Follow-up|1|||
19475014|NCT02669862|41751938|FG000|Overall Study|Withdrawal by Subject|2|||
19475015|NCT02669862|41751939|FG001|Overall Study|Withdrawal by Subject|2|||
19475016|NCT02669862|41751940|FG002|Overall Study|Withdrawal by Subject|3|||
19475017|NCT02669862|41751938|FG000|Overall Study|moved|0|||
19475018|NCT02669862|41751939|FG001|Overall Study|moved|1|||
19475019|NCT02669862|41751940|FG002|Overall Study|moved|0|||
19475020|NCT02669862|41751938|FG000|Overall Study|Protocol Violation|0|||
19475021|NCT02669862|41751939|FG001|Overall Study|Protocol Violation|0|||
19475022|NCT02669862|41751940|FG002|Overall Study|Protocol Violation|1|||
19475023|NCT01531673|41751964|FG000|Overall Study|Non-Compliance|0|||
19475024|NCT01531673|41751965|FG001|Overall Study|Non-Compliance|0|||
19475025|NCT01531673|41751966|FG002|Overall Study|Non-Compliance|0|||
19475026|NCT01531673|41751967|FG003|Overall Study|Non-Compliance|0|||
19475027|NCT01531673|41751968|FG004|Overall Study|Non-Compliance|0|||
19475028|NCT01531673|41751969|FG005|Overall Study|Non-Compliance|1|||
19475029|NCT01531673|41751970|FG006|Overall Study|Non-Compliance|0|||
19475030|NCT01531673|41751971|FG007|Overall Study|Non-Compliance|0|||
19475031|NCT01531673|41751972|FG008|Overall Study|Non-Compliance|0|||
19475032|NCT01531673|41751973|FG009|Overall Study|Non-Compliance|0|||
19475033|NCT01531673|41751974|FG010|Overall Study|Non-Compliance|0|||
19475034|NCT01531673|41751975|FG011|Overall Study|Non-Compliance|0|||
19475035|NCT01531673|41751976|FG012|Overall Study|Non-Compliance|0|||
19475036|NCT01531673|41751964|FG000|Overall Study|Adverse Event|0|||
19475037|NCT01531673|41751965|FG001|Overall Study|Adverse Event|1|||
19475038|NCT01531673|41751966|FG002|Overall Study|Adverse Event|0|||
19475039|NCT01531673|41751967|FG003|Overall Study|Adverse Event|0|||
19475040|NCT01531673|41751968|FG004|Overall Study|Adverse Event|0|||
19475041|NCT01531673|41751969|FG005|Overall Study|Adverse Event|0|||
19475042|NCT01531673|41751970|FG006|Overall Study|Adverse Event|0|||
19475043|NCT01531673|41751971|FG007|Overall Study|Adverse Event|0|||
19475044|NCT01531673|41751972|FG008|Overall Study|Adverse Event|0|||
19475045|NCT01531673|41751973|FG009|Overall Study|Adverse Event|0|||
19475046|NCT01531673|41751974|FG010|Overall Study|Adverse Event|0|||
19475047|NCT01531673|41751975|FG011|Overall Study|Adverse Event|0|||
19475048|NCT01531673|41751976|FG012|Overall Study|Adverse Event|0|||
19475049|NCT01531673|41751964|FG000|Overall Study|Lost to Follow-up|0|||
19475050|NCT01531673|41751965|FG001|Overall Study|Lost to Follow-up|0|||
19475051|NCT01531673|41751966|FG002|Overall Study|Lost to Follow-up|0|||
19475052|NCT01531673|41751967|FG003|Overall Study|Lost to Follow-up|0|||
19475053|NCT01531673|41751968|FG004|Overall Study|Lost to Follow-up|1|||
19475054|NCT01531673|41751969|FG005|Overall Study|Lost to Follow-up|0|||
19475055|NCT01531673|41751970|FG006|Overall Study|Lost to Follow-up|0|||
19475056|NCT01531673|41751971|FG007|Overall Study|Lost to Follow-up|0|||
19475057|NCT01531673|41751972|FG008|Overall Study|Lost to Follow-up|0|||
19475058|NCT01531673|41751973|FG009|Overall Study|Lost to Follow-up|0|||
19475059|NCT01531673|41751974|FG010|Overall Study|Lost to Follow-up|0|||
19475060|NCT01531673|41751975|FG011|Overall Study|Lost to Follow-up|0|||
19475061|NCT01531673|41751976|FG012|Overall Study|Lost to Follow-up|0|||
19475062|NCT01531673|41751964|FG000|Overall Study|Other|0|||
19475063|NCT01531673|41751965|FG001|Overall Study|Other|0|||
19475064|NCT01531673|41751966|FG002|Overall Study|Other|0|||
19553909|NCT01307579|42002858|FG000|Overall Study|Institutional diagnosis of IFD|21|||
19553910|NCT01307579|42002859|FG001|Overall Study|Institutional diagnosis of IFD|36|||
19553911|NCT01307579|42002858|FG000|Overall Study|Begin conditioning for HSCT|42|||
19553912|NCT01307579|42002859|FG001|Overall Study|Begin conditioning for HSCT|44|||
19553913|NCT01307579|42002858|FG000|Overall Study|Refractory or relapsed AML|38|||
19553914|NCT01307579|42002859|FG001|Overall Study|Refractory or relapsed AML|23|||
19475065|NCT01531673|41751967|FG003|Overall Study|Other|1|||
19475066|NCT01531673|41751968|FG004|Overall Study|Other|0|||
19475067|NCT01531673|41751969|FG005|Overall Study|Other|0|||
19475068|NCT01531673|41751970|FG006|Overall Study|Other|0|||
19553915|NCT01307579|42002858|FG000|Overall Study|Ineligible|3|||
19553916|NCT01307579|42002859|FG001|Overall Study|Ineligible|4|||
19475069|NCT01531673|41751971|FG007|Overall Study|Other|0|||
19475070|NCT01531673|41751972|FG008|Overall Study|Other|0|||
19475071|NCT01531673|41751973|FG009|Overall Study|Other|1|||
19475072|NCT01531673|41751974|FG010|Overall Study|Other|0|||
19475073|NCT01531673|41751975|FG011|Overall Study|Other|0|||
19475074|NCT01531673|41751976|FG012|Overall Study|Other|0|||
19475075|NCT01531205|41752028|FG000|Overall Study|Did not proceed to surgery|1|||
19475076|NCT01529645|41752044|FG000|Overall Study|Lost to Follow-up|0|||
19475077|NCT01529645|41752045|FG001|Overall Study|Lost to Follow-up|1|||
19475078|NCT01529645|41752046|FG002|Overall Study|Lost to Follow-up|1|||
19475079|NCT01529645|41752047|FG003|Overall Study|Lost to Follow-up|1|||
19475080|NCT01529645|41752048|FG004|Overall Study|Lost to Follow-up|1|||
19475081|NCT01529645|41752049|FG005|Overall Study|Lost to Follow-up|0|||
19475082|NCT01529645|41752050|FG006|Overall Study|Lost to Follow-up|2|||
19475083|NCT01529645|41752051|FG007|Overall Study|Lost to Follow-up|0|||
19475084|NCT01529645|41752052|FG008|Overall Study|Lost to Follow-up|1|||
19475085|NCT01529645|41752053|FG009|Overall Study|Lost to Follow-up|0|||
19475086|NCT01529645|41752044|FG000|Overall Study|SAE - Premature contractions|0|||
19475087|NCT01529645|41752045|FG001|Overall Study|SAE - Premature contractions|0|||
19475088|NCT01529645|41752046|FG002|Overall Study|SAE - Premature contractions|1|||
19553917|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
19553918|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
19475089|NCT01529645|41752047|FG003|Overall Study|SAE - Premature contractions|0|||
19475090|NCT01529645|41752048|FG004|Overall Study|SAE - Premature contractions|0|||
19475091|NCT01529645|41752049|FG005|Overall Study|SAE - Premature contractions|0|||
19553919|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
19475092|NCT01529645|41752050|FG006|Overall Study|SAE - Premature contractions|0|||
19475093|NCT01529645|41752051|FG007|Overall Study|SAE - Premature contractions|0|||
19475094|NCT01529645|41752052|FG008|Overall Study|SAE - Premature contractions|0|||
19475095|NCT01529645|41752053|FG009|Overall Study|SAE - Premature contractions|0|||
19475096|NCT01529645|41752044|FG000|Overall Study|Withdrawal by Subject|2|||
19475097|NCT01529645|41752045|FG001|Overall Study|Withdrawal by Subject|0|||
19475098|NCT01529645|41752046|FG002|Overall Study|Withdrawal by Subject|0|||
19475099|NCT01529645|41752047|FG003|Overall Study|Withdrawal by Subject|1|||
19475100|NCT01529645|41752048|FG004|Overall Study|Withdrawal by Subject|1|||
19475101|NCT01529645|41752049|FG005|Overall Study|Withdrawal by Subject|1|||
19475102|NCT01529645|41752050|FG006|Overall Study|Withdrawal by Subject|0|||
19475103|NCT01529645|41752051|FG007|Overall Study|Withdrawal by Subject|0|||
19475104|NCT01529645|41752052|FG008|Overall Study|Withdrawal by Subject|0|||
19475105|NCT01529645|41752053|FG009|Overall Study|Withdrawal by Subject|0|||
19475106|NCT01528787|41752087|FG000|Overall Study|Withdrawal by Subject|0|||
19475107|NCT01528787|41752088|FG001|Overall Study|Withdrawal by Subject|0|||
19475108|NCT01528787|41752089|FG002|Overall Study|Withdrawal by Subject|0|||
19475109|NCT01528787|41752090|FG003|Overall Study|Withdrawal by Subject|1|||
19475110|NCT01528787|41752087|FG000|Overall Study|Family Emergency|0|||
19475111|NCT01528787|41752088|FG001|Overall Study|Family Emergency|0|||
19475112|NCT01528787|41752089|FG002|Overall Study|Family Emergency|1|||
19475113|NCT01528787|41752090|FG003|Overall Study|Family Emergency|0|||
19475114|NCT01528709|41752102|FG000|Overall Study|Death|2|||
19475115|NCT01528709|41752103|FG001|Overall Study|Death|0|||
19475116|NCT01528709|41752102|FG000|Overall Study|Withdrawal by Subject|10|||
19475117|NCT01528709|41752103|FG001|Overall Study|Withdrawal by Subject|15|||
19475118|NCT01528709|41752102|FG000|Overall Study|allergy|1|||
19475119|NCT01528709|41752103|FG001|Overall Study|allergy|0|||
19475120|NCT01527383|41752111|FG000|Overall Study|Adverse Event|5|||
19475121|NCT01527383|41752112|FG001|Overall Study|Adverse Event|0|||
19475122|NCT01527383|41752111|FG000|Overall Study|Lost to Follow-up|3|||
19475123|NCT01527383|41752112|FG001|Overall Study|Lost to Follow-up|0|||
19475124|NCT01527383|41752111|FG000|Overall Study|Physician Decision|2|||
19475125|NCT01527383|41752112|FG001|Overall Study|Physician Decision|0|||
19475126|NCT01527383|41752111|FG000|Overall Study|Pregnancy|1|||
19475127|NCT01527383|41752112|FG001|Overall Study|Pregnancy|0|||
19475128|NCT01527383|41752111|FG000|Overall Study|Protocol Violation|1|||
19475129|NCT01527383|41752112|FG001|Overall Study|Protocol Violation|0|||
19475130|NCT01527383|41752111|FG000|Overall Study|Screen failure|1|||
19475131|NCT01527383|41752112|FG001|Overall Study|Screen failure|0|||
19475132|NCT01527383|41752111|FG000|Overall Study|Participant moved|0|||
19475133|NCT01527383|41752112|FG001|Overall Study|Participant moved|1|||
19475134|NCT01527383|41752111|FG000|Overall Study|Withdrawal by Subject|2|||
19475135|NCT01527383|41752112|FG001|Overall Study|Withdrawal by Subject|3|||
19475136|NCT01526057|41752121|FG000|Overall Study|Withdrawal by Subject|3|||
19475137|NCT01526057|41752122|FG001|Overall Study|Withdrawal by Subject|2|||
19475138|NCT01526057|41752123|FG002|Overall Study|Withdrawal by Subject|2|||
19475139|NCT01526057|41752121|FG000|Overall Study|Adverse Event|3|||
19475140|NCT01526057|41752122|FG001|Overall Study|Adverse Event|1|||
19475141|NCT01526057|41752123|FG002|Overall Study|Adverse Event|1|||
19475142|NCT01526057|41752121|FG000|Overall Study|Death|1|||
19475143|NCT01526057|41752122|FG001|Overall Study|Death|0|||
19475144|NCT01526057|41752123|FG002|Overall Study|Death|0|||
19475145|NCT01526057|41752121|FG000|Overall Study|Lost to Follow-up|1|||
19475146|NCT01526057|41752122|FG001|Overall Study|Lost to Follow-up|0|||
19475147|NCT01526057|41752123|FG002|Overall Study|Lost to Follow-up|1|||
19475148|NCT01526057|41752121|FG000|Overall Study|Other|1|||
19475149|NCT01526057|41752122|FG001|Overall Study|Other|0|||
19475150|NCT01526057|41752123|FG002|Overall Study|Other|1|||
19475151|NCT01526057|41752121|FG000|Overall Study|Protocol Violation|0|||
19475152|NCT01526057|41752122|FG001|Overall Study|Protocol Violation|0|||
19475153|NCT01526057|41752123|FG002|Overall Study|Protocol Violation|1|||
19475154|NCT01525901|41752202|FG000|Period 2: 12 Weeks|Adverse Event|0|||
19475155|NCT01525901|41752203|FG001|Period 2: 12 Weeks|Adverse Event|1|||
19475156|NCT01525901|41752204|FG002|Period 2: 12 Weeks|Adverse Event|0|||
19475157|NCT01525901|41752205|FG003|Period 2: 12 Weeks|Adverse Event|0|||
19475158|NCT01525589|41752318|FG000|Overall Study|Non-treatment-related AE|1|||
19475159|NCT01525589|41752319|FG001|Overall Study|Non-treatment-related AE|0|||
19475160|NCT01525589|41752320|FG002|Overall Study|Non-treatment-related AE|0|||
19475161|NCT01525589|41752318|FG000|Overall Study|Progressive disease|48|||
19475162|NCT01525589|41752319|FG001|Overall Study|Progressive disease|15|||
19475163|NCT01525589|41752320|FG002|Overall Study|Progressive disease|29|||
19475164|NCT01525589|41752318|FG000|Overall Study|Never treated|2|||
19475165|NCT01525589|41752319|FG001|Overall Study|Never treated|0|||
19475166|NCT01525589|41752320|FG002|Overall Study|Never treated|0|||
19475167|NCT01525589|41752318|FG000|Overall Study|Physician Decision|4|||
19475168|NCT01525589|41752319|FG001|Overall Study|Physician Decision|2|||
19475169|NCT01525589|41752320|FG002|Overall Study|Physician Decision|2|||
19475170|NCT01525589|41752318|FG000|Overall Study|Death|0|||
19475171|NCT01525589|41752319|FG001|Overall Study|Death|0|||
19475172|NCT01525589|41752320|FG002|Overall Study|Death|2|||
19475173|NCT01525589|41752318|FG000|Overall Study|Treatment-related AE|1|||
19475174|NCT01525589|41752319|FG001|Overall Study|Treatment-related AE|1|||
19475175|NCT01525589|41752320|FG002|Overall Study|Treatment-related AE|2|||
19475176|NCT01525589|41752318|FG000|Overall Study|Other reasons|0|||
19475177|NCT01525589|41752319|FG001|Overall Study|Other reasons|1|||
19475178|NCT01525589|41752320|FG002|Overall Study|Other reasons|0|||
19475179|NCT01525589|41752318|FG000|Overall Study|Withdrawal by Subject|0|||
19475180|NCT01525589|41752319|FG001|Overall Study|Withdrawal by Subject|1|||
19475181|NCT01525589|41752320|FG002|Overall Study|Withdrawal by Subject|0|||
19475182|NCT01524887|41752331|FG000|Overall Study|Withdrawal by Subject|6|||
19475183|NCT01524887|41752332|FG001|Overall Study|Withdrawal by Subject|2|||
19475184|NCT01524887|41752333|FG002|Overall Study|Withdrawal by Subject|3|||
19475185|NCT01524887|41752331|FG000|Overall Study|Adverse Event|5|||
19475186|NCT01524887|41752332|FG001|Overall Study|Adverse Event|1|||
19475187|NCT01524887|41752333|FG002|Overall Study|Adverse Event|1|||
19475188|NCT01524887|41752331|FG000|Overall Study|Protocol Violation|0|||
19475189|NCT01524887|41752332|FG001|Overall Study|Protocol Violation|0|||
19475190|NCT01524887|41752333|FG002|Overall Study|Protocol Violation|1|||
19475191|NCT01524887|41752331|FG000|Overall Study|Study termination|73|||
19475192|NCT01524887|41752332|FG001|Overall Study|Study termination|87|||
19475193|NCT01524887|41752333|FG002|Overall Study|Study termination|79|||
19475194|NCT01524887|41752331|FG000|Overall Study|Withdrawal by Caregiver|0|||
19475195|NCT01524887|41752332|FG001|Overall Study|Withdrawal by Caregiver|0|||
19475196|NCT01524887|41752333|FG002|Overall Study|Withdrawal by Caregiver|2|||
19475197|NCT01524887|41752331|FG000|Overall Study|Use of prohibited medication|1|||
19475198|NCT01524887|41752332|FG001|Overall Study|Use of prohibited medication|0|||
19475199|NCT01524887|41752333|FG002|Overall Study|Use of prohibited medication|0|||
19475200|NCT01523873|41752359|FG000|Overall Study|Protocol Violation|422|||
19475201|NCT01522235|41752384|FG000|Overall Study|Physician Decision|1|||
19475202|NCT01522235|41752385|FG001|Overall Study|Physician Decision|1|||
19475203|NCT01521923|41752422|FG000|Overall Study|AE, serious fatal|1|||
19475204|NCT01521923|41752423|FG001|Overall Study|AE, serious fatal|0|||
19475205|NCT01521923|41752424|FG002|Overall Study|AE, serious fatal|0|||
19475206|NCT01521923|41752425|FG003|Overall Study|AE, serious fatal|0|||
19475207|NCT01521923|41752422|FG000|Overall Study|SAE, non-fatal|0|||
19475208|NCT01521923|41752423|FG001|Overall Study|SAE, non-fatal|2|||
19475209|NCT01521923|41752424|FG002|Overall Study|SAE, non-fatal|2|||
19475210|NCT01521923|41752425|FG003|Overall Study|SAE, non-fatal|0|||
19475211|NCT01521923|41752422|FG000|Overall Study|AE, non-serious, non-fatal|1|||
19475212|NCT01521923|41752423|FG001|Overall Study|AE, non-serious, non-fatal|3|||
19475213|NCT01521923|41752424|FG002|Overall Study|AE, non-serious, non-fatal|6|||
19475214|NCT01521923|41752425|FG003|Overall Study|AE, non-serious, non-fatal|2|||
19475215|NCT01521923|41752422|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
19475216|NCT01521923|41752423|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
19475217|NCT01521923|41752424|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
19475218|NCT01521923|41752425|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
19475219|NCT01521923|41752422|FG000|Overall Study|Lack of Efficacy|1|||
19475220|NCT01521923|41752423|FG001|Overall Study|Lack of Efficacy|1|||
19475221|NCT01521923|41752424|FG002|Overall Study|Lack of Efficacy|0|||
19475222|NCT01521923|41752425|FG003|Overall Study|Lack of Efficacy|0|||
19475223|NCT01521923|41752422|FG000|Overall Study|Protocol Violation|0|||
19475224|NCT01521923|41752423|FG001|Overall Study|Protocol Violation|0|||
19475225|NCT01521923|41752424|FG002|Overall Study|Protocol Violation|1|||
19475226|NCT01521923|41752425|FG003|Overall Study|Protocol Violation|0|||
19475227|NCT01521923|41752422|FG000|Overall Study|Lost to Follow-up|1|||
19475228|NCT01521923|41752423|FG001|Overall Study|Lost to Follow-up|0|||
19475229|NCT01521923|41752424|FG002|Overall Study|Lost to Follow-up|2|||
19475230|NCT01521923|41752425|FG003|Overall Study|Lost to Follow-up|1|||
19475231|NCT01521923|41752422|FG000|Overall Study|Withdrawal by Subject|1|||
19475232|NCT01521923|41752423|FG001|Overall Study|Withdrawal by Subject|1|||
19475233|NCT01521923|41752424|FG002|Overall Study|Withdrawal by Subject|1|||
19475234|NCT01521923|41752425|FG003|Overall Study|Withdrawal by Subject|2|||
19475235|NCT01521923|41752422|FG000|Overall Study|Other|2|||
19475236|NCT01521923|41752423|FG001|Overall Study|Other|1|||
19475237|NCT01521923|41752424|FG002|Overall Study|Other|3|||
19475238|NCT01521923|41752425|FG003|Overall Study|Other|6|||
19475239|NCT01521923|41752422|FG000|Overall Study|AE, captured in Period 1|0|||
19475240|NCT01521923|41752423|FG001|Overall Study|AE, captured in Period 1|1|||
19475241|NCT01521923|41752424|FG002|Overall Study|AE, captured in Period 1|0|||
19475242|NCT01521923|41752425|FG003|Overall Study|AE, captured in Period 1|1|||
19475243|NCT01520987|41752549|FG000|Overall Study|Withdrawal by Subject|1|||
19475244|NCT01520987|41752550|FG001|Overall Study|Withdrawal by Subject|0|||
19475245|NCT01520987|41752551|FG002|Overall Study|Withdrawal by Subject|0|||
19475246|NCT01520987|41752552|FG003|Overall Study|Withdrawal by Subject|0|||
19475247|NCT01520987|41752553|FG004|Overall Study|Withdrawal by Subject|0|||
19475248|NCT01520987|41752554|FG005|Overall Study|Withdrawal by Subject|1|||
19475249|NCT01520987|41752555|FG006|Overall Study|Withdrawal by Subject|0|||
19475250|NCT01520987|41752556|FG007|Overall Study|Withdrawal by Subject|0|||
19475251|NCT01562275|41752630|FG000|Stage 1|Adverse Event|0|||
19475252|NCT01562275|41752631|FG001|Stage 1|Adverse Event|0|||
19475253|NCT01562275|41752632|FG002|Stage 1|Adverse Event|0|||
19475254|NCT01562275|41752633|FG003|Stage 1|Adverse Event|1|||
19475255|NCT01562275|41752634|FG004|Stage 1|Adverse Event|1|||
19475256|NCT01562275|41752635|FG005|Stage 1|Adverse Event|0|||
19475257|NCT01562275|41752636|FG006|Stage 1|Adverse Event|0|||
19475258|NCT01562275|41752637|FG007|Stage 1|Adverse Event|0|||
19475259|NCT01562275|41752638|FG008|Stage 1|Adverse Event|0|||
19475260|NCT01562275|41752639|FG009|Stage 1|Adverse Event|1|||
19475261|NCT01562275|41752640|FG010|Stage 1|Adverse Event|0|||
19475262|NCT01562275|41752641|FG011|Stage 1|Adverse Event|0|||
19475263|NCT01562275|41752642|FG012|Stage 1|Adverse Event|0|||
19475264|NCT01562275|41752630|FG000|Stage 1|Death|1|||
19475265|NCT01562275|41752631|FG001|Stage 1|Death|0|||
19475266|NCT01562275|41752632|FG002|Stage 1|Death|0|||
19475267|NCT01562275|41752633|FG003|Stage 1|Death|0|||
19475268|NCT01562275|41752634|FG004|Stage 1|Death|0|||
19475269|NCT01562275|41752635|FG005|Stage 1|Death|0|||
19475270|NCT01562275|41752636|FG006|Stage 1|Death|0|||
19475271|NCT01562275|41752637|FG007|Stage 1|Death|0|||
19475272|NCT01562275|41752638|FG008|Stage 1|Death|0|||
19475273|NCT01562275|41752639|FG009|Stage 1|Death|0|||
19475274|NCT01562275|41752640|FG010|Stage 1|Death|0|||
19475275|NCT01562275|41752641|FG011|Stage 1|Death|0|||
19475276|NCT01562275|41752642|FG012|Stage 1|Death|0|||
19475277|NCT01562275|41752630|FG000|Stage 1|Non Compliance|0|||
19475278|NCT01562275|41752631|FG001|Stage 1|Non Compliance|0|||
19475279|NCT01562275|41752632|FG002|Stage 1|Non Compliance|1|||
19475280|NCT01562275|41752633|FG003|Stage 1|Non Compliance|0|||
19475281|NCT01562275|41752634|FG004|Stage 1|Non Compliance|0|||
19475282|NCT01562275|41752635|FG005|Stage 1|Non Compliance|0|||
19475283|NCT01562275|41752636|FG006|Stage 1|Non Compliance|0|||
19475284|NCT01562275|41752637|FG007|Stage 1|Non Compliance|0|||
19475285|NCT01562275|41752638|FG008|Stage 1|Non Compliance|0|||
19475286|NCT01562275|41752639|FG009|Stage 1|Non Compliance|0|||
19475287|NCT01562275|41752640|FG010|Stage 1|Non Compliance|0|||
19475288|NCT01562275|41752641|FG011|Stage 1|Non Compliance|0|||
19475289|NCT01562275|41752642|FG012|Stage 1|Non Compliance|0|||
19475290|NCT01562275|41752630|FG000|Stage 1|Physician Decision|0|||
19475291|NCT01562275|41752631|FG001|Stage 1|Physician Decision|0|||
19475292|NCT01562275|41752632|FG002|Stage 1|Physician Decision|0|||
19475293|NCT01562275|41752633|FG003|Stage 1|Physician Decision|0|||
19475294|NCT01562275|41752634|FG004|Stage 1|Physician Decision|1|||
19475295|NCT01562275|41752635|FG005|Stage 1|Physician Decision|0|||
19475296|NCT01562275|41752636|FG006|Stage 1|Physician Decision|1|||
19475297|NCT01562275|41752637|FG007|Stage 1|Physician Decision|0|||
19475298|NCT01562275|41752638|FG008|Stage 1|Physician Decision|1|||
19475299|NCT01562275|41752639|FG009|Stage 1|Physician Decision|0|||
19475300|NCT01562275|41752640|FG010|Stage 1|Physician Decision|0|||
19475301|NCT01562275|41752641|FG011|Stage 1|Physician Decision|0|||
19475302|NCT01562275|41752642|FG012|Stage 1|Physician Decision|0|||
19475303|NCT01562275|41752630|FG000|Stage 1|Progression of Disease|2|||
19475304|NCT01562275|41752631|FG001|Stage 1|Progression of Disease|6|||
19475305|NCT01562275|41752632|FG002|Stage 1|Progression of Disease|2|||
19475306|NCT01562275|41752633|FG003|Stage 1|Progression of Disease|1|||
19475307|NCT01562275|41752634|FG004|Stage 1|Progression of Disease|2|||
19475308|NCT01562275|41752635|FG005|Stage 1|Progression of Disease|4|||
19475309|NCT01562275|41752636|FG006|Stage 1|Progression of Disease|1|||
19475310|NCT01562275|41752637|FG007|Stage 1|Progression of Disease|7|||
19475311|NCT01562275|41752638|FG008|Stage 1|Progression of Disease|2|||
19475312|NCT01562275|41752639|FG009|Stage 1|Progression of Disease|5|||
19475313|NCT01562275|41752640|FG010|Stage 1|Progression of Disease|3|||
19475314|NCT01562275|41752641|FG011|Stage 1|Progression of Disease|0|||
19475315|NCT01562275|41752642|FG012|Stage 1|Progression of Disease|0|||
19475316|NCT01562275|41752630|FG000|Stage 1|Withdrawal by Subject|0|||
19475317|NCT01562275|41752631|FG001|Stage 1|Withdrawal by Subject|1|||
19475318|NCT01562275|41752632|FG002|Stage 1|Withdrawal by Subject|0|||
19475319|NCT01562275|41752633|FG003|Stage 1|Withdrawal by Subject|2|||
19475320|NCT01562275|41752634|FG004|Stage 1|Withdrawal by Subject|0|||
19475321|NCT01562275|41752635|FG005|Stage 1|Withdrawal by Subject|0|||
19475322|NCT01562275|41752636|FG006|Stage 1|Withdrawal by Subject|1|||
19475323|NCT01562275|41752637|FG007|Stage 1|Withdrawal by Subject|0|||
19475324|NCT01562275|41752638|FG008|Stage 1|Withdrawal by Subject|0|||
19475325|NCT01562275|41752639|FG009|Stage 1|Withdrawal by Subject|1|||
19475326|NCT01562275|41752640|FG010|Stage 1|Withdrawal by Subject|0|||
19475327|NCT01562275|41752641|FG011|Stage 1|Withdrawal by Subject|0|||
19475328|NCT01562275|41752642|FG012|Stage 1|Withdrawal by Subject|0|||
19475329|NCT01562275|41752630|FG000|Stage 2|Death|0|||
19475330|NCT01562275|41752631|FG001|Stage 2|Death|0|||
19475331|NCT01562275|41752632|FG002|Stage 2|Death|0|||
19475332|NCT01562275|41752633|FG003|Stage 2|Death|0|||
19475333|NCT01562275|41752634|FG004|Stage 2|Death|0|||
19475334|NCT01562275|41752635|FG005|Stage 2|Death|0|||
19475335|NCT01562275|41752636|FG006|Stage 2|Death|0|||
19475336|NCT01562275|41752637|FG007|Stage 2|Death|0|||
19475337|NCT01562275|41752638|FG008|Stage 2|Death|0|||
19475338|NCT01562275|41752639|FG009|Stage 2|Death|0|||
19475339|NCT01562275|41752640|FG010|Stage 2|Death|0|||
19475340|NCT01562275|41752641|FG011|Stage 2|Death|2|||
19475341|NCT01562275|41752642|FG012|Stage 2|Death|1|||
19475342|NCT01562275|41752630|FG000|Stage 2|Progression of Disease|0|||
19475343|NCT01562275|41752631|FG001|Stage 2|Progression of Disease|0|||
19475344|NCT01562275|41752632|FG002|Stage 2|Progression of Disease|0|||
19475345|NCT01562275|41752633|FG003|Stage 2|Progression of Disease|0|||
19475346|NCT01562275|41752634|FG004|Stage 2|Progression of Disease|0|||
19475347|NCT01562275|41752635|FG005|Stage 2|Progression of Disease|0|||
19475348|NCT01562275|41752636|FG006|Stage 2|Progression of Disease|0|||
19475349|NCT01562275|41752637|FG007|Stage 2|Progression of Disease|0|||
19475350|NCT01562275|41752638|FG008|Stage 2|Progression of Disease|0|||
19475351|NCT01562275|41752639|FG009|Stage 2|Progression of Disease|0|||
19475352|NCT01562275|41752640|FG010|Stage 2|Progression of Disease|0|||
19475353|NCT01562275|41752641|FG011|Stage 2|Progression of Disease|12|||
19475354|NCT01562275|41752642|FG012|Stage 2|Progression of Disease|4|||
19475355|NCT01535053|41752674|FG000|Overall Study|Ineligible|1|||
19475356|NCT01535053|41752675|FG001|Overall Study|Ineligible|2|||
19475357|NCT01534663|41752683|FG000|Overall Study|Lost to Follow-up|0|||
19475358|NCT01534663|41752684|FG001|Overall Study|Lost to Follow-up|2|||
19475359|NCT01534663|41752683|FG000|Overall Study|Adverse Event|2|||
19475360|NCT01534663|41752684|FG001|Overall Study|Adverse Event|1|||
19475361|NCT01520909|41752692|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
19475362|NCT01520909|41752693|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
19475363|NCT01520909|41752694|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
19475364|NCT01520909|41752692|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
19475365|NCT01520909|41752693|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
19475366|NCT01520909|41752694|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
19475367|NCT01520909|41752692|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
19475368|NCT01520909|41752693|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
19478168|NCT01693562|41757322|FG008|Expansion Phase|Other|1|||
19475369|NCT01520909|41752694|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
19475370|NCT01520909|41752692|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
19475371|NCT01520909|41752693|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
19475372|NCT01520909|41752694|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
19475373|NCT01520363|41752716|FG000|Overall Study|Withdrawal by Subject|2|||
19475374|NCT01520363|41752717|FG001|Overall Study|Withdrawal by Subject|0|||
19475375|NCT01578499|41752749|FG000|Overall Study|Reason not Specified|0|||
19475376|NCT01578499|41752750|FG001|Overall Study|Reason not Specified|1|||
19475377|NCT01578499|41752749|FG000|Overall Study|Lost to Follow-up|2|||
19475378|NCT01578499|41752750|FG001|Overall Study|Lost to Follow-up|1|||
19475379|NCT01578499|41752749|FG000|Overall Study|Withdrawal by Subject|10|||
19475380|NCT01578499|41752750|FG001|Overall Study|Withdrawal by Subject|16|||
19381866|NCT01675167|41624967|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
19381867|NCT01675167|41624965|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
19381868|NCT01675167|41624966|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
19381869|NCT01675167|41624967|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
19381870|NCT01675167|41624965|FG000|Open-label Titration Phase|Protocol Violation|43|||
19381871|NCT01675167|41624966|FG001|Open-label Titration Phase|Protocol Violation|0|||
19381872|NCT01675167|41624967|FG002|Open-label Titration Phase|Protocol Violation|0|||
19381873|NCT01675167|41624965|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
19381874|NCT01675167|41624966|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
19381875|NCT01675167|41624967|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
19381876|NCT01675167|41624965|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
19381877|NCT01675167|41624966|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
19381878|NCT01675167|41624967|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
19381879|NCT01675167|41624965|FG000|Open-label Titration Phase|Other|55|||
19381880|NCT01675167|41624966|FG001|Open-label Titration Phase|Other|0|||
19381881|NCT01675167|41624967|FG002|Open-label Titration Phase|Other|0|||
19381882|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
19381883|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
19381884|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
19381885|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19381886|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
19381887|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
19381888|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Adverse Event|0|||
19381889|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Adverse Event|5|||
19381890|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Adverse Event|13|||
19381891|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
19381892|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
19381893|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
19381894|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
19381895|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
19381896|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
19381897|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
19381898|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
19381899|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
19475381|NCT01578499|41752749|FG000|Overall Study|Death|20|||
19475382|NCT01578499|41752750|FG001|Overall Study|Death|25|||
19475383|NCT01578499|41752749|FG000|Overall Study|Died and End of Study Page not Completed|2|||
19475384|NCT01578499|41752750|FG001|Overall Study|Died and End of Study Page not Completed|0|||
19475385|NCT01578187|41752760|FG000|Usability Phase|Withdrawal by Subject|1|||
19475386|NCT01561963|41752766|FG000|Overall Study|Adverse Event|1|||
19475387|NCT01576783|41752777|FG000|Overall Study|Change in Medical Care|1|||
19475388|NCT01576783|41752778|FG001|Overall Study|Change in Medical Care|0|||
19475389|NCT01576783|41752777|FG000|Overall Study|Lost to Follow-up|14|||
19475390|NCT01576783|41752778|FG001|Overall Study|Lost to Follow-up|16|||
19475391|NCT01576783|41752777|FG000|Overall Study|Withdrawal by Subject|5|||
19475392|NCT01576783|41752778|FG001|Overall Study|Withdrawal by Subject|1|||
19475393|NCT01534351|41752787|FG000|Overall Study|Study Terminated Early|1|||
19475394|NCT01534351|41752788|FG001|Overall Study|Study Terminated Early|0|||
19475395|NCT01534351|41752789|FG002|Overall Study|Study Terminated Early|0|||
19475396|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
19475397|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
19475398|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
19475399|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
19475400|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
19475401|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
19475402|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
19475403|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
19475404|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
19475405|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
19475406|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
19475407|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
19475408|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
19475409|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
19475410|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
19475411|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
19475412|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
19475413|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
19475414|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
19475415|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
19475416|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
19475417|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
19475418|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
19475419|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
19475420|NCT02120352|41752797|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
19475421|NCT02120352|41752798|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
19475422|NCT02120352|41752799|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
19475423|NCT02120352|41752800|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
19475424|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
19475425|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
19475426|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
19475427|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
19475428|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
19475429|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
19475430|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
19475431|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
19475432|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
19475433|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
19475434|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
19475435|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
19475436|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
19478169|NCT01693562|41757323|FG009|Expansion Phase|Other|28|||
19381900|NCT01675167|41624965|FG000|Double-blind Treatment Phase|Other|0|||
19381901|NCT01675167|41624966|FG001|Double-blind Treatment Phase|Other|7|||
19381902|NCT01675167|41624967|FG002|Double-blind Treatment Phase|Other|5|||
19381903|NCT01675011|41624977|FG000|Overall Study|Trial terminated by Sponsor|3|||
19381904|NCT01675011|41624978|FG001|Overall Study|Trial terminated by Sponsor|1|||
19390343|NCT01987960|41634111|FG001|Period 1|Withdrawal of consent before treatment|0|||
19390344|NCT01987960|41634112|FG002|Period 1|Withdrawal of consent before treatment|0|||
19390345|NCT01987960|41634113|FG003|Period 1|Withdrawal of consent before treatment|0|||
19390346|NCT01987960|41634110|FG000|Period 2|Adverse Event|0|||
19390347|NCT01987960|41634111|FG001|Period 2|Adverse Event|0|||
19390348|NCT01987960|41634112|FG002|Period 2|Adverse Event|1|||
19475437|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
19475438|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
19475439|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
19475440|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
19475441|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
19475442|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
19475443|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
19475444|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
19478170|NCT01693562|41757324|FG010|Expansion Phase|Other|4|||
19475445|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
19475446|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
19475447|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
19475448|NCT02120352|41752797|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
19475449|NCT02120352|41752798|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
19475450|NCT02120352|41752799|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
19475451|NCT02120352|41752800|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
19475452|NCT01534273|41752818|FG000|Period 1|Physician Decision|0|||
19475453|NCT01534273|41752819|FG001|Period 1|Physician Decision|0|||
19475454|NCT01534273|41752820|FG002|Period 1|Physician Decision|0|||
19475455|NCT01534273|41752821|FG003|Period 1|Physician Decision|1|||
19475456|NCT01534273|41752822|FG004|Period 1|Physician Decision|0|||
19475457|NCT01534273|41752823|FG005|Period 1|Physician Decision|0|||
19475458|NCT01534273|41752824|FG006|Period 1|Physician Decision|0|||
19475459|NCT01534195|41752847|FG000|Overall Study|Withdrawal by Subject|1|||
19475460|NCT01534195|41752848|FG001|Overall Study|Withdrawal by Subject|1|||
19475461|NCT01560949|41752854|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
19553920|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
19381905|NCT02649231|41625006|FG000|Overall Study|Adverse Event|0|||
19475462|NCT01560949|41752854|FG000|Surgery Phase|Physician Decision|3|||
19475463|NCT01372878|41752862|FG000|Overall Study|Withdrawal by Subject|63|||
19475464|NCT01372878|41752862|FG000|Overall Study|Protocol Violation|17|||
19475465|NCT01372878|41752862|FG000|Overall Study|incomplete study procedure|104|||
19475466|NCT01533493|41752868|FG000|Overall Study|Adverse Event|2|||
19475467|NCT01533493|41752869|FG001|Overall Study|Adverse Event|1|||
19475468|NCT01533493|41752868|FG000|Overall Study|Withdrawal by Subject|1|||
19475469|NCT01533493|41752869|FG001|Overall Study|Withdrawal by Subject|2|||
19475470|NCT01533493|41752868|FG000|Overall Study|Lost to Follow-up|2|||
19475471|NCT01533493|41752869|FG001|Overall Study|Lost to Follow-up|0|||
19475472|NCT01533181|41752945|FG000|Overall Study|Disease progression pre-active treatment|0|||
19475473|NCT01533181|41752946|FG001|Overall Study|Disease progression pre-active treatment|1|||
19475474|NCT01533181|41752945|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
19475475|NCT01533181|41752946|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
19475476|NCT02669082|41752952|FG000|Overall Study|Adverse Event|1|||
19475477|NCT02668692|41753016|FG000|Overall Study|Adverse Event|1|||
19475478|NCT02668692|41753017|FG001|Overall Study|Adverse Event|0|||
19475479|NCT02662764|41753031|FG000|Overall Study|Adverse Event|6|||
19475480|NCT02662764|41753031|FG000|Overall Study|Lack of Efficacy|8|||
19475481|NCT02662764|41753031|FG000|Overall Study|Protocol Violation|1|||
19475482|NCT02662764|41753031|FG000|Overall Study|Withdrawal by Subject|5|||
19475483|NCT02662764|41753031|FG000|Overall Study|Device failure|4|||
19475484|NCT02662764|41753031|FG000|Overall Study|Patient changed treatment|1|||
19475485|NCT02662764|41753031|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
19475486|NCT01519817|41753040|FG000|Overall Study|Withdrawal by Subject|1|||
19475487|NCT01519817|41753041|FG001|Overall Study|Withdrawal by Subject|0|||
19475488|NCT01519817|41753042|FG002|Overall Study|Withdrawal by Subject|0|||
19475489|NCT01519817|41753043|FG003|Overall Study|Withdrawal by Subject|0|||
19475490|NCT01519817|41753040|FG000|Overall Study|Off study due to infection|0|||
19475491|NCT01519817|41753041|FG001|Overall Study|Off study due to infection|0|||
19475492|NCT01519817|41753042|FG002|Overall Study|Off study due to infection|0|||
19475493|NCT01519817|41753043|FG003|Overall Study|Off study due to infection|1|||
19475494|NCT03478956|41753055|FG000|Overall Study|Adverse Event|1|||
19475495|NCT03478956|41753056|FG001|Overall Study|Adverse Event|0|||
19475496|NCT03478956|41753055|FG000|Overall Study|Withdrawal by Subject|0|||
19475497|NCT03478956|41753056|FG001|Overall Study|Withdrawal by Subject|1|||
19475498|NCT03478956|41753055|FG000|Overall Study|Ongoing in the Study|11|||
19475499|NCT03478956|41753056|FG001|Overall Study|Ongoing in the Study|11|||
19475500|NCT01519661|41753062|FG000|Overall Study|Protocol deviation|6|||
19475501|NCT01519661|41753062|FG000|Overall Study|Lost to Follow-up|3|||
19475502|NCT01519661|41753062|FG000|Overall Study|Withdrawal by Subject|17|||
19475503|NCT01519661|41753062|FG000|Overall Study|Lack of Efficacy|6|||
19475504|NCT01519661|41753062|FG000|Overall Study|Adverse Event|29|||
19475505|NCT01519427|41753067|FG000|Overall Study|disease progression|2|||
19475506|NCT01518257|41753073|FG000|Overall Study|Lost to Follow-up|1|||
19475507|NCT01518257|41753074|FG001|Overall Study|Lost to Follow-up|0|||
19475508|NCT01518257|41753073|FG000|Overall Study|Other Miscellaneous Reason|1|||
19475509|NCT01518257|41753074|FG001|Overall Study|Other Miscellaneous Reason|0|||
19475510|NCT02668302|41753082|FG000|Overall Study|Withdrawal by Subject|1|||
19475511|NCT02668302|41753083|FG001|Overall Study|Withdrawal by Subject|0|||
19475512|NCT01517867|41753091|FG000|Overall Study|never started treatment|29|||
19475513|NCT01517867|41753092|FG001|Overall Study|never started treatment|32|||
19475514|NCT01517867|41753091|FG000|Overall Study|Withdrawal by Subject|34|||
19475515|NCT01517867|41753092|FG001|Overall Study|Withdrawal by Subject|30|||
19475516|NCT01517867|41753091|FG000|Overall Study|Still in treatment at study end|0|||
19475517|NCT01517867|41753092|FG001|Overall Study|Still in treatment at study end|3|||
19475518|NCT01514357|41753100|FG000|Overall Study|Screen failure|2|||
19475519|NCT01514357|41753101|FG001|Overall Study|Screen failure|0|||
19475520|NCT01514357|41753100|FG000|Overall Study|Withdrawal by Subject|2|||
19475521|NCT01514357|41753101|FG001|Overall Study|Withdrawal by Subject|0|||
19475522|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
19475523|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
19475524|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
19475525|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
19475526|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
19475527|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
19475528|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
19475529|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
19475530|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
19475531|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
19475532|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
19475533|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
19475534|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
19475535|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
19475536|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
19475537|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
19553921|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
19475538|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
19475539|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
19475540|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
19475541|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
19475542|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
19475543|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
19475544|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
19475545|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
19475546|NCT01532869|41753109|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
19475547|NCT01532869|41753110|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
19475548|NCT01532869|41753109|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
19475549|NCT01532869|41753110|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
19475550|NCT01532869|41753109|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
19475551|NCT01532869|41753110|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
19475552|NCT01532869|41753109|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
19475553|NCT01532869|41753110|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
19475554|NCT01532869|41753109|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
19475555|NCT01532869|41753110|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
19475556|NCT01531387|41753123|FG000|Overall Study|Early termination of study|11|||
19475557|NCT01531387|41753124|FG001|Overall Study|Early termination of study|11|||
19475558|NCT01531153|41753133|FG000|Overall Study|Withdrawal by Subject|10|||
19475559|NCT01531153|41753134|FG001|Overall Study|Withdrawal by Subject|9|||
19475560|NCT01531153|41753135|FG002|Overall Study|Withdrawal by Subject|15|||
19475561|NCT01529749|41753150|FG000|Overall Study|Lost to Follow-up|0|||
19475562|NCT01529749|41753151|FG001|Overall Study|Lost to Follow-up|1|||
19475563|NCT01529749|41753152|FG002|Overall Study|Lost to Follow-up|1|||
19639188|NCT00717236|42088570|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
19639189|NCT00719810|42088581|FG000|Overall Study|Adverse Event|0|||
19639190|NCT00719810|42088582|FG001|Overall Study|Adverse Event|2|||
19639191|NCT00719810|42088583|FG002|Overall Study|Adverse Event|3|||
19475564|NCT01529749|41753153|FG003|Overall Study|Lost to Follow-up|0|||
19475565|NCT01529749|41753150|FG000|Overall Study|Physician Decision|0|||
19475566|NCT01529749|41753151|FG001|Overall Study|Physician Decision|0|||
19475567|NCT01529749|41753152|FG002|Overall Study|Physician Decision|0|||
19475568|NCT01529749|41753153|FG003|Overall Study|Physician Decision|1|||
19475569|NCT01529749|41753150|FG000|Overall Study|Withdrawal by Subject|0|||
19475570|NCT01529749|41753151|FG001|Overall Study|Withdrawal by Subject|1|||
19475571|NCT01529749|41753152|FG002|Overall Study|Withdrawal by Subject|1|||
19475572|NCT01529749|41753153|FG003|Overall Study|Withdrawal by Subject|0|||
19475573|NCT01529749|41753150|FG000|Overall Study|Protocol Violation|0|||
19475574|NCT01529749|41753151|FG001|Overall Study|Protocol Violation|0|||
19475575|NCT01529749|41753152|FG002|Overall Study|Protocol Violation|0|||
19475576|NCT01529749|41753153|FG003|Overall Study|Protocol Violation|1|||
19475577|NCT01529515|41753165|FG000|TRANSITION PHASE|Adverse Event|16|||
19475578|NCT01529515|41753166|FG001|TRANSITION PHASE|Adverse Event|0|||
19475579|NCT01529515|41753167|FG002|TRANSITION PHASE|Adverse Event|0|||
19475580|NCT01529515|41753168|FG003|TRANSITION PHASE|Adverse Event|0|||
19475581|NCT01529515|41753165|FG000|TRANSITION PHASE|Death|1|||
19475582|NCT01529515|41753166|FG001|TRANSITION PHASE|Death|0|||
19475583|NCT01529515|41753167|FG002|TRANSITION PHASE|Death|0|||
19475584|NCT01529515|41753168|FG003|TRANSITION PHASE|Death|0|||
19475585|NCT01529515|41753165|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
19475586|NCT01529515|41753166|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
19475587|NCT01529515|41753167|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
19381906|NCT02649231|41625007|FG001|Overall Study|Adverse Event|0|||
19475588|NCT01529515|41753168|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
19475589|NCT01529515|41753165|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
19475590|NCT01529515|41753166|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
19475591|NCT01529515|41753167|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
19475592|NCT01529515|41753168|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
19475593|NCT01529515|41753165|FG000|TRANSITION PHASE|Protocol Violation|4|||
19475594|NCT01529515|41753166|FG001|TRANSITION PHASE|Protocol Violation|0|||
19475595|NCT01529515|41753167|FG002|TRANSITION PHASE|Protocol Violation|0|||
19475596|NCT01529515|41753168|FG003|TRANSITION PHASE|Protocol Violation|0|||
19475597|NCT01529515|41753165|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
19475598|NCT01529515|41753166|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
19475599|NCT01529515|41753167|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
19475600|NCT01529515|41753168|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
19475601|NCT01529515|41753165|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
19475602|NCT01529515|41753166|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
19475603|NCT01529515|41753167|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
19475604|NCT01529515|41753168|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
19475605|NCT01529515|41753165|FG000|TRANSITION PHASE|Other|9|||
19475606|NCT01529515|41753166|FG001|TRANSITION PHASE|Other|0|||
19475607|NCT01529515|41753167|FG002|TRANSITION PHASE|Other|0|||
19475608|NCT01529515|41753168|FG003|TRANSITION PHASE|Other|0|||
19475609|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Adverse Event|0|||
19475610|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Adverse Event|10|||
19475611|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Adverse Event|0|||
19475612|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Adverse Event|0|||
19475613|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
19475614|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
19475615|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
19475616|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
19475617|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
19475618|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
19475619|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
19475620|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
19475621|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
19475622|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
19475623|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
19475624|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
19475625|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
19475626|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
19475627|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
19553922|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
19475628|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
19475629|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
19553923|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
19475630|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
19475631|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
19475632|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
19475633|NCT01529515|41753165|FG000|MAINTENANCE PHASE|Other|0|||
19475634|NCT01529515|41753166|FG001|MAINTENANCE PHASE|Other|10|||
19475635|NCT01529515|41753167|FG002|MAINTENANCE PHASE|Other|0|||
19475636|NCT01529515|41753168|FG003|MAINTENANCE PHASE|Other|0|||
19475637|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
19475638|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
19475639|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
19475640|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
19475641|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
19475642|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
19475643|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
19475644|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
19475645|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
19475646|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
19475647|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
19475648|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
19553924|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
19475649|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
19475650|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
19475651|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
19475652|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
19475653|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
19475654|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
19475655|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
19475656|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
19475657|NCT01529515|41753165|FG000|DOUBLE BLIND PHASE|Other|0|||
19475658|NCT01529515|41753166|FG001|DOUBLE BLIND PHASE|Other|0|||
19373520|NCT02758613|41614708|FG001|Treatment|Physician and Sponsor Decision|0|||
19475659|NCT01529515|41753167|FG002|DOUBLE BLIND PHASE|Other|9|||
19475660|NCT01529515|41753168|FG003|DOUBLE BLIND PHASE|Other|2|||
19475661|NCT01528969|41753177|FG000|Overall Study|absent from the school at baseline|2|||
19475662|NCT01528969|41753178|FG001|Overall Study|absent from the school at baseline|0|||
19475663|NCT01514201|41753188|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
19475664|NCT01514201|41753189|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475665|NCT01514201|41753190|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475666|NCT01514201|41753191|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475667|NCT01514201|41753188|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
19475668|NCT01514201|41753189|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
19475669|NCT01514201|41753190|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
19475670|NCT01514201|41753191|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
19475671|NCT01514201|41753188|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
19475672|NCT01514201|41753189|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
19475673|NCT01514201|41753190|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
19475674|NCT01514201|41753191|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
19475675|NCT01514201|41753188|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
19475676|NCT01514201|41753189|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
19475677|NCT01514201|41753190|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
19475678|NCT01514201|41753191|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
19475679|NCT01514201|41753188|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
19475680|NCT01514201|41753189|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
19475681|NCT01514201|41753190|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
19475682|NCT01514201|41753191|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
19475683|NCT01514201|41753188|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
19475684|NCT01514201|41753189|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
19475685|NCT01514201|41753190|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
19475686|NCT01514201|41753191|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
19475687|NCT01514201|41753188|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
19475688|NCT01514201|41753189|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
19475689|NCT01514201|41753190|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
19475690|NCT01514201|41753191|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
19475691|NCT01514201|41753188|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475692|NCT01514201|41753189|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475693|NCT01514201|41753190|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
19475694|NCT01514201|41753191|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
19475695|NCT01514201|41753188|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
19475696|NCT01514201|41753189|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
19475697|NCT01514201|41753190|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
19475698|NCT01514201|41753191|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
19475699|NCT01514201|41753188|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
19475700|NCT01514201|41753189|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
19475701|NCT01514201|41753190|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
19475702|NCT01514201|41753191|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
19475703|NCT01514201|41753188|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
19475704|NCT01514201|41753189|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
19475705|NCT01514201|41753190|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
19475706|NCT01514201|41753191|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
19475707|NCT01514201|41753188|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
19475708|NCT01514201|41753189|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
19475709|NCT01514201|41753190|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
19475710|NCT01514201|41753191|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
19475711|NCT02666664|41753213|FG000|Overall Study|Physician Decision|0|||
19475712|NCT02666664|41753214|FG001|Overall Study|Physician Decision|1|||
19475713|NCT02666664|41753213|FG000|Overall Study|Protocol Violation|0|||
19475714|NCT02666664|41753214|FG001|Overall Study|Protocol Violation|2|||
19475715|NCT02666664|41753213|FG000|Overall Study|Other|0|||
19475716|NCT02666664|41753214|FG001|Overall Study|Other|1|||
19475717|NCT02666664|41753213|FG000|Overall Study|Adverse Event|12|||
19475718|NCT02666664|41753214|FG001|Overall Study|Adverse Event|37|||
19475719|NCT02666664|41753213|FG000|Overall Study|Withdrawal by participant|23|||
19475720|NCT02666664|41753214|FG001|Overall Study|Withdrawal by participant|40|||
19475721|NCT02666664|41753213|FG000|Overall Study|Sponsor decision|0|||
19475722|NCT02666664|41753214|FG001|Overall Study|Sponsor decision|1|||
19475723|NCT02666664|41753213|FG000|Overall Study|Lost to Follow-up|1|||
19475724|NCT02666664|41753214|FG001|Overall Study|Lost to Follow-up|2|||
19475725|NCT01528735|41753222|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
19475726|NCT01528735|41753223|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
19475727|NCT01528735|41753222|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
19475728|NCT01528735|41753223|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
19475729|NCT02661594|41753235|FG000|Overall Study|Protocol Violation|1|||
19475730|NCT02661594|41753236|FG001|Overall Study|Protocol Violation|0|||
19475731|NCT02661594|41753237|FG002|Overall Study|Protocol Violation|1|||
19475732|NCT02661594|41753238|FG003|Overall Study|Protocol Violation|0|||
19475733|NCT01528345|41753250|FG000|Overall Study|Adverse Event|10|||
19475734|NCT01528345|41753251|FG001|Overall Study|Adverse Event|1|||
19475735|NCT01528345|41753250|FG000|Overall Study|Death|1|||
19475736|NCT01528345|41753251|FG001|Overall Study|Death|1|||
19475737|NCT01528345|41753250|FG000|Overall Study|Non-compliance with study treatment|1|||
19475738|NCT01528345|41753251|FG001|Overall Study|Non-compliance with study treatment|0|||
19475739|NCT01528345|41753250|FG000|Overall Study|Progressive Disease|26|||
19475740|NCT01528345|41753251|FG001|Overall Study|Progressive Disease|40|||
19475741|NCT01528345|41753250|FG000|Overall Study|Study Terminated by Sponsor|4|||
19475742|NCT01528345|41753251|FG001|Overall Study|Study Terminated by Sponsor|8|||
19475743|NCT01528345|41753250|FG000|Overall Study|Subject/Guardian Decision|5|||
19475744|NCT01528345|41753251|FG001|Overall Study|Subject/Guardian Decision|0|||
19475745|NCT01513967|41753265|FG000|Overall Study|Pregnancy|0|||
19475746|NCT01513967|41753266|FG001|Overall Study|Pregnancy|0|||
19475747|NCT01513967|41753267|FG002|Overall Study|Pregnancy|0|||
19475748|NCT01513967|41753268|FG003|Overall Study|Pregnancy|0|||
19475749|NCT01513967|41753269|FG004|Overall Study|Pregnancy|0|||
19475750|NCT01513967|41753270|FG005|Overall Study|Pregnancy|0|||
19475751|NCT01513967|41753271|FG006|Overall Study|Pregnancy|1|||
19475752|NCT01513967|41753272|FG007|Overall Study|Pregnancy|0|||
19475753|NCT01513967|41753265|FG000|Overall Study|missed a study visit|0|||
19475754|NCT01513967|41753266|FG001|Overall Study|missed a study visit|0|||
19475755|NCT01513967|41753267|FG002|Overall Study|missed a study visit|0|||
19475756|NCT01513967|41753268|FG003|Overall Study|missed a study visit|0|||
19475757|NCT01513967|41753269|FG004|Overall Study|missed a study visit|0|||
19475758|NCT01513967|41753270|FG005|Overall Study|missed a study visit|0|||
19475759|NCT01513967|41753271|FG006|Overall Study|missed a study visit|1|||
19475760|NCT01513967|41753272|FG007|Overall Study|missed a study visit|0|||
19475761|NCT01513967|41753265|FG000|Overall Study|excluded due to positive drug screen|0|||
19475762|NCT01513967|41753266|FG001|Overall Study|excluded due to positive drug screen|0|||
19475763|NCT01513967|41753267|FG002|Overall Study|excluded due to positive drug screen|0|||
19475764|NCT01513967|41753268|FG003|Overall Study|excluded due to positive drug screen|0|||
19475765|NCT01513967|41753269|FG004|Overall Study|excluded due to positive drug screen|0|||
19475766|NCT01513967|41753270|FG005|Overall Study|excluded due to positive drug screen|0|||
19475767|NCT01513967|41753271|FG006|Overall Study|excluded due to positive drug screen|0|||
19475768|NCT01513967|41753272|FG007|Overall Study|excluded due to positive drug screen|2|||
19475769|NCT01513967|41753265|FG000|Overall Study|Physician Decision|0|||
19475770|NCT01513967|41753266|FG001|Overall Study|Physician Decision|0|||
19475771|NCT01513967|41753267|FG002|Overall Study|Physician Decision|0|||
19475772|NCT01513967|41753268|FG003|Overall Study|Physician Decision|0|||
19475773|NCT01513967|41753269|FG004|Overall Study|Physician Decision|0|||
19475774|NCT01513967|41753270|FG005|Overall Study|Physician Decision|1|||
19475775|NCT01513967|41753271|FG006|Overall Study|Physician Decision|0|||
19475776|NCT01513967|41753272|FG007|Overall Study|Physician Decision|0|||
19475777|NCT01511939|41753316|FG000|Overall Study|Withdrawal by Subject|2|||
19475778|NCT01511939|41753317|FG001|Overall Study|Withdrawal by Subject|1|||
19475779|NCT01511939|41753318|FG002|Overall Study|Withdrawal by Subject|0|||
19475780|NCT01576705|41753330|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
19475781|NCT01576705|41753331|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
19475782|NCT01576705|41753332|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
19475783|NCT01576705|41753333|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
19475784|NCT01576705|41753330|FG000|Overall Study|invalid ICF|0|||
19475785|NCT01576705|41753331|FG001|Overall Study|invalid ICF|1|||
19475786|NCT01576705|41753332|FG002|Overall Study|invalid ICF|0|||
19475787|NCT01576705|41753333|FG003|Overall Study|invalid ICF|0|||
19475788|NCT02666430|41753345|FG000|Period 1|Lost to Follow-up|1|||
19475789|NCT02666430|41753346|FG001|Period 1|Lost to Follow-up|0|||
19475790|NCT02666430|41753345|FG000|Period 1|Adverse Event|0|||
19475791|NCT02666430|41753346|FG001|Period 1|Adverse Event|1|||
19475792|NCT02666430|41753345|FG000|Period 2|Withdrawal by Subject|1|||
19475793|NCT02666430|41753346|FG001|Period 2|Withdrawal by Subject|4|||
19475794|NCT02666430|41753345|FG000|Period 3|Lost to Follow-up|1|||
19475795|NCT02666430|41753346|FG001|Period 3|Lost to Follow-up|0|||
19475796|NCT01576549|41753352|FG000|Overall Study|Sponsor Decision|2|||
19475797|NCT01576159|41753365|FG000|Overall Study|Withdrawal by Subject|0|||
19475798|NCT01576159|41753366|FG001|Overall Study|Withdrawal by Subject|1|||
19475799|NCT01576159|41753367|FG002|Overall Study|Withdrawal by Subject|0|||
19475800|NCT01576159|41753368|FG003|Overall Study|Withdrawal by Subject|0|||
19475801|NCT01576159|41753365|FG000|Overall Study|Physician Decision|0|||
19475802|NCT01576159|41753366|FG001|Overall Study|Physician Decision|0|||
19475803|NCT01576159|41753367|FG002|Overall Study|Physician Decision|1|||
19475804|NCT01576159|41753368|FG003|Overall Study|Physician Decision|0|||
19475805|NCT01576159|41753365|FG000|Overall Study|Lost to Follow-up|0|||
19475806|NCT01576159|41753366|FG001|Overall Study|Lost to Follow-up|0|||
19475807|NCT01576159|41753367|FG002|Overall Study|Lost to Follow-up|0|||
19475808|NCT01576159|41753368|FG003|Overall Study|Lost to Follow-up|1|||
19475809|NCT01576159|41753365|FG000|Overall Study|Protocol Violation|1|||
19475810|NCT01576159|41753366|FG001|Overall Study|Protocol Violation|0|||
19475811|NCT01576159|41753367|FG002|Overall Study|Protocol Violation|0|||
19475812|NCT01576159|41753368|FG003|Overall Study|Protocol Violation|0|||
19475813|NCT01510769|41753399|FG000|Overall Study|Adverse Event|7|||
19475814|NCT01510769|41753400|FG001|Overall Study|Adverse Event|6|||
19475815|NCT01510769|41753401|FG002|Overall Study|Adverse Event|4|||
19475816|NCT01510769|41753399|FG000|Overall Study|Gout Flare|0|||
19475817|NCT01510769|41753400|FG001|Overall Study|Gout Flare|3|||
19475818|NCT01510769|41753401|FG002|Overall Study|Gout Flare|1|||
19475819|NCT01510769|41753399|FG000|Overall Study|Protocol Violation|11|||
19475820|NCT01510769|41753400|FG001|Overall Study|Protocol Violation|10|||
19475821|NCT01510769|41753401|FG002|Overall Study|Protocol Violation|9|||
19475822|NCT01510769|41753399|FG000|Overall Study|Lost to Follow-up|5|||
19475823|NCT01510769|41753400|FG001|Overall Study|Lost to Follow-up|1|||
19475824|NCT01510769|41753401|FG002|Overall Study|Lost to Follow-up|5|||
19478171|NCT01693562|41757325|FG011|Expansion Phase|Other|7|||
19381907|NCT02649231|41625008|FG002|Overall Study|Adverse Event|0|||
19381908|NCT02649231|41625009|FG003|Overall Study|Adverse Event|1|||
19381909|NCT02649231|41625006|FG000|Overall Study|Lost to Follow-up|2|||
19381910|NCT02649231|41625007|FG001|Overall Study|Lost to Follow-up|1|||
19381911|NCT02649231|41625008|FG002|Overall Study|Lost to Follow-up|1|||
19381912|NCT02649231|41625009|FG003|Overall Study|Lost to Follow-up|0|||
19381913|NCT02649231|41625006|FG000|Overall Study|Withdrawal by Subject|0|||
19381914|NCT02649231|41625007|FG001|Overall Study|Withdrawal by Subject|1|||
19381915|NCT02649231|41625008|FG002|Overall Study|Withdrawal by Subject|0|||
19381916|NCT02649231|41625009|FG003|Overall Study|Withdrawal by Subject|1|||
19381917|NCT02649231|41625006|FG000|Overall Study|Protocol Violation|2|||
19381918|NCT02649231|41625007|FG001|Overall Study|Protocol Violation|1|||
19381919|NCT02649231|41625008|FG002|Overall Study|Protocol Violation|1|||
19381920|NCT02649231|41625009|FG003|Overall Study|Protocol Violation|0|||
19475825|NCT01510769|41753399|FG000|Overall Study|Withdrawal by Subject|3|||
19475826|NCT01510769|41753400|FG001|Overall Study|Withdrawal by Subject|4|||
19475827|NCT01510769|41753401|FG002|Overall Study|Withdrawal by Subject|3|||
19475828|NCT01510769|41753399|FG000|Overall Study|Death|1|||
19475829|NCT01510769|41753400|FG001|Overall Study|Death|1|||
19475830|NCT01510769|41753401|FG002|Overall Study|Death|0|||
19475831|NCT01575769|41753409|FG000|Overall Study|Adverse Event|1|||
19475832|NCT01575769|41753409|FG000|Overall Study|Study terminated by sponsor|40|||
19475833|NCT01510145|41753415|FG000|Overall Study|Adverse Event|6|||
19475834|NCT01510145|41753415|FG000|Overall Study|Lost to Follow-up|5|||
19475835|NCT01510145|41753415|FG000|Overall Study|Withdrawal by Subject|6|||
19475836|NCT01510145|41753415|FG000|Overall Study|Relative reported subject withdrew|1|||
19475837|NCT01528033|41753421|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
19475838|NCT01528033|41753422|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
19475839|NCT01528033|41753421|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
19475840|NCT01528033|41753422|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
19475841|NCT01528033|41753421|FG000|Primary Endpoint Assessment ITT|Death|2|||
19475842|NCT01528033|41753422|FG001|Primary Endpoint Assessment ITT|Death|2|||
19475843|NCT01528033|41753421|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
19475844|NCT01528033|41753422|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
19475845|NCT01528033|41753421|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
19475846|NCT01528033|41753422|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
19475847|NCT01528033|41753421|FG000|Follow Up|No data available|46|||
19475848|NCT01528033|41753422|FG001|Follow Up|No data available|44|||
19475849|NCT01560871|41753439|FG000|Overall Study|transportation issues|2|||
19475850|NCT01560871|41753440|FG001|Overall Study|transportation issues|1|||
19475851|NCT01560871|41753439|FG000|Overall Study|relocation|1|||
19475852|NCT01560871|41753440|FG001|Overall Study|relocation|0|||
19475853|NCT01560871|41753439|FG000|Overall Study|readmission to a hospital|2|||
19475854|NCT01560871|41753440|FG001|Overall Study|readmission to a hospital|1|||
19475855|NCT01560871|41753439|FG000|Overall Study|Lost to Follow-up|1|||
19475856|NCT01560871|41753440|FG001|Overall Study|Lost to Follow-up|0|||
19475857|NCT01509053|41753447|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
19475858|NCT01509053|41753447|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
19475859|NCT01509053|41753447|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
19475860|NCT01509053|41753447|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
19475861|NCT01509053|41753447|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
19475862|NCT01509053|41753447|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
19475863|NCT01560403|41753461|FG000|Overall Study|Lost to Follow-up|0|||
19475864|NCT01560403|41753462|FG001|Overall Study|Lost to Follow-up|1|||
19475865|NCT01527487|41753509|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
19475866|NCT01527487|41753510|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
19475867|NCT01527487|41753509|FG000|Overall Study|Disease Progression|4|||
19475868|NCT01527487|41753510|FG001|Overall Study|Disease Progression|1|||
19475869|NCT01527487|41753509|FG000|Overall Study|Adverse Event|1|||
19475870|NCT01527487|41753510|FG001|Overall Study|Adverse Event|1|||
19475871|NCT01527487|41753509|FG000|Overall Study|Death|0|||
19475872|NCT01527487|41753510|FG001|Overall Study|Death|1|||
19475873|NCT01506947|41753521|FG000|Overall Study|Lost to Follow-up|7|||
19475874|NCT01506947|41753521|FG000|Overall Study|Adverse Event|5|||
19475875|NCT01506947|41753521|FG000|Overall Study|Death|1|||
19475876|NCT01506947|41753521|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
19475877|NCT02665338|41753538|FG000|Overall Study|Withdrawal by Subject|0|||
19475878|NCT02665338|41753539|FG001|Overall Study|Withdrawal by Subject|1|||
19475879|NCT01506479|41753548|FG000|Overall Study|Lost to Follow-up|1|||
19475880|NCT01506479|41753549|FG001|Overall Study|Lost to Follow-up|2|||
19475881|NCT01506479|41753550|FG002|Overall Study|Lost to Follow-up|2|||
19475882|NCT01506479|41753548|FG000|Overall Study|Withdrawal by Subject|1|||
19475883|NCT01506479|41753549|FG001|Overall Study|Withdrawal by Subject|2|||
19475884|NCT01506479|41753550|FG002|Overall Study|Withdrawal by Subject|1|||
19475885|NCT01506479|41753548|FG000|Overall Study|Missing assessment|1|||
19475886|NCT01506479|41753549|FG001|Overall Study|Missing assessment|0|||
19475887|NCT01506479|41753550|FG002|Overall Study|Missing assessment|0|||
19475888|NCT01506479|41753548|FG000|Overall Study|Adverse Event|0|||
19475889|NCT01506479|41753549|FG001|Overall Study|Adverse Event|1|||
19475890|NCT01506479|41753550|FG002|Overall Study|Adverse Event|0|||
19475891|NCT01506323|41753574|FG000|Overall Study|Lost to Follow-up|5|||
19475892|NCT01506323|41753575|FG001|Overall Study|Lost to Follow-up|4|||
19475893|NCT01506323|41753574|FG000|Overall Study|Withdrawal by Subject|4|||
19475894|NCT01506323|41753575|FG001|Overall Study|Withdrawal by Subject|4|||
19475895|NCT01506323|41753574|FG000|Overall Study|Lack of Efficacy|1|||
19475896|NCT01506323|41753575|FG001|Overall Study|Lack of Efficacy|3|||
19475897|NCT01506323|41753574|FG000|Overall Study|Moved out of area|5|||
19475898|NCT01506323|41753575|FG001|Overall Study|Moved out of area|2|||
19475899|NCT01506323|41753574|FG000|Overall Study|Schedule or Transportation conflict|8|||
19475900|NCT01506323|41753575|FG001|Overall Study|Schedule or Transportation conflict|0|||
19475901|NCT01506323|41753574|FG000|Overall Study|Started another treatment|1|||
19475902|NCT01506323|41753575|FG001|Overall Study|Started another treatment|0|||
19475903|NCT01505387|41753588|FG000|Overall Study|Protocol Violation|1|||
19475904|NCT01505387|41753589|FG001|Overall Study|Protocol Violation|0|||
19475905|NCT01505387|41753588|FG000|Overall Study|Withdrawal by Subject|1|||
19475906|NCT01505387|41753589|FG001|Overall Study|Withdrawal by Subject|1|||
19475907|NCT01504841|41753686|FG000|Overall Study|Withdrawal by Subject|1|||
19475908|NCT01504841|41753687|FG001|Overall Study|Withdrawal by Subject|1|||
19475909|NCT01504841|41753688|FG002|Overall Study|Withdrawal by Subject|0|||
19475910|NCT01502423|41753701|FG000|Overall Study|Withdrawal by Subject|0|||
19475911|NCT01502423|41753702|FG001|Overall Study|Withdrawal by Subject|1|||
19475912|NCT01502033|41753708|FG000|Overall Study|1 participant had scalp discomfort|1|||
19475913|NCT01502033|41753708|FG000|Overall Study|1 participant had worsening depression|1|||
19475914|NCT01502033|41753708|FG000|Overall Study|1 participant went back to school|1|||
19475915|NCT01500629|41753716|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
19475916|NCT01500629|41753717|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
19475917|NCT01500317|41753733|FG000|Overall Study|Withdrawal by Subject|3|||
19475918|NCT01500317|41753734|FG001|Overall Study|Withdrawal by Subject|2|||
19475919|NCT01500317|41753735|FG002|Overall Study|Withdrawal by Subject|0|||
19475920|NCT01500083|41753790|FG000|Overall Study|Adverse Event|4|||
19475921|NCT01500083|41753791|FG001|Overall Study|Adverse Event|17|||
19475922|NCT01500083|41753790|FG000|Overall Study|Death|0|||
19475923|NCT01500083|41753791|FG001|Overall Study|Death|2|||
19475924|NCT01500083|41753790|FG000|Overall Study|Lost to Follow-up|1|||
19475925|NCT01500083|41753791|FG001|Overall Study|Lost to Follow-up|0|||
19475926|NCT01500083|41753790|FG000|Overall Study|Withdrawal of Consent|0|||
19475927|NCT01500083|41753791|FG001|Overall Study|Withdrawal of Consent|1|||
19475928|NCT01500083|41753790|FG000|Overall Study|Disease Progression|2|||
19475929|NCT01500083|41753791|FG001|Overall Study|Disease Progression|10|||
19475930|NCT01500083|41753790|FG000|Overall Study|Investigator Discretion|3|||
19475931|NCT01500083|41753791|FG001|Overall Study|Investigator Discretion|8|||
19475932|NCT01500083|41753790|FG000|Overall Study|Other Reasons|2|||
19475933|NCT01500083|41753791|FG001|Overall Study|Other Reasons|5|||
19475934|NCT01499849|41753821|FG000|Overall Study|Adverse Event|28|||
19475935|NCT01499849|41753822|FG001|Overall Study|Adverse Event|32|||
19475936|NCT01499849|41753821|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
19475937|NCT01499849|41753822|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
19475938|NCT01499849|41753821|FG000|Overall Study|Withdrawal by Subject|43|||
19475939|NCT01499849|41753822|FG001|Overall Study|Withdrawal by Subject|43|||
19475940|NCT01499849|41753821|FG000|Overall Study|Death|5|||
19475941|NCT01499849|41753822|FG001|Overall Study|Death|7|||
19475942|NCT01499849|41753821|FG000|Overall Study|Disease Progression|11|||
19475943|NCT01499849|41753822|FG001|Overall Study|Disease Progression|10|||
19475944|NCT01499849|41753821|FG000|Overall Study|Protocol Violation|11|||
19475945|NCT01499849|41753822|FG001|Overall Study|Protocol Violation|11|||
19475946|NCT01499849|41753821|FG000|Overall Study|Physician Decision|20|||
19475947|NCT01499849|41753822|FG001|Overall Study|Physician Decision|19|||
19475948|NCT01499849|41753821|FG000|Overall Study|Lack of Efficacy|3|||
19475949|NCT01499849|41753822|FG001|Overall Study|Lack of Efficacy|4|||
19475950|NCT01499849|41753821|FG000|Overall Study|Lost to Follow-up|6|||
19475951|NCT01499849|41753822|FG001|Overall Study|Lost to Follow-up|3|||
19475952|NCT01499849|41753821|FG000|Overall Study|Other Reasons|27|||
19475953|NCT01499849|41753822|FG001|Overall Study|Other Reasons|30|||
19475954|NCT01499303|41753850|FG000|Overall Study|Ongoing|2|||
19475955|NCT01499303|41753851|FG001|Overall Study|Ongoing|1|||
19475956|NCT01499303|41753850|FG000|Overall Study|Withdrawal by Subject|0|||
19475957|NCT01499303|41753851|FG001|Overall Study|Withdrawal by Subject|1|||
19475958|NCT01499303|41753850|FG000|Overall Study|Adverse Event|1|||
19475959|NCT01499303|41753851|FG001|Overall Study|Adverse Event|4|||
19475960|NCT01499303|41753850|FG000|Overall Study|Other|0|||
19475961|NCT01499303|41753851|FG001|Overall Study|Other|1|||
19475962|NCT01498679|41753872|FG000|Overall Study|Adverse Event|1|||
19475963|NCT01498679|41753873|FG001|Overall Study|Adverse Event|4|||
19475964|NCT01498679|41753872|FG000|Overall Study|Lack of Efficacy|72|||
19475965|NCT01498679|41753873|FG001|Overall Study|Lack of Efficacy|12|||
19475966|NCT01498679|41753872|FG000|Overall Study|Protocol Violation|4|||
19475967|NCT01498679|41753873|FG001|Overall Study|Protocol Violation|0|||
19475968|NCT01498679|41753872|FG000|Overall Study|Physician Decision|0|||
19475969|NCT01498679|41753873|FG001|Overall Study|Physician Decision|2|||
19475970|NCT01498679|41753872|FG000|Overall Study|Withdrawal by Subject|12|||
19475971|NCT01498679|41753873|FG001|Overall Study|Withdrawal by Subject|4|||
19475972|NCT01526785|41753896|FG000|Overall Study|Study Terminated by Sponsor|8|||
19475973|NCT01526785|41753896|FG000|Overall Study|Death|2|||
19475974|NCT01526785|41753896|FG000|Overall Study|Physician Decision|1|||
19475975|NCT01526785|41753896|FG000|Overall Study|Withdrawal by Subject|2|||
19475976|NCT01559389|41753902|FG000|Overall Study|Withdrawal by Subject|20|||
19475977|NCT01559389|41753903|FG001|Overall Study|Withdrawal by Subject|20|||
19475978|NCT01526551|41753913|FG000|Overall Study|Lack of returned parental consent form|424|||
19475979|NCT01559311|41753991|FG000|Overall Study|Protocol Violation|0|||
19475980|NCT01559311|41753992|FG001|Overall Study|Protocol Violation|0|||
19475981|NCT01559311|41753993|FG002|Overall Study|Protocol Violation|2|||
19475982|NCT01559311|41753991|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
19475983|NCT01559311|41753992|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
19475984|NCT01559311|41753993|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
19475985|NCT01559311|41753991|FG000|Overall Study|Withdrawal by Subject|2|||
19475986|NCT01559311|41753992|FG001|Overall Study|Withdrawal by Subject|1|||
19475987|NCT01559311|41753993|FG002|Overall Study|Withdrawal by Subject|0|||
19475988|NCT01559311|41753991|FG000|Overall Study|Death|0|||
19475989|NCT01559311|41753992|FG001|Overall Study|Death|2|||
19475990|NCT01559311|41753993|FG002|Overall Study|Death|3|||
19475991|NCT01559311|41753991|FG000|Overall Study|Lost to Follow-up|0|||
19475992|NCT01559311|41753992|FG001|Overall Study|Lost to Follow-up|3|||
19475993|NCT01559311|41753993|FG002|Overall Study|Lost to Follow-up|2|||
19475994|NCT01559311|41753991|FG000|Overall Study|Adverse Event|0|||
19475995|NCT01559311|41753992|FG001|Overall Study|Adverse Event|0|||
19475996|NCT01559311|41753993|FG002|Overall Study|Adverse Event|1|||
19475997|NCT01498445|41754016|FG000|Overall Study|Lack of Efficacy|0|||
19475998|NCT01498445|41754017|FG001|Overall Study|Lack of Efficacy|0|||
19475999|NCT01498445|41754018|FG002|Overall Study|Lack of Efficacy|1|||
19476000|NCT01498445|41754019|FG003|Overall Study|Lack of Efficacy|2|||
19476001|NCT01498445|41754020|FG004|Overall Study|Lack of Efficacy|0|||
19476002|NCT01498445|41754021|FG005|Overall Study|Lack of Efficacy|0|||
19476003|NCT01498445|41754016|FG000|Overall Study|Screen Failure|0|||
19476004|NCT01498445|41754017|FG001|Overall Study|Screen Failure|0|||
19476005|NCT01498445|41754018|FG002|Overall Study|Screen Failure|0|||
19476006|NCT01498445|41754019|FG003|Overall Study|Screen Failure|0|||
19476007|NCT01498445|41754020|FG004|Overall Study|Screen Failure|1|||
19476008|NCT01498445|41754021|FG005|Overall Study|Screen Failure|1|||
19476009|NCT01558297|41754038|FG000|Overall Study|Withdrawal by Subject|2|||
19476010|NCT01558297|41754039|FG001|Overall Study|Withdrawal by Subject|2|||
19476011|NCT01558297|41754040|FG002|Overall Study|Withdrawal by Subject|1|||
19476012|NCT01525849|41754050|FG000|Overall Study|Lost to Follow-up|3|||
19476013|NCT01525849|41754051|FG001|Overall Study|Lost to Follow-up|2|||
19476014|NCT01525849|41754050|FG000|Overall Study|Withdrawal by Subject|1|||
19476015|NCT01525849|41754051|FG001|Overall Study|Withdrawal by Subject|9|||
19476016|NCT01525849|41754050|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
19476017|NCT01525849|41754051|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
19476018|NCT01525849|41754050|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
19476019|NCT01525849|41754051|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
19476020|NCT01525615|41754070|FG000|Overall Study|Adverse Event|11|||
19476021|NCT01525615|41754071|FG001|Overall Study|Adverse Event|7|||
19476022|NCT01525615|41754072|FG002|Overall Study|Adverse Event|5|||
19476023|NCT01525615|41754070|FG000|Overall Study|Lost to Follow-up|1|||
19476024|NCT01525615|41754071|FG001|Overall Study|Lost to Follow-up|0|||
19476025|NCT01525615|41754072|FG002|Overall Study|Lost to Follow-up|0|||
19476026|NCT01525615|41754070|FG000|Overall Study|Withdrawal by Subject|1|||
19476027|NCT01525615|41754071|FG001|Overall Study|Withdrawal by Subject|0|||
19476028|NCT01525615|41754072|FG002|Overall Study|Withdrawal by Subject|0|||
19476029|NCT01525615|41754070|FG000|Overall Study|Other reason not described above|1|||
19476030|NCT01525615|41754071|FG001|Overall Study|Other reason not described above|0|||
19476031|NCT01525615|41754072|FG002|Overall Study|Other reason not described above|1|||
19476032|NCT01525225|41754114|FG000|Enrollment|No longer met study criteria|1|||
19476033|NCT01525225|41754114|FG000|Enrollment|Other|1|||
19476034|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
19476035|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
19476036|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
19476037|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
19476038|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
19476039|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
19476040|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
19476041|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
19476042|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
19476043|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
19476044|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
19476045|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
19476046|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
19476047|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
19476048|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
19476049|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
19476050|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
19476051|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
19476052|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
19476053|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
19476054|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
19476055|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
19476056|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
19476057|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
19476058|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
19476059|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
19476060|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
19476061|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
19476062|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
19476063|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
19476064|NCT02660580|41754133|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
19476065|NCT02660580|41754134|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
19476066|NCT02660580|41754135|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
19476067|NCT02660580|41754136|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
19476068|NCT02660580|41754137|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
19476069|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
19476070|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
19476071|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
19476072|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
19476073|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
19476074|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
19476075|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
19476076|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
19476077|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
19476078|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
19476079|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
19476080|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
19476081|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
19476082|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
19476083|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
19476084|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
19476085|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
19476086|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
19476087|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
19476088|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
19476089|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
19476090|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
19476091|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
19476092|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
19476093|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
19476094|NCT02660580|41754133|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
19476095|NCT02660580|41754134|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
19476096|NCT02660580|41754135|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
19476097|NCT02660580|41754136|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
19476098|NCT02660580|41754137|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
19476099|NCT01524991|41754156|FG000|Overall Study|Adverse Event|12|||
19476100|NCT01524991|41754156|FG000|Overall Study|Death|1|||
19476101|NCT01524991|41754156|FG000|Overall Study|Disease ProgressionDu|17|||
19476102|NCT01524991|41754156|FG000|Overall Study|Other complicating disease|1|||
19476103|NCT01524991|41754156|FG000|Overall Study|Withdrawal by Subject|2|||
19476104|NCT01524991|41754156|FG000|Overall Study|Symptomatic Deterioration|1|||
19476105|NCT01524913|41754163|FG000|Overall Study|Lost to Follow-up|4|||
19476106|NCT01524913|41754164|FG001|Overall Study|Lost to Follow-up|0|||
19476107|NCT01524913|41754165|FG002|Overall Study|Lost to Follow-up|0|||
19476108|NCT01524679|41754175|FG000|Overall Study|Lost to Follow-up|1|||
19476109|NCT01524679|41754176|FG001|Overall Study|Lost to Follow-up|4|||
19476110|NCT01524679|41754175|FG000|Overall Study|Withdrawal by Subject|4|||
19476111|NCT01524679|41754176|FG001|Overall Study|Withdrawal by Subject|4|||
19476112|NCT01524679|41754175|FG000|Overall Study|Adverse Event|9|||
19476113|NCT01524679|41754176|FG001|Overall Study|Adverse Event|0|||
19476114|NCT01524679|41754175|FG000|Overall Study|Protocol Violation|1|||
19476115|NCT01524679|41754176|FG001|Overall Study|Protocol Violation|0|||
19476116|NCT01524679|41754175|FG000|Overall Study|Lack of Efficacy|2|||
19476117|NCT01524679|41754176|FG001|Overall Study|Lack of Efficacy|0|||
19476118|NCT01524679|41754175|FG000|Overall Study|e.g.wish for children, relocation|6|||
19476119|NCT01524679|41754176|FG001|Overall Study|e.g.wish for children, relocation|1|||
19476120|NCT01524289|41754184|FG000|Overall Study|Lost to Follow-up|0|||
19476121|NCT01524289|41754185|FG001|Overall Study|Lost to Follow-up|1|||
19476122|NCT01524289|41754184|FG000|Overall Study|Physician Decision|1|||
19476123|NCT01524289|41754185|FG001|Overall Study|Physician Decision|0|||
19476124|NCT01524289|41754184|FG000|Overall Study|Protocol Violation|5|||
19476125|NCT01524289|41754185|FG001|Overall Study|Protocol Violation|1|||
19476126|NCT01524289|41754184|FG000|Overall Study|Withdrawal by Subject|11|||
19476127|NCT01524289|41754185|FG001|Overall Study|Withdrawal by Subject|7|||
19476128|NCT01524289|41754184|FG000|Overall Study|Adverse Event|12|||
19476129|NCT01524289|41754185|FG001|Overall Study|Adverse Event|5|||
19476130|NCT01524289|41754184|FG000|Overall Study|Did not take study medication|1|||
19476131|NCT01524289|41754185|FG001|Overall Study|Did not take study medication|0|||
19476132|NCT01498289|41754195|FG000|Overall Study|Adverse Event|16|||
19476133|NCT01498289|41754196|FG001|Overall Study|Adverse Event|18|||
19476134|NCT01498289|41754195|FG000|Overall Study|Death|6|||
19476135|NCT01498289|41754196|FG001|Overall Study|Death|8|||
19476136|NCT01498289|41754195|FG000|Overall Study|Withdrawal unrelated to AE|16|||
19476137|NCT01498289|41754196|FG001|Overall Study|Withdrawal unrelated to AE|16|||
19476138|NCT01498289|41754195|FG000|Overall Study|Progression/relapse|53|||
19476139|NCT01498289|41754196|FG001|Overall Study|Progression/relapse|59|||
19476140|NCT01498289|41754195|FG000|Overall Study|Not protocol specified|7|||
19476141|NCT01498289|41754196|FG001|Overall Study|Not protocol specified|2|||
19476142|NCT01498289|41754195|FG000|Overall Study|Reason under review|0|||
19476143|NCT01498289|41754196|FG001|Overall Study|Reason under review|1|||
19476144|NCT01524133|41754209|FG000|Treatment Phase|Withdrawal by Subject|13|||
19476145|NCT01524133|41754210|FG001|Treatment Phase|Withdrawal by Subject|28|||
19476146|NCT01524133|41754211|FG002|Treatment Phase|Withdrawal by Subject|31|||
19476147|NCT01524133|41754209|FG000|Treatment Phase|Physician Decision|6|||
19476148|NCT01524133|41754210|FG001|Treatment Phase|Physician Decision|3|||
19476149|NCT01524133|41754211|FG002|Treatment Phase|Physician Decision|3|||
19476150|NCT01524133|41754209|FG000|Treatment Phase|Lost to Follow-up|0|||
19476151|NCT01524133|41754210|FG001|Treatment Phase|Lost to Follow-up|1|||
19476152|NCT01524133|41754211|FG002|Treatment Phase|Lost to Follow-up|2|||
19476153|NCT01524133|41754209|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
19476154|NCT01524133|41754210|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
19476155|NCT01524133|41754211|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
19476156|NCT01524133|41754209|FG000|Overall Study 52 Weeks|Physician Decision|1|||
19476157|NCT01524133|41754210|FG001|Overall Study 52 Weeks|Physician Decision|0|||
19476158|NCT01524133|41754211|FG002|Overall Study 52 Weeks|Physician Decision|2|||
19476159|NCT01524133|41754209|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
19476160|NCT01524133|41754210|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
19476161|NCT01524133|41754211|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
19476162|NCT04304534|41754236|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
19476163|NCT04304534|41754237|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
19476164|NCT04304534|41754238|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
19476165|NCT04304534|41754239|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
19476166|NCT04304534|41754236|FG000|Overall Study|Non-Compliance with study drug|0|||
19476167|NCT04304534|41754237|FG001|Overall Study|Non-Compliance with study drug|1|||
19476168|NCT04304534|41754238|FG002|Overall Study|Non-Compliance with study drug|1|||
19476169|NCT04304534|41754239|FG003|Overall Study|Non-Compliance with study drug|1|||
19476170|NCT04304534|41754236|FG000|Overall Study|Lost to Follow-up|0|||
19381921|NCT01376245|41625023|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
19381922|NCT01376245|41625024|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
19381923|NCT01376245|41625025|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
19381924|NCT01376245|41625026|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
19381925|NCT01376245|41625027|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
19381926|NCT01376245|41625023|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
19381927|NCT01376245|41625024|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
19381928|NCT01376245|41625025|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
19381929|NCT01376245|41625026|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
19381930|NCT01376245|41625027|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
19381931|NCT01376245|41625023|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
19381932|NCT01376245|41625024|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
19381933|NCT01376245|41625025|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
19381934|NCT01376245|41625026|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
19381935|NCT01376245|41625027|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
19476171|NCT04304534|41754237|FG001|Overall Study|Lost to Follow-up|1|||
19476172|NCT04304534|41754238|FG002|Overall Study|Lost to Follow-up|2|||
19476173|NCT04304534|41754239|FG003|Overall Study|Lost to Follow-up|3|||
19476174|NCT04304534|41754236|FG000|Overall Study|Unspecific|4|||
19381936|NCT01376245|41625023|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
19381937|NCT01376245|41625024|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
19381938|NCT01376245|41625025|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
19381939|NCT01376245|41625026|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
19381940|NCT01376245|41625027|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
19381941|NCT01376245|41625023|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
19381942|NCT01376245|41625024|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
19390349|NCT01987960|41634113|FG003|Period 2|Adverse Event|0|||
19476175|NCT04304534|41754237|FG001|Overall Study|Unspecific|2|||
19476176|NCT04304534|41754238|FG002|Overall Study|Unspecific|2|||
19476177|NCT04304534|41754239|FG003|Overall Study|Unspecific|2|||
19476178|NCT04304534|41754236|FG000|Overall Study|Technical Problems|2|||
19476179|NCT04304534|41754237|FG001|Overall Study|Technical Problems|2|||
19476180|NCT04304534|41754238|FG002|Overall Study|Technical Problems|3|||
19476181|NCT04304534|41754239|FG003|Overall Study|Technical Problems|4|||
19476182|NCT04304534|41754236|FG000|Overall Study|Death|7|||
19476183|NCT04304534|41754237|FG001|Overall Study|Death|2|||
19476184|NCT04304534|41754238|FG002|Overall Study|Death|4|||
19476185|NCT04304534|41754239|FG003|Overall Study|Death|3|||
19476186|NCT04304534|41754236|FG000|Overall Study|Withdrawal by Subject|7|||
19476187|NCT04304534|41754237|FG001|Overall Study|Withdrawal by Subject|2|||
19476188|NCT04304534|41754238|FG002|Overall Study|Withdrawal by Subject|7|||
19476189|NCT04304534|41754239|FG003|Overall Study|Withdrawal by Subject|4|||
19476190|NCT04304534|41754236|FG000|Overall Study|Physician Decision|4|||
19476191|NCT04304534|41754237|FG001|Overall Study|Physician Decision|9|||
19476192|NCT04304534|41754238|FG002|Overall Study|Physician Decision|9|||
19476193|NCT04304534|41754239|FG003|Overall Study|Physician Decision|5|||
19476194|NCT04304534|41754236|FG000|Overall Study|Subject Decision|34|||
19476195|NCT04304534|41754237|FG001|Overall Study|Subject Decision|25|||
19476196|NCT04304534|41754238|FG002|Overall Study|Subject Decision|25|||
19476197|NCT04304534|41754239|FG003|Overall Study|Subject Decision|26|||
19476198|NCT04304534|41754236|FG000|Overall Study|Adverse Event|35|||
19476199|NCT04304534|41754237|FG001|Overall Study|Adverse Event|40|||
19476200|NCT04304534|41754238|FG002|Overall Study|Adverse Event|39|||
19476201|NCT04304534|41754239|FG003|Overall Study|Adverse Event|44|||
19476202|NCT04223609|41754252|FG000|Overall Study|Adverse Event|0|||
19476203|NCT04223609|41754253|FG001|Overall Study|Adverse Event|1|||
19476204|NCT04223609|41754252|FG000|Overall Study|Missed last visit|0|||
19476205|NCT04223609|41754253|FG001|Overall Study|Missed last visit|1|||
19476206|NCT04176458|41754259|FG000|Overall Study|Covid 19|4|||
19476207|NCT03941548|41754265|FG000|Overall Study|Adverse Event|0|||
19476208|NCT03941548|41754266|FG001|Overall Study|Adverse Event|1|||
19476209|NCT03941548|41754265|FG000|Overall Study|Lost to Follow-up|0|||
19476210|NCT03941548|41754266|FG001|Overall Study|Lost to Follow-up|1|||
19476211|NCT03941548|41754265|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
19476212|NCT03941548|41754266|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
19476213|NCT03925727|41754275|FG000|Overall Study|Adverse Event|4|||
19476214|NCT03925727|41754276|FG001|Overall Study|Adverse Event|0|||
19476215|NCT03925727|41754277|FG002|Overall Study|Adverse Event|3|||
19476216|NCT03925727|41754275|FG000|Overall Study|Protocol Violation|1|||
19476217|NCT03925727|41754276|FG001|Overall Study|Protocol Violation|2|||
19476218|NCT03925727|41754277|FG002|Overall Study|Protocol Violation|2|||
19476219|NCT03925727|41754275|FG000|Overall Study|Withdrawal by Subject|3|||
19476220|NCT03925727|41754276|FG001|Overall Study|Withdrawal by Subject|2|||
19476221|NCT03925727|41754277|FG002|Overall Study|Withdrawal by Subject|4|||
19476222|NCT03925727|41754275|FG000|Overall Study|Administrative Reasons|3|||
19476223|NCT03925727|41754276|FG001|Overall Study|Administrative Reasons|1|||
19476224|NCT03925727|41754277|FG002|Overall Study|Administrative Reasons|2|||
19476225|NCT03925727|41754275|FG000|Overall Study|Randomized in error or Disqualified|8|||
19381943|NCT01376245|41625025|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
19381944|NCT01376245|41625026|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
19381945|NCT01376245|41625027|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
19381946|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
19381947|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
19381948|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
19381949|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
19381950|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
19381951|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
19381952|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
19381953|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
19381954|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
19381955|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
19381956|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
19381957|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
19381958|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
19381959|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
19381960|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
19381961|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
19381962|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
19381963|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
19381964|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
19381965|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
19381966|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19381967|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
19381968|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19381969|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
19381970|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
19476226|NCT03925727|41754276|FG001|Overall Study|Randomized in error or Disqualified|1|||
19476227|NCT03925727|41754277|FG002|Overall Study|Randomized in error or Disqualified|7|||
19476228|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
19476229|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
19476230|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
19476231|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
19476232|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
19476233|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
19476234|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
19476235|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
19476236|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
19476237|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
19476238|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
19476239|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
19476240|NCT03493854|41754289|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
19476241|NCT03493854|41754290|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
19476242|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
19476243|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
19476244|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
19476245|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
19476246|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
19476247|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
19476248|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
19476249|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
19476250|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
19476251|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
19476252|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
19476253|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
19476254|NCT03493854|41754289|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
19476255|NCT03493854|41754290|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
19476256|NCT03493854|41754289|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
19476257|NCT03493854|41754290|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
19476258|NCT03493854|41754289|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
19476259|NCT03493854|41754290|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
19639192|NCT00719810|42088581|FG000|Overall Study|Lost to Follow-up|2|||
19639193|NCT00719810|42088582|FG001|Overall Study|Lost to Follow-up|0|||
19639194|NCT00719810|42088583|FG002|Overall Study|Lost to Follow-up|3|||
19639195|NCT00719810|42088581|FG000|Overall Study|Physician Decision|0|||
19639196|NCT00719810|42088582|FG001|Overall Study|Physician Decision|1|||
19639197|NCT00719810|42088583|FG002|Overall Study|Physician Decision|0|||
19639198|NCT00719810|42088581|FG000|Overall Study|Withdrawal by Subject|1|||
19639199|NCT00719810|42088582|FG001|Overall Study|Withdrawal by Subject|1|||
19639200|NCT00719810|42088583|FG002|Overall Study|Withdrawal by Subject|2|||
19639201|NCT00719732|42088591|FG000|Overall Study|Lost to Follow-up|20|||
19639202|NCT00719732|42088591|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
19639203|NCT00719732|42088591|FG000|Overall Study|Illness not associated with device|1|||
19639204|NCT00723710|42088595|FG000|Overall Study|Disease progression|48|||
19639205|NCT00723710|42088595|FG000|Overall Study|Adverse Event|88|||
19639206|NCT00723710|42088595|FG000|Overall Study|Withdrawal by Subject|36|||
19639207|NCT00723710|42088595|FG000|Overall Study|Physician Decision|2|||
19476276|NCT03387150|41754312|FG000|Overall Study|Withdrawal by Subject|3|||
19476277|NCT03387150|41754313|FG001|Overall Study|Withdrawal by Subject|0|||
19476278|NCT03387150|41754314|FG002|Overall Study|Withdrawal by Subject|3|||
19476279|NCT03387150|41754315|FG003|Overall Study|Withdrawal by Subject|4|||
19476280|NCT03387150|41754316|FG004|Overall Study|Withdrawal by Subject|1|||
19476281|NCT03387150|41754317|FG005|Overall Study|Withdrawal by Subject|2|||
19476282|NCT03387150|41754318|FG006|Overall Study|Withdrawal by Subject|0|||
19476283|NCT03387150|41754312|FG000|Overall Study|Lost to Follow-up|3|||
19476284|NCT03387150|41754313|FG001|Overall Study|Lost to Follow-up|2|||
19476285|NCT03387150|41754314|FG002|Overall Study|Lost to Follow-up|2|||
19476286|NCT03387150|41754315|FG003|Overall Study|Lost to Follow-up|3|||
19476287|NCT03387150|41754316|FG004|Overall Study|Lost to Follow-up|3|||
19476288|NCT03387150|41754317|FG005|Overall Study|Lost to Follow-up|3|||
19476289|NCT03387150|41754318|FG006|Overall Study|Lost to Follow-up|0|||
19476290|NCT03387150|41754312|FG000|Overall Study|Participant unable to adhere to visit|0|||
19476291|NCT03387150|41754313|FG001|Overall Study|Participant unable to adhere to visit|1|||
19476292|NCT03387150|41754314|FG002|Overall Study|Participant unable to adhere to visit|0|||
19381971|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
19476293|NCT03387150|41754315|FG003|Overall Study|Participant unable to adhere to visit|0|||
19476294|NCT03387150|41754316|FG004|Overall Study|Participant unable to adhere to visit|2|||
19476295|NCT03387150|41754317|FG005|Overall Study|Participant unable to adhere to visit|2|||
19476296|NCT03387150|41754318|FG006|Overall Study|Participant unable to adhere to visit|0|||
19476297|NCT03289208|41754350|FG000|Overall Study|Adverse Event|1|||
19639208|NCT00688545|42088601|FG000|Overall Study|Lost to Follow-up|1|||
19639209|NCT00688545|42088602|FG001|Overall Study|Lost to Follow-up|4|||
19639210|NCT00688545|42088601|FG000|Overall Study|Insurance/cost of drug|0|||
19639211|NCT00688545|42088602|FG001|Overall Study|Insurance/cost of drug|1|||
19639212|NCT00688545|42088601|FG000|Overall Study|Withdrawal by Subject|2|||
19639213|NCT00688545|42088602|FG001|Overall Study|Withdrawal by Subject|3|||
19639214|NCT00688545|42088601|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
19639215|NCT00688545|42088602|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
19639216|NCT00688467|42088612|FG000|Treatment Period 1|Adverse Event|2|||
19639217|NCT00688467|42088613|FG001|Treatment Period 1|Adverse Event|1|||
19476298|NCT03289208|41754351|FG001|Overall Study|Adverse Event|0|||
19476299|NCT03289208|41754352|FG002|Overall Study|Adverse Event|0|||
19476300|NCT03036566|41754382|FG000|Overall Study|Lost to Follow-up|3|||
19476301|NCT02754141|41754413|FG000|Overall Study|Disease progression|11|||
19476302|NCT02754141|41754414|FG001|Overall Study|Disease progression|7|||
19476303|NCT02754141|41754415|FG002|Overall Study|Disease progression|8|||
19476304|NCT02754141|41754416|FG003|Overall Study|Disease progression|5|||
19476305|NCT02754141|41754417|FG004|Overall Study|Disease progression|7|||
19476306|NCT02754141|41754418|FG005|Overall Study|Disease progression|7|||
19476307|NCT02754141|41754419|FG006|Overall Study|Disease progression|7|||
19476308|NCT02754141|41754420|FG007|Overall Study|Disease progression|6|||
19476309|NCT02754141|41754421|FG008|Overall Study|Disease progression|11|||
19476310|NCT02754141|41754422|FG009|Overall Study|Disease progression|16|||
19476311|NCT02754141|41754423|FG010|Overall Study|Disease progression|18|||
19476312|NCT02754141|41754424|FG011|Overall Study|Disease progression|13|||
19476313|NCT02754141|41754425|FG012|Overall Study|Disease progression|10|||
19476314|NCT02754141|41754426|FG013|Overall Study|Disease progression|12|||
19476315|NCT02754141|41754427|FG014|Overall Study|Disease progression|12|||
19476316|NCT02754141|41754428|FG015|Overall Study|Disease progression|14|||
19381972|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
19381973|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
19381974|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
19381975|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
19381976|NCT01376245|41625023|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19381977|NCT01376245|41625024|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
19381978|NCT01376245|41625025|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
19381979|NCT01376245|41625026|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
19476317|NCT02754141|41754429|FG016|Overall Study|Disease progression|0|||
19476318|NCT02754141|41754430|FG017|Overall Study|Disease progression|1|||
19476319|NCT02754141|41754413|FG000|Overall Study|Study drug toxicity|1|||
19476320|NCT02754141|41754414|FG001|Overall Study|Study drug toxicity|1|||
19476321|NCT02754141|41754415|FG002|Overall Study|Study drug toxicity|0|||
19739408|NCT03519867|42186491|FG006|Overall Study|Protocol Violation|0|||
19739409|NCT03519867|42186492|FG007|Overall Study|Protocol Violation|0|||
19739410|NCT03519867|42186493|FG008|Overall Study|Protocol Violation|0|||
19476322|NCT02754141|41754416|FG003|Overall Study|Study drug toxicity|0|||
19476323|NCT02754141|41754417|FG004|Overall Study|Study drug toxicity|0|||
19476324|NCT02754141|41754418|FG005|Overall Study|Study drug toxicity|0|||
19476325|NCT02754141|41754419|FG006|Overall Study|Study drug toxicity|0|||
19476326|NCT02754141|41754420|FG007|Overall Study|Study drug toxicity|0|||
19476327|NCT02754141|41754421|FG008|Overall Study|Study drug toxicity|0|||
19476328|NCT02754141|41754422|FG009|Overall Study|Study drug toxicity|0|||
19476329|NCT02754141|41754423|FG010|Overall Study|Study drug toxicity|2|||
19476330|NCT02754141|41754424|FG011|Overall Study|Study drug toxicity|1|||
19476331|NCT02754141|41754425|FG012|Overall Study|Study drug toxicity|1|||
19476332|NCT02754141|41754426|FG013|Overall Study|Study drug toxicity|0|||
19476333|NCT02754141|41754427|FG014|Overall Study|Study drug toxicity|0|||
19476334|NCT02754141|41754428|FG015|Overall Study|Study drug toxicity|0|||
19476335|NCT02754141|41754429|FG016|Overall Study|Study drug toxicity|0|||
19476336|NCT02754141|41754430|FG017|Overall Study|Study drug toxicity|0|||
19476337|NCT02754141|41754413|FG000|Overall Study|AE unrelated to study drug|1|||
19476338|NCT02754141|41754414|FG001|Overall Study|AE unrelated to study drug|1|||
19476339|NCT02754141|41754415|FG002|Overall Study|AE unrelated to study drug|0|||
19476340|NCT02754141|41754416|FG003|Overall Study|AE unrelated to study drug|1|||
19476341|NCT02754141|41754417|FG004|Overall Study|AE unrelated to study drug|3|||
19476342|NCT02754141|41754418|FG005|Overall Study|AE unrelated to study drug|2|||
19476343|NCT02754141|41754419|FG006|Overall Study|AE unrelated to study drug|1|||
19476344|NCT02754141|41754420|FG007|Overall Study|AE unrelated to study drug|0|||
19476345|NCT02754141|41754421|FG008|Overall Study|AE unrelated to study drug|0|||
19476346|NCT02754141|41754422|FG009|Overall Study|AE unrelated to study drug|0|||
19476347|NCT02754141|41754423|FG010|Overall Study|AE unrelated to study drug|0|||
19476348|NCT02754141|41754424|FG011|Overall Study|AE unrelated to study drug|0|||
19381980|NCT01376245|41625027|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
19381981|NCT01674621|41625042|FG000|Overall Study|Adverse Event|3|||
19381982|NCT01674621|41625043|FG001|Overall Study|Adverse Event|2|||
19381983|NCT01674621|41625044|FG002|Overall Study|Adverse Event|5|||
19381984|NCT01674621|41625045|FG003|Overall Study|Adverse Event|5|||
19381985|NCT01674621|41625046|FG004|Overall Study|Adverse Event|1|||
19381986|NCT01674621|41625042|FG000|Overall Study|Inability to Complete Study Procedures|0|||
19476349|NCT02754141|41754425|FG012|Overall Study|AE unrelated to study drug|0|||
19476350|NCT02754141|41754426|FG013|Overall Study|AE unrelated to study drug|0|||
19476351|NCT02754141|41754427|FG014|Overall Study|AE unrelated to study drug|0|||
19381987|NCT01674621|41625043|FG001|Overall Study|Inability to Complete Study Procedures|0|||
19476352|NCT02754141|41754428|FG015|Overall Study|AE unrelated to study drug|0|||
19381988|NCT01674621|41625044|FG002|Overall Study|Inability to Complete Study Procedures|0|||
19381989|NCT01674621|41625045|FG003|Overall Study|Inability to Complete Study Procedures|0|||
19381990|NCT01674621|41625046|FG004|Overall Study|Inability to Complete Study Procedures|2|||
19381991|NCT01674621|41625042|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
19381992|NCT01674621|41625043|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
19390350|NCT01987960|41634110|FG000|Period 2|Withdrawal by Subject|0|||
19476353|NCT02754141|41754429|FG016|Overall Study|AE unrelated to study drug|0|||
19381993|NCT01674621|41625044|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
19476354|NCT02754141|41754430|FG017|Overall Study|AE unrelated to study drug|0|||
19476355|NCT02754141|41754413|FG000|Overall Study|Request to discontinue|0|||
19476356|NCT02754141|41754414|FG001|Overall Study|Request to discontinue|0|||
19476357|NCT02754141|41754415|FG002|Overall Study|Request to discontinue|0|||
19476358|NCT02754141|41754416|FG003|Overall Study|Request to discontinue|0|||
19476359|NCT02754141|41754417|FG004|Overall Study|Request to discontinue|0|||
19476360|NCT02754141|41754418|FG005|Overall Study|Request to discontinue|0|||
19476361|NCT02754141|41754419|FG006|Overall Study|Request to discontinue|0|||
19476362|NCT02754141|41754420|FG007|Overall Study|Request to discontinue|0|||
19476363|NCT02754141|41754421|FG008|Overall Study|Request to discontinue|1|||
19476364|NCT02754141|41754422|FG009|Overall Study|Request to discontinue|0|||
19476365|NCT02754141|41754423|FG010|Overall Study|Request to discontinue|0|||
19476366|NCT02754141|41754424|FG011|Overall Study|Request to discontinue|0|||
19476367|NCT02754141|41754425|FG012|Overall Study|Request to discontinue|0|||
19476368|NCT02754141|41754426|FG013|Overall Study|Request to discontinue|1|||
19476369|NCT02754141|41754427|FG014|Overall Study|Request to discontinue|1|||
19476370|NCT02754141|41754428|FG015|Overall Study|Request to discontinue|0|||
19476371|NCT02754141|41754429|FG016|Overall Study|Request to discontinue|0|||
19476372|NCT02754141|41754430|FG017|Overall Study|Request to discontinue|0|||
19476373|NCT02754141|41754413|FG000|Overall Study|Withdrew consent|0|||
19476374|NCT02754141|41754414|FG001|Overall Study|Withdrew consent|0|||
19476375|NCT02754141|41754415|FG002|Overall Study|Withdrew consent|0|||
19476376|NCT02754141|41754416|FG003|Overall Study|Withdrew consent|0|||
19476377|NCT02754141|41754417|FG004|Overall Study|Withdrew consent|0|||
19476378|NCT02754141|41754418|FG005|Overall Study|Withdrew consent|0|||
19476379|NCT02754141|41754419|FG006|Overall Study|Withdrew consent|0|||
19476380|NCT02754141|41754420|FG007|Overall Study|Withdrew consent|0|||
19476381|NCT02754141|41754421|FG008|Overall Study|Withdrew consent|0|||
19476382|NCT02754141|41754422|FG009|Overall Study|Withdrew consent|1|||
19476383|NCT02754141|41754423|FG010|Overall Study|Withdrew consent|0|||
19476384|NCT02754141|41754424|FG011|Overall Study|Withdrew consent|0|||
19476385|NCT02754141|41754425|FG012|Overall Study|Withdrew consent|0|||
19476386|NCT02754141|41754426|FG013|Overall Study|Withdrew consent|0|||
19476387|NCT02754141|41754427|FG014|Overall Study|Withdrew consent|0|||
19476388|NCT02754141|41754428|FG015|Overall Study|Withdrew consent|0|||
19476389|NCT02754141|41754429|FG016|Overall Study|Withdrew consent|0|||
19476390|NCT02754141|41754430|FG017|Overall Study|Withdrew consent|0|||
19476391|NCT02754141|41754413|FG000|Overall Study|Maximum clinical benefit|0|||
19476392|NCT02754141|41754414|FG001|Overall Study|Maximum clinical benefit|0|||
19476393|NCT02754141|41754415|FG002|Overall Study|Maximum clinical benefit|0|||
19476394|NCT02754141|41754416|FG003|Overall Study|Maximum clinical benefit|1|||
19476395|NCT02754141|41754417|FG004|Overall Study|Maximum clinical benefit|0|||
19476396|NCT02754141|41754418|FG005|Overall Study|Maximum clinical benefit|0|||
19476397|NCT02754141|41754419|FG006|Overall Study|Maximum clinical benefit|0|||
19476398|NCT02754141|41754420|FG007|Overall Study|Maximum clinical benefit|0|||
19476399|NCT02754141|41754421|FG008|Overall Study|Maximum clinical benefit|0|||
19476400|NCT02754141|41754422|FG009|Overall Study|Maximum clinical benefit|0|||
19476401|NCT02754141|41754423|FG010|Overall Study|Maximum clinical benefit|0|||
19476402|NCT02754141|41754424|FG011|Overall Study|Maximum clinical benefit|0|||
19476403|NCT02754141|41754425|FG012|Overall Study|Maximum clinical benefit|0|||
19476404|NCT02754141|41754426|FG013|Overall Study|Maximum clinical benefit|0|||
19476405|NCT02754141|41754427|FG014|Overall Study|Maximum clinical benefit|0|||
19476406|NCT02754141|41754428|FG015|Overall Study|Maximum clinical benefit|0|||
19476407|NCT02754141|41754429|FG016|Overall Study|Maximum clinical benefit|0|||
19476408|NCT02754141|41754430|FG017|Overall Study|Maximum clinical benefit|0|||
19476409|NCT02754141|41754413|FG000|Overall Study|No longer meets study criteria|0|||
19476410|NCT02754141|41754414|FG001|Overall Study|No longer meets study criteria|0|||
19476411|NCT02754141|41754415|FG002|Overall Study|No longer meets study criteria|0|||
19476412|NCT02754141|41754416|FG003|Overall Study|No longer meets study criteria|1|||
19476413|NCT02754141|41754417|FG004|Overall Study|No longer meets study criteria|0|||
19476414|NCT02754141|41754418|FG005|Overall Study|No longer meets study criteria|0|||
19476415|NCT02754141|41754419|FG006|Overall Study|No longer meets study criteria|0|||
19476416|NCT02754141|41754420|FG007|Overall Study|No longer meets study criteria|0|||
19476417|NCT02754141|41754421|FG008|Overall Study|No longer meets study criteria|0|||
19476418|NCT02754141|41754422|FG009|Overall Study|No longer meets study criteria|0|||
19476419|NCT02754141|41754423|FG010|Overall Study|No longer meets study criteria|0|||
19476420|NCT02754141|41754424|FG011|Overall Study|No longer meets study criteria|0|||
19476421|NCT02754141|41754425|FG012|Overall Study|No longer meets study criteria|0|||
19476422|NCT02754141|41754426|FG013|Overall Study|No longer meets study criteria|0|||
19476423|NCT02754141|41754427|FG014|Overall Study|No longer meets study criteria|0|||
19476424|NCT02754141|41754428|FG015|Overall Study|No longer meets study criteria|0|||
19476425|NCT02754141|41754429|FG016|Overall Study|No longer meets study criteria|0|||
19476426|NCT02754141|41754430|FG017|Overall Study|No longer meets study criteria|0|||
19476427|NCT02754141|41754413|FG000|Overall Study|Other reasons|0|||
19476428|NCT02754141|41754414|FG001|Overall Study|Other reasons|0|||
19476429|NCT02754141|41754415|FG002|Overall Study|Other reasons|0|||
19476430|NCT02754141|41754416|FG003|Overall Study|Other reasons|0|||
19476431|NCT02754141|41754417|FG004|Overall Study|Other reasons|0|||
19476432|NCT02754141|41754418|FG005|Overall Study|Other reasons|0|||
19476433|NCT02754141|41754419|FG006|Overall Study|Other reasons|0|||
19476434|NCT02754141|41754420|FG007|Overall Study|Other reasons|1|||
19476435|NCT02754141|41754421|FG008|Overall Study|Other reasons|0|||
19476436|NCT02754141|41754422|FG009|Overall Study|Other reasons|0|||
19476437|NCT02754141|41754423|FG010|Overall Study|Other reasons|0|||
19476438|NCT02754141|41754424|FG011|Overall Study|Other reasons|0|||
19476439|NCT02754141|41754425|FG012|Overall Study|Other reasons|2|||
19476440|NCT02754141|41754426|FG013|Overall Study|Other reasons|0|||
19476441|NCT02754141|41754427|FG014|Overall Study|Other reasons|0|||
19476442|NCT02754141|41754428|FG015|Overall Study|Other reasons|0|||
19476443|NCT02754141|41754429|FG016|Overall Study|Other reasons|0|||
19476444|NCT02754141|41754430|FG017|Overall Study|Other reasons|0|||
19476445|NCT02754141|41754413|FG000|Overall Study|Completed treatment as per protocol|0|||
19476446|NCT02754141|41754414|FG001|Overall Study|Completed treatment as per protocol|1|||
19476447|NCT02754141|41754415|FG002|Overall Study|Completed treatment as per protocol|0|||
19476448|NCT02754141|41754416|FG003|Overall Study|Completed treatment as per protocol|0|||
19476449|NCT02754141|41754417|FG004|Overall Study|Completed treatment as per protocol|0|||
19476450|NCT02754141|41754418|FG005|Overall Study|Completed treatment as per protocol|0|||
19476451|NCT02754141|41754419|FG006|Overall Study|Completed treatment as per protocol|0|||
19476452|NCT02754141|41754420|FG007|Overall Study|Completed treatment as per protocol|0|||
19476453|NCT02754141|41754421|FG008|Overall Study|Completed treatment as per protocol|0|||
19476454|NCT02754141|41754422|FG009|Overall Study|Completed treatment as per protocol|0|||
19476455|NCT02754141|41754423|FG010|Overall Study|Completed treatment as per protocol|0|||
19476456|NCT02754141|41754424|FG011|Overall Study|Completed treatment as per protocol|0|||
19476457|NCT02754141|41754425|FG012|Overall Study|Completed treatment as per protocol|1|||
19476458|NCT02754141|41754426|FG013|Overall Study|Completed treatment as per protocol|0|||
19476459|NCT02754141|41754427|FG014|Overall Study|Completed treatment as per protocol|0|||
19476460|NCT02754141|41754428|FG015|Overall Study|Completed treatment as per protocol|0|||
19476461|NCT02754141|41754429|FG016|Overall Study|Completed treatment as per protocol|0|||
19476462|NCT02754141|41754430|FG017|Overall Study|Completed treatment as per protocol|0|||
19476463|NCT02754141|41754413|FG000|Overall Study|Not completing monotherapy|0|||
19476464|NCT02754141|41754414|FG001|Overall Study|Not completing monotherapy|0|||
19476465|NCT02754141|41754415|FG002|Overall Study|Not completing monotherapy|0|||
19381994|NCT01674621|41625045|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
19476466|NCT02754141|41754416|FG003|Overall Study|Not completing monotherapy|0|||
19476467|NCT02754141|41754417|FG004|Overall Study|Not completing monotherapy|0|||
19476468|NCT02754141|41754418|FG005|Overall Study|Not completing monotherapy|0|||
19476469|NCT02754141|41754419|FG006|Overall Study|Not completing monotherapy|0|||
19476470|NCT02754141|41754420|FG007|Overall Study|Not completing monotherapy|0|||
19476471|NCT02754141|41754421|FG008|Overall Study|Not completing monotherapy|0|||
19476472|NCT02754141|41754422|FG009|Overall Study|Not completing monotherapy|0|||
19476473|NCT02754141|41754423|FG010|Overall Study|Not completing monotherapy|0|||
19478172|NCT01693562|41757326|FG012|Expansion Phase|Other|0|||
19476474|NCT02754141|41754424|FG011|Overall Study|Not completing monotherapy|0|||
19476475|NCT02754141|41754425|FG012|Overall Study|Not completing monotherapy|0|||
19476476|NCT02754141|41754426|FG013|Overall Study|Not completing monotherapy|1|||
19476477|NCT02754141|41754427|FG014|Overall Study|Not completing monotherapy|0|||
19476478|NCT02754141|41754428|FG015|Overall Study|Not completing monotherapy|0|||
19476479|NCT02754141|41754429|FG016|Overall Study|Not completing monotherapy|0|||
19476480|NCT02754141|41754430|FG017|Overall Study|Not completing monotherapy|0|||
19476481|NCT02659059|41754509|FG000|Overall Study|Other reasons|6|||
19476482|NCT02659059|41754510|FG001|Overall Study|Other reasons|1|||
19476483|NCT02659059|41754509|FG000|Overall Study|Disease Progression|143|||
19476484|NCT02659059|41754510|FG001|Overall Study|Disease Progression|16|||
19476485|NCT02659059|41754509|FG000|Overall Study|Study Drug toxicity|56|||
19476486|NCT02659059|41754510|FG001|Overall Study|Study Drug toxicity|9|||
19476487|NCT02659059|41754509|FG000|Overall Study|Death|3|||
19476488|NCT02659059|41754510|FG001|Overall Study|Death|1|||
19476489|NCT02659059|41754509|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
19476490|NCT02659059|41754510|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
19476491|NCT02659059|41754509|FG000|Overall Study|Participant request to discontinue study treatment|5|||
19476492|NCT02659059|41754510|FG001|Overall Study|Participant request to discontinue study treatment|0|||
19476493|NCT02659059|41754509|FG000|Overall Study|Participant withdrew consent|6|||
19476494|NCT02659059|41754510|FG001|Overall Study|Participant withdrew consent|1|||
19476495|NCT01385176|41754527|FG000|Randomization Phase|Death|1|||
19476496|NCT01385176|41754528|FG001|Randomization Phase|Death|2|||
19476497|NCT01385176|41754527|FG000|6-18 Month All VNS Active|Death|1|||
19476498|NCT01385176|41754528|FG001|6-18 Month All VNS Active|Death|2|||
19476499|NCT01385176|41754527|FG000|6-18 Month All VNS Active|Physician Decision|0|||
19476500|NCT01385176|41754528|FG001|6-18 Month All VNS Active|Physician Decision|1|||
19476501|NCT01385176|41754527|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
19476502|NCT01385176|41754528|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
19476503|NCT01385176|41754527|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
19476504|NCT01385176|41754528|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
19476505|NCT01337245|41754539|FG000|Overall Study|Lost to Follow-up|1|||
19476506|NCT01164891|41754543|FG000|Overall Study|Disease Progression|5|||
19476507|NCT01164891|41754543|FG000|Overall Study|Adverse Event|1|||
19476508|NCT01497899|41754552|FG000|Double-Blind Phase|Randomized but not Treated|1|||
19476509|NCT01497899|41754553|FG001|Double-Blind Phase|Randomized but not Treated|0|||
19476510|NCT01497899|41754554|FG002|Double-Blind Phase|Randomized but not Treated|0|||
19476511|NCT01497899|41754555|FG003|Double-Blind Phase|Randomized but not Treated|0|||
19476512|NCT01497899|41754552|FG000|Double-Blind Phase|Adverse Event|1|||
19476513|NCT01497899|41754553|FG001|Double-Blind Phase|Adverse Event|0|||
19476514|NCT01497899|41754554|FG002|Double-Blind Phase|Adverse Event|0|||
19476515|NCT01497899|41754555|FG003|Double-Blind Phase|Adverse Event|0|||
19476516|NCT01497899|41754552|FG000|Double-Blind Phase|Lack of Efficacy|0|||
19476517|NCT01497899|41754553|FG001|Double-Blind Phase|Lack of Efficacy|1|||
19476518|NCT01497899|41754554|FG002|Double-Blind Phase|Lack of Efficacy|0|||
19476519|NCT01497899|41754555|FG003|Double-Blind Phase|Lack of Efficacy|0|||
19476520|NCT01497899|41754552|FG000|Double-Blind Phase|Investigator's Discretion|1|||
19476521|NCT01497899|41754553|FG001|Double-Blind Phase|Investigator's Discretion|0|||
19476522|NCT01497899|41754554|FG002|Double-Blind Phase|Investigator's Discretion|0|||
19476523|NCT01497899|41754555|FG003|Double-Blind Phase|Investigator's Discretion|0|||
19553925|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
19553926|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
19553927|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
19553928|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
19553929|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
19553930|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
19553931|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
19553932|NCT01057693|42002865|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
19553933|NCT01057693|42002866|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
19553934|NCT01057693|42002867|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
19553935|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
19553936|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
19553937|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
19553938|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
19381995|NCT01674621|41625046|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
19476524|NCT01497899|41754552|FG000|Double-Blind Phase|Withdrew Consent|0|||
19476525|NCT01497899|41754553|FG001|Double-Blind Phase|Withdrew Consent|1|||
19553939|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
19739411|NCT03519867|42186494|FG009|Overall Study|Protocol Violation|0|||
19476526|NCT01497899|41754554|FG002|Double-Blind Phase|Withdrew Consent|0|||
19476527|NCT01497899|41754555|FG003|Double-Blind Phase|Withdrew Consent|0|||
19476528|NCT01497899|41754552|FG000|Double-Blind Phase|Lost to Follow-up|3|||
19476529|NCT01497899|41754553|FG001|Double-Blind Phase|Lost to Follow-up|2|||
19476530|NCT01497899|41754554|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19476531|NCT01497899|41754555|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19476532|NCT01497899|41754552|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
19476533|NCT01497899|41754553|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
19476534|NCT01497899|41754554|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
19476535|NCT01497899|41754555|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
19476536|NCT01497899|41754552|FG000|Open-Label Extension Phase|Adverse Event|1|||
19476537|NCT01497899|41754553|FG001|Open-Label Extension Phase|Adverse Event|0|||
19476538|NCT01497899|41754554|FG002|Open-Label Extension Phase|Adverse Event|0|||
19476539|NCT01497899|41754555|FG003|Open-Label Extension Phase|Adverse Event|0|||
19476540|NCT01497899|41754552|FG000|Open-Label Extension Phase|Death|1|||
19476541|NCT01497899|41754553|FG001|Open-Label Extension Phase|Death|0|||
19476542|NCT01497899|41754554|FG002|Open-Label Extension Phase|Death|0|||
19476543|NCT01497899|41754555|FG003|Open-Label Extension Phase|Death|0|||
19476544|NCT01497899|41754552|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
19476545|NCT01497899|41754553|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
19476546|NCT01497899|41754554|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
19476547|NCT01497899|41754555|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
19476548|NCT01497899|41754552|FG000|Open-Label Extension Phase|Pregnancy|0|||
19476549|NCT01497899|41754553|FG001|Open-Label Extension Phase|Pregnancy|1|||
19476550|NCT01497899|41754554|FG002|Open-Label Extension Phase|Pregnancy|1|||
19476551|NCT01497899|41754555|FG003|Open-Label Extension Phase|Pregnancy|0|||
19476552|NCT01497899|41754552|FG000|Open-Label Extension Phase|Protocol Violation|0|||
19476553|NCT01497899|41754553|FG001|Open-Label Extension Phase|Protocol Violation|0|||
19476554|NCT01497899|41754554|FG002|Open-Label Extension Phase|Protocol Violation|1|||
19476555|NCT01497899|41754555|FG003|Open-Label Extension Phase|Protocol Violation|0|||
19476556|NCT01497899|41754552|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
19476557|NCT01497899|41754553|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
19476558|NCT01497899|41754554|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
19476559|NCT01497899|41754555|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
19476560|NCT01497275|41754562|FG000|Overall Study|Death|1|||
19476561|NCT01497275|41754562|FG000|Overall Study|Adverse Event|1|||
19476562|NCT01557517|41754568|FG000|Overall Study|Death|1|||
19476563|NCT01557517|41754569|FG001|Overall Study|Death|0|||
19476564|NCT01557517|41754568|FG000|Overall Study|Refused further treatment|0|||
19476565|NCT01557517|41754569|FG001|Overall Study|Refused further treatment|2|||
19476566|NCT01557517|41754568|FG000|Overall Study|Adverse Event|0|||
19476567|NCT01557517|41754569|FG001|Overall Study|Adverse Event|2|||
19476568|NCT01557517|41754568|FG000|Overall Study|Pt declined before treatment started|1|||
19476569|NCT01557517|41754569|FG001|Overall Study|Pt declined before treatment started|0|||
19476570|NCT01497197|41754584|FG000|Overall Study|Lost to Follow-up|1|||
19476571|NCT01497197|41754585|FG001|Overall Study|Lost to Follow-up|0|||
19476572|NCT01497197|41754584|FG000|Overall Study|Protocol Violation|0|||
19476573|NCT01497197|41754585|FG001|Overall Study|Protocol Violation|2|||
19476574|NCT01497197|41754584|FG000|Overall Study|Withdrawal by Subject|2|||
19476575|NCT01497197|41754585|FG001|Overall Study|Withdrawal by Subject|1|||
19476576|NCT01497197|41754584|FG000|Overall Study|Excessive/lack of response to treatment|1|||
19476577|NCT01497197|41754585|FG001|Overall Study|Excessive/lack of response to treatment|0|||
19476578|NCT01497197|41754584|FG000|Overall Study|Risk of OHSS|1|||
19476579|NCT01497197|41754585|FG001|Overall Study|Risk of OHSS|0|||
19476580|NCT01497197|41754584|FG000|Overall Study|No oocytes retrieved|3|||
19476581|NCT01497197|41754585|FG001|Overall Study|No oocytes retrieved|2|||
19476582|NCT01497197|41754584|FG000|Overall Study|No fertilisation|6|||
19476583|NCT01497197|41754585|FG001|Overall Study|No fertilisation|5|||
19476584|NCT01497197|41754584|FG000|Overall Study|Intention to freeze all embryos|0|||
19476585|NCT01497197|41754585|FG001|Overall Study|Intention to freeze all embryos|1|||
19476586|NCT01497197|41754584|FG000|Overall Study|All embryos discarded|0|||
19476587|NCT01497197|41754585|FG001|Overall Study|All embryos discarded|3|||
19476588|NCT01497197|41754584|FG000|Overall Study|Other|3|||
19476589|NCT01497197|41754585|FG001|Overall Study|Other|1|||
19476590|NCT01496885|41754591|FG000|Overall Study|Lost to Follow-up|13|||
19476591|NCT01496885|41754591|FG000|Overall Study|Withdrawal by Subject|7|||
19478173|NCT01693562|41757327|FG013|Expansion Phase|Other|1|||
19476592|NCT01496885|41754591|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
19476593|NCT01496885|41754591|FG000|Overall Study|Death|1|||
19476594|NCT01557283|41754595|FG000|Overall Study|Lost to Follow-up|7|||
19476595|NCT01557283|41754595|FG000|Overall Study|Non-responder|19|||
19476596|NCT01557283|41754595|FG000|Overall Study|Adverse Event|7|||
19476597|NCT01557283|41754595|FG000|Overall Study|Lack of Efficacy|1|||
19476598|NCT01557283|41754595|FG000|Overall Study|Non-compliance|1|||
19476599|NCT01557283|41754595|FG000|Overall Study|Withdrawal by Subject|1|||
19476600|NCT01557283|41754595|FG000|Overall Study|Participant's weight too high for dose|1|||
19381996|NCT01674621|41625042|FG000|Overall Study|Withdrawal by Subject|2|||
19476601|NCT01557283|41754595|FG000|Overall Study|Worsening of psoriasis|1|||
19553940|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
19381997|NCT01674621|41625043|FG001|Overall Study|Withdrawal by Subject|5|||
19476602|NCT01557283|41754595|FG000|Overall Study|Other|6|||
19476603|NCT01523743|41754612|FG000|Period 1|Adverse Event|1|||
19476604|NCT01523743|41754613|FG001|Period 1|Adverse Event|0|||
19476605|NCT01523743|41754612|FG000|Period 1|Withdrawal by Subject|6|||
19476606|NCT01523743|41754613|FG001|Period 1|Withdrawal by Subject|2|||
19476607|NCT01523743|41754612|FG000|Period 1|Lost to Follow-up|1|||
19476608|NCT01523743|41754613|FG001|Period 1|Lost to Follow-up|0|||
19476609|NCT01523743|41754612|FG000|Period 1|Lack of Efficacy|1|||
19476610|NCT01523743|41754613|FG001|Period 1|Lack of Efficacy|0|||
19476611|NCT01523743|41754612|FG000|Period 1|Felt unable to empty bladder|1|||
19476612|NCT01523743|41754613|FG001|Period 1|Felt unable to empty bladder|0|||
19476613|NCT01523743|41754612|FG000|Period 2|Withdrawal by Subject|0|||
19476614|NCT01523743|41754613|FG001|Period 2|Withdrawal by Subject|2|||
19476615|NCT01523743|41754612|FG000|Period 2|Adverse Event|1|||
19476616|NCT01523743|41754613|FG001|Period 2|Adverse Event|0|||
19476617|NCT01496807|41754628|FG000|Overall Study|Progressive Disease|21|||
19739412|NCT03519867|42186485|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19390351|NCT01987960|41634111|FG001|Period 2|Withdrawal by Subject|0|||
19390352|NCT01987960|41634112|FG002|Period 2|Withdrawal by Subject|1|||
19390353|NCT01987960|41634113|FG003|Period 2|Withdrawal by Subject|0|||
19390354|NCT01987960|41634110|FG000|Period 2|Administrative or other reason|0|||
19390355|NCT01987960|41634111|FG001|Period 2|Administrative or other reason|5|||
19390356|NCT01987960|41634112|FG002|Period 2|Administrative or other reason|7|||
19390357|NCT01987960|41634113|FG003|Period 2|Administrative or other reason|0|||
19390358|NCT01987960|41634110|FG000|Period 3|Adverse Event|0|||
19390359|NCT01987960|41634111|FG001|Period 3|Adverse Event|0|||
19390360|NCT01987960|41634112|FG002|Period 3|Adverse Event|0|||
19476618|NCT01496807|41754628|FG000|Overall Study|Participant preference/toxicity|8|||
19476619|NCT01496807|41754628|FG000|Overall Study|Change in diagnosis|1|||
19476620|NCT01496183|41754634|FG000|Overall Study|Physician Decision|3|||
19476621|NCT01496183|41754635|FG001|Overall Study|Physician Decision|1|||
19476622|NCT01496183|41754634|FG000|Overall Study|Withdrawal by Subject|0|||
19476623|NCT01496183|41754635|FG001|Overall Study|Withdrawal by Subject|1|||
19476624|NCT03278106|41754642|FG000|Overall Study|No protocol treatment|1|||
19476625|NCT01495793|41754646|FG000|Overall Study|Lost to Follow-up|1|||
19476626|NCT01495793|41754646|FG000|Overall Study|Violation of inclusion criteria|1|||
19476627|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
19476628|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
19476629|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
19476630|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
19476631|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
19476632|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
19476633|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
19553941|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
19553942|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
19553943|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
19553944|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
19553945|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
19553946|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
19553947|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
19553948|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
19553949|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
19553950|NCT01057693|42002865|FG000|Between Single-Blind and Double-Blind|Other|6|||
19476634|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
19476635|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
19476636|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
19476637|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
19476638|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
19476639|NCT01494467|41754652|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
19476640|NCT01494467|41754653|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
19476641|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
19476642|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
19476643|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
19476644|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
19476645|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
19476646|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
19476647|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
19476648|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
19476649|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
19476650|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
19476651|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
19476652|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
19476653|NCT01494467|41754652|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
19476654|NCT01494467|41754653|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
19476655|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
19476656|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
19476657|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
19476658|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
19476659|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
19476660|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
19476661|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
19476662|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
19476663|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
19476664|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
19476665|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
19476666|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
19478174|NCT01693562|41757328|FG014|Expansion Phase|Other|1|||
19476667|NCT01493687|41754667|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
19476668|NCT01493687|41754668|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
19553951|NCT01057693|42002866|FG001|Between Single-Blind and Double-Blind|Other|0|||
19553952|NCT01057693|42002867|FG002|Between Single-Blind and Double-Blind|Other|0|||
19553953|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
19553954|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
19553955|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
19553956|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
19553957|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
19553958|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
19553959|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
19553960|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
19553961|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
19553962|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
19553963|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
19553964|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
19553965|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
19553966|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
19553967|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
19553968|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
19476669|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
19476670|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
19476671|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
19553969|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
19553970|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
19553971|NCT01057693|42002865|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
19553972|NCT01057693|42002866|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
19553973|NCT01057693|42002867|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
19553974|NCT01307501|42002875|FG000|Overall Study|Treatment Failure|1|||
19553975|NCT01307501|42002875|FG000|Overall Study|Death|20|||
19476672|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
19476673|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
19476674|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
19476675|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
19553976|NCT01307501|42002875|FG000|Overall Study|Lost to Follow-up|1|||
19553977|NCT01307501|42002875|FG000|Overall Study|Starting Hospice|1|||
19553978|NCT01034137|42002882|FG000|Overall Study|Adverse Event|9|||
19553979|NCT01034137|42002883|FG001|Overall Study|Adverse Event|10|||
19553980|NCT01034137|42002884|FG002|Overall Study|Adverse Event|8|||
19553981|NCT01034137|42002882|FG000|Overall Study|Withdrawal by Subject|4|||
19553982|NCT01034137|42002883|FG001|Overall Study|Withdrawal by Subject|3|||
19553983|NCT01034137|42002884|FG002|Overall Study|Withdrawal by Subject|3|||
19553984|NCT01034137|42002882|FG000|Overall Study|Lack of Efficacy|9|||
19553985|NCT01034137|42002883|FG001|Overall Study|Lack of Efficacy|4|||
19553986|NCT01034137|42002884|FG002|Overall Study|Lack of Efficacy|13|||
19553987|NCT01034137|42002882|FG000|Overall Study|Protocol Violation|2|||
19553988|NCT01034137|42002883|FG001|Overall Study|Protocol Violation|2|||
19553989|NCT01034137|42002884|FG002|Overall Study|Protocol Violation|1|||
19553990|NCT01034137|42002882|FG000|Overall Study|Refused treatment or did not cooperate|2|||
19553991|NCT01034137|42002883|FG001|Overall Study|Refused treatment or did not cooperate|0|||
19553992|NCT01034137|42002884|FG002|Overall Study|Refused treatment or did not cooperate|1|||
19553993|NCT01034137|42002882|FG000|Overall Study|Administrative or other|2|||
19553994|NCT01034137|42002883|FG001|Overall Study|Administrative or other|3|||
19553995|NCT01034137|42002884|FG002|Overall Study|Administrative or other|4|||
19553996|NCT01056289|42002893|FG000|Open-label Phase|Adverse Event|29|||
19553997|NCT01056289|42002894|FG001|Open-label Phase|Adverse Event|0|||
19553998|NCT01056289|42002895|FG002|Open-label Phase|Adverse Event|0|||
19553999|NCT01056289|42002896|FG003|Open-label Phase|Adverse Event|0|||
19554000|NCT01056289|42002893|FG000|Open-label Phase|Lost to Follow-up|30|||
19554001|NCT01056289|42002894|FG001|Open-label Phase|Lost to Follow-up|0|||
19554002|NCT01056289|42002895|FG002|Open-label Phase|Lost to Follow-up|0|||
19554003|NCT01056289|42002896|FG003|Open-label Phase|Lost to Follow-up|0|||
19554004|NCT01056289|42002893|FG000|Open-label Phase|Other|9|||
19554005|NCT01056289|42002894|FG001|Open-label Phase|Other|0|||
19554006|NCT01056289|42002895|FG002|Open-label Phase|Other|0|||
19554007|NCT01056289|42002896|FG003|Open-label Phase|Other|0|||
19554008|NCT01056289|42002893|FG000|Open-label Phase|Protocol Violation|6|||
19554009|NCT01056289|42002894|FG001|Open-label Phase|Protocol Violation|0|||
19554010|NCT01056289|42002895|FG002|Open-label Phase|Protocol Violation|0|||
19554011|NCT01056289|42002896|FG003|Open-label Phase|Protocol Violation|0|||
19554012|NCT01056289|42002893|FG000|Open-label Phase|Withdrawal by Subject|26|||
19554013|NCT01056289|42002894|FG001|Open-label Phase|Withdrawal by Subject|0|||
19554014|NCT01056289|42002895|FG002|Open-label Phase|Withdrawal by Subject|0|||
19554015|NCT01056289|42002896|FG003|Open-label Phase|Withdrawal by Subject|0|||
19554016|NCT01056289|42002893|FG000|Open-label Phase|Lack of Efficacy|18|||
19554017|NCT01056289|42002894|FG001|Open-label Phase|Lack of Efficacy|0|||
19554018|NCT01056289|42002895|FG002|Open-label Phase|Lack of Efficacy|0|||
19554019|NCT01056289|42002896|FG003|Open-label Phase|Lack of Efficacy|0|||
19554020|NCT01056289|42002893|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
19554021|NCT01056289|42002894|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
19554022|NCT01056289|42002895|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
19554023|NCT01056289|42002896|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
19554024|NCT01056289|42002893|FG000|Double-blind Phase|Adverse Event|0|||
19554025|NCT01056289|42002894|FG001|Double-blind Phase|Adverse Event|1|||
19554026|NCT01056289|42002895|FG002|Double-blind Phase|Adverse Event|2|||
19554027|NCT01056289|42002896|FG003|Double-blind Phase|Adverse Event|1|||
19554028|NCT01056289|42002893|FG000|Double-blind Phase|Lost to Follow-up|0|||
19739413|NCT03519867|42186486|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19554029|NCT01056289|42002894|FG001|Double-blind Phase|Lost to Follow-up|2|||
19554030|NCT01056289|42002895|FG002|Double-blind Phase|Lost to Follow-up|2|||
19554031|NCT01056289|42002896|FG003|Double-blind Phase|Lost to Follow-up|2|||
19554032|NCT01056289|42002893|FG000|Double-blind Phase|Other|0|||
19554033|NCT01056289|42002894|FG001|Double-blind Phase|Other|0|||
19554034|NCT01056289|42002895|FG002|Double-blind Phase|Other|1|||
19554035|NCT01056289|42002896|FG003|Double-blind Phase|Other|2|||
19554036|NCT01056289|42002893|FG000|Double-blind Phase|Protocol Violation|0|||
19554037|NCT01056289|42002894|FG001|Double-blind Phase|Protocol Violation|0|||
19554038|NCT01056289|42002895|FG002|Double-blind Phase|Protocol Violation|1|||
19554039|NCT01056289|42002896|FG003|Double-blind Phase|Protocol Violation|1|||
19554040|NCT01056289|42002893|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19554041|NCT01056289|42002894|FG001|Double-blind Phase|Withdrawal by Subject|0|||
19554042|NCT01056289|42002895|FG002|Double-blind Phase|Withdrawal by Subject|4|||
19554043|NCT01056289|42002896|FG003|Double-blind Phase|Withdrawal by Subject|2|||
19554044|NCT01056289|42002893|FG000|Double-blind Phase|Discontinuation symptom|0|||
19554045|NCT01056289|42002894|FG001|Double-blind Phase|Discontinuation symptom|1|||
19554046|NCT01056289|42002895|FG002|Double-blind Phase|Discontinuation symptom|2|||
19554047|NCT01056289|42002896|FG003|Double-blind Phase|Discontinuation symptom|2|||
19554048|NCT01056289|42002893|FG000|Double-blind Phase|Physician Decision|0|||
19554049|NCT01056289|42002894|FG001|Double-blind Phase|Physician Decision|0|||
19554050|NCT01056289|42002895|FG002|Double-blind Phase|Physician Decision|1|||
19554051|NCT01056289|42002896|FG003|Double-blind Phase|Physician Decision|0|||
19554052|NCT01039675|42002908|FG000|Overall Study|Adverse Event|0|||
19554053|NCT01039675|42002909|FG001|Overall Study|Adverse Event|2|||
19554054|NCT01039675|42002908|FG000|Overall Study|Lack of Efficacy|0|||
19554055|NCT01039675|42002909|FG001|Overall Study|Lack of Efficacy|2|||
19554056|NCT01039675|42002908|FG000|Overall Study|Withdrawal by Subject|0|||
19554057|NCT01039675|42002909|FG001|Overall Study|Withdrawal by Subject|1|||
19554058|NCT01039675|42002908|FG000|Overall Study|Lost to Follow-up|0|||
19554059|NCT01039675|42002909|FG001|Overall Study|Lost to Follow-up|1|||
19554060|NCT01039675|42002908|FG000|Overall Study|Physician Decision|0|||
19554061|NCT01039675|42002909|FG001|Overall Study|Physician Decision|1|||
19554062|NCT01033825|42002922|FG000|Overall Study|Withdrawal by Subject|2|||
19554063|NCT01033825|42002923|FG001|Overall Study|Withdrawal by Subject|3|||
19554064|NCT01033825|42002924|FG002|Overall Study|Withdrawal by Subject|2|||
19381998|NCT01674621|41625044|FG002|Overall Study|Withdrawal by Subject|2|||
19554065|NCT01033825|42002925|FG003|Overall Study|Withdrawal by Subject|1|||
19554066|NCT01033825|42002926|FG004|Overall Study|Withdrawal by Subject|1|||
19554067|NCT01033825|42002927|FG005|Overall Study|Withdrawal by Subject|0|||
19554068|NCT01033825|42002928|FG006|Overall Study|Withdrawal by Subject|0|||
19554069|NCT01033825|42002922|FG000|Overall Study|Adverse Event|0|||
19554070|NCT01033825|42002923|FG001|Overall Study|Adverse Event|0|||
19554071|NCT01033825|42002924|FG002|Overall Study|Adverse Event|0|||
19554072|NCT01033825|42002925|FG003|Overall Study|Adverse Event|1|||
19554073|NCT01033825|42002926|FG004|Overall Study|Adverse Event|0|||
19554074|NCT01033825|42002927|FG005|Overall Study|Adverse Event|0|||
19554075|NCT01033825|42002928|FG006|Overall Study|Adverse Event|0|||
19554076|NCT01033825|42002922|FG000|Overall Study|Protocol Violation|1|||
19554077|NCT01033825|42002923|FG001|Overall Study|Protocol Violation|0|||
19554078|NCT01033825|42002924|FG002|Overall Study|Protocol Violation|0|||
19554079|NCT01033825|42002925|FG003|Overall Study|Protocol Violation|0|||
19554080|NCT01033825|42002926|FG004|Overall Study|Protocol Violation|0|||
19554081|NCT01033825|42002927|FG005|Overall Study|Protocol Violation|0|||
19554082|NCT01033825|42002928|FG006|Overall Study|Protocol Violation|0|||
19554083|NCT01033825|42002922|FG000|Overall Study|Other|0|||
19554084|NCT01033825|42002923|FG001|Overall Study|Other|0|||
19554085|NCT01033825|42002924|FG002|Overall Study|Other|0|||
19554086|NCT01033825|42002925|FG003|Overall Study|Other|0|||
19554087|NCT01033825|42002926|FG004|Overall Study|Other|1|||
19554088|NCT01033825|42002927|FG005|Overall Study|Other|0|||
19554089|NCT01033825|42002928|FG006|Overall Study|Other|0|||
19554090|NCT01033747|42002948|FG000|Overall Study|Adverse Event|9|||
19554091|NCT01033747|42002949|FG001|Overall Study|Adverse Event|4|||
19554092|NCT01033747|42002948|FG000|Overall Study|Abnormal Laboratory Value|1|||
19554093|NCT01033747|42002949|FG001|Overall Study|Abnormal Laboratory Value|0|||
19554094|NCT01033747|42002948|FG000|Overall Study|Abnormal test procedure|0|||
19554095|NCT01033747|42002949|FG001|Overall Study|Abnormal test procedure|1|||
19554096|NCT01033747|42002948|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
19554097|NCT01033747|42002949|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19554098|NCT01033747|42002948|FG000|Overall Study|Protocol Violation|1|||
19554099|NCT01033747|42002949|FG001|Overall Study|Protocol Violation|0|||
19554100|NCT01033747|42002948|FG000|Overall Study|Withdrawal by Subject|9|||
19554101|NCT01033747|42002949|FG001|Overall Study|Withdrawal by Subject|6|||
19554102|NCT01033747|42002948|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
19554103|NCT01033747|42002949|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
19554104|NCT01033747|42002948|FG000|Overall Study|Stopped at end of Extension 1|2|||
19554105|NCT01033747|42002949|FG001|Overall Study|Stopped at end of Extension 1|0|||
19554106|NCT01091428|42002959|FG000|Phase 1|Progressive Disease|24|||
19554107|NCT01091428|42002960|FG001|Phase 1|Progressive Disease|8|||
19554108|NCT01091428|42002961|FG002|Phase 1|Progressive Disease|0|||
19554109|NCT01091428|42002962|FG003|Phase 1|Progressive Disease|0|||
19554110|NCT01091428|42002959|FG000|Phase 1|Symptomatic Deterioration|3|||
19554111|NCT01091428|42002960|FG001|Phase 1|Symptomatic Deterioration|2|||
19554112|NCT01091428|42002961|FG002|Phase 1|Symptomatic Deterioration|0|||
19554113|NCT01091428|42002962|FG003|Phase 1|Symptomatic Deterioration|0|||
19554114|NCT01091428|42002959|FG000|Phase 1|Adverse Event|2|||
19554115|NCT01091428|42002960|FG001|Phase 1|Adverse Event|0|||
19554116|NCT01091428|42002961|FG002|Phase 1|Adverse Event|0|||
19554117|NCT01091428|42002962|FG003|Phase 1|Adverse Event|0|||
19554118|NCT01091428|42002959|FG000|Phase 1|Withdrawal by Subject|7|||
19554119|NCT01091428|42002960|FG001|Phase 1|Withdrawal by Subject|0|||
19554120|NCT01091428|42002961|FG002|Phase 1|Withdrawal by Subject|0|||
19554121|NCT01091428|42002962|FG003|Phase 1|Withdrawal by Subject|0|||
19554122|NCT01091428|42002959|FG000|Phase 1|Reason not specified|0|||
19554123|NCT01091428|42002960|FG001|Phase 1|Reason not specified|1|||
19554124|NCT01091428|42002961|FG002|Phase 1|Reason not specified|0|||
19554125|NCT01091428|42002962|FG003|Phase 1|Reason not specified|0|||
19554126|NCT01091428|42002959|FG000|Phase 1|Single-Patient IND|2|||
19554127|NCT01091428|42002960|FG001|Phase 1|Single-Patient IND|0|||
19554128|NCT01091428|42002961|FG002|Phase 1|Single-Patient IND|0|||
19554129|NCT01091428|42002962|FG003|Phase 1|Single-Patient IND|0|||
19554130|NCT01091428|42002959|FG000|Phase 2|Progressive Disease|0|||
19381999|NCT01674621|41625045|FG003|Overall Study|Withdrawal by Subject|0|||
19554131|NCT01091428|42002960|FG001|Phase 2|Progressive Disease|0|||
19554132|NCT01091428|42002961|FG002|Phase 2|Progressive Disease|44|||
19554133|NCT01091428|42002962|FG003|Phase 2|Progressive Disease|46|||
19554134|NCT01091428|42002959|FG000|Phase 2|Symptomatic Deterioration|0|||
19554135|NCT01091428|42002960|FG001|Phase 2|Symptomatic Deterioration|0|||
19554136|NCT01091428|42002961|FG002|Phase 2|Symptomatic Deterioration|1|||
19554137|NCT01091428|42002962|FG003|Phase 2|Symptomatic Deterioration|6|||
19554138|NCT01091428|42002959|FG000|Phase 2|Adverse Event|0|||
19554139|NCT01091428|42002960|FG001|Phase 2|Adverse Event|0|||
19554140|NCT01091428|42002961|FG002|Phase 2|Adverse Event|12|||
19554141|NCT01091428|42002962|FG003|Phase 2|Adverse Event|5|||
19554142|NCT01091428|42002959|FG000|Phase 2|Withdrawal by Subject|0|||
19554143|NCT01091428|42002960|FG001|Phase 2|Withdrawal by Subject|0|||
19554144|NCT01091428|42002961|FG002|Phase 2|Withdrawal by Subject|9|||
19554145|NCT01091428|42002962|FG003|Phase 2|Withdrawal by Subject|8|||
19554146|NCT01091428|42002959|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
19554147|NCT01091428|42002960|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
19554148|NCT01091428|42002961|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
19554149|NCT01091428|42002962|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
19554150|NCT01091428|42002959|FG000|Phase 2|Reason not specified|0|||
19554151|NCT01091428|42002960|FG001|Phase 2|Reason not specified|0|||
19554152|NCT01091428|42002961|FG002|Phase 2|Reason not specified|4|||
19554153|NCT01091428|42002962|FG003|Phase 2|Reason not specified|3|||
19554154|NCT01091428|42002959|FG000|Phase 2|Physician Decision|0|||
19554155|NCT01091428|42002960|FG001|Phase 2|Physician Decision|0|||
19554156|NCT01091428|42002961|FG002|Phase 2|Physician Decision|2|||
19554157|NCT01091428|42002962|FG003|Phase 2|Physician Decision|0|||
19554158|NCT01096342|42002981|FG000|Overall Study|Protocol Violation|1|||
19554159|NCT01039519|42002985|FG000|Treatment|Progressive disease|20|||
19554160|NCT01039519|42002985|FG000|Treatment|Treatment failure|2|||
19554161|NCT01039519|42002985|FG000|Treatment|Adverse Event|3|||
19554162|NCT01039519|42002985|FG000|Treatment|Physician Decision|2|||
19554163|NCT01039519|42002985|FG000|Survival Follow-up|Death|23|||
19554164|NCT01039519|42002985|FG000|Survival Follow-up|Sponsor decision|4|||
19554165|NCT01096186|42002989|FG000|Overall Study|Adverse Event|16|||
19554166|NCT01096186|42002989|FG000|Overall Study|Death|4|||
19554167|NCT01096186|42002989|FG000|Overall Study|Lack of Efficacy|4|||
19554168|NCT01096186|42002989|FG000|Overall Study|Lost to Follow-up|2|||
19554169|NCT01096186|42002989|FG000|Overall Study|Withdrawal by Subject|22|||
19554170|NCT01096186|42002989|FG000|Overall Study|Physician Decision|1|||
19554171|NCT01096186|42002989|FG000|Overall Study|Noncompliance with study drug|1|||
19554172|NCT01032889|42002996|FG000|Overall Study|Adverse Event|2|||
19554173|NCT01032889|42002997|FG001|Overall Study|Adverse Event|2|||
19554174|NCT01032889|42002998|FG002|Overall Study|Adverse Event|0|||
19554175|NCT01032889|42002996|FG000|Overall Study|Withdrawal of Consent|1|||
19554176|NCT01032889|42002997|FG001|Overall Study|Withdrawal of Consent|2|||
19554177|NCT01032889|42002998|FG002|Overall Study|Withdrawal of Consent|1|||
19554178|NCT01032889|42002996|FG000|Overall Study|Patient Request|0|||
19554179|NCT01032889|42002997|FG001|Overall Study|Patient Request|1|||
19554180|NCT01032889|42002998|FG002|Overall Study|Patient Request|0|||
19554181|NCT01032889|42002996|FG000|Overall Study|Lost to Follow-up|1|||
19554182|NCT01032889|42002997|FG001|Overall Study|Lost to Follow-up|1|||
19554183|NCT01032889|42002998|FG002|Overall Study|Lost to Follow-up|0|||
19554184|NCT01032889|42002996|FG000|Overall Study|Lack of Submental Fat|2|||
19554185|NCT01032889|42002997|FG001|Overall Study|Lack of Submental Fat|8|||
19554186|NCT01032889|42002998|FG002|Overall Study|Lack of Submental Fat|1|||
19554187|NCT01032889|42002996|FG000|Overall Study|Miscellaneous Reasons|2|||
19554188|NCT01032889|42002997|FG001|Overall Study|Miscellaneous Reasons|1|||
19554189|NCT01032889|42002998|FG002|Overall Study|Miscellaneous Reasons|1|||
19554190|NCT01049503|42003012|FG000|Overall Study|Lost to Follow-up|11|||
19554191|NCT01049503|42003013|FG001|Overall Study|Lost to Follow-up|12|||
19554192|NCT01049503|42003014|FG002|Overall Study|Lost to Follow-up|24|||
19554193|NCT01049503|42003015|FG003|Overall Study|Lost to Follow-up|26|||
19554194|NCT01049503|42003016|FG004|Overall Study|Lost to Follow-up|27|||
19554195|NCT01049503|42003017|FG005|Overall Study|Lost to Follow-up|8|||
19554196|NCT01029925|42003040|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
19554197|NCT01029925|42003040|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
19554198|NCT01029925|42003040|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
19554199|NCT01029691|42003047|FG000|Continued APAP to Delivery|Death|0|||
19554200|NCT01029691|42003048|FG001|Continued APAP to Delivery|Death|0|||
19554201|NCT01029691|42003049|FG002|Continued APAP to Delivery|Death|1|||
19554202|NCT01029535|42003058|FG000|Overall Study|Lost to Follow-up|24|||
19554203|NCT01029535|42003058|FG000|Overall Study|Protocol Violation|2|||
19554204|NCT01029535|42003058|FG000|Overall Study|Participant Withdrew Consent|2|||
19554205|NCT01029535|42003058|FG000|Overall Study|Adverse Event|1|||
19554206|NCT01029535|42003058|FG000|Overall Study|Use of Another Treatment|1|||
19554207|NCT01029535|42003058|FG000|Overall Study|Death|1|||
19554208|NCT01028053|42003063|FG000|Overall Study|Screen Failure|113|||
19554209|NCT01028053|42003063|FG000|Overall Study|Patient Request|11|||
19554210|NCT01028053|42003063|FG000|Overall Study|Protocol Violation|1|||
19554211|NCT01028053|42003063|FG000|Overall Study|Physician Decision|2|||
19554212|NCT01028053|42003063|FG000|Overall Study|Technical Problem|1|||
19554213|NCT01028053|42003063|FG000|Overall Study|Terminated by Sponsor|1|||
19554214|NCT01028053|42003063|FG000|Overall Study|Various reasons|4|||
19554215|NCT01023217|42003071|FG000|Overall Study|Withdrawal by Subject|1|||
19554216|NCT01023217|42003072|FG001|Overall Study|Withdrawal by Subject|0|||
19554217|NCT01095796|42003080|FG000|Overall Study|Randomized but Not Treated|5|||
19554218|NCT01095796|42003081|FG001|Overall Study|Randomized but Not Treated|2|||
19554219|NCT01095796|42003080|FG000|Overall Study|Adverse Event|9|||
19554220|NCT01095796|42003081|FG001|Overall Study|Adverse Event|19|||
19554221|NCT01095796|42003080|FG000|Overall Study|Death|3|||
19554222|NCT01095796|42003081|FG001|Overall Study|Death|2|||
19554223|NCT01095796|42003080|FG000|Overall Study|Pregnancy|2|||
19554224|NCT01095796|42003081|FG001|Overall Study|Pregnancy|0|||
19554225|NCT01095796|42003080|FG000|Overall Study|Lack of Efficacy|5|||
19554226|NCT01095796|42003081|FG001|Overall Study|Lack of Efficacy|3|||
19554227|NCT01095796|42003080|FG000|Overall Study|Investigator's Discretion|7|||
19554228|NCT01095796|42003081|FG001|Overall Study|Investigator's Discretion|2|||
19554229|NCT01095796|42003080|FG000|Overall Study|Withdrew Consent|16|||
19554230|NCT01095796|42003081|FG001|Overall Study|Withdrew Consent|22|||
19554231|NCT01095796|42003080|FG000|Overall Study|Lost to Follow-up|27|||
19554232|NCT01095796|42003081|FG001|Overall Study|Lost to Follow-up|29|||
19554233|NCT01095796|42003080|FG000|Overall Study|Participant Noncompliance|5|||
19554234|NCT01095796|42003081|FG001|Overall Study|Participant Noncompliance|10|||
19554235|NCT01095796|42003080|FG000|Overall Study|Protocol Violation|1|||
19554236|NCT01095796|42003081|FG001|Overall Study|Protocol Violation|0|||
19554237|NCT01095796|42003080|FG000|Overall Study|Participant Transferred to Another Study|215|||
19554238|NCT01095796|42003081|FG001|Overall Study|Participant Transferred to Another Study|200|||
19554239|NCT01023061|42003087|FG000|Overall Study|Withdrawal prior to treatment|2|||
19554240|NCT01027897|42003091|FG000|Overall Study|Protocol Violation|1|||
19554241|NCT01027897|42003091|FG000|Overall Study|Withdrawal by Subject|1|||
19554242|NCT01027351|42003101|FG000|Overall Study|Withdrawal by Subject|1|||
19554243|NCT01027351|42003102|FG001|Overall Study|Withdrawal by Subject|0|||
19554244|NCT01027351|42003103|FG002|Overall Study|Withdrawal by Subject|1|||
19554245|NCT01027351|42003104|FG003|Overall Study|Withdrawal by Subject|0|||
19554246|NCT01027351|42003105|FG004|Overall Study|Withdrawal by Subject|3|||
19554247|NCT01027351|42003106|FG005|Overall Study|Withdrawal by Subject|5|||
19554248|NCT01027351|42003101|FG000|Overall Study|Lost to Follow-up|1|||
19554249|NCT01027351|42003102|FG001|Overall Study|Lost to Follow-up|1|||
19554250|NCT01027351|42003103|FG002|Overall Study|Lost to Follow-up|0|||
19554251|NCT01027351|42003104|FG003|Overall Study|Lost to Follow-up|1|||
19554252|NCT01027351|42003105|FG004|Overall Study|Lost to Follow-up|6|||
19554253|NCT01027351|42003106|FG005|Overall Study|Lost to Follow-up|0|||
19554254|NCT01027351|42003101|FG000|Overall Study|Inappropriate enrollment|0|||
19554255|NCT01027351|42003102|FG001|Overall Study|Inappropriate enrollment|0|||
19554256|NCT01027351|42003103|FG002|Overall Study|Inappropriate enrollment|0|||
19554257|NCT01027351|42003104|FG003|Overall Study|Inappropriate enrollment|0|||
19554258|NCT01027351|42003105|FG004|Overall Study|Inappropriate enrollment|1|||
19554259|NCT01027351|42003106|FG005|Overall Study|Inappropriate enrollment|0|||
19554260|NCT01027351|42003101|FG000|Overall Study|Protocol Violation|1|||
19554261|NCT01027351|42003102|FG001|Overall Study|Protocol Violation|0|||
19554262|NCT01027351|42003103|FG002|Overall Study|Protocol Violation|0|||
19554263|NCT01027351|42003104|FG003|Overall Study|Protocol Violation|1|||
19554264|NCT01027351|42003105|FG004|Overall Study|Protocol Violation|1|||
19554265|NCT01027351|42003106|FG005|Overall Study|Protocol Violation|0|||
19554266|NCT01027273|42003129|FG000|Overall Study|Lost to Follow-up|57|||
19554267|NCT01027273|42003130|FG001|Overall Study|Lost to Follow-up|31|||
19554268|NCT01027273|42003129|FG000|Overall Study|Death|2|||
19554269|NCT01027273|42003130|FG001|Overall Study|Death|2|||
19554270|NCT01022203|42003138|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
19554271|NCT01022203|42003139|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
19554272|NCT01022203|42003138|FG000|Post Treatment Assessment|Physician Decision|2|||
19554273|NCT01022203|42003139|FG001|Post Treatment Assessment|Physician Decision|0|||
19554274|NCT01022203|42003138|FG000|Post Treatment Assessment|Adverse Event|0|||
19554275|NCT01022203|42003139|FG001|Post Treatment Assessment|Adverse Event|2|||
19554276|NCT01022203|42003138|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
19554277|NCT01022203|42003139|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
19554278|NCT01296711|42003156|FG000|Overall Study|Adverse Event|3|||
19554279|NCT01296711|42003157|FG001|Overall Study|Adverse Event|1|||
19554280|NCT01296711|42003158|FG002|Overall Study|Adverse Event|4|||
19554281|NCT01296711|42003159|FG003|Overall Study|Adverse Event|3|||
19554282|NCT01296711|42003160|FG004|Overall Study|Adverse Event|1|||
19554283|NCT01296711|42003161|FG005|Overall Study|Adverse Event|6|||
19476676|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
19476677|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
19476678|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
19476679|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
19476680|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
19476681|NCT01493687|41754667|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
19476682|NCT01493687|41754668|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
19476683|NCT01493687|41754667|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
19476684|NCT01493687|41754668|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
19476685|NCT01523587|41754700|FG000|Overall Study|Other than listed|5|||
19476686|NCT01523587|41754701|FG001|Overall Study|Other than listed|5|||
19476687|NCT01523587|41754700|FG000|Overall Study|Worsening of underlying cancer disease|19|||
19476688|NCT01523587|41754701|FG001|Overall Study|Worsening of underlying cancer disease|34|||
19554284|NCT01296711|42003162|FG006|Overall Study|Adverse Event|11|||
19554285|NCT01296711|42003163|FG007|Overall Study|Adverse Event|3|||
19554286|NCT01296711|42003156|FG000|Overall Study|Lack of Efficacy|1|||
19554287|NCT01296711|42003157|FG001|Overall Study|Lack of Efficacy|4|||
19554288|NCT01296711|42003158|FG002|Overall Study|Lack of Efficacy|1|||
19554289|NCT01296711|42003159|FG003|Overall Study|Lack of Efficacy|1|||
19554290|NCT01296711|42003160|FG004|Overall Study|Lack of Efficacy|1|||
19554291|NCT01296711|42003161|FG005|Overall Study|Lack of Efficacy|0|||
19554292|NCT01296711|42003162|FG006|Overall Study|Lack of Efficacy|2|||
19554293|NCT01296711|42003163|FG007|Overall Study|Lack of Efficacy|3|||
19554294|NCT01296711|42003156|FG000|Overall Study|Lost to Follow-up|0|||
19554295|NCT01296711|42003157|FG001|Overall Study|Lost to Follow-up|0|||
19554296|NCT01296711|42003158|FG002|Overall Study|Lost to Follow-up|1|||
19554297|NCT01296711|42003159|FG003|Overall Study|Lost to Follow-up|1|||
19554298|NCT01296711|42003160|FG004|Overall Study|Lost to Follow-up|2|||
19554299|NCT01296711|42003161|FG005|Overall Study|Lost to Follow-up|0|||
19554300|NCT01296711|42003162|FG006|Overall Study|Lost to Follow-up|4|||
19554301|NCT01296711|42003163|FG007|Overall Study|Lost to Follow-up|2|||
19554302|NCT01296711|42003156|FG000|Overall Study|Protocol Violation|0|||
19554303|NCT01296711|42003157|FG001|Overall Study|Protocol Violation|0|||
19554304|NCT01296711|42003158|FG002|Overall Study|Protocol Violation|0|||
19554305|NCT01296711|42003159|FG003|Overall Study|Protocol Violation|1|||
19554306|NCT01296711|42003160|FG004|Overall Study|Protocol Violation|1|||
19554307|NCT01296711|42003161|FG005|Overall Study|Protocol Violation|0|||
19554308|NCT01296711|42003162|FG006|Overall Study|Protocol Violation|0|||
19554309|NCT01296711|42003163|FG007|Overall Study|Protocol Violation|0|||
19554310|NCT01296711|42003156|FG000|Overall Study|Withdrawal by Subject|4|||
19554311|NCT01296711|42003157|FG001|Overall Study|Withdrawal by Subject|2|||
19554312|NCT01296711|42003158|FG002|Overall Study|Withdrawal by Subject|2|||
19554313|NCT01296711|42003159|FG003|Overall Study|Withdrawal by Subject|1|||
19554314|NCT01296711|42003160|FG004|Overall Study|Withdrawal by Subject|1|||
19554315|NCT01296711|42003161|FG005|Overall Study|Withdrawal by Subject|1|||
19554316|NCT01296711|42003162|FG006|Overall Study|Withdrawal by Subject|2|||
19554317|NCT01296711|42003163|FG007|Overall Study|Withdrawal by Subject|1|||
19554318|NCT01296711|42003156|FG000|Overall Study|Study termination|8|||
19554319|NCT01296711|42003157|FG001|Overall Study|Study termination|1|||
19554320|NCT01296711|42003158|FG002|Overall Study|Study termination|5|||
19554321|NCT01296711|42003159|FG003|Overall Study|Study termination|4|||
19554322|NCT01296711|42003160|FG004|Overall Study|Study termination|4|||
19554323|NCT01296711|42003161|FG005|Overall Study|Study termination|4|||
19554324|NCT01296711|42003162|FG006|Overall Study|Study termination|8|||
19554325|NCT01296711|42003163|FG007|Overall Study|Study termination|10|||
19554326|NCT01296711|42003156|FG000|Overall Study|Continued elevated liver enzymes|0|||
19554327|NCT01296711|42003157|FG001|Overall Study|Continued elevated liver enzymes|0|||
19554328|NCT01296711|42003158|FG002|Overall Study|Continued elevated liver enzymes|0|||
19554329|NCT01296711|42003159|FG003|Overall Study|Continued elevated liver enzymes|1|||
19554330|NCT01296711|42003160|FG004|Overall Study|Continued elevated liver enzymes|0|||
19554331|NCT01296711|42003161|FG005|Overall Study|Continued elevated liver enzymes|0|||
19554332|NCT01296711|42003162|FG006|Overall Study|Continued elevated liver enzymes|0|||
19554333|NCT01296711|42003163|FG007|Overall Study|Continued elevated liver enzymes|0|||
19554334|NCT01296711|42003156|FG000|Overall Study|Methotrexate discontinued|0|||
19554335|NCT01296711|42003157|FG001|Overall Study|Methotrexate discontinued|0|||
19554336|NCT01296711|42003158|FG002|Overall Study|Methotrexate discontinued|0|||
19554337|NCT01296711|42003159|FG003|Overall Study|Methotrexate discontinued|1|||
19554338|NCT01296711|42003160|FG004|Overall Study|Methotrexate discontinued|0|||
19554339|NCT01296711|42003161|FG005|Overall Study|Methotrexate discontinued|0|||
19554340|NCT01296711|42003162|FG006|Overall Study|Methotrexate discontinued|0|||
19554341|NCT01296711|42003163|FG007|Overall Study|Methotrexate discontinued|0|||
19382000|NCT01674621|41625046|FG004|Overall Study|Withdrawal by Subject|1|||
19382001|NCT01674621|41625042|FG000|Overall Study|Other than specified|0|||
19554342|NCT01296711|42003156|FG000|Overall Study|Investigator discretion|0|||
19554343|NCT01296711|42003157|FG001|Overall Study|Investigator discretion|0|||
19554344|NCT01296711|42003158|FG002|Overall Study|Investigator discretion|0|||
19554345|NCT01296711|42003159|FG003|Overall Study|Investigator discretion|0|||
19554346|NCT01296711|42003160|FG004|Overall Study|Investigator discretion|0|||
19554347|NCT01296711|42003161|FG005|Overall Study|Investigator discretion|0|||
19554348|NCT01296711|42003162|FG006|Overall Study|Investigator discretion|1|||
19554349|NCT01296711|42003163|FG007|Overall Study|Investigator discretion|0|||
19554350|NCT01296711|42003156|FG000|Overall Study|Other|0|||
19554351|NCT01296711|42003157|FG001|Overall Study|Other|0|||
19554352|NCT01296711|42003158|FG002|Overall Study|Other|0|||
19554353|NCT01296711|42003159|FG003|Overall Study|Other|0|||
19554354|NCT01296711|42003160|FG004|Overall Study|Other|0|||
19554355|NCT01296711|42003161|FG005|Overall Study|Other|0|||
19554356|NCT01296711|42003162|FG006|Overall Study|Other|1|||
19554357|NCT01296711|42003163|FG007|Overall Study|Other|0|||
19554358|NCT01296711|42003156|FG000|Overall Study|Required restricted steroid injections|0|||
19554359|NCT01296711|42003157|FG001|Overall Study|Required restricted steroid injections|0|||
19554360|NCT01296711|42003158|FG002|Overall Study|Required restricted steroid injections|0|||
19554361|NCT01296711|42003159|FG003|Overall Study|Required restricted steroid injections|0|||
19554362|NCT01296711|42003160|FG004|Overall Study|Required restricted steroid injections|0|||
19554363|NCT01296711|42003161|FG005|Overall Study|Required restricted steroid injections|0|||
19554364|NCT01296711|42003162|FG006|Overall Study|Required restricted steroid injections|1|||
19554365|NCT01296711|42003163|FG007|Overall Study|Required restricted steroid injections|0|||
19554366|NCT01296711|42003156|FG000|Overall Study|Ongoing missed appointments|0|||
19554367|NCT01296711|42003157|FG001|Overall Study|Ongoing missed appointments|0|||
19554368|NCT01296711|42003158|FG002|Overall Study|Ongoing missed appointments|0|||
19554369|NCT01296711|42003159|FG003|Overall Study|Ongoing missed appointments|0|||
19554370|NCT01296711|42003160|FG004|Overall Study|Ongoing missed appointments|0|||
19554371|NCT01296711|42003161|FG005|Overall Study|Ongoing missed appointments|0|||
19554372|NCT01296711|42003162|FG006|Overall Study|Ongoing missed appointments|1|||
19554373|NCT01296711|42003163|FG007|Overall Study|Ongoing missed appointments|0|||
19554374|NCT01296711|42003156|FG000|Overall Study|Failure to comply with visits|0|||
19554375|NCT01296711|42003157|FG001|Overall Study|Failure to comply with visits|0|||
19554376|NCT01296711|42003158|FG002|Overall Study|Failure to comply with visits|0|||
19554377|NCT01296711|42003159|FG003|Overall Study|Failure to comply with visits|0|||
19554378|NCT01296711|42003160|FG004|Overall Study|Failure to comply with visits|0|||
19554379|NCT01296711|42003161|FG005|Overall Study|Failure to comply with visits|0|||
19554380|NCT01296711|42003162|FG006|Overall Study|Failure to comply with visits|0|||
19554381|NCT01296711|42003163|FG007|Overall Study|Failure to comply with visits|1|||
19554382|NCT01296711|42003156|FG000|Overall Study|Patient decision due to transport|0|||
19554383|NCT01296711|42003157|FG001|Overall Study|Patient decision due to transport|0|||
19554384|NCT01296711|42003158|FG002|Overall Study|Patient decision due to transport|0|||
19554385|NCT01296711|42003159|FG003|Overall Study|Patient decision due to transport|0|||
19554386|NCT01296711|42003160|FG004|Overall Study|Patient decision due to transport|0|||
19554387|NCT01296711|42003161|FG005|Overall Study|Patient decision due to transport|0|||
19554388|NCT01296711|42003162|FG006|Overall Study|Patient decision due to transport|0|||
19554389|NCT01296711|42003163|FG007|Overall Study|Patient decision due to transport|1|||
19554390|NCT01294917|42003181|FG000|Overall Study|Relocation|5|||
19554391|NCT01294917|42003181|FG000|Overall Study|Inconvenience|1|||
19554392|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
19554393|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
19554394|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
19554395|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
19554396|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
19554397|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
19554398|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
19554399|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
19554400|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
19554401|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
19554402|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
19554403|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
19554404|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
19554405|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
19554406|NCT01294683|42003189|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
19554407|NCT01294683|42003190|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
19554408|NCT01294683|42003189|FG000|Post Crossover (Period III)|Adverse Event|6|||
19554409|NCT01294683|42003190|FG001|Post Crossover (Period III)|Adverse Event|6|||
19554410|NCT01294683|42003189|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
19554411|NCT01294683|42003190|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
19554412|NCT01294683|42003189|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
19554413|NCT01294683|42003190|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
19554414|NCT01294683|42003189|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
19554415|NCT01294683|42003190|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
19554416|NCT01294449|42003204|FG000|Overall Study|Death|11|||
19554417|NCT01294449|42003205|FG001|Overall Study|Death|12|||
19554418|NCT01294449|42003204|FG000|Overall Study|Withdrawal by Subject|1|||
19554419|NCT01294449|42003205|FG001|Overall Study|Withdrawal by Subject|3|||
19554420|NCT01294371|42003211|FG000|Overall Study|Adverse Event|1|||
19554421|NCT01294371|42003211|FG000|Overall Study|Withdrawal by Subject|12|||
19554422|NCT01294371|42003211|FG000|Overall Study|Lost to Follow-up|6|||
19554423|NCT01294371|42003211|FG000|Overall Study|Administrative Reason|1|||
19554424|NCT01294371|42003211|FG000|Overall Study|Other|14|||
19554425|NCT01293123|42003220|FG000|Overall Study|Lost to Follow-up|0|||
19554426|NCT01293123|42003221|FG001|Overall Study|Lost to Follow-up|1|||
19554427|NCT01292187|42003229|FG000|Overall Study|Adverse Event|10|||
19554428|NCT01292187|42003230|FG001|Overall Study|Adverse Event|5|||
19554429|NCT01292187|42003229|FG000|Overall Study|Withdrawal by Subject|6|||
19554430|NCT01292187|42003230|FG001|Overall Study|Withdrawal by Subject|5|||
19554431|NCT01292187|42003229|FG000|Overall Study|All other reasons|1|||
19554432|NCT01292187|42003230|FG001|Overall Study|All other reasons|3|||
19554433|NCT01026493|42003245|FG000|Overall Study|Protocol Violation|0|||
19739414|NCT03519867|42186487|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19390361|NCT01987960|41634113|FG003|Period 3|Adverse Event|7|||
19554434|NCT01026493|42003246|FG001|Overall Study|Protocol Violation|1|||
19554435|NCT01026493|42003247|FG002|Overall Study|Protocol Violation|0|||
19554436|NCT01026493|42003248|FG003|Overall Study|Protocol Violation|0|||
19554437|NCT01026493|42003249|FG004|Overall Study|Protocol Violation|2|||
19554438|NCT01026493|42003250|FG005|Overall Study|Protocol Violation|3|||
19554439|NCT01026493|42003251|FG006|Overall Study|Protocol Violation|4|||
19554440|NCT01026493|42003252|FG007|Overall Study|Protocol Violation|1|||
19554441|NCT01026103|42003270|FG000|Overall Study|Physician Decision|1|||
19554442|NCT01026103|42003270|FG000|Overall Study|did not receive study device bc of error|1|||
19554443|NCT01291173|42003278|FG000|Overall Study|Adverse Event|0|||
19554444|NCT01291173|42003279|FG001|Overall Study|Adverse Event|3|||
19554445|NCT01291173|42003280|FG002|Overall Study|Adverse Event|1|||
19554446|NCT01291173|42003281|FG003|Overall Study|Adverse Event|3|||
19554447|NCT01291173|42003278|FG000|Overall Study|Protocol Violation|7|||
19554448|NCT01291173|42003279|FG001|Overall Study|Protocol Violation|2|||
19554449|NCT01291173|42003280|FG002|Overall Study|Protocol Violation|2|||
19554450|NCT01291173|42003281|FG003|Overall Study|Protocol Violation|5|||
19554451|NCT01291173|42003278|FG000|Overall Study|Withdrawal by Subject|6|||
19554452|NCT01291173|42003279|FG001|Overall Study|Withdrawal by Subject|4|||
19554453|NCT01291173|42003280|FG002|Overall Study|Withdrawal by Subject|4|||
19554454|NCT01291173|42003281|FG003|Overall Study|Withdrawal by Subject|2|||
19554455|NCT01291173|42003278|FG000|Overall Study|Lost to Follow-up|4|||
19554456|NCT01291173|42003279|FG001|Overall Study|Lost to Follow-up|6|||
19554457|NCT01291173|42003280|FG002|Overall Study|Lost to Follow-up|3|||
19554458|NCT01291173|42003281|FG003|Overall Study|Lost to Follow-up|2|||
19554459|NCT01291173|42003278|FG000|Overall Study|Unable to meet visit schedule|0|||
19554460|NCT01291173|42003279|FG001|Overall Study|Unable to meet visit schedule|0|||
19554461|NCT01291173|42003280|FG002|Overall Study|Unable to meet visit schedule|1|||
19554462|NCT01291173|42003281|FG003|Overall Study|Unable to meet visit schedule|0|||
19554463|NCT01291173|42003278|FG000|Overall Study|Lack of compliance|0|||
19554464|NCT01291173|42003279|FG001|Overall Study|Lack of compliance|0|||
19554465|NCT01291173|42003280|FG002|Overall Study|Lack of compliance|0|||
19554466|NCT01291173|42003281|FG003|Overall Study|Lack of compliance|1|||
19554467|NCT01291173|42003278|FG000|Overall Study|Subject was unblinded|0|||
19554468|NCT01291173|42003279|FG001|Overall Study|Subject was unblinded|0|||
19554469|NCT01291173|42003280|FG002|Overall Study|Subject was unblinded|1|||
19554470|NCT01291173|42003281|FG003|Overall Study|Subject was unblinded|0|||
19554471|NCT01291173|42003278|FG000|Overall Study|Excluded therapy|0|||
19554472|NCT01291173|42003279|FG001|Overall Study|Excluded therapy|0|||
19554473|NCT01291173|42003280|FG002|Overall Study|Excluded therapy|1|||
19554474|NCT01291173|42003281|FG003|Overall Study|Excluded therapy|0|||
19554475|NCT01291017|42003291|FG000|Overall Study|Lost to Follow-up|2|||
19554476|NCT01291017|42003291|FG000|Overall Study|Withdrawal by Subject|3|||
19554477|NCT01290315|42003299|FG000|Overall Study|Adverse Event|0|||
19554478|NCT01290315|42003300|FG001|Overall Study|Adverse Event|0|||
19554479|NCT01290315|42003301|FG002|Overall Study|Adverse Event|0|||
19554480|NCT01290315|42003302|FG003|Overall Study|Adverse Event|3|||
19554481|NCT01290315|42003299|FG000|Overall Study|Selection criteria/compliance|2|||
19554482|NCT01290315|42003300|FG001|Overall Study|Selection criteria/compliance|1|||
19554483|NCT01290315|42003301|FG002|Overall Study|Selection criteria/compliance|0|||
19554484|NCT01290315|42003302|FG003|Overall Study|Selection criteria/compliance|2|||
19554485|NCT01290315|42003299|FG000|Overall Study|Lost to Follow-up|0|||
19554486|NCT01290315|42003300|FG001|Overall Study|Lost to Follow-up|1|||
19554487|NCT01290315|42003301|FG002|Overall Study|Lost to Follow-up|0|||
19554488|NCT01290315|42003302|FG003|Overall Study|Lost to Follow-up|0|||
19554489|NCT01290315|42003299|FG000|Overall Study|Withdrawal by Subject|1|||
19554490|NCT01290315|42003300|FG001|Overall Study|Withdrawal by Subject|1|||
19554491|NCT01290315|42003301|FG002|Overall Study|Withdrawal by Subject|0|||
19554492|NCT01290315|42003302|FG003|Overall Study|Withdrawal by Subject|0|||
19554493|NCT01289847|42003311|FG000|Overall Study|Patient could not comply with visits|1|||
19554494|NCT01079182|42003315|FG000|Overall Study|Lost to Follow-up|1634|||
19554495|NCT01079182|42003315|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
19554496|NCT01079182|42003315|FG000|Overall Study|Lack of Efficacy|514|||
19554497|NCT01079182|42003315|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
19554498|NCT01079182|42003315|FG000|Overall Study|Reasons not Evaluated|271|||
19554499|NCT01021813|42003321|FG000|DB Treatment Phase|Adverse Event|60|||
19554500|NCT01021813|42003322|FG001|DB Treatment Phase|Adverse Event|22|||
19554501|NCT01021813|42003323|FG002|DB Treatment Phase|Adverse Event|0|||
19554502|NCT01021813|42003324|FG003|DB Treatment Phase|Adverse Event|0|||
19554503|NCT01021813|42003325|FG004|DB Treatment Phase|Adverse Event|0|||
19554504|NCT01021813|42003321|FG000|DB Treatment Phase|Lack of Efficacy|44|||
19554505|NCT01021813|42003322|FG001|DB Treatment Phase|Lack of Efficacy|28|||
19554506|NCT01021813|42003323|FG002|DB Treatment Phase|Lack of Efficacy|0|||
19554507|NCT01021813|42003324|FG003|DB Treatment Phase|Lack of Efficacy|0|||
19554508|NCT01021813|42003325|FG004|DB Treatment Phase|Lack of Efficacy|0|||
19554509|NCT01021813|42003321|FG000|DB Treatment Phase|Lost to Follow-up|14|||
19554510|NCT01021813|42003322|FG001|DB Treatment Phase|Lost to Follow-up|12|||
19554511|NCT01021813|42003323|FG002|DB Treatment Phase|Lost to Follow-up|0|||
19554512|NCT01021813|42003324|FG003|DB Treatment Phase|Lost to Follow-up|0|||
19554513|NCT01021813|42003325|FG004|DB Treatment Phase|Lost to Follow-up|0|||
19554514|NCT01021813|42003321|FG000|DB Treatment Phase|Physician Decision|17|||
19554515|NCT01021813|42003322|FG001|DB Treatment Phase|Physician Decision|8|||
19554516|NCT01021813|42003323|FG002|DB Treatment Phase|Physician Decision|0|||
19554517|NCT01021813|42003324|FG003|DB Treatment Phase|Physician Decision|0|||
19554518|NCT01021813|42003325|FG004|DB Treatment Phase|Physician Decision|0|||
19554519|NCT01021813|42003321|FG000|DB Treatment Phase|Pregnancy|1|||
19554520|NCT01021813|42003322|FG001|DB Treatment Phase|Pregnancy|0|||
19554521|NCT01021813|42003323|FG002|DB Treatment Phase|Pregnancy|0|||
19554522|NCT01021813|42003324|FG003|DB Treatment Phase|Pregnancy|0|||
19554523|NCT01021813|42003325|FG004|DB Treatment Phase|Pregnancy|0|||
19554524|NCT01021813|42003321|FG000|DB Treatment Phase|Protocol Violation|4|||
19739415|NCT03519867|42186488|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19554525|NCT01021813|42003322|FG001|DB Treatment Phase|Protocol Violation|3|||
19554526|NCT01021813|42003323|FG002|DB Treatment Phase|Protocol Violation|0|||
19554527|NCT01021813|42003324|FG003|DB Treatment Phase|Protocol Violation|0|||
19554528|NCT01021813|42003325|FG004|DB Treatment Phase|Protocol Violation|0|||
19554529|NCT01021813|42003321|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
19554530|NCT01021813|42003322|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
19554531|NCT01021813|42003323|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
19554532|NCT01021813|42003324|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
19554533|NCT01021813|42003325|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
19554534|NCT01021813|42003321|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
19554535|NCT01021813|42003322|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
19554536|NCT01021813|42003323|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
19554537|NCT01021813|42003324|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
19554538|NCT01021813|42003325|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
19554539|NCT01021813|42003321|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
19554540|NCT01021813|42003322|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
19554541|NCT01021813|42003323|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
19554542|NCT01021813|42003324|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
19554543|NCT01021813|42003325|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
19554544|NCT01021813|42003321|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
19554545|NCT01021813|42003322|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
19554546|NCT01021813|42003323|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
19554547|NCT01021813|42003324|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
19554548|NCT01021813|42003325|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
19554549|NCT01021813|42003321|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
19554550|NCT01021813|42003322|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
19554551|NCT01021813|42003323|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
19554552|NCT01021813|42003324|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
19554553|NCT01021813|42003325|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
19554554|NCT01021813|42003321|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
19554555|NCT01021813|42003322|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
19554556|NCT01021813|42003323|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
19554557|NCT01021813|42003324|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
19554558|NCT01021813|42003325|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
19554559|NCT01025635|42003344|FG000|Overall Study|Withdrawal by Subject|6|||
19554560|NCT01025635|42003345|FG001|Overall Study|Withdrawal by Subject|7|||
19554561|NCT01025635|42003344|FG000|Overall Study|Protocol Violation|4|||
19554562|NCT01025635|42003345|FG001|Overall Study|Protocol Violation|2|||
19554563|NCT01025635|42003344|FG000|Overall Study|Lack of Efficacy|0|||
19554564|NCT01025635|42003345|FG001|Overall Study|Lack of Efficacy|1|||
19554565|NCT01025635|42003344|FG000|Overall Study|Lost to Follow-up|9|||
19554566|NCT01025635|42003345|FG001|Overall Study|Lost to Follow-up|13|||
19554567|NCT01025635|42003344|FG000|Overall Study|Reason not known|4|||
19554568|NCT01025635|42003345|FG001|Overall Study|Reason not known|2|||
19554569|NCT01021423|42003353|FG000|Overall Study|Study terminated|4|||
19554570|NCT01021423|42003354|FG001|Overall Study|Study terminated|5|||
19554571|NCT01020877|42003362|FG000|Second Intervention|Withdrawal by Subject|1|||
19554572|NCT01020877|42003363|FG001|Second Intervention|Withdrawal by Subject|0|||
19554573|NCT01020799|42003372|FG000|Overall Study|Adverse Event|4|||
19554574|NCT01020799|42003373|FG001|Overall Study|Adverse Event|3|||
19554575|NCT01020799|42003374|FG002|Overall Study|Adverse Event|2|||
19554576|NCT01020799|42003372|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
19554577|NCT01020799|42003373|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
19554578|NCT01020799|42003374|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
19554579|NCT01020799|42003372|FG000|Overall Study|Protocol Violation|3|||
19554580|NCT01020799|42003373|FG001|Overall Study|Protocol Violation|2|||
19554581|NCT01020799|42003374|FG002|Overall Study|Protocol Violation|0|||
19554582|NCT01020799|42003372|FG000|Overall Study|Withdrawal by Subject|2|||
19554583|NCT01020799|42003373|FG001|Overall Study|Withdrawal by Subject|2|||
19554584|NCT01020799|42003374|FG002|Overall Study|Withdrawal by Subject|3|||
19554585|NCT01020799|42003372|FG000|Overall Study|Lost to Follow-up|6|||
19554586|NCT01020799|42003373|FG001|Overall Study|Lost to Follow-up|4|||
19554587|NCT01020799|42003374|FG002|Overall Study|Lost to Follow-up|2|||
19554588|NCT01288989|42003387|FG000|Overall Study|Death|0|||
19554589|NCT01288989|42003388|FG001|Overall Study|Death|0|||
19554590|NCT01288989|42003389|FG002|Overall Study|Death|0|||
19554591|NCT01288989|42003390|FG003|Overall Study|Death|1|||
19554592|NCT01288989|42003391|FG004|Overall Study|Death|0|||
19554593|NCT01288989|42003387|FG000|Overall Study|Dose limiting toxicity|1|||
19554594|NCT01288989|42003388|FG001|Overall Study|Dose limiting toxicity|0|||
19554595|NCT01288989|42003389|FG002|Overall Study|Dose limiting toxicity|0|||
19554596|NCT01288989|42003390|FG003|Overall Study|Dose limiting toxicity|0|||
19554597|NCT01288989|42003391|FG004|Overall Study|Dose limiting toxicity|0|||
19554598|NCT01288989|42003387|FG000|Overall Study|Adverse Event|0|||
19554599|NCT01288989|42003388|FG001|Overall Study|Adverse Event|0|||
19554600|NCT01288989|42003389|FG002|Overall Study|Adverse Event|0|||
19554601|NCT01288989|42003390|FG003|Overall Study|Adverse Event|0|||
19554602|NCT01288989|42003391|FG004|Overall Study|Adverse Event|2|||
19554603|NCT01288989|42003387|FG000|Overall Study|Physician Decision|0|||
19554604|NCT01288989|42003388|FG001|Overall Study|Physician Decision|0|||
19554605|NCT01288989|42003389|FG002|Overall Study|Physician Decision|0|||
19476689|NCT01523587|41754700|FG000|Overall Study|Adverse Event|68|||
19554606|NCT01288989|42003390|FG003|Overall Study|Physician Decision|0|||
19554607|NCT01288989|42003391|FG004|Overall Study|Physician Decision|1|||
19554608|NCT01288989|42003387|FG000|Overall Study|Withdrawal by Subject|0|||
19554609|NCT01288989|42003388|FG001|Overall Study|Withdrawal by Subject|0|||
19554610|NCT01288989|42003389|FG002|Overall Study|Withdrawal by Subject|0|||
19554611|NCT01288989|42003390|FG003|Overall Study|Withdrawal by Subject|0|||
19554612|NCT01288989|42003391|FG004|Overall Study|Withdrawal by Subject|3|||
19554613|NCT01020487|42003412|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
19554614|NCT01020487|42003413|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
19554615|NCT01020487|42003414|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
19554616|NCT01020487|42003412|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
19554617|NCT01020487|42003413|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
19554618|NCT01020487|42003414|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
19554619|NCT01020487|42003412|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
19554620|NCT01020487|42003413|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
19554621|NCT01020487|42003414|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
19554622|NCT01020487|42003412|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
19554623|NCT01020487|42003413|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
19554624|NCT01020487|42003414|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
19476690|NCT01523587|41754701|FG001|Overall Study|Adverse Event|52|||
19476691|NCT01523587|41754700|FG000|Overall Study|Protocol Violation|5|||
19476692|NCT01523587|41754701|FG001|Overall Study|Protocol Violation|3|||
19476693|NCT01523587|41754700|FG000|Overall Study|Lost to Follow-up|2|||
19476694|NCT01523587|41754701|FG001|Overall Study|Lost to Follow-up|2|||
19476695|NCT01523587|41754700|FG000|Overall Study|Withdrawal by Subject|28|||
19476696|NCT01523587|41754701|FG001|Overall Study|Withdrawal by Subject|20|||
19476697|NCT01523587|41754700|FG000|Overall Study|Withdrew due to Progressive disease|265|||
19476698|NCT01523587|41754701|FG001|Overall Study|Withdrew due to Progressive disease|279|||
19554625|NCT01020487|42003412|FG000|Part 2 Open-label Period|Adverse Event|0|||
19554626|NCT01020487|42003413|FG001|Part 2 Open-label Period|Adverse Event|4|||
19554627|NCT01020487|42003414|FG002|Part 2 Open-label Period|Adverse Event|1|||
19554628|NCT01024855|42003424|FG000|Overall Study|Inclusion/exclusion criteria|1|||
19554629|NCT01014013|42003431|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
19554630|NCT01014013|42003432|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
19554631|NCT01014013|42003431|FG000|Overall Study|Clinical adverse experience|4|||
19554632|NCT01014013|42003432|FG001|Overall Study|Clinical adverse experience|2|||
19554633|NCT01014013|42003431|FG000|Overall Study|Laboratory adverse experience|1|||
19554634|NCT01014013|42003432|FG001|Overall Study|Laboratory adverse experience|1|||
19554635|NCT01014013|42003431|FG000|Overall Study|Protocol Violation|1|||
19554636|NCT01014013|42003432|FG001|Overall Study|Protocol Violation|3|||
19554637|NCT01014013|42003431|FG000|Overall Study|Withdrawal by Subject|7|||
19554638|NCT01014013|42003432|FG001|Overall Study|Withdrawal by Subject|4|||
19554639|NCT01014013|42003431|FG000|Overall Study|Clinical/microbiologic failure|1|||
19554640|NCT01014013|42003432|FG001|Overall Study|Clinical/microbiologic failure|2|||
19554641|NCT01014013|42003431|FG000|Overall Study|Pathogen culture = no growth|26|||
19554642|NCT01014013|42003432|FG001|Overall Study|Pathogen culture = no growth|34|||
19554643|NCT01014013|42003431|FG000|Overall Study|Negative urine culture|2|||
19554644|NCT01014013|42003432|FG001|Overall Study|Negative urine culture|0|||
19554645|NCT01014013|42003431|FG000|Overall Study|Pathogen resistant|7|||
19554646|NCT01014013|42003432|FG001|Overall Study|Pathogen resistant|4|||
19554647|NCT01014013|42003431|FG000|Overall Study|Physician Decision|0|||
19554648|NCT01014013|42003432|FG001|Overall Study|Physician Decision|1|||
19554649|NCT01014013|42003431|FG000|Overall Study|Another antibiotic therapy required|0|||
19554650|NCT01014013|42003432|FG001|Overall Study|Another antibiotic therapy required|1|||
19554651|NCT01014013|42003431|FG000|Overall Study|Appendectomy|1|||
19554652|NCT01014013|42003432|FG001|Overall Study|Appendectomy|0|||
19739416|NCT03519867|42186489|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19739417|NCT03519867|42186490|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19739418|NCT03519867|42186491|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
19739419|NCT03519867|42186492|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19739420|NCT03519867|42186493|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19554653|NCT01014013|42003431|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
19554654|NCT01014013|42003432|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
19554655|NCT01013701|42003440|FG000|Overall Study|study prematurely terminated|7|||
19554656|NCT01020019|42003447|FG000|Overall Study|Lost to Follow-up|21|||
19554657|NCT01020019|42003448|FG001|Overall Study|Lost to Follow-up|18|||
19554658|NCT01020019|42003447|FG000|Overall Study|Adverse Event|1|||
19554659|NCT01020019|42003448|FG001|Overall Study|Adverse Event|5|||
19554660|NCT01020019|42003447|FG000|Overall Study|not interested in treatment|4|||
19554661|NCT01020019|42003448|FG001|Overall Study|not interested in treatment|4|||
19554662|NCT01020019|42003447|FG000|Overall Study|moving|0|||
19554663|NCT01020019|42003448|FG001|Overall Study|moving|2|||
19554664|NCT01024465|42003454|FG000|Overall Study|Adverse Event|2|||
19554665|NCT01024465|42003454|FG000|Overall Study|Physician Decision|1|||
19554666|NCT01024387|42003458|FG000|Overall Study|Radiographic Progression|29|||
19554667|NCT01024387|42003458|FG000|Overall Study|Symptomatic Progression|10|||
19554668|NCT01024387|42003458|FG000|Overall Study|Physician Decision|5|||
19373521|NCT02758613|41614709|FG002|Treatment|Physician and Sponsor Decision|0|||
19373522|NCT02758613|41614710|FG003|Treatment|Physician and Sponsor Decision|0|||
19373523|NCT02758613|41614707|FG000|Treatment|Withdrawal by Subject|1|||
19373524|NCT02758613|41614708|FG001|Treatment|Withdrawal by Subject|0|||
19373525|NCT02758613|41614709|FG002|Treatment|Withdrawal by Subject|1|||
19373526|NCT02758613|41614710|FG003|Treatment|Withdrawal by Subject|0|||
19373527|NCT02758301|41614725|FG000|Overall Study|Death|12|||
19373528|NCT02758301|41614726|FG001|Overall Study|Death|0|||
19373529|NCT02758301|41614725|FG000|Overall Study|Physician Decision|10|||
19373530|NCT02758301|41614726|FG001|Overall Study|Physician Decision|1|||
19373531|NCT02758301|41614725|FG000|Overall Study|Withdrawal by Subject|5|||
19373532|NCT02758301|41614726|FG001|Overall Study|Withdrawal by Subject|6|||
19373533|NCT02758301|41614725|FG000|Overall Study|Lost to Follow-up|7|||
19373534|NCT02758301|41614726|FG001|Overall Study|Lost to Follow-up|0|||
19373535|NCT02758301|41614725|FG000|Overall Study|Protocol Violation|0|||
19373536|NCT02758301|41614726|FG001|Overall Study|Protocol Violation|1|||
19373537|NCT02669667|41614746|FG000|Overall Study|Lost to Follow-up|0|||
19373538|NCT02669667|41614747|FG001|Overall Study|Lost to Follow-up|0|||
19373539|NCT02669667|41614748|FG002|Overall Study|Lost to Follow-up|0|||
19373540|NCT02669667|41614749|FG003|Overall Study|Lost to Follow-up|0|||
19373541|NCT02669667|41614750|FG004|Overall Study|Lost to Follow-up|0|||
19373542|NCT02669667|41614751|FG005|Overall Study|Lost to Follow-up|1|||
19373543|NCT02669667|41614752|FG006|Overall Study|Lost to Follow-up|0|||
19373544|NCT02669433|41614777|FG000|Overall Study|Protocol Violation|0|||
19373545|NCT02669433|41614778|FG001|Overall Study|Protocol Violation|4|||
19373546|NCT02669433|41614779|FG002|Overall Study|Protocol Violation|1|||
19373547|NCT02669433|41614777|FG000|Overall Study|Disease Progression|1|||
19373548|NCT02669433|41614778|FG001|Overall Study|Disease Progression|0|||
19373549|NCT02669433|41614779|FG002|Overall Study|Disease Progression|0|||
19373550|NCT02669433|41614777|FG000|Overall Study|Physician Decision|1|||
19373551|NCT02669433|41614778|FG001|Overall Study|Physician Decision|1|||
19373552|NCT02669433|41614779|FG002|Overall Study|Physician Decision|0|||
19373553|NCT02669433|41614777|FG000|Overall Study|Adverse Event|6|||
19373554|NCT02669433|41614778|FG001|Overall Study|Adverse Event|7|||
19373555|NCT02669433|41614779|FG002|Overall Study|Adverse Event|10|||
19373556|NCT02669433|41614777|FG000|Overall Study|Sponsor Termination|1|||
19373557|NCT02669433|41614778|FG001|Overall Study|Sponsor Termination|0|||
19373558|NCT02669433|41614779|FG002|Overall Study|Sponsor Termination|1|||
19373559|NCT02669433|41614777|FG000|Overall Study|Withdrawal by Subject|5|||
19373560|NCT02669433|41614778|FG001|Overall Study|Withdrawal by Subject|1|||
19373561|NCT02669433|41614779|FG002|Overall Study|Withdrawal by Subject|0|||
19373562|NCT02669433|41614777|FG000|Overall Study|Withdrawal by Caregiver|1|||
19373563|NCT02669433|41614778|FG001|Overall Study|Withdrawal by Caregiver|0|||
19373564|NCT02669433|41614779|FG002|Overall Study|Withdrawal by Caregiver|2|||
19373565|NCT02669433|41614777|FG000|Overall Study|Death|0|||
19373566|NCT02669433|41614778|FG001|Overall Study|Death|1|||
19373567|NCT02669433|41614779|FG002|Overall Study|Death|1|||
19373568|NCT02756819|41614787|FG000|Overall Study|Lost for observation|23|||
19373569|NCT02756819|41614787|FG000|Overall Study|Patient's unwillingness|16|||
19373570|NCT02756819|41614787|FG000|Overall Study|Insufficient efficacy|2|||
19373571|NCT02756819|41614787|FG000|Overall Study|Adverse Event|2|||
19373572|NCT02756819|41614787|FG000|Overall Study|Reason not Specified|9|||
19373573|NCT00829309|41614793|FG000|Washout: 7 Days|Protocol Violation|1|||
19373574|NCT00829309|41614794|FG001|Washout: 7 Days|Protocol Violation|0|||
19373575|NCT02669121|41614800|FG000|Overall Study|Adverse Event|4|||
19373576|NCT02669121|41614801|FG001|Overall Study|Adverse Event|5|||
19373577|NCT02669121|41614800|FG000|Overall Study|Lost to Follow-up|15|||
19373578|NCT02669121|41614801|FG001|Overall Study|Lost to Follow-up|27|||
19373579|NCT02669121|41614800|FG000|Overall Study|Withdrawal by Subject|132|||
19373580|NCT02669121|41614801|FG001|Overall Study|Withdrawal by Subject|140|||
19373581|NCT02669121|41614800|FG000|Overall Study|Pregnancy|0|||
19373582|NCT02669121|41614801|FG001|Overall Study|Pregnancy|1|||
19373583|NCT02669121|41614800|FG000|Overall Study|Discharged from US Military Active Service|117|||
19373584|NCT02669121|41614801|FG001|Overall Study|Discharged from US Military Active Service|91|||
19373585|NCT02669121|41614800|FG000|Overall Study|Reason not Specified|22|||
19373586|NCT02669121|41614801|FG001|Overall Study|Reason not Specified|18|||
19373587|NCT02743117|41614809|FG000|Overall Study|Lost to Follow-up|0|||
19373588|NCT02743117|41614810|FG001|Overall Study|Lost to Follow-up|1|||
19373589|NCT02743117|41614809|FG000|Overall Study|Other|1|||
19373590|NCT02743117|41614810|FG001|Overall Study|Other|0|||
19373591|NCT02669043|41614825|FG000|Overall Study|Didn't meet I/E criteria|4|||
19373592|NCT02760407|41614833|FG000|Overall Study|Death|2|||
19373593|NCT02760407|41614834|FG001|Overall Study|Death|3|||
19373594|NCT02760407|41614835|FG002|Overall Study|Death|1|||
19554669|NCT01024387|42003458|FG000|Overall Study|Withdrawal by Subject|5|||
19554670|NCT01024387|42003458|FG000|Overall Study|Death|2|||
19554671|NCT01024387|42003458|FG000|Overall Study|Prolonged Treatment Delay|1|||
19554672|NCT01024387|42003458|FG000|Overall Study|Adverse Event|3|||
19554673|NCT01024387|42003458|FG000|Overall Study|Other|5|||
19554674|NCT01019317|42003462|FG000|Overall Study|Not Eligible|4|||
19554675|NCT01024309|42003468|FG000|Overall Study|Physician Decision|4|||
19554676|NCT01024309|42003469|FG001|Overall Study|Physician Decision|0|||
19554677|NCT01024309|42003468|FG000|Overall Study|Withdrawal by Subject|4|||
19554678|NCT01024309|42003469|FG001|Overall Study|Withdrawal by Subject|4|||
19554679|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
19554680|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
19554681|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
19554682|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
19554683|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
19739421|NCT03519867|42186494|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
19739422|NCT03519867|42186485|FG000|Overall Study|Admin. of other reversal agent|1|||
19554684|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
19554685|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
19554686|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
19554687|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554688|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
19554689|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554690|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554691|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554692|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554693|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
19554694|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
19554695|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554696|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554697|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
19554698|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554699|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554700|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554701|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554702|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554703|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Other|0|||
19554704|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Other|0|||
19554705|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Other|1|||
19554706|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Other|1|||
19554707|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Other|2|||
19554708|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Other|0|||
19554709|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Other|0|||
19554710|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Other|0|||
19554711|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554712|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554713|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554714|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554715|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
19554716|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554717|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554718|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
19554719|NCT01090492|42003483|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
19554720|NCT01090492|42003484|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
19373595|NCT02760407|41614836|FG003|Overall Study|Death|1|||
19554721|NCT01090492|42003485|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
19554722|NCT01090492|42003486|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
19554723|NCT01090492|42003487|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
19554724|NCT01090492|42003488|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
19554725|NCT01090492|42003489|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
19554726|NCT01090492|42003490|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
19554727|NCT01090492|42003483|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
19554728|NCT01090492|42003484|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
19554729|NCT01090492|42003485|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
19554730|NCT01090492|42003486|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
19554731|NCT01090492|42003487|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
19554732|NCT01090492|42003488|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
19554733|NCT01090492|42003489|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
19554734|NCT01090492|42003490|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
19554735|NCT01090492|42003483|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554736|NCT01090492|42003484|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
19554737|NCT01090492|42003485|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554738|NCT01090492|42003486|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554739|NCT01090492|42003487|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554740|NCT01090492|42003488|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554741|NCT01090492|42003489|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554742|NCT01090492|42003490|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
19554743|NCT01090492|42003483|FG000|Second Intervention Period (4 Weeks)|Other|0|||
19554744|NCT01090492|42003484|FG001|Second Intervention Period (4 Weeks)|Other|1|||
19554745|NCT01090492|42003485|FG002|Second Intervention Period (4 Weeks)|Other|1|||
19554746|NCT01090492|42003486|FG003|Second Intervention Period (4 Weeks)|Other|0|||
19554747|NCT01090492|42003487|FG004|Second Intervention Period (4 Weeks)|Other|0|||
19554748|NCT01090492|42003488|FG005|Second Intervention Period (4 Weeks)|Other|0|||
19554749|NCT01090492|42003489|FG006|Second Intervention Period (4 Weeks)|Other|0|||
19554750|NCT01090492|42003490|FG007|Second Intervention Period (4 Weeks)|Other|0|||
19554751|NCT01090492|42003483|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
19554752|NCT01090492|42003484|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
19554753|NCT01090492|42003485|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
19554754|NCT01090492|42003486|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
19554755|NCT01090492|42003487|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
19382002|NCT01674621|41625043|FG001|Overall Study|Other than specified|1|||
19382003|NCT01674621|41625044|FG002|Overall Study|Other than specified|0|||
19554756|NCT01090492|42003488|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
19554757|NCT01090492|42003489|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
19554758|NCT01090492|42003490|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
19390362|NCT01987960|41634110|FG000|Period 3|Non-compliance with IMP|0|||
19554759|NCT01090492|42003483|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554760|NCT01090492|42003484|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554761|NCT01090492|42003485|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554762|NCT01090492|42003486|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554763|NCT01090492|42003487|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554764|NCT01090492|42003488|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554765|NCT01090492|42003489|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
19554766|NCT01090492|42003490|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
19554767|NCT01288911|42003511|FG000|Double-blind Period|Death|11|||
19554768|NCT01288911|42003512|FG001|Double-blind Period|Death|7|||
19554769|NCT01288911|42003511|FG000|Double-blind Period|Lost to Follow-up|0|||
19554770|NCT01288911|42003512|FG001|Double-blind Period|Lost to Follow-up|2|||
19554771|NCT01288911|42003511|FG000|Double-blind Period|Progressive Disease|75|||
19554772|NCT01288911|42003512|FG001|Double-blind Period|Progressive Disease|103|||
19554773|NCT01288911|42003511|FG000|Double-blind Period|Protocol Violation|1|||
19554774|NCT01288911|42003512|FG001|Double-blind Period|Protocol Violation|0|||
19554775|NCT01288911|42003511|FG000|Double-blind Period|Withdrawal by Subject|25|||
19554776|NCT01288911|42003512|FG001|Double-blind Period|Withdrawal by Subject|26|||
19554777|NCT01288911|42003511|FG000|Double-blind Period|Miscellaneous Reason|29|||
19554778|NCT01288911|42003512|FG001|Double-blind Period|Miscellaneous Reason|42|||
19554779|NCT01288911|42003511|FG000|Double-blind Period|Randomized but never received study drug|1|||
19373596|NCT02760407|41614833|FG000|Overall Study|Lost to Follow-up|1|||
19554780|NCT01288911|42003512|FG001|Double-blind Period|Randomized but never received study drug|2|||
19554781|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Death|0|||
19554782|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Death|1|||
19554783|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
19554784|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
19554785|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
19554786|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
19554787|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
19554788|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
19554789|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
19554790|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
19554791|NCT01288911|42003511|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
19554792|NCT01288911|42003512|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
19554793|NCT01288443|42003527|FG000|Overall Study|Adverse Event|0|||
19554794|NCT01288443|42003528|FG001|Overall Study|Adverse Event|0|||
19554795|NCT01288443|42003529|FG002|Overall Study|Adverse Event|1|||
19554796|NCT01288443|42003530|FG003|Overall Study|Adverse Event|1|||
19554797|NCT01288443|42003531|FG004|Overall Study|Adverse Event|3|||
19554798|NCT01288443|42003532|FG005|Overall Study|Adverse Event|1|||
19554799|NCT01288443|42003527|FG000|Overall Study|Poor compliance to protocol|0|||
19554800|NCT01288443|42003528|FG001|Overall Study|Poor compliance to protocol|0|||
19554801|NCT01288443|42003529|FG002|Overall Study|Poor compliance to protocol|0|||
19554802|NCT01288443|42003530|FG003|Overall Study|Poor compliance to protocol|0|||
19554803|NCT01288443|42003531|FG004|Overall Study|Poor compliance to protocol|0|||
19554804|NCT01288443|42003532|FG005|Overall Study|Poor compliance to protocol|1|||
19382004|NCT01674621|41625045|FG003|Overall Study|Other than specified|0|||
19554805|NCT01288443|42003527|FG000|Overall Study|Participant Moved|0|||
19554806|NCT01288443|42003528|FG001|Overall Study|Participant Moved|0|||
19554807|NCT01288443|42003529|FG002|Overall Study|Participant Moved|0|||
19554808|NCT01288443|42003530|FG003|Overall Study|Participant Moved|1|||
19554809|NCT01288443|42003531|FG004|Overall Study|Participant Moved|2|||
19554810|NCT01288443|42003532|FG005|Overall Study|Participant Moved|1|||
19554811|NCT01288443|42003527|FG000|Overall Study|Consent withdrawn by Participant|0|||
19554812|NCT01288443|42003528|FG001|Overall Study|Consent withdrawn by Participant|0|||
19554813|NCT01288443|42003529|FG002|Overall Study|Consent withdrawn by Participant|0|||
19554814|NCT01288443|42003530|FG003|Overall Study|Consent withdrawn by Participant|0|||
19554815|NCT01288443|42003531|FG004|Overall Study|Consent withdrawn by Participant|0|||
19554816|NCT01288443|42003532|FG005|Overall Study|Consent withdrawn by Participant|1|||
19554817|NCT01288443|42003527|FG000|Overall Study|Lost to Follow-up|0|||
19554818|NCT01288443|42003528|FG001|Overall Study|Lost to Follow-up|1|||
19554819|NCT01288443|42003529|FG002|Overall Study|Lost to Follow-up|0|||
19554820|NCT01288443|42003530|FG003|Overall Study|Lost to Follow-up|0|||
19554821|NCT01288443|42003531|FG004|Overall Study|Lost to Follow-up|0|||
19554822|NCT01288443|42003532|FG005|Overall Study|Lost to Follow-up|0|||
19554823|NCT01288443|42003527|FG000|Overall Study|Study drug auto-injector administration|0|||
19554824|NCT01288443|42003528|FG001|Overall Study|Study drug auto-injector administration|0|||
19554825|NCT01288443|42003529|FG002|Overall Study|Study drug auto-injector administration|0|||
19554826|NCT01288443|42003530|FG003|Overall Study|Study drug auto-injector administration|0|||
19554827|NCT01288443|42003531|FG004|Overall Study|Study drug auto-injector administration|1|||
19554828|NCT01288443|42003532|FG005|Overall Study|Study drug auto-injector administration|1|||
19554829|NCT01288443|42003527|FG000|Overall Study|Other than above|0|||
19554830|NCT01288443|42003528|FG001|Overall Study|Other than above|0|||
19554831|NCT01288443|42003529|FG002|Overall Study|Other than above|0|||
19554832|NCT01288443|42003530|FG003|Overall Study|Other than above|2|||
19554833|NCT01288443|42003531|FG004|Overall Study|Other than above|1|||
19554834|NCT01288443|42003532|FG005|Overall Study|Other than above|0|||
19554835|NCT01288287|42003546|FG000|Overall Study|Lost to Follow-up|8|||
19554836|NCT01288287|42003546|FG000|Overall Study|Withdrawal by Subject|4|||
19554837|NCT01288287|42003546|FG000|Overall Study|Lack of Efficacy|13|||
19554838|NCT01288287|42003546|FG000|Overall Study|Other Reason|13|||
19554839|NCT01288287|42003546|FG000|Overall Study|Unknown Reason|1|||
19554840|NCT01288287|42003546|FG000|Overall Study|Unknown Status|7|||
19554841|NCT01288209|42003553|FG000|Overall Study|Withdrawal by Subject|1|||
19554842|NCT01288209|42003554|FG001|Overall Study|Withdrawal by Subject|3|||
19554843|NCT01288209|42003553|FG000|Overall Study|Other|1|||
19554844|NCT01288209|42003554|FG001|Overall Study|Other|0|||
19554845|NCT01288053|42003560|FG000|Overall Study|Death|1|||
19554846|NCT01287897|42003568|FG000|Overall Study|Adverse Event|5|||
19382005|NCT01674621|41625046|FG004|Overall Study|Other than specified|2|||
19554847|NCT01287897|42003569|FG001|Overall Study|Adverse Event|3|||
19554848|NCT01287897|42003570|FG002|Overall Study|Adverse Event|6|||
19554849|NCT01287897|42003571|FG003|Overall Study|Adverse Event|4|||
19739423|NCT03519867|42186486|FG001|Overall Study|Admin. of other reversal agent|1|||
19739424|NCT03519867|42186487|FG002|Overall Study|Admin. of other reversal agent|0|||
19739425|NCT03519867|42186488|FG003|Overall Study|Admin. of other reversal agent|0|||
19739426|NCT03519867|42186489|FG004|Overall Study|Admin. of other reversal agent|0|||
19739427|NCT03519867|42186490|FG005|Overall Study|Admin. of other reversal agent|1|||
19739428|NCT03519867|42186491|FG006|Overall Study|Admin. of other reversal agent|0|||
19739429|NCT03519867|42186492|FG007|Overall Study|Admin. of other reversal agent|0|||
19739430|NCT03519867|42186493|FG008|Overall Study|Admin. of other reversal agent|0|||
19554850|NCT01287897|42003568|FG000|Overall Study|Lack of Efficacy|2|||
19739431|NCT03519867|42186494|FG009|Overall Study|Admin. of other reversal agent|0|||
19739432|NCT03519867|42186485|FG000|Overall Study|Reason not provided|1|||
19739433|NCT03519867|42186486|FG001|Overall Study|Reason not provided|1|||
19739434|NCT03519867|42186487|FG002|Overall Study|Reason not provided|1|||
19739435|NCT03519867|42186488|FG003|Overall Study|Reason not provided|1|||
19554851|NCT01287897|42003569|FG001|Overall Study|Lack of Efficacy|0|||
19554852|NCT01287897|42003570|FG002|Overall Study|Lack of Efficacy|0|||
19554853|NCT01287897|42003571|FG003|Overall Study|Lack of Efficacy|0|||
19554854|NCT01287897|42003568|FG000|Overall Study|Protocol Violation|1|||
19554855|NCT01287897|42003569|FG001|Overall Study|Protocol Violation|1|||
19554856|NCT01287897|42003570|FG002|Overall Study|Protocol Violation|0|||
19554857|NCT01287897|42003571|FG003|Overall Study|Protocol Violation|1|||
19554858|NCT01287897|42003568|FG000|Overall Study|Lost to Follow-up|0|||
19554859|NCT01287897|42003569|FG001|Overall Study|Lost to Follow-up|0|||
19554860|NCT01287897|42003570|FG002|Overall Study|Lost to Follow-up|2|||
19739436|NCT03519867|42186489|FG004|Overall Study|Reason not provided|0|||
19739437|NCT03519867|42186490|FG005|Overall Study|Reason not provided|1|||
19739438|NCT03519867|42186491|FG006|Overall Study|Reason not provided|0|||
19739439|NCT03519867|42186492|FG007|Overall Study|Reason not provided|1|||
19739440|NCT03519867|42186493|FG008|Overall Study|Reason not provided|1|||
19739441|NCT03519867|42186494|FG009|Overall Study|Reason not provided|0|||
19739442|NCT03519087|42186518|FG000|Clinic Evaluation|Physician Decision|15|||
19739443|NCT03519087|42186519|FG001|Clinic Evaluation|Physician Decision|18|||
19739444|NCT03519087|42186520|FG002|Clinic Evaluation|Physician Decision|0|||
19739445|NCT03519087|42186521|FG003|Clinic Evaluation|Physician Decision|0|||
19739446|NCT03519087|42186522|FG004|Clinic Evaluation|Physician Decision|0|||
19739447|NCT03519087|42186518|FG000|Clinic Evaluation|Protocol Violation|1|||
19739448|NCT03519087|42186519|FG001|Clinic Evaluation|Protocol Violation|0|||
19554861|NCT01287897|42003571|FG003|Overall Study|Lost to Follow-up|0|||
19554862|NCT01287897|42003568|FG000|Overall Study|Withdrawal by Subject|1|||
19739449|NCT03519087|42186520|FG002|Clinic Evaluation|Protocol Violation|0|||
19739450|NCT03519087|42186521|FG003|Clinic Evaluation|Protocol Violation|0|||
19554863|NCT01287897|42003569|FG001|Overall Study|Withdrawal by Subject|5|||
19554864|NCT01287897|42003570|FG002|Overall Study|Withdrawal by Subject|3|||
19554865|NCT01287897|42003571|FG003|Overall Study|Withdrawal by Subject|2|||
19476699|NCT01523587|41754700|FG000|Overall Study|Randomised but bot treated|6|||
19476700|NCT01523587|41754701|FG001|Overall Study|Randomised but bot treated|2|||
19476701|NCT01493531|41754730|FG000|Overall Study|Adverse Event|4|||
19476702|NCT01493531|41754731|FG001|Overall Study|Adverse Event|12|||
19476703|NCT01493531|41754732|FG002|Overall Study|Adverse Event|9|||
19476704|NCT01493531|41754730|FG000|Overall Study|Gout flare|3|||
19476705|NCT01493531|41754731|FG001|Overall Study|Gout flare|0|||
19476706|NCT01493531|41754732|FG002|Overall Study|Gout flare|2|||
19476707|NCT01493531|41754730|FG000|Overall Study|Protocol Violation|8|||
19476708|NCT01493531|41754731|FG001|Overall Study|Protocol Violation|15|||
19476709|NCT01493531|41754732|FG002|Overall Study|Protocol Violation|12|||
19476710|NCT01493531|41754730|FG000|Overall Study|Sponsor terminated study|5|||
19476711|NCT01493531|41754731|FG001|Overall Study|Sponsor terminated study|2|||
19554866|NCT01287897|42003568|FG000|Overall Study|Not consented properly|0|||
19554867|NCT01287897|42003569|FG001|Overall Study|Not consented properly|1|||
19554868|NCT01287897|42003570|FG002|Overall Study|Not consented properly|0|||
19554869|NCT01287897|42003571|FG003|Overall Study|Not consented properly|0|||
19554870|NCT01287897|42003568|FG000|Overall Study|Not meeting entrance criteria|1|||
19554871|NCT01287897|42003569|FG001|Overall Study|Not meeting entrance criteria|1|||
19554872|NCT01287897|42003570|FG002|Overall Study|Not meeting entrance criteria|0|||
19554873|NCT01287897|42003571|FG003|Overall Study|Not meeting entrance criteria|0|||
19554874|NCT01287897|42003568|FG000|Overall Study|Other|1|||
19554875|NCT01287897|42003569|FG001|Overall Study|Other|0|||
19554876|NCT01287897|42003570|FG002|Overall Study|Other|1|||
19554877|NCT01287897|42003571|FG003|Overall Study|Other|0|||
19554878|NCT01287195|42003585|FG000|Overall Study|Withdrawal by Subject|2|||
19554879|NCT01287117|42003593|FG000|Overall Study|Adverse Event|2|||
19554880|NCT01287117|42003594|FG001|Overall Study|Adverse Event|1|||
19554881|NCT01287117|42003595|FG002|Overall Study|Adverse Event|1|||
19554882|NCT01287117|42003596|FG003|Overall Study|Adverse Event|1|||
19554883|NCT01287117|42003593|FG000|Overall Study|Lost to Follow-up|1|||
19554884|NCT01287117|42003594|FG001|Overall Study|Lost to Follow-up|1|||
19554885|NCT01287117|42003595|FG002|Overall Study|Lost to Follow-up|0|||
19554886|NCT01287117|42003596|FG003|Overall Study|Lost to Follow-up|0|||
19554887|NCT01287117|42003593|FG000|Overall Study|Physician Decision|0|||
19554888|NCT01287117|42003594|FG001|Overall Study|Physician Decision|1|||
19554889|NCT01287117|42003595|FG002|Overall Study|Physician Decision|1|||
19554890|NCT01287117|42003596|FG003|Overall Study|Physician Decision|1|||
19554891|NCT01287117|42003593|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
19554892|NCT01287117|42003594|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
19554893|NCT01287117|42003595|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
19554894|NCT01287117|42003596|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
19554895|NCT01287117|42003593|FG000|Overall Study|Disease Progression|10|||
19554896|NCT01287117|42003594|FG001|Overall Study|Disease Progression|5|||
19554897|NCT01287117|42003595|FG002|Overall Study|Disease Progression|6|||
19554898|NCT01287117|42003596|FG003|Overall Study|Disease Progression|5|||
19554899|NCT01287039|42003608|FG000|Overall Study|Noncompliance with study procedures|0|||
19554900|NCT01287039|42003609|FG001|Overall Study|Noncompliance with study procedures|1|||
19554901|NCT01287039|42003608|FG000|Overall Study|Change of location/residence|0|||
19554902|NCT01287039|42003609|FG001|Overall Study|Change of location/residence|3|||
19554903|NCT01287039|42003608|FG000|Overall Study|Elective surgery|0|||
19554904|NCT01287039|42003609|FG001|Overall Study|Elective surgery|1|||
19554905|NCT01287039|42003608|FG000|Overall Study|Protocol Violation|2|||
19554906|NCT01287039|42003609|FG001|Overall Study|Protocol Violation|3|||
19554907|NCT01287039|42003608|FG000|Overall Study|Excluded medication taken|1|||
19554908|NCT01287039|42003609|FG001|Overall Study|Excluded medication taken|0|||
19554909|NCT01287039|42003608|FG000|Overall Study|Noncompliance with study medication|0|||
19554910|NCT01287039|42003609|FG001|Overall Study|Noncompliance with study medication|1|||
19554911|NCT01287039|42003608|FG000|Overall Study|Problem with travel|0|||
19554912|NCT01287039|42003609|FG001|Overall Study|Problem with travel|1|||
19554913|NCT01287039|42003608|FG000|Overall Study|Death|1|||
19554914|NCT01287039|42003609|FG001|Overall Study|Death|0|||
19554915|NCT01287039|42003608|FG000|Overall Study|Change of residence|1|||
19554916|NCT01287039|42003609|FG001|Overall Study|Change of residence|0|||
19476712|NCT01493531|41754732|FG002|Overall Study|Sponsor terminated study|3|||
19476713|NCT01493531|41754730|FG000|Overall Study|Lost to Follow-up|5|||
19476714|NCT01493531|41754731|FG001|Overall Study|Lost to Follow-up|7|||
19476715|NCT01493531|41754732|FG002|Overall Study|Lost to Follow-up|11|||
19476716|NCT01493531|41754730|FG000|Overall Study|Withdrawal by Subject|16|||
19476717|NCT01493531|41754731|FG001|Overall Study|Withdrawal by Subject|13|||
19476718|NCT01493531|41754732|FG002|Overall Study|Withdrawal by Subject|11|||
19476719|NCT01493531|41754730|FG000|Overall Study|Death|0|||
19476720|NCT01493531|41754731|FG001|Overall Study|Death|1|||
19476721|NCT01493531|41754732|FG002|Overall Study|Death|0|||
19476722|NCT01523275|41754756|FG000|Overall Study|Lost to Follow-up|1|||
19476723|NCT01523275|41754757|FG001|Overall Study|Lost to Follow-up|2|||
19476724|NCT01523275|41754756|FG000|Overall Study|Withdrawal by Subject|1|||
19476725|NCT01523275|41754757|FG001|Overall Study|Withdrawal by Subject|0|||
19476726|NCT01492439|41754774|FG000|Overall Study|Withdrew from RTE|4|||
19476727|NCT01492439|41754775|FG001|Overall Study|Withdrew from RTE|9|||
19476728|NCT01572727|41754810|FG000|Overall Study|Adverse Event|43|||
19476729|NCT01572727|41754811|FG001|Overall Study|Adverse Event|15|||
19476730|NCT01572727|41754810|FG000|Overall Study|Lost to Follow-up|1|||
19476731|NCT01572727|41754811|FG001|Overall Study|Lost to Follow-up|1|||
19476732|NCT01572727|41754810|FG000|Overall Study|Physician Decision|23|||
19476733|NCT01572727|41754811|FG001|Overall Study|Physician Decision|9|||
19476734|NCT01572727|41754810|FG000|Overall Study|Progressive disease|59|||
19476735|NCT01572727|41754811|FG001|Overall Study|Progressive disease|82|||
19476736|NCT01572727|41754810|FG000|Overall Study|Protocol Violation|0|||
19476737|NCT01572727|41754811|FG001|Overall Study|Protocol Violation|1|||
19476738|NCT01572727|41754810|FG000|Overall Study|Study terminated by sponsor|61|||
19476739|NCT01572727|41754811|FG001|Overall Study|Study terminated by sponsor|83|||
19476740|NCT01572727|41754810|FG000|Overall Study|Parent/guardian decision|14|||
19476741|NCT01572727|41754811|FG001|Overall Study|Parent/guardian decision|9|||
19476742|NCT01572727|41754810|FG000|Overall Study|Death|2|||
19554917|NCT01287039|42003608|FG000|Overall Study|Adverse Event|7|||
19554918|NCT01287039|42003609|FG001|Overall Study|Adverse Event|4|||
19554919|NCT01287039|42003608|FG000|Overall Study|Withdrawal by Subject|14|||
19554920|NCT01287039|42003609|FG001|Overall Study|Withdrawal by Subject|11|||
19554921|NCT01287039|42003608|FG000|Overall Study|Lost to Follow-up|3|||
19554922|NCT01287039|42003609|FG001|Overall Study|Lost to Follow-up|2|||
19554923|NCT01285401|42003617|FG000|Overall Study|Prematurely withdrawn from the study|17|||
19554924|NCT01285401|42003618|FG001|Overall Study|Prematurely withdrawn from the study|29|||
19554925|NCT01285323|42003626|FG000|Overall Study|Adverse Event|9|||
19554926|NCT01285323|42003627|FG001|Overall Study|Adverse Event|8|||
19554927|NCT01285323|42003626|FG000|Overall Study|Lack of Efficacy|4|||
19554928|NCT01285323|42003627|FG001|Overall Study|Lack of Efficacy|2|||
19554929|NCT01285323|42003626|FG000|Overall Study|Withdrawal by Subject|15|||
19554930|NCT01285323|42003627|FG001|Overall Study|Withdrawal by Subject|11|||
19554931|NCT01285323|42003626|FG000|Overall Study|Protocol Violation|1|||
19554932|NCT01285323|42003627|FG001|Overall Study|Protocol Violation|2|||
19554933|NCT01285323|42003626|FG000|Overall Study|Non-compliance with study procedures|2|||
19554934|NCT01285323|42003627|FG001|Overall Study|Non-compliance with study procedures|3|||
19554935|NCT01285323|42003626|FG000|Overall Study|Lost to Follow-up|1|||
19554936|NCT01285323|42003627|FG001|Overall Study|Lost to Follow-up|1|||
19554937|NCT01285323|42003626|FG000|Overall Study|Other|1|||
19554938|NCT01285323|42003627|FG001|Overall Study|Other|3|||
19554939|NCT01284621|42003633|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
19554940|NCT01284621|42003634|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
19554941|NCT01284621|42003635|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
19554942|NCT01284621|42003636|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
19554943|NCT01284621|42003637|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
19554944|NCT01284621|42003638|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
19554945|NCT01283139|42003652|FG000|Overall Study|Lost to Follow-up|5|||
19554946|NCT01283139|42003653|FG001|Overall Study|Lost to Follow-up|2|||
19554947|NCT01283139|42003654|FG002|Overall Study|Lost to Follow-up|3|||
19554948|NCT01283139|42003655|FG003|Overall Study|Lost to Follow-up|1|||
19554949|NCT01283139|42003652|FG000|Overall Study|Withdrawal by Subject|8|||
19554950|NCT01283139|42003653|FG001|Overall Study|Withdrawal by Subject|8|||
19554951|NCT01283139|42003654|FG002|Overall Study|Withdrawal by Subject|6|||
19554952|NCT01283139|42003655|FG003|Overall Study|Withdrawal by Subject|8|||
19554953|NCT01283139|42003652|FG000|Overall Study|Death|2|||
19554954|NCT01283139|42003653|FG001|Overall Study|Death|0|||
19554955|NCT01283139|42003654|FG002|Overall Study|Death|2|||
19554956|NCT01283139|42003655|FG003|Overall Study|Death|2|||
19554957|NCT01283139|42003652|FG000|Overall Study|Lack of Efficacy|1|||
19554958|NCT01283139|42003653|FG001|Overall Study|Lack of Efficacy|2|||
19554959|NCT01283139|42003654|FG002|Overall Study|Lack of Efficacy|2|||
19554960|NCT01283139|42003655|FG003|Overall Study|Lack of Efficacy|1|||
19554961|NCT01283139|42003652|FG000|Overall Study|Early termination due to AE/SAE|1|||
19554962|NCT01283139|42003653|FG001|Overall Study|Early termination due to AE/SAE|1|||
19554963|NCT01283139|42003654|FG002|Overall Study|Early termination due to AE/SAE|0|||
19554964|NCT01283139|42003655|FG003|Overall Study|Early termination due to AE/SAE|0|||
19554965|NCT01283139|42003652|FG000|Overall Study|Participant's refusal to continue|0|||
19554966|NCT01283139|42003653|FG001|Overall Study|Participant's refusal to continue|3|||
19554967|NCT01283139|42003654|FG002|Overall Study|Participant's refusal to continue|1|||
19554968|NCT01283139|42003655|FG003|Overall Study|Participant's refusal to continue|1|||
19554969|NCT01283139|42003652|FG000|Overall Study|Pregnancy|0|||
19554970|NCT01283139|42003653|FG001|Overall Study|Pregnancy|1|||
19554971|NCT01283139|42003654|FG002|Overall Study|Pregnancy|1|||
19554972|NCT01283139|42003655|FG003|Overall Study|Pregnancy|0|||
19554973|NCT01283139|42003652|FG000|Overall Study|Missed follow-up visit|0|||
19554974|NCT01283139|42003653|FG001|Overall Study|Missed follow-up visit|1|||
19554975|NCT01283139|42003654|FG002|Overall Study|Missed follow-up visit|2|||
19554976|NCT01283139|42003655|FG003|Overall Study|Missed follow-up visit|2|||
19554977|NCT01283139|42003652|FG000|Overall Study|Participant randomized in error|0|||
19554978|NCT01283139|42003653|FG001|Overall Study|Participant randomized in error|0|||
19554979|NCT01283139|42003654|FG002|Overall Study|Participant randomized in error|1|||
19554980|NCT01283139|42003655|FG003|Overall Study|Participant randomized in error|0|||
19554981|NCT01282203|42003665|FG000|Overall Study|Adverse Event|1|||
19554982|NCT01281969|42003674|FG000|Overall Study|not randomized didn't meet criteria|0|||
19554983|NCT01281969|42003675|FG001|Overall Study|not randomized didn't meet criteria|0|||
19554984|NCT01281969|42003676|FG002|Overall Study|not randomized didn't meet criteria|7|||
19554985|NCT01281969|42003674|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
19554986|NCT01281969|42003675|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
19554987|NCT01281969|42003676|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
19554988|NCT01281969|42003674|FG000|Overall Study|not randomized, child consent not given|0|||
19554989|NCT01281969|42003675|FG001|Overall Study|not randomized, child consent not given|0|||
19554990|NCT01281969|42003676|FG002|Overall Study|not randomized, child consent not given|2|||
19554991|NCT01281813|42003687|FG000|Overall Study|Adverse Event|0|||
19554992|NCT01281813|42003688|FG001|Overall Study|Adverse Event|0|||
19554993|NCT01281813|42003689|FG002|Overall Study|Adverse Event|10|||
19554994|NCT01281813|42003687|FG000|Overall Study|Lost to Follow-up|0|||
19554995|NCT01281813|42003688|FG001|Overall Study|Lost to Follow-up|0|||
19554996|NCT01281813|42003689|FG002|Overall Study|Lost to Follow-up|31|||
19554997|NCT01281813|42003687|FG000|Overall Study|Withdrawal by Subject|0|||
19554998|NCT01281813|42003688|FG001|Overall Study|Withdrawal by Subject|0|||
19554999|NCT01281813|42003689|FG002|Overall Study|Withdrawal by Subject|13|||
19555000|NCT01281813|42003687|FG000|Overall Study|Subject Non-Compliant|0|||
19555001|NCT01281813|42003688|FG001|Overall Study|Subject Non-Compliant|0|||
19555002|NCT01281813|42003689|FG002|Overall Study|Subject Non-Compliant|6|||
19555003|NCT01281813|42003687|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
19555004|NCT01281813|42003688|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
19555005|NCT01281813|42003689|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
19555006|NCT01281813|42003687|FG000|Overall Study|Sponsor's Decision|4|||
19555007|NCT01281813|42003688|FG001|Overall Study|Sponsor's Decision|3|||
19555008|NCT01281813|42003689|FG002|Overall Study|Sponsor's Decision|7|||
19555009|NCT01281813|42003687|FG000|Overall Study|Switched to Commercially Available Medication|0|||
19555010|NCT01281813|42003688|FG001|Overall Study|Switched to Commercially Available Medication|0|||
19555011|NCT01281813|42003689|FG002|Overall Study|Switched to Commercially Available Medication|26|||
19555012|NCT01281813|42003687|FG000|Overall Study|Other|0|||
19555013|NCT01281813|42003688|FG001|Overall Study|Other|1|||
19555014|NCT01281813|42003689|FG002|Overall Study|Other|39|||
19555015|NCT01090414|42003701|FG000|Study 101-99|Progressive Disease|28|||
19555016|NCT01090414|42003702|FG001|Study 101-99|Progressive Disease|48|||
19555017|NCT01090414|42003703|FG002|Study 101-99|Progressive Disease|10|||
19555018|NCT01090414|42003704|FG003|Study 101-99|Progressive Disease|4|||
19555019|NCT01090414|42003701|FG000|Study 101-99|Adverse Event|10|||
19555020|NCT01090414|42003702|FG001|Study 101-99|Adverse Event|28|||
19555021|NCT01090414|42003703|FG002|Study 101-99|Adverse Event|18|||
19555022|NCT01090414|42003704|FG003|Study 101-99|Adverse Event|0|||
19555023|NCT01090414|42003701|FG000|Study 101-99|Investigator Request|1|||
19555024|NCT01090414|42003702|FG001|Study 101-99|Investigator Request|11|||
19555025|NCT01090414|42003703|FG002|Study 101-99|Investigator Request|4|||
19555026|NCT01090414|42003704|FG003|Study 101-99|Investigator Request|0|||
19555027|NCT01090414|42003701|FG000|Study 101-99|Death|3|||
19555028|NCT01090414|42003702|FG001|Study 101-99|Death|8|||
19555029|NCT01090414|42003703|FG002|Study 101-99|Death|1|||
19555030|NCT01090414|42003704|FG003|Study 101-99|Death|0|||
19555031|NCT01090414|42003701|FG000|Study 101-99|Sponsor Discontinued Study|0|||
19555032|NCT01090414|42003702|FG001|Study 101-99|Sponsor Discontinued Study|7|||
19555033|NCT01090414|42003703|FG002|Study 101-99|Sponsor Discontinued Study|5|||
19555034|NCT01090414|42003704|FG003|Study 101-99|Sponsor Discontinued Study|0|||
19555035|NCT01090414|42003701|FG000|Study 101-99|Other (Unknown Reasons)|3|||
19555036|NCT01090414|42003702|FG001|Study 101-99|Other (Unknown Reasons)|3|||
19555037|NCT01090414|42003703|FG002|Study 101-99|Other (Unknown Reasons)|0|||
19555038|NCT01090414|42003704|FG003|Study 101-99|Other (Unknown Reasons)|0|||
19555039|NCT01090414|42003701|FG000|Study 101-99|Withdrew Consent|0|||
19555040|NCT01090414|42003702|FG001|Study 101-99|Withdrew Consent|2|||
19555041|NCT01090414|42003703|FG002|Study 101-99|Withdrew Consent|3|||
19555042|NCT01090414|42003704|FG003|Study 101-99|Withdrew Consent|1|||
19555043|NCT01090414|42003701|FG000|Study 101-99|Participant Request|3|||
19555044|NCT01090414|42003702|FG001|Study 101-99|Participant Request|1|||
19555045|NCT01090414|42003703|FG002|Study 101-99|Participant Request|0|||
19555046|NCT01090414|42003704|FG003|Study 101-99|Participant Request|0|||
19555047|NCT01090102|42003728|FG000|First 12 Weeks|Withdrawal by Subject|1|||
19555048|NCT01090102|42003729|FG001|First 12 Weeks|Withdrawal by Subject|1|||
19555049|NCT01090102|42003728|FG000|First 12 Weeks|Adverse Event|2|||
19555050|NCT01090102|42003729|FG001|First 12 Weeks|Adverse Event|0|||
19555051|NCT01090102|42003728|FG000|First 12 Weeks|Death|1|||
19555052|NCT01090102|42003729|FG001|First 12 Weeks|Death|1|||
19555053|NCT01090102|42003728|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
19555054|NCT01090102|42003729|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
19555055|NCT01090024|42003735|FG000|Period 1|Met exclusion criteria|0|||
19555056|NCT01090024|42003736|FG001|Period 1|Met exclusion criteria|0|||
19555057|NCT01090024|42003737|FG002|Period 1|Met exclusion criteria|0|||
19555058|NCT01090024|42003738|FG003|Period 1|Met exclusion criteria|0|||
19555059|NCT01090024|42003739|FG004|Period 1|Met exclusion criteria|0|||
19555060|NCT01090024|42003740|FG005|Period 1|Met exclusion criteria|0|||
19555061|NCT01090024|42003741|FG006|Period 1|Met exclusion criteria|0|||
19555062|NCT01090024|42003742|FG007|Period 1|Met exclusion criteria|0|||
19555063|NCT01090024|42003743|FG008|Period 1|Met exclusion criteria|0|||
19555064|NCT01090024|42003744|FG009|Period 1|Met exclusion criteria|0|||
19555065|NCT01090024|42003745|FG010|Period 1|Met exclusion criteria|0|||
19555066|NCT01090024|42003746|FG011|Period 1|Met exclusion criteria|0|||
19555067|NCT01090024|42003747|FG012|Period 1|Met exclusion criteria|0|||
19555068|NCT01090024|42003748|FG013|Period 1|Met exclusion criteria|0|||
19555069|NCT01090024|42003749|FG014|Period 1|Met exclusion criteria|1|||
19555070|NCT01090024|42003750|FG015|Period 1|Met exclusion criteria|0|||
19476743|NCT01572727|41754811|FG001|Overall Study|Death|2|||
19476744|NCT01572727|41754810|FG000|Overall Study|Untreated|4|||
19476745|NCT01572727|41754811|FG001|Overall Study|Untreated|7|||
19476746|NCT01522651|41754858|FG000|Overall Study|Adverse Event|3|||
19476747|NCT01522651|41754859|FG001|Overall Study|Adverse Event|4|||
19476748|NCT01522651|41754860|FG002|Overall Study|Adverse Event|4|||
19476749|NCT01522651|41754861|FG003|Overall Study|Adverse Event|5|||
19476750|NCT01522651|41754862|FG004|Overall Study|Adverse Event|4|||
19476751|NCT01522651|41754858|FG000|Overall Study|Cardioversion|1|||
19476752|NCT01522651|41754859|FG001|Overall Study|Cardioversion|0|||
19555071|NCT01090024|42003751|FG016|Period 1|Met exclusion criteria|0|||
19555072|NCT01090024|42003752|FG017|Period 1|Met exclusion criteria|0|||
19555073|NCT01090024|42003735|FG000|Period 1|Adverse Event|0|||
19555074|NCT01090024|42003736|FG001|Period 1|Adverse Event|0|||
19555075|NCT01090024|42003737|FG002|Period 1|Adverse Event|0|||
19555076|NCT01090024|42003738|FG003|Period 1|Adverse Event|0|||
19555077|NCT01090024|42003739|FG004|Period 1|Adverse Event|0|||
19555078|NCT01090024|42003740|FG005|Period 1|Adverse Event|0|||
19555079|NCT01090024|42003741|FG006|Period 1|Adverse Event|0|||
19555080|NCT01090024|42003742|FG007|Period 1|Adverse Event|0|||
19555081|NCT01090024|42003743|FG008|Period 1|Adverse Event|0|||
19555082|NCT01090024|42003744|FG009|Period 1|Adverse Event|1|||
19555083|NCT01090024|42003745|FG010|Period 1|Adverse Event|0|||
19555084|NCT01090024|42003746|FG011|Period 1|Adverse Event|1|||
19555085|NCT01090024|42003747|FG012|Period 1|Adverse Event|0|||
19555086|NCT01090024|42003748|FG013|Period 1|Adverse Event|0|||
19555087|NCT01090024|42003749|FG014|Period 1|Adverse Event|0|||
19555088|NCT01090024|42003750|FG015|Period 1|Adverse Event|0|||
19555089|NCT01090024|42003751|FG016|Period 1|Adverse Event|0|||
19555090|NCT01090024|42003752|FG017|Period 1|Adverse Event|1|||
19555091|NCT01090024|42003735|FG000|Period 1|Withdrawal by Subject|0|||
19555092|NCT01090024|42003736|FG001|Period 1|Withdrawal by Subject|0|||
19555093|NCT01090024|42003737|FG002|Period 1|Withdrawal by Subject|0|||
19555094|NCT01090024|42003738|FG003|Period 1|Withdrawal by Subject|1|||
19555095|NCT01090024|42003739|FG004|Period 1|Withdrawal by Subject|0|||
19555096|NCT01090024|42003740|FG005|Period 1|Withdrawal by Subject|0|||
19555097|NCT01090024|42003741|FG006|Period 1|Withdrawal by Subject|0|||
19555098|NCT01090024|42003742|FG007|Period 1|Withdrawal by Subject|0|||
19555099|NCT01090024|42003743|FG008|Period 1|Withdrawal by Subject|0|||
19555100|NCT01090024|42003744|FG009|Period 1|Withdrawal by Subject|0|||
19555101|NCT01090024|42003745|FG010|Period 1|Withdrawal by Subject|0|||
19555102|NCT01090024|42003746|FG011|Period 1|Withdrawal by Subject|0|||
19555103|NCT01090024|42003747|FG012|Period 1|Withdrawal by Subject|0|||
19555104|NCT01090024|42003748|FG013|Period 1|Withdrawal by Subject|0|||
19555105|NCT01090024|42003749|FG014|Period 1|Withdrawal by Subject|0|||
19555106|NCT01090024|42003750|FG015|Period 1|Withdrawal by Subject|0|||
19555107|NCT01090024|42003751|FG016|Period 1|Withdrawal by Subject|0|||
19555108|NCT01090024|42003752|FG017|Period 1|Withdrawal by Subject|0|||
19555109|NCT01090024|42003735|FG000|Period 1|Lost to Follow-up|0|||
19555110|NCT01090024|42003736|FG001|Period 1|Lost to Follow-up|1|||
19555111|NCT01090024|42003737|FG002|Period 1|Lost to Follow-up|0|||
19555112|NCT01090024|42003738|FG003|Period 1|Lost to Follow-up|0|||
19555113|NCT01090024|42003739|FG004|Period 1|Lost to Follow-up|0|||
19555114|NCT01090024|42003740|FG005|Period 1|Lost to Follow-up|0|||
19555115|NCT01090024|42003741|FG006|Period 1|Lost to Follow-up|0|||
19555116|NCT01090024|42003742|FG007|Period 1|Lost to Follow-up|0|||
19555117|NCT01090024|42003743|FG008|Period 1|Lost to Follow-up|0|||
19555118|NCT01090024|42003744|FG009|Period 1|Lost to Follow-up|0|||
19555119|NCT01090024|42003745|FG010|Period 1|Lost to Follow-up|0|||
19555120|NCT01090024|42003746|FG011|Period 1|Lost to Follow-up|0|||
19555121|NCT01090024|42003747|FG012|Period 1|Lost to Follow-up|0|||
19555122|NCT01090024|42003748|FG013|Period 1|Lost to Follow-up|0|||
19555123|NCT01090024|42003749|FG014|Period 1|Lost to Follow-up|0|||
19555124|NCT01090024|42003750|FG015|Period 1|Lost to Follow-up|0|||
19555125|NCT01090024|42003751|FG016|Period 1|Lost to Follow-up|0|||
19555126|NCT01090024|42003752|FG017|Period 1|Lost to Follow-up|0|||
19555127|NCT01090024|42003735|FG000|Period 2|Lost to Follow-up|0|||
19555128|NCT01090024|42003736|FG001|Period 2|Lost to Follow-up|0|||
19555129|NCT01090024|42003737|FG002|Period 2|Lost to Follow-up|0|||
19555130|NCT01090024|42003738|FG003|Period 2|Lost to Follow-up|1|||
19555131|NCT01090024|42003739|FG004|Period 2|Lost to Follow-up|0|||
19555132|NCT01090024|42003740|FG005|Period 2|Lost to Follow-up|0|||
19555133|NCT01090024|42003741|FG006|Period 2|Lost to Follow-up|0|||
19555134|NCT01090024|42003742|FG007|Period 2|Lost to Follow-up|0|||
19555135|NCT01090024|42003743|FG008|Period 2|Lost to Follow-up|0|||
19555136|NCT01090024|42003744|FG009|Period 2|Lost to Follow-up|0|||
19555137|NCT01090024|42003745|FG010|Period 2|Lost to Follow-up|0|||
19555138|NCT01090024|42003746|FG011|Period 2|Lost to Follow-up|0|||
19555139|NCT01090024|42003747|FG012|Period 2|Lost to Follow-up|0|||
19555140|NCT01090024|42003748|FG013|Period 2|Lost to Follow-up|0|||
19555141|NCT01090024|42003749|FG014|Period 2|Lost to Follow-up|0|||
19555142|NCT01090024|42003750|FG015|Period 2|Lost to Follow-up|0|||
19555143|NCT01090024|42003751|FG016|Period 2|Lost to Follow-up|0|||
19555144|NCT01090024|42003752|FG017|Period 2|Lost to Follow-up|0|||
19555145|NCT01090024|42003735|FG000|Period 2|Adverse Event|1|||
19555146|NCT01090024|42003736|FG001|Period 2|Adverse Event|0|||
19555147|NCT01090024|42003737|FG002|Period 2|Adverse Event|0|||
19555148|NCT01090024|42003738|FG003|Period 2|Adverse Event|0|||
19555149|NCT01090024|42003739|FG004|Period 2|Adverse Event|0|||
19555150|NCT01090024|42003740|FG005|Period 2|Adverse Event|0|||
19555151|NCT01090024|42003741|FG006|Period 2|Adverse Event|0|||
19555152|NCT01090024|42003742|FG007|Period 2|Adverse Event|0|||
19555153|NCT01090024|42003743|FG008|Period 2|Adverse Event|0|||
19555154|NCT01090024|42003744|FG009|Period 2|Adverse Event|0|||
19555155|NCT01090024|42003745|FG010|Period 2|Adverse Event|0|||
19555156|NCT01090024|42003746|FG011|Period 2|Adverse Event|0|||
19555157|NCT01090024|42003747|FG012|Period 2|Adverse Event|0|||
19555158|NCT01090024|42003748|FG013|Period 2|Adverse Event|0|||
19555159|NCT01090024|42003749|FG014|Period 2|Adverse Event|0|||
19555160|NCT01090024|42003750|FG015|Period 2|Adverse Event|0|||
19555161|NCT01090024|42003751|FG016|Period 2|Adverse Event|0|||
19555162|NCT01090024|42003752|FG017|Period 2|Adverse Event|0|||
19555163|NCT01090024|42003735|FG000|Period 3|Withdrawal by Subject|0|||
19555164|NCT01090024|42003736|FG001|Period 3|Withdrawal by Subject|0|||
19555165|NCT01090024|42003737|FG002|Period 3|Withdrawal by Subject|0|||
19555166|NCT01090024|42003738|FG003|Period 3|Withdrawal by Subject|0|||
19555167|NCT01090024|42003739|FG004|Period 3|Withdrawal by Subject|0|||
19555168|NCT01090024|42003740|FG005|Period 3|Withdrawal by Subject|0|||
19555169|NCT01090024|42003741|FG006|Period 3|Withdrawal by Subject|0|||
19555170|NCT01090024|42003742|FG007|Period 3|Withdrawal by Subject|0|||
19555171|NCT01090024|42003743|FG008|Period 3|Withdrawal by Subject|0|||
19555172|NCT01090024|42003744|FG009|Period 3|Withdrawal by Subject|0|||
19555173|NCT01090024|42003745|FG010|Period 3|Withdrawal by Subject|0|||
19555174|NCT01090024|42003746|FG011|Period 3|Withdrawal by Subject|0|||
19555175|NCT01090024|42003747|FG012|Period 3|Withdrawal by Subject|0|||
19555176|NCT01090024|42003748|FG013|Period 3|Withdrawal by Subject|0|||
19555177|NCT01090024|42003749|FG014|Period 3|Withdrawal by Subject|0|||
19555178|NCT01090024|42003750|FG015|Period 3|Withdrawal by Subject|1|||
19555179|NCT01090024|42003751|FG016|Period 3|Withdrawal by Subject|0|||
19555180|NCT01090024|42003752|FG017|Period 3|Withdrawal by Subject|0|||
19555181|NCT01090024|42003735|FG000|Period 3|Protocol Violation|0|||
19555182|NCT01090024|42003736|FG001|Period 3|Protocol Violation|0|||
19555183|NCT01090024|42003737|FG002|Period 3|Protocol Violation|0|||
19555184|NCT01090024|42003738|FG003|Period 3|Protocol Violation|0|||
19555185|NCT01090024|42003739|FG004|Period 3|Protocol Violation|0|||
19555186|NCT01090024|42003740|FG005|Period 3|Protocol Violation|0|||
19555187|NCT01090024|42003741|FG006|Period 3|Protocol Violation|0|||
19555188|NCT01090024|42003742|FG007|Period 3|Protocol Violation|0|||
19555189|NCT01090024|42003743|FG008|Period 3|Protocol Violation|1|||
19555190|NCT01090024|42003744|FG009|Period 3|Protocol Violation|0|||
19555191|NCT01090024|42003745|FG010|Period 3|Protocol Violation|0|||
19555192|NCT01090024|42003746|FG011|Period 3|Protocol Violation|0|||
19555193|NCT01090024|42003747|FG012|Period 3|Protocol Violation|0|||
19555194|NCT01090024|42003748|FG013|Period 3|Protocol Violation|0|||
19555195|NCT01090024|42003749|FG014|Period 3|Protocol Violation|0|||
19555196|NCT01090024|42003750|FG015|Period 3|Protocol Violation|0|||
19555197|NCT01090024|42003751|FG016|Period 3|Protocol Violation|0|||
19555198|NCT01090024|42003752|FG017|Period 3|Protocol Violation|0|||
19555199|NCT01090024|42003735|FG000|Period 3|Adverse Event|0|||
19555200|NCT01090024|42003736|FG001|Period 3|Adverse Event|0|||
19555201|NCT01090024|42003737|FG002|Period 3|Adverse Event|0|||
19555202|NCT01090024|42003738|FG003|Period 3|Adverse Event|0|||
19555203|NCT01090024|42003739|FG004|Period 3|Adverse Event|0|||
19555204|NCT01090024|42003740|FG005|Period 3|Adverse Event|1|||
19555205|NCT01090024|42003741|FG006|Period 3|Adverse Event|0|||
19555206|NCT01090024|42003742|FG007|Period 3|Adverse Event|0|||
19555207|NCT01090024|42003743|FG008|Period 3|Adverse Event|0|||
19555208|NCT01090024|42003744|FG009|Period 3|Adverse Event|0|||
19555209|NCT01090024|42003745|FG010|Period 3|Adverse Event|0|||
19555210|NCT01090024|42003746|FG011|Period 3|Adverse Event|0|||
19555211|NCT01090024|42003747|FG012|Period 3|Adverse Event|0|||
19555212|NCT01090024|42003748|FG013|Period 3|Adverse Event|0|||
19555213|NCT01090024|42003749|FG014|Period 3|Adverse Event|0|||
19555214|NCT01090024|42003750|FG015|Period 3|Adverse Event|0|||
19555215|NCT01090024|42003751|FG016|Period 3|Adverse Event|0|||
19555216|NCT01090024|42003752|FG017|Period 3|Adverse Event|0|||
19555217|NCT04868890|42003764|FG000|Overall Study|Death|2|||
19555218|NCT04868890|42003765|FG001|Overall Study|Death|1|||
19555219|NCT04868890|42003764|FG000|Overall Study|Withdrawal by Subject|1|||
19555220|NCT04868890|42003765|FG001|Overall Study|Withdrawal by Subject|5|||
19555221|NCT01281189|42003773|FG000|Overall Study|Adverse Event|7|||
19555222|NCT01281189|42003774|FG001|Overall Study|Adverse Event|9|||
19555223|NCT01281189|42003773|FG000|Overall Study|Lost to Follow-up|6|||
19555224|NCT01281189|42003774|FG001|Overall Study|Lost to Follow-up|4|||
19555225|NCT01281189|42003773|FG000|Overall Study|Withdrawal by Subject|21|||
19555226|NCT01281189|42003774|FG001|Overall Study|Withdrawal by Subject|24|||
19555227|NCT01281189|42003773|FG000|Overall Study|Physician Decision|2|||
19555228|NCT01281189|42003774|FG001|Overall Study|Physician Decision|3|||
19555229|NCT01281189|42003773|FG000|Overall Study|Death|103|||
19555230|NCT01281189|42003774|FG001|Overall Study|Death|91|||
19555231|NCT01281189|42003773|FG000|Overall Study|Other|8|||
19555232|NCT01281189|42003774|FG001|Overall Study|Other|12|||
19555233|NCT01280955|42003780|FG000|Overall Study|Death|2|||
19555234|NCT01280955|42003780|FG000|Overall Study|Withdrawal by Subject|1|||
19555235|NCT01280721|42003786|FG000|Overall Study|Adverse Event|4|||
19555236|NCT01280721|42003786|FG000|Overall Study|Physician Decision|3|||
19555237|NCT01280721|42003786|FG000|Overall Study|Withdrawal by Subject|6|||
19555238|NCT01280721|42003786|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
19555239|NCT01280721|42003786|FG000|Overall Study|No tolerability for the lowest dose|2|||
19555240|NCT01087762|42003804|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
19555241|NCT01087762|42003805|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
19555242|NCT01087762|42003806|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
19555243|NCT01087762|42003807|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
19555244|NCT01087762|42003808|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
19555245|NCT01087762|42003804|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
19555246|NCT01087762|42003805|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
19555247|NCT01087762|42003806|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
19555248|NCT01087762|42003807|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
19555249|NCT01087762|42003808|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
19555250|NCT01087762|42003804|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
19555251|NCT01087762|42003805|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
19555252|NCT01087762|42003806|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
19555253|NCT01087762|42003807|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
19555254|NCT01087762|42003808|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
19555255|NCT01087762|42003804|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
19555256|NCT01087762|42003805|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
19555257|NCT01087762|42003806|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
19555258|NCT01087762|42003807|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
19555259|NCT01087762|42003808|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
19555260|NCT01087762|42003804|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
19555261|NCT01087762|42003805|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
19555262|NCT01087762|42003806|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
19555263|NCT01087762|42003807|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
19555264|NCT01087762|42003808|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
19555265|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
19555266|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
19555267|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
19555268|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
19555269|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
19555270|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
19555271|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
19555272|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
19555273|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
19555274|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
19555275|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
19555276|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
19555277|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
19555278|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
19555279|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
19555280|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
19555281|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
19555282|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
19555283|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
19555284|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
19555285|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
19555286|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
19555287|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
19555288|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
19555289|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
19555290|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
19555291|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
19555292|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
19555293|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
19555294|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
19555295|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
19555296|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
19555297|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
19555298|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
19555299|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
19555300|NCT01087762|42003804|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
19555301|NCT01087762|42003805|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
19555302|NCT01087762|42003806|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
19555303|NCT01087762|42003807|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
19555304|NCT01087762|42003808|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
19555305|NCT01078168|42003820|FG000|Overall Study|Physician Decision|0|||
19555306|NCT01078168|42003821|FG001|Overall Study|Physician Decision|1|||
19555307|NCT01086358|42003827|FG000|First Intervention|Lost to Follow-up|9|||
19555308|NCT01086358|42003828|FG001|First Intervention|Lost to Follow-up|4|||
19555309|NCT01086358|42003827|FG000|First Intervention|Withdrawal by Subject|0|||
19555310|NCT01086358|42003828|FG001|First Intervention|Withdrawal by Subject|1|||
19555311|NCT01086358|42003827|FG000|Second Intervention|Lost to Follow-up|4|||
19555312|NCT01086358|42003828|FG001|Second Intervention|Lost to Follow-up|4|||
19555313|NCT01277601|42003838|FG000|Overall Study|Adverse Event|5|||
19555314|NCT01277601|42003839|FG001|Overall Study|Adverse Event|3|||
19555315|NCT01277601|42003840|FG002|Overall Study|Adverse Event|0|||
19555316|NCT01277601|42003841|FG003|Overall Study|Adverse Event|7|||
19555317|NCT01277601|42003838|FG000|Overall Study|Withdrawal by Subject|18|||
19555318|NCT01277601|42003839|FG001|Overall Study|Withdrawal by Subject|21|||
19555319|NCT01277601|42003840|FG002|Overall Study|Withdrawal by Subject|8|||
19555320|NCT01277601|42003841|FG003|Overall Study|Withdrawal by Subject|17|||
19555321|NCT01277601|42003838|FG000|Overall Study|Lost to Follow-up|7|||
19555322|NCT01277601|42003839|FG001|Overall Study|Lost to Follow-up|9|||
19555323|NCT01277601|42003840|FG002|Overall Study|Lost to Follow-up|4|||
19555324|NCT01277601|42003841|FG003|Overall Study|Lost to Follow-up|2|||
19555325|NCT01277601|42003838|FG000|Overall Study|Physician Decision|3|||
19555326|NCT01277601|42003839|FG001|Overall Study|Physician Decision|5|||
19555327|NCT01277601|42003840|FG002|Overall Study|Physician Decision|1|||
19555328|NCT01277601|42003841|FG003|Overall Study|Physician Decision|6|||
19555329|NCT01277601|42003838|FG000|Overall Study|Pregnancy|2|||
19555330|NCT01277601|42003839|FG001|Overall Study|Pregnancy|2|||
19555331|NCT01277601|42003840|FG002|Overall Study|Pregnancy|4|||
19555332|NCT01277601|42003841|FG003|Overall Study|Pregnancy|1|||
19476753|NCT01522651|41754860|FG002|Overall Study|Cardioversion|0|||
19476754|NCT01522651|41754861|FG003|Overall Study|Cardioversion|0|||
19476755|NCT01522651|41754862|FG004|Overall Study|Cardioversion|0|||
19476756|NCT01522651|41754858|FG000|Overall Study|Device Malfunction|0|||
19476757|NCT01522651|41754859|FG001|Overall Study|Device Malfunction|1|||
19476758|NCT01522651|41754860|FG002|Overall Study|Device Malfunction|0|||
19476759|NCT01522651|41754861|FG003|Overall Study|Device Malfunction|0|||
19476760|NCT01522651|41754862|FG004|Overall Study|Device Malfunction|0|||
19476761|NCT01522651|41754858|FG000|Overall Study|Investigator's Discretion|0|||
19476762|NCT01522651|41754859|FG001|Overall Study|Investigator's Discretion|1|||
19476763|NCT01522651|41754860|FG002|Overall Study|Investigator's Discretion|0|||
19476764|NCT01522651|41754861|FG003|Overall Study|Investigator's Discretion|0|||
19476765|NCT01522651|41754862|FG004|Overall Study|Investigator's Discretion|0|||
19476766|NCT01522651|41754858|FG000|Overall Study|Protocol Violation|3|||
19476767|NCT01522651|41754859|FG001|Overall Study|Protocol Violation|0|||
19476768|NCT01522651|41754860|FG002|Overall Study|Protocol Violation|0|||
19476769|NCT01522651|41754861|FG003|Overall Study|Protocol Violation|0|||
19476770|NCT01522651|41754862|FG004|Overall Study|Protocol Violation|0|||
19476771|NCT01522651|41754858|FG000|Overall Study|Reason Not Specified|0|||
19476772|NCT01522651|41754859|FG001|Overall Study|Reason Not Specified|0|||
19478175|NCT01693562|41757329|FG015|Expansion Phase|Other|0|||
19555333|NCT01277601|42003838|FG000|Overall Study|Noncompliance with Study Drug|1|||
19555334|NCT01277601|42003839|FG001|Overall Study|Noncompliance with Study Drug|3|||
19555335|NCT01277601|42003840|FG002|Overall Study|Noncompliance with Study Drug|2|||
19555336|NCT01277601|42003841|FG003|Overall Study|Noncompliance with Study Drug|0|||
19555337|NCT01277601|42003838|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
19555338|NCT01277601|42003839|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
19555339|NCT01277601|42003840|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
19555340|NCT01277601|42003841|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
19555341|NCT01277601|42003838|FG000|Overall Study|Protocol Violation|0|||
19555342|NCT01277601|42003839|FG001|Overall Study|Protocol Violation|2|||
19555343|NCT01277601|42003840|FG002|Overall Study|Protocol Violation|5|||
19555344|NCT01277601|42003841|FG003|Overall Study|Protocol Violation|0|||
19555345|NCT01277601|42003838|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
19555346|NCT01277601|42003839|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
19555347|NCT01277601|42003840|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
19555348|NCT01277601|42003841|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
19555349|NCT01277523|42003871|FG000|Overall Study|Adverse Event|1|||
19555350|NCT01277523|42003872|FG001|Overall Study|Adverse Event|0|||
19555351|NCT01277523|42003873|FG002|Overall Study|Adverse Event|0|||
19555352|NCT01277523|42003871|FG000|Overall Study|Protocol Violation|2|||
19555353|NCT01277523|42003872|FG001|Overall Study|Protocol Violation|0|||
19555354|NCT01277523|42003873|FG002|Overall Study|Protocol Violation|0|||
19555355|NCT01277523|42003871|FG000|Overall Study|Other Reason not Defined|0|||
19555356|NCT01277523|42003872|FG001|Overall Study|Other Reason not Defined|1|||
19555357|NCT01277523|42003873|FG002|Overall Study|Other Reason not Defined|0|||
19555358|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
19555359|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
19555360|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
19555361|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
19555362|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
19555363|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
19555364|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
19555365|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
19555366|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
19555367|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
19555368|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Death|1|||
19555369|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Death|0|||
19555370|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Death|0|||
19555371|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Death|0|||
19555372|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Death|0|||
19555373|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
19555374|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
19555375|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
19555376|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
19555377|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
19555378|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
19555379|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
19555380|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
19555381|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
19555382|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
19555383|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
19555384|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
19555385|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
19555386|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
19555387|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
19555388|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
19555389|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
19555390|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
19555391|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
19555392|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19555393|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
19555394|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19555395|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19555396|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19555397|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19555398|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Other|4|||
19555399|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Other|4|||
19555400|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Other|3|||
19555401|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Other|1|||
19555402|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Other|0|||
19555403|NCT01081834|42003886|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
19555404|NCT01081834|42003887|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
19555405|NCT01081834|42003888|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
19555406|NCT01081834|42003889|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
19555407|NCT01081834|42003890|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
19555408|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19555409|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
19555410|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
19555411|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
19555412|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
19555413|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Death|1|||
19555414|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Death|0|||
19555415|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Death|0|||
19555416|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Death|0|||
19555417|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Death|0|||
19555418|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
19555419|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
19555420|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19555421|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19555422|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19555423|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19555424|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19555425|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19555426|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19555427|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19555428|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19555429|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
19555430|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19555431|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19555432|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19555433|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
19555434|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19555435|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
19555436|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19555437|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19555438|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
19555439|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
19373597|NCT02760407|41614834|FG001|Overall Study|Lost to Follow-up|7|||
19373598|NCT02760407|41614835|FG002|Overall Study|Lost to Follow-up|4|||
19555440|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
19555441|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
19555442|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
19555443|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Other|4|||
19555444|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Other|5|||
19555445|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Other|4|||
19555446|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Other|0|||
19555447|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Other|0|||
19555448|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
19555449|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
19555450|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
19555451|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
19555452|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
19555453|NCT01081834|42003886|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19555454|NCT01081834|42003887|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
19555455|NCT01081834|42003888|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19555456|NCT01081834|42003889|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19555457|NCT01081834|42003890|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19555458|NCT01276509|42003913|FG000|Overall Study|Adverse Event|9|||
19555459|NCT01276509|42003914|FG001|Overall Study|Adverse Event|8|||
19555460|NCT01276509|42003915|FG002|Overall Study|Adverse Event|4|||
19555461|NCT01276509|42003916|FG003|Overall Study|Adverse Event|3|||
19555462|NCT01276509|42003913|FG000|Overall Study|Lack of Efficacy|2|||
19555463|NCT01276509|42003914|FG001|Overall Study|Lack of Efficacy|1|||
19555464|NCT01276509|42003915|FG002|Overall Study|Lack of Efficacy|1|||
19555465|NCT01276509|42003916|FG003|Overall Study|Lack of Efficacy|2|||
19555466|NCT01276509|42003913|FG000|Overall Study|Pregnancy|1|||
19555467|NCT01276509|42003914|FG001|Overall Study|Pregnancy|0|||
19555468|NCT01276509|42003915|FG002|Overall Study|Pregnancy|0|||
19555469|NCT01276509|42003916|FG003|Overall Study|Pregnancy|0|||
19555470|NCT01276509|42003913|FG000|Overall Study|Withdrawal by Subject|1|||
19555471|NCT01276509|42003914|FG001|Overall Study|Withdrawal by Subject|2|||
19555472|NCT01276509|42003915|FG002|Overall Study|Withdrawal by Subject|0|||
19555473|NCT01276509|42003916|FG003|Overall Study|Withdrawal by Subject|0|||
19555474|NCT01276509|42003913|FG000|Overall Study|Other|0|||
19555475|NCT01276509|42003914|FG001|Overall Study|Other|1|||
19555476|NCT01276509|42003915|FG002|Overall Study|Other|0|||
19555477|NCT01276509|42003916|FG003|Overall Study|Other|0|||
19555478|NCT01079962|42003928|FG000|Overall Study|Adverse Event|2|||
19555479|NCT01079962|42003929|FG001|Overall Study|Adverse Event|2|||
19555480|NCT01079962|42003928|FG000|Overall Study|Withdrawal by Subject|5|||
19555481|NCT01079962|42003929|FG001|Overall Study|Withdrawal by Subject|7|||
19555482|NCT01079962|42003928|FG000|Overall Study|Protocol Violation|2|||
19555483|NCT01079962|42003929|FG001|Overall Study|Protocol Violation|2|||
19555484|NCT01079962|42003928|FG000|Overall Study|No blood pressure (BP) control|3|||
19555485|NCT01079962|42003929|FG001|Overall Study|No blood pressure (BP) control|0|||
19555486|NCT01079962|42003928|FG000|Overall Study|Inclusion/exclusion criteria|1|||
19555487|NCT01079962|42003929|FG001|Overall Study|Inclusion/exclusion criteria|3|||
19555488|NCT01079962|42003928|FG000|Overall Study|Participant not returning for next visit|1|||
19555489|NCT01079962|42003929|FG001|Overall Study|Participant not returning for next visit|0|||
19555490|NCT01079962|42003928|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
19555491|NCT01079962|42003929|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
19555492|NCT01274637|42003937|FG000|Overall Study|Withdrawal by Subject|0|||
19555493|NCT01274637|42003938|FG001|Overall Study|Withdrawal by Subject|1|||
19555494|NCT01274637|42003937|FG000|Overall Study|Lost to Follow-up|0|||
19555495|NCT01274637|42003938|FG001|Overall Study|Lost to Follow-up|1|||
19555496|NCT01079806|42003946|FG000|Day 1 to Week 96|Adverse Event|0|||
19555497|NCT01079806|42003947|FG001|Day 1 to Week 96|Adverse Event|3|||
19555498|NCT01079806|42003946|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
19555499|NCT01079806|42003947|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
19555500|NCT01079806|42003946|FG000|Day 1 to Week 96|Pregnancy|0|||
19555501|NCT01079806|42003947|FG001|Day 1 to Week 96|Pregnancy|1|||
19555502|NCT01079806|42003946|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
19555503|NCT01079806|42003947|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
19555504|NCT01079806|42003946|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
19555505|NCT01079806|42003947|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
19555506|NCT01079806|42003946|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
19555507|NCT01079806|42003947|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
19555508|NCT01079806|42003946|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
19555509|NCT01079806|42003947|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
19555510|NCT01079806|42003946|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
19555511|NCT01079806|42003947|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
19382006|NCT02730169|41625063|FG000|Overall Study|Protocol Violation|1|||
19555512|NCT01079806|42003946|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
19555513|NCT01079806|42003947|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
19555514|NCT01079806|42003946|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
19555515|NCT01079806|42003947|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
19555516|NCT01078090|42003955|FG000|Overall Study|Lost to Follow-up|2363|||
19555517|NCT01078090|42003955|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
19555518|NCT01078090|42003955|FG000|Overall Study|Lack of Efficacy|1193|||
19555519|NCT01078090|42003955|FG000|Overall Study|ADR and lack of efficacy|61|||
19555520|NCT01078090|42003955|FG000|Overall Study|Other|523|||
19555521|NCT01077622|42003973|FG000|Overall Study|Physician Decision|2|||
19555522|NCT01077622|42003973|FG000|Overall Study|Withdrawal by Subject|1|||
19555523|NCT01313676|42003981|FG000|Overall Study|Adverse Event|395|||
19555524|NCT01313676|42003982|FG001|Overall Study|Adverse Event|365|||
19555525|NCT01313676|42003983|FG002|Overall Study|Adverse Event|372|||
19555526|NCT01313676|42003984|FG003|Overall Study|Adverse Event|333|||
19555527|NCT01313676|42003981|FG000|Overall Study|Lack of Efficacy|98|||
19555528|NCT01313676|42003982|FG001|Overall Study|Lack of Efficacy|90|||
19555529|NCT01313676|42003983|FG002|Overall Study|Lack of Efficacy|65|||
19555530|NCT01313676|42003984|FG003|Overall Study|Lack of Efficacy|46|||
19555531|NCT01313676|42003981|FG000|Overall Study|Protocol Violation|37|||
19555532|NCT01313676|42003982|FG001|Overall Study|Protocol Violation|44|||
19555533|NCT01313676|42003983|FG002|Overall Study|Protocol Violation|46|||
19555534|NCT01313676|42003984|FG003|Overall Study|Protocol Violation|44|||
19555535|NCT01313676|42003981|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
19555536|NCT01313676|42003982|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
19555537|NCT01313676|42003983|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
19555538|NCT01313676|42003984|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
19555539|NCT01313676|42003981|FG000|Overall Study|Study Closed/terminated|7|||
19555540|NCT01313676|42003982|FG001|Overall Study|Study Closed/terminated|6|||
19555541|NCT01313676|42003983|FG002|Overall Study|Study Closed/terminated|9|||
19555542|NCT01313676|42003984|FG003|Overall Study|Study Closed/terminated|9|||
19555543|NCT01313676|42003981|FG000|Overall Study|Lost to Follow-up|0|||
19555544|NCT01313676|42003982|FG001|Overall Study|Lost to Follow-up|0|||
19555545|NCT01313676|42003983|FG002|Overall Study|Lost to Follow-up|1|||
19555546|NCT01313676|42003984|FG003|Overall Study|Lost to Follow-up|0|||
19555547|NCT01313676|42003981|FG000|Overall Study|Physician Decision|53|||
19555548|NCT01313676|42003982|FG001|Overall Study|Physician Decision|64|||
19555549|NCT01313676|42003983|FG002|Overall Study|Physician Decision|62|||
19555550|NCT01313676|42003984|FG003|Overall Study|Physician Decision|48|||
19555551|NCT01313676|42003981|FG000|Overall Study|Decision by Participant or Proxy|643|||
19555552|NCT01313676|42003982|FG001|Overall Study|Decision by Participant or Proxy|527|||
19382007|NCT02730169|41625064|FG001|Overall Study|Protocol Violation|0|||
19555553|NCT01313676|42003983|FG002|Overall Study|Decision by Participant or Proxy|515|||
19555554|NCT01313676|42003984|FG003|Overall Study|Decision by Participant or Proxy|492|||
19555555|NCT01313676|42003981|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
19555556|NCT01313676|42003982|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
19555557|NCT01313676|42003983|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
19555558|NCT01313676|42003984|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
19555559|NCT01313676|42003981|FG000|Overall Study|Investigator Site Closed|12|||
19555560|NCT01313676|42003982|FG001|Overall Study|Investigator Site Closed|11|||
19555561|NCT01313676|42003983|FG002|Overall Study|Investigator Site Closed|15|||
19555562|NCT01313676|42003984|FG003|Overall Study|Investigator Site Closed|10|||
19555563|NCT01313676|42003981|FG000|Overall Study|Missing|1|||
19555564|NCT01313676|42003982|FG001|Overall Study|Missing|1|||
19555565|NCT01313676|42003983|FG002|Overall Study|Missing|1|||
19555566|NCT01313676|42003984|FG003|Overall Study|Missing|0|||
19555567|NCT01313286|42003995|FG000|Period 1|Withdrawal by Subject|2|||
19555568|NCT01313286|42003996|FG001|Period 1|Withdrawal by Subject|0|||
19555569|NCT01313208|42004004|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
19555570|NCT01313208|42004005|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
19555571|NCT01313208|42004004|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
19555572|NCT01313208|42004005|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
19555573|NCT01313208|42004004|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
19555574|NCT01313208|42004005|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
19555575|NCT01313208|42004004|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
19555576|NCT01313208|42004005|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
19555577|NCT01313208|42004004|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
19555578|NCT01313208|42004005|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
19555579|NCT01313208|42004004|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
19555580|NCT01313208|42004005|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
19555581|NCT01313208|42004004|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
19555582|NCT01313208|42004005|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
19555583|NCT01313208|42004004|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
19555584|NCT01313208|42004005|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
19555585|NCT01313208|42004004|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
19555586|NCT01313208|42004005|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
19555587|NCT01312428|42004015|FG000|Overall Study|Study Termination|3|||
19555588|NCT01312428|42004016|FG001|Overall Study|Study Termination|4|||
19555589|NCT01075984|42004029|FG000|Treatment Phase|Adverse Event|0|||
19555590|NCT01075984|42004030|FG001|Treatment Phase|Adverse Event|1|||
19555591|NCT01075984|42004031|FG002|Treatment Phase|Adverse Event|3|||
19555592|NCT01075984|42004032|FG003|Treatment Phase|Adverse Event|7|||
19555593|NCT01075984|42004033|FG004|Treatment Phase|Adverse Event|35|||
19555594|NCT01075984|42004029|FG000|Treatment Phase|Protocol Violation|0|||
19555595|NCT01075984|42004030|FG001|Treatment Phase|Protocol Violation|0|||
19555596|NCT01075984|42004031|FG002|Treatment Phase|Protocol Violation|1|||
19555597|NCT01075984|42004032|FG003|Treatment Phase|Protocol Violation|0|||
19555598|NCT01075984|42004033|FG004|Treatment Phase|Protocol Violation|3|||
19555599|NCT01075984|42004029|FG000|Treatment Phase|Withdrawal by Subject|0|||
19555600|NCT01075984|42004030|FG001|Treatment Phase|Withdrawal by Subject|0|||
19555601|NCT01075984|42004031|FG002|Treatment Phase|Withdrawal by Subject|2|||
19555602|NCT01075984|42004032|FG003|Treatment Phase|Withdrawal by Subject|0|||
19555603|NCT01075984|42004033|FG004|Treatment Phase|Withdrawal by Subject|15|||
19555604|NCT01075984|42004029|FG000|Treatment Phase|Treatment Failure|0|||
19555605|NCT01075984|42004030|FG001|Treatment Phase|Treatment Failure|0|||
19555606|NCT01075984|42004031|FG002|Treatment Phase|Treatment Failure|1|||
19555607|NCT01075984|42004032|FG003|Treatment Phase|Treatment Failure|0|||
19555608|NCT01075984|42004033|FG004|Treatment Phase|Treatment Failure|5|||
19555609|NCT01075984|42004029|FG000|Treatment Phase|Progression of disease|0|||
19555610|NCT01075984|42004030|FG001|Treatment Phase|Progression of disease|0|||
19555611|NCT01075984|42004031|FG002|Treatment Phase|Progression of disease|0|||
19555612|NCT01075984|42004032|FG003|Treatment Phase|Progression of disease|0|||
19555613|NCT01075984|42004033|FG004|Treatment Phase|Progression of disease|2|||
19555614|NCT01075984|42004029|FG000|Follow-up Phase|Protocol Violation|0|||
19555615|NCT01075984|42004030|FG001|Follow-up Phase|Protocol Violation|0|||
19555616|NCT01075984|42004031|FG002|Follow-up Phase|Protocol Violation|1|||
19555617|NCT01075984|42004032|FG003|Follow-up Phase|Protocol Violation|0|||
19555618|NCT01075984|42004033|FG004|Follow-up Phase|Protocol Violation|3|||
19555619|NCT01075984|42004029|FG000|Follow-up Phase|Adverse Event|0|||
19555620|NCT01075984|42004030|FG001|Follow-up Phase|Adverse Event|0|||
19555621|NCT01075984|42004031|FG002|Follow-up Phase|Adverse Event|0|||
19555622|NCT01075984|42004032|FG003|Follow-up Phase|Adverse Event|2|||
19555623|NCT01075984|42004033|FG004|Follow-up Phase|Adverse Event|27|||
19555624|NCT01075984|42004029|FG000|Follow-up Phase|Administrative|0|||
19555625|NCT01075984|42004030|FG001|Follow-up Phase|Administrative|0|||
19555626|NCT01075984|42004031|FG002|Follow-up Phase|Administrative|0|||
19555627|NCT01075984|42004032|FG003|Follow-up Phase|Administrative|0|||
19555628|NCT01075984|42004033|FG004|Follow-up Phase|Administrative|1|||
19555629|NCT01075984|42004029|FG000|Follow-up Phase|Withdrawal by Subject|0|||
19555630|NCT01075984|42004030|FG001|Follow-up Phase|Withdrawal by Subject|0|||
19555631|NCT01075984|42004031|FG002|Follow-up Phase|Withdrawal by Subject|0|||
19555632|NCT01075984|42004032|FG003|Follow-up Phase|Withdrawal by Subject|0|||
19555633|NCT01075984|42004033|FG004|Follow-up Phase|Withdrawal by Subject|10|||
19555634|NCT01075984|42004029|FG000|Follow-up Phase|Progression of disease|0|||
19555635|NCT01075984|42004030|FG001|Follow-up Phase|Progression of disease|0|||
19555636|NCT01075984|42004031|FG002|Follow-up Phase|Progression of disease|0|||
19555637|NCT01075984|42004032|FG003|Follow-up Phase|Progression of disease|0|||
19555638|NCT01075984|42004033|FG004|Follow-up Phase|Progression of disease|2|||
19555639|NCT01075984|42004029|FG000|Follow-up Phase|Treatment failure|0|||
19555640|NCT01075984|42004030|FG001|Follow-up Phase|Treatment failure|0|||
19555641|NCT01075984|42004031|FG002|Follow-up Phase|Treatment failure|0|||
19555642|NCT01075984|42004032|FG003|Follow-up Phase|Treatment failure|0|||
19555643|NCT01075984|42004033|FG004|Follow-up Phase|Treatment failure|4|||
19555644|NCT01024231|42004052|FG000|Overall Study|Other Reasons|1|||
19555645|NCT01024231|42004053|FG001|Overall Study|Other Reasons|2|||
19555646|NCT01024231|42004054|FG002|Overall Study|Other Reasons|0|||
19555647|NCT01024231|42004055|FG003|Overall Study|Other Reasons|0|||
19555648|NCT01024231|42004056|FG004|Overall Study|Other Reasons|2|||
19555649|NCT01024231|42004057|FG005|Overall Study|Other Reasons|0|||
19555650|NCT01024231|42004058|FG006|Overall Study|Other Reasons|1|||
19555651|NCT01024231|42004052|FG000|Overall Study|Maximum Clinical Benefit|1|||
19555652|NCT01024231|42004053|FG001|Overall Study|Maximum Clinical Benefit|2|||
19555653|NCT01024231|42004054|FG002|Overall Study|Maximum Clinical Benefit|0|||
19555654|NCT01024231|42004055|FG003|Overall Study|Maximum Clinical Benefit|1|||
19555655|NCT01024231|42004056|FG004|Overall Study|Maximum Clinical Benefit|1|||
19555656|NCT01024231|42004057|FG005|Overall Study|Maximum Clinical Benefit|0|||
19555657|NCT01024231|42004058|FG006|Overall Study|Maximum Clinical Benefit|0|||
19555658|NCT01024231|42004052|FG000|Overall Study|Disease Progression|3|||
19555659|NCT01024231|42004053|FG001|Overall Study|Disease Progression|1|||
19555660|NCT01024231|42004054|FG002|Overall Study|Disease Progression|3|||
19555661|NCT01024231|42004055|FG003|Overall Study|Disease Progression|0|||
19555662|NCT01024231|42004056|FG004|Overall Study|Disease Progression|4|||
19555663|NCT01024231|42004057|FG005|Overall Study|Disease Progression|11|||
19555664|NCT01024231|42004058|FG006|Overall Study|Disease Progression|6|||
19555665|NCT01024231|42004052|FG000|Overall Study|AE unrelated to Study Drug|0|||
19555666|NCT01024231|42004053|FG001|Overall Study|AE unrelated to Study Drug|1|||
19555667|NCT01024231|42004054|FG002|Overall Study|AE unrelated to Study Drug|0|||
19555668|NCT01024231|42004055|FG003|Overall Study|AE unrelated to Study Drug|0|||
19555669|NCT01024231|42004056|FG004|Overall Study|AE unrelated to Study Drug|0|||
19555670|NCT01024231|42004057|FG005|Overall Study|AE unrelated to Study Drug|0|||
19555671|NCT01024231|42004058|FG006|Overall Study|AE unrelated to Study Drug|0|||
19555672|NCT01024231|42004052|FG000|Overall Study|No longer meets criteria|0|||
19555673|NCT01024231|42004053|FG001|Overall Study|No longer meets criteria|0|||
19555674|NCT01024231|42004054|FG002|Overall Study|No longer meets criteria|0|||
19555675|NCT01024231|42004055|FG003|Overall Study|No longer meets criteria|0|||
19555676|NCT01024231|42004056|FG004|Overall Study|No longer meets criteria|1|||
19555677|NCT01024231|42004057|FG005|Overall Study|No longer meets criteria|0|||
19555678|NCT01024231|42004058|FG006|Overall Study|No longer meets criteria|1|||
19555679|NCT01024231|42004052|FG000|Overall Study|Study Drug Toxicity|1|||
19555680|NCT01024231|42004053|FG001|Overall Study|Study Drug Toxicity|6|||
19555681|NCT01024231|42004054|FG002|Overall Study|Study Drug Toxicity|6|||
19555682|NCT01024231|42004055|FG003|Overall Study|Study Drug Toxicity|4|||
19555683|NCT01024231|42004056|FG004|Overall Study|Study Drug Toxicity|2|||
19555684|NCT01024231|42004057|FG005|Overall Study|Study Drug Toxicity|0|||
19555685|NCT01024231|42004058|FG006|Overall Study|Study Drug Toxicity|7|||
19555686|NCT01024231|42004052|FG000|Overall Study|Death|6|||
19555687|NCT01024231|42004053|FG001|Overall Study|Death|2|||
19555688|NCT01024231|42004054|FG002|Overall Study|Death|1|||
19555689|NCT01024231|42004055|FG003|Overall Study|Death|0|||
19555690|NCT01024231|42004056|FG004|Overall Study|Death|4|||
19555691|NCT01024231|42004057|FG005|Overall Study|Death|3|||
19555692|NCT01024231|42004058|FG006|Overall Study|Death|5|||
19555693|NCT01024231|42004052|FG000|Overall Study|Lost to Follow-up|0|||
19555694|NCT01024231|42004053|FG001|Overall Study|Lost to Follow-up|0|||
19555695|NCT01024231|42004054|FG002|Overall Study|Lost to Follow-up|0|||
19555696|NCT01024231|42004055|FG003|Overall Study|Lost to Follow-up|0|||
19555697|NCT01024231|42004056|FG004|Overall Study|Lost to Follow-up|0|||
19555698|NCT01024231|42004057|FG005|Overall Study|Lost to Follow-up|0|||
19373599|NCT02760407|41614836|FG003|Overall Study|Lost to Follow-up|6|||
19555699|NCT01024231|42004058|FG006|Overall Study|Lost to Follow-up|1|||
19555700|NCT01024231|42004052|FG000|Overall Study|Withdrew Consent|0|||
19555701|NCT01024231|42004053|FG001|Overall Study|Withdrew Consent|1|||
19555702|NCT01024231|42004054|FG002|Overall Study|Withdrew Consent|0|||
19555703|NCT01024231|42004055|FG003|Overall Study|Withdrew Consent|0|||
19555704|NCT01024231|42004056|FG004|Overall Study|Withdrew Consent|0|||
19555705|NCT01024231|42004057|FG005|Overall Study|Withdrew Consent|0|||
19555706|NCT01024231|42004058|FG006|Overall Study|Withdrew Consent|0|||
19555707|NCT01024231|42004052|FG000|Overall Study|Continuing on Treatment|0|||
19555708|NCT01024231|42004053|FG001|Overall Study|Continuing on Treatment|0|||
19555709|NCT01024231|42004054|FG002|Overall Study|Continuing on Treatment|0|||
19555710|NCT01024231|42004055|FG003|Overall Study|Continuing on Treatment|0|||
19555711|NCT01024231|42004056|FG004|Overall Study|Continuing on Treatment|3|||
19555712|NCT01024231|42004057|FG005|Overall Study|Continuing on Treatment|2|||
19555713|NCT01024231|42004058|FG006|Overall Study|Continuing on Treatment|0|||
19555714|NCT01077544|42004081|FG000|Overall Study|New Cancer Therapy|3|||
19555715|NCT01077544|42004082|FG001|Overall Study|New Cancer Therapy|3|||
19555716|NCT01077544|42004081|FG000|Overall Study|Adverse Event|0|||
19555717|NCT01077544|42004082|FG001|Overall Study|Adverse Event|1|||
19555718|NCT01077544|42004081|FG000|Overall Study|Disease Progression|0|||
19555719|NCT01077544|42004082|FG001|Overall Study|Disease Progression|1|||
19555720|NCT01075516|42004090|FG000|Overall Study|Death|5|||
19555721|NCT01075516|42004091|FG001|Overall Study|Death|9|||
19555722|NCT01075516|42004090|FG000|Overall Study|Lost to Follow-up|10|||
19555723|NCT01075516|42004091|FG001|Overall Study|Lost to Follow-up|2|||
19555724|NCT01075516|42004090|FG000|Overall Study|Withdrawal by Subject|3|||
19555725|NCT01075516|42004091|FG001|Overall Study|Withdrawal by Subject|5|||
19555726|NCT01012999|42004097|FG000|Overall Study|Protocol Violation|1|||
19555727|NCT01017601|42004103|FG000|Overall Study|Disease Progression|12|||
19555728|NCT01017601|42004104|FG001|Overall Study|Disease Progression|12|||
19555729|NCT01017601|42004103|FG000|Overall Study|Withdrawal by Subject|0|||
19555730|NCT01017601|42004104|FG001|Overall Study|Withdrawal by Subject|1|||
19555731|NCT01016977|42004112|FG000|Overall Study|Lost to Follow-up|1|||
19555732|NCT01016977|42004113|FG001|Overall Study|Lost to Follow-up|0|||
19555733|NCT01016977|42004112|FG000|Overall Study|Withdrawal by Subject|2|||
19555734|NCT01016977|42004113|FG001|Overall Study|Withdrawal by Subject|2|||
19555735|NCT01012765|42004122|FG000|Treatment Period 1|Adverse Event|1|||
19555736|NCT01012765|42004123|FG001|Treatment Period 1|Adverse Event|0|||
19555737|NCT01012765|42004124|FG002|Treatment Period 1|Adverse Event|1|||
19555738|NCT01012765|42004125|FG003|Treatment Period 1|Adverse Event|0|||
19555739|NCT01012765|42004126|FG004|Treatment Period 1|Adverse Event|0|||
19555740|NCT01012765|42004127|FG005|Treatment Period 1|Adverse Event|0|||
19555741|NCT01012765|42004122|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19555742|NCT01012765|42004123|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19555743|NCT01012765|42004124|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19555744|NCT01012765|42004125|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19555745|NCT01012765|42004126|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19555746|NCT01012765|42004127|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19555747|NCT01012765|42004122|FG000|Treatment Period 1|Administrative problems|0|||
19555748|NCT01012765|42004123|FG001|Treatment Period 1|Administrative problems|0|||
19555749|NCT01012765|42004124|FG002|Treatment Period 1|Administrative problems|1|||
19555750|NCT01012765|42004125|FG003|Treatment Period 1|Administrative problems|1|||
19555751|NCT01012765|42004126|FG004|Treatment Period 1|Administrative problems|1|||
19555752|NCT01012765|42004127|FG005|Treatment Period 1|Administrative problems|0|||
19555753|NCT01012765|42004122|FG000|Treatment Period 1|Protocol Violation|0|||
19555754|NCT01012765|42004123|FG001|Treatment Period 1|Protocol Violation|0|||
19555755|NCT01012765|42004124|FG002|Treatment Period 1|Protocol Violation|0|||
19555756|NCT01012765|42004125|FG003|Treatment Period 1|Protocol Violation|2|||
19555757|NCT01012765|42004126|FG004|Treatment Period 1|Protocol Violation|1|||
19555758|NCT01012765|42004127|FG005|Treatment Period 1|Protocol Violation|0|||
19555759|NCT01012765|42004122|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
19555760|NCT01012765|42004123|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
19555761|NCT01012765|42004124|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
19555762|NCT01012765|42004125|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
19555763|NCT01012765|42004126|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
19555764|NCT01012765|42004127|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
19555765|NCT01012765|42004122|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19555766|NCT01012765|42004123|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19555767|NCT01012765|42004124|FG002|Treatment Period 2|Withdrawal by Subject|1|||
19555768|NCT01012765|42004125|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19555769|NCT01012765|42004126|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19555770|NCT01012765|42004127|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19555771|NCT01012765|42004122|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
19555772|NCT01012765|42004123|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
19555773|NCT01012765|42004124|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
19555774|NCT01012765|42004125|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
19555775|NCT01012765|42004126|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
19555776|NCT01012765|42004127|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
19555777|NCT01012765|42004122|FG000|Treatment Period 2|Adverse Event|0|||
19555778|NCT01012765|42004123|FG001|Treatment Period 2|Adverse Event|1|||
19555779|NCT01012765|42004124|FG002|Treatment Period 2|Adverse Event|1|||
19555780|NCT01012765|42004125|FG003|Treatment Period 2|Adverse Event|0|||
19555781|NCT01012765|42004126|FG004|Treatment Period 2|Adverse Event|0|||
19555782|NCT01012765|42004127|FG005|Treatment Period 2|Adverse Event|0|||
19555783|NCT01012765|42004122|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
19555784|NCT01012765|42004123|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
19555785|NCT01012765|42004124|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
19555786|NCT01012765|42004125|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
19555787|NCT01012765|42004126|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
19555788|NCT01012765|42004127|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
19555789|NCT01010503|42004135|FG000|Overall Study|Adverse Event|1|||
19555790|NCT01010503|42004135|FG000|Overall Study|Death|1|||
19555791|NCT01009645|42004143|FG000|Overall Study|Lost to Follow-up|2|||
19555792|NCT01009645|42004144|FG001|Overall Study|Lost to Follow-up|8|||
19555793|NCT01009645|42004145|FG002|Overall Study|Lost to Follow-up|4|||
19555794|NCT01009645|42004146|FG003|Overall Study|Lost to Follow-up|5|||
19555795|NCT01006291|42004159|FG000|Overall Study|Adverse Event|2|||
19555796|NCT01006291|42004160|FG001|Overall Study|Adverse Event|1|||
19555797|NCT01006291|42004161|FG002|Overall Study|Adverse Event|2|||
19555798|NCT01006291|42004159|FG000|Overall Study|Lack of Efficacy|2|||
19555799|NCT01006291|42004160|FG001|Overall Study|Lack of Efficacy|2|||
19555800|NCT01006291|42004161|FG002|Overall Study|Lack of Efficacy|1|||
19555801|NCT01006291|42004159|FG000|Overall Study|Protocol Violation|3|||
19555802|NCT01006291|42004160|FG001|Overall Study|Protocol Violation|3|||
19555803|NCT01006291|42004161|FG002|Overall Study|Protocol Violation|3|||
19555804|NCT01006291|42004159|FG000|Overall Study|Withdrawal criteria|5|||
19555805|NCT01006291|42004160|FG001|Overall Study|Withdrawal criteria|4|||
19555806|NCT01006291|42004161|FG002|Overall Study|Withdrawal criteria|4|||
19555807|NCT01006291|42004159|FG000|Overall Study|Other|14|||
19555808|NCT01006291|42004160|FG001|Overall Study|Other|14|||
19382008|NCT02730169|41625065|FG002|Overall Study|Protocol Violation|0|||
19555809|NCT01006291|42004161|FG002|Overall Study|Other|17|||
19555810|NCT01006135|42004169|FG000|Overall Study|Adverse Event|22|||
19555811|NCT01006135|42004169|FG000|Overall Study|Protocol Violation|14|||
19555812|NCT01006135|42004169|FG000|Overall Study|Lost to Follow-up|32|||
19555813|NCT01006135|42004169|FG000|Overall Study|Other|72|||
19555814|NCT01012609|42004175|FG000|Overall Study|Withdrawal by Subject|1|||
19555815|NCT01012609|42004176|FG001|Overall Study|Withdrawal by Subject|1|||
19555816|NCT01012219|42004183|FG000|Period 1|Withdrawal by Subject|1|||
19555817|NCT01012219|42004183|FG000|Period 2|Withdrawal by Subject|1|||
19555818|NCT01011907|42004192|FG000|Overall Study|Withdrawal by Subject|13|||
19555819|NCT01011907|42004193|FG001|Overall Study|Withdrawal by Subject|11|||
19555820|NCT01011907|42004192|FG000|Overall Study|Adverse Event|1|||
19555821|NCT01011907|42004193|FG001|Overall Study|Adverse Event|4|||
19555822|NCT01011673|42004201|FG000|Randomized|Secondary headache|2|||
19555823|NCT01011673|42004202|FG001|Randomized|Secondary headache|1|||
19555824|NCT01011673|42004201|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
19555825|NCT01011673|42004202|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
19555826|NCT01311648|42004211|FG000|Main Study|Protocol Violation|0|||
19555827|NCT01311648|42004212|FG001|Main Study|Protocol Violation|1|||
19555828|NCT01311648|42004211|FG000|Main Study|Adverse Event|0|||
19555829|NCT01311648|42004212|FG001|Main Study|Adverse Event|1|||
19555830|NCT01311648|42004211|FG000|Main Study|Inhibitor management|0|||
19555831|NCT01311648|42004212|FG001|Main Study|Inhibitor management|17|||
19555832|NCT01311648|42004211|FG000|Main Study|Withdrawal by Subject|0|||
19555833|NCT01311648|42004212|FG001|Main Study|Withdrawal by Subject|2|||
19555834|NCT01311648|42004211|FG000|Extension Study|Physician Decision|0|||
19555835|NCT01311648|42004212|FG001|Extension Study|Physician Decision|1|||
19555836|NCT01311648|42004211|FG000|Extension Study|ITI therapy with marketed product|0|||
19555837|NCT01311648|42004212|FG001|Extension Study|ITI therapy with marketed product|1|||
19555838|NCT01311648|42004211|FG000|Extension Study|Incorrect visit planning|0|||
19555839|NCT01311648|42004212|FG001|Extension Study|Incorrect visit planning|1|||
19555840|NCT01311648|42004211|FG000|Extension Study|Family's decision|0|||
19555841|NCT01311648|42004212|FG001|Extension Study|Family's decision|1|||
19555842|NCT01311648|42004211|FG000|Extension Study|Failure of ITI therapy|0|||
19555843|NCT01311648|42004212|FG001|Extension Study|Failure of ITI therapy|3|||
19555844|NCT01311648|42004211|FG000|Extension Study|Long travel|0|||
19555845|NCT01311648|42004212|FG001|Extension Study|Long travel|1|||
19555846|NCT01311648|42004211|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
19555847|NCT01311648|42004212|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
19555848|NCT01311648|42004211|FG000|Extension Study|Withdrawal by Subject|0|||
19555849|NCT01311648|42004212|FG001|Extension Study|Withdrawal by Subject|1|||
19555850|NCT01311648|42004211|FG000|Extension Study|Inhibitor management|0|||
19555851|NCT01311648|42004212|FG001|Extension Study|Inhibitor management|2|||
19555852|NCT01011439|42004225|FG000|Overall Study|Death|37|||
19555853|NCT01011439|42004225|FG000|Overall Study|Lost to Follow-up|4|||
19555854|NCT01011439|42004225|FG000|Overall Study|Withdrawal by Subject|1|||
19555855|NCT01011439|42004225|FG000|Overall Study|Sponsor's decision|15|||
19555856|NCT01311024|42004232|FG000|Overall Study|Protocol Violation|35|||
19555857|NCT01311024|42004233|FG001|Overall Study|Protocol Violation|22|||
19555858|NCT01310868|42004239|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
19555859|NCT01273155|42004247|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
19555860|NCT01273155|42004248|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
19555861|NCT01273155|42004249|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
19555862|NCT01273155|42004250|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
19555863|NCT01273155|42004251|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
19555864|NCT01273155|42004252|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
19555865|NCT01273155|42004253|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
19555866|NCT01273155|42004247|FG000|Overall Study|Change in liver function/no longer eval.|0|||
19555867|NCT01273155|42004248|FG001|Overall Study|Change in liver function/no longer eval.|1|||
19555868|NCT01273155|42004249|FG002|Overall Study|Change in liver function/no longer eval.|0|||
19555869|NCT01273155|42004250|FG003|Overall Study|Change in liver function/no longer eval.|0|||
19555870|NCT01273155|42004251|FG004|Overall Study|Change in liver function/no longer eval.|1|||
19555871|NCT01273155|42004252|FG005|Overall Study|Change in liver function/no longer eval.|0|||
19555872|NCT01273155|42004253|FG006|Overall Study|Change in liver function/no longer eval.|0|||
19555873|NCT01273155|42004247|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
19555874|NCT01273155|42004248|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
19555875|NCT01273155|42004249|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
19555876|NCT01273155|42004250|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
19555877|NCT01273155|42004251|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
19555878|NCT01273155|42004252|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
19555879|NCT01273155|42004253|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
19555880|NCT01273155|42004247|FG000|Overall Study|Died during Cycle 1|0|||
19555881|NCT01273155|42004248|FG001|Overall Study|Died during Cycle 1|0|||
19555882|NCT01273155|42004249|FG002|Overall Study|Died during Cycle 1|1|||
19555883|NCT01273155|42004250|FG003|Overall Study|Died during Cycle 1|1|||
19555884|NCT01273155|42004251|FG004|Overall Study|Died during Cycle 1|0|||
19555885|NCT01273155|42004252|FG005|Overall Study|Died during Cycle 1|2|||
19555886|NCT01273155|42004253|FG006|Overall Study|Died during Cycle 1|2|||
19555887|NCT01273155|42004247|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
19555888|NCT01273155|42004248|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
19555889|NCT01273155|42004249|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
19555890|NCT01273155|42004250|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
19555891|NCT01273155|42004251|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
19555892|NCT01273155|42004252|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
19555893|NCT01273155|42004253|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
19555894|NCT01005901|42004278|FG000|Overall Study|Withdrawal by Subject|38|||
19555895|NCT01005901|42004279|FG001|Overall Study|Withdrawal by Subject|14|||
19555896|NCT01005901|42004278|FG000|Overall Study|Adverse Event|30|||
19555897|NCT01005901|42004279|FG001|Overall Study|Adverse Event|16|||
19555898|NCT01005901|42004278|FG000|Overall Study|Administrative problems|21|||
19555899|NCT01005901|42004279|FG001|Overall Study|Administrative problems|13|||
19555900|NCT01005901|42004278|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
19555901|NCT01005901|42004279|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
19555902|NCT01005901|42004278|FG000|Overall Study|Protocol Violation|4|||
19555903|NCT01005901|42004279|FG001|Overall Study|Protocol Violation|3|||
19555904|NCT01005901|42004278|FG000|Overall Study|Death|2|||
19555905|NCT01005901|42004279|FG001|Overall Study|Death|3|||
19555906|NCT01005901|42004278|FG000|Overall Study|Lost to Follow-up|1|||
19555907|NCT01005901|42004279|FG001|Overall Study|Lost to Follow-up|2|||
19555908|NCT01005901|42004278|FG000|Overall Study|Patient's inability to use the device|1|||
19555909|NCT01005901|42004279|FG001|Overall Study|Patient's inability to use the device|1|||
19555910|NCT01005901|42004278|FG000|Overall Study|No longer requires study drug|0|||
19555911|NCT01005901|42004279|FG001|Overall Study|No longer requires study drug|1|||
19555912|NCT04968925|42004287|FG000|Phase I- Period 1|COVID-19 related|0|||
19555913|NCT04968925|42004288|FG001|Phase I- Period 1|COVID-19 related|1|||
19555914|NCT04968925|42004289|FG002|Phase I- Period 1|COVID-19 related|0|||
19555915|NCT04968925|42004290|FG003|Phase I- Period 1|COVID-19 related|0|||
19555916|NCT04968925|42004287|FG000|Phase I- Period 1|Subject enrolled in error|1|||
19555917|NCT04968925|42004288|FG001|Phase I- Period 1|Subject enrolled in error|1|||
19555918|NCT04968925|42004289|FG002|Phase I- Period 1|Subject enrolled in error|0|||
19555919|NCT04968925|42004290|FG003|Phase I- Period 1|Subject enrolled in error|0|||
19555920|NCT04968925|42004287|FG000|Phase II- Period 1|COVID-19 Related|0|||
19555921|NCT04968925|42004288|FG001|Phase II- Period 1|COVID-19 Related|0|||
19555922|NCT04968925|42004289|FG002|Phase II- Period 1|COVID-19 Related|6|||
19555923|NCT04968925|42004290|FG003|Phase II- Period 1|COVID-19 Related|6|||
19555924|NCT04968925|42004287|FG000|Phase II- Period 1|Subject enrolled in error|0|||
19555925|NCT04968925|42004288|FG001|Phase II- Period 1|Subject enrolled in error|0|||
19555926|NCT04968925|42004289|FG002|Phase II- Period 1|Subject enrolled in error|1|||
19555927|NCT04968925|42004290|FG003|Phase II- Period 1|Subject enrolled in error|0|||
19555928|NCT04968925|42004287|FG000|Phase II -Period 2|COVID-19 related|0|||
19555929|NCT04968925|42004288|FG001|Phase II -Period 2|COVID-19 related|0|||
19555930|NCT04968925|42004289|FG002|Phase II -Period 2|COVID-19 related|4|||
19555931|NCT04968925|42004290|FG003|Phase II -Period 2|COVID-19 related|3|||
19555932|NCT04968925|42004287|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
19555933|NCT04968925|42004288|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
19555934|NCT04968925|42004289|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
19555935|NCT04968925|42004290|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
19555936|NCT01266993|42004302|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
19555937|NCT01266993|42004303|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
19555938|NCT01266993|42004302|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
19555939|NCT01266993|42004303|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
19555940|NCT01309386|42004311|FG000|Overall Study|Other|2|||
19555941|NCT01309386|42004312|FG001|Overall Study|Other|0|||
19555942|NCT01309386|42004311|FG000|Overall Study|Withdrawal by Subject|2|||
19555943|NCT01309386|42004312|FG001|Overall Study|Withdrawal by Subject|0|||
19555944|NCT01309386|42004311|FG000|Overall Study|Progressive disease|9|||
19555945|NCT01309386|42004312|FG001|Overall Study|Progressive disease|11|||
19555946|NCT01309386|42004311|FG000|Overall Study|Physician Decision|1|||
19555947|NCT01309386|42004312|FG001|Overall Study|Physician Decision|1|||
19555948|NCT01309386|42004311|FG000|Overall Study|Lack of Efficacy|3|||
19555949|NCT01309386|42004312|FG001|Overall Study|Lack of Efficacy|1|||
19555950|NCT01309386|42004311|FG000|Overall Study|Adverse Event|5|||
19555951|NCT01309386|42004312|FG001|Overall Study|Adverse Event|8|||
19555952|NCT01266603|42004318|FG000|Overall Study|Adverse Event|1|||
19555953|NCT01266603|42004318|FG000|Overall Study|Lack of Efficacy|14|||
19555954|NCT01266603|42004318|FG000|Overall Study|Withdrawal by Subject|1|||
19555955|NCT01266603|42004318|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
19555956|NCT01309308|42004324|FG000|Overall Study|Lost to Follow-up|6|||
19555957|NCT01309308|42004325|FG001|Overall Study|Lost to Follow-up|4|||
19555958|NCT01266291|42004331|FG000|Overall Study|Adverse Event|1|||
19555959|NCT01004263|42004335|FG000|Overall Study|Adverse Event|15|||
19555960|NCT01004263|42004335|FG000|Overall Study|Withdrawal by Subject|58|||
19555961|NCT01004263|42004335|FG000|Overall Study|Protocol Violation|10|||
19555962|NCT01004263|42004335|FG000|Overall Study|Lost to Follow-up|64|||
19555963|NCT01004263|42004335|FG000|Overall Study|Lack of Efficacy|13|||
19555964|NCT01004263|42004335|FG000|Overall Study|Pregnancy|2|||
19555965|NCT01004263|42004335|FG000|Overall Study|Physician Decision|15|||
19555966|NCT01004263|42004335|FG000|Overall Study|Lack of Qualifying Event|2|||
19555967|NCT01308762|42004342|FG000|Overall Study|Protocol Violation|0|||
19555968|NCT01308762|42004343|FG001|Overall Study|Protocol Violation|1|||
19555969|NCT01308762|42004344|FG002|Overall Study|Protocol Violation|0|||
19555970|NCT01265823|42004355|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
19555971|NCT01265823|42004355|FG000|Overall Study|Failure to Return|4|||
19555972|NCT01265823|42004355|FG000|Overall Study|Protocol Violation|1|||
19555973|NCT01265823|42004355|FG000|Overall Study|Participant Request|1|||
19555974|NCT01004185|42004365|FG000|Overall Study|Adverse Event|1|||
19555975|NCT01004185|42004366|FG001|Overall Study|Adverse Event|1|||
19555976|NCT01004185|42004365|FG000|Overall Study|Lost to Follow-up|0|||
19555977|NCT01004185|42004366|FG001|Overall Study|Lost to Follow-up|1|||
19555978|NCT01004185|42004365|FG000|Overall Study|Lack of Efficacy|2|||
19555979|NCT01004185|42004366|FG001|Overall Study|Lack of Efficacy|1|||
19555980|NCT01004185|42004365|FG000|Overall Study|Sponsor Terminated Study|4|||
19555981|NCT01004185|42004366|FG001|Overall Study|Sponsor Terminated Study|5|||
19555982|NCT01004185|42004365|FG000|Overall Study|Withdrawal by Subject|2|||
19555983|NCT01004185|42004366|FG001|Overall Study|Withdrawal by Subject|1|||
19555984|NCT01265511|42004374|FG000|Overall Study|Lack of Efficacy|2|||
19555985|NCT01265511|42004375|FG001|Overall Study|Lack of Efficacy|1|||
19555986|NCT01265511|42004374|FG000|Overall Study|Met stopping rules|0|||
19555987|NCT01265511|42004375|FG001|Overall Study|Met stopping rules|2|||
19555988|NCT01264965|42004381|FG000|Overall Study|Withdrawal by Subject|10|||
19555989|NCT01264887|42004385|FG000|Overall Study|Adverse Event|5|||
19555990|NCT01264887|42004385|FG000|Overall Study|Death|7|||
19555991|NCT01264887|42004385|FG000|Overall Study|Lack of Efficacy|5|||
19555992|NCT01264887|42004385|FG000|Overall Study|Physician Decision|4|||
19555993|NCT01264887|42004385|FG000|Overall Study|Withdrawal by Subject|6|||
19555994|NCT01264887|42004385|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
19555995|NCT01264887|42004385|FG000|Overall Study|Other|2|||
19555996|NCT01306968|42004395|FG000|Overall Study|Lost to Follow-up|1|||
19555997|NCT01306968|42004396|FG001|Overall Study|Lost to Follow-up|1|||
19555998|NCT01306968|42004397|FG002|Overall Study|Lost to Follow-up|0|||
19555999|NCT01306968|42004398|FG003|Overall Study|Lost to Follow-up|0|||
19556000|NCT01306968|42004395|FG000|Overall Study|Physician Decision|0|||
19556001|NCT01306968|42004396|FG001|Overall Study|Physician Decision|1|||
19556002|NCT01306968|42004397|FG002|Overall Study|Physician Decision|0|||
19556003|NCT01306968|42004398|FG003|Overall Study|Physician Decision|0|||
19556004|NCT01306968|42004395|FG000|Overall Study|Relocated and left active duty|0|||
19556005|NCT01306968|42004396|FG001|Overall Study|Relocated and left active duty|1|||
19556006|NCT01306968|42004397|FG002|Overall Study|Relocated and left active duty|1|||
19382009|NCT02730169|41625066|FG003|Overall Study|Protocol Violation|1|||
19382010|NCT02730169|41625063|FG000|Overall Study|Adverse Event|2|||
19556007|NCT01306968|42004398|FG003|Overall Study|Relocated and left active duty|1|||
19556008|NCT01306968|42004395|FG000|Overall Study|Withdrew - time commitment|0|||
19556009|NCT01306968|42004396|FG001|Overall Study|Withdrew - time commitment|0|||
19556010|NCT01306968|42004397|FG002|Overall Study|Withdrew - time commitment|0|||
19556011|NCT01306968|42004398|FG003|Overall Study|Withdrew - time commitment|2|||
19556012|NCT01306968|42004395|FG000|Overall Study|Withdrew over privacy concerns|0|||
19556013|NCT01306968|42004396|FG001|Overall Study|Withdrew over privacy concerns|0|||
19556014|NCT01306968|42004397|FG002|Overall Study|Withdrew over privacy concerns|0|||
19556015|NCT01306968|42004398|FG003|Overall Study|Withdrew over privacy concerns|1|||
19556016|NCT01264419|42004410|FG000|Overall Study|Lost to Follow-up|3|||
19556017|NCT01263873|42004416|FG000|Overall Study|One provider unable to complete numbers|1|||
19556018|NCT01263873|42004417|FG001|Overall Study|One provider unable to complete numbers|1|||
19556019|NCT01263639|42004425|FG000|Overall Study|Lost to Follow-up|66|||
19556020|NCT01263639|42004426|FG001|Overall Study|Lost to Follow-up|70|||
19556021|NCT01263639|42004425|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
19556022|NCT01263639|42004426|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
19556023|NCT01011283|42004434|FG000|Overall Study|Adverse Event|4|||
19382011|NCT02730169|41625064|FG001|Overall Study|Adverse Event|3|||
19556024|NCT01011283|42004435|FG001|Overall Study|Adverse Event|2|||
19556025|NCT01011283|42004434|FG000|Overall Study|Progressive Disease|0|||
19556026|NCT01011283|42004435|FG001|Overall Study|Progressive Disease|2|||
19556027|NCT01011283|42004434|FG000|Overall Study|Terminated by Sponsor|5|||
19556028|NCT01011283|42004435|FG001|Overall Study|Terminated by Sponsor|5|||
19556029|NCT01011283|42004434|FG000|Overall Study|Other|2|||
19556030|NCT01011283|42004435|FG001|Overall Study|Other|2|||
19556031|NCT01263561|42004443|FG000|Overall Study|Death|1|||
19556032|NCT01263561|42004444|FG001|Overall Study|Death|2|||
19556033|NCT01009099|42004452|FG000|Overall Study|Lost to Follow-up|1|||
19556034|NCT01009099|42004453|FG001|Overall Study|Lost to Follow-up|0|||
19556035|NCT01009099|42004452|FG000|Overall Study|Physician Decision|3|||
19556036|NCT01009099|42004453|FG001|Overall Study|Physician Decision|2|||
19556037|NCT01009099|42004452|FG000|Overall Study|Withdrawal by Subject|1|||
19556038|NCT01009099|42004453|FG001|Overall Study|Withdrawal by Subject|1|||
19556039|NCT01009099|42004452|FG000|Overall Study|Death|0|||
19556040|NCT01009099|42004453|FG001|Overall Study|Death|1|||
19556041|NCT01263483|42004462|FG000|Overall Study|Adverse Event|4|||
19556042|NCT01263483|42004463|FG001|Overall Study|Adverse Event|0|||
19556043|NCT01263483|42004464|FG002|Overall Study|Adverse Event|3|||
19556044|NCT01263483|42004462|FG000|Overall Study|Withdrawal by Subject|1|||
19556045|NCT01263483|42004463|FG001|Overall Study|Withdrawal by Subject|0|||
19556046|NCT01263483|42004464|FG002|Overall Study|Withdrawal by Subject|0|||
19556047|NCT01263483|42004462|FG000|Overall Study|Lack of Efficacy|2|||
19556048|NCT01263483|42004463|FG001|Overall Study|Lack of Efficacy|0|||
19556049|NCT01263483|42004464|FG002|Overall Study|Lack of Efficacy|0|||
19556050|NCT01263483|42004462|FG000|Overall Study|Protocol Violation|0|||
19556051|NCT01263483|42004463|FG001|Overall Study|Protocol Violation|1|||
19556052|NCT01263483|42004464|FG002|Overall Study|Protocol Violation|1|||
19556053|NCT01263483|42004462|FG000|Overall Study|Participant Unavailability|0|||
19556054|NCT01263483|42004463|FG001|Overall Study|Participant Unavailability|1|||
19556055|NCT01263483|42004464|FG002|Overall Study|Participant Unavailability|1|||
19556056|NCT01306890|42004472|FG000|Overall Study|Adverse Event|2|||
19556057|NCT01306890|42004472|FG000|Overall Study|Death|1223|||
19556058|NCT01306890|42004472|FG000|Overall Study|Lost to Follow-up|58|||
19556059|NCT01306890|42004472|FG000|Overall Study|Withdrawal by Subject|88|||
19556060|NCT01306890|42004472|FG000|Overall Study|Unspecified reasons|104|||
19556061|NCT01306890|42004472|FG000|Overall Study|Study Termination|3|||
19556062|NCT01306890|42004472|FG000|Overall Study|No discontinuation documentation|41|||
19556063|NCT01011049|42004480|FG000|Overall Study|Protocol Violation|0|||
19556064|NCT01011049|42004481|FG001|Overall Study|Protocol Violation|0|||
19556065|NCT01011049|42004482|FG002|Overall Study|Protocol Violation|2|||
19556066|NCT01011049|42004483|FG003|Overall Study|Protocol Violation|0|||
19556067|NCT01011049|42004480|FG000|Overall Study|Lost to Follow-up|1|||
19556068|NCT01011049|42004481|FG001|Overall Study|Lost to Follow-up|2|||
19556069|NCT01011049|42004482|FG002|Overall Study|Lost to Follow-up|1|||
19556070|NCT01011049|42004483|FG003|Overall Study|Lost to Follow-up|0|||
19556071|NCT01011049|42004480|FG000|Overall Study|Withdrawal by Subject|0|||
19556072|NCT01011049|42004481|FG001|Overall Study|Withdrawal by Subject|0|||
19556073|NCT01011049|42004482|FG002|Overall Study|Withdrawal by Subject|1|||
19556074|NCT01011049|42004483|FG003|Overall Study|Withdrawal by Subject|0|||
19556075|NCT01263093|42004495|FG000|Washout|Physician Decision|1|||
19556076|NCT01263093|42004496|FG001|Washout|Physician Decision|0|||
19556077|NCT01263093|42004495|FG000|Period 2|Adverse Event|1|||
19556078|NCT01263093|42004496|FG001|Period 2|Adverse Event|0|||
19556079|NCT01010971|42004506|FG000|Overall Study|Adverse Event|2|||
19556080|NCT01010971|42004507|FG001|Overall Study|Adverse Event|4|||
19382012|NCT02730169|41625065|FG002|Overall Study|Adverse Event|3|||
19556081|NCT01010971|42004508|FG002|Overall Study|Adverse Event|3|||
19556082|NCT01010971|42004506|FG000|Overall Study|Withdrawal by Subject|0|||
19556083|NCT01010971|42004507|FG001|Overall Study|Withdrawal by Subject|2|||
19556084|NCT01010971|42004508|FG002|Overall Study|Withdrawal by Subject|5|||
19556085|NCT01010971|42004506|FG000|Overall Study|Lost to Follow-up|0|||
19556086|NCT01010971|42004507|FG001|Overall Study|Lost to Follow-up|2|||
19556087|NCT01010971|42004508|FG002|Overall Study|Lost to Follow-up|3|||
19556088|NCT01010971|42004506|FG000|Overall Study|Other|1|||
19556089|NCT01010971|42004507|FG001|Overall Study|Other|0|||
19556090|NCT01010971|42004508|FG002|Overall Study|Other|2|||
19556091|NCT01306656|42004518|FG000|Overall Study|Lost to Follow-up|1|||
19556092|NCT01306656|42004519|FG001|Overall Study|Lost to Follow-up|0|||
19556093|NCT01008943|42004527|FG000|Overall Study|Withdrawal by Subject|1|||
19556094|NCT01003639|42004533|FG000|Overall Study|Lost to Follow-up|6|||
19556095|NCT01003639|42004534|FG001|Overall Study|Lost to Follow-up|9|||
19556096|NCT01003639|42004533|FG000|Overall Study|Withdrawal by Subject|9|||
19556097|NCT01003639|42004534|FG001|Overall Study|Withdrawal by Subject|5|||
19556098|NCT01003639|42004533|FG000|Overall Study|Lack of Efficacy|1|||
19556099|NCT01003639|42004534|FG001|Overall Study|Lack of Efficacy|6|||
19556100|NCT01003639|42004533|FG000|Overall Study|Adverse Event|0|||
19556101|NCT01003639|42004534|FG001|Overall Study|Adverse Event|1|||
19556102|NCT01003639|42004533|FG000|Overall Study|Protocol Violation|0|||
19556103|NCT01003639|42004534|FG001|Overall Study|Protocol Violation|1|||
19556104|NCT01003639|42004533|FG000|Overall Study|Physician Decision|1|||
19556105|NCT01003639|42004534|FG001|Overall Study|Physician Decision|0|||
19556106|NCT01003249|42004540|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
19382013|NCT02730169|41625066|FG003|Overall Study|Adverse Event|0|||
19556107|NCT01003249|42004541|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
19382014|NCT02730169|41625063|FG000|Overall Study|Adverse Event of Special Interest|0|||
19556108|NCT01003249|42004540|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
19556109|NCT01003249|42004541|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
19556110|NCT01003249|42004540|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
19556111|NCT01003249|42004541|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19556112|NCT01003249|42004540|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
19556113|NCT01003249|42004541|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
19556114|NCT01001767|42004553|FG000|Overall Study|no baseline study performed|1|||
19556115|NCT01001767|42004554|FG001|Overall Study|no baseline study performed|0|||
19556116|NCT01001767|42004553|FG000|Overall Study|Protocol Violation|1|||
19556117|NCT01001767|42004554|FG001|Overall Study|Protocol Violation|0|||
19556118|NCT01001767|42004553|FG000|Overall Study|Lost to Follow-up|1|||
19556119|NCT01001767|42004554|FG001|Overall Study|Lost to Follow-up|0|||
19556120|NCT01001767|42004553|FG000|Overall Study|Physician Decision|1|||
19556121|NCT01001767|42004554|FG001|Overall Study|Physician Decision|0|||
19556122|NCT01306032|42004566|FG000|First Intervention|Adverse Event|1|||
19556123|NCT01306032|42004567|FG001|First Intervention|Adverse Event|0|||
19556124|NCT01306032|42004568|FG002|First Intervention|Adverse Event|1|||
19556125|NCT01306032|42004569|FG003|First Intervention|Adverse Event|0|||
19556126|NCT01306032|42004570|FG004|First Intervention|Adverse Event|0|||
19556127|NCT01306032|42004571|FG005|First Intervention|Adverse Event|1|||
19556128|NCT01306032|42004566|FG000|First Intervention|Withdrawal by Subject|0|||
19556129|NCT01306032|42004567|FG001|First Intervention|Withdrawal by Subject|2|||
19556130|NCT01306032|42004568|FG002|First Intervention|Withdrawal by Subject|0|||
19556131|NCT01306032|42004569|FG003|First Intervention|Withdrawal by Subject|1|||
19556132|NCT01306032|42004570|FG004|First Intervention|Withdrawal by Subject|0|||
19556133|NCT01306032|42004571|FG005|First Intervention|Withdrawal by Subject|0|||
19556134|NCT01306032|42004566|FG000|First Intervention|Death|0|||
19556135|NCT01306032|42004567|FG001|First Intervention|Death|0|||
19556136|NCT01306032|42004568|FG002|First Intervention|Death|1|||
19556137|NCT01306032|42004569|FG003|First Intervention|Death|0|||
19556138|NCT01306032|42004570|FG004|First Intervention|Death|0|||
19556139|NCT01306032|42004571|FG005|First Intervention|Death|0|||
19556140|NCT01306032|42004566|FG000|First Intervention|Ineligible|0|||
19556141|NCT01306032|42004567|FG001|First Intervention|Ineligible|0|||
19556142|NCT01306032|42004568|FG002|First Intervention|Ineligible|0|||
19556143|NCT01306032|42004569|FG003|First Intervention|Ineligible|0|||
19556144|NCT01306032|42004570|FG004|First Intervention|Ineligible|0|||
19556145|NCT01306032|42004571|FG005|First Intervention|Ineligible|1|||
19556146|NCT01306032|42004566|FG000|First Intervention|Progressive disease|0|||
19556147|NCT01306032|42004567|FG001|First Intervention|Progressive disease|0|||
19556148|NCT01306032|42004568|FG002|First Intervention|Progressive disease|0|||
19556149|NCT01306032|42004569|FG003|First Intervention|Progressive disease|0|||
19556150|NCT01306032|42004570|FG004|First Intervention|Progressive disease|2|||
19556151|NCT01306032|42004571|FG005|First Intervention|Progressive disease|0|||
19556152|NCT01306032|42004566|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
19556153|NCT01306032|42004567|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
19556154|NCT01306032|42004568|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
19556155|NCT01306032|42004569|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
19556156|NCT01306032|42004570|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
19556157|NCT01306032|42004571|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
19556158|NCT01306032|42004566|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
19556159|NCT01306032|42004567|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
19556160|NCT01306032|42004568|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
19556161|NCT01306032|42004569|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
19556162|NCT01306032|42004570|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
19556163|NCT01306032|42004571|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
19556164|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
19556165|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
19556166|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
19556167|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
19556168|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
19556169|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
19556170|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
19556171|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
19556172|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
19556173|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
19556174|NCT01263015|42004599|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
19556175|NCT01263015|42004600|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
19556176|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
19556177|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
19556178|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
19556179|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
19556180|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
19556181|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
19556182|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
19556183|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
19556184|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
19556185|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
19556186|NCT01263015|42004599|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
19556187|NCT01263015|42004600|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
19556188|NCT01305564|42004606|FG000|Overall Study|Death|21|||
19556189|NCT01305564|42004606|FG000|Overall Study|Lost to Follow-up|12|||
19556190|NCT01305564|42004606|FG000|Overall Study|Withdrawal by Subject|1|||
19556191|NCT01305564|42004606|FG000|Overall Study|Physician Decision|3|||
19556192|NCT01305408|42004623|FG000|Overall Study|Adverse Event|10|||
19556193|NCT01305408|42004624|FG001|Overall Study|Adverse Event|7|||
19556194|NCT01305408|42004623|FG000|Overall Study|Lack of Efficacy|3|||
19556195|NCT01305408|42004624|FG001|Overall Study|Lack of Efficacy|4|||
19556196|NCT01305408|42004623|FG000|Overall Study|Withdrawal by Subject|9|||
19556197|NCT01305408|42004624|FG001|Overall Study|Withdrawal by Subject|9|||
19556198|NCT01305408|42004623|FG000|Overall Study|Protocol Violation|4|||
19556199|NCT01305408|42004624|FG001|Overall Study|Protocol Violation|6|||
19556200|NCT01305408|42004623|FG000|Overall Study|Lost to Follow-up|5|||
19556201|NCT01305408|42004624|FG001|Overall Study|Lost to Follow-up|3|||
19556202|NCT01305408|42004623|FG000|Overall Study|Noncompliance with study medication|0|||
19556203|NCT01305408|42004624|FG001|Overall Study|Noncompliance with study medication|1|||
19556204|NCT01305408|42004623|FG000|Overall Study|Noncompliance with study procedures|0|||
19556205|NCT01305408|42004624|FG001|Overall Study|Noncompliance with study procedures|1|||
19556206|NCT01305408|42004623|FG000|Overall Study|Other|1|||
19556207|NCT01305408|42004624|FG001|Overall Study|Other|0|||
19556208|NCT01304940|42004632|FG000|Overall Study|not meet symptom severity requirement|3|||
19556209|NCT01304940|42004633|FG001|Overall Study|not meet symptom severity requirement|0|||
19556210|NCT01261611|42004642|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
19556211|NCT01261611|42004643|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
19556212|NCT01261611|42004644|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
19556213|NCT01261611|42004642|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
19556214|NCT01261611|42004643|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
19556215|NCT01261611|42004644|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
19556216|NCT01261611|42004642|FG000|Treatment Cycle 1|Adverse Event|0|||
19556217|NCT01261611|42004643|FG001|Treatment Cycle 1|Adverse Event|1|||
19556218|NCT01261611|42004644|FG002|Treatment Cycle 1|Adverse Event|0|||
19556219|NCT01261611|42004642|FG000|Treatment Cycle 1|Protocol Violation|0|||
19556220|NCT01261611|42004643|FG001|Treatment Cycle 1|Protocol Violation|0|||
19556221|NCT01261611|42004644|FG002|Treatment Cycle 1|Protocol Violation|2|||
19556222|NCT01261611|42004642|FG000|Treatment Cycle 2|Completed study|4|||
19556223|NCT01261611|42004643|FG001|Treatment Cycle 2|Completed study|0|||
19556224|NCT01261611|42004644|FG002|Treatment Cycle 2|Completed study|0|||
19556225|NCT01261611|42004642|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
19556226|NCT01261611|42004643|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
19556227|NCT01261611|42004644|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
19556228|NCT01261611|42004642|FG000|Treatment Cycle 2|Adverse Event|1|||
19556229|NCT01261611|42004643|FG001|Treatment Cycle 2|Adverse Event|0|||
19556230|NCT01261611|42004644|FG002|Treatment Cycle 2|Adverse Event|0|||
19556231|NCT01261611|42004642|FG000|Treatment Cycle 2|Protocol Violation|2|||
19556232|NCT01261611|42004643|FG001|Treatment Cycle 2|Protocol Violation|0|||
19556233|NCT01261611|42004644|FG002|Treatment Cycle 2|Protocol Violation|0|||
19556234|NCT01261611|42004642|FG000|Treatment Cycle 2|Not otherwise specified|2|||
19556235|NCT01261611|42004643|FG001|Treatment Cycle 2|Not otherwise specified|0|||
19556236|NCT01261611|42004644|FG002|Treatment Cycle 2|Not otherwise specified|0|||
19556237|NCT01261611|42004642|FG000|Treatment Cycle 3|Completed study|24|||
19556238|NCT01261611|42004643|FG001|Treatment Cycle 3|Completed study|0|||
19556239|NCT01261611|42004644|FG002|Treatment Cycle 3|Completed study|0|||
19556240|NCT01261611|42004642|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
19556241|NCT01261611|42004643|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
19556242|NCT01261611|42004644|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
19556243|NCT01261611|42004642|FG000|Treatment Cycle 3|Adverse Event|1|||
19556244|NCT01261611|42004643|FG001|Treatment Cycle 3|Adverse Event|0|||
19556245|NCT01261611|42004644|FG002|Treatment Cycle 3|Adverse Event|0|||
19556246|NCT01261611|42004642|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
19556247|NCT01261611|42004643|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
19556248|NCT01261611|42004644|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
19556249|NCT01261611|42004642|FG000|Treatment Cycle 4|Completed study|87|||
19556250|NCT01261611|42004643|FG001|Treatment Cycle 4|Completed study|0|||
19556251|NCT01261611|42004644|FG002|Treatment Cycle 4|Completed study|0|||
19556252|NCT01261611|42004642|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
19556253|NCT01261611|42004643|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
19556254|NCT01261611|42004644|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
19556255|NCT01261611|42004642|FG000|Treatment Cycle 4|Adverse Event|1|||
19556256|NCT01261611|42004643|FG001|Treatment Cycle 4|Adverse Event|0|||
19556257|NCT01261611|42004644|FG002|Treatment Cycle 4|Adverse Event|0|||
19556258|NCT01261611|42004642|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
19556259|NCT01261611|42004643|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
19556260|NCT01261611|42004644|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
19556261|NCT01261611|42004642|FG000|Treatment Cycle 4|Not otherwise specified|3|||
19556262|NCT01261611|42004643|FG001|Treatment Cycle 4|Not otherwise specified|0|||
19556263|NCT01261611|42004644|FG002|Treatment Cycle 4|Not otherwise specified|0|||
19556264|NCT01261611|42004642|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
19556265|NCT01261611|42004643|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
19556266|NCT01261611|42004644|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
19556267|NCT01261611|42004642|FG000|Treatment Cycle 5|Adverse Event|1|||
19556268|NCT01261611|42004643|FG001|Treatment Cycle 5|Adverse Event|0|||
19556269|NCT01261611|42004644|FG002|Treatment Cycle 5|Adverse Event|0|||
19556270|NCT01261611|42004642|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
19556271|NCT01261611|42004643|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
19556272|NCT01261611|42004644|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
19556273|NCT01304706|42004656|FG000|Overall Study|Adverse Event|2|||
19556274|NCT01304706|42004656|FG000|Overall Study|Lack of Efficacy|1|||
19556275|NCT01304706|42004656|FG000|Overall Study|Death|3|||
19556276|NCT01304706|42004656|FG000|Overall Study|Withdrawal by Subject|3|||
19556277|NCT01304706|42004656|FG000|Overall Study|Lost to Follow-up|7|||
19556278|NCT01304706|42004656|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
19556279|NCT01303380|42004660|FG000|Overall Study|Lack of compliance to study procedures|1|||
19556280|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Physician Decision|2|||
19556281|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Physician Decision|0|||
19556282|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Physician Decision|0|||
19556283|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Adverse Event|33|||
19556284|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Adverse Event|0|||
19556285|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Adverse Event|0|||
19556286|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
19556287|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
19556288|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
19556289|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
19556290|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
19556291|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
19556292|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
19556293|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
19556294|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
19556295|NCT01008553|42004664|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
19556296|NCT01008553|42004665|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
19556297|NCT01008553|42004666|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
19556298|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
19556299|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
19556300|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
19556301|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
19556302|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
19556303|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
19556304|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
19556305|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
19556306|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
19556307|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
19556308|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
19556309|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
19556310|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
19556311|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
19556312|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
19556313|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
19556314|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
19556315|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
19556316|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
19556317|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
19556318|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
19556319|NCT01008553|42004664|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
19556320|NCT01008553|42004665|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
19556321|NCT01008553|42004666|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
19556322|NCT01302834|42004677|FG000|Overall Study|Protocol Violation|17|||
19556323|NCT01302834|42004678|FG001|Overall Study|Protocol Violation|23|||
19556324|NCT01302834|42004677|FG000|Overall Study|HIV positive|1|||
19556325|NCT01302834|42004678|FG001|Overall Study|HIV positive|3|||
19556326|NCT01259115|42004684|FG000|Period 1|Adverse Event|1|||
19556327|NCT01259115|42004685|FG001|Period 1|Adverse Event|0|||
19556328|NCT01259115|42004684|FG000|Period 1|Protocol Violation|2|||
19556329|NCT01259115|42004685|FG001|Period 1|Protocol Violation|0|||
19556330|NCT01259115|42004684|FG000|Period 1|Lost to Follow-up|0|||
19556331|NCT01259115|42004685|FG001|Period 1|Lost to Follow-up|1|||
19556332|NCT01259115|42004684|FG000|Period 2|Adverse Event|1|||
19556333|NCT01259115|42004685|FG001|Period 2|Adverse Event|0|||
19556334|NCT01302366|42004696|FG000|Overall Study|patient choice or noncompliance|5|||
19556335|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
19556336|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
19556337|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
19556338|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
19556339|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
19556340|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
19556341|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
19556342|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
19556343|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
19556344|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
19556345|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
19556346|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
19556347|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
19556348|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
19556349|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
19556350|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
19556351|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
19556352|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
19556353|NCT01302054|42004700|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
19556354|NCT01302054|42004701|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
19556355|NCT01302054|42004702|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
19556356|NCT01302054|42004700|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
19556357|NCT01302054|42004701|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
19556358|NCT01302054|42004702|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
19556359|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19556360|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
19556361|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
19556362|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19556363|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
19556364|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
19556365|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19556366|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
19556367|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
19556368|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
19556369|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
19556370|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
19556371|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
19556372|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
19556373|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
19556374|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
19556375|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
19556376|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
19556377|NCT01302054|42004700|FG000|Double-Blind Treatment Phase|Other|0|||
19556378|NCT01302054|42004701|FG001|Double-Blind Treatment Phase|Other|4|||
19556379|NCT01302054|42004702|FG002|Double-Blind Treatment Phase|Other|9|||
19556380|NCT01301508|42004713|FG000|Overall Study|Withdrawal by Subject|1|||
19556381|NCT01301508|42004714|FG001|Overall Study|Withdrawal by Subject|2|||
19556382|NCT01301508|42004713|FG000|Overall Study|Lost to Follow-up|0|||
19556383|NCT01301508|42004714|FG001|Overall Study|Lost to Follow-up|1|||
19556384|NCT01301274|42004722|FG000|Overall Study|Physician Decision|2|||
19556385|NCT01301274|42004723|FG001|Overall Study|Physician Decision|1|||
19556386|NCT01300650|42004734|FG000|Overall Study|Adverse Event|1|||
19556387|NCT01300572|42004739|FG000|Overall Study|HAMA + post dosimetry|1|||
19556388|NCT01077154|42004746|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
19556389|NCT01077154|42004747|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
19556390|NCT01077154|42004746|FG000|Overall Study|Withdrawal by Subject|369|||
19556391|NCT01077154|42004747|FG001|Overall Study|Withdrawal by Subject|385|||
19556392|NCT01077154|42004746|FG000|Overall Study|Death|215|||
19556393|NCT01077154|42004747|FG001|Overall Study|Death|214|||
19556394|NCT01077154|42004746|FG000|Overall Study|Lost to Follow-up|43|||
19556395|NCT01077154|42004747|FG001|Overall Study|Lost to Follow-up|35|||
19556396|NCT01077154|42004746|FG000|Overall Study|Noncompliance|22|||
19556397|NCT01077154|42004747|FG001|Overall Study|Noncompliance|20|||
19556398|NCT01077154|42004746|FG000|Overall Study|Disease Progression|18|||
19556399|NCT01077154|42004747|FG001|Overall Study|Disease Progression|20|||
19556400|NCT01077154|42004746|FG000|Overall Study|Ineligibility Determined|10|||
19556401|NCT01077154|42004747|FG001|Overall Study|Ineligibility Determined|14|||
19556402|NCT01077154|42004746|FG000|Overall Study|Other|14|||
19556403|NCT01077154|42004747|FG001|Overall Study|Other|11|||
19556404|NCT01077154|42004746|FG000|Overall Study|Adverse Event|9|||
19556405|NCT01077154|42004747|FG001|Overall Study|Adverse Event|9|||
19556406|NCT01077154|42004746|FG000|Overall Study|Administrative Decision|1|||
19556407|NCT01077154|42004747|FG001|Overall Study|Administrative Decision|6|||
19556408|NCT01077154|42004746|FG000|Overall Study|Protocol Deviation|1|||
19556409|NCT01077154|42004747|FG001|Overall Study|Protocol Deviation|0|||
19556410|NCT01258101|42004757|FG000|Overall Study|Adverse Event|5|||
19556411|NCT01258101|42004758|FG001|Overall Study|Adverse Event|6|||
19556412|NCT01258101|42004759|FG002|Overall Study|Adverse Event|0|||
19556413|NCT01258101|42004760|FG003|Overall Study|Adverse Event|0|||
19556414|NCT01258101|42004757|FG000|Overall Study|Extra exclusion criterion amended|2|||
19556415|NCT01258101|42004758|FG001|Overall Study|Extra exclusion criterion amended|1|||
19556416|NCT01258101|42004759|FG002|Overall Study|Extra exclusion criterion amended|1|||
19556417|NCT01258101|42004760|FG003|Overall Study|Extra exclusion criterion amended|1|||
19556418|NCT01258101|42004757|FG000|Overall Study|Informed consent has been withdrawn|2|||
19556419|NCT01258101|42004758|FG001|Overall Study|Informed consent has been withdrawn|2|||
19556420|NCT01258101|42004759|FG002|Overall Study|Informed consent has been withdrawn|1|||
19556421|NCT01258101|42004760|FG003|Overall Study|Informed consent has been withdrawn|1|||
19556422|NCT01258101|42004757|FG000|Overall Study|Patient is not able to attend visits|8|||
19556423|NCT01258101|42004758|FG001|Overall Study|Patient is not able to attend visits|9|||
19556424|NCT01258101|42004759|FG002|Overall Study|Patient is not able to attend visits|7|||
19556425|NCT01258101|42004760|FG003|Overall Study|Patient is not able to attend visits|6|||
19556426|NCT01258101|42004757|FG000|Overall Study|Patient´s compliance|4|||
19556427|NCT01258101|42004758|FG001|Overall Study|Patient´s compliance|3|||
19556428|NCT01258101|42004759|FG002|Overall Study|Patient´s compliance|1|||
19556429|NCT01258101|42004760|FG003|Overall Study|Patient´s compliance|2|||
19556430|NCT01258101|42004757|FG000|Overall Study|Lost to Follow-up|5|||
19556431|NCT01258101|42004758|FG001|Overall Study|Lost to Follow-up|5|||
19556432|NCT01258101|42004759|FG002|Overall Study|Lost to Follow-up|0|||
19556433|NCT01258101|42004760|FG003|Overall Study|Lost to Follow-up|6|||
19556434|NCT01258101|42004757|FG000|Overall Study|PCR positive at week 24|0|||
19556435|NCT01258101|42004758|FG001|Overall Study|PCR positive at week 24|0|||
19390363|NCT01987960|41634111|FG001|Period 3|Non-compliance with IMP|0|||
19556436|NCT01258101|42004759|FG002|Overall Study|PCR positive at week 24|0|||
19556437|NCT01258101|42004760|FG003|Overall Study|PCR positive at week 24|1|||
19556438|NCT01258101|42004757|FG000|Overall Study|Other reason|7|||
19556439|NCT01258101|42004758|FG001|Overall Study|Other reason|8|||
19556440|NCT01258101|42004759|FG002|Overall Study|Other reason|1|||
19556441|NCT01258101|42004760|FG003|Overall Study|Other reason|8|||
19556442|NCT01300338|42004772|FG000|Overall Study|Lost to Follow-up|5|||
19556443|NCT01300338|42004773|FG001|Overall Study|Lost to Follow-up|0|||
19556444|NCT01300260|42004781|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
19556445|NCT01300260|42004782|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
19556446|NCT01300260|42004781|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
19556447|NCT01300260|42004782|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
19556448|NCT01300260|42004781|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
19556449|NCT01300260|42004782|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
19556450|NCT01256385|42004801|FG000|Overall Study|Physician Decision|1|||
19556451|NCT01256385|42004802|FG001|Overall Study|Physician Decision|1|||
19556452|NCT01256385|42004801|FG000|Overall Study|Withdrawal by Subject|2|||
19556453|NCT01256385|42004802|FG001|Overall Study|Withdrawal by Subject|2|||
19556454|NCT01298778|42004810|FG000|Overall Study|Lost to Follow-up|2|||
19556455|NCT01298778|42004811|FG001|Overall Study|Lost to Follow-up|3|||
19556456|NCT01298778|42004810|FG000|Overall Study|Incorrect use of VAS|1|||
19556457|NCT01298778|42004811|FG001|Overall Study|Incorrect use of VAS|0|||
19556458|NCT01298778|42004810|FG000|Overall Study|Withdrawal by Subject|0|||
19556459|NCT01298778|42004811|FG001|Overall Study|Withdrawal by Subject|1|||
19556460|NCT01298778|42004810|FG000|Overall Study|Protocol Violation|0|||
19556461|NCT01298778|42004811|FG001|Overall Study|Protocol Violation|1|||
19556462|NCT01298778|42004810|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
19556463|NCT01298778|42004811|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
19556464|NCT01298700|42004821|FG000|Overall Study|Adverse Event|50|||
19556465|NCT01298700|42004822|FG001|Overall Study|Adverse Event|51|||
19556466|NCT01298700|42004821|FG000|Overall Study|Lack of Efficacy|9|||
19556467|NCT01298700|42004822|FG001|Overall Study|Lack of Efficacy|14|||
19556468|NCT01298700|42004821|FG000|Overall Study|Lost to Follow-up|5|||
19556469|NCT01298700|42004822|FG001|Overall Study|Lost to Follow-up|2|||
19556470|NCT01298700|42004821|FG000|Overall Study|Withdrawal by Subject|12|||
19556471|NCT01298700|42004822|FG001|Overall Study|Withdrawal by Subject|9|||
19556472|NCT01298700|42004821|FG000|Overall Study|Protocol Violation|6|||
19556473|NCT01298700|42004822|FG001|Overall Study|Protocol Violation|4|||
19556474|NCT01298700|42004821|FG000|Overall Study|Other Miscellaneous Reasons|16|||
19556475|NCT01298700|42004822|FG001|Overall Study|Other Miscellaneous Reasons|15|||
19556476|NCT01298700|42004821|FG000|Overall Study|Did not Receive Study Drug|3|||
19556477|NCT01298700|42004822|FG001|Overall Study|Did not Receive Study Drug|5|||
19556478|NCT01297920|42004831|FG000|Overall Study|Adverse Event|42|||
19556479|NCT01297920|42004832|FG001|Overall Study|Adverse Event|10|||
19556480|NCT01297920|42004833|FG002|Overall Study|Adverse Event|38|||
19556481|NCT01297920|42004831|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
19556482|NCT01297920|42004832|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
19556483|NCT01297920|42004833|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
19556484|NCT01297920|42004831|FG000|Overall Study|Noncompliance|1|||
19556485|NCT01297920|42004832|FG001|Overall Study|Noncompliance|0|||
19556486|NCT01297920|42004833|FG002|Overall Study|Noncompliance|0|||
19556487|NCT01297920|42004831|FG000|Overall Study|Protocol Violation|1|||
19556488|NCT01297920|42004832|FG001|Overall Study|Protocol Violation|3|||
19556489|NCT01297920|42004833|FG002|Overall Study|Protocol Violation|0|||
19556490|NCT01297920|42004831|FG000|Overall Study|Inadequate Control of IOP|7|||
19556491|NCT01297920|42004832|FG001|Overall Study|Inadequate Control of IOP|9|||
19556492|NCT01297920|42004833|FG002|Overall Study|Inadequate Control of IOP|17|||
19556493|NCT01297920|42004831|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
19556494|NCT01297920|42004832|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
19556495|NCT01297920|42004833|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
19556496|NCT01255761|42004843|FG000|Overall Study|Adverse Event|29|||
19556497|NCT01255761|42004844|FG001|Overall Study|Adverse Event|43|||
19556498|NCT01255761|42004843|FG000|Overall Study|Lack of Efficacy|86|||
19556499|NCT01255761|42004844|FG001|Overall Study|Lack of Efficacy|74|||
19556500|NCT01255761|42004843|FG000|Overall Study|Protocol Violation|9|||
19556501|NCT01255761|42004844|FG001|Overall Study|Protocol Violation|5|||
19556502|NCT01255761|42004843|FG000|Overall Study|Lost to Follow-up|10|||
19556503|NCT01255761|42004844|FG001|Overall Study|Lost to Follow-up|8|||
19556504|NCT01255761|42004843|FG000|Overall Study|Withdrawal by Subject|11|||
19556505|NCT01255761|42004844|FG001|Overall Study|Withdrawal by Subject|27|||
19556506|NCT01255761|42004843|FG000|Overall Study|Other Reasons|37|||
19556507|NCT01255761|42004844|FG001|Overall Study|Other Reasons|18|||
19556508|NCT01297062|42004856|FG000|Overall Study|Adverse Event|2|||
19556509|NCT01297062|42004857|FG001|Overall Study|Adverse Event|0|||
19556510|NCT01297062|42004858|FG002|Overall Study|Adverse Event|1|||
19556511|NCT01297062|42004859|FG003|Overall Study|Adverse Event|0|||
19556512|NCT01297062|42004860|FG004|Overall Study|Adverse Event|0|||
19556513|NCT01297062|42004861|FG005|Overall Study|Adverse Event|0|||
19556514|NCT01297062|42004862|FG006|Overall Study|Adverse Event|0|||
19556515|NCT01297062|42004856|FG000|Overall Study|Physician Decision|1|||
19556516|NCT01297062|42004857|FG001|Overall Study|Physician Decision|0|||
19556517|NCT01297062|42004858|FG002|Overall Study|Physician Decision|1|||
19556518|NCT01297062|42004859|FG003|Overall Study|Physician Decision|0|||
19556519|NCT01297062|42004860|FG004|Overall Study|Physician Decision|0|||
19556520|NCT01297062|42004861|FG005|Overall Study|Physician Decision|0|||
19556521|NCT01297062|42004862|FG006|Overall Study|Physician Decision|6|||
19556522|NCT01297062|42004856|FG000|Overall Study|Protocol Violation|0|||
19556523|NCT01297062|42004857|FG001|Overall Study|Protocol Violation|0|||
19556524|NCT01297062|42004858|FG002|Overall Study|Protocol Violation|0|||
19556525|NCT01297062|42004859|FG003|Overall Study|Protocol Violation|0|||
19556526|NCT01297062|42004860|FG004|Overall Study|Protocol Violation|1|||
19556527|NCT01297062|42004861|FG005|Overall Study|Protocol Violation|0|||
19556528|NCT01297062|42004862|FG006|Overall Study|Protocol Violation|0|||
19556529|NCT01297062|42004856|FG000|Overall Study|Subject Decision|1|||
19556530|NCT01297062|42004857|FG001|Overall Study|Subject Decision|1|||
19556531|NCT01297062|42004858|FG002|Overall Study|Subject Decision|0|||
19556532|NCT01297062|42004859|FG003|Overall Study|Subject Decision|1|||
19556533|NCT01297062|42004860|FG004|Overall Study|Subject Decision|1|||
19556534|NCT01297062|42004861|FG005|Overall Study|Subject Decision|1|||
19556535|NCT01297062|42004862|FG006|Overall Study|Subject Decision|2|||
19556536|NCT01254747|42004874|FG000|Overall Study|Unacceptable subjective vision|0|||
19556537|NCT01254747|42004875|FG001|Overall Study|Unacceptable subjective vision|0|||
19556538|NCT01254747|42004876|FG002|Overall Study|Unacceptable subjective vision|0|||
19556539|NCT01254747|42004877|FG003|Overall Study|Unacceptable subjective vision|2|||
19556540|NCT01254747|42004874|FG000|Overall Study|Difficult removal handling|0|||
19556541|NCT01254747|42004875|FG001|Overall Study|Difficult removal handling|0|||
19556542|NCT01254747|42004876|FG002|Overall Study|Difficult removal handling|1|||
19556543|NCT01254747|42004877|FG003|Overall Study|Difficult removal handling|0|||
19556544|NCT01254747|42004874|FG000|Overall Study|Symptoms and problems|0|||
19556545|NCT01254747|42004875|FG001|Overall Study|Symptoms and problems|2|||
19556546|NCT01254747|42004876|FG002|Overall Study|Symptoms and problems|1|||
19556547|NCT01254747|42004877|FG003|Overall Study|Symptoms and problems|0|||
19556548|NCT01254747|42004874|FG000|Overall Study|Lost to Follow-up|0|||
19556549|NCT01254747|42004875|FG001|Overall Study|Lost to Follow-up|0|||
19556550|NCT01254747|42004876|FG002|Overall Study|Lost to Follow-up|1|||
19556551|NCT01254747|42004877|FG003|Overall Study|Lost to Follow-up|0|||
19556552|NCT01254747|42004874|FG000|Overall Study|Biomicroscopy|0|||
19556553|NCT01254747|42004875|FG001|Overall Study|Biomicroscopy|0|||
19556554|NCT01254747|42004876|FG002|Overall Study|Biomicroscopy|1|||
19556555|NCT01254747|42004877|FG003|Overall Study|Biomicroscopy|0|||
19556556|NCT01254747|42004874|FG000|Overall Study|Discomfort|0|||
19556557|NCT01254747|42004875|FG001|Overall Study|Discomfort|4|||
19556558|NCT01254747|42004876|FG002|Overall Study|Discomfort|0|||
19556559|NCT01254747|42004877|FG003|Overall Study|Discomfort|0|||
19556560|NCT01296672|42004889|FG000|Overall Study|Lost to Follow-up|73|||
19556561|NCT01296672|42004890|FG001|Overall Study|Lost to Follow-up|18|||
19556562|NCT01254669|42004900|FG000|Overall Study|Withdrawal by Subject|0|||
19556563|NCT01254669|42004901|FG001|Overall Study|Withdrawal by Subject|1|||
19556564|NCT01254669|42004900|FG000|Overall Study|time constraint|2|||
19556565|NCT01254669|42004901|FG001|Overall Study|time constraint|2|||
19556566|NCT01254669|42004900|FG000|Overall Study|called to clinic during intervention|1|||
19556567|NCT01254669|42004901|FG001|Overall Study|called to clinic during intervention|1|||
19556568|NCT01295814|42004911|FG000|Overall Study|Lack of Efficacy|0|||
19556569|NCT01295814|42004912|FG001|Overall Study|Lack of Efficacy|2|||
19556570|NCT01295814|42004911|FG000|Overall Study|Withdrawal by Subject|2|||
19556571|NCT01295814|42004912|FG001|Overall Study|Withdrawal by Subject|0|||
19556572|NCT01254045|42004918|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
19556573|NCT01254045|42004919|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
19556574|NCT01254045|42004920|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
19556575|NCT01254045|42004921|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
19556576|NCT01254045|42004922|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
19556577|NCT01254045|42004923|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
19556578|NCT01075282|42004936|FG000|Overall Study|Withdrawal by Subject|11|||
19556579|NCT01075282|42004937|FG001|Overall Study|Withdrawal by Subject|7|||
19556580|NCT01075282|42004938|FG002|Overall Study|Withdrawal by Subject|11|||
19556581|NCT01075282|42004936|FG000|Overall Study|Adverse Event|9|||
19556582|NCT01075282|42004937|FG001|Overall Study|Adverse Event|8|||
19556583|NCT01075282|42004938|FG002|Overall Study|Adverse Event|5|||
19556584|NCT01075282|42004936|FG000|Overall Study|Entry Criteria Not Met|3|||
19556585|NCT01075282|42004937|FG001|Overall Study|Entry Criteria Not Met|2|||
19556586|NCT01075282|42004938|FG002|Overall Study|Entry Criteria Not Met|0|||
19382015|NCT02730169|41625064|FG001|Overall Study|Adverse Event of Special Interest|1|||
19556587|NCT01075282|42004936|FG000|Overall Study|Lost to Follow-up|3|||
19556588|NCT01075282|42004937|FG001|Overall Study|Lost to Follow-up|3|||
19556589|NCT01075282|42004938|FG002|Overall Study|Lost to Follow-up|3|||
19556590|NCT01075282|42004936|FG000|Overall Study|Physician Decision|3|||
19556591|NCT01075282|42004937|FG001|Overall Study|Physician Decision|3|||
19556592|NCT01075282|42004938|FG002|Overall Study|Physician Decision|3|||
19556593|NCT01075282|42004936|FG000|Overall Study|Lack of Efficacy|1|||
19556594|NCT01075282|42004937|FG001|Overall Study|Lack of Efficacy|1|||
19556595|NCT01075282|42004938|FG002|Overall Study|Lack of Efficacy|0|||
19556596|NCT01075282|42004936|FG000|Overall Study|Treatment Non-compliance|1|||
19556597|NCT01075282|42004937|FG001|Overall Study|Treatment Non-compliance|2|||
19556598|NCT01075282|42004938|FG002|Overall Study|Treatment Non-compliance|2|||
19556599|NCT01075282|42004936|FG000|Overall Study|Protocol Violation|0|||
19556600|NCT01075282|42004937|FG001|Overall Study|Protocol Violation|2|||
19556601|NCT01075282|42004938|FG002|Overall Study|Protocol Violation|1|||
19556602|NCT01075282|42004936|FG000|Overall Study|Death|0|||
19556603|NCT01075282|42004937|FG001|Overall Study|Death|1|||
19556604|NCT01075282|42004938|FG002|Overall Study|Death|2|||
19556605|NCT01253811|42004947|FG000|Overall Study|Withdrawal criteria|1|||
19556606|NCT01295580|42004953|FG000|Overall Study|Protocol Violation|4|||
19556607|NCT01295580|42004954|FG001|Overall Study|Protocol Violation|2|||
19556608|NCT01295580|42004953|FG000|Overall Study|Withdrawal by Subject|1|||
19556609|NCT01295580|42004954|FG001|Overall Study|Withdrawal by Subject|4|||
19556610|NCT01295580|42004953|FG000|Overall Study|Adverse Event|2|||
19556611|NCT01295580|42004954|FG001|Overall Study|Adverse Event|1|||
19556612|NCT01295580|42004953|FG000|Overall Study|Lost to Follow-up|1|||
19556613|NCT01295580|42004954|FG001|Overall Study|Lost to Follow-up|0|||
19556614|NCT01295580|42004953|FG000|Overall Study|Lack of Efficacy|1|||
19556615|NCT01295580|42004954|FG001|Overall Study|Lack of Efficacy|0|||
19556616|NCT01295580|42004953|FG000|Overall Study|Other: inconvenience|1|||
19556617|NCT01295580|42004954|FG001|Overall Study|Other: inconvenience|0|||
19556618|NCT01295580|42004953|FG000|Overall Study|Other: family objection|0|||
19556619|NCT01295580|42004954|FG001|Overall Study|Other: family objection|1|||
19556620|NCT01253577|42004960|FG000|Overall Study|Lost to Follow-up|3|||
19556621|NCT01295034|42004968|FG000|Overall Study|Lost to Follow-up|5|||
19556622|NCT01295034|42004969|FG001|Overall Study|Lost to Follow-up|5|||
19556623|NCT01253421|42004980|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
19556624|NCT01253421|42004981|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
19556625|NCT01253421|42004982|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
19556626|NCT01253421|42004983|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
19556627|NCT01253421|42004984|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
19556628|NCT01253421|42004980|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
19556629|NCT01253421|42004981|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
19556630|NCT01253421|42004982|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
19556631|NCT01253421|42004983|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
19556632|NCT01253421|42004984|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
19556633|NCT01253421|42004980|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
19556634|NCT01253421|42004981|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
19556635|NCT01253421|42004982|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
19556636|NCT01253421|42004983|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
19556637|NCT01253421|42004984|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
19556638|NCT01253421|42004980|FG000|Assessment and Scheduling|Physician Decision|1|||
19556639|NCT01253421|42004981|FG001|Assessment and Scheduling|Physician Decision|0|||
19556640|NCT01253421|42004982|FG002|Assessment and Scheduling|Physician Decision|0|||
19556641|NCT01253421|42004983|FG003|Assessment and Scheduling|Physician Decision|0|||
19556642|NCT01253421|42004984|FG004|Assessment and Scheduling|Physician Decision|0|||
19556643|NCT01253421|42004980|FG000|Drug+Scanning Visit|Physician Decision|0|||
19556644|NCT01253421|42004981|FG001|Drug+Scanning Visit|Physician Decision|0|||
19556645|NCT01253421|42004982|FG002|Drug+Scanning Visit|Physician Decision|0|||
19556646|NCT01253421|42004983|FG003|Drug+Scanning Visit|Physician Decision|0|||
19556647|NCT01253421|42004984|FG004|Drug+Scanning Visit|Physician Decision|1|||
19556648|NCT01077076|42004994|FG000|First Intervention|Withdrawal by Subject|1|||
19556649|NCT01077076|42004995|FG001|First Intervention|Withdrawal by Subject|0|||
19556650|NCT01077076|42004996|FG002|First Intervention|Withdrawal by Subject|0|||
19556651|NCT01077076|42004997|FG003|First Intervention|Withdrawal by Subject|0|||
19556652|NCT01077076|42004998|FG004|First Intervention|Withdrawal by Subject|0|||
19556653|NCT01077076|42004999|FG005|First Intervention|Withdrawal by Subject|0|||
19556654|NCT01077076|42004994|FG000|Third Intervention|Death in the participant's family|0|||
19556655|NCT01077076|42004995|FG001|Third Intervention|Death in the participant's family|0|||
19556656|NCT01077076|42004996|FG002|Third Intervention|Death in the participant's family|0|||
19556657|NCT01077076|42004997|FG003|Third Intervention|Death in the participant's family|0|||
19556658|NCT01077076|42004998|FG004|Third Intervention|Death in the participant's family|0|||
19556659|NCT01077076|42004999|FG005|Third Intervention|Death in the participant's family|1|||
19556660|NCT01294800|42005011|FG000|Overall Study|Adverse Event|7|||
19556661|NCT01294800|42005012|FG001|Overall Study|Adverse Event|6|||
19556662|NCT01294800|42005013|FG002|Overall Study|Adverse Event|12|||
19556663|NCT01294800|42005014|FG003|Overall Study|Adverse Event|5|||
19556664|NCT01294800|42005011|FG000|Overall Study|Subject Withdrew Consent|2|||
19556665|NCT01294800|42005012|FG001|Overall Study|Subject Withdrew Consent|2|||
19556666|NCT01294800|42005013|FG002|Overall Study|Subject Withdrew Consent|2|||
19556667|NCT01294800|42005014|FG003|Overall Study|Subject Withdrew Consent|11|||
19556668|NCT01294800|42005011|FG000|Overall Study|Lost to Follow-up|0|||
19556669|NCT01294800|42005012|FG001|Overall Study|Lost to Follow-up|0|||
19556670|NCT01294800|42005013|FG002|Overall Study|Lost to Follow-up|1|||
19556671|NCT01294800|42005014|FG003|Overall Study|Lost to Follow-up|0|||
19556672|NCT01294800|42005011|FG000|Overall Study|Non-compliance With Protocol|0|||
19556673|NCT01294800|42005012|FG001|Overall Study|Non-compliance With Protocol|1|||
19556674|NCT01294800|42005013|FG002|Overall Study|Non-compliance With Protocol|1|||
19390364|NCT01987960|41634112|FG002|Period 3|Non-compliance with IMP|0|||
19556675|NCT01294800|42005014|FG003|Overall Study|Non-compliance With Protocol|0|||
19556676|NCT01294800|42005011|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
19556677|NCT01294800|42005012|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
19556678|NCT01294800|42005013|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
19556679|NCT01294800|42005014|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
19556680|NCT01294644|42005027|FG000|Overall Study|Adverse Event|2|||
19556681|NCT01294644|42005028|FG001|Overall Study|Adverse Event|0|||
19556682|NCT01294644|42005029|FG002|Overall Study|Adverse Event|1|||
19556683|NCT01294644|42005027|FG000|Overall Study|Withdrawal by Subject|3|||
19556684|NCT01294644|42005028|FG001|Overall Study|Withdrawal by Subject|7|||
19556685|NCT01294644|42005029|FG002|Overall Study|Withdrawal by Subject|4|||
19556686|NCT01294644|42005027|FG000|Overall Study|Lost to Follow-up|3|||
19382016|NCT02730169|41625065|FG002|Overall Study|Adverse Event of Special Interest|2|||
19556687|NCT01294644|42005028|FG001|Overall Study|Lost to Follow-up|2|||
19556688|NCT01294644|42005029|FG002|Overall Study|Lost to Follow-up|5|||
19556689|NCT01294644|42005027|FG000|Overall Study|Miscellaneous Reason|2|||
19556690|NCT01294644|42005028|FG001|Overall Study|Miscellaneous Reason|1|||
19556691|NCT01294644|42005029|FG002|Overall Study|Miscellaneous Reason|4|||
19556692|NCT01293240|42005037|FG000|Overall Study|Noncompliance|2|||
19556693|NCT01253265|42005046|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
19556694|NCT01253265|42005047|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
19556695|NCT01253265|42005048|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
19556696|NCT01253265|42005049|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
19556697|NCT01253265|42005050|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
19556698|NCT01253265|42005046|FG000|Overall Study|Withdrawal by Subject|0|||
19556699|NCT01253265|42005047|FG001|Overall Study|Withdrawal by Subject|0|||
19556700|NCT01253265|42005048|FG002|Overall Study|Withdrawal by Subject|0|||
19556701|NCT01253265|42005049|FG003|Overall Study|Withdrawal by Subject|0|||
19556702|NCT01253265|42005050|FG004|Overall Study|Withdrawal by Subject|1|||
19556703|NCT01293084|42005062|FG000|Overall Study|Physician Decision|3|||
19556704|NCT01293084|42005062|FG000|Overall Study|Withdrawal by Subject|2|||
19556705|NCT01293006|42005072|FG000|Period 2|Lost to Follow-up|1|||
19556706|NCT01293006|42005073|FG001|Period 2|Lost to Follow-up|0|||
19556707|NCT01293006|42005074|FG002|Period 2|Lost to Follow-up|0|||
19556708|NCT01293006|42005075|FG003|Period 2|Lost to Follow-up|0|||
19556709|NCT01292928|42005090|FG000|Overall Study|Death|8|||
19556710|NCT01292928|42005090|FG000|Overall Study|Withdrawal by Subject|8|||
19556711|NCT01292928|42005090|FG000|Overall Study|Lost to Follow-up|6|||
19556712|NCT01292928|42005090|FG000|Overall Study|Physician Decision|2|||
19556713|NCT01253187|42005096|FG000|Period 2|Withdrawal by Subject|0|||
19556714|NCT01253187|42005097|FG001|Period 2|Withdrawal by Subject|0|||
19556715|NCT01253187|42005098|FG002|Period 2|Withdrawal by Subject|0|||
19556716|NCT01253187|42005099|FG003|Period 2|Withdrawal by Subject|0|||
19556717|NCT01253187|42005100|FG004|Period 2|Withdrawal by Subject|1|||
19556718|NCT01253187|42005101|FG005|Period 2|Withdrawal by Subject|0|||
19556719|NCT01253187|42005096|FG000|Period 3|Pregnancy|1|||
19556720|NCT01253187|42005097|FG001|Period 3|Pregnancy|0|||
19556721|NCT01253187|42005098|FG002|Period 3|Pregnancy|0|||
19556722|NCT01253187|42005099|FG003|Period 3|Pregnancy|0|||
19556723|NCT01253187|42005100|FG004|Period 3|Pregnancy|0|||
19556724|NCT01253187|42005101|FG005|Period 3|Pregnancy|0|||
19556725|NCT01253187|42005096|FG000|Period 3|difficulty with blood sampling|0|||
19556726|NCT01253187|42005097|FG001|Period 3|difficulty with blood sampling|1|||
19556727|NCT01253187|42005098|FG002|Period 3|difficulty with blood sampling|0|||
19556728|NCT01253187|42005099|FG003|Period 3|difficulty with blood sampling|0|||
19556729|NCT01253187|42005100|FG004|Period 3|difficulty with blood sampling|0|||
19556730|NCT01253187|42005101|FG005|Period 3|difficulty with blood sampling|0|||
19556731|NCT01253187|42005096|FG000|Period 3|non-compliance|0|||
19556732|NCT01253187|42005097|FG001|Period 3|non-compliance|0|||
19556733|NCT01253187|42005098|FG002|Period 3|non-compliance|0|||
19556734|NCT01253187|42005099|FG003|Period 3|non-compliance|0|||
19556735|NCT01253187|42005100|FG004|Period 3|non-compliance|1|||
19556736|NCT01253187|42005101|FG005|Period 3|non-compliance|0|||
19556737|NCT01252953|42005114|FG000|Overall Study|Withdrawal by Subject|16|||
19556738|NCT01252953|42005115|FG001|Overall Study|Withdrawal by Subject|17|||
19556739|NCT01252953|42005114|FG000|Overall Study|Lost to Follow-up|22|||
19556740|NCT01252953|42005115|FG001|Overall Study|Lost to Follow-up|21|||
19556741|NCT01252563|42005122|FG000|Overall Study|Contract Deviation|41|||
19556742|NCT01252563|42005122|FG000|Overall Study|Centralized Registration Deviation|30|||
19556743|NCT01252563|42005122|FG000|Overall Study|Lost to Follow-up|161|||
19556744|NCT01252563|42005122|FG000|Overall Study|No visit after first day of treatment|194|||
19556745|NCT01252563|42005122|FG000|Overall Study|No drug administration|6|||
19556746|NCT01292226|42005157|FG000|Overall Study|Adverse Event|5|||
19556747|NCT01292226|42005157|FG000|Overall Study|Death|1|||
19556748|NCT01292226|42005157|FG000|Overall Study|Graft loss|1|||
19556749|NCT01292226|42005157|FG000|Overall Study|Protocol Violation|3|||
19556750|NCT01292226|42005157|FG000|Overall Study|Withdrawal by Subject|1|||
19556751|NCT01292226|42005157|FG000|Overall Study|Other|2|||
19556752|NCT01290822|42005161|FG000|Overall Study|Withdrawal by Subject|1|||
19556753|NCT01290822|42005161|FG000|Overall Study|Physician Decision|10|||
19556754|NCT01075048|42005168|FG000|Overall Study|Death|4|||
19556755|NCT01075048|42005169|FG001|Overall Study|Death|17|||
19556756|NCT01075048|42005170|FG002|Overall Study|Death|12|||
19556757|NCT01075048|42005168|FG000|Overall Study|Start of other or new therapy|4|||
19556758|NCT01075048|42005169|FG001|Overall Study|Start of other or new therapy|36|||
19556759|NCT01075048|42005170|FG002|Overall Study|Start of other or new therapy|46|||
19556760|NCT01075048|42005168|FG000|Overall Study|Withdrawal by Subject|1|||
19556761|NCT01075048|42005169|FG001|Overall Study|Withdrawal by Subject|6|||
19556762|NCT01075048|42005170|FG002|Overall Study|Withdrawal by Subject|3|||
19556763|NCT01075048|42005168|FG000|Overall Study|Lost to Follow-up|0|||
19556764|NCT01075048|42005169|FG001|Overall Study|Lost to Follow-up|1|||
19556765|NCT01075048|42005170|FG002|Overall Study|Lost to Follow-up|1|||
19556766|NCT01290666|42005181|FG000|Overall Study|Lost to Follow-up|11|||
19556767|NCT01290666|42005181|FG000|Overall Study|Withdrawal by Subject|23|||
19556768|NCT01290666|42005181|FG000|Overall Study|Early Termination of Study|4|||
19556769|NCT01252251|42005185|FG000|Overall Study|Withdrawal by Subject|1|||
19556770|NCT01289574|42005192|FG000|Overall Study|Lack of Efficacy|4|||
19556771|NCT01289574|42005193|FG001|Overall Study|Lack of Efficacy|0|||
19556772|NCT01289574|42005194|FG002|Overall Study|Lack of Efficacy|1|||
19556773|NCT01289574|42005192|FG000|Overall Study|Lost to Follow-up|2|||
19556774|NCT01289574|42005193|FG001|Overall Study|Lost to Follow-up|0|||
19556775|NCT01289574|42005194|FG002|Overall Study|Lost to Follow-up|1|||
19556776|NCT01289574|42005192|FG000|Overall Study|Withdrawal by Subject|1|||
19556777|NCT01289574|42005193|FG001|Overall Study|Withdrawal by Subject|1|||
19556778|NCT01289574|42005194|FG002|Overall Study|Withdrawal by Subject|1|||
19556779|NCT01289574|42005192|FG000|Overall Study|Adverse Event|0|||
19556780|NCT01289574|42005193|FG001|Overall Study|Adverse Event|1|||
19556781|NCT01289574|42005194|FG002|Overall Study|Adverse Event|0|||
19556782|NCT01289574|42005192|FG000|Overall Study|Subject wanted alternate treatment|0|||
19556783|NCT01289574|42005193|FG001|Overall Study|Subject wanted alternate treatment|1|||
19556784|NCT01289574|42005194|FG002|Overall Study|Subject wanted alternate treatment|0|||
19556785|NCT01252095|42005205|FG000|Overall Study|Disease progression|1|||
19556786|NCT01252095|42005206|FG001|Overall Study|Disease progression|0|||
19556787|NCT01289418|42005215|FG000|Day 8 Survey|email address invalid|283|||
19556788|NCT01289418|42005215|FG000|Day 8 Survey|participants did not complete the survey|1935|||
19556789|NCT01289418|42005215|FG000|Day 29 Survey|email address invalid|283|||
19556790|NCT01289418|42005215|FG000|Day 29 Survey|participants did not complete the survey|2185|||
19556791|NCT01074658|42005221|FG000|Overall Study|No implant attempted|19|||
19556792|NCT01074502|42005225|FG000|Overall Study|Withdrawal by Subject|1|||
19556793|NCT01289028|42005229|FG000|Overall Study|Progressive Disease|49|||
19556794|NCT01289028|42005229|FG000|Overall Study|Adverse Event|14|||
19556795|NCT01289028|42005229|FG000|Overall Study|Withdrawal by Subject|6|||
19556796|NCT01289028|42005229|FG000|Overall Study|Death|4|||
19556797|NCT01289028|42005229|FG000|Overall Study|Lack of Efficacy|2|||
19556798|NCT01289028|42005229|FG000|Overall Study|No longer required|2|||
19556799|NCT01289028|42005229|FG000|Overall Study|Lost to Follow-up|2|||
19556800|NCT01289028|42005229|FG000|Overall Study|New Cancer Therapy|2|||
19556801|NCT01289028|42005229|FG000|Overall Study|Abnormal Lab Value|1|||
19556802|NCT01289028|42005229|FG000|Overall Study|Missing reason for discon|1|||
19556803|NCT01251861|42005237|FG000|Overall Study|Disease progression|6|||
19556804|NCT01251861|42005238|FG001|Overall Study|Disease progression|6|||
19556805|NCT01251861|42005237|FG000|Overall Study|Adverse Event|2|||
19556806|NCT01251861|42005238|FG001|Overall Study|Adverse Event|17|||
19556807|NCT01251861|42005237|FG000|Overall Study|Withdrawal by Subject|2|||
19556808|NCT01251861|42005238|FG001|Overall Study|Withdrawal by Subject|2|||
19556809|NCT01251861|42005237|FG000|Overall Study|Alternative therapy|1|||
19556810|NCT01251861|42005238|FG001|Overall Study|Alternative therapy|0|||
19556811|NCT01251861|42005237|FG000|Overall Study|Other complicating disease|0|||
19556812|NCT01251861|42005238|FG001|Overall Study|Other complicating disease|1|||
19556813|NCT01251861|42005237|FG000|Overall Study|Physician Decision|1|||
19556814|NCT01251861|42005238|FG001|Overall Study|Physician Decision|0|||
19556815|NCT01251861|42005237|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
19556816|NCT01251861|42005238|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
19556817|NCT01251861|42005237|FG000|Overall Study|Other|1|||
19556818|NCT01251861|42005238|FG001|Overall Study|Other|0|||
19556819|NCT01251861|42005237|FG000|Overall Study|Never started therapy|4|||
19556820|NCT01251861|42005238|FG001|Overall Study|Never started therapy|1|||
19556821|NCT01251861|42005237|FG000|Overall Study|Potential interaction of drugs|0|||
19556822|NCT01251861|42005238|FG001|Overall Study|Potential interaction of drugs|1|||
19556823|NCT01250925|42005247|FG000|Overall Study|Lost to Follow-up|1|||
19556824|NCT01250925|42005248|FG001|Overall Study|Lost to Follow-up|1|||
19556825|NCT01250925|42005249|FG002|Overall Study|Lost to Follow-up|0|||
19556826|NCT01250925|42005247|FG000|Overall Study|Withdrawal by Subject|2|||
19556827|NCT01250925|42005248|FG001|Overall Study|Withdrawal by Subject|0|||
19556828|NCT01250925|42005249|FG002|Overall Study|Withdrawal by Subject|0|||
19556829|NCT01250925|42005247|FG000|Overall Study|Protocol Violation|2|||
19556830|NCT01250925|42005248|FG001|Overall Study|Protocol Violation|0|||
19556831|NCT01250925|42005249|FG002|Overall Study|Protocol Violation|0|||
19556832|NCT01250925|42005247|FG000|Overall Study|Physician Decision|0|||
19556833|NCT01250925|42005248|FG001|Overall Study|Physician Decision|2|||
19556834|NCT01250925|42005249|FG002|Overall Study|Physician Decision|1|||
19556835|NCT01250925|42005247|FG000|Overall Study|Adverse Event|0|||
19390365|NCT01987960|41634113|FG003|Period 3|Non-compliance with IMP|1|||
19556836|NCT01250925|42005248|FG001|Overall Study|Adverse Event|0|||
19556837|NCT01250925|42005249|FG002|Overall Study|Adverse Event|1|||
19556838|NCT01285908|42005257|FG000|Baseline Measurement|unable to insert catheter|1|||
19556839|NCT01285908|42005258|FG001|Baseline Measurement|unable to insert catheter|0|||
19556840|NCT01285908|42005259|FG002|Baseline Measurement|unable to insert catheter|0|||
19556841|NCT01285908|42005257|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
19556842|NCT01285908|42005258|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
19556843|NCT01285908|42005259|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
19556844|NCT01285908|42005257|FG000|Baseline Measurement|unable to tolerate procedure|1|||
19556845|NCT01285908|42005258|FG001|Baseline Measurement|unable to tolerate procedure|0|||
19556846|NCT01285908|42005259|FG002|Baseline Measurement|unable to tolerate procedure|0|||
19556847|NCT01250769|42005293|FG000|Overall Study|Withdrawal by Subject|0|||
19556848|NCT01250769|42005294|FG001|Overall Study|Withdrawal by Subject|1|||
19556849|NCT01250769|42005295|FG002|Overall Study|Withdrawal by Subject|1|||
19556850|NCT01250769|42005296|FG003|Overall Study|Withdrawal by Subject|0|||
19556851|NCT01250769|42005293|FG000|Overall Study|Adverse Event|0|||
19556852|NCT01250769|42005294|FG001|Overall Study|Adverse Event|0|||
19556853|NCT01250769|42005295|FG002|Overall Study|Adverse Event|1|||
19556854|NCT01250769|42005296|FG003|Overall Study|Adverse Event|0|||
19556855|NCT01074268|42005308|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
19556856|NCT01074268|42005309|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
19556857|NCT01074268|42005308|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
19556858|NCT01074268|42005309|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
19556859|NCT01074268|42005308|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
19556860|NCT01074268|42005309|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
19556861|NCT01074268|42005308|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
19556862|NCT01074268|42005309|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
19556863|NCT01074268|42005308|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
19556864|NCT01074268|42005309|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
19556865|NCT01074268|42005308|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
19556866|NCT01074268|42005309|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
19556867|NCT01074268|42005308|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
19556868|NCT01074268|42005309|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
19556869|NCT01074268|42005308|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
19556870|NCT01074268|42005309|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
19556871|NCT01074268|42005308|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
19556872|NCT01074268|42005309|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
19556873|NCT01074190|42005318|FG000|Overall Study|Emergency Cesarean Delivery|1|||
19556874|NCT01074190|42005319|FG001|Overall Study|Emergency Cesarean Delivery|2|||
19556875|NCT01074190|42005320|FG002|Overall Study|Emergency Cesarean Delivery|1|||
19556876|NCT01074190|42005318|FG000|Overall Study|Protocol Violation|2|||
19556877|NCT01074190|42005319|FG001|Overall Study|Protocol Violation|1|||
19556878|NCT01074190|42005320|FG002|Overall Study|Protocol Violation|0|||
19556879|NCT01074190|42005318|FG000|Overall Study|Delivered in under 90 minutes|0|||
19556880|NCT01074190|42005319|FG001|Overall Study|Delivered in under 90 minutes|2|||
19556881|NCT01074190|42005320|FG002|Overall Study|Delivered in under 90 minutes|1|||
19556882|NCT01074190|42005318|FG000|Overall Study|Subject withdrew consent|1|||
19556883|NCT01074190|42005319|FG001|Overall Study|Subject withdrew consent|1|||
19556884|NCT01074190|42005320|FG002|Overall Study|Subject withdrew consent|1|||
19556885|NCT01073566|42005333|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
19556886|NCT01073566|42005334|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
19556887|NCT01072396|42005342|FG000|Period One|Adverse Event|1|||
19556888|NCT01072396|42005343|FG001|Period One|Adverse Event|1|||
19556889|NCT01072396|42005342|FG000|Period One|Protocol Violation|2|||
19556890|NCT01072396|42005343|FG001|Period One|Protocol Violation|1|||
19556891|NCT01072396|42005342|FG000|Period One|Withdrawal by Subject|2|||
19556892|NCT01072396|42005343|FG001|Period One|Withdrawal by Subject|0|||
19556893|NCT01072396|42005342|FG000|Washout Period|Missing termination information|0|||
19556894|NCT01072396|42005343|FG001|Washout Period|Missing termination information|1|||
19556895|NCT01072396|42005342|FG000|Period Two|Adverse Event|0|||
19556896|NCT01072396|42005343|FG001|Period Two|Adverse Event|3|||
19556897|NCT01072396|42005342|FG000|Period Two|Lost to Follow-up|1|||
19556898|NCT01072396|42005343|FG001|Period Two|Lost to Follow-up|0|||
19556899|NCT01045096|42005352|FG000|Overall Study|Withdrawal by Subject|2|||
19556900|NCT01045096|42005353|FG001|Overall Study|Withdrawal by Subject|0|||
19556901|NCT01045096|42005354|FG002|Overall Study|Withdrawal by Subject|0|||
19556902|NCT01045096|42005352|FG000|Overall Study|Other|1|||
19556903|NCT01045096|42005353|FG001|Overall Study|Other|0|||
19556904|NCT01045096|42005354|FG002|Overall Study|Other|0|||
19556905|NCT01285518|42005370|FG000|Overall Study|Lost to Follow-up|0|||
19556906|NCT01285518|42005371|FG001|Overall Study|Lost to Follow-up|0|||
19556907|NCT01285518|42005372|FG002|Overall Study|Lost to Follow-up|0|||
19556908|NCT01285518|42005373|FG003|Overall Study|Lost to Follow-up|0|||
19556909|NCT01285518|42005374|FG004|Overall Study|Lost to Follow-up|0|||
19556910|NCT01285518|42005375|FG005|Overall Study|Lost to Follow-up|1|||
19556911|NCT01285518|42005376|FG006|Overall Study|Lost to Follow-up|0|||
19556912|NCT01285518|42005377|FG007|Overall Study|Lost to Follow-up|0|||
19556913|NCT01073020|42005400|FG000|Overall Study|Withdrawal by Subject|6|||
19556914|NCT01073020|42005401|FG001|Overall Study|Withdrawal by Subject|4|||
19556915|NCT01073020|42005402|FG002|Overall Study|Withdrawal by Subject|1|||
19556916|NCT01073020|42005403|FG003|Overall Study|Withdrawal by Subject|2|||
19556917|NCT01073020|42005400|FG000|Overall Study|Physician Decision|1|||
19556918|NCT01073020|42005401|FG001|Overall Study|Physician Decision|0|||
19556919|NCT01073020|42005402|FG002|Overall Study|Physician Decision|2|||
19556920|NCT01073020|42005403|FG003|Overall Study|Physician Decision|0|||
19556921|NCT01073020|42005400|FG000|Overall Study|Death|0|||
19556922|NCT01073020|42005401|FG001|Overall Study|Death|1|||
19556923|NCT01073020|42005402|FG002|Overall Study|Death|0|||
19556924|NCT01073020|42005403|FG003|Overall Study|Death|0|||
19556925|NCT01284114|42005413|FG000|Overall Study|viral infection|1|||
19556926|NCT01284114|42005413|FG000|Overall Study|From the results of ALLTITUDE study|1|||
19556927|NCT01284114|42005413|FG000|Overall Study|Symptomatic hypotension|1|||
19556928|NCT01284114|42005413|FG000|Overall Study|dizziness|1|||
19556929|NCT01283334|42005418|FG000|Overall Study|Withdrawal by Subject|1|||
19556930|NCT01283334|42005418|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
19556931|NCT01283334|42005418|FG000|Overall Study|Adverse Event|4|||
19556932|NCT01283334|42005418|FG000|Overall Study|Physician Decision|1|||
19556933|NCT01282866|42005424|FG000|Overall Study|Adverse Event|1|||
19556934|NCT01071070|42005430|FG000|Overall Study|Adverse Event|0|||
19556935|NCT01071070|42005431|FG001|Overall Study|Adverse Event|3|||
19556936|NCT01071070|42005430|FG000|Overall Study|Withdrawal by Subject|1|||
19382017|NCT02730169|41625066|FG003|Overall Study|Adverse Event of Special Interest|0|||
19382018|NCT02730169|41625063|FG000|Overall Study|Withdrawal by Subject|6|||
19382019|NCT02730169|41625064|FG001|Overall Study|Withdrawal by Subject|11|||
19382020|NCT02730169|41625065|FG002|Overall Study|Withdrawal by Subject|6|||
19382021|NCT02730169|41625066|FG003|Overall Study|Withdrawal by Subject|8|||
19382022|NCT02730169|41625063|FG000|Overall Study|Lost to Follow-up|5|||
19382023|NCT02730169|41625064|FG001|Overall Study|Lost to Follow-up|6|||
19382024|NCT02730169|41625065|FG002|Overall Study|Lost to Follow-up|5|||
19382025|NCT02730169|41625066|FG003|Overall Study|Lost to Follow-up|6|||
19382026|NCT02730169|41625063|FG000|Overall Study|Other|0|||
19382027|NCT02730169|41625064|FG001|Overall Study|Other|0|||
19556937|NCT01071070|42005431|FG001|Overall Study|Withdrawal by Subject|0|||
19556938|NCT01071070|42005430|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
19556939|NCT01071070|42005431|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
19556940|NCT01071070|42005430|FG000|Overall Study|Hypercalcemia|1|||
19556941|NCT01071070|42005431|FG001|Overall Study|Hypercalcemia|0|||
19556942|NCT01282476|42005437|FG000|Overall Study|Death|11|||
19556943|NCT01282164|42005443|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
19556944|NCT01282164|42005444|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
19556945|NCT01250379|42005460|FG000|Overall Study|Death|141|||
19556946|NCT01250379|42005461|FG001|Overall Study|Death|148|||
19556947|NCT01250379|42005460|FG000|Overall Study|Withdrawal by Subject|32|||
19556948|NCT01250379|42005461|FG001|Overall Study|Withdrawal by Subject|20|||
19556949|NCT01250379|42005460|FG000|Overall Study|Physician Decision|11|||
19556950|NCT01250379|42005461|FG001|Overall Study|Physician Decision|3|||
19556951|NCT01250379|42005460|FG000|Overall Study|Protocol Violation|2|||
19556952|NCT01250379|42005461|FG001|Overall Study|Protocol Violation|8|||
19556953|NCT01250379|42005460|FG000|Overall Study|Lost to Follow-up|9|||
19556954|NCT01250379|42005461|FG001|Overall Study|Lost to Follow-up|6|||
19556955|NCT01250379|42005460|FG000|Overall Study|Adverse Event|5|||
19556956|NCT01250379|42005461|FG001|Overall Study|Adverse Event|4|||
19556957|NCT01250379|42005460|FG000|Overall Study|Other|0|||
19556958|NCT01250379|42005461|FG001|Overall Study|Other|4|||
19556959|NCT01250379|42005460|FG000|Overall Study|Participant noncompliance|2|||
19556960|NCT01250379|42005461|FG001|Overall Study|Participant noncompliance|0|||
19556961|NCT01072630|42005470|FG000|Overall Study|Adverse Event|11|||
19556962|NCT01072630|42005471|FG001|Overall Study|Adverse Event|19|||
19556963|NCT01072630|42005472|FG002|Overall Study|Adverse Event|2|||
19556964|NCT01072630|42005470|FG000|Overall Study|Lack of Efficacy|10|||
19556965|NCT01072630|42005471|FG001|Overall Study|Lack of Efficacy|10|||
19556966|NCT01072630|42005472|FG002|Overall Study|Lack of Efficacy|1|||
19382028|NCT02730169|41625065|FG002|Overall Study|Other|1|||
19382029|NCT02730169|41625066|FG003|Overall Study|Other|1|||
19556967|NCT01072630|42005470|FG000|Overall Study|Withdrawal by Subject|8|||
19556968|NCT01072630|42005471|FG001|Overall Study|Withdrawal by Subject|7|||
19556969|NCT01072630|42005472|FG002|Overall Study|Withdrawal by Subject|2|||
19556970|NCT01072630|42005470|FG000|Overall Study|Protocol Violation|10|||
19556971|NCT01072630|42005471|FG001|Overall Study|Protocol Violation|8|||
19556972|NCT01072630|42005472|FG002|Overall Study|Protocol Violation|4|||
19556973|NCT01072630|42005470|FG000|Overall Study|Lost to Follow-up|11|||
19556974|NCT01072630|42005471|FG001|Overall Study|Lost to Follow-up|11|||
19556975|NCT01072630|42005472|FG002|Overall Study|Lost to Follow-up|1|||
19556976|NCT01072630|42005470|FG000|Overall Study|Noncompliance with study medication|1|||
19556977|NCT01072630|42005471|FG001|Overall Study|Noncompliance with study medication|1|||
19556978|NCT01072630|42005472|FG002|Overall Study|Noncompliance with study medication|1|||
19556979|NCT01072630|42005470|FG000|Overall Study|Noncompliance with study procedures|1|||
19556980|NCT01072630|42005471|FG001|Overall Study|Noncompliance with study procedures|2|||
19556981|NCT01072630|42005472|FG002|Overall Study|Noncompliance with study procedures|1|||
19556982|NCT01072630|42005470|FG000|Overall Study|Other|3|||
19556983|NCT01072630|42005471|FG001|Overall Study|Other|2|||
19556984|NCT01072630|42005472|FG002|Overall Study|Other|1|||
19556985|NCT01281306|42005488|FG000|Overall Study|Lack of Efficacy|0|||
19556986|NCT01281306|42005489|FG001|Overall Study|Lack of Efficacy|1|||
19556987|NCT01281306|42005490|FG002|Overall Study|Lack of Efficacy|3|||
19556988|NCT01281306|42005491|FG003|Overall Study|Lack of Efficacy|0|||
19556989|NCT01281306|42005492|FG004|Overall Study|Lack of Efficacy|2|||
19556990|NCT01281306|42005493|FG005|Overall Study|Lack of Efficacy|0|||
19556991|NCT01281306|42005494|FG006|Overall Study|Lack of Efficacy|1|||
19556992|NCT01281306|42005488|FG000|Overall Study|Withdrawal by Subject|1|||
19556993|NCT01281306|42005489|FG001|Overall Study|Withdrawal by Subject|0|||
19556994|NCT01281306|42005490|FG002|Overall Study|Withdrawal by Subject|2|||
19382030|NCT02648217|41625078|FG000|Overall Study|Adverse Event|0|||
19556995|NCT01281306|42005491|FG003|Overall Study|Withdrawal by Subject|4|||
19556996|NCT01281306|42005492|FG004|Overall Study|Withdrawal by Subject|1|||
19382031|NCT02648217|41625079|FG001|Overall Study|Adverse Event|1|||
19382032|NCT02648217|41625078|FG000|Overall Study|Lost to Follow-up|1|||
19382033|NCT02648217|41625079|FG001|Overall Study|Lost to Follow-up|1|||
19382034|NCT02648217|41625078|FG000|Overall Study|Withdrawal by Subject|4|||
19382035|NCT02648217|41625079|FG001|Overall Study|Withdrawal by Subject|3|||
19382036|NCT02648217|41625078|FG000|Overall Study|Unclassified|5|||
19382037|NCT02648217|41625079|FG001|Overall Study|Unclassified|0|||
19382038|NCT00709735|41625087|FG000|Overall Study|Lost to Follow-up|1|||
19382039|NCT00709735|41625088|FG001|Overall Study|Lost to Follow-up|1|||
19382040|NCT00709735|41625087|FG000|Overall Study|Relapse into Opioid Abuse|0|||
19382041|NCT00709735|41625088|FG001|Overall Study|Relapse into Opioid Abuse|1|||
19382042|NCT00709735|41625087|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
19556997|NCT01281306|42005493|FG005|Overall Study|Withdrawal by Subject|3|||
19556998|NCT01281306|42005494|FG006|Overall Study|Withdrawal by Subject|1|||
19556999|NCT01281306|42005488|FG000|Overall Study|Protocol deviation|0|||
19557000|NCT01281306|42005489|FG001|Overall Study|Protocol deviation|1|||
19557001|NCT01281306|42005490|FG002|Overall Study|Protocol deviation|1|||
19557002|NCT01281306|42005491|FG003|Overall Study|Protocol deviation|1|||
19557003|NCT01281306|42005492|FG004|Overall Study|Protocol deviation|1|||
19557004|NCT01281306|42005493|FG005|Overall Study|Protocol deviation|0|||
19557005|NCT01281306|42005494|FG006|Overall Study|Protocol deviation|0|||
19557006|NCT01281306|42005488|FG000|Overall Study|Condition no longer requires study drug|1|||
19557007|NCT01281306|42005489|FG001|Overall Study|Condition no longer requires study drug|0|||
19557008|NCT01281306|42005490|FG002|Overall Study|Condition no longer requires study drug|0|||
19557009|NCT01281306|42005491|FG003|Overall Study|Condition no longer requires study drug|0|||
19557010|NCT01281306|42005492|FG004|Overall Study|Condition no longer requires study drug|0|||
19382043|NCT00709735|41625088|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
19557011|NCT01281306|42005493|FG005|Overall Study|Condition no longer requires study drug|1|||
19557012|NCT01281306|42005494|FG006|Overall Study|Condition no longer requires study drug|1|||
19557013|NCT01281306|42005488|FG000|Overall Study|Lost to Follow-up|1|||
19557014|NCT01281306|42005489|FG001|Overall Study|Lost to Follow-up|0|||
19557015|NCT01281306|42005490|FG002|Overall Study|Lost to Follow-up|0|||
19557016|NCT01281306|42005491|FG003|Overall Study|Lost to Follow-up|2|||
19557017|NCT01281306|42005492|FG004|Overall Study|Lost to Follow-up|0|||
19557018|NCT01281306|42005493|FG005|Overall Study|Lost to Follow-up|0|||
19557019|NCT01281306|42005494|FG006|Overall Study|Lost to Follow-up|1|||
19557020|NCT01281306|42005488|FG000|Overall Study|Death|1|||
19557021|NCT01281306|42005489|FG001|Overall Study|Death|0|||
19557022|NCT01281306|42005490|FG002|Overall Study|Death|0|||
19557023|NCT01281306|42005491|FG003|Overall Study|Death|0|||
19557024|NCT01281306|42005492|FG004|Overall Study|Death|0|||
19557025|NCT01281306|42005493|FG005|Overall Study|Death|0|||
19557026|NCT01281306|42005494|FG006|Overall Study|Death|0|||
19557027|NCT01281306|42005488|FG000|Overall Study|Adverse Event|3|||
19557028|NCT01281306|42005489|FG001|Overall Study|Adverse Event|2|||
19557029|NCT01281306|42005490|FG002|Overall Study|Adverse Event|2|||
19557030|NCT01281306|42005491|FG003|Overall Study|Adverse Event|3|||
19557031|NCT01281306|42005492|FG004|Overall Study|Adverse Event|5|||
19557032|NCT01281306|42005493|FG005|Overall Study|Adverse Event|3|||
19557033|NCT01281306|42005494|FG006|Overall Study|Adverse Event|3|||
19557034|NCT01281306|42005488|FG000|Overall Study|Randomized in error|1|||
19557035|NCT01281306|42005489|FG001|Overall Study|Randomized in error|0|||
19557036|NCT01281306|42005490|FG002|Overall Study|Randomized in error|0|||
19557037|NCT01281306|42005491|FG003|Overall Study|Randomized in error|1|||
19557038|NCT01281306|42005492|FG004|Overall Study|Randomized in error|0|||
19557039|NCT01281306|42005493|FG005|Overall Study|Randomized in error|0|||
19557040|NCT01281306|42005494|FG006|Overall Study|Randomized in error|0|||
19557041|NCT01250145|42005512|FG000|Overall Study|Adverse Event|2|||
19557042|NCT01250145|42005513|FG001|Overall Study|Adverse Event|1|||
19557043|NCT01250145|42005512|FG000|Overall Study|Withdrawal by Subject|0|||
19557044|NCT01250145|42005513|FG001|Overall Study|Withdrawal by Subject|4|||
19557045|NCT01067326|42005535|FG000|Overall Study|Adverse Event|0|||
19557046|NCT01067326|42005536|FG001|Overall Study|Adverse Event|2|||
19557047|NCT01067326|42005535|FG000|Overall Study|Withdrawal by Subject|1|||
19557048|NCT01067326|42005536|FG001|Overall Study|Withdrawal by Subject|0|||
19557049|NCT01067326|42005535|FG000|Overall Study|Early Study Termination|1|||
19557050|NCT01067326|42005536|FG001|Overall Study|Early Study Termination|1|||
19557051|NCT01279200|42005544|FG000|Overall Study|Withdrawal by Subject|1|||
19557052|NCT01279200|42005545|FG001|Overall Study|Withdrawal by Subject|3|||
19557053|NCT01279200|42005544|FG000|Overall Study|Patient withdrawal due to high cost|0|||
19557054|NCT01279200|42005545|FG001|Overall Study|Patient withdrawal due to high cost|1|||
19382044|NCT02647905|41625094|FG000|Overall Study|Lost to Follow-up|1|||
19382045|NCT02647905|41625094|FG000|Overall Study|Withdrawal by Subject|2|||
19382046|NCT04185909|41625098|FG000|Overall Study|Lost to Follow-up|1|||
19382047|NCT04076943|41625102|FG000|Overall Study|Withdrawal by Subject|12|||
19557055|NCT01279200|42005544|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
19557056|NCT01279200|42005545|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
19557057|NCT01279200|42005544|FG000|Overall Study|ultrasound screening failure|0|||
19557058|NCT01279200|42005545|FG001|Overall Study|ultrasound screening failure|1|||
19557059|NCT01279200|42005544|FG000|Overall Study|Lost to Follow-up|0|||
19557060|NCT01279200|42005545|FG001|Overall Study|Lost to Follow-up|1|||
19557061|NCT01279200|42005544|FG000|Overall Study|Adverse Event|1|||
19557062|NCT01279200|42005545|FG001|Overall Study|Adverse Event|0|||
19557063|NCT01273818|42005554|FG000|Overall Study|Physician Decision|13|||
19557064|NCT01273818|42005555|FG001|Overall Study|Physician Decision|2|||
19557065|NCT01273818|42005556|FG002|Overall Study|Physician Decision|9|||
19557066|NCT01245387|42005564|FG000|Overall Study|Lost to Follow-up|106|||
19557067|NCT01245387|42005564|FG000|Overall Study|Lack of Efficacy|195|||
19557068|NCT01245387|42005564|FG000|Overall Study|Adverse Event|9|||
19557069|NCT01245387|42005564|FG000|Overall Study|Death|3|||
19557070|NCT01245387|42005564|FG000|Overall Study|Other|131|||
19557071|NCT01245387|42005564|FG000|Overall Study|Missing discontinuation status|369|||
19608644|NCT02007512|42057642|FG001|Open Label Treatment Period|Adverse Event|1|||
19608645|NCT02007512|42057643|FG002|Open Label Treatment Period|Adverse Event|0|||
19608646|NCT02007512|42057644|FG003|Open Label Treatment Period|Adverse Event|0|||
19608647|NCT02007512|42057641|FG000|Open Label Treatment Period|Other|0|||
19608648|NCT02007512|42057642|FG001|Open Label Treatment Period|Other|0|||
19608649|NCT02007512|42057643|FG002|Open Label Treatment Period|Other|0|||
19608650|NCT02007512|42057644|FG003|Open Label Treatment Period|Other|1|||
19608651|NCT02007512|42057641|FG000|Open Label Treatment Period|Disease progression|0|||
19608652|NCT02007512|42057642|FG001|Open Label Treatment Period|Disease progression|17|||
19608653|NCT02007512|42057643|FG002|Open Label Treatment Period|Disease progression|0|||
19608654|NCT02007512|42057644|FG003|Open Label Treatment Period|Disease progression|11|||
19608655|NCT02007512|42057641|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
19608656|NCT02007512|42057642|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
19608657|NCT02007512|42057643|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
19608658|NCT02007512|42057644|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
19608659|NCT01984346|42057659|FG000|Overall Study|Physician Decision|4|||
19608660|NCT01984346|42057660|FG001|Overall Study|Physician Decision|2|||
19608661|NCT01984346|42057659|FG000|Overall Study|Withdrawal by Subject|2|||
19608662|NCT01984346|42057660|FG001|Overall Study|Withdrawal by Subject|2|||
19608663|NCT01984346|42057659|FG000|Overall Study|Enrollment Closed|8|||
19608664|NCT01984346|42057660|FG001|Overall Study|Enrollment Closed|1|||
19608665|NCT01984346|42057659|FG000|Overall Study|Insurance Coverage|1|||
19608666|NCT01984346|42057660|FG001|Overall Study|Insurance Coverage|0|||
19382048|NCT04076943|41625102|FG000|Overall Study|Adverse Event|1|||
19382049|NCT04076943|41625102|FG000|Overall Study|Progressive Disease|2|||
19382050|NCT04076943|41625102|FG000|Overall Study|Death|13|||
19382051|NCT04076943|41625102|FG000|Overall Study|Other than specified|6|||
19382052|NCT00708643|41625108|FG000|Overall Study|Adverse Event|0|||
19382053|NCT00708643|41625109|FG001|Overall Study|Adverse Event|1|||
19382054|NCT01285557|41625172|FG000|Overall Study|Death|173|||
19382055|NCT01285557|41625173|FG001|Overall Study|Death|90|||
19382056|NCT01285557|41625172|FG000|Overall Study|Lost to Follow-up|6|||
19382057|NCT01285557|41625173|FG001|Overall Study|Lost to Follow-up|2|||
19382058|NCT01285557|41625172|FG000|Overall Study|Withdrew Consent|6|||
19382059|NCT01285557|41625173|FG001|Overall Study|Withdrew Consent|1|||
19382060|NCT01285557|41625172|FG000|Overall Study|Sponsor Study Termination|23|||
19382061|NCT01285557|41625173|FG001|Overall Study|Sponsor Study Termination|13|||
19382062|NCT01285557|41625172|FG000|Overall Study|Randomized but not treated|1|||
19382063|NCT01285557|41625173|FG001|Overall Study|Randomized but not treated|1|||
19382064|NCT01285557|41625172|FG000|Overall Study|Study follow-up ongoing|28|||
19382065|NCT01285557|41625173|FG001|Overall Study|Study follow-up ongoing|14|||
19382066|NCT01285557|41625172|FG000|Overall Study|Sponsor Decision|2|||
19382067|NCT01285557|41625173|FG001|Overall Study|Sponsor Decision|1|||
19608667|NCT01984346|42057659|FG000|Overall Study|Intra-operative Exclusion|2|||
19608668|NCT01984346|42057660|FG001|Overall Study|Intra-operative Exclusion|0|||
19608669|NCT01942135|42057668|FG000|Overall Study|Adverse Event|9|||
19608670|NCT01942135|42057669|FG001|Overall Study|Adverse Event|3|||
19608671|NCT01942135|42057668|FG000|Overall Study|Global deterioration of health status|8|||
19608672|NCT01942135|42057669|FG001|Overall Study|Global deterioration of health status|3|||
19382068|NCT01376167|41625235|FG000|Overall Study|Lost to Follow-up|2|||
19382069|NCT01376167|41625236|FG001|Overall Study|Lost to Follow-up|4|||
19557072|NCT01037218|42005572|FG000|Overall Study|Adverse Event|4|||
19557073|NCT01037218|42005573|FG001|Overall Study|Adverse Event|2|||
19557074|NCT01037218|42005574|FG002|Overall Study|Adverse Event|2|||
19557075|NCT01037218|42005575|FG003|Overall Study|Adverse Event|1|||
19557076|NCT01037218|42005572|FG000|Overall Study|Lack of Efficacy|0|||
19557077|NCT01037218|42005573|FG001|Overall Study|Lack of Efficacy|2|||
19557078|NCT01037218|42005574|FG002|Overall Study|Lack of Efficacy|1|||
19557079|NCT01037218|42005575|FG003|Overall Study|Lack of Efficacy|5|||
19557080|NCT01037218|42005572|FG000|Overall Study|Lost to Follow-up|3|||
19557081|NCT01037218|42005573|FG001|Overall Study|Lost to Follow-up|5|||
19557082|NCT01037218|42005574|FG002|Overall Study|Lost to Follow-up|4|||
19557083|NCT01037218|42005575|FG003|Overall Study|Lost to Follow-up|2|||
19557084|NCT01037218|42005572|FG000|Overall Study|Withdrawal by Subject|6|||
19557085|NCT01037218|42005573|FG001|Overall Study|Withdrawal by Subject|7|||
19557086|NCT01037218|42005574|FG002|Overall Study|Withdrawal by Subject|7|||
19557087|NCT01037218|42005575|FG003|Overall Study|Withdrawal by Subject|4|||
19557088|NCT01037218|42005572|FG000|Overall Study|Partner Withdrew Consent|0|||
19557089|NCT01037218|42005573|FG001|Overall Study|Partner Withdrew Consent|3|||
19557090|NCT01037218|42005574|FG002|Overall Study|Partner Withdrew Consent|2|||
19557091|NCT01037218|42005575|FG003|Overall Study|Partner Withdrew Consent|1|||
19557092|NCT01037218|42005572|FG000|Overall Study|Protocol Violation|0|||
19557093|NCT01037218|42005573|FG001|Overall Study|Protocol Violation|0|||
19557094|NCT01037218|42005574|FG002|Overall Study|Protocol Violation|2|||
19557095|NCT01037218|42005575|FG003|Overall Study|Protocol Violation|2|||
19557096|NCT01037218|42005572|FG000|Overall Study|Various|3|||
19557097|NCT01037218|42005573|FG001|Overall Study|Various|2|||
19557098|NCT01037218|42005574|FG002|Overall Study|Various|3|||
19557099|NCT01037218|42005575|FG003|Overall Study|Various|1|||
19557100|NCT01038856|42005585|FG000|Overall Study|Adverse Event|2|||
19557101|NCT01066546|42005591|FG000|Overall Study|Study terminated by sponsor|5|||
19557102|NCT01272804|42005601|FG000|Overall Study|Adverse Event|1|||
19557103|NCT01272804|42005602|FG001|Overall Study|Adverse Event|0|||
19557104|NCT01272804|42005603|FG002|Overall Study|Adverse Event|0|||
19557105|NCT01272804|42005604|FG003|Overall Study|Adverse Event|0|||
19557106|NCT01272804|42005605|FG004|Overall Study|Adverse Event|2|||
19557107|NCT01272804|42005606|FG005|Overall Study|Adverse Event|1|||
19557108|NCT01269918|42005622|FG000|Overall Study|Did not receive study drug|0|||
19557109|NCT01269918|42005623|FG001|Overall Study|Did not receive study drug|3|||
19557110|NCT01036594|42005629|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
19557111|NCT01036594|42005630|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
19557112|NCT01036594|42005629|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
19557113|NCT01036594|42005630|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
19557114|NCT01036594|42005629|FG000|Week 12 Evaluation|Adverse Event|5|||
19557115|NCT01036594|42005630|FG001|Week 12 Evaluation|Adverse Event|0|||
19557116|NCT01036594|42005629|FG000|Week 12 Evaluation|Physician Decision|1|||
19557117|NCT01036594|42005630|FG001|Week 12 Evaluation|Physician Decision|0|||
19557118|NCT01036594|42005629|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
19557119|NCT01036594|42005630|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
19557120|NCT01036594|42005629|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
19557121|NCT01036594|42005630|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
19557122|NCT01036594|42005629|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
19557123|NCT01036594|42005630|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
19557124|NCT01036594|42005629|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
19557125|NCT01036594|42005630|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
19557126|NCT01036594|42005629|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
19557127|NCT01036594|42005630|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
19557128|NCT01036438|42005638|FG000|Overall Study|Adverse Event|7|||
19557129|NCT01036438|42005639|FG001|Overall Study|Adverse Event|8|||
19557130|NCT01036438|42005638|FG000|Overall Study|Death|0|||
19557131|NCT01036438|42005639|FG001|Overall Study|Death|1|||
19557132|NCT01036438|42005638|FG000|Overall Study|No effect of study treatment|3|||
19557133|NCT01036438|42005639|FG001|Overall Study|No effect of study treatment|1|||
19557134|NCT01268514|42005645|FG000|Overall Study|Adverse Event|20|||
19557135|NCT01268514|42005645|FG000|Overall Study|Death|8|||
19557136|NCT01268514|42005645|FG000|Overall Study|Lost to Follow-up|5|||
19557137|NCT01268514|42005645|FG000|Overall Study|Withdrawal by Subject|3|||
19557138|NCT01268514|42005645|FG000|Overall Study|Withdrawal by Surgeon|5|||
19557139|NCT01268046|42005655|FG000|Overall Study|Withdrawal by Subject|1|||
19557140|NCT01268046|42005656|FG001|Overall Study|Withdrawal by Subject|0|||
19557141|NCT01268046|42005657|FG002|Overall Study|Withdrawal by Subject|0|||
19557142|NCT01268046|42005658|FG003|Overall Study|Withdrawal by Subject|1|||
19557143|NCT01268046|42005655|FG000|Overall Study|Lost to Follow-up|0|||
19557144|NCT01268046|42005656|FG001|Overall Study|Lost to Follow-up|0|||
19557145|NCT01268046|42005657|FG002|Overall Study|Lost to Follow-up|1|||
19557146|NCT01268046|42005658|FG003|Overall Study|Lost to Follow-up|0|||
19557147|NCT01267266|42005668|FG000|Enrollment Phase|Withdrawal by Subject|2|||
19557148|NCT01267266|42005669|FG001|Enrollment Phase|Withdrawal by Subject|0|||
19557149|NCT01267266|42005668|FG000|Lead-in Phase|Lack of Efficacy|20|||
19557150|NCT01267266|42005669|FG001|Lead-in Phase|Lack of Efficacy|0|||
19557151|NCT01267266|42005668|FG000|Lead-in Phase|Adverse Event|2|||
19557152|NCT01267266|42005669|FG001|Lead-in Phase|Adverse Event|0|||
19557153|NCT01267266|42005668|FG000|Lead-in Phase|Withdrawal by Subject|1|||
19557154|NCT01267266|42005669|FG001|Lead-in Phase|Withdrawal by Subject|0|||
19557155|NCT01034176|42005680|FG000|Overall Study|Physician Decision|2|||
19557156|NCT01034176|42005681|FG001|Overall Study|Physician Decision|0|||
19557157|NCT01034176|42005680|FG000|Overall Study|Withdrawal by Subject|0|||
19557158|NCT01034176|42005681|FG001|Overall Study|Withdrawal by Subject|1|||
19557159|NCT01034176|42005680|FG000|Overall Study|Lost to Follow-up|0|||
19557160|NCT01034176|42005681|FG001|Overall Study|Lost to Follow-up|1|||
19557161|NCT01033942|42005690|FG000|Overall Study|Withdrawal by Subject|1|||
19557162|NCT01033942|42005691|FG001|Overall Study|Withdrawal by Subject|1|||
19557163|NCT01033942|42005692|FG002|Overall Study|Withdrawal by Subject|1|||
19557164|NCT01033942|42005690|FG000|Overall Study|Lost to Follow-up|1|||
19557165|NCT01033942|42005691|FG001|Overall Study|Lost to Follow-up|0|||
19557166|NCT01033942|42005692|FG002|Overall Study|Lost to Follow-up|0|||
19557167|NCT01033942|42005690|FG000|Overall Study|Enrolled in Extension Study|0|||
19557168|NCT01033942|42005691|FG001|Overall Study|Enrolled in Extension Study|3|||
19557169|NCT01033942|42005692|FG002|Overall Study|Enrolled in Extension Study|0|||
19557170|NCT01062256|42005705|FG000|Overall Study|Adverse Event|1|||
19557171|NCT01062256|42005706|FG001|Overall Study|Adverse Event|0|||
19557172|NCT01062256|42005707|FG002|Overall Study|Adverse Event|0|||
19557173|NCT01062256|42005705|FG000|Overall Study|Withdrawal by Subject|1|||
19557174|NCT01062256|42005706|FG001|Overall Study|Withdrawal by Subject|1|||
19557175|NCT01062256|42005707|FG002|Overall Study|Withdrawal by Subject|1|||
19557176|NCT01062256|42005705|FG000|Overall Study|Ineligible|1|||
19557177|NCT01062256|42005706|FG001|Overall Study|Ineligible|4|||
19557178|NCT01062256|42005707|FG002|Overall Study|Ineligible|3|||
19557179|NCT01062256|42005705|FG000|Overall Study|Administrative|0|||
19557180|NCT01062256|42005706|FG001|Overall Study|Administrative|2|||
19557181|NCT01062256|42005707|FG002|Overall Study|Administrative|0|||
19557182|NCT01029886|42005717|FG000|Overall Study|Adverse Event|12|||
19557183|NCT01029886|42005718|FG001|Overall Study|Adverse Event|25|||
19557184|NCT01029886|42005717|FG000|Overall Study|Lost to Follow-up|1|||
19557185|NCT01029886|42005718|FG001|Overall Study|Lost to Follow-up|0|||
19557186|NCT01029886|42005717|FG000|Overall Study|Physician Decision|2|||
19557187|NCT01029886|42005718|FG001|Overall Study|Physician Decision|6|||
19557188|NCT01029886|42005717|FG000|Overall Study|Protocol Violation|17|||
19557189|NCT01029886|42005718|FG001|Overall Study|Protocol Violation|5|||
19557190|NCT01029886|42005717|FG000|Overall Study|Withdrawal by Subject|8|||
19557191|NCT01029886|42005718|FG001|Overall Study|Withdrawal by Subject|18|||
19557192|NCT01029886|42005717|FG000|Overall Study|Entry Criteria Not Met|13|||
19557193|NCT01029886|42005718|FG001|Overall Study|Entry Criteria Not Met|5|||
19557194|NCT01029886|42005717|FG000|Overall Study|Sponsor Decision|1|||
19557195|NCT01029886|42005718|FG001|Overall Study|Sponsor Decision|0|||
19557196|NCT01029886|42005717|FG000|Overall Study|Loss Glucose Control|7|||
19557197|NCT01029886|42005718|FG001|Overall Study|Loss Glucose Control|1|||
19557198|NCT01244763|42005734|FG000|Overall Study|Adverse Event|1|||
19557199|NCT01244763|42005735|FG001|Overall Study|Adverse Event|0|||
19557200|NCT01244763|42005736|FG002|Overall Study|Adverse Event|0|||
19557201|NCT01244763|42005737|FG003|Overall Study|Adverse Event|0|||
19557202|NCT01244763|42005738|FG004|Overall Study|Adverse Event|0|||
19557203|NCT01244763|42005739|FG005|Overall Study|Adverse Event|1|||
19557204|NCT01244763|42005734|FG000|Overall Study|Death|1|||
19557205|NCT01244763|42005735|FG001|Overall Study|Death|0|||
19557206|NCT01244763|42005736|FG002|Overall Study|Death|1|||
19557207|NCT01244763|42005737|FG003|Overall Study|Death|0|||
19557208|NCT01244763|42005738|FG004|Overall Study|Death|2|||
19557209|NCT01244763|42005739|FG005|Overall Study|Death|0|||
19557210|NCT01244763|42005734|FG000|Overall Study|Physician Decision|0|||
19557211|NCT01244763|42005735|FG001|Overall Study|Physician Decision|0|||
19557212|NCT01244763|42005736|FG002|Overall Study|Physician Decision|1|||
19557213|NCT01244763|42005737|FG003|Overall Study|Physician Decision|0|||
19557214|NCT01244763|42005738|FG004|Overall Study|Physician Decision|0|||
19557215|NCT01244763|42005739|FG005|Overall Study|Physician Decision|0|||
19557216|NCT01244763|42005734|FG000|Overall Study|Withdrawal by Subject|1|||
19557217|NCT01244763|42005735|FG001|Overall Study|Withdrawal by Subject|2|||
19557218|NCT01244763|42005736|FG002|Overall Study|Withdrawal by Subject|0|||
19557219|NCT01244763|42005737|FG003|Overall Study|Withdrawal by Subject|1|||
19557220|NCT01244763|42005738|FG004|Overall Study|Withdrawal by Subject|1|||
19557221|NCT01244763|42005739|FG005|Overall Study|Withdrawal by Subject|2|||
19557222|NCT01244763|42005734|FG000|Overall Study|Lost to Follow-up|0|||
19557223|NCT01244763|42005735|FG001|Overall Study|Lost to Follow-up|1|||
19557224|NCT01244763|42005736|FG002|Overall Study|Lost to Follow-up|0|||
19557225|NCT01244763|42005737|FG003|Overall Study|Lost to Follow-up|0|||
19557226|NCT01244763|42005738|FG004|Overall Study|Lost to Follow-up|0|||
19557227|NCT01244763|42005739|FG005|Overall Study|Lost to Follow-up|0|||
19557228|NCT01244763|42005734|FG000|Overall Study|Enrolled into the Extension Study|0|||
19557229|NCT01244763|42005735|FG001|Overall Study|Enrolled into the Extension Study|0|||
19557230|NCT01244763|42005736|FG002|Overall Study|Enrolled into the Extension Study|0|||
19557231|NCT01244763|42005737|FG003|Overall Study|Enrolled into the Extension Study|0|||
19557232|NCT01244763|42005738|FG004|Overall Study|Enrolled into the Extension Study|0|||
19557233|NCT01244763|42005739|FG005|Overall Study|Enrolled into the Extension Study|1|||
19557234|NCT01244061|42005755|FG000|Overall Study|Death|1|||
19557235|NCT01244061|42005756|FG001|Overall Study|Death|0|||
19557236|NCT01244061|42005755|FG000|Overall Study|Did not meet entrance criteria|1|||
19557237|NCT01244061|42005756|FG001|Overall Study|Did not meet entrance criteria|0|||
19557238|NCT01244061|42005755|FG000|Overall Study|Lack of Efficacy|1|||
19557239|NCT01244061|42005756|FG001|Overall Study|Lack of Efficacy|3|||
19557240|NCT01244061|42005755|FG000|Overall Study|Lost to Follow-up|34|||
19557241|NCT01244061|42005756|FG001|Overall Study|Lost to Follow-up|30|||
19557242|NCT01244061|42005755|FG000|Overall Study|Withdrawal by Subject|29|||
19557243|NCT01244061|42005756|FG001|Overall Study|Withdrawal by Subject|46|||
19557244|NCT01244061|42005755|FG000|Overall Study|Other|8|||
19557245|NCT01244061|42005756|FG001|Overall Study|Other|19|||
19557246|NCT01244061|42005755|FG000|Overall Study|Protocol Violation|1|||
19557247|NCT01244061|42005756|FG001|Overall Study|Protocol Violation|1|||
19557248|NCT01244061|42005755|FG000|Overall Study|Adverse Event|5|||
19557249|NCT01244061|42005756|FG001|Overall Study|Adverse Event|2|||
19557250|NCT01244061|42005755|FG000|Overall Study|Randomized but not treated|2|||
19557251|NCT01244061|42005756|FG001|Overall Study|Randomized but not treated|2|||
19557252|NCT01243671|42005762|FG000|Overall Study|Adverse Event|3|||
19557253|NCT01243671|42005762|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
19557254|NCT01243671|42005762|FG000|Overall Study|Other|1|||
19557255|NCT01240785|42005768|FG000|Overall Study|Lost to Follow-up|1|||
19557256|NCT01240785|42005769|FG001|Overall Study|Lost to Follow-up|0|||
19557257|NCT01240785|42005768|FG000|Overall Study|Protocol Violation|0|||
19557258|NCT01240785|42005769|FG001|Overall Study|Protocol Violation|3|||
19557259|NCT01240551|42005777|FG000|Overall Study|Refused further treatment|3|||
19557260|NCT01240551|42005778|FG001|Overall Study|Refused further treatment|2|||
19557261|NCT01240551|42005777|FG000|Overall Study|Lost to Follow-up|1|||
19557262|NCT01240551|42005778|FG001|Overall Study|Lost to Follow-up|1|||
19557263|NCT01239381|42005784|FG000|Overall Study|Protocol Violation|1|||
19557264|NCT01239381|42005784|FG000|Overall Study|Withdrawal by Subject|1|||
19557265|NCT01266876|42005794|FG000|Overall Study|Adverse Event|0|||
19557266|NCT01266876|42005795|FG001|Overall Study|Adverse Event|0|||
19557267|NCT01266876|42005796|FG002|Overall Study|Adverse Event|0|||
19557268|NCT01266876|42005797|FG003|Overall Study|Adverse Event|1|||
19557269|NCT01266876|42005798|FG004|Overall Study|Adverse Event|0|||
19557270|NCT01266642|42005812|FG000|Overall Study|Protocol Violation|0|||
19557271|NCT01266642|42005813|FG001|Overall Study|Protocol Violation|1|||
19557272|NCT01033240|42005822|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
19557273|NCT01033240|42005823|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
19557274|NCT01033240|42005824|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
19557275|NCT01033240|42005822|FG000|Overall Study|Death|2|||
19557276|NCT01033240|42005823|FG001|Overall Study|Death|0|||
19557277|NCT01033240|42005824|FG002|Overall Study|Death|0|||
19557278|NCT01033240|42005822|FG000|Overall Study|Withdrew Consent|2|||
19557279|NCT01033240|42005823|FG001|Overall Study|Withdrew Consent|9|||
19557280|NCT01033240|42005824|FG002|Overall Study|Withdrew Consent|2|||
19557281|NCT01033240|42005822|FG000|Overall Study|Disease Progression|35|||
19557282|NCT01033240|42005823|FG001|Overall Study|Disease Progression|32|||
19557283|NCT01033240|42005824|FG002|Overall Study|Disease Progression|41|||
19557284|NCT01033240|42005822|FG000|Overall Study|Investigator Discretion|0|||
19557285|NCT01033240|42005823|FG001|Overall Study|Investigator Discretion|0|||
19557286|NCT01033240|42005824|FG002|Overall Study|Investigator Discretion|2|||
19557287|NCT01033240|42005822|FG000|Overall Study|Other|0|||
19557288|NCT01033240|42005823|FG001|Overall Study|Other|1|||
19557289|NCT01033240|42005824|FG002|Overall Study|Other|2|||
19557290|NCT01266018|42005832|FG000|Overall Study|Physician Decision|1|||
19557291|NCT01266018|42005833|FG001|Overall Study|Physician Decision|0|||
19557292|NCT01266018|42005832|FG000|Overall Study|Progressive disease|0|||
19557293|NCT01266018|42005833|FG001|Overall Study|Progressive disease|1|||
19557294|NCT01032382|42005841|FG000|Overall Study|Disease dissemination|1|||
19557295|NCT01032382|42005842|FG001|Overall Study|Disease dissemination|1|||
19557296|NCT01032382|42005841|FG000|Overall Study|Treatment failure|3|||
19557297|NCT01032382|42005842|FG001|Overall Study|Treatment failure|1|||
19557298|NCT01032382|42005841|FG000|Overall Study|Index lesion relapse|1|||
19557299|NCT01032382|42005842|FG001|Overall Study|Index lesion relapse|3|||
19557300|NCT01029652|42005850|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
19557301|NCT01029652|42005851|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
19557302|NCT01029652|42005850|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
19557303|NCT01029652|42005851|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
19557304|NCT01029652|42005850|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
19557305|NCT01029652|42005851|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
19557306|NCT01029652|42005850|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
19557307|NCT01029652|42005851|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
19557308|NCT01029652|42005850|FG000|Core Study (0-12 Weeks)|Death|0|||
19557309|NCT01029652|42005851|FG001|Core Study (0-12 Weeks)|Death|1|||
19557310|NCT01029652|42005850|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
19557311|NCT01029652|42005851|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
19557312|NCT01029652|42005850|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
19557313|NCT01029652|42005851|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
19557314|NCT01029652|42005850|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
19557315|NCT01029652|42005851|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
19557316|NCT01029652|42005850|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
19557317|NCT01029652|42005851|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
19557318|NCT01029652|42005850|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
19557319|NCT01029652|42005851|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
19557320|NCT01029652|42005850|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
19557321|NCT01029652|42005851|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
19557322|NCT01029652|42005850|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
19557323|NCT01029652|42005851|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
19557324|NCT01029340|42005880|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
19557325|NCT01029340|42005881|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
19557326|NCT01029340|42005882|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
19557327|NCT01029340|42005883|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
19557328|NCT01029340|42005884|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
19557329|NCT01029340|42005885|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
19557330|NCT01029340|42005880|FG000|Part B Treatment Period|Protocol Violation|0|||
19557331|NCT01029340|42005881|FG001|Part B Treatment Period|Protocol Violation|0|||
19557332|NCT01029340|42005882|FG002|Part B Treatment Period|Protocol Violation|1|||
19557333|NCT01029340|42005883|FG003|Part B Treatment Period|Protocol Violation|0|||
19557334|NCT01029340|42005884|FG004|Part B Treatment Period|Protocol Violation|0|||
19557335|NCT01029340|42005885|FG005|Part B Treatment Period|Protocol Violation|0|||
19557336|NCT01029340|42005880|FG000|Extension Period|Adverse Event|0|||
19557337|NCT01029340|42005881|FG001|Extension Period|Adverse Event|0|||
19557338|NCT01029340|42005882|FG002|Extension Period|Adverse Event|0|||
19557339|NCT01029340|42005883|FG003|Extension Period|Adverse Event|0|||
19557340|NCT01029340|42005884|FG004|Extension Period|Adverse Event|0|||
19557341|NCT01029340|42005885|FG005|Extension Period|Adverse Event|1|||
19557342|NCT01029340|42005880|FG000|Extension Period|starting another study|0|||
19557343|NCT01029340|42005881|FG001|Extension Period|starting another study|0|||
19557344|NCT01029340|42005882|FG002|Extension Period|starting another study|0|||
19557345|NCT01029340|42005883|FG003|Extension Period|starting another study|0|||
19557346|NCT01029340|42005884|FG004|Extension Period|starting another study|0|||
19557347|NCT01029340|42005885|FG005|Extension Period|starting another study|8|||
19557348|NCT01029340|42005880|FG000|Extension Period|non-compliance|0|||
19557349|NCT01029340|42005881|FG001|Extension Period|non-compliance|0|||
19557350|NCT01029340|42005882|FG002|Extension Period|non-compliance|0|||
19557351|NCT01029340|42005883|FG003|Extension Period|non-compliance|0|||
19557352|NCT01029340|42005884|FG004|Extension Period|non-compliance|0|||
19557353|NCT01029340|42005885|FG005|Extension Period|non-compliance|1|||
19557354|NCT01029340|42005880|FG000|Extension Period|Withdrawal by Subject|0|||
19557355|NCT01029340|42005881|FG001|Extension Period|Withdrawal by Subject|0|||
19382070|NCT01376167|41625237|FG002|Overall Study|Lost to Follow-up|2|||
19557356|NCT01029340|42005882|FG002|Extension Period|Withdrawal by Subject|0|||
19557357|NCT01029340|42005883|FG003|Extension Period|Withdrawal by Subject|0|||
19557358|NCT01029340|42005884|FG004|Extension Period|Withdrawal by Subject|0|||
19557359|NCT01029340|42005885|FG005|Extension Period|Withdrawal by Subject|1|||
19557360|NCT01029340|42005880|FG000|Extension Period|Physician Decision|0|||
19557361|NCT01029340|42005881|FG001|Extension Period|Physician Decision|0|||
19557362|NCT01029340|42005882|FG002|Extension Period|Physician Decision|0|||
19557363|NCT01029340|42005883|FG003|Extension Period|Physician Decision|0|||
19557364|NCT01029340|42005884|FG004|Extension Period|Physician Decision|0|||
19557365|NCT01029340|42005885|FG005|Extension Period|Physician Decision|1|||
19557366|NCT01265550|42005902|FG000|Pre Randomization|Withdrawal by Subject|0|||
19557367|NCT01265550|42005903|FG001|Pre Randomization|Withdrawal by Subject|0|||
19557368|NCT01265550|42005904|FG002|Pre Randomization|Withdrawal by Subject|0|||
19557369|NCT01265550|42005905|FG003|Pre Randomization|Withdrawal by Subject|70|||
19557370|NCT01265550|42005902|FG000|Pre Randomization|Technical Exclusions|0|||
19557371|NCT01265550|42005903|FG001|Pre Randomization|Technical Exclusions|0|||
19557372|NCT01265550|42005904|FG002|Pre Randomization|Technical Exclusions|0|||
19557373|NCT01265550|42005905|FG003|Pre Randomization|Technical Exclusions|54|||
19557374|NCT01265550|42005902|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
19557375|NCT01265550|42005903|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
19557376|NCT01265550|42005904|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
19557377|NCT01265550|42005905|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
19557378|NCT01265550|42005902|FG000|Pre Randomization|Non-GERD organic disorders|0|||
19557379|NCT01265550|42005903|FG001|Pre Randomization|Non-GERD organic disorders|0|||
19557380|NCT01265550|42005904|FG002|Pre Randomization|Non-GERD organic disorders|0|||
19557381|NCT01265550|42005905|FG003|Pre Randomization|Non-GERD organic disorders|23|||
19557382|NCT01265550|42005902|FG000|Pre Randomization|Functional heartburn|0|||
19557383|NCT01265550|42005903|FG001|Pre Randomization|Functional heartburn|0|||
19557384|NCT01265550|42005904|FG002|Pre Randomization|Functional heartburn|0|||
19557385|NCT01265550|42005905|FG003|Pre Randomization|Functional heartburn|99|||
19557386|NCT01265394|42005919|FG000|Overall Study|Subjects withdrawn|37|||
19557387|NCT01029262|42005926|FG000|Overall Study|Adverse Event|9|||
19557388|NCT01029262|42005927|FG001|Overall Study|Adverse Event|52|||
19557389|NCT01029262|42005926|FG000|Overall Study|Lack of therapeutic effect|57|||
19557390|NCT01029262|42005927|FG001|Overall Study|Lack of therapeutic effect|76|||
19557391|NCT01029262|42005926|FG000|Overall Study|Withdrawal by Subject|10|||
19557392|NCT01029262|42005927|FG001|Overall Study|Withdrawal by Subject|17|||
19557393|NCT01029262|42005926|FG000|Overall Study|Protocol Violation|2|||
19557394|NCT01029262|42005927|FG001|Overall Study|Protocol Violation|3|||
19557395|NCT01029262|42005926|FG000|Overall Study|Miscellaneous|1|||
19557396|NCT01029262|42005927|FG001|Overall Study|Miscellaneous|9|||
19557397|NCT01029262|42005926|FG000|Overall Study|Death|0|||
19557398|NCT01029262|42005927|FG001|Overall Study|Death|3|||
19557399|NCT01028560|42005940|FG000|Overall Study|Lack of Efficacy|3|||
19557400|NCT01028560|42005941|FG001|Overall Study|Lack of Efficacy|6|||
19557401|NCT01028560|42005940|FG000|Overall Study|Withdrawal by Subject|7|||
19557402|NCT01028560|42005941|FG001|Overall Study|Withdrawal by Subject|12|||
19557403|NCT01061710|42005948|FG000|Overall Study|Protocol Violation|14|||
19557404|NCT01028014|42005958|FG000|Overall Study|Lost to Follow-up|1|||
19557405|NCT01028014|42005959|FG001|Overall Study|Lost to Follow-up|2|||
19557406|NCT01028014|42005960|FG002|Overall Study|Lost to Follow-up|0|||
19557407|NCT01028014|42005961|FG003|Overall Study|Lost to Follow-up|1|||
19557408|NCT01028014|42005962|FG004|Overall Study|Lost to Follow-up|1|||
19557409|NCT01028014|42005963|FG005|Overall Study|Lost to Follow-up|2|||
19557410|NCT01264770|42005983|FG000|Overall Study|Not reported|0|||
19557411|NCT01264770|42005984|FG001|Overall Study|Not reported|0|||
19557412|NCT01264770|42005985|FG002|Overall Study|Not reported|1|||
19557413|NCT01264770|42005986|FG003|Overall Study|Not reported|0|||
19557414|NCT01264770|42005987|FG004|Overall Study|Not reported|0|||
19557415|NCT01264770|42005988|FG005|Overall Study|Not reported|0|||
19557416|NCT01264770|42005983|FG000|Overall Study|e.g., change in circumstances|8|||
19557417|NCT01264770|42005984|FG001|Overall Study|e.g., change in circumstances|3|||
19557418|NCT01264770|42005985|FG002|Overall Study|e.g., change in circumstances|3|||
19557419|NCT01264770|42005986|FG003|Overall Study|e.g., change in circumstances|3|||
19557420|NCT01264770|42005987|FG004|Overall Study|e.g., change in circumstances|4|||
19557421|NCT01264770|42005988|FG005|Overall Study|e.g., change in circumstances|4|||
19557422|NCT01264770|42005983|FG000|Overall Study|Severe non-compliance to protocol|0|||
19557423|NCT01264770|42005984|FG001|Overall Study|Severe non-compliance to protocol|0|||
19557424|NCT01264770|42005985|FG002|Overall Study|Severe non-compliance to protocol|1|||
19557425|NCT01264770|42005986|FG003|Overall Study|Severe non-compliance to protocol|1|||
19557426|NCT01264770|42005987|FG004|Overall Study|Severe non-compliance to protocol|0|||
19557427|NCT01264770|42005988|FG005|Overall Study|Severe non-compliance to protocol|0|||
19557428|NCT01264770|42005983|FG000|Overall Study|Lack of therapeutic response|1|||
19557429|NCT01264770|42005984|FG001|Overall Study|Lack of therapeutic response|0|||
19557430|NCT01264770|42005985|FG002|Overall Study|Lack of therapeutic response|2|||
19557431|NCT01264770|42005986|FG003|Overall Study|Lack of therapeutic response|1|||
19557432|NCT01264770|42005987|FG004|Overall Study|Lack of therapeutic response|1|||
19557433|NCT01264770|42005988|FG005|Overall Study|Lack of therapeutic response|0|||
19557434|NCT01264770|42005983|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
19557435|NCT01264770|42005984|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
19557436|NCT01264770|42005985|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
19557437|NCT01264770|42005986|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
19557438|NCT01264770|42005987|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
19557439|NCT01264770|42005988|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
19557440|NCT01264770|42005983|FG000|Overall Study|Lost to Follow-up|0|||
19557441|NCT01264770|42005984|FG001|Overall Study|Lost to Follow-up|0|||
19557442|NCT01264770|42005985|FG002|Overall Study|Lost to Follow-up|1|||
19557443|NCT01264770|42005986|FG003|Overall Study|Lost to Follow-up|1|||
19557444|NCT01264770|42005987|FG004|Overall Study|Lost to Follow-up|0|||
19557445|NCT01264770|42005988|FG005|Overall Study|Lost to Follow-up|0|||
19557446|NCT01264770|42005983|FG000|Overall Study|Adverse Event|7|||
19557447|NCT01264770|42005984|FG001|Overall Study|Adverse Event|7|||
19557448|NCT01264770|42005985|FG002|Overall Study|Adverse Event|8|||
19557449|NCT01264770|42005986|FG003|Overall Study|Adverse Event|0|||
19557450|NCT01264770|42005987|FG004|Overall Study|Adverse Event|2|||
19557451|NCT01264770|42005988|FG005|Overall Study|Adverse Event|1|||
19557452|NCT01027702|42006008|FG000|Overall Study|Received subsequent therapy|1|||
19557453|NCT01027702|42006009|FG001|Overall Study|Received subsequent therapy|2|||
19557454|NCT01027702|42006010|FG002|Overall Study|Received subsequent therapy|0|||
19557455|NCT01027702|42006011|FG003|Overall Study|Received subsequent therapy|4|||
19557456|NCT01027702|42006012|FG004|Overall Study|Received subsequent therapy|1|||
19557457|NCT01027702|42006013|FG005|Overall Study|Received subsequent therapy|0|||
19557458|NCT01027702|42006014|FG006|Overall Study|Received subsequent therapy|1|||
19557459|NCT01027702|42006008|FG000|Overall Study|Death|0|||
19557460|NCT01027702|42006009|FG001|Overall Study|Death|0|||
19557461|NCT01027702|42006010|FG002|Overall Study|Death|1|||
19557462|NCT01027702|42006011|FG003|Overall Study|Death|0|||
19557463|NCT01027702|42006012|FG004|Overall Study|Death|0|||
19557464|NCT01027702|42006013|FG005|Overall Study|Death|0|||
19557465|NCT01027702|42006014|FG006|Overall Study|Death|0|||
19557466|NCT01302080|42006028|FG000|Overall Study|Withdrew Consent|92|||
19557467|NCT01302080|42006029|FG001|Overall Study|Withdrew Consent|39|||
19557468|NCT01302080|42006028|FG000|Overall Study|Patient/Family Moved|28|||
19557469|NCT01302080|42006029|FG001|Overall Study|Patient/Family Moved|3|||
19557470|NCT01302080|42006028|FG000|Overall Study|Lost to Follow-up|192|||
19557471|NCT01302080|42006029|FG001|Overall Study|Lost to Follow-up|93|||
19557472|NCT01302080|42006028|FG000|Overall Study|Death|1|||
19557473|NCT01302080|42006029|FG001|Overall Study|Death|0|||
19557474|NCT01302080|42006028|FG000|Overall Study|Other|52|||
19557475|NCT01302080|42006029|FG001|Overall Study|Other|8|||
19557476|NCT01302080|42006028|FG000|Overall Study|Reason Missing For Discontinuation|1|||
19557477|NCT01302080|42006029|FG001|Overall Study|Reason Missing For Discontinuation|0|||
19557478|NCT01238991|42006069|FG000|Overall Study|Adverse Event|1|||
19557479|NCT01238991|42006070|FG001|Overall Study|Adverse Event|0|||
19557480|NCT01238991|42006071|FG002|Overall Study|Adverse Event|3|||
19557481|NCT01238991|42006072|FG003|Overall Study|Adverse Event|1|||
19557482|NCT01238991|42006073|FG004|Overall Study|Adverse Event|1|||
19557483|NCT01238991|42006074|FG005|Overall Study|Adverse Event|0|||
19557484|NCT01238991|42006075|FG006|Overall Study|Adverse Event|1|||
19557485|NCT01238991|42006076|FG007|Overall Study|Adverse Event|1|||
19557486|NCT01238991|42006077|FG008|Overall Study|Adverse Event|0|||
19557487|NCT01238991|42006078|FG009|Overall Study|Adverse Event|0|||
19557488|NCT01238991|42006069|FG000|Overall Study|Death|0|||
19557489|NCT01238991|42006070|FG001|Overall Study|Death|0|||
19557490|NCT01238991|42006071|FG002|Overall Study|Death|0|||
19557491|NCT01238991|42006072|FG003|Overall Study|Death|1|||
19557492|NCT01238991|42006073|FG004|Overall Study|Death|0|||
19557493|NCT01238991|42006074|FG005|Overall Study|Death|0|||
19557494|NCT01238991|42006075|FG006|Overall Study|Death|0|||
19557495|NCT01238991|42006076|FG007|Overall Study|Death|0|||
19557496|NCT01238991|42006077|FG008|Overall Study|Death|0|||
19557497|NCT01238991|42006078|FG009|Overall Study|Death|0|||
19557498|NCT01238991|42006069|FG000|Overall Study|Lack of Efficacy|0|||
19557499|NCT01238991|42006070|FG001|Overall Study|Lack of Efficacy|0|||
19557500|NCT01238991|42006071|FG002|Overall Study|Lack of Efficacy|1|||
19557501|NCT01238991|42006072|FG003|Overall Study|Lack of Efficacy|0|||
19557502|NCT01238991|42006073|FG004|Overall Study|Lack of Efficacy|0|||
19557503|NCT01238991|42006074|FG005|Overall Study|Lack of Efficacy|0|||
19557504|NCT01238991|42006075|FG006|Overall Study|Lack of Efficacy|0|||
19557505|NCT01238991|42006076|FG007|Overall Study|Lack of Efficacy|0|||
19557506|NCT01238991|42006077|FG008|Overall Study|Lack of Efficacy|1|||
19557507|NCT01238991|42006078|FG009|Overall Study|Lack of Efficacy|0|||
19557508|NCT01238991|42006069|FG000|Overall Study|Withdrawal by Subject|0|||
19557509|NCT01238991|42006070|FG001|Overall Study|Withdrawal by Subject|0|||
19557510|NCT01238991|42006071|FG002|Overall Study|Withdrawal by Subject|1|||
19557511|NCT01238991|42006072|FG003|Overall Study|Withdrawal by Subject|0|||
19557512|NCT01238991|42006073|FG004|Overall Study|Withdrawal by Subject|0|||
19557513|NCT01238991|42006074|FG005|Overall Study|Withdrawal by Subject|0|||
19557514|NCT01238991|42006075|FG006|Overall Study|Withdrawal by Subject|0|||
19557515|NCT01238991|42006076|FG007|Overall Study|Withdrawal by Subject|0|||
19557516|NCT01238991|42006077|FG008|Overall Study|Withdrawal by Subject|0|||
19557517|NCT01238991|42006078|FG009|Overall Study|Withdrawal by Subject|0|||
19557518|NCT01238991|42006069|FG000|Overall Study|Study Terminated by Sponsor|0|||
19557519|NCT01238991|42006070|FG001|Overall Study|Study Terminated by Sponsor|0|||
19557520|NCT01238991|42006071|FG002|Overall Study|Study Terminated by Sponsor|0|||
19557521|NCT01238991|42006072|FG003|Overall Study|Study Terminated by Sponsor|0|||
19557522|NCT01238991|42006073|FG004|Overall Study|Study Terminated by Sponsor|1|||
19557523|NCT01238991|42006074|FG005|Overall Study|Study Terminated by Sponsor|0|||
19382071|NCT01376167|41625235|FG000|Overall Study|Physician Decision|1|||
19557524|NCT01238991|42006075|FG006|Overall Study|Study Terminated by Sponsor|7|||
19557525|NCT01238991|42006076|FG007|Overall Study|Study Terminated by Sponsor|4|||
19557526|NCT01238991|42006077|FG008|Overall Study|Study Terminated by Sponsor|2|||
19557527|NCT01238991|42006078|FG009|Overall Study|Study Terminated by Sponsor|2|||
19557528|NCT01238991|42006069|FG000|Overall Study|Caregiver's request|0|||
19557529|NCT01238991|42006070|FG001|Overall Study|Caregiver's request|0|||
19557530|NCT01238991|42006071|FG002|Overall Study|Caregiver's request|0|||
19557531|NCT01238991|42006072|FG003|Overall Study|Caregiver's request|0|||
19557532|NCT01238991|42006073|FG004|Overall Study|Caregiver's request|0|||
19557533|NCT01238991|42006074|FG005|Overall Study|Caregiver's request|0|||
19557534|NCT01238991|42006075|FG006|Overall Study|Caregiver's request|0|||
19557535|NCT01238991|42006076|FG007|Overall Study|Caregiver's request|0|||
19557536|NCT01238991|42006077|FG008|Overall Study|Caregiver's request|1|||
19557537|NCT01238991|42006078|FG009|Overall Study|Caregiver's request|0|||
19557538|NCT01238991|42006069|FG000|Overall Study|Admission to a nursing home|1|||
19557539|NCT01238991|42006070|FG001|Overall Study|Admission to a nursing home|0|||
19557540|NCT01238991|42006071|FG002|Overall Study|Admission to a nursing home|1|||
19557541|NCT01238991|42006072|FG003|Overall Study|Admission to a nursing home|0|||
19557542|NCT01238991|42006073|FG004|Overall Study|Admission to a nursing home|0|||
19557543|NCT01238991|42006074|FG005|Overall Study|Admission to a nursing home|0|||
19557544|NCT01238991|42006075|FG006|Overall Study|Admission to a nursing home|0|||
19557545|NCT01238991|42006076|FG007|Overall Study|Admission to a nursing home|0|||
19557546|NCT01238991|42006077|FG008|Overall Study|Admission to a nursing home|0|||
19557547|NCT01238991|42006078|FG009|Overall Study|Admission to a nursing home|0|||
19557548|NCT01238835|42006103|FG000|Overall Study|Death|124|||
19557549|NCT01238835|42006103|FG000|Overall Study|Withdrawal by Subject|9|||
19557550|NCT01238835|42006103|FG000|Overall Study|Lost to Follow-up|1|||
19557551|NCT01238835|42006103|FG000|Overall Study|Site early discontinuation|2|||
19557552|NCT01032070|42006109|FG000|Overall Study|Disease progression|13|||
19557553|NCT01032070|42006110|FG001|Overall Study|Disease progression|8|||
19557554|NCT01032070|42006109|FG000|Overall Study|Medical or ethical reasons|0|||
19557555|NCT01032070|42006110|FG001|Overall Study|Medical or ethical reasons|2|||
19557556|NCT01032070|42006109|FG000|Overall Study|Withdrawal by Subject|0|||
19557557|NCT01032070|42006110|FG001|Overall Study|Withdrawal by Subject|2|||
19557558|NCT01237899|42006127|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
19557559|NCT01237899|42006128|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
19557560|NCT01237899|42006129|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
19557561|NCT01237899|42006130|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
19557562|NCT01237899|42006131|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
19557563|NCT01237899|42006132|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
19557564|NCT01237899|42006133|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
19557565|NCT01237899|42006134|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
19557566|NCT01237899|42006135|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
19557567|NCT01237899|42006136|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
19557568|NCT01237899|42006137|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
19557569|NCT01264380|42006155|FG000|Period C|Disease Progression|0|||
19557570|NCT01264380|42006156|FG001|Period C|Disease Progression|0|||
19557571|NCT01264380|42006157|FG002|Period C|Disease Progression|4|||
19557572|NCT01264380|42006155|FG000|Period C|Death|0|||
19557573|NCT01264380|42006156|FG001|Period C|Death|0|||
19557574|NCT01264380|42006157|FG002|Period C|Death|2|||
19557575|NCT01264380|42006155|FG000|Period C|Follow-up for survival status|0|||
19557576|NCT01264380|42006156|FG001|Period C|Follow-up for survival status|0|||
19557577|NCT01264380|42006157|FG002|Period C|Follow-up for survival status|6|||
19557578|NCT01264380|42006155|FG000|Period C|Withdrawal by Subject|0|||
19557579|NCT01264380|42006156|FG001|Period C|Withdrawal by Subject|0|||
19557580|NCT01264380|42006157|FG002|Period C|Withdrawal by Subject|1|||
19557581|NCT01264380|42006155|FG000|Period C|Adverse Event|0|||
19557582|NCT01264380|42006156|FG001|Period C|Adverse Event|0|||
19557583|NCT01264380|42006157|FG002|Period C|Adverse Event|1|||
19557584|NCT01263444|42006165|FG000|Overall Study|Adverse Event|8|||
19557585|NCT01263444|42006165|FG000|Overall Study|Withdrawal by Subject|1|||
19557586|NCT01263444|42006165|FG000|Overall Study|Protocol Violation|1|||
19557587|NCT01263054|42006171|FG000|Overall Study|Death|1|||
19557588|NCT01263054|42006172|FG001|Overall Study|Death|0|||
19557589|NCT01263054|42006171|FG000|Overall Study|Lost to Follow-up|2|||
19557590|NCT01263054|42006172|FG001|Overall Study|Lost to Follow-up|2|||
19557591|NCT01263054|42006171|FG000|Overall Study|Withdrawal by Subject|1|||
19557592|NCT01263054|42006172|FG001|Overall Study|Withdrawal by Subject|3|||
19557593|NCT01263054|42006171|FG000|Overall Study|Qualification Violation|1|||
19557594|NCT01263054|42006172|FG001|Overall Study|Qualification Violation|0|||
19557595|NCT01263054|42006171|FG000|Overall Study|Other|0|||
19557596|NCT01263054|42006172|FG001|Overall Study|Other|1|||
19557597|NCT01031836|42006184|FG000|Stage I|Adverse Event|1|||
19557598|NCT01031836|42006185|FG001|Stage I|Adverse Event|1|||
19557599|NCT01031836|42006186|FG002|Stage I|Adverse Event|0|||
19557600|NCT01031836|42006187|FG003|Stage I|Adverse Event|0|||
19557601|NCT01031836|42006188|FG004|Stage I|Adverse Event|0|||
19557602|NCT01031836|42006189|FG005|Stage I|Adverse Event|0|||
19557603|NCT01031836|42006184|FG000|Stage I|Other|0|||
19557604|NCT01031836|42006185|FG001|Stage I|Other|1|||
19557605|NCT01031836|42006186|FG002|Stage I|Other|0|||
19557606|NCT01031836|42006187|FG003|Stage I|Other|0|||
19557607|NCT01031836|42006188|FG004|Stage I|Other|0|||
19557608|NCT01031836|42006189|FG005|Stage I|Other|1|||
19557609|NCT01031836|42006184|FG000|Stage II|Adverse Event|0|||
19557610|NCT01031836|42006185|FG001|Stage II|Adverse Event|0|||
19557611|NCT01031836|42006186|FG002|Stage II|Adverse Event|2|||
19557612|NCT01031836|42006187|FG003|Stage II|Adverse Event|2|||
19557613|NCT01031836|42006188|FG004|Stage II|Adverse Event|1|||
19557614|NCT01031836|42006189|FG005|Stage II|Adverse Event|1|||
19557615|NCT01031836|42006184|FG000|Stage II|Other|2|||
19557616|NCT01031836|42006185|FG001|Stage II|Other|0|||
19557617|NCT01031836|42006186|FG002|Stage II|Other|0|||
19557618|NCT01031836|42006187|FG003|Stage II|Other|1|||
19557619|NCT01031836|42006188|FG004|Stage II|Other|1|||
19557620|NCT01031836|42006189|FG005|Stage II|Other|0|||
19557621|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
19557622|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
19557623|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
19557624|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
19557625|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
19557626|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
19557627|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
19557628|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
19557629|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
19557630|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
19557631|NCT01237587|42006205|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
19557632|NCT01237587|42006206|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
19557633|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
19557634|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
19557635|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
19557636|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
19557637|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
19557638|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
19557639|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
19557640|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
19557641|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
19557642|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
19557643|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
19557644|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
19557645|NCT01237587|42006205|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
19557646|NCT01237587|42006206|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
19557647|NCT01237587|42006205|FG000|Taper Phase|Adverse Event|0|||
19557648|NCT01237587|42006206|FG001|Taper Phase|Adverse Event|2|||
19557649|NCT01237587|42006205|FG000|Taper Phase|Protocol Violation|2|||
19557650|NCT01237587|42006206|FG001|Taper Phase|Protocol Violation|0|||
19557651|NCT01237587|42006205|FG000|Taper Phase|Lack of Efficacy|2|||
19557652|NCT01237587|42006206|FG001|Taper Phase|Lack of Efficacy|5|||
19557653|NCT01237587|42006205|FG000|Taper Phase|Parent/Guardian Decision|0|||
19557654|NCT01237587|42006206|FG001|Taper Phase|Parent/Guardian Decision|2|||
19557655|NCT01237587|42006205|FG000|Taper Phase|Sponsor Decision|1|||
19557656|NCT01237587|42006206|FG001|Taper Phase|Sponsor Decision|0|||
19557657|NCT01237587|42006205|FG000|Taper Phase|Withdrawal by Subject|0|||
19557658|NCT01237587|42006206|FG001|Taper Phase|Withdrawal by Subject|1|||
19557659|NCT01031680|42006221|FG000|Overall Study|Adverse Event|8|||
19557660|NCT01031680|42006222|FG001|Overall Study|Adverse Event|3|||
19557661|NCT01031680|42006221|FG000|Overall Study|Lost to Follow-up|2|||
19557662|NCT01031680|42006222|FG001|Overall Study|Lost to Follow-up|10|||
19557663|NCT01031680|42006221|FG000|Overall Study|Withdrawal by Subject|12|||
19557664|NCT01031680|42006222|FG001|Overall Study|Withdrawal by Subject|16|||
19557665|NCT01031680|42006221|FG000|Overall Study|Death|2|||
19557666|NCT01031680|42006222|FG001|Overall Study|Death|1|||
19557667|NCT01031680|42006221|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
19557668|NCT01031680|42006222|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
19557669|NCT01031680|42006221|FG000|Overall Study|Poor/Non-compliance|5|||
19557670|NCT01031680|42006222|FG001|Overall Study|Poor/Non-compliance|6|||
19557671|NCT01031680|42006221|FG000|Overall Study|Safety|1|||
19557672|NCT01031680|42006222|FG001|Overall Study|Safety|0|||
19557673|NCT01031680|42006221|FG000|Overall Study|Incorrect Enrolment|1|||
19557674|NCT01031680|42006222|FG001|Overall Study|Incorrect Enrolment|2|||
19557675|NCT01031680|42006221|FG000|Overall Study|Administrative Reason by Sponsor|0|||
19557676|NCT01031680|42006222|FG001|Overall Study|Administrative Reason by Sponsor|1|||
19557677|NCT01031680|42006221|FG000|Overall Study|Various|0|||
19557678|NCT01031680|42006222|FG001|Overall Study|Various|2|||
19557679|NCT01031446|42006228|FG000|Overall Study|Disease Progression|38|||
19557680|NCT01031446|42006228|FG000|Overall Study|Adverse Event|9|||
19557681|NCT01031446|42006228|FG000|Overall Study|Physician Decision|4|||
19557682|NCT01031446|42006228|FG000|Overall Study|Withdrawal by Subject|3|||
19557683|NCT01031446|42006228|FG000|Overall Study|Still on treatment|1|||
19557684|NCT01030900|42006234|FG000|Overall Study|Not treated due to congestive heart failure|1|||
19557685|NCT01030900|42006234|FG000|Overall Study|Not treated due to rapid disease|1|||
19557686|NCT01030822|42006241|FG000|Overall Study|Moved/migrated from study area|6|||
19557687|NCT01030822|42006242|FG001|Overall Study|Moved/migrated from study area|7|||
19557688|NCT01030822|42006243|FG002|Overall Study|Moved/migrated from study area|3|||
19557689|NCT01030822|42006241|FG000|Overall Study|Withdrawal by Subject|16|||
19557690|NCT01030822|42006242|FG001|Overall Study|Withdrawal by Subject|13|||
19557691|NCT01030822|42006243|FG002|Overall Study|Withdrawal by Subject|16|||
19557692|NCT01030822|42006241|FG000|Overall Study|Lost to Follow-up|9|||
19557693|NCT01030822|42006242|FG001|Overall Study|Lost to Follow-up|4|||
19557694|NCT01030822|42006243|FG002|Overall Study|Lost to Follow-up|7|||
19557695|NCT01026454|42006254|FG000|Second Intervention|Pregnancy|1|||
19557696|NCT01026454|42006255|FG001|Second Intervention|Pregnancy|1|||
19557697|NCT01026220|42006261|FG000|Induction|Death|1|||
19557698|NCT01026220|42006262|FG001|Induction|Death|0|||
19557699|NCT01026220|42006263|FG002|Induction|Death|0|||
19557700|NCT01026220|42006261|FG000|Induction|Lack of Efficacy|2|||
19557701|NCT01026220|42006262|FG001|Induction|Lack of Efficacy|0|||
19557702|NCT01026220|42006263|FG002|Induction|Lack of Efficacy|0|||
19557703|NCT01026220|42006261|FG000|Induction|Physician Decision|12|||
19557704|NCT01026220|42006262|FG001|Induction|Physician Decision|0|||
19557705|NCT01026220|42006263|FG002|Induction|Physician Decision|0|||
19557706|NCT01026220|42006261|FG000|Induction|Withdrawal by Subject|9|||
19557707|NCT01026220|42006262|FG001|Induction|Withdrawal by Subject|0|||
19557708|NCT01026220|42006263|FG002|Induction|Withdrawal by Subject|0|||
19557709|NCT01026220|42006261|FG000|Induction|Ineligible|1|||
19557710|NCT01026220|42006262|FG001|Induction|Ineligible|0|||
19557711|NCT01026220|42006263|FG002|Induction|Ineligible|0|||
19557712|NCT01026220|42006261|FG000|Consolidation Maintenance|Death|0|||
19557713|NCT01026220|42006262|FG001|Consolidation Maintenance|Death|1|||
19557714|NCT01026220|42006263|FG002|Consolidation Maintenance|Death|0|||
19557715|NCT01026220|42006261|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
19557716|NCT01026220|42006262|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
19557717|NCT01026220|42006263|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
19557718|NCT01026220|42006261|FG000|Consolidation Maintenance|Physician Decision|0|||
19557719|NCT01026220|42006262|FG001|Consolidation Maintenance|Physician Decision|2|||
19557720|NCT01026220|42006263|FG002|Consolidation Maintenance|Physician Decision|7|||
19557721|NCT01026220|42006261|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
19557722|NCT01026220|42006262|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
19557723|NCT01026220|42006263|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
19557724|NCT01026142|42006280|FG000|Overall Study|Death|136|||
19557725|NCT01026142|42006281|FG001|Overall Study|Death|134|||
19557726|NCT01026142|42006280|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
19557727|NCT01026142|42006281|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
19557728|NCT01030666|42006289|FG000|Overall Study|Lost to Follow-up|3|||
19557729|NCT01030666|42006290|FG001|Overall Study|Lost to Follow-up|2|||
19557730|NCT01025752|42006299|FG000|Overall Study|Lost to Follow-up|7|||
19557731|NCT01025752|42006300|FG001|Overall Study|Lost to Follow-up|10|||
19557732|NCT01025752|42006299|FG000|Overall Study|Physician Decision|1|||
19557733|NCT01025752|42006300|FG001|Overall Study|Physician Decision|3|||
19557734|NCT01030198|42006308|FG000|Overall Study|Could not measure efficacy accurately|0|||
19557735|NCT01030198|42006309|FG001|Overall Study|Could not measure efficacy accurately|7|||
19557736|NCT01301456|42006327|FG000|Stage 1|Withdrawal by Subject|0|||
19557737|NCT01301456|42006328|FG001|Stage 1|Withdrawal by Subject|0|||
19557738|NCT01301456|42006329|FG002|Stage 1|Withdrawal by Subject|1|||
19557739|NCT01301456|42006330|FG003|Stage 1|Withdrawal by Subject|0|||
19557740|NCT01301456|42006331|FG004|Stage 1|Withdrawal by Subject|1|||
19557741|NCT01301456|42006332|FG005|Stage 1|Withdrawal by Subject|0|||
19557742|NCT01301456|42006333|FG006|Stage 1|Withdrawal by Subject|0|||
19557743|NCT01301456|42006334|FG007|Stage 1|Withdrawal by Subject|0|||
19557744|NCT01301456|42006335|FG008|Stage 1|Withdrawal by Subject|0|||
19557745|NCT01301456|42006336|FG009|Stage 1|Withdrawal by Subject|0|||
19557746|NCT01301456|42006337|FG010|Stage 1|Withdrawal by Subject|0|||
19557747|NCT01301456|42006338|FG011|Stage 1|Withdrawal by Subject|0|||
19557748|NCT01301456|42006327|FG000|Stage 1|Randomized but not treated|0|||
19557749|NCT01301456|42006328|FG001|Stage 1|Randomized but not treated|0|||
19557750|NCT01301456|42006329|FG002|Stage 1|Randomized but not treated|0|||
19557751|NCT01301456|42006330|FG003|Stage 1|Randomized but not treated|0|||
19557752|NCT01301456|42006331|FG004|Stage 1|Randomized but not treated|0|||
19557753|NCT01301456|42006332|FG005|Stage 1|Randomized but not treated|0|||
19557754|NCT01301456|42006333|FG006|Stage 1|Randomized but not treated|1|||
19557755|NCT01301456|42006334|FG007|Stage 1|Randomized but not treated|0|||
19557756|NCT01301456|42006335|FG008|Stage 1|Randomized but not treated|0|||
19557757|NCT01301456|42006336|FG009|Stage 1|Randomized but not treated|0|||
19557758|NCT01301456|42006337|FG010|Stage 1|Randomized but not treated|0|||
19557759|NCT01301456|42006338|FG011|Stage 1|Randomized but not treated|0|||
19557760|NCT01301456|42006327|FG000|Stage 2|Adverse Event|0|||
19557761|NCT01301456|42006328|FG001|Stage 2|Adverse Event|0|||
19557762|NCT01301456|42006329|FG002|Stage 2|Adverse Event|0|||
19557763|NCT01301456|42006330|FG003|Stage 2|Adverse Event|0|||
19557764|NCT01301456|42006331|FG004|Stage 2|Adverse Event|0|||
19557765|NCT01301456|42006332|FG005|Stage 2|Adverse Event|0|||
19557766|NCT01301456|42006333|FG006|Stage 2|Adverse Event|0|||
19557767|NCT01301456|42006334|FG007|Stage 2|Adverse Event|0|||
19557768|NCT01301456|42006335|FG008|Stage 2|Adverse Event|0|||
19557769|NCT01301456|42006336|FG009|Stage 2|Adverse Event|0|||
19557770|NCT01301456|42006337|FG010|Stage 2|Adverse Event|1|||
19557771|NCT01301456|42006338|FG011|Stage 2|Adverse Event|0|||
19557772|NCT01023256|42006386|FG000|Overall Study|Protocol Violation|2|||
19557773|NCT01023256|42006387|FG001|Overall Study|Protocol Violation|3|||
19557774|NCT01023256|42006388|FG002|Overall Study|Protocol Violation|0|||
19557775|NCT01023256|42006389|FG003|Overall Study|Protocol Violation|0|||
19557776|NCT01023256|42006386|FG000|Overall Study|Randomized but not treated|1|||
19557777|NCT01023256|42006387|FG001|Overall Study|Randomized but not treated|0|||
19557778|NCT01023256|42006388|FG002|Overall Study|Randomized but not treated|1|||
19557779|NCT01023256|42006389|FG003|Overall Study|Randomized but not treated|0|||
19557780|NCT01023256|42006386|FG000|Overall Study|Other|1|||
19557781|NCT01023256|42006387|FG001|Overall Study|Other|0|||
19557782|NCT01023256|42006388|FG002|Overall Study|Other|0|||
19557783|NCT01023256|42006389|FG003|Overall Study|Other|2|||
19557784|NCT01023256|42006386|FG000|Overall Study|Adverse Event|0|||
19557785|NCT01023256|42006387|FG001|Overall Study|Adverse Event|0|||
19557786|NCT01023256|42006388|FG002|Overall Study|Adverse Event|0|||
19557787|NCT01023256|42006389|FG003|Overall Study|Adverse Event|1|||
19557788|NCT01023256|42006386|FG000|Overall Study|Withdrawal by Subject|0|||
19557789|NCT01023256|42006387|FG001|Overall Study|Withdrawal by Subject|0|||
19557790|NCT01023256|42006388|FG002|Overall Study|Withdrawal by Subject|0|||
19557791|NCT01023256|42006389|FG003|Overall Study|Withdrawal by Subject|2|||
19557792|NCT01023022|42006402|FG000|Overall Study|Death|5|||
19557793|NCT01023022|42006402|FG000|Overall Study|Lost to Follow-up|7|||
19557794|NCT01023022|42006402|FG000|Overall Study|due to technical issues|2|||
19557795|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Adverse Event|8|||
19557796|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Adverse Event|15|||
19557797|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Adverse Event|25|||
19557798|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
19557799|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
19557800|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
19557801|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
19557802|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
19557803|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
19557804|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
19557805|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
19557806|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
19557807|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
19557808|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
19557809|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
19557810|NCT01058668|42006409|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
19557811|NCT01058668|42006410|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
19557812|NCT01058668|42006411|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
19557813|NCT01301066|42006421|FG000|Overall Study|Lost to Follow-up|5|||
19557814|NCT01301066|42006422|FG001|Overall Study|Lost to Follow-up|11|||
19557815|NCT01301066|42006421|FG000|Overall Study|Protocol Violation|8|||
19557816|NCT01301066|42006422|FG001|Overall Study|Protocol Violation|7|||
19557817|NCT01301066|42006421|FG000|Overall Study|Withdrawal by Subject|4|||
19557818|NCT01301066|42006422|FG001|Overall Study|Withdrawal by Subject|9|||
19557819|NCT01301066|42006421|FG000|Overall Study|Adverse Event|6|||
19557820|NCT01301066|42006422|FG001|Overall Study|Adverse Event|6|||
19557821|NCT01301066|42006421|FG000|Overall Study|Sponsor Decision|2|||
19557822|NCT01301066|42006422|FG001|Overall Study|Sponsor Decision|1|||
19557823|NCT01301066|42006421|FG000|Overall Study|Physician Decision|0|||
19557824|NCT01301066|42006422|FG001|Overall Study|Physician Decision|1|||
19557825|NCT01301066|42006421|FG000|Overall Study|Other|2|||
19557826|NCT01301066|42006422|FG001|Overall Study|Other|0|||
19557827|NCT01022398|42006430|FG000|Overall Study|Study terminated|2|||
19557828|NCT01022398|42006431|FG001|Overall Study|Study terminated|2|||
19557829|NCT01262976|42006442|FG000|Up to Month 2|Serious Adverse Event|0|||
19557830|NCT01262976|42006443|FG001|Up to Month 2|Serious Adverse Event|0|||
19557831|NCT01262976|42006444|FG002|Up to Month 2|Serious Adverse Event|1|||
19557832|NCT01262976|42006445|FG003|Up to Month 2|Serious Adverse Event|0|||
19557833|NCT01262976|42006446|FG004|Up to Month 2|Serious Adverse Event|0|||
19557834|NCT01262976|42006447|FG005|Up to Month 2|Serious Adverse Event|0|||
19557835|NCT01262976|42006442|FG000|Up to Month 2|Withdrawal by Subject|1|||
19557836|NCT01262976|42006443|FG001|Up to Month 2|Withdrawal by Subject|0|||
19557837|NCT01262976|42006444|FG002|Up to Month 2|Withdrawal by Subject|0|||
19557838|NCT01262976|42006445|FG003|Up to Month 2|Withdrawal by Subject|0|||
19557839|NCT01262976|42006446|FG004|Up to Month 2|Withdrawal by Subject|0|||
19557840|NCT01262976|42006447|FG005|Up to Month 2|Withdrawal by Subject|0|||
19557841|NCT01262976|42006442|FG000|Up to Month 2|Migrated/moved from study area|0|||
19557842|NCT01262976|42006443|FG001|Up to Month 2|Migrated/moved from study area|1|||
19557843|NCT01262976|42006444|FG002|Up to Month 2|Migrated/moved from study area|0|||
19557844|NCT01262976|42006445|FG003|Up to Month 2|Migrated/moved from study area|0|||
19557845|NCT01262976|42006446|FG004|Up to Month 2|Migrated/moved from study area|1|||
19557846|NCT01262976|42006447|FG005|Up to Month 2|Migrated/moved from study area|1|||
19557847|NCT01262976|42006442|FG000|Up to Month 2|Lost to Follow-up|1|||
19557848|NCT01262976|42006443|FG001|Up to Month 2|Lost to Follow-up|0|||
19557849|NCT01262976|42006444|FG002|Up to Month 2|Lost to Follow-up|0|||
19557850|NCT01262976|42006445|FG003|Up to Month 2|Lost to Follow-up|1|||
19557851|NCT01262976|42006446|FG004|Up to Month 2|Lost to Follow-up|1|||
19557852|NCT01262976|42006447|FG005|Up to Month 2|Lost to Follow-up|1|||
19557853|NCT01262976|42006442|FG000|Up to Month 2|Other|1|||
19557854|NCT01262976|42006443|FG001|Up to Month 2|Other|0|||
19557855|NCT01262976|42006444|FG002|Up to Month 2|Other|0|||
19557856|NCT01262976|42006445|FG003|Up to Month 2|Other|1|||
19557857|NCT01262976|42006446|FG004|Up to Month 2|Other|0|||
19557858|NCT01262976|42006447|FG005|Up to Month 2|Other|2|||
19557859|NCT01262976|42006442|FG000|Up to Month 7|Serious Adverse Event|0|||
19557860|NCT01262976|42006443|FG001|Up to Month 7|Serious Adverse Event|0|||
19557861|NCT01262976|42006444|FG002|Up to Month 7|Serious Adverse Event|2|||
19557862|NCT01262976|42006445|FG003|Up to Month 7|Serious Adverse Event|0|||
19557863|NCT01262976|42006446|FG004|Up to Month 7|Serious Adverse Event|0|||
19557864|NCT01262976|42006447|FG005|Up to Month 7|Serious Adverse Event|0|||
19557865|NCT01262976|42006442|FG000|Up to Month 7|Withdrawal by Subject|1|||
19557866|NCT01262976|42006443|FG001|Up to Month 7|Withdrawal by Subject|0|||
19557867|NCT01262976|42006444|FG002|Up to Month 7|Withdrawal by Subject|0|||
19557868|NCT01262976|42006445|FG003|Up to Month 7|Withdrawal by Subject|0|||
19557869|NCT01262976|42006446|FG004|Up to Month 7|Withdrawal by Subject|0|||
19557870|NCT01262976|42006447|FG005|Up to Month 7|Withdrawal by Subject|0|||
19557871|NCT01262976|42006442|FG000|Up to Month 7|Migrated/moved from study area|0|||
19557872|NCT01262976|42006443|FG001|Up to Month 7|Migrated/moved from study area|0|||
19557873|NCT01262976|42006444|FG002|Up to Month 7|Migrated/moved from study area|1|||
19557874|NCT01262976|42006445|FG003|Up to Month 7|Migrated/moved from study area|3|||
19557875|NCT01262976|42006446|FG004|Up to Month 7|Migrated/moved from study area|1|||
19557876|NCT01262976|42006447|FG005|Up to Month 7|Migrated/moved from study area|1|||
19557877|NCT01262976|42006442|FG000|Up to Month 7|Lost to Follow-up|1|||
19557878|NCT01262976|42006443|FG001|Up to Month 7|Lost to Follow-up|0|||
19557879|NCT01262976|42006444|FG002|Up to Month 7|Lost to Follow-up|1|||
19557880|NCT01262976|42006445|FG003|Up to Month 7|Lost to Follow-up|3|||
19557881|NCT01262976|42006446|FG004|Up to Month 7|Lost to Follow-up|1|||
19557882|NCT01262976|42006447|FG005|Up to Month 7|Lost to Follow-up|3|||
19557883|NCT01262976|42006442|FG000|Up to Month 7|Other|3|||
19557884|NCT01262976|42006443|FG001|Up to Month 7|Other|0|||
19557885|NCT01262976|42006444|FG002|Up to Month 7|Other|2|||
19557886|NCT01262976|42006445|FG003|Up to Month 7|Other|0|||
19557887|NCT01262976|42006446|FG004|Up to Month 7|Other|0|||
19557888|NCT01262976|42006447|FG005|Up to Month 7|Other|0|||
19557889|NCT01262976|42006442|FG000|Up to Year 1|Serious Adverse Event|0|||
19557890|NCT01262976|42006443|FG001|Up to Year 1|Serious Adverse Event|0|||
19557891|NCT01262976|42006444|FG002|Up to Year 1|Serious Adverse Event|2|||
19557892|NCT01262976|42006445|FG003|Up to Year 1|Serious Adverse Event|0|||
19557893|NCT01262976|42006446|FG004|Up to Year 1|Serious Adverse Event|0|||
19557894|NCT01262976|42006447|FG005|Up to Year 1|Serious Adverse Event|0|||
19557895|NCT01262976|42006442|FG000|Up to Year 1|Withdrawal by Subject|1|||
19557896|NCT01262976|42006443|FG001|Up to Year 1|Withdrawal by Subject|0|||
19557897|NCT01262976|42006444|FG002|Up to Year 1|Withdrawal by Subject|0|||
19557898|NCT01262976|42006445|FG003|Up to Year 1|Withdrawal by Subject|0|||
19557899|NCT01262976|42006446|FG004|Up to Year 1|Withdrawal by Subject|0|||
19557900|NCT01262976|42006447|FG005|Up to Year 1|Withdrawal by Subject|0|||
19557901|NCT01262976|42006442|FG000|Up to Year 1|Migrated/moved from study area|1|||
19557902|NCT01262976|42006443|FG001|Up to Year 1|Migrated/moved from study area|0|||
19557903|NCT01262976|42006444|FG002|Up to Year 1|Migrated/moved from study area|0|||
19557904|NCT01262976|42006445|FG003|Up to Year 1|Migrated/moved from study area|3|||
19557905|NCT01262976|42006446|FG004|Up to Year 1|Migrated/moved from study area|3|||
19557906|NCT01262976|42006447|FG005|Up to Year 1|Migrated/moved from study area|2|||
19557907|NCT01262976|42006442|FG000|Up to Year 1|Lost to Follow-up|4|||
19557908|NCT01262976|42006443|FG001|Up to Year 1|Lost to Follow-up|0|||
19557909|NCT01262976|42006444|FG002|Up to Year 1|Lost to Follow-up|0|||
19557910|NCT01262976|42006445|FG003|Up to Year 1|Lost to Follow-up|1|||
19557911|NCT01262976|42006446|FG004|Up to Year 1|Lost to Follow-up|6|||
19557912|NCT01262976|42006447|FG005|Up to Year 1|Lost to Follow-up|5|||
19557913|NCT01262976|42006442|FG000|Up to Year 1|Other|3|||
19557914|NCT01262976|42006443|FG001|Up to Year 1|Other|1|||
19557915|NCT01262976|42006444|FG002|Up to Year 1|Other|0|||
19557916|NCT01262976|42006445|FG003|Up to Year 1|Other|0|||
19557917|NCT01262976|42006446|FG004|Up to Year 1|Other|2|||
19557918|NCT01262976|42006447|FG005|Up to Year 1|Other|1|||
19557919|NCT01262976|42006442|FG000|Up to Year 1|Subjects with unknown completion status|0|||
19557920|NCT01262976|42006443|FG001|Up to Year 1|Subjects with unknown completion status|0|||
19557921|NCT01262976|42006444|FG002|Up to Year 1|Subjects with unknown completion status|1|||
19557922|NCT01262976|42006445|FG003|Up to Year 1|Subjects with unknown completion status|0|||
19557923|NCT01262976|42006446|FG004|Up to Year 1|Subjects with unknown completion status|0|||
19557924|NCT01262976|42006447|FG005|Up to Year 1|Subjects with unknown completion status|1|||
19557925|NCT01262976|42006442|FG000|Up to Year 2|Serious Adverse Event|0|||
19557926|NCT01262976|42006443|FG001|Up to Year 2|Serious Adverse Event|0|||
19557927|NCT01262976|42006444|FG002|Up to Year 2|Serious Adverse Event|2|||
19557928|NCT01262976|42006445|FG003|Up to Year 2|Serious Adverse Event|0|||
19557929|NCT01262976|42006446|FG004|Up to Year 2|Serious Adverse Event|0|||
19557930|NCT01262976|42006447|FG005|Up to Year 2|Serious Adverse Event|0|||
19557931|NCT01262976|42006442|FG000|Up to Year 2|Withdrawal by Subject|1|||
19557932|NCT01262976|42006443|FG001|Up to Year 2|Withdrawal by Subject|0|||
19557933|NCT01262976|42006444|FG002|Up to Year 2|Withdrawal by Subject|0|||
19557934|NCT01262976|42006445|FG003|Up to Year 2|Withdrawal by Subject|0|||
19557935|NCT01262976|42006446|FG004|Up to Year 2|Withdrawal by Subject|0|||
19557936|NCT01262976|42006447|FG005|Up to Year 2|Withdrawal by Subject|0|||
19557937|NCT01262976|42006442|FG000|Up to Year 2|Migrated/moved from study area|0|||
19557938|NCT01262976|42006443|FG001|Up to Year 2|Migrated/moved from study area|0|||
19557939|NCT01262976|42006444|FG002|Up to Year 2|Migrated/moved from study area|0|||
19557940|NCT01262976|42006445|FG003|Up to Year 2|Migrated/moved from study area|2|||
19557941|NCT01262976|42006446|FG004|Up to Year 2|Migrated/moved from study area|1|||
19557942|NCT01262976|42006447|FG005|Up to Year 2|Migrated/moved from study area|2|||
19557943|NCT01262976|42006442|FG000|Up to Year 2|Lost to Follow-up|1|||
19557944|NCT01262976|42006443|FG001|Up to Year 2|Lost to Follow-up|1|||
19557945|NCT01262976|42006444|FG002|Up to Year 2|Lost to Follow-up|2|||
19557946|NCT01262976|42006445|FG003|Up to Year 2|Lost to Follow-up|2|||
19557947|NCT01262976|42006446|FG004|Up to Year 2|Lost to Follow-up|3|||
19557948|NCT01262976|42006447|FG005|Up to Year 2|Lost to Follow-up|3|||
19557949|NCT01262976|42006442|FG000|Up to Year 2|Subjects with unknown completion status|0|||
19557950|NCT01262976|42006443|FG001|Up to Year 2|Subjects with unknown completion status|0|||
19557951|NCT01262976|42006444|FG002|Up to Year 2|Subjects with unknown completion status|1|||
19557952|NCT01262976|42006445|FG003|Up to Year 2|Subjects with unknown completion status|0|||
19557953|NCT01262976|42006446|FG004|Up to Year 2|Subjects with unknown completion status|0|||
19557954|NCT01262976|42006447|FG005|Up to Year 2|Subjects with unknown completion status|0|||
19557955|NCT01262976|42006442|FG000|Up to Year 2|Other|3|||
19557956|NCT01262976|42006443|FG001|Up to Year 2|Other|0|||
19557957|NCT01262976|42006444|FG002|Up to Year 2|Other|0|||
19557958|NCT01262976|42006445|FG003|Up to Year 2|Other|0|||
19557959|NCT01262976|42006446|FG004|Up to Year 2|Other|0|||
19557960|NCT01262976|42006447|FG005|Up to Year 2|Other|0|||
19557961|NCT01262976|42006442|FG000|Up to Year 3|Serious Adverse Event|0|||
19557962|NCT01262976|42006443|FG001|Up to Year 3|Serious Adverse Event|0|||
19557963|NCT01262976|42006444|FG002|Up to Year 3|Serious Adverse Event|2|||
19557964|NCT01262976|42006445|FG003|Up to Year 3|Serious Adverse Event|0|||
19557965|NCT01262976|42006446|FG004|Up to Year 3|Serious Adverse Event|0|||
19557966|NCT01262976|42006447|FG005|Up to Year 3|Serious Adverse Event|0|||
19557967|NCT01262976|42006442|FG000|Up to Year 3|Withdrawal by Subject|1|||
19557968|NCT01262976|42006443|FG001|Up to Year 3|Withdrawal by Subject|0|||
19557969|NCT01262976|42006444|FG002|Up to Year 3|Withdrawal by Subject|0|||
19557970|NCT01262976|42006445|FG003|Up to Year 3|Withdrawal by Subject|0|||
19557971|NCT01262976|42006446|FG004|Up to Year 3|Withdrawal by Subject|0|||
19557972|NCT01262976|42006447|FG005|Up to Year 3|Withdrawal by Subject|0|||
19557973|NCT01262976|42006442|FG000|Up to Year 3|Migrated/moved from study area|0|||
19557974|NCT01262976|42006443|FG001|Up to Year 3|Migrated/moved from study area|0|||
19557975|NCT01262976|42006444|FG002|Up to Year 3|Migrated/moved from study area|0|||
19557976|NCT01262976|42006445|FG003|Up to Year 3|Migrated/moved from study area|2|||
19557977|NCT01262976|42006446|FG004|Up to Year 3|Migrated/moved from study area|1|||
19557978|NCT01262976|42006447|FG005|Up to Year 3|Migrated/moved from study area|1|||
19557979|NCT01262976|42006442|FG000|Up to Year 3|Lost to Follow-up|2|||
19557980|NCT01262976|42006443|FG001|Up to Year 3|Lost to Follow-up|2|||
19557981|NCT01262976|42006444|FG002|Up to Year 3|Lost to Follow-up|4|||
19557982|NCT01262976|42006445|FG003|Up to Year 3|Lost to Follow-up|3|||
19557983|NCT01262976|42006446|FG004|Up to Year 3|Lost to Follow-up|1|||
19557984|NCT01262976|42006447|FG005|Up to Year 3|Lost to Follow-up|3|||
19557985|NCT01262976|42006442|FG000|Up to Year 3|Subjects with unknown completion status|0|||
19557986|NCT01262976|42006443|FG001|Up to Year 3|Subjects with unknown completion status|0|||
19557987|NCT01262976|42006444|FG002|Up to Year 3|Subjects with unknown completion status|1|||
19557988|NCT01262976|42006445|FG003|Up to Year 3|Subjects with unknown completion status|0|||
19557989|NCT01262976|42006446|FG004|Up to Year 3|Subjects with unknown completion status|0|||
19557990|NCT01262976|42006447|FG005|Up to Year 3|Subjects with unknown completion status|0|||
19557991|NCT01262976|42006442|FG000|Up to Year 3|Other|3|||
19557992|NCT01262976|42006443|FG001|Up to Year 3|Other|0|||
19557993|NCT01262976|42006444|FG002|Up to Year 3|Other|0|||
19557994|NCT01262976|42006445|FG003|Up to Year 3|Other|0|||
19557995|NCT01262976|42006446|FG004|Up to Year 3|Other|0|||
19557996|NCT01262976|42006447|FG005|Up to Year 3|Other|0|||
19557997|NCT01300286|42006462|FG000|Overall Study|did not get dosed|1|||
19557998|NCT01300052|42006469|FG000|Overall Study|Adverse Event|3|||
19557999|NCT01300052|42006470|FG001|Overall Study|Adverse Event|0|||
19558000|NCT01300052|42006469|FG000|Overall Study|Withdrawal by Subject|2|||
19558001|NCT01300052|42006470|FG001|Overall Study|Withdrawal by Subject|2|||
19558002|NCT01300052|42006469|FG000|Overall Study|Protocol Violation|1|||
19558003|NCT01300052|42006470|FG001|Overall Study|Protocol Violation|1|||
19558004|NCT01299896|42006478|FG000|Overall Study|Withdrawal by Subject|1|||
19558005|NCT01299896|42006479|FG001|Overall Study|Withdrawal by Subject|7|||
19558006|NCT01299896|42006478|FG000|Overall Study|Lost to Follow-up|0|||
19558007|NCT01299896|42006479|FG001|Overall Study|Lost to Follow-up|11|||
19558008|NCT01299584|42006485|FG000|Overall Study|Protocol Violation|9|||
19558009|NCT01236573|42006500|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558010|NCT01236573|42006501|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558011|NCT01236573|42006502|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558012|NCT01236573|42006503|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558013|NCT01236573|42006504|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558014|NCT01236573|42006505|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558015|NCT01236573|42006506|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
19558016|NCT01236573|42006507|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558017|NCT01236573|42006508|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
19558018|NCT01236573|42006509|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
19558019|NCT01236573|42006510|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
19558020|NCT01236573|42006500|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558021|NCT01236573|42006501|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558022|NCT01236573|42006502|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558023|NCT01236573|42006503|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558024|NCT01236573|42006504|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558025|NCT01236573|42006505|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558026|NCT01236573|42006506|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558027|NCT01236573|42006507|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558028|NCT01236573|42006508|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
19558029|NCT01236573|42006509|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558030|NCT01236573|42006510|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
19558031|NCT01236573|42006500|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558032|NCT01236573|42006501|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558033|NCT01236573|42006502|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558034|NCT01236573|42006503|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558035|NCT01236573|42006504|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558036|NCT01236573|42006505|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558037|NCT01236573|42006506|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558038|NCT01236573|42006507|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558039|NCT01236573|42006508|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558040|NCT01236573|42006509|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
19558041|NCT01236573|42006510|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
19558042|NCT01236339|42006537|FG000|Overall Study|Termination of study by sponsor|11|||
19558043|NCT01236339|42006538|FG001|Overall Study|Termination of study by sponsor|13|||
19558044|NCT01262898|42006549|FG000|Overall Study|Protocol Violation|1|||
19558045|NCT01262898|42006550|FG001|Overall Study|Protocol Violation|1|||
19558046|NCT01262898|42006551|FG002|Overall Study|Protocol Violation|0|||
19558047|NCT01262898|42006552|FG003|Overall Study|Protocol Violation|0|||
19558048|NCT01262898|42006549|FG000|Overall Study|Lost to Follow-up|1|||
19558049|NCT01262898|42006550|FG001|Overall Study|Lost to Follow-up|0|||
19558050|NCT01262898|42006551|FG002|Overall Study|Lost to Follow-up|0|||
19382072|NCT01376167|41625236|FG001|Overall Study|Physician Decision|1|||
19558051|NCT01262898|42006552|FG003|Overall Study|Lost to Follow-up|0|||
19558052|NCT01262898|42006549|FG000|Overall Study|Withdrawal by Subject|1|||
19558053|NCT01262898|42006550|FG001|Overall Study|Withdrawal by Subject|1|||
19558054|NCT01262898|42006551|FG002|Overall Study|Withdrawal by Subject|0|||
19558055|NCT01262898|42006552|FG003|Overall Study|Withdrawal by Subject|0|||
19558056|NCT01262820|42006565|FG000|Overall Study|Adverse Event|5|||
19558057|NCT01262820|42006565|FG000|Overall Study|Lack of Efficacy|9|||
19558058|NCT01262820|42006565|FG000|Overall Study|Drug held for 21+ days|1|||
19558059|NCT01057810|42006571|FG000|Overall Study|Disease progression|156|||
19558060|NCT01057810|42006572|FG001|Overall Study|Disease progression|197|||
19558061|NCT01057810|42006571|FG000|Overall Study|Study drug toxicity|5|||
19558062|NCT01057810|42006572|FG001|Overall Study|Study drug toxicity|114|||
19558063|NCT01057810|42006571|FG000|Overall Study|Adverse event unrelated to study drug|13|||
19558064|NCT01057810|42006572|FG001|Overall Study|Adverse event unrelated to study drug|29|||
19558065|NCT01057810|42006571|FG000|Overall Study|Withdrawal by Subject|10|||
19558066|NCT01057810|42006572|FG001|Overall Study|Withdrawal by Subject|25|||
19558067|NCT01057810|42006571|FG000|Overall Study|Death|2|||
19558068|NCT01057810|42006572|FG001|Overall Study|Death|12|||
19558069|NCT01057810|42006571|FG000|Overall Study|Maximum clinical benefit|5|||
19558070|NCT01057810|42006572|FG001|Overall Study|Maximum clinical benefit|5|||
19558071|NCT01057810|42006571|FG000|Overall Study|Poor/non-compliance|0|||
19558072|NCT01057810|42006572|FG001|Overall Study|Poor/non-compliance|1|||
19558073|NCT01057810|42006571|FG000|Overall Study|No longer met study criteria|0|||
19558074|NCT01057810|42006572|FG001|Overall Study|No longer met study criteria|1|||
19558075|NCT01057810|42006571|FG000|Overall Study|Other|7|||
19558076|NCT01057810|42006572|FG001|Overall Study|Other|14|||
19558077|NCT01262352|42006580|FG000|Period 1|Illness after randomization|1|||
19558078|NCT01262352|42006581|FG001|Period 1|Illness after randomization|0|||
19558079|NCT01262352|42006580|FG000|Washout|Adverse Event|1|||
19558080|NCT01262352|42006581|FG001|Washout|Adverse Event|1|||
19558081|NCT01262352|42006580|FG000|Washout|Extended Washout|0|||
19558082|NCT01262352|42006581|FG001|Washout|Extended Washout|1|||
19558083|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
19558084|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
19558085|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
19558086|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
19558087|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
19558088|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
19558089|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
19558090|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
19558091|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
19558092|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
19558093|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
19558094|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
19558095|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
19558096|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
19558097|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
19558098|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
19558099|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
19558100|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
19558101|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
19558102|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
19558103|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
19558104|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
19558105|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
19558106|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
19558107|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
19558108|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
19558109|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
19558110|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
19558111|NCT01299272|42006587|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
19558112|NCT01299272|42006588|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
19558113|NCT01299272|42006589|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
19558114|NCT01299272|42006590|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
19558115|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
19558116|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
19558117|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
19558118|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
19558119|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
19558120|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
19558121|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
19558122|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
19558123|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
19558124|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
19558125|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
19558126|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
19558127|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
19558128|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
19558129|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
19558130|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
19558131|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
19558132|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
19558133|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
19558134|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
19558135|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
19558136|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
19558137|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
19558138|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
19558139|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
19558140|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
19558141|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
19558142|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
19558143|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
19558144|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
19558145|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
19558146|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
19558147|NCT01299272|42006587|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
19558148|NCT01299272|42006588|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
19558149|NCT01299272|42006589|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
19558150|NCT01299272|42006590|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
19558151|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
19558152|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
19558153|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
19558154|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
19558155|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
19558156|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
19558157|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
19558158|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
19558159|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
19558160|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
19558161|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
19558162|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
19558163|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
19558164|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
19558165|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
19558166|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
19558167|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
19558168|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
19558169|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
19558170|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
19558171|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
19558172|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
19558173|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
19558174|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
19558175|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
19558176|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
19558177|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
19558178|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
19558179|NCT01299272|42006587|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
19558180|NCT01299272|42006588|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
19558181|NCT01299272|42006589|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
19558182|NCT01299272|42006590|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
19558183|NCT01299116|42006607|FG000|Overall Study|Lost to Follow-up|65|||
19558184|NCT01299116|42006608|FG001|Overall Study|Lost to Follow-up|9|||
19558185|NCT01299116|42006609|FG002|Overall Study|Lost to Follow-up|11|||
19558186|NCT01299038|42006622|FG000|Overall Study|Withdrawal by Subject|1|||
19558187|NCT01299038|42006623|FG001|Overall Study|Withdrawal by Subject|0|||
19558188|NCT01298648|42006629|FG000|Overall Study|Withdrawal by Subject|2|||
19558189|NCT01298648|42006629|FG000|Overall Study|Lost to Follow-up|21|||
19558190|NCT01261338|42006635|FG000|Overall Study|Withdrawal by Subject|3|||
19558191|NCT01261338|42006636|FG001|Overall Study|Withdrawal by Subject|2|||
19558192|NCT01260948|42006644|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
19558193|NCT01260948|42006645|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
19558194|NCT01260948|42006644|FG000|Second Intervention|Emesis|0|||
19558195|NCT01260948|42006645|FG001|Second Intervention|Emesis|1|||
19558196|NCT01025284|42006654|FG000|Overall Study|Investigator Decision|0|||
19558197|NCT01025284|42006655|FG001|Overall Study|Investigator Decision|1|||
19558198|NCT01025284|42006656|FG002|Overall Study|Investigator Decision|0|||
19558199|NCT01025284|42006654|FG000|Overall Study|Withdrawal by Subject|0|||
19558200|NCT01025284|42006655|FG001|Overall Study|Withdrawal by Subject|1|||
19558201|NCT01025284|42006656|FG002|Overall Study|Withdrawal by Subject|0|||
19558202|NCT01021852|42006674|FG000|Treatment Period 1|Adverse Event|3|||
19558203|NCT01021852|42006675|FG001|Treatment Period 1|Adverse Event|1|||
19558204|NCT01021852|42006676|FG002|Treatment Period 1|Adverse Event|1|||
19558205|NCT01021852|42006677|FG003|Treatment Period 1|Adverse Event|0|||
19558206|NCT01021852|42006678|FG004|Treatment Period 1|Adverse Event|2|||
19558207|NCT01021852|42006679|FG005|Treatment Period 1|Adverse Event|2|||
19558208|NCT01021852|42006680|FG006|Treatment Period 1|Adverse Event|0|||
19558209|NCT01021852|42006681|FG007|Treatment Period 1|Adverse Event|0|||
19558210|NCT01021852|42006674|FG000|Treatment Period 1|Pregnancy|0|||
19558211|NCT01021852|42006675|FG001|Treatment Period 1|Pregnancy|0|||
19558212|NCT01021852|42006676|FG002|Treatment Period 1|Pregnancy|1|||
19558213|NCT01021852|42006677|FG003|Treatment Period 1|Pregnancy|0|||
19558214|NCT01021852|42006678|FG004|Treatment Period 1|Pregnancy|0|||
19558215|NCT01021852|42006679|FG005|Treatment Period 1|Pregnancy|0|||
19558216|NCT01021852|42006680|FG006|Treatment Period 1|Pregnancy|0|||
19558217|NCT01021852|42006681|FG007|Treatment Period 1|Pregnancy|0|||
19558218|NCT01021852|42006674|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19558219|NCT01021852|42006675|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19558220|NCT01021852|42006676|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19558221|NCT01021852|42006677|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19558222|NCT01021852|42006678|FG004|Treatment Period 1|Withdrawal by Subject|1|||
19558223|NCT01021852|42006679|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19558224|NCT01021852|42006680|FG006|Treatment Period 1|Withdrawal by Subject|0|||
19558225|NCT01021852|42006681|FG007|Treatment Period 1|Withdrawal by Subject|1|||
19558226|NCT01021852|42006674|FG000|Treatment Period 1|Not Treated|0|||
19558227|NCT01021852|42006675|FG001|Treatment Period 1|Not Treated|0|||
19558228|NCT01021852|42006676|FG002|Treatment Period 1|Not Treated|0|||
19558229|NCT01021852|42006677|FG003|Treatment Period 1|Not Treated|2|||
19558230|NCT01021852|42006678|FG004|Treatment Period 1|Not Treated|0|||
19558231|NCT01021852|42006679|FG005|Treatment Period 1|Not Treated|0|||
19558232|NCT01021852|42006680|FG006|Treatment Period 1|Not Treated|0|||
19558233|NCT01021852|42006681|FG007|Treatment Period 1|Not Treated|0|||
19558234|NCT01021852|42006674|FG000|Washout Period-Placebo|Adverse Event|0|||
19558235|NCT01021852|42006675|FG001|Washout Period-Placebo|Adverse Event|0|||
19558236|NCT01021852|42006676|FG002|Washout Period-Placebo|Adverse Event|0|||
19558237|NCT01021852|42006677|FG003|Washout Period-Placebo|Adverse Event|1|||
19558238|NCT01021852|42006678|FG004|Washout Period-Placebo|Adverse Event|0|||
19558239|NCT01021852|42006679|FG005|Washout Period-Placebo|Adverse Event|1|||
19558240|NCT01021852|42006680|FG006|Washout Period-Placebo|Adverse Event|0|||
19558241|NCT01021852|42006681|FG007|Washout Period-Placebo|Adverse Event|0|||
19558242|NCT01021852|42006674|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
19558243|NCT01021852|42006675|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
19558244|NCT01021852|42006676|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
19558245|NCT01021852|42006677|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
19558246|NCT01021852|42006678|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
19558247|NCT01021852|42006679|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
19558248|NCT01021852|42006680|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
19558249|NCT01021852|42006681|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
19558250|NCT01021852|42006674|FG000|Washout Period-Placebo|Protocol Violation|0|||
19558251|NCT01021852|42006675|FG001|Washout Period-Placebo|Protocol Violation|0|||
19558252|NCT01021852|42006676|FG002|Washout Period-Placebo|Protocol Violation|0|||
19382073|NCT01376167|41625237|FG002|Overall Study|Physician Decision|0|||
19558253|NCT01021852|42006677|FG003|Washout Period-Placebo|Protocol Violation|0|||
19558254|NCT01021852|42006678|FG004|Washout Period-Placebo|Protocol Violation|0|||
19558255|NCT01021852|42006679|FG005|Washout Period-Placebo|Protocol Violation|0|||
19558256|NCT01021852|42006680|FG006|Washout Period-Placebo|Protocol Violation|1|||
19558257|NCT01021852|42006681|FG007|Washout Period-Placebo|Protocol Violation|0|||
19558258|NCT01021852|42006674|FG000|Washout Period-No Drug|Adverse Event|1|||
19558259|NCT01021852|42006675|FG001|Washout Period-No Drug|Adverse Event|0|||
19558260|NCT01021852|42006676|FG002|Washout Period-No Drug|Adverse Event|0|||
19558261|NCT01021852|42006677|FG003|Washout Period-No Drug|Adverse Event|0|||
19558262|NCT01021852|42006678|FG004|Washout Period-No Drug|Adverse Event|0|||
19558263|NCT01021852|42006679|FG005|Washout Period-No Drug|Adverse Event|1|||
19558264|NCT01021852|42006680|FG006|Washout Period-No Drug|Adverse Event|0|||
19558265|NCT01021852|42006681|FG007|Washout Period-No Drug|Adverse Event|0|||
19558266|NCT01021852|42006674|FG000|Treatment Period 2|Adverse Event|0|||
19558267|NCT01021852|42006675|FG001|Treatment Period 2|Adverse Event|1|||
19558268|NCT01021852|42006676|FG002|Treatment Period 2|Adverse Event|0|||
19558269|NCT01021852|42006677|FG003|Treatment Period 2|Adverse Event|0|||
19558270|NCT01021852|42006678|FG004|Treatment Period 2|Adverse Event|1|||
19558271|NCT01021852|42006679|FG005|Treatment Period 2|Adverse Event|0|||
19558272|NCT01021852|42006680|FG006|Treatment Period 2|Adverse Event|1|||
19558273|NCT01021852|42006681|FG007|Treatment Period 2|Adverse Event|0|||
19558274|NCT01021852|42006674|FG000|Treatment Period 2|Lack of Efficacy|0|||
19558275|NCT01021852|42006675|FG001|Treatment Period 2|Lack of Efficacy|0|||
19558276|NCT01021852|42006676|FG002|Treatment Period 2|Lack of Efficacy|0|||
19558277|NCT01021852|42006677|FG003|Treatment Period 2|Lack of Efficacy|0|||
19558278|NCT01021852|42006678|FG004|Treatment Period 2|Lack of Efficacy|0|||
19558279|NCT01021852|42006679|FG005|Treatment Period 2|Lack of Efficacy|1|||
19558280|NCT01021852|42006680|FG006|Treatment Period 2|Lack of Efficacy|0|||
19558281|NCT01021852|42006681|FG007|Treatment Period 2|Lack of Efficacy|0|||
19558282|NCT01021852|42006674|FG000|Treatment Period 2|Physician Decision|0|||
19558283|NCT01021852|42006675|FG001|Treatment Period 2|Physician Decision|0|||
19558284|NCT01021852|42006676|FG002|Treatment Period 2|Physician Decision|1|||
19558285|NCT01021852|42006677|FG003|Treatment Period 2|Physician Decision|0|||
19558286|NCT01021852|42006678|FG004|Treatment Period 2|Physician Decision|0|||
19558287|NCT01021852|42006679|FG005|Treatment Period 2|Physician Decision|0|||
19558288|NCT01021852|42006680|FG006|Treatment Period 2|Physician Decision|0|||
19558289|NCT01021852|42006681|FG007|Treatment Period 2|Physician Decision|0|||
19558290|NCT01021852|42006674|FG000|Treatment Period 2|Protocol Violation|0|||
19558291|NCT01021852|42006675|FG001|Treatment Period 2|Protocol Violation|0|||
19558292|NCT01021852|42006676|FG002|Treatment Period 2|Protocol Violation|0|||
19558293|NCT01021852|42006677|FG003|Treatment Period 2|Protocol Violation|0|||
19558294|NCT01021852|42006678|FG004|Treatment Period 2|Protocol Violation|1|||
19558295|NCT01021852|42006679|FG005|Treatment Period 2|Protocol Violation|0|||
19558296|NCT01021852|42006680|FG006|Treatment Period 2|Protocol Violation|1|||
19558297|NCT01021852|42006681|FG007|Treatment Period 2|Protocol Violation|0|||
19558298|NCT01021852|42006674|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19558299|NCT01021852|42006675|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19558300|NCT01021852|42006676|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19558301|NCT01021852|42006677|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19558302|NCT01021852|42006678|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19558303|NCT01021852|42006679|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19558304|NCT01021852|42006680|FG006|Treatment Period 2|Withdrawal by Subject|1|||
19558305|NCT01021852|42006681|FG007|Treatment Period 2|Withdrawal by Subject|2|||
19558306|NCT01056718|42006695|FG000|Overall Study|Withdrawal by Subject|2|||
19558307|NCT01056718|42006695|FG000|Overall Study|Ischemia on baseline stress test|1|||
19558308|NCT01298570|42006702|FG000|Overall Study|Disease progression, relapse during acti|64|||
19558309|NCT01298570|42006703|FG001|Overall Study|Disease progression, relapse during acti|40|||
19558310|NCT01298570|42006702|FG000|Overall Study|Adverse Event|20|||
19558311|NCT01298570|42006703|FG001|Overall Study|Adverse Event|2|||
19558312|NCT01298570|42006702|FG000|Overall Study|Withdrawal by Subject|21|||
19558313|NCT01298570|42006703|FG001|Overall Study|Withdrawal by Subject|6|||
19558314|NCT01298570|42006702|FG000|Overall Study|Treatment delay > 4 weeks|4|||
19558315|NCT01298570|42006703|FG001|Overall Study|Treatment delay > 4 weeks|5|||
19558316|NCT01298570|42006702|FG000|Overall Study|Physician Decision|4|||
19558317|NCT01298570|42006703|FG001|Overall Study|Physician Decision|2|||
19558318|NCT01298570|42006702|FG000|Overall Study|Other complicating disease|2|||
19558319|NCT01298570|42006703|FG001|Overall Study|Other complicating disease|1|||
19558320|NCT01298570|42006702|FG000|Overall Study|Surgery|2|||
19558321|NCT01298570|42006703|FG001|Overall Study|Surgery|1|||
19558322|NCT01298570|42006702|FG000|Overall Study|Symptomatic progression/deterioration|3|||
19558323|NCT01298570|42006703|FG001|Overall Study|Symptomatic progression/deterioration|2|||
19558324|NCT01298570|42006702|FG000|Overall Study|Death|0|||
19558325|NCT01298570|42006703|FG001|Overall Study|Death|1|||
19390366|NCT01987960|41634110|FG000|Period 3|Protocol Violation|0|||
19558326|NCT01298570|42006702|FG000|Overall Study|Ineligibility|0|||
19558327|NCT01298570|42006703|FG001|Overall Study|Ineligibility|1|||
19558328|NCT01259856|42006711|FG000|Overall Study|Adverse Event|12|||
19558329|NCT01259856|42006712|FG001|Overall Study|Adverse Event|9|||
19558330|NCT01259856|42006711|FG000|Overall Study|Death|0|||
19558331|NCT01259856|42006712|FG001|Overall Study|Death|1|||
19558332|NCT01259856|42006711|FG000|Overall Study|Lack of Efficacy|3|||
19558333|NCT01259856|42006712|FG001|Overall Study|Lack of Efficacy|1|||
19558334|NCT01259856|42006711|FG000|Overall Study|Lost to Follow-up|1|||
19558335|NCT01259856|42006712|FG001|Overall Study|Lost to Follow-up|1|||
19558336|NCT01259856|42006711|FG000|Overall Study|Physician Decision|2|||
19558337|NCT01259856|42006712|FG001|Overall Study|Physician Decision|1|||
19558338|NCT01259856|42006711|FG000|Overall Study|Withdrawal by Subject|9|||
19558339|NCT01259856|42006712|FG001|Overall Study|Withdrawal by Subject|10|||
19558340|NCT01259856|42006711|FG000|Overall Study|Treatment never started|0|||
19558341|NCT01259856|42006712|FG001|Overall Study|Treatment never started|6|||
19558342|NCT01259856|42006711|FG000|Overall Study|Study closure by sponsor|40|||
19558343|NCT01259856|42006712|FG001|Overall Study|Study closure by sponsor|41|||
19558344|NCT01259856|42006711|FG000|Overall Study|Patient developed other disease|0|||
19558345|NCT01259856|42006712|FG001|Overall Study|Patient developed other disease|1|||
19558346|NCT01259856|42006711|FG000|Overall Study|Transfer to another study|0|||
19558347|NCT01259856|42006712|FG001|Overall Study|Transfer to another study|1|||
19558348|NCT01259856|42006711|FG000|Overall Study|Unknown/missing|2|||
19558349|NCT01259856|42006712|FG001|Overall Study|Unknown/missing|2|||
19558350|NCT01020838|42006718|FG000|Overall Study|Death|90|||
19558351|NCT01020838|42006718|FG000|Overall Study|Adverse Event|1|||
19558352|NCT01020838|42006718|FG000|Overall Study|Withdrawal by Subject|9|||
19558353|NCT01020838|42006718|FG000|Overall Study|Lost to Follow-up|6|||
19558354|NCT01020838|42006718|FG000|Overall Study|Most common: Study ended by sponsor|77|||
19558355|NCT01259466|42006733|FG000|Overall Study|Withdrawal by Subject|1|||
19558356|NCT01259466|42006734|FG001|Overall Study|Withdrawal by Subject|9|||
19558357|NCT01259388|42006742|FG000|Overall Study|Adverse Event|3|||
19558358|NCT01259388|42006743|FG001|Overall Study|Adverse Event|0|||
19558359|NCT01259388|42006742|FG000|Overall Study|Withdrawal by Subject|1|||
19558360|NCT01259388|42006743|FG001|Overall Study|Withdrawal by Subject|1|||
19558361|NCT01259388|42006742|FG000|Overall Study|Physician Decision|1|||
19558362|NCT01259388|42006743|FG001|Overall Study|Physician Decision|0|||
19558363|NCT01298492|42006749|FG000|Overall Study|Death|2|||
19558364|NCT01298492|42006749|FG000|Overall Study|Insufficient Clinical Response|22|||
19558365|NCT01298492|42006749|FG000|Overall Study|Lost to Follow-up|12|||
19558366|NCT01298492|42006749|FG000|Overall Study|Withdrawal by Subject|47|||
19558367|NCT01298492|42006749|FG000|Overall Study|Other (Unspecified)|7|||
19558368|NCT01298492|42006749|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
19558369|NCT01298492|42006749|FG000|Overall Study|Protocol Violation|2|||
19558370|NCT01298492|42006749|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
19558371|NCT01298492|42006749|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
19558372|NCT01297322|42006755|FG000|Overall Study|Lost to Follow-up|1|||
19558373|NCT01297322|42006756|FG001|Overall Study|Lost to Follow-up|0|||
19558374|NCT01297322|42006755|FG000|Overall Study|Withdrawal by Subject|0|||
19558375|NCT01297322|42006756|FG001|Overall Study|Withdrawal by Subject|1|||
19558376|NCT01297322|42006755|FG000|Overall Study|Protocol Violation|0|||
19558377|NCT01297322|42006756|FG001|Overall Study|Protocol Violation|3|||
19558378|NCT01297244|42006765|FG000|Overall Study|Progressive disease|22|||
19558379|NCT01297244|42006766|FG001|Overall Study|Progressive disease|3|||
19558380|NCT01297244|42006765|FG000|Overall Study|Adverse Event|9|||
19558381|NCT01297244|42006766|FG001|Overall Study|Adverse Event|1|||
19558382|NCT01297244|42006765|FG000|Overall Study|Death|1|||
19558383|NCT01297244|42006766|FG001|Overall Study|Death|1|||
19558384|NCT01297244|42006765|FG000|Overall Study|Clinical progression|1|||
19558385|NCT01297244|42006766|FG001|Overall Study|Clinical progression|1|||
19558386|NCT01297244|42006765|FG000|Overall Study|Withdrawal by Subject|2|||
19558387|NCT01297244|42006766|FG001|Overall Study|Withdrawal by Subject|0|||
19558388|NCT03456726|42006779|FG000|Overall Study|Disease Progression|6|||
19558389|NCT03456726|42006780|FG001|Overall Study|Disease Progression|1|||
19558390|NCT03456726|42006779|FG000|Overall Study|Adverse Event|4|||
19558391|NCT03456726|42006780|FG001|Overall Study|Adverse Event|2|||
19558392|NCT03456726|42006779|FG000|Overall Study|Withdrawal by Subject|1|||
19558393|NCT03456726|42006780|FG001|Overall Study|Withdrawal by Subject|0|||
19558394|NCT03456726|42006779|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
19558395|NCT03456726|42006780|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
19558396|NCT03181932|42006788|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
19558397|NCT03181932|42006789|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
19558398|NCT03181932|42006788|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
19558399|NCT03181932|42006789|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
19558400|NCT03181932|42006788|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
19558401|NCT03181932|42006789|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
19558402|NCT03181932|42006788|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
19558403|NCT03181932|42006789|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
19558404|NCT03181932|42006788|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
19558405|NCT03181932|42006789|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
19558406|NCT03181932|42006788|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
19558407|NCT03181932|42006789|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
19558408|NCT03181932|42006788|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
19558409|NCT03181932|42006789|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
19558410|NCT03181932|42006788|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
19558411|NCT03181932|42006789|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
19558412|NCT03181932|42006788|FG000|Period 2 (Open-label Period)|Reason missing|2|||
19558413|NCT03181932|42006789|FG001|Period 2 (Open-label Period)|Reason missing|0|||
19558414|NCT02864862|42006799|FG000|Overall Study|Lost to Follow-up|1|||
19558415|NCT02864862|42006800|FG001|Overall Study|Lost to Follow-up|0|||
19558416|NCT02864862|42006801|FG002|Overall Study|Lost to Follow-up|1|||
19558417|NCT02864862|42006799|FG000|Overall Study|Protocol Violation|0|||
19558418|NCT02864862|42006800|FG001|Overall Study|Protocol Violation|0|||
19558419|NCT02864862|42006801|FG002|Overall Study|Protocol Violation|1|||
19558420|NCT01598298|42006813|FG000|Overall Study|Not eligible|5|||
19558421|NCT01598298|42006814|FG001|Overall Study|Not eligible|5|||
19558422|NCT01598298|42006813|FG000|Overall Study|Adverse Event|21|||
19558423|NCT01598298|42006814|FG001|Overall Study|Adverse Event|19|||
19558424|NCT01598298|42006813|FG000|Overall Study|Progression/relapse|0|||
19558425|NCT01598298|42006814|FG001|Overall Study|Progression/relapse|2|||
19558426|NCT01598298|42006813|FG000|Overall Study|Withdrawal by Subject|10|||
19558427|NCT01598298|42006814|FG001|Overall Study|Withdrawal by Subject|15|||
19558428|NCT01598298|42006813|FG000|Overall Study|Other reason (not protocol specified)|4|||
19558429|NCT01598298|42006814|FG001|Overall Study|Other reason (not protocol specified)|0|||
19558430|NCT01235949|42006838|FG000|Primary Phase|Migrated/moved from study area|1|||
19558431|NCT01235949|42006839|FG001|Primary Phase|Migrated/moved from study area|1|||
19558432|NCT01235949|42006840|FG002|Primary Phase|Migrated/moved from study area|0|||
19558433|NCT01235949|42006841|FG003|Primary Phase|Migrated/moved from study area|0|||
19558434|NCT01235949|42006842|FG004|Primary Phase|Migrated/moved from study area|1|||
19558435|NCT01235949|42006843|FG005|Primary Phase|Migrated/moved from study area|2|||
19558436|NCT01235949|42006844|FG006|Primary Phase|Migrated/moved from study area|0|||
19558437|NCT01235949|42006845|FG007|Primary Phase|Migrated/moved from study area|0|||
19558438|NCT01235949|42006846|FG008|Primary Phase|Migrated/moved from study area|0|||
19558439|NCT01235949|42006847|FG009|Primary Phase|Migrated/moved from study area|0|||
19558440|NCT01235949|42006848|FG010|Primary Phase|Migrated/moved from study area|0|||
19558441|NCT01235949|42006849|FG011|Primary Phase|Migrated/moved from study area|0|||
19558442|NCT01235949|42006850|FG012|Primary Phase|Migrated/moved from study area|0|||
19558443|NCT01235949|42006851|FG013|Primary Phase|Migrated/moved from study area|0|||
19558444|NCT01235949|42006852|FG014|Primary Phase|Migrated/moved from study area|0|||
19558445|NCT01235949|42006853|FG015|Primary Phase|Migrated/moved from study area|0|||
19558446|NCT01235949|42006854|FG016|Primary Phase|Migrated/moved from study area|0|||
19558447|NCT01235949|42006855|FG017|Primary Phase|Migrated/moved from study area|0|||
19558448|NCT01235949|42006838|FG000|Primary Phase|Adverse Event|0|||
19558449|NCT01235949|42006839|FG001|Primary Phase|Adverse Event|0|||
19558450|NCT01235949|42006840|FG002|Primary Phase|Adverse Event|0|||
19558451|NCT01235949|42006841|FG003|Primary Phase|Adverse Event|1|||
19558452|NCT01235949|42006842|FG004|Primary Phase|Adverse Event|0|||
19558453|NCT01235949|42006843|FG005|Primary Phase|Adverse Event|0|||
19558454|NCT01235949|42006844|FG006|Primary Phase|Adverse Event|0|||
19558455|NCT01235949|42006845|FG007|Primary Phase|Adverse Event|0|||
19382074|NCT01376167|41625235|FG000|Overall Study|Withdrawal by Subject|1|||
19382075|NCT01376167|41625236|FG001|Overall Study|Withdrawal by Subject|5|||
19382076|NCT01376167|41625237|FG002|Overall Study|Withdrawal by Subject|4|||
19558456|NCT01235949|42006846|FG008|Primary Phase|Adverse Event|0|||
19558457|NCT01235949|42006847|FG009|Primary Phase|Adverse Event|0|||
19558458|NCT01235949|42006848|FG010|Primary Phase|Adverse Event|0|||
19558459|NCT01235949|42006849|FG011|Primary Phase|Adverse Event|0|||
19558460|NCT01235949|42006850|FG012|Primary Phase|Adverse Event|0|||
19558461|NCT01235949|42006851|FG013|Primary Phase|Adverse Event|0|||
19558462|NCT01235949|42006852|FG014|Primary Phase|Adverse Event|0|||
19558463|NCT01235949|42006853|FG015|Primary Phase|Adverse Event|0|||
19558464|NCT01235949|42006854|FG016|Primary Phase|Adverse Event|0|||
19558465|NCT01235949|42006855|FG017|Primary Phase|Adverse Event|0|||
19558466|NCT01235949|42006838|FG000|Primary Phase|Withdrawal by Subject|3|||
19558467|NCT01235949|42006839|FG001|Primary Phase|Withdrawal by Subject|2|||
19558468|NCT01235949|42006840|FG002|Primary Phase|Withdrawal by Subject|2|||
19558469|NCT01235949|42006841|FG003|Primary Phase|Withdrawal by Subject|0|||
19558470|NCT01235949|42006842|FG004|Primary Phase|Withdrawal by Subject|0|||
19558471|NCT01235949|42006843|FG005|Primary Phase|Withdrawal by Subject|3|||
19558472|NCT01235949|42006844|FG006|Primary Phase|Withdrawal by Subject|0|||
19558473|NCT01235949|42006845|FG007|Primary Phase|Withdrawal by Subject|0|||
19558474|NCT01235949|42006846|FG008|Primary Phase|Withdrawal by Subject|0|||
19739451|NCT03519087|42186522|FG004|Clinic Evaluation|Protocol Violation|0|||
19739452|NCT03519087|42186518|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
19739453|NCT03519087|42186519|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
19739454|NCT03519087|42186520|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
19739455|NCT03519087|42186521|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
19739456|NCT03519087|42186522|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
19739457|NCT03519087|42186518|FG000|Re-randomization for Treatment|Not appropriate|2|||
19739458|NCT03519087|42186519|FG001|Re-randomization for Treatment|Not appropriate|3|||
19739459|NCT03519087|42186520|FG002|Re-randomization for Treatment|Not appropriate|0|||
19739460|NCT03519087|42186521|FG003|Re-randomization for Treatment|Not appropriate|0|||
19558475|NCT01235949|42006847|FG009|Primary Phase|Withdrawal by Subject|0|||
19739461|NCT03519087|42186522|FG004|Re-randomization for Treatment|Not appropriate|0|||
19739462|NCT03519087|42186518|FG000|Laboratory Testing|Lost to Follow-up|0|||
19558476|NCT01235949|42006848|FG010|Primary Phase|Withdrawal by Subject|0|||
19558477|NCT01235949|42006849|FG011|Primary Phase|Withdrawal by Subject|0|||
19558478|NCT01235949|42006850|FG012|Primary Phase|Withdrawal by Subject|0|||
19558479|NCT01235949|42006851|FG013|Primary Phase|Withdrawal by Subject|0|||
19558480|NCT01235949|42006852|FG014|Primary Phase|Withdrawal by Subject|0|||
19558481|NCT01235949|42006853|FG015|Primary Phase|Withdrawal by Subject|0|||
19558482|NCT01235949|42006854|FG016|Primary Phase|Withdrawal by Subject|0|||
19558483|NCT01235949|42006855|FG017|Primary Phase|Withdrawal by Subject|0|||
19558484|NCT01235949|42006838|FG000|Primary Phase|Lost to Follow-up|0|||
19558485|NCT01235949|42006839|FG001|Primary Phase|Lost to Follow-up|0|||
19558486|NCT01235949|42006840|FG002|Primary Phase|Lost to Follow-up|1|||
19558487|NCT01235949|42006841|FG003|Primary Phase|Lost to Follow-up|1|||
19558488|NCT01235949|42006842|FG004|Primary Phase|Lost to Follow-up|0|||
19558489|NCT01235949|42006843|FG005|Primary Phase|Lost to Follow-up|2|||
19558490|NCT01235949|42006844|FG006|Primary Phase|Lost to Follow-up|0|||
19558491|NCT01235949|42006845|FG007|Primary Phase|Lost to Follow-up|0|||
19558492|NCT01235949|42006846|FG008|Primary Phase|Lost to Follow-up|0|||
19558493|NCT01235949|42006847|FG009|Primary Phase|Lost to Follow-up|0|||
19558494|NCT01235949|42006848|FG010|Primary Phase|Lost to Follow-up|0|||
19558495|NCT01235949|42006849|FG011|Primary Phase|Lost to Follow-up|0|||
19558496|NCT01235949|42006850|FG012|Primary Phase|Lost to Follow-up|0|||
19558497|NCT01235949|42006851|FG013|Primary Phase|Lost to Follow-up|0|||
19558498|NCT01235949|42006852|FG014|Primary Phase|Lost to Follow-up|0|||
19558499|NCT01235949|42006853|FG015|Primary Phase|Lost to Follow-up|0|||
19558500|NCT01235949|42006854|FG016|Primary Phase|Lost to Follow-up|0|||
19558501|NCT01235949|42006855|FG017|Primary Phase|Lost to Follow-up|0|||
19558502|NCT01235949|42006838|FG000|Booster Phase|Migrated/moved from study area|0|||
19558503|NCT01235949|42006839|FG001|Booster Phase|Migrated/moved from study area|0|||
19558504|NCT01235949|42006840|FG002|Booster Phase|Migrated/moved from study area|0|||
19558505|NCT01235949|42006841|FG003|Booster Phase|Migrated/moved from study area|0|||
19558506|NCT01235949|42006842|FG004|Booster Phase|Migrated/moved from study area|0|||
19558507|NCT01235949|42006843|FG005|Booster Phase|Migrated/moved from study area|0|||
19558508|NCT01235949|42006844|FG006|Booster Phase|Migrated/moved from study area|0|||
19558509|NCT01235949|42006845|FG007|Booster Phase|Migrated/moved from study area|0|||
19558510|NCT01235949|42006846|FG008|Booster Phase|Migrated/moved from study area|0|||
19558511|NCT01235949|42006847|FG009|Booster Phase|Migrated/moved from study area|0|||
19558512|NCT01235949|42006848|FG010|Booster Phase|Migrated/moved from study area|0|||
19558513|NCT01235949|42006849|FG011|Booster Phase|Migrated/moved from study area|1|||
19558514|NCT01235949|42006850|FG012|Booster Phase|Migrated/moved from study area|1|||
19558515|NCT01235949|42006851|FG013|Booster Phase|Migrated/moved from study area|0|||
19558516|NCT01235949|42006852|FG014|Booster Phase|Migrated/moved from study area|0|||
19382077|NCT02647281|41625257|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19558517|NCT01235949|42006853|FG015|Booster Phase|Migrated/moved from study area|0|||
19558518|NCT01235949|42006854|FG016|Booster Phase|Migrated/moved from study area|0|||
19558519|NCT01235949|42006855|FG017|Booster Phase|Migrated/moved from study area|1|||
19558520|NCT01235949|42006838|FG000|Booster Phase|Adverse Event|0|||
19558521|NCT01235949|42006839|FG001|Booster Phase|Adverse Event|0|||
19558522|NCT01235949|42006840|FG002|Booster Phase|Adverse Event|0|||
19558523|NCT01235949|42006841|FG003|Booster Phase|Adverse Event|0|||
19558524|NCT01235949|42006842|FG004|Booster Phase|Adverse Event|0|||
19558525|NCT01235949|42006843|FG005|Booster Phase|Adverse Event|0|||
19558526|NCT01235949|42006844|FG006|Booster Phase|Adverse Event|0|||
19558527|NCT01235949|42006845|FG007|Booster Phase|Adverse Event|0|||
19558528|NCT01235949|42006846|FG008|Booster Phase|Adverse Event|0|||
19558529|NCT01235949|42006847|FG009|Booster Phase|Adverse Event|0|||
19558530|NCT01235949|42006848|FG010|Booster Phase|Adverse Event|0|||
19558531|NCT01235949|42006849|FG011|Booster Phase|Adverse Event|0|||
19558532|NCT01235949|42006850|FG012|Booster Phase|Adverse Event|0|||
19558533|NCT01235949|42006851|FG013|Booster Phase|Adverse Event|0|||
19558534|NCT01235949|42006852|FG014|Booster Phase|Adverse Event|0|||
19558535|NCT01235949|42006853|FG015|Booster Phase|Adverse Event|1|||
19558536|NCT01235949|42006854|FG016|Booster Phase|Adverse Event|0|||
19558537|NCT01235949|42006855|FG017|Booster Phase|Adverse Event|0|||
19558538|NCT01235949|42006838|FG000|Booster Phase|Withdrawal by Subject|0|||
19558539|NCT01235949|42006839|FG001|Booster Phase|Withdrawal by Subject|0|||
19558540|NCT01235949|42006840|FG002|Booster Phase|Withdrawal by Subject|0|||
19558541|NCT01235949|42006841|FG003|Booster Phase|Withdrawal by Subject|0|||
19558542|NCT01235949|42006842|FG004|Booster Phase|Withdrawal by Subject|0|||
19558543|NCT01235949|42006843|FG005|Booster Phase|Withdrawal by Subject|0|||
19558544|NCT01235949|42006844|FG006|Booster Phase|Withdrawal by Subject|0|||
19558545|NCT01235949|42006845|FG007|Booster Phase|Withdrawal by Subject|1|||
19558546|NCT01235949|42006846|FG008|Booster Phase|Withdrawal by Subject|1|||
19558547|NCT01235949|42006847|FG009|Booster Phase|Withdrawal by Subject|0|||
19558548|NCT01235949|42006848|FG010|Booster Phase|Withdrawal by Subject|1|||
19558549|NCT01235949|42006849|FG011|Booster Phase|Withdrawal by Subject|1|||
19558550|NCT01235949|42006850|FG012|Booster Phase|Withdrawal by Subject|2|||
19558551|NCT01235949|42006851|FG013|Booster Phase|Withdrawal by Subject|0|||
19558552|NCT01235949|42006852|FG014|Booster Phase|Withdrawal by Subject|2|||
19558553|NCT01235949|42006853|FG015|Booster Phase|Withdrawal by Subject|0|||
19558554|NCT01235949|42006854|FG016|Booster Phase|Withdrawal by Subject|0|||
19558555|NCT01235949|42006855|FG017|Booster Phase|Withdrawal by Subject|0|||
19558556|NCT01235949|42006838|FG000|Booster Phase|Lost to Follow-up|0|||
19558557|NCT01235949|42006839|FG001|Booster Phase|Lost to Follow-up|0|||
19558558|NCT01235949|42006840|FG002|Booster Phase|Lost to Follow-up|0|||
19558559|NCT01235949|42006841|FG003|Booster Phase|Lost to Follow-up|0|||
19558560|NCT01235949|42006842|FG004|Booster Phase|Lost to Follow-up|0|||
19558561|NCT01235949|42006843|FG005|Booster Phase|Lost to Follow-up|0|||
19558562|NCT01235949|42006844|FG006|Booster Phase|Lost to Follow-up|0|||
19558563|NCT01235949|42006845|FG007|Booster Phase|Lost to Follow-up|0|||
19558564|NCT01235949|42006846|FG008|Booster Phase|Lost to Follow-up|1|||
19558565|NCT01235949|42006847|FG009|Booster Phase|Lost to Follow-up|1|||
19558566|NCT01235949|42006848|FG010|Booster Phase|Lost to Follow-up|1|||
19558567|NCT01235949|42006849|FG011|Booster Phase|Lost to Follow-up|1|||
19558568|NCT01235949|42006850|FG012|Booster Phase|Lost to Follow-up|0|||
19558569|NCT01235949|42006851|FG013|Booster Phase|Lost to Follow-up|0|||
19558570|NCT01235949|42006852|FG014|Booster Phase|Lost to Follow-up|0|||
19558571|NCT01235949|42006853|FG015|Booster Phase|Lost to Follow-up|0|||
19558572|NCT01235949|42006854|FG016|Booster Phase|Lost to Follow-up|0|||
19558573|NCT01235949|42006855|FG017|Booster Phase|Lost to Follow-up|1|||
19558574|NCT01235793|42006893|FG000|Overall Study|Death|6|||
19558575|NCT01258998|42006898|FG000|Overall Study|Ineligible|1|||
19558576|NCT01235715|42006904|FG000|Overall Study|Physician Decision|0|||
19558577|NCT01235715|42006905|FG001|Overall Study|Physician Decision|2|||
19558578|NCT01235403|42006912|FG000|Overall Study|Adverse Event|14|||
19558579|NCT01235403|42006912|FG000|Overall Study|Lost to Follow-up|2|||
19558580|NCT01235403|42006912|FG000|Overall Study|Withdrawal by Subject|4|||
19558581|NCT01235403|42006912|FG000|Overall Study|Lack of Efficacy|2|||
19558582|NCT01235403|42006912|FG000|Overall Study|Other reasons for premature termination|4|||
19558583|NCT01024036|42006918|FG000|Blinded Treatment|Adverse Event|1|||
19558584|NCT01024036|42006919|FG001|Blinded Treatment|Adverse Event|1|||
19558585|NCT01024036|42006918|FG000|Blinded Treatment|Lack of Efficacy|16|||
19558586|NCT01024036|42006919|FG001|Blinded Treatment|Lack of Efficacy|14|||
19558587|NCT01024036|42006918|FG000|Blinded Treatment|Physician Decision|1|||
19558588|NCT01024036|42006919|FG001|Blinded Treatment|Physician Decision|0|||
19558589|NCT01024036|42006918|FG000|Blinded Treatment|Death|0|||
19558590|NCT01024036|42006919|FG001|Blinded Treatment|Death|2|||
19558591|NCT01024036|42006918|FG000|Blinded Treatment|Withdrawal by Subject|4|||
19558592|NCT01024036|42006919|FG001|Blinded Treatment|Withdrawal by Subject|3|||
19558593|NCT01024036|42006918|FG000|Unblinded Treatment|Adverse Event|0|||
19558594|NCT01024036|42006919|FG001|Unblinded Treatment|Adverse Event|1|||
19558595|NCT01024036|42006918|FG000|Unblinded Treatment|Lack of Efficacy|0|||
19558596|NCT01024036|42006919|FG001|Unblinded Treatment|Lack of Efficacy|2|||
19558597|NCT01024036|42006918|FG000|Follow-Up Period|Lost to Follow-up|1|||
19558598|NCT01024036|42006919|FG001|Follow-Up Period|Lost to Follow-up|1|||
19558599|NCT01024036|42006918|FG000|Follow-Up Period|Withdrawal by Subject|0|||
19558600|NCT01024036|42006919|FG001|Follow-Up Period|Withdrawal by Subject|1|||
19558601|NCT01024036|42006918|FG000|Follow-Up Period|Adverse Event|4|||
19558602|NCT01024036|42006919|FG001|Follow-Up Period|Adverse Event|1|||
19558603|NCT01234467|42006928|FG000|Overall Study|Adverse Event|3|||
19558604|NCT01234467|42006928|FG000|Overall Study|Death|2|||
19558605|NCT01234467|42006928|FG000|Overall Study|Withdrawal by Subject|2|||
19558606|NCT01234467|42006928|FG000|Overall Study|Disease Progression|2|||
19558607|NCT01234467|42006928|FG000|Overall Study|Clinical deterioration|1|||
19558608|NCT01234467|42006928|FG000|Overall Study|Physician Decision|1|||
19558609|NCT01234467|42006928|FG000|Overall Study|Other complicating disease (stroke)|1|||
19558610|NCT01233999|42006932|FG000|Overall Study|Withdrawal by Subject|1|||
19558611|NCT01233999|42006932|FG000|Overall Study|Lost to Follow-up|1|||
19558612|NCT01233687|42006936|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
19558613|NCT01233687|42006936|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
19558614|NCT01233687|42006936|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
19558615|NCT01023958|42006940|FG000|Overall Study|Progressive disease|48|||
19558616|NCT01023958|42006940|FG000|Overall Study|Other adverse event|1|||
19558617|NCT01023958|42006940|FG000|Overall Study|Refused to continue medication|1|||
19558618|NCT01233609|42006946|FG000|Overall Study|Death|1|||
19558619|NCT01233609|42006947|FG001|Overall Study|Death|0|||
19558620|NCT01233609|42006946|FG000|Overall Study|Lost to Follow-up|3|||
19558621|NCT01233609|42006947|FG001|Overall Study|Lost to Follow-up|1|||
19558622|NCT01233609|42006946|FG000|Overall Study|Adverse Event|2|||
19558623|NCT01233609|42006947|FG001|Overall Study|Adverse Event|1|||
19558624|NCT01233609|42006946|FG000|Overall Study|Withdrawal by Subject|3|||
19558625|NCT01233609|42006947|FG001|Overall Study|Withdrawal by Subject|0|||
19558626|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
19558627|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
19558628|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558629|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558630|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558631|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558632|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558633|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558634|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558635|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
19558636|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
19558637|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
19558638|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558639|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558640|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558641|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558642|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558643|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558644|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558645|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19558646|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
19558647|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558648|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558649|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558650|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558651|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558652|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558653|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558654|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558655|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
19558656|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
19558657|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
19558658|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558659|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558660|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558661|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558662|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558663|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558664|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558665|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19558666|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
19558667|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
19558668|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558669|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558670|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558671|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558672|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558673|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558674|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558675|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
19558676|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
19558677|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
19558678|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19382078|NCT02647281|41625258|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19558679|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558680|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558681|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558682|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558683|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558684|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558685|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
19558686|NCT01232283|42006963|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
19558687|NCT01232283|42006964|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
19558688|NCT01232283|42006965|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558689|NCT01232283|42006966|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558690|NCT01232283|42006967|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558691|NCT01232283|42006968|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558692|NCT01232283|42006969|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558693|NCT01232283|42006970|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558694|NCT01232283|42006971|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558695|NCT01232283|42006972|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
19558696|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558697|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558698|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
19558699|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
19558700|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558701|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558702|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558703|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558704|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558705|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
19558706|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558707|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558708|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
19558709|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
19558710|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558711|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558712|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558713|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558714|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558715|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
19558716|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558717|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558718|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
19558719|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558720|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558721|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558722|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558723|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558724|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19558725|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
19390367|NCT01987960|41634111|FG001|Period 3|Protocol Violation|0|||
19558726|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558727|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558728|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
19558729|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
19558730|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558731|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558732|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558733|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558734|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558735|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
19558736|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558737|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558738|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
19558739|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
19558740|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558741|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558742|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558743|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558744|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558745|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
19558746|NCT01232283|42006963|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
19558747|NCT01232283|42006964|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
19558748|NCT01232283|42006965|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
19558749|NCT01232283|42006966|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
19558750|NCT01232283|42006967|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
19558751|NCT01232283|42006968|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
19558752|NCT01232283|42006969|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
19558753|NCT01232283|42006970|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
19558754|NCT01232283|42006971|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
19558755|NCT01232283|42006972|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
19558756|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558757|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558758|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558759|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558760|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
19558761|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
19558762|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558763|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
19558764|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558765|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
19558766|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558767|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558768|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558769|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558770|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
19558771|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558772|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
19558773|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
19558774|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558775|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
19558776|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558777|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558778|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558779|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558780|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
19558781|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
19558782|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
19558783|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
19558784|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558785|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
19558786|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558787|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558788|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558789|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558790|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
19558791|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558792|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558793|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558794|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558795|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
19558796|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558797|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558798|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558799|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558800|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
19558801|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558802|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
19558803|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
19558804|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558805|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
19558806|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558807|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558808|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558809|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558810|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558811|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558812|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558813|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
19558814|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558815|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
19558816|NCT01232283|42006963|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558817|NCT01232283|42006964|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558818|NCT01232283|42006965|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558819|NCT01232283|42006966|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558820|NCT01232283|42006967|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558821|NCT01232283|42006968|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
19558822|NCT01232283|42006969|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558823|NCT01232283|42006970|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558824|NCT01232283|42006971|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558825|NCT01232283|42006972|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
19558826|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558827|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558828|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558829|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558830|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558831|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558832|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558833|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
19558834|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
19558835|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
19558836|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558837|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558838|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558839|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558840|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558841|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558842|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19390368|NCT01987960|41634112|FG002|Period 3|Protocol Violation|0|||
19558843|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
19558844|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
19558845|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
19558846|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558847|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558848|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558849|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558850|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558851|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558852|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558853|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
19558854|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
19558855|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
19558856|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558857|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558858|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558859|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558860|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558861|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558862|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558863|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
19558864|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
19558865|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
19558866|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558867|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558868|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558869|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558870|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558871|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558872|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558873|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
19558874|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
19382079|NCT02647281|41625259|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19558875|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
19558876|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558877|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558878|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558879|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558880|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558881|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558882|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558883|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558884|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
19558885|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
19558886|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558887|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558888|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558889|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558890|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558891|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558892|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558893|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558894|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
19558895|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
19558896|NCT01232283|42006963|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558897|NCT01232283|42006964|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558898|NCT01232283|42006965|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558899|NCT01232283|42006966|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558900|NCT01232283|42006967|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558901|NCT01232283|42006968|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558902|NCT01232283|42006969|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558903|NCT01232283|42006970|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
19558904|NCT01232283|42006971|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
19558905|NCT01232283|42006972|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
19558906|NCT01232127|42006994|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
19558907|NCT01232127|42006995|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
19558908|NCT01232127|42006996|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
19558909|NCT01258608|42007010|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
19558910|NCT01258608|42007011|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
19558911|NCT01258608|42007010|FG000|Overall Study|Clinical progression|1|||
19558912|NCT01258608|42007011|FG001|Overall Study|Clinical progression|0|||
19558913|NCT01258608|42007010|FG000|Overall Study|Sponsor decision|0|||
19558914|NCT01258608|42007011|FG001|Overall Study|Sponsor decision|1|||
19558915|NCT01258608|42007010|FG000|Overall Study|Physician Decision|6|||
19558916|NCT01258608|42007011|FG001|Overall Study|Physician Decision|1|||
19558917|NCT01258608|42007010|FG000|Overall Study|Lost to Follow-up|0|||
19558918|NCT01258608|42007011|FG001|Overall Study|Lost to Follow-up|1|||
19558919|NCT01258608|42007010|FG000|Overall Study|Lack of compliance|1|||
19558920|NCT01258608|42007011|FG001|Overall Study|Lack of compliance|0|||
19558921|NCT01258608|42007010|FG000|Overall Study|Lack of Efficacy|0|||
19558922|NCT01258608|42007011|FG001|Overall Study|Lack of Efficacy|1|||
19558923|NCT01258608|42007010|FG000|Overall Study|Adverse Event|6|||
19558924|NCT01258608|42007011|FG001|Overall Study|Adverse Event|10|||
19558925|NCT01258608|42007010|FG000|Overall Study|Withdrawal by Subject|6|||
19558926|NCT01258608|42007011|FG001|Overall Study|Withdrawal by Subject|5|||
19558927|NCT01015612|42007018|FG000|Overall Study|Death|113|||
19558928|NCT01015612|42007018|FG000|Overall Study|Withdrawal by Subject|40|||
19558929|NCT01231659|42007022|FG000|Overall Study|Adverse Event|9|||
19558930|NCT01231659|42007022|FG000|Overall Study|Disease Progression|48|||
19558931|NCT01231659|42007022|FG000|Overall Study|Death|2|||
19558932|NCT01231659|42007022|FG000|Overall Study|Patient refused to complete study visit|1|||
19558933|NCT01231659|42007022|FG000|Overall Study|Other protocol defined criteria|12|||
19558934|NCT01054222|42007026|FG000|Overall Study|Lack of Efficacy|1|||
19558935|NCT01054222|42007026|FG000|Overall Study|Lost to Follow-up|4|||
19382080|NCT02647281|41625260|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19558936|NCT01054222|42007026|FG000|Overall Study|Withdrawal by Subject|6|||
19558937|NCT01052428|42007032|FG000|Overall Study|Death|1|||
19558938|NCT01052428|42007033|FG001|Overall Study|Death|0|||
19558939|NCT01052428|42007032|FG000|Overall Study|Withdrawal by Subject|0|||
19558940|NCT01052428|42007033|FG001|Overall Study|Withdrawal by Subject|1|||
19558941|NCT01052272|42007043|FG000|Overall Study|Death|0|||
19558942|NCT01052272|42007044|FG001|Overall Study|Death|0|||
19558943|NCT01052272|42007045|FG002|Overall Study|Death|1|||
19558944|NCT01052272|42007046|FG003|Overall Study|Death|1|||
19558945|NCT01052272|42007043|FG000|Overall Study|Physician Decision|0|||
19558946|NCT01052272|42007044|FG001|Overall Study|Physician Decision|1|||
19558947|NCT01052272|42007045|FG002|Overall Study|Physician Decision|0|||
19558948|NCT01052272|42007046|FG003|Overall Study|Physician Decision|0|||
19558949|NCT01052272|42007043|FG000|Overall Study|patient refuses follow-up|5|||
19558950|NCT01052272|42007044|FG001|Overall Study|patient refuses follow-up|4|||
19558951|NCT01052272|42007045|FG002|Overall Study|patient refuses follow-up|2|||
19558952|NCT01052272|42007046|FG003|Overall Study|patient refuses follow-up|4|||
19558953|NCT01052272|42007043|FG000|Overall Study|Withdrawal by Subject|0|||
19558954|NCT01052272|42007044|FG001|Overall Study|Withdrawal by Subject|2|||
19558955|NCT01052272|42007045|FG002|Overall Study|Withdrawal by Subject|3|||
19558956|NCT01052272|42007046|FG003|Overall Study|Withdrawal by Subject|2|||
19558957|NCT01052272|42007043|FG000|Overall Study|placed in long-term care|0|||
19558958|NCT01052272|42007044|FG001|Overall Study|placed in long-term care|0|||
19558959|NCT01052272|42007045|FG002|Overall Study|placed in long-term care|1|||
19558960|NCT01052272|42007046|FG003|Overall Study|placed in long-term care|0|||
19558961|NCT01052272|42007043|FG000|Overall Study|decline in health|0|||
19558962|NCT01052272|42007044|FG001|Overall Study|decline in health|0|||
19558963|NCT01052272|42007045|FG002|Overall Study|decline in health|1|||
19558964|NCT01052272|42007046|FG003|Overall Study|decline in health|0|||
19558965|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
19558966|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
19558967|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
19558968|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
19558969|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
19558970|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
19558971|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
19558972|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
19558973|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
19558974|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
19558975|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
19558976|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
19558977|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
19558978|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
19558979|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
19558980|NCT01257204|42007059|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
19558981|NCT01257204|42007060|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
19558982|NCT01257204|42007061|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
19558983|NCT01257204|42007059|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
19558984|NCT01257204|42007060|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
19558985|NCT01257204|42007061|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
19558986|NCT01257204|42007059|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
19558987|NCT01257204|42007060|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
19558988|NCT01257204|42007061|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
19558989|NCT01257204|42007059|FG000|Follow-up Period (up to Week 48)|Other|0|||
19558990|NCT01257204|42007060|FG001|Follow-up Period (up to Week 48)|Other|0|||
19558991|NCT01257204|42007061|FG002|Follow-up Period (up to Week 48)|Other|5|||
19558992|NCT01231581|42007083|FG000|Overall Study|Lost to Follow-up|2|||
19558993|NCT01231581|42007084|FG001|Overall Study|Lost to Follow-up|2|||
19558994|NCT01231581|42007083|FG000|Overall Study|Withdrawal by Subject|6|||
19558995|NCT01231581|42007084|FG001|Overall Study|Withdrawal by Subject|9|||
19558996|NCT01231581|42007083|FG000|Overall Study|Study Closed/Terminated|6|||
19558997|NCT01231581|42007084|FG001|Overall Study|Study Closed/Terminated|5|||
19558998|NCT01231581|42007083|FG000|Overall Study|Death|65|||
19558999|NCT01231581|42007084|FG001|Overall Study|Death|64|||
19559000|NCT01231581|42007083|FG000|Overall Study|Ongoing|1|||
19559001|NCT01231581|42007084|FG001|Overall Study|Ongoing|0|||
19559002|NCT01050634|42007090|FG000|Overall Study|Enrolled, but Not Treated|56|||
19559003|NCT01050634|42007090|FG000|Overall Study|Death|2|||
19559004|NCT01050634|42007090|FG000|Overall Study|Adverse Event|42|||
19559005|NCT01050634|42007090|FG000|Overall Study|Lost to Follow-up|2|||
19559006|NCT01050634|42007090|FG000|Overall Study|Other|21|||
19559007|NCT01050634|42007090|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
19559008|NCT01020526|42007094|FG000|Overall Study|Withdrawal by Subject|5|||
19559009|NCT01020526|42007094|FG000|Overall Study|Other reasons|3|||
19559010|NCT01020526|42007094|FG000|Overall Study|Insufficient clinical response|3|||
19559011|NCT01020526|42007094|FG000|Overall Study|Lost to Follow-up|1|||
19559012|NCT01020526|42007094|FG000|Overall Study|Adverse Event|2|||
19559013|NCT01020448|42007098|FG000|Pre-assignment|Adverse Event|6|||
19559014|NCT01020448|42007098|FG000|Pre-assignment|Withdrawal by Subject|5|||
19559015|NCT01020448|42007098|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
19559016|NCT01020448|42007098|FG000|Treatment|Adverse Event|11|||
19559017|NCT01020448|42007098|FG000|Treatment|Consent Withdrawn|3|||
19559018|NCT01020448|42007098|FG000|Treatment|Disease Progression|2|||
19559019|NCT01020448|42007098|FG000|Treatment|Lack of Efficacy|8|||
19559020|NCT01020448|42007098|FG000|Treatment|Lost to Follow-up|2|||
19559021|NCT01256658|42007105|FG000|Period 1|Lost to Follow-up|837|||
19559022|NCT01256658|42007106|FG001|Period 1|Lost to Follow-up|661|||
19559023|NCT01256658|42007105|FG000|Period 1|Withdrawal by Subject|35|||
19559024|NCT01256658|42007106|FG001|Period 1|Withdrawal by Subject|43|||
19559025|NCT01256658|42007105|FG000|Period 1|Death|48|||
19559026|NCT01256658|42007106|FG001|Period 1|Death|44|||
19559027|NCT01256502|42007115|FG000|Overall Study|Had scaffold removed|4|||
19559028|NCT01256502|42007115|FG000|Overall Study|Personal reasons|5|||
19559029|NCT01256502|42007115|FG000|Overall Study|Protocol deviation|1|||
19559030|NCT01256190|42007126|FG000|Overall Study|Lost to Follow-up|2|||
19559031|NCT01256190|42007127|FG001|Overall Study|Lost to Follow-up|0|||
19559032|NCT01255722|42007136|FG000|Overall Study|Adverse Event|0|||
19559033|NCT01255722|42007137|FG001|Overall Study|Adverse Event|1|||
19559034|NCT01255722|42007138|FG002|Overall Study|Adverse Event|1|||
19559035|NCT01255722|42007136|FG000|Overall Study|asymptomatic patient|1|||
19559036|NCT01255722|42007137|FG001|Overall Study|asymptomatic patient|0|||
19559037|NCT01255722|42007138|FG002|Overall Study|asymptomatic patient|0|||
19559038|NCT01255722|42007136|FG000|Overall Study|beta-blocker contraindicated|2|||
19559039|NCT01255722|42007137|FG001|Overall Study|beta-blocker contraindicated|0|||
19559040|NCT01255722|42007138|FG002|Overall Study|beta-blocker contraindicated|0|||
19559041|NCT01231503|42007155|FG000|Overall Study|Adverse Event|0|||
19559042|NCT01231503|42007156|FG001|Overall Study|Adverse Event|0|||
19559043|NCT01231503|42007157|FG002|Overall Study|Adverse Event|0|||
19559044|NCT01231503|42007158|FG003|Overall Study|Adverse Event|0|||
19559045|NCT01231503|42007159|FG004|Overall Study|Adverse Event|0|||
19559046|NCT01231503|42007160|FG005|Overall Study|Adverse Event|1|||
19559047|NCT01231503|42007161|FG006|Overall Study|Adverse Event|0|||
19559048|NCT01231503|42007162|FG007|Overall Study|Adverse Event|0|||
19559049|NCT01231503|42007155|FG000|Overall Study|Adverse event, serious fatal|0|||
19559050|NCT01231503|42007156|FG001|Overall Study|Adverse event, serious fatal|0|||
19559051|NCT01231503|42007157|FG002|Overall Study|Adverse event, serious fatal|1|||
19559052|NCT01231503|42007158|FG003|Overall Study|Adverse event, serious fatal|1|||
19559053|NCT01231503|42007159|FG004|Overall Study|Adverse event, serious fatal|0|||
19559054|NCT01231503|42007160|FG005|Overall Study|Adverse event, serious fatal|1|||
19559055|NCT01231503|42007161|FG006|Overall Study|Adverse event, serious fatal|0|||
19559056|NCT01231503|42007162|FG007|Overall Study|Adverse event, serious fatal|0|||
19559057|NCT01231503|42007155|FG000|Overall Study|Withdrawal by Subject|6|||
19559058|NCT01231503|42007156|FG001|Overall Study|Withdrawal by Subject|3|||
19559059|NCT01231503|42007157|FG002|Overall Study|Withdrawal by Subject|3|||
19559060|NCT01231503|42007158|FG003|Overall Study|Withdrawal by Subject|1|||
19559061|NCT01231503|42007159|FG004|Overall Study|Withdrawal by Subject|3|||
19559062|NCT01231503|42007160|FG005|Overall Study|Withdrawal by Subject|5|||
19559063|NCT01231503|42007161|FG006|Overall Study|Withdrawal by Subject|1|||
19559064|NCT01231503|42007162|FG007|Overall Study|Withdrawal by Subject|2|||
19559065|NCT01231503|42007155|FG000|Overall Study|Lost to Follow-up|8|||
19559066|NCT01231503|42007156|FG001|Overall Study|Lost to Follow-up|10|||
19559067|NCT01231503|42007157|FG002|Overall Study|Lost to Follow-up|8|||
19559068|NCT01231503|42007158|FG003|Overall Study|Lost to Follow-up|5|||
19559069|NCT01231503|42007159|FG004|Overall Study|Lost to Follow-up|7|||
19559070|NCT01231503|42007160|FG005|Overall Study|Lost to Follow-up|9|||
19559071|NCT01231503|42007161|FG006|Overall Study|Lost to Follow-up|6|||
19559072|NCT01231503|42007162|FG007|Overall Study|Lost to Follow-up|6|||
19559073|NCT01231503|42007155|FG000|Overall Study|Protocol Violation|0|||
19559074|NCT01231503|42007156|FG001|Overall Study|Protocol Violation|0|||
19559075|NCT01231503|42007157|FG002|Overall Study|Protocol Violation|0|||
19559076|NCT01231503|42007158|FG003|Overall Study|Protocol Violation|1|||
19559077|NCT01231503|42007159|FG004|Overall Study|Protocol Violation|0|||
19559078|NCT01231503|42007160|FG005|Overall Study|Protocol Violation|0|||
19559079|NCT01231503|42007161|FG006|Overall Study|Protocol Violation|0|||
19559080|NCT01231503|42007162|FG007|Overall Study|Protocol Violation|0|||
19559081|NCT01230489|42007190|FG000|Overall Study|Death|2|||
19559082|NCT01230489|42007190|FG000|Overall Study|Adverse Event|2|||
19559083|NCT01230489|42007190|FG000|Overall Study|Treatment modality changed|1|||
19559084|NCT01229397|42007196|FG000|Overall Study|Withdrawal by Subject|3|||
19559085|NCT01229397|42007197|FG001|Overall Study|Withdrawal by Subject|3|||
19559086|NCT01229397|42007196|FG000|Overall Study|Lost to Follow-up|7|||
19559087|NCT01229397|42007197|FG001|Overall Study|Lost to Follow-up|6|||
19559088|NCT01229397|42007196|FG000|Overall Study|Migrated/moved from study area|1|||
19559089|NCT01229397|42007197|FG001|Overall Study|Migrated/moved from study area|0|||
19559090|NCT01228071|42007207|FG000|Overall Study|Protocol Violation|1|||
19559091|NCT01228071|42007207|FG000|Overall Study|Withdrawal by Subject|1|||
19559092|NCT01008475|42007218|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
19559093|NCT01008475|42007219|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
19559094|NCT01008475|42007220|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
19559095|NCT01008475|42007221|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
19559096|NCT01008475|42007222|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
19559097|NCT01008475|42007223|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
19559098|NCT01008475|42007224|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
19559099|NCT01226745|42007246|FG000|Overall Study|Did not complete schedule of assessments|8|||
19559100|NCT01226745|42007247|FG001|Overall Study|Did not complete schedule of assessments|3|||
19559101|NCT01226745|42007248|FG002|Overall Study|Did not complete schedule of assessments|6|||
19559102|NCT01226745|42007249|FG003|Overall Study|Did not complete schedule of assessments|0|||
19559103|NCT01226745|42007250|FG004|Overall Study|Did not complete schedule of assessments|0|||
19559104|NCT01226745|42007251|FG005|Overall Study|Did not complete schedule of assessments|1|||
19559105|NCT01226745|42007246|FG000|Overall Study|Lost to Follow-up|2|||
19559106|NCT01226745|42007247|FG001|Overall Study|Lost to Follow-up|6|||
19559107|NCT01226745|42007248|FG002|Overall Study|Lost to Follow-up|6|||
19559108|NCT01226745|42007249|FG003|Overall Study|Lost to Follow-up|1|||
19559109|NCT01226745|42007250|FG004|Overall Study|Lost to Follow-up|1|||
19559110|NCT01226745|42007251|FG005|Overall Study|Lost to Follow-up|2|||
19559111|NCT01226745|42007246|FG000|Overall Study|Death|1|||
19559112|NCT01226745|42007247|FG001|Overall Study|Death|0|||
19559113|NCT01226745|42007248|FG002|Overall Study|Death|0|||
19559114|NCT01226745|42007249|FG003|Overall Study|Death|0|||
19559115|NCT01226745|42007250|FG004|Overall Study|Death|0|||
19559116|NCT01226745|42007251|FG005|Overall Study|Death|1|||
19559117|NCT01226745|42007246|FG000|Overall Study|Other|6|||
19559118|NCT01226745|42007247|FG001|Overall Study|Other|7|||
19559119|NCT01226745|42007248|FG002|Overall Study|Other|8|||
19559120|NCT01226745|42007249|FG003|Overall Study|Other|4|||
19559121|NCT01226745|42007250|FG004|Overall Study|Other|3|||
19559122|NCT01226745|42007251|FG005|Overall Study|Other|1|||
19559123|NCT01226511|42007268|FG000|Acute Treatment Period|Adverse Event|7|||
19559124|NCT01226511|42007269|FG001|Acute Treatment Period|Adverse Event|6|||
19559125|NCT01226511|42007268|FG000|Acute Treatment Period|Lack of Efficacy|2|||
19559126|NCT01226511|42007269|FG001|Acute Treatment Period|Lack of Efficacy|1|||
19559127|NCT01226511|42007268|FG000|Acute Treatment Period|Lost to Follow-up|3|||
19559128|NCT01226511|42007269|FG001|Acute Treatment Period|Lost to Follow-up|6|||
19559129|NCT01226511|42007268|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
19559130|NCT01226511|42007269|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
19559131|NCT01226511|42007268|FG000|Acute Treatment Period|Protocol Violation|5|||
19559132|NCT01226511|42007269|FG001|Acute Treatment Period|Protocol Violation|5|||
19559133|NCT01226511|42007268|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
19559134|NCT01226511|42007269|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
19559135|NCT01226511|42007268|FG000|Extension Treatment Period|Adverse Event|8|||
19559136|NCT01226511|42007269|FG001|Extension Treatment Period|Adverse Event|8|||
19559137|NCT01226511|42007268|FG000|Extension Treatment Period|Lack of Efficacy|3|||
19559138|NCT01226511|42007269|FG001|Extension Treatment Period|Lack of Efficacy|2|||
19559139|NCT01226511|42007268|FG000|Extension Treatment Period|Lost to Follow-up|4|||
19559140|NCT01226511|42007269|FG001|Extension Treatment Period|Lost to Follow-up|3|||
19559141|NCT01226511|42007268|FG000|Extension Treatment Period|Protocol Violation|2|||
19559142|NCT01226511|42007269|FG001|Extension Treatment Period|Protocol Violation|2|||
19559143|NCT01226511|42007268|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
19559144|NCT01226511|42007269|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
19559145|NCT01226511|42007268|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
19559146|NCT01226511|42007269|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
19559147|NCT01226511|42007268|FG000|Extension Treatment Period|Sponsor Decision|1|||
19559148|NCT01226511|42007269|FG001|Extension Treatment Period|Sponsor Decision|1|||
19559149|NCT01226511|42007268|FG000|Taper Period|Adverse Event|1|||
19559150|NCT01226511|42007269|FG001|Taper Period|Adverse Event|0|||
19559151|NCT01226511|42007268|FG000|Taper Period|Lost to Follow-up|2|||
19559152|NCT01226511|42007269|FG001|Taper Period|Lost to Follow-up|2|||
19559153|NCT01226511|42007268|FG000|Taper Period|Protocol Violation|1|||
19559154|NCT01226511|42007269|FG001|Taper Period|Protocol Violation|0|||
19559155|NCT01226511|42007268|FG000|Taper Period|Parent/Caregiver Decision|1|||
19559156|NCT01226511|42007269|FG001|Taper Period|Parent/Caregiver Decision|1|||
19559157|NCT01226121|42007284|FG000|Overall Study|Lost to Follow-up|2|||
19559158|NCT01226121|42007285|FG001|Overall Study|Lost to Follow-up|0|||
19559159|NCT01226121|42007286|FG002|Overall Study|Lost to Follow-up|1|||
19559160|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
19559161|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
19559162|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
19559163|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
19559164|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
19559165|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
19559166|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
19559167|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
19559168|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
19559169|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
19559170|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
19559171|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
19559172|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
19559173|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
19559174|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
19559175|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
19559176|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
19559177|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
19559178|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
19559179|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
19559180|NCT01226043|42007296|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
19559181|NCT01226043|42007297|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
19559182|NCT01226043|42007298|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
19559183|NCT01226043|42007299|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
19559184|NCT01226043|42007296|FG000|6-week Re-randomization Phase|Adverse Event|0|||
19559185|NCT01226043|42007297|FG001|6-week Re-randomization Phase|Adverse Event|0|||
19559186|NCT01226043|42007298|FG002|6-week Re-randomization Phase|Adverse Event|1|||
19559187|NCT01226043|42007299|FG003|6-week Re-randomization Phase|Adverse Event|1|||
19559188|NCT01226043|42007296|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
19559189|NCT01226043|42007297|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
19559190|NCT01226043|42007298|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
19559191|NCT01226043|42007299|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
19559192|NCT01226043|42007296|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
19559193|NCT01226043|42007297|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
19559194|NCT01226043|42007298|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
19559195|NCT01226043|42007299|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
19559196|NCT01226043|42007296|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
19559197|NCT01226043|42007297|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
19559198|NCT01226043|42007298|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
19559199|NCT01226043|42007299|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
19559200|NCT01226043|42007296|FG000|6-week Re-randomization Phase|Physician Decision|0|||
19559201|NCT01226043|42007297|FG001|6-week Re-randomization Phase|Physician Decision|0|||
19559202|NCT01226043|42007298|FG002|6-week Re-randomization Phase|Physician Decision|3|||
19559203|NCT01226043|42007299|FG003|6-week Re-randomization Phase|Physician Decision|2|||
19559204|NCT01226043|42007296|FG000|6-week Re-randomization Phase|completed in error|0|||
19559205|NCT01226043|42007297|FG001|6-week Re-randomization Phase|completed in error|0|||
19559206|NCT01226043|42007298|FG002|6-week Re-randomization Phase|completed in error|0|||
19559207|NCT01226043|42007299|FG003|6-week Re-randomization Phase|completed in error|1|||
19559208|NCT01226043|42007296|FG000|30-week Observational Phase|Adverse Event|0|||
19559209|NCT01226043|42007297|FG001|30-week Observational Phase|Adverse Event|0|||
19559210|NCT01226043|42007298|FG002|30-week Observational Phase|Adverse Event|1|||
19559211|NCT01226043|42007299|FG003|30-week Observational Phase|Adverse Event|1|||
19559212|NCT01226043|42007296|FG000|30-week Observational Phase|Protocol Violation|0|||
19559213|NCT01226043|42007297|FG001|30-week Observational Phase|Protocol Violation|0|||
19559214|NCT01226043|42007298|FG002|30-week Observational Phase|Protocol Violation|0|||
19559215|NCT01226043|42007299|FG003|30-week Observational Phase|Protocol Violation|1|||
19559216|NCT01226043|42007296|FG000|30-week Observational Phase|Lost to Follow-up|0|||
19559217|NCT01226043|42007297|FG001|30-week Observational Phase|Lost to Follow-up|0|||
19559218|NCT01226043|42007298|FG002|30-week Observational Phase|Lost to Follow-up|2|||
19559219|NCT01226043|42007299|FG003|30-week Observational Phase|Lost to Follow-up|2|||
19559220|NCT01226043|42007296|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
19559221|NCT01226043|42007297|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
19559222|NCT01226043|42007298|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
19559223|NCT01226043|42007299|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
19559224|NCT01226043|42007296|FG000|30-week Observational Phase|Physician Decision|0|||
19559225|NCT01226043|42007297|FG001|30-week Observational Phase|Physician Decision|0|||
19559226|NCT01226043|42007298|FG002|30-week Observational Phase|Physician Decision|2|||
19559227|NCT01226043|42007299|FG003|30-week Observational Phase|Physician Decision|2|||
19559228|NCT01001377|42007331|FG000|Overall Study|Ineligibility determined|2|||
19559229|NCT01001377|42007332|FG001|Overall Study|Ineligibility determined|0|||
19559230|NCT01001377|42007331|FG000|Overall Study|Withdrawal by Subject|19|||
19559231|NCT01001377|42007332|FG001|Overall Study|Withdrawal by Subject|20|||
19559232|NCT01001377|42007331|FG000|Overall Study|Lost to Follow-up|14|||
19559233|NCT01001377|42007332|FG001|Overall Study|Lost to Follow-up|17|||
19559234|NCT01001377|42007331|FG000|Overall Study|Death|391|||
19559235|NCT01001377|42007332|FG001|Overall Study|Death|384|||
19559236|NCT01225887|42007338|FG000|Overall Study|Ineligible:required test not done|2|||
19559237|NCT01225887|42007338|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
19559238|NCT01225887|42007338|FG000|Overall Study|Ineligible:inadequate pathology|2|||
19559239|NCT01001299|42007342|FG000|Overall Study|Insufficient Therapeutic Response|20|||
19559240|NCT01001299|42007342|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
19559241|NCT01001299|42007342|FG000|Overall Study|Death|1|||
19559242|NCT01001299|42007342|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
19559243|NCT01001299|42007342|FG000|Overall Study|Withdrew Consent|1|||
19559244|NCT01296932|42007355|FG000|Overall Study|Dose limiting toxicity|0|||
19559245|NCT01296932|42007356|FG001|Overall Study|Dose limiting toxicity|0|||
19559246|NCT01296932|42007357|FG002|Overall Study|Dose limiting toxicity|0|||
19559247|NCT01296932|42007358|FG003|Overall Study|Dose limiting toxicity|0|||
19559248|NCT01296932|42007359|FG004|Overall Study|Dose limiting toxicity|0|||
19559249|NCT01296932|42007360|FG005|Overall Study|Dose limiting toxicity|0|||
19559250|NCT01296932|42007361|FG006|Overall Study|Dose limiting toxicity|1|||
19559251|NCT01296932|42007362|FG007|Overall Study|Dose limiting toxicity|0|||
19559252|NCT01296932|42007363|FG008|Overall Study|Dose limiting toxicity|1|||
19559253|NCT01296932|42007355|FG000|Overall Study|Progressive disease|2|||
19559254|NCT01296932|42007356|FG001|Overall Study|Progressive disease|0|||
19559255|NCT01296932|42007357|FG002|Overall Study|Progressive disease|1|||
19559256|NCT01296932|42007358|FG003|Overall Study|Progressive disease|1|||
19559257|NCT01296932|42007359|FG004|Overall Study|Progressive disease|2|||
19559258|NCT01296932|42007360|FG005|Overall Study|Progressive disease|3|||
19559259|NCT01296932|42007361|FG006|Overall Study|Progressive disease|1|||
19559260|NCT01296932|42007362|FG007|Overall Study|Progressive disease|0|||
19559261|NCT01296932|42007363|FG008|Overall Study|Progressive disease|0|||
19559262|NCT01296932|42007355|FG000|Overall Study|Withdrawal by Subject|0|||
19559263|NCT01296932|42007356|FG001|Overall Study|Withdrawal by Subject|0|||
19559264|NCT01296932|42007357|FG002|Overall Study|Withdrawal by Subject|1|||
19559265|NCT01296932|42007358|FG003|Overall Study|Withdrawal by Subject|1|||
19559266|NCT01296932|42007359|FG004|Overall Study|Withdrawal by Subject|0|||
19559267|NCT01296932|42007360|FG005|Overall Study|Withdrawal by Subject|0|||
19559268|NCT01296932|42007361|FG006|Overall Study|Withdrawal by Subject|3|||
19559269|NCT01296932|42007362|FG007|Overall Study|Withdrawal by Subject|0|||
19559270|NCT01296932|42007363|FG008|Overall Study|Withdrawal by Subject|0|||
19559271|NCT01296932|42007355|FG000|Overall Study|Adverse Event|1|||
19559272|NCT01296932|42007356|FG001|Overall Study|Adverse Event|1|||
19559273|NCT01296932|42007357|FG002|Overall Study|Adverse Event|1|||
19559274|NCT01296932|42007358|FG003|Overall Study|Adverse Event|2|||
19559275|NCT01296932|42007359|FG004|Overall Study|Adverse Event|1|||
19559276|NCT01296932|42007360|FG005|Overall Study|Adverse Event|0|||
19559277|NCT01296932|42007361|FG006|Overall Study|Adverse Event|0|||
19559278|NCT01296932|42007362|FG007|Overall Study|Adverse Event|0|||
19559279|NCT01296932|42007363|FG008|Overall Study|Adverse Event|1|||
19559280|NCT01296932|42007355|FG000|Overall Study|Investigator decision|0|||
19559281|NCT01296932|42007356|FG001|Overall Study|Investigator decision|1|||
19559282|NCT01296932|42007357|FG002|Overall Study|Investigator decision|0|||
19559283|NCT01296932|42007358|FG003|Overall Study|Investigator decision|1|||
19559284|NCT01296932|42007359|FG004|Overall Study|Investigator decision|0|||
19559285|NCT01296932|42007360|FG005|Overall Study|Investigator decision|0|||
19559286|NCT01296932|42007361|FG006|Overall Study|Investigator decision|1|||
19559287|NCT01296932|42007362|FG007|Overall Study|Investigator decision|0|||
19559288|NCT01296932|42007363|FG008|Overall Study|Investigator decision|1|||
19559289|NCT01296932|42007355|FG000|Overall Study|No clinical benefit anymore|0|||
19559290|NCT01296932|42007356|FG001|Overall Study|No clinical benefit anymore|1|||
19559291|NCT01296932|42007357|FG002|Overall Study|No clinical benefit anymore|0|||
19559292|NCT01296932|42007358|FG003|Overall Study|No clinical benefit anymore|0|||
19559293|NCT01296932|42007359|FG004|Overall Study|No clinical benefit anymore|0|||
19559294|NCT01296932|42007360|FG005|Overall Study|No clinical benefit anymore|0|||
19559295|NCT01296932|42007361|FG006|Overall Study|No clinical benefit anymore|0|||
19476773|NCT01522651|41754860|FG002|Overall Study|Reason Not Specified|0|||
19476774|NCT01522651|41754861|FG003|Overall Study|Reason Not Specified|1|||
19476775|NCT01522651|41754862|FG004|Overall Study|Reason Not Specified|0|||
19476776|NCT01522651|41754858|FG000|Overall Study|Participant Non-Compliance|1|||
19476777|NCT01522651|41754859|FG001|Overall Study|Participant Non-Compliance|0|||
19476778|NCT01522651|41754860|FG002|Overall Study|Participant Non-Compliance|0|||
19476779|NCT01522651|41754861|FG003|Overall Study|Participant Non-Compliance|0|||
19559296|NCT01296932|42007362|FG007|Overall Study|No clinical benefit anymore|0|||
19559297|NCT01296932|42007363|FG008|Overall Study|No clinical benefit anymore|0|||
19559298|NCT01296932|42007355|FG000|Overall Study|Physician Decision|0|||
19559299|NCT01296932|42007356|FG001|Overall Study|Physician Decision|0|||
19559300|NCT01296932|42007357|FG002|Overall Study|Physician Decision|1|||
19476780|NCT01522651|41754862|FG004|Overall Study|Participant Non-Compliance|0|||
19559301|NCT01296932|42007358|FG003|Overall Study|Physician Decision|0|||
19559302|NCT01296932|42007359|FG004|Overall Study|Physician Decision|0|||
19559303|NCT01296932|42007360|FG005|Overall Study|Physician Decision|0|||
19559304|NCT01296932|42007361|FG006|Overall Study|Physician Decision|0|||
19559305|NCT01296932|42007362|FG007|Overall Study|Physician Decision|0|||
19559306|NCT01296932|42007363|FG008|Overall Study|Physician Decision|0|||
19559307|NCT01296932|42007355|FG000|Overall Study|IV problems, administration not possible|0|||
19559308|NCT01296932|42007356|FG001|Overall Study|IV problems, administration not possible|0|||
19559309|NCT01296932|42007357|FG002|Overall Study|IV problems, administration not possible|1|||
19559310|NCT01296932|42007358|FG003|Overall Study|IV problems, administration not possible|0|||
19559311|NCT01296932|42007359|FG004|Overall Study|IV problems, administration not possible|0|||
19559312|NCT01296932|42007360|FG005|Overall Study|IV problems, administration not possible|0|||
19559313|NCT01296932|42007361|FG006|Overall Study|IV problems, administration not possible|0|||
19559314|NCT01296932|42007362|FG007|Overall Study|IV problems, administration not possible|0|||
19559315|NCT01296932|42007363|FG008|Overall Study|IV problems, administration not possible|0|||
19559316|NCT01296932|42007355|FG000|Overall Study|per protocol|0|||
19559317|NCT01296932|42007356|FG001|Overall Study|per protocol|0|||
19559318|NCT01296932|42007357|FG002|Overall Study|per protocol|1|||
19559319|NCT01296932|42007358|FG003|Overall Study|per protocol|1|||
19559320|NCT01296932|42007359|FG004|Overall Study|per protocol|0|||
19559321|NCT01296932|42007360|FG005|Overall Study|per protocol|0|||
19559322|NCT01296932|42007361|FG006|Overall Study|per protocol|0|||
19559323|NCT01296932|42007362|FG007|Overall Study|per protocol|0|||
19559324|NCT01296932|42007363|FG008|Overall Study|per protocol|0|||
19559325|NCT01296932|42007355|FG000|Overall Study|Low benefit and too many side effects|0|||
19559326|NCT01296932|42007356|FG001|Overall Study|Low benefit and too many side effects|0|||
19559327|NCT01296932|42007357|FG002|Overall Study|Low benefit and too many side effects|0|||
19559328|NCT01296932|42007358|FG003|Overall Study|Low benefit and too many side effects|0|||
19559329|NCT01296932|42007359|FG004|Overall Study|Low benefit and too many side effects|0|||
19559330|NCT01296932|42007360|FG005|Overall Study|Low benefit and too many side effects|0|||
19559331|NCT01296932|42007361|FG006|Overall Study|Low benefit and too many side effects|0|||
19559332|NCT01296932|42007362|FG007|Overall Study|Low benefit and too many side effects|1|||
19559333|NCT01296932|42007363|FG008|Overall Study|Low benefit and too many side effects|0|||
19559334|NCT01296932|42007355|FG000|Overall Study|No adequate treatment response|0|||
19559335|NCT01296932|42007356|FG001|Overall Study|No adequate treatment response|0|||
19559336|NCT01296932|42007357|FG002|Overall Study|No adequate treatment response|0|||
19559337|NCT01296932|42007358|FG003|Overall Study|No adequate treatment response|0|||
19559338|NCT01296932|42007359|FG004|Overall Study|No adequate treatment response|0|||
19559339|NCT01296932|42007360|FG005|Overall Study|No adequate treatment response|0|||
19559340|NCT01296932|42007361|FG006|Overall Study|No adequate treatment response|0|||
19559341|NCT01296932|42007362|FG007|Overall Study|No adequate treatment response|1|||
19559342|NCT01296932|42007363|FG008|Overall Study|No adequate treatment response|0|||
19559343|NCT01296932|42007355|FG000|Overall Study|Dosage already reduced, AE still present|0|||
19559344|NCT01296932|42007356|FG001|Overall Study|Dosage already reduced, AE still present|0|||
19559345|NCT01296932|42007357|FG002|Overall Study|Dosage already reduced, AE still present|0|||
19559346|NCT01296932|42007358|FG003|Overall Study|Dosage already reduced, AE still present|0|||
19559347|NCT01296932|42007359|FG004|Overall Study|Dosage already reduced, AE still present|0|||
19559348|NCT01296932|42007360|FG005|Overall Study|Dosage already reduced, AE still present|0|||
19559349|NCT01296932|42007361|FG006|Overall Study|Dosage already reduced, AE still present|0|||
19559350|NCT01296932|42007362|FG007|Overall Study|Dosage already reduced, AE still present|0|||
19559351|NCT01296932|42007363|FG008|Overall Study|Dosage already reduced, AE still present|1|||
19559352|NCT01296698|42007386|FG000|Overall Study|Adverse Event|1|||
19559353|NCT01296698|42007387|FG001|Overall Study|Adverse Event|0|||
19559354|NCT01296698|42007386|FG000|Overall Study|Death|1|||
19559355|NCT01296698|42007387|FG001|Overall Study|Death|0|||
19559356|NCT01296698|42007386|FG000|Overall Study|Lost to Follow-up|19|||
19559357|NCT01296698|42007387|FG001|Overall Study|Lost to Follow-up|1|||
19559358|NCT01296698|42007386|FG000|Overall Study|Withdrawal by Subject|12|||
19559359|NCT01296698|42007387|FG001|Overall Study|Withdrawal by Subject|0|||
19559360|NCT01296698|42007386|FG000|Overall Study|Difficulty Contacting Subject|2|||
19559361|NCT01296698|42007387|FG001|Overall Study|Difficulty Contacting Subject|0|||
19390369|NCT01987960|41634113|FG003|Period 3|Protocol Violation|6|||
19559362|NCT01296698|42007386|FG000|Overall Study|Study Terminated by Sponsor|209|||
19559363|NCT01296698|42007387|FG001|Overall Study|Study Terminated by Sponsor|12|||
19559364|NCT01001221|42007397|FG000|Overall Study|Adverse Event|1|||
19559365|NCT01001221|42007398|FG001|Overall Study|Adverse Event|2|||
19559366|NCT01001221|42007399|FG002|Overall Study|Adverse Event|0|||
19559367|NCT01001221|42007400|FG003|Overall Study|Adverse Event|2|||
19559368|NCT01001221|42007401|FG004|Overall Study|Adverse Event|0|||
19559369|NCT01001221|42007397|FG000|Overall Study|Disease progression|3|||
19559370|NCT01001221|42007398|FG001|Overall Study|Disease progression|2|||
19559371|NCT01001221|42007399|FG002|Overall Study|Disease progression|2|||
19559372|NCT01001221|42007400|FG003|Overall Study|Disease progression|4|||
19559373|NCT01001221|42007401|FG004|Overall Study|Disease progression|0|||
19559374|NCT01001221|42007397|FG000|Overall Study|Other|1|||
19559375|NCT01001221|42007398|FG001|Overall Study|Other|1|||
19559376|NCT01001221|42007399|FG002|Overall Study|Other|0|||
19559377|NCT01001221|42007400|FG003|Overall Study|Other|0|||
19559378|NCT01001221|42007401|FG004|Overall Study|Other|0|||
19559379|NCT01001221|42007397|FG000|Overall Study|Not treated; protocol exclusion|0|||
19559380|NCT01001221|42007398|FG001|Overall Study|Not treated; protocol exclusion|0|||
19559381|NCT01001221|42007399|FG002|Overall Study|Not treated; protocol exclusion|1|||
19559382|NCT01001221|42007400|FG003|Overall Study|Not treated; protocol exclusion|0|||
19559383|NCT01001221|42007401|FG004|Overall Study|Not treated; protocol exclusion|0|||
19559384|NCT01296152|42007412|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
19559385|NCT01002547|42007419|FG000|Overall Study|Withdrawal by Subject|4|||
19559386|NCT01002547|42007420|FG001|Overall Study|Withdrawal by Subject|0|||
19559387|NCT01002547|42007421|FG002|Overall Study|Withdrawal by Subject|5|||
19559388|NCT01002547|42007419|FG000|Overall Study|Lost to Follow-up|2|||
19559389|NCT01002547|42007420|FG001|Overall Study|Lost to Follow-up|1|||
19559390|NCT01002547|42007421|FG002|Overall Study|Lost to Follow-up|1|||
19559391|NCT01002547|42007419|FG000|Overall Study|Physician Decision|1|||
19559392|NCT01002547|42007420|FG001|Overall Study|Physician Decision|0|||
19559393|NCT01002547|42007421|FG002|Overall Study|Physician Decision|0|||
19559394|NCT01002547|42007419|FG000|Overall Study|Death|0|||
19559395|NCT01002547|42007420|FG001|Overall Study|Death|2|||
19559396|NCT01002547|42007421|FG002|Overall Study|Death|2|||
19559397|NCT01002547|42007419|FG000|Overall Study|Adverse Event|1|||
19559398|NCT01002547|42007420|FG001|Overall Study|Adverse Event|0|||
19559399|NCT01002547|42007421|FG002|Overall Study|Adverse Event|0|||
19559400|NCT01225731|42007434|FG000|Part 1|Did not meet eligibility criteria|1|||
19559401|NCT01225731|42007435|FG001|Part 1|Did not meet eligibility criteria|0|||
19559402|NCT01225731|42007436|FG002|Part 1|Did not meet eligibility criteria|0|||
19559403|NCT01225731|42007437|FG003|Part 1|Did not meet eligibility criteria|0|||
19559404|NCT01225731|42007438|FG004|Part 1|Did not meet eligibility criteria|1|||
19559405|NCT01225731|42007439|FG005|Part 1|Did not meet eligibility criteria|0|||
19559406|NCT01225731|42007440|FG006|Part 1|Did not meet eligibility criteria|0|||
19559407|NCT01225731|42007441|FG007|Part 1|Did not meet eligibility criteria|0|||
19559408|NCT01225731|42007442|FG008|Part 1|Did not meet eligibility criteria|0|||
19559409|NCT01225731|42007443|FG009|Part 1|Did not meet eligibility criteria|0|||
19559410|NCT01225731|42007444|FG010|Part 1|Did not meet eligibility criteria|0|||
19382081|NCT02647281|41625261|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19382082|NCT02647281|41625262|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19382083|NCT02647281|41625263|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19382084|NCT02647281|41625264|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
19390370|NCT01987960|41634110|FG000|Period 3|Withdrawal by Subject|0|||
19559411|NCT01225731|42007445|FG011|Part 1|Did not meet eligibility criteria|0|||
19559412|NCT01225731|42007446|FG012|Part 1|Did not meet eligibility criteria|0|||
19559413|NCT01225731|42007434|FG000|Part 1|Adverse Event|1|||
19559414|NCT01225731|42007435|FG001|Part 1|Adverse Event|2|||
19559415|NCT01225731|42007436|FG002|Part 1|Adverse Event|1|||
19559416|NCT01225731|42007437|FG003|Part 1|Adverse Event|1|||
19559417|NCT01225731|42007438|FG004|Part 1|Adverse Event|1|||
19559418|NCT01225731|42007439|FG005|Part 1|Adverse Event|0|||
19559419|NCT01225731|42007440|FG006|Part 1|Adverse Event|0|||
19559420|NCT01225731|42007441|FG007|Part 1|Adverse Event|0|||
19559421|NCT01225731|42007442|FG008|Part 1|Adverse Event|0|||
19559422|NCT01225731|42007443|FG009|Part 1|Adverse Event|0|||
19382085|NCT02647281|41625265|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
19382086|NCT02729545|41625296|FG000|Overall Study|Pregnancy|1|||
19382087|NCT02729545|41625297|FG001|Overall Study|Pregnancy|1|||
19382088|NCT02729545|41625296|FG000|Overall Study|Lost to Follow-up|0|||
19382089|NCT02729545|41625297|FG001|Overall Study|Lost to Follow-up|1|||
19382090|NCT02729545|41625296|FG000|Overall Study|Withdrawal by Subject|2|||
19382091|NCT02729545|41625297|FG001|Overall Study|Withdrawal by Subject|3|||
19382092|NCT01376089|41625305|FG000|Overall Study|Patient received no contrast media|3|||
19382093|NCT01376089|41625306|FG001|Overall Study|Patient received no contrast media|4|||
19382094|NCT00706849|41625318|FG000|Treatment Period|Adverse Event|0|||
19382095|NCT00706849|41625319|FG001|Treatment Period|Adverse Event|9|||
19382096|NCT00706849|41625318|FG000|Treatment Period|Other|0|||
19382097|NCT00706849|41625319|FG001|Treatment Period|Other|1|||
19382098|NCT00706849|41625318|FG000|Follow-up Period|Withdrawal by Subject|0|||
19382099|NCT00706849|41625319|FG001|Follow-up Period|Withdrawal by Subject|2|||
19382100|NCT00706849|41625318|FG000|Follow-up Period|Protocol non-compliance|0|||
19382101|NCT00706849|41625319|FG001|Follow-up Period|Protocol non-compliance|1|||
19382102|NCT00707161|41625325|FG000|Overall Study|Physician Decision|6|||
19382103|NCT02130466|41625343|FG000|Overall Study|Death|4|||
19559423|NCT01225731|42007444|FG010|Part 1|Adverse Event|0|||
19559424|NCT01225731|42007445|FG011|Part 1|Adverse Event|0|||
19559425|NCT01225731|42007446|FG012|Part 1|Adverse Event|0|||
19559426|NCT01225731|42007434|FG000|Part 1|Withdrawal by Subject|0|||
19382104|NCT02130466|41625344|FG001|Overall Study|Death|1|||
19382105|NCT02130466|41625345|FG002|Overall Study|Death|1|||
19382106|NCT02130466|41625346|FG003|Overall Study|Death|3|||
19382107|NCT02130466|41625347|FG004|Overall Study|Death|2|||
19382108|NCT02130466|41625348|FG005|Overall Study|Death|30|||
19382109|NCT02130466|41625349|FG006|Overall Study|Death|45|||
19382110|NCT02130466|41625350|FG007|Overall Study|Death|2|||
19382111|NCT02130466|41625351|FG008|Overall Study|Death|3|||
19559427|NCT01225731|42007435|FG001|Part 1|Withdrawal by Subject|3|||
19559428|NCT01225731|42007436|FG002|Part 1|Withdrawal by Subject|0|||
19559429|NCT01225731|42007437|FG003|Part 1|Withdrawal by Subject|0|||
19559430|NCT01225731|42007438|FG004|Part 1|Withdrawal by Subject|4|||
19559431|NCT01225731|42007439|FG005|Part 1|Withdrawal by Subject|0|||
19559432|NCT01225731|42007440|FG006|Part 1|Withdrawal by Subject|0|||
19559433|NCT01225731|42007441|FG007|Part 1|Withdrawal by Subject|0|||
19559434|NCT01225731|42007442|FG008|Part 1|Withdrawal by Subject|0|||
19559435|NCT01225731|42007443|FG009|Part 1|Withdrawal by Subject|0|||
19559436|NCT01225731|42007444|FG010|Part 1|Withdrawal by Subject|0|||
19559437|NCT01225731|42007445|FG011|Part 1|Withdrawal by Subject|0|||
19559438|NCT01225731|42007446|FG012|Part 1|Withdrawal by Subject|0|||
19559439|NCT01225731|42007434|FG000|Part 1|Protocol Violation|0|||
19559440|NCT01225731|42007435|FG001|Part 1|Protocol Violation|0|||
19559441|NCT01225731|42007436|FG002|Part 1|Protocol Violation|0|||
19559442|NCT01225731|42007437|FG003|Part 1|Protocol Violation|1|||
19559443|NCT01225731|42007438|FG004|Part 1|Protocol Violation|0|||
19559444|NCT01225731|42007439|FG005|Part 1|Protocol Violation|0|||
19559445|NCT01225731|42007440|FG006|Part 1|Protocol Violation|0|||
19559446|NCT01225731|42007441|FG007|Part 1|Protocol Violation|0|||
19559447|NCT01225731|42007442|FG008|Part 1|Protocol Violation|0|||
19559448|NCT01225731|42007443|FG009|Part 1|Protocol Violation|0|||
19559449|NCT01225731|42007444|FG010|Part 1|Protocol Violation|0|||
19559450|NCT01225731|42007445|FG011|Part 1|Protocol Violation|0|||
19559451|NCT01225731|42007446|FG012|Part 1|Protocol Violation|0|||
19559452|NCT01225731|42007434|FG000|Part 2|Protocol Violation|0|||
19559453|NCT01225731|42007435|FG001|Part 2|Protocol Violation|0|||
19559454|NCT01225731|42007436|FG002|Part 2|Protocol Violation|0|||
19559455|NCT01225731|42007437|FG003|Part 2|Protocol Violation|0|||
19559456|NCT01225731|42007438|FG004|Part 2|Protocol Violation|0|||
19559457|NCT01225731|42007439|FG005|Part 2|Protocol Violation|1|||
19382112|NCT02130466|41625352|FG009|Overall Study|Death|4|||
19559458|NCT01225731|42007440|FG006|Part 2|Protocol Violation|0|||
19559459|NCT01225731|42007441|FG007|Part 2|Protocol Violation|0|||
19559460|NCT01225731|42007442|FG008|Part 2|Protocol Violation|1|||
19559461|NCT01225731|42007443|FG009|Part 2|Protocol Violation|0|||
19559462|NCT01225731|42007444|FG010|Part 2|Protocol Violation|0|||
19559463|NCT01225731|42007445|FG011|Part 2|Protocol Violation|0|||
19559464|NCT01225731|42007446|FG012|Part 2|Protocol Violation|0|||
19559465|NCT01225731|42007434|FG000|Part 2|Adverse Event|0|||
19559466|NCT01225731|42007435|FG001|Part 2|Adverse Event|0|||
19559467|NCT01225731|42007436|FG002|Part 2|Adverse Event|0|||
19559468|NCT01225731|42007437|FG003|Part 2|Adverse Event|0|||
19559469|NCT01225731|42007438|FG004|Part 2|Adverse Event|0|||
19559470|NCT01225731|42007439|FG005|Part 2|Adverse Event|0|||
19559471|NCT01225731|42007440|FG006|Part 2|Adverse Event|4|||
19559472|NCT01225731|42007441|FG007|Part 2|Adverse Event|4|||
19559473|NCT01225731|42007442|FG008|Part 2|Adverse Event|2|||
19559474|NCT01225731|42007443|FG009|Part 2|Adverse Event|0|||
19559475|NCT01225731|42007444|FG010|Part 2|Adverse Event|0|||
19559476|NCT01225731|42007445|FG011|Part 2|Adverse Event|0|||
19559477|NCT01225731|42007446|FG012|Part 2|Adverse Event|0|||
19559478|NCT01225731|42007434|FG000|Part 2|Lack of Efficacy|0|||
19559479|NCT01225731|42007435|FG001|Part 2|Lack of Efficacy|0|||
19559480|NCT01225731|42007436|FG002|Part 2|Lack of Efficacy|0|||
19559481|NCT01225731|42007437|FG003|Part 2|Lack of Efficacy|0|||
19559482|NCT01225731|42007438|FG004|Part 2|Lack of Efficacy|0|||
19559483|NCT01225731|42007439|FG005|Part 2|Lack of Efficacy|1|||
19559484|NCT01225731|42007440|FG006|Part 2|Lack of Efficacy|0|||
19559485|NCT01225731|42007441|FG007|Part 2|Lack of Efficacy|12|||
19739463|NCT03519087|42186519|FG001|Laboratory Testing|Lost to Follow-up|0|||
19739464|NCT03519087|42186520|FG002|Laboratory Testing|Lost to Follow-up|2|||
19739465|NCT03519087|42186521|FG003|Laboratory Testing|Lost to Follow-up|3|||
19739466|NCT03519087|42186522|FG004|Laboratory Testing|Lost to Follow-up|6|||
19739467|NCT03519087|42186518|FG000|Laboratory Testing|Protocol Violation|0|||
19739468|NCT03519087|42186519|FG001|Laboratory Testing|Protocol Violation|0|||
19739469|NCT03519087|42186520|FG002|Laboratory Testing|Protocol Violation|0|||
19739470|NCT03519087|42186521|FG003|Laboratory Testing|Protocol Violation|1|||
19739471|NCT03519087|42186522|FG004|Laboratory Testing|Protocol Violation|0|||
19739472|NCT02763046|42186541|FG000|Overall Study|Adverse Event|5|||
19739473|NCT02763046|42186542|FG001|Overall Study|Adverse Event|4|||
19739474|NCT02763046|42186543|FG002|Overall Study|Adverse Event|0|||
19739475|NCT02763046|42186541|FG000|Overall Study|Lack of Efficacy|1|||
19739476|NCT02763046|42186542|FG001|Overall Study|Lack of Efficacy|1|||
19739477|NCT02763046|42186543|FG002|Overall Study|Lack of Efficacy|3|||
19739478|NCT02763046|42186541|FG000|Overall Study|Physician Decision|1|||
19739479|NCT02763046|42186542|FG001|Overall Study|Physician Decision|0|||
19739480|NCT02763046|42186543|FG002|Overall Study|Physician Decision|1|||
19739481|NCT02763046|42186541|FG000|Overall Study|Subject/guardian decision|2|||
19739482|NCT02763046|42186542|FG001|Overall Study|Subject/guardian decision|0|||
19739483|NCT02763046|42186543|FG002|Overall Study|Subject/guardian decision|4|||
19739484|NCT03518073|42186560|FG000|Overall Study|Adverse Event|2|||
19739485|NCT03518073|42186561|FG001|Overall Study|Adverse Event|4|||
19739486|NCT03518073|42186562|FG002|Overall Study|Adverse Event|2|||
19739487|NCT03518073|42186560|FG000|Overall Study|Death|2|||
19739488|NCT03518073|42186561|FG001|Overall Study|Death|1|||
19739489|NCT03518073|42186562|FG002|Overall Study|Death|3|||
19739490|NCT03518073|42186560|FG000|Overall Study|Lost to Follow-up|1|||
19739491|NCT03518073|42186561|FG001|Overall Study|Lost to Follow-up|0|||
19739492|NCT03518073|42186562|FG002|Overall Study|Lost to Follow-up|1|||
19739493|NCT03518073|42186560|FG000|Overall Study|Physician Decision|5|||
19739494|NCT03518073|42186561|FG001|Overall Study|Physician Decision|0|||
19739495|NCT03518073|42186562|FG002|Overall Study|Physician Decision|2|||
19739496|NCT03518073|42186560|FG000|Overall Study|Progressive disease|1|||
19739497|NCT03518073|42186561|FG001|Overall Study|Progressive disease|1|||
19739498|NCT03518073|42186562|FG002|Overall Study|Progressive disease|1|||
19739499|NCT03518073|42186560|FG000|Overall Study|Protocol Violation|1|||
19739500|NCT03518073|42186561|FG001|Overall Study|Protocol Violation|0|||
19739501|NCT03518073|42186562|FG002|Overall Study|Protocol Violation|0|||
19739502|NCT03518073|42186560|FG000|Overall Study|Withdrawal by Subject|30|||
19739503|NCT03518073|42186561|FG001|Overall Study|Withdrawal by Subject|34|||
19739504|NCT03518073|42186562|FG002|Overall Study|Withdrawal by Subject|29|||
19382113|NCT02130466|41625353|FG010|Overall Study|Death|5|||
19739505|NCT03518073|42186560|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
19739506|NCT03518073|42186561|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
19739507|NCT03518073|42186562|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
19739508|NCT03518073|42186560|FG000|Overall Study|Covid-19|1|||
19382114|NCT02130466|41625354|FG011|Overall Study|Death|3|||
19559486|NCT01225731|42007442|FG008|Part 2|Lack of Efficacy|3|||
19559487|NCT01225731|42007443|FG009|Part 2|Lack of Efficacy|0|||
19559488|NCT01225731|42007444|FG010|Part 2|Lack of Efficacy|0|||
19559489|NCT01225731|42007445|FG011|Part 2|Lack of Efficacy|0|||
19559490|NCT01225731|42007446|FG012|Part 2|Lack of Efficacy|0|||
19559491|NCT01225731|42007434|FG000|Part 2|Pregnancy|0|||
19559492|NCT01225731|42007435|FG001|Part 2|Pregnancy|0|||
19559493|NCT01225731|42007436|FG002|Part 2|Pregnancy|0|||
19739509|NCT03518073|42186561|FG001|Overall Study|Covid-19|2|||
19739510|NCT03518073|42186562|FG002|Overall Study|Covid-19|1|||
19739511|NCT02759692|42186572|FG000|Period 1|Test article no longer available|1|||
19739512|NCT02759692|42186573|FG001|Period 1|Test article no longer available|1|||
19739513|NCT02759692|42186572|FG000|Period 1|No longer meets eligibility criteria.|1|||
19559494|NCT01225731|42007437|FG003|Part 2|Pregnancy|0|||
19559495|NCT01225731|42007438|FG004|Part 2|Pregnancy|0|||
19559496|NCT01225731|42007439|FG005|Part 2|Pregnancy|0|||
19559497|NCT01225731|42007440|FG006|Part 2|Pregnancy|1|||
19559498|NCT01225731|42007441|FG007|Part 2|Pregnancy|0|||
19559499|NCT01225731|42007442|FG008|Part 2|Pregnancy|1|||
19559500|NCT01225731|42007443|FG009|Part 2|Pregnancy|0|||
19559501|NCT01225731|42007444|FG010|Part 2|Pregnancy|0|||
19559502|NCT01225731|42007445|FG011|Part 2|Pregnancy|0|||
19559503|NCT01225731|42007446|FG012|Part 2|Pregnancy|0|||
19559504|NCT01225731|42007434|FG000|Part 2|Lost to Follow-up|0|||
19559505|NCT01225731|42007435|FG001|Part 2|Lost to Follow-up|0|||
19559506|NCT01225731|42007436|FG002|Part 2|Lost to Follow-up|0|||
19559507|NCT01225731|42007437|FG003|Part 2|Lost to Follow-up|0|||
19559508|NCT01225731|42007438|FG004|Part 2|Lost to Follow-up|0|||
19559509|NCT01225731|42007439|FG005|Part 2|Lost to Follow-up|0|||
19559510|NCT01225731|42007440|FG006|Part 2|Lost to Follow-up|0|||
19559511|NCT01225731|42007441|FG007|Part 2|Lost to Follow-up|3|||
19559512|NCT01225731|42007442|FG008|Part 2|Lost to Follow-up|1|||
19559513|NCT01225731|42007443|FG009|Part 2|Lost to Follow-up|0|||
19559514|NCT01225731|42007444|FG010|Part 2|Lost to Follow-up|0|||
19559515|NCT01225731|42007445|FG011|Part 2|Lost to Follow-up|0|||
19559516|NCT01225731|42007446|FG012|Part 2|Lost to Follow-up|0|||
19559517|NCT01225731|42007434|FG000|Part 2|Physician Decision|0|||
19559518|NCT01225731|42007435|FG001|Part 2|Physician Decision|0|||
19559519|NCT01225731|42007436|FG002|Part 2|Physician Decision|0|||
19559520|NCT01225731|42007437|FG003|Part 2|Physician Decision|0|||
19559521|NCT01225731|42007438|FG004|Part 2|Physician Decision|0|||
19559522|NCT01225731|42007439|FG005|Part 2|Physician Decision|0|||
19559523|NCT01225731|42007440|FG006|Part 2|Physician Decision|0|||
19559524|NCT01225731|42007441|FG007|Part 2|Physician Decision|2|||
19559525|NCT01225731|42007442|FG008|Part 2|Physician Decision|2|||
19559526|NCT01225731|42007443|FG009|Part 2|Physician Decision|0|||
19559527|NCT01225731|42007444|FG010|Part 2|Physician Decision|0|||
19559528|NCT01225731|42007445|FG011|Part 2|Physician Decision|0|||
19559529|NCT01225731|42007446|FG012|Part 2|Physician Decision|0|||
19559530|NCT01225731|42007434|FG000|Part 2|Withdrawal by Subject|0|||
19559531|NCT01225731|42007435|FG001|Part 2|Withdrawal by Subject|0|||
19559532|NCT01225731|42007436|FG002|Part 2|Withdrawal by Subject|0|||
19559533|NCT01225731|42007437|FG003|Part 2|Withdrawal by Subject|0|||
19559534|NCT01225731|42007438|FG004|Part 2|Withdrawal by Subject|0|||
19559535|NCT01225731|42007439|FG005|Part 2|Withdrawal by Subject|1|||
19559536|NCT01225731|42007440|FG006|Part 2|Withdrawal by Subject|3|||
19559537|NCT01225731|42007441|FG007|Part 2|Withdrawal by Subject|4|||
19559538|NCT01225731|42007442|FG008|Part 2|Withdrawal by Subject|1|||
19559539|NCT01225731|42007443|FG009|Part 2|Withdrawal by Subject|0|||
19559540|NCT01225731|42007444|FG010|Part 2|Withdrawal by Subject|0|||
19559541|NCT01225731|42007445|FG011|Part 2|Withdrawal by Subject|0|||
19559542|NCT01225731|42007446|FG012|Part 2|Withdrawal by Subject|0|||
19559543|NCT01225731|42007434|FG000|Part 3|Adverse Event|0|||
19559544|NCT01225731|42007435|FG001|Part 3|Adverse Event|0|||
19559545|NCT01225731|42007436|FG002|Part 3|Adverse Event|0|||
19559546|NCT01225731|42007437|FG003|Part 3|Adverse Event|0|||
19559547|NCT01225731|42007438|FG004|Part 3|Adverse Event|0|||
19559548|NCT01225731|42007439|FG005|Part 3|Adverse Event|0|||
19739514|NCT02759692|42186573|FG001|Period 1|No longer meets eligibility criteria.|0|||
19739515|NCT02759692|42186572|FG000|Period 1|Miss-Randomized|1|||
19739516|NCT02759692|42186573|FG001|Period 1|Miss-Randomized|1|||
19559549|NCT01225731|42007440|FG006|Part 3|Adverse Event|0|||
19559550|NCT01225731|42007441|FG007|Part 3|Adverse Event|0|||
19559551|NCT01225731|42007442|FG008|Part 3|Adverse Event|0|||
19559552|NCT01225731|42007443|FG009|Part 3|Adverse Event|0|||
19559553|NCT01225731|42007444|FG010|Part 3|Adverse Event|1|||
19559554|NCT01225731|42007445|FG011|Part 3|Adverse Event|1|||
19559555|NCT01225731|42007446|FG012|Part 3|Adverse Event|0|||
19559556|NCT01225731|42007434|FG000|Part 3|Lost to Follow-up|0|||
19559557|NCT01225731|42007435|FG001|Part 3|Lost to Follow-up|0|||
19559558|NCT01225731|42007436|FG002|Part 3|Lost to Follow-up|0|||
19559559|NCT01225731|42007437|FG003|Part 3|Lost to Follow-up|0|||
19559560|NCT01225731|42007438|FG004|Part 3|Lost to Follow-up|0|||
19559561|NCT01225731|42007439|FG005|Part 3|Lost to Follow-up|0|||
19559562|NCT01225731|42007440|FG006|Part 3|Lost to Follow-up|0|||
19559563|NCT01225731|42007441|FG007|Part 3|Lost to Follow-up|0|||
19559564|NCT01225731|42007442|FG008|Part 3|Lost to Follow-up|0|||
19559565|NCT01225731|42007443|FG009|Part 3|Lost to Follow-up|0|||
19559566|NCT01225731|42007444|FG010|Part 3|Lost to Follow-up|1|||
19559567|NCT01225731|42007445|FG011|Part 3|Lost to Follow-up|2|||
19559568|NCT01225731|42007446|FG012|Part 3|Lost to Follow-up|1|||
19559569|NCT01225731|42007434|FG000|Part 3|Physician Decision|0|||
19559570|NCT01225731|42007435|FG001|Part 3|Physician Decision|0|||
19559571|NCT01225731|42007436|FG002|Part 3|Physician Decision|0|||
19559572|NCT01225731|42007437|FG003|Part 3|Physician Decision|0|||
19559573|NCT01225731|42007438|FG004|Part 3|Physician Decision|0|||
19559574|NCT01225731|42007439|FG005|Part 3|Physician Decision|0|||
19559575|NCT01225731|42007440|FG006|Part 3|Physician Decision|0|||
19559576|NCT01225731|42007441|FG007|Part 3|Physician Decision|0|||
19559577|NCT01225731|42007442|FG008|Part 3|Physician Decision|0|||
19559578|NCT01225731|42007443|FG009|Part 3|Physician Decision|0|||
19559579|NCT01225731|42007444|FG010|Part 3|Physician Decision|0|||
19559580|NCT01225731|42007445|FG011|Part 3|Physician Decision|1|||
19559581|NCT01225731|42007446|FG012|Part 3|Physician Decision|2|||
19559582|NCT01225731|42007434|FG000|Part 3|Withdrawal by Subject|0|||
19559583|NCT01225731|42007435|FG001|Part 3|Withdrawal by Subject|0|||
19559584|NCT01225731|42007436|FG002|Part 3|Withdrawal by Subject|0|||
19559585|NCT01225731|42007437|FG003|Part 3|Withdrawal by Subject|0|||
19559586|NCT01225731|42007438|FG004|Part 3|Withdrawal by Subject|0|||
19559587|NCT01225731|42007439|FG005|Part 3|Withdrawal by Subject|0|||
19559588|NCT01225731|42007440|FG006|Part 3|Withdrawal by Subject|0|||
19559589|NCT01225731|42007441|FG007|Part 3|Withdrawal by Subject|0|||
19559590|NCT01225731|42007442|FG008|Part 3|Withdrawal by Subject|0|||
19559591|NCT01225731|42007443|FG009|Part 3|Withdrawal by Subject|0|||
19559592|NCT01225731|42007444|FG010|Part 3|Withdrawal by Subject|4|||
19559593|NCT01225731|42007445|FG011|Part 3|Withdrawal by Subject|6|||
19559594|NCT01225731|42007446|FG012|Part 3|Withdrawal by Subject|4|||
19559595|NCT01007149|42007477|FG000|Overall Study|Administrative problems|0|||
19559596|NCT01007149|42007478|FG001|Overall Study|Administrative problems|1|||
19559597|NCT00998335|42007486|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
19559598|NCT00998335|42007487|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
19559599|NCT01294670|42007504|FG000|Overall Study|Not treated|1|||
19559600|NCT01294670|42007505|FG001|Overall Study|Not treated|0|||
19559601|NCT01294670|42007506|FG002|Overall Study|Not treated|0|||
19559602|NCT01294670|42007507|FG003|Overall Study|Not treated|0|||
19559603|NCT01294670|42007508|FG004|Overall Study|Not treated|0|||
19559604|NCT01006603|42007522|FG000|Overall Study|Withdrawal by Subject|17|||
19559605|NCT01006603|42007523|FG001|Overall Study|Withdrawal by Subject|19|||
19559606|NCT01006603|42007522|FG000|Overall Study|Lost to Follow-up|0|||
19559607|NCT01006603|42007523|FG001|Overall Study|Lost to Follow-up|1|||
19559608|NCT01006603|42007522|FG000|Overall Study|Safety reason|1|||
19559609|NCT01006603|42007523|FG001|Overall Study|Safety reason|1|||
19559610|NCT01006603|42007522|FG000|Overall Study|Protocol Violation|1|||
19559611|NCT01006603|42007523|FG001|Overall Study|Protocol Violation|3|||
19559612|NCT01006603|42007522|FG000|Overall Study|Incorrect enrolment|0|||
19559613|NCT01006603|42007523|FG001|Overall Study|Incorrect enrolment|2|||
19559614|NCT01006603|42007522|FG000|Overall Study|Adverse Event|15|||
19559615|NCT01006603|42007523|FG001|Overall Study|Adverse Event|7|||
19559616|NCT01006603|42007522|FG000|Overall Study|Death|1|||
19559617|NCT01006603|42007523|FG001|Overall Study|Death|1|||
19559618|NCT01006603|42007522|FG000|Overall Study|Study specific discontinuation criteria|33|||
19559619|NCT01006603|42007523|FG001|Overall Study|Study specific discontinuation criteria|34|||
19559620|NCT01006603|42007522|FG000|Overall Study|Other|3|||
19559621|NCT01006603|42007523|FG001|Overall Study|Other|7|||
19559622|NCT00997321|42007531|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
19559623|NCT00997321|42007532|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
19559624|NCT01294592|42007546|FG000|Overall Study|Adverse Event|28|||
19559625|NCT01294592|42007547|FG001|Overall Study|Adverse Event|13|||
19559626|NCT01294592|42007546|FG000|Overall Study|Lack of Efficacy|7|||
19559627|NCT01294592|42007547|FG001|Overall Study|Lack of Efficacy|5|||
19559628|NCT01294592|42007546|FG000|Overall Study|Protocol Violation|1|||
19559629|NCT01294592|42007547|FG001|Overall Study|Protocol Violation|7|||
19559630|NCT01294592|42007546|FG000|Overall Study|Lost to Follow-up|7|||
19559631|NCT01294592|42007547|FG001|Overall Study|Lost to Follow-up|9|||
19559632|NCT01294592|42007546|FG000|Overall Study|Physician Decision|6|||
19559633|NCT01294592|42007547|FG001|Overall Study|Physician Decision|11|||
19559634|NCT01294592|42007546|FG000|Overall Study|Withdrawal by Subject|28|||
19559635|NCT01294592|42007547|FG001|Overall Study|Withdrawal by Subject|28|||
19559636|NCT00997243|42007556|FG000|Overall Study|Early termination of study by sponsor|7|||
19559637|NCT01294514|42007560|FG000|Overall Study|Excluded due to Arrhythmia|1|||
19559638|NCT00999661|42007568|FG000|Overall Study|Lost to Follow-up|59|||
19559639|NCT00999661|42007568|FG000|Overall Study|Adverse Event|1|||
19559640|NCT00999661|42007568|FG000|Overall Study|Withdrawal by Subject|1|||
19559641|NCT00999661|42007568|FG000|Overall Study|Not meeting eligibility criteria|9|||
19559642|NCT01294436|42007574|FG000|Overall Study|Adverse Event|10|||
19559643|NCT01294436|42007575|FG001|Overall Study|Adverse Event|17|||
19559644|NCT01294436|42007574|FG000|Overall Study|Withdrawal by Subject|11|||
19559645|NCT01294436|42007575|FG001|Overall Study|Withdrawal by Subject|28|||
19559646|NCT01294436|42007574|FG000|Overall Study|subject no longer meets study criteria|5|||
19559647|NCT01294436|42007575|FG001|Overall Study|subject no longer meets study criteria|20|||
19559648|NCT01294436|42007574|FG000|Overall Study|poor/non-compliance|2|||
19559649|NCT01294436|42007575|FG001|Overall Study|poor/non-compliance|5|||
19559650|NCT00995371|42007583|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
19559651|NCT00995371|42007584|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
19559652|NCT01294358|42007592|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
19559653|NCT01294358|42007593|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
19739517|NCT02759692|42186572|FG000|Period 2|Lost to Follow-up|1|||
19739518|NCT02759692|42186573|FG001|Period 2|Lost to Follow-up|0|||
19739519|NCT02759692|42186572|FG000|Period 2|Test article no longer available|0|||
19739520|NCT02759692|42186573|FG001|Period 2|Test article no longer available|1|||
19739521|NCT03586167|42186581|FG000|Overall Study|Other|1|||
19739522|NCT03586167|42186582|FG001|Overall Study|Other|0|||
19739523|NCT02762578|42186590|FG000|Overall Study|Adverse Event|1|||
19739524|NCT02762578|42186591|FG001|Overall Study|Adverse Event|6|||
19739525|NCT02762578|42186590|FG000|Overall Study|Protocol Violation|4|||
19739526|NCT02762578|42186591|FG001|Overall Study|Protocol Violation|2|||
19739527|NCT02762578|42186590|FG000|Overall Study|Withdrawal by Subject|4|||
19559654|NCT01294358|42007594|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
19559655|NCT01294358|42007595|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
19559656|NCT01294358|42007596|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
19559657|NCT01294358|42007592|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
19559658|NCT01294358|42007593|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
19559659|NCT01294358|42007594|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
19559660|NCT01294358|42007595|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
19559661|NCT01294358|42007596|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
19559662|NCT01294358|42007592|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
19559663|NCT01294358|42007593|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
19559664|NCT01294358|42007594|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
19559665|NCT01294358|42007595|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
19559666|NCT01294358|42007596|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
19559667|NCT01294358|42007592|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
19559668|NCT01294358|42007593|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
19559669|NCT01294358|42007594|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
19559670|NCT01294358|42007595|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
19559671|NCT01294358|42007596|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
19559672|NCT00994279|42007615|FG000|Overall Study|Withdrawal by Subject|2|||
19559673|NCT00994279|42007616|FG001|Overall Study|Withdrawal by Subject|2|||
19559674|NCT00994279|42007615|FG000|Overall Study|Toxicity|1|||
19559675|NCT00994279|42007616|FG001|Overall Study|Toxicity|0|||
19559676|NCT00994279|42007615|FG000|Overall Study|Multiple reasons|1|||
19559677|NCT00994279|42007616|FG001|Overall Study|Multiple reasons|3|||
19559678|NCT01294046|42007622|FG000|Overall Study|Infection and surgical explant|1|||
19559679|NCT01294046|42007622|FG000|Overall Study|Eligibility criteria expanded|1|||
19559680|NCT01294046|42007622|FG000|Overall Study|Stimulation response inadqequate|1|||
19559681|NCT01224639|42007637|FG000|Overall Study|Withdrawal by Subject|0|||
19559682|NCT01224639|42007638|FG001|Overall Study|Withdrawal by Subject|0|||
19559683|NCT01224639|42007639|FG002|Overall Study|Withdrawal by Subject|0|||
19559684|NCT01224639|42007640|FG003|Overall Study|Withdrawal by Subject|0|||
19559685|NCT01224639|42007641|FG004|Overall Study|Withdrawal by Subject|2|||
19559686|NCT01224639|42007642|FG005|Overall Study|Withdrawal by Subject|0|||
19559687|NCT01224639|42007643|FG006|Overall Study|Withdrawal by Subject|1|||
19559688|NCT01224639|42007644|FG007|Overall Study|Withdrawal by Subject|1|||
19559689|NCT01224639|42007637|FG000|Overall Study|Adverse Event|0|||
19559690|NCT01224639|42007638|FG001|Overall Study|Adverse Event|0|||
19559691|NCT01224639|42007639|FG002|Overall Study|Adverse Event|0|||
19559692|NCT01224639|42007640|FG003|Overall Study|Adverse Event|0|||
19559693|NCT01224639|42007641|FG004|Overall Study|Adverse Event|0|||
19559694|NCT01224639|42007642|FG005|Overall Study|Adverse Event|0|||
19559695|NCT01224639|42007643|FG006|Overall Study|Adverse Event|0|||
19559696|NCT01224639|42007644|FG007|Overall Study|Adverse Event|1|||
19559697|NCT01293968|42007664|FG000|Overall Study|non-cooperation|3|||
19559698|NCT01293968|42007665|FG001|Overall Study|non-cooperation|3|||
19559699|NCT01293032|42007675|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
19559700|NCT01293032|42007676|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
19559701|NCT01293032|42007677|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
19559702|NCT01293032|42007678|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
19559703|NCT01293032|42007675|FG000|Treatment|Adverse Event|0|||
19559704|NCT01293032|42007676|FG001|Treatment|Adverse Event|0|||
19739528|NCT02762578|42186591|FG001|Overall Study|Withdrawal by Subject|2|||
19739529|NCT02762578|42186590|FG000|Overall Study|Unclassified|6|||
19559705|NCT01293032|42007677|FG002|Treatment|Adverse Event|1|||
19559706|NCT01293032|42007678|FG003|Treatment|Adverse Event|1|||
19559707|NCT01293032|42007675|FG000|Treatment|Withdrawal by Subject|2|||
19559708|NCT01293032|42007676|FG001|Treatment|Withdrawal by Subject|4|||
19559709|NCT01293032|42007677|FG002|Treatment|Withdrawal by Subject|0|||
19559710|NCT01293032|42007678|FG003|Treatment|Withdrawal by Subject|0|||
19559711|NCT01293032|42007675|FG000|Treatment|Disease Progression, relapse|0|||
19559712|NCT01293032|42007676|FG001|Treatment|Disease Progression, relapse|1|||
19559713|NCT01293032|42007677|FG002|Treatment|Disease Progression, relapse|0|||
19739530|NCT02762578|42186591|FG001|Overall Study|Unclassified|0|||
19559714|NCT01293032|42007678|FG003|Treatment|Disease Progression, relapse|0|||
19559715|NCT01292876|42007685|FG000|Overall Study|Physician Decision|4|||
19559716|NCT01224171|42007693|FG000|Overall Study|Adverse Event|8|||
19559717|NCT01224171|42007694|FG001|Overall Study|Adverse Event|4|||
19559718|NCT01224171|42007693|FG000|Overall Study|Protocol Violation|0|||
19559719|NCT01224171|42007694|FG001|Overall Study|Protocol Violation|1|||
19559720|NCT01224171|42007693|FG000|Overall Study|Lack of Efficacy|5|||
19559721|NCT01224171|42007694|FG001|Overall Study|Lack of Efficacy|1|||
19559722|NCT01224171|42007693|FG000|Overall Study|Withdrawal of Consent|2|||
19559723|NCT01224171|42007694|FG001|Overall Study|Withdrawal of Consent|4|||
19559724|NCT01224171|42007693|FG000|Overall Study|Lost to Follow-up|0|||
19559725|NCT01224171|42007694|FG001|Overall Study|Lost to Follow-up|3|||
19559726|NCT01292486|42007700|FG000|Overall Study|Protocol Violation|2|||
19559727|NCT01292486|42007700|FG000|Overall Study|Did not meet screening criteria|2|||
19559728|NCT01292486|42007700|FG000|Overall Study|Adverse Event|1|||
19559729|NCT01292486|42007700|FG000|Overall Study|Physician Decision|1|||
19559730|NCT01223937|42007707|FG000|Overall Study|Withdrawal by Subject|3|||
19559731|NCT01223937|42007708|FG001|Overall Study|Withdrawal by Subject|2|||
19559732|NCT01223937|42007707|FG000|Overall Study|Lost to Follow-up|1|||
19559733|NCT01223937|42007708|FG001|Overall Study|Lost to Follow-up|4|||
19559734|NCT01223937|42007707|FG000|Overall Study|Adverse Event|1|||
19559735|NCT01223937|42007708|FG001|Overall Study|Adverse Event|4|||
19559736|NCT01223937|42007707|FG000|Overall Study|Protocol Violation|8|||
19559737|NCT01223937|42007708|FG001|Overall Study|Protocol Violation|7|||
19559738|NCT01223937|42007707|FG000|Overall Study|Other|4|||
19559739|NCT01223937|42007708|FG001|Overall Study|Other|1|||
19559740|NCT01290224|42007714|FG000|Overall Study|Adverse Event|1|||
19559741|NCT01290224|42007714|FG000|Overall Study|Refused Further Treatment|4|||
19559742|NCT01223235|42007720|FG000|Overall Study|Withdrawal by Subject|1|||
19559743|NCT01290068|42007726|FG000|Overall Study|Adverse Event|1|||
19559744|NCT01290068|42007727|FG001|Overall Study|Adverse Event|3|||
19559745|NCT01290068|42007726|FG000|Overall Study|Lost to Follow-up|3|||
19559746|NCT01290068|42007727|FG001|Overall Study|Lost to Follow-up|0|||
19559747|NCT01290068|42007726|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
19559748|NCT01290068|42007727|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
19559749|NCT01290068|42007726|FG000|Overall Study|Other|3|||
19559750|NCT01290068|42007727|FG001|Overall Study|Other|1|||
19559751|NCT00998881|42007735|FG000|Overall Study|Adverse Event|2|||
19559752|NCT00998881|42007736|FG001|Overall Study|Adverse Event|2|||
19559753|NCT00998881|42007735|FG000|Overall Study|Lack of Efficacy|1|||
19559754|NCT00998881|42007736|FG001|Overall Study|Lack of Efficacy|0|||
19559755|NCT00998881|42007735|FG000|Overall Study|Physician Decision|3|||
19559756|NCT00998881|42007736|FG001|Overall Study|Physician Decision|0|||
19559757|NCT00998881|42007735|FG000|Overall Study|Withdrawal by Subject|1|||
19559758|NCT00998881|42007736|FG001|Overall Study|Withdrawal by Subject|0|||
19559759|NCT00998881|42007735|FG000|Overall Study|Personal matter|1|||
19559760|NCT00998881|42007736|FG001|Overall Study|Personal matter|0|||
19559761|NCT01222767|42007742|FG000|Overall Study|Progressive disease|13|||
19559762|NCT01222767|42007742|FG000|Overall Study|Adverse Event|2|||
19559763|NCT01222767|42007742|FG000|Overall Study|Surgical resection|1|||
19559764|NCT01222767|42007742|FG000|Overall Study|Never treated|1|||
19559765|NCT00993967|42007746|FG000|Overall Study|Adverse Event|8|||
19559766|NCT00993967|42007746|FG000|Overall Study|Death|1|||
19559767|NCT00993967|42007746|FG000|Overall Study|Lost to Follow-up|14|||
19559768|NCT00993967|42007746|FG000|Overall Study|Withdrawal by Subject|36|||
19559769|NCT00993967|42007746|FG000|Overall Study|Protocol Violation|2|||
19559770|NCT01222533|42007750|FG000|Overall Study|Adverse Event|5|||
19559771|NCT01222533|42007750|FG000|Overall Study|Withdrawal by Subject|5|||
19559772|NCT01222533|42007750|FG000|Overall Study|Other|4|||
19559773|NCT01221753|42007762|FG000|Overall Study|Adverse Event|1|||
19559774|NCT01221597|42007768|FG000|Overall Study|Adverse Event|4|||
19559775|NCT01221597|42007769|FG001|Overall Study|Adverse Event|1|||
19559776|NCT01221597|42007768|FG000|Overall Study|Withdrawal by Subject|20|||
19559777|NCT01221597|42007769|FG001|Overall Study|Withdrawal by Subject|6|||
19559778|NCT01221597|42007768|FG000|Overall Study|Lost to Follow-up|6|||
19559779|NCT01221597|42007769|FG001|Overall Study|Lost to Follow-up|5|||
19559780|NCT01221597|42007768|FG000|Overall Study|Protocol Violation|1|||
19559781|NCT01221597|42007769|FG001|Overall Study|Protocol Violation|0|||
19559782|NCT01221597|42007768|FG000|Overall Study|Other|3|||
19559783|NCT01221597|42007769|FG001|Overall Study|Other|4|||
19559784|NCT01221597|42007768|FG000|Overall Study|Death|2|||
19559785|NCT01221597|42007769|FG001|Overall Study|Death|0|||
19559786|NCT01221363|42007778|FG000|Overall Study|Pregnancy|1|||
19559787|NCT01221363|42007779|FG001|Overall Study|Pregnancy|0|||
19559788|NCT01221363|42007778|FG000|Overall Study|Withdrawal by Subject|11|||
19382115|NCT02130466|41625355|FG012|Overall Study|Death|11|||
19382116|NCT02130466|41625356|FG013|Overall Study|Death|7|||
19382117|NCT02130466|41625343|FG000|Overall Study|Lost to Follow-up|1|||
19382118|NCT02130466|41625344|FG001|Overall Study|Lost to Follow-up|0|||
19559789|NCT01221363|42007779|FG001|Overall Study|Withdrawal by Subject|5|||
19559790|NCT01221285|42007785|FG000|Overall Study|Withdrawal by Subject|1|||
19382119|NCT02130466|41625345|FG002|Overall Study|Lost to Follow-up|0|||
19382120|NCT02130466|41625346|FG003|Overall Study|Lost to Follow-up|0|||
19382121|NCT02130466|41625347|FG004|Overall Study|Lost to Follow-up|0|||
19382122|NCT02130466|41625348|FG005|Overall Study|Lost to Follow-up|1|||
19382123|NCT02130466|41625349|FG006|Overall Study|Lost to Follow-up|0|||
19382124|NCT02130466|41625350|FG007|Overall Study|Lost to Follow-up|0|||
19382125|NCT02130466|41625351|FG008|Overall Study|Lost to Follow-up|0|||
19382126|NCT02130466|41625352|FG009|Overall Study|Lost to Follow-up|0|||
19382127|NCT02130466|41625353|FG010|Overall Study|Lost to Follow-up|0|||
19382128|NCT02130466|41625354|FG011|Overall Study|Lost to Follow-up|0|||
19382129|NCT02130466|41625355|FG012|Overall Study|Lost to Follow-up|1|||
19382130|NCT02130466|41625356|FG013|Overall Study|Lost to Follow-up|0|||
19382131|NCT02130466|41625343|FG000|Overall Study|Physician Decision|0|||
19382132|NCT02130466|41625344|FG001|Overall Study|Physician Decision|0|||
19382133|NCT02130466|41625345|FG002|Overall Study|Physician Decision|0|||
19382134|NCT02130466|41625346|FG003|Overall Study|Physician Decision|0|||
19382135|NCT02130466|41625347|FG004|Overall Study|Physician Decision|0|||
19382136|NCT02130466|41625348|FG005|Overall Study|Physician Decision|1|||
19382137|NCT02130466|41625349|FG006|Overall Study|Physician Decision|1|||
19382138|NCT02130466|41625350|FG007|Overall Study|Physician Decision|0|||
19559791|NCT01014988|42007795|FG000|Overall Study|Adverse Event|20|||
19559792|NCT01014988|42007796|FG001|Overall Study|Adverse Event|0|||
19559793|NCT01014988|42007797|FG002|Overall Study|Adverse Event|1|||
19559794|NCT01014988|42007798|FG003|Overall Study|Adverse Event|0|||
19559795|NCT01014988|42007799|FG004|Overall Study|Adverse Event|1|||
19559796|NCT01014988|42007800|FG005|Overall Study|Adverse Event|3|||
19559797|NCT01014988|42007795|FG000|Overall Study|Lost to Follow-up|1|||
19559798|NCT01014988|42007796|FG001|Overall Study|Lost to Follow-up|0|||
19559799|NCT01014988|42007797|FG002|Overall Study|Lost to Follow-up|1|||
19382139|NCT02130466|41625351|FG008|Overall Study|Physician Decision|0|||
19559800|NCT01014988|42007798|FG003|Overall Study|Lost to Follow-up|0|||
19559801|NCT01014988|42007799|FG004|Overall Study|Lost to Follow-up|0|||
19559802|NCT01014988|42007800|FG005|Overall Study|Lost to Follow-up|0|||
19559803|NCT01014988|42007795|FG000|Overall Study|Physician Decision|1|||
19559804|NCT01014988|42007796|FG001|Overall Study|Physician Decision|0|||
19559805|NCT01014988|42007797|FG002|Overall Study|Physician Decision|0|||
19559806|NCT01014988|42007798|FG003|Overall Study|Physician Decision|0|||
19559807|NCT01014988|42007799|FG004|Overall Study|Physician Decision|0|||
19559808|NCT01014988|42007800|FG005|Overall Study|Physician Decision|0|||
19559809|NCT01014988|42007795|FG000|Overall Study|Withdrawal by Subject|1|||
19559810|NCT01014988|42007796|FG001|Overall Study|Withdrawal by Subject|0|||
19559811|NCT01014988|42007797|FG002|Overall Study|Withdrawal by Subject|0|||
19559812|NCT01014988|42007798|FG003|Overall Study|Withdrawal by Subject|0|||
19559813|NCT01014988|42007799|FG004|Overall Study|Withdrawal by Subject|0|||
19559814|NCT01014988|42007800|FG005|Overall Study|Withdrawal by Subject|0|||
19559815|NCT01014910|42007824|FG000|Overall Study|Withdrawal by Subject|0|||
19559816|NCT01014910|42007825|FG001|Overall Study|Withdrawal by Subject|2|||
19559817|NCT01019980|42007833|FG000|Overall Study|Drug not available.|2|||
19559818|NCT01019980|42007834|FG001|Overall Study|Drug not available.|0|||
19559819|NCT00993499|42007846|FG000|Run-in Period (8 Days)|Adverse Event|0|||
19559820|NCT00993499|42007847|FG001|Run-in Period (8 Days)|Adverse Event|1|||
19559821|NCT00993499|42007848|FG002|Run-in Period (8 Days)|Adverse Event|0|||
19559822|NCT00993499|42007849|FG003|Run-in Period (8 Days)|Adverse Event|0|||
19559823|NCT00993499|42007850|FG004|Run-in Period (8 Days)|Adverse Event|0|||
19559824|NCT00993499|42007851|FG005|Run-in Period (8 Days)|Adverse Event|0|||
19559825|NCT00993499|42007846|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
19559826|NCT00993499|42007847|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
19559827|NCT00993499|42007848|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
19559828|NCT00993499|42007849|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
19559829|NCT00993499|42007850|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
19559830|NCT00993499|42007851|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
19739531|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
19739532|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
19739533|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
19739534|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
19739535|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
19559831|NCT00993499|42007846|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
19559832|NCT00993499|42007847|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
19559833|NCT00993499|42007848|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
19559834|NCT00993499|42007849|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
19739536|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
19559835|NCT00993499|42007850|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
19559836|NCT00993499|42007851|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
19559837|NCT00993499|42007846|FG000|Run-in Period (8 Days)|Progressive disease|0|||
19559838|NCT00993499|42007847|FG001|Run-in Period (8 Days)|Progressive disease|1|||
19559839|NCT00993499|42007848|FG002|Run-in Period (8 Days)|Progressive disease|1|||
19559840|NCT00993499|42007849|FG003|Run-in Period (8 Days)|Progressive disease|0|||
19559841|NCT00993499|42007850|FG004|Run-in Period (8 Days)|Progressive disease|0|||
19559842|NCT00993499|42007851|FG005|Run-in Period (8 Days)|Progressive disease|0|||
19559843|NCT00993499|42007846|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
19559844|NCT00993499|42007847|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
19559845|NCT00993499|42007848|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
19559846|NCT00993499|42007849|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
19559847|NCT00993499|42007850|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
19559848|NCT00993499|42007851|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
19559849|NCT00993499|42007846|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
19559850|NCT00993499|42007847|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
19559851|NCT00993499|42007848|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
19559852|NCT00993499|42007849|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
19559853|NCT00993499|42007850|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
19559854|NCT00993499|42007851|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
19559855|NCT00993499|42007846|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
19559856|NCT00993499|42007847|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
19559857|NCT00993499|42007848|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
19559858|NCT00993499|42007849|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
19559859|NCT00993499|42007850|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
19559860|NCT00993499|42007851|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
19559861|NCT00993499|42007846|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
19559862|NCT00993499|42007847|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
19559863|NCT00993499|42007848|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
19559864|NCT00993499|42007849|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
19559865|NCT00993499|42007850|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
19559866|NCT00993499|42007851|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
19559867|NCT00993499|42007846|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
19559868|NCT00993499|42007847|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
19559869|NCT00993499|42007848|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
19559870|NCT00993499|42007849|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
19559871|NCT00993499|42007850|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
19559872|NCT00993499|42007851|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
19559873|NCT00993499|42007846|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
19559874|NCT00993499|42007847|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
19559875|NCT00993499|42007848|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
19559876|NCT00993499|42007849|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
19739537|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
19739538|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
19559877|NCT00993499|42007850|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
19559878|NCT00993499|42007851|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
19559879|NCT00993499|42007846|FG000|Discontinued After Starting Course 3|DLT|1|||
19559880|NCT00993499|42007847|FG001|Discontinued After Starting Course 3|DLT|0|||
19559881|NCT00993499|42007848|FG002|Discontinued After Starting Course 3|DLT|2|||
19559882|NCT00993499|42007849|FG003|Discontinued After Starting Course 3|DLT|1|||
19559883|NCT00993499|42007850|FG004|Discontinued After Starting Course 3|DLT|0|||
19559884|NCT00993499|42007851|FG005|Discontinued After Starting Course 3|DLT|0|||
19559885|NCT00993499|42007846|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
19559886|NCT00993499|42007847|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
19559887|NCT00993499|42007848|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
19559888|NCT00993499|42007849|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
19559889|NCT00993499|42007850|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
19559890|NCT00993499|42007851|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
19559891|NCT01014442|42007867|FG000|Overall Study|Adverse Event|0|||
19559892|NCT01014442|42007868|FG001|Overall Study|Adverse Event|8|||
19559893|NCT01014442|42007867|FG000|Overall Study|Withdrawal by Subject|4|||
19559894|NCT01014442|42007868|FG001|Overall Study|Withdrawal by Subject|4|||
19559895|NCT01014442|42007867|FG000|Overall Study|Protocol Violation|2|||
19559896|NCT01014442|42007868|FG001|Overall Study|Protocol Violation|5|||
19559897|NCT01014442|42007867|FG000|Overall Study|Lack of Compliance|0|||
19559898|NCT01014442|42007868|FG001|Overall Study|Lack of Compliance|1|||
19559899|NCT01014442|42007867|FG000|Overall Study|Unspecified Reason|1|||
19559900|NCT01014442|42007868|FG001|Overall Study|Unspecified Reason|1|||
19559901|NCT00996307|42007882|FG000|Overall Study|Adverse Event|0|||
19559902|NCT00996307|42007883|FG001|Overall Study|Adverse Event|1|||
19559903|NCT00996307|42007884|FG002|Overall Study|Adverse Event|0|||
19559904|NCT00996307|42007885|FG003|Overall Study|Adverse Event|0|||
19559905|NCT00996307|42007882|FG000|Overall Study|Withdrawal by Subject|3|||
19559906|NCT00996307|42007883|FG001|Overall Study|Withdrawal by Subject|2|||
19559907|NCT00996307|42007884|FG002|Overall Study|Withdrawal by Subject|5|||
19559908|NCT00996307|42007885|FG003|Overall Study|Withdrawal by Subject|5|||
19559909|NCT00996307|42007882|FG000|Overall Study|Lost to Follow-up|13|||
19559910|NCT00996307|42007883|FG001|Overall Study|Lost to Follow-up|13|||
19559911|NCT00996307|42007884|FG002|Overall Study|Lost to Follow-up|7|||
19559912|NCT00996307|42007885|FG003|Overall Study|Lost to Follow-up|15|||
19559913|NCT00996307|42007882|FG000|Overall Study|Administrative reason|0|||
19559914|NCT00996307|42007883|FG001|Overall Study|Administrative reason|1|||
19559915|NCT00996307|42007884|FG002|Overall Study|Administrative reason|0|||
19559916|NCT00996307|42007885|FG003|Overall Study|Administrative reason|0|||
19559917|NCT00996307|42007882|FG000|Overall Study|Unable to classify|4|||
19559918|NCT00996307|42007883|FG001|Overall Study|Unable to classify|0|||
19559919|NCT00996307|42007884|FG002|Overall Study|Unable to classify|2|||
19559920|NCT00996307|42007885|FG003|Overall Study|Unable to classify|1|||
19559921|NCT01219959|42007915|FG000|Overall Study|Adverse Event|6|||
19559922|NCT01219959|42007916|FG001|Overall Study|Adverse Event|14|||
19559923|NCT01219959|42007915|FG000|Overall Study|Physician Decision|0|||
19559924|NCT01219959|42007916|FG001|Overall Study|Physician Decision|4|||
19559925|NCT01219959|42007915|FG000|Overall Study|Withdrawal by Subject|0|||
19559926|NCT01219959|42007916|FG001|Overall Study|Withdrawal by Subject|2|||
19559927|NCT01219959|42007915|FG000|Overall Study|Renal Transplantation|0|||
19559928|NCT01219959|42007916|FG001|Overall Study|Renal Transplantation|3|||
19559929|NCT01219959|42007915|FG000|Overall Study|Other|1|||
19559930|NCT01219959|42007916|FG001|Overall Study|Other|0|||
19559931|NCT00993421|42007929|FG000|Overall Study|Adverse Event|2|||
19559932|NCT00993421|42007930|FG001|Overall Study|Adverse Event|7|||
19559933|NCT00993421|42007931|FG002|Overall Study|Adverse Event|6|||
19559934|NCT00993421|42007932|FG003|Overall Study|Adverse Event|9|||
19559935|NCT00993421|42007933|FG004|Overall Study|Adverse Event|5|||
19559936|NCT00993421|42007934|FG005|Overall Study|Adverse Event|7|||
19559937|NCT00993421|42007935|FG006|Overall Study|Adverse Event|1|||
19559938|NCT00993421|42007929|FG000|Overall Study|Sponsor Decision|36|||
19559939|NCT00993421|42007930|FG001|Overall Study|Sponsor Decision|31|||
19559940|NCT00993421|42007931|FG002|Overall Study|Sponsor Decision|28|||
19559941|NCT00993421|42007932|FG003|Overall Study|Sponsor Decision|30|||
19559942|NCT00993421|42007933|FG004|Overall Study|Sponsor Decision|38|||
19559943|NCT00993421|42007934|FG005|Overall Study|Sponsor Decision|30|||
19559944|NCT00993421|42007935|FG006|Overall Study|Sponsor Decision|29|||
19559945|NCT00993421|42007929|FG000|Overall Study|Lost to Follow-up|3|||
19559946|NCT00993421|42007930|FG001|Overall Study|Lost to Follow-up|5|||
19559947|NCT00993421|42007931|FG002|Overall Study|Lost to Follow-up|5|||
19559948|NCT00993421|42007932|FG003|Overall Study|Lost to Follow-up|0|||
19559949|NCT00993421|42007933|FG004|Overall Study|Lost to Follow-up|0|||
19559950|NCT00993421|42007934|FG005|Overall Study|Lost to Follow-up|0|||
19559951|NCT00993421|42007935|FG006|Overall Study|Lost to Follow-up|6|||
19559952|NCT00993421|42007929|FG000|Overall Study|Withdrawal by Subject|3|||
19559953|NCT00993421|42007930|FG001|Overall Study|Withdrawal by Subject|2|||
19559954|NCT00993421|42007931|FG002|Overall Study|Withdrawal by Subject|3|||
19559955|NCT00993421|42007932|FG003|Overall Study|Withdrawal by Subject|3|||
19559956|NCT00993421|42007933|FG004|Overall Study|Withdrawal by Subject|3|||
19559957|NCT00993421|42007934|FG005|Overall Study|Withdrawal by Subject|5|||
19559958|NCT00993421|42007935|FG006|Overall Study|Withdrawal by Subject|3|||
19559959|NCT00993421|42007929|FG000|Overall Study|Death|0|||
19559960|NCT00993421|42007930|FG001|Overall Study|Death|0|||
19559961|NCT00993421|42007931|FG002|Overall Study|Death|0|||
19559962|NCT00993421|42007932|FG003|Overall Study|Death|0|||
19559963|NCT00993421|42007933|FG004|Overall Study|Death|0|||
19559964|NCT00993421|42007934|FG005|Overall Study|Death|0|||
19559965|NCT00993421|42007935|FG006|Overall Study|Death|1|||
19559966|NCT00993421|42007929|FG000|Overall Study|Entry Criteria Exclusion|0|||
19559967|NCT00993421|42007930|FG001|Overall Study|Entry Criteria Exclusion|0|||
19559968|NCT00993421|42007931|FG002|Overall Study|Entry Criteria Exclusion|1|||
19559969|NCT00993421|42007932|FG003|Overall Study|Entry Criteria Exclusion|3|||
19559970|NCT00993421|42007933|FG004|Overall Study|Entry Criteria Exclusion|0|||
19559971|NCT00993421|42007934|FG005|Overall Study|Entry Criteria Exclusion|1|||
19559972|NCT00993421|42007935|FG006|Overall Study|Entry Criteria Exclusion|0|||
19559973|NCT00993421|42007929|FG000|Overall Study|Physician Decision|0|||
19559974|NCT00993421|42007930|FG001|Overall Study|Physician Decision|0|||
19559975|NCT00993421|42007931|FG002|Overall Study|Physician Decision|0|||
19559976|NCT00993421|42007932|FG003|Overall Study|Physician Decision|0|||
19559977|NCT00993421|42007933|FG004|Overall Study|Physician Decision|0|||
19559978|NCT00993421|42007934|FG005|Overall Study|Physician Decision|1|||
19559979|NCT00993421|42007935|FG006|Overall Study|Physician Decision|1|||
19559980|NCT00993421|42007929|FG000|Overall Study|Protocol Violation|0|||
19559981|NCT00993421|42007930|FG001|Overall Study|Protocol Violation|0|||
19559982|NCT00993421|42007931|FG002|Overall Study|Protocol Violation|0|||
19559983|NCT00993421|42007932|FG003|Overall Study|Protocol Violation|0|||
19559984|NCT00993421|42007933|FG004|Overall Study|Protocol Violation|0|||
19559985|NCT00993421|42007934|FG005|Overall Study|Protocol Violation|2|||
19559986|NCT00993421|42007935|FG006|Overall Study|Protocol Violation|1|||
19559987|NCT01014208|42007953|FG000|Overall Study|Lost to Follow-up|2|||
19559988|NCT01014208|42007954|FG001|Overall Study|Lost to Follow-up|5|||
19559989|NCT01014208|42007953|FG000|Overall Study|Participant Withdrew Consent|12|||
19559990|NCT01014208|42007954|FG001|Overall Study|Participant Withdrew Consent|12|||
19559991|NCT01014208|42007953|FG000|Overall Study|Did Not Receive Study Drug|2|||
19559992|NCT01014208|42007954|FG001|Overall Study|Did Not Receive Study Drug|0|||
19559993|NCT01014208|42007953|FG000|Overall Study|Study Closed/terminated|78|||
19559994|NCT01014208|42007954|FG001|Overall Study|Study Closed/terminated|83|||
19559995|NCT00991939|42007962|FG000|Overall Study|Lost to Follow-up|0|||
19559996|NCT00991939|42007963|FG001|Overall Study|Lost to Follow-up|1|||
19559997|NCT00991939|42007962|FG000|Overall Study|Withdrawal by Subject|1|||
19559998|NCT00991939|42007963|FG001|Overall Study|Withdrawal by Subject|0|||
19559999|NCT00991939|42007962|FG000|Overall Study|Entire study terminated|4|||
19560000|NCT00991939|42007963|FG001|Overall Study|Entire study terminated|1|||
19560001|NCT00993265|42007973|FG000|Overall Study|Adverse Event|1|||
19560002|NCT00993265|42007974|FG001|Overall Study|Adverse Event|0|||
19560003|NCT00993265|42007973|FG000|Overall Study|Changed dose of concomitant drug|2|||
19560004|NCT00993265|42007974|FG001|Overall Study|Changed dose of concomitant drug|0|||
19560005|NCT00993265|42007973|FG000|Overall Study|Non-compliant with study medication|1|||
19560006|NCT00993265|42007974|FG001|Overall Study|Non-compliant with study medication|0|||
19560007|NCT04211389|42007982|FG000|Overall Study|Adverse Event|1|||
19560008|NCT04211389|42007983|FG001|Overall Study|Adverse Event|2|||
19560009|NCT04211389|42007982|FG000|Overall Study|Lost to Follow-up|15|||
19560010|NCT04211389|42007983|FG001|Overall Study|Lost to Follow-up|7|||
19560011|NCT04211389|42007982|FG000|Overall Study|Protocol Violation|0|||
19560012|NCT04211389|42007983|FG001|Overall Study|Protocol Violation|1|||
19560013|NCT04211389|42007982|FG000|Overall Study|Withdrawal by Subject|10|||
19560014|NCT04211389|42007983|FG001|Overall Study|Withdrawal by Subject|11|||
19560015|NCT00993031|42007991|FG000|Overall Study|Death|0|||
19560016|NCT00993031|42007992|FG001|Overall Study|Death|1|||
19560017|NCT00993031|42007991|FG000|Overall Study|Physician Decision|0|||
19560018|NCT00993031|42007992|FG001|Overall Study|Physician Decision|2|||
19560019|NCT00993031|42007991|FG000|Overall Study|Withdrawal by Subject|3|||
19560020|NCT00993031|42007992|FG001|Overall Study|Withdrawal by Subject|3|||
19382140|NCT02130466|41625352|FG009|Overall Study|Physician Decision|0|||
19382141|NCT02130466|41625353|FG010|Overall Study|Physician Decision|0|||
19560021|NCT00993031|42007991|FG000|Overall Study|Lost to Follow-up|19|||
19560022|NCT00993031|42007992|FG001|Overall Study|Lost to Follow-up|13|||
19560023|NCT01010776|42008002|FG000|Main Phase|Withdrawal by Subject|14|||
19560024|NCT01010776|42008002|FG000|Main Phase|Lack of Efficacy|8|||
19560025|NCT01010776|42008002|FG000|Main Phase|Adverse Event|7|||
19560026|NCT01010776|42008002|FG000|Main Phase|Lost to Follow-up|6|||
19560027|NCT01010776|42008002|FG000|Main Phase|Non-compliance to study medication|5|||
19560028|NCT01010776|42008002|FG000|Main Phase|Selection failure|2|||
19560029|NCT01010776|42008002|FG000|Main Phase|Inform consent withdrawal|1|||
19560030|NCT01010776|42008002|FG000|Main Phase|Other|1|||
19560031|NCT01010776|42008002|FG000|Main Phase|Did not received study medication|5|||
19560032|NCT01010776|42008002|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
19560033|NCT01010776|42008002|FG000|Extension Phase|Other|3|||
19560034|NCT01018810|42008022|FG000|Overall Study|Withdrawal by Subject|0|||
19560035|NCT01018810|42008023|FG001|Overall Study|Withdrawal by Subject|1|||
19560036|NCT01018810|42008024|FG002|Overall Study|Withdrawal by Subject|0|||
19560037|NCT01018810|42008025|FG003|Overall Study|Withdrawal by Subject|0|||
19560038|NCT01018810|42008026|FG004|Overall Study|Withdrawal by Subject|0|||
19560039|NCT01018810|42008022|FG000|Overall Study|Sponsor Decision|2|||
19560040|NCT01018810|42008023|FG001|Overall Study|Sponsor Decision|0|||
19560041|NCT01018810|42008024|FG002|Overall Study|Sponsor Decision|1|||
19560042|NCT01018810|42008025|FG003|Overall Study|Sponsor Decision|1|||
19560043|NCT01018810|42008026|FG004|Overall Study|Sponsor Decision|1|||
19560044|NCT01018732|42008041|FG000|Overall Study|Lost to Follow-up|0|||
19560045|NCT01018732|42008042|FG001|Overall Study|Lost to Follow-up|0|||
19560046|NCT01018732|42008043|FG002|Overall Study|Lost to Follow-up|3|||
19560047|NCT01018732|42008041|FG000|Overall Study|Protocol Violation|1|||
19560048|NCT01018732|42008042|FG001|Overall Study|Protocol Violation|1|||
19560049|NCT01018732|42008043|FG002|Overall Study|Protocol Violation|0|||
19560050|NCT01018732|42008041|FG000|Overall Study|Inappropriate Enrollment|0|||
19560051|NCT01018732|42008042|FG001|Overall Study|Inappropriate Enrollment|1|||
19560052|NCT01018732|42008043|FG002|Overall Study|Inappropriate Enrollment|0|||
19560053|NCT01018732|42008041|FG000|Overall Study|Unable to Classify|0|||
19560054|NCT01018732|42008042|FG001|Overall Study|Unable to Classify|0|||
19560055|NCT01018732|42008043|FG002|Overall Study|Unable to Classify|1|||
19560056|NCT01218867|42008062|FG000|Overall Study|Death during treatment|0|||
19560057|NCT01218867|42008063|FG001|Overall Study|Death during treatment|0|||
19560058|NCT01218867|42008064|FG002|Overall Study|Death during treatment|0|||
19560059|NCT01218867|42008065|FG003|Overall Study|Death during treatment|0|||
19560060|NCT01218867|42008066|FG004|Overall Study|Death during treatment|0|||
19560061|NCT01218867|42008067|FG005|Overall Study|Death during treatment|0|||
19560062|NCT01218867|42008068|FG006|Overall Study|Death during treatment|1|||
19560063|NCT01218867|42008069|FG007|Overall Study|Death during treatment|0|||
19560064|NCT01218867|42008070|FG008|Overall Study|Death during treatment|0|||
19560065|NCT01218867|42008071|FG009|Overall Study|Death during treatment|0|||
19560066|NCT01218867|42008072|FG010|Overall Study|Death during treatment|0|||
19560067|NCT01018264|42008109|FG000|Overall Study|Withdrawal by Subject|1|||
19560068|NCT01018264|42008110|FG001|Overall Study|Withdrawal by Subject|0|||
19560069|NCT01018264|42008109|FG000|Overall Study|Lost to Follow-up|0|||
19560070|NCT01018264|42008110|FG001|Overall Study|Lost to Follow-up|1|||
19560071|NCT01018186|42008119|FG000|2-week Run-in Period|Protocol Violation|1|||
19560072|NCT01018186|42008120|FG001|2-week Run-in Period|Protocol Violation|0|||
19560073|NCT01018186|42008121|FG002|2-week Run-in Period|Protocol Violation|0|||
19560074|NCT01018186|42008122|FG003|2-week Run-in Period|Protocol Violation|0|||
19560075|NCT01018186|42008119|FG000|2-week Run-in Period|Lost to Follow-up|2|||
19560076|NCT01018186|42008120|FG001|2-week Run-in Period|Lost to Follow-up|0|||
19560077|NCT01018186|42008121|FG002|2-week Run-in Period|Lost to Follow-up|0|||
19560078|NCT01018186|42008122|FG003|2-week Run-in Period|Lost to Follow-up|0|||
19739539|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
19739540|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
19739541|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
19739542|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
19739543|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
19739544|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
19739545|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
19560079|NCT01018186|42008119|FG000|2-week Run-in Period|Physician Decision|3|||
19560080|NCT01018186|42008120|FG001|2-week Run-in Period|Physician Decision|0|||
19560081|NCT01018186|42008121|FG002|2-week Run-in Period|Physician Decision|0|||
19560082|NCT01018186|42008122|FG003|2-week Run-in Period|Physician Decision|0|||
19560083|NCT01018186|42008119|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
19560084|NCT01018186|42008120|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19560085|NCT01018186|42008121|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19560086|NCT01018186|42008122|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
19560087|NCT01018186|42008119|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
19560088|NCT01018186|42008120|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19739546|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
19739547|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
19739548|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
19739549|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
19739550|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
19739551|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
19739552|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
19739553|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
19739554|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
19739555|NCT03514641|42186601|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
19739556|NCT03514641|42186602|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
19739557|NCT03514641|42186603|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
19739558|NCT03514641|42186604|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
19739559|NCT03514641|42186601|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
19739560|NCT03514641|42186602|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
19739561|NCT03514641|42186603|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
19739562|NCT03514641|42186604|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
19739563|NCT03514641|42186601|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
19739564|NCT03514641|42186602|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
19739565|NCT03514641|42186603|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
19739566|NCT03514641|42186604|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
19739567|NCT03514641|42186601|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
19739568|NCT03514641|42186602|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
19739569|NCT03514641|42186603|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
19739570|NCT03514641|42186604|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
19739571|NCT03514641|42186601|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
19739572|NCT03514641|42186602|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
19739573|NCT03514641|42186603|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
19739574|NCT03514641|42186604|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
19739575|NCT03514641|42186601|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
19739576|NCT03514641|42186602|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
19739577|NCT03514641|42186603|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
19739578|NCT03514641|42186604|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
19560089|NCT01018186|42008121|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19560090|NCT01018186|42008122|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19560091|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
19560092|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
19560093|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
19560094|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
19560095|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
19560096|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
19560097|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
19560098|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
19560099|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
19560100|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
19560101|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
19560102|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
19560103|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
19560104|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
19560105|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
19560106|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
19560107|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
19560108|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
19560109|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
19560110|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
19560111|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
19560112|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
19560113|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
19560114|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
19560115|NCT01018186|42008119|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19560116|NCT01018186|42008120|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
19560117|NCT01018186|42008121|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
19560118|NCT01018186|42008122|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
19560119|NCT00987337|42008137|FG000|Overall Study|Adverse Event|10|||
19560120|NCT00987337|42008138|FG001|Overall Study|Adverse Event|9|||
19560121|NCT00987337|42008139|FG002|Overall Study|Adverse Event|8|||
19560122|NCT00987337|42008137|FG000|Overall Study|Insufficient Virologic Response|10|||
19560123|NCT00987337|42008138|FG001|Overall Study|Insufficient Virologic Response|7|||
19560124|NCT00987337|42008139|FG002|Overall Study|Insufficient Virologic Response|12|||
19560125|NCT00987337|42008137|FG000|Overall Study|Virologic Breakthrough|2|||
19560126|NCT00987337|42008138|FG001|Overall Study|Virologic Breakthrough|2|||
19560127|NCT00987337|42008139|FG002|Overall Study|Virologic Breakthrough|8|||
19739579|NCT00100828|42186616|FG000|Overall Study|Physician Decision|6|||
19739580|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
19739581|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
19739582|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
19739583|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
19739584|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
19739585|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
19739586|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
19739587|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
19739588|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
19739589|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
19739590|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
19739591|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
19739592|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
19739593|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
19739594|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
19739595|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
19739596|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
19739597|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
19739598|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
19739599|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
19739600|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
19739601|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
19739602|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
19739603|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
19739604|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
19739605|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
19739606|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
19739607|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
19739608|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
19739609|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
19739610|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
19739611|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
19739612|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
19739613|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
19739614|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
19739615|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
19739616|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
19739617|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
19739618|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
19739619|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
19739620|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
19739621|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
19739622|NCT00100048|42186625|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
19739623|NCT00100048|42186626|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
19739624|NCT00100048|42186627|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
19739625|NCT00100048|42186628|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
19739626|NCT00100048|42186629|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
19382142|NCT02130466|41625354|FG011|Overall Study|Physician Decision|0|||
19560128|NCT00987337|42008137|FG000|Overall Study|Lost to Follow-up|10|||
19560129|NCT00987337|42008138|FG001|Overall Study|Lost to Follow-up|6|||
19560130|NCT00987337|42008139|FG002|Overall Study|Lost to Follow-up|2|||
19560131|NCT00987337|42008137|FG000|Overall Study|Withdrawal by Subject|6|||
19560132|NCT00987337|42008138|FG001|Overall Study|Withdrawal by Subject|9|||
19560133|NCT00987337|42008139|FG002|Overall Study|Withdrawal by Subject|9|||
19560134|NCT00987337|42008137|FG000|Overall Study|Other|0|||
19560135|NCT00987337|42008138|FG001|Overall Study|Other|2|||
19639218|NCT00688467|42088612|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
19639219|NCT00688467|42088613|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
19560136|NCT00987337|42008139|FG002|Overall Study|Other|5|||
19560137|NCT00987337|42008137|FG000|Overall Study|Protocol Violation|1|||
19560138|NCT00987337|42008138|FG001|Overall Study|Protocol Violation|0|||
19560139|NCT00987337|42008139|FG002|Overall Study|Protocol Violation|2|||
19560140|NCT00987337|42008137|FG000|Overall Study|Participant Relapsed|18|||
19560141|NCT00987337|42008138|FG001|Overall Study|Participant Relapsed|20|||
19560142|NCT00987337|42008139|FG002|Overall Study|Participant Relapsed|5|||
19560143|NCT00992407|42008151|FG000|Overall Study|Protocol Violation|2|||
19560144|NCT00992407|42008152|FG001|Overall Study|Protocol Violation|1|||
19560145|NCT00992407|42008151|FG000|Overall Study|Lost to Follow-up|3|||
19560146|NCT00992407|42008152|FG001|Overall Study|Lost to Follow-up|3|||
19560147|NCT00992407|42008151|FG000|Overall Study|Adverse Event|3|||
19560148|NCT00992407|42008152|FG001|Overall Study|Adverse Event|2|||
19560149|NCT00992407|42008151|FG000|Overall Study|protocol Violation & Adverse events|2|||
19560150|NCT00992407|42008152|FG001|Overall Study|protocol Violation & Adverse events|4|||
19560151|NCT00992407|42008151|FG000|Overall Study|Other|2|||
19560152|NCT00992407|42008152|FG001|Overall Study|Other|0|||
19560153|NCT00992407|42008151|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
19560154|NCT00992407|42008152|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
19560155|NCT00992407|42008151|FG000|Overall Study|Study medication not administered|17|||
19560156|NCT00992407|42008152|FG001|Overall Study|Study medication not administered|13|||
19560157|NCT00986479|42008163|FG000|Period 1|Improved mood|1|||
19560158|NCT00986479|42008164|FG001|Period 1|Improved mood|0|||
19560159|NCT00986479|42008163|FG000|Period 1|Administrative reasons|1|||
19560160|NCT00986479|42008164|FG001|Period 1|Administrative reasons|0|||
19560161|NCT00986245|42008170|FG000|First Intervention|Poor compliance|8|||
19560162|NCT00986245|42008171|FG001|First Intervention|Poor compliance|4|||
19560163|NCT00986245|42008170|FG000|First Intervention|Lack of Efficacy|1|||
19560164|NCT00986245|42008171|FG001|First Intervention|Lack of Efficacy|2|||
19560165|NCT00986245|42008170|FG000|First Intervention|Withdrawal by Subject|0|||
19560166|NCT00986245|42008171|FG001|First Intervention|Withdrawal by Subject|1|||
19560167|NCT00986245|42008170|FG000|First Intervention|Protocol Violation|0|||
19560168|NCT00986245|42008171|FG001|First Intervention|Protocol Violation|1|||
19560169|NCT00986245|42008170|FG000|First Intervention|Out of indication|1|||
19560170|NCT00986245|42008171|FG001|First Intervention|Out of indication|0|||
19560171|NCT00986245|42008170|FG000|Second Intervention|Poor compliance|1|||
19560172|NCT00986245|42008171|FG001|Second Intervention|Poor compliance|0|||
19560173|NCT00986245|42008170|FG000|Second Intervention|Lost to Follow-up|1|||
19560174|NCT00986245|42008171|FG001|Second Intervention|Lost to Follow-up|0|||
19560175|NCT00986245|42008170|FG000|Second Intervention|Protocol Violation|0|||
19560176|NCT00986245|42008171|FG001|Second Intervention|Protocol Violation|1|||
19560177|NCT00989833|42008185|FG000|Overall Study|Lost to Follow-up|0|||
19560178|NCT00989833|42008186|FG001|Overall Study|Lost to Follow-up|1|||
19560179|NCT00989833|42008187|FG002|Overall Study|Lost to Follow-up|0|||
19560180|NCT00989833|42008185|FG000|Overall Study|Protocol Violation|1|||
19560181|NCT00989833|42008186|FG001|Overall Study|Protocol Violation|2|||
19560182|NCT00989833|42008187|FG002|Overall Study|Protocol Violation|1|||
19560183|NCT00989833|42008185|FG000|Overall Study|Withdrawal by Subject|0|||
19560184|NCT00989833|42008186|FG001|Overall Study|Withdrawal by Subject|0|||
19560185|NCT00989833|42008187|FG002|Overall Study|Withdrawal by Subject|1|||
19560186|NCT00989833|42008185|FG000|Overall Study|Incorrectly randomized|1|||
19560187|NCT00989833|42008186|FG001|Overall Study|Incorrectly randomized|0|||
19560188|NCT00989833|42008187|FG002|Overall Study|Incorrectly randomized|0|||
19560189|NCT01218477|42008199|FG000|Overall Study|Disease progression|2|||
19560190|NCT01218477|42008200|FG001|Overall Study|Disease progression|3|||
19560191|NCT01218477|42008201|FG002|Overall Study|Disease progression|6|||
19560192|NCT01218477|42008202|FG003|Overall Study|Disease progression|2|||
19560193|NCT01218477|42008199|FG000|Overall Study|Study drug toxicity|0|||
19560194|NCT01218477|42008200|FG001|Overall Study|Study drug toxicity|2|||
19560195|NCT01218477|42008201|FG002|Overall Study|Study drug toxicity|5|||
19560196|NCT01218477|42008202|FG003|Overall Study|Study drug toxicity|0|||
19560197|NCT01218477|42008199|FG000|Overall Study|No longer meets study criteria|1|||
19560198|NCT01218477|42008200|FG001|Overall Study|No longer meets study criteria|0|||
19560199|NCT01218477|42008201|FG002|Overall Study|No longer meets study criteria|0|||
19560200|NCT01218477|42008202|FG003|Overall Study|No longer meets study criteria|0|||
19560201|NCT01218477|42008199|FG000|Overall Study|Withdrawal by Subject|0|||
19560202|NCT01218477|42008200|FG001|Overall Study|Withdrawal by Subject|0|||
19560203|NCT01218477|42008201|FG002|Overall Study|Withdrawal by Subject|1|||
19560204|NCT01218477|42008202|FG003|Overall Study|Withdrawal by Subject|0|||
19560205|NCT01218477|42008199|FG000|Overall Study|Prepared for cell transplantation|0|||
19560206|NCT01218477|42008200|FG001|Overall Study|Prepared for cell transplantation|1|||
19560207|NCT01218477|42008201|FG002|Overall Study|Prepared for cell transplantation|1|||
19560208|NCT01218477|42008202|FG003|Overall Study|Prepared for cell transplantation|0|||
19560209|NCT01218477|42008199|FG000|Overall Study|Administrative reason by sponsor|0|||
19560210|NCT01218477|42008200|FG001|Overall Study|Administrative reason by sponsor|0|||
19560211|NCT01218477|42008201|FG002|Overall Study|Administrative reason by sponsor|1|||
19560212|NCT01218477|42008202|FG003|Overall Study|Administrative reason by sponsor|0|||
19560213|NCT01218477|42008199|FG000|Overall Study|Maximum clinical benefit|0|||
19560214|NCT01218477|42008200|FG001|Overall Study|Maximum clinical benefit|2|||
19560215|NCT01218477|42008201|FG002|Overall Study|Maximum clinical benefit|0|||
19560216|NCT01218477|42008202|FG003|Overall Study|Maximum clinical benefit|0|||
19560217|NCT01218243|42008218|FG000|Overall Study|Lack of Efficacy|1|||
19560218|NCT01218243|42008219|FG001|Overall Study|Lack of Efficacy|1|||
19560219|NCT01218243|42008218|FG000|Overall Study|Lost to Follow-up|3|||
19560220|NCT01218243|42008219|FG001|Overall Study|Lost to Follow-up|3|||
19560221|NCT01218243|42008218|FG000|Overall Study|Protocol Violation|5|||
19560222|NCT01218243|42008219|FG001|Overall Study|Protocol Violation|10|||
19560223|NCT00989287|42008227|FG000|Overall Study|Adverse Event|1|||
19560224|NCT00989287|42008228|FG001|Overall Study|Adverse Event|0|||
19560225|NCT00989287|42008227|FG000|Overall Study|Lost to Follow-up|0|||
19560226|NCT00989287|42008228|FG001|Overall Study|Lost to Follow-up|1|||
19560227|NCT01218087|42008249|FG000|Overall Study|Death|2|||
19560228|NCT01218087|42008250|FG001|Overall Study|Death|1|||
19560229|NCT01218087|42008249|FG000|Overall Study|Withdrawal by Subject|5|||
19560230|NCT01218087|42008250|FG001|Overall Study|Withdrawal by Subject|0|||
19560231|NCT01218087|42008249|FG000|Overall Study|Transferred|8|||
19560232|NCT01218087|42008250|FG001|Overall Study|Transferred|5|||
19560233|NCT01218009|42008258|FG000|Overall Study|Protocol Violation|2|||
19560234|NCT01218009|42008259|FG001|Overall Study|Protocol Violation|1|||
19560235|NCT01218009|42008258|FG000|Overall Study|Withdrawal by Subject|3|||
19560236|NCT01218009|42008259|FG001|Overall Study|Withdrawal by Subject|1|||
19560237|NCT01218009|42008258|FG000|Overall Study|Sponsor terminated study|161|||
19560238|NCT01218009|42008259|FG001|Overall Study|Sponsor terminated study|163|||
19560239|NCT00992017|42008265|FG000|Overall Study|Lost to Follow-up|2|||
19560240|NCT00992017|42008265|FG000|Overall Study|Withdrawal by Subject|2|||
19560241|NCT00992017|42008265|FG000|Overall Study|Unable to get to clinic|5|||
19560242|NCT00992017|42008265|FG000|Overall Study|Not adhere to study requirements|1|||
19560243|NCT01217463|42008276|FG000|Overall Study|Adverse Event|8|||
19560244|NCT01217463|42008277|FG001|Overall Study|Adverse Event|5|||
19560245|NCT01217463|42008276|FG000|Overall Study|Physician Decision|0|||
19560246|NCT01217463|42008277|FG001|Overall Study|Physician Decision|1|||
19560247|NCT01217463|42008276|FG000|Overall Study|Withdrawal by Subject|3|||
19560248|NCT01217463|42008277|FG001|Overall Study|Withdrawal by Subject|0|||
19560249|NCT01217463|42008276|FG000|Overall Study|Surgery on the Target Limb|0|||
19560250|NCT01217463|42008277|FG001|Overall Study|Surgery on the Target Limb|1|||
19560251|NCT01217463|42008276|FG000|Overall Study|Patient Non-compliant|1|||
19560252|NCT01217463|42008277|FG001|Overall Study|Patient Non-compliant|0|||
19560253|NCT01217463|42008276|FG000|Overall Study|Other|1|||
19560254|NCT01217463|42008277|FG001|Overall Study|Other|1|||
19560255|NCT01217307|42008287|FG000|Overall Study|Withdrawal by Subject|0|||
19560256|NCT01217307|42008288|FG001|Overall Study|Withdrawal by Subject|1|||
19560257|NCT01217229|42008294|FG000|Overall Study|Adverse Event|1|||
19560258|NCT01217229|42008294|FG000|Overall Study|Disease progression, deterioration|2|||
19560259|NCT01217229|42008294|FG000|Overall Study|Disease progression, Cheson criteria|14|||
19560260|NCT01217229|42008294|FG000|Overall Study|Protocol Violation|1|||
19560261|NCT01217229|42008294|FG000|Overall Study|Disease progression not confirmed|2|||
19560262|NCT01013740|42008300|FG000|Overall Study|Lost to Follow-up|3|||
19560263|NCT01013740|42008301|FG001|Overall Study|Lost to Follow-up|5|||
19560264|NCT01013740|42008300|FG000|Overall Study|Physician Decision|2|||
19560265|NCT01013740|42008301|FG001|Overall Study|Physician Decision|0|||
19560266|NCT01013740|42008300|FG000|Overall Study|Withdrawal by Subject|2|||
19560267|NCT01013740|42008301|FG001|Overall Study|Withdrawal by Subject|10|||
19560268|NCT01013740|42008300|FG000|Overall Study|study close / terminated : done in error|2|||
19560269|NCT01013740|42008301|FG001|Overall Study|study close / terminated : done in error|1|||
19560270|NCT01013740|42008300|FG000|Overall Study|Missing|2|||
19560271|NCT01013740|42008301|FG001|Overall Study|Missing|1|||
19560272|NCT01013740|42008300|FG000|Overall Study|Ongoing: Study records not completed|0|||
19560273|NCT01013740|42008301|FG001|Overall Study|Ongoing: Study records not completed|2|||
19560274|NCT01013350|42008311|FG000|Overall Study|Lost to Follow-up|15|||
19560275|NCT01013350|42008312|FG001|Overall Study|Lost to Follow-up|95|||
19560276|NCT01013350|42008311|FG000|Overall Study|Adverse Event|0|||
19560277|NCT01013350|42008312|FG001|Overall Study|Adverse Event|1|||
19560278|NCT01013350|42008311|FG000|Overall Study|Physician Decision|4|||
19560279|NCT01013350|42008312|FG001|Overall Study|Physician Decision|20|||
19560280|NCT01013350|42008311|FG000|Overall Study|Withdrawal by Subject|15|||
19560281|NCT01013350|42008312|FG001|Overall Study|Withdrawal by Subject|38|||
19560282|NCT01013350|42008311|FG000|Overall Study|Death|3|||
19560283|NCT01013350|42008312|FG001|Overall Study|Death|5|||
19560284|NCT01013350|42008311|FG000|Overall Study|Participant entered interventional study|0|||
19560285|NCT01013350|42008312|FG001|Overall Study|Participant entered interventional study|8|||
19560286|NCT01013350|42008311|FG000|Overall Study|Other|1|||
19560287|NCT01013350|42008312|FG001|Overall Study|Other|25|||
19560288|NCT01018030|42008322|FG000|Overall Study|Adverse Event|10|||
19560289|NCT01018030|42008323|FG001|Overall Study|Adverse Event|5|||
19560290|NCT01018030|42008324|FG002|Overall Study|Adverse Event|5|||
19639220|NCT00688467|42088612|FG000|Treatment Period 2|Protocol Violation|0|||
19639221|NCT00688467|42088613|FG001|Treatment Period 2|Protocol Violation|1|||
19639222|NCT00688467|42088612|FG000|Treatment Period 2|Adverse Event|0|||
19639223|NCT00688467|42088613|FG001|Treatment Period 2|Adverse Event|1|||
19639224|NCT00688155|42088623|FG000|Overall Study|Withdrawal by Subject|2|||
19560291|NCT01018030|42008322|FG000|Overall Study|Withdrawal by Subject|2|||
19560292|NCT01018030|42008323|FG001|Overall Study|Withdrawal by Subject|2|||
19560293|NCT01018030|42008324|FG002|Overall Study|Withdrawal by Subject|4|||
19560294|NCT01018030|42008322|FG000|Overall Study|Lost to Follow-up|2|||
19560295|NCT01018030|42008323|FG001|Overall Study|Lost to Follow-up|0|||
19560296|NCT01018030|42008324|FG002|Overall Study|Lost to Follow-up|3|||
19560297|NCT01018030|42008322|FG000|Overall Study|Protocol Violation|2|||
19560298|NCT01018030|42008323|FG001|Overall Study|Protocol Violation|1|||
19560299|NCT01018030|42008324|FG002|Overall Study|Protocol Violation|0|||
19560300|NCT01018030|42008322|FG000|Overall Study|Physician Decision|1|||
19560301|NCT01018030|42008323|FG001|Overall Study|Physician Decision|0|||
19560302|NCT01018030|42008324|FG002|Overall Study|Physician Decision|1|||
19560303|NCT01018030|42008322|FG000|Overall Study|Lack of Efficacy|1|||
19560304|NCT01018030|42008323|FG001|Overall Study|Lack of Efficacy|0|||
19560305|NCT01018030|42008324|FG002|Overall Study|Lack of Efficacy|0|||
19560306|NCT01018030|42008322|FG000|Overall Study|Did Not Receive Study Drug|1|||
19560307|NCT01018030|42008323|FG001|Overall Study|Did Not Receive Study Drug|3|||
19560308|NCT01018030|42008324|FG002|Overall Study|Did Not Receive Study Drug|0|||
19639225|NCT00688155|42088624|FG001|Overall Study|Withdrawal by Subject|2|||
19639226|NCT00688155|42088625|FG002|Overall Study|Withdrawal by Subject|1|||
19639227|NCT00688155|42088626|FG003|Overall Study|Withdrawal by Subject|1|||
19560309|NCT01217073|42008340|FG000|Base Period|Adverse Event|1|||
19560310|NCT01217073|42008341|FG001|Base Period|Adverse Event|0|||
19560311|NCT01217073|42008342|FG002|Base Period|Adverse Event|1|||
19560312|NCT01217073|42008343|FG003|Base Period|Adverse Event|0|||
19560313|NCT01217073|42008344|FG004|Base Period|Adverse Event|4|||
19560314|NCT01217073|42008345|FG005|Base Period|Adverse Event|1|||
19560315|NCT01217073|42008346|FG006|Base Period|Adverse Event|0|||
19560316|NCT01217073|42008347|FG007|Base Period|Adverse Event|0|||
19560317|NCT01217073|42008340|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
19560318|NCT01217073|42008341|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560319|NCT01217073|42008342|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560320|NCT01217073|42008343|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560321|NCT01217073|42008344|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560322|NCT01217073|42008345|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560323|NCT01217073|42008346|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560324|NCT01217073|42008347|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
19560325|NCT01217073|42008340|FG000|Base Period|Excluded medication|0|||
19560326|NCT01217073|42008341|FG001|Base Period|Excluded medication|0|||
19639228|NCT00690573|42088636|FG000|Overall Study|Lack of Efficacy|8|||
19639229|NCT00690573|42088636|FG000|Overall Study|Withdrawal by Subject|1|||
19639230|NCT00719264|42088642|FG000|Overall Study|Adverse Event|41|||
19639231|NCT00719264|42088643|FG001|Overall Study|Adverse Event|49|||
19639232|NCT00719264|42088642|FG000|Overall Study|Death|13|||
19639233|NCT00719264|42088643|FG001|Overall Study|Death|10|||
19739627|NCT00100048|42186630|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
19739628|NCT02757430|42186655|FG000|Overall Study|Physician Decision|6|||
19739629|NCT02757430|42186655|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
19739630|NCT02757430|42186655|FG000|Overall Study|No informed consent|1|||
19739631|NCT02757430|42186655|FG000|Overall Study|No procedure performed|2|||
19739632|NCT02757352|42186671|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
19739633|NCT02757352|42186672|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739634|NCT02757352|42186673|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
19560327|NCT01217073|42008342|FG002|Base Period|Excluded medication|0|||
19560328|NCT01217073|42008343|FG003|Base Period|Excluded medication|0|||
19560329|NCT01217073|42008344|FG004|Base Period|Excluded medication|1|||
19560330|NCT01217073|42008345|FG005|Base Period|Excluded medication|0|||
19560331|NCT01217073|42008346|FG006|Base Period|Excluded medication|0|||
19560332|NCT01217073|42008347|FG007|Base Period|Excluded medication|0|||
19639234|NCT00719264|42088642|FG000|Overall Study|Administrative Problems|6|||
19739635|NCT02757352|42186674|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739636|NCT02757352|42186675|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739637|NCT02757352|42186676|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739638|NCT02757352|42186677|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19560333|NCT01217073|42008340|FG000|Base Period|Lack of Efficacy|0|||
19560334|NCT01217073|42008341|FG001|Base Period|Lack of Efficacy|0|||
19560335|NCT01217073|42008342|FG002|Base Period|Lack of Efficacy|0|||
19560336|NCT01217073|42008343|FG003|Base Period|Lack of Efficacy|0|||
19560337|NCT01217073|42008344|FG004|Base Period|Lack of Efficacy|0|||
19560338|NCT01217073|42008345|FG005|Base Period|Lack of Efficacy|1|||
19560339|NCT01217073|42008346|FG006|Base Period|Lack of Efficacy|0|||
19560340|NCT01217073|42008347|FG007|Base Period|Lack of Efficacy|0|||
19560341|NCT01217073|42008340|FG000|Base Period|Lost to Follow-up|0|||
19560342|NCT01217073|42008341|FG001|Base Period|Lost to Follow-up|0|||
19560343|NCT01217073|42008342|FG002|Base Period|Lost to Follow-up|1|||
19560344|NCT01217073|42008343|FG003|Base Period|Lost to Follow-up|1|||
19560345|NCT01217073|42008344|FG004|Base Period|Lost to Follow-up|3|||
19560346|NCT01217073|42008345|FG005|Base Period|Lost to Follow-up|0|||
19560347|NCT01217073|42008346|FG006|Base Period|Lost to Follow-up|0|||
19560348|NCT01217073|42008347|FG007|Base Period|Lost to Follow-up|0|||
19560349|NCT01217073|42008340|FG000|Base Period|Physician Decision|0|||
19560350|NCT01217073|42008341|FG001|Base Period|Physician Decision|0|||
19560351|NCT01217073|42008342|FG002|Base Period|Physician Decision|0|||
19560352|NCT01217073|42008343|FG003|Base Period|Physician Decision|0|||
19560353|NCT01217073|42008344|FG004|Base Period|Physician Decision|1|||
19560354|NCT01217073|42008345|FG005|Base Period|Physician Decision|0|||
19560355|NCT01217073|42008346|FG006|Base Period|Physician Decision|0|||
19560356|NCT01217073|42008347|FG007|Base Period|Physician Decision|0|||
19560357|NCT01217073|42008340|FG000|Base Period|Protocol Violation|1|||
19560358|NCT01217073|42008341|FG001|Base Period|Protocol Violation|0|||
19560359|NCT01217073|42008342|FG002|Base Period|Protocol Violation|0|||
19560360|NCT01217073|42008343|FG003|Base Period|Protocol Violation|0|||
19560361|NCT01217073|42008344|FG004|Base Period|Protocol Violation|1|||
19560362|NCT01217073|42008345|FG005|Base Period|Protocol Violation|2|||
19560363|NCT01217073|42008346|FG006|Base Period|Protocol Violation|0|||
19560364|NCT01217073|42008347|FG007|Base Period|Protocol Violation|0|||
19560365|NCT01217073|42008340|FG000|Base Period|Withdrawal by Subject|4|||
19560366|NCT01217073|42008341|FG001|Base Period|Withdrawal by Subject|5|||
19560367|NCT01217073|42008342|FG002|Base Period|Withdrawal by Subject|5|||
19560368|NCT01217073|42008343|FG003|Base Period|Withdrawal by Subject|1|||
19560369|NCT01217073|42008344|FG004|Base Period|Withdrawal by Subject|5|||
19560370|NCT01217073|42008345|FG005|Base Period|Withdrawal by Subject|5|||
19560371|NCT01217073|42008346|FG006|Base Period|Withdrawal by Subject|0|||
19560372|NCT01217073|42008347|FG007|Base Period|Withdrawal by Subject|0|||
19560373|NCT01217073|42008340|FG000|Extension Period|Adverse Event|0|||
19560374|NCT01217073|42008341|FG001|Extension Period|Adverse Event|0|||
19560375|NCT01217073|42008342|FG002|Extension Period|Adverse Event|0|||
19560376|NCT01217073|42008343|FG003|Extension Period|Adverse Event|0|||
19560377|NCT01217073|42008344|FG004|Extension Period|Adverse Event|0|||
19560378|NCT01217073|42008345|FG005|Extension Period|Adverse Event|0|||
19560379|NCT01217073|42008346|FG006|Extension Period|Adverse Event|19|||
19560380|NCT01217073|42008347|FG007|Extension Period|Adverse Event|5|||
19560381|NCT01217073|42008340|FG000|Extension Period|ALT/AST|0|||
19560382|NCT01217073|42008341|FG001|Extension Period|ALT/AST|0|||
19560383|NCT01217073|42008342|FG002|Extension Period|ALT/AST|0|||
19560384|NCT01217073|42008343|FG003|Extension Period|ALT/AST|0|||
19560385|NCT01217073|42008344|FG004|Extension Period|ALT/AST|0|||
19560386|NCT01217073|42008345|FG005|Extension Period|ALT/AST|0|||
19560387|NCT01217073|42008346|FG006|Extension Period|ALT/AST|2|||
19560388|NCT01217073|42008347|FG007|Extension Period|ALT/AST|0|||
19560389|NCT01217073|42008340|FG000|Extension Period|Contraindication to study medication|0|||
19560390|NCT01217073|42008341|FG001|Extension Period|Contraindication to study medication|0|||
19560391|NCT01217073|42008342|FG002|Extension Period|Contraindication to study medication|0|||
19560392|NCT01217073|42008343|FG003|Extension Period|Contraindication to study medication|0|||
19560393|NCT01217073|42008344|FG004|Extension Period|Contraindication to study medication|0|||
19560394|NCT01217073|42008345|FG005|Extension Period|Contraindication to study medication|0|||
19560395|NCT01217073|42008346|FG006|Extension Period|Contraindication to study medication|1|||
19560396|NCT01217073|42008347|FG007|Extension Period|Contraindication to study medication|0|||
19560397|NCT01217073|42008340|FG000|Extension Period|Creatinine/eGFR|0|||
19560398|NCT01217073|42008341|FG001|Extension Period|Creatinine/eGFR|0|||
19560399|NCT01217073|42008342|FG002|Extension Period|Creatinine/eGFR|0|||
19560400|NCT01217073|42008343|FG003|Extension Period|Creatinine/eGFR|0|||
19560401|NCT01217073|42008344|FG004|Extension Period|Creatinine/eGFR|0|||
19560402|NCT01217073|42008345|FG005|Extension Period|Creatinine/eGFR|0|||
19560403|NCT01217073|42008346|FG006|Extension Period|Creatinine/eGFR|11|||
19560404|NCT01217073|42008347|FG007|Extension Period|Creatinine/eGFR|1|||
19560405|NCT01217073|42008340|FG000|Extension Period|Death|0|||
19560406|NCT01217073|42008341|FG001|Extension Period|Death|0|||
19560407|NCT01217073|42008342|FG002|Extension Period|Death|0|||
19560408|NCT01217073|42008343|FG003|Extension Period|Death|0|||
19560409|NCT01217073|42008344|FG004|Extension Period|Death|0|||
19560410|NCT01217073|42008345|FG005|Extension Period|Death|0|||
19560411|NCT01217073|42008346|FG006|Extension Period|Death|1|||
19560412|NCT01217073|42008347|FG007|Extension Period|Death|0|||
19560413|NCT01217073|42008340|FG000|Extension Period|Excluded medication|0|||
19560414|NCT01217073|42008341|FG001|Extension Period|Excluded medication|0|||
19560415|NCT01217073|42008342|FG002|Extension Period|Excluded medication|0|||
19560416|NCT01217073|42008343|FG003|Extension Period|Excluded medication|0|||
19560417|NCT01217073|42008344|FG004|Extension Period|Excluded medication|0|||
19560418|NCT01217073|42008345|FG005|Extension Period|Excluded medication|0|||
19560419|NCT01217073|42008346|FG006|Extension Period|Excluded medication|2|||
19560420|NCT01217073|42008347|FG007|Extension Period|Excluded medication|0|||
19560421|NCT01217073|42008340|FG000|Extension Period|Lack of Efficacy|0|||
19560422|NCT01217073|42008341|FG001|Extension Period|Lack of Efficacy|0|||
19560423|NCT01217073|42008342|FG002|Extension Period|Lack of Efficacy|0|||
19560424|NCT01217073|42008343|FG003|Extension Period|Lack of Efficacy|0|||
19560425|NCT01217073|42008344|FG004|Extension Period|Lack of Efficacy|0|||
19560426|NCT01217073|42008345|FG005|Extension Period|Lack of Efficacy|0|||
19560427|NCT01217073|42008346|FG006|Extension Period|Lack of Efficacy|3|||
19560428|NCT01217073|42008347|FG007|Extension Period|Lack of Efficacy|0|||
19560429|NCT01217073|42008340|FG000|Extension Period|Lost to Follow-up|0|||
19560430|NCT01217073|42008341|FG001|Extension Period|Lost to Follow-up|0|||
19560431|NCT01217073|42008342|FG002|Extension Period|Lost to Follow-up|0|||
19560432|NCT01217073|42008343|FG003|Extension Period|Lost to Follow-up|0|||
19560433|NCT01217073|42008344|FG004|Extension Period|Lost to Follow-up|0|||
19560434|NCT01217073|42008345|FG005|Extension Period|Lost to Follow-up|0|||
19739639|NCT02757352|42186678|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19560435|NCT01217073|42008346|FG006|Extension Period|Lost to Follow-up|9|||
19560436|NCT01217073|42008347|FG007|Extension Period|Lost to Follow-up|1|||
19560437|NCT01217073|42008340|FG000|Extension Period|Non-compliance with study drug|0|||
19560438|NCT01217073|42008341|FG001|Extension Period|Non-compliance with study drug|0|||
19560439|NCT01217073|42008342|FG002|Extension Period|Non-compliance with study drug|0|||
19560440|NCT01217073|42008343|FG003|Extension Period|Non-compliance with study drug|0|||
19560441|NCT01217073|42008344|FG004|Extension Period|Non-compliance with study drug|0|||
19560442|NCT01217073|42008345|FG005|Extension Period|Non-compliance with study drug|0|||
19560443|NCT01217073|42008346|FG006|Extension Period|Non-compliance with study drug|0|||
19560444|NCT01217073|42008347|FG007|Extension Period|Non-compliance with study drug|1|||
19560445|NCT01217073|42008340|FG000|Extension Period|Physician Decision|0|||
19560446|NCT01217073|42008341|FG001|Extension Period|Physician Decision|0|||
19739640|NCT02757352|42186679|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739641|NCT02757352|42186680|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
19739642|NCT02757352|42186671|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739643|NCT02757352|42186672|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739644|NCT02757352|42186673|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
19739645|NCT02757352|42186674|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739646|NCT02757352|42186675|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739647|NCT02757352|42186676|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19560447|NCT01217073|42008342|FG002|Extension Period|Physician Decision|0|||
19560448|NCT01217073|42008343|FG003|Extension Period|Physician Decision|0|||
19560449|NCT01217073|42008344|FG004|Extension Period|Physician Decision|0|||
19560450|NCT01217073|42008345|FG005|Extension Period|Physician Decision|0|||
19560451|NCT01217073|42008346|FG006|Extension Period|Physician Decision|4|||
19560452|NCT01217073|42008347|FG007|Extension Period|Physician Decision|1|||
19560453|NCT01217073|42008340|FG000|Extension Period|Protocol Violation|0|||
19560454|NCT01217073|42008341|FG001|Extension Period|Protocol Violation|0|||
19560455|NCT01217073|42008342|FG002|Extension Period|Protocol Violation|0|||
19560456|NCT01217073|42008343|FG003|Extension Period|Protocol Violation|0|||
19560457|NCT01217073|42008344|FG004|Extension Period|Protocol Violation|0|||
19560458|NCT01217073|42008345|FG005|Extension Period|Protocol Violation|0|||
19560459|NCT01217073|42008346|FG006|Extension Period|Protocol Violation|2|||
19560460|NCT01217073|42008347|FG007|Extension Period|Protocol Violation|1|||
19560461|NCT01217073|42008340|FG000|Extension Period|Site discontinued study participation|0|||
19560462|NCT01217073|42008341|FG001|Extension Period|Site discontinued study participation|0|||
19560463|NCT01217073|42008342|FG002|Extension Period|Site discontinued study participation|0|||
19560464|NCT01217073|42008343|FG003|Extension Period|Site discontinued study participation|0|||
19560465|NCT01217073|42008344|FG004|Extension Period|Site discontinued study participation|0|||
19560466|NCT01217073|42008345|FG005|Extension Period|Site discontinued study participation|0|||
19560467|NCT01217073|42008346|FG006|Extension Period|Site discontinued study participation|7|||
19560468|NCT01217073|42008347|FG007|Extension Period|Site discontinued study participation|2|||
19560469|NCT01217073|42008340|FG000|Extension Period|Withdrawal by Subject|0|||
19560470|NCT01217073|42008341|FG001|Extension Period|Withdrawal by Subject|0|||
19560471|NCT01217073|42008342|FG002|Extension Period|Withdrawal by Subject|0|||
19560472|NCT01217073|42008343|FG003|Extension Period|Withdrawal by Subject|0|||
19560473|NCT01217073|42008344|FG004|Extension Period|Withdrawal by Subject|0|||
19560474|NCT01217073|42008345|FG005|Extension Period|Withdrawal by Subject|0|||
19560475|NCT01217073|42008346|FG006|Extension Period|Withdrawal by Subject|30|||
19560476|NCT01217073|42008347|FG007|Extension Period|Withdrawal by Subject|8|||
19560477|NCT00985621|42008375|FG000|Overall Study|Adverse Event|2|||
19560478|NCT00985621|42008376|FG001|Overall Study|Adverse Event|3|||
19560479|NCT00985621|42008377|FG002|Overall Study|Adverse Event|4|||
19560480|NCT00985621|42008378|FG003|Overall Study|Adverse Event|16|||
19560481|NCT00985621|42008375|FG000|Overall Study|Lack of Efficacy|10|||
19560482|NCT00985621|42008376|FG001|Overall Study|Lack of Efficacy|6|||
19560483|NCT00985621|42008377|FG002|Overall Study|Lack of Efficacy|5|||
19560484|NCT00985621|42008378|FG003|Overall Study|Lack of Efficacy|12|||
19560485|NCT00985621|42008375|FG000|Overall Study|Lost to Follow-up|2|||
19560486|NCT00985621|42008376|FG001|Overall Study|Lost to Follow-up|3|||
19560487|NCT00985621|42008377|FG002|Overall Study|Lost to Follow-up|4|||
19560488|NCT00985621|42008378|FG003|Overall Study|Lost to Follow-up|4|||
19560489|NCT00985621|42008375|FG000|Overall Study|Study Terminated by Sponsor|89|||
19560490|NCT00985621|42008376|FG001|Overall Study|Study Terminated by Sponsor|108|||
19560491|NCT00985621|42008377|FG002|Overall Study|Study Terminated by Sponsor|99|||
19560492|NCT00985621|42008378|FG003|Overall Study|Study Terminated by Sponsor|92|||
19560493|NCT00985621|42008375|FG000|Overall Study|Protocol Violation|1|||
19382143|NCT02130466|41625355|FG012|Overall Study|Physician Decision|0|||
19382144|NCT02130466|41625356|FG013|Overall Study|Physician Decision|0|||
19382145|NCT02130466|41625343|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
19560494|NCT00985621|42008376|FG001|Overall Study|Protocol Violation|1|||
19560495|NCT00985621|42008377|FG002|Overall Study|Protocol Violation|1|||
19560496|NCT00985621|42008378|FG003|Overall Study|Protocol Violation|0|||
19560497|NCT00985621|42008375|FG000|Overall Study|Withdrawal by Subject|8|||
19560498|NCT00985621|42008376|FG001|Overall Study|Withdrawal by Subject|10|||
19560499|NCT00985621|42008377|FG002|Overall Study|Withdrawal by Subject|8|||
19560500|NCT00985621|42008378|FG003|Overall Study|Withdrawal by Subject|12|||
19560501|NCT00985621|42008375|FG000|Overall Study|Other|1|||
19560502|NCT00985621|42008376|FG001|Overall Study|Other|0|||
19560503|NCT00985621|42008377|FG002|Overall Study|Other|0|||
19560504|NCT00985621|42008378|FG003|Overall Study|Other|0|||
19560505|NCT00985621|42008375|FG000|Overall Study|Randomized but not Treated|1|||
19560506|NCT00985621|42008376|FG001|Overall Study|Randomized but not Treated|0|||
19560507|NCT00985621|42008377|FG002|Overall Study|Randomized but not Treated|2|||
19560508|NCT00985621|42008378|FG003|Overall Study|Randomized but not Treated|1|||
19560509|NCT01215981|42008392|FG000|Overall Study|Physician Decision|0|||
19560510|NCT01215981|42008393|FG001|Overall Study|Physician Decision|1|||
19560511|NCT01215981|42008392|FG000|Overall Study|Protocol Violation|1|||
19560512|NCT01215981|42008393|FG001|Overall Study|Protocol Violation|0|||
19560513|NCT01215981|42008392|FG000|Overall Study|Withdrawal by Subject|1|||
19560514|NCT01215981|42008393|FG001|Overall Study|Withdrawal by Subject|0|||
19560515|NCT01215513|42008399|FG000|Overall Study|Not completed CS42|9|||
19560516|NCT01215513|42008399|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
19560517|NCT01215513|42008399|FG000|Overall Study|Adverse event (CS42A)|2|||
19560518|NCT01215513|42008399|FG000|Overall Study|Physician decision (CS42A)|6|||
19739648|NCT02757352|42186677|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739649|NCT02757352|42186678|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739650|NCT02757352|42186679|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739651|NCT02757352|42186680|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
19739652|NCT02757352|42186671|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
19739653|NCT02757352|42186672|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
19739654|NCT02757352|42186673|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
19739655|NCT02757352|42186674|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19739656|NCT02757352|42186675|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19382146|NCT02130466|41625344|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
19739657|NCT02757352|42186676|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19739658|NCT02757352|42186677|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19739659|NCT02757352|42186678|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19382147|NCT02130466|41625345|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
19382148|NCT02130466|41625346|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
19382149|NCT02130466|41625347|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
19382150|NCT02130466|41625348|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
19382151|NCT02130466|41625349|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
19382152|NCT02130466|41625350|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
19560519|NCT01215513|42008399|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
19560520|NCT01215513|42008399|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
19560521|NCT01215435|42008406|FG000|Overall Study|Adverse Event|1|||
19560522|NCT01215435|42008407|FG001|Overall Study|Adverse Event|0|||
19560523|NCT01215435|42008406|FG000|Overall Study|Protocol Violation|2|||
19560524|NCT01215435|42008407|FG001|Overall Study|Protocol Violation|0|||
19560525|NCT01215435|42008406|FG000|Overall Study|Withdrawal Criteria|8|||
19560526|NCT01215435|42008407|FG001|Overall Study|Withdrawal Criteria|11|||
19560527|NCT01215435|42008406|FG000|Overall Study|Lost to Follow-up|3|||
19560528|NCT01215435|42008407|FG001|Overall Study|Lost to Follow-up|0|||
19560529|NCT01215435|42008406|FG000|Overall Study|Unclassified|5|||
19560530|NCT01215435|42008407|FG001|Overall Study|Unclassified|5|||
19560531|NCT01215357|42008413|FG000|Overall Study|Withdrawal by Subject|3|||
19560532|NCT01215357|42008413|FG000|Overall Study|Protocol Violation|9|||
19560533|NCT00984295|42008420|FG000|Overall Study|Lost to Follow-up|31|||
19560534|NCT00984295|42008421|FG001|Overall Study|Lost to Follow-up|12|||
19560535|NCT00984295|42008422|FG002|Overall Study|Lost to Follow-up|13|||
19560536|NCT00984295|42008420|FG000|Overall Study|Protocol Violation|2|||
19560537|NCT00984295|42008421|FG001|Overall Study|Protocol Violation|1|||
19560538|NCT00984295|42008422|FG002|Overall Study|Protocol Violation|4|||
19382153|NCT02130466|41625351|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
19382154|NCT02130466|41625352|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
19382155|NCT02130466|41625353|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
19382156|NCT02130466|41625354|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
19382157|NCT02130466|41625355|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
19560539|NCT00984295|42008420|FG000|Overall Study|Withdrawal by Subject|18|||
19560540|NCT00984295|42008421|FG001|Overall Study|Withdrawal by Subject|9|||
19560541|NCT00984295|42008422|FG002|Overall Study|Withdrawal by Subject|12|||
19560542|NCT00984295|42008420|FG000|Overall Study|CAE - discontinued test vaccine|0|||
19560543|NCT00984295|42008421|FG001|Overall Study|CAE - discontinued test vaccine|1|||
19560544|NCT00984295|42008422|FG002|Overall Study|CAE - discontinued test vaccine|3|||
19560545|NCT00984295|42008420|FG000|Overall Study|Missed one or more blood samplings|3|||
19560546|NCT00984295|42008421|FG001|Overall Study|Missed one or more blood samplings|7|||
19560547|NCT00984295|42008422|FG002|Overall Study|Missed one or more blood samplings|2|||
19382158|NCT02130466|41625356|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
19382159|NCT02130466|41625343|FG000|Overall Study|Withdrawal by Subject|1|||
19382160|NCT02130466|41625344|FG001|Overall Study|Withdrawal by Subject|0|||
19382161|NCT02130466|41625345|FG002|Overall Study|Withdrawal by Subject|0|||
19382162|NCT02130466|41625346|FG003|Overall Study|Withdrawal by Subject|0|||
19382163|NCT02130466|41625347|FG004|Overall Study|Withdrawal by Subject|0|||
19382164|NCT02130466|41625348|FG005|Overall Study|Withdrawal by Subject|1|||
19560548|NCT00984295|42008420|FG000|Overall Study|Incomplete safety follow-up|11|||
19560549|NCT00984295|42008421|FG001|Overall Study|Incomplete safety follow-up|2|||
19560550|NCT00984295|42008422|FG002|Overall Study|Incomplete safety follow-up|3|||
19560551|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
19560552|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19560553|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19560554|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19560555|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19560556|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
19560557|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
19560558|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
19560559|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
19560560|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
19560561|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
19560562|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
19560563|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
19560564|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
19560565|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
19560566|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
19560567|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19560568|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19560569|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19560570|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19560571|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
19560572|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
19560573|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
19560574|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
19560575|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
19560576|NCT01017952|42008434|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
19560577|NCT01017952|42008435|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19560578|NCT01017952|42008436|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19560579|NCT01017952|42008437|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19560580|NCT01017952|42008438|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19560581|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
19382165|NCT02130466|41625349|FG006|Overall Study|Withdrawal by Subject|0|||
19382166|NCT02130466|41625350|FG007|Overall Study|Withdrawal by Subject|0|||
19382167|NCT02130466|41625351|FG008|Overall Study|Withdrawal by Subject|1|||
19382168|NCT02130466|41625352|FG009|Overall Study|Withdrawal by Subject|0|||
19382169|NCT02130466|41625353|FG010|Overall Study|Withdrawal by Subject|0|||
19382170|NCT02130466|41625354|FG011|Overall Study|Withdrawal by Subject|0|||
19382171|NCT02130466|41625355|FG012|Overall Study|Withdrawal by Subject|0|||
19382172|NCT02130466|41625356|FG013|Overall Study|Withdrawal by Subject|0|||
19382173|NCT02163538|41625405|FG000|Overall Study|Protocol Violation|1|||
19382174|NCT02163538|41625406|FG001|Overall Study|Protocol Violation|0|||
19382175|NCT02163538|41625405|FG000|Overall Study|Physician Decision|0|||
19382176|NCT02163538|41625406|FG001|Overall Study|Physician Decision|1|||
19560582|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
19382177|NCT02163226|41625414|FG000|Overall Study|Death|2|||
19382178|NCT02163226|41625415|FG001|Overall Study|Death|1|||
19382179|NCT02163226|41625414|FG000|Overall Study|Withdrawal by Subject|5|||
19382180|NCT02163226|41625415|FG001|Overall Study|Withdrawal by Subject|2|||
19382181|NCT02163226|41625414|FG000|Overall Study|Returned home, local radiotherapy|3|||
19382182|NCT02163226|41625415|FG001|Overall Study|Returned home, local radiotherapy|0|||
19560583|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
19560584|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
19560585|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
19560586|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19560587|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
19560588|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
19560589|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
19560590|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
19560591|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
19560592|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
19560593|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
19560594|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
19560595|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
19560596|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
19560597|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
19560598|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
19560599|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
19560600|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
19560601|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
19560602|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
19560603|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
19560604|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
19560605|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
19560606|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19560607|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
19560608|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
19560609|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19560610|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19560611|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19560612|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
19560613|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
19560614|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
19560615|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
19560616|NCT01017952|42008434|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
19560617|NCT01017952|42008435|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
19560618|NCT01017952|42008436|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
19560619|NCT01017952|42008437|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
19560620|NCT01017952|42008438|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
19560621|NCT01214655|42008451|FG000|Part A|Progressive Disease|7|||
19560622|NCT01214655|42008452|FG001|Part A|Progressive Disease|0|||
19560623|NCT01214655|42008453|FG002|Part A|Progressive Disease|0|||
19560624|NCT01214655|42008451|FG000|Part A|Physician Decision|1|||
19560625|NCT01214655|42008452|FG001|Part A|Physician Decision|0|||
19560626|NCT01214655|42008453|FG002|Part A|Physician Decision|0|||
19560627|NCT01214655|42008451|FG000|Part B|Progressive disease|0|||
19560628|NCT01214655|42008452|FG001|Part B|Progressive disease|10|||
19560629|NCT01214655|42008453|FG002|Part B|Progressive disease|0|||
19560630|NCT01214655|42008451|FG000|Part B|Death|0|||
19560631|NCT01214655|42008452|FG001|Part B|Death|1|||
19560632|NCT01214655|42008453|FG002|Part B|Death|0|||
19560633|NCT01214655|42008451|FG000|Part B|Withdrawal by Subject|0|||
19560634|NCT01214655|42008452|FG001|Part B|Withdrawal by Subject|2|||
19560635|NCT01214655|42008453|FG002|Part B|Withdrawal by Subject|0|||
19560636|NCT01214655|42008451|FG000|Part C|Progressive Disease|0|||
19560637|NCT01214655|42008452|FG001|Part C|Progressive Disease|0|||
19560638|NCT01214655|42008453|FG002|Part C|Progressive Disease|5|||
19560639|NCT01214655|42008451|FG000|Part C|Death|0|||
19560640|NCT01214655|42008452|FG001|Part C|Death|0|||
19560641|NCT01214655|42008453|FG002|Part C|Death|1|||
19560642|NCT01214655|42008451|FG000|Part C|Physician Decision|0|||
19560643|NCT01214655|42008452|FG001|Part C|Physician Decision|0|||
19560644|NCT01214655|42008453|FG002|Part C|Physician Decision|1|||
19560645|NCT01017874|42008501|FG000|Overall Study|Withdrawal by Subject|23|||
19560646|NCT01017874|42008502|FG001|Overall Study|Withdrawal by Subject|20|||
19560647|NCT01017874|42008501|FG000|Overall Study|Sponsor decision|3|||
19560648|NCT01017874|42008502|FG001|Overall Study|Sponsor decision|1|||
19560649|NCT01017874|42008501|FG000|Overall Study|Lost to Follow-up|3|||
19560650|NCT01017874|42008502|FG001|Overall Study|Lost to Follow-up|2|||
19560651|NCT01017874|42008501|FG000|Overall Study|Physician Decision|1|||
19560652|NCT01017874|42008502|FG001|Overall Study|Physician Decision|3|||
19560653|NCT01015768|42008508|FG000|Overall Study|Some subject data unuseable|4|||
19560654|NCT01015768|42008509|FG001|Overall Study|Some subject data unuseable|4|||
19560655|NCT04426630|42008517|FG000|Overall Study|Death|4|||
19560656|NCT04426630|42008517|FG000|Overall Study|Lost to Follow-up|2|||
19560657|NCT01010230|42008523|FG000|Overall Study|Withdrawal by Subject|6|||
19560658|NCT01010230|42008524|FG001|Overall Study|Withdrawal by Subject|5|||
19560659|NCT01010230|42008523|FG000|Overall Study|Lost to Follow-up|4|||
19560660|NCT01010230|42008524|FG001|Overall Study|Lost to Follow-up|2|||
19560661|NCT01009840|42008530|FG000|Overall Study|Lost to Follow-up|1|||
19560662|NCT01009840|42008530|FG000|Overall Study|Adverse Event|4|||
19560663|NCT01009840|42008530|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
19560664|NCT01009840|42008530|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
19560665|NCT01009840|42008530|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
19560666|NCT00982657|42008538|FG000|Overall Study|Death|1|||
19560667|NCT00982657|42008539|FG001|Overall Study|Death|0|||
19560668|NCT00982657|42008540|FG002|Overall Study|Death|1|||
19560669|NCT00982657|42008541|FG003|Overall Study|Death|1|||
19560670|NCT00982657|42008538|FG000|Overall Study|Withdrawal by Subject|0|||
19560671|NCT00982657|42008539|FG001|Overall Study|Withdrawal by Subject|0|||
19560672|NCT00982657|42008540|FG002|Overall Study|Withdrawal by Subject|1|||
19560673|NCT00982657|42008541|FG003|Overall Study|Withdrawal by Subject|3|||
19560674|NCT00982657|42008538|FG000|Overall Study|Other|0|||
19560675|NCT00982657|42008539|FG001|Overall Study|Other|0|||
19560676|NCT00982657|42008540|FG002|Overall Study|Other|0|||
19560677|NCT00982657|42008541|FG003|Overall Study|Other|4|||
19560678|NCT00982657|42008538|FG000|Overall Study|On going at date of cut-off|0|||
19560679|NCT00982657|42008539|FG001|Overall Study|On going at date of cut-off|0|||
19739660|NCT02757352|42186679|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19739661|NCT02757352|42186680|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
19739662|NCT02757352|42186671|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739663|NCT02757352|42186672|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
19739664|NCT02757352|42186673|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739665|NCT02757352|42186674|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739666|NCT02757352|42186675|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739667|NCT02757352|42186676|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739668|NCT02757352|42186677|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739669|NCT02757352|42186678|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739670|NCT02757352|42186679|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739671|NCT02757352|42186680|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
19739672|NCT02757352|42186671|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739673|NCT02757352|42186672|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
19739674|NCT02757352|42186673|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739675|NCT02757352|42186674|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739676|NCT02757352|42186675|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739677|NCT02757352|42186676|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739678|NCT02757352|42186677|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739679|NCT02757352|42186678|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739680|NCT02757352|42186679|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739681|NCT02757352|42186680|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739682|NCT02757352|42186671|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
19739683|NCT02757352|42186672|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
19739684|NCT02757352|42186673|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
19739685|NCT02757352|42186674|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739686|NCT02757352|42186675|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739687|NCT02757352|42186676|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19382183|NCT02163226|41625414|FG000|Overall Study|Repeat imaging showed no disease|2|||
19560680|NCT00982657|42008540|FG002|Overall Study|On going at date of cut-off|0|||
19560681|NCT00982657|42008541|FG003|Overall Study|On going at date of cut-off|1|||
19560682|NCT01005316|42008564|FG000|Overall Study|Adverse Event|0|||
19560683|NCT01005316|42008565|FG001|Overall Study|Adverse Event|0|||
19560684|NCT01005316|42008566|FG002|Overall Study|Adverse Event|0|||
19560685|NCT01005316|42008567|FG003|Overall Study|Adverse Event|1|||
19560686|NCT01005316|42008564|FG000|Overall Study|Death|20|||
19560687|NCT01005316|42008565|FG001|Overall Study|Death|5|||
19560688|NCT01005316|42008566|FG002|Overall Study|Death|1|||
19560689|NCT01005316|42008567|FG003|Overall Study|Death|15|||
19560690|NCT01005316|42008564|FG000|Overall Study|Study Termination|5|||
19560691|NCT01005316|42008565|FG001|Overall Study|Study Termination|63|||
19560692|NCT01005316|42008566|FG002|Overall Study|Study Termination|9|||
19560693|NCT01005316|42008567|FG003|Overall Study|Study Termination|85|||
19560694|NCT01005316|42008564|FG000|Overall Study|Lost to Follow-up|1|||
19560695|NCT01005316|42008565|FG001|Overall Study|Lost to Follow-up|3|||
19560696|NCT01005316|42008566|FG002|Overall Study|Lost to Follow-up|0|||
19560697|NCT01005316|42008567|FG003|Overall Study|Lost to Follow-up|2|||
19560698|NCT01005316|42008564|FG000|Overall Study|Physician Decision|6|||
19560699|NCT01005316|42008565|FG001|Overall Study|Physician Decision|0|||
19560700|NCT01005316|42008566|FG002|Overall Study|Physician Decision|0|||
19560701|NCT01005316|42008567|FG003|Overall Study|Physician Decision|0|||
19560702|NCT01005316|42008564|FG000|Overall Study|Sponsor Decision|6|||
19560703|NCT01005316|42008565|FG001|Overall Study|Sponsor Decision|3|||
19739688|NCT02757352|42186677|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19560704|NCT01005316|42008566|FG002|Overall Study|Sponsor Decision|0|||
19560705|NCT01005316|42008567|FG003|Overall Study|Sponsor Decision|0|||
19560706|NCT01005316|42008564|FG000|Overall Study|Withdrawal by Subject|1|||
19560707|NCT01005316|42008565|FG001|Overall Study|Withdrawal by Subject|1|||
19560708|NCT01005316|42008566|FG002|Overall Study|Withdrawal by Subject|0|||
19560709|NCT01005316|42008567|FG003|Overall Study|Withdrawal by Subject|2|||
19560710|NCT01005316|42008564|FG000|Overall Study|Consented to Another Study|2|||
19560711|NCT01005316|42008565|FG001|Overall Study|Consented to Another Study|0|||
19560712|NCT01005316|42008566|FG002|Overall Study|Consented to Another Study|0|||
19560713|NCT01005316|42008567|FG003|Overall Study|Consented to Another Study|0|||
19560714|NCT01005316|42008564|FG000|Overall Study|Delisted|8|||
19560715|NCT01005316|42008565|FG001|Overall Study|Delisted|0|||
19560716|NCT01005316|42008566|FG002|Overall Study|Delisted|0|||
19560717|NCT01005316|42008567|FG003|Overall Study|Delisted|0|||
19560718|NCT01005316|42008564|FG000|Overall Study|Transferred Care|1|||
19560719|NCT01005316|42008565|FG001|Overall Study|Transferred Care|0|||
19560720|NCT01005316|42008566|FG002|Overall Study|Transferred Care|1|||
19560721|NCT01005316|42008567|FG003|Overall Study|Transferred Care|3|||
19560722|NCT01005316|42008564|FG000|Overall Study|Retransplanted|0|||
19560723|NCT01005316|42008565|FG001|Overall Study|Retransplanted|1|||
19560724|NCT01005316|42008566|FG002|Overall Study|Retransplanted|0|||
19560725|NCT01005316|42008567|FG003|Overall Study|Retransplanted|0|||
19560726|NCT01004848|42008580|FG000|Overall Study|Lost to Follow-up|55|||
19560727|NCT01004848|42008581|FG001|Overall Study|Lost to Follow-up|45|||
19560728|NCT01009294|42008589|FG000|Overall Study|Study discontinued by Sponsor|6|||
19560729|NCT01009060|42008595|FG000|Overall Study|Adverse Event|1|||
19560730|NCT01009060|42008596|FG001|Overall Study|Adverse Event|2|||
19560731|NCT01009060|42008595|FG000|Overall Study|Protocol Violation|0|||
19382184|NCT02163226|41625415|FG001|Overall Study|Repeat imaging showed no disease|0|||
19739689|NCT02757352|42186678|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19382185|NCT02163226|41625414|FG000|Overall Study|Incomplete radiotherapy|3|||
19382186|NCT02163226|41625415|FG001|Overall Study|Incomplete radiotherapy|0|||
19560732|NCT01009060|42008596|FG001|Overall Study|Protocol Violation|1|||
19560733|NCT01009060|42008595|FG000|Overall Study|Lost to Follow-up|1|||
19739690|NCT02757352|42186679|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739691|NCT02757352|42186680|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739692|NCT02757352|42186671|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
19739693|NCT02757352|42186672|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
19739694|NCT02757352|42186673|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
19739695|NCT02757352|42186674|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739696|NCT02757352|42186675|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19560734|NCT01009060|42008596|FG001|Overall Study|Lost to Follow-up|0|||
19560735|NCT01009060|42008595|FG000|Overall Study|Physician Decision|1|||
19560736|NCT01009060|42008596|FG001|Overall Study|Physician Decision|1|||
19560737|NCT01009060|42008595|FG000|Overall Study|Withdrawal by Subject|1|||
19382187|NCT02163226|41625414|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
19382188|NCT02163226|41625415|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
19382189|NCT02163226|41625414|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
19382190|NCT02163226|41625415|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
19382191|NCT02163226|41625414|FG000|Overall Study|ineligible|0|||
19382192|NCT02163226|41625415|FG001|Overall Study|ineligible|3|||
19382193|NCT02193178|41625421|FG000|Overall Study|Lost to Follow-up|1|||
19382194|NCT02193178|41625421|FG000|Overall Study|Dry eyes|1|||
19382195|NCT02129608|41625442|FG000|Overall Study|Lost to Follow-up|0|||
19382196|NCT02129608|41625443|FG001|Overall Study|Lost to Follow-up|1|||
19382197|NCT02129608|41625444|FG002|Overall Study|Lost to Follow-up|1|||
19382198|NCT02129608|41625442|FG000|Overall Study|Withdrawal by Subject|0|||
19382199|NCT02129608|41625443|FG001|Overall Study|Withdrawal by Subject|0|||
19382200|NCT02129608|41625444|FG002|Overall Study|Withdrawal by Subject|2|||
19382201|NCT01631188|41625452|FG000|Overall Study|Physician Decision|75|||
19382202|NCT02129062|41625456|FG000|Overall Study|Death|1|||
19560738|NCT01009060|42008596|FG001|Overall Study|Withdrawal by Subject|1|||
19560739|NCT00988429|42008609|FG000|Overall Study|Adverse Event|9|||
19560740|NCT00988429|42008610|FG001|Overall Study|Adverse Event|21|||
19560741|NCT00988429|42008611|FG002|Overall Study|Adverse Event|45|||
19560742|NCT00988429|42008609|FG000|Overall Study|Lack of Efficacy|0|||
19560743|NCT00988429|42008610|FG001|Overall Study|Lack of Efficacy|0|||
19560744|NCT00988429|42008611|FG002|Overall Study|Lack of Efficacy|1|||
19560745|NCT00988429|42008609|FG000|Overall Study|Non-Compliance with Study Drug|5|||
19560746|NCT00988429|42008610|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19560747|NCT00988429|42008611|FG002|Overall Study|Non-Compliance with Study Drug|3|||
19560748|NCT00988429|42008609|FG000|Overall Study|Physician Decision|1|||
19560749|NCT00988429|42008610|FG001|Overall Study|Physician Decision|0|||
19560750|NCT00988429|42008611|FG002|Overall Study|Physician Decision|3|||
19560751|NCT00988429|42008609|FG000|Overall Study|Pregnancy|2|||
19560752|NCT00988429|42008610|FG001|Overall Study|Pregnancy|1|||
19560753|NCT00988429|42008611|FG002|Overall Study|Pregnancy|0|||
19560754|NCT00988429|42008609|FG000|Overall Study|Protocol Violation|4|||
19560755|NCT00988429|42008610|FG001|Overall Study|Protocol Violation|3|||
19560756|NCT00988429|42008611|FG002|Overall Study|Protocol Violation|3|||
19560757|NCT00988429|42008609|FG000|Overall Study|Withdrawal by Subject|7|||
19382203|NCT02129062|41625456|FG000|Overall Study|Disease Progression|2|||
19560758|NCT00988429|42008610|FG001|Overall Study|Withdrawal by Subject|7|||
19560759|NCT00988429|42008611|FG002|Overall Study|Withdrawal by Subject|12|||
19560760|NCT00988429|42008609|FG000|Overall Study|Administrative Reasons|1|||
19560761|NCT00988429|42008610|FG001|Overall Study|Administrative Reasons|2|||
19560762|NCT00988429|42008611|FG002|Overall Study|Administrative Reasons|1|||
19560763|NCT00988429|42008609|FG000|Overall Study|other reasons|8|||
19560764|NCT00988429|42008610|FG001|Overall Study|other reasons|8|||
19560765|NCT00988429|42008611|FG002|Overall Study|other reasons|1|||
19560766|NCT01008904|42008620|FG000|Overall Study|Lost to Follow-up|1|||
19560767|NCT01008904|42008620|FG000|Overall Study|Adverse Event|2|||
19560768|NCT01008904|42008620|FG000|Overall Study|unexpected unrelated surgery|1|||
19560769|NCT01004614|42008628|FG000|Washout|Withdrawal by Subject|0|||
19560770|NCT01004614|42008629|FG001|Washout|Withdrawal by Subject|1|||
19560771|NCT01004614|42008630|FG002|Washout|Withdrawal by Subject|0|||
19560772|NCT01004614|42008631|FG003|Washout|Withdrawal by Subject|0|||
19560773|NCT00981409|42008643|FG000|Overall Study|Adverse Event|4|||
19560774|NCT00981409|42008644|FG001|Overall Study|Adverse Event|0|||
19560775|NCT00981409|42008643|FG000|Overall Study|Protocol Violation|0|||
19560776|NCT00981409|42008644|FG001|Overall Study|Protocol Violation|1|||
19560777|NCT00981409|42008643|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
19560778|NCT00981409|42008644|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
19560779|NCT01008748|42008650|FG000|Overall Study|Lost to Follow-up|80|||
19560780|NCT01008748|42008650|FG000|Overall Study|Other|1|||
19560781|NCT01004146|42008656|FG000|Overall Study|Withdrawal by Subject|4|||
19560782|NCT01004146|42008657|FG001|Overall Study|Withdrawal by Subject|5|||
19560783|NCT01012414|42008663|FG000|Overall Study|Withdrawal by Subject|2|||
19560784|NCT01012414|42008663|FG000|Overall Study|Lost to Follow-up|1|||
19382204|NCT02162758|41625462|FG000|Overall Study|Study termination|0|||
19382205|NCT02162758|41625463|FG001|Overall Study|Study termination|1|||
19382206|NCT02192164|41625469|FG000|Overall Study|Other|8|||
19560785|NCT01012414|42008663|FG000|Overall Study|Trial was stopped before completed|7|||
19560786|NCT00975715|42008671|FG000|Titration Period|Adverse Event|6|||
19560787|NCT00975715|42008672|FG001|Titration Period|Adverse Event|0|||
19382207|NCT02192164|41625469|FG000|Overall Study|Withdrawal by Subject|1|||
19382208|NCT02192164|41625469|FG000|Overall Study|Physician Decision|4|||
19382209|NCT02192164|41625469|FG000|Overall Study|Did not meet the exclusion criteria|1|||
19560788|NCT00975715|42008671|FG000|Titration Period|Protocol Violation|1|||
19560789|NCT00975715|42008672|FG001|Titration Period|Protocol Violation|0|||
19560790|NCT00975715|42008671|FG000|Maintenance Period|Adverse Event|2|||
19560791|NCT00975715|42008672|FG001|Maintenance Period|Adverse Event|1|||
19560792|NCT03962491|42008680|FG000|Overall Study|Lost to Follow-up|4|||
19560793|NCT03962491|42008681|FG001|Overall Study|Lost to Follow-up|5|||
19560794|NCT00978757|42008689|FG000|Overall Study|Physician Decision|1|||
19560795|NCT00978757|42008690|FG001|Overall Study|Physician Decision|3|||
19560796|NCT01214421|42008700|FG000|Overall Study|Lost to Follow-up|7|||
19560797|NCT01214421|42008701|FG001|Overall Study|Lost to Follow-up|3|||
19560798|NCT01214421|42008702|FG002|Overall Study|Lost to Follow-up|7|||
19560799|NCT01214421|42008703|FG003|Overall Study|Lost to Follow-up|3|||
19560800|NCT01214421|42008700|FG000|Overall Study|Adverse Event|16|||
19560801|NCT01214421|42008701|FG001|Overall Study|Adverse Event|35|||
19560802|NCT01214421|42008702|FG002|Overall Study|Adverse Event|14|||
19560803|NCT01214421|42008703|FG003|Overall Study|Adverse Event|3|||
19560804|NCT01214421|42008700|FG000|Overall Study|Sponsor Discontinued Site|1|||
19560805|NCT01214421|42008701|FG001|Overall Study|Sponsor Discontinued Site|2|||
19560806|NCT01214421|42008702|FG002|Overall Study|Sponsor Discontinued Site|0|||
19560807|NCT01214421|42008703|FG003|Overall Study|Sponsor Discontinued Site|0|||
19560808|NCT01214421|42008700|FG000|Overall Study|Withdrawal Criteria Met|3|||
19560809|NCT01214421|42008701|FG001|Overall Study|Withdrawal Criteria Met|0|||
19560810|NCT01214421|42008702|FG002|Overall Study|Withdrawal Criteria Met|2|||
19560811|NCT01214421|42008703|FG003|Overall Study|Withdrawal Criteria Met|1|||
19560812|NCT01214421|42008700|FG000|Overall Study|Physician Decision|2|||
19560813|NCT01214421|42008701|FG001|Overall Study|Physician Decision|0|||
19560814|NCT01214421|42008702|FG002|Overall Study|Physician Decision|4|||
19560815|NCT01214421|42008703|FG003|Overall Study|Physician Decision|0|||
19560816|NCT01214421|42008700|FG000|Overall Study|Withdrawal by Subject|21|||
19560817|NCT01214421|42008701|FG001|Overall Study|Withdrawal by Subject|18|||
19560818|NCT01214421|42008702|FG002|Overall Study|Withdrawal by Subject|11|||
19739697|NCT02757352|42186676|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739698|NCT02757352|42186677|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739699|NCT02757352|42186678|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739700|NCT02757352|42186679|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739701|NCT02757352|42186680|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
19739702|NCT02757352|42186671|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739703|NCT02757352|42186672|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739704|NCT02757352|42186673|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739705|NCT02757352|42186674|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
19739706|NCT02757352|42186675|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739707|NCT02757352|42186676|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
19560819|NCT01214421|42008703|FG003|Overall Study|Withdrawal by Subject|2|||
19560820|NCT04102111|42008715|FG000|Overall Study|Withdrawal by Subject|2|||
19560821|NCT04102111|42008716|FG001|Overall Study|Withdrawal by Subject|3|||
19560822|NCT04102111|42008715|FG000|Overall Study|Adverse Event|1|||
19560823|NCT04102111|42008716|FG001|Overall Study|Adverse Event|1|||
19560824|NCT04102111|42008715|FG000|Overall Study|Study terminated by sponsor|1|||
19560825|NCT04102111|42008716|FG001|Overall Study|Study terminated by sponsor|3|||
19560826|NCT01214187|42008724|FG000|Overall Study|Adverse Event|6|||
19560827|NCT01214187|42008725|FG001|Overall Study|Adverse Event|2|||
19560828|NCT01214187|42008724|FG000|Overall Study|Death|1|||
19560829|NCT01214187|42008725|FG001|Overall Study|Death|1|||
19560830|NCT01214187|42008724|FG000|Overall Study|Withdrawal by Subject|0|||
19560831|NCT01214187|42008725|FG001|Overall Study|Withdrawal by Subject|3|||
19560832|NCT01003990|42008734|FG000|Overall Study|Adverse Event|8|||
19560833|NCT01003990|42008735|FG001|Overall Study|Adverse Event|5|||
19560834|NCT01003990|42008736|FG002|Overall Study|Adverse Event|11|||
19560835|NCT01003990|42008734|FG000|Overall Study|Death|0|||
19560836|NCT01003990|42008735|FG001|Overall Study|Death|8|||
19560837|NCT01003990|42008736|FG002|Overall Study|Death|1|||
19560838|NCT01003990|42008734|FG000|Overall Study|Lack of Efficacy|10|||
19560839|NCT01003990|42008735|FG001|Overall Study|Lack of Efficacy|2|||
19560840|NCT01003990|42008736|FG002|Overall Study|Lack of Efficacy|3|||
19560841|NCT01003990|42008734|FG000|Overall Study|Lost to Follow-up|30|||
19560842|NCT01003990|42008735|FG001|Overall Study|Lost to Follow-up|12|||
19560843|NCT01003990|42008736|FG002|Overall Study|Lost to Follow-up|7|||
19560844|NCT01003990|42008734|FG000|Overall Study|Reasons Not Identified|14|||
19560845|NCT01003990|42008735|FG001|Overall Study|Reasons Not Identified|13|||
19560846|NCT01003990|42008736|FG002|Overall Study|Reasons Not Identified|8|||
19560847|NCT01003990|42008734|FG000|Overall Study|Poor/Non-compliance|4|||
19560848|NCT01003990|42008735|FG001|Overall Study|Poor/Non-compliance|3|||
19560849|NCT01003990|42008736|FG002|Overall Study|Poor/Non-compliance|2|||
19560850|NCT01003990|42008734|FG000|Overall Study|Pregnancy|10|||
19560851|NCT01003990|42008735|FG001|Overall Study|Pregnancy|2|||
19560852|NCT01003990|42008736|FG002|Overall Study|Pregnancy|4|||
19560853|NCT01003990|42008734|FG000|Overall Study|No Longer Met Study Criteria|4|||
19560854|NCT01003990|42008735|FG001|Overall Study|No Longer Met Study Criteria|1|||
19560855|NCT01003990|42008736|FG002|Overall Study|No Longer Met Study Criteria|0|||
19560856|NCT01003990|42008734|FG000|Overall Study|Subject Withdrew Consent|12|||
19560857|NCT01003990|42008735|FG001|Overall Study|Subject Withdrew Consent|5|||
19560858|NCT01003990|42008736|FG002|Overall Study|Subject Withdrew Consent|7|||
19560859|NCT01003210|42008746|FG000|Overall Study|Lost to Follow-up|1|||
19560860|NCT01003210|42008747|FG001|Overall Study|Lost to Follow-up|3|||
19560861|NCT01002820|42008753|FG000|Overall Study|Adverse Event|1|||
19560862|NCT01002820|42008753|FG000|Overall Study|Withdrawal by Subject|2|||
19560863|NCT01002820|42008753|FG000|Overall Study|Lack of Efficacy|1|||
19560864|NCT01012258|42008757|FG000|Overall Study|Death|14|||
19560865|NCT01012258|42008757|FG000|Overall Study|Lost to Follow-up|1|||
19560866|NCT01012258|42008757|FG000|Overall Study|Adverse Event|1|||
19560867|NCT01012258|42008757|FG000|Overall Study|Progressive Disease (PD)|18|||
19560868|NCT01012258|42008757|FG000|Overall Study|Symptomatic Deterioration|1|||
19560869|NCT01012258|42008757|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
19560870|NCT01012258|42008757|FG000|Overall Study|Another Tumor Discovered|1|||
19560871|NCT01012258|42008757|FG000|Overall Study|Ongoing|29|||
19560872|NCT01011946|42008762|FG000|Overall Study|Transferred to another hospital|2|||
19560873|NCT01011946|42008762|FG000|Overall Study|No pathological lab value|1|||
19560874|NCT00975481|42008766|FG000|Second Intervention Period|Adverse Event|2|||
19382210|NCT02191618|41625476|FG000|Overall Study|Withdrawal by Subject|3|||
19382211|NCT02191618|41625476|FG000|Overall Study|Missed Visit|4|||
19382212|NCT02646891|41625490|FG000|Overall Study|Adverse Event|0|||
19382213|NCT02646891|41625491|FG001|Overall Study|Adverse Event|1|||
19382214|NCT02646891|41625492|FG002|Overall Study|Adverse Event|0|||
19382215|NCT02646891|41625493|FG003|Overall Study|Adverse Event|0|||
19382216|NCT02646891|41625494|FG004|Overall Study|Adverse Event|0|||
19382217|NCT02646891|41625495|FG005|Overall Study|Adverse Event|0|||
19382218|NCT02646891|41625496|FG006|Overall Study|Adverse Event|0|||
19382219|NCT02646891|41625497|FG007|Overall Study|Adverse Event|0|||
19382220|NCT02646891|41625498|FG008|Overall Study|Adverse Event|0|||
19382221|NCT02646891|41625499|FG009|Overall Study|Adverse Event|0|||
19382222|NCT02646891|41625490|FG000|Overall Study|Lost to Follow-up|0|||
19382223|NCT02646891|41625491|FG001|Overall Study|Lost to Follow-up|0|||
19560875|NCT00975481|42008767|FG001|Second Intervention Period|Adverse Event|1|||
19560876|NCT00975481|42008768|FG002|Second Intervention Period|Adverse Event|0|||
19560877|NCT00975481|42008769|FG003|Second Intervention Period|Adverse Event|0|||
19560878|NCT00975481|42008770|FG004|Second Intervention Period|Adverse Event|0|||
19560879|NCT00975481|42008771|FG005|Second Intervention Period|Adverse Event|0|||
19560880|NCT00975481|42008766|FG000|Second Intervention Period|Withdrawal by Subject|0|||
19560881|NCT00975481|42008767|FG001|Second Intervention Period|Withdrawal by Subject|0|||
19560882|NCT00975481|42008768|FG002|Second Intervention Period|Withdrawal by Subject|1|||
19560883|NCT00975481|42008769|FG003|Second Intervention Period|Withdrawal by Subject|0|||
19560884|NCT00975481|42008770|FG004|Second Intervention Period|Withdrawal by Subject|0|||
19560885|NCT00975481|42008771|FG005|Second Intervention Period|Withdrawal by Subject|0|||
19560886|NCT00975481|42008766|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
19560887|NCT00975481|42008767|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
19560888|NCT00975481|42008768|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
19560889|NCT00975481|42008769|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
19560890|NCT00975481|42008770|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
19560891|NCT00975481|42008771|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
19560892|NCT00975481|42008766|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
19560893|NCT00975481|42008767|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
19560894|NCT00975481|42008768|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
19560895|NCT00975481|42008769|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
19560896|NCT00975481|42008770|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
19560897|NCT00975481|42008771|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
19560898|NCT01011868|42008792|FG000|After Week 18 Follow-up|Adverse Event|8|||
19560899|NCT01011868|42008793|FG001|After Week 18 Follow-up|Adverse Event|6|||
19560900|NCT01011868|42008794|FG002|After Week 18 Follow-up|Adverse Event|13|||
19560901|NCT01011868|42008792|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
19560902|NCT01011868|42008793|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
19560903|NCT01011868|42008794|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
19560904|NCT01011868|42008792|FG000|After Week 18 Follow-up|Protocol Violation|1|||
19560905|NCT01011868|42008793|FG001|After Week 18 Follow-up|Protocol Violation|1|||
19560906|NCT01011868|42008794|FG002|After Week 18 Follow-up|Protocol Violation|1|||
19560907|NCT01011868|42008792|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
19560908|NCT01011868|42008793|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
19560909|NCT01011868|42008794|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
19560910|NCT01011868|42008792|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
19560911|NCT01011868|42008793|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
19560912|NCT01011868|42008794|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
19560913|NCT01011868|42008792|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
19560914|NCT01011868|42008793|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
19560915|NCT01011868|42008794|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
19560916|NCT01011868|42008792|FG000|After Week 78 Follow-up|Adverse Event|14|||
19560917|NCT01011868|42008793|FG001|After Week 78 Follow-up|Adverse Event|18|||
19560918|NCT01011868|42008794|FG002|After Week 78 Follow-up|Adverse Event|21|||
19560919|NCT01011868|42008792|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
19560920|NCT01011868|42008793|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
19560921|NCT01011868|42008794|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
19560922|NCT01011868|42008792|FG000|After Week 78 Follow-up|Protocol Violation|9|||
19560923|NCT01011868|42008793|FG001|After Week 78 Follow-up|Protocol Violation|1|||
19560924|NCT01011868|42008794|FG002|After Week 78 Follow-up|Protocol Violation|2|||
19560925|NCT01011868|42008792|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
19560926|NCT01011868|42008793|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
19560927|NCT01011868|42008794|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
19560928|NCT01011868|42008792|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
19560929|NCT01011868|42008793|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
19560930|NCT01011868|42008794|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
19560931|NCT01011868|42008792|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
19560932|NCT01011868|42008793|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
19560933|NCT01011868|42008794|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
19560934|NCT01213251|42008805|FG000|Overall Study|Death|2|||
19560935|NCT01213251|42008806|FG001|Overall Study|Death|1|||
19560936|NCT01213251|42008807|FG002|Overall Study|Death|2|||
19560937|NCT01213251|42008805|FG000|Overall Study|Exit|3|||
19560938|NCT01213251|42008806|FG001|Overall Study|Exit|2|||
19560939|NCT01213251|42008807|FG002|Overall Study|Exit|8|||
19560940|NCT01213251|42008805|FG000|Overall Study|Protocol Violation|1|||
19560941|NCT01213251|42008806|FG001|Overall Study|Protocol Violation|1|||
19560942|NCT01213251|42008807|FG002|Overall Study|Protocol Violation|0|||
19560943|NCT01213251|42008805|FG000|Overall Study|Missed 18-Month Follow-up|0|||
19560944|NCT01213251|42008806|FG001|Overall Study|Missed 18-Month Follow-up|0|||
19560945|NCT01213251|42008807|FG002|Overall Study|Missed 18-Month Follow-up|1|||
19560946|NCT01213173|42008822|FG000|Overall Study|Protocol Violation|2|||
19560947|NCT01213173|42008823|FG001|Overall Study|Protocol Violation|0|||
19560948|NCT01213173|42008822|FG000|Overall Study|Adverse Event|4|||
19560949|NCT01213173|42008823|FG001|Overall Study|Adverse Event|8|||
19560950|NCT01213173|42008822|FG000|Overall Study|Withdrawal by Subject|5|||
19560951|NCT01213173|42008823|FG001|Overall Study|Withdrawal by Subject|5|||
19560952|NCT01213173|42008822|FG000|Overall Study|Incorrect Enrollment|1|||
19560953|NCT01213173|42008823|FG001|Overall Study|Incorrect Enrollment|3|||
19560954|NCT01212159|42008831|FG000|Overall Study|Withdrawal by Subject|12|||
19560955|NCT01212159|42008832|FG001|Overall Study|Withdrawal by Subject|12|||
19560956|NCT00973765|42008840|FG000|Overall Study|Lost to Follow-up|8|||
19560957|NCT00973765|42008841|FG001|Overall Study|Lost to Follow-up|14|||
19560958|NCT01211769|42008851|FG000|Overall Study|Lost to Follow-up|7|||
19560959|NCT01211769|42008852|FG001|Overall Study|Lost to Follow-up|9|||
19560960|NCT01211769|42008853|FG002|Overall Study|Lost to Follow-up|5|||
19560961|NCT01211769|42008854|FG003|Overall Study|Lost to Follow-up|9|||
19560962|NCT01211769|42008851|FG000|Overall Study|Physician Decision|2|||
19560963|NCT01211769|42008852|FG001|Overall Study|Physician Decision|0|||
19560964|NCT01211769|42008853|FG002|Overall Study|Physician Decision|2|||
19560965|NCT01211769|42008854|FG003|Overall Study|Physician Decision|1|||
19560966|NCT01211769|42008851|FG000|Overall Study|Adverse Event|0|||
19560967|NCT01211769|42008852|FG001|Overall Study|Adverse Event|1|||
19560968|NCT01211769|42008853|FG002|Overall Study|Adverse Event|1|||
19560969|NCT01211769|42008854|FG003|Overall Study|Adverse Event|1|||
19560970|NCT01211613|42008867|FG000|Overall Study|Lost to Follow-up|2|||
19560971|NCT01211613|42008868|FG001|Overall Study|Lost to Follow-up|2|||
19560972|NCT01211613|42008869|FG002|Overall Study|Lost to Follow-up|2|||
19560973|NCT01211613|42008867|FG000|Overall Study|Withdrawal by Subject|1|||
19560974|NCT01211613|42008868|FG001|Overall Study|Withdrawal by Subject|0|||
19560975|NCT01211613|42008869|FG002|Overall Study|Withdrawal by Subject|0|||
19560976|NCT01211535|42008879|FG000|Overall Study|Adverse Event|0|||
19560977|NCT01211535|42008880|FG001|Overall Study|Adverse Event|1|||
19560978|NCT01011556|42008890|FG000|Overall Study|Adverse Event|1|||
19560979|NCT01011556|42008891|FG001|Overall Study|Adverse Event|3|||
19560980|NCT01011556|42008892|FG002|Overall Study|Adverse Event|2|||
19560981|NCT01011556|42008893|FG003|Overall Study|Adverse Event|1|||
19560982|NCT01011556|42008890|FG000|Overall Study|Lost to Follow-up|1|||
19560983|NCT01011556|42008891|FG001|Overall Study|Lost to Follow-up|0|||
19560984|NCT01011556|42008892|FG002|Overall Study|Lost to Follow-up|0|||
19560985|NCT01011556|42008893|FG003|Overall Study|Lost to Follow-up|0|||
19560986|NCT01011556|42008890|FG000|Overall Study|Physician Decision|1|||
19560987|NCT01011556|42008891|FG001|Overall Study|Physician Decision|0|||
19560988|NCT01011556|42008892|FG002|Overall Study|Physician Decision|0|||
19560989|NCT01011556|42008893|FG003|Overall Study|Physician Decision|1|||
19560990|NCT01011556|42008890|FG000|Overall Study|Protocol Violation|0|||
19560991|NCT01011556|42008891|FG001|Overall Study|Protocol Violation|1|||
19560992|NCT01011556|42008892|FG002|Overall Study|Protocol Violation|0|||
19560993|NCT01011556|42008893|FG003|Overall Study|Protocol Violation|0|||
19560994|NCT01011556|42008890|FG000|Overall Study|Withdrawal by Subject|1|||
19560995|NCT01011556|42008891|FG001|Overall Study|Withdrawal by Subject|2|||
19560996|NCT01011556|42008892|FG002|Overall Study|Withdrawal by Subject|4|||
19560997|NCT01011556|42008893|FG003|Overall Study|Withdrawal by Subject|4|||
19560998|NCT01011556|42008890|FG000|Overall Study|Sponsor decision|0|||
19560999|NCT01011556|42008891|FG001|Overall Study|Sponsor decision|1|||
19561000|NCT01011556|42008892|FG002|Overall Study|Sponsor decision|1|||
19561001|NCT01011556|42008893|FG003|Overall Study|Sponsor decision|2|||
19561002|NCT01011556|42008890|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
19561003|NCT01011556|42008891|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
19561004|NCT01011556|42008892|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
19561005|NCT01011556|42008893|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
19561006|NCT01211145|42008910|FG000|Overall Study|Reason not specified|3|||
19561007|NCT01211145|42008911|FG001|Overall Study|Reason not specified|2|||
19561008|NCT01211145|42008912|FG002|Overall Study|Reason not specified|2|||
19561009|NCT01211145|42008913|FG003|Overall Study|Reason not specified|1|||
19561010|NCT01211145|42008910|FG000|Overall Study|Lost to Follow-up|3|||
19561011|NCT01211145|42008911|FG001|Overall Study|Lost to Follow-up|2|||
19561012|NCT01211145|42008912|FG002|Overall Study|Lost to Follow-up|1|||
19561013|NCT01211145|42008913|FG003|Overall Study|Lost to Follow-up|2|||
19561014|NCT01211145|42008910|FG000|Overall Study|Study-specific withdrawal criteria|1|||
19561015|NCT01211145|42008911|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19561016|NCT01211145|42008912|FG002|Overall Study|Study-specific withdrawal criteria|0|||
19561017|NCT01211145|42008913|FG003|Overall Study|Study-specific withdrawal criteria|0|||
19561018|NCT01211145|42008910|FG000|Overall Study|Severe noncompliance to protocol|1|||
19561019|NCT01211145|42008911|FG001|Overall Study|Severe noncompliance to protocol|0|||
19561020|NCT01211145|42008912|FG002|Overall Study|Severe noncompliance to protocol|0|||
19561021|NCT01211145|42008913|FG003|Overall Study|Severe noncompliance to protocol|0|||
19561022|NCT01211145|42008910|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
19561023|NCT01211145|42008911|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
19561024|NCT01211145|42008912|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
19561025|NCT01211145|42008913|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
19561026|NCT01211145|42008910|FG000|Overall Study|Patient decision|2|||
19561027|NCT01211145|42008911|FG001|Overall Study|Patient decision|1|||
19561028|NCT01211145|42008912|FG002|Overall Study|Patient decision|0|||
19561029|NCT01211145|42008913|FG003|Overall Study|Patient decision|2|||
19561030|NCT00977665|42008925|FG000|Overall Study|Withdrawal by Subject|1|||
19561031|NCT00977665|42008926|FG001|Overall Study|Withdrawal by Subject|3|||
19561032|NCT00977665|42008925|FG000|Overall Study|Physician Decision|2|||
19561033|NCT00977665|42008926|FG001|Overall Study|Physician Decision|1|||
19561034|NCT00977665|42008925|FG000|Overall Study|Sponsor requested withdrawal|0|||
19561035|NCT00977665|42008926|FG001|Overall Study|Sponsor requested withdrawal|1|||
19561036|NCT00977665|42008925|FG000|Overall Study|Lost to Follow-up|1|||
19561037|NCT00977665|42008926|FG001|Overall Study|Lost to Follow-up|0|||
19561038|NCT00977665|42008925|FG000|Overall Study|Death|3|||
19561039|NCT00977665|42008926|FG001|Overall Study|Death|2|||
19561040|NCT00977665|42008925|FG000|Overall Study|Adverse Event|14|||
19561041|NCT00977665|42008926|FG001|Overall Study|Adverse Event|7|||
19561042|NCT00977665|42008925|FG000|Overall Study|Treatment failure|0|||
19561043|NCT00977665|42008926|FG001|Overall Study|Treatment failure|1|||
19561044|NCT01210443|42008932|FG000|Overall Study|Study terminated by sponsor|2|||
19561045|NCT01007812|42008936|FG000|Period 1, One Week|Lost to Follow-up|0|||
19561046|NCT01007812|42008937|FG001|Period 1, One Week|Lost to Follow-up|1|||
19561047|NCT01007812|42008936|FG000|Period 1, One Week|Discomfort|1|||
19561048|NCT01007812|42008937|FG001|Period 1, One Week|Discomfort|0|||
19561049|NCT01208961|42008943|FG000|High-Fat Period III|Protocol Violation|1|||
19561050|NCT01208961|42008944|FG001|High-Fat Period III|Protocol Violation|0|||
19561051|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
19561052|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
19561053|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
19561054|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
19561055|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
19561056|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
19561057|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
19561058|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
19561059|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
19561060|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
19561061|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
19561062|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
19561063|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
19561064|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
19561065|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
19561066|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
19561067|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
19561068|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
19561069|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
19561070|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
19561071|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
19561072|NCT01001572|42008951|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
19561073|NCT01001572|42008952|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
19561074|NCT01001572|42008953|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
19561075|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
19561076|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
19561077|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
19561078|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19561079|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
19561080|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
19561081|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
19561082|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
19561083|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
19561084|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
19561085|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
19561086|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
19561087|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
19561088|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
19561089|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
19561090|NCT01001572|42008951|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19561091|NCT01001572|42008952|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19561092|NCT01001572|42008953|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
19561093|NCT01208415|42008959|FG000|Overall Study|Death|1|||
19561094|NCT01208415|42008959|FG000|Overall Study|Lost to Follow-up|2|||
19561095|NCT01208415|42008959|FG000|Overall Study|Withdrawal by Subject|3|||
19561096|NCT01208415|42008959|FG000|Overall Study|Device not placed|1|||
19561097|NCT01208415|42008959|FG000|Overall Study|Still be eligible for follow-up|33|||
19561098|NCT01208337|42008963|FG000|Overall Study|Death|3|||
19561099|NCT01208181|42008979|FG000|Part 1|Withdrawal by Subject|11|||
19561100|NCT01208181|42008980|FG001|Part 1|Withdrawal by Subject|10|||
19561101|NCT01208181|42008981|FG002|Part 1|Withdrawal by Subject|0|||
19561102|NCT01208181|42008982|FG003|Part 1|Withdrawal by Subject|0|||
19561103|NCT01208181|42008983|FG004|Part 1|Withdrawal by Subject|0|||
19561104|NCT01208181|42008979|FG000|Part 1|Technical problem|5|||
19561105|NCT01208181|42008980|FG001|Part 1|Technical problem|0|||
19561106|NCT01208181|42008981|FG002|Part 1|Technical problem|0|||
19561107|NCT01208181|42008982|FG003|Part 1|Technical problem|0|||
19561108|NCT01208181|42008983|FG004|Part 1|Technical problem|0|||
19561109|NCT01208181|42008979|FG000|Part 1|Protocol Violation|10|||
19561110|NCT01208181|42008980|FG001|Part 1|Protocol Violation|5|||
19561111|NCT01208181|42008981|FG002|Part 1|Protocol Violation|0|||
19561112|NCT01208181|42008982|FG003|Part 1|Protocol Violation|0|||
19561113|NCT01208181|42008983|FG004|Part 1|Protocol Violation|0|||
19561114|NCT01208181|42008979|FG000|Part 1|Physician Decision|4|||
19561115|NCT01208181|42008980|FG001|Part 1|Physician Decision|0|||
19561116|NCT01208181|42008981|FG002|Part 1|Physician Decision|0|||
19561117|NCT01208181|42008982|FG003|Part 1|Physician Decision|0|||
19561118|NCT01208181|42008983|FG004|Part 1|Physician Decision|0|||
19561119|NCT01208181|42008979|FG000|Part 1|Non-compliance with study drug|1|||
19561120|NCT01208181|42008980|FG001|Part 1|Non-compliance with study drug|1|||
19561121|NCT01208181|42008981|FG002|Part 1|Non-compliance with study drug|0|||
19561122|NCT01208181|42008982|FG003|Part 1|Non-compliance with study drug|0|||
19561123|NCT01208181|42008983|FG004|Part 1|Non-compliance with study drug|0|||
19561124|NCT01208181|42008979|FG000|Part 1|Lost to Follow-up|5|||
19561125|NCT01208181|42008980|FG001|Part 1|Lost to Follow-up|3|||
19561126|NCT01208181|42008981|FG002|Part 1|Lost to Follow-up|0|||
19561127|NCT01208181|42008982|FG003|Part 1|Lost to Follow-up|0|||
19561128|NCT01208181|42008983|FG004|Part 1|Lost to Follow-up|1|||
19561129|NCT01208181|42008979|FG000|Part 1|Lack of Efficacy|37|||
19561130|NCT01208181|42008980|FG001|Part 1|Lack of Efficacy|12|||
19561131|NCT01208181|42008981|FG002|Part 1|Lack of Efficacy|0|||
19561132|NCT01208181|42008982|FG003|Part 1|Lack of Efficacy|0|||
19561133|NCT01208181|42008983|FG004|Part 1|Lack of Efficacy|17|||
19561134|NCT01208181|42008979|FG000|Part 1|Adverse Event|26|||
19561135|NCT01208181|42008980|FG001|Part 1|Adverse Event|24|||
19561136|NCT01208181|42008981|FG002|Part 1|Adverse Event|0|||
19561137|NCT01208181|42008982|FG003|Part 1|Adverse Event|0|||
19561138|NCT01208181|42008983|FG004|Part 1|Adverse Event|4|||
19561139|NCT01208181|42008979|FG000|Part 2|Adverse Event|0|||
19561140|NCT01208181|42008980|FG001|Part 2|Adverse Event|0|||
19561141|NCT01208181|42008981|FG002|Part 2|Adverse Event|6|||
19561142|NCT01208181|42008982|FG003|Part 2|Adverse Event|7|||
19561143|NCT01208181|42008983|FG004|Part 2|Adverse Event|0|||
19561144|NCT01208181|42008979|FG000|Part 2|Withdrawal by Subject|0|||
19561145|NCT01208181|42008980|FG001|Part 2|Withdrawal by Subject|0|||
19561146|NCT01208181|42008981|FG002|Part 2|Withdrawal by Subject|1|||
19561147|NCT01208181|42008982|FG003|Part 2|Withdrawal by Subject|1|||
19561148|NCT01208181|42008983|FG004|Part 2|Withdrawal by Subject|0|||
19561149|NCT01208181|42008979|FG000|Part 2|Protocol Violation|0|||
19561150|NCT01208181|42008980|FG001|Part 2|Protocol Violation|0|||
19561151|NCT01208181|42008981|FG002|Part 2|Protocol Violation|1|||
19561152|NCT01208181|42008982|FG003|Part 2|Protocol Violation|0|||
19561153|NCT01208181|42008983|FG004|Part 2|Protocol Violation|0|||
19561154|NCT01208181|42008979|FG000|Part 2|Physician Decision|0|||
19561155|NCT01208181|42008980|FG001|Part 2|Physician Decision|0|||
19561156|NCT01208181|42008981|FG002|Part 2|Physician Decision|1|||
19561157|NCT01208181|42008982|FG003|Part 2|Physician Decision|2|||
19561158|NCT01208181|42008983|FG004|Part 2|Physician Decision|0|||
19561159|NCT01208181|42008979|FG000|Part 2|Non-compliance with study drug|0|||
19561160|NCT01208181|42008980|FG001|Part 2|Non-compliance with study drug|0|||
19561161|NCT01208181|42008981|FG002|Part 2|Non-compliance with study drug|1|||
19561162|NCT01208181|42008982|FG003|Part 2|Non-compliance with study drug|1|||
19561163|NCT01208181|42008983|FG004|Part 2|Non-compliance with study drug|0|||
19561164|NCT01208181|42008979|FG000|Part 2|Lost to Follow-up|0|||
19561165|NCT01208181|42008980|FG001|Part 2|Lost to Follow-up|0|||
19561166|NCT01208181|42008981|FG002|Part 2|Lost to Follow-up|1|||
19561167|NCT01208181|42008982|FG003|Part 2|Lost to Follow-up|2|||
19561168|NCT01208181|42008983|FG004|Part 2|Lost to Follow-up|0|||
19561169|NCT01208181|42008979|FG000|Part 2|Lack of Efficacy|0|||
19561170|NCT01208181|42008980|FG001|Part 2|Lack of Efficacy|0|||
19561171|NCT01208181|42008981|FG002|Part 2|Lack of Efficacy|5|||
19561172|NCT01208181|42008982|FG003|Part 2|Lack of Efficacy|7|||
19561173|NCT01208181|42008983|FG004|Part 2|Lack of Efficacy|0|||
19561174|NCT01208103|42009000|FG000|Overall Study|Adverse Event|1|||
19561175|NCT01208103|42009000|FG000|Overall Study|Withdrawal by Subject|1|||
19561176|NCT01206777|42009005|FG000|Overall Study|Death|1|||
19561177|NCT01206777|42009005|FG000|Overall Study|Adverse Event|1|||
19561178|NCT01001494|42009012|FG000|Overall Study|Adverse Event|8|||
19561179|NCT01001494|42009013|FG001|Overall Study|Adverse Event|4|||
19561180|NCT01001494|42009014|FG002|Overall Study|Adverse Event|6|||
19561181|NCT01001494|42009012|FG000|Overall Study|Protocol Violation|0|||
19561182|NCT01001494|42009013|FG001|Overall Study|Protocol Violation|1|||
19561183|NCT01001494|42009014|FG002|Overall Study|Protocol Violation|1|||
19561184|NCT01001494|42009012|FG000|Overall Study|Lost to Follow-up|2|||
19561185|NCT01001494|42009013|FG001|Overall Study|Lost to Follow-up|0|||
19561186|NCT01001494|42009014|FG002|Overall Study|Lost to Follow-up|1|||
19561187|NCT01001494|42009012|FG000|Overall Study|Withdrawal by Subject|9|||
19561188|NCT01001494|42009013|FG001|Overall Study|Withdrawal by Subject|7|||
19561189|NCT01001494|42009014|FG002|Overall Study|Withdrawal by Subject|17|||
19561190|NCT01001494|42009012|FG000|Overall Study|COPD exacerbation|3|||
19561191|NCT01001494|42009013|FG001|Overall Study|COPD exacerbation|4|||
19561192|NCT01001494|42009014|FG002|Overall Study|COPD exacerbation|5|||
19561193|NCT01001494|42009012|FG000|Overall Study|Lack of Efficacy|2|||
19561194|NCT01001494|42009013|FG001|Overall Study|Lack of Efficacy|0|||
19561195|NCT01001494|42009014|FG002|Overall Study|Lack of Efficacy|8|||
19561196|NCT01001494|42009012|FG000|Overall Study|Other|0|||
19561197|NCT01001494|42009013|FG001|Overall Study|Other|1|||
19561198|NCT01001494|42009014|FG002|Overall Study|Other|3|||
19561199|NCT01205685|42009022|FG000|Overall Study|Disease Progression|10|||
19561200|NCT01205685|42009022|FG000|Overall Study|Withdrawal by Subject|1|||
19561201|NCT01205529|42009026|FG000|Overall Study|Procedure Cancelled|4|||
19561202|NCT01205529|42009026|FG000|Overall Study|Withdrawal by Subject|2|||
19561203|NCT01205529|42009026|FG000|Overall Study|Physician Decision|4|||
19561204|NCT01205529|42009026|FG000|Overall Study|Unstable post op|15|||
19561205|NCT01205529|42009026|FG000|Overall Study|No longer met criteria|30|||
19561206|NCT01205451|42009032|FG000|Overall Study|Lost to Follow-up|1|||
19561207|NCT01205451|42009033|FG001|Overall Study|Lost to Follow-up|1|||
19561208|NCT01205451|42009032|FG000|Overall Study|Withdrawal by Subject|5|||
19561209|NCT01205451|42009033|FG001|Overall Study|Withdrawal by Subject|9|||
19561210|NCT01001104|42009043|FG000|Overall Study|Adverse Event|2|||
19561211|NCT01001104|42009044|FG001|Overall Study|Adverse Event|1|||
19561212|NCT01001104|42009045|FG002|Overall Study|Adverse Event|0|||
19739708|NCT02757352|42186677|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739709|NCT02757352|42186678|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739710|NCT02757352|42186679|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739711|NCT02757352|42186680|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
19739712|NCT02757352|42186671|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739713|NCT02757352|42186672|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739714|NCT02757352|42186673|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739715|NCT02757352|42186674|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
19739716|NCT02757352|42186675|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
19739717|NCT02757352|42186676|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
19739718|NCT02757352|42186677|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739719|NCT02757352|42186678|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739720|NCT02757352|42186679|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739721|NCT02757352|42186680|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
19739722|NCT02757352|42186671|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739723|NCT02757352|42186672|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739724|NCT02757352|42186673|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739725|NCT02757352|42186674|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739726|NCT02757352|42186675|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
19739727|NCT02757352|42186676|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739728|NCT02757352|42186677|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739729|NCT02757352|42186678|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739730|NCT02757352|42186679|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739731|NCT02757352|42186680|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
19739732|NCT02757352|42186671|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739733|NCT02757352|42186672|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739734|NCT02757352|42186673|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739735|NCT02757352|42186674|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739736|NCT02757352|42186675|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739737|NCT02757352|42186676|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
19739738|NCT02757352|42186677|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739739|NCT02757352|42186678|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739740|NCT02757352|42186679|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739741|NCT02757352|42186680|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
19739742|NCT02757352|42186671|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739743|NCT02757352|42186672|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739744|NCT02757352|42186673|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739745|NCT02757352|42186674|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
19561213|NCT01001104|42009046|FG003|Overall Study|Adverse Event|0|||
19561214|NCT01001104|42009043|FG000|Overall Study|Lost to Follow-up|0|||
19561215|NCT01001104|42009044|FG001|Overall Study|Lost to Follow-up|0|||
19561216|NCT01001104|42009045|FG002|Overall Study|Lost to Follow-up|1|||
19561217|NCT01001104|42009046|FG003|Overall Study|Lost to Follow-up|0|||
19561218|NCT01001104|42009043|FG000|Overall Study|Entry Criteria Not Met|0|||
19561219|NCT01001104|42009044|FG001|Overall Study|Entry Criteria Not Met|0|||
19561220|NCT01001104|42009045|FG002|Overall Study|Entry Criteria Not Met|0|||
19561221|NCT01001104|42009046|FG003|Overall Study|Entry Criteria Not Met|1|||
19561222|NCT01001104|42009043|FG000|Overall Study|Withdrawal by Subject|0|||
19561223|NCT01001104|42009044|FG001|Overall Study|Withdrawal by Subject|0|||
19561224|NCT01001104|42009045|FG002|Overall Study|Withdrawal by Subject|0|||
19561225|NCT01001104|42009046|FG003|Overall Study|Withdrawal by Subject|2|||
19561226|NCT00998764|42009061|FG000|Overall Study|Lack of Efficacy|3|||
19561227|NCT00998764|42009062|FG001|Overall Study|Lack of Efficacy|6|||
19561228|NCT00998764|42009061|FG000|Overall Study|Adverse Event|17|||
19561229|NCT00998764|42009062|FG001|Overall Study|Adverse Event|12|||
19561230|NCT00998764|42009061|FG000|Overall Study|Withdrawal by Subject|19|||
19561231|NCT00998764|42009062|FG001|Overall Study|Withdrawal by Subject|25|||
19561232|NCT00998764|42009061|FG000|Overall Study|Physician Decision|3|||
19561233|NCT00998764|42009062|FG001|Overall Study|Physician Decision|3|||
19561234|NCT00998764|42009061|FG000|Overall Study|Death|3|||
19561235|NCT00998764|42009062|FG001|Overall Study|Death|1|||
19561236|NCT00998764|42009061|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
19561237|NCT00998764|42009062|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
19561238|NCT00998764|42009061|FG000|Overall Study|Protocol Violation|0|||
19561239|NCT00998764|42009062|FG001|Overall Study|Protocol Violation|1|||
19561240|NCT00998764|42009061|FG000|Overall Study|Failed to Return|1|||
19561241|NCT00998764|42009062|FG001|Overall Study|Failed to Return|1|||
19561242|NCT00998764|42009061|FG000|Overall Study|Lost to Follow-up|1|||
19561243|NCT00998764|42009062|FG001|Overall Study|Lost to Follow-up|1|||
19561244|NCT00998764|42009061|FG000|Overall Study|Loss of Caregiver|0|||
19561245|NCT00998764|42009062|FG001|Overall Study|Loss of Caregiver|3|||
19561246|NCT00998764|42009061|FG000|Overall Study|Other|4|||
19561247|NCT00998764|42009062|FG001|Overall Study|Other|4|||
19561248|NCT00998764|42009061|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
19561249|NCT00998764|42009062|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
19561250|NCT01204671|42009075|FG000|Overall Study|Adverse Event|4|||
19561251|NCT01204671|42009076|FG001|Overall Study|Adverse Event|3|||
19561252|NCT01204671|42009077|FG002|Overall Study|Adverse Event|3|||
19561253|NCT01204671|42009078|FG003|Overall Study|Adverse Event|3|||
19561254|NCT01204671|42009079|FG004|Overall Study|Adverse Event|1|||
19561255|NCT01204671|42009075|FG000|Overall Study|Withdrawal by Subject|2|||
19561256|NCT01204671|42009076|FG001|Overall Study|Withdrawal by Subject|3|||
19561257|NCT01204671|42009077|FG002|Overall Study|Withdrawal by Subject|4|||
19561258|NCT01204671|42009078|FG003|Overall Study|Withdrawal by Subject|5|||
19561259|NCT01204671|42009079|FG004|Overall Study|Withdrawal by Subject|3|||
19561260|NCT01204671|42009075|FG000|Overall Study|Lost to Follow-up|7|||
19561261|NCT01204671|42009076|FG001|Overall Study|Lost to Follow-up|8|||
19561262|NCT01204671|42009077|FG002|Overall Study|Lost to Follow-up|6|||
19561263|NCT01204671|42009078|FG003|Overall Study|Lost to Follow-up|4|||
19561264|NCT01204671|42009079|FG004|Overall Study|Lost to Follow-up|0|||
19561265|NCT01204671|42009075|FG000|Overall Study|Unknown Completion Status|1|||
19561266|NCT01204671|42009076|FG001|Overall Study|Unknown Completion Status|1|||
19561267|NCT01204671|42009077|FG002|Overall Study|Unknown Completion Status|0|||
19561268|NCT01204671|42009078|FG003|Overall Study|Unknown Completion Status|0|||
19561269|NCT01204671|42009079|FG004|Overall Study|Unknown Completion Status|0|||
19561270|NCT01204671|42009075|FG000|Overall Study|Physician Decision|0|||
19561271|NCT01204671|42009076|FG001|Overall Study|Physician Decision|0|||
19561272|NCT01204671|42009077|FG002|Overall Study|Physician Decision|0|||
19561273|NCT01204671|42009078|FG003|Overall Study|Physician Decision|1|||
19561274|NCT01204671|42009079|FG004|Overall Study|Physician Decision|0|||
19561275|NCT01202955|42009097|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
19561276|NCT01202955|42009098|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
19561277|NCT01202877|42009107|FG000|Overall Study|Disease Progression|0|||
19561278|NCT01202877|42009108|FG001|Overall Study|Disease Progression|1|||
19561279|NCT01202877|42009109|FG002|Overall Study|Disease Progression|2|||
19561280|NCT01202877|42009107|FG000|Overall Study|Adverse Event|0|||
19561281|NCT01202877|42009108|FG001|Overall Study|Adverse Event|0|||
19561282|NCT01202877|42009109|FG002|Overall Study|Adverse Event|2|||
19561283|NCT01202877|42009107|FG000|Overall Study|Withdrawal by Subject|0|||
19561284|NCT01202877|42009108|FG001|Overall Study|Withdrawal by Subject|0|||
19561285|NCT01202877|42009109|FG002|Overall Study|Withdrawal by Subject|1|||
19561286|NCT01202877|42009107|FG000|Overall Study|Death|0|||
19561287|NCT01202877|42009108|FG001|Overall Study|Death|0|||
19561288|NCT01202877|42009109|FG002|Overall Study|Death|1|||
19561289|NCT01202409|42009117|FG000|Overall Study|Adverse Event|1|||
19561290|NCT01202409|42009117|FG000|Overall Study|Ineligible - KRAS mutants|7|||
19561291|NCT01202175|42009123|FG000|Overall Study|Lost to Follow-up|2|||
19561292|NCT01202175|42009123|FG000|Overall Study|Withdrawal by Subject|1|||
19561293|NCT01202175|42009123|FG000|Overall Study|Adverse Event|2|||
19561294|NCT01201785|42009128|FG000|Overall Study|Lost to Follow-up|16|||
19561295|NCT01201317|42009135|FG000|Overall Study|Withdrawal by Subject|5|||
19561296|NCT01201317|42009136|FG001|Overall Study|Withdrawal by Subject|0|||
19561297|NCT01201317|42009137|FG002|Overall Study|Withdrawal by Subject|3|||
19561298|NCT01201317|42009135|FG000|Overall Study|Adverse Event|2|||
19561299|NCT01201317|42009136|FG001|Overall Study|Adverse Event|2|||
19561300|NCT01201317|42009137|FG002|Overall Study|Adverse Event|2|||
19561301|NCT01201317|42009135|FG000|Overall Study|Screen failure|1|||
19561302|NCT01201317|42009136|FG001|Overall Study|Screen failure|1|||
19561303|NCT01201317|42009137|FG002|Overall Study|Screen failure|0|||
19561304|NCT01201317|42009135|FG000|Overall Study|Protocol Violation|0|||
19561305|NCT01201317|42009136|FG001|Overall Study|Protocol Violation|1|||
19561306|NCT01201317|42009137|FG002|Overall Study|Protocol Violation|1|||
19561307|NCT01201317|42009135|FG000|Overall Study|Death|0|||
19561308|NCT01201317|42009136|FG001|Overall Study|Death|1|||
19561309|NCT01201317|42009137|FG002|Overall Study|Death|0|||
19561310|NCT01201317|42009135|FG000|Overall Study|Study-specific withdrawal criteria|0|||
19561311|NCT01201317|42009136|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19561312|NCT01201317|42009137|FG002|Overall Study|Study-specific withdrawal criteria|1|||
19561313|NCT01201317|42009135|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
19561314|NCT01201317|42009136|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
19561315|NCT01201317|42009137|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
19561316|NCT01201317|42009135|FG000|Overall Study|Decrease in renal function|0|||
19561317|NCT01201317|42009136|FG001|Overall Study|Decrease in renal function|1|||
19561318|NCT01201317|42009137|FG002|Overall Study|Decrease in renal function|0|||
19561319|NCT01201317|42009135|FG000|Overall Study|Lack of Efficacy|1|||
19561320|NCT01201317|42009136|FG001|Overall Study|Lack of Efficacy|0|||
19561321|NCT01201317|42009137|FG002|Overall Study|Lack of Efficacy|0|||
19561322|NCT01201317|42009135|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
19561323|NCT01201317|42009136|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
19561324|NCT01201317|42009137|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
19561325|NCT01200069|42009147|FG000|Overall Study|Withdrawal by Subject|0|||
19561326|NCT01200069|42009148|FG001|Overall Study|Withdrawal by Subject|1|||
19561327|NCT01199601|42009199|FG000|Overall Study|Lost to Follow-up|47|||
19739746|NCT02757352|42186675|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
19739747|NCT02757352|42186676|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
19739748|NCT02757352|42186677|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739749|NCT02757352|42186678|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19561328|NCT01199601|42009200|FG001|Overall Study|Lost to Follow-up|66|||
19561329|NCT01199601|42009199|FG000|Overall Study|Withdrawal by Subject|15|||
19561330|NCT01199601|42009200|FG001|Overall Study|Withdrawal by Subject|3|||
19561331|NCT01199601|42009199|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
19561332|NCT01199601|42009200|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
19561333|NCT01199289|42009210|FG000|Overall Study|Ineligibility determined|2|||
19561334|NCT01199289|42009211|FG001|Overall Study|Ineligibility determined|1|||
19561335|NCT01199289|42009212|FG002|Overall Study|Ineligibility determined|0|||
19561336|NCT01199289|42009213|FG003|Overall Study|Ineligibility determined|0|||
19561337|NCT01199289|42009210|FG000|Overall Study|Protocol Violation|1|||
19561338|NCT01199289|42009211|FG001|Overall Study|Protocol Violation|0|||
19561339|NCT01199289|42009212|FG002|Overall Study|Protocol Violation|0|||
19561340|NCT01199289|42009213|FG003|Overall Study|Protocol Violation|1|||
19561341|NCT01199289|42009210|FG000|Overall Study|Noncompliance|1|||
19561342|NCT01199289|42009211|FG001|Overall Study|Noncompliance|0|||
19561343|NCT01199289|42009212|FG002|Overall Study|Noncompliance|2|||
19561344|NCT01199289|42009213|FG003|Overall Study|Noncompliance|0|||
19561345|NCT01199289|42009210|FG000|Overall Study|Adverse Event|0|||
19561346|NCT01199289|42009211|FG001|Overall Study|Adverse Event|3|||
19561347|NCT01199289|42009212|FG002|Overall Study|Adverse Event|1|||
19561348|NCT01199289|42009213|FG003|Overall Study|Adverse Event|4|||
19561349|NCT01199289|42009210|FG000|Overall Study|Full consent withdrawn|2|||
19561350|NCT01199289|42009211|FG001|Overall Study|Full consent withdrawn|2|||
19561351|NCT01199289|42009212|FG002|Overall Study|Full consent withdrawn|2|||
19561352|NCT01199289|42009213|FG003|Overall Study|Full consent withdrawn|3|||
19561353|NCT01199289|42009210|FG000|Overall Study|Administrative decision|0|||
19561354|NCT01199289|42009211|FG001|Overall Study|Administrative decision|0|||
19561355|NCT01199289|42009212|FG002|Overall Study|Administrative decision|0|||
19561356|NCT01199289|42009213|FG003|Overall Study|Administrative decision|1|||
19561357|NCT01199289|42009210|FG000|Overall Study|Lost to Follow-up|0|||
19561358|NCT01199289|42009211|FG001|Overall Study|Lost to Follow-up|0|||
19561359|NCT01199289|42009212|FG002|Overall Study|Lost to Follow-up|0|||
19561360|NCT01199289|42009213|FG003|Overall Study|Lost to Follow-up|1|||
19561361|NCT01199289|42009210|FG000|Overall Study|Protocol-specified criteria|3|||
19561362|NCT01199289|42009211|FG001|Overall Study|Protocol-specified criteria|0|||
19561363|NCT01199289|42009212|FG002|Overall Study|Protocol-specified criteria|0|||
19561364|NCT01199289|42009213|FG003|Overall Study|Protocol-specified criteria|1|||
19561365|NCT01199289|42009210|FG000|Overall Study|Pregnancy|0|||
19561366|NCT01199289|42009211|FG001|Overall Study|Pregnancy|1|||
19561367|NCT01199289|42009212|FG002|Overall Study|Pregnancy|0|||
19561368|NCT01199289|42009213|FG003|Overall Study|Pregnancy|1|||
19561369|NCT01199055|42009229|FG000|Overall Study|Death|0|||
19561370|NCT01199055|42009230|FG001|Overall Study|Death|1|||
19561371|NCT01199055|42009231|FG002|Overall Study|Death|0|||
19561372|NCT01199055|42009229|FG000|Overall Study|Physician Decision|0|||
19561373|NCT01199055|42009230|FG001|Overall Study|Physician Decision|1|||
19561374|NCT01199055|42009231|FG002|Overall Study|Physician Decision|1|||
19561375|NCT01199055|42009229|FG000|Overall Study|Progressive disease|2|||
19561376|NCT01199055|42009230|FG001|Overall Study|Progressive disease|1|||
19561377|NCT01199055|42009231|FG002|Overall Study|Progressive disease|2|||
19561378|NCT01199055|42009229|FG000|Overall Study|Withdrawal by Subject|0|||
19561379|NCT01199055|42009230|FG001|Overall Study|Withdrawal by Subject|0|||
19561380|NCT01199055|42009231|FG002|Overall Study|Withdrawal by Subject|1|||
19561381|NCT01198977|42009243|FG000|Overall Study|Lost to Follow-up|1|||
19561382|NCT01198977|42009244|FG001|Overall Study|Lost to Follow-up|0|||
19561383|NCT01198587|42009256|FG000|Overall Study|Lost to Follow-up|8|||
19561384|NCT01198587|42009257|FG001|Overall Study|Lost to Follow-up|0|||
19561385|NCT01198587|42009258|FG002|Overall Study|Lost to Follow-up|9|||
19561386|NCT01198587|42009259|FG003|Overall Study|Lost to Follow-up|0|||
19561387|NCT01198509|42009280|FG000|Overall Study|Withdrawal by Subject|1|||
19739750|NCT02757352|42186679|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739751|NCT02757352|42186680|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
19739752|NCT02757352|42186671|FG000|Follow-Up Period|Adverse Event|0|||
19739753|NCT02757352|42186672|FG001|Follow-Up Period|Adverse Event|0|||
19739754|NCT02757352|42186673|FG002|Follow-Up Period|Adverse Event|0|||
19739755|NCT02757352|42186674|FG003|Follow-Up Period|Adverse Event|0|||
19561388|NCT01198509|42009281|FG001|Overall Study|Withdrawal by Subject|0|||
19561389|NCT01198509|42009282|FG002|Overall Study|Withdrawal by Subject|0|||
19561390|NCT01198509|42009283|FG003|Overall Study|Withdrawal by Subject|0|||
19561391|NCT01198509|42009284|FG004|Overall Study|Withdrawal by Subject|0|||
19561392|NCT01198509|42009285|FG005|Overall Study|Withdrawal by Subject|0|||
19561393|NCT01198275|42009299|FG000|Overall Study|Adverse Event|2|||
19561394|NCT01198275|42009300|FG001|Overall Study|Adverse Event|3|||
19561395|NCT01198275|42009299|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
19561396|NCT01198275|42009300|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
19561397|NCT01197417|42009308|FG000|Overall Study|Physician Decision|3|||
19561398|NCT01197417|42009309|FG001|Overall Study|Physician Decision|2|||
19561399|NCT01197417|42009308|FG000|Overall Study|Withdrawal by Subject|2|||
19561400|NCT01197417|42009309|FG001|Overall Study|Withdrawal by Subject|4|||
19561401|NCT01197417|42009308|FG000|Overall Study|Site miscommunication|0|||
19561402|NCT01197417|42009309|FG001|Overall Study|Site miscommunication|1|||
19561403|NCT01197417|42009308|FG000|Overall Study|Subject transferred to intensive care|0|||
19561404|NCT01197417|42009309|FG001|Overall Study|Subject transferred to intensive care|1|||
19561405|NCT01197417|42009308|FG000|Overall Study|Not consented in time to receive drug|0|||
19561406|NCT01197417|42009309|FG001|Overall Study|Not consented in time to receive drug|1|||
19561407|NCT01197417|42009308|FG000|Overall Study|Hypotension|1|||
19561408|NCT01197417|42009309|FG001|Overall Study|Hypotension|2|||
19561409|NCT01197417|42009308|FG000|Overall Study|Found to be ineligible|2|||
19561410|NCT01197417|42009309|FG001|Overall Study|Found to be ineligible|5|||
19561411|NCT01197417|42009308|FG000|Overall Study|No 25-hour magnesium level|0|||
19561412|NCT01197417|42009309|FG001|Overall Study|No 25-hour magnesium level|2|||
19561413|NCT00977431|42009320|FG000|Overall Study|Other than listed|1|||
19561414|NCT00977431|42009321|FG001|Overall Study|Other than listed|0|||
19561415|NCT00977431|42009322|FG002|Overall Study|Other than listed|0|||
19561416|NCT00977431|42009323|FG003|Overall Study|Other than listed|0|||
19561417|NCT00977431|42009324|FG004|Overall Study|Other than listed|2|||
19561418|NCT00977431|42009320|FG000|Overall Study|Protocol Violation|0|||
19561419|NCT00977431|42009321|FG001|Overall Study|Protocol Violation|0|||
19561420|NCT00977431|42009322|FG002|Overall Study|Protocol Violation|1|||
19561421|NCT00977431|42009323|FG003|Overall Study|Protocol Violation|0|||
19561422|NCT00977431|42009324|FG004|Overall Study|Protocol Violation|0|||
19561423|NCT00977431|42009320|FG000|Overall Study|Adverse Event|3|||
19561424|NCT00977431|42009321|FG001|Overall Study|Adverse Event|0|||
19561425|NCT00977431|42009322|FG002|Overall Study|Adverse Event|4|||
19561426|NCT00977431|42009323|FG003|Overall Study|Adverse Event|0|||
19561427|NCT00977431|42009324|FG004|Overall Study|Adverse Event|6|||
19561428|NCT00977431|42009320|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
19561429|NCT00977431|42009321|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
19561430|NCT00977431|42009322|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
19561431|NCT00977431|42009323|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
19561432|NCT00977431|42009324|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
19561433|NCT00977431|42009320|FG000|Overall Study|Progressive disease|2|||
19561434|NCT00977431|42009321|FG001|Overall Study|Progressive disease|6|||
19561435|NCT00977431|42009322|FG002|Overall Study|Progressive disease|1|||
19561436|NCT00977431|42009323|FG003|Overall Study|Progressive disease|3|||
19561437|NCT00977431|42009324|FG004|Overall Study|Progressive disease|5|||
19561438|NCT00977197|42009342|FG000|Overall Study|Withdrawal by Subject|3|||
19561439|NCT00977197|42009343|FG001|Overall Study|Withdrawal by Subject|4|||
19561440|NCT00977197|42009342|FG000|Overall Study|Adverse Event|3|||
19561441|NCT00977197|42009343|FG001|Overall Study|Adverse Event|1|||
19561442|NCT00977197|42009342|FG000|Overall Study|Lack of Efficacy|1|||
19739756|NCT02757352|42186675|FG004|Follow-Up Period|Adverse Event|0|||
19739757|NCT02757352|42186676|FG005|Follow-Up Period|Adverse Event|0|||
19739758|NCT02757352|42186677|FG006|Follow-Up Period|Adverse Event|1|||
19739759|NCT02757352|42186678|FG007|Follow-Up Period|Adverse Event|0|||
19739760|NCT02757352|42186679|FG008|Follow-Up Period|Adverse Event|2|||
19561443|NCT00977197|42009343|FG001|Overall Study|Lack of Efficacy|0|||
19561444|NCT00977197|42009342|FG000|Overall Study|Lost to Follow-up|1|||
19561445|NCT00977197|42009343|FG001|Overall Study|Lost to Follow-up|3|||
19561446|NCT00977197|42009342|FG000|Overall Study|Nonadherence|1|||
19561447|NCT00977197|42009343|FG001|Overall Study|Nonadherence|1|||
19561448|NCT00974311|42009351|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
19561449|NCT00974311|42009352|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
19561450|NCT00974311|42009351|FG000|DB Phase (up to 24 Months)|Death|561|||
19739761|NCT02757352|42186680|FG009|Follow-Up Period|Adverse Event|0|||
19739762|NCT02757352|42186671|FG000|Follow-Up Period|Lost to Follow-up|0|||
19739763|NCT02757352|42186672|FG001|Follow-Up Period|Lost to Follow-up|0|||
19561451|NCT00974311|42009352|FG001|DB Phase (up to 24 Months)|Death|298|||
19561452|NCT00974311|42009351|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
19561453|NCT00974311|42009352|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
19561454|NCT00974311|42009351|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
19561455|NCT00974311|42009352|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
19561456|NCT00974311|42009351|FG000|DB Phase (up to 24 Months)|Other|1|||
19561457|NCT00974311|42009352|FG001|DB Phase (up to 24 Months)|Other|0|||
19561458|NCT00974311|42009351|FG000|OLE Phase (up to 77 Months)|Death|14|||
19561459|NCT00974311|42009352|FG001|OLE Phase (up to 77 Months)|Death|21|||
19561460|NCT00974311|42009351|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
19561461|NCT00974311|42009352|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
19561462|NCT00974311|42009351|FG000|OLE Phase (up to 77 Months)|Other|15|||
19561463|NCT00974311|42009352|FG001|OLE Phase (up to 77 Months)|Other|2|||
19561464|NCT00974311|42009351|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
19561465|NCT00974311|42009352|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
19561466|NCT00974233|42009361|FG000|Induction Chemoimmunotherapy|Death|2|||
19561467|NCT00974233|42009361|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
19561468|NCT00974233|42009361|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
19561469|NCT00974233|42009361|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
19561470|NCT00974233|42009361|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
19561471|NCT00974233|42009361|FG000|Maintenance Lenalidomide|Adverse Event|8|||
19561472|NCT00973921|42009373|FG000|Overall Study|IVUS results were not available|9|||
19561473|NCT00972595|42009377|FG000|Period 1|Adverse Event|1|||
19561474|NCT00972595|42009378|FG001|Period 1|Adverse Event|0|||
19561475|NCT01196091|42009387|FG000|Overall Study|Adverse Event|22|||
19561476|NCT01196091|42009388|FG001|Overall Study|Adverse Event|27|||
19561477|NCT01196091|42009389|FG002|Overall Study|Adverse Event|26|||
19561478|NCT01196091|42009387|FG000|Overall Study|Death|3|||
19739764|NCT02757352|42186673|FG002|Follow-Up Period|Lost to Follow-up|0|||
19739765|NCT02757352|42186674|FG003|Follow-Up Period|Lost to Follow-up|0|||
19561479|NCT01196091|42009388|FG001|Overall Study|Death|2|||
19561480|NCT01196091|42009389|FG002|Overall Study|Death|2|||
19561481|NCT01196091|42009387|FG000|Overall Study|Entry Criteria Not Met|11|||
19561482|NCT01196091|42009388|FG001|Overall Study|Entry Criteria Not Met|11|||
19561483|NCT01196091|42009389|FG002|Overall Study|Entry Criteria Not Met|10|||
19561484|NCT01196091|42009387|FG000|Overall Study|Lack of Efficacy|15|||
19561485|NCT01196091|42009388|FG001|Overall Study|Lack of Efficacy|12|||
19561486|NCT01196091|42009389|FG002|Overall Study|Lack of Efficacy|17|||
19561487|NCT01196091|42009387|FG000|Overall Study|Lost to Follow-up|5|||
19561488|NCT01196091|42009388|FG001|Overall Study|Lost to Follow-up|5|||
19561489|NCT01196091|42009389|FG002|Overall Study|Lost to Follow-up|6|||
19561490|NCT01196091|42009387|FG000|Overall Study|Parent/Caregiver Decision|0|||
19561491|NCT01196091|42009388|FG001|Overall Study|Parent/Caregiver Decision|0|||
19561492|NCT01196091|42009389|FG002|Overall Study|Parent/Caregiver Decision|1|||
19561493|NCT01196091|42009387|FG000|Overall Study|Withdrawal by Subject|16|||
19561494|NCT01196091|42009388|FG001|Overall Study|Withdrawal by Subject|19|||
19561495|NCT01196091|42009389|FG002|Overall Study|Withdrawal by Subject|22|||
19561496|NCT01196091|42009387|FG000|Overall Study|Physician Decision|3|||
19561497|NCT01196091|42009388|FG001|Overall Study|Physician Decision|3|||
19561498|NCT01196091|42009389|FG002|Overall Study|Physician Decision|4|||
19561499|NCT01196091|42009387|FG000|Overall Study|Protocol Violation|1|||
19561500|NCT01196091|42009388|FG001|Overall Study|Protocol Violation|3|||
19561501|NCT01196091|42009389|FG002|Overall Study|Protocol Violation|3|||
19561502|NCT01196091|42009387|FG000|Overall Study|Sponsor Decision|6|||
19561503|NCT01196091|42009388|FG001|Overall Study|Sponsor Decision|5|||
19561504|NCT01196091|42009389|FG002|Overall Study|Sponsor Decision|4|||
19561505|NCT01196091|42009387|FG000|Overall Study|Excluded Site|5|||
19561506|NCT01196091|42009388|FG001|Overall Study|Excluded Site|11|||
19561507|NCT01196091|42009389|FG002|Overall Study|Excluded Site|8|||
19561508|NCT01196091|42009387|FG000|Overall Study|Randomized, No Study Drug Received|1|||
19561509|NCT01196091|42009388|FG001|Overall Study|Randomized, No Study Drug Received|0|||
19561510|NCT01196091|42009389|FG002|Overall Study|Randomized, No Study Drug Received|1|||
19561511|NCT01195623|42009404|FG000|Overall Study|Lost to Follow-up|35|||
19561512|NCT01195623|42009405|FG001|Overall Study|Lost to Follow-up|37|||
19561513|NCT01195545|42009411|FG000|Overall Study|Protocol Violation|4|||
19561514|NCT01194999|42009415|FG000|Overall Study|Lost to Follow-up|17|||
19561515|NCT01194531|42009421|FG000|Overall Study|Withdrawal by Subject|1|||
19561516|NCT01194531|42009422|FG001|Overall Study|Withdrawal by Subject|0|||
19561517|NCT01194531|42009421|FG000|Overall Study|Protocol Violation|4|||
19561518|NCT01194531|42009422|FG001|Overall Study|Protocol Violation|1|||
19561519|NCT01194531|42009421|FG000|Overall Study|Physician Decision|0|||
19561520|NCT01194531|42009422|FG001|Overall Study|Physician Decision|2|||
19561521|NCT00972517|42009428|FG000|Overall Study|Adverse Event|0|||
19561522|NCT00972517|42009429|FG001|Overall Study|Adverse Event|0|||
19561523|NCT00972517|42009430|FG002|Overall Study|Adverse Event|0|||
19561524|NCT00972517|42009431|FG003|Overall Study|Adverse Event|1|||
19561525|NCT00972517|42009432|FG004|Overall Study|Adverse Event|0|||
19561526|NCT00972517|42009433|FG005|Overall Study|Adverse Event|0|||
19561527|NCT00972517|42009428|FG000|Overall Study|Withdrawal by Subject|0|||
19561528|NCT00972517|42009429|FG001|Overall Study|Withdrawal by Subject|1|||
19561529|NCT00972517|42009430|FG002|Overall Study|Withdrawal by Subject|0|||
19561530|NCT00972517|42009431|FG003|Overall Study|Withdrawal by Subject|2|||
19561531|NCT00972517|42009432|FG004|Overall Study|Withdrawal by Subject|1|||
19561532|NCT00972517|42009433|FG005|Overall Study|Withdrawal by Subject|0|||
19561533|NCT00972283|42009455|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
19561534|NCT00972283|42009456|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
19561535|NCT00972283|42009455|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
19561536|NCT00972283|42009456|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
19561537|NCT00972283|42009455|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
19561538|NCT00972283|42009456|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
19561539|NCT00972283|42009455|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
19561540|NCT00972283|42009456|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
19561541|NCT00972283|42009455|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
19561542|NCT00972283|42009456|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
19561543|NCT00972283|42009455|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
19561544|NCT00972283|42009456|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
19561545|NCT00972283|42009455|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
19561546|NCT00972283|42009456|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
19561547|NCT00972283|42009455|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
19561548|NCT00972283|42009456|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
19561549|NCT00972283|42009455|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
19561550|NCT00972283|42009456|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
19561551|NCT00972283|42009455|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
19561552|NCT00972283|42009456|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
19561553|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
19561554|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
19561555|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561556|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561557|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561558|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561559|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561560|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561561|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561562|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
19561563|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
19561564|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
19561565|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561566|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561567|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561568|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561569|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561570|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561571|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561572|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
19561573|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
19561574|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561575|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561576|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561577|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561578|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19739766|NCT02757352|42186675|FG004|Follow-Up Period|Lost to Follow-up|0|||
19561579|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561580|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561581|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561582|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
19561583|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
19561584|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
19561585|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561586|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561587|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561588|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561589|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561590|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561591|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561592|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
19561593|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561594|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
19561595|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561596|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561597|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561598|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561599|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561600|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561601|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19561602|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
19739767|NCT02757352|42186676|FG005|Follow-Up Period|Lost to Follow-up|0|||
19561603|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
19561604|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
19561605|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561606|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561607|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561608|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561609|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561610|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561611|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561612|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
19561613|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
19561614|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
19561615|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561616|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561617|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561618|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561619|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561620|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561621|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561622|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
19561623|NCT01194219|42009464|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
19561624|NCT01194219|42009465|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
19561625|NCT01194219|42009466|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561626|NCT01194219|42009467|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561627|NCT01194219|42009468|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561628|NCT01194219|42009469|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561629|NCT01194219|42009470|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561630|NCT01194219|42009471|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561631|NCT01194219|42009472|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561632|NCT01194219|42009473|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
19561633|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561634|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561635|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
19561636|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
19561637|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561638|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561639|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561640|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561641|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561642|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
19561643|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561644|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561645|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
19561646|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
19561647|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561648|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561649|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561650|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561651|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561652|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
19561653|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561654|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561655|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
19561656|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
19561657|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561658|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561659|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561660|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561661|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561662|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
19561663|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561664|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561665|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
19561666|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
19561667|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561668|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561669|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561670|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561671|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561672|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
19561673|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561674|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561675|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
19561676|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561677|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561678|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561679|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561680|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561681|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561682|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
19561683|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561684|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561685|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561686|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
19561687|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561688|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561689|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561690|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561691|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561692|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
19561693|NCT01194219|42009464|FG000|Maintenance Phase Weeks16-32|Other|0|||
19561694|NCT01194219|42009465|FG001|Maintenance Phase Weeks16-32|Other|0|||
19561695|NCT01194219|42009466|FG002|Maintenance Phase Weeks16-32|Other|2|||
19561696|NCT01194219|42009467|FG003|Maintenance Phase Weeks16-32|Other|1|||
19561697|NCT01194219|42009468|FG004|Maintenance Phase Weeks16-32|Other|0|||
19561698|NCT01194219|42009469|FG005|Maintenance Phase Weeks16-32|Other|0|||
19561699|NCT01194219|42009470|FG006|Maintenance Phase Weeks16-32|Other|0|||
19561700|NCT01194219|42009471|FG007|Maintenance Phase Weeks16-32|Other|0|||
19561701|NCT01194219|42009472|FG008|Maintenance Phase Weeks16-32|Other|0|||
19561702|NCT01194219|42009473|FG009|Maintenance Phase Weeks16-32|Other|0|||
19561703|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561704|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561705|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561706|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561707|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561708|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
19561709|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
19561710|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
19561711|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561712|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
19561713|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561714|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561715|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561716|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561717|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
19561718|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
19561719|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
19561720|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
19561721|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561722|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
19561723|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561724|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561725|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561726|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561727|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
19561728|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561729|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
19561730|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561731|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561732|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
19561733|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561734|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561735|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561736|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561737|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
19561738|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561739|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
19561740|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
19561741|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561742|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
19561743|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561744|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19382224|NCT02646891|41625492|FG002|Overall Study|Lost to Follow-up|0|||
19382225|NCT02646891|41625493|FG003|Overall Study|Lost to Follow-up|0|||
19382226|NCT02646891|41625494|FG004|Overall Study|Lost to Follow-up|0|||
19382227|NCT02646891|41625495|FG005|Overall Study|Lost to Follow-up|0|||
19382228|NCT02646891|41625496|FG006|Overall Study|Lost to Follow-up|2|||
19382229|NCT02646891|41625497|FG007|Overall Study|Lost to Follow-up|2|||
19382230|NCT02646891|41625498|FG008|Overall Study|Lost to Follow-up|2|||
19382231|NCT02646891|41625499|FG009|Overall Study|Lost to Follow-up|2|||
19382232|NCT02646891|41625490|FG000|Overall Study|Protocol Violation|0|||
19382233|NCT02646891|41625491|FG001|Overall Study|Protocol Violation|0|||
19382234|NCT02646891|41625492|FG002|Overall Study|Protocol Violation|0|||
19739768|NCT02757352|42186677|FG006|Follow-Up Period|Lost to Follow-up|0|||
19739769|NCT02757352|42186678|FG007|Follow-Up Period|Lost to Follow-up|0|||
19739770|NCT02757352|42186679|FG008|Follow-Up Period|Lost to Follow-up|1|||
19739771|NCT02757352|42186680|FG009|Follow-Up Period|Lost to Follow-up|0|||
19739772|NCT02757352|42186671|FG000|Follow-Up Period|Lack of Efficacy|0|||
19739773|NCT02757352|42186672|FG001|Follow-Up Period|Lack of Efficacy|0|||
19739774|NCT02757352|42186673|FG002|Follow-Up Period|Lack of Efficacy|0|||
19739775|NCT02757352|42186674|FG003|Follow-Up Period|Lack of Efficacy|0|||
19739776|NCT02757352|42186675|FG004|Follow-Up Period|Lack of Efficacy|0|||
19382235|NCT02646891|41625493|FG003|Overall Study|Protocol Violation|0|||
19561745|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561746|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561747|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
19561748|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
19561749|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
19561750|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561751|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561752|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
19561753|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561754|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561755|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561756|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561757|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561758|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561759|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561760|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
19561761|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561762|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
19561763|NCT01194219|42009464|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561764|NCT01194219|42009465|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561765|NCT01194219|42009466|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561766|NCT01194219|42009467|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561767|NCT01194219|42009468|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561768|NCT01194219|42009469|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561769|NCT01194219|42009470|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
19561770|NCT01194219|42009471|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561771|NCT01194219|42009472|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561772|NCT01194219|42009473|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
19561773|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561774|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561775|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561776|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561777|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561778|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561779|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561780|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
19561781|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
19561782|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
19561783|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561784|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561785|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561786|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561787|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561788|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561789|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561790|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
19561791|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
19561792|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
19561793|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561794|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561795|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561796|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561797|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561798|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19739777|NCT02757352|42186676|FG005|Follow-Up Period|Lack of Efficacy|0|||
19739778|NCT02757352|42186677|FG006|Follow-Up Period|Lack of Efficacy|0|||
19739779|NCT02757352|42186678|FG007|Follow-Up Period|Lack of Efficacy|0|||
19739780|NCT02757352|42186679|FG008|Follow-Up Period|Lack of Efficacy|1|||
19739781|NCT02757352|42186680|FG009|Follow-Up Period|Lack of Efficacy|1|||
19382236|NCT02646891|41625494|FG004|Overall Study|Protocol Violation|0|||
19739782|NCT02757352|42186671|FG000|Follow-Up Period|Withdrawal by Subject|0|||
19739783|NCT02757352|42186672|FG001|Follow-Up Period|Withdrawal by Subject|0|||
19739784|NCT02757352|42186673|FG002|Follow-Up Period|Withdrawal by Subject|0|||
19739785|NCT02757352|42186674|FG003|Follow-Up Period|Withdrawal by Subject|0|||
19739786|NCT02757352|42186675|FG004|Follow-Up Period|Withdrawal by Subject|0|||
19739787|NCT02757352|42186676|FG005|Follow-Up Period|Withdrawal by Subject|0|||
19739788|NCT02757352|42186677|FG006|Follow-Up Period|Withdrawal by Subject|0|||
19739789|NCT02757352|42186678|FG007|Follow-Up Period|Withdrawal by Subject|1|||
19739790|NCT02757352|42186679|FG008|Follow-Up Period|Withdrawal by Subject|6|||
19739791|NCT02757352|42186680|FG009|Follow-Up Period|Withdrawal by Subject|2|||
19739792|NCT04588480|42186713|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
19739793|NCT04588480|42186714|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
19739794|NCT04588480|42186715|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
19739795|NCT04588480|42186713|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
19739796|NCT04588480|42186714|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
19739797|NCT04588480|42186715|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
19739798|NCT02756650|42186722|FG000|Overall Study|Physician Decision|1|||
19739799|NCT02756650|42186722|FG000|Overall Study|Adverse Event|1|||
19739800|NCT00110357|42186728|FG000|Overall Study|Deterioration without progression|2|||
19739801|NCT00110357|42186729|FG001|Overall Study|Deterioration without progression|0|||
19739802|NCT00110357|42186728|FG000|Overall Study|Disease progression/relapse|20|||
19739803|NCT00110357|42186729|FG001|Overall Study|Disease progression/relapse|15|||
19561799|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561800|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
19561801|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
19561802|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
19561803|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561804|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561805|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561806|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561807|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561808|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561809|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561810|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
19561811|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
19561812|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
19561813|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
19561814|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
19561815|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
19561816|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
19561817|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
19561818|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
19561819|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
19561820|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
19561821|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
19561822|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
19561823|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561824|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561825|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561826|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561827|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19739804|NCT00110357|42186728|FG000|Overall Study|Study Closure|1|||
19739805|NCT00110357|42186729|FG001|Overall Study|Study Closure|0|||
19739806|NCT00110357|42186728|FG000|Overall Study|Study Drug Toxicity|1|||
19739807|NCT00110357|42186729|FG001|Overall Study|Study Drug Toxicity|3|||
19739808|NCT00110357|42186728|FG000|Overall Study|Withdrawal by Subject|3|||
19739809|NCT00110357|42186729|FG001|Overall Study|Withdrawal by Subject|1|||
19739810|NCT02752906|42186764|FG000|Overall Study|Protocol Violation|2|||
19739811|NCT02752906|42186765|FG001|Overall Study|Protocol Violation|1|||
19739812|NCT02752906|42186764|FG000|Overall Study|Withdrawal by Subject|2|||
19739813|NCT02752906|42186765|FG001|Overall Study|Withdrawal by Subject|2|||
19739814|NCT02752906|42186764|FG000|Overall Study|Lost to Follow-up|3|||
19739815|NCT02752906|42186765|FG001|Overall Study|Lost to Follow-up|2|||
19739816|NCT02756338|42186771|FG000|Overall Study|Withdrawn by Investigator|1|||
19561828|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561829|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561830|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
19561831|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
19561832|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
19561833|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561834|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561835|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561836|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561837|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561838|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561839|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561840|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561841|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
19561842|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
19561843|NCT01194219|42009464|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561844|NCT01194219|42009465|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561845|NCT01194219|42009466|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561846|NCT01194219|42009467|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561847|NCT01194219|42009468|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561848|NCT01194219|42009469|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561849|NCT01194219|42009470|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561850|NCT01194219|42009471|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
19561851|NCT01194219|42009472|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
19561852|NCT01194219|42009473|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
19561853|NCT00969709|42009500|FG000|Overall Study|Adverse Event|3|||
19561854|NCT00969709|42009501|FG001|Overall Study|Adverse Event|13|||
19561855|NCT00969709|42009502|FG002|Overall Study|Adverse Event|26|||
19561856|NCT00969709|42009503|FG003|Overall Study|Adverse Event|12|||
19561857|NCT00969709|42009500|FG000|Overall Study|Lack of Efficacy|7|||
19561858|NCT00969709|42009501|FG001|Overall Study|Lack of Efficacy|4|||
19561859|NCT00969709|42009502|FG002|Overall Study|Lack of Efficacy|1|||
19739817|NCT02756338|42186771|FG000|Overall Study|Device Replaced with Pacemaker|4|||
19739818|NCT00293033|42186775|FG000|Open-label Titration Period|Adverse Event|10|||
19476781|NCT01522651|41754858|FG000|Overall Study|Withdrew Consent|1|||
19476782|NCT01522651|41754859|FG001|Overall Study|Withdrew Consent|1|||
19476783|NCT01522651|41754860|FG002|Overall Study|Withdrew Consent|0|||
19476784|NCT01522651|41754861|FG003|Overall Study|Withdrew Consent|1|||
19476785|NCT01522651|41754862|FG004|Overall Study|Withdrew Consent|1|||
19476786|NCT01522651|41754858|FG000|Overall Study|Randomized but Never Treated|0|||
19476787|NCT01522651|41754859|FG001|Overall Study|Randomized but Never Treated|1|||
19476788|NCT01522651|41754860|FG002|Overall Study|Randomized but Never Treated|0|||
19561860|NCT00969709|42009503|FG003|Overall Study|Lack of Efficacy|3|||
19561861|NCT00969709|42009500|FG000|Overall Study|Protocol Violation|9|||
19561862|NCT00969709|42009501|FG001|Overall Study|Protocol Violation|5|||
19561863|NCT00969709|42009502|FG002|Overall Study|Protocol Violation|9|||
19561864|NCT00969709|42009503|FG003|Overall Study|Protocol Violation|10|||
19739819|NCT00293033|42186775|FG000|Open-label Titration Period|Death|3|||
19739820|NCT00293033|42186775|FG000|Open-label Titration Period|Lack of Efficacy|5|||
19739821|NCT00293033|42186775|FG000|Open-label Titration Period|Protocol Violation|2|||
19739822|NCT00293033|42186775|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
19739823|NCT00293033|42186775|FG000|Open-label Titration Period|Noncompliance and other|27|||
19739824|NCT00293033|42186775|FG000|Double-blind Treatment Period|Adverse Event|3|||
19561865|NCT00969709|42009500|FG000|Overall Study|Withdrawal by Subject|9|||
19561866|NCT00969709|42009501|FG001|Overall Study|Withdrawal by Subject|12|||
19561867|NCT00969709|42009502|FG002|Overall Study|Withdrawal by Subject|11|||
19561868|NCT00969709|42009503|FG003|Overall Study|Withdrawal by Subject|23|||
19561869|NCT00969709|42009500|FG000|Overall Study|Lost to Follow-up|10|||
19561870|NCT00969709|42009501|FG001|Overall Study|Lost to Follow-up|14|||
19561871|NCT00969709|42009502|FG002|Overall Study|Lost to Follow-up|8|||
19561872|NCT00969709|42009503|FG003|Overall Study|Lost to Follow-up|15|||
19561873|NCT00969709|42009500|FG000|Overall Study|Other reasons|0|||
19561874|NCT00969709|42009501|FG001|Overall Study|Other reasons|0|||
19561875|NCT00969709|42009502|FG002|Overall Study|Other reasons|3|||
19561876|NCT00969709|42009503|FG003|Overall Study|Other reasons|0|||
19561877|NCT01193517|42009520|FG000|Overall Study|Early Progression|1|||
19561878|NCT01193517|42009521|FG001|Overall Study|Early Progression|0|||
19561879|NCT01193517|42009522|FG002|Overall Study|Early Progression|0|||
19561880|NCT01193283|42009531|FG000|Overall Study|Death|1|||
19561881|NCT00971425|42009537|FG000|Overall Study|Adverse Event|1|||
19561882|NCT00971425|42009538|FG001|Overall Study|Adverse Event|1|||
19561883|NCT00971425|42009537|FG000|Overall Study|Withdrawal by Subject|0|||
19561884|NCT00971425|42009538|FG001|Overall Study|Withdrawal by Subject|1|||
19561885|NCT01193127|42009548|FG000|Randomized|Surgery Cancelled|0|||
19561886|NCT01193127|42009549|FG001|Randomized|Surgery Cancelled|0|||
19561887|NCT01193127|42009550|FG002|Randomized|Surgery Cancelled|0|||
19561888|NCT01193127|42009551|FG003|Randomized|Surgery Cancelled|1|||
19561889|NCT01193127|42009548|FG000|Treated|Withdrawal by Subject|0|||
19561890|NCT01193127|42009549|FG001|Treated|Withdrawal by Subject|0|||
19561891|NCT01193127|42009550|FG002|Treated|Withdrawal by Subject|0|||
19561892|NCT01193127|42009551|FG003|Treated|Withdrawal by Subject|1|||
19561893|NCT01192815|42009563|FG000|Overall Study|Withdrawal by Subject|1|||
19561894|NCT01192815|42009563|FG000|Overall Study|Lack of Efficacy|1|||
19561895|NCT01192347|42009567|FG000|Overall Study|Death|3|||
19561896|NCT01192347|42009567|FG000|Overall Study|Lost to Follow-up|3|||
19561897|NCT01192347|42009567|FG000|Overall Study|Withdrawal by Subject|1|||
19561898|NCT01192347|42009567|FG000|Overall Study|Adverse Event|1|||
19561899|NCT01192347|42009567|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
19561900|NCT01192347|42009567|FG000|Overall Study|Patient seen in different hospital|1|||
19561901|NCT01192347|42009567|FG000|Overall Study|Patient not visiting hospital regularly|1|||
19561902|NCT01192347|42009567|FG000|Overall Study|Patient did not show up for visits|1|||
19561903|NCT01192191|42009573|FG000|Overall Study|Adverse Event|7|||
19561904|NCT01192191|42009574|FG001|Overall Study|Adverse Event|12|||
19561905|NCT01192191|42009573|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
19561906|NCT01192191|42009574|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
19561907|NCT01192191|42009573|FG000|Overall Study|Lost to Follow-up|0|||
19561908|NCT01192191|42009574|FG001|Overall Study|Lost to Follow-up|1|||
19561909|NCT01192191|42009573|FG000|Overall Study|Withdrawal by Subject|1|||
19561910|NCT01192191|42009574|FG001|Overall Study|Withdrawal by Subject|6|||
19561911|NCT01307267|42009603|FG000|Overall Study|Death|4|||
19561912|NCT01307267|42009604|FG001|Overall Study|Death|3|||
19561913|NCT01307267|42009605|FG002|Overall Study|Death|5|||
19561914|NCT01307267|42009606|FG003|Overall Study|Death|3|||
19561915|NCT01307267|42009607|FG004|Overall Study|Death|1|||
19561916|NCT01307267|42009608|FG005|Overall Study|Death|26|||
19739825|NCT00293033|42186775|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
19739826|NCT00293033|42186775|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
19739827|NCT00293033|42186775|FG000|Double-blind Treatment Period|Noncompliance|4|||
19739828|NCT02756182|42186783|FG000|Overall Study|StudyTechnical Difficulties|4|||
19739829|NCT03823703|42186792|FG000|Overall Study|Sponsor request|0|||
19739830|NCT03823703|42186793|FG001|Overall Study|Sponsor request|3|||
19739831|NCT03823703|42186794|FG002|Overall Study|Sponsor request|4|||
19739832|NCT03823703|42186792|FG000|Overall Study|Adverse Event|3|||
19739833|NCT03823703|42186793|FG001|Overall Study|Adverse Event|1|||
19739834|NCT03823703|42186794|FG002|Overall Study|Adverse Event|0|||
19739835|NCT03823703|42186792|FG000|Overall Study|Withdrawal by Subject|0|||
19739836|NCT03823703|42186793|FG001|Overall Study|Withdrawal by Subject|1|||
19739837|NCT03823703|42186794|FG002|Overall Study|Withdrawal by Subject|0|||
19739838|NCT00109577|42186804|FG000|Overall Study|Withdrawal by Subject|3|||
19739839|NCT00109577|42186805|FG001|Overall Study|Withdrawal by Subject|3|||
19739840|NCT02755090|42186813|FG000|Overall Study|equipment malfunction|1|||
19739841|NCT02755090|42186814|FG001|Overall Study|equipment malfunction|0|||
19739842|NCT00109343|42186823|FG000|Overall Study|Adverse Event|1|||
19561917|NCT01307267|42009609|FG006|Overall Study|Death|2|||
19561918|NCT01307267|42009610|FG007|Overall Study|Death|2|||
19561919|NCT01307267|42009611|FG008|Overall Study|Death|21|||
19561920|NCT01307267|42009612|FG009|Overall Study|Death|2|||
19561921|NCT01307267|42009613|FG010|Overall Study|Death|3|||
19561922|NCT01307267|42009614|FG011|Overall Study|Death|9|||
19561923|NCT01307267|42009615|FG012|Overall Study|Death|0|||
19739843|NCT00109343|42186824|FG001|Overall Study|Adverse Event|0|||
19739844|NCT00109343|42186825|FG002|Overall Study|Adverse Event|2|||
19739845|NCT00109343|42186823|FG000|Overall Study|Lack of Efficacy|1|||
19739846|NCT00109343|42186824|FG001|Overall Study|Lack of Efficacy|0|||
19739847|NCT00109343|42186825|FG002|Overall Study|Lack of Efficacy|0|||
19739848|NCT00109343|42186823|FG000|Overall Study|Lost to Follow-up|35|||
19561924|NCT01307267|42009616|FG013|Overall Study|Death|0|||
19561925|NCT01307267|42009617|FG014|Overall Study|Death|0|||
19561926|NCT01307267|42009618|FG015|Overall Study|Death|0|||
19561927|NCT01307267|42009619|FG016|Overall Study|Death|1|||
19561928|NCT01307267|42009620|FG017|Overall Study|Death|1|||
19561929|NCT01307267|42009621|FG018|Overall Study|Death|2|||
19561930|NCT01307267|42009622|FG019|Overall Study|Death|8|||
19561931|NCT01307267|42009623|FG020|Overall Study|Death|1|||
19561932|NCT01307267|42009624|FG021|Overall Study|Death|2|||
19561933|NCT01307267|42009625|FG022|Overall Study|Death|2|||
19561934|NCT01307267|42009603|FG000|Overall Study|Lost to Follow-up|0|||
19561935|NCT01307267|42009604|FG001|Overall Study|Lost to Follow-up|0|||
19561936|NCT01307267|42009605|FG002|Overall Study|Lost to Follow-up|0|||
19561937|NCT01307267|42009606|FG003|Overall Study|Lost to Follow-up|0|||
19561938|NCT01307267|42009607|FG004|Overall Study|Lost to Follow-up|0|||
19561939|NCT01307267|42009608|FG005|Overall Study|Lost to Follow-up|7|||
19561940|NCT01307267|42009609|FG006|Overall Study|Lost to Follow-up|0|||
19561941|NCT01307267|42009610|FG007|Overall Study|Lost to Follow-up|0|||
19561942|NCT01307267|42009611|FG008|Overall Study|Lost to Follow-up|1|||
19561943|NCT01307267|42009612|FG009|Overall Study|Lost to Follow-up|2|||
19561944|NCT01307267|42009613|FG010|Overall Study|Lost to Follow-up|1|||
19561945|NCT01307267|42009614|FG011|Overall Study|Lost to Follow-up|0|||
19739849|NCT00109343|42186824|FG001|Overall Study|Lost to Follow-up|20|||
19561946|NCT01307267|42009615|FG012|Overall Study|Lost to Follow-up|0|||
19561947|NCT01307267|42009616|FG013|Overall Study|Lost to Follow-up|0|||
19561948|NCT01307267|42009617|FG014|Overall Study|Lost to Follow-up|0|||
19561949|NCT01307267|42009618|FG015|Overall Study|Lost to Follow-up|0|||
19561950|NCT01307267|42009619|FG016|Overall Study|Lost to Follow-up|0|||
19739850|NCT00109343|42186825|FG002|Overall Study|Lost to Follow-up|14|||
19739851|NCT00109343|42186823|FG000|Overall Study|Protocol Violation|1|||
19739852|NCT00109343|42186824|FG001|Overall Study|Protocol Violation|2|||
19561951|NCT01307267|42009620|FG017|Overall Study|Lost to Follow-up|0|||
19561952|NCT01307267|42009621|FG018|Overall Study|Lost to Follow-up|0|||
19561953|NCT01307267|42009622|FG019|Overall Study|Lost to Follow-up|2|||
19561954|NCT01307267|42009623|FG020|Overall Study|Lost to Follow-up|0|||
19561955|NCT01307267|42009624|FG021|Overall Study|Lost to Follow-up|0|||
19561956|NCT01307267|42009625|FG022|Overall Study|Lost to Follow-up|0|||
19561957|NCT01307267|42009603|FG000|Overall Study|Withdrawal by Subject|0|||
19561958|NCT01307267|42009604|FG001|Overall Study|Withdrawal by Subject|0|||
19561959|NCT01307267|42009605|FG002|Overall Study|Withdrawal by Subject|0|||
19561960|NCT01307267|42009606|FG003|Overall Study|Withdrawal by Subject|0|||
19561961|NCT01307267|42009607|FG004|Overall Study|Withdrawal by Subject|0|||
19561962|NCT01307267|42009608|FG005|Overall Study|Withdrawal by Subject|1|||
19561963|NCT01307267|42009609|FG006|Overall Study|Withdrawal by Subject|0|||
19561964|NCT01307267|42009610|FG007|Overall Study|Withdrawal by Subject|1|||
19561965|NCT01307267|42009611|FG008|Overall Study|Withdrawal by Subject|5|||
19561966|NCT01307267|42009612|FG009|Overall Study|Withdrawal by Subject|1|||
19561967|NCT01307267|42009613|FG010|Overall Study|Withdrawal by Subject|1|||
19561968|NCT01307267|42009614|FG011|Overall Study|Withdrawal by Subject|1|||
19561969|NCT01307267|42009615|FG012|Overall Study|Withdrawal by Subject|0|||
19561970|NCT01307267|42009616|FG013|Overall Study|Withdrawal by Subject|0|||
19561971|NCT01307267|42009617|FG014|Overall Study|Withdrawal by Subject|0|||
19561972|NCT01307267|42009618|FG015|Overall Study|Withdrawal by Subject|0|||
19561973|NCT01307267|42009619|FG016|Overall Study|Withdrawal by Subject|0|||
19561974|NCT01307267|42009620|FG017|Overall Study|Withdrawal by Subject|0|||
19561975|NCT01307267|42009621|FG018|Overall Study|Withdrawal by Subject|0|||
19561976|NCT01307267|42009622|FG019|Overall Study|Withdrawal by Subject|3|||
19561977|NCT01307267|42009623|FG020|Overall Study|Withdrawal by Subject|0|||
19561978|NCT01307267|42009624|FG021|Overall Study|Withdrawal by Subject|0|||
19561979|NCT01307267|42009625|FG022|Overall Study|Withdrawal by Subject|0|||
19561980|NCT01307267|42009603|FG000|Overall Study|Other|0|||
19561981|NCT01307267|42009604|FG001|Overall Study|Other|0|||
19561982|NCT01307267|42009605|FG002|Overall Study|Other|0|||
19561983|NCT01307267|42009606|FG003|Overall Study|Other|0|||
19561984|NCT01307267|42009607|FG004|Overall Study|Other|0|||
19561985|NCT01307267|42009608|FG005|Overall Study|Other|7|||
19561986|NCT01307267|42009609|FG006|Overall Study|Other|0|||
19561987|NCT01307267|42009610|FG007|Overall Study|Other|1|||
19739853|NCT00109343|42186825|FG002|Overall Study|Protocol Violation|2|||
19739854|NCT00109343|42186823|FG000|Overall Study|Withdrawal by Subject|15|||
19739855|NCT00109343|42186824|FG001|Overall Study|Withdrawal by Subject|11|||
19561988|NCT01307267|42009611|FG008|Overall Study|Other|3|||
19561989|NCT01307267|42009612|FG009|Overall Study|Other|0|||
19382237|NCT02646891|41625495|FG005|Overall Study|Protocol Violation|0|||
19561990|NCT01307267|42009613|FG010|Overall Study|Other|1|||
19561991|NCT01307267|42009614|FG011|Overall Study|Other|1|||
19561992|NCT01307267|42009615|FG012|Overall Study|Other|1|||
19561993|NCT01307267|42009616|FG013|Overall Study|Other|0|||
19561994|NCT01307267|42009617|FG014|Overall Study|Other|2|||
19561995|NCT01307267|42009618|FG015|Overall Study|Other|1|||
19739856|NCT00109343|42186825|FG002|Overall Study|Withdrawal by Subject|10|||
19739857|NCT00109343|42186823|FG000|Overall Study|Subject Moved|6|||
19739858|NCT00109343|42186824|FG001|Overall Study|Subject Moved|2|||
19739859|NCT00109343|42186825|FG002|Overall Study|Subject Moved|1|||
19739860|NCT00109343|42186823|FG000|Overall Study|Other|5|||
19739861|NCT00109343|42186824|FG001|Overall Study|Other|2|||
19739862|NCT00109343|42186825|FG002|Overall Study|Other|1|||
19739863|NCT00108485|42186835|FG000|Overall Study|Withdrawal by Subject|3|||
19739864|NCT00108485|42186836|FG001|Overall Study|Withdrawal by Subject|0|||
19739865|NCT00108485|42186835|FG000|Overall Study|Lost to Follow-up|0|||
19739866|NCT00108485|42186836|FG001|Overall Study|Lost to Follow-up|2|||
19739867|NCT00107783|42186844|FG000|Overall Study|Adverse Event|0|||
19739868|NCT00107783|42186845|FG001|Overall Study|Adverse Event|2|||
19739869|NCT00107783|42186844|FG000|Overall Study|Death|0|||
19739870|NCT00107783|42186845|FG001|Overall Study|Death|1|||
19739871|NCT00107783|42186844|FG000|Overall Study|Withdrawal by Subject|2|||
19739872|NCT00107783|42186845|FG001|Overall Study|Withdrawal by Subject|0|||
19739873|NCT00107783|42186844|FG000|Overall Study|Second hip replacement|1|||
19739874|NCT00107783|42186845|FG001|Overall Study|Second hip replacement|1|||
19739875|NCT00095303|42186853|FG000|Main Study|Lost to Follow-up|91|||
19739876|NCT00095303|42186854|FG001|Main Study|Lost to Follow-up|87|||
19561996|NCT01307267|42009619|FG016|Overall Study|Other|0|||
19561997|NCT01307267|42009620|FG017|Overall Study|Other|0|||
19561998|NCT01307267|42009621|FG018|Overall Study|Other|0|||
19561999|NCT01307267|42009622|FG019|Overall Study|Other|19|||
19562000|NCT01307267|42009623|FG020|Overall Study|Other|2|||
19562001|NCT01307267|42009624|FG021|Overall Study|Other|3|||
19562002|NCT01307267|42009625|FG022|Overall Study|Other|2|||
19562003|NCT01307111|42009687|FG000|IUD Insertion|Lost to Follow-up|2|||
19562004|NCT01307111|42009688|FG001|IUD Insertion|Lost to Follow-up|0|||
19562005|NCT01307111|42009687|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
19562006|NCT01307111|42009688|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
19562007|NCT01306877|42009696|FG000|Overall Study|Lost to Follow-up|3|||
19562008|NCT01306877|42009697|FG001|Overall Study|Lost to Follow-up|3|||
19562009|NCT01306877|42009696|FG000|Overall Study|Physician Decision|0|||
19562010|NCT01306877|42009697|FG001|Overall Study|Physician Decision|1|||
19562011|NCT01191801|42009705|FG000|Overall Study|Death|36|||
19562012|NCT01191801|42009706|FG001|Overall Study|Death|12|||
19562013|NCT01191801|42009705|FG000|Overall Study|Lack of Efficacy|176|||
19562014|NCT01191801|42009706|FG001|Overall Study|Lack of Efficacy|258|||
19562015|NCT01191801|42009705|FG000|Overall Study|Adverse Event|9|||
19562016|NCT01191801|42009706|FG001|Overall Study|Adverse Event|8|||
19562017|NCT01191801|42009705|FG000|Overall Study|Protocol Violation|2|||
19562018|NCT01191801|42009706|FG001|Overall Study|Protocol Violation|4|||
19562019|NCT01191801|42009705|FG000|Overall Study|Physician Decision|47|||
19562020|NCT01191801|42009706|FG001|Overall Study|Physician Decision|24|||
19562021|NCT01191801|42009705|FG000|Overall Study|Withdrawal by Subject|1|||
19562022|NCT01191801|42009706|FG001|Overall Study|Withdrawal by Subject|4|||
19562023|NCT01191801|42009705|FG000|Overall Study|Not Provided|45|||
19562024|NCT01191801|42009706|FG001|Overall Study|Not Provided|27|||
19562025|NCT01306643|42009712|FG000|Overall Study|Adverse Event|5|||
19562026|NCT01306643|42009712|FG000|Overall Study|Disease Progression|7|||
19562027|NCT01306643|42009712|FG000|Overall Study|Other: Change in Eligibility Status|1|||
19562028|NCT01306331|42009718|FG000|Overall Study|Adverse Event|28|||
19562029|NCT01306331|42009719|FG001|Overall Study|Adverse Event|25|||
19562030|NCT01306331|42009718|FG000|Overall Study|Lost to Follow-up|321|||
19562031|NCT01306331|42009719|FG001|Overall Study|Lost to Follow-up|323|||
19562032|NCT01306331|42009718|FG000|Overall Study|Physician Decision|26|||
19739877|NCT00095303|42186853|FG000|Follow Up Study|Lost to Follow-up|59|||
19739878|NCT00095303|42186854|FG001|Follow Up Study|Lost to Follow-up|58|||
19562033|NCT01306331|42009719|FG001|Overall Study|Physician Decision|22|||
19739879|NCT00105521|42186864|FG000|Overall Study|Other|1|||
19562034|NCT01306331|42009718|FG000|Overall Study|Pregnancy|136|||
19562035|NCT01306331|42009719|FG001|Overall Study|Pregnancy|151|||
19562036|NCT01306331|42009718|FG000|Overall Study|Protocol Violation|154|||
19562037|NCT01306331|42009719|FG001|Overall Study|Protocol Violation|124|||
19739880|NCT00105521|42186865|FG001|Overall Study|Other|1|||
19739881|NCT00105521|42186866|FG002|Overall Study|Other|2|||
19562038|NCT01306331|42009718|FG000|Overall Study|Withdrawal by Subject|163|||
19562039|NCT01306331|42009719|FG001|Overall Study|Withdrawal by Subject|152|||
19562040|NCT01306331|42009718|FG000|Overall Study|Not sexually active|29|||
19562041|NCT01306331|42009719|FG001|Overall Study|Not sexually active|28|||
19562042|NCT01306331|42009718|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
19562043|NCT01306331|42009719|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
19562044|NCT01306331|42009718|FG000|Overall Study|Other|34|||
19562045|NCT01306331|42009719|FG001|Overall Study|Other|32|||
19562046|NCT01306253|42009727|FG000|Overall Study|Lost to Follow-up|1|||
19562047|NCT01306253|42009728|FG001|Overall Study|Lost to Follow-up|1|||
19562048|NCT01305941|42009734|FG000|Overall Study|Adverse Event|6|||
19562049|NCT01305941|42009734|FG000|Overall Study|Clinical decline|2|||
19562050|NCT01305941|42009734|FG000|Overall Study|Withdrawal by Subject|1|||
19562051|NCT01305941|42009734|FG000|Overall Study|Death|1|||
19562052|NCT01305239|42009738|FG000|Overall Study|Adverse Event|22|||
19562053|NCT01305239|42009738|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
19562054|NCT01304693|42009747|FG000|Overall Study|Adverse Event|0|||
19562055|NCT01304693|42009748|FG001|Overall Study|Adverse Event|0|||
19562056|NCT01304693|42009749|FG002|Overall Study|Adverse Event|0|||
19562057|NCT01304693|42009750|FG003|Overall Study|Adverse Event|0|||
19562058|NCT01304693|42009751|FG004|Overall Study|Adverse Event|1|||
19562059|NCT01304693|42009747|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
19562060|NCT01304693|42009748|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
19562061|NCT01304693|42009749|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
19562062|NCT01304693|42009750|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
19562063|NCT01304693|42009751|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
19562064|NCT01304147|42009763|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
19562065|NCT01304147|42009764|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
19562066|NCT01303445|42009770|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
19739882|NCT00105521|42186867|FG003|Overall Study|Other|0|||
19739883|NCT00105521|42186864|FG000|Overall Study|Adverse Event|10|||
19739884|NCT00105521|42186865|FG001|Overall Study|Adverse Event|4|||
19739885|NCT00105521|42186866|FG002|Overall Study|Adverse Event|10|||
19739886|NCT00105521|42186867|FG003|Overall Study|Adverse Event|8|||
19739887|NCT00105521|42186864|FG000|Overall Study|Withdrawal by Subject|1|||
19739888|NCT00105521|42186865|FG001|Overall Study|Withdrawal by Subject|0|||
19739889|NCT00105521|42186866|FG002|Overall Study|Withdrawal by Subject|1|||
19739890|NCT00105521|42186867|FG003|Overall Study|Withdrawal by Subject|4|||
19739891|NCT00105521|42186864|FG000|Overall Study|Lack of Efficacy|0|||
19739892|NCT00105521|42186865|FG001|Overall Study|Lack of Efficacy|0|||
19739893|NCT00105521|42186866|FG002|Overall Study|Lack of Efficacy|0|||
19739894|NCT00105521|42186867|FG003|Overall Study|Lack of Efficacy|1|||
19562067|NCT01303445|42009771|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
19562068|NCT01303445|42009770|FG000|Second Intervention (7 Days)|Adverse Event|0|||
19562069|NCT01303445|42009771|FG001|Second Intervention (7 Days)|Adverse Event|2|||
19562070|NCT01303445|42009770|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
19562071|NCT01303445|42009771|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
19562072|NCT01303445|42009770|FG000|Washout (14 Days)|Protocol Violation|1|||
19562073|NCT01303445|42009771|FG001|Washout (14 Days)|Protocol Violation|0|||
19562074|NCT01303445|42009770|FG000|Washout (14 Days)|Lost to Follow-up|0|||
19562075|NCT01303445|42009771|FG001|Washout (14 Days)|Lost to Follow-up|2|||
19562076|NCT01303445|42009770|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
19562077|NCT01303445|42009771|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
19562078|NCT01303445|42009770|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
19739895|NCT00105521|42186864|FG000|Overall Study|Protocol Violation|3|||
19739896|NCT00105521|42186865|FG001|Overall Study|Protocol Violation|5|||
19739897|NCT00105521|42186866|FG002|Overall Study|Protocol Violation|4|||
19739898|NCT00105521|42186867|FG003|Overall Study|Protocol Violation|4|||
19739899|NCT00105521|42186864|FG000|Overall Study|Lost to Follow-up|0|||
19739900|NCT00105521|42186865|FG001|Overall Study|Lost to Follow-up|1|||
19739901|NCT00105521|42186866|FG002|Overall Study|Lost to Follow-up|0|||
19739902|NCT00105521|42186867|FG003|Overall Study|Lost to Follow-up|0|||
19739903|NCT00291551|42186877|FG000|Overall Study|Death|7|||
19739904|NCT00291551|42186877|FG000|Overall Study|Withdrawal by Subject|6|||
19739905|NCT02752048|42186901|FG000|Overall Study|Withdrawal by Subject|0|||
19739906|NCT02752048|42186902|FG001|Overall Study|Withdrawal by Subject|0|||
19739907|NCT02752048|42186903|FG002|Overall Study|Withdrawal by Subject|3|||
19739908|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
19562079|NCT01303445|42009771|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
19562080|NCT01188681|42009785|FG000|Overall Study|bladder cancer|0|||
19562081|NCT01188681|42009786|FG001|Overall Study|bladder cancer|0|||
19562082|NCT01188681|42009787|FG002|Overall Study|bladder cancer|1|||
19562083|NCT01188681|42009788|FG003|Overall Study|bladder cancer|0|||
19562084|NCT01188681|42009785|FG000|Overall Study|Withdrawal by Subject|0|||
19562085|NCT01188681|42009786|FG001|Overall Study|Withdrawal by Subject|0|||
19562086|NCT01188681|42009787|FG002|Overall Study|Withdrawal by Subject|0|||
19562087|NCT01188681|42009788|FG003|Overall Study|Withdrawal by Subject|1|||
19562088|NCT01302899|42009804|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
19562089|NCT01302899|42009805|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
19562090|NCT01302899|42009804|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
19562091|NCT01302899|42009805|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
19562092|NCT01187901|42009817|FG000|Overall Study|Protocol Violation|1|||
19562093|NCT01187901|42009818|FG001|Overall Study|Protocol Violation|0|||
19562094|NCT01187901|42009817|FG000|Overall Study|Lost to Follow-up|1|||
19562095|NCT01187901|42009818|FG001|Overall Study|Lost to Follow-up|2|||
19562096|NCT01187901|42009817|FG000|Overall Study|Unrelated Health Reasons|1|||
19562097|NCT01187901|42009818|FG001|Overall Study|Unrelated Health Reasons|2|||
19562098|NCT01187901|42009817|FG000|Overall Study|Suspected Allergic Reaction|1|||
19562099|NCT01187901|42009818|FG001|Overall Study|Suspected Allergic Reaction|1|||
19562100|NCT01187901|42009817|FG000|Overall Study|Adverse Event|3|||
19562101|NCT01187901|42009818|FG001|Overall Study|Adverse Event|0|||
19562102|NCT01187901|42009817|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
19562103|NCT01187901|42009818|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
19562104|NCT01187901|42009817|FG000|Overall Study|Pregnancy|0|||
19562105|NCT01187901|42009818|FG001|Overall Study|Pregnancy|2|||
19739909|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
19739910|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
19739911|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
19562106|NCT01302119|42009826|FG000|Overall Study|Withdrawal by Subject|30|||
19562107|NCT01302119|42009827|FG001|Overall Study|Withdrawal by Subject|20|||
19562108|NCT01302119|42009826|FG000|Overall Study|Lost to Follow-up|10|||
19562109|NCT01302119|42009827|FG001|Overall Study|Lost to Follow-up|4|||
19562110|NCT01302119|42009826|FG000|Overall Study|Adverse Event|2|||
19562111|NCT01302119|42009827|FG001|Overall Study|Adverse Event|1|||
19562112|NCT01302119|42009826|FG000|Overall Study|Non-compliance|4|||
19562113|NCT01302119|42009827|FG001|Overall Study|Non-compliance|2|||
19562114|NCT01302119|42009826|FG000|Overall Study|Non-specific|4|||
19562115|NCT01302119|42009827|FG001|Overall Study|Non-specific|1|||
19562116|NCT01302041|42009833|FG000|Overall Study|Death|5|||
19562117|NCT01302041|42009833|FG000|Overall Study|Withdrawal by Subject|4|||
19562118|NCT01302041|42009833|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
19562119|NCT01302041|42009833|FG000|Overall Study|Other-Miscellaneous Reason|2|||
19562120|NCT01301729|42009838|FG000|Overall Study|Withdrawal by Subject|2|||
19562121|NCT01301729|42009838|FG000|Overall Study|Participant did not Return for Treatment|1|||
19562122|NCT01301729|42009838|FG000|Overall Study|Violated Selection Criteria|1|||
19562123|NCT01187043|42009848|FG000|Overall Study|Adverse Event|0|||
19562124|NCT01187043|42009849|FG001|Overall Study|Adverse Event|0|||
19562125|NCT01187043|42009850|FG002|Overall Study|Adverse Event|0|||
19562126|NCT01187043|42009851|FG003|Overall Study|Adverse Event|0|||
19562127|NCT01187043|42009852|FG004|Overall Study|Adverse Event|1|||
19562128|NCT01187043|42009848|FG000|Overall Study|Unable to make scheduled visits|1|||
19562129|NCT01187043|42009849|FG001|Overall Study|Unable to make scheduled visits|0|||
19562130|NCT01187043|42009850|FG002|Overall Study|Unable to make scheduled visits|4|||
19562131|NCT01187043|42009851|FG003|Overall Study|Unable to make scheduled visits|0|||
19562132|NCT01187043|42009852|FG004|Overall Study|Unable to make scheduled visits|1|||
19562133|NCT01186809|42009864|FG000|Overall Study|Death|30|||
19562134|NCT01186419|42009870|FG000|Overall Study|Withdrawal by Subject|5|||
19562135|NCT01186419|42009871|FG001|Overall Study|Withdrawal by Subject|3|||
19562136|NCT01186419|42009870|FG000|Overall Study|Adverse Event|1|||
19562137|NCT01186419|42009871|FG001|Overall Study|Adverse Event|2|||
19562138|NCT01186419|42009870|FG000|Overall Study|Physician Decision|0|||
19562139|NCT01186419|42009871|FG001|Overall Study|Physician Decision|3|||
19562140|NCT01186419|42009870|FG000|Overall Study|Other|1|||
19562141|NCT01186419|42009871|FG001|Overall Study|Other|1|||
19562142|NCT01301027|42009878|FG000|Overall Study|Physician Decision|2|||
19562143|NCT01301027|42009879|FG001|Overall Study|Physician Decision|0|||
19562144|NCT01301027|42009878|FG000|Overall Study|Withdrawal by Subject|2|||
19562145|NCT01301027|42009879|FG001|Overall Study|Withdrawal by Subject|3|||
19739912|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
19739913|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
19562146|NCT01301027|42009878|FG000|Overall Study|Adverse Event|0|||
19562147|NCT01301027|42009879|FG001|Overall Study|Adverse Event|2|||
19562148|NCT01301027|42009878|FG000|Overall Study|Fracture|1|||
19562149|NCT01301027|42009879|FG001|Overall Study|Fracture|3|||
19562150|NCT01301027|42009878|FG000|Overall Study|Transplant|0|||
19562151|NCT01301027|42009879|FG001|Overall Study|Transplant|2|||
19562152|NCT01301027|42009878|FG000|Overall Study|Volume Overload|3|||
19562153|NCT01301027|42009879|FG001|Overall Study|Volume Overload|0|||
19562154|NCT01185639|42009885|FG000|Overall Study|Progressed and didn't receive therapy|2|||
19562155|NCT01185561|42009891|FG000|Overall Study|Lost to Follow-up|0|||
19562156|NCT01185561|42009892|FG001|Overall Study|Lost to Follow-up|4|||
19739914|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
19739915|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
19739916|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
19739917|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
19739918|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
19739919|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
19739920|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
19739921|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
19739922|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
19739923|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
19739924|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
19739925|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
19739926|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
19739927|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
19739928|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
19739929|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
19739930|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
19739931|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
19739932|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
19739933|NCT00095147|42186918|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
19739934|NCT00095147|42186919|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
19739935|NCT00095147|42186920|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
19739936|NCT00095147|42186921|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
19562157|NCT01185561|42009891|FG000|Overall Study|Withdrawal by Subject|2|||
19562158|NCT01185561|42009892|FG001|Overall Study|Withdrawal by Subject|8|||
19562159|NCT01185249|42009898|FG000|Overall Study|Patients discharged or change in status|42|||
19562160|NCT01185171|42009903|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
19562161|NCT01185171|42009903|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
19562162|NCT01185171|42009903|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
19562163|NCT01185171|42009903|FG000|Maintenance|Elevated liver transaminases|3|||
19562164|NCT01185171|42009903|FG000|Maintenance|Rush|2|||
19562165|NCT01185171|42009903|FG000|Maintenance|Diarrhea|1|||
19562166|NCT01185171|42009903|FG000|Maintenance|Xerostomia|1|||
19562167|NCT01185171|42009903|FG000|Maintenance|Nausea|1|||
19562168|NCT01185171|42009903|FG000|Maintenance|Comorbid Illness|2|||
19562169|NCT01185171|42009903|FG000|Maintenance|Withdrawal by Subject|1|||
19562170|NCT01185171|42009903|FG000|Maintenance|Disease Recurrence|1|||
19562171|NCT01184859|42009912|FG000|Period 1: Single Dose|Insufficient urine production|0|||
19562172|NCT01184859|42009913|FG001|Period 1: Single Dose|Insufficient urine production|1|||
19562173|NCT01184859|42009914|FG002|Period 1: Single Dose|Insufficient urine production|0|||
19562174|NCT01184859|42009915|FG003|Period 1: Single Dose|Insufficient urine production|0|||
19562175|NCT01184859|42009916|FG004|Period 1: Single Dose|Insufficient urine production|0|||
19562176|NCT01184859|42009912|FG000|Period 1: Single Dose|Protocol Violation|0|||
19562177|NCT01184859|42009913|FG001|Period 1: Single Dose|Protocol Violation|1|||
19562178|NCT01184859|42009914|FG002|Period 1: Single Dose|Protocol Violation|0|||
19562179|NCT01184859|42009915|FG003|Period 1: Single Dose|Protocol Violation|0|||
19562180|NCT01184859|42009916|FG004|Period 1: Single Dose|Protocol Violation|0|||
19562181|NCT01184859|42009912|FG000|Period 1: Single Dose|Adverse Event|0|||
19562182|NCT01184859|42009913|FG001|Period 1: Single Dose|Adverse Event|0|||
19562183|NCT01184859|42009914|FG002|Period 1: Single Dose|Adverse Event|0|||
19562184|NCT01184859|42009915|FG003|Period 1: Single Dose|Adverse Event|0|||
19562185|NCT01184859|42009916|FG004|Period 1: Single Dose|Adverse Event|1|||
19562186|NCT01184859|42009912|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
19562187|NCT01184859|42009913|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
19562188|NCT01184859|42009914|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
19562189|NCT01184859|42009915|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
19562190|NCT01184859|42009916|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
19562191|NCT01184859|42009912|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
19562192|NCT01184859|42009913|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
19562193|NCT01184859|42009914|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
19562194|NCT01184859|42009915|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
19562195|NCT01184859|42009916|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
19562196|NCT01184079|42009935|FG000|Overall Study|Lost to Follow-up|14|||
19562197|NCT01184079|42009936|FG001|Overall Study|Lost to Follow-up|2|||
19562198|NCT01190865|42009944|FG000|Overall Study|Withdrawal by Subject|1|||
19562199|NCT01190865|42009944|FG000|Overall Study|Non-compliance|2|||
19562200|NCT01190475|42009951|FG000|Overall Study|Withdrawal by Subject|0|||
19562201|NCT01190475|42009952|FG001|Overall Study|Withdrawal by Subject|0|||
19562202|NCT01190475|42009953|FG002|Overall Study|Withdrawal by Subject|1|||
19562203|NCT01289990|42009976|FG000|Overall Study|Death|0|||
19562204|NCT01289990|42009977|FG001|Overall Study|Death|0|||
19562205|NCT01289990|42009978|FG002|Overall Study|Death|0|||
19562206|NCT01289990|42009979|FG003|Overall Study|Death|1|||
19562207|NCT01289990|42009980|FG004|Overall Study|Death|2|||
19562208|NCT01289990|42009981|FG005|Overall Study|Death|1|||
19562209|NCT01289990|42009982|FG006|Overall Study|Death|0|||
19562210|NCT01289990|42009983|FG007|Overall Study|Death|0|||
19562211|NCT01289990|42009984|FG008|Overall Study|Death|0|||
19562212|NCT01289990|42009985|FG009|Overall Study|Death|0|||
19562213|NCT01289990|42009986|FG010|Overall Study|Death|0|||
19562214|NCT01289990|42009987|FG011|Overall Study|Death|1|||
19562215|NCT01289990|42009988|FG012|Overall Study|Death|0|||
19562216|NCT01289990|42009976|FG000|Overall Study|Lost to Follow-up|3|||
19562217|NCT01289990|42009977|FG001|Overall Study|Lost to Follow-up|2|||
19562218|NCT01289990|42009978|FG002|Overall Study|Lost to Follow-up|5|||
19562219|NCT01289990|42009979|FG003|Overall Study|Lost to Follow-up|5|||
19562220|NCT01289990|42009980|FG004|Overall Study|Lost to Follow-up|3|||
19562221|NCT01289990|42009981|FG005|Overall Study|Lost to Follow-up|4|||
19562222|NCT01289990|42009982|FG006|Overall Study|Lost to Follow-up|2|||
19562223|NCT01289990|42009983|FG007|Overall Study|Lost to Follow-up|2|||
19562224|NCT01289990|42009984|FG008|Overall Study|Lost to Follow-up|1|||
19562225|NCT01289990|42009985|FG009|Overall Study|Lost to Follow-up|4|||
19562226|NCT01289990|42009986|FG010|Overall Study|Lost to Follow-up|2|||
19562227|NCT01289990|42009987|FG011|Overall Study|Lost to Follow-up|1|||
19562228|NCT01289990|42009988|FG012|Overall Study|Lost to Follow-up|2|||
19562229|NCT01289990|42009976|FG000|Overall Study|Withdrawal by Subject|15|||
19562230|NCT01289990|42009977|FG001|Overall Study|Withdrawal by Subject|14|||
19562231|NCT01289990|42009978|FG002|Overall Study|Withdrawal by Subject|12|||
19562232|NCT01289990|42009979|FG003|Overall Study|Withdrawal by Subject|13|||
19562233|NCT01289990|42009980|FG004|Overall Study|Withdrawal by Subject|8|||
19562234|NCT01289990|42009981|FG005|Overall Study|Withdrawal by Subject|7|||
19562235|NCT01289990|42009982|FG006|Overall Study|Withdrawal by Subject|13|||
19562236|NCT01289990|42009983|FG007|Overall Study|Withdrawal by Subject|9|||
19562237|NCT01289990|42009984|FG008|Overall Study|Withdrawal by Subject|12|||
19562238|NCT01289990|42009985|FG009|Overall Study|Withdrawal by Subject|13|||
19739937|NCT00095147|42186922|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
19739938|NCT00095147|42186918|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
19562239|NCT01289990|42009986|FG010|Overall Study|Withdrawal by Subject|11|||
19562240|NCT01289990|42009987|FG011|Overall Study|Withdrawal by Subject|13|||
19562241|NCT01289990|42009988|FG012|Overall Study|Withdrawal by Subject|16|||
19562242|NCT01289990|42009976|FG000|Overall Study|discontinued in preceding trial|18|||
19562243|NCT01289990|42009977|FG001|Overall Study|discontinued in preceding trial|20|||
19562244|NCT01289990|42009978|FG002|Overall Study|discontinued in preceding trial|41|||
19562245|NCT01289990|42009979|FG003|Overall Study|discontinued in preceding trial|17|||
19562246|NCT01289990|42009980|FG004|Overall Study|discontinued in preceding trial|11|||
19562247|NCT01289990|42009981|FG005|Overall Study|discontinued in preceding trial|12|||
19562248|NCT01289990|42009982|FG006|Overall Study|discontinued in preceding trial|18|||
19562249|NCT01289990|42009983|FG007|Overall Study|discontinued in preceding trial|8|||
19562250|NCT01289990|42009984|FG008|Overall Study|discontinued in preceding trial|17|||
19562251|NCT01289990|42009985|FG009|Overall Study|discontinued in preceding trial|21|||
19562252|NCT01289990|42009986|FG010|Overall Study|discontinued in preceding trial|17|||
19562253|NCT01289990|42009987|FG011|Overall Study|discontinued in preceding trial|17|||
19562254|NCT01289990|42009988|FG012|Overall Study|discontinued in preceding trial|24|||
19562255|NCT01289990|42009976|FG000|Overall Study|did not continue in extension|41|||
19562256|NCT01289990|42009977|FG001|Overall Study|did not continue in extension|45|||
19562257|NCT01289990|42009978|FG002|Overall Study|did not continue in extension|51|||
19562258|NCT01289990|42009979|FG003|Overall Study|did not continue in extension|51|||
19562259|NCT01289990|42009980|FG004|Overall Study|did not continue in extension|48|||
19562260|NCT01289990|42009981|FG005|Overall Study|did not continue in extension|50|||
19562261|NCT01289990|42009982|FG006|Overall Study|did not continue in extension|54|||
19562262|NCT01289990|42009983|FG007|Overall Study|did not continue in extension|36|||
19562263|NCT01289990|42009984|FG008|Overall Study|did not continue in extension|44|||
19562264|NCT01289990|42009985|FG009|Overall Study|did not continue in extension|48|||
19562265|NCT01289990|42009986|FG010|Overall Study|did not continue in extension|45|||
19562266|NCT01289990|42009987|FG011|Overall Study|did not continue in extension|34|||
19562267|NCT01289990|42009988|FG012|Overall Study|did not continue in extension|56|||
19562268|NCT01289990|42009976|FG000|Overall Study|Not treated|0|||
19562269|NCT01289990|42009977|FG001|Overall Study|Not treated|0|||
19562270|NCT01289990|42009978|FG002|Overall Study|Not treated|0|||
19562271|NCT01289990|42009979|FG003|Overall Study|Not treated|0|||
19562272|NCT01289990|42009980|FG004|Overall Study|Not treated|0|||
19739939|NCT00095147|42186919|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
19562273|NCT01289990|42009981|FG005|Overall Study|Not treated|0|||
19562274|NCT01289990|42009982|FG006|Overall Study|Not treated|1|||
19562275|NCT01289990|42009983|FG007|Overall Study|Not treated|0|||
19562276|NCT01289990|42009984|FG008|Overall Study|Not treated|1|||
19562277|NCT01289990|42009985|FG009|Overall Study|Not treated|0|||
19562278|NCT01289990|42009986|FG010|Overall Study|Not treated|1|||
19562279|NCT01289990|42009987|FG011|Overall Study|Not treated|2|||
19562280|NCT01289990|42009988|FG012|Overall Study|Not treated|0|||
19562281|NCT01190007|42010016|FG000|Overall Study|Withdrawal by Subject|4|||
19562282|NCT01190007|42010016|FG000|Overall Study|Adverse Event|8|||
19562283|NCT01190007|42010016|FG000|Overall Study|Difficulty of visit for complications|1|||
19562284|NCT01190007|42010016|FG000|Overall Study|Participant was arrested|1|||
19562285|NCT01189461|42010020|FG000|Overall Study|Lack of Efficacy|13|||
19562286|NCT01189461|42010020|FG000|Overall Study|Lost to Follow-up|1|||
19562287|NCT01189461|42010020|FG000|Overall Study|Withdrawal by Subject|6|||
19562288|NCT01189461|42010020|FG000|Overall Study|Protocol Violation|1|||
19562289|NCT01189461|42010020|FG000|Overall Study|Adverse Event|2|||
19562290|NCT01189461|42010020|FG000|Overall Study|Did not meet entrance criteria|3|||
19562291|NCT01189461|42010020|FG000|Overall Study|Other|8|||
19562292|NCT01189227|42010026|FG000|Overall Study|Study terminated due to low accrual|6|||
19739940|NCT00095147|42186920|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
19739941|NCT00095147|42186921|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
19739942|NCT00095147|42186922|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
19739943|NCT00095147|42186918|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
19739944|NCT00095147|42186919|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
19739945|NCT00095147|42186920|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
19739946|NCT00095147|42186921|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
19739947|NCT00095147|42186922|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
19739948|NCT00095147|42186918|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
19739949|NCT00095147|42186919|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
19739950|NCT00095147|42186920|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
19739951|NCT00095147|42186921|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
19739952|NCT00095147|42186922|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
19739953|NCT00095147|42186918|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
19739954|NCT00095147|42186919|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
19739955|NCT00095147|42186920|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
19739956|NCT00095147|42186921|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
19739957|NCT00095147|42186922|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
19739958|NCT00095147|42186918|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
19739959|NCT00095147|42186919|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
19739960|NCT00095147|42186920|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
19739961|NCT00095147|42186921|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
19739962|NCT00095147|42186922|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
19739963|NCT00095147|42186918|FG000|Long-term Extension Period|Death|0|||
19739964|NCT00095147|42186919|FG001|Long-term Extension Period|Death|0|||
19739965|NCT00095147|42186920|FG002|Long-term Extension Period|Death|0|||
19739966|NCT00095147|42186921|FG003|Long-term Extension Period|Death|0|||
19739967|NCT00095147|42186922|FG004|Long-term Extension Period|Death|3|||
19739968|NCT00095147|42186918|FG000|Long-term Extension Period|Adverse Event|0|||
19739969|NCT00095147|42186919|FG001|Long-term Extension Period|Adverse Event|0|||
19739970|NCT00095147|42186920|FG002|Long-term Extension Period|Adverse Event|0|||
19739971|NCT00095147|42186921|FG003|Long-term Extension Period|Adverse Event|0|||
19739972|NCT00095147|42186922|FG004|Long-term Extension Period|Adverse Event|11|||
19739973|NCT00095147|42186918|FG000|Long-term Extension Period|Lack of Efficacy|0|||
19739974|NCT00095147|42186919|FG001|Long-term Extension Period|Lack of Efficacy|0|||
19739975|NCT00095147|42186920|FG002|Long-term Extension Period|Lack of Efficacy|0|||
19739976|NCT00095147|42186921|FG003|Long-term Extension Period|Lack of Efficacy|0|||
19739977|NCT00095147|42186922|FG004|Long-term Extension Period|Lack of Efficacy|9|||
19739978|NCT00095147|42186918|FG000|Long-term Extension Period|Lost to Follow-up|0|||
19739979|NCT00095147|42186919|FG001|Long-term Extension Period|Lost to Follow-up|0|||
19739980|NCT00095147|42186920|FG002|Long-term Extension Period|Lost to Follow-up|0|||
19739981|NCT00095147|42186921|FG003|Long-term Extension Period|Lost to Follow-up|0|||
19739982|NCT00095147|42186922|FG004|Long-term Extension Period|Lost to Follow-up|6|||
19739983|NCT00095147|42186918|FG000|Long-term Extension Period|Withdrawal of consent|0|||
19739984|NCT00095147|42186919|FG001|Long-term Extension Period|Withdrawal of consent|0|||
19562293|NCT01189227|42010027|FG001|Overall Study|Study terminated due to low accrual|3|||
19562294|NCT01300247|42010035|FG000|Overall Study|Death|1|||
19562295|NCT01300247|42010036|FG001|Overall Study|Death|1|||
19562296|NCT01300247|42010035|FG000|Overall Study|Lost to Follow-up|2|||
19562297|NCT01300247|42010036|FG001|Overall Study|Lost to Follow-up|0|||
19562298|NCT01300247|42010035|FG000|Overall Study|Withdrawal by Subject|1|||
19562299|NCT01300247|42010036|FG001|Overall Study|Withdrawal by Subject|0|||
19739985|NCT00095147|42186920|FG002|Long-term Extension Period|Withdrawal of consent|0|||
19739986|NCT00095147|42186921|FG003|Long-term Extension Period|Withdrawal of consent|0|||
19739987|NCT00095147|42186922|FG004|Long-term Extension Period|Withdrawal of consent|12|||
19739988|NCT00095147|42186918|FG000|Long-term Extension Period|Pregnancy|0|||
19739989|NCT00095147|42186919|FG001|Long-term Extension Period|Pregnancy|0|||
19739990|NCT00095147|42186920|FG002|Long-term Extension Period|Pregnancy|0|||
19739991|NCT00095147|42186921|FG003|Long-term Extension Period|Pregnancy|0|||
19739992|NCT00095147|42186922|FG004|Long-term Extension Period|Pregnancy|1|||
19739993|NCT00095147|42186918|FG000|Long-term Extension Period|No longer meets study criteria|0|||
19739994|NCT00095147|42186919|FG001|Long-term Extension Period|No longer meets study criteria|0|||
19739995|NCT00095147|42186920|FG002|Long-term Extension Period|No longer meets study criteria|0|||
19739996|NCT00095147|42186921|FG003|Long-term Extension Period|No longer meets study criteria|0|||
19739997|NCT00095147|42186922|FG004|Long-term Extension Period|No longer meets study criteria|1|||
19739998|NCT00095147|42186918|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
19739999|NCT00095147|42186919|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
19740000|NCT00095147|42186920|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
19740001|NCT00095147|42186921|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
19740002|NCT00095147|42186922|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
19562300|NCT01300247|42010035|FG000|Overall Study|Non-Compliance|0|||
19562301|NCT01300247|42010036|FG001|Overall Study|Non-Compliance|1|||
19562302|NCT01289678|42010042|FG000|Overall Study|Physician Decision|6|||
19562303|NCT01289210|42010046|FG000|Overall Study|Adverse Event|1|||
19562304|NCT01183221|42010052|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
19562305|NCT01183221|42010053|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
19562306|NCT01183143|42010059|FG000|Overall Study|Protocol Violation|115|||
19562307|NCT01183143|42010059|FG000|Overall Study|Withdrawal by Subject|19|||
19562308|NCT01183143|42010059|FG000|Overall Study|Subject Questionnaires not returned|5|||
19562309|NCT01183143|42010059|FG000|Overall Study|Subjects enrolled, but not treated|11|||
19562310|NCT01183065|42010063|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
19562311|NCT01182441|42010069|FG000|Overall Study|Patient Still in Follow-up|152|||
19562312|NCT01182441|42010070|FG001|Overall Study|Patient Still in Follow-up|72|||
19562313|NCT01182441|42010069|FG000|Overall Study|Death|37|||
19562314|NCT01182441|42010070|FG001|Overall Study|Death|25|||
19562315|NCT01182441|42010069|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
19562316|NCT01182441|42010070|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
19562317|NCT01182441|42010069|FG000|Overall Study|Lost to Follow-up|5|||
19562318|NCT01182441|42010070|FG001|Overall Study|Lost to Follow-up|8|||
19562319|NCT01182441|42010069|FG000|Overall Study|Withdrawal by Subject|6|||
19562320|NCT01182441|42010070|FG001|Overall Study|Withdrawal by Subject|13|||
19562321|NCT01182441|42010069|FG000|Overall Study|Implant Not Attempted|4|||
19562322|NCT01182441|42010070|FG001|Overall Study|Implant Not Attempted|0|||
19562323|NCT01182441|42010069|FG000|Overall Study|Adverse Event|2|||
19562324|NCT01182441|42010070|FG001|Overall Study|Adverse Event|0|||
19562325|NCT01182441|42010069|FG000|Overall Study|Physician Decision|1|||
19562326|NCT01182441|42010070|FG001|Overall Study|Physician Decision|1|||
19562327|NCT01182285|42010076|FG000|First Intervention Week 1-10|Disease progression|1|||
19562328|NCT01182285|42010077|FG001|First Intervention Week 1-10|Disease progression|0|||
19562329|NCT01182285|42010078|FG002|First Intervention Week 1-10|Disease progression|0|||
19382238|NCT02646891|41625496|FG006|Overall Study|Protocol Violation|1|||
19382239|NCT02646891|41625497|FG007|Overall Study|Protocol Violation|1|||
19562330|NCT01182285|42010076|FG000|First Intervention Week 1-10|Adverse Event|1|||
19562331|NCT01182285|42010077|FG001|First Intervention Week 1-10|Adverse Event|0|||
19740003|NCT00095147|42186918|FG000|Long-term Extension Period|Leaving country|0|||
19562332|NCT01182285|42010078|FG002|First Intervention Week 1-10|Adverse Event|0|||
19562333|NCT01182285|42010076|FG000|First Intervention Week 1-10|Non-compliance|1|||
19562334|NCT01182285|42010077|FG001|First Intervention Week 1-10|Non-compliance|0|||
19562335|NCT01182285|42010078|FG002|First Intervention Week 1-10|Non-compliance|0|||
19562336|NCT01182285|42010076|FG000|Third Intervention Week 11-52|Disease Progression|0|||
19562337|NCT01182285|42010077|FG001|Third Intervention Week 11-52|Disease Progression|0|||
19562338|NCT01182285|42010078|FG002|Third Intervention Week 11-52|Disease Progression|6|||
19562339|NCT01182285|42010076|FG000|Third Intervention Week 11-52|Other|0|||
19562340|NCT01182285|42010077|FG001|Third Intervention Week 11-52|Other|0|||
19562341|NCT01182285|42010078|FG002|Third Intervention Week 11-52|Other|2|||
19562342|NCT01182207|42010087|FG000|First Intervention|Positive Hepatitis Results|0|||
19562343|NCT01182207|42010088|FG001|First Intervention|Positive Hepatitis Results|1|||
19562344|NCT01182207|42010087|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
19562345|NCT01182207|42010088|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
19562346|NCT01181895|42010097|FG000|Overall Study|Adverse Event|3|||
19562347|NCT01181895|42010098|FG001|Overall Study|Adverse Event|1|||
19562348|NCT01181895|42010099|FG002|Overall Study|Adverse Event|1|||
19562349|NCT01181895|42010097|FG000|Overall Study|Lack of Efficacy|8|||
19562350|NCT01181895|42010098|FG001|Overall Study|Lack of Efficacy|9|||
19562351|NCT01181895|42010099|FG002|Overall Study|Lack of Efficacy|9|||
19562352|NCT01181895|42010097|FG000|Overall Study|Protocol Violation|2|||
19562353|NCT01181895|42010098|FG001|Overall Study|Protocol Violation|1|||
19562354|NCT01181895|42010099|FG002|Overall Study|Protocol Violation|0|||
19562355|NCT01181895|42010097|FG000|Overall Study|Lost to Follow-up|0|||
19562356|NCT01181895|42010098|FG001|Overall Study|Lost to Follow-up|1|||
19562357|NCT01181895|42010099|FG002|Overall Study|Lost to Follow-up|2|||
19562358|NCT01181895|42010097|FG000|Overall Study|Investigator Discretion|1|||
19562359|NCT01181895|42010098|FG001|Overall Study|Investigator Discretion|2|||
19740004|NCT00095147|42186919|FG001|Long-term Extension Period|Leaving country|0|||
19740005|NCT00095147|42186920|FG002|Long-term Extension Period|Leaving country|0|||
19740006|NCT00095147|42186921|FG003|Long-term Extension Period|Leaving country|0|||
19740007|NCT00095147|42186922|FG004|Long-term Extension Period|Leaving country|1|||
19740008|NCT02751580|42186940|FG000|Overall Study|Lost to Follow-up|4|||
19740009|NCT02751580|42186940|FG000|Overall Study|Death|2|||
19740010|NCT02751502|42186944|FG000|Overall Study|Lack of funding|4|||
19740011|NCT02257918|42186951|FG000|Overall Study|Lost to Follow-up|4|||
19740012|NCT02257918|42186952|FG001|Overall Study|Lost to Follow-up|1|||
19740013|NCT02257918|42186953|FG002|Overall Study|Lost to Follow-up|0|||
19740014|NCT02257918|42186951|FG000|Overall Study|Withdrawal by Subject|0|||
19740015|NCT02257918|42186952|FG001|Overall Study|Withdrawal by Subject|0|||
19740016|NCT02257918|42186953|FG002|Overall Study|Withdrawal by Subject|1|||
19740017|NCT02257918|42186951|FG000|Overall Study|Pregnancy|0|||
19740018|NCT02257918|42186952|FG001|Overall Study|Pregnancy|0|||
19740019|NCT02257918|42186953|FG002|Overall Study|Pregnancy|1|||
19562360|NCT01181895|42010099|FG002|Overall Study|Investigator Discretion|1|||
19740020|NCT02751424|42186970|FG000|Part 2|Adverse Event|0|||
19740021|NCT02751424|42186971|FG001|Part 2|Adverse Event|0|||
19562361|NCT01181895|42010097|FG000|Overall Study|Withdrawal by Subject|3|||
19562362|NCT01181895|42010098|FG001|Overall Study|Withdrawal by Subject|0|||
19562363|NCT01181895|42010099|FG002|Overall Study|Withdrawal by Subject|5|||
19740022|NCT02751424|42186972|FG002|Part 2|Adverse Event|0|||
19740023|NCT02751424|42186973|FG003|Part 2|Adverse Event|0|||
19740024|NCT02751424|42186974|FG004|Part 2|Adverse Event|0|||
19740025|NCT02751424|42186975|FG005|Part 2|Adverse Event|0|||
19740026|NCT02751424|42186976|FG006|Part 2|Adverse Event|0|||
19740027|NCT02751424|42186977|FG007|Part 2|Adverse Event|5|||
19740028|NCT02751424|42186978|FG008|Part 2|Adverse Event|0|||
19740029|NCT00094835|42187008|FG000|Overall Study|Physician Decision|1|||
19740030|NCT00094835|42187009|FG001|Overall Study|Physician Decision|0|||
19740031|NCT00094835|42187010|FG002|Overall Study|Physician Decision|0|||
19740032|NCT00094835|42187011|FG003|Overall Study|Physician Decision|0|||
19740033|NCT00094835|42187012|FG004|Overall Study|Physician Decision|0|||
19740034|NCT00094835|42187013|FG005|Overall Study|Physician Decision|1|||
19740035|NCT00094835|42187014|FG006|Overall Study|Physician Decision|0|||
19740036|NCT00094835|42187008|FG000|Overall Study|Withdrawal by Subject|0|||
19740037|NCT00094835|42187009|FG001|Overall Study|Withdrawal by Subject|0|||
19740038|NCT00094835|42187010|FG002|Overall Study|Withdrawal by Subject|0|||
19740039|NCT00094835|42187011|FG003|Overall Study|Withdrawal by Subject|0|||
19740040|NCT00094835|42187012|FG004|Overall Study|Withdrawal by Subject|0|||
19740041|NCT00094835|42187013|FG005|Overall Study|Withdrawal by Subject|0|||
19740042|NCT00094835|42187014|FG006|Overall Study|Withdrawal by Subject|1|||
19740043|NCT00094835|42187008|FG000|Overall Study|Lost to Follow-up|0|||
19740044|NCT00094835|42187009|FG001|Overall Study|Lost to Follow-up|0|||
19740045|NCT00094835|42187010|FG002|Overall Study|Lost to Follow-up|0|||
19740046|NCT00094835|42187011|FG003|Overall Study|Lost to Follow-up|0|||
19562364|NCT01181271|42010107|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
19562365|NCT01181271|42010107|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
19562366|NCT01181271|42010107|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
19562367|NCT01181271|42010107|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
19562368|NCT01180647|42010113|FG000|Overall Study|Lost to Follow-up|5|||
19562369|NCT01180647|42010114|FG001|Overall Study|Lost to Follow-up|6|||
19562370|NCT00969553|42010129|FG000|Overall Study|Progressive disease (PD)|2|||
19562371|NCT00969553|42010130|FG001|Overall Study|Progressive disease (PD)|2|||
19562372|NCT00969553|42010131|FG002|Overall Study|Progressive disease (PD)|6|||
19562373|NCT00969553|42010132|FG003|Overall Study|Progressive disease (PD)|9|||
19562374|NCT00969553|42010133|FG004|Overall Study|Progressive disease (PD)|2|||
19562375|NCT00969553|42010134|FG005|Overall Study|Progressive disease (PD)|4|||
19562376|NCT00969553|42010135|FG006|Overall Study|Progressive disease (PD)|2|||
19562377|NCT00969553|42010136|FG007|Overall Study|Progressive disease (PD)|12|||
19562378|NCT00969553|42010137|FG008|Overall Study|Progressive disease (PD)|3|||
19562379|NCT00969553|42010129|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562380|NCT00969553|42010130|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562381|NCT00969553|42010131|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562382|NCT00969553|42010132|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562383|NCT00969553|42010133|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
19562384|NCT00969553|42010134|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562385|NCT00969553|42010135|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562386|NCT00969553|42010136|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562387|NCT00969553|42010137|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
19562388|NCT00969553|42010129|FG000|Overall Study|Other Adverse Event|0|||
19562389|NCT00969553|42010130|FG001|Overall Study|Other Adverse Event|0|||
19562390|NCT00969553|42010131|FG002|Overall Study|Other Adverse Event|0|||
19740047|NCT00094835|42187012|FG004|Overall Study|Lost to Follow-up|1|||
19562391|NCT00969553|42010132|FG003|Overall Study|Other Adverse Event|1|||
19382240|NCT02646891|41625498|FG008|Overall Study|Protocol Violation|0|||
19382241|NCT02646891|41625499|FG009|Overall Study|Protocol Violation|0|||
19562392|NCT00969553|42010133|FG004|Overall Study|Other Adverse Event|0|||
19562393|NCT00969553|42010134|FG005|Overall Study|Other Adverse Event|0|||
19740048|NCT00094835|42187013|FG005|Overall Study|Lost to Follow-up|0|||
19740049|NCT00094835|42187014|FG006|Overall Study|Lost to Follow-up|0|||
19382242|NCT02646891|41625490|FG000|Overall Study|Withdrawal by Subject|2|||
19562394|NCT00969553|42010135|FG006|Overall Study|Other Adverse Event|1|||
19562395|NCT00969553|42010136|FG007|Overall Study|Other Adverse Event|0|||
19562396|NCT00969553|42010137|FG008|Overall Study|Other Adverse Event|0|||
19562397|NCT00969553|42010129|FG000|Overall Study|Refused cont. medication|1|||
19740050|NCT00094835|42187008|FG000|Overall Study|Death|1|||
19740051|NCT00094835|42187009|FG001|Overall Study|Death|0|||
19740052|NCT00094835|42187010|FG002|Overall Study|Death|0|||
19740053|NCT00094835|42187011|FG003|Overall Study|Death|0|||
19740054|NCT00094835|42187012|FG004|Overall Study|Death|1|||
19740055|NCT00094835|42187013|FG005|Overall Study|Death|0|||
19562398|NCT00969553|42010130|FG001|Overall Study|Refused cont. medication|1|||
19562399|NCT00969553|42010131|FG002|Overall Study|Refused cont. medication|0|||
19562400|NCT00969553|42010132|FG003|Overall Study|Refused cont. medication|2|||
19562401|NCT00969553|42010133|FG004|Overall Study|Refused cont. medication|0|||
19562402|NCT00969553|42010134|FG005|Overall Study|Refused cont. medication|0|||
19562403|NCT00969553|42010135|FG006|Overall Study|Refused cont. medication|0|||
19562404|NCT00969553|42010136|FG007|Overall Study|Refused cont. medication|1|||
19562405|NCT00969553|42010137|FG008|Overall Study|Refused cont. medication|0|||
19562406|NCT00969553|42010129|FG000|Overall Study|Not specified above|0|||
19562407|NCT00969553|42010130|FG001|Overall Study|Not specified above|0|||
19562408|NCT00969553|42010131|FG002|Overall Study|Not specified above|0|||
19562409|NCT00969553|42010132|FG003|Overall Study|Not specified above|4|||
19562410|NCT00969553|42010133|FG004|Overall Study|Not specified above|0|||
19562411|NCT00969553|42010134|FG005|Overall Study|Not specified above|0|||
19562412|NCT00969553|42010135|FG006|Overall Study|Not specified above|1|||
19562413|NCT00969553|42010136|FG007|Overall Study|Not specified above|1|||
19562414|NCT00969553|42010137|FG008|Overall Study|Not specified above|0|||
19562415|NCT01179477|42010165|FG000|Overall Study|Death|542|||
19562416|NCT01179477|42010165|FG000|Overall Study|Unsuccessful implant|80|||
19562417|NCT01179477|42010165|FG000|Overall Study|Non-death withdrawal|438|||
19562418|NCT01179477|42010165|FG000|Overall Study|Did not complete final visit|27|||
19562419|NCT01179399|42010169|FG000|Overall Study|Adverse Event|1|||
19562420|NCT01179399|42010169|FG000|Overall Study|Lack of Efficacy|30|||
19562421|NCT01179399|42010169|FG000|Overall Study|Withdrawal by Subject|1|||
19562422|NCT01178853|42010175|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
19562423|NCT01178853|42010176|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
19562424|NCT01178853|42010175|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
19562425|NCT01178853|42010176|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
19562426|NCT01178853|42010175|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
19562427|NCT01178853|42010176|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
19562428|NCT01178853|42010175|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
19562429|NCT01178853|42010176|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
19562430|NCT01178853|42010175|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
19562431|NCT01178853|42010176|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
19562432|NCT01178385|42010184|FG000|Overall Study|Withdrawal by Subject|2|||
19562433|NCT01178385|42010185|FG001|Overall Study|Withdrawal by Subject|0|||
19562434|NCT01288976|42010194|FG000|Overall Study|Withdrawal by Subject|58|||
19562435|NCT01288976|42010195|FG001|Overall Study|Withdrawal by Subject|12|||
19562436|NCT01288976|42010196|FG002|Overall Study|Withdrawal by Subject|9|||
19562437|NCT01288976|42010194|FG000|Overall Study|Death|98|||
19562438|NCT01288976|42010195|FG001|Overall Study|Death|6|||
19562439|NCT01288976|42010196|FG002|Overall Study|Death|4|||
19562440|NCT01288976|42010194|FG000|Overall Study|Data unavailable|22|||
19740056|NCT00094835|42187014|FG006|Overall Study|Death|0|||
19382243|NCT02646891|41625491|FG001|Overall Study|Withdrawal by Subject|0|||
19562441|NCT01288976|42010195|FG001|Overall Study|Data unavailable|9|||
19562442|NCT01288976|42010196|FG002|Overall Study|Data unavailable|7|||
19562443|NCT00970489|42010204|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
19562444|NCT00970489|42010205|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
19562445|NCT00968617|42010211|FG000|Overall Study|Study terminated by sponsor|6|||
19562446|NCT00968539|42010217|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
19740057|NCT00094835|42187008|FG000|Overall Study|Non-compliance|1|||
19740058|NCT00094835|42187009|FG001|Overall Study|Non-compliance|2|||
19740059|NCT00094835|42187010|FG002|Overall Study|Non-compliance|2|||
19390371|NCT01987960|41634111|FG001|Period 3|Withdrawal by Subject|0|||
19562447|NCT00968539|42010218|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19562448|NCT00976573|42010227|FG000|Overall Study|Ineligible|0|||
19562449|NCT00976573|42010228|FG001|Overall Study|Ineligible|1|||
19562450|NCT00976573|42010227|FG000|Overall Study|Cancel prior to receiving treatment|4|||
19562451|NCT00976573|42010228|FG001|Overall Study|Cancel prior to receiving treatment|2|||
19562452|NCT03661723|42010236|FG000|Overall Study|Disease Progression|4|||
19562453|NCT03661723|42010237|FG001|Overall Study|Disease Progression|24|||
19562454|NCT03661723|42010238|FG002|Overall Study|Disease Progression|4|||
19562455|NCT03661723|42010239|FG003|Overall Study|Disease Progression|19|||
19562456|NCT03661723|42010236|FG000|Overall Study|Withdrawal by Subject|1|||
19562457|NCT03661723|42010237|FG001|Overall Study|Withdrawal by Subject|0|||
19562458|NCT03661723|42010238|FG002|Overall Study|Withdrawal by Subject|2|||
19562459|NCT03661723|42010239|FG003|Overall Study|Withdrawal by Subject|4|||
19562460|NCT03661723|42010236|FG000|Overall Study|Physician Decision|1|||
19562461|NCT03661723|42010237|FG001|Overall Study|Physician Decision|0|||
19562462|NCT03661723|42010238|FG002|Overall Study|Physician Decision|0|||
19562463|NCT03661723|42010239|FG003|Overall Study|Physician Decision|0|||
19562464|NCT03661723|42010236|FG000|Overall Study|Clinical Deterioration|0|||
19562465|NCT03661723|42010237|FG001|Overall Study|Clinical Deterioration|0|||
19562466|NCT03661723|42010238|FG002|Overall Study|Clinical Deterioration|0|||
19562467|NCT03661723|42010239|FG003|Overall Study|Clinical Deterioration|1|||
19562468|NCT00976495|42010248|FG000|Overall Study|Withdrawal by Subject|0|||
19562469|NCT00976495|42010249|FG001|Overall Study|Withdrawal by Subject|1|||
19562470|NCT00976495|42010250|FG002|Overall Study|Withdrawal by Subject|0|||
19562471|NCT01288430|42010268|FG000|Part 1|Progressive disease|2|||
19562472|NCT01288430|42010269|FG001|Part 1|Progressive disease|1|||
19562473|NCT01288430|42010270|FG002|Part 1|Progressive disease|1|||
19562474|NCT01288430|42010271|FG003|Part 1|Progressive disease|6|||
19562475|NCT01288430|42010272|FG004|Part 1|Progressive disease|2|||
19562476|NCT01288430|42010273|FG005|Part 1|Progressive disease|4|||
19562477|NCT01288430|42010274|FG006|Part 1|Progressive disease|2|||
19562478|NCT01288430|42010275|FG007|Part 1|Progressive disease|0|||
19562479|NCT01288430|42010276|FG008|Part 1|Progressive disease|0|||
19562480|NCT01288430|42010277|FG009|Part 1|Progressive disease|0|||
19562481|NCT01288430|42010268|FG000|Part 1|Clinical disease progression|0|||
19562482|NCT01288430|42010269|FG001|Part 1|Clinical disease progression|0|||
19562483|NCT01288430|42010270|FG002|Part 1|Clinical disease progression|1|||
19562484|NCT01288430|42010271|FG003|Part 1|Clinical disease progression|0|||
19562485|NCT01288430|42010272|FG004|Part 1|Clinical disease progression|0|||
19562486|NCT01288430|42010273|FG005|Part 1|Clinical disease progression|2|||
19562487|NCT01288430|42010274|FG006|Part 1|Clinical disease progression|2|||
19562488|NCT01288430|42010275|FG007|Part 1|Clinical disease progression|0|||
19562489|NCT01288430|42010276|FG008|Part 1|Clinical disease progression|0|||
19562490|NCT01288430|42010277|FG009|Part 1|Clinical disease progression|0|||
19562491|NCT01288430|42010268|FG000|Part 1|Death due to disease progression|0|||
19562492|NCT01288430|42010269|FG001|Part 1|Death due to disease progression|0|||
19562493|NCT01288430|42010270|FG002|Part 1|Death due to disease progression|0|||
19562494|NCT01288430|42010271|FG003|Part 1|Death due to disease progression|0|||
19562495|NCT01288430|42010272|FG004|Part 1|Death due to disease progression|1|||
19562496|NCT01288430|42010273|FG005|Part 1|Death due to disease progression|0|||
19562497|NCT01288430|42010274|FG006|Part 1|Death due to disease progression|0|||
19562498|NCT01288430|42010275|FG007|Part 1|Death due to disease progression|0|||
19562499|NCT01288430|42010276|FG008|Part 1|Death due to disease progression|0|||
19562500|NCT01288430|42010277|FG009|Part 1|Death due to disease progression|0|||
19562501|NCT01288430|42010268|FG000|Part 1|Adverse Event|0|||
19390372|NCT01987960|41634112|FG002|Period 3|Withdrawal by Subject|0|||
19562502|NCT01288430|42010269|FG001|Part 1|Adverse Event|0|||
19562503|NCT01288430|42010270|FG002|Part 1|Adverse Event|3|||
19562504|NCT01288430|42010271|FG003|Part 1|Adverse Event|1|||
19562505|NCT01288430|42010272|FG004|Part 1|Adverse Event|0|||
19562506|NCT01288430|42010273|FG005|Part 1|Adverse Event|0|||
19562507|NCT01288430|42010274|FG006|Part 1|Adverse Event|2|||
19562508|NCT01288430|42010275|FG007|Part 1|Adverse Event|0|||
19562509|NCT01288430|42010276|FG008|Part 1|Adverse Event|0|||
19562510|NCT01288430|42010277|FG009|Part 1|Adverse Event|0|||
19562511|NCT01288430|42010268|FG000|Part 1|Other|0|||
19562512|NCT01288430|42010269|FG001|Part 1|Other|2|||
19562513|NCT01288430|42010270|FG002|Part 1|Other|0|||
19562514|NCT01288430|42010271|FG003|Part 1|Other|0|||
19562515|NCT01288430|42010272|FG004|Part 1|Other|0|||
19562516|NCT01288430|42010273|FG005|Part 1|Other|0|||
19562517|NCT01288430|42010274|FG006|Part 1|Other|1|||
19562518|NCT01288430|42010275|FG007|Part 1|Other|0|||
19562519|NCT01288430|42010276|FG008|Part 1|Other|0|||
19562520|NCT01288430|42010277|FG009|Part 1|Other|0|||
19562521|NCT01288430|42010268|FG000|Part 2|Progressive disease|0|||
19562522|NCT01288430|42010269|FG001|Part 2|Progressive disease|0|||
19562523|NCT01288430|42010270|FG002|Part 2|Progressive disease|0|||
19562524|NCT01288430|42010271|FG003|Part 2|Progressive disease|0|||
19562525|NCT01288430|42010272|FG004|Part 2|Progressive disease|0|||
19562526|NCT01288430|42010273|FG005|Part 2|Progressive disease|0|||
19562527|NCT01288430|42010274|FG006|Part 2|Progressive disease|0|||
19562528|NCT01288430|42010275|FG007|Part 2|Progressive disease|8|||
19562529|NCT01288430|42010276|FG008|Part 2|Progressive disease|7|||
19562530|NCT01288430|42010277|FG009|Part 2|Progressive disease|2|||
19562531|NCT01288430|42010268|FG000|Part 2|Clinical disease progression|0|||
19562532|NCT01288430|42010269|FG001|Part 2|Clinical disease progression|0|||
19562533|NCT01288430|42010270|FG002|Part 2|Clinical disease progression|0|||
19562534|NCT01288430|42010271|FG003|Part 2|Clinical disease progression|0|||
19562535|NCT01288430|42010272|FG004|Part 2|Clinical disease progression|0|||
19562536|NCT01288430|42010273|FG005|Part 2|Clinical disease progression|0|||
19562537|NCT01288430|42010274|FG006|Part 2|Clinical disease progression|0|||
19562538|NCT01288430|42010275|FG007|Part 2|Clinical disease progression|2|||
19562539|NCT01288430|42010276|FG008|Part 2|Clinical disease progression|0|||
19562540|NCT01288430|42010277|FG009|Part 2|Clinical disease progression|0|||
19562541|NCT01288430|42010268|FG000|Part 2|Withdrawal by Subject|0|||
19562542|NCT01288430|42010269|FG001|Part 2|Withdrawal by Subject|0|||
19562543|NCT01288430|42010270|FG002|Part 2|Withdrawal by Subject|0|||
19562544|NCT01288430|42010271|FG003|Part 2|Withdrawal by Subject|0|||
19562545|NCT01288430|42010272|FG004|Part 2|Withdrawal by Subject|0|||
19562546|NCT01288430|42010273|FG005|Part 2|Withdrawal by Subject|0|||
19562547|NCT01288430|42010274|FG006|Part 2|Withdrawal by Subject|0|||
19562548|NCT01288430|42010275|FG007|Part 2|Withdrawal by Subject|1|||
19562549|NCT01288430|42010276|FG008|Part 2|Withdrawal by Subject|4|||
19562550|NCT01288430|42010277|FG009|Part 2|Withdrawal by Subject|0|||
19562551|NCT01288430|42010268|FG000|Part 2|Adverse Event|0|||
19562552|NCT01288430|42010269|FG001|Part 2|Adverse Event|0|||
19562553|NCT01288430|42010270|FG002|Part 2|Adverse Event|0|||
19562554|NCT01288430|42010271|FG003|Part 2|Adverse Event|0|||
19562555|NCT01288430|42010272|FG004|Part 2|Adverse Event|0|||
19562556|NCT01288430|42010273|FG005|Part 2|Adverse Event|0|||
19562557|NCT01288430|42010274|FG006|Part 2|Adverse Event|0|||
19562558|NCT01288430|42010275|FG007|Part 2|Adverse Event|1|||
19562559|NCT01288430|42010276|FG008|Part 2|Adverse Event|1|||
19562560|NCT01288430|42010277|FG009|Part 2|Adverse Event|0|||
19562561|NCT01288430|42010268|FG000|Part 2|Other|0|||
19562562|NCT01288430|42010269|FG001|Part 2|Other|0|||
19562563|NCT01288430|42010270|FG002|Part 2|Other|0|||
19562564|NCT01288430|42010271|FG003|Part 2|Other|0|||
19562565|NCT01288430|42010272|FG004|Part 2|Other|0|||
19562566|NCT01288430|42010273|FG005|Part 2|Other|0|||
19562567|NCT01288430|42010274|FG006|Part 2|Other|0|||
19562568|NCT01288430|42010275|FG007|Part 2|Other|0|||
19562569|NCT01288430|42010276|FG008|Part 2|Other|0|||
19562570|NCT01288430|42010277|FG009|Part 2|Other|1|||
19562571|NCT01287416|42010306|FG000|Pre-post Training|Withdrawal by Subject|17|||
19562572|NCT01287416|42010307|FG001|Pre-post Training|Withdrawal by Subject|24|||
19562573|NCT01287416|42010306|FG000|Pre-post Training|Lost to Follow-up|5|||
19562574|NCT01287416|42010307|FG001|Pre-post Training|Lost to Follow-up|1|||
19562575|NCT01287416|42010306|FG000|6 Month Follow-up|Lost to Follow-up|3|||
19562576|NCT01287416|42010307|FG001|6 Month Follow-up|Lost to Follow-up|2|||
19562577|NCT00998296|42010324|FG000|Overall Study|Progressive disease|0|||
19562578|NCT00998296|42010325|FG001|Overall Study|Progressive disease|1|||
19562579|NCT00998296|42010326|FG002|Overall Study|Progressive disease|0|||
19562580|NCT00998296|42010327|FG003|Overall Study|Progressive disease|0|||
19562581|NCT00998296|42010328|FG004|Overall Study|Progressive disease|0|||
19562582|NCT00998296|42010329|FG005|Overall Study|Progressive disease|0|||
19562583|NCT00998296|42010330|FG006|Overall Study|Progressive disease|1|||
19562584|NCT00998296|42010331|FG007|Overall Study|Progressive disease|0|||
19562585|NCT00998296|42010332|FG008|Overall Study|Progressive disease|0|||
19562586|NCT00998296|42010333|FG009|Overall Study|Progressive disease|14|||
19562587|NCT00998296|42010334|FG010|Overall Study|Progressive disease|5|||
19562588|NCT00998296|42010324|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562589|NCT00998296|42010325|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562590|NCT00998296|42010326|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562591|NCT00998296|42010327|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562592|NCT00998296|42010328|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
19382244|NCT02646891|41625492|FG002|Overall Study|Withdrawal by Subject|1|||
19562593|NCT00998296|42010329|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562594|NCT00998296|42010330|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562595|NCT00998296|42010331|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
19562596|NCT00998296|42010332|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
19562597|NCT00998296|42010333|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562598|NCT00998296|42010334|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
19562599|NCT00998296|42010324|FG000|Overall Study|Other adverse event|0|||
19562600|NCT00998296|42010325|FG001|Overall Study|Other adverse event|0|||
19562601|NCT00998296|42010326|FG002|Overall Study|Other adverse event|0|||
19562602|NCT00998296|42010327|FG003|Overall Study|Other adverse event|0|||
19562603|NCT00998296|42010328|FG004|Overall Study|Other adverse event|1|||
19562604|NCT00998296|42010329|FG005|Overall Study|Other adverse event|0|||
19562605|NCT00998296|42010330|FG006|Overall Study|Other adverse event|0|||
19562606|NCT00998296|42010331|FG007|Overall Study|Other adverse event|0|||
19562607|NCT00998296|42010332|FG008|Overall Study|Other adverse event|0|||
19562608|NCT00998296|42010333|FG009|Overall Study|Other adverse event|1|||
19562609|NCT00998296|42010334|FG010|Overall Study|Other adverse event|2|||
19562610|NCT00998296|42010324|FG000|Overall Study|Refused to continue taking trial med.|0|||
19562611|NCT00998296|42010325|FG001|Overall Study|Refused to continue taking trial med.|0|||
19562612|NCT00998296|42010326|FG002|Overall Study|Refused to continue taking trial med.|0|||
19562613|NCT00998296|42010327|FG003|Overall Study|Refused to continue taking trial med.|0|||
19562614|NCT00998296|42010328|FG004|Overall Study|Refused to continue taking trial med.|0|||
19562615|NCT00998296|42010329|FG005|Overall Study|Refused to continue taking trial med.|0|||
19562616|NCT00998296|42010330|FG006|Overall Study|Refused to continue taking trial med.|0|||
19562617|NCT00998296|42010331|FG007|Overall Study|Refused to continue taking trial med.|0|||
19562618|NCT00998296|42010332|FG008|Overall Study|Refused to continue taking trial med.|0|||
19562619|NCT00998296|42010333|FG009|Overall Study|Refused to continue taking trial med.|2|||
19562620|NCT00998296|42010334|FG010|Overall Study|Refused to continue taking trial med.|0|||
19562621|NCT00998296|42010324|FG000|Overall Study|Reason other than those specified above|0|||
19562622|NCT00998296|42010325|FG001|Overall Study|Reason other than those specified above|0|||
19562623|NCT00998296|42010326|FG002|Overall Study|Reason other than those specified above|0|||
19562624|NCT00998296|42010327|FG003|Overall Study|Reason other than those specified above|0|||
19562625|NCT00998296|42010328|FG004|Overall Study|Reason other than those specified above|0|||
19562626|NCT00998296|42010329|FG005|Overall Study|Reason other than those specified above|0|||
19562627|NCT00998296|42010330|FG006|Overall Study|Reason other than those specified above|0|||
19562628|NCT00998296|42010331|FG007|Overall Study|Reason other than those specified above|0|||
19562629|NCT00998296|42010332|FG008|Overall Study|Reason other than those specified above|0|||
19562630|NCT00998296|42010333|FG009|Overall Study|Reason other than those specified above|1|||
19562631|NCT00998296|42010334|FG010|Overall Study|Reason other than those specified above|0|||
19562632|NCT01178073|42010366|FG000|Overall Study|Adverse Event|34|||
19562633|NCT01178073|42010367|FG001|Overall Study|Adverse Event|27|||
19562634|NCT01178073|42010368|FG002|Overall Study|Adverse Event|24|||
19562635|NCT01178073|42010366|FG000|Overall Study|Protocol Violation|1|||
19562636|NCT01178073|42010367|FG001|Overall Study|Protocol Violation|1|||
19562637|NCT01178073|42010368|FG002|Overall Study|Protocol Violation|1|||
19562638|NCT01178073|42010366|FG000|Overall Study|Lost to Follow-up|2|||
19562639|NCT01178073|42010367|FG001|Overall Study|Lost to Follow-up|0|||
19562640|NCT01178073|42010368|FG002|Overall Study|Lost to Follow-up|3|||
19562641|NCT01178073|42010366|FG000|Overall Study|Physician Decision|14|||
19562642|NCT01178073|42010367|FG001|Overall Study|Physician Decision|10|||
19562643|NCT01178073|42010368|FG002|Overall Study|Physician Decision|10|||
19562644|NCT01178073|42010366|FG000|Overall Study|Withdrawal by Subject|10|||
19562645|NCT01178073|42010367|FG001|Overall Study|Withdrawal by Subject|6|||
19562646|NCT01178073|42010368|FG002|Overall Study|Withdrawal by Subject|8|||
19562647|NCT01178073|42010366|FG000|Overall Study|Missing Completion Status|1|||
19562648|NCT01178073|42010367|FG001|Overall Study|Missing Completion Status|0|||
19562649|NCT01178073|42010368|FG002|Overall Study|Missing Completion Status|0|||
19562650|NCT00997984|42010380|FG000|Overall Study|Adverse Event|1|||
19562651|NCT00997984|42010381|FG001|Overall Study|Adverse Event|8|||
19562652|NCT00997984|42010382|FG002|Overall Study|Adverse Event|8|||
19562653|NCT00997984|42010380|FG000|Overall Study|Protocol Violation|1|||
19562654|NCT00997984|42010381|FG001|Overall Study|Protocol Violation|3|||
19562655|NCT00997984|42010382|FG002|Overall Study|Protocol Violation|0|||
19562656|NCT00997984|42010380|FG000|Overall Study|Withdrawal by Subject|6|||
19562657|NCT00997984|42010381|FG001|Overall Study|Withdrawal by Subject|9|||
19562658|NCT00997984|42010382|FG002|Overall Study|Withdrawal by Subject|5|||
19562659|NCT00997984|42010380|FG000|Overall Study|Lost to Follow-up|8|||
19562660|NCT00997984|42010381|FG001|Overall Study|Lost to Follow-up|5|||
19382245|NCT02646891|41625493|FG003|Overall Study|Withdrawal by Subject|0|||
19382246|NCT02646891|41625494|FG004|Overall Study|Withdrawal by Subject|0|||
19562661|NCT00997984|42010382|FG002|Overall Study|Lost to Follow-up|4|||
19562662|NCT00997984|42010380|FG000|Overall Study|Lack of Efficacy|20|||
19562663|NCT00997984|42010381|FG001|Overall Study|Lack of Efficacy|6|||
19562664|NCT00997984|42010382|FG002|Overall Study|Lack of Efficacy|3|||
19562665|NCT00997984|42010380|FG000|Overall Study|Met exclusion criteria|1|||
19562666|NCT00997984|42010381|FG001|Overall Study|Met exclusion criteria|0|||
19562667|NCT00997984|42010382|FG002|Overall Study|Met exclusion criteria|0|||
19562668|NCT00997984|42010380|FG000|Overall Study|non-compliance|0|||
19562669|NCT00997984|42010381|FG001|Overall Study|non-compliance|2|||
19562670|NCT00997984|42010382|FG002|Overall Study|non-compliance|3|||
19562671|NCT00997984|42010380|FG000|Overall Study|Wrong medication dispensed|0|||
19562672|NCT00997984|42010381|FG001|Overall Study|Wrong medication dispensed|1|||
19562673|NCT00997984|42010382|FG002|Overall Study|Wrong medication dispensed|0|||
19562674|NCT00997984|42010380|FG000|Overall Study|Suicidal ideation|0|||
19562675|NCT00997984|42010381|FG001|Overall Study|Suicidal ideation|0|||
19562676|NCT00997984|42010382|FG002|Overall Study|Suicidal ideation|1|||
19562677|NCT00997984|42010380|FG000|Overall Study|Work schedule|0|||
19562678|NCT00997984|42010381|FG001|Overall Study|Work schedule|0|||
19562679|NCT00997984|42010382|FG002|Overall Study|Work schedule|2|||
19562680|NCT01177293|42010392|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
19562681|NCT01177293|42010393|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
19562682|NCT01177137|42010402|FG000|Overall Study|Withdrawal by Subject|10|||
19562683|NCT01177137|42010403|FG001|Overall Study|Withdrawal by Subject|10|||
19562684|NCT01177137|42010404|FG002|Overall Study|Withdrawal by Subject|2|||
19562685|NCT01177059|42010415|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
19562686|NCT01177059|42010415|FG000|Overall Study|Withdrew consent|2|||
19562687|NCT01177059|42010415|FG000|Overall Study|Lost to Follow-up|18|||
19562688|NCT01176513|42010419|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
19562689|NCT01299389|42010425|FG000|Double-blind|Adverse Event|45|||
19562690|NCT01299389|42010426|FG001|Double-blind|Adverse Event|27|||
19562691|NCT01299389|42010427|FG002|Double-blind|Adverse Event|0|||
19562692|NCT01299389|42010428|FG003|Double-blind|Adverse Event|0|||
19562693|NCT01299389|42010425|FG000|Double-blind|Lack of Efficacy|45|||
19562694|NCT01299389|42010426|FG001|Double-blind|Lack of Efficacy|21|||
19562695|NCT01299389|42010427|FG002|Double-blind|Lack of Efficacy|0|||
19562696|NCT01299389|42010428|FG003|Double-blind|Lack of Efficacy|0|||
19562697|NCT01299389|42010425|FG000|Double-blind|Lost to Follow-up|2|||
19562698|NCT01299389|42010426|FG001|Double-blind|Lost to Follow-up|1|||
19562699|NCT01299389|42010427|FG002|Double-blind|Lost to Follow-up|0|||
19562700|NCT01299389|42010428|FG003|Double-blind|Lost to Follow-up|0|||
19562701|NCT01299389|42010425|FG000|Double-blind|Withdrawal by Subject|16|||
19562702|NCT01299389|42010426|FG001|Double-blind|Withdrawal by Subject|13|||
19562703|NCT01299389|42010427|FG002|Double-blind|Withdrawal by Subject|0|||
19562704|NCT01299389|42010428|FG003|Double-blind|Withdrawal by Subject|0|||
19562705|NCT01299389|42010425|FG000|Double-blind|Other|1|||
19562706|NCT01299389|42010426|FG001|Double-blind|Other|1|||
19562707|NCT01299389|42010427|FG002|Double-blind|Other|0|||
19562708|NCT01299389|42010428|FG003|Double-blind|Other|0|||
19562709|NCT01299389|42010425|FG000|Double-blind|"fail to meet study population criteria"|0|||
19562710|NCT01299389|42010426|FG001|Double-blind|"fail to meet study population criteria"|1|||
19562711|NCT01299389|42010427|FG002|Double-blind|"fail to meet study population criteria"|0|||
19562712|NCT01299389|42010428|FG003|Double-blind|"fail to meet study population criteria"|0|||
19562713|NCT01299389|42010425|FG000|Post-observational|Other|0|||
19562714|NCT01299389|42010426|FG001|Post-observational|Other|0|||
19562715|NCT01299389|42010427|FG002|Post-observational|Other|12|||
19562716|NCT01299389|42010428|FG003|Post-observational|Other|6|||
19562717|NCT01298999|42010439|FG000|Overall Study|Physician Decision|0|||
19562718|NCT01298999|42010440|FG001|Overall Study|Physician Decision|1|||
19562719|NCT01298999|42010439|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
19562720|NCT01298999|42010440|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
19562721|NCT01007032|42010450|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
19562722|NCT01007032|42010451|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
19562723|NCT01007032|42010452|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
19562724|NCT01007032|42010453|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
19562725|NCT01007032|42010450|FG000|Overall Study|Withdrawal by Subject|0|||
19562726|NCT01007032|42010451|FG001|Overall Study|Withdrawal by Subject|0|||
19562727|NCT01007032|42010452|FG002|Overall Study|Withdrawal by Subject|0|||
19562728|NCT01007032|42010453|FG003|Overall Study|Withdrawal by Subject|1|||
19562729|NCT00976027|42010470|FG000|Overall Study|Serious Adverse Event|36|||
19562730|NCT00976027|42010471|FG001|Overall Study|Serious Adverse Event|17|||
19562731|NCT00976027|42010470|FG000|Overall Study|Adverse Event|0|||
19562732|NCT00976027|42010471|FG001|Overall Study|Adverse Event|2|||
19562733|NCT00976027|42010470|FG000|Overall Study|Protocol Violation|60|||
19562734|NCT00976027|42010471|FG001|Overall Study|Protocol Violation|27|||
19562735|NCT00976027|42010470|FG000|Overall Study|Lost to Follow-up|208|||
19562736|NCT00976027|42010471|FG001|Overall Study|Lost to Follow-up|103|||
19562737|NCT00976027|42010470|FG000|Overall Study|Withdrawal by Subject|107|||
19562738|NCT00976027|42010471|FG001|Overall Study|Withdrawal by Subject|66|||
19562739|NCT01298765|42010477|FG000|Titration Period|Adverse Event|26|||
19562740|NCT01298765|42010477|FG000|Titration Period|Death|1|||
19562741|NCT01298765|42010477|FG000|Titration Period|Lack of Efficacy|21|||
19562742|NCT01298765|42010477|FG000|Titration Period|Lost to Follow-up|9|||
19562743|NCT01298765|42010477|FG000|Titration Period|Physician Decision|1|||
19562744|NCT01298765|42010477|FG000|Titration Period|Withdrawal by Subject|10|||
19562745|NCT01298765|42010477|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
19562746|NCT01298765|42010477|FG000|Long-Term Treatment Period|Adverse Event|19|||
19562747|NCT01298765|42010477|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
19562748|NCT01298765|42010477|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
19562749|NCT01298765|42010477|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
19562750|NCT01298765|42010477|FG000|Long-Term Treatment Period|Physician Decision|1|||
19562751|NCT01298765|42010477|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
19562752|NCT00997438|42010484|FG000|Overall Study|Blood draw difficulty|2|||
19562753|NCT00997438|42010485|FG001|Overall Study|Blood draw difficulty|0|||
19562754|NCT00997438|42010486|FG002|Overall Study|Blood draw difficulty|1|||
19562755|NCT00997438|42010484|FG000|Overall Study|Withdrawal by Subject|1|||
19562756|NCT00997438|42010485|FG001|Overall Study|Withdrawal by Subject|1|||
19562757|NCT00997438|42010486|FG002|Overall Study|Withdrawal by Subject|0|||
19562758|NCT00997438|42010484|FG000|Overall Study|Exclusion criteria at visit 1|2|||
19562759|NCT00997438|42010485|FG001|Overall Study|Exclusion criteria at visit 1|2|||
19562760|NCT00997438|42010486|FG002|Overall Study|Exclusion criteria at visit 1|3|||
19562761|NCT00997126|42010497|FG000|Overall Study|Physician Decision|7|||
19562762|NCT00997126|42010498|FG001|Overall Study|Physician Decision|11|||
19562763|NCT01000636|42010504|FG000|Overall Study|Withdrawal by Subject|1|||
19562764|NCT01000636|42010504|FG000|Overall Study|Adverse Event|1|||
19562765|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Adverse Event|33|||
19562766|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
19562767|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
19562768|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
19562769|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Physician Decision|6|||
19562770|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
19562771|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
19562772|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
19562773|NCT00965419|42010508|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
19562774|NCT00965419|42010508|FG000|Follow-up Phase|Adverse Event|9|||
19562775|NCT00965419|42010508|FG000|Follow-up Phase|Protocol Violation|4|||
19562776|NCT00965419|42010508|FG000|Follow-up Phase|Withdrawal by Subject|8|||
19562777|NCT00965419|42010508|FG000|Follow-up Phase|Physician Decision|4|||
19562778|NCT00965419|42010508|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
19562779|NCT00965419|42010508|FG000|Follow-up Phase|Lack of Efficacy|28|||
19562780|NCT01000480|42010513|FG000|Induction Phase|Adverse Event|2|||
19562781|NCT01000480|42010513|FG000|Induction Phase|Lost to Follow-up|1|||
19562782|NCT01000480|42010513|FG000|Induction Phase|Physician Decision|1|||
19562783|NCT01000480|42010513|FG000|Induction Phase|Entry Criteria Not Met|3|||
19562784|NCT01000480|42010513|FG000|Concurrent Therapy Phase|Adverse Event|4|||
19562785|NCT01000480|42010513|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
19562786|NCT01000480|42010513|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
19562787|NCT01000480|42010513|FG000|Concurrent Therapy Phase|Physician Decision|1|||
19562788|NCT00965341|42010519|FG000|Overall Study|Withdrew consent|1|||
19562789|NCT00965341|42010520|FG001|Overall Study|Withdrew consent|5|||
19562790|NCT00965341|42010519|FG000|Overall Study|Lost to Follow-up|1|||
19562791|NCT00965341|42010520|FG001|Overall Study|Lost to Follow-up|0|||
19562792|NCT00965341|42010519|FG000|Overall Study|Transportation issues|4|||
19562793|NCT00965341|42010520|FG001|Overall Study|Transportation issues|3|||
19740060|NCT00094835|42187011|FG003|Overall Study|Non-compliance|0|||
19562794|NCT01175811|42010528|FG000|Overall Study|Adverse Event|1|||
19562795|NCT01175811|42010529|FG001|Overall Study|Adverse Event|1|||
19562796|NCT01175811|42010528|FG000|Overall Study|Entry criteria not met|3|||
19562797|NCT01175811|42010529|FG001|Overall Study|Entry criteria not met|1|||
19562798|NCT01175811|42010528|FG000|Overall Study|Lack of Efficacy|1|||
19562799|NCT01175811|42010529|FG001|Overall Study|Lack of Efficacy|0|||
19562800|NCT01175811|42010528|FG000|Overall Study|Lost to Follow-up|3|||
19562801|NCT01175811|42010529|FG001|Overall Study|Lost to Follow-up|2|||
19562802|NCT01175811|42010528|FG000|Overall Study|Physician Decision|1|||
19382247|NCT02646891|41625495|FG005|Overall Study|Withdrawal by Subject|0|||
19562803|NCT01175811|42010529|FG001|Overall Study|Physician Decision|1|||
19562804|NCT01175811|42010528|FG000|Overall Study|Protocol Violation|1|||
19562805|NCT01175811|42010529|FG001|Overall Study|Protocol Violation|2|||
19562806|NCT01175811|42010528|FG000|Overall Study|Withdrawal by Subject|6|||
19562807|NCT01175811|42010529|FG001|Overall Study|Withdrawal by Subject|7|||
19562808|NCT00965263|42010537|FG000|Overall Study|Physician Decision|2|||
19562809|NCT00965263|42010538|FG001|Overall Study|Physician Decision|0|||
19562810|NCT00965263|42010537|FG000|Overall Study|Family emergency|0|||
19562811|NCT00965263|42010538|FG001|Overall Study|Family emergency|1|||
19562812|NCT00965263|42010537|FG000|Overall Study|Protocol Violation|0|||
19562813|NCT00965263|42010538|FG001|Overall Study|Protocol Violation|2|||
19562814|NCT00965185|42010564|FG000|Overall Study|Lost to Follow-up|2|||
19562815|NCT00965185|42010565|FG001|Overall Study|Lost to Follow-up|0|||
19562816|NCT00965185|42010564|FG000|Overall Study|Withdrawal by Subject|0|||
19562817|NCT00965185|42010565|FG001|Overall Study|Withdrawal by Subject|1|||
19562818|NCT01174563|42010573|FG000|Overall Study|Progressive Disease|45|||
19562819|NCT01174563|42010573|FG000|Overall Study|Death|5|||
19562820|NCT01174563|42010573|FG000|Overall Study|Investigator's Discretion|5|||
19562821|NCT01174563|42010573|FG000|Overall Study|Participant Withdrew Consent|3|||
19562822|NCT01174563|42010573|FG000|Overall Study|Rash Adverse Event|1|||
19562823|NCT01174563|42010573|FG000|Overall Study|Sponsor's decision|1|||
19562824|NCT01298531|42010579|FG000|Overall Study|Lack of Efficacy|0|||
19562825|NCT01298531|42010580|FG001|Overall Study|Lack of Efficacy|1|||
19562826|NCT01298531|42010579|FG000|Overall Study|Lost to Follow-up|2|||
19562827|NCT01298531|42010580|FG001|Overall Study|Lost to Follow-up|0|||
19562828|NCT01298531|42010579|FG000|Overall Study|Protocol Violation|1|||
19562829|NCT01298531|42010580|FG001|Overall Study|Protocol Violation|1|||
19562830|NCT01298531|42010579|FG000|Overall Study|Adverse Event|4|||
19562831|NCT01298531|42010580|FG001|Overall Study|Adverse Event|3|||
19562832|NCT01298531|42010579|FG000|Overall Study|Does not meet entrance criteria|0|||
19562833|NCT01298531|42010580|FG001|Overall Study|Does not meet entrance criteria|1|||
19562834|NCT01298531|42010579|FG000|Overall Study|Other|2|||
19562835|NCT01298531|42010580|FG001|Overall Study|Other|1|||
19562836|NCT01174173|42010587|FG000|Overall Study|drug-drug interaction|1|||
19562837|NCT00964795|42010592|FG000|Overall Study|Withdrawal by Subject|79|||
19562838|NCT00964795|42010592|FG000|Overall Study|Adverse Event|12|||
19562839|NCT00964795|42010592|FG000|Overall Study|Death|14|||
19562840|NCT00964795|42010592|FG000|Overall Study|Lost to Follow-up|7|||
19562841|NCT00964795|42010592|FG000|Overall Study|Termination of Study by Sponsor|169|||
19562842|NCT00964795|42010592|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
19562843|NCT00964795|42010592|FG000|Overall Study|Other|23|||
19562844|NCT01173471|42010601|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19562845|NCT01173471|42010602|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19562846|NCT01173471|42010603|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
19562847|NCT01173471|42010604|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
19562848|NCT01173471|42010601|FG000|Overall Study|Condition under investigation worsened|2|||
19562849|NCT01173471|42010602|FG001|Overall Study|Condition under investigation worsened|0|||
19562850|NCT01173471|42010603|FG002|Overall Study|Condition under investigation worsened|0|||
19562851|NCT01173471|42010604|FG003|Overall Study|Condition under investigation worsened|0|||
19562852|NCT01173471|42010601|FG000|Overall Study|Lost to Follow-up|0|||
19562853|NCT01173471|42010602|FG001|Overall Study|Lost to Follow-up|0|||
19562854|NCT01173471|42010603|FG002|Overall Study|Lost to Follow-up|1|||
19562855|NCT01173471|42010604|FG003|Overall Study|Lost to Follow-up|0|||
19562856|NCT01173471|42010601|FG000|Overall Study|Reason given as Other|0|||
19562857|NCT01173471|42010602|FG001|Overall Study|Reason given as Other|0|||
19562858|NCT01173471|42010603|FG002|Overall Study|Reason given as Other|1|||
19562859|NCT01173471|42010604|FG003|Overall Study|Reason given as Other|0|||
19562860|NCT01172847|42010614|FG000|Overall Study|Withdrawal by Subject|3|||
19562861|NCT00966355|42010627|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
19562862|NCT00966355|42010628|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
19562863|NCT00966355|42010629|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
19562864|NCT00966355|42010627|FG000|Overall Study|newly diagnosed advanced HCC|11|||
19562865|NCT00966355|42010628|FG001|Overall Study|newly diagnosed advanced HCC|12|||
19562866|NCT00966355|42010629|FG002|Overall Study|newly diagnosed advanced HCC|10|||
19562867|NCT00966355|42010627|FG000|Overall Study|Lost to Follow-up|5|||
19562868|NCT00966355|42010628|FG001|Overall Study|Lost to Follow-up|4|||
19562869|NCT00966355|42010629|FG002|Overall Study|Lost to Follow-up|3|||
19562870|NCT01172535|42010637|FG000|Overall Study|Death|3|||
19562871|NCT01172535|42010637|FG000|Overall Study|Withdrawal by Subject|2|||
19562872|NCT01172535|42010637|FG000|Overall Study|Lost to Follow-up|1|||
19562873|NCT01172535|42010637|FG000|Overall Study|Ineligible at study entry|1|||
19562874|NCT01172535|42010637|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
19562875|NCT00966277|42010646|FG000|Overall Study|Withdrawal by Subject|3|||
19562876|NCT00966277|42010647|FG001|Overall Study|Withdrawal by Subject|0|||
19562877|NCT00966277|42010646|FG000|Overall Study|Ineligible|1|||
19562878|NCT00966277|42010647|FG001|Overall Study|Ineligible|3|||
19562879|NCT00966277|42010646|FG000|Overall Study|Treatment Plan Changed|0|||
19562880|NCT00966277|42010647|FG001|Overall Study|Treatment Plan Changed|1|||
19562881|NCT01298141|42010653|FG000|Overall Study|Adverse Event|3|||
19562882|NCT01298141|42010653|FG000|Overall Study|Refusal of Required Study Procedures|1|||
19562883|NCT01298141|42010653|FG000|Overall Study|Withdrawal by Subject|6|||
19562884|NCT01298141|42010653|FG000|Overall Study|Termination of Study by the Investigator|5|||
19562885|NCT01298141|42010653|FG000|Overall Study|Other|5|||
19562886|NCT01298141|42010653|FG000|Overall Study|Lost to Follow-up|1|||
19562887|NCT01298141|42010653|FG000|Overall Study|Death|6|||
19562888|NCT01298141|42010653|FG000|Overall Study|Not treated|4|||
19562889|NCT01171989|42010660|FG000|Overall Study|Lost to Follow-up|0|||
19562890|NCT01171989|42010661|FG001|Overall Study|Lost to Follow-up|0|||
19562891|NCT01171989|42010662|FG002|Overall Study|Lost to Follow-up|1|||
19562892|NCT01297517|42010673|FG000|Overall Study|Adverse Event|21|||
19562893|NCT01297517|42010674|FG001|Overall Study|Adverse Event|7|||
19562894|NCT01297517|42010675|FG002|Overall Study|Adverse Event|16|||
19562895|NCT01297517|42010673|FG000|Overall Study|Lost to Follow-up|1|||
19562896|NCT01297517|42010674|FG001|Overall Study|Lost to Follow-up|0|||
19562897|NCT01297517|42010675|FG002|Overall Study|Lost to Follow-up|1|||
19562898|NCT01297517|42010673|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
19562899|NCT01297517|42010674|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
19562900|NCT01297517|42010675|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
19562901|NCT01297517|42010673|FG000|Overall Study|Noncompliance|1|||
19562902|NCT01297517|42010674|FG001|Overall Study|Noncompliance|0|||
19562903|NCT01297517|42010675|FG002|Overall Study|Noncompliance|0|||
19562904|NCT01297517|42010673|FG000|Overall Study|Protocol Violation|1|||
19562905|NCT01297517|42010674|FG001|Overall Study|Protocol Violation|1|||
19562906|NCT01297517|42010675|FG002|Overall Study|Protocol Violation|1|||
19562907|NCT01297517|42010673|FG000|Overall Study|Inadequate Control of IOP|1|||
19562908|NCT01297517|42010674|FG001|Overall Study|Inadequate Control of IOP|1|||
19562909|NCT01297517|42010675|FG002|Overall Study|Inadequate Control of IOP|2|||
19562910|NCT01171677|42010685|FG000|Overall Study|Withdrawal by Subject|0|||
19562911|NCT01171677|42010686|FG001|Overall Study|Withdrawal by Subject|3|||
19562912|NCT01171677|42010685|FG000|Overall Study|Adverse Event|1|||
19562913|NCT01171677|42010686|FG001|Overall Study|Adverse Event|0|||
19562914|NCT01171677|42010685|FG000|Overall Study|completed <70% IntenSati classes|5|||
19562915|NCT01171677|42010686|FG001|Overall Study|completed <70% IntenSati classes|0|||
19562916|NCT01171521|42010692|FG000|Overall Study|Lost to Follow-up|5|||
19562917|NCT01171521|42010692|FG000|Overall Study|screen failure|1|||
19562918|NCT01296347|42010698|FG000|Allocation|Withdrawal by Subject|1|||
19562919|NCT01296347|42010699|FG001|Allocation|Withdrawal by Subject|2|||
19562920|NCT01296347|42010698|FG000|Allocation|Lack of Efficacy|1|||
19562921|NCT01296347|42010699|FG001|Allocation|Lack of Efficacy|2|||
19562922|NCT01296347|42010698|FG000|Allocation|not received infusion|1|||
19562923|NCT01296347|42010699|FG001|Allocation|not received infusion|0|||
19562924|NCT01296347|42010698|FG000|6 Week Follow up|Death|0|||
19562925|NCT01296347|42010699|FG001|6 Week Follow up|Death|1|||
19562926|NCT01296347|42010698|FG000|3 Month Follow up|Death|1|||
19562927|NCT01296347|42010699|FG001|3 Month Follow up|Death|0|||
19562928|NCT01296347|42010698|FG000|3 Month Follow up|Lost to Follow-up|0|||
19562929|NCT01296347|42010699|FG001|3 Month Follow up|Lost to Follow-up|1|||
19562930|NCT01296347|42010698|FG000|6 Month Follow up|Death|2|||
19562931|NCT01296347|42010699|FG001|6 Month Follow up|Death|1|||
19562932|NCT01296347|42010698|FG000|6 Month Follow up|Lost to Follow-up|0|||
19562933|NCT01296347|42010699|FG001|6 Month Follow up|Lost to Follow-up|1|||
19562934|NCT01296347|42010698|FG000|12 Month Follow up|Lost to Follow-up|3|||
19562935|NCT01296347|42010699|FG001|12 Month Follow up|Lost to Follow-up|1|||
19562936|NCT01296347|42010698|FG000|12 Month Follow up|Death|1|||
19562937|NCT01296347|42010699|FG001|12 Month Follow up|Death|1|||
19562938|NCT01296347|42010698|FG000|12 Month Follow up|Withdrawal by Subject|0|||
19562939|NCT01296347|42010699|FG001|12 Month Follow up|Withdrawal by Subject|1|||
19562940|NCT01296035|42010708|FG000|Overall Study|Withdrawal by Subject|1|||
19562941|NCT01294787|42010712|FG000|Period 1|Adverse Event|0|||
19562942|NCT01294787|42010713|FG001|Period 1|Adverse Event|0|||
19562943|NCT01294787|42010714|FG002|Period 1|Adverse Event|0|||
19562944|NCT01294787|42010715|FG003|Period 1|Adverse Event|0|||
19562945|NCT01294787|42010716|FG004|Period 1|Adverse Event|1|||
19562946|NCT01294787|42010717|FG005|Period 1|Adverse Event|0|||
19562947|NCT01294787|42010712|FG000|Period 1|Withdrawal by Subject|0|||
19562948|NCT01294787|42010713|FG001|Period 1|Withdrawal by Subject|0|||
19562949|NCT01294787|42010714|FG002|Period 1|Withdrawal by Subject|0|||
19562950|NCT01294787|42010715|FG003|Period 1|Withdrawal by Subject|1|||
19562951|NCT01294787|42010716|FG004|Period 1|Withdrawal by Subject|1|||
19562952|NCT01294787|42010717|FG005|Period 1|Withdrawal by Subject|1|||
19562953|NCT01294787|42010712|FG000|Period 1|Administrative problem|0|||
19562954|NCT01294787|42010713|FG001|Period 1|Administrative problem|0|||
19562955|NCT01294787|42010714|FG002|Period 1|Administrative problem|1|||
19562956|NCT01294787|42010715|FG003|Period 1|Administrative problem|0|||
19562957|NCT01294787|42010716|FG004|Period 1|Administrative problem|0|||
19562958|NCT01294787|42010717|FG005|Period 1|Administrative problem|1|||
19562959|NCT01294787|42010712|FG000|Period 2|Adverse Event|0|||
19562960|NCT01294787|42010713|FG001|Period 2|Adverse Event|3|||
19562961|NCT01294787|42010714|FG002|Period 2|Adverse Event|0|||
19562962|NCT01294787|42010715|FG003|Period 2|Adverse Event|1|||
19562963|NCT01294787|42010716|FG004|Period 2|Adverse Event|0|||
19562964|NCT01294787|42010717|FG005|Period 2|Adverse Event|0|||
19562965|NCT01294787|42010712|FG000|Period 2|No longer needs study drug|0|||
19562966|NCT01294787|42010713|FG001|Period 2|No longer needs study drug|0|||
19562967|NCT01294787|42010714|FG002|Period 2|No longer needs study drug|0|||
19562968|NCT01294787|42010715|FG003|Period 2|No longer needs study drug|1|||
19562969|NCT01294787|42010716|FG004|Period 2|No longer needs study drug|0|||
19562970|NCT01294787|42010717|FG005|Period 2|No longer needs study drug|0|||
19562971|NCT01294787|42010712|FG000|Period 3|Adverse Event|0|||
19562972|NCT01294787|42010713|FG001|Period 3|Adverse Event|0|||
19562973|NCT01294787|42010714|FG002|Period 3|Adverse Event|0|||
19562974|NCT01294787|42010715|FG003|Period 3|Adverse Event|0|||
19562975|NCT01294787|42010716|FG004|Period 3|Adverse Event|1|||
19562976|NCT01294787|42010717|FG005|Period 3|Adverse Event|0|||
19562977|NCT01294553|42010728|FG000|Overall Study|Duplicated Participants|1|||
19562978|NCT01294553|42010728|FG000|Overall Study|Protocol Violation|268|||
19562979|NCT01294397|42010733|FG000|Overall Study|Withdrawal by Subject|1|||
19562980|NCT01294397|42010733|FG000|Overall Study|Administrative Decision|1|||
19562981|NCT01293695|42010741|FG000|Overall Study|Withdrawal by Subject|7|||
19562982|NCT01293695|42010742|FG001|Overall Study|Withdrawal by Subject|1|||
19562983|NCT01293695|42010741|FG000|Overall Study|Lost to Follow-up|8|||
19562984|NCT01293695|42010742|FG001|Overall Study|Lost to Follow-up|6|||
19562985|NCT01293539|42010751|FG000|Overall Study|Physician Decision|1|||
19562986|NCT01292837|42010755|FG000|Overall Study|Adverse Event|1|||
19562987|NCT01292837|42010755|FG000|Overall Study|Further treatment determined|1|||
19562988|NCT00965731|42010761|FG000|Overall Study|Death|0|||
19562989|NCT00965731|42010762|FG001|Overall Study|Death|4|||
19562990|NCT00965731|42010761|FG000|Overall Study|Withdrawal by Subject|0|||
19562991|NCT00965731|42010762|FG001|Overall Study|Withdrawal by Subject|1|||
19562992|NCT00965731|42010761|FG000|Overall Study|Other|7|||
19562993|NCT00965731|42010762|FG001|Overall Study|Other|15|||
19562994|NCT00965575|42010775|FG000|Overall Study|subject unwillingness to swallow study c|1|||
19562995|NCT00965575|42010776|FG001|Overall Study|subject unwillingness to swallow study c|0|||
19562996|NCT00965497|42010784|FG000|Overall Study|Physician Decision|1|||
19562997|NCT00963937|42010791|FG000|Overall Study|Protocol Violation|1|||
19562998|NCT00963937|42010792|FG001|Overall Study|Protocol Violation|1|||
19562999|NCT00963937|42010793|FG002|Overall Study|Protocol Violation|0|||
19563000|NCT00963937|42010791|FG000|Overall Study|Physician Decision|18|||
19563001|NCT00963937|42010792|FG001|Overall Study|Physician Decision|10|||
19563002|NCT00963937|42010793|FG002|Overall Study|Physician Decision|4|||
19563003|NCT01170663|42010806|FG000|Overall Study|Lost to Follow-up|3|||
19563004|NCT01170663|42010807|FG001|Overall Study|Lost to Follow-up|9|||
19563005|NCT01170663|42010806|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
19563006|NCT01170663|42010807|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
19563007|NCT01170273|42010815|FG000|Overall Study|Lost to Follow-up|6|||
19563008|NCT01170273|42010816|FG001|Overall Study|Lost to Follow-up|8|||
19563009|NCT01170273|42010815|FG000|Overall Study|Protocol Violation|1|||
19563010|NCT01170273|42010816|FG001|Overall Study|Protocol Violation|0|||
19563011|NCT01170273|42010815|FG000|Overall Study|Death|1|||
19563012|NCT01170273|42010816|FG001|Overall Study|Death|0|||
19563013|NCT01170273|42010815|FG000|Overall Study|Adverse Event|0|||
19563014|NCT01170273|42010816|FG001|Overall Study|Adverse Event|1|||
19563015|NCT01170039|42010824|FG000|Overall Study|Withdrawal by Subject|5|||
19563016|NCT01170039|42010825|FG001|Overall Study|Withdrawal by Subject|3|||
19563017|NCT01170039|42010824|FG000|Overall Study|Lack of funding, drug not available|3|||
19563018|NCT01170039|42010825|FG001|Overall Study|Lack of funding, drug not available|3|||
19563019|NCT01169649|42010831|FG000|Overall Study|Patient Not Treated|3|||
19563020|NCT01169493|42010841|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
19563021|NCT01169493|42010842|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
19563022|NCT01169493|42010843|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
19563023|NCT01169493|42010844|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
19563024|NCT01169493|42010845|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
19563025|NCT01169493|42010846|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
19563026|NCT01169493|42010841|FG000|Period 3 (6 Months)|Adverse Event|0|||
19563027|NCT01169493|42010842|FG001|Period 3 (6 Months)|Adverse Event|1|||
19563028|NCT01169493|42010843|FG002|Period 3 (6 Months)|Adverse Event|0|||
19563029|NCT01169493|42010844|FG003|Period 3 (6 Months)|Adverse Event|0|||
19563030|NCT01169493|42010845|FG004|Period 3 (6 Months)|Adverse Event|0|||
19563031|NCT01169493|42010846|FG005|Period 3 (6 Months)|Adverse Event|0|||
19563032|NCT01169493|42010841|FG000|Period 3 (6 Months)|Physician Decision|0|||
19563033|NCT01169493|42010842|FG001|Period 3 (6 Months)|Physician Decision|1|||
19563034|NCT01169493|42010843|FG002|Period 3 (6 Months)|Physician Decision|1|||
19563035|NCT01169493|42010844|FG003|Period 3 (6 Months)|Physician Decision|0|||
19563036|NCT01169493|42010845|FG004|Period 3 (6 Months)|Physician Decision|0|||
19563037|NCT01169493|42010846|FG005|Period 3 (6 Months)|Physician Decision|0|||
19563038|NCT01287104|42010858|FG000|Overall Study|Patient developed progressive disease|1|||
19390373|NCT01987960|41634113|FG003|Period 3|Withdrawal by Subject|9|||
19563039|NCT01287104|42010859|FG001|Overall Study|Patient developed progressive disease|1|||
19563040|NCT01287104|42010860|FG002|Overall Study|Patient developed progressive disease|3|||
19563041|NCT01287104|42010861|FG003|Overall Study|Patient developed progressive disease|2|||
19563042|NCT01287104|42010858|FG000|Overall Study|Donor anaphylaxis|0|||
19563043|NCT01287104|42010859|FG001|Overall Study|Donor anaphylaxis|1|||
19563044|NCT01287104|42010860|FG002|Overall Study|Donor anaphylaxis|0|||
19563045|NCT01287104|42010861|FG003|Overall Study|Donor anaphylaxis|1|||
19563046|NCT01287104|42010858|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
19563047|NCT01287104|42010859|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
19563048|NCT01287104|42010860|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
19563049|NCT01287104|42010861|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
19563050|NCT01287104|42010858|FG000|Overall Study|Low donor chimerism|0|||
19563051|NCT01287104|42010859|FG001|Overall Study|Low donor chimerism|1|||
19563052|NCT01287104|42010860|FG002|Overall Study|Low donor chimerism|0|||
19563053|NCT01287104|42010861|FG003|Overall Study|Low donor chimerism|0|||
19563054|NCT01287104|42010858|FG000|Overall Study|NK cells did not meet release criteria|0|||
19563055|NCT01287104|42010859|FG001|Overall Study|NK cells did not meet release criteria|1|||
19563056|NCT01287104|42010860|FG002|Overall Study|NK cells did not meet release criteria|0|||
19563057|NCT01287104|42010861|FG003|Overall Study|NK cells did not meet release criteria|0|||
19563058|NCT01286558|42010880|FG000|Overall Study|Adverse Event|1|||
19563059|NCT01286558|42010881|FG001|Overall Study|Adverse Event|1|||
19563060|NCT01286558|42010880|FG000|Overall Study|Withdrawal by Subject|0|||
19563061|NCT01286558|42010881|FG001|Overall Study|Withdrawal by Subject|1|||
19563062|NCT01169103|42010889|FG000|Overall Study|Lost to Follow-up|3|||
19563063|NCT01169103|42010890|FG001|Overall Study|Lost to Follow-up|3|||
19563064|NCT01169103|42010889|FG000|Overall Study|Withdrawal by Subject|3|||
19563065|NCT01169103|42010890|FG001|Overall Study|Withdrawal by Subject|1|||
19563066|NCT01286480|42010898|FG000|Overall Study|Withdrawal by Subject|5|||
19563067|NCT01286480|42010899|FG001|Overall Study|Withdrawal by Subject|3|||
19563068|NCT01286168|42010905|FG000|Overall Study|Withdrawal by Subject|1|||
19563069|NCT01286168|42010905|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
19563070|NCT01286012|42010912|FG000|Overall Study|Adverse Event|3|||
19563071|NCT01286012|42010913|FG001|Overall Study|Adverse Event|3|||
19563072|NCT01286012|42010912|FG000|Overall Study|Death|2|||
19563073|NCT01286012|42010913|FG001|Overall Study|Death|3|||
19563074|NCT01286012|42010912|FG000|Overall Study|Protocol Violation|1|||
19563075|NCT01286012|42010913|FG001|Overall Study|Protocol Violation|1|||
19563076|NCT01286012|42010912|FG000|Overall Study|Withdrawal by Subject|4|||
19563077|NCT01286012|42010913|FG001|Overall Study|Withdrawal by Subject|4|||
19563078|NCT01286012|42010912|FG000|Overall Study|Physician Decision|2|||
19563079|NCT01286012|42010913|FG001|Overall Study|Physician Decision|0|||
19563080|NCT01286012|42010912|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
19563081|NCT01286012|42010913|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
19563082|NCT00963547|42010924|FG000|Overall Study|Adverse Event|0|||
19563083|NCT00963547|42010925|FG001|Overall Study|Adverse Event|1|||
19563084|NCT00963547|42010926|FG002|Overall Study|Adverse Event|0|||
19563085|NCT00963547|42010927|FG003|Overall Study|Adverse Event|1|||
19563086|NCT00963547|42010928|FG004|Overall Study|Adverse Event|0|||
19563087|NCT00963547|42010929|FG005|Overall Study|Adverse Event|0|||
19563088|NCT00963547|42010930|FG006|Overall Study|Adverse Event|0|||
19563089|NCT00963547|42010924|FG000|Overall Study|Physician Decision|1|||
19563090|NCT00963547|42010925|FG001|Overall Study|Physician Decision|1|||
19563091|NCT00963547|42010926|FG002|Overall Study|Physician Decision|0|||
19563092|NCT00963547|42010927|FG003|Overall Study|Physician Decision|0|||
19563093|NCT00963547|42010928|FG004|Overall Study|Physician Decision|0|||
19563094|NCT00963547|42010929|FG005|Overall Study|Physician Decision|0|||
19563095|NCT00963547|42010930|FG006|Overall Study|Physician Decision|0|||
19563096|NCT00963547|42010924|FG000|Overall Study|Progressive Disease|3|||
19563097|NCT00963547|42010925|FG001|Overall Study|Progressive Disease|8|||
19563098|NCT00963547|42010926|FG002|Overall Study|Progressive Disease|9|||
19563099|NCT00963547|42010927|FG003|Overall Study|Progressive Disease|5|||
19563100|NCT00963547|42010928|FG004|Overall Study|Progressive Disease|0|||
19563101|NCT00963547|42010929|FG005|Overall Study|Progressive Disease|0|||
19563102|NCT00963547|42010930|FG006|Overall Study|Progressive Disease|0|||
19563103|NCT00963547|42010924|FG000|Overall Study|Withdrawal by Subject|0|||
19563104|NCT00963547|42010925|FG001|Overall Study|Withdrawal by Subject|0|||
19563105|NCT00963547|42010926|FG002|Overall Study|Withdrawal by Subject|3|||
19563106|NCT00963547|42010927|FG003|Overall Study|Withdrawal by Subject|0|||
19563107|NCT00963547|42010928|FG004|Overall Study|Withdrawal by Subject|0|||
19563108|NCT00963547|42010929|FG005|Overall Study|Withdrawal by Subject|0|||
19563109|NCT00963547|42010930|FG006|Overall Study|Withdrawal by Subject|0|||
19563110|NCT00963547|42010924|FG000|Overall Study|Reason Unknown|0|||
19563111|NCT00963547|42010925|FG001|Overall Study|Reason Unknown|1|||
19563112|NCT00963547|42010926|FG002|Overall Study|Reason Unknown|0|||
19563113|NCT00963547|42010927|FG003|Overall Study|Reason Unknown|0|||
19563114|NCT00963547|42010928|FG004|Overall Study|Reason Unknown|0|||
19563115|NCT00963547|42010929|FG005|Overall Study|Reason Unknown|0|||
19563116|NCT00963547|42010930|FG006|Overall Study|Reason Unknown|0|||
19563117|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
19563118|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
19563119|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
19563120|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
19563121|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
19563122|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
19563123|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
19563124|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
19563125|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
19563126|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
19563127|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
19563128|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
19563129|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
19563130|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
19563131|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
19563132|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
19563133|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
19563134|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
19563135|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
19563136|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
19563137|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
19563138|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
19563139|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
19563140|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
19563141|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
19563142|NCT01285310|42010946|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
19563143|NCT01285310|42010947|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
19563144|NCT01285310|42010948|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
19563145|NCT01285310|42010949|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
19563146|NCT01285310|42010950|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
19563147|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
19563148|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
19563149|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
19563150|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
19563151|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
19563152|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
19563153|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
19563154|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
19563155|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
19563156|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
19563157|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
19563158|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
19563159|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
19563160|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
19563161|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
19563162|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
19563163|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
19563164|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
19563165|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
19563166|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
19563167|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
19563168|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
19563169|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
19563170|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
19563171|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
19563172|NCT01285310|42010946|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
19563173|NCT01285310|42010947|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
19563174|NCT01285310|42010948|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
19563175|NCT01285310|42010949|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
19563176|NCT01285310|42010950|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
19563177|NCT01254630|42010992|FG000|Overall Study|Adverse Event|36|||
19563178|NCT01254630|42010993|FG001|Overall Study|Adverse Event|15|||
19563179|NCT01254630|42010994|FG002|Overall Study|Adverse Event|40|||
19740061|NCT00094835|42187012|FG004|Overall Study|Non-compliance|2|||
19563180|NCT01254630|42010995|FG003|Overall Study|Adverse Event|8|||
19563181|NCT01254630|42010992|FG000|Overall Study|Death|461|||
19563182|NCT01254630|42010993|FG001|Overall Study|Death|151|||
19563183|NCT01254630|42010994|FG002|Overall Study|Death|478|||
19563184|NCT01254630|42010995|FG003|Overall Study|Death|139|||
19563185|NCT01254630|42010992|FG000|Overall Study|Lost to Follow-up|80|||
19563186|NCT01254630|42010993|FG001|Overall Study|Lost to Follow-up|26|||
19563187|NCT01254630|42010994|FG002|Overall Study|Lost to Follow-up|89|||
19563188|NCT01254630|42010995|FG003|Overall Study|Lost to Follow-up|32|||
19563189|NCT01254630|42010992|FG000|Overall Study|Physician Decision|24|||
19563190|NCT01254630|42010993|FG001|Overall Study|Physician Decision|8|||
19563191|NCT01254630|42010994|FG002|Overall Study|Physician Decision|16|||
19563192|NCT01254630|42010995|FG003|Overall Study|Physician Decision|7|||
19563193|NCT01254630|42010992|FG000|Overall Study|Withdrawal by Subject|201|||
19563194|NCT01254630|42010993|FG001|Overall Study|Withdrawal by Subject|94|||
19563195|NCT01254630|42010994|FG002|Overall Study|Withdrawal by Subject|188|||
19563196|NCT01254630|42010995|FG003|Overall Study|Withdrawal by Subject|89|||
19563197|NCT01254630|42010992|FG000|Overall Study|Study terminated by sponsor|0|||
19563198|NCT01254630|42010993|FG001|Overall Study|Study terminated by sponsor|994|||
19563199|NCT01254630|42010994|FG002|Overall Study|Study terminated by sponsor|0|||
19563200|NCT01254630|42010995|FG003|Overall Study|Study terminated by sponsor|1010|||
19563201|NCT01254630|42010992|FG000|Overall Study|Status not recorded|0|||
19563202|NCT01254630|42010993|FG001|Overall Study|Status not recorded|0|||
19563203|NCT01254630|42010994|FG002|Overall Study|Status not recorded|1|||
19563204|NCT01254630|42010995|FG003|Overall Study|Status not recorded|0|||
19563205|NCT01284140|42011005|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
19563206|NCT01284140|42011006|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
19563207|NCT01284140|42011005|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
19563208|NCT01284140|42011006|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
19563209|NCT01254318|42011012|FG000|Overall Study|Lost to Follow-up|5|||
19563210|NCT01254318|42011012|FG000|Overall Study|Death|47|||
19563211|NCT01284062|42011020|FG000|Overall Study|Adverse Event|4|||
19563212|NCT01284062|42011021|FG001|Overall Study|Adverse Event|5|||
19563213|NCT01284062|42011022|FG002|Overall Study|Adverse Event|0|||
19563214|NCT01284062|42011023|FG003|Overall Study|Adverse Event|5|||
19563215|NCT01284062|42011020|FG000|Overall Study|Lack of Efficacy|3|||
19563216|NCT01284062|42011021|FG001|Overall Study|Lack of Efficacy|2|||
19563217|NCT01284062|42011022|FG002|Overall Study|Lack of Efficacy|2|||
19563218|NCT01284062|42011023|FG003|Overall Study|Lack of Efficacy|1|||
19563219|NCT01284062|42011020|FG000|Overall Study|Medication error without adverse event|0|||
19563220|NCT01284062|42011021|FG001|Overall Study|Medication error without adverse event|0|||
19563221|NCT01284062|42011022|FG002|Overall Study|Medication error without adverse event|1|||
19563222|NCT01284062|42011023|FG003|Overall Study|Medication error without adverse event|0|||
19563223|NCT01284062|42011020|FG000|Overall Study|Protocol Violation|1|||
19563224|NCT01284062|42011021|FG001|Overall Study|Protocol Violation|0|||
19563225|NCT01284062|42011022|FG002|Overall Study|Protocol Violation|0|||
19563226|NCT01284062|42011023|FG003|Overall Study|Protocol Violation|2|||
19563227|NCT01284062|42011020|FG000|Overall Study|Withdrawal by Subject|3|||
19563228|NCT01284062|42011021|FG001|Overall Study|Withdrawal by Subject|1|||
19563229|NCT01284062|42011022|FG002|Overall Study|Withdrawal by Subject|2|||
19563230|NCT01284062|42011023|FG003|Overall Study|Withdrawal by Subject|5|||
19563231|NCT01284062|42011020|FG000|Overall Study|Other|0|||
19563232|NCT01284062|42011021|FG001|Overall Study|Other|0|||
19563233|NCT01284062|42011022|FG002|Overall Study|Other|0|||
19563234|NCT01284062|42011023|FG003|Overall Study|Other|1|||
19563235|NCT01284062|42011020|FG000|Overall Study|Site Closed|0|||
19563236|NCT01284062|42011021|FG001|Overall Study|Site Closed|0|||
19563237|NCT01284062|42011022|FG002|Overall Study|Site Closed|1|||
19563238|NCT01284062|42011023|FG003|Overall Study|Site Closed|0|||
19563239|NCT01253304|42011040|FG000|Overall Study|Adverse Event|0|||
19563240|NCT01253304|42011041|FG001|Overall Study|Adverse Event|0|||
19563241|NCT01253304|42011042|FG002|Overall Study|Adverse Event|0|||
19563242|NCT01253304|42011043|FG003|Overall Study|Adverse Event|1|||
19563243|NCT01253226|42011058|FG000|Overall Study|Adverse Event|0|||
19563244|NCT01253226|42011059|FG001|Overall Study|Adverse Event|0|||
19563245|NCT01253226|42011060|FG002|Overall Study|Adverse Event|1|||
19563246|NCT01253226|42011061|FG003|Overall Study|Adverse Event|0|||
19563247|NCT01253226|42011062|FG004|Overall Study|Adverse Event|0|||
19563248|NCT01253226|42011058|FG000|Overall Study|Death|0|||
19563249|NCT01253226|42011059|FG001|Overall Study|Death|1|||
19563250|NCT01253226|42011060|FG002|Overall Study|Death|0|||
19563251|NCT01253226|42011061|FG003|Overall Study|Death|0|||
19563252|NCT01253226|42011062|FG004|Overall Study|Death|0|||
19563253|NCT01253226|42011058|FG000|Overall Study|Physician Decision|0|||
19563254|NCT01253226|42011059|FG001|Overall Study|Physician Decision|0|||
19563255|NCT01253226|42011060|FG002|Overall Study|Physician Decision|0|||
19563256|NCT01253226|42011061|FG003|Overall Study|Physician Decision|0|||
19563257|NCT01253226|42011062|FG004|Overall Study|Physician Decision|2|||
19563258|NCT01253226|42011058|FG000|Overall Study|Withdrawal by Subject|0|||
19563259|NCT01253226|42011059|FG001|Overall Study|Withdrawal by Subject|0|||
19563260|NCT01253226|42011060|FG002|Overall Study|Withdrawal by Subject|0|||
19563261|NCT01253226|42011061|FG003|Overall Study|Withdrawal by Subject|1|||
19740062|NCT00094835|42187013|FG005|Overall Study|Non-compliance|2|||
19563262|NCT01253226|42011062|FG004|Overall Study|Withdrawal by Subject|0|||
19563263|NCT01252290|42011074|FG000|Overall Study|Withdrawal by Subject|1|||
19563264|NCT01252134|42011078|FG000|Period 1, 8 Hours|Personal Reasons|0|||
19563265|NCT01252134|42011079|FG001|Period 1, 8 Hours|Personal Reasons|1|||
19563266|NCT01252134|42011080|FG002|Period 1, 8 Hours|Personal Reasons|1|||
19563267|NCT01252134|42011081|FG003|Period 1, 8 Hours|Personal Reasons|0|||
19563268|NCT01252134|42011082|FG004|Period 1, 8 Hours|Personal Reasons|0|||
19563269|NCT01252134|42011083|FG005|Period 1, 8 Hours|Personal Reasons|0|||
19563270|NCT01251744|42011093|FG000|Overall Study|Lost to Follow-up|1|||
19563271|NCT01251744|42011094|FG001|Overall Study|Lost to Follow-up|0|||
19563272|NCT01251354|42011107|FG000|Overall Study|Adverse Event|1|||
19563273|NCT01251354|42011107|FG000|Overall Study|Investigator's Decision|1|||
19563274|NCT01251354|42011107|FG000|Overall Study|Disease Progression|4|||
19563275|NCT01251276|42011113|FG000|Overall Study|Protocol Violation|1|||
19563276|NCT01251276|42011114|FG001|Overall Study|Protocol Violation|0|||
19563277|NCT01251276|42011113|FG000|Overall Study|Lost to Follow-up|0|||
19563278|NCT01251276|42011114|FG001|Overall Study|Lost to Follow-up|1|||
19563279|NCT01251120|42011122|FG000|Overall Study|Lack of Efficacy|0|||
19563280|NCT01251120|42011123|FG001|Overall Study|Lack of Efficacy|1|||
19563281|NCT01250418|42011131|FG000|Overall Study|monitor data failure|1|||
19563282|NCT01250418|42011132|FG001|Overall Study|monitor data failure|1|||
19563283|NCT01292603|42011143|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
19563284|NCT01292603|42011144|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
19563285|NCT01292603|42011145|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
19563286|NCT01292603|42011146|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
19563287|NCT01292603|42011147|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
19563288|NCT01292603|42011148|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
19563289|NCT01292603|42011143|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
19563290|NCT01292603|42011144|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
19563291|NCT01292603|42011145|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
19563292|NCT01292603|42011146|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
19563293|NCT01292603|42011147|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
19563294|NCT01292603|42011148|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
19563295|NCT01292603|42011143|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
19563296|NCT01292603|42011144|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
19563297|NCT01292603|42011145|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
19563298|NCT01292603|42011146|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
19563299|NCT01292603|42011147|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
19563300|NCT01292603|42011148|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
19563301|NCT01292603|42011143|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
19563302|NCT01292603|42011144|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
19563303|NCT01292603|42011145|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
19563304|NCT01292603|42011146|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
19563305|NCT01292603|42011147|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
19563306|NCT01292603|42011148|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
19563307|NCT01292603|42011143|FG000|Part 1: Regular Follow-Up Period|Death|3|||
19563308|NCT01292603|42011144|FG001|Part 1: Regular Follow-Up Period|Death|1|||
19563309|NCT01292603|42011145|FG002|Part 1: Regular Follow-Up Period|Death|3|||
19563310|NCT01292603|42011146|FG003|Part 1: Regular Follow-Up Period|Death|1|||
19563311|NCT01292603|42011147|FG004|Part 1: Regular Follow-Up Period|Death|0|||
19563312|NCT01292603|42011148|FG005|Part 1: Regular Follow-Up Period|Death|0|||
19563313|NCT01292603|42011143|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
19563314|NCT01292603|42011144|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
19563315|NCT01292603|42011145|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
19563316|NCT01292603|42011146|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
19382248|NCT02646891|41625496|FG006|Overall Study|Withdrawal by Subject|5|||
19382249|NCT02646891|41625497|FG007|Overall Study|Withdrawal by Subject|9|||
19563317|NCT01292603|42011147|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
19563318|NCT01292603|42011148|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
19563319|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Death|0|||
19563320|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Death|0|||
19563321|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Death|0|||
19563322|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Death|0|||
19563323|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Death|1|||
19563324|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Death|0|||
19563325|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
19563326|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
19563327|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
19563328|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
19563329|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
19563330|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
19563331|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
19563332|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
19563333|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
19563334|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
19563335|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
19563336|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
19563337|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
19563338|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
19563339|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
19563340|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
19563341|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
19563342|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
19563343|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
19563344|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
19563345|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
19563346|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
19563347|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
19563348|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
19563349|NCT01292603|42011143|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
19563350|NCT01292603|42011144|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
19563351|NCT01292603|42011145|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
19563352|NCT01292603|42011146|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
19563353|NCT01292603|42011147|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
19563354|NCT01292603|42011148|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
19563355|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Death|0|||
19563356|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Death|0|||
19563357|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Death|0|||
19563358|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Death|0|||
19563359|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Death|6|||
19563360|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Death|3|||
19563361|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
19563362|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
19563363|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
19563364|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
19563365|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
19563366|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
19563367|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
19563368|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
19563369|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
19563370|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
19563371|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
19563372|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
19563373|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
19563374|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
19563375|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
19563376|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
19563377|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
19563378|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
19563379|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
19563380|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
19563381|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
19563382|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
19563383|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
19563384|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
19563385|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
19563386|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
19563387|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
19563388|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
19563389|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
19563390|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
19563391|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
19563392|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
19563393|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
19563394|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
19563395|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
19563396|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
19563397|NCT01292603|42011143|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
19563398|NCT01292603|42011144|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
19563399|NCT01292603|42011145|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
19563400|NCT01292603|42011146|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
19563401|NCT01292603|42011147|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
19563402|NCT01292603|42011148|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
19563403|NCT01292603|42011143|FG000|Overall Survival Status|Death|3|||
19563404|NCT01292603|42011144|FG001|Overall Survival Status|Death|1|||
19563405|NCT01292603|42011145|FG002|Overall Survival Status|Death|3|||
19563406|NCT01292603|42011146|FG003|Overall Survival Status|Death|1|||
19563407|NCT01292603|42011147|FG004|Overall Survival Status|Death|16|||
19563408|NCT01292603|42011148|FG005|Overall Survival Status|Death|10|||
19563409|NCT01292057|42011171|FG000|Overall Study|Protocol Violation|1|||
19563410|NCT01292057|42011172|FG001|Overall Study|Protocol Violation|1|||
19563411|NCT01292057|42011171|FG000|Overall Study|Lost to Follow-up|1|||
19563412|NCT01292057|42011172|FG001|Overall Study|Lost to Follow-up|1|||
19563413|NCT01291277|42011180|FG000|Overall Study|Death|2|||
19563414|NCT01291277|42011181|FG001|Overall Study|Death|2|||
19563415|NCT01291277|42011180|FG000|Overall Study|Lost to Follow-up|3|||
19563416|NCT01291277|42011181|FG001|Overall Study|Lost to Follow-up|1|||
19563417|NCT01290887|42011189|FG000|Overall Study|Adverse Event|6|||
19563418|NCT01290887|42011190|FG001|Overall Study|Adverse Event|11|||
19563419|NCT01290887|42011189|FG000|Overall Study|Lack of Efficacy|4|||
19563420|NCT01290887|42011190|FG001|Overall Study|Lack of Efficacy|5|||
19563421|NCT01290887|42011189|FG000|Overall Study|Withdrawal by Subject|26|||
19563422|NCT01290887|42011190|FG001|Overall Study|Withdrawal by Subject|32|||
19563423|NCT01290887|42011189|FG000|Overall Study|Protocol Violation|2|||
19563424|NCT01290887|42011190|FG001|Overall Study|Protocol Violation|1|||
19563425|NCT01290887|42011189|FG000|Overall Study|Lost to Follow-up|4|||
19563426|NCT01290887|42011190|FG001|Overall Study|Lost to Follow-up|4|||
19563427|NCT01290887|42011189|FG000|Overall Study|Non-compliance to study procedures|0|||
19563428|NCT01290887|42011190|FG001|Overall Study|Non-compliance to study procedures|1|||
19563429|NCT01290887|42011189|FG000|Overall Study|Non-compliance to study medications|1|||
19563430|NCT01290887|42011190|FG001|Overall Study|Non-compliance to study medications|0|||
19563431|NCT01290887|42011189|FG000|Overall Study|Sponsor closure of study|420|||
19563432|NCT01290887|42011190|FG001|Overall Study|Sponsor closure of study|476|||
19563433|NCT01290887|42011189|FG000|Overall Study|Other|3|||
19563434|NCT01290887|42011190|FG001|Overall Study|Other|6|||
19563435|NCT01290731|42011196|FG000|Overall Study|Withdrawal by Subject|1|||
19563436|NCT01290341|42011202|FG000|Overall Study|Protocol Violation|7|||
19563437|NCT01290341|42011203|FG001|Overall Study|Protocol Violation|3|||
19563438|NCT01290341|42011202|FG000|Overall Study|Adverse Event|1|||
19563439|NCT01290341|42011203|FG001|Overall Study|Adverse Event|0|||
19563440|NCT01290341|42011202|FG000|Overall Study|Lost to Follow-up|21|||
19563441|NCT01290341|42011203|FG001|Overall Study|Lost to Follow-up|10|||
19563442|NCT01290341|42011202|FG000|Overall Study|Withdrawal by Subject|19|||
19563443|NCT01290341|42011203|FG001|Overall Study|Withdrawal by Subject|5|||
19563444|NCT01290341|42011202|FG000|Overall Study|Negative baseline culture and others|44|||
19563445|NCT01290341|42011203|FG001|Overall Study|Negative baseline culture and others|11|||
19563446|NCT01290263|42011211|FG000|Overall Study|Adverse Event|0|||
19563447|NCT01290263|42011212|FG001|Overall Study|Adverse Event|0|||
19563448|NCT01290263|42011213|FG002|Overall Study|Adverse Event|0|||
19563449|NCT01290263|42011214|FG003|Overall Study|Adverse Event|1|||
19563450|NCT01290263|42011215|FG004|Overall Study|Adverse Event|1|||
19563451|NCT01290263|42011211|FG000|Overall Study|Lack of Efficacy|8|||
19563452|NCT01290263|42011212|FG001|Overall Study|Lack of Efficacy|2|||
19563453|NCT01290263|42011213|FG002|Overall Study|Lack of Efficacy|7|||
19563454|NCT01290263|42011214|FG003|Overall Study|Lack of Efficacy|24|||
19563455|NCT01290263|42011215|FG004|Overall Study|Lack of Efficacy|33|||
19563456|NCT01290263|42011211|FG000|Overall Study|Withdrawal by Subject|3|||
19563457|NCT01290263|42011212|FG001|Overall Study|Withdrawal by Subject|1|||
19563458|NCT01290263|42011213|FG002|Overall Study|Withdrawal by Subject|0|||
19563459|NCT01290263|42011214|FG003|Overall Study|Withdrawal by Subject|1|||
19563460|NCT01290263|42011215|FG004|Overall Study|Withdrawal by Subject|2|||
19563461|NCT01290263|42011211|FG000|Overall Study|Participant Non-Compliance|0|||
19563462|NCT01290263|42011212|FG001|Overall Study|Participant Non-Compliance|0|||
19563463|NCT01290263|42011213|FG002|Overall Study|Participant Non-Compliance|0|||
19563464|NCT01290263|42011214|FG003|Overall Study|Participant Non-Compliance|1|||
19740063|NCT00094835|42187014|FG006|Overall Study|Non-compliance|1|||
19740064|NCT00094835|42187008|FG000|Overall Study|Other|1|||
19563465|NCT01290263|42011215|FG004|Overall Study|Participant Non-Compliance|1|||
19563466|NCT01290029|42011223|FG000|Overall Study|Other|2|||
19563467|NCT01289639|42011230|FG000|Overall Study|Lost to Follow-up|1|||
19563468|NCT01289639|42011231|FG001|Overall Study|Lost to Follow-up|0|||
19563469|NCT01289639|42011232|FG002|Overall Study|Lost to Follow-up|0|||
19563470|NCT01289015|42011242|FG000|Overall Study|Protocol Violation|12|||
19563471|NCT01289015|42011243|FG001|Overall Study|Protocol Violation|9|||
19563472|NCT01289015|42011242|FG000|Overall Study|Adverse Event|3|||
19563473|NCT01289015|42011243|FG001|Overall Study|Adverse Event|0|||
19563474|NCT01289015|42011242|FG000|Overall Study|Lost to Follow-up|33|||
19563475|NCT01289015|42011243|FG001|Overall Study|Lost to Follow-up|17|||
19563476|NCT01289015|42011242|FG000|Overall Study|Withdrawal by Subject|17|||
19563477|NCT01289015|42011243|FG001|Overall Study|Withdrawal by Subject|8|||
19563478|NCT01289015|42011242|FG000|Overall Study|Disease progression|1|||
19563479|NCT01289015|42011243|FG001|Overall Study|Disease progression|0|||
19563480|NCT01289015|42011242|FG000|Overall Study|Negative baseline culture and others|33|||
19563481|NCT01289015|42011243|FG001|Overall Study|Negative baseline culture and others|20|||
19563482|NCT01288937|42011251|FG000|Overall Study|Adverse Event|1|||
19563483|NCT01288937|42011252|FG001|Overall Study|Adverse Event|0|||
19563484|NCT01288469|42011261|FG000|Overall Study|Adverse Event|4|||
19563485|NCT01288469|42011262|FG001|Overall Study|Adverse Event|1|||
19563486|NCT01288469|42011263|FG002|Overall Study|Adverse Event|1|||
19563487|NCT01288469|42011261|FG000|Overall Study|Poor compliance to protocol|0|||
19563488|NCT01288469|42011262|FG001|Overall Study|Poor compliance to protocol|1|||
19563489|NCT01288469|42011263|FG002|Overall Study|Poor compliance to protocol|0|||
19740065|NCT00094835|42187009|FG001|Overall Study|Other|1|||
19563490|NCT01288469|42011261|FG000|Overall Study|Participant Moved|1|||
19563491|NCT01288469|42011262|FG001|Overall Study|Participant Moved|0|||
19563492|NCT01288469|42011263|FG002|Overall Study|Participant Moved|0|||
19563493|NCT01288469|42011261|FG000|Overall Study|Consent withdrawn by subject|1|||
19563494|NCT01288469|42011262|FG001|Overall Study|Consent withdrawn by subject|1|||
19563495|NCT01288469|42011263|FG002|Overall Study|Consent withdrawn by subject|1|||
19563496|NCT01288469|42011261|FG000|Overall Study|Exclusion criteria finally met|1|||
19563497|NCT01288469|42011262|FG001|Overall Study|Exclusion criteria finally met|0|||
19563498|NCT01288469|42011263|FG002|Overall Study|Exclusion criteria finally met|0|||
19563499|NCT01288079|42011275|FG000|Overall Study|Withdrawal by Subject|2|||
19563500|NCT01288079|42011276|FG001|Overall Study|Withdrawal by Subject|4|||
19563501|NCT01288079|42011277|FG002|Overall Study|Withdrawal by Subject|1|||
19563502|NCT01288079|42011278|FG003|Overall Study|Withdrawal by Subject|0|||
19563503|NCT01288079|42011275|FG000|Overall Study|Adverse Event|2|||
19563504|NCT01288079|42011276|FG001|Overall Study|Adverse Event|1|||
19563505|NCT01288079|42011277|FG002|Overall Study|Adverse Event|2|||
19563506|NCT01288079|42011278|FG003|Overall Study|Adverse Event|3|||
19563507|NCT01288079|42011275|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
19563508|NCT01288079|42011276|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
19563509|NCT01288079|42011277|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
19563510|NCT01288079|42011278|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
19563511|NCT01288079|42011275|FG000|Overall Study|Condition under Investigation Worsened|0|||
19563512|NCT01288079|42011276|FG001|Overall Study|Condition under Investigation Worsened|0|||
19563513|NCT01288079|42011277|FG002|Overall Study|Condition under Investigation Worsened|0|||
19563514|NCT01288079|42011278|FG003|Overall Study|Condition under Investigation Worsened|1|||
19563515|NCT01288079|42011275|FG000|Overall Study|Lack of Efficacy|2|||
19563516|NCT01288079|42011276|FG001|Overall Study|Lack of Efficacy|2|||
19563517|NCT01288079|42011277|FG002|Overall Study|Lack of Efficacy|0|||
19563518|NCT01288079|42011278|FG003|Overall Study|Lack of Efficacy|2|||
19563519|NCT01288079|42011275|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
19563520|NCT01288079|42011276|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
19563521|NCT01288079|42011277|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
19563522|NCT01288079|42011278|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
19563523|NCT01288079|42011275|FG000|Overall Study|Lost to Follow-up|1|||
19563524|NCT01288079|42011276|FG001|Overall Study|Lost to Follow-up|1|||
19563525|NCT01288079|42011277|FG002|Overall Study|Lost to Follow-up|1|||
19563526|NCT01288079|42011278|FG003|Overall Study|Lost to Follow-up|0|||
19563527|NCT01288079|42011275|FG000|Overall Study|Other or Study Termination|11|||
19563528|NCT01288079|42011276|FG001|Overall Study|Other or Study Termination|15|||
19563529|NCT01288079|42011277|FG002|Overall Study|Other or Study Termination|14|||
19563530|NCT01288079|42011278|FG003|Overall Study|Other or Study Termination|8|||
19563531|NCT01287221|42011290|FG000|Overall Study|Lack of Perceived Benefit|1|||
19563532|NCT01287221|42011291|FG001|Overall Study|Lack of Perceived Benefit|1|||
19563533|NCT01287221|42011290|FG000|Overall Study|Adverse Event|3|||
19563534|NCT01287221|42011291|FG001|Overall Study|Adverse Event|3|||
19563535|NCT01287221|42011290|FG000|Overall Study|Withdrawal by Subject|0|||
19563536|NCT01287221|42011291|FG001|Overall Study|Withdrawal by Subject|1|||
19563537|NCT01168401|42011308|FG000|Overall Study|Lost to Follow-up|1|||
19563538|NCT01168401|42011309|FG001|Overall Study|Lost to Follow-up|1|||
19563539|NCT01168401|42011310|FG002|Overall Study|Lost to Follow-up|2|||
19563540|NCT01168401|42011311|FG003|Overall Study|Lost to Follow-up|1|||
19563541|NCT01168401|42011312|FG004|Overall Study|Lost to Follow-up|0|||
19563542|NCT01168401|42011313|FG005|Overall Study|Lost to Follow-up|0|||
19563543|NCT01168401|42011314|FG006|Overall Study|Lost to Follow-up|0|||
19563544|NCT01168401|42011315|FG007|Overall Study|Lost to Follow-up|0|||
19563545|NCT01168401|42011316|FG008|Overall Study|Lost to Follow-up|0|||
19563546|NCT01168401|42011317|FG009|Overall Study|Lost to Follow-up|0|||
19563547|NCT01168401|42011318|FG010|Overall Study|Lost to Follow-up|0|||
19563548|NCT01168401|42011308|FG000|Overall Study|Withdrawal by Subject|0|||
19563549|NCT01168401|42011309|FG001|Overall Study|Withdrawal by Subject|0|||
19563550|NCT01168401|42011310|FG002|Overall Study|Withdrawal by Subject|0|||
19563551|NCT01168401|42011311|FG003|Overall Study|Withdrawal by Subject|1|||
19563552|NCT01168401|42011312|FG004|Overall Study|Withdrawal by Subject|0|||
19563553|NCT01168401|42011313|FG005|Overall Study|Withdrawal by Subject|0|||
19563554|NCT01168401|42011314|FG006|Overall Study|Withdrawal by Subject|0|||
19563555|NCT01168401|42011315|FG007|Overall Study|Withdrawal by Subject|0|||
19563556|NCT01168401|42011316|FG008|Overall Study|Withdrawal by Subject|0|||
19563557|NCT01168401|42011317|FG009|Overall Study|Withdrawal by Subject|0|||
19563558|NCT01168401|42011318|FG010|Overall Study|Withdrawal by Subject|0|||
19563559|NCT01287065|42011342|FG000|Treatment Period 1|Adverse Event|0|||
19563560|NCT01287065|42011343|FG001|Treatment Period 1|Adverse Event|0|||
19563561|NCT01287065|42011344|FG002|Treatment Period 1|Adverse Event|0|||
19563562|NCT01287065|42011345|FG003|Treatment Period 1|Adverse Event|0|||
19563563|NCT01287065|42011346|FG004|Treatment Period 1|Adverse Event|1|||
19740066|NCT00094835|42187010|FG002|Overall Study|Other|1|||
19563564|NCT01287065|42011347|FG005|Treatment Period 1|Adverse Event|0|||
19563565|NCT01287065|42011342|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19563566|NCT01287065|42011343|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19563567|NCT01287065|42011344|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19563568|NCT01287065|42011345|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19563569|NCT01287065|42011346|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19563570|NCT01287065|42011347|FG005|Treatment Period 1|Withdrawal by Subject|1|||
19563571|NCT01167153|42011357|FG000|Overall Study|Non-effective therapy|1|||
19563572|NCT01167153|42011358|FG001|Overall Study|Non-effective therapy|4|||
19563573|NCT01167153|42011357|FG000|Overall Study|AE including clinical laboratory AE|2|||
19563574|NCT01167153|42011358|FG001|Overall Study|AE including clinical laboratory AE|8|||
19563575|NCT01167153|42011357|FG000|Overall Study|Hypotension|1|||
19563576|NCT01167153|42011358|FG001|Overall Study|Hypotension|0|||
19563577|NCT01167153|42011357|FG000|Overall Study|Lost to Follow-up|7|||
19563578|NCT01167153|42011358|FG001|Overall Study|Lost to Follow-up|9|||
19563579|NCT01167153|42011357|FG000|Overall Study|Non-compliance to concomitant medication|0|||
19563580|NCT01167153|42011358|FG001|Overall Study|Non-compliance to concomitant medication|2|||
19563581|NCT01167153|42011357|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
19563582|NCT01167153|42011358|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
19563583|NCT01167153|42011357|FG000|Overall Study|Withdrawal consent|1|||
19563584|NCT01167153|42011358|FG001|Overall Study|Withdrawal consent|1|||
19563585|NCT01167153|42011357|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
19563586|NCT01167153|42011358|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
19563587|NCT01166763|42011364|FG000|Overall Study|Withdrawal by Subject|3|||
19563588|NCT01166373|42011372|FG000|Overall Study|Lost to Follow-up|3|||
19563589|NCT01166373|42011373|FG001|Overall Study|Lost to Follow-up|2|||
19563590|NCT01166373|42011374|FG002|Overall Study|Lost to Follow-up|2|||
19563591|NCT01166373|42011375|FG003|Overall Study|Lost to Follow-up|2|||
19563592|NCT01166373|42011372|FG000|Overall Study|Withdrawal by Subject|1|||
19563593|NCT01166373|42011373|FG001|Overall Study|Withdrawal by Subject|2|||
19563594|NCT01166373|42011374|FG002|Overall Study|Withdrawal by Subject|2|||
19563595|NCT01166373|42011375|FG003|Overall Study|Withdrawal by Subject|3|||
19563596|NCT01166373|42011372|FG000|Overall Study|Physician Decision|1|||
19563597|NCT01166373|42011373|FG001|Overall Study|Physician Decision|0|||
19563598|NCT01166373|42011374|FG002|Overall Study|Physician Decision|0|||
19563599|NCT01166373|42011375|FG003|Overall Study|Physician Decision|0|||
19563600|NCT00963235|42011387|FG000|Overall Study|Withdrawal by Subject|22|||
19563601|NCT00963235|42011387|FG000|Overall Study|Lost to Follow-up|14|||
19563602|NCT00963235|42011387|FG000|Overall Study|Failed to return|9|||
19563603|NCT00963235|42011387|FG000|Overall Study|Protocol Violation|7|||
19563604|NCT00963235|42011387|FG000|Overall Study|Adverse Event|5|||
19563605|NCT00963235|42011387|FG000|Overall Study|Physician Decision|2|||
19563606|NCT00963235|42011387|FG000|Overall Study|Other|1|||
19563607|NCT01165281|42011396|FG000|Overall Study|Adverse Event|12|||
19740067|NCT00094835|42187011|FG003|Overall Study|Other|1|||
19740068|NCT00094835|42187012|FG004|Overall Study|Other|0|||
19740069|NCT00094835|42187013|FG005|Overall Study|Other|0|||
19740070|NCT00094835|42187014|FG006|Overall Study|Other|0|||
19740071|NCT00094757|42187038|FG000|Overall Study|Adverse Event|11|||
19740072|NCT00094757|42187039|FG001|Overall Study|Adverse Event|9|||
19740073|NCT00094757|42187040|FG002|Overall Study|Adverse Event|6|||
19740074|NCT00094757|42187038|FG000|Overall Study|Lack of Efficacy|11|||
19740075|NCT00094757|42187039|FG001|Overall Study|Lack of Efficacy|15|||
19740076|NCT00094757|42187040|FG002|Overall Study|Lack of Efficacy|8|||
19740077|NCT00094757|42187038|FG000|Overall Study|Lost to Follow-up|3|||
19740078|NCT00094757|42187039|FG001|Overall Study|Lost to Follow-up|5|||
19740079|NCT00094757|42187040|FG002|Overall Study|Lost to Follow-up|6|||
19740080|NCT00094757|42187038|FG000|Overall Study|Patient Moved|2|||
19740081|NCT00094757|42187039|FG001|Overall Study|Patient Moved|1|||
19740082|NCT00094757|42187040|FG002|Overall Study|Patient Moved|1|||
19740083|NCT00094757|42187038|FG000|Overall Study|Protocol Violation|8|||
19740084|NCT00094757|42187039|FG001|Overall Study|Protocol Violation|5|||
19740085|NCT00094757|42187040|FG002|Overall Study|Protocol Violation|3|||
19563608|NCT01165281|42011397|FG001|Overall Study|Adverse Event|14|||
19563609|NCT01165281|42011396|FG000|Overall Study|Death|3|||
19740086|NCT00094757|42187038|FG000|Overall Study|Withdrawal by Subject|14|||
19740087|NCT00094757|42187039|FG001|Overall Study|Withdrawal by Subject|21|||
19740088|NCT00094757|42187040|FG002|Overall Study|Withdrawal by Subject|5|||
19740089|NCT00094757|42187038|FG000|Overall Study|Other|3|||
19740090|NCT00094757|42187039|FG001|Overall Study|Other|3|||
19563610|NCT01165281|42011397|FG001|Overall Study|Death|4|||
19563611|NCT01165281|42011396|FG000|Overall Study|Lack of Efficacy|4|||
19563612|NCT01165281|42011397|FG001|Overall Study|Lack of Efficacy|1|||
19563613|NCT01165281|42011396|FG000|Overall Study|Lost to Follow-up|0|||
19740091|NCT00094757|42187040|FG002|Overall Study|Other|1|||
19563614|NCT01165281|42011397|FG001|Overall Study|Lost to Follow-up|1|||
19563615|NCT01165281|42011396|FG000|Overall Study|Physician Decision|8|||
19563616|NCT01165281|42011397|FG001|Overall Study|Physician Decision|1|||
19740092|NCT00094757|42187038|FG000|Overall Study|Protocol specified discontinuation|1|||
19740093|NCT00094757|42187039|FG001|Overall Study|Protocol specified discontinuation|3|||
19740094|NCT00094757|42187040|FG002|Overall Study|Protocol specified discontinuation|0|||
19740095|NCT00082433|42187050|FG000|Overall Study|Adverse Event|12|||
19740096|NCT00082433|42187051|FG001|Overall Study|Adverse Event|17|||
19740097|NCT00082433|42187050|FG000|Overall Study|Death|8|||
19740098|NCT00082433|42187051|FG001|Overall Study|Death|18|||
19740099|NCT00082433|42187050|FG000|Overall Study|Disease Progression/Relapse|270|||
19740100|NCT00082433|42187051|FG001|Overall Study|Disease Progression/Relapse|388|||
19740101|NCT00082433|42187050|FG000|Overall Study|Physician Decision|50|||
19740102|NCT00082433|42187051|FG001|Overall Study|Physician Decision|61|||
19740103|NCT00082433|42187050|FG000|Overall Study|Lost to Follow-up|1|||
19740104|NCT00082433|42187051|FG001|Overall Study|Lost to Follow-up|2|||
19740105|NCT00082433|42187050|FG000|Overall Study|Study Drug Toxicity|179|||
19740106|NCT00082433|42187051|FG001|Overall Study|Study Drug Toxicity|66|||
19740107|NCT00082433|42187050|FG000|Overall Study|Withdrawal by Subject|55|||
19740108|NCT00082433|42187051|FG001|Overall Study|Withdrawal by Subject|30|||
19740109|NCT00082433|42187050|FG000|Overall Study|Still On Treatment|2|||
19740110|NCT00082433|42187051|FG001|Overall Study|Still On Treatment|1|||
19740111|NCT00082433|42187050|FG000|Overall Study|Not Treated|12|||
19740112|NCT00082433|42187051|FG001|Overall Study|Not Treated|11|||
19740113|NCT00082433|42187050|FG000|Overall Study|Ineligible|2|||
19740114|NCT00082433|42187051|FG001|Overall Study|Ineligible|1|||
19740115|NCT00082433|42187050|FG000|Overall Study|Noncompliance|2|||
19740116|NCT00082433|42187051|FG001|Overall Study|Noncompliance|1|||
19563617|NCT01165281|42011396|FG000|Overall Study|Protocol Violation|6|||
19563618|NCT01165281|42011397|FG001|Overall Study|Protocol Violation|5|||
19563619|NCT01165281|42011396|FG000|Overall Study|Withdrawal by Subject|8|||
19563620|NCT01165281|42011397|FG001|Overall Study|Withdrawal by Subject|7|||
19563621|NCT01165281|42011396|FG000|Overall Study|Noncompliance with Study Drug|1|||
19563622|NCT01165281|42011397|FG001|Overall Study|Noncompliance with Study Drug|4|||
19563623|NCT01165281|42011396|FG000|Overall Study|Progressive Disease|10|||
19563624|NCT01165281|42011397|FG001|Overall Study|Progressive Disease|14|||
19563625|NCT01165281|42011396|FG000|Overall Study|Other|6|||
19563626|NCT01165281|42011397|FG001|Overall Study|Other|0|||
19563627|NCT01165203|42011405|FG000|Active Phase|Serious Adverse Event|1|||
19563628|NCT01165203|42011406|FG001|Active Phase|Serious Adverse Event|0|||
19563629|NCT01165203|42011405|FG000|Active Phase|Withdrawal by Subject|2|||
19563630|NCT01165203|42011406|FG001|Active Phase|Withdrawal by Subject|1|||
19563631|NCT01165203|42011405|FG000|Active Phase|Migrated/moved from study area|0|||
19563632|NCT01165203|42011406|FG001|Active Phase|Migrated/moved from study area|1|||
19563633|NCT01165203|42011405|FG000|Active Phase|Lost to Follow-up|2|||
19563634|NCT01165203|42011406|FG001|Active Phase|Lost to Follow-up|0|||
19563635|NCT01165203|42011405|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
19563636|NCT01165203|42011406|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
19563637|NCT01165203|42011405|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
19563638|NCT01165203|42011406|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
19563639|NCT01165203|42011405|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
19563640|NCT01165203|42011406|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
19740117|NCT00082433|42187050|FG000|Overall Study|New primary cancer|1|||
19740118|NCT00082433|42187051|FG001|Overall Study|New primary cancer|0|||
19740119|NCT00082433|42187050|FG000|Overall Study|Impending surgery|0|||
19740120|NCT00082433|42187051|FG001|Overall Study|Impending surgery|1|||
19740121|NCT00094445|42187057|FG000|Overall Study|Withdrawal by Subject|3|||
19740122|NCT00094445|42187057|FG000|Overall Study|Lost to Follow-up|1|||
19740123|NCT00094445|42187057|FG000|Overall Study|Progressive Disease|2|||
19740124|NCT00082355|42187061|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
19740125|NCT00082355|42187061|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
19740126|NCT00082355|42187061|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
19740127|NCT00094055|42187065|FG000|Overall Study|Adverse Event|11|||
19563641|NCT01165203|42011405|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
19563642|NCT01165203|42011406|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
19563643|NCT01165203|42011405|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
19563644|NCT01165203|42011406|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
19563645|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
19740128|NCT00094055|42187065|FG000|Overall Study|Death|4|||
19740129|NCT00094055|42187065|FG000|Overall Study|Lack of Efficacy|17|||
19740130|NCT00094055|42187065|FG000|Overall Study|Lost to Follow-up|2|||
19740131|NCT00094055|42187065|FG000|Overall Study|progressive disease|2|||
19740132|NCT00094055|42187065|FG000|Overall Study|clinical progression|1|||
19740133|NCT00094055|42187065|FG000|Overall Study|roll-over to another study|14|||
19740134|NCT00094055|42187065|FG000|Overall Study|Withdrawal by Subject|9|||
19740135|NCT00099983|42187071|FG000|Overall Study|Lost to Follow-up|2|||
19740136|NCT00099983|42187072|FG001|Overall Study|Lost to Follow-up|3|||
19740137|NCT00099983|42187071|FG000|Overall Study|Missing Source Documents|14|||
19740138|NCT00099983|42187072|FG001|Overall Study|Missing Source Documents|15|||
19390374|NCT01987960|41634110|FG000|Period 3|Lost to Follow-up|0|||
19563646|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
19563647|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
19563648|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
19563649|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
19563650|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
19563651|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
19563652|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
19563653|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
19563654|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
19563655|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
19563656|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
19563657|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
19563658|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
19563659|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
19563660|NCT00960661|42011421|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
19563661|NCT00960661|42011422|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
19563662|NCT00960661|42011423|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
19563663|NCT00960661|42011421|FG000|Interventional Phase|Adverse Event|0|||
19563664|NCT00960661|42011422|FG001|Interventional Phase|Adverse Event|17|||
19563665|NCT00960661|42011423|FG002|Interventional Phase|Adverse Event|8|||
19563666|NCT00960661|42011421|FG000|Interventional Phase|Death|0|||
19563667|NCT00960661|42011422|FG001|Interventional Phase|Death|1|||
19563668|NCT00960661|42011423|FG002|Interventional Phase|Death|0|||
19563669|NCT00960661|42011421|FG000|Interventional Phase|Lost to Follow-up|0|||
19563670|NCT00960661|42011422|FG001|Interventional Phase|Lost to Follow-up|0|||
19563671|NCT00960661|42011423|FG002|Interventional Phase|Lost to Follow-up|2|||
19563672|NCT00960661|42011421|FG000|Interventional Phase|entry criteria not met|0|||
19563673|NCT00960661|42011422|FG001|Interventional Phase|entry criteria not met|3|||
19563674|NCT00960661|42011423|FG002|Interventional Phase|entry criteria not met|0|||
19563675|NCT00960661|42011421|FG000|Interventional Phase|Protocol Violation|0|||
19563676|NCT00960661|42011422|FG001|Interventional Phase|Protocol Violation|7|||
19563677|NCT00960661|42011423|FG002|Interventional Phase|Protocol Violation|2|||
19563678|NCT00960661|42011421|FG000|Interventional Phase|Withdrawal by Subject|0|||
19563679|NCT00960661|42011422|FG001|Interventional Phase|Withdrawal by Subject|18|||
19563680|NCT00960661|42011423|FG002|Interventional Phase|Withdrawal by Subject|29|||
19563681|NCT00960661|42011421|FG000|Interventional Phase|Physician Decision|0|||
19563682|NCT00960661|42011422|FG001|Interventional Phase|Physician Decision|3|||
19563683|NCT00960661|42011423|FG002|Interventional Phase|Physician Decision|5|||
19563684|NCT00960661|42011421|FG000|Interventional Phase|sponsor decision|0|||
19563685|NCT00960661|42011422|FG001|Interventional Phase|sponsor decision|1|||
19563686|NCT00960661|42011423|FG002|Interventional Phase|sponsor decision|0|||
19563687|NCT00960661|42011421|FG000|Interventional Phase|Lack of Efficacy|0|||
19563688|NCT00960661|42011422|FG001|Interventional Phase|Lack of Efficacy|2|||
19563689|NCT00960661|42011423|FG002|Interventional Phase|Lack of Efficacy|0|||
19563690|NCT00960193|42011429|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
19563691|NCT00960115|42011438|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
19563692|NCT00960115|42011439|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
19563693|NCT00959647|42011445|FG000|Overall Study|Adverse Event|2|||
19563694|NCT00959647|42011445|FG000|Overall Study|Progressive disease|6|||
19563695|NCT00959647|42011445|FG000|Overall Study|Study terminated by sponsor|4|||
19563696|NCT00959647|42011445|FG000|Overall Study|Withdrawal by Subject|7|||
19563697|NCT00957931|42011449|FG000|Overall Study|Death|4|||
19563698|NCT00957853|42011456|FG000|Overall Study|Withdrawal by Subject|1|||
19563699|NCT00957853|42011457|FG001|Overall Study|Withdrawal by Subject|0|||
19563700|NCT00957853|42011458|FG002|Overall Study|Withdrawal by Subject|0|||
19563701|NCT00957229|42011468|FG000|Study Start|Adverse Event|0|||
19563702|NCT00957229|42011469|FG001|Study Start|Adverse Event|3|||
19563703|NCT00957229|42011468|FG000|Study Start|Disease Progression|1|||
19563704|NCT00957229|42011469|FG001|Study Start|Disease Progression|0|||
19563705|NCT00957229|42011468|FG000|Reallocated to or Continued Vismodegib|Death|1|||
19563706|NCT00957229|42011469|FG001|Reallocated to or Continued Vismodegib|Death|1|||
19563707|NCT00957229|42011468|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
19563708|NCT00957229|42011469|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
19563709|NCT02604511|42011475|FG000|Overall Study|Adverse Event|3|||
19563710|NCT02604511|42011475|FG000|Overall Study|Disease Progression|4|||
19563711|NCT02604511|42011475|FG000|Overall Study|Withdrawal by Subject|3|||
19563712|NCT02604511|42011475|FG000|Overall Study|Participant ineligible|1|||
19563713|NCT02604511|42011475|FG000|Overall Study|Intercurrent illness|1|||
19563714|NCT00956839|42011483|FG000|Overall Study|Lost to Follow-up|3|||
19563715|NCT00956839|42011484|FG001|Overall Study|Lost to Follow-up|0|||
19563716|NCT00956839|42011485|FG002|Overall Study|Lost to Follow-up|3|||
19740139|NCT00099983|42187071|FG000|Overall Study|Withdrawal by Subject|3|||
19740140|NCT00099983|42187072|FG001|Overall Study|Withdrawal by Subject|2|||
19740141|NCT00099983|42187071|FG000|Overall Study|Adverse Event|1|||
19740142|NCT00099983|42187072|FG001|Overall Study|Adverse Event|1|||
19740143|NCT00099983|42187071|FG000|Overall Study|Lack of Efficacy|0|||
19740144|NCT00099983|42187072|FG001|Overall Study|Lack of Efficacy|1|||
19740145|NCT00099983|42187071|FG000|Overall Study|Unable to return for appointments|1|||
19563717|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
19563718|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
19563719|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
19563720|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Death|0|||
19563721|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Death|0|||
19563722|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Death|1|||
19563723|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
19563724|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
19563725|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
19563726|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
19563727|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
19563728|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
19563729|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
19563730|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
19563731|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
19563732|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Graft loss|0|||
19563733|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Graft loss|0|||
19563734|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Graft loss|7|||
19563735|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
19563736|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
19563737|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
19563738|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
19563739|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
19563740|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
19563741|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
19563742|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
19563743|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
19563744|NCT00956293|42011495|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
19563745|NCT00956293|42011496|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
19563746|NCT00956293|42011497|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
19563747|NCT00956293|42011495|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
19563748|NCT00956293|42011496|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
19563749|NCT00956293|42011497|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
19563750|NCT00956293|42011495|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
19563751|NCT00956293|42011496|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
19563752|NCT00956293|42011497|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
19563753|NCT00956293|42011495|FG000|Main Period (Randomization)|Adverse Event|0|||
19563754|NCT00956293|42011496|FG001|Main Period (Randomization)|Adverse Event|15|||
19563755|NCT00956293|42011497|FG002|Main Period (Randomization)|Adverse Event|0|||
19563756|NCT00956293|42011495|FG000|Follow-up Period|Follow-up period was terminated.|20|||
19563757|NCT00956293|42011496|FG001|Follow-up Period|Follow-up period was terminated.|32|||
19563758|NCT00956293|42011497|FG002|Follow-up Period|Follow-up period was terminated.|0|||
19563759|NCT00955825|42011505|FG000|Overall Study|Adverse Event|15|||
19563760|NCT00955825|42011506|FG001|Overall Study|Adverse Event|2|||
19563761|NCT00955825|42011505|FG000|Overall Study|Withdrawal by Subject|4|||
19563762|NCT00955825|42011506|FG001|Overall Study|Withdrawal by Subject|6|||
19563763|NCT00955825|42011505|FG000|Overall Study|Any other reason not above-mentioned|7|||
19563764|NCT00955825|42011506|FG001|Overall Study|Any other reason not above-mentioned|9|||
19563765|NCT01164579|42011515|FG000|Overall Study|Lack of Efficacy|0|||
19563766|NCT01164579|42011516|FG001|Overall Study|Lack of Efficacy|0|||
19563767|NCT01164579|42011517|FG002|Overall Study|Lack of Efficacy|6|||
19563768|NCT01164579|42011515|FG000|Overall Study|Lost to Follow-up|1|||
19563769|NCT01164579|42011516|FG001|Overall Study|Lost to Follow-up|1|||
19563770|NCT01164579|42011517|FG002|Overall Study|Lost to Follow-up|0|||
19563771|NCT01164579|42011515|FG000|Overall Study|Withdrawal by Subject|2|||
19563772|NCT01164579|42011516|FG001|Overall Study|Withdrawal by Subject|5|||
19563773|NCT01164579|42011517|FG002|Overall Study|Withdrawal by Subject|3|||
19563774|NCT01164579|42011515|FG000|Overall Study|Protocol Violation|0|||
19563775|NCT01164579|42011516|FG001|Overall Study|Protocol Violation|1|||
19563776|NCT01164579|42011517|FG002|Overall Study|Protocol Violation|2|||
19563777|NCT01164579|42011515|FG000|Overall Study|Adverse Event|4|||
19563778|NCT01164579|42011516|FG001|Overall Study|Adverse Event|2|||
19563779|NCT01164579|42011517|FG002|Overall Study|Adverse Event|5|||
19563780|NCT01164579|42011515|FG000|Overall Study|Reason not specified|1|||
19740146|NCT00099983|42187072|FG001|Overall Study|Unable to return for appointments|1|||
19740147|NCT00099983|42187071|FG000|Overall Study|Moved|1|||
19563781|NCT01164579|42011516|FG001|Overall Study|Reason not specified|0|||
19563782|NCT01164579|42011517|FG002|Overall Study|Reason not specified|0|||
19563783|NCT00958789|42011526|FG000|Overall Study|Death|5|||
19563784|NCT00958789|42011526|FG000|Overall Study|Lost to Follow-up|14|||
19563785|NCT00958789|42011526|FG000|Overall Study|Withdrawal by Subject|17|||
19563786|NCT00958789|42011526|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
19563787|NCT00958789|42011526|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
19563788|NCT00958789|42011526|FG000|Overall Study|Subject terminated|2|||
19563789|NCT00958789|42011526|FG000|Overall Study|Revision|7|||
19563790|NCT02445391|42011537|FG000|Overall Study|No active protocol treatment|3|||
19563791|NCT02445391|42011538|FG001|Overall Study|No active protocol treatment|0|||
19563792|NCT02445391|42011539|FG002|Overall Study|No active protocol treatment|0|||
19563793|NCT02445391|42011537|FG000|Overall Study|Adverse Event|0|||
19563794|NCT02445391|42011538|FG001|Overall Study|Adverse Event|21|||
19563795|NCT02445391|42011539|FG002|Overall Study|Adverse Event|12|||
19563796|NCT02445391|42011537|FG000|Overall Study|Alternative therapy|0|||
19563797|NCT02445391|42011538|FG001|Overall Study|Alternative therapy|0|||
19563798|NCT02445391|42011539|FG002|Overall Study|Alternative therapy|1|||
19563799|NCT02445391|42011537|FG000|Overall Study|Disease progression|0|||
19563800|NCT02445391|42011538|FG001|Overall Study|Disease progression|7|||
19563801|NCT02445391|42011539|FG002|Overall Study|Disease progression|22|||
19563802|NCT02445391|42011537|FG000|Overall Study|Complicating disease|0|||
19563803|NCT02445391|42011538|FG001|Overall Study|Complicating disease|2|||
19563804|NCT02445391|42011539|FG002|Overall Study|Complicating disease|1|||
19563805|NCT02445391|42011537|FG000|Overall Study|Withdrawal by Subject|0|||
19563806|NCT02445391|42011538|FG001|Overall Study|Withdrawal by Subject|4|||
19563807|NCT02445391|42011539|FG002|Overall Study|Withdrawal by Subject|9|||
19563808|NCT02445391|42011537|FG000|Overall Study|Financial issue|0|||
19563809|NCT02445391|42011538|FG001|Overall Study|Financial issue|0|||
19563810|NCT02445391|42011539|FG002|Overall Study|Financial issue|2|||
19563811|NCT02445391|42011537|FG000|Overall Study|Still on treatment|0|||
19563812|NCT02445391|42011538|FG001|Overall Study|Still on treatment|7|||
19563813|NCT02445391|42011539|FG002|Overall Study|Still on treatment|16|||
19563814|NCT02445391|42011537|FG000|Overall Study|Not start protocol therapy|0|||
19563815|NCT02445391|42011538|FG001|Overall Study|Not start protocol therapy|12|||
19563816|NCT02445391|42011539|FG002|Overall Study|Not start protocol therapy|9|||
19563817|NCT01246986|42011555|FG000|Overall Study|Lost to Follow-up|0|||
19563818|NCT01246986|42011556|FG001|Overall Study|Lost to Follow-up|1|||
19563819|NCT01246986|42011557|FG002|Overall Study|Lost to Follow-up|3|||
19563820|NCT01246986|42011558|FG003|Overall Study|Lost to Follow-up|0|||
19563821|NCT01246986|42011559|FG004|Overall Study|Lost to Follow-up|0|||
19563822|NCT01246986|42011560|FG005|Overall Study|Lost to Follow-up|1|||
19563823|NCT01246986|42011561|FG006|Overall Study|Lost to Follow-up|0|||
19563824|NCT01246986|42011555|FG000|Overall Study|Withdrawal by Subject|3|||
19563825|NCT01246986|42011556|FG001|Overall Study|Withdrawal by Subject|4|||
19563826|NCT01246986|42011557|FG002|Overall Study|Withdrawal by Subject|3|||
19563827|NCT01246986|42011558|FG003|Overall Study|Withdrawal by Subject|0|||
19563828|NCT01246986|42011559|FG004|Overall Study|Withdrawal by Subject|4|||
19563829|NCT01246986|42011560|FG005|Overall Study|Withdrawal by Subject|0|||
19563830|NCT01246986|42011561|FG006|Overall Study|Withdrawal by Subject|0|||
19563831|NCT01164501|42011595|FG000|Overall Study|Not treated|2|||
19563832|NCT01164501|42011596|FG001|Overall Study|Not treated|0|||
19563833|NCT01164501|42011597|FG002|Overall Study|Not treated|1|||
19563834|NCT01164501|42011595|FG000|Overall Study|Adverse Event|18|||
19563835|NCT01164501|42011596|FG001|Overall Study|Adverse Event|4|||
19563836|NCT01164501|42011597|FG002|Overall Study|Adverse Event|21|||
19563837|NCT01164501|42011595|FG000|Overall Study|Lack of Efficacy|0|||
19563838|NCT01164501|42011596|FG001|Overall Study|Lack of Efficacy|0|||
19563839|NCT01164501|42011597|FG002|Overall Study|Lack of Efficacy|1|||
19563840|NCT01164501|42011595|FG000|Overall Study|Non compliant with protocol|1|||
19563841|NCT01164501|42011596|FG001|Overall Study|Non compliant with protocol|1|||
19563842|NCT01164501|42011597|FG002|Overall Study|Non compliant with protocol|4|||
19563843|NCT01164501|42011595|FG000|Overall Study|Lost to Follow-up|3|||
19563844|NCT01164501|42011596|FG001|Overall Study|Lost to Follow-up|0|||
19563845|NCT01164501|42011597|FG002|Overall Study|Lost to Follow-up|3|||
19563846|NCT01164501|42011595|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
19563847|NCT01164501|42011596|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
19563848|NCT01164501|42011597|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
19563849|NCT01164501|42011595|FG000|Overall Study|Other reason not defined above|9|||
19563850|NCT01164501|42011596|FG001|Overall Study|Other reason not defined above|1|||
19563851|NCT01164501|42011597|FG002|Overall Study|Other reason not defined above|4|||
19563852|NCT00958711|42011609|FG000|Overall Study|Withdrawal by Subject|0|||
19563853|NCT00958711|42011610|FG001|Overall Study|Withdrawal by Subject|4|||
19563854|NCT00958711|42011609|FG000|Overall Study|Physician Decision|5|||
19563855|NCT00958711|42011610|FG001|Overall Study|Physician Decision|7|||
19563856|NCT00958711|42011609|FG000|Overall Study|Lost to Follow-up|4|||
19563857|NCT00958711|42011610|FG001|Overall Study|Lost to Follow-up|1|||
19563858|NCT00958711|42011609|FG000|Overall Study|Other|2|||
19740148|NCT00099983|42187072|FG001|Overall Study|Moved|0|||
19740149|NCT00099983|42187071|FG000|Overall Study|Other psychiatric problem|1|||
19740150|NCT00099983|42187072|FG001|Overall Study|Other psychiatric problem|0|||
19740151|NCT00099983|42187071|FG000|Overall Study|Incarcerated|0|||
19563859|NCT00958711|42011610|FG001|Overall Study|Other|5|||
19563860|NCT00958711|42011609|FG000|Overall Study|Death|1|||
19563861|NCT00958711|42011610|FG001|Overall Study|Death|2|||
19563862|NCT00958711|42011609|FG000|Overall Study|Adverse Event|1|||
19563863|NCT00958711|42011610|FG001|Overall Study|Adverse Event|2|||
19563864|NCT01163721|42011618|FG000|Overall Study|Adverse Event|5|||
19563865|NCT01163721|42011619|FG001|Overall Study|Adverse Event|6|||
19563866|NCT01163721|42011618|FG000|Overall Study|Withdrawal by Subject|3|||
19563867|NCT01163721|42011619|FG001|Overall Study|Withdrawal by Subject|4|||
19563868|NCT01163721|42011618|FG000|Overall Study|Lost to Follow-up|0|||
19563869|NCT01163721|42011619|FG001|Overall Study|Lost to Follow-up|1|||
19563870|NCT01163721|42011618|FG000|Overall Study|Physician Decision|0|||
19563871|NCT01163721|42011619|FG001|Overall Study|Physician Decision|1|||
19563872|NCT00958243|42011631|FG000|Overall Study|Withdrawal by Subject|0|||
19563873|NCT00958243|42011632|FG001|Overall Study|Withdrawal by Subject|1|||
19563874|NCT00958243|42011633|FG002|Overall Study|Withdrawal by Subject|3|||
19563875|NCT00958243|42011634|FG003|Overall Study|Withdrawal by Subject|1|||
19563876|NCT00958243|42011635|FG004|Overall Study|Withdrawal by Subject|1|||
19563877|NCT00958243|42011636|FG005|Overall Study|Withdrawal by Subject|5|||
19563878|NCT00958243|42011631|FG000|Overall Study|Lost to Follow-up|2|||
19563879|NCT00958243|42011632|FG001|Overall Study|Lost to Follow-up|5|||
19563880|NCT00958243|42011633|FG002|Overall Study|Lost to Follow-up|11|||
19563881|NCT00958243|42011634|FG003|Overall Study|Lost to Follow-up|2|||
19563882|NCT00958243|42011635|FG004|Overall Study|Lost to Follow-up|8|||
19563883|NCT00958243|42011636|FG005|Overall Study|Lost to Follow-up|5|||
19563884|NCT01241760|42011658|FG000|Overall Study|Adverse Event|1|||
19563885|NCT01241760|42011659|FG001|Overall Study|Adverse Event|0|||
19563886|NCT01241760|42011658|FG000|Overall Study|Lost to Follow-up|18|||
19563887|NCT01241760|42011659|FG001|Overall Study|Lost to Follow-up|22|||
19563888|NCT01241760|42011658|FG000|Overall Study|Withdrawal by Subject|13|||
19563889|NCT01241760|42011659|FG001|Overall Study|Withdrawal by Subject|13|||
19563890|NCT01241760|42011658|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
19563891|NCT01241760|42011659|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
19563892|NCT01241760|42011658|FG000|Overall Study|Other|1|||
19563893|NCT01241760|42011659|FG001|Overall Study|Other|1|||
19563894|NCT00958165|42011666|FG000|Overall Study|Lost to Follow-up|5|||
19563895|NCT00958165|42011666|FG000|Overall Study|Not eligible|9|||
19563896|NCT00958009|42011670|FG000|Overall Study|Adverse Event|1|||
19563897|NCT00958009|42011670|FG000|Overall Study|Subject found device difficult to use|1|||
19563898|NCT00953407|42011679|FG000|Overall Study|Failed inclusion criteria|1|||
19563899|NCT00953407|42011680|FG001|Overall Study|Failed inclusion criteria|1|||
19563900|NCT00953407|42011681|FG002|Overall Study|Failed inclusion criteria|1|||
19563901|NCT00953407|42011682|FG003|Overall Study|Failed inclusion criteria|1|||
19563902|NCT00953407|42011683|FG004|Overall Study|Failed inclusion criteria|1|||
19563903|NCT00953407|42011679|FG000|Overall Study|Lost to Follow-up|0|||
19563904|NCT00953407|42011680|FG001|Overall Study|Lost to Follow-up|0|||
19563905|NCT00953407|42011681|FG002|Overall Study|Lost to Follow-up|0|||
19563906|NCT00953407|42011682|FG003|Overall Study|Lost to Follow-up|1|||
19563907|NCT00953407|42011683|FG004|Overall Study|Lost to Follow-up|0|||
19563908|NCT00953329|42011695|FG000|Overall Study|Lack of Efficacy|1|||
19563909|NCT00953017|42011703|FG000|Overall Study|DId not show up for colonoscopy|4|||
19563910|NCT00953017|42011704|FG001|Overall Study|DId not show up for colonoscopy|4|||
19563911|NCT00953017|42011705|FG002|Overall Study|DId not show up for colonoscopy|5|||
19563912|NCT00953017|42011706|FG003|Overall Study|DId not show up for colonoscopy|4|||
19563913|NCT00953017|42011703|FG000|Overall Study|Incomplete data|1|||
19563914|NCT00953017|42011704|FG001|Overall Study|Incomplete data|1|||
19563915|NCT00953017|42011705|FG002|Overall Study|Incomplete data|0|||
19563916|NCT00953017|42011706|FG003|Overall Study|Incomplete data|0|||
19563917|NCT00953017|42011703|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
19563918|NCT00953017|42011704|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
19563919|NCT00953017|42011705|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
19563920|NCT00953017|42011706|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
19563921|NCT00953017|42011703|FG000|Overall Study|Brown stool prior to procedure|0|||
19563922|NCT00953017|42011704|FG001|Overall Study|Brown stool prior to procedure|0|||
19740152|NCT00099983|42187072|FG001|Overall Study|Incarcerated|1|||
19740153|NCT00099983|42187071|FG000|Overall Study|Intolerant of burden of visits|0|||
19740154|NCT00099983|42187072|FG001|Overall Study|Intolerant of burden of visits|1|||
19563923|NCT00953017|42011705|FG002|Overall Study|Brown stool prior to procedure|1|||
19563924|NCT00953017|42011706|FG003|Overall Study|Brown stool prior to procedure|0|||
19563925|NCT00952705|42011719|FG000|Overall Study|Lost to Follow-up|24|||
19563926|NCT00952705|42011720|FG001|Overall Study|Lost to Follow-up|8|||
19563927|NCT00952705|42011721|FG002|Overall Study|Lost to Follow-up|9|||
19740155|NCT00099983|42187071|FG000|Overall Study|Other issue|1|||
19563928|NCT00952705|42011719|FG000|Overall Study|Withdrawal by Subject|2|||
19563929|NCT00952705|42011720|FG001|Overall Study|Withdrawal by Subject|1|||
19563930|NCT00952705|42011721|FG002|Overall Study|Withdrawal by Subject|1|||
19563931|NCT00952705|42011719|FG000|Overall Study|Death|2|||
19563932|NCT00952705|42011720|FG001|Overall Study|Death|0|||
19563933|NCT00952705|42011721|FG002|Overall Study|Death|0|||
19563934|NCT00952705|42011719|FG000|Overall Study|Incarcerated post dose|5|||
19563935|NCT00952705|42011720|FG001|Overall Study|Incarcerated post dose|0|||
19563936|NCT00952705|42011721|FG002|Overall Study|Incarcerated post dose|0|||
19563937|NCT00952705|42011719|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
19563938|NCT00952705|42011720|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
19563939|NCT00952705|42011721|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
19563940|NCT00955357|42011735|FG000|Titration Phase|Adverse Event|9|||
19563941|NCT00955357|42011736|FG001|Titration Phase|Adverse Event|46|||
19563942|NCT00955357|42011735|FG000|Titration Phase|Lack of Efficacy|0|||
19563943|NCT00955357|42011736|FG001|Titration Phase|Lack of Efficacy|2|||
19563944|NCT00955357|42011735|FG000|Titration Phase|Protocol Violation|3|||
19563945|NCT00955357|42011736|FG001|Titration Phase|Protocol Violation|7|||
19563946|NCT00955357|42011735|FG000|Titration Phase|Lost to Follow-up|1|||
19563947|NCT00955357|42011736|FG001|Titration Phase|Lost to Follow-up|3|||
19563948|NCT00955357|42011735|FG000|Titration Phase|Withdrawal by Subject|3|||
19563949|NCT00955357|42011736|FG001|Titration Phase|Withdrawal by Subject|5|||
19563950|NCT00955357|42011735|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
19563951|NCT00955357|42011736|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
19563952|NCT00955357|42011735|FG000|Titration Phase|Study medication not tolerated|0|||
19563953|NCT00955357|42011736|FG001|Titration Phase|Study medication not tolerated|1|||
19563954|NCT00955357|42011735|FG000|Titration Phase|Non compliance to study procedures|0|||
19563955|NCT00955357|42011736|FG001|Titration Phase|Non compliance to study procedures|1|||
19563956|NCT00955357|42011735|FG000|Maintenance Phase|Adverse Event|3|||
19563957|NCT00955357|42011736|FG001|Maintenance Phase|Adverse Event|23|||
19563958|NCT00955357|42011735|FG000|Maintenance Phase|Lack of Efficacy|0|||
19563959|NCT00955357|42011736|FG001|Maintenance Phase|Lack of Efficacy|4|||
19563960|NCT00955357|42011735|FG000|Maintenance Phase|Protocol Violation|2|||
19563961|NCT00955357|42011736|FG001|Maintenance Phase|Protocol Violation|6|||
19563962|NCT00955357|42011735|FG000|Maintenance Phase|Lost to Follow-up|2|||
19563963|NCT00955357|42011736|FG001|Maintenance Phase|Lost to Follow-up|7|||
19563964|NCT00955357|42011735|FG000|Maintenance Phase|Withdrawal by Subject|4|||
19563965|NCT00955357|42011736|FG001|Maintenance Phase|Withdrawal by Subject|4|||
19563966|NCT00955357|42011735|FG000|Maintenance Phase|Patient moving out of area|0|||
19563967|NCT00955357|42011736|FG001|Maintenance Phase|Patient moving out of area|1|||
19563968|NCT00955357|42011735|FG000|Maintenance Phase|Non compliance to study procedures|1|||
19563969|NCT00955357|42011736|FG001|Maintenance Phase|Non compliance to study procedures|0|||
19563970|NCT00955279|42011745|FG000|Overall Study|Other|0|||
19563971|NCT00955279|42011746|FG001|Overall Study|Other|0|||
19563972|NCT00955279|42011747|FG002|Overall Study|Other|3|||
19563973|NCT00955279|42011745|FG000|Overall Study|Death|1|||
19563974|NCT00955279|42011746|FG001|Overall Study|Death|1|||
19563975|NCT00955279|42011747|FG002|Overall Study|Death|1|||
19563976|NCT00955279|42011745|FG000|Overall Study|Lost to Follow-up|0|||
19563977|NCT00955279|42011746|FG001|Overall Study|Lost to Follow-up|3|||
19563978|NCT00955279|42011747|FG002|Overall Study|Lost to Follow-up|1|||
19563979|NCT00955279|42011745|FG000|Overall Study|Withdrawal by Subject|2|||
19563980|NCT00955279|42011746|FG001|Overall Study|Withdrawal by Subject|0|||
19563981|NCT00955279|42011747|FG002|Overall Study|Withdrawal by Subject|3|||
19563982|NCT00954733|42011755|FG000|Overall Study|blood gas machine did not work|1|||
19563983|NCT00954421|42011759|FG000|Screening|screen failures|3|||
19563984|NCT00954421|42011759|FG000|6 Months of DBS|Withdrawal by Subject|1|||
19563985|NCT00954421|42011759|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
19563986|NCT01241448|42011769|FG000|Overall Study|Adverse Event|1|||
19563987|NCT01241448|42011770|FG001|Overall Study|Adverse Event|0|||
19563988|NCT01241448|42011771|FG002|Overall Study|Adverse Event|2|||
19563989|NCT01241448|42011772|FG003|Overall Study|Adverse Event|2|||
19563990|NCT01241448|42011769|FG000|Overall Study|Lost to Follow-up|2|||
19563991|NCT01241448|42011770|FG001|Overall Study|Lost to Follow-up|1|||
19563992|NCT01241448|42011771|FG002|Overall Study|Lost to Follow-up|1|||
19563993|NCT01241448|42011772|FG003|Overall Study|Lost to Follow-up|1|||
19563994|NCT01241448|42011769|FG000|Overall Study|Physician Decision|0|||
19563995|NCT01241448|42011770|FG001|Overall Study|Physician Decision|2|||
19563996|NCT01241448|42011771|FG002|Overall Study|Physician Decision|0|||
19563997|NCT01241448|42011772|FG003|Overall Study|Physician Decision|0|||
19563998|NCT01241448|42011769|FG000|Overall Study|Protocol Violation|10|||
19563999|NCT01241448|42011770|FG001|Overall Study|Protocol Violation|5|||
19564000|NCT01241448|42011771|FG002|Overall Study|Protocol Violation|3|||
19564001|NCT01241448|42011772|FG003|Overall Study|Protocol Violation|6|||
19564002|NCT01241448|42011769|FG000|Overall Study|Sponsor Decision|17|||
19564003|NCT01241448|42011770|FG001|Overall Study|Sponsor Decision|14|||
19564004|NCT01241448|42011771|FG002|Overall Study|Sponsor Decision|12|||
19564005|NCT01241448|42011772|FG003|Overall Study|Sponsor Decision|6|||
19564006|NCT01241448|42011769|FG000|Overall Study|Withdrawal by Subject|4|||
19564007|NCT01241448|42011770|FG001|Overall Study|Withdrawal by Subject|5|||
19564008|NCT01241448|42011771|FG002|Overall Study|Withdrawal by Subject|3|||
19564009|NCT01241448|42011772|FG003|Overall Study|Withdrawal by Subject|6|||
19564010|NCT01241448|42011769|FG000|Overall Study|Excluded due to data integrity issues|3|||
19564011|NCT01241448|42011770|FG001|Overall Study|Excluded due to data integrity issues|2|||
19564012|NCT01241448|42011771|FG002|Overall Study|Excluded due to data integrity issues|2|||
19564013|NCT01241448|42011772|FG003|Overall Study|Excluded due to data integrity issues|2|||
19564014|NCT01240356|42011785|FG000|Overall Study|Withdrawal by Subject|2|||
19564015|NCT01240356|42011786|FG001|Overall Study|Withdrawal by Subject|0|||
19564016|NCT01240356|42011785|FG000|Overall Study|MRI contraindication|1|||
19564017|NCT01240356|42011786|FG001|Overall Study|MRI contraindication|0|||
19564018|NCT01239732|42011795|FG000|Overall Study|Termination of study per protocol|667|||
19564019|NCT01239732|42011795|FG000|Overall Study|Death|226|||
19564020|NCT01239732|42011795|FG000|Overall Study|Withdrawal by Subject|87|||
19564021|NCT01239732|42011795|FG000|Overall Study|Adverse Event|6|||
19564022|NCT01239732|42011795|FG000|Overall Study|Protocol Violation|3|||
19564023|NCT01239732|42011795|FG000|Overall Study|Participant non compliance|5|||
19564024|NCT01239732|42011795|FG000|Overall Study|Study termination by sponsor|2|||
19564025|NCT01239732|42011795|FG000|Overall Study|Investigator's decision|4|||
19564026|NCT01239732|42011795|FG000|Overall Study|Treatment failure|2|||
19564027|NCT01239732|42011795|FG000|Overall Study|Other|19|||
19564028|NCT02227147|42011801|FG000|Controlled Treatment Period|Adverse Event|4|||
19564029|NCT02227147|42011802|FG001|Controlled Treatment Period|Adverse Event|3|||
19564030|NCT02227147|42011801|FG000|Controlled Treatment Period|Other|2|||
19564031|NCT02227147|42011802|FG001|Controlled Treatment Period|Other|0|||
19564032|NCT02227147|42011801|FG000|Follow-up Period|Other|3|||
19564033|NCT02227147|42011802|FG001|Follow-up Period|Other|5|||
19564034|NCT00948025|42011814|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
19564035|NCT00948025|42011815|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
19564036|NCT00948025|42011814|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
19564037|NCT00948025|42011815|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
19564038|NCT00948025|42011814|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
19564039|NCT00948025|42011815|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
19564040|NCT00947011|42011822|FG000|Overall Study|Study was terminated,PI left institution|12|||
19564041|NCT01239342|42011830|FG000|Overall Study|Adverse Event|1|||
19564042|NCT01239342|42011831|FG001|Overall Study|Adverse Event|0|||
19564043|NCT01239342|42011830|FG000|Overall Study|Withdrawal by Subject|1|||
19564044|NCT01239342|42011831|FG001|Overall Study|Withdrawal by Subject|5|||
19564045|NCT01239342|42011830|FG000|Overall Study|Reason Unknown|1|||
19740156|NCT00099983|42187072|FG001|Overall Study|Other issue|0|||
19564046|NCT01239342|42011831|FG001|Overall Study|Reason Unknown|1|||
19740157|NCT00099359|42187081|FG000|Overall Study|Death|11|||
19740158|NCT00099359|42187082|FG001|Overall Study|Death|15|||
19564047|NCT00946309|42011839|FG000|Overall Study|Protocol Violation|1|||
19564048|NCT00946309|42011840|FG001|Overall Study|Protocol Violation|0|||
19564049|NCT00946309|42011839|FG000|Overall Study|Lost to Follow-up|0|||
19740159|NCT00099359|42187083|FG002|Overall Study|Death|17|||
19564050|NCT00946309|42011840|FG001|Overall Study|Lost to Follow-up|1|||
19564051|NCT00946309|42011839|FG000|Overall Study|Procedure cancelled/discontinued|0|||
19564052|NCT00946309|42011840|FG001|Overall Study|Procedure cancelled/discontinued|3|||
19564053|NCT01236534|42011849|FG000|Overall Study|Adverse Event|3|||
19564054|NCT01236534|42011850|FG001|Overall Study|Adverse Event|0|||
19564055|NCT01235598|42011858|FG000|Overall Study|Adverse Event|0|||
19564056|NCT01235598|42011859|FG001|Overall Study|Adverse Event|3|||
19564057|NCT01235598|42011858|FG000|Overall Study|Lack of Efficacy|0|||
19564058|NCT01235598|42011859|FG001|Overall Study|Lack of Efficacy|1|||
19564059|NCT01235598|42011858|FG000|Overall Study|Withdrawal by Subject|1|||
19564060|NCT01235598|42011859|FG001|Overall Study|Withdrawal by Subject|0|||
19564061|NCT01235442|42011868|FG000|Overall Study|Lost to Follow-up|12|||
19564062|NCT01235442|42011869|FG001|Overall Study|Lost to Follow-up|10|||
19564063|NCT01235442|42011868|FG000|Overall Study|Death|0|||
19564064|NCT01235442|42011869|FG001|Overall Study|Death|2|||
19564065|NCT01235442|42011868|FG000|Overall Study|Pregnancy|1|||
19564066|NCT01235442|42011869|FG001|Overall Study|Pregnancy|1|||
19564067|NCT01235442|42011868|FG000|Overall Study|Ineligibility determined|5|||
19564068|NCT01235442|42011869|FG001|Overall Study|Ineligibility determined|4|||
19564069|NCT01235442|42011868|FG000|Overall Study|Protocol Violation|3|||
19564070|NCT01235442|42011869|FG001|Overall Study|Protocol Violation|3|||
19564071|NCT01235442|42011868|FG000|Overall Study|Adverse Event|4|||
19564072|NCT01235442|42011869|FG001|Overall Study|Adverse Event|6|||
19564073|NCT01235442|42011868|FG000|Overall Study|Withdrawal by Subject|15|||
19564074|NCT01235442|42011869|FG001|Overall Study|Withdrawal by Subject|9|||
19564075|NCT01235442|42011868|FG000|Overall Study|Lack of Efficacy|1|||
19564076|NCT01235442|42011869|FG001|Overall Study|Lack of Efficacy|3|||
19564077|NCT01235442|42011868|FG000|Overall Study|Noncompliance|1|||
19564078|NCT01235442|42011869|FG001|Overall Study|Noncompliance|2|||
19564079|NCT01235442|42011868|FG000|Overall Study|Administrative decision|1|||
19564080|NCT01235442|42011869|FG001|Overall Study|Administrative decision|2|||
19564081|NCT01235442|42011868|FG000|Overall Study|Other unspecified|1|||
19564082|NCT01235442|42011869|FG001|Overall Study|Other unspecified|2|||
19564083|NCT01163253|42011877|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
19564084|NCT01163253|42011878|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
19564085|NCT01163253|42011877|FG000|Overall Study|Study Terminated by Sponsor|978|||
19564086|NCT01163253|42011878|FG001|Overall Study|Study Terminated by Sponsor|349|||
19564087|NCT01163253|42011877|FG000|Overall Study|Protocol Violation|43|||
19564088|NCT01163253|42011878|FG001|Overall Study|Protocol Violation|12|||
19564089|NCT01163253|42011877|FG000|Overall Study|Withdrawal by Subject|199|||
19564090|NCT01163253|42011878|FG001|Overall Study|Withdrawal by Subject|50|||
19564091|NCT01163253|42011877|FG000|Overall Study|Medication Error|1|||
19564092|NCT01163253|42011878|FG001|Overall Study|Medication Error|0|||
19564093|NCT01163253|42011877|FG000|Overall Study|Lost to Follow-up|125|||
19564094|NCT01163253|42011878|FG001|Overall Study|Lost to Follow-up|23|||
19564095|NCT01163253|42011877|FG000|Overall Study|Insufficient Clinical Response|423|||
19564096|NCT01163253|42011878|FG001|Overall Study|Insufficient Clinical Response|29|||
19564097|NCT01163253|42011877|FG000|Overall Study|Adverse Event|300|||
19564098|NCT01163253|42011878|FG001|Overall Study|Adverse Event|78|||
19564099|NCT01163253|42011877|FG000|Overall Study|Death|17|||
19564100|NCT01163253|42011878|FG001|Overall Study|Death|5|||
19564101|NCT01163253|42011877|FG000|Overall Study|Ongoing|13|||
19564102|NCT01163253|42011878|FG001|Overall Study|Ongoing|4|||
19564103|NCT01163253|42011877|FG000|Overall Study|Other Unspecified|170|||
19564104|NCT01163253|42011878|FG001|Overall Study|Other Unspecified|34|||
19564105|NCT01162863|42011887|FG000|Overall Study|Lack of Efficacy|1|||
19564106|NCT01162863|42011888|FG001|Overall Study|Lack of Efficacy|0|||
19564107|NCT01162863|42011889|FG002|Overall Study|Lack of Efficacy|0|||
19564108|NCT01162863|42011887|FG000|Overall Study|Adverse Event|0|||
19564109|NCT01162863|42011888|FG001|Overall Study|Adverse Event|1|||
19564110|NCT01162863|42011889|FG002|Overall Study|Adverse Event|0|||
19564111|NCT01162473|42011899|FG000|Overall Study|Adverse Event|2|||
19564112|NCT01162473|42011900|FG001|Overall Study|Adverse Event|1|||
19564113|NCT01162473|42011899|FG000|Overall Study|Withdrawal by Subject|0|||
19564114|NCT01162473|42011900|FG001|Overall Study|Withdrawal by Subject|4|||
19564115|NCT01162239|42011910|FG000|Treatment Phase|Withdrawal by Subject|1|||
19564116|NCT01162239|42011911|FG001|Treatment Phase|Withdrawal by Subject|3|||
19564117|NCT01162239|42011912|FG002|Treatment Phase|Withdrawal by Subject|2|||
19564118|NCT01162239|42011913|FG003|Treatment Phase|Withdrawal by Subject|3|||
19564119|NCT01162239|42011910|FG000|Treatment Phase|Death|0|||
19564120|NCT01162239|42011911|FG001|Treatment Phase|Death|0|||
19564121|NCT01162239|42011912|FG002|Treatment Phase|Death|0|||
19564122|NCT01162239|42011913|FG003|Treatment Phase|Death|1|||
19564123|NCT01162239|42011910|FG000|Treatment Phase|Lost to Follow-up|5|||
19564124|NCT01162239|42011911|FG001|Treatment Phase|Lost to Follow-up|4|||
19564125|NCT01162239|42011912|FG002|Treatment Phase|Lost to Follow-up|2|||
19564126|NCT01162239|42011913|FG003|Treatment Phase|Lost to Follow-up|1|||
19564127|NCT01162239|42011910|FG000|Extended Follow-up|Lost to Follow-up|8|||
19564128|NCT01162239|42011911|FG001|Extended Follow-up|Lost to Follow-up|13|||
19564129|NCT01162239|42011912|FG002|Extended Follow-up|Lost to Follow-up|8|||
19564130|NCT01162239|42011913|FG003|Extended Follow-up|Lost to Follow-up|6|||
19564131|NCT01161537|42011924|FG000|Part B|Withdrawal by Subject|2|||
19564132|NCT01234350|42011935|FG000|Overall Study|Adverse Event|277|||
19564133|NCT01234350|42011936|FG001|Overall Study|Adverse Event|92|||
19564134|NCT01234350|42011935|FG000|Overall Study|Withdrawal by Subject|61|||
19564135|NCT01234350|42011936|FG001|Overall Study|Withdrawal by Subject|36|||
19564136|NCT01234350|42011935|FG000|Overall Study|Lost to Follow-up|115|||
19564137|NCT01234350|42011936|FG001|Overall Study|Lost to Follow-up|47|||
19564138|NCT01234350|42011935|FG000|Overall Study|Covers a diverse set of reasons|234|||
19564139|NCT01234350|42011936|FG001|Overall Study|Covers a diverse set of reasons|92|||
19564140|NCT01233258|42011947|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
19564141|NCT01233258|42011948|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
19564142|NCT01233258|42011949|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
19564143|NCT01233258|42011950|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
19564144|NCT01233258|42011951|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
19564145|NCT01233258|42011952|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
19564146|NCT01233258|42011947|FG000|First Intervention (6 Months)|Protocol Violation|0|||
19564147|NCT01233258|42011948|FG001|First Intervention (6 Months)|Protocol Violation|0|||
19564148|NCT01233258|42011949|FG002|First Intervention (6 Months)|Protocol Violation|1|||
19564149|NCT01233258|42011950|FG003|First Intervention (6 Months)|Protocol Violation|0|||
19564150|NCT01233258|42011951|FG004|First Intervention (6 Months)|Protocol Violation|0|||
19564151|NCT01233258|42011952|FG005|First Intervention (6 Months)|Protocol Violation|0|||
19564152|NCT01233258|42011947|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
19564153|NCT01233258|42011948|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
19564154|NCT01233258|42011949|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
19564155|NCT01233258|42011950|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
19564156|NCT01233258|42011951|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
19564157|NCT01233258|42011952|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
19564158|NCT01232868|42011969|FG000|Overall Study|Lost to Follow-up|2|||
19564159|NCT01232868|42011970|FG001|Overall Study|Lost to Follow-up|4|||
19564160|NCT01232790|42011976|FG000|Randomization|Withdrawal by Subject|2|||
19564161|NCT01232790|42011977|FG001|Randomization|Withdrawal by Subject|0|||
19564162|NCT01232790|42011976|FG000|Randomization|Protocol Violation|0|||
19564163|NCT01232790|42011977|FG001|Randomization|Protocol Violation|1|||
19564164|NCT01232790|42011976|FG000|Randomization|Physician Decision|0|||
19564165|NCT01232790|42011977|FG001|Randomization|Physician Decision|1|||
19564166|NCT01232790|42011976|FG000|Initial Assessment|Withdrawal by Subject|0|||
19564167|NCT01232790|42011977|FG001|Initial Assessment|Withdrawal by Subject|1|||
19564168|NCT01232790|42011976|FG000|First Crossover|Withdrawal by Subject|1|||
19564169|NCT01232790|42011977|FG001|First Crossover|Withdrawal by Subject|0|||
19564170|NCT01232790|42011976|FG000|Second Crossover|Withdrawal by Subject|1|||
19564171|NCT01232790|42011977|FG001|Second Crossover|Withdrawal by Subject|2|||
19564172|NCT01232556|42011995|FG000|Overall Study|Withdrawal by Subject|21|||
19564173|NCT01232556|42011996|FG001|Overall Study|Withdrawal by Subject|17|||
19564174|NCT01232556|42011995|FG000|Overall Study|Death|97|||
19564175|NCT01232556|42011996|FG001|Overall Study|Death|97|||
19564176|NCT01232556|42011995|FG000|Overall Study|Lost to Follow-up|0|||
19564177|NCT01232556|42011996|FG001|Overall Study|Lost to Follow-up|2|||
19564178|NCT01232556|42011995|FG000|Overall Study|Terminated by Sponsor|35|||
19564179|NCT01232556|42011996|FG001|Overall Study|Terminated by Sponsor|51|||
19564180|NCT01232556|42011995|FG000|Overall Study|Other|6|||
19564181|NCT01232556|42011996|FG001|Overall Study|Other|4|||
19564182|NCT00946153|42012007|FG000|Phase 2|Adverse Event|0|||
19564183|NCT00946153|42012008|FG001|Phase 2|Adverse Event|0|||
19564184|NCT00946153|42012009|FG002|Phase 2|Adverse Event|0|||
19564185|NCT00946153|42012010|FG003|Phase 2|Adverse Event|0|||
19564186|NCT00946153|42012011|FG004|Phase 2|Adverse Event|6|||
19564187|NCT00946153|42012007|FG000|Phase 2|Need more reduction of dose|0|||
19564188|NCT00946153|42012008|FG001|Phase 2|Need more reduction of dose|0|||
19564189|NCT00946153|42012009|FG002|Phase 2|Need more reduction of dose|0|||
19564190|NCT00946153|42012010|FG003|Phase 2|Need more reduction of dose|0|||
19564191|NCT00946153|42012011|FG004|Phase 2|Need more reduction of dose|2|||
19564192|NCT00946153|42012007|FG000|Phase 2|Physician Decision|0|||
19564193|NCT00946153|42012008|FG001|Phase 2|Physician Decision|0|||
19564194|NCT00946153|42012009|FG002|Phase 2|Physician Decision|0|||
19564195|NCT00946153|42012010|FG003|Phase 2|Physician Decision|0|||
19564196|NCT00946153|42012011|FG004|Phase 2|Physician Decision|1|||
19564197|NCT00946153|42012007|FG000|Phase 2|14 days washout for recovery due to AE|0|||
19564198|NCT00946153|42012008|FG001|Phase 2|14 days washout for recovery due to AE|0|||
19564199|NCT00946153|42012009|FG002|Phase 2|14 days washout for recovery due to AE|0|||
19564200|NCT00946153|42012010|FG003|Phase 2|14 days washout for recovery due to AE|0|||
19564201|NCT00946153|42012011|FG004|Phase 2|14 days washout for recovery due to AE|4|||
19564202|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
19564203|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
19564204|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
19564205|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
19564206|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
19564207|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
19564208|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
19564209|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
19564210|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
19564211|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
19564212|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
19564213|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
19564214|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
19564215|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
19564216|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
19564217|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
19564218|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
19740160|NCT00099359|42187081|FG000|Overall Study|Withdrawal by Subject|19|||
19740161|NCT00099359|42187082|FG001|Overall Study|Withdrawal by Subject|19|||
19564219|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
19564220|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
19564221|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
19564222|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
19564223|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
19564224|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
19564225|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
19564226|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
19564227|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
19564228|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
19564229|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
19564230|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
19564231|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
19564232|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
19564233|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
19564234|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
19564235|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
19564236|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
19564237|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
19564238|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
19564239|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
19564240|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
19564241|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
19564242|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
19564243|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
19564244|NCT01160289|42012033|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
19564245|NCT01160289|42012034|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
19564246|NCT01160289|42012035|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
19564247|NCT01160289|42012036|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
19564248|NCT01160289|42012037|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
19564249|NCT01160289|42012038|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
19564250|NCT01160289|42012033|FG000|Post-Randomization Period|Adverse Event|0|||
19564251|NCT01160289|42012034|FG001|Post-Randomization Period|Adverse Event|4|||
19564252|NCT01160289|42012035|FG002|Post-Randomization Period|Adverse Event|4|||
19564253|NCT01160289|42012036|FG003|Post-Randomization Period|Adverse Event|2|||
19564254|NCT01160289|42012037|FG004|Post-Randomization Period|Adverse Event|0|||
19564255|NCT01160289|42012038|FG005|Post-Randomization Period|Adverse Event|0|||
19564256|NCT01160289|42012033|FG000|Post-Randomization Period|Death|0|||
19564257|NCT01160289|42012034|FG001|Post-Randomization Period|Death|0|||
19564258|NCT01160289|42012035|FG002|Post-Randomization Period|Death|0|||
19564259|NCT01160289|42012036|FG003|Post-Randomization Period|Death|1|||
19564260|NCT01160289|42012037|FG004|Post-Randomization Period|Death|0|||
19564261|NCT01160289|42012038|FG005|Post-Randomization Period|Death|0|||
19564262|NCT01160289|42012033|FG000|Post-Randomization Period|Lack of Efficacy|0|||
19564263|NCT01160289|42012034|FG001|Post-Randomization Period|Lack of Efficacy|1|||
19564264|NCT01160289|42012035|FG002|Post-Randomization Period|Lack of Efficacy|0|||
19564265|NCT01160289|42012036|FG003|Post-Randomization Period|Lack of Efficacy|3|||
19564266|NCT01160289|42012037|FG004|Post-Randomization Period|Lack of Efficacy|0|||
19564267|NCT01160289|42012038|FG005|Post-Randomization Period|Lack of Efficacy|0|||
19564268|NCT01160289|42012033|FG000|Post-Randomization Period|Lost to Follow-up|0|||
19564269|NCT01160289|42012034|FG001|Post-Randomization Period|Lost to Follow-up|3|||
19564270|NCT01160289|42012035|FG002|Post-Randomization Period|Lost to Follow-up|2|||
19564271|NCT01160289|42012036|FG003|Post-Randomization Period|Lost to Follow-up|5|||
19564272|NCT01160289|42012037|FG004|Post-Randomization Period|Lost to Follow-up|3|||
19564273|NCT01160289|42012038|FG005|Post-Randomization Period|Lost to Follow-up|4|||
19564274|NCT01160289|42012033|FG000|Post-Randomization Period|Physician Decision|0|||
19564275|NCT01160289|42012034|FG001|Post-Randomization Period|Physician Decision|0|||
19564276|NCT01160289|42012035|FG002|Post-Randomization Period|Physician Decision|1|||
19564277|NCT01160289|42012036|FG003|Post-Randomization Period|Physician Decision|0|||
19564278|NCT01160289|42012037|FG004|Post-Randomization Period|Physician Decision|0|||
19564279|NCT01160289|42012038|FG005|Post-Randomization Period|Physician Decision|0|||
19564280|NCT01160289|42012033|FG000|Post-Randomization Period|Protocol Violation|0|||
19564281|NCT01160289|42012034|FG001|Post-Randomization Period|Protocol Violation|4|||
19564282|NCT01160289|42012035|FG002|Post-Randomization Period|Protocol Violation|2|||
19564283|NCT01160289|42012036|FG003|Post-Randomization Period|Protocol Violation|0|||
19564284|NCT01160289|42012037|FG004|Post-Randomization Period|Protocol Violation|1|||
19564285|NCT01160289|42012038|FG005|Post-Randomization Period|Protocol Violation|3|||
19564286|NCT01160289|42012033|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
19564287|NCT01160289|42012034|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
19564288|NCT01160289|42012035|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
19564289|NCT01160289|42012036|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
19564290|NCT01160289|42012037|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
19564291|NCT01160289|42012038|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
19564292|NCT01160289|42012033|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
19564293|NCT01160289|42012034|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
19564294|NCT01160289|42012035|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
19564295|NCT01160289|42012036|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
19564296|NCT01160289|42012037|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
19564297|NCT01160289|42012038|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
19564298|NCT01160289|42012033|FG000|Post-Randomization Period|Sponsor Decision|0|||
19564299|NCT01160289|42012034|FG001|Post-Randomization Period|Sponsor Decision|1|||
19564300|NCT01160289|42012035|FG002|Post-Randomization Period|Sponsor Decision|0|||
19564301|NCT01160289|42012036|FG003|Post-Randomization Period|Sponsor Decision|0|||
19564302|NCT01160289|42012037|FG004|Post-Randomization Period|Sponsor Decision|0|||
19564303|NCT01160289|42012038|FG005|Post-Randomization Period|Sponsor Decision|0|||
19564304|NCT01159665|42012057|FG000|Overall Study|Withdrawal by Subject|0|||
19564305|NCT01159665|42012058|FG001|Overall Study|Withdrawal by Subject|1|||
19564306|NCT01159665|42012059|FG002|Overall Study|Withdrawal by Subject|0|||
19564307|NCT01159665|42012060|FG003|Overall Study|Withdrawal by Subject|0|||
19564308|NCT01159665|42012061|FG004|Overall Study|Withdrawal by Subject|0|||
19564309|NCT01159665|42012062|FG005|Overall Study|Withdrawal by Subject|0|||
19564310|NCT01159431|42012078|FG000|Overall Study|Adverse Event|1|||
19564311|NCT01159431|42012079|FG001|Overall Study|Adverse Event|2|||
19564312|NCT01159431|42012078|FG000|Overall Study|non-compliance|1|||
19564313|NCT01159431|42012079|FG001|Overall Study|non-compliance|1|||
19564314|NCT01159431|42012078|FG000|Overall Study|Lack of Efficacy|0|||
19564315|NCT01159431|42012079|FG001|Overall Study|Lack of Efficacy|3|||
19564316|NCT01158261|42012092|FG000|Overall Study|Lost to Follow-up|9|||
19564317|NCT01158261|42012092|FG000|Overall Study|Death|7|||
19564318|NCT01158261|42012092|FG000|Overall Study|Withdrawal by Subject|1|||
19564319|NCT01157169|42012098|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
19564320|NCT01157169|42012099|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
19564321|NCT01157169|42012098|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
19564322|NCT01157169|42012099|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
19564323|NCT01231620|42012108|FG000|Overall Study|Physician Decision|3|||
19564324|NCT01231620|42012109|FG001|Overall Study|Physician Decision|5|||
19564325|NCT01231620|42012110|FG002|Overall Study|Physician Decision|10|||
19564326|NCT01231620|42012108|FG000|Overall Study|Death|12|||
19564327|NCT01231620|42012109|FG001|Overall Study|Death|14|||
19564328|NCT01231620|42012110|FG002|Overall Study|Death|11|||
19564329|NCT01231620|42012108|FG000|Overall Study|Adverse Event|2|||
19564330|NCT01231620|42012109|FG001|Overall Study|Adverse Event|2|||
19564331|NCT01231620|42012110|FG002|Overall Study|Adverse Event|1|||
19564332|NCT01231620|42012108|FG000|Overall Study|Withdrawal by Subject|6|||
19564333|NCT01231620|42012109|FG001|Overall Study|Withdrawal by Subject|6|||
19564334|NCT01231620|42012110|FG002|Overall Study|Withdrawal by Subject|8|||
19564335|NCT01231620|42012108|FG000|Overall Study|Lost to Follow-up|3|||
19564336|NCT01231620|42012109|FG001|Overall Study|Lost to Follow-up|4|||
19564337|NCT01231620|42012110|FG002|Overall Study|Lost to Follow-up|9|||
19564338|NCT01809691|42012120|FG000|Overall Study|Currently on Treatment|192|||
19564339|NCT01809691|42012121|FG001|Overall Study|Currently on Treatment|100|||
19564340|NCT01809691|42012120|FG000|Overall Study|No Protocol Treatment|10|||
19564341|NCT01809691|42012121|FG001|Overall Study|No Protocol Treatment|11|||
19564342|NCT01809691|42012120|FG000|Overall Study|Adverse Event|80|||
19564343|NCT01809691|42012121|FG001|Overall Study|Adverse Event|21|||
19564344|NCT01809691|42012120|FG000|Overall Study|Disease Progression|226|||
19564345|NCT01809691|42012121|FG001|Overall Study|Disease Progression|372|||
19564346|NCT01809691|42012120|FG000|Overall Study|Death|26|||
19564347|NCT01809691|42012121|FG001|Overall Study|Death|13|||
19564348|NCT01809691|42012120|FG000|Overall Study|Participant Refusal|70|||
19564349|NCT01809691|42012121|FG001|Overall Study|Participant Refusal|72|||
19564350|NCT01809691|42012120|FG000|Overall Study|Other, Not Specified|34|||
19564351|NCT01809691|42012121|FG001|Overall Study|Other, Not Specified|52|||
19564352|NCT01231464|42012129|FG000|Overall Study|Adverse Event|0|||
19564353|NCT01231464|42012130|FG001|Overall Study|Adverse Event|1|||
19564354|NCT01231464|42012129|FG000|Overall Study|Protocol Violation|1|||
19564355|NCT01231464|42012130|FG001|Overall Study|Protocol Violation|2|||
19564356|NCT01231464|42012129|FG000|Overall Study|Lost to Follow-up|1|||
19564357|NCT01231464|42012130|FG001|Overall Study|Lost to Follow-up|2|||
19564358|NCT01231464|42012129|FG000|Overall Study|Withdrawal by Subject|3|||
19740162|NCT00099359|42187083|FG002|Overall Study|Withdrawal by Subject|23|||
19564359|NCT01231464|42012130|FG001|Overall Study|Withdrawal by Subject|2|||
19564360|NCT01156311|42012140|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
19564361|NCT01156311|42012141|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
19564362|NCT01156311|42012142|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
19564363|NCT01156311|42012143|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
19564364|NCT01156311|42012140|FG000|2-Month Monotherapy Period|Physician Decision|0|||
19564365|NCT01156311|42012141|FG001|2-Month Monotherapy Period|Physician Decision|1|||
19564366|NCT01156311|42012142|FG002|2-Month Monotherapy Period|Physician Decision|0|||
19564367|NCT01156311|42012143|FG003|2-Month Monotherapy Period|Physician Decision|0|||
19564368|NCT01156311|42012140|FG000|2-Month Monotherapy Period|Other|1|||
19564369|NCT01156311|42012141|FG001|2-Month Monotherapy Period|Other|0|||
19564370|NCT01156311|42012142|FG002|2-Month Monotherapy Period|Other|0|||
19564371|NCT01156311|42012143|FG003|2-Month Monotherapy Period|Other|0|||
19564372|NCT01156311|42012140|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
19564373|NCT01156311|42012141|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
19564374|NCT01156311|42012142|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
19564375|NCT01156311|42012143|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
19564376|NCT01156311|42012140|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
19564377|NCT01156311|42012141|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
19564378|NCT01156311|42012142|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
19564379|NCT01156311|42012143|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
19564380|NCT01156311|42012140|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
19564381|NCT01156311|42012141|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
19564382|NCT01156311|42012142|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
19564383|NCT01156311|42012143|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
19564384|NCT01156311|42012140|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
19564385|NCT01156311|42012141|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
19564386|NCT01156311|42012142|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
19564387|NCT01156311|42012143|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
19564388|NCT01156311|42012140|FG000|6-month Add-on Therapy Period|Other|0|||
19564389|NCT01156311|42012141|FG001|6-month Add-on Therapy Period|Other|0|||
19564390|NCT01156311|42012142|FG002|6-month Add-on Therapy Period|Other|1|||
19564391|NCT01156311|42012143|FG003|6-month Add-on Therapy Period|Other|2|||
19564392|NCT01230060|42012154|FG000|Overall Study|Withdrawal by Subject|1|||
19564393|NCT01155531|42012162|FG000|Overall Study|Adverse Event|0|||
19564394|NCT01155531|42012163|FG001|Overall Study|Adverse Event|0|||
19564395|NCT01155531|42012164|FG002|Overall Study|Adverse Event|1|||
19564396|NCT01155531|42012165|FG003|Overall Study|Adverse Event|0|||
19564397|NCT01155531|42012162|FG000|Overall Study|Lost to Follow-up|0|||
19564398|NCT01155531|42012163|FG001|Overall Study|Lost to Follow-up|0|||
19564399|NCT01155531|42012164|FG002|Overall Study|Lost to Follow-up|0|||
19564400|NCT01155531|42012165|FG003|Overall Study|Lost to Follow-up|1|||
19564401|NCT01155531|42012162|FG000|Overall Study|Withdrawal by Subject|1|||
19564402|NCT01155531|42012163|FG001|Overall Study|Withdrawal by Subject|0|||
19564403|NCT01155531|42012164|FG002|Overall Study|Withdrawal by Subject|1|||
19564404|NCT01155531|42012165|FG003|Overall Study|Withdrawal by Subject|0|||
19564405|NCT01155219|42012177|FG000|Overall Study|Adverse Event|3|||
19564406|NCT01155219|42012178|FG001|Overall Study|Adverse Event|1|||
19564407|NCT01155219|42012177|FG000|Overall Study|non-medical reason|1|||
19564408|NCT01155219|42012178|FG001|Overall Study|non-medical reason|2|||
19564409|NCT01229436|42012184|FG000|Overall Study|Withdrawal by Subject|2|||
19564410|NCT01229436|42012184|FG000|Overall Study|Lost to Follow-up|3|||
19564411|NCT01155141|42012188|FG000|Overall Study|Withdrawal by Subject|1|||
19564412|NCT01155141|42012188|FG000|Overall Study|Screen Failure|1|||
19564413|NCT01155063|42012192|FG000|Overall Study|Adverse Event|1|||
19564414|NCT01155063|42012192|FG000|Overall Study|Withdrawal by Subject|1|||
19564415|NCT01155063|42012192|FG000|Overall Study|Study terminated by sponsor|87|||
19564416|NCT01154673|42012198|FG000|Overall Study|Lost to Follow-up|1|||
19564417|NCT01154673|42012199|FG001|Overall Study|Lost to Follow-up|0|||
19564418|NCT01154673|42012198|FG000|Overall Study|moved out of province|1|||
19564419|NCT01154673|42012199|FG001|Overall Study|moved out of province|0|||
19564420|NCT01154283|42012207|FG000|0-6 Weeks|Withdrawal by Subject|7|||
19564421|NCT01154283|42012208|FG001|0-6 Weeks|Withdrawal by Subject|2|||
19564422|NCT01154283|42012207|FG000|0-6 Weeks|Death|0|||
19564423|NCT01154283|42012208|FG001|0-6 Weeks|Death|1|||
19564424|NCT01154283|42012207|FG000|7-12 Weeks|Death|1|||
19564425|NCT01154283|42012208|FG001|7-12 Weeks|Death|0|||
19564426|NCT01154283|42012207|FG000|7-12 Weeks|Withdrawal by Subject|0|||
19564427|NCT01154283|42012208|FG001|7-12 Weeks|Withdrawal by Subject|1|||
19564428|NCT00944125|42012214|FG000|3 to 6 Months|Withdrawal by Subject|0|||
19564429|NCT00944125|42012215|FG001|3 to 6 Months|Withdrawal by Subject|2|||
19564430|NCT00944125|42012214|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
19564431|NCT00944125|42012215|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
19564432|NCT00912223|42012221|FG000|Overall Study|Withdrawal by Subject|1|||
19564433|NCT00912223|42012221|FG000|Overall Study|Not transplanted|1|||
19564434|NCT00912223|42012221|FG000|Overall Study|Transformed disease|1|||
19564435|NCT01154127|42012227|FG000|Period 1 (21 Days)|Adverse Event|3|||
19564436|NCT01154127|42012228|FG001|Period 1 (21 Days)|Adverse Event|4|||
19564437|NCT01154127|42012227|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
19564438|NCT01154127|42012228|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
19564439|NCT01154127|42012227|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
19564440|NCT01154127|42012228|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
19564441|NCT01154127|42012227|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
19564442|NCT01154127|42012228|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
19564443|NCT01154127|42012227|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
19564444|NCT01154127|42012228|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
19564445|NCT01228734|42012236|FG000|Overall Study|Randomized, but not treated|0|||
19564446|NCT01228734|42012237|FG001|Overall Study|Randomized, but not treated|4|||
19564447|NCT01227954|42012243|FG000|Overall Study|Protocol Violation|6|||
19564448|NCT01227954|42012243|FG000|Overall Study|No protocol treatment|7|||
19564449|NCT01153971|42012247|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
19564450|NCT01153971|42012247|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
19564451|NCT01153971|42012247|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
19564452|NCT01153971|42012247|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
19564453|NCT01153971|42012247|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
19564454|NCT01153971|42012247|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
19564455|NCT01153971|42012247|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
19564456|NCT01153893|42012253|FG000|Overall Study|Adverse Event|1|||
19564457|NCT01153893|42012254|FG001|Overall Study|Adverse Event|0|||
19564458|NCT00951379|42012262|FG000|Overall Study|Adverse Event|4|||
19564459|NCT00951379|42012263|FG001|Overall Study|Adverse Event|1|||
19564460|NCT00951379|42012262|FG000|Overall Study|Withdrawal by Subject|1|||
19564461|NCT00951379|42012263|FG001|Overall Study|Withdrawal by Subject|0|||
19564462|NCT00951379|42012262|FG000|Overall Study|Noncompliance|1|||
19564463|NCT00951379|42012263|FG001|Overall Study|Noncompliance|0|||
19564464|NCT00951379|42012262|FG000|Overall Study|Disease Progression|0|||
19564465|NCT00951379|42012263|FG001|Overall Study|Disease Progression|1|||
19564466|NCT01153815|42012279|FG000|Overall Study|Adverse Event|3|||
19564467|NCT01153815|42012280|FG001|Overall Study|Adverse Event|1|||
19564468|NCT01153815|42012279|FG000|Overall Study|Withdrawal by Subject|6|||
19564469|NCT01153815|42012280|FG001|Overall Study|Withdrawal by Subject|4|||
19564470|NCT01153425|42012288|FG000|Overall Study|Withdrawal by Subject|3|||
19564471|NCT01153425|42012289|FG001|Overall Study|Withdrawal by Subject|3|||
19564472|NCT01153347|42012300|FG000|Overall Study|Withdrawal by Subject|7|||
19564473|NCT01153347|42012301|FG001|Overall Study|Withdrawal by Subject|7|||
19564474|NCT01153347|42012302|FG002|Overall Study|Withdrawal by Subject|7|||
19564475|NCT01153347|42012303|FG003|Overall Study|Withdrawal by Subject|7|||
19564476|NCT01153347|42012300|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19564477|NCT01153347|42012301|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19564478|NCT01153347|42012302|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
19564479|NCT01153347|42012303|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
19564480|NCT01153347|42012300|FG000|Overall Study|Adverse Event|3|||
19564481|NCT01153347|42012301|FG001|Overall Study|Adverse Event|9|||
19564482|NCT01153347|42012302|FG002|Overall Study|Adverse Event|21|||
19564483|NCT01153347|42012303|FG003|Overall Study|Adverse Event|7|||
19564484|NCT01153347|42012300|FG000|Overall Study|Severe non-compliance to protocol|6|||
19564485|NCT01153347|42012301|FG001|Overall Study|Severe non-compliance to protocol|7|||
19564486|NCT01153347|42012302|FG002|Overall Study|Severe non-compliance to protocol|4|||
19564487|NCT01153347|42012303|FG003|Overall Study|Severe non-compliance to protocol|3|||
19564488|NCT01153347|42012300|FG000|Overall Study|Condition under investigation worsened|1|||
19564489|NCT01153347|42012301|FG001|Overall Study|Condition under investigation worsened|1|||
19564490|NCT01153347|42012302|FG002|Overall Study|Condition under investigation worsened|0|||
19564491|NCT01153347|42012303|FG003|Overall Study|Condition under investigation worsened|0|||
19564492|NCT01153347|42012300|FG000|Overall Study|Lack of Efficacy|2|||
19564493|NCT01153347|42012301|FG001|Overall Study|Lack of Efficacy|2|||
19564494|NCT01153347|42012302|FG002|Overall Study|Lack of Efficacy|0|||
19564495|NCT01153347|42012303|FG003|Overall Study|Lack of Efficacy|4|||
19564496|NCT01153347|42012300|FG000|Overall Study|Study-specific withdrawal criteria|4|||
19564497|NCT01153347|42012301|FG001|Overall Study|Study-specific withdrawal criteria|3|||
19564498|NCT01153347|42012302|FG002|Overall Study|Study-specific withdrawal criteria|1|||
19740163|NCT00099359|42187081|FG000|Overall Study|Lost to Follow-up|15|||
19740164|NCT00099359|42187082|FG001|Overall Study|Lost to Follow-up|24|||
19740165|NCT00099359|42187083|FG002|Overall Study|Lost to Follow-up|24|||
19740166|NCT00099359|42187081|FG000|Overall Study|moved out of area|9|||
19740167|NCT00099359|42187082|FG001|Overall Study|moved out of area|7|||
19564499|NCT01153347|42012303|FG003|Overall Study|Study-specific withdrawal criteria|2|||
19564500|NCT01153347|42012300|FG000|Overall Study|Lost to Follow-up|4|||
19564501|NCT01153347|42012301|FG001|Overall Study|Lost to Follow-up|9|||
19564502|NCT01153347|42012302|FG002|Overall Study|Lost to Follow-up|11|||
19564503|NCT01153347|42012303|FG003|Overall Study|Lost to Follow-up|8|||
19564504|NCT01153347|42012300|FG000|Overall Study|Other|5|||
19564505|NCT01153347|42012301|FG001|Overall Study|Other|5|||
19564506|NCT01153347|42012302|FG002|Overall Study|Other|4|||
19564507|NCT01153347|42012303|FG003|Overall Study|Other|0|||
19564508|NCT01153347|42012300|FG000|Overall Study|Death|1|||
19564509|NCT01153347|42012301|FG001|Overall Study|Death|0|||
19564510|NCT01153347|42012302|FG002|Overall Study|Death|0|||
19564511|NCT01153347|42012303|FG003|Overall Study|Death|0|||
19564512|NCT01153269|42012313|FG000|Overall Study|Withdrawal by Subject|1|||
19564513|NCT01153269|42012313|FG000|Overall Study|Antiretroviral therapy break|1|||
19564514|NCT01152021|42012322|FG000|Overall Study|Adverse Event|4|||
19564515|NCT01152021|42012323|FG001|Overall Study|Adverse Event|4|||
19564516|NCT01152021|42012322|FG000|Overall Study|Study drug had expired|1|||
19740168|NCT00099359|42187083|FG002|Overall Study|moved out of area|4|||
19564517|NCT01152021|42012323|FG001|Overall Study|Study drug had expired|0|||
19564518|NCT01152021|42012322|FG000|Overall Study|Physician Decision|1|||
19564519|NCT01152021|42012323|FG001|Overall Study|Physician Decision|1|||
19564520|NCT01152021|42012322|FG000|Overall Study|No access to study drug in Pharmacy|0|||
19564521|NCT01152021|42012323|FG001|Overall Study|No access to study drug in Pharmacy|1|||
19740169|NCT00092495|42187105|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
19564522|NCT01151085|42012331|FG000|Overall Study|Lost to Follow-up|31|||
19564523|NCT01151085|42012331|FG000|Overall Study|Protocol Violation|25|||
19564524|NCT01149681|42012342|FG000|Overall Study|Withdrawal by Subject|7|||
19564525|NCT01149681|42012342|FG000|Overall Study|Progressive disease|1|||
19564526|NCT01149681|42012342|FG000|Overall Study|Physician Decision|2|||
19564527|NCT01149681|42012342|FG000|Overall Study|adverse events nonrelated study drug|2|||
19564528|NCT01149369|42012349|FG000|Overall Study|Adverse Event|6|||
19564529|NCT01149369|42012350|FG001|Overall Study|Adverse Event|3|||
19564530|NCT01740427|42012358|FG000|Overall Study|Ongoing|45|||
19564531|NCT01740427|42012359|FG001|Overall Study|Ongoing|5|||
19564532|NCT01740427|42012358|FG000|Overall Study|Objective Progression or Relapse|281|||
19564533|NCT01740427|42012359|FG001|Overall Study|Objective Progression or Relapse|171|||
19564534|NCT01740427|42012358|FG000|Overall Study|Adverse Event|31|||
19564535|NCT01740427|42012359|FG001|Overall Study|Adverse Event|9|||
19564536|NCT01740427|42012358|FG000|Overall Study|Global Deterioration of Health Status|28|||
19564537|NCT01740427|42012359|FG001|Overall Study|Global Deterioration of Health Status|12|||
19564538|NCT01740427|42012358|FG000|Overall Study|Participant Refused Continued Treatment|26|||
19564539|NCT01740427|42012359|FG001|Overall Study|Participant Refused Continued Treatment|15|||
19564540|NCT01740427|42012358|FG000|Overall Study|Unspecified reasons|15|||
19564541|NCT01740427|42012359|FG001|Overall Study|Unspecified reasons|4|||
19564542|NCT01740427|42012358|FG000|Overall Study|Death|10|||
19564543|NCT01740427|42012359|FG001|Overall Study|Death|3|||
19564544|NCT01740427|42012358|FG000|Overall Study|Protocol Violation|5|||
19564545|NCT01740427|42012359|FG001|Overall Study|Protocol Violation|3|||
19564546|NCT01740427|42012358|FG000|Overall Study|Lost to Follow-up|2|||
19564547|NCT01740427|42012359|FG001|Overall Study|Lost to Follow-up|0|||
19564548|NCT01740427|42012358|FG000|Overall Study|Site Terminated by Sponsor|1|||
19564549|NCT01740427|42012359|FG001|Overall Study|Site Terminated by Sponsor|0|||
19564550|NCT01149057|42012365|FG000|Overall Study|Lack of Efficacy|16|||
19564551|NCT01149057|42012365|FG000|Overall Study|Adverse Event|13|||
19564552|NCT01149057|42012365|FG000|Overall Study|Withdrawal by Subject|9|||
19564553|NCT01149057|42012365|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
19564554|NCT01149057|42012365|FG000|Overall Study|B Cell Depletion|4|||
19564555|NCT01149057|42012365|FG000|Overall Study|Participant Non-Compliance|2|||
19564556|NCT01149057|42012365|FG000|Overall Study|Lost to Follow-up|1|||
19564557|NCT01149057|42012365|FG000|Overall Study|High Parathyroid Hormone Value|1|||
19564558|NCT01149057|42012365|FG000|Overall Study|Other|6|||
19564559|NCT01227564|42012372|FG000|Overall Study|No Longer Willing to Participate|4|||
19564560|NCT01227564|42012373|FG001|Overall Study|No Longer Willing to Participate|2|||
19564561|NCT01227564|42012374|FG002|Overall Study|No Longer Willing to Participate|5|||
19564562|NCT01227564|42012372|FG000|Overall Study|Participant moved to another town|0|||
19564563|NCT01227564|42012373|FG001|Overall Study|Participant moved to another town|0|||
19564564|NCT01227564|42012374|FG002|Overall Study|Participant moved to another town|1|||
19564565|NCT01148979|42012390|FG000|Overall Study|Lost to Follow-up|0|||
19564566|NCT01148979|42012391|FG001|Overall Study|Lost to Follow-up|1|||
19564567|NCT01148511|42012399|FG000|Exposed to Study Drug|Protocol Violation|2|||
19564568|NCT01148511|42012400|FG001|Exposed to Study Drug|Protocol Violation|0|||
19564569|NCT01148511|42012401|FG002|Exposed to Study Drug|Protocol Violation|0|||
19564570|NCT01148511|42012399|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
19564571|NCT01148511|42012400|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
19564572|NCT01148511|42012401|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
19564573|NCT01148511|42012399|FG000|Randomized|Adverse Event|0|||
19564574|NCT01148511|42012400|FG001|Randomized|Adverse Event|1|||
19564575|NCT01148511|42012401|FG002|Randomized|Adverse Event|0|||
19564576|NCT01148511|42012399|FG000|Randomized|Protocol Violation|0|||
19564577|NCT01148511|42012400|FG001|Randomized|Protocol Violation|2|||
19564578|NCT01148511|42012401|FG002|Randomized|Protocol Violation|1|||
19564579|NCT01148511|42012399|FG000|Randomized|Lost to Follow-up|0|||
19564580|NCT01148511|42012400|FG001|Randomized|Lost to Follow-up|1|||
19564581|NCT01148511|42012401|FG002|Randomized|Lost to Follow-up|1|||
19564582|NCT01148511|42012399|FG000|Randomized|Consent withdrawal|0|||
19564583|NCT01148511|42012400|FG001|Randomized|Consent withdrawal|5|||
19564584|NCT01148511|42012401|FG002|Randomized|Consent withdrawal|3|||
19564585|NCT01148511|42012399|FG000|Randomized|Other|0|||
19564586|NCT01148511|42012400|FG001|Randomized|Other|1|||
19564587|NCT01148511|42012401|FG002|Randomized|Other|1|||
19564588|NCT00547339|42012412|FG000|Overall Study|Physician Decision|0|||
19564589|NCT00547339|42012413|FG001|Overall Study|Physician Decision|0|||
19564590|NCT00547339|42012414|FG002|Overall Study|Physician Decision|1|||
19564591|NCT00547339|42012415|FG003|Overall Study|Physician Decision|0|||
19564592|NCT01227252|42012438|FG000|Overall Study|Sponsor Decision|0|||
19564593|NCT01227252|42012439|FG001|Overall Study|Sponsor Decision|1|||
19564594|NCT01227252|42012440|FG002|Overall Study|Sponsor Decision|0|||
19564595|NCT01227252|42012441|FG003|Overall Study|Sponsor Decision|0|||
19564596|NCT01227252|42012438|FG000|Overall Study|Lost to Follow-up|0|||
19564597|NCT01227252|42012439|FG001|Overall Study|Lost to Follow-up|1|||
19564598|NCT01227252|42012440|FG002|Overall Study|Lost to Follow-up|0|||
19564599|NCT01227252|42012441|FG003|Overall Study|Lost to Follow-up|0|||
19564600|NCT01227252|42012438|FG000|Overall Study|Withdrawal by Subject|0|||
19564601|NCT01227252|42012439|FG001|Overall Study|Withdrawal by Subject|1|||
19564602|NCT01227252|42012440|FG002|Overall Study|Withdrawal by Subject|0|||
19564603|NCT01227252|42012441|FG003|Overall Study|Withdrawal by Subject|0|||
19564604|NCT01661881|42012454|FG000|Overall Study|Disease Progression|1|||
19564605|NCT01227018|42012458|FG000|Overall Study|Disease progression|9|||
19564606|NCT01227018|42012458|FG000|Overall Study|Toxicity|2|||
19564607|NCT01227018|42012458|FG000|Overall Study|Withdrew after beginning treatment|4|||
19564608|NCT01226472|42012472|FG000|Overall Study|Progressive Disease|1|||
19564609|NCT01225146|42012478|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
19564610|NCT01225146|42012479|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
19564611|NCT01223196|42012489|FG000|Overall Study|Lost to Follow-up|2|||
19564612|NCT01223196|42012490|FG001|Overall Study|Lost to Follow-up|0|||
19564613|NCT01223196|42012489|FG000|Overall Study|Physician Decision|1|||
19564614|NCT01223196|42012490|FG001|Overall Study|Physician Decision|0|||
19564615|NCT01223196|42012489|FG000|Overall Study|Withdrawal by Subject|1|||
19564616|NCT01223196|42012490|FG001|Overall Study|Withdrawal by Subject|0|||
19564617|NCT01222416|42012500|FG000|Overall Study|ineligible;metastasis|3|||
19564618|NCT01222416|42012501|FG001|Overall Study|ineligible;metastasis|0|||
19564619|NCT01222416|42012500|FG000|Overall Study|Adverse Event|4|||
19564620|NCT01222416|42012501|FG001|Overall Study|Adverse Event|0|||
19564621|NCT01222416|42012500|FG000|Overall Study|Withdrawal by Subject|5|||
19564622|NCT01222416|42012501|FG001|Overall Study|Withdrawal by Subject|0|||
19564623|NCT01222416|42012500|FG000|Overall Study|scheduling|6|||
19564624|NCT01222416|42012501|FG001|Overall Study|scheduling|0|||
19564625|NCT01222416|42012500|FG000|Overall Study|missed view/scan|1|||
19564626|NCT01222416|42012501|FG001|Overall Study|missed view/scan|0|||
19564627|NCT01222416|42012500|FG000|Overall Study|Death|1|||
19564628|NCT01222416|42012501|FG001|Overall Study|Death|0|||
19564629|NCT01222104|42012507|FG000|Overall Study|Lost to Follow-up|37|||
19564630|NCT01222104|42012507|FG000|Overall Study|Death|10|||
19564631|NCT01221948|42012517|FG000|Overall Study|Physician Decision|5|||
19564632|NCT01221948|42012517|FG000|Overall Study|Withdrawal by Subject|2|||
19564633|NCT01221948|42012517|FG000|Overall Study|not disclosed|2|||
19564634|NCT01221948|42012517|FG000|Overall Study|Death|1|||
19564635|NCT01221948|42012517|FG000|Overall Study|Protocol Violation|4|||
19564636|NCT01221090|42012525|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
19564637|NCT01221090|42012526|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
19564638|NCT01221090|42012527|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
19564639|NCT01221090|42012528|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
19564640|NCT01221090|42012525|FG000|Overall Study|Withdrawal by Subject|0|||
19564641|NCT01221090|42012526|FG001|Overall Study|Withdrawal by Subject|22|||
19564642|NCT01221090|42012527|FG002|Overall Study|Withdrawal by Subject|27|||
19564643|NCT01221090|42012528|FG003|Overall Study|Withdrawal by Subject|2|||
19564644|NCT00950911|42012540|FG000|Overall Study|Adverse Event|0|||
19564645|NCT00950911|42012541|FG001|Overall Study|Adverse Event|2|||
19564646|NCT00950911|42012540|FG000|Overall Study|Death|4|||
19564647|NCT00950911|42012541|FG001|Overall Study|Death|6|||
19564648|NCT00950911|42012540|FG000|Overall Study|Disease progression|2|||
19564649|NCT00950911|42012541|FG001|Overall Study|Disease progression|2|||
19564650|NCT00950911|42012540|FG000|Overall Study|Consent withdrawn|1|||
19564651|NCT00950911|42012541|FG001|Overall Study|Consent withdrawn|3|||
19564652|NCT00950911|42012540|FG000|Overall Study|Administrative decision|3|||
19564653|NCT00950911|42012541|FG001|Overall Study|Administrative decision|1|||
19564654|NCT00950911|42012540|FG000|Overall Study|Ineligibility determined|1|||
19564655|NCT00950911|42012541|FG001|Overall Study|Ineligibility determined|0|||
19564656|NCT00950911|42012540|FG000|Overall Study|Noncompliance|1|||
19564657|NCT00950911|42012541|FG001|Overall Study|Noncompliance|0|||
19564658|NCT00950911|42012540|FG000|Overall Study|Poor performance status|0|||
19564659|NCT00950911|42012541|FG001|Overall Study|Poor performance status|1|||
19564660|NCT01220856|42012549|FG000|Overall Study|graft loss|3|||
19564661|NCT01220856|42012550|FG001|Overall Study|graft loss|3|||
19564662|NCT01220856|42012549|FG000|Overall Study|Lost to Follow-up|1|||
19564663|NCT01220856|42012550|FG001|Overall Study|Lost to Follow-up|0|||
19564664|NCT01218594|42012559|FG000|Overall Study|Death|1|||
19564665|NCT01218594|42012559|FG000|Overall Study|Withdrawal by Subject|3|||
19564666|NCT01218594|42012559|FG000|Overall Study|Adverse Event|2|||
19564667|NCT01218594|42012559|FG000|Overall Study|Physician Decision|6|||
19740170|NCT00092495|42187106|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
19740171|NCT00092495|42187107|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19740172|NCT00092495|42187108|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
19740173|NCT00092495|42187109|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
19740174|NCT00092495|42187105|FG000|Base Study Vaccination Period|Extended|0|||
19740175|NCT00092495|42187106|FG001|Base Study Vaccination Period|Extended|0|||
19740176|NCT00092495|42187107|FG002|Base Study Vaccination Period|Extended|0|||
19740177|NCT00092495|42187108|FG003|Base Study Vaccination Period|Extended|1|||
19740178|NCT00092495|42187109|FG004|Base Study Vaccination Period|Extended|0|||
19740179|NCT00092495|42187105|FG000|Base Study Vaccination Period|*Clinical AE|1|||
19740180|NCT00092495|42187106|FG001|Base Study Vaccination Period|*Clinical AE|0|||
19740181|NCT00092495|42187107|FG002|Base Study Vaccination Period|*Clinical AE|1|||
19740182|NCT00092495|42187108|FG003|Base Study Vaccination Period|*Clinical AE|2|||
19740183|NCT00092495|42187109|FG004|Base Study Vaccination Period|*Clinical AE|0|||
19740184|NCT00092495|42187105|FG000|Base Study Vaccination Period|*Other reasons|1|||
19740185|NCT00092495|42187106|FG001|Base Study Vaccination Period|*Other reasons|0|||
19740186|NCT00092495|42187107|FG002|Base Study Vaccination Period|*Other reasons|0|||
19740187|NCT00092495|42187108|FG003|Base Study Vaccination Period|*Other reasons|1|||
19740188|NCT00092495|42187109|FG004|Base Study Vaccination Period|*Other reasons|0|||
19740189|NCT00092495|42187105|FG000|Base Study Vaccination Period|*Pregnancy|0|||
19740190|NCT00092495|42187106|FG001|Base Study Vaccination Period|*Pregnancy|2|||
19740191|NCT00092495|42187107|FG002|Base Study Vaccination Period|*Pregnancy|5|||
19740192|NCT00092495|42187108|FG003|Base Study Vaccination Period|*Pregnancy|7|||
19740193|NCT00092495|42187109|FG004|Base Study Vaccination Period|*Pregnancy|0|||
19740194|NCT00092495|42187105|FG000|Base Study Vaccination Period|Adverse Event|1|||
19740195|NCT00092495|42187106|FG001|Base Study Vaccination Period|Adverse Event|0|||
19740196|NCT00092495|42187107|FG002|Base Study Vaccination Period|Adverse Event|0|||
19740197|NCT00092495|42187108|FG003|Base Study Vaccination Period|Adverse Event|3|||
19740198|NCT00092495|42187109|FG004|Base Study Vaccination Period|Adverse Event|0|||
19740199|NCT00092495|42187105|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
19740200|NCT00092495|42187106|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
19740201|NCT00092495|42187107|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
19740202|NCT00092495|42187108|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
19740203|NCT00092495|42187109|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
19740204|NCT00092495|42187105|FG000|Base Study Vaccination Period|Moved|3|||
19740205|NCT00092495|42187106|FG001|Base Study Vaccination Period|Moved|1|||
19740206|NCT00092495|42187107|FG002|Base Study Vaccination Period|Moved|2|||
19740207|NCT00092495|42187108|FG003|Base Study Vaccination Period|Moved|2|||
19740208|NCT00092495|42187109|FG004|Base Study Vaccination Period|Moved|0|||
19740209|NCT00092495|42187105|FG000|Base Study Vaccination Period|Other|1|||
19740210|NCT00092495|42187106|FG001|Base Study Vaccination Period|Other|1|||
19740211|NCT00092495|42187107|FG002|Base Study Vaccination Period|Other|0|||
19564668|NCT01610557|42012567|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
19564669|NCT01610557|42012568|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
19564670|NCT01610557|42012569|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
19564671|NCT01610557|42012570|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
19564672|NCT01610557|42012571|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
19564673|NCT01610557|42012567|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
19564674|NCT01610557|42012568|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
19564675|NCT01610557|42012569|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
19564676|NCT01610557|42012570|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
19564677|NCT01610557|42012571|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
19564678|NCT00943735|42012582|FG000|Overall Study|Adverse Event|12|||
19564679|NCT00943735|42012582|FG000|Overall Study|Withdrawal by Subject|8|||
19564680|NCT00943735|42012582|FG000|Overall Study|Death|1|||
19564681|NCT00943735|42012582|FG000|Overall Study|Other|8|||
19564682|NCT00943735|42012582|FG000|Overall Study|Other|3|||
19564683|NCT00943579|42012588|FG000|Overall Study|Adverse Event|4|||
19564684|NCT00943579|42012589|FG001|Overall Study|Adverse Event|3|||
19564685|NCT00943579|42012588|FG000|Overall Study|Lack of Efficacy|2|||
19564686|NCT00943579|42012589|FG001|Overall Study|Lack of Efficacy|2|||
19564687|NCT00489307|42012600|FG000|Overall Study|Death|1|||
19564688|NCT00489307|42012601|FG001|Overall Study|Death|1|||
19564689|NCT00489307|42012600|FG000|Overall Study|Lost to Follow-up|2|||
19564690|NCT00489307|42012601|FG001|Overall Study|Lost to Follow-up|2|||
19564691|NCT00489307|42012600|FG000|Overall Study|Physician Decision|1|||
19564692|NCT00489307|42012601|FG001|Overall Study|Physician Decision|0|||
19564693|NCT00489307|42012600|FG000|Overall Study|Withdrawal by Subject|2|||
19564694|NCT00489307|42012601|FG001|Overall Study|Withdrawal by Subject|4|||
19564695|NCT00489307|42012600|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
19564696|NCT00489307|42012601|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
19564697|NCT00489307|42012600|FG000|Overall Study|Surgery after assignment|1|||
19740212|NCT00092495|42187108|FG003|Base Study Vaccination Period|Other|2|||
19564698|NCT00489307|42012601|FG001|Overall Study|Surgery after assignment|0|||
19564699|NCT00489307|42012600|FG000|Overall Study|Did not fill up the forms|2|||
19564700|NCT00489307|42012601|FG001|Overall Study|Did not fill up the forms|1|||
19564701|NCT00489307|42012600|FG000|Overall Study|Patient or family refusal|5|||
19564702|NCT00489307|42012601|FG001|Overall Study|Patient or family refusal|9|||
19564703|NCT01147809|42012613|FG000|Phase I (168 Days)|Adverse Event|0|||
19564704|NCT01147809|42012614|FG001|Phase I (168 Days)|Adverse Event|0|||
19564705|NCT01147809|42012615|FG002|Phase I (168 Days)|Adverse Event|0|||
19564706|NCT01147809|42012616|FG003|Phase I (168 Days)|Adverse Event|1|||
19564707|NCT01147809|42012617|FG004|Phase I (168 Days)|Adverse Event|0|||
19564708|NCT01147809|42012618|FG005|Phase I (168 Days)|Adverse Event|0|||
19564709|NCT01147809|42012613|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
19564710|NCT01147809|42012614|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
19564711|NCT01147809|42012615|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
19564712|NCT01147809|42012616|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
19564713|NCT01147809|42012617|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
19564714|NCT01147809|42012618|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
19564715|NCT01147809|42012613|FG000|Phase I (168 Days)|Physician Decision|0|||
19564716|NCT01147809|42012614|FG001|Phase I (168 Days)|Physician Decision|1|||
19564717|NCT01147809|42012615|FG002|Phase I (168 Days)|Physician Decision|2|||
19564718|NCT01147809|42012616|FG003|Phase I (168 Days)|Physician Decision|0|||
19564719|NCT01147809|42012617|FG004|Phase I (168 Days)|Physician Decision|0|||
19564720|NCT01147809|42012618|FG005|Phase I (168 Days)|Physician Decision|0|||
19564721|NCT01147809|42012613|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
19564722|NCT01147809|42012614|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
19564723|NCT01147809|42012615|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
19564724|NCT01147809|42012616|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
19564725|NCT01147809|42012617|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
19564726|NCT01147809|42012618|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
19564727|NCT01147809|42012613|FG000|Phase II (168 Days)|Adverse Event|0|||
19564728|NCT01147809|42012614|FG001|Phase II (168 Days)|Adverse Event|0|||
19564729|NCT01147809|42012615|FG002|Phase II (168 Days)|Adverse Event|0|||
19564730|NCT01147809|42012616|FG003|Phase II (168 Days)|Adverse Event|0|||
19564731|NCT01147809|42012617|FG004|Phase II (168 Days)|Adverse Event|3|||
19564732|NCT01147809|42012618|FG005|Phase II (168 Days)|Adverse Event|6|||
19740213|NCT00092495|42187109|FG004|Base Study Vaccination Period|Other|0|||
19740214|NCT00092495|42187105|FG000|Base Study Vaccination Period|Pregnancy|2|||
19740215|NCT00092495|42187106|FG001|Base Study Vaccination Period|Pregnancy|0|||
19740216|NCT00092495|42187107|FG002|Base Study Vaccination Period|Pregnancy|0|||
19740217|NCT00092495|42187108|FG003|Base Study Vaccination Period|Pregnancy|0|||
19740218|NCT00092495|42187109|FG004|Base Study Vaccination Period|Pregnancy|0|||
19740219|NCT00092495|42187105|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
19740220|NCT00092495|42187106|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
19564733|NCT01147809|42012613|FG000|Phase II (168 Days)|Protocol Violation|0|||
19564734|NCT01147809|42012614|FG001|Phase II (168 Days)|Protocol Violation|0|||
19564735|NCT01147809|42012615|FG002|Phase II (168 Days)|Protocol Violation|0|||
19564736|NCT01147809|42012616|FG003|Phase II (168 Days)|Protocol Violation|0|||
19564737|NCT01147809|42012617|FG004|Phase II (168 Days)|Protocol Violation|0|||
19564738|NCT01147809|42012618|FG005|Phase II (168 Days)|Protocol Violation|1|||
19564739|NCT01147809|42012613|FG000|Phase II (168 Days)|Physician Decision|0|||
19564740|NCT01147809|42012614|FG001|Phase II (168 Days)|Physician Decision|0|||
19564741|NCT01147809|42012615|FG002|Phase II (168 Days)|Physician Decision|0|||
19564742|NCT01147809|42012616|FG003|Phase II (168 Days)|Physician Decision|0|||
19564743|NCT01147809|42012617|FG004|Phase II (168 Days)|Physician Decision|5|||
19564744|NCT01147809|42012618|FG005|Phase II (168 Days)|Physician Decision|11|||
19564745|NCT01147809|42012613|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
19564746|NCT01147809|42012614|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
19564747|NCT01147809|42012615|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
19564748|NCT01147809|42012616|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
19382250|NCT02646891|41625498|FG008|Overall Study|Withdrawal by Subject|7|||
19564749|NCT01147809|42012617|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
19564750|NCT01147809|42012618|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
19564751|NCT01147809|42012613|FG000|Phase II (168 Days)|Ongoing|0|||
19564752|NCT01147809|42012614|FG001|Phase II (168 Days)|Ongoing|0|||
19740221|NCT00092495|42187107|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
19382251|NCT02646891|41625499|FG009|Overall Study|Withdrawal by Subject|3|||
19382252|NCT02646891|41625490|FG000|Overall Study|Death|0|||
19564753|NCT01147809|42012615|FG002|Phase II (168 Days)|Ongoing|0|||
19564754|NCT01147809|42012616|FG003|Phase II (168 Days)|Ongoing|0|||
19564755|NCT01147809|42012617|FG004|Phase II (168 Days)|Ongoing|1|||
19564756|NCT01147809|42012618|FG005|Phase II (168 Days)|Ongoing|0|||
19564757|NCT00943111|42012635|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
19564758|NCT00943111|42012636|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
19564759|NCT00943111|42012637|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
19564760|NCT00943111|42012635|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
19564761|NCT00943111|42012636|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
19564762|NCT00943111|42012637|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
19564763|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
19564764|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
19564765|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
19564766|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
19564767|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
19564768|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
19564769|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
19564770|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
19740222|NCT00092495|42187108|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
19740223|NCT00092495|42187109|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
19740224|NCT00092495|42187105|FG000|Base Study Vaccination Period|Protocol Violation|1|||
19564771|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
19564772|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
19564773|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
19564774|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
19564775|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
19564776|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
19740225|NCT00092495|42187106|FG001|Base Study Vaccination Period|Protocol Violation|0|||
19740226|NCT00092495|42187107|FG002|Base Study Vaccination Period|Protocol Violation|0|||
19740227|NCT00092495|42187108|FG003|Base Study Vaccination Period|Protocol Violation|0|||
19740228|NCT00092495|42187109|FG004|Base Study Vaccination Period|Protocol Violation|0|||
19564777|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
19564778|NCT00943111|42012635|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
19564779|NCT00943111|42012636|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
19564780|NCT00943111|42012637|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
19564781|NCT01147497|42012646|FG000|Overall Study|failed insertion|2|||
19564782|NCT01147497|42012647|FG001|Overall Study|failed insertion|0|||
19564783|NCT01147341|42012655|FG000|Double Blind Period|Lack of Efficacy|1|||
19476789|NCT01522651|41754861|FG003|Overall Study|Randomized but Never Treated|1|||
19476790|NCT01522651|41754862|FG004|Overall Study|Randomized but Never Treated|1|||
19564784|NCT01147341|42012656|FG001|Double Blind Period|Lack of Efficacy|1|||
19564785|NCT01147341|42012655|FG000|Double Blind Period|Withdrawal by Subject|0|||
19564786|NCT01147341|42012656|FG001|Double Blind Period|Withdrawal by Subject|1|||
19564787|NCT01147341|42012655|FG000|Open Label Period|Lack of Efficacy|3|||
19564788|NCT01147341|42012656|FG001|Open Label Period|Lack of Efficacy|0|||
19740229|NCT00092495|42187105|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
19740230|NCT00092495|42187106|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
19740231|NCT00092495|42187107|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
19740232|NCT00092495|42187108|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
19740233|NCT00092495|42187109|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
19740234|NCT00092495|42187105|FG000|Base Study Follow-up Period|Extended|0|||
19740235|NCT00092495|42187106|FG001|Base Study Follow-up Period|Extended|0|||
19740236|NCT00092495|42187107|FG002|Base Study Follow-up Period|Extended|1|||
19564789|NCT01147341|42012655|FG000|Open Label Period|Subject moved|1|||
19564790|NCT01147341|42012656|FG001|Open Label Period|Subject moved|0|||
19564791|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
19564792|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
19564793|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
19564794|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
19740237|NCT00092495|42187108|FG003|Base Study Follow-up Period|Extended|2|||
19740238|NCT00092495|42187109|FG004|Base Study Follow-up Period|Extended|0|||
19740239|NCT00092495|42187105|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
19740240|NCT00092495|42187106|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
19740241|NCT00092495|42187107|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
19740242|NCT00092495|42187108|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
19740243|NCT00092495|42187109|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
19740244|NCT00092495|42187105|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
19740245|NCT00092495|42187106|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
19740246|NCT00092495|42187107|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
19740247|NCT00092495|42187108|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
19740248|NCT00092495|42187109|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
19740249|NCT00092417|42187124|FG000|Overall Study|Lost to Follow-up|2|||
19740250|NCT00092417|42187125|FG001|Overall Study|Lost to Follow-up|0|||
19740251|NCT00092417|42187124|FG000|Overall Study|Withdrawal by Subject|2|||
19740252|NCT00092417|42187125|FG001|Overall Study|Withdrawal by Subject|1|||
19740253|NCT00092417|42187124|FG000|Overall Study|Other|1|||
19740254|NCT00092417|42187125|FG001|Overall Study|Other|0|||
19740255|NCT00091949|42187133|FG000|Overall Study|Withdrawal by Subject|117|||
19740256|NCT00091949|42187134|FG001|Overall Study|Withdrawal by Subject|110|||
19740257|NCT00091949|42187133|FG000|Overall Study|Lost to Follow-up|58|||
19740258|NCT00091949|42187134|FG001|Overall Study|Lost to Follow-up|41|||
19740259|NCT02258542|42187144|FG000|Overall Study|eg. not made to the visit|7|||
19740260|NCT02258542|42187145|FG001|Overall Study|eg. not made to the visit|4|||
19740261|NCT02258542|42187146|FG002|Overall Study|eg. not made to the visit|0|||
19740262|NCT02258542|42187147|FG003|Overall Study|eg. not made to the visit|1|||
19564795|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
19564796|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
19564797|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
19564798|NCT00950755|42012662|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
19564799|NCT00950755|42012662|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
19564800|NCT00950755|42012662|FG000|Long-Term Follow-Up|Death|8|||
19564801|NCT01147107|42012668|FG000|Overall Study|Lack of Efficacy|5|||
19564802|NCT01147107|42012669|FG001|Overall Study|Lack of Efficacy|0|||
19564803|NCT01147107|42012668|FG000|Overall Study|Withdrawal by Subject|1|||
19740263|NCT02258542|42187144|FG000|Overall Study|study specific discount. criteria|1|||
19740264|NCT02258542|42187145|FG001|Overall Study|study specific discount. criteria|1|||
19740265|NCT02258542|42187146|FG002|Overall Study|study specific discount. criteria|0|||
19740266|NCT02258542|42187147|FG003|Overall Study|study specific discount. criteria|0|||
19740267|NCT02258542|42187144|FG000|Overall Study|Withdrawal by Subject|20|||
19740268|NCT02258542|42187145|FG001|Overall Study|Withdrawal by Subject|20|||
19740269|NCT02258542|42187146|FG002|Overall Study|Withdrawal by Subject|7|||
19740270|NCT02258542|42187147|FG003|Overall Study|Withdrawal by Subject|1|||
19740271|NCT02258542|42187144|FG000|Overall Study|Lost to Follow-up|5|||
19564804|NCT01147107|42012669|FG001|Overall Study|Withdrawal by Subject|1|||
19564805|NCT00942409|42012675|FG000|Overall Study|Lack of Efficacy|1|||
19564806|NCT00942409|42012675|FG000|Overall Study|study drug unavailable|2|||
19564807|NCT01146951|42012681|FG000|Overall Study|Adverse Event|4|||
19564808|NCT01146951|42012682|FG001|Overall Study|Adverse Event|1|||
19564809|NCT01146873|42012690|FG000|Overall Study|Transfer out|0|||
19564810|NCT01146873|42012691|FG001|Overall Study|Transfer out|6|||
19564811|NCT01146795|42012697|FG000|Overall Study|Withdrawal by Subject|4|||
19564812|NCT01146795|42012697|FG000|Overall Study|Adverse Event|6|||
19564813|NCT01146795|42012697|FG000|Overall Study|Still in treatment at study closure|10|||
19564814|NCT01146561|42012701|FG000|Overall Study|Withdrawal by Subject|1|||
19564815|NCT01146561|42012701|FG000|Overall Study|Lost to Follow-up|1|||
19564816|NCT00942175|42012709|FG000|Overall Study|Adverse Event|2|||
19564817|NCT00942175|42012710|FG001|Overall Study|Adverse Event|1|||
19564818|NCT00942175|42012711|FG002|Overall Study|Adverse Event|0|||
19564819|NCT00942175|42012712|FG003|Overall Study|Adverse Event|0|||
19564820|NCT00942175|42012709|FG000|Overall Study|Protocol Violation|0|||
19564821|NCT00942175|42012710|FG001|Overall Study|Protocol Violation|1|||
19564822|NCT00942175|42012711|FG002|Overall Study|Protocol Violation|2|||
19564823|NCT00942175|42012712|FG003|Overall Study|Protocol Violation|0|||
19564824|NCT00942175|42012709|FG000|Overall Study|Pregnancy|0|||
19564825|NCT00942175|42012710|FG001|Overall Study|Pregnancy|0|||
19564826|NCT00942175|42012711|FG002|Overall Study|Pregnancy|0|||
19564827|NCT00942175|42012712|FG003|Overall Study|Pregnancy|1|||
19564828|NCT00942175|42012709|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
19564829|NCT00942175|42012710|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
19564830|NCT00942175|42012711|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
19564831|NCT00942175|42012712|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
19564832|NCT00942175|42012709|FG000|Overall Study|Low Platelet Count|0|||
19564833|NCT00942175|42012710|FG001|Overall Study|Low Platelet Count|2|||
19564834|NCT00942175|42012711|FG002|Overall Study|Low Platelet Count|0|||
19564835|NCT00942175|42012712|FG003|Overall Study|Low Platelet Count|0|||
19564836|NCT01145625|42012732|FG000|Overall Study|Lost to Follow-up|8|||
19564837|NCT01145625|42012733|FG001|Overall Study|Lost to Follow-up|9|||
19564838|NCT01145625|42012732|FG000|Overall Study|Adverse Event|6|||
19564839|NCT01145625|42012733|FG001|Overall Study|Adverse Event|4|||
19564840|NCT01145625|42012732|FG000|Overall Study|Protocol Violation|3|||
19564841|NCT01145625|42012733|FG001|Overall Study|Protocol Violation|1|||
19564842|NCT01145625|42012732|FG000|Overall Study|Withdrawal by Subject|7|||
19740272|NCT02258542|42187145|FG001|Overall Study|Lost to Follow-up|12|||
19564843|NCT01145625|42012733|FG001|Overall Study|Withdrawal by Subject|16|||
19740273|NCT02258542|42187146|FG002|Overall Study|Lost to Follow-up|1|||
19740274|NCT02258542|42187147|FG003|Overall Study|Lost to Follow-up|2|||
19740275|NCT02258542|42187144|FG000|Overall Study|Death|5|||
19740276|NCT02258542|42187145|FG001|Overall Study|Death|4|||
19740277|NCT02258542|42187146|FG002|Overall Study|Death|0|||
19740278|NCT02258542|42187147|FG003|Overall Study|Death|1|||
19740279|NCT02258542|42187144|FG000|Overall Study|Adverse Event|3|||
19740280|NCT02258542|42187145|FG001|Overall Study|Adverse Event|4|||
19740281|NCT02258542|42187146|FG002|Overall Study|Adverse Event|0|||
19740282|NCT02258542|42187147|FG003|Overall Study|Adverse Event|0|||
19740283|NCT02258542|42187144|FG000|Overall Study|Protocol Violation|1|||
19740284|NCT02258542|42187145|FG001|Overall Study|Protocol Violation|2|||
19740285|NCT02258542|42187146|FG002|Overall Study|Protocol Violation|0|||
19740286|NCT02258542|42187147|FG003|Overall Study|Protocol Violation|0|||
19740287|NCT02258542|42187144|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19740288|NCT02258542|42187145|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
19740289|NCT02258542|42187146|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
19740290|NCT02258542|42187147|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
19740291|NCT00091793|42187177|FG000|Overall Study|Adverse Event|1|||
19740292|NCT00091793|42187178|FG001|Overall Study|Adverse Event|2|||
19740293|NCT00091793|42187177|FG000|Overall Study|Withdrawal by Subject|10|||
19740294|NCT00091793|42187178|FG001|Overall Study|Withdrawal by Subject|15|||
19740295|NCT00091793|42187177|FG000|Overall Study|Ineligibility determined|2|||
19740296|NCT00091793|42187178|FG001|Overall Study|Ineligibility determined|0|||
19740297|NCT00091793|42187177|FG000|Overall Study|Lost to Follow-up|7|||
19740298|NCT00091793|42187178|FG001|Overall Study|Lost to Follow-up|5|||
19740299|NCT00091793|42187177|FG000|Overall Study|Noncompliance|2|||
19740300|NCT00091793|42187178|FG001|Overall Study|Noncompliance|0|||
19382253|NCT02646891|41625491|FG001|Overall Study|Death|0|||
19382254|NCT02646891|41625492|FG002|Overall Study|Death|0|||
19382255|NCT02646891|41625493|FG003|Overall Study|Death|0|||
19382256|NCT02646891|41625494|FG004|Overall Study|Death|0|||
19382257|NCT02646891|41625495|FG005|Overall Study|Death|0|||
19382258|NCT02646891|41625496|FG006|Overall Study|Death|1|||
19382259|NCT02646891|41625497|FG007|Overall Study|Death|1|||
19382260|NCT02646891|41625498|FG008|Overall Study|Death|1|||
19382261|NCT02646891|41625499|FG009|Overall Study|Death|0|||
19382262|NCT02646423|41625539|FG000|Overall Study|Adverse Event|5|||
19382263|NCT02646423|41625540|FG001|Overall Study|Adverse Event|7|||
19382264|NCT02646423|41625539|FG000|Overall Study|Ineligible|2|||
19382265|NCT02646423|41625540|FG001|Overall Study|Ineligible|1|||
19382266|NCT02647359|41625566|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
19382267|NCT02647359|41625567|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
19382268|NCT02647359|41625566|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
19382269|NCT02647359|41625567|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
19382270|NCT02647359|41625566|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
19382271|NCT02647359|41625567|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
19382272|NCT02647359|41625566|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
19382273|NCT02647359|41625567|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
19382274|NCT02647359|41625566|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
19382275|NCT02647359|41625567|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
19382276|NCT02647359|41625566|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
19382277|NCT02647359|41625567|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
19382278|NCT02645409|41625579|FG000|Overall Study|Withdrawal by Subject|3|||
19382279|NCT02645409|41625580|FG001|Overall Study|Withdrawal by Subject|0|||
19382280|NCT02645409|41625579|FG000|Overall Study|Physician Decision|1|||
19382281|NCT02645409|41625580|FG001|Overall Study|Physician Decision|0|||
19740301|NCT00091793|42187177|FG000|Overall Study|Other|2|||
19740302|NCT00091793|42187178|FG001|Overall Study|Other|0|||
19740303|NCT00098813|42187184|FG000|Overall Study|Death|8|||
19740304|NCT00098813|42187184|FG000|Overall Study|Protocol Violation|1|||
19740305|NCT00098813|42187184|FG000|Overall Study|Withdrawal by Subject|7|||
19740306|NCT00098813|42187184|FG000|Overall Study|Progression of Disease|1|||
19740307|NCT00098813|42187184|FG000|Overall Study|Other complicating disease|1|||
19740308|NCT00098813|42187184|FG000|Overall Study|Reversal of RAI resistance|1|||
19382282|NCT01597479|41625587|FG000|Overall Study|Protocol Violation|1|||
19382283|NCT01597479|41625588|FG001|Overall Study|Protocol Violation|0|||
19382284|NCT01597479|41625587|FG000|Overall Study|Lost to Follow-up|1|||
19740309|NCT00091169|42187190|FG000|Overall Study|Disease progression|3|||
19740310|NCT00091169|42187191|FG001|Overall Study|Disease progression|1|||
19740311|NCT00091169|42187190|FG000|Overall Study|Adverse Event|11|||
19740312|NCT00091169|42187191|FG001|Overall Study|Adverse Event|17|||
19382285|NCT01597479|41625588|FG001|Overall Study|Lost to Follow-up|0|||
19382286|NCT04248465|41625597|FG000|Randomized-Controlled Period|Death|12|||
19382287|NCT04248465|41625598|FG001|Randomized-Controlled Period|Death|5|||
19382288|NCT04248465|41625597|FG000|Randomized-Controlled Period|Adverse Event|2|||
19382289|NCT04248465|41625598|FG001|Randomized-Controlled Period|Adverse Event|0|||
19382290|NCT04248465|41625597|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
19382291|NCT04248465|41625598|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
19382292|NCT04248465|41625597|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
19740313|NCT00091169|42187190|FG000|Overall Study|Death|4|||
19740314|NCT00091169|42187191|FG001|Overall Study|Death|1|||
19740315|NCT00091169|42187190|FG000|Overall Study|Withdrawal by Subject|10|||
19740316|NCT00091169|42187191|FG001|Overall Study|Withdrawal by Subject|13|||
19740317|NCT00091169|42187190|FG000|Overall Study|Other|3|||
19740318|NCT00091169|42187191|FG001|Overall Study|Other|4|||
19740319|NCT00091169|42187190|FG000|Overall Study|Not start protocol therapy|26|||
19740320|NCT00091169|42187191|FG001|Overall Study|Not start protocol therapy|17|||
19740321|NCT00090857|42187201|FG000|Overall Study|Lost to Follow-up|0|||
19740322|NCT00090857|42187202|FG001|Overall Study|Lost to Follow-up|1|||
19740323|NCT00090857|42187201|FG000|Overall Study|Withdrawal by Subject|2|||
19740324|NCT00090857|42187202|FG001|Overall Study|Withdrawal by Subject|0|||
19740325|NCT00090857|42187201|FG000|Overall Study|Adverse Event|2|||
19740326|NCT00090857|42187202|FG001|Overall Study|Adverse Event|2|||
19740327|NCT00090779|42187210|FG000|Step 1|Withdrawal by Subject|4|||
19740328|NCT00090779|42187211|FG001|Step 1|Withdrawal by Subject|2|||
19740329|NCT00090779|42187210|FG000|Step 1|Lost to Follow-up|3|||
19740330|NCT00090779|42187211|FG001|Step 1|Lost to Follow-up|2|||
19740331|NCT00090779|42187210|FG000|Step 1|Death|0|||
19740332|NCT00090779|42187211|FG001|Step 1|Death|2|||
19382293|NCT04248465|41625598|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
19382294|NCT04248465|41625597|FG000|Randomized-Controlled Period|Physician Decision|1|||
19382295|NCT04248465|41625598|FG001|Randomized-Controlled Period|Physician Decision|1|||
19740333|NCT00090779|42187210|FG000|Step 1|Physician Decision|1|||
19740334|NCT00090779|42187211|FG001|Step 1|Physician Decision|0|||
19740335|NCT00090779|42187210|FG000|Step 1|Pregnancy|1|||
19740336|NCT00090779|42187211|FG001|Step 1|Pregnancy|0|||
19740337|NCT00090779|42187210|FG000|Step 1|Non-compliance to study requirements|0|||
19740338|NCT00090779|42187211|FG001|Step 1|Non-compliance to study requirements|1|||
19740339|NCT00090779|42187210|FG000|Step 1|Subject relocated|2|||
19740340|NCT00090779|42187211|FG001|Step 1|Subject relocated|8|||
19740341|NCT00090779|42187210|FG000|Step 2|Off study per study closure|6|||
19740342|NCT00090779|42187211|FG001|Step 2|Off study per study closure|16|||
19740343|NCT00090779|42187210|FG000|Step 2|Subject relocated|0|||
19740344|NCT00090779|42187211|FG001|Step 2|Subject relocated|1|||
19740345|NCT00090779|42187210|FG000|Step 2|Non-compliance to study requirements|0|||
19740346|NCT00090779|42187211|FG001|Step 2|Non-compliance to study requirements|1|||
19740347|NCT00090779|42187210|FG000|Step 3|Initiation of ART and off extended study|3|||
19740348|NCT00090779|42187211|FG001|Step 3|Initiation of ART and off extended study|2|||
19740349|NCT00090779|42187210|FG000|Step 3|Off extended study due to study closure|4|||
19740350|NCT00090779|42187211|FG001|Step 3|Off extended study due to study closure|3|||
19740351|NCT00098345|42187217|FG000|Overall Study|Adverse Event|7|||
19740352|NCT00098345|42187217|FG000|Overall Study|Withdrawal by Subject|2|||
19740353|NCT00098345|42187217|FG000|Overall Study|progression|4|||
19740354|NCT02224456|42187221|FG000|Overall Study|Lack of Efficacy|1|||
19740355|NCT02224456|42187221|FG000|Overall Study|Lost to Follow-up|15|||
19740356|NCT02224456|42187221|FG000|Overall Study|Withdrawal by Subject|9|||
19740357|NCT02224456|42187221|FG000|Overall Study|Physician Decision|3|||
19740358|NCT02224456|42187221|FG000|Overall Study|Death|2|||
19740359|NCT02224456|42187221|FG000|Overall Study|Pregnancy|4|||
19740360|NCT02224456|42187221|FG000|Overall Study|Protocol Violation|1|||
19740361|NCT02224456|42187221|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
19740362|NCT00097721|42187227|FG000|Overall Study|Adverse Event|8|||
19740363|NCT00097721|42187228|FG001|Overall Study|Adverse Event|1|||
19740364|NCT00097721|42187227|FG000|Overall Study|Withdrawal by Subject|6|||
19740365|NCT00097721|42187228|FG001|Overall Study|Withdrawal by Subject|1|||
19740366|NCT00097721|42187227|FG000|Overall Study|Progressive Disease|55|||
19740367|NCT00097721|42187228|FG001|Overall Study|Progressive Disease|27|||
19740368|NCT00097721|42187227|FG000|Overall Study|Physician Decision|1|||
19740369|NCT00097721|42187228|FG001|Overall Study|Physician Decision|3|||
19740370|NCT00097721|42187227|FG000|Overall Study|Reason not given|1|||
19740371|NCT00097721|42187228|FG001|Overall Study|Reason not given|1|||
19740372|NCT03553498|42187236|FG000|Overall Study|Missing primary outcome|1|||
19740373|NCT03553498|42187237|FG001|Overall Study|Missing primary outcome|2|||
19740374|NCT00096941|42187243|FG000|Overall Study|disease progression|3|||
19740375|NCT00096785|42187249|FG000|Overall Study|Lost to Follow-up|1|||
19740376|NCT00096785|42187250|FG001|Overall Study|Lost to Follow-up|0|||
19740377|NCT00096785|42187249|FG000|Overall Study|Withdrawal by Subject|0|||
19740378|NCT00096785|42187250|FG001|Overall Study|Withdrawal by Subject|1|||
19740379|NCT00096785|42187249|FG000|Overall Study|Relocated|1|||
19740380|NCT00096785|42187250|FG001|Overall Study|Relocated|0|||
19740381|NCT00090545|42187281|FG000|Overall Study|Disease progression on study|21|||
19740382|NCT00090545|42187282|FG001|Overall Study|Disease progression on study|17|||
19740383|NCT00090545|42187281|FG000|Overall Study|Refused further treatment|1|||
19740384|NCT00090545|42187282|FG001|Overall Study|Refused further treatment|4|||
19740385|NCT00090545|42187281|FG000|Overall Study|Death|0|||
19740386|NCT00090545|42187282|FG001|Overall Study|Death|1|||
19740387|NCT00090545|42187281|FG000|Overall Study|Adverse Event|0|||
19740388|NCT00090545|42187282|FG001|Overall Study|Adverse Event|2|||
19740389|NCT03249376|42187292|FG000|Overall Study|Adverse Event|11|||
19740390|NCT03249376|42187293|FG001|Overall Study|Adverse Event|5|||
19740391|NCT03249376|42187292|FG000|Overall Study|Lack of Efficacy|2|||
19740392|NCT03249376|42187293|FG001|Overall Study|Lack of Efficacy|4|||
19740393|NCT03249376|42187292|FG000|Overall Study|Protocol Violation|3|||
19740394|NCT03249376|42187293|FG001|Overall Study|Protocol Violation|2|||
19740395|NCT03249376|42187292|FG000|Overall Study|Physician Decision|0|||
19740396|NCT03249376|42187293|FG001|Overall Study|Physician Decision|2|||
19740397|NCT03249376|42187292|FG000|Overall Study|Withdrawal by Subject|3|||
19740398|NCT03249376|42187293|FG001|Overall Study|Withdrawal by Subject|9|||
19740399|NCT03249376|42187292|FG000|Overall Study|LTFU|2|||
19740400|NCT03249376|42187293|FG001|Overall Study|LTFU|1|||
19740401|NCT00070109|42187304|FG000|Overall Study|Death|1|||
19740402|NCT00070109|42187305|FG001|Overall Study|Death|1|||
19740403|NCT00070109|42187306|FG002|Overall Study|Death|0|||
19740404|NCT00070109|42187307|FG003|Overall Study|Death|0|||
19740405|NCT00070109|42187308|FG004|Overall Study|Death|1|||
19740406|NCT00070109|42187304|FG000|Overall Study|Lack of Efficacy|6|||
19740407|NCT00070109|42187305|FG001|Overall Study|Lack of Efficacy|4|||
19740408|NCT00070109|42187306|FG002|Overall Study|Lack of Efficacy|5|||
19740409|NCT00070109|42187307|FG003|Overall Study|Lack of Efficacy|15|||
19740410|NCT00070109|42187308|FG004|Overall Study|Lack of Efficacy|5|||
19740411|NCT00070109|42187304|FG000|Overall Study|Physician Decision|1|||
19740412|NCT00070109|42187305|FG001|Overall Study|Physician Decision|0|||
19740413|NCT00070109|42187306|FG002|Overall Study|Physician Decision|0|||
19740414|NCT00070109|42187307|FG003|Overall Study|Physician Decision|0|||
19740415|NCT00070109|42187308|FG004|Overall Study|Physician Decision|0|||
19740416|NCT00070109|42187304|FG000|Overall Study|Withdrawal by Subject|0|||
19740417|NCT00070109|42187305|FG001|Overall Study|Withdrawal by Subject|1|||
19740418|NCT00070109|42187306|FG002|Overall Study|Withdrawal by Subject|1|||
19740419|NCT00070109|42187307|FG003|Overall Study|Withdrawal by Subject|0|||
19740420|NCT00070109|42187308|FG004|Overall Study|Withdrawal by Subject|0|||
19740421|NCT00070109|42187304|FG000|Overall Study|Adverse Event|0|||
19740422|NCT00070109|42187305|FG001|Overall Study|Adverse Event|0|||
19740423|NCT00070109|42187306|FG002|Overall Study|Adverse Event|2|||
19740424|NCT00070109|42187307|FG003|Overall Study|Adverse Event|4|||
19740425|NCT00070109|42187308|FG004|Overall Study|Adverse Event|2|||
19740426|NCT00070109|42187304|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
19740427|NCT00070109|42187305|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
19740428|NCT00070109|42187306|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
19740429|NCT00070109|42187307|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
19740430|NCT00070109|42187308|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
19740431|NCT00090233|42187329|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
19740432|NCT00090233|42187330|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
19740433|NCT00090233|42187329|FG000|Overall Study|Adverse Event|214|||
19740434|NCT00090233|42187330|FG001|Overall Study|Adverse Event|198|||
19740435|NCT00090233|42187329|FG000|Overall Study|Lost to Follow-up|68|||
19740436|NCT00090233|42187330|FG001|Overall Study|Lost to Follow-up|95|||
19740437|NCT00090233|42187329|FG000|Overall Study|Protocol Violation|960|||
19740438|NCT00090233|42187330|FG001|Overall Study|Protocol Violation|1022|||
19740439|NCT00090233|42187329|FG000|Overall Study|Withdrawal by Subject|182|||
19740440|NCT00090233|42187330|FG001|Overall Study|Withdrawal by Subject|211|||
19740441|NCT00090233|42187329|FG000|Overall Study|Moved|203|||
19740442|NCT00090233|42187330|FG001|Overall Study|Moved|189|||
19740443|NCT00090233|42187329|FG000|Overall Study|Other|1211|||
19740444|NCT00090233|42187330|FG001|Overall Study|Other|1160|||
19740445|NCT00090233|42187329|FG000|Overall Study|Data not available at data cut-off point|1552|||
19740446|NCT00090233|42187330|FG001|Overall Study|Data not available at data cut-off point|1563|||
19740447|NCT00069953|42187340|FG000|Overall Study|Protocol Violation|2|||
19564844|NCT01145625|42012732|FG000|Overall Study|Pregnancy|0|||
19564845|NCT01145625|42012733|FG001|Overall Study|Pregnancy|1|||
19564846|NCT01144377|42012744|FG000|52 Week Treatment Period|Adverse Event|0|||
19564847|NCT01144377|42012745|FG001|52 Week Treatment Period|Adverse Event|0|||
19564848|NCT01144377|42012746|FG002|52 Week Treatment Period|Adverse Event|3|||
19564849|NCT01144377|42012747|FG003|52 Week Treatment Period|Adverse Event|2|||
19564850|NCT01144377|42012748|FG004|52 Week Treatment Period|Adverse Event|1|||
19564851|NCT01144377|42012744|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
19564852|NCT01144377|42012745|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
19564853|NCT01144377|42012746|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
19564854|NCT01144377|42012747|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
19564855|NCT01144377|42012748|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
19564856|NCT01144377|42012744|FG000|52 Week Treatment Period|Protocol Violation|0|||
19564857|NCT01144377|42012745|FG001|52 Week Treatment Period|Protocol Violation|0|||
19564858|NCT01144377|42012746|FG002|52 Week Treatment Period|Protocol Violation|0|||
19564859|NCT01144377|42012747|FG003|52 Week Treatment Period|Protocol Violation|0|||
19564860|NCT01144377|42012748|FG004|52 Week Treatment Period|Protocol Violation|1|||
19564861|NCT01144377|42012744|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
19564862|NCT01144377|42012745|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
19564863|NCT01144377|42012746|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
19564864|NCT01144377|42012747|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
19564865|NCT01144377|42012748|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
19564866|NCT01144377|42012744|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
19564867|NCT01144377|42012745|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
19564868|NCT01144377|42012746|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
19564869|NCT01144377|42012747|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
19564870|NCT01144377|42012748|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
19564871|NCT01144377|42012744|FG000|52 Week Treatment Period|Sponsor Decision|0|||
19564872|NCT01144377|42012745|FG001|52 Week Treatment Period|Sponsor Decision|0|||
19564873|NCT01144377|42012746|FG002|52 Week Treatment Period|Sponsor Decision|0|||
19564874|NCT01144377|42012747|FG003|52 Week Treatment Period|Sponsor Decision|0|||
19564875|NCT01144377|42012748|FG004|52 Week Treatment Period|Sponsor Decision|1|||
19564876|NCT01144377|42012744|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
19564877|NCT01144377|42012745|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
19564878|NCT01144377|42012746|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
19564879|NCT01144377|42012747|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
19564880|NCT01144377|42012748|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
19564881|NCT01144377|42012744|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
19564882|NCT01144377|42012745|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
19564883|NCT01144377|42012746|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
19564884|NCT01144377|42012747|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
19564885|NCT01144377|42012748|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
19564886|NCT01144377|42012744|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
19564887|NCT01144377|42012745|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
19564888|NCT01144377|42012746|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
19564889|NCT01144377|42012747|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
19564890|NCT01144377|42012748|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
19564891|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564892|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564893|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564894|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
19564895|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564896|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564897|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564898|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564899|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564900|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
19564901|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19564902|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19564903|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Adverse Event|1|||
19564904|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Adverse Event|1|||
19564905|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Adverse Event|1|||
19564906|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Adverse Event|1|||
19564907|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Adverse Event|0|||
19564908|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Adverse Event|0|||
19564909|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Adverse Event|0|||
19564910|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Adverse Event|0|||
19564911|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
19564912|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
19564913|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
19564914|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
19564915|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
19564916|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
19564917|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
19564918|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
19564919|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
19564920|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
19564921|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564922|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564923|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564924|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
19564925|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
19564926|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
19740448|NCT03118570|42187349|FG000|Overall Study|Adverse Event|2|||
19740449|NCT03118570|42187350|FG001|Overall Study|Adverse Event|0|||
19564927|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564928|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
19564929|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564930|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
19564931|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
19564932|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
19564933|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564934|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564935|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564936|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564937|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564938|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
19564939|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564940|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
19564941|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564942|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564943|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564944|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564945|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
19564946|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
19564947|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564948|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564949|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564950|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
19564951|NCT00950599|42012770|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
19564952|NCT00950599|42012771|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
19564953|NCT00950599|42012772|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
19564954|NCT00950599|42012773|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
19564955|NCT00950599|42012774|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
19564956|NCT00950599|42012775|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
19564957|NCT00950599|42012776|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
19564958|NCT00950599|42012777|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
19564959|NCT00950599|42012778|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
19564960|NCT00950599|42012779|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
19564961|NCT00950599|42012770|FG000|Follow-Up Period|Adverse Event|0|||
19564962|NCT00950599|42012771|FG001|Follow-Up Period|Adverse Event|0|||
19564963|NCT00950599|42012772|FG002|Follow-Up Period|Adverse Event|0|||
19564964|NCT00950599|42012773|FG003|Follow-Up Period|Adverse Event|0|||
19564965|NCT00950599|42012774|FG004|Follow-Up Period|Adverse Event|0|||
19564966|NCT00950599|42012775|FG005|Follow-Up Period|Adverse Event|0|||
19564967|NCT00950599|42012776|FG006|Follow-Up Period|Adverse Event|0|||
19564968|NCT00950599|42012777|FG007|Follow-Up Period|Adverse Event|0|||
19564969|NCT00950599|42012778|FG008|Follow-Up Period|Adverse Event|1|||
19564970|NCT00950599|42012779|FG009|Follow-Up Period|Adverse Event|0|||
19740450|NCT03118570|42187351|FG002|Overall Study|Adverse Event|0|||
19564971|NCT00950599|42012770|FG000|Follow-Up Period|Lack of Efficacy|0|||
19564972|NCT00950599|42012771|FG001|Follow-Up Period|Lack of Efficacy|0|||
19564973|NCT00950599|42012772|FG002|Follow-Up Period|Lack of Efficacy|0|||
19564974|NCT00950599|42012773|FG003|Follow-Up Period|Lack of Efficacy|0|||
19564975|NCT00950599|42012774|FG004|Follow-Up Period|Lack of Efficacy|0|||
19564976|NCT00950599|42012775|FG005|Follow-Up Period|Lack of Efficacy|0|||
19564977|NCT00950599|42012776|FG006|Follow-Up Period|Lack of Efficacy|0|||
19564978|NCT00950599|42012777|FG007|Follow-Up Period|Lack of Efficacy|0|||
19564979|NCT00950599|42012778|FG008|Follow-Up Period|Lack of Efficacy|3|||
19564980|NCT00950599|42012779|FG009|Follow-Up Period|Lack of Efficacy|0|||
19564981|NCT00950599|42012770|FG000|Follow-Up Period|Lost to Follow-up|0|||
19564982|NCT00950599|42012771|FG001|Follow-Up Period|Lost to Follow-up|0|||
19564983|NCT00950599|42012772|FG002|Follow-Up Period|Lost to Follow-up|0|||
19564984|NCT00950599|42012773|FG003|Follow-Up Period|Lost to Follow-up|0|||
19564985|NCT00950599|42012774|FG004|Follow-Up Period|Lost to Follow-up|0|||
19564986|NCT00950599|42012775|FG005|Follow-Up Period|Lost to Follow-up|0|||
19564987|NCT00950599|42012776|FG006|Follow-Up Period|Lost to Follow-up|0|||
19564988|NCT00950599|42012777|FG007|Follow-Up Period|Lost to Follow-up|0|||
19564989|NCT00950599|42012778|FG008|Follow-Up Period|Lost to Follow-up|5|||
19564990|NCT00950599|42012779|FG009|Follow-Up Period|Lost to Follow-up|1|||
19564991|NCT00950599|42012770|FG000|Follow-Up Period|Physician Decision|0|||
19564992|NCT00950599|42012771|FG001|Follow-Up Period|Physician Decision|0|||
19564993|NCT00950599|42012772|FG002|Follow-Up Period|Physician Decision|0|||
19564994|NCT00950599|42012773|FG003|Follow-Up Period|Physician Decision|0|||
19564995|NCT00950599|42012774|FG004|Follow-Up Period|Physician Decision|0|||
19564996|NCT00950599|42012775|FG005|Follow-Up Period|Physician Decision|0|||
19564997|NCT00950599|42012776|FG006|Follow-Up Period|Physician Decision|0|||
19564998|NCT00950599|42012777|FG007|Follow-Up Period|Physician Decision|0|||
19564999|NCT00950599|42012778|FG008|Follow-Up Period|Physician Decision|1|||
19565000|NCT00950599|42012779|FG009|Follow-Up Period|Physician Decision|0|||
19565001|NCT00950599|42012770|FG000|Follow-Up Period|Poor/Noncompliance|0|||
19565002|NCT00950599|42012771|FG001|Follow-Up Period|Poor/Noncompliance|0|||
19565003|NCT00950599|42012772|FG002|Follow-Up Period|Poor/Noncompliance|0|||
19565004|NCT00950599|42012773|FG003|Follow-Up Period|Poor/Noncompliance|0|||
19565005|NCT00950599|42012774|FG004|Follow-Up Period|Poor/Noncompliance|0|||
19565006|NCT00950599|42012775|FG005|Follow-Up Period|Poor/Noncompliance|0|||
19565007|NCT00950599|42012776|FG006|Follow-Up Period|Poor/Noncompliance|0|||
19565008|NCT00950599|42012777|FG007|Follow-Up Period|Poor/Noncompliance|0|||
19565009|NCT00950599|42012778|FG008|Follow-Up Period|Poor/Noncompliance|1|||
19565010|NCT00950599|42012779|FG009|Follow-Up Period|Poor/Noncompliance|0|||
19565011|NCT00950599|42012770|FG000|Follow-Up Period|Subject withdrew Consent|0|||
19565012|NCT00950599|42012771|FG001|Follow-Up Period|Subject withdrew Consent|0|||
19565013|NCT00950599|42012772|FG002|Follow-Up Period|Subject withdrew Consent|0|||
19565014|NCT00950599|42012773|FG003|Follow-Up Period|Subject withdrew Consent|0|||
19565015|NCT00950599|42012774|FG004|Follow-Up Period|Subject withdrew Consent|0|||
19565016|NCT00950599|42012775|FG005|Follow-Up Period|Subject withdrew Consent|0|||
19565017|NCT00950599|42012776|FG006|Follow-Up Period|Subject withdrew Consent|0|||
19565018|NCT00950599|42012777|FG007|Follow-Up Period|Subject withdrew Consent|0|||
19740451|NCT03118570|42187352|FG003|Overall Study|Adverse Event|0|||
19740452|NCT03118570|42187353|FG004|Overall Study|Adverse Event|3|||
19740453|NCT03118570|42187349|FG000|Overall Study|Withdrawal by Subject|0|||
19740454|NCT03118570|42187350|FG001|Overall Study|Withdrawal by Subject|1|||
19740455|NCT03118570|42187351|FG002|Overall Study|Withdrawal by Subject|4|||
19740456|NCT03118570|42187352|FG003|Overall Study|Withdrawal by Subject|0|||
19565019|NCT00950599|42012778|FG008|Follow-Up Period|Subject withdrew Consent|2|||
19565020|NCT00950599|42012779|FG009|Follow-Up Period|Subject withdrew Consent|1|||
19565021|NCT01144299|42012804|FG000|Overall Study|Lost to Follow-up|1|||
19740457|NCT03118570|42187353|FG004|Overall Study|Withdrawal by Subject|1|||
19740458|NCT03118570|42187349|FG000|Overall Study|Lost to Follow-up|2|||
19740459|NCT03118570|42187350|FG001|Overall Study|Lost to Follow-up|3|||
19740460|NCT03118570|42187351|FG002|Overall Study|Lost to Follow-up|1|||
19565022|NCT01144299|42012805|FG001|Overall Study|Lost to Follow-up|0|||
19565023|NCT01144299|42012804|FG000|Overall Study|Withdrawal by Subject|1|||
19565024|NCT01144299|42012805|FG001|Overall Study|Withdrawal by Subject|0|||
19565025|NCT01143207|42012811|FG000|Overall Study|Lost to Follow-up|2|||
19565026|NCT01143051|42012821|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
19565027|NCT01143051|42012822|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
19565028|NCT01143051|42012823|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
19565029|NCT01143051|42012824|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
19565030|NCT01143051|42012825|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
19565031|NCT01143051|42012826|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
19565032|NCT01143051|42012821|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
19565033|NCT01143051|42012822|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
19565034|NCT01143051|42012823|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
19740461|NCT03118570|42187352|FG003|Overall Study|Lost to Follow-up|0|||
19740462|NCT03118570|42187353|FG004|Overall Study|Lost to Follow-up|1|||
19740463|NCT03118570|42187349|FG000|Overall Study|Other, Not Specified|1|||
19565035|NCT01143051|42012824|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
19565036|NCT01143051|42012825|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
19565037|NCT01143051|42012826|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
19565038|NCT01142661|42012836|FG000|Overall Study|Adverse Event|2|||
19565039|NCT01142661|42012836|FG000|Overall Study|Withdrawal by Subject|1|||
19565040|NCT01142661|42012836|FG000|Overall Study|Physician Decision|1|||
19565041|NCT01142193|42012842|FG000|Overall Study|Adverse Event|12|||
19565042|NCT01142193|42012843|FG001|Overall Study|Adverse Event|4|||
19565043|NCT01142193|42012842|FG000|Overall Study|Lack of Efficacy|2|||
19565044|NCT01142193|42012843|FG001|Overall Study|Lack of Efficacy|1|||
19565045|NCT01142193|42012842|FG000|Overall Study|Physician Decision|1|||
19565046|NCT01142193|42012843|FG001|Overall Study|Physician Decision|1|||
19565047|NCT01142193|42012842|FG000|Overall Study|Withdrawal by Subject|4|||
19565048|NCT01142193|42012843|FG001|Overall Study|Withdrawal by Subject|3|||
19565049|NCT01142193|42012842|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
19565050|NCT01142193|42012843|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
19565051|NCT01142193|42012842|FG000|Overall Study|Other|1|||
19565052|NCT01142193|42012843|FG001|Overall Study|Other|2|||
19565053|NCT01142115|42012849|FG000|First Intervention|Lack of Efficacy|1|||
19565054|NCT01142115|42012850|FG001|First Intervention|Lack of Efficacy|1|||
19565055|NCT01142115|42012849|FG000|First Intervention|Adverse Event|1|||
19565056|NCT01142115|42012850|FG001|First Intervention|Adverse Event|0|||
19565057|NCT01140477|42012857|FG000|Overall Study|Lost to Follow-up|4|||
19565058|NCT01140477|42012858|FG001|Overall Study|Lost to Follow-up|0|||
19565059|NCT01140477|42012857|FG000|Overall Study|Withdrawal by Subject|1|||
19565060|NCT01140477|42012858|FG001|Overall Study|Withdrawal by Subject|4|||
19565061|NCT01140477|42012857|FG000|Overall Study|Surgical complication preventing implant|2|||
19565062|NCT01140477|42012858|FG001|Overall Study|Surgical complication preventing implant|0|||
19565063|NCT01140477|42012857|FG000|Overall Study|Death|1|||
19565064|NCT01140477|42012858|FG001|Overall Study|Death|1|||
19565065|NCT01140477|42012857|FG000|Overall Study|Subject explanted|0|||
19565066|NCT01140477|42012858|FG001|Overall Study|Subject explanted|1|||
19565067|NCT01139775|42012867|FG000|Overall Study|Adverse Event|0|||
19565068|NCT01139775|42012868|FG001|Overall Study|Adverse Event|6|||
19565069|NCT01139775|42012869|FG002|Overall Study|Adverse Event|2|||
19565070|NCT01139775|42012867|FG000|Overall Study|Protocol Violation|0|||
19565071|NCT01139775|42012868|FG001|Overall Study|Protocol Violation|5|||
19565072|NCT01139775|42012869|FG002|Overall Study|Protocol Violation|0|||
19565073|NCT01139775|42012867|FG000|Overall Study|Withdrawal by Subject|1|||
19565074|NCT01139775|42012868|FG001|Overall Study|Withdrawal by Subject|0|||
19565075|NCT01139775|42012869|FG002|Overall Study|Withdrawal by Subject|2|||
19565076|NCT01139775|42012867|FG000|Overall Study|Physician Decision|0|||
19565077|NCT01139775|42012868|FG001|Overall Study|Physician Decision|2|||
19565078|NCT01139775|42012869|FG002|Overall Study|Physician Decision|2|||
19565079|NCT01283516|42012888|FG000|Overall Study|Adverse Event|0|||
19565080|NCT01283516|42012889|FG001|Overall Study|Adverse Event|0|||
19565081|NCT01283516|42012890|FG002|Overall Study|Adverse Event|0|||
19565082|NCT01283516|42012891|FG003|Overall Study|Adverse Event|0|||
19565083|NCT01283516|42012892|FG004|Overall Study|Adverse Event|0|||
19565084|NCT01283516|42012893|FG005|Overall Study|Adverse Event|0|||
19740464|NCT03118570|42187350|FG001|Overall Study|Other, Not Specified|3|||
19565085|NCT01283516|42012894|FG006|Overall Study|Adverse Event|2|||
19565086|NCT01283516|42012895|FG007|Overall Study|Adverse Event|0|||
19565087|NCT01283516|42012896|FG008|Overall Study|Adverse Event|28|||
19565088|NCT01283516|42012888|FG000|Overall Study|Death|0|||
19565089|NCT01283516|42012889|FG001|Overall Study|Death|0|||
19565090|NCT01283516|42012890|FG002|Overall Study|Death|0|||
19565091|NCT01283516|42012891|FG003|Overall Study|Death|0|||
19565092|NCT01283516|42012892|FG004|Overall Study|Death|0|||
19565093|NCT01283516|42012893|FG005|Overall Study|Death|1|||
19565094|NCT01283516|42012894|FG006|Overall Study|Death|0|||
19565095|NCT01283516|42012895|FG007|Overall Study|Death|1|||
19565096|NCT01283516|42012896|FG008|Overall Study|Death|12|||
19565097|NCT01283516|42012888|FG000|Overall Study|Disease Progression|2|||
19565098|NCT01283516|42012889|FG001|Overall Study|Disease Progression|2|||
19565099|NCT01283516|42012890|FG002|Overall Study|Disease Progression|3|||
19565100|NCT01283516|42012891|FG003|Overall Study|Disease Progression|3|||
19565101|NCT01283516|42012892|FG004|Overall Study|Disease Progression|13|||
19565102|NCT01283516|42012893|FG005|Overall Study|Disease Progression|8|||
19565103|NCT01283516|42012894|FG006|Overall Study|Disease Progression|6|||
19565104|NCT01283516|42012895|FG007|Overall Study|Disease Progression|3|||
19565105|NCT01283516|42012896|FG008|Overall Study|Disease Progression|139|||
19565106|NCT01283516|42012888|FG000|Overall Study|Withdrawal by Subject|0|||
19565107|NCT01283516|42012889|FG001|Overall Study|Withdrawal by Subject|0|||
19565108|NCT01283516|42012890|FG002|Overall Study|Withdrawal by Subject|0|||
19565109|NCT01283516|42012891|FG003|Overall Study|Withdrawal by Subject|0|||
19565110|NCT01283516|42012892|FG004|Overall Study|Withdrawal by Subject|1|||
19565111|NCT01283516|42012893|FG005|Overall Study|Withdrawal by Subject|0|||
19565112|NCT01283516|42012894|FG006|Overall Study|Withdrawal by Subject|1|||
19565113|NCT01283516|42012895|FG007|Overall Study|Withdrawal by Subject|0|||
19565114|NCT01283516|42012896|FG008|Overall Study|Withdrawal by Subject|36|||
19740465|NCT03118570|42187351|FG002|Overall Study|Other, Not Specified|0|||
19740466|NCT03118570|42187352|FG003|Overall Study|Other, Not Specified|0|||
19740467|NCT03118570|42187353|FG004|Overall Study|Other, Not Specified|0|||
19740468|NCT02750800|42187372|FG000|Overall Study|Adverse Event|18|||
19740469|NCT02750800|42187372|FG000|Overall Study|Lost to Follow-up|12|||
19740470|NCT02750800|42187372|FG000|Overall Study|Investigator decision|53|||
19740471|NCT02750800|42187372|FG000|Overall Study|Patient request|12|||
19740472|NCT02750800|42187372|FG000|Overall Study|Other, not specified|3|||
19740473|NCT01329562|42187392|FG000|Overall Study|Protocol Violation|5|||
19740474|NCT01329562|42187393|FG001|Overall Study|Protocol Violation|3|||
19740475|NCT01329562|42187392|FG000|Overall Study|Lost to Follow-up|1|||
19740476|NCT01329562|42187393|FG001|Overall Study|Lost to Follow-up|1|||
19740477|NCT01329562|42187392|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
19740478|NCT01329562|42187393|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
19740479|NCT01329562|42187392|FG000|Overall Study|Physician Decision|0|||
19740480|NCT01329562|42187393|FG001|Overall Study|Physician Decision|1|||
19740481|NCT00069641|42187404|FG000|Overall Study|Death|1|||
19740482|NCT00069641|42187405|FG001|Overall Study|Death|0|||
19740483|NCT00069641|42187406|FG002|Overall Study|Death|1|||
19740484|NCT03653026|42187417|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
19740485|NCT03653026|42187418|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
19740486|NCT03653026|42187419|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
19740487|NCT03653026|42187420|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
19740488|NCT03653026|42187417|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
19740489|NCT03653026|42187418|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
19740490|NCT03653026|42187419|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19740491|NCT03653026|42187420|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19740492|NCT03653026|42187417|FG000|Part 1: Placebo-controlled Period|Other|0|||
19740493|NCT03653026|42187418|FG001|Part 1: Placebo-controlled Period|Other|3|||
19740494|NCT03653026|42187419|FG002|Part 1: Placebo-controlled Period|Other|0|||
19740495|NCT03653026|42187420|FG003|Part 1: Placebo-controlled Period|Other|0|||
19740496|NCT03653026|42187417|FG000|Part 2: Open-label Extension|Adverse Event|0|||
19740497|NCT03653026|42187418|FG001|Part 2: Open-label Extension|Adverse Event|0|||
19740498|NCT03653026|42187419|FG002|Part 2: Open-label Extension|Adverse Event|1|||
19740499|NCT03653026|42187420|FG003|Part 2: Open-label Extension|Adverse Event|1|||
19740500|NCT03653026|42187417|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
19740501|NCT03653026|42187418|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
19740502|NCT03653026|42187419|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
19390375|NCT01987960|41634111|FG001|Period 3|Lost to Follow-up|0|||
19565115|NCT01283516|42012888|FG000|Overall Study|Administrative problems|0|||
19740503|NCT03653026|42187420|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
19740504|NCT03653026|42187417|FG000|Part 2: Open-label Extension|Other|0|||
19740505|NCT03653026|42187418|FG001|Part 2: Open-label Extension|Other|0|||
19740506|NCT03653026|42187419|FG002|Part 2: Open-label Extension|Other|1|||
19740507|NCT03653026|42187420|FG003|Part 2: Open-label Extension|Other|2|||
19740508|NCT01329328|42187431|FG000|Overall Study|Withdrawal by Subject|2|||
19740509|NCT01329328|42187432|FG001|Overall Study|Withdrawal by Subject|4|||
19740510|NCT01329328|42187433|FG002|Overall Study|Withdrawal by Subject|3|||
19740511|NCT01337986|42187443|FG000|Overall Study|Adverse Event|2|||
19740512|NCT01337986|42187444|FG001|Overall Study|Adverse Event|2|||
19740513|NCT01337986|42187443|FG000|Overall Study|Lost to Follow-up|1|||
19740514|NCT01337986|42187444|FG001|Overall Study|Lost to Follow-up|0|||
19740515|NCT01337986|42187443|FG000|Overall Study|Protocol Violation|0|||
19740516|NCT01337986|42187444|FG001|Overall Study|Protocol Violation|3|||
19740517|NCT01337674|42187468|FG000|Treatment Period 1|Adverse Event|0|||
19740518|NCT01337674|42187469|FG001|Treatment Period 1|Adverse Event|1|||
19740519|NCT01337674|42187470|FG002|Treatment Period 1|Adverse Event|0|||
19740520|NCT01337674|42187471|FG003|Treatment Period 1|Adverse Event|0|||
19740521|NCT01337674|42187468|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
19740522|NCT01337674|42187469|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
19740523|NCT01337674|42187470|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
19740524|NCT01337674|42187471|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
19740525|NCT01337674|42187468|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19740526|NCT01337674|42187469|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19740527|NCT01337674|42187470|FG002|Treatment Period 2|Withdrawal by Subject|1|||
19740528|NCT01337674|42187471|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19740529|NCT02750410|42187486|FG000|Double-Blind Treatment Period|Adverse Event|2|||
19740530|NCT02750410|42187487|FG001|Double-Blind Treatment Period|Adverse Event|2|||
19740531|NCT02750410|42187486|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19740532|NCT02750410|42187487|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19740533|NCT02750410|42187486|FG000|Open-Label Extension Period|Adverse Event|5|||
19740534|NCT02750410|42187487|FG001|Open-Label Extension Period|Adverse Event|3|||
19740535|NCT02750410|42187486|FG000|Open-Label Extension Period|Protocol Violation|0|||
19740536|NCT02750410|42187487|FG001|Open-Label Extension Period|Protocol Violation|1|||
19740537|NCT02750410|42187486|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
19740538|NCT02750410|42187487|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
19740539|NCT02750332|42187497|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19740540|NCT02750332|42187498|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19740541|NCT01337596|42187513|FG000|Overall Study|Withdrawal by Subject|0|||
19740542|NCT01337596|42187514|FG001|Overall Study|Withdrawal by Subject|0|||
19740543|NCT01337596|42187515|FG002|Overall Study|Withdrawal by Subject|0|||
19740544|NCT01337596|42187516|FG003|Overall Study|Withdrawal by Subject|0|||
19740545|NCT01337596|42187517|FG004|Overall Study|Withdrawal by Subject|2|||
19740546|NCT01337596|42187518|FG005|Overall Study|Withdrawal by Subject|0|||
19740547|NCT01337596|42187519|FG006|Overall Study|Withdrawal by Subject|0|||
19740548|NCT01337596|42187520|FG007|Overall Study|Withdrawal by Subject|0|||
19740549|NCT01337596|42187521|FG008|Overall Study|Withdrawal by Subject|0|||
19740550|NCT00069095|42187550|FG000|Primary Treatment Phase|Ongoing|0|||
19740551|NCT00069095|42187551|FG001|Primary Treatment Phase|Ongoing|0|||
19740552|NCT00069095|42187552|FG002|Primary Treatment Phase|Ongoing|5|||
19740553|NCT00069095|42187553|FG003|Primary Treatment Phase|Ongoing|7|||
19740554|NCT00069095|42187554|FG004|Primary Treatment Phase|Ongoing|7|||
19740555|NCT00069095|42187555|FG005|Primary Treatment Phase|Ongoing|4|||
19740556|NCT00069095|42187550|FG000|Primary Treatment Phase|Admin/Other|29|||
19740557|NCT00069095|42187551|FG001|Primary Treatment Phase|Admin/Other|38|||
19740558|NCT00069095|42187552|FG002|Primary Treatment Phase|Admin/Other|31|||
19740559|NCT00069095|42187553|FG003|Primary Treatment Phase|Admin/Other|45|||
19740560|NCT00069095|42187554|FG004|Primary Treatment Phase|Admin/Other|48|||
19740561|NCT00069095|42187555|FG005|Primary Treatment Phase|Admin/Other|42|||
19740562|NCT00069095|42187550|FG000|Primary Treatment Phase|Adverse Event|99|||
19740563|NCT00069095|42187551|FG001|Primary Treatment Phase|Adverse Event|92|||
19740564|NCT00069095|42187552|FG002|Primary Treatment Phase|Adverse Event|71|||
19740565|NCT00069095|42187553|FG003|Primary Treatment Phase|Adverse Event|72|||
19740566|NCT00069095|42187554|FG004|Primary Treatment Phase|Adverse Event|109|||
19740567|NCT00069095|42187555|FG005|Primary Treatment Phase|Adverse Event|101|||
19740568|NCT00069095|42187550|FG000|Primary Treatment Phase|Death|14|||
19740569|NCT00069095|42187551|FG001|Primary Treatment Phase|Death|8|||
19740570|NCT00069095|42187552|FG002|Primary Treatment Phase|Death|2|||
19740571|NCT00069095|42187553|FG003|Primary Treatment Phase|Death|5|||
19740572|NCT00069095|42187554|FG004|Primary Treatment Phase|Death|8|||
19740573|NCT00069095|42187555|FG005|Primary Treatment Phase|Death|8|||
19740574|NCT00069095|42187550|FG000|Primary Treatment Phase|Failure to return|5|||
19740575|NCT00069095|42187551|FG001|Primary Treatment Phase|Failure to return|5|||
19740576|NCT00069095|42187552|FG002|Primary Treatment Phase|Failure to return|0|||
19740577|NCT00069095|42187553|FG003|Primary Treatment Phase|Failure to return|0|||
19740578|NCT00069095|42187554|FG004|Primary Treatment Phase|Failure to return|0|||
19740579|NCT00069095|42187555|FG005|Primary Treatment Phase|Failure to return|2|||
19740580|NCT00069095|42187550|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
19740581|NCT00069095|42187551|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
19740582|NCT00069095|42187552|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
19740583|NCT00069095|42187553|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
19740584|NCT00069095|42187554|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
19382296|NCT04248465|41625597|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
19565116|NCT01283516|42012889|FG001|Overall Study|Administrative problems|0|||
19565117|NCT01283516|42012890|FG002|Overall Study|Administrative problems|0|||
19565118|NCT01283516|42012891|FG003|Overall Study|Administrative problems|0|||
19565119|NCT01283516|42012892|FG004|Overall Study|Administrative problems|0|||
19565120|NCT01283516|42012893|FG005|Overall Study|Administrative problems|1|||
19565121|NCT01283516|42012894|FG006|Overall Study|Administrative problems|1|||
19565122|NCT01283516|42012895|FG007|Overall Study|Administrative problems|1|||
19565123|NCT01283516|42012896|FG008|Overall Study|Administrative problems|39|||
19565124|NCT01283516|42012888|FG000|Overall Study|Lost to Follow-up|0|||
19565125|NCT01283516|42012889|FG001|Overall Study|Lost to Follow-up|0|||
19565126|NCT01283516|42012890|FG002|Overall Study|Lost to Follow-up|0|||
19565127|NCT01283516|42012891|FG003|Overall Study|Lost to Follow-up|0|||
19565128|NCT01283516|42012892|FG004|Overall Study|Lost to Follow-up|0|||
19565129|NCT01283516|42012893|FG005|Overall Study|Lost to Follow-up|0|||
19565130|NCT01283516|42012894|FG006|Overall Study|Lost to Follow-up|0|||
19565131|NCT01283516|42012895|FG007|Overall Study|Lost to Follow-up|0|||
19565132|NCT01283516|42012896|FG008|Overall Study|Lost to Follow-up|1|||
19565133|NCT01137435|42012924|FG000|Overall Study|Lost to Follow-up|24|||
19565134|NCT01137435|42012924|FG000|Overall Study|Off label usage|4|||
19565135|NCT01283282|42012928|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
19565136|NCT01283282|42012929|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
19565137|NCT01283282|42012928|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
19565138|NCT01283282|42012929|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
19565139|NCT01283282|42012928|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
19565140|NCT01283282|42012929|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
19740585|NCT00069095|42187555|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
19740586|NCT00069095|42187550|FG000|Primary Treatment Phase|Refused treatment|15|||
19740587|NCT00069095|42187551|FG001|Primary Treatment Phase|Refused treatment|26|||
19740588|NCT00069095|42187552|FG002|Primary Treatment Phase|Refused treatment|17|||
19740589|NCT00069095|42187553|FG003|Primary Treatment Phase|Refused treatment|31|||
19740590|NCT00069095|42187554|FG004|Primary Treatment Phase|Refused treatment|24|||
19740591|NCT00069095|42187555|FG005|Primary Treatment Phase|Refused treatment|27|||
19740592|NCT00069095|42187550|FG000|Primary Treatment Phase|Withdrew|2|||
19740593|NCT00069095|42187551|FG001|Primary Treatment Phase|Withdrew|3|||
19740594|NCT00069095|42187552|FG002|Primary Treatment Phase|Withdrew|8|||
19740595|NCT00069095|42187553|FG003|Primary Treatment Phase|Withdrew|2|||
19740596|NCT00069095|42187554|FG004|Primary Treatment Phase|Withdrew|4|||
19740597|NCT00069095|42187555|FG005|Primary Treatment Phase|Withdrew|9|||
19740598|NCT00069095|42187550|FG000|Primary Treatment Phase|Other Violation|0|||
19740599|NCT00069095|42187551|FG001|Primary Treatment Phase|Other Violation|1|||
19740600|NCT00069095|42187552|FG002|Primary Treatment Phase|Other Violation|1|||
19740601|NCT00069095|42187553|FG003|Primary Treatment Phase|Other Violation|1|||
19740602|NCT00069095|42187554|FG004|Primary Treatment Phase|Other Violation|0|||
19740603|NCT00069095|42187555|FG005|Primary Treatment Phase|Other Violation|1|||
19740604|NCT00069095|42187550|FG000|Primary Treatment Phase|Violation criteria|0|||
19740605|NCT00069095|42187551|FG001|Primary Treatment Phase|Violation criteria|2|||
19740606|NCT00069095|42187552|FG002|Primary Treatment Phase|Violation criteria|4|||
19740607|NCT00069095|42187553|FG003|Primary Treatment Phase|Violation criteria|3|||
19740608|NCT00069095|42187554|FG004|Primary Treatment Phase|Violation criteria|1|||
19740609|NCT00069095|42187555|FG005|Primary Treatment Phase|Violation criteria|5|||
19740610|NCT00069095|42187550|FG000|Post-study Treatment Phase|Missing reason|1|||
19740611|NCT00069095|42187551|FG001|Post-study Treatment Phase|Missing reason|3|||
19740612|NCT00069095|42187552|FG002|Post-study Treatment Phase|Missing reason|12|||
19740613|NCT00069095|42187553|FG003|Post-study Treatment Phase|Missing reason|8|||
19740614|NCT00069095|42187554|FG004|Post-study Treatment Phase|Missing reason|18|||
19740615|NCT00069095|42187555|FG005|Post-study Treatment Phase|Missing reason|17|||
19740616|NCT00069095|42187550|FG000|Post-study Treatment Phase|Adverse Event|2|||
19740617|NCT00069095|42187551|FG001|Post-study Treatment Phase|Adverse Event|3|||
19740618|NCT00069095|42187552|FG002|Post-study Treatment Phase|Adverse Event|1|||
19740619|NCT00069095|42187553|FG003|Post-study Treatment Phase|Adverse Event|0|||
19740620|NCT00069095|42187554|FG004|Post-study Treatment Phase|Adverse Event|5|||
19740621|NCT00069095|42187555|FG005|Post-study Treatment Phase|Adverse Event|1|||
19740622|NCT00069095|42187550|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
19740623|NCT00069095|42187551|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
19740624|NCT00069095|42187552|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
19740625|NCT00069095|42187553|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
19740626|NCT00069095|42187554|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
19740627|NCT00069095|42187555|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
19740628|NCT00069095|42187550|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
19740629|NCT00069095|42187551|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
19740630|NCT00069095|42187552|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
19740631|NCT00069095|42187553|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
19740632|NCT00069095|42187554|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
19740633|NCT00069095|42187555|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
19740634|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
19740635|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
19740636|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
19740637|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
19740638|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
19740639|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
19740640|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant had complete response|1|||
19740641|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant had complete response|1|||
19740642|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant had complete response|0|||
19740643|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant had complete response|0|||
19740644|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant had complete response|0|||
19740645|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant had complete response|0|||
19740646|NCT00069095|42187550|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
19740647|NCT00069095|42187551|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
19740648|NCT00069095|42187552|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
19740649|NCT00069095|42187553|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
19740650|NCT00069095|42187554|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
19740651|NCT00069095|42187555|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
19740652|NCT00069095|42187550|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
19740653|NCT00069095|42187551|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
19740654|NCT00069095|42187552|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
19740655|NCT00069095|42187553|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
19740656|NCT00069095|42187554|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
19740657|NCT00069095|42187555|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
19740658|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
19740659|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
19740660|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
19565141|NCT01282814|42012938|FG000|First Intervention|Emesis During Dosing Interval|0|||
19565142|NCT01282814|42012939|FG001|First Intervention|Emesis During Dosing Interval|3|||
19740661|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
19740662|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
19740663|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
19740664|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
19740665|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
19740666|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
19740667|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
19740668|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
19740669|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
19740670|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
19740671|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
19740672|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
19740673|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
19740674|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
19740675|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
19740676|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
19740677|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
19740678|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
19740679|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
19740680|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
19740681|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
19740682|NCT00069095|42187550|FG000|Post-study Treatment Phase|Surgery|0|||
19740683|NCT00069095|42187551|FG001|Post-study Treatment Phase|Surgery|0|||
19565143|NCT01282814|42012938|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
19565144|NCT01282814|42012939|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19565145|NCT00941863|42012950|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
19565146|NCT00941863|42012951|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
19565147|NCT00941863|42012952|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
19740684|NCT00069095|42187552|FG002|Post-study Treatment Phase|Surgery|0|||
19740685|NCT00069095|42187553|FG003|Post-study Treatment Phase|Surgery|1|||
19740686|NCT00069095|42187554|FG004|Post-study Treatment Phase|Surgery|1|||
19740687|NCT00069095|42187555|FG005|Post-study Treatment Phase|Surgery|0|||
19740688|NCT00069095|42187550|FG000|Post-study Treatment Phase|Death|0|||
19740689|NCT00069095|42187551|FG001|Post-study Treatment Phase|Death|0|||
19740690|NCT00069095|42187552|FG002|Post-study Treatment Phase|Death|0|||
19740691|NCT00069095|42187553|FG003|Post-study Treatment Phase|Death|0|||
19740692|NCT00069095|42187554|FG004|Post-study Treatment Phase|Death|1|||
19740693|NCT00069095|42187555|FG005|Post-study Treatment Phase|Death|0|||
19740694|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
19565148|NCT00941863|42012953|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
19740695|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
19740696|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
19740697|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
19740698|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
19740699|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
19740700|NCT00069095|42187550|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
19740701|NCT00069095|42187551|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
19740702|NCT00069095|42187552|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
19740703|NCT00069095|42187553|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
19740704|NCT00069095|42187554|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
19740705|NCT00069095|42187555|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
19740706|NCT00069095|42187550|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
19740707|NCT00069095|42187551|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
19740708|NCT00069095|42187552|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
19740709|NCT00069095|42187553|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
19740710|NCT00069095|42187554|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
19740711|NCT00069095|42187555|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
19740712|NCT00069095|42187550|FG000|Post-study Treatment Phase|Investigator decision|0|||
19740713|NCT00069095|42187551|FG001|Post-study Treatment Phase|Investigator decision|0|||
19740714|NCT00069095|42187552|FG002|Post-study Treatment Phase|Investigator decision|0|||
19740715|NCT00069095|42187553|FG003|Post-study Treatment Phase|Investigator decision|0|||
19740716|NCT00069095|42187554|FG004|Post-study Treatment Phase|Investigator decision|0|||
19740717|NCT00069095|42187555|FG005|Post-study Treatment Phase|Investigator decision|1|||
19740718|NCT00069095|42187550|FG000|Follow-up Phase|Death|174|||
19740719|NCT00069095|42187551|FG001|Follow-up Phase|Death|206|||
19740720|NCT00069095|42187552|FG002|Follow-up Phase|Death|120|||
19740721|NCT00069095|42187553|FG003|Follow-up Phase|Death|112|||
19740722|NCT00069095|42187554|FG004|Follow-up Phase|Death|92|||
19740723|NCT00069095|42187555|FG005|Follow-up Phase|Death|101|||
19740724|NCT00086411|42187571|FG000|Overall Study|Lost to Follow-up|11|||
19740725|NCT00086411|42187572|FG001|Overall Study|Lost to Follow-up|11|||
19740726|NCT00086411|42187573|FG002|Overall Study|Lost to Follow-up|13|||
19740727|NCT00086411|42187574|FG003|Overall Study|Lost to Follow-up|12|||
19740728|NCT00068393|42187585|FG000|Overall Study|Adverse Event|2|||
19740729|NCT00068393|42187585|FG000|Overall Study|Death|3|||
19740730|NCT00068393|42187585|FG000|Overall Study|Withdrawal by Subject|3|||
19740731|NCT00068393|42187585|FG000|Overall Study|Alternative treatment|1|||
19740732|NCT00068393|42187585|FG000|Overall Study|Quality of life worsening|1|||
19740733|NCT00068237|42187589|FG000|Overall Study|Ineligible|3|||
19740734|NCT00068237|42187589|FG000|Overall Study|No protocol treatment received|2|||
19740735|NCT03809039|42187602|FG000|Part 1|Withdrawal by Subject|1|||
19740736|NCT03809039|42187603|FG001|Part 1|Withdrawal by Subject|0|||
19740737|NCT03809039|42187604|FG002|Part 1|Withdrawal by Subject|0|||
19740738|NCT03809039|42187605|FG003|Part 1|Withdrawal by Subject|1|||
19740739|NCT03809039|42187606|FG004|Part 1|Withdrawal by Subject|0|||
19740740|NCT03809039|42187607|FG005|Part 1|Withdrawal by Subject|0|||
19740741|NCT03809039|42187608|FG006|Part 1|Withdrawal by Subject|0|||
19740742|NCT03809039|42187609|FG007|Part 1|Withdrawal by Subject|0|||
19740743|NCT03809039|42187610|FG008|Part 1|Withdrawal by Subject|0|||
19740744|NCT03809039|42187602|FG000|Part 3|Withdrawn by study termination|0|||
19740745|NCT03809039|42187603|FG001|Part 3|Withdrawn by study termination|0|||
19740746|NCT03809039|42187604|FG002|Part 3|Withdrawn by study termination|0|||
19740747|NCT03809039|42187605|FG003|Part 3|Withdrawn by study termination|0|||
19740748|NCT03809039|42187606|FG004|Part 3|Withdrawn by study termination|0|||
19740749|NCT03809039|42187607|FG005|Part 3|Withdrawn by study termination|0|||
19740750|NCT03809039|42187608|FG006|Part 3|Withdrawn by study termination|0|||
19740751|NCT03809039|42187609|FG007|Part 3|Withdrawn by study termination|2|||
19740752|NCT03809039|42187610|FG008|Part 3|Withdrawn by study termination|6|||
19740753|NCT00055601|42187645|FG000|Overall Study|Protocol Violation|1|||
19740754|NCT00055601|42187646|FG001|Overall Study|Protocol Violation|1|||
19740755|NCT00055601|42187645|FG000|Overall Study|No protocol treatment received|1|||
19740756|NCT00055601|42187646|FG001|Overall Study|No protocol treatment received|1|||
19740757|NCT03806231|42187654|FG000|Overall Study|Physician Decision|1|||
19740758|NCT03806231|42187655|FG001|Overall Study|Physician Decision|0|||
19740759|NCT03806231|42187654|FG000|Overall Study|Withdrawal by Subject|1|||
19740760|NCT03806231|42187655|FG001|Overall Study|Withdrawal by Subject|0|||
19740761|NCT00054275|42187661|FG000|Overall Study|Withdrawal by Subject|4|||
19740762|NCT00054275|42187661|FG000|Overall Study|Adverse Event|5|||
19740763|NCT00054275|42187661|FG000|Overall Study|Progressive disease in cycle 1|1|||
19740764|NCT00054275|42187661|FG000|Overall Study|Physician Decision|1|||
19740765|NCT00053417|42187669|FG000|Overall Study|Adverse Event|1|||
19740766|NCT00053417|42187670|FG001|Overall Study|Adverse Event|0|||
19740767|NCT00053417|42187671|FG002|Overall Study|Adverse Event|1|||
19740768|NCT00053417|42187672|FG003|Overall Study|Adverse Event|5|||
19740769|NCT00053417|42187669|FG000|Overall Study|Non-Compliance|0|||
19740770|NCT00053417|42187670|FG001|Overall Study|Non-Compliance|0|||
19740771|NCT00053417|42187671|FG002|Overall Study|Non-Compliance|0|||
19740772|NCT00053417|42187672|FG003|Overall Study|Non-Compliance|1|||
19740773|NCT00053417|42187669|FG000|Overall Study|Withdrawal by Subject|0|||
19740774|NCT00053417|42187670|FG001|Overall Study|Withdrawal by Subject|1|||
19740775|NCT00053417|42187671|FG002|Overall Study|Withdrawal by Subject|0|||
19740776|NCT00053417|42187672|FG003|Overall Study|Withdrawal by Subject|0|||
19740777|NCT00053417|42187669|FG000|Overall Study|Lost to Follow-up|1|||
19740778|NCT00053417|42187670|FG001|Overall Study|Lost to Follow-up|1|||
19740779|NCT00053417|42187671|FG002|Overall Study|Lost to Follow-up|0|||
19740780|NCT00053417|42187672|FG003|Overall Study|Lost to Follow-up|0|||
19740781|NCT00052715|42187682|FG000|Overall Study|wrong histology|1|||
19740782|NCT00051311|42187688|FG000|Overall Study|Starting new study|0|||
19740783|NCT00051311|42187689|FG001|Overall Study|Starting new study|1|||
19740784|NCT00051311|42187688|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
19740785|NCT00051311|42187689|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
19740786|NCT00051311|42187688|FG000|Overall Study|Death of recipient|8|||
19740787|NCT00051311|42187689|FG001|Overall Study|Death of recipient|8|||
19740788|NCT00051311|42187688|FG000|Overall Study|Recipient taken off study|4|||
19740789|NCT00051311|42187689|FG001|Overall Study|Recipient taken off study|4|||
19740790|NCT00049673|42187695|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
19740791|NCT00049673|42187696|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
19565149|NCT00941863|42012954|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
19565150|NCT00941863|42012950|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
19565151|NCT00941863|42012951|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
19565152|NCT00941863|42012952|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
19565153|NCT00941863|42012953|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
19565154|NCT00941863|42012954|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
19565155|NCT00941863|42012950|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
19565156|NCT00941863|42012951|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
19565157|NCT00941863|42012952|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
19565158|NCT00941863|42012953|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
19565159|NCT00941863|42012954|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
19740792|NCT00049517|42187704|FG000|Induction|Disease progression|0|||
19740793|NCT00049517|42187705|FG001|Induction|Disease progression|0|||
19740794|NCT00049517|42187706|FG002|Induction|Disease progression|0|||
19740795|NCT00049517|42187707|FG003|Induction|Disease progression|0|||
19740796|NCT00049517|42187708|FG004|Induction|Disease progression|18|||
19740797|NCT00049517|42187709|FG005|Induction|Disease progression|11|||
19740798|NCT00049517|42187704|FG000|Induction|Adverse Event|0|||
19740799|NCT00049517|42187705|FG001|Induction|Adverse Event|0|||
19740800|NCT00049517|42187706|FG002|Induction|Adverse Event|0|||
19740801|NCT00049517|42187707|FG003|Induction|Adverse Event|0|||
19740802|NCT00049517|42187708|FG004|Induction|Adverse Event|5|||
19740803|NCT00049517|42187709|FG005|Induction|Adverse Event|7|||
19740804|NCT00049517|42187704|FG000|Induction|Death|0|||
19740805|NCT00049517|42187705|FG001|Induction|Death|0|||
19740806|NCT00049517|42187706|FG002|Induction|Death|0|||
19740807|NCT00049517|42187707|FG003|Induction|Death|0|||
19740808|NCT00049517|42187708|FG004|Induction|Death|9|||
19740809|NCT00049517|42187709|FG005|Induction|Death|6|||
19740810|NCT00049517|42187704|FG000|Induction|Withdrawal by Subject|0|||
19740811|NCT00049517|42187705|FG001|Induction|Withdrawal by Subject|0|||
19740812|NCT00049517|42187706|FG002|Induction|Withdrawal by Subject|0|||
19740813|NCT00049517|42187707|FG003|Induction|Withdrawal by Subject|0|||
19740814|NCT00049517|42187708|FG004|Induction|Withdrawal by Subject|1|||
19740815|NCT00049517|42187709|FG005|Induction|Withdrawal by Subject|3|||
19740816|NCT00049517|42187704|FG000|Induction|Alternative therapy|0|||
19740817|NCT00049517|42187705|FG001|Induction|Alternative therapy|0|||
19740818|NCT00049517|42187706|FG002|Induction|Alternative therapy|0|||
19740819|NCT00049517|42187707|FG003|Induction|Alternative therapy|0|||
19740820|NCT00049517|42187708|FG004|Induction|Alternative therapy|2|||
19740821|NCT00049517|42187709|FG005|Induction|Alternative therapy|2|||
19740822|NCT00049517|42187704|FG000|Induction|Other complicating disease|0|||
19740823|NCT00049517|42187705|FG001|Induction|Other complicating disease|0|||
19740824|NCT00049517|42187706|FG002|Induction|Other complicating disease|0|||
19740825|NCT00049517|42187707|FG003|Induction|Other complicating disease|0|||
19740826|NCT00049517|42187708|FG004|Induction|Other complicating disease|3|||
19740827|NCT00049517|42187709|FG005|Induction|Other complicating disease|0|||
19740828|NCT00049517|42187704|FG000|Induction|Reasons not reported|0|||
19740829|NCT00049517|42187705|FG001|Induction|Reasons not reported|0|||
19740830|NCT00049517|42187706|FG002|Induction|Reasons not reported|0|||
19740831|NCT00049517|42187707|FG003|Induction|Reasons not reported|0|||
19740832|NCT00049517|42187708|FG004|Induction|Reasons not reported|22|||
19740833|NCT00049517|42187709|FG005|Induction|Reasons not reported|25|||
19740834|NCT00049517|42187704|FG000|Conditioning/Transplant|Disease progression|14|||
19740835|NCT00049517|42187705|FG001|Conditioning/Transplant|Disease progression|6|||
19740836|NCT00049517|42187706|FG002|Conditioning/Transplant|Disease progression|10|||
19740837|NCT00049517|42187707|FG003|Conditioning/Transplant|Disease progression|6|||
19740838|NCT00049517|42187708|FG004|Conditioning/Transplant|Disease progression|0|||
19740839|NCT00049517|42187709|FG005|Conditioning/Transplant|Disease progression|0|||
19740840|NCT00049517|42187704|FG000|Conditioning/Transplant|Adverse Event|2|||
19740841|NCT00049517|42187705|FG001|Conditioning/Transplant|Adverse Event|1|||
19740842|NCT00049517|42187706|FG002|Conditioning/Transplant|Adverse Event|4|||
19565160|NCT00941863|42012950|FG000|Until Primary Completion Date (PCD)|Death|0|||
19740843|NCT00049517|42187707|FG003|Conditioning/Transplant|Adverse Event|8|||
19740844|NCT00049517|42187708|FG004|Conditioning/Transplant|Adverse Event|0|||
19740845|NCT00049517|42187709|FG005|Conditioning/Transplant|Adverse Event|0|||
19740846|NCT00049517|42187704|FG000|Conditioning/Transplant|Death|1|||
19740847|NCT00049517|42187705|FG001|Conditioning/Transplant|Death|0|||
19740848|NCT00049517|42187706|FG002|Conditioning/Transplant|Death|0|||
19740849|NCT00049517|42187707|FG003|Conditioning/Transplant|Death|2|||
19740850|NCT00049517|42187708|FG004|Conditioning/Transplant|Death|0|||
19740851|NCT00049517|42187709|FG005|Conditioning/Transplant|Death|0|||
19740852|NCT00049517|42187704|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
19740853|NCT00049517|42187705|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
19740854|NCT00049517|42187706|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
19740855|NCT00049517|42187707|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
19740856|NCT00049517|42187708|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
19740857|NCT00049517|42187709|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
19740858|NCT00049517|42187704|FG000|Conditioning/Transplant|Alternative therapy|4|||
19740859|NCT00049517|42187705|FG001|Conditioning/Transplant|Alternative therapy|4|||
19740860|NCT00049517|42187706|FG002|Conditioning/Transplant|Alternative therapy|2|||
19740861|NCT00049517|42187707|FG003|Conditioning/Transplant|Alternative therapy|1|||
19740862|NCT00049517|42187708|FG004|Conditioning/Transplant|Alternative therapy|1|||
19740863|NCT00049517|42187709|FG005|Conditioning/Transplant|Alternative therapy|0|||
19740864|NCT00049517|42187704|FG000|Conditioning/Transplant|Other complicating disease|2|||
19740865|NCT00049517|42187705|FG001|Conditioning/Transplant|Other complicating disease|0|||
19565161|NCT00941863|42012951|FG001|Until Primary Completion Date (PCD)|Death|0|||
19565162|NCT00941863|42012952|FG002|Until Primary Completion Date (PCD)|Death|1|||
19565163|NCT00941863|42012953|FG003|Until Primary Completion Date (PCD)|Death|2|||
19565164|NCT00941863|42012954|FG004|Until Primary Completion Date (PCD)|Death|7|||
19565165|NCT00941863|42012950|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
19565166|NCT00941863|42012951|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
19565167|NCT00941863|42012952|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
19565168|NCT00941863|42012953|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
19565169|NCT00941863|42012954|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
19565170|NCT00941863|42012950|FG000|Continued After PCD|Withdrawal by Subject|0|||
19565171|NCT00941863|42012951|FG001|Continued After PCD|Withdrawal by Subject|0|||
19565172|NCT00941863|42012952|FG002|Continued After PCD|Withdrawal by Subject|0|||
19565173|NCT00941863|42012953|FG003|Continued After PCD|Withdrawal by Subject|0|||
19565174|NCT00941863|42012954|FG004|Continued After PCD|Withdrawal by Subject|1|||
19565175|NCT00941863|42012950|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
19565176|NCT00941863|42012951|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
19565177|NCT00941863|42012952|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
19565178|NCT00941863|42012953|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
19565179|NCT00941863|42012954|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
19565180|NCT01282424|42012970|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
19565181|NCT01282424|42012970|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
19565182|NCT01282424|42012970|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
19565183|NCT01282424|42012970|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
19565184|NCT01282424|42012970|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
19565185|NCT01282424|42012970|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
19565186|NCT01282424|42012970|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
19565187|NCT01282424|42012970|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
19565188|NCT01281956|42012974|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
19565189|NCT01281956|42012975|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
19565190|NCT01279850|42012984|FG000|Overall Study|Protocol Violation|50|||
19565191|NCT01279850|42012984|FG000|Overall Study|No Drug Administration Information|7|||
19565192|NCT01279850|42012984|FG000|Overall Study|No Visit After Treatment|34|||
19565193|NCT00949975|42012992|FG000|Overall Study|Voluntary discontinuation|6|||
19565194|NCT00949975|42012993|FG001|Overall Study|Voluntary discontinuation|5|||
19565195|NCT00949975|42012994|FG002|Overall Study|Voluntary discontinuation|3|||
19565196|NCT00949975|42012995|FG003|Overall Study|Voluntary discontinuation|6|||
19565197|NCT00949975|42012992|FG000|Overall Study|Adverse Event|11|||
19565198|NCT00949975|42012993|FG001|Overall Study|Adverse Event|11|||
19565199|NCT00949975|42012994|FG002|Overall Study|Adverse Event|10|||
19565200|NCT00949975|42012995|FG003|Overall Study|Adverse Event|10|||
19565201|NCT00949975|42012992|FG000|Overall Study|Safety reason|0|||
19565202|NCT00949975|42012993|FG001|Overall Study|Safety reason|1|||
19565203|NCT00949975|42012994|FG002|Overall Study|Safety reason|0|||
19565204|NCT00949975|42012995|FG003|Overall Study|Safety reason|0|||
19565205|NCT00949975|42012992|FG000|Overall Study|Study-specific criteria|0|||
19565206|NCT00949975|42012993|FG001|Overall Study|Study-specific criteria|1|||
19565207|NCT00949975|42012994|FG002|Overall Study|Study-specific criteria|1|||
19565208|NCT00949975|42012995|FG003|Overall Study|Study-specific criteria|0|||
19565209|NCT00949975|42012992|FG000|Overall Study|Incorrect enrolment|5|||
19565210|NCT00949975|42012993|FG001|Overall Study|Incorrect enrolment|10|||
19565211|NCT00949975|42012994|FG002|Overall Study|Incorrect enrolment|4|||
19565212|NCT00949975|42012995|FG003|Overall Study|Incorrect enrolment|7|||
19565213|NCT00949975|42012992|FG000|Overall Study|Severe non-compliance|3|||
19565214|NCT00949975|42012993|FG001|Overall Study|Severe non-compliance|1|||
19565215|NCT00949975|42012994|FG002|Overall Study|Severe non-compliance|0|||
19565216|NCT00949975|42012995|FG003|Overall Study|Severe non-compliance|2|||
19565217|NCT00949975|42012992|FG000|Overall Study|Lost to Follow-up|1|||
19565218|NCT00949975|42012993|FG001|Overall Study|Lost to Follow-up|0|||
19565219|NCT00949975|42012994|FG002|Overall Study|Lost to Follow-up|1|||
19565220|NCT00949975|42012995|FG003|Overall Study|Lost to Follow-up|3|||
19565221|NCT00949975|42012992|FG000|Overall Study|Other|1|||
19565222|NCT00949975|42012993|FG001|Overall Study|Other|0|||
19565223|NCT00949975|42012994|FG002|Overall Study|Other|0|||
19565224|NCT00949975|42012995|FG003|Overall Study|Other|0|||
19565225|NCT00939055|42013007|FG000|Overall Study|Discontinuation prior to procedure|4|||
19565226|NCT00939055|42013008|FG001|Overall Study|Discontinuation prior to procedure|0|||
19565227|NCT01136967|42013017|FG000|Overall Study|Adverse Event|9|||
19565228|NCT01136967|42013018|FG001|Overall Study|Adverse Event|12|||
19565229|NCT01136967|42013017|FG000|Overall Study|Participant Choice|8|||
19565230|NCT01136967|42013018|FG001|Overall Study|Participant Choice|3|||
19740866|NCT00049517|42187706|FG002|Conditioning/Transplant|Other complicating disease|0|||
19740867|NCT00049517|42187707|FG003|Conditioning/Transplant|Other complicating disease|4|||
19740868|NCT00049517|42187708|FG004|Conditioning/Transplant|Other complicating disease|0|||
19740869|NCT00049517|42187709|FG005|Conditioning/Transplant|Other complicating disease|1|||
19740870|NCT00049517|42187704|FG000|Conditioning/Transplant|Reasons not reported|25|||
19740871|NCT00049517|42187705|FG001|Conditioning/Transplant|Reasons not reported|31|||
19740872|NCT00049517|42187706|FG002|Conditioning/Transplant|Reasons not reported|18|||
19740873|NCT00049517|42187707|FG003|Conditioning/Transplant|Reasons not reported|15|||
19740874|NCT00049517|42187708|FG004|Conditioning/Transplant|Reasons not reported|5|||
19740875|NCT00049517|42187709|FG005|Conditioning/Transplant|Reasons not reported|5|||
19740876|NCT00049127|42187722|FG000|Overall Study|Withdrawal by Subject|0|||
19740877|NCT00049127|42187723|FG001|Overall Study|Withdrawal by Subject|0|||
19740878|NCT00049127|42187724|FG002|Overall Study|Withdrawal by Subject|1|||
19740879|NCT00049127|42187725|FG003|Overall Study|Withdrawal by Subject|0|||
19740880|NCT00049127|42187726|FG004|Overall Study|Withdrawal by Subject|0|||
19740881|NCT00066365|42187740|FG000|Overall Study|Adverse Event|1|||
19740882|NCT00066365|42187741|FG001|Overall Study|Adverse Event|0|||
19740883|NCT00066365|42187740|FG000|Overall Study|Lack of Efficacy|15|||
19740884|NCT00066365|42187741|FG001|Overall Study|Lack of Efficacy|12|||
19740885|NCT00066365|42187740|FG000|Overall Study|Physician Decision|1|||
19740886|NCT00066365|42187741|FG001|Overall Study|Physician Decision|0|||
19740887|NCT00066365|42187740|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
19740888|NCT00066365|42187741|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
19740889|NCT00066365|42187740|FG000|Overall Study|Ineligible|4|||
19740890|NCT00066365|42187741|FG001|Overall Study|Ineligible|2|||
19740891|NCT00048581|42187751|FG000|Double-Blind Period|Adverse Event|9|||
19740892|NCT00048581|42187752|FG001|Double-Blind Period|Adverse Event|5|||
19740893|NCT00048581|42187753|FG002|Double-Blind Period|Adverse Event|0|||
19740894|NCT00048581|42187751|FG000|Double-Blind Period|Lack of Efficacy|14|||
19740895|NCT00048581|42187752|FG001|Double-Blind Period|Lack of Efficacy|27|||
19740896|NCT00048581|42187753|FG002|Double-Blind Period|Lack of Efficacy|0|||
19740897|NCT00048581|42187751|FG000|Double-Blind Period|Lost to Follow-up|5|||
19740898|NCT00048581|42187752|FG001|Double-Blind Period|Lost to Follow-up|0|||
19740899|NCT00048581|42187753|FG002|Double-Blind Period|Lost to Follow-up|0|||
19740900|NCT00048581|42187751|FG000|Double-Blind Period|Withdrawal by Subject|5|||
19740901|NCT00048581|42187752|FG001|Double-Blind Period|Withdrawal by Subject|2|||
19740902|NCT00048581|42187753|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19740903|NCT00048581|42187751|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
19740904|NCT00048581|42187752|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
19740905|NCT00048581|42187753|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
19740906|NCT00048581|42187751|FG000|Double-Blind Period|Investigator Decision|1|||
19740907|NCT00048581|42187752|FG001|Double-Blind Period|Investigator Decision|0|||
19740908|NCT00048581|42187753|FG002|Double-Blind Period|Investigator Decision|0|||
19740909|NCT00048581|42187751|FG000|Open-Label Period|Death|0|||
19740910|NCT00048581|42187752|FG001|Open-Label Period|Death|0|||
19740911|NCT00048581|42187753|FG002|Open-Label Period|Death|4|||
19740912|NCT00048581|42187751|FG000|Open-Label Period|Adverse Event|0|||
19740913|NCT00048581|42187752|FG001|Open-Label Period|Adverse Event|0|||
19740914|NCT00048581|42187753|FG002|Open-Label Period|Adverse Event|37|||
19740915|NCT00048581|42187751|FG000|Open-Label Period|Lack of Efficacy|0|||
19740916|NCT00048581|42187752|FG001|Open-Label Period|Lack of Efficacy|0|||
19740917|NCT00048581|42187753|FG002|Open-Label Period|Lack of Efficacy|69|||
19740918|NCT00048581|42187751|FG000|Open-Label Period|Lost to Follow-up|0|||
19740919|NCT00048581|42187752|FG001|Open-Label Period|Lost to Follow-up|0|||
19565231|NCT01136967|42013017|FG000|Overall Study|Lost to Follow-up|0|||
19565232|NCT01136967|42013018|FG001|Overall Study|Lost to Follow-up|1|||
19565233|NCT01136967|42013017|FG000|Overall Study|Withdrawal by Subject|1|||
19565234|NCT01136967|42013018|FG001|Overall Study|Withdrawal by Subject|2|||
19740920|NCT00048581|42187753|FG002|Open-Label Period|Lost to Follow-up|14|||
19740921|NCT00048581|42187751|FG000|Open-Label Period|Withdrawal by Subject|0|||
19740922|NCT00048581|42187752|FG001|Open-Label Period|Withdrawal by Subject|0|||
19740923|NCT00048581|42187753|FG002|Open-Label Period|Withdrawal by Subject|20|||
19740924|NCT00048581|42187751|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
19740925|NCT00048581|42187752|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
19740926|NCT00048581|42187753|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
19740927|NCT00048581|42187751|FG000|Open-Label Period|Poor/Non-compliance|0|||
19740928|NCT00048581|42187752|FG001|Open-Label Period|Poor/Non-compliance|0|||
19740929|NCT00048581|42187753|FG002|Open-Label Period|Poor/Non-compliance|5|||
19740930|NCT00048581|42187751|FG000|Open-Label Period|Pregnancy|0|||
19740931|NCT00048581|42187752|FG001|Open-Label Period|Pregnancy|0|||
19740932|NCT00048581|42187753|FG002|Open-Label Period|Pregnancy|7|||
19740933|NCT00048581|42187751|FG000|Open-Label Period|Study Site Closure|0|||
19740934|NCT00048581|42187752|FG001|Open-Label Period|Study Site Closure|0|||
19740935|NCT00048581|42187753|FG002|Open-Label Period|Study Site Closure|2|||
19740936|NCT00048581|42187751|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
19740937|NCT00048581|42187752|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
19740938|NCT00048581|42187753|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
19740939|NCT00048581|42187751|FG000|Open-Label Period|Problem With Transportation To Site|0|||
19740940|NCT00048581|42187752|FG001|Open-Label Period|Problem With Transportation To Site|0|||
19740941|NCT00048581|42187753|FG002|Open-Label Period|Problem With Transportation To Site|1|||
19740942|NCT00048581|42187751|FG000|Open-Label Period|Primary Investigator Retired|0|||
19740943|NCT00048581|42187752|FG001|Open-Label Period|Primary Investigator Retired|0|||
19740944|NCT00048581|42187753|FG002|Open-Label Period|Primary Investigator Retired|2|||
19740945|NCT00048581|42187751|FG000|Open-Label Period|Study Ended By Sponsor|0|||
19740946|NCT00048581|42187752|FG001|Open-Label Period|Study Ended By Sponsor|0|||
19740947|NCT00048581|42187753|FG002|Open-Label Period|Study Ended By Sponsor|1|||
19740948|NCT00048347|42187766|FG000|Overall Study|Screen failure|2|||
19740949|NCT00065507|42187772|FG000|Overall Study|Death|16|||
19740950|NCT00065507|42187773|FG001|Overall Study|Death|17|||
19740951|NCT00065507|42187772|FG000|Overall Study|Adverse Event|4|||
19740952|NCT00065507|42187773|FG001|Overall Study|Adverse Event|3|||
19740953|NCT00065507|42187772|FG000|Overall Study|Lack of Efficacy|0|||
19740954|NCT00065507|42187773|FG001|Overall Study|Lack of Efficacy|6|||
19740955|NCT00065507|42187772|FG000|Overall Study|Poor/Non-compliance|3|||
19740956|NCT00065507|42187773|FG001|Overall Study|Poor/Non-compliance|2|||
19740957|NCT00065507|42187772|FG000|Overall Study|Lost to Follow-up|3|||
19740958|NCT00065507|42187773|FG001|Overall Study|Lost to Follow-up|0|||
19740959|NCT00065507|42187772|FG000|Overall Study|Subject Withdrew Consent|2|||
19740960|NCT00065507|42187773|FG001|Overall Study|Subject Withdrew Consent|1|||
19740961|NCT00065507|42187772|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
19740962|NCT00065507|42187773|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
19740963|NCT00065429|42187790|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740964|NCT00065429|42187791|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740965|NCT00065429|42187792|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740966|NCT00065429|42187793|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740967|NCT00065429|42187794|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740968|NCT00065429|42187795|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
19740969|NCT00065429|42187796|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
19740970|NCT00065429|42187790|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740971|NCT00065429|42187791|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740972|NCT00065429|42187792|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
19740973|NCT00065429|42187793|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740974|NCT00065429|42187794|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740975|NCT00065429|42187795|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740976|NCT00065429|42187796|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
19740977|NCT00065429|42187790|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
19740978|NCT00065429|42187791|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740979|NCT00065429|42187792|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740980|NCT00065429|42187793|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740981|NCT00065429|42187794|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740982|NCT00065429|42187795|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740983|NCT00065429|42187796|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
19740984|NCT00065429|42187790|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
19740985|NCT00065429|42187791|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
19740986|NCT00065429|42187792|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
19740987|NCT00065429|42187793|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
19740988|NCT00065429|42187794|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
19740989|NCT00065429|42187795|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
19740990|NCT00065429|42187796|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
19740991|NCT00065429|42187790|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
19382297|NCT04248465|41625598|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
19740992|NCT00065429|42187791|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
19565235|NCT01136967|42013017|FG000|Overall Study|Clinical Progression|3|||
19565236|NCT01136967|42013018|FG001|Overall Study|Clinical Progression|5|||
19565237|NCT01136967|42013017|FG000|Overall Study|Radiation|1|||
19565238|NCT01136967|42013018|FG001|Overall Study|Radiation|0|||
19565239|NCT01136967|42013017|FG000|Overall Study|Non-compliance|1|||
19565240|NCT01136967|42013018|FG001|Overall Study|Non-compliance|0|||
19565241|NCT01136967|42013017|FG000|Overall Study|Investigator's Choice|1|||
19565242|NCT01136967|42013018|FG001|Overall Study|Investigator's Choice|1|||
19565243|NCT01136967|42013017|FG000|Overall Study|Increase in Lesion Size|0|||
19565244|NCT01136967|42013018|FG001|Overall Study|Increase in Lesion Size|2|||
19565245|NCT01136967|42013017|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
19565246|NCT01136967|42013018|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
19565247|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
19565248|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
19565249|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
19565250|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
19565251|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
19565252|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
19565253|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
19565254|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
19565255|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
19565256|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
19565257|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
19565258|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
19565259|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
19565260|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
19565261|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
19565262|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
19565263|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
19565264|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
19565265|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
19740993|NCT00065429|42187792|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
19740994|NCT00065429|42187793|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
19740995|NCT00065429|42187794|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
19740996|NCT00065429|42187795|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
19740997|NCT00065429|42187796|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
19740998|NCT00065429|42187790|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19740999|NCT00065429|42187791|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19741000|NCT00065429|42187792|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19741001|NCT00065429|42187793|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19741002|NCT00065429|42187794|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
19741003|NCT00065429|42187795|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19741004|NCT00065429|42187796|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
19741005|NCT00065429|42187790|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741006|NCT00065429|42187791|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741007|NCT00065429|42187792|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741008|NCT00065429|42187793|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741009|NCT00065429|42187794|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
19741010|NCT00065429|42187795|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741011|NCT00065429|42187796|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
19741012|NCT00048035|42187813|FG000|Core Period|Early Withdrawals|4|||
19741013|NCT00048035|42187814|FG001|Core Period|Early Withdrawals|2|||
19741014|NCT00048035|42187815|FG002|Core Period|Early Withdrawals|1|||
19741015|NCT00048035|42187816|FG003|Core Period|Early Withdrawals|1|||
19741016|NCT00048035|42187817|FG004|Core Period|Early Withdrawals|1|||
19741017|NCT00048035|42187818|FG005|Core Period|Early Withdrawals|1|||
19741018|NCT00048035|42187819|FG006|Core Period|Early Withdrawals|0|||
19741019|NCT00048035|42187820|FG007|Core Period|Early Withdrawals|0|||
19741020|NCT00048035|42187813|FG000|Extension Year 1|Early Withdrawals|0|||
19741021|NCT00048035|42187814|FG001|Extension Year 1|Early Withdrawals|0|||
19741022|NCT00048035|42187815|FG002|Extension Year 1|Early Withdrawals|0|||
19741023|NCT00048035|42187816|FG003|Extension Year 1|Early Withdrawals|0|||
19741024|NCT00048035|42187817|FG004|Extension Year 1|Early Withdrawals|0|||
19741025|NCT00048035|42187818|FG005|Extension Year 1|Early Withdrawals|0|||
19741026|NCT00048035|42187819|FG006|Extension Year 1|Early Withdrawals|11|||
19741027|NCT00048035|42187820|FG007|Extension Year 1|Early Withdrawals|11|||
19741028|NCT00048035|42187813|FG000|Extension Year 2|Early Withdrawals|0|||
19741029|NCT00048035|42187814|FG001|Extension Year 2|Early Withdrawals|0|||
19741030|NCT00048035|42187815|FG002|Extension Year 2|Early Withdrawals|0|||
19741031|NCT00048035|42187816|FG003|Extension Year 2|Early Withdrawals|0|||
19741032|NCT00048035|42187817|FG004|Extension Year 2|Early Withdrawals|0|||
19741033|NCT00048035|42187818|FG005|Extension Year 2|Early Withdrawals|0|||
19741034|NCT00048035|42187819|FG006|Extension Year 2|Early Withdrawals|3|||
19741035|NCT00048035|42187820|FG007|Extension Year 2|Early Withdrawals|3|||
19741036|NCT00047879|42187837|FG000|Overall Study|Progressive disease|4|||
19741037|NCT00047879|42187838|FG001|Overall Study|Progressive disease|3|||
19741038|NCT00064337|42187844|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
19741039|NCT00064337|42187844|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
19741040|NCT00064337|42187844|FG000|PBSCC or Induction/PBSCC|Progression|3|||
19741041|NCT00064337|42187844|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
19741042|NCT00064337|42187844|FG000|PBSCC or Induction/PBSCC|Death|2|||
19741043|NCT00064337|42187844|FG000|Transplant|Adverse Event|9|||
19741044|NCT00064337|42187844|FG000|Transplant|Not protocol-specified|5|||
19741045|NCT00064337|42187844|FG000|Transplant|Death|3|||
19741046|NCT00064337|42187844|FG000|Transplant|Patient Refusal|2|||
19741047|NCT00064337|42187844|FG000|Transplant|Progression|2|||
19741048|NCT00064337|42187844|FG000|Maintenance|Adverse Event|3|||
19741049|NCT00064337|42187844|FG000|Maintenance|Progression|2|||
19741050|NCT00064337|42187844|FG000|Maintenance|On treatment at time of analysis|2|||
19741051|NCT00064337|42187844|FG000|Maintenance|Not protocol-specified|2|||
19741052|NCT00064337|42187844|FG000|Maintenance|Death|1|||
19741053|NCT00045305|42187851|FG000|Overall Study|Lack of Efficacy|6|||
19741054|NCT00045305|42187851|FG000|Overall Study|Adverse Event|3|||
19741055|NCT00045305|42187851|FG000|Overall Study|Death|3|||
19741056|NCT00045305|42187851|FG000|Overall Study|site error|2|||
19741057|NCT00064259|42187855|FG000|Overall Study|Adverse Event|1|||
19741058|NCT00064259|42187856|FG001|Overall Study|Adverse Event|0|||
19741059|NCT00064259|42187857|FG002|Overall Study|Adverse Event|0|||
19741060|NCT00064259|42187858|FG003|Overall Study|Adverse Event|1|||
19741061|NCT00044213|42187867|FG000|Overall Study|Withdrawal by Subject|50|||
19741062|NCT00044213|42187868|FG001|Overall Study|Withdrawal by Subject|65|||
19741063|NCT00044213|42187869|FG002|Overall Study|Withdrawal by Subject|91|||
19741064|NCT00044213|42187870|FG003|Overall Study|Withdrawal by Subject|83|||
19741065|NCT00044213|42187867|FG000|Overall Study|Death|42|||
19741066|NCT00044213|42187868|FG001|Overall Study|Death|42|||
19741067|NCT00044213|42187869|FG002|Overall Study|Death|42|||
19741068|NCT00044213|42187870|FG003|Overall Study|Death|49|||
19741069|NCT00044213|42187867|FG000|Overall Study|Lost to Follow-up|8|||
19741070|NCT00044213|42187868|FG001|Overall Study|Lost to Follow-up|5|||
19741071|NCT00044213|42187869|FG002|Overall Study|Lost to Follow-up|5|||
19741072|NCT00044213|42187870|FG003|Overall Study|Lost to Follow-up|4|||
19741073|NCT00064025|42187880|FG000|Overall Study|Ineligible|4|||
19741074|NCT00064025|42187880|FG000|Overall Study|Inevaluable|3|||
19741075|NCT02095132|42187895|FG000|Overall Study|Adverse Event|0|||
19741076|NCT02095132|42187896|FG001|Overall Study|Adverse Event|0|||
19741077|NCT02095132|42187897|FG002|Overall Study|Adverse Event|0|||
19741078|NCT02095132|42187898|FG003|Overall Study|Adverse Event|0|||
19741079|NCT02095132|42187899|FG004|Overall Study|Adverse Event|1|||
19741080|NCT02095132|42187900|FG005|Overall Study|Adverse Event|0|||
19741081|NCT02095132|42187901|FG006|Overall Study|Adverse Event|1|||
19741082|NCT02095132|42187902|FG007|Overall Study|Adverse Event|0|||
19741083|NCT02095132|42187903|FG008|Overall Study|Adverse Event|0|||
19741084|NCT02095132|42187895|FG000|Overall Study|Death|0|||
19741085|NCT02095132|42187896|FG001|Overall Study|Death|0|||
19741086|NCT02095132|42187897|FG002|Overall Study|Death|0|||
19741087|NCT02095132|42187898|FG003|Overall Study|Death|0|||
19741088|NCT02095132|42187899|FG004|Overall Study|Death|0|||
19741089|NCT02095132|42187900|FG005|Overall Study|Death|0|||
19741090|NCT02095132|42187901|FG006|Overall Study|Death|1|||
19741091|NCT02095132|42187902|FG007|Overall Study|Death|0|||
19741092|NCT02095132|42187903|FG008|Overall Study|Death|0|||
19741093|NCT02095132|42187895|FG000|Overall Study|Lack of Efficacy|3|||
19741094|NCT02095132|42187896|FG001|Overall Study|Lack of Efficacy|5|||
19741095|NCT02095132|42187897|FG002|Overall Study|Lack of Efficacy|2|||
19741096|NCT02095132|42187898|FG003|Overall Study|Lack of Efficacy|8|||
19741097|NCT02095132|42187899|FG004|Overall Study|Lack of Efficacy|3|||
19741098|NCT02095132|42187900|FG005|Overall Study|Lack of Efficacy|6|||
19741099|NCT02095132|42187901|FG006|Overall Study|Lack of Efficacy|10|||
19741100|NCT02095132|42187902|FG007|Overall Study|Lack of Efficacy|9|||
19741101|NCT02095132|42187903|FG008|Overall Study|Lack of Efficacy|8|||
19741102|NCT02095132|42187895|FG000|Overall Study|Physician Decision|1|||
19741103|NCT02095132|42187896|FG001|Overall Study|Physician Decision|0|||
19741104|NCT02095132|42187897|FG002|Overall Study|Physician Decision|0|||
19741105|NCT02095132|42187898|FG003|Overall Study|Physician Decision|0|||
19741106|NCT02095132|42187899|FG004|Overall Study|Physician Decision|0|||
19741107|NCT02095132|42187900|FG005|Overall Study|Physician Decision|0|||
19741108|NCT02095132|42187901|FG006|Overall Study|Physician Decision|1|||
19741109|NCT02095132|42187902|FG007|Overall Study|Physician Decision|0|||
19741110|NCT02095132|42187903|FG008|Overall Study|Physician Decision|2|||
19741111|NCT02095132|42187895|FG000|Overall Study|Withdrawal by Subject|0|||
19741112|NCT02095132|42187896|FG001|Overall Study|Withdrawal by Subject|0|||
19741113|NCT02095132|42187897|FG002|Overall Study|Withdrawal by Subject|2|||
19741114|NCT02095132|42187898|FG003|Overall Study|Withdrawal by Subject|2|||
19741115|NCT02095132|42187899|FG004|Overall Study|Withdrawal by Subject|3|||
19741116|NCT02095132|42187900|FG005|Overall Study|Withdrawal by Subject|0|||
19741117|NCT02095132|42187901|FG006|Overall Study|Withdrawal by Subject|5|||
19741118|NCT02095132|42187902|FG007|Overall Study|Withdrawal by Subject|0|||
19741119|NCT02095132|42187903|FG008|Overall Study|Withdrawal by Subject|0|||
19741120|NCT00043979|42187928|FG000|Period 1|recipient with progressive disease|7|||
19741121|NCT00043979|42187929|FG001|Period 1|recipient with progressive disease|4|||
19741122|NCT00043979|42187930|FG002|Period 1|recipient with progressive disease|3|||
19741123|NCT00039377|42187947|FG000|Initial Registration|Adverse Event|2|||
19741124|NCT00039377|42187948|FG001|Initial Registration|Adverse Event|0|||
19741125|NCT00039377|42187949|FG002|Initial Registration|Adverse Event|0|||
19741126|NCT00039377|42187950|FG003|Initial Registration|Adverse Event|0|||
19741127|NCT00039377|42187947|FG000|Initial Registration|Relapsed|6|||
19741128|NCT00039377|42187948|FG001|Initial Registration|Relapsed|0|||
19741129|NCT00039377|42187949|FG002|Initial Registration|Relapsed|0|||
19741130|NCT00039377|42187950|FG003|Initial Registration|Relapsed|0|||
19741131|NCT00039377|42187947|FG000|Initial Registration|Received non-protocol therapy|11|||
19741132|NCT00039377|42187948|FG001|Initial Registration|Received non-protocol therapy|0|||
19741133|NCT00039377|42187949|FG002|Initial Registration|Received non-protocol therapy|0|||
19741134|NCT00039377|42187950|FG003|Initial Registration|Received non-protocol therapy|0|||
19741135|NCT00039377|42187947|FG000|Initial Registration|Withdrawal by Subject|3|||
19741136|NCT00039377|42187948|FG001|Initial Registration|Withdrawal by Subject|0|||
19565266|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
19565267|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
19741137|NCT00039377|42187949|FG002|Initial Registration|Withdrawal by Subject|0|||
19741138|NCT00039377|42187950|FG003|Initial Registration|Withdrawal by Subject|0|||
19741139|NCT00154102|42187960|FG000|Overall Study|investigational study phase ongoing|7|||
19741140|NCT00154102|42187961|FG001|Overall Study|investigational study phase ongoing|2|||
19741141|NCT03687502|42187984|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
19741142|NCT03687502|42187984|FG000|Overall Study|Lumason not available|1|||
19741143|NCT00035555|42187993|FG000|Overall Study|Adverse Event|5|||
19741144|NCT00035555|42187994|FG001|Overall Study|Adverse Event|8|||
19741145|NCT00035555|42187995|FG002|Overall Study|Adverse Event|9|||
19741146|NCT00035555|42187993|FG000|Overall Study|Allograft loss|1|||
19741147|NCT00035555|42187994|FG001|Overall Study|Allograft loss|1|||
19741148|NCT00035555|42187995|FG002|Overall Study|Allograft loss|2|||
19565268|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
19565269|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
19565270|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
19565271|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
19565272|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
19565273|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
19565274|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
19565275|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
19565276|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
19565277|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
19565278|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
19565279|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
19565280|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
19565281|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
19565282|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
19565283|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
19565284|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
19565285|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
19565286|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
19565287|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
19565288|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
19565289|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
19565290|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
19565291|NCT01218516|42013026|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
19565292|NCT01218516|42013027|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
19565293|NCT01218516|42013028|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
19741149|NCT00035555|42187993|FG000|Overall Study|Death|0|||
19741150|NCT00035555|42187994|FG001|Overall Study|Death|0|||
19390376|NCT01987960|41634112|FG002|Period 3|Lost to Follow-up|0|||
19741151|NCT00035555|42187995|FG002|Overall Study|Death|2|||
19741152|NCT00035555|42187993|FG000|Overall Study|Lost to Follow-up|0|||
19741153|NCT00035555|42187994|FG001|Overall Study|Lost to Follow-up|0|||
19741154|NCT00035555|42187995|FG002|Overall Study|Lost to Follow-up|1|||
19741155|NCT00035555|42187993|FG000|Overall Study|Noncompliance|0|||
19741156|NCT00035555|42187994|FG001|Overall Study|Noncompliance|1|||
19741157|NCT00035555|42187995|FG002|Overall Study|Noncompliance|1|||
19741158|NCT00035555|42187993|FG000|Overall Study|Prohibited medication|1|||
19741159|NCT00035555|42187994|FG001|Overall Study|Prohibited medication|1|||
19741160|NCT00035555|42187995|FG002|Overall Study|Prohibited medication|0|||
19741161|NCT00035555|42187993|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
19741162|NCT00035555|42187994|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
19741163|NCT00035555|42187995|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
19741164|NCT00035555|42187993|FG000|Overall Study|Withdrawal by Subject|2|||
19741165|NCT00035555|42187994|FG001|Overall Study|Withdrawal by Subject|0|||
19741166|NCT00035555|42187995|FG002|Overall Study|Withdrawal by Subject|2|||
19741167|NCT00035555|42187993|FG000|Overall Study|Investigator deemed not a good candidate|0|||
19741168|NCT00035555|42187994|FG001|Overall Study|Investigator deemed not a good candidate|0|||
19741169|NCT00035555|42187995|FG002|Overall Study|Investigator deemed not a good candidate|1|||
19741170|NCT00035555|42187993|FG000|Overall Study|Received cyclosporin in error|0|||
19741171|NCT00035555|42187994|FG001|Overall Study|Received cyclosporin in error|0|||
19565294|NCT01218516|42013029|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
19741172|NCT00035555|42187995|FG002|Overall Study|Received cyclosporin in error|1|||
19741173|NCT03894046|42188007|FG000|Overall Study|Protocol Violation|1|||
19741174|NCT03894046|42188008|FG001|Overall Study|Protocol Violation|0|||
19741175|NCT03894046|42188009|FG002|Overall Study|Protocol Violation|0|||
19741176|NCT03894046|42188007|FG000|Overall Study|Adverse Event|0|||
19741177|NCT03894046|42188008|FG001|Overall Study|Adverse Event|1|||
19741178|NCT03894046|42188009|FG002|Overall Study|Adverse Event|0|||
19565295|NCT00938431|42013042|FG000|Overall Study|Adverse Event|5|||
19565296|NCT00938431|42013043|FG001|Overall Study|Adverse Event|8|||
19565297|NCT00938431|42013044|FG002|Overall Study|Adverse Event|6|||
19565298|NCT00938431|42013042|FG000|Overall Study|Lack of Efficacy|0|||
19565299|NCT00938431|42013043|FG001|Overall Study|Lack of Efficacy|1|||
19565300|NCT00938431|42013044|FG002|Overall Study|Lack of Efficacy|0|||
19565301|NCT00938431|42013042|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
19565302|NCT00938431|42013043|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
19565303|NCT00938431|42013044|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
19565304|NCT00938431|42013042|FG000|Overall Study|Dosing compliance issue|0|||
19565305|NCT00938431|42013043|FG001|Overall Study|Dosing compliance issue|0|||
19565306|NCT00938431|42013044|FG002|Overall Study|Dosing compliance issue|1|||
19565307|NCT00938431|42013042|FG000|Overall Study|Reached maximum dose early|0|||
19565308|NCT00938431|42013043|FG001|Overall Study|Reached maximum dose early|0|||
19565309|NCT00938431|42013044|FG002|Overall Study|Reached maximum dose early|1|||
19565310|NCT01136811|42013056|FG000|Overall Study|Physician Decision|11|||
19565311|NCT00949117|42013062|FG000|Overall Study|Lack of Efficacy|2|||
19565312|NCT00949117|42013063|FG001|Overall Study|Lack of Efficacy|3|||
19565313|NCT00949117|42013062|FG000|Overall Study|Protocol Violation|1|||
19565314|NCT00949117|42013063|FG001|Overall Study|Protocol Violation|1|||
19565315|NCT00949117|42013062|FG000|Overall Study|Adverse Event|0|||
19565316|NCT00949117|42013063|FG001|Overall Study|Adverse Event|1|||
19565317|NCT00938041|42013071|FG000|Overall Study|Lost to Follow-up|6|||
19565318|NCT00938041|42013071|FG000|Overall Study|Received Alternative Therapy|1|||
19565319|NCT00938041|42013071|FG000|Overall Study|Progressive Disease|5|||
19565320|NCT00938041|42013071|FG000|Overall Study|Death|12|||
19565321|NCT00938041|42013071|FG000|Overall Study|Adrenal Insufficiency|3|||
19565322|NCT01218438|42013075|FG000|Epoch 1|Physician Decision|2|||
19565323|NCT01218438|42013075|FG000|Epoch 1|Adverse Event|1|||
19565324|NCT01218438|42013075|FG000|Epoch 3|Withdrawal by Subject|3|||
19565325|NCT01218438|42013075|FG000|Epoch 3|Adverse Event|1|||
19565326|NCT01218438|42013075|FG000|Epoch 4|Physician Decision|1|||
19565327|NCT01218438|42013075|FG000|Epoch 4|Withdrawal by Subject|2|||
19565328|NCT00935701|42013149|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
19565329|NCT01277510|42013156|FG000|Double-blind Phase|Non-compliance|0|||
19565330|NCT01277510|42013157|FG001|Double-blind Phase|Non-compliance|1|||
19565331|NCT01277510|42013156|FG000|Double-blind Phase|Adverse Event|1|||
19565332|NCT01277510|42013157|FG001|Double-blind Phase|Adverse Event|0|||
19565333|NCT01277510|42013156|FG000|Double-blind Phase|Withdrawal by Subject|2|||
19565334|NCT01277510|42013157|FG001|Double-blind Phase|Withdrawal by Subject|0|||
19565335|NCT01277510|42013156|FG000|Double-blind Phase|Administrative decision|7|||
19565336|NCT01277510|42013157|FG001|Double-blind Phase|Administrative decision|9|||
19565337|NCT01277510|42013156|FG000|Double-blind Phase|Death|0|||
19565338|NCT01277510|42013157|FG001|Double-blind Phase|Death|1|||
19565339|NCT01277510|42013156|FG000|Double-blind Phase|Protocol-specified criteria|2|||
19565340|NCT01277510|42013157|FG001|Double-blind Phase|Protocol-specified criteria|6|||
19565341|NCT01277510|42013156|FG000|Double-blind Phase|Other|1|||
19565342|NCT01277510|42013157|FG001|Double-blind Phase|Other|1|||
19565343|NCT01277510|42013156|FG000|Open-label Phase|Administrative decision|4|||
19565344|NCT01277510|42013157|FG001|Open-label Phase|Administrative decision|3|||
19565345|NCT01277510|42013156|FG000|Open-label Phase|Protocol-specified criteria|1|||
19565346|NCT01277510|42013157|FG001|Open-label Phase|Protocol-specified criteria|0|||
19565347|NCT01277510|42013156|FG000|Open-label Phase|Never received investigational product|2|||
19565348|NCT01277510|42013157|FG001|Open-label Phase|Never received investigational product|0|||
19741179|NCT03894046|42188007|FG000|Overall Study|Withdrawal by Subject|2|||
19565349|NCT00937495|42013165|FG000|Overall Study|Protocol Violation|2|||
19565350|NCT01268306|42013169|FG000|Overall Study|Lost to Follow-up|1|||
19565351|NCT00936715|42013173|FG000|Overall Study|Investigators Discretion|1|||
19565352|NCT00936715|42013173|FG000|Overall Study|Protocol Violation|1|||
19565353|NCT00936715|42013173|FG000|Overall Study|Safety or Tolerability Reasons|4|||
19565354|NCT01268150|42013177|FG000|Treatment Phase|Progression of disease|18|||
19741180|NCT03894046|42188008|FG001|Overall Study|Withdrawal by Subject|3|||
19741181|NCT03894046|42188009|FG002|Overall Study|Withdrawal by Subject|1|||
19741182|NCT03894046|42188007|FG000|Overall Study|Death|15|||
19741183|NCT03894046|42188008|FG001|Overall Study|Death|21|||
19741184|NCT03894046|42188009|FG002|Overall Study|Death|4|||
19741185|NCT03894046|42188007|FG000|Overall Study|No growth of ABC|2|||
19741186|NCT03894046|42188008|FG001|Overall Study|No growth of ABC|1|||
19741187|NCT03894046|42188009|FG002|Overall Study|No growth of ABC|0|||
19741188|NCT03894046|42188007|FG000|Overall Study|Physician Decision|1|||
19741189|NCT03894046|42188008|FG001|Overall Study|Physician Decision|1|||
19741190|NCT03894046|42188009|FG002|Overall Study|Physician Decision|1|||
19741191|NCT03894046|42188007|FG000|Overall Study|Prohibited concomitant medication|1|||
19741192|NCT03894046|42188008|FG001|Overall Study|Prohibited concomitant medication|0|||
19741193|NCT03894046|42188009|FG002|Overall Study|Prohibited concomitant medication|0|||
19741194|NCT03894046|42188007|FG000|Overall Study|Transferred to other arm/group|1|||
19741195|NCT03894046|42188008|FG001|Overall Study|Transferred to other arm/group|1|||
19741196|NCT03894046|42188009|FG002|Overall Study|Transferred to other arm/group|0|||
19741197|NCT00033371|42188018|FG000|Overall Study|Adverse Event|1|||
19741198|NCT00033371|42188019|FG001|Overall Study|Adverse Event|5|||
19741199|NCT00033371|42188018|FG000|Overall Study|Lost to Follow-up|2|||
19741200|NCT00033371|42188019|FG001|Overall Study|Lost to Follow-up|1|||
19741201|NCT00033371|42188018|FG000|Overall Study|Withdrawal by Subject|3|||
19741202|NCT00033371|42188019|FG001|Overall Study|Withdrawal by Subject|3|||
19741203|NCT00033371|42188018|FG000|Overall Study|Disease Progression|0|||
19741204|NCT00033371|42188019|FG001|Overall Study|Disease Progression|1|||
19741205|NCT00081731|42188031|FG000|Overall Study|scientific integrity issue|8|||
19741206|NCT00081731|42188032|FG001|Overall Study|scientific integrity issue|8|||
19741207|NCT00079937|42188040|FG000|Overall Study|Adverse Event|2|||
19741208|NCT00079937|42188041|FG001|Overall Study|Adverse Event|1|||
19741209|NCT00079937|42188040|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19741210|NCT00079937|42188041|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19741211|NCT00079937|42188040|FG000|Overall Study|Subject no longer requires study drug|3|||
19741212|NCT00079937|42188041|FG001|Overall Study|Subject no longer requires study drug|0|||
19741213|NCT00079937|42188040|FG000|Overall Study|Protocol Violation|8|||
19741214|NCT00079937|42188041|FG001|Overall Study|Protocol Violation|6|||
19741215|NCT00079937|42188040|FG000|Overall Study|Withdrawal by Subject|21|||
19741216|NCT00079937|42188041|FG001|Overall Study|Withdrawal by Subject|7|||
19741217|NCT00079937|42188040|FG000|Overall Study|Lost to Follow-up|12|||
19741218|NCT00079937|42188041|FG001|Overall Study|Lost to Follow-up|5|||
19741219|NCT00079937|42188040|FG000|Overall Study|Administrative problems|22|||
19741220|NCT00079937|42188041|FG001|Overall Study|Administrative problems|11|||
19741221|NCT00909610|42188049|FG000|Period: First Intervention|Adverse Event|0|||
19741222|NCT00909610|42188050|FG001|Period: First Intervention|Adverse Event|1|||
19741223|NCT00909610|42188049|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
19741224|NCT00909610|42188050|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
19741225|NCT00909610|42188049|FG000|Period: Second Intervention|Adverse Event|1|||
19741226|NCT00909610|42188050|FG001|Period: Second Intervention|Adverse Event|0|||
19741227|NCT03126110|42188072|FG000|Phase 1|Death|2|||
19741228|NCT03126110|42188073|FG001|Phase 1|Death|2|||
19741229|NCT03126110|42188074|FG002|Phase 1|Death|4|||
19741230|NCT03126110|42188075|FG003|Phase 1|Death|3|||
19741231|NCT03126110|42188076|FG004|Phase 1|Death|4|||
19741232|NCT03126110|42188077|FG005|Phase 1|Death|4|||
19741233|NCT03126110|42188078|FG006|Phase 1|Death|3|||
19741234|NCT03126110|42188079|FG007|Phase 1|Death|4|||
19741235|NCT03126110|42188080|FG008|Phase 1|Death|5|||
19741236|NCT03126110|42188081|FG009|Phase 1|Death|2|||
19741237|NCT03126110|42188082|FG010|Phase 1|Death|6|||
19741238|NCT03126110|42188083|FG011|Phase 1|Death|0|||
19741239|NCT03126110|42188084|FG012|Phase 1|Death|0|||
19741240|NCT03126110|42188085|FG013|Phase 1|Death|0|||
19741241|NCT03126110|42188086|FG014|Phase 1|Death|0|||
19741242|NCT03126110|42188087|FG015|Phase 1|Death|0|||
19741243|NCT03126110|42188088|FG016|Phase 1|Death|0|||
19741244|NCT03126110|42188072|FG000|Phase 1|Lost to Follow-up|0|||
19741245|NCT03126110|42188073|FG001|Phase 1|Lost to Follow-up|1|||
19741246|NCT03126110|42188074|FG002|Phase 1|Lost to Follow-up|0|||
19741247|NCT03126110|42188075|FG003|Phase 1|Lost to Follow-up|0|||
19741248|NCT03126110|42188076|FG004|Phase 1|Lost to Follow-up|0|||
19741249|NCT03126110|42188077|FG005|Phase 1|Lost to Follow-up|0|||
19741250|NCT03126110|42188078|FG006|Phase 1|Lost to Follow-up|0|||
19741251|NCT03126110|42188079|FG007|Phase 1|Lost to Follow-up|0|||
19741252|NCT03126110|42188080|FG008|Phase 1|Lost to Follow-up|1|||
19741253|NCT03126110|42188081|FG009|Phase 1|Lost to Follow-up|0|||
19741254|NCT03126110|42188082|FG010|Phase 1|Lost to Follow-up|0|||
19741255|NCT03126110|42188083|FG011|Phase 1|Lost to Follow-up|0|||
19741256|NCT03126110|42188084|FG012|Phase 1|Lost to Follow-up|0|||
19741257|NCT03126110|42188085|FG013|Phase 1|Lost to Follow-up|0|||
19741258|NCT03126110|42188086|FG014|Phase 1|Lost to Follow-up|0|||
19741259|NCT03126110|42188087|FG015|Phase 1|Lost to Follow-up|0|||
19741260|NCT03126110|42188088|FG016|Phase 1|Lost to Follow-up|0|||
19741261|NCT03126110|42188072|FG000|Phase 1|Withdrawal by Subject|1|||
19565355|NCT01268150|42013177|FG000|Treatment Phase|Adverse Event|3|||
19565356|NCT01268150|42013177|FG000|Treatment Phase|Withdrawal by Subject|3|||
19565357|NCT01268150|42013177|FG000|Treatment Phase|Other|4|||
19565358|NCT01268150|42013177|FG000|Extension Phase|Adverse Event|3|||
19565359|NCT01268150|42013177|FG000|Extension Phase|Disease progression|18|||
19565360|NCT01268150|42013177|FG000|Extension Phase|Other|6|||
19565361|NCT01267994|42013181|FG000|Overall Study|Adverse Event|2|||
19565362|NCT00934843|42013188|FG000|Overall Study|Protocol Violation|0|||
19565363|NCT00934843|42013189|FG001|Overall Study|Protocol Violation|1|||
19565364|NCT01266902|42013197|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
19565365|NCT01266902|42013198|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
19565366|NCT01266902|42013199|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
19565367|NCT01266902|42013197|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
19565368|NCT01266902|42013198|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
19565369|NCT01266902|42013199|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
19565370|NCT01266902|42013197|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
19565371|NCT01266902|42013198|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
19565372|NCT01266902|42013199|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
19565373|NCT01266902|42013197|FG000|Period 1 (Main Study)|Adverse Event|3|||
19565374|NCT01266902|42013198|FG001|Period 1 (Main Study)|Adverse Event|11|||
19565375|NCT01266902|42013199|FG002|Period 1 (Main Study)|Adverse Event|0|||
19565376|NCT01266902|42013197|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
19565377|NCT01266902|42013198|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
19565378|NCT01266902|42013199|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
19565379|NCT01266902|42013197|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
19565380|NCT01266902|42013198|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
19565381|NCT01266902|42013199|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
19565382|NCT01266902|42013197|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
19565383|NCT01266902|42013198|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
19565384|NCT01266902|42013199|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
19565385|NCT01266902|42013197|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
19565386|NCT01266902|42013198|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
19565387|NCT01266902|42013199|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
19565388|NCT01266902|42013197|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
19565389|NCT01266902|42013198|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
19565390|NCT01266902|42013199|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
19565391|NCT01266902|42013197|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
19565392|NCT01266902|42013198|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
19565393|NCT01266902|42013199|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
19565394|NCT01266824|42013209|FG000|Overall Study|Study terminated prior to completion|2|||
19565395|NCT01266824|42013210|FG001|Overall Study|Study terminated prior to completion|3|||
19565396|NCT01266590|42013216|FG000|Overall Study|Adverse Event|3|||
19565397|NCT01266590|42013216|FG000|Overall Study|Lost to Follow-up|1|||
19565398|NCT01266590|42013216|FG000|Overall Study|Withdrawal by Subject|1|||
19565399|NCT01266590|42013216|FG000|Overall Study|Physician Decision|1|||
19565400|NCT01266122|42013225|FG000|Overall Study|Lost to Follow-up|6|||
19565401|NCT01266122|42013226|FG001|Overall Study|Lost to Follow-up|6|||
19565402|NCT01265498|42013234|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
19741262|NCT03126110|42188073|FG001|Phase 1|Withdrawal by Subject|0|||
19741263|NCT03126110|42188074|FG002|Phase 1|Withdrawal by Subject|0|||
19741264|NCT03126110|42188075|FG003|Phase 1|Withdrawal by Subject|1|||
19741265|NCT03126110|42188076|FG004|Phase 1|Withdrawal by Subject|1|||
19741266|NCT03126110|42188077|FG005|Phase 1|Withdrawal by Subject|0|||
19741267|NCT03126110|42188078|FG006|Phase 1|Withdrawal by Subject|0|||
19741268|NCT03126110|42188079|FG007|Phase 1|Withdrawal by Subject|0|||
19741269|NCT03126110|42188080|FG008|Phase 1|Withdrawal by Subject|2|||
19741270|NCT03126110|42188081|FG009|Phase 1|Withdrawal by Subject|1|||
19741271|NCT03126110|42188082|FG010|Phase 1|Withdrawal by Subject|0|||
19741272|NCT03126110|42188083|FG011|Phase 1|Withdrawal by Subject|0|||
19741273|NCT03126110|42188084|FG012|Phase 1|Withdrawal by Subject|0|||
19741274|NCT03126110|42188085|FG013|Phase 1|Withdrawal by Subject|0|||
19741275|NCT03126110|42188086|FG014|Phase 1|Withdrawal by Subject|0|||
19741276|NCT03126110|42188087|FG015|Phase 1|Withdrawal by Subject|0|||
19741277|NCT03126110|42188088|FG016|Phase 1|Withdrawal by Subject|0|||
19741278|NCT03126110|42188072|FG000|Phase 1|Safety follow-up no longer necessary|1|||
19741279|NCT03126110|42188073|FG001|Phase 1|Safety follow-up no longer necessary|0|||
19741280|NCT03126110|42188074|FG002|Phase 1|Safety follow-up no longer necessary|0|||
19741281|NCT03126110|42188075|FG003|Phase 1|Safety follow-up no longer necessary|0|||
19741282|NCT03126110|42188076|FG004|Phase 1|Safety follow-up no longer necessary|0|||
19741283|NCT03126110|42188077|FG005|Phase 1|Safety follow-up no longer necessary|0|||
19741284|NCT03126110|42188078|FG006|Phase 1|Safety follow-up no longer necessary|0|||
19741285|NCT03126110|42188079|FG007|Phase 1|Safety follow-up no longer necessary|0|||
19741286|NCT03126110|42188080|FG008|Phase 1|Safety follow-up no longer necessary|0|||
19741287|NCT03126110|42188081|FG009|Phase 1|Safety follow-up no longer necessary|0|||
19741288|NCT03126110|42188082|FG010|Phase 1|Safety follow-up no longer necessary|0|||
19741289|NCT03126110|42188083|FG011|Phase 1|Safety follow-up no longer necessary|0|||
19741290|NCT03126110|42188084|FG012|Phase 1|Safety follow-up no longer necessary|0|||
19741291|NCT03126110|42188085|FG013|Phase 1|Safety follow-up no longer necessary|0|||
19741292|NCT03126110|42188086|FG014|Phase 1|Safety follow-up no longer necessary|0|||
19741293|NCT03126110|42188087|FG015|Phase 1|Safety follow-up no longer necessary|0|||
19741294|NCT03126110|42188088|FG016|Phase 1|Safety follow-up no longer necessary|0|||
19741295|NCT03126110|42188072|FG000|Phase 1|Survival follow-up no longer necessary|0|||
19741296|NCT03126110|42188073|FG001|Phase 1|Survival follow-up no longer necessary|0|||
19741297|NCT03126110|42188074|FG002|Phase 1|Survival follow-up no longer necessary|1|||
19741298|NCT03126110|42188075|FG003|Phase 1|Survival follow-up no longer necessary|0|||
19741299|NCT03126110|42188076|FG004|Phase 1|Survival follow-up no longer necessary|0|||
19741300|NCT03126110|42188077|FG005|Phase 1|Survival follow-up no longer necessary|0|||
19741301|NCT03126110|42188078|FG006|Phase 1|Survival follow-up no longer necessary|0|||
19741302|NCT03126110|42188079|FG007|Phase 1|Survival follow-up no longer necessary|0|||
19741303|NCT03126110|42188080|FG008|Phase 1|Survival follow-up no longer necessary|0|||
19741304|NCT03126110|42188081|FG009|Phase 1|Survival follow-up no longer necessary|0|||
19741305|NCT03126110|42188082|FG010|Phase 1|Survival follow-up no longer necessary|0|||
19741306|NCT03126110|42188083|FG011|Phase 1|Survival follow-up no longer necessary|0|||
19741307|NCT03126110|42188084|FG012|Phase 1|Survival follow-up no longer necessary|0|||
19741308|NCT03126110|42188085|FG013|Phase 1|Survival follow-up no longer necessary|0|||
19741309|NCT03126110|42188086|FG014|Phase 1|Survival follow-up no longer necessary|0|||
19741310|NCT03126110|42188087|FG015|Phase 1|Survival follow-up no longer necessary|0|||
19741311|NCT03126110|42188088|FG016|Phase 1|Survival follow-up no longer necessary|0|||
19741312|NCT03126110|42188072|FG000|Phase 2|Study terminated by the sponsor|0|||
19741313|NCT03126110|42188073|FG001|Phase 2|Study terminated by the sponsor|0|||
19741314|NCT03126110|42188074|FG002|Phase 2|Study terminated by the sponsor|0|||
19741315|NCT03126110|42188075|FG003|Phase 2|Study terminated by the sponsor|0|||
19741316|NCT03126110|42188076|FG004|Phase 2|Study terminated by the sponsor|0|||
19741317|NCT03126110|42188077|FG005|Phase 2|Study terminated by the sponsor|0|||
19741318|NCT03126110|42188078|FG006|Phase 2|Study terminated by the sponsor|0|||
19741319|NCT03126110|42188079|FG007|Phase 2|Study terminated by the sponsor|0|||
19741320|NCT03126110|42188080|FG008|Phase 2|Study terminated by the sponsor|0|||
19741321|NCT03126110|42188081|FG009|Phase 2|Study terminated by the sponsor|0|||
19741322|NCT03126110|42188082|FG010|Phase 2|Study terminated by the sponsor|0|||
19741323|NCT03126110|42188083|FG011|Phase 2|Study terminated by the sponsor|0|||
19741324|NCT03126110|42188084|FG012|Phase 2|Study terminated by the sponsor|0|||
19741325|NCT03126110|42188085|FG013|Phase 2|Study terminated by the sponsor|4|||
19741326|NCT03126110|42188086|FG014|Phase 2|Study terminated by the sponsor|0|||
19741327|NCT03126110|42188087|FG015|Phase 2|Study terminated by the sponsor|0|||
19741328|NCT03126110|42188088|FG016|Phase 2|Study terminated by the sponsor|0|||
19741329|NCT03126110|42188072|FG000|Phase 2|Withdrawal by Subject|0|||
19741330|NCT03126110|42188073|FG001|Phase 2|Withdrawal by Subject|0|||
19741331|NCT03126110|42188074|FG002|Phase 2|Withdrawal by Subject|0|||
19741332|NCT03126110|42188075|FG003|Phase 2|Withdrawal by Subject|0|||
19741333|NCT03126110|42188076|FG004|Phase 2|Withdrawal by Subject|0|||
19741334|NCT03126110|42188077|FG005|Phase 2|Withdrawal by Subject|0|||
19741335|NCT03126110|42188078|FG006|Phase 2|Withdrawal by Subject|0|||
19741336|NCT03126110|42188079|FG007|Phase 2|Withdrawal by Subject|0|||
19741337|NCT03126110|42188080|FG008|Phase 2|Withdrawal by Subject|0|||
19741338|NCT03126110|42188081|FG009|Phase 2|Withdrawal by Subject|0|||
19741339|NCT03126110|42188082|FG010|Phase 2|Withdrawal by Subject|0|||
19741340|NCT03126110|42188083|FG011|Phase 2|Withdrawal by Subject|1|||
19741341|NCT03126110|42188084|FG012|Phase 2|Withdrawal by Subject|3|||
19741342|NCT03126110|42188085|FG013|Phase 2|Withdrawal by Subject|3|||
19741343|NCT03126110|42188086|FG014|Phase 2|Withdrawal by Subject|2|||
19741344|NCT03126110|42188087|FG015|Phase 2|Withdrawal by Subject|1|||
19741345|NCT03126110|42188088|FG016|Phase 2|Withdrawal by Subject|0|||
19741346|NCT03126110|42188072|FG000|Phase 2|Lost to Follow-up|0|||
19741347|NCT03126110|42188073|FG001|Phase 2|Lost to Follow-up|0|||
19741348|NCT03126110|42188074|FG002|Phase 2|Lost to Follow-up|0|||
19741349|NCT03126110|42188075|FG003|Phase 2|Lost to Follow-up|0|||
19741350|NCT03126110|42188076|FG004|Phase 2|Lost to Follow-up|0|||
19741351|NCT03126110|42188077|FG005|Phase 2|Lost to Follow-up|0|||
19741352|NCT03126110|42188078|FG006|Phase 2|Lost to Follow-up|0|||
19741353|NCT03126110|42188079|FG007|Phase 2|Lost to Follow-up|0|||
19741354|NCT03126110|42188080|FG008|Phase 2|Lost to Follow-up|0|||
19741355|NCT03126110|42188081|FG009|Phase 2|Lost to Follow-up|0|||
19741356|NCT03126110|42188082|FG010|Phase 2|Lost to Follow-up|0|||
19741357|NCT03126110|42188083|FG011|Phase 2|Lost to Follow-up|1|||
19741358|NCT03126110|42188084|FG012|Phase 2|Lost to Follow-up|1|||
19741359|NCT03126110|42188085|FG013|Phase 2|Lost to Follow-up|1|||
19741360|NCT03126110|42188086|FG014|Phase 2|Lost to Follow-up|2|||
19741361|NCT03126110|42188087|FG015|Phase 2|Lost to Follow-up|0|||
19741362|NCT03126110|42188088|FG016|Phase 2|Lost to Follow-up|0|||
19741363|NCT03126110|42188072|FG000|Phase 2|Death|0|||
19741364|NCT03126110|42188073|FG001|Phase 2|Death|0|||
19741365|NCT03126110|42188074|FG002|Phase 2|Death|0|||
19741366|NCT03126110|42188075|FG003|Phase 2|Death|0|||
19741367|NCT03126110|42188076|FG004|Phase 2|Death|0|||
19741368|NCT03126110|42188077|FG005|Phase 2|Death|0|||
19741369|NCT03126110|42188078|FG006|Phase 2|Death|0|||
19741370|NCT03126110|42188079|FG007|Phase 2|Death|0|||
19741371|NCT03126110|42188080|FG008|Phase 2|Death|0|||
19741372|NCT03126110|42188081|FG009|Phase 2|Death|0|||
19741373|NCT03126110|42188082|FG010|Phase 2|Death|0|||
19741374|NCT03126110|42188083|FG011|Phase 2|Death|6|||
19741375|NCT03126110|42188084|FG012|Phase 2|Death|12|||
19741376|NCT03126110|42188085|FG013|Phase 2|Death|25|||
19741377|NCT03126110|42188086|FG014|Phase 2|Death|11|||
19741378|NCT03126110|42188087|FG015|Phase 2|Death|3|||
19741379|NCT03126110|42188088|FG016|Phase 2|Death|2|||
19741380|NCT03126110|42188072|FG000|Phase 2|Progressive Disease|0|||
19741381|NCT03126110|42188073|FG001|Phase 2|Progressive Disease|0|||
19741382|NCT03126110|42188074|FG002|Phase 2|Progressive Disease|0|||
19741383|NCT03126110|42188075|FG003|Phase 2|Progressive Disease|0|||
19741384|NCT03126110|42188076|FG004|Phase 2|Progressive Disease|0|||
19741385|NCT03126110|42188077|FG005|Phase 2|Progressive Disease|0|||
19741386|NCT03126110|42188078|FG006|Phase 2|Progressive Disease|0|||
19741387|NCT03126110|42188079|FG007|Phase 2|Progressive Disease|0|||
19741388|NCT03126110|42188080|FG008|Phase 2|Progressive Disease|0|||
19741389|NCT03126110|42188081|FG009|Phase 2|Progressive Disease|0|||
19741390|NCT03126110|42188082|FG010|Phase 2|Progressive Disease|0|||
19741391|NCT03126110|42188083|FG011|Phase 2|Progressive Disease|0|||
19741392|NCT03126110|42188084|FG012|Phase 2|Progressive Disease|0|||
19741393|NCT03126110|42188085|FG013|Phase 2|Progressive Disease|1|||
19741394|NCT03126110|42188086|FG014|Phase 2|Progressive Disease|0|||
19741395|NCT03126110|42188087|FG015|Phase 2|Progressive Disease|0|||
19741396|NCT03126110|42188088|FG016|Phase 2|Progressive Disease|0|||
19741397|NCT03126110|42188072|FG000|Phase 2|Started new treatment|0|||
19741398|NCT03126110|42188073|FG001|Phase 2|Started new treatment|0|||
19741399|NCT03126110|42188074|FG002|Phase 2|Started new treatment|0|||
19741400|NCT03126110|42188075|FG003|Phase 2|Started new treatment|0|||
19741401|NCT03126110|42188076|FG004|Phase 2|Started new treatment|0|||
19741402|NCT03126110|42188077|FG005|Phase 2|Started new treatment|0|||
19741403|NCT03126110|42188078|FG006|Phase 2|Started new treatment|0|||
19741404|NCT03126110|42188079|FG007|Phase 2|Started new treatment|0|||
19741405|NCT03126110|42188080|FG008|Phase 2|Started new treatment|0|||
19741406|NCT03126110|42188081|FG009|Phase 2|Started new treatment|0|||
19741407|NCT03126110|42188082|FG010|Phase 2|Started new treatment|0|||
19741408|NCT03126110|42188083|FG011|Phase 2|Started new treatment|0|||
19741409|NCT03126110|42188084|FG012|Phase 2|Started new treatment|0|||
19741410|NCT03126110|42188085|FG013|Phase 2|Started new treatment|0|||
19741411|NCT03126110|42188086|FG014|Phase 2|Started new treatment|1|||
19741412|NCT03126110|42188087|FG015|Phase 2|Started new treatment|0|||
19741413|NCT03126110|42188088|FG016|Phase 2|Started new treatment|0|||
19741414|NCT00905164|42188138|FG000|Period 1|Protocol Violation|0|||
19741415|NCT00905164|42188139|FG001|Period 1|Protocol Violation|1|||
19741416|NCT03181958|42188146|FG000|Overall Study|Lost to Follow-up|17|||
19741417|NCT03181958|42188147|FG001|Overall Study|Lost to Follow-up|21|||
19741418|NCT03181958|42188148|FG002|Overall Study|Lost to Follow-up|15|||
19741419|NCT03165110|42188156|FG000|Overall Study|Anroid phone software incompatibility|1|||
19741420|NCT00079781|42188163|FG000|Pre-implant Period|Withdrawal by Subject|2|||
19741421|NCT00079781|42188164|FG001|Pre-implant Period|Withdrawal by Subject|0|||
19741422|NCT00079781|42188165|FG002|Pre-implant Period|Withdrawal by Subject|0|||
19565403|NCT01265498|42013235|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
19741423|NCT00079781|42188163|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
19741424|NCT00079781|42188164|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
19741425|NCT00079781|42188165|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
19741426|NCT00079781|42188163|FG000|Follow-up Period|Withdrawal by Subject|3|||
19741427|NCT00079781|42188164|FG001|Follow-up Period|Withdrawal by Subject|0|||
19741428|NCT00079781|42188165|FG002|Follow-up Period|Withdrawal by Subject|1|||
19741429|NCT00079781|42188163|FG000|Follow-up Period|Lost to Follow-up|1|||
19741430|NCT00079781|42188164|FG001|Follow-up Period|Lost to Follow-up|0|||
19741431|NCT00079781|42188165|FG002|Follow-up Period|Lost to Follow-up|0|||
19741432|NCT00079781|42188163|FG000|Follow-up Period|Death|0|||
19741433|NCT00079781|42188164|FG001|Follow-up Period|Death|0|||
19741434|NCT00079781|42188165|FG002|Follow-up Period|Death|1|||
19741435|NCT03176966|42188173|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
19741436|NCT03176966|42188174|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
19741437|NCT03176966|42188173|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
19741438|NCT03176966|42188174|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
19565404|NCT01265420|42013241|FG000|Overall Study|Lost to Follow-up|1|||
19565405|NCT01264718|42013247|FG000|Overall Study|Lost to Follow-up|3|||
19565406|NCT01264718|42013248|FG001|Overall Study|Lost to Follow-up|2|||
19565407|NCT01264718|42013247|FG000|Overall Study|Withdrawal by Subject|9|||
19565408|NCT01264718|42013248|FG001|Overall Study|Withdrawal by Subject|15|||
19565409|NCT01264718|42013247|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
19565410|NCT01264718|42013248|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
19565411|NCT01264016|42013254|FG000|Overall Study|Withdrawal by Subject|1|||
19565412|NCT01264016|42013254|FG000|Overall Study|Felt faint at sight of blood|1|||
19565413|NCT01263782|42013263|FG000|Overall Study|Death|0|||
19565414|NCT01263782|42013264|FG001|Overall Study|Death|0|||
19565415|NCT01263782|42013265|FG002|Overall Study|Death|1|||
19565416|NCT01263782|42013266|FG003|Overall Study|Death|0|||
19565417|NCT01263782|42013263|FG000|Overall Study|Progressive disease|0|||
19565418|NCT01263782|42013264|FG001|Overall Study|Progressive disease|0|||
19565419|NCT01263782|42013265|FG002|Overall Study|Progressive disease|0|||
19565420|NCT01263782|42013266|FG003|Overall Study|Progressive disease|1|||
19565421|NCT01263782|42013263|FG000|Overall Study|Too early|0|||
19565422|NCT01263782|42013264|FG001|Overall Study|Too early|0|||
19565423|NCT01263782|42013265|FG002|Overall Study|Too early|1|||
19565424|NCT01263782|42013266|FG003|Overall Study|Too early|0|||
19565425|NCT01263782|42013263|FG000|Overall Study|Inevaluable|0|||
19565426|NCT01263782|42013264|FG001|Overall Study|Inevaluable|0|||
19565427|NCT01263782|42013265|FG002|Overall Study|Inevaluable|1|||
19565428|NCT01263782|42013266|FG003|Overall Study|Inevaluable|0|||
19565429|NCT01263704|42013276|FG000|Overall Study|Progressive disease|18|||
19565430|NCT01263704|42013276|FG000|Overall Study|Adverse Event|3|||
19565431|NCT01263704|42013276|FG000|Overall Study|Death|2|||
19565432|NCT01263704|42013276|FG000|Overall Study|Patient withdrew consent|2|||
19565433|NCT01263704|42013276|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
19565434|NCT01263704|42013276|FG000|Overall Study|Lost to Follow-up|1|||
19565435|NCT01263704|42013276|FG000|Overall Study|Colon metastases|1|||
19565436|NCT01263704|42013276|FG000|Overall Study|Principal Investigator (PI) decision|1|||
19476791|NCT01554241|41754889|FG000|Overall Study|Death|3|||
19476792|NCT01554241|41754890|FG001|Overall Study|Death|1|||
19476793|NCT01554241|41754891|FG002|Overall Study|Death|1|||
19476794|NCT01554241|41754892|FG003|Overall Study|Death|0|||
19476795|NCT01554241|41754889|FG000|Overall Study|protocol specified renal stone|0|||
19476796|NCT01554241|41754890|FG001|Overall Study|protocol specified renal stone|0|||
19476797|NCT01554241|41754891|FG002|Overall Study|protocol specified renal stone|0|||
19476798|NCT01554241|41754892|FG003|Overall Study|protocol specified renal stone|1|||
19476799|NCT01554241|41754889|FG000|Overall Study|protocol specified change in eGFR|0|||
19476800|NCT01554241|41754890|FG001|Overall Study|protocol specified change in eGFR|0|||
19476801|NCT01554241|41754891|FG002|Overall Study|protocol specified change in eGFR|1|||
19476802|NCT01554241|41754892|FG003|Overall Study|protocol specified change in eGFR|0|||
19476803|NCT01554241|41754889|FG000|Overall Study|Withdrawal by Subject|0|||
19476804|NCT01554241|41754890|FG001|Overall Study|Withdrawal by Subject|0|||
19476805|NCT01554241|41754891|FG002|Overall Study|Withdrawal by Subject|2|||
19476806|NCT01554241|41754892|FG003|Overall Study|Withdrawal by Subject|0|||
19476807|NCT01521559|41754904|FG000|Overall Study|Adverse Event|0|||
19476808|NCT01521559|41754905|FG001|Overall Study|Adverse Event|4|||
19476809|NCT01521559|41754904|FG000|Overall Study|Death|1|||
19476810|NCT01521559|41754905|FG001|Overall Study|Death|0|||
19476811|NCT01521559|41754904|FG000|Overall Study|Withdrawal by Subject|9|||
19476812|NCT01521559|41754905|FG001|Overall Study|Withdrawal by Subject|11|||
19476813|NCT01521559|41754904|FG000|Overall Study|Lost to Follow-up|3|||
19476814|NCT01521559|41754905|FG001|Overall Study|Lost to Follow-up|1|||
19476815|NCT01521559|41754904|FG000|Overall Study|Protocol Violation|1|||
19476816|NCT01521559|41754905|FG001|Overall Study|Protocol Violation|0|||
19476817|NCT01521559|41754904|FG000|Overall Study|Other|1|||
19476818|NCT01521559|41754905|FG001|Overall Study|Other|2|||
19476819|NCT01554163|41754914|FG000|Overall Study|Adverse Event|3|||
19476820|NCT01554163|41754915|FG001|Overall Study|Adverse Event|0|||
19476821|NCT01554163|41754914|FG000|Overall Study|Lack of Efficacy|1|||
19476822|NCT01554163|41754915|FG001|Overall Study|Lack of Efficacy|0|||
19476823|NCT01554163|41754914|FG000|Overall Study|Lost to Follow-up|1|||
19476824|NCT01554163|41754915|FG001|Overall Study|Lost to Follow-up|0|||
19476825|NCT01554163|41754914|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19476826|NCT01554163|41754915|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19476827|NCT01554163|41754914|FG000|Overall Study|Protocol Violation|0|||
19476828|NCT01554163|41754915|FG001|Overall Study|Protocol Violation|4|||
19565437|NCT01263470|42013286|FG000|Overall Study|Adverse Event|2|||
19565438|NCT01263470|42013287|FG001|Overall Study|Adverse Event|2|||
19565439|NCT01263470|42013288|FG002|Overall Study|Adverse Event|1|||
19565440|NCT01263470|42013289|FG003|Overall Study|Adverse Event|1|||
19565441|NCT01263470|42013290|FG004|Overall Study|Adverse Event|2|||
19565442|NCT01263470|42013291|FG005|Overall Study|Adverse Event|2|||
19741439|NCT03176966|42188173|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
19741440|NCT03176966|42188174|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
19741441|NCT03176966|42188173|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
19741442|NCT03176966|42188174|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
19741443|NCT03176966|42188173|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
19741444|NCT03176966|42188174|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
19741445|NCT03176966|42188173|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
19741446|NCT03176966|42188174|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
19741447|NCT03176966|42188173|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
19741448|NCT03176966|42188174|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
19741449|NCT03175562|42188180|FG000|Overall Study|Adverse Event|1|||
19741450|NCT03175562|42188180|FG000|Overall Study|Lost to Follow-up|3|||
19741451|NCT03175562|42188180|FG000|Overall Study|Withdrawal by Subject|7|||
19741452|NCT03175562|42188180|FG000|Overall Study|Other (Not Specified)|5|||
19741453|NCT00079391|42188187|FG000|Overall Study|Withdrawal by Subject|1|||
19741454|NCT03209570|42188195|FG000|Overall Study|Death|1|||
19741455|NCT03209570|42188196|FG001|Overall Study|Death|0|||
19741456|NCT03209570|42188195|FG000|Overall Study|Incomplete Data|8|||
19741457|NCT03209570|42188196|FG001|Overall Study|Incomplete Data|10|||
19741458|NCT03209570|42188195|FG000|Overall Study|Protocol Violation|1|||
19741459|NCT03209570|42188196|FG001|Overall Study|Protocol Violation|0|||
19741460|NCT03209570|42188195|FG000|Overall Study|Withdrawal by Subject|0|||
19741461|NCT03209570|42188196|FG001|Overall Study|Withdrawal by Subject|3|||
19741462|NCT03209492|42188202|FG000|Overall Study|Case Report Forms Uncollected|5|||
19741463|NCT03208244|42188206|FG000|Overall Study|Death|1|||
19741464|NCT03175172|42188210|FG000|Overall Study|Death|3|||
19741465|NCT03175172|42188210|FG000|Overall Study|Withdrawal by Subject|3|||
19741466|NCT03175172|42188210|FG000|Overall Study|Lost to Follow-up|1|||
19741467|NCT03175172|42188210|FG000|Overall Study|Study Terminated by Sponsor|3|||
19741468|NCT03172364|42188216|FG000|Overall Study|Adverse Event|1|||
19741469|NCT03172364|42188217|FG001|Overall Study|Adverse Event|1|||
19741470|NCT03172364|42188216|FG000|Overall Study|Protocol Violation|1|||
19741471|NCT03172364|42188217|FG001|Overall Study|Protocol Violation|0|||
19741472|NCT00078767|42188225|FG000|Overall Study|Withdrawal by Subject|1|||
19741473|NCT00078767|42188226|FG001|Overall Study|Withdrawal by Subject|1|||
19741474|NCT03208088|42188232|FG000|Period 2|Withdrawal by Subject|0|||
19741475|NCT03208088|42188233|FG001|Period 2|Withdrawal by Subject|0|||
19741476|NCT03208088|42188234|FG002|Period 2|Withdrawal by Subject|0|||
19741477|NCT03208088|42188235|FG003|Period 2|Withdrawal by Subject|0|||
19741478|NCT03208088|42188236|FG004|Period 2|Withdrawal by Subject|0|||
19741479|NCT03208088|42188237|FG005|Period 2|Withdrawal by Subject|0|||
19741480|NCT03208088|42188238|FG006|Period 2|Withdrawal by Subject|0|||
19741481|NCT03208088|42188239|FG007|Period 2|Withdrawal by Subject|0|||
19741482|NCT03208088|42188240|FG008|Period 2|Withdrawal by Subject|1|||
19741483|NCT03208088|42188241|FG009|Period 2|Withdrawal by Subject|0|||
19741484|NCT03208088|42188232|FG000|Period 3|Unsatisfactory Test Article|0|||
19741485|NCT03208088|42188233|FG001|Period 3|Unsatisfactory Test Article|0|||
19741486|NCT03208088|42188234|FG002|Period 3|Unsatisfactory Test Article|0|||
19741487|NCT03208088|42188235|FG003|Period 3|Unsatisfactory Test Article|1|||
19741488|NCT03208088|42188236|FG004|Period 3|Unsatisfactory Test Article|0|||
19741489|NCT03208088|42188237|FG005|Period 3|Unsatisfactory Test Article|0|||
19741490|NCT03208088|42188238|FG006|Period 3|Unsatisfactory Test Article|0|||
19741491|NCT03208088|42188239|FG007|Period 3|Unsatisfactory Test Article|0|||
19741492|NCT03208088|42188240|FG008|Period 3|Unsatisfactory Test Article|0|||
19741493|NCT03208088|42188241|FG009|Period 3|Unsatisfactory Test Article|0|||
19741494|NCT03208088|42188232|FG000|Period 4|Unsatisfactory Test Article|0|||
19741495|NCT03208088|42188233|FG001|Period 4|Unsatisfactory Test Article|0|||
19741496|NCT03208088|42188234|FG002|Period 4|Unsatisfactory Test Article|0|||
19741497|NCT03208088|42188235|FG003|Period 4|Unsatisfactory Test Article|1|||
19741498|NCT03208088|42188236|FG004|Period 4|Unsatisfactory Test Article|0|||
19741499|NCT03208088|42188237|FG005|Period 4|Unsatisfactory Test Article|0|||
19741500|NCT03208088|42188238|FG006|Period 4|Unsatisfactory Test Article|0|||
19741501|NCT03208088|42188239|FG007|Period 4|Unsatisfactory Test Article|0|||
19741502|NCT03208088|42188240|FG008|Period 4|Unsatisfactory Test Article|0|||
19741503|NCT03208088|42188241|FG009|Period 4|Unsatisfactory Test Article|0|||
19741504|NCT00078377|42188256|FG000|Overall Study|Adverse Event|2|||
19741505|NCT00078377|42188257|FG001|Overall Study|Adverse Event|5|||
19741506|NCT00078377|42188258|FG002|Overall Study|Adverse Event|1|||
19741507|NCT00078377|42188256|FG000|Overall Study|Lack of Efficacy|2|||
19741508|NCT00078377|42188257|FG001|Overall Study|Lack of Efficacy|0|||
19741509|NCT00078377|42188258|FG002|Overall Study|Lack of Efficacy|2|||
19741510|NCT00078377|42188256|FG000|Overall Study|Lost to Follow-up|0|||
19741511|NCT00078377|42188257|FG001|Overall Study|Lost to Follow-up|1|||
19741512|NCT00078377|42188258|FG002|Overall Study|Lost to Follow-up|1|||
19741513|NCT00078377|42188256|FG000|Overall Study|Physician Decision|2|||
19741514|NCT00078377|42188257|FG001|Overall Study|Physician Decision|0|||
19741515|NCT00078377|42188258|FG002|Overall Study|Physician Decision|0|||
19741516|NCT00078377|42188256|FG000|Overall Study|Withdrawal by Subject|3|||
19741517|NCT00078377|42188257|FG001|Overall Study|Withdrawal by Subject|4|||
19741518|NCT00078377|42188258|FG002|Overall Study|Withdrawal by Subject|4|||
19741519|NCT00078377|42188256|FG000|Overall Study|Miscellaneous|2|||
19741520|NCT00078377|42188257|FG001|Overall Study|Miscellaneous|6|||
19741521|NCT00078377|42188258|FG002|Overall Study|Miscellaneous|1|||
19741522|NCT00886600|42188271|FG000|Double-blind Monotherapy|Adverse Event|1|||
19741523|NCT00886600|42188272|FG001|Double-blind Monotherapy|Adverse Event|1|||
19741524|NCT00886600|42188273|FG002|Double-blind Monotherapy|Adverse Event|1|||
19741525|NCT00886600|42188274|FG003|Double-blind Monotherapy|Adverse Event|1|||
19741526|NCT00886600|42188271|FG000|Double-blind Monotherapy|Protocol Violation|0|||
19741527|NCT00886600|42188272|FG001|Double-blind Monotherapy|Protocol Violation|0|||
19741528|NCT00886600|42188273|FG002|Double-blind Monotherapy|Protocol Violation|0|||
19741529|NCT00886600|42188274|FG003|Double-blind Monotherapy|Protocol Violation|1|||
19741530|NCT00886600|42188271|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
19741531|NCT00886600|42188272|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
19741532|NCT00886600|42188273|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
19741533|NCT00886600|42188274|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
19741534|NCT00886600|42188271|FG000|Combination Therapy Period|Adverse Event|0|||
19741535|NCT00886600|42188272|FG001|Combination Therapy Period|Adverse Event|0|||
19741536|NCT00886600|42188273|FG002|Combination Therapy Period|Adverse Event|1|||
19741537|NCT00886600|42188274|FG003|Combination Therapy Period|Adverse Event|0|||
19741538|NCT00886600|42188271|FG000|Combination Therapy Period|Protocol Violation|0|||
19741539|NCT00886600|42188272|FG001|Combination Therapy Period|Protocol Violation|0|||
19741540|NCT00886600|42188273|FG002|Combination Therapy Period|Protocol Violation|1|||
19741541|NCT00886600|42188274|FG003|Combination Therapy Period|Protocol Violation|0|||
19741542|NCT03172130|42188282|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
19741543|NCT03172130|42188283|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
19741544|NCT00870688|42188299|FG000|Overall Study|Lost to Follow-up|2|||
19741545|NCT00870688|42188299|FG000|Overall Study|Death, Unrelated|1|||
19741546|NCT00870688|42188299|FG000|Overall Study|Granules in the Stools|1|||
19741547|NCT00869128|42188302|FG000|Overall Study|lack of Compliance|6|||
19741548|NCT00869128|42188303|FG001|Overall Study|lack of Compliance|6|||
19741549|NCT00077675|42188309|FG000|Overall Study|Adverse Event|1|||
19741550|NCT00077675|42188310|FG001|Overall Study|Adverse Event|2|||
19741551|NCT00077675|42188309|FG000|Overall Study|Lost to Follow-up|6|||
19741552|NCT00077675|42188310|FG001|Overall Study|Lost to Follow-up|3|||
19741553|NCT00077675|42188309|FG000|Overall Study|Withdrawal by Subject|1|||
19741554|NCT00077675|42188310|FG001|Overall Study|Withdrawal by Subject|0|||
19741555|NCT00077675|42188309|FG000|Overall Study|Other|0|||
19741556|NCT00077675|42188310|FG001|Overall Study|Other|1|||
19741557|NCT00077675|42188309|FG000|Overall Study|Never received study treatment|3|||
19741558|NCT00077675|42188310|FG001|Overall Study|Never received study treatment|3|||
19741559|NCT02576444|42188327|FG000|Overall Study|Death|1|||
19741560|NCT02576444|42188328|FG001|Overall Study|Death|1|||
19741561|NCT02576444|42188329|FG002|Overall Study|Death|0|||
19741562|NCT02576444|42188330|FG003|Overall Study|Death|0|||
19741563|NCT02576444|42188327|FG000|Overall Study|Withdrawal by Subject|0|||
19741564|NCT02576444|42188328|FG001|Overall Study|Withdrawal by Subject|0|||
19741565|NCT02576444|42188329|FG002|Overall Study|Withdrawal by Subject|2|||
19741566|NCT02576444|42188330|FG003|Overall Study|Withdrawal by Subject|0|||
19741567|NCT02576444|42188327|FG000|Overall Study|Adverse Event|0|||
19741568|NCT02576444|42188328|FG001|Overall Study|Adverse Event|0|||
19741569|NCT02576444|42188329|FG002|Overall Study|Adverse Event|1|||
19741570|NCT02576444|42188330|FG003|Overall Study|Adverse Event|0|||
19741571|NCT02576444|42188327|FG000|Overall Study|Physician Decision|0|||
19741572|NCT02576444|42188328|FG001|Overall Study|Physician Decision|0|||
19741573|NCT02576444|42188329|FG002|Overall Study|Physician Decision|1|||
19741574|NCT02576444|42188330|FG003|Overall Study|Physician Decision|0|||
19741575|NCT00850174|42188341|FG000|Washout: One Week|Withdrawal by Subject|0|||
19741576|NCT00850174|42188342|FG001|Washout: One Week|Withdrawal by Subject|2|||
19741577|NCT00850174|42188341|FG000|Second Intervention|Withdrawal by Subject|1|||
19741578|NCT00850174|42188342|FG001|Second Intervention|Withdrawal by Subject|0|||
19741579|NCT00077207|42188353|FG000|Overall Study|Adverse Event|5|||
19741580|NCT00077207|42188353|FG000|Overall Study|Lack of Efficacy|12|||
19741581|NCT00077207|42188353|FG000|Overall Study|Physician Decision|6|||
19741582|NCT00077207|42188353|FG000|Overall Study|Withdrawal by Subject|6|||
19741583|NCT00077207|42188353|FG000|Overall Study|Ineligible|1|||
19741584|NCT03206918|42188358|FG000|Overall Study|Death|11|||
19741585|NCT03206918|42188358|FG000|Overall Study|Withdrawal by Subject|5|||
19741586|NCT03206918|42188358|FG000|Overall Study|Study terminated by sponsor|12|||
19741587|NCT03206918|42188358|FG000|Overall Study|Lost to Follow-up|3|||
19741588|NCT03206918|42188358|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
19741589|NCT03206216|42188365|FG000|Overall Study|Withdrawal by Subject|0|||
19741590|NCT03206216|42188366|FG001|Overall Study|Withdrawal by Subject|1|||
19741591|NCT03169244|42188374|FG000|Overall Study|Lost to Follow-up|1|||
19741592|NCT03169244|42188375|FG001|Overall Study|Lost to Follow-up|2|||
19741593|NCT03169244|42188374|FG000|Overall Study|Adverse Event|1|||
19741594|NCT03169244|42188375|FG001|Overall Study|Adverse Event|0|||
19741595|NCT03169244|42188374|FG000|Overall Study|Withdrawal by Subject|2|||
19741596|NCT03169244|42188375|FG001|Overall Study|Withdrawal by Subject|2|||
19741597|NCT03169244|42188374|FG000|Overall Study|Physician Decision|1|||
19741598|NCT03169244|42188375|FG001|Overall Study|Physician Decision|0|||
19741599|NCT02486042|42188383|FG000|Overall Study|Physician Decision|1|||
19741600|NCT02486042|42188384|FG001|Overall Study|Physician Decision|7|||
19741601|NCT02486042|42188383|FG000|Overall Study|Hospital transfer|2|||
19741602|NCT02486042|42188384|FG001|Overall Study|Hospital transfer|2|||
19741603|NCT02486042|42188383|FG000|Overall Study|Withdrawal by Subject|0|||
19741604|NCT02486042|42188384|FG001|Overall Study|Withdrawal by Subject|2|||
19741605|NCT00057941|42188392|FG000|Overall Study|Death|1|||
19741606|NCT00057941|42188393|FG001|Overall Study|Death|2|||
19741607|NCT00057941|42188392|FG000|Overall Study|Adverse Event|7|||
19741608|NCT00057941|42188393|FG001|Overall Study|Adverse Event|9|||
19741609|NCT00057941|42188392|FG000|Overall Study|Lack of Efficacy|54|||
19741610|NCT00057941|42188393|FG001|Overall Study|Lack of Efficacy|53|||
19741611|NCT00057941|42188392|FG000|Overall Study|Withdrawal by Subject|6|||
19741612|NCT00057941|42188393|FG001|Overall Study|Withdrawal by Subject|1|||
19741613|NCT00057941|42188392|FG000|Overall Study|still on treatment|3|||
19741614|NCT00057941|42188393|FG001|Overall Study|still on treatment|1|||
19741615|NCT00057941|42188392|FG000|Overall Study|insurance, symptomatic deterioration|1|||
19741616|NCT00057941|42188393|FG001|Overall Study|insurance, symptomatic deterioration|3|||
19741617|NCT00057941|42188392|FG000|Overall Study|Ineligible|2|||
19741618|NCT00057941|42188393|FG001|Overall Study|Ineligible|5|||
19741619|NCT00075881|42188408|FG000|Overall Study|Lack of Efficacy|18|||
19741620|NCT00075881|42188408|FG000|Overall Study|Adverse Event|7|||
19741621|NCT00075881|42188408|FG000|Overall Study|Death|1|||
19741622|NCT00075881|42188408|FG000|Overall Study|Withdrawal by Subject|2|||
19741623|NCT00075881|42188408|FG000|Overall Study|Protocol Violation|4|||
19741624|NCT00075881|42188408|FG000|Overall Study|other complicating disease|3|||
19741625|NCT00075881|42188408|FG000|Overall Study|other|4|||
19741626|NCT00075881|42188408|FG000|Overall Study|missing data|2|||
19741627|NCT00075881|42188408|FG000|Overall Study|Ineligible|1|||
19741628|NCT00075881|42188408|FG000|Overall Study|never start protocol therapy|1|||
19741629|NCT00838630|42188416|FG000|First Intervention|Adverse Event|1|||
19741630|NCT00838630|42188417|FG001|First Intervention|Adverse Event|0|||
19741631|NCT00838630|42188416|FG000|Washout: 7 Days|Protocol Violation|1|||
19741632|NCT00838630|42188417|FG001|Washout: 7 Days|Protocol Violation|0|||
19741633|NCT02996474|42188421|FG000|Overall Study|Physician Decision|5|||
19741634|NCT03667924|42188428|FG000|Baseline Completed|Lost to Follow-up|0|||
19741635|NCT03667924|42188429|FG001|Baseline Completed|Lost to Follow-up|2|||
19741636|NCT03667924|42188430|FG002|Baseline Completed|Lost to Follow-up|0|||
19741637|NCT03667924|42188428|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
19565443|NCT01263470|42013286|FG000|Overall Study|Protocol Violation|0|||
19741638|NCT03667924|42188429|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
19741639|NCT03667924|42188430|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
19741640|NCT03667924|42188428|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
19741641|NCT03667924|42188429|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
19741642|NCT03667924|42188430|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
19565444|NCT01263470|42013287|FG001|Overall Study|Protocol Violation|1|||
19741643|NCT03667924|42188428|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
19741644|NCT03667924|42188429|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
19741645|NCT03667924|42188430|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
19741646|NCT03667924|42188428|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
19741647|NCT03667924|42188429|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
19741648|NCT03667924|42188430|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
19741649|NCT03667924|42188428|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
19741650|NCT03667924|42188429|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
19741651|NCT03667924|42188430|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
19741652|NCT03667924|42188428|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
19741653|NCT03667924|42188429|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
19741654|NCT03667924|42188430|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
19741655|NCT03205046|42188442|FG000|Overall Study|Death|10|||
19741656|NCT03205046|42188443|FG001|Overall Study|Death|6|||
19741657|NCT03205046|42188442|FG000|Overall Study|Withdrawal by Subject|1|||
19741658|NCT03205046|42188443|FG001|Overall Study|Withdrawal by Subject|2|||
19741659|NCT03205046|42188442|FG000|Overall Study|Lost to Follow-up|0|||
19741660|NCT03205046|42188443|FG001|Overall Study|Lost to Follow-up|1|||
19741661|NCT03205046|42188442|FG000|Overall Study|Study terminated by sponsor|2|||
19741662|NCT03205046|42188443|FG001|Overall Study|Study terminated by sponsor|1|||
19741663|NCT03204812|42188449|FG000|Overall Study|Adverse Event|3|||
19741664|NCT02339090|42188455|FG000|Overall Study|Adverse Event|1|||
19741665|NCT02339090|42188456|FG001|Overall Study|Adverse Event|0|||
19741666|NCT02339090|42188455|FG000|Overall Study|Lost to Follow-up|0|||
19741667|NCT02339090|42188456|FG001|Overall Study|Lost to Follow-up|1|||
19741668|NCT02339090|42188455|FG000|Overall Study|Non-compliance With Study Drug|0|||
19741669|NCT02339090|42188456|FG001|Overall Study|Non-compliance With Study Drug|1|||
19741670|NCT02339090|42188455|FG000|Overall Study|Withdrawal by Subject|2|||
19741671|NCT02339090|42188456|FG001|Overall Study|Withdrawal by Subject|1|||
19741672|NCT02339090|42188455|FG000|Overall Study|Poor Growth|3|||
19741673|NCT02339090|42188456|FG001|Overall Study|Poor Growth|0|||
19741674|NCT02339090|42188455|FG000|Overall Study|Randomized but not treated|0|||
19741675|NCT02339090|42188456|FG001|Overall Study|Randomized but not treated|2|||
19741676|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
19741677|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
19741678|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
19741679|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
19741680|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
19741681|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
19741682|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
19741683|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
19741684|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
19741685|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
19741686|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
19741687|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
19741688|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
19741689|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
19741690|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
19741691|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
19741692|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
19741693|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
19741694|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
19741695|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
19741696|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
19741697|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
19741698|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
19741699|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
19741700|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
19741701|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
19741702|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
19741703|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
19741704|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
19741705|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
19741706|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
19741707|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
19741708|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
19741709|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
19741710|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
19741711|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
19741712|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
19741713|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
19741714|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
19741715|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
19741716|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
19741717|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
19741718|NCT03524092|42188477|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
19741719|NCT03524092|42188478|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
19741720|NCT03524092|42188479|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
19741721|NCT03524092|42188480|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
19741722|NCT03524092|42188481|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
19741723|NCT03524092|42188482|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
19741724|NCT03524092|42188477|FG000|Loss of Response Rescue Period|Adverse Event|0|||
19741725|NCT03524092|42188478|FG001|Loss of Response Rescue Period|Adverse Event|0|||
19741726|NCT03524092|42188479|FG002|Loss of Response Rescue Period|Adverse Event|0|||
19741727|NCT03524092|42188480|FG003|Loss of Response Rescue Period|Adverse Event|2|||
19741728|NCT03524092|42188481|FG004|Loss of Response Rescue Period|Adverse Event|0|||
19741729|NCT03524092|42188482|FG005|Loss of Response Rescue Period|Adverse Event|0|||
19741730|NCT03524092|42188477|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
19741731|NCT03524092|42188478|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
19565445|NCT01263470|42013288|FG002|Overall Study|Protocol Violation|0|||
19741732|NCT03524092|42188479|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
19741733|NCT03524092|42188480|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
19741734|NCT03524092|42188481|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
19741735|NCT03524092|42188482|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
19741736|NCT03524092|42188477|FG000|Loss of Response Rescue Period|Pregnancy|0|||
19741737|NCT03524092|42188478|FG001|Loss of Response Rescue Period|Pregnancy|0|||
19741738|NCT03524092|42188479|FG002|Loss of Response Rescue Period|Pregnancy|0|||
19741739|NCT03524092|42188480|FG003|Loss of Response Rescue Period|Pregnancy|1|||
19741740|NCT03524092|42188481|FG004|Loss of Response Rescue Period|Pregnancy|0|||
19741741|NCT03524092|42188482|FG005|Loss of Response Rescue Period|Pregnancy|0|||
19565446|NCT01263470|42013289|FG003|Overall Study|Protocol Violation|0|||
19565447|NCT01263470|42013290|FG004|Overall Study|Protocol Violation|0|||
19565448|NCT01263470|42013291|FG005|Overall Study|Protocol Violation|1|||
19565449|NCT01263470|42013286|FG000|Overall Study|Withdrawal by Subject|0|||
19565450|NCT01263470|42013287|FG001|Overall Study|Withdrawal by Subject|1|||
19565451|NCT01263470|42013288|FG002|Overall Study|Withdrawal by Subject|1|||
19565452|NCT01263470|42013289|FG003|Overall Study|Withdrawal by Subject|2|||
19565453|NCT01263470|42013290|FG004|Overall Study|Withdrawal by Subject|0|||
19565454|NCT01263470|42013291|FG005|Overall Study|Withdrawal by Subject|2|||
19565455|NCT01263470|42013286|FG000|Overall Study|Lack of Efficacy|0|||
19565456|NCT01263470|42013287|FG001|Overall Study|Lack of Efficacy|0|||
19565457|NCT01263470|42013288|FG002|Overall Study|Lack of Efficacy|2|||
19565458|NCT01263470|42013289|FG003|Overall Study|Lack of Efficacy|0|||
19565459|NCT01263470|42013290|FG004|Overall Study|Lack of Efficacy|0|||
19565460|NCT01263470|42013291|FG005|Overall Study|Lack of Efficacy|0|||
19565461|NCT01263470|42013286|FG000|Overall Study|Participant Unavailability|0|||
19565462|NCT01263470|42013287|FG001|Overall Study|Participant Unavailability|1|||
19565463|NCT01263470|42013288|FG002|Overall Study|Participant Unavailability|0|||
19565464|NCT01263470|42013289|FG003|Overall Study|Participant Unavailability|0|||
19565465|NCT01263470|42013290|FG004|Overall Study|Participant Unavailability|0|||
19565466|NCT01263470|42013291|FG005|Overall Study|Participant Unavailability|0|||
19565467|NCT01263470|42013286|FG000|Overall Study|Study Drug Non-compliance|0|||
19565468|NCT01263470|42013287|FG001|Overall Study|Study Drug Non-compliance|0|||
19565469|NCT01263470|42013288|FG002|Overall Study|Study Drug Non-compliance|0|||
19565470|NCT01263470|42013289|FG003|Overall Study|Study Drug Non-compliance|0|||
19565471|NCT01263470|42013290|FG004|Overall Study|Study Drug Non-compliance|1|||
19565472|NCT01263470|42013291|FG005|Overall Study|Study Drug Non-compliance|0|||
19565473|NCT01262456|42013308|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
19565474|NCT01262456|42013309|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
19565475|NCT01262456|42013310|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
19565476|NCT01262456|42013308|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
19565477|NCT01262456|42013309|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
19565478|NCT01262456|42013310|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
19565479|NCT01262456|42013308|FG000|3-Month Double-Blind Period|Adverse Event|6|||
19565480|NCT01262456|42013309|FG001|3-Month Double-Blind Period|Adverse Event|4|||
19565481|NCT01262456|42013310|FG002|3-Month Double-Blind Period|Adverse Event|8|||
19565482|NCT01262456|42013308|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
19565483|NCT01262456|42013309|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
19565484|NCT01262456|42013310|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
19741742|NCT03524092|42188477|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
19741743|NCT03524092|42188478|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
19741744|NCT03524092|42188479|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
19741745|NCT03524092|42188480|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
19741746|NCT03524092|42188481|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
19741747|NCT03524092|42188482|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
19741748|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
19741749|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
19741750|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
19741751|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
19741752|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
19741753|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
19741754|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
19741755|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
19741756|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
19741757|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
19741758|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
19741759|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
19741760|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
19741761|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
19741762|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
19741763|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
19741764|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
19741765|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
19741766|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
19741767|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
19741768|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
19741769|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
19741770|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
19741771|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
19741772|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
19565485|NCT01262456|42013308|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
19565486|NCT01262456|42013309|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
19565487|NCT01262456|42013310|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
19565488|NCT01262456|42013308|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
19565489|NCT01262456|42013309|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
19565490|NCT01262456|42013310|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
19565491|NCT01262456|42013308|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
19565492|NCT01262456|42013309|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
19565493|NCT01262456|42013310|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
19565494|NCT01262456|42013308|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
19565495|NCT01262456|42013309|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
19565496|NCT01262456|42013310|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
19565497|NCT01262456|42013308|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
19565498|NCT01262456|42013309|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
19565499|NCT01262456|42013310|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
19565500|NCT00932893|42013328|FG000|Overall Study|Death|115|||
19565501|NCT00932893|42013329|FG001|Overall Study|Death|24|||
19565502|NCT00932893|42013328|FG000|Overall Study|Lost to Follow-up|8|||
19565503|NCT00932893|42013329|FG001|Overall Study|Lost to Follow-up|0|||
19565504|NCT00932893|42013328|FG000|Overall Study|Withdrawal by Subject|5|||
19565505|NCT00932893|42013329|FG001|Overall Study|Withdrawal by Subject|2|||
19565506|NCT00932893|42013328|FG000|Overall Study|Other|5|||
19565507|NCT00932893|42013329|FG001|Overall Study|Other|144|||
19565508|NCT01260896|42013338|FG000|First Intervention|Withdrawn Due to Emesis|2|||
19565509|NCT01260896|42013339|FG001|First Intervention|Withdrawn Due to Emesis|0|||
19565510|NCT00932737|42013347|FG000|Overall Study|Not treated in second episode|1|||
19565511|NCT00932737|42013348|FG001|Overall Study|Not treated in second episode|0|||
19565512|NCT00932737|42013347|FG000|Overall Study|Adverse Event|0|||
19565513|NCT00932737|42013348|FG001|Overall Study|Adverse Event|1|||
19565514|NCT00939523|42013354|FG000|Overall Study|Lack of Efficacy|1|||
19741773|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
19741774|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
19741775|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
19741776|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
19741777|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
19741778|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
19741779|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
19741780|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
19741781|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
19741782|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
19741783|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
19741784|NCT03524092|42188477|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
19741785|NCT03524092|42188478|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
19741786|NCT03524092|42188479|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
19741787|NCT03524092|42188480|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
19741788|NCT03524092|42188481|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
19741789|NCT03524092|42188482|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
19741790|NCT03524092|42188477|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
19741791|NCT03524092|42188478|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
19741792|NCT03524092|42188479|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
19741793|NCT03524092|42188480|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
19741794|NCT03524092|42188481|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
19741795|NCT03524092|42188482|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
19741796|NCT03524092|42188477|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
19741797|NCT03524092|42188478|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
19741798|NCT03524092|42188479|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
19741799|NCT03524092|42188480|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
19741800|NCT03524092|42188481|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
19741801|NCT03524092|42188482|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
19741802|NCT03524092|42188477|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
19741803|NCT03524092|42188478|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
19741804|NCT03524092|42188479|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
19741805|NCT03524092|42188480|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
19741806|NCT03524092|42188481|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
19741807|NCT03524092|42188482|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
19741808|NCT03524092|42188477|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
19741809|NCT03524092|42188478|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
19741810|NCT03524092|42188479|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
19741811|NCT03524092|42188480|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
19741812|NCT03524092|42188481|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
19741813|NCT03524092|42188482|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
19741814|NCT03331562|42188495|FG000|Overall Study|Adverse Event|2|||
19741815|NCT03331562|42188496|FG001|Overall Study|Adverse Event|0|||
19741816|NCT03331562|42188495|FG000|Overall Study|Death|1|||
19741817|NCT03331562|42188496|FG001|Overall Study|Death|0|||
19741818|NCT02038634|42188508|FG000|Overall Study|Lost to Follow-up|0|||
19741819|NCT02038634|42188509|FG001|Overall Study|Lost to Follow-up|1|||
19741820|NCT00836056|42188517|FG000|First Intervention|Adverse Event|1|||
19741821|NCT00836056|42188518|FG001|First Intervention|Adverse Event|0|||
19741822|NCT03200912|42188525|FG000|Overall Study|Adverse Event|3|||
19741823|NCT03200912|42188526|FG001|Overall Study|Adverse Event|0|||
19741824|NCT03200912|42188527|FG002|Overall Study|Adverse Event|0|||
19741825|NCT03200912|42188525|FG000|Overall Study|Withdrawal by Subject|1|||
19741826|NCT03200912|42188526|FG001|Overall Study|Withdrawal by Subject|2|||
19741827|NCT03200912|42188527|FG002|Overall Study|Withdrawal by Subject|4|||
19741828|NCT03200912|42188525|FG000|Overall Study|Non-compliance with study drug|0|||
19741829|NCT03200912|42188526|FG001|Overall Study|Non-compliance with study drug|1|||
19741830|NCT03200912|42188527|FG002|Overall Study|Non-compliance with study drug|0|||
19741831|NCT00835666|42188537|FG000|Washout|Protocol Violation|1|||
19741832|NCT00835666|42188538|FG001|Washout|Protocol Violation|0|||
19741833|NCT00835666|42188537|FG000|Washout|Withdrawal by Subject|1|||
19741834|NCT00835666|42188538|FG001|Washout|Withdrawal by Subject|0|||
19741835|NCT03200366|42188552|FG000|Patient Navigation Intervention Given|Death|0|||
19741836|NCT03200366|42188553|FG001|Patient Navigation Intervention Given|Death|2|||
19741837|NCT03200366|42188554|FG002|Patient Navigation Intervention Given|Death|0|||
19741838|NCT03200366|42188552|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
19741839|NCT03200366|42188553|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
19741840|NCT03200366|42188554|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
19741841|NCT03200366|42188552|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
19741842|NCT03200366|42188553|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
19741843|NCT03200366|42188554|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
19741844|NCT03200366|42188552|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
19741845|NCT03200366|42188553|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
19741846|NCT03200366|42188554|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
19741847|NCT03200366|42188552|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
19741848|NCT03200366|42188553|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
19741849|NCT03200366|42188554|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
19741850|NCT03200366|42188552|FG000|6 Month Post-Baseline Interview|Death|1|||
19741851|NCT03200366|42188553|FG001|6 Month Post-Baseline Interview|Death|1|||
19741852|NCT03200366|42188554|FG002|6 Month Post-Baseline Interview|Death|1|||
19741853|NCT03200366|42188552|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
19741854|NCT03200366|42188553|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
19741855|NCT03200366|42188554|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
19741856|NCT03200366|42188552|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
19741857|NCT03200366|42188553|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
19741858|NCT03200366|42188554|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
19741859|NCT03200366|42188552|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
19741860|NCT03200366|42188553|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
19741861|NCT03200366|42188554|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
19741862|NCT03200366|42188552|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
19741863|NCT03200366|42188553|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
19741864|NCT03200366|42188554|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
19741865|NCT03200366|42188552|FG000|9 Month Post-Baseline Interview|Death|1|||
19741866|NCT03200366|42188553|FG001|9 Month Post-Baseline Interview|Death|1|||
19741867|NCT03200366|42188554|FG002|9 Month Post-Baseline Interview|Death|1|||
19741868|NCT03200366|42188552|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
19741869|NCT03200366|42188553|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
19741870|NCT03200366|42188554|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
19741871|NCT03200366|42188552|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
19565515|NCT00939523|42013354|FG000|Overall Study|Physician Decision|2|||
19565516|NCT01260584|42013362|FG000|Period 1|Protocol Violation|0|||
19565517|NCT01260584|42013363|FG001|Period 1|Protocol Violation|0|||
19565518|NCT01260584|42013364|FG002|Period 1|Protocol Violation|1|||
19565519|NCT01260584|42013365|FG003|Period 1|Protocol Violation|1|||
19565520|NCT01260584|42013362|FG000|Period 1|Adverse Event|0|||
19565521|NCT01260584|42013363|FG001|Period 1|Adverse Event|0|||
19565522|NCT01260584|42013364|FG002|Period 1|Adverse Event|1|||
19565523|NCT01260584|42013365|FG003|Period 1|Adverse Event|0|||
19565524|NCT01260584|42013362|FG000|Period 2|Protocol Violation|0|||
19565525|NCT01260584|42013363|FG001|Period 2|Protocol Violation|2|||
19565526|NCT01260584|42013364|FG002|Period 2|Protocol Violation|3|||
19565527|NCT01260584|42013365|FG003|Period 2|Protocol Violation|1|||
19565528|NCT01260584|42013362|FG000|Period 2|Adverse Event|1|||
19565529|NCT01260584|42013363|FG001|Period 2|Adverse Event|0|||
19565530|NCT01260584|42013364|FG002|Period 2|Adverse Event|2|||
19565531|NCT01260584|42013365|FG003|Period 2|Adverse Event|0|||
19565532|NCT01260584|42013362|FG000|Period 2|Withdrawal by Subject|0|||
19565533|NCT01260584|42013363|FG001|Period 2|Withdrawal by Subject|1|||
19565534|NCT01260584|42013364|FG002|Period 2|Withdrawal by Subject|0|||
19565535|NCT01260584|42013365|FG003|Period 2|Withdrawal by Subject|0|||
19565536|NCT00927589|42013375|FG000|Overall Study|Death|1|||
19565537|NCT00927589|42013375|FG000|Overall Study|Physician Decision|1|||
19565538|NCT00927589|42013375|FG000|Overall Study|Withdrawal by Subject|3|||
19565539|NCT00927589|42013375|FG000|Overall Study|Adverse Event|2|||
19565540|NCT00927589|42013375|FG000|Overall Study|Disease Progression|8|||
19565541|NCT00927589|42013375|FG000|Overall Study|Non-compliance|1|||
19565542|NCT00932425|42013381|FG000|Overall Study|Lost to Follow-up|0|||
19565543|NCT00932425|42013382|FG001|Overall Study|Lost to Follow-up|1|||
19565544|NCT00932425|42013381|FG000|Overall Study|Withdrawal by Subject|0|||
19565545|NCT00932425|42013382|FG001|Overall Study|Withdrawal by Subject|1|||
19565546|NCT00932113|42013390|FG000|Overall Study|Lost to Follow-up|1|||
19565547|NCT00932113|42013391|FG001|Overall Study|Lost to Follow-up|0|||
19565548|NCT00931801|42013400|FG000|Overall Study|Adverse Event|0|||
19565549|NCT00931801|42013401|FG001|Overall Study|Adverse Event|0|||
19565550|NCT00931801|42013402|FG002|Overall Study|Adverse Event|1|||
19565551|NCT00931801|42013400|FG000|Overall Study|Lost to Follow-up|0|||
19565552|NCT00931801|42013401|FG001|Overall Study|Lost to Follow-up|1|||
19565553|NCT00931801|42013402|FG002|Overall Study|Lost to Follow-up|0|||
19565554|NCT00931801|42013400|FG000|Overall Study|Withdrawal by Subject|1|||
19565555|NCT00931801|42013401|FG001|Overall Study|Withdrawal by Subject|0|||
19565556|NCT00931801|42013402|FG002|Overall Study|Withdrawal by Subject|0|||
19565557|NCT00931801|42013400|FG000|Overall Study|Confirmed Virologic Failure|0|||
19565558|NCT00931801|42013401|FG001|Overall Study|Confirmed Virologic Failure|0|||
19565559|NCT00931801|42013402|FG002|Overall Study|Confirmed Virologic Failure|3|||
19565560|NCT00931723|42013416|FG000|Overall Study|Withdrawal by Subject|11|||
19565561|NCT00931723|42013417|FG001|Overall Study|Withdrawal by Subject|13|||
19565562|NCT00931723|42013416|FG000|Overall Study|Adverse Event|6|||
19565563|NCT00931723|42013417|FG001|Overall Study|Adverse Event|13|||
19565564|NCT00931723|42013416|FG000|Overall Study|Lithium found in blood|0|||
19565565|NCT00931723|42013417|FG001|Overall Study|Lithium found in blood|1|||
19565566|NCT00931723|42013416|FG000|Overall Study|Condition under investigation worsened|1|||
19565567|NCT00931723|42013417|FG001|Overall Study|Condition under investigation worsened|2|||
19565568|NCT00931723|42013416|FG000|Overall Study|Lost to Follow-up|1|||
19565569|NCT00931723|42013417|FG001|Overall Study|Lost to Follow-up|2|||
19565570|NCT00931723|42013416|FG000|Overall Study|Study-specific discontinuation criteria|1|||
19565571|NCT00931723|42013417|FG001|Overall Study|Study-specific discontinuation criteria|1|||
19565572|NCT00931723|42013416|FG000|Overall Study|Severe non-compliance to protocol|2|||
19565573|NCT00931723|42013417|FG001|Overall Study|Severe non-compliance to protocol|0|||
19565574|NCT00931723|42013416|FG000|Overall Study|Safety reasons|0|||
19565575|NCT00931723|42013417|FG001|Overall Study|Safety reasons|1|||
19565576|NCT00931723|42013416|FG000|Overall Study|Took prohibited concomitant medication|0|||
19565577|NCT00931723|42013417|FG001|Overall Study|Took prohibited concomitant medication|1|||
19565578|NCT00931723|42013416|FG000|Overall Study|Lack or insufficient theraputic response|2|||
19565579|NCT00931723|42013417|FG001|Overall Study|Lack or insufficient theraputic response|5|||
19741872|NCT03200366|42188553|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
19565580|NCT00931723|42013416|FG000|Overall Study|Sponsor decision|1|||
19565581|NCT00931723|42013417|FG001|Overall Study|Sponsor decision|0|||
19565582|NCT00931723|42013416|FG000|Overall Study|Late hospital discharge|1|||
19565583|NCT00931723|42013417|FG001|Overall Study|Late hospital discharge|0|||
19565584|NCT00931411|42013425|FG000|First Intervention - 42 Days|Adverse Event|2|||
19565585|NCT00931411|42013426|FG001|First Intervention - 42 Days|Adverse Event|3|||
19741873|NCT03200366|42188554|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
19741874|NCT03200366|42188552|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
19741875|NCT03200366|42188553|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
19741876|NCT03200366|42188554|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
19741877|NCT00835354|42188566|FG000|First Intervention|Adverse Event|0|||
19741878|NCT00835354|42188567|FG001|First Intervention|Adverse Event|1|||
19741879|NCT00835042|42188611|FG000|First Intervention|Withdrawal by Subject|3|||
19741880|NCT00835042|42188612|FG001|First Intervention|Withdrawal by Subject|0|||
19741881|NCT00835042|42188611|FG000|First Intervention|Adverse Event|1|||
19741882|NCT00835042|42188612|FG001|First Intervention|Adverse Event|2|||
19741883|NCT00835042|42188611|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
19741884|NCT00835042|42188612|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
19741885|NCT00834418|42188649|FG000|Overall Study|Adverse Event|0|||
19741886|NCT00834418|42188650|FG001|Overall Study|Adverse Event|2|||
19741887|NCT00834340|42188656|FG000|Washout|Adverse Event|1|||
19741888|NCT00834340|42188657|FG001|Washout|Adverse Event|0|||
19741889|NCT00834340|42188656|FG000|Washout|Withdrawal by Subject|1|||
19741890|NCT00834340|42188657|FG001|Washout|Withdrawal by Subject|0|||
19741891|NCT00151996|42188663|FG000|Overall Study|Adverse Event|3|||
19741892|NCT00151996|42188664|FG001|Overall Study|Adverse Event|2|||
19741893|NCT00151996|42188663|FG000|Overall Study|Withdrawal by Subject|1|||
19741894|NCT00151996|42188664|FG001|Overall Study|Withdrawal by Subject|1|||
19741895|NCT00151996|42188663|FG000|Overall Study|Protocol Violation|1|||
19741896|NCT00151996|42188664|FG001|Overall Study|Protocol Violation|2|||
19741897|NCT00151996|42188663|FG000|Overall Study|Sponsor's decision|0|||
19741898|NCT00151996|42188664|FG001|Overall Study|Sponsor's decision|2|||
19741899|NCT00830206|42188672|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
19741900|NCT00830206|42188673|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
19741901|NCT00829504|42188679|FG000|First Intervention|Adverse Event|1|||
19741902|NCT00829504|42188680|FG001|First Intervention|Adverse Event|0|||
19741903|NCT00829504|42188679|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19741904|NCT00829504|42188680|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19741905|NCT00829504|42188679|FG000|Second Intervention|Physician Decision|1|||
19741906|NCT00829504|42188680|FG001|Second Intervention|Physician Decision|0|||
19741907|NCT00829426|42188686|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19741908|NCT00829426|42188687|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
19741909|NCT00152464|42188693|FG000|Overall Study|Adverse Event|3|||
19741910|NCT00152464|42188694|FG001|Overall Study|Adverse Event|6|||
19741911|NCT00152464|42188693|FG000|Overall Study|Lost to Follow-up|8|||
19741912|NCT00152464|42188694|FG001|Overall Study|Lost to Follow-up|4|||
19741913|NCT00152464|42188693|FG000|Overall Study|Protocol Violation|3|||
19741914|NCT00152464|42188694|FG001|Overall Study|Protocol Violation|1|||
19741915|NCT00152464|42188693|FG000|Overall Study|Withdrawal by Subject|21|||
19741916|NCT00152464|42188694|FG001|Overall Study|Withdrawal by Subject|22|||
19741917|NCT00152464|42188693|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
19741918|NCT00152464|42188694|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
19741919|NCT00152464|42188693|FG000|Overall Study|Eczema deterioration|0|||
19741920|NCT00152464|42188694|FG001|Overall Study|Eczema deterioration|1|||
19741921|NCT00152464|42188693|FG000|Overall Study|Parent decision|1|||
19741922|NCT00152464|42188694|FG001|Overall Study|Parent decision|1|||
19741923|NCT00152464|42188693|FG000|Overall Study|Investigator decision|1|||
19741924|NCT00152464|42188694|FG001|Overall Study|Investigator decision|0|||
19741925|NCT00152464|42188693|FG000|Overall Study|Lack of Efficacy|1|||
19741926|NCT00152464|42188694|FG001|Overall Study|Lack of Efficacy|0|||
19741927|NCT00152464|42188693|FG000|Overall Study|Eczema poorly controlled|1|||
19741928|NCT00152464|42188694|FG001|Overall Study|Eczema poorly controlled|0|||
19741929|NCT00152464|42188693|FG000|Overall Study|Patient relocated|1|||
19741930|NCT00152464|42188694|FG001|Overall Study|Patient relocated|0|||
19741931|NCT00674440|42188700|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
19741932|NCT00674440|42188700|FG000|Overall Study|did not have surgery, so unevaluable|7|||
19741933|NCT00674440|42188700|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
19741934|NCT02742766|42188724|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741935|NCT02742766|42188725|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741936|NCT02742766|42188726|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19565586|NCT00931411|42013425|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
19565587|NCT00931411|42013426|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
19565588|NCT00931411|42013425|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
19741937|NCT02742766|42188727|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741938|NCT02742766|42188728|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741939|NCT02742766|42188729|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741940|NCT02742766|42188730|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741941|NCT02742766|42188731|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741942|NCT02742766|42188732|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741943|NCT02742766|42188733|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741944|NCT02742766|42188734|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741945|NCT02742766|42188735|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741946|NCT02742766|42188736|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741947|NCT02742766|42188737|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
19741948|NCT02742766|42188738|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741949|NCT02742766|42188739|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741950|NCT02742766|42188740|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741951|NCT02742766|42188741|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741952|NCT02742766|42188742|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
19741953|NCT02742766|42188724|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741954|NCT02742766|42188725|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741955|NCT02742766|42188726|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741956|NCT02742766|42188727|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741957|NCT02742766|42188728|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741958|NCT02742766|42188729|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741959|NCT02742766|42188730|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741960|NCT02742766|42188731|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741961|NCT02742766|42188732|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741962|NCT02742766|42188733|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741963|NCT02742766|42188734|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741964|NCT02742766|42188735|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741965|NCT02742766|42188736|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
19741966|NCT02742766|42188737|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
19741967|NCT02742766|42188738|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741968|NCT02742766|42188739|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
19741969|NCT02742766|42188740|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741970|NCT02742766|42188741|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741971|NCT02742766|42188742|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
19741972|NCT01468922|42188820|FG000|Overall Study|Screening failure|0|||
19741973|NCT01468922|42188821|FG001|Overall Study|Screening failure|0|||
19741974|NCT01468922|42188822|FG002|Overall Study|Screening failure|0|||
19741975|NCT01468922|42188823|FG003|Overall Study|Screening failure|0|||
19741976|NCT01468922|42188824|FG004|Overall Study|Screening failure|0|||
19741977|NCT01468922|42188825|FG005|Overall Study|Screening failure|0|||
19741978|NCT01468922|42188826|FG006|Overall Study|Screening failure|0|||
19741979|NCT01468922|42188827|FG007|Overall Study|Screening failure|0|||
19741980|NCT01468922|42188828|FG008|Overall Study|Screening failure|1|||
19741981|NCT01468922|42188820|FG000|Overall Study|Per patient choice|1|||
19741982|NCT01468922|42188821|FG001|Overall Study|Per patient choice|0|||
19741983|NCT01468922|42188822|FG002|Overall Study|Per patient choice|0|||
19741984|NCT01468922|42188823|FG003|Overall Study|Per patient choice|0|||
19741985|NCT01468922|42188824|FG004|Overall Study|Per patient choice|0|||
19741986|NCT01468922|42188825|FG005|Overall Study|Per patient choice|0|||
19741987|NCT01468922|42188826|FG006|Overall Study|Per patient choice|0|||
19741988|NCT01468922|42188827|FG007|Overall Study|Per patient choice|0|||
19741989|NCT01468922|42188828|FG008|Overall Study|Per patient choice|0|||
19382298|NCT04248465|41625597|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
19565589|NCT00931411|42013426|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
19565590|NCT00931255|42013438|FG000|Overall Study|Follow up biopsy not done|2|||
19565591|NCT00931255|42013439|FG001|Overall Study|Follow up biopsy not done|3|||
19565592|NCT00930553|42013445|FG000|Overall Study|Adverse Event|1|||
19565593|NCT00930553|42013445|FG000|Overall Study|Lack of Efficacy|7|||
19565594|NCT00930553|42013445|FG000|Overall Study|Physician Decision|39|||
19565595|NCT00930553|42013445|FG000|Overall Study|Protocol Violation|1|||
19565596|NCT00930553|42013445|FG000|Overall Study|Pregnancy|1|||
19565597|NCT00930553|42013445|FG000|Overall Study|Withdrawal by Subject|88|||
19565598|NCT00930553|42013445|FG000|Overall Study|Lost to Follow-up|25|||
19565599|NCT00930553|42013445|FG000|Overall Study|Death|9|||
19565600|NCT00930553|42013445|FG000|Overall Study|Study terminated by sponsor|24|||
19565601|NCT00930553|42013445|FG000|Overall Study|Other than specified above|28|||
19565602|NCT00929695|42013469|FG000|Overall Study|Death|2|||
19565603|NCT00929695|42013470|FG001|Overall Study|Death|1|||
19565604|NCT00929695|42013469|FG000|Overall Study|Withdrawal by Subject|0|||
19565605|NCT00929695|42013470|FG001|Overall Study|Withdrawal by Subject|2|||
19565606|NCT00929695|42013469|FG000|Overall Study|discharge home|4|||
19565607|NCT00929695|42013470|FG001|Overall Study|discharge home|3|||
19565608|NCT00929695|42013469|FG000|Overall Study|incorrect stratification|2|||
19565609|NCT00929695|42013470|FG001|Overall Study|incorrect stratification|0|||
19741990|NCT01468922|42188820|FG000|Overall Study|Switched to alternative treatment|1|||
19741991|NCT01468922|42188821|FG001|Overall Study|Switched to alternative treatment|0|||
19741992|NCT01468922|42188822|FG002|Overall Study|Switched to alternative treatment|0|||
19741993|NCT01468922|42188823|FG003|Overall Study|Switched to alternative treatment|0|||
19741994|NCT01468922|42188824|FG004|Overall Study|Switched to alternative treatment|1|||
19565610|NCT00927355|42013483|FG000|Overall Study|Adverse Event|1|||
19565611|NCT00927355|42013484|FG001|Overall Study|Adverse Event|1|||
19565612|NCT00923845|42013504|FG000|Induction Therapy|Poor performance status|0|||
19565613|NCT00923845|42013505|FG001|Induction Therapy|Poor performance status|2|||
19565614|NCT00922987|42013512|FG000|Overall Study|Insufficient clinical response|1|||
19565615|NCT00922987|42013512|FG000|Overall Study|Protocol Violation|2|||
19565616|NCT00922987|42013512|FG000|Overall Study|Adverse Event|1|||
19565617|NCT00928135|42013518|FG000|Overall Study|Withdrawal by Subject|1|||
19565618|NCT00928135|42013519|FG001|Overall Study|Withdrawal by Subject|0|||
19565619|NCT00928057|42013527|FG000|Overall Study|Adverse Event|1|||
19565620|NCT00928057|42013528|FG001|Overall Study|Adverse Event|2|||
19565621|NCT00928057|42013527|FG000|Overall Study|Withdrawal by Subject|1|||
19565622|NCT00928057|42013528|FG001|Overall Study|Withdrawal by Subject|0|||
19565623|NCT00928057|42013527|FG000|Overall Study|Lost to Follow-up|0|||
19565624|NCT00928057|42013528|FG001|Overall Study|Lost to Follow-up|1|||
19565625|NCT00928057|42013527|FG000|Overall Study|Protocol Violation|0|||
19565626|NCT00928057|42013528|FG001|Overall Study|Protocol Violation|1|||
19565627|NCT00927901|42013544|FG000|Treatment Period 1|Subject withdrew consent|0|||
19565628|NCT00927901|42013545|FG001|Treatment Period 1|Subject withdrew consent|0|||
19565629|NCT00927901|42013546|FG002|Treatment Period 1|Subject withdrew consent|1|||
19565630|NCT00927901|42013547|FG003|Treatment Period 1|Subject withdrew consent|0|||
19565631|NCT00927901|42013544|FG000|Treatment Period 4|Adverse Event|0|||
19565632|NCT00927901|42013545|FG001|Treatment Period 4|Adverse Event|0|||
19565633|NCT00927901|42013546|FG002|Treatment Period 4|Adverse Event|0|||
19565634|NCT00927901|42013547|FG003|Treatment Period 4|Adverse Event|1|||
19565635|NCT00927901|42013544|FG000|Treatment Period 4|Subject withdrew consent|0|||
19565636|NCT00927901|42013545|FG001|Treatment Period 4|Subject withdrew consent|0|||
19565637|NCT00927901|42013546|FG002|Treatment Period 4|Subject withdrew consent|1|||
19565638|NCT00927901|42013547|FG003|Treatment Period 4|Subject withdrew consent|0|||
19565639|NCT01218204|42013562|FG000|Part B Washout|Adverse Event|0|||
19565640|NCT01218204|42013563|FG001|Part B Washout|Adverse Event|1|||
19565641|NCT01218204|42013564|FG002|Part B Washout|Adverse Event|0|||
19565642|NCT01218204|42013565|FG003|Part B Washout|Adverse Event|0|||
19565643|NCT01218204|42013562|FG000|Part B Washout|Lost to Follow-up|0|||
19565644|NCT01218204|42013563|FG001|Part B Washout|Lost to Follow-up|2|||
19565645|NCT01218204|42013564|FG002|Part B Washout|Lost to Follow-up|0|||
19565646|NCT01218204|42013565|FG003|Part B Washout|Lost to Follow-up|0|||
19565647|NCT01218204|42013562|FG000|Part B Washout|Physician Decision|0|||
19565648|NCT01218204|42013563|FG001|Part B Washout|Physician Decision|14|||
19565649|NCT01218204|42013564|FG002|Part B Washout|Physician Decision|0|||
19565650|NCT01218204|42013565|FG003|Part B Washout|Physician Decision|0|||
19565651|NCT01218204|42013562|FG000|Part B Washout|Withdrawal by Subject|0|||
19565652|NCT01218204|42013563|FG001|Part B Washout|Withdrawal by Subject|14|||
19565653|NCT01218204|42013564|FG002|Part B Washout|Withdrawal by Subject|0|||
19565654|NCT01218204|42013565|FG003|Part B Washout|Withdrawal by Subject|0|||
19565655|NCT01218204|42013562|FG000|Part B Washout|Reached defined stopping criteria|0|||
19565656|NCT01218204|42013563|FG001|Part B Washout|Reached defined stopping criteria|2|||
19565657|NCT01218204|42013564|FG002|Part B Washout|Reached defined stopping criteria|0|||
19565658|NCT01218204|42013565|FG003|Part B Washout|Reached defined stopping criteria|0|||
19565659|NCT01218204|42013562|FG000|Part B Washout|Did not meet continuation criteria|0|||
19565660|NCT01218204|42013563|FG001|Part B Washout|Did not meet continuation criteria|112|||
19565661|NCT01218204|42013564|FG002|Part B Washout|Did not meet continuation criteria|0|||
19565662|NCT01218204|42013565|FG003|Part B Washout|Did not meet continuation criteria|0|||
19565663|NCT01218204|42013562|FG000|Part B Run-in|Adverse Event|0|||
19565664|NCT01218204|42013563|FG001|Part B Run-in|Adverse Event|0|||
19741995|NCT01468922|42188825|FG005|Overall Study|Switched to alternative treatment|0|||
19741996|NCT01468922|42188826|FG006|Overall Study|Switched to alternative treatment|0|||
19741997|NCT01468922|42188827|FG007|Overall Study|Switched to alternative treatment|0|||
19741998|NCT01468922|42188828|FG008|Overall Study|Switched to alternative treatment|0|||
19741999|NCT01468922|42188820|FG000|Overall Study|Enrolled on new protocol|0|||
19742000|NCT01468922|42188821|FG001|Overall Study|Enrolled on new protocol|0|||
19742001|NCT01468922|42188822|FG002|Overall Study|Enrolled on new protocol|0|||
19742002|NCT01468922|42188823|FG003|Overall Study|Enrolled on new protocol|0|||
19742003|NCT01468922|42188824|FG004|Overall Study|Enrolled on new protocol|1|||
19742004|NCT01468922|42188825|FG005|Overall Study|Enrolled on new protocol|0|||
19742005|NCT01468922|42188826|FG006|Overall Study|Enrolled on new protocol|0|||
19742006|NCT01468922|42188827|FG007|Overall Study|Enrolled on new protocol|0|||
19742007|NCT01468922|42188828|FG008|Overall Study|Enrolled on new protocol|0|||
19742008|NCT01468922|42188820|FG000|Overall Study|Adverse Event|0|||
19742009|NCT01468922|42188821|FG001|Overall Study|Adverse Event|0|||
19565665|NCT01218204|42013564|FG002|Part B Run-in|Adverse Event|1|||
19565666|NCT01218204|42013565|FG003|Part B Run-in|Adverse Event|0|||
19565667|NCT01218204|42013562|FG000|Part B Run-in|Protocol Violation|0|||
19565668|NCT01218204|42013563|FG001|Part B Run-in|Protocol Violation|0|||
19565669|NCT01218204|42013564|FG002|Part B Run-in|Protocol Violation|2|||
19565670|NCT01218204|42013565|FG003|Part B Run-in|Protocol Violation|0|||
19565671|NCT01218204|42013562|FG000|Part B Run-in|Withdrawal by Subject|0|||
19565672|NCT01218204|42013563|FG001|Part B Run-in|Withdrawal by Subject|0|||
19565673|NCT01218204|42013564|FG002|Part B Run-in|Withdrawal by Subject|3|||
19742010|NCT01468922|42188822|FG002|Overall Study|Adverse Event|0|||
19742011|NCT01468922|42188823|FG003|Overall Study|Adverse Event|0|||
19742012|NCT01468922|42188824|FG004|Overall Study|Adverse Event|0|||
19742013|NCT01468922|42188825|FG005|Overall Study|Adverse Event|0|||
19742014|NCT01468922|42188826|FG006|Overall Study|Adverse Event|0|||
19742015|NCT01468922|42188827|FG007|Overall Study|Adverse Event|1|||
19742016|NCT01468922|42188828|FG008|Overall Study|Adverse Event|0|||
19742017|NCT01468922|42188820|FG000|Overall Study|Infection of blood|0|||
19742018|NCT01468922|42188821|FG001|Overall Study|Infection of blood|0|||
19742019|NCT01468922|42188822|FG002|Overall Study|Infection of blood|0|||
19742020|NCT01468922|42188823|FG003|Overall Study|Infection of blood|0|||
19742021|NCT01468922|42188824|FG004|Overall Study|Infection of blood|0|||
19742022|NCT01468922|42188825|FG005|Overall Study|Infection of blood|0|||
19742023|NCT01468922|42188826|FG006|Overall Study|Infection of blood|0|||
19742024|NCT01468922|42188827|FG007|Overall Study|Infection of blood|1|||
19742025|NCT01468922|42188828|FG008|Overall Study|Infection of blood|0|||
19742026|NCT01468922|42188820|FG000|Overall Study|Patient choice - surgery|0|||
19742027|NCT01468922|42188821|FG001|Overall Study|Patient choice - surgery|0|||
19742028|NCT01468922|42188822|FG002|Overall Study|Patient choice - surgery|0|||
19476829|NCT01554163|41754914|FG000|Overall Study|Withdrawal by Subject|1|||
19476830|NCT01554163|41754915|FG001|Overall Study|Withdrawal by Subject|5|||
19476831|NCT01554163|41754914|FG000|Overall Study|Not Treated|1|||
19476832|NCT01554163|41754915|FG001|Overall Study|Not Treated|0|||
19476833|NCT01553851|41754921|FG000|Overall Study|Adverse Event|2|||
19476834|NCT01553851|41754921|FG000|Overall Study|constipation|1|||
19476835|NCT01552915|41754941|FG000|Overall Study|Adverse Event|3|||
19476836|NCT01552915|41754942|FG001|Overall Study|Adverse Event|14|||
19476837|NCT01552915|41754943|FG002|Overall Study|Adverse Event|3|||
19476838|NCT01552915|41754941|FG000|Overall Study|Lost to Follow-up|4|||
19476839|NCT01552915|41754942|FG001|Overall Study|Lost to Follow-up|6|||
19476840|NCT01552915|41754943|FG002|Overall Study|Lost to Follow-up|5|||
19476841|NCT01552915|41754941|FG000|Overall Study|Withdrawal by Subject|6|||
19476842|NCT01552915|41754942|FG001|Overall Study|Withdrawal by Subject|4|||
19476843|NCT01552915|41754943|FG002|Overall Study|Withdrawal by Subject|5|||
19476844|NCT01552915|41754941|FG000|Overall Study|Protocol Violation|0|||
19476845|NCT01552915|41754942|FG001|Overall Study|Protocol Violation|4|||
19476846|NCT01552915|41754943|FG002|Overall Study|Protocol Violation|4|||
19565674|NCT01218204|42013565|FG003|Part B Run-in|Withdrawal by Subject|0|||
19565675|NCT01218204|42013562|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
19565676|NCT01218204|42013563|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
19565677|NCT01218204|42013564|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
19565678|NCT01218204|42013565|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
19565679|NCT01218204|42013562|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
19565680|NCT01218204|42013563|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
19565681|NCT01218204|42013564|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
19565682|NCT01218204|42013565|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
19565683|NCT00926575|42013614|FG000|Overall Study|Adverse Event|1|||
19565684|NCT00926575|42013615|FG001|Overall Study|Adverse Event|1|||
19565685|NCT00926575|42013614|FG000|Overall Study|Death|4|||
19565686|NCT00926575|42013615|FG001|Overall Study|Death|4|||
19565687|NCT00926575|42013614|FG000|Overall Study|Lost to Follow-up|1|||
19565688|NCT00926575|42013615|FG001|Overall Study|Lost to Follow-up|1|||
19565689|NCT00926575|42013614|FG000|Overall Study|Physician Decision|1|||
19565690|NCT00926575|42013615|FG001|Overall Study|Physician Decision|2|||
19565691|NCT00926575|42013614|FG000|Overall Study|Protocol Violation|1|||
19565692|NCT00926575|42013615|FG001|Overall Study|Protocol Violation|0|||
19565693|NCT00926575|42013614|FG000|Overall Study|Withdrawal by Subject|8|||
19565694|NCT00926575|42013615|FG001|Overall Study|Withdrawal by Subject|9|||
19565695|NCT01218126|42013625|FG000|Overall Study|Adverse Event|8|||
19742029|NCT01468922|42188823|FG003|Overall Study|Patient choice - surgery|0|||
19742030|NCT01468922|42188824|FG004|Overall Study|Patient choice - surgery|0|||
19476847|NCT01552915|41754941|FG000|Overall Study|Lack of Efficacy|8|||
19476848|NCT01552915|41754942|FG001|Overall Study|Lack of Efficacy|1|||
19742031|NCT01468922|42188825|FG005|Overall Study|Patient choice - surgery|0|||
19742032|NCT01468922|42188826|FG006|Overall Study|Patient choice - surgery|0|||
19742033|NCT01468922|42188827|FG007|Overall Study|Patient choice - surgery|1|||
19742034|NCT01468922|42188828|FG008|Overall Study|Patient choice - surgery|0|||
19742035|NCT01468922|42188820|FG000|Overall Study|Refused further treatment|0|||
19742036|NCT01468922|42188821|FG001|Overall Study|Refused further treatment|0|||
19742037|NCT01468922|42188822|FG002|Overall Study|Refused further treatment|0|||
19742038|NCT01468922|42188823|FG003|Overall Study|Refused further treatment|0|||
19742039|NCT01468922|42188824|FG004|Overall Study|Refused further treatment|0|||
19742040|NCT01468922|42188825|FG005|Overall Study|Refused further treatment|0|||
19742041|NCT01468922|42188826|FG006|Overall Study|Refused further treatment|0|||
19742042|NCT01468922|42188827|FG007|Overall Study|Refused further treatment|1|||
19742043|NCT01468922|42188828|FG008|Overall Study|Refused further treatment|0|||
19742044|NCT01381094|42188851|FG000|Overall Study|Adverse Event|1|||
19742045|NCT01381094|42188852|FG001|Overall Study|Adverse Event|2|||
19742046|NCT01381094|42188853|FG002|Overall Study|Adverse Event|0|||
19742047|NCT01381094|42188854|FG003|Overall Study|Adverse Event|1|||
19742048|NCT01381094|42188855|FG004|Overall Study|Adverse Event|0|||
19742049|NCT01381094|42188851|FG000|Overall Study|Lost to Follow-up|0|||
19742050|NCT01381094|42188852|FG001|Overall Study|Lost to Follow-up|0|||
19742051|NCT01381094|42188853|FG002|Overall Study|Lost to Follow-up|0|||
19742052|NCT01381094|42188854|FG003|Overall Study|Lost to Follow-up|0|||
19742053|NCT01381094|42188855|FG004|Overall Study|Lost to Follow-up|1|||
19742054|NCT01381094|42188851|FG000|Overall Study|Withdrawal of informed consent|0|||
19742055|NCT01381094|42188852|FG001|Overall Study|Withdrawal of informed consent|1|||
19742056|NCT01381094|42188853|FG002|Overall Study|Withdrawal of informed consent|0|||
19742057|NCT01381094|42188854|FG003|Overall Study|Withdrawal of informed consent|0|||
19742058|NCT01381094|42188855|FG004|Overall Study|Withdrawal of informed consent|0|||
19742059|NCT01381094|42188851|FG000|Overall Study|Participant given Aranesp injection|1|||
19742060|NCT01381094|42188852|FG001|Overall Study|Participant given Aranesp injection|0|||
19742061|NCT01381094|42188853|FG002|Overall Study|Participant given Aranesp injection|0|||
19742062|NCT01381094|42188854|FG003|Overall Study|Participant given Aranesp injection|0|||
19742063|NCT01381094|42188855|FG004|Overall Study|Participant given Aranesp injection|0|||
19742064|NCT03197558|42188867|FG000|Overall Study|Tubes not placed|1|||
19742065|NCT03197324|42188873|FG000|Overall Study|Adverse Event|0|||
19742066|NCT03197324|42188874|FG001|Overall Study|Adverse Event|1|||
19742067|NCT03162614|42188886|FG000|Overall Study|Lost to Follow-up|2|||
19742068|NCT03162614|42188887|FG001|Overall Study|Lost to Follow-up|1|||
19742069|NCT03162614|42188888|FG002|Overall Study|Lost to Follow-up|1|||
19742070|NCT03162614|42188889|FG003|Overall Study|Lost to Follow-up|1|||
19742071|NCT03162614|42188890|FG004|Overall Study|Lost to Follow-up|2|||
19742072|NCT03162614|42188891|FG005|Overall Study|Lost to Follow-up|0|||
19742073|NCT03162614|42188886|FG000|Overall Study|Protocol Violation|0|||
19742074|NCT03162614|42188887|FG001|Overall Study|Protocol Violation|1|||
19742075|NCT03162614|42188888|FG002|Overall Study|Protocol Violation|0|||
19742076|NCT03162614|42188889|FG003|Overall Study|Protocol Violation|1|||
19742077|NCT03162614|42188890|FG004|Overall Study|Protocol Violation|0|||
19742078|NCT03162614|42188891|FG005|Overall Study|Protocol Violation|0|||
19742079|NCT03162614|42188886|FG000|Overall Study|Withdrawal by Subject|2|||
19742080|NCT03162614|42188887|FG001|Overall Study|Withdrawal by Subject|1|||
19742081|NCT03162614|42188888|FG002|Overall Study|Withdrawal by Subject|1|||
19742082|NCT03162614|42188889|FG003|Overall Study|Withdrawal by Subject|1|||
19742083|NCT03162614|42188890|FG004|Overall Study|Withdrawal by Subject|0|||
19742084|NCT03162614|42188891|FG005|Overall Study|Withdrawal by Subject|0|||
19742085|NCT03162614|42188886|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
19742086|NCT03162614|42188887|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
19742087|NCT03162614|42188888|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
19742088|NCT03162614|42188889|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
19742089|NCT03162614|42188890|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
19742090|NCT03162614|42188891|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
19742091|NCT03160898|42188909|FG000|Overall Study|Adverse Event|4|||
19742092|NCT03160898|42188910|FG001|Overall Study|Adverse Event|8|||
19742093|NCT03160898|42188911|FG002|Overall Study|Adverse Event|7|||
19742094|NCT03160898|42188912|FG003|Overall Study|Adverse Event|10|||
19742095|NCT03160898|42188909|FG000|Overall Study|Death|1|||
19742096|NCT03160898|42188910|FG001|Overall Study|Death|0|||
19742097|NCT03160898|42188911|FG002|Overall Study|Death|0|||
19742098|NCT03160898|42188912|FG003|Overall Study|Death|1|||
19742099|NCT03160898|42188909|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
19742100|NCT03160898|42188910|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
19742101|NCT03160898|42188911|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
19742102|NCT03160898|42188912|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
19742103|NCT03160898|42188909|FG000|Overall Study|Lost to Follow-up|1|||
19742104|NCT03160898|42188910|FG001|Overall Study|Lost to Follow-up|1|||
19742105|NCT03160898|42188911|FG002|Overall Study|Lost to Follow-up|1|||
19742106|NCT03160898|42188912|FG003|Overall Study|Lost to Follow-up|2|||
19742107|NCT03160898|42188909|FG000|Overall Study|Physician Decision|1|||
19742108|NCT03160898|42188910|FG001|Overall Study|Physician Decision|0|||
19742109|NCT03160898|42188911|FG002|Overall Study|Physician Decision|0|||
19742110|NCT03160898|42188912|FG003|Overall Study|Physician Decision|1|||
19742111|NCT03160898|42188909|FG000|Overall Study|Progressive Disease|4|||
19742112|NCT03160898|42188910|FG001|Overall Study|Progressive Disease|1|||
19742113|NCT03160898|42188911|FG002|Overall Study|Progressive Disease|2|||
19742114|NCT03160898|42188912|FG003|Overall Study|Progressive Disease|1|||
19742115|NCT03160898|42188909|FG000|Overall Study|Protocol Violation|1|||
19742116|NCT03160898|42188910|FG001|Overall Study|Protocol Violation|0|||
19742117|NCT03160898|42188911|FG002|Overall Study|Protocol Violation|2|||
19742118|NCT03160898|42188912|FG003|Overall Study|Protocol Violation|0|||
19742119|NCT03160898|42188909|FG000|Overall Study|Sponsor Discretion|2|||
19742120|NCT03160898|42188910|FG001|Overall Study|Sponsor Discretion|0|||
19742121|NCT03160898|42188911|FG002|Overall Study|Sponsor Discretion|0|||
19742122|NCT03160898|42188912|FG003|Overall Study|Sponsor Discretion|0|||
19742123|NCT03160898|42188909|FG000|Overall Study|Withdrawal by Subject|1|||
19742124|NCT03160898|42188910|FG001|Overall Study|Withdrawal by Subject|3|||
19742125|NCT03160898|42188911|FG002|Overall Study|Withdrawal by Subject|2|||
19742126|NCT03160898|42188912|FG003|Overall Study|Withdrawal by Subject|1|||
19742127|NCT03160898|42188909|FG000|Overall Study|Other|2|||
19742128|NCT03160898|42188910|FG001|Overall Study|Other|0|||
19742129|NCT03160898|42188911|FG002|Overall Study|Other|2|||
19742130|NCT03160898|42188912|FG003|Overall Study|Other|2|||
19742131|NCT03193736|42188923|FG000|Overall Study|Death|2|||
19742132|NCT03193736|42188923|FG000|Overall Study|Withdrawal by Subject|1|||
19742133|NCT03193736|42188923|FG000|Overall Study|Lost to Follow-up|1|||
19742134|NCT03193736|42188923|FG000|Overall Study|implant not received|1|||
19742135|NCT03192488|42188940|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
19742136|NCT03192488|42188941|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
19742137|NCT03192488|42188942|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
19742138|NCT03192488|42188943|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
19742139|NCT03192488|42188944|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
19742140|NCT03192488|42188945|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
19742141|NCT03192488|42188940|FG000|Third Intervention (d1)|Adverse Event|0|||
19742142|NCT03192488|42188941|FG001|Third Intervention (d1)|Adverse Event|0|||
19742143|NCT03192488|42188942|FG002|Third Intervention (d1)|Adverse Event|0|||
19742144|NCT03192488|42188943|FG003|Third Intervention (d1)|Adverse Event|0|||
19742145|NCT03192488|42188944|FG004|Third Intervention (d1)|Adverse Event|1|||
19742146|NCT03192488|42188945|FG005|Third Intervention (d1)|Adverse Event|0|||
19742147|NCT03192176|42188967|FG000|Overall Study|Adverse Event|1|||
19742148|NCT03192176|42188968|FG001|Overall Study|Adverse Event|0|||
19742149|NCT03192176|42188969|FG002|Overall Study|Adverse Event|4|||
19742150|NCT03192176|42188970|FG003|Overall Study|Adverse Event|5|||
19742151|NCT03192176|42188971|FG004|Overall Study|Adverse Event|3|||
19742152|NCT03192176|42188972|FG005|Overall Study|Adverse Event|2|||
19742153|NCT03192176|42188973|FG006|Overall Study|Adverse Event|3|||
19742154|NCT03192176|42188974|FG007|Overall Study|Adverse Event|3|||
19742155|NCT03192176|42188967|FG000|Overall Study|Lost to Follow-up|0|||
19742156|NCT03192176|42188968|FG001|Overall Study|Lost to Follow-up|0|||
19742157|NCT03192176|42188969|FG002|Overall Study|Lost to Follow-up|1|||
19742158|NCT03192176|42188970|FG003|Overall Study|Lost to Follow-up|2|||
19742159|NCT03192176|42188971|FG004|Overall Study|Lost to Follow-up|3|||
19742160|NCT03192176|42188972|FG005|Overall Study|Lost to Follow-up|1|||
19742161|NCT03192176|42188973|FG006|Overall Study|Lost to Follow-up|1|||
19742162|NCT03192176|42188974|FG007|Overall Study|Lost to Follow-up|1|||
19742163|NCT03192176|42188967|FG000|Overall Study|Physician Decision|1|||
19742164|NCT03192176|42188968|FG001|Overall Study|Physician Decision|0|||
19742165|NCT03192176|42188969|FG002|Overall Study|Physician Decision|0|||
19742166|NCT03192176|42188970|FG003|Overall Study|Physician Decision|0|||
19742167|NCT03192176|42188971|FG004|Overall Study|Physician Decision|0|||
19742168|NCT03192176|42188972|FG005|Overall Study|Physician Decision|2|||
19742169|NCT03192176|42188973|FG006|Overall Study|Physician Decision|1|||
19742170|NCT03192176|42188974|FG007|Overall Study|Physician Decision|0|||
19742171|NCT03192176|42188967|FG000|Overall Study|Protocol Deviation|1|||
19742172|NCT03192176|42188968|FG001|Overall Study|Protocol Deviation|1|||
19742173|NCT03192176|42188969|FG002|Overall Study|Protocol Deviation|0|||
19742174|NCT03192176|42188970|FG003|Overall Study|Protocol Deviation|0|||
19742175|NCT03192176|42188971|FG004|Overall Study|Protocol Deviation|2|||
19742176|NCT03192176|42188972|FG005|Overall Study|Protocol Deviation|0|||
19742177|NCT03192176|42188973|FG006|Overall Study|Protocol Deviation|0|||
19742178|NCT03192176|42188974|FG007|Overall Study|Protocol Deviation|0|||
19742179|NCT03192176|42188967|FG000|Overall Study|Withdrawal by Subject|3|||
19742180|NCT03192176|42188968|FG001|Overall Study|Withdrawal by Subject|4|||
19742181|NCT03192176|42188969|FG002|Overall Study|Withdrawal by Subject|0|||
19742182|NCT03192176|42188970|FG003|Overall Study|Withdrawal by Subject|4|||
19742183|NCT03192176|42188971|FG004|Overall Study|Withdrawal by Subject|3|||
19742184|NCT03192176|42188972|FG005|Overall Study|Withdrawal by Subject|4|||
19742185|NCT03192176|42188973|FG006|Overall Study|Withdrawal by Subject|4|||
19742186|NCT03192176|42188974|FG007|Overall Study|Withdrawal by Subject|2|||
19742187|NCT03192176|42188967|FG000|Overall Study|Miscellaneous|1|||
19742188|NCT03192176|42188968|FG001|Overall Study|Miscellaneous|0|||
19742189|NCT03192176|42188969|FG002|Overall Study|Miscellaneous|1|||
19742190|NCT03192176|42188970|FG003|Overall Study|Miscellaneous|1|||
19742191|NCT03192176|42188971|FG004|Overall Study|Miscellaneous|1|||
19742192|NCT03192176|42188972|FG005|Overall Study|Miscellaneous|2|||
19742193|NCT03192176|42188973|FG006|Overall Study|Miscellaneous|0|||
19742194|NCT03192176|42188974|FG007|Overall Study|Miscellaneous|1|||
19742195|NCT01642004|42188995|FG000|Randomization|Adverse Event unrelated to study drug|1|||
19742196|NCT01642004|42188996|FG001|Randomization|Adverse Event unrelated to study drug|0|||
19742197|NCT01642004|42188995|FG000|Randomization|Participant withdrew consent|1|||
19742198|NCT01642004|42188996|FG001|Randomization|Participant withdrew consent|6|||
19742199|NCT01642004|42188995|FG000|Randomization|No longer meets study criteria|2|||
19742200|NCT01642004|42188996|FG001|Randomization|No longer meets study criteria|2|||
19742201|NCT01642004|42188995|FG000|Treatment|Disease progression|95|||
19742202|NCT01642004|42188996|FG001|Treatment|Disease progression|79|||
19742203|NCT01642004|42188995|FG000|Treatment|Study drug toxicity|10|||
19742204|NCT01642004|42188996|FG001|Treatment|Study drug toxicity|13|||
19742205|NCT01642004|42188995|FG000|Treatment|Death|1|||
19742206|NCT01642004|42188996|FG001|Treatment|Death|1|||
19742207|NCT01642004|42188995|FG000|Treatment|Adverse event unrelated to study drug|9|||
19742208|NCT01642004|42188996|FG001|Treatment|Adverse event unrelated to study drug|13|||
19742209|NCT01642004|42188995|FG000|Treatment|Maximum clinical benefit|1|||
19742210|NCT01642004|42188996|FG001|Treatment|Maximum clinical benefit|9|||
19742211|NCT01642004|42188995|FG000|Treatment|Poor/non-compliance|1|||
19742212|NCT01642004|42188996|FG001|Treatment|Poor/non-compliance|0|||
19742213|NCT01642004|42188995|FG000|Treatment|No longer meets study criteria|1|||
19742214|NCT01642004|42188996|FG001|Treatment|No longer meets study criteria|2|||
19742215|NCT01642004|42188995|FG000|Treatment|Other reasons|2|||
19742216|NCT01642004|42188996|FG001|Treatment|Other reasons|0|||
19742217|NCT01642004|42188995|FG000|Treatment|Not reported|0|||
19742218|NCT01642004|42188996|FG001|Treatment|Not reported|3|||
19742219|NCT01642004|42188995|FG000|Treatment|Participant request to discontinue study treatment|6|||
19742220|NCT01642004|42188996|FG001|Treatment|Participant request to discontinue study treatment|4|||
19742221|NCT01642004|42188995|FG000|Treatment|Participant withdrew consent|5|||
19742222|NCT01642004|42188996|FG001|Treatment|Participant withdrew consent|5|||
19742223|NCT00042289|42189052|FG000|Overall Study|Lost to Follow-up|3|||
19742224|NCT00042289|42189053|FG001|Overall Study|Lost to Follow-up|0|||
19742225|NCT00042289|42189054|FG002|Overall Study|Lost to Follow-up|0|||
19742226|NCT00042289|42189055|FG003|Overall Study|Lost to Follow-up|1|||
19742227|NCT00042289|42189056|FG004|Overall Study|Lost to Follow-up|3|||
19742228|NCT00042289|42189057|FG005|Overall Study|Lost to Follow-up|3|||
19742229|NCT00042289|42189058|FG006|Overall Study|Lost to Follow-up|6|||
19742230|NCT00042289|42189059|FG007|Overall Study|Lost to Follow-up|1|||
19742231|NCT00042289|42189060|FG008|Overall Study|Lost to Follow-up|1|||
19742232|NCT00042289|42189061|FG009|Overall Study|Lost to Follow-up|0|||
19742233|NCT00042289|42189062|FG010|Overall Study|Lost to Follow-up|0|||
19742234|NCT00042289|42189063|FG011|Overall Study|Lost to Follow-up|0|||
19742235|NCT00042289|42189064|FG012|Overall Study|Lost to Follow-up|0|||
19742236|NCT00042289|42189065|FG013|Overall Study|Lost to Follow-up|0|||
19742237|NCT00042289|42189066|FG014|Overall Study|Lost to Follow-up|0|||
19742238|NCT00042289|42189067|FG015|Overall Study|Lost to Follow-up|1|||
19742239|NCT00042289|42189068|FG016|Overall Study|Lost to Follow-up|1|||
19742240|NCT00042289|42189069|FG017|Overall Study|Lost to Follow-up|0|||
19742241|NCT00042289|42189070|FG018|Overall Study|Lost to Follow-up|3|||
19742242|NCT00042289|42189071|FG019|Overall Study|Lost to Follow-up|2|||
19742243|NCT00042289|42189072|FG020|Overall Study|Lost to Follow-up|0|||
19742244|NCT00042289|42189073|FG021|Overall Study|Lost to Follow-up|0|||
19742245|NCT00042289|42189074|FG022|Overall Study|Lost to Follow-up|0|||
19742246|NCT00042289|42189075|FG023|Overall Study|Lost to Follow-up|0|||
19742247|NCT00042289|42189076|FG024|Overall Study|Lost to Follow-up|0|||
19742248|NCT00042289|42189077|FG025|Overall Study|Lost to Follow-up|0|||
19742249|NCT00042289|42189078|FG026|Overall Study|Lost to Follow-up|2|||
19742250|NCT00042289|42189079|FG027|Overall Study|Lost to Follow-up|2|||
19742251|NCT00042289|42189080|FG028|Overall Study|Lost to Follow-up|2|||
19742252|NCT00042289|42189081|FG029|Overall Study|Lost to Follow-up|0|||
19742253|NCT00042289|42189082|FG030|Overall Study|Lost to Follow-up|0|||
19742254|NCT00042289|42189083|FG031|Overall Study|Lost to Follow-up|2|||
19742255|NCT00042289|42189084|FG032|Overall Study|Lost to Follow-up|1|||
19742256|NCT00042289|42189085|FG033|Overall Study|Lost to Follow-up|1|||
19742257|NCT00042289|42189086|FG034|Overall Study|Lost to Follow-up|1|||
19742258|NCT00042289|42189087|FG035|Overall Study|Lost to Follow-up|2|||
19742259|NCT00042289|42189088|FG036|Overall Study|Lost to Follow-up|1|||
19742260|NCT00042289|42189089|FG037|Overall Study|Lost to Follow-up|1|||
19742261|NCT00042289|42189090|FG038|Overall Study|Lost to Follow-up|0|||
19742262|NCT00042289|42189091|FG039|Overall Study|Lost to Follow-up|5|||
19742263|NCT00042289|42189092|FG040|Overall Study|Lost to Follow-up|0|||
19742264|NCT00042289|42189093|FG041|Overall Study|Lost to Follow-up|2|||
19742265|NCT00042289|42189094|FG042|Overall Study|Lost to Follow-up|2|||
19742266|NCT00042289|42189095|FG043|Overall Study|Lost to Follow-up|0|||
19742267|NCT00042289|42189096|FG044|Overall Study|Lost to Follow-up|0|||
19742268|NCT00042289|42189097|FG045|Overall Study|Lost to Follow-up|1|||
19742269|NCT00042289|42189098|FG046|Overall Study|Lost to Follow-up|0|||
19742270|NCT00042289|42189052|FG000|Overall Study|Other reason|0|||
19742271|NCT00042289|42189053|FG001|Overall Study|Other reason|0|||
19742272|NCT00042289|42189054|FG002|Overall Study|Other reason|0|||
19742273|NCT00042289|42189055|FG003|Overall Study|Other reason|2|||
19742274|NCT00042289|42189056|FG004|Overall Study|Other reason|0|||
19742275|NCT00042289|42189057|FG005|Overall Study|Other reason|0|||
19742276|NCT00042289|42189058|FG006|Overall Study|Other reason|0|||
19742277|NCT00042289|42189059|FG007|Overall Study|Other reason|0|||
19742278|NCT00042289|42189060|FG008|Overall Study|Other reason|0|||
19742279|NCT00042289|42189061|FG009|Overall Study|Other reason|0|||
19742280|NCT00042289|42189062|FG010|Overall Study|Other reason|0|||
19742281|NCT00042289|42189063|FG011|Overall Study|Other reason|0|||
19742282|NCT00042289|42189064|FG012|Overall Study|Other reason|0|||
19742283|NCT00042289|42189065|FG013|Overall Study|Other reason|0|||
19742284|NCT00042289|42189066|FG014|Overall Study|Other reason|0|||
19742285|NCT00042289|42189067|FG015|Overall Study|Other reason|0|||
19742286|NCT00042289|42189068|FG016|Overall Study|Other reason|0|||
19742287|NCT00042289|42189069|FG017|Overall Study|Other reason|0|||
19742288|NCT00042289|42189070|FG018|Overall Study|Other reason|1|||
19742289|NCT00042289|42189071|FG019|Overall Study|Other reason|0|||
19742290|NCT00042289|42189072|FG020|Overall Study|Other reason|0|||
19742291|NCT00042289|42189073|FG021|Overall Study|Other reason|0|||
19742292|NCT00042289|42189074|FG022|Overall Study|Other reason|0|||
19742293|NCT00042289|42189075|FG023|Overall Study|Other reason|1|||
19742294|NCT00042289|42189076|FG024|Overall Study|Other reason|0|||
19742295|NCT00042289|42189077|FG025|Overall Study|Other reason|0|||
19742296|NCT00042289|42189078|FG026|Overall Study|Other reason|1|||
19742297|NCT00042289|42189079|FG027|Overall Study|Other reason|0|||
19742298|NCT00042289|42189080|FG028|Overall Study|Other reason|3|||
19742299|NCT00042289|42189081|FG029|Overall Study|Other reason|0|||
19742300|NCT00042289|42189082|FG030|Overall Study|Other reason|0|||
19742301|NCT00042289|42189083|FG031|Overall Study|Other reason|1|||
19742302|NCT00042289|42189084|FG032|Overall Study|Other reason|0|||
19742303|NCT00042289|42189085|FG033|Overall Study|Other reason|1|||
19742304|NCT00042289|42189086|FG034|Overall Study|Other reason|0|||
19742305|NCT00042289|42189087|FG035|Overall Study|Other reason|2|||
19742306|NCT00042289|42189088|FG036|Overall Study|Other reason|0|||
19742307|NCT00042289|42189089|FG037|Overall Study|Other reason|0|||
19742308|NCT00042289|42189090|FG038|Overall Study|Other reason|0|||
19742309|NCT00042289|42189091|FG039|Overall Study|Other reason|0|||
19742310|NCT00042289|42189092|FG040|Overall Study|Other reason|0|||
19742311|NCT00042289|42189093|FG041|Overall Study|Other reason|0|||
19742312|NCT00042289|42189094|FG042|Overall Study|Other reason|0|||
19742313|NCT00042289|42189095|FG043|Overall Study|Other reason|1|||
19742314|NCT00042289|42189096|FG044|Overall Study|Other reason|0|||
19742315|NCT00042289|42189097|FG045|Overall Study|Other reason|0|||
19742316|NCT00042289|42189098|FG046|Overall Study|Other reason|0|||
19742317|NCT00042289|42189052|FG000|Overall Study|Severe debilitation, unable to continue|0|||
19742318|NCT00042289|42189053|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19742319|NCT00042289|42189054|FG002|Overall Study|Severe debilitation, unable to continue|0|||
19742320|NCT00042289|42189055|FG003|Overall Study|Severe debilitation, unable to continue|0|||
19742321|NCT00042289|42189056|FG004|Overall Study|Severe debilitation, unable to continue|0|||
19742322|NCT00042289|42189057|FG005|Overall Study|Severe debilitation, unable to continue|0|||
19742323|NCT00042289|42189058|FG006|Overall Study|Severe debilitation, unable to continue|0|||
19742324|NCT00042289|42189059|FG007|Overall Study|Severe debilitation, unable to continue|0|||
19742325|NCT00042289|42189060|FG008|Overall Study|Severe debilitation, unable to continue|0|||
19742326|NCT00042289|42189061|FG009|Overall Study|Severe debilitation, unable to continue|0|||
19742327|NCT00042289|42189062|FG010|Overall Study|Severe debilitation, unable to continue|0|||
19742328|NCT00042289|42189063|FG011|Overall Study|Severe debilitation, unable to continue|0|||
19742329|NCT00042289|42189064|FG012|Overall Study|Severe debilitation, unable to continue|0|||
19742330|NCT00042289|42189065|FG013|Overall Study|Severe debilitation, unable to continue|0|||
19742331|NCT00042289|42189066|FG014|Overall Study|Severe debilitation, unable to continue|0|||
19742332|NCT00042289|42189067|FG015|Overall Study|Severe debilitation, unable to continue|0|||
19742333|NCT00042289|42189068|FG016|Overall Study|Severe debilitation, unable to continue|0|||
19742334|NCT00042289|42189069|FG017|Overall Study|Severe debilitation, unable to continue|0|||
19742335|NCT00042289|42189070|FG018|Overall Study|Severe debilitation, unable to continue|0|||
19742336|NCT00042289|42189071|FG019|Overall Study|Severe debilitation, unable to continue|0|||
19742337|NCT00042289|42189072|FG020|Overall Study|Severe debilitation, unable to continue|0|||
19742338|NCT00042289|42189073|FG021|Overall Study|Severe debilitation, unable to continue|1|||
19742339|NCT00042289|42189074|FG022|Overall Study|Severe debilitation, unable to continue|0|||
19742340|NCT00042289|42189075|FG023|Overall Study|Severe debilitation, unable to continue|1|||
19742341|NCT00042289|42189076|FG024|Overall Study|Severe debilitation, unable to continue|0|||
19742342|NCT00042289|42189077|FG025|Overall Study|Severe debilitation, unable to continue|0|||
19742343|NCT00042289|42189078|FG026|Overall Study|Severe debilitation, unable to continue|0|||
19742344|NCT00042289|42189079|FG027|Overall Study|Severe debilitation, unable to continue|1|||
19742345|NCT00042289|42189080|FG028|Overall Study|Severe debilitation, unable to continue|0|||
19742346|NCT00042289|42189081|FG029|Overall Study|Severe debilitation, unable to continue|0|||
19742347|NCT00042289|42189082|FG030|Overall Study|Severe debilitation, unable to continue|0|||
19742348|NCT00042289|42189083|FG031|Overall Study|Severe debilitation, unable to continue|1|||
19742349|NCT00042289|42189084|FG032|Overall Study|Severe debilitation, unable to continue|1|||
19742350|NCT00042289|42189085|FG033|Overall Study|Severe debilitation, unable to continue|0|||
19742351|NCT00042289|42189086|FG034|Overall Study|Severe debilitation, unable to continue|0|||
19742352|NCT00042289|42189087|FG035|Overall Study|Severe debilitation, unable to continue|0|||
19742353|NCT00042289|42189088|FG036|Overall Study|Severe debilitation, unable to continue|0|||
19742354|NCT00042289|42189089|FG037|Overall Study|Severe debilitation, unable to continue|0|||
19742355|NCT00042289|42189090|FG038|Overall Study|Severe debilitation, unable to continue|0|||
19742356|NCT00042289|42189091|FG039|Overall Study|Severe debilitation, unable to continue|0|||
19742357|NCT00042289|42189092|FG040|Overall Study|Severe debilitation, unable to continue|0|||
19742358|NCT00042289|42189093|FG041|Overall Study|Severe debilitation, unable to continue|0|||
19742359|NCT00042289|42189094|FG042|Overall Study|Severe debilitation, unable to continue|0|||
19742360|NCT00042289|42189095|FG043|Overall Study|Severe debilitation, unable to continue|0|||
19742361|NCT00042289|42189096|FG044|Overall Study|Severe debilitation, unable to continue|0|||
19742362|NCT00042289|42189097|FG045|Overall Study|Severe debilitation, unable to continue|0|||
19742363|NCT00042289|42189098|FG046|Overall Study|Severe debilitation, unable to continue|0|||
19565696|NCT01218126|42013626|FG001|Overall Study|Adverse Event|10|||
19565697|NCT01218126|42013627|FG002|Overall Study|Adverse Event|12|||
19565698|NCT01218126|42013628|FG003|Overall Study|Adverse Event|16|||
19565699|NCT01218126|42013625|FG000|Overall Study|Lack of Efficacy|7|||
19742364|NCT00042289|42189052|FG000|Overall Study|Site closed|0|||
19742365|NCT00042289|42189053|FG001|Overall Study|Site closed|0|||
19742366|NCT00042289|42189054|FG002|Overall Study|Site closed|0|||
19742367|NCT00042289|42189055|FG003|Overall Study|Site closed|0|||
19742368|NCT00042289|42189056|FG004|Overall Study|Site closed|0|||
19742369|NCT00042289|42189057|FG005|Overall Study|Site closed|0|||
19742370|NCT00042289|42189058|FG006|Overall Study|Site closed|0|||
19742371|NCT00042289|42189059|FG007|Overall Study|Site closed|0|||
19742372|NCT00042289|42189060|FG008|Overall Study|Site closed|0|||
19742373|NCT00042289|42189061|FG009|Overall Study|Site closed|0|||
19742374|NCT00042289|42189062|FG010|Overall Study|Site closed|0|||
19742375|NCT00042289|42189063|FG011|Overall Study|Site closed|0|||
19742376|NCT00042289|42189064|FG012|Overall Study|Site closed|0|||
19742377|NCT00042289|42189065|FG013|Overall Study|Site closed|0|||
19742378|NCT00042289|42189066|FG014|Overall Study|Site closed|0|||
19742379|NCT00042289|42189067|FG015|Overall Study|Site closed|0|||
19742380|NCT00042289|42189068|FG016|Overall Study|Site closed|0|||
19742381|NCT00042289|42189069|FG017|Overall Study|Site closed|0|||
19476849|NCT01552915|41754943|FG002|Overall Study|Lack of Efficacy|4|||
19565700|NCT01218126|42013626|FG001|Overall Study|Lack of Efficacy|2|||
19742382|NCT00042289|42189070|FG018|Overall Study|Site closed|0|||
19742383|NCT00042289|42189071|FG019|Overall Study|Site closed|0|||
19742384|NCT00042289|42189072|FG020|Overall Study|Site closed|0|||
19742385|NCT00042289|42189073|FG021|Overall Study|Site closed|0|||
19742386|NCT00042289|42189074|FG022|Overall Study|Site closed|0|||
19742387|NCT00042289|42189075|FG023|Overall Study|Site closed|0|||
19742388|NCT00042289|42189076|FG024|Overall Study|Site closed|0|||
19742389|NCT00042289|42189077|FG025|Overall Study|Site closed|0|||
19742390|NCT00042289|42189078|FG026|Overall Study|Site closed|0|||
19742391|NCT00042289|42189079|FG027|Overall Study|Site closed|0|||
19742392|NCT00042289|42189080|FG028|Overall Study|Site closed|0|||
19742393|NCT00042289|42189081|FG029|Overall Study|Site closed|0|||
19742394|NCT00042289|42189082|FG030|Overall Study|Site closed|0|||
19742395|NCT00042289|42189083|FG031|Overall Study|Site closed|3|||
19742396|NCT00042289|42189084|FG032|Overall Study|Site closed|0|||
19742397|NCT00042289|42189085|FG033|Overall Study|Site closed|0|||
19742398|NCT00042289|42189086|FG034|Overall Study|Site closed|0|||
19742399|NCT00042289|42189087|FG035|Overall Study|Site closed|0|||
19742400|NCT00042289|42189088|FG036|Overall Study|Site closed|1|||
19742401|NCT00042289|42189089|FG037|Overall Study|Site closed|0|||
19742402|NCT00042289|42189090|FG038|Overall Study|Site closed|0|||
19742403|NCT00042289|42189091|FG039|Overall Study|Site closed|0|||
19742404|NCT00042289|42189092|FG040|Overall Study|Site closed|0|||
19742405|NCT00042289|42189093|FG041|Overall Study|Site closed|0|||
19742406|NCT00042289|42189094|FG042|Overall Study|Site closed|1|||
19742407|NCT00042289|42189095|FG043|Overall Study|Site closed|0|||
19742408|NCT00042289|42189096|FG044|Overall Study|Site closed|0|||
19742409|NCT00042289|42189097|FG045|Overall Study|Site closed|0|||
19742410|NCT00042289|42189098|FG046|Overall Study|Site closed|0|||
19742411|NCT00042289|42189052|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
19742412|NCT00042289|42189053|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
19742413|NCT00042289|42189054|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
19742414|NCT00042289|42189055|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
19742415|NCT00042289|42189056|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
19742416|NCT00042289|42189057|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
19742417|NCT00042289|42189058|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
19742418|NCT00042289|42189059|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
19742419|NCT00042289|42189060|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
19742420|NCT00042289|42189061|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
19742421|NCT00042289|42189062|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
19742422|NCT00042289|42189063|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
19742423|NCT00042289|42189064|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
19742424|NCT00042289|42189065|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
19742425|NCT00042289|42189066|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
19742426|NCT00042289|42189067|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
19742427|NCT00042289|42189068|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
19742428|NCT00042289|42189069|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
19742429|NCT00042289|42189070|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
19742430|NCT00042289|42189071|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
19742431|NCT00042289|42189072|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
19742432|NCT00042289|42189073|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
19742433|NCT00042289|42189074|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
19742434|NCT00042289|42189075|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
19742435|NCT00042289|42189076|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
19742436|NCT00042289|42189077|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
19742437|NCT00042289|42189078|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
19742438|NCT00042289|42189079|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
19742439|NCT00042289|42189080|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
19742440|NCT00042289|42189081|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
19742441|NCT00042289|42189082|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
19742442|NCT00042289|42189083|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
19742443|NCT00042289|42189084|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
19742444|NCT00042289|42189085|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
19742445|NCT00042289|42189086|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
19742446|NCT00042289|42189087|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
19742447|NCT00042289|42189088|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
19742448|NCT00042289|42189089|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
19742449|NCT00042289|42189090|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
19742450|NCT00042289|42189091|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
19476850|NCT01552915|41754941|FG000|Overall Study|Other|2|||
19742451|NCT00042289|42189092|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
19742452|NCT00042289|42189093|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
19742453|NCT00042289|42189094|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
19742454|NCT00042289|42189095|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
19742455|NCT00042289|42189096|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
19742456|NCT00042289|42189097|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
19565701|NCT01218126|42013627|FG002|Overall Study|Lack of Efficacy|2|||
19565702|NCT01218126|42013628|FG003|Overall Study|Lack of Efficacy|6|||
19565703|NCT01218126|42013625|FG000|Overall Study|Protocol Violation|5|||
19565704|NCT01218126|42013626|FG001|Overall Study|Protocol Violation|2|||
19565705|NCT01218126|42013627|FG002|Overall Study|Protocol Violation|2|||
19565706|NCT01218126|42013628|FG003|Overall Study|Protocol Violation|3|||
19565707|NCT01218126|42013625|FG000|Overall Study|Protocol-defined stopping criteria|1|||
19565708|NCT01218126|42013626|FG001|Overall Study|Protocol-defined stopping criteria|1|||
19565709|NCT01218126|42013627|FG002|Overall Study|Protocol-defined stopping criteria|0|||
19565710|NCT01218126|42013628|FG003|Overall Study|Protocol-defined stopping criteria|0|||
19565711|NCT01218126|42013625|FG000|Overall Study|Lost to Follow-up|0|||
19565712|NCT01218126|42013626|FG001|Overall Study|Lost to Follow-up|0|||
19565713|NCT01218126|42013627|FG002|Overall Study|Lost to Follow-up|0|||
19565714|NCT01218126|42013628|FG003|Overall Study|Lost to Follow-up|2|||
19565715|NCT01218126|42013625|FG000|Overall Study|Physician Decision|1|||
19565716|NCT01218126|42013626|FG001|Overall Study|Physician Decision|2|||
19565717|NCT01218126|42013627|FG002|Overall Study|Physician Decision|4|||
19565718|NCT01218126|42013628|FG003|Overall Study|Physician Decision|2|||
19565719|NCT01218126|42013625|FG000|Overall Study|Withdrawal by Subject|2|||
19565720|NCT01218126|42013626|FG001|Overall Study|Withdrawal by Subject|5|||
19565721|NCT01218126|42013627|FG002|Overall Study|Withdrawal by Subject|4|||
19565722|NCT01218126|42013628|FG003|Overall Study|Withdrawal by Subject|6|||
19565723|NCT01217892|42013642|FG000|Overall Study|Adverse Event|1|||
19565724|NCT01217892|42013643|FG001|Overall Study|Adverse Event|1|||
19565725|NCT01217892|42013644|FG002|Overall Study|Adverse Event|1|||
19565726|NCT01217892|42013645|FG003|Overall Study|Adverse Event|0|||
19565727|NCT01217892|42013642|FG000|Overall Study|Withdrawal by Subject|0|||
19565728|NCT01217892|42013643|FG001|Overall Study|Withdrawal by Subject|2|||
19565729|NCT01217892|42013644|FG002|Overall Study|Withdrawal by Subject|1|||
19565730|NCT01217892|42013645|FG003|Overall Study|Withdrawal by Subject|0|||
19565731|NCT01217892|42013642|FG000|Overall Study|Lab value|1|||
19565732|NCT01217892|42013643|FG001|Overall Study|Lab value|0|||
19565733|NCT01217892|42013644|FG002|Overall Study|Lab value|1|||
19565734|NCT01217892|42013645|FG003|Overall Study|Lab value|0|||
19565735|NCT01217892|42013642|FG000|Overall Study|Subject no longer meets study criteria|5|||
19565736|NCT01217892|42013643|FG001|Overall Study|Subject no longer meets study criteria|2|||
19565737|NCT01217892|42013644|FG002|Overall Study|Subject no longer meets study criteria|4|||
19565738|NCT01217892|42013645|FG003|Overall Study|Subject no longer meets study criteria|8|||
19565739|NCT01217892|42013642|FG000|Overall Study|Incorrect enrollment|0|||
19565740|NCT01217892|42013643|FG001|Overall Study|Incorrect enrollment|1|||
19565741|NCT01217892|42013644|FG002|Overall Study|Incorrect enrollment|1|||
19565742|NCT01217892|42013645|FG003|Overall Study|Incorrect enrollment|0|||
19565743|NCT01217892|42013642|FG000|Overall Study|Poor/Non-Compliance|0|||
19565744|NCT01217892|42013643|FG001|Overall Study|Poor/Non-Compliance|0|||
19565745|NCT01217892|42013644|FG002|Overall Study|Poor/Non-Compliance|1|||
19565746|NCT01217892|42013645|FG003|Overall Study|Poor/Non-Compliance|0|||
19565747|NCT01217814|42013658|FG000|Overall Study|Adverse Event|1|||
19565748|NCT01217814|42013659|FG001|Overall Study|Adverse Event|1|||
19565749|NCT01217814|42013660|FG002|Overall Study|Adverse Event|0|||
19565750|NCT01217814|42013658|FG000|Overall Study|Lack of Efficacy|0|||
19565751|NCT01217814|42013659|FG001|Overall Study|Lack of Efficacy|0|||
19565752|NCT01217814|42013660|FG002|Overall Study|Lack of Efficacy|1|||
19565753|NCT01217190|42013671|FG000|Second Dosing|Withdrawal by Subject|0|||
19565754|NCT01217190|42013672|FG001|Second Dosing|Withdrawal by Subject|2|||
19565755|NCT01136733|42013688|FG000|Phase 1b|Adverse Event|0|||
19565756|NCT01136733|42013689|FG001|Phase 1b|Adverse Event|3|||
19565757|NCT01136733|42013690|FG002|Phase 1b|Adverse Event|1|||
19565758|NCT01136733|42013691|FG003|Phase 1b|Adverse Event|0|||
19565759|NCT01136733|42013692|FG004|Phase 1b|Adverse Event|0|||
19565760|NCT01136733|42013693|FG005|Phase 1b|Adverse Event|0|||
19565761|NCT01136733|42013694|FG006|Phase 1b|Adverse Event|0|||
19565762|NCT01136733|42013688|FG000|Phase 1b|Participant Choice|0|||
19565763|NCT01136733|42013689|FG001|Phase 1b|Participant Choice|0|||
19565764|NCT01136733|42013690|FG002|Phase 1b|Participant Choice|1|||
19565765|NCT01136733|42013691|FG003|Phase 1b|Participant Choice|0|||
19565766|NCT01136733|42013692|FG004|Phase 1b|Participant Choice|0|||
19565767|NCT01136733|42013693|FG005|Phase 1b|Participant Choice|0|||
19565768|NCT01136733|42013694|FG006|Phase 1b|Participant Choice|0|||
19565769|NCT01136733|42013688|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
19565770|NCT01136733|42013689|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
19565771|NCT01136733|42013690|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
19742457|NCT00042289|42189098|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
19742458|NCT00042289|42189052|FG000|Overall Study|Protocol Violation|0|||
19742459|NCT00042289|42189053|FG001|Overall Study|Protocol Violation|0|||
19742460|NCT00042289|42189054|FG002|Overall Study|Protocol Violation|0|||
19742461|NCT00042289|42189055|FG003|Overall Study|Protocol Violation|0|||
19742462|NCT00042289|42189056|FG004|Overall Study|Protocol Violation|0|||
19742463|NCT00042289|42189057|FG005|Overall Study|Protocol Violation|1|||
19742464|NCT00042289|42189058|FG006|Overall Study|Protocol Violation|0|||
19742465|NCT00042289|42189059|FG007|Overall Study|Protocol Violation|1|||
19742466|NCT00042289|42189060|FG008|Overall Study|Protocol Violation|0|||
19742467|NCT00042289|42189061|FG009|Overall Study|Protocol Violation|0|||
19742468|NCT00042289|42189062|FG010|Overall Study|Protocol Violation|0|||
19742469|NCT00042289|42189063|FG011|Overall Study|Protocol Violation|0|||
19742470|NCT00042289|42189064|FG012|Overall Study|Protocol Violation|0|||
19742471|NCT00042289|42189065|FG013|Overall Study|Protocol Violation|0|||
19742472|NCT00042289|42189066|FG014|Overall Study|Protocol Violation|0|||
19742473|NCT00042289|42189067|FG015|Overall Study|Protocol Violation|0|||
19742474|NCT00042289|42189068|FG016|Overall Study|Protocol Violation|0|||
19742475|NCT00042289|42189069|FG017|Overall Study|Protocol Violation|0|||
19742476|NCT00042289|42189070|FG018|Overall Study|Protocol Violation|0|||
19742477|NCT00042289|42189071|FG019|Overall Study|Protocol Violation|0|||
19742478|NCT00042289|42189072|FG020|Overall Study|Protocol Violation|0|||
19742479|NCT00042289|42189073|FG021|Overall Study|Protocol Violation|0|||
19742480|NCT00042289|42189074|FG022|Overall Study|Protocol Violation|0|||
19742481|NCT00042289|42189075|FG023|Overall Study|Protocol Violation|1|||
19742482|NCT00042289|42189076|FG024|Overall Study|Protocol Violation|1|||
19742483|NCT00042289|42189077|FG025|Overall Study|Protocol Violation|0|||
19742484|NCT00042289|42189078|FG026|Overall Study|Protocol Violation|2|||
19742485|NCT00042289|42189079|FG027|Overall Study|Protocol Violation|0|||
19742486|NCT00042289|42189080|FG028|Overall Study|Protocol Violation|0|||
19742487|NCT00042289|42189081|FG029|Overall Study|Protocol Violation|0|||
19742488|NCT00042289|42189082|FG030|Overall Study|Protocol Violation|1|||
19742489|NCT00042289|42189083|FG031|Overall Study|Protocol Violation|0|||
19742490|NCT00042289|42189084|FG032|Overall Study|Protocol Violation|0|||
19742491|NCT00042289|42189085|FG033|Overall Study|Protocol Violation|0|||
19742492|NCT00042289|42189086|FG034|Overall Study|Protocol Violation|0|||
19742493|NCT00042289|42189087|FG035|Overall Study|Protocol Violation|0|||
19742494|NCT00042289|42189088|FG036|Overall Study|Protocol Violation|0|||
19742495|NCT00042289|42189089|FG037|Overall Study|Protocol Violation|0|||
19742496|NCT00042289|42189090|FG038|Overall Study|Protocol Violation|0|||
19742497|NCT00042289|42189091|FG039|Overall Study|Protocol Violation|0|||
19742498|NCT00042289|42189092|FG040|Overall Study|Protocol Violation|0|||
19742499|NCT00042289|42189093|FG041|Overall Study|Protocol Violation|1|||
19742500|NCT00042289|42189094|FG042|Overall Study|Protocol Violation|1|||
19742501|NCT00042289|42189095|FG043|Overall Study|Protocol Violation|1|||
19742502|NCT00042289|42189096|FG044|Overall Study|Protocol Violation|0|||
19742503|NCT00042289|42189097|FG045|Overall Study|Protocol Violation|0|||
19742504|NCT00042289|42189098|FG046|Overall Study|Protocol Violation|0|||
19742505|NCT00042289|42189052|FG000|Overall Study|Withdrawal by Subject|4|||
19742506|NCT00042289|42189053|FG001|Overall Study|Withdrawal by Subject|1|||
19742507|NCT00042289|42189054|FG002|Overall Study|Withdrawal by Subject|0|||
19742508|NCT00042289|42189055|FG003|Overall Study|Withdrawal by Subject|2|||
19742509|NCT00042289|42189056|FG004|Overall Study|Withdrawal by Subject|0|||
19742510|NCT00042289|42189057|FG005|Overall Study|Withdrawal by Subject|2|||
19742511|NCT00042289|42189058|FG006|Overall Study|Withdrawal by Subject|0|||
19742512|NCT00042289|42189059|FG007|Overall Study|Withdrawal by Subject|0|||
19742513|NCT00042289|42189060|FG008|Overall Study|Withdrawal by Subject|0|||
19742514|NCT00042289|42189061|FG009|Overall Study|Withdrawal by Subject|1|||
19742515|NCT00042289|42189062|FG010|Overall Study|Withdrawal by Subject|0|||
19742516|NCT00042289|42189063|FG011|Overall Study|Withdrawal by Subject|0|||
19742517|NCT00042289|42189064|FG012|Overall Study|Withdrawal by Subject|2|||
19742518|NCT00042289|42189065|FG013|Overall Study|Withdrawal by Subject|0|||
19742519|NCT00042289|42189066|FG014|Overall Study|Withdrawal by Subject|0|||
19742520|NCT00042289|42189067|FG015|Overall Study|Withdrawal by Subject|0|||
19742521|NCT00042289|42189068|FG016|Overall Study|Withdrawal by Subject|0|||
19742522|NCT00042289|42189069|FG017|Overall Study|Withdrawal by Subject|0|||
19742523|NCT00042289|42189070|FG018|Overall Study|Withdrawal by Subject|0|||
19742524|NCT00042289|42189071|FG019|Overall Study|Withdrawal by Subject|0|||
19742525|NCT00042289|42189072|FG020|Overall Study|Withdrawal by Subject|0|||
19742526|NCT00042289|42189073|FG021|Overall Study|Withdrawal by Subject|1|||
19742527|NCT00042289|42189074|FG022|Overall Study|Withdrawal by Subject|1|||
19742528|NCT00042289|42189075|FG023|Overall Study|Withdrawal by Subject|1|||
19742529|NCT00042289|42189076|FG024|Overall Study|Withdrawal by Subject|0|||
19742530|NCT00042289|42189077|FG025|Overall Study|Withdrawal by Subject|0|||
19742531|NCT00042289|42189078|FG026|Overall Study|Withdrawal by Subject|1|||
19742532|NCT00042289|42189079|FG027|Overall Study|Withdrawal by Subject|0|||
19742533|NCT00042289|42189080|FG028|Overall Study|Withdrawal by Subject|2|||
19742534|NCT00042289|42189081|FG029|Overall Study|Withdrawal by Subject|0|||
19742535|NCT00042289|42189082|FG030|Overall Study|Withdrawal by Subject|0|||
19742536|NCT00042289|42189083|FG031|Overall Study|Withdrawal by Subject|1|||
19742537|NCT00042289|42189084|FG032|Overall Study|Withdrawal by Subject|2|||
19742538|NCT00042289|42189085|FG033|Overall Study|Withdrawal by Subject|1|||
19742539|NCT00042289|42189086|FG034|Overall Study|Withdrawal by Subject|0|||
19742540|NCT00042289|42189087|FG035|Overall Study|Withdrawal by Subject|0|||
19742541|NCT00042289|42189088|FG036|Overall Study|Withdrawal by Subject|0|||
19742542|NCT00042289|42189089|FG037|Overall Study|Withdrawal by Subject|1|||
19742543|NCT00042289|42189090|FG038|Overall Study|Withdrawal by Subject|0|||
19742544|NCT00042289|42189091|FG039|Overall Study|Withdrawal by Subject|0|||
19742545|NCT00042289|42189092|FG040|Overall Study|Withdrawal by Subject|0|||
19742546|NCT00042289|42189093|FG041|Overall Study|Withdrawal by Subject|0|||
19742547|NCT00042289|42189094|FG042|Overall Study|Withdrawal by Subject|1|||
19742548|NCT00042289|42189095|FG043|Overall Study|Withdrawal by Subject|0|||
19742549|NCT00042289|42189096|FG044|Overall Study|Withdrawal by Subject|0|||
19742550|NCT00042289|42189097|FG045|Overall Study|Withdrawal by Subject|0|||
19742551|NCT00042289|42189098|FG046|Overall Study|Withdrawal by Subject|0|||
19742552|NCT02886728|42189270|FG000|Overall Study|Withdrew Consent|31|||
19742553|NCT02886728|42189271|FG001|Overall Study|Withdrew Consent|13|||
19742554|NCT02886728|42189272|FG002|Overall Study|Withdrew Consent|11|||
19742555|NCT02886728|42189273|FG003|Overall Study|Withdrew Consent|47|||
19742556|NCT02886728|42189270|FG000|Overall Study|Lost to Follow-up|12|||
19742557|NCT02886728|42189271|FG001|Overall Study|Lost to Follow-up|6|||
19742558|NCT02886728|42189272|FG002|Overall Study|Lost to Follow-up|13|||
19742559|NCT02886728|42189273|FG003|Overall Study|Lost to Follow-up|12|||
19742560|NCT02886728|42189270|FG000|Overall Study|Adverse Event|13|||
19742561|NCT02886728|42189271|FG001|Overall Study|Adverse Event|5|||
19742562|NCT02886728|42189272|FG002|Overall Study|Adverse Event|5|||
19742563|NCT02886728|42189273|FG003|Overall Study|Adverse Event|11|||
19742564|NCT02886728|42189270|FG000|Overall Study|Investigator's Discretion|11|||
19742565|NCT02886728|42189271|FG001|Overall Study|Investigator's Discretion|7|||
19742566|NCT02886728|42189272|FG002|Overall Study|Investigator's Discretion|5|||
19742567|NCT02886728|42189273|FG003|Overall Study|Investigator's Discretion|11|||
19742568|NCT02886728|42189270|FG000|Overall Study|Death|3|||
19742569|NCT02886728|42189271|FG001|Overall Study|Death|1|||
19742570|NCT02886728|42189272|FG002|Overall Study|Death|0|||
19742571|NCT02886728|42189273|FG003|Overall Study|Death|0|||
19742572|NCT02886728|42189270|FG000|Overall Study|Protocol Violation|0|||
19742573|NCT02886728|42189271|FG001|Overall Study|Protocol Violation|0|||
19742574|NCT02886728|42189272|FG002|Overall Study|Protocol Violation|0|||
19742575|NCT02886728|42189273|FG003|Overall Study|Protocol Violation|4|||
19742576|NCT02886728|42189270|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19742577|NCT02886728|42189271|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19742578|NCT02886728|42189272|FG002|Overall Study|Non-Compliance with Study Drug|1|||
19742579|NCT02886728|42189273|FG003|Overall Study|Non-Compliance with Study Drug|0|||
19742580|NCT02886728|42189270|FG000|Overall Study|Pregnancy|0|||
19742581|NCT02886728|42189271|FG001|Overall Study|Pregnancy|0|||
19742582|NCT02886728|42189272|FG002|Overall Study|Pregnancy|1|||
19742583|NCT02886728|42189273|FG003|Overall Study|Pregnancy|0|||
19742584|NCT02886728|42189270|FG000|Overall Study|Randomized but Not Dosed|1|||
19742585|NCT02886728|42189271|FG001|Overall Study|Randomized but Not Dosed|0|||
19742586|NCT02886728|42189272|FG002|Overall Study|Randomized but Not Dosed|0|||
19742587|NCT02886728|42189273|FG003|Overall Study|Randomized but Not Dosed|2|||
19742588|NCT00039871|42189283|FG000|Overall Study|Adverse Event|165|||
19742589|NCT00039871|42189283|FG000|Overall Study|Lost to Follow-up|18|||
19742590|NCT00039871|42189283|FG000|Overall Study|Protocol Violation|24|||
19742591|NCT00039871|42189283|FG000|Overall Study|Withdrawal by Subject|97|||
19742592|NCT00039871|42189283|FG000|Overall Study|Did not meet eligibility criteria|11|||
19742593|NCT00039871|42189283|FG000|Overall Study|Administrative|1|||
19742594|NCT00039871|42189283|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
19742595|NCT00039871|42189283|FG000|Overall Study|Never entered follow-up|7|||
19742596|NCT00015457|42189287|FG000|First Intervention|Adverse Event|0|||
19742597|NCT00015457|42189288|FG001|First Intervention|Adverse Event|2|||
19742598|NCT00015457|42189287|FG000|First Intervention|Lack of Efficacy|0|||
19742599|NCT00015457|42189288|FG001|First Intervention|Lack of Efficacy|1|||
19742600|NCT00015457|42189287|FG000|Second Intervention|Withdrawal by Subject|1|||
19742601|NCT00015457|42189288|FG001|Second Intervention|Withdrawal by Subject|0|||
19742602|NCT03191630|42189301|FG000|Overall Study|Lost to Follow-up|7|||
19742603|NCT03191630|42189302|FG001|Overall Study|Lost to Follow-up|7|||
19742604|NCT03191552|42189313|FG000|Overall Study|Lost to Follow-up|1|||
19742605|NCT03191552|42189314|FG001|Overall Study|Lost to Follow-up|0|||
19742606|NCT03191552|42189315|FG002|Overall Study|Lost to Follow-up|0|||
19742607|NCT03191552|42189313|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
19742608|NCT03191552|42189314|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
19742609|NCT03191552|42189315|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
19742610|NCT03191396|42189329|FG000|Overall Study|Lost to Follow-up|0|||
19742611|NCT03191396|42189330|FG001|Overall Study|Lost to Follow-up|3|||
19742612|NCT03191396|42189329|FG000|Overall Study|Withdrawal by Subject|3|||
19742613|NCT03191396|42189330|FG001|Overall Study|Withdrawal by Subject|2|||
19742614|NCT00007345|42189338|FG000|Overall Study|Refused further treatment|0|||
19742615|NCT00007345|42189339|FG001|Overall Study|Refused further treatment|7|||
19742616|NCT00007345|42189338|FG000|Overall Study|Switched to alternative treatment|0|||
19742617|NCT00007345|42189339|FG001|Overall Study|Switched to alternative treatment|3|||
19742618|NCT00007345|42189338|FG000|Overall Study|Intercurrent illness|1|||
19742619|NCT00007345|42189339|FG001|Overall Study|Intercurrent illness|0|||
19742620|NCT00007345|42189338|FG000|Overall Study|Death on study|1|||
19742621|NCT00007345|42189339|FG001|Overall Study|Death on study|1|||
19742622|NCT03405662|42189347|FG000|Overall Study|COVID-19 restriction|1|||
19742623|NCT03405662|42189348|FG001|Overall Study|COVID-19 restriction|0|||
19742624|NCT03405662|42189347|FG000|Overall Study|unblinding|0|||
19742625|NCT03405662|42189348|FG001|Overall Study|unblinding|1|||
19742626|NCT03405662|42189347|FG000|Overall Study|placement in memory care facility|0|||
19742627|NCT03405662|42189348|FG001|Overall Study|placement in memory care facility|2|||
19742628|NCT00031447|42189356|FG000|Overall Study|Lost to Follow-up|0|||
19742629|NCT00031447|42189357|FG001|Overall Study|Lost to Follow-up|1|||
19742630|NCT00031447|42189356|FG000|Overall Study|Non-compliant|1|||
19742631|NCT00031447|42189357|FG001|Overall Study|Non-compliant|1|||
19742632|NCT00031447|42189356|FG000|Overall Study|Re-activation of Disease|2|||
19742633|NCT00031447|42189357|FG001|Overall Study|Re-activation of Disease|1|||
19742634|NCT00031447|42189356|FG000|Overall Study|Disruption of blinded study drug supply|7|||
19742635|NCT00031447|42189357|FG001|Overall Study|Disruption of blinded study drug supply|4|||
19742636|NCT00006721|42189366|FG000|Overall Study|Adverse Event|0|||
19742637|NCT00006721|42189367|FG001|Overall Study|Adverse Event|4|||
19742638|NCT00006721|42189368|FG002|Overall Study|Adverse Event|4|||
19742639|NCT00006721|42189366|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
19742640|NCT00006721|42189367|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
19742641|NCT00006721|42189368|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
19742642|NCT00006721|42189366|FG000|Overall Study|Progression/Relapse|0|||
19742643|NCT00006721|42189367|FG001|Overall Study|Progression/Relapse|1|||
19742644|NCT00006721|42189368|FG002|Overall Study|Progression/Relapse|2|||
19742645|NCT00006721|42189366|FG000|Overall Study|Death|0|||
19742646|NCT00006721|42189367|FG001|Overall Study|Death|1|||
19742647|NCT00006721|42189368|FG002|Overall Study|Death|2|||
19742648|NCT00006721|42189366|FG000|Overall Study|Other - Not Protocol Specified|0|||
19742649|NCT00006721|42189367|FG001|Overall Study|Other - Not Protocol Specified|7|||
19742650|NCT00006721|42189368|FG002|Overall Study|Other - Not Protocol Specified|7|||
19742651|NCT00006721|42189366|FG000|Overall Study|Ineligible|2|||
19742652|NCT00006721|42189367|FG001|Overall Study|Ineligible|12|||
19742653|NCT00006721|42189368|FG002|Overall Study|Ineligible|10|||
19742654|NCT00006721|42189366|FG000|Overall Study|Eligible but no Treatment Received|1|||
19742655|NCT00006721|42189367|FG001|Overall Study|Eligible but no Treatment Received|0|||
19742656|NCT00006721|42189368|FG002|Overall Study|Eligible but no Treatment Received|0|||
19742657|NCT00006409|42189384|FG000|Baseline|Protocol Violation|48|||
19742658|NCT00006409|42189385|FG001|Baseline|Protocol Violation|70|||
19742659|NCT00006409|42189386|FG002|Baseline|Protocol Violation|0|||
19742660|NCT00006409|42189387|FG003|Baseline|Protocol Violation|0|||
19742661|NCT00006409|42189388|FG004|Baseline|Protocol Violation|0|||
19742662|NCT00006409|42189389|FG005|Baseline|Protocol Violation|0|||
19742663|NCT00006409|42189384|FG000|Post-2 Year Intervention|Protocol Violation|0|||
19742664|NCT00006409|42189385|FG001|Post-2 Year Intervention|Protocol Violation|0|||
19742665|NCT00006409|42189386|FG002|Post-2 Year Intervention|Protocol Violation|251|||
19742666|NCT00006409|42189387|FG003|Post-2 Year Intervention|Protocol Violation|168|||
19742667|NCT00006409|42189388|FG004|Post-2 Year Intervention|Protocol Violation|0|||
19742668|NCT00006409|42189389|FG005|Post-2 Year Intervention|Protocol Violation|0|||
19742669|NCT00006409|42189384|FG000|Post-3 Year Intervention|Protocol Violation|0|||
19742670|NCT00006409|42189385|FG001|Post-3 Year Intervention|Protocol Violation|0|||
19742671|NCT00006409|42189386|FG002|Post-3 Year Intervention|Protocol Violation|0|||
19742672|NCT00006409|42189387|FG003|Post-3 Year Intervention|Protocol Violation|0|||
19742673|NCT00006409|42189388|FG004|Post-3 Year Intervention|Protocol Violation|62|||
19742674|NCT00006409|42189389|FG005|Post-3 Year Intervention|Protocol Violation|62|||
19742675|NCT00006289|42189405|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
19742676|NCT00006289|42189406|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
19742677|NCT00006289|42189405|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
19742678|NCT00006289|42189406|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
19742679|NCT00005947|42189424|FG000|Overall Study|Death|54|||
19742680|NCT00005947|42189425|FG001|Overall Study|Death|40|||
19742681|NCT00005947|42189424|FG000|Overall Study|Patient Refused to Continue|2|||
19742682|NCT00005947|42189425|FG001|Overall Study|Patient Refused to Continue|1|||
19742683|NCT00005947|42189424|FG000|Overall Study|Site Closure|1|||
19742684|NCT00005947|42189425|FG001|Overall Study|Site Closure|0|||
19742685|NCT00005047|42189437|FG000|Overall Study|Withdrawal by Subject|12|||
19742686|NCT00005047|42189438|FG001|Overall Study|Withdrawal by Subject|0|||
19742687|NCT00005047|42189439|FG002|Overall Study|Withdrawal by Subject|0|||
19742688|NCT00005047|42189440|FG003|Overall Study|Withdrawal by Subject|0|||
19742689|NCT00005047|42189437|FG000|Overall Study|Adverse Event|5|||
19742690|NCT00005047|42189438|FG001|Overall Study|Adverse Event|0|||
19742691|NCT00005047|42189439|FG002|Overall Study|Adverse Event|0|||
19742692|NCT00005047|42189440|FG003|Overall Study|Adverse Event|0|||
19742693|NCT00005047|42189437|FG000|Overall Study|Lost to Follow-up|1|||
19742694|NCT00005047|42189438|FG001|Overall Study|Lost to Follow-up|0|||
19742695|NCT00005047|42189439|FG002|Overall Study|Lost to Follow-up|0|||
19742696|NCT00005047|42189440|FG003|Overall Study|Lost to Follow-up|0|||
19742697|NCT00005047|42189437|FG000|Overall Study|Lack of Efficacy|1|||
19742698|NCT00005047|42189438|FG001|Overall Study|Lack of Efficacy|0|||
19742699|NCT00005047|42189439|FG002|Overall Study|Lack of Efficacy|0|||
19742700|NCT00005047|42189440|FG003|Overall Study|Lack of Efficacy|0|||
19742701|NCT00003907|42189452|FG000|Overall Study|Adverse Event|2|||
19742702|NCT00003907|42189453|FG001|Overall Study|Adverse Event|11|||
19742703|NCT00003907|42189452|FG000|Overall Study|Death|2|||
19742704|NCT00003907|42189453|FG001|Overall Study|Death|0|||
19742705|NCT00003907|42189452|FG000|Overall Study|Withdrawal by Subject|1|||
19742706|NCT00003907|42189453|FG001|Overall Study|Withdrawal by Subject|3|||
19742707|NCT00003907|42189452|FG000|Overall Study|Progressive disease|4|||
19742708|NCT00003907|42189453|FG001|Overall Study|Progressive disease|4|||
19742709|NCT00003907|42189452|FG000|Overall Study|Complicating disease|1|||
19742710|NCT00003907|42189453|FG001|Overall Study|Complicating disease|0|||
19742711|NCT00003907|42189452|FG000|Overall Study|Other|1|||
19742712|NCT00003907|42189453|FG001|Overall Study|Other|3|||
19742713|NCT00003907|42189452|FG000|Overall Study|ineligible or not treated|2|||
19742714|NCT00003907|42189453|FG001|Overall Study|ineligible or not treated|2|||
19742715|NCT00003901|42189459|FG000|Overall Study|Adverse Event|1|||
19742716|NCT00003901|42189459|FG000|Overall Study|Withdrawal by Subject|1|||
19742717|NCT00003901|42189459|FG000|Overall Study|Ineligible|6|||
19742718|NCT00003901|42189459|FG000|Overall Study|CT Scan not within protocol requirement|2|||
19742719|NCT00003901|42189459|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
19565772|NCT01136733|42013691|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
19742720|NCT00003901|42189459|FG000|Overall Study|Medical problems|6|||
19742721|NCT00003895|42189468|FG000|Overall Study|Adverse Event|4|||
19742722|NCT00003895|42189469|FG001|Overall Study|Adverse Event|0|||
19742723|NCT00003895|42189468|FG000|Overall Study|Lack of Efficacy|1|||
19742724|NCT00003895|42189469|FG001|Overall Study|Lack of Efficacy|1|||
19742725|NCT00003895|42189468|FG000|Overall Study|Patient Vacation|2|||
19742726|NCT00003895|42189469|FG001|Overall Study|Patient Vacation|0|||
19742727|NCT00003895|42189468|FG000|Overall Study|Withdrawal by Subject|0|||
19742728|NCT00003895|42189469|FG001|Overall Study|Withdrawal by Subject|3|||
19742729|NCT03800173|42189480|FG000|Overall Study|Lost to Follow-up|0|||
19742730|NCT03800173|42189481|FG001|Overall Study|Lost to Follow-up|0|||
19742731|NCT03800173|42189482|FG002|Overall Study|Lost to Follow-up|0|||
19742732|NCT03800173|42189483|FG003|Overall Study|Lost to Follow-up|0|||
19742733|NCT03800173|42189484|FG004|Overall Study|Lost to Follow-up|1|||
19742734|NCT00003631|42189503|FG000|Overall Study|Patient not treated|1|||
19742735|NCT00003631|42189504|FG001|Overall Study|Patient not treated|0|||
19742736|NCT00003631|42189505|FG002|Overall Study|Patient not treated|1|||
19742737|NCT00003631|42189503|FG000|Overall Study|Protocol Violation|1|||
19742738|NCT00003631|42189504|FG001|Overall Study|Protocol Violation|0|||
19742739|NCT00003631|42189505|FG002|Overall Study|Protocol Violation|0|||
19742740|NCT00003631|42189503|FG000|Overall Study|Adverse Event|1|||
19742741|NCT00003631|42189504|FG001|Overall Study|Adverse Event|1|||
19742742|NCT00003631|42189505|FG002|Overall Study|Adverse Event|5|||
19742743|NCT00003631|42189503|FG000|Overall Study|Death|0|||
19565773|NCT01136733|42013692|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
19565774|NCT01136733|42013693|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
19565775|NCT01136733|42013694|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
19565776|NCT01136733|42013688|FG000|Phase 1b|Clinical Progression|1|||
19565777|NCT01136733|42013689|FG001|Phase 1b|Clinical Progression|1|||
19565778|NCT01136733|42013690|FG002|Phase 1b|Clinical Progression|0|||
19565779|NCT01136733|42013691|FG003|Phase 1b|Clinical Progression|0|||
19565780|NCT01136733|42013692|FG004|Phase 1b|Clinical Progression|0|||
19565781|NCT01136733|42013693|FG005|Phase 1b|Clinical Progression|0|||
19565782|NCT01136733|42013694|FG006|Phase 1b|Clinical Progression|0|||
19565783|NCT01136733|42013688|FG000|Phase 2|Disease Progression|0|||
19565784|NCT01136733|42013689|FG001|Phase 2|Disease Progression|0|||
19565785|NCT01136733|42013690|FG002|Phase 2|Disease Progression|0|||
19565786|NCT01136733|42013691|FG003|Phase 2|Disease Progression|0|||
19565787|NCT01136733|42013692|FG004|Phase 2|Disease Progression|30|||
19565788|NCT01136733|42013693|FG005|Phase 2|Disease Progression|32|||
19565789|NCT01136733|42013694|FG006|Phase 2|Disease Progression|38|||
19565790|NCT01136733|42013688|FG000|Phase 2|Adverse Event|0|||
19565791|NCT01136733|42013689|FG001|Phase 2|Adverse Event|0|||
19565792|NCT01136733|42013690|FG002|Phase 2|Adverse Event|0|||
19565793|NCT01136733|42013691|FG003|Phase 2|Adverse Event|0|||
19565794|NCT01136733|42013692|FG004|Phase 2|Adverse Event|11|||
19565795|NCT01136733|42013693|FG005|Phase 2|Adverse Event|13|||
19565796|NCT01136733|42013694|FG006|Phase 2|Adverse Event|5|||
19565797|NCT01136733|42013688|FG000|Phase 2|Participant Choice|0|||
19565798|NCT01136733|42013689|FG001|Phase 2|Participant Choice|0|||
19565799|NCT01136733|42013690|FG002|Phase 2|Participant Choice|0|||
19565800|NCT01136733|42013691|FG003|Phase 2|Participant Choice|0|||
19565801|NCT01136733|42013692|FG004|Phase 2|Participant Choice|3|||
19565802|NCT01136733|42013693|FG005|Phase 2|Participant Choice|0|||
19565803|NCT01136733|42013694|FG006|Phase 2|Participant Choice|1|||
19565804|NCT01136733|42013688|FG000|Phase 2|Administrative-Withdrew Consent|0|||
19565805|NCT01136733|42013689|FG001|Phase 2|Administrative-Withdrew Consent|0|||
19565806|NCT01136733|42013690|FG002|Phase 2|Administrative-Withdrew Consent|0|||
19565807|NCT01136733|42013691|FG003|Phase 2|Administrative-Withdrew Consent|0|||
19565808|NCT01136733|42013692|FG004|Phase 2|Administrative-Withdrew Consent|1|||
19565809|NCT01136733|42013693|FG005|Phase 2|Administrative-Withdrew Consent|0|||
19565810|NCT01136733|42013694|FG006|Phase 2|Administrative-Withdrew Consent|0|||
19565811|NCT01136733|42013688|FG000|Phase 2|Other|0|||
19565812|NCT01136733|42013689|FG001|Phase 2|Other|0|||
19565813|NCT01136733|42013690|FG002|Phase 2|Other|0|||
19565814|NCT01136733|42013691|FG003|Phase 2|Other|0|||
19565815|NCT01136733|42013692|FG004|Phase 2|Other|6|||
19565816|NCT01136733|42013693|FG005|Phase 2|Other|7|||
19565817|NCT01136733|42013694|FG006|Phase 2|Other|6|||
19742744|NCT00003631|42189504|FG001|Overall Study|Death|0|||
19742745|NCT00003631|42189505|FG002|Overall Study|Death|1|||
19742746|NCT00003631|42189503|FG000|Overall Study|Evaluable for toxicity only|0|||
19565818|NCT01136655|42013724|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
19565819|NCT01136655|42013724|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
19565820|NCT01136655|42013724|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
19742747|NCT00003631|42189504|FG001|Overall Study|Evaluable for toxicity only|0|||
19742748|NCT00003631|42189505|FG002|Overall Study|Evaluable for toxicity only|2|||
19742749|NCT00003535|42189513|FG000|Overall Study|Not evaluable|5|||
19742750|NCT00003511|42189517|FG000|Overall Study|Not evaluable|4|||
19742751|NCT00003499|42189521|FG000|Overall Study|Not evaluable|8|||
19742752|NCT00003487|42189525|FG000|Overall Study|Not evaluable|2|||
19742753|NCT00003475|42189529|FG000|Overall Study|Not evaluable|13|||
19742754|NCT00003457|42189534|FG000|Overall Study|Not evaluable|9|||
19742755|NCT00030901|42189540|FG000|Initial Registration|Ineligible|167|||
19742756|NCT00030901|42189541|FG001|Initial Registration|Ineligible|0|||
19742757|NCT00030901|42189542|FG002|Initial Registration|Ineligible|0|||
19742758|NCT00030901|42189540|FG000|Randomization|Adverse Event|0|||
19742759|NCT00030901|42189541|FG001|Randomization|Adverse Event|11|||
19742760|NCT00030901|42189542|FG002|Randomization|Adverse Event|7|||
19742761|NCT00030901|42189540|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
19742762|NCT00030901|42189541|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
19742763|NCT00030901|42189542|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
19742764|NCT00030901|42189540|FG000|Randomization|Progression/Relapse|0|||
19742765|NCT00030901|42189541|FG001|Randomization|Progression/Relapse|22|||
19742766|NCT00030901|42189542|FG002|Randomization|Progression/Relapse|21|||
19742767|NCT00030901|42189540|FG000|Randomization|Death|0|||
19742768|NCT00030901|42189541|FG001|Randomization|Death|1|||
19742769|NCT00030901|42189542|FG002|Randomization|Death|3|||
19742770|NCT00030901|42189540|FG000|Randomization|Other|0|||
19742771|NCT00030901|42189541|FG001|Randomization|Other|36|||
19742772|NCT00030901|42189542|FG002|Randomization|Other|33|||
19742773|NCT00030901|42189540|FG000|Randomization|Ineligible|0|||
19742774|NCT00030901|42189541|FG001|Randomization|Ineligible|15|||
19742775|NCT00030901|42189542|FG002|Randomization|Ineligible|14|||
19742776|NCT00003199|42189548|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
19742777|NCT00003199|42189548|FG000|Overall Study|Lack of insurance clearance|2|||
19742778|NCT00003199|42189548|FG000|Overall Study|Screen fail|15|||
19742779|NCT00030823|42189552|FG000|Overall Study|Withdrawal by Subject|1|||
19742780|NCT00001849|42189556|FG000|Overall Study|Death|4|||
19742781|NCT00001849|42189556|FG000|Overall Study|Lost to Follow-up|2|||
19742782|NCT00001849|42189556|FG000|Overall Study|Withdrawal by Subject|2|||
19742783|NCT00001849|42189556|FG000|Overall Study|tumor remained occult|6|||
19742784|NCT01342952|42189573|FG000|Overall Study|Adverse Event|0|||
19742785|NCT01342952|42189574|FG001|Overall Study|Adverse Event|5|||
19742786|NCT01342952|42189575|FG002|Overall Study|Adverse Event|1|||
19742787|NCT01342952|42189576|FG003|Overall Study|Adverse Event|0|||
19742788|NCT01342952|42189573|FG000|Overall Study|Lost to Follow-up|0|||
19742789|NCT01342952|42189574|FG001|Overall Study|Lost to Follow-up|2|||
19742790|NCT01342952|42189575|FG002|Overall Study|Lost to Follow-up|0|||
19742791|NCT01342952|42189576|FG003|Overall Study|Lost to Follow-up|0|||
19742792|NCT01342952|42189573|FG000|Overall Study|Withdrawal by Subject|1|||
19742793|NCT01342952|42189574|FG001|Overall Study|Withdrawal by Subject|1|||
19742794|NCT01342952|42189575|FG002|Overall Study|Withdrawal by Subject|0|||
19742795|NCT01342952|42189576|FG003|Overall Study|Withdrawal by Subject|0|||
19742796|NCT01342952|42189573|FG000|Overall Study|Physician Decision|3|||
19742797|NCT01342952|42189574|FG001|Overall Study|Physician Decision|3|||
19742798|NCT01342952|42189575|FG002|Overall Study|Physician Decision|1|||
19742799|NCT01342952|42189576|FG003|Overall Study|Physician Decision|0|||
19742800|NCT02886884|42189603|FG000|Follow-up|Withdrawal by Subject|0|||
19742801|NCT02886884|42189604|FG001|Follow-up|Withdrawal by Subject|0|||
19742802|NCT02886884|42189605|FG002|Follow-up|Withdrawal by Subject|0|||
19742803|NCT02886884|42189606|FG003|Follow-up|Withdrawal by Subject|1|||
19742804|NCT01240694|42189625|FG000|Overall Study|Adverse Event|9|||
19742805|NCT01240694|42189625|FG000|Overall Study|Lack of Efficacy|6|||
19742806|NCT01240694|42189625|FG000|Overall Study|Withdrawal by Subject|6|||
19565821|NCT01136655|42013724|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
19565822|NCT01135017|42013739|FG000|Overall Study|Adverse Event|3|||
19565823|NCT01135017|42013740|FG001|Overall Study|Adverse Event|8|||
19565824|NCT01135017|42013739|FG000|Overall Study|Other than above|3|||
19565825|NCT01135017|42013740|FG001|Overall Study|Other than above|4|||
19565826|NCT01134939|42013754|FG000|Overall Study|Adverse Event|9|||
19565827|NCT01134939|42013755|FG001|Overall Study|Adverse Event|3|||
19565828|NCT01134939|42013756|FG002|Overall Study|Adverse Event|4|||
19565829|NCT01134939|42013757|FG003|Overall Study|Adverse Event|5|||
19565830|NCT01134939|42013758|FG004|Overall Study|Adverse Event|5|||
19565831|NCT01134939|42013759|FG005|Overall Study|Adverse Event|5|||
19565832|NCT01134939|42013760|FG006|Overall Study|Adverse Event|1|||
19565833|NCT01134939|42013761|FG007|Overall Study|Adverse Event|0|||
19565834|NCT01134939|42013754|FG000|Overall Study|Lack of Efficacy|2|||
19565835|NCT01134939|42013755|FG001|Overall Study|Lack of Efficacy|5|||
19565836|NCT01134939|42013756|FG002|Overall Study|Lack of Efficacy|1|||
19565837|NCT01134939|42013757|FG003|Overall Study|Lack of Efficacy|0|||
19565838|NCT01134939|42013758|FG004|Overall Study|Lack of Efficacy|3|||
19565839|NCT01134939|42013759|FG005|Overall Study|Lack of Efficacy|0|||
19565840|NCT01134939|42013760|FG006|Overall Study|Lack of Efficacy|1|||
19565841|NCT01134939|42013761|FG007|Overall Study|Lack of Efficacy|0|||
19565842|NCT01134939|42013754|FG000|Overall Study|Lost to Follow-up|2|||
19565843|NCT01134939|42013755|FG001|Overall Study|Lost to Follow-up|3|||
19565844|NCT01134939|42013756|FG002|Overall Study|Lost to Follow-up|0|||
19565845|NCT01134939|42013757|FG003|Overall Study|Lost to Follow-up|1|||
19565846|NCT01134939|42013758|FG004|Overall Study|Lost to Follow-up|2|||
19565847|NCT01134939|42013759|FG005|Overall Study|Lost to Follow-up|1|||
19565848|NCT01134939|42013760|FG006|Overall Study|Lost to Follow-up|0|||
19565849|NCT01134939|42013761|FG007|Overall Study|Lost to Follow-up|0|||
19565850|NCT01134939|42013754|FG000|Overall Study|Death|0|||
19565851|NCT01134939|42013755|FG001|Overall Study|Death|1|||
19565852|NCT01134939|42013756|FG002|Overall Study|Death|0|||
19565853|NCT01134939|42013757|FG003|Overall Study|Death|0|||
19565854|NCT01134939|42013758|FG004|Overall Study|Death|0|||
19565855|NCT01134939|42013759|FG005|Overall Study|Death|0|||
19565856|NCT01134939|42013760|FG006|Overall Study|Death|0|||
19565857|NCT01134939|42013761|FG007|Overall Study|Death|0|||
19565858|NCT01134939|42013754|FG000|Overall Study|Termination page not available|4|||
19565859|NCT01134939|42013755|FG001|Overall Study|Termination page not available|6|||
19565860|NCT01134939|42013756|FG002|Overall Study|Termination page not available|5|||
19565861|NCT01134939|42013757|FG003|Overall Study|Termination page not available|8|||
19565862|NCT01134939|42013758|FG004|Overall Study|Termination page not available|0|||
19565863|NCT01134939|42013759|FG005|Overall Study|Termination page not available|3|||
19565864|NCT01134939|42013760|FG006|Overall Study|Termination page not available|7|||
19565865|NCT01134939|42013761|FG007|Overall Study|Termination page not available|0|||
19565866|NCT01134783|42013777|FG000|Overall Study|Pregnancy|16|||
19565867|NCT01134783|42013778|FG001|Overall Study|Pregnancy|8|||
19565868|NCT01134783|42013777|FG000|Overall Study|Withdrawal by Subject|15|||
19742807|NCT01240694|42189625|FG000|Overall Study|Protocol Violation|2|||
19742808|NCT01240694|42189625|FG000|Overall Study|Lost to Follow-up|2|||
19742809|NCT01240694|42189625|FG000|Overall Study|Other than specified|3|||
19742810|NCT01240694|42189625|FG000|Overall Study|Withdrawn due to early study termination|107|||
19742811|NCT01112306|42189629|FG000|Overall Study|Death|175|||
19742812|NCT01112306|42189629|FG000|Overall Study|Lost to Follow-up|9|||
19742813|NCT01112306|42189629|FG000|Overall Study|Withdrawal by Subject|31|||
19742814|NCT01112306|42189629|FG000|Overall Study|Other|70|||
19742815|NCT03162224|42189636|FG000|Overall Study|Death|4|||
19742816|NCT03162224|42189637|FG001|Overall Study|Death|5|||
19742817|NCT03162224|42189638|FG002|Overall Study|Death|8|||
19742818|NCT03162224|42189636|FG000|Overall Study|Withdrawal by Subject|1|||
19742819|NCT03162224|42189637|FG001|Overall Study|Withdrawal by Subject|0|||
19742820|NCT03162224|42189638|FG002|Overall Study|Withdrawal by Subject|1|||
19742821|NCT03162224|42189636|FG000|Overall Study|Lost to Follow-up|0|||
19742822|NCT03162224|42189637|FG001|Overall Study|Lost to Follow-up|1|||
19742823|NCT03162224|42189638|FG002|Overall Study|Lost to Follow-up|0|||
19742824|NCT03162224|42189636|FG000|Overall Study|Other|6|||
19742825|NCT03162224|42189637|FG001|Overall Study|Other|2|||
19742826|NCT03162224|42189638|FG002|Overall Study|Other|1|||
19742827|NCT02886338|42189677|FG000|Overall Study|Withdrawal by Subject|1|||
19742828|NCT00004124|42189683|FG000|Overall Study|Received no protocol therapy|12|||
19742829|NCT00004124|42189684|FG001|Overall Study|Received no protocol therapy|20|||
19742830|NCT00383552|42189694|FG000|Overall Study|Adverse Event|7|||
19742831|NCT00383552|42189695|FG001|Overall Study|Adverse Event|6|||
19742832|NCT00383552|42189696|FG002|Overall Study|Adverse Event|9|||
19742833|NCT00383552|42189697|FG003|Overall Study|Adverse Event|6|||
19742834|NCT00383552|42189694|FG000|Overall Study|Lack of Efficacy|4|||
19742835|NCT00383552|42189695|FG001|Overall Study|Lack of Efficacy|13|||
19742836|NCT00383552|42189696|FG002|Overall Study|Lack of Efficacy|29|||
19742837|NCT00383552|42189697|FG003|Overall Study|Lack of Efficacy|42|||
19742838|NCT00383552|42189694|FG000|Overall Study|Lost to Follow-up|0|||
19742839|NCT00383552|42189695|FG001|Overall Study|Lost to Follow-up|1|||
19742840|NCT00383552|42189696|FG002|Overall Study|Lost to Follow-up|5|||
19742841|NCT00383552|42189697|FG003|Overall Study|Lost to Follow-up|1|||
19742842|NCT00383552|42189694|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
19742843|NCT00383552|42189695|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
19742844|NCT00383552|42189696|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
19742845|NCT00383552|42189697|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
19742846|NCT00383552|42189694|FG000|Overall Study|Did not wish to continue (related)|1|||
19742847|NCT00383552|42189695|FG001|Overall Study|Did not wish to continue (related)|0|||
19742848|NCT00383552|42189696|FG002|Overall Study|Did not wish to continue (related)|2|||
19742849|NCT00383552|42189697|FG003|Overall Study|Did not wish to continue (related)|3|||
19742850|NCT00383552|42189694|FG000|Overall Study|Noncompliance with the protocol|11|||
19742851|NCT00383552|42189695|FG001|Overall Study|Noncompliance with the protocol|6|||
19742852|NCT00383552|42189696|FG002|Overall Study|Noncompliance with the protocol|8|||
19742853|NCT00383552|42189697|FG003|Overall Study|Noncompliance with the protocol|10|||
19742854|NCT00383552|42189694|FG000|Overall Study|Did not meet protocol eligibility|8|||
19742855|NCT00383552|42189695|FG001|Overall Study|Did not meet protocol eligibility|6|||
19742856|NCT00383552|42189696|FG002|Overall Study|Did not meet protocol eligibility|2|||
19565869|NCT01134783|42013778|FG001|Overall Study|Withdrawal by Subject|9|||
19742857|NCT00383552|42189697|FG003|Overall Study|Did not meet protocol eligibility|3|||
19742858|NCT00383552|42189694|FG000|Overall Study|Administrative|1|||
19742859|NCT00383552|42189695|FG001|Overall Study|Administrative|0|||
19742860|NCT00383552|42189696|FG002|Overall Study|Administrative|1|||
19742861|NCT00383552|42189697|FG003|Overall Study|Administrative|1|||
19742862|NCT03158012|42189714|FG000|Overall Study|Withdrawal by Subject|0|||
19742863|NCT03158012|42189715|FG001|Overall Study|Withdrawal by Subject|1|||
19742864|NCT01776424|42189724|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
19742865|NCT01776424|42189725|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
19742866|NCT01776424|42189726|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
19742867|NCT01776424|42189724|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
19742868|NCT01776424|42189725|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
19742869|NCT01776424|42189726|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
19742870|NCT01776424|42189724|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
19742871|NCT01776424|42189725|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
19742872|NCT01776424|42189726|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
19742873|NCT01776424|42189724|FG000|LTOLE Part (Open Label)|Refused|5|||
19742874|NCT01776424|42189725|FG001|LTOLE Part (Open Label)|Refused|2|||
19742875|NCT01776424|42189726|FG002|LTOLE Part (Open Label)|Refused|11|||
19742876|NCT01776424|42189724|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
19742877|NCT01776424|42189725|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
19742878|NCT01776424|42189726|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
19742879|NCT03799627|42189752|FG000|Overall Study|Adverse Event|1|||
19742880|NCT03799627|42189753|FG001|Overall Study|Adverse Event|2|||
19742881|NCT03799627|42189754|FG002|Overall Study|Adverse Event|0|||
19742882|NCT03799627|42189755|FG003|Overall Study|Adverse Event|0|||
19742883|NCT03799627|42189756|FG004|Overall Study|Adverse Event|2|||
19742884|NCT03799627|42189757|FG005|Overall Study|Adverse Event|5|||
19742885|NCT03799627|42189758|FG006|Overall Study|Adverse Event|0|||
19742886|NCT03799627|42189759|FG007|Overall Study|Adverse Event|2|||
19742887|NCT03799627|42189760|FG008|Overall Study|Adverse Event|0|||
19742888|NCT03799627|42189752|FG000|Overall Study|Physician Decision|2|||
19742889|NCT03799627|42189753|FG001|Overall Study|Physician Decision|2|||
19742890|NCT03799627|42189754|FG002|Overall Study|Physician Decision|0|||
19742891|NCT03799627|42189755|FG003|Overall Study|Physician Decision|0|||
19742892|NCT03799627|42189756|FG004|Overall Study|Physician Decision|2|||
19742893|NCT03799627|42189757|FG005|Overall Study|Physician Decision|2|||
19742894|NCT03799627|42189758|FG006|Overall Study|Physician Decision|0|||
19742895|NCT03799627|42189759|FG007|Overall Study|Physician Decision|0|||
19742896|NCT03799627|42189760|FG008|Overall Study|Physician Decision|0|||
19742897|NCT03799627|42189752|FG000|Overall Study|Withdrawal by Subject|1|||
19742898|NCT03799627|42189753|FG001|Overall Study|Withdrawal by Subject|1|||
19742899|NCT03799627|42189754|FG002|Overall Study|Withdrawal by Subject|0|||
19742900|NCT03799627|42189755|FG003|Overall Study|Withdrawal by Subject|2|||
19742901|NCT03799627|42189756|FG004|Overall Study|Withdrawal by Subject|0|||
19742902|NCT03799627|42189757|FG005|Overall Study|Withdrawal by Subject|3|||
19742903|NCT03799627|42189758|FG006|Overall Study|Withdrawal by Subject|0|||
19742904|NCT03799627|42189759|FG007|Overall Study|Withdrawal by Subject|0|||
19742905|NCT03799627|42189760|FG008|Overall Study|Withdrawal by Subject|0|||
19742906|NCT03799627|42189752|FG000|Overall Study|Lack of Efficacy|0|||
19742907|NCT03799627|42189753|FG001|Overall Study|Lack of Efficacy|0|||
19742908|NCT03799627|42189754|FG002|Overall Study|Lack of Efficacy|0|||
19742909|NCT03799627|42189755|FG003|Overall Study|Lack of Efficacy|1|||
19742910|NCT03799627|42189756|FG004|Overall Study|Lack of Efficacy|0|||
19742911|NCT03799627|42189757|FG005|Overall Study|Lack of Efficacy|0|||
19742912|NCT03799627|42189758|FG006|Overall Study|Lack of Efficacy|0|||
19742913|NCT03799627|42189759|FG007|Overall Study|Lack of Efficacy|0|||
19742914|NCT03799627|42189760|FG008|Overall Study|Lack of Efficacy|0|||
19742915|NCT03799627|42189752|FG000|Overall Study|Lost to Follow-up|0|||
19742916|NCT03799627|42189753|FG001|Overall Study|Lost to Follow-up|0|||
19742917|NCT03799627|42189754|FG002|Overall Study|Lost to Follow-up|0|||
19742918|NCT03799627|42189755|FG003|Overall Study|Lost to Follow-up|0|||
19742919|NCT03799627|42189756|FG004|Overall Study|Lost to Follow-up|0|||
19742920|NCT03799627|42189757|FG005|Overall Study|Lost to Follow-up|0|||
19742921|NCT03799627|42189758|FG006|Overall Study|Lost to Follow-up|1|||
19742922|NCT03799627|42189759|FG007|Overall Study|Lost to Follow-up|0|||
19742923|NCT03799627|42189760|FG008|Overall Study|Lost to Follow-up|1|||
19742924|NCT03799627|42189752|FG000|Overall Study|Death|0|||
19742925|NCT03799627|42189753|FG001|Overall Study|Death|0|||
19742926|NCT03799627|42189754|FG002|Overall Study|Death|0|||
19742927|NCT03799627|42189755|FG003|Overall Study|Death|1|||
19742928|NCT03799627|42189756|FG004|Overall Study|Death|0|||
19742929|NCT03799627|42189757|FG005|Overall Study|Death|0|||
19742930|NCT03799627|42189758|FG006|Overall Study|Death|0|||
19742931|NCT03799627|42189759|FG007|Overall Study|Death|0|||
19742932|NCT03799627|42189760|FG008|Overall Study|Death|0|||
19742933|NCT03799627|42189752|FG000|Overall Study|Study Drug Put on Hold|1|||
19742934|NCT03799627|42189753|FG001|Overall Study|Study Drug Put on Hold|0|||
19742935|NCT03799627|42189754|FG002|Overall Study|Study Drug Put on Hold|0|||
19742936|NCT03799627|42189755|FG003|Overall Study|Study Drug Put on Hold|0|||
19742937|NCT03799627|42189756|FG004|Overall Study|Study Drug Put on Hold|0|||
19742938|NCT03799627|42189757|FG005|Overall Study|Study Drug Put on Hold|0|||
19742939|NCT03799627|42189758|FG006|Overall Study|Study Drug Put on Hold|0|||
19742940|NCT03799627|42189759|FG007|Overall Study|Study Drug Put on Hold|0|||
19742941|NCT03799627|42189760|FG008|Overall Study|Study Drug Put on Hold|0|||
19742942|NCT03799627|42189752|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
19742943|NCT03799627|42189753|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
19742944|NCT03799627|42189754|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
19742945|NCT03799627|42189755|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
19742946|NCT03799627|42189756|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
19742947|NCT03799627|42189757|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
19742948|NCT03799627|42189758|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
19742949|NCT03799627|42189759|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
19742950|NCT03799627|42189760|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
19742951|NCT03799627|42189752|FG000|Overall Study|Kidney Transplantation|1|||
19742952|NCT03799627|42189753|FG001|Overall Study|Kidney Transplantation|0|||
19742953|NCT03799627|42189754|FG002|Overall Study|Kidney Transplantation|0|||
19742954|NCT03799627|42189755|FG003|Overall Study|Kidney Transplantation|1|||
19742955|NCT03799627|42189756|FG004|Overall Study|Kidney Transplantation|1|||
19742956|NCT03799627|42189757|FG005|Overall Study|Kidney Transplantation|0|||
19742957|NCT03799627|42189758|FG006|Overall Study|Kidney Transplantation|0|||
19742958|NCT03799627|42189759|FG007|Overall Study|Kidney Transplantation|0|||
19742959|NCT03799627|42189760|FG008|Overall Study|Kidney Transplantation|0|||
19742960|NCT03799627|42189752|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
19742961|NCT03799627|42189753|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
19742962|NCT03799627|42189754|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
19742963|NCT03799627|42189755|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
19742964|NCT03799627|42189756|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
19742965|NCT03799627|42189757|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
19742966|NCT03799627|42189758|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
19742967|NCT03799627|42189759|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
19742968|NCT03799627|42189760|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
19742969|NCT03799627|42189752|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742970|NCT03799627|42189753|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
19742971|NCT03799627|42189754|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742972|NCT03799627|42189755|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742973|NCT03799627|42189756|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742974|NCT03799627|42189757|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742975|NCT03799627|42189758|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742976|NCT03799627|42189759|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742977|NCT03799627|42189760|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
19742978|NCT03799627|42189752|FG000|Overall Study|Met Exclusion Criteria|0|||
19742979|NCT03799627|42189753|FG001|Overall Study|Met Exclusion Criteria|0|||
19742980|NCT03799627|42189754|FG002|Overall Study|Met Exclusion Criteria|0|||
19742981|NCT03799627|42189755|FG003|Overall Study|Met Exclusion Criteria|1|||
19742982|NCT03799627|42189756|FG004|Overall Study|Met Exclusion Criteria|0|||
19742983|NCT03799627|42189757|FG005|Overall Study|Met Exclusion Criteria|0|||
19742984|NCT03799627|42189758|FG006|Overall Study|Met Exclusion Criteria|0|||
19742985|NCT03799627|42189759|FG007|Overall Study|Met Exclusion Criteria|0|||
19742986|NCT03799627|42189760|FG008|Overall Study|Met Exclusion Criteria|0|||
19742987|NCT03799627|42189752|FG000|Overall Study|Investigational Product Noncompliance|0|||
19742988|NCT03799627|42189753|FG001|Overall Study|Investigational Product Noncompliance|0|||
19742989|NCT03799627|42189754|FG002|Overall Study|Investigational Product Noncompliance|0|||
19742990|NCT03799627|42189755|FG003|Overall Study|Investigational Product Noncompliance|1|||
19742991|NCT03799627|42189756|FG004|Overall Study|Investigational Product Noncompliance|0|||
19565870|NCT01134783|42013777|FG000|Overall Study|Lost to Follow-up|5|||
19565871|NCT01134783|42013778|FG001|Overall Study|Lost to Follow-up|20|||
19565872|NCT01134705|42013790|FG000|Overall Study|Adverse Event|1|||
19565873|NCT01134705|42013791|FG001|Overall Study|Adverse Event|7|||
19565874|NCT01134705|42013790|FG000|Overall Study|Withdrawal by Subject|6|||
19565875|NCT01134705|42013791|FG001|Overall Study|Withdrawal by Subject|6|||
19565876|NCT01134705|42013790|FG000|Overall Study|Pregnancy|1|||
19565877|NCT01134705|42013791|FG001|Overall Study|Pregnancy|0|||
19565878|NCT01134705|42013790|FG000|Overall Study|Lost to Follow-up|5|||
19565879|NCT01134705|42013791|FG001|Overall Study|Lost to Follow-up|2|||
19565880|NCT01134705|42013790|FG000|Overall Study|Protocol Violation|1|||
19565881|NCT01134705|42013791|FG001|Overall Study|Protocol Violation|1|||
19565882|NCT01134705|42013790|FG000|Overall Study|Other|1|||
19565883|NCT01134705|42013791|FG001|Overall Study|Other|6|||
19565884|NCT00927823|42013797|FG000|Continuous Dosing Period|Death|0|||
19565885|NCT00927823|42013798|FG001|Continuous Dosing Period|Death|0|||
19565886|NCT00927823|42013799|FG002|Continuous Dosing Period|Death|6|||
19565887|NCT00927823|42013800|FG003|Continuous Dosing Period|Death|0|||
19565888|NCT00927823|42013797|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
19565889|NCT00927823|42013798|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
19565890|NCT00927823|42013799|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
19565891|NCT00927823|42013800|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
19565892|NCT00927823|42013797|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
19565893|NCT00927823|42013798|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
19565894|NCT00927823|42013799|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
19565895|NCT00927823|42013800|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
19565896|NCT00927823|42013797|FG000|Continuous Dosing Period|Other|1|||
19565897|NCT00927823|42013798|FG001|Continuous Dosing Period|Other|2|||
19565898|NCT00927823|42013799|FG002|Continuous Dosing Period|Other|9|||
19565899|NCT00927823|42013800|FG003|Continuous Dosing Period|Other|3|||
19565900|NCT01134627|42013819|FG000|Overall Study|Adverse Event|47|||
19565901|NCT01134627|42013820|FG001|Overall Study|Adverse Event|31|||
19565902|NCT01134627|42013819|FG000|Overall Study|Lost to Follow-up|1|||
19565903|NCT01134627|42013820|FG001|Overall Study|Lost to Follow-up|2|||
19565904|NCT01134627|42013819|FG000|Overall Study|Protocol Violation|3|||
19565905|NCT01134627|42013820|FG001|Overall Study|Protocol Violation|5|||
19565906|NCT01134627|42013819|FG000|Overall Study|Lack of Efficacy|2|||
19565907|NCT01134627|42013820|FG001|Overall Study|Lack of Efficacy|12|||
19565908|NCT01134627|42013819|FG000|Overall Study|Withdrawal by Subject|4|||
19565909|NCT01134627|42013820|FG001|Overall Study|Withdrawal by Subject|3|||
19565910|NCT01134627|42013819|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
19565911|NCT01134627|42013820|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
19565912|NCT01134627|42013819|FG000|Overall Study|Other|11|||
19565913|NCT01134627|42013820|FG001|Overall Study|Other|14|||
19565914|NCT01134393|42013826|FG000|Overall Study|Adverse Event|18|||
19565915|NCT01134393|42013826|FG000|Overall Study|Lack of Efficacy|2|||
19565916|NCT01134393|42013826|FG000|Overall Study|Protocol Violation|12|||
19565917|NCT01134393|42013826|FG000|Overall Study|Lost to Follow-up|3|||
19565918|NCT01134393|42013826|FG000|Overall Study|Withdrawal by Subject|11|||
19565919|NCT01134393|42013826|FG000|Overall Study|Other|6|||
19742992|NCT03799627|42189757|FG005|Overall Study|Investigational Product Noncompliance|0|||
19565920|NCT00922441|42013834|FG000|Overall Study|Protocol Violation|0|||
19565921|NCT00922441|42013835|FG001|Overall Study|Protocol Violation|0|||
19565922|NCT00922441|42013836|FG002|Overall Study|Protocol Violation|2|||
19742993|NCT03799627|42189758|FG006|Overall Study|Investigational Product Noncompliance|0|||
19742994|NCT03799627|42189759|FG007|Overall Study|Investigational Product Noncompliance|0|||
19742995|NCT03799627|42189760|FG008|Overall Study|Investigational Product Noncompliance|0|||
19742996|NCT03799627|42189752|FG000|Overall Study|Participant Relocation|0|||
19742997|NCT03799627|42189753|FG001|Overall Study|Participant Relocation|0|||
19742998|NCT03799627|42189754|FG002|Overall Study|Participant Relocation|0|||
19742999|NCT03799627|42189755|FG003|Overall Study|Participant Relocation|1|||
19743000|NCT03799627|42189756|FG004|Overall Study|Participant Relocation|0|||
19743001|NCT03799627|42189757|FG005|Overall Study|Participant Relocation|1|||
19743002|NCT03799627|42189758|FG006|Overall Study|Participant Relocation|0|||
19743003|NCT03799627|42189759|FG007|Overall Study|Participant Relocation|0|||
19743004|NCT03799627|42189760|FG008|Overall Study|Participant Relocation|0|||
19743005|NCT03799627|42189752|FG000|Overall Study|Eurofin Issue|0|||
19743006|NCT03799627|42189753|FG001|Overall Study|Eurofin Issue|0|||
19743007|NCT03799627|42189754|FG002|Overall Study|Eurofin Issue|0|||
19743008|NCT03799627|42189755|FG003|Overall Study|Eurofin Issue|0|||
19743009|NCT03799627|42189756|FG004|Overall Study|Eurofin Issue|1|||
19743010|NCT03799627|42189757|FG005|Overall Study|Eurofin Issue|0|||
19743011|NCT03799627|42189758|FG006|Overall Study|Eurofin Issue|0|||
19743012|NCT03799627|42189759|FG007|Overall Study|Eurofin Issue|0|||
19743013|NCT03799627|42189760|FG008|Overall Study|Eurofin Issue|0|||
19743014|NCT03799627|42189752|FG000|Overall Study|Noncompliance with Site Instructions|0|||
19743015|NCT03799627|42189753|FG001|Overall Study|Noncompliance with Site Instructions|0|||
19743016|NCT03799627|42189754|FG002|Overall Study|Noncompliance with Site Instructions|0|||
19743017|NCT03799627|42189755|FG003|Overall Study|Noncompliance with Site Instructions|0|||
19743018|NCT03799627|42189756|FG004|Overall Study|Noncompliance with Site Instructions|1|||
19743019|NCT03799627|42189757|FG005|Overall Study|Noncompliance with Site Instructions|0|||
19743020|NCT03799627|42189758|FG006|Overall Study|Noncompliance with Site Instructions|0|||
19743021|NCT03799627|42189759|FG007|Overall Study|Noncompliance with Site Instructions|0|||
19743022|NCT03799627|42189760|FG008|Overall Study|Noncompliance with Site Instructions|0|||
19743023|NCT03799627|42189752|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743024|NCT03799627|42189753|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743025|NCT03799627|42189754|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743026|NCT03799627|42189755|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743027|NCT03799627|42189756|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
19743028|NCT03799627|42189757|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743029|NCT03799627|42189758|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743030|NCT03799627|42189759|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743031|NCT03799627|42189760|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
19743032|NCT03799627|42189752|FG000|Overall Study|Changes In Hemoglobin Values|1|||
19743033|NCT03799627|42189753|FG001|Overall Study|Changes In Hemoglobin Values|2|||
19743034|NCT03799627|42189754|FG002|Overall Study|Changes In Hemoglobin Values|1|||
19743035|NCT03799627|42189755|FG003|Overall Study|Changes In Hemoglobin Values|0|||
19743036|NCT03799627|42189756|FG004|Overall Study|Changes In Hemoglobin Values|0|||
19743037|NCT03799627|42189757|FG005|Overall Study|Changes In Hemoglobin Values|2|||
19743038|NCT03799627|42189758|FG006|Overall Study|Changes In Hemoglobin Values|1|||
19743039|NCT03799627|42189759|FG007|Overall Study|Changes In Hemoglobin Values|0|||
19743040|NCT03799627|42189760|FG008|Overall Study|Changes In Hemoglobin Values|1|||
19743041|NCT00756574|42189801|FG000|Overall Study|Withdrawal by Subject|9|||
19743042|NCT00756574|42189802|FG001|Overall Study|Withdrawal by Subject|7|||
19743043|NCT00756574|42189801|FG000|Overall Study|Lost to Follow-up|4|||
19743044|NCT00756574|42189802|FG001|Overall Study|Lost to Follow-up|4|||
19743045|NCT02743780|42189811|FG000|Part 3 (7 Days)|Adverse Event|0|||
19743046|NCT02743780|42189812|FG001|Part 3 (7 Days)|Adverse Event|0|||
19743047|NCT02743780|42189813|FG002|Part 3 (7 Days)|Adverse Event|1|||
19743048|NCT02743780|42189814|FG003|Part 3 (7 Days)|Adverse Event|0|||
19743049|NCT02743780|42189815|FG004|Part 3 (7 Days)|Adverse Event|0|||
19743050|NCT02880956|42189839|FG000|Overall Study|Adverse Event|3|||
19743051|NCT02880956|42189840|FG001|Overall Study|Adverse Event|6|||
19743052|NCT02880956|42189841|FG002|Overall Study|Adverse Event|5|||
19743053|NCT02880956|42189842|FG003|Overall Study|Adverse Event|4|||
19743054|NCT02880956|42189839|FG000|Overall Study|Withdrawal by Subject|9|||
19743055|NCT02880956|42189840|FG001|Overall Study|Withdrawal by Subject|4|||
19743056|NCT02880956|42189841|FG002|Overall Study|Withdrawal by Subject|6|||
19565923|NCT00922441|42013834|FG000|Overall Study|Withdrawal by Subject|0|||
19565924|NCT00922441|42013835|FG001|Overall Study|Withdrawal by Subject|0|||
19565925|NCT00922441|42013836|FG002|Overall Study|Withdrawal by Subject|1|||
19565926|NCT01217112|42013849|FG000|Overall Study|Adverse Event|0|||
19565927|NCT01217112|42013850|FG001|Overall Study|Adverse Event|2|||
19565928|NCT01217112|42013851|FG002|Overall Study|Adverse Event|0|||
19565929|NCT01217112|42013852|FG003|Overall Study|Adverse Event|2|||
19565930|NCT01217112|42013853|FG004|Overall Study|Adverse Event|0|||
19565931|NCT01217112|42013849|FG000|Overall Study|Withdrawal by Subject|0|||
19565932|NCT01217112|42013850|FG001|Overall Study|Withdrawal by Subject|0|||
19565933|NCT01217112|42013851|FG002|Overall Study|Withdrawal by Subject|1|||
19565934|NCT01217112|42013852|FG003|Overall Study|Withdrawal by Subject|0|||
19565935|NCT01217112|42013853|FG004|Overall Study|Withdrawal by Subject|0|||
19565936|NCT01217112|42013849|FG000|Overall Study|Physician Decision|0|||
19565937|NCT01217112|42013850|FG001|Overall Study|Physician Decision|0|||
19565938|NCT01217112|42013851|FG002|Overall Study|Physician Decision|0|||
19565939|NCT01217112|42013852|FG003|Overall Study|Physician Decision|0|||
19565940|NCT01217112|42013853|FG004|Overall Study|Physician Decision|1|||
19565941|NCT01216332|42013867|FG000|Overall Study|Withdrawal by Subject|4|||
19565942|NCT01216332|42013868|FG001|Overall Study|Withdrawal by Subject|0|||
19565943|NCT00922207|42013877|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
19565944|NCT00922207|42013878|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
19565945|NCT00922207|42013879|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
19565946|NCT00922207|42013877|FG000|Overall Study|Insufficient Therapeutic Response|0|||
19565947|NCT00922207|42013878|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19565948|NCT00922207|42013879|FG002|Overall Study|Insufficient Therapeutic Response|1|||
19565949|NCT00922207|42013877|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
19565950|NCT00922207|42013878|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19565951|NCT00922207|42013879|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
19565952|NCT00922207|42013877|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
19565953|NCT00922207|42013878|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
19565954|NCT00922207|42013879|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
19565955|NCT00922207|42013877|FG000|Overall Study|Withdrew Consent|2|||
19565956|NCT00922207|42013878|FG001|Overall Study|Withdrew Consent|5|||
19565957|NCT00922207|42013879|FG002|Overall Study|Withdrew Consent|2|||
19565958|NCT00922207|42013877|FG000|Overall Study|Abnormality of Laboratory Test|0|||
19565959|NCT00922207|42013878|FG001|Overall Study|Abnormality of Laboratory Test|1|||
19565960|NCT00922207|42013879|FG002|Overall Study|Abnormality of Laboratory Test|1|||
19565961|NCT01134315|42013889|FG000|Overall Study|Adverse Event|1|||
19565962|NCT01134315|42013890|FG001|Overall Study|Adverse Event|2|||
19565963|NCT01134315|42013889|FG000|Overall Study|Other Reason|8|||
19565964|NCT01134315|42013890|FG001|Overall Study|Other Reason|17|||
19565965|NCT01216176|42013899|FG000|Overall Study|Adverse Event|0|||
19565966|NCT01216176|42013900|FG001|Overall Study|Adverse Event|8|||
19565967|NCT01216176|42013901|FG002|Overall Study|Adverse Event|0|||
19565968|NCT01216176|42013899|FG000|Overall Study|Physician Decision|0|||
19565969|NCT01216176|42013900|FG001|Overall Study|Physician Decision|0|||
19565970|NCT01216176|42013901|FG002|Overall Study|Physician Decision|1|||
19565971|NCT01133847|42013913|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
19565972|NCT01133847|42013914|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
19565973|NCT01133847|42013915|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
19565974|NCT01133847|42013913|FG000|Follow-Up Phase|Lost to Follow-up|1|||
19743057|NCT02880956|42189842|FG003|Overall Study|Withdrawal by Subject|11|||
19743058|NCT02880956|42189839|FG000|Overall Study|Lost to Follow-up|0|||
19743059|NCT02880956|42189840|FG001|Overall Study|Lost to Follow-up|1|||
19743060|NCT02880956|42189841|FG002|Overall Study|Lost to Follow-up|0|||
19743061|NCT02880956|42189842|FG003|Overall Study|Lost to Follow-up|0|||
19743062|NCT02880956|42189839|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
19743063|NCT02880956|42189840|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
19743064|NCT02880956|42189841|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
19743065|NCT02880956|42189842|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
19743066|NCT02880956|42189839|FG000|Overall Study|Other, Not Specified|4|||
19743067|NCT02880956|42189840|FG001|Overall Study|Other, Not Specified|2|||
19743068|NCT02880956|42189841|FG002|Overall Study|Other, Not Specified|0|||
19743069|NCT02880956|42189842|FG003|Overall Study|Other, Not Specified|3|||
19743070|NCT01352416|42189859|FG000|Overall Study|Physician Decision|1|||
19743071|NCT01352416|42189860|FG001|Overall Study|Physician Decision|2|||
19743072|NCT01352416|42189861|FG002|Overall Study|Physician Decision|2|||
19743073|NCT01352416|42189862|FG003|Overall Study|Physician Decision|1|||
19743074|NCT00439738|42189874|FG000|Overall Study|Withdrawal by Subject|16|||
19743075|NCT00439738|42189875|FG001|Overall Study|Withdrawal by Subject|13|||
19743076|NCT00439738|42189874|FG000|Overall Study|Adverse Event|6|||
19743077|NCT00439738|42189875|FG001|Overall Study|Adverse Event|4|||
19743078|NCT00439738|42189874|FG000|Overall Study|Lost to Follow-up|5|||
19743079|NCT00439738|42189875|FG001|Overall Study|Lost to Follow-up|6|||
19743080|NCT00439738|42189874|FG000|Overall Study|Protocol Violation|6|||
19743081|NCT00439738|42189875|FG001|Overall Study|Protocol Violation|3|||
19743082|NCT00439738|42189874|FG000|Overall Study|Lack of Efficacy|2|||
19743083|NCT00439738|42189875|FG001|Overall Study|Lack of Efficacy|2|||
19743084|NCT00439738|42189874|FG000|Overall Study|Abnormal Lab Values|1|||
19743085|NCT00439738|42189875|FG001|Overall Study|Abnormal Lab Values|0|||
19743086|NCT00338104|42189882|FG000|Overall Study|Protocol Violation|2|||
19743087|NCT00338104|42189883|FG001|Overall Study|Protocol Violation|1|||
19743088|NCT00338104|42189884|FG002|Overall Study|Protocol Violation|3|||
19743089|NCT02883452|42189895|FG000|Overall Study|Withdrawal by Subject|1|||
19743090|NCT02883452|42189896|FG001|Overall Study|Withdrawal by Subject|1|||
19743091|NCT02883452|42189897|FG002|Overall Study|Withdrawal by Subject|3|||
19743092|NCT02883452|42189898|FG003|Overall Study|Withdrawal by Subject|0|||
19743093|NCT02883452|42189899|FG004|Overall Study|Withdrawal by Subject|2|||
19743094|NCT02883452|42189900|FG005|Overall Study|Withdrawal by Subject|5|||
19743095|NCT02883452|42189895|FG000|Overall Study|Disease progression|1|||
19743096|NCT02883452|42189896|FG001|Overall Study|Disease progression|0|||
19743097|NCT02883452|42189897|FG002|Overall Study|Disease progression|0|||
19743098|NCT02883452|42189898|FG003|Overall Study|Disease progression|1|||
19743099|NCT02883452|42189899|FG004|Overall Study|Disease progression|4|||
19743100|NCT02883452|42189900|FG005|Overall Study|Disease progression|5|||
19743101|NCT02883452|42189895|FG000|Overall Study|Adverse Event|2|||
19743102|NCT02883452|42189896|FG001|Overall Study|Adverse Event|1|||
19743103|NCT02883452|42189897|FG002|Overall Study|Adverse Event|1|||
19743104|NCT02883452|42189898|FG003|Overall Study|Adverse Event|1|||
19743105|NCT02883452|42189899|FG004|Overall Study|Adverse Event|1|||
19743106|NCT02883452|42189900|FG005|Overall Study|Adverse Event|3|||
19743107|NCT02883452|42189895|FG000|Overall Study|Physician Decision|0|||
19743108|NCT02883452|42189896|FG001|Overall Study|Physician Decision|0|||
19743109|NCT02883452|42189897|FG002|Overall Study|Physician Decision|0|||
19743110|NCT02883452|42189898|FG003|Overall Study|Physician Decision|0|||
19743111|NCT02883452|42189899|FG004|Overall Study|Physician Decision|4|||
19743112|NCT02883452|42189900|FG005|Overall Study|Physician Decision|1|||
19743113|NCT02883452|42189895|FG000|Overall Study|Death|1|||
19743114|NCT02883452|42189896|FG001|Overall Study|Death|0|||
19743115|NCT02883452|42189897|FG002|Overall Study|Death|1|||
19743116|NCT02883452|42189898|FG003|Overall Study|Death|0|||
19743117|NCT02883452|42189899|FG004|Overall Study|Death|0|||
19743118|NCT02883452|42189900|FG005|Overall Study|Death|0|||
19743119|NCT02883452|42189895|FG000|Overall Study|Other|0|||
19743120|NCT02883452|42189896|FG001|Overall Study|Other|0|||
19743121|NCT02883452|42189897|FG002|Overall Study|Other|0|||
19743122|NCT02883452|42189898|FG003|Overall Study|Other|0|||
19743123|NCT02883452|42189899|FG004|Overall Study|Other|0|||
19743124|NCT02883452|42189900|FG005|Overall Study|Other|1|||
19743125|NCT00151372|42189917|FG000|Overall Study|Death|12|||
19743126|NCT00151372|42189918|FG001|Overall Study|Death|11|||
19743127|NCT00151372|42189917|FG000|Overall Study|Lost to Follow-up|5|||
19743128|NCT00151372|42189918|FG001|Overall Study|Lost to Follow-up|5|||
19743129|NCT00151372|42189917|FG000|Overall Study|Too sick medically to continue|5|||
19743130|NCT00151372|42189918|FG001|Overall Study|Too sick medically to continue|6|||
19743131|NCT00151372|42189917|FG000|Overall Study|Withdrawal by Subject|7|||
19743132|NCT00151372|42189918|FG001|Overall Study|Withdrawal by Subject|7|||
19743133|NCT02603809|42189930|FG000|Overall Study|Withdrawal by Subject|4|||
19743134|NCT02603809|42189931|FG001|Overall Study|Withdrawal by Subject|1|||
19743135|NCT02603809|42189932|FG002|Overall Study|Withdrawal by Subject|2|||
19743136|NCT02603809|42189933|FG003|Overall Study|Withdrawal by Subject|3|||
19743137|NCT02603809|42189934|FG004|Overall Study|Withdrawal by Subject|3|||
19743138|NCT02603809|42189935|FG005|Overall Study|Withdrawal by Subject|4|||
19743139|NCT02603809|42189930|FG000|Overall Study|Lost to Follow-up|2|||
19743140|NCT02603809|42189931|FG001|Overall Study|Lost to Follow-up|3|||
19743141|NCT02603809|42189932|FG002|Overall Study|Lost to Follow-up|1|||
19743142|NCT02603809|42189933|FG003|Overall Study|Lost to Follow-up|4|||
19743143|NCT02603809|42189934|FG004|Overall Study|Lost to Follow-up|2|||
19743144|NCT02603809|42189935|FG005|Overall Study|Lost to Follow-up|2|||
19743145|NCT02603809|42189930|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
19743146|NCT02603809|42189931|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
19743147|NCT02603809|42189932|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
19743148|NCT02603809|42189933|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
19743149|NCT02603809|42189934|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
19743150|NCT02603809|42189935|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
19743151|NCT02603809|42189930|FG000|Overall Study|Physician Decision|0|||
19743152|NCT02603809|42189931|FG001|Overall Study|Physician Decision|0|||
19743153|NCT02603809|42189932|FG002|Overall Study|Physician Decision|0|||
19743154|NCT02603809|42189933|FG003|Overall Study|Physician Decision|1|||
19743155|NCT02603809|42189934|FG004|Overall Study|Physician Decision|2|||
19565975|NCT01133847|42013914|FG001|Follow-Up Phase|Lost to Follow-up|3|||
19743156|NCT02603809|42189935|FG005|Overall Study|Physician Decision|1|||
19743157|NCT02603809|42189930|FG000|Overall Study|Adverse Event|3|||
19743158|NCT02603809|42189931|FG001|Overall Study|Adverse Event|0|||
19743159|NCT02603809|42189932|FG002|Overall Study|Adverse Event|2|||
19743160|NCT02603809|42189933|FG003|Overall Study|Adverse Event|2|||
19743161|NCT02603809|42189934|FG004|Overall Study|Adverse Event|1|||
19743162|NCT02603809|42189935|FG005|Overall Study|Adverse Event|1|||
19743163|NCT02603809|42189930|FG000|Overall Study|Lack of Efficacy|0|||
19743164|NCT02603809|42189931|FG001|Overall Study|Lack of Efficacy|1|||
19743165|NCT02603809|42189932|FG002|Overall Study|Lack of Efficacy|0|||
19743166|NCT02603809|42189933|FG003|Overall Study|Lack of Efficacy|0|||
19743167|NCT02603809|42189934|FG004|Overall Study|Lack of Efficacy|0|||
19743168|NCT02603809|42189935|FG005|Overall Study|Lack of Efficacy|1|||
19743169|NCT02741596|42189953|FG000|Overall Study|Adverse Event|1|||
19743170|NCT02741596|42189954|FG001|Overall Study|Adverse Event|5|||
19743171|NCT02741596|42189953|FG000|Overall Study|Lost to Follow-up|1|||
19743172|NCT02741596|42189954|FG001|Overall Study|Lost to Follow-up|1|||
19743173|NCT02741596|42189953|FG000|Overall Study|Physician Decision|2|||
19743174|NCT02741596|42189954|FG001|Overall Study|Physician Decision|1|||
19743175|NCT02741596|42189953|FG000|Overall Study|Pregnancy|3|||
19743176|NCT02741596|42189954|FG001|Overall Study|Pregnancy|1|||
19743177|NCT02741596|42189953|FG000|Overall Study|Other (Unspecified)|0|||
19743178|NCT02741596|42189954|FG001|Overall Study|Other (Unspecified)|3|||
19743179|NCT02741596|42189953|FG000|Overall Study|Subject withdrawn-Other|17|||
19743180|NCT02741596|42189954|FG001|Overall Study|Subject withdrawn-Other|4|||
19743181|NCT02741596|42189953|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
19743182|NCT02741596|42189954|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
19743183|NCT03147248|42189966|FG000|Overall Study|Adverse Event|0|||
19743184|NCT03147248|42189967|FG001|Overall Study|Adverse Event|2|||
19743185|NCT03147248|42189968|FG002|Overall Study|Adverse Event|2|||
19743186|NCT03147248|42189969|FG003|Overall Study|Adverse Event|2|||
19743187|NCT03147248|42189970|FG004|Overall Study|Adverse Event|6|||
19743188|NCT03147248|42189971|FG005|Overall Study|Adverse Event|11|||
19743189|NCT03147248|42189966|FG000|Overall Study|Disease progression|1|||
19743190|NCT03147248|42189967|FG001|Overall Study|Disease progression|0|||
19743191|NCT03147248|42189968|FG002|Overall Study|Disease progression|0|||
19743192|NCT03147248|42189969|FG003|Overall Study|Disease progression|0|||
19743193|NCT03147248|42189970|FG004|Overall Study|Disease progression|0|||
19743194|NCT03147248|42189971|FG005|Overall Study|Disease progression|2|||
19743195|NCT03147248|42189966|FG000|Overall Study|Withdrawal by Subject|0|||
19743196|NCT03147248|42189967|FG001|Overall Study|Withdrawal by Subject|0|||
19743197|NCT03147248|42189968|FG002|Overall Study|Withdrawal by Subject|0|||
19743198|NCT03147248|42189969|FG003|Overall Study|Withdrawal by Subject|0|||
19743199|NCT03147248|42189970|FG004|Overall Study|Withdrawal by Subject|12|||
19743200|NCT03147248|42189971|FG005|Overall Study|Withdrawal by Subject|9|||
19743201|NCT03147248|42189966|FG000|Overall Study|Protocol Violation|0|||
19743202|NCT03147248|42189967|FG001|Overall Study|Protocol Violation|0|||
19743203|NCT03147248|42189968|FG002|Overall Study|Protocol Violation|0|||
19743204|NCT03147248|42189969|FG003|Overall Study|Protocol Violation|0|||
19743205|NCT03147248|42189970|FG004|Overall Study|Protocol Violation|2|||
19743206|NCT03147248|42189971|FG005|Overall Study|Protocol Violation|0|||
19743207|NCT03147248|42189966|FG000|Overall Study|Lost to Follow-up|0|||
19743208|NCT03147248|42189967|FG001|Overall Study|Lost to Follow-up|0|||
19743209|NCT03147248|42189968|FG002|Overall Study|Lost to Follow-up|0|||
19743210|NCT03147248|42189969|FG003|Overall Study|Lost to Follow-up|0|||
19743211|NCT03147248|42189970|FG004|Overall Study|Lost to Follow-up|2|||
19743212|NCT03147248|42189971|FG005|Overall Study|Lost to Follow-up|0|||
19743213|NCT03147248|42189966|FG000|Overall Study|Pregnancy|0|||
19743214|NCT03147248|42189967|FG001|Overall Study|Pregnancy|0|||
19743215|NCT03147248|42189968|FG002|Overall Study|Pregnancy|0|||
19743216|NCT03147248|42189969|FG003|Overall Study|Pregnancy|0|||
19743217|NCT03147248|42189970|FG004|Overall Study|Pregnancy|1|||
19743218|NCT03147248|42189971|FG005|Overall Study|Pregnancy|0|||
19743219|NCT03147248|42189966|FG000|Overall Study|Death|0|||
19743220|NCT03147248|42189967|FG001|Overall Study|Death|0|||
19743221|NCT03147248|42189968|FG002|Overall Study|Death|0|||
19743222|NCT03147248|42189969|FG003|Overall Study|Death|0|||
19743223|NCT03147248|42189970|FG004|Overall Study|Death|0|||
19743224|NCT03147248|42189971|FG005|Overall Study|Death|4|||
19743225|NCT03147248|42189966|FG000|Overall Study|Physician Decision|0|||
19743226|NCT03147248|42189967|FG001|Overall Study|Physician Decision|0|||
19743227|NCT03147248|42189968|FG002|Overall Study|Physician Decision|0|||
19743228|NCT03147248|42189969|FG003|Overall Study|Physician Decision|0|||
19743229|NCT03147248|42189970|FG004|Overall Study|Physician Decision|2|||
19743230|NCT03147248|42189971|FG005|Overall Study|Physician Decision|4|||
19743231|NCT03147248|42189966|FG000|Overall Study|Prolonged Dosing Interval|0|||
19743232|NCT03147248|42189967|FG001|Overall Study|Prolonged Dosing Interval|0|||
19743233|NCT03147248|42189968|FG002|Overall Study|Prolonged Dosing Interval|0|||
19743234|NCT03147248|42189969|FG003|Overall Study|Prolonged Dosing Interval|0|||
19743235|NCT03147248|42189970|FG004|Overall Study|Prolonged Dosing Interval|1|||
19743236|NCT03147248|42189971|FG005|Overall Study|Prolonged Dosing Interval|1|||
19743237|NCT03796039|42189987|FG000|Overall Study|Death|2|||
19743238|NCT03796039|42189988|FG001|Overall Study|Death|1|||
19743239|NCT03796039|42189987|FG000|Overall Study|Withdrawal by Subject|7|||
19743240|NCT03796039|42189988|FG001|Overall Study|Withdrawal by Subject|4|||
19743241|NCT03794089|42189996|FG000|Overall Study|Lost to Follow-up|4|||
19743242|NCT03794089|42189997|FG001|Overall Study|Lost to Follow-up|1|||
19743243|NCT03794089|42189996|FG000|Overall Study|Withdrawal by Subject|2|||
19743244|NCT03794089|42189997|FG001|Overall Study|Withdrawal by Subject|0|||
19743245|NCT03151304|42190003|FG000|Overall Study|Termination of study by Sponsor|23|||
19743246|NCT03151304|42190003|FG000|Overall Study|missing|3|||
19743247|NCT03151304|42190003|FG000|Overall Study|Withdrawal by Subject|8|||
19743248|NCT03151304|42190003|FG000|Overall Study|multiple reasons|30|||
19743249|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
19743250|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
19743251|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
19565976|NCT01133847|42013915|FG002|Follow-Up Phase|Lost to Follow-up|7|||
19565977|NCT01133379|42013927|FG000|Overall Study|Withdrawal by Subject|0|||
19565978|NCT01133379|42013928|FG001|Overall Study|Withdrawal by Subject|1|||
19565979|NCT01133379|42013929|FG002|Overall Study|Withdrawal by Subject|1|||
19565980|NCT01133379|42013927|FG000|Overall Study|Lost to Follow-up|1|||
19565981|NCT01133379|42013928|FG001|Overall Study|Lost to Follow-up|1|||
19565982|NCT01133379|42013929|FG002|Overall Study|Lost to Follow-up|1|||
19565983|NCT01133067|42013937|FG000|Overall Study|Death|136|||
19565984|NCT01133067|42013937|FG000|Overall Study|Lost to Follow-up|3|||
19565985|NCT01132755|42013941|FG000|Overall Study|Procedure not done due to medical reason|23|||
19565986|NCT01132755|42013941|FG000|Overall Study|Protocol Violation|15|||
19565987|NCT01132755|42013941|FG000|Overall Study|Withdrawal by Subject|4|||
19565988|NCT00919711|42013947|FG000|Overall Study|Withdrawal by Subject|15|||
19565989|NCT00919711|42013948|FG001|Overall Study|Withdrawal by Subject|7|||
19565990|NCT00919711|42013947|FG000|Overall Study|Adverse Event|13|||
19565991|NCT00919711|42013948|FG001|Overall Study|Adverse Event|3|||
19565992|NCT00919711|42013947|FG000|Overall Study|Other|1|||
19565993|NCT00919711|42013948|FG001|Overall Study|Other|2|||
19565994|NCT00919711|42013947|FG000|Overall Study|Administrative Decision|0|||
19565995|NCT00919711|42013948|FG001|Overall Study|Administrative Decision|1|||
19565996|NCT00919711|42013947|FG000|Overall Study|Lost to Follow-up|2|||
19565997|NCT00919711|42013948|FG001|Overall Study|Lost to Follow-up|0|||
19565998|NCT00919711|42013947|FG000|Overall Study|Death|1|||
19565999|NCT00919711|42013948|FG001|Overall Study|Death|0|||
19566000|NCT00919711|42013947|FG000|Overall Study|Noncompliance|1|||
19566001|NCT00919711|42013948|FG001|Overall Study|Noncompliance|0|||
19566002|NCT01131585|42013956|FG000|Overall Study|Adverse Event|0|||
19566003|NCT01131585|42013957|FG001|Overall Study|Adverse Event|2|||
19566004|NCT01131585|42013956|FG000|Overall Study|Abnormal laboratory value|1|||
19566005|NCT01131585|42013957|FG001|Overall Study|Abnormal laboratory value|0|||
19566006|NCT01131585|42013956|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19566007|NCT01131585|42013957|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19566008|NCT01131585|42013956|FG000|Overall Study|Protocol Violation|2|||
19566009|NCT01131585|42013957|FG001|Overall Study|Protocol Violation|1|||
19566010|NCT01131585|42013956|FG000|Overall Study|Withdrawal by Subject|3|||
19566011|NCT01131585|42013957|FG001|Overall Study|Withdrawal by Subject|3|||
19566012|NCT01131585|42013956|FG000|Overall Study|Lost to Follow-up|0|||
19566013|NCT01131585|42013957|FG001|Overall Study|Lost to Follow-up|1|||
19566014|NCT01131585|42013956|FG000|Overall Study|Administrative problems|1|||
19566015|NCT01131585|42013957|FG001|Overall Study|Administrative problems|1|||
19566016|NCT01131585|42013956|FG000|Overall Study|Study termination|78|||
19566017|NCT01131585|42013957|FG001|Overall Study|Study termination|32|||
19566018|NCT01131507|42013963|FG000|Overall Study|Adverse Event|1|||
19566019|NCT01131507|42013963|FG000|Overall Study|Lost to Follow-up|1|||
19566020|NCT01131507|42013963|FG000|Overall Study|Withdrawal by Subject|1|||
19743252|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
19743253|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
19743254|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
19743255|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
19566021|NCT01131351|42013969|FG000|Overall Study|Adverse Event|0|||
19743256|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
19743257|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
19743258|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
19743259|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
19743260|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
19743261|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
19743262|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
19743263|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
19743264|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19743265|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19743266|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19743267|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19743268|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19743269|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
19743270|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
19743271|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
19743272|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
19743273|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
19743274|NCT03152552|42190012|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
19743275|NCT03152552|42190013|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
19743276|NCT03152552|42190014|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
19743277|NCT03152552|42190015|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
19743278|NCT03152552|42190016|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
19743279|NCT03152552|42190012|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
19743280|NCT03152552|42190013|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
19743281|NCT03152552|42190014|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
19743282|NCT03152552|42190015|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
19743283|NCT03152552|42190016|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
19743284|NCT03151226|42190029|FG000|Overall Study|Withdrawal by Subject|2|||
19743285|NCT03151226|42190029|FG000|Overall Study|not wear device correctly|1|||
19743286|NCT03151148|42190035|FG000|Overall Study|Lost to Follow-up|1|||
19743287|NCT03151148|42190036|FG001|Overall Study|Lost to Follow-up|0|||
19743288|NCT03151148|42190035|FG000|Overall Study|Withdrawal by Subject|1|||
19743289|NCT03151148|42190036|FG001|Overall Study|Withdrawal by Subject|0|||
19743290|NCT02741518|42190045|FG000|Overall Study|Withdrawal by Subject|1|||
19743291|NCT02741518|42190046|FG001|Overall Study|Withdrawal by Subject|1|||
19743292|NCT03145766|42190057|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
19743293|NCT03145766|42190058|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
19743294|NCT03145766|42190059|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
19743295|NCT03145766|42190060|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
19743296|NCT03145766|42190061|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
19743297|NCT03145766|42190057|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
19743298|NCT03145766|42190058|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
19743299|NCT03145766|42190059|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
19743300|NCT03145766|42190060|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
19743301|NCT03145766|42190061|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
19743302|NCT03145766|42190057|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
19743303|NCT03145766|42190058|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
19743304|NCT03145766|42190059|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
19743305|NCT03145766|42190060|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
19743306|NCT03145766|42190061|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
19743307|NCT03145766|42190057|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
19743308|NCT03145766|42190058|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
19743309|NCT03145766|42190059|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
19743310|NCT03145766|42190060|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
19743311|NCT03145766|42190061|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
19743312|NCT03145766|42190057|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
19743313|NCT03145766|42190058|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
19743314|NCT03145766|42190059|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
19743315|NCT03145766|42190060|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
19743316|NCT03145766|42190061|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
19743317|NCT03145766|42190057|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
19743318|NCT03145766|42190058|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
19743319|NCT03145766|42190059|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
19743320|NCT03145766|42190060|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
19743321|NCT03145766|42190061|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
19743322|NCT03145766|42190057|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
19743323|NCT03145766|42190058|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
19743324|NCT03145766|42190059|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
19743325|NCT03145766|42190060|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
19743326|NCT03145766|42190061|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
19743327|NCT03145064|42190074|FG000|Overall Study|Death|24|||
19743328|NCT03145064|42190074|FG000|Overall Study|Lost to Follow-up|3|||
19743329|NCT03145064|42190074|FG000|Overall Study|Withdrawal by Subject|6|||
19743330|NCT03145064|42190074|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
19743331|NCT03145064|42190074|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
19743332|NCT03144674|42190092|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
19743333|NCT03144674|42190093|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
19743334|NCT03144674|42190094|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
19743335|NCT03144674|42190095|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
19743336|NCT03144674|42190092|FG000|Overall Study|Death|3|||
19743337|NCT03144674|42190093|FG001|Overall Study|Death|1|||
19743338|NCT03144674|42190094|FG002|Overall Study|Death|1|||
19743339|NCT03144674|42190095|FG003|Overall Study|Death|10|||
19743340|NCT03144674|42190092|FG000|Overall Study|Lost to Follow-up|0|||
19743341|NCT03144674|42190093|FG001|Overall Study|Lost to Follow-up|1|||
19743342|NCT03144674|42190094|FG002|Overall Study|Lost to Follow-up|1|||
19743343|NCT03144674|42190095|FG003|Overall Study|Lost to Follow-up|1|||
19743344|NCT03144674|42190092|FG000|Overall Study|Withdrawal by Participant|0|||
19743345|NCT03144674|42190093|FG001|Overall Study|Withdrawal by Participant|0|||
19743346|NCT03144674|42190094|FG002|Overall Study|Withdrawal by Participant|0|||
19743347|NCT03144674|42190095|FG003|Overall Study|Withdrawal by Participant|3|||
19743348|NCT03144674|42190092|FG000|Overall Study|Reason not Specified|0|||
19743349|NCT03144674|42190093|FG001|Overall Study|Reason not Specified|0|||
19743350|NCT03144674|42190094|FG002|Overall Study|Reason not Specified|2|||
19743351|NCT03144674|42190095|FG003|Overall Study|Reason not Specified|4|||
19743352|NCT03787615|42190121|FG000|Overall Study|Withdrawal by Subject|2|||
19743353|NCT03787615|42190121|FG000|Overall Study|Lost to Follow-up|2|||
19743354|NCT03784963|42190130|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
19743355|NCT03784963|42190131|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
19743356|NCT03784963|42190132|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
19743357|NCT03784963|42190133|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
19743358|NCT03787303|42190143|FG000|Overall Study|Death|1|||
19743359|NCT03787303|42190143|FG000|Overall Study|Premature Termination of Study|1|||
19743360|NCT04170296|42190149|FG000|Overall Study|Adverse Event|1|||
19743361|NCT04170296|42190150|FG001|Overall Study|Adverse Event|0|||
19743362|NCT04170296|42190149|FG000|Overall Study|Withdrawal by Subject|3|||
19743363|NCT04170296|42190150|FG001|Overall Study|Withdrawal by Subject|2|||
19743364|NCT04170296|42190149|FG000|Overall Study|Lost to Follow-up|4|||
19743365|NCT04170296|42190150|FG001|Overall Study|Lost to Follow-up|2|||
19743366|NCT03141788|42190177|FG000|Overall Study|Lost to Follow-up|1|||
19743367|NCT03141788|42190177|FG000|Overall Study|Protocol Violation|3|||
19743368|NCT03141788|42190177|FG000|Overall Study|Withdrawal by Subject|4|||
19743369|NCT03781375|42190186|FG000|Double-blind Phase|Adverse Event|0|||
19743370|NCT03781375|42190187|FG001|Double-blind Phase|Adverse Event|1|||
19743371|NCT03781375|42190186|FG000|Double-blind Phase|Lack of Response|6|||
19743372|NCT03781375|42190187|FG001|Double-blind Phase|Lack of Response|2|||
19743373|NCT03781375|42190186|FG000|Double-blind Phase|Other|1|||
19743374|NCT03781375|42190187|FG001|Double-blind Phase|Other|3|||
19743375|NCT03781375|42190186|FG000|Open-label Phase|Protocol Issues|0|||
19743376|NCT03781375|42190187|FG001|Open-label Phase|Protocol Issues|1|||
19743377|NCT03781375|42190186|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
19743378|NCT03781375|42190187|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
19743379|NCT03781375|42190186|FG000|Open-label Phase|Other|2|||
19743380|NCT03781375|42190187|FG001|Open-label Phase|Other|2|||
19743381|NCT03779503|42190194|FG000|First Intervention|Adverse Event|0|||
19743382|NCT03779503|42190195|FG001|First Intervention|Adverse Event|1|||
19743383|NCT03779503|42190194|FG000|First Intervention|Withdrawal by Subject|1|||
19743384|NCT03779503|42190195|FG001|First Intervention|Withdrawal by Subject|0|||
19743385|NCT03150056|42190207|FG000|Overall Study|Withdrawal by Subject|0|||
19743386|NCT03150056|42190208|FG001|Overall Study|Withdrawal by Subject|0|||
19743387|NCT03150056|42190209|FG002|Overall Study|Withdrawal by Subject|0|||
19743388|NCT03150056|42190210|FG003|Overall Study|Withdrawal by Subject|0|||
19743389|NCT03150056|42190211|FG004|Overall Study|Withdrawal by Subject|0|||
19743390|NCT03150056|42190212|FG005|Overall Study|Withdrawal by Subject|2|||
19743391|NCT03150056|42190207|FG000|Overall Study|Study terminated by Sponsor|1|||
19743392|NCT03150056|42190208|FG001|Overall Study|Study terminated by Sponsor|3|||
19743393|NCT03150056|42190209|FG002|Overall Study|Study terminated by Sponsor|1|||
19743394|NCT03150056|42190210|FG003|Overall Study|Study terminated by Sponsor|1|||
19743395|NCT03150056|42190211|FG004|Overall Study|Study terminated by Sponsor|5|||
19743396|NCT03150056|42190212|FG005|Overall Study|Study terminated by Sponsor|6|||
19743397|NCT03150056|42190207|FG000|Overall Study|Death|9|||
19743398|NCT03150056|42190208|FG001|Overall Study|Death|2|||
19743399|NCT03150056|42190209|FG002|Overall Study|Death|2|||
19743400|NCT03150056|42190210|FG003|Overall Study|Death|7|||
19743401|NCT03150056|42190211|FG004|Overall Study|Death|8|||
19743402|NCT03150056|42190212|FG005|Overall Study|Death|10|||
19743403|NCT02640664|42190232|FG000|Epoch 1|Withdrawal of informed consent|1|||
19743404|NCT02640664|42190233|FG001|Epoch 1|Withdrawal of informed consent|0|||
19743405|NCT02640664|42190234|FG002|Epoch 1|Withdrawal of informed consent|0|||
19743406|NCT02640664|42190232|FG000|Epoch 1|Death|0|||
19743407|NCT02640664|42190233|FG001|Epoch 1|Death|0|||
19743408|NCT02640664|42190234|FG002|Epoch 1|Death|1|||
19743409|NCT02640664|42190232|FG000|Epoch 2|Withdrawal of informed consent|3|||
19743410|NCT02640664|42190233|FG001|Epoch 2|Withdrawal of informed consent|4|||
19743411|NCT02640664|42190234|FG002|Epoch 2|Withdrawal of informed consent|2|||
19743412|NCT02640664|42190232|FG000|Epoch 2|Subject/guardian decision|0|||
19743413|NCT02640664|42190233|FG001|Epoch 2|Subject/guardian decision|2|||
19743414|NCT02640664|42190234|FG002|Epoch 2|Subject/guardian decision|2|||
19743415|NCT02640664|42190232|FG000|Epoch 2|Lost to Follow-up|3|||
19743416|NCT02640664|42190233|FG001|Epoch 2|Lost to Follow-up|4|||
19743417|NCT02640664|42190234|FG002|Epoch 2|Lost to Follow-up|1|||
19743418|NCT02640664|42190232|FG000|Epoch 2|Death|0|||
19743419|NCT02640664|42190233|FG001|Epoch 2|Death|0|||
19743420|NCT02640664|42190234|FG002|Epoch 2|Death|1|||
19743421|NCT00812006|42190246|FG000|Overall Study|Lost to Follow-up|0|||
19743422|NCT00812006|42190247|FG001|Overall Study|Lost to Follow-up|0|||
19743423|NCT00812006|42190248|FG002|Overall Study|Lost to Follow-up|2|||
19743424|NCT00812006|42190246|FG000|Overall Study|Physician Decision|0|||
19743425|NCT00812006|42190247|FG001|Overall Study|Physician Decision|0|||
19566022|NCT01131351|42013970|FG001|Overall Study|Adverse Event|2|||
19743426|NCT00812006|42190248|FG002|Overall Study|Physician Decision|1|||
19743427|NCT00812006|42190246|FG000|Overall Study|Withdrawal by Subject|2|||
19743428|NCT00812006|42190247|FG001|Overall Study|Withdrawal by Subject|1|||
19743429|NCT00812006|42190248|FG002|Overall Study|Withdrawal by Subject|1|||
19743430|NCT00812006|42190246|FG000|Overall Study|Lack of Qualifying Event|4|||
19743431|NCT00812006|42190247|FG001|Overall Study|Lack of Qualifying Event|2|||
19743432|NCT00812006|42190248|FG002|Overall Study|Lack of Qualifying Event|2|||
19743433|NCT03772327|42190263|FG000|Overall Study|Lost to Follow-up|3|||
19743434|NCT03772327|42190264|FG001|Overall Study|Lost to Follow-up|4|||
19743435|NCT03772327|42190263|FG000|Overall Study|Withdrawal by Subject|2|||
19743436|NCT03772327|42190264|FG001|Overall Study|Withdrawal by Subject|3|||
19743437|NCT04364763|42190307|FG000|Overall Study|Death|1|||
19743438|NCT04364763|42190308|FG001|Overall Study|Death|2|||
19743439|NCT04364763|42190307|FG000|Overall Study|Lost to Follow-up|1|||
19743440|NCT04364763|42190308|FG001|Overall Study|Lost to Follow-up|0|||
19743441|NCT04247815|42190325|FG000|Overall Study|Adverse Event|1|||
19743442|NCT04247815|42190326|FG001|Overall Study|Adverse Event|0|||
19566023|NCT01131351|42013969|FG000|Overall Study|Protocol Deviation|0|||
19566024|NCT01131351|42013970|FG001|Overall Study|Protocol Deviation|1|||
19566025|NCT00919633|42013980|FG000|Overall Study|Adverse Event|1|||
19566026|NCT00919633|42013981|FG001|Overall Study|Adverse Event|9|||
19566027|NCT00919633|42013982|FG002|Overall Study|Adverse Event|12|||
19566028|NCT00919633|42013983|FG003|Overall Study|Adverse Event|10|||
19566029|NCT00919633|42013980|FG000|Overall Study|Death|0|||
19566030|NCT00919633|42013981|FG001|Overall Study|Death|0|||
19566031|NCT00919633|42013982|FG002|Overall Study|Death|2|||
19566032|NCT00919633|42013983|FG003|Overall Study|Death|0|||
19566033|NCT00919633|42013980|FG000|Overall Study|Lack of Efficacy|17|||
19566034|NCT00919633|42013981|FG001|Overall Study|Lack of Efficacy|3|||
19566035|NCT00919633|42013982|FG002|Overall Study|Lack of Efficacy|2|||
19566036|NCT00919633|42013983|FG003|Overall Study|Lack of Efficacy|3|||
19566037|NCT00919633|42013980|FG000|Overall Study|Withdrawal by Subject|1|||
19566038|NCT00919633|42013981|FG001|Overall Study|Withdrawal by Subject|2|||
19566039|NCT00919633|42013982|FG002|Overall Study|Withdrawal by Subject|4|||
19566040|NCT00919633|42013983|FG003|Overall Study|Withdrawal by Subject|3|||
19566041|NCT00919633|42013980|FG000|Overall Study|Lost to Follow-up|3|||
19566042|NCT00919633|42013981|FG001|Overall Study|Lost to Follow-up|1|||
19566043|NCT00919633|42013982|FG002|Overall Study|Lost to Follow-up|0|||
19566044|NCT00919633|42013983|FG003|Overall Study|Lost to Follow-up|2|||
19566045|NCT00919633|42013980|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
19566046|NCT00919633|42013981|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
19566047|NCT00919633|42013982|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
19566048|NCT00919633|42013983|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
19566049|NCT00919633|42013980|FG000|Overall Study|Protocol Violation|0|||
19566050|NCT00919633|42013981|FG001|Overall Study|Protocol Violation|0|||
19566051|NCT00919633|42013982|FG002|Overall Study|Protocol Violation|0|||
19566052|NCT00919633|42013983|FG003|Overall Study|Protocol Violation|1|||
19566053|NCT00919633|42013980|FG000|Overall Study|Physician Decision|0|||
19566054|NCT00919633|42013981|FG001|Overall Study|Physician Decision|0|||
19566055|NCT00919633|42013982|FG002|Overall Study|Physician Decision|0|||
19566056|NCT00919633|42013983|FG003|Overall Study|Physician Decision|1|||
19566057|NCT00919633|42013980|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
19566058|NCT00919633|42013981|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
19566059|NCT00919633|42013982|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
19566060|NCT00919633|42013983|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
19566061|NCT00919633|42013980|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
19566062|NCT00919633|42013981|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
19566063|NCT00919633|42013982|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
19566064|NCT00919633|42013983|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
19566065|NCT01130883|42013993|FG000|Overall Study|Patient Noncompliance|6|||
19566066|NCT01130883|42013993|FG000|Overall Study|Reason Unknown|1|||
19566067|NCT01130883|42013993|FG000|Overall Study|Adverse Event|3|||
19566068|NCT00926029|42014000|FG000|Overall Study|Lost to Follow-up|2|||
19566069|NCT00926029|42014001|FG001|Overall Study|Lost to Follow-up|1|||
19566070|NCT00926029|42014002|FG002|Overall Study|Lost to Follow-up|1|||
19566071|NCT01130493|42014012|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
19566072|NCT01130493|42014013|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
19566073|NCT01130493|42014014|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
19566074|NCT01130493|42014012|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
19566075|NCT01130493|42014013|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
19566076|NCT01130493|42014014|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
19566077|NCT01130493|42014012|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
19566078|NCT01130493|42014013|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
19566079|NCT01130493|42014014|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
19566080|NCT01130493|42014012|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
19566081|NCT01130493|42014013|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
19566082|NCT01130493|42014014|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
19566083|NCT01130493|42014012|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
19566084|NCT01130493|42014013|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
19743443|NCT04247815|42190325|FG000|Overall Study|Withdrawal by Subject|1|||
19743444|NCT04247815|42190326|FG001|Overall Study|Withdrawal by Subject|0|||
19743445|NCT04247815|42190325|FG000|Overall Study|Protocol Violation|0|||
19743446|NCT04247815|42190326|FG001|Overall Study|Protocol Violation|1|||
19743447|NCT03432819|42190361|FG000|Overall Study|Lost to Follow-up|2|||
19743448|NCT03432819|42190362|FG001|Overall Study|Lost to Follow-up|2|||
19743449|NCT03432819|42190361|FG000|Overall Study|Withdrawal by Subject|5|||
19743450|NCT03432819|42190362|FG001|Overall Study|Withdrawal by Subject|3|||
19743451|NCT03272347|42190381|FG000|Overall Study|Death|0|||
19743452|NCT03272347|42190382|FG001|Overall Study|Death|0|||
19743453|NCT03272347|42190383|FG002|Overall Study|Death|0|||
19743454|NCT03272347|42190384|FG003|Overall Study|Death|1|||
19743455|NCT03272347|42190381|FG000|Overall Study|Lost to Follow-up|1|||
19743456|NCT03272347|42190382|FG001|Overall Study|Lost to Follow-up|3|||
19743457|NCT03272347|42190383|FG002|Overall Study|Lost to Follow-up|5|||
19743458|NCT03272347|42190384|FG003|Overall Study|Lost to Follow-up|1|||
19743459|NCT03272347|42190381|FG000|Overall Study|Physician Decision|4|||
19743460|NCT03272347|42190382|FG001|Overall Study|Physician Decision|2|||
19743461|NCT03272347|42190383|FG002|Overall Study|Physician Decision|5|||
19743462|NCT03272347|42190384|FG003|Overall Study|Physician Decision|4|||
19743463|NCT03272347|42190381|FG000|Overall Study|Screen Failure|1|||
19743464|NCT03272347|42190382|FG001|Overall Study|Screen Failure|0|||
19743465|NCT03272347|42190383|FG002|Overall Study|Screen Failure|0|||
19743466|NCT03272347|42190384|FG003|Overall Study|Screen Failure|0|||
19743467|NCT03272347|42190381|FG000|Overall Study|Withdrawal by Subject|5|||
19743468|NCT03272347|42190382|FG001|Overall Study|Withdrawal by Subject|1|||
19743469|NCT03272347|42190383|FG002|Overall Study|Withdrawal by Subject|2|||
19743470|NCT03272347|42190384|FG003|Overall Study|Withdrawal by Subject|1|||
19743471|NCT03259568|42190406|FG000|Overall Study|Participant performance was low|3|||
19743472|NCT03239470|42190416|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
19743473|NCT03239470|42190417|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
19743474|NCT03167723|42190423|FG000|Overall Study|Protocol Violation|4|||
19743475|NCT03167723|42190424|FG001|Overall Study|Protocol Violation|6|||
19743476|NCT03103152|42190436|FG000|Overall Study|Physician Decision|5|||
19743477|NCT03103152|42190437|FG001|Overall Study|Physician Decision|2|||
19743478|NCT03103152|42190438|FG002|Overall Study|Physician Decision|6|||
19743479|NCT03103152|42190439|FG003|Overall Study|Physician Decision|3|||
19743480|NCT03103152|42190440|FG004|Overall Study|Physician Decision|3|||
19743481|NCT03103152|42190441|FG005|Overall Study|Physician Decision|1|||
19743482|NCT03103152|42190436|FG000|Overall Study|Protocol Violation|2|||
19743483|NCT03103152|42190437|FG001|Overall Study|Protocol Violation|2|||
19743484|NCT03103152|42190438|FG002|Overall Study|Protocol Violation|1|||
19743485|NCT03103152|42190439|FG003|Overall Study|Protocol Violation|2|||
19743486|NCT03103152|42190440|FG004|Overall Study|Protocol Violation|1|||
19743487|NCT03103152|42190441|FG005|Overall Study|Protocol Violation|1|||
19743488|NCT03103152|42190436|FG000|Overall Study|Inter-current illness|0|||
19743489|NCT03103152|42190437|FG001|Overall Study|Inter-current illness|0|||
19743490|NCT03103152|42190438|FG002|Overall Study|Inter-current illness|1|||
19743491|NCT03103152|42190439|FG003|Overall Study|Inter-current illness|0|||
19743492|NCT03103152|42190440|FG004|Overall Study|Inter-current illness|0|||
19743493|NCT03103152|42190441|FG005|Overall Study|Inter-current illness|0|||
19743494|NCT03103152|42190436|FG000|Overall Study|Death|0|||
19743495|NCT03103152|42190437|FG001|Overall Study|Death|1|||
19743496|NCT03103152|42190438|FG002|Overall Study|Death|0|||
19743497|NCT03103152|42190439|FG003|Overall Study|Death|0|||
19743498|NCT03103152|42190440|FG004|Overall Study|Death|0|||
19743499|NCT03103152|42190441|FG005|Overall Study|Death|0|||
19743500|NCT03103152|42190436|FG000|Overall Study|Adverse Event|0|||
19743501|NCT03103152|42190437|FG001|Overall Study|Adverse Event|0|||
19743502|NCT03103152|42190438|FG002|Overall Study|Adverse Event|1|||
19743503|NCT03103152|42190439|FG003|Overall Study|Adverse Event|0|||
19743504|NCT03103152|42190440|FG004|Overall Study|Adverse Event|0|||
19743505|NCT03103152|42190441|FG005|Overall Study|Adverse Event|1|||
19743506|NCT03103152|42190436|FG000|Overall Study|Withdrawal by Subject|1|||
19743507|NCT03103152|42190437|FG001|Overall Study|Withdrawal by Subject|0|||
19743508|NCT03103152|42190438|FG002|Overall Study|Withdrawal by Subject|1|||
19743509|NCT03103152|42190439|FG003|Overall Study|Withdrawal by Subject|1|||
19743510|NCT03103152|42190440|FG004|Overall Study|Withdrawal by Subject|1|||
19743511|NCT03103152|42190441|FG005|Overall Study|Withdrawal by Subject|1|||
19743512|NCT03103152|42190436|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
19743513|NCT03103152|42190437|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
19743514|NCT03103152|42190438|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
19743515|NCT03103152|42190439|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
19743516|NCT03103152|42190440|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
19743517|NCT03103152|42190441|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
19743518|NCT03103152|42190436|FG000|Overall Study|Unacceptable side effects|0|||
19743519|NCT03103152|42190437|FG001|Overall Study|Unacceptable side effects|0|||
19743520|NCT03103152|42190438|FG002|Overall Study|Unacceptable side effects|0|||
19743521|NCT03103152|42190439|FG003|Overall Study|Unacceptable side effects|0|||
19743522|NCT03103152|42190440|FG004|Overall Study|Unacceptable side effects|0|||
19743523|NCT03103152|42190441|FG005|Overall Study|Unacceptable side effects|1|||
19743524|NCT03103152|42190436|FG000|Overall Study|Lost to Follow-up|0|||
19743525|NCT03103152|42190437|FG001|Overall Study|Lost to Follow-up|1|||
19743526|NCT03103152|42190438|FG002|Overall Study|Lost to Follow-up|0|||
19743527|NCT03103152|42190439|FG003|Overall Study|Lost to Follow-up|1|||
19743528|NCT03103152|42190440|FG004|Overall Study|Lost to Follow-up|0|||
19743529|NCT03103152|42190441|FG005|Overall Study|Lost to Follow-up|1|||
19743530|NCT03103152|42190436|FG000|Overall Study|Testicular pain|0|||
19743531|NCT03103152|42190437|FG001|Overall Study|Testicular pain|0|||
19743532|NCT03103152|42190438|FG002|Overall Study|Testicular pain|0|||
19743533|NCT03103152|42190439|FG003|Overall Study|Testicular pain|1|||
19743534|NCT03103152|42190440|FG004|Overall Study|Testicular pain|0|||
19743535|NCT03103152|42190441|FG005|Overall Study|Testicular pain|0|||
19743536|NCT03033901|42190455|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
19743537|NCT03033901|42190455|FG000|Overall Study|Refused PSG|23|||
19743538|NCT03033901|42190455|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
19743539|NCT03033901|42190455|FG000|Overall Study|Missing Oximetry Data|3|||
19743540|NCT02625324|42190498|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
19743541|NCT02625324|42190498|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
19743542|NCT02625324|42190498|FG000|6-Month Follow-up Subject Accountability|Death|5|||
19743543|NCT02625324|42190498|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
19743544|NCT02625324|42190498|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
19743545|NCT02625324|42190498|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
19743546|NCT02625324|42190498|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
19743547|NCT02625324|42190498|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
19743548|NCT02625324|42190498|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
19743549|NCT02625324|42190498|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
19743550|NCT02625324|42190498|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
19743551|NCT02625324|42190498|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
19743552|NCT02625324|42190498|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
19743553|NCT02625324|42190498|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
19743554|NCT02625324|42190498|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
19743555|NCT02603887|42190510|FG000|Stage 1|Adverse Event|4|||
19743556|NCT02603887|42190510|FG000|Stage 1|Disease progression|1|||
19743557|NCT02603887|42190510|FG000|Stage 2|FDA guidance|1|||
19743558|NCT02475681|42190526|FG000|Overall Study|Death|16|||
19743559|NCT02475681|42190527|FG001|Overall Study|Death|6|||
19743560|NCT02475681|42190528|FG002|Overall Study|Death|9|||
19743561|NCT02475681|42190526|FG000|Overall Study|Physician Decision|0|||
19743562|NCT02475681|42190527|FG001|Overall Study|Physician Decision|3|||
19743563|NCT02475681|42190528|FG002|Overall Study|Physician Decision|1|||
19743564|NCT02475681|42190526|FG000|Overall Study|Withdrawal by Subject|12|||
19743565|NCT02475681|42190527|FG001|Overall Study|Withdrawal by Subject|6|||
19743566|NCT02475681|42190528|FG002|Overall Study|Withdrawal by Subject|9|||
19743567|NCT02475681|42190526|FG000|Overall Study|Lost to Follow-up|2|||
19743568|NCT02475681|42190527|FG001|Overall Study|Lost to Follow-up|1|||
19743569|NCT02475681|42190528|FG002|Overall Study|Lost to Follow-up|3|||
19743570|NCT02475681|42190526|FG000|Overall Study|Ongoing in Study|0|||
19743571|NCT02475681|42190527|FG001|Overall Study|Ongoing in Study|163|||
19743572|NCT02475681|42190528|FG002|Overall Study|Ongoing in Study|157|||
19743573|NCT02475681|42190526|FG000|Overall Study|Reasons other than above listed|2|||
19743574|NCT02475681|42190527|FG001|Overall Study|Reasons other than above listed|0|||
19743575|NCT02475681|42190528|FG002|Overall Study|Reasons other than above listed|0|||
19743576|NCT02315196|42190538|FG000|Overall Study|Withdrew consent|9|||
19743577|NCT02133573|42190544|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
19743578|NCT02133573|42190545|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
19743579|NCT02133573|42190544|FG000|Overall Study|Child Deaths|3|||
19743580|NCT02133573|42190545|FG001|Overall Study|Child Deaths|5|||
19743581|NCT02133573|42190544|FG000|Overall Study|Child Declined Follow Ups|2|||
19743582|NCT02133573|42190545|FG001|Overall Study|Child Declined Follow Ups|1|||
19743583|NCT02133573|42190544|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
19799378|NCT02873221|42257357|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
19743584|NCT02133573|42190545|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
19743585|NCT02059005|42190557|FG000|Overall Study|Death|1|||
19743586|NCT02059005|42190558|FG001|Overall Study|Death|3|||
19743587|NCT02059005|42190557|FG000|Overall Study|Lost to Follow-up|19|||
19743588|NCT02059005|42190558|FG001|Overall Study|Lost to Follow-up|19|||
19743589|NCT02059005|42190557|FG000|Overall Study|Incarceration|0|||
19743590|NCT02059005|42190558|FG001|Overall Study|Incarceration|1|||
19743591|NCT02059005|42190557|FG000|Overall Study|Inpatient|0|||
19743592|NCT02059005|42190558|FG001|Overall Study|Inpatient|1|||
19743593|NCT01393821|42190568|FG000|Overall Study|Cancel|1|||
19743594|NCT01393821|42190569|FG001|Overall Study|Cancel|1|||
19743595|NCT01393821|42190568|FG000|Overall Study|not evaluable for primary endpoint|4|||
19743596|NCT01393821|42190569|FG001|Overall Study|not evaluable for primary endpoint|2|||
19743597|NCT01199575|42190575|FG000|Overall Study|Withdrawal by Subject|5|||
19743598|NCT00496873|42190586|FG000|Overall Study|Ineligible|2|||
19743599|NCT00496873|42190586|FG000|Overall Study|Death|2|||
19743600|NCT00496873|42190586|FG000|Overall Study|Withdrawal by Subject|3|||
19743601|NCT00492778|42190592|FG000|Overall Study|Ineligible by Pathology Review|8|||
19743602|NCT00492778|42190593|FG001|Overall Study|Ineligible by Pathology Review|1|||
19743603|NCT03775681|42190627|FG000|Overall Study|Physician Decision|3|||
19743604|NCT03774823|42190633|FG000|Overall Study|Withdrawal by Subject|1|||
19743605|NCT03774823|42190634|FG001|Overall Study|Withdrawal by Subject|1|||
19743606|NCT03149042|42190640|FG000|Overall Study|Invasive FFR not performed|21|||
19743607|NCT03149042|42190640|FG000|Overall Study|Poor CT Image Quality|1|||
19743608|NCT03149042|42190640|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
19743609|NCT03774433|42190645|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
19743610|NCT03136484|42190651|FG000|Overall Study|Withdrawal by Subject|19|||
19743611|NCT03136484|42190652|FG001|Overall Study|Withdrawal by Subject|14|||
19743612|NCT03136484|42190651|FG000|Overall Study|Lost to Follow-up|7|||
19743613|NCT03136484|42190652|FG001|Overall Study|Lost to Follow-up|8|||
19743614|NCT03136484|42190651|FG000|Overall Study|Death|1|||
19743615|NCT03136484|42190652|FG001|Overall Study|Death|0|||
19743616|NCT03922711|42190661|FG000|Overall Study|Adverse Event|3|||
19743617|NCT03922711|42190662|FG001|Overall Study|Adverse Event|2|||
19743618|NCT03922711|42190663|FG002|Overall Study|Adverse Event|2|||
19743619|NCT03922711|42190661|FG000|Overall Study|Protocol Violation|1|||
19743620|NCT03922711|42190662|FG001|Overall Study|Protocol Violation|0|||
19743621|NCT03922711|42190663|FG002|Overall Study|Protocol Violation|0|||
19743622|NCT03922711|42190661|FG000|Overall Study|Withdrawal by Subject|0|||
19743623|NCT03922711|42190662|FG001|Overall Study|Withdrawal by Subject|3|||
19743624|NCT03922711|42190663|FG002|Overall Study|Withdrawal by Subject|1|||
19743625|NCT03922711|42190661|FG000|Overall Study|Not further specified|0|||
19743626|NCT03922711|42190662|FG001|Overall Study|Not further specified|0|||
19743627|NCT03922711|42190663|FG002|Overall Study|Not further specified|1|||
19743628|NCT02877680|42190672|FG000|Overall Study|Lost to Follow-up|1|||
19743629|NCT02877680|42190673|FG001|Overall Study|Lost to Follow-up|1|||
19743630|NCT03141086|42190685|FG000|Overall Study|Study Terminated By Sponsor|1|||
19743631|NCT03141086|42190686|FG001|Overall Study|Study Terminated By Sponsor|1|||
19743632|NCT03141086|42190685|FG000|Overall Study|Withdrawal by Subject|0|||
19743633|NCT03141086|42190686|FG001|Overall Study|Withdrawal by Subject|1|||
19743634|NCT03141086|42190685|FG000|Overall Study|Protocol Violation|0|||
19743635|NCT03141086|42190686|FG001|Overall Study|Protocol Violation|1|||
19743636|NCT03141086|42190685|FG000|Overall Study|Adverse Event|0|||
19743637|NCT03141086|42190686|FG001|Overall Study|Adverse Event|2|||
19743638|NCT03135548|42190695|FG000|Overall Study|Lost to Follow-up|3|||
19743639|NCT03135548|42190696|FG001|Overall Study|Lost to Follow-up|0|||
19743640|NCT03135548|42190697|FG002|Overall Study|Lost to Follow-up|0|||
19743641|NCT03135548|42190695|FG000|Overall Study|Withdrawal by Subject|2|||
19743642|NCT03135548|42190696|FG001|Overall Study|Withdrawal by Subject|2|||
19743643|NCT03135548|42190697|FG002|Overall Study|Withdrawal by Subject|1|||
19743644|NCT03135548|42190695|FG000|Overall Study|Other than listed|0|||
19743645|NCT03135548|42190696|FG001|Overall Study|Other than listed|2|||
19743646|NCT03135548|42190697|FG002|Overall Study|Other than listed|2|||
19743647|NCT03134222|42190708|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
19743648|NCT03134222|42190709|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
19743649|NCT03134222|42190710|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
19743650|NCT03134222|42190711|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
19743651|NCT03134222|42190712|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
19743652|NCT03134222|42190708|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
19743653|NCT03134222|42190709|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
19743654|NCT03134222|42190710|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
19743655|NCT03134222|42190711|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
19743656|NCT03134222|42190712|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
19743657|NCT03134222|42190708|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
19743658|NCT03134222|42190709|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
19743659|NCT03134222|42190710|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
19743660|NCT03134222|42190711|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
19743661|NCT03134222|42190712|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
19743662|NCT03134222|42190708|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
19743663|NCT03134222|42190709|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
19743664|NCT03134222|42190710|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
19743665|NCT03134222|42190711|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
19743666|NCT03134222|42190712|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
19743667|NCT03134222|42190708|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
19743668|NCT03134222|42190709|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
19743669|NCT03134222|42190710|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
19743670|NCT03134222|42190711|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
19743671|NCT03134222|42190712|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
19743672|NCT03134222|42190708|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
19743673|NCT03134222|42190709|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
19743674|NCT03134222|42190710|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
19743675|NCT03134222|42190711|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
19743676|NCT03134222|42190712|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
19743677|NCT03134222|42190708|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
19743678|NCT03134222|42190709|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
19743679|NCT03134222|42190710|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
19743680|NCT03134222|42190711|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
19743681|NCT03134222|42190712|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
19743682|NCT03134222|42190708|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
19743683|NCT03134222|42190709|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
19743684|NCT03134222|42190710|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
19743685|NCT03134222|42190711|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
19743686|NCT03134222|42190712|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
19743687|NCT03769753|42190722|FG000|Overall Study|Not Treated|6|||
19743688|NCT03769753|42190722|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
19743689|NCT03263923|42190728|FG000|Overall Study|Withdrawal by Subject|10|||
19743690|NCT03263923|42190729|FG001|Overall Study|Withdrawal by Subject|8|||
19743691|NCT03263923|42190728|FG000|Overall Study|Lost to Follow-up|15|||
19743692|NCT03263923|42190729|FG001|Overall Study|Lost to Follow-up|13|||
19743693|NCT03139604|42190739|FG000|Overall Study|Other|7|||
19743694|NCT03139604|42190740|FG001|Overall Study|Other|3|||
19743695|NCT03139604|42190739|FG000|Overall Study|Withdrawal by Subject|16|||
19743696|NCT03139604|42190740|FG001|Overall Study|Withdrawal by Subject|17|||
19743697|NCT03139604|42190739|FG000|Overall Study|Physician Decision|1|||
19743698|NCT03139604|42190740|FG001|Overall Study|Physician Decision|2|||
19743699|NCT03139604|42190739|FG000|Overall Study|Lost to Follow-up|3|||
19743700|NCT03139604|42190740|FG001|Overall Study|Lost to Follow-up|1|||
19743701|NCT03139604|42190739|FG000|Overall Study|Death|65|||
19743702|NCT03139604|42190740|FG001|Overall Study|Death|67|||
19566085|NCT01130493|42014014|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
19566086|NCT01130493|42014012|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
19566087|NCT01130493|42014013|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
19566088|NCT01130493|42014014|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
19566089|NCT01130493|42014012|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
19566090|NCT01130493|42014013|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
19566091|NCT01130493|42014014|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
19566092|NCT01130493|42014012|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
19566093|NCT01130493|42014013|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
19566094|NCT01130493|42014014|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
19566095|NCT01130493|42014012|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
19566096|NCT01130493|42014013|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
19566097|NCT01130493|42014014|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
19566098|NCT01130493|42014012|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
19566099|NCT01130493|42014013|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
19566100|NCT01130493|42014014|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
19566101|NCT01130493|42014012|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
19566102|NCT01130493|42014013|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
19566103|NCT01130493|42014014|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
19566104|NCT01130493|42014012|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
19566105|NCT01130493|42014013|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
19566106|NCT01130493|42014014|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
19566107|NCT01130493|42014012|FG000|Part 2: OLE|Adverse Event|0|||
19566108|NCT01130493|42014013|FG001|Part 2: OLE|Adverse Event|2|||
19566109|NCT01130493|42014014|FG002|Part 2: OLE|Adverse Event|1|||
19743703|NCT03139604|42190739|FG000|Overall Study|Study Terminated by Sponsor|122|||
19743704|NCT03139604|42190740|FG001|Overall Study|Study Terminated by Sponsor|127|||
19743705|NCT03139604|42190739|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
19743706|NCT03139604|42190740|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
19743707|NCT03139448|42190749|FG000|Overall Study|Lack of Efficacy|6|||
19743708|NCT03139448|42190750|FG001|Overall Study|Lack of Efficacy|7|||
19743709|NCT03139448|42190749|FG000|Overall Study|Location of procedure changed|2|||
19743710|NCT03139448|42190750|FG001|Overall Study|Location of procedure changed|8|||
19743711|NCT03139448|42190749|FG000|Overall Study|Withdrawal by Subject|3|||
19743712|NCT03139448|42190750|FG001|Overall Study|Withdrawal by Subject|6|||
19743713|NCT03139448|42190749|FG000|Overall Study|Screen fail|1|||
19743714|NCT03139448|42190750|FG001|Overall Study|Screen fail|3|||
19743715|NCT03139448|42190749|FG000|Overall Study|Physician Decision|0|||
19743716|NCT03139448|42190750|FG001|Overall Study|Physician Decision|2|||
19743717|NCT02875340|42190756|FG000|Overall Study|Death|2|||
19743718|NCT02875340|42190756|FG000|Overall Study|Withdrawal by Subject|2|||
19743719|NCT02875340|42190756|FG000|Overall Study|Physician Decision|3|||
19743720|NCT02875340|42190756|FG000|Overall Study|Adverse Event|1|||
19743721|NCT03237325|42190768|FG000|Overall Study|Lost to Follow-up|3|||
19743722|NCT03237325|42190769|FG001|Overall Study|Lost to Follow-up|5|||
19743723|NCT03237325|42190768|FG000|Overall Study|Physician Decision|2|||
19743724|NCT03237325|42190769|FG001|Overall Study|Physician Decision|4|||
19743725|NCT03237325|42190768|FG000|Overall Study|Withdrawal by Subject|9|||
19743726|NCT03237325|42190769|FG001|Overall Study|Withdrawal by Subject|12|||
19743727|NCT03237325|42190768|FG000|Overall Study|Noncompliance with Study Procedures|1|||
19743728|NCT03237325|42190769|FG001|Overall Study|Noncompliance with Study Procedures|1|||
19743729|NCT03237325|42190768|FG000|Overall Study|Termination by Sponsor|0|||
19743730|NCT03237325|42190769|FG001|Overall Study|Termination by Sponsor|1|||
19743731|NCT03237325|42190768|FG000|Overall Study|Reason other than described|0|||
19743732|NCT03237325|42190769|FG001|Overall Study|Reason other than described|2|||
19743733|NCT03113383|42190775|FG000|Overall Study|Death|4|||
19743734|NCT03113383|42190776|FG001|Overall Study|Death|0|||
19743735|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
19743736|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
19743737|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
19743738|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
19743739|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
19743740|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
19743741|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
19743742|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
19743743|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
19743744|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
19743745|NCT03762265|42190797|FG000|BT Period: Weeks 1 to 37|Other|0|||
19743746|NCT03762265|42190798|FG001|BT Period: Weeks 1 to 37|Other|1|||
19743747|NCT03762265|42190797|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
19743748|NCT03762265|42190798|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
19743749|NCT03762265|42190797|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
19743750|NCT03762265|42190798|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
19743751|NCT03762265|42190797|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
19743752|NCT03762265|42190798|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
19743753|NCT03762265|42190797|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
19743754|NCT03762265|42190798|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
19743755|NCT03762265|42190797|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
19743756|NCT03762265|42190798|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
19743757|NCT03762265|42190797|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
19743758|NCT03762265|42190798|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
19743759|NCT03762265|42190797|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
19743760|NCT03762265|42190798|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
19743761|NCT03762265|42190797|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
19743762|NCT03762265|42190798|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
19743763|NCT03762265|42190797|FG000|LTE Period: Weeks 61 to 109|Other|1|||
19743764|NCT03762265|42190798|FG001|LTE Period: Weeks 61 to 109|Other|0|||
19743765|NCT03131960|42190822|FG000|Overall Study|Adverse Event|0|||
19743766|NCT03131960|42190823|FG001|Overall Study|Adverse Event|1|||
19743767|NCT03225170|42190832|FG000|Overall Study|Lost to Follow-up|4|||
19743768|NCT03225170|42190833|FG001|Overall Study|Lost to Follow-up|4|||
19743769|NCT03225170|42190834|FG002|Overall Study|Lost to Follow-up|0|||
19743770|NCT03225170|42190832|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
19743771|NCT03225170|42190833|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
19743772|NCT03225170|42190834|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
19743773|NCT02115139|42190840|FG000|Overall Study|Protocol Violation|1|||
19743774|NCT02115139|42190840|FG000|Overall Study|treatment discontinuation|6|||
19743775|NCT01763827|42190888|FG000|Overall Study|Withdrawal by Subject|1|||
19743776|NCT01763827|42190889|FG001|Overall Study|Withdrawal by Subject|0|||
19743777|NCT01763827|42190890|FG002|Overall Study|Withdrawal by Subject|0|||
19743778|NCT01763827|42190891|FG003|Overall Study|Withdrawal by Subject|0|||
19743779|NCT01763827|42190892|FG004|Overall Study|Withdrawal by Subject|2|||
19743780|NCT01763827|42190893|FG005|Overall Study|Withdrawal by Subject|0|||
19743781|NCT01763827|42190888|FG000|Overall Study|Decision by sponsor|2|||
19743782|NCT01763827|42190889|FG001|Overall Study|Decision by sponsor|0|||
19743783|NCT01763827|42190890|FG002|Overall Study|Decision by sponsor|3|||
19743784|NCT01763827|42190891|FG003|Overall Study|Decision by sponsor|0|||
19743785|NCT01763827|42190892|FG004|Overall Study|Decision by sponsor|2|||
19743786|NCT01763827|42190893|FG005|Overall Study|Decision by sponsor|1|||
19743787|NCT01763827|42190888|FG000|Overall Study|Lost to Follow-up|0|||
19743788|NCT01763827|42190889|FG001|Overall Study|Lost to Follow-up|1|||
19743789|NCT01763827|42190890|FG002|Overall Study|Lost to Follow-up|1|||
19743790|NCT01763827|42190891|FG003|Overall Study|Lost to Follow-up|1|||
19743791|NCT01763827|42190892|FG004|Overall Study|Lost to Follow-up|2|||
19743792|NCT01763827|42190893|FG005|Overall Study|Lost to Follow-up|1|||
19743793|NCT01732783|42190946|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
19743794|NCT01732783|42190947|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
19743795|NCT01732783|42190948|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
19743796|NCT01732783|42190946|FG000|Overall Study|Death|13|||
19743797|NCT01732783|42190947|FG001|Overall Study|Death|4|||
19743798|NCT01732783|42190948|FG002|Overall Study|Death|1|||
19743799|NCT01732783|42190946|FG000|Overall Study|Lost to Follow-up|7|||
19743800|NCT01732783|42190947|FG001|Overall Study|Lost to Follow-up|1|||
19743801|NCT01732783|42190948|FG002|Overall Study|Lost to Follow-up|1|||
19743802|NCT01732783|42190946|FG000|Overall Study|Administrative Decision|8|||
19743803|NCT01732783|42190947|FG001|Overall Study|Administrative Decision|2|||
19743804|NCT01732783|42190948|FG002|Overall Study|Administrative Decision|1|||
19743805|NCT01732783|42190946|FG000|Overall Study|Withdrawal by Subject|1|||
19743806|NCT01732783|42190947|FG001|Overall Study|Withdrawal by Subject|0|||
19743807|NCT01732783|42190948|FG002|Overall Study|Withdrawal by Subject|0|||
19743808|NCT02787850|42190975|FG000|Overall Study|Withdrawal by Subject|0|||
19743809|NCT02787850|42190976|FG001|Overall Study|Withdrawal by Subject|1|||
19743810|NCT01375777|42191000|FG000|Overall Study|Withdrawal by Subject|0|||
19743811|NCT01375777|42191001|FG001|Overall Study|Withdrawal by Subject|2|||
19743812|NCT01375777|42191002|FG002|Overall Study|Withdrawal by Subject|1|||
19743813|NCT01375777|42191003|FG003|Overall Study|Withdrawal by Subject|0|||
19743814|NCT01375777|42191004|FG004|Overall Study|Withdrawal by Subject|1|||
19743815|NCT01375777|42191005|FG005|Overall Study|Withdrawal by Subject|1|||
19743816|NCT01375777|42191006|FG006|Overall Study|Withdrawal by Subject|1|||
19743817|NCT01375777|42191007|FG007|Overall Study|Withdrawal by Subject|2|||
19743818|NCT01375777|42191008|FG008|Overall Study|Withdrawal by Subject|1|||
19743819|NCT01375777|42191000|FG000|Overall Study|Lost to Follow-up|1|||
19743820|NCT01375777|42191001|FG001|Overall Study|Lost to Follow-up|0|||
19743821|NCT01375777|42191002|FG002|Overall Study|Lost to Follow-up|0|||
19743822|NCT01375777|42191003|FG003|Overall Study|Lost to Follow-up|0|||
19743823|NCT01375777|42191004|FG004|Overall Study|Lost to Follow-up|0|||
19743824|NCT01375777|42191005|FG005|Overall Study|Lost to Follow-up|0|||
19743825|NCT01375777|42191006|FG006|Overall Study|Lost to Follow-up|1|||
19743826|NCT01375777|42191007|FG007|Overall Study|Lost to Follow-up|0|||
19743827|NCT01375777|42191008|FG008|Overall Study|Lost to Follow-up|0|||
19743828|NCT01375777|42191000|FG000|Overall Study|Other|1|||
19743829|NCT01375777|42191001|FG001|Overall Study|Other|1|||
19743830|NCT01375777|42191002|FG002|Overall Study|Other|0|||
19743831|NCT01375777|42191003|FG003|Overall Study|Other|0|||
19743832|NCT01375777|42191004|FG004|Overall Study|Other|0|||
19743833|NCT01375777|42191005|FG005|Overall Study|Other|0|||
19743834|NCT01375777|42191006|FG006|Overall Study|Other|0|||
19743835|NCT01375777|42191007|FG007|Overall Study|Other|0|||
19743836|NCT01375777|42191008|FG008|Overall Study|Other|1|||
19743837|NCT02431702|42191028|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
19743838|NCT02431702|42191029|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743839|NCT02431702|42191030|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743840|NCT02431702|42191031|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743841|NCT02431702|42191032|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743842|NCT02431702|42191033|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743843|NCT02431702|42191034|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
19743844|NCT02431702|42191028|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
19743845|NCT02431702|42191029|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
19743846|NCT02431702|42191030|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
19743847|NCT02431702|42191031|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
19743848|NCT02431702|42191032|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
19743849|NCT02431702|42191033|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
19743850|NCT02431702|42191034|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
19743851|NCT02431702|42191028|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
19743852|NCT02431702|42191029|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
19743853|NCT02431702|42191030|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
19743854|NCT02431702|42191031|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
19743855|NCT02431702|42191032|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
19743856|NCT02431702|42191033|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
19743857|NCT02431702|42191034|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
19743858|NCT02431702|42191028|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
19743859|NCT02431702|42191029|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
19743860|NCT02431702|42191030|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
19743861|NCT02431702|42191031|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
19743862|NCT02431702|42191032|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
19743863|NCT02431702|42191033|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
19743864|NCT02431702|42191034|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
19743865|NCT02431702|42191028|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
19743866|NCT02431702|42191029|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743867|NCT02431702|42191030|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743868|NCT02431702|42191031|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743869|NCT02431702|42191032|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743870|NCT02431702|42191033|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743871|NCT02431702|42191034|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
19743872|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
19743873|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
19743874|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
19743875|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
19743876|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
19743877|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
19743878|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
19743879|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
19743880|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
19743881|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
19743882|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
19743883|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
19743884|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
19743885|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
19743886|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
19743887|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
19743888|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
19743889|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
19743890|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
19743891|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
19743892|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
19743893|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743894|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
19743895|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743896|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743897|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743898|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743899|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
19743900|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
19743901|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
19743902|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
19743903|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
19743904|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
19743905|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
19743906|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
19743907|NCT02431702|42191028|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743908|NCT02431702|42191029|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743909|NCT02431702|42191030|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
19743910|NCT02431702|42191031|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743911|NCT02431702|42191032|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743912|NCT02431702|42191033|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743913|NCT02431702|42191034|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
19743914|NCT02431702|42191028|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
19743915|NCT02431702|42191029|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
19743916|NCT02431702|42191030|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
19743917|NCT02431702|42191031|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
19743918|NCT02431702|42191032|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
19743919|NCT02431702|42191033|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
19743920|NCT02431702|42191034|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
19743921|NCT02431702|42191028|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
19743922|NCT02431702|42191029|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
19743923|NCT02431702|42191030|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
19743924|NCT02431702|42191031|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
19743925|NCT02431702|42191032|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
19743926|NCT02431702|42191033|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
19743927|NCT02431702|42191034|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
19743928|NCT02431702|42191028|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
19743929|NCT02431702|42191029|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
19743930|NCT02431702|42191030|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
19743931|NCT02431702|42191031|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
19743932|NCT02431702|42191032|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
19743933|NCT02431702|42191033|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
19743934|NCT02431702|42191034|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
19743935|NCT02431702|42191028|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
19743936|NCT02431702|42191029|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
19743937|NCT02431702|42191030|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
19743938|NCT02431702|42191031|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
19743939|NCT02431702|42191032|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
19743940|NCT02431702|42191033|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
19743941|NCT02431702|42191034|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
19743942|NCT02086552|42191067|FG000|Overall Study|Withdrawal by Subject|1|||
19743943|NCT03131570|42191112|FG000|Overall Study|Adverse Event|1|||
19743944|NCT03131570|42191113|FG001|Overall Study|Adverse Event|0|||
19743945|NCT02930018|42191123|FG000|Overall Study|Lost to Follow-up|1|||
19743946|NCT02930018|42191124|FG001|Overall Study|Lost to Follow-up|1|||
19743947|NCT02930018|42191123|FG000|Overall Study|Withdrawal by Subject|5|||
19743948|NCT02930018|42191124|FG001|Overall Study|Withdrawal by Subject|2|||
19743949|NCT02875028|42191132|FG000|Washout Period|Withdrawal by Subject|0|||
19743950|NCT02875028|42191133|FG001|Washout Period|Withdrawal by Subject|1|||
19743951|NCT00943618|42191144|FG000|Overall Study|Lost to Follow-up|38|||
19743952|NCT00943618|42191145|FG001|Overall Study|Lost to Follow-up|48|||
19743953|NCT00943618|42191146|FG002|Overall Study|Lost to Follow-up|20|||
19743954|NCT00943618|42191144|FG000|Overall Study|Discontinued Medication|17|||
19743955|NCT00943618|42191145|FG001|Overall Study|Discontinued Medication|29|||
19743956|NCT00943618|42191146|FG002|Overall Study|Discontinued Medication|11|||
19743957|NCT02710084|42191169|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
19743958|NCT02710084|42191170|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
19743959|NCT02849990|42191177|FG000|Overall Study|Adverse Event|1|||
19743960|NCT02849990|42191177|FG000|Overall Study|Withdrawal by Subject|1|||
19743961|NCT02017964|42191181|FG000|Overall Study|Patient deemed ineligible|1|||
19743962|NCT01956110|42191187|FG000|Overall Study|Protocol Violation|25|||
19743963|NCT01956110|42191188|FG001|Overall Study|Protocol Violation|11|||
19743964|NCT01956110|42191187|FG000|Overall Study|Adverse Event|9|||
19743965|NCT01956110|42191188|FG001|Overall Study|Adverse Event|10|||
19743966|NCT01956110|42191187|FG000|Overall Study|Personal reasons|1|||
19743967|NCT01956110|42191188|FG001|Overall Study|Personal reasons|1|||
19743968|NCT03116828|42191219|FG000|Overall Study|Adverse Event|1|||
19743969|NCT03116828|42191220|FG001|Overall Study|Adverse Event|10|||
19743970|NCT03116828|42191219|FG000|Overall Study|Withdrawal by Subject|4|||
19743971|NCT03116828|42191220|FG001|Overall Study|Withdrawal by Subject|8|||
19743972|NCT03116828|42191219|FG000|Overall Study|OTHER|3|||
19743973|NCT03116828|42191220|FG001|Overall Study|OTHER|3|||
19743974|NCT03938272|42191228|FG000|Overall Study|Withdrawal by Subject|1|||
19743975|NCT03938272|42191229|FG001|Overall Study|Withdrawal by Subject|0|||
19743976|NCT03938272|42191228|FG000|Overall Study|Physician Decision|0|||
19743977|NCT03938272|42191229|FG001|Overall Study|Physician Decision|2|||
19743978|NCT03938272|42191228|FG000|Overall Study|Study termination by sponsor|10|||
19743979|NCT03938272|42191229|FG001|Overall Study|Study termination by sponsor|8|||
19743980|NCT02565914|42191235|FG000|Overall Study|Adverse Event|17|||
19743981|NCT02565914|42191235|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
19743982|NCT02565914|42191235|FG000|Overall Study|Lost to Follow-up|12|||
19743983|NCT02565914|42191235|FG000|Overall Study|Death (not treatment emergent)|1|||
19743984|NCT02565914|42191235|FG000|Overall Study|Other noncompliance|6|||
19743985|NCT02565914|42191235|FG000|Overall Study|Physician Decision|6|||
19743986|NCT02565914|42191235|FG000|Overall Study|Parent study termination by sponsor|1|||
19743987|NCT02565914|42191235|FG000|Overall Study|Commercial drug available|5|||
19743988|NCT02565914|42191235|FG000|Overall Study|Other|18|||
19743989|NCT02565914|42191235|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
19743990|NCT03126344|42191259|FG000|Overall Study|Lost to Follow-up|0|||
19743991|NCT03126344|42191260|FG001|Overall Study|Lost to Follow-up|0|||
19743992|NCT03126344|42191261|FG002|Overall Study|Lost to Follow-up|5|||
19743993|NCT03115112|42191282|FG000|Overall Study|Adverse Event|5|||
19743994|NCT03115112|42191283|FG001|Overall Study|Adverse Event|1|||
19743995|NCT03115112|42191282|FG000|Overall Study|Withdrawal by Subject|4|||
19743996|NCT03115112|42191283|FG001|Overall Study|Withdrawal by Subject|2|||
19743997|NCT03115112|42191282|FG000|Overall Study|Lost to Follow-up|0|||
19743998|NCT03115112|42191283|FG001|Overall Study|Lost to Follow-up|1|||
19743999|NCT03115112|42191282|FG000|Overall Study|Death|1|||
19566110|NCT01130493|42014012|FG000|Part 2: OLE|Withdrawal by Subject|0|||
19566111|NCT01130493|42014013|FG001|Part 2: OLE|Withdrawal by Subject|1|||
19566112|NCT01130493|42014014|FG002|Part 2: OLE|Withdrawal by Subject|4|||
19566113|NCT01130337|42014025|FG000|Overall Study|Withdrawal by Subject|3|||
19566114|NCT01130337|42014025|FG000|Overall Study|Principal investigator decision|1|||
19566115|NCT01130337|42014025|FG000|Overall Study|Death|1|||
19566116|NCT01130337|42014025|FG000|Overall Study|Disease progression|1|||
19566117|NCT01130337|42014025|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
19566118|NCT01130337|42014025|FG000|Overall Study|Surgical resection (R2)|1|||
19566119|NCT01130103|42014031|FG000|Randomized Treatment|Adverse Event|1|||
19566120|NCT01130103|42014032|FG001|Randomized Treatment|Adverse Event|1|||
19566121|NCT01130103|42014031|FG000|Randomized Treatment|Lost to Follow-up|1|||
19566122|NCT01130103|42014032|FG001|Randomized Treatment|Lost to Follow-up|0|||
19566123|NCT01130103|42014031|FG000|Randomized Treatment|Protocol Violation|3|||
19566124|NCT01130103|42014032|FG001|Randomized Treatment|Protocol Violation|2|||
19744000|NCT03115112|42191283|FG001|Overall Study|Death|0|||
19744001|NCT03115112|42191282|FG000|Overall Study|Pregnancy|1|||
19744002|NCT03115112|42191283|FG001|Overall Study|Pregnancy|0|||
19744003|NCT03115112|42191282|FG000|Overall Study|Site closure|1|||
19744004|NCT03115112|42191283|FG001|Overall Study|Site closure|1|||
19744005|NCT03556358|42191302|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
19744006|NCT03556358|42191303|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
19744007|NCT03556358|42191302|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
19744008|NCT03556358|42191303|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
19744009|NCT03556358|42191302|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
19744010|NCT03556358|42191303|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
19744011|NCT03556358|42191302|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
19744012|NCT03556358|42191303|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
19744013|NCT03556358|42191302|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
19744014|NCT03556358|42191303|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
19744015|NCT03556358|42191302|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
19744016|NCT03556358|42191303|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
19744017|NCT03556358|42191302|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
19744018|NCT03556358|42191303|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
19744019|NCT03228680|42191311|FG000|Overall Study|Adverse Event|13|||
19744020|NCT03228680|42191312|FG001|Overall Study|Adverse Event|18|||
19744021|NCT03228680|42191311|FG000|Overall Study|Randomization failure|0|||
19744022|NCT03228680|42191312|FG001|Overall Study|Randomization failure|1|||
19744023|NCT03228680|42191311|FG000|Overall Study|Withdrawal by Subject|1|||
19744024|NCT03228680|42191312|FG001|Overall Study|Withdrawal by Subject|0|||
19744025|NCT03228680|42191311|FG000|Overall Study|Other|9|||
19744026|NCT03228680|42191312|FG001|Overall Study|Other|16|||
19744027|NCT03118934|42191340|FG000|Overall Study|Adverse Event|0|||
19744028|NCT03118934|42191341|FG001|Overall Study|Adverse Event|0|||
19744029|NCT03118934|42191342|FG002|Overall Study|Adverse Event|0|||
19744030|NCT03118934|42191343|FG003|Overall Study|Adverse Event|0|||
19744031|NCT03118934|42191344|FG004|Overall Study|Adverse Event|0|||
19744032|NCT03118934|42191345|FG005|Overall Study|Adverse Event|1|||
19744033|NCT03118934|42191340|FG000|Overall Study|Physician Decision|0|||
19744034|NCT03118934|42191341|FG001|Overall Study|Physician Decision|0|||
19744035|NCT03118934|42191342|FG002|Overall Study|Physician Decision|0|||
19744036|NCT03118934|42191343|FG003|Overall Study|Physician Decision|0|||
19744037|NCT03118934|42191344|FG004|Overall Study|Physician Decision|0|||
19744038|NCT03118934|42191345|FG005|Overall Study|Physician Decision|1|||
19744039|NCT03118934|42191340|FG000|Overall Study|Discontinued prior to exposure|0|||
19744040|NCT03118934|42191341|FG001|Overall Study|Discontinued prior to exposure|1|||
19744041|NCT03118934|42191342|FG002|Overall Study|Discontinued prior to exposure|1|||
19744042|NCT03118934|42191343|FG003|Overall Study|Discontinued prior to exposure|1|||
19744043|NCT03118934|42191344|FG004|Overall Study|Discontinued prior to exposure|2|||
19744044|NCT03118934|42191345|FG005|Overall Study|Discontinued prior to exposure|0|||
19744045|NCT03114488|42191355|FG000|Time Period 2|Withdrawal by Subject|1|||
19744046|NCT03114488|42191356|FG001|Time Period 2|Withdrawal by Subject|3|||
19744047|NCT03135262|42191375|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
19744048|NCT03135262|42191376|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
19744049|NCT03135262|42191377|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
19744050|NCT03135262|42191378|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
19744051|NCT03135262|42191379|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
19744052|NCT03135262|42191375|FG000|Overall Study|Progression of disease|0|||
19744053|NCT03135262|42191376|FG001|Overall Study|Progression of disease|0|||
19744054|NCT03135262|42191377|FG002|Overall Study|Progression of disease|0|||
19744055|NCT03135262|42191378|FG003|Overall Study|Progression of disease|1|||
19744056|NCT03135262|42191379|FG004|Overall Study|Progression of disease|0|||
19744057|NCT03135262|42191375|FG000|Overall Study|Death|6|||
19744058|NCT03135262|42191376|FG001|Overall Study|Death|2|||
19744059|NCT03135262|42191377|FG002|Overall Study|Death|2|||
19744060|NCT03135262|42191378|FG003|Overall Study|Death|2|||
19744061|NCT03135262|42191379|FG004|Overall Study|Death|0|||
19744062|NCT03135262|42191375|FG000|Overall Study|Withdrawal by Subject|0|||
19744063|NCT03135262|42191376|FG001|Overall Study|Withdrawal by Subject|0|||
19744064|NCT03135262|42191377|FG002|Overall Study|Withdrawal by Subject|1|||
19744065|NCT03135262|42191378|FG003|Overall Study|Withdrawal by Subject|0|||
19744066|NCT03135262|42191379|FG004|Overall Study|Withdrawal by Subject|1|||
19744067|NCT03135262|42191375|FG000|Overall Study|Study terminated by sponsor|2|||
19744068|NCT03135262|42191376|FG001|Overall Study|Study terminated by sponsor|4|||
19744069|NCT03135262|42191377|FG002|Overall Study|Study terminated by sponsor|4|||
19744070|NCT03135262|42191378|FG003|Overall Study|Study terminated by sponsor|3|||
19744071|NCT03135262|42191379|FG004|Overall Study|Study terminated by sponsor|0|||
19744072|NCT03535194|42191414|FG000|Induction Period|Adverse Event|2|||
19744073|NCT03535194|42191415|FG001|Induction Period|Adverse Event|2|||
19744074|NCT03535194|42191416|FG002|Induction Period|Adverse Event|1|||
19744075|NCT03535194|42191417|FG003|Induction Period|Adverse Event|3|||
19744076|NCT03535194|42191418|FG004|Induction Period|Adverse Event|0|||
19744077|NCT03535194|42191414|FG000|Induction Period|Death|0|||
19744078|NCT03535194|42191415|FG001|Induction Period|Death|1|||
19744079|NCT03535194|42191416|FG002|Induction Period|Death|0|||
19744080|NCT03535194|42191417|FG003|Induction Period|Death|0|||
19744081|NCT03535194|42191418|FG004|Induction Period|Death|0|||
19744082|NCT03535194|42191414|FG000|Induction Period|Lack of Efficacy|1|||
19744083|NCT03535194|42191415|FG001|Induction Period|Lack of Efficacy|3|||
19744084|NCT03535194|42191416|FG002|Induction Period|Lack of Efficacy|2|||
19744085|NCT03535194|42191417|FG003|Induction Period|Lack of Efficacy|2|||
19744086|NCT03535194|42191418|FG004|Induction Period|Lack of Efficacy|0|||
19744087|NCT03535194|42191414|FG000|Induction Period|Lost to Follow-up|3|||
19744088|NCT03535194|42191415|FG001|Induction Period|Lost to Follow-up|5|||
19744089|NCT03535194|42191416|FG002|Induction Period|Lost to Follow-up|2|||
19744090|NCT03535194|42191417|FG003|Induction Period|Lost to Follow-up|3|||
19744091|NCT03535194|42191418|FG004|Induction Period|Lost to Follow-up|0|||
19744092|NCT03535194|42191414|FG000|Induction Period|Physician Decision|1|||
19744093|NCT03535194|42191415|FG001|Induction Period|Physician Decision|1|||
19744094|NCT03535194|42191416|FG002|Induction Period|Physician Decision|0|||
19744095|NCT03535194|42191417|FG003|Induction Period|Physician Decision|0|||
19744096|NCT03535194|42191418|FG004|Induction Period|Physician Decision|0|||
19744097|NCT03535194|42191414|FG000|Induction Period|Protocol Violation|1|||
19744098|NCT03535194|42191415|FG001|Induction Period|Protocol Violation|0|||
19744099|NCT03535194|42191416|FG002|Induction Period|Protocol Violation|0|||
19744100|NCT03535194|42191417|FG003|Induction Period|Protocol Violation|1|||
19744101|NCT03535194|42191418|FG004|Induction Period|Protocol Violation|0|||
19744102|NCT03535194|42191414|FG000|Induction Period|Screen Failure|0|||
19744103|NCT03535194|42191415|FG001|Induction Period|Screen Failure|1|||
19744104|NCT03535194|42191416|FG002|Induction Period|Screen Failure|0|||
19744105|NCT03535194|42191417|FG003|Induction Period|Screen Failure|0|||
19744106|NCT03535194|42191418|FG004|Induction Period|Screen Failure|0|||
19744107|NCT03535194|42191414|FG000|Induction Period|Withdrawal by Subject|3|||
19744108|NCT03535194|42191415|FG001|Induction Period|Withdrawal by Subject|4|||
19744109|NCT03535194|42191416|FG002|Induction Period|Withdrawal by Subject|3|||
19744110|NCT03535194|42191417|FG003|Induction Period|Withdrawal by Subject|2|||
19744111|NCT03535194|42191418|FG004|Induction Period|Withdrawal by Subject|0|||
19744112|NCT03535194|42191414|FG000|Maintenance Period|Adverse Event|6|||
19744113|NCT03535194|42191415|FG001|Maintenance Period|Adverse Event|5|||
19744114|NCT03535194|42191416|FG002|Maintenance Period|Adverse Event|1|||
19744115|NCT03535194|42191417|FG003|Maintenance Period|Adverse Event|11|||
19744116|NCT03535194|42191418|FG004|Maintenance Period|Adverse Event|4|||
19744117|NCT03535194|42191414|FG000|Maintenance Period|Lack of Efficacy|3|||
19744118|NCT03535194|42191415|FG001|Maintenance Period|Lack of Efficacy|2|||
19744119|NCT03535194|42191416|FG002|Maintenance Period|Lack of Efficacy|5|||
19744120|NCT03535194|42191417|FG003|Maintenance Period|Lack of Efficacy|9|||
19744121|NCT03535194|42191418|FG004|Maintenance Period|Lack of Efficacy|0|||
19744122|NCT03535194|42191414|FG000|Maintenance Period|Lost to Follow-up|4|||
19744123|NCT03535194|42191415|FG001|Maintenance Period|Lost to Follow-up|2|||
19744124|NCT03535194|42191416|FG002|Maintenance Period|Lost to Follow-up|1|||
19744125|NCT03535194|42191417|FG003|Maintenance Period|Lost to Follow-up|5|||
19744126|NCT03535194|42191418|FG004|Maintenance Period|Lost to Follow-up|2|||
19744127|NCT03535194|42191414|FG000|Maintenance Period|Other|1|||
19744128|NCT03535194|42191415|FG001|Maintenance Period|Other|2|||
19744129|NCT03535194|42191416|FG002|Maintenance Period|Other|0|||
19744130|NCT03535194|42191417|FG003|Maintenance Period|Other|0|||
19744131|NCT03535194|42191418|FG004|Maintenance Period|Other|0|||
19744132|NCT03535194|42191414|FG000|Maintenance Period|Physician Decision|1|||
19744133|NCT03535194|42191415|FG001|Maintenance Period|Physician Decision|2|||
19744134|NCT03535194|42191416|FG002|Maintenance Period|Physician Decision|0|||
19744135|NCT03535194|42191417|FG003|Maintenance Period|Physician Decision|2|||
19744136|NCT03535194|42191418|FG004|Maintenance Period|Physician Decision|0|||
19744137|NCT03535194|42191414|FG000|Maintenance Period|Pregnancy|0|||
19744138|NCT03535194|42191415|FG001|Maintenance Period|Pregnancy|0|||
19744139|NCT03535194|42191416|FG002|Maintenance Period|Pregnancy|0|||
19744140|NCT03535194|42191417|FG003|Maintenance Period|Pregnancy|2|||
19744141|NCT03535194|42191418|FG004|Maintenance Period|Pregnancy|0|||
19744142|NCT03535194|42191414|FG000|Maintenance Period|Protocol Violation|0|||
19744143|NCT03535194|42191415|FG001|Maintenance Period|Protocol Violation|1|||
19744144|NCT03535194|42191416|FG002|Maintenance Period|Protocol Violation|0|||
19744145|NCT03535194|42191417|FG003|Maintenance Period|Protocol Violation|0|||
19744146|NCT03535194|42191418|FG004|Maintenance Period|Protocol Violation|0|||
19744147|NCT03535194|42191414|FG000|Maintenance Period|Withdrawal by Subject|7|||
19744148|NCT03535194|42191415|FG001|Maintenance Period|Withdrawal by Subject|2|||
19744149|NCT03535194|42191416|FG002|Maintenance Period|Withdrawal by Subject|1|||
19744150|NCT03535194|42191417|FG003|Maintenance Period|Withdrawal by Subject|8|||
19744151|NCT03535194|42191418|FG004|Maintenance Period|Withdrawal by Subject|0|||
19744152|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Adverse Event|4|||
19744153|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Adverse Event|5|||
19744154|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Adverse Event|1|||
19744155|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Adverse Event|8|||
19744156|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Adverse Event|0|||
19744157|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
19744158|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
19744159|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
19744160|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
19744161|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
19744162|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
19744163|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
19744164|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
19744165|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
19744166|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
19744167|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Other|1|||
19744168|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Other|0|||
19744169|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Other|0|||
19744170|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Other|5|||
19744171|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Other|0|||
19744172|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Physician Decision|0|||
19744173|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Physician Decision|2|||
19744174|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Physician Decision|1|||
19744175|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Physician Decision|1|||
19744176|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Physician Decision|0|||
19744177|NCT03535194|42191414|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
19744178|NCT03535194|42191415|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
19744179|NCT03535194|42191416|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
19744180|NCT03535194|42191417|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
19744181|NCT03535194|42191418|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19744182|NCT03559530|42191442|FG000|Overall Study|non-location of medical records|44|||
19744183|NCT03559530|42191443|FG001|Overall Study|non-location of medical records|0|||
19744184|NCT03559530|42191442|FG000|Overall Study|culture results not considered for treat|29|||
19744185|NCT03559530|42191443|FG001|Overall Study|culture results not considered for treat|0|||
19744186|NCT03559530|42191442|FG000|Overall Study|duplicate cases|8|||
19744187|NCT03559530|42191443|FG001|Overall Study|duplicate cases|0|||
19744188|NCT03559530|42191442|FG000|Overall Study|other species of Acinetobacte|7|||
19744189|NCT03559530|42191443|FG001|Overall Study|other species of Acinetobacte|0|||
19744190|NCT03559530|42191442|FG000|Overall Study|contamination / colonization|3|||
19744191|NCT03559530|42191443|FG001|Overall Study|contamination / colonization|0|||
19744192|NCT01898650|42191471|FG000|Overall Study|the subject would not lie still for imaging|1|||
19744193|NCT03124784|42191475|FG000|Overall Study|Adverse Event|1|||
19744194|NCT03124784|42191475|FG000|Overall Study|Computer/Equip Malfunction|1|||
19744195|NCT03531840|42191483|FG000|Overall Study|Death on study|3|||
19744196|NCT03531840|42191484|FG001|Overall Study|Death on study|2|||
19744197|NCT03531840|42191485|FG002|Overall Study|Death on study|1|||
19744198|NCT03531840|42191486|FG003|Overall Study|Death on study|2|||
19744199|NCT03531840|42191483|FG000|Overall Study|Death during follow up|2|||
19744200|NCT03531840|42191484|FG001|Overall Study|Death during follow up|3|||
19744201|NCT03531840|42191485|FG002|Overall Study|Death during follow up|4|||
19744202|NCT03531840|42191486|FG003|Overall Study|Death during follow up|1|||
19744203|NCT03110900|42191503|FG000|Overall Study|Sponsor withdrew|1|||
19744204|NCT03110900|42191504|FG001|Overall Study|Sponsor withdrew|1|||
19744205|NCT03867734|42191510|FG000|Overall Study|Lost to Follow-up|2|||
19744206|NCT03446456|42191520|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
19744207|NCT03446456|42191521|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
19744208|NCT03446456|42191520|FG000|Overall Study|Lost to Follow-up|1|||
19744209|NCT03446456|42191521|FG001|Overall Study|Lost to Follow-up|3|||
19744210|NCT03446456|42191520|FG000|Overall Study|Participant failed the toxicology test|1|||
19744211|NCT03446456|42191521|FG001|Overall Study|Participant failed the toxicology test|0|||
19744212|NCT03446456|42191520|FG000|Overall Study|Break down of the experimental equipment|1|||
19744213|NCT03446456|42191521|FG001|Overall Study|Break down of the experimental equipment|0|||
19744214|NCT03495102|42191530|FG000|Overall Study|Adverse Event|5|||
19744215|NCT03495102|42191531|FG001|Overall Study|Adverse Event|7|||
19744216|NCT03495102|42191532|FG002|Overall Study|Adverse Event|10|||
19744217|NCT03495102|42191530|FG000|Overall Study|Death|3|||
19744218|NCT03495102|42191531|FG001|Overall Study|Death|4|||
19744219|NCT03495102|42191532|FG002|Overall Study|Death|4|||
19744220|NCT03495102|42191530|FG000|Overall Study|Lost to Follow-up|15|||
19744221|NCT03495102|42191531|FG001|Overall Study|Lost to Follow-up|16|||
19744222|NCT03495102|42191532|FG002|Overall Study|Lost to Follow-up|17|||
19744223|NCT03495102|42191530|FG000|Overall Study|Physician Decision|2|||
19744224|NCT03495102|42191531|FG001|Overall Study|Physician Decision|0|||
19744225|NCT03495102|42191532|FG002|Overall Study|Physician Decision|2|||
19744226|NCT03495102|42191530|FG000|Overall Study|Withdrawal by Subject|25|||
19744227|NCT03495102|42191531|FG001|Overall Study|Withdrawal by Subject|36|||
19744228|NCT03495102|42191532|FG002|Overall Study|Withdrawal by Subject|18|||
19744229|NCT03495102|42191530|FG000|Overall Study|Protocol Violation|1|||
19744230|NCT03495102|42191531|FG001|Overall Study|Protocol Violation|1|||
19744231|NCT03495102|42191532|FG002|Overall Study|Protocol Violation|0|||
19744232|NCT03495102|42191530|FG000|Overall Study|Site Closure|3|||
19744233|NCT03495102|42191531|FG001|Overall Study|Site Closure|1|||
19744234|NCT03495102|42191532|FG002|Overall Study|Site Closure|2|||
19744235|NCT03495102|42191530|FG000|Overall Study|Non-compliance|1|||
19744236|NCT03495102|42191531|FG001|Overall Study|Non-compliance|0|||
19744237|NCT03495102|42191532|FG002|Overall Study|Non-compliance|0|||
19744238|NCT03495102|42191530|FG000|Overall Study|Participant Duplicated at Another Site|0|||
19744239|NCT03495102|42191531|FG001|Overall Study|Participant Duplicated at Another Site|0|||
19744240|NCT03495102|42191532|FG002|Overall Study|Participant Duplicated at Another Site|1|||
19744241|NCT03495102|42191530|FG000|Overall Study|Primary Care Physician Recommendation|0|||
19744242|NCT03495102|42191531|FG001|Overall Study|Primary Care Physician Recommendation|1|||
19744243|NCT03495102|42191532|FG002|Overall Study|Primary Care Physician Recommendation|0|||
19744244|NCT03495102|42191530|FG000|Overall Study|Relocated to Another Country|0|||
19744245|NCT03495102|42191531|FG001|Overall Study|Relocated to Another Country|1|||
19744246|NCT03495102|42191532|FG002|Overall Study|Relocated to Another Country|0|||
19744247|NCT03495102|42191530|FG000|Overall Study|Participant was in Rehabilitation|1|||
19744248|NCT03495102|42191531|FG001|Overall Study|Participant was in Rehabilitation|0|||
19744249|NCT03495102|42191532|FG002|Overall Study|Participant was in Rehabilitation|0|||
19744250|NCT03105362|42191540|FG000|Overall Study|Withdrawal by Subject|1|||
19744251|NCT03105362|42191540|FG000|Overall Study|Lost to Follow-up|1|||
19744252|NCT03559218|42191549|FG000|Overall Study|Withdrawal by Subject|1|||
19744253|NCT03559218|42191550|FG001|Overall Study|Withdrawal by Subject|0|||
19744254|NCT03104816|42191559|FG000|Overall Study|Lack of Efficacy|0|||
19744255|NCT03104816|42191560|FG001|Overall Study|Lack of Efficacy|2|||
19744256|NCT03104816|42191561|FG002|Overall Study|Lack of Efficacy|0|||
19744257|NCT03104816|42191559|FG000|Overall Study|Protocol Violation|2|||
19744258|NCT03104816|42191560|FG001|Overall Study|Protocol Violation|0|||
19744259|NCT03104816|42191561|FG002|Overall Study|Protocol Violation|2|||
19744260|NCT03559062|42191572|FG000|Overall Study|Other|0|||
19744261|NCT03559062|42191573|FG001|Overall Study|Other|1|||
19744262|NCT03559062|42191574|FG002|Overall Study|Other|0|||
19744263|NCT00089791|42191585|FG000|Overall Study|Physician Decision|6|||
19744264|NCT00089791|42191586|FG001|Overall Study|Physician Decision|3|||
19744265|NCT00089791|42191585|FG000|Overall Study|Adverse Event|81|||
19744266|NCT00089791|42191586|FG001|Overall Study|Adverse Event|93|||
19744267|NCT00089791|42191585|FG000|Overall Study|Withdrawal by Subject|403|||
19744268|NCT00089791|42191586|FG001|Overall Study|Withdrawal by Subject|344|||
19744269|NCT00089791|42191585|FG000|Overall Study|Death|78|||
19744270|NCT00089791|42191586|FG001|Overall Study|Death|62|||
19744271|NCT00089791|42191585|FG000|Overall Study|Disease progression|7|||
19744272|NCT00089791|42191586|FG001|Overall Study|Disease progression|3|||
19744273|NCT00089791|42191585|FG000|Overall Study|Ineligibility determined|12|||
19744274|NCT00089791|42191586|FG001|Overall Study|Ineligibility determined|9|||
19744275|NCT00089791|42191585|FG000|Overall Study|Lost to Follow-up|57|||
19744276|NCT00089791|42191586|FG001|Overall Study|Lost to Follow-up|57|||
19744277|NCT00089791|42191585|FG000|Overall Study|Noncompliance|17|||
19744278|NCT00089791|42191586|FG001|Overall Study|Noncompliance|13|||
19744279|NCT00089791|42191585|FG000|Overall Study|Other|20|||
19744280|NCT00089791|42191586|FG001|Overall Study|Other|32|||
19744281|NCT00089791|42191585|FG000|Overall Study|Protocol deviation|12|||
19744282|NCT00089791|42191586|FG001|Overall Study|Protocol deviation|10|||
19744283|NCT00089791|42191585|FG000|Overall Study|Requirement for alternative therapy|7|||
19744284|NCT00089791|42191586|FG001|Overall Study|Requirement for alternative therapy|4|||
19744285|NCT03558672|42191592|FG000|Overall Study|Study Early Termination|10|||
19744286|NCT03558516|42191598|FG000|Overall Study|Protocol Violation|2|||
19744287|NCT03558516|42191599|FG001|Overall Study|Protocol Violation|2|||
19744288|NCT03557970|42191607|FG000|Overall Study|Study closure|1|||
19744289|NCT03557970|42191608|FG001|Overall Study|Study closure|0|||
19744290|NCT03557970|42191607|FG000|Overall Study|Physician Decision|0|||
19566125|NCT01130103|42014031|FG000|Randomized Treatment|Withdrawal by Subject|1|||
19566126|NCT01130103|42014032|FG001|Randomized Treatment|Withdrawal by Subject|2|||
19566127|NCT01130103|42014031|FG000|Maintenance Treatment|Lack of Efficacy|0|||
19566128|NCT01130103|42014032|FG001|Maintenance Treatment|Lack of Efficacy|1|||
19566129|NCT01130103|42014031|FG000|Maintenance Treatment|Lost to Follow-up|1|||
19566130|NCT01130103|42014032|FG001|Maintenance Treatment|Lost to Follow-up|1|||
19566131|NCT01130103|42014031|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
19566132|NCT01130103|42014032|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
19566133|NCT01129557|42014041|FG000|Overall Study|Adverse Event|1|||
19566134|NCT01129557|42014042|FG001|Overall Study|Adverse Event|2|||
19566135|NCT01129557|42014043|FG002|Overall Study|Adverse Event|2|||
19566136|NCT01129557|42014041|FG000|Overall Study|Novartis terminated study early|3|||
19566137|NCT01129557|42014042|FG001|Overall Study|Novartis terminated study early|3|||
19566138|NCT01129557|42014043|FG002|Overall Study|Novartis terminated study early|2|||
19566139|NCT01129011|42014064|FG000|Overall Study|Adverse Event|20|||
19566140|NCT01129011|42014065|FG001|Overall Study|Adverse Event|30|||
19566141|NCT01129011|42014064|FG000|Overall Study|Withdrawal by Subject|24|||
19566142|NCT01129011|42014065|FG001|Overall Study|Withdrawal by Subject|8|||
19566143|NCT01129011|42014064|FG000|Overall Study|Lost to Follow-up|6|||
19566144|NCT01129011|42014065|FG001|Overall Study|Lost to Follow-up|7|||
19566145|NCT01129011|42014064|FG000|Overall Study|Duodenal Ulcer|2|||
19566146|NCT01129011|42014065|FG001|Overall Study|Duodenal Ulcer|8|||
19566147|NCT01129011|42014064|FG000|Overall Study|misc|7|||
19566148|NCT01129011|42014065|FG001|Overall Study|misc|4|||
19566149|NCT01215942|42014073|FG000|Treatment Period|Adverse Event|15|||
19566150|NCT01215942|42014074|FG001|Treatment Period|Adverse Event|26|||
19566151|NCT01215942|42014073|FG000|Treatment Period|Death|2|||
19566152|NCT01215942|42014074|FG001|Treatment Period|Death|4|||
19566153|NCT01215942|42014073|FG000|Treatment Period|Lack of Efficacy|23|||
19566154|NCT01215942|42014074|FG001|Treatment Period|Lack of Efficacy|62|||
19566155|NCT01215942|42014073|FG000|Treatment Period|Lost to Follow-up|3|||
19566156|NCT01215942|42014074|FG001|Treatment Period|Lost to Follow-up|4|||
19566157|NCT01215942|42014073|FG000|Treatment Period|Withdrawal by Subject|17|||
19566158|NCT01215942|42014074|FG001|Treatment Period|Withdrawal by Subject|40|||
19566159|NCT01215942|42014073|FG000|Treatment Period|Physician Decision|5|||
19566160|NCT01215942|42014074|FG001|Treatment Period|Physician Decision|5|||
19566161|NCT01215942|42014073|FG000|Treatment Period|Protocol Violation|0|||
19566162|NCT01215942|42014074|FG001|Treatment Period|Protocol Violation|1|||
19566163|NCT01215942|42014073|FG000|Treatment Period|Sponsor Decision|349|||
19566164|NCT01215942|42014074|FG001|Treatment Period|Sponsor Decision|530|||
19566165|NCT01215942|42014073|FG000|Post-Treatment Follow-Up Period|Death|0|||
19566166|NCT01215942|42014074|FG001|Post-Treatment Follow-Up Period|Death|1|||
19566167|NCT01215942|42014073|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
19566168|NCT01215942|42014074|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
19566169|NCT01215942|42014073|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
19566170|NCT01215942|42014074|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
19566171|NCT01215942|42014073|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
19566172|NCT01215942|42014074|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
19566173|NCT01215942|42014073|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
19566174|NCT01215942|42014074|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
19566175|NCT00919867|42014097|FG000|First Intervention|Withdrawal by Subject|0|||
19566176|NCT00919867|42014098|FG001|First Intervention|Withdrawal by Subject|0|||
19566177|NCT00919867|42014099|FG002|First Intervention|Withdrawal by Subject|1|||
19566178|NCT00919867|42014100|FG003|First Intervention|Withdrawal by Subject|0|||
19566179|NCT00919867|42014101|FG004|First Intervention|Withdrawal by Subject|0|||
19566180|NCT00919867|42014102|FG005|First Intervention|Withdrawal by Subject|0|||
19566181|NCT00919867|42014097|FG000|First Intervention|Physician Decision|0|||
19566182|NCT00919867|42014098|FG001|First Intervention|Physician Decision|0|||
19566183|NCT00919867|42014099|FG002|First Intervention|Physician Decision|0|||
19566184|NCT00919867|42014100|FG003|First Intervention|Physician Decision|0|||
19566185|NCT00919867|42014101|FG004|First Intervention|Physician Decision|0|||
19566186|NCT00919867|42014102|FG005|First Intervention|Physician Decision|1|||
19566187|NCT01128621|42014112|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
19566188|NCT01128621|42014113|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
19566189|NCT00918463|42014135|FG000|Overall Study|Death|1|||
19566190|NCT00918463|42014135|FG000|Overall Study|Lack of Efficacy|1|||
19566191|NCT01128543|42014139|FG000|Overall Study|Withdrawal by Subject|3|||
19566192|NCT01128543|42014139|FG000|Overall Study|Protocol Violation|1|||
19566193|NCT01128387|42014145|FG000|Overall Study|Physician Decision|0|||
19744291|NCT03557970|42191608|FG001|Overall Study|Physician Decision|1|||
19744292|NCT03557970|42191607|FG000|Overall Study|Death|0|||
19744293|NCT03557970|42191608|FG001|Overall Study|Death|1|||
19744294|NCT02815280|42191616|FG000|Double-Blind Phase|Adverse Event|1|||
19744295|NCT02815280|42191617|FG001|Double-Blind Phase|Adverse Event|1|||
19744296|NCT02815280|42191616|FG000|Double-Blind Phase|Lost to Follow-up|10|||
19744297|NCT02815280|42191617|FG001|Double-Blind Phase|Lost to Follow-up|9|||
19744298|NCT02815280|42191616|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
19744299|NCT02815280|42191617|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
19744300|NCT02815280|42191616|FG000|Double-Blind Phase|Protocol Violation|2|||
19744301|NCT02815280|42191617|FG001|Double-Blind Phase|Protocol Violation|2|||
19744302|NCT02815280|42191616|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
19744303|NCT02815280|42191617|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
19744304|NCT02815280|42191616|FG000|Open-Label Phase|Adverse Event|2|||
19744305|NCT02815280|42191617|FG001|Open-Label Phase|Adverse Event|3|||
19744306|NCT02815280|42191616|FG000|Open-Label Phase|Lost to Follow-up|18|||
19744307|NCT02815280|42191617|FG001|Open-Label Phase|Lost to Follow-up|9|||
19744308|NCT02815280|42191616|FG000|Open-Label Phase|Withdrawal by Subject|33|||
19744309|NCT02815280|42191617|FG001|Open-Label Phase|Withdrawal by Subject|18|||
19744310|NCT02815280|42191616|FG000|Open-Label Phase|Protocol Violation|3|||
19744311|NCT02815280|42191617|FG001|Open-Label Phase|Protocol Violation|0|||
19744312|NCT02815280|42191616|FG000|Open-Label Phase|Administrative|26|||
19744313|NCT02815280|42191617|FG001|Open-Label Phase|Administrative|12|||
19744314|NCT02815280|42191616|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
19744315|NCT02815280|42191617|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
19744316|NCT02737930|42191629|FG000|Overall Study|Withdrawal by Subject|0|||
19744317|NCT02737930|42191630|FG001|Overall Study|Withdrawal by Subject|1|||
19744318|NCT03493698|42191636|FG000|Treatment Period C|Adverse Event|1|||
19744319|NCT03493698|42191636|FG000|Treatment Period C|Withdrawal by Subject|1|||
19744320|NCT02737852|42191650|FG000|Overall Study|Withdrawal by Subject|2|||
19744321|NCT03528174|42191654|FG000|Overall Study|Adverse Event|1|||
19744322|NCT03528174|42191654|FG000|Overall Study|sensors dislodged|1|||
19744323|NCT03109184|42191664|FG000|Overall Study|Lost to Follow-up|6|||
19744324|NCT03109184|42191665|FG001|Overall Study|Lost to Follow-up|6|||
19744325|NCT03109184|42191664|FG000|Overall Study|Withdrawal by Subject|1|||
19744326|NCT03109184|42191665|FG001|Overall Study|Withdrawal by Subject|1|||
19744327|NCT03493542|42191683|FG000|Overall Study|Ongoing|2|||
19744328|NCT03493542|42191684|FG001|Overall Study|Ongoing|3|||
19744329|NCT03493542|42191683|FG000|Overall Study|Withdrawal by parent or guardian|3|||
19744330|NCT03493542|42191684|FG001|Overall Study|Withdrawal by parent or guardian|0|||
19744331|NCT03493542|42191683|FG000|Overall Study|Withdrawal by Subject|2|||
19744332|NCT03493542|42191684|FG001|Overall Study|Withdrawal by Subject|6|||
19744333|NCT03493386|42191692|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19744334|NCT03493386|42191693|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
19744335|NCT03493386|42191694|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19744336|NCT03493386|42191695|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19744337|NCT03478644|42191714|FG000|Phase 2|Withdrawal by Subject|2|||
19744338|NCT03478644|42191715|FG001|Phase 2|Withdrawal by Subject|1|||
19744339|NCT03478644|42191714|FG000|Phase 2|Lost to Follow-up|1|||
19744340|NCT03478644|42191715|FG001|Phase 2|Lost to Follow-up|0|||
19744341|NCT03527550|42191723|FG000|Overall Study|Lost to Follow-up|4|||
19744342|NCT03527550|42191724|FG001|Overall Study|Lost to Follow-up|2|||
19744343|NCT03527550|42191723|FG000|Overall Study|Withdrawal by Subject|4|||
19744344|NCT03527550|42191724|FG001|Overall Study|Withdrawal by Subject|1|||
19744345|NCT03527550|42191723|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
19744346|NCT03527550|42191724|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
19744347|NCT03475056|42191734|FG000|Overall Study|Lost to Follow-up|0|||
19744348|NCT03475056|42191735|FG001|Overall Study|Lost to Follow-up|1|||
19744349|NCT03475056|42191734|FG000|Overall Study|Moved from Area|0|||
19744350|NCT03475056|42191735|FG001|Overall Study|Moved from Area|2|||
19744351|NCT00938912|42191742|FG000|Overall Study|Withdrawal by Subject|28|||
19744352|NCT00938912|42191742|FG000|Overall Study|Lost to Follow-up|4|||
19744353|NCT00938912|42191742|FG000|Overall Study|Lack of Efficacy|43|||
19744354|NCT00938912|42191742|FG000|Overall Study|Adverse event, non-fatal|24|||
19744355|NCT00938912|42191742|FG000|Overall Study|Adverse event, fatal|1|||
19744356|NCT00938912|42191742|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
19744357|NCT00938912|42191742|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
19744358|NCT00938912|42191742|FG000|Overall Study|Participant needed prohibit medication|1|||
19744359|NCT00938912|42191742|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
19744360|NCT00938912|42191742|FG000|Overall Study|Did not meet Eligibility criteria|1|||
19744361|NCT00938912|42191742|FG000|Overall Study|Participant relocated not related to AE|1|||
19744362|NCT00938912|42191742|FG000|Overall Study|Participant moved to another city|1|||
19744363|NCT00938912|42191742|FG000|Overall Study|Participant experienced break through seizures|1|||
19744364|NCT00938912|42191742|FG000|Overall Study|No longer wished to participate in the study|1|||
19744365|NCT00938912|42191742|FG000|Overall Study|Protocol Deviation|2|||
19744366|NCT03473808|42191749|FG000|Overall Study|Withdrawal by Subject|1|||
19744367|NCT03473340|42191755|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
19744368|NCT03473340|42191756|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
19744369|NCT03473340|42191755|FG000|Overall Study|Withdrawal by Subject|1|||
19744370|NCT03473340|42191756|FG001|Overall Study|Withdrawal by Subject|0|||
19744371|NCT03473340|42191755|FG000|Overall Study|Lost to Follow-up|1|||
19744372|NCT03473340|42191756|FG001|Overall Study|Lost to Follow-up|2|||
19744373|NCT03490032|42191765|FG000|Overall Study|family issue (child custody)|1|||
19744374|NCT03490032|42191766|FG001|Overall Study|family issue (child custody)|0|||
19744375|NCT03490032|42191767|FG002|Overall Study|family issue (child custody)|0|||
19744376|NCT03489720|42191778|FG000|Overall Study|Withdrawal by Subject|2|||
19744377|NCT03489720|42191779|FG001|Overall Study|Withdrawal by Subject|0|||
19744378|NCT03527160|42191791|FG000|Overall Study|No urine collected|13|||
19744379|NCT03527160|42191791|FG000|Overall Study|No clinical serum creatinine collected|6|||
19744380|NCT03527160|42191791|FG000|Overall Study|Did not meet inclusion|2|||
19744381|NCT03739138|42191801|FG000|Overall Study|Death|0|||
19744382|NCT03739138|42191802|FG001|Overall Study|Death|7|||
19744383|NCT03739138|42191803|FG002|Overall Study|Death|4|||
19744384|NCT03739138|42191804|FG003|Overall Study|Death|13|||
19744385|NCT03739138|42191805|FG004|Overall Study|Death|0|||
19744386|NCT03739138|42191801|FG000|Overall Study|Lost to Follow-up|0|||
19744387|NCT03739138|42191802|FG001|Overall Study|Lost to Follow-up|0|||
19744388|NCT03739138|42191803|FG002|Overall Study|Lost to Follow-up|1|||
19744389|NCT03739138|42191804|FG003|Overall Study|Lost to Follow-up|0|||
19744390|NCT03739138|42191805|FG004|Overall Study|Lost to Follow-up|0|||
19744391|NCT03739138|42191801|FG000|Overall Study|Study Terminated By Sponsor|0|||
19744392|NCT03739138|42191802|FG001|Overall Study|Study Terminated By Sponsor|0|||
19744393|NCT03739138|42191803|FG002|Overall Study|Study Terminated By Sponsor|0|||
19744394|NCT03739138|42191804|FG003|Overall Study|Study Terminated By Sponsor|4|||
19744395|NCT03739138|42191805|FG004|Overall Study|Study Terminated By Sponsor|0|||
19744396|NCT03739138|42191801|FG000|Overall Study|Withdrawal by Subject|0|||
19744397|NCT03739138|42191802|FG001|Overall Study|Withdrawal by Subject|0|||
19744398|NCT03739138|42191803|FG002|Overall Study|Withdrawal by Subject|0|||
19744399|NCT03739138|42191804|FG003|Overall Study|Withdrawal by Subject|1|||
19744400|NCT03739138|42191805|FG004|Overall Study|Withdrawal by Subject|0|||
19566194|NCT01128387|42014146|FG001|Overall Study|Physician Decision|1|||
19566195|NCT01214850|42014155|FG000|Overall Study|Withdrawal by Subject|38|||
19566196|NCT01214850|42014156|FG001|Overall Study|Withdrawal by Subject|31|||
19566197|NCT01214850|42014157|FG002|Overall Study|Withdrawal by Subject|28|||
19566198|NCT01214850|42014155|FG000|Overall Study|Lost to Follow-up|124|||
19566199|NCT01214850|42014156|FG001|Overall Study|Lost to Follow-up|98|||
19566200|NCT01214850|42014157|FG002|Overall Study|Lost to Follow-up|123|||
19566201|NCT01214850|42014155|FG000|Overall Study|Protocol Violation|5|||
19566202|NCT01214850|42014156|FG001|Overall Study|Protocol Violation|5|||
19566203|NCT01214850|42014157|FG002|Overall Study|Protocol Violation|6|||
19566204|NCT01214850|42014155|FG000|Overall Study|Adverse event or death|11|||
19566205|NCT01214850|42014156|FG001|Overall Study|Adverse event or death|8|||
19566206|NCT01214850|42014157|FG002|Overall Study|Adverse event or death|3|||
19566207|NCT01214850|42014155|FG000|Overall Study|Inappropriate enrollment|2|||
19566208|NCT01214850|42014156|FG001|Overall Study|Inappropriate enrollment|1|||
19566209|NCT01214850|42014157|FG002|Overall Study|Inappropriate enrollment|0|||
19566210|NCT01214850|42014155|FG000|Overall Study|Administrative reason|1|||
19566211|NCT01214850|42014156|FG001|Overall Study|Administrative reason|0|||
19566212|NCT01214850|42014157|FG002|Overall Study|Administrative reason|0|||
19566213|NCT01214850|42014155|FG000|Overall Study|Unable to classify|2|||
19566214|NCT01214850|42014156|FG001|Overall Study|Unable to classify|1|||
19566215|NCT01214850|42014157|FG002|Overall Study|Unable to classify|1|||
19566216|NCT01128153|42014170|FG000|Overall Study|Adverse Event|1|||
19566217|NCT01128153|42014171|FG001|Overall Study|Adverse Event|3|||
19566218|NCT01128153|42014170|FG000|Overall Study|Condition under investigation worsened|8|||
19566219|NCT01128153|42014171|FG001|Overall Study|Condition under investigation worsened|7|||
19566220|NCT01128153|42014170|FG000|Overall Study|Withdrawal by Subject|2|||
19566221|NCT01128153|42014171|FG001|Overall Study|Withdrawal by Subject|3|||
19744401|NCT03472326|42191815|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
19744402|NCT03472326|42191816|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
19744403|NCT03472326|42191817|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
19744404|NCT03472326|42191818|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
19744405|NCT03472326|42191815|FG000|Part 2: Combination Therapy|Pregnancy|0|||
19566222|NCT01128153|42014170|FG000|Overall Study|Incorrect enrolment to study|2|||
19566223|NCT01128153|42014171|FG001|Overall Study|Incorrect enrolment to study|1|||
19744406|NCT03472326|42191816|FG001|Part 2: Combination Therapy|Pregnancy|0|||
19744407|NCT03472326|42191817|FG002|Part 2: Combination Therapy|Pregnancy|0|||
19744408|NCT03472326|42191818|FG003|Part 2: Combination Therapy|Pregnancy|1|||
19744409|NCT02737618|42191827|FG000|Overall Study|Withdrawal by Subject|9|||
19744410|NCT03472014|42191831|FG000|Overall Study|Lost to Follow-up|4|||
19744411|NCT03526458|42191837|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
19744412|NCT03526458|42191838|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
19744413|NCT03526458|42191837|FG000|Overall Study|Stone passed, surgery cancelled|2|||
19744414|NCT03526458|42191838|FG001|Overall Study|Stone passed, surgery cancelled|1|||
19744415|NCT03526458|42191837|FG000|Overall Study|Withdrawal by Subject|1|||
19744416|NCT03526458|42191838|FG001|Overall Study|Withdrawal by Subject|0|||
19744417|NCT03526458|42191837|FG000|Overall Study|Physician Decision|2|||
19744418|NCT03526458|42191838|FG001|Overall Study|Physician Decision|1|||
19744419|NCT03526458|42191837|FG000|Overall Study|Lack of equipment|1|||
19744420|NCT03526458|42191838|FG001|Overall Study|Lack of equipment|1|||
19744421|NCT03488238|42191844|FG000|Overall Study|Equipment malfunction|1|||
19744422|NCT03488238|42191844|FG000|Overall Study|Adverse Event|1|||
19744423|NCT03525834|42191848|FG000|Overall Study|Progressive disease|1|||
19744424|NCT03525444|42191890|FG000|Overall Study|Adverse Event|0|||
19744425|NCT03525444|42191891|FG001|Overall Study|Adverse Event|1|||
19744426|NCT03525444|42191890|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
19744427|NCT03525444|42191891|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
19744428|NCT03525444|42191890|FG000|Overall Study|Other|0|||
19744429|NCT03525444|42191891|FG001|Overall Study|Other|1|||
19744430|NCT03921424|42191900|FG000|Overall Study|Lost to Follow-up|0|||
19744431|NCT03921424|42191901|FG001|Overall Study|Lost to Follow-up|1|||
19744432|NCT03921424|42191900|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
19744433|NCT03921424|42191901|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
19744434|NCT03487848|42191909|FG000|Overall Study|Lost to Follow-up|1|||
19744435|NCT03524664|42191915|FG000|Overall Study|Withdrawal by Subject|1|||
19744436|NCT03524664|42191916|FG001|Overall Study|Withdrawal by Subject|2|||
19744437|NCT03524664|42191915|FG000|Overall Study|Lost to Follow-up|4|||
19744438|NCT03524664|42191916|FG001|Overall Study|Lost to Follow-up|13|||
19744439|NCT04377620|42191925|FG000|Overall Study|Death|42|||
19744440|NCT04377620|42191926|FG001|Overall Study|Death|48|||
19744441|NCT04377620|42191927|FG002|Overall Study|Death|36|||
19744442|NCT04377620|42191925|FG000|Overall Study|Withdrawal by Subject|0|||
19744443|NCT04377620|42191926|FG001|Overall Study|Withdrawal by Subject|2|||
19744444|NCT04377620|42191927|FG002|Overall Study|Withdrawal by Subject|0|||
19744445|NCT03486834|42191939|FG000|Overall Study|Withdrawal by Subject|46|||
19744446|NCT03486834|42191940|FG001|Overall Study|Withdrawal by Subject|46|||
19744447|NCT03486834|42191941|FG002|Overall Study|Withdrawal by Subject|52|||
19744448|NCT03486834|42191939|FG000|Overall Study|Adverse Event|8|||
19744449|NCT03486834|42191940|FG001|Overall Study|Adverse Event|7|||
19744450|NCT03486834|42191941|FG002|Overall Study|Adverse Event|0|||
19744451|NCT03486834|42191939|FG000|Overall Study|Lost to Follow-up|41|||
19744452|NCT03486834|42191940|FG001|Overall Study|Lost to Follow-up|24|||
19744453|NCT03486834|42191941|FG002|Overall Study|Lost to Follow-up|39|||
19744454|NCT03486834|42191939|FG000|Overall Study|Non-compliance with Study Drug|2|||
19744455|NCT03486834|42191940|FG001|Overall Study|Non-compliance with Study Drug|2|||
19744456|NCT03486834|42191941|FG002|Overall Study|Non-compliance with Study Drug|0|||
19744457|NCT03486834|42191939|FG000|Overall Study|Physician Decision|5|||
19744458|NCT03486834|42191940|FG001|Overall Study|Physician Decision|2|||
19744459|NCT03486834|42191941|FG002|Overall Study|Physician Decision|3|||
19744460|NCT03486834|42191939|FG000|Overall Study|Pregnancy|10|||
19744461|NCT03486834|42191940|FG001|Overall Study|Pregnancy|12|||
19744462|NCT03486834|42191941|FG002|Overall Study|Pregnancy|12|||
19744463|NCT03486834|42191939|FG000|Overall Study|Protocol Deviation|2|||
19744464|NCT03486834|42191940|FG001|Overall Study|Protocol Deviation|3|||
19744465|NCT03486834|42191941|FG002|Overall Study|Protocol Deviation|3|||
19744466|NCT03486834|42191939|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19744467|NCT03486834|42191940|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
19744468|NCT03486834|42191941|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
19744469|NCT03486834|42191939|FG000|Overall Study|Randomized but not treated|4|||
19744470|NCT03486834|42191940|FG001|Overall Study|Randomized but not treated|4|||
19744471|NCT03486834|42191941|FG002|Overall Study|Randomized but not treated|1|||
19744472|NCT03522948|42191951|FG000|Overall Study|Lost to Follow-up|1|||
19744473|NCT03406078|42191957|FG000|Overall Study|Death|1|||
19744474|NCT03406078|42191958|FG001|Overall Study|Death|0|||
19744475|NCT03406078|42191957|FG000|Overall Study|Lost to Follow-up|0|||
19744476|NCT03406078|42191958|FG001|Overall Study|Lost to Follow-up|1|||
19744477|NCT03406078|42191957|FG000|Overall Study|Withdrawal by Subject|5|||
19744478|NCT03406078|42191958|FG001|Overall Study|Withdrawal by Subject|2|||
19744479|NCT03634033|42191971|FG000|Overall Study|Did not have a post-assessment|384|||
19744480|NCT03634033|42191972|FG001|Overall Study|Did not have a post-assessment|291|||
19744481|NCT03634033|42191973|FG002|Overall Study|Did not have a post-assessment|114|||
19744482|NCT03634033|42191974|FG003|Overall Study|Did not have a post-assessment|161|||
19744483|NCT03634033|42191975|FG004|Overall Study|Did not have a post-assessment|5|||
19744484|NCT03634033|42191976|FG005|Overall Study|Did not have a post-assessment|0|||
19744485|NCT03634033|42191977|FG006|Overall Study|Did not have a post-assessment|0|||
19744486|NCT03634033|42191971|FG000|Overall Study|Death|0|||
19744487|NCT03634033|42191972|FG001|Overall Study|Death|0|||
19744488|NCT03634033|42191973|FG002|Overall Study|Death|0|||
19744489|NCT03634033|42191974|FG003|Overall Study|Death|0|||
19744490|NCT03634033|42191975|FG004|Overall Study|Death|0|||
19744491|NCT03634033|42191976|FG005|Overall Study|Death|7|||
19744492|NCT03634033|42191977|FG006|Overall Study|Death|7|||
19744493|NCT03634033|42191971|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
19744494|NCT03634033|42191972|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
19744495|NCT03634033|42191973|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
19744496|NCT03634033|42191974|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
19744497|NCT03634033|42191975|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
19744498|NCT03634033|42191976|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
19744499|NCT03634033|42191977|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
19744500|NCT03634033|42191971|FG000|Overall Study|Lost to Follow-up|0|||
19744501|NCT03634033|42191972|FG001|Overall Study|Lost to Follow-up|0|||
19744502|NCT03634033|42191973|FG002|Overall Study|Lost to Follow-up|0|||
19744503|NCT03634033|42191974|FG003|Overall Study|Lost to Follow-up|0|||
19744504|NCT03634033|42191975|FG004|Overall Study|Lost to Follow-up|0|||
19744505|NCT03634033|42191976|FG005|Overall Study|Lost to Follow-up|1|||
19744506|NCT03634033|42191977|FG006|Overall Study|Lost to Follow-up|2|||
19744507|NCT03634033|42191971|FG000|Overall Study|Withdrawal by Subject|0|||
19744508|NCT03634033|42191972|FG001|Overall Study|Withdrawal by Subject|0|||
19744509|NCT03634033|42191973|FG002|Overall Study|Withdrawal by Subject|0|||
19744510|NCT03634033|42191974|FG003|Overall Study|Withdrawal by Subject|0|||
19744511|NCT03634033|42191975|FG004|Overall Study|Withdrawal by Subject|0|||
19744512|NCT03634033|42191976|FG005|Overall Study|Withdrawal by Subject|0|||
19744513|NCT03634033|42191977|FG006|Overall Study|Withdrawal by Subject|1|||
19744514|NCT03103100|42192011|FG000|Overall Study|Adverse Event|1|||
19744515|NCT03103100|42192012|FG001|Overall Study|Adverse Event|0|||
19744516|NCT03103100|42192013|FG002|Overall Study|Adverse Event|0|||
19744517|NCT03103100|42192011|FG000|Overall Study|Physician Decision|1|||
19744518|NCT03103100|42192012|FG001|Overall Study|Physician Decision|0|||
19744519|NCT03103100|42192013|FG002|Overall Study|Physician Decision|2|||
19744520|NCT03438006|42192021|FG000|Overall Study|Adverse Event|1|||
19744521|NCT03438006|42192021|FG000|Overall Study|Lost to Follow-up|67|||
19744522|NCT03438006|42192021|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
19744523|NCT03438006|42192021|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
19744524|NCT04206020|42192027|FG000|Overall Study|Adverse Event|1|||
19744525|NCT04206020|42192028|FG001|Overall Study|Adverse Event|4|||
19744526|NCT04206020|42192027|FG000|Overall Study|Protocol Violation|2|||
19744527|NCT04206020|42192028|FG001|Overall Study|Protocol Violation|0|||
19744528|NCT04206020|42192027|FG000|Overall Study|Withdrawal by Subject|2|||
19744529|NCT04206020|42192028|FG001|Overall Study|Withdrawal by Subject|0|||
19744530|NCT04206020|42192027|FG000|Overall Study|Lost to Follow-up|2|||
19744531|NCT04206020|42192028|FG001|Overall Study|Lost to Follow-up|0|||
19744532|NCT04206020|42192027|FG000|Overall Study|Pregnancy|0|||
19744533|NCT04206020|42192028|FG001|Overall Study|Pregnancy|1|||
19744534|NCT04206020|42192027|FG000|Overall Study|Unable to attend visits|1|||
19744535|NCT04206020|42192028|FG001|Overall Study|Unable to attend visits|2|||
19744536|NCT03466086|42192034|FG000|Period 1|Sponsor decision due to study timeline|1|||
19744537|NCT03466086|42192035|FG001|Period 1|Sponsor decision due to study timeline|0|||
19744538|NCT03466086|42192034|FG000|Period 1|Withdrawal by Subject|1|||
19744539|NCT03466086|42192035|FG001|Period 1|Withdrawal by Subject|0|||
19744540|NCT03101462|42192043|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
19744541|NCT03101462|42192044|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
19744542|NCT02873936|42192053|FG000|Overall Study|Withdrew Consent|4|||
19744543|NCT02873936|42192054|FG001|Overall Study|Withdrew Consent|11|||
19744544|NCT02873936|42192055|FG002|Overall Study|Withdrew Consent|20|||
19744545|NCT02873936|42192053|FG000|Overall Study|Investigator's Discretion|3|||
19744546|NCT02873936|42192054|FG001|Overall Study|Investigator's Discretion|5|||
19744547|NCT02873936|42192055|FG002|Overall Study|Investigator's Discretion|4|||
19744548|NCT02873936|42192053|FG000|Overall Study|Adverse Event|3|||
19744549|NCT02873936|42192054|FG001|Overall Study|Adverse Event|5|||
19744550|NCT02873936|42192055|FG002|Overall Study|Adverse Event|3|||
19744551|NCT02873936|42192053|FG000|Overall Study|Protocol Violation|0|||
19744552|NCT02873936|42192054|FG001|Overall Study|Protocol Violation|1|||
19744553|NCT02873936|42192055|FG002|Overall Study|Protocol Violation|3|||
19744554|NCT02873936|42192053|FG000|Overall Study|Lost to Follow-up|1|||
19744555|NCT02873936|42192054|FG001|Overall Study|Lost to Follow-up|1|||
19744556|NCT02873936|42192055|FG002|Overall Study|Lost to Follow-up|1|||
19744557|NCT02873936|42192053|FG000|Overall Study|Non-compliance With Study Drug|1|||
19744558|NCT02873936|42192054|FG001|Overall Study|Non-compliance With Study Drug|0|||
19744559|NCT02873936|42192055|FG002|Overall Study|Non-compliance With Study Drug|1|||
19744560|NCT02873936|42192053|FG000|Overall Study|Randomized but not Dosed|1|||
19744561|NCT02873936|42192054|FG001|Overall Study|Randomized but not Dosed|0|||
19744562|NCT02873936|42192055|FG002|Overall Study|Randomized but not Dosed|0|||
19744563|NCT02874794|42192065|FG000|Overall Study|Physician Decision|3|||
19744564|NCT02874794|42192066|FG001|Overall Study|Physician Decision|2|||
19744565|NCT02874794|42192065|FG000|Overall Study|Withdrawal by Subject|2|||
19744566|NCT02874794|42192066|FG001|Overall Study|Withdrawal by Subject|8|||
19744567|NCT02874794|42192065|FG000|Overall Study|Death|2|||
19744568|NCT02874794|42192066|FG001|Overall Study|Death|1|||
19744569|NCT03102710|42192078|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
19744570|NCT03102710|42192079|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
19744571|NCT03102710|42192080|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
19744572|NCT03102710|42192078|FG000|Overall Study|Technical issues during final MRI scan|0|||
19744573|NCT03102710|42192079|FG001|Overall Study|Technical issues during final MRI scan|1|||
19744574|NCT03102710|42192080|FG002|Overall Study|Technical issues during final MRI scan|0|||
19744575|NCT03102710|42192078|FG000|Overall Study|Nausea during MRI scan|0|||
19744576|NCT03102710|42192079|FG001|Overall Study|Nausea during MRI scan|1|||
19744577|NCT03102710|42192080|FG002|Overall Study|Nausea during MRI scan|0|||
19744578|NCT03102710|42192078|FG000|Overall Study|Subject unable to attend final session|0|||
19744579|NCT03102710|42192079|FG001|Overall Study|Subject unable to attend final session|1|||
19744580|NCT03102710|42192080|FG002|Overall Study|Subject unable to attend final session|0|||
19744581|NCT03101150|42192090|FG000|Overall Study|Lost to Follow-up|2|||
19744582|NCT03101150|42192091|FG001|Overall Study|Lost to Follow-up|4|||
19744583|NCT03101150|42192090|FG000|Overall Study|Miscarriage|3|||
19744584|NCT03101150|42192091|FG001|Overall Study|Miscarriage|6|||
19744585|NCT03101930|42192100|FG000|Overall Study|Withdrawal by Subject|2|||
19744586|NCT03101930|42192101|FG001|Overall Study|Withdrawal by Subject|1|||
19744587|NCT03101930|42192102|FG002|Overall Study|Withdrawal by Subject|2|||
19744588|NCT02928848|42192112|FG000|Arm 2|Withdrawal by Subject|1|||
19744589|NCT02928848|42192113|FG001|Arm 2|Withdrawal by Subject|0|||
19744590|NCT02928770|42192121|FG000|Overall Study|Withdrawal by Subject|2|||
19744591|NCT03464136|42192127|FG000|Overall Study|Lost to Follow-up|5|||
19744592|NCT03464136|42192128|FG001|Overall Study|Lost to Follow-up|8|||
19744593|NCT03464136|42192127|FG000|Overall Study|Withdrawal by Subject|16|||
19744594|NCT03464136|42192128|FG001|Overall Study|Withdrawal by Subject|13|||
19744595|NCT03464136|42192127|FG000|Overall Study|Death|1|||
19744596|NCT03464136|42192128|FG001|Overall Study|Death|0|||
19744597|NCT03464136|42192127|FG000|Overall Study|Other|8|||
19744598|NCT03464136|42192128|FG001|Overall Study|Other|4|||
19744599|NCT03100838|42192134|FG000|Overall Study|Adverse Event|1|||
19744600|NCT03100838|42192135|FG001|Overall Study|Adverse Event|0|||
19744601|NCT03100838|42192136|FG002|Overall Study|Adverse Event|0|||
19744602|NCT03100838|42192137|FG003|Overall Study|Adverse Event|0|||
19744603|NCT03100838|42192134|FG000|Overall Study|Physician Decision|1|||
19744604|NCT03100838|42192135|FG001|Overall Study|Physician Decision|1|||
19744605|NCT03100838|42192136|FG002|Overall Study|Physician Decision|1|||
19744606|NCT03100838|42192137|FG003|Overall Study|Physician Decision|1|||
19744607|NCT03100838|42192134|FG000|Overall Study|Pregnancy|0|||
19744608|NCT03100838|42192135|FG001|Overall Study|Pregnancy|1|||
19744609|NCT03100838|42192136|FG002|Overall Study|Pregnancy|0|||
19744610|NCT03100838|42192137|FG003|Overall Study|Pregnancy|0|||
19744611|NCT03100838|42192134|FG000|Overall Study|Lost to Follow-up|0|||
19744612|NCT03100838|42192135|FG001|Overall Study|Lost to Follow-up|0|||
19744613|NCT03100838|42192136|FG002|Overall Study|Lost to Follow-up|1|||
19744614|NCT03100838|42192137|FG003|Overall Study|Lost to Follow-up|0|||
19744615|NCT03480750|42192153|FG000|Overall Study|Withdrawal by Subject|0|||
19744616|NCT03480750|42192154|FG001|Overall Study|Withdrawal by Subject|1|||
19744617|NCT03480750|42192155|FG002|Overall Study|Withdrawal by Subject|0|||
19744618|NCT03480750|42192156|FG003|Overall Study|Withdrawal by Subject|0|||
19744619|NCT03480750|42192157|FG004|Overall Study|Withdrawal by Subject|0|||
19744620|NCT03480750|42192158|FG005|Overall Study|Withdrawal by Subject|0|||
19744621|NCT03480750|42192153|FG000|Overall Study|The interruption in Trientine shippment|0|||
19744622|NCT03480750|42192154|FG001|Overall Study|The interruption in Trientine shippment|0|||
19744623|NCT03480750|42192155|FG002|Overall Study|The interruption in Trientine shippment|0|||
19744624|NCT03480750|42192156|FG003|Overall Study|The interruption in Trientine shippment|0|||
19744625|NCT03480750|42192157|FG004|Overall Study|The interruption in Trientine shippment|0|||
19744626|NCT03480750|42192158|FG005|Overall Study|The interruption in Trientine shippment|1|||
19744627|NCT03462030|42192183|FG000|Overall Study|Withdrawal by Subject|1|||
19744628|NCT03462030|42192184|FG001|Overall Study|Withdrawal by Subject|1|||
19566224|NCT01128153|42014170|FG000|Overall Study|Protocol Violation|2|||
19744629|NCT03412734|42192192|FG000|Overall Study|Incorrect labeling of samples|2|||
19744630|NCT03412734|42192193|FG001|Overall Study|Incorrect labeling of samples|0|||
19744631|NCT03412734|42192192|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
19744632|NCT03412734|42192193|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
19744633|NCT02374814|42192205|FG000|Overall Study|Lost to Follow-up|1|||
19744634|NCT02374814|42192206|FG001|Overall Study|Lost to Follow-up|1|||
19744635|NCT02374814|42192207|FG002|Overall Study|Lost to Follow-up|0|||
19744636|NCT02374814|42192208|FG003|Overall Study|Lost to Follow-up|1|||
19744637|NCT02374814|42192209|FG004|Overall Study|Lost to Follow-up|0|||
19744638|NCT02374814|42192210|FG005|Overall Study|Lost to Follow-up|0|||
19744639|NCT02374814|42192205|FG000|Overall Study|Withdrawal by Subject|0|||
19744640|NCT02374814|42192206|FG001|Overall Study|Withdrawal by Subject|0|||
19744641|NCT02374814|42192207|FG002|Overall Study|Withdrawal by Subject|1|||
19744642|NCT02374814|42192208|FG003|Overall Study|Withdrawal by Subject|1|||
19744643|NCT02374814|42192209|FG004|Overall Study|Withdrawal by Subject|0|||
19744644|NCT02374814|42192210|FG005|Overall Study|Withdrawal by Subject|0|||
19744645|NCT04608344|42192234|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
19744646|NCT04608344|42192235|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
19744647|NCT04608344|42192234|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
19744648|NCT04608344|42192235|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
19744649|NCT03433482|42192253|FG000|Overall Study|Lost to Follow-up|1|||
19744650|NCT03433482|42192254|FG001|Overall Study|Lost to Follow-up|0|||
19744651|NCT03433482|42192255|FG002|Overall Study|Lost to Follow-up|1|||
19744652|NCT03433482|42192256|FG003|Overall Study|Lost to Follow-up|1|||
19744653|NCT03433482|42192253|FG000|Overall Study|Withdrawal by Subject|0|||
19744654|NCT03433482|42192254|FG001|Overall Study|Withdrawal by Subject|0|||
19744655|NCT03433482|42192255|FG002|Overall Study|Withdrawal by Subject|1|||
19744656|NCT03433482|42192256|FG003|Overall Study|Withdrawal by Subject|0|||
19744657|NCT03433482|42192253|FG000|Overall Study|Unknown reason|0|||
19744658|NCT03433482|42192254|FG001|Overall Study|Unknown reason|0|||
19744659|NCT03433482|42192255|FG002|Overall Study|Unknown reason|2|||
19744660|NCT03433482|42192256|FG003|Overall Study|Unknown reason|0|||
19744661|NCT03432858|42192269|FG000|Overall Study|Protocol Violation|2|||
19744662|NCT03432858|42192270|FG001|Overall Study|Protocol Violation|1|||
19744663|NCT03432858|42192271|FG002|Overall Study|Protocol Violation|9|||
19744664|NCT03432858|42192269|FG000|Overall Study|Withdrawal by Subject|0|||
19744665|NCT03432858|42192270|FG001|Overall Study|Withdrawal by Subject|1|||
19744666|NCT03432858|42192271|FG002|Overall Study|Withdrawal by Subject|1|||
19744667|NCT03432858|42192269|FG000|Overall Study|Procedure canceled/rescheduled|0|||
19744668|NCT03432858|42192270|FG001|Overall Study|Procedure canceled/rescheduled|9|||
19744669|NCT03432858|42192271|FG002|Overall Study|Procedure canceled/rescheduled|6|||
19744670|NCT03432858|42192269|FG000|Overall Study|Required postop mobilization with splinting|0|||
19744671|NCT03432858|42192270|FG001|Overall Study|Required postop mobilization with splinting|0|||
19744672|NCT03432858|42192271|FG002|Overall Study|Required postop mobilization with splinting|1|||
19744673|NCT03432390|42192281|FG000|Apnea Period|Protocol Violation|2|||
19744674|NCT03432390|42192282|FG001|Apnea Period|Protocol Violation|2|||
19744675|NCT03456960|42192294|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19744676|NCT03456960|42192295|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19744677|NCT03456960|42192296|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
19744678|NCT03456960|42192297|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
19744679|NCT03456960|42192298|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19744680|NCT03456960|42192299|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19744681|NCT03456960|42192294|FG000|Period 2 (1 Day)|Adverse Event|1|||
19744682|NCT03456960|42192295|FG001|Period 2 (1 Day)|Adverse Event|0|||
19744683|NCT03456960|42192296|FG002|Period 2 (1 Day)|Adverse Event|0|||
19744684|NCT03456960|42192297|FG003|Period 2 (1 Day)|Adverse Event|1|||
19744685|NCT03456960|42192298|FG004|Period 2 (1 Day)|Adverse Event|0|||
19744686|NCT03456960|42192299|FG005|Period 2 (1 Day)|Adverse Event|0|||
19744687|NCT03430986|42192317|FG000|24-week Control Period|Adverse Event|1|||
19744688|NCT03430986|42192318|FG001|24-week Control Period|Adverse Event|0|||
19744689|NCT03430986|42192317|FG000|24-week Control Period|Lost to Follow-up|2|||
19744690|NCT03430986|42192318|FG001|24-week Control Period|Lost to Follow-up|2|||
19744691|NCT03430986|42192317|FG000|24-week Control Period|Withdrawal by Participant|5|||
19744692|NCT03430986|42192318|FG001|24-week Control Period|Withdrawal by Participant|0|||
19566225|NCT01128153|42014171|FG001|Overall Study|Protocol Violation|0|||
19566226|NCT01128153|42014170|FG000|Overall Study|Developed discontinuation criteria|1|||
19566227|NCT01128153|42014171|FG001|Overall Study|Developed discontinuation criteria|1|||
19566228|NCT00925015|42014180|FG000|Overall Study|Adverse Event|1|||
19566229|NCT00925015|42014181|FG001|Overall Study|Adverse Event|2|||
19566230|NCT00925015|42014182|FG002|Overall Study|Adverse Event|1|||
19566231|NCT00925015|42014180|FG000|Overall Study|Physician Decision|0|||
19566232|NCT00925015|42014181|FG001|Overall Study|Physician Decision|1|||
19566233|NCT00925015|42014182|FG002|Overall Study|Physician Decision|0|||
19566234|NCT00925015|42014180|FG000|Overall Study|Progressive Disease|7|||
19566235|NCT00925015|42014181|FG001|Overall Study|Progressive Disease|3|||
19566236|NCT00925015|42014182|FG002|Overall Study|Progressive Disease|4|||
19566237|NCT00925015|42014180|FG000|Overall Study|Withdrawal by Subject|0|||
19566238|NCT00925015|42014181|FG001|Overall Study|Withdrawal by Subject|0|||
19566239|NCT00925015|42014182|FG002|Overall Study|Withdrawal by Subject|1|||
19566240|NCT01127763|42014194|FG000|Overall Study|Adverse Event|2|||
19566241|NCT01127763|42014194|FG000|Overall Study|Withdrawal by Subject|1|||
19566242|NCT01127763|42014194|FG000|Overall Study|Physician Decision|2|||
19566243|NCT01127607|42014204|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
19566244|NCT01127607|42014205|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
19566245|NCT01127607|42014204|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
19566246|NCT01127607|42014205|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
19566247|NCT00924781|42014232|FG000|Overall Study|Study terminated by sponsor|12|||
19566248|NCT00924781|42014233|FG001|Overall Study|Study terminated by sponsor|10|||
19566249|NCT01127451|42014251|FG000|Overall Study|Other|2|||
19566250|NCT01127451|42014252|FG001|Overall Study|Other|1|||
19566251|NCT01127451|42014251|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
19566252|NCT01127451|42014252|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
19566253|NCT01127451|42014251|FG000|Overall Study|Death|22|||
19566254|NCT01127451|42014252|FG001|Overall Study|Death|17|||
19566255|NCT01127451|42014251|FG000|Overall Study|Lost to Follow-up|3|||
19566256|NCT01127451|42014252|FG001|Overall Study|Lost to Follow-up|0|||
19566257|NCT01127451|42014251|FG000|Overall Study|Administrative Reason by Sponsor|2|||
19566258|NCT01127451|42014252|FG001|Overall Study|Administrative Reason by Sponsor|2|||
19566259|NCT01127373|42014258|FG000|Overall Study|Not Treated|3|||
19566260|NCT01127373|42014258|FG000|Overall Study|Lost to Follow-up|7|||
19566261|NCT01127373|42014258|FG000|Overall Study|Withdrawal by Subject|1|||
19566262|NCT01127373|42014258|FG000|Overall Study|Disease progression|1|||
19566263|NCT01127139|42014262|FG000|Overall Study|Adverse Event|40|||
19566264|NCT01127139|42014262|FG000|Overall Study|Incompliance|12|||
19566265|NCT01127139|42014262|FG000|Overall Study|Lack of Efficacy|4|||
19566266|NCT01127139|42014262|FG000|Overall Study|Reason not specified|1|||
19566267|NCT01214616|42014273|FG000|Overall Study|Progressive disease|2|||
19566268|NCT01214616|42014274|FG001|Overall Study|Progressive disease|2|||
19566269|NCT01214616|42014275|FG002|Overall Study|Progressive disease|2|||
19566270|NCT01214616|42014276|FG003|Overall Study|Progressive disease|4|||
19566271|NCT01214616|42014273|FG000|Overall Study|Dose limiting toxicity|0|||
19566272|NCT01214616|42014274|FG001|Overall Study|Dose limiting toxicity|2|||
19566273|NCT01214616|42014275|FG002|Overall Study|Dose limiting toxicity|0|||
19566274|NCT01214616|42014276|FG003|Overall Study|Dose limiting toxicity|0|||
19566275|NCT01214616|42014273|FG000|Overall Study|Other adverse events|0|||
19566276|NCT01214616|42014274|FG001|Overall Study|Other adverse events|1|||
19566277|NCT01214616|42014275|FG002|Overall Study|Other adverse events|1|||
19566278|NCT01214616|42014276|FG003|Overall Study|Other adverse events|1|||
19566279|NCT01214616|42014273|FG000|Overall Study|Withdrawal by Subject|1|||
19744693|NCT03430986|42192317|FG000|24-week Control Period|Protocol Deviation|0|||
19744694|NCT03430986|42192318|FG001|24-week Control Period|Protocol Deviation|2|||
19744695|NCT03430986|42192317|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
19744696|NCT03430986|42192318|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
19744697|NCT03430986|42192317|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
19744698|NCT03430986|42192318|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
19744699|NCT03448536|42192329|FG000|Overall Study|Protocol Violation|2|||
19744700|NCT03448536|42192330|FG001|Overall Study|Protocol Violation|0|||
19744701|NCT03448536|42192329|FG000|Overall Study|Pregnancy|1|||
19744702|NCT03448536|42192330|FG001|Overall Study|Pregnancy|0|||
19744703|NCT03448536|42192329|FG000|Overall Study|Withdrawal by Subject|1|||
19744704|NCT03448536|42192330|FG001|Overall Study|Withdrawal by Subject|2|||
19744705|NCT03448536|42192329|FG000|Overall Study|Lost to Follow-up|3|||
19744706|NCT03448536|42192330|FG001|Overall Study|Lost to Follow-up|2|||
19744707|NCT03448536|42192329|FG000|Overall Study|Inadequate pain reporter|1|||
19744708|NCT03448536|42192330|FG001|Overall Study|Inadequate pain reporter|0|||
19744709|NCT03448536|42192329|FG000|Overall Study|Other|3|||
19744710|NCT03448536|42192330|FG001|Overall Study|Other|0|||
19744711|NCT03448536|42192329|FG000|Overall Study|Physician Decision|1|||
19744712|NCT03448536|42192330|FG001|Overall Study|Physician Decision|0|||
19744713|NCT03448224|42192338|FG000|Overall Study|Provided same answer to every question|1|||
19566280|NCT01214616|42014274|FG001|Overall Study|Withdrawal by Subject|0|||
19566281|NCT01214616|42014275|FG002|Overall Study|Withdrawal by Subject|0|||
19566282|NCT01214616|42014276|FG003|Overall Study|Withdrawal by Subject|1|||
19566283|NCT01213836|42014296|FG000|Period 1, First Intervention|Adverse Event|2|||
19566284|NCT01213836|42014297|FG001|Period 1, First Intervention|Adverse Event|1|||
19566285|NCT01213836|42014296|FG000|Period 1, First Intervention|Protocol Violation|0|||
19566286|NCT01213836|42014297|FG001|Period 1, First Intervention|Protocol Violation|1|||
19566287|NCT01213836|42014296|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
19566288|NCT01213836|42014297|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
19566289|NCT01127061|42014308|FG000|Overall Study|Lost to Follow-up|7|||
19566290|NCT01127061|42014309|FG001|Overall Study|Lost to Follow-up|10|||
19566291|NCT01127061|42014308|FG000|Overall Study|Physician Decision|3|||
19566292|NCT01127061|42014309|FG001|Overall Study|Physician Decision|3|||
19566293|NCT00924703|42014315|FG000|Overall Study|Withdrawal by Subject|11|||
19566294|NCT00924703|42014315|FG000|Overall Study|Physician Decision|5|||
19566295|NCT00924703|42014315|FG000|Overall Study|Lost to Follow-up|3|||
19566296|NCT00924703|42014315|FG000|Overall Study|Adverse Event|2|||
19566297|NCT00924703|42014315|FG000|Overall Study|Withdrawal by Sponsor|1|||
19566298|NCT01213524|42014321|FG000|Baseline|Withdrawal by Subject|5|||
19566299|NCT01213524|42014321|FG000|Baseline|high breath alcohol levels|1|||
19566300|NCT01213524|42014321|FG000|Baseline|Physician Decision|1|||
19566301|NCT01213524|42014321|FG000|Session 2|Withdrawal by Subject|5|||
19566302|NCT01213524|42014321|FG000|Session 3|Withdrawal by Subject|4|||
19566303|NCT01213524|42014321|FG000|Session 4|Physician Decision|1|||
19566304|NCT01213524|42014321|FG000|Session 4|Withdrawal by Subject|2|||
19566305|NCT01212744|42014332|FG000|Overall Study|Withdrawal by Subject|1|||
19744714|NCT03448224|42192339|FG001|Overall Study|Provided same answer to every question|0|||
19744715|NCT03424044|42192345|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744716|NCT03424044|42192346|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744717|NCT03424044|42192347|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
19744718|NCT03424044|42192348|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744719|NCT03424044|42192349|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744720|NCT03424044|42192350|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744721|NCT03424044|42192351|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744722|NCT03424044|42192352|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744723|NCT03424044|42192353|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
19744724|NCT03424044|42192345|FG000|First Intervention (76 Hours)|Adverse Event|0|||
19744725|NCT03424044|42192346|FG001|First Intervention (76 Hours)|Adverse Event|0|||
19744726|NCT03424044|42192347|FG002|First Intervention (76 Hours)|Adverse Event|0|||
19744727|NCT03424044|42192348|FG003|First Intervention (76 Hours)|Adverse Event|0|||
19744728|NCT03424044|42192349|FG004|First Intervention (76 Hours)|Adverse Event|1|||
19744729|NCT03424044|42192350|FG005|First Intervention (76 Hours)|Adverse Event|0|||
19744730|NCT03424044|42192351|FG006|First Intervention (76 Hours)|Adverse Event|0|||
19744731|NCT03424044|42192352|FG007|First Intervention (76 Hours)|Adverse Event|0|||
19744732|NCT03424044|42192353|FG008|First Intervention (76 Hours)|Adverse Event|0|||
19744733|NCT03424044|42192345|FG000|First Intervention (76 Hours)|device issues|0|||
19744734|NCT03424044|42192346|FG001|First Intervention (76 Hours)|device issues|0|||
19744735|NCT03424044|42192347|FG002|First Intervention (76 Hours)|device issues|0|||
19744736|NCT03424044|42192348|FG003|First Intervention (76 Hours)|device issues|0|||
19744737|NCT03424044|42192349|FG004|First Intervention (76 Hours)|device issues|0|||
19744738|NCT03424044|42192350|FG005|First Intervention (76 Hours)|device issues|0|||
19744739|NCT03424044|42192351|FG006|First Intervention (76 Hours)|device issues|1|||
19744740|NCT03424044|42192352|FG007|First Intervention (76 Hours)|device issues|1|||
19744741|NCT03424044|42192353|FG008|First Intervention (76 Hours)|device issues|1|||
19744742|NCT03424044|42192345|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
19744743|NCT03424044|42192346|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
19744744|NCT03424044|42192347|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
19744745|NCT03424044|42192348|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
19744746|NCT03424044|42192349|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
19744747|NCT03424044|42192350|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
19744748|NCT03424044|42192351|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
19744749|NCT03424044|42192352|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
19744750|NCT03424044|42192353|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
19744751|NCT03424044|42192345|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744752|NCT03424044|42192346|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744753|NCT03424044|42192347|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19566306|NCT01212588|42014340|FG000|Overall Study|Physician Decision|0|||
19566307|NCT01212588|42014341|FG001|Overall Study|Physician Decision|1|||
19566308|NCT01212588|42014340|FG000|Overall Study|Protocol Violation|1|||
19744754|NCT03424044|42192348|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
19744755|NCT03424044|42192349|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744756|NCT03424044|42192350|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744757|NCT03424044|42192351|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744758|NCT03424044|42192352|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744759|NCT03424044|42192353|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
19744760|NCT03422250|42192367|FG000|Intervention|Adverse Event|0|||
19744761|NCT03422250|42192368|FG001|Intervention|Adverse Event|1|||
19744762|NCT03422250|42192369|FG002|Intervention|Adverse Event|0|||
19744763|NCT03422250|42192370|FG003|Intervention|Adverse Event|1|||
19744764|NCT03422250|42192367|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
19744765|NCT03422250|42192368|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
19744766|NCT03422250|42192369|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
19744767|NCT03422250|42192370|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
19744768|NCT03422250|42192367|FG000|Follow-up|Withdrawal by Subject|0|||
19744769|NCT03422250|42192368|FG001|Follow-up|Withdrawal by Subject|0|||
19744770|NCT03422250|42192369|FG002|Follow-up|Withdrawal by Subject|0|||
19744771|NCT03422250|42192370|FG003|Follow-up|Withdrawal by Subject|1|||
19744772|NCT03422250|42192367|FG000|Follow-up|Adverse Event|0|||
19744773|NCT03422250|42192368|FG001|Follow-up|Adverse Event|0|||
19744774|NCT03422250|42192369|FG002|Follow-up|Adverse Event|0|||
19744775|NCT03422250|42192370|FG003|Follow-up|Adverse Event|1|||
19744776|NCT01266031|42192385|FG000|Overall Study|Not treated|0|||
19744777|NCT01266031|42192386|FG001|Overall Study|Not treated|3|||
19744778|NCT01266031|42192387|FG002|Overall Study|Not treated|2|||
19744779|NCT00075725|42192418|FG000|Overall Study|Adverse Event|6|||
19744780|NCT00075725|42192419|FG001|Overall Study|Adverse Event|6|||
19744781|NCT00075725|42192420|FG002|Overall Study|Adverse Event|20|||
19744782|NCT00075725|42192421|FG003|Overall Study|Adverse Event|8|||
19744783|NCT00075725|42192422|FG004|Overall Study|Adverse Event|4|||
19744784|NCT00075725|42192423|FG005|Overall Study|Adverse Event|38|||
19744785|NCT00075725|42192424|FG006|Overall Study|Adverse Event|3|||
19744786|NCT00075725|42192425|FG007|Overall Study|Adverse Event|51|||
19744787|NCT00075725|42192426|FG008|Overall Study|Adverse Event|15|||
19744788|NCT00075725|42192427|FG009|Overall Study|Adverse Event|4|||
19744789|NCT00075725|42192428|FG010|Overall Study|Adverse Event|2|||
19744790|NCT00075725|42192429|FG011|Overall Study|Adverse Event|2|||
19744791|NCT00075725|42192418|FG000|Overall Study|Death|3|||
19744792|NCT00075725|42192419|FG001|Overall Study|Death|5|||
19744793|NCT00075725|42192420|FG002|Overall Study|Death|10|||
19744794|NCT00075725|42192421|FG003|Overall Study|Death|2|||
19744795|NCT00075725|42192422|FG004|Overall Study|Death|3|||
19744796|NCT00075725|42192423|FG005|Overall Study|Death|25|||
19744797|NCT00075725|42192424|FG006|Overall Study|Death|4|||
19744798|NCT00075725|42192425|FG007|Overall Study|Death|22|||
19744799|NCT00075725|42192426|FG008|Overall Study|Death|14|||
19744800|NCT00075725|42192427|FG009|Overall Study|Death|4|||
19744801|NCT00075725|42192428|FG010|Overall Study|Death|3|||
19744802|NCT00075725|42192429|FG011|Overall Study|Death|0|||
19744803|NCT00075725|42192418|FG000|Overall Study|Lost to Follow-up|1|||
19744804|NCT00075725|42192419|FG001|Overall Study|Lost to Follow-up|1|||
19744805|NCT00075725|42192420|FG002|Overall Study|Lost to Follow-up|4|||
19744806|NCT00075725|42192421|FG003|Overall Study|Lost to Follow-up|1|||
19744807|NCT00075725|42192422|FG004|Overall Study|Lost to Follow-up|0|||
19744808|NCT00075725|42192423|FG005|Overall Study|Lost to Follow-up|13|||
19744809|NCT00075725|42192424|FG006|Overall Study|Lost to Follow-up|2|||
19744810|NCT00075725|42192425|FG007|Overall Study|Lost to Follow-up|4|||
19744811|NCT00075725|42192426|FG008|Overall Study|Lost to Follow-up|1|||
19744812|NCT00075725|42192427|FG009|Overall Study|Lost to Follow-up|0|||
19744813|NCT00075725|42192428|FG010|Overall Study|Lost to Follow-up|0|||
19744814|NCT00075725|42192429|FG011|Overall Study|Lost to Follow-up|0|||
19744815|NCT00075725|42192418|FG000|Overall Study|Physician Decision|2|||
19744816|NCT00075725|42192419|FG001|Overall Study|Physician Decision|6|||
19744817|NCT00075725|42192420|FG002|Overall Study|Physician Decision|5|||
19744818|NCT00075725|42192421|FG003|Overall Study|Physician Decision|8|||
19390377|NCT01987960|41634113|FG003|Period 3|Lost to Follow-up|5|||
19744819|NCT00075725|42192422|FG004|Overall Study|Physician Decision|4|||
19744820|NCT00075725|42192423|FG005|Overall Study|Physician Decision|19|||
19744821|NCT00075725|42192424|FG006|Overall Study|Physician Decision|3|||
19744822|NCT00075725|42192425|FG007|Overall Study|Physician Decision|17|||
19744823|NCT00075725|42192426|FG008|Overall Study|Physician Decision|5|||
19744824|NCT00075725|42192427|FG009|Overall Study|Physician Decision|0|||
19744825|NCT00075725|42192428|FG010|Overall Study|Physician Decision|1|||
19744826|NCT00075725|42192429|FG011|Overall Study|Physician Decision|0|||
19744827|NCT00075725|42192418|FG000|Overall Study|Pregnancy|0|||
19744828|NCT00075725|42192419|FG001|Overall Study|Pregnancy|0|||
19744829|NCT00075725|42192420|FG002|Overall Study|Pregnancy|0|||
19744830|NCT00075725|42192421|FG003|Overall Study|Pregnancy|0|||
19744831|NCT00075725|42192422|FG004|Overall Study|Pregnancy|0|||
19744832|NCT00075725|42192423|FG005|Overall Study|Pregnancy|1|||
19744833|NCT00075725|42192424|FG006|Overall Study|Pregnancy|0|||
19744834|NCT00075725|42192425|FG007|Overall Study|Pregnancy|1|||
19744835|NCT00075725|42192426|FG008|Overall Study|Pregnancy|0|||
19744836|NCT00075725|42192427|FG009|Overall Study|Pregnancy|0|||
19744837|NCT00075725|42192428|FG010|Overall Study|Pregnancy|0|||
19744838|NCT00075725|42192429|FG011|Overall Study|Pregnancy|0|||
19744839|NCT00075725|42192418|FG000|Overall Study|Protocol Violation|1|||
19744840|NCT00075725|42192419|FG001|Overall Study|Protocol Violation|1|||
19744841|NCT00075725|42192420|FG002|Overall Study|Protocol Violation|0|||
19744842|NCT00075725|42192421|FG003|Overall Study|Protocol Violation|3|||
19744843|NCT00075725|42192422|FG004|Overall Study|Protocol Violation|3|||
19744844|NCT00075725|42192423|FG005|Overall Study|Protocol Violation|2|||
19744845|NCT00075725|42192424|FG006|Overall Study|Protocol Violation|1|||
19744846|NCT00075725|42192425|FG007|Overall Study|Protocol Violation|2|||
19744847|NCT00075725|42192426|FG008|Overall Study|Protocol Violation|3|||
19744848|NCT00075725|42192427|FG009|Overall Study|Protocol Violation|0|||
19744849|NCT00075725|42192428|FG010|Overall Study|Protocol Violation|0|||
19744850|NCT00075725|42192429|FG011|Overall Study|Protocol Violation|1|||
19744851|NCT00075725|42192418|FG000|Overall Study|Withdrawal by Subject|12|||
19744852|NCT00075725|42192419|FG001|Overall Study|Withdrawal by Subject|3|||
19744853|NCT00075725|42192420|FG002|Overall Study|Withdrawal by Subject|6|||
19744854|NCT00075725|42192421|FG003|Overall Study|Withdrawal by Subject|10|||
19744855|NCT00075725|42192422|FG004|Overall Study|Withdrawal by Subject|6|||
19744856|NCT00075725|42192423|FG005|Overall Study|Withdrawal by Subject|27|||
19744857|NCT00075725|42192424|FG006|Overall Study|Withdrawal by Subject|7|||
19744858|NCT00075725|42192425|FG007|Overall Study|Withdrawal by Subject|31|||
19744859|NCT00075725|42192426|FG008|Overall Study|Withdrawal by Subject|10|||
19744860|NCT00075725|42192427|FG009|Overall Study|Withdrawal by Subject|2|||
19744861|NCT00075725|42192428|FG010|Overall Study|Withdrawal by Subject|0|||
19744862|NCT00075725|42192429|FG011|Overall Study|Withdrawal by Subject|0|||
19744863|NCT00075725|42192418|FG000|Overall Study|Disease Progression, all other reasons|17|||
19744864|NCT00075725|42192419|FG001|Overall Study|Disease Progression, all other reasons|5|||
19744865|NCT00075725|42192420|FG002|Overall Study|Disease Progression, all other reasons|33|||
19744866|NCT00075725|42192421|FG003|Overall Study|Disease Progression, all other reasons|6|||
19744867|NCT00075725|42192422|FG004|Overall Study|Disease Progression, all other reasons|21|||
19744868|NCT00075725|42192423|FG005|Overall Study|Disease Progression, all other reasons|59|||
19744869|NCT00075725|42192424|FG006|Overall Study|Disease Progression, all other reasons|20|||
19744870|NCT00075725|42192425|FG007|Overall Study|Disease Progression, all other reasons|46|||
19744871|NCT00075725|42192426|FG008|Overall Study|Disease Progression, all other reasons|21|||
19744872|NCT00075725|42192427|FG009|Overall Study|Disease Progression, all other reasons|4|||
19744873|NCT00075725|42192428|FG010|Overall Study|Disease Progression, all other reasons|0|||
19744874|NCT00075725|42192429|FG011|Overall Study|Disease Progression, all other reasons|5|||
19744875|NCT00075725|42192418|FG000|Overall Study|Patient off treatment|0|||
19382299|NCT04248465|41625598|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
19744876|NCT00075725|42192419|FG001|Overall Study|Patient off treatment|0|||
19744877|NCT00075725|42192420|FG002|Overall Study|Patient off treatment|1|||
19744878|NCT00075725|42192421|FG003|Overall Study|Patient off treatment|2|||
19744879|NCT00075725|42192422|FG004|Overall Study|Patient off treatment|1|||
19744880|NCT00075725|42192423|FG005|Overall Study|Patient off treatment|0|||
19744881|NCT00075725|42192424|FG006|Overall Study|Patient off treatment|0|||
19744882|NCT00075725|42192425|FG007|Overall Study|Patient off treatment|2|||
19744883|NCT00075725|42192426|FG008|Overall Study|Patient off treatment|1|||
19744884|NCT00075725|42192427|FG009|Overall Study|Patient off treatment|0|||
19744885|NCT00075725|42192428|FG010|Overall Study|Patient off treatment|0|||
19744886|NCT00075725|42192429|FG011|Overall Study|Patient off treatment|0|||
19382300|NCT04248465|41625597|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
19744887|NCT00075725|42192418|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
19744888|NCT00075725|42192419|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
19744889|NCT00075725|42192420|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
19744890|NCT00075725|42192421|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
19744891|NCT00075725|42192422|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
19744892|NCT00075725|42192423|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
19744893|NCT00075725|42192424|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
19744894|NCT00075725|42192425|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
19744895|NCT00075725|42192426|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
19744896|NCT00075725|42192427|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
19744897|NCT00075725|42192428|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
19744898|NCT00075725|42192429|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
19744899|NCT00075725|42192418|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
19744900|NCT00075725|42192419|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
19744901|NCT00075725|42192420|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
19744902|NCT00075725|42192421|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
19744903|NCT00075725|42192422|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
19744904|NCT00075725|42192423|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
19744905|NCT00075725|42192424|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
19744906|NCT00075725|42192425|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
19744907|NCT00075725|42192426|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
19744908|NCT00075725|42192427|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
19744909|NCT00075725|42192428|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
19744910|NCT00075725|42192429|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
19744911|NCT00075725|42192418|FG000|Overall Study|Pt non compliant with therapy|2|||
19744912|NCT00075725|42192419|FG001|Overall Study|Pt non compliant with therapy|1|||
19744913|NCT00075725|42192420|FG002|Overall Study|Pt non compliant with therapy|1|||
19744914|NCT00075725|42192421|FG003|Overall Study|Pt non compliant with therapy|0|||
19744915|NCT00075725|42192422|FG004|Overall Study|Pt non compliant with therapy|2|||
19744916|NCT00075725|42192423|FG005|Overall Study|Pt non compliant with therapy|14|||
19744917|NCT00075725|42192424|FG006|Overall Study|Pt non compliant with therapy|2|||
19744918|NCT00075725|42192425|FG007|Overall Study|Pt non compliant with therapy|5|||
19744919|NCT00075725|42192426|FG008|Overall Study|Pt non compliant with therapy|3|||
19744920|NCT00075725|42192427|FG009|Overall Study|Pt non compliant with therapy|0|||
19744921|NCT00075725|42192428|FG010|Overall Study|Pt non compliant with therapy|0|||
19744922|NCT00075725|42192429|FG011|Overall Study|Pt non compliant with therapy|0|||
19744923|NCT00075725|42192418|FG000|Overall Study|Pt age out of range for treatment|0|||
19744924|NCT00075725|42192419|FG001|Overall Study|Pt age out of range for treatment|1|||
19744925|NCT00075725|42192420|FG002|Overall Study|Pt age out of range for treatment|0|||
19744926|NCT00075725|42192421|FG003|Overall Study|Pt age out of range for treatment|0|||
19744927|NCT00075725|42192422|FG004|Overall Study|Pt age out of range for treatment|0|||
19744928|NCT00075725|42192423|FG005|Overall Study|Pt age out of range for treatment|1|||
19744929|NCT00075725|42192424|FG006|Overall Study|Pt age out of range for treatment|0|||
19744930|NCT00075725|42192425|FG007|Overall Study|Pt age out of range for treatment|1|||
19744931|NCT00075725|42192426|FG008|Overall Study|Pt age out of range for treatment|0|||
19744932|NCT00075725|42192427|FG009|Overall Study|Pt age out of range for treatment|0|||
19744933|NCT00075725|42192428|FG010|Overall Study|Pt age out of range for treatment|0|||
19744934|NCT00075725|42192429|FG011|Overall Study|Pt age out of range for treatment|0|||
19744935|NCT00075725|42192418|FG000|Overall Study|Insurance issues|0|||
19744936|NCT00075725|42192419|FG001|Overall Study|Insurance issues|1|||
19744937|NCT00075725|42192420|FG002|Overall Study|Insurance issues|0|||
19744938|NCT00075725|42192421|FG003|Overall Study|Insurance issues|1|||
19744939|NCT00075725|42192422|FG004|Overall Study|Insurance issues|1|||
19744940|NCT00075725|42192423|FG005|Overall Study|Insurance issues|1|||
19744941|NCT00075725|42192424|FG006|Overall Study|Insurance issues|0|||
19744942|NCT00075725|42192425|FG007|Overall Study|Insurance issues|1|||
19744943|NCT00075725|42192426|FG008|Overall Study|Insurance issues|0|||
19744944|NCT00075725|42192427|FG009|Overall Study|Insurance issues|0|||
19744945|NCT00075725|42192428|FG010|Overall Study|Insurance issues|0|||
19744946|NCT00075725|42192429|FG011|Overall Study|Insurance issues|0|||
19744947|NCT00075725|42192418|FG000|Overall Study|MRD positive after extended ind|0|||
19744948|NCT00075725|42192419|FG001|Overall Study|MRD positive after extended ind|1|||
19744949|NCT00075725|42192420|FG002|Overall Study|MRD positive after extended ind|1|||
19744950|NCT00075725|42192421|FG003|Overall Study|MRD positive after extended ind|0|||
19744951|NCT00075725|42192422|FG004|Overall Study|MRD positive after extended ind|1|||
19744952|NCT00075725|42192423|FG005|Overall Study|MRD positive after extended ind|2|||
19744953|NCT00075725|42192424|FG006|Overall Study|MRD positive after extended ind|0|||
19744954|NCT00075725|42192425|FG007|Overall Study|MRD positive after extended ind|1|||
19744955|NCT00075725|42192426|FG008|Overall Study|MRD positive after extended ind|0|||
19744956|NCT00075725|42192427|FG009|Overall Study|MRD positive after extended ind|0|||
19744957|NCT00075725|42192428|FG010|Overall Study|MRD positive after extended ind|0|||
19744958|NCT00075725|42192429|FG011|Overall Study|MRD positive after extended ind|0|||
19744959|NCT00075725|42192418|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
19744960|NCT00075725|42192419|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
19744961|NCT00075725|42192420|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
19744962|NCT00075725|42192421|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
19744963|NCT00075725|42192422|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
19744964|NCT00075725|42192423|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
19744965|NCT00075725|42192424|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
19744966|NCT00075725|42192425|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
19744967|NCT00075725|42192426|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
19744968|NCT00075725|42192427|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
19744969|NCT00075725|42192428|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
19744970|NCT00075725|42192429|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
19744971|NCT00075725|42192418|FG000|Overall Study|Inevaluable|1|||
19744972|NCT00075725|42192419|FG001|Overall Study|Inevaluable|1|||
19744973|NCT00075725|42192420|FG002|Overall Study|Inevaluable|4|||
19744974|NCT00075725|42192421|FG003|Overall Study|Inevaluable|2|||
19744975|NCT00075725|42192422|FG004|Overall Study|Inevaluable|2|||
19744976|NCT00075725|42192423|FG005|Overall Study|Inevaluable|9|||
19744977|NCT00075725|42192424|FG006|Overall Study|Inevaluable|1|||
19744978|NCT00075725|42192425|FG007|Overall Study|Inevaluable|11|||
19744979|NCT00075725|42192426|FG008|Overall Study|Inevaluable|2|||
19744980|NCT00075725|42192427|FG009|Overall Study|Inevaluable|0|||
19744981|NCT00075725|42192428|FG010|Overall Study|Inevaluable|1|||
19744982|NCT00075725|42192429|FG011|Overall Study|Inevaluable|0|||
19744983|NCT00075725|42192418|FG000|Overall Study|Other|4|||
19744984|NCT00075725|42192419|FG001|Overall Study|Other|2|||
19744985|NCT00075725|42192420|FG002|Overall Study|Other|1|||
19744986|NCT00075725|42192421|FG003|Overall Study|Other|1|||
19744987|NCT00075725|42192422|FG004|Overall Study|Other|1|||
19744988|NCT00075725|42192423|FG005|Overall Study|Other|4|||
19744989|NCT00075725|42192424|FG006|Overall Study|Other|2|||
19744990|NCT00075725|42192425|FG007|Overall Study|Other|9|||
19744991|NCT00075725|42192426|FG008|Overall Study|Other|2|||
19744992|NCT00075725|42192427|FG009|Overall Study|Other|1|||
19744993|NCT00075725|42192428|FG010|Overall Study|Other|0|||
19744994|NCT00075725|42192429|FG011|Overall Study|Other|3|||
19744995|NCT00075725|42192418|FG000|Overall Study|Pt trying to find a BM donor|0|||
19744996|NCT00075725|42192419|FG001|Overall Study|Pt trying to find a BM donor|1|||
19744997|NCT00075725|42192420|FG002|Overall Study|Pt trying to find a BM donor|0|||
19744998|NCT00075725|42192421|FG003|Overall Study|Pt trying to find a BM donor|0|||
19744999|NCT00075725|42192422|FG004|Overall Study|Pt trying to find a BM donor|0|||
19745000|NCT00075725|42192423|FG005|Overall Study|Pt trying to find a BM donor|0|||
19745001|NCT00075725|42192424|FG006|Overall Study|Pt trying to find a BM donor|0|||
19745002|NCT00075725|42192425|FG007|Overall Study|Pt trying to find a BM donor|0|||
19745003|NCT00075725|42192426|FG008|Overall Study|Pt trying to find a BM donor|0|||
19745004|NCT00075725|42192427|FG009|Overall Study|Pt trying to find a BM donor|0|||
19745005|NCT00075725|42192428|FG010|Overall Study|Pt trying to find a BM donor|0|||
19745006|NCT00075725|42192429|FG011|Overall Study|Pt trying to find a BM donor|0|||
19745007|NCT00075725|42192418|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
19745008|NCT00075725|42192419|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
19745009|NCT00075725|42192420|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
19745010|NCT00075725|42192421|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
19745011|NCT00075725|42192422|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
19745012|NCT00075725|42192423|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
19745013|NCT00075725|42192424|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
19745014|NCT00075725|42192425|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
19745015|NCT00075725|42192426|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
19745016|NCT00075725|42192427|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
19745017|NCT00075725|42192428|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
19745018|NCT00075725|42192429|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
19745019|NCT00075725|42192418|FG000|Overall Study|Unsuccessful institutional transfer|0|||
19745020|NCT00075725|42192419|FG001|Overall Study|Unsuccessful institutional transfer|0|||
19745021|NCT00075725|42192420|FG002|Overall Study|Unsuccessful institutional transfer|2|||
19745022|NCT00075725|42192421|FG003|Overall Study|Unsuccessful institutional transfer|0|||
19745023|NCT00075725|42192422|FG004|Overall Study|Unsuccessful institutional transfer|0|||
19745024|NCT00075725|42192423|FG005|Overall Study|Unsuccessful institutional transfer|0|||
19745025|NCT00075725|42192424|FG006|Overall Study|Unsuccessful institutional transfer|0|||
19745026|NCT00075725|42192425|FG007|Overall Study|Unsuccessful institutional transfer|0|||
19745027|NCT00075725|42192426|FG008|Overall Study|Unsuccessful institutional transfer|0|||
19745028|NCT00075725|42192427|FG009|Overall Study|Unsuccessful institutional transfer|1|||
19745029|NCT00075725|42192428|FG010|Overall Study|Unsuccessful institutional transfer|0|||
19745030|NCT00075725|42192429|FG011|Overall Study|Unsuccessful institutional transfer|0|||
19745031|NCT00075725|42192418|FG000|Overall Study|specimen(s) not submitted|0|||
19745032|NCT00075725|42192419|FG001|Overall Study|specimen(s) not submitted|0|||
19745033|NCT00075725|42192420|FG002|Overall Study|specimen(s) not submitted|2|||
19745034|NCT00075725|42192421|FG003|Overall Study|specimen(s) not submitted|0|||
19745035|NCT00075725|42192422|FG004|Overall Study|specimen(s) not submitted|0|||
19745036|NCT00075725|42192423|FG005|Overall Study|specimen(s) not submitted|0|||
19745037|NCT00075725|42192424|FG006|Overall Study|specimen(s) not submitted|0|||
19745038|NCT00075725|42192425|FG007|Overall Study|specimen(s) not submitted|0|||
19745039|NCT00075725|42192426|FG008|Overall Study|specimen(s) not submitted|0|||
19745040|NCT00075725|42192427|FG009|Overall Study|specimen(s) not submitted|0|||
19745041|NCT00075725|42192428|FG010|Overall Study|specimen(s) not submitted|0|||
19745042|NCT00075725|42192429|FG011|Overall Study|specimen(s) not submitted|0|||
19745043|NCT00075725|42192418|FG000|Overall Study|Pt went to transplant|0|||
19745044|NCT00075725|42192419|FG001|Overall Study|Pt went to transplant|0|||
19745045|NCT00075725|42192420|FG002|Overall Study|Pt went to transplant|0|||
19745046|NCT00075725|42192421|FG003|Overall Study|Pt went to transplant|1|||
19745047|NCT00075725|42192422|FG004|Overall Study|Pt went to transplant|0|||
19745048|NCT00075725|42192423|FG005|Overall Study|Pt went to transplant|1|||
19745049|NCT00075725|42192424|FG006|Overall Study|Pt went to transplant|0|||
19745050|NCT00075725|42192425|FG007|Overall Study|Pt went to transplant|0|||
19745051|NCT00075725|42192426|FG008|Overall Study|Pt went to transplant|0|||
19745052|NCT00075725|42192427|FG009|Overall Study|Pt went to transplant|0|||
19745053|NCT00075725|42192428|FG010|Overall Study|Pt went to transplant|0|||
19745054|NCT00075725|42192429|FG011|Overall Study|Pt went to transplant|0|||
19745055|NCT00075725|42192418|FG000|Overall Study|Pt received additional steroids|0|||
19745056|NCT00075725|42192419|FG001|Overall Study|Pt received additional steroids|0|||
19745057|NCT00075725|42192420|FG002|Overall Study|Pt received additional steroids|0|||
19745058|NCT00075725|42192421|FG003|Overall Study|Pt received additional steroids|1|||
19745059|NCT00075725|42192422|FG004|Overall Study|Pt received additional steroids|0|||
19745060|NCT00075725|42192423|FG005|Overall Study|Pt received additional steroids|0|||
19745061|NCT00075725|42192424|FG006|Overall Study|Pt received additional steroids|0|||
19745062|NCT00075725|42192425|FG007|Overall Study|Pt received additional steroids|0|||
19745063|NCT00075725|42192426|FG008|Overall Study|Pt received additional steroids|0|||
19745064|NCT00075725|42192427|FG009|Overall Study|Pt received additional steroids|0|||
19745065|NCT00075725|42192428|FG010|Overall Study|Pt received additional steroids|0|||
19745066|NCT00075725|42192429|FG011|Overall Study|Pt received additional steroids|0|||
19745067|NCT00075725|42192418|FG000|Overall Study|Pt relocated|0|||
19745068|NCT00075725|42192419|FG001|Overall Study|Pt relocated|0|||
19745069|NCT00075725|42192420|FG002|Overall Study|Pt relocated|0|||
19745070|NCT00075725|42192421|FG003|Overall Study|Pt relocated|2|||
19745071|NCT00075725|42192422|FG004|Overall Study|Pt relocated|0|||
19745072|NCT00075725|42192423|FG005|Overall Study|Pt relocated|1|||
19745073|NCT00075725|42192424|FG006|Overall Study|Pt relocated|1|||
19745074|NCT00075725|42192425|FG007|Overall Study|Pt relocated|2|||
19745075|NCT00075725|42192426|FG008|Overall Study|Pt relocated|1|||
19745076|NCT00075725|42192427|FG009|Overall Study|Pt relocated|0|||
19745077|NCT00075725|42192428|FG010|Overall Study|Pt relocated|0|||
19745078|NCT00075725|42192429|FG011|Overall Study|Pt relocated|0|||
19745079|NCT00075725|42192418|FG000|Overall Study|Institution Terminated|0|||
19745080|NCT00075725|42192419|FG001|Overall Study|Institution Terminated|0|||
19745081|NCT00075725|42192420|FG002|Overall Study|Institution Terminated|0|||
19745082|NCT00075725|42192421|FG003|Overall Study|Institution Terminated|0|||
19745083|NCT00075725|42192422|FG004|Overall Study|Institution Terminated|1|||
19745084|NCT00075725|42192423|FG005|Overall Study|Institution Terminated|0|||
19745085|NCT00075725|42192424|FG006|Overall Study|Institution Terminated|0|||
19745086|NCT00075725|42192425|FG007|Overall Study|Institution Terminated|3|||
19745087|NCT00075725|42192426|FG008|Overall Study|Institution Terminated|0|||
19745088|NCT00075725|42192427|FG009|Overall Study|Institution Terminated|0|||
19745089|NCT00075725|42192428|FG010|Overall Study|Institution Terminated|0|||
19745090|NCT00075725|42192429|FG011|Overall Study|Institution Terminated|0|||
19745091|NCT00075725|42192418|FG000|Overall Study|Study Closure|1|||
19745092|NCT00075725|42192419|FG001|Overall Study|Study Closure|0|||
19745093|NCT00075725|42192420|FG002|Overall Study|Study Closure|0|||
19745094|NCT00075725|42192421|FG003|Overall Study|Study Closure|0|||
19745095|NCT00075725|42192422|FG004|Overall Study|Study Closure|1|||
19745096|NCT00075725|42192423|FG005|Overall Study|Study Closure|3|||
19745097|NCT00075725|42192424|FG006|Overall Study|Study Closure|0|||
19745098|NCT00075725|42192425|FG007|Overall Study|Study Closure|1|||
19745099|NCT00075725|42192426|FG008|Overall Study|Study Closure|0|||
19745100|NCT00075725|42192427|FG009|Overall Study|Study Closure|0|||
19745101|NCT00075725|42192428|FG010|Overall Study|Study Closure|0|||
19745102|NCT00075725|42192429|FG011|Overall Study|Study Closure|0|||
19745103|NCT00075725|42192418|FG000|Overall Study|Other complications|0|||
19745104|NCT00075725|42192419|FG001|Overall Study|Other complications|0|||
19745105|NCT00075725|42192420|FG002|Overall Study|Other complications|0|||
19745106|NCT00075725|42192421|FG003|Overall Study|Other complications|0|||
19745107|NCT00075725|42192422|FG004|Overall Study|Other complications|0|||
19745108|NCT00075725|42192423|FG005|Overall Study|Other complications|1|||
19745109|NCT00075725|42192424|FG006|Overall Study|Other complications|0|||
19745110|NCT00075725|42192425|FG007|Overall Study|Other complications|0|||
19745111|NCT00075725|42192426|FG008|Overall Study|Other complications|0|||
19745112|NCT00075725|42192427|FG009|Overall Study|Other complications|0|||
19745113|NCT00075725|42192428|FG010|Overall Study|Other complications|0|||
19745114|NCT00075725|42192429|FG011|Overall Study|Other complications|0|||
19745115|NCT00075725|42192418|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
19745116|NCT00075725|42192419|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
19745117|NCT00075725|42192420|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
19745118|NCT00075725|42192421|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
19745119|NCT00075725|42192422|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
19745120|NCT00075725|42192423|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
19745121|NCT00075725|42192424|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
19745122|NCT00075725|42192425|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
19745123|NCT00075725|42192426|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
19745124|NCT00075725|42192427|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
19745125|NCT00075725|42192428|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
19745126|NCT00075725|42192429|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
19745127|NCT00075725|42192418|FG000|Overall Study|Pt incarcerated|0|||
19745128|NCT00075725|42192419|FG001|Overall Study|Pt incarcerated|0|||
19745129|NCT00075725|42192420|FG002|Overall Study|Pt incarcerated|0|||
19745130|NCT00075725|42192421|FG003|Overall Study|Pt incarcerated|0|||
19745131|NCT00075725|42192422|FG004|Overall Study|Pt incarcerated|0|||
19745132|NCT00075725|42192423|FG005|Overall Study|Pt incarcerated|0|||
19745133|NCT00075725|42192424|FG006|Overall Study|Pt incarcerated|0|||
19745134|NCT00075725|42192425|FG007|Overall Study|Pt incarcerated|1|||
19745135|NCT00075725|42192426|FG008|Overall Study|Pt incarcerated|0|||
19745136|NCT00075725|42192427|FG009|Overall Study|Pt incarcerated|0|||
19745137|NCT00075725|42192428|FG010|Overall Study|Pt incarcerated|0|||
19745138|NCT00075725|42192429|FG011|Overall Study|Pt incarcerated|0|||
19745139|NCT02953782|42192468|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
19745140|NCT02953782|42192469|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
19745141|NCT02953782|42192470|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
19745142|NCT02953782|42192471|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
19745143|NCT02953782|42192472|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
19745144|NCT02953782|42192473|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
19745145|NCT02953782|42192474|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
19745146|NCT02953782|42192475|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
19745147|NCT02953782|42192468|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
19745148|NCT02953782|42192469|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
19745149|NCT02953782|42192470|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
19745150|NCT02953782|42192471|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
19745151|NCT02953782|42192472|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
19745152|NCT02953782|42192473|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
19745153|NCT02953782|42192474|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
19745154|NCT02953782|42192475|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
19745155|NCT02953782|42192468|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
19745156|NCT02953782|42192469|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
19745157|NCT02953782|42192470|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
19745158|NCT02953782|42192471|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
19745159|NCT02953782|42192472|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
19745160|NCT02953782|42192473|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
19745161|NCT02953782|42192474|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
19745162|NCT02953782|42192475|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
19745163|NCT02953782|42192468|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745164|NCT02953782|42192469|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745165|NCT02953782|42192470|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
19745166|NCT02953782|42192471|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
19745167|NCT02953782|42192472|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745168|NCT02953782|42192473|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745169|NCT02953782|42192474|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745170|NCT02953782|42192475|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
19745171|NCT02953782|42192468|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
19745172|NCT02953782|42192469|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
19745173|NCT02953782|42192470|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
19745174|NCT02953782|42192471|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
19745175|NCT02953782|42192472|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
19745176|NCT02953782|42192473|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
19745177|NCT02953782|42192474|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
19745178|NCT02953782|42192475|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
19745179|NCT02953782|42192468|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
19745180|NCT02953782|42192469|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
19745181|NCT02953782|42192470|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
19745182|NCT02953782|42192471|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
19745183|NCT02953782|42192472|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
19745184|NCT02953782|42192473|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
19745185|NCT02953782|42192474|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
19745186|NCT02953782|42192475|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
19745187|NCT02953782|42192468|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
19745188|NCT02953782|42192469|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
19745189|NCT02953782|42192470|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
19745190|NCT02953782|42192471|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
19745191|NCT02953782|42192472|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
19745192|NCT02953782|42192473|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
19745193|NCT02953782|42192474|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
19745194|NCT02953782|42192475|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
19745195|NCT02953782|42192468|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745196|NCT02953782|42192469|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745197|NCT02953782|42192470|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745198|NCT02953782|42192471|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745199|NCT02953782|42192472|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745200|NCT02953782|42192473|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745201|NCT02953782|42192474|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
19745202|NCT02953782|42192475|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
19745203|NCT03760081|42192498|FG000|Overall Study|Miscellaneous|0|||
19745204|NCT03760081|42192499|FG001|Overall Study|Miscellaneous|1|||
19745205|NCT03760081|42192498|FG000|Overall Study|Progressive Disease|5|||
19745206|NCT03760081|42192499|FG001|Overall Study|Progressive Disease|10|||
19745207|NCT03760081|42192498|FG000|Overall Study|Death|1|||
19745208|NCT03760081|42192499|FG001|Overall Study|Death|1|||
19745209|NCT03422172|42192507|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
19745210|NCT03422172|42192507|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
19745211|NCT03422172|42192507|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
19745212|NCT00057863|42192516|FG000|Overall Study|Death|1|||
19745213|NCT00057863|42192516|FG000|Overall Study|Withdrawal by Subject|2|||
19745214|NCT00075023|42192522|FG000|Pilot Study|Physician Decision|1|||
19745215|NCT00075023|42192523|FG001|Pilot Study|Physician Decision|2|||
19745216|NCT00075023|42192522|FG000|Pilot Study|Withdrawal by Subject|1|||
19745217|NCT00075023|42192523|FG001|Pilot Study|Withdrawal by Subject|0|||
19745218|NCT00074711|42192532|FG000|Overall Study|Withdrawal by Subject|1|||
19745219|NCT00074711|42192533|FG001|Overall Study|Withdrawal by Subject|1|||
19745220|NCT00074711|42192532|FG000|Overall Study|Lost to Follow-up|10|||
19745221|NCT00074711|42192533|FG001|Overall Study|Lost to Follow-up|8|||
19745222|NCT00074711|42192532|FG000|Overall Study|Participant stopped study drug|4|||
19745223|NCT00074711|42192533|FG001|Overall Study|Participant stopped study drug|6|||
19745224|NCT03420300|42192539|FG000|Overall Study|Death|2|||
19745225|NCT03419598|42192543|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
19745226|NCT03407430|42192551|FG000|Washout|Protocol Violation|1|||
19745227|NCT03407430|42192552|FG001|Washout|Protocol Violation|0|||
19745228|NCT03407118|42192565|FG000|Period 2|Withdrawal by Subject|1|||
19745229|NCT03407118|42192566|FG001|Period 2|Withdrawal by Subject|0|||
19745230|NCT03406962|42192572|FG000|Overall Study|Death|2|||
19745231|NCT03406962|42192572|FG000|Overall Study|Adverse Event|1|||
19745232|NCT03406260|42192583|FG000|Period 1|Adverse Event|0|||
19745233|NCT03406260|42192584|FG001|Period 1|Adverse Event|0|||
19745234|NCT03406260|42192585|FG002|Period 1|Adverse Event|0|||
19745235|NCT03406260|42192586|FG003|Period 1|Adverse Event|0|||
19745236|NCT03406260|42192587|FG004|Period 1|Adverse Event|1|||
19745237|NCT03406260|42192588|FG005|Period 1|Adverse Event|0|||
19745238|NCT03419364|42192601|FG000|Overall Study|Delivery due to maternal condition|2|||
19745239|NCT03419364|42192602|FG001|Overall Study|Delivery due to maternal condition|0|||
19745240|NCT03419364|42192603|FG002|Overall Study|Delivery due to maternal condition|0|||
19745241|NCT02954172|42192613|FG000|Overall Study|Protocol Violation|3|||
19745242|NCT02954172|42192614|FG001|Overall Study|Protocol Violation|0|||
19745243|NCT02954172|42192613|FG000|Overall Study|allergic reaction|2|||
19745244|NCT02954172|42192614|FG001|Overall Study|allergic reaction|1|||
19745245|NCT02954172|42192613|FG000|Overall Study|non-measurable lesions at baseline|1|||
19745246|NCT02954172|42192614|FG001|Overall Study|non-measurable lesions at baseline|2|||
19745247|NCT02953938|42192623|FG000|Overall Study|Adverse Event|0|||
19745248|NCT02953938|42192624|FG001|Overall Study|Adverse Event|1|||
19745249|NCT02953938|42192623|FG000|Overall Study|Withdrawal by Subject|1|||
19745250|NCT02953938|42192624|FG001|Overall Study|Withdrawal by Subject|1|||
19745251|NCT03758443|42192635|FG000|Induction Period|Adverse Event|2|||
19745252|NCT03758443|42192636|FG001|Induction Period|Adverse Event|4|||
19745253|NCT03758443|42192637|FG002|Induction Period|Adverse Event|2|||
19745254|NCT03758443|42192638|FG003|Induction Period|Adverse Event|3|||
19745255|NCT03758443|42192635|FG000|Induction Period|Physician Decision|1|||
19745256|NCT03758443|42192636|FG001|Induction Period|Physician Decision|1|||
19745257|NCT03758443|42192637|FG002|Induction Period|Physician Decision|3|||
19745258|NCT03758443|42192638|FG003|Induction Period|Physician Decision|0|||
19745259|NCT03758443|42192635|FG000|Induction Period|Protocol Violation|0|||
19745260|NCT03758443|42192636|FG001|Induction Period|Protocol Violation|0|||
19745261|NCT03758443|42192637|FG002|Induction Period|Protocol Violation|0|||
19745262|NCT03758443|42192638|FG003|Induction Period|Protocol Violation|1|||
19745263|NCT03758443|42192635|FG000|Induction Period|Withdrawal by Subject|3|||
19745264|NCT03758443|42192636|FG001|Induction Period|Withdrawal by Subject|2|||
19745265|NCT03758443|42192637|FG002|Induction Period|Withdrawal by Subject|2|||
19745266|NCT03758443|42192638|FG003|Induction Period|Withdrawal by Subject|4|||
19745267|NCT03758443|42192635|FG000|Extended Induction Period|Adverse Event|1|||
19745268|NCT03758443|42192636|FG001|Extended Induction Period|Adverse Event|1|||
19745269|NCT03758443|42192637|FG002|Extended Induction Period|Adverse Event|0|||
19745270|NCT03758443|42192638|FG003|Extended Induction Period|Adverse Event|1|||
19745271|NCT03758443|42192635|FG000|Extended Induction Period|Lost to Follow-up|1|||
19745272|NCT03758443|42192636|FG001|Extended Induction Period|Lost to Follow-up|0|||
19745273|NCT03758443|42192637|FG002|Extended Induction Period|Lost to Follow-up|0|||
19745274|NCT03758443|42192638|FG003|Extended Induction Period|Lost to Follow-up|0|||
19745275|NCT03758443|42192635|FG000|Extended Induction Period|Physician Decision|2|||
19745276|NCT03758443|42192636|FG001|Extended Induction Period|Physician Decision|1|||
19745277|NCT03758443|42192637|FG002|Extended Induction Period|Physician Decision|2|||
19745278|NCT03758443|42192638|FG003|Extended Induction Period|Physician Decision|2|||
19745279|NCT03758443|42192635|FG000|Extended Induction Period|Protocol Violation|0|||
19745280|NCT03758443|42192636|FG001|Extended Induction Period|Protocol Violation|0|||
19745281|NCT03758443|42192637|FG002|Extended Induction Period|Protocol Violation|0|||
19745282|NCT03758443|42192638|FG003|Extended Induction Period|Protocol Violation|1|||
19745283|NCT03758443|42192635|FG000|Extended Induction Period|Withdrawal by Subject|8|||
19745284|NCT03758443|42192636|FG001|Extended Induction Period|Withdrawal by Subject|1|||
19745285|NCT03758443|42192637|FG002|Extended Induction Period|Withdrawal by Subject|7|||
19745286|NCT03758443|42192638|FG003|Extended Induction Period|Withdrawal by Subject|3|||
19745287|NCT03758443|42192635|FG000|Extended Induction Period|Miscellaneous|1|||
19745288|NCT03758443|42192636|FG001|Extended Induction Period|Miscellaneous|0|||
19745289|NCT03758443|42192637|FG002|Extended Induction Period|Miscellaneous|0|||
19745290|NCT03758443|42192638|FG003|Extended Induction Period|Miscellaneous|0|||
19745291|NCT03758443|42192635|FG000|Maintenance Period|Adverse Event|1|||
19745292|NCT03758443|42192636|FG001|Maintenance Period|Adverse Event|2|||
19745293|NCT03758443|42192637|FG002|Maintenance Period|Adverse Event|0|||
19745294|NCT03758443|42192638|FG003|Maintenance Period|Adverse Event|0|||
19745295|NCT03758443|42192635|FG000|Maintenance Period|Lost to Follow-up|0|||
19745296|NCT03758443|42192636|FG001|Maintenance Period|Lost to Follow-up|0|||
19745297|NCT03758443|42192637|FG002|Maintenance Period|Lost to Follow-up|0|||
19745298|NCT03758443|42192638|FG003|Maintenance Period|Lost to Follow-up|1|||
19745299|NCT03758443|42192635|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
19745300|NCT03758443|42192636|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
19745301|NCT03758443|42192637|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
19745302|NCT03758443|42192638|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
19745303|NCT03758443|42192635|FG000|Maintenance Period|Protocol Violation|0|||
19745304|NCT03758443|42192636|FG001|Maintenance Period|Protocol Violation|1|||
19745305|NCT03758443|42192637|FG002|Maintenance Period|Protocol Violation|0|||
19745306|NCT03758443|42192638|FG003|Maintenance Period|Protocol Violation|0|||
19745307|NCT03758443|42192635|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
19745308|NCT03758443|42192636|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
19745309|NCT03758443|42192637|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
19745310|NCT03758443|42192638|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
19745311|NCT03758443|42192635|FG000|Maintenance Period|Withdrawal by Subject|1|||
19745312|NCT03758443|42192636|FG001|Maintenance Period|Withdrawal by Subject|0|||
19745313|NCT03758443|42192637|FG002|Maintenance Period|Withdrawal by Subject|1|||
19745314|NCT03758443|42192638|FG003|Maintenance Period|Withdrawal by Subject|1|||
19745315|NCT03758443|42192635|FG000|Maintenance Period|Miscellaneous|0|||
19745316|NCT03758443|42192636|FG001|Maintenance Period|Miscellaneous|0|||
19745317|NCT03758443|42192637|FG002|Maintenance Period|Miscellaneous|1|||
19745318|NCT03758443|42192638|FG003|Maintenance Period|Miscellaneous|0|||
19745319|NCT03442764|42192660|FG000|Overall Study|Adverse Event|1|||
19745320|NCT03442764|42192661|FG001|Overall Study|Adverse Event|0|||
19745321|NCT03442764|42192662|FG002|Overall Study|Adverse Event|0|||
19745322|NCT03442296|42192673|FG000|3 Month Follow-up|Death|3|||
19745323|NCT03442296|42192674|FG001|3 Month Follow-up|Death|1|||
19745324|NCT03442296|42192673|FG000|3 Month Follow-up|Lost to Follow-up|1|||
19745325|NCT03442296|42192674|FG001|3 Month Follow-up|Lost to Follow-up|1|||
19745326|NCT03442296|42192673|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
19745327|NCT03442296|42192674|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
19745328|NCT03442296|42192673|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
19745329|NCT03442296|42192674|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
19745330|NCT03442296|42192673|FG000|12 Month Follow-up|Incomplete measurement|1|||
19745331|NCT03442296|42192674|FG001|12 Month Follow-up|Incomplete measurement|1|||
19745332|NCT03441984|42192682|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745333|NCT03441984|42192683|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745334|NCT03441984|42192684|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
19745335|NCT03441984|42192685|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745336|NCT03441984|42192686|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745337|NCT03441984|42192687|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745338|NCT03441984|42192688|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745339|NCT03441984|42192689|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745340|NCT03441984|42192690|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745341|NCT03441984|42192691|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745342|NCT03441984|42192692|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745343|NCT03441984|42192693|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
19745344|NCT03441360|42192711|FG000|Overall Study|Radiological disease progression|5|||
19745345|NCT03441360|42192712|FG001|Overall Study|Radiological disease progression|6|||
19745346|NCT03441360|42192713|FG002|Overall Study|Radiological disease progression|4|||
19745347|NCT03441360|42192711|FG000|Overall Study|Clinical disease progression|2|||
19745348|NCT03441360|42192712|FG001|Overall Study|Clinical disease progression|2|||
19745349|NCT03441360|42192713|FG002|Overall Study|Clinical disease progression|0|||
19745350|NCT03441360|42192711|FG000|Overall Study|Adverse Event|1|||
19745351|NCT03441360|42192712|FG001|Overall Study|Adverse Event|0|||
19745352|NCT03441360|42192713|FG002|Overall Study|Adverse Event|1|||
19745353|NCT01347840|42192721|FG000|Overall Study|Withdrawal by Subject|1|||
19745354|NCT01347762|42192729|FG000|Overall Study|Lost to Follow-up|0|||
19745355|NCT01347762|42192730|FG001|Overall Study|Lost to Follow-up|1|||
19745356|NCT01347762|42192731|FG002|Overall Study|Lost to Follow-up|6|||
19745357|NCT01347762|42192732|FG003|Overall Study|Lost to Follow-up|5|||
19745358|NCT01347762|42192729|FG000|Overall Study|Withdrawal by Subject|4|||
19745359|NCT01347762|42192730|FG001|Overall Study|Withdrawal by Subject|1|||
19745360|NCT01347762|42192731|FG002|Overall Study|Withdrawal by Subject|3|||
19745361|NCT01347762|42192732|FG003|Overall Study|Withdrawal by Subject|3|||
19745362|NCT03438396|42192742|FG000|Overall Study|Ongoing on study treatment|4|||
19745363|NCT03438396|42192742|FG000|Overall Study|Ongoing in survival follow-up|33|||
19745364|NCT03438396|42192742|FG000|Overall Study|Withdrawal by Subject|4|||
19745365|NCT03438396|42192742|FG000|Overall Study|Lost to Follow-up|2|||
19745366|NCT03438396|42192742|FG000|Overall Study|Death|58|||
19745367|NCT03438396|42192742|FG000|Overall Study|Not treated|1|||
19745368|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
19745369|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
19745370|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
19745371|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
19745372|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
19745373|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
19745374|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
19745375|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
19745376|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
19745377|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
19745378|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
19745379|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
19745380|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
19745381|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
19745382|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
19745383|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
19745384|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
19745385|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
19745386|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
19745387|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
19745388|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
19745389|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
19745390|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
19745391|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
19745392|NCT00073307|42192748|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
19745393|NCT00073307|42192749|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
19745394|NCT00073307|42192750|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
19745395|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
19745396|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
19745397|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
19745398|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
19745399|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
19745400|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
19745401|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
19745402|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
19745403|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
19745404|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
19745405|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
19745406|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
19745407|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
19745408|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
19745409|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
19745410|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
19745411|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
19745412|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
19745413|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
19745414|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
19745415|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
19745416|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
19745417|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
19745418|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
19745419|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
19745420|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
19745421|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
19745422|NCT00073307|42192748|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
19745423|NCT00073307|42192749|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
19745424|NCT00073307|42192750|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
19745425|NCT03388164|42192761|FG000|Overall Study|Withdrawal by Subject|3|||
19745426|NCT03388164|42192762|FG001|Overall Study|Withdrawal by Subject|1|||
19745427|NCT03403374|42192768|FG000|Overall Study|Lost to Follow-up|1|||
19745428|NCT03387462|42192772|FG000|Overall Study|Lost to Follow-up|1|||
19745429|NCT03756883|42192779|FG000|Overall Study|Adverse Event|2|||
19745430|NCT03756883|42192780|FG001|Overall Study|Adverse Event|2|||
19745431|NCT03756883|42192781|FG002|Overall Study|Adverse Event|2|||
19745432|NCT03756883|42192779|FG000|Overall Study|Lack of Efficacy|0|||
19745433|NCT03756883|42192780|FG001|Overall Study|Lack of Efficacy|1|||
19745434|NCT03756883|42192781|FG002|Overall Study|Lack of Efficacy|2|||
19745435|NCT03756883|42192779|FG000|Overall Study|Lost to Follow-up|3|||
19745436|NCT03756883|42192780|FG001|Overall Study|Lost to Follow-up|3|||
19745437|NCT03756883|42192781|FG002|Overall Study|Lost to Follow-up|0|||
19745438|NCT03756883|42192779|FG000|Overall Study|Protocol Violation|2|||
19745439|NCT03756883|42192780|FG001|Overall Study|Protocol Violation|0|||
19745440|NCT03756883|42192781|FG002|Overall Study|Protocol Violation|1|||
19745441|NCT03756883|42192779|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
19745442|NCT03756883|42192780|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
19745443|NCT03756883|42192781|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
19745444|NCT03756883|42192779|FG000|Overall Study|Withdrawal by Subject|4|||
19745445|NCT03756883|42192780|FG001|Overall Study|Withdrawal by Subject|1|||
19745446|NCT03756883|42192781|FG002|Overall Study|Withdrawal by Subject|0|||
19745447|NCT03756883|42192779|FG000|Overall Study|Other Reasons|2|||
19745448|NCT03756883|42192780|FG001|Overall Study|Other Reasons|4|||
19745449|NCT03756883|42192781|FG002|Overall Study|Other Reasons|0|||
19745450|NCT03386994|42192792|FG000|Overall Study|Lung transplant|1|||
19745451|NCT03386994|42192792|FG000|Overall Study|Adverse Event|14|||
19745452|NCT03386994|42192792|FG000|Overall Study|Lost to Follow-up|4|||
19745453|NCT03386994|42192792|FG000|Overall Study|Withdrawal by Subject|3|||
19745454|NCT03386994|42192792|FG000|Overall Study|Death|16|||
19745455|NCT03756571|42192809|FG000|Overall Study|Lost to Follow-up|1|||
19745456|NCT03756571|42192810|FG001|Overall Study|Lost to Follow-up|1|||
19745457|NCT03386448|42192818|FG000|Overall Study|Adverse Event|0|||
19745458|NCT03386448|42192819|FG001|Overall Study|Adverse Event|2|||
19745459|NCT02951988|42192828|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
19745460|NCT02951988|42192829|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
19745461|NCT02951988|42192830|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
19745462|NCT02951988|42192831|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
19745463|NCT02951988|42192828|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
19745464|NCT02951988|42192829|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
19745465|NCT02951988|42192830|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
19745466|NCT02951988|42192831|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
19745467|NCT02951988|42192828|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
19745468|NCT02951988|42192829|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
19745469|NCT02951988|42192830|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
19745470|NCT02951988|42192831|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
19745471|NCT02951988|42192828|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
19745472|NCT02951988|42192829|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
19745473|NCT02951988|42192830|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
19745474|NCT02951988|42192831|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
19745475|NCT02951988|42192828|FG000|Open-Label Treatment Period|Protocol Violation|22|||
19745476|NCT02951988|42192829|FG001|Open-Label Treatment Period|Protocol Violation|0|||
19745477|NCT02951988|42192830|FG002|Open-Label Treatment Period|Protocol Violation|0|||
19745478|NCT02951988|42192831|FG003|Open-Label Treatment Period|Protocol Violation|0|||
19745479|NCT02951988|42192828|FG000|Open-Label Treatment Period|Pregnancy|2|||
19745480|NCT02951988|42192829|FG001|Open-Label Treatment Period|Pregnancy|0|||
19745481|NCT02951988|42192830|FG002|Open-Label Treatment Period|Pregnancy|0|||
19745482|NCT02951988|42192831|FG003|Open-Label Treatment Period|Pregnancy|0|||
19745483|NCT02951988|42192828|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
19745484|NCT02951988|42192829|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
19745485|NCT02951988|42192830|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
19745486|NCT02951988|42192831|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
19745487|NCT02951988|42192828|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
19745488|NCT02951988|42192829|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
19745489|NCT02951988|42192830|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
19745490|NCT02951988|42192831|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
19745491|NCT02951988|42192828|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
19745492|NCT02951988|42192829|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
19745493|NCT02951988|42192830|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
19745494|NCT02951988|42192831|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
19745495|NCT02951988|42192828|FG000|Open-Label Treatment Period|Adverse Event|45|||
19745496|NCT02951988|42192829|FG001|Open-Label Treatment Period|Adverse Event|0|||
19745497|NCT02951988|42192830|FG002|Open-Label Treatment Period|Adverse Event|0|||
19745498|NCT02951988|42192831|FG003|Open-Label Treatment Period|Adverse Event|0|||
19745499|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
19745500|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
19745501|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
19745502|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
19745503|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
19745504|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
19745505|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
19745506|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
19745507|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
19745508|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
19745509|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
19745510|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
19745511|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
19745512|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
19745513|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
19745514|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
19745515|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Pregnancy|0|||
19745516|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Pregnancy|1|||
19745517|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Pregnancy|1|||
19745518|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Pregnancy|0|||
19745519|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19745520|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
19745521|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
19745522|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
19745523|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19745524|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
19745525|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
19745526|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
19745527|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19745528|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Adverse Event|8|||
19745529|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Adverse Event|3|||
19745530|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Adverse Event|6|||
19745531|NCT02951988|42192828|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
19745532|NCT02951988|42192829|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
19745533|NCT02951988|42192830|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
19745534|NCT02951988|42192831|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
19745535|NCT00009737|42192843|FG000|Overall Study|Adverse Event|112|||
19745536|NCT00009737|42192844|FG001|Overall Study|Adverse Event|75|||
19745537|NCT00009737|42192843|FG000|Overall Study|Death|4|||
19745538|NCT00009737|42192844|FG001|Overall Study|Death|6|||
19745539|NCT00009737|42192843|FG000|Overall Study|Lack of Efficacy|17|||
19745540|NCT00009737|42192844|FG001|Overall Study|Lack of Efficacy|15|||
19745541|NCT00009737|42192843|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
19745542|NCT00009737|42192844|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
19745543|NCT00009737|42192843|FG000|Overall Study|Other Protocol Violation|1|||
19745544|NCT00009737|42192844|FG001|Overall Study|Other Protocol Violation|0|||
19745545|NCT00009737|42192843|FG000|Overall Study|Refused Treatment|15|||
19745546|NCT00009737|42192844|FG001|Overall Study|Refused Treatment|16|||
19745547|NCT00009737|42192843|FG000|Overall Study|Lost to Follow-up|1|||
19745548|NCT00009737|42192844|FG001|Overall Study|Lost to Follow-up|1|||
19745549|NCT00009737|42192843|FG000|Overall Study|Administrative/Other Reasons|7|||
19745550|NCT00009737|42192844|FG001|Overall Study|Administrative/Other Reasons|1|||
19745551|NCT03417102|42192852|FG000|Overall Study|Adverse Event|0|||
19566309|NCT01212588|42014341|FG001|Overall Study|Protocol Violation|1|||
19566310|NCT00918385|42014349|FG000|Monotherapy|Adverse Event|1|||
19566311|NCT00918385|42014350|FG001|Monotherapy|Adverse Event|6|||
19566312|NCT00918385|42014349|FG000|Monotherapy|Complicating illness|1|||
19566313|NCT00918385|42014350|FG001|Monotherapy|Complicating illness|0|||
19566314|NCT00918385|42014349|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
19566315|NCT00918385|42014350|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
19566316|NCT00918385|42014349|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
19566317|NCT00918385|42014350|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
19566318|NCT00918385|42014349|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
19566319|NCT00918385|42014350|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
19566320|NCT00918385|42014349|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
19566321|NCT00918385|42014350|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
19566322|NCT01211262|42014360|FG000|Overall Study|Progressive Disease|18|||
19566323|NCT01211262|42014361|FG001|Overall Study|Progressive Disease|9|||
19566324|NCT01211262|42014360|FG000|Overall Study|Adverse Event|4|||
19566325|NCT01211262|42014361|FG001|Overall Study|Adverse Event|0|||
19566326|NCT01211262|42014360|FG000|Overall Study|Withdrawal of Consent|1|||
19566327|NCT01211262|42014361|FG001|Overall Study|Withdrawal of Consent|0|||
19566328|NCT01211262|42014360|FG000|Overall Study|Other|0|||
19566329|NCT01211262|42014361|FG001|Overall Study|Other|1|||
19566330|NCT01211184|42014373|FG000|Overall Study|Withdrawal by Subject|0|||
19566331|NCT01211184|42014374|FG001|Overall Study|Withdrawal by Subject|2|||
19566332|NCT01211184|42014375|FG002|Overall Study|Withdrawal by Subject|1|||
19566333|NCT00924469|42014388|FG000|Overall Study|Adverse Event|2|||
19566334|NCT00924469|42014389|FG001|Overall Study|Adverse Event|0|||
19566335|NCT00924469|42014388|FG000|Overall Study|Withdrawal by Subject|0|||
19566336|NCT00924469|42014389|FG001|Overall Study|Withdrawal by Subject|1|||
19566337|NCT00924469|42014388|FG000|Overall Study|Lost to Follow-up|0|||
19566338|NCT00924469|42014389|FG001|Overall Study|Lost to Follow-up|1|||
19566339|NCT00924313|42014395|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
19566340|NCT01209780|42014403|FG000|Overall Study|Adverse Event|0|||
19566341|NCT01209780|42014404|FG001|Overall Study|Adverse Event|1|||
19566342|NCT01209780|42014405|FG002|Overall Study|Adverse Event|0|||
19566343|NCT01209780|42014406|FG003|Overall Study|Adverse Event|0|||
19566344|NCT01209780|42014407|FG004|Overall Study|Adverse Event|0|||
19566345|NCT01209780|42014403|FG000|Overall Study|Withdrawal by Subject|9|||
19566346|NCT01209780|42014404|FG001|Overall Study|Withdrawal by Subject|2|||
19566347|NCT01209780|42014405|FG002|Overall Study|Withdrawal by Subject|1|||
19566348|NCT01209780|42014406|FG003|Overall Study|Withdrawal by Subject|1|||
19566349|NCT01209780|42014407|FG004|Overall Study|Withdrawal by Subject|0|||
19566350|NCT01209780|42014403|FG000|Overall Study|Lost to Follow-up|17|||
19566351|NCT01209780|42014404|FG001|Overall Study|Lost to Follow-up|12|||
19745552|NCT03417102|42192853|FG001|Overall Study|Adverse Event|1|||
19745553|NCT03417102|42192852|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
19745554|NCT03417102|42192853|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
19566352|NCT01209780|42014405|FG002|Overall Study|Lost to Follow-up|3|||
19566353|NCT01209780|42014406|FG003|Overall Study|Lost to Follow-up|9|||
19566354|NCT01209780|42014407|FG004|Overall Study|Lost to Follow-up|4|||
19566355|NCT01209780|42014403|FG000|Overall Study|Protocol Violation|0|||
19566356|NCT01209780|42014404|FG001|Overall Study|Protocol Violation|1|||
19566357|NCT01209780|42014405|FG002|Overall Study|Protocol Violation|0|||
19745555|NCT03417102|42192852|FG000|Overall Study|Other|0|||
19745556|NCT03417102|42192853|FG001|Overall Study|Other|1|||
19382301|NCT04248465|41625598|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
19566358|NCT01209780|42014406|FG003|Overall Study|Protocol Violation|0|||
19566359|NCT01209780|42014407|FG004|Overall Study|Protocol Violation|0|||
19566360|NCT01209780|42014403|FG000|Overall Study|Inappropriate enrollment|0|||
19566361|NCT01209780|42014404|FG001|Overall Study|Inappropriate enrollment|2|||
19566362|NCT01209780|42014405|FG002|Overall Study|Inappropriate enrollment|0|||
19566363|NCT01209780|42014406|FG003|Overall Study|Inappropriate enrollment|0|||
19566364|NCT01209780|42014407|FG004|Overall Study|Inappropriate enrollment|1|||
19566365|NCT00916357|42014420|FG000|Period 1|Withdrawal by Subject|1|||
19566366|NCT00916357|42014421|FG001|Period 1|Withdrawal by Subject|0|||
19566367|NCT00916357|42014422|FG002|Period 1|Withdrawal by Subject|0|||
19566368|NCT00916357|42014423|FG003|Period 1|Withdrawal by Subject|0|||
19566369|NCT00916357|42014424|FG004|Period 1|Withdrawal by Subject|0|||
19566370|NCT00916357|42014425|FG005|Period 1|Withdrawal by Subject|0|||
19566371|NCT00916357|42014420|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
19566372|NCT00916357|42014421|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
19566373|NCT00916357|42014422|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
19566374|NCT00916357|42014423|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
19566375|NCT00916357|42014424|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
19566376|NCT00916357|42014425|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
19566377|NCT01209624|42014434|FG000|Overall Study|Death|2|||
19566378|NCT01209624|42014434|FG000|Overall Study|Adverse Event|13|||
19566379|NCT01209624|42014434|FG000|Overall Study|Lack of Efficacy|17|||
19566380|NCT01209624|42014434|FG000|Overall Study|Lost to Follow-up|290|||
19566381|NCT01209624|42014434|FG000|Overall Study|Other|4|||
19566382|NCT00916279|42014438|FG000|Overall Study|Death|2|||
19566383|NCT00916279|42014438|FG000|Overall Study|Lost to Follow-up|2|||
19566384|NCT01209078|42014447|FG000|Overall Study|Adverse Event|5|||
19566385|NCT01209078|42014448|FG001|Overall Study|Adverse Event|0|||
19566386|NCT01209078|42014447|FG000|Overall Study|Lost to Follow-up|4|||
19566387|NCT01209078|42014448|FG001|Overall Study|Lost to Follow-up|0|||
19566388|NCT01209078|42014447|FG000|Overall Study|Physician Decision|5|||
19566389|NCT01209078|42014448|FG001|Overall Study|Physician Decision|2|||
19566390|NCT01209078|42014447|FG000|Overall Study|Withdrawal by Subject|2|||
19566391|NCT01209078|42014448|FG001|Overall Study|Withdrawal by Subject|1|||
19566392|NCT01207596|42014456|FG000|Overall Study|Physician Decision|4|||
19566393|NCT01207596|42014456|FG000|Overall Study|Lack of Efficacy|1|||
19566394|NCT01207596|42014456|FG000|Overall Study|Adverse Event|3|||
19566395|NCT01207596|42014456|FG000|Overall Study|Withdrawal by Subject|1|||
19566396|NCT00915343|42014460|FG000|Part B - Open Label Period|Treatment switch|0|||
19566397|NCT00915343|42014461|FG001|Part B - Open Label Period|Treatment switch|0|||
19566398|NCT00915343|42014462|FG002|Part B - Open Label Period|Treatment switch|1|||
19566399|NCT00915343|42014460|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
19566400|NCT00915343|42014461|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
19566401|NCT00915343|42014462|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
19566402|NCT00911989|42014474|FG000|Overall Study|Adverse Event|1|||
19566403|NCT00910273|42014480|FG000|Overall Study|Lack of Efficacy|6|||
19566404|NCT00910273|42014481|FG001|Overall Study|Lack of Efficacy|9|||
19566405|NCT00910273|42014480|FG000|Overall Study|Adverse Event|1|||
19566406|NCT00910273|42014481|FG001|Overall Study|Adverse Event|1|||
19566407|NCT00910273|42014480|FG000|Overall Study|Withdrawal by Subject|1|||
19382302|NCT02643693|41625606|FG000|Overall Study|Physician Decision|0|||
19566408|NCT00910273|42014481|FG001|Overall Study|Withdrawal by Subject|0|||
19566409|NCT00910273|42014480|FG000|Overall Study|Discontinuation of study by sponsor|8|||
19566410|NCT00910273|42014481|FG001|Overall Study|Discontinuation of study by sponsor|2|||
19566411|NCT00910273|42014480|FG000|Overall Study|Protocol Violation|1|||
19566412|NCT00910273|42014481|FG001|Overall Study|Protocol Violation|0|||
19566413|NCT00910273|42014480|FG000|Overall Study|Lost to Follow-up|1|||
19566414|NCT00910273|42014481|FG001|Overall Study|Lost to Follow-up|1|||
19566415|NCT00910039|42014487|FG000|Overall Study|Physician Decision|1|||
19566416|NCT00909181|42014495|FG000|Overall Study|Lost to Follow-up|39|||
19566417|NCT00909181|42014496|FG001|Overall Study|Lost to Follow-up|18|||
19566418|NCT00909181|42014497|FG002|Overall Study|Lost to Follow-up|33|||
19566419|NCT01286987|42014520|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
19566420|NCT01286987|42014521|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
19566421|NCT01286987|42014522|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
19566422|NCT01286987|42014523|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
19566423|NCT01286987|42014524|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
19566424|NCT01286987|42014525|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
19566425|NCT01286987|42014526|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
19566426|NCT01286987|42014527|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
19566427|NCT01286987|42014528|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
19566428|NCT01286987|42014529|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
19745557|NCT03417024|42192859|FG000|Overall Study|Study Termination prior to follow-up|11|||
19745558|NCT03417024|42192859|FG000|Overall Study|Physician Decision|2|||
19566429|NCT01286987|42014530|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
19566430|NCT01286987|42014531|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
19566431|NCT01286987|42014532|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
19566432|NCT01286987|42014533|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
19566433|NCT01286987|42014534|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
19566434|NCT01286987|42014520|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
19566435|NCT01286987|42014521|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
19566436|NCT01286987|42014522|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
19566437|NCT01286987|42014523|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
19566438|NCT01286987|42014524|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
19566439|NCT01286987|42014525|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
19566440|NCT01286987|42014526|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
19566441|NCT01286987|42014527|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
19566442|NCT01286987|42014528|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
19566443|NCT01286987|42014529|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
19566444|NCT01286987|42014530|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
19566445|NCT01286987|42014531|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
19566446|NCT01286987|42014532|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
19566447|NCT01286987|42014533|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
19566448|NCT01286987|42014534|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
19566449|NCT01286987|42014520|FG000|Part 1: Dose Escalation|Physician Decision|0|||
19566450|NCT01286987|42014521|FG001|Part 1: Dose Escalation|Physician Decision|0|||
19566451|NCT01286987|42014522|FG002|Part 1: Dose Escalation|Physician Decision|0|||
19566452|NCT01286987|42014523|FG003|Part 1: Dose Escalation|Physician Decision|0|||
19566453|NCT01286987|42014524|FG004|Part 1: Dose Escalation|Physician Decision|1|||
19566454|NCT01286987|42014525|FG005|Part 1: Dose Escalation|Physician Decision|0|||
19566455|NCT01286987|42014526|FG006|Part 1: Dose Escalation|Physician Decision|0|||
19566456|NCT01286987|42014527|FG007|Part 1: Dose Escalation|Physician Decision|0|||
19566457|NCT01286987|42014528|FG008|Part 1: Dose Escalation|Physician Decision|0|||
19566458|NCT01286987|42014529|FG009|Part 1: Dose Escalation|Physician Decision|0|||
19566459|NCT01286987|42014530|FG010|Part 1: Dose Escalation|Physician Decision|0|||
19566460|NCT01286987|42014531|FG011|Part 1: Dose Escalation|Physician Decision|0|||
19566461|NCT01286987|42014532|FG012|Part 1: Dose Escalation|Physician Decision|0|||
19566462|NCT01286987|42014533|FG013|Part 1: Dose Escalation|Physician Decision|0|||
19566463|NCT01286987|42014534|FG014|Part 1: Dose Escalation|Physician Decision|0|||
19566464|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Death|0|||
19566465|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Death|0|||
19566466|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Death|0|||
19745559|NCT00028769|42192863|FG000|Overall Study|Adverse Event|2|||
19566467|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Death|0|||
19566468|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Death|0|||
19566469|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Death|0|||
19566470|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Death|0|||
19566471|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Death|0|||
19566472|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Death|0|||
19566473|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Death|0|||
19566474|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Death|0|||
19566475|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Death|0|||
19566476|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Death|1|||
19566477|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Death|1|||
19566478|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Death|0|||
19566479|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Physician Decision|0|||
19566480|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Physician Decision|0|||
19566481|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Physician Decision|0|||
19566482|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Physician Decision|0|||
19566483|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Physician Decision|0|||
19566484|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Physician Decision|0|||
19566485|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Physician Decision|0|||
19566486|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Physician Decision|0|||
19566487|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Physician Decision|0|||
19566488|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Physician Decision|0|||
19566489|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Physician Decision|1|||
19566490|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Physician Decision|1|||
19566491|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Physician Decision|0|||
19566492|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Physician Decision|1|||
19566493|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Physician Decision|0|||
19566494|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Other|0|||
19566495|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Other|0|||
19566496|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Other|0|||
19566497|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Other|0|||
19566498|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Other|0|||
19566499|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Other|0|||
19566500|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Other|0|||
19566501|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Other|0|||
19566502|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Other|0|||
19566503|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Other|0|||
19566504|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Other|0|||
19566505|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Other|0|||
19566506|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Other|0|||
19566507|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Other|1|||
19566508|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Other|0|||
19566509|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
19566510|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
19566511|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
19566512|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
19566513|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
19566514|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
19566515|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
19566516|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
19566517|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
19566518|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
19566519|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
19566520|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
19566521|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
19566522|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
19566523|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
19566524|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
19566525|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
19566526|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
19566527|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
19566528|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
19566529|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
19566530|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
19566531|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
19566532|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
19566533|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
19566534|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
19566535|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
19566536|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
19566537|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
19566538|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
19566539|NCT01286987|42014520|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566540|NCT01286987|42014521|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566541|NCT01286987|42014522|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566542|NCT01286987|42014523|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566543|NCT01286987|42014524|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19745560|NCT00028769|42192863|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
19745561|NCT00028769|42192863|FG000|Overall Study|Progression or Death|31|||
19745562|NCT00028769|42192863|FG000|Overall Study|Other - Not Protocol Specified|1|||
19745563|NCT00028769|42192863|FG000|Overall Study|Ineligible|5|||
19566544|NCT01286987|42014525|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19382303|NCT02643693|41625607|FG001|Overall Study|Physician Decision|1|||
19566545|NCT01286987|42014526|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566546|NCT01286987|42014527|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566547|NCT01286987|42014528|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566548|NCT01286987|42014529|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566549|NCT01286987|42014530|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
19566550|NCT01286987|42014531|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566551|NCT01286987|42014532|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566552|NCT01286987|42014533|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566553|NCT01286987|42014534|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
19566554|NCT01286753|42014577|FG000|Overall Study|Adverse Event|7|||
19566555|NCT01286753|42014578|FG001|Overall Study|Adverse Event|6|||
19566556|NCT01286753|42014577|FG000|Overall Study|Progression|11|||
19566557|NCT01286753|42014578|FG001|Overall Study|Progression|13|||
19566558|NCT01286753|42014577|FG000|Overall Study|Refused Treatment|1|||
19566559|NCT01286753|42014578|FG001|Overall Study|Refused Treatment|0|||
19566560|NCT01286753|42014577|FG000|Overall Study|Withdrawal of Consent|0|||
19566561|NCT01286753|42014578|FG001|Overall Study|Withdrawal of Consent|2|||
19566562|NCT01286753|42014577|FG000|Overall Study|Discontinued to Join Extension Study|6|||
19566563|NCT01286753|42014578|FG001|Overall Study|Discontinued to Join Extension Study|4|||
19566564|NCT01286753|42014577|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
19566565|NCT01286753|42014578|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
19566566|NCT01286129|42014587|FG000|Overall Study|Withdrawal by Subject|4|||
19566567|NCT01286129|42014588|FG001|Overall Study|Withdrawal by Subject|1|||
19566568|NCT01286129|42014587|FG000|Overall Study|Could not comply with study requirements|4|||
19566569|NCT01286129|42014588|FG001|Overall Study|Could not comply with study requirements|4|||
19566570|NCT01285349|42014599|FG000|Overall Study|Lost to Follow-up|27|||
19566571|NCT01285349|42014600|FG001|Overall Study|Lost to Follow-up|20|||
19566572|NCT01285349|42014601|FG002|Overall Study|Lost to Follow-up|27|||
19566573|NCT01284959|42014613|FG000|Overall Study|Withdrawal by Subject|1|||
19566574|NCT01284959|42014614|FG001|Overall Study|Withdrawal by Subject|0|||
19566575|NCT01284959|42014615|FG002|Overall Study|Withdrawal by Subject|0|||
19566576|NCT01284959|42014613|FG000|Overall Study|Adverse Event|0|||
19566577|NCT01284959|42014614|FG001|Overall Study|Adverse Event|0|||
19566578|NCT01284959|42014615|FG002|Overall Study|Adverse Event|1|||
19566579|NCT01284491|42014623|FG000|Overall Study|Study termination|13|||
19566580|NCT01283009|42014631|FG000|Overall Study|Death|83|||
19566581|NCT01283009|42014632|FG001|Overall Study|Death|78|||
19382304|NCT02643693|41625608|FG002|Overall Study|Physician Decision|0|||
19566582|NCT01283009|42014631|FG000|Overall Study|Study ended early|23|||
19566583|NCT01283009|42014632|FG001|Overall Study|Study ended early|26|||
19566584|NCT01283009|42014631|FG000|Overall Study|Withdrawal by Subject|10|||
19566585|NCT01283009|42014632|FG001|Overall Study|Withdrawal by Subject|8|||
19566586|NCT01283009|42014631|FG000|Overall Study|Physician Decision|1|||
19566587|NCT01283009|42014632|FG001|Overall Study|Physician Decision|1|||
19566588|NCT01283009|42014631|FG000|Overall Study|Lost to Follow-up|1|||
19566589|NCT01283009|42014632|FG001|Overall Study|Lost to Follow-up|0|||
19566590|NCT01283009|42014631|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
19566591|NCT01283009|42014632|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
19566592|NCT01282463|42014641|FG000|Overall Study|Lost to Follow-up|1|||
19566593|NCT01282463|42014642|FG001|Overall Study|Lost to Follow-up|0|||
19566594|NCT01282463|42014643|FG002|Overall Study|Lost to Follow-up|0|||
19566595|NCT01282463|42014641|FG000|Overall Study|Withdrawal by Subject|6|||
19566596|NCT01282463|42014642|FG001|Overall Study|Withdrawal by Subject|2|||
19566597|NCT01282463|42014643|FG002|Overall Study|Withdrawal by Subject|3|||
19566598|NCT01282463|42014641|FG000|Overall Study|"Never Treated Death"|0|||
19566599|NCT01282463|42014642|FG001|Overall Study|"Never Treated Death"|1|||
19566600|NCT01282463|42014643|FG002|Overall Study|"Never Treated Death"|0|||
19566601|NCT01282463|42014641|FG000|Overall Study|"Never Treated PD"|0|||
19566602|NCT01282463|42014642|FG001|Overall Study|"Never Treated PD"|1|||
19566603|NCT01282463|42014643|FG002|Overall Study|"Never Treated PD"|0|||
19566604|NCT01282463|42014641|FG000|Overall Study|Protocol Violation|0|||
19566605|NCT01282463|42014642|FG001|Overall Study|Protocol Violation|0|||
19566606|NCT01282463|42014643|FG002|Overall Study|Protocol Violation|1|||
19566607|NCT01282463|42014641|FG000|Overall Study|Physician Decision|1|||
19566608|NCT01282463|42014642|FG001|Overall Study|Physician Decision|0|||
19566609|NCT01282463|42014643|FG002|Overall Study|Physician Decision|0|||
19566610|NCT01282229|42014659|FG000|Overall Study|Protocol Violation|2|||
19566611|NCT01281917|42014677|FG000|Overall Study|Withdrawal by Subject|1|||
19566612|NCT01281839|42014683|FG000|Overall Study|Lost to Follow-up|6|||
19566613|NCT01281839|42014684|FG001|Overall Study|Lost to Follow-up|3|||
19566614|NCT01281839|42014683|FG000|Overall Study|Withdrawal by Subject|4|||
19566615|NCT01281839|42014684|FG001|Overall Study|Withdrawal by Subject|10|||
19566616|NCT01281839|42014683|FG000|Overall Study|Reason not specified|0|||
19566617|NCT01281839|42014684|FG001|Overall Study|Reason not specified|1|||
19566618|NCT01281137|42014692|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
19566619|NCT01281137|42014693|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
19566620|NCT01281137|42014692|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
19566621|NCT01281137|42014693|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
19566622|NCT01281137|42014692|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
19566623|NCT01281137|42014693|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
19566624|NCT01281137|42014692|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
19566625|NCT01281137|42014693|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
19566626|NCT01281137|42014692|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
19566627|NCT01281137|42014693|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
19566628|NCT01280981|42014717|FG000|Overall Study|Withdrawal by Subject|11|||
19566629|NCT01280981|42014717|FG000|Overall Study|Protocol Violation|2|||
19566630|NCT01280981|42014717|FG000|Overall Study|Lack of Efficacy|13|||
19566631|NCT01280981|42014717|FG000|Overall Study|Lost to Follow-up|3|||
19566632|NCT01280981|42014717|FG000|Overall Study|Adverse Event|6|||
19566633|NCT01280981|42014717|FG000|Overall Study|Irregular or discontinued menses|3|||
19566634|NCT01280981|42014717|FG000|Overall Study|Failed to return|45|||
19566635|NCT01280981|42014717|FG000|Overall Study|Non-compliance with protocol|3|||
19566636|NCT01280981|42014717|FG000|Overall Study|Withdrawal of consent|3|||
19566637|NCT01280981|42014717|FG000|Overall Study|Elective surgery|2|||
19566638|NCT01280981|42014717|FG000|Overall Study|Study site closure|1|||
19566639|NCT01280903|42014723|FG000|Overall Study|Lost to Follow-up|23|||
19566640|NCT01280903|42014724|FG001|Overall Study|Lost to Follow-up|16|||
19566641|NCT01280591|42014734|FG000|Overall Study|Withdrawal by Subject|0|||
19566642|NCT01280591|42014735|FG001|Overall Study|Withdrawal by Subject|0|||
19566643|NCT01280591|42014736|FG002|Overall Study|Withdrawal by Subject|0|||
19566644|NCT01280591|42014737|FG003|Overall Study|Withdrawal by Subject|2|||
19566645|NCT01280591|42014734|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
19382305|NCT02643693|41625609|FG003|Overall Study|Physician Decision|0|||
19566646|NCT01280591|42014735|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
19566647|NCT01280591|42014736|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
19566648|NCT01280591|42014737|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
19566649|NCT01280357|42014747|FG000|Overall Study|Excluded no internal monitoring|14|||
19566650|NCT01280357|42014747|FG000|Overall Study|IInsufficient data/No data supplied|12|||
19566651|NCT01274351|42014754|FG000|Overall Study|Lost to Follow-up|1|||
19566652|NCT01274351|42014754|FG000|Overall Study|patient not compliant with the protocol|1|||
19566653|NCT01274351|42014754|FG000|Overall Study|Pregnancy|1|||
19566654|NCT01274351|42014754|FG000|Overall Study|Death|2|||
19566655|NCT01274351|42014754|FG000|Overall Study|Withdrawal by Subject|3|||
19566656|NCT01274351|42014754|FG000|Overall Study|Adverse Event|8|||
19566657|NCT01274351|42014754|FG000|Overall Study|progression of disease|3|||
19566658|NCT01274351|42014754|FG000|Overall Study|hospitalization|1|||
19566659|NCT01271933|42014758|FG000|Single-Blind Phase|Lack of Efficacy|37|||
19566660|NCT01271933|42014759|FG001|Single-Blind Phase|Lack of Efficacy|0|||
19566661|NCT01271933|42014760|FG002|Single-Blind Phase|Lack of Efficacy|0|||
19566662|NCT01271933|42014758|FG000|Single-Blind Phase|Lost to Follow-up|10|||
19566663|NCT01271933|42014759|FG001|Single-Blind Phase|Lost to Follow-up|0|||
19566664|NCT01271933|42014760|FG002|Single-Blind Phase|Lost to Follow-up|0|||
19566665|NCT01271933|42014758|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
19566666|NCT01271933|42014759|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
19566667|NCT01271933|42014760|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
19566668|NCT01271933|42014758|FG000|Single-Blind Phase|Protocol Violation|3|||
19566669|NCT01271933|42014759|FG001|Single-Blind Phase|Protocol Violation|0|||
19566670|NCT01271933|42014760|FG002|Single-Blind Phase|Protocol Violation|0|||
19566671|NCT01271933|42014758|FG000|Single-Blind Phase|Adverse Event|52|||
19566672|NCT01271933|42014759|FG001|Single-Blind Phase|Adverse Event|0|||
19566673|NCT01271933|42014760|FG002|Single-Blind Phase|Adverse Event|0|||
19566674|NCT01271933|42014758|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
19566675|NCT01271933|42014759|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
19566676|NCT01271933|42014760|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
19566677|NCT01271933|42014758|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
19566678|NCT01271933|42014759|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
19566679|NCT01271933|42014760|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
19566680|NCT01271933|42014758|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
19566681|NCT01271933|42014759|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
19566682|NCT01271933|42014760|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
19566683|NCT01271933|42014758|FG000|Double-Blind Phase|Randomized but not treated|0|||
19566684|NCT01271933|42014759|FG001|Double-Blind Phase|Randomized but not treated|0|||
19566685|NCT01271933|42014760|FG002|Double-Blind Phase|Randomized but not treated|1|||
19566686|NCT01271933|42014758|FG000|Double-Blind Phase|Lack of Efficacy|0|||
19566687|NCT01271933|42014759|FG001|Double-Blind Phase|Lack of Efficacy|6|||
19566688|NCT01271933|42014760|FG002|Double-Blind Phase|Lack of Efficacy|9|||
19566689|NCT01271933|42014758|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19566690|NCT01271933|42014759|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19566691|NCT01271933|42014760|FG002|Double-Blind Phase|Lost to Follow-up|1|||
19566692|NCT01271933|42014758|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19566693|NCT01271933|42014759|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
19566694|NCT01271933|42014760|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
19566695|NCT01271933|42014758|FG000|Double-Blind Phase|Adverse Event|0|||
19566696|NCT01271933|42014759|FG001|Double-Blind Phase|Adverse Event|3|||
19566697|NCT01271933|42014760|FG002|Double-Blind Phase|Adverse Event|0|||
19745564|NCT00028769|42192863|FG000|Overall Study|Not Analyzable|1|||
19745565|NCT02953314|42192869|FG000|Overall Study|Adverse Event|0|||
19745566|NCT02953314|42192870|FG001|Overall Study|Adverse Event|1|||
19745567|NCT02953314|42192869|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
19566698|NCT01271933|42014758|FG000|Double-Blind Phase|Participant request-personal reason|0|||
19566699|NCT01271933|42014759|FG001|Double-Blind Phase|Participant request-personal reason|1|||
19566700|NCT01271933|42014760|FG002|Double-Blind Phase|Participant request-personal reason|0|||
19566701|NCT01269125|42014773|FG000|Overall Study|Adverse Event|3|||
19566702|NCT01269125|42014774|FG001|Overall Study|Adverse Event|5|||
19566703|NCT01269125|42014775|FG002|Overall Study|Adverse Event|0|||
19566704|NCT01269125|42014773|FG000|Overall Study|Lost to Follow-up|4|||
19566705|NCT01269125|42014774|FG001|Overall Study|Lost to Follow-up|0|||
19566706|NCT01269125|42014775|FG002|Overall Study|Lost to Follow-up|0|||
19566707|NCT01268891|42014785|FG000|Overall Study|Adverse Event|3|||
19566708|NCT01268891|42014786|FG001|Overall Study|Adverse Event|7|||
19566709|NCT01268891|42014785|FG000|Overall Study|Lack of Efficacy|1|||
19566710|NCT01268891|42014786|FG001|Overall Study|Lack of Efficacy|0|||
19566711|NCT01268891|42014785|FG000|Overall Study|Withdrawal of Consent|3|||
19566712|NCT01268891|42014786|FG001|Overall Study|Withdrawal of Consent|1|||
19566713|NCT01268891|42014785|FG000|Overall Study|Administrative or other reason(s)|1|||
19566714|NCT01268891|42014786|FG001|Overall Study|Administrative or other reason(s)|0|||
19566715|NCT01268501|42014792|FG000|Overall Study|Lost to Follow-up|1|||
19566716|NCT01268501|42014792|FG000|Overall Study|Withdrawal by Subject|3|||
19566717|NCT01268501|42014792|FG000|Overall Study|Unacceptable Subjective Vision|3|||
19566718|NCT01268501|42014792|FG000|Overall Study|Handling Difficulties|2|||
19566719|NCT01268267|42014796|FG000|Overall Study|Protocol Violation|1|||
19566720|NCT01267253|42014801|FG000|Overall Study|Ineligible - required test not done|1|||
19566721|NCT01267253|42014801|FG000|Overall Study|Inevaluable-never received study treatme|2|||
19566722|NCT01267175|42014805|FG000|Overall Study|Withdrawal by Subject|1|||
19566723|NCT01267175|42014805|FG000|Overall Study|Lost to Follow-up|1|||
19566724|NCT01266317|42014809|FG000|Overall Study|Withdrawal by Subject|2|||
19566725|NCT01266161|42014815|FG000|Overall Study|Ineligible|1|||
19566726|NCT01266161|42014816|FG001|Overall Study|Ineligible|0|||
19566727|NCT01266161|42014815|FG000|Overall Study|Lack of Efficacy|0|||
19566728|NCT01266161|42014816|FG001|Overall Study|Lack of Efficacy|1|||
19566729|NCT01266161|42014815|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
19566730|NCT01266161|42014816|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
19566731|NCT01265849|42014825|FG000|Overall Study|Randomized//Treatment not initiated|1|||
19566732|NCT01265849|42014826|FG001|Overall Study|Randomized//Treatment not initiated|4|||
19566733|NCT01265849|42014827|FG002|Overall Study|Randomized//Treatment not initiated|0|||
19566734|NCT01265849|42014825|FG000|Overall Study|Physician Decision|1|||
19566735|NCT01265849|42014826|FG001|Overall Study|Physician Decision|2|||
19566736|NCT01265849|42014827|FG002|Overall Study|Physician Decision|0|||
19566737|NCT01265849|42014825|FG000|Overall Study|Lost to Follow-up|18|||
19566738|NCT01265849|42014826|FG001|Overall Study|Lost to Follow-up|15|||
19566739|NCT01265849|42014827|FG002|Overall Study|Lost to Follow-up|5|||
19566740|NCT01265849|42014825|FG000|Overall Study|Not otherwise specified|1|||
19566741|NCT01265849|42014826|FG001|Overall Study|Not otherwise specified|6|||
19566742|NCT01265849|42014827|FG002|Overall Study|Not otherwise specified|1|||
19566743|NCT01265849|42014825|FG000|Overall Study|Withdrawal by Subject|25|||
19566744|NCT01265849|42014826|FG001|Overall Study|Withdrawal by Subject|34|||
19566745|NCT01265849|42014827|FG002|Overall Study|Withdrawal by Subject|13|||
19566746|NCT01265615|42014843|FG000|Overall Study|Protocol Violation|2|||
19566747|NCT01265615|42014844|FG001|Overall Study|Protocol Violation|2|||
19566748|NCT01265615|42014845|FG002|Overall Study|Protocol Violation|4|||
19566749|NCT01265615|42014846|FG003|Overall Study|Protocol Violation|3|||
19566750|NCT01264835|42014856|FG000|Overall Study|Lost to Follow-up|1|||
19566751|NCT01264679|42014860|FG000|Overall Study|Participation in Another Clinical Trial|1|||
19566752|NCT01264679|42014860|FG000|Overall Study|Physician Decision|1|||
19566753|NCT01264679|42014860|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
19566754|NCT01264679|42014860|FG000|Overall Study|Withdrawal by Subject|1|||
19566755|NCT01263665|42014865|FG000|Overall Study|Withdrew Consent|1|||
19566756|NCT01263665|42014865|FG000|Overall Study|Lost to Follow-up|3|||
19566757|NCT01263665|42014865|FG000|Overall Study|Death|2|||
19566758|NCT01263665|42014865|FG000|Overall Study|Amputation above the ankle|1|||
19566759|NCT01263665|42014865|FG000|Overall Study|Surgical Bypass|2|||
19566760|NCT01263509|42014871|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
19566761|NCT01263509|42014872|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
19566762|NCT01263509|42014873|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
19566763|NCT01263509|42014874|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
19566764|NCT01263509|42014871|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19566765|NCT01263509|42014872|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
19566766|NCT01263509|42014873|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19566767|NCT01263509|42014874|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19566768|NCT01263509|42014871|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19566769|NCT01263509|42014872|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19566770|NCT01263509|42014873|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19566771|NCT01263509|42014874|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19566772|NCT01263509|42014871|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
19566773|NCT01263509|42014872|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
19382306|NCT02643693|41625610|FG004|Overall Study|Physician Decision|0|||
19382307|NCT02643693|41625611|FG005|Overall Study|Physician Decision|0|||
19566774|NCT01263509|42014873|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19566775|NCT01263509|42014874|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19566776|NCT01263509|42014871|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
19566777|NCT01263509|42014872|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
19566778|NCT01263509|42014873|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
19566779|NCT01263509|42014874|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
19566780|NCT01263197|42014882|FG000|First Intervention (Period 1)|Adverse Event|0|||
19566781|NCT01263197|42014883|FG001|First Intervention (Period 1)|Adverse Event|0|||
19566782|NCT01263197|42014884|FG002|First Intervention (Period 1)|Adverse Event|0|||
19566783|NCT01263197|42014885|FG003|First Intervention (Period 1)|Adverse Event|0|||
19566784|NCT01263197|42014886|FG004|First Intervention (Period 1)|Adverse Event|0|||
19566785|NCT01263197|42014887|FG005|First Intervention (Period 1)|Adverse Event|1|||
19566786|NCT01263197|42014882|FG000|Washout Period 1|Protocol Violation|0|||
19566787|NCT01263197|42014883|FG001|Washout Period 1|Protocol Violation|0|||
19566788|NCT01263197|42014884|FG002|Washout Period 1|Protocol Violation|0|||
19566789|NCT01263197|42014885|FG003|Washout Period 1|Protocol Violation|0|||
19566790|NCT01263197|42014886|FG004|Washout Period 1|Protocol Violation|1|||
19566791|NCT01263197|42014887|FG005|Washout Period 1|Protocol Violation|0|||
19566792|NCT01263197|42014882|FG000|Washout Period 2|Physician Decision|0|||
19566793|NCT01263197|42014883|FG001|Washout Period 2|Physician Decision|0|||
19566794|NCT01263197|42014884|FG002|Washout Period 2|Physician Decision|0|||
19566795|NCT01263197|42014885|FG003|Washout Period 2|Physician Decision|0|||
19566796|NCT01263197|42014886|FG004|Washout Period 2|Physician Decision|0|||
19566797|NCT01263197|42014887|FG005|Washout Period 2|Physician Decision|1|||
19566798|NCT01263197|42014882|FG000|Washout Period 2|Protocol Violation|0|||
19566799|NCT01263197|42014883|FG001|Washout Period 2|Protocol Violation|0|||
19566800|NCT01263197|42014884|FG002|Washout Period 2|Protocol Violation|0|||
19566801|NCT01263197|42014885|FG003|Washout Period 2|Protocol Violation|1|||
19566802|NCT01263197|42014886|FG004|Washout Period 2|Protocol Violation|0|||
19566803|NCT01263197|42014887|FG005|Washout Period 2|Protocol Violation|0|||
19566804|NCT01263197|42014882|FG000|Third Intervention (Period 3)|Adverse Event|0|||
19566805|NCT01263197|42014883|FG001|Third Intervention (Period 3)|Adverse Event|1|||
19566806|NCT01263197|42014884|FG002|Third Intervention (Period 3)|Adverse Event|0|||
19566807|NCT01263197|42014885|FG003|Third Intervention (Period 3)|Adverse Event|0|||
19566808|NCT01263197|42014886|FG004|Third Intervention (Period 3)|Adverse Event|0|||
19566809|NCT01263197|42014887|FG005|Third Intervention (Period 3)|Adverse Event|0|||
19566810|NCT01263119|42014901|FG000|Period 1|Protocol Violation|2|||
19566811|NCT01263119|42014901|FG000|Period 2|Adverse Event|2|||
19566812|NCT01262651|42014911|FG000|Overall Study|Adverse Event|40|||
19566813|NCT01262651|42014912|FG001|Overall Study|Adverse Event|35|||
19566814|NCT01262651|42014911|FG000|Overall Study|Withdrawal by Subject|15|||
19566815|NCT01262651|42014912|FG001|Overall Study|Withdrawal by Subject|11|||
19566816|NCT01262651|42014911|FG000|Overall Study|Withdrawal by Investigator|2|||
19566817|NCT01262651|42014912|FG001|Overall Study|Withdrawal by Investigator|2|||
19566818|NCT01262651|42014911|FG000|Overall Study|Met Withdrawal Criteria|1|||
19566819|NCT01262651|42014912|FG001|Overall Study|Met Withdrawal Criteria|0|||
19566820|NCT01262573|42014920|FG000|Overall Study|Withdrawal by Subject|0|||
19566821|NCT01262573|42014921|FG001|Overall Study|Withdrawal by Subject|1|||
19566822|NCT01262027|42014927|FG000|Overall Study|Adverse Event|1|||
19566823|NCT01262027|42014927|FG000|Overall Study|Withdrawal by Subject|3|||
19566824|NCT01262027|42014927|FG000|Overall Study|Protocol Violation|1|||
19566825|NCT01261793|42014934|FG000|Overall Study|Lack of Efficacy|44|||
19566826|NCT01261793|42014935|FG001|Overall Study|Lack of Efficacy|37|||
19566827|NCT01261793|42014936|FG002|Overall Study|Lack of Efficacy|32|||
19566828|NCT01261793|42014934|FG000|Overall Study|Protocol Violation|3|||
19566829|NCT01261793|42014935|FG001|Overall Study|Protocol Violation|5|||
19566830|NCT01261793|42014936|FG002|Overall Study|Protocol Violation|6|||
19566831|NCT01261793|42014934|FG000|Overall Study|Lost to Follow-up|10|||
19566832|NCT01261793|42014935|FG001|Overall Study|Lost to Follow-up|3|||
19566833|NCT01261793|42014936|FG002|Overall Study|Lost to Follow-up|7|||
19566834|NCT01261793|42014934|FG000|Overall Study|Withdrawal by Subject|12|||
19566835|NCT01261793|42014935|FG001|Overall Study|Withdrawal by Subject|14|||
19566836|NCT01261793|42014936|FG002|Overall Study|Withdrawal by Subject|14|||
19566837|NCT01261793|42014934|FG000|Overall Study|Death|3|||
19566838|NCT01261793|42014935|FG001|Overall Study|Death|1|||
19566839|NCT01261793|42014936|FG002|Overall Study|Death|0|||
19566840|NCT01261793|42014934|FG000|Overall Study|Adverse Event|9|||
19566841|NCT01261793|42014935|FG001|Overall Study|Adverse Event|24|||
19566842|NCT01261793|42014936|FG002|Overall Study|Adverse Event|19|||
19566843|NCT01261793|42014934|FG000|Overall Study|Patient non-availability|1|||
19566844|NCT01261793|42014935|FG001|Overall Study|Patient non-availability|1|||
19566845|NCT01261793|42014936|FG002|Overall Study|Patient non-availability|1|||
19745568|NCT02953314|42192870|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
19382308|NCT02643693|41625606|FG000|Overall Study|Withdrawal by Subject|0|||
19382309|NCT02643693|41625607|FG001|Overall Study|Withdrawal by Subject|1|||
19382310|NCT02643693|41625608|FG002|Overall Study|Withdrawal by Subject|0|||
19382311|NCT02643693|41625609|FG003|Overall Study|Withdrawal by Subject|0|||
19382312|NCT02643693|41625610|FG004|Overall Study|Withdrawal by Subject|0|||
19382313|NCT02643693|41625611|FG005|Overall Study|Withdrawal by Subject|0|||
19382314|NCT02643693|41625606|FG000|Overall Study|Protocol Adherence Issues|2|||
19382315|NCT02643693|41625607|FG001|Overall Study|Protocol Adherence Issues|0|||
19382316|NCT02643693|41625608|FG002|Overall Study|Protocol Adherence Issues|1|||
19382317|NCT02643693|41625609|FG003|Overall Study|Protocol Adherence Issues|0|||
19382318|NCT02643693|41625610|FG004|Overall Study|Protocol Adherence Issues|0|||
19382319|NCT02643693|41625611|FG005|Overall Study|Protocol Adherence Issues|1|||
19382320|NCT02726113|41625621|FG000|Total Enrollment|Physician Decision|0|||
19382321|NCT02726113|41625622|FG001|Total Enrollment|Physician Decision|1|||
19382322|NCT02726113|41625621|FG000|Total Enrollment|Protocol Violation|1|||
19382323|NCT02726113|41625622|FG001|Total Enrollment|Protocol Violation|0|||
19382324|NCT02726113|41625621|FG000|Total Enrollment|Withdrawal by Subject|2|||
19382325|NCT02726113|41625622|FG001|Total Enrollment|Withdrawal by Subject|1|||
19382326|NCT02726113|41625621|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
19382327|NCT02726113|41625622|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
19382328|NCT02726113|41625621|FG000|Genomic Analysis|Protocol Violation|1|||
19382329|NCT02726113|41625622|FG001|Genomic Analysis|Protocol Violation|0|||
19382330|NCT02726113|41625621|FG000|Genomic Analysis|Withdrawal by Subject|2|||
19382331|NCT02726113|41625622|FG001|Genomic Analysis|Withdrawal by Subject|1|||
19382332|NCT02726113|41625621|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
19382333|NCT02726113|41625622|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
19382334|NCT01361919|41625640|FG000|Overall Study|technical issues|10|||
19382335|NCT01361919|41625641|FG001|Overall Study|technical issues|12|||
19382336|NCT01361919|41625642|FG002|Overall Study|technical issues|10|||
19382337|NCT02642679|41625650|FG000|Overall Study|Withdrawal by Subject|1|||
19382338|NCT02642679|41625650|FG000|Overall Study|Physician Decision|1|||
19382339|NCT02642679|41625650|FG000|Overall Study|Physician Decision|1|||
19382340|NCT00705523|41625656|FG000|Overall Study|Lost to Follow-up|2|||
19382341|NCT00705523|41625657|FG001|Overall Study|Lost to Follow-up|3|||
19382342|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
19382343|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
19382344|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
19382345|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
19382346|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
19382347|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
19382348|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
19382349|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
19382350|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
19382351|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Other|1|||
19382352|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Other|4|||
19382353|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Other|5|||
19382354|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
19382355|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
19382356|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
19382357|NCT02725411|41625666|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
19382358|NCT02725411|41625667|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
19382359|NCT02725411|41625668|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
19382360|NCT02725411|41625666|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
19382361|NCT02725411|41625667|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
19382362|NCT02725411|41625668|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
19382363|NCT02725411|41625666|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
19382364|NCT02725411|41625667|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
19382365|NCT02725411|41625668|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
19382366|NCT02725411|41625666|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
19382367|NCT02725411|41625667|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
19382368|NCT02725411|41625668|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
19382369|NCT02725411|41625666|FG000|Follow-up Period (24 Weeks)|Other|1|||
19382370|NCT02725411|41625667|FG001|Follow-up Period (24 Weeks)|Other|4|||
19382371|NCT02725411|41625668|FG002|Follow-up Period (24 Weeks)|Other|2|||
19382372|NCT02725411|41625666|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
19382373|NCT02725411|41625667|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
19382374|NCT02725411|41625668|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
19382375|NCT02190604|41625704|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382376|NCT02190604|41625705|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382377|NCT02190604|41625706|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382378|NCT02190604|41625707|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382379|NCT02190604|41625708|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382380|NCT02190604|41625709|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382381|NCT02190604|41625710|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382382|NCT02190604|41625711|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382383|NCT02190604|41625712|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19745569|NCT03402750|42192878|FG000|Overall Study|Lost to Follow-up|2|||
19745570|NCT03402750|42192879|FG001|Overall Study|Lost to Follow-up|1|||
19745571|NCT00007475|42192888|FG000|Overall Study|Withdrawal by Subject|1|||
19745572|NCT00007475|42192889|FG001|Overall Study|Withdrawal by Subject|0|||
19745573|NCT00007475|42192890|FG002|Overall Study|Withdrawal by Subject|0|||
19745574|NCT00007475|42192891|FG003|Overall Study|Withdrawal by Subject|0|||
19745575|NCT00007475|42192888|FG000|Overall Study|Adverse Event|3|||
19745576|NCT00007475|42192889|FG001|Overall Study|Adverse Event|0|||
19745577|NCT00007475|42192890|FG002|Overall Study|Adverse Event|0|||
19745578|NCT00007475|42192891|FG003|Overall Study|Adverse Event|0|||
19382384|NCT02190604|41625713|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382385|NCT02190604|41625714|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382386|NCT02190604|41625715|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382387|NCT02190604|41625716|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382388|NCT02190604|41625717|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382389|NCT02190604|41625718|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
19382390|NCT02190604|41625719|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382391|NCT02190604|41625720|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382392|NCT02190604|41625721|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382393|NCT02190604|41625722|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
19382394|NCT02190604|41625704|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382395|NCT02190604|41625705|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382396|NCT02190604|41625706|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382397|NCT02190604|41625707|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382398|NCT02190604|41625708|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382399|NCT02190604|41625709|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382400|NCT02190604|41625710|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382401|NCT02190604|41625711|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382402|NCT02190604|41625712|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382403|NCT02190604|41625713|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382404|NCT02190604|41625714|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382405|NCT02190604|41625715|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382406|NCT02190604|41625716|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382407|NCT02190604|41625717|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
19382408|NCT02190604|41625718|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382409|NCT02190604|41625719|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382410|NCT02190604|41625720|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382411|NCT02190604|41625721|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382412|NCT02190604|41625722|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
19382413|NCT02127970|41625781|FG000|Overall Study|Adverse Event|2|||
19382414|NCT02127970|41625782|FG001|Overall Study|Adverse Event|1|||
19382415|NCT02127970|41625781|FG000|Overall Study|Death|1|||
19382416|NCT02127970|41625782|FG001|Overall Study|Death|1|||
19382417|NCT02127970|41625781|FG000|Overall Study|Lost to Follow-up|14|||
19382418|NCT02127970|41625782|FG001|Overall Study|Lost to Follow-up|14|||
19382419|NCT02127970|41625781|FG000|Overall Study|Reason not Specified|4|||
19382420|NCT02127970|41625782|FG001|Overall Study|Reason not Specified|7|||
19382421|NCT02127970|41625781|FG000|Overall Study|Pregnancy|0|||
19382422|NCT02127970|41625782|FG001|Overall Study|Pregnancy|1|||
19382423|NCT02127970|41625781|FG000|Overall Study|Subject Withdrew Consent|5|||
19382424|NCT02127970|41625782|FG001|Overall Study|Subject Withdrew Consent|3|||
19382425|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
19382426|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
19382427|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
19382428|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
19382429|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
19382430|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
19382431|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
19382432|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
19382433|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
19382434|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
19382435|NCT03549871|41625790|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
19382436|NCT03549871|41625791|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
19382437|NCT03549871|41625790|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
19382438|NCT03549871|41625791|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
19382439|NCT03549871|41625790|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
19382440|NCT03549871|41625791|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
19382441|NCT03549871|41625790|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
19566846|NCT01261793|42014934|FG000|Overall Study|Suspected pregnancy|1|||
19566847|NCT01261793|42014935|FG001|Overall Study|Suspected pregnancy|1|||
19566848|NCT01261793|42014936|FG002|Overall Study|Suspected pregnancy|0|||
19566849|NCT01261793|42014934|FG000|Overall Study|Patient non-compliance|1|||
19566850|NCT01261793|42014935|FG001|Overall Study|Patient non-compliance|0|||
19566851|NCT01261793|42014936|FG002|Overall Study|Patient non-compliance|1|||
19566852|NCT01261793|42014934|FG000|Overall Study|Patient pregnant|1|||
19745579|NCT00025883|42192903|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
19745580|NCT00025883|42192903|FG000|Overall Study|no baseline data|1|||
19745581|NCT00025883|42192903|FG000|Overall Study|Death|1|||
19745582|NCT00025883|42192903|FG000|Overall Study|Adverse Event|1|||
19745583|NCT00025883|42192903|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
19745584|NCT00072293|42192910|FG000|Overall Study|Lost to Follow-up|1|||
19745585|NCT00072293|42192911|FG001|Overall Study|Lost to Follow-up|1|||
19745586|NCT00072293|42192910|FG000|Overall Study|Withdrawal by Subject|0|||
19745587|NCT00072293|42192911|FG001|Overall Study|Withdrawal by Subject|1|||
19745588|NCT03753763|42192919|FG000|Overall Study|Adverse Event|2|||
19745589|NCT03753763|42192920|FG001|Overall Study|Adverse Event|0|||
19745590|NCT03753763|42192919|FG000|Overall Study|Withdrawal by Subject|3|||
19745591|NCT03753763|42192920|FG001|Overall Study|Withdrawal by Subject|1|||
19745592|NCT03753763|42192919|FG000|Overall Study|clinical deterioration|1|||
19745593|NCT03753763|42192920|FG001|Overall Study|clinical deterioration|0|||
19745594|NCT03384966|42192929|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
19745595|NCT03384966|42192930|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
19745596|NCT03384966|42192931|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
19745597|NCT03384966|42192929|FG000|Follow-up Period|Adverse Event|1|||
19745598|NCT03384966|42192930|FG001|Follow-up Period|Adverse Event|0|||
19745599|NCT03384966|42192931|FG002|Follow-up Period|Adverse Event|0|||
19745600|NCT03402126|42192948|FG000|Overall Study|Lost to Follow-up|6|||
19745601|NCT03402126|42192948|FG000|Overall Study|Protocol Violation|10|||
19745602|NCT03402126|42192948|FG000|Overall Study|Sponsor request/Study termination|29|||
19745603|NCT03402126|42192948|FG000|Overall Study|Study product no longer in use|1|||
19745604|NCT03402126|42192948|FG000|Overall Study|Technical problems|1|||
19745605|NCT03402126|42192948|FG000|Overall Study|Withdrawal by Subject|6|||
19745606|NCT03402126|42192948|FG000|Overall Study|Physician Decision|2|||
19745607|NCT03402126|42192948|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
19745608|NCT03402126|42192948|FG000|Overall Study|Death|4|||
19745609|NCT03355326|42192954|FG000|Overall Study|Protocol Violation|3|||
19745610|NCT03355326|42192955|FG001|Overall Study|Protocol Violation|3|||
19745611|NCT03353220|42192961|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
19745612|NCT03353220|42192962|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
19745613|NCT03751657|42192970|FG000|Overall Study|Physician Decision|0|||
19745614|NCT03751657|42192971|FG001|Overall Study|Physician Decision|1|||
19745615|NCT03751657|42192970|FG000|Overall Study|Withdrawal by Subject|1|||
19745616|NCT03751657|42192971|FG001|Overall Study|Withdrawal by Subject|1|||
19745617|NCT03751657|42192970|FG000|Overall Study|Lost to Follow-up|2|||
19745618|NCT03751657|42192971|FG001|Overall Study|Lost to Follow-up|1|||
19745619|NCT00025259|42192984|FG000|Overall Study|Death|1|||
19745620|NCT00025259|42192985|FG001|Overall Study|Death|3|||
19745621|NCT00025259|42192986|FG002|Overall Study|Death|0|||
19382442|NCT03549871|41625791|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
19382443|NCT03549871|41625790|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
19382444|NCT03549871|41625791|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
19382445|NCT03549871|41625790|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
19382446|NCT03549871|41625791|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
19382447|NCT00705367|41625814|FG000|Long-term Extension Period|Adverse Event|2|||
19382448|NCT00705367|41625815|FG001|Long-term Extension Period|Adverse Event|0|||
19382449|NCT00705367|41625814|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
19382450|NCT00705367|41625815|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
19382451|NCT00705367|41625814|FG000|Long-term Extension Period|Lack of Efficacy|1|||
19382452|NCT00705367|41625815|FG001|Long-term Extension Period|Lack of Efficacy|0|||
19382453|NCT00705367|41625814|FG000|Long-term Extension Period|No longer met study criteria|1|||
19382454|NCT00705367|41625815|FG001|Long-term Extension Period|No longer met study criteria|0|||
19382455|NCT00705367|41625814|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
19382456|NCT00705367|41625815|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
19382457|NCT02864251|41625826|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
19382458|NCT02864251|41625827|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
19382459|NCT02864251|41625828|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
19382460|NCT02864251|41625826|FG000|Pre-Treatment|Withdrawal by Participant|0|||
19382461|NCT02864251|41625827|FG001|Pre-Treatment|Withdrawal by Participant|0|||
19382462|NCT02864251|41625828|FG002|Pre-Treatment|Withdrawal by Participant|4|||
19382463|NCT02864251|41625826|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
19382464|NCT02864251|41625827|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
19382465|NCT02864251|41625828|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
19382466|NCT02864251|41625826|FG000|Pre-Treatment|Other Reasons|0|||
19382467|NCT02864251|41625827|FG001|Pre-Treatment|Other Reasons|1|||
19382468|NCT02864251|41625828|FG002|Pre-Treatment|Other Reasons|1|||
19382469|NCT02864251|41625826|FG000|Treatment|Disease Progression|109|||
19382470|NCT02864251|41625827|FG001|Treatment|Disease Progression|52|||
19382471|NCT02864251|41625828|FG002|Treatment|Disease Progression|100|||
19382472|NCT02864251|41625826|FG000|Treatment|Study Drug Toxicity|9|||
19382473|NCT02864251|41625827|FG001|Treatment|Study Drug Toxicity|4|||
19382474|NCT02864251|41625828|FG002|Treatment|Study Drug Toxicity|10|||
19382475|NCT02864251|41625826|FG000|Treatment|Death|0|||
19382476|NCT02864251|41625827|FG001|Treatment|Death|2|||
19382477|NCT02864251|41625828|FG002|Treatment|Death|3|||
19382478|NCT02864251|41625826|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
19382479|NCT02864251|41625827|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
19382480|NCT02864251|41625828|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
19382481|NCT02864251|41625826|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
19382482|NCT02864251|41625827|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
19382483|NCT02864251|41625828|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
19382484|NCT02864251|41625826|FG000|Treatment|Withdrawal by Participant|8|||
19382485|NCT02864251|41625827|FG001|Treatment|Withdrawal by Participant|5|||
19382486|NCT02864251|41625828|FG002|Treatment|Withdrawal by Participant|13|||
19382487|NCT02864251|41625826|FG000|Treatment|Maximum Clinical Benefit|1|||
19382488|NCT02864251|41625827|FG001|Treatment|Maximum Clinical Benefit|0|||
19382489|NCT02864251|41625828|FG002|Treatment|Maximum Clinical Benefit|1|||
19382490|NCT02864251|41625826|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
19382491|NCT02864251|41625827|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
19382492|NCT02864251|41625828|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
19382493|NCT02864251|41625826|FG000|Treatment|Other Reasons|0|||
19382494|NCT02864251|41625827|FG001|Treatment|Other Reasons|1|||
19382495|NCT02864251|41625828|FG002|Treatment|Other Reasons|3|||
19382496|NCT02864251|41625826|FG000|Treatment|Not Reported|1|||
19382497|NCT02864251|41625827|FG001|Treatment|Not Reported|0|||
19745622|NCT00025259|42192987|FG003|Overall Study|Death|3|||
19745623|NCT00025259|42192988|FG004|Overall Study|Death|0|||
19382498|NCT02864251|41625828|FG002|Treatment|Not Reported|0|||
19382499|NCT02864251|41625826|FG000|Treatment|Ongoing Treatment|1|||
19382500|NCT02864251|41625827|FG001|Treatment|Ongoing Treatment|0|||
19382501|NCT02864251|41625828|FG002|Treatment|Ongoing Treatment|2|||
19382502|NCT00705289|41625836|FG000|Overall Study|Subject or treating physician's choice|131|||
19745624|NCT00025259|42192989|FG005|Overall Study|Death|1|||
19745625|NCT00025259|42192990|FG006|Overall Study|Death|2|||
19745626|NCT00025259|42192984|FG000|Overall Study|Lack of Efficacy|2|||
19745627|NCT00025259|42192985|FG001|Overall Study|Lack of Efficacy|46|||
19382503|NCT02038777|41625865|FG000|Overall Study|Death|0|||
19382504|NCT02038777|41625866|FG001|Overall Study|Death|2|||
19382505|NCT02038777|41625867|FG002|Overall Study|Death|0|||
19382506|NCT02038777|41625868|FG003|Overall Study|Death|1|||
19382507|NCT02038777|41625869|FG004|Overall Study|Death|2|||
19382508|NCT02038777|41625870|FG005|Overall Study|Death|4|||
19382509|NCT02038777|41625871|FG006|Overall Study|Death|0|||
19382510|NCT02038777|41625872|FG007|Overall Study|Death|10|||
19382511|NCT02038777|41625865|FG000|Overall Study|Lost to Follow-up|0|||
19382512|NCT02038777|41625866|FG001|Overall Study|Lost to Follow-up|0|||
19382513|NCT02038777|41625867|FG002|Overall Study|Lost to Follow-up|0|||
19382514|NCT02038777|41625868|FG003|Overall Study|Lost to Follow-up|1|||
19382515|NCT02038777|41625869|FG004|Overall Study|Lost to Follow-up|0|||
19382516|NCT02038777|41625870|FG005|Overall Study|Lost to Follow-up|0|||
19382517|NCT02038777|41625871|FG006|Overall Study|Lost to Follow-up|0|||
19382518|NCT02038777|41625872|FG007|Overall Study|Lost to Follow-up|0|||
19382519|NCT02038777|41625865|FG000|Overall Study|Other|0|||
19382520|NCT02038777|41625866|FG001|Overall Study|Other|1|||
19382521|NCT02038777|41625867|FG002|Overall Study|Other|0|||
19382522|NCT02038777|41625868|FG003|Overall Study|Other|2|||
19382523|NCT02038777|41625869|FG004|Overall Study|Other|1|||
19382524|NCT02038777|41625870|FG005|Overall Study|Other|0|||
19382525|NCT02038777|41625871|FG006|Overall Study|Other|0|||
19382526|NCT02038777|41625872|FG007|Overall Study|Other|0|||
19382527|NCT02038777|41625865|FG000|Overall Study|Randomized but not treated|0|||
19382528|NCT02038777|41625866|FG001|Overall Study|Randomized but not treated|1|||
19382529|NCT02038777|41625867|FG002|Overall Study|Randomized but not treated|0|||
19382530|NCT02038777|41625868|FG003|Overall Study|Randomized but not treated|0|||
19382531|NCT02038777|41625869|FG004|Overall Study|Randomized but not treated|0|||
19382532|NCT02038777|41625870|FG005|Overall Study|Randomized but not treated|0|||
19382533|NCT02038777|41625871|FG006|Overall Study|Randomized but not treated|0|||
19382534|NCT02038777|41625872|FG007|Overall Study|Randomized but not treated|0|||
19382535|NCT02038777|41625865|FG000|Overall Study|Started Chemotherapy|1|||
19382536|NCT02038777|41625866|FG001|Overall Study|Started Chemotherapy|0|||
19382537|NCT02038777|41625867|FG002|Overall Study|Started Chemotherapy|3|||
19382538|NCT02038777|41625868|FG003|Overall Study|Started Chemotherapy|0|||
19382539|NCT02038777|41625869|FG004|Overall Study|Started Chemotherapy|0|||
19382540|NCT02038777|41625870|FG005|Overall Study|Started Chemotherapy|0|||
19382541|NCT02038777|41625871|FG006|Overall Study|Started Chemotherapy|0|||
19382542|NCT02038777|41625872|FG007|Overall Study|Started Chemotherapy|0|||
19382543|NCT00703963|41625891|FG000|Overall Study|Withdrawal by Subject|7|||
19382544|NCT00703963|41625892|FG001|Overall Study|Withdrawal by Subject|13|||
19382545|NCT00703963|41625891|FG000|Overall Study|Physician Decision|0|||
19382546|NCT00703963|41625892|FG001|Overall Study|Physician Decision|1|||
19382547|NCT02721355|41625900|FG000|Overall Study|Lost to Follow-up|6|||
19382548|NCT02721355|41625901|FG001|Overall Study|Lost to Follow-up|1|||
19382549|NCT02733991|41625909|FG000|Overall Study|Adverse Event|1|||
19382550|NCT02733991|41625910|FG001|Overall Study|Adverse Event|0|||
19382551|NCT02733991|41625909|FG000|Overall Study|Withdrawal by Subject|0|||
19382552|NCT02733991|41625910|FG001|Overall Study|Withdrawal by Subject|5|||
19382553|NCT00702949|41625919|FG000|Overall Study|Refusal|3|||
19382554|NCT00702949|41625920|FG001|Overall Study|Refusal|2|||
19382555|NCT00702949|41625921|FG002|Overall Study|Refusal|2|||
19382556|NCT00702949|41625919|FG000|Overall Study|Adverse Event|1|||
19382557|NCT00702949|41625920|FG001|Overall Study|Adverse Event|6|||
19382558|NCT00702949|41625921|FG002|Overall Study|Adverse Event|3|||
19382559|NCT00702949|41625919|FG000|Overall Study|Other Medical Reason/unknown|1|||
19382560|NCT00702949|41625920|FG001|Overall Study|Other Medical Reason/unknown|1|||
19382561|NCT00702949|41625921|FG002|Overall Study|Other Medical Reason/unknown|3|||
19382562|NCT00702715|41625933|FG000|Overall Study|Lost to Follow-up|1|||
19382563|NCT00702715|41625934|FG001|Overall Study|Lost to Follow-up|0|||
19382564|NCT00702403|41625940|FG000|From Consent to Engraftment|Progressive leukemia|6|||
19382565|NCT00702403|41625940|FG000|From Consent to Engraftment|Critically ill|2|||
19382566|NCT00702403|41625940|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
19382567|NCT00702403|41625940|FG000|From Consent to Engraftment|Myocardial infarction|1|||
19382568|NCT00702403|41625940|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
19382569|NCT00702403|41625940|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
19382570|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
19382571|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
19382572|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Non-compliance|2|||
19382573|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
19382574|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
19382575|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Suicide|1|||
19382576|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
19382577|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
19382578|NCT00702403|41625940|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
19382579|NCT00702325|41625949|FG000|Overall Study|Adverse Event|1|||
19382580|NCT00702325|41625950|FG001|Overall Study|Adverse Event|0|||
19382581|NCT00702325|41625949|FG000|Overall Study|Withdrawal by Subject|7|||
19382582|NCT00702325|41625950|FG001|Overall Study|Withdrawal by Subject|7|||
19382583|NCT00702325|41625949|FG000|Overall Study|Lost to Follow-up|3|||
19382584|NCT00702325|41625950|FG001|Overall Study|Lost to Follow-up|4|||
19382585|NCT00702325|41625949|FG000|Overall Study|Incorrect enrollment|5|||
19382586|NCT00702325|41625950|FG001|Overall Study|Incorrect enrollment|7|||
19382587|NCT00702325|41625949|FG000|Overall Study|Developed study discontinuation criteria|18|||
19382588|NCT00702325|41625950|FG001|Overall Study|Developed study discontinuation criteria|28|||
19382589|NCT00702325|41625949|FG000|Overall Study|Severe noncompliance to protocol|3|||
19382590|NCT00702325|41625950|FG001|Overall Study|Severe noncompliance to protocol|3|||
19382591|NCT00702325|41625949|FG000|Overall Study|Termination due to lab results|1|||
19382592|NCT00702325|41625950|FG001|Overall Study|Termination due to lab results|0|||
19382593|NCT00702325|41625949|FG000|Overall Study|Didn't follow study medication dosage|0|||
19382594|NCT00702325|41625950|FG001|Overall Study|Didn't follow study medication dosage|2|||
19382595|NCT00702325|41625949|FG000|Overall Study|Withdrew consent|0|||
19382596|NCT00702325|41625950|FG001|Overall Study|Withdrew consent|1|||
19382597|NCT00702325|41625949|FG000|Overall Study|Incorrectly Discontinued|0|||
19382598|NCT00702325|41625950|FG001|Overall Study|Incorrectly Discontinued|1|||
19382599|NCT02719171|41625961|FG000|Overall Study|Adverse Event|1|||
19382600|NCT02719171|41625962|FG001|Overall Study|Adverse Event|2|||
19382601|NCT02719171|41625963|FG002|Overall Study|Adverse Event|0|||
19382602|NCT02719171|41625964|FG003|Overall Study|Adverse Event|0|||
19382603|NCT02719171|41625965|FG004|Overall Study|Adverse Event|2|||
19382604|NCT02719171|41625961|FG000|Overall Study|Lost to Follow-up|0|||
19382605|NCT02719171|41625962|FG001|Overall Study|Lost to Follow-up|0|||
19382606|NCT02719171|41625963|FG002|Overall Study|Lost to Follow-up|1|||
19382607|NCT02719171|41625964|FG003|Overall Study|Lost to Follow-up|0|||
19382608|NCT02719171|41625965|FG004|Overall Study|Lost to Follow-up|0|||
19382609|NCT02719171|41625961|FG000|Overall Study|Subject Withdrawal|0|||
19382610|NCT02719171|41625962|FG001|Overall Study|Subject Withdrawal|2|||
19382611|NCT02719171|41625963|FG002|Overall Study|Subject Withdrawal|2|||
19382612|NCT02719171|41625964|FG003|Overall Study|Subject Withdrawal|1|||
19382613|NCT02719171|41625965|FG004|Overall Study|Subject Withdrawal|0|||
19382614|NCT02719171|41625961|FG000|Overall Study|Other|0|||
19382615|NCT02719171|41625962|FG001|Overall Study|Other|0|||
19382616|NCT02719171|41625963|FG002|Overall Study|Other|0|||
19382617|NCT02719171|41625964|FG003|Overall Study|Other|1|||
19382618|NCT02719171|41625965|FG004|Overall Study|Other|0|||
19382619|NCT02718625|41625982|FG000|Overall Study|Adverse Event|0|||
19382620|NCT02718625|41625983|FG001|Overall Study|Adverse Event|1|||
19382621|NCT02718625|41625982|FG000|Overall Study|Termination of Study by Sponsor|0|||
19382622|NCT02718625|41625983|FG001|Overall Study|Termination of Study by Sponsor|1|||
19382623|NCT02716987|41625995|FG000|Overall Study|Ligand synthesis failure|0|||
19382624|NCT02716987|41625996|FG001|Overall Study|Ligand synthesis failure|0|||
19382625|NCT02716987|41625997|FG002|Overall Study|Ligand synthesis failure|1|||
19382626|NCT02716987|41625998|FG003|Overall Study|Ligand synthesis failure|0|||
19382627|NCT02716987|41625999|FG004|Overall Study|Ligand synthesis failure|0|||
19382628|NCT02716987|41626000|FG005|Overall Study|Ligand synthesis failure|0|||
19382629|NCT02716987|41625995|FG000|Overall Study|Withdrawal by Subject|0|||
19382630|NCT02716987|41625996|FG001|Overall Study|Withdrawal by Subject|0|||
19382631|NCT02716987|41625997|FG002|Overall Study|Withdrawal by Subject|0|||
19566853|NCT01261793|42014935|FG001|Overall Study|Patient pregnant|0|||
19382632|NCT02716987|41625998|FG003|Overall Study|Withdrawal by Subject|0|||
19382633|NCT02716987|41625999|FG004|Overall Study|Withdrawal by Subject|1|||
19382634|NCT02716987|41626000|FG005|Overall Study|Withdrawal by Subject|1|||
19382635|NCT00701779|41626025|FG000|Overall Study|Adverse Event|6|||
19382636|NCT00701779|41626025|FG000|Overall Study|Lost to Follow-up|1|||
19382637|NCT00701779|41626025|FG000|Overall Study|Withdrawal by Subject|2|||
19382638|NCT03707977|41626048|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
19382639|NCT03707977|41626049|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
19382640|NCT03707977|41626050|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
19382641|NCT03707977|41626048|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
19382642|NCT03707977|41626049|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
19382643|NCT03707977|41626050|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
19382644|NCT03332095|41626066|FG000|Overall Study|Lost to Follow-up|1|||
19382645|NCT03332095|41626067|FG001|Overall Study|Lost to Follow-up|0|||
19382646|NCT03332095|41626066|FG000|Overall Study|Pregnancy|0|||
19382647|NCT03332095|41626067|FG001|Overall Study|Pregnancy|1|||
19382648|NCT02764489|41626074|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
19382649|NCT02764489|41626075|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
19382650|NCT02764489|41626074|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
19382651|NCT02764489|41626075|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
19382652|NCT02764489|41626074|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
19382653|NCT02764489|41626075|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
19382654|NCT02764489|41626074|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
19382655|NCT02764489|41626075|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
19382656|NCT02001623|41626100|FG000|Overall Study|Disease Progression|2|||
19382657|NCT02001623|41626101|FG001|Overall Study|Disease Progression|2|||
19382658|NCT02001623|41626102|FG002|Overall Study|Disease Progression|3|||
19382659|NCT02001623|41626103|FG003|Overall Study|Disease Progression|2|||
19382660|NCT02001623|41626104|FG004|Overall Study|Disease Progression|3|||
19382661|NCT02001623|41626105|FG005|Overall Study|Disease Progression|2|||
19382662|NCT02001623|41626106|FG006|Overall Study|Disease Progression|3|||
19382663|NCT02001623|41626107|FG007|Overall Study|Disease Progression|3|||
19382664|NCT02001623|41626108|FG008|Overall Study|Disease Progression|7|||
19382665|NCT02001623|41626109|FG009|Overall Study|Disease Progression|40|||
19382666|NCT02001623|41626110|FG010|Overall Study|Disease Progression|5|||
19382667|NCT02001623|41626111|FG011|Overall Study|Disease Progression|9|||
19382668|NCT02001623|41626112|FG012|Overall Study|Disease Progression|9|||
19382669|NCT02001623|41626113|FG013|Overall Study|Disease Progression|20|||
19382670|NCT02001623|41626114|FG014|Overall Study|Disease Progression|9|||
19382671|NCT02001623|41626100|FG000|Overall Study|Physician Decision|0|||
19382672|NCT02001623|41626101|FG001|Overall Study|Physician Decision|0|||
19382673|NCT02001623|41626102|FG002|Overall Study|Physician Decision|0|||
19382674|NCT02001623|41626103|FG003|Overall Study|Physician Decision|0|||
19382675|NCT02001623|41626104|FG004|Overall Study|Physician Decision|0|||
19382676|NCT02001623|41626105|FG005|Overall Study|Physician Decision|0|||
19382677|NCT02001623|41626106|FG006|Overall Study|Physician Decision|0|||
19382678|NCT02001623|41626107|FG007|Overall Study|Physician Decision|0|||
19382679|NCT02001623|41626108|FG008|Overall Study|Physician Decision|3|||
19382680|NCT02001623|41626109|FG009|Overall Study|Physician Decision|2|||
19382681|NCT02001623|41626110|FG010|Overall Study|Physician Decision|3|||
19382682|NCT02001623|41626111|FG011|Overall Study|Physician Decision|3|||
19382683|NCT02001623|41626112|FG012|Overall Study|Physician Decision|1|||
19382684|NCT02001623|41626113|FG013|Overall Study|Physician Decision|2|||
19382685|NCT02001623|41626114|FG014|Overall Study|Physician Decision|1|||
19382686|NCT02001623|41626100|FG000|Overall Study|Death|0|||
19382687|NCT02001623|41626101|FG001|Overall Study|Death|1|||
19382688|NCT02001623|41626102|FG002|Overall Study|Death|0|||
19382689|NCT02001623|41626103|FG003|Overall Study|Death|0|||
19382690|NCT02001623|41626104|FG004|Overall Study|Death|0|||
19382691|NCT02001623|41626105|FG005|Overall Study|Death|0|||
19382692|NCT02001623|41626106|FG006|Overall Study|Death|0|||
19382693|NCT02001623|41626107|FG007|Overall Study|Death|0|||
19382694|NCT02001623|41626108|FG008|Overall Study|Death|0|||
19382695|NCT02001623|41626109|FG009|Overall Study|Death|0|||
19382696|NCT02001623|41626110|FG010|Overall Study|Death|0|||
19382697|NCT02001623|41626111|FG011|Overall Study|Death|0|||
19382698|NCT02001623|41626112|FG012|Overall Study|Death|0|||
19382699|NCT02001623|41626113|FG013|Overall Study|Death|0|||
19382700|NCT02001623|41626114|FG014|Overall Study|Death|0|||
19382701|NCT02001623|41626100|FG000|Overall Study|Adverse Event|0|||
19382702|NCT02001623|41626101|FG001|Overall Study|Adverse Event|0|||
19382703|NCT02001623|41626102|FG002|Overall Study|Adverse Event|0|||
19382704|NCT02001623|41626103|FG003|Overall Study|Adverse Event|0|||
19382705|NCT02001623|41626104|FG004|Overall Study|Adverse Event|0|||
19382706|NCT02001623|41626105|FG005|Overall Study|Adverse Event|1|||
19382707|NCT02001623|41626106|FG006|Overall Study|Adverse Event|0|||
19382708|NCT02001623|41626107|FG007|Overall Study|Adverse Event|3|||
19382709|NCT02001623|41626108|FG008|Overall Study|Adverse Event|4|||
19382710|NCT02001623|41626109|FG009|Overall Study|Adverse Event|6|||
19382711|NCT02001623|41626110|FG010|Overall Study|Adverse Event|4|||
19382712|NCT02001623|41626111|FG011|Overall Study|Adverse Event|0|||
19382713|NCT02001623|41626112|FG012|Overall Study|Adverse Event|3|||
19382714|NCT02001623|41626113|FG013|Overall Study|Adverse Event|5|||
19382715|NCT02001623|41626114|FG014|Overall Study|Adverse Event|6|||
19382716|NCT02001623|41626100|FG000|Overall Study|Other - Miscellaneous|0|||
19382717|NCT02001623|41626101|FG001|Overall Study|Other - Miscellaneous|0|||
19382718|NCT02001623|41626102|FG002|Overall Study|Other - Miscellaneous|0|||
19382719|NCT02001623|41626103|FG003|Overall Study|Other - Miscellaneous|0|||
19382720|NCT02001623|41626104|FG004|Overall Study|Other - Miscellaneous|0|||
19382721|NCT02001623|41626105|FG005|Overall Study|Other - Miscellaneous|0|||
19382722|NCT02001623|41626106|FG006|Overall Study|Other - Miscellaneous|0|||
19382723|NCT02001623|41626107|FG007|Overall Study|Other - Miscellaneous|0|||
19382724|NCT02001623|41626108|FG008|Overall Study|Other - Miscellaneous|0|||
19382725|NCT02001623|41626109|FG009|Overall Study|Other - Miscellaneous|1|||
19382726|NCT02001623|41626110|FG010|Overall Study|Other - Miscellaneous|0|||
19382727|NCT02001623|41626111|FG011|Overall Study|Other - Miscellaneous|0|||
19382728|NCT02001623|41626112|FG012|Overall Study|Other - Miscellaneous|0|||
19382729|NCT02001623|41626113|FG013|Overall Study|Other - Miscellaneous|1|||
19382730|NCT02001623|41626114|FG014|Overall Study|Other - Miscellaneous|0|||
19382731|NCT02001623|41626100|FG000|Overall Study|Withdrawal by Subject|1|||
19382732|NCT02001623|41626101|FG001|Overall Study|Withdrawal by Subject|0|||
19382733|NCT02001623|41626102|FG002|Overall Study|Withdrawal by Subject|0|||
19382734|NCT02001623|41626103|FG003|Overall Study|Withdrawal by Subject|0|||
19382735|NCT02001623|41626104|FG004|Overall Study|Withdrawal by Subject|0|||
19382736|NCT02001623|41626105|FG005|Overall Study|Withdrawal by Subject|0|||
19382737|NCT02001623|41626106|FG006|Overall Study|Withdrawal by Subject|0|||
19382738|NCT02001623|41626107|FG007|Overall Study|Withdrawal by Subject|0|||
19382739|NCT02001623|41626108|FG008|Overall Study|Withdrawal by Subject|1|||
19382740|NCT02001623|41626109|FG009|Overall Study|Withdrawal by Subject|3|||
19382741|NCT02001623|41626110|FG010|Overall Study|Withdrawal by Subject|2|||
19382742|NCT02001623|41626111|FG011|Overall Study|Withdrawal by Subject|2|||
19382743|NCT02001623|41626112|FG012|Overall Study|Withdrawal by Subject|1|||
19382744|NCT02001623|41626113|FG013|Overall Study|Withdrawal by Subject|5|||
19382745|NCT02001623|41626114|FG014|Overall Study|Withdrawal by Subject|2|||
19382746|NCT02001623|41626100|FG000|Overall Study|Lost to Follow-up|0|||
19382747|NCT02001623|41626101|FG001|Overall Study|Lost to Follow-up|0|||
19382748|NCT02001623|41626102|FG002|Overall Study|Lost to Follow-up|0|||
19382749|NCT02001623|41626103|FG003|Overall Study|Lost to Follow-up|0|||
19382750|NCT02001623|41626104|FG004|Overall Study|Lost to Follow-up|0|||
19382751|NCT02001623|41626105|FG005|Overall Study|Lost to Follow-up|0|||
19382752|NCT02001623|41626106|FG006|Overall Study|Lost to Follow-up|0|||
19382753|NCT02001623|41626107|FG007|Overall Study|Lost to Follow-up|0|||
19382754|NCT02001623|41626108|FG008|Overall Study|Lost to Follow-up|0|||
19382755|NCT02001623|41626109|FG009|Overall Study|Lost to Follow-up|1|||
19382756|NCT02001623|41626110|FG010|Overall Study|Lost to Follow-up|0|||
19382757|NCT02001623|41626111|FG011|Overall Study|Lost to Follow-up|0|||
19382758|NCT02001623|41626112|FG012|Overall Study|Lost to Follow-up|0|||
19382759|NCT02001623|41626113|FG013|Overall Study|Lost to Follow-up|0|||
19382760|NCT02001623|41626114|FG014|Overall Study|Lost to Follow-up|0|||
19382761|NCT02001623|41626100|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
19382762|NCT02001623|41626101|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
19382763|NCT02001623|41626102|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
19382764|NCT02001623|41626103|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
19382765|NCT02001623|41626104|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
19382766|NCT02001623|41626105|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
19382767|NCT02001623|41626106|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
19382768|NCT02001623|41626107|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
19382769|NCT02001623|41626108|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
19382770|NCT02001623|41626109|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
19382771|NCT02001623|41626110|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
19382772|NCT02001623|41626111|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
19382773|NCT02001623|41626112|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
19382774|NCT02001623|41626113|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
19382775|NCT02001623|41626114|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
19382776|NCT02001623|41626100|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
19382777|NCT02001623|41626101|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
19382778|NCT02001623|41626102|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
19382779|NCT02001623|41626103|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
19382780|NCT02001623|41626104|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
19382781|NCT02001623|41626105|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
19382782|NCT02001623|41626106|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
19382783|NCT02001623|41626107|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
19382784|NCT02001623|41626108|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
19382785|NCT02001623|41626109|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
19382786|NCT02001623|41626110|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
19382787|NCT02001623|41626111|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
19382788|NCT02001623|41626112|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
19382789|NCT02001623|41626113|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
19382790|NCT02001623|41626114|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
19382791|NCT02713867|41626165|FG000|Randomization|Other Reason|2|||
19382792|NCT02713867|41626166|FG001|Randomization|Other Reason|1|||
19382793|NCT02713867|41626165|FG000|Randomization|Participant Withdrew consent|0|||
19382794|NCT02713867|41626166|FG001|Randomization|Participant Withdrew consent|2|||
19382795|NCT02713867|41626165|FG000|Treatment Period|Other Reasons|22|||
19382796|NCT02713867|41626166|FG001|Treatment Period|Other Reasons|28|||
19382797|NCT02713867|41626165|FG000|Treatment Period|Administrative reason by sponsor|21|||
19382798|NCT02713867|41626166|FG001|Treatment Period|Administrative reason by sponsor|16|||
19382799|NCT02713867|41626165|FG000|Treatment Period|No longer meets study criteria|2|||
19382800|NCT02713867|41626166|FG001|Treatment Period|No longer meets study criteria|1|||
19382801|NCT02713867|41626165|FG000|Treatment Period|Poor/Non Compliance|1|||
19382802|NCT02713867|41626166|FG001|Treatment Period|Poor/Non Compliance|0|||
19382803|NCT02713867|41626165|FG000|Treatment Period|Maximum Clinical Benefit|5|||
19382804|NCT02713867|41626166|FG001|Treatment Period|Maximum Clinical Benefit|6|||
19382805|NCT02713867|41626165|FG000|Treatment Period|Withdrew consent|3|||
19382806|NCT02713867|41626166|FG001|Treatment Period|Withdrew consent|6|||
19382807|NCT02713867|41626165|FG000|Treatment Period|Requested to Discontinue|8|||
19382808|NCT02713867|41626166|FG001|Treatment Period|Requested to Discontinue|8|||
19382809|NCT02713867|41626165|FG000|Treatment Period|AE unrelated to Study Drug|11|||
19382810|NCT02713867|41626166|FG001|Treatment Period|AE unrelated to Study Drug|10|||
19382811|NCT02713867|41626165|FG000|Treatment Period|Death|7|||
19382812|NCT02713867|41626166|FG001|Treatment Period|Death|3|||
19382813|NCT02713867|41626165|FG000|Treatment Period|Study Drug Toxicity|16|||
19382814|NCT02713867|41626166|FG001|Treatment Period|Study Drug Toxicity|19|||
19382815|NCT02713867|41626165|FG000|Treatment Period|Disease Progression|82|||
19382816|NCT02713867|41626166|FG001|Treatment Period|Disease Progression|83|||
19382817|NCT01854775|41626175|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
19382818|NCT01854775|41626176|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
19382819|NCT01854775|41626177|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
19382820|NCT01854775|41626175|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
19382821|NCT01854775|41626176|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
19382822|NCT01854775|41626177|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
19382823|NCT01854775|41626175|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
19382824|NCT01854775|41626176|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
19382825|NCT01854775|41626177|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
19382826|NCT01854775|41626175|FG000|Extension Phase|Pregnancy|3|||
19382827|NCT01854775|41626176|FG001|Extension Phase|Pregnancy|0|||
19382828|NCT01854775|41626177|FG002|Extension Phase|Pregnancy|0|||
19382829|NCT01854775|41626175|FG000|Extension Phase|Investigator's Discretion|1|||
19382830|NCT01854775|41626176|FG001|Extension Phase|Investigator's Discretion|0|||
19382831|NCT01854775|41626177|FG002|Extension Phase|Investigator's Discretion|0|||
19382832|NCT01854775|41626175|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
19382833|NCT01854775|41626176|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
19382834|NCT01854775|41626177|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
19382835|NCT01854775|41626175|FG000|Extension Phase|Lost to Follow-up|2|||
19382836|NCT01854775|41626176|FG001|Extension Phase|Lost to Follow-up|0|||
19382837|NCT01854775|41626177|FG002|Extension Phase|Lost to Follow-up|0|||
19382838|NCT01854775|41626175|FG000|Extension Phase|Still on Study|32|||
19382839|NCT01854775|41626176|FG001|Extension Phase|Still on Study|47|||
19382840|NCT01854775|41626177|FG002|Extension Phase|Still on Study|18|||
19382841|NCT02730455|41626188|FG000|Overall Study|Death|5|||
19382842|NCT02730455|41626189|FG001|Overall Study|Death|6|||
19382843|NCT02730455|41626190|FG002|Overall Study|Death|4|||
19382844|NCT02730455|41626188|FG000|Overall Study|Consent withdrawn|2|||
19382845|NCT02730455|41626189|FG001|Overall Study|Consent withdrawn|4|||
19382846|NCT02730455|41626190|FG002|Overall Study|Consent withdrawn|1|||
19382847|NCT02730455|41626188|FG000|Overall Study|Lost to Follow-up|3|||
19382848|NCT02730455|41626189|FG001|Overall Study|Lost to Follow-up|1|||
19382849|NCT02730455|41626190|FG002|Overall Study|Lost to Follow-up|4|||
19382850|NCT02730455|41626188|FG000|Overall Study|Other|1|||
19382851|NCT02730455|41626189|FG001|Overall Study|Other|1|||
19382852|NCT02730455|41626190|FG002|Overall Study|Other|2|||
19382853|NCT02730455|41626188|FG000|Overall Study|Other|2|||
19382854|NCT02730455|41626189|FG001|Overall Study|Other|2|||
19382855|NCT02730455|41626190|FG002|Overall Study|Other|0|||
19382856|NCT04440449|41626200|FG000|Overall Study|Lost to Follow-up|2|||
19382857|NCT04440449|41626201|FG001|Overall Study|Lost to Follow-up|0|||
19382858|NCT00701311|41626208|FG000|Overall Study|Lack of Efficacy|3|||
19382859|NCT00701311|41626208|FG000|Overall Study|Adverse Event|3|||
19382860|NCT00701311|41626208|FG000|Overall Study|Withdrawal by Subject|2|||
19382861|NCT02730377|41626218|FG000|Overall Study|Other|5|||
19382862|NCT02730377|41626219|FG001|Overall Study|Other|4|||
19382863|NCT02730377|41626218|FG000|Overall Study|Death|1|||
19382864|NCT02730377|41626219|FG001|Overall Study|Death|8|||
19382865|NCT02730377|41626218|FG000|Overall Study|Inadequate glycaemic control|368|||
19382866|NCT02730377|41626219|FG001|Overall Study|Inadequate glycaemic control|473|||
19382867|NCT02730377|41626218|FG000|Overall Study|Adverse Event|79|||
19382868|NCT02730377|41626219|FG001|Overall Study|Adverse Event|41|||
19382869|NCT02730377|41626218|FG000|Overall Study|Protocol Violation|23|||
19382870|NCT02730377|41626219|FG001|Overall Study|Protocol Violation|30|||
19382871|NCT02730377|41626218|FG000|Overall Study|Lack of Efficacy|4|||
19382872|NCT02730377|41626219|FG001|Overall Study|Lack of Efficacy|13|||
19382873|NCT02730377|41626218|FG000|Overall Study|Pregnancy|0|||
19566854|NCT01261793|42014936|FG002|Overall Study|Patient pregnant|0|||
19566855|NCT01261793|42014934|FG000|Overall Study|Outside the study area|0|||
19382874|NCT02730377|41626219|FG001|Overall Study|Pregnancy|1|||
19382875|NCT02730377|41626218|FG000|Overall Study|Withdrawal by Subject|45|||
19382876|NCT02730377|41626219|FG001|Overall Study|Withdrawal by Subject|42|||
19382877|NCT02730377|41626218|FG000|Overall Study|Lost to Follow-up|25|||
19382878|NCT02730377|41626219|FG001|Overall Study|Lost to Follow-up|21|||
19382879|NCT02714569|41626236|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
19382880|NCT02714569|41626237|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
19382881|NCT02714569|41626238|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
19382882|NCT02714569|41626239|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
19382883|NCT02714569|41626240|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
19382884|NCT02714569|41626241|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
19382885|NCT02714569|41626242|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
19382886|NCT02714569|41626243|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
19382887|NCT02714569|41626244|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
19382888|NCT02714569|41626245|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
19382889|NCT02714569|41626246|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
19382890|NCT02714569|41626236|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382891|NCT02714569|41626237|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382892|NCT02714569|41626238|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382893|NCT02714569|41626239|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
19382894|NCT02714569|41626240|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382895|NCT02714569|41626241|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382896|NCT02714569|41626242|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382897|NCT02714569|41626243|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382898|NCT02714569|41626244|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382899|NCT02714569|41626245|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382900|NCT02714569|41626246|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
19382901|NCT02714569|41626236|FG000|Part A Third Intervention|Adverse Event|0|||
19382902|NCT02714569|41626237|FG001|Part A Third Intervention|Adverse Event|0|||
19382903|NCT02714569|41626238|FG002|Part A Third Intervention|Adverse Event|1|||
19382904|NCT02714569|41626239|FG003|Part A Third Intervention|Adverse Event|0|||
19382905|NCT02714569|41626240|FG004|Part A Third Intervention|Adverse Event|0|||
19382906|NCT02714569|41626241|FG005|Part A Third Intervention|Adverse Event|0|||
19382907|NCT02714569|41626242|FG006|Part A Third Intervention|Adverse Event|0|||
19382908|NCT02714569|41626243|FG007|Part A Third Intervention|Adverse Event|0|||
19382909|NCT02714569|41626244|FG008|Part A Third Intervention|Adverse Event|0|||
19382910|NCT02714569|41626245|FG009|Part A Third Intervention|Adverse Event|0|||
19382911|NCT02714569|41626246|FG010|Part A Third Intervention|Adverse Event|0|||
19382912|NCT02714569|41626236|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
19382913|NCT02714569|41626237|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382914|NCT02714569|41626238|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382915|NCT02714569|41626239|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382916|NCT02714569|41626240|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382917|NCT02714569|41626241|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
19382918|NCT02714569|41626242|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382919|NCT02714569|41626243|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382920|NCT02714569|41626244|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382921|NCT02714569|41626245|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382922|NCT02714569|41626246|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
19382923|NCT02714569|41626236|FG000|Part B (Overall)|Lost to Follow-up|0|||
19382924|NCT02714569|41626237|FG001|Part B (Overall)|Lost to Follow-up|0|||
19382925|NCT02714569|41626238|FG002|Part B (Overall)|Lost to Follow-up|0|||
19382926|NCT02714569|41626239|FG003|Part B (Overall)|Lost to Follow-up|0|||
19382927|NCT02714569|41626240|FG004|Part B (Overall)|Lost to Follow-up|0|||
19382928|NCT02714569|41626241|FG005|Part B (Overall)|Lost to Follow-up|0|||
19382929|NCT02714569|41626242|FG006|Part B (Overall)|Lost to Follow-up|1|||
19382930|NCT02714569|41626243|FG007|Part B (Overall)|Lost to Follow-up|0|||
19382931|NCT02714569|41626244|FG008|Part B (Overall)|Lost to Follow-up|0|||
19382932|NCT02714569|41626245|FG009|Part B (Overall)|Lost to Follow-up|0|||
19382933|NCT02714569|41626246|FG010|Part B (Overall)|Lost to Follow-up|0|||
19382934|NCT02714569|41626236|FG000|Part B (Overall)|Withdrawal by Subject|0|||
19382935|NCT02714569|41626237|FG001|Part B (Overall)|Withdrawal by Subject|0|||
19382936|NCT02714569|41626238|FG002|Part B (Overall)|Withdrawal by Subject|0|||
19382937|NCT02714569|41626239|FG003|Part B (Overall)|Withdrawal by Subject|0|||
19382938|NCT02714569|41626240|FG004|Part B (Overall)|Withdrawal by Subject|0|||
19382939|NCT02714569|41626241|FG005|Part B (Overall)|Withdrawal by Subject|0|||
19382940|NCT02714569|41626242|FG006|Part B (Overall)|Withdrawal by Subject|0|||
19382941|NCT02714569|41626243|FG007|Part B (Overall)|Withdrawal by Subject|1|||
19382942|NCT02714569|41626244|FG008|Part B (Overall)|Withdrawal by Subject|0|||
19382943|NCT02714569|41626245|FG009|Part B (Overall)|Withdrawal by Subject|1|||
19566856|NCT01261793|42014935|FG001|Overall Study|Outside the study area|2|||
19566857|NCT01261793|42014936|FG002|Overall Study|Outside the study area|1|||
19566858|NCT01261793|42014934|FG000|Overall Study|Lack of efficacy & patient not available|0|||
19566859|NCT01261793|42014935|FG001|Overall Study|Lack of efficacy & patient not available|1|||
19566860|NCT01261793|42014936|FG002|Overall Study|Lack of efficacy & patient not available|0|||
19382944|NCT02714569|41626246|FG010|Part B (Overall)|Withdrawal by Subject|0|||
19476851|NCT01552915|41754942|FG001|Overall Study|Other|0|||
19476852|NCT01552915|41754943|FG002|Overall Study|Other|6|||
19476853|NCT01552681|41754972|FG000|Overall Study|Withdrawal by Subject|4|||
19476854|NCT01552681|41754973|FG001|Overall Study|Withdrawal by Subject|0|||
19476855|NCT01552681|41754972|FG000|Overall Study|Physician Decision|1|||
19476856|NCT01552681|41754973|FG001|Overall Study|Physician Decision|0|||
19476857|NCT01552681|41754972|FG000|Overall Study|Subject moved away|0|||
19476858|NCT01552681|41754973|FG001|Overall Study|Subject moved away|1|||
19476859|NCT01570387|41755005|FG000|Overall Study|Adverse Event|1|||
19476860|NCT01570387|41755006|FG001|Overall Study|Adverse Event|0|||
19476861|NCT01570387|41755007|FG002|Overall Study|Adverse Event|0|||
19476862|NCT01570387|41755008|FG003|Overall Study|Adverse Event|0|||
19476863|NCT01570387|41755005|FG000|Overall Study|Death|0|||
19476864|NCT01570387|41755006|FG001|Overall Study|Death|0|||
19476865|NCT01570387|41755007|FG002|Overall Study|Death|0|||
19476866|NCT01570387|41755008|FG003|Overall Study|Death|1|||
19476867|NCT01570387|41755005|FG000|Overall Study|Withdrawal by Subject|0|||
19476868|NCT01570387|41755006|FG001|Overall Study|Withdrawal by Subject|0|||
19476869|NCT01570387|41755007|FG002|Overall Study|Withdrawal by Subject|0|||
19476870|NCT01570387|41755008|FG003|Overall Study|Withdrawal by Subject|1|||
19476871|NCT01570309|41755017|FG000|Overall Study|Withdrawal by Subject|3|||
19476872|NCT01570309|41755018|FG001|Overall Study|Withdrawal by Subject|3|||
19476873|NCT01519921|41755030|FG000|Overall Study|Adverse Event|10|||
19476874|NCT01519921|41755031|FG001|Overall Study|Adverse Event|9|||
19476875|NCT01519921|41755030|FG000|Overall Study|Lack of Efficacy|4|||
19476876|NCT01519921|41755031|FG001|Overall Study|Lack of Efficacy|3|||
19476877|NCT01519921|41755030|FG000|Overall Study|Withdrawal by Subject|3|||
19476878|NCT01519921|41755031|FG001|Overall Study|Withdrawal by Subject|0|||
19476879|NCT01519921|41755030|FG000|Overall Study|Lost to Follow-up|2|||
19476880|NCT01519921|41755031|FG001|Overall Study|Lost to Follow-up|1|||
19476881|NCT01519921|41755030|FG000|Overall Study|Treatment refusal|2|||
19476882|NCT01519921|41755031|FG001|Overall Study|Treatment refusal|1|||
19476883|NCT01519921|41755030|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
19745628|NCT00025259|42192986|FG002|Overall Study|Lack of Efficacy|60|||
19382945|NCT02714569|41626236|FG000|Part B (Overall)|Adverse Event|0|||
19476884|NCT01519921|41755031|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
19476885|NCT01519765|41755039|FG000|Overall Study|Adverse Event|0|||
19476886|NCT01519765|41755040|FG001|Overall Study|Adverse Event|1|||
19476887|NCT01519765|41755039|FG000|Overall Study|Lack of Efficacy|2|||
19476888|NCT01519765|41755040|FG001|Overall Study|Lack of Efficacy|0|||
19382946|NCT02714569|41626237|FG001|Part B (Overall)|Adverse Event|0|||
19382947|NCT02714569|41626238|FG002|Part B (Overall)|Adverse Event|0|||
19382948|NCT02714569|41626239|FG003|Part B (Overall)|Adverse Event|0|||
19382949|NCT02714569|41626240|FG004|Part B (Overall)|Adverse Event|0|||
19382950|NCT02714569|41626241|FG005|Part B (Overall)|Adverse Event|0|||
19382951|NCT02714569|41626242|FG006|Part B (Overall)|Adverse Event|0|||
19382952|NCT02714569|41626243|FG007|Part B (Overall)|Adverse Event|0|||
19382953|NCT02714569|41626244|FG008|Part B (Overall)|Adverse Event|0|||
19382954|NCT02714569|41626245|FG009|Part B (Overall)|Adverse Event|1|||
19382955|NCT02714569|41626246|FG010|Part B (Overall)|Adverse Event|0|||
19382956|NCT02713789|41626309|FG000|Overall Study|Lost to Follow-up|0|||
19382957|NCT02713789|41626310|FG001|Overall Study|Lost to Follow-up|1|||
19382958|NCT02713789|41626311|FG002|Overall Study|Lost to Follow-up|1|||
19382959|NCT04086121|41626319|FG000|Overall Study|Other than listed|8|||
19382960|NCT04086121|41626319|FG000|Overall Study|Withdrawal by Subject|3|||
19382961|NCT04086121|41626319|FG000|Overall Study|Lost to Follow-up|2|||
19382962|NCT04086121|41626319|FG000|Overall Study|Adverse Event|1|||
19382963|NCT02729909|41626326|FG000|Overall Study|Lost to Follow-up|0|||
19382964|NCT02729909|41626327|FG001|Overall Study|Lost to Follow-up|1|||
19382965|NCT02729909|41626326|FG000|Overall Study|Lack of Efficacy|0|||
19382966|NCT02729909|41626327|FG001|Overall Study|Lack of Efficacy|2|||
19382967|NCT02729909|41626326|FG000|Overall Study|Significant Protocol Deviation|0|||
19382968|NCT02729909|41626327|FG001|Overall Study|Significant Protocol Deviation|2|||
19382969|NCT02729909|41626326|FG000|Overall Study|Voluntary Withdrawal|1|||
19382970|NCT02729909|41626327|FG001|Overall Study|Voluntary Withdrawal|0|||
19382971|NCT02713243|41626335|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
19382972|NCT02713243|41626336|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
19382973|NCT02713243|41626335|FG000|Overall Study|Administrative problems|0|||
19382974|NCT02713243|41626336|FG001|Overall Study|Administrative problems|1|||
19382975|NCT02713243|41626335|FG000|Overall Study|Protocol deviation|0|||
19382976|NCT02713243|41626336|FG001|Overall Study|Protocol deviation|1|||
19382977|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
19382978|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
19382979|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
19382980|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
19382981|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
19382982|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
19382983|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
19566861|NCT01261793|42014934|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
19566862|NCT01261793|42014935|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
19566863|NCT01261793|42014936|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
19566864|NCT01261793|42014934|FG000|Overall Study|Randomization error|0|||
19566865|NCT01261793|42014935|FG001|Overall Study|Randomization error|1|||
19566866|NCT01261793|42014936|FG002|Overall Study|Randomization error|0|||
19566867|NCT01261793|42014934|FG000|Overall Study|Patient unable to start IV line|0|||
19566868|NCT01261793|42014935|FG001|Overall Study|Patient unable to start IV line|0|||
19566869|NCT01261793|42014936|FG002|Overall Study|Patient unable to start IV line|1|||
19566870|NCT01261325|42014947|FG000|Overall Study|Lack of Efficacy|1|||
19566871|NCT01261325|42014948|FG001|Overall Study|Lack of Efficacy|1|||
19566872|NCT01261325|42014949|FG002|Overall Study|Lack of Efficacy|0|||
19566873|NCT01261325|42014947|FG000|Overall Study|Withdrawal by Subject|2|||
19566874|NCT01261325|42014948|FG001|Overall Study|Withdrawal by Subject|2|||
19566875|NCT01261325|42014949|FG002|Overall Study|Withdrawal by Subject|4|||
19566876|NCT01261325|42014947|FG000|Overall Study|SAE, non-fatal|1|||
19566877|NCT01261325|42014948|FG001|Overall Study|SAE, non-fatal|5|||
19566878|NCT01261325|42014949|FG002|Overall Study|SAE, non-fatal|1|||
19566879|NCT01261325|42014947|FG000|Overall Study|AE, non-serious non-fatal|9|||
19566880|NCT01261325|42014948|FG001|Overall Study|AE, non-serious non-fatal|15|||
19566881|NCT01261325|42014949|FG002|Overall Study|AE, non-serious non-fatal|13|||
19566882|NCT01261325|42014947|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19566883|NCT01261325|42014948|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19566884|NCT01261325|42014949|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19566885|NCT01261325|42014947|FG000|Overall Study|Non Compliance|2|||
19382984|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
19476889|NCT01519765|41755039|FG000|Overall Study|Protocol Violation|1|||
19566886|NCT01261325|42014948|FG001|Overall Study|Non Compliance|0|||
19566887|NCT01261325|42014949|FG002|Overall Study|Non Compliance|0|||
19566888|NCT01261325|42014947|FG000|Overall Study|Patient Randomized by Mistake|0|||
19566889|NCT01261325|42014948|FG001|Overall Study|Patient Randomized by Mistake|1|||
19566890|NCT01261325|42014949|FG002|Overall Study|Patient Randomized by Mistake|0|||
19566891|NCT01261325|42014947|FG000|Overall Study|Erroneously Randomized|1|||
19745629|NCT00025259|42192987|FG003|Overall Study|Lack of Efficacy|78|||
19382985|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
19382986|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
19382987|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
19382988|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
19382989|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
19382990|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
19382991|NCT03434041|41626344|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
19382992|NCT03434041|41626345|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
19382993|NCT03434041|41626344|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
19382994|NCT03434041|41626345|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
19382995|NCT03434041|41626344|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
19382996|NCT03434041|41626345|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
19382997|NCT03434041|41626344|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
19382998|NCT03434041|41626345|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
19382999|NCT00708461|41626360|FG000|Overall Study|Lost to Follow-up|18|||
19383000|NCT00708461|41626361|FG001|Overall Study|Lost to Follow-up|11|||
19383001|NCT00708461|41626360|FG000|Overall Study|Withdrawal by Subject|8|||
19383002|NCT00708461|41626361|FG001|Overall Study|Withdrawal by Subject|9|||
19383003|NCT00708461|41626360|FG000|Overall Study|left workforce|115|||
19383004|NCT00708461|41626361|FG001|Overall Study|left workforce|180|||
19383005|NCT00700999|41626369|FG000|Overall Study|Lost to Follow-up|7|||
19383006|NCT00700999|41626370|FG001|Overall Study|Lost to Follow-up|7|||
19383007|NCT00700999|41626369|FG000|Overall Study|Excluded - did not meet study criteria|0|||
19383008|NCT00700999|41626370|FG001|Overall Study|Excluded - did not meet study criteria|1|||
19383009|NCT00700999|41626369|FG000|Overall Study|Withdrawal by Subject|8|||
19383010|NCT00700999|41626370|FG001|Overall Study|Withdrawal by Subject|1|||
19383011|NCT02729831|41626380|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
19383012|NCT02729831|41626381|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
19383013|NCT02729831|41626382|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
19383014|NCT02729831|41626383|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
19383015|NCT02729831|41626380|FG000|1 Week Post-visit|Lost to Follow-up|43|||
19383016|NCT02729831|41626381|FG001|1 Week Post-visit|Lost to Follow-up|40|||
19383017|NCT02729831|41626382|FG002|1 Week Post-visit|Lost to Follow-up|38|||
19383018|NCT02729831|41626383|FG003|1 Week Post-visit|Lost to Follow-up|36|||
19383019|NCT02729831|41626380|FG000|6 Month Follow-up|Lost to Follow-up|54|||
19383020|NCT02729831|41626381|FG001|6 Month Follow-up|Lost to Follow-up|51|||
19383021|NCT02729831|41626382|FG002|6 Month Follow-up|Lost to Follow-up|48|||
19383022|NCT02729831|41626383|FG003|6 Month Follow-up|Lost to Follow-up|42|||
19383023|NCT02729831|41626380|FG000|6 Month Follow-up|Death|1|||
19383024|NCT02729831|41626381|FG001|6 Month Follow-up|Death|3|||
19383025|NCT02729831|41626382|FG002|6 Month Follow-up|Death|0|||
19383026|NCT02729831|41626383|FG003|6 Month Follow-up|Death|1|||
19383027|NCT02729753|41626395|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
19383028|NCT02729753|41626396|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
19383029|NCT00709319|41626405|FG000|Overall Study|Death|4|||
19383030|NCT00709319|41626405|FG000|Overall Study|Withdrawal by Subject|2|||
19383031|NCT02729051|41626450|FG000|Overall Study|Adverse Event|21|||
19383032|NCT02729051|41626451|FG001|Overall Study|Adverse Event|11|||
19383033|NCT02729051|41626450|FG000|Overall Study|Lack of Efficacy|1|||
19383034|NCT02729051|41626451|FG001|Overall Study|Lack of Efficacy|1|||
19383035|NCT02729051|41626450|FG000|Overall Study|Lost to Follow-up|1|||
19383036|NCT02729051|41626451|FG001|Overall Study|Lost to Follow-up|2|||
19383037|NCT02729051|41626450|FG000|Overall Study|Physician Decision|1|||
19383038|NCT02729051|41626451|FG001|Overall Study|Physician Decision|1|||
19383039|NCT02729051|41626450|FG000|Overall Study|Withdrawal by Subject|6|||
19383040|NCT02729051|41626451|FG001|Overall Study|Withdrawal by Subject|17|||
19383041|NCT00707993|41626459|FG000|Overall Study|Adverse Event|16|||
19383042|NCT00707993|41626460|FG001|Overall Study|Adverse Event|20|||
19383043|NCT00707993|41626459|FG000|Overall Study|Protocol Violation|4|||
19383044|NCT00707993|41626460|FG001|Overall Study|Protocol Violation|7|||
19383045|NCT00707993|41626459|FG000|Overall Study|Lost to Follow-up|0|||
19383046|NCT00707993|41626460|FG001|Overall Study|Lost to Follow-up|4|||
19383047|NCT00707993|41626459|FG000|Overall Study|Withdrawal by Subject|12|||
19383048|NCT00707993|41626460|FG001|Overall Study|Withdrawal by Subject|16|||
19383049|NCT00707993|41626459|FG000|Overall Study|Hyperglycemic Rescue|55|||
19383050|NCT00707993|41626460|FG001|Overall Study|Hyperglycemic Rescue|47|||
19383051|NCT00707993|41626459|FG000|Overall Study|Other|2|||
19383052|NCT00707993|41626460|FG001|Overall Study|Other|0|||
19383053|NCT00708227|41626470|FG000|Overall Study|Physician Decision|0|||
19383054|NCT00708227|41626471|FG001|Overall Study|Physician Decision|3|||
19383055|NCT00708227|41626472|FG002|Overall Study|Physician Decision|1|||
19383056|NCT00708227|41626473|FG003|Overall Study|Physician Decision|2|||
19383057|NCT00708227|41626470|FG000|Overall Study|Withdrawal by Subject|1|||
19383058|NCT00708227|41626471|FG001|Overall Study|Withdrawal by Subject|2|||
19383059|NCT00708227|41626472|FG002|Overall Study|Withdrawal by Subject|0|||
19383060|NCT00708227|41626473|FG003|Overall Study|Withdrawal by Subject|1|||
19476890|NCT01519765|41755040|FG001|Overall Study|Protocol Violation|0|||
19383061|NCT02425891|41626505|FG000|Overall Study|Death|333|||
19383062|NCT02425891|41626506|FG001|Overall Study|Death|314|||
19383063|NCT02425891|41626505|FG000|Overall Study|Lost to Follow-up|4|||
19383064|NCT02425891|41626506|FG001|Overall Study|Lost to Follow-up|6|||
19383065|NCT02425891|41626505|FG000|Overall Study|Non-Compliance|1|||
19383066|NCT02425891|41626506|FG001|Overall Study|Non-Compliance|1|||
19383067|NCT02425891|41626505|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
19383068|NCT02425891|41626506|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
19383069|NCT02425891|41626505|FG000|Overall Study|Physician Decision|0|||
19383070|NCT02425891|41626506|FG001|Overall Study|Physician Decision|1|||
19383071|NCT02425891|41626505|FG000|Overall Study|Protocol Violation|1|||
19383072|NCT02425891|41626506|FG001|Overall Study|Protocol Violation|1|||
19383073|NCT02425891|41626505|FG000|Overall Study|Study Terminated By Sponsor|85|||
19383074|NCT02425891|41626506|FG001|Overall Study|Study Terminated By Sponsor|95|||
19383075|NCT02425891|41626505|FG000|Overall Study|Withdrawal by Subject|27|||
19383076|NCT02425891|41626506|FG001|Overall Study|Withdrawal by Subject|32|||
19383077|NCT03241225|41626516|FG000|Overall Study|Lost to Follow-up|2|||
19383078|NCT03241225|41626517|FG001|Overall Study|Lost to Follow-up|1|||
19383079|NCT03241225|41626516|FG000|Overall Study|Protocol Violation|4|||
19383080|NCT03241225|41626517|FG001|Overall Study|Protocol Violation|1|||
19383081|NCT03241225|41626516|FG000|Overall Study|Withdrawal by Subject|1|||
19383082|NCT03241225|41626517|FG001|Overall Study|Withdrawal by Subject|0|||
19383083|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
19383084|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
19383085|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
19383086|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
19383087|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383088|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383089|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383090|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383091|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383092|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383093|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383094|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383095|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383096|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383097|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383098|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383099|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383100|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383101|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383102|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383103|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
19383104|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
19383105|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
19383106|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
19383107|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
19383108|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383109|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383110|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383111|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383112|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383113|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383114|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383115|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383116|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383117|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383118|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383119|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383120|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383121|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383122|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383123|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383124|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
19383125|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
19383126|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
19383127|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
19383128|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
19383129|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383130|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383131|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383132|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383133|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383134|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383135|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383136|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383137|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383138|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383139|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383140|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383141|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383142|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383143|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383144|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383145|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
19383146|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
19383147|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
19383148|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
19383149|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19478176|NCT01693562|41757330|FG016|Expansion Phase|Other|28|||
19383150|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383151|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383152|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383153|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383154|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383155|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383156|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383157|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383158|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383159|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383160|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383161|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383162|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383163|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383164|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383165|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383166|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
19383167|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
19383168|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383169|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383170|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
19383171|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383172|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383173|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383174|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383175|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383176|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383177|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383178|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383179|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383180|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383181|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383182|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383183|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383184|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383185|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383186|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383187|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
19383188|NCT01597245|41626527|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
19383189|NCT01597245|41626528|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
19383190|NCT01597245|41626529|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
19383191|NCT01597245|41626530|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383192|NCT01597245|41626531|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383193|NCT01597245|41626532|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383194|NCT01597245|41626533|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383195|NCT01597245|41626534|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383196|NCT01597245|41626535|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383197|NCT01597245|41626536|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383198|NCT01597245|41626537|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383199|NCT01597245|41626538|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383200|NCT01597245|41626539|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383201|NCT01597245|41626540|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383202|NCT01597245|41626541|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383203|NCT01597245|41626542|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383204|NCT01597245|41626543|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383205|NCT01597245|41626544|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383206|NCT01597245|41626545|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19478177|NCT01693562|41757331|FG017|Expansion Phase|Other|0|||
19383207|NCT01597245|41626546|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383208|NCT01597245|41626547|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
19383209|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383210|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383211|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383212|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383213|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383214|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
19383215|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
19383216|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383217|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383218|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383219|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383220|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383221|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383222|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383223|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383224|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383225|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383226|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383227|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383228|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383229|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
19383230|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383231|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383232|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383233|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383234|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
19383235|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
19383236|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
19383237|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
19383238|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383239|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
19476891|NCT01519765|41755039|FG000|Overall Study|Withdrawal by Subject|0|||
19383240|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383241|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383242|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383243|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383244|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383245|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383246|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383247|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383248|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383249|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383250|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
19383251|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383252|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383253|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19566892|NCT01261325|42014948|FG001|Overall Study|Erroneously Randomized|0|||
19566893|NCT01261325|42014949|FG002|Overall Study|Erroneously Randomized|0|||
19566894|NCT01261325|42014947|FG000|Overall Study|Screen Failure|1|||
19566895|NCT01261325|42014948|FG001|Overall Study|Screen Failure|0|||
19566896|NCT01261325|42014949|FG002|Overall Study|Screen Failure|0|||
19566897|NCT01261325|42014947|FG000|Overall Study|Randomized in Error|0|||
19566898|NCT01261325|42014948|FG001|Overall Study|Randomized in Error|0|||
19566899|NCT01261325|42014949|FG002|Overall Study|Randomized in Error|1|||
19566900|NCT01261325|42014947|FG000|Overall Study|Protocol Violation|0|||
19566901|NCT01261325|42014948|FG001|Overall Study|Protocol Violation|3|||
19566902|NCT01261325|42014949|FG002|Overall Study|Protocol Violation|1|||
19566903|NCT01261325|42014947|FG000|Overall Study|Lost to Follow-up|0|||
19566904|NCT01261325|42014948|FG001|Overall Study|Lost to Follow-up|1|||
19566905|NCT01261325|42014949|FG002|Overall Study|Lost to Follow-up|3|||
19566906|NCT01261325|42014947|FG000|Overall Study|AE, serious fatal|0|||
19566907|NCT01261325|42014948|FG001|Overall Study|AE, serious fatal|0|||
19566908|NCT01261325|42014949|FG002|Overall Study|AE, serious fatal|2|||
19566909|NCT01260701|42014960|FG000|Overall Study|Adverse Event|9|||
19566910|NCT01260701|42014960|FG000|Overall Study|Withdrawal by Subject|2|||
19566911|NCT01260701|42014960|FG000|Overall Study|Progression|53|||
19566912|NCT01260701|42014960|FG000|Overall Study|Death|2|||
19566913|NCT01260701|42014960|FG000|Overall Study|Not protocol specified|3|||
19566914|NCT01260701|42014960|FG000|Overall Study|Under review|1|||
19566915|NCT01260701|42014960|FG000|Overall Study|Ineligible|4|||
19566916|NCT01260701|42014960|FG000|Overall Study|Did not begin protocol therapy|1|||
19566917|NCT01260467|42014964|FG000|Overall Study|Withdrawal by Subject|2|||
19566918|NCT01260311|42014970|FG000|Overall Study|Adverse Event|11|||
19566919|NCT01260311|42014970|FG000|Overall Study|Lack of Efficacy|4|||
19566920|NCT01260311|42014970|FG000|Overall Study|Lost to Follow-up|25|||
19566921|NCT01260311|42014970|FG000|Overall Study|Withdrawal by Subject|6|||
19566922|NCT01260311|42014970|FG000|Overall Study|Financial Constraints|77|||
19566923|NCT01260311|42014970|FG000|Overall Study|Gone to Province|2|||
19566924|NCT01260311|42014970|FG000|Overall Study|Medication Stopped|1|||
19566925|NCT01260311|42014970|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
19566926|NCT01259375|42014974|FG000|Overall Study|Adverse Event|1|||
19566927|NCT01940471|42014991|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
19566928|NCT01940471|42014992|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
19566929|NCT01940471|42014991|FG000|Double-Blind Phase|Withdrew Consent|13|||
19566930|NCT01940471|42014992|FG001|Double-Blind Phase|Withdrew Consent|7|||
19566931|NCT01940471|42014991|FG000|Double-Blind Phase|Adverse Event|1|||
19566932|NCT01940471|42014992|FG001|Double-Blind Phase|Adverse Event|2|||
19566933|NCT01940471|42014991|FG000|Double-Blind Phase|Lost to Follow-up|3|||
19566934|NCT01940471|42014992|FG001|Double-Blind Phase|Lost to Follow-up|2|||
19566935|NCT01940471|42014991|FG000|Double-Blind Phase|Pregnancy|2|||
19566936|NCT01940471|42014992|FG001|Double-Blind Phase|Pregnancy|1|||
19566937|NCT01940471|42014991|FG000|Double-Blind Phase|Investigator's Discretion|5|||
19383254|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383255|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383256|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
19383257|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383258|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383259|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
19383260|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383261|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
19383262|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
19383263|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
19383264|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383265|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383266|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383267|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383268|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383269|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19476892|NCT01519765|41755040|FG001|Overall Study|Withdrawal by Subject|1|||
19383270|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383271|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
19383272|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383273|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383274|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383275|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383276|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
19383277|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
19383278|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
19383279|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
19383280|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
19383281|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
19383282|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
19383283|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
19383284|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
19383285|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383286|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383287|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383288|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383289|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383290|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383291|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383292|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
19383293|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383294|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383295|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383296|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383297|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
19476893|NCT01552603|41755047|FG000|Overall Study|Physician Decision|1|||
19566938|NCT01940471|42014992|FG001|Double-Blind Phase|Investigator's Discretion|0|||
19566939|NCT01940471|42014991|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19566940|NCT01940471|42014992|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19566941|NCT01940471|42014991|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
19566942|NCT01940471|42014992|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
19566943|NCT01940471|42014991|FG000|Double-Blind Phase|Death|1|||
19566944|NCT01940471|42014992|FG001|Double-Blind Phase|Death|0|||
19566945|NCT01940471|42014991|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19566946|NCT01940471|42014992|FG001|Double-Blind Phase|Lack of Efficacy|0|||
19566947|NCT01940471|42014991|FG000|Double-Blind Phase|Protocol Violation|0|||
19566948|NCT01940471|42014992|FG001|Double-Blind Phase|Protocol Violation|1|||
19566949|NCT01940471|42014991|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
19566950|NCT01940471|42014992|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
19566951|NCT01940471|42014991|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
19566952|NCT01940471|42014992|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
19566953|NCT01321073|42014999|FG000|Overall Study|Did not attempt implant|4|||
19566954|NCT01321073|42014999|FG000|Overall Study|Death|3|||
19566955|NCT01259297|42015011|FG000|Double Blind Randomized Period|Death|1|||
19566956|NCT01259297|42015012|FG001|Double Blind Randomized Period|Death|1|||
19566957|NCT01259297|42015013|FG002|Double Blind Randomized Period|Death|1|||
19566958|NCT01259297|42015014|FG003|Double Blind Randomized Period|Death|2|||
19566959|NCT01259297|42015015|FG004|Double Blind Randomized Period|Death|1|||
19566960|NCT01259297|42015016|FG005|Double Blind Randomized Period|Death|5|||
19566961|NCT01259297|42015017|FG006|Double Blind Randomized Period|Death|2|||
19566962|NCT01259297|42015018|FG007|Double Blind Randomized Period|Death|1|||
19566963|NCT01259297|42015011|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
19383298|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
19383299|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
19383300|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383301|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
19383302|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
19383303|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
19383304|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
19383305|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
19383306|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383307|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383308|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383309|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383310|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383311|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383312|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383313|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
19383314|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383315|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383316|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383317|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383318|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
19383319|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383320|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383321|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383322|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
19383323|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
19383324|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
19383325|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383326|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
19383327|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383328|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383329|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383330|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383331|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383332|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383333|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383334|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
19383335|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383336|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383337|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383338|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383339|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
19383340|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
19383341|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
19383342|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383343|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
19383344|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
19383345|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
19383346|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
19383347|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
19383348|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383349|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383350|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383351|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383352|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383353|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383354|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383355|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
19383356|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383357|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383358|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383359|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19745630|NCT00025259|42192988|FG004|Overall Study|Lack of Efficacy|11|||
19566964|NCT01259297|42015012|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
19566965|NCT01259297|42015013|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
19566966|NCT01259297|42015014|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
19566967|NCT01259297|42015015|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
19566968|NCT01259297|42015016|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
19566969|NCT01259297|42015017|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
19566970|NCT01259297|42015018|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
19566971|NCT01259297|42015011|FG000|Double Blind Randomized Period|Other reasons|0|||
19566972|NCT01259297|42015012|FG001|Double Blind Randomized Period|Other reasons|1|||
19566973|NCT01259297|42015013|FG002|Double Blind Randomized Period|Other reasons|0|||
19566974|NCT01259297|42015014|FG003|Double Blind Randomized Period|Other reasons|0|||
19566975|NCT01259297|42015015|FG004|Double Blind Randomized Period|Other reasons|1|||
19566976|NCT01259297|42015016|FG005|Double Blind Randomized Period|Other reasons|2|||
19566977|NCT01259297|42015017|FG006|Double Blind Randomized Period|Other reasons|3|||
19566978|NCT01259297|42015018|FG007|Double Blind Randomized Period|Other reasons|1|||
19566979|NCT01126437|42015038|FG000|Overall Study|Not treated|11|||
19566980|NCT01126437|42015039|FG001|Overall Study|Not treated|18|||
19566981|NCT01126437|42015040|FG002|Overall Study|Not treated|19|||
19566982|NCT01126437|42015038|FG000|Overall Study|Sites with data irregularities/fraud|6|||
19566983|NCT01126437|42015039|FG001|Overall Study|Sites with data irregularities/fraud|6|||
19566984|NCT01126437|42015040|FG002|Overall Study|Sites with data irregularities/fraud|7|||
19566985|NCT01126437|42015038|FG000|Overall Study|Adverse Event|602|||
19566986|NCT01126437|42015039|FG001|Overall Study|Adverse Event|606|||
19566987|NCT01126437|42015040|FG002|Overall Study|Adverse Event|635|||
19566988|NCT01126437|42015038|FG000|Overall Study|Lack of Efficacy|65|||
19566989|NCT01126437|42015039|FG001|Overall Study|Lack of Efficacy|60|||
19566990|NCT01126437|42015040|FG002|Overall Study|Lack of Efficacy|59|||
19566991|NCT01126437|42015038|FG000|Overall Study|Protocol Violation|64|||
19566992|NCT01126437|42015039|FG001|Overall Study|Protocol Violation|66|||
19566993|NCT01126437|42015040|FG002|Overall Study|Protocol Violation|41|||
19566994|NCT01126437|42015038|FG000|Overall Study|Lost to Follow-up|52|||
19566995|NCT01126437|42015039|FG001|Overall Study|Lost to Follow-up|63|||
19566996|NCT01126437|42015040|FG002|Overall Study|Lost to Follow-up|55|||
19566997|NCT01126437|42015038|FG000|Overall Study|Withdrawal by Subject|331|||
19566998|NCT01126437|42015039|FG001|Overall Study|Withdrawal by Subject|335|||
19566999|NCT01126437|42015040|FG002|Overall Study|Withdrawal by Subject|319|||
19567000|NCT01126437|42015038|FG000|Overall Study|Other reason not specified|210|||
19567001|NCT01126437|42015039|FG001|Overall Study|Other reason not specified|176|||
19567002|NCT01126437|42015040|FG002|Overall Study|Other reason not specified|178|||
19567003|NCT01258595|42015050|FG000|Overall Study|Lost to Follow-up|1|||
19567004|NCT01258595|42015051|FG001|Overall Study|Lost to Follow-up|0|||
19567005|NCT01258595|42015050|FG000|Overall Study|Withdrawal by Subject|0|||
19567006|NCT01258595|42015051|FG001|Overall Study|Withdrawal by Subject|1|||
19567007|NCT01257737|42015059|FG000|Overall Study|Lost to Follow-up|1|||
19567008|NCT01257737|42015060|FG001|Overall Study|Lost to Follow-up|2|||
19567009|NCT01257737|42015059|FG000|Overall Study|Liver transplant|1|||
19567010|NCT01257737|42015060|FG001|Overall Study|Liver transplant|0|||
19567011|NCT01257737|42015059|FG000|Overall Study|Relocation out of the country|0|||
19567012|NCT01257737|42015060|FG001|Overall Study|Relocation out of the country|1|||
19567013|NCT01257737|42015059|FG000|Overall Study|Withdrew from study|0|||
19567014|NCT01257737|42015060|FG001|Overall Study|Withdrew from study|1|||
19567015|NCT01126359|42015067|FG000|First Intervention (20-minutes)|Physician Decision|0|||
19567016|NCT01126359|42015068|FG001|First Intervention (20-minutes)|Physician Decision|1|||
19567017|NCT01125813|42015078|FG000|Overall Study|Death|1|||
19567018|NCT01125813|42015078|FG000|Overall Study|Withdrawal by Subject|1|||
19567019|NCT01125813|42015078|FG000|Overall Study|Screen Failures|4|||
19567020|NCT00996892|42015082|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
19567021|NCT00996892|42015083|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
19567022|NCT00996892|42015084|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
19745631|NCT00025259|42192989|FG005|Overall Study|Lack of Efficacy|30|||
19476894|NCT01552369|41755053|FG000|Overall Study|Did not consent to extended follow up|8|||
19567023|NCT00996892|42015085|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
19476895|NCT01552369|41755054|FG001|Overall Study|Did not consent to extended follow up|9|||
19476896|NCT01552057|41755064|FG000|Overall Study|Adverse Event|14|||
19567024|NCT00996892|42015086|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
19476897|NCT01552057|41755065|FG001|Overall Study|Adverse Event|15|||
19476898|NCT01552057|41755064|FG000|Overall Study|Lack of Efficacy|8|||
19383360|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383361|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
19383362|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19476899|NCT01552057|41755065|FG001|Overall Study|Lack of Efficacy|23|||
19383363|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383364|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
19383365|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
19383366|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
19383367|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
19383368|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383369|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383370|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19567025|NCT00996892|42015087|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
19567026|NCT00996892|42015088|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
19567027|NCT00996892|42015089|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
19567028|NCT00996892|42015090|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
19567029|NCT00996892|42015091|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
19567030|NCT00996892|42015092|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
19567031|NCT00996892|42015093|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
19567032|NCT00996892|42015094|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
19567033|NCT00996892|42015095|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
19567034|NCT00996892|42015096|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
19567035|NCT00996892|42015097|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
19567036|NCT00996892|42015098|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
19567037|NCT00996892|42015099|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
19567038|NCT00996892|42015100|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
19567039|NCT00996892|42015101|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
19567040|NCT00996892|42015082|FG000|Dose-Escalation Stage 1|Death|1|||
19567041|NCT00996892|42015083|FG001|Dose-Escalation Stage 1|Death|0|||
19567042|NCT00996892|42015084|FG002|Dose-Escalation Stage 1|Death|0|||
19567043|NCT00996892|42015085|FG003|Dose-Escalation Stage 1|Death|0|||
19567044|NCT00996892|42015086|FG004|Dose-Escalation Stage 1|Death|0|||
19567045|NCT00996892|42015087|FG005|Dose-Escalation Stage 1|Death|1|||
19567046|NCT00996892|42015088|FG006|Dose-Escalation Stage 1|Death|0|||
19567047|NCT00996892|42015089|FG007|Dose-Escalation Stage 1|Death|0|||
19745632|NCT00025259|42192990|FG006|Overall Study|Lack of Efficacy|38|||
19383371|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383372|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383373|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383374|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383375|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383376|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
19383377|NCT01597245|41626527|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383378|NCT01597245|41626528|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383379|NCT01597245|41626529|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383380|NCT01597245|41626530|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383381|NCT01597245|41626531|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383382|NCT01597245|41626532|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383383|NCT01597245|41626533|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383384|NCT01597245|41626534|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383385|NCT01597245|41626535|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383386|NCT01597245|41626536|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383387|NCT01597245|41626537|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
19383388|NCT01597245|41626538|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383389|NCT01597245|41626539|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383390|NCT01597245|41626540|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383391|NCT01597245|41626541|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383392|NCT01597245|41626542|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383393|NCT01597245|41626543|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383394|NCT01597245|41626544|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383395|NCT01597245|41626545|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383396|NCT01597245|41626546|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383397|NCT01597245|41626547|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
19383398|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383399|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383400|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383401|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383402|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383403|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383404|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383405|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383406|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383407|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383408|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383409|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383410|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383411|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
19383412|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
19383413|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
19383414|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383415|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383416|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383417|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383418|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
19383419|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383420|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383421|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19567048|NCT00996892|42015090|FG008|Dose-Escalation Stage 1|Death|0|||
19567049|NCT00996892|42015091|FG009|Dose-Escalation Stage 1|Death|0|||
19567050|NCT00996892|42015092|FG010|Dose-Escalation Stage 1|Death|0|||
19567051|NCT00996892|42015093|FG011|Dose-Escalation Stage 1|Death|0|||
19567052|NCT00996892|42015094|FG012|Dose-Escalation Stage 1|Death|0|||
19567053|NCT00996892|42015095|FG013|Dose-Escalation Stage 1|Death|0|||
19567054|NCT00996892|42015096|FG014|Dose-Escalation Stage 1|Death|0|||
19567055|NCT00996892|42015097|FG015|Dose-Escalation Stage 1|Death|0|||
19567056|NCT00996892|42015098|FG016|Dose-Escalation Stage 1|Death|0|||
19567057|NCT00996892|42015099|FG017|Dose-Escalation Stage 1|Death|0|||
19567058|NCT00996892|42015100|FG018|Dose-Escalation Stage 1|Death|0|||
19567059|NCT00996892|42015101|FG019|Dose-Escalation Stage 1|Death|0|||
19567060|NCT00996892|42015082|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
19567061|NCT00996892|42015083|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
19567062|NCT00996892|42015084|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
19567063|NCT00996892|42015085|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
19567064|NCT00996892|42015086|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
19567065|NCT00996892|42015087|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
19567066|NCT00996892|42015088|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
19567067|NCT00996892|42015089|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
19567068|NCT00996892|42015090|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
19567069|NCT00996892|42015091|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
19567070|NCT00996892|42015092|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
19567071|NCT00996892|42015093|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
19567072|NCT00996892|42015094|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
19567073|NCT00996892|42015095|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
19567074|NCT00996892|42015096|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
19567075|NCT00996892|42015097|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
19567076|NCT00996892|42015098|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
19567077|NCT00996892|42015099|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
19567078|NCT00996892|42015100|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
19567079|NCT00996892|42015101|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
19567080|NCT00996892|42015082|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567081|NCT00996892|42015083|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
19567082|NCT00996892|42015084|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567083|NCT00996892|42015085|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
19567084|NCT00996892|42015086|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
19567085|NCT00996892|42015087|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
19567086|NCT00996892|42015088|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
19567087|NCT00996892|42015089|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567088|NCT00996892|42015090|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567089|NCT00996892|42015091|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567090|NCT00996892|42015092|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567091|NCT00996892|42015093|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567092|NCT00996892|42015094|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567093|NCT00996892|42015095|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567094|NCT00996892|42015096|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567095|NCT00996892|42015097|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567096|NCT00996892|42015098|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567097|NCT00996892|42015099|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19745633|NCT00025259|42192984|FG000|Overall Study|Lost to Follow-up|2|||
19383422|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383423|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383424|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383425|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383426|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383427|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383428|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383429|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383430|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383431|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383432|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
19383433|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
19383434|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
19383435|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383436|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383437|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383438|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383439|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
19383440|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383441|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383442|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383443|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383444|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383445|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383446|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383447|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383448|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383449|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383450|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383451|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383452|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383453|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383454|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
19383455|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
19383456|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383457|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383458|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383459|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383460|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
19383461|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383462|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383463|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383464|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383465|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383466|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383467|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383468|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383469|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383470|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383471|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383472|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383473|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383474|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383475|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
19383476|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
19383477|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383478|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383479|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383480|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383481|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
19383482|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383483|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383484|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383485|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383486|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383487|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383488|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383489|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383490|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383491|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383492|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383493|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383494|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383495|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
19383496|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
19383497|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
19383498|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383499|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383500|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383501|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383502|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
19383503|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383504|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383505|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383506|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383507|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383508|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383509|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383510|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383511|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383512|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
19476900|NCT01552057|41755064|FG000|Overall Study|Withdrawal by Subject|5|||
19476901|NCT01552057|41755065|FG001|Overall Study|Withdrawal by Subject|8|||
19745634|NCT00025259|42192985|FG001|Overall Study|Lost to Follow-up|9|||
19383513|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383514|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383515|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383516|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383517|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
19383518|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
19383519|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383520|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383521|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383522|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383523|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
19383524|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383525|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383526|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383527|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383528|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383529|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383530|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383531|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383532|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383533|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383534|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383535|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383536|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383537|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383538|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
19383539|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
19383540|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383541|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383542|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383543|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383544|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
19383545|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383546|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383547|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383548|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383549|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19478178|NCT01693562|41757332|FG018|Expansion Phase|Other|1|||
19383550|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383551|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19478179|NCT01693562|41757333|FG019|Expansion Phase|Other|0|||
19567098|NCT00996892|42015100|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567099|NCT00996892|42015101|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
19567100|NCT00996892|42015082|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
19567101|NCT00996892|42015083|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
19567102|NCT00996892|42015084|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
19567103|NCT00996892|42015085|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
19567104|NCT00996892|42015086|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
19567105|NCT00996892|42015087|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
19567106|NCT00996892|42015088|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
19567107|NCT00996892|42015089|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
19567108|NCT00996892|42015090|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
19567109|NCT00996892|42015091|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
19567110|NCT00996892|42015092|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
19567111|NCT00996892|42015093|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
19567112|NCT00996892|42015094|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
19567113|NCT00996892|42015095|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
19567114|NCT00996892|42015096|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
19567115|NCT00996892|42015097|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
19567116|NCT00996892|42015098|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
19567117|NCT00996892|42015099|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
19567118|NCT00996892|42015100|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
19567119|NCT00996892|42015101|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
19567120|NCT00996892|42015082|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
19567121|NCT00996892|42015083|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
19567122|NCT00996892|42015084|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
19567123|NCT00996892|42015085|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
19567124|NCT00996892|42015086|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
19567125|NCT00996892|42015087|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
19567126|NCT00996892|42015088|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
19567127|NCT00996892|42015089|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
19567128|NCT00996892|42015090|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
19567129|NCT00996892|42015091|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
19567130|NCT00996892|42015092|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
19567131|NCT00996892|42015093|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
19567132|NCT00996892|42015094|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
19567133|NCT00996892|42015095|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
19567134|NCT00996892|42015096|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
19567135|NCT00996892|42015097|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
19567136|NCT00996892|42015098|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
19567137|NCT00996892|42015099|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
19567138|NCT00996892|42015100|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
19567139|NCT00996892|42015101|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
19567140|NCT00996892|42015082|FG000|Dose-Escalation Stage 1A|Death|0|||
19567141|NCT00996892|42015083|FG001|Dose-Escalation Stage 1A|Death|0|||
19567142|NCT00996892|42015084|FG002|Dose-Escalation Stage 1A|Death|0|||
19567143|NCT00996892|42015085|FG003|Dose-Escalation Stage 1A|Death|0|||
19567144|NCT00996892|42015086|FG004|Dose-Escalation Stage 1A|Death|0|||
19567145|NCT00996892|42015087|FG005|Dose-Escalation Stage 1A|Death|0|||
19567146|NCT00996892|42015088|FG006|Dose-Escalation Stage 1A|Death|0|||
19567147|NCT00996892|42015089|FG007|Dose-Escalation Stage 1A|Death|0|||
19567148|NCT00996892|42015090|FG008|Dose-Escalation Stage 1A|Death|0|||
19567149|NCT00996892|42015091|FG009|Dose-Escalation Stage 1A|Death|2|||
19567150|NCT00996892|42015092|FG010|Dose-Escalation Stage 1A|Death|0|||
19567151|NCT00996892|42015093|FG011|Dose-Escalation Stage 1A|Death|1|||
19567152|NCT00996892|42015094|FG012|Dose-Escalation Stage 1A|Death|1|||
19383552|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383553|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383554|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383555|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383556|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383557|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383558|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383559|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
19383560|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
19383561|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383562|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383563|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383564|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383565|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
19383566|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383567|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383568|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383569|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383570|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383571|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383572|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383573|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383574|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383575|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383576|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383577|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383578|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383579|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383580|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
19383581|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
19383582|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383583|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383584|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383585|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383586|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
19383587|NCT01597245|41626527|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383588|NCT01597245|41626528|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383589|NCT01597245|41626529|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383590|NCT01597245|41626530|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383591|NCT01597245|41626531|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383592|NCT01597245|41626532|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383593|NCT01597245|41626533|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383594|NCT01597245|41626534|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383595|NCT01597245|41626535|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383596|NCT01597245|41626536|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383597|NCT01597245|41626537|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383598|NCT01597245|41626538|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383599|NCT01597245|41626539|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383600|NCT01597245|41626540|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
19383601|NCT01597245|41626541|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19567153|NCT00996892|42015095|FG013|Dose-Escalation Stage 1A|Death|0|||
19567154|NCT00996892|42015096|FG014|Dose-Escalation Stage 1A|Death|0|||
19567155|NCT00996892|42015097|FG015|Dose-Escalation Stage 1A|Death|0|||
19567156|NCT00996892|42015098|FG016|Dose-Escalation Stage 1A|Death|0|||
19567157|NCT00996892|42015099|FG017|Dose-Escalation Stage 1A|Death|0|||
19567158|NCT00996892|42015100|FG018|Dose-Escalation Stage 1A|Death|0|||
19567159|NCT00996892|42015101|FG019|Dose-Escalation Stage 1A|Death|0|||
19567160|NCT00996892|42015082|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
19567161|NCT00996892|42015083|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
19567162|NCT00996892|42015084|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
19567163|NCT00996892|42015085|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
19567164|NCT00996892|42015086|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
19567165|NCT00996892|42015087|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
19567166|NCT00996892|42015088|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
19567167|NCT00996892|42015089|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
19567168|NCT00996892|42015090|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
19567169|NCT00996892|42015091|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
19567170|NCT00996892|42015092|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
19567171|NCT00996892|42015093|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
19567172|NCT00996892|42015094|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
19567173|NCT00996892|42015095|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
19567174|NCT00996892|42015096|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
19567175|NCT00996892|42015097|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
19567176|NCT00996892|42015098|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
19567177|NCT00996892|42015099|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
19567178|NCT00996892|42015100|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
19567179|NCT00996892|42015101|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
19567180|NCT00996892|42015082|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567181|NCT00996892|42015083|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567182|NCT00996892|42015084|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567183|NCT00996892|42015085|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567184|NCT00996892|42015086|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567185|NCT00996892|42015087|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567186|NCT00996892|42015088|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567187|NCT00996892|42015089|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567188|NCT00996892|42015090|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567189|NCT00996892|42015091|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
19567190|NCT00996892|42015092|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
19567191|NCT00996892|42015093|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
19745635|NCT00025259|42192986|FG002|Overall Study|Lost to Follow-up|13|||
19567192|NCT00996892|42015094|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
19383602|NCT01597245|41626542|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383603|NCT01597245|41626543|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383604|NCT01597245|41626544|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383605|NCT01597245|41626545|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383606|NCT01597245|41626546|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383607|NCT01597245|41626547|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
19383608|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383609|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383610|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383611|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383612|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383613|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383614|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383615|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383616|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383617|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383618|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383619|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383620|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383621|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383622|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383623|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
19383624|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
19383625|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
19383626|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
19383627|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
19383628|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
19383629|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383630|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383631|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383632|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383633|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383634|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383635|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383636|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383637|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383638|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383639|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383640|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383641|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383642|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383643|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383644|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383645|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
19383646|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
19383647|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
19383648|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
19383649|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
19383650|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383651|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383652|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383653|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383654|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383655|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383656|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383657|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383658|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383659|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383660|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383661|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383662|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383663|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383664|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383665|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383666|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
19383667|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383668|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
19383669|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
19383670|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
19383671|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383672|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383673|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383674|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383675|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383676|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383677|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383678|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383679|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383680|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383681|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383682|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383683|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383684|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383685|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383686|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383687|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383688|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
19383689|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
19383690|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
19383691|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
19383692|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383693|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383694|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383695|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383696|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383697|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383698|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383699|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383700|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383701|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383702|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383703|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383704|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383705|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383706|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383707|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383708|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
19383709|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383710|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
19383711|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
19383712|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
19383713|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383714|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383715|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383716|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383717|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383718|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383719|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383720|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383721|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383722|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383723|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383724|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383725|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383726|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383727|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383728|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383729|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
19383730|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383731|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
19383732|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
19383733|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
19383734|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383735|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383736|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383737|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383738|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383739|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383740|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383741|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383742|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383743|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383744|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383745|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383746|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383747|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383748|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383749|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383750|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
19383751|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383752|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383753|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
19383754|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
19383755|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383756|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383757|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383758|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383759|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383760|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383761|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383762|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383763|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383764|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383765|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383766|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383767|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383768|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383769|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383770|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383771|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
19383772|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383773|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383774|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
19383775|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
19383776|NCT01597245|41626527|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383777|NCT01597245|41626528|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383778|NCT01597245|41626529|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19567193|NCT00996892|42015095|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567194|NCT00996892|42015096|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567195|NCT00996892|42015097|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567196|NCT00996892|42015098|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567197|NCT00996892|42015099|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567198|NCT00996892|42015100|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567199|NCT00996892|42015101|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
19567200|NCT00996892|42015082|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
19567201|NCT00996892|42015083|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
19567202|NCT00996892|42015084|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
19567203|NCT00996892|42015085|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
19567204|NCT00996892|42015086|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
19567205|NCT00996892|42015087|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
19567206|NCT00996892|42015088|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
19567207|NCT00996892|42015089|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
19567208|NCT00996892|42015090|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
19567209|NCT00996892|42015091|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
19567210|NCT00996892|42015092|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
19567211|NCT00996892|42015093|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
19567212|NCT00996892|42015094|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
19567213|NCT00996892|42015095|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
19567214|NCT00996892|42015096|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
19567215|NCT00996892|42015097|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
19567216|NCT00996892|42015098|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
19567217|NCT00996892|42015099|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
19567218|NCT00996892|42015100|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
19567219|NCT00996892|42015101|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
19567220|NCT00996892|42015082|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
19567221|NCT00996892|42015083|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
19567222|NCT00996892|42015084|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
19567223|NCT00996892|42015085|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
19567224|NCT00996892|42015086|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
19567225|NCT00996892|42015087|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
19567226|NCT00996892|42015088|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
19567227|NCT00996892|42015089|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
19567228|NCT00996892|42015090|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
19745636|NCT00025259|42192987|FG003|Overall Study|Lost to Follow-up|13|||
19745637|NCT00025259|42192988|FG004|Overall Study|Lost to Follow-up|1|||
19745638|NCT00025259|42192989|FG005|Overall Study|Lost to Follow-up|3|||
19745639|NCT00025259|42192990|FG006|Overall Study|Lost to Follow-up|1|||
19383779|NCT01597245|41626530|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383780|NCT01597245|41626531|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383781|NCT01597245|41626532|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383782|NCT01597245|41626533|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383783|NCT01597245|41626534|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383784|NCT01597245|41626535|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383785|NCT01597245|41626536|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383786|NCT01597245|41626537|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383787|NCT01597245|41626538|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383788|NCT01597245|41626539|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383789|NCT01597245|41626540|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383790|NCT01597245|41626541|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383791|NCT01597245|41626542|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383792|NCT01597245|41626543|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383793|NCT01597245|41626544|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383794|NCT01597245|41626545|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383795|NCT01597245|41626546|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
19383796|NCT01597245|41626547|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
19383797|NCT00707057|41626582|FG000|Overall Study|Withdrawal by Subject|8|||
19383798|NCT00707057|41626583|FG001|Overall Study|Withdrawal by Subject|3|||
19383799|NCT00707057|41626582|FG000|Overall Study|Dosed incorrectly|0|||
19383800|NCT00707057|41626583|FG001|Overall Study|Dosed incorrectly|1|||
19383801|NCT02639247|41626591|FG000|Overall Study|Lost to Follow-up|2|||
19383802|NCT02639247|41626592|FG001|Overall Study|Lost to Follow-up|1|||
19383803|NCT02639247|41626591|FG000|Overall Study|Death|2|||
19476902|NCT01552057|41755064|FG000|Overall Study|Entry Criteria Not Met|2|||
19567229|NCT00996892|42015091|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
19567230|NCT00996892|42015092|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
19567231|NCT00996892|42015093|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
19567232|NCT00996892|42015094|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
19567233|NCT00996892|42015095|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
19567234|NCT00996892|42015096|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
19567235|NCT00996892|42015097|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
19567236|NCT00996892|42015098|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
19567237|NCT00996892|42015099|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
19567238|NCT00996892|42015100|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
19567239|NCT00996892|42015101|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
19567240|NCT00996892|42015082|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
19567241|NCT00996892|42015083|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
19567242|NCT00996892|42015084|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
19567243|NCT00996892|42015085|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
19567244|NCT00996892|42015086|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
19567245|NCT00996892|42015087|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
19567246|NCT00996892|42015088|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
19383804|NCT02639247|41626592|FG001|Overall Study|Death|0|||
19383805|NCT02639247|41626591|FG000|Overall Study|Withdrew Consent|0|||
19383806|NCT02639247|41626592|FG001|Overall Study|Withdrew Consent|1|||
19383807|NCT02639247|41626591|FG000|Overall Study|Protocol Violation|1|||
19383808|NCT02639247|41626592|FG001|Overall Study|Protocol Violation|0|||
19567247|NCT00996892|42015089|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
19567248|NCT00996892|42015090|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
19567249|NCT00996892|42015091|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
19567250|NCT00996892|42015092|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
19567251|NCT00996892|42015093|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
19567252|NCT00996892|42015094|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
19567253|NCT00996892|42015095|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
19567254|NCT00996892|42015096|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
19567255|NCT00996892|42015097|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
19567256|NCT00996892|42015098|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
19567257|NCT00996892|42015099|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
19567258|NCT00996892|42015100|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
19567259|NCT00996892|42015101|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
19567260|NCT00996892|42015082|FG000|Expansion Stage 2|Adverse Event|0|||
19567261|NCT00996892|42015083|FG001|Expansion Stage 2|Adverse Event|0|||
19567262|NCT00996892|42015084|FG002|Expansion Stage 2|Adverse Event|0|||
19567263|NCT00996892|42015085|FG003|Expansion Stage 2|Adverse Event|0|||
19567264|NCT00996892|42015086|FG004|Expansion Stage 2|Adverse Event|0|||
19567265|NCT00996892|42015087|FG005|Expansion Stage 2|Adverse Event|0|||
19567266|NCT00996892|42015088|FG006|Expansion Stage 2|Adverse Event|0|||
19567267|NCT00996892|42015089|FG007|Expansion Stage 2|Adverse Event|0|||
19567268|NCT00996892|42015090|FG008|Expansion Stage 2|Adverse Event|0|||
19567269|NCT00996892|42015091|FG009|Expansion Stage 2|Adverse Event|0|||
19567270|NCT00996892|42015092|FG010|Expansion Stage 2|Adverse Event|0|||
19567271|NCT00996892|42015093|FG011|Expansion Stage 2|Adverse Event|0|||
19567272|NCT00996892|42015094|FG012|Expansion Stage 2|Adverse Event|0|||
19567273|NCT00996892|42015095|FG013|Expansion Stage 2|Adverse Event|0|||
19567274|NCT00996892|42015096|FG014|Expansion Stage 2|Adverse Event|0|||
19567275|NCT00996892|42015097|FG015|Expansion Stage 2|Adverse Event|0|||
19567276|NCT00996892|42015098|FG016|Expansion Stage 2|Adverse Event|0|||
19567277|NCT00996892|42015099|FG017|Expansion Stage 2|Adverse Event|0|||
19567278|NCT00996892|42015100|FG018|Expansion Stage 2|Adverse Event|3|||
19567279|NCT00996892|42015101|FG019|Expansion Stage 2|Adverse Event|0|||
19567280|NCT00996892|42015082|FG000|Expansion Stage 2|Death|0|||
19567281|NCT00996892|42015083|FG001|Expansion Stage 2|Death|0|||
19567282|NCT00996892|42015084|FG002|Expansion Stage 2|Death|0|||
19567283|NCT00996892|42015085|FG003|Expansion Stage 2|Death|0|||
19567284|NCT00996892|42015086|FG004|Expansion Stage 2|Death|0|||
19567285|NCT00996892|42015087|FG005|Expansion Stage 2|Death|0|||
19567286|NCT00996892|42015088|FG006|Expansion Stage 2|Death|0|||
19567287|NCT00996892|42015089|FG007|Expansion Stage 2|Death|0|||
19567288|NCT00996892|42015090|FG008|Expansion Stage 2|Death|0|||
19567289|NCT00996892|42015091|FG009|Expansion Stage 2|Death|0|||
19567290|NCT00996892|42015092|FG010|Expansion Stage 2|Death|0|||
19567291|NCT00996892|42015093|FG011|Expansion Stage 2|Death|0|||
19567292|NCT00996892|42015094|FG012|Expansion Stage 2|Death|0|||
19567293|NCT00996892|42015095|FG013|Expansion Stage 2|Death|0|||
19567294|NCT00996892|42015096|FG014|Expansion Stage 2|Death|0|||
19567295|NCT00996892|42015097|FG015|Expansion Stage 2|Death|0|||
19567296|NCT00996892|42015098|FG016|Expansion Stage 2|Death|0|||
19567297|NCT00996892|42015099|FG017|Expansion Stage 2|Death|0|||
19567298|NCT00996892|42015100|FG018|Expansion Stage 2|Death|2|||
19567299|NCT00996892|42015101|FG019|Expansion Stage 2|Death|0|||
19567300|NCT00996892|42015082|FG000|Expansion Stage 2|Physician Decision|0|||
19567301|NCT00996892|42015083|FG001|Expansion Stage 2|Physician Decision|0|||
19567302|NCT00996892|42015084|FG002|Expansion Stage 2|Physician Decision|0|||
19567303|NCT00996892|42015085|FG003|Expansion Stage 2|Physician Decision|0|||
19567304|NCT00996892|42015086|FG004|Expansion Stage 2|Physician Decision|0|||
19567305|NCT00996892|42015087|FG005|Expansion Stage 2|Physician Decision|0|||
19567306|NCT00996892|42015088|FG006|Expansion Stage 2|Physician Decision|0|||
19567307|NCT00996892|42015089|FG007|Expansion Stage 2|Physician Decision|0|||
19567308|NCT00996892|42015090|FG008|Expansion Stage 2|Physician Decision|0|||
19567309|NCT00996892|42015091|FG009|Expansion Stage 2|Physician Decision|0|||
19567310|NCT00996892|42015092|FG010|Expansion Stage 2|Physician Decision|0|||
19567311|NCT00996892|42015093|FG011|Expansion Stage 2|Physician Decision|0|||
19567312|NCT00996892|42015094|FG012|Expansion Stage 2|Physician Decision|0|||
19567313|NCT00996892|42015095|FG013|Expansion Stage 2|Physician Decision|0|||
19567314|NCT00996892|42015096|FG014|Expansion Stage 2|Physician Decision|0|||
19567315|NCT00996892|42015097|FG015|Expansion Stage 2|Physician Decision|0|||
19567316|NCT00996892|42015098|FG016|Expansion Stage 2|Physician Decision|0|||
19383809|NCT00706901|41626601|FG000|Overall Study|Lost to Follow-up|2|||
19567317|NCT00996892|42015099|FG017|Expansion Stage 2|Physician Decision|0|||
19383810|NCT00706901|41626602|FG001|Overall Study|Lost to Follow-up|3|||
19567318|NCT00996892|42015100|FG018|Expansion Stage 2|Physician Decision|1|||
19567319|NCT00996892|42015101|FG019|Expansion Stage 2|Physician Decision|0|||
19567320|NCT00996892|42015082|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
19745640|NCT00025259|42192984|FG000|Overall Study|Physician Decision|12|||
19745641|NCT00025259|42192985|FG001|Overall Study|Physician Decision|1|||
19745642|NCT00025259|42192986|FG002|Overall Study|Physician Decision|0|||
19745643|NCT00025259|42192987|FG003|Overall Study|Physician Decision|5|||
19745644|NCT00025259|42192988|FG004|Overall Study|Physician Decision|4|||
19745645|NCT00025259|42192989|FG005|Overall Study|Physician Decision|2|||
19745646|NCT00025259|42192990|FG006|Overall Study|Physician Decision|1|||
19745647|NCT00025259|42192984|FG000|Overall Study|Protocol Violation|3|||
19745648|NCT00025259|42192985|FG001|Overall Study|Protocol Violation|2|||
19745649|NCT00025259|42192986|FG002|Overall Study|Protocol Violation|2|||
19745650|NCT00025259|42192987|FG003|Overall Study|Protocol Violation|1|||
19745651|NCT00025259|42192988|FG004|Overall Study|Protocol Violation|2|||
19745652|NCT00025259|42192989|FG005|Overall Study|Protocol Violation|1|||
19745653|NCT00025259|42192990|FG006|Overall Study|Protocol Violation|3|||
19745654|NCT00025259|42192984|FG000|Overall Study|Withdrawal by Subject|9|||
19567321|NCT00996892|42015083|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
19567322|NCT00996892|42015084|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
19567323|NCT00996892|42015085|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
19567324|NCT00996892|42015086|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
19567325|NCT00996892|42015087|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
19567326|NCT00996892|42015088|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
19567327|NCT00996892|42015089|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
19567328|NCT00996892|42015090|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
19567329|NCT00996892|42015091|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
19567330|NCT00996892|42015092|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
19567331|NCT00996892|42015093|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
19567332|NCT00996892|42015094|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
19567333|NCT00996892|42015095|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
19567334|NCT00996892|42015096|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
19567335|NCT00996892|42015097|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
19567336|NCT00996892|42015098|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
19567337|NCT00996892|42015099|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
19567338|NCT00996892|42015100|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
19567339|NCT00996892|42015101|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
19567340|NCT00996892|42015082|FG000|Expansion Stage 2|Disease Progression|0|||
19567341|NCT00996892|42015083|FG001|Expansion Stage 2|Disease Progression|0|||
19567342|NCT00996892|42015084|FG002|Expansion Stage 2|Disease Progression|0|||
19567343|NCT00996892|42015085|FG003|Expansion Stage 2|Disease Progression|0|||
19567344|NCT00996892|42015086|FG004|Expansion Stage 2|Disease Progression|0|||
19567345|NCT00996892|42015087|FG005|Expansion Stage 2|Disease Progression|0|||
19567346|NCT00996892|42015088|FG006|Expansion Stage 2|Disease Progression|0|||
19567347|NCT00996892|42015089|FG007|Expansion Stage 2|Disease Progression|0|||
19567348|NCT00996892|42015090|FG008|Expansion Stage 2|Disease Progression|0|||
19567349|NCT00996892|42015091|FG009|Expansion Stage 2|Disease Progression|0|||
19567350|NCT00996892|42015092|FG010|Expansion Stage 2|Disease Progression|0|||
19567351|NCT00996892|42015093|FG011|Expansion Stage 2|Disease Progression|0|||
19567352|NCT00996892|42015094|FG012|Expansion Stage 2|Disease Progression|0|||
19567353|NCT00996892|42015095|FG013|Expansion Stage 2|Disease Progression|0|||
19567354|NCT00996892|42015096|FG014|Expansion Stage 2|Disease Progression|0|||
19567355|NCT00996892|42015097|FG015|Expansion Stage 2|Disease Progression|0|||
19567356|NCT00996892|42015098|FG016|Expansion Stage 2|Disease Progression|0|||
19567357|NCT00996892|42015099|FG017|Expansion Stage 2|Disease Progression|0|||
19567358|NCT00996892|42015100|FG018|Expansion Stage 2|Disease Progression|28|||
19567359|NCT00996892|42015101|FG019|Expansion Stage 2|Disease Progression|0|||
19567360|NCT00996892|42015082|FG000|Expansion Stage 2A|Adverse Event|0|||
19567361|NCT00996892|42015083|FG001|Expansion Stage 2A|Adverse Event|0|||
19567362|NCT00996892|42015084|FG002|Expansion Stage 2A|Adverse Event|0|||
19567363|NCT00996892|42015085|FG003|Expansion Stage 2A|Adverse Event|0|||
19567364|NCT00996892|42015086|FG004|Expansion Stage 2A|Adverse Event|0|||
19567365|NCT00996892|42015087|FG005|Expansion Stage 2A|Adverse Event|0|||
19567366|NCT00996892|42015088|FG006|Expansion Stage 2A|Adverse Event|0|||
19567367|NCT00996892|42015089|FG007|Expansion Stage 2A|Adverse Event|0|||
19567368|NCT00996892|42015090|FG008|Expansion Stage 2A|Adverse Event|0|||
19567369|NCT00996892|42015091|FG009|Expansion Stage 2A|Adverse Event|0|||
19567370|NCT00996892|42015092|FG010|Expansion Stage 2A|Adverse Event|0|||
19567371|NCT00996892|42015093|FG011|Expansion Stage 2A|Adverse Event|0|||
19567372|NCT00996892|42015094|FG012|Expansion Stage 2A|Adverse Event|0|||
19567373|NCT00996892|42015095|FG013|Expansion Stage 2A|Adverse Event|0|||
19567374|NCT00996892|42015096|FG014|Expansion Stage 2A|Adverse Event|0|||
19567375|NCT00996892|42015097|FG015|Expansion Stage 2A|Adverse Event|0|||
19567376|NCT00996892|42015098|FG016|Expansion Stage 2A|Adverse Event|0|||
19567377|NCT00996892|42015099|FG017|Expansion Stage 2A|Adverse Event|0|||
19567378|NCT00996892|42015100|FG018|Expansion Stage 2A|Adverse Event|0|||
19567379|NCT00996892|42015101|FG019|Expansion Stage 2A|Adverse Event|8|||
19567380|NCT00996892|42015082|FG000|Expansion Stage 2A|Physician Decision|0|||
19567381|NCT00996892|42015083|FG001|Expansion Stage 2A|Physician Decision|0|||
19567382|NCT00996892|42015084|FG002|Expansion Stage 2A|Physician Decision|0|||
19567383|NCT00996892|42015085|FG003|Expansion Stage 2A|Physician Decision|0|||
19567384|NCT00996892|42015086|FG004|Expansion Stage 2A|Physician Decision|0|||
19383811|NCT00706901|41626603|FG002|Overall Study|Lost to Follow-up|2|||
19383812|NCT00706901|41626601|FG000|Overall Study|Withdrawal by Subject|4|||
19383813|NCT00706901|41626602|FG001|Overall Study|Withdrawal by Subject|2|||
19383814|NCT00706901|41626603|FG002|Overall Study|Withdrawal by Subject|5|||
19383815|NCT00706901|41626601|FG000|Overall Study|In Jail|1|||
19383816|NCT00706901|41626602|FG001|Overall Study|In Jail|0|||
19383817|NCT00706901|41626603|FG002|Overall Study|In Jail|1|||
19383818|NCT00706901|41626601|FG000|Overall Study|Death|1|||
19383819|NCT00706901|41626602|FG001|Overall Study|Death|0|||
19383820|NCT00706901|41626603|FG002|Overall Study|Death|0|||
19383821|NCT01673373|41626612|FG000|Overall Study|Death|2|||
19383822|NCT01236547|41626621|FG000|Overall Study|Protocol Violation|0|||
19567385|NCT00996892|42015087|FG005|Expansion Stage 2A|Physician Decision|0|||
19567386|NCT00996892|42015088|FG006|Expansion Stage 2A|Physician Decision|0|||
19567387|NCT00996892|42015089|FG007|Expansion Stage 2A|Physician Decision|0|||
19567388|NCT00996892|42015090|FG008|Expansion Stage 2A|Physician Decision|0|||
19567389|NCT00996892|42015091|FG009|Expansion Stage 2A|Physician Decision|0|||
19567390|NCT00996892|42015092|FG010|Expansion Stage 2A|Physician Decision|0|||
19567391|NCT00996892|42015093|FG011|Expansion Stage 2A|Physician Decision|0|||
19567392|NCT00996892|42015094|FG012|Expansion Stage 2A|Physician Decision|0|||
19567393|NCT00996892|42015095|FG013|Expansion Stage 2A|Physician Decision|0|||
19567394|NCT00996892|42015096|FG014|Expansion Stage 2A|Physician Decision|0|||
19567395|NCT00996892|42015097|FG015|Expansion Stage 2A|Physician Decision|0|||
19567396|NCT00996892|42015098|FG016|Expansion Stage 2A|Physician Decision|0|||
19567397|NCT00996892|42015099|FG017|Expansion Stage 2A|Physician Decision|0|||
19567398|NCT00996892|42015100|FG018|Expansion Stage 2A|Physician Decision|0|||
19567399|NCT00996892|42015101|FG019|Expansion Stage 2A|Physician Decision|2|||
19567400|NCT00996892|42015082|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
19567401|NCT00996892|42015083|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
19567402|NCT00996892|42015084|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
19567403|NCT00996892|42015085|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
19567404|NCT00996892|42015086|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
19567405|NCT00996892|42015087|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
19567406|NCT00996892|42015088|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
19567407|NCT00996892|42015089|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
19567408|NCT00996892|42015090|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
19567409|NCT00996892|42015091|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
19567410|NCT00996892|42015092|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
19567411|NCT00996892|42015093|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
19567412|NCT00996892|42015094|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
19567413|NCT00996892|42015095|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
19567414|NCT00996892|42015096|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
19567415|NCT00996892|42015097|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
19383823|NCT01236547|41626622|FG001|Overall Study|Protocol Violation|1|||
19383824|NCT01236547|41626623|FG002|Overall Study|Protocol Violation|1|||
19383825|NCT01236547|41626624|FG003|Overall Study|Protocol Violation|6|||
19567416|NCT00996892|42015098|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
19567417|NCT00996892|42015099|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
19567418|NCT00996892|42015100|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
19567419|NCT00996892|42015101|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
19383826|NCT01236547|41626625|FG004|Overall Study|Protocol Violation|12|||
19383827|NCT02167945|41626638|FG000|Overall Study|Adverse Event|16|||
19567420|NCT00996892|42015082|FG000|Expansion Stage 2A|Disease Progression|0|||
19567421|NCT00996892|42015083|FG001|Expansion Stage 2A|Disease Progression|0|||
19567422|NCT00996892|42015084|FG002|Expansion Stage 2A|Disease Progression|0|||
19383828|NCT02167945|41626638|FG000|Overall Study|Withdrew Consent|42|||
19567423|NCT00996892|42015085|FG003|Expansion Stage 2A|Disease Progression|0|||
19567424|NCT00996892|42015086|FG004|Expansion Stage 2A|Disease Progression|0|||
19567425|NCT00996892|42015087|FG005|Expansion Stage 2A|Disease Progression|0|||
19383829|NCT02167945|41626638|FG000|Overall Study|Lost to Follow-up|122|||
19383830|NCT02167945|41626638|FG000|Overall Study|COVID-19 logistical restrictions|6|||
19567426|NCT00996892|42015088|FG006|Expansion Stage 2A|Disease Progression|0|||
19567427|NCT00996892|42015089|FG007|Expansion Stage 2A|Disease Progression|0|||
19567428|NCT00996892|42015090|FG008|Expansion Stage 2A|Disease Progression|0|||
19567429|NCT00996892|42015091|FG009|Expansion Stage 2A|Disease Progression|0|||
19567430|NCT00996892|42015092|FG010|Expansion Stage 2A|Disease Progression|0|||
19567431|NCT00996892|42015093|FG011|Expansion Stage 2A|Disease Progression|0|||
19567432|NCT00996892|42015094|FG012|Expansion Stage 2A|Disease Progression|0|||
19383831|NCT02167945|41626638|FG000|Overall Study|Other, not specified|63|||
19567433|NCT00996892|42015095|FG013|Expansion Stage 2A|Disease Progression|0|||
19567434|NCT00996892|42015096|FG014|Expansion Stage 2A|Disease Progression|0|||
19567435|NCT00996892|42015097|FG015|Expansion Stage 2A|Disease Progression|0|||
19567436|NCT00996892|42015098|FG016|Expansion Stage 2A|Disease Progression|0|||
19383832|NCT01991977|41626650|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
19383833|NCT01991977|41626650|FG000|Overall Study|Withdrew after start of treatment|5|||
19383834|NCT01375075|41626660|FG000|Overall Study|Adverse Event|0|||
19383835|NCT01375075|41626661|FG001|Overall Study|Adverse Event|0|||
19567437|NCT00996892|42015099|FG017|Expansion Stage 2A|Disease Progression|0|||
19567438|NCT00996892|42015100|FG018|Expansion Stage 2A|Disease Progression|0|||
19383836|NCT01375075|41626662|FG002|Overall Study|Adverse Event|3|||
19383837|NCT01375075|41626663|FG003|Overall Study|Adverse Event|1|||
19383838|NCT01375075|41626664|FG004|Overall Study|Adverse Event|0|||
19383839|NCT01375075|41626665|FG005|Overall Study|Adverse Event|1|||
19383840|NCT01375075|41626660|FG000|Overall Study|Entry Criterion Not Met|1|||
19383841|NCT01375075|41626661|FG001|Overall Study|Entry Criterion Not Met|0|||
19567439|NCT00996892|42015101|FG019|Expansion Stage 2A|Disease Progression|31|||
19567440|NCT01257581|42015165|FG000|Overall Study|Early Termination|3|||
19383842|NCT01375075|41626662|FG002|Overall Study|Entry Criterion Not Met|0|||
19383843|NCT01375075|41626663|FG003|Overall Study|Entry Criterion Not Met|0|||
19383844|NCT01375075|41626664|FG004|Overall Study|Entry Criterion Not Met|0|||
19383845|NCT01375075|41626665|FG005|Overall Study|Entry Criterion Not Met|1|||
19383846|NCT01375075|41626660|FG000|Overall Study|Withdrawal by Subject|0|||
19383847|NCT01375075|41626661|FG001|Overall Study|Withdrawal by Subject|1|||
19567441|NCT01257581|42015166|FG001|Overall Study|Early Termination|1|||
19567442|NCT01257581|42015167|FG002|Overall Study|Early Termination|2|||
19567443|NCT01257581|42015165|FG000|Overall Study|Death|2|||
19567444|NCT01257581|42015166|FG001|Overall Study|Death|2|||
19567445|NCT01257581|42015167|FG002|Overall Study|Death|4|||
19567446|NCT01257503|42015177|FG000|Overall Study|Lost to Follow-up|7|||
19567447|NCT01257503|42015178|FG001|Overall Study|Lost to Follow-up|10|||
19567448|NCT01257503|42015177|FG000|Overall Study|Over 5 years old at enrollment|0|||
19567449|NCT01257503|42015178|FG001|Overall Study|Over 5 years old at enrollment|1|||
19567450|NCT01257503|42015177|FG000|Overall Study|strep culture positive at enrollment|1|||
19567451|NCT01257503|42015178|FG001|Overall Study|strep culture positive at enrollment|0|||
19567452|NCT00995566|42015184|FG000|Overall Study|Adverse Event|2|||
19567453|NCT00995566|42015184|FG000|Overall Study|Early study termination|52|||
19567454|NCT01257425|42015190|FG000|Overall Study|Lack of Efficacy|3|||
19567455|NCT01257425|42015191|FG001|Overall Study|Lack of Efficacy|3|||
19567456|NCT01257425|42015190|FG000|Overall Study|Adverse Event|1|||
19567457|NCT01257425|42015191|FG001|Overall Study|Adverse Event|1|||
19567458|NCT01257425|42015190|FG000|Overall Study|Protocol Violation|1|||
19383848|NCT01375075|41626662|FG002|Overall Study|Withdrawal by Subject|0|||
19383849|NCT01375075|41626663|FG003|Overall Study|Withdrawal by Subject|0|||
19383850|NCT01375075|41626664|FG004|Overall Study|Withdrawal by Subject|0|||
19383851|NCT01375075|41626665|FG005|Overall Study|Withdrawal by Subject|1|||
19383852|NCT00706433|41626687|FG000|Overall Study|Lost to Follow-up|3|||
19383853|NCT00706433|41626688|FG001|Overall Study|Lost to Follow-up|1|||
19383854|NCT00706433|41626689|FG002|Overall Study|Lost to Follow-up|6|||
19567459|NCT01257425|42015191|FG001|Overall Study|Protocol Violation|1|||
19567460|NCT01257425|42015190|FG000|Overall Study|Withdrawal by Subject|0|||
19567461|NCT01257425|42015191|FG001|Overall Study|Withdrawal by Subject|1|||
19567462|NCT01257425|42015190|FG000|Overall Study|Death|1|||
19567463|NCT01257425|42015191|FG001|Overall Study|Death|0|||
19567464|NCT00995488|42015197|FG000|Overall Study|Withdrawal by Subject|1|||
19567465|NCT01256879|42015201|FG000|Overall Study|Withdrawal by Subject|1|||
19567466|NCT01125189|42015214|FG000|Treatment Period|Lack of Efficacy|15|||
19567467|NCT01125189|42015215|FG001|Treatment Period|Lack of Efficacy|18|||
19567468|NCT01125189|42015216|FG002|Treatment Period|Lack of Efficacy|25|||
19567469|NCT01125189|42015214|FG000|Treatment Period|Adverse Event|7|||
19383855|NCT00706433|41626690|FG003|Overall Study|Lost to Follow-up|0|||
19383856|NCT00706433|41626687|FG000|Overall Study|Withdrawal by Subject|1|||
19383857|NCT00706433|41626688|FG001|Overall Study|Withdrawal by Subject|2|||
19567470|NCT01125189|42015215|FG001|Treatment Period|Adverse Event|8|||
19567471|NCT01125189|42015216|FG002|Treatment Period|Adverse Event|8|||
19567472|NCT01125189|42015214|FG000|Treatment Period|Withdrawal by Subject|3|||
19567473|NCT01125189|42015215|FG001|Treatment Period|Withdrawal by Subject|1|||
19567474|NCT01125189|42015216|FG002|Treatment Period|Withdrawal by Subject|1|||
19567475|NCT01125189|42015214|FG000|Treatment Period|Death|1|||
19567476|NCT01125189|42015215|FG001|Treatment Period|Death|0|||
19567477|NCT01125189|42015216|FG002|Treatment Period|Death|0|||
19567478|NCT01125189|42015214|FG000|Treatment Period|Lost to Follow-up|1|||
19567479|NCT01125189|42015215|FG001|Treatment Period|Lost to Follow-up|2|||
19567480|NCT01125189|42015216|FG002|Treatment Period|Lost to Follow-up|1|||
19567481|NCT01125189|42015214|FG000|Treatment Period|Poor compliance/noncompliance|0|||
19567482|NCT01125189|42015215|FG001|Treatment Period|Poor compliance/noncompliance|1|||
19567483|NCT01125189|42015216|FG002|Treatment Period|Poor compliance/noncompliance|0|||
19567484|NCT01125189|42015214|FG000|Treatment Period|Participants requested to discontinue|1|||
19567485|NCT01125189|42015215|FG001|Treatment Period|Participants requested to discontinue|3|||
19567486|NCT01125189|42015216|FG002|Treatment Period|Participants requested to discontinue|4|||
19567487|NCT01125189|42015214|FG000|Treatment Period|Other reasons|1|||
19567488|NCT01125189|42015215|FG001|Treatment Period|Other reasons|1|||
19567489|NCT01125189|42015216|FG002|Treatment Period|Other reasons|0|||
19567490|NCT01125189|42015214|FG000|Treatment Period|Completed 24 week treatment period only|2|||
19567491|NCT01125189|42015215|FG001|Treatment Period|Completed 24 week treatment period only|1|||
19567492|NCT01125189|42015216|FG002|Treatment Period|Completed 24 week treatment period only|2|||
19567493|NCT01125189|42015214|FG000|Follow up Period|Withdrawal by Subject|3|||
19567494|NCT01125189|42015215|FG001|Follow up Period|Withdrawal by Subject|2|||
19567495|NCT01125189|42015216|FG002|Follow up Period|Withdrawal by Subject|5|||
19567496|NCT01125189|42015214|FG000|Follow up Period|Death|1|||
19567497|NCT01125189|42015215|FG001|Follow up Period|Death|0|||
19567498|NCT01125189|42015216|FG002|Follow up Period|Death|0|||
19567499|NCT01125189|42015214|FG000|Follow up Period|Lost to Follow-up|12|||
19567500|NCT01125189|42015215|FG001|Follow up Period|Lost to Follow-up|9|||
19567501|NCT01125189|42015216|FG002|Follow up Period|Lost to Follow-up|6|||
19567502|NCT01125189|42015214|FG000|Follow up Period|Other reasons|4|||
19567503|NCT01125189|42015215|FG001|Follow up Period|Other reasons|4|||
19567504|NCT01125189|42015216|FG002|Follow up Period|Other reasons|5|||
19567505|NCT01256567|42015227|FG000|Overall Study|Withdrawal by Subject|1|||
19567506|NCT00996736|42015234|FG000|Overall Study|Death|1|||
19567507|NCT00996736|42015235|FG001|Overall Study|Death|1|||
19567508|NCT00996736|42015234|FG000|Overall Study|Lost to Follow-up|15|||
19567509|NCT00996736|42015235|FG001|Overall Study|Lost to Follow-up|14|||
19567510|NCT00996736|42015234|FG000|Overall Study|Visit not within 3-month window|5|||
19567511|NCT00996736|42015235|FG001|Overall Study|Visit not within 3-month window|3|||
19567512|NCT00996658|42015243|FG000|Overall Study|Adverse Event|2|||
19567513|NCT00996658|42015244|FG001|Overall Study|Adverse Event|5|||
19567514|NCT00996658|42015243|FG000|Overall Study|Protocol Violation|0|||
19567515|NCT00996658|42015244|FG001|Overall Study|Protocol Violation|1|||
19567516|NCT00996658|42015243|FG000|Overall Study|Lost to Follow-up|2|||
19567517|NCT00996658|42015244|FG001|Overall Study|Lost to Follow-up|5|||
19567518|NCT00996658|42015243|FG000|Overall Study|Non-compliance issues|3|||
19567519|NCT00996658|42015244|FG001|Overall Study|Non-compliance issues|3|||
19567520|NCT00996658|42015243|FG000|Overall Study|Other|9|||
19567521|NCT00996658|42015244|FG001|Overall Study|Other|7|||
19567522|NCT01124643|42015250|FG000|Overall Study|Death|1|||
19567523|NCT01256411|42015258|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
19567524|NCT01256411|42015259|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
19567525|NCT01256411|42015260|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
19383858|NCT00706433|41626689|FG002|Overall Study|Withdrawal by Subject|3|||
19383859|NCT00706433|41626690|FG003|Overall Study|Withdrawal by Subject|1|||
19383860|NCT00706433|41626687|FG000|Overall Study|Adverse Event|0|||
19383861|NCT00706433|41626688|FG001|Overall Study|Adverse Event|0|||
19383862|NCT00706433|41626689|FG002|Overall Study|Adverse Event|1|||
19383863|NCT00706433|41626690|FG003|Overall Study|Adverse Event|0|||
19567526|NCT01256411|42015261|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
19567527|NCT01256411|42015262|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
19567528|NCT01256411|42015263|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
19567529|NCT01256411|42015258|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
19567530|NCT01256411|42015259|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
19383864|NCT00706433|41626687|FG000|Overall Study|Protocol Violation|1|||
19383865|NCT00706433|41626688|FG001|Overall Study|Protocol Violation|0|||
19383866|NCT00706433|41626689|FG002|Overall Study|Protocol Violation|0|||
19567531|NCT01256411|42015260|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
19567532|NCT01256411|42015261|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
19567533|NCT01256411|42015262|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
19567534|NCT01256411|42015263|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
19567535|NCT01256411|42015258|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
19567536|NCT01256411|42015259|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
19567537|NCT01256411|42015260|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
19383867|NCT00706433|41626690|FG003|Overall Study|Protocol Violation|0|||
19383868|NCT00706433|41626687|FG000|Overall Study|new job|0|||
19567538|NCT01256411|42015261|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
19567539|NCT01256411|42015262|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
19383869|NCT00706433|41626688|FG001|Overall Study|new job|0|||
19383870|NCT00706433|41626689|FG002|Overall Study|new job|0|||
19567540|NCT01256411|42015263|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
19567541|NCT01256411|42015258|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
19567542|NCT01256411|42015259|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
19567543|NCT01256411|42015260|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
19567544|NCT01256411|42015261|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
19567545|NCT01256411|42015262|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
19567546|NCT01256411|42015263|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
19567547|NCT01256411|42015258|FG000|Extension by Maximum Treatment|Adverse Event|4|||
19567548|NCT01256411|42015259|FG001|Extension by Maximum Treatment|Adverse Event|2|||
19567549|NCT01256411|42015260|FG002|Extension by Maximum Treatment|Adverse Event|1|||
19567550|NCT01256411|42015261|FG003|Extension by Maximum Treatment|Adverse Event|0|||
19567551|NCT01256411|42015262|FG004|Extension by Maximum Treatment|Adverse Event|0|||
19383871|NCT00706433|41626690|FG003|Overall Study|new job|1|||
19383872|NCT02638623|41626702|FG000|Overall Study|Surgery timing|5|||
19383873|NCT02638623|41626703|FG001|Overall Study|Surgery timing|6|||
19567552|NCT01256411|42015263|FG005|Extension by Maximum Treatment|Adverse Event|0|||
19567553|NCT01256411|42015258|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
19567554|NCT01256411|42015259|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
19567555|NCT01256411|42015260|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
19567556|NCT01256411|42015261|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
19567557|NCT01256411|42015262|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
19567558|NCT01256411|42015263|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
19567559|NCT01256411|42015258|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
19567560|NCT01256411|42015259|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
19567561|NCT01256411|42015260|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
19567562|NCT01256411|42015261|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
19567563|NCT01256411|42015262|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
19567564|NCT01256411|42015263|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
19567565|NCT01256411|42015258|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
19567566|NCT01256411|42015259|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
19567567|NCT01256411|42015260|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
19567568|NCT01256411|42015261|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
19567569|NCT01256411|42015262|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
19567570|NCT01256411|42015263|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
19567571|NCT01256411|42015258|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
19567572|NCT01256411|42015259|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
19567573|NCT01256411|42015260|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
19567574|NCT01256411|42015261|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
19567575|NCT01256411|42015262|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
19567576|NCT01256411|42015263|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
19567577|NCT01256411|42015258|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
19567578|NCT01256411|42015259|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
19567579|NCT01256411|42015260|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
19567580|NCT01256411|42015261|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
19567581|NCT01256411|42015262|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
19567582|NCT01256411|42015263|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
19567583|NCT00996580|42015277|FG000|Overall Study|Adverse Event|466|||
19567584|NCT00996580|42015277|FG000|Overall Study|Lost to Follow-up|480|||
19567585|NCT00996580|42015277|FG000|Overall Study|Noncompliance with the protocol|137|||
19567586|NCT00996580|42015277|FG000|Overall Study|Physician Decision|5|||
19567587|NCT00996580|42015277|FG000|Overall Study|Pregnancy|68|||
19567588|NCT00996580|42015277|FG000|Overall Study|Protocol Violation|16|||
19567589|NCT00996580|42015277|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
19567590|NCT00996580|42015277|FG000|Overall Study|Withdrawal by Subject|217|||
19567591|NCT00996580|42015277|FG000|Overall Study|Other|29|||
19567592|NCT01124175|42015286|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
19567593|NCT01124175|42015287|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
19567594|NCT01256177|42015295|FG000|Overall Study|Withdrawal by Subject|23|||
19567595|NCT01256177|42015296|FG001|Overall Study|Withdrawal by Subject|22|||
19567596|NCT01256177|42015295|FG000|Overall Study|Lost to Follow-up|2|||
19567597|NCT01256177|42015296|FG001|Overall Study|Lost to Follow-up|2|||
19567598|NCT01256177|42015295|FG000|Overall Study|Adverse Event|8|||
19567599|NCT01256177|42015296|FG001|Overall Study|Adverse Event|9|||
19567600|NCT01256177|42015295|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
19567601|NCT01256177|42015296|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
19383874|NCT02638623|41626702|FG000|Overall Study|Not given intervention|2|||
19383875|NCT02638623|41626703|FG001|Overall Study|Not given intervention|0|||
19567602|NCT01256177|42015295|FG000|Overall Study|Condition under Investigation Worsened|1|||
19567603|NCT01256177|42015296|FG001|Overall Study|Condition under Investigation Worsened|0|||
19567604|NCT01256177|42015295|FG000|Overall Study|Lack of Efficacy|11|||
19567605|NCT01256177|42015296|FG001|Overall Study|Lack of Efficacy|2|||
19567606|NCT01256177|42015295|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
19567607|NCT01256177|42015296|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
19567608|NCT00999544|42015302|FG000|Overall Study|Withdrawal by Subject|1|||
19567609|NCT01124097|42015339|FG000|Overall Study|Withdrawal by Subject|4|||
19567610|NCT01124097|42015340|FG001|Overall Study|Withdrawal by Subject|3|||
19567611|NCT01124097|42015341|FG002|Overall Study|Withdrawal by Subject|2|||
19567612|NCT01124097|42015342|FG003|Overall Study|Withdrawal by Subject|3|||
19567613|NCT01124097|42015339|FG000|Overall Study|Lack of Efficacy|2|||
19567614|NCT01124097|42015340|FG001|Overall Study|Lack of Efficacy|3|||
19567615|NCT01124097|42015341|FG002|Overall Study|Lack of Efficacy|1|||
19567616|NCT01124097|42015342|FG003|Overall Study|Lack of Efficacy|3|||
19567617|NCT01124097|42015339|FG000|Overall Study|Adverse Event|24|||
19567618|NCT01124097|42015340|FG001|Overall Study|Adverse Event|15|||
19567619|NCT01124097|42015341|FG002|Overall Study|Adverse Event|15|||
19567620|NCT01124097|42015342|FG003|Overall Study|Adverse Event|7|||
19567621|NCT01124097|42015339|FG000|Overall Study|Protocol Violation|2|||
19567622|NCT01124097|42015340|FG001|Overall Study|Protocol Violation|0|||
19567623|NCT01124097|42015341|FG002|Overall Study|Protocol Violation|2|||
19567624|NCT01124097|42015342|FG003|Overall Study|Protocol Violation|1|||
19567625|NCT01124097|42015339|FG000|Overall Study|Physician Decision|2|||
19567626|NCT01124097|42015340|FG001|Overall Study|Physician Decision|1|||
19567627|NCT01124097|42015341|FG002|Overall Study|Physician Decision|0|||
19567628|NCT01124097|42015342|FG003|Overall Study|Physician Decision|0|||
19567629|NCT01123941|42015354|FG000|Overall Study|Lost to Follow-up|2|||
19567630|NCT01123941|42015355|FG001|Overall Study|Lost to Follow-up|1|||
19567631|NCT01123395|42015361|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
19567632|NCT01123395|42015362|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
19567633|NCT01255787|42015372|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
19567634|NCT01255787|42015373|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
19567635|NCT01255787|42015374|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
19567636|NCT01255787|42015375|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
19567637|NCT01255787|42015372|FG000|Overall Study|Major Protocol Deviation|1|||
19567638|NCT01255787|42015373|FG001|Overall Study|Major Protocol Deviation|1|||
19567639|NCT01255787|42015374|FG002|Overall Study|Major Protocol Deviation|0|||
19567640|NCT01255787|42015375|FG003|Overall Study|Major Protocol Deviation|4|||
19567641|NCT01255787|42015372|FG000|Overall Study|Lost to Follow-up|1|||
19567642|NCT01255787|42015373|FG001|Overall Study|Lost to Follow-up|2|||
19567643|NCT01255787|42015374|FG002|Overall Study|Lost to Follow-up|4|||
19567644|NCT01255787|42015375|FG003|Overall Study|Lost to Follow-up|2|||
19567645|NCT01255787|42015372|FG000|Overall Study|Withdrawal of Consent|3|||
19567646|NCT01255787|42015373|FG001|Overall Study|Withdrawal of Consent|9|||
19567647|NCT01255787|42015374|FG002|Overall Study|Withdrawal of Consent|3|||
19567648|NCT01255787|42015375|FG003|Overall Study|Withdrawal of Consent|4|||
19567649|NCT01255787|42015372|FG000|Overall Study|Pregnancy|0|||
19567650|NCT01255787|42015373|FG001|Overall Study|Pregnancy|0|||
19567651|NCT01255787|42015374|FG002|Overall Study|Pregnancy|0|||
19567652|NCT01255787|42015375|FG003|Overall Study|Pregnancy|1|||
19567653|NCT01255787|42015372|FG000|Overall Study|Lack of Efficacy|2|||
19567654|NCT01255787|42015373|FG001|Overall Study|Lack of Efficacy|2|||
19567655|NCT01255787|42015374|FG002|Overall Study|Lack of Efficacy|2|||
19567656|NCT01255787|42015375|FG003|Overall Study|Lack of Efficacy|2|||
19567657|NCT01255787|42015372|FG000|Overall Study|Noncompliance with Study Drug|3|||
19567658|NCT01255787|42015373|FG001|Overall Study|Noncompliance with Study Drug|1|||
19567659|NCT01255787|42015374|FG002|Overall Study|Noncompliance with Study Drug|0|||
19567660|NCT01255787|42015375|FG003|Overall Study|Noncompliance with Study Drug|0|||
19567661|NCT01123161|42015387|FG000|Overall Study|Lost to Follow-up|1|||
19567662|NCT01123161|42015388|FG001|Overall Study|Lost to Follow-up|0|||
19567663|NCT01123161|42015387|FG000|Overall Study|Withdrawal by Subject|1|||
19567664|NCT01123161|42015388|FG001|Overall Study|Withdrawal by Subject|0|||
19567665|NCT01255631|42015399|FG000|Overall Study|poor enrollment, no data analyzed|9|||
19567666|NCT01255631|42015400|FG001|Overall Study|poor enrollment, no data analyzed|6|||
19567667|NCT00999466|42015409|FG000|Main Part|Withdrawal by Subject|0|||
19567668|NCT00999466|42015410|FG001|Main Part|Withdrawal by Subject|0|||
19567669|NCT00999466|42015411|FG002|Main Part|Withdrawal by Subject|2|||
19567670|NCT00999466|42015409|FG000|Main Part|Adverse Event|0|||
19567671|NCT00999466|42015410|FG001|Main Part|Adverse Event|4|||
19567672|NCT00999466|42015411|FG002|Main Part|Adverse Event|2|||
19567673|NCT01255163|42015421|FG000|Overall Study|Withdrawal by Subject|1|||
19567674|NCT01255163|42015422|FG001|Overall Study|Withdrawal by Subject|0|||
19567675|NCT01255163|42015421|FG000|Overall Study|Lost to Follow-up|2|||
19567676|NCT01255163|42015422|FG001|Overall Study|Lost to Follow-up|0|||
19567677|NCT01255163|42015421|FG000|Overall Study|Adverse Event|0|||
19567678|NCT01255163|42015422|FG001|Overall Study|Adverse Event|2|||
19567679|NCT01255163|42015421|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
19567680|NCT01255163|42015422|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
19567681|NCT01123083|42015432|FG000|Overall Study|Investigator recommendation|1|||
19567682|NCT01123083|42015433|FG001|Overall Study|Investigator recommendation|1|||
19567683|NCT01123083|42015432|FG000|Overall Study|Administrative reasons|0|||
19383876|NCT02637141|41626712|FG000|Overall Study|Adverse Event|1|||
19383877|NCT02637141|41626713|FG001|Overall Study|Adverse Event|1|||
19383878|NCT02637141|41626714|FG002|Overall Study|Adverse Event|0|||
19383879|NCT02637141|41626712|FG000|Overall Study|Withdrawal by Subject|1|||
19383880|NCT02637141|41626713|FG001|Overall Study|Withdrawal by Subject|1|||
19383881|NCT02637141|41626714|FG002|Overall Study|Withdrawal by Subject|1|||
19383882|NCT02637063|41626725|FG000|Overall Study|Lost to Follow-up|3|||
19383883|NCT02637063|41626726|FG001|Overall Study|Lost to Follow-up|2|||
19383884|NCT02637063|41626727|FG002|Overall Study|Lost to Follow-up|3|||
19383885|NCT02637063|41626725|FG000|Overall Study|Withdrawal by Subject|2|||
19383886|NCT02637063|41626726|FG001|Overall Study|Withdrawal by Subject|2|||
19383887|NCT02637063|41626727|FG002|Overall Study|Withdrawal by Subject|3|||
19567684|NCT01123083|42015433|FG001|Overall Study|Administrative reasons|4|||
19567685|NCT01123083|42015432|FG000|Overall Study|Lost to Follow-up|2|||
19567686|NCT01123083|42015433|FG001|Overall Study|Lost to Follow-up|6|||
19567687|NCT01123083|42015432|FG000|Overall Study|Adverse Event|1|||
19567688|NCT01123083|42015433|FG001|Overall Study|Adverse Event|0|||
19567689|NCT01123083|42015432|FG000|Overall Study|Withdrew for another reason not covered|0|||
19567690|NCT01123083|42015433|FG001|Overall Study|Withdrew for another reason not covered|1|||
19567691|NCT01123083|42015432|FG000|Overall Study|Participant/legal representative request|7|||
19567692|NCT01123083|42015433|FG001|Overall Study|Participant/legal representative request|3|||
19567693|NCT01254305|42015442|FG000|Overall Study|Adverse Event|6|||
19567694|NCT01254305|42015443|FG001|Overall Study|Adverse Event|3|||
19567695|NCT01254305|42015444|FG002|Overall Study|Adverse Event|2|||
19383888|NCT02635737|41626735|FG000|Overall Study|Protocol Violation|1|||
19383889|NCT02636907|41626739|FG000|Autoinjector Assessment Period|Adverse Event|2|||
19383890|NCT02636907|41626739|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
19567696|NCT01254305|42015442|FG000|Overall Study|Lack of Efficacy|1|||
19567697|NCT01254305|42015443|FG001|Overall Study|Lack of Efficacy|0|||
19567698|NCT01254305|42015444|FG002|Overall Study|Lack of Efficacy|1|||
19383891|NCT02636907|41626739|FG000|Extension Phase|Adverse Event|2|||
19383892|NCT02636907|41626739|FG000|Extension Phase|Withdrawal by Subject|4|||
19383893|NCT02636907|41626739|FG000|Extension Phase|Physician Decision|1|||
19567699|NCT01254305|42015442|FG000|Overall Study|Protocol Violation|1|||
19567700|NCT01254305|42015443|FG001|Overall Study|Protocol Violation|7|||
19567701|NCT01254305|42015444|FG002|Overall Study|Protocol Violation|3|||
19567702|NCT01254305|42015442|FG000|Overall Study|Withdrawal by Subject|4|||
19567703|NCT01254305|42015443|FG001|Overall Study|Withdrawal by Subject|2|||
19567704|NCT01254305|42015444|FG002|Overall Study|Withdrawal by Subject|4|||
19567705|NCT01254305|42015442|FG000|Overall Study|Lost to Follow-up|10|||
19567706|NCT01254305|42015443|FG001|Overall Study|Lost to Follow-up|6|||
19567707|NCT01254305|42015444|FG002|Overall Study|Lost to Follow-up|5|||
19567708|NCT01254305|42015442|FG000|Overall Study|Other Reasons|0|||
19567709|NCT01254305|42015443|FG001|Overall Study|Other Reasons|0|||
19567710|NCT01254305|42015444|FG002|Overall Study|Other Reasons|2|||
19383894|NCT02636907|41626739|FG000|Extension Phase|Lost to Follow-up|2|||
19567711|NCT01122927|42015455|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
19567712|NCT01122927|42015456|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
19567713|NCT01122927|42015455|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
19567714|NCT01122927|42015456|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
19567715|NCT01122927|42015455|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
19567716|NCT01122927|42015456|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
19567717|NCT01122927|42015455|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
19567718|NCT01122927|42015456|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
19567719|NCT01122927|42015455|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
19567720|NCT01122927|42015456|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
19567721|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
19567722|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
19567723|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
19567724|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
19567725|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
19567726|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
19567727|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
19567728|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
19567729|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
19567730|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
19567731|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
19383895|NCT02636907|41626739|FG000|Extension Phase|Lack of Efficacy|1|||
19383896|NCT01374919|41626743|FG000|Overall Study|Withdrawal by Subject|2|||
19383897|NCT02726945|41626754|FG000|Overall Study|Withdrawal by Subject|0|||
19383898|NCT02726945|41626755|FG001|Overall Study|Withdrawal by Subject|0|||
19383899|NCT02726945|41626756|FG002|Overall Study|Withdrawal by Subject|1|||
19383900|NCT02726945|41626754|FG000|Overall Study|Elected to have total knee replacement|0|||
19383901|NCT02726945|41626755|FG001|Overall Study|Elected to have total knee replacement|1|||
19383902|NCT02726945|41626756|FG002|Overall Study|Elected to have total knee replacement|0|||
19383903|NCT02635347|41626766|FG000|Overall Study|Failed screening|20|||
19383904|NCT02635347|41626767|FG001|Overall Study|Failed screening|7|||
19383905|NCT02726399|41626787|FG000|Overall Study|Participant Non-Compliance|1|||
19383906|NCT02726399|41626787|FG000|Overall Study|Adverse Event|2|||
19383907|NCT02726399|41626787|FG000|Overall Study|Progression of disease|4|||
19383908|NCT02634801|41626794|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
19383909|NCT02634801|41626795|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
19383910|NCT02634801|41626796|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
19383911|NCT02634801|41626794|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
19383912|NCT02634801|41626795|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
19383913|NCT02634801|41626796|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
19383914|NCT02634801|41626794|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
19383915|NCT02634801|41626795|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
19567732|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
19567733|NCT01122927|42015455|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
19567734|NCT01122927|42015456|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
19567735|NCT01254227|42015466|FG000|Overall Study|Withdrawal by Subject|6|||
19567736|NCT01254227|42015466|FG000|Overall Study|Lost to Follow-up|6|||
19567737|NCT01254227|42015466|FG000|Overall Study|Adverse Event|5|||
19567738|NCT01254227|42015466|FG000|Overall Study|Abnormal test procedure result|5|||
19567739|NCT01254227|42015466|FG000|Overall Study|Administrative problems|2|||
19567740|NCT01254227|42015466|FG000|Overall Study|Death|1|||
19567741|NCT01254227|42015466|FG000|Overall Study|Protocol deviation|1|||
19567742|NCT00995410|42015470|FG000|Overall Study|Adverse Event|51|||
19567743|NCT00995410|42015470|FG000|Overall Study|Withdrawal by Subject|7|||
19567744|NCT00995410|42015470|FG000|Overall Study|Lost to Follow-up|2|||
19567745|NCT00995410|42015470|FG000|Overall Study|Misc|28|||
19567746|NCT00995020|42015476|FG000|Overall Study|margin analysis not performed|2|||
19567747|NCT00995020|42015477|FG001|Overall Study|margin analysis not performed|5|||
19567748|NCT00995020|42015476|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
19567749|NCT00995020|42015477|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
19567750|NCT01122381|42015487|FG000|Overall Study|study terminated early|0|||
19567751|NCT01122381|42015488|FG001|Overall Study|study terminated early|1|||
19567752|NCT00996034|42015494|FG000|Overall Study|Lost to Follow-up|2|||
19567753|NCT00996034|42015494|FG000|Overall Study|withdrawn by PI|1|||
19567754|NCT01253447|42015498|FG000|Overall Study|Adverse Event|2|||
19567755|NCT01121991|42015503|FG000|Overall Study|Lack of Ovarian Response|2|||
19567756|NCT01121991|42015503|FG000|Overall Study|No Oocytes Retrieved|3|||
19567757|NCT01121991|42015503|FG000|Overall Study|No Fertilization|1|||
19567758|NCT00994240|42015509|FG000|Overall Study|Lost to Follow-up|3|||
19567759|NCT00994240|42015510|FG001|Overall Study|Lost to Follow-up|2|||
19567760|NCT00994240|42015509|FG000|Overall Study|Withdrawal by Subject|1|||
19383916|NCT02634801|41626796|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
19567761|NCT00994240|42015510|FG001|Overall Study|Withdrawal by Subject|0|||
19567762|NCT00994240|42015509|FG000|Overall Study|study termination|2|||
19567763|NCT00994240|42015510|FG001|Overall Study|study termination|3|||
19567764|NCT01253369|42015516|FG000|Overall Study|Adverse Event|4|||
19567765|NCT01253369|42015516|FG000|Overall Study|Withdrawal by Subject|2|||
19567766|NCT01253369|42015516|FG000|Overall Study|Death|1|||
19567767|NCT01253369|42015516|FG000|Overall Study|Progressive disease|23|||
19567768|NCT01253369|42015516|FG000|Overall Study|Not Evaluable|3|||
19567769|NCT01121913|42015520|FG000|First Intervention Period|Adverse Event|0|||
19567770|NCT01121913|42015521|FG001|First Intervention Period|Adverse Event|0|||
19567771|NCT01121913|42015522|FG002|First Intervention Period|Adverse Event|1|||
19567772|NCT01121913|42015523|FG003|First Intervention Period|Adverse Event|0|||
19567773|NCT01121913|42015520|FG000|First Washout Period|Withdrawal by Subject|1|||
19383917|NCT02634801|41626794|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
19567774|NCT01121913|42015521|FG001|First Washout Period|Withdrawal by Subject|0|||
19567775|NCT01121913|42015522|FG002|First Washout Period|Withdrawal by Subject|0|||
19567776|NCT01121913|42015523|FG003|First Washout Period|Withdrawal by Subject|0|||
19567777|NCT01121913|42015520|FG000|Second Intervention Period|Adverse Event|0|||
19567778|NCT01121913|42015521|FG001|Second Intervention Period|Adverse Event|0|||
19567779|NCT01121913|42015522|FG002|Second Intervention Period|Adverse Event|1|||
19567780|NCT01121913|42015523|FG003|Second Intervention Period|Adverse Event|0|||
19567781|NCT01121913|42015520|FG000|Second Washout Period|Withdrawal by Subject|0|||
19567782|NCT01121913|42015521|FG001|Second Washout Period|Withdrawal by Subject|0|||
19567783|NCT01121913|42015522|FG002|Second Washout Period|Withdrawal by Subject|1|||
19567784|NCT01121913|42015523|FG003|Second Washout Period|Withdrawal by Subject|0|||
19567785|NCT01121913|42015520|FG000|Third Washout Period|Adverse Event|1|||
19567786|NCT01121913|42015521|FG001|Third Washout Period|Adverse Event|0|||
19567787|NCT01121913|42015522|FG002|Third Washout Period|Adverse Event|0|||
19567788|NCT01121913|42015523|FG003|Third Washout Period|Adverse Event|0|||
19567789|NCT00994162|42015535|FG000|Overall Study|Withdrawal by Subject|1|||
19383918|NCT02634801|41626795|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
19383919|NCT02634801|41626796|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
19383920|NCT02634801|41626794|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
19383921|NCT02634801|41626795|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
19383922|NCT02634801|41626796|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
19383923|NCT02634801|41626794|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
19383924|NCT02634801|41626795|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
19383925|NCT02634801|41626796|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
19383926|NCT02634801|41626794|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
19383927|NCT02634801|41626795|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
19383928|NCT02634801|41626796|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
19383929|NCT02634801|41626794|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
19383930|NCT02634801|41626795|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
19383931|NCT02634801|41626796|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
19383932|NCT02634801|41626794|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
19383933|NCT02634801|41626795|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
19383934|NCT02634801|41626796|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
19383935|NCT02634801|41626794|FG000|Follow-up Period|Lost to Follow-up|3|||
19383936|NCT02634801|41626795|FG001|Follow-up Period|Lost to Follow-up|1|||
19383937|NCT02634801|41626796|FG002|Follow-up Period|Lost to Follow-up|2|||
19383938|NCT02634801|41626794|FG000|Follow-up Period|Physician Decision|0|||
19383939|NCT02634801|41626795|FG001|Follow-up Period|Physician Decision|0|||
19383940|NCT02634801|41626796|FG002|Follow-up Period|Physician Decision|1|||
19567790|NCT00994162|42015535|FG000|Overall Study|Lost to Follow-up|2|||
19567791|NCT00994162|42015535|FG000|Overall Study|Product Complaint|1|||
19567792|NCT00994162|42015535|FG000|Overall Study|Poor Compliance|5|||
19567793|NCT00994162|42015535|FG000|Overall Study|Lack of Response|3|||
19567794|NCT00994162|42015535|FG000|Overall Study|Discharged from Hospital|4|||
19567795|NCT00994162|42015535|FG000|Overall Study|Death|2|||
19567796|NCT00994162|42015535|FG000|Overall Study|Care Transferred to Another Physician|2|||
19567797|NCT00994162|42015535|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
19383941|NCT02634801|41626794|FG000|Follow-up Period|Withdrawal by Subject|1|||
19383942|NCT02634801|41626795|FG001|Follow-up Period|Withdrawal by Subject|2|||
19383943|NCT02634801|41626796|FG002|Follow-up Period|Withdrawal by Subject|5|||
19383944|NCT02634801|41626794|FG000|Follow-up Period|Adverse Event|1|||
19383945|NCT02634801|41626795|FG001|Follow-up Period|Adverse Event|5|||
19567798|NCT00994162|42015535|FG000|Overall Study|Physician Decision|2|||
19567799|NCT00994162|42015535|FG000|Overall Study|Surrounding Wound Erythematous|1|||
19567800|NCT00994162|42015535|FG000|Overall Study|Machine Losing Vaccum|1|||
19567801|NCT00994162|42015535|FG000|Overall Study|Patient Lived Too Far Away|1|||
19567802|NCT00994162|42015535|FG000|Overall Study|Above Knee Amputation|1|||
19567803|NCT00994162|42015535|FG000|Overall Study|Reason Not Reported By Site|1|||
19567804|NCT00993928|42015542|FG000|Overall Study|Withdrawal by Subject|4|||
19567805|NCT00993928|42015543|FG001|Overall Study|Withdrawal by Subject|7|||
19567806|NCT00993928|42015542|FG000|Overall Study|ineligible|1|||
19567807|NCT00993928|42015543|FG001|Overall Study|ineligible|0|||
19567808|NCT01253291|42015558|FG000|Overall Study|Withdrawal by Subject|1|||
19567809|NCT01253291|42015559|FG001|Overall Study|Withdrawal by Subject|1|||
19567810|NCT01253291|42015560|FG002|Overall Study|Withdrawal by Subject|0|||
19567811|NCT01253291|42015561|FG003|Overall Study|Withdrawal by Subject|0|||
19567812|NCT01253291|42015562|FG004|Overall Study|Withdrawal by Subject|0|||
19567813|NCT01253291|42015558|FG000|Overall Study|Adverse Event|0|||
19567814|NCT01253291|42015559|FG001|Overall Study|Adverse Event|1|||
19567815|NCT01253291|42015560|FG002|Overall Study|Adverse Event|0|||
19567816|NCT01253291|42015561|FG003|Overall Study|Adverse Event|0|||
19567817|NCT01253291|42015562|FG004|Overall Study|Adverse Event|0|||
19567818|NCT01253291|42015558|FG000|Overall Study|Lack of Efficacy|1|||
19567819|NCT01253291|42015559|FG001|Overall Study|Lack of Efficacy|0|||
19567820|NCT01253291|42015560|FG002|Overall Study|Lack of Efficacy|0|||
19567821|NCT01253291|42015561|FG003|Overall Study|Lack of Efficacy|0|||
19567822|NCT01253291|42015562|FG004|Overall Study|Lack of Efficacy|0|||
19567823|NCT01253291|42015558|FG000|Overall Study|Physician Decision|2|||
19567824|NCT01253291|42015559|FG001|Overall Study|Physician Decision|0|||
19567825|NCT01253291|42015560|FG002|Overall Study|Physician Decision|0|||
19567826|NCT01253291|42015561|FG003|Overall Study|Physician Decision|0|||
19567827|NCT01253291|42015562|FG004|Overall Study|Physician Decision|2|||
19567828|NCT01121757|42015577|FG000|First Drug|Death|1|||
19567829|NCT01121757|42015578|FG001|First Drug|Death|0|||
19567830|NCT01121757|42015577|FG000|First Drug|Disease Progression|0|||
19567831|NCT01121757|42015578|FG001|First Drug|Disease Progression|2|||
19567832|NCT01121757|42015577|FG000|Combination|Physician Decision|0|||
19567833|NCT01121757|42015578|FG001|Combination|Physician Decision|1|||
19567834|NCT01121757|42015577|FG000|Combination|Disease Progression|2|||
19567835|NCT01121757|42015578|FG001|Combination|Disease Progression|0|||
19567836|NCT01253135|42015586|FG000|Original Protocol|Protocol Amendment|15|||
19567837|NCT01253135|42015586|FG000|Amended Protocol|Non-compliance|1|||
19567838|NCT00993616|42015594|FG000|Overall Study|No tumor at entry|1|||
19567839|NCT00993616|42015594|FG000|Overall Study|Never treated|1|||
19567840|NCT01120899|42015604|FG000|Overall Study|Withdrawal by Subject|3|||
19567841|NCT01120275|42015608|FG000|Overall Study|Adverse Event|3|||
19567842|NCT01120275|42015608|FG000|Overall Study|Progression|27|||
19567843|NCT01120275|42015608|FG000|Overall Study|Ineligible|3|||
19567844|NCT01120275|42015608|FG000|Overall Study|Withdrawal by Subject|1|||
19567845|NCT01120275|42015608|FG000|Overall Study|Refusal|1|||
19567846|NCT01120275|42015608|FG000|Overall Study|Not specific|1|||
19567847|NCT00991510|42015615|FG000|Period I (Days 1-14)|Adverse Event|1|||
19567848|NCT00991510|42015616|FG001|Period I (Days 1-14)|Adverse Event|0|||
19567849|NCT00991510|42015615|FG000|Period III (Days 29-112)|Adverse Event|1|||
19567850|NCT00991510|42015616|FG001|Period III (Days 29-112)|Adverse Event|1|||
19567851|NCT01119963|42015628|FG000|Overall Study|Lost to Follow-up|1|||
19567852|NCT01119963|42015629|FG001|Overall Study|Lost to Follow-up|1|||
19567853|NCT01252667|42015643|FG000|Overall Study|Transplant aborted post-conditioning|0|||
19567854|NCT01252667|42015644|FG001|Overall Study|Transplant aborted post-conditioning|0|||
19567855|NCT01252667|42015645|FG002|Overall Study|Transplant aborted post-conditioning|0|||
19567856|NCT01252667|42015646|FG003|Overall Study|Transplant aborted post-conditioning|0|||
19567857|NCT01252667|42015647|FG004|Overall Study|Transplant aborted post-conditioning|0|||
19383946|NCT02634801|41626796|FG002|Follow-up Period|Adverse Event|0|||
19567858|NCT01252667|42015648|FG005|Overall Study|Transplant aborted post-conditioning|1|||
19567859|NCT01119105|42015665|FG000|Overall Study|Withdrawal by Subject|1|||
19567860|NCT01119105|42015666|FG001|Overall Study|Withdrawal by Subject|1|||
19567861|NCT01119105|42015667|FG002|Overall Study|Withdrawal by Subject|1|||
19567862|NCT01119105|42015665|FG000|Overall Study|Lost to Follow-up|0|||
19567863|NCT01119105|42015666|FG001|Overall Study|Lost to Follow-up|2|||
19567864|NCT01119105|42015667|FG002|Overall Study|Lost to Follow-up|5|||
19567865|NCT01119105|42015665|FG000|Overall Study|Adverse Event|1|||
19567866|NCT01119105|42015666|FG001|Overall Study|Adverse Event|0|||
19567867|NCT01119105|42015667|FG002|Overall Study|Adverse Event|1|||
19567868|NCT01119105|42015665|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
19567869|NCT01119105|42015666|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
19567870|NCT01119105|42015667|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
19567871|NCT01119105|42015665|FG000|Overall Study|Other|1|||
19567872|NCT01119105|42015666|FG001|Overall Study|Other|1|||
19567873|NCT01119105|42015667|FG002|Overall Study|Other|0|||
19567874|NCT01118949|42015675|FG000|Overall Study|Adverse Event|5|||
19567875|NCT01118949|42015675|FG000|Overall Study|Withdrawal by Subject|4|||
19567876|NCT01252355|42015682|FG000|Overall Study|Adverse Event|9|||
19567877|NCT01252355|42015683|FG001|Overall Study|Adverse Event|17|||
19567878|NCT01252355|42015684|FG002|Overall Study|Adverse Event|22|||
19567879|NCT01252355|42015682|FG000|Overall Study|Lack of Efficacy|6|||
19567880|NCT01252355|42015683|FG001|Overall Study|Lack of Efficacy|4|||
19567881|NCT01252355|42015684|FG002|Overall Study|Lack of Efficacy|2|||
19567882|NCT01252355|42015682|FG000|Overall Study|Lost to Follow-up|0|||
19567883|NCT01252355|42015683|FG001|Overall Study|Lost to Follow-up|0|||
19567884|NCT01252355|42015684|FG002|Overall Study|Lost to Follow-up|1|||
19567885|NCT01252355|42015682|FG000|Overall Study|Poor Compliance to Protocol|1|||
19567886|NCT01252355|42015683|FG001|Overall Study|Poor Compliance to Protocol|1|||
19567887|NCT01252355|42015684|FG002|Overall Study|Poor Compliance to Protocol|1|||
19567888|NCT01252355|42015682|FG000|Overall Study|Progressive Disease|2|||
19567889|NCT01252355|42015683|FG001|Overall Study|Progressive Disease|0|||
19567890|NCT01252355|42015684|FG002|Overall Study|Progressive Disease|0|||
19567891|NCT01252355|42015682|FG000|Overall Study|Sponsor Early Termination of Study|149|||
19567892|NCT01252355|42015683|FG001|Overall Study|Sponsor Early Termination of Study|149|||
19567893|NCT01252355|42015684|FG002|Overall Study|Sponsor Early Termination of Study|146|||
19567894|NCT01252355|42015682|FG000|Overall Study|Randomized but not Treated|2|||
19567895|NCT01252355|42015683|FG001|Overall Study|Randomized but not Treated|0|||
19567896|NCT01252355|42015684|FG002|Overall Study|Randomized but not Treated|0|||
19567897|NCT01252355|42015682|FG000|Overall Study|Other Than Above|8|||
19567898|NCT01252355|42015683|FG001|Overall Study|Other Than Above|7|||
19567899|NCT01252355|42015684|FG002|Overall Study|Other Than Above|7|||
19567900|NCT01118325|42015695|FG000|Overall Study|Adverse Event|1|||
19567901|NCT01118325|42015696|FG001|Overall Study|Adverse Event|0|||
19567902|NCT01118325|42015697|FG002|Overall Study|Adverse Event|1|||
19567903|NCT01117857|42015718|FG000|Overall Study|Lost to Follow-up|4|||
19567904|NCT01117857|42015718|FG000|Overall Study|Withdrawal by Subject|4|||
19567905|NCT01117857|42015718|FG000|Overall Study|Physician Decision|1|||
19567906|NCT01251965|42015725|FG000|Overall Study|Participant/physician decision|1|||
19567907|NCT01251965|42015726|FG001|Overall Study|Participant/physician decision|2|||
19567908|NCT01251965|42015727|FG002|Overall Study|Participant/physician decision|0|||
19567909|NCT01251965|42015725|FG000|Overall Study|Death|0|||
19567910|NCT01251965|42015726|FG001|Overall Study|Death|0|||
19567911|NCT01251965|42015727|FG002|Overall Study|Death|11|||
19567912|NCT01251887|42015739|FG000|Overall Study|Scheduling conflict|1|||
19567913|NCT01251887|42015740|FG001|Overall Study|Scheduling conflict|2|||
19567914|NCT01251887|42015741|FG002|Overall Study|Scheduling conflict|2|||
19567915|NCT01251887|42015739|FG000|Overall Study|Physician Decision|0|||
19567916|NCT01251887|42015740|FG001|Overall Study|Physician Decision|1|||
19567917|NCT01251887|42015741|FG002|Overall Study|Physician Decision|0|||
19567918|NCT00991276|42015755|FG000|First Intervention Period|Adverse Event|0|||
19567919|NCT00991276|42015756|FG001|First Intervention Period|Adverse Event|1|||
19567920|NCT00991276|42015757|FG002|First Intervention Period|Adverse Event|0|||
19567921|NCT00991276|42015758|FG003|First Intervention Period|Adverse Event|1|||
19567922|NCT00991276|42015759|FG004|First Intervention Period|Adverse Event|0|||
19567923|NCT00991276|42015760|FG005|First Intervention Period|Adverse Event|0|||
19567924|NCT00991276|42015755|FG000|First Intervention Period|Protocol Violation|0|||
19567925|NCT00991276|42015756|FG001|First Intervention Period|Protocol Violation|0|||
19567926|NCT00991276|42015757|FG002|First Intervention Period|Protocol Violation|0|||
19567927|NCT00991276|42015758|FG003|First Intervention Period|Protocol Violation|0|||
19478180|NCT01693562|41757334|FG020|Expansion Phase|Other|1|||
19567928|NCT00991276|42015759|FG004|First Intervention Period|Protocol Violation|2|||
19567929|NCT00991276|42015760|FG005|First Intervention Period|Protocol Violation|0|||
19567930|NCT00991276|42015755|FG000|First Intervention Period|Insufficient clinical response|0|||
19567931|NCT00991276|42015756|FG001|First Intervention Period|Insufficient clinical response|0|||
19383947|NCT02724839|41626811|FG000|Overall Study|Withdrawal by Subject|1|||
19383948|NCT02724839|41626812|FG001|Overall Study|Withdrawal by Subject|1|||
19567932|NCT00991276|42015757|FG002|First Intervention Period|Insufficient clinical response|0|||
19567933|NCT00991276|42015758|FG003|First Intervention Period|Insufficient clinical response|0|||
19567934|NCT00991276|42015759|FG004|First Intervention Period|Insufficient clinical response|1|||
19567935|NCT00991276|42015760|FG005|First Intervention Period|Insufficient clinical response|0|||
19567936|NCT00991276|42015755|FG000|First Intervention Period|Other|0|||
19567937|NCT00991276|42015756|FG001|First Intervention Period|Other|0|||
19567938|NCT00991276|42015757|FG002|First Intervention Period|Other|0|||
19567939|NCT00991276|42015758|FG003|First Intervention Period|Other|1|||
19567940|NCT00991276|42015759|FG004|First Intervention Period|Other|1|||
19567941|NCT00991276|42015760|FG005|First Intervention Period|Other|0|||
19567942|NCT00991276|42015755|FG000|First Intervention Period|Withdrawal by Subject|0|||
19567943|NCT00991276|42015756|FG001|First Intervention Period|Withdrawal by Subject|1|||
19567944|NCT00991276|42015757|FG002|First Intervention Period|Withdrawal by Subject|0|||
19567945|NCT00991276|42015758|FG003|First Intervention Period|Withdrawal by Subject|1|||
19567946|NCT00991276|42015759|FG004|First Intervention Period|Withdrawal by Subject|0|||
19567947|NCT00991276|42015760|FG005|First Intervention Period|Withdrawal by Subject|1|||
19567948|NCT00991276|42015755|FG000|First Intervention Period|Lost to Follow-up|0|||
19567949|NCT00991276|42015756|FG001|First Intervention Period|Lost to Follow-up|1|||
19567950|NCT00991276|42015757|FG002|First Intervention Period|Lost to Follow-up|0|||
19567951|NCT00991276|42015758|FG003|First Intervention Period|Lost to Follow-up|1|||
19567952|NCT00991276|42015759|FG004|First Intervention Period|Lost to Follow-up|0|||
19567953|NCT00991276|42015760|FG005|First Intervention Period|Lost to Follow-up|0|||
19567954|NCT00991276|42015755|FG000|Second Intervention Period|Adverse Event|0|||
19567955|NCT00991276|42015756|FG001|Second Intervention Period|Adverse Event|2|||
19567956|NCT00991276|42015757|FG002|Second Intervention Period|Adverse Event|0|||
19567957|NCT00991276|42015758|FG003|Second Intervention Period|Adverse Event|1|||
19567958|NCT00991276|42015759|FG004|Second Intervention Period|Adverse Event|1|||
19567959|NCT00991276|42015760|FG005|Second Intervention Period|Adverse Event|0|||
19567960|NCT00991276|42015755|FG000|Second Intervention Period|Protocol Violation|1|||
19567961|NCT00991276|42015756|FG001|Second Intervention Period|Protocol Violation|0|||
19567962|NCT00991276|42015757|FG002|Second Intervention Period|Protocol Violation|0|||
19567963|NCT00991276|42015758|FG003|Second Intervention Period|Protocol Violation|0|||
19567964|NCT00991276|42015759|FG004|Second Intervention Period|Protocol Violation|0|||
19567965|NCT00991276|42015760|FG005|Second Intervention Period|Protocol Violation|0|||
19567966|NCT00991276|42015755|FG000|Second Intervention Period|Other|0|||
19567967|NCT00991276|42015756|FG001|Second Intervention Period|Other|0|||
19567968|NCT00991276|42015757|FG002|Second Intervention Period|Other|0|||
19567969|NCT00991276|42015758|FG003|Second Intervention Period|Other|1|||
19567970|NCT00991276|42015759|FG004|Second Intervention Period|Other|0|||
19567971|NCT00991276|42015760|FG005|Second Intervention Period|Other|1|||
19567972|NCT00991276|42015755|FG000|Third Intervention Period|Protocol Violation|1|||
19567973|NCT00991276|42015756|FG001|Third Intervention Period|Protocol Violation|0|||
19567974|NCT00991276|42015757|FG002|Third Intervention Period|Protocol Violation|0|||
19567975|NCT00991276|42015758|FG003|Third Intervention Period|Protocol Violation|0|||
19567976|NCT00991276|42015759|FG004|Third Intervention Period|Protocol Violation|0|||
19567977|NCT00991276|42015760|FG005|Third Intervention Period|Protocol Violation|0|||
19567978|NCT00991276|42015755|FG000|Third Intervention Period|Other|0|||
19567979|NCT00991276|42015756|FG001|Third Intervention Period|Other|0|||
19567980|NCT00991276|42015757|FG002|Third Intervention Period|Other|0|||
19567981|NCT00991276|42015758|FG003|Third Intervention Period|Other|0|||
19567982|NCT00991276|42015759|FG004|Third Intervention Period|Other|0|||
19567983|NCT00991276|42015760|FG005|Third Intervention Period|Other|1|||
19567984|NCT00991276|42015755|FG000|Third Intervention Period|Adverse Event|0|||
19567985|NCT00991276|42015756|FG001|Third Intervention Period|Adverse Event|0|||
19567986|NCT00991276|42015757|FG002|Third Intervention Period|Adverse Event|1|||
19383949|NCT02724839|41626813|FG002|Overall Study|Withdrawal by Subject|0|||
19383950|NCT02724839|41626811|FG000|Overall Study|Lost to Follow-up|0|||
19383951|NCT02724839|41626812|FG001|Overall Study|Lost to Follow-up|3|||
19383952|NCT02724839|41626813|FG002|Overall Study|Lost to Follow-up|2|||
19567987|NCT00991276|42015758|FG003|Third Intervention Period|Adverse Event|0|||
19567988|NCT00991276|42015759|FG004|Third Intervention Period|Adverse Event|0|||
19567989|NCT00991276|42015760|FG005|Third Intervention Period|Adverse Event|0|||
19567990|NCT00991276|42015755|FG000|Third Intervention Period|Withdrawal by Subject|0|||
19567991|NCT00991276|42015756|FG001|Third Intervention Period|Withdrawal by Subject|0|||
19567992|NCT00991276|42015757|FG002|Third Intervention Period|Withdrawal by Subject|0|||
19567993|NCT00991276|42015758|FG003|Third Intervention Period|Withdrawal by Subject|1|||
19567994|NCT00991276|42015759|FG004|Third Intervention Period|Withdrawal by Subject|0|||
19567995|NCT00991276|42015760|FG005|Third Intervention Period|Withdrawal by Subject|0|||
19567996|NCT00990652|42015769|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
19383953|NCT02724839|41626811|FG000|Overall Study|Physician Decision|0|||
19567997|NCT00990652|42015769|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
19567998|NCT00990340|42015776|FG000|First 14-day Treatment|Not Compliant|2|||
19567999|NCT00990340|42015777|FG001|First 14-day Treatment|Not Compliant|1|||
19568000|NCT00990340|42015776|FG000|First 14-day Treatment|Lost to Follow-up|2|||
19568001|NCT00990340|42015777|FG001|First 14-day Treatment|Lost to Follow-up|1|||
19568002|NCT00990340|42015776|FG000|First 14-day Treatment|Protocol Violation|2|||
19568003|NCT00990340|42015777|FG001|First 14-day Treatment|Protocol Violation|2|||
19568004|NCT01207440|42015792|FG000|Overall Study|Adverse Event|46|||
19383954|NCT02724839|41626812|FG001|Overall Study|Physician Decision|0|||
19383955|NCT02724839|41626813|FG002|Overall Study|Physician Decision|3|||
19383956|NCT01375751|41626831|FG000|Overall Study|Other|0|||
19383957|NCT01375751|41626832|FG001|Overall Study|Other|1|||
19383958|NCT01375751|41626833|FG002|Overall Study|Other|0|||
19383959|NCT00705575|41626843|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19568005|NCT01207440|42015793|FG001|Overall Study|Adverse Event|11|||
19568006|NCT01207440|42015794|FG002|Overall Study|Adverse Event|7|||
19383960|NCT00705575|41626844|FG001|Overall Study|Abnormal laboratory value(s)|3|||
19383961|NCT00705575|41626843|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19383962|NCT00705575|41626844|FG001|Overall Study|Abnormal test procedure result(s)|12|||
19383963|NCT00705575|41626843|FG000|Overall Study|Adverse Event|11|||
19383964|NCT00705575|41626844|FG001|Overall Study|Adverse Event|15|||
19383965|NCT00705575|41626843|FG000|Overall Study|Lost to Follow-up|3|||
19383966|NCT00705575|41626844|FG001|Overall Study|Lost to Follow-up|4|||
19383967|NCT00705575|41626843|FG000|Overall Study|Protocol Violation|2|||
19383968|NCT00705575|41626844|FG001|Overall Study|Protocol Violation|2|||
19383969|NCT00705575|41626843|FG000|Overall Study|Withdrawal by Subject|5|||
19383970|NCT00705575|41626844|FG001|Overall Study|Withdrawal by Subject|10|||
19383971|NCT02636595|41626850|FG000|Overall Study|Lost to Follow-up|1|||
19383972|NCT02636595|41626850|FG000|Overall Study|Other|1|||
19383973|NCT02636361|41626854|FG000|Period 4|Physician Decision|0|||
19383974|NCT02636361|41626855|FG001|Period 4|Physician Decision|0|||
19383975|NCT02636361|41626856|FG002|Period 4|Physician Decision|0|||
19383976|NCT02636361|41626857|FG003|Period 4|Physician Decision|1|||
19383977|NCT02636361|41626858|FG004|Period 4|Physician Decision|0|||
19383978|NCT02636283|41626874|FG000|Overall Study|Adverse Event|2|||
19568007|NCT01207440|42015795|FG003|Overall Study|Adverse Event|2|||
19568008|NCT01207440|42015796|FG004|Overall Study|Adverse Event|6|||
19568009|NCT01207440|42015797|FG005|Overall Study|Adverse Event|6|||
19568010|NCT01207440|42015798|FG006|Overall Study|Adverse Event|2|||
19568011|NCT01207440|42015792|FG000|Overall Study|Death|6|||
19568012|NCT01207440|42015793|FG001|Overall Study|Death|3|||
19568013|NCT01207440|42015794|FG002|Overall Study|Death|2|||
19568014|NCT01207440|42015795|FG003|Overall Study|Death|2|||
19568015|NCT01207440|42015796|FG004|Overall Study|Death|7|||
19568016|NCT01207440|42015797|FG005|Overall Study|Death|5|||
19568017|NCT01207440|42015798|FG006|Overall Study|Death|1|||
19568018|NCT01207440|42015792|FG000|Overall Study|Lack of Efficacy|13|||
19568019|NCT01207440|42015793|FG001|Overall Study|Lack of Efficacy|2|||
19568020|NCT01207440|42015794|FG002|Overall Study|Lack of Efficacy|5|||
19568021|NCT01207440|42015795|FG003|Overall Study|Lack of Efficacy|1|||
19568022|NCT01207440|42015796|FG004|Overall Study|Lack of Efficacy|2|||
19568023|NCT01207440|42015797|FG005|Overall Study|Lack of Efficacy|3|||
19568024|NCT01207440|42015798|FG006|Overall Study|Lack of Efficacy|0|||
19568025|NCT01207440|42015792|FG000|Overall Study|Lost to Follow-up|0|||
19568026|NCT01207440|42015793|FG001|Overall Study|Lost to Follow-up|0|||
19568027|NCT01207440|42015794|FG002|Overall Study|Lost to Follow-up|2|||
19568028|NCT01207440|42015795|FG003|Overall Study|Lost to Follow-up|1|||
19568029|NCT01207440|42015796|FG004|Overall Study|Lost to Follow-up|0|||
19568030|NCT01207440|42015797|FG005|Overall Study|Lost to Follow-up|0|||
19568031|NCT01207440|42015798|FG006|Overall Study|Lost to Follow-up|0|||
19568032|NCT01207440|42015792|FG000|Overall Study|Non-compliance with Study Drug|3|||
19568033|NCT01207440|42015793|FG001|Overall Study|Non-compliance with Study Drug|0|||
19568034|NCT01207440|42015794|FG002|Overall Study|Non-compliance with Study Drug|1|||
19568035|NCT01207440|42015795|FG003|Overall Study|Non-compliance with Study Drug|0|||
19568036|NCT01207440|42015796|FG004|Overall Study|Non-compliance with Study Drug|0|||
19568037|NCT01207440|42015797|FG005|Overall Study|Non-compliance with Study Drug|0|||
19568038|NCT01207440|42015798|FG006|Overall Study|Non-compliance with Study Drug|0|||
19568039|NCT01207440|42015792|FG000|Overall Study|Physician Decision|6|||
19568040|NCT01207440|42015793|FG001|Overall Study|Physician Decision|5|||
19568041|NCT01207440|42015794|FG002|Overall Study|Physician Decision|5|||
19568042|NCT01207440|42015795|FG003|Overall Study|Physician Decision|0|||
19568043|NCT01207440|42015796|FG004|Overall Study|Physician Decision|1|||
19568044|NCT01207440|42015797|FG005|Overall Study|Physician Decision|0|||
19568045|NCT01207440|42015798|FG006|Overall Study|Physician Decision|0|||
19568046|NCT01207440|42015792|FG000|Overall Study|Progressive Disease|19|||
19383979|NCT02636283|41626875|FG001|Overall Study|Adverse Event|0|||
19383980|NCT02636283|41626874|FG000|Overall Study|Trial Terminated Prematurely|0|||
19383981|NCT02636283|41626875|FG001|Overall Study|Trial Terminated Prematurely|3|||
19383982|NCT04430855|41626883|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
19568047|NCT01207440|42015793|FG001|Overall Study|Progressive Disease|10|||
19568048|NCT01207440|42015794|FG002|Overall Study|Progressive Disease|19|||
19568049|NCT01207440|42015795|FG003|Overall Study|Progressive Disease|7|||
19568050|NCT01207440|42015796|FG004|Overall Study|Progressive Disease|23|||
19568051|NCT01207440|42015797|FG005|Overall Study|Progressive Disease|27|||
19568052|NCT01207440|42015798|FG006|Overall Study|Progressive Disease|0|||
19568053|NCT01207440|42015792|FG000|Overall Study|Protocol Violation|2|||
19568054|NCT01207440|42015793|FG001|Overall Study|Protocol Violation|0|||
19568055|NCT01207440|42015794|FG002|Overall Study|Protocol Violation|0|||
19568056|NCT01207440|42015795|FG003|Overall Study|Protocol Violation|0|||
19568057|NCT01207440|42015796|FG004|Overall Study|Protocol Violation|0|||
19568058|NCT01207440|42015797|FG005|Overall Study|Protocol Violation|0|||
19568059|NCT01207440|42015798|FG006|Overall Study|Protocol Violation|0|||
19568060|NCT01207440|42015792|FG000|Overall Study|Site Terminated by Sponsor|69|||
19568061|NCT01207440|42015793|FG001|Overall Study|Site Terminated by Sponsor|19|||
19568062|NCT01207440|42015794|FG002|Overall Study|Site Terminated by Sponsor|12|||
19568063|NCT01207440|42015795|FG003|Overall Study|Site Terminated by Sponsor|2|||
19568064|NCT01207440|42015796|FG004|Overall Study|Site Terminated by Sponsor|3|||
19383983|NCT04430855|41626884|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
19383984|NCT04430855|41626883|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
19383985|NCT04430855|41626884|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
19383986|NCT04430855|41626883|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
19383987|NCT04430855|41626884|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
19383988|NCT04430855|41626883|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
19568065|NCT01207440|42015797|FG005|Overall Study|Site Terminated by Sponsor|0|||
19568066|NCT01207440|42015798|FG006|Overall Study|Site Terminated by Sponsor|2|||
19568067|NCT01207440|42015792|FG000|Overall Study|Withdrawal by Subject|29|||
19568068|NCT01207440|42015793|FG001|Overall Study|Withdrawal by Subject|4|||
19568069|NCT01207440|42015794|FG002|Overall Study|Withdrawal by Subject|5|||
19568070|NCT01207440|42015795|FG003|Overall Study|Withdrawal by Subject|3|||
19383989|NCT04430855|41626884|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
19383990|NCT04430855|41626883|FG000|Period 1 (Weeks 1-12)|Other|0|||
19383991|NCT04430855|41626884|FG001|Period 1 (Weeks 1-12)|Other|1|||
19383992|NCT04430855|41626883|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
19383993|NCT04430855|41626884|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
19383994|NCT04430855|41626883|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
19383995|NCT04430855|41626884|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
19383996|NCT04430855|41626883|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
19383997|NCT04430855|41626884|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
19383998|NCT01375673|41626894|FG000|Overall Study|Withdrawal by Subject|0|||
19383999|NCT01375673|41626895|FG001|Overall Study|Withdrawal by Subject|1|||
19384000|NCT03652961|41626901|FG000|Overall Study|Lost to Follow-up|3|||
19384001|NCT03652961|41626901|FG000|Overall Study|Screen Failure|1|||
19384002|NCT02723591|41626907|FG000|Overall Study|Adverse Event|48|||
19384003|NCT02723591|41626908|FG001|Overall Study|Adverse Event|40|||
19384004|NCT02723591|41626907|FG000|Overall Study|Death|2|||
19384005|NCT02723591|41626908|FG001|Overall Study|Death|2|||
19384006|NCT02723591|41626907|FG000|Overall Study|Lack of Efficacy|4|||
19568071|NCT01207440|42015796|FG004|Overall Study|Withdrawal by Subject|2|||
19568072|NCT01207440|42015797|FG005|Overall Study|Withdrawal by Subject|2|||
19568073|NCT01207440|42015798|FG006|Overall Study|Withdrawal by Subject|0|||
19568074|NCT01207440|42015792|FG000|Overall Study|Reason Not Specified|10|||
19568075|NCT01207440|42015793|FG001|Overall Study|Reason Not Specified|10|||
19568076|NCT01207440|42015794|FG002|Overall Study|Reason Not Specified|7|||
19568077|NCT01207440|42015795|FG003|Overall Study|Reason Not Specified|0|||
19568078|NCT01207440|42015796|FG004|Overall Study|Reason Not Specified|4|||
19568079|NCT01207440|42015797|FG005|Overall Study|Reason Not Specified|3|||
19568080|NCT01207440|42015798|FG006|Overall Study|Reason Not Specified|0|||
19568081|NCT00990184|42015820|FG000|Overall Study|Physician Decision|1|||
19568082|NCT00986830|42015826|FG000|Overall Study|Death|1|||
19568083|NCT00986830|42015826|FG000|Overall Study|Lost to Follow-up|1|||
19568084|NCT00986830|42015826|FG000|Overall Study|Lack of Efficacy|1|||
19568085|NCT00986830|42015826|FG000|Overall Study|Unable to access sinus with device|5|||
19384007|NCT02723591|41626908|FG001|Overall Study|Lack of Efficacy|3|||
19384008|NCT02723591|41626907|FG000|Overall Study|Lost to Follow-up|1|||
19384009|NCT02723591|41626908|FG001|Overall Study|Lost to Follow-up|7|||
19384010|NCT02723591|41626907|FG000|Overall Study|Protocol Violation|20|||
19384011|NCT02723591|41626908|FG001|Overall Study|Protocol Violation|23|||
19384012|NCT02723591|41626907|FG000|Overall Study|Withdrawal by Subject|4|||
19384013|NCT02723591|41626908|FG001|Overall Study|Withdrawal by Subject|8|||
19384014|NCT02723591|41626907|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
19384015|NCT02723591|41626908|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
19384016|NCT02723591|41626907|FG000|Overall Study|Miscellaneous|5|||
19384017|NCT02723591|41626908|FG001|Overall Study|Miscellaneous|6|||
19384018|NCT00705341|41626916|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
19384019|NCT00705341|41626917|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
19384020|NCT00705341|41626918|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
19384021|NCT00705341|41626919|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
19568086|NCT00990106|42015832|FG000|Overall Study|"too busy to continue"|1|||
19568087|NCT00990106|42015833|FG001|Overall Study|"too busy to continue"|2|||
19568088|NCT00990106|42015832|FG000|Overall Study|Lost to Follow-up|1|||
19568089|NCT00990106|42015833|FG001|Overall Study|Lost to Follow-up|3|||
19568090|NCT00990106|42015832|FG000|Overall Study|Withdrawal by Subject|2|||
19568091|NCT00990106|42015833|FG001|Overall Study|Withdrawal by Subject|1|||
19568092|NCT00990106|42015832|FG000|Overall Study|opted for open label prazosin|1|||
19568093|NCT00990106|42015833|FG001|Overall Study|opted for open label prazosin|1|||
19568094|NCT00990106|42015832|FG000|Overall Study|relocation/deployment|4|||
19568095|NCT00990106|42015833|FG001|Overall Study|relocation/deployment|1|||
19568096|NCT00990106|42015832|FG000|Overall Study|started exclusionary medication|0|||
19384022|NCT00705341|41626916|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
19384023|NCT00705341|41626917|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
19384024|NCT00705341|41626918|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
19384025|NCT00705341|41626919|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
19384026|NCT02723201|41626930|FG000|Second Intervention Period|Protocol Violation|1|||
19568097|NCT00990106|42015833|FG001|Overall Study|started exclusionary medication|1|||
19568098|NCT00990106|42015832|FG000|Overall Study|planned major surgery|0|||
19568099|NCT00990106|42015833|FG001|Overall Study|planned major surgery|1|||
19568100|NCT00990106|42015832|FG000|Overall Study|scheduling conflicts|0|||
19568101|NCT00990106|42015833|FG001|Overall Study|scheduling conflicts|2|||
19384027|NCT02723201|41626931|FG001|Second Intervention Period|Protocol Violation|0|||
19568102|NCT00983476|42015842|FG000|Overall Study|Did not receive intervention|17|||
19568103|NCT00983476|42015843|FG001|Overall Study|Did not receive intervention|22|||
19568104|NCT00983476|42015844|FG002|Overall Study|Did not receive intervention|0|||
19568105|NCT00982228|42015860|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
19568106|NCT00982228|42015861|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
19568107|NCT00982228|42015860|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
19568108|NCT00982228|42015861|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
19568109|NCT00982228|42015860|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
19568110|NCT00982228|42015861|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
19568111|NCT00982228|42015860|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
19568112|NCT00982228|42015861|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
19568113|NCT00982228|42015860|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
19568114|NCT00982228|42015861|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
19568115|NCT00982228|42015860|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
19568116|NCT00982228|42015861|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
19568117|NCT00982228|42015860|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
19568118|NCT00982228|42015861|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
19568119|NCT00982228|42015860|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
19568120|NCT00982228|42015861|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
19568121|NCT00982228|42015860|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
19568122|NCT00982228|42015861|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
19568123|NCT00982228|42015860|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
19568124|NCT00982228|42015861|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
19568125|NCT01260350|42015887|FG000|Overall Study|Lack of Efficacy|0|||
19568126|NCT01260350|42015888|FG001|Overall Study|Lack of Efficacy|0|||
19568127|NCT01260350|42015889|FG002|Overall Study|Lack of Efficacy|0|||
19568128|NCT01260350|42015890|FG003|Overall Study|Lack of Efficacy|0|||
19568129|NCT01260350|42015891|FG004|Overall Study|Lack of Efficacy|0|||
19568130|NCT01260350|42015892|FG005|Overall Study|Lack of Efficacy|0|||
19568131|NCT01260350|42015893|FG006|Overall Study|Lack of Efficacy|0|||
19568132|NCT01260350|42015894|FG007|Overall Study|Lack of Efficacy|0|||
19568133|NCT01260350|42015895|FG008|Overall Study|Lack of Efficacy|0|||
19568134|NCT01260350|42015896|FG009|Overall Study|Lack of Efficacy|0|||
19568135|NCT01260350|42015897|FG010|Overall Study|Lack of Efficacy|0|||
19568136|NCT01260350|42015898|FG011|Overall Study|Lack of Efficacy|0|||
19568137|NCT01260350|42015899|FG012|Overall Study|Lack of Efficacy|0|||
19568138|NCT01260350|42015900|FG013|Overall Study|Lack of Efficacy|0|||
19568139|NCT01260350|42015901|FG014|Overall Study|Lack of Efficacy|0|||
19568140|NCT01260350|42015902|FG015|Overall Study|Lack of Efficacy|0|||
19568141|NCT01260350|42015903|FG016|Overall Study|Lack of Efficacy|0|||
19568142|NCT01260350|42015904|FG017|Overall Study|Lack of Efficacy|1|||
19568143|NCT01260350|42015905|FG018|Overall Study|Lack of Efficacy|0|||
19568144|NCT01260350|42015906|FG019|Overall Study|Lack of Efficacy|0|||
19568145|NCT01260350|42015907|FG020|Overall Study|Lack of Efficacy|3|||
19568146|NCT01260350|42015908|FG021|Overall Study|Lack of Efficacy|0|||
19568147|NCT01260350|42015887|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19384028|NCT02723201|41626932|FG002|Second Intervention Period|Protocol Violation|0|||
19384029|NCT02723201|41626930|FG000|Second Intervention Period|Adverse Event|1|||
19384030|NCT02723201|41626931|FG001|Second Intervention Period|Adverse Event|0|||
19568148|NCT01260350|42015888|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568149|NCT01260350|42015889|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568150|NCT01260350|42015890|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568151|NCT01260350|42015891|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568152|NCT01260350|42015892|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568153|NCT01260350|42015893|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568154|NCT01260350|42015894|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568155|NCT01260350|42015895|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
19568156|NCT01260350|42015896|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568157|NCT01260350|42015897|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568158|NCT01260350|42015898|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568159|NCT01260350|42015899|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568160|NCT01260350|42015900|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568161|NCT01260350|42015901|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568162|NCT01260350|42015902|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568163|NCT01260350|42015903|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568164|NCT01260350|42015904|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568165|NCT01260350|42015905|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568166|NCT01260350|42015906|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568167|NCT01260350|42015907|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568168|NCT01260350|42015908|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
19568169|NCT01260194|42015962|FG000|Overall Study|Withdrawal of Consent|1|||
19568170|NCT01259726|42015970|FG000|Overall Study|Death|1|||
19568171|NCT01259726|42015971|FG001|Overall Study|Death|0|||
19568172|NCT01259726|42015972|FG002|Overall Study|Death|0|||
19568173|NCT01259726|42015973|FG003|Overall Study|Death|0|||
19568174|NCT01259726|42015970|FG000|Overall Study|Physician Decision|2|||
19568175|NCT01259726|42015971|FG001|Overall Study|Physician Decision|0|||
19568176|NCT01259726|42015972|FG002|Overall Study|Physician Decision|1|||
19568177|NCT01259726|42015973|FG003|Overall Study|Physician Decision|1|||
19568178|NCT01259726|42015970|FG000|Overall Study|Withdrawal by Subject|1|||
19568179|NCT01259726|42015971|FG001|Overall Study|Withdrawal by Subject|3|||
19568180|NCT01259726|42015972|FG002|Overall Study|Withdrawal by Subject|2|||
19568181|NCT01259726|42015973|FG003|Overall Study|Withdrawal by Subject|1|||
19568182|NCT01259726|42015970|FG000|Overall Study|Lost to Follow-up|1|||
19568183|NCT01259726|42015971|FG001|Overall Study|Lost to Follow-up|1|||
19568184|NCT01259726|42015972|FG002|Overall Study|Lost to Follow-up|1|||
19568185|NCT01259726|42015973|FG003|Overall Study|Lost to Follow-up|3|||
19568186|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
19568187|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
19568188|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
19568189|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
19568190|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
19568191|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
19568192|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
19568193|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
19568194|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
19568195|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
19568196|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
19568197|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
19568198|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
19568199|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
19568200|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
19568201|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
19568202|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
19568203|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
19568204|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
19568205|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
19568206|NCT01259492|42015987|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
19568207|NCT01259492|42015988|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
19568208|NCT01259492|42015989|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
19568209|NCT01259492|42015990|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
19568210|NCT01259492|42015987|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
19568211|NCT01259492|42015988|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
19568212|NCT01259492|42015989|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
19568213|NCT01259492|42015990|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
19568214|NCT01259492|42015987|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
19568215|NCT01259492|42015988|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
19568216|NCT01259492|42015989|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
19568217|NCT01259492|42015990|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
19384031|NCT02723201|41626932|FG002|Second Intervention Period|Adverse Event|0|||
19568218|NCT01259492|42015987|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
19568219|NCT01259492|42015988|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
19384032|NCT03846479|41626946|FG000|Overall Study|Death|8|||
19568220|NCT01259492|42015989|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
19568221|NCT01259492|42015990|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
19568222|NCT01259492|42015987|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
19568223|NCT01259492|42015988|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
19568224|NCT01259492|42015989|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
19568225|NCT01259492|42015990|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
19568226|NCT01259492|42015987|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
19568227|NCT01259492|42015988|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
19568228|NCT01259492|42015989|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
19568229|NCT01259492|42015990|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
19568230|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
19568231|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
19568232|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
19568233|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
19568234|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
19568235|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
19568236|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
19568237|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
19568238|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
19568239|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
19568240|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
19568241|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
19568242|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
19568243|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
19568244|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
19568245|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
19568246|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
19568247|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
19568248|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
19568249|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
19568250|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
19568251|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
19568252|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
19568253|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
19568254|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
19568255|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
19568256|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
19568257|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
19568258|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
19568259|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
19568260|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
19568261|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
19568262|NCT01259492|42015987|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
19568263|NCT01259492|42015988|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
19568264|NCT01259492|42015989|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
19568265|NCT01259492|42015990|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
19568266|NCT01117623|42016007|FG000|Overall Study|Adverse Event|0|||
19568267|NCT01117623|42016008|FG001|Overall Study|Adverse Event|2|||
19568268|NCT01117623|42016009|FG002|Overall Study|Adverse Event|4|||
19568269|NCT01117623|42016010|FG003|Overall Study|Adverse Event|0|||
19568270|NCT01117623|42016011|FG004|Overall Study|Adverse Event|2|||
19568271|NCT01117623|42016012|FG005|Overall Study|Adverse Event|0|||
19568272|NCT01117623|42016013|FG006|Overall Study|Adverse Event|0|||
19568273|NCT01117623|42016014|FG007|Overall Study|Adverse Event|2|||
19568274|NCT01117623|42016007|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
19568275|NCT01117623|42016008|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
19568276|NCT01117623|42016009|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
19568277|NCT01117623|42016010|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
19568278|NCT01117623|42016011|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
19568279|NCT01117623|42016012|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
19568280|NCT01117623|42016013|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
19568281|NCT01117623|42016014|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
19568282|NCT01117623|42016007|FG000|Overall Study|Withdrawal by Subject|0|||
19568283|NCT01117623|42016008|FG001|Overall Study|Withdrawal by Subject|0|||
19568284|NCT01117623|42016009|FG002|Overall Study|Withdrawal by Subject|2|||
19568285|NCT01117623|42016010|FG003|Overall Study|Withdrawal by Subject|0|||
19568286|NCT01117623|42016011|FG004|Overall Study|Withdrawal by Subject|0|||
19568287|NCT01117623|42016012|FG005|Overall Study|Withdrawal by Subject|1|||
19568288|NCT01117623|42016013|FG006|Overall Study|Withdrawal by Subject|1|||
19568289|NCT01117623|42016014|FG007|Overall Study|Withdrawal by Subject|1|||
19568290|NCT01117623|42016007|FG000|Overall Study|Non-compliance with study medication|0|||
19568291|NCT01117623|42016008|FG001|Overall Study|Non-compliance with study medication|0|||
19568292|NCT01117623|42016009|FG002|Overall Study|Non-compliance with study medication|0|||
19568293|NCT01117623|42016010|FG003|Overall Study|Non-compliance with study medication|0|||
19568294|NCT01117623|42016011|FG004|Overall Study|Non-compliance with study medication|0|||
19568295|NCT01117623|42016012|FG005|Overall Study|Non-compliance with study medication|0|||
19568296|NCT01117623|42016013|FG006|Overall Study|Non-compliance with study medication|0|||
19568297|NCT01117623|42016014|FG007|Overall Study|Non-compliance with study medication|1|||
19568298|NCT01117623|42016007|FG000|Overall Study|Invest. text: completed all planned txs|0|||
19568299|NCT01117623|42016008|FG001|Overall Study|Invest. text: completed all planned txs|0|||
19568300|NCT01117623|42016009|FG002|Overall Study|Invest. text: completed all planned txs|0|||
19568301|NCT01117623|42016010|FG003|Overall Study|Invest. text: completed all planned txs|0|||
19568302|NCT01117623|42016011|FG004|Overall Study|Invest. text: completed all planned txs|0|||
19568303|NCT01117623|42016012|FG005|Overall Study|Invest. text: completed all planned txs|1|||
19568304|NCT01117623|42016013|FG006|Overall Study|Invest. text: completed all planned txs|0|||
19568305|NCT01117623|42016014|FG007|Overall Study|Invest. text: completed all planned txs|0|||
19568306|NCT01116687|42016034|FG000|Overall Study|Withdrawal by Subject|4|||
19568307|NCT01114737|42016040|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
19568308|NCT01114737|42016041|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
19568309|NCT01114737|42016040|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
19568310|NCT01114737|42016041|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
19568311|NCT01114737|42016040|FG000|Randomized Treatment Period|Pregnancy|1|||
19568312|NCT01114737|42016041|FG001|Randomized Treatment Period|Pregnancy|0|||
19568313|NCT01114737|42016040|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
19568314|NCT01114737|42016041|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
19568315|NCT01114737|42016040|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
19568316|NCT01114737|42016041|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
19568317|NCT01114737|42016040|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
19568318|NCT01114737|42016041|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
19568319|NCT01113879|42016064|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
19568320|NCT01113879|42016065|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
19568321|NCT00979576|42016076|FG000|Combination Treatment Phase|Progressive disease|3|||
19568322|NCT00979576|42016077|FG001|Combination Treatment Phase|Progressive disease|1|||
19568323|NCT00979576|42016078|FG002|Combination Treatment Phase|Progressive disease|5|||
19568324|NCT00979576|42016076|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
19568325|NCT00979576|42016077|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
19568326|NCT00979576|42016078|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
19568327|NCT00979576|42016076|FG000|Combination Treatment Phase|Adverse Event|0|||
19568328|NCT00979576|42016077|FG001|Combination Treatment Phase|Adverse Event|2|||
19568329|NCT00979576|42016078|FG002|Combination Treatment Phase|Adverse Event|2|||
19568330|NCT00979576|42016076|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
19384033|NCT03846479|41626946|FG000|Overall Study|Lost to Follow-up|1|||
19384034|NCT00705263|41626950|FG000|Overall Study|Withdrawal by Subject|2|||
19384035|NCT00704405|41626968|FG000|Overall Study (NC Population)|Adverse Event|1|||
19384036|NCT00704405|41626969|FG001|Overall Study (NC Population)|Adverse Event|0|||
19568331|NCT00979576|42016077|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
19568332|NCT00979576|42016078|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
19568333|NCT00979420|42016091|FG000|Overall Study|Adverse Event|1|||
19568334|NCT00979420|42016092|FG001|Overall Study|Adverse Event|0|||
19568335|NCT00979420|42016093|FG002|Overall Study|Adverse Event|0|||
19568336|NCT00979420|42016094|FG003|Overall Study|Adverse Event|0|||
19568337|NCT00979420|42016091|FG000|Overall Study|Lack of Efficacy|3|||
19568338|NCT00979420|42016092|FG001|Overall Study|Lack of Efficacy|0|||
19568339|NCT00979420|42016093|FG002|Overall Study|Lack of Efficacy|1|||
19568340|NCT00979420|42016094|FG003|Overall Study|Lack of Efficacy|1|||
19568341|NCT00979420|42016091|FG000|Overall Study|Other reasons not related to Viramune|3|||
19568342|NCT00979420|42016092|FG001|Overall Study|Other reasons not related to Viramune|0|||
19568343|NCT00979420|42016093|FG002|Overall Study|Other reasons not related to Viramune|0|||
19568344|NCT00979420|42016094|FG003|Overall Study|Other reasons not related to Viramune|1|||
19568345|NCT02702180|42016105|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
19568346|NCT02702180|42016106|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
19568347|NCT02702180|42016107|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19568348|NCT02702180|42016105|FG000|Double-blind Treatment Period|Adverse Event|0|||
19384037|NCT00704405|41626970|FG002|Overall Study (NC Population)|Adverse Event|0|||
19384038|NCT00704405|41626971|FG003|Overall Study (NC Population)|Adverse Event|0|||
19384039|NCT00704405|41626972|FG004|Overall Study (NC Population)|Adverse Event|0|||
19568349|NCT02702180|42016106|FG001|Double-blind Treatment Period|Adverse Event|0|||
19568350|NCT02702180|42016107|FG002|Double-blind Treatment Period|Adverse Event|1|||
19568351|NCT02702180|42016105|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
19384040|NCT00704405|41626968|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
19384041|NCT00704405|41626969|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
19568352|NCT02702180|42016106|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
19568353|NCT02702180|42016107|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
19568354|NCT02702180|42016105|FG000|Double-blind Treatment Period|Protocol Violation|0|||
19568355|NCT02702180|42016106|FG001|Double-blind Treatment Period|Protocol Violation|0|||
19568356|NCT02702180|42016107|FG002|Double-blind Treatment Period|Protocol Violation|2|||
19568357|NCT02702180|42016105|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
19568358|NCT02702180|42016106|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
19568359|NCT02702180|42016107|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
19568360|NCT02702180|42016105|FG000|Open-label Treatment Period|Withdrawn in error|0|||
19568361|NCT02702180|42016106|FG001|Open-label Treatment Period|Withdrawn in error|0|||
19568362|NCT02702180|42016107|FG002|Open-label Treatment Period|Withdrawn in error|1|||
19568363|NCT00980980|42016119|FG000|Overall Study|Withdrawal by Hospital|0|||
19568364|NCT00980980|42016120|FG001|Overall Study|Withdrawal by Hospital|1|||
19568365|NCT00980980|42016121|FG002|Overall Study|Withdrawal by Hospital|0|||
19568366|NCT00980200|42016132|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
19568367|NCT00980200|42016133|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
19568368|NCT00980200|42016134|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
19568369|NCT00980200|42016135|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
19568370|NCT00980200|42016136|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
19568371|NCT00980200|42016132|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
19568372|NCT00980200|42016133|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
19568373|NCT00980200|42016134|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
19568374|NCT00980200|42016135|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
19568375|NCT00980200|42016136|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
19568376|NCT00979654|42016148|FG000|Overall Study|Lost to Follow-up|1|||
19568377|NCT00979654|42016148|FG000|Overall Study|Withdrawal by Subject|22|||
19568378|NCT00979654|42016148|FG000|Overall Study|Death|1|||
19568379|NCT00979654|42016148|FG000|Overall Study|Lack of Efficacy|6|||
19568380|NCT00979654|42016148|FG000|Overall Study|Adverse Event|1|||
19568381|NCT00979654|42016148|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
19384042|NCT00704405|41626970|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
19384043|NCT00704405|41626971|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
19384044|NCT00704405|41626972|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
19568382|NCT00979654|42016148|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
19568383|NCT00979654|42016148|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
19568384|NCT00979654|42016148|FG000|Overall Study|Serious Adverse Event|1|||
19568385|NCT00979654|42016148|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
19384045|NCT00704405|41626968|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
19384046|NCT00704405|41626969|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
19568386|NCT00978562|42016152|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
19568387|NCT02865460|42016160|FG000|Overall Study|Adverse Event|1|||
19568388|NCT02865460|42016161|FG001|Overall Study|Adverse Event|0|||
19568389|NCT02865460|42016160|FG000|Overall Study|Withdrawal by Subject|1|||
19568390|NCT02865460|42016161|FG001|Overall Study|Withdrawal by Subject|1|||
19568391|NCT02865460|42016160|FG000|Overall Study|Lost to Follow-up|7|||
19568392|NCT02865460|42016161|FG001|Overall Study|Lost to Follow-up|4|||
19568393|NCT02865460|42016160|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
19568394|NCT02865460|42016161|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
19568395|NCT00946712|42016169|FG000|Overall Study|Adverse Event|118|||
19384047|NCT00704405|41626970|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
19384048|NCT00704405|41626971|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
19384049|NCT00704405|41626972|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
19568396|NCT00946712|42016170|FG001|Overall Study|Adverse Event|124|||
19568397|NCT00946712|42016169|FG000|Overall Study|Disease progression|308|||
19384050|NCT00704405|41626968|FG000|Overall Study (NC Population)|Other|0|||
19568398|NCT00946712|42016170|FG001|Overall Study|Disease progression|404|||
19568399|NCT00946712|42016169|FG000|Overall Study|Death|21|||
19568400|NCT00946712|42016170|FG001|Overall Study|Death|22|||
19568401|NCT00946712|42016169|FG000|Overall Study|No treatment given|25|||
19568402|NCT00946712|42016170|FG001|Overall Study|No treatment given|29|||
19568403|NCT00946712|42016169|FG000|Overall Study|Other reasons|61|||
19568404|NCT00946712|42016170|FG001|Overall Study|Other reasons|73|||
19568405|NCT00946712|42016169|FG000|Overall Study|On Treatment|0|||
19568406|NCT00946712|42016170|FG001|Overall Study|On Treatment|4|||
19568407|NCT00946712|42016169|FG000|Overall Study|Ineligible|14|||
19568408|NCT00946712|42016170|FG001|Overall Study|Ineligible|6|||
19568409|NCT01206816|42016184|FG000|Overall Study|Protocol Violation|0|||
19568410|NCT01206816|42016185|FG001|Overall Study|Protocol Violation|0|||
19568411|NCT01206816|42016186|FG002|Overall Study|Protocol Violation|1|||
19568412|NCT01206816|42016187|FG003|Overall Study|Protocol Violation|0|||
19568413|NCT01206816|42016188|FG004|Overall Study|Protocol Violation|0|||
19568414|NCT01206816|42016189|FG005|Overall Study|Protocol Violation|0|||
19568415|NCT01206816|42016190|FG006|Overall Study|Protocol Violation|0|||
19568416|NCT01206816|42016184|FG000|Overall Study|Withdrawal by Subject|0|||
19568417|NCT01206816|42016185|FG001|Overall Study|Withdrawal by Subject|0|||
19568418|NCT01206816|42016186|FG002|Overall Study|Withdrawal by Subject|1|||
19568419|NCT01206816|42016187|FG003|Overall Study|Withdrawal by Subject|0|||
19568420|NCT01206816|42016188|FG004|Overall Study|Withdrawal by Subject|0|||
19568421|NCT01206816|42016189|FG005|Overall Study|Withdrawal by Subject|0|||
19568422|NCT01206816|42016190|FG006|Overall Study|Withdrawal by Subject|0|||
19568423|NCT01206816|42016184|FG000|Overall Study|Progressive disease|3|||
19568424|NCT01206816|42016185|FG001|Overall Study|Progressive disease|3|||
19568425|NCT01206816|42016186|FG002|Overall Study|Progressive disease|13|||
19568426|NCT01206816|42016187|FG003|Overall Study|Progressive disease|3|||
19745655|NCT00025259|42192985|FG001|Overall Study|Withdrawal by Subject|27|||
19745656|NCT00025259|42192986|FG002|Overall Study|Withdrawal by Subject|6|||
19568427|NCT01206816|42016188|FG004|Overall Study|Progressive disease|3|||
19568428|NCT01206816|42016189|FG005|Overall Study|Progressive disease|16|||
19568429|NCT01206816|42016190|FG006|Overall Study|Progressive disease|3|||
19568430|NCT01206816|42016184|FG000|Overall Study|Other AE|0|||
19568431|NCT01206816|42016185|FG001|Overall Study|Other AE|0|||
19568432|NCT01206816|42016186|FG002|Overall Study|Other AE|4|||
19568433|NCT01206816|42016187|FG003|Overall Study|Other AE|0|||
19568434|NCT01206816|42016188|FG004|Overall Study|Other AE|0|||
19568435|NCT01206816|42016189|FG005|Overall Study|Other AE|3|||
19568436|NCT01206816|42016190|FG006|Overall Study|Other AE|2|||
19568437|NCT01206816|42016184|FG000|Overall Study|other than stated above|0|||
19568438|NCT01206816|42016185|FG001|Overall Study|other than stated above|0|||
19568439|NCT01206816|42016186|FG002|Overall Study|other than stated above|1|||
19568440|NCT01206816|42016187|FG003|Overall Study|other than stated above|0|||
19568441|NCT01206816|42016188|FG004|Overall Study|other than stated above|0|||
19568442|NCT01206816|42016189|FG005|Overall Study|other than stated above|0|||
19568443|NCT01206816|42016190|FG006|Overall Study|other than stated above|1|||
19568444|NCT01206582|42016212|FG000|Overall Study|Withdrew prior to study|1|||
19568445|NCT01206582|42016213|FG001|Overall Study|Withdrew prior to study|0|||
19568446|NCT01206582|42016212|FG000|Overall Study|Discontinued intervention before week 8|1|||
19568447|NCT01206582|42016213|FG001|Overall Study|Discontinued intervention before week 8|2|||
19568448|NCT01259102|42016224|FG000|Overall Study|Adverse Event|1|||
19568449|NCT01259102|42016225|FG001|Overall Study|Adverse Event|0|||
19568450|NCT01259102|42016226|FG002|Overall Study|Adverse Event|1|||
19568451|NCT01259102|42016227|FG003|Overall Study|Adverse Event|1|||
19568452|NCT01259102|42016228|FG004|Overall Study|Adverse Event|0|||
19568453|NCT01259102|42016224|FG000|Overall Study|Other|0|||
19568454|NCT01259102|42016225|FG001|Overall Study|Other|0|||
19568455|NCT01259102|42016226|FG002|Overall Study|Other|1|||
19568456|NCT01259102|42016227|FG003|Overall Study|Other|1|||
19568457|NCT01259102|42016228|FG004|Overall Study|Other|1|||
19568458|NCT00978250|42016244|FG000|Overall Study|Late determination of ineligibility|0|||
19384051|NCT00704405|41626969|FG001|Overall Study (NC Population)|Other|0|||
19568459|NCT00978250|42016245|FG001|Overall Study|Late determination of ineligibility|1|||
19568460|NCT00978250|42016246|FG002|Overall Study|Late determination of ineligibility|0|||
19384052|NCT00704405|41626970|FG002|Overall Study (NC Population)|Other|0|||
19384053|NCT00704405|41626971|FG003|Overall Study (NC Population)|Other|0|||
19384054|NCT00704405|41626972|FG004|Overall Study (NC Population)|Other|1|||
19384055|NCT00704405|41626968|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
19384056|NCT00704405|41626969|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
19384057|NCT00704405|41626970|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
19384058|NCT00704405|41626971|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
19568461|NCT00978250|42016247|FG003|Overall Study|Late determination of ineligibility|1|||
19568462|NCT01259024|42016259|FG000|Overall Study|Physician Decision|1|||
19568463|NCT01257698|42016265|FG000|Overall Study|Protocol Violation|4|||
19568464|NCT01257698|42016266|FG001|Overall Study|Protocol Violation|0|||
19568465|NCT01257542|42016274|FG000|Overall Study|Protocol Violation|3|||
19568466|NCT01257542|42016275|FG001|Overall Study|Protocol Violation|5|||
19568467|NCT01257542|42016274|FG000|Overall Study|Withdrawal by Subject|0|||
19476903|NCT01552057|41755065|FG001|Overall Study|Entry Criteria Not Met|2|||
19476904|NCT01552057|41755064|FG000|Overall Study|Physician Decision|1|||
19476905|NCT01552057|41755065|FG001|Overall Study|Physician Decision|0|||
19476906|NCT01551745|41755071|FG000|Overall Study|Withdrawal by Subject|1|||
19476907|NCT01551745|41755071|FG000|Overall Study|Disease Progression|2|||
19568468|NCT01257542|42016275|FG001|Overall Study|Withdrawal by Subject|2|||
19568469|NCT01257230|42016284|FG000|Overall Study|Not Treated|0|||
19568470|NCT01257230|42016285|FG001|Overall Study|Not Treated|0|||
19568471|NCT01257230|42016286|FG002|Overall Study|Not Treated|1|||
19568472|NCT01257230|42016284|FG000|Overall Study|Adverse Event|2|||
19568473|NCT01257230|42016285|FG001|Overall Study|Adverse Event|0|||
19568474|NCT01257230|42016286|FG002|Overall Study|Adverse Event|0|||
19476908|NCT01551355|41755081|FG000|Overall Study|Lost to Follow-up|51|||
19476909|NCT01551355|41755082|FG001|Overall Study|Lost to Follow-up|49|||
19476910|NCT01551355|41755083|FG002|Overall Study|Lost to Follow-up|34|||
19476911|NCT01551355|41755084|FG003|Overall Study|Lost to Follow-up|24|||
19384059|NCT00704405|41626972|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
19568475|NCT01257230|42016284|FG000|Overall Study|Lack of Efficacy|0|||
19568476|NCT01257230|42016285|FG001|Overall Study|Lack of Efficacy|1|||
19568477|NCT01257230|42016286|FG002|Overall Study|Lack of Efficacy|0|||
19568478|NCT01257230|42016284|FG000|Overall Study|Protocol Violation|3|||
19568479|NCT01257230|42016285|FG001|Overall Study|Protocol Violation|0|||
19568480|NCT01257230|42016286|FG002|Overall Study|Protocol Violation|1|||
19568481|NCT01257230|42016284|FG000|Overall Study|Withdrawal by Subject|0|||
19568482|NCT01257230|42016285|FG001|Overall Study|Withdrawal by Subject|4|||
19568483|NCT01257230|42016286|FG002|Overall Study|Withdrawal by Subject|1|||
19568484|NCT01257230|42016284|FG000|Overall Study|Other reason not defined above|1|||
19568485|NCT01257230|42016285|FG001|Overall Study|Other reason not defined above|5|||
19568486|NCT01257230|42016286|FG002|Overall Study|Other reason not defined above|3|||
19568487|NCT01113801|42016299|FG000|Overall Study|Adverse Event|4|||
19384060|NCT00704405|41626968|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
19384061|NCT00704405|41626969|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
19384062|NCT00704405|41626970|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
19384063|NCT00704405|41626971|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
19384064|NCT00704405|41626972|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
19384065|NCT01534481|41626992|FG000|Overall Study|Lost to Follow-up|29|||
19384066|NCT01534481|41626993|FG001|Overall Study|Lost to Follow-up|24|||
19568488|NCT01113801|42016300|FG001|Overall Study|Adverse Event|0|||
19568489|NCT01113801|42016301|FG002|Overall Study|Adverse Event|2|||
19568490|NCT01113801|42016302|FG003|Overall Study|Adverse Event|6|||
19568491|NCT01113801|42016299|FG000|Overall Study|Death|4|||
19568492|NCT01113801|42016300|FG001|Overall Study|Death|5|||
19568493|NCT01113801|42016301|FG002|Overall Study|Death|3|||
19568494|NCT01113801|42016302|FG003|Overall Study|Death|4|||
19568495|NCT01113801|42016299|FG000|Overall Study|Protocol Violation|0|||
19568496|NCT01113801|42016300|FG001|Overall Study|Protocol Violation|1|||
19568497|NCT01113801|42016301|FG002|Overall Study|Protocol Violation|0|||
19568498|NCT01113801|42016302|FG003|Overall Study|Protocol Violation|0|||
19568499|NCT01113801|42016299|FG000|Overall Study|Withdrawal by Subject|9|||
19568500|NCT01113801|42016300|FG001|Overall Study|Withdrawal by Subject|7|||
19568501|NCT01113801|42016301|FG002|Overall Study|Withdrawal by Subject|7|||
19568502|NCT01113801|42016302|FG003|Overall Study|Withdrawal by Subject|8|||
19568503|NCT01113801|42016299|FG000|Overall Study|Physician Decision|2|||
19568504|NCT01113801|42016300|FG001|Overall Study|Physician Decision|2|||
19568505|NCT01113801|42016301|FG002|Overall Study|Physician Decision|3|||
19568506|NCT01113801|42016302|FG003|Overall Study|Physician Decision|3|||
19568507|NCT01113801|42016299|FG000|Overall Study|Sponsor Decision|15|||
19568508|NCT01113801|42016300|FG001|Overall Study|Sponsor Decision|21|||
19568509|NCT01113801|42016301|FG002|Overall Study|Sponsor Decision|20|||
19568510|NCT01113801|42016302|FG003|Overall Study|Sponsor Decision|15|||
19568511|NCT01113801|42016299|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
19568512|NCT01113801|42016300|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
19568513|NCT01113801|42016301|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
19568514|NCT01113801|42016302|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
19568515|NCT01256684|42016315|FG000|Overall Study|Adverse Event|1|||
19568516|NCT01256684|42016316|FG001|Overall Study|Adverse Event|4|||
19568517|NCT01256684|42016317|FG002|Overall Study|Adverse Event|2|||
19568518|NCT01256684|42016315|FG000|Overall Study|Withdrawal by Subject|4|||
19568519|NCT01256684|42016316|FG001|Overall Study|Withdrawal by Subject|0|||
19568520|NCT01256684|42016317|FG002|Overall Study|Withdrawal by Subject|2|||
19568521|NCT01256684|42016315|FG000|Overall Study|Physician Decision|0|||
19568522|NCT01256684|42016316|FG001|Overall Study|Physician Decision|1|||
19568523|NCT01256684|42016317|FG002|Overall Study|Physician Decision|0|||
19568524|NCT01256684|42016315|FG000|Overall Study|Lack of Efficacy|0|||
19568525|NCT01256684|42016316|FG001|Overall Study|Lack of Efficacy|1|||
19568526|NCT01256684|42016317|FG002|Overall Study|Lack of Efficacy|1|||
19568527|NCT01256684|42016315|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
19568528|NCT01256684|42016316|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
19568529|NCT01256684|42016317|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
19568530|NCT01204710|42016327|FG000|Randomization Treatment|Lost to Follow-up|1|||
19568531|NCT01204710|42016328|FG001|Randomization Treatment|Lost to Follow-up|0|||
19568532|NCT01204710|42016327|FG000|Randomization Treatment|Withdrawal by Subject|6|||
19568533|NCT01204710|42016328|FG001|Randomization Treatment|Withdrawal by Subject|5|||
19568534|NCT01204710|42016327|FG000|Randomization Treatment|Physician Decision|3|||
19568535|NCT01204710|42016328|FG001|Randomization Treatment|Physician Decision|2|||
19568536|NCT01204710|42016327|FG000|Randomization Treatment|Entry criteria not met|0|||
19568537|NCT01204710|42016328|FG001|Randomization Treatment|Entry criteria not met|1|||
19568538|NCT01204710|42016327|FG000|Randomization Treatment|Adverse Event|4|||
19384067|NCT01534481|41626992|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
19384068|NCT01534481|41626993|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
19568539|NCT01204710|42016328|FG001|Randomization Treatment|Adverse Event|2|||
19568540|NCT01204710|42016327|FG000|Randomization Treatment|Sponsor Decision|0|||
19568541|NCT01204710|42016328|FG001|Randomization Treatment|Sponsor Decision|1|||
19568542|NCT01204710|42016327|FG000|Randomization Treatment|Worsening of General condition|0|||
19568543|NCT01204710|42016328|FG001|Randomization Treatment|Worsening of General condition|1|||
19568544|NCT01204710|42016327|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
19568545|NCT01204710|42016328|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
19568546|NCT01204710|42016327|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
19568547|NCT01204710|42016328|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
19568548|NCT01204710|42016327|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
19568549|NCT01204710|42016328|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
19568550|NCT01204710|42016327|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
19568551|NCT01204710|42016328|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
19568552|NCT01256450|42016343|FG000|Open-label Titration|Adverse Event|39|||
19568553|NCT01256450|42016344|FG001|Open-label Titration|Adverse Event|0|||
19568554|NCT01256450|42016345|FG002|Open-label Titration|Adverse Event|0|||
19568555|NCT01256450|42016343|FG000|Open-label Titration|Lost to Follow-up|7|||
19568556|NCT01256450|42016344|FG001|Open-label Titration|Lost to Follow-up|0|||
19568557|NCT01256450|42016345|FG002|Open-label Titration|Lost to Follow-up|0|||
19568558|NCT01256450|42016343|FG000|Open-label Titration|Lack of analgesic effect|30|||
19568559|NCT01256450|42016344|FG001|Open-label Titration|Lack of analgesic effect|0|||
19568560|NCT01256450|42016345|FG002|Open-label Titration|Lack of analgesic effect|0|||
19384069|NCT00704171|41627001|FG000|Overall Study|Withdrawal by Subject|1|||
19568561|NCT01256450|42016343|FG000|Open-label Titration|Non-compliance|9|||
19568562|NCT01256450|42016344|FG001|Open-label Titration|Non-compliance|0|||
19568563|NCT01256450|42016345|FG002|Open-label Titration|Non-compliance|0|||
19568564|NCT01256450|42016343|FG000|Open-label Titration|Screen failure|1|||
19568565|NCT01256450|42016344|FG001|Open-label Titration|Screen failure|0|||
19568566|NCT01256450|42016345|FG002|Open-label Titration|Screen failure|0|||
19568567|NCT01256450|42016343|FG000|Open-label Titration|Other|13|||
19568568|NCT01256450|42016344|FG001|Open-label Titration|Other|0|||
19568569|NCT01256450|42016345|FG002|Open-label Titration|Other|0|||
19568570|NCT01256450|42016343|FG000|Double-blind Treatment|Adverse Event|0|||
19568571|NCT01256450|42016344|FG001|Double-blind Treatment|Adverse Event|8|||
19568572|NCT01256450|42016345|FG002|Double-blind Treatment|Adverse Event|6|||
19568573|NCT01256450|42016343|FG000|Double-blind Treatment|Lost to Follow-up|0|||
19568574|NCT01256450|42016344|FG001|Double-blind Treatment|Lost to Follow-up|1|||
19568575|NCT01256450|42016345|FG002|Double-blind Treatment|Lost to Follow-up|7|||
19568576|NCT01256450|42016343|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
19568577|NCT01256450|42016344|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
19568578|NCT01256450|42016345|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
19568579|NCT01256450|42016343|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
19568580|NCT01256450|42016344|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
19568581|NCT01256450|42016345|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
19568582|NCT01256450|42016343|FG000|Double-blind Treatment|Non-compliance|0|||
19568583|NCT01256450|42016344|FG001|Double-blind Treatment|Non-compliance|5|||
19568584|NCT01256450|42016345|FG002|Double-blind Treatment|Non-compliance|4|||
19568585|NCT01256450|42016343|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
19568586|NCT01256450|42016344|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
19568587|NCT01256450|42016345|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
19568588|NCT01256450|42016343|FG000|Double-blind Treatment|Other|0|||
19568589|NCT01256450|42016344|FG001|Double-blind Treatment|Other|9|||
19568590|NCT01256450|42016345|FG002|Double-blind Treatment|Other|12|||
19568591|NCT01204398|42016352|FG000|Overall Study|Adverse Event|1|||
19568592|NCT01111851|42016358|FG000|Overall Study|All planned PET scans were not obtained.|2|||
19568593|NCT01111851|42016359|FG001|Overall Study|All planned PET scans were not obtained.|0|||
19568594|NCT01256294|42016365|FG000|Overall Study|Adverse Event|1|||
19568595|NCT01256294|42016366|FG001|Overall Study|Adverse Event|0|||
19568596|NCT01256294|42016365|FG000|Overall Study|Withdrawal by Subject|1|||
19568597|NCT01256294|42016366|FG001|Overall Study|Withdrawal by Subject|1|||
19568598|NCT01256294|42016365|FG000|Overall Study|Protocol deviation|2|||
19568599|NCT01256294|42016366|FG001|Overall Study|Protocol deviation|1|||
19568600|NCT01256060|42016372|FG000|Overall Study|Lost to Follow-up|0|||
19568601|NCT01256060|42016373|FG001|Overall Study|Lost to Follow-up|1|||
19568602|NCT01256060|42016374|FG002|Overall Study|Lost to Follow-up|0|||
19568603|NCT01256060|42016375|FG003|Overall Study|Lost to Follow-up|0|||
19568604|NCT01255904|42016383|FG000|Overall Study|Physician Decision|1|||
19568605|NCT01255904|42016384|FG001|Overall Study|Physician Decision|4|||
19568606|NCT01255670|42016392|FG000|Overall Study|Adverse Event|10|||
19568607|NCT01255670|42016393|FG001|Overall Study|Adverse Event|10|||
19568608|NCT01255670|42016392|FG000|Overall Study|Lost to Follow-up|16|||
19568609|NCT01255670|42016393|FG001|Overall Study|Lost to Follow-up|10|||
19568610|NCT01255592|42016401|FG000|Overall Study|Adverse Event|5|||
19568611|NCT01255592|42016402|FG001|Overall Study|Adverse Event|0|||
19384070|NCT00704171|41627002|FG001|Overall Study|Withdrawal by Subject|0|||
19384071|NCT00703781|41627010|FG000|Overall Study|Withdrawal by Subject|1|||
19384072|NCT00703781|41627011|FG001|Overall Study|Withdrawal by Subject|2|||
19568612|NCT01255592|42016401|FG000|Overall Study|Withdrawal by Subject|1|||
19568613|NCT01255592|42016402|FG001|Overall Study|Withdrawal by Subject|0|||
19568614|NCT01255592|42016401|FG000|Overall Study|Other|0|||
19568615|NCT01255592|42016402|FG001|Overall Study|Other|1|||
19568616|NCT01255436|42016411|FG000|Overall Study|Lost to Follow-up|178|||
19568617|NCT01255436|42016412|FG001|Overall Study|Lost to Follow-up|191|||
19568618|NCT01255436|42016411|FG000|Overall Study|Death, stroke, or MI|4|||
19568619|NCT01255436|42016412|FG001|Overall Study|Death, stroke, or MI|3|||
19568620|NCT01203930|42016420|FG000|Overall Study|Disease Progression|0|||
19568621|NCT01203930|42016421|FG001|Overall Study|Disease Progression|4|||
19568622|NCT01203930|42016420|FG000|Overall Study|Death|3|||
19568623|NCT01203930|42016421|FG001|Overall Study|Death|1|||
19568624|NCT01203930|42016420|FG000|Overall Study|Withdrew Consent|1|||
19568625|NCT01203930|42016421|FG001|Overall Study|Withdrew Consent|10|||
19568626|NCT01203930|42016420|FG000|Overall Study|Investigator Request|0|||
19568627|NCT01203930|42016421|FG001|Overall Study|Investigator Request|8|||
19568628|NCT01203930|42016420|FG000|Overall Study|Study Terminated by Sponsor|0|||
19568629|NCT01203930|42016421|FG001|Overall Study|Study Terminated by Sponsor|12|||
19568630|NCT01203930|42016420|FG000|Overall Study|Poor tolerance of study drug|0|||
19568631|NCT01203930|42016421|FG001|Overall Study|Poor tolerance of study drug|1|||
19568632|NCT01203930|42016420|FG000|Overall Study|Adverse Event|17|||
19568633|NCT01203930|42016421|FG001|Overall Study|Adverse Event|5|||
19568634|NCT01254890|42016431|FG000|Overall Study|Ineligible|0|||
19568635|NCT01254890|42016432|FG001|Overall Study|Ineligible|3|||
19568636|NCT01254890|42016431|FG000|Overall Study|Withdrawal by Subject|1|||
19568637|NCT01254890|42016432|FG001|Overall Study|Withdrawal by Subject|2|||
19568638|NCT01254890|42016431|FG000|Overall Study|Disease Progression|0|||
19568639|NCT01254890|42016432|FG001|Overall Study|Disease Progression|5|||
19568640|NCT01203852|42016437|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
19568641|NCT01203852|42016437|FG000|Washout 2 Weeks|Physician Decision|46|||
19568642|NCT01105533|42016444|FG000|Overall Study|Death|0|||
19568643|NCT01105533|42016445|FG001|Overall Study|Death|0|||
19568644|NCT01105533|42016446|FG002|Overall Study|Death|0|||
19568645|NCT01105533|42016447|FG003|Overall Study|Death|0|||
19568646|NCT01105533|42016448|FG004|Overall Study|Death|1|||
19568647|NCT01105533|42016449|FG005|Overall Study|Death|0|||
19568648|NCT01105533|42016450|FG006|Overall Study|Death|0|||
19568649|NCT01105533|42016451|FG007|Overall Study|Death|0|||
19568650|NCT01105533|42016452|FG008|Overall Study|Death|0|||
19568651|NCT01105533|42016444|FG000|Overall Study|Lack of Efficacy|1|||
19568652|NCT01105533|42016445|FG001|Overall Study|Lack of Efficacy|1|||
19568653|NCT01105533|42016446|FG002|Overall Study|Lack of Efficacy|3|||
19568654|NCT01105533|42016447|FG003|Overall Study|Lack of Efficacy|3|||
19568655|NCT01105533|42016448|FG004|Overall Study|Lack of Efficacy|4|||
19568656|NCT01105533|42016449|FG005|Overall Study|Lack of Efficacy|5|||
19568657|NCT01105533|42016450|FG006|Overall Study|Lack of Efficacy|3|||
19568658|NCT01105533|42016451|FG007|Overall Study|Lack of Efficacy|2|||
19568659|NCT01105533|42016452|FG008|Overall Study|Lack of Efficacy|9|||
19568660|NCT01105533|42016444|FG000|Overall Study|Adverse Event|0|||
19568661|NCT01105533|42016445|FG001|Overall Study|Adverse Event|0|||
19568662|NCT01105533|42016446|FG002|Overall Study|Adverse Event|0|||
19568663|NCT01105533|42016447|FG003|Overall Study|Adverse Event|0|||
19568664|NCT01105533|42016448|FG004|Overall Study|Adverse Event|1|||
19568665|NCT01105533|42016449|FG005|Overall Study|Adverse Event|2|||
19568666|NCT01105533|42016450|FG006|Overall Study|Adverse Event|2|||
19568667|NCT01105533|42016451|FG007|Overall Study|Adverse Event|0|||
19568668|NCT01105533|42016452|FG008|Overall Study|Adverse Event|1|||
19568669|NCT01105533|42016444|FG000|Overall Study|Other|0|||
19568670|NCT01105533|42016445|FG001|Overall Study|Other|0|||
19568671|NCT01105533|42016446|FG002|Overall Study|Other|0|||
19568672|NCT01105533|42016447|FG003|Overall Study|Other|0|||
19568673|NCT01105533|42016448|FG004|Overall Study|Other|1|||
19568674|NCT01105533|42016449|FG005|Overall Study|Other|0|||
19568675|NCT01105533|42016450|FG006|Overall Study|Other|3|||
19568676|NCT01105533|42016451|FG007|Overall Study|Other|1|||
19568677|NCT01105533|42016452|FG008|Overall Study|Other|2|||
19568678|NCT01105533|42016444|FG000|Overall Study|Physician Decision|0|||
19568679|NCT01105533|42016445|FG001|Overall Study|Physician Decision|0|||
19568680|NCT01105533|42016446|FG002|Overall Study|Physician Decision|0|||
19568681|NCT01105533|42016447|FG003|Overall Study|Physician Decision|0|||
19568682|NCT01105533|42016448|FG004|Overall Study|Physician Decision|0|||
19568683|NCT01105533|42016449|FG005|Overall Study|Physician Decision|0|||
19384073|NCT00703781|41627010|FG000|Overall Study|Cancelled surgery|1|||
19476912|NCT01551355|41755085|FG004|Overall Study|Lost to Follow-up|9|||
19568684|NCT01105533|42016450|FG006|Overall Study|Physician Decision|0|||
19568685|NCT01105533|42016451|FG007|Overall Study|Physician Decision|1|||
19568686|NCT01105533|42016452|FG008|Overall Study|Physician Decision|0|||
19568687|NCT01203072|42016470|FG000|Overall Study|Adverse Event|5|||
19568688|NCT01203072|42016471|FG001|Overall Study|Adverse Event|3|||
19568689|NCT01203072|42016472|FG002|Overall Study|Adverse Event|2|||
19568690|NCT01203072|42016473|FG003|Overall Study|Adverse Event|4|||
19568691|NCT01203072|42016474|FG004|Overall Study|Adverse Event|2|||
19568692|NCT01203072|42016470|FG000|Overall Study|Lack of Efficacy|1|||
19568693|NCT01203072|42016471|FG001|Overall Study|Lack of Efficacy|0|||
19568694|NCT01203072|42016472|FG002|Overall Study|Lack of Efficacy|0|||
19568695|NCT01203072|42016473|FG003|Overall Study|Lack of Efficacy|0|||
19568696|NCT01203072|42016474|FG004|Overall Study|Lack of Efficacy|0|||
19568697|NCT01203072|42016470|FG000|Overall Study|Lost to Follow-up|0|||
19568698|NCT01203072|42016471|FG001|Overall Study|Lost to Follow-up|1|||
19568699|NCT01203072|42016472|FG002|Overall Study|Lost to Follow-up|0|||
19568700|NCT01203072|42016473|FG003|Overall Study|Lost to Follow-up|0|||
19568701|NCT01203072|42016474|FG004|Overall Study|Lost to Follow-up|0|||
19568702|NCT01203072|42016470|FG000|Overall Study|Protocol Violation|2|||
19568703|NCT01203072|42016471|FG001|Overall Study|Protocol Violation|0|||
19745657|NCT00025259|42192987|FG003|Overall Study|Withdrawal by Subject|14|||
19745658|NCT00025259|42192988|FG004|Overall Study|Withdrawal by Subject|11|||
19745659|NCT00025259|42192989|FG005|Overall Study|Withdrawal by Subject|8|||
19745660|NCT00025259|42192990|FG006|Overall Study|Withdrawal by Subject|3|||
19745661|NCT00025259|42192984|FG000|Overall Study|Ineligible|14|||
19384074|NCT00703781|41627011|FG001|Overall Study|Cancelled surgery|0|||
19384075|NCT00703157|41627019|FG000|Overall Study|Lost to Follow-up|0|||
19384076|NCT00703157|41627020|FG001|Overall Study|Lost to Follow-up|1|||
19745662|NCT00025259|42192985|FG001|Overall Study|Ineligible|1|||
19745663|NCT00025259|42192986|FG002|Overall Study|Ineligible|0|||
19745664|NCT00025259|42192987|FG003|Overall Study|Ineligible|0|||
19745665|NCT00025259|42192988|FG004|Overall Study|Ineligible|6|||
19745666|NCT00025259|42192989|FG005|Overall Study|Ineligible|0|||
19745667|NCT00025259|42192990|FG006|Overall Study|Ineligible|1|||
19745668|NCT00025259|42192984|FG000|Overall Study|Randomization error|1|||
19745669|NCT00025259|42192985|FG001|Overall Study|Randomization error|0|||
19745670|NCT00025259|42192986|FG002|Overall Study|Randomization error|0|||
19745671|NCT00025259|42192987|FG003|Overall Study|Randomization error|0|||
19745672|NCT00025259|42192988|FG004|Overall Study|Randomization error|1|||
19745673|NCT00025259|42192989|FG005|Overall Study|Randomization error|7|||
19745674|NCT00025259|42192990|FG006|Overall Study|Randomization error|2|||
19745675|NCT00025259|42192984|FG000|Overall Study|Adverse Event|1|||
19745676|NCT00025259|42192985|FG001|Overall Study|Adverse Event|0|||
19745677|NCT00025259|42192986|FG002|Overall Study|Adverse Event|0|||
19745678|NCT00025259|42192987|FG003|Overall Study|Adverse Event|0|||
19745679|NCT00025259|42192988|FG004|Overall Study|Adverse Event|0|||
19745680|NCT00025259|42192989|FG005|Overall Study|Adverse Event|0|||
19745681|NCT00025259|42192990|FG006|Overall Study|Adverse Event|0|||
19745682|NCT03351738|42193015|FG000|Overall Study|Withdrawal by Subject|0|||
19745683|NCT03351738|42193016|FG001|Overall Study|Withdrawal by Subject|1|||
19568704|NCT01203072|42016472|FG002|Overall Study|Protocol Violation|0|||
19568705|NCT01203072|42016473|FG003|Overall Study|Protocol Violation|0|||
19745684|NCT03351738|42193017|FG002|Overall Study|Withdrawal by Subject|0|||
19745685|NCT03351738|42193018|FG003|Overall Study|Withdrawal by Subject|1|||
19745686|NCT03351738|42193019|FG004|Overall Study|Withdrawal by Subject|0|||
19745687|NCT03351738|42193020|FG005|Overall Study|Withdrawal by Subject|0|||
19745688|NCT03351114|42193039|FG000|Overall Study|Withdrawal by Subject|1|||
19384077|NCT00703157|41627019|FG000|Overall Study|source data permanently lost/ other|4|||
19745689|NCT03350256|42193043|FG000|Overall Study|Inclusion/exclusion violation|4|||
19568706|NCT01203072|42016474|FG004|Overall Study|Protocol Violation|1|||
19384078|NCT00703157|41627020|FG001|Overall Study|source data permanently lost/ other|1|||
19384079|NCT03307967|41627028|FG000|Overall Study|Lost to Follow-up|4|||
19384080|NCT02722967|41627035|FG000|Overall Study|Adverse Event|1|||
19384081|NCT02722967|41627036|FG001|Overall Study|Adverse Event|0|||
19384082|NCT02722967|41627037|FG002|Overall Study|Adverse Event|0|||
19384083|NCT02722967|41627035|FG000|Overall Study|Lost to Follow-up|0|||
19384084|NCT02722967|41627036|FG001|Overall Study|Lost to Follow-up|1|||
19384085|NCT02722967|41627037|FG002|Overall Study|Lost to Follow-up|0|||
19384086|NCT02722967|41627035|FG000|Overall Study|Non-compliance with patch wearing|2|||
19384087|NCT02722967|41627036|FG001|Overall Study|Non-compliance with patch wearing|1|||
19384088|NCT02722967|41627037|FG002|Overall Study|Non-compliance with patch wearing|1|||
19384089|NCT02722967|41627035|FG000|Overall Study|Withdrawal by Subject|1|||
19384090|NCT02722967|41627036|FG001|Overall Study|Withdrawal by Subject|0|||
19384091|NCT02722967|41627037|FG002|Overall Study|Withdrawal by Subject|1|||
19384092|NCT02722967|41627035|FG000|Overall Study|Physician Decision|1|||
19384093|NCT02722967|41627036|FG001|Overall Study|Physician Decision|0|||
19384094|NCT02722967|41627037|FG002|Overall Study|Physician Decision|0|||
19384095|NCT02722967|41627035|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
19384096|NCT02722967|41627036|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
19745690|NCT03350256|42193043|FG000|Overall Study|Recommended for other therapies|2|||
19745691|NCT03350256|42193043|FG000|Overall Study|Protocol Violation|3|||
19745692|NCT03350256|42193043|FG000|Overall Study|Non compliance|2|||
19745693|NCT03350256|42193043|FG000|Overall Study|Denial by insurance|1|||
19745694|NCT03350256|42193043|FG000|Overall Study|Adverse Event|2|||
19384097|NCT02722967|41627037|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
19476913|NCT01551355|41755086|FG005|Overall Study|Lost to Follow-up|6|||
19745695|NCT03350256|42193043|FG000|Overall Study|Trial failure|12|||
19745696|NCT03350256|42193043|FG000|Overall Study|Did not proceed to permanent implant|3|||
19745697|NCT03350256|42193043|FG000|Overall Study|Withdrawal by Subject|3|||
19745698|NCT03350256|42193043|FG000|Overall Study|Subject moving out of state|1|||
19568707|NCT01203072|42016470|FG000|Overall Study|Withdrawal by Subject|2|||
19568708|NCT01203072|42016471|FG001|Overall Study|Withdrawal by Subject|2|||
19568709|NCT01203072|42016472|FG002|Overall Study|Withdrawal by Subject|1|||
19568710|NCT01203072|42016473|FG003|Overall Study|Withdrawal by Subject|2|||
19568711|NCT01203072|42016474|FG004|Overall Study|Withdrawal by Subject|3|||
19568712|NCT01105377|42016488|FG000|Overall Study|Withdrawal by Subject|0|||
19568713|NCT01105377|42016489|FG001|Overall Study|Withdrawal by Subject|1|||
19568714|NCT01105065|42016495|FG000|Overall Study|Adverse Event|5|||
19568715|NCT01105065|42016495|FG000|Overall Study|Technical Problems|1|||
19568716|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
19568717|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19568718|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19568719|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19568720|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19568721|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
19568722|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19568723|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19568724|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19568725|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19568726|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
19568727|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19568728|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19568729|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19568730|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19568731|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
19568732|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
19568733|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
19568734|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
19568735|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
19568736|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
19568737|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
19568738|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
19568739|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
19568740|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
19568741|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
19568742|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19568743|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19568744|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19568745|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19568746|NCT01111539|42016501|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
19568747|NCT01111539|42016502|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
19568748|NCT01111539|42016503|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
19568749|NCT01111539|42016504|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
19568750|NCT01111539|42016505|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
19568751|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19568752|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19568753|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
19568754|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
19384098|NCT02722499|41627048|FG000|Overall Study|Lost to Follow-up|2|||
19384099|NCT02722499|41627049|FG001|Overall Study|Lost to Follow-up|0|||
19384100|NCT02722499|41627050|FG002|Overall Study|Lost to Follow-up|1|||
19568755|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
19568756|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19568757|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19568758|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
19568759|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19568760|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
19568761|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
19568762|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
19568763|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
19568764|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
19568765|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
19568766|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
19568767|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
19568768|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
19568769|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
19568770|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
19568771|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
19568772|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
19568773|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
19568774|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
19568775|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
19568776|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
19568777|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
19568778|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
19568779|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
19568780|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
19568781|NCT01111539|42016501|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19568782|NCT01111539|42016502|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19568783|NCT01111539|42016503|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19568784|NCT01111539|42016504|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19568785|NCT01111539|42016505|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
19568786|NCT01111461|42016515|FG000|Overall Study|Adverse Event|32|||
19568787|NCT01111461|42016515|FG000|Overall Study|Participant choice|11|||
19568788|NCT01111461|42016515|FG000|Overall Study|Lost to Follow-up|1|||
19568789|NCT01111461|42016515|FG000|Overall Study|Withdrawal by Subject|1|||
19568790|NCT01111461|42016515|FG000|Overall Study|Other|6|||
19384101|NCT02721875|41627060|FG000|Overall Study|Progressive disease/relapse|1|||
19384102|NCT02721875|41627061|FG001|Overall Study|Progressive disease/relapse|0|||
19568791|NCT01111149|42016522|FG000|Overall Study|Protocol Violation|1|||
19568792|NCT01111149|42016523|FG001|Overall Study|Protocol Violation|1|||
19568793|NCT01111149|42016524|FG002|Overall Study|Protocol Violation|2|||
19568794|NCT01111149|42016522|FG000|Overall Study|Withdrawal by Subject|1|||
19568795|NCT01111149|42016523|FG001|Overall Study|Withdrawal by Subject|0|||
19568796|NCT01111149|42016524|FG002|Overall Study|Withdrawal by Subject|2|||
19476914|NCT01569841|41755094|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
19568797|NCT01254656|42016535|FG000|Overall Study|Discontinued due to termination of study|40|||
19568798|NCT01254656|42016536|FG001|Overall Study|Discontinued due to termination of study|39|||
19568799|NCT01254656|42016537|FG002|Overall Study|Discontinued due to termination of study|13|||
19568800|NCT01254656|42016535|FG000|Overall Study|Lack of Efficacy|3|||
19568801|NCT01254656|42016536|FG001|Overall Study|Lack of Efficacy|0|||
19568802|NCT01254656|42016537|FG002|Overall Study|Lack of Efficacy|0|||
19568803|NCT01254656|42016535|FG000|Overall Study|Lost to Follow-up|1|||
19568804|NCT01254656|42016536|FG001|Overall Study|Lost to Follow-up|0|||
19568805|NCT01254656|42016537|FG002|Overall Study|Lost to Follow-up|2|||
19568806|NCT01254656|42016535|FG000|Overall Study|Withdrawal by Subject|2|||
19568807|NCT01254656|42016536|FG001|Overall Study|Withdrawal by Subject|2|||
19568808|NCT01254656|42016537|FG002|Overall Study|Withdrawal by Subject|1|||
19568809|NCT01254656|42016535|FG000|Overall Study|Pregnancy|0|||
19568810|NCT01254656|42016536|FG001|Overall Study|Pregnancy|0|||
19568811|NCT01254656|42016537|FG002|Overall Study|Pregnancy|2|||
19568812|NCT01254656|42016535|FG000|Overall Study|Adverse Event|1|||
19568813|NCT01254656|42016536|FG001|Overall Study|Adverse Event|1|||
19568814|NCT01254656|42016537|FG002|Overall Study|Adverse Event|0|||
19568815|NCT01254656|42016535|FG000|Overall Study|Death|0|||
19568816|NCT01254656|42016536|FG001|Overall Study|Death|1|||
19568817|NCT01254656|42016537|FG002|Overall Study|Death|0|||
19568818|NCT01110915|42016547|FG000|Overall Study|Death|2|||
19568819|NCT01110915|42016548|FG001|Overall Study|Death|1|||
19568820|NCT01110915|42016547|FG000|Overall Study|Lost to Follow-up|1|||
19568821|NCT01110915|42016548|FG001|Overall Study|Lost to Follow-up|0|||
19568822|NCT01110915|42016547|FG000|Overall Study|Withdrawal by Subject|7|||
19568823|NCT01110915|42016548|FG001|Overall Study|Withdrawal by Subject|1|||
19568824|NCT01254344|42016557|FG000|Overall Study|Adverse Event|2|||
19568825|NCT01254344|42016558|FG001|Overall Study|Adverse Event|5|||
19568826|NCT01254344|42016557|FG000|Overall Study|Physician Decision|7|||
19568827|NCT01254344|42016558|FG001|Overall Study|Physician Decision|4|||
19568828|NCT01254344|42016557|FG000|Overall Study|Protocol Violation|1|||
19568829|NCT01254344|42016558|FG001|Overall Study|Protocol Violation|4|||
19568830|NCT01254344|42016557|FG000|Overall Study|Withdrawal by Subject|3|||
19568831|NCT01254344|42016558|FG001|Overall Study|Withdrawal by Subject|6|||
19568832|NCT01102803|42016566|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
19568833|NCT01102803|42016567|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
19476915|NCT01569841|41755095|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
19568834|NCT01102803|42016566|FG000|Post to Follow-Up|Lost to Follow-up|1|||
19568835|NCT01102803|42016567|FG001|Post to Follow-Up|Lost to Follow-up|3|||
19568836|NCT01254188|42016575|FG000|Overall Study|Disease Progression|6|||
19568837|NCT01254188|42016575|FG000|Overall Study|Protocol Violation|6|||
19568838|NCT01254188|42016575|FG000|Overall Study|Pregnancy|2|||
19568839|NCT01254188|42016575|FG000|Overall Study|Death|4|||
19568840|NCT01254188|42016575|FG000|Overall Study|Lost to Follow-up|5|||
19568841|NCT01254188|42016575|FG000|Overall Study|Withdrawal by Subject|7|||
19568842|NCT01254188|42016575|FG000|Overall Study|Adverse Event|43|||
19568843|NCT01254188|42016575|FG000|Overall Study|per investigator discretion|20|||
19568844|NCT01109979|42016581|FG000|Overall Study|Physician Decision|2|||
19568845|NCT01109979|42016582|FG001|Overall Study|Physician Decision|0|||
19568846|NCT01109979|42016581|FG000|Overall Study|Withdrawal by Subject|0|||
19568847|NCT01109979|42016582|FG001|Overall Study|Withdrawal by Subject|1|||
19568848|NCT01102491|42016590|FG000|Overall Study|Protocol Violation|11|||
19568849|NCT01102491|42016591|FG001|Overall Study|Protocol Violation|12|||
19568850|NCT01102257|42016599|FG000|Overall Study|Adverse Event|1|||
19568851|NCT01102257|42016600|FG001|Overall Study|Adverse Event|0|||
19568852|NCT01102257|42016599|FG000|Overall Study|Adverse Event|1|||
19568853|NCT01102257|42016600|FG001|Overall Study|Adverse Event|0|||
19568854|NCT01253564|42016606|FG000|Overall Study|Disease Progression|22|||
19568855|NCT01253564|42016606|FG000|Overall Study|Withdrawal by Subject|1|||
19568856|NCT01253564|42016606|FG000|Overall Study|Serious Adverse Event|1|||
19568857|NCT01108809|42016610|FG000|Overall Study|Adverse Event|3|||
19568858|NCT01108809|42016610|FG000|Overall Study|Lost to Follow-up|1|||
19568859|NCT01253408|42016618|FG000|Overall Study|Adverse Event|0|||
19568860|NCT01253408|42016619|FG001|Overall Study|Adverse Event|1|||
19568861|NCT01253408|42016620|FG002|Overall Study|Adverse Event|0|||
19568862|NCT01253174|42016628|FG000|Period 1|Randomized but not treated|0|||
19568863|NCT01253174|42016629|FG001|Period 1|Randomized but not treated|1|||
19568864|NCT01253174|42016630|FG002|Period 1|Randomized but not treated|1|||
19568865|NCT01253174|42016631|FG003|Period 1|Randomized but not treated|0|||
19568866|NCT01253174|42016632|FG004|Period 1|Randomized but not treated|1|||
19568867|NCT01253174|42016633|FG005|Period 1|Randomized but not treated|0|||
19568868|NCT01253174|42016628|FG000|Period 2|Adverse Event|0|||
19568869|NCT01253174|42016629|FG001|Period 2|Adverse Event|0|||
19568870|NCT01253174|42016630|FG002|Period 2|Adverse Event|1|||
19568871|NCT01253174|42016631|FG003|Period 2|Adverse Event|0|||
19568872|NCT01253174|42016632|FG004|Period 2|Adverse Event|0|||
19568873|NCT01253174|42016633|FG005|Period 2|Adverse Event|0|||
19568874|NCT01253174|42016628|FG000|Period 3|Withdrawal by Subject|0|||
19568875|NCT01253174|42016629|FG001|Period 3|Withdrawal by Subject|1|||
19568876|NCT01253174|42016630|FG002|Period 3|Withdrawal by Subject|0|||
19568877|NCT01253174|42016631|FG003|Period 3|Withdrawal by Subject|0|||
19384103|NCT02721251|41627070|FG000|Overall Study|Withdrawal by Subject|8|||
19384104|NCT02721251|41627071|FG001|Overall Study|Withdrawal by Subject|7|||
19384105|NCT02721251|41627072|FG002|Overall Study|Withdrawal by Subject|9|||
19384106|NCT02721251|41627070|FG000|Overall Study|poor adherence|2|||
19384107|NCT02721251|41627071|FG001|Overall Study|poor adherence|2|||
19384108|NCT02721251|41627072|FG002|Overall Study|poor adherence|2|||
19384109|NCT00702221|41627083|FG000|Overall Study|Adverse Event|4|||
19384110|NCT00702221|41627084|FG001|Overall Study|Adverse Event|3|||
19384111|NCT02634333|41627092|FG000|Overall Study|Completed out of Window|3|||
19384112|NCT02634333|41627093|FG001|Overall Study|Completed out of Window|2|||
19384113|NCT02634333|41627092|FG000|Overall Study|Missed Visit|5|||
19384114|NCT02634333|41627093|FG001|Overall Study|Missed Visit|2|||
19384115|NCT02634333|41627092|FG000|Overall Study|Lost to Follow-up|12|||
19384116|NCT02634333|41627093|FG001|Overall Study|Lost to Follow-up|7|||
19384117|NCT02634333|41627092|FG000|Overall Study|Withdrawal by Subject|9|||
19384118|NCT02634333|41627093|FG001|Overall Study|Withdrawal by Subject|13|||
19384119|NCT02634333|41627092|FG000|Overall Study|Death|11|||
19384120|NCT02634333|41627093|FG001|Overall Study|Death|8|||
19384121|NCT00702143|41627103|FG000|Overall Study|Lost to Follow-up|0|||
19384122|NCT00702143|41627104|FG001|Overall Study|Lost to Follow-up|0|||
19384123|NCT00702143|41627105|FG002|Overall Study|Lost to Follow-up|1|||
19384124|NCT00702923|41627111|FG000|Overall Study|Adverse Event|1|||
19384125|NCT02633787|41627116|FG000|Overall Study|Withdrawal by Subject|1|||
19384126|NCT02719691|41627127|FG000|Overall Study|Physician Decision|0|||
19384127|NCT02719691|41627128|FG001|Overall Study|Physician Decision|0|||
19568878|NCT01253174|42016632|FG004|Period 3|Withdrawal by Subject|1|||
19568879|NCT01253174|42016633|FG005|Period 3|Withdrawal by Subject|0|||
19568880|NCT01253174|42016628|FG000|Period 3|Pregnancy|0|||
19568881|NCT01253174|42016629|FG001|Period 3|Pregnancy|0|||
19568882|NCT01253174|42016630|FG002|Period 3|Pregnancy|1|||
19568883|NCT01253174|42016631|FG003|Period 3|Pregnancy|0|||
19568884|NCT01253174|42016632|FG004|Period 3|Pregnancy|0|||
19568885|NCT01253174|42016633|FG005|Period 3|Pregnancy|0|||
19384128|NCT02719691|41627129|FG002|Overall Study|Physician Decision|1|||
19384129|NCT02719691|41627130|FG003|Overall Study|Physician Decision|0|||
19384130|NCT02719691|41627131|FG004|Overall Study|Physician Decision|0|||
19384131|NCT02719691|41627132|FG005|Overall Study|Physician Decision|0|||
19384132|NCT02719691|41627133|FG006|Overall Study|Physician Decision|0|||
19384133|NCT02719691|41627127|FG000|Overall Study|Withdrawal by Subject|0|||
19384134|NCT02719691|41627128|FG001|Overall Study|Withdrawal by Subject|0|||
19384135|NCT02719691|41627129|FG002|Overall Study|Withdrawal by Subject|0|||
19384136|NCT02719691|41627130|FG003|Overall Study|Withdrawal by Subject|0|||
19568886|NCT01108731|42016644|FG000|Overall Study|Withdrawal by Subject|1|||
19384137|NCT02719691|41627131|FG004|Overall Study|Withdrawal by Subject|0|||
19384138|NCT02719691|41627132|FG005|Overall Study|Withdrawal by Subject|1|||
19384139|NCT02719691|41627133|FG006|Overall Study|Withdrawal by Subject|0|||
19384140|NCT02720081|41627152|FG000|Overall Study|Adverse Event|0|||
19384141|NCT02720081|41627153|FG001|Overall Study|Adverse Event|3|||
19384142|NCT02720081|41627152|FG000|Overall Study|Protocol Violation|4|||
19384143|NCT02720081|41627153|FG001|Overall Study|Protocol Violation|1|||
19384144|NCT04248933|41627159|FG000|Overall Study|Lost to Follow-up|9|||
19384145|NCT04248933|41627159|FG000|Overall Study|Withdrawal by Subject|2|||
19384146|NCT02718131|41627165|FG000|Overall Study|Withdrawal by Subject|1|||
19384147|NCT02718131|41627166|FG001|Overall Study|Withdrawal by Subject|0|||
19384148|NCT02718131|41627165|FG000|Overall Study|Adverse Event|1|||
19568887|NCT01108731|42016645|FG001|Overall Study|Withdrawal by Subject|1|||
19568888|NCT01108731|42016644|FG000|Overall Study|Adverse Event|3|||
19568889|NCT01108731|42016645|FG001|Overall Study|Adverse Event|3|||
19568890|NCT01253018|42016653|FG000|Overall Study|Lost to Follow-up|1|||
19568891|NCT01253018|42016654|FG001|Overall Study|Lost to Follow-up|1|||
19568892|NCT01253018|42016653|FG000|Overall Study|Robot Repair Issues|2|||
19568893|NCT01253018|42016654|FG001|Overall Study|Robot Repair Issues|0|||
19568894|NCT01253018|42016653|FG000|Overall Study|Withdrawal by Subject|1|||
19568895|NCT01253018|42016654|FG001|Overall Study|Withdrawal by Subject|1|||
19568896|NCT01108341|42016661|FG000|Overall Study|Death|2|||
19568897|NCT01108341|42016661|FG000|Overall Study|Withdrawal by Subject|1|||
19568898|NCT01108341|42016661|FG000|Overall Study|Lost to Follow-up|1|||
19568899|NCT01108341|42016661|FG000|Overall Study|Other|1|||
19568900|NCT01108263|42016667|FG000|Overall Study|Adverse Event|0|||
19568901|NCT01108263|42016668|FG001|Overall Study|Adverse Event|1|||
19568902|NCT01108185|42016674|FG000|Overall Study|Non-compliance|15|||
19568903|NCT01108185|42016674|FG000|Overall Study|Lost to Follow-up|12|||
19568904|NCT01252940|42016680|FG000|Main Study Phase|Randomized but not treated|4|||
19568905|NCT01252940|42016681|FG001|Main Study Phase|Randomized but not treated|2|||
19568906|NCT01252940|42016680|FG000|Main Study Phase|Adverse Event|3|||
19568907|NCT01252940|42016681|FG001|Main Study Phase|Adverse Event|1|||
19568908|NCT01252940|42016680|FG000|Main Study Phase|Lack of Efficacy|1|||
19568909|NCT01252940|42016681|FG001|Main Study Phase|Lack of Efficacy|0|||
19568910|NCT01252940|42016680|FG000|Main Study Phase|Lost to Follow-up|6|||
19568911|NCT01252940|42016681|FG001|Main Study Phase|Lost to Follow-up|1|||
19568912|NCT01252940|42016680|FG000|Main Study Phase|Physician Decision|1|||
19568913|NCT01252940|42016681|FG001|Main Study Phase|Physician Decision|0|||
19568914|NCT01252940|42016680|FG000|Main Study Phase|Protocol Violation|4|||
19568915|NCT01252940|42016681|FG001|Main Study Phase|Protocol Violation|2|||
19568916|NCT01252940|42016680|FG000|Main Study Phase|Withdrawal by Subject|6|||
19568917|NCT01252940|42016681|FG001|Main Study Phase|Withdrawal by Subject|5|||
19568918|NCT01252940|42016680|FG000|Main Study Phase|Subject Non-compliance|1|||
19568919|NCT01252940|42016681|FG001|Main Study Phase|Subject Non-compliance|1|||
19568920|NCT01252940|42016680|FG000|Extension Phase|Adverse Event|2|||
19568921|NCT01252940|42016681|FG001|Extension Phase|Adverse Event|1|||
19568922|NCT01252940|42016680|FG000|Extension Phase|Lack of Efficacy|1|||
19568923|NCT01252940|42016681|FG001|Extension Phase|Lack of Efficacy|0|||
19568924|NCT01252940|42016680|FG000|Extension Phase|Lost to Follow-up|5|||
19568925|NCT01252940|42016681|FG001|Extension Phase|Lost to Follow-up|0|||
19568926|NCT01252940|42016680|FG000|Extension Phase|Physician Decision|0|||
19568927|NCT01252940|42016681|FG001|Extension Phase|Physician Decision|1|||
19568928|NCT01252940|42016680|FG000|Extension Phase|Subject Non-compliance|1|||
19568929|NCT01252940|42016681|FG001|Extension Phase|Subject Non-compliance|0|||
19568930|NCT01252940|42016680|FG000|Extension Phase|Withdrawal by Subject|1|||
19568931|NCT01252940|42016681|FG001|Extension Phase|Withdrawal by Subject|1|||
19568932|NCT01252238|42016691|FG000|Overall Study|Sponsor terminated study|4|||
19568933|NCT01252238|42016692|FG001|Overall Study|Sponsor terminated study|4|||
19568934|NCT01252238|42016693|FG002|Overall Study|Sponsor terminated study|4|||
19568935|NCT01101477|42016707|FG000|Overall Study|Protocol Violation|5|||
19568936|NCT01101477|42016708|FG001|Overall Study|Protocol Violation|3|||
19568937|NCT01101477|42016709|FG002|Overall Study|Protocol Violation|1|||
19568938|NCT01251770|42016719|FG000|Overall Study|Protocol Violation|13|||
19384149|NCT02718131|41627166|FG001|Overall Study|Adverse Event|0|||
19568939|NCT01251770|42016720|FG001|Overall Study|Protocol Violation|7|||
19568940|NCT01101321|42016726|FG000|Period 1|Withdrawal by Subject|1|||
19568941|NCT01101321|42016727|FG001|Period 1|Withdrawal by Subject|1|||
19568942|NCT01101321|42016726|FG000|Period 1|Adverse Event|3|||
19568943|NCT01101321|42016727|FG001|Period 1|Adverse Event|3|||
19568944|NCT01101165|42016733|FG000|Period 1|Adverse Event|1|||
19568945|NCT01101165|42016734|FG001|Period 1|Adverse Event|2|||
19384150|NCT02718131|41627165|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
19384151|NCT02718131|41627166|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
19568946|NCT01101165|42016733|FG000|Period 1|Withdrawal by Subject|0|||
19568947|NCT01101165|42016734|FG001|Period 1|Withdrawal by Subject|2|||
19568948|NCT01101165|42016733|FG000|Period 1|Positive Drug Screen|0|||
19568949|NCT01101165|42016734|FG001|Period 1|Positive Drug Screen|1|||
19568950|NCT01101165|42016733|FG000|Period 1|Lost to Follow-up|1|||
19568951|NCT01101165|42016734|FG001|Period 1|Lost to Follow-up|0|||
19568952|NCT01101165|42016733|FG000|Period 2|Withdrawal by Subject|3|||
19568953|NCT01101165|42016734|FG001|Period 2|Withdrawal by Subject|1|||
19568954|NCT01101165|42016733|FG000|Period 2|Adverse Event|1|||
19568955|NCT01101165|42016734|FG001|Period 2|Adverse Event|0|||
19568956|NCT01100853|42016742|FG000|Overall Study|Lost to Follow-up|11|||
19568957|NCT01100853|42016743|FG001|Overall Study|Lost to Follow-up|6|||
19568958|NCT01100853|42016742|FG000|Overall Study|Received <4 study injections|10|||
19568959|NCT01100853|42016743|FG001|Overall Study|Received <4 study injections|13|||
19568960|NCT01100853|42016742|FG000|Overall Study|Withdrawal by Subject|6|||
19568961|NCT01100853|42016743|FG001|Overall Study|Withdrawal by Subject|4|||
19568962|NCT01100307|42016751|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
19568963|NCT01100307|42016752|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
19568964|NCT01100307|42016751|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
19568965|NCT01100307|42016752|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
19568966|NCT01100307|42016751|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
19568967|NCT01100307|42016752|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
19568968|NCT01100307|42016751|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
19568969|NCT01100307|42016752|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
19568970|NCT01100307|42016751|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
19568971|NCT01100307|42016752|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
19568972|NCT01100307|42016751|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
19568973|NCT01100307|42016752|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
19568974|NCT01100073|42016760|FG000|Overall Study|Lack of Efficacy|4|||
19568975|NCT01100073|42016760|FG000|Overall Study|Insufficient Tolerability|21|||
19568976|NCT01100073|42016760|FG000|Overall Study|Withdrawal by Subject|13|||
19568977|NCT01100073|42016760|FG000|Overall Study|Lost to Follow-up|39|||
19568978|NCT01100073|42016760|FG000|Overall Study|Lack of effect + patient's wish|2|||
19568979|NCT01100073|42016760|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
19568980|NCT01100073|42016760|FG000|Overall Study|Other|8|||
19568981|NCT01100073|42016760|FG000|Overall Study|Missing|5|||
19568982|NCT01099917|42016764|FG000|Overall Study|Adverse Event|3|||
19568983|NCT01099917|42016764|FG000|Overall Study|Not Treated|24|||
19568984|NCT01099215|42016770|FG000|Overall Study|Withdrawal by Subject|1|||
19568985|NCT01099215|42016771|FG001|Overall Study|Withdrawal by Subject|0|||
19568986|NCT01099215|42016770|FG000|Overall Study|Adverse Event|0|||
19568987|NCT01099215|42016771|FG001|Overall Study|Adverse Event|1|||
19568988|NCT01097655|42016777|FG000|Overall Study|Withdrawal by Subject|1|||
19568989|NCT01097655|42016777|FG000|Overall Study|Subject Documented Twice|1|||
19568990|NCT01097655|42016777|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
19568991|NCT01107405|42016786|FG000|Overall Study|Adverse Event|1|||
19568992|NCT01107405|42016787|FG001|Overall Study|Adverse Event|1|||
19568993|NCT01107405|42016788|FG002|Overall Study|Adverse Event|0|||
19568994|NCT01107405|42016789|FG003|Overall Study|Adverse Event|0|||
19568995|NCT01107405|42016790|FG004|Overall Study|Adverse Event|2|||
19568996|NCT01107405|42016786|FG000|Overall Study|Withdrawal by Subject|1|||
19568997|NCT01107405|42016787|FG001|Overall Study|Withdrawal by Subject|0|||
19568998|NCT01107405|42016788|FG002|Overall Study|Withdrawal by Subject|1|||
19568999|NCT01107405|42016789|FG003|Overall Study|Withdrawal by Subject|2|||
19569000|NCT01107405|42016790|FG004|Overall Study|Withdrawal by Subject|1|||
19569001|NCT01107405|42016786|FG000|Overall Study|Protocol Violation|0|||
19569002|NCT01107405|42016787|FG001|Overall Study|Protocol Violation|0|||
19569003|NCT01107405|42016788|FG002|Overall Study|Protocol Violation|1|||
19384152|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
19569004|NCT01107405|42016789|FG003|Overall Study|Protocol Violation|1|||
19569005|NCT01107405|42016790|FG004|Overall Study|Protocol Violation|0|||
19569006|NCT01097577|42016804|FG000|Overall Study|Adverse Event|0|||
19569007|NCT01097577|42016805|FG001|Overall Study|Adverse Event|1|||
19569008|NCT01097421|42016811|FG000|Overall Study|Adverse Event|8|||
19569009|NCT01097421|42016811|FG000|Overall Study|Protocol Violation|2|||
19569010|NCT01097421|42016811|FG000|Overall Study|Lost to Follow-up|1|||
19569011|NCT01097421|42016811|FG000|Overall Study|Withdrawal by Subject|3|||
19569012|NCT01251614|42016818|FG000|Overall Study|Adverse Event|1|||
19569013|NCT01251614|42016819|FG001|Overall Study|Adverse Event|0|||
19569014|NCT01251614|42016820|FG002|Overall Study|Adverse Event|1|||
19569015|NCT01251614|42016818|FG000|Overall Study|Lack of Efficacy|1|||
19569016|NCT01251614|42016819|FG001|Overall Study|Lack of Efficacy|9|||
19569017|NCT01251614|42016820|FG002|Overall Study|Lack of Efficacy|4|||
19569018|NCT01251614|42016818|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
19569019|NCT01251614|42016819|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
19569020|NCT01251614|42016820|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
19569021|NCT01251614|42016818|FG000|Overall Study|Pregnancy|0|||
19569022|NCT01251614|42016819|FG001|Overall Study|Pregnancy|0|||
19569023|NCT01251614|42016820|FG002|Overall Study|Pregnancy|2|||
19569024|NCT01251614|42016818|FG000|Overall Study|Loss of Disease Control|0|||
19569025|NCT01251614|42016819|FG001|Overall Study|Loss of Disease Control|1|||
19569026|NCT01251614|42016820|FG002|Overall Study|Loss of Disease Control|0|||
19569027|NCT01251614|42016818|FG000|Overall Study|Withdrawal by Subject|0|||
19569028|NCT01251614|42016819|FG001|Overall Study|Withdrawal by Subject|2|||
19569029|NCT01251614|42016820|FG002|Overall Study|Withdrawal by Subject|1|||
19569030|NCT01251614|42016818|FG000|Overall Study|Lost to Follow-up|0|||
19569031|NCT01251614|42016819|FG001|Overall Study|Lost to Follow-up|1|||
19569032|NCT01251614|42016820|FG002|Overall Study|Lost to Follow-up|0|||
19569033|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
19569034|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
19569035|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
19569036|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
19569037|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
19569038|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
19569039|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
19569040|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
19569041|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
19569042|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
19569043|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
19569044|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
19569045|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
19569046|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
19569047|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
19569048|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
19569049|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
19569050|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19569051|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
19569052|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
19569053|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
19569054|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
19569055|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
19569056|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19569057|NCT01106625|42016841|FG000|Core Period: Baseline to Week 26|Other|8|||
19569058|NCT01106625|42016842|FG001|Core Period: Baseline to Week 26|Other|7|||
19569059|NCT01106625|42016843|FG002|Core Period: Baseline to Week 26|Other|4|||
19569060|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
19569061|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
19569062|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
19569063|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
19569064|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
19569065|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
19569066|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
19569067|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19569068|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
19569069|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19384153|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
19745699|NCT03350256|42193043|FG000|Overall Study|Lost to Follow-up|1|||
19745700|NCT03350256|42193043|FG000|Overall Study|Lack of Efficacy|2|||
19569070|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19569071|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
19569072|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
19569073|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19569074|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19569075|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
19569076|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
19569077|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
19569078|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
19569079|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
19569080|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
19569081|NCT01106625|42016841|FG000|Extension Period: Week 26 to Week 52|Other|5|||
19569082|NCT01106625|42016842|FG001|Extension Period: Week 26 to Week 52|Other|5|||
19569083|NCT01106625|42016843|FG002|Extension Period: Week 26 to Week 52|Other|4|||
19569084|NCT01251380|42016854|FG000|Overall Study|Other (Not otherwise specified)|12|||
19569085|NCT01251380|42016854|FG000|Overall Study|Withdrawal by Subject|6|||
19569086|NCT01251380|42016854|FG000|Overall Study|Lack of Efficacy|1|||
19569087|NCT01251380|42016854|FG000|Overall Study|Adverse Event|1|||
19569088|NCT01251380|42016854|FG000|Overall Study|Lost to Follow-up|2|||
19569089|NCT01251146|42016865|FG000|Overall Study|Lost to Follow-up|3|||
19569090|NCT01251146|42016866|FG001|Overall Study|Lost to Follow-up|10|||
19569091|NCT01096017|42016872|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
19569092|NCT01096017|42016873|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
19569093|NCT01106157|42016881|FG000|Overall Study|Withdrawal by Subject|1|||
19569094|NCT01106157|42016882|FG001|Overall Study|Withdrawal by Subject|0|||
19569095|NCT01094301|42016888|FG000|Trial Stage|Withdrawal by Subject|1|||
19569096|NCT01094301|42016888|FG000|Implant Stage|Adverse Event|1|||
19569097|NCT01094301|42016888|FG000|Implant Stage|Protocol Violation|1|||
19569098|NCT01094301|42016888|FG000|Implant Stage|Withdrawal by Subject|2|||
19569099|NCT01094301|42016888|FG000|Implant Stage|No return of pain|4|||
19569100|NCT01093755|42016896|FG000|Overall Study|Withdrawal by Subject|3|||
19569101|NCT01093755|42016897|FG001|Overall Study|Withdrawal by Subject|4|||
19569102|NCT01093599|42016905|FG000|Overall Study|Lost to Follow-up|32|||
19569103|NCT01093599|42016906|FG001|Overall Study|Lost to Follow-up|46|||
19569104|NCT01092663|42016914|FG000|Overall Study|Withdrawal by Subject|3|||
19569105|NCT01092663|42016915|FG001|Overall Study|Withdrawal by Subject|2|||
19569106|NCT01092663|42016914|FG000|Overall Study|Glucose >300mg/dL|1|||
19569107|NCT01092663|42016915|FG001|Overall Study|Glucose >300mg/dL|0|||
19569108|NCT01092663|42016914|FG000|Overall Study|High fasting triglyceride|2|||
19569109|NCT01092663|42016915|FG001|Overall Study|High fasting triglyceride|0|||
19569110|NCT01092663|42016914|FG000|Overall Study|Adverse Event|1|||
19569111|NCT01092663|42016915|FG001|Overall Study|Adverse Event|1|||
19569112|NCT01092663|42016914|FG000|Overall Study|Protocol Violation|0|||
19569113|NCT01092663|42016915|FG001|Overall Study|Protocol Violation|1|||
19569114|NCT01078623|42016926|FG000|Treatment Period 1|Adverse Event|1|||
19569115|NCT01078623|42016927|FG001|Treatment Period 1|Adverse Event|1|||
19569116|NCT01078623|42016928|FG002|Treatment Period 1|Adverse Event|1|||
19569117|NCT01078623|42016929|FG003|Treatment Period 1|Adverse Event|0|||
19569118|NCT01078623|42016930|FG004|Treatment Period 1|Adverse Event|0|||
19569119|NCT01078623|42016931|FG005|Treatment Period 1|Adverse Event|0|||
19569120|NCT01078623|42016932|FG006|Treatment Period 1|Adverse Event|1|||
19569121|NCT01078623|42016933|FG007|Treatment Period 1|Adverse Event|0|||
19569122|NCT01078623|42016934|FG008|Treatment Period 1|Adverse Event|1|||
19569123|NCT01078623|42016935|FG009|Treatment Period 1|Adverse Event|1|||
19569124|NCT01078623|42016936|FG010|Treatment Period 1|Adverse Event|0|||
19569125|NCT01078623|42016937|FG011|Treatment Period 1|Adverse Event|0|||
19569126|NCT01078623|42016938|FG012|Treatment Period 1|Adverse Event|0|||
19569127|NCT01078623|42016939|FG013|Treatment Period 1|Adverse Event|0|||
19569128|NCT01078623|42016940|FG014|Treatment Period 1|Adverse Event|0|||
19569129|NCT01078623|42016941|FG015|Treatment Period 1|Adverse Event|0|||
19569130|NCT01078623|42016942|FG016|Treatment Period 1|Adverse Event|0|||
19569131|NCT01078623|42016943|FG017|Treatment Period 1|Adverse Event|0|||
19569132|NCT01078623|42016944|FG018|Treatment Period 1|Adverse Event|0|||
19569133|NCT01078623|42016945|FG019|Treatment Period 1|Adverse Event|0|||
19569134|NCT01078623|42016926|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19569135|NCT01078623|42016927|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19569136|NCT01078623|42016928|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19569137|NCT01078623|42016929|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19569138|NCT01078623|42016930|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19569139|NCT01078623|42016931|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19569140|NCT01078623|42016932|FG006|Treatment Period 1|Withdrawal by Subject|0|||
19569141|NCT01078623|42016933|FG007|Treatment Period 1|Withdrawal by Subject|1|||
19569142|NCT01078623|42016934|FG008|Treatment Period 1|Withdrawal by Subject|0|||
19569143|NCT01078623|42016935|FG009|Treatment Period 1|Withdrawal by Subject|0|||
19569144|NCT01078623|42016936|FG010|Treatment Period 1|Withdrawal by Subject|1|||
19569145|NCT01078623|42016937|FG011|Treatment Period 1|Withdrawal by Subject|0|||
19569146|NCT01078623|42016938|FG012|Treatment Period 1|Withdrawal by Subject|0|||
19569147|NCT01078623|42016939|FG013|Treatment Period 1|Withdrawal by Subject|0|||
19569148|NCT01078623|42016940|FG014|Treatment Period 1|Withdrawal by Subject|0|||
19569149|NCT01078623|42016941|FG015|Treatment Period 1|Withdrawal by Subject|0|||
19569150|NCT01078623|42016942|FG016|Treatment Period 1|Withdrawal by Subject|0|||
19569151|NCT01078623|42016943|FG017|Treatment Period 1|Withdrawal by Subject|0|||
19569152|NCT01078623|42016944|FG018|Treatment Period 1|Withdrawal by Subject|0|||
19569153|NCT01078623|42016945|FG019|Treatment Period 1|Withdrawal by Subject|0|||
19569154|NCT01078623|42016926|FG000|Treatment Period 1|Protocol Violation|0|||
19569155|NCT01078623|42016927|FG001|Treatment Period 1|Protocol Violation|0|||
19569156|NCT01078623|42016928|FG002|Treatment Period 1|Protocol Violation|0|||
19569157|NCT01078623|42016929|FG003|Treatment Period 1|Protocol Violation|0|||
19569158|NCT01078623|42016930|FG004|Treatment Period 1|Protocol Violation|0|||
19569159|NCT01078623|42016931|FG005|Treatment Period 1|Protocol Violation|1|||
19569160|NCT01078623|42016932|FG006|Treatment Period 1|Protocol Violation|0|||
19569161|NCT01078623|42016933|FG007|Treatment Period 1|Protocol Violation|0|||
19569162|NCT01078623|42016934|FG008|Treatment Period 1|Protocol Violation|0|||
19569163|NCT01078623|42016935|FG009|Treatment Period 1|Protocol Violation|0|||
19569164|NCT01078623|42016936|FG010|Treatment Period 1|Protocol Violation|0|||
19569165|NCT01078623|42016937|FG011|Treatment Period 1|Protocol Violation|0|||
19569166|NCT01078623|42016938|FG012|Treatment Period 1|Protocol Violation|0|||
19569167|NCT01078623|42016939|FG013|Treatment Period 1|Protocol Violation|0|||
19569168|NCT01078623|42016940|FG014|Treatment Period 1|Protocol Violation|0|||
19569169|NCT01078623|42016941|FG015|Treatment Period 1|Protocol Violation|0|||
19569170|NCT01078623|42016942|FG016|Treatment Period 1|Protocol Violation|0|||
19569171|NCT01078623|42016943|FG017|Treatment Period 1|Protocol Violation|0|||
19384154|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
19384155|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
19384156|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
19384157|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
19384158|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
19384159|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19384160|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19569172|NCT01078623|42016944|FG018|Treatment Period 1|Protocol Violation|0|||
19569173|NCT01078623|42016945|FG019|Treatment Period 1|Protocol Violation|0|||
19569174|NCT01078623|42016926|FG000|Treatment Period 2|Adverse Event|0|||
19569175|NCT01078623|42016927|FG001|Treatment Period 2|Adverse Event|0|||
19569176|NCT01078623|42016928|FG002|Treatment Period 2|Adverse Event|0|||
19569177|NCT01078623|42016929|FG003|Treatment Period 2|Adverse Event|0|||
19569178|NCT01078623|42016930|FG004|Treatment Period 2|Adverse Event|0|||
19569179|NCT01078623|42016931|FG005|Treatment Period 2|Adverse Event|0|||
19569180|NCT01078623|42016932|FG006|Treatment Period 2|Adverse Event|1|||
19569181|NCT01078623|42016933|FG007|Treatment Period 2|Adverse Event|0|||
19569182|NCT01078623|42016934|FG008|Treatment Period 2|Adverse Event|0|||
19569183|NCT01078623|42016935|FG009|Treatment Period 2|Adverse Event|0|||
19569184|NCT01078623|42016936|FG010|Treatment Period 2|Adverse Event|0|||
19569185|NCT01078623|42016937|FG011|Treatment Period 2|Adverse Event|0|||
19569186|NCT01078623|42016938|FG012|Treatment Period 2|Adverse Event|0|||
19569187|NCT01078623|42016939|FG013|Treatment Period 2|Adverse Event|0|||
19569188|NCT01078623|42016940|FG014|Treatment Period 2|Adverse Event|0|||
19569189|NCT01078623|42016941|FG015|Treatment Period 2|Adverse Event|0|||
19569190|NCT01078623|42016942|FG016|Treatment Period 2|Adverse Event|0|||
19569191|NCT01078623|42016943|FG017|Treatment Period 2|Adverse Event|0|||
19569192|NCT01078623|42016944|FG018|Treatment Period 2|Adverse Event|1|||
19384161|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
19384162|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
19384163|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
19384164|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
19384165|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
19384166|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
19384167|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
19384168|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
19384169|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
19384170|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
19569193|NCT01078623|42016945|FG019|Treatment Period 2|Adverse Event|0|||
19569194|NCT01078623|42016926|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19569195|NCT01078623|42016927|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19569196|NCT01078623|42016928|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19569197|NCT01078623|42016929|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19569198|NCT01078623|42016930|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19569199|NCT01078623|42016931|FG005|Treatment Period 2|Withdrawal by Subject|1|||
19569200|NCT01078623|42016932|FG006|Treatment Period 2|Withdrawal by Subject|0|||
19569201|NCT01078623|42016933|FG007|Treatment Period 2|Withdrawal by Subject|0|||
19569202|NCT01078623|42016934|FG008|Treatment Period 2|Withdrawal by Subject|0|||
19569203|NCT01078623|42016935|FG009|Treatment Period 2|Withdrawal by Subject|0|||
19569204|NCT01078623|42016936|FG010|Treatment Period 2|Withdrawal by Subject|0|||
19569205|NCT01078623|42016937|FG011|Treatment Period 2|Withdrawal by Subject|0|||
19569206|NCT01078623|42016938|FG012|Treatment Period 2|Withdrawal by Subject|0|||
19569207|NCT01078623|42016939|FG013|Treatment Period 2|Withdrawal by Subject|0|||
19569208|NCT01078623|42016940|FG014|Treatment Period 2|Withdrawal by Subject|0|||
19569209|NCT01078623|42016941|FG015|Treatment Period 2|Withdrawal by Subject|0|||
19569210|NCT01078623|42016942|FG016|Treatment Period 2|Withdrawal by Subject|0|||
19569211|NCT01078623|42016943|FG017|Treatment Period 2|Withdrawal by Subject|0|||
19569212|NCT01078623|42016944|FG018|Treatment Period 2|Withdrawal by Subject|0|||
19569213|NCT01078623|42016945|FG019|Treatment Period 2|Withdrawal by Subject|0|||
19569214|NCT01078623|42016926|FG000|Treatment Period 3|Adverse Event|0|||
19569215|NCT01078623|42016927|FG001|Treatment Period 3|Adverse Event|0|||
19569216|NCT01078623|42016928|FG002|Treatment Period 3|Adverse Event|0|||
19569217|NCT01078623|42016929|FG003|Treatment Period 3|Adverse Event|0|||
19569218|NCT01078623|42016930|FG004|Treatment Period 3|Adverse Event|1|||
19569219|NCT01078623|42016931|FG005|Treatment Period 3|Adverse Event|0|||
19569220|NCT01078623|42016932|FG006|Treatment Period 3|Adverse Event|0|||
19569221|NCT01078623|42016933|FG007|Treatment Period 3|Adverse Event|0|||
19569222|NCT01078623|42016934|FG008|Treatment Period 3|Adverse Event|0|||
19569223|NCT01078623|42016935|FG009|Treatment Period 3|Adverse Event|0|||
19569224|NCT01078623|42016936|FG010|Treatment Period 3|Adverse Event|0|||
19569225|NCT01078623|42016937|FG011|Treatment Period 3|Adverse Event|0|||
19569226|NCT01078623|42016938|FG012|Treatment Period 3|Adverse Event|0|||
19569227|NCT01078623|42016939|FG013|Treatment Period 3|Adverse Event|1|||
19569228|NCT01078623|42016940|FG014|Treatment Period 3|Adverse Event|0|||
19569229|NCT01078623|42016941|FG015|Treatment Period 3|Adverse Event|0|||
19569230|NCT01078623|42016942|FG016|Treatment Period 3|Adverse Event|0|||
19569231|NCT01078623|42016943|FG017|Treatment Period 3|Adverse Event|0|||
19569232|NCT01078623|42016944|FG018|Treatment Period 3|Adverse Event|0|||
19569233|NCT01078623|42016945|FG019|Treatment Period 3|Adverse Event|0|||
19569234|NCT01078623|42016926|FG000|Treatment Period 4|Adverse Event|0|||
19569235|NCT01078623|42016927|FG001|Treatment Period 4|Adverse Event|0|||
19569236|NCT01078623|42016928|FG002|Treatment Period 4|Adverse Event|1|||
19569237|NCT01078623|42016929|FG003|Treatment Period 4|Adverse Event|0|||
19569238|NCT01078623|42016930|FG004|Treatment Period 4|Adverse Event|0|||
19569239|NCT01078623|42016931|FG005|Treatment Period 4|Adverse Event|0|||
19569240|NCT01078623|42016932|FG006|Treatment Period 4|Adverse Event|0|||
19569241|NCT01078623|42016933|FG007|Treatment Period 4|Adverse Event|0|||
19569242|NCT01078623|42016934|FG008|Treatment Period 4|Adverse Event|0|||
19569243|NCT01078623|42016935|FG009|Treatment Period 4|Adverse Event|0|||
19569244|NCT01078623|42016936|FG010|Treatment Period 4|Adverse Event|0|||
19569245|NCT01078623|42016937|FG011|Treatment Period 4|Adverse Event|0|||
19569246|NCT01078623|42016938|FG012|Treatment Period 4|Adverse Event|0|||
19569247|NCT01078623|42016939|FG013|Treatment Period 4|Adverse Event|0|||
19569248|NCT01078623|42016940|FG014|Treatment Period 4|Adverse Event|0|||
19569249|NCT01078623|42016941|FG015|Treatment Period 4|Adverse Event|0|||
19569250|NCT01078623|42016942|FG016|Treatment Period 4|Adverse Event|0|||
19569251|NCT01078623|42016943|FG017|Treatment Period 4|Adverse Event|0|||
19569252|NCT01078623|42016944|FG018|Treatment Period 4|Adverse Event|0|||
19569253|NCT01078623|42016945|FG019|Treatment Period 4|Adverse Event|0|||
19569254|NCT01078623|42016926|FG000|Treatment Period 4|Withdrawal by Subject|0|||
19569255|NCT01078623|42016927|FG001|Treatment Period 4|Withdrawal by Subject|0|||
19569256|NCT01078623|42016928|FG002|Treatment Period 4|Withdrawal by Subject|0|||
19569257|NCT01078623|42016929|FG003|Treatment Period 4|Withdrawal by Subject|0|||
19569258|NCT01078623|42016930|FG004|Treatment Period 4|Withdrawal by Subject|0|||
19569259|NCT01078623|42016931|FG005|Treatment Period 4|Withdrawal by Subject|0|||
19569260|NCT01078623|42016932|FG006|Treatment Period 4|Withdrawal by Subject|0|||
19569261|NCT01078623|42016933|FG007|Treatment Period 4|Withdrawal by Subject|0|||
19569262|NCT01078623|42016934|FG008|Treatment Period 4|Withdrawal by Subject|0|||
19569263|NCT01078623|42016935|FG009|Treatment Period 4|Withdrawal by Subject|0|||
19569264|NCT01078623|42016936|FG010|Treatment Period 4|Withdrawal by Subject|0|||
19569265|NCT01078623|42016937|FG011|Treatment Period 4|Withdrawal by Subject|0|||
19569266|NCT01078623|42016938|FG012|Treatment Period 4|Withdrawal by Subject|0|||
19569267|NCT01078623|42016939|FG013|Treatment Period 4|Withdrawal by Subject|0|||
19569268|NCT01078623|42016940|FG014|Treatment Period 4|Withdrawal by Subject|0|||
19569269|NCT01078623|42016941|FG015|Treatment Period 4|Withdrawal by Subject|1|||
19569270|NCT01078623|42016942|FG016|Treatment Period 4|Withdrawal by Subject|0|||
19569271|NCT01078623|42016943|FG017|Treatment Period 4|Withdrawal by Subject|0|||
19569272|NCT01078623|42016944|FG018|Treatment Period 4|Withdrawal by Subject|0|||
19569273|NCT01078623|42016945|FG019|Treatment Period 4|Withdrawal by Subject|0|||
19569274|NCT01092507|42016959|FG000|Overall Study|Withdrawal by Subject|2|||
19569275|NCT01092507|42016960|FG001|Overall Study|Withdrawal by Subject|0|||
19569276|NCT01078545|42016966|FG000|Overall Study|Lost to Follow-up|13|||
19569277|NCT01078545|42016966|FG000|Overall Study|Physician Decision|6|||
19569278|NCT01078545|42016966|FG000|Overall Study|Withdrawal by Subject|3|||
19569279|NCT01078545|42016966|FG000|Overall Study|Death|3|||
19569280|NCT01078545|42016966|FG000|Overall Study|Participant moved to another physician|1|||
19569281|NCT01202760|42016973|FG000|Overall Study|Entry Criteria Not Met|0|||
19569282|NCT01202760|42016974|FG001|Overall Study|Entry Criteria Not Met|3|||
19569283|NCT01202760|42016975|FG002|Overall Study|Entry Criteria Not Met|1|||
19569284|NCT01202760|42016973|FG000|Overall Study|Adverse Event|11|||
19569285|NCT01202760|42016974|FG001|Overall Study|Adverse Event|9|||
19569286|NCT01202760|42016975|FG002|Overall Study|Adverse Event|10|||
19569287|NCT01202760|42016973|FG000|Overall Study|Death|2|||
19569288|NCT01202760|42016974|FG001|Overall Study|Death|1|||
19569289|NCT01202760|42016975|FG002|Overall Study|Death|0|||
19569290|NCT01202760|42016973|FG000|Overall Study|Lack of Efficacy|6|||
19569291|NCT01202760|42016974|FG001|Overall Study|Lack of Efficacy|8|||
19569292|NCT01202760|42016975|FG002|Overall Study|Lack of Efficacy|7|||
19569293|NCT01202760|42016973|FG000|Overall Study|Lost to Follow-up|0|||
19569294|NCT01202760|42016974|FG001|Overall Study|Lost to Follow-up|2|||
19569295|NCT01202760|42016975|FG002|Overall Study|Lost to Follow-up|1|||
19569296|NCT01202760|42016973|FG000|Overall Study|Parent / Caregiver Decision|0|||
19569297|NCT01202760|42016974|FG001|Overall Study|Parent / Caregiver Decision|1|||
19569298|NCT01202760|42016975|FG002|Overall Study|Parent / Caregiver Decision|0|||
19569299|NCT01202760|42016973|FG000|Overall Study|Withdrawal by Subject|17|||
19569300|NCT01202760|42016974|FG001|Overall Study|Withdrawal by Subject|18|||
19569301|NCT01202760|42016975|FG002|Overall Study|Withdrawal by Subject|14|||
19569302|NCT01202760|42016973|FG000|Overall Study|Physician Decision|0|||
19569303|NCT01202760|42016974|FG001|Overall Study|Physician Decision|1|||
19569304|NCT01202760|42016975|FG002|Overall Study|Physician Decision|0|||
19569305|NCT01202760|42016973|FG000|Overall Study|Protocol Violation|7|||
19569306|NCT01202760|42016974|FG001|Overall Study|Protocol Violation|5|||
19569307|NCT01202760|42016975|FG002|Overall Study|Protocol Violation|2|||
19569308|NCT01202760|42016973|FG000|Overall Study|Sponsor Decision|4|||
19569309|NCT01202760|42016974|FG001|Overall Study|Sponsor Decision|4|||
19569310|NCT01202760|42016975|FG002|Overall Study|Sponsor Decision|0|||
19569311|NCT01091259|42016995|FG000|Overall Study|Adverse Event|3|||
19569312|NCT01091259|42016995|FG000|Overall Study|Lack of Efficacy|2|||
19569313|NCT01091103|42016999|FG000|Overall Study|Adverse Event|1|||
19569314|NCT01091103|42016999|FG000|Overall Study|Progressive Disease|3|||
19569315|NCT01078389|42017007|FG000|Overall Study|Adverse Event|10|||
19569316|NCT01078389|42017008|FG001|Overall Study|Adverse Event|6|||
19569317|NCT01078389|42017007|FG000|Overall Study|Major Protocol Deviation|2|||
19569318|NCT01078389|42017008|FG001|Overall Study|Major Protocol Deviation|0|||
19569319|NCT01078389|42017007|FG000|Overall Study|Lost to Follow-up|23|||
19569320|NCT01078389|42017008|FG001|Overall Study|Lost to Follow-up|23|||
19569321|NCT01078389|42017007|FG000|Overall Study|Voluntary Withdrawal|20|||
19569322|NCT01078389|42017008|FG001|Overall Study|Voluntary Withdrawal|36|||
19569323|NCT01078389|42017007|FG000|Overall Study|Other|9|||
19569324|NCT01078389|42017008|FG001|Overall Study|Other|2|||
19569325|NCT01090323|42017016|FG000|Overall Study|Adverse Event|12|||
19569326|NCT01090323|42017017|FG001|Overall Study|Adverse Event|2|||
19569327|NCT01090323|42017016|FG000|Overall Study|Abnormal Lab Values|3|||
19569328|NCT01090323|42017017|FG001|Overall Study|Abnormal Lab Values|1|||
19569329|NCT01090323|42017016|FG000|Overall Study|Abnormal Test Procedure Results|2|||
19569330|NCT01090323|42017017|FG001|Overall Study|Abnormal Test Procedure Results|0|||
19569331|NCT01090323|42017016|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19569332|NCT01090323|42017017|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19569333|NCT01090323|42017016|FG000|Overall Study|Condition no longer requires drug|5|||
19569334|NCT01090323|42017017|FG001|Overall Study|Condition no longer requires drug|4|||
19569335|NCT01090323|42017016|FG000|Overall Study|Protocol Violation|2|||
19569336|NCT01090323|42017017|FG001|Overall Study|Protocol Violation|1|||
19569337|NCT01090323|42017016|FG000|Overall Study|Withdrew consent|33|||
19569338|NCT01090323|42017017|FG001|Overall Study|Withdrew consent|11|||
19569339|NCT01090323|42017016|FG000|Overall Study|Lost to Follow-up|11|||
19569340|NCT01090323|42017017|FG001|Overall Study|Lost to Follow-up|6|||
19569341|NCT01090323|42017016|FG000|Overall Study|Administrative problems|6|||
19569342|NCT01090323|42017017|FG001|Overall Study|Administrative problems|4|||
19569343|NCT01090323|42017016|FG000|Overall Study|Death|1|||
19569344|NCT01090323|42017017|FG001|Overall Study|Death|2|||
19569345|NCT01090323|42017016|FG000|Overall Study|Stopped end of core|7|||
19569346|NCT01090323|42017017|FG001|Overall Study|Stopped end of core|0|||
19569347|NCT01090323|42017016|FG000|Overall Study|Stopped end of extension 1#|3|||
19569348|NCT01090323|42017017|FG001|Overall Study|Stopped end of extension 1#|1|||
19569349|NCT01078155|42017023|FG000|Overall Study|Adverse Event|7|||
19569350|NCT01078155|42017023|FG000|Overall Study|Lack of Efficacy|16|||
19569351|NCT01078155|42017023|FG000|Overall Study|Participant's Decision|6|||
19569352|NCT01078155|42017023|FG000|Overall Study|Lost to Follow-up|15|||
19569353|NCT01201356|42017027|FG000|Overall Study|Adverse Event|170|||
19569354|NCT01201356|42017027|FG000|Overall Study|Abnormal laboratory value(s)|51|||
19569355|NCT01201356|42017027|FG000|Overall Study|Abnormal test procedure result(s)|3|||
19569356|NCT01201356|42017027|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
19569357|NCT01201356|42017027|FG000|Overall Study|Condition no longer requires study drug|12|||
19569358|NCT01201356|42017027|FG000|Overall Study|Withdrawal by Subject|144|||
19569359|NCT01201356|42017027|FG000|Overall Study|Lost to Follow-up|50|||
19569360|NCT01201356|42017027|FG000|Overall Study|administrative problems|74|||
19569361|NCT01201356|42017027|FG000|Overall Study|Death|16|||
19569362|NCT01201356|42017027|FG000|Overall Study|Protocol Violation|12|||
19569363|NCT01200810|42017033|FG000|Overall Study|Physician Decision|1|||
19569364|NCT01200810|42017034|FG001|Overall Study|Physician Decision|0|||
19569365|NCT01200810|42017033|FG000|Overall Study|Withdrawal by Subject|1|||
19569366|NCT01200810|42017034|FG001|Overall Study|Withdrawal by Subject|2|||
19569367|NCT01200810|42017033|FG000|Overall Study|Sponsor stopped making study drug|3|||
19569368|NCT01200810|42017034|FG001|Overall Study|Sponsor stopped making study drug|3|||
19569369|NCT01200342|42017040|FG000|Overall Study|Disease Progression|1|||
19569370|NCT01199016|42017044|FG000|Overall Study|No longer meets eligibility criteria|4|||
19569371|NCT01199016|42017044|FG000|Overall Study|Entrance criteria|5|||
19569372|NCT01199016|42017044|FG000|Overall Study|Protocol Violation|9|||
19569373|NCT01199016|42017044|FG000|Overall Study|Other|13|||
19569374|NCT01199016|42017044|FG000|Overall Study|Withdrawal by Subject|21|||
19745701|NCT00024167|42193050|FG000|Overall Study|Death|53|||
19569375|NCT01199016|42017044|FG000|Overall Study|Lost to Follow-up|25|||
19745702|NCT00024167|42193051|FG001|Overall Study|Death|47|||
19569376|NCT01198548|42017048|FG000|Overall Study|Disease Progression|9|||
19569377|NCT01198548|42017048|FG000|Overall Study|Administrative Decision|1|||
19569378|NCT01198470|42017052|FG000|Overall Study|Adverse Event|2|||
19569379|NCT00977938|42017060|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
19569380|NCT00977938|42017061|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
19569381|NCT00977938|42017062|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
19569382|NCT00977938|42017063|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
19569383|NCT00977938|42017060|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
19569384|NCT00977938|42017061|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
19569385|NCT00977938|42017062|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
19569386|NCT00977938|42017063|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
19569387|NCT00977938|42017060|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
19569388|NCT00977938|42017061|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
19569389|NCT00977938|42017062|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
19569390|NCT00977938|42017063|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
19569391|NCT00977938|42017060|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
19569392|NCT00977938|42017061|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
19569393|NCT00977938|42017062|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
19569394|NCT00977938|42017063|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
19569395|NCT00977938|42017060|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
19569396|NCT00977938|42017061|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
19569397|NCT00977938|42017062|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
19569398|NCT00977938|42017063|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
19569399|NCT00977938|42017060|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
19569400|NCT00977938|42017061|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
19569401|NCT00977938|42017062|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
19569402|NCT00977938|42017063|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
19569403|NCT02716675|42017078|FG000|Overall Study|Death|2|||
19569404|NCT02716675|42017079|FG001|Overall Study|Death|3|||
19569405|NCT02716675|42017080|FG002|Overall Study|Death|0|||
19569406|NCT02716675|42017078|FG000|Overall Study|Physician Decision|2|||
19569407|NCT02716675|42017079|FG001|Overall Study|Physician Decision|1|||
19569408|NCT02716675|42017080|FG002|Overall Study|Physician Decision|1|||
19569409|NCT02716675|42017078|FG000|Overall Study|Lost to Follow-up|100|||
19569410|NCT02716675|42017079|FG001|Overall Study|Lost to Follow-up|87|||
19569411|NCT02716675|42017080|FG002|Overall Study|Lost to Follow-up|99|||
19569412|NCT02716675|42017078|FG000|Overall Study|Withdrawal by Subject|22|||
19569413|NCT02716675|42017079|FG001|Overall Study|Withdrawal by Subject|25|||
19569414|NCT02716675|42017080|FG002|Overall Study|Withdrawal by Subject|20|||
19569415|NCT02716675|42017078|FG000|Overall Study|Protocol Violation|0|||
19569416|NCT02716675|42017079|FG001|Overall Study|Protocol Violation|3|||
19569417|NCT02716675|42017080|FG002|Overall Study|Protocol Violation|1|||
19569418|NCT02716675|42017078|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
19569419|NCT02716675|42017079|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
19569420|NCT02716675|42017080|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
19569421|NCT02716675|42017078|FG000|Overall Study|Other|38|||
19569422|NCT02716675|42017079|FG001|Overall Study|Other|47|||
19384171|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
19384172|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
19384173|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
19569423|NCT02716675|42017080|FG002|Overall Study|Other|48|||
19569424|NCT00977548|42017093|FG000|Overall Study|Ineligible|4|||
19569425|NCT00977548|42017093|FG000|Overall Study|Adverse Event|8|||
19569426|NCT00977548|42017093|FG000|Overall Study|Withdrawal by Subject|1|||
19569427|NCT01090011|42017097|FG000|Overall Study|Progressive disease|128|||
19569428|NCT01090011|42017097|FG000|Overall Study|Adverse Event|32|||
19569429|NCT01090011|42017097|FG000|Overall Study|Protocol Violation|1|||
19569430|NCT01090011|42017097|FG000|Overall Study|Refusal to start/continue medication|5|||
19569431|NCT01090011|42017097|FG000|Overall Study|Other reason not defined above|5|||
19569432|NCT01251653|42017118|FG000|Overall Study|Progressive Disease|1|||
19569433|NCT01251653|42017119|FG001|Overall Study|Progressive Disease|7|||
19569434|NCT01251653|42017120|FG002|Overall Study|Progressive Disease|16|||
19569435|NCT01251653|42017121|FG003|Overall Study|Progressive Disease|4|||
19569436|NCT01251653|42017122|FG004|Overall Study|Progressive Disease|0|||
19569437|NCT01251653|42017123|FG005|Overall Study|Progressive Disease|17|||
19569438|NCT01251653|42017124|FG006|Overall Study|Progressive Disease|14|||
19569439|NCT01251653|42017125|FG007|Overall Study|Progressive Disease|7|||
19569440|NCT01251653|42017126|FG008|Overall Study|Progressive Disease|5|||
19569441|NCT01251653|42017118|FG000|Overall Study|Dose-limiting toxicity|0|||
19569442|NCT01251653|42017119|FG001|Overall Study|Dose-limiting toxicity|1|||
19569443|NCT01251653|42017120|FG002|Overall Study|Dose-limiting toxicity|1|||
19569444|NCT01251653|42017121|FG003|Overall Study|Dose-limiting toxicity|1|||
19569445|NCT01251653|42017122|FG004|Overall Study|Dose-limiting toxicity|0|||
19569446|NCT01251653|42017123|FG005|Overall Study|Dose-limiting toxicity|0|||
19569447|NCT01251653|42017124|FG006|Overall Study|Dose-limiting toxicity|2|||
19569448|NCT01251653|42017125|FG007|Overall Study|Dose-limiting toxicity|0|||
19569449|NCT01251653|42017126|FG008|Overall Study|Dose-limiting toxicity|0|||
19569450|NCT01251653|42017118|FG000|Overall Study|Adverse Event|1|||
19569451|NCT01251653|42017119|FG001|Overall Study|Adverse Event|0|||
19569452|NCT01251653|42017120|FG002|Overall Study|Adverse Event|2|||
19569453|NCT01251653|42017121|FG003|Overall Study|Adverse Event|1|||
19569454|NCT01251653|42017122|FG004|Overall Study|Adverse Event|1|||
19569455|NCT01251653|42017123|FG005|Overall Study|Adverse Event|0|||
19569456|NCT01251653|42017124|FG006|Overall Study|Adverse Event|2|||
19569457|NCT01251653|42017125|FG007|Overall Study|Adverse Event|2|||
19569458|NCT01251653|42017126|FG008|Overall Study|Adverse Event|1|||
19569459|NCT01251653|42017118|FG000|Overall Study|Withdrawal by Subject|1|||
19569460|NCT01251653|42017119|FG001|Overall Study|Withdrawal by Subject|0|||
19569461|NCT01251653|42017120|FG002|Overall Study|Withdrawal by Subject|1|||
19569462|NCT01251653|42017121|FG003|Overall Study|Withdrawal by Subject|0|||
19569463|NCT01251653|42017122|FG004|Overall Study|Withdrawal by Subject|1|||
19569464|NCT01251653|42017123|FG005|Overall Study|Withdrawal by Subject|1|||
19569465|NCT01251653|42017124|FG006|Overall Study|Withdrawal by Subject|0|||
19569466|NCT01251653|42017125|FG007|Overall Study|Withdrawal by Subject|1|||
19569467|NCT01251653|42017126|FG008|Overall Study|Withdrawal by Subject|0|||
19569468|NCT01251653|42017118|FG000|Overall Study|Other reason not mentioned above|0|||
19569469|NCT01251653|42017119|FG001|Overall Study|Other reason not mentioned above|0|||
19569470|NCT01251653|42017120|FG002|Overall Study|Other reason not mentioned above|0|||
19569471|NCT01251653|42017121|FG003|Overall Study|Other reason not mentioned above|0|||
19569472|NCT01251653|42017122|FG004|Overall Study|Other reason not mentioned above|0|||
19569473|NCT01251653|42017123|FG005|Overall Study|Other reason not mentioned above|0|||
19569474|NCT01251653|42017124|FG006|Overall Study|Other reason not mentioned above|0|||
19569475|NCT01251653|42017125|FG007|Overall Study|Other reason not mentioned above|2|||
19569476|NCT01251653|42017126|FG008|Overall Study|Other reason not mentioned above|0|||
19569477|NCT00910663|42017164|FG000|Period 1|Withdrawal by Subject|0|||
19569478|NCT00910663|42017165|FG001|Period 1|Withdrawal by Subject|1|||
19569479|NCT01077375|42017173|FG000|Overall Study|Adverse Event|2|||
19569480|NCT01077375|42017174|FG001|Overall Study|Adverse Event|15|||
19569481|NCT01077375|42017173|FG000|Overall Study|Lack of Efficacy|6|||
19569482|NCT01077375|42017174|FG001|Overall Study|Lack of Efficacy|8|||
19569483|NCT01077375|42017173|FG000|Overall Study|Withdrawal by Subject|0|||
19569484|NCT01077375|42017174|FG001|Overall Study|Withdrawal by Subject|6|||
19569485|NCT01077375|42017173|FG000|Overall Study|Lost to Follow-up|2|||
19569486|NCT01077375|42017174|FG001|Overall Study|Lost to Follow-up|5|||
19569487|NCT01077375|42017173|FG000|Overall Study|Other Reason|0|||
19569488|NCT01077375|42017174|FG001|Overall Study|Other Reason|1|||
19569489|NCT01250873|42017182|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
19569490|NCT01250873|42017182|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
19569491|NCT01250171|42017191|FG000|Overall Study|Administrative reasons|1|||
19745703|NCT00022763|42193060|FG000|Overall Study|Adverse Event|1|||
19745704|NCT00022763|42193061|FG001|Overall Study|Adverse Event|2|||
19569492|NCT01250171|42017192|FG001|Overall Study|Administrative reasons|0|||
19569493|NCT01250171|42017193|FG002|Overall Study|Administrative reasons|0|||
19569494|NCT01077063|42017203|FG000|Overall Study|Adverse Event|3|||
19745705|NCT00022763|42193060|FG000|Overall Study|Injection Site Reactions|0|||
19569495|NCT01077063|42017204|FG001|Overall Study|Adverse Event|0|||
19569496|NCT01077063|42017203|FG000|Overall Study|Death|1|||
19569497|NCT01077063|42017204|FG001|Overall Study|Death|1|||
19569498|NCT01077063|42017203|FG000|Overall Study|Withdrawal by Subject|0|||
19569499|NCT01077063|42017204|FG001|Overall Study|Withdrawal by Subject|2|||
19569500|NCT01248065|42017212|FG000|Overall Study|Lost to Follow-up|3|||
19569501|NCT01248065|42017213|FG001|Overall Study|Lost to Follow-up|5|||
19569502|NCT01248065|42017212|FG000|Overall Study|Withdrawal by Subject|14|||
19569503|NCT01248065|42017213|FG001|Overall Study|Withdrawal by Subject|11|||
19569504|NCT01248065|42017212|FG000|Overall Study|Adverse Event|3|||
19569505|NCT01248065|42017213|FG001|Overall Study|Adverse Event|0|||
19569506|NCT01248065|42017212|FG000|Overall Study|Third treatment failure event|3|||
19569507|NCT01248065|42017213|FG001|Overall Study|Third treatment failure event|1|||
19569508|NCT01248065|42017212|FG000|Overall Study|Other|3|||
19569509|NCT01248065|42017213|FG001|Overall Study|Other|5|||
19569510|NCT01250756|42017221|FG000|Infant Series|Withdrawal by Subject|4|||
19569511|NCT01250756|42017222|FG001|Infant Series|Withdrawal by Subject|5|||
19569512|NCT01250756|42017221|FG000|Infant Series|Randomized, Not Vaccinated|2|||
19569513|NCT01250756|42017222|FG001|Infant Series|Randomized, Not Vaccinated|2|||
19569514|NCT01250756|42017221|FG000|Infant Series|Other|22|||
19569515|NCT01250756|42017222|FG001|Infant Series|Other|0|||
19569516|NCT01250756|42017221|FG000|After Infant Series|Adverse Event|5|||
19569517|NCT01250756|42017222|FG001|After Infant Series|Adverse Event|2|||
19569518|NCT01250756|42017221|FG000|After Infant Series|Withdrawal by Subject|4|||
19569519|NCT01250756|42017222|FG001|After Infant Series|Withdrawal by Subject|1|||
19569520|NCT01250756|42017221|FG000|After Infant Series|Other|2|||
19569521|NCT01250756|42017222|FG001|After Infant Series|Other|1|||
19569522|NCT01250756|42017221|FG000|Toddler Dose|Adverse Event|0|||
19569523|NCT01250756|42017222|FG001|Toddler Dose|Adverse Event|1|||
19569524|NCT01250756|42017221|FG000|After Toddler Dose|Adverse Event|0|||
19569525|NCT01250756|42017222|FG001|After Toddler Dose|Adverse Event|1|||
19569526|NCT01250054|42017234|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
19569527|NCT01250054|42017235|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
19569528|NCT00977470|42017243|FG000|Overall Study|Lack of Efficacy|32|||
19569529|NCT00977470|42017244|FG001|Overall Study|Lack of Efficacy|30|||
19569530|NCT00977470|42017243|FG000|Overall Study|Physician Decision|2|||
19569531|NCT00977470|42017244|FG001|Overall Study|Physician Decision|0|||
19569532|NCT00977470|42017243|FG000|Overall Study|Adverse Event|1|||
19569533|NCT00977470|42017244|FG001|Overall Study|Adverse Event|2|||
19569534|NCT00977470|42017243|FG000|Overall Study|Protocol Violation|1|||
19569535|NCT00977470|42017244|FG001|Overall Study|Protocol Violation|0|||
19569536|NCT00977470|42017243|FG000|Overall Study|Withdrawal by Subject|0|||
19569537|NCT00977470|42017244|FG001|Overall Study|Withdrawal by Subject|2|||
19569538|NCT00977470|42017243|FG000|Overall Study|Death|0|||
19569539|NCT00977470|42017244|FG001|Overall Study|Death|2|||
19569540|NCT00977470|42017243|FG000|Overall Study|clinical decline|0|||
19569541|NCT00977470|42017244|FG001|Overall Study|clinical decline|1|||
19569542|NCT00977470|42017243|FG000|Overall Study|prolonged recovery post-surgery|0|||
19569543|NCT00977470|42017244|FG001|Overall Study|prolonged recovery post-surgery|1|||
19569544|NCT00977470|42017243|FG000|Overall Study|Still on-study|2|||
19569545|NCT00977470|42017244|FG001|Overall Study|Still on-study|0|||
19569546|NCT01245374|42017250|FG000|Overall Study|Protocol Violation|1|||
19569547|NCT01245374|42017250|FG000|Overall Study|Withdrawal by Subject|3|||
19569548|NCT00977314|42017257|FG000|Overall Study|Withdrawal by Subject|1|||
19569549|NCT00977314|42017258|FG001|Overall Study|Withdrawal by Subject|0|||
19569550|NCT00977314|42017257|FG000|Overall Study|Physician Decision|1|||
19569551|NCT00977314|42017258|FG001|Overall Study|Physician Decision|0|||
19569552|NCT01087203|42017266|FG000|Overall Study|Lost to Follow-up|2|||
19569553|NCT01087203|42017267|FG001|Overall Study|Lost to Follow-up|0|||
19569554|NCT01087203|42017266|FG000|Overall Study|Withdrawal by Subject|2|||
19569555|NCT01087203|42017267|FG001|Overall Study|Withdrawal by Subject|6|||
19569556|NCT01087203|42017266|FG000|Overall Study|Lack of Efficacy|1|||
19569557|NCT01087203|42017267|FG001|Overall Study|Lack of Efficacy|2|||
19569558|NCT01087203|42017266|FG000|Overall Study|Study terminated by sponsor|27|||
19569559|NCT01087203|42017267|FG001|Overall Study|Study terminated by sponsor|27|||
19569560|NCT01246583|42017278|FG000|Overall Study|Lost to Follow-up|0|||
19569561|NCT01246583|42017279|FG001|Overall Study|Lost to Follow-up|0|||
19569562|NCT01246583|42017280|FG002|Overall Study|Lost to Follow-up|0|||
19569563|NCT01246583|42017281|FG003|Overall Study|Lost to Follow-up|1|||
19569564|NCT01246583|42017278|FG000|Overall Study|Protocol Violation|0|||
19569565|NCT01246583|42017279|FG001|Overall Study|Protocol Violation|0|||
19569566|NCT01246583|42017280|FG002|Overall Study|Protocol Violation|1|||
19569567|NCT01246583|42017281|FG003|Overall Study|Protocol Violation|0|||
19569568|NCT01246583|42017278|FG000|Overall Study|Withdrawal by Subject|1|||
19569569|NCT01246583|42017279|FG001|Overall Study|Withdrawal by Subject|0|||
19569570|NCT01246583|42017280|FG002|Overall Study|Withdrawal by Subject|0|||
19569571|NCT01246583|42017281|FG003|Overall Study|Withdrawal by Subject|0|||
19569572|NCT01084239|42017294|FG000|28-Day Follow-up|Lost to Follow-up|4|||
19569573|NCT01084239|42017295|FG001|28-Day Follow-up|Lost to Follow-up|9|||
19569574|NCT01244906|42017303|FG000|Overall Study|Death|2|||
19569575|NCT01244906|42017303|FG000|Overall Study|Progression of disease post treatment|6|||
19569576|NCT01080807|42017309|FG000|Overall Study|Adverse Event|9|||
19384174|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
19569577|NCT01080807|42017310|FG001|Overall Study|Adverse Event|1|||
19569578|NCT01080807|42017309|FG000|Overall Study|Lack of Efficacy|0|||
19569579|NCT01080807|42017310|FG001|Overall Study|Lack of Efficacy|1|||
19569580|NCT01080807|42017309|FG000|Overall Study|Withdrawal by Subject|7|||
19569581|NCT01080807|42017310|FG001|Overall Study|Withdrawal by Subject|2|||
19569582|NCT01080807|42017309|FG000|Overall Study|Protocol Violation|7|||
19569583|NCT01080807|42017310|FG001|Overall Study|Protocol Violation|6|||
19569584|NCT01080807|42017309|FG000|Overall Study|Lost to Follow-up|6|||
19569585|NCT01080807|42017310|FG001|Overall Study|Lost to Follow-up|4|||
19569586|NCT01080807|42017309|FG000|Overall Study|Noncompliance with drug administration|1|||
19569587|NCT01080807|42017310|FG001|Overall Study|Noncompliance with drug administration|1|||
19569588|NCT01080807|42017309|FG000|Overall Study|Noncompliance to study procedures|1|||
19569589|NCT01080807|42017310|FG001|Overall Study|Noncompliance to study procedures|1|||
19569590|NCT01080807|42017309|FG000|Overall Study|Began working day shift|0|||
19569591|NCT01080807|42017310|FG001|Overall Study|Began working day shift|2|||
19569592|NCT01080807|42017309|FG000|Overall Study|Laid off or terminated from job|1|||
19569593|NCT01080807|42017310|FG001|Overall Study|Laid off or terminated from job|2|||
19569594|NCT01080807|42017309|FG000|Overall Study|Stopped working consistent night shifts|0|||
19569595|NCT01080807|42017310|FG001|Overall Study|Stopped working consistent night shifts|1|||
19569596|NCT01080807|42017309|FG000|Overall Study|Work schedule changing|1|||
19569597|NCT01080807|42017310|FG001|Overall Study|Work schedule changing|1|||
19569598|NCT01080807|42017309|FG000|Overall Study|Work schedule and travel|0|||
19569599|NCT01080807|42017310|FG001|Overall Study|Work schedule and travel|1|||
19569600|NCT01080807|42017309|FG000|Overall Study|Switched to first shift|1|||
19569601|NCT01080807|42017310|FG001|Overall Study|Switched to first shift|0|||
19569602|NCT01080807|42017309|FG000|Overall Study|Moved away without notifying center|1|||
19569603|NCT01080807|42017310|FG001|Overall Study|Moved away without notifying center|0|||
19569604|NCT01076361|42017316|FG000|Overall Study|22 leads were excluded from analysis|21|||
19569605|NCT01079949|42017322|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
19569606|NCT01079949|42017323|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
19569607|NCT01079949|42017322|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
19569608|NCT01079949|42017323|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
19569609|NCT01079949|42017322|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
19569610|NCT01079949|42017323|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
19569611|NCT01079949|42017322|FG000|Overall Study|Randomized but not treated|1|||
19569612|NCT01079949|42017323|FG001|Overall Study|Randomized but not treated|0|||
19384175|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
19384176|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
19384177|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
19384178|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
19384179|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
19384180|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
19384181|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
19384182|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
19384183|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
19569613|NCT00910429|42017331|FG000|Overall Study|Death|18|||
19569614|NCT00910429|42017332|FG001|Overall Study|Death|12|||
19569615|NCT00910429|42017331|FG000|Overall Study|Withdrawal by Subject|3|||
19569616|NCT00910429|42017332|FG001|Overall Study|Withdrawal by Subject|2|||
19569617|NCT00910429|42017331|FG000|Overall Study|Protocol Violation|1|||
19569618|NCT00910429|42017332|FG001|Overall Study|Protocol Violation|0|||
19569619|NCT00910429|42017331|FG000|Overall Study|Lost to Follow-up|2|||
19569620|NCT00910429|42017332|FG001|Overall Study|Lost to Follow-up|1|||
19569621|NCT00910429|42017331|FG000|Overall Study|Adverse Event|10|||
19569622|NCT00910429|42017332|FG001|Overall Study|Adverse Event|5|||
19569623|NCT00910429|42017331|FG000|Overall Study|Drug non-compliance|1|||
19569624|NCT00910429|42017332|FG001|Overall Study|Drug non-compliance|0|||
19569625|NCT00910429|42017331|FG000|Overall Study|Lack of Efficacy|4|||
19569626|NCT00910429|42017332|FG001|Overall Study|Lack of Efficacy|1|||
19569627|NCT00909727|42017340|FG000|Overall Study|Adverse Event|1|||
19569628|NCT00909727|42017341|FG001|Overall Study|Adverse Event|0|||
19569629|NCT00909727|42017340|FG000|Overall Study|Wrong Genotype|1|||
19569630|NCT00909727|42017341|FG001|Overall Study|Wrong Genotype|0|||
19384184|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
19384185|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
19384186|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
19384187|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
19384188|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
19384189|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
19569631|NCT00909727|42017340|FG000|Overall Study|Withdrawal of Consent|1|||
19569632|NCT00909727|42017341|FG001|Overall Study|Withdrawal of Consent|0|||
19569633|NCT00909727|42017340|FG000|Overall Study|Prohibited Medication|1|||
19569634|NCT00909727|42017341|FG001|Overall Study|Prohibited Medication|0|||
19569635|NCT00977080|42017351|FG000|Overall Study|Adverse Event|2|||
19569636|NCT00977080|42017352|FG001|Overall Study|Adverse Event|7|||
19384190|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
19384191|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
19384192|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
19384193|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
19569637|NCT00977080|42017353|FG002|Overall Study|Adverse Event|7|||
19569638|NCT00977080|42017354|FG003|Overall Study|Adverse Event|7|||
19569639|NCT00977080|42017351|FG000|Overall Study|Withdrawal by Subject|1|||
19569640|NCT00977080|42017352|FG001|Overall Study|Withdrawal by Subject|5|||
19569641|NCT00977080|42017353|FG002|Overall Study|Withdrawal by Subject|1|||
19569642|NCT00977080|42017354|FG003|Overall Study|Withdrawal by Subject|5|||
19384194|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
19384195|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
19569643|NCT00977080|42017351|FG000|Overall Study|Protocol Violation|7|||
19569644|NCT00977080|42017352|FG001|Overall Study|Protocol Violation|3|||
19569645|NCT00977080|42017353|FG002|Overall Study|Protocol Violation|4|||
19569646|NCT00977080|42017354|FG003|Overall Study|Protocol Violation|3|||
19384196|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
19384197|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
19384198|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
19384199|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
19569647|NCT00977080|42017351|FG000|Overall Study|Noncompliance|0|||
19569648|NCT00977080|42017352|FG001|Overall Study|Noncompliance|2|||
19569649|NCT00977080|42017353|FG002|Overall Study|Noncompliance|1|||
19569650|NCT00977080|42017354|FG003|Overall Study|Noncompliance|0|||
19569651|NCT00977080|42017351|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
19569652|NCT00977080|42017352|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
19384200|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
19384201|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
19384202|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
19384203|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
19384204|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
19384205|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
19384206|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
19384207|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
19384208|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
19476916|NCT01569763|41755105|FG000|Overall Study|Lack of Efficacy|2|||
19569653|NCT00977080|42017353|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
19569654|NCT00977080|42017354|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
19569655|NCT00977080|42017351|FG000|Overall Study|Required kidney transplantation|1|||
19569656|NCT00977080|42017352|FG001|Overall Study|Required kidney transplantation|3|||
19569657|NCT00977080|42017353|FG002|Overall Study|Required kidney transplantation|3|||
19569658|NCT00977080|42017354|FG003|Overall Study|Required kidney transplantation|1|||
19569659|NCT00977080|42017351|FG000|Overall Study|Travel for family reasons|1|||
19569660|NCT00977080|42017352|FG001|Overall Study|Travel for family reasons|0|||
19569661|NCT00977080|42017353|FG002|Overall Study|Travel for family reasons|0|||
19569662|NCT00977080|42017354|FG003|Overall Study|Travel for family reasons|0|||
19569663|NCT00975676|42017366|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
19569664|NCT00975676|42017367|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
19569665|NCT00975286|42017380|FG000|Overall Study|Adverse Event|9|||
19569666|NCT00975286|42017381|FG001|Overall Study|Adverse Event|19|||
19569667|NCT00975286|42017380|FG000|Overall Study|Protocol Violation|1|||
19569668|NCT00975286|42017381|FG001|Overall Study|Protocol Violation|2|||
19569669|NCT00975286|42017380|FG000|Overall Study|Withdrawal by Subject|0|||
19569670|NCT00975286|42017381|FG001|Overall Study|Withdrawal by Subject|2|||
19569671|NCT00975286|42017380|FG000|Overall Study|Familial and Personal Reasons|2|||
19569672|NCT00975286|42017381|FG001|Overall Study|Familial and Personal Reasons|2|||
19569673|NCT00975286|42017380|FG000|Overall Study|Poor Compliance to Protocol|0|||
19569674|NCT00975286|42017381|FG001|Overall Study|Poor Compliance to Protocol|2|||
19569675|NCT00975286|42017380|FG000|Overall Study|Sponsor Decision|0|||
19569676|NCT00975286|42017381|FG001|Overall Study|Sponsor Decision|2|||
19569677|NCT00907777|42017389|FG000|Overall Study|Withdrawal by Subject|0|||
19569678|NCT00907777|42017390|FG001|Overall Study|Withdrawal by Subject|1|||
19569679|NCT00908011|42017398|FG000|Overall Study|Withdrawal by Subject|2|||
19569680|NCT00908011|42017399|FG001|Overall Study|Withdrawal by Subject|2|||
19569681|NCT00976456|42017407|FG000|Overall Study|Adverse Event|17|||
19569682|NCT00976456|42017408|FG001|Overall Study|Adverse Event|22|||
19569683|NCT00976456|42017407|FG000|Overall Study|Death|7|||
19569684|NCT00976456|42017408|FG001|Overall Study|Death|9|||
19569685|NCT00976456|42017407|FG000|Overall Study|Lack of Efficacy|5|||
19569686|NCT00976456|42017408|FG001|Overall Study|Lack of Efficacy|2|||
19569687|NCT00976456|42017407|FG000|Overall Study|Withdrawal by Subject|3|||
19569688|NCT00976456|42017408|FG001|Overall Study|Withdrawal by Subject|1|||
19569689|NCT00976456|42017407|FG000|Overall Study|screening failure, unknown|11|||
19569690|NCT00976456|42017408|FG001|Overall Study|screening failure, unknown|4|||
19569691|NCT01243151|42017419|FG000|Overall Study|Adverse Event|0|||
19569692|NCT01243151|42017420|FG001|Overall Study|Adverse Event|1|||
19569693|NCT01243151|42017421|FG002|Overall Study|Adverse Event|0|||
19569694|NCT01243151|42017422|FG003|Overall Study|Adverse Event|0|||
19569695|NCT01243151|42017423|FG004|Overall Study|Adverse Event|0|||
19569696|NCT01243151|42017419|FG000|Overall Study|Protocol Violation|0|||
19569697|NCT01243151|42017420|FG001|Overall Study|Protocol Violation|0|||
19384209|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
19569698|NCT01243151|42017421|FG002|Overall Study|Protocol Violation|1|||
19569699|NCT01243151|42017422|FG003|Overall Study|Protocol Violation|0|||
19569700|NCT01243151|42017423|FG004|Overall Study|Protocol Violation|0|||
19569701|NCT01243151|42017419|FG000|Overall Study|Other|0|||
19569702|NCT01243151|42017420|FG001|Overall Study|Other|0|||
19569703|NCT01243151|42017421|FG002|Overall Study|Other|0|||
19569704|NCT01243151|42017422|FG003|Overall Study|Other|1|||
19569705|NCT01243151|42017423|FG004|Overall Study|Other|0|||
19569706|NCT01243151|42017419|FG000|Overall Study|Randomized but not treated|0|||
19569707|NCT01243151|42017420|FG001|Overall Study|Randomized but not treated|0|||
19569708|NCT01243151|42017421|FG002|Overall Study|Randomized but not treated|0|||
19569709|NCT01243151|42017422|FG003|Overall Study|Randomized but not treated|1|||
19569710|NCT01243151|42017423|FG004|Overall Study|Randomized but not treated|0|||
19569711|NCT00993148|42017439|FG000|Overall Study|Lost to Follow-up|2|||
19569712|NCT00993148|42017439|FG000|Overall Study|never initiated treatment|1|||
19569713|NCT00907621|42017445|FG000|Overall Study|Lost to Follow-up|6|||
19569714|NCT00907621|42017446|FG001|Overall Study|Lost to Follow-up|3|||
19384210|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
19476917|NCT01569763|41755106|FG001|Overall Study|Lack of Efficacy|7|||
19569715|NCT00907621|42017445|FG000|Overall Study|intercurrent febrile illness|1|||
19569716|NCT00907621|42017446|FG001|Overall Study|intercurrent febrile illness|1|||
19569717|NCT00907153|42017465|FG000|Overall Study|Lost to Follow-up|1|||
19569718|NCT00907153|42017466|FG001|Overall Study|Lost to Follow-up|1|||
19569719|NCT00907153|42017465|FG000|Overall Study|Withdrawal by Subject|1|||
19569720|NCT00907153|42017466|FG001|Overall Study|Withdrawal by Subject|3|||
19569721|NCT00904033|42017476|FG000|Overall Study|Withdrawal by Subject|1|||
19569722|NCT00904033|42017477|FG001|Overall Study|Withdrawal by Subject|1|||
19569723|NCT00904033|42017478|FG002|Overall Study|Withdrawal by Subject|0|||
19569724|NCT00904033|42017479|FG003|Overall Study|Withdrawal by Subject|0|||
19569725|NCT00904033|42017476|FG000|Overall Study|Physician Decision|0|||
19569726|NCT00904033|42017477|FG001|Overall Study|Physician Decision|0|||
19569727|NCT00904033|42017478|FG002|Overall Study|Physician Decision|1|||
19569728|NCT00904033|42017479|FG003|Overall Study|Physician Decision|0|||
19569729|NCT00904033|42017476|FG000|Overall Study|Unable to obtain final blood draw|0|||
19569730|NCT00904033|42017477|FG001|Overall Study|Unable to obtain final blood draw|0|||
19569731|NCT00904033|42017478|FG002|Overall Study|Unable to obtain final blood draw|0|||
19569732|NCT00904033|42017479|FG003|Overall Study|Unable to obtain final blood draw|2|||
19569733|NCT00903877|42017490|FG000|Overall Study|Did not meet study criteria|33|||
19569734|NCT00903877|42017490|FG000|Overall Study|Withdrawal by Subject|3|||
19569735|NCT00903877|42017490|FG000|Overall Study|Adverse Event|2|||
19569736|NCT00903877|42017490|FG000|Overall Study|Lost to Follow-up|1|||
19569737|NCT00903877|42017490|FG000|Overall Study|Participation put on hold|4|||
19569738|NCT01241591|42017498|FG000|Overall Study|Lack of Efficacy|5|||
19569739|NCT01241591|42017499|FG001|Overall Study|Lack of Efficacy|2|||
19569740|NCT01241591|42017500|FG002|Overall Study|Lack of Efficacy|2|||
19569741|NCT01241591|42017501|FG003|Overall Study|Lack of Efficacy|3|||
19569742|NCT01241591|42017498|FG000|Overall Study|Protocol Violation|5|||
19569743|NCT01241591|42017499|FG001|Overall Study|Protocol Violation|2|||
19569744|NCT01241591|42017500|FG002|Overall Study|Protocol Violation|3|||
19569745|NCT01241591|42017501|FG003|Overall Study|Protocol Violation|0|||
19569746|NCT01241591|42017498|FG000|Overall Study|Lost to Follow-up|1|||
19569747|NCT01241591|42017499|FG001|Overall Study|Lost to Follow-up|2|||
19569748|NCT01241591|42017500|FG002|Overall Study|Lost to Follow-up|2|||
19569749|NCT01241591|42017501|FG003|Overall Study|Lost to Follow-up|2|||
19569750|NCT01241591|42017498|FG000|Overall Study|Screen Failure|3|||
19569751|NCT01241591|42017499|FG001|Overall Study|Screen Failure|2|||
19569752|NCT01241591|42017500|FG002|Overall Study|Screen Failure|1|||
19569753|NCT01241591|42017501|FG003|Overall Study|Screen Failure|0|||
19569754|NCT01241591|42017498|FG000|Overall Study|Withdrawal by Subject|6|||
19569755|NCT01241591|42017499|FG001|Overall Study|Withdrawal by Subject|4|||
19569756|NCT01241591|42017500|FG002|Overall Study|Withdrawal by Subject|2|||
19569757|NCT01241591|42017501|FG003|Overall Study|Withdrawal by Subject|2|||
19569758|NCT01241591|42017498|FG000|Overall Study|Other|0|||
19569759|NCT01241591|42017499|FG001|Overall Study|Other|1|||
19569760|NCT01241591|42017500|FG002|Overall Study|Other|0|||
19569761|NCT01241591|42017501|FG003|Overall Study|Other|1|||
19569762|NCT01241591|42017498|FG000|Overall Study|Adverse Event|3|||
19569763|NCT01241591|42017499|FG001|Overall Study|Adverse Event|11|||
19569764|NCT01241591|42017500|FG002|Overall Study|Adverse Event|12|||
19569765|NCT01241591|42017501|FG003|Overall Study|Adverse Event|4|||
19569766|NCT00906373|42017513|FG000|Overall Study|Withdrawal by Subject|0|||
19569767|NCT00906373|42017514|FG001|Overall Study|Withdrawal by Subject|5|||
19569768|NCT00906373|42017513|FG000|Overall Study|Other|0|||
19569769|NCT00906373|42017514|FG001|Overall Study|Other|1|||
19569770|NCT00906373|42017513|FG000|Overall Study|Still on treatment at cutoff date|0|||
19569771|NCT00906373|42017514|FG001|Overall Study|Still on treatment at cutoff date|2|||
19569772|NCT00905437|42017523|FG000|Overall Study|Adverse Event|3|||
19569773|NCT00905437|42017524|FG001|Overall Study|Adverse Event|2|||
19569774|NCT00905437|42017523|FG000|Overall Study|Lost to Follow-up|0|||
19569775|NCT00905437|42017524|FG001|Overall Study|Lost to Follow-up|1|||
19569776|NCT00905437|42017523|FG000|Overall Study|Withdrawal by Subject|0|||
19569777|NCT00905437|42017524|FG001|Overall Study|Withdrawal by Subject|1|||
19569778|NCT00905437|42017523|FG000|Overall Study|Other|5|||
19569779|NCT00905437|42017524|FG001|Overall Study|Other|6|||
19569780|NCT01238861|42017536|FG000|Overall Study|Lost to Follow-up|4|||
19569781|NCT01238861|42017537|FG001|Overall Study|Lost to Follow-up|2|||
19569782|NCT01238861|42017538|FG002|Overall Study|Lost to Follow-up|3|||
19569783|NCT01238861|42017539|FG003|Overall Study|Lost to Follow-up|1|||
19569784|NCT01238861|42017540|FG004|Overall Study|Lost to Follow-up|1|||
19569785|NCT01238861|42017541|FG005|Overall Study|Lost to Follow-up|2|||
19569786|NCT01238861|42017536|FG000|Overall Study|Unplanned surgery|1|||
19569787|NCT01238861|42017537|FG001|Overall Study|Unplanned surgery|0|||
19384211|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
19384212|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
19569788|NCT01238861|42017538|FG002|Overall Study|Unplanned surgery|0|||
19569789|NCT01238861|42017539|FG003|Overall Study|Unplanned surgery|0|||
19384213|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
19384214|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
19384215|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
19476918|NCT01569763|41755105|FG000|Overall Study|Adverse Event|1|||
19569790|NCT01238861|42017540|FG004|Overall Study|Unplanned surgery|0|||
19569791|NCT01238861|42017541|FG005|Overall Study|Unplanned surgery|0|||
19569792|NCT01238861|42017536|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
19569793|NCT01238861|42017537|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
19569794|NCT01238861|42017538|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
19569795|NCT01238861|42017539|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
19569796|NCT01238861|42017540|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
19569797|NCT01238861|42017541|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
19569798|NCT01238861|42017536|FG000|Overall Study|Incorrect enrollment/randomization|0|||
19569799|NCT01238861|42017537|FG001|Overall Study|Incorrect enrollment/randomization|0|||
19569800|NCT01238861|42017538|FG002|Overall Study|Incorrect enrollment/randomization|1|||
19569801|NCT01238861|42017539|FG003|Overall Study|Incorrect enrollment/randomization|0|||
19569802|NCT01238861|42017540|FG004|Overall Study|Incorrect enrollment/randomization|1|||
19476919|NCT01569763|41755106|FG001|Overall Study|Adverse Event|0|||
19569803|NCT01238861|42017541|FG005|Overall Study|Incorrect enrollment/randomization|0|||
19569804|NCT01238861|42017536|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
19569805|NCT01238861|42017537|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
19569806|NCT01238861|42017538|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
19569807|NCT01238861|42017539|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
19569808|NCT01238861|42017540|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
19569809|NCT01238861|42017541|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
19569810|NCT01238861|42017536|FG000|Overall Study|Subject moved out of state/area|0|||
19569811|NCT01238861|42017537|FG001|Overall Study|Subject moved out of state/area|0|||
19569812|NCT01238861|42017538|FG002|Overall Study|Subject moved out of state/area|1|||
19569813|NCT01238861|42017539|FG003|Overall Study|Subject moved out of state/area|1|||
19569814|NCT01238861|42017540|FG004|Overall Study|Subject moved out of state/area|0|||
19569815|NCT01238861|42017541|FG005|Overall Study|Subject moved out of state/area|0|||
19569816|NCT01238861|42017536|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
19569817|NCT01238861|42017537|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
19569818|NCT01238861|42017538|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
19569819|NCT01238861|42017539|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
19569820|NCT01238861|42017540|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
19569821|NCT01238861|42017541|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
19569822|NCT01238861|42017536|FG000|Overall Study|Personal problems|0|||
19569823|NCT01238861|42017537|FG001|Overall Study|Personal problems|0|||
19569824|NCT01238861|42017538|FG002|Overall Study|Personal problems|0|||
19569825|NCT01238861|42017539|FG003|Overall Study|Personal problems|1|||
19569826|NCT01238861|42017540|FG004|Overall Study|Personal problems|0|||
19569827|NCT01238861|42017541|FG005|Overall Study|Personal problems|0|||
19569828|NCT01238861|42017536|FG000|Overall Study|Unable to continue visits|0|||
19569829|NCT01238861|42017537|FG001|Overall Study|Unable to continue visits|0|||
19569830|NCT01238861|42017538|FG002|Overall Study|Unable to continue visits|0|||
19569831|NCT01238861|42017539|FG003|Overall Study|Unable to continue visits|1|||
19384216|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
19569832|NCT01238861|42017540|FG004|Overall Study|Unable to continue visits|0|||
19569833|NCT01238861|42017541|FG005|Overall Study|Unable to continue visits|1|||
19569834|NCT01238861|42017536|FG000|Overall Study|Serious adverse event|0|||
19569835|NCT01238861|42017537|FG001|Overall Study|Serious adverse event|0|||
19569836|NCT01238861|42017538|FG002|Overall Study|Serious adverse event|0|||
19569837|NCT01238861|42017539|FG003|Overall Study|Serious adverse event|0|||
19569838|NCT01238861|42017540|FG004|Overall Study|Serious adverse event|0|||
19569839|NCT01238861|42017541|FG005|Overall Study|Serious adverse event|1|||
19569840|NCT01238861|42017536|FG000|Overall Study|Lack of compliance|0|||
19569841|NCT01238861|42017537|FG001|Overall Study|Lack of compliance|0|||
19569842|NCT01238861|42017538|FG002|Overall Study|Lack of compliance|0|||
19569843|NCT01238861|42017539|FG003|Overall Study|Lack of compliance|0|||
19569844|NCT01238861|42017540|FG004|Overall Study|Lack of compliance|0|||
19569845|NCT01238861|42017541|FG005|Overall Study|Lack of compliance|1|||
19569846|NCT01238861|42017536|FG000|Overall Study|Adverse Event|0|||
19569847|NCT01238861|42017537|FG001|Overall Study|Adverse Event|1|||
19569848|NCT01238861|42017538|FG002|Overall Study|Adverse Event|0|||
19569849|NCT01238861|42017539|FG003|Overall Study|Adverse Event|0|||
19569850|NCT01238861|42017540|FG004|Overall Study|Adverse Event|0|||
19569851|NCT01238861|42017541|FG005|Overall Study|Adverse Event|0|||
19569852|NCT01238861|42017536|FG000|Overall Study|Withdrawal by Subject|6|||
19569853|NCT01238861|42017537|FG001|Overall Study|Withdrawal by Subject|5|||
19569854|NCT01238861|42017538|FG002|Overall Study|Withdrawal by Subject|4|||
19569855|NCT01238861|42017539|FG003|Overall Study|Withdrawal by Subject|8|||
19569856|NCT01238861|42017540|FG004|Overall Study|Withdrawal by Subject|10|||
19569857|NCT01238861|42017541|FG005|Overall Study|Withdrawal by Subject|9|||
19569858|NCT00903409|42017564|FG000|Overall Study|Adverse Event|11|||
19569859|NCT00903409|42017565|FG001|Overall Study|Adverse Event|9|||
19569860|NCT00903409|42017564|FG000|Overall Study|Non-compliance with Protocol|1|||
19569861|NCT00903409|42017565|FG001|Overall Study|Non-compliance with Protocol|1|||
19569862|NCT00903409|42017564|FG000|Overall Study|Laboratory Abnormality|2|||
19569863|NCT00903409|42017565|FG001|Overall Study|Laboratory Abnormality|0|||
19569864|NCT00903409|42017564|FG000|Overall Study|Withdrawal by Subject|8|||
19569865|NCT00903409|42017565|FG001|Overall Study|Withdrawal by Subject|8|||
19569866|NCT00903409|42017564|FG000|Overall Study|Other|2|||
19569867|NCT00903409|42017565|FG001|Overall Study|Other|3|||
19384217|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
19384218|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
19569868|NCT00903409|42017564|FG000|Overall Study|Lost to Follow-up|2|||
19569869|NCT00903409|42017565|FG001|Overall Study|Lost to Follow-up|6|||
19569870|NCT01237223|42017579|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
19569871|NCT01237223|42017580|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
19569872|NCT01237223|42017581|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
19569873|NCT01237223|42017582|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
19569874|NCT01237223|42017583|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
19569875|NCT01237223|42017584|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
19569876|NCT01237223|42017579|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
19476920|NCT01550965|41755112|FG000|Overall Study|Adverse Event|26|||
19476921|NCT01550965|41755112|FG000|Overall Study|Withdrawal by Subject|10|||
19569877|NCT01237223|42017580|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
19569878|NCT01237223|42017581|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
19569879|NCT01237223|42017582|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
19569880|NCT01237223|42017583|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
19569881|NCT01237223|42017584|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
19569882|NCT01237223|42017579|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
19569883|NCT01237223|42017580|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
19569884|NCT01237223|42017581|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
19569885|NCT01237223|42017582|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
19569886|NCT01237223|42017583|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
19569887|NCT01237223|42017584|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
19569888|NCT01237223|42017579|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
19569889|NCT01237223|42017580|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
19569890|NCT01237223|42017581|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
19569891|NCT01237223|42017582|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
19569892|NCT01237223|42017583|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
19569893|NCT01237223|42017584|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
19569894|NCT01237223|42017579|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
19569895|NCT01237223|42017580|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
19569896|NCT01237223|42017581|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
19569897|NCT01237223|42017582|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
19384219|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
19569898|NCT01237223|42017583|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
19569899|NCT01237223|42017584|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
19569900|NCT01237223|42017579|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
19569901|NCT01237223|42017580|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
19569902|NCT01237223|42017581|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
19569903|NCT01237223|42017582|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
19569904|NCT01237223|42017583|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
19569905|NCT01237223|42017584|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
19569906|NCT01237223|42017579|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
19569907|NCT01237223|42017580|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
19569908|NCT01237223|42017581|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
19569909|NCT01237223|42017582|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
19569910|NCT01237223|42017583|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
19569911|NCT01237223|42017584|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
19569912|NCT01237223|42017579|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
19569913|NCT01237223|42017580|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
19569914|NCT01237223|42017581|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
19569915|NCT01237223|42017582|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
19569916|NCT01237223|42017583|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
19569917|NCT01237223|42017584|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
19569918|NCT01237223|42017579|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
19569919|NCT01237223|42017580|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
19569920|NCT01237223|42017581|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
19569921|NCT01237223|42017582|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
19384220|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
19384221|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
19384222|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
19384223|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
19384224|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
19384225|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
19384226|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
19384227|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
19384228|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
19384229|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
19384230|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
19384231|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
19384232|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
19384233|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
19384234|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
19476922|NCT01550965|41755112|FG000|Overall Study|Lost to Follow-up|2|||
19569922|NCT01237223|42017583|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
19569923|NCT01237223|42017584|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
19569924|NCT01237223|42017579|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
19569925|NCT01237223|42017580|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
19569926|NCT01237223|42017581|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
19569927|NCT01237223|42017582|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
19569928|NCT01237223|42017583|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
19569929|NCT01237223|42017584|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
19569930|NCT01236755|42017600|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
19569931|NCT01236755|42017600|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
19569932|NCT01236755|42017600|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
19569933|NCT01236755|42017600|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
19569934|NCT01236365|42017607|FG000|Overall Study|Lost to Follow-up|0|||
19569935|NCT01236365|42017608|FG001|Overall Study|Lost to Follow-up|2|||
19569936|NCT01236365|42017607|FG000|Overall Study|Moved Out of State|1|||
19569937|NCT01236365|42017608|FG001|Overall Study|Moved Out of State|0|||
19569938|NCT01236365|42017607|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
19569939|NCT01236365|42017608|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
19569940|NCT01235975|42017628|FG000|Overall Study|Serious Adverse Event|0|||
19569941|NCT01235975|42017629|FG001|Overall Study|Serious Adverse Event|1|||
19569942|NCT01235975|42017628|FG000|Overall Study|Withdrawal by Subject|8|||
19569943|NCT01235975|42017629|FG001|Overall Study|Withdrawal by Subject|2|||
19569944|NCT01235975|42017628|FG000|Overall Study|Migrated/moved from study area|2|||
19569945|NCT01235975|42017629|FG001|Overall Study|Migrated/moved from study area|1|||
19569946|NCT01235975|42017628|FG000|Overall Study|Lost to Follow-up|7|||
19569947|NCT01235975|42017629|FG001|Overall Study|Lost to Follow-up|3|||
19569948|NCT00903331|42017637|FG000|Overall Study|Death|4|||
19569949|NCT00903331|42017638|FG001|Overall Study|Death|8|||
19569950|NCT00903331|42017637|FG000|Overall Study|Withdrawal of consent|1|||
19569951|NCT00903331|42017638|FG001|Overall Study|Withdrawal of consent|8|||
19569952|NCT00903331|42017637|FG000|Overall Study|Lung transplant|0|||
19569953|NCT00903331|42017638|FG001|Overall Study|Lung transplant|2|||
19569954|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
19569955|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
19569956|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
19569957|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
19569958|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
19569959|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
19569960|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
19569961|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
19569962|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
19569963|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
19569964|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
19569965|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
19569966|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
19569967|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
19569968|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
19569969|NCT01235741|42017647|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
19569970|NCT01235741|42017648|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
19569971|NCT01235741|42017649|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
19569972|NCT01235741|42017647|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
19569973|NCT01235741|42017648|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
19569974|NCT01235741|42017649|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
19569975|NCT01235741|42017647|FG000|Randomized to Treatment|Adverse Event|0|||
19569976|NCT01235741|42017648|FG001|Randomized to Treatment|Adverse Event|1|||
19569977|NCT01235741|42017649|FG002|Randomized to Treatment|Adverse Event|1|||
19569978|NCT01235741|42017647|FG000|Randomized to Treatment|Sponsor terminated study|0|||
19569979|NCT01235741|42017648|FG001|Randomized to Treatment|Sponsor terminated study|35|||
19569980|NCT01235741|42017649|FG002|Randomized to Treatment|Sponsor terminated study|34|||
19569981|NCT01235741|42017647|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
19569982|NCT01235741|42017648|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
19569983|NCT01235741|42017649|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
19569984|NCT01235741|42017647|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
19569985|NCT01235741|42017648|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
19569986|NCT01235741|42017649|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
19569987|NCT01235741|42017647|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
19569988|NCT01235741|42017648|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
19569989|NCT01235741|42017649|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
19569990|NCT01235507|42017661|FG000|Overall Study|Adverse Event|1|||
19569991|NCT01235507|42017661|FG000|Overall Study|Withdrawal by Subject|1|||
19569992|NCT01235351|42017667|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
19569993|NCT01235351|42017668|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
19569994|NCT01076205|42017678|FG000|Overall Study|Adverse Drug Reaction|299|||
19569995|NCT01076205|42017678|FG000|Overall Study|Lack of Effectiveness|1423|||
19569996|NCT01076205|42017678|FG000|Overall Study|Other Reason|1075|||
19569997|NCT01076205|42017678|FG000|Overall Study|Unknown Reason|71|||
19569998|NCT01076205|42017678|FG000|Overall Study|Lost to Follow-up|3151|||
19569999|NCT01234883|42017700|FG000|Overall Study|Early treatment release|8|||
19570000|NCT01234883|42017701|FG001|Overall Study|Early treatment release|10|||
19570001|NCT01234883|42017700|FG000|Overall Study|Parent/guardian withdrew consent|1|||
19570002|NCT01234883|42017701|FG001|Overall Study|Parent/guardian withdrew consent|2|||
19570003|NCT01234883|42017700|FG000|Overall Study|Technical difficulties with IV infusion|0|||
19570004|NCT01234883|42017701|FG001|Overall Study|Technical difficulties with IV infusion|1|||
19570005|NCT01234883|42017700|FG000|Overall Study|Inclusion/exclusion failure|1|||
19570006|NCT01234883|42017701|FG001|Overall Study|Inclusion/exclusion failure|0|||
19570007|NCT01234649|42017709|FG000|Overall Study|Withdrawal by Subject|32|||
19570008|NCT01234649|42017710|FG001|Overall Study|Withdrawal by Subject|26|||
19570009|NCT01234649|42017709|FG000|Overall Study|Pregnancy|6|||
19570010|NCT01234649|42017710|FG001|Overall Study|Pregnancy|6|||
19570011|NCT01234649|42017709|FG000|Overall Study|intolerant to side effects|4|||
19570012|NCT01234649|42017710|FG001|Overall Study|intolerant to side effects|3|||
19570013|NCT01234649|42017709|FG000|Overall Study|Allergic reaction|1|||
19570014|NCT01234649|42017710|FG001|Overall Study|Allergic reaction|0|||
19570015|NCT01234649|42017709|FG000|Overall Study|Lack of Efficacy|0|||
19570016|NCT01234649|42017710|FG001|Overall Study|Lack of Efficacy|3|||
19570017|NCT01075815|42017718|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
19570018|NCT01075815|42017719|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
19570019|NCT01075815|42017718|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
19570020|NCT01075815|42017719|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
19570021|NCT01075815|42017718|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
19570022|NCT01075815|42017719|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
19570023|NCT01075191|42017725|FG000|Overall Study|Death|1|||
19570024|NCT01075191|42017725|FG000|Overall Study|Intensification|3|||
19570025|NCT01075191|42017725|FG000|Overall Study|Co-morbidities|1|||
19570026|NCT01075191|42017725|FG000|Overall Study|Adverse Event|4|||
19570027|NCT01075191|42017725|FG000|Overall Study|Noncompliance|3|||
19570028|NCT01075191|42017725|FG000|Overall Study|Therapy Break|3|||
19570029|NCT01075191|42017725|FG000|Overall Study|Patient's Wish|2|||
19570030|NCT01075191|42017725|FG000|Overall Study|Unknown Reasons|1|||
19570031|NCT00905359|42017731|FG000|Overall Study|Lost to Follow-up|17|||
19570032|NCT00905359|42017732|FG001|Overall Study|Lost to Follow-up|10|||
19570033|NCT00905359|42017731|FG000|Overall Study|Death|2|||
19570034|NCT00905359|42017732|FG001|Overall Study|Death|0|||
19570035|NCT00905359|42017731|FG000|Overall Study|Withdrawal consent|5|||
19570036|NCT00905359|42017732|FG001|Overall Study|Withdrawal consent|6|||
19570037|NCT01072149|42017738|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570038|NCT01072149|42017739|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570039|NCT01072149|42017740|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
19570040|NCT01072149|42017741|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570041|NCT01072149|42017742|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570042|NCT01072149|42017743|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570043|NCT01072149|42017744|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570044|NCT01072149|42017745|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570045|NCT01072149|42017746|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570046|NCT01072149|42017747|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570047|NCT01072149|42017748|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570048|NCT01072149|42017749|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570049|NCT01072149|42017750|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570050|NCT01072149|42017751|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570051|NCT01072149|42017752|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570052|NCT01072149|42017753|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570053|NCT01072149|42017754|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570054|NCT01072149|42017755|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19570055|NCT01072149|42017738|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570056|NCT01072149|42017739|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570057|NCT01072149|42017740|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570058|NCT01072149|42017741|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570059|NCT01072149|42017742|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570060|NCT01072149|42017743|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570061|NCT01072149|42017744|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570062|NCT01072149|42017745|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570063|NCT01072149|42017746|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570064|NCT01072149|42017747|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570065|NCT01072149|42017748|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570066|NCT01072149|42017749|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570067|NCT01072149|42017750|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570068|NCT01072149|42017751|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570069|NCT01072149|42017752|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570070|NCT01072149|42017753|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570071|NCT01072149|42017754|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
19570072|NCT01072149|42017755|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
19570073|NCT01072149|42017738|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570074|NCT01072149|42017739|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570075|NCT01072149|42017740|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570076|NCT01072149|42017741|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570077|NCT01072149|42017742|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570078|NCT01072149|42017743|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570079|NCT01072149|42017744|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570080|NCT01072149|42017745|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570081|NCT01072149|42017746|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570082|NCT01072149|42017747|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570083|NCT01072149|42017748|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
19384235|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
19384236|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
19384237|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
19384238|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
19384239|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
19384240|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
19384241|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
19384242|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
19384243|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
19384244|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
19384245|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
19384246|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
19384247|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
19384248|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
19384249|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
19384250|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
19384251|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
19384252|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
19570084|NCT01072149|42017749|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570085|NCT01072149|42017750|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570086|NCT01072149|42017751|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570087|NCT01072149|42017752|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570088|NCT01072149|42017753|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570089|NCT01072149|42017754|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570090|NCT01072149|42017755|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19570091|NCT01072149|42017738|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570092|NCT01072149|42017739|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
19570093|NCT01072149|42017740|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19384253|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
19384254|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
19570094|NCT01072149|42017741|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570095|NCT01072149|42017742|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570096|NCT01072149|42017743|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570097|NCT01072149|42017744|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570098|NCT01072149|42017745|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570099|NCT01072149|42017746|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19384255|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
19384256|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
19570100|NCT01072149|42017747|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570101|NCT01072149|42017748|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570102|NCT01072149|42017749|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570103|NCT01072149|42017750|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570104|NCT01072149|42017751|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570105|NCT01072149|42017752|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19384257|NCT02717195|41627201|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
19384258|NCT02717195|41627202|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
19384259|NCT02717195|41627203|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
19384260|NCT02717195|41627204|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
19384261|NCT02717195|41627205|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
19384262|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
19570106|NCT01072149|42017753|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570107|NCT01072149|42017754|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570108|NCT01072149|42017755|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19570109|NCT01072149|42017738|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570110|NCT01072149|42017739|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570111|NCT01072149|42017740|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
19570112|NCT01072149|42017741|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570113|NCT01072149|42017742|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570114|NCT01072149|42017743|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570115|NCT01072149|42017744|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570116|NCT01072149|42017745|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570117|NCT01072149|42017746|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570118|NCT01072149|42017747|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570119|NCT01072149|42017748|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570120|NCT01072149|42017749|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570121|NCT01072149|42017750|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570122|NCT01072149|42017751|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570123|NCT01072149|42017752|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570124|NCT01072149|42017753|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570125|NCT01072149|42017754|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570126|NCT01072149|42017755|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
19570127|NCT01072149|42017738|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570128|NCT01072149|42017739|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570129|NCT01072149|42017740|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570130|NCT01072149|42017741|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570131|NCT01072149|42017742|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570132|NCT01072149|42017743|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570133|NCT01072149|42017744|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570134|NCT01072149|42017745|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
19570135|NCT01072149|42017746|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570136|NCT01072149|42017747|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570137|NCT01072149|42017748|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570138|NCT01072149|42017749|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570139|NCT01072149|42017750|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570140|NCT01072149|42017751|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570141|NCT01072149|42017752|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570142|NCT01072149|42017753|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570143|NCT01072149|42017754|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570144|NCT01072149|42017755|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
19570145|NCT01072149|42017738|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
19384263|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
19570146|NCT01072149|42017739|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
19570147|NCT01072149|42017740|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
19570148|NCT01072149|42017741|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
19570149|NCT01072149|42017742|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
19570150|NCT01072149|42017743|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
19570151|NCT01072149|42017744|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
19570152|NCT01072149|42017745|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
19570153|NCT01072149|42017746|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
19570154|NCT01072149|42017747|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
19570155|NCT01072149|42017748|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
19570156|NCT01072149|42017749|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
19570157|NCT01072149|42017750|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
19570158|NCT01072149|42017751|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
19570159|NCT01072149|42017752|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
19570160|NCT01072149|42017753|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
19570161|NCT01072149|42017754|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
19570162|NCT01072149|42017755|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
19570163|NCT01072149|42017738|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570164|NCT01072149|42017739|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570165|NCT01072149|42017740|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570166|NCT01072149|42017741|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570167|NCT01072149|42017742|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570168|NCT01072149|42017743|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570169|NCT01072149|42017744|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570170|NCT01072149|42017745|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570171|NCT01072149|42017746|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570172|NCT01072149|42017747|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570173|NCT01072149|42017748|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570174|NCT01072149|42017749|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570175|NCT01072149|42017750|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570176|NCT01072149|42017751|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570177|NCT01072149|42017752|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570178|NCT01072149|42017753|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
19570179|NCT01072149|42017754|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570180|NCT01072149|42017755|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
19570181|NCT01072149|42017738|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
19570182|NCT01072149|42017739|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
19570183|NCT01072149|42017740|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
19570184|NCT01072149|42017741|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
19570185|NCT01072149|42017742|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
19570186|NCT01072149|42017743|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
19570187|NCT01072149|42017744|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
19570188|NCT01072149|42017745|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
19570189|NCT01072149|42017746|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
19570190|NCT01072149|42017747|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
19570191|NCT01072149|42017748|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
19570192|NCT01072149|42017749|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
19570193|NCT01072149|42017750|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
19570194|NCT01072149|42017751|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
19570195|NCT01072149|42017752|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
19570196|NCT01072149|42017753|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
19570197|NCT01072149|42017754|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
19570198|NCT01072149|42017755|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
19570199|NCT01072149|42017738|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570200|NCT01072149|42017739|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570201|NCT01072149|42017740|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570202|NCT01072149|42017741|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570203|NCT01072149|42017742|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570204|NCT01072149|42017743|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19476923|NCT01550965|41755112|FG000|Overall Study|Lack of Efficacy|59|||
19570205|NCT01072149|42017744|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570206|NCT01072149|42017745|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570207|NCT01072149|42017746|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570208|NCT01072149|42017747|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570209|NCT01072149|42017748|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570210|NCT01072149|42017749|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570211|NCT01072149|42017750|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
19570212|NCT01072149|42017751|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570213|NCT01072149|42017752|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570214|NCT01072149|42017753|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570215|NCT01072149|42017754|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570216|NCT01072149|42017755|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
19570217|NCT01072149|42017738|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570218|NCT01072149|42017739|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570219|NCT01072149|42017740|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
19570220|NCT01072149|42017741|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570221|NCT01072149|42017742|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570222|NCT01072149|42017743|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570223|NCT01072149|42017744|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570224|NCT01072149|42017745|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570225|NCT01072149|42017746|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570226|NCT01072149|42017747|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570227|NCT01072149|42017748|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570228|NCT01072149|42017749|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19384264|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
19384265|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
19384266|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
19384267|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
19384268|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
19384269|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
19745706|NCT00022763|42193061|FG001|Overall Study|Injection Site Reactions|2|||
19745707|NCT00022763|42193060|FG000|Overall Study|Death|0|||
19745708|NCT00022763|42193061|FG001|Overall Study|Death|1|||
19384270|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
19384271|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
19384272|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
19384273|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
19384274|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
19384275|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
19384276|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
19384277|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
19384278|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
19384279|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
19384280|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
19384281|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
19384282|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
19384283|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
19384284|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
19384285|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
19384286|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
19384287|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
19384288|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
19384289|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
19384290|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
19384291|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
19384292|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
19384293|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
19384294|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
19384295|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
19384296|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
19384297|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
19384298|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
19384299|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
19384300|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
19384301|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
19384302|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
19384303|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
19384304|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
19384305|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
19384306|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
19384307|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
19384308|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
19384309|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
19384310|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
19384311|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
19384312|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
19384313|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
19384314|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
19384315|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
19384316|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
19384317|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
19384318|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
19384319|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
19384320|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
19476924|NCT01550965|41755112|FG000|Overall Study|Other|13|||
19384321|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
19384322|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
19384323|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
19384324|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
19384325|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
19384326|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
19384327|NCT02717195|41627201|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
19384328|NCT02717195|41627202|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
19384329|NCT02717195|41627203|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
19570229|NCT01072149|42017750|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570230|NCT01072149|42017751|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
19570231|NCT01072149|42017752|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570232|NCT01072149|42017753|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570233|NCT01072149|42017754|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570234|NCT01072149|42017755|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
19570235|NCT01071915|42017765|FG000|Overall Study|Adverse Event|3|||
19570236|NCT01071915|42017765|FG000|Overall Study|Physician Decision|2|||
19570237|NCT01071915|42017765|FG000|Overall Study|Withdrawal by Subject|2|||
19570238|NCT01071915|42017765|FG000|Overall Study|Miscellaneous Reasons|2|||
19570239|NCT00904969|42017769|FG000|Overall Study|Lost to Follow-up|4|||
19570240|NCT00904969|42017769|FG000|Overall Study|Withdrawal by Subject|3|||
19570241|NCT00904969|42017769|FG000|Overall Study|Additional Treatments|11|||
19570242|NCT00904969|42017769|FG000|Overall Study|Case Aborted; Subject Exited|1|||
19570243|NCT01070979|42017791|FG000|Overall Study|Adverse Event|2|||
19570244|NCT01070979|42017792|FG001|Overall Study|Adverse Event|3|||
19570245|NCT01070979|42017793|FG002|Overall Study|Adverse Event|3|||
19570246|NCT01070979|42017791|FG000|Overall Study|Lost to Follow-up|2|||
19570247|NCT01070979|42017792|FG001|Overall Study|Lost to Follow-up|1|||
19570248|NCT01070979|42017793|FG002|Overall Study|Lost to Follow-up|1|||
19570249|NCT01070979|42017791|FG000|Overall Study|Protocol Violation|0|||
19570250|NCT01070979|42017792|FG001|Overall Study|Protocol Violation|2|||
19570251|NCT01070979|42017793|FG002|Overall Study|Protocol Violation|6|||
19570252|NCT01070979|42017791|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
19570253|NCT01070979|42017792|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
19570254|NCT01070979|42017793|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
19570255|NCT01070979|42017791|FG000|Overall Study|Withdrawal by Subject|3|||
19570256|NCT01070979|42017792|FG001|Overall Study|Withdrawal by Subject|1|||
19570257|NCT01070979|42017793|FG002|Overall Study|Withdrawal by Subject|1|||
19570258|NCT01070979|42017791|FG000|Overall Study|No study drug taken|0|||
19570259|NCT01070979|42017792|FG001|Overall Study|No study drug taken|1|||
19570260|NCT01070979|42017793|FG002|Overall Study|No study drug taken|0|||
19570261|NCT01234337|42017803|FG000|Overall Study|Adverse Event|58|||
19570262|NCT01234337|42017804|FG001|Overall Study|Adverse Event|21|||
19570263|NCT01234337|42017803|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
19570264|NCT01234337|42017804|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
19570265|NCT01234337|42017803|FG000|Overall Study|Investi. decision not protocol driven|5|||
19570266|NCT01234337|42017804|FG001|Overall Study|Investi. decision not protocol driven|6|||
19570267|NCT01234337|42017803|FG000|Overall Study|Non-compliant with study medication|3|||
19570268|NCT01234337|42017804|FG001|Overall Study|Non-compliant with study medication|2|||
19570269|NCT01234337|42017803|FG000|Overall Study|Randomized but not treated|6|||
19570270|NCT01234337|42017804|FG001|Overall Study|Randomized but not treated|4|||
19570271|NCT01234337|42017803|FG000|Overall Study|Lost to Follow-up|0|||
19570272|NCT01234337|42017804|FG001|Overall Study|Lost to Follow-up|1|||
19570273|NCT01234337|42017803|FG000|Overall Study|Protocol Violation|2|||
19570274|NCT01234337|42017804|FG001|Overall Study|Protocol Violation|3|||
19570275|NCT01234337|42017803|FG000|Overall Study|Withdrawal by Subject|11|||
19570276|NCT01234337|42017804|FG001|Overall Study|Withdrawal by Subject|9|||
19570277|NCT01234337|42017803|FG000|Overall Study|Death|0|||
19570278|NCT01234337|42017804|FG001|Overall Study|Death|1|||
19570279|NCT01234337|42017803|FG000|Overall Study|Switch to commercial drug|0|||
19570280|NCT01234337|42017804|FG001|Overall Study|Switch to commercial drug|1|||
19570281|NCT01070043|42017812|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
19570282|NCT01070043|42017813|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
19570283|NCT01070043|42017814|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
19570284|NCT01070043|42017812|FG000|Double-Blind Treatment|Adverse Event|0|||
19570285|NCT01070043|42017813|FG001|Double-Blind Treatment|Adverse Event|0|||
19570286|NCT01070043|42017814|FG002|Double-Blind Treatment|Adverse Event|2|||
19570287|NCT01074255|42017820|FG000|Overall Study|Did not receive EMEND|2|||
19384330|NCT02717195|41627204|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
19384331|NCT02717195|41627205|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
19384332|NCT00701441|41627220|FG000|Overall Study|failure in cpap compliance|0|||
19384333|NCT00701441|41627221|FG001|Overall Study|failure in cpap compliance|4|||
19570288|NCT01073943|42017826|FG000|Overall Study|Withdrawal by Subject|8|||
19570289|NCT01073943|42017827|FG001|Overall Study|Withdrawal by Subject|2|||
19570290|NCT01073943|42017826|FG000|Overall Study|Protocol Violation|2|||
19570291|NCT01073943|42017827|FG001|Overall Study|Protocol Violation|1|||
19570292|NCT01073943|42017826|FG000|Overall Study|Adverse Event|1|||
19570293|NCT01073943|42017827|FG001|Overall Study|Adverse Event|1|||
19570294|NCT01073943|42017826|FG000|Overall Study|Lost to Follow-up|0|||
19570295|NCT01073943|42017827|FG001|Overall Study|Lost to Follow-up|2|||
19570296|NCT01073943|42017826|FG000|Overall Study|Power outage; colonoscopy not done|1|||
19570297|NCT01073943|42017827|FG001|Overall Study|Power outage; colonoscopy not done|0|||
19570298|NCT01073943|42017826|FG000|Overall Study|Subject forgot|0|||
19570299|NCT01073943|42017827|FG001|Overall Study|Subject forgot|1|||
19570300|NCT01073943|42017826|FG000|Overall Study|Unable to return for follow-up|0|||
19570301|NCT01073943|42017827|FG001|Overall Study|Unable to return for follow-up|1|||
19570302|NCT01073943|42017826|FG000|Overall Study|Could not tolerate prep|1|||
19570303|NCT01073943|42017827|FG001|Overall Study|Could not tolerate prep|0|||
19570304|NCT01073865|42017835|FG000|Overall Study|Reasons other than below|19|||
19570305|NCT01073865|42017836|FG001|Overall Study|Reasons other than below|31|||
19570306|NCT01073865|42017835|FG000|Overall Study|Lost to Follow-up|1|||
19570307|NCT01073865|42017836|FG001|Overall Study|Lost to Follow-up|1|||
19570308|NCT01073865|42017835|FG000|Overall Study|Death|3|||
19570309|NCT01073865|42017836|FG001|Overall Study|Death|2|||
19570310|NCT01073865|42017835|FG000|Overall Study|Withdrawal by Subject|5|||
19570311|NCT01073865|42017836|FG001|Overall Study|Withdrawal by Subject|5|||
19570312|NCT04862065|42017845|FG000|Screening|Protocol Violation|54|||
19570313|NCT04862065|42017846|FG001|Screening|Protocol Violation|0|||
19570314|NCT04862065|42017847|FG002|Screening|Protocol Violation|0|||
19570315|NCT04862065|42017845|FG000|Screening|Insufficient Sample|1|||
19570316|NCT04862065|42017846|FG001|Screening|Insufficient Sample|0|||
19570317|NCT04862065|42017847|FG002|Screening|Insufficient Sample|0|||
19570318|NCT04862065|42017845|FG000|Follow-Up|Lost to Follow-up|3|||
19570319|NCT04862065|42017846|FG001|Follow-Up|Lost to Follow-up|0|||
19570320|NCT04862065|42017847|FG002|Follow-Up|Lost to Follow-up|0|||
19570321|NCT01073631|42017853|FG000|Overall Study|Death|82|||
19384334|NCT02628873|41627233|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
19570322|NCT01073631|42017853|FG000|Overall Study|Adverse Event|24|||
19570323|NCT01073631|42017853|FG000|Overall Study|Other|63|||
19570324|NCT01073163|42017857|FG000|Overall Study|Adverse Event|1|||
19570325|NCT01073163|42017857|FG000|Overall Study|Disease Progression|1|||
19570326|NCT01073163|42017857|FG000|Overall Study|Early termination|1|||
19570327|NCT01233869|42017869|FG000|Initial Treatment Period (24 Months)|Death|1|||
19570328|NCT01233869|42017870|FG001|Initial Treatment Period (24 Months)|Death|0|||
19570329|NCT01233869|42017871|FG002|Initial Treatment Period (24 Months)|Death|0|||
19570330|NCT01233869|42017872|FG003|Initial Treatment Period (24 Months)|Death|0|||
19570331|NCT01233869|42017869|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
19570332|NCT01233869|42017870|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
19570333|NCT01233869|42017871|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
19570334|NCT01233869|42017872|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
19570335|NCT01233869|42017869|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
19570336|NCT01233869|42017870|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
19570337|NCT01233869|42017871|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
19570338|NCT01233869|42017872|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
19570339|NCT01233869|42017869|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
19570340|NCT01233869|42017870|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
19570341|NCT01233869|42017871|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
19570342|NCT01233869|42017872|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
19570343|NCT01233869|42017869|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
19570344|NCT01233869|42017870|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
19570345|NCT01233869|42017871|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
19570346|NCT01233869|42017872|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
19570347|NCT01233869|42017869|FG000|Extended Treatment Period (46 Months)|Other|3|||
19570348|NCT01233869|42017870|FG001|Extended Treatment Period (46 Months)|Other|0|||
19570349|NCT01233869|42017871|FG002|Extended Treatment Period (46 Months)|Other|0|||
19570350|NCT01233869|42017872|FG003|Extended Treatment Period (46 Months)|Other|3|||
19570351|NCT01233869|42017869|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
19570352|NCT01233869|42017870|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
19570353|NCT01233869|42017871|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
19570354|NCT01233869|42017872|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
19570355|NCT01072929|42017885|FG000|Overall Study|Adverse Event|8|||
19570356|NCT01072929|42017886|FG001|Overall Study|Adverse Event|11|||
19570357|NCT01072929|42017887|FG002|Overall Study|Adverse Event|2|||
19570358|NCT01072929|42017885|FG000|Overall Study|Lack of Efficacy|7|||
19570359|NCT01072929|42017886|FG001|Overall Study|Lack of Efficacy|4|||
19384335|NCT02628873|41627234|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
19384336|NCT02628873|41627233|FG000|Second Test (1 Hour)|Physician Decision|1|||
19570360|NCT01072929|42017887|FG002|Overall Study|Lack of Efficacy|0|||
19570361|NCT01072929|42017885|FG000|Overall Study|Withdrawal by Subject|7|||
19570362|NCT01072929|42017886|FG001|Overall Study|Withdrawal by Subject|15|||
19570363|NCT01072929|42017887|FG002|Overall Study|Withdrawal by Subject|3|||
19570364|NCT01072929|42017885|FG000|Overall Study|Protocol Violation|13|||
19570365|NCT01072929|42017886|FG001|Overall Study|Protocol Violation|11|||
19384337|NCT02628873|41627234|FG001|Second Test (1 Hour)|Physician Decision|0|||
19570366|NCT01072929|42017887|FG002|Overall Study|Protocol Violation|2|||
19570367|NCT01072929|42017885|FG000|Overall Study|Lost to Follow-up|8|||
19570368|NCT01072929|42017886|FG001|Overall Study|Lost to Follow-up|4|||
19570369|NCT01072929|42017887|FG002|Overall Study|Lost to Follow-up|1|||
19570370|NCT01072929|42017885|FG000|Overall Study|Noncompliance with study medication|0|||
19570371|NCT01072929|42017886|FG001|Overall Study|Noncompliance with study medication|3|||
19570372|NCT01072929|42017887|FG002|Overall Study|Noncompliance with study medication|0|||
19570373|NCT01072929|42017885|FG000|Overall Study|Noncompliance with study procedures|1|||
19570374|NCT01072929|42017886|FG001|Overall Study|Noncompliance with study procedures|0|||
19570375|NCT01072929|42017887|FG002|Overall Study|Noncompliance with study procedures|1|||
19570376|NCT01072929|42017885|FG000|Overall Study|Other|0|||
19570377|NCT01072929|42017886|FG001|Overall Study|Other|3|||
19745709|NCT00022763|42193060|FG000|Overall Study|Lost to Follow-up|0|||
19384338|NCT02629965|41627244|FG000|Period 1|Adverse Event|1|||
19570378|NCT01072929|42017887|FG002|Overall Study|Other|0|||
19570379|NCT01231607|42017901|FG000|Overall Study|Adverse Event|0|||
19570380|NCT01231607|42017902|FG001|Overall Study|Adverse Event|8|||
19570381|NCT01231607|42017903|FG002|Overall Study|Adverse Event|4|||
19570382|NCT01231607|42017904|FG003|Overall Study|Adverse Event|4|||
19570383|NCT01231607|42017905|FG004|Overall Study|Adverse Event|5|||
19570384|NCT01231607|42017901|FG000|Overall Study|Lost to Follow-up|13|||
19570385|NCT01231607|42017902|FG001|Overall Study|Lost to Follow-up|11|||
19570386|NCT01231607|42017903|FG002|Overall Study|Lost to Follow-up|10|||
19570387|NCT01231607|42017904|FG003|Overall Study|Lost to Follow-up|10|||
19570388|NCT01231607|42017905|FG004|Overall Study|Lost to Follow-up|4|||
19570389|NCT01231607|42017901|FG000|Overall Study|Physician Decision|4|||
19570390|NCT01231607|42017902|FG001|Overall Study|Physician Decision|4|||
19570391|NCT01231607|42017903|FG002|Overall Study|Physician Decision|3|||
19384339|NCT02629965|41627245|FG001|Period 1|Adverse Event|0|||
19384340|NCT02629965|41627244|FG000|Period 1|Unexpected worsening of disease|2|||
19384341|NCT02629965|41627245|FG001|Period 1|Unexpected worsening of disease|0|||
19384342|NCT02629965|41627244|FG000|Period 1|Other than listed above|1|||
19384343|NCT02629965|41627245|FG001|Period 1|Other than listed above|2|||
19384344|NCT02629965|41627244|FG000|Period 2|Adverse Event|1|||
19384345|NCT02629965|41627245|FG001|Period 2|Adverse Event|0|||
19384346|NCT01671111|41627251|FG000|Overall Study|Adverse Event|2|||
19384347|NCT01671111|41627251|FG000|Overall Study|Lack of Efficacy|1|||
19384348|NCT01671111|41627251|FG000|Overall Study|Withdrawal by Subject|2|||
19384349|NCT01671111|41627251|FG000|Overall Study|Physician Decision|1|||
19384350|NCT01671111|41627251|FG000|Overall Study|Other|24|||
19384351|NCT01671345|41627257|FG000|Overall Study|Lost to Follow-up|10|||
19384352|NCT01671345|41627258|FG001|Overall Study|Lost to Follow-up|6|||
19384353|NCT01671345|41627257|FG000|Overall Study|visit with non-participating physician|3|||
19384354|NCT01671345|41627258|FG001|Overall Study|visit with non-participating physician|3|||
19384355|NCT04338321|41627280|FG000|Overall Study|Adverse Event|4|||
19384356|NCT04338321|41627281|FG001|Overall Study|Adverse Event|10|||
19384357|NCT04338321|41627280|FG000|Overall Study|Death|1|||
19384358|NCT04338321|41627281|FG001|Overall Study|Death|1|||
19384359|NCT04338321|41627280|FG000|Overall Study|Lost to Follow-up|4|||
19384360|NCT04338321|41627281|FG001|Overall Study|Lost to Follow-up|9|||
19384361|NCT04338321|41627280|FG000|Overall Study|Withdrawal by Subject|45|||
19384362|NCT04338321|41627281|FG001|Overall Study|Withdrawal by Subject|69|||
19384363|NCT04338321|41627280|FG000|Overall Study|Physician Decision|5|||
19384364|NCT04338321|41627281|FG001|Overall Study|Physician Decision|9|||
19384365|NCT04338321|41627280|FG000|Overall Study|Other|3|||
19384366|NCT04338321|41627281|FG001|Overall Study|Other|10|||
19384367|NCT02487095|41627297|FG000|Dose Expansion|Unable to scan/restage participant|0|||
19384368|NCT02487095|41627298|FG001|Dose Expansion|Unable to scan/restage participant|0|||
19570392|NCT01231607|42017904|FG003|Overall Study|Physician Decision|5|||
19570393|NCT01231607|42017905|FG004|Overall Study|Physician Decision|4|||
19570394|NCT01231607|42017901|FG000|Overall Study|Protocol Violation|3|||
19384369|NCT02487095|41627299|FG002|Dose Expansion|Unable to scan/restage participant|0|||
19384370|NCT02487095|41627300|FG003|Dose Expansion|Unable to scan/restage participant|0|||
19384371|NCT02487095|41627301|FG004|Dose Expansion|Unable to scan/restage participant|1|||
19384372|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
19384373|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
19384374|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
19570395|NCT01231607|42017902|FG001|Overall Study|Protocol Violation|2|||
19384375|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
19384376|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
19384377|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
19384378|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
19384379|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
19384380|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
19384381|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
19570396|NCT01231607|42017903|FG002|Overall Study|Protocol Violation|0|||
19570397|NCT01231607|42017904|FG003|Overall Study|Protocol Violation|2|||
19570398|NCT01231607|42017905|FG004|Overall Study|Protocol Violation|2|||
19570399|NCT01231607|42017901|FG000|Overall Study|Withdrawal by Subject|9|||
19570400|NCT01231607|42017902|FG001|Overall Study|Withdrawal by Subject|9|||
19570401|NCT01231607|42017903|FG002|Overall Study|Withdrawal by Subject|14|||
19570402|NCT01231607|42017904|FG003|Overall Study|Withdrawal by Subject|17|||
19570403|NCT01231607|42017905|FG004|Overall Study|Withdrawal by Subject|9|||
19570404|NCT01231373|42017924|FG000|Overall Study|Withdrew consent prior to randomization|2|||
19570405|NCT01231373|42017925|FG001|Overall Study|Withdrew consent prior to randomization|1|||
19570406|NCT01231373|42017926|FG002|Overall Study|Withdrew consent prior to randomization|0|||
19570407|NCT01231373|42017927|FG003|Overall Study|Withdrew consent prior to randomization|0|||
19570408|NCT01231373|42017924|FG000|Overall Study|Lost to Follow-up|0|||
19570409|NCT01231373|42017925|FG001|Overall Study|Lost to Follow-up|0|||
19570410|NCT01231373|42017926|FG002|Overall Study|Lost to Follow-up|0|||
19570411|NCT01231373|42017927|FG003|Overall Study|Lost to Follow-up|1|||
19570412|NCT01231373|42017924|FG000|Overall Study|Withdrew Consent|1|||
19570413|NCT01231373|42017925|FG001|Overall Study|Withdrew Consent|0|||
19570414|NCT01231373|42017926|FG002|Overall Study|Withdrew Consent|0|||
19570415|NCT01231373|42017927|FG003|Overall Study|Withdrew Consent|0|||
19570416|NCT00975130|42017939|FG000|Study Part 1|Adverse Event|150|||
19570417|NCT00975130|42017940|FG001|Study Part 1|Adverse Event|0|||
19570418|NCT00975130|42017941|FG002|Study Part 1|Adverse Event|0|||
19570419|NCT00975130|42017939|FG000|Study Part 1|Lost to Follow-up|19|||
19570420|NCT00975130|42017940|FG001|Study Part 1|Lost to Follow-up|0|||
19570421|NCT00975130|42017941|FG002|Study Part 1|Lost to Follow-up|0|||
19570422|NCT00975130|42017939|FG000|Study Part 1|Withdrawal by Subject|61|||
19570423|NCT00975130|42017940|FG001|Study Part 1|Withdrawal by Subject|0|||
19570424|NCT00975130|42017941|FG002|Study Part 1|Withdrawal by Subject|0|||
19570425|NCT00975130|42017939|FG000|Study Part 1|Protocol Violation|13|||
19570426|NCT00975130|42017940|FG001|Study Part 1|Protocol Violation|0|||
19570427|NCT00975130|42017941|FG002|Study Part 1|Protocol Violation|0|||
19570428|NCT00975130|42017939|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
19570429|NCT00975130|42017940|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
19570430|NCT00975130|42017941|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
19570431|NCT00975130|42017939|FG000|Study Part 1|Administrative|4|||
19570432|NCT00975130|42017940|FG001|Study Part 1|Administrative|0|||
19570433|NCT00975130|42017941|FG002|Study Part 1|Administrative|0|||
19570434|NCT00975130|42017939|FG000|Study Part 1|Withdrew Consent|24|||
19570435|NCT00975130|42017940|FG001|Study Part 1|Withdrew Consent|0|||
19570436|NCT00975130|42017941|FG002|Study Part 1|Withdrew Consent|0|||
19570437|NCT00975130|42017939|FG000|Study Part 2|Adverse Event|0|||
19570438|NCT00975130|42017940|FG001|Study Part 2|Adverse Event|14|||
19570439|NCT00975130|42017941|FG002|Study Part 2|Adverse Event|7|||
19570440|NCT00975130|42017939|FG000|Study Part 2|Lost to Follow-up|0|||
19570441|NCT00975130|42017940|FG001|Study Part 2|Lost to Follow-up|0|||
19570442|NCT00975130|42017941|FG002|Study Part 2|Lost to Follow-up|1|||
19570443|NCT00975130|42017939|FG000|Study Part 2|Withdrawal by Subject|0|||
19570444|NCT00975130|42017940|FG001|Study Part 2|Withdrawal by Subject|13|||
19384382|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
19570445|NCT00975130|42017941|FG002|Study Part 2|Withdrawal by Subject|5|||
19570446|NCT00975130|42017939|FG000|Study Part 2|Withdrew Consent|0|||
19570447|NCT00975130|42017940|FG001|Study Part 2|Withdrew Consent|6|||
19570448|NCT00975130|42017941|FG002|Study Part 2|Withdrew Consent|2|||
19384383|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
19745710|NCT00022763|42193061|FG001|Overall Study|Lost to Follow-up|3|||
19745711|NCT00022763|42193060|FG000|Overall Study|Withdrawal by Subject|4|||
19570449|NCT00975130|42017939|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
19570450|NCT00975130|42017940|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
19570451|NCT00975130|42017941|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
19570452|NCT00975130|42017939|FG000|Study Part 2|Administrative|0|||
19570453|NCT00975130|42017940|FG001|Study Part 2|Administrative|1|||
19570454|NCT00975130|42017941|FG002|Study Part 2|Administrative|0|||
19570455|NCT00975130|42017939|FG000|Study Part 2|Protocol Violation|0|||
19570456|NCT00975130|42017940|FG001|Study Part 2|Protocol Violation|0|||
19745712|NCT00022763|42193061|FG001|Overall Study|Withdrawal by Subject|7|||
19384384|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
19384385|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
19384386|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
19384387|NCT03855137|41627324|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
19384388|NCT03855137|41627325|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
19384389|NCT03855137|41627326|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
19384390|NCT03855137|41627324|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
19384391|NCT03855137|41627325|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
19384392|NCT03855137|41627326|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
19384393|NCT03855137|41627324|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
19384394|NCT03855137|41627325|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
19384395|NCT03855137|41627326|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
19384396|NCT03855137|41627324|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
19384397|NCT03855137|41627325|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
19384398|NCT03855137|41627326|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
19384399|NCT03855137|41627324|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
19384400|NCT03855137|41627325|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
19570457|NCT00975130|42017941|FG002|Study Part 2|Protocol Violation|1|||
19570458|NCT01230827|42017958|FG000|Overall Study|Lost to Follow-up|0|||
19570459|NCT01230827|42017959|FG001|Overall Study|Lost to Follow-up|0|||
19570460|NCT01230827|42017960|FG002|Overall Study|Lost to Follow-up|1|||
19570461|NCT01230827|42017961|FG003|Overall Study|Lost to Follow-up|3|||
19570462|NCT01230827|42017958|FG000|Overall Study|Withdrawal by Subject|1|||
19570463|NCT01230827|42017959|FG001|Overall Study|Withdrawal by Subject|0|||
19570464|NCT01230827|42017960|FG002|Overall Study|Withdrawal by Subject|3|||
19570465|NCT01230827|42017961|FG003|Overall Study|Withdrawal by Subject|2|||
19570466|NCT01230827|42017958|FG000|Overall Study|Lack of Efficacy|14|||
19570467|NCT01230827|42017959|FG001|Overall Study|Lack of Efficacy|1|||
19570468|NCT01230827|42017960|FG002|Overall Study|Lack of Efficacy|2|||
19570469|NCT01230827|42017961|FG003|Overall Study|Lack of Efficacy|3|||
19570470|NCT01230827|42017958|FG000|Overall Study|Adverse Event|4|||
19570471|NCT01230827|42017959|FG001|Overall Study|Adverse Event|2|||
19570472|NCT01230827|42017960|FG002|Overall Study|Adverse Event|3|||
19570473|NCT01230827|42017961|FG003|Overall Study|Adverse Event|7|||
19570474|NCT01230827|42017958|FG000|Overall Study|Recovery|0|||
19570475|NCT01230827|42017959|FG001|Overall Study|Recovery|6|||
19570476|NCT01230827|42017960|FG002|Overall Study|Recovery|0|||
19570477|NCT01230827|42017961|FG003|Overall Study|Recovery|0|||
19570478|NCT01230827|42017958|FG000|Overall Study|Study terminated by Sponsor|0|||
19570479|NCT01230827|42017959|FG001|Overall Study|Study terminated by Sponsor|2|||
19570480|NCT01230827|42017960|FG002|Overall Study|Study terminated by Sponsor|56|||
19570481|NCT01230827|42017961|FG003|Overall Study|Study terminated by Sponsor|63|||
19570482|NCT01230749|42017973|FG000|Overall Study|Adverse Event|0|||
19570483|NCT01230749|42017974|FG001|Overall Study|Adverse Event|0|||
19570484|NCT01230749|42017975|FG002|Overall Study|Adverse Event|0|||
19570485|NCT01230749|42017976|FG003|Overall Study|Adverse Event|1|||
19570486|NCT01230749|42017973|FG000|Overall Study|Physician Decision|0|||
19570487|NCT01230749|42017974|FG001|Overall Study|Physician Decision|0|||
19570488|NCT01230749|42017975|FG002|Overall Study|Physician Decision|1|||
19570489|NCT01230749|42017976|FG003|Overall Study|Physician Decision|0|||
19570490|NCT01230749|42017973|FG000|Overall Study|Withdrawal by Subject|0|||
19570491|NCT01230749|42017974|FG001|Overall Study|Withdrawal by Subject|1|||
19570492|NCT01230749|42017975|FG002|Overall Study|Withdrawal by Subject|0|||
19570493|NCT01230749|42017976|FG003|Overall Study|Withdrawal by Subject|0|||
19570494|NCT01230749|42017973|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
19570495|NCT01230749|42017974|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
19570496|NCT01230749|42017975|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
19570497|NCT01230749|42017976|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
19570498|NCT00903175|42017991|FG000|Period 1 - First Line|Adverse Event|36|||
19570499|NCT00903175|42017992|FG001|Period 1 - First Line|Adverse Event|50|||
19570500|NCT00903175|42017991|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
19570501|NCT00903175|42017992|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
19570502|NCT00903175|42017991|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
19570503|NCT00903175|42017992|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
19745713|NCT00022763|42193060|FG000|Overall Study|Insufficient Therapy|1|||
19570504|NCT00903175|42017991|FG000|Period 1 - First Line|Protocol Violation|3|||
19570505|NCT00903175|42017992|FG001|Period 1 - First Line|Protocol Violation|3|||
19570506|NCT00903175|42017991|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
19570507|NCT00903175|42017992|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
19570508|NCT00903175|42017991|FG000|Period 1 - First Line|Administrative problems|12|||
19570509|NCT00903175|42017992|FG001|Period 1 - First Line|Administrative problems|13|||
19570510|NCT00903175|42017991|FG000|Period 1 - First Line|Death|17|||
19570511|NCT00903175|42017992|FG001|Period 1 - First Line|Death|10|||
19570512|NCT00903175|42017991|FG000|Period 2 - Second Line|Missing|1|||
19570513|NCT00903175|42017992|FG001|Period 2 - Second Line|Missing|0|||
19570514|NCT00903175|42017991|FG000|Period 2 - Second Line|Adverse Event|16|||
19570515|NCT00903175|42017992|FG001|Period 2 - Second Line|Adverse Event|20|||
19570516|NCT00903175|42017991|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
19570517|NCT00903175|42017992|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
19570518|NCT00903175|42017991|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
19570519|NCT00903175|42017992|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
19570520|NCT00903175|42017991|FG000|Period 2 - Second Line|Administrative problems|19|||
19570521|NCT00903175|42017992|FG001|Period 2 - Second Line|Administrative problems|9|||
19570522|NCT00903175|42017991|FG000|Period 2 - Second Line|Death|5|||
19570523|NCT00903175|42017992|FG001|Period 2 - Second Line|Death|2|||
19570524|NCT01229735|42018000|FG000|Overall Study|Lack of Efficacy|8|||
19570525|NCT01229735|42018001|FG001|Overall Study|Lack of Efficacy|8|||
19570526|NCT01229735|42018000|FG000|Overall Study|Protocol Violation|13|||
19384401|NCT03855137|41627326|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
19384402|NCT00701363|41627348|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
19384403|NCT00701363|41627349|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
19384404|NCT00701363|41627350|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
19570527|NCT01229735|42018001|FG001|Overall Study|Protocol Violation|8|||
19570528|NCT01229735|42018000|FG000|Overall Study|Lost to Follow-up|0|||
19570529|NCT01229735|42018001|FG001|Overall Study|Lost to Follow-up|2|||
19570530|NCT01229735|42018000|FG000|Overall Study|Withdrawal by Subject|18|||
19570531|NCT01229735|42018001|FG001|Overall Study|Withdrawal by Subject|17|||
19570532|NCT01229735|42018000|FG000|Overall Study|Other Reason|13|||
19570533|NCT01229735|42018001|FG001|Overall Study|Other Reason|10|||
19570534|NCT01229735|42018000|FG000|Overall Study|SAE, non-fatal|0|||
19570535|NCT01229735|42018001|FG001|Overall Study|SAE, non-fatal|4|||
19570536|NCT01229735|42018000|FG000|Overall Study|AE, non-serious non-fatal|13|||
19570537|NCT01229735|42018001|FG001|Overall Study|AE, non-serious non-fatal|17|||
19570538|NCT01229735|42018000|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19570539|NCT01229735|42018001|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19570540|NCT00974974|42018020|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
19570541|NCT00974974|42018021|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
19570542|NCT00974974|42018020|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
19570543|NCT00974974|42018021|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
19570544|NCT00974974|42018020|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
19570545|NCT00974974|42018021|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
19570546|NCT00974974|42018020|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
19570547|NCT00974974|42018021|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
19570548|NCT00974974|42018020|FG000|IR CD-LD Dose Adjustment|Various|0|||
19570549|NCT00974974|42018021|FG001|IR CD-LD Dose Adjustment|Various|9|||
19570550|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Adverse Event|23|||
19570551|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Adverse Event|0|||
19570552|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Death|2|||
19570553|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Death|0|||
19570554|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
19570555|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
19570556|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
19570557|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
19570558|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Various|3|||
19570559|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Various|0|||
19570560|NCT00974974|42018020|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
19570561|NCT00974974|42018021|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
19570562|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
19570563|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
19570564|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
19570565|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
19570566|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
19570567|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
19384405|NCT00701363|41627351|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
19384406|NCT00701363|41627348|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
19384407|NCT00701363|41627349|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
19384408|NCT00701363|41627350|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
19384409|NCT00701363|41627351|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
19476925|NCT01569295|41755233|FG000|Overall Study|Progressive Disease|75|||
19476926|NCT01569295|41755234|FG001|Overall Study|Progressive Disease|139|||
19570568|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
19570569|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
19570570|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
19570571|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
19384410|NCT00701363|41627348|FG000|Treatment Phase 1|Adverse Event|7|||
19384411|NCT00701363|41627349|FG001|Treatment Phase 1|Adverse Event|0|||
19384412|NCT00701363|41627350|FG002|Treatment Phase 1|Adverse Event|0|||
19384413|NCT00701363|41627351|FG003|Treatment Phase 1|Adverse Event|0|||
19384414|NCT00701363|41627348|FG000|Treatment Phase 1|Protocol Violation|1|||
19384415|NCT00701363|41627349|FG001|Treatment Phase 1|Protocol Violation|0|||
19384416|NCT00701363|41627350|FG002|Treatment Phase 1|Protocol Violation|0|||
19384417|NCT00701363|41627351|FG003|Treatment Phase 1|Protocol Violation|0|||
19384418|NCT00701363|41627348|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
19384419|NCT00701363|41627349|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
19384420|NCT00701363|41627350|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
19384421|NCT00701363|41627351|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
19570572|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
19570573|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
19570574|NCT00974974|42018020|FG000|Maintenance - Double Blind Treatment|Various|4|||
19570575|NCT00974974|42018021|FG001|Maintenance - Double Blind Treatment|Various|0|||
19570576|NCT00992992|42018027|FG000|Overall Study|Lost to Follow-up|3|||
19570577|NCT00992992|42018027|FG000|Overall Study|Death|16|||
19570578|NCT00992992|42018027|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
19570579|NCT00992992|42018027|FG000|Overall Study|Sponsor Closed the Study|4|||
19570580|NCT00992836|42018031|FG000|Overall Study|Lost to Follow-up|1|||
19570581|NCT00992836|42018031|FG000|Overall Study|Withdrawal by Subject|2|||
19570582|NCT00992836|42018031|FG000|Overall Study|Protocol Violation|2|||
19570583|NCT00992446|42018041|FG000|Overall Study|Disease Progression|1|||
19570584|NCT00992446|42018041|FG000|Overall Study|Withdrawal by Subject|2|||
19570585|NCT00992446|42018041|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
19570586|NCT00970294|42018045|FG000|Overall Study|Physician Decision|4|||
19570587|NCT00970294|42018045|FG000|Overall Study|Withdrawal by Subject|1|||
19570588|NCT00969436|42018052|FG000|Overall Study|Protocol Violation|1|||
19570589|NCT00969436|42018053|FG001|Overall Study|Protocol Violation|3|||
19570590|NCT00969436|42018054|FG002|Overall Study|Protocol Violation|0|||
19570591|NCT00969436|42018052|FG000|Overall Study|Migrated/moved from study area|12|||
19570592|NCT00969436|42018053|FG001|Overall Study|Migrated/moved from study area|10|||
19570593|NCT00969436|42018054|FG002|Overall Study|Migrated/moved from study area|2|||
19570594|NCT00969436|42018052|FG000|Overall Study|Father - serious health problem|0|||
19570595|NCT00969436|42018053|FG001|Overall Study|Father - serious health problem|0|||
19570596|NCT00969436|42018054|FG002|Overall Study|Father - serious health problem|1|||
19570597|NCT00969436|42018052|FG000|Overall Study|Parents personal problem|0|||
19570598|NCT00969436|42018053|FG001|Overall Study|Parents personal problem|0|||
19570599|NCT00969436|42018054|FG002|Overall Study|Parents personal problem|1|||
19570600|NCT00969436|42018052|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
19570601|NCT00969436|42018053|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
19570602|NCT00969436|42018054|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
19570603|NCT00969436|42018052|FG000|Overall Study|Withdrawal by Subject|3|||
19570604|NCT00969436|42018053|FG001|Overall Study|Withdrawal by Subject|0|||
19570605|NCT00969436|42018054|FG002|Overall Study|Withdrawal by Subject|2|||
19570606|NCT00969436|42018052|FG000|Overall Study|Lost to Follow-up|8|||
19570607|NCT00969436|42018053|FG001|Overall Study|Lost to Follow-up|8|||
19570608|NCT00969436|42018054|FG002|Overall Study|Lost to Follow-up|5|||
19570609|NCT00900757|42018062|FG000|Overall Study|screen failure|19|||
19570610|NCT00969280|42018068|FG000|Overall Study|Protocol Violation|2|||
19570611|NCT00969280|42018069|FG001|Overall Study|Protocol Violation|1|||
19570612|NCT00969280|42018068|FG000|Overall Study|Withdrawal by Subject|0|||
19570613|NCT00969280|42018069|FG001|Overall Study|Withdrawal by Subject|1|||
19570614|NCT00969280|42018068|FG000|Overall Study|infection of influenza A(H1N1)|0|||
19570615|NCT00969280|42018069|FG001|Overall Study|infection of influenza A(H1N1)|1|||
19570616|NCT00969124|42018075|FG000|Overall Study|Protocol Violation|2|||
19570617|NCT00969124|42018075|FG000|Overall Study|Inadequate bowel preparation|15|||
19570618|NCT00969124|42018075|FG000|Overall Study|Inability to reach cecum|9|||
19570619|NCT00969124|42018075|FG000|Overall Study|Previously unrecognized disease|3|||
19570620|NCT00969124|42018075|FG000|Overall Study|Technical error|1|||
19570621|NCT00900601|42018080|FG000|Overall Study|Physician Decision|1|||
19570622|NCT00901927|42018107|FG000|Overall Study|Lack of Efficacy|1|||
19570623|NCT00901927|42018107|FG000|Overall Study|Protocol Violation|3|||
19570624|NCT00901927|42018107|FG000|Overall Study|Withdrawal by Subject|2|||
19570625|NCT00968968|42018113|FG000|Overall Study|Study closed/terminated|10|||
19570626|NCT00968968|42018114|FG001|Overall Study|Study closed/terminated|10|||
19570627|NCT00968968|42018113|FG000|Overall Study|Protocol defined stopping criteria|3|||
19570628|NCT00968968|42018114|FG001|Overall Study|Protocol defined stopping criteria|1|||
19570629|NCT00968968|42018113|FG000|Overall Study|Withdrawal by Subject|2|||
19570630|NCT00968968|42018114|FG001|Overall Study|Withdrawal by Subject|0|||
19570631|NCT00968968|42018113|FG000|Overall Study|Physician Decision|1|||
19570632|NCT00968968|42018114|FG001|Overall Study|Physician Decision|2|||
19570633|NCT00968968|42018113|FG000|Overall Study|Lost to Follow-up|0|||
19570634|NCT00968968|42018114|FG001|Overall Study|Lost to Follow-up|1|||
19570635|NCT00973102|42018123|FG000|Overall Study|Protocol Violation|1|||
19384422|NCT00701363|41627348|FG000|Treatment Phase 1|Lack of Efficacy|1|||
19570636|NCT00973102|42018124|FG001|Overall Study|Protocol Violation|0|||
19570637|NCT00973102|42018123|FG000|Overall Study|Prisoner|0|||
19570638|NCT00973102|42018124|FG001|Overall Study|Prisoner|1|||
19570639|NCT00901459|42018130|FG000|Overall Study|Withdrawal by Subject|6|||
19570640|NCT00896233|42018141|FG000|Overall Study|Claustrophobia during MRI|1|||
19570641|NCT00899431|42018166|FG000|Overall Study|Physician Decision|1|||
19570642|NCT00899431|42018167|FG001|Overall Study|Physician Decision|0|||
19384423|NCT00701363|41627349|FG001|Treatment Phase 1|Lack of Efficacy|0|||
19384424|NCT00701363|41627350|FG002|Treatment Phase 1|Lack of Efficacy|0|||
19384425|NCT00701363|41627351|FG003|Treatment Phase 1|Lack of Efficacy|0|||
19384426|NCT00701363|41627348|FG000|Treatment Phase 2|Adverse Event|0|||
19384427|NCT00701363|41627349|FG001|Treatment Phase 2|Adverse Event|0|||
19384428|NCT00701363|41627350|FG002|Treatment Phase 2|Adverse Event|1|||
19570643|NCT00899431|42018168|FG002|Overall Study|Physician Decision|0|||
19570644|NCT00899353|42018179|FG000|Overall Study|Adverse Event|2|||
19384429|NCT00701363|41627351|FG003|Treatment Phase 2|Adverse Event|0|||
19384430|NCT00701363|41627348|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
19384431|NCT00701363|41627349|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
19384432|NCT00701363|41627350|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
19384433|NCT00701363|41627351|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
19384434|NCT01670877|41627375|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
19384435|NCT01670877|41627376|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
19384436|NCT01670877|41627377|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
19570645|NCT00899353|42018179|FG000|Overall Study|Lost to Follow-up|1|||
19570646|NCT00899353|42018179|FG000|Overall Study|Withdrawal by Subject|2|||
19570647|NCT00898807|42018202|FG000|Overall Study|Withdrawal by Subject|5|||
19570648|NCT00898807|42018203|FG001|Overall Study|Withdrawal by Subject|3|||
19570649|NCT00898807|42018202|FG000|Overall Study|Family pressure to discontinue|2|||
19570650|NCT00898807|42018203|FG001|Overall Study|Family pressure to discontinue|2|||
19570651|NCT00898807|42018202|FG000|Overall Study|Lost to Follow-up|1|||
19570652|NCT00898807|42018203|FG001|Overall Study|Lost to Follow-up|3|||
19570653|NCT00898807|42018202|FG000|Overall Study|Death|0|||
19570654|NCT00898807|42018203|FG001|Overall Study|Death|1|||
19570655|NCT01229267|42018214|FG000|Overall Study|Adverse Event|4|||
19570656|NCT01229267|42018215|FG001|Overall Study|Adverse Event|6|||
19570657|NCT01229267|42018216|FG002|Overall Study|Adverse Event|3|||
19570658|NCT01229267|42018217|FG003|Overall Study|Adverse Event|2|||
19570659|NCT01229267|42018218|FG004|Overall Study|Adverse Event|10|||
19570660|NCT01229267|42018214|FG000|Overall Study|Death|40|||
19570661|NCT01229267|42018215|FG001|Overall Study|Death|37|||
19570662|NCT01229267|42018216|FG002|Overall Study|Death|35|||
19570663|NCT01229267|42018217|FG003|Overall Study|Death|13|||
19570664|NCT01229267|42018218|FG004|Overall Study|Death|103|||
19570665|NCT01229267|42018214|FG000|Overall Study|Withdrawal by Subject|23|||
19570666|NCT01229267|42018215|FG001|Overall Study|Withdrawal by Subject|22|||
19570667|NCT01229267|42018216|FG002|Overall Study|Withdrawal by Subject|32|||
19570668|NCT01229267|42018217|FG003|Overall Study|Withdrawal by Subject|14|||
19570669|NCT01229267|42018218|FG004|Overall Study|Withdrawal by Subject|59|||
19570670|NCT01229267|42018214|FG000|Overall Study|Protocol Violation|0|||
19570671|NCT01229267|42018215|FG001|Overall Study|Protocol Violation|1|||
19570672|NCT01229267|42018216|FG002|Overall Study|Protocol Violation|0|||
19570673|NCT01229267|42018217|FG003|Overall Study|Protocol Violation|0|||
19384437|NCT01670877|41627378|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
19384438|NCT01670877|41627379|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
19570674|NCT01229267|42018218|FG004|Overall Study|Protocol Violation|0|||
19570675|NCT01229267|42018214|FG000|Overall Study|Progressive disease|0|||
19570676|NCT01229267|42018215|FG001|Overall Study|Progressive disease|0|||
19384439|NCT01670877|41627380|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
19570677|NCT01229267|42018216|FG002|Overall Study|Progressive disease|0|||
19570678|NCT01229267|42018217|FG003|Overall Study|Progressive disease|0|||
19570679|NCT01229267|42018218|FG004|Overall Study|Progressive disease|1|||
19570680|NCT01229267|42018214|FG000|Overall Study|Physician Decision|8|||
19570681|NCT01229267|42018215|FG001|Overall Study|Physician Decision|11|||
19570682|NCT01229267|42018216|FG002|Overall Study|Physician Decision|8|||
19570683|NCT01229267|42018217|FG003|Overall Study|Physician Decision|3|||
19570684|NCT01229267|42018218|FG004|Overall Study|Physician Decision|25|||
19570685|NCT01229267|42018214|FG000|Overall Study|Lost to Follow-up|6|||
19570686|NCT01229267|42018215|FG001|Overall Study|Lost to Follow-up|5|||
19570687|NCT01229267|42018216|FG002|Overall Study|Lost to Follow-up|8|||
19570688|NCT01229267|42018217|FG003|Overall Study|Lost to Follow-up|3|||
19570689|NCT01229267|42018218|FG004|Overall Study|Lost to Follow-up|22|||
19570690|NCT00897715|42018227|FG000|Overall Study|Lost to Follow-up|0|||
19570691|NCT00897715|42018228|FG001|Overall Study|Lost to Follow-up|1|||
19570692|NCT00897715|42018227|FG000|Overall Study|Physician Decision|1|||
19570693|NCT00897715|42018228|FG001|Overall Study|Physician Decision|0|||
19570694|NCT00897715|42018227|FG000|Overall Study|increased risk of infection|1|||
19570695|NCT00897715|42018228|FG001|Overall Study|increased risk of infection|0|||
19570696|NCT01229111|42018234|FG000|Overall Study|Death|1|||
19570697|NCT00894361|42018240|FG000|Overall Study|deaths and less than 2 years followup|24|||
19570698|NCT00894361|42018241|FG001|Overall Study|deaths and less than 2 years followup|64|||
19570699|NCT01228175|42018251|FG000|Overall Study|Lost to Follow-up|64|||
19570700|NCT01228175|42018252|FG001|Overall Study|Lost to Follow-up|50|||
19570701|NCT01228175|42018251|FG000|Overall Study|Withdrawal by Subject|1|||
19570702|NCT01228175|42018252|FG001|Overall Study|Withdrawal by Subject|2|||
19570703|NCT01228175|42018251|FG000|Overall Study|Physician Decision|1|||
19570704|NCT01228175|42018252|FG001|Overall Study|Physician Decision|1|||
19570705|NCT01228019|42018258|FG000|Overall Study|Dose Violation|70|||
19570706|NCT01228019|42018258|FG000|Overall Study|Duplicate enrollment|1|||
19570707|NCT01228019|42018258|FG000|Overall Study|Missing pre-treatment data|72|||
19570708|NCT01228019|42018258|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
19570709|NCT01228019|42018258|FG000|Overall Study|Violation of Entry Criterion|9|||
19570710|NCT02987959|42018262|FG000|Overall Study|Grantor stopped supply of drugs|6|||
19570711|NCT01227707|42018266|FG000|Overall Study|Adverse Event|10|||
19570712|NCT01227707|42018266|FG000|Overall Study|Progression of disease|3|||
19570713|NCT01227707|42018266|FG000|Overall Study|Withdrawal by Subject|1|||
19570714|NCT01227707|42018266|FG000|Overall Study|Patient non-compliance|3|||
19570715|NCT01227707|42018266|FG000|Overall Study|Medical decision|6|||
19570716|NCT01227707|42018266|FG000|Overall Study|Death|1|||
19570717|NCT00895843|42018272|FG000|Overall Study|Protocol Violation|12|||
19570718|NCT00895843|42018273|FG001|Overall Study|Protocol Violation|12|||
19570719|NCT00895453|42018282|FG000|Overall Study|Lost to Follow-up|25|||
19570720|NCT00895453|42018283|FG001|Overall Study|Lost to Follow-up|25|||
19570721|NCT00895453|42018284|FG002|Overall Study|Lost to Follow-up|23|||
19570722|NCT00893971|42018292|FG000|Overall Study|Physician Decision|3|||
19570723|NCT00893737|42018305|FG000|Overall Study|Adverse Event|4|||
19570724|NCT00893737|42018305|FG000|Overall Study|Withdrawal by Subject|2|||
19570725|NCT00893737|42018305|FG000|Overall Study|Lost to Follow-up|6|||
19570726|NCT00893113|42018311|FG000|Overall Study|Lost to Follow-up|4|||
19570727|NCT00893113|42018312|FG001|Overall Study|Lost to Follow-up|8|||
19570728|NCT00893113|42018311|FG000|Overall Study|Early Termination|1|||
19570729|NCT00893113|42018312|FG001|Overall Study|Early Termination|1|||
19570730|NCT00893113|42018311|FG000|Overall Study|Withdrew Consent|8|||
19570731|NCT00893113|42018312|FG001|Overall Study|Withdrew Consent|7|||
19570732|NCT00892957|42018320|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
19570733|NCT00892957|42018321|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
19570734|NCT00892957|42018320|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
19570735|NCT00892957|42018321|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
19570736|NCT00968812|42018344|FG000|Overall Study|Adverse Event|30|||
19745714|NCT00022763|42193061|FG001|Overall Study|Insufficient Therapy|0|||
19570737|NCT00968812|42018345|FG001|Overall Study|Adverse Event|46|||
19570738|NCT00968812|42018346|FG002|Overall Study|Adverse Event|33|||
19570739|NCT00968812|42018344|FG000|Overall Study|Death|2|||
19570740|NCT00968812|42018345|FG001|Overall Study|Death|2|||
19570741|NCT00968812|42018346|FG002|Overall Study|Death|1|||
19570742|NCT00968812|42018344|FG000|Overall Study|Lack of Efficacy|9|||
19570743|NCT00968812|42018345|FG001|Overall Study|Lack of Efficacy|7|||
19570744|NCT00968812|42018346|FG002|Overall Study|Lack of Efficacy|16|||
19384440|NCT01670877|41627375|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
19384441|NCT01670877|41627376|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
19384442|NCT01670877|41627377|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
19384443|NCT01670877|41627378|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
19384444|NCT01670877|41627379|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
19384445|NCT01670877|41627380|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
19384446|NCT01670877|41627375|FG000|Part I and Part 2|Grade 2 vomiting|0|||
19384447|NCT01670877|41627376|FG001|Part I and Part 2|Grade 2 vomiting|0|||
19384448|NCT01670877|41627377|FG002|Part I and Part 2|Grade 2 vomiting|0|||
19384449|NCT01670877|41627378|FG003|Part I and Part 2|Grade 2 vomiting|1|||
19384450|NCT01670877|41627379|FG004|Part I and Part 2|Grade 2 vomiting|0|||
19384451|NCT01670877|41627380|FG005|Part I and Part 2|Grade 2 vomiting|0|||
19384452|NCT01670877|41627375|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
19384453|NCT01670877|41627376|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
19384454|NCT01670877|41627377|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
19384455|NCT01670877|41627378|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
19570745|NCT00968812|42018344|FG000|Overall Study|Lost to Follow-up|17|||
19570746|NCT00968812|42018345|FG001|Overall Study|Lost to Follow-up|12|||
19570747|NCT00968812|42018346|FG002|Overall Study|Lost to Follow-up|11|||
19570748|NCT00968812|42018344|FG000|Overall Study|Physician Decision|8|||
19570749|NCT00968812|42018345|FG001|Overall Study|Physician Decision|5|||
19570750|NCT00968812|42018346|FG002|Overall Study|Physician Decision|9|||
19570751|NCT00968812|42018344|FG000|Overall Study|Protocol Violation|7|||
19570752|NCT00968812|42018345|FG001|Overall Study|Protocol Violation|4|||
19570753|NCT00968812|42018346|FG002|Overall Study|Protocol Violation|3|||
19570754|NCT00968812|42018344|FG000|Overall Study|Withdrawal by Subject|17|||
19570755|NCT00968812|42018345|FG001|Overall Study|Withdrawal by Subject|23|||
19570756|NCT00968812|42018346|FG002|Overall Study|Withdrawal by Subject|25|||
19570757|NCT00968812|42018344|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
19570758|NCT00968812|42018345|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
19570759|NCT00968812|42018346|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
19570760|NCT00968812|42018344|FG000|Overall Study|Noncompliance with study drug|4|||
19570761|NCT00968812|42018345|FG001|Overall Study|Noncompliance with study drug|1|||
19570762|NCT00968812|42018346|FG002|Overall Study|Noncompliance with study drug|6|||
19570763|NCT00968812|42018344|FG000|Overall Study|Unable to take rescue therapy|12|||
19570764|NCT00968812|42018345|FG001|Overall Study|Unable to take rescue therapy|12|||
19570765|NCT00968812|42018346|FG002|Overall Study|Unable to take rescue therapy|17|||
19570766|NCT00968812|42018344|FG000|Overall Study|Other|25|||
19570767|NCT00968812|42018345|FG001|Overall Study|Other|37|||
19570768|NCT00968812|42018346|FG002|Overall Study|Other|40|||
19570769|NCT00992056|42018359|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
19570770|NCT00992056|42018360|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
19570771|NCT00992056|42018359|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
19570772|NCT00992056|42018360|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
19570773|NCT00972322|42018368|FG000|Overall Study|Adverse Event|2|||
19570774|NCT00972322|42018369|FG001|Overall Study|Adverse Event|1|||
19570775|NCT00972322|42018368|FG000|Overall Study|Positive drug screen|0|||
19570776|NCT00972322|42018369|FG001|Overall Study|Positive drug screen|1|||
19570777|NCT00972322|42018368|FG000|Overall Study|Lost to Follow-up|0|||
19570778|NCT00972322|42018369|FG001|Overall Study|Lost to Follow-up|1|||
19570779|NCT00972322|42018368|FG000|Overall Study|Consistently high glucose values|1|||
19570780|NCT00972322|42018369|FG001|Overall Study|Consistently high glucose values|0|||
19570781|NCT00967798|42018377|FG000|Overall Study|Withdrawal by Subject|5|||
19384456|NCT01670877|41627379|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
19570782|NCT00967798|42018378|FG001|Overall Study|Withdrawal by Subject|2|||
19570783|NCT00967798|42018377|FG000|Overall Study|Lost to Follow-up|4|||
19570784|NCT00967798|42018378|FG001|Overall Study|Lost to Follow-up|1|||
19570785|NCT00965458|42018386|FG000|Overall Study|Adverse Event|1|||
19570786|NCT00965458|42018387|FG001|Overall Study|Adverse Event|0|||
19570787|NCT00965458|42018386|FG000|Overall Study|Lost to Follow-up|1|||
19570788|NCT00965458|42018387|FG001|Overall Study|Lost to Follow-up|3|||
19570789|NCT00965458|42018386|FG000|Overall Study|Withdrawal by Subject|0|||
19570790|NCT00965458|42018387|FG001|Overall Study|Withdrawal by Subject|1|||
19570791|NCT00972244|42018400|FG000|Overall Study|Incorrect Enrolment|1|||
19570792|NCT00972244|42018401|FG001|Overall Study|Incorrect Enrolment|0|||
19570793|NCT00972244|42018402|FG002|Overall Study|Incorrect Enrolment|0|||
19570794|NCT00972244|42018403|FG003|Overall Study|Incorrect Enrolment|0|||
19570795|NCT00972244|42018404|FG004|Overall Study|Incorrect Enrolment|0|||
19570796|NCT00972244|42018400|FG000|Overall Study|Adverse Event|0|||
19570797|NCT00972244|42018401|FG001|Overall Study|Adverse Event|1|||
19570798|NCT00972244|42018402|FG002|Overall Study|Adverse Event|1|||
19570799|NCT00972244|42018403|FG003|Overall Study|Adverse Event|0|||
19570800|NCT00972244|42018404|FG004|Overall Study|Adverse Event|0|||
19570801|NCT00972244|42018400|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
19570802|NCT00972244|42018401|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
19570803|NCT00972244|42018402|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
19570804|NCT00972244|42018403|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
19570805|NCT00972244|42018404|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
19570806|NCT00972244|42018400|FG000|Overall Study|Withdrawal by Subject|1|||
19570807|NCT00972244|42018401|FG001|Overall Study|Withdrawal by Subject|2|||
19570808|NCT00972244|42018402|FG002|Overall Study|Withdrawal by Subject|1|||
19570809|NCT00972244|42018403|FG003|Overall Study|Withdrawal by Subject|0|||
19570810|NCT00972244|42018404|FG004|Overall Study|Withdrawal by Subject|1|||
19570811|NCT00972244|42018400|FG000|Overall Study|Safety|0|||
19570812|NCT00972244|42018401|FG001|Overall Study|Safety|0|||
19570813|NCT00972244|42018402|FG002|Overall Study|Safety|0|||
19570814|NCT00972244|42018403|FG003|Overall Study|Safety|0|||
19570815|NCT00972244|42018404|FG004|Overall Study|Safety|1|||
19570816|NCT00972244|42018400|FG000|Overall Study|Death|1|||
19570817|NCT00972244|42018401|FG001|Overall Study|Death|0|||
19570818|NCT00972244|42018402|FG002|Overall Study|Death|0|||
19570819|NCT00972244|42018403|FG003|Overall Study|Death|0|||
19570820|NCT00972244|42018404|FG004|Overall Study|Death|0|||
19570821|NCT00972244|42018400|FG000|Overall Study|Various|0|||
19570822|NCT00972244|42018401|FG001|Overall Study|Various|0|||
19570823|NCT00972244|42018402|FG002|Overall Study|Various|0|||
19570824|NCT00972244|42018403|FG003|Overall Study|Various|0|||
19570825|NCT00972244|42018404|FG004|Overall Study|Various|2|||
19570826|NCT00892723|42018419|FG000|Overall Study|Lost to Follow-up|1|||
19570827|NCT00892723|42018420|FG001|Overall Study|Lost to Follow-up|3|||
19570828|NCT00892723|42018421|FG002|Overall Study|Lost to Follow-up|1|||
19570829|NCT00892723|42018419|FG000|Overall Study|Withdrawal by Subject|1|||
19570830|NCT00892723|42018420|FG001|Overall Study|Withdrawal by Subject|1|||
19570831|NCT00892723|42018421|FG002|Overall Study|Withdrawal by Subject|1|||
19570832|NCT03811912|42018464|FG000|Overall Study|Withdrew Consent|4|||
19570833|NCT03811912|42018465|FG001|Overall Study|Withdrew Consent|2|||
19570834|NCT00971932|42018471|FG000|Overall Study|Withdrawal by Subject|1|||
19570835|NCT00971932|42018471|FG000|Overall Study|Investigator's decision|2|||
19570836|NCT00971932|42018471|FG000|Overall Study|Ongoing|4|||
19570837|NCT00970684|42018475|FG000|Overall Study|Lack of Efficacy|5|||
19570838|NCT00970684|42018475|FG000|Overall Study|Adverse Event|4|||
19570839|NCT00970684|42018475|FG000|Overall Study|Withdrawal by Subject|1|||
19570840|NCT00967330|42018481|FG000|Overall Study|Protocol Violation|3|||
19570841|NCT00967330|42018482|FG001|Overall Study|Protocol Violation|4|||
19570842|NCT00967330|42018481|FG000|Overall Study|Regular|10|||
19570843|NCT00967330|42018482|FG001|Overall Study|Regular|3|||
19570844|NCT00967330|42018481|FG000|Overall Study|Withdrawal by Subject|6|||
19570845|NCT00967330|42018482|FG001|Overall Study|Withdrawal by Subject|0|||
19570846|NCT00967330|42018481|FG000|Overall Study|Lost to Follow-up|1|||
19570847|NCT00967330|42018482|FG001|Overall Study|Lost to Follow-up|1|||
19570848|NCT00967330|42018481|FG000|Overall Study|Death|102|||
19570849|NCT00967330|42018482|FG001|Overall Study|Death|51|||
19570850|NCT00967330|42018481|FG000|Overall Study|Severe protocol deviation|0|||
19570851|NCT00967330|42018482|FG001|Overall Study|Severe protocol deviation|1|||
19570852|NCT00967018|42018488|FG000|Overall Study|Adverse Event|2|||
19570853|NCT00967018|42018488|FG000|Overall Study|Physician Decision|7|||
19570854|NCT00967018|42018488|FG000|Overall Study|Lost to Follow-up|2|||
19570855|NCT00967018|42018488|FG000|Overall Study|Withdrawal by Subject|1|||
19570856|NCT00967018|42018488|FG000|Overall Study|Miscellaneous Reasons|9|||
19570857|NCT00965146|42018492|FG000|Overall Study|Death|7|||
19570858|NCT00965146|42018492|FG000|Overall Study|Lost to Follow-up|22|||
19570859|NCT00965146|42018492|FG000|Overall Study|Withdrawal by Subject|17|||
19570860|NCT00965146|42018492|FG000|Overall Study|Unable to return|1|||
19570861|NCT00965146|42018492|FG000|Overall Study|Unwilling to return|11|||
19570862|NCT00965146|42018492|FG000|Overall Study|Intercurrent illness|1|||
19570863|NCT00965146|42018492|FG000|Overall Study|Revision / Removal of Study Implant|6|||
19570864|NCT00965146|42018492|FG000|Overall Study|Overall Study Termination|145|||
19570865|NCT00966940|42018498|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
19570866|NCT00966940|42018499|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
19570867|NCT00966940|42018498|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
19570868|NCT00966940|42018499|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
19570869|NCT00965848|42018505|FG000|Overall Study|Protocol Violation|3|||
19570870|NCT00965848|42018506|FG001|Overall Study|Protocol Violation|0|||
19570871|NCT00965848|42018507|FG002|Overall Study|Protocol Violation|1|||
19570872|NCT00965848|42018505|FG000|Overall Study|Death|11|||
19570873|NCT00965848|42018506|FG001|Overall Study|Death|1|||
19570874|NCT00965848|42018507|FG002|Overall Study|Death|5|||
19570875|NCT00965848|42018505|FG000|Overall Study|Lost to Follow-up|0|||
19570876|NCT00965848|42018506|FG001|Overall Study|Lost to Follow-up|0|||
19570877|NCT00965848|42018507|FG002|Overall Study|Lost to Follow-up|1|||
19570878|NCT00965848|42018505|FG000|Overall Study|Withdrawal by Subject|1|||
19570879|NCT00965848|42018506|FG001|Overall Study|Withdrawal by Subject|0|||
19570880|NCT00965848|42018507|FG002|Overall Study|Withdrawal by Subject|0|||
19570881|NCT00965848|42018505|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
19570882|NCT00965848|42018506|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
19570883|NCT00965848|42018507|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
19570884|NCT00965848|42018505|FG000|Overall Study|Not Clinically Evaluable|7|||
19570885|NCT00965848|42018506|FG001|Overall Study|Not Clinically Evaluable|1|||
19570886|NCT00965848|42018507|FG002|Overall Study|Not Clinically Evaluable|1|||
19570887|NCT00965848|42018505|FG000|Overall Study|Other|5|||
19570888|NCT00965848|42018506|FG001|Overall Study|Other|0|||
19570889|NCT00965848|42018507|FG002|Overall Study|Other|1|||
19570890|NCT00961636|42018518|FG000|Overall Study|Adverse Event|35|||
19570891|NCT00961636|42018519|FG001|Overall Study|Adverse Event|54|||
19384457|NCT01670877|41627380|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
19384458|NCT01670877|41627375|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
19384459|NCT01670877|41627376|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
19384460|NCT01670877|41627377|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
19384461|NCT01670877|41627378|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
19384462|NCT01670877|41627379|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
19384463|NCT01670877|41627380|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
19384464|NCT00701129|41627394|FG000|Overall Study|Death|2|||
19384465|NCT01670721|41627398|FG000|Overall Study|Participant's decision|15|||
19384466|NCT01670721|41627398|FG000|Overall Study|Other than specified above|38|||
19570892|NCT00961636|42018520|FG002|Overall Study|Adverse Event|13|||
19570893|NCT00961636|42018518|FG000|Overall Study|Flushing Symptoms|29|||
19570894|NCT00961636|42018519|FG001|Overall Study|Flushing Symptoms|46|||
19570895|NCT00961636|42018520|FG002|Overall Study|Flushing Symptoms|3|||
19570896|NCT00961636|42018518|FG000|Overall Study|Lost to Follow-up|2|||
19570897|NCT00961636|42018519|FG001|Overall Study|Lost to Follow-up|3|||
19570898|NCT00961636|42018520|FG002|Overall Study|Lost to Follow-up|1|||
19570899|NCT00961636|42018518|FG000|Overall Study|Physician Decision|3|||
19570900|NCT00961636|42018519|FG001|Overall Study|Physician Decision|1|||
19570901|NCT00961636|42018520|FG002|Overall Study|Physician Decision|1|||
19570902|NCT00961636|42018518|FG000|Overall Study|Protocol Violation|9|||
19570903|NCT00961636|42018519|FG001|Overall Study|Protocol Violation|5|||
19570904|NCT00961636|42018520|FG002|Overall Study|Protocol Violation|1|||
19570905|NCT00961636|42018518|FG000|Overall Study|Withdrawal by Subject|29|||
19570906|NCT00961636|42018519|FG001|Overall Study|Withdrawal by Subject|22|||
19570907|NCT00961636|42018520|FG002|Overall Study|Withdrawal by Subject|13|||
19570908|NCT00964678|42018528|FG000|Overall Study|Physician Decision|4|||
19570909|NCT00964366|42018535|FG000|Overall Study|Did not qualify at Day 1|1|||
19570910|NCT00964366|42018536|FG001|Overall Study|Did not qualify at Day 1|0|||
19570911|NCT00964366|42018535|FG000|Overall Study|Withdrawal by Subject|0|||
19570912|NCT00964366|42018536|FG001|Overall Study|Withdrawal by Subject|1|||
19570913|NCT00960154|42018544|FG000|Overall Study|Study termination|25|||
19570914|NCT00960154|42018545|FG001|Overall Study|Study termination|25|||
19570915|NCT00960076|42018553|FG000|Overall Study|Adverse Event|1|||
19570916|NCT00960076|42018554|FG001|Overall Study|Adverse Event|7|||
19570917|NCT00960076|42018553|FG000|Overall Study|No longer met study criteria|1|||
19570918|NCT00960076|42018554|FG001|Overall Study|No longer met study criteria|5|||
19570919|NCT00960076|42018553|FG000|Overall Study|Withdrawal by Subject|1|||
19570920|NCT00960076|42018554|FG001|Overall Study|Withdrawal by Subject|2|||
19570921|NCT00960076|42018553|FG000|Overall Study|Lost to Follow-up|3|||
19570922|NCT00960076|42018554|FG001|Overall Study|Lost to Follow-up|3|||
19570923|NCT00960076|42018553|FG000|Overall Study|Severe non-compliance to protocol|1|||
19570924|NCT00960076|42018554|FG001|Overall Study|Severe non-compliance to protocol|2|||
19570925|NCT00960076|42018553|FG000|Overall Study|Hyperglycemia|1|||
19570926|NCT00960076|42018554|FG001|Overall Study|Hyperglycemia|5|||
19570927|NCT00960076|42018553|FG000|Overall Study|Did not attend the termination visit|0|||
19570928|NCT00960076|42018554|FG001|Overall Study|Did not attend the termination visit|1|||
19570929|NCT01227629|42018570|FG000|Overall Study|Adverse Event|2|||
19570930|NCT01227629|42018571|FG001|Overall Study|Adverse Event|2|||
19570931|NCT01227629|42018572|FG002|Overall Study|Adverse Event|1|||
19570932|NCT01227629|42018573|FG003|Overall Study|Adverse Event|6|||
19570933|NCT01227629|42018574|FG004|Overall Study|Adverse Event|1|||
19570934|NCT01227629|42018575|FG005|Overall Study|Adverse Event|1|||
19570935|NCT01227629|42018576|FG006|Overall Study|Adverse Event|6|||
19570936|NCT01227629|42018577|FG007|Overall Study|Adverse Event|6|||
19570937|NCT01227629|42018578|FG008|Overall Study|Adverse Event|4|||
19570938|NCT01227629|42018579|FG009|Overall Study|Adverse Event|0|||
19570939|NCT01227629|42018570|FG000|Overall Study|Protocol Violation|0|||
19570940|NCT01227629|42018571|FG001|Overall Study|Protocol Violation|0|||
19570941|NCT01227629|42018572|FG002|Overall Study|Protocol Violation|0|||
19570942|NCT01227629|42018573|FG003|Overall Study|Protocol Violation|1|||
19570943|NCT01227629|42018574|FG004|Overall Study|Protocol Violation|0|||
19570944|NCT01227629|42018575|FG005|Overall Study|Protocol Violation|0|||
19570945|NCT01227629|42018576|FG006|Overall Study|Protocol Violation|0|||
19570946|NCT01227629|42018577|FG007|Overall Study|Protocol Violation|0|||
19570947|NCT01227629|42018578|FG008|Overall Study|Protocol Violation|0|||
19570948|NCT01227629|42018579|FG009|Overall Study|Protocol Violation|0|||
19570949|NCT01227629|42018570|FG000|Overall Study|Lost to Follow-up|0|||
19570950|NCT01227629|42018571|FG001|Overall Study|Lost to Follow-up|0|||
19570951|NCT01227629|42018572|FG002|Overall Study|Lost to Follow-up|0|||
19570952|NCT01227629|42018573|FG003|Overall Study|Lost to Follow-up|0|||
19570953|NCT01227629|42018574|FG004|Overall Study|Lost to Follow-up|1|||
19570954|NCT01227629|42018575|FG005|Overall Study|Lost to Follow-up|0|||
19384467|NCT02711137|41627417|FG000|Overall Study|Death|1|||
19384468|NCT02711137|41627418|FG001|Overall Study|Death|4|||
19384469|NCT02711137|41627419|FG002|Overall Study|Death|5|||
19570955|NCT01227629|42018576|FG006|Overall Study|Lost to Follow-up|0|||
19570956|NCT01227629|42018577|FG007|Overall Study|Lost to Follow-up|0|||
19570957|NCT01227629|42018578|FG008|Overall Study|Lost to Follow-up|0|||
19570958|NCT01227629|42018579|FG009|Overall Study|Lost to Follow-up|0|||
19570959|NCT01227629|42018570|FG000|Overall Study|Withdrawal by Subject|0|||
19570960|NCT01227629|42018571|FG001|Overall Study|Withdrawal by Subject|0|||
19384470|NCT02711137|41627420|FG003|Overall Study|Death|5|||
19384471|NCT02711137|41627421|FG004|Overall Study|Death|3|||
19570961|NCT01227629|42018572|FG002|Overall Study|Withdrawal by Subject|0|||
19570962|NCT01227629|42018573|FG003|Overall Study|Withdrawal by Subject|0|||
19570963|NCT01227629|42018574|FG004|Overall Study|Withdrawal by Subject|0|||
19570964|NCT01227629|42018575|FG005|Overall Study|Withdrawal by Subject|0|||
19570965|NCT01227629|42018576|FG006|Overall Study|Withdrawal by Subject|2|||
19570966|NCT01227629|42018577|FG007|Overall Study|Withdrawal by Subject|0|||
19384472|NCT02711137|41627422|FG005|Overall Study|Death|1|||
19384473|NCT02711137|41627423|FG006|Overall Study|Death|61|||
19384474|NCT02711137|41627424|FG007|Overall Study|Death|3|||
19384475|NCT02711137|41627425|FG008|Overall Study|Death|0|||
19384476|NCT02711137|41627426|FG009|Overall Study|Death|1|||
19384477|NCT02711137|41627427|FG010|Overall Study|Death|1|||
19384478|NCT02711137|41627428|FG011|Overall Study|Death|1|||
19384479|NCT02711137|41627429|FG012|Overall Study|Death|0|||
19570967|NCT01227629|42018578|FG008|Overall Study|Withdrawal by Subject|0|||
19570968|NCT01227629|42018579|FG009|Overall Study|Withdrawal by Subject|1|||
19570969|NCT01227629|42018570|FG000|Overall Study|Other|0|||
19570970|NCT01227629|42018571|FG001|Overall Study|Other|0|||
19570971|NCT01227629|42018572|FG002|Overall Study|Other|0|||
19570972|NCT01227629|42018573|FG003|Overall Study|Other|1|||
19570973|NCT01227629|42018574|FG004|Overall Study|Other|0|||
19570974|NCT01227629|42018575|FG005|Overall Study|Other|0|||
19570975|NCT01227629|42018576|FG006|Overall Study|Other|0|||
19570976|NCT01227629|42018577|FG007|Overall Study|Other|0|||
19570977|NCT01227629|42018578|FG008|Overall Study|Other|2|||
19384480|NCT02711137|41627430|FG013|Overall Study|Death|0|||
19384481|NCT02711137|41627431|FG014|Overall Study|Death|0|||
19384482|NCT02711137|41627417|FG000|Overall Study|Study Terminated by Sponsor|0|||
19384483|NCT02711137|41627418|FG001|Overall Study|Study Terminated by Sponsor|0|||
19570978|NCT01227629|42018579|FG009|Overall Study|Other|1|||
19570979|NCT00963820|42018625|FG000|Dose Escalation Phase|Progressive Disease|3|||
19570980|NCT00963820|42018626|FG001|Dose Escalation Phase|Progressive Disease|3|||
19570981|NCT00963820|42018627|FG002|Dose Escalation Phase|Progressive Disease|3|||
19384484|NCT02711137|41627419|FG002|Overall Study|Study Terminated by Sponsor|1|||
19384485|NCT02711137|41627420|FG003|Overall Study|Study Terminated by Sponsor|0|||
19570982|NCT00963820|42018628|FG003|Dose Escalation Phase|Progressive Disease|3|||
19570983|NCT00963820|42018629|FG004|Dose Escalation Phase|Progressive Disease|4|||
19570984|NCT00963820|42018630|FG005|Dose Escalation Phase|Progressive Disease|3|||
19570985|NCT00963820|42018631|FG006|Dose Escalation Phase|Progressive Disease|3|||
19570986|NCT00963820|42018632|FG007|Dose Escalation Phase|Progressive Disease|2|||
19570987|NCT00963820|42018633|FG008|Dose Escalation Phase|Progressive Disease|0|||
19384486|NCT02711137|41627421|FG004|Overall Study|Study Terminated by Sponsor|0|||
19384487|NCT02711137|41627422|FG005|Overall Study|Study Terminated by Sponsor|0|||
19570988|NCT00963820|42018634|FG009|Dose Escalation Phase|Progressive Disease|0|||
19570989|NCT00963820|42018635|FG010|Dose Escalation Phase|Progressive Disease|0|||
19570990|NCT00963820|42018636|FG011|Dose Escalation Phase|Progressive Disease|0|||
19570991|NCT00963820|42018625|FG000|Dose Escalation Phase|Adverse Event|0|||
19570992|NCT00963820|42018626|FG001|Dose Escalation Phase|Adverse Event|0|||
19570993|NCT00963820|42018627|FG002|Dose Escalation Phase|Adverse Event|0|||
19570994|NCT00963820|42018628|FG003|Dose Escalation Phase|Adverse Event|0|||
19570995|NCT00963820|42018629|FG004|Dose Escalation Phase|Adverse Event|0|||
19384488|NCT02711137|41627423|FG006|Overall Study|Study Terminated by Sponsor|1|||
19384489|NCT02711137|41627424|FG007|Overall Study|Study Terminated by Sponsor|0|||
19384490|NCT02711137|41627425|FG008|Overall Study|Study Terminated by Sponsor|0|||
19384491|NCT02711137|41627426|FG009|Overall Study|Study Terminated by Sponsor|0|||
19384492|NCT02711137|41627427|FG010|Overall Study|Study Terminated by Sponsor|0|||
19384493|NCT02711137|41627428|FG011|Overall Study|Study Terminated by Sponsor|0|||
19384494|NCT02711137|41627429|FG012|Overall Study|Study Terminated by Sponsor|0|||
19384495|NCT02711137|41627430|FG013|Overall Study|Study Terminated by Sponsor|0|||
19570996|NCT00963820|42018630|FG005|Dose Escalation Phase|Adverse Event|0|||
19570997|NCT00963820|42018631|FG006|Dose Escalation Phase|Adverse Event|3|||
19384496|NCT02711137|41627431|FG014|Overall Study|Study Terminated by Sponsor|0|||
19384497|NCT02711137|41627417|FG000|Overall Study|Physician Decision|1|||
19384498|NCT02711137|41627418|FG001|Overall Study|Physician Decision|0|||
19384499|NCT02711137|41627419|FG002|Overall Study|Physician Decision|2|||
19384500|NCT02711137|41627420|FG003|Overall Study|Physician Decision|1|||
19384501|NCT02711137|41627421|FG004|Overall Study|Physician Decision|1|||
19384502|NCT02711137|41627422|FG005|Overall Study|Physician Decision|0|||
19384503|NCT02711137|41627423|FG006|Overall Study|Physician Decision|12|||
19384504|NCT02711137|41627424|FG007|Overall Study|Physician Decision|2|||
19384505|NCT02711137|41627425|FG008|Overall Study|Physician Decision|1|||
19384506|NCT02711137|41627426|FG009|Overall Study|Physician Decision|1|||
19384507|NCT02711137|41627427|FG010|Overall Study|Physician Decision|3|||
19384508|NCT02711137|41627428|FG011|Overall Study|Physician Decision|2|||
19384509|NCT02711137|41627429|FG012|Overall Study|Physician Decision|1|||
19384510|NCT02711137|41627430|FG013|Overall Study|Physician Decision|1|||
19384511|NCT02711137|41627431|FG014|Overall Study|Physician Decision|2|||
19384512|NCT02711137|41627417|FG000|Overall Study|Other|0|||
19384513|NCT02711137|41627418|FG001|Overall Study|Other|1|||
19384514|NCT02711137|41627419|FG002|Overall Study|Other|0|||
19570998|NCT00963820|42018632|FG007|Dose Escalation Phase|Adverse Event|1|||
19570999|NCT00963820|42018633|FG008|Dose Escalation Phase|Adverse Event|0|||
19571000|NCT00963820|42018634|FG009|Dose Escalation Phase|Adverse Event|0|||
19571001|NCT00963820|42018635|FG010|Dose Escalation Phase|Adverse Event|0|||
19571002|NCT00963820|42018636|FG011|Dose Escalation Phase|Adverse Event|0|||
19571003|NCT00963820|42018625|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
19571004|NCT00963820|42018626|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
19745715|NCT00022763|42193060|FG000|Overall Study|Admin|3|||
19384515|NCT02711137|41627420|FG003|Overall Study|Other|0|||
19384516|NCT02711137|41627421|FG004|Overall Study|Other|0|||
19571005|NCT00963820|42018627|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
19571006|NCT00963820|42018628|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19571007|NCT00963820|42018629|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
19571008|NCT00963820|42018630|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
19571009|NCT00963820|42018631|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
19571010|NCT00963820|42018632|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
19571011|NCT00963820|42018633|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
19571012|NCT00963820|42018634|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
19571013|NCT00963820|42018635|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
19571014|NCT00963820|42018636|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
19571015|NCT00963820|42018625|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571016|NCT00963820|42018626|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571017|NCT00963820|42018627|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571018|NCT00963820|42018628|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571019|NCT00963820|42018629|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571020|NCT00963820|42018630|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19384517|NCT02711137|41627422|FG005|Overall Study|Other|0|||
19384518|NCT02711137|41627423|FG006|Overall Study|Other|3|||
19384519|NCT02711137|41627424|FG007|Overall Study|Other|0|||
19384520|NCT02711137|41627425|FG008|Overall Study|Other|0|||
19384521|NCT02711137|41627426|FG009|Overall Study|Other|0|||
19571021|NCT00963820|42018631|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
19571022|NCT00963820|42018632|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571023|NCT00963820|42018633|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571024|NCT00963820|42018634|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571025|NCT00963820|42018635|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571026|NCT00963820|42018636|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19571027|NCT00963820|42018625|FG000|Expansion Phase|Progressive Disease|0|||
19571028|NCT00963820|42018626|FG001|Expansion Phase|Progressive Disease|0|||
19571029|NCT00963820|42018627|FG002|Expansion Phase|Progressive Disease|0|||
19571030|NCT00963820|42018628|FG003|Expansion Phase|Progressive Disease|0|||
19571031|NCT00963820|42018629|FG004|Expansion Phase|Progressive Disease|0|||
19571032|NCT00963820|42018630|FG005|Expansion Phase|Progressive Disease|0|||
19571033|NCT00963820|42018631|FG006|Expansion Phase|Progressive Disease|0|||
19571034|NCT00963820|42018632|FG007|Expansion Phase|Progressive Disease|0|||
19571035|NCT00963820|42018633|FG008|Expansion Phase|Progressive Disease|8|||
19571036|NCT00963820|42018634|FG009|Expansion Phase|Progressive Disease|6|||
19571037|NCT00963820|42018635|FG010|Expansion Phase|Progressive Disease|4|||
19571038|NCT00963820|42018636|FG011|Expansion Phase|Progressive Disease|2|||
19571039|NCT00963820|42018625|FG000|Expansion Phase|Adverse Event|0|||
19571040|NCT00963820|42018626|FG001|Expansion Phase|Adverse Event|0|||
19571041|NCT00963820|42018627|FG002|Expansion Phase|Adverse Event|0|||
19571042|NCT00963820|42018628|FG003|Expansion Phase|Adverse Event|0|||
19571043|NCT00963820|42018629|FG004|Expansion Phase|Adverse Event|0|||
19571044|NCT00963820|42018630|FG005|Expansion Phase|Adverse Event|0|||
19571045|NCT00963820|42018631|FG006|Expansion Phase|Adverse Event|0|||
19571046|NCT00963820|42018632|FG007|Expansion Phase|Adverse Event|0|||
19571047|NCT00963820|42018633|FG008|Expansion Phase|Adverse Event|1|||
19571048|NCT00963820|42018634|FG009|Expansion Phase|Adverse Event|3|||
19571049|NCT00963820|42018635|FG010|Expansion Phase|Adverse Event|0|||
19571050|NCT00963820|42018636|FG011|Expansion Phase|Adverse Event|0|||
19571051|NCT00963820|42018625|FG000|Expansion Phase|Withdrawal by Subject|0|||
19571052|NCT00963820|42018626|FG001|Expansion Phase|Withdrawal by Subject|0|||
19571053|NCT00963820|42018627|FG002|Expansion Phase|Withdrawal by Subject|0|||
19571054|NCT00963820|42018628|FG003|Expansion Phase|Withdrawal by Subject|0|||
19571055|NCT00963820|42018629|FG004|Expansion Phase|Withdrawal by Subject|0|||
19571056|NCT00963820|42018630|FG005|Expansion Phase|Withdrawal by Subject|0|||
19571057|NCT00963820|42018631|FG006|Expansion Phase|Withdrawal by Subject|0|||
19745716|NCT00022763|42193061|FG001|Overall Study|Admin|2|||
19384522|NCT02711137|41627427|FG010|Overall Study|Other|0|||
19384523|NCT02711137|41627428|FG011|Overall Study|Other|0|||
19571058|NCT00963820|42018632|FG007|Expansion Phase|Withdrawal by Subject|0|||
19571059|NCT00963820|42018633|FG008|Expansion Phase|Withdrawal by Subject|1|||
19571060|NCT00963820|42018634|FG009|Expansion Phase|Withdrawal by Subject|0|||
19571061|NCT00963820|42018635|FG010|Expansion Phase|Withdrawal by Subject|1|||
19571062|NCT00963820|42018636|FG011|Expansion Phase|Withdrawal by Subject|1|||
19571063|NCT00963820|42018625|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571064|NCT00963820|42018626|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571065|NCT00963820|42018627|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571066|NCT00963820|42018628|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571067|NCT00963820|42018629|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571068|NCT00963820|42018630|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571069|NCT00963820|42018631|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571070|NCT00963820|42018632|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571071|NCT00963820|42018633|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571072|NCT00963820|42018634|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571073|NCT00963820|42018635|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19571074|NCT00963820|42018636|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
19571075|NCT01227395|42018655|FG000|Overall Study|Protocol Violation|0|||
19571076|NCT01227395|42018656|FG001|Overall Study|Protocol Violation|1|||
19571077|NCT01226459|42018683|FG000|Overall Study|Adverse Event|2|||
19571078|NCT01226459|42018684|FG001|Overall Study|Adverse Event|8|||
19571079|NCT01226459|42018683|FG000|Overall Study|Protocol Violation|4|||
19571080|NCT01226459|42018684|FG001|Overall Study|Protocol Violation|3|||
19571081|NCT01226459|42018683|FG000|Overall Study|Withdrawal by Subject|10|||
19571082|NCT01226459|42018684|FG001|Overall Study|Withdrawal by Subject|13|||
19571083|NCT01226459|42018683|FG000|Overall Study|Lost to Follow-up|4|||
19571084|NCT01226459|42018684|FG001|Overall Study|Lost to Follow-up|8|||
19571085|NCT01226459|42018683|FG000|Overall Study|Pregnancy|1|||
19571086|NCT01226459|42018684|FG001|Overall Study|Pregnancy|0|||
19571087|NCT01225991|42018690|FG000|Overall Study|Withdrawal by Subject|6|||
19571088|NCT00959374|42018694|FG000|Overall Study|Withdrawal by Subject|2|||
19571089|NCT00959374|42018694|FG000|Overall Study|Lost to Follow-up|14|||
19571090|NCT00959374|42018694|FG000|Overall Study|Death|1|||
19571091|NCT00959374|42018694|FG000|Overall Study|Protocol Violation|1|||
19571092|NCT00959374|42018694|FG000|Overall Study|Implant Removed/Not Replaced|4|||
19571093|NCT00959374|42018694|FG000|Overall Study|Physician Decision|1|||
19571094|NCT01225835|42018704|FG000|Overall Study|Completed protocol|2|||
19571095|NCT01225835|42018705|FG001|Overall Study|Completed protocol|1|||
19571096|NCT01225835|42018704|FG000|Overall Study|Did not meet hCG criterion|2|||
19571097|NCT01225835|42018705|FG001|Overall Study|Did not meet hCG criterion|0|||
19571098|NCT01225835|42018704|FG000|Overall Study|Adverse Event|2|||
19571099|NCT01225835|42018705|FG001|Overall Study|Adverse Event|1|||
19571100|NCT01225835|42018704|FG000|Overall Study|Other|1|||
19571101|NCT01225835|42018705|FG001|Overall Study|Other|1|||
19571102|NCT02923180|42018717|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
19571103|NCT02923180|42018717|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
19571104|NCT00962650|42018721|FG000|Overall Study|Transgastric DP was not completed|2|||
19571105|NCT00958828|42018729|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
19571106|NCT00958828|42018730|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
19571107|NCT00958828|42018729|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
19571108|NCT00958828|42018730|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
19571109|NCT00960934|42018742|FG000|Overall Study|Adverse Event|2|||
19571110|NCT00960934|42018743|FG001|Overall Study|Adverse Event|3|||
19571111|NCT00960934|42018744|FG002|Overall Study|Adverse Event|3|||
19571112|NCT00960934|42018745|FG003|Overall Study|Adverse Event|2|||
19571113|NCT00960934|42018746|FG004|Overall Study|Adverse Event|4|||
19571114|NCT00960934|42018747|FG005|Overall Study|Adverse Event|3|||
19571115|NCT00960934|42018742|FG000|Overall Study|Lack of Efficacy|1|||
19571116|NCT00960934|42018743|FG001|Overall Study|Lack of Efficacy|0|||
19571117|NCT00960934|42018744|FG002|Overall Study|Lack of Efficacy|0|||
19571118|NCT00960934|42018745|FG003|Overall Study|Lack of Efficacy|0|||
19571119|NCT00960934|42018746|FG004|Overall Study|Lack of Efficacy|0|||
19571120|NCT00960934|42018747|FG005|Overall Study|Lack of Efficacy|0|||
19571121|NCT00960934|42018742|FG000|Overall Study|Lost to Follow-up|0|||
19571122|NCT00960934|42018743|FG001|Overall Study|Lost to Follow-up|1|||
19571123|NCT00960934|42018744|FG002|Overall Study|Lost to Follow-up|0|||
19571124|NCT00960934|42018745|FG003|Overall Study|Lost to Follow-up|0|||
19571125|NCT00960934|42018746|FG004|Overall Study|Lost to Follow-up|0|||
19571126|NCT00960934|42018747|FG005|Overall Study|Lost to Follow-up|0|||
19571127|NCT00960934|42018742|FG000|Overall Study|Other|2|||
19571128|NCT00960934|42018743|FG001|Overall Study|Other|1|||
19571129|NCT00960934|42018744|FG002|Overall Study|Other|5|||
19571130|NCT00960934|42018745|FG003|Overall Study|Other|4|||
19571131|NCT00960934|42018746|FG004|Overall Study|Other|2|||
19571132|NCT00960934|42018747|FG005|Overall Study|Other|2|||
19571133|NCT00960934|42018742|FG000|Overall Study|Physician Decision|0|||
19571134|NCT00960934|42018743|FG001|Overall Study|Physician Decision|1|||
19571135|NCT00960934|42018744|FG002|Overall Study|Physician Decision|0|||
19571136|NCT00960934|42018745|FG003|Overall Study|Physician Decision|0|||
19571137|NCT00960934|42018746|FG004|Overall Study|Physician Decision|0|||
19571138|NCT00960934|42018747|FG005|Overall Study|Physician Decision|0|||
19571139|NCT00960934|42018742|FG000|Overall Study|Progressive Disease|1|||
19571140|NCT00960934|42018743|FG001|Overall Study|Progressive Disease|1|||
19571141|NCT00960934|42018744|FG002|Overall Study|Progressive Disease|0|||
19571142|NCT00960934|42018745|FG003|Overall Study|Progressive Disease|0|||
19571143|NCT00960934|42018746|FG004|Overall Study|Progressive Disease|1|||
19571144|NCT00960934|42018747|FG005|Overall Study|Progressive Disease|1|||
19571145|NCT00960934|42018742|FG000|Overall Study|Protocol Violation|3|||
19571146|NCT00960934|42018743|FG001|Overall Study|Protocol Violation|4|||
19571147|NCT00960934|42018744|FG002|Overall Study|Protocol Violation|0|||
19571148|NCT00960934|42018745|FG003|Overall Study|Protocol Violation|3|||
19571149|NCT00960934|42018746|FG004|Overall Study|Protocol Violation|3|||
19571150|NCT00960934|42018747|FG005|Overall Study|Protocol Violation|2|||
19571151|NCT00960934|42018742|FG000|Overall Study|Withdrawal by Subject|5|||
19571152|NCT00960934|42018743|FG001|Overall Study|Withdrawal by Subject|6|||
19571153|NCT00960934|42018744|FG002|Overall Study|Withdrawal by Subject|4|||
19571154|NCT00960934|42018745|FG003|Overall Study|Withdrawal by Subject|5|||
19571155|NCT00960934|42018746|FG004|Overall Study|Withdrawal by Subject|5|||
19571156|NCT00960934|42018747|FG005|Overall Study|Withdrawal by Subject|7|||
19571157|NCT00960934|42018742|FG000|Overall Study|Study Terminated by Sponsor|50|||
19571158|NCT00960934|42018743|FG001|Overall Study|Study Terminated by Sponsor|46|||
19571159|NCT00960934|42018744|FG002|Overall Study|Study Terminated by Sponsor|52|||
19571160|NCT00960934|42018745|FG003|Overall Study|Study Terminated by Sponsor|50|||
19571161|NCT00960934|42018746|FG004|Overall Study|Study Terminated by Sponsor|49|||
19571162|NCT00960934|42018747|FG005|Overall Study|Study Terminated by Sponsor|49|||
19571163|NCT00892177|42018764|FG000|Phase II|Ineligible|0|||
19571164|NCT00892177|42018765|FG001|Phase II|Ineligible|0|||
19571165|NCT00892177|42018766|FG002|Phase II|Ineligible|0|||
19571166|NCT00892177|42018767|FG003|Phase II|Ineligible|0|||
19571167|NCT00892177|42018768|FG004|Phase II|Ineligible|1|||
19571168|NCT00892177|42018769|FG005|Phase II|Ineligible|1|||
19571169|NCT00892177|42018764|FG000|Phase II|Withdrawal by Subject|0|||
19571170|NCT00892177|42018765|FG001|Phase II|Withdrawal by Subject|0|||
19571171|NCT00892177|42018766|FG002|Phase II|Withdrawal by Subject|0|||
19571172|NCT00892177|42018767|FG003|Phase II|Withdrawal by Subject|0|||
19571173|NCT00892177|42018768|FG004|Phase II|Withdrawal by Subject|4|||
19571174|NCT00892177|42018769|FG005|Phase II|Withdrawal by Subject|1|||
19571175|NCT00962104|42018786|FG000|Overall Study|Adverse Event|10|||
19571176|NCT00962104|42018787|FG001|Overall Study|Adverse Event|3|||
19571177|NCT00962104|42018786|FG000|Overall Study|Entry Criteria Not Met|1|||
19571178|NCT00962104|42018787|FG001|Overall Study|Entry Criteria Not Met|2|||
19571179|NCT00962104|42018786|FG000|Overall Study|Lack of Efficacy|0|||
19571180|NCT00962104|42018787|FG001|Overall Study|Lack of Efficacy|1|||
19571181|NCT00962104|42018786|FG000|Overall Study|Lost to Follow-up|10|||
19571182|NCT00962104|42018787|FG001|Overall Study|Lost to Follow-up|4|||
19571183|NCT00962104|42018786|FG000|Overall Study|Physician Decision|1|||
19571184|NCT00962104|42018787|FG001|Overall Study|Physician Decision|0|||
19571185|NCT00962104|42018786|FG000|Overall Study|Protocol Violation|6|||
19571186|NCT00962104|42018787|FG001|Overall Study|Protocol Violation|8|||
19571187|NCT00962104|42018786|FG000|Overall Study|Sponsor Decision|0|||
19571188|NCT00962104|42018787|FG001|Overall Study|Sponsor Decision|1|||
19571189|NCT00962104|42018786|FG000|Overall Study|Withdrawal by Subject|10|||
19384524|NCT02711137|41627429|FG012|Overall Study|Other|0|||
19571190|NCT00962104|42018787|FG001|Overall Study|Withdrawal by Subject|6|||
19571191|NCT00962104|42018786|FG000|Overall Study|Other|2|||
19571192|NCT00962104|42018787|FG001|Overall Study|Other|0|||
19571193|NCT02821000|42018793|FG000|Overall Study|Death|44|||
19571194|NCT02821000|42018793|FG000|Overall Study|Withdrawal by Subject|1|||
19571195|NCT02821000|42018793|FG000|Overall Study|Ongoing in Study|58|||
19571196|NCT00892099|42018800|FG000|Overall Study|Death|1|||
19571197|NCT00892099|42018801|FG001|Overall Study|Death|0|||
19571198|NCT00892099|42018802|FG002|Overall Study|Death|1|||
19571199|NCT00892099|42018800|FG000|Overall Study|Adverse Event|1|||
19571200|NCT00892099|42018801|FG001|Overall Study|Adverse Event|0|||
19571201|NCT00892099|42018802|FG002|Overall Study|Adverse Event|0|||
19571202|NCT00892099|42018800|FG000|Overall Study|replocated|1|||
19571203|NCT00892099|42018801|FG001|Overall Study|replocated|0|||
19571204|NCT00892099|42018802|FG002|Overall Study|replocated|2|||
19571205|NCT00892099|42018800|FG000|Overall Study|Prolonged hospitalization|1|||
19571206|NCT00892099|42018801|FG001|Overall Study|Prolonged hospitalization|0|||
19571207|NCT00892099|42018802|FG002|Overall Study|Prolonged hospitalization|1|||
19571208|NCT00892099|42018800|FG000|Overall Study|no further details|1|||
19384525|NCT02711137|41627430|FG013|Overall Study|Other|0|||
19384526|NCT02711137|41627431|FG014|Overall Study|Other|1|||
19384527|NCT02711137|41627417|FG000|Overall Study|Withdrawal by Subject|1|||
19384528|NCT02711137|41627418|FG001|Overall Study|Withdrawal by Subject|0|||
19384529|NCT02711137|41627419|FG002|Overall Study|Withdrawal by Subject|0|||
19384530|NCT02711137|41627420|FG003|Overall Study|Withdrawal by Subject|1|||
19571209|NCT00892099|42018801|FG001|Overall Study|no further details|0|||
19571210|NCT00892099|42018802|FG002|Overall Study|no further details|1|||
19571211|NCT00892099|42018800|FG000|Overall Study|kidney function recovered|0|||
19571212|NCT00892099|42018801|FG001|Overall Study|kidney function recovered|1|||
19571213|NCT00892099|42018802|FG002|Overall Study|kidney function recovered|0|||
19571214|NCT00892099|42018800|FG000|Overall Study|investigator decision|0|||
19571215|NCT00892099|42018801|FG001|Overall Study|investigator decision|0|||
19571216|NCT00892099|42018802|FG002|Overall Study|investigator decision|1|||
19571217|NCT00892099|42018800|FG000|Overall Study|Lost to Follow-up|0|||
19571218|NCT00892099|42018801|FG001|Overall Study|Lost to Follow-up|0|||
19571219|NCT00892099|42018802|FG002|Overall Study|Lost to Follow-up|1|||
19571220|NCT00960856|42018810|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19571221|NCT00960856|42018811|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
19571222|NCT00960856|42018812|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
19571223|NCT00960856|42018813|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
19571224|NCT00960856|42018810|FG000|Washout Period of 7 Days|Adverse Event|0|||
19571225|NCT00960856|42018811|FG001|Washout Period of 7 Days|Adverse Event|0|||
19571226|NCT00960856|42018812|FG002|Washout Period of 7 Days|Adverse Event|1|||
19571227|NCT00960856|42018813|FG003|Washout Period of 7 Days|Adverse Event|0|||
19384531|NCT02711137|41627421|FG004|Overall Study|Withdrawal by Subject|1|||
19571228|NCT00958438|42018826|FG000|Overall Study|Protocol Violation|3|||
19571229|NCT00958438|42018827|FG001|Overall Study|Protocol Violation|2|||
19571230|NCT00958438|42018828|FG002|Overall Study|Protocol Violation|2|||
19571231|NCT00958438|42018826|FG000|Overall Study|Withdrawal by Subject|4|||
19571232|NCT00958438|42018827|FG001|Overall Study|Withdrawal by Subject|2|||
19571233|NCT00958438|42018828|FG002|Overall Study|Withdrawal by Subject|1|||
19571234|NCT00958438|42018826|FG000|Overall Study|Adverse Event|0|||
19571235|NCT00958438|42018827|FG001|Overall Study|Adverse Event|3|||
19571236|NCT00958438|42018828|FG002|Overall Study|Adverse Event|0|||
19571237|NCT00958438|42018826|FG000|Overall Study|Physician Decision|1|||
19571238|NCT00958438|42018827|FG001|Overall Study|Physician Decision|0|||
19571239|NCT00958438|42018828|FG002|Overall Study|Physician Decision|1|||
19571240|NCT00958438|42018826|FG000|Overall Study|Other than specified above|2|||
19571241|NCT00958438|42018827|FG001|Overall Study|Other than specified above|3|||
19571242|NCT00958438|42018828|FG002|Overall Study|Other than specified above|2|||
19571243|NCT00958360|42018838|FG000|Overall Study|Withdrawal by Subject|3|||
19571244|NCT00958360|42018839|FG001|Overall Study|Withdrawal by Subject|1|||
19571245|NCT00958360|42018838|FG000|Overall Study|Death|6|||
19571246|NCT00958360|42018839|FG001|Overall Study|Death|7|||
19571247|NCT00958360|42018838|FG000|Overall Study|Physician Decision|2|||
19571248|NCT00958360|42018839|FG001|Overall Study|Physician Decision|1|||
19571249|NCT00958360|42018838|FG000|Overall Study|Lost to Follow-up|0|||
19571250|NCT00958360|42018839|FG001|Overall Study|Lost to Follow-up|1|||
19571251|NCT00888433|42018847|FG000|Overall Study|Withdrawal by Subject|1|||
19571252|NCT00888433|42018848|FG001|Overall Study|Withdrawal by Subject|2|||
19571253|NCT00888433|42018847|FG000|Overall Study|Missed Visit|2|||
19571254|NCT00888433|42018848|FG001|Overall Study|Missed Visit|1|||
19571255|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
19571256|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
19571257|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
19571258|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
19571259|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
19571260|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
19571261|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
19571262|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
19571263|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
19571264|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
19571265|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
19571266|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
19571267|NCT01243424|42018856|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
19571268|NCT01243424|42018857|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
19571269|NCT01243424|42018856|FG000|Discontinuation From Treatment|Not treated|5|||
19571270|NCT01243424|42018857|FG001|Discontinuation From Treatment|Not treated|4|||
19571271|NCT01243424|42018856|FG000|Discontinuation From Treatment|Adverse Event|457|||
19571272|NCT01243424|42018857|FG001|Discontinuation From Treatment|Adverse Event|523|||
19571273|NCT01243424|42018856|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
19571274|NCT01243424|42018857|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
19571275|NCT01243424|42018856|FG000|Discontinuation From Treatment|Protocol Violation|46|||
19571276|NCT01243424|42018857|FG001|Discontinuation From Treatment|Protocol Violation|47|||
19571277|NCT01243424|42018856|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
19571278|NCT01243424|42018857|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
19571279|NCT01243424|42018856|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
19571280|NCT01243424|42018857|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
19571281|NCT01243424|42018856|FG000|Discontinuation From Treatment|Other than listed above|230|||
19571282|NCT01243424|42018857|FG001|Discontinuation From Treatment|Other than listed above|211|||
19571283|NCT00887809|42018866|FG000|Overall Study|Patient Not Treated|3|||
19571284|NCT00887809|42018867|FG001|Overall Study|Patient Not Treated|0|||
19571285|NCT00887809|42018866|FG000|Overall Study|Death|1|||
19571286|NCT00887809|42018867|FG001|Overall Study|Death|0|||
19571287|NCT00958126|42018881|FG000|Overall Study|Serious Adverse Event|0|||
19571288|NCT00958126|42018882|FG001|Overall Study|Serious Adverse Event|2|||
19571289|NCT00958126|42018883|FG002|Overall Study|Serious Adverse Event|0|||
19571290|NCT00958126|42018884|FG003|Overall Study|Serious Adverse Event|0|||
19571291|NCT00958126|42018885|FG004|Overall Study|Serious Adverse Event|0|||
19571292|NCT00958126|42018886|FG005|Overall Study|Serious Adverse Event|0|||
19571293|NCT00958126|42018887|FG006|Overall Study|Serious Adverse Event|1|||
19571294|NCT00958126|42018888|FG007|Overall Study|Serious Adverse Event|0|||
19571295|NCT00958126|42018881|FG000|Overall Study|Withdrawal by Subject|0|||
19571296|NCT00958126|42018882|FG001|Overall Study|Withdrawal by Subject|2|||
19571297|NCT00958126|42018883|FG002|Overall Study|Withdrawal by Subject|0|||
19571298|NCT00958126|42018884|FG003|Overall Study|Withdrawal by Subject|0|||
19571299|NCT00958126|42018885|FG004|Overall Study|Withdrawal by Subject|0|||
19571300|NCT00958126|42018886|FG005|Overall Study|Withdrawal by Subject|0|||
19571301|NCT00958126|42018887|FG006|Overall Study|Withdrawal by Subject|0|||
19571302|NCT00958126|42018888|FG007|Overall Study|Withdrawal by Subject|0|||
19571303|NCT00958126|42018881|FG000|Overall Study|Moved away from study area|0|||
19571304|NCT00958126|42018882|FG001|Overall Study|Moved away from study area|0|||
19571305|NCT00958126|42018883|FG002|Overall Study|Moved away from study area|1|||
19571306|NCT00958126|42018884|FG003|Overall Study|Moved away from study area|1|||
19571307|NCT00958126|42018885|FG004|Overall Study|Moved away from study area|0|||
19571308|NCT00958126|42018886|FG005|Overall Study|Moved away from study area|0|||
19571309|NCT00958126|42018887|FG006|Overall Study|Moved away from study area|0|||
19571310|NCT00958126|42018888|FG007|Overall Study|Moved away from study area|0|||
19571311|NCT00958126|42018881|FG000|Overall Study|Lost to Follow-up|1|||
19571312|NCT00958126|42018882|FG001|Overall Study|Lost to Follow-up|5|||
19571313|NCT00958126|42018883|FG002|Overall Study|Lost to Follow-up|9|||
19571314|NCT00958126|42018884|FG003|Overall Study|Lost to Follow-up|8|||
19571315|NCT00958126|42018885|FG004|Overall Study|Lost to Follow-up|0|||
19571316|NCT00958126|42018886|FG005|Overall Study|Lost to Follow-up|0|||
19571317|NCT00958126|42018887|FG006|Overall Study|Lost to Follow-up|0|||
19571318|NCT00958126|42018888|FG007|Overall Study|Lost to Follow-up|0|||
19571319|NCT00958126|42018881|FG000|Overall Study|Sponsor/Investigator decision|0|||
19571320|NCT00958126|42018882|FG001|Overall Study|Sponsor/Investigator decision|0|||
19571321|NCT00958126|42018883|FG002|Overall Study|Sponsor/Investigator decision|0|||
19571322|NCT00958126|42018884|FG003|Overall Study|Sponsor/Investigator decision|1|||
19571323|NCT00958126|42018885|FG004|Overall Study|Sponsor/Investigator decision|0|||
19571324|NCT00958126|42018886|FG005|Overall Study|Sponsor/Investigator decision|0|||
19571325|NCT00958126|42018887|FG006|Overall Study|Sponsor/Investigator decision|0|||
19571326|NCT00958126|42018888|FG007|Overall Study|Sponsor/Investigator decision|0|||
19571327|NCT00958126|42018881|FG000|Overall Study|Other Reason|0|||
19571328|NCT00958126|42018882|FG001|Overall Study|Other Reason|0|||
19571329|NCT00958126|42018883|FG002|Overall Study|Other Reason|0|||
19571330|NCT00958126|42018884|FG003|Overall Study|Other Reason|1|||
19571331|NCT00958126|42018885|FG004|Overall Study|Other Reason|0|||
19571332|NCT00958126|42018886|FG005|Overall Study|Other Reason|1|||
19571333|NCT00958126|42018887|FG006|Overall Study|Other Reason|0|||
19571334|NCT00958126|42018888|FG007|Overall Study|Other Reason|0|||
19571335|NCT00887341|42018912|FG000|Overall Study|Refused treatment|1|||
19571336|NCT00887341|42018913|FG001|Overall Study|Refused treatment|0|||
19571337|NCT00887341|42018912|FG000|Overall Study|Withdrawal by Subject|1|||
19571338|NCT00887341|42018913|FG001|Overall Study|Withdrawal by Subject|1|||
19571339|NCT00887341|42018912|FG000|Overall Study|Adverse Event|0|||
19571340|NCT00887341|42018913|FG001|Overall Study|Adverse Event|1|||
19571341|NCT00887341|42018912|FG000|Overall Study|Lost to Follow-up|0|||
19571342|NCT00887341|42018913|FG001|Overall Study|Lost to Follow-up|1|||
19571343|NCT00886795|42018919|FG000|Overall Study|Lack of Efficacy|1|||
19745717|NCT00071981|42193070|FG000|Overall Study|Lack of Efficacy|37|||
19571344|NCT00889681|42018936|FG000|Overall Study|Not meeting qualification Criteria|2|||
19571345|NCT00889681|42018936|FG000|Overall Study|Insurance disapproval|1|||
19571346|NCT00957658|42018940|FG000|Overall Study|Death|1|||
19571347|NCT00957658|42018940|FG000|Overall Study|Lost to Follow-up|4|||
19571348|NCT00957658|42018940|FG000|Overall Study|Withdrawal by Subject|12|||
19571349|NCT00957658|42018940|FG000|Overall Study|Revision|1|||
19571350|NCT00957658|42018940|FG000|Overall Study|Incomplete 2 yr data|28|||
19745718|NCT00071981|42193071|FG001|Overall Study|Lack of Efficacy|29|||
19571351|NCT00957658|42018940|FG000|Overall Study|Site termination|10|||
19571352|NCT00957658|42018940|FG000|Overall Study|unwilling/unable to return|2|||
19571353|NCT00957658|42018940|FG000|Overall Study|surgery cancelled|2|||
19571354|NCT00957658|42018940|FG000|Overall Study|Protocol Violation|5|||
19571355|NCT00953680|42018946|FG000|Period 1|Withdrawal by Subject|0|||
19571356|NCT00953680|42018947|FG001|Period 1|Withdrawal by Subject|1|||
19571357|NCT00890929|42018953|FG000|Overall Study|Death before treatment|2|||
19571358|NCT00890929|42018953|FG000|Overall Study|Withdrawal by Subject|3|||
19571359|NCT00890929|42018953|FG000|Overall Study|Physician Decision|1|||
19571360|NCT00886639|42018957|FG000|Overall Study|acute exacerbation|14|||
19571361|NCT00886639|42018957|FG000|Overall Study|non-compliance|2|||
19571362|NCT00889603|42018961|FG000|Overall Study|Adverse Event|7|||
19571363|NCT00889603|42018961|FG000|Overall Study|Death|3|||
19571364|NCT00889603|42018961|FG000|Overall Study|Lost to Follow-up|19|||
19571365|NCT00889603|42018961|FG000|Overall Study|No longer willing to participant in stud|4|||
19571366|NCT00889603|42018961|FG000|Overall Study|Other|4|||
19571367|NCT00886483|42018967|FG000|Overall Study|Lost to Follow-up|0|||
19571368|NCT00886483|42018968|FG001|Overall Study|Lost to Follow-up|1|||
19571369|NCT00886483|42018967|FG000|Overall Study|Pursue medications|1|||
19571370|NCT00886483|42018968|FG001|Overall Study|Pursue medications|2|||
19571371|NCT00886483|42018967|FG000|Overall Study|Distance to center, poor grades|1|||
19571372|NCT00886483|42018968|FG001|Overall Study|Distance to center, poor grades|0|||
19571373|NCT00886015|42018984|FG000|Overall Study|Death|0|||
19571374|NCT00886015|42018985|FG001|Overall Study|Death|2|||
19384532|NCT02711137|41627422|FG005|Overall Study|Withdrawal by Subject|0|||
19384533|NCT02711137|41627423|FG006|Overall Study|Withdrawal by Subject|7|||
19384534|NCT02711137|41627424|FG007|Overall Study|Withdrawal by Subject|0|||
19384535|NCT02711137|41627425|FG008|Overall Study|Withdrawal by Subject|0|||
19384536|NCT02711137|41627426|FG009|Overall Study|Withdrawal by Subject|0|||
19384537|NCT02711137|41627427|FG010|Overall Study|Withdrawal by Subject|0|||
19384538|NCT02711137|41627428|FG011|Overall Study|Withdrawal by Subject|0|||
19384539|NCT02711137|41627429|FG012|Overall Study|Withdrawal by Subject|0|||
19384540|NCT02711137|41627430|FG013|Overall Study|Withdrawal by Subject|1|||
19384541|NCT02711137|41627431|FG014|Overall Study|Withdrawal by Subject|0|||
19384542|NCT02711137|41627417|FG000|Overall Study|Lost to Follow-up|1|||
19384543|NCT02711137|41627418|FG001|Overall Study|Lost to Follow-up|0|||
19384544|NCT02711137|41627419|FG002|Overall Study|Lost to Follow-up|0|||
19384545|NCT02711137|41627420|FG003|Overall Study|Lost to Follow-up|0|||
19384546|NCT02711137|41627421|FG004|Overall Study|Lost to Follow-up|0|||
19384547|NCT02711137|41627422|FG005|Overall Study|Lost to Follow-up|0|||
19384548|NCT02711137|41627423|FG006|Overall Study|Lost to Follow-up|2|||
19384549|NCT02711137|41627424|FG007|Overall Study|Lost to Follow-up|0|||
19384550|NCT02711137|41627425|FG008|Overall Study|Lost to Follow-up|0|||
19384551|NCT02711137|41627426|FG009|Overall Study|Lost to Follow-up|0|||
19384552|NCT02711137|41627427|FG010|Overall Study|Lost to Follow-up|0|||
19384553|NCT02711137|41627428|FG011|Overall Study|Lost to Follow-up|0|||
19571375|NCT00890695|42018993|FG000|Overall Study|Protocol Violation|1|||
19571376|NCT00890695|42018994|FG001|Overall Study|Protocol Violation|0|||
19571377|NCT00957580|42019003|FG000|Overall Study|Ongoing at data cut-off|0|||
19571378|NCT00957580|42019004|FG001|Overall Study|Ongoing at data cut-off|1|||
19571379|NCT00957580|42019005|FG002|Overall Study|Ongoing at data cut-off|0|||
19384554|NCT02711137|41627429|FG012|Overall Study|Lost to Follow-up|0|||
19384555|NCT02711137|41627430|FG013|Overall Study|Lost to Follow-up|0|||
19571380|NCT00957580|42019003|FG000|Overall Study|Enrolled but not treated|0|||
19571381|NCT00957580|42019004|FG001|Overall Study|Enrolled but not treated|1|||
19384556|NCT02711137|41627431|FG014|Overall Study|Lost to Follow-up|0|||
19571382|NCT00957580|42019005|FG002|Overall Study|Enrolled but not treated|0|||
19571383|NCT00957424|42019026|FG000|Overall Study|Lost to Follow-up|19|||
19571384|NCT00957424|42019026|FG000|Overall Study|Protocol Violation|3|||
19571385|NCT00957424|42019026|FG000|Overall Study|Withdrawal by Subject|1|||
19571386|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
19571387|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
19571388|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
19571389|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
19571390|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
19384557|NCT02151981|41627470|FG000|Overall Study|Death|184|||
19384558|NCT02151981|41627471|FG001|Overall Study|Death|88|||
19571391|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
19571392|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
19571393|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
19571394|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
19571395|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
19571396|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
19571397|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
19571398|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
19571399|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
19571400|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
19571401|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
19571402|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
19571403|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
19571404|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
19571405|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
19571406|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
19571407|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
19571408|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
19571409|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
19571410|NCT01061151|42019034|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
19571411|NCT01061151|42019035|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
19571412|NCT01061151|42019036|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
19571413|NCT01061151|42019037|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
19571414|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
19571415|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
19571416|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
19571417|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
19571418|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
19571419|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
19571420|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
19571421|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
19571422|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
19571423|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
19571424|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
19571425|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
19571426|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
19571427|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
19571428|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
19571429|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
19571430|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
19571431|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
19571432|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
19571433|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
19571434|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
19571435|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
19571436|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
19571437|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
19571438|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
19571439|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
19571440|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
19571441|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
19571442|NCT01061151|42019034|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
19571443|NCT01061151|42019035|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
19571444|NCT01061151|42019036|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
19571445|NCT01061151|42019037|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
19571446|NCT01241552|42019061|FG000|Overall Study|Lack of Efficacy|1|||
19571447|NCT01241552|42019062|FG001|Overall Study|Lack of Efficacy|0|||
19571448|NCT01241552|42019063|FG002|Overall Study|Lack of Efficacy|0|||
19571449|NCT01241552|42019064|FG003|Overall Study|Lack of Efficacy|0|||
19571450|NCT01241552|42019061|FG000|Overall Study|Death|26|||
19571451|NCT01241552|42019062|FG001|Overall Study|Death|30|||
19571452|NCT01241552|42019063|FG002|Overall Study|Death|20|||
19571453|NCT01241552|42019064|FG003|Overall Study|Death|25|||
19571454|NCT01241552|42019061|FG000|Overall Study|Adverse Event|1|||
19571455|NCT01241552|42019062|FG001|Overall Study|Adverse Event|1|||
19571456|NCT01241552|42019063|FG002|Overall Study|Adverse Event|0|||
19571457|NCT01241552|42019064|FG003|Overall Study|Adverse Event|0|||
19571458|NCT01241552|42019061|FG000|Overall Study|Technical Problems|2|||
19571459|NCT01241552|42019062|FG001|Overall Study|Technical Problems|0|||
19571460|NCT01241552|42019063|FG002|Overall Study|Technical Problems|2|||
19571461|NCT01241552|42019064|FG003|Overall Study|Technical Problems|2|||
19571462|NCT01241552|42019061|FG000|Overall Study|Progressive Disease|0|||
19571463|NCT01241552|42019062|FG001|Overall Study|Progressive Disease|0|||
19571464|NCT01241552|42019063|FG002|Overall Study|Progressive Disease|1|||
19571465|NCT01241552|42019064|FG003|Overall Study|Progressive Disease|2|||
19571466|NCT01241552|42019061|FG000|Overall Study|Protocol Violation|0|||
19571467|NCT01241552|42019062|FG001|Overall Study|Protocol Violation|2|||
19571468|NCT01241552|42019063|FG002|Overall Study|Protocol Violation|6|||
19571469|NCT01241552|42019064|FG003|Overall Study|Protocol Violation|1|||
19571470|NCT01241552|42019061|FG000|Overall Study|Withdrawal by Subject|7|||
19571471|NCT01241552|42019062|FG001|Overall Study|Withdrawal by Subject|15|||
19571472|NCT01241552|42019063|FG002|Overall Study|Withdrawal by Subject|14|||
19571473|NCT01241552|42019064|FG003|Overall Study|Withdrawal by Subject|15|||
19571474|NCT01241552|42019061|FG000|Overall Study|Physician Decision|2|||
19571475|NCT01241552|42019062|FG001|Overall Study|Physician Decision|4|||
19571476|NCT01241552|42019063|FG002|Overall Study|Physician Decision|2|||
19571477|NCT01241552|42019064|FG003|Overall Study|Physician Decision|3|||
19571478|NCT01241552|42019061|FG000|Overall Study|Lost to Follow-up|2|||
19571479|NCT01241552|42019062|FG001|Overall Study|Lost to Follow-up|11|||
19571480|NCT01241552|42019063|FG002|Overall Study|Lost to Follow-up|15|||
19571481|NCT01241552|42019064|FG003|Overall Study|Lost to Follow-up|16|||
19571482|NCT00948922|42019077|FG000|Overall Study|Did not start study treatment|2|||
19571483|NCT00948922|42019078|FG001|Overall Study|Did not start study treatment|5|||
19571484|NCT00948922|42019079|FG002|Overall Study|Did not start study treatment|0|||
19571485|NCT00948922|42019077|FG000|Overall Study|Withdrawal by Subject|0|||
19571486|NCT00948922|42019078|FG001|Overall Study|Withdrawal by Subject|2|||
19571487|NCT00948922|42019079|FG002|Overall Study|Withdrawal by Subject|1|||
19571488|NCT00948922|42019077|FG000|Overall Study|Death|3|||
19571489|NCT00948922|42019078|FG001|Overall Study|Death|0|||
19571490|NCT00948922|42019079|FG002|Overall Study|Death|0|||
19571491|NCT00948922|42019077|FG000|Overall Study|Disease progression|0|||
19571492|NCT00948922|42019078|FG001|Overall Study|Disease progression|1|||
19571493|NCT00948922|42019079|FG002|Overall Study|Disease progression|0|||
19571494|NCT00948922|42019077|FG000|Overall Study|Insurance issues|1|||
19571495|NCT00948922|42019078|FG001|Overall Study|Insurance issues|0|||
19571496|NCT00948922|42019079|FG002|Overall Study|Insurance issues|0|||
19571497|NCT00948922|42019077|FG000|Overall Study|Transplant eligibility issues|2|||
19571498|NCT00948922|42019078|FG001|Overall Study|Transplant eligibility issues|3|||
19571499|NCT00948922|42019079|FG002|Overall Study|Transplant eligibility issues|0|||
19571500|NCT00948922|42019077|FG000|Overall Study|Not evaluable at time of analysis|0|||
19571501|NCT00948922|42019078|FG001|Overall Study|Not evaluable at time of analysis|3|||
19571502|NCT00948922|42019079|FG002|Overall Study|Not evaluable at time of analysis|0|||
19571503|NCT01239992|42019091|FG000|Overall Study|Withdrawal by Subject|2|||
19571504|NCT01072539|42019095|FG000|Overall Study|Treated prior to the Site Initiation|1|||
19571505|NCT01072539|42019095|FG000|Overall Study|Protocol Violation|2|||
19571506|NCT01239680|42019101|FG000|Overall Study|Withdrawal by Subject|2|||
19571507|NCT01239680|42019102|FG001|Overall Study|Withdrawal by Subject|0|||
19571508|NCT01238900|42019108|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
19571509|NCT01238900|42019108|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
19571510|NCT01238822|42019113|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
19571511|NCT01238588|42019123|FG000|Overall Study|Withdrawal by Subject|1|||
19571512|NCT01238588|42019123|FG000|Overall Study|Physician Decision|2|||
19571513|NCT01047501|42019130|FG000|Overall Study|Adverse Event|7|||
19571514|NCT01047501|42019131|FG001|Overall Study|Adverse Event|8|||
19571515|NCT01047501|42019132|FG002|Overall Study|Adverse Event|5|||
19571516|NCT01047501|42019130|FG000|Overall Study|Withdrew Consent|6|||
19571517|NCT01047501|42019131|FG001|Overall Study|Withdrew Consent|2|||
19571518|NCT01047501|42019132|FG002|Overall Study|Withdrew Consent|4|||
19571519|NCT01047501|42019130|FG000|Overall Study|Lost to Follow-up|0|||
19384559|NCT02151981|41627470|FG000|Overall Study|Lost to Follow-up|7|||
19384560|NCT02151981|41627471|FG001|Overall Study|Lost to Follow-up|1|||
19384561|NCT02151981|41627470|FG000|Overall Study|Withdrawal by Subject|27|||
19384562|NCT02151981|41627471|FG001|Overall Study|Withdrawal by Subject|21|||
19571520|NCT01047501|42019131|FG001|Overall Study|Lost to Follow-up|1|||
19571521|NCT01047501|42019132|FG002|Overall Study|Lost to Follow-up|1|||
19571522|NCT01047501|42019130|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
19571523|NCT01047501|42019131|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
19571524|NCT01047501|42019132|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
19571525|NCT01047501|42019130|FG000|Overall Study|Death|1|||
19571526|NCT01047501|42019131|FG001|Overall Study|Death|0|||
19571527|NCT01047501|42019132|FG002|Overall Study|Death|0|||
19571528|NCT01047501|42019130|FG000|Overall Study|Other discontinuation|1|||
19571529|NCT01047501|42019131|FG001|Overall Study|Other discontinuation|0|||
19571530|NCT01047501|42019132|FG002|Overall Study|Other discontinuation|1|||
19571531|NCT01047501|42019130|FG000|Overall Study|Investigator judgement|0|||
19571532|NCT01047501|42019131|FG001|Overall Study|Investigator judgement|0|||
19571533|NCT01047501|42019132|FG002|Overall Study|Investigator judgement|1|||
19571534|NCT01238120|42019144|FG000|Overall Study|Withdrawal by Subject|4|||
19571535|NCT01238120|42019145|FG001|Overall Study|Withdrawal by Subject|1|||
19571536|NCT01238120|42019146|FG002|Overall Study|Withdrawal by Subject|2|||
19571537|NCT01238120|42019147|FG003|Overall Study|Withdrawal by Subject|5|||
19571538|NCT01238120|42019144|FG000|Overall Study|Lost to Follow-up|2|||
19571539|NCT01238120|42019145|FG001|Overall Study|Lost to Follow-up|0|||
19571540|NCT01238120|42019146|FG002|Overall Study|Lost to Follow-up|1|||
19571541|NCT01238120|42019147|FG003|Overall Study|Lost to Follow-up|1|||
19571542|NCT01238120|42019144|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
19571543|NCT01238120|42019145|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
19571544|NCT01238120|42019146|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
19571545|NCT01238120|42019147|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
19571546|NCT01237340|42019157|FG000|Overall Study|Adverse Event|3|||
19571547|NCT01237340|42019157|FG000|Overall Study|Withdrawal by Subject|1|||
19571548|NCT01237340|42019157|FG000|Overall Study|Early termination of the trial|36|||
19571549|NCT01045707|42019166|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
19571550|NCT01045707|42019167|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
19571551|NCT01045707|42019166|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
19571552|NCT01045707|42019167|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
19571553|NCT01045707|42019166|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
19571554|NCT01045707|42019167|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
19571555|NCT01045707|42019166|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
19571556|NCT01045707|42019167|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
19571557|NCT01045707|42019166|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
19571558|NCT01045707|42019167|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
19571559|NCT01045707|42019166|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
19571560|NCT01045707|42019167|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
19571561|NCT01045707|42019166|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
19571562|NCT01045707|42019167|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
19571563|NCT01045707|42019166|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
19571564|NCT01045707|42019167|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
19571565|NCT01045707|42019166|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
19384563|NCT02151981|41627470|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
19745719|NCT00071981|42193072|FG002|Overall Study|Lack of Efficacy|30|||
19571566|NCT01045707|42019167|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
19571567|NCT01054599|42019175|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
19571568|NCT01054599|42019176|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
19571569|NCT01054599|42019175|FG000|Overall Study|Protocol Violation|1|||
19571570|NCT01054599|42019176|FG001|Overall Study|Protocol Violation|0|||
19571571|NCT01054599|42019175|FG000|Overall Study|Spells/seizure-like episodes|1|||
19571572|NCT01054599|42019176|FG001|Overall Study|Spells/seizure-like episodes|1|||
19571573|NCT01054599|42019175|FG000|Overall Study|Timing/scheduling difficulties|1|||
19571574|NCT01054599|42019176|FG001|Overall Study|Timing/scheduling difficulties|1|||
19571575|NCT01054599|42019175|FG000|Overall Study|Visual impairment, WTAR <80|0|||
19571576|NCT01054599|42019176|FG001|Overall Study|Visual impairment, WTAR <80|1|||
19571577|NCT01054599|42019175|FG000|Overall Study|Lost to Follow-up|0|||
19571578|NCT01054599|42019176|FG001|Overall Study|Lost to Follow-up|2|||
19571579|NCT01054599|42019175|FG000|Overall Study|Adverse Event|0|||
19384564|NCT02151981|41627471|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
19384565|NCT02151981|41627470|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19384566|NCT02151981|41627471|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19384567|NCT02151981|41627470|FG000|Overall Study|Patient had no clinical benefit|1|||
19571580|NCT01054599|42019176|FG001|Overall Study|Adverse Event|1|||
19571581|NCT01054599|42019175|FG000|Overall Study|Withdrawal by Subject|0|||
19571582|NCT01054599|42019176|FG001|Overall Study|Withdrawal by Subject|1|||
19571583|NCT01236560|42019188|FG000|Overall Study|Adverse Event|0|||
19571584|NCT01236560|42019189|FG001|Overall Study|Adverse Event|2|||
19571585|NCT01236560|42019190|FG002|Overall Study|Adverse Event|1|||
19571586|NCT01236560|42019191|FG003|Overall Study|Adverse Event|3|||
19571587|NCT01236560|42019192|FG004|Overall Study|Adverse Event|0|||
19571588|NCT01236560|42019193|FG005|Overall Study|Adverse Event|0|||
19571589|NCT01236560|42019188|FG000|Overall Study|Death|0|||
19571590|NCT01236560|42019189|FG001|Overall Study|Death|1|||
19571591|NCT01236560|42019190|FG002|Overall Study|Death|0|||
19571592|NCT01236560|42019191|FG003|Overall Study|Death|1|||
19571593|NCT01236560|42019192|FG004|Overall Study|Death|0|||
19571594|NCT01236560|42019193|FG005|Overall Study|Death|0|||
19571595|NCT01236560|42019188|FG000|Overall Study|Lost to Follow-up|0|||
19571596|NCT01236560|42019189|FG001|Overall Study|Lost to Follow-up|1|||
19571597|NCT01236560|42019190|FG002|Overall Study|Lost to Follow-up|1|||
19571598|NCT01236560|42019191|FG003|Overall Study|Lost to Follow-up|0|||
19571599|NCT01236560|42019192|FG004|Overall Study|Lost to Follow-up|0|||
19571600|NCT01236560|42019193|FG005|Overall Study|Lost to Follow-up|0|||
19571601|NCT01236560|42019188|FG000|Overall Study|Physician Decision|0|||
19571602|NCT01236560|42019189|FG001|Overall Study|Physician Decision|1|||
19571603|NCT01236560|42019190|FG002|Overall Study|Physician Decision|8|||
19571604|NCT01236560|42019191|FG003|Overall Study|Physician Decision|0|||
19571605|NCT01236560|42019192|FG004|Overall Study|Physician Decision|0|||
19571606|NCT01236560|42019193|FG005|Overall Study|Physician Decision|0|||
19745720|NCT00071981|42193073|FG003|Overall Study|Lack of Efficacy|43|||
19384568|NCT02151981|41627471|FG001|Overall Study|Patient had no clinical benefit|0|||
19384569|NCT02151981|41627470|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
19384570|NCT02151981|41627471|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
19384571|NCT02151981|41627470|FG000|Overall Study|Study terminated|0|||
19384572|NCT02151981|41627471|FG001|Overall Study|Study terminated|1|||
19384573|NCT02710045|41627480|FG000|Overall Study|Death|1|||
19384574|NCT02710045|41627481|FG001|Overall Study|Death|2|||
19384575|NCT02710045|41627482|FG002|Overall Study|Death|0|||
19571607|NCT01236560|42019188|FG000|Overall Study|Withdrawal by Subject|0|||
19571608|NCT01236560|42019189|FG001|Overall Study|Withdrawal by Subject|0|||
19384576|NCT02710045|41627480|FG000|Overall Study|Withdrawal by Subject|6|||
19384577|NCT02710045|41627481|FG001|Overall Study|Withdrawal by Subject|6|||
19384578|NCT02710045|41627482|FG002|Overall Study|Withdrawal by Subject|2|||
19384579|NCT02710045|41627480|FG000|Overall Study|Protocol Violation|1|||
19384580|NCT02710045|41627481|FG001|Overall Study|Protocol Violation|2|||
19384581|NCT02710045|41627482|FG002|Overall Study|Protocol Violation|3|||
19384582|NCT02710045|41627480|FG000|Overall Study|Lost to Follow-up|3|||
19384583|NCT02710045|41627481|FG001|Overall Study|Lost to Follow-up|6|||
19384584|NCT02710045|41627482|FG002|Overall Study|Lost to Follow-up|7|||
19384585|NCT02710045|41627480|FG000|Overall Study|Physician Decision|0|||
19384586|NCT02710045|41627481|FG001|Overall Study|Physician Decision|0|||
19384587|NCT02710045|41627482|FG002|Overall Study|Physician Decision|1|||
19384588|NCT02710045|41627480|FG000|Overall Study|Poor Attendance|0|||
19384589|NCT02710045|41627481|FG001|Overall Study|Poor Attendance|1|||
19384590|NCT02710045|41627482|FG002|Overall Study|Poor Attendance|0|||
19384591|NCT02714153|41627490|FG000|Overall Study|Death|1|||
19384592|NCT04369469|41627496|FG000|Overall Study|Lost to Follow-up|2|||
19384593|NCT04369469|41627497|FG001|Overall Study|Lost to Follow-up|4|||
19384594|NCT04369469|41627496|FG000|Overall Study|Physician Decision|2|||
19384595|NCT04369469|41627497|FG001|Overall Study|Physician Decision|1|||
19384596|NCT04369469|41627496|FG000|Overall Study|Withdrawal by Subject|2|||
19384597|NCT04369469|41627497|FG001|Overall Study|Withdrawal by Subject|3|||
19384598|NCT04369469|41627496|FG000|Overall Study|Adverse Event|1|||
19384599|NCT04369469|41627497|FG001|Overall Study|Adverse Event|0|||
19384600|NCT04369469|41627496|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
19384601|NCT04369469|41627497|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
19384602|NCT04369469|41627496|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
19384603|NCT04369469|41627497|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
19384604|NCT04369469|41627496|FG000|Overall Study|Unable to Provide Consent|0|||
19384605|NCT04369469|41627497|FG001|Overall Study|Unable to Provide Consent|1|||
19384606|NCT01670097|41627518|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
19384607|NCT01670097|41627519|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
19384608|NCT01670097|41627518|FG000|Overall Study|Study burden|1|||
19384609|NCT01670097|41627519|FG001|Overall Study|Study burden|0|||
19384610|NCT01670097|41627518|FG000|Overall Study|COPD exacerbation|0|||
19384611|NCT01670097|41627519|FG001|Overall Study|COPD exacerbation|1|||
19384612|NCT01670097|41627518|FG000|Overall Study|Neutropenia|0|||
19384613|NCT01670097|41627519|FG001|Overall Study|Neutropenia|1|||
19384614|NCT01670097|41627518|FG000|Overall Study|Clinical deterioration|0|||
19745721|NCT00071981|42193070|FG000|Overall Study|Adverse Event|4|||
19384615|NCT01670097|41627519|FG001|Overall Study|Clinical deterioration|1|||
19384616|NCT01670097|41627518|FG000|Overall Study|Disease progression|0|||
19384617|NCT01670097|41627519|FG001|Overall Study|Disease progression|1|||
19384618|NCT01670019|41627527|FG000|Overall Study|Adverse Event|3|||
19384619|NCT01670019|41627528|FG001|Overall Study|Adverse Event|0|||
19384620|NCT01670019|41627527|FG000|Overall Study|Withdrawal by Subject|6|||
19384621|NCT01670019|41627528|FG001|Overall Study|Withdrawal by Subject|0|||
19384622|NCT01669629|41627534|FG000|Period 1|protocol deviation|1|||
19384623|NCT01669629|41627535|FG001|Period 1|protocol deviation|2|||
19384624|NCT00701051|41627543|FG000|Screening|Failed Screening|40|||
19384625|NCT00701051|41627544|FG001|Screening|Failed Screening|0|||
19384626|NCT00701051|41627545|FG002|Screening|Failed Screening|0|||
19384627|NCT00701051|41627543|FG000|Screening|Time conflicts|19|||
19384628|NCT00701051|41627544|FG001|Screening|Time conflicts|0|||
19384629|NCT00701051|41627545|FG002|Screening|Time conflicts|0|||
19384630|NCT00701051|41627543|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
19384631|NCT00701051|41627544|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
19384632|NCT00701051|41627545|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
19384633|NCT00700817|41627556|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
19384634|NCT00700817|41627557|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
19384635|NCT00700817|41627558|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
19384636|NCT00700817|41627559|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
19384637|NCT00700817|41627560|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
19384638|NCT00700817|41627556|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
19384639|NCT00700817|41627557|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
19384640|NCT00700817|41627558|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
19384641|NCT00700817|41627559|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
19384642|NCT00700817|41627560|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
19384643|NCT00700817|41627556|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
19384644|NCT00700817|41627557|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
19384645|NCT00700817|41627558|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
19384646|NCT00700817|41627559|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
19384647|NCT00700817|41627560|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
19384648|NCT00700817|41627556|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
19384649|NCT00700817|41627557|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
19384650|NCT00700817|41627558|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
19384651|NCT00700817|41627559|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
19384652|NCT00700817|41627560|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
19384653|NCT00700817|41627556|FG000|Week 0-26 (Main Period)|Unclassified|14|||
19384654|NCT00700817|41627557|FG001|Week 0-26 (Main Period)|Unclassified|4|||
19384655|NCT00700817|41627558|FG002|Week 0-26 (Main Period)|Unclassified|8|||
19384656|NCT00700817|41627559|FG003|Week 0-26 (Main Period)|Unclassified|0|||
19384657|NCT00700817|41627560|FG004|Week 0-26 (Main Period)|Unclassified|0|||
19384658|NCT00700817|41627556|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
19384659|NCT00700817|41627557|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
19384660|NCT00700817|41627558|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
19384661|NCT00700817|41627559|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
19384662|NCT00700817|41627560|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
19384663|NCT00700817|41627556|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
19384664|NCT00700817|41627557|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
19384665|NCT00700817|41627558|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
19384666|NCT00700817|41627559|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
19384667|NCT00700817|41627560|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
19384668|NCT00700817|41627556|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
19384669|NCT00700817|41627557|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
19384670|NCT00700817|41627558|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
19384671|NCT00700817|41627559|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
19384672|NCT00700817|41627560|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
19384673|NCT00700817|41627556|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
19384674|NCT00700817|41627557|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
19384675|NCT00700817|41627558|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
19384676|NCT00700817|41627559|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
19384677|NCT00700817|41627560|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
19384678|NCT00700817|41627556|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
19384679|NCT00700817|41627557|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
19384680|NCT00700817|41627558|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
19384681|NCT00700817|41627559|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
19384682|NCT00700817|41627560|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
19384683|NCT00700817|41627556|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
19384684|NCT00700817|41627557|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
19384685|NCT00700817|41627558|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
19384686|NCT00700817|41627559|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
19384687|NCT00700817|41627560|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
19384688|NCT00700817|41627556|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
19384689|NCT00700817|41627557|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
19384690|NCT00700817|41627558|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
19384691|NCT00700817|41627559|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
19384692|NCT00700817|41627560|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
19476927|NCT01569295|41755233|FG000|Overall Study|Adverse Event|39|||
19384693|NCT00700817|41627556|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
19384694|NCT00700817|41627557|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
19384695|NCT00700817|41627558|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
19384696|NCT00700817|41627559|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
19384697|NCT00700817|41627560|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
19384698|NCT00700817|41627556|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
19384699|NCT00700817|41627557|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
19384700|NCT00700817|41627558|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
19384701|NCT00700817|41627559|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
19384702|NCT00700817|41627560|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
19384703|NCT00700817|41627556|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
19384704|NCT00700817|41627557|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
19384705|NCT00700817|41627558|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
19384706|NCT00700817|41627559|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
19384707|NCT00700817|41627560|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
19384708|NCT02625909|41627572|FG000|Overall Study|Death|2|||
19384709|NCT02625909|41627573|FG001|Overall Study|Death|0|||
19384710|NCT02625909|41627572|FG000|Overall Study|Lost to Follow-up|3|||
19384711|NCT02625909|41627573|FG001|Overall Study|Lost to Follow-up|5|||
19384712|NCT02625909|41627572|FG000|Overall Study|Lack of Efficacy|9|||
19384713|NCT02625909|41627573|FG001|Overall Study|Lack of Efficacy|2|||
19384714|NCT02625909|41627572|FG000|Overall Study|Reinfection|3|||
19384715|NCT02625909|41627573|FG001|Overall Study|Reinfection|2|||
19384716|NCT02623959|41627581|FG000|Overall Study|Progression|0|||
19384717|NCT02623959|41627582|FG001|Overall Study|Progression|1|||
19384718|NCT00700739|41627592|FG000|Overall Study|Lost to Follow-up|4|||
19384719|NCT00700739|41627593|FG001|Overall Study|Lost to Follow-up|4|||
19384720|NCT02623335|41627602|FG000|Overall Study|Death|8|||
19384721|NCT02623335|41627603|FG001|Overall Study|Death|7|||
19384722|NCT02623335|41627602|FG000|Overall Study|Lost to Follow-up|15|||
19384723|NCT02623335|41627603|FG001|Overall Study|Lost to Follow-up|23|||
19384724|NCT02623335|41627602|FG000|Overall Study|Withdrawal by Subject|2|||
19384725|NCT02623335|41627603|FG001|Overall Study|Withdrawal by Subject|5|||
19384726|NCT02623335|41627602|FG000|Overall Study|Protocol Violation|2|||
19384727|NCT02623335|41627603|FG001|Overall Study|Protocol Violation|1|||
19384728|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
19384729|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
19384730|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
19384731|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
19384732|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
19384733|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
19384734|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
19384735|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
19384736|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
19384737|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
19384738|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
19384739|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
19384740|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
19384741|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
19384742|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
19384743|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
19384744|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
19384745|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
19476928|NCT01569295|41755234|FG001|Overall Study|Adverse Event|14|||
19384746|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
19384747|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
19384748|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
19384749|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
19384750|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
19384751|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
19384752|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
19384753|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
19384754|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
19384755|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
19384756|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
19384757|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
19384758|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
19384759|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
19384760|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
19384761|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
19384762|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
19384763|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
19384764|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
19384765|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
19384766|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
19384767|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
19384768|NCT00700427|41627613|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
19384769|NCT00700427|41627614|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
19384770|NCT00700427|41627615|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
19384771|NCT00700427|41627616|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
19384772|NCT00700427|41627617|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
19384773|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
19384774|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
19384775|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
19384776|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
19384777|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
19384778|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
19384779|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
19384780|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
19384781|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
19384782|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
19384783|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
19571609|NCT01236560|42019190|FG002|Overall Study|Withdrawal by Subject|1|||
19745722|NCT00071981|42193071|FG001|Overall Study|Adverse Event|4|||
19384784|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
19384785|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
19384786|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
19384787|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
19384788|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
19384789|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
19384790|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
19384791|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
19384792|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
19384793|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
19384794|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
19384795|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
19384796|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
19384797|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
19384798|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
19384799|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
19384800|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
19384801|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
19384802|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
19384803|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
19384804|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
19384805|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
19384806|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
19384807|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
19384808|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
19384809|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
19384810|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
19384811|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
19384812|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
19384813|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
19384814|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
19384815|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
19384816|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
19384817|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
19384818|NCT00700427|41627613|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
19384819|NCT00700427|41627614|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
19384820|NCT00700427|41627615|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
19384821|NCT00700427|41627616|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
19384822|NCT00700427|41627617|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
19384823|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
19384824|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
19384825|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
19384826|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
19384827|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
19384828|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
19384829|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
19384830|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
19384831|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
19384832|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
19384833|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
19384834|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
19384835|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
19384836|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
19745723|NCT00071981|42193072|FG002|Overall Study|Adverse Event|3|||
19384837|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
19384838|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
19384839|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
19384840|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
19384841|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
19384842|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
19384843|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
19384844|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
19384845|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
19384846|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
19384847|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
19384848|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
19384849|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
19384850|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
19384851|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
19384852|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
19384853|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
19384854|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
19384855|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
19384856|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
19384857|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
19384858|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
19384859|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
19384860|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
19384861|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
19384862|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
19384863|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
19384864|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
19384865|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
19384866|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
19384867|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
19384868|NCT00700427|41627613|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
19384869|NCT00700427|41627614|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
19384870|NCT00700427|41627615|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
19384871|NCT00700427|41627616|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
19384872|NCT00700427|41627617|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
19384873|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
19384874|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
19384875|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
19384876|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
19384877|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
19384878|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
19571610|NCT01236560|42019191|FG003|Overall Study|Withdrawal by Subject|2|||
19571611|NCT01236560|42019192|FG004|Overall Study|Withdrawal by Subject|0|||
19571612|NCT01236560|42019193|FG005|Overall Study|Withdrawal by Subject|0|||
19571613|NCT01236560|42019188|FG000|Overall Study|Progressive disease|5|||
19571614|NCT01236560|42019189|FG001|Overall Study|Progressive disease|19|||
19571615|NCT01236560|42019190|FG002|Overall Study|Progressive disease|9|||
19571616|NCT01236560|42019191|FG003|Overall Study|Progressive disease|16|||
19571617|NCT01236560|42019192|FG004|Overall Study|Progressive disease|0|||
19571618|NCT01236560|42019193|FG005|Overall Study|Progressive disease|0|||
19384879|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
19571619|NCT00948766|42019205|FG000|Core Study|Adverse Event|73|||
19384880|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
19384881|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
19384882|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
19384883|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
19384884|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
19384885|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
19384886|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
19384887|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
19384888|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
19384889|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
19384890|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
19384891|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
19384892|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
19384893|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
19384894|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
19384895|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
19384896|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
19384897|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
19384898|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
19384899|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
19384900|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
19384901|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
19384902|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
19384903|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
19384904|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
19384905|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
19384906|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
19384907|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
19384908|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
19384909|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
19384910|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
19384911|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
19384912|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
19384913|NCT00700427|41627613|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
19384914|NCT00700427|41627614|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
19384915|NCT00700427|41627615|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
19384916|NCT00700427|41627616|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
19384917|NCT00700427|41627617|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
19384918|NCT02128763|41627627|FG000|Overall Study|Death|1|||
19384919|NCT02128763|41627628|FG001|Overall Study|Death|0|||
19384920|NCT02128763|41627627|FG000|Overall Study|Lost to Follow-up|19|||
19384921|NCT02128763|41627628|FG001|Overall Study|Lost to Follow-up|16|||
19384922|NCT02124772|41627650|FG000|Overall Study|Lack of Efficacy|2|||
19384923|NCT02124772|41627651|FG001|Overall Study|Lack of Efficacy|0|||
19384924|NCT02124772|41627652|FG002|Overall Study|Lack of Efficacy|0|||
19384925|NCT02124772|41627653|FG003|Overall Study|Lack of Efficacy|1|||
19384926|NCT02124772|41627654|FG004|Overall Study|Lack of Efficacy|2|||
19384927|NCT02124772|41627655|FG005|Overall Study|Lack of Efficacy|3|||
19384928|NCT02124772|41627656|FG006|Overall Study|Lack of Efficacy|0|||
19384929|NCT02124772|41627657|FG007|Overall Study|Lack of Efficacy|2|||
19384930|NCT02124772|41627658|FG008|Overall Study|Lack of Efficacy|0|||
19384931|NCT02124772|41627659|FG009|Overall Study|Lack of Efficacy|1|||
19384932|NCT02124772|41627660|FG010|Overall Study|Lack of Efficacy|0|||
19384933|NCT02124772|41627661|FG011|Overall Study|Lack of Efficacy|0|||
19384934|NCT02124772|41627662|FG012|Overall Study|Lack of Efficacy|1|||
19384935|NCT02124772|41627650|FG000|Overall Study|Adverse Event|1|||
19384936|NCT02124772|41627651|FG001|Overall Study|Adverse Event|4|||
19384937|NCT02124772|41627652|FG002|Overall Study|Adverse Event|1|||
19384938|NCT02124772|41627653|FG003|Overall Study|Adverse Event|5|||
19384939|NCT02124772|41627654|FG004|Overall Study|Adverse Event|2|||
19384940|NCT02124772|41627655|FG005|Overall Study|Adverse Event|1|||
19384941|NCT02124772|41627656|FG006|Overall Study|Adverse Event|1|||
19384942|NCT02124772|41627657|FG007|Overall Study|Adverse Event|5|||
19384943|NCT02124772|41627658|FG008|Overall Study|Adverse Event|0|||
19384944|NCT02124772|41627659|FG009|Overall Study|Adverse Event|3|||
19384945|NCT02124772|41627660|FG010|Overall Study|Adverse Event|1|||
19384946|NCT02124772|41627661|FG011|Overall Study|Adverse Event|3|||
19384947|NCT02124772|41627662|FG012|Overall Study|Adverse Event|1|||
19384948|NCT02124772|41627650|FG000|Overall Study|Withdrawal consent|0|||
19384949|NCT02124772|41627651|FG001|Overall Study|Withdrawal consent|1|||
19384950|NCT02124772|41627652|FG002|Overall Study|Withdrawal consent|1|||
19384951|NCT02124772|41627653|FG003|Overall Study|Withdrawal consent|1|||
19384952|NCT02124772|41627654|FG004|Overall Study|Withdrawal consent|0|||
19384953|NCT02124772|41627655|FG005|Overall Study|Withdrawal consent|1|||
19384954|NCT02124772|41627656|FG006|Overall Study|Withdrawal consent|1|||
19384955|NCT02124772|41627657|FG007|Overall Study|Withdrawal consent|0|||
19384956|NCT02124772|41627658|FG008|Overall Study|Withdrawal consent|0|||
19384957|NCT02124772|41627659|FG009|Overall Study|Withdrawal consent|1|||
19384958|NCT02124772|41627660|FG010|Overall Study|Withdrawal consent|0|||
19384959|NCT02124772|41627661|FG011|Overall Study|Withdrawal consent|1|||
19384960|NCT02124772|41627662|FG012|Overall Study|Withdrawal consent|0|||
19384961|NCT02124772|41627650|FG000|Overall Study|Investigator discretion|0|||
19384962|NCT02124772|41627651|FG001|Overall Study|Investigator discretion|2|||
19384963|NCT02124772|41627652|FG002|Overall Study|Investigator discretion|2|||
19384964|NCT02124772|41627653|FG003|Overall Study|Investigator discretion|1|||
19384965|NCT02124772|41627654|FG004|Overall Study|Investigator discretion|1|||
19384966|NCT02124772|41627655|FG005|Overall Study|Investigator discretion|0|||
19384967|NCT02124772|41627656|FG006|Overall Study|Investigator discretion|1|||
19384968|NCT02124772|41627657|FG007|Overall Study|Investigator discretion|0|||
19384969|NCT02124772|41627658|FG008|Overall Study|Investigator discretion|0|||
19384970|NCT02124772|41627659|FG009|Overall Study|Investigator discretion|1|||
19384971|NCT02124772|41627660|FG010|Overall Study|Investigator discretion|0|||
19384972|NCT02124772|41627661|FG011|Overall Study|Investigator discretion|1|||
19384973|NCT02124772|41627662|FG012|Overall Study|Investigator discretion|0|||
19384974|NCT02124772|41627650|FG000|Overall Study|Progressive disease|0|||
19384975|NCT02124772|41627651|FG001|Overall Study|Progressive disease|0|||
19384976|NCT02124772|41627652|FG002|Overall Study|Progressive disease|0|||
19384977|NCT02124772|41627653|FG003|Overall Study|Progressive disease|0|||
19384978|NCT02124772|41627654|FG004|Overall Study|Progressive disease|0|||
19384979|NCT02124772|41627655|FG005|Overall Study|Progressive disease|0|||
19384980|NCT02124772|41627656|FG006|Overall Study|Progressive disease|1|||
19384981|NCT02124772|41627657|FG007|Overall Study|Progressive disease|1|||
19384982|NCT02124772|41627658|FG008|Overall Study|Progressive disease|0|||
19384983|NCT02124772|41627659|FG009|Overall Study|Progressive disease|0|||
19384984|NCT02124772|41627660|FG010|Overall Study|Progressive disease|0|||
19384985|NCT02124772|41627661|FG011|Overall Study|Progressive disease|0|||
19384986|NCT02124772|41627662|FG012|Overall Study|Progressive disease|0|||
19384987|NCT02124772|41627650|FG000|Overall Study|Other|0|||
19384988|NCT02124772|41627651|FG001|Overall Study|Other|7|||
19384989|NCT02124772|41627652|FG002|Overall Study|Other|2|||
19384990|NCT02124772|41627653|FG003|Overall Study|Other|5|||
19384991|NCT02124772|41627654|FG004|Overall Study|Other|4|||
19384992|NCT02124772|41627655|FG005|Overall Study|Other|3|||
19476929|NCT01569295|41755233|FG000|Overall Study|Withdrawal by Subject|25|||
19384993|NCT02124772|41627656|FG006|Overall Study|Other|4|||
19384994|NCT02124772|41627657|FG007|Overall Study|Other|1|||
19384995|NCT02124772|41627658|FG008|Overall Study|Other|1|||
19384996|NCT02124772|41627659|FG009|Overall Study|Other|1|||
19384997|NCT02124772|41627660|FG010|Overall Study|Other|1|||
19384998|NCT02124772|41627661|FG011|Overall Study|Other|1|||
19384999|NCT02124772|41627662|FG012|Overall Study|Other|0|||
19639235|NCT00719264|42088643|FG001|Overall Study|Administrative Problems|4|||
19639236|NCT00719264|42088642|FG000|Overall Study|Lost to Follow-up|1|||
19639237|NCT00719264|42088643|FG001|Overall Study|Lost to Follow-up|1|||
19639238|NCT00719264|42088642|FG000|Overall Study|Withdrawal by Subject|12|||
19571620|NCT00948766|42019206|FG001|Core Study|Adverse Event|51|||
19571621|NCT00948766|42019205|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
19571622|NCT00948766|42019206|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
19571623|NCT00948766|42019205|FG000|Core Study|Patient Withdrew Consent|27|||
19571624|NCT00948766|42019206|FG001|Core Study|Patient Withdrew Consent|46|||
19571625|NCT00948766|42019205|FG000|Core Study|Lost to Follow-up|3|||
19571626|NCT00948766|42019206|FG001|Core Study|Lost to Follow-up|2|||
19571627|NCT00948766|42019205|FG000|Core Study|Administrative Problems|2|||
19571628|NCT00948766|42019206|FG001|Core Study|Administrative Problems|2|||
19571629|NCT00948766|42019205|FG000|Core Study|Death|1|||
19571630|NCT00948766|42019206|FG001|Core Study|Death|1|||
19571631|NCT00948766|42019205|FG000|Core Study|Protocol Deviation|8|||
19571632|NCT00948766|42019206|FG001|Core Study|Protocol Deviation|10|||
19571633|NCT00948766|42019205|FG000|Extension Study|Adverse Event|43|||
19571634|NCT00948766|42019206|FG001|Extension Study|Adverse Event|0|||
19571635|NCT00948766|42019205|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
19571636|NCT00948766|42019206|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
19571637|NCT00948766|42019205|FG000|Extension Study|Study Drug No Longer Required|1|||
19571638|NCT00948766|42019206|FG001|Extension Study|Study Drug No Longer Required|0|||
19571639|NCT00948766|42019205|FG000|Extension Study|Patient Withdrew Consent|32|||
19571640|NCT00948766|42019206|FG001|Extension Study|Patient Withdrew Consent|0|||
19571641|NCT00948766|42019205|FG000|Extension Study|Lost to Follow-up|8|||
19571642|NCT00948766|42019206|FG001|Extension Study|Lost to Follow-up|0|||
19571643|NCT00948766|42019205|FG000|Extension Study|Administrative Problems|1|||
19571644|NCT00948766|42019206|FG001|Extension Study|Administrative Problems|0|||
19571645|NCT00948766|42019205|FG000|Extension Study|Death|4|||
19571646|NCT00948766|42019206|FG001|Extension Study|Death|0|||
19571647|NCT01053663|42019216|FG000|Overall Study|Death|2|||
19571648|NCT01053663|42019216|FG000|Overall Study|Lost to Follow-up|1|||
19571649|NCT01053663|42019216|FG000|Overall Study|Poor IV Access|1|||
19571650|NCT01053663|42019216|FG000|Overall Study|Transferred to Another Hospital|1|||
19571651|NCT01053663|42019216|FG000|Overall Study|Negative Influenza Diagnosis|1|||
19571652|NCT01235546|42019228|FG000|Overall Study|Staff error, medication not administered|1|||
19571653|NCT01235546|42019229|FG001|Overall Study|Staff error, medication not administered|0|||
19571654|NCT01235546|42019228|FG000|Overall Study|Protocol Violation|1|||
19571655|NCT01235546|42019229|FG001|Overall Study|Protocol Violation|1|||
19571656|NCT01053429|42019244|FG000|Overall Study|Adverse Event|64|||
19571657|NCT01053429|42019244|FG000|Overall Study|Other|309|||
19571658|NCT01233284|42019248|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
19385004|NCT02159482|41627723|FG000|Overall Study|Withdrawal by Subject|2|||
19385005|NCT02159482|41627723|FG000|Overall Study|Physician Decision|3|||
19385006|NCT02622321|41627731|FG000|Overall Study|Withdrawal by Subject|2|||
19571659|NCT01233284|42019249|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19571660|NCT01233284|42019250|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19571661|NCT01233284|42019251|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19571662|NCT01233284|42019252|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19385007|NCT02622321|41627732|FG001|Overall Study|Withdrawal by Subject|0|||
19385008|NCT02622321|41627733|FG002|Overall Study|Withdrawal by Subject|0|||
19385009|NCT02622321|41627734|FG003|Overall Study|Withdrawal by Subject|0|||
19385010|NCT02622321|41627731|FG000|Overall Study|Death|0|||
19385011|NCT02622321|41627732|FG001|Overall Study|Death|0|||
19385012|NCT02622321|41627733|FG002|Overall Study|Death|1|||
19385013|NCT02622321|41627734|FG003|Overall Study|Death|0|||
19385014|NCT02622321|41627731|FG000|Overall Study|Physician Decision|1|||
19385015|NCT02622321|41627732|FG001|Overall Study|Physician Decision|0|||
19385016|NCT02622321|41627733|FG002|Overall Study|Physician Decision|0|||
19385017|NCT02622321|41627734|FG003|Overall Study|Physician Decision|0|||
19385018|NCT02187172|41627760|FG000|Overall Study|Lost to Follow-up|1|||
19385019|NCT02187172|41627761|FG001|Overall Study|Lost to Follow-up|2|||
19385020|NCT02187172|41627760|FG000|Overall Study|Lack of Efficacy|1|||
19385021|NCT02187172|41627761|FG001|Overall Study|Lack of Efficacy|2|||
19385022|NCT02187172|41627760|FG000|Overall Study|Adverse Event|0|||
19385023|NCT02187172|41627761|FG001|Overall Study|Adverse Event|1|||
19385024|NCT02187172|41627760|FG000|Overall Study|Physician Decision|1|||
19385025|NCT02187172|41627761|FG001|Overall Study|Physician Decision|1|||
19385026|NCT02621931|41627772|FG000|Overall Study|Death|0|||
19385027|NCT02621931|41627773|FG001|Overall Study|Death|1|||
19385028|NCT02621931|41627774|FG002|Overall Study|Death|0|||
19385029|NCT02621931|41627772|FG000|Overall Study|Adverse Event|8|||
19385030|NCT02621931|41627773|FG001|Overall Study|Adverse Event|5|||
19385031|NCT02621931|41627774|FG002|Overall Study|Adverse Event|7|||
19385032|NCT02621931|41627772|FG000|Overall Study|Withdrawal by Subject|12|||
19385033|NCT02621931|41627773|FG001|Overall Study|Withdrawal by Subject|10|||
19385034|NCT02621931|41627774|FG002|Overall Study|Withdrawal by Subject|11|||
19385035|NCT02621931|41627772|FG000|Overall Study|Protocol Violation|2|||
19385036|NCT02621931|41627773|FG001|Overall Study|Protocol Violation|2|||
19385037|NCT02621931|41627774|FG002|Overall Study|Protocol Violation|2|||
19385038|NCT02621931|41627772|FG000|Overall Study|Pregnancy|2|||
19385039|NCT02621931|41627773|FG001|Overall Study|Pregnancy|0|||
19385040|NCT02621931|41627774|FG002|Overall Study|Pregnancy|0|||
19385041|NCT02621931|41627772|FG000|Overall Study|Noncompliance to study procedures|0|||
19385042|NCT02621931|41627773|FG001|Overall Study|Noncompliance to study procedures|1|||
19385043|NCT02621931|41627774|FG002|Overall Study|Noncompliance to study procedures|2|||
19385044|NCT02621931|41627772|FG000|Overall Study|Lost to Follow-up|8|||
19385045|NCT02621931|41627773|FG001|Overall Study|Lost to Follow-up|7|||
19385046|NCT02621931|41627774|FG002|Overall Study|Lost to Follow-up|10|||
19385047|NCT02621931|41627772|FG000|Overall Study|Lack of Efficacy|0|||
19385048|NCT02621931|41627773|FG001|Overall Study|Lack of Efficacy|0|||
19385049|NCT02621931|41627774|FG002|Overall Study|Lack of Efficacy|1|||
19385050|NCT02621931|41627772|FG000|Overall Study|Other|1|||
19385051|NCT02621931|41627773|FG001|Overall Study|Other|1|||
19385052|NCT02621931|41627774|FG002|Overall Study|Other|3|||
19385053|NCT02621073|41627786|FG000|Overall Study|Lost to Follow-up|0|||
19385054|NCT02621073|41627787|FG001|Overall Study|Lost to Follow-up|1|||
19385055|NCT02621073|41627786|FG000|Overall Study|Physician Decision|3|||
19385056|NCT02621073|41627787|FG001|Overall Study|Physician Decision|2|||
19385057|NCT02158936|41627795|FG000|Overall Study|Study closed/ terminated|57|||
19385058|NCT02158936|41627796|FG001|Overall Study|Study closed/ terminated|77|||
19385059|NCT02158936|41627795|FG000|Overall Study|Azacitidine tx discontinued|53|||
19385060|NCT02158936|41627796|FG001|Overall Study|Azacitidine tx discontinued|46|||
19385061|NCT02158936|41627795|FG000|Overall Study|Adverse Event|39|||
19385062|NCT02158936|41627796|FG001|Overall Study|Adverse Event|24|||
19385063|NCT02158936|41627795|FG000|Overall Study|Withdrawal by Subject|15|||
19385064|NCT02158936|41627796|FG001|Overall Study|Withdrawal by Subject|16|||
19385065|NCT02158936|41627795|FG000|Overall Study|Physician Decision|15|||
19385066|NCT02158936|41627796|FG001|Overall Study|Physician Decision|13|||
19385067|NCT02158936|41627795|FG000|Overall Study|Lost to Follow-up|0|||
19385068|NCT02158936|41627796|FG001|Overall Study|Lost to Follow-up|1|||
19385069|NCT02158546|41627806|FG000|Overall Study|Physician Decision|0|||
19385070|NCT02158546|41627807|FG001|Overall Study|Physician Decision|1|||
19385071|NCT02158546|41627808|FG002|Overall Study|Physician Decision|0|||
19385072|NCT02158546|41627809|FG003|Overall Study|Physician Decision|0|||
19385073|NCT02158546|41627806|FG000|Overall Study|Non-compliance|0|||
19385074|NCT02158546|41627807|FG001|Overall Study|Non-compliance|1|||
19385075|NCT02158546|41627808|FG002|Overall Study|Non-compliance|0|||
19385076|NCT02158546|41627809|FG003|Overall Study|Non-compliance|1|||
19385077|NCT02158546|41627806|FG000|Overall Study|Failure to meet eligibility criteria|0|||
19385078|NCT02158546|41627807|FG001|Overall Study|Failure to meet eligibility criteria|1|||
19385079|NCT02158546|41627808|FG002|Overall Study|Failure to meet eligibility criteria|0|||
19385080|NCT02158546|41627809|FG003|Overall Study|Failure to meet eligibility criteria|0|||
19385081|NCT02158546|41627806|FG000|Overall Study|Lack of Efficacy|1|||
19385082|NCT02158546|41627807|FG001|Overall Study|Lack of Efficacy|1|||
19385083|NCT02158546|41627808|FG002|Overall Study|Lack of Efficacy|0|||
19385084|NCT02158546|41627809|FG003|Overall Study|Lack of Efficacy|0|||
19385085|NCT02158546|41627806|FG000|Overall Study|Adverse Event|2|||
19385086|NCT02158546|41627807|FG001|Overall Study|Adverse Event|2|||
19385087|NCT02158546|41627808|FG002|Overall Study|Adverse Event|0|||
19385088|NCT02158546|41627809|FG003|Overall Study|Adverse Event|0|||
19385089|NCT02158546|41627806|FG000|Overall Study|Withdrawal by Subject|6|||
19385090|NCT02158546|41627807|FG001|Overall Study|Withdrawal by Subject|2|||
19385091|NCT02158546|41627808|FG002|Overall Study|Withdrawal by Subject|1|||
19385092|NCT02158546|41627809|FG003|Overall Study|Withdrawal by Subject|0|||
19385093|NCT02158546|41627806|FG000|Overall Study|Lost to Follow-up|5|||
19385094|NCT02158546|41627807|FG001|Overall Study|Lost to Follow-up|4|||
19385095|NCT02158546|41627808|FG002|Overall Study|Lost to Follow-up|0|||
19385096|NCT02158546|41627809|FG003|Overall Study|Lost to Follow-up|1|||
19385097|NCT02158546|41627806|FG000|Overall Study|Site Excluded|5|||
19385098|NCT02158546|41627807|FG001|Overall Study|Site Excluded|5|||
19385099|NCT02158546|41627808|FG002|Overall Study|Site Excluded|3|||
19385100|NCT02158546|41627809|FG003|Overall Study|Site Excluded|4|||
19385101|NCT02123446|41627819|FG000|Washout Period (1 Day)|Physician Decision|1|||
19385102|NCT02123446|41627820|FG001|Washout Period (1 Day)|Physician Decision|0|||
19385103|NCT02123134|41627828|FG000|Overall Study|Withdrawal of consent|3|||
19385104|NCT02123134|41627829|FG001|Overall Study|Withdrawal of consent|2|||
19385105|NCT02123134|41627828|FG000|Overall Study|Administrative decision|0|||
19385106|NCT02123134|41627829|FG001|Overall Study|Administrative decision|1|||
19385107|NCT02185534|41627841|FG000|First Period|Withdrawal by Subject|0|||
19385108|NCT02185534|41627842|FG001|First Period|Withdrawal by Subject|0|||
19385109|NCT02185534|41627843|FG002|First Period|Withdrawal by Subject|0|||
19385110|NCT02185534|41627844|FG003|First Period|Withdrawal by Subject|1|||
19385111|NCT02185534|41627845|FG004|First Period|Withdrawal by Subject|0|||
19385112|NCT02185534|41627846|FG005|First Period|Withdrawal by Subject|0|||
19385113|NCT02185534|41627841|FG000|First Washout Period|Withdrawal by Subject|1|||
19385114|NCT02185534|41627842|FG001|First Washout Period|Withdrawal by Subject|0|||
19385115|NCT02185534|41627843|FG002|First Washout Period|Withdrawal by Subject|0|||
19385116|NCT02185534|41627844|FG003|First Washout Period|Withdrawal by Subject|0|||
19385117|NCT02185534|41627845|FG004|First Washout Period|Withdrawal by Subject|1|||
19385118|NCT02185534|41627846|FG005|First Washout Period|Withdrawal by Subject|0|||
19385119|NCT02185534|41627841|FG000|First Washout Period|Protocol Violation|0|||
19385120|NCT02185534|41627842|FG001|First Washout Period|Protocol Violation|0|||
19385121|NCT02185534|41627843|FG002|First Washout Period|Protocol Violation|0|||
19385122|NCT02185534|41627844|FG003|First Washout Period|Protocol Violation|0|||
19385123|NCT02185534|41627845|FG004|First Washout Period|Protocol Violation|0|||
19385124|NCT02185534|41627846|FG005|First Washout Period|Protocol Violation|1|||
19385125|NCT02121808|41627855|FG000|Overall Study|Technical problem|3|||
19385126|NCT02157376|41627866|FG000|Overall Study|Death|10|||
19385127|NCT02157376|41627867|FG001|Overall Study|Death|4|||
19385128|NCT02157376|41627866|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19385129|NCT02157376|41627867|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19385130|NCT02157376|41627866|FG000|Overall Study|Withdrawal by Subject|3|||
19385131|NCT02157376|41627867|FG001|Overall Study|Withdrawal by Subject|8|||
19385132|NCT02157376|41627866|FG000|Overall Study|Not treated|8|||
19385133|NCT02157376|41627867|FG001|Overall Study|Not treated|3|||
19385134|NCT02157376|41627866|FG000|Overall Study|Investigator's misjudgement|1|||
19385135|NCT02157376|41627867|FG001|Overall Study|Investigator's misjudgement|2|||
19385136|NCT02157298|41627875|FG000|Overall Study|Adverse Event|1|||
19385137|NCT02157298|41627876|FG001|Overall Study|Adverse Event|0|||
19385138|NCT02157298|41627875|FG000|Overall Study|Subject no longer meets study criteria|1|||
19385139|NCT02157298|41627876|FG001|Overall Study|Subject no longer meets study criteria|2|||
19385140|NCT02157298|41627875|FG000|Overall Study|Poor/Non-compliance|1|||
19385141|NCT02157298|41627876|FG001|Overall Study|Poor/Non-compliance|0|||
19745724|NCT00071981|42193073|FG003|Overall Study|Adverse Event|1|||
19385142|NCT02157298|41627875|FG000|Overall Study|Withdrawal by Subject|1|||
19385143|NCT02157298|41627876|FG001|Overall Study|Withdrawal by Subject|0|||
19385144|NCT02184988|41627882|FG000|Overall Study|Pregnancy|2|||
19385145|NCT02184988|41627882|FG000|Overall Study|Adverse Event|2|||
19385146|NCT02184988|41627882|FG000|Overall Study|moving away/travelling/unable to complet|6|||
19385147|NCT02184988|41627882|FG000|Overall Study|work scheduling issues|4|||
19385148|NCT02184988|41627882|FG000|Overall Study|various other reasons|9|||
19385149|NCT02184988|41627882|FG000|Overall Study|Lost to Follow-up|32|||
19385150|NCT02121262|41627888|FG000|Overall Study|Adverse Event|6|||
19385151|NCT02121262|41627889|FG001|Overall Study|Adverse Event|3|||
19385152|NCT02121262|41627888|FG000|Overall Study|Lack of Efficacy|3|||
19385153|NCT02121262|41627889|FG001|Overall Study|Lack of Efficacy|0|||
19385154|NCT02121262|41627888|FG000|Overall Study|Personal Reasons|19|||
19385155|NCT02121262|41627889|FG001|Overall Study|Personal Reasons|5|||
19385156|NCT02121262|41627888|FG000|Overall Study|Protocol Violation|1|||
19385157|NCT02121262|41627889|FG001|Overall Study|Protocol Violation|1|||
19385158|NCT02121262|41627888|FG000|Overall Study|Participant Dropped-out|0|||
19385159|NCT02121262|41627889|FG001|Overall Study|Participant Dropped-out|1|||
19385160|NCT02121262|41627888|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
19385161|NCT02121262|41627889|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
19385162|NCT02121262|41627888|FG000|Overall Study|Consent Withdrawn|1|||
19385163|NCT02121262|41627889|FG001|Overall Study|Consent Withdrawn|0|||
19385164|NCT02120950|41627897|FG000|Overall Study|Adverse Event|5|||
19385165|NCT02120950|41627898|FG001|Overall Study|Adverse Event|4|||
19385166|NCT02120950|41627899|FG002|Overall Study|Adverse Event|3|||
19385167|NCT02120950|41627897|FG000|Overall Study|Death|3|||
19385168|NCT02120950|41627898|FG001|Overall Study|Death|0|||
19385169|NCT02120950|41627899|FG002|Overall Study|Death|1|||
19385170|NCT02120950|41627897|FG000|Overall Study|Withdrawal by Subject|6|||
19385171|NCT02120950|41627898|FG001|Overall Study|Withdrawal by Subject|3|||
19385172|NCT02120950|41627899|FG002|Overall Study|Withdrawal by Subject|2|||
19385173|NCT02120950|41627897|FG000|Overall Study|Protocol Violation|1|||
19385174|NCT02120950|41627898|FG001|Overall Study|Protocol Violation|1|||
19385175|NCT02120950|41627899|FG002|Overall Study|Protocol Violation|7|||
19385176|NCT02120950|41627897|FG000|Overall Study|Other reasons|5|||
19385177|NCT02120950|41627898|FG001|Overall Study|Other reasons|4|||
19385178|NCT02120950|41627899|FG002|Overall Study|Other reasons|1|||
19385179|NCT02120950|41627897|FG000|Overall Study|Lost to Follow-up|0|||
19385180|NCT02120950|41627898|FG001|Overall Study|Lost to Follow-up|2|||
19385181|NCT02120950|41627899|FG002|Overall Study|Lost to Follow-up|1|||
19385182|NCT02120794|41627906|FG000|Overall Study|Withdrawal by Subject|43|||
19385183|NCT02120794|41627906|FG000|Overall Study|Adverse Event|10|||
19385184|NCT02120794|41627906|FG000|Overall Study|Physician Decision|4|||
19385185|NCT02120794|41627906|FG000|Overall Study|Due to insurance coverage|1|||
19385186|NCT02184442|41627912|FG000|Overall Study|Death|61|||
19385187|NCT02184442|41627913|FG001|Overall Study|Death|65|||
19385188|NCT02184442|41627912|FG000|Overall Study|Withdrawal by Subject|3|||
19385189|NCT02184442|41627913|FG001|Overall Study|Withdrawal by Subject|11|||
19385190|NCT02155738|41627923|FG000|Overall Study|Missing critical information|1|||
19385191|NCT02155738|41627924|FG001|Overall Study|Missing critical information|0|||
19385192|NCT02155738|41627925|FG002|Overall Study|Missing critical information|0|||
19385193|NCT02155738|41627926|FG003|Overall Study|Missing critical information|1|||
19385194|NCT02181790|41627938|FG000|Overall Study|study terminated|2|||
19385195|NCT02181790|41627939|FG001|Overall Study|study terminated|0|||
19385196|NCT02618967|41627955|FG000|Overall Study|Lost to Follow-up|0|||
19385197|NCT02618967|41627956|FG001|Overall Study|Lost to Follow-up|0|||
19385198|NCT02618967|41627957|FG002|Overall Study|Lost to Follow-up|1|||
19385199|NCT02618967|41627958|FG003|Overall Study|Lost to Follow-up|0|||
19385200|NCT02618967|41627959|FG004|Overall Study|Lost to Follow-up|2|||
19385201|NCT02618967|41627960|FG005|Overall Study|Lost to Follow-up|0|||
19385202|NCT02618967|41627961|FG006|Overall Study|Lost to Follow-up|0|||
19385203|NCT02618967|41627962|FG007|Overall Study|Lost to Follow-up|0|||
19385204|NCT02618967|41627955|FG000|Overall Study|Withdrawal by Subject|1|||
19385205|NCT02618967|41627956|FG001|Overall Study|Withdrawal by Subject|0|||
19385206|NCT02618967|41627957|FG002|Overall Study|Withdrawal by Subject|0|||
19385207|NCT02618967|41627958|FG003|Overall Study|Withdrawal by Subject|0|||
19385208|NCT02618967|41627959|FG004|Overall Study|Withdrawal by Subject|0|||
19385209|NCT02618967|41627960|FG005|Overall Study|Withdrawal by Subject|0|||
19385210|NCT02618967|41627961|FG006|Overall Study|Withdrawal by Subject|0|||
19385211|NCT02618967|41627962|FG007|Overall Study|Withdrawal by Subject|0|||
19385212|NCT02616783|41627982|FG000|Overall Study|Randomized but Not Treated|1|||
19385213|NCT02616783|41627983|FG001|Overall Study|Randomized but Not Treated|0|||
19385214|NCT02616783|41627982|FG000|Overall Study|Adverse Event|1|||
19385215|NCT02616783|41627983|FG001|Overall Study|Adverse Event|0|||
19385216|NCT02616783|41627982|FG000|Overall Study|Death|1|||
19385217|NCT02616783|41627983|FG001|Overall Study|Death|0|||
19385218|NCT02616783|41627982|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19385219|NCT02616783|41627983|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19385220|NCT02616783|41627982|FG000|Overall Study|Protocol Violation|1|||
19385221|NCT02616783|41627983|FG001|Overall Study|Protocol Violation|1|||
19385222|NCT02616783|41627982|FG000|Overall Study|Withdrew Consent|1|||
19385223|NCT02616783|41627983|FG001|Overall Study|Withdrew Consent|1|||
19385224|NCT02616393|41627992|FG000|Overall Study|Death|5|||
19385225|NCT02616393|41627993|FG001|Overall Study|Death|12|||
19385226|NCT02616393|41627994|FG002|Overall Study|Death|1|||
19385227|NCT02616393|41627992|FG000|Overall Study|Termination by Sponsor|4|||
19385228|NCT02616393|41627993|FG001|Overall Study|Termination by Sponsor|5|||
19385229|NCT02616393|41627994|FG002|Overall Study|Termination by Sponsor|2|||
19385230|NCT02616393|41627992|FG000|Overall Study|Other|3|||
19385231|NCT02616393|41627993|FG001|Overall Study|Other|0|||
19385232|NCT02616393|41627994|FG002|Overall Study|Other|0|||
19571663|NCT01233284|42019248|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19385233|NCT02616393|41627992|FG000|Overall Study|Withdrawal by Subject|1|||
19385234|NCT02616393|41627993|FG001|Overall Study|Withdrawal by Subject|1|||
19385235|NCT02616393|41627994|FG002|Overall Study|Withdrawal by Subject|0|||
19385236|NCT02616393|41627992|FG000|Overall Study|Lost to Follow-up|0|||
19385237|NCT02616393|41627993|FG001|Overall Study|Lost to Follow-up|2|||
19385238|NCT02616393|41627994|FG002|Overall Study|Lost to Follow-up|0|||
19385239|NCT02155660|41628022|FG000|Overall Study|Other Reason|8|||
19385240|NCT02155660|41628023|FG001|Overall Study|Other Reason|6|||
19385241|NCT02155660|41628024|FG002|Overall Study|Other Reason|10|||
19385242|NCT02155660|41628025|FG003|Overall Study|Other Reason|10|||
19385243|NCT02155660|41628022|FG000|Overall Study|Study-specific withdrawal criteria|0|||
19385244|NCT02155660|41628023|FG001|Overall Study|Study-specific withdrawal criteria|1|||
19385245|NCT02155660|41628024|FG002|Overall Study|Study-specific withdrawal criteria|1|||
19385246|NCT02155660|41628025|FG003|Overall Study|Study-specific withdrawal criteria|1|||
19385247|NCT02155660|41628022|FG000|Overall Study|Severe non-compliance|0|||
19385248|NCT02155660|41628023|FG001|Overall Study|Severe non-compliance|4|||
19385249|NCT02155660|41628024|FG002|Overall Study|Severe non-compliance|0|||
19385250|NCT02155660|41628025|FG003|Overall Study|Severe non-compliance|1|||
19385251|NCT02155660|41628022|FG000|Overall Study|Adverse Event|2|||
19385252|NCT02155660|41628023|FG001|Overall Study|Adverse Event|6|||
19385253|NCT02155660|41628024|FG002|Overall Study|Adverse Event|3|||
19385254|NCT02155660|41628025|FG003|Overall Study|Adverse Event|1|||
19385255|NCT02155660|41628022|FG000|Overall Study|Lost to Follow-up|3|||
19385256|NCT02155660|41628023|FG001|Overall Study|Lost to Follow-up|6|||
19385257|NCT02155660|41628024|FG002|Overall Study|Lost to Follow-up|5|||
19385258|NCT02155660|41628025|FG003|Overall Study|Lost to Follow-up|8|||
19385259|NCT02155660|41628022|FG000|Overall Study|Death|17|||
19385260|NCT02155660|41628023|FG001|Overall Study|Death|19|||
19385261|NCT02155660|41628024|FG002|Overall Study|Death|17|||
19385262|NCT02155660|41628025|FG003|Overall Study|Death|19|||
19385263|NCT02155660|41628022|FG000|Overall Study|Withdrawal by Subject|28|||
19385264|NCT02155660|41628023|FG001|Overall Study|Withdrawal by Subject|31|||
19385265|NCT02155660|41628024|FG002|Overall Study|Withdrawal by Subject|24|||
19385266|NCT02155660|41628025|FG003|Overall Study|Withdrawal by Subject|21|||
19385267|NCT02119936|41628035|FG000|Overall Study|Lost to Follow-up|10|||
19385268|NCT02181634|41628039|FG000|Overall Study|Lack of Efficacy|33|||
19385269|NCT02181634|41628039|FG000|Overall Study|Adverse Event|17|||
19385270|NCT02181634|41628039|FG000|Overall Study|Physician Decision|8|||
19385271|NCT02181634|41628039|FG000|Overall Study|Withdrawal by Subject|5|||
19385272|NCT02181634|41628039|FG000|Overall Study|Death|2|||
19385273|NCT02181634|41628039|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
19385274|NCT02181634|41628039|FG000|Overall Study|Ineligible|1|||
19385275|NCT02181634|41628039|FG000|Overall Study|Max number of dose reduction|1|||
19385276|NCT02181634|41628039|FG000|Overall Study|Symptomatic progression|1|||
19385277|NCT02181634|41628039|FG000|Overall Study|Patient opted to proceed to surgery|1|||
19385278|NCT01595529|41628045|FG000|Overall Study|Adverse Event|2|||
19385279|NCT01595529|41628046|FG001|Overall Study|Adverse Event|0|||
19385280|NCT01595529|41628045|FG000|Overall Study|Subject Non-Compliant|2|||
19385281|NCT01595529|41628046|FG001|Overall Study|Subject Non-Compliant|0|||
19385282|NCT01595529|41628045|FG000|Overall Study|Lost to Follow-up|8|||
19385283|NCT01595529|41628046|FG001|Overall Study|Lost to Follow-up|14|||
19385284|NCT01595529|41628045|FG000|Overall Study|Protocol Violation|1|||
19385285|NCT01595529|41628046|FG001|Overall Study|Protocol Violation|2|||
19385286|NCT01595529|41628045|FG000|Overall Study|Physician Decision|1|||
19385287|NCT01595529|41628046|FG001|Overall Study|Physician Decision|0|||
19385288|NCT01595529|41628045|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
19385289|NCT01595529|41628046|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
19385290|NCT01595529|41628045|FG000|Overall Study|Administrative Decision|1|||
19385291|NCT01595529|41628046|FG001|Overall Study|Administrative Decision|0|||
19385292|NCT01595529|41628045|FG000|Overall Study|Entry Failure/Screening Failure|6|||
19385293|NCT01595529|41628046|FG001|Overall Study|Entry Failure/Screening Failure|1|||
19385294|NCT02615145|41628055|FG000|Overall Study|Did Not Start Treatment|0|||
19385295|NCT02615145|41628056|FG001|Overall Study|Did Not Start Treatment|0|||
19385296|NCT02615145|41628057|FG002|Overall Study|Did Not Start Treatment|1|||
19385297|NCT02615145|41628058|FG003|Overall Study|Did Not Start Treatment|1|||
19385298|NCT02615145|41628055|FG000|Overall Study|Failure to Return|20|||
19385299|NCT02615145|41628056|FG001|Overall Study|Failure to Return|10|||
19385300|NCT02615145|41628057|FG002|Overall Study|Failure to Return|7|||
19385301|NCT02615145|41628058|FG003|Overall Study|Failure to Return|0|||
19385302|NCT02615145|41628055|FG000|Overall Study|Death|2|||
19385303|NCT02615145|41628056|FG001|Overall Study|Death|3|||
19385304|NCT02615145|41628057|FG002|Overall Study|Death|0|||
19385305|NCT02615145|41628058|FG003|Overall Study|Death|0|||
19385306|NCT02615145|41628055|FG000|Overall Study|Other, Not Specified|5|||
19385307|NCT02615145|41628056|FG001|Overall Study|Other, Not Specified|2|||
19385308|NCT02615145|41628057|FG002|Overall Study|Other, Not Specified|0|||
19385309|NCT02615145|41628058|FG003|Overall Study|Other, Not Specified|0|||
19385310|NCT02119156|41628087|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
19385311|NCT02119156|41628088|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
19385312|NCT02119156|41628089|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
19385313|NCT02119156|41628087|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
19385314|NCT02119156|41628088|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
19385315|NCT02119156|41628089|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
19385316|NCT02119156|41628087|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
19385317|NCT02119156|41628088|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
19385318|NCT02119156|41628089|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
19385319|NCT02119156|41628087|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
19385320|NCT02119156|41628088|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
19385321|NCT02119156|41628089|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
19385322|NCT02119156|41628087|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
19385323|NCT02119156|41628088|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
19385324|NCT02119156|41628089|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
19385325|NCT02181556|41628104|FG000|Overall Study|Withdrawal by Subject|1|||
19385326|NCT02614131|41628115|FG000|Overall Study|Withdrawal by Subject|1|||
19385327|NCT02614131|41628116|FG001|Overall Study|Withdrawal by Subject|0|||
19385328|NCT02614131|41628117|FG002|Overall Study|Withdrawal by Subject|0|||
19385329|NCT02614131|41628118|FG003|Overall Study|Withdrawal by Subject|0|||
19385330|NCT02614131|41628119|FG004|Overall Study|Withdrawal by Subject|0|||
19385331|NCT02614131|41628120|FG005|Overall Study|Withdrawal by Subject|0|||
19385332|NCT02614131|41628121|FG006|Overall Study|Withdrawal by Subject|0|||
19385333|NCT02614131|41628115|FG000|Overall Study|Adverse Event|0|||
19385334|NCT02614131|41628116|FG001|Overall Study|Adverse Event|0|||
19385335|NCT02614131|41628117|FG002|Overall Study|Adverse Event|0|||
19385336|NCT02614131|41628118|FG003|Overall Study|Adverse Event|0|||
19385337|NCT02614131|41628119|FG004|Overall Study|Adverse Event|0|||
19385338|NCT02614131|41628120|FG005|Overall Study|Adverse Event|0|||
19385339|NCT02614131|41628121|FG006|Overall Study|Adverse Event|1|||
19385340|NCT01903733|41628147|FG000|Overall Study|Death|23|||
19385341|NCT01903733|41628148|FG001|Overall Study|Death|54|||
19385342|NCT01903733|41628149|FG002|Overall Study|Death|30|||
19385343|NCT01903733|41628150|FG003|Overall Study|Death|98|||
19385344|NCT01903733|41628147|FG000|Overall Study|Participant refused further follow-up|35|||
19385345|NCT01903733|41628148|FG001|Overall Study|Participant refused further follow-up|38|||
19385346|NCT01903733|41628149|FG002|Overall Study|Participant refused further follow-up|13|||
19385347|NCT01903733|41628150|FG003|Overall Study|Participant refused further follow-up|9|||
19385348|NCT01903733|41628147|FG000|Overall Study|Lost to Follow-up|18|||
19385349|NCT01903733|41628148|FG001|Overall Study|Lost to Follow-up|19|||
19385350|NCT01903733|41628149|FG002|Overall Study|Lost to Follow-up|6|||
19385351|NCT01903733|41628150|FG003|Overall Study|Lost to Follow-up|9|||
19385352|NCT01903733|41628147|FG000|Overall Study|Other|10|||
19385353|NCT01903733|41628148|FG001|Overall Study|Other|15|||
19385354|NCT01903733|41628149|FG002|Overall Study|Other|12|||
19385355|NCT01903733|41628150|FG003|Overall Study|Other|3|||
19385356|NCT01903733|41628147|FG000|Overall Study|Missing|2|||
19385357|NCT01903733|41628148|FG001|Overall Study|Missing|0|||
19385358|NCT01903733|41628149|FG002|Overall Study|Missing|0|||
19385359|NCT01903733|41628150|FG003|Overall Study|Missing|0|||
19385360|NCT01903733|41628147|FG000|Overall Study|Investigator request|18|||
19385361|NCT01903733|41628148|FG001|Overall Study|Investigator request|0|||
19385362|NCT01903733|41628149|FG002|Overall Study|Investigator request|0|||
19385363|NCT01903733|41628150|FG003|Overall Study|Investigator request|0|||
19385364|NCT01375205|41628172|FG000|Overall Study|Lost to Follow-up|15|||
19385365|NCT01375205|41628173|FG001|Overall Study|Lost to Follow-up|12|||
19385366|NCT01375205|41628172|FG000|Overall Study|Withdrawal by Subject|6|||
19385367|NCT01375205|41628173|FG001|Overall Study|Withdrawal by Subject|1|||
19385368|NCT00700271|41628181|FG000|Overall Study|Adverse Event|4|||
19385369|NCT00700271|41628182|FG001|Overall Study|Adverse Event|6|||
19385370|NCT00700271|41628181|FG000|Overall Study|Protocol Violation|1|||
19385371|NCT00700271|41628182|FG001|Overall Study|Protocol Violation|0|||
19385372|NCT00700271|41628181|FG000|Overall Study|Administrative Reasons|1|||
19385373|NCT00700271|41628182|FG001|Overall Study|Administrative Reasons|0|||
19385374|NCT00700271|41628181|FG000|Overall Study|Withdrawal by Subject|6|||
19385375|NCT00700271|41628182|FG001|Overall Study|Withdrawal by Subject|4|||
19385376|NCT00700271|41628181|FG000|Overall Study|Lost to Follow-up|2|||
19385377|NCT00700271|41628182|FG001|Overall Study|Lost to Follow-up|2|||
19385378|NCT02613507|41628190|FG000|Overall Study|Disease Progression|237|||
19385379|NCT02613507|41628191|FG001|Overall Study|Disease Progression|109|||
19385380|NCT02613507|41628190|FG000|Overall Study|Study Drug Toxicity|15|||
19385381|NCT02613507|41628191|FG001|Overall Study|Study Drug Toxicity|14|||
19385382|NCT02613507|41628190|FG000|Overall Study|Death|3|||
19385383|NCT02613507|41628191|FG001|Overall Study|Death|0|||
19385384|NCT02613507|41628190|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
19385385|NCT02613507|41628191|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
19385386|NCT02613507|41628190|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
19385387|NCT02613507|41628191|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
19385388|NCT02613507|41628190|FG000|Overall Study|Participant Withdrew Consent|0|||
19385389|NCT02613507|41628191|FG001|Overall Study|Participant Withdrew Consent|2|||
19385390|NCT02613507|41628190|FG000|Overall Study|Lost to Follow-up|1|||
19385391|NCT02613507|41628191|FG001|Overall Study|Lost to Follow-up|0|||
19385392|NCT02613507|41628190|FG000|Overall Study|Maximum Clinical Benefit|4|||
19385393|NCT02613507|41628191|FG001|Overall Study|Maximum Clinical Benefit|10|||
19385394|NCT02613507|41628190|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
19385395|NCT02613507|41628191|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
19385396|NCT02613507|41628190|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
19385397|NCT02613507|41628191|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
19385398|NCT02613507|41628190|FG000|Overall Study|Randomized but not Treated|1|||
19385399|NCT02613507|41628191|FG001|Overall Study|Randomized but not Treated|10|||
19385400|NCT01375049|41628197|FG000|Overall Study|Adverse Event|2|||
19385401|NCT01375049|41628197|FG000|Overall Study|Lost to Follow-up|1|||
19385402|NCT01375049|41628197|FG000|Overall Study|Withdrawal by Subject|2|||
19385403|NCT01375049|41628197|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
19385404|NCT01594749|41628207|FG000|Overall Study|Adverse Event|2|||
19385405|NCT01594749|41628208|FG001|Overall Study|Adverse Event|1|||
19385406|NCT01594749|41628207|FG000|Overall Study|Withdrawal by Subject|2|||
19385407|NCT01594749|41628208|FG001|Overall Study|Withdrawal by Subject|2|||
19385408|NCT01594749|41628207|FG000|Overall Study|Protocol Violation|2|||
19385409|NCT01594749|41628208|FG001|Overall Study|Protocol Violation|0|||
19385410|NCT01594749|41628207|FG000|Overall Study|Physician Decision|1|||
19385411|NCT01594749|41628208|FG001|Overall Study|Physician Decision|1|||
19385412|NCT01594749|41628207|FG000|Overall Study|Non-compliance with Protocol|0|||
19385413|NCT01594749|41628208|FG001|Overall Study|Non-compliance with Protocol|1|||
19385414|NCT01594749|41628207|FG000|Overall Study|Lost to Follow-up|1|||
19385415|NCT01594749|41628208|FG001|Overall Study|Lost to Follow-up|0|||
19385416|NCT01594749|41628207|FG000|Overall Study|Death|9|||
19385417|NCT01594749|41628208|FG001|Overall Study|Death|3|||
19385418|NCT01594749|41628207|FG000|Overall Study|Not Treated|4|||
19385419|NCT01594749|41628208|FG001|Overall Study|Not Treated|10|||
19385420|NCT01594749|41628207|FG000|Overall Study|Lost Source Documentation|1|||
19385421|NCT01594749|41628208|FG001|Overall Study|Lost Source Documentation|0|||
19385422|NCT02179918|41628219|FG000|Overall Study|Death|0|||
19385423|NCT02179918|41628220|FG001|Overall Study|Death|0|||
19385424|NCT02179918|41628221|FG002|Overall Study|Death|0|||
19385425|NCT02179918|41628222|FG003|Overall Study|Death|1|||
19385426|NCT02179918|41628223|FG004|Overall Study|Death|0|||
19385427|NCT02179918|41628219|FG000|Overall Study|Lost to Follow-up|0|||
19385428|NCT02179918|41628220|FG001|Overall Study|Lost to Follow-up|0|||
19385429|NCT02179918|41628221|FG002|Overall Study|Lost to Follow-up|1|||
19385430|NCT02179918|41628222|FG003|Overall Study|Lost to Follow-up|0|||
19385431|NCT02179918|41628223|FG004|Overall Study|Lost to Follow-up|0|||
19385432|NCT02179918|41628219|FG000|Overall Study|Progressive Disease|4|||
19385433|NCT02179918|41628220|FG001|Overall Study|Progressive Disease|1|||
19385434|NCT02179918|41628221|FG002|Overall Study|Progressive Disease|1|||
19385435|NCT02179918|41628222|FG003|Overall Study|Progressive Disease|2|||
19385436|NCT02179918|41628223|FG004|Overall Study|Progressive Disease|6|||
19385437|NCT02179918|41628219|FG000|Overall Study|Other|0|||
19385438|NCT02179918|41628220|FG001|Overall Study|Other|1|||
19385439|NCT02179918|41628221|FG002|Overall Study|Other|0|||
19385440|NCT02179918|41628222|FG003|Overall Study|Other|0|||
19385441|NCT02179918|41628223|FG004|Overall Study|Other|1|||
19385442|NCT02179918|41628219|FG000|Overall Study|Subject refused further follow-up|0|||
19385443|NCT02179918|41628220|FG001|Overall Study|Subject refused further follow-up|1|||
19385444|NCT02179918|41628221|FG002|Overall Study|Subject refused further follow-up|0|||
19385445|NCT02179918|41628222|FG003|Overall Study|Subject refused further follow-up|0|||
19385446|NCT02179918|41628223|FG004|Overall Study|Subject refused further follow-up|1|||
19385447|NCT02611479|41628236|FG000|Baseline Enrollment|Exited study|13|||
19385448|NCT02611479|41628236|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
19385449|NCT02611479|41628236|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
19385450|NCT02611479|41628236|FG000|Data Cleaning|No baseline function or pain metrics|2|||
19385451|NCT02153788|41628242|FG000|Overall Study|Physician Decision|2|||
19385452|NCT02153788|41628243|FG001|Overall Study|Physician Decision|1|||
19385453|NCT02153398|41628254|FG000|Overall Study|Withdrawal by Subject|1|||
19385454|NCT02153398|41628255|FG001|Overall Study|Withdrawal by Subject|0|||
19385455|NCT02153398|41628256|FG002|Overall Study|Withdrawal by Subject|0|||
19385456|NCT02153398|41628257|FG003|Overall Study|Withdrawal by Subject|0|||
19385457|NCT02153398|41628258|FG004|Overall Study|Withdrawal by Subject|0|||
19385458|NCT02153398|41628254|FG000|Overall Study|Adverse Event|0|||
19385459|NCT02153398|41628255|FG001|Overall Study|Adverse Event|0|||
19385460|NCT02153398|41628256|FG002|Overall Study|Adverse Event|1|||
19385461|NCT02153398|41628257|FG003|Overall Study|Adverse Event|1|||
19385462|NCT02153398|41628258|FG004|Overall Study|Adverse Event|0|||
19385463|NCT02118766|41628272|FG000|Overall Study|Adverse Event|7|||
19385464|NCT02118766|41628273|FG001|Overall Study|Adverse Event|2|||
19385465|NCT02118766|41628272|FG000|Overall Study|Withdrawal by Subject|3|||
19385466|NCT02118766|41628273|FG001|Overall Study|Withdrawal by Subject|6|||
19385467|NCT02118766|41628272|FG000|Overall Study|Lost to Follow-up|5|||
19385468|NCT02118766|41628273|FG001|Overall Study|Lost to Follow-up|4|||
19385469|NCT02118766|41628272|FG000|Overall Study|Withdrawal by parent/guardian|12|||
19385470|NCT02118766|41628273|FG001|Overall Study|Withdrawal by parent/guardian|18|||
19385471|NCT02118766|41628272|FG000|Overall Study|Other|3|||
19385472|NCT02118766|41628273|FG001|Overall Study|Other|1|||
19385473|NCT02614287|41628281|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
19385474|NCT02614287|41628282|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
19385475|NCT02614287|41628281|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
19385476|NCT02614287|41628282|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
19385477|NCT02614287|41628281|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
19385478|NCT02614287|41628282|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
19385479|NCT02614287|41628281|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
19385480|NCT02614287|41628282|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
19385481|NCT02614287|41628281|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
19385482|NCT02614287|41628282|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
19385483|NCT02614287|41628281|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
19385484|NCT02614287|41628282|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
19385485|NCT02614287|41628281|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
19385486|NCT02614287|41628282|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
19385487|NCT02614287|41628281|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
19385488|NCT02614287|41628282|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
19385489|NCT01374971|41628293|FG000|Overall Study|Withdrawal by Subject|1|||
19385490|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
19385491|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
19385492|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
19385493|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
19385494|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
19385495|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
19385496|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
19385497|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
19385498|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
19385499|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
19385500|NCT02178592|41628299|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
19385501|NCT02178592|41628300|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
19385502|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
19385503|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
19385504|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
19385505|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
19385506|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
19385507|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
19385508|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
19385509|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
19385510|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
19385511|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
19385512|NCT02178592|41628299|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
19385513|NCT02178592|41628300|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
19385514|NCT02610777|41628311|FG000|Overall Study|Lost to Follow-up|1|||
19385515|NCT02610777|41628312|FG001|Overall Study|Lost to Follow-up|0|||
19385516|NCT02610777|41628311|FG000|Overall Study|Site Terminated by Sponsor|9|||
19385517|NCT02610777|41628312|FG001|Overall Study|Site Terminated by Sponsor|8|||
19385518|NCT02610777|41628311|FG000|Overall Study|Withdrawal by Subject|2|||
19385519|NCT02610777|41628312|FG001|Overall Study|Withdrawal by Subject|2|||
19385520|NCT02610777|41628311|FG000|Overall Study|Reason not Specified|0|||
19385521|NCT02610777|41628312|FG001|Overall Study|Reason not Specified|1|||
19385522|NCT02610777|41628311|FG000|Overall Study|Death|50|||
19385523|NCT02610777|41628312|FG001|Overall Study|Death|47|||
19385524|NCT01628692|41628326|FG000|Overall Study|Lack of Efficacy|4|||
19385525|NCT01628692|41628327|FG001|Overall Study|Lack of Efficacy|4|||
19385526|NCT01628692|41628328|FG002|Overall Study|Lack of Efficacy|5|||
19385527|NCT01628692|41628329|FG003|Overall Study|Lack of Efficacy|1|||
19385528|NCT01628692|41628330|FG004|Overall Study|Lack of Efficacy|4|||
19385529|NCT01628692|41628331|FG005|Overall Study|Lack of Efficacy|7|||
19385530|NCT01628692|41628326|FG000|Overall Study|Adverse Event|2|||
19385531|NCT01628692|41628327|FG001|Overall Study|Adverse Event|0|||
19385532|NCT01628692|41628328|FG002|Overall Study|Adverse Event|2|||
19385533|NCT01628692|41628329|FG003|Overall Study|Adverse Event|0|||
19385534|NCT01628692|41628330|FG004|Overall Study|Adverse Event|0|||
19385535|NCT01628692|41628331|FG005|Overall Study|Adverse Event|0|||
19385536|NCT01628692|41628326|FG000|Overall Study|Withdrawal by Subject|0|||
19385537|NCT01628692|41628327|FG001|Overall Study|Withdrawal by Subject|1|||
19385538|NCT01628692|41628328|FG002|Overall Study|Withdrawal by Subject|1|||
19385539|NCT01628692|41628329|FG003|Overall Study|Withdrawal by Subject|0|||
19385540|NCT01628692|41628330|FG004|Overall Study|Withdrawal by Subject|0|||
19385541|NCT01628692|41628331|FG005|Overall Study|Withdrawal by Subject|0|||
19385542|NCT01628692|41628326|FG000|Overall Study|Death|0|||
19385543|NCT01628692|41628327|FG001|Overall Study|Death|1|||
19385544|NCT01628692|41628328|FG002|Overall Study|Death|0|||
19385545|NCT01628692|41628329|FG003|Overall Study|Death|0|||
19385546|NCT01628692|41628330|FG004|Overall Study|Death|0|||
19385547|NCT01628692|41628331|FG005|Overall Study|Death|0|||
19385548|NCT01628692|41628326|FG000|Overall Study|Poor compliance/noncompliance|1|||
19385549|NCT01628692|41628327|FG001|Overall Study|Poor compliance/noncompliance|0|||
19385550|NCT01628692|41628328|FG002|Overall Study|Poor compliance/noncompliance|0|||
19385551|NCT01628692|41628329|FG003|Overall Study|Poor compliance/noncompliance|0|||
19385552|NCT01628692|41628330|FG004|Overall Study|Poor compliance/noncompliance|0|||
19385553|NCT01628692|41628331|FG005|Overall Study|Poor compliance/noncompliance|0|||
19385554|NCT01628692|41628326|FG000|Overall Study|Administrative reason by sponsor|0|||
19385555|NCT01628692|41628327|FG001|Overall Study|Administrative reason by sponsor|0|||
19385556|NCT01628692|41628328|FG002|Overall Study|Administrative reason by sponsor|0|||
19385557|NCT01628692|41628329|FG003|Overall Study|Administrative reason by sponsor|0|||
19385558|NCT01628692|41628330|FG004|Overall Study|Administrative reason by sponsor|0|||
19385559|NCT01628692|41628331|FG005|Overall Study|Administrative reason by sponsor|1|||
19385560|NCT01628692|41628326|FG000|Overall Study|Completed 12 Week only|0|||
19385561|NCT01628692|41628327|FG001|Overall Study|Completed 12 Week only|0|||
19385562|NCT01628692|41628328|FG002|Overall Study|Completed 12 Week only|0|||
19385563|NCT01628692|41628329|FG003|Overall Study|Completed 12 Week only|0|||
19385564|NCT01628692|41628330|FG004|Overall Study|Completed 12 Week only|0|||
19385565|NCT01628692|41628331|FG005|Overall Study|Completed 12 Week only|1|||
19385566|NCT02612727|41628350|FG000|Overall Study|Parent request|4|||
19385567|NCT02612727|41628351|FG001|Overall Study|Parent request|1|||
19385568|NCT02612727|41628350|FG000|Overall Study|Needed treatment incompatible with PT|1|||
19385569|NCT02612727|41628351|FG001|Overall Study|Needed treatment incompatible with PT|1|||
19385570|NCT02612727|41628350|FG000|Overall Study|Direct hyperbilirubinemia|0|||
19385571|NCT02612727|41628351|FG001|Overall Study|Direct hyperbilirubinemia|2|||
19385572|NCT01594827|41628359|FG000|Overall Study|Adverse Event|1|||
19385573|NCT01594827|41628360|FG001|Overall Study|Adverse Event|0|||
19385574|NCT01594827|41628359|FG000|Overall Study|Physician Decision|3|||
19385575|NCT01594827|41628360|FG001|Overall Study|Physician Decision|0|||
19385576|NCT02610231|41628368|FG000|Overall Study|Withdrawal by Subject|27|||
19385577|NCT02610231|41628368|FG000|Overall Study|Adverse Event|20|||
19385578|NCT02610231|41628368|FG000|Overall Study|Death|5|||
19385579|NCT02610231|41628368|FG000|Overall Study|Surgery|2|||
19385580|NCT02610231|41628368|FG000|Overall Study|Physician Decision|1|||
19385581|NCT02610231|41628368|FG000|Overall Study|Non Compliance|2|||
19385582|NCT02610231|41628368|FG000|Overall Study|Other|3|||
19385583|NCT02178358|41628378|FG000|Overall Study|Withdrawal by Subject|0|||
19385584|NCT02178358|41628379|FG001|Overall Study|Withdrawal by Subject|2|||
19385585|NCT02178358|41628380|FG002|Overall Study|Withdrawal by Subject|2|||
19385586|NCT02178358|41628378|FG000|Overall Study|Lost to Follow-up|1|||
19385587|NCT02178358|41628379|FG001|Overall Study|Lost to Follow-up|0|||
19385588|NCT02178358|41628380|FG002|Overall Study|Lost to Follow-up|0|||
19385589|NCT01598896|41628391|FG000|Overall Study|Withdrawal by Subject|0|||
19385590|NCT01598896|41628392|FG001|Overall Study|Withdrawal by Subject|1|||
19385591|NCT01598896|41628391|FG000|Overall Study|Lack of Efficacy|0|||
19385592|NCT01598896|41628392|FG001|Overall Study|Lack of Efficacy|1|||
19385593|NCT01598662|41628400|FG000|Overall Study|Lost to Follow-up|10|||
19385594|NCT01598662|41628401|FG001|Overall Study|Lost to Follow-up|17|||
19385595|NCT01598662|41628400|FG000|Overall Study|Physician Decision|1|||
19385596|NCT01598662|41628401|FG001|Overall Study|Physician Decision|2|||
19385597|NCT01598662|41628400|FG000|Overall Study|IUD expelled before month 6|0|||
19385598|NCT01598662|41628401|FG001|Overall Study|IUD expelled before month 6|2|||
19385599|NCT01629706|41628407|FG000|Phase 1 PureVision|Screen Failure|4|||
19385600|NCT01629706|41628407|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
19385601|NCT01629706|41628407|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
19385602|NCT01629706|41628407|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
19385603|NCT01629706|41628407|FG000|Phase 2 Habitual|Screen Failure|6|||
19385604|NCT01629706|41628407|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
19385605|NCT01629706|41628407|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
19385606|NCT01629706|41628407|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
19385607|NCT01629706|41628407|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
19385608|NCT02153086|41628415|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
19385609|NCT02153086|41628415|FG000|Overall Study|Other|2|||
19385610|NCT02117050|41628419|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
19385611|NCT02728895|41628426|FG000|Overall Study|Other|1|||
19385612|NCT02728895|41628427|FG001|Overall Study|Other|2|||
19385613|NCT02728895|41628426|FG000|Overall Study|Withdrawal by Subject|0|||
19385614|NCT02728895|41628427|FG001|Overall Study|Withdrawal by Subject|3|||
19385615|NCT02606877|41628435|FG000|Overall Study|Adverse Event|3|||
19385616|NCT02606877|41628436|FG001|Overall Study|Adverse Event|0|||
19385617|NCT02606877|41628435|FG000|Overall Study|Non-compliance with protocol|0|||
19385618|NCT02606877|41628436|FG001|Overall Study|Non-compliance with protocol|1|||
19385619|NCT02606877|41628435|FG000|Overall Study|Other than listed above|1|||
19385620|NCT02606877|41628436|FG001|Overall Study|Other than listed above|0|||
19385621|NCT02606643|41628446|FG000|Overall Study|did not meet inclusion criteria|1|||
19385622|NCT02606643|41628447|FG001|Overall Study|did not meet inclusion criteria|3|||
19385623|NCT02609607|41628478|FG000|Overall Study|Lost to Follow-up|0|||
19385624|NCT02609607|41628479|FG001|Overall Study|Lost to Follow-up|1|||
19385625|NCT02606253|41628488|FG000|Overall Study|Adverse Event|2|||
19385626|NCT02606253|41628489|FG001|Overall Study|Adverse Event|0|||
19385627|NCT02606253|41628490|FG002|Overall Study|Adverse Event|0|||
19385628|NCT02606253|41628488|FG000|Overall Study|Protocol Violation|2|||
19385629|NCT02606253|41628489|FG001|Overall Study|Protocol Violation|1|||
19385630|NCT02606253|41628490|FG002|Overall Study|Protocol Violation|0|||
19385631|NCT02606253|41628488|FG000|Overall Study|Physician Decision|1|||
19385632|NCT02606253|41628489|FG001|Overall Study|Physician Decision|1|||
19385633|NCT02606253|41628490|FG002|Overall Study|Physician Decision|0|||
19385634|NCT02607735|41628500|FG000|Primary Study|Randomized but Never Treated|1|||
19385635|NCT02607735|41628501|FG001|Primary Study|Randomized but Never Treated|0|||
19385636|NCT02607735|41628502|FG002|Primary Study|Randomized but Never Treated|0|||
19385637|NCT02607735|41628500|FG000|Primary Study|Lost to Follow-up|4|||
19385638|NCT02607735|41628501|FG001|Primary Study|Lost to Follow-up|0|||
19385639|NCT02607735|41628502|FG002|Primary Study|Lost to Follow-up|0|||
19385640|NCT02607735|41628500|FG000|Primary Study|Withdrew Consent|2|||
19385641|NCT02607735|41628501|FG001|Primary Study|Withdrew Consent|0|||
19385642|NCT02607735|41628502|FG002|Primary Study|Withdrew Consent|0|||
19385643|NCT02607735|41628500|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
19385644|NCT02607735|41628501|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
19385645|NCT02607735|41628502|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
19385646|NCT02607735|41628500|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
19385647|NCT02607735|41628501|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
19385648|NCT02607735|41628502|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
19385649|NCT01668537|41628512|FG000|Overall Study|Request to Discontinue Prematurely|1|||
19385650|NCT01668537|41628513|FG001|Overall Study|Request to Discontinue Prematurely|1|||
19385651|NCT01668537|41628512|FG000|Overall Study|Subject unwilling/unable to comply|5|||
19385652|NCT01668537|41628513|FG001|Overall Study|Subject unwilling/unable to comply|0|||
19385653|NCT01668537|41628512|FG000|Overall Study|Reason Precludes Participation|1|||
19385654|NCT01668537|41628513|FG001|Overall Study|Reason Precludes Participation|0|||
19385655|NCT01668537|41628512|FG000|Overall Study|Lost to Follow-up|13|||
19385656|NCT01668537|41628513|FG001|Overall Study|Lost to Follow-up|6|||
19385657|NCT01668537|41628512|FG000|Overall Study|Other|2|||
19385658|NCT01668537|41628513|FG001|Overall Study|Other|3|||
19385659|NCT01668147|41628519|FG000|Overall Study|Withdrawal by Subject|6|||
19385660|NCT02600559|41628527|FG000|Overall Study|Withdrawal by Subject|3|||
19385661|NCT02600559|41628527|FG000|Overall Study|Lost to Follow-up|20|||
19385662|NCT02601573|41628536|FG000|Overall Study|Lost to Follow-up|0|||
19385663|NCT02601573|41628537|FG001|Overall Study|Lost to Follow-up|3|||
19385664|NCT02601573|41628538|FG002|Overall Study|Lost to Follow-up|1|||
19385665|NCT02601573|41628539|FG003|Overall Study|Lost to Follow-up|0|||
19385666|NCT02601573|41628540|FG004|Overall Study|Lost to Follow-up|2|||
19385667|NCT02601573|41628536|FG000|Overall Study|Withdrawal by Subject|0|||
19385668|NCT02601573|41628537|FG001|Overall Study|Withdrawal by Subject|1|||
19385669|NCT02601573|41628538|FG002|Overall Study|Withdrawal by Subject|0|||
19385670|NCT02601573|41628539|FG003|Overall Study|Withdrawal by Subject|1|||
19385671|NCT02601573|41628540|FG004|Overall Study|Withdrawal by Subject|0|||
19385672|NCT02601027|41628554|FG000|Registration to Surgery|Withdrawal by Subject|20|||
19385673|NCT02601027|41628555|FG001|Registration to Surgery|Withdrawal by Subject|10|||
19385674|NCT02600871|41628563|FG000|Overall Study|Lost to Follow-up|13|||
19385675|NCT02600871|41628564|FG001|Overall Study|Lost to Follow-up|10|||
19385676|NCT02598297|41628573|FG000|Overall Study|Study terminated by Sponsor|21|||
19385677|NCT02598297|41628574|FG001|Overall Study|Study terminated by Sponsor|23|||
19385678|NCT02598297|41628573|FG000|Overall Study|Adverse Event|1|||
19385679|NCT02598297|41628574|FG001|Overall Study|Adverse Event|1|||
19385680|NCT02598297|41628573|FG000|Overall Study|Physician Decision|1|||
19385681|NCT02598297|41628574|FG001|Overall Study|Physician Decision|0|||
19385682|NCT02598297|41628573|FG000|Overall Study|Subject/guardian decision|1|||
19385683|NCT02598297|41628574|FG001|Overall Study|Subject/guardian decision|0|||
19385684|NCT02598297|41628573|FG000|Overall Study|Followed for survival|1|||
19385685|NCT02598297|41628574|FG001|Overall Study|Followed for survival|0|||
19385686|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
19385687|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
19385688|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
19385689|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
19385690|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
19385691|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
19478181|NCT01693562|41757335|FG021|Expansion Phase|Other|17|||
19385692|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
19385693|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
19385694|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
19385695|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
19385696|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
19385697|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
19385698|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
19385699|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
19385700|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
19385701|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
19385702|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
19385703|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
19385704|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
19385705|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
19385706|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
19385707|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
19385708|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
19385709|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
19385710|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
19385711|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
19385712|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
19385713|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
19385714|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
19385715|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
19385716|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
19385717|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
19385718|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
19385719|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
19385720|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
19385721|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
19385722|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
19385723|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
19385724|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
19385725|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
19385726|NCT02596893|41628584|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
19385727|NCT02596893|41628585|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
19385728|NCT02596893|41628586|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
19385729|NCT02596893|41628587|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
19385730|NCT02592447|41628603|FG000|Overall Study|Lost to Follow-up|1|||
19385731|NCT02592447|41628604|FG001|Overall Study|Lost to Follow-up|0|||
19385732|NCT02592447|41628603|FG000|Overall Study|Ineligible after randomization|1|||
19385733|NCT02592447|41628604|FG001|Overall Study|Ineligible after randomization|0|||
19385734|NCT02592447|41628603|FG000|Overall Study|Withdrawal by Subject|0|||
19385735|NCT02592447|41628604|FG001|Overall Study|Withdrawal by Subject|1|||
19385736|NCT02595723|41628613|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
19385737|NCT02595723|41628614|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
19385738|NCT02595723|41628615|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
19385739|NCT02595723|41628613|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
19385740|NCT02595723|41628614|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
19385741|NCT02595723|41628615|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
19385742|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
19385743|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
19385744|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
19385745|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
19385746|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
19385747|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
19385748|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
19385749|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
19385750|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
19385751|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
19385752|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
19385753|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
19385754|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
19385755|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
19385756|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
19385757|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
19385758|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
19385759|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
19385760|NCT01667679|41628625|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
19385761|NCT01667679|41628626|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
19385762|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
19385763|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
19385764|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
19385765|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
19385766|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
19385767|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
19385768|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
19385769|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
19385770|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
19385771|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
19385772|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
19385773|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
19385774|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
19385775|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
19385776|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
19385777|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
19385778|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
19385779|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
19385780|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
19385781|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
19385782|NCT01667679|41628625|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
19385783|NCT01667679|41628626|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
19385784|NCT02597049|41628637|FG000|Overall Study|Lost to Follow-up|0|||
19385785|NCT02597049|41628638|FG001|Overall Study|Lost to Follow-up|3|||
19385786|NCT02597049|41628639|FG002|Overall Study|Lost to Follow-up|2|||
19385787|NCT02597049|41628637|FG000|Overall Study|Withdrawal by Subject|2|||
19385788|NCT02597049|41628638|FG001|Overall Study|Withdrawal by Subject|2|||
19385789|NCT02597049|41628639|FG002|Overall Study|Withdrawal by Subject|1|||
19385790|NCT02597049|41628637|FG000|Overall Study|Adverse Event|2|||
19385791|NCT02597049|41628638|FG001|Overall Study|Adverse Event|0|||
19385792|NCT02597049|41628639|FG002|Overall Study|Adverse Event|0|||
19385793|NCT02597049|41628637|FG000|Overall Study|Death|2|||
19385794|NCT02597049|41628638|FG001|Overall Study|Death|0|||
19385795|NCT02597049|41628639|FG002|Overall Study|Death|0|||
19385796|NCT02597049|41628637|FG000|Overall Study|Noncompliant with Study Visits|1|||
19385797|NCT02597049|41628638|FG001|Overall Study|Noncompliant with Study Visits|0|||
19385798|NCT02597049|41628639|FG002|Overall Study|Noncompliant with Study Visits|0|||
19385799|NCT02594163|41628649|FG000|Treatment Period|Progressive disease|2|||
19385800|NCT02594163|41628650|FG001|Treatment Period|Progressive disease|3|||
19385801|NCT02594163|41628649|FG000|Treatment Period|Adverse Event|1|||
19385802|NCT02594163|41628650|FG001|Treatment Period|Adverse Event|5|||
19385803|NCT02594163|41628649|FG000|Treatment Period|Physician Decision|1|||
19385804|NCT02594163|41628650|FG001|Treatment Period|Physician Decision|3|||
19385805|NCT02594163|41628649|FG000|Treatment Period|Study termination by sponsor|2|||
19385806|NCT02594163|41628650|FG001|Treatment Period|Study termination by sponsor|1|||
19385807|NCT02594163|41628649|FG000|Treatment Period|Other, Non-AE|1|||
19385808|NCT02594163|41628650|FG001|Treatment Period|Other, Non-AE|0|||
19385809|NCT02594163|41628649|FG000|Follow-up Period|Withdrawal by Subject|0|||
19385810|NCT02594163|41628650|FG001|Follow-up Period|Withdrawal by Subject|1|||
19385811|NCT02594163|41628649|FG000|Follow-up Period|Study Termination by Sponsor|6|||
19385812|NCT02594163|41628650|FG001|Follow-up Period|Study Termination by Sponsor|4|||
19385813|NCT02594163|41628649|FG000|Follow-up Period|Lost to Follow-up|1|||
19385814|NCT02594163|41628650|FG001|Follow-up Period|Lost to Follow-up|0|||
19385815|NCT02594163|41628649|FG000|Follow-up Period|Death|2|||
19385816|NCT02594163|41628650|FG001|Follow-up Period|Death|5|||
19385817|NCT02594163|41628649|FG000|Follow-up Period|Adverse Event|0|||
19385818|NCT02594163|41628650|FG001|Follow-up Period|Adverse Event|1|||
19385819|NCT02594163|41628649|FG000|Follow-up Period|Progressive Disease|2|||
19385820|NCT02594163|41628650|FG001|Follow-up Period|Progressive Disease|0|||
19385821|NCT02594163|41628649|FG000|Follow-up Period|Physician Decision|0|||
19385822|NCT02594163|41628650|FG001|Follow-up Period|Physician Decision|1|||
19385823|NCT02712983|41628665|FG000|Treatment Phase|Adverse Event|3|||
19385824|NCT02712983|41628666|FG001|Treatment Phase|Adverse Event|1|||
19385825|NCT02712983|41628667|FG002|Treatment Phase|Adverse Event|1|||
19385826|NCT02712983|41628668|FG003|Treatment Phase|Adverse Event|4|||
19385827|NCT02712983|41628669|FG004|Treatment Phase|Adverse Event|3|||
19385828|NCT02712983|41628670|FG005|Treatment Phase|Adverse Event|0|||
19385829|NCT02712983|41628671|FG006|Treatment Phase|Adverse Event|6|||
19385830|NCT02712983|41628672|FG007|Treatment Phase|Adverse Event|6|||
19385831|NCT02712983|41628673|FG008|Treatment Phase|Adverse Event|1|||
19385832|NCT02712983|41628665|FG000|Treatment Phase|Protocol Deviation|0|||
19385833|NCT02712983|41628666|FG001|Treatment Phase|Protocol Deviation|0|||
19385834|NCT02712983|41628667|FG002|Treatment Phase|Protocol Deviation|0|||
19385835|NCT02712983|41628668|FG003|Treatment Phase|Protocol Deviation|2|||
19385836|NCT02712983|41628669|FG004|Treatment Phase|Protocol Deviation|0|||
19385837|NCT02712983|41628670|FG005|Treatment Phase|Protocol Deviation|0|||
19385838|NCT02712983|41628671|FG006|Treatment Phase|Protocol Deviation|1|||
19385839|NCT02712983|41628672|FG007|Treatment Phase|Protocol Deviation|0|||
19385840|NCT02712983|41628673|FG008|Treatment Phase|Protocol Deviation|0|||
19385841|NCT02712983|41628665|FG000|Treatment Phase|Technical Problems|0|||
19385842|NCT02712983|41628666|FG001|Treatment Phase|Technical Problems|0|||
19385843|NCT02712983|41628667|FG002|Treatment Phase|Technical Problems|0|||
19385844|NCT02712983|41628668|FG003|Treatment Phase|Technical Problems|0|||
19385845|NCT02712983|41628669|FG004|Treatment Phase|Technical Problems|0|||
19385846|NCT02712983|41628670|FG005|Treatment Phase|Technical Problems|0|||
19385847|NCT02712983|41628671|FG006|Treatment Phase|Technical Problems|1|||
19385848|NCT02712983|41628672|FG007|Treatment Phase|Technical Problems|0|||
19385849|NCT02712983|41628673|FG008|Treatment Phase|Technical Problems|0|||
19385850|NCT02712983|41628665|FG000|Treatment Phase|Physician Decision|0|||
19385851|NCT02712983|41628666|FG001|Treatment Phase|Physician Decision|0|||
19385852|NCT02712983|41628667|FG002|Treatment Phase|Physician Decision|0|||
19385853|NCT02712983|41628668|FG003|Treatment Phase|Physician Decision|0|||
19385854|NCT02712983|41628669|FG004|Treatment Phase|Physician Decision|0|||
19385855|NCT02712983|41628670|FG005|Treatment Phase|Physician Decision|0|||
19385856|NCT02712983|41628671|FG006|Treatment Phase|Physician Decision|0|||
19385857|NCT02712983|41628672|FG007|Treatment Phase|Physician Decision|1|||
19385858|NCT02712983|41628673|FG008|Treatment Phase|Physician Decision|1|||
19385859|NCT02712983|41628665|FG000|Treatment Phase|Subject Decision|2|||
19385860|NCT02712983|41628666|FG001|Treatment Phase|Subject Decision|0|||
19385861|NCT02712983|41628667|FG002|Treatment Phase|Subject Decision|0|||
19385862|NCT02712983|41628668|FG003|Treatment Phase|Subject Decision|2|||
19385863|NCT02712983|41628669|FG004|Treatment Phase|Subject Decision|1|||
19385864|NCT02712983|41628670|FG005|Treatment Phase|Subject Decision|0|||
19385865|NCT02712983|41628671|FG006|Treatment Phase|Subject Decision|1|||
19385866|NCT02712983|41628672|FG007|Treatment Phase|Subject Decision|2|||
19385867|NCT02712983|41628673|FG008|Treatment Phase|Subject Decision|0|||
19385868|NCT02712983|41628665|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385869|NCT02712983|41628666|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
19385870|NCT02712983|41628667|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385871|NCT02712983|41628668|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385872|NCT02712983|41628669|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385873|NCT02712983|41628670|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385874|NCT02712983|41628671|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
19385875|NCT02712983|41628672|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
19385876|NCT02712983|41628673|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19385877|NCT02712983|41628665|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385878|NCT02712983|41628666|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19478182|NCT01693562|41757336|FG022|Expansion Phase|Other|1|||
19385879|NCT02712983|41628667|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385880|NCT02712983|41628668|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
19385881|NCT02712983|41628669|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385882|NCT02712983|41628670|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385883|NCT02712983|41628671|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385884|NCT02712983|41628672|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385885|NCT02712983|41628673|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
19385886|NCT02712983|41628665|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
19385887|NCT02712983|41628666|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
19385888|NCT02712983|41628667|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
19385889|NCT02712983|41628668|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
19385890|NCT02712983|41628669|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
19385891|NCT02712983|41628670|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
19385892|NCT02712983|41628671|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
19385893|NCT02712983|41628672|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
19385894|NCT02712983|41628673|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
19385895|NCT02596971|41628696|FG000|Overall Study|Death|5|||
19385896|NCT02596971|41628697|FG001|Overall Study|Death|1|||
19385897|NCT02596971|41628698|FG002|Overall Study|Death|5|||
19385898|NCT02596971|41628696|FG000|Overall Study|Withdrawal by Subject|5|||
19385899|NCT02596971|41628697|FG001|Overall Study|Withdrawal by Subject|1|||
19385900|NCT02596971|41628698|FG002|Overall Study|Withdrawal by Subject|4|||
19385901|NCT02593773|41628709|FG000|Overall Study|Voluntary Withdrawal|3|||
19385902|NCT02593773|41628709|FG000|Overall Study|Study Terminated by Sponsor|31|||
19385903|NCT02593773|41628709|FG000|Overall Study|Death|1|||
19385904|NCT02593539|41628713|FG000|Overall Study|Adverse Event|1|||
19385905|NCT00919763|41628722|FG000|Overall Study|Adverse Event|7|||
19385906|NCT00919763|41628723|FG001|Overall Study|Adverse Event|1|||
19385907|NCT00919763|41628722|FG000|Overall Study|Lost to Follow-up|1|||
19385908|NCT00919763|41628723|FG001|Overall Study|Lost to Follow-up|0|||
19385909|NCT00919763|41628722|FG000|Overall Study|Protocol Violation|1|||
19385910|NCT00919763|41628723|FG001|Overall Study|Protocol Violation|1|||
19385911|NCT00919763|41628722|FG000|Overall Study|Withdrawal by Subject|3|||
19385912|NCT00919763|41628723|FG001|Overall Study|Withdrawal by Subject|1|||
19385913|NCT00919763|41628722|FG000|Overall Study|Non-compliance|0|||
19385914|NCT00919763|41628723|FG001|Overall Study|Non-compliance|1|||
19385915|NCT02593305|41628741|FG000|Post 1|Comparison only group. No intervention.|0|||
19385916|NCT02593305|41628742|FG001|Post 1|Comparison only group. No intervention.|0|||
19385917|NCT02593305|41628743|FG002|Post 1|Comparison only group. No intervention.|10|||
19385918|NCT02593149|41628754|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
19385919|NCT02593149|41628755|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
19385920|NCT02593149|41628754|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
19385921|NCT02593149|41628755|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
19385922|NCT02177812|41628770|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385923|NCT02177812|41628771|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385924|NCT02177812|41628772|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385925|NCT02177812|41628773|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385926|NCT02177812|41628774|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385927|NCT02177812|41628775|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
19385928|NCT02177812|41628776|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
19385929|NCT02177812|41628777|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
19385930|NCT02177812|41628778|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
19385931|NCT02177812|41628770|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385932|NCT02177812|41628771|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385933|NCT02177812|41628772|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385934|NCT02177812|41628773|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385935|NCT02177812|41628774|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385936|NCT02177812|41628775|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
19385937|NCT02177812|41628776|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
19385938|NCT02177812|41628777|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19385939|NCT02177812|41628778|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
19745725|NCT00071981|42193070|FG000|Overall Study|Death|0|||
19385940|NCT02177812|41628770|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
19385941|NCT02177812|41628771|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
19385942|NCT02177812|41628772|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
19385943|NCT02177812|41628773|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
19385944|NCT02177812|41628774|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
19385945|NCT02177812|41628775|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
19385946|NCT02177812|41628776|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
19385947|NCT02177812|41628777|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
19385948|NCT02177812|41628778|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
19385949|NCT01626352|41628822|FG000|Overall Study|Disease Progression|3|||
19385950|NCT01626352|41628822|FG000|Overall Study|Intercurrent Illness|2|||
19385951|NCT01626352|41628822|FG000|Overall Study|Death|2|||
19385952|NCT01626352|41628822|FG000|Overall Study|Withdrawal by Subject|1|||
19385953|NCT01626352|41628822|FG000|Overall Study|Non-Compliance|1|||
19385954|NCT01626352|41628822|FG000|Overall Study|Never Treated|1|||
19385955|NCT01626118|41628833|FG000|Overall Study|Lack of Efficacy|1|||
19385956|NCT01626118|41628834|FG001|Overall Study|Lack of Efficacy|0|||
19385957|NCT01626118|41628835|FG002|Overall Study|Lack of Efficacy|1|||
19385958|NCT01626118|41628836|FG003|Overall Study|Lack of Efficacy|3|||
19385959|NCT01626118|41628833|FG000|Overall Study|Lost to Follow-up|1|||
19385960|NCT01626118|41628834|FG001|Overall Study|Lost to Follow-up|0|||
19385961|NCT01626118|41628835|FG002|Overall Study|Lost to Follow-up|0|||
19385962|NCT01626118|41628836|FG003|Overall Study|Lost to Follow-up|0|||
19385963|NCT01626118|41628833|FG000|Overall Study|Adverse Event|0|||
19385964|NCT01626118|41628834|FG001|Overall Study|Adverse Event|1|||
19385965|NCT01626118|41628835|FG002|Overall Study|Adverse Event|1|||
19385966|NCT01626118|41628836|FG003|Overall Study|Adverse Event|0|||
19385967|NCT01626118|41628833|FG000|Overall Study|Investigator Decision|0|||
19385968|NCT01626118|41628834|FG001|Overall Study|Investigator Decision|1|||
19385969|NCT01626118|41628835|FG002|Overall Study|Investigator Decision|0|||
19385970|NCT01626118|41628836|FG003|Overall Study|Investigator Decision|0|||
19385971|NCT02152384|41628846|FG000|Period 1|Withdrawal by Subject|0|||
19385972|NCT02152384|41628847|FG001|Period 1|Withdrawal by Subject|1|||
19385973|NCT02152384|41628846|FG000|Period 1|Adverse Event|1|||
19385974|NCT02152384|41628847|FG001|Period 1|Adverse Event|1|||
19385975|NCT02177266|41628859|FG000|Overall Study|Adverse Event|0|||
19385976|NCT02177266|41628860|FG001|Overall Study|Adverse Event|1|||
19385977|NCT02177266|41628859|FG000|Overall Study|Withdrawal by Subject|1|||
19385978|NCT02177266|41628860|FG001|Overall Study|Withdrawal by Subject|0|||
19385979|NCT02177032|41628870|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
19385980|NCT02177032|41628871|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
19385981|NCT02177032|41628872|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
19385982|NCT02177032|41628873|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
19385983|NCT02177032|41628870|FG000|Overall Study|Lost to Follow-up|0|||
19385984|NCT02177032|41628871|FG001|Overall Study|Lost to Follow-up|2|||
19385985|NCT02177032|41628872|FG002|Overall Study|Lost to Follow-up|0|||
19385986|NCT02177032|41628873|FG003|Overall Study|Lost to Follow-up|0|||
19385987|NCT02177032|41628870|FG000|Overall Study|OTHER|2|||
19385988|NCT02177032|41628871|FG001|Overall Study|OTHER|0|||
19385989|NCT02177032|41628872|FG002|Overall Study|OTHER|1|||
19385990|NCT02177032|41628873|FG003|Overall Study|OTHER|0|||
19385991|NCT02177032|41628870|FG000|Overall Study|Withdrawal by Subject|1|||
19385992|NCT02177032|41628871|FG001|Overall Study|Withdrawal by Subject|0|||
19385993|NCT02177032|41628872|FG002|Overall Study|Withdrawal by Subject|1|||
19385994|NCT02177032|41628873|FG003|Overall Study|Withdrawal by Subject|0|||
19385995|NCT02116972|41628897|FG000|Overall Study|Adverse Event|4|||
19385996|NCT02116972|41628898|FG001|Overall Study|Adverse Event|4|||
19385997|NCT02116972|41628899|FG002|Overall Study|Adverse Event|1|||
19385998|NCT02116972|41628897|FG000|Overall Study|Withdrawal by Subject|1|||
19385999|NCT02116972|41628898|FG001|Overall Study|Withdrawal by Subject|1|||
19386000|NCT02116972|41628899|FG002|Overall Study|Withdrawal by Subject|5|||
19386001|NCT02116972|41628897|FG000|Overall Study|Protocol Violation|1|||
19386002|NCT02116972|41628898|FG001|Overall Study|Protocol Violation|0|||
19386003|NCT02116972|41628899|FG002|Overall Study|Protocol Violation|1|||
19386004|NCT02116972|41628897|FG000|Overall Study|Lost to Follow-up|4|||
19386005|NCT02116972|41628898|FG001|Overall Study|Lost to Follow-up|3|||
19386006|NCT02116972|41628899|FG002|Overall Study|Lost to Follow-up|1|||
19386007|NCT02116972|41628897|FG000|Overall Study|Lack of Efficacy|6|||
19386008|NCT02116972|41628898|FG001|Overall Study|Lack of Efficacy|6|||
19386009|NCT02116972|41628899|FG002|Overall Study|Lack of Efficacy|5|||
19386010|NCT02116972|41628897|FG000|Overall Study|scheduling conflicts and relocation|3|||
19386011|NCT02116972|41628898|FG001|Overall Study|scheduling conflicts and relocation|3|||
19386012|NCT02116972|41628899|FG002|Overall Study|scheduling conflicts and relocation|6|||
19386013|NCT02176642|41628911|FG000|Overall Study|Withdrawal by Subject|0|||
19386014|NCT02176642|41628912|FG001|Overall Study|Withdrawal by Subject|1|||
19386015|NCT02116660|41628920|FG000|Overall Study|Deteriorating renal function|0|||
19386016|NCT02116660|41628921|FG001|Overall Study|Deteriorating renal function|1|||
19386017|NCT02116660|41628920|FG000|Overall Study|Adverse Event|1|||
19386018|NCT02116660|41628921|FG001|Overall Study|Adverse Event|1|||
19386019|NCT02116660|41628920|FG000|Overall Study|Withdrawal by Subject|0|||
19386020|NCT02116660|41628921|FG001|Overall Study|Withdrawal by Subject|2|||
19386021|NCT02116660|41628920|FG000|Overall Study|Organization reason|1|||
19386022|NCT02116660|41628921|FG001|Overall Study|Organization reason|0|||
19386023|NCT02589405|41628929|FG000|Overall Study|Adverse Event|3|||
19386024|NCT02589405|41628929|FG000|Overall Study|Withdrawal by Subject|1|||
19386025|NCT02176018|41628935|FG000|Overall Study|Adverse Event|0|||
19386026|NCT02176018|41628936|FG001|Overall Study|Adverse Event|2|||
19386027|NCT02176018|41628935|FG000|Overall Study|Lost to Follow-up|3|||
19386028|NCT02176018|41628936|FG001|Overall Study|Lost to Follow-up|1|||
19386029|NCT02176018|41628935|FG000|Overall Study|Protocol Violation|1|||
19386030|NCT02176018|41628936|FG001|Overall Study|Protocol Violation|1|||
19386031|NCT02176018|41628935|FG000|Overall Study|Withdrawal by Subject|1|||
19386032|NCT02176018|41628936|FG001|Overall Study|Withdrawal by Subject|2|||
19386033|NCT02116582|41628942|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
19386034|NCT02116582|41628942|FG000|Overall Study|Adverse Event|22|||
19386035|NCT02116582|41628942|FG000|Overall Study|Death|9|||
19386036|NCT02116582|41628942|FG000|Overall Study|Progressive Disease|148|||
19386037|NCT02116582|41628942|FG000|Overall Study|Protocol Violation|3|||
19386038|NCT02116582|41628942|FG000|Overall Study|Withdrawal by Subject|8|||
19386039|NCT02116582|41628942|FG000|Overall Study|Other: Miscellaneous|11|||
19386040|NCT02116582|41628942|FG000|Overall Study|Lost to Follow-up|1|||
19386041|NCT02116582|41628942|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
19386042|NCT02589639|41628949|FG000|Overall Study|Lost to Follow-up|1|||
19745726|NCT00071981|42193071|FG001|Overall Study|Death|0|||
19386043|NCT02589639|41628950|FG001|Overall Study|Lost to Follow-up|0|||
19386044|NCT02589639|41628951|FG002|Overall Study|Lost to Follow-up|0|||
19386045|NCT02589639|41628949|FG000|Overall Study|Protocol Violation|1|||
19386046|NCT02589639|41628950|FG001|Overall Study|Protocol Violation|0|||
19386047|NCT02589639|41628951|FG002|Overall Study|Protocol Violation|0|||
19386048|NCT02589639|41628949|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
19386049|NCT02589639|41628950|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
19386050|NCT02589639|41628951|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
19571664|NCT01233284|42019249|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
19571665|NCT01233284|42019250|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19571666|NCT01233284|42019251|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19571667|NCT01233284|42019252|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19571668|NCT01233284|42019248|FG000|Period 1 (4 Weeks)|Other|0|||
19571669|NCT01233284|42019249|FG001|Period 1 (4 Weeks)|Other|0|||
19571670|NCT01233284|42019250|FG002|Period 1 (4 Weeks)|Other|1|||
19571671|NCT01233284|42019251|FG003|Period 1 (4 Weeks)|Other|0|||
19571672|NCT01233284|42019252|FG004|Period 1 (4 Weeks)|Other|0|||
19571673|NCT01233284|42019248|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19571674|NCT01233284|42019249|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19571675|NCT01233284|42019250|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
19571676|NCT01233284|42019251|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19571677|NCT01233284|42019252|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19571678|NCT01233284|42019248|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19571679|NCT01233284|42019249|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19571680|NCT01233284|42019250|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
19571681|NCT01233284|42019251|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19571682|NCT01233284|42019252|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19571683|NCT01233284|42019248|FG000|Period 3 (4 Weeks)|Other|0|||
19571684|NCT01233284|42019249|FG001|Period 3 (4 Weeks)|Other|0|||
19571685|NCT01233284|42019250|FG002|Period 3 (4 Weeks)|Other|0|||
19571686|NCT01233284|42019251|FG003|Period 3 (4 Weeks)|Other|1|||
19571687|NCT01233284|42019252|FG004|Period 3 (4 Weeks)|Other|0|||
19571688|NCT01233284|42019248|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
19571689|NCT01233284|42019249|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
19571690|NCT01233284|42019250|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
19571691|NCT01233284|42019251|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
19571692|NCT01233284|42019252|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
19571693|NCT01233284|42019248|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
19571694|NCT01233284|42019249|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
19571695|NCT01233284|42019250|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
19571696|NCT01233284|42019251|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
19571697|NCT01233284|42019252|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
19571698|NCT00948688|42019262|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
19571699|NCT00948688|42019263|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
19571700|NCT00948688|42019262|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
19571701|NCT00948688|42019263|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
19571702|NCT00948688|42019262|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
19571703|NCT00948688|42019263|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
19571704|NCT01233050|42019272|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
19571705|NCT01233050|42019273|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
19571706|NCT01232894|42019281|FG000|Overall Study|Lost to Follow-up|0|||
19571707|NCT01232894|42019282|FG001|Overall Study|Lost to Follow-up|1|||
19571708|NCT01232894|42019281|FG000|Overall Study|Death|1|||
19571709|NCT01232894|42019282|FG001|Overall Study|Death|0|||
19571710|NCT01232894|42019281|FG000|Overall Study|Protocol Violation|1|||
19571711|NCT01232894|42019282|FG001|Overall Study|Protocol Violation|1|||
19571712|NCT01232894|42019281|FG000|Overall Study|Withdrawal by Subject|8|||
19571713|NCT01232894|42019282|FG001|Overall Study|Withdrawal by Subject|5|||
19571714|NCT01232894|42019281|FG000|Overall Study|Physician Decision|2|||
19571715|NCT01232894|42019282|FG001|Overall Study|Physician Decision|1|||
19571716|NCT01049217|42019290|FG000|Overall Study|Adverse Event|2|||
19571717|NCT01049217|42019291|FG001|Overall Study|Adverse Event|1|||
19571718|NCT01049217|42019290|FG000|Overall Study|Lack of Efficacy|1|||
19571719|NCT01049217|42019291|FG001|Overall Study|Lack of Efficacy|1|||
19386051|NCT02589639|41628949|FG000|Overall Study|Adverse Event|4|||
19386052|NCT02589639|41628950|FG001|Overall Study|Adverse Event|5|||
19571720|NCT01049217|42019290|FG000|Overall Study|Lost to Follow-up|3|||
19571721|NCT01049217|42019291|FG001|Overall Study|Lost to Follow-up|8|||
19571722|NCT01049217|42019290|FG000|Overall Study|Withdrawal by Subject|4|||
19571723|NCT01049217|42019291|FG001|Overall Study|Withdrawal by Subject|3|||
19386053|NCT02589639|41628951|FG002|Overall Study|Adverse Event|3|||
19386054|NCT02589639|41628949|FG000|Overall Study|Other reason than specified above|1|||
19386055|NCT02589639|41628950|FG001|Overall Study|Other reason than specified above|2|||
19386056|NCT02589639|41628951|FG002|Overall Study|Other reason than specified above|1|||
19386057|NCT02589639|41628949|FG000|Overall Study|Not Treated|0|||
19386058|NCT02589639|41628950|FG001|Overall Study|Not Treated|3|||
19386059|NCT02589639|41628951|FG002|Overall Study|Not Treated|0|||
19386060|NCT02151682|41628961|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
19386061|NCT02151682|41628962|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
19386062|NCT02151682|41628963|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
19386063|NCT02151682|41628964|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
19386064|NCT02151682|41628965|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
19386065|NCT02151682|41628966|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
19386066|NCT02151682|41628961|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
19386067|NCT02151682|41628962|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
19386068|NCT02151682|41628963|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
19386069|NCT02151682|41628964|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
19386070|NCT02151682|41628965|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
19386071|NCT02151682|41628966|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
19386072|NCT02151682|41628961|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
19386073|NCT02151682|41628962|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
19386074|NCT02151682|41628963|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
19386075|NCT02151682|41628964|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
19386076|NCT02151682|41628965|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
19386077|NCT02151682|41628966|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
19386078|NCT02151682|41628961|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
19386079|NCT02151682|41628962|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
19386080|NCT02151682|41628963|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
19386081|NCT02151682|41628964|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
19386082|NCT02151682|41628965|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
19386083|NCT02151682|41628966|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
19386084|NCT02151682|41628961|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
19386085|NCT02151682|41628962|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
19386086|NCT02151682|41628963|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
19386087|NCT02151682|41628964|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
19386088|NCT02151682|41628965|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
19386089|NCT02151682|41628966|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
19386090|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
19386091|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
19386092|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
19386093|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
19386094|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
19386095|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
19386096|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
19386097|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
19386098|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
19386099|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
19386100|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
19386101|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
19386102|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
19386103|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
19386104|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
19386105|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
19386106|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
19386107|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
19386108|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
19386109|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
19386110|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
19386111|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
19386112|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
19386113|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
19386114|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
19386115|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
19386116|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
19386117|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
19386118|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
19386119|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
19386120|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
19386121|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
19386122|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
19386123|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
19386124|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
19386125|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
19386126|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
19386127|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
19386128|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
19386129|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
19386130|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
19386131|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
19386132|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
19386133|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
19386134|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
19386135|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
19386136|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
19386137|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
19386138|NCT02151682|41628961|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
19386139|NCT02151682|41628962|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
19386140|NCT02151682|41628963|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
19386141|NCT02151682|41628964|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
19745727|NCT00071981|42193072|FG002|Overall Study|Death|1|||
19745728|NCT00071981|42193073|FG003|Overall Study|Death|1|||
19745729|NCT00071981|42193070|FG000|Overall Study|Withdrawal by Subject|3|||
19745730|NCT00071981|42193071|FG001|Overall Study|Withdrawal by Subject|1|||
19745731|NCT00071981|42193072|FG002|Overall Study|Withdrawal by Subject|0|||
19745732|NCT00071981|42193073|FG003|Overall Study|Withdrawal by Subject|0|||
19745733|NCT00071981|42193070|FG000|Overall Study|No protocol therapy|2|||
19745734|NCT00071981|42193071|FG001|Overall Study|No protocol therapy|5|||
19745735|NCT00071981|42193072|FG002|Overall Study|No protocol therapy|1|||
19745736|NCT00071981|42193073|FG003|Overall Study|No protocol therapy|0|||
19745737|NCT00071981|42193070|FG000|Overall Study|others (not specified in the study)|0|||
19745738|NCT00071981|42193071|FG001|Overall Study|others (not specified in the study)|2|||
19745739|NCT00071981|42193072|FG002|Overall Study|others (not specified in the study)|2|||
19745740|NCT00071981|42193073|FG003|Overall Study|others (not specified in the study)|0|||
19745741|NCT00071513|42193085|FG000|Intervention Component|Withdrawal by Subject|2|||
19745742|NCT00071513|42193086|FG001|Intervention Component|Withdrawal by Subject|3|||
19745743|NCT00071513|42193085|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
19745744|NCT00071513|42193086|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
19745745|NCT00006389|42193094|FG000|Overall Study|Adverse Event|1|||
19745746|NCT00006305|42193103|FG000|Overall Study|Withdrawal by Subject|17|||
19745747|NCT00006305|42193104|FG001|Overall Study|Withdrawal by Subject|10|||
19386142|NCT02151682|41628965|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
19386143|NCT02151682|41628966|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
19386144|NCT02151682|41628961|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
19386145|NCT02151682|41628962|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
19386146|NCT02151682|41628963|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
19386147|NCT02151682|41628964|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
19386148|NCT02151682|41628965|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
19386149|NCT02151682|41628966|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
19386150|NCT02151682|41628961|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
19386151|NCT02151682|41628962|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
19745748|NCT00006305|42193105|FG002|Overall Study|Withdrawal by Subject|15|||
19745749|NCT00006305|42193106|FG003|Overall Study|Withdrawal by Subject|14|||
19745750|NCT03529773|42193156|FG000|Overall Study|Adverse Event|0|||
19745751|NCT03529773|42193157|FG001|Overall Study|Adverse Event|0|||
19745752|NCT03529773|42193158|FG002|Overall Study|Adverse Event|0|||
19745753|NCT03529773|42193159|FG003|Overall Study|Adverse Event|0|||
19745754|NCT03529773|42193160|FG004|Overall Study|Adverse Event|0|||
19386152|NCT02151682|41628963|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
19386153|NCT02151682|41628964|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
19386154|NCT02151682|41628965|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
19386155|NCT02151682|41628966|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
19386156|NCT02151682|41628961|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
19386157|NCT02151682|41628962|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
19386158|NCT02151682|41628963|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
19386159|NCT02151682|41628964|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
19386160|NCT02151682|41628965|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
19386161|NCT02151682|41628966|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
19386162|NCT02151682|41628961|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
19386163|NCT02151682|41628962|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
19386164|NCT02151682|41628963|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
19386165|NCT02151682|41628964|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
19386166|NCT02151682|41628965|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
19386167|NCT02151682|41628966|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
19386168|NCT02174848|41628996|FG000|Overall Study|Adverse Event|2|||
19386169|NCT02174848|41628997|FG001|Overall Study|Adverse Event|1|||
19386170|NCT02174848|41628996|FG000|Overall Study|Withdrawal by Subject|3|||
19386171|NCT02174848|41628997|FG001|Overall Study|Withdrawal by Subject|3|||
19386172|NCT02174848|41628996|FG000|Overall Study|Lost to Follow-up|0|||
19386173|NCT02174848|41628997|FG001|Overall Study|Lost to Follow-up|1|||
19386174|NCT02174848|41628996|FG000|Overall Study|Worsening of disease|1|||
19386175|NCT02174848|41628997|FG001|Overall Study|Worsening of disease|1|||
19386176|NCT02174848|41628996|FG000|Overall Study|Unable to comply with study requirements|1|||
19386177|NCT02174848|41628997|FG001|Overall Study|Unable to comply with study requirements|0|||
19386178|NCT02151058|41629011|FG000|Overall Study|Withdrawal by Subject|1|||
19386179|NCT02151058|41629012|FG001|Overall Study|Withdrawal by Subject|1|||
19386180|NCT02151058|41629013|FG002|Overall Study|Withdrawal by Subject|3|||
19386181|NCT02151058|41629011|FG000|Overall Study|Lost to Follow-up|1|||
19386182|NCT02151058|41629012|FG001|Overall Study|Lost to Follow-up|0|||
19386183|NCT02151058|41629013|FG002|Overall Study|Lost to Follow-up|2|||
19386184|NCT02149810|41629023|FG000|Overall Study|Physician Decision|1|||
19386185|NCT02149810|41629024|FG001|Overall Study|Physician Decision|2|||
19386186|NCT02149810|41629023|FG000|Overall Study|Lost to Follow-up|2|||
19386187|NCT02149810|41629024|FG001|Overall Study|Lost to Follow-up|1|||
19386188|NCT02149810|41629023|FG000|Overall Study|Withdrawal by Subject|5|||
19386189|NCT02149810|41629024|FG001|Overall Study|Withdrawal by Subject|1|||
19386190|NCT02149420|41629033|FG000|Core Study|Administrative problems|0|||
19386191|NCT02149420|41629034|FG001|Core Study|Administrative problems|1|||
19386192|NCT02149420|41629035|FG002|Core Study|Administrative problems|2|||
19386193|NCT02149420|41629033|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
19386194|NCT02149420|41629034|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
19386195|NCT02149420|41629035|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
19386196|NCT02149264|41629048|FG000|Overall Study|Withdrawal by Subject|9|||
19745755|NCT03529773|42193161|FG005|Overall Study|Adverse Event|0|||
19386197|NCT02149264|41629048|FG000|Overall Study|Adverse Event|7|||
19386198|NCT02149264|41629048|FG000|Overall Study|Physician Decision|3|||
19386199|NCT02149264|41629048|FG000|Overall Study|Protocol Violation|1|||
19386200|NCT02115256|41629054|FG000|Overall Study|Withdrawal by Subject|0|||
19386201|NCT02115256|41629055|FG001|Overall Study|Withdrawal by Subject|1|||
19386202|NCT02173054|41629064|FG000|Overall Study|lack of compliance|1|||
19386203|NCT02173054|41629065|FG001|Overall Study|lack of compliance|0|||
19745756|NCT03529773|42193162|FG006|Overall Study|Adverse Event|0|||
19745757|NCT03529773|42193163|FG007|Overall Study|Adverse Event|0|||
19386204|NCT02173054|41629066|FG002|Overall Study|lack of compliance|0|||
19386205|NCT02173054|41629064|FG000|Overall Study|Withdrawal by Subject|0|||
19386206|NCT02173054|41629065|FG001|Overall Study|Withdrawal by Subject|0|||
19386207|NCT02173054|41629066|FG002|Overall Study|Withdrawal by Subject|1|||
19386208|NCT02149108|41629095|FG000|Overall Study|Not treated|1|||
19745758|NCT03529773|42193164|FG008|Overall Study|Adverse Event|0|||
19745759|NCT03529773|42193165|FG009|Overall Study|Adverse Event|0|||
19745760|NCT03529773|42193166|FG010|Overall Study|Adverse Event|0|||
19745761|NCT03529773|42193167|FG011|Overall Study|Adverse Event|0|||
19745762|NCT03529773|42193168|FG012|Overall Study|Adverse Event|0|||
19745763|NCT03529773|42193169|FG013|Overall Study|Adverse Event|0|||
19386209|NCT02149108|41629096|FG001|Overall Study|Not treated|2|||
19386210|NCT02149108|41629095|FG000|Overall Study|Progressive Disease (PD)|324|||
19386211|NCT02149108|41629096|FG001|Overall Study|Progressive Disease (PD)|318|||
19386212|NCT02149108|41629095|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
19386213|NCT02149108|41629096|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
19386214|NCT02149108|41629095|FG000|Overall Study|Other Adverse Event (AE)|8|||
19386215|NCT02149108|41629096|FG001|Overall Study|Other Adverse Event (AE)|18|||
19386216|NCT02149108|41629095|FG000|Overall Study|Other not defined above|0|||
19386217|NCT02149108|41629096|FG001|Overall Study|Other not defined above|2|||
19386218|NCT02149108|41629095|FG000|Overall Study|Refusal to continue trial medication|15|||
19386219|NCT02149108|41629096|FG001|Overall Study|Refusal to continue trial medication|11|||
19386220|NCT02149108|41629095|FG000|Overall Study|Lost to Follow-up|1|||
19386221|NCT02149108|41629096|FG001|Overall Study|Lost to Follow-up|0|||
19386222|NCT02148952|41629104|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
19386223|NCT02148952|41629105|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
19386224|NCT02148952|41629104|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
19386225|NCT02148952|41629105|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
19386226|NCT02148952|41629104|FG000|Follow-Up|Lost to Follow-up|219|||
19386227|NCT02148952|41629105|FG001|Follow-Up|Lost to Follow-up|231|||
19386228|NCT02148952|41629104|FG000|Follow-Up|Withdrawal by Subject|46|||
19386229|NCT02148952|41629105|FG001|Follow-Up|Withdrawal by Subject|48|||
19386230|NCT02148718|41629129|FG000|Overall Study|Protocol Violation|26|||
19386231|NCT02148718|41629129|FG000|Overall Study|Discontinued Study Prematurely|5|||
19386232|NCT02148250|41629133|FG000|Screening|Withdrawal by Subject|5|||
19386233|NCT02148250|41629134|FG001|Screening|Withdrawal by Subject|0|||
19386234|NCT02147626|41629143|FG000|Overall Study|Lost to Follow-up|4|||
19386235|NCT02147626|41629144|FG001|Overall Study|Lost to Follow-up|4|||
19386236|NCT02147626|41629143|FG000|Overall Study|Pregnancy|1|||
19386237|NCT02147626|41629144|FG001|Overall Study|Pregnancy|2|||
19386238|NCT02147626|41629143|FG000|Overall Study|Withdrawal by Subject|0|||
19386239|NCT02147626|41629144|FG001|Overall Study|Withdrawal by Subject|1|||
19745764|NCT03529773|42193170|FG014|Overall Study|Adverse Event|0|||
19745765|NCT03529773|42193171|FG015|Overall Study|Adverse Event|0|||
19745766|NCT03529773|42193172|FG016|Overall Study|Adverse Event|0|||
19745767|NCT03529773|42193173|FG017|Overall Study|Adverse Event|0|||
19745768|NCT03529773|42193174|FG018|Overall Study|Adverse Event|0|||
19745769|NCT03529773|42193175|FG019|Overall Study|Adverse Event|0|||
19745770|NCT03529773|42193176|FG020|Overall Study|Adverse Event|0|||
19745771|NCT03529773|42193177|FG021|Overall Study|Adverse Event|0|||
19745772|NCT03529773|42193178|FG022|Overall Study|Adverse Event|0|||
19745773|NCT03529773|42193179|FG023|Overall Study|Adverse Event|0|||
19745774|NCT03529773|42193180|FG024|Overall Study|Adverse Event|0|||
19745775|NCT03529773|42193181|FG025|Overall Study|Adverse Event|0|||
19745776|NCT03529773|42193182|FG026|Overall Study|Adverse Event|0|||
19745777|NCT03529773|42193183|FG027|Overall Study|Adverse Event|0|||
19745778|NCT03529773|42193184|FG028|Overall Study|Adverse Event|0|||
19745779|NCT03529773|42193185|FG029|Overall Study|Adverse Event|0|||
19745780|NCT03529773|42193186|FG030|Overall Study|Adverse Event|1|||
19745781|NCT03529773|42193187|FG031|Overall Study|Adverse Event|0|||
19745782|NCT03529773|42193188|FG032|Overall Study|Adverse Event|0|||
19386240|NCT02172664|41629150|FG000|Overall Study|Lost to Follow-up|4|||
19386241|NCT02172664|41629151|FG001|Overall Study|Lost to Follow-up|4|||
19386242|NCT02172664|41629150|FG000|Overall Study|Death|1|||
19386243|NCT02172664|41629151|FG001|Overall Study|Death|1|||
19386244|NCT02172664|41629150|FG000|Overall Study|Moved out of area|1|||
19386245|NCT02172664|41629151|FG001|Overall Study|Moved out of area|1|||
19386246|NCT02172040|41629160|FG000|Overall Study|Adverse Event|0|||
19386247|NCT02172040|41629161|FG001|Overall Study|Adverse Event|2|||
19386248|NCT02172040|41629162|FG002|Overall Study|Adverse Event|0|||
19745783|NCT03529773|42193189|FG033|Overall Study|Adverse Event|0|||
19745784|NCT03529773|42193190|FG034|Overall Study|Adverse Event|0|||
19386249|NCT02172040|41629163|FG003|Overall Study|Adverse Event|0|||
19386250|NCT02172040|41629160|FG000|Overall Study|Protocol Violation|0|||
19386251|NCT02172040|41629161|FG001|Overall Study|Protocol Violation|1|||
19386252|NCT02172040|41629162|FG002|Overall Study|Protocol Violation|0|||
19386253|NCT02172040|41629163|FG003|Overall Study|Protocol Violation|0|||
19386254|NCT02172040|41629160|FG000|Overall Study|Withdrawal by Subject|0|||
19386255|NCT02172040|41629161|FG001|Overall Study|Withdrawal by Subject|0|||
19386256|NCT02172040|41629162|FG002|Overall Study|Withdrawal by Subject|1|||
19386257|NCT02172040|41629163|FG003|Overall Study|Withdrawal by Subject|0|||
19386258|NCT02172040|41629160|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
19386259|NCT02172040|41629161|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
19386260|NCT02172040|41629162|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
19386261|NCT02172040|41629163|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
19386262|NCT02172040|41629160|FG000|Overall Study|Family emergency abroad|0|||
19386263|NCT02172040|41629161|FG001|Overall Study|Family emergency abroad|0|||
19386264|NCT02172040|41629162|FG002|Overall Study|Family emergency abroad|0|||
19386265|NCT02172040|41629163|FG003|Overall Study|Family emergency abroad|1|||
19386266|NCT02112994|41629203|FG000|Overall Study|Progressive Disease|0|||
19386267|NCT02112994|41629204|FG001|Overall Study|Progressive Disease|0|||
19386268|NCT02112994|41629205|FG002|Overall Study|Progressive Disease|1|||
19386269|NCT02112994|41629203|FG000|Overall Study|Pregnancy|0|||
19386270|NCT02112994|41629204|FG001|Overall Study|Pregnancy|1|||
19386271|NCT02112994|41629205|FG002|Overall Study|Pregnancy|1|||
19386272|NCT02112994|41629203|FG000|Overall Study|Liver Transplant|0|||
19386273|NCT02112994|41629204|FG001|Overall Study|Liver Transplant|1|||
19386274|NCT02112994|41629205|FG002|Overall Study|Liver Transplant|0|||
19386275|NCT02112994|41629203|FG000|Overall Study|Withdrawal by Subject|0|||
19386276|NCT02112994|41629204|FG001|Overall Study|Withdrawal by Subject|0|||
19386277|NCT02112994|41629205|FG002|Overall Study|Withdrawal by Subject|1|||
19386278|NCT02147158|41629223|FG000|Treatment Course 1|Adverse Event|1|||
19386279|NCT02147158|41629224|FG001|Treatment Course 1|Adverse Event|4|||
19386280|NCT02147158|41629225|FG002|Treatment Course 1|Adverse Event|3|||
19386281|NCT02147158|41629226|FG003|Treatment Course 1|Adverse Event|4|||
19386282|NCT02147158|41629227|FG004|Treatment Course 1|Adverse Event|1|||
19386283|NCT02147158|41629228|FG005|Treatment Course 1|Adverse Event|2|||
19386284|NCT02147158|41629223|FG000|Treatment Course 1|Lost to Follow-up|2|||
19386285|NCT02147158|41629224|FG001|Treatment Course 1|Lost to Follow-up|4|||
19386286|NCT02147158|41629225|FG002|Treatment Course 1|Lost to Follow-up|3|||
19386287|NCT02147158|41629226|FG003|Treatment Course 1|Lost to Follow-up|3|||
19386288|NCT02147158|41629227|FG004|Treatment Course 1|Lost to Follow-up|2|||
19386289|NCT02147158|41629228|FG005|Treatment Course 1|Lost to Follow-up|4|||
19386290|NCT02147158|41629223|FG000|Treatment Course 1|Protocol Violation|0|||
19386291|NCT02147158|41629224|FG001|Treatment Course 1|Protocol Violation|0|||
19386292|NCT02147158|41629225|FG002|Treatment Course 1|Protocol Violation|1|||
19386293|NCT02147158|41629226|FG003|Treatment Course 1|Protocol Violation|1|||
19386294|NCT02147158|41629227|FG004|Treatment Course 1|Protocol Violation|0|||
19386295|NCT02147158|41629228|FG005|Treatment Course 1|Protocol Violation|0|||
19386296|NCT02147158|41629223|FG000|Treatment Course 1|Withdrawal of Consent|1|||
19386297|NCT02147158|41629224|FG001|Treatment Course 1|Withdrawal of Consent|1|||
19386298|NCT02147158|41629225|FG002|Treatment Course 1|Withdrawal of Consent|1|||
19386299|NCT02147158|41629226|FG003|Treatment Course 1|Withdrawal of Consent|5|||
19386300|NCT02147158|41629227|FG004|Treatment Course 1|Withdrawal of Consent|3|||
19386301|NCT02147158|41629228|FG005|Treatment Course 1|Withdrawal of Consent|2|||
19386302|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Adverse Event|1|||
19386303|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Adverse Event|0|||
19386304|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Adverse Event|0|||
19386305|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Adverse Event|1|||
19386306|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Adverse Event|0|||
19386307|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Adverse Event|0|||
19386308|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
19386309|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
19386310|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
19386311|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
19386312|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
19386313|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
19386314|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
19386315|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
19386316|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
19386317|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
19386318|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
19386319|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
19386320|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
19386321|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
19386322|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
19386323|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
19386324|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
19386325|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
19386326|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
19386327|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
19386328|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
19386329|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
19386330|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
19386331|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
19386332|NCT02147158|41629223|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
19386333|NCT02147158|41629224|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
19386334|NCT02147158|41629225|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
19386335|NCT02147158|41629226|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
19386336|NCT02147158|41629227|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
19386337|NCT02147158|41629228|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
19386338|NCT02147158|41629223|FG000|Treatment Course 2|Adverse Event|0|||
19386339|NCT02147158|41629224|FG001|Treatment Course 2|Adverse Event|4|||
19386340|NCT02147158|41629225|FG002|Treatment Course 2|Adverse Event|2|||
19386341|NCT02147158|41629226|FG003|Treatment Course 2|Adverse Event|1|||
19386342|NCT02147158|41629227|FG004|Treatment Course 2|Adverse Event|0|||
19386343|NCT02147158|41629228|FG005|Treatment Course 2|Adverse Event|1|||
19386344|NCT02147158|41629223|FG000|Treatment Course 2|Withdrawal of Consent|0|||
19386345|NCT02147158|41629224|FG001|Treatment Course 2|Withdrawal of Consent|1|||
19386346|NCT02147158|41629225|FG002|Treatment Course 2|Withdrawal of Consent|2|||
19386347|NCT02147158|41629226|FG003|Treatment Course 2|Withdrawal of Consent|3|||
19386348|NCT02147158|41629227|FG004|Treatment Course 2|Withdrawal of Consent|0|||
19386349|NCT02147158|41629228|FG005|Treatment Course 2|Withdrawal of Consent|0|||
19386350|NCT02147158|41629223|FG000|Treatment Course 2|Lost to Follow-up|1|||
19386351|NCT02147158|41629224|FG001|Treatment Course 2|Lost to Follow-up|0|||
19386352|NCT02147158|41629225|FG002|Treatment Course 2|Lost to Follow-up|1|||
19386353|NCT02147158|41629226|FG003|Treatment Course 2|Lost to Follow-up|1|||
19386354|NCT02147158|41629227|FG004|Treatment Course 2|Lost to Follow-up|0|||
19386355|NCT02147158|41629228|FG005|Treatment Course 2|Lost to Follow-up|1|||
19386356|NCT02147158|41629223|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
19386357|NCT02147158|41629224|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
19386358|NCT02147158|41629225|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
19386359|NCT02147158|41629226|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
19386360|NCT02147158|41629227|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
19386361|NCT02147158|41629228|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
19386362|NCT02147158|41629223|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
19386363|NCT02147158|41629224|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
19386364|NCT02147158|41629225|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
19386365|NCT02147158|41629226|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
19386366|NCT02147158|41629227|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
19386367|NCT02147158|41629228|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
19386368|NCT02147158|41629223|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
19386369|NCT02147158|41629224|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
19386370|NCT02147158|41629225|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
19386371|NCT02147158|41629226|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
19386372|NCT02147158|41629227|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
19386373|NCT02147158|41629228|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
19386374|NCT02147158|41629223|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
19386375|NCT02147158|41629224|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
19386376|NCT02147158|41629225|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
19386377|NCT02147158|41629226|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
19386378|NCT02147158|41629227|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
19386379|NCT02147158|41629228|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
19386380|NCT02147158|41629223|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
19386381|NCT02147158|41629224|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
19386382|NCT02147158|41629225|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
19386383|NCT02147158|41629226|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
19386384|NCT02147158|41629227|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
19386385|NCT02147158|41629228|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
19386386|NCT02112448|41629247|FG000|Overall Study|lab values precluding use of ketorolac|2|||
19386387|NCT02112448|41629248|FG001|Overall Study|lab values precluding use of ketorolac|2|||
19386388|NCT02112448|41629247|FG000|Overall Study|Protocol Violation|1|||
19386389|NCT02112448|41629248|FG001|Overall Study|Protocol Violation|2|||
19386390|NCT02112448|41629247|FG000|Overall Study|Physician Decision|4|||
19386391|NCT02112448|41629248|FG001|Overall Study|Physician Decision|6|||
19386392|NCT02112448|41629247|FG000|Overall Study|required heparin so could not use ketoro|1|||
19386393|NCT02112448|41629248|FG001|Overall Study|required heparin so could not use ketoro|0|||
19386394|NCT02171260|41629260|FG000|Overall Study|Death|0|||
19386395|NCT02171260|41629261|FG001|Overall Study|Death|0|||
19386396|NCT02171260|41629262|FG002|Overall Study|Death|0|||
19386397|NCT02171260|41629263|FG003|Overall Study|Death|1|||
19386398|NCT02171260|41629260|FG000|Overall Study|Physician Decision|1|||
19386399|NCT02171260|41629261|FG001|Overall Study|Physician Decision|0|||
19386400|NCT02171260|41629262|FG002|Overall Study|Physician Decision|1|||
19386401|NCT02171260|41629263|FG003|Overall Study|Physician Decision|0|||
19571724|NCT01049217|42019290|FG000|Overall Study|Protocol Violation|1|||
19571725|NCT01049217|42019291|FG001|Overall Study|Protocol Violation|3|||
19386402|NCT02171260|41629260|FG000|Overall Study|Withdrawal by Subject|1|||
19386403|NCT02171260|41629261|FG001|Overall Study|Withdrawal by Subject|0|||
19386404|NCT02171260|41629262|FG002|Overall Study|Withdrawal by Subject|0|||
19386405|NCT02171260|41629263|FG003|Overall Study|Withdrawal by Subject|0|||
19386406|NCT02171260|41629260|FG000|Overall Study|Evidence of progressive disease|4|||
19386407|NCT02171260|41629261|FG001|Overall Study|Evidence of progressive disease|6|||
19386408|NCT02171260|41629262|FG002|Overall Study|Evidence of progressive disease|4|||
19386409|NCT02171260|41629263|FG003|Overall Study|Evidence of progressive disease|4|||
19386410|NCT02110732|41629281|FG000|Overall Study|Physician Decision|5|||
19386411|NCT02110732|41629282|FG001|Overall Study|Physician Decision|2|||
19386412|NCT02110732|41629281|FG000|Overall Study|Lost to Follow-up|1|||
19386413|NCT02110732|41629282|FG001|Overall Study|Lost to Follow-up|1|||
19386414|NCT02109562|41629291|FG000|Overall Study|Insufficient clinical response|2|||
19386415|NCT02109562|41629292|FG001|Overall Study|Insufficient clinical response|0|||
19386416|NCT02109562|41629293|FG002|Overall Study|Insufficient clinical response|4|||
19386417|NCT02109562|41629291|FG000|Overall Study|Adverse Event|0|||
19386418|NCT02109562|41629292|FG001|Overall Study|Adverse Event|2|||
19386419|NCT02109562|41629293|FG002|Overall Study|Adverse Event|3|||
19386420|NCT02109562|41629291|FG000|Overall Study|Lost to Follow-up|1|||
19386421|NCT02109562|41629292|FG001|Overall Study|Lost to Follow-up|0|||
19386422|NCT02109562|41629293|FG002|Overall Study|Lost to Follow-up|1|||
19386423|NCT02109562|41629291|FG000|Overall Study|Protocol Violation|0|||
19386424|NCT02109562|41629292|FG001|Overall Study|Protocol Violation|3|||
19386425|NCT02109562|41629293|FG002|Overall Study|Protocol Violation|1|||
19386426|NCT02109562|41629291|FG000|Overall Study|Withdrawal by Subject|20|||
19386427|NCT02109562|41629292|FG001|Overall Study|Withdrawal by Subject|25|||
19386428|NCT02109562|41629293|FG002|Overall Study|Withdrawal by Subject|21|||
19386429|NCT02109562|41629291|FG000|Overall Study|Physician Decision|3|||
19386430|NCT02109562|41629292|FG001|Overall Study|Physician Decision|4|||
19386431|NCT02109562|41629293|FG002|Overall Study|Physician Decision|5|||
19386432|NCT02109484|41629309|FG000|Overall Study|Lost to Follow-up|0|||
19386433|NCT02109484|41629310|FG001|Overall Study|Lost to Follow-up|0|||
19386434|NCT02109484|41629311|FG002|Overall Study|Lost to Follow-up|0|||
19386435|NCT02109484|41629312|FG003|Overall Study|Lost to Follow-up|1|||
19386436|NCT02109484|41629313|FG004|Overall Study|Lost to Follow-up|1|||
19386437|NCT02109484|41629314|FG005|Overall Study|Lost to Follow-up|0|||
19386438|NCT02109484|41629315|FG006|Overall Study|Lost to Follow-up|1|||
19386439|NCT02109484|41629316|FG007|Overall Study|Lost to Follow-up|0|||
19386440|NCT02109484|41629309|FG000|Overall Study|Withdrawal by Subject|0|||
19386441|NCT02109484|41629310|FG001|Overall Study|Withdrawal by Subject|0|||
19386442|NCT02109484|41629311|FG002|Overall Study|Withdrawal by Subject|0|||
19386443|NCT02109484|41629312|FG003|Overall Study|Withdrawal by Subject|0|||
19386444|NCT02109484|41629313|FG004|Overall Study|Withdrawal by Subject|1|||
19386445|NCT02109484|41629314|FG005|Overall Study|Withdrawal by Subject|1|||
19386446|NCT02109484|41629315|FG006|Overall Study|Withdrawal by Subject|1|||
19386447|NCT02109484|41629316|FG007|Overall Study|Withdrawal by Subject|0|||
19386448|NCT02109484|41629309|FG000|Overall Study|Physician Decision|0|||
19386449|NCT02109484|41629310|FG001|Overall Study|Physician Decision|0|||
19386450|NCT02109484|41629311|FG002|Overall Study|Physician Decision|0|||
19386451|NCT02109484|41629312|FG003|Overall Study|Physician Decision|0|||
19386452|NCT02109484|41629313|FG004|Overall Study|Physician Decision|2|||
19386453|NCT02109484|41629314|FG005|Overall Study|Physician Decision|0|||
19386454|NCT02109484|41629315|FG006|Overall Study|Physician Decision|0|||
19386455|NCT02109484|41629316|FG007|Overall Study|Physician Decision|0|||
19386456|NCT02109484|41629309|FG000|Overall Study|Death|0|||
19386457|NCT02109484|41629310|FG001|Overall Study|Death|0|||
19386458|NCT02109484|41629311|FG002|Overall Study|Death|0|||
19386459|NCT02109484|41629312|FG003|Overall Study|Death|0|||
19386460|NCT02109484|41629313|FG004|Overall Study|Death|0|||
19386461|NCT02109484|41629314|FG005|Overall Study|Death|0|||
19386462|NCT02109484|41629315|FG006|Overall Study|Death|0|||
19386463|NCT02109484|41629316|FG007|Overall Study|Death|2|||
19386464|NCT02109484|41629309|FG000|Overall Study|Moved away from study area|0|||
19386465|NCT02109484|41629310|FG001|Overall Study|Moved away from study area|0|||
19386466|NCT02109484|41629311|FG002|Overall Study|Moved away from study area|0|||
19386467|NCT02109484|41629312|FG003|Overall Study|Moved away from study area|0|||
19386468|NCT02109484|41629313|FG004|Overall Study|Moved away from study area|0|||
19386469|NCT02109484|41629314|FG005|Overall Study|Moved away from study area|0|||
19386470|NCT02109484|41629315|FG006|Overall Study|Moved away from study area|1|||
19386471|NCT02109484|41629316|FG007|Overall Study|Moved away from study area|1|||
19386472|NCT02105974|41629353|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
19386473|NCT02105974|41629354|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
19386474|NCT02105974|41629355|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
19386475|NCT02105974|41629353|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
19386476|NCT02105974|41629354|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
19386477|NCT02105974|41629355|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
19386478|NCT02105974|41629353|FG000|2 Week Run-in Period|Adverse Event|6|||
19386479|NCT02105974|41629354|FG001|2 Week Run-in Period|Adverse Event|0|||
19386480|NCT02105974|41629355|FG002|2 Week Run-in Period|Adverse Event|0|||
19386481|NCT02105974|41629353|FG000|2 Week Run-in Period|Study closed/terminated|1|||
19386482|NCT02105974|41629354|FG001|2 Week Run-in Period|Study closed/terminated|0|||
19386483|NCT02105974|41629355|FG002|2 Week Run-in Period|Study closed/terminated|0|||
19386484|NCT02105974|41629353|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
19386485|NCT02105974|41629354|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
19386486|NCT02105974|41629355|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
19386487|NCT02105974|41629353|FG000|2 Week Run-in Period|Withdrew consent|23|||
19386488|NCT02105974|41629354|FG001|2 Week Run-in Period|Withdrew consent|0|||
19386489|NCT02105974|41629355|FG002|2 Week Run-in Period|Withdrew consent|0|||
19386490|NCT02105974|41629353|FG000|2 Week Run-in Period|Investigator discretion|8|||
19386491|NCT02105974|41629354|FG001|2 Week Run-in Period|Investigator discretion|0|||
19386492|NCT02105974|41629355|FG002|2 Week Run-in Period|Investigator discretion|0|||
19386493|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
19386494|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
19386495|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
19386496|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
19386497|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
19386498|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
19386499|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
19386500|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
19386501|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
19386502|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
19386503|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
19386504|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
19386505|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
19386506|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
19386507|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
19386508|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
19386509|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
19386510|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
19386511|NCT02105974|41629353|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
19386512|NCT02105974|41629354|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
19386513|NCT02105974|41629355|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
19386514|NCT02105662|41629361|FG000|Overall Study|Lost to Follow-up|5|||
19386515|NCT02105662|41629361|FG000|Overall Study|Withdrawal by Subject|1|||
19386516|NCT02143102|41629367|FG000|Overall Study|Lost to Follow-up|11|||
19386517|NCT02143102|41629368|FG001|Overall Study|Lost to Follow-up|0|||
19386518|NCT02143024|41629376|FG000|Overall Study|Lost to Follow-up|1|||
19386519|NCT02143024|41629377|FG001|Overall Study|Lost to Follow-up|1|||
19386520|NCT02143024|41629376|FG000|Overall Study|Withdrawal by Subject|1|||
19386521|NCT02143024|41629377|FG001|Overall Study|Withdrawal by Subject|0|||
19386522|NCT02142712|41629386|FG000|Overall Study|Lost to Follow-up|1|||
19386523|NCT02142712|41629387|FG001|Overall Study|Lost to Follow-up|1|||
19386524|NCT02142712|41629388|FG002|Overall Study|Lost to Follow-up|1|||
19386525|NCT02142712|41629389|FG003|Overall Study|Lost to Follow-up|0|||
19386526|NCT02105272|41629400|FG000|Overall Study|Adverse Event|1|||
19386527|NCT02105272|41629401|FG001|Overall Study|Adverse Event|2|||
19386528|NCT02105272|41629400|FG000|Overall Study|Physician Decision|0|||
19386529|NCT02105272|41629401|FG001|Overall Study|Physician Decision|1|||
19386530|NCT02105272|41629400|FG000|Overall Study|Protocol Violation|2|||
19386531|NCT02105272|41629401|FG001|Overall Study|Protocol Violation|0|||
19386532|NCT02105272|41629400|FG000|Overall Study|Withdrawal by Subject|2|||
19386533|NCT02105272|41629401|FG001|Overall Study|Withdrawal by Subject|0|||
19386534|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
19386535|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19386536|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19386537|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19386538|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19386539|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19386540|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
19386541|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19386542|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19386543|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19386544|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19386545|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19386546|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
19386547|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19386548|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19386549|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19386550|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19386551|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19386552|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Other|14|||
19386553|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Other|0|||
19386554|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Other|0|||
19386555|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Other|0|||
19386556|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Other|0|||
19386557|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Other|0|||
19386558|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
19386559|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
19386560|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
19386561|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
19386562|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
19386563|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
19386564|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
19386565|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19386566|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19386567|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19386568|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19386569|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19386570|NCT02141854|41629412|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
19386571|NCT02141854|41629413|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19386572|NCT02141854|41629414|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19386573|NCT02141854|41629415|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19386574|NCT02141854|41629416|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19386575|NCT02141854|41629417|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19386576|NCT02141854|41629412|FG000|Treatment Period|Protocol Violation|0|||
19386577|NCT02141854|41629413|FG001|Treatment Period|Protocol Violation|1|||
19386578|NCT02141854|41629414|FG002|Treatment Period|Protocol Violation|0|||
19386579|NCT02141854|41629415|FG003|Treatment Period|Protocol Violation|2|||
19386580|NCT02141854|41629416|FG004|Treatment Period|Protocol Violation|2|||
19386581|NCT02141854|41629417|FG005|Treatment Period|Protocol Violation|1|||
19386582|NCT02141854|41629412|FG000|Treatment Period|Noncompliance|0|||
19386583|NCT02141854|41629413|FG001|Treatment Period|Noncompliance|0|||
19386584|NCT02141854|41629414|FG002|Treatment Period|Noncompliance|0|||
19386585|NCT02141854|41629415|FG003|Treatment Period|Noncompliance|1|||
19386586|NCT02141854|41629416|FG004|Treatment Period|Noncompliance|0|||
19386587|NCT02141854|41629417|FG005|Treatment Period|Noncompliance|0|||
19386588|NCT02141854|41629412|FG000|Treatment Period|Lack of Efficacy|0|||
19386589|NCT02141854|41629413|FG001|Treatment Period|Lack of Efficacy|0|||
19386590|NCT02141854|41629414|FG002|Treatment Period|Lack of Efficacy|0|||
19386591|NCT02141854|41629415|FG003|Treatment Period|Lack of Efficacy|1|||
19386592|NCT02141854|41629416|FG004|Treatment Period|Lack of Efficacy|1|||
19386593|NCT02141854|41629417|FG005|Treatment Period|Lack of Efficacy|7|||
19386594|NCT02141854|41629412|FG000|Treatment Period|Pregnancy|0|||
19386595|NCT02141854|41629413|FG001|Treatment Period|Pregnancy|1|||
19386596|NCT02141854|41629414|FG002|Treatment Period|Pregnancy|0|||
19386597|NCT02141854|41629415|FG003|Treatment Period|Pregnancy|0|||
19386598|NCT02141854|41629416|FG004|Treatment Period|Pregnancy|0|||
19386599|NCT02141854|41629417|FG005|Treatment Period|Pregnancy|0|||
19386600|NCT02141854|41629412|FG000|Treatment Period|Other|0|||
19386601|NCT02141854|41629413|FG001|Treatment Period|Other|1|||
19386602|NCT02141854|41629414|FG002|Treatment Period|Other|2|||
19386603|NCT02141854|41629415|FG003|Treatment Period|Other|0|||
19386604|NCT02141854|41629416|FG004|Treatment Period|Other|1|||
19386605|NCT02141854|41629417|FG005|Treatment Period|Other|2|||
19386606|NCT02141854|41629412|FG000|Treatment Period|Adverse Event|0|||
19386607|NCT02141854|41629413|FG001|Treatment Period|Adverse Event|2|||
19386608|NCT02141854|41629414|FG002|Treatment Period|Adverse Event|2|||
19386609|NCT02141854|41629415|FG003|Treatment Period|Adverse Event|0|||
19386610|NCT02141854|41629416|FG004|Treatment Period|Adverse Event|2|||
19386611|NCT02141854|41629417|FG005|Treatment Period|Adverse Event|2|||
19386612|NCT02141854|41629412|FG000|Treatment Period|Withdrawal by Subject|0|||
19386613|NCT02141854|41629413|FG001|Treatment Period|Withdrawal by Subject|2|||
19386614|NCT02141854|41629414|FG002|Treatment Period|Withdrawal by Subject|3|||
19386615|NCT02141854|41629415|FG003|Treatment Period|Withdrawal by Subject|3|||
19386616|NCT02141854|41629416|FG004|Treatment Period|Withdrawal by Subject|4|||
19386617|NCT02141854|41629417|FG005|Treatment Period|Withdrawal by Subject|7|||
19386618|NCT02141854|41629412|FG000|Treatment Period|Disease progression|0|||
19386619|NCT02141854|41629413|FG001|Treatment Period|Disease progression|2|||
19386620|NCT02141854|41629414|FG002|Treatment Period|Disease progression|1|||
19386621|NCT02141854|41629415|FG003|Treatment Period|Disease progression|3|||
19386622|NCT02141854|41629416|FG004|Treatment Period|Disease progression|0|||
19386623|NCT02141854|41629417|FG005|Treatment Period|Disease progression|18|||
19386624|NCT02141854|41629412|FG000|Treatment Period|Lost to Follow-up|0|||
19386625|NCT02141854|41629413|FG001|Treatment Period|Lost to Follow-up|1|||
19386626|NCT02141854|41629414|FG002|Treatment Period|Lost to Follow-up|1|||
19386627|NCT02141854|41629415|FG003|Treatment Period|Lost to Follow-up|1|||
19386628|NCT02141854|41629416|FG004|Treatment Period|Lost to Follow-up|0|||
19386629|NCT02141854|41629417|FG005|Treatment Period|Lost to Follow-up|1|||
19386630|NCT02587221|41629431|FG000|Overall Study|Adverse Event|3|||
19386631|NCT02587221|41629432|FG001|Overall Study|Adverse Event|3|||
19386632|NCT02587221|41629431|FG000|Overall Study|Death|33|||
19386633|NCT02587221|41629432|FG001|Overall Study|Death|34|||
19386634|NCT02587221|41629431|FG000|Overall Study|Withdrawal by Subject|66|||
19386635|NCT02587221|41629432|FG001|Overall Study|Withdrawal by Subject|61|||
19386636|NCT02587221|41629431|FG000|Overall Study|Lost to Follow-up|21|||
19386637|NCT02587221|41629432|FG001|Overall Study|Lost to Follow-up|19|||
19386638|NCT02587221|41629431|FG000|Overall Study|Protocol Violation|6|||
19386639|NCT02587221|41629432|FG001|Overall Study|Protocol Violation|5|||
19386640|NCT02587221|41629431|FG000|Overall Study|Other Reason or Unspecified|2|||
19386641|NCT02587221|41629432|FG001|Overall Study|Other Reason or Unspecified|1|||
19386642|NCT02141620|41629438|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
19386643|NCT02141620|41629439|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
19386644|NCT02106910|41629447|FG000|Overall Study|Lost to Follow-up|1|||
19386645|NCT02106910|41629448|FG001|Overall Study|Lost to Follow-up|1|||
19386646|NCT01664949|41629457|FG000|Overall Study|Adverse Event|11|||
19386647|NCT01664949|41629458|FG001|Overall Study|Adverse Event|12|||
19386648|NCT01664949|41629457|FG000|Overall Study|Lack of Efficacy|1|||
19386649|NCT01664949|41629458|FG001|Overall Study|Lack of Efficacy|1|||
19386650|NCT01664949|41629457|FG000|Overall Study|Lost to Follow-up|1|||
19386651|NCT01664949|41629458|FG001|Overall Study|Lost to Follow-up|2|||
19386652|NCT01664949|41629457|FG000|Overall Study|Personal Reasons|3|||
19386653|NCT01664949|41629458|FG001|Overall Study|Personal Reasons|4|||
19386654|NCT01664949|41629457|FG000|Overall Study|Protocol Violation|5|||
19386655|NCT01664949|41629458|FG001|Overall Study|Protocol Violation|5|||
19386656|NCT01664949|41629457|FG000|Overall Study|Other Miscellaneous Reasons|3|||
19386657|NCT01664949|41629458|FG001|Overall Study|Other Miscellaneous Reasons|1|||
19386658|NCT02587143|41629466|FG000|Overall Study|Adverse Event|1|||
19386659|NCT02587143|41629467|FG001|Overall Study|Adverse Event|0|||
19386660|NCT02587065|41629473|FG000|Overall Study|Adverse Event|14|||
19386661|NCT02587065|41629473|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
19386662|NCT02587065|41629473|FG000|Overall Study|Non-adherence to the Protocol|3|||
19386663|NCT02587065|41629473|FG000|Overall Study|Discontinuation of Study Medication|2|||
19386664|NCT02587065|41629473|FG000|Overall Study|Reason not Specified|3|||
19386665|NCT02106832|41629481|FG000|Overall Study|Adverse Event|1|||
19386666|NCT02106832|41629482|FG001|Overall Study|Adverse Event|2|||
19386667|NCT02106832|41629483|FG002|Overall Study|Adverse Event|3|||
19386668|NCT02106832|41629484|FG003|Overall Study|Adverse Event|0|||
19386669|NCT02106832|41629481|FG000|Overall Study|Death|4|||
19571726|NCT01049217|42019290|FG000|Overall Study|Pregnancy|1|||
19571727|NCT01049217|42019291|FG001|Overall Study|Pregnancy|0|||
19571728|NCT01049217|42019290|FG000|Overall Study|Study Terminated by Sponsor|43|||
19571729|NCT01049217|42019291|FG001|Overall Study|Study Terminated by Sponsor|43|||
19571730|NCT01049217|42019290|FG000|Overall Study|Other|1|||
19571731|NCT01049217|42019291|FG001|Overall Study|Other|2|||
19571732|NCT01049217|42019290|FG000|Overall Study|Randomized but not Treated|0|||
19571733|NCT01049217|42019291|FG001|Overall Study|Randomized but not Treated|2|||
19571734|NCT01232738|42019297|FG000|Overall Study|Death|3|||
19571735|NCT01232738|42019297|FG000|Overall Study|Physician Decision|2|||
19571736|NCT01232738|42019297|FG000|Overall Study|Lost to Follow-up|1|||
19571737|NCT01232738|42019297|FG000|Overall Study|Withdrawal by Subject|2|||
19571738|NCT01232738|42019297|FG000|Overall Study|Adverse Event|5|||
19571739|NCT00957268|42019310|FG000|Overall Study|Voluntary Withdrawal|0|||
19571740|NCT00957268|42019311|FG001|Overall Study|Voluntary Withdrawal|0|||
19571741|NCT00957268|42019312|FG002|Overall Study|Voluntary Withdrawal|1|||
19571742|NCT00957268|42019313|FG003|Overall Study|Voluntary Withdrawal|0|||
19571743|NCT00957268|42019314|FG004|Overall Study|Voluntary Withdrawal|0|||
19571744|NCT01230788|42019326|FG000|Overall Study|Prescribed exclusion drug|1|||
19571745|NCT01230710|42019330|FG000|Overall Study|Disease Progression|41|||
19571746|NCT01230710|42019330|FG000|Overall Study|Lost to Follow-up|3|||
19571747|NCT01230710|42019330|FG000|Overall Study|Death|4|||
19571748|NCT01230710|42019330|FG000|Overall Study|Withdrawal of Consent|1|||
19571749|NCT01230554|42019334|FG000|Overall Study|Lost to Follow-up|2|||
19571750|NCT01230554|42019334|FG000|Overall Study|Inability to maintain visit schedule|1|||
19571751|NCT01040793|42019338|FG000|Overall Study|Adverse Event|5|||
19571752|NCT01040793|42019339|FG001|Overall Study|Adverse Event|3|||
19571753|NCT01040793|42019340|FG002|Overall Study|Adverse Event|0|||
19571754|NCT01040793|42019341|FG003|Overall Study|Adverse Event|2|||
19571755|NCT01040793|42019342|FG004|Overall Study|Adverse Event|2|||
19571756|NCT01040793|42019343|FG005|Overall Study|Adverse Event|1|||
19571757|NCT01040793|42019338|FG000|Overall Study|Protocol Violation|1|||
19571758|NCT01040793|42019339|FG001|Overall Study|Protocol Violation|1|||
19571759|NCT01040793|42019340|FG002|Overall Study|Protocol Violation|1|||
19571760|NCT01040793|42019341|FG003|Overall Study|Protocol Violation|0|||
19571761|NCT01040793|42019342|FG004|Overall Study|Protocol Violation|1|||
19571762|NCT01040793|42019343|FG005|Overall Study|Protocol Violation|0|||
19571763|NCT01040793|42019338|FG000|Overall Study|Lost to Follow-up|0|||
19571764|NCT01040793|42019339|FG001|Overall Study|Lost to Follow-up|1|||
19571765|NCT01040793|42019340|FG002|Overall Study|Lost to Follow-up|1|||
19571766|NCT01040793|42019341|FG003|Overall Study|Lost to Follow-up|0|||
19571767|NCT01040793|42019342|FG004|Overall Study|Lost to Follow-up|0|||
19571768|NCT01040793|42019343|FG005|Overall Study|Lost to Follow-up|0|||
19571769|NCT01040793|42019338|FG000|Overall Study|Withdrawal by Subject|0|||
19571770|NCT01040793|42019339|FG001|Overall Study|Withdrawal by Subject|0|||
19571771|NCT01040793|42019340|FG002|Overall Study|Withdrawal by Subject|0|||
19571772|NCT01040793|42019341|FG003|Overall Study|Withdrawal by Subject|2|||
19571773|NCT01040793|42019342|FG004|Overall Study|Withdrawal by Subject|0|||
19571774|NCT01040793|42019343|FG005|Overall Study|Withdrawal by Subject|0|||
19571775|NCT01040793|42019338|FG000|Overall Study|Other reasons not listed above|0|||
19571776|NCT01040793|42019339|FG001|Overall Study|Other reasons not listed above|0|||
19571777|NCT01040793|42019340|FG002|Overall Study|Other reasons not listed above|1|||
19386670|NCT02106832|41629482|FG001|Overall Study|Death|4|||
19386671|NCT02106832|41629483|FG002|Overall Study|Death|1|||
19571778|NCT01040793|42019341|FG003|Overall Study|Other reasons not listed above|0|||
19571779|NCT01040793|42019342|FG004|Overall Study|Other reasons not listed above|1|||
19571780|NCT01040793|42019343|FG005|Overall Study|Other reasons not listed above|0|||
19571781|NCT00948064|42019356|FG000|Phase I|No treatment received|1|||
19571782|NCT00948064|42019357|FG001|Phase I|No treatment received|0|||
19571783|NCT00948064|42019358|FG002|Phase I|No treatment received|0|||
19571784|NCT00948064|42019356|FG000|Phase II|Physician Decision|0|||
19571785|NCT00948064|42019357|FG001|Phase II|Physician Decision|0|||
19386672|NCT02106832|41629484|FG003|Overall Study|Death|4|||
19571786|NCT00948064|42019358|FG002|Phase II|Physician Decision|1|||
19571787|NCT00948064|42019356|FG000|Phase II|Withdrawal by Subject|0|||
19571788|NCT00948064|42019357|FG001|Phase II|Withdrawal by Subject|1|||
19571789|NCT00948064|42019358|FG002|Phase II|Withdrawal by Subject|0|||
19571790|NCT00953524|42019372|FG000|Overall Study|Adverse Event|2|||
19571791|NCT00953524|42019373|FG001|Overall Study|Adverse Event|0|||
19386673|NCT02106832|41629481|FG000|Overall Study|Deterioration of general conditions|0|||
19386674|NCT02106832|41629482|FG001|Overall Study|Deterioration of general conditions|0|||
19386675|NCT02106832|41629483|FG002|Overall Study|Deterioration of general conditions|1|||
19386676|NCT02106832|41629484|FG003|Overall Study|Deterioration of general conditions|0|||
19386677|NCT02106832|41629481|FG000|Overall Study|Lost to Follow-up|0|||
19386678|NCT02106832|41629482|FG001|Overall Study|Lost to Follow-up|1|||
19386679|NCT02106832|41629483|FG002|Overall Study|Lost to Follow-up|1|||
19386680|NCT02106832|41629484|FG003|Overall Study|Lost to Follow-up|3|||
19386681|NCT02106832|41629481|FG000|Overall Study|Physician Decision|1|||
19386682|NCT02106832|41629482|FG001|Overall Study|Physician Decision|0|||
19386683|NCT02106832|41629483|FG002|Overall Study|Physician Decision|0|||
19386684|NCT02106832|41629484|FG003|Overall Study|Physician Decision|0|||
19386685|NCT02106832|41629481|FG000|Overall Study|Protocol Violation|0|||
19386686|NCT02106832|41629482|FG001|Overall Study|Protocol Violation|0|||
19386687|NCT02106832|41629483|FG002|Overall Study|Protocol Violation|0|||
19386688|NCT02106832|41629484|FG003|Overall Study|Protocol Violation|1|||
19386689|NCT02106832|41629481|FG000|Overall Study|Withdrawal by Subject|17|||
19386690|NCT02106832|41629482|FG001|Overall Study|Withdrawal by Subject|17|||
19386691|NCT02106832|41629483|FG002|Overall Study|Withdrawal by Subject|10|||
19386692|NCT02106832|41629484|FG003|Overall Study|Withdrawal by Subject|7|||
19386693|NCT02106832|41629481|FG000|Overall Study|Technical problems|0|||
19386694|NCT02106832|41629482|FG001|Overall Study|Technical problems|1|||
19386695|NCT02106832|41629483|FG002|Overall Study|Technical problems|0|||
19386696|NCT02106832|41629484|FG003|Overall Study|Technical problems|0|||
19386697|NCT02106442|41629496|FG000|Overall Study|Case Report Forms Uncollected|7|||
19386698|NCT02106442|41629496|FG000|Overall Study|Protocol Deviation|30|||
19386699|NCT02105116|41629500|FG000|Overall Study|not eligible for step 2 of trial|5|||
19386700|NCT02105116|41629500|FG000|Overall Study|Death|1|||
19386701|NCT02104804|41629506|FG000|Overall Study|Did not take study medication|0|||
19386702|NCT02104804|41629507|FG001|Overall Study|Did not take study medication|1|||
19571792|NCT00953524|42019374|FG002|Overall Study|Adverse Event|1|||
19571793|NCT00953524|42019375|FG003|Overall Study|Adverse Event|2|||
19571794|NCT00953524|42019372|FG000|Overall Study|Protocol Violation|18|||
19571795|NCT00953524|42019373|FG001|Overall Study|Protocol Violation|10|||
19571796|NCT00953524|42019374|FG002|Overall Study|Protocol Violation|11|||
19571797|NCT00953524|42019375|FG003|Overall Study|Protocol Violation|6|||
19571798|NCT00953524|42019372|FG000|Overall Study|Lost to Follow-up|0|||
19571799|NCT00953524|42019373|FG001|Overall Study|Lost to Follow-up|1|||
19571800|NCT00953524|42019374|FG002|Overall Study|Lost to Follow-up|1|||
19571801|NCT00953524|42019375|FG003|Overall Study|Lost to Follow-up|0|||
19571802|NCT00953524|42019372|FG000|Overall Study|Withdrawal by Subject|2|||
19571803|NCT00953524|42019373|FG001|Overall Study|Withdrawal by Subject|4|||
19571804|NCT00953524|42019374|FG002|Overall Study|Withdrawal by Subject|1|||
19571805|NCT00953524|42019375|FG003|Overall Study|Withdrawal by Subject|0|||
19571806|NCT01040403|42019394|FG000|Overall Study|Adverse Event|10|||
19571807|NCT01040403|42019394|FG000|Overall Study|Protocol Violation|2|||
19571808|NCT01040403|42019394|FG000|Overall Study|Lost to Follow-up|1|||
19571809|NCT01040403|42019394|FG000|Overall Study|Not treated|1|||
19571810|NCT01040403|42019394|FG000|Overall Study|Other reason not defined above|6|||
19571811|NCT00957034|42019416|FG000|Overall Study|Adverse Event|0|||
19571812|NCT00957034|42019417|FG001|Overall Study|Adverse Event|1|||
19571813|NCT00957034|42019418|FG002|Overall Study|Adverse Event|1|||
19571814|NCT00957034|42019416|FG000|Overall Study|Sponsor Terminated Study|6|||
19571815|NCT00957034|42019417|FG001|Overall Study|Sponsor Terminated Study|1|||
19571816|NCT00957034|42019418|FG002|Overall Study|Sponsor Terminated Study|5|||
19571817|NCT00957034|42019416|FG000|Overall Study|Withdrawal by Subject|0|||
19571818|NCT00957034|42019417|FG001|Overall Study|Withdrawal by Subject|2|||
19571819|NCT00957034|42019418|FG002|Overall Study|Withdrawal by Subject|0|||
19571820|NCT00953056|42019441|FG000|Overall Study|Withdrew Consent|0|||
19571821|NCT00953056|42019442|FG001|Overall Study|Withdrew Consent|0|||
19571822|NCT00953056|42019443|FG002|Overall Study|Withdrew Consent|0|||
19571823|NCT00953056|42019444|FG003|Overall Study|Withdrew Consent|0|||
19571824|NCT00953056|42019445|FG004|Overall Study|Withdrew Consent|2|||
19571825|NCT00953056|42019446|FG005|Overall Study|Withdrew Consent|3|||
19571826|NCT00953056|42019441|FG000|Overall Study|Serious Adverse Event|0|||
19571827|NCT00953056|42019442|FG001|Overall Study|Serious Adverse Event|0|||
19571828|NCT00953056|42019443|FG002|Overall Study|Serious Adverse Event|0|||
19571829|NCT00953056|42019444|FG003|Overall Study|Serious Adverse Event|0|||
19571830|NCT00953056|42019445|FG004|Overall Study|Serious Adverse Event|0|||
19571831|NCT00953056|42019446|FG005|Overall Study|Serious Adverse Event|1|||
19571832|NCT00952822|42019471|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
19386703|NCT02104804|41629506|FG000|Overall Study|Study specific discontinuation criteria|6|||
19386704|NCT02104804|41629507|FG001|Overall Study|Study specific discontinuation criteria|1|||
19386705|NCT02104804|41629506|FG000|Overall Study|Other listed|2|||
19386706|NCT02104804|41629507|FG001|Overall Study|Other listed|1|||
19386707|NCT02104804|41629506|FG000|Overall Study|Protocol Violation|0|||
19571833|NCT00952822|42019472|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
19571834|NCT00952822|42019473|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
19571835|NCT00952822|42019474|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
19571836|NCT00952822|42019471|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
19571837|NCT00952822|42019472|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
19571838|NCT00952822|42019473|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
19571839|NCT00952822|42019474|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
19571840|NCT01038297|42019488|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
19571841|NCT01038297|42019489|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
19571842|NCT01038297|42019490|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
19571843|NCT00955708|42019507|FG000|Overall Study|Death|269|||
19571844|NCT00955708|42019507|FG000|Overall Study|Lost to Follow-up|72|||
19571845|NCT00955708|42019507|FG000|Overall Study|Physician Decision|36|||
19571846|NCT00955708|42019507|FG000|Overall Study|Protocol Violation|134|||
19571847|NCT00955708|42019507|FG000|Overall Study|Registry Conclusion|186|||
19571848|NCT00955708|42019507|FG000|Overall Study|Product removed from service|94|||
19571849|NCT00955708|42019507|FG000|Overall Study|Patient Refused to participate further|116|||
19571850|NCT00955708|42019507|FG000|Overall Study|Closure of study location|60|||
19571851|NCT00955708|42019507|FG000|Overall Study|Patient changed care provider/moved|91|||
19571852|NCT01037985|42019511|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
19571853|NCT01037985|42019512|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
19571854|NCT01037985|42019511|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
19571855|NCT01037985|42019512|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
19571856|NCT01037985|42019511|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
19571857|NCT01037985|42019512|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
19571858|NCT01037985|42019511|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
19571859|NCT01037985|42019512|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
19571860|NCT00955474|42019524|FG000|Overall Study|Physician Decision|7|||
19571861|NCT00955474|42019525|FG001|Overall Study|Physician Decision|5|||
19571862|NCT01229150|42019537|FG000|Overall Study|Toxicity|2|||
19571863|NCT01229150|42019538|FG001|Overall Study|Toxicity|2|||
19571864|NCT01229150|42019539|FG002|Overall Study|Toxicity|0|||
19571865|NCT01229150|42019540|FG003|Overall Study|Toxicity|0|||
19571866|NCT00952588|42019556|FG000|Overall Study|Death|28|||
19571867|NCT00952588|42019557|FG001|Overall Study|Death|13|||
19571868|NCT00952588|42019556|FG000|Overall Study|Withdrawal by Subject|2|||
19571869|NCT00952588|42019557|FG001|Overall Study|Withdrawal by Subject|5|||
19571870|NCT00952588|42019556|FG000|Overall Study|Adverse Event|2|||
19571871|NCT00952588|42019557|FG001|Overall Study|Adverse Event|3|||
19571872|NCT00952588|42019556|FG000|Overall Study|Lost to Follow-up|2|||
19571873|NCT00952588|42019557|FG001|Overall Study|Lost to Follow-up|0|||
19571874|NCT00952588|42019556|FG000|Overall Study|Physician Decision|0|||
19571875|NCT00952588|42019557|FG001|Overall Study|Physician Decision|1|||
19571876|NCT00952588|42019556|FG000|Overall Study|Lack of Efficacy|2|||
19571877|NCT00952588|42019557|FG001|Overall Study|Lack of Efficacy|2|||
19571878|NCT01227902|42019567|FG000|Overall Study|Adverse Event|12|||
19571879|NCT01227902|42019568|FG001|Overall Study|Adverse Event|8|||
19571880|NCT01227902|42019569|FG002|Overall Study|Adverse Event|11|||
19571881|NCT01227902|42019570|FG003|Overall Study|Adverse Event|4|||
19571882|NCT01227902|42019567|FG000|Overall Study|Lack of Efficacy|1|||
19571883|NCT01227902|42019568|FG001|Overall Study|Lack of Efficacy|2|||
19571884|NCT01227902|42019569|FG002|Overall Study|Lack of Efficacy|2|||
19571885|NCT01227902|42019570|FG003|Overall Study|Lack of Efficacy|1|||
19571886|NCT01227902|42019567|FG000|Overall Study|Protocol Violation|1|||
19571887|NCT01227902|42019568|FG001|Overall Study|Protocol Violation|0|||
19571888|NCT01227902|42019569|FG002|Overall Study|Protocol Violation|0|||
19571889|NCT01227902|42019570|FG003|Overall Study|Protocol Violation|0|||
19571890|NCT01227902|42019567|FG000|Overall Study|Lost to Follow-up|0|||
19571891|NCT01227902|42019568|FG001|Overall Study|Lost to Follow-up|0|||
19571892|NCT01227902|42019569|FG002|Overall Study|Lost to Follow-up|1|||
19571893|NCT01227902|42019570|FG003|Overall Study|Lost to Follow-up|2|||
19571894|NCT01227902|42019567|FG000|Overall Study|Physician Decision|0|||
19571895|NCT01227902|42019568|FG001|Overall Study|Physician Decision|1|||
19571896|NCT01227902|42019569|FG002|Overall Study|Physician Decision|1|||
19571897|NCT01227902|42019570|FG003|Overall Study|Physician Decision|0|||
19571898|NCT01227902|42019567|FG000|Overall Study|Withdrawal by Subject|4|||
19571899|NCT01227902|42019568|FG001|Overall Study|Withdrawal by Subject|2|||
19571900|NCT01227902|42019569|FG002|Overall Study|Withdrawal by Subject|4|||
19571901|NCT01227902|42019570|FG003|Overall Study|Withdrawal by Subject|3|||
19571902|NCT00946192|42019584|FG000|Overall Study|Lost to Follow-up|6|||
19571903|NCT00946192|42019585|FG001|Overall Study|Lost to Follow-up|11|||
19571904|NCT00946192|42019586|FG002|Overall Study|Lost to Follow-up|9|||
19386708|NCT02104804|41629507|FG001|Overall Study|Protocol Violation|1|||
19571905|NCT00946192|42019584|FG000|Overall Study|Withdrawal by Subject|10|||
19571906|NCT00946192|42019585|FG001|Overall Study|Withdrawal by Subject|7|||
19571907|NCT00946192|42019586|FG002|Overall Study|Withdrawal by Subject|3|||
19571908|NCT00946192|42019584|FG000|Overall Study|Did not start medication|2|||
19571909|NCT00946192|42019585|FG001|Overall Study|Did not start medication|0|||
19571910|NCT00946192|42019586|FG002|Overall Study|Did not start medication|0|||
19571911|NCT01037127|42019596|FG000|Overall Study|Lost to Follow-up|2|||
19571912|NCT01037127|42019597|FG001|Overall Study|Lost to Follow-up|4|||
19571913|NCT01037127|42019596|FG000|Overall Study|Physician Decision|1|||
19571914|NCT01037127|42019597|FG001|Overall Study|Physician Decision|0|||
19571915|NCT01037127|42019596|FG000|Overall Study|Study Closed Terminated|2|||
19571916|NCT01037127|42019597|FG001|Overall Study|Study Closed Terminated|17|||
19571917|NCT00946114|42019615|FG000|Overall Study|Death|5|||
19571918|NCT00946114|42019616|FG001|Overall Study|Death|2|||
19571919|NCT00946114|42019615|FG000|Overall Study|Other|1|||
19571920|NCT00946114|42019616|FG001|Overall Study|Other|0|||
19571921|NCT00946114|42019615|FG000|Overall Study|Withdrawal by Subject|2|||
19571922|NCT00946114|42019616|FG001|Overall Study|Withdrawal by Subject|0|||
19571923|NCT01038921|42019624|FG000|Overall Study|Withdrawal by Subject|1|||
19571924|NCT01038921|42019625|FG001|Overall Study|Withdrawal by Subject|0|||
19571925|NCT01038921|42019624|FG000|Overall Study|Physician Decision|1|||
19571926|NCT01038921|42019625|FG001|Overall Study|Physician Decision|0|||
19571927|NCT01038687|42019634|FG000|Overall Study|Adverse Event|0|||
19571928|NCT01038687|42019635|FG001|Overall Study|Adverse Event|2|||
19571929|NCT01038687|42019636|FG002|Overall Study|Adverse Event|1|||
19571930|NCT01081912|42019644|FG000|Conversion/Titration|Adverse Event|47|||
19571931|NCT01081912|42019645|FG001|Conversion/Titration|Adverse Event|0|||
19571932|NCT01081912|42019646|FG002|Conversion/Titration|Adverse Event|0|||
19571933|NCT01081912|42019644|FG000|Conversion/Titration|Lack of Efficacy|17|||
19571934|NCT01081912|42019645|FG001|Conversion/Titration|Lack of Efficacy|0|||
19571935|NCT01081912|42019646|FG002|Conversion/Titration|Lack of Efficacy|0|||
19571936|NCT01081912|42019644|FG000|Conversion/Titration|Lost to Follow-up|5|||
19571937|NCT01081912|42019645|FG001|Conversion/Titration|Lost to Follow-up|0|||
19571938|NCT01081912|42019646|FG002|Conversion/Titration|Lost to Follow-up|0|||
19571939|NCT01081912|42019644|FG000|Conversion/Titration|Physician Decision|2|||
19571940|NCT01081912|42019645|FG001|Conversion/Titration|Physician Decision|0|||
19571941|NCT01081912|42019646|FG002|Conversion/Titration|Physician Decision|0|||
19571942|NCT01081912|42019644|FG000|Conversion/Titration|Protocol Violation|67|||
19571943|NCT01081912|42019645|FG001|Conversion/Titration|Protocol Violation|0|||
19571944|NCT01081912|42019646|FG002|Conversion/Titration|Protocol Violation|0|||
19571945|NCT01081912|42019644|FG000|Conversion/Titration|Withdrawal by Subject|23|||
19571946|NCT01081912|42019645|FG001|Conversion/Titration|Withdrawal by Subject|0|||
19571947|NCT01081912|42019646|FG002|Conversion/Titration|Withdrawal by Subject|0|||
19571948|NCT01081912|42019644|FG000|Conversion/Titration|Non-Compliance|47|||
19571949|NCT01081912|42019645|FG001|Conversion/Titration|Non-Compliance|0|||
19571950|NCT01081912|42019646|FG002|Conversion/Titration|Non-Compliance|0|||
19571951|NCT01081912|42019644|FG000|Maintenance Treatment|Adverse Event|0|||
19571952|NCT01081912|42019645|FG001|Maintenance Treatment|Adverse Event|2|||
19571953|NCT01081912|42019646|FG002|Maintenance Treatment|Adverse Event|12|||
19386709|NCT02104804|41629506|FG000|Overall Study|Adverse Event|4|||
19386710|NCT02104804|41629507|FG001|Overall Study|Adverse Event|3|||
19386711|NCT02104804|41629506|FG000|Overall Study|Withdrawal by Subject|4|||
19386712|NCT02104804|41629507|FG001|Overall Study|Withdrawal by Subject|12|||
19386713|NCT02075008|41629513|FG000|Overall Study|Technical problems|1|||
19386714|NCT02075008|41629513|FG000|Overall Study|Pregnancy|1|||
19386715|NCT02075008|41629513|FG000|Overall Study|Physician Decision|1|||
19386716|NCT02075008|41629513|FG000|Overall Study|Lost to Follow-up|1|||
19386717|NCT02075008|41629513|FG000|Overall Study|Lack of Efficacy|1|||
19386718|NCT02075008|41629513|FG000|Overall Study|Death|1|||
19386719|NCT02075008|41629513|FG000|Overall Study|Adverse Event|5|||
19386720|NCT02075008|41629513|FG000|Overall Study|Withdrawal by Subject|6|||
19386721|NCT02075008|41629513|FG000|Overall Study|Study terminated by Sponsor|159|||
19386722|NCT01666119|41629517|FG000|Overall Study|Adverse Event|6|||
19386723|NCT01666119|41629517|FG000|Overall Study|Withdrawal by Subject|16|||
19386724|NCT01666119|41629517|FG000|Overall Study|Lost to Follow-up|7|||
19386725|NCT01666119|41629517|FG000|Overall Study|non compliance with study medication, pa|18|||
19386726|NCT01666119|41629517|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
19386727|NCT02586207|41629521|FG000|Overall Study|Physician Decision|1|||
19386728|NCT02586207|41629521|FG000|Overall Study|Withdrawal by Subject|1|||
19386729|NCT01665807|41629528|FG000|Overall Study|Withdrawal by Subject|2|||
19386730|NCT01665807|41629529|FG001|Overall Study|Withdrawal by Subject|0|||
19386731|NCT01665807|41629530|FG002|Overall Study|Withdrawal by Subject|1|||
19386732|NCT02584959|41629541|FG000|Period 1|Withdrawn from study|3|||
19386733|NCT02584959|41629542|FG001|Period 1|Withdrawn from study|4|||
19386734|NCT02584959|41629543|FG002|Period 1|Withdrawn from study|0|||
19386735|NCT02584959|41629541|FG000|Period 2|Withdrawn from study|6|||
19386736|NCT02584959|41629542|FG001|Period 2|Withdrawn from study|1|||
19571954|NCT01081912|42019644|FG000|Maintenance Treatment|Lack of Efficacy|0|||
19571955|NCT01081912|42019645|FG001|Maintenance Treatment|Lack of Efficacy|14|||
19386737|NCT02584959|41629543|FG002|Period 2|Withdrawn from study|2|||
19386738|NCT02584257|41629560|FG000|Period 1|Withdrawal by Subject|0|||
19571956|NCT01081912|42019646|FG002|Maintenance Treatment|Lack of Efficacy|64|||
19386739|NCT02584257|41629561|FG001|Period 1|Withdrawal by Subject|0|||
19386740|NCT02584257|41629562|FG002|Period 1|Withdrawal by Subject|0|||
19386741|NCT02584257|41629563|FG003|Period 1|Withdrawal by Subject|0|||
19386742|NCT02584257|41629564|FG004|Period 1|Withdrawal by Subject|0|||
19571957|NCT01081912|42019644|FG000|Maintenance Treatment|Lost to Follow-up|0|||
19571958|NCT01081912|42019645|FG001|Maintenance Treatment|Lost to Follow-up|1|||
19571959|NCT01081912|42019646|FG002|Maintenance Treatment|Lost to Follow-up|0|||
19386743|NCT02584257|41629565|FG005|Period 1|Withdrawal by Subject|0|||
19386744|NCT02584257|41629566|FG006|Period 1|Withdrawal by Subject|1|||
19386745|NCT02584257|41629567|FG007|Period 1|Withdrawal by Subject|0|||
19386746|NCT02584257|41629568|FG008|Period 1|Withdrawal by Subject|0|||
19386747|NCT02584257|41629560|FG000|Period 2|Physician Decision|1|||
19386748|NCT02584257|41629561|FG001|Period 2|Physician Decision|0|||
19386749|NCT02584257|41629562|FG002|Period 2|Physician Decision|0|||
19386750|NCT02584257|41629563|FG003|Period 2|Physician Decision|0|||
19386751|NCT02584257|41629564|FG004|Period 2|Physician Decision|0|||
19386752|NCT02584257|41629565|FG005|Period 2|Physician Decision|0|||
19386753|NCT02584257|41629566|FG006|Period 2|Physician Decision|0|||
19386754|NCT02584257|41629567|FG007|Period 2|Physician Decision|0|||
19386755|NCT02584257|41629568|FG008|Period 2|Physician Decision|0|||
19386756|NCT02584257|41629560|FG000|Period 2|Adverse Event|0|||
19386757|NCT02584257|41629561|FG001|Period 2|Adverse Event|1|||
19386758|NCT02584257|41629562|FG002|Period 2|Adverse Event|0|||
19386759|NCT02584257|41629563|FG003|Period 2|Adverse Event|0|||
19386760|NCT02584257|41629564|FG004|Period 2|Adverse Event|0|||
19386761|NCT02584257|41629565|FG005|Period 2|Adverse Event|0|||
19386762|NCT02584257|41629566|FG006|Period 2|Adverse Event|0|||
19571960|NCT01081912|42019644|FG000|Maintenance Treatment|Physician Decision|0|||
19571961|NCT01081912|42019645|FG001|Maintenance Treatment|Physician Decision|0|||
19571962|NCT01081912|42019646|FG002|Maintenance Treatment|Physician Decision|1|||
19571963|NCT01081912|42019644|FG000|Maintenance Treatment|Protocol Violation|0|||
19571964|NCT01081912|42019645|FG001|Maintenance Treatment|Protocol Violation|1|||
19571965|NCT01081912|42019646|FG002|Maintenance Treatment|Protocol Violation|2|||
19571966|NCT01081912|42019644|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
19571967|NCT01081912|42019645|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
19571968|NCT01081912|42019646|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
19571969|NCT01081912|42019644|FG000|Maintenance Treatment|Non-Compliance|0|||
19571970|NCT01081912|42019645|FG001|Maintenance Treatment|Non-Compliance|4|||
19571971|NCT01081912|42019646|FG002|Maintenance Treatment|Non-Compliance|7|||
19571972|NCT01081912|42019644|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
19571973|NCT01081912|42019645|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
19571974|NCT01081912|42019646|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
19571975|NCT01038609|42019658|FG000|Overall Study|Adverse Event|0|||
19571976|NCT01038609|42019659|FG001|Overall Study|Adverse Event|0|||
19571977|NCT01038609|42019660|FG002|Overall Study|Adverse Event|1|||
19571978|NCT01038609|42019661|FG003|Overall Study|Adverse Event|0|||
19571979|NCT01038609|42019662|FG004|Overall Study|Adverse Event|0|||
19571980|NCT01038609|42019658|FG000|Overall Study|Dosing Error|0|||
19571981|NCT01038609|42019659|FG001|Overall Study|Dosing Error|0|||
19571982|NCT01038609|42019660|FG002|Overall Study|Dosing Error|0|||
19571983|NCT01038609|42019661|FG003|Overall Study|Dosing Error|1|||
19571984|NCT01038609|42019662|FG004|Overall Study|Dosing Error|1|||
19571985|NCT01038609|42019658|FG000|Overall Study|Death in the Family|1|||
19571986|NCT01038609|42019659|FG001|Overall Study|Death in the Family|0|||
19571987|NCT01038609|42019660|FG002|Overall Study|Death in the Family|0|||
19386763|NCT02584257|41629567|FG007|Period 2|Adverse Event|0|||
19571988|NCT01038609|42019661|FG003|Overall Study|Death in the Family|0|||
19571989|NCT01038609|42019662|FG004|Overall Study|Death in the Family|0|||
19571990|NCT01038609|42019658|FG000|Overall Study|Refusal of Blood Draws|0|||
19386764|NCT02584257|41629568|FG008|Period 2|Adverse Event|0|||
19386765|NCT02583711|41629583|FG000|Overall Study|Withdrawal by Subject|0|||
19386766|NCT02583711|41629584|FG001|Overall Study|Withdrawal by Subject|10|||
19386767|NCT02583711|41629585|FG002|Overall Study|Withdrawal by Subject|0|||
19386768|NCT02583477|41629597|FG000|Overall Study|Adverse Event|0|||
19386769|NCT02583477|41629598|FG001|Overall Study|Adverse Event|2|||
19386770|NCT02583477|41629597|FG000|Overall Study|Death|1|||
19386771|NCT02583477|41629598|FG001|Overall Study|Death|16|||
19386772|NCT02583477|41629597|FG000|Overall Study|Study terminated|2|||
19386773|NCT02583477|41629598|FG001|Overall Study|Study terminated|2|||
19386774|NCT02583399|41629605|FG000|Overall Study|Able to be discharged|3|||
19386775|NCT02583399|41629605|FG000|Overall Study|Wanted to use a restricted medication|3|||
19386776|NCT02580591|41629613|FG000|Overall Study|Adverse Event|0|||
19386777|NCT02580591|41629614|FG001|Overall Study|Adverse Event|1|||
19386778|NCT02580591|41629615|FG002|Overall Study|Adverse Event|2|||
19386779|NCT02580591|41629616|FG003|Overall Study|Adverse Event|5|||
19386780|NCT02580591|41629613|FG000|Overall Study|Protocol Violation|3|||
19386781|NCT02580591|41629614|FG001|Overall Study|Protocol Violation|2|||
19386782|NCT02580591|41629615|FG002|Overall Study|Protocol Violation|1|||
19386783|NCT02580591|41629616|FG003|Overall Study|Protocol Violation|1|||
19386784|NCT02580591|41629613|FG000|Overall Study|Lost to Follow-up|5|||
19386785|NCT02580591|41629614|FG001|Overall Study|Lost to Follow-up|3|||
19571991|NCT01038609|42019659|FG001|Overall Study|Refusal of Blood Draws|1|||
19571992|NCT01038609|42019660|FG002|Overall Study|Refusal of Blood Draws|0|||
19386786|NCT02580591|41629615|FG002|Overall Study|Lost to Follow-up|3|||
19386787|NCT02580591|41629616|FG003|Overall Study|Lost to Follow-up|1|||
19386788|NCT02580591|41629613|FG000|Overall Study|Withdrawal by Subject|6|||
19386789|NCT02580591|41629614|FG001|Overall Study|Withdrawal by Subject|1|||
19386790|NCT02580591|41629615|FG002|Overall Study|Withdrawal by Subject|2|||
19386791|NCT02580591|41629616|FG003|Overall Study|Withdrawal by Subject|3|||
19386792|NCT02580591|41629613|FG000|Overall Study|Not treated|1|||
19386793|NCT02580591|41629614|FG001|Overall Study|Not treated|1|||
19386794|NCT02580591|41629615|FG002|Overall Study|Not treated|0|||
19386795|NCT02580591|41629616|FG003|Overall Study|Not treated|0|||
19386796|NCT02580591|41629613|FG000|Overall Study|Other than specified|3|||
19386797|NCT02580591|41629614|FG001|Overall Study|Other than specified|2|||
19386798|NCT02580591|41629615|FG002|Overall Study|Other than specified|5|||
19386799|NCT02580591|41629616|FG003|Overall Study|Other than specified|2|||
19386800|NCT02580357|41629629|FG000|Overall Study|Lost to Follow-up|2|||
19386801|NCT02580357|41629630|FG001|Overall Study|Lost to Follow-up|0|||
19386802|NCT02580357|41629631|FG002|Overall Study|Lost to Follow-up|0|||
19386803|NCT02580357|41629629|FG000|Overall Study|Protocol Violation|1|||
19386804|NCT02580357|41629630|FG001|Overall Study|Protocol Violation|0|||
19386805|NCT02580357|41629631|FG002|Overall Study|Protocol Violation|0|||
19386806|NCT01664091|41629639|FG000|Overall Study|Death|1|||
19386807|NCT01664091|41629639|FG000|Overall Study|Disease Progression|2|||
19386808|NCT01664091|41629639|FG000|Overall Study|Lost to Follow-up|2|||
19386809|NCT01664091|41629639|FG000|Overall Study|Withdrawal by Subject|1|||
19386810|NCT02577315|41629646|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19571993|NCT01038609|42019661|FG003|Overall Study|Refusal of Blood Draws|0|||
19571994|NCT01038609|42019662|FG004|Overall Study|Refusal of Blood Draws|0|||
19571995|NCT02357134|42019678|FG000|Overall Study|Lost to Follow-up|1|||
19571996|NCT02357134|42019679|FG001|Overall Study|Lost to Follow-up|0|||
19571997|NCT02357134|42019680|FG002|Overall Study|Lost to Follow-up|0|||
19571998|NCT02357134|42019681|FG003|Overall Study|Lost to Follow-up|0|||
19571999|NCT00745420|42019691|FG000|Overall Study|Ineligible|1|||
19572000|NCT02853370|42019695|FG000|Overall Study|Physician Decision|1|||
19572001|NCT02853370|42019695|FG000|Overall Study|Lack of Efficacy|2|||
19572002|NCT02853370|42019695|FG000|Overall Study|Death|1|||
19572003|NCT02853370|42019695|FG000|Overall Study|Adverse Event|4|||
19572004|NCT02853370|42019695|FG000|Overall Study|Withdrawal by Subject|3|||
19572005|NCT01879072|42019700|FG000|Overall Study|Withdrawal by Subject|121|||
19386811|NCT02577315|41629647|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
19386812|NCT02711345|41629663|FG000|Overall Study|Adverse Event|0|||
19386813|NCT02711345|41629664|FG001|Overall Study|Adverse Event|0|||
19386814|NCT02711345|41629665|FG002|Overall Study|Adverse Event|0|||
19386815|NCT02711345|41629666|FG003|Overall Study|Adverse Event|1|||
19386816|NCT02711345|41629667|FG004|Overall Study|Adverse Event|1|||
19386817|NCT02711345|41629668|FG005|Overall Study|Adverse Event|2|||
19386818|NCT02711345|41629669|FG006|Overall Study|Adverse Event|1|||
19386819|NCT02711345|41629670|FG007|Overall Study|Adverse Event|0|||
19386820|NCT02711345|41629671|FG008|Overall Study|Adverse Event|0|||
19386821|NCT02711345|41629672|FG009|Overall Study|Adverse Event|2|||
19386822|NCT02711345|41629663|FG000|Overall Study|Physician Decision|0|||
19386823|NCT02711345|41629664|FG001|Overall Study|Physician Decision|0|||
19386824|NCT02711345|41629665|FG002|Overall Study|Physician Decision|1|||
19386825|NCT02711345|41629666|FG003|Overall Study|Physician Decision|0|||
19386826|NCT02711345|41629667|FG004|Overall Study|Physician Decision|0|||
19386827|NCT02711345|41629668|FG005|Overall Study|Physician Decision|0|||
19386828|NCT02711345|41629669|FG006|Overall Study|Physician Decision|0|||
19386829|NCT02711345|41629670|FG007|Overall Study|Physician Decision|0|||
19386830|NCT02711345|41629671|FG008|Overall Study|Physician Decision|1|||
19386831|NCT02711345|41629672|FG009|Overall Study|Physician Decision|0|||
19386832|NCT02711345|41629663|FG000|Overall Study|Progressive disease|1|||
19386833|NCT02711345|41629664|FG001|Overall Study|Progressive disease|3|||
19572006|NCT01879072|42019700|FG000|Overall Study|Not Transplanted|30|||
19572007|NCT00954538|42019706|FG000|Part III|Withdrawal by Subject|0|||
19572008|NCT00954538|42019707|FG001|Part III|Withdrawal by Subject|0|||
19572009|NCT00954538|42019708|FG002|Part III|Withdrawal by Subject|0|||
19572010|NCT00954538|42019709|FG003|Part III|Withdrawal by Subject|0|||
19386834|NCT02711345|41629665|FG002|Overall Study|Progressive disease|5|||
19386835|NCT02711345|41629666|FG003|Overall Study|Progressive disease|3|||
19386836|NCT02711345|41629667|FG004|Overall Study|Progressive disease|7|||
19386837|NCT02711345|41629668|FG005|Overall Study|Progressive disease|2|||
19386838|NCT02711345|41629669|FG006|Overall Study|Progressive disease|8|||
19386839|NCT02711345|41629670|FG007|Overall Study|Progressive disease|4|||
19386840|NCT02711345|41629671|FG008|Overall Study|Progressive disease|5|||
19386841|NCT02711345|41629672|FG009|Overall Study|Progressive disease|6|||
19572011|NCT00954538|42019710|FG004|Part III|Withdrawal by Subject|1|||
19572012|NCT00954538|42019711|FG005|Part III|Withdrawal by Subject|0|||
19572013|NCT00943852|42019720|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572014|NCT00943852|42019721|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19386842|NCT02711345|41629663|FG000|Overall Study|Subject/guardian decision|0|||
19386843|NCT02711345|41629664|FG001|Overall Study|Subject/guardian decision|0|||
19386844|NCT02711345|41629665|FG002|Overall Study|Subject/guardian decision|0|||
19386845|NCT02711345|41629666|FG003|Overall Study|Subject/guardian decision|0|||
19386846|NCT02711345|41629667|FG004|Overall Study|Subject/guardian decision|0|||
19386847|NCT02711345|41629668|FG005|Overall Study|Subject/guardian decision|2|||
19386848|NCT02711345|41629669|FG006|Overall Study|Subject/guardian decision|3|||
19386849|NCT02711345|41629670|FG007|Overall Study|Subject/guardian decision|1|||
19386850|NCT02711345|41629671|FG008|Overall Study|Subject/guardian decision|0|||
19745785|NCT03529773|42193191|FG035|Overall Study|Adverse Event|1|||
19386851|NCT02711345|41629672|FG009|Overall Study|Subject/guardian decision|4|||
19386852|NCT02711345|41629663|FG000|Overall Study|Death|1|||
19386853|NCT02711345|41629664|FG001|Overall Study|Death|0|||
19386854|NCT02711345|41629665|FG002|Overall Study|Death|0|||
19386855|NCT02711345|41629666|FG003|Overall Study|Death|0|||
19386856|NCT02711345|41629667|FG004|Overall Study|Death|0|||
19572015|NCT00943852|42019722|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572016|NCT00943852|42019723|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
19572017|NCT00943852|42019724|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572018|NCT00943852|42019725|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572019|NCT00943852|42019726|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572020|NCT00943852|42019727|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572021|NCT00943852|42019728|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572022|NCT00943852|42019729|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
19572023|NCT00943852|42019720|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572024|NCT00943852|42019721|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572025|NCT00943852|42019722|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572026|NCT00943852|42019723|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19386857|NCT02711345|41629668|FG005|Overall Study|Death|0|||
19386858|NCT02711345|41629669|FG006|Overall Study|Death|0|||
19386859|NCT02711345|41629670|FG007|Overall Study|Death|1|||
19386860|NCT02711345|41629671|FG008|Overall Study|Death|0|||
19386861|NCT02711345|41629672|FG009|Overall Study|Death|0|||
19572027|NCT00943852|42019724|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572028|NCT00943852|42019725|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
19572029|NCT00943852|42019726|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572030|NCT00943852|42019727|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572031|NCT00943852|42019728|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572032|NCT00943852|42019729|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
19572033|NCT00943852|42019720|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572034|NCT00943852|42019721|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572035|NCT00943852|42019722|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572036|NCT00943852|42019723|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572037|NCT00943852|42019724|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572038|NCT00943852|42019725|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572039|NCT00943852|42019726|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
19572040|NCT00943852|42019727|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572041|NCT00943852|42019728|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572042|NCT00943852|42019729|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
19572043|NCT00943852|42019720|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572044|NCT00943852|42019721|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19386862|NCT02581995|41629709|FG000|Overall Study|Unspecified other|3|||
19386863|NCT02581995|41629709|FG000|Overall Study|Adverse Event|6|||
19386864|NCT02581995|41629709|FG000|Overall Study|Lost to Follow-up|5|||
19386865|NCT02581995|41629709|FG000|Overall Study|Withdrawal by participant|12|||
19386866|NCT02581995|41629709|FG000|Overall Study|Physician Decision|1|||
19386867|NCT02581995|41629709|FG000|Overall Study|Death|4|||
19386868|NCT02577003|41629715|FG000|Overall Study|Adverse Event|2|||
19572045|NCT00943852|42019722|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572046|NCT00943852|42019723|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572047|NCT00943852|42019724|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572048|NCT00943852|42019725|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572049|NCT00943852|42019726|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572050|NCT00943852|42019727|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
19572051|NCT00943852|42019728|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572052|NCT00943852|42019729|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
19572053|NCT00943852|42019720|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
19572054|NCT00943852|42019721|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572055|NCT00943852|42019722|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
19572056|NCT00943852|42019723|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
19572057|NCT00943852|42019724|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572058|NCT00943852|42019725|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572059|NCT00943852|42019726|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
19572060|NCT00943852|42019727|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572061|NCT00943852|42019728|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572062|NCT00943852|42019729|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
19572063|NCT00952276|42019744|FG000|Overall Study|Withdrawal by Subject|1|||
19572064|NCT00952276|42019745|FG001|Overall Study|Withdrawal by Subject|0|||
19572065|NCT00952276|42019746|FG002|Overall Study|Withdrawal by Subject|0|||
19572066|NCT00952276|42019747|FG003|Overall Study|Withdrawal by Subject|1|||
19572067|NCT00952276|42019748|FG004|Overall Study|Withdrawal by Subject|0|||
19572068|NCT00943384|42019760|FG000|Overall Study|Dispositioned prior to treatment|23|||
19572069|NCT00943384|42019760|FG000|Overall Study|Treated off protocol-protocol violation|5|||
19572070|NCT00943384|42019760|FG000|Overall Study|Lost to Follow-up|16|||
19572071|NCT00943384|42019760|FG000|Overall Study|Withdrawal by Subject|5|||
19572072|NCT00943306|42019764|FG000|Overall Study|Physician Decision|1|||
19572073|NCT00943306|42019764|FG000|Overall Study|Death|1|||
19572074|NCT00943306|42019764|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
19572075|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
19572076|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
19572077|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
19572078|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
19572079|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
19572080|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
19572081|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
19572082|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
19572083|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
19572084|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
19572085|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
19572086|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
19572087|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
19572088|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
19572089|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
19572090|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
19572091|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
19572092|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
19572093|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
19572094|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
19572095|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
19572096|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
19572097|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
19572098|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
19572099|NCT01198002|42019771|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
19572100|NCT01198002|42019772|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
19572101|NCT01198002|42019773|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
19572102|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
19572103|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
19572104|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
19572105|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
19572106|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
19572107|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
19572108|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
19572109|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
19572110|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
19572111|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
19572112|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
19572113|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
19572114|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
19386869|NCT02577003|41629716|FG001|Overall Study|Adverse Event|4|||
19386870|NCT02577003|41629715|FG000|Overall Study|Withdrawal by Subject|0|||
19386871|NCT02577003|41629716|FG001|Overall Study|Withdrawal by Subject|1|||
19386872|NCT02746809|41629722|FG000|Enrollment|Inclusion Exclusion not met|9|||
19386873|NCT02746809|41629722|FG000|Enrollment|Withdrawal by Subject|1|||
19386874|NCT02746809|41629722|FG000|Enrollment|Study Closed to Enrollment|2|||
19386875|NCT02746809|41629722|FG000|Procedure|Death|1|||
19386876|NCT02746809|41629722|FG000|1-Month|Death|5|||
19386877|NCT02746809|41629722|FG000|6-Month|Death|2|||
19386878|NCT02746809|41629722|FG000|6-Month|Withdrawal by Subject|1|||
19386879|NCT02746809|41629722|FG000|12-Month|Death|3|||
19572115|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
19572116|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
19572117|NCT01198002|42019771|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
19572118|NCT01198002|42019772|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
19572119|NCT01198002|42019773|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
19572120|NCT01197534|42019806|FG000|Overall Study|Not reported|16|||
19386880|NCT02746809|41629722|FG000|12-Month|Withdrawal by Subject|2|||
19386881|NCT02746809|41629722|FG000|24-Month|Death|1|||
19386882|NCT02746809|41629722|FG000|24-Month|Withdrawal by Subject|1|||
19572121|NCT01197534|42019807|FG001|Overall Study|Not reported|10|||
19572122|NCT01197534|42019808|FG002|Overall Study|Not reported|16|||
19572123|NCT01197534|42019806|FG000|Overall Study|Enrolment in long term extension|57|||
19572124|NCT01197534|42019807|FG001|Overall Study|Enrolment in long term extension|66|||
19572125|NCT01197534|42019808|FG002|Overall Study|Enrolment in long term extension|119|||
19572126|NCT01197534|42019806|FG000|Overall Study|Severe non-compliance to protocol|3|||
19572127|NCT01197534|42019807|FG001|Overall Study|Severe non-compliance to protocol|4|||
19572128|NCT01197534|42019808|FG002|Overall Study|Severe non-compliance to protocol|1|||
19572129|NCT01197534|42019806|FG000|Overall Study|Lack of therapeutic response|9|||
19572130|NCT01197534|42019807|FG001|Overall Study|Lack of therapeutic response|4|||
19572131|NCT01197534|42019808|FG002|Overall Study|Lack of therapeutic response|9|||
19572132|NCT01197534|42019806|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
19572133|NCT01197534|42019807|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
19572134|NCT01197534|42019808|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
19572135|NCT01197534|42019806|FG000|Overall Study|Lost to Follow-up|1|||
19572136|NCT01197534|42019807|FG001|Overall Study|Lost to Follow-up|4|||
19572137|NCT01197534|42019808|FG002|Overall Study|Lost to Follow-up|2|||
19572138|NCT01197534|42019806|FG000|Overall Study|Adverse Event|35|||
19572139|NCT01197534|42019807|FG001|Overall Study|Adverse Event|36|||
19572140|NCT01197534|42019808|FG002|Overall Study|Adverse Event|24|||
19572141|NCT01197378|42019819|FG000|Overall Study|Adverse Event|3|||
19572142|NCT01197378|42019819|FG000|Overall Study|Withdrawal by Subject|1|||
19572143|NCT01197378|42019819|FG000|Overall Study|Physician Decision|1|||
19572144|NCT01197378|42019819|FG000|Overall Study|Other|2|||
19572145|NCT01197300|42019825|FG000|Overall Study|Lost to Follow-up|0|||
19572146|NCT01197300|42019826|FG001|Overall Study|Lost to Follow-up|1|||
19572147|NCT01197300|42019825|FG000|Overall Study|Protocol Violation|0|||
19572148|NCT01197300|42019826|FG001|Overall Study|Protocol Violation|1|||
19572149|NCT01196988|42019841|FG000|Overall Study|Adverse Event|1|||
19572150|NCT01196988|42019842|FG001|Overall Study|Adverse Event|2|||
19572151|NCT01196988|42019843|FG002|Overall Study|Adverse Event|0|||
19572152|NCT01196988|42019844|FG003|Overall Study|Adverse Event|0|||
19572153|NCT01196988|42019841|FG000|Overall Study|Withdrawal by Subject|5|||
19572154|NCT01196988|42019842|FG001|Overall Study|Withdrawal by Subject|1|||
19572155|NCT01196988|42019843|FG002|Overall Study|Withdrawal by Subject|4|||
19572156|NCT01196988|42019844|FG003|Overall Study|Withdrawal by Subject|0|||
19572157|NCT01196988|42019841|FG000|Overall Study|Lost to Follow-up|16|||
19572158|NCT01196988|42019842|FG001|Overall Study|Lost to Follow-up|29|||
19572159|NCT01196988|42019843|FG002|Overall Study|Lost to Follow-up|21|||
19572160|NCT01196988|42019844|FG003|Overall Study|Lost to Follow-up|1|||
19572161|NCT01196988|42019841|FG000|Overall Study|Other|2|||
19386883|NCT02746809|41629722|FG000|36-Month|Death|8|||
19386884|NCT02746809|41629722|FG000|36-Month|Withdrawal by Subject|1|||
19386885|NCT02746809|41629722|FG000|48-Month|Death|7|||
19386886|NCT02746809|41629722|FG000|48-Month|Withdrawal by Subject|1|||
19476930|NCT01569295|41755234|FG001|Overall Study|Withdrawal by Subject|12|||
19476931|NCT01569295|41755233|FG000|Overall Study|Death|19|||
19476932|NCT01569295|41755234|FG001|Overall Study|Death|15|||
19572162|NCT01196988|42019842|FG001|Overall Study|Other|0|||
19386887|NCT02746809|41629722|FG000|60-Month|Death|1|||
19386888|NCT02746809|41629722|FG000|60-Month|Lost to Follow-up|2|||
19386889|NCT02446899|41629730|FG000|Overall Study|Adverse Event|4|||
19386890|NCT02446899|41629731|FG001|Overall Study|Adverse Event|7|||
19572163|NCT01196988|42019843|FG002|Overall Study|Other|0|||
19386891|NCT02446899|41629730|FG000|Overall Study|Condition Under Investigation Worsened|1|||
19572164|NCT01196988|42019844|FG003|Overall Study|Other|0|||
19572165|NCT01196052|42019855|FG000|Overall Study|Adverse Event|9|||
19572166|NCT01196052|42019855|FG000|Overall Study|Lost to Follow-up|1|||
19572167|NCT01196052|42019855|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
19572168|NCT01196052|42019855|FG000|Overall Study|Reason not Specified|5|||
19572169|NCT01196052|42019855|FG000|Overall Study|Withdrawal by Subject|6|||
19572170|NCT01195662|42019862|FG000|Double Blind Treatment Period|Adverse Event|4|||
19572171|NCT01195662|42019863|FG001|Double Blind Treatment Period|Adverse Event|1|||
19572172|NCT01195662|42019864|FG002|Double Blind Treatment Period|Adverse Event|2|||
19572173|NCT01195662|42019862|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
19572174|NCT01195662|42019863|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
19572175|NCT01195662|42019864|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
19572176|NCT01195662|42019862|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
19572177|NCT01195662|42019863|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
19572178|NCT01195662|42019864|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
19572179|NCT01195662|42019862|FG000|Double Blind Treatment Period|Administrative reason|2|||
19572180|NCT01195662|42019863|FG001|Double Blind Treatment Period|Administrative reason|1|||
19572181|NCT01195662|42019864|FG002|Double Blind Treatment Period|Administrative reason|1|||
19572182|NCT01195662|42019862|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
19572183|NCT01195662|42019863|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
19572184|NCT01195662|42019864|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
19572185|NCT01195662|42019862|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
19572186|NCT01195662|42019863|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
19572187|NCT01195662|42019864|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
19572188|NCT01195662|42019862|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
19572189|NCT01195662|42019863|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
19572190|NCT01195662|42019864|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
19572191|NCT01195662|42019862|FG000|Double Blind Treatment Period|Non-specified|3|||
19572192|NCT01195662|42019863|FG001|Double Blind Treatment Period|Non-specified|0|||
19572193|NCT01195662|42019864|FG002|Double Blind Treatment Period|Non-specified|0|||
19572194|NCT01195662|42019862|FG000|Double Blind Treatment Period|Missing disposition information|0|||
19572195|NCT01195662|42019863|FG001|Double Blind Treatment Period|Missing disposition information|1|||
19386892|NCT02446899|41629731|FG001|Overall Study|Condition Under Investigation Worsened|4|||
19386893|NCT02446899|41629730|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
19572196|NCT01195662|42019864|FG002|Double Blind Treatment Period|Missing disposition information|1|||
19572197|NCT01195662|42019862|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
19572198|NCT01195662|42019863|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
19572199|NCT01195662|42019864|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
19572200|NCT01195662|42019862|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
19572201|NCT01195662|42019863|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
19572202|NCT01195662|42019864|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
19572203|NCT01195272|42019873|FG000|Overall Study|Adverse Event|1|||
19572204|NCT01195272|42019873|FG000|Overall Study|Lack of Efficacy|3|||
19572205|NCT01194804|42019877|FG000|Overall Study|Withdrawal by Subject|1|||
19572206|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
19386894|NCT02446899|41629731|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
19572207|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
19572208|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
19572209|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
19386895|NCT02446899|41629730|FG000|Overall Study|Lack of Efficacy|2|||
19386896|NCT02446899|41629731|FG001|Overall Study|Lack of Efficacy|8|||
19572210|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
19386897|NCT02446899|41629730|FG000|Overall Study|Lost to Follow-up|1|||
19386898|NCT02446899|41629731|FG001|Overall Study|Lost to Follow-up|3|||
19386899|NCT02446899|41629730|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
19386900|NCT02446899|41629731|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
19386901|NCT02446899|41629730|FG000|Overall Study|Withdrawal by Subject|11|||
19386902|NCT02446899|41629731|FG001|Overall Study|Withdrawal by Subject|19|||
19386903|NCT02446899|41629730|FG000|Overall Study|Miscellaneous|5|||
19386904|NCT02446899|41629731|FG001|Overall Study|Miscellaneous|4|||
19386905|NCT02446899|41629730|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
19386906|NCT02446899|41629731|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
19386907|NCT02709785|41629740|FG000|Overall Study|Withdrawal by Subject|1|||
19386908|NCT02709785|41629741|FG001|Overall Study|Withdrawal by Subject|2|||
19386909|NCT02709785|41629742|FG002|Overall Study|Withdrawal by Subject|1|||
19386910|NCT02356887|41629750|FG000|Overall Study|poor compliance|2|||
19386911|NCT01604265|41629762|FG000|Overall Study|Adverse Event|1|||
19386912|NCT01604265|41629763|FG001|Overall Study|Adverse Event|0|||
19386913|NCT01604265|41629762|FG000|Overall Study|Withdrawal by Subject|1|||
19386914|NCT01604265|41629763|FG001|Overall Study|Withdrawal by Subject|0|||
19386915|NCT01664247|41629771|FG000|Overall Study|Adverse Event|5|||
19386916|NCT01664247|41629772|FG001|Overall Study|Adverse Event|3|||
19386917|NCT01664247|41629771|FG000|Overall Study|Protocol Violation|3|||
19386918|NCT01664247|41629772|FG001|Overall Study|Protocol Violation|5|||
19386919|NCT01664247|41629771|FG000|Overall Study|Withdrawal Criteria|1|||
19386920|NCT01664247|41629772|FG001|Overall Study|Withdrawal Criteria|4|||
19386921|NCT01664247|41629771|FG000|Overall Study|Unclassified|5|||
19386922|NCT01664247|41629772|FG001|Overall Study|Unclassified|29|||
19386923|NCT03191903|41629796|FG000|Overall Study|Withdrawal by Subject|6|||
19386924|NCT03191903|41629797|FG001|Overall Study|Withdrawal by Subject|5|||
19386925|NCT03191903|41629798|FG002|Overall Study|Withdrawal by Subject|4|||
19386926|NCT03191903|41629796|FG000|Overall Study|Adverse Event|1|||
19386927|NCT03191903|41629797|FG001|Overall Study|Adverse Event|0|||
19386928|NCT03191903|41629798|FG002|Overall Study|Adverse Event|0|||
19386929|NCT02576535|41629811|FG000|Overall Study|Withdrawal by Subject|2|||
19386930|NCT02576145|41629817|FG000|Overall Study|Adverse Event|1|||
19572211|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
19572212|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
19572213|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
19572214|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
19572215|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
19572216|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
19572217|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
19572218|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
19572219|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
19572220|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
19572221|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
19572222|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
19572223|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
19572224|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
19572225|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
19572226|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
19572227|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
19572228|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
19572229|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
19572230|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Other|0|||
19386931|NCT02576145|41629818|FG001|Overall Study|Adverse Event|0|||
19386932|NCT02576145|41629817|FG000|Overall Study|Withdrawal by Subject|1|||
19386933|NCT02576145|41629818|FG001|Overall Study|Withdrawal by Subject|0|||
19386934|NCT02576145|41629817|FG000|Overall Study|Acute rejection|1|||
19386935|NCT02576145|41629818|FG001|Overall Study|Acute rejection|0|||
19386936|NCT02576145|41629817|FG000|Overall Study|Tetanus Titers Decreased|0|||
19386937|NCT02576145|41629818|FG001|Overall Study|Tetanus Titers Decreased|1|||
19386938|NCT02576067|41629826|FG000|Overall Study|Death|0|||
19386939|NCT02576067|41629827|FG001|Overall Study|Death|1|||
19386940|NCT02576067|41629826|FG000|Overall Study|Lack of Efficacy|1|||
19386941|NCT02576067|41629827|FG001|Overall Study|Lack of Efficacy|0|||
19386942|NCT02576067|41629826|FG000|Overall Study|Lost to Follow-up|11|||
19572231|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Other|1|||
19572232|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Other|0|||
19572233|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Other|0|||
19572234|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
19572235|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
19572236|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
19572237|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
19572238|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
19572239|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
19572240|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
19572241|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
19572242|NCT01194414|42019901|FG000|24 Weeks Double Blind Period|Death|0|||
19572243|NCT01194414|42019902|FG001|24 Weeks Double Blind Period|Death|1|||
19572244|NCT01194414|42019903|FG002|24 Weeks Double Blind Period|Death|0|||
19572245|NCT01194414|42019904|FG003|24 Weeks Double Blind Period|Death|0|||
19572246|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
19572247|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
19572248|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
19572249|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
19572250|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
19572251|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
19572252|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
19572253|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
19572254|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
19572255|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
19572256|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
19572257|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
19572258|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
19572259|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
19572260|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
19572261|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
19572262|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
19572263|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
19572264|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
19572265|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
19572266|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
19572267|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
19572268|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
19572269|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
19572270|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Other|2|||
19572271|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Other|1|||
19572272|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Other|0|||
19572273|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Other|0|||
19572274|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
19572275|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
19572276|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
19572277|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
19572278|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
19572279|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
19572280|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
19572281|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
19572282|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
19572283|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
19572284|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
19572285|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
19572286|NCT01194414|42019901|FG000|72 Weeks Open Label Extension|Death|1|||
19572287|NCT01194414|42019902|FG001|72 Weeks Open Label Extension|Death|2|||
19572288|NCT01194414|42019903|FG002|72 Weeks Open Label Extension|Death|0|||
19572289|NCT01194414|42019904|FG003|72 Weeks Open Label Extension|Death|2|||
19572290|NCT01194258|42019916|FG000|Titration Period|Withdrawal by Subject|6|||
19572291|NCT01194258|42019917|FG001|Titration Period|Withdrawal by Subject|0|||
19572292|NCT01194258|42019918|FG002|Titration Period|Withdrawal by Subject|0|||
19572293|NCT01194258|42019919|FG003|Titration Period|Withdrawal by Subject|0|||
19572294|NCT01194258|42019920|FG004|Titration Period|Withdrawal by Subject|0|||
19572295|NCT01194258|42019916|FG000|Titration Period|Lost to Follow-up|2|||
19572296|NCT01194258|42019917|FG001|Titration Period|Lost to Follow-up|0|||
19572297|NCT01194258|42019918|FG002|Titration Period|Lost to Follow-up|0|||
19572298|NCT01194258|42019919|FG003|Titration Period|Lost to Follow-up|0|||
19572299|NCT01194258|42019920|FG004|Titration Period|Lost to Follow-up|0|||
19572300|NCT01194258|42019916|FG000|Titration Period|Titration failure|3|||
19572301|NCT01194258|42019917|FG001|Titration Period|Titration failure|0|||
19572302|NCT01194258|42019918|FG002|Titration Period|Titration failure|0|||
19572303|NCT01194258|42019919|FG003|Titration Period|Titration failure|0|||
19572304|NCT01194258|42019920|FG004|Titration Period|Titration failure|0|||
19572305|NCT01194258|42019916|FG000|Period 1 (12 Weeks)|Death|0|||
19572306|NCT01194258|42019917|FG001|Period 1 (12 Weeks)|Death|0|||
19572307|NCT01194258|42019918|FG002|Period 1 (12 Weeks)|Death|0|||
19572308|NCT01194258|42019919|FG003|Period 1 (12 Weeks)|Death|0|||
19572309|NCT01194258|42019920|FG004|Period 1 (12 Weeks)|Death|1|||
19572310|NCT01194258|42019916|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
19572311|NCT01194258|42019917|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
19572312|NCT01194258|42019918|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
19572313|NCT01194258|42019919|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
19572314|NCT01194258|42019920|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
19572315|NCT01194258|42019916|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
19572316|NCT01194258|42019917|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
19572317|NCT01194258|42019918|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
19572318|NCT01194258|42019919|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
19572319|NCT01194258|42019920|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
19572320|NCT01194258|42019916|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19572321|NCT01194258|42019917|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19572322|NCT01194258|42019918|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19572323|NCT01194258|42019919|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19572324|NCT01194258|42019920|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19572325|NCT01193556|42019933|FG000|Overall Study|Study termination|26|||
19572326|NCT01193556|42019934|FG001|Overall Study|Study termination|25|||
19572327|NCT00951496|42019947|FG000|Overall Study|Did not initiate study treatment|10|||
19572328|NCT00951496|42019948|FG001|Overall Study|Did not initiate study treatment|8|||
19572329|NCT00951496|42019949|FG002|Overall Study|Did not initiate study treatment|13|||
19572330|NCT01193244|42019962|FG000|Overall Study|Withdrawal by Subject|79|||
19572331|NCT01193244|42019963|FG001|Overall Study|Withdrawal by Subject|97|||
19572332|NCT01193244|42019962|FG000|Overall Study|Other|303|||
19572333|NCT01193244|42019963|FG001|Overall Study|Other|278|||
19572334|NCT01193244|42019962|FG000|Overall Study|Lost to Follow-up|6|||
19572335|NCT01193244|42019963|FG001|Overall Study|Lost to Follow-up|15|||
19572336|NCT01192152|42019969|FG000|Period 1|left prematurely (while on treatment B)|0|||
19572337|NCT01192152|42019970|FG001|Period 1|left prematurely (while on treatment B)|1|||
19572338|NCT01192152|42019969|FG000|Period 3|family emergency|1|||
19572339|NCT01192152|42019970|FG001|Period 3|family emergency|0|||
19572340|NCT01191840|42019980|FG000|Overall Study|withdrew consent|2|||
19572341|NCT01191840|42019981|FG001|Overall Study|withdrew consent|1|||
19572342|NCT01191840|42019980|FG000|Overall Study|Subject discontinued treatment|1|||
19572343|NCT01191840|42019981|FG001|Overall Study|Subject discontinued treatment|2|||
19572344|NCT01191840|42019980|FG000|Overall Study|Lost to Follow-up|4|||
19572345|NCT01191840|42019981|FG001|Overall Study|Lost to Follow-up|6|||
19572346|NCT01191840|42019980|FG000|Overall Study|Non Staph Infection|4|||
19572347|NCT01191840|42019981|FG001|Overall Study|Non Staph Infection|3|||
19572348|NCT01191840|42019980|FG000|Overall Study|ineligible at enrollment|1|||
19572349|NCT01191840|42019981|FG001|Overall Study|ineligible at enrollment|0|||
19572350|NCT01191840|42019980|FG000|Overall Study|IRB approval lapse|0|||
19572351|NCT01191840|42019981|FG001|Overall Study|IRB approval lapse|2|||
19572352|NCT01191840|42019980|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
19572353|NCT01191840|42019981|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
19572354|NCT01191840|42019980|FG000|Overall Study|Withdrawal by Subject|2|||
19572355|NCT01191840|42019981|FG001|Overall Study|Withdrawal by Subject|0|||
19572356|NCT00943072|42019993|FG000|Overall Study|Adverse Event|0|||
19572357|NCT00943072|42019994|FG001|Overall Study|Adverse Event|3|||
19572358|NCT00943072|42019993|FG000|Overall Study|Death|0|||
19572359|NCT00943072|42019994|FG001|Overall Study|Death|2|||
19572360|NCT00943072|42019993|FG000|Overall Study|Withdrawal by Subject|3|||
19572361|NCT00943072|42019994|FG001|Overall Study|Withdrawal by Subject|1|||
19572362|NCT00943072|42019993|FG000|Overall Study|Protocol Violation|0|||
19572363|NCT00943072|42019994|FG001|Overall Study|Protocol Violation|1|||
19572364|NCT00943072|42019993|FG000|Overall Study|Lost to Follow-up|1|||
19572365|NCT00943072|42019994|FG001|Overall Study|Lost to Follow-up|2|||
19572366|NCT00943072|42019993|FG000|Overall Study|Lack of Efficacy|0|||
19572367|NCT00943072|42019994|FG001|Overall Study|Lack of Efficacy|4|||
19572368|NCT00943072|42019993|FG000|Overall Study|Other|1|||
19572369|NCT00943072|42019994|FG001|Overall Study|Other|1|||
19572370|NCT00942994|42020004|FG000|Overall Study|Adverse Event|7|||
19572371|NCT00942994|42020005|FG001|Overall Study|Adverse Event|4|||
19572372|NCT00942994|42020004|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19572373|NCT00942994|42020005|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19572374|NCT00942994|42020004|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19572375|NCT00942994|42020005|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19572376|NCT00942994|42020004|FG000|Overall Study|Patient withdrew consent|5|||
19572377|NCT00942994|42020005|FG001|Overall Study|Patient withdrew consent|8|||
19572378|NCT00942994|42020004|FG000|Overall Study|Lost to Follow-up|1|||
19386943|NCT02576067|41629827|FG001|Overall Study|Lost to Follow-up|0|||
19386944|NCT02576067|41629826|FG000|Overall Study|Withdrawal by Subject|11|||
19572379|NCT00942994|42020005|FG001|Overall Study|Lost to Follow-up|4|||
19572380|NCT00942994|42020004|FG000|Overall Study|Protocol deviation|1|||
19572381|NCT00942994|42020005|FG001|Overall Study|Protocol deviation|2|||
19572382|NCT00942604|42020013|FG000|Overall Study|Protocol Violation|1|||
19572383|NCT00942604|42020014|FG001|Overall Study|Protocol Violation|1|||
19572384|NCT00942604|42020013|FG000|Overall Study|Adverse Event|0|||
19572385|NCT00942604|42020014|FG001|Overall Study|Adverse Event|1|||
19572386|NCT00942604|42020013|FG000|Overall Study|Withdrawal by Subject|0|||
19572387|NCT00942604|42020014|FG001|Overall Study|Withdrawal by Subject|1|||
19386945|NCT02576067|41629827|FG001|Overall Study|Withdrawal by Subject|2|||
19386946|NCT02576067|41629826|FG000|Overall Study|study closure of main CIRT trial)|0|||
19572388|NCT00942604|42020013|FG000|Overall Study|Patient relocation|1|||
19572389|NCT00942604|42020014|FG001|Overall Study|Patient relocation|1|||
19572390|NCT01188564|42020022|FG000|Double-blind Phase|randomized not treated|1|||
19572391|NCT01188564|42020023|FG001|Double-blind Phase|randomized not treated|0|||
19572392|NCT01187550|42020031|FG000|Overall Study|Protocol Violation|3|||
19572393|NCT01187550|42020032|FG001|Overall Study|Protocol Violation|1|||
19572394|NCT01187550|42020031|FG000|Overall Study|Other|3|||
19572395|NCT01187550|42020032|FG001|Overall Study|Other|0|||
19572396|NCT01187550|42020031|FG000|Overall Study|Randomized but not treated|8|||
19572397|NCT01187550|42020032|FG001|Overall Study|Randomized but not treated|0|||
19572398|NCT01186770|42020042|FG000|Overall Study|Ineligibility|0|||
19572399|NCT01186770|42020043|FG001|Overall Study|Ineligibility|0|||
19572400|NCT01186770|42020044|FG002|Overall Study|Ineligibility|2|||
19572401|NCT01186770|42020045|FG003|Overall Study|Ineligibility|0|||
19572402|NCT01186770|42020042|FG000|Overall Study|Protocol Violation|7|||
19572403|NCT01186770|42020043|FG001|Overall Study|Protocol Violation|9|||
19572404|NCT01186770|42020044|FG002|Overall Study|Protocol Violation|12|||
19572405|NCT01186770|42020045|FG003|Overall Study|Protocol Violation|14|||
19572406|NCT01186770|42020042|FG000|Overall Study|Adverse Event|2|||
19572407|NCT01186770|42020043|FG001|Overall Study|Adverse Event|9|||
19572408|NCT01186770|42020044|FG002|Overall Study|Adverse Event|7|||
19572409|NCT01186770|42020045|FG003|Overall Study|Adverse Event|9|||
19572410|NCT01186770|42020042|FG000|Overall Study|Withdrawal by Subject|15|||
19572411|NCT01186770|42020043|FG001|Overall Study|Withdrawal by Subject|13|||
19572412|NCT01186770|42020044|FG002|Overall Study|Withdrawal by Subject|11|||
19572413|NCT01186770|42020045|FG003|Overall Study|Withdrawal by Subject|17|||
19572414|NCT01186770|42020042|FG000|Overall Study|Lost to Follow-up|10|||
19572415|NCT01186770|42020043|FG001|Overall Study|Lost to Follow-up|6|||
19572416|NCT01186770|42020044|FG002|Overall Study|Lost to Follow-up|14|||
19572417|NCT01186770|42020045|FG003|Overall Study|Lost to Follow-up|9|||
19572418|NCT01186770|42020042|FG000|Overall Study|Insufficient response to treatment|7|||
19572419|NCT01186770|42020043|FG001|Overall Study|Insufficient response to treatment|8|||
19572420|NCT01186770|42020044|FG002|Overall Study|Insufficient response to treatment|5|||
19572421|NCT01186770|42020045|FG003|Overall Study|Insufficient response to treatment|7|||
19572422|NCT01186770|42020042|FG000|Overall Study|Other than specified|0|||
19572423|NCT01186770|42020043|FG001|Overall Study|Other than specified|1|||
19572424|NCT01186770|42020044|FG002|Overall Study|Other than specified|1|||
19572425|NCT01186770|42020045|FG003|Overall Study|Other than specified|2|||
19572426|NCT01186692|42020055|FG000|Overall Study|Not Catheterized|11|||
19572427|NCT01186692|42020055|FG000|Overall Study|Futher testing contraindicated implant|19|||
19572428|NCT01186692|42020055|FG000|Overall Study|Adverse Event|2|||
19572429|NCT01186458|42020063|FG000|Overall Study|Adverse Event|1|||
19572430|NCT01185834|42020067|FG000|Overall Study|Lost to Follow-up|2|||
19572431|NCT01185834|42020067|FG000|Overall Study|Discomfort|4|||
19572432|NCT01185834|42020067|FG000|Overall Study|Biomicroscopy|4|||
19572433|NCT01185834|42020067|FG000|Overall Study|Time/Job Conflict|2|||
19572434|NCT01185834|42020067|FG000|Overall Study|Early exit - Site error|2|||
19572435|NCT01185600|42020073|FG000|Overall Study|Adverse Event|1|||
19572436|NCT01185600|42020074|FG001|Overall Study|Adverse Event|1|||
19572437|NCT01185600|42020073|FG000|Overall Study|Death|0|||
19572438|NCT01185600|42020074|FG001|Overall Study|Death|1|||
19572439|NCT01185600|42020073|FG000|Overall Study|Lost to Follow-up|0|||
19572440|NCT01185600|42020074|FG001|Overall Study|Lost to Follow-up|5|||
19572441|NCT01185600|42020073|FG000|Overall Study|Physician Decision|29|||
19572442|NCT01185600|42020074|FG001|Overall Study|Physician Decision|35|||
19572443|NCT01185600|42020073|FG000|Overall Study|Withdrawal by Subject|1|||
19572444|NCT01185600|42020074|FG001|Overall Study|Withdrawal by Subject|1|||
19572445|NCT01185600|42020073|FG000|Overall Study|Hold by DSMB|1|||
19572446|NCT01185600|42020074|FG001|Overall Study|Hold by DSMB|2|||
19572447|NCT01185522|42020083|FG000|Overall Study|Lack of Efficacy|28|||
19572448|NCT01185522|42020083|FG000|Overall Study|Lost to Follow-up|19|||
19572449|NCT01185522|42020083|FG000|Overall Study|Withdrawal by Subject|10|||
19572450|NCT01185522|42020083|FG000|Overall Study|Poor tolerance|39|||
19572451|NCT01185522|42020083|FG000|Overall Study|Other reasons|12|||
19572452|NCT01185366|42020090|FG000|First Line Therapy|Insurance Coverage Denied|1|||
19572453|NCT01185366|42020091|FG001|First Line Therapy|Insurance Coverage Denied|1|||
19572454|NCT01185366|42020090|FG000|First Line Therapy|Withdrawal by Subject|1|||
19572455|NCT01185366|42020091|FG001|First Line Therapy|Withdrawal by Subject|0|||
19572456|NCT01185366|42020090|FG000|First Line Therapy|Lack of Metastatic Site|1|||
19572457|NCT01185366|42020091|FG001|First Line Therapy|Lack of Metastatic Site|0|||
19572458|NCT01185366|42020090|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
19572459|NCT01185366|42020091|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
19572460|NCT01185366|42020090|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
19572461|NCT01185366|42020091|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
19572462|NCT01185366|42020090|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
19572463|NCT01185366|42020091|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
19572464|NCT01185366|42020090|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
19572465|NCT01185366|42020091|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
19572466|NCT01185288|42020101|FG000|Overall Study|Adverse Event|7|||
19572467|NCT01185288|42020102|FG001|Overall Study|Adverse Event|6|||
19572468|NCT01185288|42020101|FG000|Overall Study|Withdrawal by Subject|6|||
19572469|NCT01185288|42020102|FG001|Overall Study|Withdrawal by Subject|4|||
19572470|NCT01185288|42020101|FG000|Overall Study|Lost to Follow-up|2|||
19572471|NCT01185288|42020102|FG001|Overall Study|Lost to Follow-up|5|||
19572472|NCT01185288|42020101|FG000|Overall Study|Lack of Efficacy|2|||
19572473|NCT01185288|42020102|FG001|Overall Study|Lack of Efficacy|0|||
19572474|NCT01185288|42020101|FG000|Overall Study|Investigator discretion|1|||
19572475|NCT01185288|42020102|FG001|Overall Study|Investigator discretion|0|||
19572476|NCT01185288|42020101|FG000|Overall Study|Did not meet inclusion criteria|1|||
19572477|NCT01185288|42020102|FG001|Overall Study|Did not meet inclusion criteria|0|||
19572478|NCT01185288|42020101|FG000|Overall Study|Noncompliance|0|||
19572479|NCT01185288|42020102|FG001|Overall Study|Noncompliance|1|||
19572480|NCT01184508|42020110|FG000|Overall Study|Adverse Event|4|||
19572481|NCT01184508|42020111|FG001|Overall Study|Adverse Event|6|||
19572482|NCT01184508|42020110|FG000|Overall Study|Lack of Efficacy|1|||
19572483|NCT01184508|42020111|FG001|Overall Study|Lack of Efficacy|1|||
19572484|NCT01184508|42020110|FG000|Overall Study|Lost to Follow-up|1|||
19572485|NCT01184508|42020111|FG001|Overall Study|Lost to Follow-up|1|||
19572486|NCT01184508|42020110|FG000|Overall Study|Physician Decision|1|||
19572487|NCT01184508|42020111|FG001|Overall Study|Physician Decision|0|||
19572488|NCT01184508|42020110|FG000|Overall Study|Protocol Violation|3|||
19572489|NCT01184508|42020111|FG001|Overall Study|Protocol Violation|1|||
19572490|NCT01184508|42020110|FG000|Overall Study|Sponsor Decision|5|||
19572491|NCT01184508|42020111|FG001|Overall Study|Sponsor Decision|2|||
19386947|NCT02576067|41629827|FG001|Overall Study|study closure of main CIRT trial)|8|||
19386948|NCT02576067|41629826|FG000|Overall Study|not randomized, failed run-in|7|||
19386949|NCT02576067|41629827|FG001|Overall Study|not randomized, failed run-in|0|||
19386950|NCT02576067|41629826|FG000|Overall Study|screen failure/ re-enrolled|0|||
19386951|NCT02576067|41629827|FG001|Overall Study|screen failure/ re-enrolled|25|||
19386952|NCT02576067|41629826|FG000|Overall Study|Physician Decision|4|||
19386953|NCT02576067|41629827|FG001|Overall Study|Physician Decision|0|||
19386954|NCT02575911|41629833|FG000|Overall Study|Lost to Follow-up|1|||
19386955|NCT02575833|41629847|FG000|Overall Study|Withdrawal by Subject|0|||
19386956|NCT02575833|41629848|FG001|Overall Study|Withdrawal by Subject|1|||
19386957|NCT02575833|41629847|FG000|Overall Study|Lost to Follow-up|1|||
19386958|NCT02575833|41629848|FG001|Overall Study|Lost to Follow-up|0|||
19386959|NCT02709083|41629854|FG000|Overall Study|Original PI left institution|7|||
19386960|NCT02709005|41629860|FG000|Overall Study|Lost to Follow-up|1|||
19386961|NCT02709005|41629861|FG001|Overall Study|Lost to Follow-up|1|||
19386962|NCT02709005|41629860|FG000|Overall Study|Withdrawal by Subject|3|||
19386963|NCT02709005|41629861|FG001|Overall Study|Withdrawal by Subject|0|||
19386964|NCT02573883|41629869|FG000|Six Month Follow Up|Lost to Follow-up|1|||
19386965|NCT02573883|41629870|FG001|Six Month Follow Up|Lost to Follow-up|0|||
19386966|NCT02573883|41629871|FG002|Six Month Follow Up|Lost to Follow-up|0|||
19386967|NCT02573883|41629872|FG003|Six Month Follow Up|Lost to Follow-up|0|||
19386968|NCT02573883|41629869|FG000|One Year Follow Up|Lost to Follow-up|2|||
19386969|NCT02573883|41629870|FG001|One Year Follow Up|Lost to Follow-up|1|||
19386970|NCT02573883|41629871|FG002|One Year Follow Up|Lost to Follow-up|0|||
19386971|NCT02573883|41629872|FG003|One Year Follow Up|Lost to Follow-up|0|||
19386972|NCT02575365|41629887|FG000|Overall Study|Lost to Follow-up|4|||
19386973|NCT02707991|41629893|FG000|Overall Study|Protocol Violation|1|||
19572492|NCT01184508|42020110|FG000|Overall Study|Withdrawal by Subject|1|||
19386974|NCT02707991|41629894|FG001|Overall Study|Protocol Violation|0|||
19572493|NCT01184508|42020111|FG001|Overall Study|Withdrawal by Subject|3|||
19572494|NCT01184508|42020110|FG000|Overall Study|Randomized, Not Treated|0|||
19572495|NCT01184508|42020111|FG001|Overall Study|Randomized, Not Treated|1|||
19386975|NCT02707991|41629893|FG000|Overall Study|Became ineligible|0|||
19386976|NCT02707991|41629894|FG001|Overall Study|Became ineligible|1|||
19386977|NCT02707757|41629902|FG000|Overall Study|Protocol Violation|3|||
19386978|NCT02707757|41629903|FG001|Overall Study|Protocol Violation|2|||
19386979|NCT02707757|41629902|FG000|Overall Study|Withdrawal by Subject|2|||
19386980|NCT02707757|41629903|FG001|Overall Study|Withdrawal by Subject|0|||
19386981|NCT02707757|41629902|FG000|Overall Study|Death|0|||
19386982|NCT02707757|41629903|FG001|Overall Study|Death|1|||
19386983|NCT02707757|41629902|FG000|Overall Study|Adverse Event|6|||
19386984|NCT02707757|41629903|FG001|Overall Study|Adverse Event|4|||
19386985|NCT02707757|41629902|FG000|Overall Study|Renal transplant/elective operation|1|||
19386986|NCT02707757|41629903|FG001|Overall Study|Renal transplant/elective operation|5|||
19386987|NCT02572401|41629913|FG000|Overall Study|Lost to Follow-up|5|||
19386988|NCT02572401|41629914|FG001|Overall Study|Lost to Follow-up|8|||
19386989|NCT02572401|41629915|FG002|Overall Study|Lost to Follow-up|9|||
19386990|NCT02572401|41629916|FG003|Overall Study|Lost to Follow-up|9|||
19572496|NCT01184118|42020118|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
19572497|NCT01184118|42020118|FG000|Overall Study|No physiologic confirmation of asthma|8|||
19572498|NCT01184118|42020118|FG000|Overall Study|FEV1 <60% predicted|2|||
19572499|NCT01184118|42020118|FG000|Overall Study|Exclusionary medical condition|2|||
19572500|NCT01184118|42020118|FG000|Overall Study|Withdrawal by Subject|5|||
19572501|NCT01183884|42020122|FG000|Overall Study|Progressive Disease|26|||
19572502|NCT01183884|42020122|FG000|Overall Study|Adverse Event|3|||
19572503|NCT01183884|42020122|FG000|Overall Study|Withdrawal by Subject|1|||
19572504|NCT01183884|42020122|FG000|Overall Study|Other Complicating Disease|3|||
19572505|NCT01183884|42020122|FG000|Overall Study|Not Treated|1|||
19572506|NCT01183884|42020122|FG000|Overall Study|Other|4|||
19572507|NCT01183260|42020128|FG000|Overall Study|Intraop screen failure|2|||
19572508|NCT01183260|42020129|FG001|Overall Study|Intraop screen failure|0|||
19572509|NCT01183260|42020128|FG000|Overall Study|Withdrawal by Subject|1|||
19572510|NCT01183260|42020129|FG001|Overall Study|Withdrawal by Subject|1|||
19572511|NCT01183260|42020128|FG000|Overall Study|Revised within 30 days|0|||
19572512|NCT01183260|42020129|FG001|Overall Study|Revised within 30 days|1|||
19572513|NCT01183260|42020128|FG000|Overall Study|Death|1|||
19572514|NCT01183260|42020129|FG001|Overall Study|Death|0|||
19572515|NCT01191762|42020137|FG000|Overall Study|Adverse Event|1|||
19572516|NCT01191762|42020138|FG001|Overall Study|Adverse Event|0|||
19572517|NCT01723774|42020147|FG000|Neoadjuvant|Ki67 > 10%|4|||
19572518|NCT01723774|42020148|FG001|Neoadjuvant|Ki67 > 10%|0|||
19572519|NCT01723774|42020149|FG002|Neoadjuvant|Ki67 > 10%|10|||
19572520|NCT01723774|42020150|FG003|Neoadjuvant|Ki67 > 10%|0|||
19572521|NCT01723774|42020147|FG000|Neoadjuvant|Withdrawal by Subject|3|||
19572522|NCT01723774|42020148|FG001|Neoadjuvant|Withdrawal by Subject|1|||
19572523|NCT01723774|42020149|FG002|Neoadjuvant|Withdrawal by Subject|0|||
19572524|NCT01723774|42020150|FG003|Neoadjuvant|Withdrawal by Subject|0|||
19572525|NCT01723774|42020147|FG000|Neoadjuvant|Disease progression|0|||
19572526|NCT01723774|42020148|FG001|Neoadjuvant|Disease progression|1|||
19572527|NCT01723774|42020149|FG002|Neoadjuvant|Disease progression|1|||
19572528|NCT01723774|42020150|FG003|Neoadjuvant|Disease progression|0|||
19572529|NCT01723774|42020147|FG000|Neoadjuvant|Adverse Event|0|||
19572530|NCT01723774|42020148|FG001|Neoadjuvant|Adverse Event|1|||
19386991|NCT02572401|41629913|FG000|Overall Study|Death|0|||
19386992|NCT02572401|41629914|FG001|Overall Study|Death|0|||
19386993|NCT02572401|41629915|FG002|Overall Study|Death|0|||
19572531|NCT01723774|42020149|FG002|Neoadjuvant|Adverse Event|2|||
19572532|NCT01723774|42020150|FG003|Neoadjuvant|Adverse Event|0|||
19572533|NCT01723774|42020147|FG000|Neoadjuvant|High estradiol|0|||
19572534|NCT01723774|42020148|FG001|Neoadjuvant|High estradiol|1|||
19572535|NCT01723774|42020149|FG002|Neoadjuvant|High estradiol|0|||
19386994|NCT02572401|41629916|FG003|Overall Study|Death|1|||
19386995|NCT02103478|41629933|FG000|Overall Study|Adverse Event|0|||
19572536|NCT01723774|42020150|FG003|Neoadjuvant|High estradiol|0|||
19572537|NCT01723774|42020147|FG000|Adjuvant|Still on active treatment|0|||
19572538|NCT01723774|42020148|FG001|Adjuvant|Still on active treatment|0|||
19386996|NCT02103478|41629934|FG001|Overall Study|Adverse Event|0|||
19572539|NCT01723774|42020149|FG002|Adjuvant|Still on active treatment|0|||
19386997|NCT02103478|41629935|FG002|Overall Study|Adverse Event|1|||
19386998|NCT02103478|41629936|FG003|Overall Study|Adverse Event|1|||
19386999|NCT02103478|41629937|FG004|Overall Study|Adverse Event|2|||
19387000|NCT02103478|41629938|FG005|Overall Study|Adverse Event|1|||
19387001|NCT02103478|41629939|FG006|Overall Study|Adverse Event|0|||
19387002|NCT02103478|41629940|FG007|Overall Study|Adverse Event|0|||
19387003|NCT02103478|41629941|FG008|Overall Study|Adverse Event|0|||
19387004|NCT02103478|41629933|FG000|Overall Study|Death|2|||
19572540|NCT01723774|42020150|FG003|Adjuvant|Still on active treatment|1|||
19572541|NCT01190514|42020159|FG000|First Intervention (Period 1)|Adverse Event|1|||
19572542|NCT01190514|42020160|FG001|First Intervention (Period 1)|Adverse Event|0|||
19572543|NCT01190514|42020161|FG002|First Intervention (Period 1)|Adverse Event|0|||
19572544|NCT01190514|42020162|FG003|First Intervention (Period 1)|Adverse Event|0|||
19572545|NCT01190514|42020159|FG000|Third Intervention (Period 3)|Adverse Event|1|||
19572546|NCT01190514|42020160|FG001|Third Intervention (Period 3)|Adverse Event|0|||
19572547|NCT01190514|42020161|FG002|Third Intervention (Period 3)|Adverse Event|0|||
19572548|NCT01190514|42020162|FG003|Third Intervention (Period 3)|Adverse Event|0|||
19572549|NCT01190436|42020172|FG000|Overall Study|Lost to Follow-up|35|||
19572550|NCT01190436|42020172|FG000|Overall Study|Other|4|||
19572551|NCT01035255|42020179|FG000|Overall Study|Death|724|||
19572552|NCT01035255|42020180|FG001|Overall Study|Death|844|||
19572553|NCT01035255|42020179|FG000|Overall Study|Lost to Follow-up|2|||
19572554|NCT01035255|42020180|FG001|Overall Study|Lost to Follow-up|5|||
19572555|NCT01035255|42020179|FG000|Overall Study|patient's request|15|||
19572556|NCT01035255|42020180|FG001|Overall Study|patient's request|13|||
19572557|NCT01190124|42020189|FG000|Overall Study|Death|3|||
19572558|NCT01190124|42020190|FG001|Overall Study|Death|0|||
19572559|NCT01190124|42020191|FG002|Overall Study|Death|0|||
19572560|NCT01190124|42020189|FG000|Overall Study|Therapeutic Failure|12|||
19572561|NCT01190124|42020190|FG001|Overall Study|Therapeutic Failure|0|||
19572562|NCT01190124|42020191|FG002|Overall Study|Therapeutic Failure|1|||
19572563|NCT01190124|42020189|FG000|Overall Study|Lost to Follow-up|2|||
19572564|NCT01190124|42020190|FG001|Overall Study|Lost to Follow-up|0|||
19572565|NCT01190124|42020191|FG002|Overall Study|Lost to Follow-up|0|||
19572566|NCT01189890|42020204|FG000|Overall Study|Adverse Event|3|||
19572567|NCT01189890|42020205|FG001|Overall Study|Adverse Event|4|||
19572568|NCT01189890|42020204|FG000|Overall Study|Lack of Efficacy|7|||
19572569|NCT01189890|42020205|FG001|Overall Study|Lack of Efficacy|2|||
19572570|NCT01189890|42020204|FG000|Overall Study|Lost to Follow-up|1|||
19572571|NCT01189890|42020205|FG001|Overall Study|Lost to Follow-up|7|||
19572572|NCT01189890|42020204|FG000|Overall Study|Protocol Violation|1|||
19572573|NCT01189890|42020205|FG001|Overall Study|Protocol Violation|5|||
19572574|NCT01189890|42020204|FG000|Overall Study|Withdrawal by Subject|15|||
19572575|NCT01189890|42020205|FG001|Overall Study|Withdrawal by Subject|11|||
19572576|NCT01189890|42020204|FG000|Overall Study|Non Compliance|0|||
19572577|NCT01189890|42020205|FG001|Overall Study|Non Compliance|1|||
19572578|NCT01189890|42020204|FG000|Overall Study|Physician Decision|5|||
19572579|NCT01189890|42020205|FG001|Overall Study|Physician Decision|4|||
19572580|NCT01189890|42020204|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
19572581|NCT01189890|42020205|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
19572582|NCT01189812|42020213|FG000|Overall Study|Withdrawal by Subject|2|||
19572583|NCT01189812|42020214|FG001|Overall Study|Withdrawal by Subject|3|||
19572584|NCT01189812|42020213|FG000|Overall Study|Adverse Event|1|||
19572585|NCT01189812|42020214|FG001|Overall Study|Adverse Event|0|||
19572586|NCT01189812|42020213|FG000|Overall Study|Out of Window|4|||
19572587|NCT01189812|42020214|FG001|Overall Study|Out of Window|3|||
19572588|NCT01189812|42020213|FG000|Overall Study|Moved out of State|1|||
19572589|NCT01189812|42020214|FG001|Overall Study|Moved out of State|2|||
19572590|NCT00950950|42020222|FG000|Overall Study|Adverse Event|1|||
19572591|NCT00950950|42020223|FG001|Overall Study|Adverse Event|0|||
19572592|NCT00950950|42020222|FG000|Overall Study|Withdrawal by Subject|0|||
19572593|NCT00950950|42020223|FG001|Overall Study|Withdrawal by Subject|1|||
19572594|NCT00950872|42020230|FG000|Overall Study|Withdrawal by Subject|1|||
19572595|NCT00950872|42020230|FG000|Overall Study|Did not have surgery|2|||
19572596|NCT01189500|42020234|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
19387005|NCT02103478|41629934|FG001|Overall Study|Death|2|||
19387006|NCT02103478|41629935|FG002|Overall Study|Death|1|||
19387007|NCT02103478|41629936|FG003|Overall Study|Death|1|||
19387008|NCT02103478|41629937|FG004|Overall Study|Death|5|||
19387009|NCT02103478|41629938|FG005|Overall Study|Death|15|||
19572597|NCT01189500|42020234|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
19572598|NCT00938860|42020243|FG000|Overall Study|Adverse Event|2|||
19387010|NCT02103478|41629939|FG006|Overall Study|Death|14|||
19387011|NCT02103478|41629940|FG007|Overall Study|Death|10|||
19572599|NCT00938860|42020244|FG001|Overall Study|Adverse Event|1|||
19572600|NCT00938860|42020243|FG000|Overall Study|Abnormal laboratory values|2|||
19572601|NCT00938860|42020244|FG001|Overall Study|Abnormal laboratory values|2|||
19572602|NCT00938860|42020243|FG000|Overall Study|Withdrawal by Subject|11|||
19572603|NCT00938860|42020244|FG001|Overall Study|Withdrawal by Subject|8|||
19572604|NCT00938860|42020243|FG000|Overall Study|Lost to Follow-up|4|||
19572605|NCT00938860|42020244|FG001|Overall Study|Lost to Follow-up|4|||
19387012|NCT02103478|41629941|FG008|Overall Study|Death|11|||
19387013|NCT02103478|41629933|FG000|Overall Study|Progressive Disease|2|||
19387014|NCT02103478|41629934|FG001|Overall Study|Progressive Disease|1|||
19387015|NCT02103478|41629935|FG002|Overall Study|Progressive Disease|2|||
19572606|NCT00938860|42020243|FG000|Overall Study|Administration problems|2|||
19572607|NCT00938860|42020244|FG001|Overall Study|Administration problems|0|||
19572608|NCT00938860|42020243|FG000|Overall Study|Death|1|||
19572609|NCT00938860|42020244|FG001|Overall Study|Death|1|||
19572610|NCT00938860|42020243|FG000|Overall Study|Protocol Violation|3|||
19572611|NCT00938860|42020244|FG001|Overall Study|Protocol Violation|1|||
19572612|NCT00938470|42020252|FG000|Overall Study|Disease Progression|3|||
19572613|NCT00938470|42020253|FG001|Overall Study|Disease Progression|0|||
19572614|NCT00938470|42020252|FG000|Overall Study|Alternate Treatment|1|||
19572615|NCT00938470|42020253|FG001|Overall Study|Alternate Treatment|0|||
19572616|NCT00938470|42020252|FG000|Overall Study|Death|3|||
19572617|NCT00938470|42020253|FG001|Overall Study|Death|2|||
19572618|NCT00938470|42020252|FG000|Overall Study|Other Reason|0|||
19572619|NCT00938470|42020253|FG001|Overall Study|Other Reason|1|||
19572620|NCT00938392|42020261|FG000|Overall Study|Adverse Event|0|||
19572621|NCT00938392|42020262|FG001|Overall Study|Adverse Event|1|||
19572622|NCT00938392|42020261|FG000|Overall Study|Withdrawal by Subject|0|||
19572623|NCT00938392|42020262|FG001|Overall Study|Withdrawal by Subject|1|||
19572624|NCT00938392|42020261|FG000|Overall Study|Lost to Follow-up|2|||
19572625|NCT00938392|42020262|FG001|Overall Study|Lost to Follow-up|2|||
19572626|NCT01022853|42020273|FG000|Overall Study|Progressive disease|2|||
19572627|NCT01022853|42020274|FG001|Overall Study|Progressive disease|3|||
19572628|NCT01022853|42020275|FG002|Overall Study|Progressive disease|11|||
19572629|NCT01022853|42020276|FG003|Overall Study|Progressive disease|7|||
19572630|NCT01022853|42020277|FG004|Overall Study|Progressive disease|1|||
19572631|NCT01022853|42020273|FG000|Overall Study|Dose-limiting toxicity|0|||
19572632|NCT01022853|42020274|FG001|Overall Study|Dose-limiting toxicity|0|||
19572633|NCT01022853|42020275|FG002|Overall Study|Dose-limiting toxicity|0|||
19572634|NCT01022853|42020276|FG003|Overall Study|Dose-limiting toxicity|0|||
19572635|NCT01022853|42020277|FG004|Overall Study|Dose-limiting toxicity|1|||
19572636|NCT01022853|42020273|FG000|Overall Study|Withdrawal by Subject|0|||
19572637|NCT01022853|42020274|FG001|Overall Study|Withdrawal by Subject|1|||
19572638|NCT01022853|42020275|FG002|Overall Study|Withdrawal by Subject|1|||
19572639|NCT01022853|42020276|FG003|Overall Study|Withdrawal by Subject|1|||
19572640|NCT01022853|42020277|FG004|Overall Study|Withdrawal by Subject|0|||
19572641|NCT01022853|42020273|FG000|Overall Study|Other not stated above|1|||
19572642|NCT01022853|42020274|FG001|Overall Study|Other not stated above|0|||
19572643|NCT01022853|42020275|FG002|Overall Study|Other not stated above|1|||
19572644|NCT01022853|42020276|FG003|Overall Study|Other not stated above|0|||
19572645|NCT01022853|42020277|FG004|Overall Study|Other not stated above|0|||
19572646|NCT01034709|42020294|FG000|Overall Study|Protocol Violation|9|||
19572647|NCT01034709|42020295|FG001|Overall Study|Protocol Violation|16|||
19572648|NCT00937768|42020303|FG000|Overall Study|Refused Further Treatment|3|||
19572649|NCT00937768|42020304|FG001|Overall Study|Refused Further Treatment|2|||
19572650|NCT00937768|42020303|FG000|Overall Study|Disease Progression|1|||
19572651|NCT00937768|42020304|FG001|Overall Study|Disease Progression|1|||
19572652|NCT00937768|42020303|FG000|Overall Study|Alternate Treatment|0|||
19572653|NCT00937768|42020304|FG001|Overall Study|Alternate Treatment|1|||
19572654|NCT00937768|42020303|FG000|Overall Study|No Further Funding|4|||
19572655|NCT00937768|42020304|FG001|Overall Study|No Further Funding|4|||
19572656|NCT00940888|42020310|FG000|Overall Study|Unsuccessful Implant|4|||
19572657|NCT00940888|42020310|FG000|Overall Study|Death|461|||
19572658|NCT00940888|42020310|FG000|Overall Study|Withdrawn - Non-Death|364|||
19572659|NCT00940888|42020310|FG000|Overall Study|Lost to Follow-up|6|||
19572660|NCT01189266|42020317|FG000|Overall Study|Adverse Event|1|||
19572661|NCT01189266|42020318|FG001|Overall Study|Adverse Event|0|||
19572662|NCT01189266|42020319|FG002|Overall Study|Adverse Event|5|||
19572663|NCT01189266|42020317|FG000|Overall Study|Death|0|||
19572664|NCT01189266|42020318|FG001|Overall Study|Death|0|||
19572665|NCT01189266|42020319|FG002|Overall Study|Death|5|||
19572666|NCT01189266|42020317|FG000|Overall Study|Lack of Efficacy|4|||
19572667|NCT01189266|42020318|FG001|Overall Study|Lack of Efficacy|5|||
19572668|NCT01189266|42020319|FG002|Overall Study|Lack of Efficacy|44|||
19572669|NCT01189266|42020317|FG000|Overall Study|Physician Decision|0|||
19572670|NCT01189266|42020318|FG001|Overall Study|Physician Decision|0|||
19572671|NCT01189266|42020319|FG002|Overall Study|Physician Decision|1|||
19572672|NCT01189266|42020317|FG000|Overall Study|Protocol Violation|0|||
19572673|NCT01189266|42020318|FG001|Overall Study|Protocol Violation|1|||
19572674|NCT01189266|42020319|FG002|Overall Study|Protocol Violation|1|||
19572675|NCT01189266|42020317|FG000|Overall Study|Withdrawal by Subject|0|||
19572676|NCT01189266|42020318|FG001|Overall Study|Withdrawal by Subject|0|||
19572677|NCT01189266|42020319|FG002|Overall Study|Withdrawal by Subject|1|||
19572678|NCT01189266|42020317|FG000|Overall Study|Patient refuses further therapy|1|||
19572679|NCT01189266|42020318|FG001|Overall Study|Patient refuses further therapy|0|||
19572680|NCT01189266|42020319|FG002|Overall Study|Patient refuses further therapy|7|||
19572681|NCT01189266|42020317|FG000|Overall Study|No treatment|0|||
19572682|NCT01189266|42020318|FG001|Overall Study|No treatment|0|||
19572683|NCT01189266|42020319|FG002|Overall Study|No treatment|1|||
19572684|NCT01189032|42020331|FG000|Overall Study|Adverse Event|1|||
19572685|NCT01189032|42020332|FG001|Overall Study|Adverse Event|3|||
19572686|NCT01189032|42020333|FG002|Overall Study|Adverse Event|4|||
19572687|NCT01189032|42020331|FG000|Overall Study|Lack of Efficacy|2|||
19572688|NCT01189032|42020332|FG001|Overall Study|Lack of Efficacy|3|||
19572689|NCT01189032|42020333|FG002|Overall Study|Lack of Efficacy|0|||
19572690|NCT01189032|42020331|FG000|Overall Study|Withdrawal by Subject|1|||
19572691|NCT01189032|42020332|FG001|Overall Study|Withdrawal by Subject|0|||
19572692|NCT01189032|42020333|FG002|Overall Study|Withdrawal by Subject|1|||
19572693|NCT01189032|42020331|FG000|Overall Study|Protocol Violation|1|||
19572694|NCT01189032|42020332|FG001|Overall Study|Protocol Violation|1|||
19572695|NCT01189032|42020333|FG002|Overall Study|Protocol Violation|1|||
19572696|NCT01188798|42020343|FG000|Overall Study|Death|0|||
19572697|NCT01188798|42020344|FG001|Overall Study|Death|1|||
19572698|NCT01188798|42020343|FG000|Overall Study|Required additional transplant|1|||
19572699|NCT01188798|42020344|FG001|Overall Study|Required additional transplant|1|||
19572700|NCT01188798|42020343|FG000|Overall Study|Protocol closure|1|||
19572701|NCT01188798|42020344|FG001|Overall Study|Protocol closure|1|||
19572702|NCT01183104|42020353|FG000|Overall Study|Adverse Event|8|||
19572703|NCT01183104|42020354|FG001|Overall Study|Adverse Event|6|||
19572704|NCT01183104|42020353|FG000|Overall Study|Death|0|||
19572705|NCT01183104|42020354|FG001|Overall Study|Death|1|||
19572706|NCT01183104|42020353|FG000|Overall Study|Lost to Follow-up|14|||
19572707|NCT01183104|42020354|FG001|Overall Study|Lost to Follow-up|7|||
19572708|NCT01183104|42020353|FG000|Overall Study|Physician Decision|5|||
19572709|NCT01183104|42020354|FG001|Overall Study|Physician Decision|8|||
19572710|NCT01183104|42020353|FG000|Overall Study|Withdrawal by Subject|6|||
19572711|NCT01183104|42020354|FG001|Overall Study|Withdrawal by Subject|11|||
19387016|NCT02103478|41629936|FG003|Overall Study|Progressive Disease|0|||
19387017|NCT02103478|41629937|FG004|Overall Study|Progressive Disease|9|||
19387018|NCT02103478|41629938|FG005|Overall Study|Progressive Disease|1|||
19387019|NCT02103478|41629939|FG006|Overall Study|Progressive Disease|2|||
19387020|NCT02103478|41629940|FG007|Overall Study|Progressive Disease|0|||
19572712|NCT01183104|42020353|FG000|Overall Study|Nonparticipation in Extension Study|39|||
19572713|NCT01183104|42020354|FG001|Overall Study|Nonparticipation in Extension Study|50|||
19572714|NCT01183104|42020353|FG000|Overall Study|Did not receive study drug|5|||
19572715|NCT01183104|42020354|FG001|Overall Study|Did not receive study drug|9|||
19572716|NCT01163292|42020362|FG000|Overall Study|Lack of Efficacy|9|||
19572717|NCT01163292|42020363|FG001|Overall Study|Lack of Efficacy|0|||
19572718|NCT01163292|42020362|FG000|Overall Study|Adverse Event|6|||
19572719|NCT01163292|42020363|FG001|Overall Study|Adverse Event|0|||
19572720|NCT01163292|42020362|FG000|Overall Study|Initiation of biological therapy|0|||
19572721|NCT01163292|42020363|FG001|Overall Study|Initiation of biological therapy|15|||
19572722|NCT01163292|42020362|FG000|Overall Study|Sufficient response to adalimumab|8|||
19572723|NCT01163292|42020363|FG001|Overall Study|Sufficient response to adalimumab|0|||
19572724|NCT01163292|42020362|FG000|Overall Study|Refusal to receive adalimumab|7|||
19572725|NCT01163292|42020363|FG001|Overall Study|Refusal to receive adalimumab|0|||
19387021|NCT02103478|41629941|FG008|Overall Study|Progressive Disease|1|||
19572726|NCT01163292|42020362|FG000|Overall Study|Economic reasons|6|||
19572727|NCT01163292|42020363|FG001|Overall Study|Economic reasons|0|||
19572728|NCT01163292|42020362|FG000|Overall Study|No further visits|5|||
19572729|NCT01163292|42020363|FG001|Overall Study|No further visits|7|||
19572730|NCT00950248|42020371|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
19572731|NCT00950248|42020372|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
19572732|NCT00950248|42020373|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
19387022|NCT02103478|41629933|FG000|Overall Study|Withdrawal by Subject|2|||
19387023|NCT02103478|41629934|FG001|Overall Study|Withdrawal by Subject|0|||
19387024|NCT02103478|41629935|FG002|Overall Study|Withdrawal by Subject|0|||
19387025|NCT02103478|41629936|FG003|Overall Study|Withdrawal by Subject|4|||
19387026|NCT02103478|41629937|FG004|Overall Study|Withdrawal by Subject|0|||
19387027|NCT02103478|41629938|FG005|Overall Study|Withdrawal by Subject|0|||
19387028|NCT02103478|41629939|FG006|Overall Study|Withdrawal by Subject|1|||
19387029|NCT02103478|41629940|FG007|Overall Study|Withdrawal by Subject|1|||
19387030|NCT02103478|41629941|FG008|Overall Study|Withdrawal by Subject|0|||
19387031|NCT02103478|41629933|FG000|Overall Study|Lost to Follow-up|0|||
19387032|NCT02103478|41629934|FG001|Overall Study|Lost to Follow-up|0|||
19387033|NCT02103478|41629935|FG002|Overall Study|Lost to Follow-up|0|||
19387034|NCT02103478|41629936|FG003|Overall Study|Lost to Follow-up|0|||
19387035|NCT02103478|41629937|FG004|Overall Study|Lost to Follow-up|0|||
19387036|NCT02103478|41629938|FG005|Overall Study|Lost to Follow-up|0|||
19387037|NCT02103478|41629939|FG006|Overall Study|Lost to Follow-up|0|||
19387038|NCT02103478|41629940|FG007|Overall Study|Lost to Follow-up|1|||
19387039|NCT02103478|41629941|FG008|Overall Study|Lost to Follow-up|0|||
19387040|NCT02103478|41629933|FG000|Overall Study|Other|1|||
19387041|NCT02103478|41629934|FG001|Overall Study|Other|3|||
19387042|NCT02103478|41629935|FG002|Overall Study|Other|2|||
19387043|NCT02103478|41629936|FG003|Overall Study|Other|0|||
19387044|NCT02103478|41629937|FG004|Overall Study|Other|3|||
19387045|NCT02103478|41629938|FG005|Overall Study|Other|8|||
19387046|NCT02103478|41629939|FG006|Overall Study|Other|8|||
19387047|NCT02103478|41629940|FG007|Overall Study|Other|4|||
19572733|NCT00950248|42020371|FG000|Year 1: Baseline|worsening of symptoms|2|||
19572734|NCT00950248|42020372|FG001|Year 1: Baseline|worsening of symptoms|0|||
19572735|NCT00950248|42020373|FG002|Year 1: Baseline|worsening of symptoms|0|||
19572736|NCT00950248|42020371|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
19572737|NCT00950248|42020372|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
19572738|NCT00950248|42020373|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
19572739|NCT00950248|42020371|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
19572740|NCT00950248|42020372|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
19387048|NCT02103478|41629941|FG008|Overall Study|Other|2|||
19387049|NCT02102464|41629973|FG000|Randomized Study|Withdrawal by Subject|0|||
19387050|NCT02102464|41629974|FG001|Randomized Study|Withdrawal by Subject|1|||
19387051|NCT02102464|41629975|FG002|Randomized Study|Withdrawal by Subject|0|||
19387052|NCT02707601|41629986|FG000|Overall Study|Death|0|||
19387053|NCT02707601|41629987|FG001|Overall Study|Death|1|||
19387054|NCT02707601|41629986|FG000|Overall Study|Lack of Efficacy|0|||
19387055|NCT02707601|41629987|FG001|Overall Study|Lack of Efficacy|1|||
19387056|NCT02707601|41629986|FG000|Overall Study|Investigator's Discretion|1|||
19387057|NCT02707601|41629987|FG001|Overall Study|Investigator's Discretion|0|||
19387058|NCT02707601|41629986|FG000|Overall Study|Withdrew Consent|0|||
19387059|NCT02707601|41629987|FG001|Overall Study|Withdrew Consent|1|||
19387060|NCT02707601|41629986|FG000|Overall Study|Lost to Follow-up|1|||
19387061|NCT02707601|41629987|FG001|Overall Study|Lost to Follow-up|1|||
19387062|NCT02707601|41629986|FG000|Overall Study|Participants Randomized but Not Treated|2|||
19387063|NCT02707601|41629987|FG001|Overall Study|Participants Randomized but Not Treated|0|||
19387064|NCT02707055|41629999|FG000|Phase 1|Withdrawal by Subject|1|||
19387065|NCT02707055|41630000|FG001|Phase 1|Withdrawal by Subject|2|||
19387066|NCT02707055|41629999|FG000|Phase 1|Physician Decision|0|||
19387067|NCT02707055|41630000|FG001|Phase 1|Physician Decision|1|||
19387068|NCT02707055|41629999|FG000|Phase 2|Adverse Event|1|||
19387069|NCT02707055|41630000|FG001|Phase 2|Adverse Event|2|||
19387070|NCT02073682|41630008|FG000|Overall Study|Low Creatinine Clearance|1|||
19387071|NCT02073682|41630009|FG001|Overall Study|Low Creatinine Clearance|2|||
19387072|NCT02073682|41630008|FG000|Overall Study|Death|86|||
19387073|NCT02073682|41630009|FG001|Overall Study|Death|100|||
19387074|NCT02073682|41630008|FG000|Overall Study|Cancer Cured|10|||
19387075|NCT02073682|41630009|FG001|Overall Study|Cancer Cured|15|||
19387076|NCT02073682|41630008|FG000|Overall Study|ID: Patient Noncompliance|1|||
19387077|NCT02073682|41630009|FG001|Overall Study|ID: Patient Noncompliance|2|||
19387078|NCT02073682|41630008|FG000|Overall Study|ID: Palliative Treatment Only|10|||
19387079|NCT02073682|41630009|FG001|Overall Study|ID: Palliative Treatment Only|7|||
19387080|NCT02073682|41630008|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
19387081|NCT02073682|41630009|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
19387082|NCT02073682|41630008|FG000|Overall Study|Platelet Count <50,000/mL|1|||
19387083|NCT02073682|41630009|FG001|Overall Study|Platelet Count <50,000/mL|2|||
19387084|NCT02073682|41630008|FG000|Overall Study|Surgery/Medical Procedure|3|||
19387085|NCT02073682|41630009|FG001|Overall Study|Surgery/Medical Procedure|1|||
19387086|NCT02073682|41630008|FG000|Overall Study|Withdrawal by Subject|6|||
19387087|NCT02073682|41630009|FG001|Overall Study|Withdrawal by Subject|8|||
19387088|NCT02073682|41630008|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
19572741|NCT00950248|42020373|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
19572742|NCT00950248|42020371|FG000|Year 2&3 Treatment Randomization|Death|0|||
19572743|NCT00950248|42020372|FG001|Year 2&3 Treatment Randomization|Death|0|||
19572744|NCT00950248|42020373|FG002|Year 2&3 Treatment Randomization|Death|1|||
19572745|NCT00950248|42020371|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
19572746|NCT00950248|42020372|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
19572747|NCT00950248|42020373|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
19572748|NCT00950170|42020380|FG000|Overall Study|Parent/Legal Guardian Request|1|||
19572749|NCT00950170|42020380|FG000|Overall Study|Adverse Event|2|||
19572750|NCT00950170|42020380|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
19572751|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
19572752|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
19572753|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
19572754|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
19572755|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
19572756|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
19572757|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
19572758|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
19572759|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
19572760|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
19572761|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
19572762|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
19572763|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
19572764|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
19572765|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
19572766|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
19572767|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
19572768|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
19572769|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
19572770|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
19572771|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
19572772|NCT01227824|42020404|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
19572773|NCT01227824|42020405|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
19572774|NCT01227824|42020406|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
19572775|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
19572776|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
19572777|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
19572778|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
19572779|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
19572780|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
19572781|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
19572782|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
19572783|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
19572784|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
19572785|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
19572786|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
19572787|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
19572788|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
19572789|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
19572790|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
19572791|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
19572792|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
19572793|NCT01227824|42020404|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
19572794|NCT01227824|42020405|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
19572795|NCT01227824|42020406|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
19572796|NCT00949702|42020413|FG000|Overall Study|Death|40|||
19572797|NCT00949702|42020413|FG000|Overall Study|Disease progression|7|||
19572798|NCT00949702|42020413|FG000|Overall Study|Withdrawal of consent|1|||
19572799|NCT01034631|42020420|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
19572800|NCT01034631|42020421|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
19572801|NCT01034631|42020422|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
19572802|NCT01034631|42020420|FG000|Phase II|Not Evaluable per protocol|0|||
19572803|NCT01034631|42020421|FG001|Phase II|Not Evaluable per protocol|0|||
19572804|NCT01034631|42020422|FG002|Phase II|Not Evaluable per protocol|2|||
19572805|NCT01034631|42020420|FG000|Phase II|Determined Ineligible per protocol|0|||
19572806|NCT01034631|42020421|FG001|Phase II|Determined Ineligible per protocol|1|||
19572807|NCT01034631|42020422|FG002|Phase II|Determined Ineligible per protocol|0|||
19572808|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
19572809|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
19572810|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
19572811|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
19572812|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
19572813|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
19572814|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
19572815|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
19572816|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
19572817|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
19572818|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
19572819|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
19572820|NCT01227668|42020434|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
19572821|NCT01227668|42020435|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
19572822|NCT01227668|42020434|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
19572823|NCT01227668|42020435|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
19572824|NCT01227668|42020434|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
19572825|NCT01227668|42020435|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
19572826|NCT01227668|42020434|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
19572827|NCT01227668|42020435|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
19572828|NCT01227668|42020434|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
19572829|NCT01227668|42020435|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
19572830|NCT01227668|42020434|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
19572831|NCT01227668|42020435|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
19572832|NCT01227512|42020447|FG000|Overall Study|Physician Decision|6|||
19572833|NCT01227512|42020448|FG001|Overall Study|Physician Decision|6|||
19572834|NCT01227512|42020447|FG000|Overall Study|Adverse Event|4|||
19572835|NCT01227512|42020448|FG001|Overall Study|Adverse Event|3|||
19572836|NCT01227512|42020447|FG000|Overall Study|Withdrawal by Subject|3|||
19572837|NCT01227512|42020448|FG001|Overall Study|Withdrawal by Subject|0|||
19572838|NCT01227512|42020447|FG000|Overall Study|Participant met withdrawal criteria|0|||
19572839|NCT01227512|42020448|FG001|Overall Study|Participant met withdrawal criteria|1|||
19572840|NCT01227278|42020458|FG000|Overall Study|Withdrawal by Subject|4|||
19572841|NCT01227278|42020459|FG001|Overall Study|Withdrawal by Subject|4|||
19572842|NCT01227278|42020458|FG000|Overall Study|Death|0|||
19572843|NCT01227278|42020459|FG001|Overall Study|Death|2|||
19572844|NCT01227278|42020458|FG000|Overall Study|Other|1|||
19572845|NCT01227278|42020459|FG001|Overall Study|Other|2|||
19572846|NCT01034397|42020467|FG000|Overall Study|Lack of compliance|0|||
19572847|NCT01034397|42020468|FG001|Overall Study|Lack of compliance|1|||
19572848|NCT01034397|42020467|FG000|Overall Study|Lack of Efficacy|3|||
19572849|NCT01034397|42020468|FG001|Overall Study|Lack of Efficacy|0|||
19572850|NCT01034397|42020467|FG000|Overall Study|Adverse Event|4|||
19572851|NCT01034397|42020468|FG001|Overall Study|Adverse Event|0|||
19572852|NCT01034397|42020467|FG000|Overall Study|Other|0|||
19572853|NCT01034397|42020468|FG001|Overall Study|Other|1|||
19572854|NCT01227044|42020485|FG000|Overall Study|Lost to Follow-up|5|||
19572855|NCT01227044|42020486|FG001|Overall Study|Lost to Follow-up|7|||
19572856|NCT01227044|42020485|FG000|Overall Study|Discontinued Intervention|1|||
19572857|NCT01227044|42020486|FG001|Overall Study|Discontinued Intervention|2|||
19572858|NCT01225952|42020495|FG000|Overall Study|Lost to Follow-up|1|||
19572859|NCT01225952|42020496|FG001|Overall Study|Lost to Follow-up|0|||
19572860|NCT01225952|42020497|FG002|Overall Study|Lost to Follow-up|0|||
19572861|NCT01225952|42020495|FG000|Overall Study|Study Eye Explanted|0|||
19572862|NCT01225952|42020496|FG001|Overall Study|Study Eye Explanted|0|||
19572863|NCT01225952|42020497|FG002|Overall Study|Study Eye Explanted|1|||
19572864|NCT01225952|42020495|FG000|Overall Study|Withdrawal by Subject|4|||
19572865|NCT01225952|42020496|FG001|Overall Study|Withdrawal by Subject|4|||
19572866|NCT01225952|42020497|FG002|Overall Study|Withdrawal by Subject|5|||
19572867|NCT01225952|42020495|FG000|Overall Study|Surgical complications|1|||
19572868|NCT01225952|42020496|FG001|Overall Study|Surgical complications|0|||
19572869|NCT01225952|42020497|FG002|Overall Study|Surgical complications|0|||
19387089|NCT02073682|41630009|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
19572870|NCT01034163|42020507|FG000|Overall Study|Treatment completed as per protocol|8|||
19572871|NCT01034163|42020508|FG001|Overall Study|Treatment completed as per protocol|7|||
19572872|NCT01034163|42020507|FG000|Overall Study|Withdrawal by Subject|8|||
19572873|NCT01034163|42020508|FG001|Overall Study|Withdrawal by Subject|2|||
19572874|NCT01034163|42020507|FG000|Overall Study|Protocol deviation|1|||
19572875|NCT01034163|42020508|FG001|Overall Study|Protocol deviation|0|||
19572876|NCT01034163|42020507|FG000|Overall Study|Disease progression|3|||
19572877|NCT01034163|42020508|FG001|Overall Study|Disease progression|4|||
19572878|NCT01034163|42020507|FG000|Overall Study|Adverse Event|6|||
19572879|NCT01034163|42020508|FG001|Overall Study|Adverse Event|0|||
19572880|NCT01034163|42020507|FG000|Overall Study|Administrative problems|0|||
19572881|NCT01034163|42020508|FG001|Overall Study|Administrative problems|1|||
19572882|NCT01034163|42020507|FG000|Overall Study|Abnormal laboratory value|1|||
19572883|NCT01034163|42020508|FG001|Overall Study|Abnormal laboratory value|0|||
19572884|NCT01033851|42020516|FG000|Overall Study|Withdrawal by Subject|3|||
19572885|NCT01033851|42020517|FG001|Overall Study|Withdrawal by Subject|7|||
19572886|NCT01162122|42020525|FG000|Overall Study|Withdrawal by Subject|52|||
19572887|NCT01162122|42020526|FG001|Overall Study|Withdrawal by Subject|43|||
19572888|NCT01162122|42020525|FG000|Overall Study|Lost to Follow-up|73|||
19572889|NCT01162122|42020526|FG001|Overall Study|Lost to Follow-up|91|||
19572890|NCT01162122|42020525|FG000|Overall Study|Adverse Event|3|||
19572891|NCT01162122|42020526|FG001|Overall Study|Adverse Event|2|||
19572892|NCT01162122|42020525|FG000|Overall Study|Death|51|||
19572893|NCT01162122|42020526|FG001|Overall Study|Death|46|||
19572894|NCT01162122|42020525|FG000|Overall Study|Protocol Violation|2|||
19572895|NCT01162122|42020526|FG001|Overall Study|Protocol Violation|2|||
19572896|NCT01162122|42020525|FG000|Overall Study|Inappropriate enrollment|5|||
19572897|NCT01162122|42020526|FG001|Overall Study|Inappropriate enrollment|4|||
19572898|NCT01162122|42020525|FG000|Overall Study|Administrative reason|1|||
19572899|NCT01162122|42020526|FG001|Overall Study|Administrative reason|1|||
19572900|NCT01162122|42020525|FG000|Overall Study|Unable to classify|3|||
19572901|NCT01162122|42020526|FG001|Overall Study|Unable to classify|7|||
19572902|NCT01162122|42020525|FG000|Overall Study|Missing primary reason|1|||
19572903|NCT01162122|42020526|FG001|Overall Study|Missing primary reason|0|||
19572904|NCT01033071|42020538|FG000|Overall Study|Adverse Event|28|||
19387090|NCT02073682|41630008|FG000|Overall Study|Cancer Progression|53|||
19387091|NCT02073682|41630009|FG001|Overall Study|Cancer Progression|33|||
19387092|NCT02073682|41630008|FG000|Overall Study|Protocol Violation|1|||
19387093|NCT02073682|41630009|FG001|Overall Study|Protocol Violation|0|||
19387094|NCT02073682|41630008|FG000|Overall Study|Adverse Event|79|||
19387095|NCT02073682|41630009|FG001|Overall Study|Adverse Event|62|||
19387096|NCT02073682|41630008|FG000|Overall Study|No reason provided|11|||
19387097|NCT02073682|41630009|FG001|Overall Study|No reason provided|9|||
19387098|NCT02073682|41630008|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
19387099|NCT02073682|41630009|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
19387100|NCT02073682|41630008|FG000|Overall Study|Lost to Follow-up|1|||
19572905|NCT01033071|42020539|FG001|Overall Study|Adverse Event|51|||
19572906|NCT01033071|42020540|FG002|Overall Study|Adverse Event|26|||
19572907|NCT01033071|42020538|FG000|Overall Study|Protocol Violation|0|||
19572908|NCT01033071|42020539|FG001|Overall Study|Protocol Violation|2|||
19572909|NCT01033071|42020540|FG002|Overall Study|Protocol Violation|1|||
19572910|NCT01033071|42020538|FG000|Overall Study|Lost to Follow-up|4|||
19572911|NCT01033071|42020539|FG001|Overall Study|Lost to Follow-up|5|||
19572912|NCT01033071|42020540|FG002|Overall Study|Lost to Follow-up|5|||
19572913|NCT01033071|42020538|FG000|Overall Study|Withdrawal by Subject|17|||
19572914|NCT01033071|42020539|FG001|Overall Study|Withdrawal by Subject|14|||
19572915|NCT01033071|42020540|FG002|Overall Study|Withdrawal by Subject|11|||
19387101|NCT02073682|41630009|FG001|Overall Study|Lost to Follow-up|1|||
19387102|NCT02073682|41630008|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
19387103|NCT02073682|41630009|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
19572916|NCT01033071|42020538|FG000|Overall Study|Lack of Efficacy|0|||
19572917|NCT01033071|42020539|FG001|Overall Study|Lack of Efficacy|1|||
19572918|NCT01033071|42020540|FG002|Overall Study|Lack of Efficacy|1|||
19572919|NCT01033071|42020538|FG000|Overall Study|Other|6|||
19572920|NCT01033071|42020539|FG001|Overall Study|Other|4|||
19572921|NCT01033071|42020540|FG002|Overall Study|Other|3|||
19572922|NCT01032915|42020552|FG000|Overall Study|Adverse Event|2|||
19572923|NCT01032915|42020553|FG001|Overall Study|Adverse Event|2|||
19572924|NCT01032915|42020554|FG002|Overall Study|Adverse Event|1|||
19572925|NCT01032915|42020555|FG003|Overall Study|Adverse Event|1|||
19572926|NCT01032915|42020552|FG000|Overall Study|Abnormal test procedure result|0|||
19572927|NCT01032915|42020553|FG001|Overall Study|Abnormal test procedure result|0|||
19572928|NCT01032915|42020554|FG002|Overall Study|Abnormal test procedure result|1|||
19572929|NCT01032915|42020555|FG003|Overall Study|Abnormal test procedure result|0|||
19572930|NCT01032915|42020552|FG000|Overall Study|Withdrawal by Subject|0|||
19572931|NCT01032915|42020553|FG001|Overall Study|Withdrawal by Subject|3|||
19572932|NCT01032915|42020554|FG002|Overall Study|Withdrawal by Subject|1|||
19572933|NCT01032915|42020555|FG003|Overall Study|Withdrawal by Subject|1|||
19572934|NCT01032915|42020552|FG000|Overall Study|Administrative reasons|5|||
19572935|NCT01032915|42020553|FG001|Overall Study|Administrative reasons|6|||
19572936|NCT01032915|42020554|FG002|Overall Study|Administrative reasons|4|||
19572937|NCT01032915|42020555|FG003|Overall Study|Administrative reasons|4|||
19572938|NCT01032915|42020552|FG000|Overall Study|Protocol Violation|1|||
19572939|NCT01032915|42020553|FG001|Overall Study|Protocol Violation|0|||
19572940|NCT01032915|42020554|FG002|Overall Study|Protocol Violation|0|||
19572941|NCT01032915|42020555|FG003|Overall Study|Protocol Violation|1|||
19572942|NCT01161498|42020567|FG000|Overall Study|Disease Progression|0|||
19572943|NCT01161498|42020568|FG001|Overall Study|Disease Progression|1|||
19572944|NCT01180998|42020577|FG000|Overall Study|Poor Vision|0|||
19572945|NCT01180998|42020578|FG001|Overall Study|Poor Vision|2|||
19572946|NCT01180998|42020579|FG002|Overall Study|Poor Vision|2|||
19572947|NCT01180998|42020577|FG000|Overall Study|Lost to Follow-up|0|||
19572948|NCT01180998|42020578|FG001|Overall Study|Lost to Follow-up|0|||
19572949|NCT01180998|42020579|FG002|Overall Study|Lost to Follow-up|1|||
19572950|NCT01180998|42020577|FG000|Overall Study|Protocol Violation|1|||
19572951|NCT01180998|42020578|FG001|Overall Study|Protocol Violation|2|||
19572952|NCT01180998|42020579|FG002|Overall Study|Protocol Violation|0|||
19572953|NCT01180998|42020577|FG000|Overall Study|Withdrawal by Subject|0|||
19572954|NCT01180998|42020578|FG001|Overall Study|Withdrawal by Subject|0|||
19572955|NCT01180998|42020579|FG002|Overall Study|Withdrawal by Subject|1|||
19572956|NCT01180998|42020577|FG000|Overall Study|Poor comfort|3|||
19572957|NCT01180998|42020578|FG001|Overall Study|Poor comfort|0|||
19572958|NCT01180998|42020579|FG002|Overall Study|Poor comfort|4|||
19572959|NCT01180998|42020577|FG000|Overall Study|Poor lens handling|0|||
19572960|NCT01180998|42020578|FG001|Overall Study|Poor lens handling|0|||
19572961|NCT01180998|42020579|FG002|Overall Study|Poor lens handling|2|||
19572962|NCT01029795|42020590|FG000|Overall Study|Entry Criteria Not Met|2|||
19572963|NCT01029795|42020591|FG001|Overall Study|Entry Criteria Not Met|1|||
19572964|NCT01029795|42020590|FG000|Overall Study|Physician Decision|2|||
19572965|NCT01029795|42020591|FG001|Overall Study|Physician Decision|1|||
19572966|NCT01029795|42020590|FG000|Overall Study|Sponsor Decision|11|||
19572967|NCT01029795|42020591|FG001|Overall Study|Sponsor Decision|17|||
19572968|NCT01029795|42020590|FG000|Overall Study|Withdrawal by Subject|1|||
19572969|NCT01029795|42020591|FG001|Overall Study|Withdrawal by Subject|3|||
19572970|NCT01032837|42020601|FG000|Overall Study|Adverse event/internal illness|0|||
19572971|NCT01032837|42020602|FG001|Overall Study|Adverse event/internal illness|1|||
19387104|NCT02072980|41630015|FG000|Period 2, Second Wear|Adverse Event|0|||
19387105|NCT02072980|41630016|FG001|Period 2, Second Wear|Adverse Event|1|||
19387106|NCT02706899|41630024|FG000|Overall Study|Withdrawal by Subject|1|||
19572972|NCT01032837|42020603|FG002|Overall Study|Adverse event/internal illness|0|||
19572973|NCT01032837|42020604|FG003|Overall Study|Adverse event/internal illness|1|||
19572974|NCT01032837|42020601|FG000|Overall Study|Withdrew consent|0|||
19572975|NCT01032837|42020602|FG001|Overall Study|Withdrew consent|2|||
19572976|NCT01032837|42020603|FG002|Overall Study|Withdrew consent|0|||
19572977|NCT01032837|42020604|FG003|Overall Study|Withdrew consent|1|||
19572978|NCT01032837|42020601|FG000|Overall Study|Failed to return|0|||
19572979|NCT01032837|42020602|FG001|Overall Study|Failed to return|0|||
19572980|NCT01032837|42020603|FG002|Overall Study|Failed to return|1|||
19572981|NCT01032837|42020604|FG003|Overall Study|Failed to return|0|||
19572982|NCT01032837|42020601|FG000|Overall Study|Refused treatment|0|||
19572983|NCT01032837|42020602|FG001|Overall Study|Refused treatment|0|||
19572984|NCT01032837|42020603|FG002|Overall Study|Refused treatment|0|||
19572985|NCT01032837|42020604|FG003|Overall Study|Refused treatment|1|||
19572986|NCT01180296|42020616|FG000|Overall Study|Protocol Violation|1|||
19572987|NCT01180296|42020617|FG001|Overall Study|Protocol Violation|2|||
19572988|NCT01160640|42020627|FG000|Overall Study|Physician Decision|3|||
19572989|NCT01160640|42020628|FG001|Overall Study|Physician Decision|3|||
19572990|NCT01160640|42020627|FG000|Overall Study|Incarceration|1|||
19572991|NCT01160640|42020628|FG001|Overall Study|Incarceration|0|||
19572992|NCT01160640|42020627|FG000|Overall Study|Withdrawal by Subject|0|||
19572993|NCT01160640|42020628|FG001|Overall Study|Withdrawal by Subject|3|||
19572994|NCT01160484|42020636|FG000|Overall Study|Lack of Efficacy|9|||
19572995|NCT01160484|42020636|FG000|Overall Study|Adverse Event|6|||
19572996|NCT01160484|42020636|FG000|Overall Study|Withdrawal by Subject|2|||
19572997|NCT01160484|42020636|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
19572998|NCT01032291|42020643|FG000|Safety Lead-in|Adverse Event|1|||
19572999|NCT01032291|42020644|FG001|Safety Lead-in|Adverse Event|0|||
19573000|NCT01032291|42020645|FG002|Safety Lead-in|Adverse Event|0|||
19573001|NCT01032291|42020643|FG000|Safety Lead-in|Death|1|||
19573002|NCT01032291|42020644|FG001|Safety Lead-in|Death|0|||
19573003|NCT01032291|42020645|FG002|Safety Lead-in|Death|0|||
19573004|NCT01032291|42020643|FG000|Proof of Concept|Adverse Event|0|||
19573005|NCT01032291|42020644|FG001|Proof of Concept|Adverse Event|5|||
19573006|NCT01032291|42020645|FG002|Proof of Concept|Adverse Event|1|||
19573007|NCT01032291|42020643|FG000|Proof of Concept|Death|0|||
19573008|NCT01032291|42020644|FG001|Proof of Concept|Death|1|||
19573009|NCT01032291|42020645|FG002|Proof of Concept|Death|2|||
19573010|NCT01032291|42020643|FG000|Proof of Concept|Lack of Efficacy|0|||
19573011|NCT01032291|42020644|FG001|Proof of Concept|Lack of Efficacy|1|||
19573012|NCT01032291|42020645|FG002|Proof of Concept|Lack of Efficacy|0|||
19573013|NCT01032291|42020643|FG000|Proof of Concept|Never Received Study Drug|0|||
19573014|NCT01032291|42020644|FG001|Proof of Concept|Never Received Study Drug|1|||
19573015|NCT01032291|42020645|FG002|Proof of Concept|Never Received Study Drug|0|||
19573016|NCT01159938|42020659|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
19573017|NCT01159938|42020660|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
19573018|NCT01159938|42020661|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
19573019|NCT01159938|42020662|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
19573020|NCT01159938|42020663|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
19573021|NCT01029405|42020688|FG000|Overall Study|Withdrawal by Subject|0|||
19573022|NCT01029405|42020689|FG001|Overall Study|Withdrawal by Subject|1|||
19573023|NCT01029405|42020690|FG002|Overall Study|Withdrawal by Subject|2|||
19573024|NCT01029405|42020691|FG003|Overall Study|Withdrawal by Subject|0|||
19573025|NCT01029405|42020688|FG000|Overall Study|Protocol Violation|0|||
19573026|NCT01029405|42020689|FG001|Overall Study|Protocol Violation|0|||
19573027|NCT01029405|42020690|FG002|Overall Study|Protocol Violation|0|||
19573028|NCT01029405|42020691|FG003|Overall Study|Protocol Violation|1|||
19573029|NCT01029405|42020688|FG000|Overall Study|Adverse Event|0|||
19573030|NCT01029405|42020689|FG001|Overall Study|Adverse Event|0|||
19573031|NCT01029405|42020690|FG002|Overall Study|Adverse Event|1|||
19573032|NCT01029405|42020691|FG003|Overall Study|Adverse Event|1|||
19573033|NCT01029405|42020688|FG000|Overall Study|Lost to Follow-up|2|||
19573034|NCT01029405|42020689|FG001|Overall Study|Lost to Follow-up|1|||
19573035|NCT01029405|42020690|FG002|Overall Study|Lost to Follow-up|1|||
19573036|NCT01029405|42020691|FG003|Overall Study|Lost to Follow-up|2|||
19573037|NCT01029405|42020688|FG000|Overall Study|Other|0|||
19573038|NCT01029405|42020689|FG001|Overall Study|Other|1|||
19573039|NCT01029405|42020690|FG002|Overall Study|Other|0|||
19476933|NCT01569295|41755233|FG000|Overall Study|Physician Decision|13|||
19573040|NCT01029405|42020691|FG003|Overall Study|Other|1|||
19573041|NCT01021683|42020701|FG000|Overall Study|Lack of Efficacy|12|||
19573042|NCT01021683|42020701|FG000|Overall Study|Recovery of neutrophil count|51|||
19573043|NCT01021683|42020701|FG000|Overall Study|Other|8|||
19573044|NCT01021293|42020707|FG000|Overall Study|Serious Adverse Event|2|||
19573045|NCT01021293|42020708|FG001|Overall Study|Serious Adverse Event|1|||
19573046|NCT01021293|42020707|FG000|Overall Study|Adverse Event|2|||
19573047|NCT01021293|42020708|FG001|Overall Study|Adverse Event|1|||
19573048|NCT01021293|42020707|FG000|Overall Study|Withdrawal by Subject|1|||
19573049|NCT01021293|42020708|FG001|Overall Study|Withdrawal by Subject|3|||
19573050|NCT01021293|42020707|FG000|Overall Study|Migrated/moved from study area|6|||
19573051|NCT01021293|42020708|FG001|Overall Study|Migrated/moved from study area|18|||
19573052|NCT01021293|42020707|FG000|Overall Study|Lost to Follow-up|1|||
19573053|NCT01021293|42020708|FG001|Overall Study|Lost to Follow-up|1|||
19573054|NCT04625725|42020717|FG000|Overall Study|Death|4|||
19573055|NCT04625725|42020718|FG001|Overall Study|Death|4|||
19573056|NCT04625725|42020717|FG000|Overall Study|Lost to Follow-up|11|||
19573057|NCT04625725|42020718|FG001|Overall Study|Lost to Follow-up|8|||
19573058|NCT04625725|42020717|FG000|Overall Study|Physician Decision|1|||
19573059|NCT04625725|42020718|FG001|Overall Study|Physician Decision|0|||
19573060|NCT04625725|42020717|FG000|Overall Study|Withdrawal by Subject|56|||
19573061|NCT04625725|42020718|FG001|Overall Study|Withdrawal by Subject|32|||
19573062|NCT04625725|42020717|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
19573063|NCT04625725|42020718|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
19573064|NCT04625725|42020717|FG000|Overall Study|Ongoing in study|3409|||
19573065|NCT04625725|42020718|FG001|Overall Study|Ongoing in study|1700|||
19573066|NCT04625725|42020717|FG000|Overall Study|Protocol Deviation|1|||
19573067|NCT04625725|42020718|FG001|Overall Study|Protocol Deviation|0|||
19573068|NCT01021215|42020726|FG000|Overall Study|Lost to Follow-up|3|||
19573069|NCT01021215|42020727|FG001|Overall Study|Lost to Follow-up|0|||
19573070|NCT01021137|42020737|FG000|Overall Study|Lost to Follow-up|9|||
19573071|NCT01021137|42020738|FG001|Overall Study|Lost to Follow-up|4|||
19573072|NCT01021137|42020739|FG002|Overall Study|Lost to Follow-up|2|||
19387107|NCT02706899|41630025|FG001|Overall Study|Withdrawal by Subject|0|||
19387108|NCT02706899|41630024|FG000|Overall Study|Death|8|||
19387109|NCT02706899|41630025|FG001|Overall Study|Death|0|||
19387110|NCT02706899|41630024|FG000|Overall Study|Study Termination by Sponsor|4|||
19387111|NCT02706899|41630025|FG001|Overall Study|Study Termination by Sponsor|6|||
19387112|NCT02072824|41630034|FG000|Overall Study|Insufficient clinical response|1|||
19387113|NCT02072824|41630035|FG001|Overall Study|Insufficient clinical response|0|||
19387114|NCT02072824|41630036|FG002|Overall Study|Insufficient clinical response|1|||
19387115|NCT02072824|41630034|FG000|Overall Study|No longer willing to participate|1|||
19387116|NCT02072824|41630035|FG001|Overall Study|No longer willing to participate|0|||
19387117|NCT02072824|41630036|FG002|Overall Study|No longer willing to participate|1|||
19387118|NCT02072824|41630034|FG000|Overall Study|Medication error|0|||
19387119|NCT02072824|41630035|FG001|Overall Study|Medication error|1|||
19387120|NCT02072824|41630036|FG002|Overall Study|Medication error|0|||
19387121|NCT02072824|41630034|FG000|Overall Study|Adverse Event|0|||
19387122|NCT02072824|41630035|FG001|Overall Study|Adverse Event|0|||
19573073|NCT01021137|42020740|FG003|Overall Study|Lost to Follow-up|6|||
19573074|NCT01021137|42020737|FG000|Overall Study|Withdrawal by Subject|1|||
19573075|NCT01021137|42020738|FG001|Overall Study|Withdrawal by Subject|0|||
19573076|NCT01021137|42020739|FG002|Overall Study|Withdrawal by Subject|0|||
19573077|NCT01021137|42020740|FG003|Overall Study|Withdrawal by Subject|3|||
19573078|NCT01020981|42020753|FG000|Overall Study|Did not return mailed survey|74|||
19573079|NCT01020981|42020754|FG001|Overall Study|Did not return mailed survey|58|||
19573080|NCT01020981|42020753|FG000|Overall Study|Survey returned undeliverable|8|||
19573081|NCT01020981|42020754|FG001|Overall Study|Survey returned undeliverable|32|||
19573082|NCT01020981|42020753|FG000|Overall Study|Participant declined to complete survey|2|||
19573083|NCT01020981|42020754|FG001|Overall Study|Participant declined to complete survey|0|||
19573084|NCT01020747|42020762|FG000|Overall Study|Withdrawal by Subject|1|||
19573085|NCT01020435|42020769|FG000|Overall Study|Lost to Follow-up|0|||
19573086|NCT01020435|42020770|FG001|Overall Study|Lost to Follow-up|1|||
19573087|NCT01031979|42020779|FG000|Overall Study|Lost to Follow-up|5|||
19387123|NCT02072824|41630036|FG002|Overall Study|Adverse Event|1|||
19387124|NCT02072668|41630044|FG000|Second Intervention|Lost to Follow-up|1|||
19387125|NCT02072668|41630045|FG001|Second Intervention|Lost to Follow-up|0|||
19573088|NCT01031979|42020780|FG001|Overall Study|Lost to Follow-up|4|||
19573089|NCT01020123|42020793|FG000|Main Period|Withdrawal by Subject|6|||
19573090|NCT01020123|42020794|FG001|Main Period|Withdrawal by Subject|5|||
19573091|NCT01020123|42020795|FG002|Main Period|Withdrawal by Subject|3|||
19573092|NCT01020123|42020796|FG003|Main Period|Withdrawal by Subject|1|||
19573093|NCT01020123|42020797|FG004|Main Period|Withdrawal by Subject|6|||
19573094|NCT01020123|42020798|FG005|Main Period|Withdrawal by Subject|3|||
19573095|NCT01020123|42020799|FG006|Main Period|Withdrawal by Subject|2|||
19573096|NCT01020123|42020793|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
19573097|NCT01020123|42020794|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
19573098|NCT01020123|42020795|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
19573099|NCT01020123|42020796|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
19573100|NCT01020123|42020797|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
19573101|NCT01020123|42020798|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
19573102|NCT01020123|42020799|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
19573103|NCT01020123|42020793|FG000|Main Period|Adverse Event|5|||
19573104|NCT01020123|42020794|FG001|Main Period|Adverse Event|2|||
19573105|NCT01020123|42020795|FG002|Main Period|Adverse Event|2|||
19573106|NCT01020123|42020796|FG003|Main Period|Adverse Event|1|||
19573107|NCT01020123|42020797|FG004|Main Period|Adverse Event|1|||
19573108|NCT01020123|42020798|FG005|Main Period|Adverse Event|2|||
19573109|NCT01020123|42020799|FG006|Main Period|Adverse Event|1|||
19573110|NCT01020123|42020793|FG000|Main Period|Protocol Violation|4|||
19573111|NCT01020123|42020794|FG001|Main Period|Protocol Violation|4|||
19573112|NCT01020123|42020795|FG002|Main Period|Protocol Violation|2|||
19573113|NCT01020123|42020796|FG003|Main Period|Protocol Violation|5|||
19573114|NCT01020123|42020797|FG004|Main Period|Protocol Violation|2|||
19573115|NCT01020123|42020798|FG005|Main Period|Protocol Violation|3|||
19573116|NCT01020123|42020799|FG006|Main Period|Protocol Violation|2|||
19573117|NCT01020123|42020793|FG000|Main Period|Lost to Follow-up|0|||
19573118|NCT01020123|42020794|FG001|Main Period|Lost to Follow-up|2|||
19573119|NCT01020123|42020795|FG002|Main Period|Lost to Follow-up|0|||
19573120|NCT01020123|42020796|FG003|Main Period|Lost to Follow-up|0|||
19573121|NCT01020123|42020797|FG004|Main Period|Lost to Follow-up|0|||
19573122|NCT01020123|42020798|FG005|Main Period|Lost to Follow-up|0|||
19573123|NCT01020123|42020799|FG006|Main Period|Lost to Follow-up|0|||
19573124|NCT01020123|42020793|FG000|Main Period|Unclasified|2|||
19573125|NCT01020123|42020794|FG001|Main Period|Unclasified|0|||
19573126|NCT01020123|42020795|FG002|Main Period|Unclasified|1|||
19573127|NCT01020123|42020796|FG003|Main Period|Unclasified|0|||
19573128|NCT01020123|42020797|FG004|Main Period|Unclasified|1|||
19573129|NCT01020123|42020798|FG005|Main Period|Unclasified|3|||
19573130|NCT01020123|42020799|FG006|Main Period|Unclasified|6|||
19573131|NCT01020123|42020793|FG000|Extention Period|Withdrawal by Subject|2|||
19573132|NCT01020123|42020794|FG001|Extention Period|Withdrawal by Subject|1|||
19387126|NCT02140762|41630055|FG000|Overall Study|Adverse Event|1|||
19387127|NCT02140762|41630056|FG001|Overall Study|Adverse Event|1|||
19387128|NCT02140762|41630055|FG000|Overall Study|Lost to Follow-up|9|||
19387129|NCT02140762|41630056|FG001|Overall Study|Lost to Follow-up|5|||
19387130|NCT02140762|41630055|FG000|Overall Study|Protocol Violation|1|||
19387131|NCT02140762|41630056|FG001|Overall Study|Protocol Violation|1|||
19573133|NCT01020123|42020795|FG002|Extention Period|Withdrawal by Subject|1|||
19573134|NCT01020123|42020796|FG003|Extention Period|Withdrawal by Subject|0|||
19573135|NCT01020123|42020797|FG004|Extention Period|Withdrawal by Subject|0|||
19573136|NCT01020123|42020798|FG005|Extention Period|Withdrawal by Subject|0|||
19573137|NCT01020123|42020799|FG006|Extention Period|Withdrawal by Subject|0|||
19573138|NCT01020123|42020793|FG000|Extention Period|Adverse Event|0|||
19573139|NCT01020123|42020794|FG001|Extention Period|Adverse Event|0|||
19573140|NCT01020123|42020795|FG002|Extention Period|Adverse Event|0|||
19573141|NCT01020123|42020796|FG003|Extention Period|Adverse Event|1|||
19573142|NCT01020123|42020797|FG004|Extention Period|Adverse Event|0|||
19573143|NCT01020123|42020798|FG005|Extention Period|Adverse Event|0|||
19573144|NCT01020123|42020799|FG006|Extention Period|Adverse Event|0|||
19573145|NCT01020123|42020793|FG000|Extention Period|Protocol Violation|1|||
19573146|NCT01020123|42020794|FG001|Extention Period|Protocol Violation|1|||
19573147|NCT01020123|42020795|FG002|Extention Period|Protocol Violation|1|||
19573148|NCT01020123|42020796|FG003|Extention Period|Protocol Violation|0|||
19573149|NCT01020123|42020797|FG004|Extention Period|Protocol Violation|0|||
19573150|NCT01020123|42020798|FG005|Extention Period|Protocol Violation|0|||
19573151|NCT01020123|42020799|FG006|Extention Period|Protocol Violation|1|||
19573152|NCT01020123|42020793|FG000|Extention Period|Lost to Follow-up|0|||
19573153|NCT01020123|42020794|FG001|Extention Period|Lost to Follow-up|0|||
19573154|NCT01020123|42020795|FG002|Extention Period|Lost to Follow-up|0|||
19387132|NCT02140762|41630055|FG000|Overall Study|Withdrawal by Subject|6|||
19387133|NCT02140762|41630056|FG001|Overall Study|Withdrawal by Subject|4|||
19387134|NCT02140762|41630055|FG000|Overall Study|Other|0|||
19573155|NCT01020123|42020796|FG003|Extention Period|Lost to Follow-up|0|||
19573156|NCT01020123|42020797|FG004|Extention Period|Lost to Follow-up|0|||
19573157|NCT01020123|42020798|FG005|Extention Period|Lost to Follow-up|2|||
19573158|NCT01020123|42020799|FG006|Extention Period|Lost to Follow-up|0|||
19387135|NCT02140762|41630056|FG001|Overall Study|Other|1|||
19573159|NCT01028391|42020840|FG000|Overall Study|Adverse Event|4|||
19573160|NCT01028391|42020841|FG001|Overall Study|Adverse Event|0|||
19573161|NCT01028391|42020840|FG000|Overall Study|Lack of Efficacy|0|||
19573162|NCT01028391|42020841|FG001|Overall Study|Lack of Efficacy|2|||
19573163|NCT01028391|42020840|FG000|Overall Study|Lost to Follow-up|3|||
19573164|NCT01028391|42020841|FG001|Overall Study|Lost to Follow-up|4|||
19573165|NCT01028391|42020840|FG000|Overall Study|Physician Decision|0|||
19573166|NCT01028391|42020841|FG001|Overall Study|Physician Decision|1|||
19573167|NCT01028391|42020840|FG000|Overall Study|Withdrawal by Subject|6|||
19573168|NCT01028391|42020841|FG001|Overall Study|Withdrawal by Subject|3|||
19573169|NCT01028391|42020840|FG000|Overall Study|Needed excluded medication|1|||
19573170|NCT01028391|42020841|FG001|Overall Study|Needed excluded medication|1|||
19573171|NCT01179672|42020849|FG000|Overall Study|Adverse Event|17|||
19573172|NCT01179672|42020850|FG001|Overall Study|Adverse Event|8|||
19573173|NCT01179672|42020849|FG000|Overall Study|Withdrawal by Subject|10|||
19573174|NCT01179672|42020850|FG001|Overall Study|Withdrawal by Subject|12|||
19573175|NCT01179672|42020849|FG000|Overall Study|Entry Criteria Not Met|0|||
19573176|NCT01179672|42020850|FG001|Overall Study|Entry Criteria Not Met|2|||
19573177|NCT01179672|42020849|FG000|Overall Study|Lost to Follow-up|0|||
19573178|NCT01179672|42020850|FG001|Overall Study|Lost to Follow-up|1|||
19573179|NCT01179672|42020849|FG000|Overall Study|Protocol Violation|2|||
19573180|NCT01179672|42020850|FG001|Overall Study|Protocol Violation|2|||
19573181|NCT01179672|42020849|FG000|Overall Study|Physician Decision|1|||
19573182|NCT01179672|42020850|FG001|Overall Study|Physician Decision|1|||
19573183|NCT01030965|42020864|FG000|Overall Study|Lack of Efficacy|3|||
19573184|NCT01030965|42020865|FG001|Overall Study|Lack of Efficacy|2|||
19573185|NCT01030965|42020866|FG002|Overall Study|Lack of Efficacy|0|||
19573186|NCT01030965|42020867|FG003|Overall Study|Lack of Efficacy|3|||
19573187|NCT01030965|42020864|FG000|Overall Study|Protocol Violation|1|||
19573188|NCT01030965|42020865|FG001|Overall Study|Protocol Violation|1|||
19573189|NCT01030965|42020866|FG002|Overall Study|Protocol Violation|1|||
19573190|NCT01030965|42020867|FG003|Overall Study|Protocol Violation|1|||
19573191|NCT01030965|42020864|FG000|Overall Study|Adverse Event|0|||
19573192|NCT01030965|42020865|FG001|Overall Study|Adverse Event|1|||
19573193|NCT01030965|42020866|FG002|Overall Study|Adverse Event|2|||
19573194|NCT01030965|42020867|FG003|Overall Study|Adverse Event|1|||
19573195|NCT01030965|42020864|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
19573196|NCT01030965|42020865|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
19573197|NCT01030965|42020866|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
19573198|NCT01030965|42020867|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
19573199|NCT01030965|42020864|FG000|Overall Study|Withdrawal by Subject|0|||
19573200|NCT01030965|42020865|FG001|Overall Study|Withdrawal by Subject|1|||
19573201|NCT01030965|42020866|FG002|Overall Study|Withdrawal by Subject|0|||
19573202|NCT01030965|42020867|FG003|Overall Study|Withdrawal by Subject|2|||
19573203|NCT01179516|42020880|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
19573204|NCT01179516|42020881|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
19573205|NCT01179516|42020882|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
19573206|NCT01179516|42020880|FG000|Overall Study|Lack of Efficacy|4|||
19573207|NCT01179516|42020881|FG001|Overall Study|Lack of Efficacy|2|||
19573208|NCT01179516|42020882|FG002|Overall Study|Lack of Efficacy|0|||
19573209|NCT01179516|42020880|FG000|Overall Study|Noncompliance with Study Drug|2|||
19573210|NCT01179516|42020881|FG001|Overall Study|Noncompliance with Study Drug|0|||
19573211|NCT01179516|42020882|FG002|Overall Study|Noncompliance with Study Drug|1|||
19573212|NCT01179516|42020880|FG000|Overall Study|Protocol Deviations|4|||
19573213|NCT01179516|42020881|FG001|Overall Study|Protocol Deviations|3|||
19573214|NCT01179516|42020882|FG002|Overall Study|Protocol Deviations|3|||
19573215|NCT01179516|42020880|FG000|Overall Study|Withdrawal of Consent|2|||
19573216|NCT01179516|42020881|FG001|Overall Study|Withdrawal of Consent|6|||
19573217|NCT01179516|42020882|FG002|Overall Study|Withdrawal of Consent|10|||
19573218|NCT01179516|42020880|FG000|Overall Study|Lost to Follow-up|7|||
19573219|NCT01179516|42020881|FG001|Overall Study|Lost to Follow-up|7|||
19573220|NCT01179516|42020882|FG002|Overall Study|Lost to Follow-up|3|||
19573221|NCT01179516|42020880|FG000|Overall Study|Other|2|||
19573222|NCT01179516|42020881|FG001|Overall Study|Other|0|||
19573223|NCT01179516|42020882|FG002|Overall Study|Other|2|||
19573224|NCT01018953|42020890|FG000|Overall Study|Adverse Event|2|||
19573225|NCT01018953|42020890|FG000|Overall Study|Withdrawal by Subject|1|||
19573226|NCT01018953|42020890|FG000|Overall Study|Study termination by sponsor|5|||
19573227|NCT01158924|42020897|FG000|Overall Study|Withdrawal by Subject|1|||
19573228|NCT01158924|42020898|FG001|Overall Study|Withdrawal by Subject|2|||
19573229|NCT01158924|42020897|FG000|Overall Study|Lost to Follow-up|0|||
19573230|NCT01158924|42020898|FG001|Overall Study|Lost to Follow-up|1|||
19573231|NCT01027845|42020906|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
19573232|NCT01027845|42020907|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
19573233|NCT01027845|42020908|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
19573234|NCT01027845|42020909|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
19573235|NCT01027845|42020906|FG000|Primary Vaccination Phase|Adverse Event|1|||
19573236|NCT01027845|42020907|FG001|Primary Vaccination Phase|Adverse Event|0|||
19387136|NCT02101294|41630067|FG000|Overall Study|Withdrawal by Subject|5|||
19387137|NCT02101294|41630067|FG000|Overall Study|Lost to Follow-up|6|||
19387138|NCT01598506|41630074|FG000|Overall Study|Withdrawal by Subject|2|||
19387139|NCT02140060|41630085|FG000|Overall Study|Adverse Event|0|||
19387140|NCT02140060|41630086|FG001|Overall Study|Adverse Event|0|||
19387141|NCT02140060|41630087|FG002|Overall Study|Adverse Event|0|||
19573237|NCT01027845|42020908|FG002|Primary Vaccination Phase|Adverse Event|0|||
19573238|NCT01027845|42020909|FG003|Primary Vaccination Phase|Adverse Event|0|||
19573239|NCT01027845|42020906|FG000|Primary Vaccination Phase|Protocol Violation|1|||
19573240|NCT01027845|42020907|FG001|Primary Vaccination Phase|Protocol Violation|0|||
19573241|NCT01027845|42020908|FG002|Primary Vaccination Phase|Protocol Violation|0|||
19573242|NCT01027845|42020909|FG003|Primary Vaccination Phase|Protocol Violation|0|||
19573243|NCT01027845|42020906|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
19573244|NCT01027845|42020907|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
19573245|NCT01027845|42020908|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
19573246|NCT01027845|42020909|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
19573247|NCT01027845|42020906|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
19573248|NCT01027845|42020907|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
19573249|NCT01027845|42020908|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
19573250|NCT01027845|42020909|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
19573251|NCT01027845|42020906|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
19573252|NCT01027845|42020907|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
19573253|NCT01027845|42020908|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
19573254|NCT01027845|42020909|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
19573255|NCT01017549|42020918|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
19573256|NCT01017549|42020918|FG000|One-year Follow-up|Lost to Follow-up|2|||
19573257|NCT01017549|42020918|FG000|One-year Follow-up|Withdrawal by Subject|5|||
19573258|NCT01017549|42020918|FG000|5 Year Follow-up|Lost to Follow-up|9|||
19573259|NCT01017549|42020918|FG000|5 Year Follow-up|Mastectomy|3|||
19387142|NCT02140060|41630088|FG003|Overall Study|Adverse Event|1|||
19387143|NCT02140060|41630089|FG004|Overall Study|Adverse Event|1|||
19387144|NCT02140060|41630090|FG005|Overall Study|Adverse Event|1|||
19476934|NCT01569295|41755234|FG001|Overall Study|Physician Decision|18|||
19573260|NCT01030341|42020922|FG000|Overall Study|Withdrawal by Subject|1|||
19573261|NCT01030341|42020922|FG000|Overall Study|Lost to Follow-up|2|||
19573262|NCT01026831|42020928|FG000|Overall Study|Adverse Event|4|||
19573263|NCT01026831|42020929|FG001|Overall Study|Adverse Event|3|||
19573264|NCT01026831|42020928|FG000|Overall Study|Lost to Follow-up|2|||
19573265|NCT01026831|42020929|FG001|Overall Study|Lost to Follow-up|0|||
19573266|NCT01026831|42020928|FG000|Overall Study|Physician Decision|1|||
19573267|NCT01026831|42020929|FG001|Overall Study|Physician Decision|1|||
19573268|NCT01026831|42020928|FG000|Overall Study|Protocol Violation|0|||
19573269|NCT01026831|42020929|FG001|Overall Study|Protocol Violation|2|||
19573270|NCT01026831|42020928|FG000|Overall Study|Withdrawal by Subject|7|||
19573271|NCT01026831|42020929|FG001|Overall Study|Withdrawal by Subject|5|||
19573272|NCT01016067|42020937|FG000|Overall Study|Lost to Follow-up|1|||
19573273|NCT01016067|42020938|FG001|Overall Study|Lost to Follow-up|2|||
19573274|NCT01016067|42020937|FG000|Overall Study|Physician Decision|1|||
19573275|NCT01016067|42020938|FG001|Overall Study|Physician Decision|1|||
19573276|NCT01016067|42020937|FG000|Overall Study|Withdrew due to Relocation|0|||
19573277|NCT01016067|42020938|FG001|Overall Study|Withdrew due to Relocation|1|||
19573278|NCT01015833|42020946|FG000|Overall Study|Death|1|||
19573279|NCT01015833|42020947|FG001|Overall Study|Death|0|||
19573280|NCT01015833|42020946|FG000|Overall Study|Withdrawal by Subject|3|||
19573281|NCT01015833|42020947|FG001|Overall Study|Withdrawal by Subject|2|||
19573282|NCT01015833|42020946|FG000|Overall Study|Adverse Event|0|||
19573283|NCT01015833|42020947|FG001|Overall Study|Adverse Event|1|||
19573284|NCT01015833|42020946|FG000|Overall Study|Physician Decision|2|||
19573285|NCT01015833|42020947|FG001|Overall Study|Physician Decision|0|||
19573286|NCT01015833|42020946|FG000|Overall Study|Symptomatic deterioration|0|||
19573287|NCT01015833|42020947|FG001|Overall Study|Symptomatic deterioration|1|||
19573288|NCT01015833|42020946|FG000|Overall Study|Other|5|||
19573289|NCT01015833|42020947|FG001|Overall Study|Other|1|||
19573290|NCT01015833|42020946|FG000|Overall Study|Motor Vehicle Accidents|1|||
19573291|NCT01015833|42020947|FG001|Overall Study|Motor Vehicle Accidents|0|||
19573292|NCT01015833|42020946|FG000|Overall Study|Did not start treatment|1|||
19573293|NCT01015833|42020947|FG001|Overall Study|Did not start treatment|0|||
19573294|NCT01015677|42020965|FG000|Overall Study|Adverse Event|0|||
19573295|NCT01015677|42020966|FG001|Overall Study|Adverse Event|1|||
19573296|NCT01015677|42020967|FG002|Overall Study|Adverse Event|0|||
19573297|NCT01015677|42020965|FG000|Overall Study|Lack of Efficacy|0|||
19573298|NCT01015677|42020966|FG001|Overall Study|Lack of Efficacy|1|||
19387145|NCT02140060|41630085|FG000|Overall Study|Lack of Efficacy|0|||
19387146|NCT02140060|41630086|FG001|Overall Study|Lack of Efficacy|0|||
19387147|NCT02140060|41630087|FG002|Overall Study|Lack of Efficacy|0|||
19387148|NCT02140060|41630088|FG003|Overall Study|Lack of Efficacy|1|||
19573299|NCT01015677|42020967|FG002|Overall Study|Lack of Efficacy|0|||
19387149|NCT02140060|41630089|FG004|Overall Study|Lack of Efficacy|0|||
19387150|NCT02140060|41630090|FG005|Overall Study|Lack of Efficacy|0|||
19387151|NCT02139982|41630115|FG000|Overall Study|Lack of Efficacy|0|||
19387152|NCT02139982|41630116|FG001|Overall Study|Lack of Efficacy|1|||
19387153|NCT02139982|41630117|FG002|Overall Study|Lack of Efficacy|0|||
19387154|NCT02139982|41630118|FG003|Overall Study|Lack of Efficacy|1|||
19387155|NCT02139982|41630119|FG004|Overall Study|Lack of Efficacy|0|||
19387156|NCT02139982|41630120|FG005|Overall Study|Lack of Efficacy|0|||
19387157|NCT02139982|41630121|FG006|Overall Study|Lack of Efficacy|0|||
19387158|NCT02139982|41630122|FG007|Overall Study|Lack of Efficacy|0|||
19387159|NCT02139982|41630123|FG008|Overall Study|Lack of Efficacy|0|||
19387160|NCT02139982|41630124|FG009|Overall Study|Lack of Efficacy|0|||
19387161|NCT02139826|41630146|FG000|Overall Study|Adverse Event|1|||
19387162|NCT02139592|41630156|FG000|Overall Study|Case Report Forms Uncollected|8|||
19387163|NCT02139280|41630162|FG000|Overall Study|No longer eligible|2|||
19573300|NCT01015677|42020965|FG000|Overall Study|Protocol Violation|0|||
19573301|NCT01015677|42020966|FG001|Overall Study|Protocol Violation|1|||
19573302|NCT01015677|42020967|FG002|Overall Study|Protocol Violation|0|||
19573303|NCT01015677|42020965|FG000|Overall Study|Withdrawal by Subject|1|||
19573304|NCT01015677|42020966|FG001|Overall Study|Withdrawal by Subject|1|||
19573305|NCT01015677|42020967|FG002|Overall Study|Withdrawal by Subject|0|||
19573306|NCT01225211|42021007|FG000|Overall Study|Adverse Event|0|||
19573307|NCT01225211|42021008|FG001|Overall Study|Adverse Event|0|||
19573308|NCT01225211|42021009|FG002|Overall Study|Adverse Event|1|||
19573309|NCT01225211|42021010|FG003|Overall Study|Adverse Event|0|||
19573310|NCT01225211|42021011|FG004|Overall Study|Adverse Event|0|||
19573311|NCT01225211|42021012|FG005|Overall Study|Adverse Event|0|||
19573312|NCT01225211|42021013|FG006|Overall Study|Adverse Event|0|||
19573313|NCT01225211|42021014|FG007|Overall Study|Adverse Event|0|||
19573314|NCT01225211|42021015|FG008|Overall Study|Adverse Event|0|||
19573315|NCT01225211|42021016|FG009|Overall Study|Adverse Event|1|||
19573316|NCT01225211|42021007|FG000|Overall Study|Withdrawal by Subject|0|||
19573317|NCT01225211|42021008|FG001|Overall Study|Withdrawal by Subject|0|||
19573318|NCT01225211|42021009|FG002|Overall Study|Withdrawal by Subject|0|||
19573319|NCT01225211|42021010|FG003|Overall Study|Withdrawal by Subject|0|||
19573320|NCT01225211|42021011|FG004|Overall Study|Withdrawal by Subject|0|||
19573321|NCT01225211|42021012|FG005|Overall Study|Withdrawal by Subject|0|||
19573322|NCT01225211|42021013|FG006|Overall Study|Withdrawal by Subject|1|||
19573323|NCT01225211|42021014|FG007|Overall Study|Withdrawal by Subject|0|||
19573324|NCT01225211|42021015|FG008|Overall Study|Withdrawal by Subject|1|||
19573325|NCT01225211|42021016|FG009|Overall Study|Withdrawal by Subject|3|||
19573326|NCT01225211|42021007|FG000|Overall Study|Other|0|||
19573327|NCT01225211|42021008|FG001|Overall Study|Other|0|||
19573328|NCT01225211|42021009|FG002|Overall Study|Other|0|||
19573329|NCT01225211|42021010|FG003|Overall Study|Other|0|||
19573330|NCT01225211|42021011|FG004|Overall Study|Other|0|||
19573331|NCT01225211|42021012|FG005|Overall Study|Other|0|||
19573332|NCT01225211|42021013|FG006|Overall Study|Other|0|||
19573333|NCT01225211|42021014|FG007|Overall Study|Other|0|||
19573334|NCT01225211|42021015|FG008|Overall Study|Other|0|||
19573335|NCT01225211|42021016|FG009|Overall Study|Other|1|||
19573336|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
19573337|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
19573338|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
19573339|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
19573340|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
19573341|NCT01224821|42021099|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
19573342|NCT01224821|42021099|FG000|Long-Term Follow-Up|Death|2|||
19573343|NCT01224821|42021099|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
19573344|NCT01224431|42021116|FG000|Overall Study|not randomized|0|||
19573345|NCT01224431|42021117|FG001|Overall Study|not randomized|4|||
19573346|NCT01224431|42021116|FG000|Overall Study|no video record|0|||
19573347|NCT01224431|42021117|FG001|Overall Study|no video record|1|||
19573348|NCT01223183|42021127|FG000|Imaging Day 1|Physician Decision|0|||
19573349|NCT01223183|42021128|FG001|Imaging Day 1|Physician Decision|1|||
19573350|NCT01223183|42021127|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
19573351|NCT01223183|42021128|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
19573352|NCT01223183|42021127|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
19387164|NCT02139280|41630163|FG001|Overall Study|No longer eligible|0|||
19387165|NCT02072434|41630171|FG000|Overall Study|Protocol Violation|10|||
19573353|NCT01223183|42021128|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
19745786|NCT03529773|42193192|FG036|Overall Study|Adverse Event|0|||
19387166|NCT02072434|41630172|FG001|Overall Study|Protocol Violation|9|||
19387167|NCT02072434|41630171|FG000|Overall Study|Physician Decision|5|||
19573354|NCT01223027|42021137|FG000|Overall Study|Adverse Event|20|||
19573355|NCT01223027|42021138|FG001|Overall Study|Adverse Event|10|||
19573356|NCT01223027|42021137|FG000|Overall Study|Death|42|||
19573357|NCT01223027|42021138|FG001|Overall Study|Death|42|||
19573358|NCT01223027|42021137|FG000|Overall Study|Lost to Follow-up|2|||
19573359|NCT01223027|42021138|FG001|Overall Study|Lost to Follow-up|1|||
19573360|NCT01223027|42021137|FG000|Overall Study|Physician Decision|4|||
19573361|NCT01223027|42021138|FG001|Overall Study|Physician Decision|8|||
19573362|NCT01223027|42021137|FG000|Overall Study|Progressive Disease|167|||
19573363|NCT01223027|42021138|FG001|Overall Study|Progressive Disease|183|||
19573364|NCT01223027|42021137|FG000|Overall Study|Protocol Violation|2|||
19573365|NCT01223027|42021138|FG001|Overall Study|Protocol Violation|1|||
19573366|NCT01223027|42021137|FG000|Overall Study|Subject/guardian decicion|18|||
19573367|NCT01223027|42021138|FG001|Overall Study|Subject/guardian decicion|16|||
19573368|NCT01223027|42021137|FG000|Overall Study|New therapy for study indication|17|||
19573369|NCT01223027|42021138|FG001|Overall Study|New therapy for study indication|8|||
19573370|NCT01223027|42021137|FG000|Overall Study|Study terminated by sponsor|2|||
19387168|NCT02072434|41630172|FG001|Overall Study|Physician Decision|10|||
19387169|NCT02072434|41630171|FG000|Overall Study|Adverse event, serious fatal|1|||
19387170|NCT02072434|41630172|FG001|Overall Study|Adverse event, serious fatal|6|||
19387171|NCT02072434|41630171|FG000|Overall Study|Adverse Event|7|||
19387172|NCT02072434|41630172|FG001|Overall Study|Adverse Event|6|||
19387173|NCT02072434|41630171|FG000|Overall Study|Withdrawal by Subject|17|||
19387174|NCT02072434|41630172|FG001|Overall Study|Withdrawal by Subject|29|||
19387175|NCT02072434|41630171|FG000|Overall Study|Other|14|||
19387176|NCT02072434|41630172|FG001|Overall Study|Other|29|||
19387177|NCT02072434|41630171|FG000|Overall Study|Lost to Follow-up|0|||
19387178|NCT02072434|41630172|FG001|Overall Study|Lost to Follow-up|1|||
19387179|NCT02101060|41630180|FG000|Overall Study|Adverse Event|1|||
19387180|NCT02101060|41630181|FG001|Overall Study|Adverse Event|0|||
19387181|NCT02101060|41630180|FG000|Overall Study|Withdrawal by Subject|1|||
19573371|NCT01223027|42021138|FG001|Overall Study|Study terminated by sponsor|8|||
19573372|NCT01015287|42021146|FG000|Overall Study|Death|21|||
19573373|NCT01015287|42021147|FG001|Overall Study|Death|16|||
19573374|NCT01015287|42021146|FG000|Overall Study|Adverse Event|1|||
19573375|NCT01015287|42021147|FG001|Overall Study|Adverse Event|0|||
19573376|NCT01015287|42021146|FG000|Overall Study|Sponsor Decision|3|||
19573377|NCT01015287|42021147|FG001|Overall Study|Sponsor Decision|7|||
19573378|NCT01015287|42021146|FG000|Overall Study|Physician Decision|19|||
19573379|NCT01015287|42021147|FG001|Overall Study|Physician Decision|21|||
19573380|NCT01015287|42021146|FG000|Overall Study|Withdrawal by Subject|14|||
19573381|NCT01015287|42021147|FG001|Overall Study|Withdrawal by Subject|19|||
19573382|NCT01015287|42021146|FG000|Overall Study|Entry Criteria not Met|11|||
19573383|NCT01015287|42021147|FG001|Overall Study|Entry Criteria not Met|14|||
19573384|NCT01015287|42021146|FG000|Overall Study|Lost to Follow-up|2|||
19573385|NCT01015287|42021147|FG001|Overall Study|Lost to Follow-up|1|||
19573386|NCT01015287|42021146|FG000|Overall Study|Protocol Violation|1|||
19573387|NCT01015287|42021147|FG001|Overall Study|Protocol Violation|1|||
19573388|NCT01015131|42021155|FG000|Overall Study|Physician Decision|1|||
19573389|NCT01015131|42021155|FG000|Overall Study|Protocol Violation|1|||
19573390|NCT01015131|42021155|FG000|Overall Study|Withdrawal by Subject|2|||
19573391|NCT01015131|42021155|FG000|Overall Study|Other Protocol Specified Criteria|4|||
19573392|NCT01222715|42021161|FG000|Overall Study|Adverse Event|0|||
19573393|NCT01222715|42021162|FG001|Overall Study|Adverse Event|4|||
19573394|NCT01222715|42021161|FG000|Overall Study|Death|0|||
19573395|NCT01222715|42021162|FG001|Overall Study|Death|1|||
19573396|NCT01222715|42021161|FG000|Overall Study|Lack of Efficacy|22|||
19573397|NCT01222715|42021162|FG001|Overall Study|Lack of Efficacy|14|||
19573398|NCT01222715|42021161|FG000|Overall Study|Physician Decision|12|||
19573399|NCT01222715|42021162|FG001|Overall Study|Physician Decision|2|||
19573400|NCT01222715|42021161|FG000|Overall Study|Refusal of further protocol therapy|0|||
19573401|NCT01222715|42021162|FG001|Overall Study|Refusal of further protocol therapy|4|||
19573402|NCT01222715|42021161|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
19573403|NCT01222715|42021162|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
19573404|NCT01222715|42021161|FG000|Overall Study|Ineligible|0|||
19573405|NCT01222715|42021162|FG001|Overall Study|Ineligible|1|||
19387182|NCT02101060|41630181|FG001|Overall Study|Withdrawal by Subject|1|||
19573406|NCT01222715|42021161|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
19573407|NCT01222715|42021162|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
19573408|NCT01222403|42021170|FG000|Overall Study|Inappropriate enrollment|0|||
19387183|NCT02101060|41630180|FG000|Overall Study|Lost to Follow-up|3|||
19387184|NCT02101060|41630181|FG001|Overall Study|Lost to Follow-up|3|||
19573409|NCT01222403|42021171|FG001|Overall Study|Inappropriate enrollment|2|||
19573410|NCT01222247|42021179|FG000|Overall Study|Lost to Follow-up|2|||
19573411|NCT01222247|42021180|FG001|Overall Study|Lost to Follow-up|2|||
19573412|NCT01014975|42021186|FG000|Overall Study|Withdrawal by Subject|1|||
19573413|NCT01014975|42021187|FG001|Overall Study|Withdrawal by Subject|0|||
19573414|NCT01014975|42021188|FG002|Overall Study|Withdrawal by Subject|1|||
19573415|NCT01014975|42021186|FG000|Overall Study|Death|3|||
19573416|NCT01014975|42021187|FG001|Overall Study|Death|3|||
19573417|NCT01014975|42021188|FG002|Overall Study|Death|4|||
19573418|NCT01014975|42021186|FG000|Overall Study|Lost to Follow-up|0|||
19573419|NCT01014975|42021187|FG001|Overall Study|Lost to Follow-up|0|||
19573420|NCT01014975|42021188|FG002|Overall Study|Lost to Follow-up|1|||
19573421|NCT01221623|42021198|FG000|Overall Study|Withdrawal by Subject|19|||
19573422|NCT01221623|42021199|FG001|Overall Study|Withdrawal by Subject|8|||
19573423|NCT01221623|42021198|FG000|Overall Study|Lost to Follow-up|7|||
19573424|NCT01221623|42021199|FG001|Overall Study|Lost to Follow-up|1|||
19573425|NCT01221623|42021198|FG000|Overall Study|Adverse Event|6|||
19573426|NCT01221623|42021199|FG001|Overall Study|Adverse Event|3|||
19573427|NCT01221623|42021198|FG000|Overall Study|Death|1|||
19573428|NCT01221623|42021199|FG001|Overall Study|Death|0|||
19573429|NCT01221623|42021198|FG000|Overall Study|Other|5|||
19573430|NCT01221623|42021199|FG001|Overall Study|Other|2|||
19573431|NCT01014585|42021209|FG000|Overall Study|Adverse Event|0|||
19387185|NCT02139124|41630192|FG000|Overall Study|Adverse Event|2|||
19387186|NCT02139124|41630193|FG001|Overall Study|Adverse Event|0|||
19573432|NCT01014585|42021210|FG001|Overall Study|Adverse Event|2|||
19573433|NCT01014585|42021211|FG002|Overall Study|Adverse Event|0|||
19573434|NCT01014585|42021212|FG003|Overall Study|Adverse Event|3|||
19573435|NCT01014585|42021209|FG000|Overall Study|Withdrawal by Subject|2|||
19573436|NCT01014585|42021210|FG001|Overall Study|Withdrawal by Subject|0|||
19573437|NCT01014585|42021211|FG002|Overall Study|Withdrawal by Subject|1|||
19573438|NCT01014585|42021212|FG003|Overall Study|Withdrawal by Subject|3|||
19573439|NCT01014585|42021209|FG000|Overall Study|Lost to Follow-up|0|||
19573440|NCT01014585|42021210|FG001|Overall Study|Lost to Follow-up|0|||
19573441|NCT01014585|42021211|FG002|Overall Study|Lost to Follow-up|0|||
19573442|NCT01014585|42021212|FG003|Overall Study|Lost to Follow-up|2|||
19573443|NCT01014585|42021209|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
19573444|NCT01014585|42021210|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
19573445|NCT01014585|42021211|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
19573446|NCT01014585|42021212|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
19573447|NCT01221233|42021224|FG000|Overall Study|Withdrawal by Subject|3|||
19573448|NCT01221233|42021225|FG001|Overall Study|Withdrawal by Subject|1|||
19573449|NCT01220609|42021231|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
19573450|NCT01220609|42021231|FG000|Overall Study|Ineligible- Wrong cell type|1|||
19573451|NCT01220609|42021231|FG000|Overall Study|Ineligible-Never treated|1|||
19573452|NCT01220297|42021243|FG000|Overall Study|Death|2|||
19573453|NCT01220297|42021243|FG000|Overall Study|Lost to Follow-up|1|||
19573454|NCT01219985|42021249|FG000|Overall Study|Physician Decision|20|||
19573455|NCT01218659|42021257|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
19573456|NCT01218659|42021258|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
19573457|NCT01218659|42021259|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
19573458|NCT01218659|42021257|FG000|18-Month Randomized Period|Did not receive study drug|0|||
19573459|NCT01218659|42021258|FG001|18-Month Randomized Period|Did not receive study drug|3|||
19573460|NCT01218659|42021259|FG002|18-Month Randomized Period|Did not receive study drug|0|||
19573461|NCT01218659|42021257|FG000|12-Month OLE|Withdrawal by Subject|0|||
19573462|NCT01218659|42021258|FG001|12-Month OLE|Withdrawal by Subject|0|||
19387187|NCT02139124|41630194|FG002|Overall Study|Adverse Event|1|||
19387188|NCT02139124|41630195|FG003|Overall Study|Adverse Event|2|||
19387189|NCT02139124|41630196|FG004|Overall Study|Adverse Event|5|||
19387190|NCT02139124|41630192|FG000|Overall Study|Withdrawal by Subject|2|||
19387191|NCT02139124|41630193|FG001|Overall Study|Withdrawal by Subject|2|||
19387192|NCT02139124|41630194|FG002|Overall Study|Withdrawal by Subject|2|||
19387193|NCT02139124|41630195|FG003|Overall Study|Withdrawal by Subject|2|||
19387194|NCT02139124|41630196|FG004|Overall Study|Withdrawal by Subject|3|||
19573463|NCT01218659|42021259|FG002|12-Month OLE|Withdrawal by Subject|2|||
19573464|NCT01218659|42021257|FG000|12-Month OLE|Physician Decision|0|||
19573465|NCT01218659|42021258|FG001|12-Month OLE|Physician Decision|0|||
19387195|NCT02139124|41630192|FG000|Overall Study|Protocol Violation|0|||
19573466|NCT01218659|42021259|FG002|12-Month OLE|Physician Decision|1|||
19573467|NCT01218659|42021257|FG000|12-Month OLE|Lost to Follow-up|0|||
19573468|NCT01218659|42021258|FG001|12-Month OLE|Lost to Follow-up|0|||
19573469|NCT01218659|42021259|FG002|12-Month OLE|Lost to Follow-up|1|||
19573470|NCT01218659|42021257|FG000|12-Month OLE|Pregnancy|0|||
19573471|NCT01218659|42021258|FG001|12-Month OLE|Pregnancy|0|||
19573472|NCT01218659|42021259|FG002|12-Month OLE|Pregnancy|1|||
19573473|NCT01218659|42021257|FG000|12-Month OLE|Lack of Efficacy|0|||
19573474|NCT01218659|42021258|FG001|12-Month OLE|Lack of Efficacy|0|||
19573475|NCT01218659|42021259|FG002|12-Month OLE|Lack of Efficacy|1|||
19573476|NCT01218659|42021257|FG000|12-Month OLE|Declined to participate in the OLE|0|||
19573477|NCT01218659|42021258|FG001|12-Month OLE|Declined to participate in the OLE|0|||
19573478|NCT01218659|42021259|FG002|12-Month OLE|Declined to participate in the OLE|4|||
19573479|NCT00940498|42021274|FG000|Overall Study|Death|2|||
19573480|NCT00940498|42021275|FG001|Overall Study|Death|0|||
19573481|NCT00940498|42021276|FG002|Overall Study|Death|0|||
19573482|NCT00940498|42021277|FG003|Overall Study|Death|1|||
19573483|NCT00940498|42021278|FG004|Overall Study|Death|5|||
19573484|NCT00940498|42021279|FG005|Overall Study|Death|0|||
19573485|NCT00940498|42021280|FG006|Overall Study|Death|1|||
19573486|NCT00940498|42021281|FG007|Overall Study|Death|0|||
19573487|NCT00940498|42021274|FG000|Overall Study|Lost to Follow-up|1|||
19573488|NCT00940498|42021275|FG001|Overall Study|Lost to Follow-up|1|||
19573489|NCT00940498|42021276|FG002|Overall Study|Lost to Follow-up|2|||
19573490|NCT00940498|42021277|FG003|Overall Study|Lost to Follow-up|0|||
19573491|NCT00940498|42021278|FG004|Overall Study|Lost to Follow-up|1|||
19573492|NCT00940498|42021279|FG005|Overall Study|Lost to Follow-up|0|||
19573493|NCT00940498|42021280|FG006|Overall Study|Lost to Follow-up|0|||
19573494|NCT00940498|42021281|FG007|Overall Study|Lost to Follow-up|1|||
19573495|NCT00940498|42021274|FG000|Overall Study|Disease Progression|0|||
19573496|NCT00940498|42021275|FG001|Overall Study|Disease Progression|0|||
19573497|NCT00940498|42021276|FG002|Overall Study|Disease Progression|1|||
19573498|NCT00940498|42021277|FG003|Overall Study|Disease Progression|1|||
19573499|NCT00940498|42021278|FG004|Overall Study|Disease Progression|0|||
19573500|NCT00940498|42021279|FG005|Overall Study|Disease Progression|1|||
19573501|NCT00940498|42021280|FG006|Overall Study|Disease Progression|0|||
19573502|NCT00940498|42021281|FG007|Overall Study|Disease Progression|0|||
19387196|NCT02139124|41630193|FG001|Overall Study|Protocol Violation|0|||
19387197|NCT02139124|41630194|FG002|Overall Study|Protocol Violation|0|||
19387198|NCT02139124|41630195|FG003|Overall Study|Protocol Violation|1|||
19387199|NCT02139124|41630196|FG004|Overall Study|Protocol Violation|1|||
19387200|NCT02139124|41630192|FG000|Overall Study|non-compliant|1|||
19387201|NCT02139124|41630193|FG001|Overall Study|non-compliant|0|||
19387202|NCT02139124|41630194|FG002|Overall Study|non-compliant|0|||
19387203|NCT02139124|41630195|FG003|Overall Study|non-compliant|2|||
19387204|NCT02139124|41630196|FG004|Overall Study|non-compliant|0|||
19387205|NCT02139124|41630192|FG000|Overall Study|incarceration|0|||
19387206|NCT02139124|41630193|FG001|Overall Study|incarceration|0|||
19387207|NCT02139124|41630194|FG002|Overall Study|incarceration|1|||
19387208|NCT02139124|41630195|FG003|Overall Study|incarceration|0|||
19387209|NCT02139124|41630196|FG004|Overall Study|incarceration|0|||
19387210|NCT02139124|41630192|FG000|Overall Study|subject moved|1|||
19387211|NCT02139124|41630193|FG001|Overall Study|subject moved|0|||
19387212|NCT02139124|41630194|FG002|Overall Study|subject moved|0|||
19387213|NCT02139124|41630195|FG003|Overall Study|subject moved|0|||
19387214|NCT02139124|41630196|FG004|Overall Study|subject moved|0|||
19387215|NCT02139124|41630192|FG000|Overall Study|Lost to Follow-up|3|||
19387216|NCT02139124|41630193|FG001|Overall Study|Lost to Follow-up|2|||
19387217|NCT02139124|41630194|FG002|Overall Study|Lost to Follow-up|0|||
19387218|NCT02139124|41630195|FG003|Overall Study|Lost to Follow-up|5|||
19387219|NCT02139124|41630196|FG004|Overall Study|Lost to Follow-up|4|||
19387220|NCT02139046|41630213|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
19387221|NCT02139046|41630214|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
19387222|NCT02139046|41630215|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
19387223|NCT02139046|41630216|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
19387224|NCT02139046|41630217|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
19387225|NCT02139046|41630213|FG000|Overall Study|Major Protocol Deviation|9|||
19573503|NCT00940498|42021274|FG000|Overall Study|Physician Decision|0|||
19573504|NCT00940498|42021275|FG001|Overall Study|Physician Decision|0|||
19573505|NCT00940498|42021276|FG002|Overall Study|Physician Decision|0|||
19573506|NCT00940498|42021277|FG003|Overall Study|Physician Decision|0|||
19573507|NCT00940498|42021278|FG004|Overall Study|Physician Decision|2|||
19573508|NCT00940498|42021279|FG005|Overall Study|Physician Decision|0|||
19573509|NCT00940498|42021280|FG006|Overall Study|Physician Decision|0|||
19573510|NCT00940498|42021281|FG007|Overall Study|Physician Decision|0|||
19573511|NCT00940498|42021274|FG000|Overall Study|Not treated due to disease related pain|0|||
19573512|NCT00940498|42021275|FG001|Overall Study|Not treated due to disease related pain|0|||
19573513|NCT00940498|42021276|FG002|Overall Study|Not treated due to disease related pain|0|||
19573514|NCT00940498|42021277|FG003|Overall Study|Not treated due to disease related pain|0|||
19573515|NCT00940498|42021278|FG004|Overall Study|Not treated due to disease related pain|1|||
19387226|NCT02139046|41630214|FG001|Overall Study|Major Protocol Deviation|10|||
19387227|NCT02139046|41630215|FG002|Overall Study|Major Protocol Deviation|16|||
19387228|NCT02139046|41630216|FG003|Overall Study|Major Protocol Deviation|12|||
19573516|NCT00940498|42021279|FG005|Overall Study|Not treated due to disease related pain|0|||
19573517|NCT00940498|42021280|FG006|Overall Study|Not treated due to disease related pain|0|||
19573518|NCT00940498|42021281|FG007|Overall Study|Not treated due to disease related pain|0|||
19573519|NCT00940342|42021308|FG000|Overall Study|Adverse Event|0|||
19387229|NCT02139046|41630217|FG004|Overall Study|Major Protocol Deviation|6|||
19387230|NCT02139046|41630213|FG000|Overall Study|Lost to Follow-up|13|||
19387231|NCT02139046|41630214|FG001|Overall Study|Lost to Follow-up|16|||
19387232|NCT02139046|41630215|FG002|Overall Study|Lost to Follow-up|16|||
19387233|NCT02139046|41630216|FG003|Overall Study|Lost to Follow-up|18|||
19387234|NCT02139046|41630217|FG004|Overall Study|Lost to Follow-up|13|||
19387235|NCT02139046|41630213|FG000|Overall Study|Voluntary Withdrawal|20|||
19573520|NCT00940342|42021309|FG001|Overall Study|Adverse Event|2|||
19573521|NCT00940342|42021310|FG002|Overall Study|Adverse Event|1|||
19573522|NCT00936910|42021318|FG000|Overall Study|Lack of Efficacy|3|||
19573523|NCT00940108|42021327|FG000|Overall Study|Adverse Event|2|||
19573524|NCT00940108|42021328|FG001|Overall Study|Adverse Event|4|||
19573525|NCT00940108|42021329|FG002|Overall Study|Adverse Event|0|||
19573526|NCT00940108|42021330|FG003|Overall Study|Adverse Event|2|||
19573527|NCT00940108|42021327|FG000|Overall Study|Withdrew Consent|2|||
19573528|NCT00940108|42021328|FG001|Overall Study|Withdrew Consent|1|||
19573529|NCT00940108|42021329|FG002|Overall Study|Withdrew Consent|0|||
19573530|NCT00940108|42021330|FG003|Overall Study|Withdrew Consent|1|||
19573531|NCT00940108|42021327|FG000|Overall Study|Dose 2 contraindicated|1|||
19573532|NCT00940108|42021328|FG001|Overall Study|Dose 2 contraindicated|1|||
19573533|NCT00940108|42021329|FG002|Overall Study|Dose 2 contraindicated|0|||
19573534|NCT00940108|42021330|FG003|Overall Study|Dose 2 contraindicated|1|||
19573535|NCT00940108|42021327|FG000|Overall Study|Declined further vaccination|0|||
19573536|NCT00940108|42021328|FG001|Overall Study|Declined further vaccination|1|||
19573537|NCT00940108|42021329|FG002|Overall Study|Declined further vaccination|3|||
19573538|NCT00940108|42021330|FG003|Overall Study|Declined further vaccination|0|||
19573539|NCT00940108|42021327|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
19573540|NCT00940108|42021328|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
19573541|NCT00940108|42021329|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
19573542|NCT00940108|42021330|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
19573543|NCT00940108|42021327|FG000|Overall Study|Viral illness after Dose 1|0|||
19573544|NCT00940108|42021328|FG001|Overall Study|Viral illness after Dose 1|1|||
19573545|NCT00940108|42021329|FG002|Overall Study|Viral illness after Dose 1|0|||
19573546|NCT00940108|42021330|FG003|Overall Study|Viral illness after Dose 1|0|||
19573547|NCT00940108|42021327|FG000|Overall Study|Diagnosed with H1N1|0|||
19573548|NCT00940108|42021328|FG001|Overall Study|Diagnosed with H1N1|0|||
19573549|NCT00940108|42021329|FG002|Overall Study|Diagnosed with H1N1|0|||
19573550|NCT00940108|42021330|FG003|Overall Study|Diagnosed with H1N1|1|||
19573551|NCT00936598|42021342|FG000|Overall Study|Withdrawal by Subject|1|||
19573552|NCT00936598|42021343|FG001|Overall Study|Withdrawal by Subject|0|||
19573553|NCT00936598|42021342|FG000|Overall Study|Ineligible after consent|1|||
19573554|NCT00936598|42021343|FG001|Overall Study|Ineligible after consent|0|||
19573555|NCT01025817|42021351|FG000|Completed Study Medication|Adverse Event|66|||
19573556|NCT01025817|42021352|FG001|Completed Study Medication|Adverse Event|39|||
19573557|NCT01025817|42021351|FG000|Completed Study Medication|Protocol Deviation|9|||
19573558|NCT01025817|42021352|FG001|Completed Study Medication|Protocol Deviation|8|||
19573559|NCT01025817|42021351|FG000|Completed Study Medication|Withdrawal by Subject|8|||
19573560|NCT01025817|42021352|FG001|Completed Study Medication|Withdrawal by Subject|9|||
19573561|NCT01025817|42021351|FG000|Completed Study Medication|Administrative problems|7|||
19573562|NCT01025817|42021352|FG001|Completed Study Medication|Administrative problems|5|||
19387236|NCT02139046|41630214|FG001|Overall Study|Voluntary Withdrawal|8|||
19387237|NCT02139046|41630215|FG002|Overall Study|Voluntary Withdrawal|10|||
19387238|NCT02139046|41630216|FG003|Overall Study|Voluntary Withdrawal|15|||
19387239|NCT02139046|41630217|FG004|Overall Study|Voluntary Withdrawal|16|||
19573563|NCT01025817|42021351|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
19573564|NCT01025817|42021352|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
19573565|NCT01025817|42021351|FG000|Completed Study Medication|Abnormal test procedure|4|||
19573566|NCT01025817|42021352|FG001|Completed Study Medication|Abnormal test procedure|0|||
19573567|NCT01025817|42021351|FG000|Completed Study Medication|Graft loss|2|||
19573568|NCT01025817|42021352|FG001|Completed Study Medication|Graft loss|5|||
19573569|NCT01025817|42021351|FG000|Completed Study Medication|Death|2|||
19573570|NCT01025817|42021352|FG001|Completed Study Medication|Death|2|||
19573571|NCT01025817|42021351|FG000|Completed Study Medication|Abnormal lab values|0|||
19573572|NCT01025817|42021352|FG001|Completed Study Medication|Abnormal lab values|2|||
19573573|NCT01025817|42021351|FG000|Completed Study Medication|Subject no longer required study drug|0|||
19573574|NCT01025817|42021352|FG001|Completed Study Medication|Subject no longer required study drug|1|||
19573575|NCT01025817|42021351|FG000|Completed Study Medication|Lost to Follow-up|0|||
19573576|NCT01025817|42021352|FG001|Completed Study Medication|Lost to Follow-up|1|||
19573577|NCT01025817|42021351|FG000|Completed Study|Withdrawal by Subject|8|||
19573578|NCT01025817|42021352|FG001|Completed Study|Withdrawal by Subject|16|||
19573579|NCT01025817|42021351|FG000|Completed Study|Death|6|||
19573580|NCT01025817|42021352|FG001|Completed Study|Death|5|||
19387240|NCT02139046|41630213|FG000|Overall Study|Lack of Efficacy|0|||
19573581|NCT01025817|42021351|FG000|Completed Study|Missing|2|||
19573582|NCT01025817|42021352|FG001|Completed Study|Missing|0|||
19573583|NCT01025817|42021351|FG000|Completed Study|Lost to Follow-up|0|||
19573584|NCT01025817|42021352|FG001|Completed Study|Lost to Follow-up|1|||
19573585|NCT00939640|42021358|FG000|Overall Study|Physician Decision|1|||
19573586|NCT01218113|42021370|FG000|Overall Study|Withdrawal by Subject|1|||
19573587|NCT01218113|42021371|FG001|Overall Study|Withdrawal by Subject|0|||
19573588|NCT01218113|42021372|FG002|Overall Study|Withdrawal by Subject|1|||
19573589|NCT01218113|42021370|FG000|Overall Study|Lost to Follow-up|4|||
19573590|NCT01218113|42021371|FG001|Overall Study|Lost to Follow-up|1|||
19573591|NCT01218113|42021372|FG002|Overall Study|Lost to Follow-up|4|||
19573592|NCT01218113|42021370|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
19573593|NCT01218113|42021371|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
19573594|NCT01218113|42021372|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
19573595|NCT03873493|42021387|FG000|Overall Study|Withdrawal by Subject|1|||
19573596|NCT03873493|42021387|FG000|Overall Study|Death|9|||
19573597|NCT03873493|42021387|FG000|Overall Study|Lost to Follow-up|1|||
19573598|NCT03873493|42021387|FG000|Overall Study|Study Terminated by Sponsor|1|||
19573599|NCT03873493|42021387|FG000|Overall Study|Other|2|||
19573600|NCT00939484|42021407|FG000|Overall Study|Progression/Relapse|8|||
19573601|NCT00939484|42021408|FG001|Overall Study|Progression/Relapse|20|||
19573602|NCT00939484|42021409|FG002|Overall Study|Progression/Relapse|3|||
19573603|NCT01010217|42021424|FG000|Overall Study|Lost to Follow-up|4|||
19573604|NCT01010217|42021425|FG001|Overall Study|Lost to Follow-up|5|||
19573605|NCT01010217|42021426|FG002|Overall Study|Lost to Follow-up|1|||
19573606|NCT01010217|42021427|FG003|Overall Study|Lost to Follow-up|0|||
19573607|NCT01010217|42021428|FG004|Overall Study|Lost to Follow-up|0|||
19573608|NCT01010217|42021424|FG000|Overall Study|Withdrawal by Subject|1|||
19573609|NCT01010217|42021425|FG001|Overall Study|Withdrawal by Subject|0|||
19573610|NCT01010217|42021426|FG002|Overall Study|Withdrawal by Subject|0|||
19573611|NCT01010217|42021427|FG003|Overall Study|Withdrawal by Subject|0|||
19573612|NCT01010217|42021428|FG004|Overall Study|Withdrawal by Subject|0|||
19573613|NCT01010217|42021424|FG000|Overall Study|Physician Decision|0|||
19573614|NCT01010217|42021425|FG001|Overall Study|Physician Decision|0|||
19573615|NCT01010217|42021426|FG002|Overall Study|Physician Decision|0|||
19573616|NCT01010217|42021427|FG003|Overall Study|Physician Decision|6|||
19573617|NCT01010217|42021428|FG004|Overall Study|Physician Decision|3|||
19573618|NCT01013961|42021442|FG000|Overall Study|Adverse Event|2|||
19573619|NCT01013961|42021443|FG001|Overall Study|Adverse Event|2|||
19573620|NCT01013961|42021442|FG000|Overall Study|Withdrawal by Subject|1|||
19573621|NCT01013961|42021443|FG001|Overall Study|Withdrawal by Subject|0|||
19573622|NCT01013961|42021442|FG000|Overall Study|Physician Decision|0|||
19573623|NCT01013961|42021443|FG001|Overall Study|Physician Decision|1|||
19573624|NCT01217957|42021454|FG000|Phase 1|Withdrawal by Patient|1|||
19573625|NCT01217957|42021455|FG001|Phase 1|Withdrawal by Patient|0|||
19573626|NCT01217957|42021456|FG002|Phase 1|Withdrawal by Patient|1|||
19573627|NCT01217957|42021457|FG003|Phase 1|Withdrawal by Patient|1|||
19573628|NCT01217957|42021458|FG004|Phase 1|Withdrawal by Patient|0|||
19573629|NCT01217957|42021454|FG000|Phase 2|Withdrawal by Patient|0|||
19573630|NCT01217957|42021455|FG001|Phase 2|Withdrawal by Patient|0|||
19573631|NCT01217957|42021456|FG002|Phase 2|Withdrawal by Patient|0|||
19573632|NCT01217957|42021457|FG003|Phase 2|Withdrawal by Patient|0|||
19573633|NCT01217957|42021458|FG004|Phase 2|Withdrawal by Patient|1|||
19573634|NCT00939094|42021481|FG000|Overall Study|Adverse Event|9|||
19573635|NCT00939094|42021482|FG001|Overall Study|Adverse Event|0|||
19573636|NCT00939094|42021481|FG000|Overall Study|Withdrawal by Subject|1|||
19573637|NCT00939094|42021482|FG001|Overall Study|Withdrawal by Subject|6|||
19573638|NCT00939094|42021481|FG000|Overall Study|Lost to Follow-up|1|||
19573639|NCT00939094|42021482|FG001|Overall Study|Lost to Follow-up|1|||
19573640|NCT00939094|42021481|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19573641|NCT00939094|42021482|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19573642|NCT00939094|42021481|FG000|Overall Study|Severe non-compliance to protocol|0|||
19573643|NCT00939094|42021482|FG001|Overall Study|Severe non-compliance to protocol|1|||
19573644|NCT00939094|42021481|FG000|Overall Study|Study stopped by sponsor|0|||
19573645|NCT00939094|42021482|FG001|Overall Study|Study stopped by sponsor|2|||
19573646|NCT00939094|42021481|FG000|Overall Study|Abnormal ECG findings|1|||
19573647|NCT00939094|42021482|FG001|Overall Study|Abnormal ECG findings|0|||
19573648|NCT01217801|42021490|FG000|Period 1|Protocol Violation|1|||
19573649|NCT01217801|42021491|FG001|Period 1|Protocol Violation|1|||
19573650|NCT01217801|42021490|FG000|Period 1|Withdrawal by Subject|0|||
19573651|NCT01217801|42021491|FG001|Period 1|Withdrawal by Subject|1|||
19573652|NCT00935818|42021499|FG000|Overall Study|Withdrawal by Subject|45|||
19573653|NCT00935818|42021500|FG001|Overall Study|Withdrawal by Subject|50|||
19573654|NCT00935818|42021499|FG000|Overall Study|Lost to Follow-up|40|||
19573655|NCT00935818|42021500|FG001|Overall Study|Lost to Follow-up|42|||
19573656|NCT00935818|42021499|FG000|Overall Study|Adverse Event|6|||
19573657|NCT00935818|42021500|FG001|Overall Study|Adverse Event|7|||
19573658|NCT00935818|42021499|FG000|Overall Study|Physician Decision|0|||
19573659|NCT00935818|42021500|FG001|Overall Study|Physician Decision|1|||
19573660|NCT01216319|42021506|FG000|Overall Study|Lost to Follow-up|2|||
19573661|NCT01216319|42021506|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
19573662|NCT00936208|42021512|FG000|Overall Study|Protocol Violation|37|||
19573663|NCT00936208|42021513|FG001|Overall Study|Protocol Violation|22|||
19573664|NCT01216163|42021522|FG000|Overall Study|Withdrawal by Subject|1|||
19573665|NCT01216163|42021523|FG001|Overall Study|Withdrawal by Subject|1|||
19573666|NCT01216163|42021524|FG002|Overall Study|Withdrawal by Subject|0|||
19573667|NCT00933244|42021535|FG000|Overall Study|Withdrawal by Subject|5|||
19573668|NCT00933244|42021536|FG001|Overall Study|Withdrawal by Subject|1|||
19573669|NCT00933244|42021537|FG002|Overall Study|Withdrawal by Subject|3|||
19573670|NCT00930046|42021547|FG000|Overall Study|Wound catheter malfunctioned|1|||
19573671|NCT00930046|42021548|FG001|Overall Study|Wound catheter malfunctioned|2|||
19573672|NCT00935584|42021556|FG000|Overall Study|Withdrawal by Subject|9|||
19573673|NCT00935584|42021557|FG001|Overall Study|Withdrawal by Subject|0|||
19573674|NCT00935584|42021556|FG000|Overall Study|Death|3|||
19573675|NCT00935584|42021557|FG001|Overall Study|Death|0|||
19573676|NCT00935584|42021556|FG000|Overall Study|Lost to Follow-up|8|||
19573677|NCT00935584|42021557|FG001|Overall Study|Lost to Follow-up|0|||
19573678|NCT00935584|42021556|FG000|Overall Study|No show|9|||
19573679|NCT00935584|42021557|FG001|Overall Study|No show|0|||
19573680|NCT00935584|42021556|FG000|Overall Study|Relocated|3|||
19573681|NCT00935584|42021557|FG001|Overall Study|Relocated|0|||
19573682|NCT00935584|42021556|FG000|Overall Study|Patient changed provider|3|||
19573683|NCT00935584|42021557|FG001|Overall Study|Patient changed provider|0|||
19573684|NCT00935584|42021556|FG000|Overall Study|Provider dropped out of study|14|||
19573685|NCT00935584|42021557|FG001|Overall Study|Provider dropped out of study|4|||
19573686|NCT01215851|42021567|FG000|Treatment Period|Adverse Event|1|||
19573687|NCT01215851|42021568|FG001|Treatment Period|Adverse Event|1|||
19573688|NCT01215851|42021569|FG002|Treatment Period|Adverse Event|1|||
19573689|NCT01215851|42021570|FG003|Treatment Period|Adverse Event|3|||
19573690|NCT01215851|42021571|FG004|Treatment Period|Adverse Event|0|||
19573691|NCT01215851|42021572|FG005|Treatment Period|Adverse Event|1|||
19387241|NCT02139046|41630214|FG001|Overall Study|Lack of Efficacy|1|||
19573692|NCT01215851|42021567|FG000|Follow up Period|Lost to Follow-up|0|||
19573693|NCT01215851|42021568|FG001|Follow up Period|Lost to Follow-up|0|||
19573694|NCT01215851|42021569|FG002|Follow up Period|Lost to Follow-up|0|||
19573695|NCT01215851|42021570|FG003|Follow up Period|Lost to Follow-up|0|||
19573696|NCT01215851|42021571|FG004|Follow up Period|Lost to Follow-up|0|||
19573697|NCT01215851|42021572|FG005|Follow up Period|Lost to Follow-up|1|||
19573698|NCT00933166|42021587|FG000|Overall Study|Lost to Follow-up|4|||
19387242|NCT02139046|41630215|FG002|Overall Study|Lack of Efficacy|2|||
19387243|NCT02139046|41630216|FG003|Overall Study|Lack of Efficacy|1|||
19387244|NCT02139046|41630217|FG004|Overall Study|Lack of Efficacy|2|||
19387245|NCT02139046|41630213|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
19387246|NCT02139046|41630214|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
19387247|NCT02139046|41630215|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
19387248|NCT02139046|41630216|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
19387249|NCT02139046|41630217|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
19387250|NCT02139046|41630213|FG000|Overall Study|Other Miscellaneous Reasons|10|||
19387251|NCT02139046|41630214|FG001|Overall Study|Other Miscellaneous Reasons|9|||
19387252|NCT02139046|41630215|FG002|Overall Study|Other Miscellaneous Reasons|4|||
19387253|NCT02139046|41630216|FG003|Overall Study|Other Miscellaneous Reasons|9|||
19476935|NCT01569295|41755233|FG000|Overall Study|Study Terminated by Sponsor|24|||
19476936|NCT01569295|41755234|FG001|Overall Study|Study Terminated by Sponsor|2|||
19573699|NCT00933166|42021587|FG000|Overall Study|Lack of Efficacy|9|||
19476937|NCT01569295|41755233|FG000|Overall Study|Other Reason not Specified|3|||
19573700|NCT00933166|42021587|FG000|Overall Study|Unavailable|4|||
19573701|NCT00933166|42021587|FG000|Overall Study|Withdrawal by Subject|1|||
19573702|NCT00935272|42021593|FG000|Overall Study|Lost to Follow-up|10|||
19573703|NCT00935272|42021594|FG001|Overall Study|Lost to Follow-up|3|||
19573704|NCT00935272|42021593|FG000|Overall Study|Withdrawal by Subject|8|||
19387254|NCT02139046|41630217|FG004|Overall Study|Other Miscellaneous Reasons|12|||
19387255|NCT02138890|41630231|FG000|Overall Study|Adverse Event|1|||
19387256|NCT02138890|41630232|FG001|Overall Study|Adverse Event|0|||
19387257|NCT02100670|41630243|FG000|Overall Study|Adverse Event|10|||
19387258|NCT02100670|41630244|FG001|Overall Study|Adverse Event|3|||
19387259|NCT02100670|41630245|FG002|Overall Study|Adverse Event|3|||
19387260|NCT02100670|41630246|FG003|Overall Study|Adverse Event|0|||
19573705|NCT00935272|42021594|FG001|Overall Study|Withdrawal by Subject|2|||
19573706|NCT00935272|42021593|FG000|Overall Study|Physician Decision|1|||
19573707|NCT00935272|42021594|FG001|Overall Study|Physician Decision|0|||
19573708|NCT00935272|42021593|FG000|Overall Study|Protocol Violation|0|||
19573709|NCT00935272|42021594|FG001|Overall Study|Protocol Violation|1|||
19573710|NCT01010061|42021603|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
19573711|NCT01010061|42021604|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
19573712|NCT01010061|42021603|FG000|Overall Study|Disease Progression|2|||
19573713|NCT01010061|42021604|FG001|Overall Study|Disease Progression|8|||
19573714|NCT01010061|42021603|FG000|Overall Study|Withdrew Consent|5|||
19573715|NCT01010061|42021604|FG001|Overall Study|Withdrew Consent|1|||
19573716|NCT01010061|42021603|FG000|Overall Study|Death|3|||
19573717|NCT01010061|42021604|FG001|Overall Study|Death|6|||
19573718|NCT01010061|42021603|FG000|Overall Study|Administrative/Other|0|||
19573719|NCT01010061|42021604|FG001|Overall Study|Administrative/Other|1|||
19573720|NCT01010061|42021603|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
19573721|NCT01010061|42021604|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
19573722|NCT01010061|42021603|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19573723|NCT01010061|42021604|FG001|Overall Study|Insufficient Therapeutic Response|5|||
19573724|NCT01010061|42021603|FG000|Overall Study|Violation of Selection Criteria|0|||
19573725|NCT01010061|42021604|FG001|Overall Study|Violation of Selection Criteria|1|||
19573726|NCT01010061|42021603|FG000|Overall Study|Did Not Receive Treatment|2|||
19573727|NCT01010061|42021604|FG001|Overall Study|Did Not Receive Treatment|2|||
19573728|NCT00929734|42021624|FG000|Overall Study|Lost to Follow-up|2|||
19573729|NCT00929734|42021625|FG001|Overall Study|Lost to Follow-up|1|||
19573730|NCT00929734|42021624|FG000|Overall Study|Withdrawal by Subject|0|||
19573731|NCT00929734|42021625|FG001|Overall Study|Withdrawal by Subject|2|||
19573732|NCT01013883|42021633|FG000|Overall Study|Lost to Follow-up|2|||
19573733|NCT01013883|42021634|FG001|Overall Study|Lost to Follow-up|2|||
19573734|NCT01009983|42021640|FG000|Overall Study|necessary scans not completed|1|||
19573735|NCT01215227|42021654|FG000|Overall Study|Adverse Event|11|||
19573736|NCT01215227|42021655|FG001|Overall Study|Adverse Event|11|||
19573737|NCT01215227|42021656|FG002|Overall Study|Adverse Event|4|||
19573738|NCT01215227|42021657|FG003|Overall Study|Adverse Event|8|||
19387261|NCT02100670|41630243|FG000|Overall Study|Lost to Follow-up|1|||
19387262|NCT02100670|41630244|FG001|Overall Study|Lost to Follow-up|0|||
19387263|NCT02100670|41630245|FG002|Overall Study|Lost to Follow-up|0|||
19387264|NCT02100670|41630246|FG003|Overall Study|Lost to Follow-up|0|||
19387265|NCT02100670|41630243|FG000|Overall Study|Protocol Violation|0|||
19387266|NCT02100670|41630244|FG001|Overall Study|Protocol Violation|1|||
19573739|NCT01215227|42021658|FG004|Overall Study|Adverse Event|7|||
19573740|NCT01215227|42021659|FG005|Overall Study|Adverse Event|6|||
19573741|NCT01215227|42021654|FG000|Overall Study|Treatment Failure|8|||
19573742|NCT01215227|42021655|FG001|Overall Study|Treatment Failure|4|||
19573743|NCT01215227|42021656|FG002|Overall Study|Treatment Failure|1|||
19573744|NCT01215227|42021657|FG003|Overall Study|Treatment Failure|5|||
19573745|NCT01215227|42021658|FG004|Overall Study|Treatment Failure|1|||
19387267|NCT02100670|41630245|FG002|Overall Study|Protocol Violation|0|||
19387268|NCT02100670|41630246|FG003|Overall Study|Protocol Violation|1|||
19387269|NCT02100670|41630243|FG000|Overall Study|Withdrawal of Consent|0|||
19387270|NCT02100670|41630244|FG001|Overall Study|Withdrawal of Consent|1|||
19387271|NCT02100670|41630245|FG002|Overall Study|Withdrawal of Consent|1|||
19387272|NCT02100670|41630246|FG003|Overall Study|Withdrawal of Consent|0|||
19387273|NCT02100670|41630243|FG000|Overall Study|No swelling no pain|1|||
19387274|NCT02100670|41630244|FG001|Overall Study|No swelling no pain|0|||
19387275|NCT02100670|41630245|FG002|Overall Study|No swelling no pain|0|||
19387276|NCT02100670|41630246|FG003|Overall Study|No swelling no pain|0|||
19387277|NCT02100670|41630243|FG000|Overall Study|Poor Efficacy|0|||
19387278|NCT02100670|41630244|FG001|Overall Study|Poor Efficacy|1|||
19387279|NCT02100670|41630245|FG002|Overall Study|Poor Efficacy|0|||
19387280|NCT02100670|41630246|FG003|Overall Study|Poor Efficacy|0|||
19387281|NCT02100670|41630243|FG000|Overall Study|Physician Decision|0|||
19387282|NCT02100670|41630244|FG001|Overall Study|Physician Decision|1|||
19573746|NCT01215227|42021659|FG005|Overall Study|Treatment Failure|1|||
19573747|NCT01215227|42021654|FG000|Overall Study|Lost to Follow-up|1|||
19573748|NCT01215227|42021655|FG001|Overall Study|Lost to Follow-up|4|||
19573749|NCT01215227|42021656|FG002|Overall Study|Lost to Follow-up|1|||
19573750|NCT01215227|42021657|FG003|Overall Study|Lost to Follow-up|1|||
19573751|NCT01215227|42021658|FG004|Overall Study|Lost to Follow-up|1|||
19573752|NCT01215227|42021659|FG005|Overall Study|Lost to Follow-up|2|||
19573753|NCT01215227|42021654|FG000|Overall Study|Subject Withdrew Consent|16|||
19387283|NCT02100670|41630245|FG002|Overall Study|Physician Decision|0|||
19387284|NCT02100670|41630246|FG003|Overall Study|Physician Decision|0|||
19387285|NCT02100670|41630243|FG000|Overall Study|Withdrawal by Subject|1|||
19387286|NCT02100670|41630244|FG001|Overall Study|Withdrawal by Subject|0|||
19387287|NCT02100670|41630245|FG002|Overall Study|Withdrawal by Subject|0|||
19387288|NCT02100670|41630246|FG003|Overall Study|Withdrawal by Subject|0|||
19573754|NCT01215227|42021655|FG001|Overall Study|Subject Withdrew Consent|20|||
19573755|NCT01215227|42021656|FG002|Overall Study|Subject Withdrew Consent|7|||
19573756|NCT01215227|42021657|FG003|Overall Study|Subject Withdrew Consent|10|||
19573757|NCT01215227|42021658|FG004|Overall Study|Subject Withdrew Consent|11|||
19573758|NCT01215227|42021659|FG005|Overall Study|Subject Withdrew Consent|8|||
19387289|NCT02070484|41630265|FG000|Overall Study|Withdrawal by Subject|1|||
19387290|NCT02070484|41630266|FG001|Overall Study|Withdrawal by Subject|0|||
19387291|NCT02100514|41630274|FG000|Treatment Period|Adverse Event|0|||
19573759|NCT01215227|42021654|FG000|Overall Study|Non-Compliance With Protocol|2|||
19573760|NCT01215227|42021655|FG001|Overall Study|Non-Compliance With Protocol|6|||
19573761|NCT01215227|42021656|FG002|Overall Study|Non-Compliance With Protocol|1|||
19573762|NCT01215227|42021657|FG003|Overall Study|Non-Compliance With Protocol|0|||
19573763|NCT01215227|42021658|FG004|Overall Study|Non-Compliance With Protocol|0|||
19573764|NCT01215227|42021659|FG005|Overall Study|Non-Compliance With Protocol|0|||
19573765|NCT01215227|42021654|FG000|Overall Study|Administrative|83|||
19573766|NCT01215227|42021655|FG001|Overall Study|Administrative|73|||
19573767|NCT01215227|42021656|FG002|Overall Study|Administrative|42|||
19573768|NCT01215227|42021657|FG003|Overall Study|Administrative|24|||
19573769|NCT01215227|42021658|FG004|Overall Study|Administrative|28|||
19573770|NCT01215227|42021659|FG005|Overall Study|Administrative|40|||
19573771|NCT01215227|42021654|FG000|Overall Study|Missing Status|0|||
19573772|NCT01215227|42021655|FG001|Overall Study|Missing Status|1|||
19573773|NCT01215227|42021656|FG002|Overall Study|Missing Status|0|||
19573774|NCT01215227|42021657|FG003|Overall Study|Missing Status|0|||
19573775|NCT01215227|42021658|FG004|Overall Study|Missing Status|0|||
19573776|NCT01215227|42021659|FG005|Overall Study|Missing Status|0|||
19573777|NCT01215227|42021654|FG000|Overall Study|Randomized but not treated|0|||
19573778|NCT01215227|42021655|FG001|Overall Study|Randomized but not treated|0|||
19573779|NCT01215227|42021656|FG002|Overall Study|Randomized but not treated|1|||
19573780|NCT01215227|42021657|FG003|Overall Study|Randomized but not treated|1|||
19573781|NCT01215227|42021658|FG004|Overall Study|Randomized but not treated|0|||
19573782|NCT01215227|42021659|FG005|Overall Study|Randomized but not treated|1|||
19573783|NCT01009515|42021673|FG000|Overall Study|Withdrawal by Subject|3|||
19573784|NCT01214915|42021677|FG000|Overall Study|Adverse Event|8|||
19573785|NCT01214915|42021677|FG000|Overall Study|Lack of Efficacy|3|||
19573786|NCT01009281|42021681|FG000|Overall Study|Administrative problems|7|||
19573787|NCT01009203|42021685|FG000|Overall Study|Withdrawal by Subject|1|||
19387292|NCT02100514|41630275|FG001|Treatment Period|Adverse Event|5|||
19387293|NCT02100514|41630276|FG002|Treatment Period|Adverse Event|0|||
19387294|NCT02100514|41630277|FG003|Treatment Period|Adverse Event|0|||
19387295|NCT02100514|41630278|FG004|Treatment Period|Adverse Event|0|||
19573788|NCT01009203|42021685|FG000|Overall Study|Adverse Event|5|||
19573789|NCT01009203|42021685|FG000|Overall Study|Treatment-unrelated death|1|||
19573790|NCT01009047|42021691|FG000|Overall Study|Adverse Event|5|||
19573791|NCT01009047|42021692|FG001|Overall Study|Adverse Event|0|||
19573792|NCT01009047|42021691|FG000|Overall Study|Lost to Follow-up|0|||
19573793|NCT01009047|42021692|FG001|Overall Study|Lost to Follow-up|2|||
19573794|NCT01009047|42021691|FG000|Overall Study|Lack of Efficacy|4|||
19573795|NCT01009047|42021692|FG001|Overall Study|Lack of Efficacy|11|||
19573796|NCT01009047|42021691|FG000|Overall Study|Withdrawal by consent|16|||
19573797|NCT01009047|42021692|FG001|Overall Study|Withdrawal by consent|11|||
19573798|NCT01009047|42021691|FG000|Overall Study|Other|3|||
19573799|NCT01009047|42021692|FG001|Overall Study|Other|2|||
19573800|NCT01025193|42021698|FG000|Overall Study|Protocol Violation|1|||
19573801|NCT01025193|42021698|FG000|Overall Study|Adverse Event|3|||
19573802|NCT01025037|42021706|FG000|Overall Study|Adverse Event|3|||
19573803|NCT01025037|42021706|FG000|Overall Study|Lost to Follow-up|7|||
19573804|NCT01025037|42021706|FG000|Overall Study|Withdrawal by Subject|1|||
19573805|NCT01214837|42021713|FG000|Overall Study|Death|0|||
19573806|NCT01214837|42021714|FG001|Overall Study|Death|0|||
19573807|NCT01214837|42021715|FG002|Overall Study|Death|1|||
19573808|NCT01214837|42021713|FG000|Overall Study|Adverse Event|1|||
19573809|NCT01214837|42021714|FG001|Overall Study|Adverse Event|2|||
19573810|NCT01214837|42021715|FG002|Overall Study|Adverse Event|1|||
19573811|NCT01214837|42021713|FG000|Overall Study|Withdrawal by Subject|27|||
19573812|NCT01214837|42021714|FG001|Overall Study|Withdrawal by Subject|36|||
19573813|NCT01214837|42021715|FG002|Overall Study|Withdrawal by Subject|28|||
19573814|NCT01214837|42021713|FG000|Overall Study|Lost to Follow-up|20|||
19573815|NCT01214837|42021714|FG001|Overall Study|Lost to Follow-up|15|||
19573816|NCT01214837|42021715|FG002|Overall Study|Lost to Follow-up|21|||
19573817|NCT01214837|42021713|FG000|Overall Study|Inappropriate Enrolment|0|||
19573818|NCT01214837|42021714|FG001|Overall Study|Inappropriate Enrolment|1|||
19573819|NCT01214837|42021715|FG002|Overall Study|Inappropriate Enrolment|2|||
19573820|NCT01214837|42021713|FG000|Overall Study|Administrative Reason|2|||
19573821|NCT01214837|42021714|FG001|Overall Study|Administrative Reason|6|||
19573822|NCT01214837|42021715|FG002|Overall Study|Administrative Reason|4|||
19573823|NCT01214837|42021713|FG000|Overall Study|Protocol Violation|3|||
19573824|NCT01214837|42021714|FG001|Overall Study|Protocol Violation|1|||
19573825|NCT01214837|42021715|FG002|Overall Study|Protocol Violation|5|||
19573826|NCT01214837|42021713|FG000|Overall Study|Unable to Classify|1|||
19573827|NCT01214837|42021714|FG001|Overall Study|Unable to Classify|3|||
19573828|NCT01214837|42021715|FG002|Overall Study|Unable to Classify|0|||
19573829|NCT01024959|42021724|FG000|Overall Study|ineligible|12|||
19573830|NCT01024959|42021724|FG000|Overall Study|results not evaluable|12|||
19573831|NCT01024959|42021724|FG000|Overall Study|missing results required for analysis|17|||
19573832|NCT03672175|42021736|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
19573833|NCT03672175|42021737|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
19573834|NCT03672175|42021738|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
19573835|NCT03672175|42021736|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
19573836|NCT03672175|42021737|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
19573837|NCT03672175|42021738|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
19573838|NCT03672175|42021736|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
19573839|NCT03672175|42021737|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
19573840|NCT03672175|42021738|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
19573841|NCT03672175|42021736|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
19573842|NCT03672175|42021737|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
19573843|NCT03672175|42021738|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
19573844|NCT03672175|42021736|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
19573845|NCT03672175|42021737|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
19573846|NCT03672175|42021738|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
19573847|NCT03672175|42021736|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
19573848|NCT03672175|42021737|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
19573849|NCT03672175|42021738|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
19573850|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
19573851|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
19573852|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
19573853|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
19573854|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
19573855|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
19573856|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
19573857|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
19573858|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
19573859|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
19573860|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
19573861|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
19573862|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
19573863|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
19573864|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
19476938|NCT01569295|41755234|FG001|Overall Study|Other Reason not Specified|5|||
19476939|NCT01569295|41755233|FG000|Overall Study|Non-Compliance with Study Drug|6|||
19387296|NCT02100514|41630274|FG000|Treatment Period|Death|2|||
19387297|NCT02100514|41630275|FG001|Treatment Period|Death|2|||
19387298|NCT02100514|41630276|FG002|Treatment Period|Death|0|||
19387299|NCT02100514|41630277|FG003|Treatment Period|Death|0|||
19387300|NCT02100514|41630278|FG004|Treatment Period|Death|0|||
19573865|NCT03672175|42021736|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
19573866|NCT03672175|42021737|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
19573867|NCT03672175|42021738|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
19573868|NCT01008423|42021766|FG000|Overall Study|Adverse Event|13|||
19573869|NCT01008423|42021767|FG001|Overall Study|Adverse Event|6|||
19573870|NCT01008423|42021766|FG000|Overall Study|Withdrawal by Subject|4|||
19573871|NCT01008423|42021767|FG001|Overall Study|Withdrawal by Subject|7|||
19573872|NCT01008423|42021766|FG000|Overall Study|Lost to Follow-up|0|||
19573873|NCT01008423|42021767|FG001|Overall Study|Lost to Follow-up|2|||
19573874|NCT01008423|42021766|FG000|Overall Study|Low Cortisol|0|||
19573875|NCT01008423|42021767|FG001|Overall Study|Low Cortisol|1|||
19573876|NCT01008423|42021766|FG000|Overall Study|Lack of Efficacy|0|||
19573877|NCT01008423|42021767|FG001|Overall Study|Lack of Efficacy|5|||
19573878|NCT01008423|42021766|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
19573879|NCT01008423|42021767|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
19573880|NCT01008423|42021766|FG000|Overall Study|Personal Conflict|1|||
19573881|NCT01008423|42021767|FG001|Overall Study|Personal Conflict|0|||
19573882|NCT01008423|42021766|FG000|Overall Study|Other|0|||
19573883|NCT01008423|42021767|FG001|Overall Study|Other|1|||
19573884|NCT01012947|42021778|FG000|Overall Study|Lost to Follow-up|131|||
19573885|NCT01012947|42021779|FG001|Overall Study|Lost to Follow-up|135|||
19573886|NCT01012947|42021780|FG002|Overall Study|Lost to Follow-up|130|||
19573887|NCT01012947|42021781|FG003|Overall Study|Lost to Follow-up|118|||
19573888|NCT01012947|42021782|FG004|Overall Study|Lost to Follow-up|142|||
19573889|NCT01214603|42021814|FG000|Overall Study|Adverse Event|0|||
19573890|NCT01214603|42021815|FG001|Overall Study|Adverse Event|0|||
19573891|NCT01214603|42021816|FG002|Overall Study|Adverse Event|1|||
19573892|NCT01214603|42021814|FG000|Overall Study|Death|1|||
19573893|NCT01214603|42021815|FG001|Overall Study|Death|0|||
19573894|NCT01214603|42021816|FG002|Overall Study|Death|0|||
19573895|NCT01214603|42021814|FG000|Overall Study|Progressive Disease|4|||
19573896|NCT01214603|42021815|FG001|Overall Study|Progressive Disease|1|||
19573897|NCT01214603|42021816|FG002|Overall Study|Progressive Disease|3|||
19573898|NCT01212185|42021827|FG000|Overall Study|Protocol Violation|2|||
19573899|NCT01212185|42021828|FG001|Overall Study|Protocol Violation|1|||
19573900|NCT01995175|42021834|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
19573901|NCT01995175|42021834|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
19573902|NCT01995175|42021834|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
19573903|NCT01995175|42021834|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
19573904|NCT01995175|42021834|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
19573905|NCT01995175|42021834|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
19573906|NCT01995175|42021834|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
19573907|NCT01995175|42021834|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
19573908|NCT01995175|42021834|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
19573909|NCT02243605|42021914|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
19573910|NCT02243605|42021915|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
19573911|NCT02243605|42021914|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
19573912|NCT02243605|42021915|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
19573913|NCT02243605|42021914|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
19573914|NCT02243605|42021915|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
19387301|NCT02100514|41630274|FG000|Treatment Period|Lost to Follow-up|5|||
19387302|NCT02100514|41630275|FG001|Treatment Period|Lost to Follow-up|17|||
19573915|NCT02243605|42021914|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
19573916|NCT02243605|42021915|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
19573917|NCT02243605|42021914|FG000|Stage 2 - Final Analysis Population|Progression|0|||
19573918|NCT02243605|42021915|FG001|Stage 2 - Final Analysis Population|Progression|1|||
19573919|NCT01752907|42021932|FG000|Overall Study|Withdrawal by Subject|4|||
19573920|NCT01752907|42021933|FG001|Overall Study|Withdrawal by Subject|10|||
19573921|NCT01752907|42021932|FG000|Overall Study|Lost to Follow-up|2|||
19573922|NCT01752907|42021933|FG001|Overall Study|Lost to Follow-up|1|||
19573923|NCT01752907|42021932|FG000|Overall Study|Decision by Sponsor|6|||
19573924|NCT01752907|42021933|FG001|Overall Study|Decision by Sponsor|9|||
19573925|NCT03439189|42021939|FG000|Overall Study|Protocol Violation|19|||
19573926|NCT03439189|42021939|FG000|Overall Study|Lack of Efficacy|63|||
19573927|NCT01211483|42021948|FG000|Phase 1b|Death|6|||
19573928|NCT01211483|42021949|FG001|Phase 1b|Death|0|||
19573929|NCT01211483|42021950|FG002|Phase 1b|Death|0|||
19573930|NCT01211483|42021951|FG003|Phase 1b|Death|0|||
19573931|NCT01211483|42021948|FG000|Phase 1b|Withdrawal by Subject|1|||
19573932|NCT01211483|42021949|FG001|Phase 1b|Withdrawal by Subject|0|||
19573933|NCT01211483|42021950|FG002|Phase 1b|Withdrawal by Subject|0|||
19573934|NCT01211483|42021951|FG003|Phase 1b|Withdrawal by Subject|0|||
19573935|NCT01211483|42021948|FG000|Phase 2|Lost to Follow-up|0|||
19573936|NCT01211483|42021949|FG001|Phase 2|Lost to Follow-up|1|||
19573937|NCT01211483|42021950|FG002|Phase 2|Lost to Follow-up|1|||
19573938|NCT01211483|42021951|FG003|Phase 2|Lost to Follow-up|2|||
19573939|NCT01211483|42021948|FG000|Phase 2|Death|0|||
19573940|NCT01211483|42021949|FG001|Phase 2|Death|64|||
19573941|NCT01211483|42021950|FG002|Phase 2|Death|53|||
19573942|NCT01211483|42021951|FG003|Phase 2|Death|53|||
19573943|NCT01211483|42021948|FG000|Phase 2|Withdrawal by Subject|0|||
19573944|NCT01211483|42021949|FG001|Phase 2|Withdrawal by Subject|1|||
19573945|NCT01211483|42021950|FG002|Phase 2|Withdrawal by Subject|10|||
19573946|NCT01211483|42021951|FG003|Phase 2|Withdrawal by Subject|5|||
19573947|NCT01211483|42021948|FG000|Phase 2|Study terminated by Sponsor|0|||
19573948|NCT01211483|42021949|FG001|Phase 2|Study terminated by Sponsor|6|||
19573949|NCT01211483|42021950|FG002|Phase 2|Study terminated by Sponsor|8|||
19573950|NCT01211483|42021951|FG003|Phase 2|Study terminated by Sponsor|11|||
19573951|NCT01210001|42021968|FG000|Overall Study|Not treated|1|||
19573952|NCT01210001|42021969|FG001|Overall Study|Not treated|0|||
19573953|NCT01210001|42021970|FG002|Overall Study|Not treated|0|||
19573954|NCT01210001|42021968|FG000|Overall Study|Adverse Event|4|||
19573955|NCT01210001|42021969|FG001|Overall Study|Adverse Event|2|||
19573956|NCT01210001|42021970|FG002|Overall Study|Adverse Event|5|||
19573957|NCT01210001|42021968|FG000|Overall Study|Non compliant with protocol|2|||
19573958|NCT01210001|42021969|FG001|Overall Study|Non compliant with protocol|2|||
19573959|NCT01210001|42021970|FG002|Overall Study|Non compliant with protocol|3|||
19573960|NCT01210001|42021968|FG000|Overall Study|Lost to Follow-up|4|||
19573961|NCT01210001|42021969|FG001|Overall Study|Lost to Follow-up|3|||
19573962|NCT01210001|42021970|FG002|Overall Study|Lost to Follow-up|2|||
19573963|NCT01210001|42021968|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
19573964|NCT01210001|42021969|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
19573965|NCT01210001|42021970|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
19573966|NCT01210001|42021968|FG000|Overall Study|Other reason not defined above|2|||
19573967|NCT01210001|42021969|FG001|Overall Study|Other reason not defined above|2|||
19573968|NCT01210001|42021970|FG002|Overall Study|Other reason not defined above|1|||
19573969|NCT01209689|42022011|FG000|Overall Study|Insufficient Therapeutic Response|7|||
19573970|NCT01209689|42022012|FG001|Overall Study|Insufficient Therapeutic Response|2|||
19573971|NCT01209689|42022011|FG000|Overall Study|Refused Treatment|8|||
19573972|NCT01209689|42022012|FG001|Overall Study|Refused Treatment|3|||
19573973|NCT01209689|42022011|FG000|Overall Study|Adverse Event|4|||
19573974|NCT01209689|42022012|FG001|Overall Study|Adverse Event|0|||
19573975|NCT01209689|42022011|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
19573976|NCT01209689|42022012|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
19573977|NCT01209689|42022011|FG000|Overall Study|Failure to Return|3|||
19573978|NCT01209689|42022012|FG001|Overall Study|Failure to Return|0|||
19573979|NCT01209689|42022011|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
19573980|NCT01209689|42022012|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
19573981|NCT01209143|42022020|FG000|Overall Study|Adverse Event|2|||
19573982|NCT01209143|42022021|FG001|Overall Study|Adverse Event|1|||
19573983|NCT01209143|42022020|FG000|Overall Study|Death|0|||
19573984|NCT01209143|42022021|FG001|Overall Study|Death|1|||
19573985|NCT01209143|42022020|FG000|Overall Study|Physician Decision|3|||
19573986|NCT01209143|42022021|FG001|Overall Study|Physician Decision|1|||
19573987|NCT01209143|42022020|FG000|Overall Study|Lost to Follow-up|1|||
19573988|NCT01209143|42022021|FG001|Overall Study|Lost to Follow-up|0|||
19573989|NCT01209143|42022020|FG000|Overall Study|Withdrawal by Subject|2|||
19573990|NCT01209143|42022021|FG001|Overall Study|Withdrawal by Subject|1|||
19573991|NCT01209143|42022020|FG000|Overall Study|Disease progression|11|||
19573992|NCT01209143|42022021|FG001|Overall Study|Disease progression|16|||
19387303|NCT02100514|41630276|FG002|Treatment Period|Lost to Follow-up|0|||
19387304|NCT02100514|41630277|FG003|Treatment Period|Lost to Follow-up|0|||
19387305|NCT02100514|41630278|FG004|Treatment Period|Lost to Follow-up|0|||
19387306|NCT02100514|41630274|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
19387307|NCT02100514|41630275|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
19387308|NCT02100514|41630276|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
19387309|NCT02100514|41630277|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
19387310|NCT02100514|41630278|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
19387311|NCT02100514|41630274|FG000|Treatment Period|Protocol Violation|1|||
19387312|NCT02100514|41630275|FG001|Treatment Period|Protocol Violation|1|||
19387313|NCT02100514|41630276|FG002|Treatment Period|Protocol Violation|0|||
19387314|NCT02100514|41630277|FG003|Treatment Period|Protocol Violation|0|||
19387315|NCT02100514|41630278|FG004|Treatment Period|Protocol Violation|0|||
19387316|NCT02100514|41630274|FG000|Treatment Period|Withdrawal by Subject|12|||
19387317|NCT02100514|41630275|FG001|Treatment Period|Withdrawal by Subject|37|||
19387318|NCT02100514|41630276|FG002|Treatment Period|Withdrawal by Subject|0|||
19573993|NCT01023789|42022040|FG000|3 - Year Visit|Death|29|||
19573994|NCT01023789|42022040|FG000|3 - Year Visit|Withdrawal of consent|1|||
19573995|NCT01023789|42022040|FG000|3 - Year Visit|Lost to Follow-up|13|||
19573996|NCT01208207|42022047|FG000|Part I|Adverse Event|19|||
19573997|NCT01208207|42022048|FG001|Part I|Adverse Event|2|||
19573998|NCT01208207|42022049|FG002|Part I|Adverse Event|6|||
19573999|NCT01208207|42022050|FG003|Part I|Adverse Event|0|||
19574000|NCT01208207|42022051|FG004|Part I|Adverse Event|0|||
19574001|NCT01208207|42022052|FG005|Part I|Adverse Event|0|||
19574002|NCT01208207|42022053|FG006|Part I|Adverse Event|0|||
19574003|NCT01208207|42022047|FG000|Part I|Lack of Efficacy|21|||
19574004|NCT01208207|42022048|FG001|Part I|Lack of Efficacy|3|||
19574005|NCT01208207|42022049|FG002|Part I|Lack of Efficacy|2|||
19574006|NCT01208207|42022050|FG003|Part I|Lack of Efficacy|0|||
19387319|NCT02100514|41630277|FG003|Treatment Period|Withdrawal by Subject|0|||
19387320|NCT02100514|41630278|FG004|Treatment Period|Withdrawal by Subject|0|||
19476940|NCT01569295|41755234|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19476941|NCT01569295|41755233|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
19476942|NCT01569295|41755234|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
19476943|NCT01569295|41755233|FG000|Overall Study|Lost to Follow-up|1|||
19476944|NCT01569295|41755234|FG001|Overall Study|Lost to Follow-up|1|||
19476945|NCT01549951|41755291|FG000|Overall Study|Adverse Event|15|||
19476946|NCT01549951|41755291|FG000|Overall Study|Withdrawal by Subject|2|||
19476947|NCT01549951|41755291|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
19476948|NCT01549951|41755291|FG000|Overall Study|Progressive disease|29|||
19476949|NCT01549951|41755291|FG000|Overall Study|Symptomatic deterioration|1|||
19476950|NCT01549951|41755291|FG000|Overall Study|Other|2|||
19574007|NCT01208207|42022051|FG004|Part I|Lack of Efficacy|0|||
19574008|NCT01208207|42022052|FG005|Part I|Lack of Efficacy|0|||
19574009|NCT01208207|42022053|FG006|Part I|Lack of Efficacy|0|||
19574010|NCT01208207|42022047|FG000|Part I|Lost to Follow-up|6|||
19574011|NCT01208207|42022048|FG001|Part I|Lost to Follow-up|1|||
19574012|NCT01208207|42022049|FG002|Part I|Lost to Follow-up|0|||
19574013|NCT01208207|42022050|FG003|Part I|Lost to Follow-up|0|||
19574014|NCT01208207|42022051|FG004|Part I|Lost to Follow-up|0|||
19574015|NCT01208207|42022052|FG005|Part I|Lost to Follow-up|0|||
19574016|NCT01208207|42022053|FG006|Part I|Lost to Follow-up|0|||
19574017|NCT01208207|42022047|FG000|Part I|Non-Compliance With Study Drug|1|||
19574018|NCT01208207|42022048|FG001|Part I|Non-Compliance With Study Drug|0|||
19574019|NCT01208207|42022049|FG002|Part I|Non-Compliance With Study Drug|1|||
19574020|NCT01208207|42022050|FG003|Part I|Non-Compliance With Study Drug|0|||
19574021|NCT01208207|42022051|FG004|Part I|Non-Compliance With Study Drug|0|||
19574022|NCT01208207|42022052|FG005|Part I|Non-Compliance With Study Drug|0|||
19574023|NCT01208207|42022053|FG006|Part I|Non-Compliance With Study Drug|0|||
19387321|NCT02100514|41630274|FG000|Treatment Period|Other|9|||
19574024|NCT01208207|42022047|FG000|Part I|Physician Decision|0|||
19574025|NCT01208207|42022048|FG001|Part I|Physician Decision|1|||
19574026|NCT01208207|42022049|FG002|Part I|Physician Decision|0|||
19574027|NCT01208207|42022050|FG003|Part I|Physician Decision|0|||
19574028|NCT01208207|42022051|FG004|Part I|Physician Decision|0|||
19574029|NCT01208207|42022052|FG005|Part I|Physician Decision|0|||
19574030|NCT01208207|42022053|FG006|Part I|Physician Decision|0|||
19574031|NCT01208207|42022047|FG000|Part I|Progressive Disease|1|||
19574032|NCT01208207|42022048|FG001|Part I|Progressive Disease|0|||
19574033|NCT01208207|42022049|FG002|Part I|Progressive Disease|0|||
19574034|NCT01208207|42022050|FG003|Part I|Progressive Disease|0|||
19574035|NCT01208207|42022051|FG004|Part I|Progressive Disease|0|||
19574036|NCT01208207|42022052|FG005|Part I|Progressive Disease|0|||
19574037|NCT01208207|42022053|FG006|Part I|Progressive Disease|0|||
19574038|NCT01208207|42022047|FG000|Part I|Protocol Violation|8|||
19574039|NCT01208207|42022048|FG001|Part I|Protocol Violation|0|||
19387322|NCT02100514|41630275|FG001|Treatment Period|Other|11|||
19387323|NCT02100514|41630276|FG002|Treatment Period|Other|0|||
19387324|NCT02100514|41630277|FG003|Treatment Period|Other|0|||
19387325|NCT02100514|41630278|FG004|Treatment Period|Other|0|||
19387326|NCT02100514|41630274|FG000|Extension Period|Withdrew consent|0|||
19387327|NCT02100514|41630275|FG001|Extension Period|Withdrew consent|0|||
19387328|NCT02100514|41630276|FG002|Extension Period|Withdrew consent|2|||
19387329|NCT02100514|41630277|FG003|Extension Period|Withdrew consent|0|||
19387330|NCT02100514|41630278|FG004|Extension Period|Withdrew consent|0|||
19387331|NCT02069392|41630294|FG000|Overall Study|Withdrawal by Subject|4|||
19387332|NCT02069392|41630295|FG001|Overall Study|Withdrawal by Subject|2|||
19574040|NCT01208207|42022049|FG002|Part I|Protocol Violation|2|||
19574041|NCT01208207|42022050|FG003|Part I|Protocol Violation|0|||
19574042|NCT01208207|42022051|FG004|Part I|Protocol Violation|0|||
19574043|NCT01208207|42022052|FG005|Part I|Protocol Violation|0|||
19574044|NCT01208207|42022053|FG006|Part I|Protocol Violation|0|||
19574045|NCT01208207|42022047|FG000|Part I|Withdrawal by Subject|14|||
19574046|NCT01208207|42022048|FG001|Part I|Withdrawal by Subject|4|||
19574047|NCT01208207|42022049|FG002|Part I|Withdrawal by Subject|4|||
19387337|NCT02047318|41630334|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
19387338|NCT02047318|41630334|FG000|Core Study Period|Adverse Event|1|||
19574048|NCT01208207|42022050|FG003|Part I|Withdrawal by Subject|0|||
19574049|NCT01208207|42022051|FG004|Part I|Withdrawal by Subject|0|||
19574050|NCT01208207|42022052|FG005|Part I|Withdrawal by Subject|0|||
19574051|NCT01208207|42022053|FG006|Part I|Withdrawal by Subject|0|||
19574052|NCT01208207|42022047|FG000|Part II|Withdrawal by Subject|0|||
19574053|NCT01208207|42022048|FG001|Part II|Withdrawal by Subject|0|||
19574054|NCT01208207|42022049|FG002|Part II|Withdrawal by Subject|0|||
19574055|NCT01208207|42022050|FG003|Part II|Withdrawal by Subject|10|||
19574056|NCT01208207|42022051|FG004|Part II|Withdrawal by Subject|9|||
19574057|NCT01208207|42022052|FG005|Part II|Withdrawal by Subject|3|||
19574058|NCT01208207|42022053|FG006|Part II|Withdrawal by Subject|5|||
19574059|NCT01208207|42022047|FG000|Part II|Adverse Event|0|||
19574060|NCT01208207|42022048|FG001|Part II|Adverse Event|0|||
19574061|NCT01208207|42022049|FG002|Part II|Adverse Event|0|||
19574062|NCT01208207|42022050|FG003|Part II|Adverse Event|5|||
19574063|NCT01208207|42022051|FG004|Part II|Adverse Event|9|||
19574064|NCT01208207|42022052|FG005|Part II|Adverse Event|4|||
19574065|NCT01208207|42022053|FG006|Part II|Adverse Event|2|||
19574066|NCT01208207|42022047|FG000|Part II|Lack of Efficacy|0|||
19574067|NCT01208207|42022048|FG001|Part II|Lack of Efficacy|0|||
19574068|NCT01208207|42022049|FG002|Part II|Lack of Efficacy|0|||
19574069|NCT01208207|42022050|FG003|Part II|Lack of Efficacy|6|||
19574070|NCT01208207|42022051|FG004|Part II|Lack of Efficacy|4|||
19574071|NCT01208207|42022052|FG005|Part II|Lack of Efficacy|3|||
19574072|NCT01208207|42022053|FG006|Part II|Lack of Efficacy|3|||
19574073|NCT01208207|42022047|FG000|Part II|Lost to Follow-up|0|||
19574074|NCT01208207|42022048|FG001|Part II|Lost to Follow-up|0|||
19574075|NCT01208207|42022049|FG002|Part II|Lost to Follow-up|0|||
19574076|NCT01208207|42022050|FG003|Part II|Lost to Follow-up|4|||
19574077|NCT01208207|42022051|FG004|Part II|Lost to Follow-up|0|||
19574078|NCT01208207|42022052|FG005|Part II|Lost to Follow-up|2|||
19387339|NCT02047318|41630334|FG000|Core Study Period|Withdrawal by caregiver|3|||
19387340|NCT02047318|41630334|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
19387341|NCT02100124|41630352|FG000|Overall Study|Lost to Follow-up|5|||
19387342|NCT02100124|41630353|FG001|Overall Study|Lost to Follow-up|11|||
19387343|NCT02100124|41630354|FG002|Overall Study|Lost to Follow-up|3|||
19387344|NCT02100124|41630352|FG000|Overall Study|Withdrawal by Subject|1|||
19387345|NCT02100124|41630353|FG001|Overall Study|Withdrawal by Subject|0|||
19574079|NCT01208207|42022053|FG006|Part II|Lost to Follow-up|1|||
19574080|NCT01208207|42022047|FG000|Part II|Non-Compliance With Study Drug|0|||
19574081|NCT01208207|42022048|FG001|Part II|Non-Compliance With Study Drug|0|||
19574082|NCT01208207|42022049|FG002|Part II|Non-Compliance With Study Drug|0|||
19574083|NCT01208207|42022050|FG003|Part II|Non-Compliance With Study Drug|4|||
19574084|NCT01208207|42022051|FG004|Part II|Non-Compliance With Study Drug|1|||
19574085|NCT01208207|42022052|FG005|Part II|Non-Compliance With Study Drug|1|||
19574086|NCT01208207|42022053|FG006|Part II|Non-Compliance With Study Drug|0|||
19574087|NCT01208207|42022047|FG000|Part II|Physician Decision|0|||
19574088|NCT01208207|42022048|FG001|Part II|Physician Decision|0|||
19574089|NCT01208207|42022049|FG002|Part II|Physician Decision|0|||
19574090|NCT01208207|42022050|FG003|Part II|Physician Decision|1|||
19574091|NCT01208207|42022051|FG004|Part II|Physician Decision|0|||
19574092|NCT01208207|42022052|FG005|Part II|Physician Decision|2|||
19574093|NCT01208207|42022053|FG006|Part II|Physician Decision|0|||
19574094|NCT01208207|42022047|FG000|Part II|Protocol Violation|0|||
19574095|NCT01208207|42022048|FG001|Part II|Protocol Violation|0|||
19574096|NCT01208207|42022049|FG002|Part II|Protocol Violation|0|||
19574097|NCT01208207|42022050|FG003|Part II|Protocol Violation|1|||
19574098|NCT01208207|42022051|FG004|Part II|Protocol Violation|0|||
19574099|NCT01208207|42022052|FG005|Part II|Protocol Violation|0|||
19574100|NCT01208207|42022053|FG006|Part II|Protocol Violation|0|||
19574101|NCT01208207|42022047|FG000|Part II|Technical Problems|0|||
19574102|NCT01208207|42022048|FG001|Part II|Technical Problems|0|||
19574103|NCT01208207|42022049|FG002|Part II|Technical Problems|0|||
19574104|NCT01208207|42022050|FG003|Part II|Technical Problems|1|||
19574105|NCT01208207|42022051|FG004|Part II|Technical Problems|0|||
19574106|NCT01208207|42022052|FG005|Part II|Technical Problems|1|||
19574107|NCT01208207|42022053|FG006|Part II|Technical Problems|0|||
19574108|NCT01012713|42022084|FG000|Overall Study|Lack of Efficacy|3|||
19387346|NCT02100124|41630354|FG002|Overall Study|Withdrawal by Subject|0|||
19387347|NCT02068768|41630362|FG000|Overall Study|Lost to Follow-up|5|||
19574109|NCT01007253|42022089|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
19574110|NCT01007253|42022090|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
19574111|NCT01007253|42022091|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
19574112|NCT01007253|42022092|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
19574113|NCT01006707|42022102|FG000|Study Session 1|Lost to Follow-up|2|||
19574114|NCT01006707|42022103|FG001|Study Session 1|Lost to Follow-up|0|||
19574115|NCT01006707|42022104|FG002|Study Session 1|Lost to Follow-up|0|||
19574116|NCT01006707|42022102|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
19574117|NCT01006707|42022103|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
19574118|NCT01006707|42022104|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
19574119|NCT01006629|42022112|FG000|Overall Study|Adverse Event|1|||
19574120|NCT01006629|42022112|FG000|Overall Study|Parent refused to continue participation|1|||
19574121|NCT01006629|42022112|FG000|Overall Study|Parent unable to perform site visit|4|||
19574122|NCT01012323|42022116|FG000|Overall Study|Investigator Judgment|1|||
19574123|NCT01011933|42022120|FG000|Overall Study|Wrong cell type|1|||
19574124|NCT01011933|42022120|FG000|Overall Study|Improper pre-protocol Rx|1|||
19574125|NCT01011933|42022120|FG000|Overall Study|Inadequate pathology|1|||
19574126|NCT01011933|42022120|FG000|Overall Study|Never treated|1|||
19574127|NCT01011465|42022142|FG000|Overall Study|Withdrawal by Subject|2|||
19574128|NCT01011465|42022143|FG001|Overall Study|Withdrawal by Subject|1|||
19574129|NCT01011465|42022144|FG002|Overall Study|Withdrawal by Subject|0|||
19574130|NCT01011465|42022145|FG003|Overall Study|Withdrawal by Subject|0|||
19574131|NCT01011465|42022146|FG004|Overall Study|Withdrawal by Subject|1|||
19574132|NCT01011465|42022147|FG005|Overall Study|Withdrawal by Subject|0|||
19574133|NCT01011465|42022148|FG006|Overall Study|Withdrawal by Subject|1|||
19574134|NCT01011465|42022149|FG007|Overall Study|Withdrawal by Subject|0|||
19574135|NCT01011387|42022174|FG000|Overall Study|Withdrawal by Subject|3|||
19574136|NCT01011387|42022174|FG000|Overall Study|Adverse Event|2|||
19574137|NCT01011387|42022174|FG000|Overall Study|Protocol Violation|1|||
19574138|NCT01011309|42022181|FG000|Overall Study|Adverse Event|2|||
19574139|NCT01011309|42022182|FG001|Overall Study|Adverse Event|1|||
19574140|NCT01011309|42022183|FG002|Overall Study|Adverse Event|2|||
19574141|NCT01011309|42022181|FG000|Overall Study|Lack of Efficacy|0|||
19574142|NCT01011309|42022182|FG001|Overall Study|Lack of Efficacy|1|||
19574143|NCT01011309|42022183|FG002|Overall Study|Lack of Efficacy|0|||
19574144|NCT01011309|42022181|FG000|Overall Study|Protocol Violation|0|||
19574145|NCT01011309|42022182|FG001|Overall Study|Protocol Violation|1|||
19574146|NCT01011309|42022183|FG002|Overall Study|Protocol Violation|3|||
19574147|NCT01011153|42022194|FG000|Overall Study|Less than 78 cases completed|8|||
19574148|NCT01011153|42022195|FG001|Overall Study|Less than 78 cases completed|11|||
19574149|NCT01011153|42022196|FG002|Overall Study|Less than 78 cases completed|9|||
19574150|NCT00997893|42022228|FG000|Overall Study|Adverse Event|1|||
19574151|NCT00997893|42022229|FG001|Overall Study|Adverse Event|0|||
19574152|NCT00997893|42022230|FG002|Overall Study|Adverse Event|0|||
19574153|NCT00997893|42022228|FG000|Overall Study|Unable to meet study timelines|1|||
19574154|NCT00997893|42022229|FG001|Overall Study|Unable to meet study timelines|0|||
19574155|NCT00997893|42022230|FG002|Overall Study|Unable to meet study timelines|0|||
19574156|NCT00997893|42022228|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
19574157|NCT00997893|42022229|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
19574158|NCT00997893|42022230|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
19574159|NCT02905825|42022247|FG000|Overall Study|Protocol Violation|11|||
19574160|NCT02905825|42022247|FG000|Overall Study|Device Malfunction|1|||
19574161|NCT01208051|42022256|FG000|Total Enrollment|Withdrawal by Subject|0|||
19574162|NCT01208051|42022257|FG001|Total Enrollment|Withdrawal by Subject|1|||
19574163|NCT01208051|42022258|FG002|Total Enrollment|Withdrawal by Subject|0|||
19574164|NCT01208051|42022259|FG003|Total Enrollment|Withdrawal by Subject|0|||
19574165|NCT01208051|42022260|FG004|Total Enrollment|Withdrawal by Subject|2|||
19574166|NCT01208051|42022256|FG000|Total Enrollment|Brain metastases|0|||
19574167|NCT01208051|42022257|FG001|Total Enrollment|Brain metastases|0|||
19574168|NCT01208051|42022258|FG002|Total Enrollment|Brain metastases|1|||
19574169|NCT01208051|42022259|FG003|Total Enrollment|Brain metastases|0|||
19574170|NCT01208051|42022260|FG004|Total Enrollment|Brain metastases|0|||
19574171|NCT02860039|42022278|FG000|Overall Study|Death|4|||
19574172|NCT02860039|42022279|FG001|Overall Study|Death|0|||
19574173|NCT02860039|42022278|FG000|Overall Study|Lost to Follow-up|2|||
19574174|NCT02860039|42022279|FG001|Overall Study|Lost to Follow-up|2|||
19574175|NCT02860039|42022278|FG000|Overall Study|Protocol Violation|3|||
19574176|NCT02860039|42022279|FG001|Overall Study|Protocol Violation|1|||
19574177|NCT02860039|42022278|FG000|Overall Study|Withdrawal by Subject|1|||
19574178|NCT02860039|42022279|FG001|Overall Study|Withdrawal by Subject|0|||
19574179|NCT02860039|42022278|FG000|Overall Study|Not otherwise eligible|1|||
19574180|NCT02860039|42022279|FG001|Overall Study|Not otherwise eligible|1|||
19574181|NCT01207583|42022288|FG000|Overall Study|Withdrawal by Subject|0|||
19574182|NCT01207583|42022289|FG001|Overall Study|Withdrawal by Subject|3|||
19574183|NCT01207583|42022290|FG002|Overall Study|Withdrawal by Subject|1|||
19574184|NCT01207583|42022288|FG000|Overall Study|Participant failed to return|1|||
19574185|NCT01207583|42022289|FG001|Overall Study|Participant failed to return|0|||
19574186|NCT01207583|42022290|FG002|Overall Study|Participant failed to return|0|||
19574187|NCT01207583|42022288|FG000|Overall Study|Lost to Follow-up|0|||
19574188|NCT01207583|42022289|FG001|Overall Study|Lost to Follow-up|2|||
19574189|NCT01207583|42022290|FG002|Overall Study|Lost to Follow-up|0|||
19574190|NCT01207427|42022314|FG000|Double-blind Treatment Period|Adverse Event|0|||
19574191|NCT01207427|42022315|FG001|Double-blind Treatment Period|Adverse Event|1|||
19574192|NCT01207427|42022316|FG002|Double-blind Treatment Period|Adverse Event|0|||
19574193|NCT01207427|42022314|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19574194|NCT01207427|42022315|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
19574195|NCT01207427|42022316|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
19574196|NCT01207427|42022314|FG000|Double-blind Treatment Period|Protocol Violation|2|||
19574197|NCT01207427|42022315|FG001|Double-blind Treatment Period|Protocol Violation|1|||
19574198|NCT01207427|42022316|FG002|Double-blind Treatment Period|Protocol Violation|1|||
19574199|NCT01207427|42022314|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
19574200|NCT01207427|42022315|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
19574201|NCT01207427|42022316|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19574202|NCT04713553|42022329|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
19574203|NCT04713553|42022330|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
19574204|NCT04713553|42022331|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
19574205|NCT04713553|42022332|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
19574206|NCT04713553|42022333|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
19574207|NCT04713553|42022334|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
19574208|NCT04713553|42022335|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
19574209|NCT04713553|42022329|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574210|NCT04713553|42022330|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574211|NCT04713553|42022331|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574212|NCT04713553|42022332|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
19574213|NCT04713553|42022333|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574214|NCT04713553|42022334|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574215|NCT04713553|42022335|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
19574216|NCT04713553|42022329|FG000|Primary Study (2 Months)|Other|1|||
19574217|NCT04713553|42022330|FG001|Primary Study (2 Months)|Other|2|||
19574218|NCT04713553|42022331|FG002|Primary Study (2 Months)|Other|0|||
19574219|NCT04713553|42022332|FG003|Primary Study (2 Months)|Other|0|||
19574220|NCT04713553|42022333|FG004|Primary Study (2 Months)|Other|1|||
19574221|NCT04713553|42022334|FG005|Primary Study (2 Months)|Other|0|||
19574222|NCT04713553|42022335|FG006|Primary Study (2 Months)|Other|0|||
19574223|NCT04713553|42022329|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
19574224|NCT04713553|42022330|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
19574225|NCT04713553|42022331|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
19574226|NCT04713553|42022332|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
19574227|NCT04713553|42022333|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
19574228|NCT04713553|42022334|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
19574229|NCT04713553|42022335|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
19574230|NCT04713553|42022329|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574231|NCT04713553|42022330|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574232|NCT04713553|42022331|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
19574233|NCT04713553|42022332|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574234|NCT04713553|42022333|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574235|NCT04713553|42022334|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574236|NCT04713553|42022335|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
19574237|NCT01206101|42022358|FG000|Overall Study|Adverse Event|1|||
19574238|NCT01206101|42022359|FG001|Overall Study|Adverse Event|0|||
19574239|NCT01206101|42022358|FG000|Overall Study|Physician Decision|0|||
19574240|NCT01206101|42022359|FG001|Overall Study|Physician Decision|1|||
19574241|NCT01206101|42022358|FG000|Overall Study|Unclassified|1|||
19574242|NCT01206101|42022359|FG001|Overall Study|Unclassified|0|||
19574243|NCT01205165|42022365|FG000|Overall Study|Lost to Follow-up|2|||
19574244|NCT00997503|42022370|FG000|Overall Study|Death|53|||
19574245|NCT00997503|42022370|FG000|Overall Study|Withdrawal by Subject|76|||
19387348|NCT02068768|41630362|FG000|Overall Study|Early Termination by Sponsor|2|||
19387349|NCT02046616|41630366|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
19574246|NCT00997503|42022370|FG000|Overall Study|Lost to Follow-up|33|||
19574247|NCT00997503|42022370|FG000|Overall Study|Adverse Event|3|||
19574248|NCT00997503|42022370|FG000|Overall Study|Physician Decision|10|||
19574249|NCT00997503|42022370|FG000|Overall Study|Missed 12-month follow-up|85|||
19574250|NCT00997503|42022370|FG000|Overall Study|Other reason|13|||
19574251|NCT01204775|42022379|FG000|Overall Study|Poor/non-compliance|0|||
19387350|NCT02046616|41630366|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
19574252|NCT01204775|42022380|FG001|Overall Study|Poor/non-compliance|1|||
19574253|NCT01204775|42022379|FG000|Overall Study|Withdrawal by Subject|1|||
19574254|NCT01204775|42022380|FG001|Overall Study|Withdrawal by Subject|0|||
19574255|NCT00997035|42022388|FG000|3-week Followup Visit|Lost to Follow-up|9|||
19574256|NCT00997035|42022389|FG001|3-week Followup Visit|Lost to Follow-up|6|||
19574257|NCT00997035|42022388|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
19574258|NCT00997035|42022389|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
19574259|NCT01204697|42022407|FG000|Overall Study|Death|26|||
19574260|NCT01204697|42022408|FG001|Overall Study|Death|27|||
19574261|NCT01204697|42022407|FG000|Overall Study|Lost to Follow-up|3|||
19574262|NCT01204697|42022408|FG001|Overall Study|Lost to Follow-up|4|||
19574263|NCT01204697|42022407|FG000|Overall Study|Withdrawal by Subject|2|||
19574264|NCT01204697|42022408|FG001|Overall Study|Withdrawal by Subject|4|||
19574265|NCT01204697|42022407|FG000|Overall Study|Randomized, but not treated|0|||
19574266|NCT01204697|42022408|FG001|Overall Study|Randomized, but not treated|1|||
19574267|NCT01001325|42022416|FG000|Overall Study|Lost to Follow-up|16|||
19574268|NCT01001325|42022417|FG001|Overall Study|Lost to Follow-up|10|||
19574269|NCT01001325|42022416|FG000|Overall Study|Protocol Violation|2|||
19574270|NCT01001325|42022417|FG001|Overall Study|Protocol Violation|0|||
19574271|NCT01203917|42022423|FG000|Overall Study|Death|29|||
19574272|NCT01203917|42022423|FG000|Overall Study|Lost to Follow-up|2|||
19574273|NCT01203917|42022423|FG000|Overall Study|Withdrawal by Subject|3|||
19574274|NCT01203917|42022423|FG000|Overall Study|Due to objective disease progression|1|||
19387351|NCT02046616|41630366|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
19387352|NCT02046616|41630366|FG000|24-Week Treatment Period|Physician Decision|3|||
19387353|NCT02046616|41630366|FG000|24-Week Treatment Period|Other|1|||
19387354|NCT02046616|41630366|FG000|8-Week FU Period|Lost to Follow-up|1|||
19387355|NCT02099344|41630372|FG000|Overall Study|Physician Decision|1|||
19387356|NCT02099344|41630373|FG001|Overall Study|Physician Decision|0|||
19387357|NCT02068222|41630381|FG000|Overall Study|Lost to Follow-up|1|||
19387358|NCT02099110|41630390|FG000|Overall Study|Protocol Violation|2|||
19387359|NCT02099110|41630391|FG001|Overall Study|Protocol Violation|1|||
19387360|NCT02099110|41630392|FG002|Overall Study|Protocol Violation|0|||
19387361|NCT02099110|41630393|FG003|Overall Study|Protocol Violation|3|||
19387362|NCT02099110|41630394|FG004|Overall Study|Protocol Violation|1|||
19574275|NCT01203917|42022423|FG000|Overall Study|Due to EGFR M+I patient|1|||
19574276|NCT01202903|42022429|FG000|Overall Study|Administrative Probelms|1|||
19574277|NCT01202903|42022430|FG001|Overall Study|Administrative Probelms|4|||
19574278|NCT01202903|42022429|FG000|Overall Study|Protocol Violation|0|||
19574279|NCT01202903|42022430|FG001|Overall Study|Protocol Violation|1|||
19574280|NCT01202903|42022429|FG000|Overall Study|Death|1|||
19574281|NCT01202903|42022430|FG001|Overall Study|Death|0|||
19574282|NCT01202903|42022429|FG000|Overall Study|Lost to Follow-up|1|||
19574283|NCT01202903|42022430|FG001|Overall Study|Lost to Follow-up|1|||
19574284|NCT01202903|42022429|FG000|Overall Study|Lack of Efficacy|1|||
19574285|NCT01202903|42022430|FG001|Overall Study|Lack of Efficacy|3|||
19574286|NCT01202903|42022429|FG000|Overall Study|Adverse Event|3|||
19574287|NCT01202903|42022430|FG001|Overall Study|Adverse Event|3|||
19574288|NCT01202903|42022429|FG000|Overall Study|Withdrawal by Subject|4|||
19574289|NCT01202903|42022430|FG001|Overall Study|Withdrawal by Subject|4|||
19387363|NCT02099110|41630390|FG000|Overall Study|Participant moved|1|||
19387364|NCT02099110|41630391|FG001|Overall Study|Participant moved|1|||
19387365|NCT02099110|41630392|FG002|Overall Study|Participant moved|1|||
19574290|NCT01001169|42022438|FG000|Overall Study|Withdrawal by Subject|2|||
19574291|NCT01001169|42022439|FG001|Overall Study|Withdrawal by Subject|1|||
19574292|NCT01202747|42022453|FG000|Overall Study|Withdrawal by Subject|1|||
19574293|NCT00996801|42022463|FG000|Overall Study|Adverse Event|6|||
19574294|NCT00996801|42022464|FG001|Overall Study|Adverse Event|4|||
19574295|NCT00996801|42022465|FG002|Overall Study|Adverse Event|12|||
19574296|NCT00996801|42022466|FG003|Overall Study|Adverse Event|17|||
19574297|NCT00996801|42022467|FG004|Overall Study|Adverse Event|31|||
19574298|NCT00996801|42022468|FG005|Overall Study|Adverse Event|3|||
19574299|NCT00996801|42022463|FG000|Overall Study|Lack of Efficacy|3|||
19574300|NCT00996801|42022464|FG001|Overall Study|Lack of Efficacy|0|||
19574301|NCT00996801|42022465|FG002|Overall Study|Lack of Efficacy|1|||
19574302|NCT00996801|42022466|FG003|Overall Study|Lack of Efficacy|3|||
19574303|NCT00996801|42022467|FG004|Overall Study|Lack of Efficacy|0|||
19574304|NCT00996801|42022468|FG005|Overall Study|Lack of Efficacy|1|||
19387366|NCT02099110|41630393|FG003|Overall Study|Participant moved|0|||
19387367|NCT02099110|41630394|FG004|Overall Study|Participant moved|2|||
19387368|NCT02099110|41630390|FG000|Overall Study|Withdrawal by Subject|7|||
19387369|NCT02099110|41630391|FG001|Overall Study|Withdrawal by Subject|11|||
19387370|NCT02099110|41630392|FG002|Overall Study|Withdrawal by Subject|13|||
19387371|NCT02099110|41630393|FG003|Overall Study|Withdrawal by Subject|9|||
19387372|NCT02099110|41630394|FG004|Overall Study|Withdrawal by Subject|13|||
19387373|NCT02099110|41630390|FG000|Overall Study|Adverse Event|3|||
19387374|NCT02099110|41630391|FG001|Overall Study|Adverse Event|5|||
19387375|NCT02099110|41630392|FG002|Overall Study|Adverse Event|2|||
19387376|NCT02099110|41630393|FG003|Overall Study|Adverse Event|3|||
19387377|NCT02099110|41630394|FG004|Overall Study|Adverse Event|2|||
19387378|NCT02099110|41630390|FG000|Overall Study|Lost to Follow-up|6|||
19387379|NCT02099110|41630391|FG001|Overall Study|Lost to Follow-up|12|||
19387380|NCT02099110|41630392|FG002|Overall Study|Lost to Follow-up|11|||
19387381|NCT02099110|41630393|FG003|Overall Study|Lost to Follow-up|5|||
19387382|NCT02099110|41630394|FG004|Overall Study|Lost to Follow-up|6|||
19387383|NCT02099110|41630390|FG000|Overall Study|Death|0|||
19387384|NCT02099110|41630391|FG001|Overall Study|Death|1|||
19387385|NCT02099110|41630392|FG002|Overall Study|Death|0|||
19387386|NCT02099110|41630393|FG003|Overall Study|Death|0|||
19387387|NCT02099110|41630394|FG004|Overall Study|Death|0|||
19387388|NCT02099110|41630390|FG000|Overall Study|Screen failure|0|||
19387389|NCT02099110|41630391|FG001|Overall Study|Screen failure|0|||
19387390|NCT02099110|41630392|FG002|Overall Study|Screen failure|0|||
19387391|NCT02099110|41630393|FG003|Overall Study|Screen failure|0|||
19387392|NCT02099110|41630394|FG004|Overall Study|Screen failure|1|||
19387393|NCT02099110|41630390|FG000|Overall Study|Non-compliance with study drug|2|||
19387394|NCT02099110|41630391|FG001|Overall Study|Non-compliance with study drug|0|||
19387395|NCT02099110|41630392|FG002|Overall Study|Non-compliance with study drug|0|||
19387396|NCT02099110|41630393|FG003|Overall Study|Non-compliance with study drug|0|||
19387397|NCT02099110|41630394|FG004|Overall Study|Non-compliance with study drug|1|||
19387398|NCT02099110|41630390|FG000|Overall Study|Physician Decision|3|||
19387399|NCT02099110|41630391|FG001|Overall Study|Physician Decision|0|||
19387400|NCT02099110|41630392|FG002|Overall Study|Physician Decision|1|||
19387401|NCT02099110|41630393|FG003|Overall Study|Physician Decision|2|||
19387402|NCT02099110|41630394|FG004|Overall Study|Physician Decision|1|||
19387403|NCT02098876|41630408|FG000|Overall Study|Withdrawal by Subject|5|||
19387404|NCT02098876|41630409|FG001|Overall Study|Withdrawal by Subject|5|||
19387405|NCT01624090|41630419|FG000|Overall Study|DLT, taken off therapy|0|||
19387406|NCT01624090|41630420|FG001|Overall Study|DLT, taken off therapy|1|||
19387407|NCT01624090|41630421|FG002|Overall Study|DLT, taken off therapy|0|||
19387408|NCT01624090|41630422|FG003|Overall Study|DLT, taken off therapy|0|||
19387409|NCT01624090|41630419|FG000|Overall Study|Withdrew prior to treatment|0|||
19387410|NCT01624090|41630420|FG001|Overall Study|Withdrew prior to treatment|1|||
19387411|NCT01624090|41630421|FG002|Overall Study|Withdrew prior to treatment|0|||
19387412|NCT01624090|41630422|FG003|Overall Study|Withdrew prior to treatment|0|||
19387413|NCT01624090|41630419|FG000|Overall Study|Died on study|0|||
19387414|NCT01624090|41630420|FG001|Overall Study|Died on study|0|||
19387415|NCT01624090|41630421|FG002|Overall Study|Died on study|2|||
19387416|NCT01624090|41630422|FG003|Overall Study|Died on study|0|||
19387417|NCT01624090|41630419|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
19387418|NCT01624090|41630420|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
19387419|NCT01624090|41630421|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
19387420|NCT01624090|41630422|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
19387421|NCT01624090|41630419|FG000|Overall Study|Dose escalated|0|||
19387422|NCT01624090|41630420|FG001|Overall Study|Dose escalated|0|||
19387423|NCT01624090|41630421|FG002|Overall Study|Dose escalated|3|||
19387424|NCT01624090|41630422|FG003|Overall Study|Dose escalated|0|||
19387425|NCT02571777|41630437|FG000|Overall Study|Subject/guardian decision|34|||
19387426|NCT02571777|41630438|FG001|Overall Study|Subject/guardian decision|26|||
19387427|NCT02571777|41630439|FG002|Overall Study|Subject/guardian decision|26|||
19387428|NCT02571777|41630440|FG003|Overall Study|Subject/guardian decision|25|||
19387429|NCT02571777|41630441|FG004|Overall Study|Subject/guardian decision|27|||
19476951|NCT01517893|41755297|FG000|Overall Study|Withdrawal by Subject|3|||
19387430|NCT02571777|41630437|FG000|Overall Study|Protocol Deviation|2|||
19387431|NCT02571777|41630438|FG001|Overall Study|Protocol Deviation|3|||
19387432|NCT02571777|41630439|FG002|Overall Study|Protocol Deviation|4|||
19387433|NCT02571777|41630440|FG003|Overall Study|Protocol Deviation|8|||
19387434|NCT02571777|41630441|FG004|Overall Study|Protocol Deviation|4|||
19387435|NCT02571777|41630437|FG000|Overall Study|Death|1|||
19387436|NCT02571777|41630438|FG001|Overall Study|Death|1|||
19387437|NCT02571777|41630439|FG002|Overall Study|Death|4|||
19387438|NCT02571777|41630440|FG003|Overall Study|Death|0|||
19387439|NCT02571777|41630441|FG004|Overall Study|Death|0|||
19387440|NCT02571777|41630437|FG000|Overall Study|Lost to Follow-up|1|||
19387441|NCT02571777|41630438|FG001|Overall Study|Lost to Follow-up|1|||
19387442|NCT02571777|41630439|FG002|Overall Study|Lost to Follow-up|2|||
19387443|NCT02571777|41630440|FG003|Overall Study|Lost to Follow-up|0|||
19387444|NCT02571777|41630441|FG004|Overall Study|Lost to Follow-up|1|||
19387445|NCT02571777|41630437|FG000|Overall Study|Physician Decision|1|||
19387446|NCT02571777|41630438|FG001|Overall Study|Physician Decision|7|||
19387447|NCT02571777|41630439|FG002|Overall Study|Physician Decision|5|||
19387448|NCT02571777|41630440|FG003|Overall Study|Physician Decision|2|||
19387449|NCT02571777|41630441|FG004|Overall Study|Physician Decision|4|||
19387450|NCT02571777|41630437|FG000|Overall Study|Pregnancy|0|||
19387451|NCT02571777|41630438|FG001|Overall Study|Pregnancy|0|||
19387452|NCT02571777|41630439|FG002|Overall Study|Pregnancy|0|||
19387453|NCT02571777|41630440|FG003|Overall Study|Pregnancy|2|||
19387454|NCT02571777|41630441|FG004|Overall Study|Pregnancy|0|||
19387455|NCT02571075|41630455|FG000|Overall Study|Lost to Follow-up|20|||
19387456|NCT02571075|41630456|FG001|Overall Study|Lost to Follow-up|24|||
19387457|NCT02705105|41630470|FG000|Treatment|Objective Disease Progression|1|||
19387458|NCT02705105|41630471|FG001|Treatment|Objective Disease Progression|50|||
19387459|NCT02705105|41630470|FG000|Treatment|Withdrawal by Subject|3|||
19387460|NCT02705105|41630471|FG001|Treatment|Withdrawal by Subject|5|||
19387461|NCT02705105|41630470|FG000|Treatment|Adverse Event|0|||
19387462|NCT02705105|41630471|FG001|Treatment|Adverse Event|17|||
19387463|NCT02705105|41630470|FG000|Treatment|Clinical Disease Progression|0|||
19387464|NCT02705105|41630471|FG001|Treatment|Clinical Disease Progression|32|||
19387465|NCT02705105|41630470|FG000|Treatment|Physician Decision|0|||
19387466|NCT02705105|41630471|FG001|Treatment|Physician Decision|3|||
19387467|NCT02705105|41630470|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
19387468|NCT02705105|41630471|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
19387469|NCT02705105|41630470|FG000|Follow-Up|Death|3|||
19387470|NCT02705105|41630471|FG001|Follow-Up|Death|68|||
19387471|NCT02705105|41630470|FG000|Follow-Up|Withdrawal by Subject|1|||
19387472|NCT02705105|41630471|FG001|Follow-Up|Withdrawal by Subject|14|||
19387473|NCT02705105|41630470|FG000|Follow-Up|Study Terminated|0|||
19387474|NCT02705105|41630471|FG001|Follow-Up|Study Terminated|26|||
19387475|NCT02705105|41630470|FG000|Follow-Up|Discontinued per Amendment 3|0|||
19387476|NCT02705105|41630471|FG001|Follow-Up|Discontinued per Amendment 3|2|||
19387477|NCT02097472|41630497|FG000|Received Vaccination 2|Adverse Event|0|||
19387478|NCT02097472|41630498|FG001|Received Vaccination 2|Adverse Event|0|||
19387479|NCT02097472|41630499|FG002|Received Vaccination 2|Adverse Event|0|||
19387480|NCT02097472|41630500|FG003|Received Vaccination 2|Adverse Event|0|||
19387481|NCT02097472|41630501|FG004|Received Vaccination 2|Adverse Event|0|||
19387482|NCT02097472|41630502|FG005|Received Vaccination 2|Adverse Event|0|||
19387483|NCT02097472|41630503|FG006|Received Vaccination 2|Adverse Event|1|||
19387484|NCT02097472|41630504|FG007|Received Vaccination 2|Adverse Event|0|||
19387485|NCT01623310|41630588|FG000|Overall Study|Adverse Event|21|||
19387486|NCT01623310|41630588|FG000|Overall Study|Lost to Follow-up|18|||
19387487|NCT01623310|41630588|FG000|Overall Study|Lack of Efficacy|6|||
19387488|NCT01623310|41630588|FG000|Overall Study|Protocol Violation|6|||
19387489|NCT01623310|41630588|FG000|Overall Study|Withdrawal by Subject|25|||
19387490|NCT01623310|41630588|FG000|Overall Study|Became potentially child-bearing|1|||
19387491|NCT01623310|41630588|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
19387492|NCT01623310|41630588|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
19387493|NCT02046226|41630592|FG000|Overall Study|Lost to Follow-up|7|||
19387494|NCT02046148|41630599|FG000|Overall Study|Lost to Follow-up|1|||
19387495|NCT02046148|41630600|FG001|Overall Study|Lost to Follow-up|1|||
19387496|NCT02046148|41630599|FG000|Overall Study|Withdrawal by Subject|0|||
19387497|NCT02046148|41630600|FG001|Overall Study|Withdrawal by Subject|2|||
19387498|NCT02097238|41630606|FG000|Overall Study|Death|1|||
19387499|NCT02097238|41630606|FG000|Overall Study|Physician Decision|1|||
19387500|NCT02097238|41630606|FG000|Overall Study|Progressive Disease|17|||
19387501|NCT02704091|41630613|FG000|Overall Study|Adverse Event|4|||
19387502|NCT02704091|41630614|FG001|Overall Study|Adverse Event|3|||
19387503|NCT02704091|41630613|FG000|Overall Study|Protocol Violation|5|||
19387504|NCT02704091|41630614|FG001|Overall Study|Protocol Violation|3|||
19387505|NCT02704091|41630613|FG000|Overall Study|Consent withdrawn|4|||
19387506|NCT02704091|41630614|FG001|Overall Study|Consent withdrawn|4|||
19387507|NCT02704091|41630613|FG000|Overall Study|Lost to Follow-up|13|||
19387508|NCT02704091|41630614|FG001|Overall Study|Lost to Follow-up|5|||
19387509|NCT02704091|41630613|FG000|Overall Study|Other|2|||
19387510|NCT02704091|41630614|FG001|Overall Study|Other|8|||
19574305|NCT00996801|42022463|FG000|Overall Study|Lost to Follow-up|0|||
19574306|NCT00996801|42022464|FG001|Overall Study|Lost to Follow-up|0|||
19574307|NCT00996801|42022465|FG002|Overall Study|Lost to Follow-up|0|||
19574308|NCT00996801|42022466|FG003|Overall Study|Lost to Follow-up|3|||
19574309|NCT00996801|42022467|FG004|Overall Study|Lost to Follow-up|3|||
19574310|NCT00996801|42022468|FG005|Overall Study|Lost to Follow-up|2|||
19574311|NCT00996801|42022463|FG000|Overall Study|Physician Decision|0|||
19574312|NCT00996801|42022464|FG001|Overall Study|Physician Decision|0|||
19574313|NCT00996801|42022465|FG002|Overall Study|Physician Decision|0|||
19574314|NCT00996801|42022466|FG003|Overall Study|Physician Decision|1|||
19574315|NCT00996801|42022467|FG004|Overall Study|Physician Decision|0|||
19574316|NCT00996801|42022468|FG005|Overall Study|Physician Decision|0|||
19574317|NCT00996801|42022463|FG000|Overall Study|Progressive Disease|0|||
19574318|NCT00996801|42022464|FG001|Overall Study|Progressive Disease|1|||
19574319|NCT00996801|42022465|FG002|Overall Study|Progressive Disease|0|||
19574320|NCT00996801|42022466|FG003|Overall Study|Progressive Disease|0|||
19574321|NCT00996801|42022467|FG004|Overall Study|Progressive Disease|0|||
19574322|NCT00996801|42022468|FG005|Overall Study|Progressive Disease|0|||
19574323|NCT00996801|42022463|FG000|Overall Study|Protocol Violation|3|||
19574324|NCT00996801|42022464|FG001|Overall Study|Protocol Violation|4|||
19574325|NCT00996801|42022465|FG002|Overall Study|Protocol Violation|1|||
19574326|NCT00996801|42022466|FG003|Overall Study|Protocol Violation|2|||
19574327|NCT00996801|42022467|FG004|Overall Study|Protocol Violation|3|||
19574328|NCT00996801|42022468|FG005|Overall Study|Protocol Violation|4|||
19574329|NCT00996801|42022463|FG000|Overall Study|Study Terminated by Sponsor|0|||
19574330|NCT00996801|42022464|FG001|Overall Study|Study Terminated by Sponsor|1|||
19387511|NCT02702609|41630622|FG000|Overall Study|Lost to Follow-up|8|||
19387512|NCT02702609|41630623|FG001|Overall Study|Lost to Follow-up|4|||
19387513|NCT02702609|41630622|FG000|Overall Study|Physician Decision|1|||
19387514|NCT02702609|41630623|FG001|Overall Study|Physician Decision|0|||
19387515|NCT02046070|41630632|FG000|Overall Study|Progressive Disease|18|||
19387516|NCT02046070|41630633|FG001|Overall Study|Progressive Disease|11|||
19387517|NCT02046070|41630634|FG002|Overall Study|Progressive Disease|40|||
19387518|NCT02046070|41630632|FG000|Overall Study|Adverse Event|8|||
19387519|NCT02046070|41630633|FG001|Overall Study|Adverse Event|10|||
19387520|NCT02046070|41630634|FG002|Overall Study|Adverse Event|17|||
19387521|NCT02046070|41630632|FG000|Overall Study|Withdrawal by Subject|1|||
19574331|NCT00996801|42022465|FG002|Overall Study|Study Terminated by Sponsor|0|||
19574332|NCT00996801|42022466|FG003|Overall Study|Study Terminated by Sponsor|0|||
19574333|NCT00996801|42022467|FG004|Overall Study|Study Terminated by Sponsor|46|||
19574334|NCT00996801|42022468|FG005|Overall Study|Study Terminated by Sponsor|0|||
19574335|NCT00996801|42022463|FG000|Overall Study|Withdrawal by Subject|8|||
19574336|NCT00996801|42022464|FG001|Overall Study|Withdrawal by Subject|6|||
19574337|NCT00996801|42022465|FG002|Overall Study|Withdrawal by Subject|9|||
19574338|NCT00996801|42022466|FG003|Overall Study|Withdrawal by Subject|5|||
19574339|NCT00996801|42022467|FG004|Overall Study|Withdrawal by Subject|5|||
19574340|NCT00996801|42022468|FG005|Overall Study|Withdrawal by Subject|9|||
19574341|NCT00996489|42022484|FG000|Overall Study|Device failure|45|||
19574342|NCT00996489|42022484|FG000|Overall Study|Discontinued|116|||
19387522|NCT02046070|41630633|FG001|Overall Study|Withdrawal by Subject|2|||
19387523|NCT02046070|41630634|FG002|Overall Study|Withdrawal by Subject|6|||
19387524|NCT02046070|41630632|FG000|Overall Study|Study Terminated by Sponsor|1|||
19387525|NCT02046070|41630633|FG001|Overall Study|Study Terminated by Sponsor|1|||
19387526|NCT02046070|41630634|FG002|Overall Study|Study Terminated by Sponsor|1|||
19387527|NCT02046070|41630632|FG000|Overall Study|Reason not Specified|4|||
19387528|NCT02046070|41630633|FG001|Overall Study|Reason not Specified|4|||
19387529|NCT02046070|41630634|FG002|Overall Study|Reason not Specified|6|||
19387530|NCT01663857|41630646|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
19574343|NCT01000311|42022490|FG000|Overall Study|Adverse Event|2|||
19574344|NCT01000311|42022491|FG001|Overall Study|Adverse Event|5|||
19574345|NCT01000311|42022490|FG000|Overall Study|Withdrawal by Subject|16|||
19574346|NCT01000311|42022491|FG001|Overall Study|Withdrawal by Subject|24|||
19574347|NCT01000311|42022490|FG000|Overall Study|Lost to Follow-up|15|||
19574348|NCT01000311|42022491|FG001|Overall Study|Lost to Follow-up|24|||
19574349|NCT01000311|42022490|FG000|Overall Study|Protocol Violation|1|||
19574350|NCT01000311|42022491|FG001|Overall Study|Protocol Violation|2|||
19574351|NCT01000311|42022490|FG000|Overall Study|Inappropriate enrollment|2|||
19574352|NCT01000311|42022491|FG001|Overall Study|Inappropriate enrollment|0|||
19574353|NCT01000311|42022490|FG000|Overall Study|Administrative reason|9|||
19574354|NCT01000311|42022491|FG001|Overall Study|Administrative reason|15|||
19574355|NCT01003899|42022497|FG000|Overall Study|Other Adverse Event|8|||
19574356|NCT01003899|42022497|FG000|Overall Study|Not entered|4|||
19574357|NCT01003899|42022497|FG000|Overall Study|Not treated|1|||
19574358|NCT01003899|42022497|FG000|Overall Study|Progressive disease|34|||
19574359|NCT01000155|42022501|FG000|Overall Study|Withdrawal by Subject|1|||
19574360|NCT01000155|42022501|FG000|Overall Study|Adverse Event|1|||
19574361|NCT00999921|42022507|FG000|Overall Study|Lost to Follow-up|10|||
19574362|NCT00999921|42022508|FG001|Overall Study|Lost to Follow-up|19|||
19574363|NCT01002573|42022519|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
19574364|NCT01002573|42022520|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
19574365|NCT00999687|42022526|FG000|First Intervention|Withdrawal by Subject|1|||
19574366|NCT00999687|42022526|FG000|Second Intervention|Withdrawal by Subject|2|||
19574367|NCT00999687|42022526|FG000|Second Intervention|Lack of Efficacy|1|||
19574368|NCT00996333|42022532|FG000|Overall Study|Screen failure|1|||
19574369|NCT00996333|42022532|FG000|Overall Study|Withdrawal by Subject|1|||
19574370|NCT00996333|42022532|FG000|Overall Study|Death|4|||
19574371|NCT00996333|42022532|FG000|Overall Study|Adverse Event|1|||
19574372|NCT00996333|42022532|FG000|Overall Study|Physician Decision|1|||
19574373|NCT00996333|42022532|FG000|Overall Study|Other|5|||
19574374|NCT00995865|42022539|FG000|Overall Study|Protocol Violation|2|||
19574375|NCT00995865|42022540|FG001|Overall Study|Protocol Violation|0|||
19574376|NCT00995865|42022541|FG002|Overall Study|Protocol Violation|0|||
19574377|NCT00995865|42022539|FG000|Overall Study|Lost to Follow-up|0|||
19574378|NCT00995865|42022540|FG001|Overall Study|Lost to Follow-up|0|||
19574379|NCT00995865|42022541|FG002|Overall Study|Lost to Follow-up|1|||
19574380|NCT00995709|42022557|FG000|Overall Study|Adverse Event|4|||
19574381|NCT00995709|42022558|FG001|Overall Study|Adverse Event|2|||
19574382|NCT00995709|42022559|FG002|Overall Study|Adverse Event|0|||
19574383|NCT00995709|42022557|FG000|Overall Study|Lack of Efficacy|0|||
19745787|NCT03529773|42193193|FG037|Overall Study|Adverse Event|0|||
19745788|NCT03529773|42193194|FG038|Overall Study|Adverse Event|1|||
19745789|NCT03529773|42193195|FG039|Overall Study|Adverse Event|1|||
19745790|NCT03529773|42193156|FG000|Overall Study|Death|0|||
19745791|NCT03529773|42193157|FG001|Overall Study|Death|0|||
19745792|NCT03529773|42193158|FG002|Overall Study|Death|0|||
19745793|NCT03529773|42193159|FG003|Overall Study|Death|0|||
19745794|NCT03529773|42193160|FG004|Overall Study|Death|0|||
19745795|NCT03529773|42193161|FG005|Overall Study|Death|0|||
19745796|NCT03529773|42193162|FG006|Overall Study|Death|0|||
19745797|NCT03529773|42193163|FG007|Overall Study|Death|0|||
19745798|NCT03529773|42193164|FG008|Overall Study|Death|0|||
19745799|NCT03529773|42193165|FG009|Overall Study|Death|0|||
19745800|NCT03529773|42193166|FG010|Overall Study|Death|0|||
19745801|NCT03529773|42193167|FG011|Overall Study|Death|0|||
19745802|NCT03529773|42193168|FG012|Overall Study|Death|1|||
19745803|NCT03529773|42193169|FG013|Overall Study|Death|0|||
19745804|NCT03529773|42193170|FG014|Overall Study|Death|0|||
19745805|NCT03529773|42193171|FG015|Overall Study|Death|0|||
19745806|NCT03529773|42193172|FG016|Overall Study|Death|0|||
19745807|NCT03529773|42193173|FG017|Overall Study|Death|0|||
19745808|NCT03529773|42193174|FG018|Overall Study|Death|0|||
19745809|NCT03529773|42193175|FG019|Overall Study|Death|1|||
19745810|NCT03529773|42193176|FG020|Overall Study|Death|0|||
19745811|NCT03529773|42193177|FG021|Overall Study|Death|0|||
19745812|NCT03529773|42193178|FG022|Overall Study|Death|1|||
19745813|NCT03529773|42193179|FG023|Overall Study|Death|0|||
19745814|NCT03529773|42193180|FG024|Overall Study|Death|0|||
19574384|NCT00995709|42022558|FG001|Overall Study|Lack of Efficacy|1|||
19574385|NCT00995709|42022559|FG002|Overall Study|Lack of Efficacy|4|||
19574386|NCT00995709|42022557|FG000|Overall Study|Withdrawal by Subject|0|||
19574387|NCT00995709|42022558|FG001|Overall Study|Withdrawal by Subject|4|||
19574388|NCT00995709|42022559|FG002|Overall Study|Withdrawal by Subject|1|||
19574389|NCT00995709|42022557|FG000|Overall Study|Lost to Follow-up|1|||
19574390|NCT00995709|42022558|FG001|Overall Study|Lost to Follow-up|0|||
19745815|NCT03529773|42193181|FG025|Overall Study|Death|0|||
19574391|NCT00995709|42022559|FG002|Overall Study|Lost to Follow-up|0|||
19574392|NCT00995709|42022557|FG000|Overall Study|Death|0|||
19574393|NCT00995709|42022558|FG001|Overall Study|Death|1|||
19574394|NCT00995709|42022559|FG002|Overall Study|Death|0|||
19745816|NCT03529773|42193182|FG026|Overall Study|Death|0|||
19574395|NCT00995709|42022557|FG000|Overall Study|Protocol Violation|2|||
19574396|NCT00995709|42022558|FG001|Overall Study|Protocol Violation|1|||
19574397|NCT00995709|42022559|FG002|Overall Study|Protocol Violation|0|||
19574398|NCT00998985|42022581|FG000|Overall Study|Withdrawal by Subject|0|||
19574399|NCT00998985|42022582|FG001|Overall Study|Withdrawal by Subject|0|||
19574400|NCT00998985|42022583|FG002|Overall Study|Withdrawal by Subject|0|||
19574401|NCT00998985|42022584|FG003|Overall Study|Withdrawal by Subject|0|||
19574402|NCT00998985|42022585|FG004|Overall Study|Withdrawal by Subject|0|||
19574403|NCT00998985|42022586|FG005|Overall Study|Withdrawal by Subject|0|||
19574404|NCT00998985|42022587|FG006|Overall Study|Withdrawal by Subject|0|||
19574405|NCT00998985|42022588|FG007|Overall Study|Withdrawal by Subject|0|||
19574406|NCT00998985|42022589|FG008|Overall Study|Withdrawal by Subject|1|||
19574407|NCT00998985|42022590|FG009|Overall Study|Withdrawal by Subject|0|||
19574408|NCT00998985|42022591|FG010|Overall Study|Withdrawal by Subject|0|||
19574409|NCT00998985|42022592|FG011|Overall Study|Withdrawal by Subject|0|||
19574410|NCT00998985|42022593|FG012|Overall Study|Withdrawal by Subject|0|||
19574411|NCT00998985|42022594|FG013|Overall Study|Withdrawal by Subject|0|||
19574412|NCT00998985|42022581|FG000|Overall Study|Protocol Violation|0|||
19574413|NCT00998985|42022582|FG001|Overall Study|Protocol Violation|0|||
19574414|NCT00998985|42022583|FG002|Overall Study|Protocol Violation|0|||
19574415|NCT00998985|42022584|FG003|Overall Study|Protocol Violation|0|||
19574416|NCT00998985|42022585|FG004|Overall Study|Protocol Violation|0|||
19574417|NCT00998985|42022586|FG005|Overall Study|Protocol Violation|1|||
19574418|NCT00998985|42022587|FG006|Overall Study|Protocol Violation|0|||
19574419|NCT00998985|42022588|FG007|Overall Study|Protocol Violation|0|||
19574420|NCT00998985|42022589|FG008|Overall Study|Protocol Violation|0|||
19574421|NCT00998985|42022590|FG009|Overall Study|Protocol Violation|0|||
19574422|NCT00998985|42022591|FG010|Overall Study|Protocol Violation|0|||
19574423|NCT00998985|42022592|FG011|Overall Study|Protocol Violation|0|||
19574424|NCT00998985|42022593|FG012|Overall Study|Protocol Violation|0|||
19574425|NCT00998985|42022594|FG013|Overall Study|Protocol Violation|0|||
19574426|NCT00995553|42022641|FG000|Overall Study|Withdrawal by Subject|2|||
19574427|NCT00995553|42022642|FG001|Overall Study|Withdrawal by Subject|6|||
19574428|NCT00991887|42022650|FG000|Overall Study|Lost to Follow-up|2|||
19574429|NCT00991887|42022651|FG001|Overall Study|Lost to Follow-up|1|||
19574430|NCT01002339|42022660|FG000|Overall Study|Withdrawal by Subject|0|||
19574431|NCT01002339|42022661|FG001|Overall Study|Withdrawal by Subject|1|||
19574432|NCT01002339|42022662|FG002|Overall Study|Withdrawal by Subject|0|||
19574433|NCT01002339|42022660|FG000|Overall Study|Incorrect treatment assignment|0|||
19574434|NCT01002339|42022661|FG001|Overall Study|Incorrect treatment assignment|0|||
19574435|NCT01002339|42022662|FG002|Overall Study|Incorrect treatment assignment|1|||
19574436|NCT01002339|42022660|FG000|Overall Study|Protocol Violation|0|||
19574437|NCT01002339|42022661|FG001|Overall Study|Protocol Violation|0|||
19574438|NCT01002339|42022662|FG002|Overall Study|Protocol Violation|2|||
19574439|NCT01002339|42022660|FG000|Overall Study|Lung cancer detected before transplant|0|||
19574440|NCT01002339|42022661|FG001|Overall Study|Lung cancer detected before transplant|0|||
19574441|NCT01002339|42022662|FG002|Overall Study|Lung cancer detected before transplant|1|||
19574442|NCT01002339|42022660|FG000|Overall Study|Randomized. Not transplanted|0|||
19574443|NCT01002339|42022661|FG001|Overall Study|Randomized. Not transplanted|0|||
19574444|NCT01002339|42022662|FG002|Overall Study|Randomized. Not transplanted|1|||
19574445|NCT01002105|42022672|FG000|Overall Study|Lost to Follow-up|10|||
19574446|NCT01002105|42022673|FG001|Overall Study|Lost to Follow-up|16|||
19574447|NCT01002105|42022672|FG000|Overall Study|non compliance|5|||
19574448|NCT01002105|42022673|FG001|Overall Study|non compliance|3|||
19574449|NCT01002105|42022672|FG000|Overall Study|condition worsened|4|||
19574450|NCT01002105|42022673|FG001|Overall Study|condition worsened|2|||
19574451|NCT02605993|42022686|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
19574452|NCT02605993|42022687|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
19574453|NCT02605993|42022688|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
19574454|NCT02605993|42022689|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
19574455|NCT00995085|42022699|FG000|Overall Study|Withdrawal by Subject|5|||
19574456|NCT00603733|42022705|FG000|Active Phase ITT|Adverse Event|8|||
19574457|NCT00603733|42022706|FG001|Active Phase ITT|Adverse Event|7|||
19574458|NCT00603733|42022705|FG000|Active Phase ITT|Withdrawal by Subject|0|||
19574459|NCT00603733|42022706|FG001|Active Phase ITT|Withdrawal by Subject|3|||
19574460|NCT00603733|42022705|FG000|Active Phase ITT|Lost to Follow-up|0|||
19574461|NCT00603733|42022706|FG001|Active Phase ITT|Lost to Follow-up|1|||
19574462|NCT00603733|42022705|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
19574463|NCT00603733|42022706|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
19574464|NCT00603733|42022705|FG000|Active Phase ITT|Lack of Efficacy|1|||
19574465|NCT00603733|42022706|FG001|Active Phase ITT|Lack of Efficacy|2|||
19574466|NCT00603733|42022705|FG000|Active Phase ITT|Subject moved, site closed|1|||
19574467|NCT00603733|42022706|FG001|Active Phase ITT|Subject moved, site closed|1|||
19574468|NCT00603733|42022705|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
19574469|NCT00603733|42022706|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
19574470|NCT00603733|42022705|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
19574471|NCT00603733|42022706|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
19574472|NCT00603733|42022705|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
19574473|NCT00603733|42022706|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
19574474|NCT00603733|42022705|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
19574475|NCT00603733|42022706|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
19574476|NCT00603733|42022705|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
19574477|NCT00603733|42022706|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
19574478|NCT00603733|42022705|FG000|Maintenance Phase ITT|Adverse Event|3|||
19574479|NCT00603733|42022706|FG001|Maintenance Phase ITT|Adverse Event|6|||
19574480|NCT00603733|42022705|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
19574481|NCT00603733|42022706|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
19574482|NCT00603733|42022705|FG000|Maintenance Phase ITT|Protocol Violation|1|||
19574483|NCT00603733|42022706|FG001|Maintenance Phase ITT|Protocol Violation|1|||
19574484|NCT00603733|42022705|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
19574485|NCT00603733|42022706|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
19574486|NCT00603733|42022705|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
19574487|NCT00603733|42022706|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
19574488|NCT00603733|42022705|FG000|Maintenance Phase ITT|Physician Decision|0|||
19574489|NCT00603733|42022706|FG001|Maintenance Phase ITT|Physician Decision|1|||
19574490|NCT00603733|42022705|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
19574491|NCT00603733|42022706|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
19574492|NCT04631107|42022712|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
19574493|NCT04631107|42022712|FG000|Second Intervention (1 Night)|Adverse Event|1|||
19574494|NCT04631107|42022712|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
19574495|NCT04631107|42022712|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
19574496|NCT00995007|42022722|FG000|Overall Study|Withdrew consent|1|||
19574497|NCT00995007|42022723|FG001|Overall Study|Withdrew consent|0|||
19574498|NCT00995007|42022722|FG000|Overall Study|Refused further treatment|8|||
19574499|NCT00995007|42022723|FG001|Overall Study|Refused further treatment|2|||
19574500|NCT00995007|42022722|FG000|Overall Study|Toxicity|8|||
19574501|NCT00995007|42022723|FG001|Overall Study|Toxicity|0|||
19574502|NCT00994461|42022741|FG000|Overall Study|Adverse Event|2|||
19574503|NCT00994461|42022742|FG001|Overall Study|Adverse Event|1|||
19574504|NCT00994461|42022743|FG002|Overall Study|Adverse Event|0|||
19574505|NCT00993915|42022751|FG000|Overall Study|Insufficient clinical response|3|||
19574506|NCT00993915|42022751|FG000|Overall Study|Withdrawal by Subject|2|||
19574507|NCT00993915|42022751|FG000|Overall Study|Other|1|||
19574508|NCT00993915|42022751|FG000|Overall Study|Ongoing|3|||
19574509|NCT01202591|42022761|FG000|Overall Study|Adverse Event|2|||
19574510|NCT01202591|42022762|FG001|Overall Study|Adverse Event|1|||
19574511|NCT01202591|42022763|FG002|Overall Study|Adverse Event|4|||
19574512|NCT01202591|42022764|FG003|Overall Study|Adverse Event|4|||
19574513|NCT01202591|42022765|FG004|Overall Study|Adverse Event|0|||
19574514|NCT01202591|42022766|FG005|Overall Study|Adverse Event|0|||
19574515|NCT01202591|42022761|FG000|Overall Study|Other reason as per investigator|3|||
19574516|NCT01202591|42022762|FG001|Overall Study|Other reason as per investigator|4|||
19574517|NCT01202591|42022763|FG002|Overall Study|Other reason as per investigator|7|||
19574518|NCT01202591|42022764|FG003|Overall Study|Other reason as per investigator|3|||
19574519|NCT01202591|42022765|FG004|Overall Study|Other reason as per investigator|1|||
19574520|NCT01202591|42022766|FG005|Overall Study|Other reason as per investigator|3|||
19574521|NCT01202591|42022761|FG000|Overall Study|Withdrawal by Subject|0|||
19574522|NCT01202591|42022762|FG001|Overall Study|Withdrawal by Subject|0|||
19574523|NCT01202591|42022763|FG002|Overall Study|Withdrawal by Subject|0|||
19574524|NCT01202591|42022764|FG003|Overall Study|Withdrawal by Subject|0|||
19574525|NCT01202591|42022765|FG004|Overall Study|Withdrawal by Subject|2|||
19574526|NCT01202591|42022766|FG005|Overall Study|Withdrawal by Subject|1|||
19574527|NCT01202591|42022761|FG000|Overall Study|Objective Disease Progression|0|||
19574528|NCT01202591|42022762|FG001|Overall Study|Objective Disease Progression|0|||
19574529|NCT01202591|42022763|FG002|Overall Study|Objective Disease Progression|0|||
19574530|NCT01202591|42022764|FG003|Overall Study|Objective Disease Progression|0|||
19574531|NCT01202591|42022765|FG004|Overall Study|Objective Disease Progression|2|||
19574532|NCT01202591|42022766|FG005|Overall Study|Objective Disease Progression|0|||
19574533|NCT01202279|42022782|FG000|Overall Study|Adverse Event|8|||
19574534|NCT01202279|42022783|FG001|Overall Study|Adverse Event|6|||
19574535|NCT01202279|42022782|FG000|Overall Study|Withdrawal by Subject|13|||
19574536|NCT01202279|42022783|FG001|Overall Study|Withdrawal by Subject|10|||
19574537|NCT01202279|42022782|FG000|Overall Study|Physician Decision|0|||
19574538|NCT01202279|42022783|FG001|Overall Study|Physician Decision|1|||
19574539|NCT01202279|42022782|FG000|Overall Study|Lost to Follow-up|10|||
19574540|NCT01202279|42022783|FG001|Overall Study|Lost to Follow-up|7|||
19574541|NCT01202279|42022782|FG000|Overall Study|Protocol Violation|1|||
19574542|NCT01202279|42022783|FG001|Overall Study|Protocol Violation|1|||
19574543|NCT01202279|42022782|FG000|Overall Study|study compliance|5|||
19574544|NCT01202279|42022783|FG001|Overall Study|study compliance|2|||
19574545|NCT01201967|42022791|FG000|Overall Study|Lost to Follow-up|6|||
19574546|NCT01201967|42022792|FG001|Overall Study|Lost to Follow-up|5|||
19574547|NCT01201811|42022808|FG000|Overall Study|Adverse Event|6|||
19574548|NCT01201811|42022808|FG000|Overall Study|Disease progression|3|||
19574549|NCT01201811|42022808|FG000|Overall Study|Withdrawal by Subject|3|||
19574550|NCT01201811|42022808|FG000|Overall Study|Death|4|||
19574551|NCT01201811|42022808|FG000|Overall Study|Treatment Failure|2|||
19574552|NCT01201811|42022808|FG000|Overall Study|Physician Decision|1|||
19574553|NCT01201343|42022812|FG000|Overall Study|Adverse Event|6|||
19574554|NCT01201343|42022812|FG000|Overall Study|Withdrawal by Subject|5|||
19574555|NCT01201343|42022812|FG000|Overall Study|Lost to Follow-up|2|||
19574556|NCT01201343|42022812|FG000|Overall Study|Lack of Efficacy|2|||
19574557|NCT01201343|42022812|FG000|Overall Study|Participant wrongly included in trial|1|||
19574558|NCT01201343|42022812|FG000|Overall Study|Randomized, not treated|3|||
19574559|NCT01201265|42022816|FG000|Overall Study|Death|14|||
19574560|NCT01201265|42022816|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19574561|NCT01201265|42022816|FG000|Overall Study|Lost to Follow-up|10|||
19574562|NCT01201265|42022816|FG000|Overall Study|Withdrawal by Subject|7|||
19387531|NCT01663857|41630647|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
19387532|NCT01663857|41630648|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
19387533|NCT01663857|41630649|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
19387534|NCT01663857|41630646|FG000|Overall Study|Lost to Follow-up|0|||
19387535|NCT01663857|41630647|FG001|Overall Study|Lost to Follow-up|0|||
19387536|NCT01663857|41630648|FG002|Overall Study|Lost to Follow-up|3|||
19387537|NCT01663857|41630649|FG003|Overall Study|Lost to Follow-up|1|||
19387538|NCT02094898|41630665|FG000|Overall Study|Clinical Worsening|2|||
19387539|NCT02094898|41630665|FG000|Overall Study|Adverse Event|2|||
19387540|NCT02094898|41630665|FG000|Overall Study|Lack of Efficacy|1|||
19387541|NCT02045836|41630673|FG000|Overall Study|Adverse Event|4|||
19387542|NCT02045836|41630674|FG001|Overall Study|Adverse Event|4|||
19387543|NCT02045836|41630673|FG000|Overall Study|Withdrawal by Subject|1|||
19387544|NCT02045836|41630674|FG001|Overall Study|Withdrawal by Subject|1|||
19387545|NCT02045836|41630673|FG000|Overall Study|Lost to Follow-up|4|||
19387546|NCT02045836|41630674|FG001|Overall Study|Lost to Follow-up|7|||
19387547|NCT02045836|41630673|FG000|Overall Study|Migrated from study area|0|||
19387548|NCT02045836|41630674|FG001|Overall Study|Migrated from study area|2|||
19387549|NCT02569437|41630683|FG000|Overall Study|Lost to Follow-up|12|||
19387550|NCT02569437|41630684|FG001|Overall Study|Lost to Follow-up|14|||
19387551|NCT02045212|41630692|FG000|Overall Study|Adverse Event|0|||
19387552|NCT02045212|41630693|FG001|Overall Study|Adverse Event|1|||
19387553|NCT02045212|41630692|FG000|Overall Study|Withdrawal by Subject|1|||
19387554|NCT02045212|41630693|FG001|Overall Study|Withdrawal by Subject|0|||
19387555|NCT02045212|41630692|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
19387556|NCT02045212|41630693|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
19387557|NCT02044822|41630703|FG000|Overall Study|Study Terminated by Sponsor|77|||
19387558|NCT02044822|41630703|FG000|Overall Study|Investigator's Discretion|10|||
19387559|NCT02044822|41630703|FG000|Overall Study|Withdrew Consent|3|||
19387560|NCT02044822|41630703|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
19387561|NCT02044822|41630703|FG000|Overall Study|Lost to Follow-up|1|||
19387562|NCT02044510|41630709|FG000|Overall Study|Adverse Event|1|||
19387563|NCT02044510|41630710|FG001|Overall Study|Adverse Event|2|||
19387564|NCT02067676|41630722|FG000|Overall Study|Withdrawal by Subject|1|||
19387565|NCT02067676|41630723|FG001|Overall Study|Withdrawal by Subject|0|||
19387566|NCT02067676|41630724|FG002|Overall Study|Withdrawal by Subject|0|||
19387567|NCT02067676|41630725|FG003|Overall Study|Withdrawal by Subject|0|||
19387568|NCT02067676|41630726|FG004|Overall Study|Withdrawal by Subject|0|||
19387569|NCT02067676|41630727|FG005|Overall Study|Withdrawal by Subject|0|||
19574563|NCT01201265|42022816|FG000|Overall Study|Disease Progression|4|||
19387570|NCT01623154|41630746|FG000|Overall Study|Did not drink Pranactin Citric|4|||
19387571|NCT00702689|41630752|FG000|Overall Study|Withdrawal by Subject|4|||
19387572|NCT00702689|41630752|FG000|Overall Study|Recurrent malignancy|1|||
19387573|NCT00702689|41630752|FG000|Overall Study|Adverse Event|1|||
19387574|NCT02065570|41630758|FG000|Induction Study|Adverse Event|5|||
19387575|NCT02065570|41630759|FG001|Induction Study|Adverse Event|12|||
19387576|NCT02065570|41630760|FG002|Induction Study|Adverse Event|0|||
19387577|NCT02065570|41630761|FG003|Induction Study|Adverse Event|0|||
19387578|NCT02065570|41630758|FG000|Induction Study|Withdrawal by Subject|2|||
19387579|NCT02065570|41630759|FG001|Induction Study|Withdrawal by Subject|3|||
19387580|NCT02065570|41630760|FG002|Induction Study|Withdrawal by Subject|0|||
19387581|NCT02065570|41630761|FG003|Induction Study|Withdrawal by Subject|0|||
19387582|NCT02065570|41630758|FG000|Induction Study|Lost to Follow-up|1|||
19387583|NCT02065570|41630759|FG001|Induction Study|Lost to Follow-up|1|||
19387584|NCT02065570|41630760|FG002|Induction Study|Lost to Follow-up|0|||
19387585|NCT02065570|41630761|FG003|Induction Study|Lost to Follow-up|0|||
19387586|NCT02065570|41630758|FG000|Induction Study|Other, Not Specified|6|||
19387587|NCT02065570|41630759|FG001|Induction Study|Other, Not Specified|5|||
19387588|NCT02065570|41630760|FG002|Induction Study|Other, Not Specified|0|||
19387589|NCT02065570|41630761|FG003|Induction Study|Other, Not Specified|0|||
19387590|NCT02065570|41630758|FG000|Maintenance Study|Adverse Event|0|||
19387591|NCT02065570|41630759|FG001|Maintenance Study|Adverse Event|0|||
19387592|NCT02065570|41630760|FG002|Maintenance Study|Adverse Event|8|||
19387593|NCT02065570|41630761|FG003|Maintenance Study|Adverse Event|8|||
19387594|NCT02065570|41630758|FG000|Maintenance Study|Withdrawal by Subject|0|||
19387595|NCT02065570|41630759|FG001|Maintenance Study|Withdrawal by Subject|0|||
19387596|NCT02065570|41630760|FG002|Maintenance Study|Withdrawal by Subject|1|||
19387597|NCT02065570|41630761|FG003|Maintenance Study|Withdrawal by Subject|4|||
19387598|NCT02065570|41630758|FG000|Maintenance Study|Lost to Follow-up|0|||
19387599|NCT02065570|41630759|FG001|Maintenance Study|Lost to Follow-up|0|||
19387600|NCT02065570|41630760|FG002|Maintenance Study|Lost to Follow-up|2|||
19387601|NCT02065570|41630761|FG003|Maintenance Study|Lost to Follow-up|2|||
19387602|NCT02065570|41630758|FG000|Maintenance Study|Other, Not Specified|0|||
19387603|NCT02065570|41630759|FG001|Maintenance Study|Other, Not Specified|0|||
19387604|NCT02065570|41630760|FG002|Maintenance Study|Other, Not Specified|11|||
19387605|NCT02065570|41630761|FG003|Maintenance Study|Other, Not Specified|5|||
19387606|NCT02566005|41630774|FG000|Overall Study|vaginal bleeding|0|||
19387607|NCT02566005|41630775|FG001|Overall Study|vaginal bleeding|1|||
19387608|NCT02566005|41630774|FG000|Overall Study|received foley|8|||
19387609|NCT02566005|41630775|FG001|Overall Study|received foley|0|||
19387610|NCT02566005|41630774|FG000|Overall Study|did not receive foley|0|||
19387611|NCT02566005|41630775|FG001|Overall Study|did not receive foley|1|||
19387612|NCT02566005|41630774|FG000|Overall Study|labor after randomization|0|||
19387613|NCT02566005|41630775|FG001|Overall Study|labor after randomization|4|||
19387614|NCT02065336|41630793|FG000|Extension Phase|Study Terminated by Sponsor|0|||
19387615|NCT02065336|41630794|FG001|Extension Phase|Study Terminated by Sponsor|0|||
19387616|NCT02065336|41630795|FG002|Extension Phase|Study Terminated by Sponsor|0|||
19387617|NCT02065336|41630796|FG003|Extension Phase|Study Terminated by Sponsor|0|||
19387618|NCT02065336|41630797|FG004|Extension Phase|Study Terminated by Sponsor|0|||
19387619|NCT02065336|41630798|FG005|Extension Phase|Study Terminated by Sponsor|0|||
19387620|NCT02065336|41630799|FG006|Extension Phase|Study Terminated by Sponsor|0|||
19387621|NCT02065336|41630800|FG007|Extension Phase|Study Terminated by Sponsor|0|||
19387622|NCT02065336|41630801|FG008|Extension Phase|Study Terminated by Sponsor|2|||
19387623|NCT02065336|41630802|FG009|Extension Phase|Study Terminated by Sponsor|8|||
19387624|NCT02701985|41630835|FG000|Overall Study|Withdrawal by Subject|1|||
19387625|NCT02701985|41630836|FG001|Overall Study|Withdrawal by Subject|1|||
19387626|NCT02701985|41630835|FG000|Overall Study|Lost to Follow-up|1|||
19387627|NCT02701985|41630836|FG001|Overall Study|Lost to Follow-up|0|||
19387628|NCT02701985|41630835|FG000|Overall Study|Death|1|||
19387629|NCT02701985|41630836|FG001|Overall Study|Death|0|||
19387630|NCT02701985|41630835|FG000|Overall Study|Adverse Event|0|||
19387631|NCT02701985|41630836|FG001|Overall Study|Adverse Event|5|||
19387632|NCT02064868|41630845|FG000|Overall Study|Lost to Follow-up|14|||
19387633|NCT02064868|41630846|FG001|Overall Study|Lost to Follow-up|8|||
19387634|NCT02064868|41630845|FG000|Overall Study|Physician Decision|1|||
19387635|NCT02064868|41630846|FG001|Overall Study|Physician Decision|0|||
19387636|NCT02064868|41630845|FG000|Overall Study|Withdrawal by Subject|14|||
19387637|NCT02064868|41630846|FG001|Overall Study|Withdrawal by Subject|3|||
19387638|NCT02064868|41630845|FG000|Overall Study|Technical Problems or Missing|5|||
19387639|NCT02064868|41630846|FG001|Overall Study|Technical Problems or Missing|2|||
19387640|NCT02064166|41630854|FG000|Overall Study|Adverse Event|1|||
19387641|NCT02064166|41630855|FG001|Overall Study|Adverse Event|0|||
19387642|NCT02565615|41630888|FG000|Overall Study|Death|0|||
19387643|NCT02565615|41630889|FG001|Overall Study|Death|1|||
19387644|NCT02565615|41630890|FG002|Overall Study|Death|0|||
19387645|NCT02565615|41630891|FG003|Overall Study|Death|0|||
19387646|NCT02565615|41630892|FG004|Overall Study|Death|4|||
19387647|NCT02565615|41630888|FG000|Overall Study|Not willing to participate in study|2|||
19387648|NCT02565615|41630889|FG001|Overall Study|Not willing to participate in study|21|||
19387649|NCT02565615|41630890|FG002|Overall Study|Not willing to participate in study|0|||
19387650|NCT02565615|41630891|FG003|Overall Study|Not willing to participate in study|1|||
19387651|NCT02565615|41630892|FG004|Overall Study|Not willing to participate in study|169|||
19387652|NCT02565615|41630888|FG000|Overall Study|Lost to Follow-up|0|||
19387653|NCT02565615|41630889|FG001|Overall Study|Lost to Follow-up|4|||
19387654|NCT02565615|41630890|FG002|Overall Study|Lost to Follow-up|0|||
19387655|NCT02565615|41630891|FG003|Overall Study|Lost to Follow-up|1|||
19387656|NCT02565615|41630892|FG004|Overall Study|Lost to Follow-up|765|||
19387657|NCT02565615|41630888|FG000|Overall Study|Not meeting eligibility criteria|0|||
19387658|NCT02565615|41630889|FG001|Overall Study|Not meeting eligibility criteria|7|||
19387659|NCT02565615|41630890|FG002|Overall Study|Not meeting eligibility criteria|0|||
19387660|NCT02565615|41630891|FG003|Overall Study|Not meeting eligibility criteria|0|||
19387661|NCT02565615|41630892|FG004|Overall Study|Not meeting eligibility criteria|25|||
19387662|NCT02565615|41630888|FG000|Overall Study|Reason not defined|0|||
19387663|NCT02565615|41630889|FG001|Overall Study|Reason not defined|2|||
19387664|NCT02565615|41630890|FG002|Overall Study|Reason not defined|0|||
19387665|NCT02565615|41630891|FG003|Overall Study|Reason not defined|1|||
19387666|NCT02565615|41630892|FG004|Overall Study|Reason not defined|62|||
19387667|NCT02565615|41630888|FG000|Overall Study|Adverse Event|1|||
19387668|NCT02565615|41630889|FG001|Overall Study|Adverse Event|1|||
19387669|NCT02565615|41630890|FG002|Overall Study|Adverse Event|0|||
19387670|NCT02565615|41630891|FG003|Overall Study|Adverse Event|0|||
19387671|NCT02565615|41630892|FG004|Overall Study|Adverse Event|9|||
19387672|NCT02565615|41630888|FG000|Overall Study|Untreated|0|||
19387673|NCT02565615|41630889|FG001|Overall Study|Untreated|0|||
19387674|NCT02565615|41630890|FG002|Overall Study|Untreated|0|||
19387675|NCT02565615|41630891|FG003|Overall Study|Untreated|0|||
19387676|NCT02565615|41630892|FG004|Overall Study|Untreated|567|||
19387677|NCT02701361|41630907|FG000|Overall Study|Lost to Follow-up|5|||
19387678|NCT02701361|41630908|FG001|Overall Study|Lost to Follow-up|2|||
19387679|NCT02701361|41630909|FG002|Overall Study|Lost to Follow-up|1|||
19387680|NCT02701361|41630907|FG000|Overall Study|Withdrawal by Subject|4|||
19387681|NCT02701361|41630908|FG001|Overall Study|Withdrawal by Subject|0|||
19387682|NCT02701361|41630909|FG002|Overall Study|Withdrawal by Subject|0|||
19387683|NCT02701361|41630907|FG000|Overall Study|timed out in rehab center|0|||
19387684|NCT02701361|41630908|FG001|Overall Study|timed out in rehab center|1|||
19387685|NCT02701361|41630909|FG002|Overall Study|timed out in rehab center|0|||
19387686|NCT02701361|41630907|FG000|Overall Study|incarceration|0|||
19387687|NCT02701361|41630908|FG001|Overall Study|incarceration|0|||
19387688|NCT02701361|41630909|FG002|Overall Study|incarceration|1|||
19387689|NCT02566785|41630930|FG000|Overall Study|Lost to Follow-up|0|||
19387690|NCT02566785|41630931|FG001|Overall Study|Lost to Follow-up|2|||
19387691|NCT02566785|41630930|FG000|Overall Study|Worsening condition|1|||
19387692|NCT02566785|41630931|FG001|Overall Study|Worsening condition|1|||
19387693|NCT01662999|41630943|FG000|Period 3|Withdrawal by Subject|0|||
19387694|NCT01662999|41630944|FG001|Period 3|Withdrawal by Subject|1|||
19387695|NCT01662999|41630945|FG002|Period 3|Withdrawal by Subject|0|||
19387696|NCT01662999|41630946|FG003|Period 3|Withdrawal by Subject|0|||
19387697|NCT01662999|41630947|FG004|Period 3|Withdrawal by Subject|0|||
19387698|NCT01662999|41630948|FG005|Period 3|Withdrawal by Subject|0|||
19387699|NCT02565381|41630981|FG000|Overall Study|Lost to Follow-up|1|||
19387700|NCT02565381|41630982|FG001|Overall Study|Lost to Follow-up|0|||
19387701|NCT02565381|41630983|FG002|Overall Study|Lost to Follow-up|1|||
19387702|NCT02063854|41630998|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
19387703|NCT02063854|41630999|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
19387704|NCT02063854|41631000|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
19387705|NCT02063854|41631001|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
19387706|NCT02063854|41631002|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
19387707|NCT02063854|41631003|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
19387708|NCT02063854|41631004|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
19387709|NCT02063854|41630998|FG000|Overall Study|Major Protocol Deviation|0|||
19387710|NCT02063854|41630999|FG001|Overall Study|Major Protocol Deviation|0|||
19387711|NCT02063854|41631000|FG002|Overall Study|Major Protocol Deviation|3|||
19387712|NCT02063854|41631001|FG003|Overall Study|Major Protocol Deviation|0|||
19387713|NCT02063854|41631002|FG004|Overall Study|Major Protocol Deviation|0|||
19387714|NCT02063854|41631003|FG005|Overall Study|Major Protocol Deviation|0|||
19387715|NCT02063854|41631004|FG006|Overall Study|Major Protocol Deviation|0|||
19387716|NCT02063854|41630998|FG000|Overall Study|Voluntary Withdrawal|2|||
19387717|NCT02063854|41630999|FG001|Overall Study|Voluntary Withdrawal|0|||
19387718|NCT02063854|41631000|FG002|Overall Study|Voluntary Withdrawal|8|||
19387719|NCT02063854|41631001|FG003|Overall Study|Voluntary Withdrawal|1|||
19387720|NCT02063854|41631002|FG004|Overall Study|Voluntary Withdrawal|3|||
19387721|NCT02063854|41631003|FG005|Overall Study|Voluntary Withdrawal|6|||
19387722|NCT02063854|41631004|FG006|Overall Study|Voluntary Withdrawal|1|||
19387723|NCT02063854|41630998|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
19387724|NCT02063854|41630999|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
19387725|NCT02063854|41631000|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
19387726|NCT02063854|41631001|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
19387727|NCT02063854|41631002|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
19387728|NCT02063854|41631003|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
19387729|NCT02063854|41631004|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
19387730|NCT02063854|41630998|FG000|Overall Study|Reason Not Specified|1|||
19387731|NCT02063854|41630999|FG001|Overall Study|Reason Not Specified|0|||
19387732|NCT02063854|41631000|FG002|Overall Study|Reason Not Specified|0|||
19387733|NCT02063854|41631001|FG003|Overall Study|Reason Not Specified|0|||
19387734|NCT02063854|41631002|FG004|Overall Study|Reason Not Specified|0|||
19387735|NCT02063854|41631003|FG005|Overall Study|Reason Not Specified|0|||
19387736|NCT02063854|41631004|FG006|Overall Study|Reason Not Specified|0|||
19387737|NCT02063854|41630998|FG000|Overall Study|Did Not Receive Study Drug|0|||
19387738|NCT02063854|41630999|FG001|Overall Study|Did Not Receive Study Drug|0|||
19387739|NCT02063854|41631000|FG002|Overall Study|Did Not Receive Study Drug|0|||
19387740|NCT02063854|41631001|FG003|Overall Study|Did Not Receive Study Drug|0|||
19387741|NCT02063854|41631002|FG004|Overall Study|Did Not Receive Study Drug|0|||
19387742|NCT02063854|41631003|FG005|Overall Study|Did Not Receive Study Drug|1|||
19387743|NCT02063854|41631004|FG006|Overall Study|Did Not Receive Study Drug|0|||
19387744|NCT02063698|41631024|FG000|Overall Study|did not complete booklet for days 2-8|1|||
19387745|NCT02063698|41631025|FG001|Overall Study|did not complete booklet for days 2-8|2|||
19387746|NCT04701333|41631033|FG000|Overall Study|Lost to Follow-up|3|||
19387747|NCT04701333|41631034|FG001|Overall Study|Lost to Follow-up|7|||
19387748|NCT04701333|41631033|FG000|Overall Study|Withdrawal by Subject|0|||
19387749|NCT04701333|41631034|FG001|Overall Study|Withdrawal by Subject|1|||
19387750|NCT02062450|41631042|FG000|Overall Study|No follow-up visit|124|||
19387751|NCT02561247|41631050|FG000|Overall Study|Protocol Violation|1|||
19387752|NCT02561247|41631050|FG000|Overall Study|Withdrawal by Subject|1|||
19387753|NCT02561247|41631050|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
19387754|NCT02061592|41631056|FG000|Period 1|Withdrawal by Subject|1|||
19387755|NCT02061592|41631057|FG001|Period 1|Withdrawal by Subject|0|||
19387756|NCT02061592|41631056|FG000|Period 1|Protocol Violation|1|||
19387757|NCT02061592|41631057|FG001|Period 1|Protocol Violation|0|||
19387758|NCT02061592|41631056|FG000|Period 2|Lost to Follow-up|0|||
19387759|NCT02061592|41631057|FG001|Period 2|Lost to Follow-up|1|||
19387760|NCT01663623|41631067|FG000|Overall Study|Adverse Event|3|||
19387761|NCT01663623|41631068|FG001|Overall Study|Adverse Event|7|||
19387762|NCT01663623|41631067|FG000|Overall Study|Lack of Efficacy|5|||
19387763|NCT01663623|41631068|FG001|Overall Study|Lack of Efficacy|6|||
19387764|NCT01663623|41631067|FG000|Overall Study|Protocol Violation|0|||
19574564|NCT04246801|42022822|FG000|Overall Study|Adverse Event|1|||
19574565|NCT04246801|42022823|FG001|Overall Study|Adverse Event|1|||
19574566|NCT04246801|42022822|FG000|Overall Study|Protocol Violation|1|||
19574567|NCT04246801|42022823|FG001|Overall Study|Protocol Violation|1|||
19574568|NCT04246801|42022822|FG000|Overall Study|Lack of Efficacy|0|||
19574569|NCT04246801|42022823|FG001|Overall Study|Lack of Efficacy|2|||
19574570|NCT04246801|42022822|FG000|Overall Study|Lost to Follow-up|1|||
19574571|NCT04246801|42022823|FG001|Overall Study|Lost to Follow-up|1|||
19574572|NCT04246801|42022822|FG000|Overall Study|Withdrawal by Subject|2|||
19574573|NCT04246801|42022823|FG001|Overall Study|Withdrawal by Subject|1|||
19387765|NCT01663623|41631068|FG001|Overall Study|Protocol Violation|1|||
19387766|NCT01663623|41631067|FG000|Overall Study|Other-Study closed/terminated|1|||
19387767|NCT01663623|41631068|FG001|Overall Study|Other-Study closed/terminated|1|||
19387768|NCT01663623|41631067|FG000|Overall Study|Physician Decision|1|||
19574574|NCT01200797|42022829|FG000|Overall Study|symptomatic deterioration|2|||
19387769|NCT01663623|41631068|FG001|Overall Study|Physician Decision|4|||
19387770|NCT01663623|41631067|FG000|Overall Study|Withdrawal by Subject|2|||
19387771|NCT01663623|41631068|FG001|Overall Study|Withdrawal by Subject|1|||
19574575|NCT01200797|42022829|FG000|Overall Study|Adverse Event|4|||
19574576|NCT01200797|42022829|FG000|Overall Study|Disease Progression|13|||
19574577|NCT01200485|42022834|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
19574578|NCT01200485|42022835|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
19574579|NCT01200485|42022836|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
19574580|NCT01200485|42022834|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
19574581|NCT01200485|42022835|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
19574582|NCT01200485|42022836|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
19574583|NCT01200407|42022843|FG000|Overall Study|Lost to Follow-up|56|||
19574584|NCT01200407|42022843|FG000|Overall Study|Adverse Event|3|||
19574585|NCT01200407|42022843|FG000|Overall Study|Withdrawal by Subject|4|||
19574586|NCT01200407|42022843|FG000|Overall Study|Other|19|||
19574587|NCT01200329|42022847|FG000|Overall Study|Lack of financial coverage|2|||
19574588|NCT01200329|42022847|FG000|Overall Study|Progressive disease|1|||
19574589|NCT01199939|42022851|FG000|Overall Study|Adverse Event|4|||
19574590|NCT01199939|42022851|FG000|Overall Study|Protocol Violation|3|||
19574591|NCT01199939|42022851|FG000|Overall Study|Lost to Follow-up|2|||
19574592|NCT01199939|42022851|FG000|Overall Study|Reached a virologic endpoint|4|||
19574593|NCT01199861|42022857|FG000|Overall Study|Administrative problems|1|||
19574594|NCT01199861|42022858|FG001|Overall Study|Administrative problems|0|||
19574595|NCT01199861|42022857|FG000|Overall Study|Adverse Event|1|||
19574596|NCT01199861|42022858|FG001|Overall Study|Adverse Event|0|||
19574597|NCT01199705|42022878|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
19574598|NCT01199471|42022893|FG000|Overall Study|Protocol Violation|4|||
19574599|NCT01199471|42022893|FG000|Overall Study|Withdrawal by Subject|1|||
19574600|NCT01199471|42022893|FG000|Overall Study|Physician Decision|1|||
19574601|NCT01198145|42022900|FG000|Overall Study|Withdrawal by Subject|1|||
19574602|NCT01198145|42022901|FG001|Overall Study|Withdrawal by Subject|1|||
19574603|NCT01197911|42022911|FG000|Overall Study|Adverse Event|0|||
19574604|NCT01197911|42022912|FG001|Overall Study|Adverse Event|0|||
19574605|NCT01197911|42022913|FG002|Overall Study|Adverse Event|1|||
19574606|NCT01197755|42022925|FG000|Overall Study|Adverse Event|8|||
19574607|NCT01197755|42022926|FG001|Overall Study|Adverse Event|10|||
19574608|NCT01197755|42022927|FG002|Overall Study|Adverse Event|10|||
19574609|NCT01197755|42022925|FG000|Overall Study|Study-specific discontinuation criteria|2|||
19574610|NCT01197755|42022926|FG001|Overall Study|Study-specific discontinuation criteria|1|||
19574611|NCT01197755|42022927|FG002|Overall Study|Study-specific discontinuation criteria|0|||
19574612|NCT01197755|42022925|FG000|Overall Study|Entered the long-term extension study|18|||
19574613|NCT01197755|42022926|FG001|Overall Study|Entered the long-term extension study|21|||
19574614|NCT01197755|42022927|FG002|Overall Study|Entered the long-term extension study|35|||
19574615|NCT01197755|42022925|FG000|Overall Study|Lack of therapeutic response|0|||
19574616|NCT01197755|42022926|FG001|Overall Study|Lack of therapeutic response|7|||
19574617|NCT01197755|42022927|FG002|Overall Study|Lack of therapeutic response|4|||
19574618|NCT01197755|42022925|FG000|Overall Study|Severe non-compliance to the protocol|2|||
19574619|NCT01197755|42022926|FG001|Overall Study|Severe non-compliance to the protocol|1|||
19574620|NCT01197755|42022927|FG002|Overall Study|Severe non-compliance to the protocol|2|||
19574621|NCT01197755|42022925|FG000|Overall Study|Withdrawal by Subject|1|||
19574622|NCT01197755|42022926|FG001|Overall Study|Withdrawal by Subject|0|||
19574623|NCT01197755|42022927|FG002|Overall Study|Withdrawal by Subject|0|||
19574624|NCT01197755|42022925|FG000|Overall Study|Lost to Follow-up|0|||
19574625|NCT01197755|42022926|FG001|Overall Study|Lost to Follow-up|0|||
19574626|NCT01197755|42022927|FG002|Overall Study|Lost to Follow-up|1|||
19574627|NCT01197755|42022925|FG000|Overall Study|eg, change in circumstances|7|||
19574628|NCT01197755|42022926|FG001|Overall Study|eg, change in circumstances|3|||
19574629|NCT01197755|42022927|FG002|Overall Study|eg, change in circumstances|2|||
19574630|NCT01179048|42022939|FG000|Overall Study|Withdrawn - does not allow contact|4|||
19574631|NCT01179048|42022940|FG001|Overall Study|Withdrawn - does not allow contact|8|||
19574632|NCT01179048|42022939|FG000|Overall Study|Lost to Follow-up|8|||
19574633|NCT01179048|42022940|FG001|Overall Study|Lost to Follow-up|9|||
19574634|NCT01179048|42022939|FG000|Overall Study|Alive|127|||
19574635|NCT01179048|42022940|FG001|Overall Study|Alive|142|||
19574636|NCT00603265|42022949|FG000|Overall Study|Adverse Event|2|||
19574637|NCT00603265|42022950|FG001|Overall Study|Adverse Event|11|||
19574638|NCT00603265|42022951|FG002|Overall Study|Adverse Event|1|||
19387772|NCT02042950|41631074|FG000|Overall Study|Progressive Disease|4|||
19574639|NCT00603265|42022949|FG000|Overall Study|Withdrawal by Subject|1|||
19574640|NCT00603265|42022950|FG001|Overall Study|Withdrawal by Subject|2|||
19574641|NCT00603265|42022951|FG002|Overall Study|Withdrawal by Subject|1|||
19574642|NCT00603265|42022949|FG000|Overall Study|Lack of Efficacy|3|||
19574643|NCT00603265|42022950|FG001|Overall Study|Lack of Efficacy|0|||
19574644|NCT00603265|42022951|FG002|Overall Study|Lack of Efficacy|3|||
19574645|NCT00603265|42022949|FG000|Overall Study|Lost to Follow-up|0|||
19574646|NCT00603265|42022950|FG001|Overall Study|Lost to Follow-up|1|||
19574647|NCT00603265|42022951|FG002|Overall Study|Lost to Follow-up|0|||
19387773|NCT02042404|41631078|FG000|Overall Study|Death|1|||
19574648|NCT00603265|42022949|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
19574649|NCT00603265|42022950|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
19574650|NCT00603265|42022951|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
19574651|NCT00603265|42022949|FG000|Overall Study|Participant Left Country, No Responses|0|||
19574652|NCT00603265|42022950|FG001|Overall Study|Participant Left Country, No Responses|1|||
19574653|NCT00603265|42022951|FG002|Overall Study|Participant Left Country, No Responses|0|||
19574654|NCT00603265|42022949|FG000|Overall Study|Protocol Violation|1|||
19574655|NCT00603265|42022950|FG001|Overall Study|Protocol Violation|0|||
19574656|NCT00603265|42022951|FG002|Overall Study|Protocol Violation|0|||
19574657|NCT04010227|42022961|FG000|Overall Study|Death|1|||
19574658|NCT04010227|42022962|FG001|Overall Study|Death|2|||
19574659|NCT04010227|42022961|FG000|Overall Study|Medical Reasons|4|||
19574660|NCT04010227|42022962|FG001|Overall Study|Medical Reasons|3|||
19574661|NCT04010227|42022961|FG000|Overall Study|Withdrawal by Subject|2|||
19574662|NCT04010227|42022962|FG001|Overall Study|Withdrawal by Subject|0|||
19574663|NCT04010227|42022961|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
19574664|NCT04010227|42022962|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
19574665|NCT01158534|42022969|FG000|Overall Study|Withdrawal by Subject|1|||
19574666|NCT01158534|42022969|FG000|Overall Study|Death|1|||
19574667|NCT01158534|42022969|FG000|Overall Study|Other|1|||
19574668|NCT01158378|42022975|FG000|Overall Study|Death|4|||
19574669|NCT01158378|42022976|FG001|Overall Study|Death|5|||
19574670|NCT01158378|42022975|FG000|Overall Study|Lost to Follow-up|2|||
19574671|NCT01158378|42022976|FG001|Overall Study|Lost to Follow-up|4|||
19574672|NCT01158378|42022975|FG000|Overall Study|Withdrawal by Subject|4|||
19574673|NCT01158378|42022976|FG001|Overall Study|Withdrawal by Subject|0|||
19574674|NCT00602797|42022983|FG000|Overall Study|Adverse Event|1|||
19574675|NCT01158222|42022988|FG000|Overall Study|Not eligible for intermediate phase|17|||
19574676|NCT01197521|42022995|FG000|Overall Study|Not reported|24|||
19574677|NCT01197521|42022996|FG001|Overall Study|Not reported|25|||
19574678|NCT01197521|42022997|FG002|Overall Study|Not reported|21|||
19574679|NCT01197521|42022995|FG000|Overall Study|Enrolment in long term extension|42|||
19574680|NCT01197521|42022996|FG001|Overall Study|Enrolment in long term extension|36|||
19574681|NCT01197521|42022997|FG002|Overall Study|Enrolment in long term extension|87|||
19574682|NCT01197521|42022995|FG000|Overall Study|Severe non-compliance to protocol|1|||
19574683|NCT01197521|42022996|FG001|Overall Study|Severe non-compliance to protocol|3|||
19574684|NCT01197521|42022997|FG002|Overall Study|Severe non-compliance to protocol|3|||
19574685|NCT01197521|42022995|FG000|Overall Study|Lack of therapeutic response|2|||
19574686|NCT01197521|42022996|FG001|Overall Study|Lack of therapeutic response|3|||
19574687|NCT01197521|42022997|FG002|Overall Study|Lack of therapeutic response|4|||
19574688|NCT01197521|42022995|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
19574689|NCT01197521|42022996|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
19574690|NCT01197521|42022997|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
19574691|NCT01197521|42022995|FG000|Overall Study|Lost to Follow-up|3|||
19574692|NCT01197521|42022996|FG001|Overall Study|Lost to Follow-up|2|||
19574693|NCT01197521|42022997|FG002|Overall Study|Lost to Follow-up|2|||
19574694|NCT01197521|42022995|FG000|Overall Study|Adverse Event|25|||
19574695|NCT01197521|42022996|FG001|Overall Study|Adverse Event|28|||
19574696|NCT01197521|42022997|FG002|Overall Study|Adverse Event|24|||
19574697|NCT01157676|42023010|FG000|Randomization|Death|1|||
19574698|NCT01157676|42023011|FG001|Randomization|Death|1|||
19574699|NCT01157676|42023010|FG000|Randomization|unresectable|2|||
19574700|NCT01157676|42023011|FG001|Randomization|unresectable|3|||
19574701|NCT01157676|42023010|FG000|Randomization|Withdrawal by Subject|17|||
19574702|NCT01157676|42023011|FG001|Randomization|Withdrawal by Subject|13|||
19574703|NCT01157676|42023010|FG000|Randomization|Physician Decision|1|||
19574704|NCT01157676|42023011|FG001|Randomization|Physician Decision|0|||
19574705|NCT01157676|42023010|FG000|Surgery|underwent open cystectomy|0|||
19574706|NCT01157676|42023011|FG001|Surgery|underwent open cystectomy|4|||
19574707|NCT01157676|42023010|FG000|Surgery|converted to open procedure|0|||
19574708|NCT01157676|42023011|FG001|Surgery|converted to open procedure|5|||
19574709|NCT01157676|42023010|FG000|Surgery|underwent robotic cystectomy|1|||
19574710|NCT01157676|42023011|FG001|Surgery|underwent robotic cystectomy|0|||
19574711|NCT00991341|42023025|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
19574712|NCT00991341|42023026|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
19574713|NCT00991341|42023025|FG000|Overall Study|Death|3|||
19574714|NCT00991341|42023026|FG001|Overall Study|Death|0|||
19574715|NCT00991341|42023025|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
19574716|NCT00991341|42023026|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
19574717|NCT00991341|42023025|FG000|Overall Study|Physician Decision|1|||
19574718|NCT00991341|42023026|FG001|Overall Study|Physician Decision|2|||
19574719|NCT00991341|42023025|FG000|Overall Study|Withdrawal by Subject|3|||
19574720|NCT00991341|42023026|FG001|Overall Study|Withdrawal by Subject|4|||
19574721|NCT00990249|42023032|FG000|Overall Study|Disease Progression|8|||
19574722|NCT00990249|42023032|FG000|Overall Study|Non-Compliance|1|||
19574723|NCT00990249|42023032|FG000|Overall Study|Death|2|||
19574724|NCT00990249|42023032|FG000|Overall Study|Not treated|2|||
19574725|NCT02846545|42023038|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
19574726|NCT02846545|42023039|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
19574727|NCT02846545|42023038|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
19574728|NCT02846545|42023039|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
19574729|NCT02846545|42023038|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
19574730|NCT02846545|42023039|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
19574731|NCT02846545|42023038|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
19574732|NCT02846545|42023039|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
19574733|NCT02846545|42023038|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
19574734|NCT02846545|42023039|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
19574735|NCT00990093|42023049|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
19574736|NCT00990093|42023050|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
19574737|NCT00990093|42023049|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
19574738|NCT00990093|42023050|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
19574739|NCT00990093|42023049|FG000|Test Period 1 (1-14 Days)|Other|1|||
19574740|NCT00990093|42023050|FG001|Test Period 1 (1-14 Days)|Other|0|||
19574741|NCT00990093|42023049|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
19574742|NCT00990093|42023050|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
19574743|NCT00990093|42023049|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
19574744|NCT00990093|42023050|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
19387774|NCT02042404|41631079|FG001|Overall Study|Death|0|||
19574745|NCT00990093|42023049|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
19574746|NCT00990093|42023050|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
19574747|NCT00990093|42023049|FG000|Test Period 2 (15-28 Days)|Other|0|||
19574748|NCT00990093|42023050|FG001|Test Period 2 (15-28 Days)|Other|1|||
19574749|NCT00984165|42023060|FG000|Overall Study|Death on study|2|||
19574750|NCT00984165|42023061|FG001|Overall Study|Death on study|0|||
19574751|NCT00984165|42023062|FG002|Overall Study|Death on study|0|||
19574752|NCT00984165|42023063|FG003|Overall Study|Death on study|0|||
19574753|NCT00984165|42023060|FG000|Overall Study|Disease progression on study|5|||
19574754|NCT00984165|42023061|FG001|Overall Study|Disease progression on study|1|||
19574755|NCT00984165|42023062|FG002|Overall Study|Disease progression on study|0|||
19574756|NCT00984165|42023063|FG003|Overall Study|Disease progression on study|0|||
19574757|NCT00984165|42023060|FG000|Overall Study|Death of recipient|0|||
19574758|NCT00984165|42023061|FG001|Overall Study|Death of recipient|0|||
19574759|NCT00984165|42023062|FG002|Overall Study|Death of recipient|0|||
19574760|NCT00984165|42023063|FG003|Overall Study|Death of recipient|1|||
19574761|NCT00984165|42023060|FG000|Overall Study|New protocol|0|||
19574762|NCT00984165|42023061|FG001|Overall Study|New protocol|0|||
19574763|NCT00984165|42023062|FG002|Overall Study|New protocol|0|||
19574764|NCT00984165|42023063|FG003|Overall Study|New protocol|1|||
19574765|NCT00984165|42023060|FG000|Overall Study|P+/donor pair removed from protocol|0|||
19574766|NCT00984165|42023061|FG001|Overall Study|P+/donor pair removed from protocol|0|||
19574767|NCT00984165|42023062|FG002|Overall Study|P+/donor pair removed from protocol|0|||
19574768|NCT00984165|42023063|FG003|Overall Study|P+/donor pair removed from protocol|1|||
19574769|NCT00984165|42023060|FG000|Overall Study|removed with a pair recipient|0|||
19574770|NCT00984165|42023061|FG001|Overall Study|removed with a pair recipient|0|||
19574771|NCT00984165|42023062|FG002|Overall Study|removed with a pair recipient|0|||
19574772|NCT00984165|42023063|FG003|Overall Study|removed with a pair recipient|1|||
19574773|NCT00993291|42023074|FG000|Overall Study|Withdrawal by Subject|1|||
19574774|NCT01196975|42023083|FG000|Overall Study|Adverse Event|2|||
19574775|NCT01196975|42023084|FG001|Overall Study|Adverse Event|2|||
19574776|NCT01196975|42023085|FG002|Overall Study|Adverse Event|0|||
19574777|NCT01196975|42023086|FG003|Overall Study|Adverse Event|0|||
19574778|NCT01196975|42023087|FG004|Overall Study|Adverse Event|2|||
19574779|NCT01196975|42023083|FG000|Overall Study|Withdrawal by Subject|2|||
19574780|NCT01196975|42023084|FG001|Overall Study|Withdrawal by Subject|1|||
19574781|NCT01196975|42023085|FG002|Overall Study|Withdrawal by Subject|0|||
19574782|NCT01196975|42023086|FG003|Overall Study|Withdrawal by Subject|1|||
19574783|NCT01196975|42023087|FG004|Overall Study|Withdrawal by Subject|0|||
19574784|NCT01196975|42023083|FG000|Overall Study|Lost to Follow-up|11|||
19574785|NCT01196975|42023084|FG001|Overall Study|Lost to Follow-up|6|||
19574786|NCT01196975|42023085|FG002|Overall Study|Lost to Follow-up|5|||
19574787|NCT01196975|42023086|FG003|Overall Study|Lost to Follow-up|5|||
19574788|NCT01196975|42023087|FG004|Overall Study|Lost to Follow-up|11|||
19574789|NCT00992589|42023122|FG000|Open-Label Phase|Adverse Event|4|||
19574790|NCT00992589|42023123|FG001|Open-Label Phase|Adverse Event|0|||
19574791|NCT00992589|42023124|FG002|Open-Label Phase|Adverse Event|0|||
19574792|NCT00992589|42023125|FG003|Open-Label Phase|Adverse Event|0|||
19574793|NCT00992589|42023122|FG000|Open-Label Phase|Withdrawal by Subject|20|||
19574794|NCT00992589|42023123|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19574795|NCT00992589|42023124|FG002|Open-Label Phase|Withdrawal by Subject|0|||
19574796|NCT00992589|42023125|FG003|Open-Label Phase|Withdrawal by Subject|0|||
19574797|NCT00992589|42023122|FG000|Open-Label Phase|Lost to Follow-up|1|||
19574798|NCT00992589|42023123|FG001|Open-Label Phase|Lost to Follow-up|0|||
19574799|NCT00992589|42023124|FG002|Open-Label Phase|Lost to Follow-up|0|||
19574800|NCT00992589|42023125|FG003|Open-Label Phase|Lost to Follow-up|0|||
19574801|NCT00992589|42023122|FG000|Open-Label Phase|Protocol Violation|3|||
19574802|NCT00992589|42023123|FG001|Open-Label Phase|Protocol Violation|0|||
19574803|NCT00992589|42023124|FG002|Open-Label Phase|Protocol Violation|0|||
19574804|NCT00992589|42023125|FG003|Open-Label Phase|Protocol Violation|0|||
19574805|NCT00992589|42023122|FG000|Open-Label Phase|Physician Decision|4|||
19574806|NCT00992589|42023123|FG001|Open-Label Phase|Physician Decision|0|||
19574807|NCT00992589|42023124|FG002|Open-Label Phase|Physician Decision|0|||
19574808|NCT00992589|42023125|FG003|Open-Label Phase|Physician Decision|0|||
19574809|NCT00992589|42023122|FG000|Open-Label Phase|Other|45|||
19574810|NCT00992589|42023123|FG001|Open-Label Phase|Other|0|||
19574811|NCT00992589|42023124|FG002|Open-Label Phase|Other|0|||
19574812|NCT00992589|42023125|FG003|Open-Label Phase|Other|0|||
19574813|NCT00992589|42023122|FG000|Double-Blind Phase|Adverse Event|0|||
19574814|NCT00992589|42023123|FG001|Double-Blind Phase|Adverse Event|6|||
19574815|NCT00992589|42023124|FG002|Double-Blind Phase|Adverse Event|2|||
19574816|NCT00992589|42023125|FG003|Double-Blind Phase|Adverse Event|3|||
19574817|NCT00992589|42023122|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19574818|NCT00992589|42023123|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
19574819|NCT00992589|42023124|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
19574820|NCT00992589|42023125|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
19574821|NCT00992589|42023122|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19574822|NCT00992589|42023123|FG001|Double-Blind Phase|Lost to Follow-up|0|||
19574823|NCT00992589|42023124|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19574824|NCT00992589|42023125|FG003|Double-Blind Phase|Lost to Follow-up|2|||
19574825|NCT00992589|42023122|FG000|Double-Blind Phase|Other|0|||
19574826|NCT00992589|42023123|FG001|Double-Blind Phase|Other|1|||
19574827|NCT00992589|42023124|FG002|Double-Blind Phase|Other|6|||
19574828|NCT00992589|42023125|FG003|Double-Blind Phase|Other|3|||
19574829|NCT01196741|42023145|FG000|Overall Study|Disease progression|34|||
19574830|NCT01196741|42023146|FG001|Overall Study|Disease progression|14|||
19574831|NCT01196741|42023145|FG000|Overall Study|Adverse Event|10|||
19574832|NCT01196741|42023146|FG001|Overall Study|Adverse Event|6|||
19574833|NCT01196741|42023145|FG000|Overall Study|Serious Adverse Event|3|||
19574834|NCT01196741|42023146|FG001|Overall Study|Serious Adverse Event|1|||
19574835|NCT01196741|42023145|FG000|Overall Study|Dose limiting Adverse Event|2|||
19574836|NCT01196741|42023146|FG001|Overall Study|Dose limiting Adverse Event|1|||
19574837|NCT01196741|42023145|FG000|Overall Study|Withdrawal by Subject|3|||
19574838|NCT01196741|42023146|FG001|Overall Study|Withdrawal by Subject|0|||
19574839|NCT01196741|42023145|FG000|Overall Study|Other reason|3|||
19574840|NCT01196741|42023146|FG001|Overall Study|Other reason|3|||
19574841|NCT01196741|42023145|FG000|Overall Study|Other|3|||
19574842|NCT01196741|42023146|FG001|Overall Study|Other|2|||
19574843|NCT01196741|42023145|FG000|Overall Study|Protocol Violation|2|||
19574844|NCT01196741|42023146|FG001|Overall Study|Protocol Violation|1|||
19574845|NCT00983385|42023152|FG000|Observation Period|Not eligible to be dosed|20|||
19574846|NCT00983385|42023152|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
19574847|NCT00992511|42023175|FG000|Overall Study|Migrated/moved from study area|1|||
19574848|NCT00992511|42023176|FG001|Overall Study|Migrated/moved from study area|0|||
19574849|NCT00992511|42023177|FG002|Overall Study|Migrated/moved from study area|1|||
19574850|NCT00992511|42023178|FG003|Overall Study|Migrated/moved from study area|2|||
19574851|NCT00992511|42023175|FG000|Overall Study|Lost to Follow-up|1|||
19574852|NCT00992511|42023176|FG001|Overall Study|Lost to Follow-up|0|||
19574853|NCT00992511|42023177|FG002|Overall Study|Lost to Follow-up|0|||
19574854|NCT00992511|42023178|FG003|Overall Study|Lost to Follow-up|2|||
19574855|NCT00992511|42023175|FG000|Overall Study|Withdrawal by Subject|0|||
19574856|NCT00992511|42023176|FG001|Overall Study|Withdrawal by Subject|0|||
19574857|NCT00992511|42023177|FG002|Overall Study|Withdrawal by Subject|1|||
19574858|NCT00992511|42023178|FG003|Overall Study|Withdrawal by Subject|1|||
19574859|NCT01196429|42023190|FG000|Overall Study|Ineligible - inadequate pathology|1|||
19574860|NCT01196429|42023191|FG001|Overall Study|Ineligible - inadequate pathology|0|||
19574861|NCT01196429|42023190|FG000|Overall Study|Ineligible - wrong cell type|1|||
19574862|NCT01196429|42023191|FG001|Overall Study|Ineligible - wrong cell type|0|||
19574863|NCT01196429|42023190|FG000|Overall Study|Refused - Never Treated|1|||
19574864|NCT01196429|42023191|FG001|Overall Study|Refused - Never Treated|0|||
19574865|NCT01157364|42023205|FG000|Overall Study|Other Reasons|1|||
19574866|NCT01157364|42023206|FG001|Overall Study|Other Reasons|1|||
19574867|NCT01157364|42023207|FG002|Overall Study|Other Reasons|2|||
19574868|NCT01157364|42023208|FG003|Overall Study|Other Reasons|1|||
19574869|NCT01157364|42023209|FG004|Overall Study|Other Reasons|0|||
19574870|NCT01157364|42023210|FG005|Overall Study|Other Reasons|0|||
19574871|NCT01157364|42023205|FG000|Overall Study|Personal Reasons|0|||
19574872|NCT01157364|42023206|FG001|Overall Study|Personal Reasons|2|||
19574873|NCT01157364|42023207|FG002|Overall Study|Personal Reasons|0|||
19574874|NCT01157364|42023208|FG003|Overall Study|Personal Reasons|0|||
19574875|NCT01157364|42023209|FG004|Overall Study|Personal Reasons|1|||
19574876|NCT01157364|42023210|FG005|Overall Study|Personal Reasons|1|||
19574877|NCT01157364|42023205|FG000|Overall Study|Lost to Follow-up|1|||
19574878|NCT01157364|42023206|FG001|Overall Study|Lost to Follow-up|0|||
19574879|NCT01157364|42023207|FG002|Overall Study|Lost to Follow-up|1|||
19574880|NCT01157364|42023208|FG003|Overall Study|Lost to Follow-up|0|||
19574881|NCT01157364|42023209|FG004|Overall Study|Lost to Follow-up|0|||
19574882|NCT01157364|42023210|FG005|Overall Study|Lost to Follow-up|0|||
19574883|NCT01157364|42023205|FG000|Overall Study|Lack of Efficacy|0|||
19574884|NCT01157364|42023206|FG001|Overall Study|Lack of Efficacy|0|||
19574885|NCT01157364|42023207|FG002|Overall Study|Lack of Efficacy|0|||
19574886|NCT01157364|42023208|FG003|Overall Study|Lack of Efficacy|1|||
19574887|NCT01157364|42023209|FG004|Overall Study|Lack of Efficacy|0|||
19574888|NCT01157364|42023210|FG005|Overall Study|Lack of Efficacy|0|||
19574889|NCT01157364|42023205|FG000|Overall Study|Adverse Event|0|||
19574890|NCT01157364|42023206|FG001|Overall Study|Adverse Event|1|||
19574891|NCT01157364|42023207|FG002|Overall Study|Adverse Event|1|||
19574892|NCT01157364|42023208|FG003|Overall Study|Adverse Event|0|||
19574893|NCT01157364|42023209|FG004|Overall Study|Adverse Event|1|||
19574894|NCT01157364|42023210|FG005|Overall Study|Adverse Event|0|||
19574895|NCT01195415|42023224|FG000|Overall Study|No repeat biopsy due to progression|2|||
19574896|NCT01195103|42023231|FG000|Overall Study|Withdrawal by Subject|1|||
19574897|NCT01195103|42023232|FG001|Overall Study|Withdrawal by Subject|0|||
19574898|NCT01195103|42023233|FG002|Overall Study|Withdrawal by Subject|0|||
19574899|NCT01194869|42023241|FG000|Overall Study|Disease Progression|2|||
19574900|NCT01194869|42023241|FG000|Overall Study|Toxicity|2|||
19574901|NCT01177800|42023247|FG000|Overall Study|Adverse Event|9|||
19574902|NCT01177800|42023248|FG001|Overall Study|Adverse Event|3|||
19574903|NCT01177800|42023247|FG000|Overall Study|Protocol Violation|0|||
19574904|NCT01177800|42023248|FG001|Overall Study|Protocol Violation|1|||
19574905|NCT01177800|42023247|FG000|Overall Study|Physician Decision|1|||
19574906|NCT01177800|42023248|FG001|Overall Study|Physician Decision|0|||
19574907|NCT01177800|42023247|FG000|Overall Study|Withdrawal of informed consent|0|||
19574908|NCT01177800|42023248|FG001|Overall Study|Withdrawal of informed consent|1|||
19574909|NCT01177722|42023258|FG000|Overall Study|Serious Adverse Event|0|||
19574910|NCT01177722|42023259|FG001|Overall Study|Serious Adverse Event|0|||
19574911|NCT01177722|42023260|FG002|Overall Study|Serious Adverse Event|1|||
19574912|NCT01177722|42023261|FG003|Overall Study|Serious Adverse Event|0|||
19574913|NCT01177722|42023258|FG000|Overall Study|Protocol Violation|0|||
19574914|NCT01177722|42023259|FG001|Overall Study|Protocol Violation|0|||
19574915|NCT01177722|42023260|FG002|Overall Study|Protocol Violation|1|||
19574916|NCT01177722|42023261|FG003|Overall Study|Protocol Violation|0|||
19574917|NCT01177722|42023258|FG000|Overall Study|Lost to Follow-up|3|||
19574918|NCT01177722|42023259|FG001|Overall Study|Lost to Follow-up|4|||
19574919|NCT01177722|42023260|FG002|Overall Study|Lost to Follow-up|3|||
19574920|NCT01177722|42023261|FG003|Overall Study|Lost to Follow-up|1|||
19574921|NCT01177722|42023258|FG000|Overall Study|Withdrawal by Subject|10|||
19574922|NCT01177722|42023259|FG001|Overall Study|Withdrawal by Subject|6|||
19574923|NCT01177722|42023260|FG002|Overall Study|Withdrawal by Subject|4|||
19574924|NCT01177722|42023261|FG003|Overall Study|Withdrawal by Subject|6|||
19574925|NCT01177410|42023275|FG000|Overall Study|Adverse Event|0|||
19574926|NCT01177410|42023276|FG001|Overall Study|Adverse Event|2|||
19574927|NCT01177410|42023277|FG002|Overall Study|Adverse Event|2|||
19574928|NCT01177410|42023275|FG000|Overall Study|Withdrawal by Subject|1|||
19574929|NCT01177410|42023276|FG001|Overall Study|Withdrawal by Subject|4|||
19574930|NCT01177410|42023277|FG002|Overall Study|Withdrawal by Subject|3|||
19574931|NCT01177410|42023275|FG000|Overall Study|Lost to Follow-up|0|||
19574932|NCT01177410|42023276|FG001|Overall Study|Lost to Follow-up|1|||
19574933|NCT01177410|42023277|FG002|Overall Study|Lost to Follow-up|0|||
19574934|NCT01156116|42023287|FG000|Overall Study|Withdrawal by Subject|3|||
19574935|NCT01156116|42023288|FG001|Overall Study|Withdrawal by Subject|1|||
19574936|NCT01156116|42023287|FG000|Overall Study|CPAP intolerance|2|||
19574937|NCT01156116|42023288|FG001|Overall Study|CPAP intolerance|0|||
19574938|NCT01155726|42023294|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
19574939|NCT01155726|42023295|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
19574940|NCT01155726|42023296|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
19574941|NCT01155726|42023297|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
19574942|NCT01155570|42023319|FG000|Overall Study|Adverse Event|39|||
19574943|NCT01155570|42023319|FG000|Overall Study|Lack of Efficacy|46|||
19574944|NCT01155570|42023319|FG000|Overall Study|Participant's Economic Reasons|17|||
19574945|NCT01155570|42023319|FG000|Overall Study|No Hospital Visits|7|||
19574946|NCT01155570|42023319|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
19574947|NCT01155570|42023319|FG000|Overall Study|Adverse Event + Other Reasons|7|||
19574948|NCT01155570|42023319|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
19574949|NCT01155570|42023319|FG000|Overall Study|Other Reasons|23|||
19574950|NCT01155024|42023325|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
19574951|NCT01155024|42023326|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
19574952|NCT01155024|42023325|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
19574953|NCT01155024|42023326|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
19574954|NCT01155024|42023325|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
19574955|NCT01155024|42023326|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
19574956|NCT01176240|42023337|FG000|Study 306A|Lack of Efficacy|2|||
19574957|NCT01176240|42023338|FG001|Study 306A|Lack of Efficacy|1|||
19574958|NCT01176240|42023337|FG000|Study 306A|Protocol Violation|0|||
19574959|NCT01176240|42023338|FG001|Study 306A|Protocol Violation|1|||
19574960|NCT01176240|42023337|FG000|Study 306A|Withdrawal by Subject|0|||
19574961|NCT01176240|42023338|FG001|Study 306A|Withdrawal by Subject|1|||
19574962|NCT01176240|42023337|FG000|Study 306A|Stop due to diverse problems|1|||
19574963|NCT01176240|42023338|FG001|Study 306A|Stop due to diverse problems|0|||
19574964|NCT01176240|42023337|FG000|Study 306B|Lack of Efficacy|5|||
19574965|NCT01176240|42023338|FG001|Study 306B|Lack of Efficacy|3|||
19574966|NCT01176240|42023337|FG000|Study 306B|Adverse Event|10|||
19574967|NCT01176240|42023338|FG001|Study 306B|Adverse Event|5|||
19574968|NCT01176240|42023337|FG000|Study 306B|Protocol Violation|2|||
19574969|NCT01176240|42023338|FG001|Study 306B|Protocol Violation|3|||
19574970|NCT01176240|42023337|FG000|Study 306B|Withdrawal by Subject|4|||
19574971|NCT01176240|42023338|FG001|Study 306B|Withdrawal by Subject|1|||
19574972|NCT01176240|42023337|FG000|Study 306B|Physician Decision|2|||
19574973|NCT01176240|42023338|FG001|Study 306B|Physician Decision|1|||
19574974|NCT01176240|42023337|FG000|Study 306B|Supine Hypertension|1|||
19574975|NCT01176240|42023338|FG001|Study 306B|Supine Hypertension|2|||
19574976|NCT01176240|42023337|FG000|Study 306B|Lost to Follow-up|0|||
19574977|NCT01176240|42023338|FG001|Study 306B|Lost to Follow-up|1|||
19574978|NCT01176240|42023337|FG000|Study 306B|withdrew prior to dosing|2|||
19574979|NCT01176240|42023338|FG001|Study 306B|withdrew prior to dosing|1|||
19574980|NCT00988221|42023347|FG000|Part I|Adverse Event|0|||
19574981|NCT00988221|42023348|FG001|Part I|Adverse Event|1|||
19574982|NCT00988221|42023349|FG002|Part I|Adverse Event|2|||
19574983|NCT00988221|42023350|FG003|Part I|Adverse Event|0|||
19574984|NCT00988221|42023347|FG000|Part I|Insufficient Therapeutic Response|4|||
19574985|NCT00988221|42023348|FG001|Part I|Insufficient Therapeutic Response|6|||
19574986|NCT00988221|42023349|FG002|Part I|Insufficient Therapeutic Response|5|||
19574987|NCT00988221|42023350|FG003|Part I|Insufficient Therapeutic Response|0|||
19574988|NCT00988221|42023347|FG000|Part I|Refused Treatment|0|||
19574989|NCT00988221|42023348|FG001|Part I|Refused Treatment|2|||
19574990|NCT00988221|42023349|FG002|Part I|Refused Treatment|1|||
19574991|NCT00988221|42023350|FG003|Part I|Refused Treatment|0|||
19574992|NCT00988221|42023347|FG000|Part I|Lost to Follow-up|0|||
19574993|NCT00988221|42023348|FG001|Part I|Lost to Follow-up|1|||
19574994|NCT00988221|42023349|FG002|Part I|Lost to Follow-up|0|||
19574995|NCT00988221|42023350|FG003|Part I|Lost to Follow-up|0|||
19574996|NCT00988221|42023347|FG000|Part II|Adverse Event|1|||
19574997|NCT00988221|42023348|FG001|Part II|Adverse Event|0|||
19574998|NCT00988221|42023349|FG002|Part II|Adverse Event|0|||
19574999|NCT00988221|42023350|FG003|Part II|Adverse Event|1|||
19575000|NCT00988221|42023347|FG000|Part II|Withdrawal by Subject|0|||
19575001|NCT00988221|42023348|FG001|Part II|Withdrawal by Subject|0|||
19575002|NCT00988221|42023349|FG002|Part II|Withdrawal by Subject|2|||
19575003|NCT00988221|42023350|FG003|Part II|Withdrawal by Subject|2|||
19575004|NCT00988221|42023347|FG000|Part II|Reason not Specified|0|||
19575005|NCT00988221|42023348|FG001|Part II|Reason not Specified|0|||
19575006|NCT00988221|42023349|FG002|Part II|Reason not Specified|1|||
19575007|NCT00988221|42023350|FG003|Part II|Reason not Specified|0|||
19575008|NCT00988221|42023347|FG000|Part III|Adverse Event|1|||
19575009|NCT00988221|42023348|FG001|Part III|Adverse Event|0|||
19575010|NCT00988221|42023349|FG002|Part III|Adverse Event|1|||
19575011|NCT00988221|42023350|FG003|Part III|Adverse Event|0|||
19575012|NCT00988221|42023347|FG000|Part III|Insufficient Therapeutic Response|0|||
19575013|NCT00988221|42023348|FG001|Part III|Insufficient Therapeutic Response|1|||
19575014|NCT00988221|42023349|FG002|Part III|Insufficient Therapeutic Response|1|||
19575015|NCT00988221|42023350|FG003|Part III|Insufficient Therapeutic Response|0|||
19575016|NCT00988221|42023347|FG000|Part III|Refused Treatment|0|||
19575017|NCT00988221|42023348|FG001|Part III|Refused Treatment|0|||
19575018|NCT00988221|42023349|FG002|Part III|Refused Treatment|1|||
19575019|NCT00988221|42023350|FG003|Part III|Refused Treatment|0|||
19575020|NCT01149096|42023371|FG000|Overall Study|Lost to Follow-up|0|||
19575021|NCT01149096|42023372|FG001|Overall Study|Lost to Follow-up|1|||
19575022|NCT01175382|42023382|FG000|Overall Study|Lost to Follow-up|4|||
19575023|NCT01175382|42023383|FG001|Overall Study|Lost to Follow-up|3|||
19575024|NCT01175382|42023384|FG002|Overall Study|Lost to Follow-up|1|||
19575025|NCT01175382|42023382|FG000|Overall Study|Physician Decision|0|||
19575026|NCT01175382|42023383|FG001|Overall Study|Physician Decision|1|||
19575027|NCT01175382|42023384|FG002|Overall Study|Physician Decision|0|||
19575028|NCT01175382|42023382|FG000|Overall Study|Withdrawal by Subject|0|||
19575029|NCT01175382|42023383|FG001|Overall Study|Withdrawal by Subject|0|||
19575030|NCT01175382|42023384|FG002|Overall Study|Withdrawal by Subject|1|||
19575031|NCT01175382|42023382|FG000|Overall Study|No longer having problem|1|||
19575032|NCT01175382|42023383|FG001|Overall Study|No longer having problem|0|||
19575033|NCT01175382|42023384|FG002|Overall Study|No longer having problem|1|||
19575034|NCT01175382|42023382|FG000|Overall Study|Unable/unwilling to attend visits|3|||
19575035|NCT01175382|42023383|FG001|Overall Study|Unable/unwilling to attend visits|1|||
19575036|NCT01175382|42023384|FG002|Overall Study|Unable/unwilling to attend visits|2|||
19575037|NCT01175382|42023382|FG000|Overall Study|Unwilling to follow protocol|0|||
19575038|NCT01175382|42023383|FG001|Overall Study|Unwilling to follow protocol|1|||
19575039|NCT01175382|42023384|FG002|Overall Study|Unwilling to follow protocol|0|||
19575040|NCT01175382|42023382|FG000|Overall Study|Unable to tolerate study meds|0|||
19575041|NCT01175382|42023383|FG001|Overall Study|Unable to tolerate study meds|1|||
19575042|NCT01175382|42023384|FG002|Overall Study|Unable to tolerate study meds|1|||
19575043|NCT01194245|42023397|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
19575044|NCT01194245|42023398|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
19575045|NCT01194245|42023399|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
19575046|NCT01194245|42023400|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
19575047|NCT01194245|42023401|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
19575048|NCT01194245|42023397|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
19575049|NCT01194245|42023398|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
19575050|NCT01194245|42023399|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
19575051|NCT01194245|42023400|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
19575052|NCT01194245|42023401|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
19575053|NCT01194245|42023397|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
19575054|NCT01194245|42023398|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
19575055|NCT01194245|42023399|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
19575056|NCT01194245|42023400|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
19575057|NCT01194245|42023401|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
19575058|NCT01194245|42023397|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
19575059|NCT01194245|42023398|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
19575060|NCT01194245|42023399|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
19575061|NCT01194245|42023400|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
19575062|NCT01194245|42023401|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
19575063|NCT01194245|42023397|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19575064|NCT01194245|42023398|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19575065|NCT01194245|42023399|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19575066|NCT01194245|42023400|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19575067|NCT01194245|42023401|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
19575068|NCT01194245|42023397|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19575069|NCT01194245|42023398|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19575070|NCT01194245|42023399|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
19575071|NCT01194245|42023400|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
19575072|NCT01194245|42023401|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
19575073|NCT00979407|42023412|FG000|Overall Study|Withdrawal by Subject|3|||
19575074|NCT00979407|42023413|FG001|Overall Study|Withdrawal by Subject|4|||
19575075|NCT00979407|42023412|FG000|Overall Study|Lost to Follow-up|3|||
19575076|NCT00979407|42023413|FG001|Overall Study|Lost to Follow-up|3|||
19575077|NCT01148862|42023421|FG000|Second Intervention|Withdrawal by Subject|0|||
19575078|NCT01148862|42023422|FG001|Second Intervention|Withdrawal by Subject|2|||
19575079|NCT00975975|42023428|FG000|Overall Study|Death|6|||
19575080|NCT01193153|42023432|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
19575081|NCT01193153|42023433|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
19575082|NCT01193153|42023432|FG000|Open-label Lead in Period|Pregnancy|1|||
19575083|NCT01193153|42023433|FG001|Open-label Lead in Period|Pregnancy|0|||
19575084|NCT01193153|42023432|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
19575085|NCT01193153|42023433|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
19575086|NCT01193153|42023432|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
19575087|NCT01193153|42023433|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
19575088|NCT01193153|42023432|FG000|Open-label Lead in Period|Other|14|||
19575089|NCT01193153|42023433|FG001|Open-label Lead in Period|Other|0|||
19575090|NCT01193153|42023432|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
19575091|NCT01193153|42023433|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
19575092|NCT01193153|42023432|FG000|Open-label Lead in Period|Adverse Event|41|||
19575093|NCT01193153|42023433|FG001|Open-label Lead in Period|Adverse Event|0|||
19575094|NCT01193153|42023432|FG000|Open-label Lead in Period|Death|1|||
19575095|NCT01193153|42023433|FG001|Open-label Lead in Period|Death|0|||
19575096|NCT01193153|42023432|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
19575097|NCT01193153|42023433|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
19575098|NCT01193153|42023432|FG000|Open-label Stabilization Period|Adverse Event|9|||
19575099|NCT01193153|42023433|FG001|Open-label Stabilization Period|Adverse Event|0|||
19575100|NCT01193153|42023432|FG000|Open-label Stabilization Period|Death|2|||
19575101|NCT01193153|42023433|FG001|Open-label Stabilization Period|Death|0|||
19575102|NCT01193153|42023432|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
19575103|NCT01193153|42023433|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
19575104|NCT01193153|42023432|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
19575105|NCT01193153|42023433|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
19575106|NCT01193153|42023432|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
19575107|NCT01193153|42023433|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
19575108|NCT01193153|42023432|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
19575109|NCT01193153|42023433|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
19575110|NCT01193153|42023432|FG000|Open-label Stabilization Period|Other|8|||
19575111|NCT01193153|42023433|FG001|Open-label Stabilization Period|Other|0|||
19575112|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Other|2|||
19575113|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Other|3|||
19575114|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
19575115|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
19575116|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Death|2|||
19575117|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Death|0|||
19575118|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
19575119|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
19575120|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
19575121|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
19575122|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
19575123|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
19575124|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
19575125|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
19575126|NCT01193153|42023432|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
19575127|NCT01193153|42023433|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
19575128|NCT01192295|42023444|FG000|Overall Study|Adverse Event|3|||
19575129|NCT01192295|42023445|FG001|Overall Study|Adverse Event|7|||
19575130|NCT01192295|42023444|FG000|Overall Study|Withdrawal by Subject|3|||
19575131|NCT01192295|42023445|FG001|Overall Study|Withdrawal by Subject|4|||
19575132|NCT01192295|42023444|FG000|Overall Study|Lost to Follow-up|0|||
19575133|NCT01192295|42023445|FG001|Overall Study|Lost to Follow-up|1|||
19575134|NCT01192295|42023444|FG000|Overall Study|Lack of Efficacy|0|||
19575135|NCT01192295|42023445|FG001|Overall Study|Lack of Efficacy|5|||
19575136|NCT01192295|42023444|FG000|Overall Study|Administrative|4|||
19575137|NCT01192295|42023445|FG001|Overall Study|Administrative|6|||
19575138|NCT01154166|42023455|FG000|Overall Study|Adverse Event|14|||
19575139|NCT01154166|42023456|FG001|Overall Study|Adverse Event|9|||
19575140|NCT01154166|42023455|FG000|Overall Study|Lost to Follow-up|1|||
19575141|NCT01154166|42023456|FG001|Overall Study|Lost to Follow-up|1|||
19575142|NCT01154166|42023455|FG000|Overall Study|Protocol Violation|4|||
19575143|NCT01154166|42023456|FG001|Overall Study|Protocol Violation|1|||
19575144|NCT01154166|42023455|FG000|Overall Study|Withdrawal by Subject|10|||
19575145|NCT01154166|42023456|FG001|Overall Study|Withdrawal by Subject|1|||
19575146|NCT01154166|42023455|FG000|Overall Study|Lack of Efficacy|3|||
19575147|NCT01154166|42023456|FG001|Overall Study|Lack of Efficacy|0|||
19575148|NCT01154166|42023455|FG000|Overall Study|Disease Progression|1|||
19575149|NCT01154166|42023456|FG001|Overall Study|Disease Progression|0|||
19575150|NCT01154166|42023455|FG000|Overall Study|Poor Compliance|1|||
19575151|NCT01154166|42023456|FG001|Overall Study|Poor Compliance|0|||
19575152|NCT01154088|42023465|FG000|Overall Study|Lost to Follow-up|4|||
19575153|NCT01154088|42023466|FG001|Overall Study|Lost to Follow-up|6|||
19575154|NCT01154088|42023467|FG002|Overall Study|Lost to Follow-up|7|||
19575155|NCT00975585|42023478|FG000|Overall Study|Adverse Event|0|||
19575156|NCT00975585|42023479|FG001|Overall Study|Adverse Event|4|||
19575157|NCT00975585|42023478|FG000|Overall Study|Lost to Follow-up|3|||
19575158|NCT00975585|42023479|FG001|Overall Study|Lost to Follow-up|5|||
19575159|NCT00975585|42023478|FG000|Overall Study|Withdrawal by Subject|2|||
19575160|NCT00975585|42023479|FG001|Overall Study|Withdrawal by Subject|1|||
19575161|NCT00975585|42023478|FG000|Overall Study|Lens issue|2|||
19575162|NCT00975585|42023479|FG001|Overall Study|Lens issue|2|||
19575163|NCT01181921|42023487|FG000|Overall Study|Lost to Follow-up|1|||
19575164|NCT01174446|42023491|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
19575165|NCT01174446|42023492|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
19575166|NCT01174446|42023493|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
19575167|NCT01174446|42023494|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
19575168|NCT01174446|42023491|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
19575169|NCT01174446|42023492|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
19575170|NCT01174446|42023493|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
19575171|NCT01174446|42023494|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
19575172|NCT01174446|42023491|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
19575173|NCT01174446|42023492|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
19575174|NCT01174446|42023493|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
19575175|NCT01174446|42023494|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
19575176|NCT01174446|42023491|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
19575177|NCT01174446|42023492|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
19575178|NCT01174446|42023493|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
19575179|NCT01174446|42023494|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
19575180|NCT00932698|42023552|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
19575181|NCT00932698|42023553|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
19575182|NCT00932698|42023554|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
19575183|NCT00932698|42023555|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
19575184|NCT00932698|42023556|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
19575185|NCT00932698|42023557|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
19575186|NCT00932698|42023558|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
19575187|NCT00932698|42023559|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
19575188|NCT00932698|42023560|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
19575189|NCT00932698|42023561|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
19575190|NCT00932698|42023562|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
19575191|NCT00932698|42023552|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575192|NCT00932698|42023553|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
19575193|NCT00932698|42023554|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575194|NCT00932698|42023555|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
19575195|NCT00932698|42023556|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575196|NCT00932698|42023557|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
19575197|NCT00932698|42023558|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
19575198|NCT00932698|42023559|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575199|NCT00932698|42023560|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575200|NCT00932698|42023561|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575201|NCT00932698|42023562|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
19575202|NCT00932698|42023552|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
19575203|NCT00932698|42023553|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
19575204|NCT00932698|42023554|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
19575205|NCT00932698|42023555|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
19575206|NCT00932698|42023556|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
19575207|NCT00932698|42023557|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
19575208|NCT00932698|42023558|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
19575209|NCT00932698|42023559|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
19575210|NCT00932698|42023560|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
19575211|NCT00932698|42023561|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
19575212|NCT00932698|42023562|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
19575213|NCT00932698|42023552|FG000|Part 1 (Dose Escalation)|Other|0|||
19575214|NCT00932698|42023553|FG001|Part 1 (Dose Escalation)|Other|0|||
19575215|NCT00932698|42023554|FG002|Part 1 (Dose Escalation)|Other|1|||
19575216|NCT00932698|42023555|FG003|Part 1 (Dose Escalation)|Other|0|||
19575217|NCT00932698|42023556|FG004|Part 1 (Dose Escalation)|Other|0|||
19575218|NCT00932698|42023557|FG005|Part 1 (Dose Escalation)|Other|0|||
19575219|NCT00932698|42023558|FG006|Part 1 (Dose Escalation)|Other|1|||
19575220|NCT00932698|42023559|FG007|Part 1 (Dose Escalation)|Other|0|||
19575221|NCT00932698|42023560|FG008|Part 1 (Dose Escalation)|Other|0|||
19575222|NCT00932698|42023561|FG009|Part 1 (Dose Escalation)|Other|0|||
19575223|NCT00932698|42023562|FG010|Part 1 (Dose Escalation)|Other|0|||
19575224|NCT00932698|42023552|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575225|NCT00932698|42023553|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575226|NCT00932698|42023554|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575227|NCT00932698|42023555|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575228|NCT00932698|42023556|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575229|NCT00932698|42023557|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575230|NCT00932698|42023558|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
19575231|NCT00932698|42023559|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
19575232|NCT00932698|42023560|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
19575233|NCT00932698|42023561|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
19575234|NCT00932698|42023562|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
19575235|NCT00932698|42023552|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575236|NCT00932698|42023553|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575237|NCT00932698|42023554|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575238|NCT00932698|42023555|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575239|NCT00932698|42023556|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575240|NCT00932698|42023557|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575241|NCT00932698|42023558|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575242|NCT00932698|42023559|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
19575243|NCT00932698|42023560|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
19575244|NCT00932698|42023561|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
19575245|NCT00932698|42023562|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
19575246|NCT00932698|42023552|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
19575247|NCT00932698|42023553|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
19575248|NCT00932698|42023554|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
19575249|NCT00932698|42023555|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
19575250|NCT00932698|42023556|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
19575251|NCT00932698|42023557|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
19575252|NCT00932698|42023558|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
19575253|NCT00932698|42023559|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
19575254|NCT00932698|42023560|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
19575255|NCT00932698|42023561|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
19575256|NCT00932698|42023562|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
19575257|NCT00978627|42023590|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
19575258|NCT00978627|42023591|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
19575259|NCT00978627|42023590|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
19575260|NCT00978627|42023591|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
19575261|NCT00978627|42023590|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
19575262|NCT00978627|42023591|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
19575263|NCT00978627|42023590|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
19575264|NCT00978627|42023591|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
19575265|NCT00978627|42023590|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
19575266|NCT00978627|42023591|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
19575267|NCT00978627|42023590|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
19575268|NCT00978627|42023591|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
19575269|NCT00978627|42023590|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
19575270|NCT00978627|42023591|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
19575271|NCT00978627|42023590|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
19575272|NCT00978627|42023591|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
19575273|NCT00978627|42023590|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
19575274|NCT00978627|42023591|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
19575275|NCT01181609|42023597|FG000|Overall Study|Adverse Event|1|||
19575276|NCT01181609|42023597|FG000|Overall Study|Withdrawal by Subject|1|||
19575277|NCT01181609|42023597|FG000|Overall Study|Lost to Follow-up|1|||
19575278|NCT01181609|42023597|FG000|Overall Study|Death|50|||
19575279|NCT01154010|42023603|FG000|Overall Study|Lost to Follow-up|0|||
19575280|NCT01154010|42023604|FG001|Overall Study|Lost to Follow-up|1|||
19575281|NCT01153698|42023610|FG000|Overall Study|Adverse Event|12|||
19575282|NCT01153698|42023610|FG000|Overall Study|Lost to Follow-up|4|||
19575283|NCT01153698|42023610|FG000|Overall Study|Withdrawal by Subject|2|||
19575284|NCT01153698|42023610|FG000|Overall Study|Switch to other anticoagulants|4|||
19575285|NCT01153698|42023610|FG000|Overall Study|Other|2|||
19575286|NCT01153698|42023610|FG000|Overall Study|Not treated with Pradaxa|5|||
19575287|NCT01174368|42023615|FG000|Overall Study|Withdrawal by Subject|1|||
19575288|NCT01147926|42023621|FG000|Overall Study|Subject Withdrew Consent|9|||
19575289|NCT01147926|42023622|FG001|Overall Study|Subject Withdrew Consent|10|||
19575290|NCT01147926|42023621|FG000|Overall Study|Adverse Event|7|||
19575291|NCT01147926|42023622|FG001|Overall Study|Adverse Event|6|||
19575292|NCT01147926|42023621|FG000|Overall Study|Subject Non-Compliant|5|||
19575293|NCT01147926|42023622|FG001|Overall Study|Subject Non-Compliant|4|||
19575294|NCT01147926|42023621|FG000|Overall Study|Principal investigator left hospital|1|||
19575295|NCT01147926|42023622|FG001|Overall Study|Principal investigator left hospital|3|||
19575296|NCT01147926|42023621|FG000|Overall Study|Selection criteria not met|3|||
19575297|NCT01147926|42023622|FG001|Overall Study|Selection criteria not met|1|||
19575298|NCT01147926|42023621|FG000|Overall Study|Lost to Follow-up|0|||
19575299|NCT01147926|42023622|FG001|Overall Study|Lost to Follow-up|2|||
19575300|NCT01147926|42023621|FG000|Overall Study|Sponsor's Decision|0|||
19575301|NCT01147926|42023622|FG001|Overall Study|Sponsor's Decision|1|||
19575302|NCT01147926|42023621|FG000|Overall Study|Lack of Efficacy|1|||
19575303|NCT01147926|42023622|FG001|Overall Study|Lack of Efficacy|0|||
19575304|NCT01147926|42023621|FG000|Overall Study|Too busy, no time for study|1|||
19575305|NCT01147926|42023622|FG001|Overall Study|Too busy, no time for study|0|||
19575306|NCT01147926|42023621|FG000|Overall Study|Went on holiday|0|||
19575307|NCT01147926|42023622|FG001|Overall Study|Went on holiday|1|||
19575308|NCT01147926|42023621|FG000|Overall Study|Colonoscopy result|0|||
19575309|NCT01147926|42023622|FG001|Overall Study|Colonoscopy result|1|||
19575310|NCT00975507|42023630|FG000|Overall Study|Adverse Event|1|||
19575311|NCT00975507|42023631|FG001|Overall Study|Adverse Event|0|||
19575312|NCT00975507|42023630|FG000|Overall Study|Lost to Follow-up|7|||
19575313|NCT00975507|42023631|FG001|Overall Study|Lost to Follow-up|1|||
19575314|NCT00975507|42023630|FG000|Overall Study|Protocol Violation|2|||
19575315|NCT00975507|42023631|FG001|Overall Study|Protocol Violation|0|||
19575316|NCT00975507|42023630|FG000|Overall Study|Withdrawal by Subject|10|||
19575317|NCT00975507|42023631|FG001|Overall Study|Withdrawal by Subject|3|||
19575318|NCT01147848|42023641|FG000|Run-in Period|Screen Failure|623|||
19575319|NCT01147848|42023642|FG001|Run-in Period|Screen Failure|0|||
19575320|NCT01147848|42023643|FG002|Run-in Period|Screen Failure|0|||
19575321|NCT01147848|42023641|FG000|Run-in Period|Run-in Failure|135|||
19575322|NCT01147848|42023642|FG001|Run-in Period|Run-in Failure|0|||
19575323|NCT01147848|42023643|FG002|Run-in Period|Run-in Failure|0|||
19575324|NCT01147848|42023641|FG000|Randomized Phase|Adverse Event|0|||
19575325|NCT01147848|42023642|FG001|Randomized Phase|Adverse Event|6|||
19575326|NCT01147848|42023643|FG002|Randomized Phase|Adverse Event|8|||
19575327|NCT01147848|42023641|FG000|Randomized Phase|Lack of Efficacy|0|||
19575328|NCT01147848|42023642|FG001|Randomized Phase|Lack of Efficacy|20|||
19575329|NCT01147848|42023643|FG002|Randomized Phase|Lack of Efficacy|11|||
19575330|NCT01147848|42023641|FG000|Randomized Phase|Protocol Violation|0|||
19575331|NCT01147848|42023642|FG001|Randomized Phase|Protocol Violation|7|||
19575332|NCT01147848|42023643|FG002|Randomized Phase|Protocol Violation|10|||
19575333|NCT01147848|42023641|FG000|Randomized Phase|Lost to Follow-up|0|||
19575334|NCT01147848|42023642|FG001|Randomized Phase|Lost to Follow-up|5|||
19575335|NCT01147848|42023643|FG002|Randomized Phase|Lost to Follow-up|7|||
19575336|NCT01147848|42023641|FG000|Randomized Phase|Physician Decision|0|||
19575337|NCT01147848|42023642|FG001|Randomized Phase|Physician Decision|0|||
19575338|NCT01147848|42023643|FG002|Randomized Phase|Physician Decision|1|||
19575339|NCT01147848|42023641|FG000|Randomized Phase|Withdrawal by Subject|0|||
19575340|NCT01147848|42023642|FG001|Randomized Phase|Withdrawal by Subject|7|||
19575341|NCT01147848|42023643|FG002|Randomized Phase|Withdrawal by Subject|9|||
19575342|NCT00929656|42023652|FG000|Overall Study|Lost to Follow-up|0|||
19575343|NCT00929656|42023653|FG001|Overall Study|Lost to Follow-up|1|||
19575344|NCT00977613|42023659|FG000|Overall Study|Lost to Follow-up|16|||
19575345|NCT01152996|42023663|FG000|Overall Study|Withdrawal by Subject|142|||
19575346|NCT01152996|42023663|FG000|Overall Study|Adverse Event|115|||
19575347|NCT01152996|42023663|FG000|Overall Study|Lost to Follow-up|112|||
19575348|NCT01152996|42023663|FG000|Overall Study|Lack of Efficacy|68|||
19575349|NCT01152996|42023663|FG000|Overall Study|Noncompliance|41|||
19575350|NCT01152996|42023663|FG000|Overall Study|Other|36|||
19575351|NCT01152996|42023663|FG000|Overall Study|Protocol Violation|22|||
19575352|NCT01152996|42023663|FG000|Overall Study|Elevated liver enzymes|1|||
19575353|NCT00979953|42023671|FG000|Overall Study|Adverse Event|5|||
19575354|NCT00979953|42023672|FG001|Overall Study|Adverse Event|2|||
19387775|NCT02042404|41631078|FG000|Overall Study|Unrelated Adverse Event|3|||
19387776|NCT02042404|41631079|FG001|Overall Study|Unrelated Adverse Event|0|||
19387777|NCT02042404|41631078|FG000|Overall Study|Inability to meet time requirements|1|||
19387778|NCT02042404|41631079|FG001|Overall Study|Inability to meet time requirements|0|||
19387779|NCT02042014|41631086|FG000|Overall Study|Adverse Event|1|||
19387780|NCT02042014|41631086|FG000|Overall Study|Physician Decision|7|||
19575355|NCT00979953|42023673|FG002|Overall Study|Adverse Event|17|||
19387781|NCT02041702|41631092|FG000|Overall Study|Lost to Follow-up|1|||
19387782|NCT02041702|41631093|FG001|Overall Study|Lost to Follow-up|6|||
19387783|NCT02041702|41631092|FG000|Overall Study|Death|4|||
19575356|NCT00979953|42023674|FG003|Overall Study|Adverse Event|4|||
19575357|NCT00979953|42023671|FG000|Overall Study|Lack of Efficacy|1|||
19575358|NCT00979953|42023672|FG001|Overall Study|Lack of Efficacy|2|||
19575359|NCT00979953|42023673|FG002|Overall Study|Lack of Efficacy|0|||
19575360|NCT00979953|42023674|FG003|Overall Study|Lack of Efficacy|0|||
19575361|NCT00979953|42023671|FG000|Overall Study|Lost to Follow-up|1|||
19575362|NCT00979953|42023672|FG001|Overall Study|Lost to Follow-up|1|||
19575363|NCT00979953|42023673|FG002|Overall Study|Lost to Follow-up|1|||
19575364|NCT00979953|42023674|FG003|Overall Study|Lost to Follow-up|0|||
19575365|NCT00979953|42023671|FG000|Overall Study|Withdrawal by Subject|0|||
19575366|NCT00979953|42023672|FG001|Overall Study|Withdrawal by Subject|0|||
19575367|NCT00979953|42023673|FG002|Overall Study|Withdrawal by Subject|2|||
19575368|NCT00979953|42023674|FG003|Overall Study|Withdrawal by Subject|1|||
19575369|NCT00979953|42023671|FG000|Overall Study|Protocol Violation|1|||
19575370|NCT00979953|42023672|FG001|Overall Study|Protocol Violation|0|||
19575371|NCT00979953|42023673|FG002|Overall Study|Protocol Violation|2|||
19575372|NCT00979953|42023674|FG003|Overall Study|Protocol Violation|2|||
19575373|NCT01181531|42023686|FG000|Overall Study|Other|17|||
19575374|NCT01181531|42023687|FG001|Overall Study|Other|12|||
19575375|NCT01181531|42023686|FG000|Overall Study|Partial consent by subject withdrawn|0|||
19575376|NCT01181531|42023687|FG001|Overall Study|Partial consent by subject withdrawn|1|||
19575377|NCT01181531|42023686|FG000|Overall Study|Physician Decision|3|||
19575378|NCT01181531|42023687|FG001|Overall Study|Physician Decision|1|||
19575379|NCT01181531|42023686|FG000|Overall Study|Noncompliance|2|||
19575380|NCT01181531|42023687|FG001|Overall Study|Noncompliance|2|||
19575381|NCT01181531|42023686|FG000|Overall Study|Ineligibility determined|1|||
19575382|NCT01181531|42023687|FG001|Overall Study|Ineligibility determined|2|||
19575383|NCT01181531|42023686|FG000|Overall Study|Protocol Specified Criteria|15|||
19575384|NCT01181531|42023687|FG001|Overall Study|Protocol Specified Criteria|8|||
19575385|NCT01181531|42023686|FG000|Overall Study|Pregnancy|0|||
19575386|NCT01181531|42023687|FG001|Overall Study|Pregnancy|1|||
19575387|NCT01181531|42023686|FG000|Overall Study|Withdrawal by Subject|8|||
19575388|NCT01181531|42023687|FG001|Overall Study|Withdrawal by Subject|7|||
19575389|NCT01181531|42023686|FG000|Overall Study|Protocol Violation|6|||
19575390|NCT01181531|42023687|FG001|Overall Study|Protocol Violation|6|||
19575391|NCT01181531|42023686|FG000|Overall Study|Death|9|||
19575392|NCT01181531|42023687|FG001|Overall Study|Death|12|||
19575393|NCT01181531|42023686|FG000|Overall Study|Adverse Event|0|||
19575394|NCT01181531|42023687|FG001|Overall Study|Adverse Event|1|||
19575395|NCT01152450|42023693|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
19575396|NCT01152450|42023694|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
19575397|NCT01152450|42023695|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
19575398|NCT01152450|42023696|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
19575399|NCT01152450|42023697|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
19575400|NCT01152450|42023698|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
19575401|NCT01152450|42023693|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
19575402|NCT01152450|42023694|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
19575403|NCT01152450|42023695|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
19575404|NCT01152450|42023696|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
19575405|NCT01152450|42023697|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
19575406|NCT01152450|42023698|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
19575407|NCT01152450|42023693|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19575408|NCT01152450|42023694|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
19575409|NCT01152450|42023695|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
19575410|NCT01152450|42023696|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19575411|NCT01152450|42023697|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19575412|NCT01152450|42023698|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
19575413|NCT01181141|42023708|FG000|Overall Study|Adverse Event|2|||
19575414|NCT01181141|42023709|FG001|Overall Study|Adverse Event|1|||
19575415|NCT01181141|42023708|FG000|Overall Study|Lack of Efficacy|1|||
19575416|NCT01181141|42023709|FG001|Overall Study|Lack of Efficacy|0|||
19575417|NCT01181141|42023708|FG000|Overall Study|Lost to Follow-up|1|||
19575418|NCT01181141|42023709|FG001|Overall Study|Lost to Follow-up|1|||
19575419|NCT01181141|42023708|FG000|Overall Study|Physician Decision|2|||
19575420|NCT01181141|42023709|FG001|Overall Study|Physician Decision|0|||
19575421|NCT01181141|42023708|FG000|Overall Study|Protocol Violation|3|||
19575422|NCT01181141|42023709|FG001|Overall Study|Protocol Violation|1|||
19575423|NCT01181141|42023708|FG000|Overall Study|Withdrawal by Subject|3|||
19575424|NCT01181141|42023709|FG001|Overall Study|Withdrawal by Subject|1|||
19575425|NCT01173120|42023715|FG000|Overall Study|Lack of Efficacy|2|||
19575426|NCT01173120|42023715|FG000|Overall Study|Lost to Follow-up|1|||
19575427|NCT01173120|42023715|FG000|Overall Study|Participant Decision|2|||
19575428|NCT01173120|42023715|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
19575429|NCT01173120|42023715|FG000|Overall Study|Switch-Participant Decision|12|||
19575430|NCT01173120|42023715|FG000|Overall Study|Switch-Difficulty With Device|12|||
19575431|NCT00977379|42023723|FG000|Overall Study|Withdrawal by Subject|1|||
19575432|NCT00977379|42023724|FG001|Overall Study|Withdrawal by Subject|1|||
19575433|NCT00977379|42023723|FG000|Overall Study|Death|7|||
19745817|NCT03529773|42193183|FG027|Overall Study|Death|0|||
19745818|NCT03529773|42193184|FG028|Overall Study|Death|0|||
19745819|NCT03529773|42193185|FG029|Overall Study|Death|0|||
19745820|NCT03529773|42193186|FG030|Overall Study|Death|0|||
19745821|NCT03529773|42193187|FG031|Overall Study|Death|0|||
19745822|NCT03529773|42193188|FG032|Overall Study|Death|0|||
19745823|NCT03529773|42193189|FG033|Overall Study|Death|1|||
19745824|NCT03529773|42193190|FG034|Overall Study|Death|1|||
19745825|NCT03529773|42193191|FG035|Overall Study|Death|0|||
19745826|NCT03529773|42193192|FG036|Overall Study|Death|1|||
19745827|NCT03529773|42193193|FG037|Overall Study|Death|0|||
19745828|NCT03529773|42193194|FG038|Overall Study|Death|0|||
19745829|NCT03529773|42193195|FG039|Overall Study|Death|0|||
19745830|NCT03529773|42193156|FG000|Overall Study|Lost to Follow-up|0|||
19745831|NCT03529773|42193157|FG001|Overall Study|Lost to Follow-up|0|||
19745832|NCT03529773|42193158|FG002|Overall Study|Lost to Follow-up|1|||
19745833|NCT03529773|42193159|FG003|Overall Study|Lost to Follow-up|0|||
19745834|NCT03529773|42193160|FG004|Overall Study|Lost to Follow-up|1|||
19745835|NCT03529773|42193161|FG005|Overall Study|Lost to Follow-up|1|||
19745836|NCT03529773|42193162|FG006|Overall Study|Lost to Follow-up|0|||
19745837|NCT03529773|42193163|FG007|Overall Study|Lost to Follow-up|0|||
19745838|NCT03529773|42193164|FG008|Overall Study|Lost to Follow-up|0|||
19745839|NCT03529773|42193165|FG009|Overall Study|Lost to Follow-up|0|||
19745840|NCT03529773|42193166|FG010|Overall Study|Lost to Follow-up|0|||
19745841|NCT03529773|42193167|FG011|Overall Study|Lost to Follow-up|0|||
19745842|NCT03529773|42193168|FG012|Overall Study|Lost to Follow-up|0|||
19387784|NCT02041702|41631093|FG001|Overall Study|Death|0|||
19387785|NCT02041702|41631092|FG000|Overall Study|Withdrawal by Subject|4|||
19745843|NCT03529773|42193169|FG013|Overall Study|Lost to Follow-up|1|||
19745844|NCT03529773|42193170|FG014|Overall Study|Lost to Follow-up|4|||
19745845|NCT03529773|42193171|FG015|Overall Study|Lost to Follow-up|1|||
19387786|NCT02041702|41631093|FG001|Overall Study|Withdrawal by Subject|3|||
19575434|NCT00977379|42023724|FG001|Overall Study|Death|9|||
19575435|NCT00977379|42023723|FG000|Overall Study|Premature Study Termination|4|||
19745846|NCT03529773|42193172|FG016|Overall Study|Lost to Follow-up|1|||
19745847|NCT03529773|42193173|FG017|Overall Study|Lost to Follow-up|0|||
19745848|NCT03529773|42193174|FG018|Overall Study|Lost to Follow-up|1|||
19745849|NCT03529773|42193175|FG019|Overall Study|Lost to Follow-up|1|||
19745850|NCT03529773|42193176|FG020|Overall Study|Lost to Follow-up|2|||
19745851|NCT03529773|42193177|FG021|Overall Study|Lost to Follow-up|4|||
19745852|NCT03529773|42193178|FG022|Overall Study|Lost to Follow-up|3|||
19575436|NCT00977379|42023724|FG001|Overall Study|Premature Study Termination|0|||
19575437|NCT00977379|42023723|FG000|Overall Study|Participant Moving House|0|||
19575438|NCT00977379|42023724|FG001|Overall Study|Participant Moving House|1|||
19575439|NCT00977379|42023723|FG000|Overall Study|Randomization Error|0|||
19575440|NCT00977379|42023724|FG001|Overall Study|Randomization Error|1|||
19575441|NCT01180985|42023730|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
19575442|NCT01180985|42023731|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
19575443|NCT01147536|42023738|FG000|Overall Study|Administrative study close|2|||
19575444|NCT01147536|42023738|FG000|Overall Study|Death|1|||
19575445|NCT01180049|42023744|FG000|Overall Study|Other|9|||
19575446|NCT01180049|42023745|FG001|Overall Study|Other|7|||
19575447|NCT01180049|42023744|FG000|Overall Study|Lost to Follow-up|8|||
19575448|NCT01180049|42023745|FG001|Overall Study|Lost to Follow-up|6|||
19575449|NCT01180049|42023744|FG000|Overall Study|Death|36|||
19575450|NCT01180049|42023745|FG001|Overall Study|Death|35|||
19575451|NCT01147458|42023751|FG000|First Intervention|Study terminated by sponsor|8|||
19575452|NCT01147458|42023752|FG001|First Intervention|Study terminated by sponsor|8|||
19575453|NCT01147458|42023753|FG002|First Intervention|Study terminated by sponsor|7|||
19575454|NCT01147458|42023754|FG003|First Intervention|Study terminated by sponsor|8|||
19575455|NCT01147458|42023751|FG000|First Intervention|Protocol Violation|2|||
19575456|NCT01147458|42023752|FG001|First Intervention|Protocol Violation|3|||
19575457|NCT01147458|42023753|FG002|First Intervention|Protocol Violation|2|||
19575458|NCT01147458|42023754|FG003|First Intervention|Protocol Violation|3|||
19575459|NCT01147458|42023751|FG000|First Intervention|Withdrawal by Subject|3|||
19575460|NCT01147458|42023752|FG001|First Intervention|Withdrawal by Subject|0|||
19575461|NCT01147458|42023753|FG002|First Intervention|Withdrawal by Subject|1|||
19575462|NCT01147458|42023754|FG003|First Intervention|Withdrawal by Subject|0|||
19575463|NCT01147458|42023751|FG000|First Intervention|Adverse Event|0|||
19575464|NCT01147458|42023752|FG001|First Intervention|Adverse Event|3|||
19575465|NCT01147458|42023753|FG002|First Intervention|Adverse Event|2|||
19575466|NCT01147458|42023754|FG003|First Intervention|Adverse Event|3|||
19575467|NCT01147458|42023751|FG000|First Intervention|Other|1|||
19575468|NCT01147458|42023752|FG001|First Intervention|Other|2|||
19575469|NCT01147458|42023753|FG002|First Intervention|Other|0|||
19575470|NCT01147458|42023754|FG003|First Intervention|Other|0|||
19575471|NCT01147458|42023751|FG000|Second Intervention|Study terminated by sponsor|7|||
19575472|NCT01147458|42023752|FG001|Second Intervention|Study terminated by sponsor|5|||
19575473|NCT01147458|42023753|FG002|Second Intervention|Study terminated by sponsor|5|||
19575474|NCT01147458|42023754|FG003|Second Intervention|Study terminated by sponsor|3|||
19575475|NCT01147458|42023751|FG000|Second Intervention|Protocol Violation|0|||
19575476|NCT01147458|42023752|FG001|Second Intervention|Protocol Violation|1|||
19575477|NCT01147458|42023753|FG002|Second Intervention|Protocol Violation|1|||
19575478|NCT01147458|42023754|FG003|Second Intervention|Protocol Violation|0|||
19575479|NCT01147458|42023751|FG000|Second Intervention|Withdrawal by Subject|0|||
19575480|NCT01147458|42023752|FG001|Second Intervention|Withdrawal by Subject|1|||
19575481|NCT01147458|42023753|FG002|Second Intervention|Withdrawal by Subject|0|||
19575482|NCT01147458|42023754|FG003|Second Intervention|Withdrawal by Subject|0|||
19575483|NCT01147458|42023751|FG000|Second Intervention|Adverse Event|2|||
19575484|NCT01147458|42023752|FG001|Second Intervention|Adverse Event|0|||
19575485|NCT01147458|42023753|FG002|Second Intervention|Adverse Event|1|||
19575486|NCT01147458|42023754|FG003|Second Intervention|Adverse Event|1|||
19575487|NCT01147458|42023751|FG000|Second Intervention|Other|0|||
19575488|NCT01147458|42023752|FG001|Second Intervention|Other|0|||
19575489|NCT01147458|42023753|FG002|Second Intervention|Other|1|||
19575490|NCT01147458|42023754|FG003|Second Intervention|Other|0|||
19575491|NCT01172808|42023770|FG000|Overall Study|Adverse Event|8|||
19575492|NCT01172808|42023771|FG001|Overall Study|Adverse Event|4|||
19575493|NCT01172808|42023772|FG002|Overall Study|Adverse Event|8|||
19575494|NCT01172808|42023773|FG003|Overall Study|Adverse Event|3|||
19575495|NCT01172808|42023770|FG000|Overall Study|Lack of Efficacy|1|||
19575496|NCT01172808|42023771|FG001|Overall Study|Lack of Efficacy|0|||
19575497|NCT01172808|42023772|FG002|Overall Study|Lack of Efficacy|0|||
19575498|NCT01172808|42023773|FG003|Overall Study|Lack of Efficacy|0|||
19575499|NCT01172808|42023770|FG000|Overall Study|Protocol Violation|2|||
19575500|NCT01172808|42023771|FG001|Overall Study|Protocol Violation|2|||
19575501|NCT01172808|42023772|FG002|Overall Study|Protocol Violation|2|||
19575502|NCT01172808|42023773|FG003|Overall Study|Protocol Violation|0|||
19575503|NCT01172808|42023770|FG000|Overall Study|Lost to Follow-up|0|||
19575504|NCT01172808|42023771|FG001|Overall Study|Lost to Follow-up|1|||
19575505|NCT01172808|42023772|FG002|Overall Study|Lost to Follow-up|1|||
19575506|NCT01172808|42023773|FG003|Overall Study|Lost to Follow-up|3|||
19575507|NCT01172808|42023770|FG000|Overall Study|Withdrawal by Subject|4|||
19575508|NCT01172808|42023771|FG001|Overall Study|Withdrawal by Subject|1|||
19575509|NCT01172808|42023772|FG002|Overall Study|Withdrawal by Subject|3|||
19575510|NCT01172808|42023773|FG003|Overall Study|Withdrawal by Subject|2|||
19575511|NCT01172808|42023770|FG000|Overall Study|Other|6|||
19575512|NCT01172808|42023771|FG001|Overall Study|Other|5|||
19575513|NCT01172808|42023772|FG002|Overall Study|Other|9|||
19575514|NCT01172808|42023773|FG003|Overall Study|Other|7|||
19575515|NCT04066491|42023786|FG000|Overall Study|Treatment ongoing|2|||
19575516|NCT04066491|42023787|FG001|Overall Study|Treatment ongoing|72|||
19575517|NCT04066491|42023788|FG002|Overall Study|Treatment ongoing|66|||
19575518|NCT04066491|42023786|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
19575519|NCT04066491|42023787|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
19575520|NCT04066491|42023788|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
19575521|NCT04066491|42023786|FG000|Overall Study|Randomized, not treated|0|||
19575522|NCT04066491|42023787|FG001|Overall Study|Randomized, not treated|0|||
19575523|NCT04066491|42023788|FG002|Overall Study|Randomized, not treated|2|||
19575524|NCT01151280|42023797|FG000|Overall Study|Adverse Event|1|||
19575525|NCT01151280|42023797|FG000|Overall Study|Lack of Efficacy|3|||
19575526|NCT01149486|42023803|FG000|First Intervention|Adverse Event|0|||
19575527|NCT01149486|42023804|FG001|First Intervention|Adverse Event|1|||
19575528|NCT00601705|42023810|FG000|Overall Study|Withdrawal by Subject|1|||
19575529|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
19575530|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
19575531|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
19575532|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
19575533|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
19575534|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
19575535|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
19575536|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
19575537|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
19575538|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
19745853|NCT03529773|42193179|FG023|Overall Study|Lost to Follow-up|4|||
19575539|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
19575540|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
19575541|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2|Death|0|||
19575542|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2|Death|0|||
19575543|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2|Death|1|||
19575544|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2|Death|0|||
19575545|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
19575546|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
19575547|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
19575548|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
19575549|NCT01179737|42023819|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
19575550|NCT01179737|42023820|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
19575551|NCT01179737|42023821|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
19575552|NCT01179737|42023822|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
19575553|NCT01179737|42023819|FG000|Extension|The study was terminated|3|||
19575554|NCT01179737|42023820|FG001|Extension|The study was terminated|0|||
19575555|NCT01179737|42023821|FG002|Extension|The study was terminated|0|||
19575556|NCT01179737|42023822|FG003|Extension|The study was terminated|0|||
19575557|NCT00929110|42023834|FG000|Overall Study|Adverse Event|40|||
19575558|NCT00929110|42023835|FG001|Overall Study|Adverse Event|29|||
19575559|NCT00929110|42023836|FG002|Overall Study|Adverse Event|18|||
19575560|NCT00929110|42023834|FG000|Overall Study|Subject withdrew consent|40|||
19575561|NCT00929110|42023835|FG001|Overall Study|Subject withdrew consent|23|||
19575562|NCT00929110|42023836|FG002|Overall Study|Subject withdrew consent|26|||
19575563|NCT00929110|42023834|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
19575564|NCT00929110|42023835|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
19575565|NCT00929110|42023836|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
19575566|NCT00929110|42023834|FG000|Overall Study|Lost to Follow-up|7|||
19575567|NCT00929110|42023835|FG001|Overall Study|Lost to Follow-up|7|||
19575568|NCT00929110|42023836|FG002|Overall Study|Lost to Follow-up|3|||
19575569|NCT00929110|42023834|FG000|Overall Study|Protocol deviation|5|||
19575570|NCT00929110|42023835|FG001|Overall Study|Protocol deviation|2|||
19575571|NCT00929110|42023836|FG002|Overall Study|Protocol deviation|4|||
19575572|NCT00929110|42023834|FG000|Overall Study|Administrative problems|4|||
19575573|NCT00929110|42023835|FG001|Overall Study|Administrative problems|1|||
19575574|NCT00929110|42023836|FG002|Overall Study|Administrative problems|2|||
19575575|NCT00929110|42023834|FG000|Overall Study|Death|2|||
19575576|NCT00929110|42023835|FG001|Overall Study|Death|2|||
19575577|NCT00929110|42023836|FG002|Overall Study|Death|2|||
19575578|NCT00929110|42023834|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19575579|NCT00929110|42023835|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19575580|NCT00929110|42023836|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19575581|NCT00929110|42023834|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19575582|NCT00929110|42023835|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19575583|NCT00929110|42023836|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19575584|NCT00929110|42023834|FG000|Overall Study|Patient inability to use the device|0|||
19575585|NCT00929110|42023835|FG001|Overall Study|Patient inability to use the device|1|||
19575586|NCT00929110|42023836|FG002|Overall Study|Patient inability to use the device|0|||
19575587|NCT01147068|42023851|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
19575588|NCT01147068|42023852|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
19575589|NCT01147068|42023853|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
19575590|NCT01147068|42023854|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
19575591|NCT01147068|42023855|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
19575592|NCT01147068|42023856|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
19575593|NCT01147068|42023857|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
19575594|NCT01147068|42023851|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
19575595|NCT01147068|42023852|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
19575596|NCT01147068|42023853|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
19575597|NCT01147068|42023854|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
19575598|NCT01147068|42023855|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
19575599|NCT01147068|42023856|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
19575600|NCT01147068|42023857|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
19575601|NCT01147068|42023851|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
19575602|NCT01147068|42023852|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
19575603|NCT01147068|42023853|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
19575604|NCT01147068|42023854|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
19575605|NCT01147068|42023855|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
19575606|NCT01147068|42023856|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
19575607|NCT01147068|42023857|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
19575608|NCT01147068|42023851|FG000|Subjects That Received 2nd Dose|Other|0|||
19575609|NCT01147068|42023852|FG001|Subjects That Received 2nd Dose|Other|3|||
19575610|NCT01147068|42023853|FG002|Subjects That Received 2nd Dose|Other|3|||
19575611|NCT01147068|42023854|FG003|Subjects That Received 2nd Dose|Other|0|||
19575612|NCT01147068|42023855|FG004|Subjects That Received 2nd Dose|Other|1|||
19575613|NCT01147068|42023856|FG005|Subjects That Received 2nd Dose|Other|0|||
19575614|NCT01147068|42023857|FG006|Subjects That Received 2nd Dose|Other|0|||
19575615|NCT01147068|42023851|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
19575616|NCT01147068|42023852|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
19575617|NCT01147068|42023853|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
19575618|NCT01147068|42023854|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
19575619|NCT01147068|42023855|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
19575620|NCT01147068|42023856|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
19575621|NCT01147068|42023857|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
19575622|NCT01147068|42023851|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575623|NCT01147068|42023852|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575624|NCT01147068|42023853|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575625|NCT01147068|42023854|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
19575626|NCT01147068|42023855|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575627|NCT01147068|42023856|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575628|NCT01147068|42023857|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
19575629|NCT01147068|42023851|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575630|NCT01147068|42023852|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
19575631|NCT01147068|42023853|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575632|NCT01147068|42023854|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575633|NCT01147068|42023855|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575634|NCT01147068|42023856|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575635|NCT01147068|42023857|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
19575636|NCT01146912|42023880|FG000|Overall Study|Already received influenza vaccination|817|||
19575637|NCT01146912|42023881|FG001|Overall Study|Already received influenza vaccination|822|||
19575638|NCT01146912|42023882|FG002|Overall Study|Already received influenza vaccination|13|||
19575639|NCT01146912|42023883|FG003|Overall Study|Already received influenza vaccination|15|||
19575640|NCT01146912|42023884|FG004|Overall Study|Already received influenza vaccination|41|||
19575641|NCT01146912|42023885|FG005|Overall Study|Already received influenza vaccination|61|||
19575642|NCT01146912|42023886|FG006|Overall Study|Already received influenza vaccination|56|||
19575643|NCT01146912|42023887|FG007|Overall Study|Already received influenza vaccination|0|||
19575644|NCT01146912|42023880|FG000|Overall Study|< 14 weeks gestational age|0|||
19575645|NCT01146912|42023881|FG001|Overall Study|< 14 weeks gestational age|0|||
19575646|NCT01146912|42023882|FG002|Overall Study|< 14 weeks gestational age|3|||
19575647|NCT01146912|42023883|FG003|Overall Study|< 14 weeks gestational age|2|||
19575648|NCT01146912|42023884|FG004|Overall Study|< 14 weeks gestational age|0|||
19575649|NCT01146912|42023885|FG005|Overall Study|< 14 weeks gestational age|0|||
19575650|NCT01146912|42023886|FG006|Overall Study|< 14 weeks gestational age|0|||
19575651|NCT01146912|42023887|FG007|Overall Study|< 14 weeks gestational age|0|||
19575652|NCT01146912|42023880|FG000|Overall Study|Duplicate patient|0|||
19575653|NCT01146912|42023881|FG001|Overall Study|Duplicate patient|0|||
19575654|NCT01146912|42023882|FG002|Overall Study|Duplicate patient|1|||
19575655|NCT01146912|42023883|FG003|Overall Study|Duplicate patient|0|||
19575656|NCT01146912|42023884|FG004|Overall Study|Duplicate patient|0|||
19575657|NCT01146912|42023885|FG005|Overall Study|Duplicate patient|0|||
19575658|NCT01146912|42023886|FG006|Overall Study|Duplicate patient|0|||
19575659|NCT01146912|42023887|FG007|Overall Study|Duplicate patient|0|||
19575660|NCT01134042|42023909|FG000|Overall Study|Adverse Event|3|||
19575661|NCT01134042|42023910|FG001|Overall Study|Adverse Event|7|||
19575662|NCT01134042|42023911|FG002|Overall Study|Adverse Event|2|||
19575663|NCT01134042|42023909|FG000|Overall Study|Lack of Efficacy|21|||
19575664|NCT01134042|42023910|FG001|Overall Study|Lack of Efficacy|6|||
19575665|NCT01134042|42023911|FG002|Overall Study|Lack of Efficacy|18|||
19575666|NCT01134042|42023909|FG000|Overall Study|Protocol Violation|5|||
19575667|NCT01134042|42023910|FG001|Overall Study|Protocol Violation|3|||
19575668|NCT01134042|42023911|FG002|Overall Study|Protocol Violation|5|||
19575669|NCT01134042|42023909|FG000|Overall Study|Lost to Follow-up|2|||
19575670|NCT01134042|42023910|FG001|Overall Study|Lost to Follow-up|0|||
19575671|NCT01134042|42023911|FG002|Overall Study|Lost to Follow-up|1|||
19575672|NCT01134042|42023909|FG000|Overall Study|Physician Decision|4|||
19575673|NCT01134042|42023910|FG001|Overall Study|Physician Decision|8|||
19575674|NCT01134042|42023911|FG002|Overall Study|Physician Decision|1|||
19575675|NCT01134042|42023909|FG000|Overall Study|Withdrawal by Subject|13|||
19575676|NCT01134042|42023910|FG001|Overall Study|Withdrawal by Subject|4|||
19575677|NCT01134042|42023911|FG002|Overall Study|Withdrawal by Subject|7|||
19575678|NCT01179347|42023922|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
19575679|NCT01179347|42023923|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
19575680|NCT01179347|42023922|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
19575681|NCT01179347|42023923|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
19575682|NCT01179347|42023922|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
19575683|NCT01179347|42023923|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
19575684|NCT01179347|42023922|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
19575685|NCT01179347|42023923|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
19575686|NCT01179347|42023922|FG000|Double-blind Period (12 Weeks)|Other|2|||
19575687|NCT01179347|42023923|FG001|Double-blind Period (12 Weeks)|Other|4|||
19575688|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
19575689|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
19575690|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
19575691|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
19575692|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
19575693|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
19575694|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
19575695|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
19575696|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
19575697|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
19575698|NCT01179347|42023922|FG000|Open-label Period (12 Weeks)|Other|7|||
19575699|NCT01179347|42023923|FG001|Open-label Period (12 Weeks)|Other|4|||
19575700|NCT01146288|42023933|FG000|First Intervention(1 Day)|Adverse Event|0|||
19575701|NCT01146288|42023934|FG001|First Intervention(1 Day)|Adverse Event|1|||
19575702|NCT01146054|42023941|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
19575703|NCT01146054|42023941|FG000|Overall Study|Rapid tumor progression|2|||
19575704|NCT01146054|42023941|FG000|Overall Study|Other illness precluded treatment|2|||
19387787|NCT02041702|41631092|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
19575705|NCT01146054|42023941|FG000|Overall Study|Lost to Follow-up|1|||
19575706|NCT01145898|42023947|FG000|3-year Treatment|medication change by treating physician|3|||
19575707|NCT01145898|42023948|FG001|3-year Treatment|medication change by treating physician|16|||
19387788|NCT02041702|41631093|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
19575708|NCT01133418|42023955|FG000|Overall Study|Lost to Follow-up|5|||
19575709|NCT01133418|42023956|FG001|Overall Study|Lost to Follow-up|6|||
19575710|NCT00931918|42023964|FG000|Overall Study|Adverse Event|4|||
19575711|NCT00931918|42023965|FG001|Overall Study|Adverse Event|6|||
19575712|NCT00931918|42023964|FG000|Overall Study|Progressive Disease|2|||
19575713|NCT00931918|42023965|FG001|Overall Study|Progressive Disease|1|||
19575714|NCT00931918|42023964|FG000|Overall Study|Symptomatic Deterioration|1|||
19575715|NCT00931918|42023965|FG001|Overall Study|Symptomatic Deterioration|0|||
19575716|NCT00931918|42023964|FG000|Overall Study|Withdrawal by Patient|3|||
19575717|NCT00931918|42023965|FG001|Overall Study|Withdrawal by Patient|4|||
19575718|NCT00931918|42023964|FG000|Overall Study|Other Reason not Specified|4|||
19575719|NCT00931918|42023965|FG001|Overall Study|Other Reason not Specified|4|||
19575720|NCT00931918|42023964|FG000|Overall Study|Did not receive study drug|3|||
19575721|NCT00931918|42023965|FG001|Overall Study|Did not receive study drug|2|||
19575722|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
19575723|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
19575724|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
19575725|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
19575726|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
19575727|NCT01179191|42023971|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
19575728|NCT01179191|42023971|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
19575729|NCT01179191|42023971|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
19575730|NCT01179191|42023971|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
19575731|NCT01179191|42023971|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
19575732|NCT01179191|42023971|FG000|Maintenance Phase (8 Weeks)|Other|66|||
19575733|NCT01169844|42023977|FG000|Overall Study|Adverse Event|0|||
19575734|NCT01169844|42023978|FG001|Overall Study|Adverse Event|1|||
19575735|NCT01169844|42023977|FG000|Overall Study|Patient withdrew consent|4|||
19575736|NCT01169844|42023978|FG001|Overall Study|Patient withdrew consent|0|||
19575737|NCT01169844|42023977|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19575738|NCT01169844|42023978|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19575739|NCT01132482|42023986|FG000|Overall Study|Adverse Event|1|||
19575740|NCT01132482|42023987|FG001|Overall Study|Adverse Event|0|||
19575741|NCT00931762|42023993|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
19575742|NCT00931762|42023993|FG000|Overall Study|Administrative Problems|5|||
19575743|NCT00931762|42023993|FG000|Overall Study|Death|1|||
19575744|NCT00931762|42023993|FG000|Overall Study|Disease Progression|3|||
19575745|NCT00931762|42023993|FG000|Overall Study|Adverse Event (s)|11|||
19575746|NCT00931762|42023993|FG000|Overall Study|Subject withdrew consent|13|||
19575747|NCT01132326|42023997|FG000|Overall Study|Lack of Efficacy|25|||
19575748|NCT01132326|42023997|FG000|Overall Study|Adverse Event|37|||
19575749|NCT01132326|42023997|FG000|Overall Study|Protocol Violation|1|||
19575750|NCT01132326|42023997|FG000|Overall Study|Lost to Follow-up|16|||
19575751|NCT01132326|42023997|FG000|Overall Study|Withdrawal by Subject|40|||
19575752|NCT01132326|42023997|FG000|Overall Study|Physician Decision|10|||
19575753|NCT01132326|42023997|FG000|Overall Study|Study Termination|80|||
19575754|NCT01132326|42023997|FG000|Overall Study|Declining Health|1|||
19575755|NCT01132326|42023997|FG000|Overall Study|Pregnancy|1|||
19575756|NCT01132326|42023997|FG000|Overall Study|Caregiver Withdrew Consent|1|||
19575757|NCT01132326|42023997|FG000|Overall Study|Death|5|||
19575758|NCT01132326|42023997|FG000|Overall Study|Subject Unable to Come To Visits|1|||
19575759|NCT01178411|42024001|FG000|Overall Study|Adverse Event|5|||
19575760|NCT01178411|42024001|FG000|Overall Study|Withdrawal by Subject|4|||
19575761|NCT01178411|42024001|FG000|Overall Study|Protocol Violation|1|||
19575762|NCT01178411|42024001|FG000|Overall Study|Progressive disease per RECIST|32|||
19575763|NCT01178411|42024001|FG000|Overall Study|Progressive disease per clinician|9|||
19575764|NCT01178411|42024001|FG000|Overall Study|Physician Decision|6|||
19575765|NCT01178411|42024001|FG000|Overall Study|Death|1|||
19575766|NCT01178411|42024001|FG000|Overall Study|No reason provided|1|||
19575767|NCT01178411|42024001|FG000|Overall Study|Drug manufacturing ended|1|||
19575768|NCT01145508|42024007|FG000|Overall Study|Adverse Event|1|||
19575769|NCT01145508|42024008|FG001|Overall Study|Adverse Event|0|||
19575770|NCT01145508|42024007|FG000|Overall Study|Death|1|||
19575771|NCT01145508|42024008|FG001|Overall Study|Death|0|||
19575772|NCT01145508|42024007|FG000|Overall Study|Physician Decision|2|||
19575773|NCT01145508|42024008|FG001|Overall Study|Physician Decision|1|||
19575774|NCT01145508|42024007|FG000|Overall Study|Never started treatment|1|||
19575775|NCT01145508|42024008|FG001|Overall Study|Never started treatment|1|||
19575776|NCT00931528|42024016|FG000|Overall Study|Protocol Violation|9|||
19575777|NCT00931528|42024017|FG001|Overall Study|Protocol Violation|12|||
19575778|NCT00931528|42024016|FG000|Overall Study|Withdrawal by Subject|4|||
19575779|NCT00931528|42024017|FG001|Overall Study|Withdrawal by Subject|12|||
19575780|NCT00931528|42024016|FG000|Overall Study|Lost to Follow-up|6|||
19575781|NCT00931528|42024017|FG001|Overall Study|Lost to Follow-up|13|||
19575782|NCT00931528|42024016|FG000|Overall Study|Assessment outside of Time Frame|22|||
19575783|NCT00931528|42024017|FG001|Overall Study|Assessment outside of Time Frame|23|||
19575784|NCT00975195|42024026|FG000|Overall Study|Adverse Event|108|||
19575785|NCT00975195|42024027|FG001|Overall Study|Adverse Event|101|||
19575786|NCT00975195|42024026|FG000|Overall Study|Lack of Efficacy|6|||
19575787|NCT00975195|42024027|FG001|Overall Study|Lack of Efficacy|6|||
19575788|NCT00975195|42024026|FG000|Overall Study|Protocol Violation|27|||
19575789|NCT00975195|42024027|FG001|Overall Study|Protocol Violation|23|||
19575790|NCT00975195|42024026|FG000|Overall Study|Lost to Follow-up|9|||
19575791|NCT00975195|42024027|FG001|Overall Study|Lost to Follow-up|7|||
19575792|NCT00975195|42024026|FG000|Overall Study|Withdrawal by Subject|48|||
19575793|NCT00975195|42024027|FG001|Overall Study|Withdrawal by Subject|61|||
19575794|NCT00975195|42024026|FG000|Overall Study|Other reason not defined above|29|||
19575795|NCT00975195|42024027|FG001|Overall Study|Other reason not defined above|33|||
19575796|NCT00975195|42024026|FG000|Overall Study|Not treated|1|||
19575797|NCT00975195|42024027|FG001|Overall Study|Not treated|2|||
19575798|NCT01145352|42024033|FG000|Overall Study|Found to have been registered twice|6|||
19575799|NCT01145352|42024033|FG000|Overall Study|Treated before marketing approval|4|||
19575800|NCT01145352|42024033|FG000|Overall Study|Syringe formulation was used|1|||
19575801|NCT01178099|42024041|FG000|Overall Study|Physician Decision|0|||
19575802|NCT01178099|42024042|FG001|Overall Study|Physician Decision|1|||
19575803|NCT01169532|42024052|FG000|Overall Study|Withdrawal by Subject|1|||
19575804|NCT00928564|42024058|FG000|Overall Study|Lost to Follow-up|6|||
19575805|NCT00928564|42024059|FG001|Overall Study|Lost to Follow-up|0|||
19575806|NCT01177943|42024067|FG000|First Intervention|Withdrawal by Subject|2|||
19575807|NCT01177943|42024068|FG001|First Intervention|Withdrawal by Subject|0|||
19575808|NCT01131312|42024077|FG000|Overall Study|Lost to Follow-up|425|||
19575809|NCT01131312|42024078|FG001|Overall Study|Lost to Follow-up|229|||
19575810|NCT01131312|42024079|FG002|Overall Study|Lost to Follow-up|351|||
19575811|NCT01177787|42024087|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
19575812|NCT01177787|42024087|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
19575813|NCT01177787|42024087|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
19575814|NCT00928486|42024099|FG000|Overall Study|Adverse Event|2|||
19575815|NCT00928486|42024099|FG000|Overall Study|Disease Progression|7|||
19575816|NCT00928486|42024099|FG000|Overall Study|Withdrawal by Subject|1|||
19575817|NCT01168596|42024105|FG000|Overall Study|Withdrawal by Subject|3|||
19575818|NCT01168596|42024106|FG001|Overall Study|Withdrawal by Subject|1|||
19575819|NCT01177553|42024114|FG000|Overall Study|babies not yet 6 months of age|1|||
19575820|NCT01177553|42024115|FG001|Overall Study|babies not yet 6 months of age|0|||
19575821|NCT00928408|42024121|FG000|Overall Study|Other|2|||
19575822|NCT00928408|42024121|FG000|Overall Study|Withdrawal by Subject|4|||
19575823|NCT00928408|42024121|FG000|Overall Study|Death|5|||
19575824|NCT00928408|42024121|FG000|Overall Study|Lost to Follow-up|12|||
19575825|NCT00928252|42024125|FG000|Overall Study|Physician Decision|3|||
19575826|NCT01177007|42024131|FG000|Overall Study|Lost to Follow-up|2|||
19575827|NCT01177007|42024131|FG000|Overall Study|Death|4|||
19575828|NCT01177007|42024131|FG000|Overall Study|Entered hospice care|5|||
19575829|NCT01177007|42024131|FG000|Overall Study|Required additional Y90 treatment|6|||
19575830|NCT01177007|42024131|FG000|Overall Study|Change in treatment modality|21|||
19575831|NCT00930982|42024139|FG000|Overall Study|Adverse Event|19|||
19575832|NCT00930982|42024140|FG001|Overall Study|Adverse Event|23|||
19575833|NCT00930982|42024139|FG000|Overall Study|Protocol Violation|1|||
19575834|NCT00930982|42024140|FG001|Overall Study|Protocol Violation|5|||
19575835|NCT00930982|42024139|FG000|Overall Study|Withdrawal by Subject|1|||
19575836|NCT00930982|42024140|FG001|Overall Study|Withdrawal by Subject|1|||
19575837|NCT01176773|42024146|FG000|Overall Study|Screen Failure|2|||
19575838|NCT01176773|42024146|FG000|Overall Study|Withdrew consent|1|||
19575839|NCT00928018|42024153|FG000|Overall Study|Withdrawal by Subject|1|||
19575840|NCT00928018|42024154|FG001|Overall Study|Withdrawal by Subject|0|||
19575841|NCT00927940|42024164|FG000|Overall Study|Death|1|||
19575842|NCT00927862|42024171|FG000|Overall Study|Missing data needed for endpt analyses|27|||
19575843|NCT00927862|42024172|FG001|Overall Study|Missing data needed for endpt analyses|45|||
19575844|NCT00976989|42024183|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
19575845|NCT00976989|42024184|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
19575846|NCT00976989|42024185|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
19575847|NCT00976989|42024183|FG000|Overall Study|Death|5|||
19575848|NCT00976989|42024184|FG001|Overall Study|Death|7|||
19575849|NCT00976989|42024185|FG002|Overall Study|Death|10|||
19575850|NCT00976989|42024183|FG000|Overall Study|Refused Treatment|4|||
19575851|NCT00976989|42024184|FG001|Overall Study|Refused Treatment|3|||
19575852|NCT00976989|42024185|FG002|Overall Study|Refused Treatment|5|||
19575853|NCT00976989|42024183|FG000|Overall Study|Failure to Return|2|||
19575854|NCT00976989|42024184|FG001|Overall Study|Failure to Return|1|||
19575855|NCT00976989|42024185|FG002|Overall Study|Failure to Return|0|||
19575856|NCT00976989|42024183|FG000|Overall Study|Recurrence of Disease|0|||
19575857|NCT00976989|42024184|FG001|Overall Study|Recurrence of Disease|1|||
19575858|NCT00976989|42024185|FG002|Overall Study|Recurrence of Disease|0|||
19575859|NCT00976989|42024183|FG000|Overall Study|Other|1|||
19575860|NCT00976989|42024184|FG001|Overall Study|Other|0|||
19575861|NCT00976989|42024185|FG002|Overall Study|Other|1|||
19575862|NCT00927784|42024195|FG000|Overall Study|Death|1|||
19575863|NCT00927784|42024196|FG001|Overall Study|Death|0|||
19575864|NCT00927784|42024195|FG000|Overall Study|Withdrawal by Subject|1|||
19575865|NCT00927784|42024196|FG001|Overall Study|Withdrawal by Subject|0|||
19575866|NCT00927472|42024204|FG000|Overall Study|Withdrawal by Subject|10|||
19575867|NCT00927472|42024205|FG001|Overall Study|Withdrawal by Subject|11|||
19575868|NCT00927472|42024204|FG000|Overall Study|Lost to Follow-up|1|||
19575869|NCT00927472|42024205|FG001|Overall Study|Lost to Follow-up|6|||
19575870|NCT00927472|42024204|FG000|Overall Study|Protocol Violation|0|||
19575871|NCT00927472|42024205|FG001|Overall Study|Protocol Violation|1|||
19575872|NCT00927472|42024204|FG000|Overall Study|Post treatment Assessment out of window|0|||
19575873|NCT00927472|42024205|FG001|Overall Study|Post treatment Assessment out of window|4|||
19575874|NCT00927394|42024213|FG000|Overall Study|Adverse Event|14|||
19575875|NCT00927394|42024214|FG001|Overall Study|Adverse Event|9|||
19575876|NCT00927394|42024213|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
19575877|NCT00927394|42024214|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
19575878|NCT00927394|42024213|FG000|Overall Study|Withdrawal by Subject|20|||
19575879|NCT00927394|42024214|FG001|Overall Study|Withdrawal by Subject|24|||
19575880|NCT00927394|42024213|FG000|Overall Study|Lost to Follow-up|8|||
19575881|NCT00927394|42024214|FG001|Overall Study|Lost to Follow-up|14|||
19575882|NCT00927394|42024213|FG000|Overall Study|Administrative Problem|1|||
19575883|NCT00927394|42024214|FG001|Overall Study|Administrative Problem|0|||
19575884|NCT00927394|42024213|FG000|Overall Study|Death|1|||
19575885|NCT00927394|42024214|FG001|Overall Study|Death|1|||
19575886|NCT00927394|42024213|FG000|Overall Study|Protocol deviation|16|||
19575887|NCT00927394|42024214|FG001|Overall Study|Protocol deviation|13|||
19575888|NCT00927394|42024213|FG000|Overall Study|Randomized in error|0|||
19575889|NCT00927394|42024214|FG001|Overall Study|Randomized in error|1|||
19575890|NCT00976911|42024223|FG000|Overall Study|Withdrawal by Subject|4|||
19575891|NCT00976911|42024224|FG001|Overall Study|Withdrawal by Subject|6|||
19575892|NCT00976911|42024223|FG000|Overall Study|Death|138|||
19575893|NCT00976911|42024224|FG001|Overall Study|Death|126|||
19575894|NCT00976911|42024223|FG000|Overall Study|Adverse Event|0|||
19575895|NCT00976911|42024224|FG001|Overall Study|Adverse Event|1|||
19575896|NCT00976911|42024223|FG000|Overall Study|Protocol Violation|2|||
19575897|NCT00976911|42024224|FG001|Overall Study|Protocol Violation|0|||
19575898|NCT00976911|42024223|FG000|Overall Study|Other|8|||
19575899|NCT00976911|42024224|FG001|Overall Study|Other|9|||
19575900|NCT00976911|42024223|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
19575901|NCT00976911|42024224|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
19575902|NCT00934648|42024230|FG000|Overall Study|Failure to return|8|||
19575903|NCT00934648|42024230|FG000|Overall Study|Withdrawal by Subject|1|||
19575904|NCT01175213|42024238|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
19575905|NCT01175213|42024239|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
19575906|NCT01175213|42024238|FG000|IGSC, 10%/rHuPH20|Death|1|||
19575907|NCT01175213|42024239|FG001|IGSC, 10%/rHuPH20|Death|0|||
19575908|NCT01175213|42024238|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
19575909|NCT01175213|42024239|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
19575910|NCT01175213|42024238|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
19575911|NCT01175213|42024239|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
19575912|NCT01175213|42024238|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
19575913|NCT01175213|42024239|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
19575914|NCT01175213|42024238|FG000|Safety Follow-up|Adverse Event|1|||
19575915|NCT01175213|42024239|FG001|Safety Follow-up|Adverse Event|0|||
19575916|NCT00974259|42024250|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
19575917|NCT00974259|42024251|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
19575918|NCT00927082|42024261|FG000|Overall Study|Lost to Follow-up|9|||
19575919|NCT00927082|42024262|FG001|Overall Study|Lost to Follow-up|8|||
19575920|NCT00927082|42024263|FG002|Overall Study|Lost to Follow-up|12|||
19575921|NCT00927082|42024264|FG003|Overall Study|Lost to Follow-up|16|||
19575922|NCT00927082|42024261|FG000|Overall Study|Withdrawal by Subject|3|||
19575923|NCT00927082|42024262|FG001|Overall Study|Withdrawal by Subject|2|||
19575924|NCT00927082|42024263|FG002|Overall Study|Withdrawal by Subject|7|||
19575925|NCT00927082|42024264|FG003|Overall Study|Withdrawal by Subject|2|||
19575926|NCT00927082|42024261|FG000|Overall Study|Death|0|||
19575927|NCT00927082|42024262|FG001|Overall Study|Death|0|||
19575928|NCT00927082|42024263|FG002|Overall Study|Death|1|||
19575929|NCT00927082|42024264|FG003|Overall Study|Death|0|||
19575930|NCT00927082|42024261|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
19575931|NCT00927082|42024262|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
19575932|NCT00927082|42024263|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
19575933|NCT00927082|42024264|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
19575934|NCT00976677|42024280|FG000|Overall Study|Adverse Event|1|||
19575935|NCT00976677|42024281|FG001|Overall Study|Adverse Event|0|||
19575936|NCT00976677|42024280|FG000|Overall Study|Withdrawal by Subject|0|||
19575937|NCT00976677|42024281|FG001|Overall Study|Withdrawal by Subject|2|||
19575938|NCT00976677|42024280|FG000|Overall Study|Disease progression|1|||
19575939|NCT00976677|42024281|FG001|Overall Study|Disease progression|1|||
19575940|NCT00976677|42024280|FG000|Overall Study|Trial unblinded|2|||
19575941|NCT00976677|42024281|FG001|Overall Study|Trial unblinded|2|||
19575942|NCT00976677|42024280|FG000|Overall Study|Unknown/Missing|1|||
19575943|NCT00976677|42024281|FG001|Overall Study|Unknown/Missing|0|||
19575944|NCT00926536|42024289|FG000|Overall Study|Physician Decision|1|||
19575945|NCT00926536|42024290|FG001|Overall Study|Physician Decision|2|||
19575946|NCT00923260|42024298|FG000|Overall Study|Lost to Follow-up|1|||
19575947|NCT00923260|42024299|FG001|Overall Study|Lost to Follow-up|1|||
19575948|NCT00934102|42024305|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
19575949|NCT00934102|42024306|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
19575950|NCT00934102|42024307|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
19575951|NCT00970281|42024326|FG000|Overall Study|Lack of Efficacy|1|||
19575952|NCT00970281|42024327|FG001|Overall Study|Lack of Efficacy|14|||
19575953|NCT00970281|42024326|FG000|Overall Study|Withdrawal by Subject|0|||
19575954|NCT00970281|42024327|FG001|Overall Study|Withdrawal by Subject|1|||
19575955|NCT00970281|42024326|FG000|Overall Study|Physician Decision|1|||
19575956|NCT00970281|42024327|FG001|Overall Study|Physician Decision|1|||
19575957|NCT00976209|42024335|FG000|Treatment Period 1|Protocol Violation|1|||
19575958|NCT00976209|42024336|FG001|Treatment Period 1|Protocol Violation|0|||
19575959|NCT00976209|42024335|FG000|Treatment Period 1|Lost to Follow-up|2|||
19575960|NCT00976209|42024336|FG001|Treatment Period 1|Lost to Follow-up|0|||
19575961|NCT00976209|42024335|FG000|Treatment Period 1|Other|0|||
19575962|NCT00976209|42024336|FG001|Treatment Period 1|Other|1|||
19575963|NCT00976209|42024335|FG000|Wash-out Period|Adverse Event|1|||
19575964|NCT00976209|42024336|FG001|Wash-out Period|Adverse Event|2|||
19575965|NCT00976209|42024335|FG000|Wash-out Period|Lost to Follow-up|1|||
19575966|NCT00976209|42024336|FG001|Wash-out Period|Lost to Follow-up|0|||
19575967|NCT00976209|42024335|FG000|Wash-out Period|Protocol Violation|1|||
19575968|NCT00976209|42024336|FG001|Wash-out Period|Protocol Violation|0|||
19575969|NCT00976209|42024335|FG000|Wash-out Period|Other|1|||
19575970|NCT00976209|42024336|FG001|Wash-out Period|Other|0|||
19575971|NCT00976209|42024335|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19575972|NCT00976209|42024336|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19575973|NCT00976209|42024335|FG000|Treatment Period 2|Lost to Follow-up|0|||
19575974|NCT00976209|42024336|FG001|Treatment Period 2|Lost to Follow-up|1|||
19575975|NCT00925990|42024343|FG000|Overall Study|Adverse Event|1|||
19575976|NCT00925990|42024344|FG001|Overall Study|Adverse Event|3|||
19575977|NCT00925990|42024343|FG000|Overall Study|Withdrawal by Subject|2|||
19575978|NCT00925990|42024344|FG001|Overall Study|Withdrawal by Subject|2|||
19575979|NCT00925990|42024343|FG000|Overall Study|Lost to Follow-up|1|||
19575980|NCT00925990|42024344|FG001|Overall Study|Lost to Follow-up|3|||
19575981|NCT00925990|42024343|FG000|Overall Study|Physician Decision|1|||
19575982|NCT00925990|42024344|FG001|Overall Study|Physician Decision|1|||
19575983|NCT00925990|42024343|FG000|Overall Study|moved out of state, missed medication|0|||
19575984|NCT00925990|42024344|FG001|Overall Study|moved out of state, missed medication|2|||
19575985|NCT01131078|42024353|FG000|Overall Study|Adverse Event|22|||
19575986|NCT01131078|42024354|FG001|Overall Study|Adverse Event|12|||
19575987|NCT01131078|42024355|FG002|Overall Study|Adverse Event|17|||
19575988|NCT01131078|42024353|FG000|Overall Study|Progressive Disease|58|||
19575989|NCT01131078|42024354|FG001|Overall Study|Progressive Disease|77|||
19575990|NCT01131078|42024355|FG002|Overall Study|Progressive Disease|71|||
19575991|NCT01131078|42024353|FG000|Overall Study|Protocol Violation|1|||
19575992|NCT01131078|42024354|FG001|Overall Study|Protocol Violation|0|||
19575993|NCT01131078|42024355|FG002|Overall Study|Protocol Violation|0|||
19575994|NCT01131078|42024353|FG000|Overall Study|Lost to Follow-up|1|||
19575995|NCT01131078|42024354|FG001|Overall Study|Lost to Follow-up|1|||
19387789|NCT02041702|41631092|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
19387790|NCT02041702|41631093|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
19387791|NCT02565147|41631101|FG000|Overall Study|Withdrawal by Subject|5|||
19387792|NCT02565147|41631102|FG001|Overall Study|Withdrawal by Subject|1|||
19387793|NCT02565147|41631101|FG000|Overall Study|Lost to Follow-up|0|||
19575996|NCT01131078|42024355|FG002|Overall Study|Lost to Follow-up|1|||
19575997|NCT01131078|42024353|FG000|Overall Study|Withdrawal by Subject|2|||
19575998|NCT01131078|42024354|FG001|Overall Study|Withdrawal by Subject|4|||
19575999|NCT01131078|42024355|FG002|Overall Study|Withdrawal by Subject|3|||
19576000|NCT01131078|42024353|FG000|Overall Study|Non-compliance|3|||
19576001|NCT01131078|42024354|FG001|Overall Study|Non-compliance|0|||
19576002|NCT01131078|42024355|FG002|Overall Study|Non-compliance|0|||
19576003|NCT01131078|42024353|FG000|Overall Study|Physician Decision|10|||
19576004|NCT01131078|42024354|FG001|Overall Study|Physician Decision|6|||
19576005|NCT01131078|42024355|FG002|Overall Study|Physician Decision|8|||
19576006|NCT01131078|42024353|FG000|Overall Study|Death|4|||
19576007|NCT01131078|42024354|FG001|Overall Study|Death|0|||
19576008|NCT01131078|42024355|FG002|Overall Study|Death|2|||
19576009|NCT01131078|42024353|FG000|Overall Study|Other|0|||
19576010|NCT01131078|42024354|FG001|Overall Study|Other|1|||
19576011|NCT01131078|42024355|FG002|Overall Study|Other|0|||
19576012|NCT01167582|42024367|FG000|Overall Study|Lost to Follow-up|0|||
19576013|NCT01167582|42024368|FG001|Overall Study|Lost to Follow-up|1|||
19576014|NCT01167426|42024374|FG000|Overall Study|Lost to Follow-up|6|||
19576015|NCT01167426|42024374|FG000|Overall Study|Protocol Violation|1|||
19576016|NCT01167426|42024374|FG000|Overall Study|Withdrawal by Subject|2|||
19576017|NCT01167426|42024374|FG000|Overall Study|Sponsor Decision|1|||
19576018|NCT00968799|42024379|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
19576019|NCT00922636|42024388|FG000|Overall Study|Adverse Event|3|||
19576020|NCT00922636|42024389|FG001|Overall Study|Adverse Event|3|||
19576021|NCT00922636|42024390|FG002|Overall Study|Adverse Event|2|||
19576022|NCT00922636|42024391|FG003|Overall Study|Adverse Event|3|||
19576023|NCT00922636|42024392|FG004|Overall Study|Adverse Event|2|||
19576024|NCT00922636|42024388|FG000|Overall Study|Lack of Efficacy|1|||
19576025|NCT00922636|42024389|FG001|Overall Study|Lack of Efficacy|7|||
19576026|NCT00922636|42024390|FG002|Overall Study|Lack of Efficacy|3|||
19576027|NCT00922636|42024391|FG003|Overall Study|Lack of Efficacy|2|||
19576028|NCT00922636|42024392|FG004|Overall Study|Lack of Efficacy|4|||
19576029|NCT00922636|42024388|FG000|Overall Study|Sponsor Decision|0|||
19576030|NCT00922636|42024389|FG001|Overall Study|Sponsor Decision|0|||
19576031|NCT00922636|42024390|FG002|Overall Study|Sponsor Decision|2|||
19576032|NCT00922636|42024391|FG003|Overall Study|Sponsor Decision|0|||
19576033|NCT00922636|42024392|FG004|Overall Study|Sponsor Decision|0|||
19576034|NCT00922636|42024388|FG000|Overall Study|Withdrawal by Subject|0|||
19576035|NCT00922636|42024389|FG001|Overall Study|Withdrawal by Subject|0|||
19576036|NCT00922636|42024390|FG002|Overall Study|Withdrawal by Subject|5|||
19576037|NCT00922636|42024391|FG003|Overall Study|Withdrawal by Subject|2|||
19576038|NCT00922636|42024392|FG004|Overall Study|Withdrawal by Subject|4|||
19576039|NCT00922636|42024388|FG000|Overall Study|Protocol Violation|0|||
19387794|NCT02565147|41631102|FG001|Overall Study|Lost to Follow-up|1|||
19476952|NCT01517893|41755298|FG001|Overall Study|Withdrawal by Subject|0|||
19576040|NCT00922636|42024389|FG001|Overall Study|Protocol Violation|0|||
19576041|NCT00922636|42024390|FG002|Overall Study|Protocol Violation|2|||
19576042|NCT00922636|42024391|FG003|Overall Study|Protocol Violation|2|||
19576043|NCT00922636|42024392|FG004|Overall Study|Protocol Violation|0|||
19576044|NCT00922636|42024388|FG000|Overall Study|Entry Criteria Not Met|0|||
19576045|NCT00922636|42024389|FG001|Overall Study|Entry Criteria Not Met|0|||
19576046|NCT00922636|42024390|FG002|Overall Study|Entry Criteria Not Met|1|||
19576047|NCT00922636|42024391|FG003|Overall Study|Entry Criteria Not Met|1|||
19576048|NCT00922636|42024392|FG004|Overall Study|Entry Criteria Not Met|0|||
19576049|NCT00922636|42024388|FG000|Overall Study|Parent/Caregiver Decision|2|||
19576050|NCT00922636|42024389|FG001|Overall Study|Parent/Caregiver Decision|4|||
19576051|NCT00922636|42024390|FG002|Overall Study|Parent/Caregiver Decision|3|||
19576052|NCT00922636|42024391|FG003|Overall Study|Parent/Caregiver Decision|5|||
19576053|NCT00922636|42024392|FG004|Overall Study|Parent/Caregiver Decision|2|||
19576054|NCT00922636|42024388|FG000|Overall Study|Lost to Follow-up|1|||
19576055|NCT00922636|42024389|FG001|Overall Study|Lost to Follow-up|2|||
19576056|NCT00922636|42024390|FG002|Overall Study|Lost to Follow-up|2|||
19576057|NCT00922636|42024391|FG003|Overall Study|Lost to Follow-up|2|||
19576058|NCT00922636|42024392|FG004|Overall Study|Lost to Follow-up|4|||
19576059|NCT01175135|42024413|FG000|Overall Study|Adverse Event|2|||
19576060|NCT01175135|42024414|FG001|Overall Study|Adverse Event|5|||
19576061|NCT01175135|42024415|FG002|Overall Study|Adverse Event|3|||
19576062|NCT01175135|42024416|FG003|Overall Study|Adverse Event|4|||
19576063|NCT01175135|42024413|FG000|Overall Study|Death|1|||
19576064|NCT01175135|42024414|FG001|Overall Study|Death|0|||
19576065|NCT01175135|42024415|FG002|Overall Study|Death|0|||
19576066|NCT01175135|42024416|FG003|Overall Study|Death|0|||
19576067|NCT01175135|42024413|FG000|Overall Study|Lack of Efficacy|4|||
19576068|NCT01175135|42024414|FG001|Overall Study|Lack of Efficacy|5|||
19576069|NCT01175135|42024415|FG002|Overall Study|Lack of Efficacy|0|||
19576070|NCT01175135|42024416|FG003|Overall Study|Lack of Efficacy|5|||
19576071|NCT01175135|42024413|FG000|Overall Study|Lost to Follow-up|1|||
19576072|NCT01175135|42024414|FG001|Overall Study|Lost to Follow-up|2|||
19576073|NCT01175135|42024415|FG002|Overall Study|Lost to Follow-up|0|||
19576074|NCT01175135|42024416|FG003|Overall Study|Lost to Follow-up|0|||
19576075|NCT01175135|42024413|FG000|Overall Study|Protocol Violation|1|||
19576076|NCT01175135|42024414|FG001|Overall Study|Protocol Violation|1|||
19576077|NCT01175135|42024415|FG002|Overall Study|Protocol Violation|0|||
19576078|NCT01175135|42024416|FG003|Overall Study|Protocol Violation|0|||
19576079|NCT01175135|42024413|FG000|Overall Study|Withdrawal by Subject|4|||
19576080|NCT01175135|42024414|FG001|Overall Study|Withdrawal by Subject|8|||
19576081|NCT01175135|42024415|FG002|Overall Study|Withdrawal by Subject|5|||
19576082|NCT01175135|42024416|FG003|Overall Study|Withdrawal by Subject|5|||
19576083|NCT01175135|42024413|FG000|Overall Study|Other|3|||
19576084|NCT01175135|42024414|FG001|Overall Study|Other|1|||
19576085|NCT01175135|42024415|FG002|Overall Study|Other|3|||
19576086|NCT01175135|42024416|FG003|Overall Study|Other|0|||
19576087|NCT01175135|42024413|FG000|Overall Study|Randomized But Not Treated|0|||
19576088|NCT01175135|42024414|FG001|Overall Study|Randomized But Not Treated|0|||
19576089|NCT01175135|42024415|FG002|Overall Study|Randomized But Not Treated|1|||
19576090|NCT01175135|42024416|FG003|Overall Study|Randomized But Not Treated|0|||
19576091|NCT00922480|42024428|FG000|Main Study|Protocol Violation|3|||
19576092|NCT00922480|42024429|FG001|Main Study|Protocol Violation|6|||
19576093|NCT00922480|42024428|FG000|Main Study|Adverse Event|6|||
19576094|NCT00922480|42024429|FG001|Main Study|Adverse Event|7|||
19576095|NCT00922480|42024428|FG000|Main Study|Lack of Efficacy|3|||
19576096|NCT00922480|42024429|FG001|Main Study|Lack of Efficacy|0|||
19576097|NCT00922480|42024428|FG000|Main Study|Withdrawal by Subject|20|||
19576098|NCT00922480|42024429|FG001|Main Study|Withdrawal by Subject|15|||
19576099|NCT00922480|42024428|FG000|Main Study|Lost to Follow-up|5|||
19576100|NCT00922480|42024429|FG001|Main Study|Lost to Follow-up|0|||
19576101|NCT00922480|42024428|FG000|Main Study|Physician Decision|0|||
19576102|NCT00922480|42024429|FG001|Main Study|Physician Decision|1|||
19576103|NCT00922480|42024428|FG000|Extension Study|Protocol Violation|3|||
19576104|NCT00922480|42024429|FG001|Extension Study|Protocol Violation|0|||
19576105|NCT00922480|42024428|FG000|Extension Study|Adverse Event|1|||
19576106|NCT00922480|42024429|FG001|Extension Study|Adverse Event|1|||
19576107|NCT00922480|42024428|FG000|Extension Study|Withdrawal by Subject|1|||
19576108|NCT00922480|42024429|FG001|Extension Study|Withdrawal by Subject|1|||
19576109|NCT00922480|42024428|FG000|Extension Study|Others|0|||
19576110|NCT00922480|42024429|FG001|Extension Study|Others|1|||
19576111|NCT00973479|42024439|FG000|Overall Study|Lost to Follow-up|0|||
19576112|NCT00973479|42024440|FG001|Overall Study|Lost to Follow-up|3|||
19576113|NCT00973479|42024439|FG000|Overall Study|Death|2|||
19576114|NCT00973479|42024440|FG001|Overall Study|Death|2|||
19576115|NCT00973479|42024439|FG000|Overall Study|Withdrawal by Subject|15|||
19576116|NCT00973479|42024440|FG001|Overall Study|Withdrawal by Subject|16|||
19576117|NCT00973479|42024439|FG000|Overall Study|Lack of Efficacy|5|||
19576118|NCT00973479|42024440|FG001|Overall Study|Lack of Efficacy|7|||
19576119|NCT00973479|42024439|FG000|Overall Study|Adverse Event|12|||
19576120|NCT00973479|42024440|FG001|Overall Study|Adverse Event|32|||
19576121|NCT00973479|42024439|FG000|Overall Study|Protocol Violation|2|||
19576122|NCT00973479|42024440|FG001|Overall Study|Protocol Violation|2|||
19576123|NCT00973479|42024439|FG000|Overall Study|Other|1|||
19576124|NCT00973479|42024440|FG001|Overall Study|Other|7|||
19576125|NCT01174043|42024448|FG000|Overall Study|Disease progression|5|||
19576126|NCT01174043|42024448|FG000|Overall Study|Adverse Event|3|||
19576127|NCT01174043|42024448|FG000|Overall Study|Death|1|||
19576128|NCT01174043|42024448|FG000|Overall Study|Withdrawal by Subject|2|||
19576129|NCT01173653|42024454|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
19576130|NCT01173653|42024455|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
19576131|NCT01172873|42024463|FG000|Overall Study|Withdrawal by Subject|3|||
19576132|NCT01172873|42024464|FG001|Overall Study|Withdrawal by Subject|2|||
19576133|NCT00925600|42024476|FG000|Overall Study|Withdrawal by Subject|16|||
19576134|NCT00925600|42024477|FG001|Overall Study|Withdrawal by Subject|14|||
19576135|NCT00925600|42024476|FG000|Overall Study|Death|4|||
19576136|NCT00925600|42024477|FG001|Overall Study|Death|3|||
19576137|NCT00925600|42024476|FG000|Overall Study|Lost to Follow-up|2|||
19576138|NCT00925600|42024477|FG001|Overall Study|Lost to Follow-up|2|||
19576139|NCT00925600|42024476|FG000|Overall Study|Disease Progression|1|||
19576140|NCT00925600|42024477|FG001|Overall Study|Disease Progression|3|||
19576141|NCT00925600|42024476|FG000|Overall Study|Administrative Decision|1|||
19576142|NCT00925600|42024477|FG001|Overall Study|Administrative Decision|1|||
19576143|NCT00925600|42024476|FG000|Overall Study|Noncompliance|2|||
19576144|NCT00925600|42024477|FG001|Overall Study|Noncompliance|0|||
19576145|NCT00925600|42024476|FG000|Overall Study|Ineligibility Determined|2|||
19576146|NCT00925600|42024477|FG001|Overall Study|Ineligibility Determined|0|||
19576147|NCT00925600|42024476|FG000|Overall Study|Protocol Deviation|0|||
19576148|NCT00925600|42024477|FG001|Overall Study|Protocol Deviation|1|||
19576149|NCT00925600|42024476|FG000|Overall Study|Requirement for Alternative Therapy|0|||
19576150|NCT00925600|42024477|FG001|Overall Study|Requirement for Alternative Therapy|1|||
19576151|NCT00925600|42024476|FG000|Overall Study|Other|3|||
19576152|NCT00925600|42024477|FG001|Overall Study|Other|1|||
19576153|NCT00925600|42024476|FG000|Overall Study|Adverse Event|1|||
19576154|NCT00925600|42024477|FG001|Overall Study|Adverse Event|2|||
19576155|NCT00968253|42024490|FG000|Overall Study|Death|0|||
19576156|NCT00968253|42024491|FG001|Overall Study|Death|0|||
19576157|NCT00968253|42024492|FG002|Overall Study|Death|2|||
19576158|NCT00968253|42024490|FG000|Overall Study|Withdrawal by Subject|0|||
19576159|NCT00968253|42024491|FG001|Overall Study|Withdrawal by Subject|0|||
19576160|NCT00968253|42024492|FG002|Overall Study|Withdrawal by Subject|1|||
19576161|NCT00968253|42024490|FG000|Overall Study|Disease Progression|0|||
19576162|NCT00968253|42024491|FG001|Overall Study|Disease Progression|3|||
19576163|NCT00968253|42024492|FG002|Overall Study|Disease Progression|3|||
19576164|NCT00968253|42024490|FG000|Overall Study|Adverse Event|0|||
19576165|NCT00968253|42024491|FG001|Overall Study|Adverse Event|0|||
19576166|NCT00968253|42024492|FG002|Overall Study|Adverse Event|1|||
19576167|NCT00964743|42024501|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
19576168|NCT00925522|42024505|FG000|Overall Study|study closed -- business decision|20|||
19576169|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
19576170|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
19576171|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
19576172|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
19576173|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
19576174|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
19576175|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
19576176|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
19576177|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
19576178|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
19576179|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
19576180|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
19576181|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
19576182|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
19576183|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
19576184|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
19576185|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
19576186|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
19576187|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
19576188|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
19576189|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
19576190|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
19576191|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
19576192|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
19576193|NCT01130532|42024512|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
19576194|NCT01130532|42024513|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
19576195|NCT01130532|42024514|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
19576196|NCT01130532|42024515|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
19576197|NCT01130532|42024512|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
19576198|NCT01130532|42024513|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
19576199|NCT01130532|42024514|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
19576200|NCT01130532|42024515|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
19576201|NCT01130532|42024512|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
19576202|NCT01130532|42024513|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
19576203|NCT01130532|42024514|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
19576204|NCT01130532|42024515|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
19576205|NCT01130532|42024512|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
19576206|NCT01130532|42024513|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
19576207|NCT01130532|42024514|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
19576208|NCT01130532|42024515|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
19576209|NCT01130532|42024512|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
19576210|NCT01130532|42024513|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
19576211|NCT01130532|42024514|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
19576212|NCT01130532|42024515|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
19576213|NCT00972777|42024529|FG000|Overall Study|Adverse Event|3|||
19576214|NCT00972777|42024530|FG001|Overall Study|Adverse Event|2|||
19576215|NCT00972777|42024529|FG000|Overall Study|Lost to Follow-up|0|||
19576216|NCT00972777|42024530|FG001|Overall Study|Lost to Follow-up|4|||
19576217|NCT00972777|42024529|FG000|Overall Study|Withdrawal by Subject|4|||
19576218|NCT00972777|42024530|FG001|Overall Study|Withdrawal by Subject|5|||
19576219|NCT00972777|42024529|FG000|Overall Study|Physician Decision|4|||
19576220|NCT00972777|42024530|FG001|Overall Study|Physician Decision|0|||
19576221|NCT00972777|42024529|FG000|Overall Study|Protocol Violation|0|||
19576222|NCT00972777|42024530|FG001|Overall Study|Protocol Violation|2|||
19576223|NCT00972777|42024529|FG000|Overall Study|Screening Failure|2|||
19576224|NCT00972777|42024530|FG001|Overall Study|Screening Failure|1|||
19576225|NCT00972777|42024529|FG000|Overall Study|Missed visit|1|||
19576226|NCT00972777|42024530|FG001|Overall Study|Missed visit|0|||
19576227|NCT00918736|42024536|FG000|Overall Study|Withdrawal by Subject|4|||
19576228|NCT01172639|42024545|FG000|Overall Study|Death|1|||
19576229|NCT01172639|42024546|FG001|Overall Study|Death|1|||
19576230|NCT01172639|42024547|FG002|Overall Study|Death|0|||
19576231|NCT01172639|42024548|FG003|Overall Study|Death|0|||
19576232|NCT01172639|42024549|FG004|Overall Study|Death|0|||
19576233|NCT01172639|42024545|FG000|Overall Study|Lost to Follow-up|9|||
19576234|NCT01172639|42024546|FG001|Overall Study|Lost to Follow-up|7|||
19576235|NCT01172639|42024547|FG002|Overall Study|Lost to Follow-up|11|||
19576236|NCT01172639|42024548|FG003|Overall Study|Lost to Follow-up|6|||
19576237|NCT01172639|42024549|FG004|Overall Study|Lost to Follow-up|6|||
19576238|NCT01172639|42024545|FG000|Overall Study|Withdrawal by Subject|3|||
19576239|NCT01172639|42024546|FG001|Overall Study|Withdrawal by Subject|3|||
19576240|NCT01172639|42024547|FG002|Overall Study|Withdrawal by Subject|5|||
19576241|NCT01172639|42024548|FG003|Overall Study|Withdrawal by Subject|5|||
19576242|NCT01172639|42024549|FG004|Overall Study|Withdrawal by Subject|0|||
19576243|NCT01144182|42024563|FG000|Overall Study|Death|5|||
19576244|NCT01144182|42024564|FG001|Overall Study|Death|6|||
19576245|NCT01144182|42024563|FG000|Overall Study|Withdrawal by Subject|3|||
19576246|NCT01144182|42024564|FG001|Overall Study|Withdrawal by Subject|6|||
19576247|NCT01144182|42024563|FG000|Overall Study|Lost to Follow-up|9|||
19576248|NCT01144182|42024564|FG001|Overall Study|Lost to Follow-up|9|||
19576249|NCT01225562|42024574|FG000|Overall Study|Withdrawal by Subject|52|||
19576250|NCT01225562|42024575|FG001|Overall Study|Withdrawal by Subject|50|||
19576251|NCT01225562|42024576|FG002|Overall Study|Withdrawal by Subject|52|||
19576252|NCT01225562|42024574|FG000|Overall Study|Lost to Follow-up|3|||
19576253|NCT01225562|42024575|FG001|Overall Study|Lost to Follow-up|6|||
19576254|NCT01225562|42024576|FG002|Overall Study|Lost to Follow-up|1|||
19576255|NCT00925288|42024586|FG000|Overall Study|Lost to Follow-up|9|||
19576256|NCT00925288|42024587|FG001|Overall Study|Lost to Follow-up|7|||
19576257|NCT01143714|42024597|FG000|Overall Study|Adverse Event|4|||
19576258|NCT01143714|42024598|FG001|Overall Study|Adverse Event|2|||
19576259|NCT01143714|42024597|FG000|Overall Study|Withdrawal by Subject|1|||
19576260|NCT01143714|42024598|FG001|Overall Study|Withdrawal by Subject|0|||
19576261|NCT01143714|42024597|FG000|Overall Study|Subject non-compliance|0|||
19576262|NCT01143714|42024598|FG001|Overall Study|Subject non-compliance|1|||
19576263|NCT01143714|42024597|FG000|Overall Study|wound closed = deemed healed|1|||
19576264|NCT01143714|42024598|FG001|Overall Study|wound closed = deemed healed|0|||
19576265|NCT01143714|42024597|FG000|Overall Study|wound size increased|1|||
19576266|NCT01143714|42024598|FG001|Overall Study|wound size increased|0|||
19576267|NCT00972543|42024619|FG000|Overall Study|Adverse Event|1|||
19576268|NCT00972543|42024620|FG001|Overall Study|Adverse Event|0|||
19576269|NCT00972543|42024619|FG000|Overall Study|Early study termination by sponsor|4|||
19576270|NCT00972543|42024620|FG001|Overall Study|Early study termination by sponsor|1|||
19576271|NCT00925132|42024626|FG000|Overall Study|Withdrawal by Subject|2|||
19576272|NCT00925132|42024627|FG001|Overall Study|Withdrawal by Subject|0|||
19576273|NCT00925132|42024628|FG002|Overall Study|Withdrawal by Subject|0|||
19576274|NCT00925132|42024629|FG003|Overall Study|Withdrawal by Subject|0|||
19576275|NCT00925132|42024630|FG004|Overall Study|Withdrawal by Subject|1|||
19576276|NCT00925132|42024626|FG000|Overall Study|Removed due to disease progression|0|||
19576277|NCT00925132|42024627|FG001|Overall Study|Removed due to disease progression|0|||
19576278|NCT00925132|42024628|FG002|Overall Study|Removed due to disease progression|0|||
19576279|NCT00925132|42024629|FG003|Overall Study|Removed due to disease progression|0|||
19576280|NCT00925132|42024630|FG004|Overall Study|Removed due to disease progression|4|||
19576281|NCT01143402|42024639|FG000|Overall Study|Rapid clinical decline|1|||
19576282|NCT01143402|42024640|FG001|Overall Study|Rapid clinical decline|1|||
19576283|NCT01143402|42024641|FG002|Overall Study|Rapid clinical decline|0|||
19576284|NCT01143402|42024639|FG000|Overall Study|Not Treated|0|||
19576285|NCT01143402|42024640|FG001|Overall Study|Not Treated|0|||
19576286|NCT01143402|42024641|FG002|Overall Study|Not Treated|1|||
19576287|NCT01171625|42024648|FG000|Overall Study|On-Protocol|67|||
19576288|NCT01171625|42024648|FG000|Overall Study|Death|38|||
19576289|NCT01171625|42024648|FG000|Overall Study|Withdrawal by Subject|31|||
19576290|NCT01171625|42024648|FG000|Overall Study|Explanted|10|||
19576291|NCT01171625|42024648|FG000|Overall Study|Lost to Follow-up|5|||
19576292|NCT01171625|42024648|FG000|Overall Study|Patient received valve-in-valve|3|||
19576293|NCT01171625|42024648|FG000|Overall Study|Other|1|||
19576294|NCT01171625|42024648|FG000|Overall Study|Consented but did not receive device|25|||
19576295|NCT00924898|42024660|FG000|Overall Study|Withdrawal by Subject|2|||
19576296|NCT01167192|42024669|FG000|Overall Study|Adverse Event|1|||
19576297|NCT01167192|42024669|FG000|Overall Study|Death|1|||
19576298|NCT01167192|42024669|FG000|Overall Study|Withdrawal by Subject|1|||
19576299|NCT01167192|42024669|FG000|Overall Study|Insurance denial|1|||
19576300|NCT01166958|42024675|FG000|Overall Study|Withdrawal by Subject|1|||
19576301|NCT01166958|42024676|FG001|Overall Study|Withdrawal by Subject|0|||
19576302|NCT01170221|42024684|FG000|Overall Study|Lost to Follow-up|22|||
19576303|NCT01170221|42024685|FG001|Overall Study|Lost to Follow-up|21|||
19576304|NCT01170221|42024684|FG000|Overall Study|Withdrawal by Subject|9|||
19576305|NCT01170221|42024685|FG001|Overall Study|Withdrawal by Subject|7|||
19576306|NCT01170221|42024684|FG000|Overall Study|Subject completed only screening and LFU|1|||
19576307|NCT01170221|42024685|FG001|Overall Study|Subject completed only screening and LFU|0|||
19576308|NCT01170221|42024684|FG000|Overall Study|Randomized but not treated|1|||
19576309|NCT01170221|42024685|FG001|Overall Study|Randomized but not treated|0|||
19576310|NCT01166646|42024693|FG000|Overall Study|Protocol Violation|0|||
19576311|NCT01166646|42024694|FG001|Overall Study|Protocol Violation|1|||
19576312|NCT01166646|42024693|FG000|Overall Study|Adverse Event|1|||
19576313|NCT01166646|42024694|FG001|Overall Study|Adverse Event|0|||
19576314|NCT01129284|42024703|FG000|Overall Study|Adverse Event|2|||
19576315|NCT01129284|42024704|FG001|Overall Study|Adverse Event|0|||
19576316|NCT01129284|42024705|FG002|Overall Study|Adverse Event|1|||
19576317|NCT01166568|42024716|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
19576318|NCT01166568|42024717|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
19576319|NCT01166568|42024718|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
19576320|NCT01166568|42024716|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
19576321|NCT01166568|42024717|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
19576322|NCT01166568|42024718|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
19576323|NCT01166568|42024716|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
19576324|NCT01166568|42024717|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
19576325|NCT01166568|42024718|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
19576326|NCT01166178|42024726|FG000|Overall Study|Withdrawal by Subject|1|||
19576327|NCT01166178|42024727|FG001|Overall Study|Withdrawal by Subject|0|||
19576328|NCT01166178|42024726|FG000|Overall Study|Study was terminated|20|||
19576329|NCT01166178|42024727|FG001|Overall Study|Study was terminated|8|||
19476953|NCT01489891|41755306|FG000|Overall Study|Endoscopy failure|1|||
19476954|NCT01489891|41755307|FG001|Overall Study|Endoscopy failure|0|||
19476955|NCT04062240|41755389|FG000|Overall Study|equipment malfunction|1|||
19576330|NCT00924820|42024733|FG000|Overall Study|Death|2|||
19576331|NCT00924820|42024733|FG000|Overall Study|Ineligible, Screen Failure|5|||
19576332|NCT01225172|42024739|FG000|Overall Study|Subject decision to stop|1|||
19576333|NCT01225172|42024740|FG001|Overall Study|Subject decision to stop|0|||
19576334|NCT01225172|42024739|FG000|Overall Study|Subject request to discontinue treatment|3|||
19576335|NCT01225172|42024740|FG001|Overall Study|Subject request to discontinue treatment|1|||
19576336|NCT01225172|42024739|FG000|Overall Study|Subject no longer meets study criteria|1|||
19576337|NCT01225172|42024740|FG001|Overall Study|Subject no longer meets study criteria|0|||
19576338|NCT01225172|42024739|FG000|Overall Study|Withdrawal by Subject|1|||
19576339|NCT01225172|42024740|FG001|Overall Study|Withdrawal by Subject|0|||
19576340|NCT01143324|42024746|FG000|Overall Study|Lost to Follow-up|11|||
19576341|NCT01143324|42024746|FG000|Overall Study|Withdrawal by Subject|4|||
19576342|NCT01143324|42024746|FG000|Overall Study|Explant of the device|4|||
19576343|NCT01224782|42024750|FG000|Overall Study|Lost to Follow-up|177|||
19576344|NCT01224782|42024750|FG000|Overall Study|Withdrawal by Subject|16|||
19576345|NCT01224782|42024750|FG000|Overall Study|Death|14|||
19576346|NCT01224782|42024750|FG000|Overall Study|Improvement|13|||
19576347|NCT01224782|42024750|FG000|Overall Study|Adverse Event|12|||
19576348|NCT01224782|42024750|FG000|Overall Study|Adverse Reaction|11|||
19576349|NCT01224782|42024750|FG000|Overall Study|Noncompliance|10|||
19576350|NCT01224782|42024750|FG000|Overall Study|Other|4|||
19576351|NCT01224782|42024750|FG000|Overall Study|Start of Dialysis|3|||
19576352|NCT01224782|42024750|FG000|Overall Study|Change of Treatment|1|||
19576353|NCT01224782|42024750|FG000|Overall Study|Financial Reasons|1|||
19576354|NCT01224782|42024750|FG000|Overall Study|Deterioration|1|||
19576355|NCT01224782|42024750|FG000|Overall Study|Transplantation|1|||
19576356|NCT01224158|42024756|FG000|Overall Study|Withdrawal by Subject|1|||
19576357|NCT01224158|42024757|FG001|Overall Study|Withdrawal by Subject|0|||
19576358|NCT01129128|42024766|FG000|Overall Study|Lost to Follow-up|2|||
19576359|NCT01129128|42024767|FG001|Overall Study|Lost to Follow-up|2|||
19576360|NCT01129128|42024768|FG002|Overall Study|Lost to Follow-up|1|||
19576361|NCT01129128|42024766|FG000|Overall Study|Protocol Violation|0|||
19576362|NCT01129128|42024767|FG001|Overall Study|Protocol Violation|1|||
19576363|NCT01129128|42024768|FG002|Overall Study|Protocol Violation|0|||
19576364|NCT01129128|42024766|FG000|Overall Study|Withdrawal by Subject|0|||
19576365|NCT01129128|42024767|FG001|Overall Study|Withdrawal by Subject|1|||
19576366|NCT01129128|42024768|FG002|Overall Study|Withdrawal by Subject|3|||
19576367|NCT01129128|42024766|FG000|Overall Study|Physician Decision|1|||
19576368|NCT01129128|42024767|FG001|Overall Study|Physician Decision|0|||
19576369|NCT01129128|42024768|FG002|Overall Study|Physician Decision|0|||
19576370|NCT01222520|42024778|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
19576371|NCT01222520|42024779|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
19576372|NCT01222520|42024778|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
19576373|NCT01222520|42024779|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
19576374|NCT01222520|42024778|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
19576375|NCT01222520|42024779|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
19576376|NCT01222520|42024778|FG000|Double-blind Period|Adverse Event|0|||
19576377|NCT01222520|42024779|FG001|Double-blind Period|Adverse Event|1|||
19576378|NCT01222520|42024778|FG000|Double-blind Period|Lack of Efficacy|0|||
19576379|NCT01222520|42024779|FG001|Double-blind Period|Lack of Efficacy|1|||
19476956|NCT02790138|41755395|FG000|Overall Study|Adverse Event|5|||
19576380|NCT01222520|42024778|FG000|Double-blind Period|Study medication stolen|1|||
19576381|NCT01222520|42024779|FG001|Double-blind Period|Study medication stolen|0|||
19576382|NCT01221350|42024787|FG000|Overall Study|Discontinued intervention (GERD)|1|||
19576383|NCT01221350|42024788|FG001|Overall Study|Discontinued intervention (GERD)|0|||
19576384|NCT01221350|42024787|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
19576385|NCT01221350|42024788|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
19576386|NCT01221350|42024787|FG000|Overall Study|Withdrawal by Subject|4|||
19576387|NCT01221350|42024788|FG001|Overall Study|Withdrawal by Subject|2|||
19576388|NCT01221272|42024796|FG000|Period 1|Adverse Event|2|||
19576389|NCT01221272|42024797|FG001|Period 1|Adverse Event|0|||
19576390|NCT01221272|42024796|FG000|Period 1|Consent Withdrawal|0|||
19576391|NCT01221272|42024797|FG001|Period 1|Consent Withdrawal|1|||
19576392|NCT01221272|42024796|FG000|Period 1|Significant Dosing Noncompliance|0|||
19576393|NCT01221272|42024797|FG001|Period 1|Significant Dosing Noncompliance|1|||
19576394|NCT01221272|42024796|FG000|Period 2|Adverse Event|0|||
19576395|NCT01221272|42024797|FG001|Period 2|Adverse Event|2|||
19576396|NCT01220414|42024808|FG000|Overall Study|Withdrawal by Subject|1|||
19576397|NCT01220414|42024809|FG001|Overall Study|Withdrawal by Subject|0|||
19576398|NCT01220414|42024810|FG002|Overall Study|Withdrawal by Subject|0|||
19576399|NCT01220414|42024811|FG003|Overall Study|Withdrawal by Subject|1|||
19576400|NCT01128894|42024820|FG000|Overall Study|Adverse Event|31|||
19576401|NCT01128894|42024821|FG001|Overall Study|Adverse Event|41|||
19576402|NCT01128894|42024820|FG000|Overall Study|Protocol Violation|2|||
19576403|NCT01128894|42024821|FG001|Overall Study|Protocol Violation|1|||
19576404|NCT01128894|42024820|FG000|Overall Study|Noncompliance|4|||
19576405|NCT01128894|42024821|FG001|Overall Study|Noncompliance|5|||
19576406|NCT01128894|42024820|FG000|Overall Study|Lost to Follow-up|8|||
19576407|NCT01128894|42024821|FG001|Overall Study|Lost to Follow-up|8|||
19576408|NCT01128894|42024820|FG000|Overall Study|Withdrawal by Subject|10|||
19576409|NCT01128894|42024821|FG001|Overall Study|Withdrawal by Subject|12|||
19576410|NCT01128894|42024820|FG000|Overall Study|Physician Decision|2|||
19576411|NCT01128894|42024821|FG001|Overall Study|Physician Decision|1|||
19576412|NCT01128894|42024820|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
19576413|NCT01128894|42024821|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
19576414|NCT01220180|42024830|FG000|Overall Study|Lost to Follow-up|76|||
19576415|NCT01220180|42024830|FG000|Overall Study|Other|72|||
19576416|NCT01220180|42024830|FG000|Overall Study|Adverse Event|35|||
19576417|NCT01220180|42024830|FG000|Overall Study|Lack of Efficacy|22|||
19576418|NCT01220180|42024830|FG000|Overall Study|Death|1|||
19576419|NCT01220180|42024830|FG000|Overall Study|Randomized but not treated|1|||
19576420|NCT01220024|42024836|FG000|Overall Study|Lost to Follow-up|1|||
19576421|NCT01220024|42024837|FG001|Overall Study|Lost to Follow-up|1|||
19576422|NCT01128738|42024845|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
19576423|NCT01128738|42024846|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
19576424|NCT01128738|42024845|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
19576425|NCT01128738|42024846|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
19576426|NCT01128738|42024845|FG000|Second TP|Lost to Follow-up|0|||
19576427|NCT01128738|42024846|FG001|Second TP|Lost to Follow-up|1|||
19576428|NCT01128738|42024845|FG000|Second TP|Withdrawal by Subject|0|||
19576429|NCT01128738|42024846|FG001|Second TP|Withdrawal by Subject|2|||
19576430|NCT01143090|42024853|FG000|Overall Study|Lack of Efficacy|2|||
19576431|NCT01143090|42024853|FG000|Overall Study|Adverse Event|17|||
19576432|NCT01143090|42024853|FG000|Overall Study|Lost to Follow-up|9|||
19576433|NCT01143090|42024853|FG000|Overall Study|Protocol Violation|2|||
19576434|NCT01143090|42024853|FG000|Overall Study|Withdrawal by Subject|18|||
19576435|NCT01143090|42024853|FG000|Overall Study|Non-compliance with study drug|1|||
19576436|NCT01143090|42024853|FG000|Overall Study|Failure to meet eligibility criteria|1|||
19576437|NCT01143090|42024853|FG000|Overall Study|Administrative|1|||
19576438|NCT01165554|42024857|FG000|Overall Study|Withdrawal by Subject|23|||
19576439|NCT01218308|42024866|FG000|Overall Study|Adverse Event|1|||
19576440|NCT01218308|42024867|FG001|Overall Study|Adverse Event|2|||
19576441|NCT01218308|42024866|FG000|Overall Study|Protocol Violation|0|||
19576442|NCT01218308|42024867|FG001|Overall Study|Protocol Violation|2|||
19576443|NCT01218308|42024866|FG000|Overall Study|Withdrawal by Subject|61|||
19576444|NCT01218308|42024867|FG001|Overall Study|Withdrawal by Subject|64|||
19576445|NCT01218308|42024866|FG000|Overall Study|Lost to Follow-up|27|||
19576446|NCT01218308|42024867|FG001|Overall Study|Lost to Follow-up|31|||
19576447|NCT01218308|42024866|FG000|Overall Study|Other|14|||
19576448|NCT01218308|42024867|FG001|Overall Study|Other|21|||
19576449|NCT01165320|42024875|FG000|Overall Study|Clinical adverse experience|2|||
19576450|NCT01165320|42024876|FG001|Overall Study|Clinical adverse experience|1|||
19576451|NCT01165320|42024877|FG002|Overall Study|Clinical adverse experience|0|||
19576452|NCT01165320|42024875|FG000|Overall Study|Laboratory adverse experience|1|||
19576453|NCT01165320|42024876|FG001|Overall Study|Laboratory adverse experience|0|||
19576454|NCT01165320|42024877|FG002|Overall Study|Laboratory adverse experience|0|||
19576455|NCT01165320|42024875|FG000|Overall Study|Lack of Efficacy|0|||
19576456|NCT01165320|42024876|FG001|Overall Study|Lack of Efficacy|2|||
19576457|NCT01165320|42024877|FG002|Overall Study|Lack of Efficacy|0|||
19576458|NCT01165320|42024875|FG000|Overall Study|Reason unknown|0|||
19576459|NCT01165320|42024876|FG001|Overall Study|Reason unknown|1|||
19576460|NCT01165320|42024877|FG002|Overall Study|Reason unknown|0|||
19576461|NCT01217606|42024885|FG000|Initial Treatment Phase|Other Reasons|0|||
19576462|NCT01217606|42024886|FG001|Initial Treatment Phase|Other Reasons|2|||
19576463|NCT01217606|42024885|FG000|Initial Treatment Phase|Protocol Violation|3|||
19576464|NCT01217606|42024886|FG001|Initial Treatment Phase|Protocol Violation|2|||
19576465|NCT01217606|42024885|FG000|Initial Treatment Phase|Personal Reasons|0|||
19576466|NCT01217606|42024886|FG001|Initial Treatment Phase|Personal Reasons|2|||
19576467|NCT01217606|42024885|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
19576468|NCT01217606|42024886|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
19576469|NCT01217606|42024885|FG000|Initial Treatment Phase|Adverse Event|10|||
19576470|NCT01217606|42024886|FG001|Initial Treatment Phase|Adverse Event|6|||
19576471|NCT01217606|42024885|FG000|9-Month Masked Extension|Adverse Event|3|||
19576472|NCT01217606|42024886|FG001|9-Month Masked Extension|Adverse Event|6|||
19576473|NCT01217606|42024885|FG000|9-Month Masked Extension|Other Reasons|4|||
19576474|NCT01217606|42024886|FG001|9-Month Masked Extension|Other Reasons|4|||
19576475|NCT01217606|42024885|FG000|9-Month Masked Extension|Personal Reasons|2|||
19576476|NCT01217606|42024886|FG001|9-Month Masked Extension|Personal Reasons|1|||
19576477|NCT01217606|42024885|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
19576478|NCT01217606|42024886|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
19576479|NCT01217606|42024885|FG000|9-Month Masked Extension|Pregnancy|1|||
19576480|NCT01217606|42024886|FG001|9-Month Masked Extension|Pregnancy|0|||
19576481|NCT01217606|42024885|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
19576482|NCT01217606|42024886|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
19576483|NCT01128114|42024892|FG000|Overall Study|Treatment Withdrawn|6|||
19576484|NCT01128114|42024892|FG000|Overall Study|Screening Failed|2|||
19576485|NCT01217060|42024896|FG000|Overall Study|Withdrawal by Subject|1|||
19576486|NCT01216202|42024902|FG000|Overall Study|Withdrawal by Subject|8|||
19576487|NCT01216202|42024903|FG001|Overall Study|Withdrawal by Subject|0|||
19576488|NCT01216202|42024902|FG000|Overall Study|Death|0|||
19576489|NCT01216202|42024903|FG001|Overall Study|Death|2|||
19576490|NCT01216202|42024902|FG000|Overall Study|Lost to Follow-up|14|||
19576491|NCT01216202|42024903|FG001|Overall Study|Lost to Follow-up|0|||
19576492|NCT04816669|42024915|FG000|Part 1|Adverse Event|1|||
19576493|NCT04816669|42024916|FG001|Part 1|Adverse Event|1|||
19576494|NCT04816669|42024917|FG002|Part 1|Adverse Event|0|||
19576495|NCT04816669|42024918|FG003|Part 1|Adverse Event|0|||
19576496|NCT04816669|42024915|FG000|Part 1|Lost to Follow-up|2|||
19576497|NCT04816669|42024916|FG001|Part 1|Lost to Follow-up|2|||
19576498|NCT04816669|42024917|FG002|Part 1|Lost to Follow-up|0|||
19576499|NCT04816669|42024918|FG003|Part 1|Lost to Follow-up|0|||
19576500|NCT04816669|42024915|FG000|Part 1|Protocol Violation|0|||
19576501|NCT04816669|42024916|FG001|Part 1|Protocol Violation|1|||
19576502|NCT04816669|42024917|FG002|Part 1|Protocol Violation|0|||
19576503|NCT04816669|42024918|FG003|Part 1|Protocol Violation|0|||
19576504|NCT04816669|42024915|FG000|Part 1|Withdrawal by Subject|1|||
19576505|NCT04816669|42024916|FG001|Part 1|Withdrawal by Subject|2|||
19576506|NCT04816669|42024917|FG002|Part 1|Withdrawal by Subject|0|||
19576507|NCT04816669|42024918|FG003|Part 1|Withdrawal by Subject|0|||
19576508|NCT04816669|42024915|FG000|Part 2|Other|0|||
19576509|NCT04816669|42024916|FG001|Part 2|Other|0|||
19576510|NCT04816669|42024917|FG002|Part 2|Other|1|||
19576511|NCT04816669|42024918|FG003|Part 2|Other|0|||
19576512|NCT04816669|42024915|FG000|Part 2|Withdrawal by Subject|0|||
19576513|NCT04816669|42024916|FG001|Part 2|Withdrawal by Subject|0|||
19576514|NCT04816669|42024917|FG002|Part 2|Withdrawal by Subject|0|||
19576515|NCT04816669|42024918|FG003|Part 2|Withdrawal by Subject|1|||
19576516|NCT04816669|42024915|FG000|Part 2|Lost to Follow-up|0|||
19576517|NCT04816669|42024916|FG001|Part 2|Lost to Follow-up|0|||
19576518|NCT04816669|42024917|FG002|Part 2|Lost to Follow-up|1|||
19576519|NCT04816669|42024918|FG003|Part 2|Lost to Follow-up|0|||
19576520|NCT01165242|42024935|FG000|Overall Study|Unreachable Subjects|1|||
19576521|NCT01165242|42024936|FG001|Overall Study|Unreachable Subjects|0|||
19576522|NCT01165242|42024937|FG002|Overall Study|Unreachable Subjects|0|||
19576523|NCT01165242|42024935|FG000|Overall Study|Incarcerated Subjects|0|||
19576524|NCT01165242|42024936|FG001|Overall Study|Incarcerated Subjects|1|||
19576525|NCT01165242|42024937|FG002|Overall Study|Incarcerated Subjects|0|||
19576526|NCT01165242|42024935|FG000|Overall Study|Visit 2 Declined by Subject|0|||
19576527|NCT01165242|42024936|FG001|Overall Study|Visit 2 Declined by Subject|0|||
19576528|NCT01165242|42024937|FG002|Overall Study|Visit 2 Declined by Subject|1|||
19576529|NCT01165242|42024935|FG000|Overall Study|Withdrawal by Subject|0|||
19576530|NCT01165242|42024936|FG001|Overall Study|Withdrawal by Subject|2|||
19576531|NCT01165242|42024937|FG002|Overall Study|Withdrawal by Subject|2|||
19576532|NCT01165242|42024935|FG000|Overall Study|Extended Holiday|0|||
19576533|NCT01165242|42024936|FG001|Overall Study|Extended Holiday|0|||
19576534|NCT01165242|42024937|FG002|Overall Study|Extended Holiday|1|||
19576535|NCT01165242|42024935|FG000|Overall Study|Lost to Follow-up|9|||
19576536|NCT01165242|42024936|FG001|Overall Study|Lost to Follow-up|7|||
19576537|NCT01165242|42024937|FG002|Overall Study|Lost to Follow-up|10|||
19576538|NCT01170065|42024950|FG000|Overall Study|Adverse Event|17|||
19576539|NCT01170065|42024951|FG001|Overall Study|Adverse Event|50|||
19576540|NCT01170065|42024952|FG002|Overall Study|Adverse Event|10|||
19576541|NCT01170065|42024950|FG000|Overall Study|Lost to Follow-up|1|||
19576542|NCT01170065|42024951|FG001|Overall Study|Lost to Follow-up|4|||
19576543|NCT01170065|42024952|FG002|Overall Study|Lost to Follow-up|1|||
19576544|NCT01170065|42024950|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
19576545|NCT01170065|42024951|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
19576546|NCT01170065|42024952|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
19576547|NCT01170065|42024950|FG000|Overall Study|Reason other than specified|3|||
19576548|NCT01170065|42024951|FG001|Overall Study|Reason other than specified|8|||
19576549|NCT01170065|42024952|FG002|Overall Study|Reason other than specified|3|||
19576550|NCT01170065|42024950|FG000|Overall Study|Ongoing after planned observation time|5|||
19576551|NCT01170065|42024951|FG001|Overall Study|Ongoing after planned observation time|26|||
19576552|NCT01170065|42024952|FG002|Overall Study|Ongoing after planned observation time|10|||
19576553|NCT00966693|42024964|FG000|Overall Study|Adverse Event|0|||
19576554|NCT00966693|42024965|FG001|Overall Study|Adverse Event|0|||
19576555|NCT00966693|42024966|FG002|Overall Study|Adverse Event|1|||
19576556|NCT00966693|42024967|FG003|Overall Study|Adverse Event|2|||
19576557|NCT00966693|42024964|FG000|Overall Study|Death|0|||
19576558|NCT00966693|42024965|FG001|Overall Study|Death|0|||
19576559|NCT00966693|42024966|FG002|Overall Study|Death|1|||
19576560|NCT00966693|42024967|FG003|Overall Study|Death|0|||
19576561|NCT00966693|42024964|FG000|Overall Study|Withdrawal by Subject|1|||
19576562|NCT00966693|42024965|FG001|Overall Study|Withdrawal by Subject|0|||
19576563|NCT00966693|42024966|FG002|Overall Study|Withdrawal by Subject|0|||
19576564|NCT00966693|42024967|FG003|Overall Study|Withdrawal by Subject|5|||
19576565|NCT00966693|42024964|FG000|Overall Study|Disease Progression|0|||
19576566|NCT00966693|42024965|FG001|Overall Study|Disease Progression|0|||
19576567|NCT00966693|42024966|FG002|Overall Study|Disease Progression|1|||
19576568|NCT00966693|42024967|FG003|Overall Study|Disease Progression|16|||
19576569|NCT01215968|42024979|FG000|Overall Study|Adverse Event|0|||
19576570|NCT01215968|42024980|FG001|Overall Study|Adverse Event|2|||
19576571|NCT01215968|42024979|FG000|Overall Study|Protocol Violation|2|||
19576572|NCT01215968|42024980|FG001|Overall Study|Protocol Violation|4|||
19576573|NCT01215968|42024979|FG000|Overall Study|Not received study drug|0|||
19576574|NCT01215968|42024980|FG001|Overall Study|Not received study drug|1|||
19576575|NCT00963807|42024989|FG000|Overall Study|Physician Decision|2|||
19576576|NCT00963807|42024989|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
19576577|NCT00963807|42024989|FG000|Overall Study|Disease progression|15|||
19576578|NCT01142466|42024997|FG000|Overall Study|Adverse Event|2|||
19576579|NCT01142466|42024998|FG001|Overall Study|Adverse Event|1|||
19576580|NCT01142466|42024997|FG000|Overall Study|Withdrawal by Subject|1|||
19576581|NCT01142466|42024998|FG001|Overall Study|Withdrawal by Subject|1|||
19576582|NCT01215734|42025006|FG000|Overall Study|Death|0|||
19576583|NCT01215734|42025007|FG001|Overall Study|Death|1|||
19576584|NCT01169987|42025013|FG000|Overall Study|Withdrawal by Subject|3|||
19576585|NCT01169987|42025013|FG000|Overall Study|Lost to Follow-up|24|||
19576586|NCT01169987|42025013|FG000|Overall Study|Other|4|||
19576587|NCT01215422|42025027|FG000|Overall Study|Relocation|1|||
19576588|NCT01215422|42025028|FG001|Overall Study|Relocation|0|||
19576589|NCT01215422|42025029|FG002|Overall Study|Relocation|0|||
19576590|NCT01215422|42025030|FG003|Overall Study|Relocation|0|||
19576591|NCT01215422|42025027|FG000|Overall Study|Failed intubations|0|||
19576592|NCT01215422|42025028|FG001|Overall Study|Failed intubations|0|||
19576593|NCT01215422|42025029|FG002|Overall Study|Failed intubations|3|||
19576594|NCT01215422|42025030|FG003|Overall Study|Failed intubations|8|||
19576595|NCT01215422|42025027|FG000|Overall Study|Did not complete all intubations|7|||
19576596|NCT01215422|42025028|FG001|Overall Study|Did not complete all intubations|0|||
19576597|NCT01215422|42025029|FG002|Overall Study|Did not complete all intubations|0|||
19576598|NCT01215422|42025030|FG003|Overall Study|Did not complete all intubations|0|||
19576599|NCT00972153|42025055|FG000|Overall Study|Equipment malfunction during case|0|||
19576600|NCT00972153|42025056|FG001|Overall Study|Equipment malfunction during case|1|||
19576601|NCT00972153|42025057|FG002|Overall Study|Equipment malfunction during case|0|||
19576602|NCT00971997|42025065|FG000|Overall Study|Adverse Event|2|||
19576603|NCT00971997|42025065|FG000|Overall Study|Death|1|||
19576604|NCT00971997|42025065|FG000|Overall Study|Protocol Violation|4|||
19576605|NCT00971997|42025065|FG000|Overall Study|Withdrawal by Subject|5|||
19576606|NCT00971997|42025065|FG000|Overall Study|Physician Decision|7|||
19576607|NCT01142388|42025074|FG000|Overall Study|Lack of Efficacy|21|||
19576608|NCT01142388|42025075|FG001|Overall Study|Lack of Efficacy|31|||
19576609|NCT01142388|42025074|FG000|Overall Study|Adverse Event|9|||
19576610|NCT01142388|42025075|FG001|Overall Study|Adverse Event|5|||
19576611|NCT01142388|42025074|FG000|Overall Study|Death|3|||
19576612|NCT01142388|42025075|FG001|Overall Study|Death|2|||
19576613|NCT01142388|42025074|FG000|Overall Study|Withdrawal by Subject|5|||
19576614|NCT01142388|42025075|FG001|Overall Study|Withdrawal by Subject|3|||
19576615|NCT01142388|42025074|FG000|Overall Study|Alternative therapy|1|||
19576616|NCT01142388|42025075|FG001|Overall Study|Alternative therapy|0|||
19576617|NCT01142388|42025074|FG000|Overall Study|Other complications|0|||
19576618|NCT01142388|42025075|FG001|Overall Study|Other complications|2|||
19576619|NCT01142388|42025074|FG000|Overall Study|Other|1|||
19576620|NCT01142388|42025075|FG001|Overall Study|Other|1|||
19576621|NCT01142388|42025074|FG000|Overall Study|Never started therapy|7|||
19576622|NCT01142388|42025075|FG001|Overall Study|Never started therapy|3|||
19576623|NCT01127646|42025083|FG000|Overall Study|Entry Criteria Not Met|1|||
19576624|NCT01127646|42025084|FG001|Overall Study|Entry Criteria Not Met|0|||
19576625|NCT01127646|42025083|FG000|Overall Study|Protocol Violation|0|||
19576626|NCT01127646|42025084|FG001|Overall Study|Protocol Violation|1|||
19576627|NCT01215188|42025095|FG000|Overall Study|Lost to Follow-up|22|||
19576628|NCT01215188|42025096|FG001|Overall Study|Lost to Follow-up|22|||
19576629|NCT01215188|42025097|FG002|Overall Study|Lost to Follow-up|16|||
19576630|NCT01215188|42025095|FG000|Overall Study|Adverse Event|1|||
19576631|NCT01215188|42025096|FG001|Overall Study|Adverse Event|1|||
19576632|NCT01215188|42025097|FG002|Overall Study|Adverse Event|3|||
19576633|NCT01215188|42025095|FG000|Overall Study|Physician Decision|2|||
19576634|NCT01215188|42025096|FG001|Overall Study|Physician Decision|1|||
19576635|NCT01215188|42025097|FG002|Overall Study|Physician Decision|0|||
19576636|NCT01215188|42025095|FG000|Overall Study|Lack of Efficacy|0|||
19576637|NCT01215188|42025096|FG001|Overall Study|Lack of Efficacy|0|||
19576638|NCT01215188|42025097|FG002|Overall Study|Lack of Efficacy|1|||
19576639|NCT01215188|42025095|FG000|Overall Study|Protocol Violation|1|||
19576640|NCT01215188|42025096|FG001|Overall Study|Protocol Violation|1|||
19576641|NCT01215188|42025097|FG002|Overall Study|Protocol Violation|1|||
19576642|NCT01215188|42025095|FG000|Overall Study|Withdrawal by Subject|32|||
19576643|NCT01215188|42025096|FG001|Overall Study|Withdrawal by Subject|34|||
19576644|NCT01215188|42025097|FG002|Overall Study|Withdrawal by Subject|31|||
19576645|NCT01215032|42025105|FG000|Overall Study|Adverse Event|3|||
19576646|NCT01215032|42025105|FG000|Overall Study|Lack of Efficacy|17|||
19576647|NCT00962247|42025111|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
19576648|NCT00962247|42025111|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
19576649|NCT00918580|42025117|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
19576650|NCT00918580|42025117|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
19576651|NCT00918580|42025117|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
19576652|NCT00918580|42025117|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
19576653|NCT00918580|42025117|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
19576654|NCT00918580|42025117|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
19576655|NCT00918580|42025117|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
19576656|NCT00920686|42025127|FG000|Overall Study|Lost to Follow-up|2|||
19576657|NCT00920686|42025128|FG001|Overall Study|Lost to Follow-up|3|||
19576658|NCT00920686|42025129|FG002|Overall Study|Lost to Follow-up|1|||
19576659|NCT00920686|42025127|FG000|Overall Study|Study drug dosing criteria not met|17|||
19576660|NCT00920686|42025128|FG001|Overall Study|Study drug dosing criteria not met|19|||
19576661|NCT00920686|42025129|FG002|Overall Study|Study drug dosing criteria not met|12|||
19576662|NCT01214720|42025143|FG000|Overall Study|Alive and still on treatment|34|||
19576663|NCT01214720|42025144|FG001|Overall Study|Alive and still on treatment|18|||
19576664|NCT01214720|42025143|FG000|Overall Study|Alive and in follow-up|45|||
19576665|NCT01214720|42025144|FG001|Overall Study|Alive and in follow-up|48|||
19576666|NCT01214720|42025143|FG000|Overall Study|Lost to Follow-up|6|||
19576667|NCT01214720|42025144|FG001|Overall Study|Lost to Follow-up|2|||
19576668|NCT01142232|42025155|FG000|Overall Study|Adverse Event|1|||
19576669|NCT01142232|42025156|FG001|Overall Study|Adverse Event|2|||
19576670|NCT01142232|42025157|FG002|Overall Study|Adverse Event|1|||
19576671|NCT01142232|42025158|FG003|Overall Study|Adverse Event|0|||
19576672|NCT01142232|42025159|FG004|Overall Study|Adverse Event|4|||
19576673|NCT01142232|42025155|FG000|Overall Study|Death|0|||
19576674|NCT01142232|42025156|FG001|Overall Study|Death|0|||
19576675|NCT01142232|42025157|FG002|Overall Study|Death|0|||
19576676|NCT01142232|42025158|FG003|Overall Study|Death|0|||
19576677|NCT01142232|42025159|FG004|Overall Study|Death|1|||
19576678|NCT01142232|42025155|FG000|Overall Study|Disease Progression|2|||
19576679|NCT01142232|42025156|FG001|Overall Study|Disease Progression|0|||
19576680|NCT01142232|42025157|FG002|Overall Study|Disease Progression|1|||
19576681|NCT01142232|42025158|FG003|Overall Study|Disease Progression|2|||
19576682|NCT01142232|42025159|FG004|Overall Study|Disease Progression|12|||
19576683|NCT01142232|42025155|FG000|Overall Study|Withdrawal by Subject|0|||
19576684|NCT01142232|42025156|FG001|Overall Study|Withdrawal by Subject|0|||
19576685|NCT01142232|42025157|FG002|Overall Study|Withdrawal by Subject|0|||
19576686|NCT01142232|42025158|FG003|Overall Study|Withdrawal by Subject|1|||
19576687|NCT01142232|42025159|FG004|Overall Study|Withdrawal by Subject|3|||
19576688|NCT01142232|42025155|FG000|Overall Study|Physician Decision|0|||
19576689|NCT01142232|42025156|FG001|Overall Study|Physician Decision|1|||
19576690|NCT01142232|42025157|FG002|Overall Study|Physician Decision|0|||
19576691|NCT01142232|42025158|FG003|Overall Study|Physician Decision|2|||
19576692|NCT01142232|42025159|FG004|Overall Study|Physician Decision|10|||
19576693|NCT01142232|42025155|FG000|Overall Study|Alternative Therapy|0|||
19576694|NCT01142232|42025156|FG001|Overall Study|Alternative Therapy|1|||
19576695|NCT01142232|42025157|FG002|Overall Study|Alternative Therapy|1|||
19576696|NCT01142232|42025158|FG003|Overall Study|Alternative Therapy|0|||
19576697|NCT01142232|42025159|FG004|Overall Study|Alternative Therapy|1|||
19576698|NCT01142232|42025155|FG000|Overall Study|Off Trt for other complicating disease|0|||
19576699|NCT01142232|42025156|FG001|Overall Study|Off Trt for other complicating disease|0|||
19576700|NCT01142232|42025157|FG002|Overall Study|Off Trt for other complicating disease|0|||
19576701|NCT01142232|42025158|FG003|Overall Study|Off Trt for other complicating disease|0|||
19576702|NCT01142232|42025159|FG004|Overall Study|Off Trt for other complicating disease|1|||
19576703|NCT01142232|42025155|FG000|Overall Study|Noncompliance|0|||
19576704|NCT01142232|42025156|FG001|Overall Study|Noncompliance|0|||
19576705|NCT01142232|42025157|FG002|Overall Study|Noncompliance|0|||
19576706|NCT01142232|42025158|FG003|Overall Study|Noncompliance|0|||
19576707|NCT01142232|42025159|FG004|Overall Study|Noncompliance|2|||
19576708|NCT01140906|42025175|FG000|Overall Study|Adverse Event|7|||
19576709|NCT01140906|42025176|FG001|Overall Study|Adverse Event|10|||
19576710|NCT01140906|42025177|FG002|Overall Study|Adverse Event|17|||
19576711|NCT01140906|42025178|FG003|Overall Study|Adverse Event|7|||
19576712|NCT01140906|42025175|FG000|Overall Study|Lack of Efficacy|6|||
19576713|NCT01140906|42025176|FG001|Overall Study|Lack of Efficacy|8|||
19576714|NCT01140906|42025177|FG002|Overall Study|Lack of Efficacy|2|||
19576715|NCT01140906|42025178|FG003|Overall Study|Lack of Efficacy|1|||
19576716|NCT01140906|42025175|FG000|Overall Study|Non-compliance|0|||
19576717|NCT01140906|42025176|FG001|Overall Study|Non-compliance|1|||
19576718|NCT01140906|42025177|FG002|Overall Study|Non-compliance|0|||
19476957|NCT02790138|41755396|FG001|Overall Study|Adverse Event|2|||
19387795|NCT02565147|41631101|FG000|Overall Study|Death|1|||
19576719|NCT01140906|42025178|FG003|Overall Study|Non-compliance|1|||
19576720|NCT01140906|42025175|FG000|Overall Study|Protocol Violation|5|||
19576721|NCT01140906|42025176|FG001|Overall Study|Protocol Violation|3|||
19576722|NCT01140906|42025177|FG002|Overall Study|Protocol Violation|2|||
19576723|NCT01140906|42025178|FG003|Overall Study|Protocol Violation|1|||
19576724|NCT01140906|42025175|FG000|Overall Study|Withdrawal of consent|6|||
19576725|NCT01140906|42025176|FG001|Overall Study|Withdrawal of consent|6|||
19576726|NCT01140906|42025177|FG002|Overall Study|Withdrawal of consent|2|||
19576727|NCT01140906|42025178|FG003|Overall Study|Withdrawal of consent|2|||
19576728|NCT01140906|42025175|FG000|Overall Study|Lost to Follow-up|1|||
19576729|NCT01140906|42025176|FG001|Overall Study|Lost to Follow-up|1|||
19576730|NCT01140906|42025177|FG002|Overall Study|Lost to Follow-up|0|||
19387796|NCT02565147|41631102|FG001|Overall Study|Death|1|||
19387797|NCT02061280|41631110|FG000|Overall Study|Protocol Violation|12|||
19387798|NCT02061280|41631111|FG001|Overall Study|Protocol Violation|8|||
19387799|NCT02061280|41631110|FG000|Overall Study|moved out of state|0|||
19387800|NCT02061280|41631111|FG001|Overall Study|moved out of state|1|||
19387801|NCT02061280|41631110|FG000|Overall Study|Withdrawal by Subject|1|||
19576731|NCT01140906|42025178|FG003|Overall Study|Lost to Follow-up|2|||
19576732|NCT01140906|42025175|FG000|Overall Study|Administrative or other reason|0|||
19576733|NCT01140906|42025176|FG001|Overall Study|Administrative or other reason|5|||
19576734|NCT01140906|42025177|FG002|Overall Study|Administrative or other reason|3|||
19576735|NCT01140906|42025178|FG003|Overall Study|Administrative or other reason|2|||
19576736|NCT00962091|42025195|FG000|Overall Study|Withdrawal by Subject|1|||
19576737|NCT00962091|42025196|FG001|Overall Study|Withdrawal by Subject|2|||
19576738|NCT00962091|42025197|FG002|Overall Study|Withdrawal by Subject|1|||
19387802|NCT02061280|41631111|FG001|Overall Study|Withdrawal by Subject|2|||
19387803|NCT02061280|41631110|FG000|Overall Study|Lost to Follow-up|5|||
19387804|NCT02061280|41631111|FG001|Overall Study|Lost to Follow-up|1|||
19387805|NCT02061202|41631122|FG000|Overall Study|Lost to Follow-up|1|||
19387806|NCT02061202|41631123|FG001|Overall Study|Lost to Follow-up|1|||
19387807|NCT02059408|41631132|FG000|Overall Study|Did not get tested|0|||
19387808|NCT02059408|41631133|FG001|Overall Study|Did not get tested|330|||
19387809|NCT02059408|41631134|FG002|Overall Study|Did not get tested|358|||
19387810|NCT01625338|41631147|FG000|Overall Study|Enrolled but not Treated|0|||
19387811|NCT01625338|41631148|FG001|Overall Study|Enrolled but not Treated|0|||
19387812|NCT01625338|41631149|FG002|Overall Study|Enrolled but not Treated|1|||
19387813|NCT01625338|41631147|FG000|Overall Study|Efficacy Failure|27|||
19576739|NCT00962091|42025198|FG003|Overall Study|Withdrawal by Subject|1|||
19576740|NCT00962091|42025199|FG004|Overall Study|Withdrawal by Subject|0|||
19576741|NCT00962091|42025200|FG005|Overall Study|Withdrawal by Subject|1|||
19576742|NCT00962091|42025201|FG006|Overall Study|Withdrawal by Subject|0|||
19576743|NCT00962091|42025195|FG000|Overall Study|Adverse Event|0|||
19576744|NCT00962091|42025196|FG001|Overall Study|Adverse Event|0|||
19576745|NCT00962091|42025197|FG002|Overall Study|Adverse Event|0|||
19576746|NCT00962091|42025198|FG003|Overall Study|Adverse Event|0|||
19576747|NCT00962091|42025199|FG004|Overall Study|Adverse Event|0|||
19576748|NCT00962091|42025200|FG005|Overall Study|Adverse Event|0|||
19576749|NCT00962091|42025201|FG006|Overall Study|Adverse Event|1|||
19576750|NCT01163916|42025228|FG000|Overall Study|Withdrawal by Subject|2|||
19576751|NCT01163916|42025229|FG001|Overall Study|Withdrawal by Subject|0|||
19576752|NCT01163916|42025230|FG002|Overall Study|Withdrawal by Subject|2|||
19576753|NCT01163916|42025228|FG000|Overall Study|Adverse Event|2|||
19576754|NCT01163916|42025229|FG001|Overall Study|Adverse Event|0|||
19576755|NCT01163916|42025230|FG002|Overall Study|Adverse Event|1|||
19576756|NCT01163916|42025228|FG000|Overall Study|Lack of Efficacy|2|||
19576757|NCT01163916|42025229|FG001|Overall Study|Lack of Efficacy|0|||
19576758|NCT01163916|42025230|FG002|Overall Study|Lack of Efficacy|1|||
19576759|NCT01163916|42025228|FG000|Overall Study|Other|24|||
19576760|NCT01163916|42025229|FG001|Overall Study|Other|4|||
19576761|NCT01163916|42025230|FG002|Overall Study|Other|16|||
19576762|NCT01122576|42025246|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
19576763|NCT01122576|42025247|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
19576764|NCT01122576|42025248|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
19576765|NCT01122576|42025246|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
19576766|NCT01122576|42025247|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
19576767|NCT01122576|42025248|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
19576768|NCT01122576|42025246|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
19576769|NCT01122576|42025247|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
19576770|NCT01122576|42025248|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
19576771|NCT00965523|42025259|FG000|Study 221|Progressive Disease|4|||
19576772|NCT00965523|42025259|FG000|Study 221|Physician Decision|3|||
19576773|NCT00965523|42025259|FG000|Study 224|Progressive Disease|5|||
19576774|NCT00965523|42025259|FG000|Study 224|Physician Decision|1|||
19576775|NCT01122264|42025266|FG000|Overall Study|Adverse Event|6|||
19576776|NCT01122264|42025267|FG001|Overall Study|Adverse Event|5|||
19576777|NCT01122264|42025268|FG002|Overall Study|Adverse Event|7|||
19576778|NCT01122264|42025266|FG000|Overall Study|Death|1|||
19576779|NCT01122264|42025267|FG001|Overall Study|Death|0|||
19576780|NCT01122264|42025268|FG002|Overall Study|Death|0|||
19576781|NCT01122264|42025266|FG000|Overall Study|Lost to Follow-up|5|||
19576782|NCT01122264|42025267|FG001|Overall Study|Lost to Follow-up|9|||
19576783|NCT01122264|42025268|FG002|Overall Study|Lost to Follow-up|13|||
19576784|NCT01122264|42025266|FG000|Overall Study|Entry Criteria Not Met|1|||
19576785|NCT01122264|42025267|FG001|Overall Study|Entry Criteria Not Met|0|||
19576786|NCT01122264|42025268|FG002|Overall Study|Entry Criteria Not Met|0|||
19576787|NCT01122264|42025266|FG000|Overall Study|Protocol Violation|7|||
19576788|NCT01122264|42025267|FG001|Overall Study|Protocol Violation|7|||
19576789|NCT01122264|42025268|FG002|Overall Study|Protocol Violation|9|||
19576790|NCT01122264|42025266|FG000|Overall Study|Withdrawal by Subject|6|||
19576791|NCT01122264|42025267|FG001|Overall Study|Withdrawal by Subject|6|||
19576792|NCT01122264|42025268|FG002|Overall Study|Withdrawal by Subject|16|||
19576793|NCT01122264|42025266|FG000|Overall Study|Physician Decision|3|||
19576794|NCT01122264|42025267|FG001|Overall Study|Physician Decision|1|||
19576795|NCT01122264|42025268|FG002|Overall Study|Physician Decision|1|||
19576796|NCT01122264|42025266|FG000|Overall Study|Lack of Efficacy|3|||
19576797|NCT01122264|42025267|FG001|Overall Study|Lack of Efficacy|1|||
19576798|NCT01122264|42025268|FG002|Overall Study|Lack of Efficacy|1|||
19576799|NCT00920218|42025284|FG000|Overall Study|Serious Adverse Event|2|||
19576800|NCT00920218|42025285|FG001|Overall Study|Serious Adverse Event|0|||
19576801|NCT00920218|42025286|FG002|Overall Study|Serious Adverse Event|2|||
19576802|NCT00920218|42025287|FG003|Overall Study|Serious Adverse Event|1|||
19576803|NCT00920218|42025284|FG000|Overall Study|Withdrawal by Subject|0|||
19576804|NCT00920218|42025285|FG001|Overall Study|Withdrawal by Subject|3|||
19576805|NCT00920218|42025286|FG002|Overall Study|Withdrawal by Subject|2|||
19576806|NCT00920218|42025287|FG003|Overall Study|Withdrawal by Subject|0|||
19576807|NCT00920218|42025284|FG000|Overall Study|Migrated/moved from study area|0|||
19576808|NCT00920218|42025285|FG001|Overall Study|Migrated/moved from study area|0|||
19576809|NCT00920218|42025286|FG002|Overall Study|Migrated/moved from study area|1|||
19576810|NCT00920218|42025287|FG003|Overall Study|Migrated/moved from study area|0|||
19576811|NCT00920218|42025284|FG000|Overall Study|Lost to Follow-up|0|||
19576812|NCT00920218|42025285|FG001|Overall Study|Lost to Follow-up|1|||
19576813|NCT00920218|42025286|FG002|Overall Study|Lost to Follow-up|0|||
19576814|NCT00920218|42025287|FG003|Overall Study|Lost to Follow-up|3|||
19576815|NCT00920218|42025284|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
19576816|NCT00920218|42025285|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
19745854|NCT03529773|42193180|FG024|Overall Study|Lost to Follow-up|3|||
19576817|NCT00920218|42025286|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
19576818|NCT00920218|42025287|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
19576819|NCT00920218|42025284|FG000|Overall Study|Other|0|||
19576820|NCT00920218|42025285|FG001|Overall Study|Other|0|||
19576821|NCT00920218|42025286|FG002|Overall Study|Other|1|||
19576822|NCT00920218|42025287|FG003|Overall Study|Other|0|||
19576823|NCT01121562|42025301|FG000|Overall Study|Objective progression or relapse|8|||
19576824|NCT01121562|42025301|FG000|Overall Study|Withdrawal by Subject|1|||
19576825|NCT01121562|42025301|FG000|Overall Study|Adverse Event|1|||
19576826|NCT01121562|42025301|FG000|Overall Study|Sponsor Decision|1|||
19576827|NCT01121562|42025301|FG000|Overall Study|Met study discontinuation criteria|1|||
19576828|NCT01121484|42025307|FG000|Overall Study|Adverse Event|12|||
19576829|NCT01121484|42025308|FG001|Overall Study|Adverse Event|5|||
19576830|NCT01121484|42025307|FG000|Overall Study|Lack of Efficacy|3|||
19576831|NCT01121484|42025308|FG001|Overall Study|Lack of Efficacy|11|||
19576832|NCT01121484|42025307|FG000|Overall Study|Lost to Follow-up|5|||
19576833|NCT01121484|42025308|FG001|Overall Study|Lost to Follow-up|9|||
19576834|NCT01121484|42025307|FG000|Overall Study|Physician Decision|0|||
19576835|NCT01121484|42025308|FG001|Overall Study|Physician Decision|3|||
19576836|NCT01121484|42025307|FG000|Overall Study|Protocol Violation|1|||
19576837|NCT01121484|42025308|FG001|Overall Study|Protocol Violation|0|||
19576838|NCT01121484|42025307|FG000|Overall Study|Withdrawal by Subject|8|||
19576839|NCT01121484|42025308|FG001|Overall Study|Withdrawal by Subject|7|||
19576840|NCT01121484|42025307|FG000|Overall Study|Discontinuation of study by sponsor|0|||
19576841|NCT01121484|42025308|FG001|Overall Study|Discontinuation of study by sponsor|1|||
19576842|NCT01121484|42025307|FG000|Overall Study|Other|3|||
19576843|NCT01121484|42025308|FG001|Overall Study|Other|3|||
19576844|NCT01121484|42025307|FG000|Overall Study|Randomized, not treated|1|||
19576845|NCT01121484|42025308|FG001|Overall Study|Randomized, not treated|4|||
19576846|NCT01169675|42025319|FG000|Overall Study|Progressive disease|13|||
19576847|NCT01169675|42025320|FG001|Overall Study|Progressive disease|2|||
19576848|NCT01169675|42025321|FG002|Overall Study|Progressive disease|5|||
19576849|NCT01169675|42025322|FG003|Overall Study|Progressive disease|15|||
19576850|NCT01169675|42025323|FG004|Overall Study|Progressive disease|1|||
19576851|NCT01169675|42025319|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
19576852|NCT01169675|42025320|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19576853|NCT01169675|42025321|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19576854|NCT01169675|42025322|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19576855|NCT01169675|42025323|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19576856|NCT01169675|42025319|FG000|Overall Study|Adverse Event|5|||
19576857|NCT01169675|42025320|FG001|Overall Study|Adverse Event|1|||
19576858|NCT01169675|42025321|FG002|Overall Study|Adverse Event|2|||
19576859|NCT01169675|42025322|FG003|Overall Study|Adverse Event|0|||
19576860|NCT01169675|42025323|FG004|Overall Study|Adverse Event|0|||
19576861|NCT01169675|42025319|FG000|Overall Study|Withdrawal by Subject|1|||
19576862|NCT01169675|42025320|FG001|Overall Study|Withdrawal by Subject|0|||
19576863|NCT01169675|42025321|FG002|Overall Study|Withdrawal by Subject|0|||
19387814|NCT01625338|41631148|FG001|Overall Study|Efficacy Failure|39|||
19387815|NCT01625338|41631149|FG002|Overall Study|Efficacy Failure|31|||
19387816|NCT01625338|41631147|FG000|Overall Study|Lost to Follow-up|3|||
19387817|NCT01625338|41631148|FG001|Overall Study|Lost to Follow-up|3|||
19387818|NCT01625338|41631149|FG002|Overall Study|Lost to Follow-up|2|||
19387819|NCT01625338|41631147|FG000|Overall Study|Investigator Decision|0|||
19387820|NCT01625338|41631148|FG001|Overall Study|Investigator Decision|2|||
19387821|NCT01625338|41631149|FG002|Overall Study|Investigator Decision|1|||
19387822|NCT01625338|41631147|FG000|Overall Study|Subject Withdrew Consent|1|||
19387823|NCT01625338|41631148|FG001|Overall Study|Subject Withdrew Consent|0|||
19476958|NCT02790138|41755395|FG000|Overall Study|Significant Protocol Deviation|0|||
19576864|NCT01169675|42025322|FG003|Overall Study|Withdrawal by Subject|1|||
19576865|NCT01169675|42025323|FG004|Overall Study|Withdrawal by Subject|2|||
19576866|NCT01169675|42025319|FG000|Overall Study|Other Reason Not Defined Above|0|||
19576867|NCT01169675|42025320|FG001|Overall Study|Other Reason Not Defined Above|0|||
19576868|NCT01169675|42025321|FG002|Overall Study|Other Reason Not Defined Above|0|||
19576869|NCT01169675|42025322|FG003|Overall Study|Other Reason Not Defined Above|1|||
19576870|NCT01169675|42025323|FG004|Overall Study|Other Reason Not Defined Above|1|||
19576871|NCT00924664|42025337|FG000|Overall Study|Adverse Event|23|||
19576872|NCT00924664|42025338|FG001|Overall Study|Adverse Event|39|||
19576873|NCT00924664|42025337|FG000|Overall Study|Lack of Efficacy|10|||
19576874|NCT00924664|42025338|FG001|Overall Study|Lack of Efficacy|15|||
19576875|NCT00924664|42025337|FG000|Overall Study|Lost to Follow-up|10|||
19576876|NCT00924664|42025338|FG001|Overall Study|Lost to Follow-up|12|||
19576877|NCT00924664|42025337|FG000|Overall Study|Withdrawal by Subject|47|||
19576878|NCT00924664|42025338|FG001|Overall Study|Withdrawal by Subject|71|||
19576879|NCT00924664|42025337|FG000|Overall Study|Protocol Violation|2|||
19576880|NCT00924664|42025338|FG001|Overall Study|Protocol Violation|5|||
19576881|NCT00924664|42025337|FG000|Overall Study|Pregnancy|1|||
19576882|NCT00924664|42025338|FG001|Overall Study|Pregnancy|1|||
19576883|NCT00924664|42025337|FG000|Overall Study|Death|0|||
19576884|NCT00924664|42025338|FG001|Overall Study|Death|2|||
19576885|NCT00924664|42025337|FG000|Overall Study|Study terminated by sponsor|199|||
19576886|NCT00924664|42025338|FG001|Overall Study|Study terminated by sponsor|330|||
19576887|NCT00924664|42025337|FG000|Overall Study|Other|29|||
19576888|NCT00924664|42025338|FG001|Overall Study|Other|52|||
19576889|NCT00924664|42025337|FG000|Overall Study|Randomized but not Treated|1|||
19576890|NCT00924664|42025338|FG001|Overall Study|Randomized but not Treated|0|||
19576891|NCT00600067|42025346|FG000|Overall Study|Adverse Event|0|||
19576892|NCT00600067|42025347|FG001|Overall Study|Adverse Event|1|||
19576893|NCT00600067|42025346|FG000|Overall Study|Lost to Follow-up|2|||
19576894|NCT00600067|42025347|FG001|Overall Study|Lost to Follow-up|3|||
19576895|NCT00600067|42025346|FG000|Overall Study|protocol non-compliance|0|||
19576896|NCT00600067|42025347|FG001|Overall Study|protocol non-compliance|3|||
19576897|NCT00600067|42025346|FG000|Overall Study|Lack of Efficacy|1|||
19576898|NCT00600067|42025347|FG001|Overall Study|Lack of Efficacy|0|||
19576899|NCT00970593|42025361|FG000|Overall Study|Adverse Event|1|||
19576900|NCT00970593|42025362|FG001|Overall Study|Adverse Event|1|||
19576901|NCT00970593|42025363|FG002|Overall Study|Adverse Event|0|||
19576902|NCT00970593|42025364|FG003|Overall Study|Adverse Event|0|||
19576903|NCT00970593|42025365|FG004|Overall Study|Adverse Event|0|||
19576904|NCT00970593|42025366|FG005|Overall Study|Adverse Event|0|||
19576905|NCT00970593|42025367|FG006|Overall Study|Adverse Event|0|||
19576906|NCT00970593|42025361|FG000|Overall Study|Discontinuation of study by sponsor|0|||
19576907|NCT00970593|42025362|FG001|Overall Study|Discontinuation of study by sponsor|0|||
19576908|NCT00970593|42025363|FG002|Overall Study|Discontinuation of study by sponsor|5|||
19576909|NCT00970593|42025364|FG003|Overall Study|Discontinuation of study by sponsor|0|||
19576910|NCT00970593|42025365|FG004|Overall Study|Discontinuation of study by sponsor|0|||
19576911|NCT00970593|42025366|FG005|Overall Study|Discontinuation of study by sponsor|0|||
19576912|NCT00970593|42025367|FG006|Overall Study|Discontinuation of study by sponsor|2|||
19576913|NCT00970593|42025361|FG000|Overall Study|Withdrawal by Subject|0|||
19576914|NCT00970593|42025362|FG001|Overall Study|Withdrawal by Subject|0|||
19576915|NCT00970593|42025363|FG002|Overall Study|Withdrawal by Subject|1|||
19576916|NCT00970593|42025364|FG003|Overall Study|Withdrawal by Subject|0|||
19576917|NCT00970593|42025365|FG004|Overall Study|Withdrawal by Subject|0|||
19576918|NCT00970593|42025366|FG005|Overall Study|Withdrawal by Subject|0|||
19576919|NCT00970593|42025367|FG006|Overall Study|Withdrawal by Subject|0|||
19576920|NCT00962013|42025387|FG000|Overall Study|Did not have surgery|1|||
19576921|NCT00962013|42025387|FG000|Overall Study|Death|8|||
19576922|NCT00962013|42025387|FG000|Overall Study|Lost to Follow-up|12|||
19576923|NCT00962013|42025387|FG000|Overall Study|Unable/Unwilling to return|6|||
19576924|NCT00962013|42025387|FG000|Overall Study|Withdrawal by Subject|8|||
19576925|NCT00962013|42025387|FG000|Overall Study|Removal of study device|3|||
19576926|NCT00962013|42025387|FG000|Overall Study|Site Termination|24|||
19576927|NCT00962013|42025387|FG000|Overall Study|No 5 year evaluation|6|||
19576928|NCT00970359|42025391|FG000|Overall Study|Not Treated|4|||
19576929|NCT01121406|42025397|FG000|Overall Study|Progressive disease RECIST|44|||
19576930|NCT01121406|42025398|FG001|Overall Study|Progressive disease RECIST|28|||
19576931|NCT01121406|42025397|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
19576932|NCT01121406|42025398|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
19576933|NCT01121406|42025397|FG000|Overall Study|Other AE|3|||
19576934|NCT01121406|42025398|FG001|Overall Study|Other AE|10|||
19576935|NCT01121406|42025397|FG000|Overall Study|Non-compliant with protocol|0|||
19576936|NCT01121406|42025398|FG001|Overall Study|Non-compliant with protocol|2|||
19576937|NCT01121406|42025397|FG000|Overall Study|Lost to Follow-up|0|||
19576938|NCT01121406|42025398|FG001|Overall Study|Lost to Follow-up|1|||
19576939|NCT01121406|42025397|FG000|Overall Study|Refused continuation of study med.|1|||
19576940|NCT01121406|42025398|FG001|Overall Study|Refused continuation of study med.|2|||
19576941|NCT01121406|42025397|FG000|Overall Study|Reason other than specified above|2|||
19576942|NCT01121406|42025398|FG001|Overall Study|Reason other than specified above|6|||
19576943|NCT01121406|42025397|FG000|Overall Study|Not treated|1|||
19576944|NCT01121406|42025398|FG001|Overall Study|Not treated|0|||
19576945|NCT00960687|42025407|FG000|Washout Period of 7 Days|Adverse Event|3|||
19576946|NCT00960687|42025408|FG001|Washout Period of 7 Days|Adverse Event|2|||
19576947|NCT00960687|42025407|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
19576948|NCT00960687|42025408|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19576949|NCT00920140|42025419|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
19576950|NCT00920140|42025420|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
19576951|NCT00920140|42025421|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
19576952|NCT00920140|42025422|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
19576953|NCT00920140|42025423|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
19576954|NCT00920140|42025419|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
19576955|NCT00920140|42025420|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
19576956|NCT00920140|42025421|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
19576957|NCT00920140|42025422|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
19576958|NCT00920140|42025423|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
19576959|NCT00920140|42025419|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
19576960|NCT00920140|42025420|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
19576961|NCT00920140|42025421|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
19576962|NCT00920140|42025422|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
19576963|NCT00920140|42025423|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
19576964|NCT00920140|42025419|FG000|Phase 2|Adverse Event|0|||
19576965|NCT00920140|42025420|FG001|Phase 2|Adverse Event|0|||
19576966|NCT00920140|42025421|FG002|Phase 2|Adverse Event|14|||
19576967|NCT00920140|42025422|FG003|Phase 2|Adverse Event|2|||
19576968|NCT00920140|42025423|FG004|Phase 2|Adverse Event|3|||
19576969|NCT00920140|42025419|FG000|Phase 2|Lack of Efficacy|0|||
19576970|NCT00920140|42025420|FG001|Phase 2|Lack of Efficacy|0|||
19576971|NCT00920140|42025421|FG002|Phase 2|Lack of Efficacy|29|||
19576972|NCT00920140|42025422|FG003|Phase 2|Lack of Efficacy|14|||
19576973|NCT00920140|42025423|FG004|Phase 2|Lack of Efficacy|5|||
19576974|NCT00920140|42025419|FG000|Phase 2|Lost to Follow-up|0|||
19576975|NCT00920140|42025420|FG001|Phase 2|Lost to Follow-up|0|||
19576976|NCT00920140|42025421|FG002|Phase 2|Lost to Follow-up|0|||
19576977|NCT00920140|42025422|FG003|Phase 2|Lost to Follow-up|1|||
19576978|NCT00920140|42025423|FG004|Phase 2|Lost to Follow-up|0|||
19576979|NCT00920140|42025419|FG000|Phase 2|Physician Decision|0|||
19576980|NCT00920140|42025420|FG001|Phase 2|Physician Decision|0|||
19576981|NCT00920140|42025421|FG002|Phase 2|Physician Decision|3|||
19576982|NCT00920140|42025422|FG003|Phase 2|Physician Decision|3|||
19576983|NCT00920140|42025423|FG004|Phase 2|Physician Decision|2|||
19576984|NCT00920140|42025419|FG000|Phase 2|Withdrawal by Subject|0|||
19576985|NCT00920140|42025420|FG001|Phase 2|Withdrawal by Subject|0|||
19576986|NCT00920140|42025421|FG002|Phase 2|Withdrawal by Subject|4|||
19576987|NCT00920140|42025422|FG003|Phase 2|Withdrawal by Subject|2|||
19576988|NCT00920140|42025423|FG004|Phase 2|Withdrawal by Subject|1|||
19576989|NCT01120782|42025436|FG000|Overall Study|Test article shipping error|11|||
19576990|NCT01120626|42025442|FG000|Overall Study|Withdrawal by Subject|1|||
19576991|NCT01120626|42025443|FG001|Overall Study|Withdrawal by Subject|0|||
19576992|NCT00924508|42025449|FG000|Overall Study|Withdrawal by Subject|3|||
19576993|NCT01139658|42025458|FG000|Overall Study|Adverse Event|10|||
19576994|NCT01139658|42025459|FG001|Overall Study|Adverse Event|27|||
19576995|NCT01139658|42025458|FG000|Overall Study|Lack of Efficacy|15|||
19576996|NCT01139658|42025459|FG001|Overall Study|Lack of Efficacy|7|||
19576997|NCT01139658|42025458|FG000|Overall Study|Withdrawal by Subject|2|||
19576998|NCT01139658|42025459|FG001|Overall Study|Withdrawal by Subject|4|||
19576999|NCT01139658|42025458|FG000|Overall Study|No documentation of treatment|1|||
19577000|NCT01139658|42025459|FG001|Overall Study|No documentation of treatment|0|||
19577001|NCT01139658|42025458|FG000|Overall Study|Other|28|||
19577002|NCT01139658|42025459|FG001|Overall Study|Other|75|||
19577003|NCT01139580|42025467|FG000|Overall Study|Adverse Event|5|||
19577004|NCT01139580|42025468|FG001|Overall Study|Adverse Event|4|||
19577005|NCT01139580|42025467|FG000|Overall Study|Lost to Follow-up|9|||
19577006|NCT01139580|42025468|FG001|Overall Study|Lost to Follow-up|1|||
19577007|NCT01139580|42025467|FG000|Overall Study|Lack of Efficacy|0|||
19577008|NCT01139580|42025468|FG001|Overall Study|Lack of Efficacy|2|||
19577009|NCT01139580|42025467|FG000|Overall Study|Withdrawal by Subject|6|||
19577010|NCT01139580|42025468|FG001|Overall Study|Withdrawal by Subject|9|||
19577011|NCT01139580|42025467|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
19577012|NCT01139580|42025468|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
19577013|NCT01139580|42025467|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
19577014|NCT01139580|42025468|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
19577015|NCT01139580|42025467|FG000|Overall Study|Misrandomized|1|||
19577016|NCT01139580|42025468|FG001|Overall Study|Misrandomized|0|||
19577017|NCT01139580|42025467|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
19577018|NCT01139580|42025468|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
19577019|NCT01139580|42025467|FG000|Overall Study|Participant Randomization in Error|0|||
19577020|NCT01139580|42025468|FG001|Overall Study|Participant Randomization in Error|1|||
19577021|NCT00917644|42025474|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
19577022|NCT00917644|42025475|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
19577023|NCT00917644|42025474|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
19577024|NCT00917644|42025475|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
19577025|NCT00917644|42025474|FG000|Period 2: Second Intervention|family emergency|1|||
19577026|NCT00917644|42025475|FG001|Period 2: Second Intervention|family emergency|0|||
19577027|NCT01137786|42025483|FG000|Overall Study|Lost to Follow-up|0|||
19577028|NCT01137786|42025484|FG001|Overall Study|Lost to Follow-up|2|||
19577029|NCT01137786|42025483|FG000|Overall Study|Withdrawal by Subject|1|||
19577030|NCT01137786|42025484|FG001|Overall Study|Withdrawal by Subject|1|||
19577031|NCT00599755|42025492|FG000|Overall Study|Adverse Event|11|||
19577032|NCT00599755|42025492|FG000|Overall Study|Withdrawal by Subject|2|||
19577033|NCT00599755|42025492|FG000|Overall Study|Progression of Disease|3|||
19577034|NCT00599755|42025492|FG000|Overall Study|Other Reason|2|||
19577035|NCT00599755|42025492|FG000|Overall Study|No data available|1|||
19577036|NCT00600613|42025496|FG000|Overall Study|Protocol Deviation|1|||
19577037|NCT01125930|42025502|FG000|Overall Study|Adverse Event|0|||
19577038|NCT01125930|42025503|FG001|Overall Study|Adverse Event|1|||
19577039|NCT01125930|42025502|FG000|Overall Study|Withdrawal by Subject|1|||
19577040|NCT01125930|42025503|FG001|Overall Study|Withdrawal by Subject|6|||
19577041|NCT01125930|42025502|FG000|Overall Study|Protocol Violation|0|||
19577042|NCT01125930|42025503|FG001|Overall Study|Protocol Violation|1|||
19577043|NCT01125930|42025502|FG000|Overall Study|Lost to Follow-up|0|||
19577044|NCT01125930|42025503|FG001|Overall Study|Lost to Follow-up|2|||
19577045|NCT00918346|42025534|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
19577046|NCT00918346|42025535|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
19577047|NCT00913978|42025546|FG000|Overall Study|Surgeon choice|1|||
19577048|NCT00913978|42025547|FG001|Overall Study|Surgeon choice|3|||
19577049|NCT01137474|42025557|FG000|Overall Study|Adverse Event|3|||
19577050|NCT01137474|42025558|FG001|Overall Study|Adverse Event|5|||
19577051|NCT01137474|42025559|FG002|Overall Study|Adverse Event|1|||
19577052|NCT01137474|42025560|FG003|Overall Study|Adverse Event|3|||
19577053|NCT01137474|42025557|FG000|Overall Study|Withdrawal by Subject|7|||
19577054|NCT01137474|42025558|FG001|Overall Study|Withdrawal by Subject|2|||
19577055|NCT01137474|42025559|FG002|Overall Study|Withdrawal by Subject|6|||
19577056|NCT01137474|42025560|FG003|Overall Study|Withdrawal by Subject|9|||
19577057|NCT01137474|42025557|FG000|Overall Study|No longer met study criteria|6|||
19577058|NCT01137474|42025558|FG001|Overall Study|No longer met study criteria|1|||
19577059|NCT01137474|42025559|FG002|Overall Study|No longer met study criteria|0|||
19577060|NCT01137474|42025560|FG003|Overall Study|No longer met study criteria|5|||
19577061|NCT01137474|42025557|FG000|Overall Study|Lost to Follow-up|5|||
19577062|NCT01137474|42025558|FG001|Overall Study|Lost to Follow-up|1|||
19577063|NCT01137474|42025559|FG002|Overall Study|Lost to Follow-up|0|||
19577064|NCT01137474|42025560|FG003|Overall Study|Lost to Follow-up|2|||
19577065|NCT01137474|42025557|FG000|Overall Study|Lack of Efficacy|0|||
19577066|NCT01137474|42025558|FG001|Overall Study|Lack of Efficacy|0|||
19577067|NCT01137474|42025559|FG002|Overall Study|Lack of Efficacy|0|||
19577068|NCT01137474|42025560|FG003|Overall Study|Lack of Efficacy|2|||
19577069|NCT01137474|42025557|FG000|Overall Study|Other|3|||
19577070|NCT01137474|42025558|FG001|Overall Study|Other|1|||
19577071|NCT01137474|42025559|FG002|Overall Study|Other|0|||
19577072|NCT01137474|42025560|FG003|Overall Study|Other|0|||
19577073|NCT01137474|42025557|FG000|Overall Study|Pregnancy|0|||
19577074|NCT01137474|42025558|FG001|Overall Study|Pregnancy|1|||
19577075|NCT01137474|42025559|FG002|Overall Study|Pregnancy|0|||
19577076|NCT01137474|42025560|FG003|Overall Study|Pregnancy|0|||
19577077|NCT01137474|42025557|FG000|Overall Study|Administrative reason by sponsor|0|||
19577078|NCT01137474|42025558|FG001|Overall Study|Administrative reason by sponsor|1|||
19577079|NCT01137474|42025559|FG002|Overall Study|Administrative reason by sponsor|0|||
19577080|NCT01137474|42025560|FG003|Overall Study|Administrative reason by sponsor|0|||
19577081|NCT01168973|42025572|FG000|Overall Study|Progressive Disease|341|||
19577082|NCT01168973|42025573|FG001|Overall Study|Progressive Disease|429|||
19577083|NCT01168973|42025572|FG000|Overall Study|Adverse Event|94|||
19577084|NCT01168973|42025573|FG001|Overall Study|Adverse Event|55|||
19577085|NCT01168973|42025572|FG000|Overall Study|Withdrawal by Subject|90|||
19577086|NCT01168973|42025573|FG001|Overall Study|Withdrawal by Subject|53|||
19577087|NCT01168973|42025572|FG000|Overall Study|Death|42|||
19577088|NCT01168973|42025573|FG001|Overall Study|Death|45|||
19577089|NCT01168973|42025572|FG000|Overall Study|Physician Decision|37|||
19577090|NCT01168973|42025573|FG001|Overall Study|Physician Decision|19|||
19577091|NCT01168973|42025572|FG000|Overall Study|Sponsor Decision|2|||
19577092|NCT01168973|42025573|FG001|Overall Study|Sponsor Decision|1|||
19577093|NCT01168973|42025572|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
19577094|NCT01168973|42025573|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
19577095|NCT03918109|42025583|FG000|Overall Study|Withdrawal by Subject|0|||
19577096|NCT03918109|42025584|FG001|Overall Study|Withdrawal by Subject|0|||
19577097|NCT03918109|42025585|FG002|Overall Study|Withdrawal by Subject|2|||
19577098|NCT03918109|42025586|FG003|Overall Study|Withdrawal by Subject|1|||
19577099|NCT03918109|42025583|FG000|Overall Study|Lost to Follow-up|0|||
19577100|NCT03918109|42025584|FG001|Overall Study|Lost to Follow-up|0|||
19577101|NCT03918109|42025585|FG002|Overall Study|Lost to Follow-up|0|||
19577102|NCT03918109|42025586|FG003|Overall Study|Lost to Follow-up|1|||
19577103|NCT01168427|42025596|FG000|Overall Study|Patient exited prior to implant|1|||
19577104|NCT01124916|42025602|FG000|Overall Study|Lost to Follow-up|3|||
19577105|NCT01124916|42025603|FG001|Overall Study|Lost to Follow-up|2|||
19577106|NCT00916006|42025611|FG000|Overall Study|Adverse Event|1|||
19577107|NCT00916006|42025612|FG001|Overall Study|Adverse Event|1|||
19577108|NCT00916006|42025611|FG000|Overall Study|Withdrawal by Subject|2|||
19577109|NCT00916006|42025612|FG001|Overall Study|Withdrawal by Subject|5|||
19577110|NCT00916006|42025611|FG000|Overall Study|Protocol Violation|0|||
19577111|NCT00916006|42025612|FG001|Overall Study|Protocol Violation|1|||
19577112|NCT01168349|42025629|FG000|Overall Study|Death|157|||
19577113|NCT01168349|42025629|FG000|Overall Study|Lost to Follow-up|34|||
19577114|NCT01168349|42025629|FG000|Overall Study|Withdrawal by Subject|9|||
19577115|NCT01168349|42025629|FG000|Overall Study|Kidney transplantation|3|||
19577116|NCT01168349|42025629|FG000|Overall Study|Other|22|||
19577117|NCT01168349|42025629|FG000|Overall Study|Protocol Violation|76|||
19577118|NCT00915772|42025652|FG000|Overall Study|Adverse Event|12|||
19577119|NCT00915772|42025653|FG001|Overall Study|Adverse Event|13|||
19577120|NCT00915772|42025654|FG002|Overall Study|Adverse Event|11|||
19577121|NCT00915772|42025652|FG000|Overall Study|Protocol Violation|4|||
19577122|NCT00915772|42025653|FG001|Overall Study|Protocol Violation|1|||
19577123|NCT00915772|42025654|FG002|Overall Study|Protocol Violation|2|||
19577124|NCT00915772|42025652|FG000|Overall Study|Lost to Follow-up|1|||
19577125|NCT00915772|42025653|FG001|Overall Study|Lost to Follow-up|2|||
19577126|NCT00915772|42025654|FG002|Overall Study|Lost to Follow-up|2|||
19577127|NCT00915772|42025652|FG000|Overall Study|Lack of Efficacy|9|||
19577128|NCT00915772|42025653|FG001|Overall Study|Lack of Efficacy|15|||
19577129|NCT00915772|42025654|FG002|Overall Study|Lack of Efficacy|3|||
19577130|NCT00915772|42025652|FG000|Overall Study|Refused to continue trial medication|6|||
19577131|NCT00915772|42025653|FG001|Overall Study|Refused to continue trial medication|8|||
19577132|NCT00915772|42025654|FG002|Overall Study|Refused to continue trial medication|4|||
19577133|NCT00915772|42025652|FG000|Overall Study|Any other reason|4|||
19577134|NCT00915772|42025653|FG001|Overall Study|Any other reason|7|||
19577135|NCT00915772|42025654|FG002|Overall Study|Any other reason|7|||
19577136|NCT03848845|42025666|FG000|Overall Study|Lost to Follow-up|0|||
19577137|NCT03848845|42025667|FG001|Overall Study|Lost to Follow-up|1|||
19577138|NCT03848845|42025668|FG002|Overall Study|Lost to Follow-up|0|||
19577139|NCT03848845|42025666|FG000|Overall Study|Withdrawal by Subject|3|||
19577140|NCT03848845|42025667|FG001|Overall Study|Withdrawal by Subject|2|||
19577141|NCT03848845|42025668|FG002|Overall Study|Withdrawal by Subject|6|||
19577142|NCT03848845|42025666|FG000|Overall Study|In Follow-up|0|||
19577143|NCT03848845|42025667|FG001|Overall Study|In Follow-up|1|||
19577144|NCT03848845|42025668|FG002|Overall Study|In Follow-up|12|||
19577145|NCT03848845|42025666|FG000|Overall Study|On Study Treatment|0|||
19577146|NCT03848845|42025667|FG001|Overall Study|On Study Treatment|0|||
19577147|NCT03848845|42025668|FG002|Overall Study|On Study Treatment|4|||
19577148|NCT03848845|42025666|FG000|Overall Study|Physician Decision|0|||
19577149|NCT03848845|42025667|FG001|Overall Study|Physician Decision|0|||
19577150|NCT03848845|42025668|FG002|Overall Study|Physician Decision|1|||
19577151|NCT00912964|42025679|FG000|Overall Study|Eligibility criterion not met|1|||
19577152|NCT00912964|42025680|FG001|Overall Study|Eligibility criterion not met|1|||
19577153|NCT00912964|42025681|FG002|Overall Study|Eligibility criterion not met|0|||
19577154|NCT00912964|42025679|FG000|Overall Study|Adverse Event|15|||
19577155|NCT00912964|42025680|FG001|Overall Study|Adverse Event|18|||
19577156|NCT00912964|42025681|FG002|Overall Study|Adverse Event|12|||
19577157|NCT00912964|42025679|FG000|Overall Study|Lack of Efficacy|11|||
19577158|NCT00912964|42025680|FG001|Overall Study|Lack of Efficacy|4|||
19577159|NCT00912964|42025681|FG002|Overall Study|Lack of Efficacy|3|||
19577160|NCT00912964|42025679|FG000|Overall Study|Withdrawal by Subject|20|||
19577161|NCT00912964|42025680|FG001|Overall Study|Withdrawal by Subject|12|||
19577162|NCT00912964|42025681|FG002|Overall Study|Withdrawal by Subject|18|||
19577163|NCT00912964|42025679|FG000|Overall Study|Lost to Follow-up|4|||
19577164|NCT00912964|42025680|FG001|Overall Study|Lost to Follow-up|3|||
19577165|NCT00912964|42025681|FG002|Overall Study|Lost to Follow-up|3|||
19577166|NCT00912964|42025679|FG000|Overall Study|Protocol Violation|5|||
19577167|NCT00912964|42025680|FG001|Overall Study|Protocol Violation|3|||
19577168|NCT00912964|42025681|FG002|Overall Study|Protocol Violation|8|||
19577169|NCT00912964|42025679|FG000|Overall Study|Taking exclusionary medications|7|||
19577170|NCT00912964|42025680|FG001|Overall Study|Taking exclusionary medications|4|||
19577171|NCT00912964|42025681|FG002|Overall Study|Taking exclusionary medications|8|||
19577172|NCT00912964|42025679|FG000|Overall Study|Medical History|1|||
19577173|NCT00912964|42025680|FG001|Overall Study|Medical History|0|||
19577174|NCT00912964|42025681|FG002|Overall Study|Medical History|0|||
19577175|NCT00912964|42025679|FG000|Overall Study|Non-compliance with study procedures|2|||
19577176|NCT00912964|42025680|FG001|Overall Study|Non-compliance with study procedures|0|||
19577177|NCT00912964|42025681|FG002|Overall Study|Non-compliance with study procedures|0|||
19577178|NCT00912964|42025679|FG000|Overall Study|Violation of exclusion criterion|0|||
19577179|NCT00912964|42025680|FG001|Overall Study|Violation of exclusion criterion|0|||
19577180|NCT00912964|42025681|FG002|Overall Study|Violation of exclusion criterion|2|||
19577181|NCT00912964|42025679|FG000|Overall Study|Randomized but never received study drug|0|||
19577182|NCT00912964|42025680|FG001|Overall Study|Randomized but never received study drug|1|||
19577183|NCT00912964|42025681|FG002|Overall Study|Randomized but never received study drug|0|||
19577184|NCT00913744|42025691|FG000|Overall Study|Adverse Event|2|||
19577185|NCT00913744|42025692|FG001|Overall Study|Adverse Event|0|||
19577186|NCT00913744|42025691|FG000|Overall Study|Withdrawal by Subject|2|||
19577187|NCT00913744|42025692|FG001|Overall Study|Withdrawal by Subject|1|||
19577188|NCT00913744|42025691|FG000|Overall Study|Death|1|||
19577189|NCT00913744|42025692|FG001|Overall Study|Death|0|||
19577190|NCT00912808|42025700|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
19577191|NCT00912808|42025701|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
19577192|NCT00912808|42025700|FG000|Washout|Withdrawal by Subject|0|||
19577193|NCT00912808|42025701|FG001|Washout|Withdrawal by Subject|1|||
19577194|NCT00912808|42025700|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
19577195|NCT00912808|42025701|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
19577196|NCT00912808|42025700|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
19577197|NCT00912808|42025701|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
19577198|NCT00960531|42025718|FG000|Overall Study|Lack of Efficacy|1|||
19577199|NCT00960531|42025719|FG001|Overall Study|Lack of Efficacy|0|||
19577200|NCT00960531|42025720|FG002|Overall Study|Lack of Efficacy|0|||
19577201|NCT00960531|42025721|FG003|Overall Study|Lack of Efficacy|0|||
19577202|NCT00960531|42025722|FG004|Overall Study|Lack of Efficacy|0|||
19577203|NCT00960531|42025723|FG005|Overall Study|Lack of Efficacy|0|||
19577204|NCT00960531|42025724|FG006|Overall Study|Lack of Efficacy|0|||
19577205|NCT00960531|42025725|FG007|Overall Study|Lack of Efficacy|0|||
19577206|NCT00960531|42025726|FG008|Overall Study|Lack of Efficacy|0|||
19577207|NCT00960531|42025727|FG009|Overall Study|Lack of Efficacy|0|||
19577208|NCT00960531|42025718|FG000|Overall Study|Withdrawal by Subject|1|||
19577209|NCT00960531|42025719|FG001|Overall Study|Withdrawal by Subject|0|||
19577210|NCT00960531|42025720|FG002|Overall Study|Withdrawal by Subject|5|||
19577211|NCT00960531|42025721|FG003|Overall Study|Withdrawal by Subject|2|||
19577212|NCT00960531|42025722|FG004|Overall Study|Withdrawal by Subject|0|||
19577213|NCT00960531|42025723|FG005|Overall Study|Withdrawal by Subject|0|||
19577214|NCT00960531|42025724|FG006|Overall Study|Withdrawal by Subject|2|||
19577215|NCT00960531|42025725|FG007|Overall Study|Withdrawal by Subject|0|||
19577216|NCT00960531|42025726|FG008|Overall Study|Withdrawal by Subject|1|||
19577217|NCT00960531|42025727|FG009|Overall Study|Withdrawal by Subject|0|||
19577218|NCT00960531|42025718|FG000|Overall Study|Caregiver Request|2|||
19476959|NCT02790138|41755396|FG001|Overall Study|Significant Protocol Deviation|1|||
19577219|NCT00960531|42025719|FG001|Overall Study|Caregiver Request|0|||
19577220|NCT00960531|42025720|FG002|Overall Study|Caregiver Request|6|||
19577221|NCT00960531|42025721|FG003|Overall Study|Caregiver Request|5|||
19577222|NCT00960531|42025722|FG004|Overall Study|Caregiver Request|0|||
19577223|NCT00960531|42025723|FG005|Overall Study|Caregiver Request|2|||
19577224|NCT00960531|42025724|FG006|Overall Study|Caregiver Request|3|||
19577225|NCT00960531|42025725|FG007|Overall Study|Caregiver Request|1|||
19577226|NCT00960531|42025726|FG008|Overall Study|Caregiver Request|3|||
19577227|NCT00960531|42025727|FG009|Overall Study|Caregiver Request|0|||
19577228|NCT00960531|42025718|FG000|Overall Study|Investigator Request|0|||
19577229|NCT00960531|42025719|FG001|Overall Study|Investigator Request|0|||
19577230|NCT00960531|42025720|FG002|Overall Study|Investigator Request|1|||
19577231|NCT00960531|42025721|FG003|Overall Study|Investigator Request|0|||
19577232|NCT00960531|42025722|FG004|Overall Study|Investigator Request|0|||
19577233|NCT00960531|42025723|FG005|Overall Study|Investigator Request|0|||
19577234|NCT00960531|42025724|FG006|Overall Study|Investigator Request|0|||
19577235|NCT00960531|42025725|FG007|Overall Study|Investigator Request|0|||
19577236|NCT00960531|42025726|FG008|Overall Study|Investigator Request|0|||
19577237|NCT00960531|42025727|FG009|Overall Study|Investigator Request|0|||
19577238|NCT00960531|42025718|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
19577239|NCT00960531|42025719|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19577240|NCT00960531|42025720|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
19577241|NCT00960531|42025721|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
19577242|NCT00960531|42025722|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
19577243|NCT00960531|42025723|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
19577244|NCT00960531|42025724|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
19577245|NCT00960531|42025725|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
19577246|NCT00960531|42025726|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
19577247|NCT00960531|42025727|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
19577248|NCT00960531|42025718|FG000|Overall Study|Lost to Follow-up|0|||
19577249|NCT00960531|42025719|FG001|Overall Study|Lost to Follow-up|0|||
19577250|NCT00960531|42025720|FG002|Overall Study|Lost to Follow-up|1|||
19577251|NCT00960531|42025721|FG003|Overall Study|Lost to Follow-up|0|||
19577252|NCT00960531|42025722|FG004|Overall Study|Lost to Follow-up|0|||
19577253|NCT00960531|42025723|FG005|Overall Study|Lost to Follow-up|0|||
19577254|NCT00960531|42025724|FG006|Overall Study|Lost to Follow-up|1|||
19577255|NCT00960531|42025725|FG007|Overall Study|Lost to Follow-up|0|||
19577256|NCT00960531|42025726|FG008|Overall Study|Lost to Follow-up|0|||
19577257|NCT00960531|42025727|FG009|Overall Study|Lost to Follow-up|0|||
19577258|NCT00960531|42025718|FG000|Overall Study|Failed to Return|2|||
19577259|NCT00960531|42025719|FG001|Overall Study|Failed to Return|0|||
19577260|NCT00960531|42025720|FG002|Overall Study|Failed to Return|0|||
19577261|NCT00960531|42025721|FG003|Overall Study|Failed to Return|0|||
19577262|NCT00960531|42025722|FG004|Overall Study|Failed to Return|0|||
19577263|NCT00960531|42025723|FG005|Overall Study|Failed to Return|0|||
19577264|NCT00960531|42025724|FG006|Overall Study|Failed to Return|0|||
19577265|NCT00960531|42025725|FG007|Overall Study|Failed to Return|2|||
19577266|NCT00960531|42025726|FG008|Overall Study|Failed to Return|0|||
19577267|NCT00960531|42025727|FG009|Overall Study|Failed to Return|0|||
19577268|NCT00960531|42025718|FG000|Overall Study|Adverse Event (AE)|2|||
19577269|NCT00960531|42025719|FG001|Overall Study|Adverse Event (AE)|0|||
19577270|NCT00960531|42025720|FG002|Overall Study|Adverse Event (AE)|0|||
19577271|NCT00960531|42025721|FG003|Overall Study|Adverse Event (AE)|0|||
19577272|NCT00960531|42025722|FG004|Overall Study|Adverse Event (AE)|0|||
19577273|NCT00960531|42025723|FG005|Overall Study|Adverse Event (AE)|1|||
19577274|NCT00960531|42025724|FG006|Overall Study|Adverse Event (AE)|2|||
19577275|NCT00960531|42025725|FG007|Overall Study|Adverse Event (AE)|0|||
19577276|NCT00960531|42025726|FG008|Overall Study|Adverse Event (AE)|2|||
19577277|NCT00960531|42025727|FG009|Overall Study|Adverse Event (AE)|0|||
19577278|NCT00960531|42025718|FG000|Overall Study|Reason not Specified|2|||
19577279|NCT00960531|42025719|FG001|Overall Study|Reason not Specified|1|||
19577280|NCT00960531|42025720|FG002|Overall Study|Reason not Specified|13|||
19577281|NCT00960531|42025721|FG003|Overall Study|Reason not Specified|1|||
19577282|NCT00960531|42025722|FG004|Overall Study|Reason not Specified|2|||
19577283|NCT00960531|42025723|FG005|Overall Study|Reason not Specified|0|||
19577284|NCT00960531|42025724|FG006|Overall Study|Reason not Specified|16|||
19577285|NCT00960531|42025725|FG007|Overall Study|Reason not Specified|0|||
19577286|NCT00960531|42025726|FG008|Overall Study|Reason not Specified|8|||
19577287|NCT00960531|42025727|FG009|Overall Study|Reason not Specified|1|||
19577288|NCT00960375|42025755|FG000|Overall Study|Lost to Follow-up|20|||
19577289|NCT00960375|42025756|FG001|Overall Study|Lost to Follow-up|22|||
19577290|NCT00957801|42025775|FG000|Overall Study|Withdrawal by Subject|0|||
19577291|NCT00957801|42025776|FG001|Overall Study|Withdrawal by Subject|0|||
19577292|NCT00957801|42025777|FG002|Overall Study|Withdrawal by Subject|0|||
19577293|NCT00957801|42025778|FG003|Overall Study|Withdrawal by Subject|1|||
19577294|NCT00957723|42025788|FG000|Overall Study|Death|3|||
19577295|NCT00957723|42025788|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
19577296|NCT00957723|42025788|FG000|Overall Study|Lost to Follow-up|8|||
19577297|NCT00957723|42025788|FG000|Overall Study|Withdrawal by Subject|24|||
19577298|NCT00957723|42025788|FG000|Overall Study|Investigative Site Terminated|61|||
19577299|NCT00957723|42025788|FG000|Overall Study|Intercurrent Illness|2|||
19577300|NCT00957723|42025788|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
19577301|NCT03778021|42025796|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
19577302|NCT03778021|42025797|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
19577303|NCT00911170|42025806|FG000|Treatment Period|Randomized in error|1|||
19577304|NCT00911170|42025807|FG001|Treatment Period|Randomized in error|1|||
19577305|NCT00911170|42025806|FG000|Treatment Period|Ineligibility determined|1|||
19577306|NCT00911170|42025807|FG001|Treatment Period|Ineligibility determined|3|||
19577307|NCT00911170|42025806|FG000|Treatment Period|Protocol deviation|1|||
19577308|NCT00911170|42025807|FG001|Treatment Period|Protocol deviation|2|||
19577309|NCT00911170|42025806|FG000|Treatment Period|Adverse Event|9|||
19577310|NCT00911170|42025807|FG001|Treatment Period|Adverse Event|10|||
19577311|NCT00911170|42025806|FG000|Treatment Period|Withdrawal by Subject|4|||
19577312|NCT00911170|42025807|FG001|Treatment Period|Withdrawal by Subject|4|||
19577313|NCT00911170|42025806|FG000|Treatment Period|Disease progression|0|||
19577314|NCT00911170|42025807|FG001|Treatment Period|Disease progression|2|||
19577315|NCT00911170|42025806|FG000|Treatment Period|Physician Decision|5|||
19577316|NCT00911170|42025807|FG001|Treatment Period|Physician Decision|5|||
19577317|NCT00911170|42025806|FG000|Treatment Period|Lost to Follow-up|0|||
19577318|NCT00911170|42025807|FG001|Treatment Period|Lost to Follow-up|1|||
19577319|NCT00911170|42025806|FG000|Treatment Period|Death|6|||
19577320|NCT00911170|42025807|FG001|Treatment Period|Death|9|||
19577321|NCT00911170|42025806|FG000|Long Term Follow-Up|Continuing in study|274|||
19577322|NCT00911170|42025807|FG001|Long Term Follow-Up|Continuing in study|269|||
19745855|NCT03529773|42193181|FG025|Overall Study|Lost to Follow-up|5|||
19577323|NCT00911170|42025806|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
19577324|NCT00911170|42025807|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
19577325|NCT00911170|42025806|FG000|Long Term Follow-Up|Physician Decision|5|||
19577326|NCT00911170|42025807|FG001|Long Term Follow-Up|Physician Decision|4|||
19577327|NCT00911170|42025806|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
19577328|NCT00911170|42025807|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
19577329|NCT00911170|42025806|FG000|Long Term Follow-Up|Death|116|||
19577330|NCT00911170|42025807|FG001|Long Term Follow-Up|Death|121|||
19577331|NCT01167881|42025815|FG000|Overall Study|Adverse Event|47|||
19577332|NCT01167881|42025816|FG001|Overall Study|Adverse Event|51|||
19577333|NCT01167881|42025815|FG000|Overall Study|Lack of Efficacy|4|||
19577334|NCT01167881|42025816|FG001|Overall Study|Lack of Efficacy|7|||
19577335|NCT01167881|42025815|FG000|Overall Study|Non compliant with protocol|9|||
19577336|NCT01167881|42025816|FG001|Overall Study|Non compliant with protocol|18|||
19577337|NCT01167881|42025815|FG000|Overall Study|Lost to Follow-up|19|||
19577338|NCT01167881|42025816|FG001|Overall Study|Lost to Follow-up|20|||
19577339|NCT01167881|42025815|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
19577340|NCT01167881|42025816|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
19577341|NCT01167881|42025815|FG000|Overall Study|Not treated|4|||
19577342|NCT01167881|42025816|FG001|Overall Study|Not treated|0|||
19577343|NCT01167881|42025815|FG000|Overall Study|Other not defined above|31|||
19577344|NCT01167881|42025816|FG001|Overall Study|Other not defined above|55|||
19577345|NCT00960063|42025825|FG000|Overall Study|Adverse Event|1|||
19577346|NCT00960063|42025826|FG001|Overall Study|Adverse Event|0|||
19577347|NCT00960063|42025827|FG002|Overall Study|Adverse Event|0|||
19577348|NCT00960063|42025825|FG000|Overall Study|Progression of Disease|0|||
19577349|NCT00960063|42025826|FG001|Overall Study|Progression of Disease|0|||
19577350|NCT00960063|42025827|FG002|Overall Study|Progression of Disease|3|||
19577351|NCT00959907|42025837|FG000|Overall Study|Protocol Violation|0|||
19577352|NCT00959907|42025838|FG001|Overall Study|Protocol Violation|1|||
19577353|NCT00959907|42025837|FG000|Overall Study|Adverse Event|1|||
19577354|NCT00959907|42025838|FG001|Overall Study|Adverse Event|0|||
19577355|NCT00959907|42025837|FG000|Overall Study|Withdrawal by Subject|2|||
19577356|NCT00959907|42025838|FG001|Overall Study|Withdrawal by Subject|0|||
19577357|NCT00912340|42025847|FG000|Overall Study|Adverse Event|2|||
19577358|NCT00912340|42025848|FG001|Overall Study|Adverse Event|4|||
19577359|NCT00912340|42025849|FG002|Overall Study|Adverse Event|0|||
19577360|NCT00912340|42025847|FG000|Overall Study|Protocol revised to remove arm|0|||
19577361|NCT00912340|42025848|FG001|Overall Study|Protocol revised to remove arm|0|||
19577362|NCT00912340|42025849|FG002|Overall Study|Protocol revised to remove arm|4|||
19577363|NCT01167257|42025859|FG000|Overall Study|Lost to Follow-up|2|||
19577364|NCT01167257|42025860|FG001|Overall Study|Lost to Follow-up|2|||
19577365|NCT01167257|42025859|FG000|Overall Study|Withdrew consent|1|||
19577366|NCT01167257|42025860|FG001|Overall Study|Withdrew consent|1|||
19577367|NCT01119846|42025873|FG000|Overall Study|Adverse Event|1|||
19577368|NCT01119846|42025874|FG001|Overall Study|Adverse Event|0|||
19577369|NCT01119846|42025875|FG002|Overall Study|Adverse Event|6|||
19577370|NCT01119846|42025873|FG000|Overall Study|Physician Decision|1|||
19577371|NCT01119846|42025874|FG001|Overall Study|Physician Decision|0|||
19577372|NCT01119846|42025875|FG002|Overall Study|Physician Decision|0|||
19577373|NCT01119846|42025873|FG000|Overall Study|Protocol Violation|0|||
19577374|NCT01119846|42025874|FG001|Overall Study|Protocol Violation|0|||
19577375|NCT01119846|42025875|FG002|Overall Study|Protocol Violation|1|||
19577376|NCT01119846|42025873|FG000|Overall Study|Withdrawal by Subject|0|||
19577377|NCT01119846|42025874|FG001|Overall Study|Withdrawal by Subject|0|||
19577378|NCT01119846|42025875|FG002|Overall Study|Withdrawal by Subject|4|||
19577379|NCT01167179|42025912|FG000|Overall Study|disease recurrence|4|||
19577380|NCT01167179|42025913|FG001|Overall Study|disease recurrence|4|||
19577381|NCT01167179|42025912|FG000|Overall Study|Death|4|||
19577382|NCT01167179|42025913|FG001|Overall Study|Death|10|||
19577383|NCT01167179|42025912|FG000|Overall Study|Withdrawal by Subject|1|||
19577384|NCT01167179|42025913|FG001|Overall Study|Withdrawal by Subject|2|||
19577385|NCT01167179|42025912|FG000|Overall Study|diverse|6|||
19577386|NCT01167179|42025913|FG001|Overall Study|diverse|5|||
19577387|NCT01167023|42025986|FG000|Overall Study|Lost to Follow-up|0|||
19577388|NCT01167023|42025987|FG001|Overall Study|Lost to Follow-up|1|||
19577389|NCT01167023|42025988|FG002|Overall Study|Lost to Follow-up|1|||
19577390|NCT01167023|42025986|FG000|Overall Study|Screen Failure|0|||
19577391|NCT01167023|42025987|FG001|Overall Study|Screen Failure|1|||
19577392|NCT01167023|42025988|FG002|Overall Study|Screen Failure|0|||
19577393|NCT01167023|42025986|FG000|Overall Study|Sponsor Decision|0|||
19577394|NCT01167023|42025987|FG001|Overall Study|Sponsor Decision|1|||
19577395|NCT01167023|42025988|FG002|Overall Study|Sponsor Decision|0|||
19577396|NCT01167023|42025986|FG000|Overall Study|Withdrawal by Subject|0|||
19577397|NCT01167023|42025987|FG001|Overall Study|Withdrawal by Subject|0|||
19577398|NCT01167023|42025988|FG002|Overall Study|Withdrawal by Subject|1|||
19577399|NCT03484117|42025996|FG000|Overall Study|Lost to Follow-up|1|||
19577400|NCT03484117|42025997|FG001|Overall Study|Lost to Follow-up|3|||
19577401|NCT03484117|42025996|FG000|Overall Study|Declined participation in exit assess|1|||
19577402|NCT03484117|42025997|FG001|Overall Study|Declined participation in exit assess|1|||
19577403|NCT01166945|42026005|FG000|Randomized|diagnosed with Group A strep|4|||
19577404|NCT01166945|42026006|FG001|Randomized|diagnosed with Group A strep|4|||
19577405|NCT01166945|42026005|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
19577406|NCT01166945|42026006|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
19577407|NCT01166945|42026005|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
19577408|NCT01166945|42026006|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
19577409|NCT01166945|42026005|FG000|Day 30|Lost to Follow-up|4|||
19577410|NCT01166945|42026006|FG001|Day 30|Lost to Follow-up|3|||
19577411|NCT00910000|42026020|FG000|Overall Study|Adverse Event|0|||
19577412|NCT00910000|42026021|FG001|Overall Study|Adverse Event|3|||
19577413|NCT00910000|42026022|FG002|Overall Study|Adverse Event|2|||
19577414|NCT00910000|42026023|FG003|Overall Study|Adverse Event|2|||
19577415|NCT00910000|42026024|FG004|Overall Study|Adverse Event|0|||
19577416|NCT00910000|42026025|FG005|Overall Study|Adverse Event|1|||
19577417|NCT00910000|42026020|FG000|Overall Study|Withdrawal by Subject|0|||
19577418|NCT00910000|42026021|FG001|Overall Study|Withdrawal by Subject|0|||
19577419|NCT00910000|42026022|FG002|Overall Study|Withdrawal by Subject|1|||
19577420|NCT00910000|42026023|FG003|Overall Study|Withdrawal by Subject|0|||
19577421|NCT00910000|42026024|FG004|Overall Study|Withdrawal by Subject|1|||
19577422|NCT00910000|42026025|FG005|Overall Study|Withdrawal by Subject|0|||
19577423|NCT01119768|42026046|FG000|Treatment Period|Lack of Efficacy|18|||
19577424|NCT01119768|42026047|FG001|Treatment Period|Lack of Efficacy|25|||
19577425|NCT01165307|42026055|FG000|Overall Study|Lost to Follow-up|11|||
19577426|NCT01165307|42026056|FG001|Overall Study|Lost to Follow-up|3|||
19577427|NCT01165307|42026055|FG000|Overall Study|Withdrawal by Subject|2|||
19577428|NCT01165307|42026056|FG001|Overall Study|Withdrawal by Subject|0|||
19577429|NCT01165307|42026055|FG000|Overall Study|Subject not available for contact|1|||
19577430|NCT01165307|42026056|FG001|Overall Study|Subject not available for contact|0|||
19577431|NCT00960999|42026064|FG000|Overall Study|Withdrawal by Subject|1|||
19577432|NCT00960999|42026065|FG001|Overall Study|Withdrawal by Subject|0|||
19577433|NCT00960999|42026064|FG000|Overall Study|Protocol Violation|5|||
19577434|NCT00960999|42026065|FG001|Overall Study|Protocol Violation|2|||
19577435|NCT00960999|42026064|FG000|Overall Study|RT dose constraints not met|2|||
19577436|NCT00960999|42026065|FG001|Overall Study|RT dose constraints not met|0|||
19577437|NCT01124838|42026073|FG000|Overall Study|Miscellaneous|4|||
19577438|NCT01124838|42026074|FG001|Overall Study|Miscellaneous|2|||
19577439|NCT01124838|42026073|FG000|Overall Study|Adverse Event|7|||
19577440|NCT01124838|42026074|FG001|Overall Study|Adverse Event|11|||
19577441|NCT01124838|42026073|FG000|Overall Study|Lack of Efficacy|2|||
19577442|NCT01124838|42026074|FG001|Overall Study|Lack of Efficacy|0|||
19577443|NCT01124838|42026073|FG000|Overall Study|Withdrawal by Subject|3|||
19577444|NCT01124838|42026074|FG001|Overall Study|Withdrawal by Subject|2|||
19577445|NCT01124838|42026073|FG000|Overall Study|Lost to Follow-up|2|||
19577446|NCT01124838|42026074|FG001|Overall Study|Lost to Follow-up|0|||
19577447|NCT00959751|42026084|FG000|Overall Study|Lost to Follow-up|2|||
19577448|NCT00959751|42026085|FG001|Overall Study|Lost to Follow-up|3|||
19577449|NCT00959751|42026084|FG000|Overall Study|Consent Withdrawn|0|||
19577450|NCT00959751|42026085|FG001|Overall Study|Consent Withdrawn|1|||
19577451|NCT00959751|42026084|FG000|Overall Study|Non-compliance to Study Procedures|0|||
19577452|NCT00959751|42026085|FG001|Overall Study|Non-compliance to Study Procedures|1|||
19577453|NCT00959751|42026084|FG000|Overall Study|No migraine headache without aura|7|||
19577454|NCT00959751|42026085|FG001|Overall Study|No migraine headache without aura|7|||
19577455|NCT00910858|42026094|FG000|Pharmacokinetic Phase|Adverse Event|1|||
19577456|NCT00910858|42026095|FG001|Pharmacokinetic Phase|Adverse Event|0|||
19577457|NCT00910858|42026096|FG002|Pharmacokinetic Phase|Adverse Event|0|||
19577458|NCT00910858|42026094|FG000|Monotherapy Phase|Adverse Event|3|||
19577459|NCT00910858|42026095|FG001|Monotherapy Phase|Adverse Event|2|||
19577460|NCT00910858|42026096|FG002|Monotherapy Phase|Adverse Event|0|||
19577461|NCT00910858|42026094|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
19577462|NCT00910858|42026095|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
19577463|NCT00910858|42026096|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
19577464|NCT00910858|42026094|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
19577465|NCT00910858|42026095|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
19577466|NCT00910858|42026096|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
19577467|NCT00910858|42026094|FG000|Monotherapy Phase|Protocol Violation|1|||
19577468|NCT00910858|42026095|FG001|Monotherapy Phase|Protocol Violation|0|||
19577469|NCT00910858|42026096|FG002|Monotherapy Phase|Protocol Violation|0|||
19577470|NCT00910858|42026094|FG000|Monotherapy Phase|Other|3|||
19577471|NCT00910858|42026095|FG001|Monotherapy Phase|Other|4|||
19577472|NCT00910858|42026096|FG002|Monotherapy Phase|Other|2|||
19577473|NCT00910858|42026094|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
19577474|NCT00910858|42026095|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
19577475|NCT00910858|42026096|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
19577476|NCT00910858|42026094|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
19577477|NCT00910858|42026095|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
19745856|NCT03529773|42193182|FG026|Overall Study|Lost to Follow-up|5|||
19577478|NCT00910858|42026096|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
19577479|NCT00910858|42026094|FG000|Combined Treatment Phase|Protocol Violation|1|||
19577480|NCT00910858|42026095|FG001|Combined Treatment Phase|Protocol Violation|0|||
19577481|NCT00910858|42026096|FG002|Combined Treatment Phase|Protocol Violation|0|||
19577482|NCT00910858|42026094|FG000|Combined Treatment Phase|Other|0|||
19577483|NCT00910858|42026095|FG001|Combined Treatment Phase|Other|2|||
19577484|NCT00910858|42026096|FG002|Combined Treatment Phase|Other|1|||
19577485|NCT00598975|42026114|FG000|Overall Study|Adverse Event|1|||
19577486|NCT00598975|42026115|FG001|Overall Study|Adverse Event|1|||
19577487|NCT00598975|42026114|FG000|Overall Study|Brain metastases|1|||
19577488|NCT00598975|42026115|FG001|Overall Study|Brain metastases|0|||
19577489|NCT00598975|42026114|FG000|Overall Study|Withdrawal by Subject|1|||
19577490|NCT00598975|42026115|FG001|Overall Study|Withdrawal by Subject|1|||
19577491|NCT00598975|42026114|FG000|Overall Study|Withdrawal of consent|0|||
19577492|NCT00598975|42026115|FG001|Overall Study|Withdrawal of consent|1|||
19577493|NCT00598975|42026114|FG000|Overall Study|Disease progression|8|||
19577494|NCT00598975|42026115|FG001|Overall Study|Disease progression|3|||
19577495|NCT00598975|42026114|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
19577496|NCT00598975|42026115|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
19577497|NCT00957021|42026123|FG000|Overall Study|Death|5|||
19577498|NCT00957021|42026123|FG000|Overall Study|Lost to Follow-up|8|||
19577499|NCT00957021|42026123|FG000|Overall Study|Withdrawal by Subject|34|||
19577500|NCT00957021|42026123|FG000|Overall Study|No 2 yr ROM data|35|||
19577501|NCT00957021|42026123|FG000|Overall Study|Revised study component by 2 yr visit|8|||
19577502|NCT00957021|42026123|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
19577503|NCT00957021|42026123|FG000|Overall Study|Surgery Cancelled|9|||
19577504|NCT00957021|42026123|FG000|Overall Study|Termination due to language issue|2|||
19577505|NCT01124604|42026130|FG000|Overall Study|Adverse Event|10|||
19577506|NCT01124604|42026131|FG001|Overall Study|Adverse Event|1|||
19577507|NCT01124604|42026130|FG000|Overall Study|Lack of Efficacy|1|||
19577508|NCT01124604|42026131|FG001|Overall Study|Lack of Efficacy|0|||
19577509|NCT01124604|42026130|FG000|Overall Study|Withdrawal by Subject|4|||
19577510|NCT01124604|42026131|FG001|Overall Study|Withdrawal by Subject|0|||
19577511|NCT01124604|42026130|FG000|Overall Study|Disease Progression|0|||
19577512|NCT01124604|42026131|FG001|Overall Study|Disease Progression|1|||
19577513|NCT00909844|42026137|FG000|Overall Study|Adverse Event|1|||
19577514|NCT00909844|42026137|FG000|Overall Study|Withdrawal by Subject|1|||
19577515|NCT00909844|42026137|FG000|Overall Study|Lost to Follow-up|2|||
19577516|NCT01124448|42026144|FG000|Overall Study|Lost to Follow-up|0|||
19577517|NCT01124448|42026145|FG001|Overall Study|Lost to Follow-up|3|||
19577518|NCT01124448|42026144|FG000|Overall Study|Protocol Violation|2|||
19577519|NCT01124448|42026145|FG001|Overall Study|Protocol Violation|0|||
19577520|NCT01124292|42026154|FG000|Overall Study|Lost to Follow-up|2|||
19577521|NCT01124292|42026155|FG001|Overall Study|Lost to Follow-up|4|||
19577522|NCT01124292|42026156|FG002|Overall Study|Lost to Follow-up|3|||
19577523|NCT01124292|42026154|FG000|Overall Study|Physician Decision|0|||
19577524|NCT01124292|42026155|FG001|Overall Study|Physician Decision|3|||
19577525|NCT01124292|42026156|FG002|Overall Study|Physician Decision|2|||
19577526|NCT01124292|42026154|FG000|Overall Study|Withdrawal by Subject|0|||
19577527|NCT01124292|42026155|FG001|Overall Study|Withdrawal by Subject|6|||
19577528|NCT01124292|42026156|FG002|Overall Study|Withdrawal by Subject|2|||
19577529|NCT01124292|42026154|FG000|Overall Study|medical issue unrelated to the study|0|||
19577530|NCT01124292|42026155|FG001|Overall Study|medical issue unrelated to the study|0|||
19577531|NCT01124292|42026156|FG002|Overall Study|medical issue unrelated to the study|2|||
19577532|NCT01124292|42026154|FG000|Overall Study|piercing track closed|0|||
19577533|NCT01124292|42026155|FG001|Overall Study|piercing track closed|2|||
19577534|NCT01124292|42026156|FG002|Overall Study|piercing track closed|1|||
19577535|NCT01136772|42026169|FG000|Overall Study|Adverse Event|15|||
19577536|NCT01136772|42026170|FG001|Overall Study|Adverse Event|14|||
19577537|NCT01136772|42026169|FG000|Overall Study|Lack of Efficacy|42|||
19577538|NCT01136772|42026170|FG001|Overall Study|Lack of Efficacy|39|||
19577539|NCT01136772|42026169|FG000|Overall Study|Administrative|14|||
19577540|NCT01136772|42026170|FG001|Overall Study|Administrative|12|||
19577541|NCT01136772|42026169|FG000|Overall Study|Withdrawal by Subject|33|||
19577542|NCT01136772|42026170|FG001|Overall Study|Withdrawal by Subject|36|||
19577543|NCT01136772|42026169|FG000|Overall Study|Did not receive injection|10|||
19577544|NCT01136772|42026170|FG001|Overall Study|Did not receive injection|7|||
19577545|NCT01136772|42026169|FG000|Overall Study|Did not follow up after first injection|2|||
19577546|NCT01136772|42026170|FG001|Overall Study|Did not follow up after first injection|2|||
19577547|NCT00909532|42026178|FG000|Overall Study|Adverse Event|4|||
19577548|NCT00909532|42026179|FG001|Overall Study|Adverse Event|1|||
19577549|NCT00909532|42026178|FG000|Overall Study|Pregnancy|0|||
19577550|NCT00909532|42026179|FG001|Overall Study|Pregnancy|1|||
19577551|NCT00909532|42026178|FG000|Overall Study|Prohibited Medication|2|||
19577552|NCT00909532|42026179|FG001|Overall Study|Prohibited Medication|1|||
19577553|NCT00909532|42026178|FG000|Overall Study|Withdrawal of Consent|1|||
19577554|NCT00909532|42026179|FG001|Overall Study|Withdrawal of Consent|1|||
19577555|NCT00909532|42026178|FG000|Overall Study|Noncompliance with Study Requirements|0|||
19577556|NCT00909532|42026179|FG001|Overall Study|Noncompliance with Study Requirements|2|||
19577557|NCT00909532|42026178|FG000|Overall Study|Physician Decision|1|||
19577558|NCT00909532|42026179|FG001|Overall Study|Physician Decision|0|||
19577559|NCT00909532|42026178|FG000|Overall Study|Wrong Genotype|1|||
19577560|NCT00909532|42026179|FG001|Overall Study|Wrong Genotype|0|||
19577561|NCT00909532|42026178|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
19577562|NCT00909532|42026179|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
19577563|NCT01136382|42026188|FG000|Overall Study|Other|8|||
19577564|NCT01136382|42026189|FG001|Overall Study|Other|3|||
19577565|NCT01136382|42026188|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
19577566|NCT01136382|42026189|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
19577567|NCT01136382|42026188|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
19577568|NCT01136382|42026189|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
19577569|NCT01136382|42026188|FG000|Overall Study|Withdrawal by Subject|4|||
19577570|NCT01136382|42026189|FG001|Overall Study|Withdrawal by Subject|1|||
19577571|NCT00912028|42026198|FG000|Overall Study|Lost to Follow-up|2|||
19577572|NCT00912028|42026199|FG001|Overall Study|Lost to Follow-up|3|||
19577573|NCT00912028|42026200|FG002|Overall Study|Lost to Follow-up|0|||
19577574|NCT00912028|42026201|FG003|Overall Study|Lost to Follow-up|1|||
19577575|NCT00912028|42026202|FG004|Overall Study|Lost to Follow-up|3|||
19577576|NCT00912028|42026198|FG000|Overall Study|Withdrawal by Subject|3|||
19577577|NCT00912028|42026199|FG001|Overall Study|Withdrawal by Subject|0|||
19577578|NCT00912028|42026200|FG002|Overall Study|Withdrawal by Subject|0|||
19577579|NCT00912028|42026201|FG003|Overall Study|Withdrawal by Subject|0|||
19577580|NCT00912028|42026202|FG004|Overall Study|Withdrawal by Subject|0|||
19577581|NCT02731729|42026214|FG000|Overall Study|Death|2|||
19577582|NCT02731729|42026215|FG001|Overall Study|Death|2|||
19577583|NCT02731729|42026214|FG000|Overall Study|Study terminated by Sponsor|6|||
19577584|NCT02731729|42026215|FG001|Overall Study|Study terminated by Sponsor|6|||
19577585|NCT02731729|42026214|FG000|Overall Study|Withdrawal by Subject|1|||
19577586|NCT02731729|42026215|FG001|Overall Study|Withdrawal by Subject|0|||
19577587|NCT01119066|42026225|FG000|Overall Study|Withdrawal by Subject|4|||
19577588|NCT01119066|42026226|FG001|Overall Study|Withdrawal by Subject|6|||
19577589|NCT01119066|42026227|FG002|Overall Study|Withdrawal by Subject|0|||
19577590|NCT01119066|42026228|FG003|Overall Study|Withdrawal by Subject|0|||
19577591|NCT01119066|42026225|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
19577592|NCT01119066|42026226|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
19577593|NCT01119066|42026227|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
19577594|NCT01119066|42026228|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
19577595|NCT01119066|42026225|FG000|Overall Study|Relapse identified before transplant|1|||
19577596|NCT01119066|42026226|FG001|Overall Study|Relapse identified before transplant|0|||
19577597|NCT01119066|42026227|FG002|Overall Study|Relapse identified before transplant|0|||
19577598|NCT01119066|42026228|FG003|Overall Study|Relapse identified before transplant|0|||
19577599|NCT01119066|42026225|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
19577600|NCT01119066|42026226|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
19577601|NCT01119066|42026227|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
19577602|NCT01119066|42026228|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
19577603|NCT01119066|42026225|FG000|Overall Study|Relapse identified before transplant|0|||
19577604|NCT01119066|42026226|FG001|Overall Study|Relapse identified before transplant|4|||
19577605|NCT01119066|42026227|FG002|Overall Study|Relapse identified before transplant|0|||
19577606|NCT01119066|42026228|FG003|Overall Study|Relapse identified before transplant|0|||
19577607|NCT00910624|42026242|FG000|Treatment Phase|Adverse Event|2|||
19577608|NCT00910624|42026243|FG001|Treatment Phase|Adverse Event|6|||
19577609|NCT00910624|42026244|FG002|Treatment Phase|Adverse Event|6|||
19577610|NCT00910624|42026245|FG003|Treatment Phase|Adverse Event|0|||
19577611|NCT00910624|42026242|FG000|Treatment Phase|Treatment Failure|23|||
19577612|NCT00910624|42026243|FG001|Treatment Phase|Treatment Failure|10|||
19577613|NCT00910624|42026244|FG002|Treatment Phase|Treatment Failure|0|||
19577614|NCT00910624|42026245|FG003|Treatment Phase|Treatment Failure|0|||
19577615|NCT00910624|42026242|FG000|Treatment Phase|Lost to Follow-up|0|||
19577616|NCT00910624|42026243|FG001|Treatment Phase|Lost to Follow-up|0|||
19577617|NCT00910624|42026244|FG002|Treatment Phase|Lost to Follow-up|1|||
19577618|NCT00910624|42026245|FG003|Treatment Phase|Lost to Follow-up|0|||
19577619|NCT00910624|42026242|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
19577620|NCT00910624|42026243|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
19577621|NCT00910624|42026244|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
19577622|NCT00910624|42026245|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
19577623|NCT00910624|42026242|FG000|Treatment Phase|Withdrawal by Subject|2|||
19577624|NCT00910624|42026243|FG001|Treatment Phase|Withdrawal by Subject|1|||
19577625|NCT00910624|42026244|FG002|Treatment Phase|Withdrawal by Subject|0|||
19577626|NCT00910624|42026245|FG003|Treatment Phase|Withdrawal by Subject|0|||
19577627|NCT00910624|42026242|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
19577628|NCT00910624|42026243|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
19577629|NCT00910624|42026244|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
19577630|NCT00910624|42026245|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
19577631|NCT00910624|42026242|FG000|Follow-Up Phase|Adverse Event|0|||
19577632|NCT00910624|42026243|FG001|Follow-Up Phase|Adverse Event|0|||
19577633|NCT00910624|42026244|FG002|Follow-Up Phase|Adverse Event|1|||
19577634|NCT00910624|42026245|FG003|Follow-Up Phase|Adverse Event|0|||
19577635|NCT00910624|42026242|FG000|Follow-Up Phase|Lost to Follow-up|3|||
19577636|NCT00910624|42026243|FG001|Follow-Up Phase|Lost to Follow-up|1|||
19577637|NCT00910624|42026244|FG002|Follow-Up Phase|Lost to Follow-up|2|||
19577638|NCT00910624|42026245|FG003|Follow-Up Phase|Lost to Follow-up|0|||
19577639|NCT00910624|42026242|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
19577640|NCT00910624|42026243|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
19577641|NCT00910624|42026244|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
19577642|NCT00910624|42026245|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
19577643|NCT00910624|42026242|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
19577644|NCT00910624|42026243|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
19577645|NCT00910624|42026244|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
19577646|NCT00910624|42026245|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
19577647|NCT00910624|42026242|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
19577648|NCT00910624|42026243|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
19577649|NCT00910624|42026244|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
19577650|NCT00910624|42026245|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
19577651|NCT00910624|42026242|FG000|Follow-Up Phase|Administrative|0|||
19577652|NCT00910624|42026243|FG001|Follow-Up Phase|Administrative|1|||
19577653|NCT00910624|42026244|FG002|Follow-Up Phase|Administrative|1|||
19577654|NCT00910624|42026245|FG003|Follow-Up Phase|Administrative|0|||
19577655|NCT01123980|42026259|FG000|Overall Study|Adverse Event|1|||
19577656|NCT01123980|42026260|FG001|Overall Study|Adverse Event|1|||
19577657|NCT01123980|42026259|FG000|Overall Study|Lack of Efficacy|1|||
19577658|NCT01123980|42026260|FG001|Overall Study|Lack of Efficacy|0|||
19577659|NCT01123980|42026259|FG000|Overall Study|Physician Decision|0|||
19577660|NCT01123980|42026260|FG001|Overall Study|Physician Decision|1|||
19577661|NCT01123980|42026259|FG000|Overall Study|Lost to Follow-up|0|||
19577662|NCT01123980|42026260|FG001|Overall Study|Lost to Follow-up|6|||
19577663|NCT01123980|42026259|FG000|Overall Study|Protocol Violation|6|||
19577664|NCT01123980|42026260|FG001|Overall Study|Protocol Violation|6|||
19577665|NCT01123980|42026259|FG000|Overall Study|Withdrawal by Subject|5|||
19577666|NCT01123980|42026260|FG001|Overall Study|Withdrawal by Subject|3|||
19577667|NCT01123980|42026259|FG000|Overall Study|Unclassified|6|||
19577668|NCT01123980|42026260|FG001|Overall Study|Unclassified|7|||
19577669|NCT01118520|42026269|FG000|Overall Study|AAA repair|9|||
19577670|NCT01118520|42026270|FG001|Overall Study|AAA repair|7|||
19577671|NCT01118520|42026271|FG002|Overall Study|AAA repair|9|||
19577672|NCT01118520|42026269|FG000|Overall Study|Adverse Event|3|||
19577673|NCT01118520|42026270|FG001|Overall Study|Adverse Event|3|||
19577674|NCT01118520|42026271|FG002|Overall Study|Adverse Event|3|||
19577675|NCT01118520|42026269|FG000|Overall Study|Withdrawal by Subject|8|||
19577676|NCT01118520|42026270|FG001|Overall Study|Withdrawal by Subject|13|||
19577677|NCT01118520|42026271|FG002|Overall Study|Withdrawal by Subject|8|||
19577678|NCT01135992|42026279|FG000|Overall Study|Adverse Event|1|||
19745857|NCT03529773|42193183|FG027|Overall Study|Lost to Follow-up|0|||
19745858|NCT03529773|42193184|FG028|Overall Study|Lost to Follow-up|0|||
19745859|NCT03529773|42193185|FG029|Overall Study|Lost to Follow-up|0|||
19745860|NCT03529773|42193186|FG030|Overall Study|Lost to Follow-up|1|||
19745861|NCT03529773|42193187|FG031|Overall Study|Lost to Follow-up|0|||
19745862|NCT03529773|42193188|FG032|Overall Study|Lost to Follow-up|0|||
19745863|NCT03529773|42193189|FG033|Overall Study|Lost to Follow-up|1|||
19745864|NCT03529773|42193190|FG034|Overall Study|Lost to Follow-up|1|||
19745865|NCT03529773|42193191|FG035|Overall Study|Lost to Follow-up|0|||
19745866|NCT03529773|42193192|FG036|Overall Study|Lost to Follow-up|0|||
19745867|NCT03529773|42193193|FG037|Overall Study|Lost to Follow-up|3|||
19745868|NCT03529773|42193194|FG038|Overall Study|Lost to Follow-up|1|||
19745869|NCT03529773|42193195|FG039|Overall Study|Lost to Follow-up|1|||
19745870|NCT03529773|42193156|FG000|Overall Study|No longer meets eligibility criteria|0|||
19476960|NCT02790138|41755395|FG000|Overall Study|Lost to Follow-up|1|||
19577679|NCT01135992|42026279|FG000|Overall Study|Lack of Efficacy|1|||
19577680|NCT01135992|42026279|FG000|Overall Study|Protocol Violation|2|||
19577681|NCT01135992|42026279|FG000|Overall Study|Withdrawal criteria|10|||
19577682|NCT01135992|42026279|FG000|Overall Study|Unclassified|7|||
19577683|NCT00959049|42026289|FG000|Overall Study|Adverse Event|1|||
19577684|NCT00959049|42026290|FG001|Overall Study|Adverse Event|0|||
19577685|NCT00959049|42026291|FG002|Overall Study|Adverse Event|0|||
19577686|NCT00959049|42026292|FG003|Overall Study|Adverse Event|0|||
19577687|NCT00959049|42026293|FG004|Overall Study|Adverse Event|0|||
19577688|NCT00959049|42026294|FG005|Overall Study|Adverse Event|0|||
19577689|NCT00959049|42026289|FG000|Overall Study|Lost to Follow-up|17|||
19577690|NCT00959049|42026290|FG001|Overall Study|Lost to Follow-up|5|||
19577691|NCT00959049|42026291|FG002|Overall Study|Lost to Follow-up|1|||
19577692|NCT00959049|42026292|FG003|Overall Study|Lost to Follow-up|10|||
19577693|NCT00959049|42026293|FG004|Overall Study|Lost to Follow-up|9|||
19577694|NCT00959049|42026294|FG005|Overall Study|Lost to Follow-up|1|||
19577695|NCT00959049|42026289|FG000|Overall Study|Contraindicated medication|0|||
19577696|NCT00959049|42026290|FG001|Overall Study|Contraindicated medication|0|||
19577697|NCT00959049|42026291|FG002|Overall Study|Contraindicated medication|0|||
19577698|NCT00959049|42026292|FG003|Overall Study|Contraindicated medication|1|||
19577699|NCT00959049|42026293|FG004|Overall Study|Contraindicated medication|0|||
19577700|NCT00959049|42026294|FG005|Overall Study|Contraindicated medication|0|||
19577701|NCT00959049|42026289|FG000|Overall Study|Withdrawal by Subject|0|||
19577702|NCT00959049|42026290|FG001|Overall Study|Withdrawal by Subject|2|||
19577703|NCT00959049|42026291|FG002|Overall Study|Withdrawal by Subject|0|||
19577704|NCT00959049|42026292|FG003|Overall Study|Withdrawal by Subject|0|||
19577705|NCT00959049|42026293|FG004|Overall Study|Withdrawal by Subject|0|||
19577706|NCT00959049|42026294|FG005|Overall Study|Withdrawal by Subject|0|||
19577707|NCT00956943|42026321|FG000|Overall Study|Lost to Follow-up|9|||
19577708|NCT00956943|42026322|FG001|Overall Study|Lost to Follow-up|10|||
19577709|NCT00958893|42026328|FG000|Overall Study|Study prematurely terminated|4|||
19577710|NCT01135914|42026335|FG000|Overall Study|Withdrawal by Subject|1|||
19577711|NCT01135914|42026336|FG001|Overall Study|Withdrawal by Subject|3|||
19577712|NCT01135914|42026337|FG002|Overall Study|Withdrawal by Subject|6|||
19577713|NCT01135914|42026335|FG000|Overall Study|Lost to Follow-up|1|||
19577714|NCT01135914|42026336|FG001|Overall Study|Lost to Follow-up|0|||
19577715|NCT01135914|42026337|FG002|Overall Study|Lost to Follow-up|1|||
19577716|NCT01135914|42026335|FG000|Overall Study|Protocol Violation|0|||
19577717|NCT01135914|42026336|FG001|Overall Study|Protocol Violation|0|||
19577718|NCT01135914|42026337|FG002|Overall Study|Protocol Violation|3|||
19577719|NCT01135914|42026335|FG000|Overall Study|Lack of Efficacy|2|||
19577720|NCT01135914|42026336|FG001|Overall Study|Lack of Efficacy|1|||
19577721|NCT01135914|42026337|FG002|Overall Study|Lack of Efficacy|10|||
19577722|NCT01135914|42026335|FG000|Overall Study|Adverse Event|0|||
19577723|NCT01135914|42026336|FG001|Overall Study|Adverse Event|1|||
19577724|NCT01135914|42026337|FG002|Overall Study|Adverse Event|2|||
19577725|NCT00907738|42026350|FG000|Overall Study|Adverse Event|2|||
19577726|NCT00907738|42026351|FG001|Overall Study|Adverse Event|0|||
19577727|NCT00907738|42026352|FG002|Overall Study|Adverse Event|1|||
19577728|NCT00907738|42026353|FG003|Overall Study|Adverse Event|0|||
19577729|NCT00907738|42026354|FG004|Overall Study|Adverse Event|0|||
19577730|NCT00907738|42026350|FG000|Overall Study|not specified or withdrew consent|3|||
19577731|NCT00907738|42026351|FG001|Overall Study|not specified or withdrew consent|0|||
19577732|NCT00907738|42026352|FG002|Overall Study|not specified or withdrew consent|0|||
19577733|NCT00907738|42026353|FG003|Overall Study|not specified or withdrew consent|0|||
19745871|NCT03529773|42193157|FG001|Overall Study|No longer meets eligibility criteria|0|||
19745872|NCT03529773|42193158|FG002|Overall Study|No longer meets eligibility criteria|0|||
19745873|NCT03529773|42193159|FG003|Overall Study|No longer meets eligibility criteria|0|||
19745874|NCT03529773|42193160|FG004|Overall Study|No longer meets eligibility criteria|0|||
19577734|NCT00907738|42026354|FG004|Overall Study|not specified or withdrew consent|0|||
19577735|NCT00907738|42026350|FG000|Overall Study|Disease progression|8|||
19577736|NCT00907738|42026351|FG001|Overall Study|Disease progression|1|||
19577737|NCT00907738|42026352|FG002|Overall Study|Disease progression|6|||
19577738|NCT00907738|42026353|FG003|Overall Study|Disease progression|4|||
19577739|NCT00907738|42026354|FG004|Overall Study|Disease progression|2|||
19577740|NCT01123356|42026370|FG000|Overall Study|Adverse Event|2|||
19577741|NCT01123356|42026370|FG000|Overall Study|Lack of Efficacy|4|||
19577742|NCT01123356|42026370|FG000|Overall Study|Withdrawal by Subject|1|||
19577743|NCT00908596|42026379|FG000|Overall Study|Other reasons|46|||
19577744|NCT00908596|42026380|FG001|Overall Study|Other reasons|6|||
19577745|NCT00908596|42026381|FG002|Overall Study|Other reasons|2|||
19577746|NCT00908596|42026382|FG003|Overall Study|Other reasons|0|||
19577747|NCT00908596|42026379|FG000|Overall Study|Lost to Follow-up|0|||
19577748|NCT00908596|42026380|FG001|Overall Study|Lost to Follow-up|1|||
19577749|NCT00908596|42026381|FG002|Overall Study|Lost to Follow-up|12|||
19577750|NCT00908596|42026382|FG003|Overall Study|Lost to Follow-up|4|||
19577751|NCT00908596|42026379|FG000|Overall Study|Death|0|||
19577752|NCT00908596|42026380|FG001|Overall Study|Death|5|||
19577753|NCT00908596|42026381|FG002|Overall Study|Death|57|||
19577754|NCT00908596|42026382|FG003|Overall Study|Death|32|||
19577755|NCT00908596|42026379|FG000|Overall Study|Protocol Violation|1|||
19577756|NCT00908596|42026380|FG001|Overall Study|Protocol Violation|0|||
19577757|NCT00908596|42026381|FG002|Overall Study|Protocol Violation|0|||
19577758|NCT00908596|42026382|FG003|Overall Study|Protocol Violation|0|||
19577759|NCT00908596|42026379|FG000|Overall Study|Withdrawal by Subject|0|||
19577760|NCT00908596|42026380|FG001|Overall Study|Withdrawal by Subject|1|||
19577761|NCT00908596|42026381|FG002|Overall Study|Withdrawal by Subject|3|||
19577762|NCT00908596|42026382|FG003|Overall Study|Withdrawal by Subject|1|||
19577763|NCT01118052|42026392|FG000|Overall Study|Never treated|2|||
19577764|NCT01123200|42026402|FG000|Overall Study|Withdrawal by Subject|1|||
19577765|NCT00955617|42026406|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
19577766|NCT00955617|42026407|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
19577767|NCT00955617|42026406|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
19577768|NCT00955617|42026407|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
19577769|NCT00955617|42026406|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
19577770|NCT00955617|42026407|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
19577771|NCT00955617|42026406|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
19577772|NCT00955617|42026407|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
19577773|NCT00958347|42026413|FG000|Overall Study|Death|43|||
19577774|NCT00958347|42026413|FG000|Overall Study|Withdrawal by Subject|23|||
19577775|NCT00958347|42026413|FG000|Overall Study|Lost to Follow-up|15|||
19577776|NCT00958347|42026413|FG000|Overall Study|revision/removal|10|||
19577777|NCT00958347|42026413|FG000|Overall Study|study termination|135|||
19577778|NCT00958191|42026417|FG000|Overall Study|Death|4|||
19577779|NCT00958191|42026417|FG000|Overall Study|Lost to Follow-up|5|||
19577780|NCT00958191|42026417|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
19577781|NCT00958191|42026417|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
19577782|NCT00958191|42026417|FG000|Overall Study|Revision of study device|4|||
19577783|NCT00958191|42026417|FG000|Overall Study|Site termination|11|||
19577784|NCT00958191|42026417|FG000|Overall Study|No 5 yr x-rays|56|||
19577785|NCT00960843|42026425|FG000|Overall Study|Lost to Follow-up|2|||
19577786|NCT00960843|42026426|FG001|Overall Study|Lost to Follow-up|0|||
19639239|NCT00719264|42088643|FG001|Overall Study|Withdrawal by Subject|7|||
19639240|NCT00719264|42088642|FG000|Overall Study|Protocol Deviation|1|||
19639241|NCT00719264|42088643|FG001|Overall Study|Protocol Deviation|3|||
19639242|NCT00719264|42088642|FG000|Overall Study|New Cancer Therapy|4|||
19639243|NCT00719264|42088643|FG001|Overall Study|New Cancer Therapy|2|||
19639244|NCT00719264|42088642|FG000|Overall Study|Disease Progression|104|||
19639245|NCT00719264|42088643|FG001|Overall Study|Disease Progression|107|||
19639246|NCT00687609|42088649|FG000|Overall Study|Physician Decision|1|||
19745875|NCT03529773|42193161|FG005|Overall Study|No longer meets eligibility criteria|0|||
19577787|NCT00960843|42026425|FG000|Overall Study|Protocol Violation|0|||
19745876|NCT03529773|42193162|FG006|Overall Study|No longer meets eligibility criteria|0|||
19745877|NCT03529773|42193163|FG007|Overall Study|No longer meets eligibility criteria|0|||
19745878|NCT03529773|42193164|FG008|Overall Study|No longer meets eligibility criteria|0|||
19745879|NCT03529773|42193165|FG009|Overall Study|No longer meets eligibility criteria|0|||
19745880|NCT03529773|42193166|FG010|Overall Study|No longer meets eligibility criteria|0|||
19745881|NCT03529773|42193167|FG011|Overall Study|No longer meets eligibility criteria|0|||
19577788|NCT00960843|42026426|FG001|Overall Study|Protocol Violation|4|||
19577789|NCT00960843|42026425|FG000|Overall Study|Repeated needle dislodgment|0|||
19577790|NCT00960843|42026426|FG001|Overall Study|Repeated needle dislodgment|1|||
19577791|NCT01874353|42026434|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
19577792|NCT01874353|42026435|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
19577793|NCT01874353|42026436|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
19577794|NCT01874353|42026437|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
19577795|NCT01874353|42026434|FG000|Overall Study|Lost to Follow-up|2|||
19577796|NCT01874353|42026435|FG001|Overall Study|Lost to Follow-up|2|||
19577797|NCT01874353|42026436|FG002|Overall Study|Lost to Follow-up|2|||
19577798|NCT01874353|42026437|FG003|Overall Study|Lost to Follow-up|0|||
19577799|NCT01874353|42026434|FG000|Overall Study|Death|110|||
19577800|NCT01874353|42026435|FG001|Overall Study|Death|60|||
19577801|NCT01874353|42026436|FG002|Overall Study|Death|13|||
19577802|NCT01874353|42026437|FG003|Overall Study|Death|7|||
19577803|NCT01874353|42026434|FG000|Overall Study|Withdrawal by Subject|13|||
19577804|NCT01874353|42026435|FG001|Overall Study|Withdrawal by Subject|11|||
19577805|NCT01874353|42026436|FG002|Overall Study|Withdrawal by Subject|0|||
19577806|NCT01874353|42026437|FG003|Overall Study|Withdrawal by Subject|0|||
19577807|NCT02396199|42026449|FG000|Overall Study|Lost to Follow-up|1|||
19577808|NCT02396199|42026449|FG000|Overall Study|Death|4|||
19577809|NCT01605253|42026455|FG000|Overall Study|Physician Decision|3|||
19577810|NCT01605253|42026456|FG001|Overall Study|Physician Decision|2|||
19577811|NCT01605253|42026455|FG000|Overall Study|Lost to Follow-up|3|||
19577812|NCT01605253|42026456|FG001|Overall Study|Lost to Follow-up|1|||
19577813|NCT00955305|42026466|FG000|Overall Study|Disease progression|39|||
19577814|NCT00955305|42026467|FG001|Overall Study|Disease progression|41|||
19577815|NCT00955305|42026466|FG000|Overall Study|Adverse Event|22|||
19577816|NCT00955305|42026467|FG001|Overall Study|Adverse Event|22|||
19577817|NCT00955305|42026466|FG000|Overall Study|Death|2|||
19577818|NCT00955305|42026467|FG001|Overall Study|Death|1|||
19577819|NCT00955305|42026466|FG000|Overall Study|Withdrawal by Subject|5|||
19577820|NCT00955305|42026467|FG001|Overall Study|Withdrawal by Subject|4|||
19577821|NCT00955305|42026466|FG000|Overall Study|Alternative therapy|4|||
19577822|NCT00955305|42026467|FG001|Overall Study|Alternative therapy|0|||
19577823|NCT00955305|42026466|FG000|Overall Study|Other complicating disease|2|||
19577824|NCT00955305|42026467|FG001|Overall Study|Other complicating disease|4|||
19577825|NCT00955305|42026466|FG000|Overall Study|Physician Decision|1|||
19577826|NCT00955305|42026467|FG001|Overall Study|Physician Decision|0|||
19577827|NCT00955305|42026466|FG000|Overall Study|Continued presence of residual disease|0|||
19577828|NCT00955305|42026467|FG001|Overall Study|Continued presence of residual disease|1|||
19577829|NCT00955305|42026466|FG000|Overall Study|Functional decline|2|||
19577830|NCT00955305|42026467|FG001|Overall Study|Functional decline|0|||
19577831|NCT00955305|42026466|FG000|Overall Study|Maximum response achieved|0|||
19577832|NCT00955305|42026467|FG001|Overall Study|Maximum response achieved|1|||
19577833|NCT00955305|42026466|FG000|Overall Study|Lost to Follow-up|0|||
19577834|NCT00955305|42026467|FG001|Overall Study|Lost to Follow-up|1|||
19577835|NCT00955305|42026466|FG000|Overall Study|No off-treatment reason submitted|1|||
19577836|NCT00955305|42026467|FG001|Overall Study|No off-treatment reason submitted|0|||
19577837|NCT00955305|42026466|FG000|Overall Study|Never started protocol treatment|5|||
19577838|NCT00955305|42026467|FG001|Overall Study|Never started protocol treatment|5|||
19577839|NCT00955305|42026466|FG000|Overall Study|Ineligible|5|||
19577840|NCT00955305|42026467|FG001|Overall Study|Ineligible|7|||
19577841|NCT00598585|42026475|FG000|Overall Study|Lost to Follow-up|1|||
19577842|NCT00598585|42026476|FG001|Overall Study|Lost to Follow-up|0|||
19577843|NCT00953667|42026482|FG000|Overall Study|Lost to Follow-up|11|||
19577844|NCT00953667|42026482|FG000|Overall Study|Physician Decision|35|||
19577845|NCT00953667|42026482|FG000|Overall Study|Withdrawal by Subject|63|||
19577846|NCT00953667|42026482|FG000|Overall Study|Adverse Event|10|||
19577847|NCT00953667|42026482|FG000|Overall Study|poor venous access,unable to draw blood|4|||
19577848|NCT00883129|42026488|FG000|Overall Study|Adverse Event|7|||
19577849|NCT00883129|42026489|FG001|Overall Study|Adverse Event|15|||
19577850|NCT00883129|42026488|FG000|Overall Study|Withdrawal by Subject|8|||
19577851|NCT00883129|42026489|FG001|Overall Study|Withdrawal by Subject|9|||
19476961|NCT02790138|41755396|FG001|Overall Study|Lost to Follow-up|0|||
19577852|NCT00883129|42026488|FG000|Overall Study|Non-compliance|3|||
19577853|NCT00883129|42026489|FG001|Overall Study|Non-compliance|6|||
19577854|NCT00883129|42026488|FG000|Overall Study|Lost to Follow-up|1|||
19577855|NCT00883129|42026489|FG001|Overall Study|Lost to Follow-up|2|||
19577856|NCT00883129|42026488|FG000|Overall Study|Death|1|||
19577857|NCT00883129|42026489|FG001|Overall Study|Death|2|||
19577858|NCT00883129|42026488|FG000|Overall Study|Defined Treatment Failure|0|||
19577859|NCT00883129|42026489|FG001|Overall Study|Defined Treatment Failure|2|||
19577860|NCT00905632|42026520|FG000|Overall Study|Adverse Event|0|||
19577861|NCT00905632|42026521|FG001|Overall Study|Adverse Event|0|||
19577862|NCT00905632|42026522|FG002|Overall Study|Adverse Event|0|||
19577863|NCT00905632|42026523|FG003|Overall Study|Adverse Event|0|||
19577864|NCT00905632|42026524|FG004|Overall Study|Adverse Event|0|||
19577865|NCT00905632|42026525|FG005|Overall Study|Adverse Event|1|||
19577866|NCT00905632|42026526|FG006|Overall Study|Adverse Event|4|||
19577867|NCT00954447|42026551|FG000|Overall Study|Adverse Event|33|||
19577868|NCT00954447|42026552|FG001|Overall Study|Adverse Event|25|||
19577869|NCT00954447|42026551|FG000|Overall Study|Lack of Efficacy|17|||
19577870|NCT00954447|42026552|FG001|Overall Study|Lack of Efficacy|3|||
19577871|NCT00954447|42026551|FG000|Overall Study|Protocol Violation|5|||
19577872|NCT00954447|42026552|FG001|Overall Study|Protocol Violation|7|||
19577873|NCT00954447|42026551|FG000|Overall Study|Lost to Follow-up|8|||
19577874|NCT00954447|42026552|FG001|Overall Study|Lost to Follow-up|14|||
19577875|NCT00954447|42026551|FG000|Overall Study|Withdrawal by Subject|26|||
19577876|NCT00954447|42026552|FG001|Overall Study|Withdrawal by Subject|21|||
19577877|NCT00954447|42026551|FG000|Overall Study|Other|21|||
19577878|NCT00954447|42026552|FG001|Overall Study|Other|18|||
19577879|NCT00904150|42026560|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
19577880|NCT00904150|42026561|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
19577881|NCT00904150|42026560|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
19577882|NCT00904150|42026561|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
19577883|NCT00903760|42026569|FG000|Overall Study|Disease Progression/Death|8|||
19577884|NCT00903760|42026570|FG001|Overall Study|Disease Progression/Death|6|||
19577885|NCT00903760|42026569|FG000|Overall Study|Stem Cell Transplant|8|||
19577886|NCT00903760|42026570|FG001|Overall Study|Stem Cell Transplant|4|||
19577887|NCT00903760|42026569|FG000|Overall Study|Physician Decision|1|||
19577888|NCT00903760|42026570|FG001|Overall Study|Physician Decision|2|||
19577889|NCT00903760|42026569|FG000|Overall Study|Death|0|||
19577890|NCT00903760|42026570|FG001|Overall Study|Death|1|||
19577891|NCT00903760|42026569|FG000|Overall Study|Lost to Follow-up|1|||
19577892|NCT00903760|42026570|FG001|Overall Study|Lost to Follow-up|0|||
19577893|NCT00903760|42026569|FG000|Overall Study|Withdrawal by Subject|1|||
19577894|NCT00903760|42026570|FG001|Overall Study|Withdrawal by Subject|2|||
19577895|NCT00903760|42026569|FG000|Overall Study|Off treatment for long period|0|||
19577896|NCT00903760|42026570|FG001|Overall Study|Off treatment for long period|1|||
19577897|NCT00883051|42026581|FG000|Overall Study|Lost to Follow-up|0|||
19577898|NCT00883051|42026582|FG001|Overall Study|Lost to Follow-up|0|||
19577899|NCT00883051|42026583|FG002|Overall Study|Lost to Follow-up|0|||
19577900|NCT00883051|42026584|FG003|Overall Study|Lost to Follow-up|0|||
19577901|NCT00883051|42026585|FG004|Overall Study|Lost to Follow-up|1|||
19577902|NCT00883051|42026581|FG000|Overall Study|Did not use study medication|24|||
19577903|NCT00883051|42026582|FG001|Overall Study|Did not use study medication|22|||
19577904|NCT00883051|42026583|FG002|Overall Study|Did not use study medication|29|||
19577905|NCT00883051|42026584|FG003|Overall Study|Did not use study medication|29|||
19577906|NCT00883051|42026585|FG004|Overall Study|Did not use study medication|17|||
19577907|NCT00903682|42026599|FG000|Overall Study|Adverse Event|6|||
19577908|NCT00903682|42026600|FG001|Overall Study|Adverse Event|13|||
19577909|NCT00903682|42026599|FG000|Overall Study|Lost to Follow-up|1|||
19577910|NCT00903682|42026600|FG001|Overall Study|Lost to Follow-up|0|||
19577911|NCT00903682|42026599|FG000|Overall Study|Withdrawal by Subject|5|||
19577912|NCT00903682|42026600|FG001|Overall Study|Withdrawal by Subject|0|||
19577913|NCT00903682|42026599|FG000|Overall Study|Pregnancy|0|||
19577914|NCT00903682|42026600|FG001|Overall Study|Pregnancy|1|||
19387824|NCT01625338|41631149|FG002|Overall Study|Subject Withdrew Consent|2|||
19577915|NCT00903682|42026599|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
19577916|NCT00903682|42026600|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
19577917|NCT00903682|42026599|FG000|Overall Study|Subject Non-Compliant|1|||
19577918|NCT00903682|42026600|FG001|Overall Study|Subject Non-Compliant|0|||
19577919|NCT00903682|42026599|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
19577920|NCT00903682|42026600|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
19577921|NCT00903682|42026599|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
19577922|NCT00903682|42026600|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
19577923|NCT01117428|42026612|FG000|Overall Study|Lack of Efficacy|1|||
19577924|NCT01117428|42026613|FG001|Overall Study|Lack of Efficacy|0|||
19577925|NCT01117428|42026614|FG002|Overall Study|Lack of Efficacy|0|||
19577926|NCT01117428|42026615|FG003|Overall Study|Lack of Efficacy|0|||
19577927|NCT01117428|42026616|FG004|Overall Study|Lack of Efficacy|0|||
19577928|NCT01117428|42026617|FG005|Overall Study|Lack of Efficacy|0|||
19577929|NCT01117428|42026612|FG000|Overall Study|Adverse Event|4|||
19577930|NCT01117428|42026613|FG001|Overall Study|Adverse Event|0|||
19577931|NCT01117428|42026614|FG002|Overall Study|Adverse Event|0|||
19577932|NCT01117428|42026615|FG003|Overall Study|Adverse Event|0|||
19577933|NCT01117428|42026616|FG004|Overall Study|Adverse Event|1|||
19577934|NCT01117428|42026617|FG005|Overall Study|Adverse Event|2|||
19577935|NCT01117428|42026612|FG000|Overall Study|Death|0|||
19577936|NCT01117428|42026613|FG001|Overall Study|Death|1|||
19577937|NCT01117428|42026614|FG002|Overall Study|Death|2|||
19577938|NCT01117428|42026615|FG003|Overall Study|Death|0|||
19577939|NCT01117428|42026616|FG004|Overall Study|Death|0|||
19577940|NCT01117428|42026617|FG005|Overall Study|Death|1|||
19577941|NCT01117428|42026612|FG000|Overall Study|Physician Decision|0|||
19577942|NCT01117428|42026613|FG001|Overall Study|Physician Decision|1|||
19577943|NCT01117428|42026614|FG002|Overall Study|Physician Decision|0|||
19577944|NCT01117428|42026615|FG003|Overall Study|Physician Decision|0|||
19577945|NCT01117428|42026616|FG004|Overall Study|Physician Decision|0|||
19577946|NCT01117428|42026617|FG005|Overall Study|Physician Decision|0|||
19577947|NCT01117428|42026612|FG000|Overall Study|Withdrawal by Subject|0|||
19577948|NCT01117428|42026613|FG001|Overall Study|Withdrawal by Subject|0|||
19577949|NCT01117428|42026614|FG002|Overall Study|Withdrawal by Subject|1|||
19577950|NCT01117428|42026615|FG003|Overall Study|Withdrawal by Subject|0|||
19577951|NCT01117428|42026616|FG004|Overall Study|Withdrawal by Subject|0|||
19577952|NCT01117428|42026617|FG005|Overall Study|Withdrawal by Subject|0|||
19577953|NCT01117428|42026612|FG000|Overall Study|Progressive disease|15|||
19577954|NCT01117428|42026613|FG001|Overall Study|Progressive disease|27|||
19577955|NCT01117428|42026614|FG002|Overall Study|Progressive disease|10|||
19577956|NCT01117428|42026615|FG003|Overall Study|Progressive disease|12|||
19577957|NCT01117428|42026616|FG004|Overall Study|Progressive disease|16|||
19577958|NCT01117428|42026617|FG005|Overall Study|Progressive disease|17|||
19577959|NCT01135524|42026646|FG000|Overall Study|Withdrawal by Subject|14|||
19577960|NCT01135524|42026646|FG000|Overall Study|Adverse Event|20|||
19577961|NCT01135524|42026646|FG000|Overall Study|Lost to Follow-up|3|||
19577962|NCT01135524|42026646|FG000|Overall Study|Administrative|151|||
19577963|NCT01135524|42026646|FG000|Overall Study|Lack of Efficacy|8|||
19577964|NCT00948675|42026652|FG000|Overall Study|Lost to Follow-up|1|||
19577965|NCT00948675|42026653|FG001|Overall Study|Lost to Follow-up|0|||
19577966|NCT00903370|42026661|FG000|Overall Study|Death|13|||
19577967|NCT00903370|42026662|FG001|Overall Study|Death|10|||
19577968|NCT00903370|42026661|FG000|Overall Study|Withdrawal by Subject|9|||
19577969|NCT00903370|42026662|FG001|Overall Study|Withdrawal by Subject|6|||
19577970|NCT00903370|42026661|FG000|Overall Study|Lost to Follow-up|6|||
19577971|NCT00903370|42026662|FG001|Overall Study|Lost to Follow-up|8|||
19577972|NCT01110408|42026670|FG000|Overall Study|Protocol Violation|1|||
19577973|NCT01110408|42026671|FG001|Overall Study|Protocol Violation|0|||
19577974|NCT00953043|42026679|FG000|Overall Study|Withdrawal by Subject|4|||
19577975|NCT00953043|42026680|FG001|Overall Study|Withdrawal by Subject|0|||
19577976|NCT00953043|42026679|FG000|Overall Study|Physician Decision|0|||
19577977|NCT00953043|42026680|FG001|Overall Study|Physician Decision|2|||
19577978|NCT01135134|42026688|FG000|Overall Study|Adverse Event|1|||
19577979|NCT01135134|42026689|FG001|Overall Study|Adverse Event|1|||
19577980|NCT01135134|42026688|FG000|Overall Study|Did not meet protocol eligibility|1|||
19577981|NCT01135134|42026689|FG001|Overall Study|Did not meet protocol eligibility|0|||
19577982|NCT00948441|42026697|FG000|Overall Study|no longer meet inclusion criteria|1|||
19577983|NCT00948441|42026698|FG001|Overall Study|no longer meet inclusion criteria|4|||
19577984|NCT01117350|42026708|FG000|Comparative Period|Not Treated|5|||
19577985|NCT01117350|42026709|FG001|Comparative Period|Not Treated|8|||
19577986|NCT01117350|42026708|FG000|Comparative Period|Adverse Event|6|||
19577987|NCT01117350|42026709|FG001|Comparative Period|Adverse Event|33|||
19577988|NCT01117350|42026708|FG000|Comparative Period|Lost to Follow-up|11|||
19577989|NCT01117350|42026709|FG001|Comparative Period|Lost to Follow-up|7|||
19577990|NCT01117350|42026708|FG000|Comparative Period|Withdrawal by Subject|9|||
19577991|NCT01117350|42026709|FG001|Comparative Period|Withdrawal by Subject|13|||
19577992|NCT01117350|42026708|FG000|Comparative Period|Protocol Violation|8|||
19577993|NCT01117350|42026709|FG001|Comparative Period|Protocol Violation|12|||
19577994|NCT01117350|42026708|FG000|Comparative Period|Lack of Efficacy|1|||
19577995|NCT01117350|42026709|FG001|Comparative Period|Lack of Efficacy|0|||
19577996|NCT01117350|42026708|FG000|Comparative Period|Physician Decision|0|||
19577997|NCT01117350|42026709|FG001|Comparative Period|Physician Decision|1|||
19577998|NCT01117350|42026708|FG000|Comparative Period|Move to another city/country|2|||
19577999|NCT01117350|42026709|FG001|Comparative Period|Move to another city/country|1|||
19578000|NCT01117350|42026708|FG000|Extension Period|Not included in extension, not treated|0|||
19578001|NCT01117350|42026709|FG001|Extension Period|Not included in extension, not treated|50|||
19578002|NCT01117350|42026708|FG000|Extension Period|Adverse Event|0|||
19578003|NCT01117350|42026709|FG001|Extension Period|Adverse Event|2|||
19578004|NCT01117350|42026708|FG000|Extension Period|Protocol Violation|0|||
19578005|NCT01117350|42026709|FG001|Extension Period|Protocol Violation|2|||
19578006|NCT01117350|42026708|FG000|Extension Period|Lost to Follow-up|0|||
19578007|NCT01117350|42026709|FG001|Extension Period|Lost to Follow-up|2|||
19578008|NCT01117350|42026708|FG000|Extension Period|Withdrawal by Subject|0|||
19578009|NCT01117350|42026709|FG001|Extension Period|Withdrawal by Subject|3|||
19578010|NCT01117350|42026708|FG000|Extension Period|Lack of Efficacy|0|||
19578011|NCT01117350|42026709|FG001|Extension Period|Lack of Efficacy|2|||
19578012|NCT01117350|42026708|FG000|Extension Period|Inclusion criteria not respected|0|||
19578013|NCT01117350|42026709|FG001|Extension Period|Inclusion criteria not respected|1|||
19578014|NCT01117350|42026708|FG000|Extension Period|Prohibited medication|0|||
19578015|NCT01117350|42026709|FG001|Extension Period|Prohibited medication|1|||
19578016|NCT00952731|42026720|FG000|Overall Study|Drug supply expired|1|||
19578017|NCT00952731|42026721|FG001|Overall Study|Drug supply expired|0|||
19578018|NCT00947427|42026729|FG000|Overall Study|Withdrawal by Subject|1|||
19578019|NCT00947427|42026730|FG001|Overall Study|Withdrawal by Subject|3|||
19578020|NCT00947427|42026729|FG000|Overall Study|Protocol Violation|0|||
19578021|NCT00947427|42026730|FG001|Overall Study|Protocol Violation|1|||
19578022|NCT01116882|42026738|FG000|30-day|Lost to Follow-up|50|||
19578023|NCT01116882|42026739|FG001|30-day|Lost to Follow-up|21|||
19578024|NCT01116882|42026738|FG000|30-day|Withdrawal by Subject|2|||
19578025|NCT01116882|42026739|FG001|30-day|Withdrawal by Subject|4|||
19578026|NCT01116882|42026738|FG000|30-day|Other Reasons|16|||
19578027|NCT01116882|42026739|FG001|30-day|Other Reasons|6|||
19578028|NCT01116882|42026738|FG000|12-month|Lost to Follow-up|111|||
19578029|NCT01116882|42026739|FG001|12-month|Lost to Follow-up|42|||
19578030|NCT01116882|42026738|FG000|12-month|Other Reasons|151|||
19578031|NCT01116882|42026739|FG001|12-month|Other Reasons|49|||
19578032|NCT01116882|42026738|FG000|12-month|Withdrawal by Subject|5|||
19578033|NCT01116882|42026739|FG001|12-month|Withdrawal by Subject|8|||
19578034|NCT00953745|42026750|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
19578035|NCT00953745|42026751|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
19578036|NCT00953745|42026750|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
19578037|NCT00953745|42026751|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
19578038|NCT00953745|42026750|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
19578039|NCT00953745|42026751|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
19578040|NCT00953745|42026750|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
19578041|NCT00953745|42026751|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
19578042|NCT00953745|42026750|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
19578043|NCT00953745|42026751|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
19578044|NCT00953745|42026750|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
19578045|NCT00953745|42026751|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
19578046|NCT00902746|42026768|FG000|Overall Study|Protocol Violation|7|||
19578047|NCT00902746|42026768|FG000|Overall Study|Withdrawal by Subject|16|||
19578048|NCT00902746|42026768|FG000|Overall Study|Adverse Event|8|||
19578049|NCT00902746|42026768|FG000|Overall Study|Lost to Follow-up|3|||
19578050|NCT00902746|42026768|FG000|Overall Study|Physician Decision|2|||
19578051|NCT00902668|42026781|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
19578052|NCT00947349|42026789|FG000|Triple Treatment Combination Period|Adverse Event|0|||
19578053|NCT00947349|42026790|FG001|Triple Treatment Combination Period|Adverse Event|1|||
19578054|NCT00947349|42026791|FG002|Triple Treatment Combination Period|Adverse Event|0|||
19578055|NCT00947349|42026792|FG003|Triple Treatment Combination Period|Adverse Event|0|||
19578056|NCT00947349|42026789|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
19578057|NCT00947349|42026790|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
19578058|NCT00947349|42026791|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
19578059|NCT00947349|42026792|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
19578060|NCT00947349|42026789|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
19578061|NCT00947349|42026790|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
19578062|NCT00947349|42026791|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
19578063|NCT00947349|42026792|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
19578064|NCT00947349|42026789|FG000|Overall Study Standard of Care|Other|0|||
19578065|NCT00947349|42026790|FG001|Overall Study Standard of Care|Other|0|||
19578066|NCT00947349|42026791|FG002|Overall Study Standard of Care|Other|0|||
19578067|NCT00947349|42026792|FG003|Overall Study Standard of Care|Other|1|||
19578068|NCT00947193|42026820|FG000|Overall Study|Lost to Follow-up|1|||
19578069|NCT00947193|42026821|FG001|Overall Study|Lost to Follow-up|0|||
19578070|NCT00947193|42026820|FG000|Overall Study|Withdrawal by Subject|1|||
19578071|NCT00947193|42026821|FG001|Overall Study|Withdrawal by Subject|0|||
19578072|NCT00947193|42026820|FG000|Overall Study|Factor VIII >1%|1|||
19578073|NCT00947193|42026821|FG001|Overall Study|Factor VIII >1%|0|||
19578074|NCT00947115|42026829|FG000|Overall Study|Missed reporting interval|3|||
19578075|NCT00947115|42026830|FG001|Overall Study|Missed reporting interval|4|||
19578076|NCT00947115|42026831|FG002|Overall Study|Missed reporting interval|2|||
19578077|NCT00947115|42026829|FG000|Overall Study|Physician Decision|0|||
19578078|NCT00947115|42026830|FG001|Overall Study|Physician Decision|2|||
19578079|NCT00947115|42026831|FG002|Overall Study|Physician Decision|0|||
19578080|NCT00947115|42026829|FG000|Overall Study|Death|0|||
19578081|NCT00947115|42026830|FG001|Overall Study|Death|1|||
19578082|NCT00947115|42026831|FG002|Overall Study|Death|1|||
19578083|NCT00947115|42026829|FG000|Overall Study|Migrated from study area|2|||
19578084|NCT00947115|42026830|FG001|Overall Study|Migrated from study area|0|||
19578085|NCT00947115|42026831|FG002|Overall Study|Migrated from study area|0|||
19578086|NCT00947115|42026829|FG000|Overall Study|Withdrawal by Subject|1|||
19578087|NCT00947115|42026830|FG001|Overall Study|Withdrawal by Subject|3|||
19578088|NCT00947115|42026831|FG002|Overall Study|Withdrawal by Subject|4|||
19578089|NCT00947115|42026829|FG000|Overall Study|Lost to Follow-up|11|||
19578090|NCT00947115|42026830|FG001|Overall Study|Lost to Follow-up|12|||
19578091|NCT00947115|42026831|FG002|Overall Study|Lost to Follow-up|8|||
19578092|NCT00952419|42026842|FG000|Overall Study|Adverse Event|2|||
19578093|NCT00952419|42026843|FG001|Overall Study|Adverse Event|0|||
19578094|NCT00952419|42026844|FG002|Overall Study|Adverse Event|0|||
19578095|NCT00952419|42026842|FG000|Overall Study|Protocol Violation|3|||
19578096|NCT00952419|42026843|FG001|Overall Study|Protocol Violation|7|||
19578097|NCT00952419|42026844|FG002|Overall Study|Protocol Violation|0|||
19578098|NCT00952419|42026842|FG000|Overall Study|Withdrawal by Subject|1|||
19578099|NCT00952419|42026843|FG001|Overall Study|Withdrawal by Subject|3|||
19578100|NCT00952419|42026844|FG002|Overall Study|Withdrawal by Subject|0|||
19639247|NCT00687609|42088649|FG000|Overall Study|Withdrawal by Subject|2|||
19578101|NCT00902278|42026857|FG000|Overall Study|Physician Decision|1|||
19578102|NCT00902278|42026858|FG001|Overall Study|Physician Decision|0|||
19578103|NCT00902278|42026859|FG002|Overall Study|Physician Decision|2|||
19578104|NCT00902278|42026860|FG003|Overall Study|Physician Decision|0|||
19578105|NCT00902278|42026861|FG004|Overall Study|Physician Decision|1|||
19578106|NCT00902278|42026857|FG000|Overall Study|Lost to Follow-up|3|||
19578107|NCT00902278|42026858|FG001|Overall Study|Lost to Follow-up|2|||
19578108|NCT00902278|42026859|FG002|Overall Study|Lost to Follow-up|3|||
19578109|NCT00902278|42026860|FG003|Overall Study|Lost to Follow-up|0|||
19578110|NCT00902278|42026861|FG004|Overall Study|Lost to Follow-up|1|||
19578111|NCT01998633|42026875|FG000|Overall Study|Death|1|||
19578112|NCT00952341|42026885|FG000|Cycle 1|Adverse Event|4|||
19578113|NCT00952341|42026886|FG001|Cycle 1|Adverse Event|1|||
19578114|NCT00952341|42026885|FG000|Cycle 1|Withdrawal by Subject|3|||
19578115|NCT00952341|42026886|FG001|Cycle 1|Withdrawal by Subject|8|||
19578116|NCT00952341|42026885|FG000|Cycle 1|Protocol Violation|2|||
19578117|NCT00952341|42026886|FG001|Cycle 1|Protocol Violation|1|||
19578118|NCT00952341|42026885|FG000|Cycle 1|Lost to Follow-up|11|||
19578119|NCT00952341|42026886|FG001|Cycle 1|Lost to Follow-up|2|||
19578120|NCT00952341|42026885|FG000|Cycle 1|Physician Decision|0|||
19578121|NCT00952341|42026886|FG001|Cycle 1|Physician Decision|1|||
19578122|NCT00952341|42026885|FG000|Cycle 2|Withdrawal by Subject|1|||
19578123|NCT00952341|42026886|FG001|Cycle 2|Withdrawal by Subject|1|||
19578124|NCT00952341|42026885|FG000|Cycle 2|Protocol Violation|1|||
19578125|NCT00952341|42026886|FG001|Cycle 2|Protocol Violation|0|||
19578126|NCT00952341|42026885|FG000|Cycle 2|Lost to Follow-up|6|||
19578127|NCT00952341|42026886|FG001|Cycle 2|Lost to Follow-up|9|||
19578128|NCT00952341|42026885|FG000|Cycle 2|Physician Decision|1|||
19578129|NCT00952341|42026886|FG001|Cycle 2|Physician Decision|1|||
19578130|NCT00952341|42026885|FG000|Cycle 2|Progressive Disease|0|||
19578131|NCT00952341|42026886|FG001|Cycle 2|Progressive Disease|1|||
19578132|NCT00946881|42026892|FG000|First Treatment|Withdrawal by Subject|1|||
19578133|NCT00946881|42026892|FG000|First Treatment|Patient relocated to another state|1|||
19578134|NCT00946881|42026892|FG000|Retreatment|Withdrawal by Subject|1|||
19578135|NCT01214642|42026929|FG000|Overall Study|Progressive Disease|3|||
19578136|NCT01214642|42026930|FG001|Overall Study|Progressive Disease|2|||
19578137|NCT01214642|42026931|FG002|Overall Study|Progressive Disease|3|||
19578138|NCT01214642|42026932|FG003|Overall Study|Progressive Disease|5|||
19578139|NCT01214642|42026933|FG004|Overall Study|Progressive Disease|5|||
19578140|NCT01214642|42026934|FG005|Overall Study|Progressive Disease|3|||
19578141|NCT01214642|42026935|FG006|Overall Study|Progressive Disease|5|||
19578142|NCT01214642|42026936|FG007|Overall Study|Progressive Disease|3|||
19578143|NCT01214642|42026937|FG008|Overall Study|Progressive Disease|10|||
19578144|NCT01214642|42026938|FG009|Overall Study|Progressive Disease|2|||
19578145|NCT01214642|42026939|FG010|Overall Study|Progressive Disease|1|||
19578146|NCT01214642|42026940|FG011|Overall Study|Progressive Disease|4|||
19578147|NCT01214642|42026929|FG000|Overall Study|Adverse Event|0|||
19578148|NCT01214642|42026930|FG001|Overall Study|Adverse Event|1|||
19578149|NCT01214642|42026931|FG002|Overall Study|Adverse Event|0|||
19578150|NCT01214642|42026932|FG003|Overall Study|Adverse Event|0|||
19578151|NCT01214642|42026933|FG004|Overall Study|Adverse Event|0|||
19578152|NCT01214642|42026934|FG005|Overall Study|Adverse Event|0|||
19578153|NCT01214642|42026935|FG006|Overall Study|Adverse Event|1|||
19578154|NCT01214642|42026936|FG007|Overall Study|Adverse Event|0|||
19578155|NCT01214642|42026937|FG008|Overall Study|Adverse Event|0|||
19578156|NCT01214642|42026938|FG009|Overall Study|Adverse Event|1|||
19578157|NCT01214642|42026939|FG010|Overall Study|Adverse Event|1|||
19578158|NCT01214642|42026940|FG011|Overall Study|Adverse Event|0|||
19578159|NCT01214642|42026929|FG000|Overall Study|Death|0|||
19578160|NCT01214642|42026930|FG001|Overall Study|Death|0|||
19578161|NCT01214642|42026931|FG002|Overall Study|Death|1|||
19578162|NCT01214642|42026932|FG003|Overall Study|Death|0|||
19578163|NCT01214642|42026933|FG004|Overall Study|Death|0|||
19578164|NCT01214642|42026934|FG005|Overall Study|Death|0|||
19578165|NCT01214642|42026935|FG006|Overall Study|Death|0|||
19578166|NCT01214642|42026936|FG007|Overall Study|Death|0|||
19578167|NCT01214642|42026937|FG008|Overall Study|Death|0|||
19578168|NCT01214642|42026938|FG009|Overall Study|Death|0|||
19578169|NCT01214642|42026939|FG010|Overall Study|Death|1|||
19578170|NCT01214642|42026940|FG011|Overall Study|Death|0|||
19578171|NCT01214642|42026929|FG000|Overall Study|Withdrawal by Subject|0|||
19578172|NCT01214642|42026930|FG001|Overall Study|Withdrawal by Subject|0|||
19578173|NCT01214642|42026931|FG002|Overall Study|Withdrawal by Subject|1|||
19578174|NCT01214642|42026932|FG003|Overall Study|Withdrawal by Subject|0|||
19578175|NCT01214642|42026933|FG004|Overall Study|Withdrawal by Subject|0|||
19578176|NCT01214642|42026934|FG005|Overall Study|Withdrawal by Subject|0|||
19578177|NCT01214642|42026935|FG006|Overall Study|Withdrawal by Subject|0|||
19578178|NCT01214642|42026936|FG007|Overall Study|Withdrawal by Subject|0|||
19578179|NCT01214642|42026937|FG008|Overall Study|Withdrawal by Subject|3|||
19578180|NCT01214642|42026938|FG009|Overall Study|Withdrawal by Subject|1|||
19578181|NCT01214642|42026939|FG010|Overall Study|Withdrawal by Subject|1|||
19578182|NCT01214642|42026940|FG011|Overall Study|Withdrawal by Subject|0|||
19578183|NCT01214642|42026929|FG000|Overall Study|Physician Decision|0|||
19578184|NCT01214642|42026930|FG001|Overall Study|Physician Decision|0|||
19578185|NCT01214642|42026931|FG002|Overall Study|Physician Decision|1|||
19578186|NCT01214642|42026932|FG003|Overall Study|Physician Decision|1|||
19578187|NCT01214642|42026933|FG004|Overall Study|Physician Decision|1|||
19578188|NCT01214642|42026934|FG005|Overall Study|Physician Decision|0|||
19578189|NCT01214642|42026935|FG006|Overall Study|Physician Decision|0|||
19578190|NCT01214642|42026936|FG007|Overall Study|Physician Decision|0|||
19578191|NCT01214642|42026937|FG008|Overall Study|Physician Decision|0|||
19578192|NCT01214642|42026938|FG009|Overall Study|Physician Decision|0|||
19578193|NCT01214642|42026939|FG010|Overall Study|Physician Decision|0|||
19578194|NCT01214642|42026940|FG011|Overall Study|Physician Decision|2|||
19578195|NCT01214252|42026983|FG000|Overall Study|Not eligible per protocol|82|||
19578196|NCT01214174|42026991|FG000|Overall Study|Withdrawal by Subject|0|||
19578197|NCT01214174|42026992|FG001|Overall Study|Withdrawal by Subject|0|||
19578198|NCT01214174|42026993|FG002|Overall Study|Withdrawal by Subject|1|||
19578199|NCT00901342|42027001|FG000|Overall Study|Adverse Event|1|||
19578200|NCT00901342|42027001|FG000|Overall Study|Death|4|||
19578201|NCT00901342|42027001|FG000|Overall Study|Disease progression|1|||
19578202|NCT00901342|42027001|FG000|Overall Study|Withdrawal by Subject|9|||
19578203|NCT00901186|42027007|FG000|Overall Study|Lack of Efficacy|0|||
19578204|NCT00901186|42027008|FG001|Overall Study|Lack of Efficacy|1|||
19578205|NCT00901186|42027007|FG000|Overall Study|Abnormal laboratory values|0|||
19578206|NCT00901186|42027008|FG001|Overall Study|Abnormal laboratory values|1|||
19578207|NCT00901186|42027007|FG000|Overall Study|Lost to Follow-up|2|||
19578208|NCT00901186|42027008|FG001|Overall Study|Lost to Follow-up|0|||
19578209|NCT00901186|42027007|FG000|Overall Study|Adverse Event|2|||
19578210|NCT00901186|42027008|FG001|Overall Study|Adverse Event|4|||
19578211|NCT00901186|42027007|FG000|Overall Study|Administration problems|0|||
19578212|NCT00901186|42027008|FG001|Overall Study|Administration problems|1|||
19578213|NCT00901186|42027007|FG000|Overall Study|Protocol deviations|5|||
19578214|NCT00901186|42027008|FG001|Overall Study|Protocol deviations|4|||
19578215|NCT01213472|42027014|FG000|Overall Study|Recurrence/Progressive disease|25|||
19578216|NCT01213472|42027014|FG000|Overall Study|Withdrawal by Subject|1|||
19578217|NCT01213472|42027014|FG000|Overall Study|Physician Decision|1|||
19578218|NCT00900796|42027018|FG000|Phase 1|Lacked sufficient information|4|||
19578219|NCT00900796|42027018|FG000|Phase 1|Missing information at Week 16|7|||
19578220|NCT00900796|42027018|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
19578221|NCT00900796|42027018|FG000|Phase 2|Lost to Follow-up|5|||
19578222|NCT01213082|42027026|FG000|Overall Study|Lost to Follow-up|6|||
19578223|NCT01213082|42027027|FG001|Overall Study|Lost to Follow-up|7|||
19578224|NCT01213082|42027028|FG002|Overall Study|Lost to Follow-up|4|||
19578225|NCT01213082|42027026|FG000|Overall Study|Physician Decision|0|||
19578226|NCT01213082|42027027|FG001|Overall Study|Physician Decision|0|||
19578227|NCT01213082|42027028|FG002|Overall Study|Physician Decision|1|||
19578228|NCT00885703|42027043|FG000|Overall Study|Death|9|||
19578229|NCT00885703|42027044|FG001|Overall Study|Death|7|||
19578230|NCT00885703|42027045|FG002|Overall Study|Death|8|||
19578231|NCT00885703|42027046|FG003|Overall Study|Death|7|||
19578232|NCT00885703|42027047|FG004|Overall Study|Death|7|||
19578233|NCT00885703|42027048|FG005|Overall Study|Death|8|||
19578234|NCT00885703|42027049|FG006|Overall Study|Death|4|||
19578235|NCT00885703|42027043|FG000|Overall Study|Lost to Follow-up|0|||
19578236|NCT00885703|42027044|FG001|Overall Study|Lost to Follow-up|0|||
19578237|NCT00885703|42027045|FG002|Overall Study|Lost to Follow-up|1|||
19578238|NCT00885703|42027046|FG003|Overall Study|Lost to Follow-up|0|||
19578239|NCT00885703|42027047|FG004|Overall Study|Lost to Follow-up|0|||
19578240|NCT00885703|42027048|FG005|Overall Study|Lost to Follow-up|1|||
19578241|NCT00885703|42027049|FG006|Overall Study|Lost to Follow-up|0|||
19578242|NCT00885703|42027043|FG000|Overall Study|Withdrawal by Subject|0|||
19578243|NCT00885703|42027044|FG001|Overall Study|Withdrawal by Subject|0|||
19578244|NCT00885703|42027045|FG002|Overall Study|Withdrawal by Subject|0|||
19578245|NCT00885703|42027046|FG003|Overall Study|Withdrawal by Subject|1|||
19578246|NCT00885703|42027047|FG004|Overall Study|Withdrawal by Subject|3|||
19578247|NCT00885703|42027048|FG005|Overall Study|Withdrawal by Subject|1|||
19578248|NCT00885703|42027049|FG006|Overall Study|Withdrawal by Subject|1|||
19578249|NCT00885703|42027043|FG000|Overall Study|Ineligible (no CM)|1|||
19578250|NCT00885703|42027044|FG001|Overall Study|Ineligible (no CM)|3|||
19578251|NCT00885703|42027045|FG002|Overall Study|Ineligible (no CM)|2|||
19578252|NCT00885703|42027046|FG003|Overall Study|Ineligible (no CM)|1|||
19578253|NCT00885703|42027047|FG004|Overall Study|Ineligible (no CM)|2|||
19578254|NCT00885703|42027048|FG005|Overall Study|Ineligible (no CM)|3|||
19578255|NCT00885703|42027049|FG006|Overall Study|Ineligible (no CM)|1|||
19578256|NCT00901576|42027075|FG000|Second Intervention|Withdrawal by Subject|0|||
19578257|NCT00901576|42027076|FG001|Second Intervention|Withdrawal by Subject|0|||
19578258|NCT00901576|42027077|FG002|Second Intervention|Withdrawal by Subject|0|||
19578259|NCT00901576|42027078|FG003|Second Intervention|Withdrawal by Subject|1|||
19578260|NCT00901576|42027079|FG004|Second Intervention|Withdrawal by Subject|0|||
19578261|NCT00901576|42027080|FG005|Second Intervention|Withdrawal by Subject|1|||
19578262|NCT00901576|42027075|FG000|Second Intervention|Physician Decision|1|||
19578263|NCT00901576|42027076|FG001|Second Intervention|Physician Decision|0|||
19578264|NCT00901576|42027077|FG002|Second Intervention|Physician Decision|0|||
19578265|NCT00901576|42027078|FG003|Second Intervention|Physician Decision|0|||
19578266|NCT00901576|42027079|FG004|Second Intervention|Physician Decision|0|||
19578267|NCT00901576|42027080|FG005|Second Intervention|Physician Decision|0|||
19578268|NCT00882583|42027090|FG000|Overall Study|Physician Decision|1|||
19578269|NCT00882583|42027091|FG001|Overall Study|Physician Decision|0|||
19578270|NCT00882583|42027090|FG000|Overall Study|Adverse Event|0|||
19578271|NCT00882583|42027091|FG001|Overall Study|Adverse Event|1|||
19578272|NCT00900562|42027099|FG000|Overall Study|Progressive disease|9|||
19578273|NCT00900562|42027100|FG001|Overall Study|Progressive disease|5|||
19578274|NCT00900562|42027099|FG000|Overall Study|Toxicity|1|||
19578275|NCT00900562|42027100|FG001|Overall Study|Toxicity|0|||
19578276|NCT00900562|42027099|FG000|Overall Study|Death|1|||
19387825|NCT01625338|41631147|FG000|Overall Study|Adverse Event|1|||
19578277|NCT00900562|42027100|FG001|Overall Study|Death|1|||
19578278|NCT00900562|42027099|FG000|Overall Study|Withdrawal by Subject|0|||
19578279|NCT00900562|42027100|FG001|Overall Study|Withdrawal by Subject|1|||
19578280|NCT00900562|42027099|FG000|Overall Study|Unrelated adverse event|1|||
19578281|NCT00900562|42027100|FG001|Overall Study|Unrelated adverse event|0|||
19578282|NCT00599521|42027109|FG000|Overall Study|Lack of Efficacy|4|||
19578283|NCT00599521|42027110|FG001|Overall Study|Lack of Efficacy|8|||
19578284|NCT00599521|42027109|FG000|Overall Study|Adverse Event|4|||
19578285|NCT00599521|42027110|FG001|Overall Study|Adverse Event|1|||
19578286|NCT00599521|42027109|FG000|Overall Study|Withdrawal by Subject|28|||
19578287|NCT00599521|42027110|FG001|Overall Study|Withdrawal by Subject|34|||
19578288|NCT00599521|42027109|FG000|Overall Study|Protocol Violation|1|||
19578289|NCT00599521|42027110|FG001|Overall Study|Protocol Violation|1|||
19578290|NCT00599521|42027109|FG000|Overall Study|Lost to Follow-up|23|||
19578291|NCT00599521|42027110|FG001|Overall Study|Lost to Follow-up|23|||
19578292|NCT00599521|42027109|FG000|Overall Study|Pregnancy|0|||
19578293|NCT00599521|42027110|FG001|Overall Study|Pregnancy|2|||
19578294|NCT00882115|42027116|FG000|Overall Study|Withdrawal by Subject|3|||
19578295|NCT00882115|42027116|FG000|Overall Study|did not respond to DEP challe|6|||
19578296|NCT00881959|42027122|FG000|Overall Study|Lost to Follow-up|2|||
19578297|NCT00881959|42027123|FG001|Overall Study|Lost to Follow-up|4|||
19578298|NCT00884377|42027131|FG000|Overall Study|Withdrawal by Subject|1|||
19578299|NCT00884377|42027132|FG001|Overall Study|Withdrawal by Subject|0|||
19578300|NCT00884377|42027131|FG000|Overall Study|Could not confirm diagnosis|1|||
19578301|NCT00884377|42027132|FG001|Overall Study|Could not confirm diagnosis|0|||
19578302|NCT00884377|42027131|FG000|Overall Study|Physician Decision|0|||
19578303|NCT00884377|42027132|FG001|Overall Study|Physician Decision|1|||
19578304|NCT00884221|42027146|FG000|Overall Study|Withdrawal by Subject|0|||
19578305|NCT00884221|42027147|FG001|Overall Study|Withdrawal by Subject|3|||
19578306|NCT00884221|42027146|FG000|Overall Study|Adverse Event|6|||
19578307|NCT00884221|42027147|FG001|Overall Study|Adverse Event|3|||
19578308|NCT00884221|42027146|FG000|Overall Study|Protocol Violation|16|||
19578309|NCT00884221|42027147|FG001|Overall Study|Protocol Violation|13|||
19578310|NCT00884221|42027146|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
19578311|NCT00884221|42027147|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
19578312|NCT00899548|42027168|FG000|Overall Study|Physician Decision|3|||
19578313|NCT00899392|42027178|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
19578314|NCT00899392|42027179|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
19578315|NCT00690898|42027185|FG000|SCREENING|Screen failure|18|||
19578316|NCT00690898|42027185|FG000|TREATMENT|Adverse Event|3|||
19578317|NCT00690898|42027185|FG000|TREATMENT|Lack of Efficacy|18|||
19578318|NCT00690898|42027185|FG000|TREATMENT|Withdrawal by Subject|4|||
19578319|NCT00690898|42027185|FG000|TREATMENT|Other (not otherwise specified)|1|||
19578320|NCT00895414|42027189|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
19578321|NCT00895414|42027190|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
19578322|NCT00895414|42027189|FG000|First Intervention (14 Days)|Physician Decision|0|||
19578323|NCT00895414|42027190|FG001|First Intervention (14 Days)|Physician Decision|1|||
19578324|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
19578325|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
19578326|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
19578327|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578328|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578329|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578330|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578331|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578332|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19578333|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
19578334|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
19578335|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
19578336|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578337|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578338|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578339|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578340|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578341|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19578342|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
19578343|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
19578344|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
19578345|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578346|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578347|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578348|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578349|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578350|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19578351|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
19578352|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578353|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
19578354|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578355|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578356|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578357|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578358|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578359|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19578360|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578361|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578362|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
19578363|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578364|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578365|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578366|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578367|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578368|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19578369|NCT01212770|42027199|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
19578370|NCT01212770|42027200|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
19578371|NCT01212770|42027201|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
19578372|NCT01212770|42027202|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578373|NCT01212770|42027203|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578374|NCT01212770|42027204|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578375|NCT01212770|42027205|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578376|NCT01212770|42027206|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578377|NCT01212770|42027207|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
19578378|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
19578379|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
19578380|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
19578381|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
19578382|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
19578383|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
19578384|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
19578385|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
19578386|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
19578387|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
19578388|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
19578389|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
19578390|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
19578391|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
19578392|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
19578393|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
19578394|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
19578395|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
19578396|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
19578397|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
19578398|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
19578399|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
19578400|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
19578401|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
19578402|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
19578403|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
19578404|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
19578405|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578406|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578407|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
19578408|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578409|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578410|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578411|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578412|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578413|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
19578414|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578415|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578416|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578417|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
19578418|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578419|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578420|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578421|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578422|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
19578423|NCT01212770|42027199|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578424|NCT01212770|42027200|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578425|NCT01212770|42027201|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
19578426|NCT01212770|42027202|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
19578427|NCT01212770|42027203|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578428|NCT01212770|42027204|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578429|NCT01212770|42027205|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578430|NCT01212770|42027206|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578431|NCT01212770|42027207|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
19578432|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578433|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
19578434|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
19578435|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578436|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578437|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578438|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578439|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19578440|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
19578441|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19578442|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
19578443|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
19578444|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19578445|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19578446|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19578447|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19578448|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
19578449|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
19578450|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578451|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
19578452|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578453|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578454|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578455|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578456|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578457|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578458|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
19578459|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19578460|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
19578461|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
19578462|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19578463|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19578464|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19578465|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19578466|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
19578467|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
19578468|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
19578469|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
19578470|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
19578471|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
19578472|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
19578473|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
19578474|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
19578475|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
19578476|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
19578477|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578478|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
19578479|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
19578480|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578481|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578482|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578483|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578484|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19578485|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
19578486|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19578487|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
19578488|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
19578489|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19578490|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19578491|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19578492|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19578493|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
19578494|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
19578495|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19578496|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
19578497|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
19578498|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19578499|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19578500|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19578501|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19578502|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
19578503|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
19578504|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19578505|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
19578506|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
19578507|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19578508|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19578509|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19578510|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19578511|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
19578512|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
19578513|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578514|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
19578515|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578516|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578517|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578518|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578519|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578520|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578521|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19578522|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578523|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578524|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578525|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578526|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578527|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578528|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578529|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
19578530|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
19578531|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19578532|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
19578533|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
19578534|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19578535|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19578536|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19578537|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19578538|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
19578539|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
19578540|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578541|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
19578542|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
19578543|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578544|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578545|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578546|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578547|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19578548|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
19578549|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578550|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
19578551|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
19578552|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578553|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578554|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578555|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578556|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
19578557|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19578558|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578559|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
19578560|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
19578561|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578562|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578563|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578564|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578565|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
19578566|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
19578567|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578568|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
19578569|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
19578570|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578571|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578572|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578573|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578574|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578575|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19578576|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578577|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578578|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
19578579|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578580|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578581|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578582|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578583|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19745882|NCT03529773|42193168|FG012|Overall Study|No longer meets eligibility criteria|0|||
19578584|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19578585|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578586|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
19578587|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578588|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578589|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578590|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578591|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578592|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19578593|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
19578594|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
19578595|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
19578596|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
19578597|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
19578598|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
19578599|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
19578600|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
19578601|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
19578602|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
19578603|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578604|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578605|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
19578606|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578607|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578608|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578609|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578610|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578611|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19578612|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578613|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578614|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
19578615|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578616|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578617|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578618|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578619|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19578620|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
19578621|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578622|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578623|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
19578624|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578625|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578626|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578627|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578628|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578629|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19578630|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578631|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
19578632|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
19578633|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578634|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578635|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578636|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578637|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
19578638|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19578639|NCT01212770|42027199|FG000|Long-term Safety Phase (Year 5)|Death|0|||
19578640|NCT01212770|42027200|FG001|Long-term Safety Phase (Year 5)|Death|0|||
19578641|NCT01212770|42027201|FG002|Long-term Safety Phase (Year 5)|Death|0|||
19578642|NCT01212770|42027202|FG003|Long-term Safety Phase (Year 5)|Death|0|||
19578643|NCT01212770|42027203|FG004|Long-term Safety Phase (Year 5)|Death|0|||
19578644|NCT01212770|42027204|FG005|Long-term Safety Phase (Year 5)|Death|0|||
19578645|NCT01212770|42027205|FG006|Long-term Safety Phase (Year 5)|Death|0|||
19578646|NCT01212770|42027206|FG007|Long-term Safety Phase (Year 5)|Death|1|||
19578647|NCT01212770|42027207|FG008|Long-term Safety Phase (Year 5)|Death|0|||
19578648|NCT00598273|42027232|FG000|Overall Study|Adverse Event|4|||
19578649|NCT00598273|42027233|FG001|Overall Study|Adverse Event|5|||
19578650|NCT00598273|42027234|FG002|Overall Study|Adverse Event|2|||
19578651|NCT00598273|42027232|FG000|Overall Study|Death|6|||
19578652|NCT00598273|42027233|FG001|Overall Study|Death|12|||
19578653|NCT00598273|42027234|FG002|Overall Study|Death|8|||
19578654|NCT00598273|42027232|FG000|Overall Study|Lost to Follow-up|8|||
19578655|NCT00598273|42027233|FG001|Overall Study|Lost to Follow-up|3|||
19578656|NCT00598273|42027234|FG002|Overall Study|Lost to Follow-up|5|||
19578657|NCT00598273|42027232|FG000|Overall Study|Physician Decision|0|||
19578658|NCT00598273|42027233|FG001|Overall Study|Physician Decision|0|||
19578659|NCT00598273|42027234|FG002|Overall Study|Physician Decision|1|||
19578660|NCT00598273|42027232|FG000|Overall Study|Withdrawal by Subject|12|||
19578661|NCT00598273|42027233|FG001|Overall Study|Withdrawal by Subject|10|||
19578662|NCT00598273|42027234|FG002|Overall Study|Withdrawal by Subject|10|||
19578663|NCT00598273|42027232|FG000|Overall Study|Noncompliance|3|||
19578664|NCT00598273|42027233|FG001|Overall Study|Noncompliance|2|||
19578665|NCT00598273|42027234|FG002|Overall Study|Noncompliance|3|||
19578666|NCT00598273|42027232|FG000|Overall Study|Relocation|0|||
19578667|NCT00598273|42027233|FG001|Overall Study|Relocation|2|||
19578668|NCT00598273|42027234|FG002|Overall Study|Relocation|4|||
19578669|NCT00598273|42027232|FG000|Overall Study|Renal transplant|1|||
19578670|NCT00598273|42027233|FG001|Overall Study|Renal transplant|0|||
19578671|NCT00598273|42027234|FG002|Overall Study|Renal transplant|1|||
19578672|NCT00598273|42027232|FG000|Overall Study|Site elected to close|1|||
19578673|NCT00598273|42027233|FG001|Overall Study|Site elected to close|0|||
19578674|NCT00598273|42027234|FG002|Overall Study|Site elected to close|0|||
19578675|NCT00598273|42027232|FG000|Overall Study|Started dialysis|6|||
19578676|NCT00598273|42027233|FG001|Overall Study|Started dialysis|4|||
19578677|NCT00598273|42027234|FG002|Overall Study|Started dialysis|5|||
19578678|NCT01211522|42027245|FG000|Overall Study|Withdrawal by Subject|3|||
19578679|NCT01211522|42027246|FG001|Overall Study|Withdrawal by Subject|7|||
19578680|NCT01211522|42027247|FG002|Overall Study|Withdrawal by Subject|5|||
19578681|NCT01211288|42027257|FG000|Overall Study|Lost to Follow-up|1|||
19578682|NCT01211288|42027258|FG001|Overall Study|Lost to Follow-up|1|||
19578683|NCT00883753|42027266|FG000|Overall Study|Adverse Event|37|||
19578684|NCT00883753|42027266|FG000|Overall Study|Death|2|||
19578685|NCT00883753|42027266|FG000|Overall Study|Insufficient therapeutic response|16|||
19578686|NCT00883753|42027266|FG000|Overall Study|Lost to Follow-up|4|||
19578687|NCT00883753|42027266|FG000|Overall Study|Violation of selection criteria at entry|7|||
19578688|NCT00883753|42027266|FG000|Overall Study|Protocol Violation|2|||
19578689|NCT00883753|42027266|FG000|Overall Study|Refused treatment|4|||
19578690|NCT00883753|42027266|FG000|Overall Study|Withdrew consent|10|||
19578691|NCT00883753|42027266|FG000|Overall Study|Investigator's decision|17|||
19578692|NCT00883753|42027266|FG000|Overall Study|Administrative/Other|8|||
19578693|NCT01210664|42027273|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
19578694|NCT01210664|42027274|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
19578695|NCT01210664|42027275|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
19578696|NCT01210664|42027276|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
19578697|NCT01210664|42027273|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578698|NCT01210664|42027274|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578699|NCT01210664|42027275|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
19578700|NCT01210664|42027276|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578701|NCT01210664|42027273|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578702|NCT01210664|42027274|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578703|NCT01210664|42027275|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
19578704|NCT01210664|42027276|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
19578705|NCT00881569|42027288|FG000|Overall Study|Disease progression|1|||
19578706|NCT00881569|42027289|FG001|Overall Study|Disease progression|1|||
19578707|NCT00881335|42027297|FG000|Overall Study|Lost to Follow-up|3|||
19578708|NCT00881335|42027298|FG001|Overall Study|Lost to Follow-up|2|||
19578709|NCT02382406|42027307|FG000|Study Treatment|Disease Progression|8|||
19578710|NCT02382406|42027308|FG001|Study Treatment|Disease Progression|0|||
19578711|NCT02382406|42027309|FG002|Study Treatment|Disease Progression|20|||
19578712|NCT02382406|42027307|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
19578713|NCT02382406|42027308|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
19578714|NCT02382406|42027309|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
19578715|NCT02382406|42027307|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
19578716|NCT02382406|42027308|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
19578717|NCT02382406|42027309|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
19578718|NCT02382406|42027307|FG000|Study Treatment|symptomatic deterioration|1|||
19578719|NCT02382406|42027308|FG001|Study Treatment|symptomatic deterioration|0|||
19578720|NCT02382406|42027309|FG002|Study Treatment|symptomatic deterioration|1|||
19578721|NCT02382406|42027307|FG000|Study Treatment|Death|0|||
19578722|NCT02382406|42027308|FG001|Study Treatment|Death|0|||
19578723|NCT02382406|42027309|FG002|Study Treatment|Death|2|||
19578724|NCT02382406|42027307|FG000|Follow up|Death|11|||
19578725|NCT02382406|42027308|FG001|Follow up|Death|0|||
19578726|NCT02382406|42027309|FG002|Follow up|Death|19|||
19578727|NCT02382406|42027307|FG000|Follow up|Symptomatic deterioration|1|||
19578728|NCT02382406|42027308|FG001|Follow up|Symptomatic deterioration|0|||
19578729|NCT02382406|42027309|FG002|Follow up|Symptomatic deterioration|1|||
19578730|NCT02382406|42027307|FG000|Follow up|Patient Refused Follow-up|1|||
19578731|NCT02382406|42027308|FG001|Follow up|Patient Refused Follow-up|0|||
19578732|NCT02382406|42027309|FG002|Follow up|Patient Refused Follow-up|0|||
19578733|NCT02382406|42027307|FG000|Follow up|Study Terminated|1|||
19578734|NCT02382406|42027308|FG001|Follow up|Study Terminated|0|||
19578735|NCT02382406|42027309|FG002|Follow up|Study Terminated|8|||
19578736|NCT02382406|42027307|FG000|Follow up|Withdrawal by Subject|0|||
19578737|NCT02382406|42027308|FG001|Follow up|Withdrawal by Subject|0|||
19578738|NCT02382406|42027309|FG002|Follow up|Withdrawal by Subject|2|||
19578739|NCT00879775|42027330|FG000|Overall Study|Lost to Follow-up|2|||
19578740|NCT00879775|42027331|FG001|Overall Study|Lost to Follow-up|1|||
19578741|NCT00894790|42027339|FG000|Overall Study|Protocol Violation|0|||
19578742|NCT00894790|42027340|FG001|Overall Study|Protocol Violation|1|||
19578743|NCT00894790|42027339|FG000|Overall Study|Lost to Follow-up|0|||
19578744|NCT00894790|42027340|FG001|Overall Study|Lost to Follow-up|1|||
19578745|NCT00894790|42027339|FG000|Overall Study|Did not meet entrance criteria|1|||
19578746|NCT00894790|42027340|FG001|Overall Study|Did not meet entrance criteria|0|||
19578747|NCT00879229|42027348|FG000|Overall Study|Study terminated by Sponsor|13|||
19578748|NCT00879229|42027349|FG001|Overall Study|Study terminated by Sponsor|12|||
19578749|NCT00879229|42027348|FG000|Overall Study|Death|4|||
19578750|NCT00879229|42027349|FG001|Overall Study|Death|2|||
19578751|NCT00879229|42027348|FG000|Overall Study|Adverse Event|2|||
19578752|NCT00879229|42027349|FG001|Overall Study|Adverse Event|0|||
19578753|NCT00879229|42027348|FG000|Overall Study|Withdrawal by Subject|1|||
19578754|NCT00879229|42027349|FG001|Overall Study|Withdrawal by Subject|0|||
19578755|NCT00879229|42027348|FG000|Overall Study|Clinical status did not improve|1|||
19578756|NCT00879229|42027349|FG001|Overall Study|Clinical status did not improve|0|||
19578757|NCT00879229|42027348|FG000|Overall Study|Other|1|||
19578758|NCT00879229|42027349|FG001|Overall Study|Other|0|||
19578759|NCT00878995|42027357|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
19578760|NCT00878995|42027358|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
19578761|NCT00879697|42027366|FG000|Overall Study|Physician Decision|2|||
19578762|NCT00879697|42027367|FG001|Overall Study|Physician Decision|2|||
19578763|NCT00894556|42027376|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
19578764|NCT00894556|42027377|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
19578765|NCT00894556|42027378|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
19578766|NCT00894556|42027379|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
19578767|NCT00894556|42027376|FG000|Treatment Phase|Lost to Follow-up|2|||
19578768|NCT00894556|42027377|FG001|Treatment Phase|Lost to Follow-up|3|||
19578769|NCT00894556|42027378|FG002|Treatment Phase|Lost to Follow-up|1|||
19578770|NCT00894556|42027379|FG003|Treatment Phase|Lost to Follow-up|0|||
19578771|NCT00894556|42027376|FG000|Treatment Phase|Lack of Qualifying Event|2|||
19578772|NCT00894556|42027377|FG001|Treatment Phase|Lack of Qualifying Event|1|||
19578773|NCT00894556|42027378|FG002|Treatment Phase|Lack of Qualifying Event|0|||
19578774|NCT00894556|42027379|FG003|Treatment Phase|Lack of Qualifying Event|0|||
19578775|NCT01210352|42027395|FG000|Overall Study|Adverse Event|0|||
19578776|NCT01210352|42027396|FG001|Overall Study|Adverse Event|0|||
19578777|NCT01210352|42027397|FG002|Overall Study|Adverse Event|0|||
19578778|NCT01210352|42027398|FG003|Overall Study|Adverse Event|0|||
19578779|NCT01210352|42027399|FG004|Overall Study|Adverse Event|0|||
19578780|NCT01210352|42027400|FG005|Overall Study|Adverse Event|0|||
19578781|NCT01210352|42027401|FG006|Overall Study|Adverse Event|0|||
19578782|NCT01210352|42027402|FG007|Overall Study|Adverse Event|2|||
19578783|NCT01210352|42027403|FG008|Overall Study|Adverse Event|1|||
19578784|NCT01210352|42027395|FG000|Overall Study|Lack of Efficacy|0|||
19578785|NCT01210352|42027396|FG001|Overall Study|Lack of Efficacy|0|||
19578786|NCT01210352|42027397|FG002|Overall Study|Lack of Efficacy|0|||
19578787|NCT01210352|42027398|FG003|Overall Study|Lack of Efficacy|0|||
19578788|NCT01210352|42027399|FG004|Overall Study|Lack of Efficacy|0|||
19578789|NCT01210352|42027400|FG005|Overall Study|Lack of Efficacy|0|||
19578790|NCT01210352|42027401|FG006|Overall Study|Lack of Efficacy|1|||
19578791|NCT01210352|42027402|FG007|Overall Study|Lack of Efficacy|0|||
19578792|NCT01210352|42027403|FG008|Overall Study|Lack of Efficacy|0|||
19578793|NCT01210352|42027395|FG000|Overall Study|Physician Decision|0|||
19578794|NCT01210352|42027396|FG001|Overall Study|Physician Decision|0|||
19578795|NCT01210352|42027397|FG002|Overall Study|Physician Decision|0|||
19578796|NCT01210352|42027398|FG003|Overall Study|Physician Decision|0|||
19578797|NCT01210352|42027399|FG004|Overall Study|Physician Decision|0|||
19578798|NCT01210352|42027400|FG005|Overall Study|Physician Decision|0|||
19578799|NCT01210352|42027401|FG006|Overall Study|Physician Decision|0|||
19578800|NCT01210352|42027402|FG007|Overall Study|Physician Decision|1|||
19578801|NCT01210352|42027403|FG008|Overall Study|Physician Decision|2|||
19578802|NCT01210352|42027395|FG000|Overall Study|Withdrawal by Subject|0|||
19578803|NCT01210352|42027396|FG001|Overall Study|Withdrawal by Subject|0|||
19578804|NCT01210352|42027397|FG002|Overall Study|Withdrawal by Subject|1|||
19578805|NCT01210352|42027398|FG003|Overall Study|Withdrawal by Subject|0|||
19578806|NCT01210352|42027399|FG004|Overall Study|Withdrawal by Subject|0|||
19578807|NCT01210352|42027400|FG005|Overall Study|Withdrawal by Subject|0|||
19578808|NCT01210352|42027401|FG006|Overall Study|Withdrawal by Subject|1|||
19578809|NCT01210352|42027402|FG007|Overall Study|Withdrawal by Subject|0|||
19578810|NCT01210352|42027403|FG008|Overall Study|Withdrawal by Subject|1|||
19578811|NCT01210352|42027395|FG000|Overall Study|Patient Discharged Early|0|||
19578812|NCT01210352|42027396|FG001|Overall Study|Patient Discharged Early|0|||
19578813|NCT01210352|42027397|FG002|Overall Study|Patient Discharged Early|1|||
19578814|NCT01210352|42027398|FG003|Overall Study|Patient Discharged Early|0|||
19578815|NCT01210352|42027399|FG004|Overall Study|Patient Discharged Early|0|||
19578816|NCT01210352|42027400|FG005|Overall Study|Patient Discharged Early|0|||
19578817|NCT01210352|42027401|FG006|Overall Study|Patient Discharged Early|0|||
19578818|NCT01210352|42027402|FG007|Overall Study|Patient Discharged Early|0|||
19578819|NCT01210352|42027403|FG008|Overall Study|Patient Discharged Early|0|||
19578820|NCT01210118|42027510|FG000|Overall Study|Lost to Follow-up|1|||
19578821|NCT01210118|42027511|FG001|Overall Study|Lost to Follow-up|1|||
19578822|NCT01210118|42027510|FG000|Overall Study|Protocol Violation|1|||
19578823|NCT01210118|42027511|FG001|Overall Study|Protocol Violation|1|||
19578824|NCT01210118|42027510|FG000|Overall Study|Spontaneous abortion|1|||
19578825|NCT01210118|42027511|FG001|Overall Study|Spontaneous abortion|3|||
19578826|NCT01208870|42027522|FG000|Overall Study|Lost to Follow-up|2|||
19578827|NCT01208870|42027523|FG001|Overall Study|Lost to Follow-up|8|||
19578828|NCT00880555|42027534|FG000|Overall Study|Physician Decision|0|||
19578829|NCT00880555|42027535|FG001|Overall Study|Physician Decision|8|||
19578830|NCT00880555|42027536|FG002|Overall Study|Physician Decision|0|||
19578831|NCT00880555|42027537|FG003|Overall Study|Physician Decision|2|||
19578832|NCT00880555|42027538|FG004|Overall Study|Physician Decision|1|||
19578833|NCT00880555|42027539|FG005|Overall Study|Physician Decision|0|||
19578834|NCT00880555|42027534|FG000|Overall Study|Withdrawal by Subject|1|||
19578835|NCT00880555|42027535|FG001|Overall Study|Withdrawal by Subject|1|||
19578836|NCT00880555|42027536|FG002|Overall Study|Withdrawal by Subject|0|||
19578837|NCT00880555|42027537|FG003|Overall Study|Withdrawal by Subject|0|||
19578838|NCT00880555|42027538|FG004|Overall Study|Withdrawal by Subject|0|||
19578839|NCT00880555|42027539|FG005|Overall Study|Withdrawal by Subject|0|||
19578840|NCT00880555|42027534|FG000|Overall Study|Lack of resources (hired rater)|9|||
19578841|NCT00880555|42027535|FG001|Overall Study|Lack of resources (hired rater)|7|||
19578842|NCT00880555|42027536|FG002|Overall Study|Lack of resources (hired rater)|5|||
19578843|NCT00880555|42027537|FG003|Overall Study|Lack of resources (hired rater)|0|||
19578844|NCT00880555|42027538|FG004|Overall Study|Lack of resources (hired rater)|0|||
19578845|NCT00880555|42027539|FG005|Overall Study|Lack of resources (hired rater)|0|||
19578846|NCT00880555|42027534|FG000|Overall Study|Death|0|||
19578847|NCT00880555|42027535|FG001|Overall Study|Death|0|||
19578848|NCT00880555|42027536|FG002|Overall Study|Death|0|||
19745883|NCT03529773|42193169|FG013|Overall Study|No longer meets eligibility criteria|0|||
19578849|NCT00880555|42027537|FG003|Overall Study|Death|0|||
19578850|NCT00880555|42027538|FG004|Overall Study|Death|0|||
19578851|NCT00880555|42027539|FG005|Overall Study|Death|1|||
19578852|NCT00880555|42027534|FG000|Overall Study|Lost to Follow-up|0|||
19578853|NCT00880555|42027535|FG001|Overall Study|Lost to Follow-up|1|||
19578854|NCT00880555|42027536|FG002|Overall Study|Lost to Follow-up|0|||
19578855|NCT00880555|42027537|FG003|Overall Study|Lost to Follow-up|0|||
19578856|NCT00880555|42027538|FG004|Overall Study|Lost to Follow-up|0|||
19578857|NCT00880555|42027539|FG005|Overall Study|Lost to Follow-up|0|||
19578858|NCT01208402|42027552|FG000|Overall Study|Withdrawal by Subject|1|||
19578859|NCT01208402|42027553|FG001|Overall Study|Withdrawal by Subject|0|||
19578860|NCT01208324|42027563|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
19578861|NCT01208324|42027564|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
19578862|NCT01208324|42027565|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
19578863|NCT01208324|42027566|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
19578864|NCT00880399|42027579|FG000|Overall Study|Adverse Event|4|||
19578865|NCT00880399|42027580|FG001|Overall Study|Adverse Event|6|||
19578866|NCT00880399|42027581|FG002|Overall Study|Adverse Event|5|||
19578867|NCT00880399|42027579|FG000|Overall Study|Lack of Efficacy|1|||
19578868|NCT00880399|42027580|FG001|Overall Study|Lack of Efficacy|4|||
19578869|NCT00880399|42027581|FG002|Overall Study|Lack of Efficacy|2|||
19578870|NCT00880399|42027579|FG000|Overall Study|Protocol Violation|4|||
19578871|NCT00880399|42027580|FG001|Overall Study|Protocol Violation|4|||
19578872|NCT00880399|42027581|FG002|Overall Study|Protocol Violation|6|||
19578873|NCT00880399|42027579|FG000|Overall Study|Study closed/terminated|3|||
19578874|NCT00880399|42027580|FG001|Overall Study|Study closed/terminated|7|||
19578875|NCT00880399|42027581|FG002|Overall Study|Study closed/terminated|4|||
19578876|NCT00880399|42027579|FG000|Overall Study|Lost to Follow-up|8|||
19578877|NCT00880399|42027580|FG001|Overall Study|Lost to Follow-up|5|||
19578878|NCT00880399|42027581|FG002|Overall Study|Lost to Follow-up|3|||
19578879|NCT00880399|42027579|FG000|Overall Study|Physician Decision|5|||
19578880|NCT00880399|42027580|FG001|Overall Study|Physician Decision|0|||
19578881|NCT00880399|42027581|FG002|Overall Study|Physician Decision|3|||
19578882|NCT00880399|42027579|FG000|Overall Study|Withdrawal by Subject|6|||
19578883|NCT00880399|42027580|FG001|Overall Study|Withdrawal by Subject|3|||
19578884|NCT00880399|42027581|FG002|Overall Study|Withdrawal by Subject|3|||
19578885|NCT01207388|42027589|FG000|Overall Study|Death|67|||
19578886|NCT01207388|42027589|FG000|Overall Study|Withdrawal by Subject|1|||
19578887|NCT01206764|42027601|FG000|Overall Study|Adverse Event|20|||
19578888|NCT01206764|42027601|FG000|Overall Study|Abnormal laboratory value|2|||
19578889|NCT01206764|42027601|FG000|Overall Study|Abnormal test procedure result|1|||
19578890|NCT01206764|42027601|FG000|Overall Study|Patient withdrew consent|5|||
19578891|NCT01206764|42027601|FG000|Overall Study|Lost to Follow-up|6|||
19578892|NCT01206764|42027601|FG000|Overall Study|Death|11|||
19578893|NCT01206764|42027601|FG000|Overall Study|New cancer therapy|2|||
19578894|NCT01206764|42027601|FG000|Overall Study|Disease progression|88|||
19578895|NCT01206764|42027601|FG000|Overall Study|Protocol deviation|3|||
19608673|NCT01942135|42057668|FG000|Overall Study|Randomized Not Treated|2|||
19608674|NCT01942135|42057669|FG001|Overall Study|Randomized Not Treated|2|||
19608675|NCT01942135|42057668|FG000|Overall Study|Death|0|||
19608676|NCT01942135|42057669|FG001|Overall Study|Death|1|||
19608677|NCT01942135|42057668|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
19608678|NCT01942135|42057669|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
19608679|NCT01942135|42057668|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
19608680|NCT01942135|42057669|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
19608681|NCT01942135|42057668|FG000|Overall Study|Withdrawal by Subject|4|||
19608682|NCT01942135|42057669|FG001|Overall Study|Withdrawal by Subject|2|||
19608683|NCT01942135|42057668|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
19608684|NCT01942135|42057669|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
19608685|NCT01889238|42057675|FG000|Overall Study|Treatment ongoing|9|||
19608686|NCT01696968|42057698|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
19608687|NCT01696968|42057699|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
19608688|NCT01696968|42057698|FG000|Overall Study|Died Before Randomization|3|||
19608689|NCT01696968|42057699|FG001|Overall Study|Died Before Randomization|8|||
19608690|NCT01696968|42057698|FG000|Overall Study|Died Before ASU (Control)|278|||
19608691|NCT01696968|42057699|FG001|Overall Study|Died Before ASU (Control)|0|||
19608692|NCT01696968|42057698|FG000|Overall Study|Refused ASU (Control)|920|||
19608693|NCT01696968|42057699|FG001|Overall Study|Refused ASU (Control)|0|||
19608694|NCT01696968|42057698|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
19608695|NCT01696968|42057699|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
19608696|NCT00539591|42057714|FG000|Overall Study|Toxicity|3|||
19608697|NCT00539591|42057715|FG001|Overall Study|Toxicity|0|||
19608698|NCT00539591|42057716|FG002|Overall Study|Toxicity|0|||
19578896|NCT00894322|42027608|FG000|Overall Study|Withdrawal by Subject|1|||
19578897|NCT00894322|42027609|FG001|Overall Study|Withdrawal by Subject|0|||
19578898|NCT00894322|42027610|FG002|Overall Study|Withdrawal by Subject|0|||
19578899|NCT00596635|42027623|FG000|Overall Study|Lost to Follow-up|0|||
19578900|NCT00596635|42027624|FG001|Overall Study|Lost to Follow-up|2|||
19578901|NCT00596635|42027625|FG002|Overall Study|Lost to Follow-up|0|||
19578902|NCT00596635|42027623|FG000|Overall Study|Treatment for symptomatic UTI|4|||
19578903|NCT00596635|42027624|FG001|Overall Study|Treatment for symptomatic UTI|6|||
19578904|NCT00596635|42027625|FG002|Overall Study|Treatment for symptomatic UTI|3|||
19578905|NCT00596635|42027623|FG000|Overall Study|Hip fracture|2|||
19578906|NCT00596635|42027624|FG001|Overall Study|Hip fracture|3|||
19578907|NCT00596635|42027625|FG002|Overall Study|Hip fracture|3|||
19578908|NCT00596635|42027623|FG000|Overall Study|Could not provide urine specimen|1|||
19578909|NCT00596635|42027624|FG001|Overall Study|Could not provide urine specimen|2|||
19578910|NCT00596635|42027625|FG002|Overall Study|Could not provide urine specimen|2|||
19578911|NCT00894166|42027641|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
19578912|NCT00894166|42027642|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
19578913|NCT00894166|42027643|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
19578914|NCT00894166|42027644|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
19578915|NCT00894166|42027645|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
19578916|NCT00894166|42027646|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
19578917|NCT00894166|42027647|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
19578918|NCT00894166|42027648|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
19578919|NCT00894166|42027641|FG000|Overall Study|Death|0|||
19578920|NCT00894166|42027642|FG001|Overall Study|Death|0|||
19578921|NCT00894166|42027643|FG002|Overall Study|Death|0|||
19578922|NCT00894166|42027644|FG003|Overall Study|Death|1|||
19578923|NCT00894166|42027645|FG004|Overall Study|Death|0|||
19578924|NCT00894166|42027646|FG005|Overall Study|Death|0|||
19578925|NCT00894166|42027647|FG006|Overall Study|Death|0|||
19578926|NCT00894166|42027648|FG007|Overall Study|Death|0|||
19578927|NCT00880165|42027673|FG000|Overall Study|Withdrawal by Subject|27|||
19578928|NCT00880165|42027674|FG001|Overall Study|Withdrawal by Subject|23|||
19578929|NCT00880165|42027673|FG000|Overall Study|Not diagnosed with OSA|14|||
19578930|NCT00880165|42027674|FG001|Overall Study|Not diagnosed with OSA|8|||
19578931|NCT00880165|42027673|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
19578932|NCT00880165|42027674|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
19578933|NCT00880165|42027673|FG000|Overall Study|Lost to follow|9|||
19578934|NCT00880165|42027674|FG001|Overall Study|Lost to follow|15|||
19578935|NCT01165229|42027682|FG000|Overall Study|Serious Adverse Event|456|||
19578936|NCT01165229|42027683|FG001|Overall Study|Serious Adverse Event|487|||
19578937|NCT01165229|42027682|FG000|Overall Study|Non-Serious Adverse Event|47|||
19578938|NCT01165229|42027683|FG001|Overall Study|Non-Serious Adverse Event|15|||
19578939|NCT01165229|42027682|FG000|Overall Study|Protocol Violation|6|||
19578940|NCT01165229|42027683|FG001|Overall Study|Protocol Violation|8|||
19578941|NCT01165229|42027682|FG000|Overall Study|Withdrawal by Subject|387|||
19578942|NCT01165229|42027683|FG001|Overall Study|Withdrawal by Subject|396|||
19578943|NCT01165229|42027682|FG000|Overall Study|Migrated/moved from study area|51|||
19578944|NCT01165229|42027683|FG001|Overall Study|Migrated/moved from study area|46|||
19578945|NCT01165229|42027682|FG000|Overall Study|Lost to Follow-up|123|||
19578946|NCT01165229|42027683|FG001|Overall Study|Lost to Follow-up|133|||
19578947|NCT01165229|42027682|FG000|Overall Study|Suspected HZ Episode|2|||
19578948|NCT01165229|42027683|FG001|Overall Study|Suspected HZ Episode|2|||
19578949|NCT01165229|42027682|FG000|Overall Study|No reason from the subject|108|||
19578950|NCT01165229|42027683|FG001|Overall Study|No reason from the subject|102|||
19578951|NCT01165229|42027682|FG000|Overall Study|Unknown completion status|0|||
19578952|NCT01165229|42027683|FG001|Overall Study|Unknown completion status|1|||
19578953|NCT00596011|42027721|FG000|Overall Study|Withdrawal by Subject|2|||
19578954|NCT00596011|42027722|FG001|Overall Study|Withdrawal by Subject|3|||
19578955|NCT00596011|42027721|FG000|Overall Study|Adverse Event|11|||
19578956|NCT00596011|42027722|FG001|Overall Study|Adverse Event|7|||
19578957|NCT01163747|42027730|FG000|Overall Study|Adverse Event|0|||
19578958|NCT01163747|42027731|FG001|Overall Study|Adverse Event|5|||
19578959|NCT01163747|42027730|FG000|Overall Study|Insufficient Therapeutic Response|0|||
19578960|NCT01163747|42027731|FG001|Overall Study|Insufficient Therapeutic Response|1|||
19578961|NCT01163747|42027730|FG000|Overall Study|Protocol Violation|0|||
19578962|NCT01163747|42027731|FG001|Overall Study|Protocol Violation|1|||
19578963|NCT01163747|42027730|FG000|Overall Study|Refused Treatment|6|||
19578964|NCT01163747|42027731|FG001|Overall Study|Refused Treatment|4|||
19578965|NCT01163279|42027739|FG000|Overall Study|Withdrawal by Subject|2|||
19578966|NCT01163279|42027740|FG001|Overall Study|Withdrawal by Subject|0|||
19578967|NCT01162499|42027747|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
19578968|NCT01162499|42027748|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
19578969|NCT01206140|42027758|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
19578970|NCT01206140|42027759|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
19578971|NCT01162421|42027767|FG000|Overall Study|Did not receive study drug|2|||
19578972|NCT01162421|42027768|FG001|Overall Study|Did not receive study drug|1|||
19578973|NCT01162421|42027767|FG000|Overall Study|Adverse Event|2|||
19578974|NCT01162421|42027768|FG001|Overall Study|Adverse Event|5|||
19578975|NCT01162421|42027767|FG000|Overall Study|Lost to Follow-up|0|||
19578976|NCT01162421|42027768|FG001|Overall Study|Lost to Follow-up|2|||
19578977|NCT01162421|42027767|FG000|Overall Study|Lack of Efficacy|2|||
19578978|NCT01162421|42027768|FG001|Overall Study|Lack of Efficacy|2|||
19578979|NCT01162421|42027767|FG000|Overall Study|Other|2|||
19578980|NCT01162421|42027768|FG001|Overall Study|Other|3|||
19578981|NCT01162343|42027774|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
19578982|NCT01162343|42027774|FG000|Overall Study|Refused psychiatrist assessment|12|||
19578983|NCT01188551|42027782|FG000|Overall Study|Pharmacy issues|1|||
19578984|NCT01188551|42027783|FG001|Overall Study|Pharmacy issues|0|||
19578985|NCT01188551|42027784|FG002|Overall Study|Pharmacy issues|0|||
19578986|NCT01188551|42027785|FG003|Overall Study|Pharmacy issues|0|||
19578987|NCT01161407|42027797|FG000|Overall Study|Protocol Violation|3|||
19578988|NCT01161407|42027798|FG001|Overall Study|Protocol Violation|1|||
19578989|NCT01161173|42027804|FG000|Overall Study|Protocol Violation|13|||
19578990|NCT01161173|42027804|FG000|Overall Study|Lost to Follow-up|7|||
19578991|NCT01161173|42027804|FG000|Overall Study|Progressive Disease|82|||
19578992|NCT01161173|42027804|FG000|Overall Study|Withdrawal of Consent|5|||
19578993|NCT01161173|42027804|FG000|Overall Study|Unacceptable Toxicity|21|||
19578994|NCT01161173|42027804|FG000|Overall Study|Death|194|||
19578995|NCT01161173|42027804|FG000|Overall Study|End of Study|2|||
19578996|NCT01161173|42027804|FG000|Overall Study|Reasons Not Specified|23|||
19578997|NCT01159769|42027808|FG000|Overall Study|Adverse Event|1|||
19578998|NCT01159691|42027812|FG000|Overall Study|Lost to Follow-up|2|||
19578999|NCT01159691|42027812|FG000|Overall Study|Unknown reasons|1|||
19579000|NCT01159691|42027812|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
19579001|NCT01159691|42027812|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
19579002|NCT01159691|42027812|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
19579003|NCT01159691|42027812|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
19579004|NCT01159691|42027812|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
19579005|NCT01159691|42027812|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
19579006|NCT01157897|42027820|FG000|Overall Study|Lost to Follow-up|2|||
19579007|NCT01157897|42027821|FG001|Overall Study|Lost to Follow-up|0|||
19579008|NCT01157897|42027822|FG002|Overall Study|Lost to Follow-up|0|||
19579009|NCT01157897|42027823|FG003|Overall Study|Lost to Follow-up|1|||
19579010|NCT01157897|42027820|FG000|Overall Study|Relocated|0|||
19579011|NCT01157897|42027821|FG001|Overall Study|Relocated|2|||
19579012|NCT01157897|42027822|FG002|Overall Study|Relocated|0|||
19579013|NCT01157897|42027823|FG003|Overall Study|Relocated|0|||
19579014|NCT01185821|42027838|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19579015|NCT01185821|42027839|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19579016|NCT01185821|42027840|FG002|Overall Study|Abnormal laboratory value(s)|1|||
19579017|NCT01185821|42027841|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19579018|NCT01185821|42027842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
19579019|NCT01185821|42027838|FG000|Overall Study|Protocol Violation|0|||
19579020|NCT01185821|42027839|FG001|Overall Study|Protocol Violation|0|||
19579021|NCT01185821|42027840|FG002|Overall Study|Protocol Violation|0|||
19579022|NCT01185821|42027841|FG003|Overall Study|Protocol Violation|1|||
19579023|NCT01185821|42027842|FG004|Overall Study|Protocol Violation|1|||
19579024|NCT01185821|42027838|FG000|Overall Study|Abnormal test procedure result|0|||
19579025|NCT01185821|42027839|FG001|Overall Study|Abnormal test procedure result|0|||
19579026|NCT01185821|42027840|FG002|Overall Study|Abnormal test procedure result|0|||
19579027|NCT01185821|42027841|FG003|Overall Study|Abnormal test procedure result|0|||
19579028|NCT01185821|42027842|FG004|Overall Study|Abnormal test procedure result|1|||
19579029|NCT01185821|42027838|FG000|Overall Study|Death|0|||
19579030|NCT01185821|42027839|FG001|Overall Study|Death|1|||
19579031|NCT01185821|42027840|FG002|Overall Study|Death|0|||
19579032|NCT01185821|42027841|FG003|Overall Study|Death|0|||
19579033|NCT01185821|42027842|FG004|Overall Study|Death|0|||
19579034|NCT01185821|42027838|FG000|Overall Study|Condition no longer required study drug|0|||
19579035|NCT01185821|42027839|FG001|Overall Study|Condition no longer required study drug|0|||
19579036|NCT01185821|42027840|FG002|Overall Study|Condition no longer required study drug|0|||
19579037|NCT01185821|42027841|FG003|Overall Study|Condition no longer required study drug|0|||
19579038|NCT01185821|42027842|FG004|Overall Study|Condition no longer required study drug|1|||
19579039|NCT01185821|42027838|FG000|Overall Study|Adverse Event|2|||
19579040|NCT01185821|42027839|FG001|Overall Study|Adverse Event|3|||
19579041|NCT01185821|42027840|FG002|Overall Study|Adverse Event|1|||
19579042|NCT01185821|42027841|FG003|Overall Study|Adverse Event|2|||
19579043|NCT01185821|42027842|FG004|Overall Study|Adverse Event|5|||
19579044|NCT01185821|42027838|FG000|Overall Study|Lack of Efficacy|0|||
19579045|NCT01185821|42027839|FG001|Overall Study|Lack of Efficacy|0|||
19579046|NCT01185821|42027840|FG002|Overall Study|Lack of Efficacy|3|||
19579047|NCT01185821|42027841|FG003|Overall Study|Lack of Efficacy|0|||
19579048|NCT01185821|42027842|FG004|Overall Study|Lack of Efficacy|9|||
19579049|NCT01185821|42027838|FG000|Overall Study|Withdrawal by Subject|3|||
19579050|NCT01185821|42027839|FG001|Overall Study|Withdrawal by Subject|2|||
19579051|NCT01185821|42027840|FG002|Overall Study|Withdrawal by Subject|2|||
19579052|NCT01185821|42027841|FG003|Overall Study|Withdrawal by Subject|1|||
19579053|NCT01185821|42027842|FG004|Overall Study|Withdrawal by Subject|3|||
19579054|NCT01185821|42027838|FG000|Overall Study|Lost to Follow-up|1|||
19579055|NCT01185821|42027839|FG001|Overall Study|Lost to Follow-up|1|||
19579056|NCT01185821|42027840|FG002|Overall Study|Lost to Follow-up|2|||
19579057|NCT01185821|42027841|FG003|Overall Study|Lost to Follow-up|1|||
19579058|NCT01185821|42027842|FG004|Overall Study|Lost to Follow-up|2|||
19579059|NCT01185821|42027838|FG000|Overall Study|Administrative problems|0|||
19579060|NCT01185821|42027839|FG001|Overall Study|Administrative problems|0|||
19579061|NCT01185821|42027840|FG002|Overall Study|Administrative problems|1|||
19579062|NCT01185821|42027841|FG003|Overall Study|Administrative problems|1|||
19579063|NCT01185821|42027842|FG004|Overall Study|Administrative problems|2|||
19579064|NCT00893464|42027864|FG000|Overall Study|Did not complete therapy/experience PD|0|||
19579065|NCT00893464|42027865|FG001|Overall Study|Did not complete therapy/experience PD|0|||
19579066|NCT00893464|42027866|FG002|Overall Study|Did not complete therapy/experience PD|0|||
19579067|NCT00893464|42027867|FG003|Overall Study|Did not complete therapy/experience PD|0|||
19579068|NCT00893464|42027868|FG004|Overall Study|Did not complete therapy/experience PD|0|||
19579069|NCT00893464|42027869|FG005|Overall Study|Did not complete therapy/experience PD|0|||
19579070|NCT00893464|42027870|FG006|Overall Study|Did not complete therapy/experience PD|2|||
19579071|NCT00893464|42027871|FG007|Overall Study|Did not complete therapy/experience PD|2|||
19579072|NCT00891904|42027894|FG000|Overall Study|Death|1|||
19579073|NCT00891904|42027894|FG000|Overall Study|Adverse Event|1|||
19579074|NCT01157351|42027900|FG000|Overall Study|Adverse Event|5|||
19579075|NCT01157351|42027901|FG001|Overall Study|Adverse Event|4|||
19579076|NCT01157351|42027900|FG000|Overall Study|Death|1|||
19579077|NCT01157351|42027901|FG001|Overall Study|Death|0|||
19579078|NCT01157351|42027900|FG000|Overall Study|Lost to Follow-up|53|||
19579079|NCT01157351|42027901|FG001|Overall Study|Lost to Follow-up|55|||
19579080|NCT01157351|42027900|FG000|Overall Study|Withdrawal by Subject|37|||
19579081|NCT01157351|42027901|FG001|Overall Study|Withdrawal by Subject|27|||
19579082|NCT01157351|42027900|FG000|Overall Study|Physician Decision|5|||
19579083|NCT01157351|42027901|FG001|Overall Study|Physician Decision|4|||
19579084|NCT01157351|42027900|FG000|Overall Study|Protocol Violation|0|||
19579085|NCT01157351|42027901|FG001|Overall Study|Protocol Violation|1|||
19579086|NCT01157351|42027900|FG000|Overall Study|Other|32|||
19579087|NCT01157351|42027901|FG001|Overall Study|Other|36|||
19579088|NCT01157351|42027900|FG000|Overall Study|Noncompliance with Study Drug|0|||
19579089|NCT01157351|42027901|FG001|Overall Study|Noncompliance with Study Drug|3|||
19579090|NCT01157351|42027900|FG000|Overall Study|Randomized but not Treated|4|||
19579091|NCT01157351|42027901|FG001|Overall Study|Randomized but not Treated|2|||
19579092|NCT01157117|42027910|FG000|Overall Study|Dosing Symptoms|0|||
19579093|NCT01157117|42027911|FG001|Overall Study|Dosing Symptoms|4|||
19579094|NCT01157117|42027912|FG002|Overall Study|Dosing Symptoms|0|||
19579095|NCT01157117|42027910|FG000|Overall Study|Withdrawal by Subject|4|||
19579096|NCT01157117|42027911|FG001|Overall Study|Withdrawal by Subject|1|||
19579097|NCT01157117|42027912|FG002|Overall Study|Withdrawal by Subject|1|||
19579098|NCT01157117|42027910|FG000|Overall Study|Lack of Efficacy|1|||
19579099|NCT01157117|42027911|FG001|Overall Study|Lack of Efficacy|1|||
19579100|NCT01157117|42027912|FG002|Overall Study|Lack of Efficacy|0|||
19579101|NCT01157117|42027910|FG000|Overall Study|Lost to Follow-up|0|||
19579102|NCT01157117|42027911|FG001|Overall Study|Lost to Follow-up|0|||
19579103|NCT01157117|42027912|FG002|Overall Study|Lost to Follow-up|1|||
19579104|NCT01157117|42027910|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
19579105|NCT01157117|42027911|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
19579106|NCT01157117|42027912|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
19579107|NCT00891202|42027922|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
19579108|NCT00891202|42027923|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
19579109|NCT00891202|42027924|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
19579110|NCT00891202|42027925|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
19579111|NCT00891202|42027922|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
19579112|NCT00891202|42027923|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
19579113|NCT00891202|42027924|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
19579114|NCT00891202|42027925|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
19579115|NCT00891202|42027922|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
19579116|NCT00891202|42027923|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
19579117|NCT00891202|42027924|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
19579118|NCT00891202|42027925|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
19579119|NCT00891202|42027922|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
19579120|NCT00891202|42027923|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
19579121|NCT00891202|42027924|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
19579122|NCT00891202|42027925|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
19579123|NCT01185509|42027935|FG000|Overall Study|Progression/Relapse|9|||
19579124|NCT01185509|42027936|FG001|Overall Study|Progression/Relapse|15|||
19579125|NCT01185509|42027935|FG000|Overall Study|Physician Decision|2|||
19579126|NCT01185509|42027936|FG001|Overall Study|Physician Decision|2|||
19579127|NCT01185509|42027935|FG000|Overall Study|Withdrawal by Subject|0|||
19579128|NCT01185509|42027936|FG001|Overall Study|Withdrawal by Subject|1|||
19579129|NCT01185509|42027935|FG000|Overall Study|Death|0|||
19579130|NCT01185509|42027936|FG001|Overall Study|Death|1|||
19579131|NCT01185509|42027935|FG000|Overall Study|Intercurrent Illness|0|||
19579132|NCT01185509|42027936|FG001|Overall Study|Intercurrent Illness|1|||
19579133|NCT00891046|42027948|FG000|Overall Study|Protocol Violation|1|||
19579134|NCT00891046|42027949|FG001|Overall Study|Protocol Violation|1|||
19579135|NCT00891046|42027950|FG002|Overall Study|Protocol Violation|0|||
19579136|NCT00891046|42027951|FG003|Overall Study|Protocol Violation|0|||
19579137|NCT00891046|42027952|FG004|Overall Study|Protocol Violation|1|||
19579138|NCT00891046|42027948|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
19579139|NCT00891046|42027949|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19579140|NCT00891046|42027950|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
19579141|NCT00891046|42027951|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
19579142|NCT00891046|42027952|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
19579143|NCT00891046|42027948|FG000|Overall Study|Administrative problems|0|||
19579144|NCT00891046|42027949|FG001|Overall Study|Administrative problems|0|||
19579145|NCT00891046|42027950|FG002|Overall Study|Administrative problems|0|||
19579146|NCT00891046|42027951|FG003|Overall Study|Administrative problems|0|||
19579147|NCT00891046|42027952|FG004|Overall Study|Administrative problems|1|||
19579148|NCT00891046|42027948|FG000|Overall Study|Participant no longer required drug|0|||
19579149|NCT00891046|42027949|FG001|Overall Study|Participant no longer required drug|2|||
19579150|NCT00891046|42027950|FG002|Overall Study|Participant no longer required drug|0|||
19579151|NCT00891046|42027951|FG003|Overall Study|Participant no longer required drug|0|||
19579152|NCT00891046|42027952|FG004|Overall Study|Participant no longer required drug|1|||
19579153|NCT00891046|42027948|FG000|Overall Study|Adverse Event|4|||
19579154|NCT00891046|42027949|FG001|Overall Study|Adverse Event|3|||
19579155|NCT00891046|42027950|FG002|Overall Study|Adverse Event|2|||
19579156|NCT00891046|42027951|FG003|Overall Study|Adverse Event|0|||
19579157|NCT00891046|42027952|FG004|Overall Study|Adverse Event|14|||
19579158|NCT00891046|42027948|FG000|Overall Study|Withdrawal by Subject|2|||
19579159|NCT00891046|42027949|FG001|Overall Study|Withdrawal by Subject|1|||
19579160|NCT00891046|42027950|FG002|Overall Study|Withdrawal by Subject|2|||
19579161|NCT00891046|42027951|FG003|Overall Study|Withdrawal by Subject|1|||
19579162|NCT00891046|42027952|FG004|Overall Study|Withdrawal by Subject|1|||
19579163|NCT00891046|42027948|FG000|Overall Study|Lost to Follow-up|0|||
19579164|NCT00891046|42027949|FG001|Overall Study|Lost to Follow-up|0|||
19579165|NCT00891046|42027950|FG002|Overall Study|Lost to Follow-up|0|||
19579166|NCT00891046|42027951|FG003|Overall Study|Lost to Follow-up|0|||
19579167|NCT00891046|42027952|FG004|Overall Study|Lost to Follow-up|1|||
19579168|NCT00889720|42027979|FG000|Overall Study|Withdrawal by Subject|4|||
19579169|NCT00889720|42027979|FG000|Overall Study|Other|4|||
19579170|NCT01116648|42027998|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
19579171|NCT01116648|42027999|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
19579172|NCT01116648|42028000|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
19579173|NCT01116648|42028001|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
19579174|NCT01116648|42028002|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
19579175|NCT01116648|42028003|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
19579176|NCT01116648|42028004|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
19579177|NCT01116648|42028005|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
19579178|NCT01116648|42028006|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
19579179|NCT01116648|42028007|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
19579180|NCT01116648|42028008|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
19579181|NCT01116648|42028009|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
19579182|NCT01116648|42028010|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
19579183|NCT01116648|42028011|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
19579184|NCT01116648|42028012|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
19579185|NCT00880087|42028039|FG000|Overall Study|Lost to Follow-up|0|||
19387826|NCT01625338|41631148|FG001|Overall Study|Adverse Event|0|||
19387827|NCT01625338|41631149|FG002|Overall Study|Adverse Event|1|||
19579186|NCT00880087|42028040|FG001|Overall Study|Lost to Follow-up|2|||
19579187|NCT00889252|42028048|FG000|Overall Study|Adverse Event|2|||
19579188|NCT00889252|42028049|FG001|Overall Study|Adverse Event|4|||
19579189|NCT00889252|42028048|FG000|Overall Study|Withdrawal by Subject|3|||
19579190|NCT00889252|42028049|FG001|Overall Study|Withdrawal by Subject|0|||
19579191|NCT00889252|42028048|FG000|Overall Study|Protocol Violation|2|||
19579192|NCT00889252|42028049|FG001|Overall Study|Protocol Violation|0|||
19579193|NCT01110330|42028058|FG000|Overall Study|Adverse Event|0|||
19579194|NCT01110330|42028059|FG001|Overall Study|Adverse Event|4|||
19579195|NCT01110330|42028060|FG002|Overall Study|Adverse Event|3|||
19579196|NCT01110330|42028058|FG000|Overall Study|Lack of Efficacy|3|||
19579197|NCT01110330|42028059|FG001|Overall Study|Lack of Efficacy|1|||
19579198|NCT01110330|42028060|FG002|Overall Study|Lack of Efficacy|1|||
19579199|NCT01110330|42028058|FG000|Overall Study|Lost to Follow-up|9|||
19579200|NCT01110330|42028059|FG001|Overall Study|Lost to Follow-up|10|||
19579201|NCT01110330|42028060|FG002|Overall Study|Lost to Follow-up|15|||
19579202|NCT01110330|42028058|FG000|Overall Study|Physician Decision|0|||
19579203|NCT01110330|42028059|FG001|Overall Study|Physician Decision|1|||
19579204|NCT01110330|42028060|FG002|Overall Study|Physician Decision|0|||
19579205|NCT01110330|42028058|FG000|Overall Study|Protocol Violation|2|||
19579206|NCT01110330|42028059|FG001|Overall Study|Protocol Violation|0|||
19579207|NCT01110330|42028060|FG002|Overall Study|Protocol Violation|4|||
19579208|NCT01110330|42028058|FG000|Overall Study|Withdrawal by Subject|0|||
19579209|NCT01110330|42028059|FG001|Overall Study|Withdrawal by Subject|6|||
19579210|NCT01110330|42028060|FG002|Overall Study|Withdrawal by Subject|2|||
19579211|NCT01110330|42028058|FG000|Overall Study|Other|1|||
19579212|NCT01110330|42028059|FG001|Overall Study|Other|1|||
19579213|NCT01110330|42028060|FG002|Overall Study|Other|1|||
19579214|NCT00596947|42028070|FG000|Overall Study|study halted due to low enrollment|5|||
19579215|NCT00596947|42028071|FG001|Overall Study|study halted due to low enrollment|3|||
19579216|NCT00596947|42028070|FG000|Overall Study|Lost to Follow-up|1|||
19579217|NCT00596947|42028071|FG001|Overall Study|Lost to Follow-up|0|||
19579218|NCT00888940|42028079|FG000|Overall Study|Adverse Event|12|||
19579219|NCT00888940|42028080|FG001|Overall Study|Adverse Event|3|||
19579220|NCT00888940|42028079|FG000|Overall Study|Lost to Follow-up|5|||
19579221|NCT00888940|42028080|FG001|Overall Study|Lost to Follow-up|5|||
19579222|NCT00888940|42028079|FG000|Overall Study|Randomized Not Treated|11|||
19579223|NCT00888940|42028080|FG001|Overall Study|Randomized Not Treated|13|||
19579224|NCT00595621|42028088|FG000|Open Label Run in|Adverse Event|1|||
19579225|NCT00595621|42028089|FG001|Open Label Run in|Adverse Event|0|||
19579226|NCT00595621|42028088|FG000|Open Label Run in|Physician Decision|1|||
19579227|NCT00595621|42028089|FG001|Open Label Run in|Physician Decision|0|||
19579228|NCT00595621|42028088|FG000|Open Label Run in|Withdrawal by Subject|1|||
19579229|NCT00595621|42028089|FG001|Open Label Run in|Withdrawal by Subject|0|||
19579230|NCT00595621|42028088|FG000|Randomization and Study|Adverse Event|2|||
19579231|NCT00595621|42028089|FG001|Randomization and Study|Adverse Event|0|||
19579232|NCT00595621|42028088|FG000|Randomization and Study|Withdrawal by Subject|0|||
19579233|NCT00595621|42028089|FG001|Randomization and Study|Withdrawal by Subject|1|||
19579234|NCT00888238|42028096|FG000|Washout Period After Period 2|Adverse Event|0|||
19579235|NCT00888238|42028097|FG001|Washout Period After Period 2|Adverse Event|0|||
19579236|NCT00888238|42028098|FG002|Washout Period After Period 2|Adverse Event|1|||
19579237|NCT00595465|42028107|FG000|Overall Study|Adverse Event|4|||
19579238|NCT00595465|42028108|FG001|Overall Study|Adverse Event|3|||
19579239|NCT00595465|42028109|FG002|Overall Study|Adverse Event|3|||
19579240|NCT00595465|42028107|FG000|Overall Study|Pregnancy|0|||
19579241|NCT00595465|42028108|FG001|Overall Study|Pregnancy|0|||
19579242|NCT00595465|42028109|FG002|Overall Study|Pregnancy|1|||
19387828|NCT01625338|41631147|FG000|Overall Study|Study Discontinued by Sponsor|0|||
19579243|NCT00595465|42028107|FG000|Overall Study|Protocol Violation|2|||
19579244|NCT00595465|42028108|FG001|Overall Study|Protocol Violation|1|||
19579245|NCT00595465|42028109|FG002|Overall Study|Protocol Violation|0|||
19579246|NCT00595465|42028107|FG000|Overall Study|Lost to Follow-up|0|||
19579247|NCT00595465|42028108|FG001|Overall Study|Lost to Follow-up|0|||
19579248|NCT00595465|42028109|FG002|Overall Study|Lost to Follow-up|2|||
19579249|NCT00595465|42028107|FG000|Overall Study|administrative reason|0|||
19579250|NCT00595465|42028108|FG001|Overall Study|administrative reason|0|||
19579251|NCT00595465|42028109|FG002|Overall Study|administrative reason|1|||
19579252|NCT01205438|42028120|FG000|Overall Study|Adverse Event|19|||
19579253|NCT01205438|42028121|FG001|Overall Study|Adverse Event|17|||
19639248|NCT00723554|42088653|FG000|Overall Study|Adverse Event|12|||
19639249|NCT00723554|42088653|FG000|Overall Study|Investigator's judgement|5|||
19639250|NCT00723554|42088653|FG000|Overall Study|Inhaled medication other than iloprost|4|||
19639251|NCT00723554|42088653|FG000|Overall Study|Withdrawal of consent|3|||
19639252|NCT00723554|42088653|FG000|Overall Study|Other|3|||
19579254|NCT01205438|42028122|FG002|Overall Study|Adverse Event|24|||
19579255|NCT01205438|42028120|FG000|Overall Study|Death|1|||
19579256|NCT01205438|42028121|FG001|Overall Study|Death|1|||
19579257|NCT01205438|42028122|FG002|Overall Study|Death|3|||
19579258|NCT01205438|42028120|FG000|Overall Study|Entry Criteria Not Met|16|||
19579259|NCT01205438|42028121|FG001|Overall Study|Entry Criteria Not Met|15|||
19579260|NCT01205438|42028122|FG002|Overall Study|Entry Criteria Not Met|13|||
19579261|NCT01205438|42028120|FG000|Overall Study|Lack of Efficacy|14|||
19579262|NCT01205438|42028121|FG001|Overall Study|Lack of Efficacy|11|||
19579263|NCT01205438|42028122|FG002|Overall Study|Lack of Efficacy|14|||
19579264|NCT01205438|42028120|FG000|Overall Study|Lost to Follow-up|6|||
19579265|NCT01205438|42028121|FG001|Overall Study|Lost to Follow-up|7|||
19579266|NCT01205438|42028122|FG002|Overall Study|Lost to Follow-up|8|||
19579267|NCT01205438|42028120|FG000|Overall Study|Withdrawal by Subject|19|||
19579268|NCT01205438|42028121|FG001|Overall Study|Withdrawal by Subject|25|||
19579269|NCT01205438|42028122|FG002|Overall Study|Withdrawal by Subject|19|||
19579270|NCT01205438|42028120|FG000|Overall Study|Physician Decision|0|||
19579271|NCT01205438|42028121|FG001|Overall Study|Physician Decision|3|||
19579272|NCT01205438|42028122|FG002|Overall Study|Physician Decision|2|||
19579273|NCT01205438|42028120|FG000|Overall Study|Protocol Violation|2|||
19579274|NCT01205438|42028121|FG001|Overall Study|Protocol Violation|7|||
19579275|NCT01205438|42028122|FG002|Overall Study|Protocol Violation|4|||
19579276|NCT01205438|42028120|FG000|Overall Study|Sponsor Decision|0|||
19579277|NCT01205438|42028121|FG001|Overall Study|Sponsor Decision|1|||
19579278|NCT01205438|42028122|FG002|Overall Study|Sponsor Decision|1|||
19579279|NCT01104870|42028136|FG000|Overall Study|Adverse Event|1|||
19579280|NCT01104870|42028137|FG001|Overall Study|Adverse Event|1|||
19579281|NCT01104870|42028138|FG002|Overall Study|Adverse Event|0|||
19579282|NCT01104870|42028136|FG000|Overall Study|Death|0|||
19579283|NCT01104870|42028137|FG001|Overall Study|Death|0|||
19579284|NCT01104870|42028138|FG002|Overall Study|Death|1|||
19579285|NCT01104870|42028136|FG000|Overall Study|Withdrawal by Subject|0|||
19387829|NCT01625338|41631148|FG001|Overall Study|Study Discontinued by Sponsor|0|||
19579286|NCT01104870|42028137|FG001|Overall Study|Withdrawal by Subject|0|||
19579287|NCT01104870|42028138|FG002|Overall Study|Withdrawal by Subject|1|||
19579288|NCT01104792|42028146|FG000|Overall Study|Adverse Event|77|||
19579289|NCT01104792|42028146|FG000|Overall Study|Insufficient Therapeutic Response|22|||
19579290|NCT01104792|42028146|FG000|Overall Study|Protocol Violation|45|||
19579291|NCT01104792|42028146|FG000|Overall Study|Withdrawal of Consent|179|||
19579292|NCT01104792|42028146|FG000|Overall Study|Lost to Follow-up|43|||
19579293|NCT01104792|42028146|FG000|Overall Study|Reasons Not Specified|27|||
19579294|NCT01104792|42028146|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
19579295|NCT01205126|42028152|FG000|Titration Phase|Adverse Event|5|||
19579296|NCT01205126|42028153|FG001|Titration Phase|Adverse Event|3|||
19579297|NCT01205126|42028152|FG000|Titration Phase|Withdrawal by Subject|5|||
19579298|NCT01205126|42028153|FG001|Titration Phase|Withdrawal by Subject|5|||
19579299|NCT01205126|42028152|FG000|Titration Phase|Lost to Follow-up|2|||
19579300|NCT01205126|42028153|FG001|Titration Phase|Lost to Follow-up|2|||
19579301|NCT01205126|42028152|FG000|Titration Phase|No stable titration dose|1|||
19579302|NCT01205126|42028153|FG001|Titration Phase|No stable titration dose|0|||
19579303|NCT01205126|42028152|FG000|Titration Phase|More than maximum dosage required|2|||
19579304|NCT01205126|42028153|FG001|Titration Phase|More than maximum dosage required|3|||
19579305|NCT01205126|42028152|FG000|Titration Phase|Other|8|||
19579306|NCT01205126|42028153|FG001|Titration Phase|Other|6|||
19579307|NCT01205126|42028152|FG000|Between Titration & Maintenance Phase|Other|0|||
19579308|NCT01205126|42028153|FG001|Between Titration & Maintenance Phase|Other|4|||
19579309|NCT01205126|42028152|FG000|Maintenance Phase|Adverse Event|3|||
19579310|NCT01205126|42028153|FG001|Maintenance Phase|Adverse Event|7|||
19579311|NCT01205126|42028152|FG000|Maintenance Phase|Death|4|||
19579312|NCT01205126|42028153|FG001|Maintenance Phase|Death|4|||
19579313|NCT01205126|42028152|FG000|Maintenance Phase|More than the maximum dosage required|5|||
19579314|NCT01205126|42028153|FG001|Maintenance Phase|More than the maximum dosage required|5|||
19579315|NCT01205126|42028152|FG000|Maintenance Phase|Prohibited drugs used|1|||
19579316|NCT01205126|42028153|FG001|Maintenance Phase|Prohibited drugs used|0|||
19579317|NCT01205126|42028152|FG000|Maintenance Phase|Other|11|||
19579318|NCT01205126|42028153|FG001|Maintenance Phase|Other|8|||
19579319|NCT01205126|42028152|FG000|Maintenance Phase|Lost to Follow-up|5|||
19579320|NCT01205126|42028153|FG001|Maintenance Phase|Lost to Follow-up|5|||
19579321|NCT01205126|42028152|FG000|Maintenance Phase|Withdrawal by Subject|8|||
19579322|NCT01205126|42028153|FG001|Maintenance Phase|Withdrawal by Subject|11|||
19579323|NCT00946647|42028164|FG000|Phase 1 Part|Adverse Event|2|||
19579324|NCT00946647|42028165|FG001|Phase 1 Part|Adverse Event|5|||
19579325|NCT00946647|42028166|FG002|Phase 1 Part|Adverse Event|3|||
19579326|NCT00946647|42028167|FG003|Phase 1 Part|Adverse Event|0|||
19579327|NCT00946647|42028168|FG004|Phase 1 Part|Adverse Event|0|||
19579328|NCT00946647|42028164|FG000|Phase 1 Part|Disease progression|3|||
19579329|NCT00946647|42028165|FG001|Phase 1 Part|Disease progression|6|||
19579330|NCT00946647|42028166|FG002|Phase 1 Part|Disease progression|1|||
19579331|NCT00946647|42028167|FG003|Phase 1 Part|Disease progression|0|||
19387830|NCT01625338|41631149|FG002|Overall Study|Study Discontinued by Sponsor|1|||
19579332|NCT00946647|42028168|FG004|Phase 1 Part|Disease progression|0|||
19579333|NCT00946647|42028164|FG000|Phase 1 Part|Withdrawal by Subject|1|||
19579334|NCT00946647|42028165|FG001|Phase 1 Part|Withdrawal by Subject|4|||
19579335|NCT00946647|42028166|FG002|Phase 1 Part|Withdrawal by Subject|3|||
19579336|NCT00946647|42028167|FG003|Phase 1 Part|Withdrawal by Subject|0|||
19579337|NCT00946647|42028168|FG004|Phase 1 Part|Withdrawal by Subject|0|||
19387831|NCT02560623|41631161|FG000|Overall Study|Unable to swallow sponge|0|||
19579338|NCT00946647|42028164|FG000|Phase 1 Part|Abnormal values|0|||
19579339|NCT00946647|42028165|FG001|Phase 1 Part|Abnormal values|2|||
19579340|NCT00946647|42028166|FG002|Phase 1 Part|Abnormal values|0|||
19579341|NCT00946647|42028167|FG003|Phase 1 Part|Abnormal values|0|||
19579342|NCT00946647|42028168|FG004|Phase 1 Part|Abnormal values|0|||
19579343|NCT00946647|42028164|FG000|Phase 1 Part|Reason missing|0|||
19579344|NCT00946647|42028165|FG001|Phase 1 Part|Reason missing|1|||
19579345|NCT00946647|42028166|FG002|Phase 1 Part|Reason missing|0|||
19579346|NCT00946647|42028167|FG003|Phase 1 Part|Reason missing|0|||
19579347|NCT00946647|42028168|FG004|Phase 1 Part|Reason missing|0|||
19579348|NCT00946647|42028164|FG000|Phase ll Part|Untreated|0|||
19579349|NCT00946647|42028165|FG001|Phase ll Part|Untreated|0|||
19579350|NCT00946647|42028166|FG002|Phase ll Part|Untreated|0|||
19579351|NCT00946647|42028167|FG003|Phase ll Part|Untreated|0|||
19579352|NCT00946647|42028168|FG004|Phase ll Part|Untreated|2|||
19579353|NCT00946647|42028164|FG000|Phase ll Part|Adverse Event|0|||
19579354|NCT00946647|42028165|FG001|Phase ll Part|Adverse Event|0|||
19579355|NCT00946647|42028166|FG002|Phase ll Part|Adverse Event|0|||
19579356|NCT00946647|42028167|FG003|Phase ll Part|Adverse Event|10|||
19579357|NCT00946647|42028168|FG004|Phase ll Part|Adverse Event|6|||
19579358|NCT00946647|42028164|FG000|Phase ll Part|Withdrawal by Subject|0|||
19579359|NCT00946647|42028165|FG001|Phase ll Part|Withdrawal by Subject|0|||
19579360|NCT00946647|42028166|FG002|Phase ll Part|Withdrawal by Subject|0|||
19579361|NCT00946647|42028167|FG003|Phase ll Part|Withdrawal by Subject|8|||
19579362|NCT00946647|42028168|FG004|Phase ll Part|Withdrawal by Subject|6|||
19579363|NCT00946647|42028164|FG000|Phase ll Part|Administrative problems|0|||
19579364|NCT00946647|42028165|FG001|Phase ll Part|Administrative problems|0|||
19579365|NCT00946647|42028166|FG002|Phase ll Part|Administrative problems|0|||
19579366|NCT00946647|42028167|FG003|Phase ll Part|Administrative problems|3|||
19579367|NCT00946647|42028168|FG004|Phase ll Part|Administrative problems|8|||
19579368|NCT00946647|42028164|FG000|Phase ll Part|Death|0|||
19579369|NCT00946647|42028165|FG001|Phase ll Part|Death|0|||
19579370|NCT00946647|42028166|FG002|Phase ll Part|Death|0|||
19579371|NCT00946647|42028167|FG003|Phase ll Part|Death|7|||
19579372|NCT00946647|42028168|FG004|Phase ll Part|Death|4|||
19579373|NCT00946647|42028164|FG000|Phase ll Part|Disease progression|0|||
19579374|NCT00946647|42028165|FG001|Phase ll Part|Disease progression|0|||
19579375|NCT00946647|42028166|FG002|Phase ll Part|Disease progression|0|||
19579376|NCT00946647|42028167|FG003|Phase ll Part|Disease progression|6|||
19579377|NCT00946647|42028168|FG004|Phase ll Part|Disease progression|14|||
19579378|NCT00946647|42028164|FG000|Phase ll Part|Protocol Violation|0|||
19579379|NCT00946647|42028165|FG001|Phase ll Part|Protocol Violation|0|||
19579380|NCT00946647|42028166|FG002|Phase ll Part|Protocol Violation|0|||
19579381|NCT00946647|42028167|FG003|Phase ll Part|Protocol Violation|4|||
19579382|NCT00946647|42028168|FG004|Phase ll Part|Protocol Violation|2|||
19579383|NCT00946647|42028164|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
19579384|NCT00946647|42028165|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
19579385|NCT00946647|42028166|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
19579386|NCT00946647|42028167|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
19579387|NCT00946647|42028168|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
19579388|NCT00946101|42028183|FG000|Overall Study|Lost to Follow-up|2|||
19579389|NCT00946101|42028184|FG001|Overall Study|Lost to Follow-up|1|||
19579390|NCT00946101|42028183|FG000|Overall Study|Withdrawal of consent|2|||
19579391|NCT00946101|42028184|FG001|Overall Study|Withdrawal of consent|0|||
19579392|NCT00946101|42028183|FG000|Overall Study|Physician Decision|0|||
19579393|NCT00946101|42028184|FG001|Overall Study|Physician Decision|1|||
19579394|NCT01109940|42028198|FG000|Overall Study|Administrative problems|2|||
19579395|NCT01109940|42028199|FG001|Overall Study|Administrative problems|0|||
19579396|NCT01109940|42028200|FG002|Overall Study|Administrative problems|0|||
19579397|NCT01109940|42028201|FG003|Overall Study|Administrative problems|0|||
19579398|NCT01109940|42028198|FG000|Overall Study|Serious Adverse Event|2|||
19579399|NCT01109940|42028199|FG001|Overall Study|Serious Adverse Event|1|||
19579400|NCT01109940|42028200|FG002|Overall Study|Serious Adverse Event|0|||
19579401|NCT01109940|42028201|FG003|Overall Study|Serious Adverse Event|0|||
19579402|NCT01109940|42028198|FG000|Overall Study|Lost to Follow-up|1|||
19579403|NCT01109940|42028199|FG001|Overall Study|Lost to Follow-up|0|||
19579404|NCT01109940|42028200|FG002|Overall Study|Lost to Follow-up|0|||
19579405|NCT01109940|42028201|FG003|Overall Study|Lost to Follow-up|0|||
19579406|NCT01109940|42028198|FG000|Overall Study|Patient withdrew consent|1|||
19579407|NCT01109940|42028199|FG001|Overall Study|Patient withdrew consent|1|||
19579408|NCT01109940|42028200|FG002|Overall Study|Patient withdrew consent|0|||
19579409|NCT01109940|42028201|FG003|Overall Study|Patient withdrew consent|0|||
19579410|NCT01109940|42028198|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19579411|NCT01109940|42028199|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19579412|NCT01109940|42028200|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
19579413|NCT01109940|42028201|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
19579414|NCT00595309|42028211|FG000|Overall Study|Lost to Follow-up|1|||
19579415|NCT00595309|42028211|FG000|Overall Study|planned vaccination against yellow fever|1|||
19579416|NCT00595309|42028211|FG000|Overall Study|acute infection after V0|1|||
19579417|NCT00595309|42028211|FG000|Overall Study|personal reason|1|||
19579418|NCT00595075|42028217|FG000|Overall Study|Withdrawal by Subject|1|||
19579419|NCT00595075|42028218|FG001|Overall Study|Withdrawal by Subject|0|||
19579420|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
19579421|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
19579422|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
19579423|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
19579424|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
19579425|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
19579426|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
19579427|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
19579428|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
19579429|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
19579430|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
19579431|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
19579432|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Other|1|||
19579433|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Other|0|||
19579434|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Other|0|||
19579435|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
19579436|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
19387832|NCT02560623|41631162|FG001|Overall Study|Unable to swallow sponge|1|||
19579437|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
19579438|NCT00887224|42028227|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
19579439|NCT00887224|42028228|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
19579440|NCT00887224|42028229|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
19579441|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
19579442|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
19579443|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
19579444|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
19579445|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
19579446|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
19579447|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
19579448|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
19579449|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
19579450|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
19579451|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
19579452|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
19579453|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Other|1|||
19579454|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Other|0|||
19579455|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Other|0|||
19579456|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
19579457|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
19579458|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
19579459|NCT00887224|42028227|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
19579460|NCT00887224|42028228|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
19579461|NCT00887224|42028229|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
19579462|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
19579463|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
19579464|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
19579465|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
19579466|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
19579467|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
19579468|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
19579469|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
19579470|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
19579471|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
19579472|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
19579473|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
19579474|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Other|30|||
19579475|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Other|0|||
19579476|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Other|0|||
19579477|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
19579478|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
19579479|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
19579480|NCT00887224|42028227|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
19579481|NCT00887224|42028228|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
19579482|NCT00887224|42028229|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
19579483|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Adverse Event|0|||
19579484|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Adverse Event|7|||
19579485|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Adverse Event|2|||
19579486|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Failed to return|0|||
19579487|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Failed to return|2|||
19579488|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Failed to return|2|||
19579489|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
19579490|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
19579491|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
19579492|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
19579493|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
19579494|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
19387833|NCT02560623|41631163|FG002|Overall Study|Unable to swallow sponge|0|||
19579495|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Other|0|||
19579496|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Other|2|||
19579497|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Other|0|||
19579498|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
19579499|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
19579500|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
19579501|NCT00887224|42028227|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
19579502|NCT00887224|42028228|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
19579503|NCT00887224|42028229|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
19579504|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
19579505|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
19579506|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
19579507|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
19579508|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
19579509|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
19579510|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
19579511|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
19579512|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
19579513|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
19579514|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
19579515|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
19579516|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
19579517|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
19579518|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
19579519|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
19579520|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
19579521|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
19579522|NCT00887224|42028227|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
19579523|NCT00887224|42028228|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
19579524|NCT00887224|42028229|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
19579525|NCT01109316|42028247|FG000|Study Period 1|Adverse Event|0|||
19579526|NCT01109316|42028248|FG001|Study Period 1|Adverse Event|0|||
19579527|NCT01109316|42028249|FG002|Study Period 1|Adverse Event|1|||
19579528|NCT01109316|42028250|FG003|Study Period 1|Adverse Event|0|||
19579529|NCT01109316|42028251|FG004|Study Period 1|Adverse Event|0|||
19579530|NCT01109316|42028252|FG005|Study Period 1|Adverse Event|0|||
19579531|NCT01109316|42028247|FG000|Study Period 1|Lost to Follow-up|0|||
19579532|NCT01109316|42028248|FG001|Study Period 1|Lost to Follow-up|0|||
19579533|NCT01109316|42028249|FG002|Study Period 1|Lost to Follow-up|1|||
19579534|NCT01109316|42028250|FG003|Study Period 1|Lost to Follow-up|1|||
19579535|NCT01109316|42028251|FG004|Study Period 1|Lost to Follow-up|0|||
19579536|NCT01109316|42028252|FG005|Study Period 1|Lost to Follow-up|0|||
19579537|NCT01109316|42028247|FG000|Study Period 1|Withdrawal by Subject|0|||
19579538|NCT01109316|42028248|FG001|Study Period 1|Withdrawal by Subject|0|||
19579539|NCT01109316|42028249|FG002|Study Period 1|Withdrawal by Subject|1|||
19579540|NCT01109316|42028250|FG003|Study Period 1|Withdrawal by Subject|0|||
19579541|NCT01109316|42028251|FG004|Study Period 1|Withdrawal by Subject|2|||
19579542|NCT01109316|42028252|FG005|Study Period 1|Withdrawal by Subject|0|||
19579543|NCT01109316|42028247|FG000|Study Period 1|Sponsor Decision|0|||
19579544|NCT01109316|42028248|FG001|Study Period 1|Sponsor Decision|0|||
19579545|NCT01109316|42028249|FG002|Study Period 1|Sponsor Decision|0|||
19579546|NCT01109316|42028250|FG003|Study Period 1|Sponsor Decision|0|||
19579547|NCT01109316|42028251|FG004|Study Period 1|Sponsor Decision|0|||
19579548|NCT01109316|42028252|FG005|Study Period 1|Sponsor Decision|2|||
19579549|NCT01109316|42028247|FG000|Study Period 2|Entry Criteria Not Met|0|||
19579550|NCT01109316|42028248|FG001|Study Period 2|Entry Criteria Not Met|1|||
19579551|NCT01109316|42028249|FG002|Study Period 2|Entry Criteria Not Met|0|||
19579552|NCT01109316|42028250|FG003|Study Period 2|Entry Criteria Not Met|0|||
19579553|NCT01109316|42028251|FG004|Study Period 2|Entry Criteria Not Met|0|||
19579554|NCT01109316|42028252|FG005|Study Period 2|Entry Criteria Not Met|0|||
19579555|NCT01109316|42028247|FG000|Study Period 2|Physician Decision|0|||
19579556|NCT01109316|42028248|FG001|Study Period 2|Physician Decision|0|||
19579557|NCT01109316|42028249|FG002|Study Period 2|Physician Decision|0|||
19579558|NCT01109316|42028250|FG003|Study Period 2|Physician Decision|1|||
19579559|NCT01109316|42028251|FG004|Study Period 2|Physician Decision|0|||
19579560|NCT01109316|42028252|FG005|Study Period 2|Physician Decision|0|||
19579561|NCT01109316|42028247|FG000|Study Period 2|Protocol Violation|1|||
19579562|NCT01109316|42028248|FG001|Study Period 2|Protocol Violation|0|||
19579563|NCT01109316|42028249|FG002|Study Period 2|Protocol Violation|0|||
19579564|NCT01109316|42028250|FG003|Study Period 2|Protocol Violation|0|||
19579565|NCT01109316|42028251|FG004|Study Period 2|Protocol Violation|0|||
19579566|NCT01109316|42028252|FG005|Study Period 2|Protocol Violation|0|||
19579567|NCT01109316|42028247|FG000|Study Period 2|Withdrawal by Subject|0|||
19579568|NCT01109316|42028248|FG001|Study Period 2|Withdrawal by Subject|0|||
19579569|NCT01109316|42028249|FG002|Study Period 2|Withdrawal by Subject|1|||
19579570|NCT01109316|42028250|FG003|Study Period 2|Withdrawal by Subject|0|||
19579571|NCT01109316|42028251|FG004|Study Period 2|Withdrawal by Subject|0|||
19579572|NCT01109316|42028252|FG005|Study Period 2|Withdrawal by Subject|1|||
19579573|NCT01109316|42028247|FG000|Study Period 3|Lost to Follow-up|0|||
19579574|NCT01109316|42028248|FG001|Study Period 3|Lost to Follow-up|0|||
19579575|NCT01109316|42028249|FG002|Study Period 3|Lost to Follow-up|0|||
19579576|NCT01109316|42028250|FG003|Study Period 3|Lost to Follow-up|0|||
19579577|NCT01109316|42028251|FG004|Study Period 3|Lost to Follow-up|1|||
19579578|NCT01109316|42028252|FG005|Study Period 3|Lost to Follow-up|0|||
19579579|NCT01109316|42028247|FG000|Study Period 3|Withdrawal by Subject|1|||
19579580|NCT01109316|42028248|FG001|Study Period 3|Withdrawal by Subject|0|||
19579581|NCT01109316|42028249|FG002|Study Period 3|Withdrawal by Subject|0|||
19579582|NCT01109316|42028250|FG003|Study Period 3|Withdrawal by Subject|0|||
19579583|NCT01109316|42028251|FG004|Study Period 3|Withdrawal by Subject|1|||
19579584|NCT01109316|42028252|FG005|Study Period 3|Withdrawal by Subject|0|||
19579585|NCT00887068|42028262|FG000|Overall Study|Withdrawal by Subject|2|||
19579586|NCT00887068|42028263|FG001|Overall Study|Withdrawal by Subject|0|||
19579587|NCT00887068|42028262|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
19579588|NCT00887068|42028263|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
19579589|NCT00941031|42028273|FG000|Induction Period|Lack of Efficacy|2|||
19579590|NCT00941031|42028274|FG001|Induction Period|Lack of Efficacy|1|||
19579591|NCT00941031|42028275|FG002|Induction Period|Lack of Efficacy|0|||
19579592|NCT00941031|42028276|FG003|Induction Period|Lack of Efficacy|5|||
19579593|NCT00941031|42028277|FG004|Induction Period|Lack of Efficacy|0|||
19579594|NCT00941031|42028278|FG005|Induction Period|Lack of Efficacy|0|||
19579595|NCT00941031|42028279|FG006|Induction Period|Lack of Efficacy|0|||
19579596|NCT00941031|42028273|FG000|Induction Period|Withdrawal by Subject|1|||
19579597|NCT00941031|42028274|FG001|Induction Period|Withdrawal by Subject|2|||
19579598|NCT00941031|42028275|FG002|Induction Period|Withdrawal by Subject|2|||
19579599|NCT00941031|42028276|FG003|Induction Period|Withdrawal by Subject|2|||
19579600|NCT00941031|42028277|FG004|Induction Period|Withdrawal by Subject|0|||
19579601|NCT00941031|42028278|FG005|Induction Period|Withdrawal by Subject|0|||
19579602|NCT00941031|42028279|FG006|Induction Period|Withdrawal by Subject|0|||
19579603|NCT00941031|42028273|FG000|Induction Period|Adminstative Problems|1|||
19579604|NCT00941031|42028274|FG001|Induction Period|Adminstative Problems|1|||
19579605|NCT00941031|42028275|FG002|Induction Period|Adminstative Problems|1|||
19579606|NCT00941031|42028276|FG003|Induction Period|Adminstative Problems|0|||
19579607|NCT00941031|42028277|FG004|Induction Period|Adminstative Problems|0|||
19579608|NCT00941031|42028278|FG005|Induction Period|Adminstative Problems|0|||
19579609|NCT00941031|42028279|FG006|Induction Period|Adminstative Problems|0|||
19579610|NCT00941031|42028273|FG000|Induction Period|Adverse Event|1|||
19579611|NCT00941031|42028274|FG001|Induction Period|Adverse Event|0|||
19579612|NCT00941031|42028275|FG002|Induction Period|Adverse Event|3|||
19579613|NCT00941031|42028276|FG003|Induction Period|Adverse Event|2|||
19579614|NCT00941031|42028277|FG004|Induction Period|Adverse Event|0|||
19579615|NCT00941031|42028278|FG005|Induction Period|Adverse Event|0|||
19579616|NCT00941031|42028279|FG006|Induction Period|Adverse Event|0|||
19579617|NCT00941031|42028273|FG000|Maintenance Period|Withdrawal by Subject|0|||
19579618|NCT00941031|42028274|FG001|Maintenance Period|Withdrawal by Subject|0|||
19579619|NCT00941031|42028275|FG002|Maintenance Period|Withdrawal by Subject|0|||
19579620|NCT00941031|42028276|FG003|Maintenance Period|Withdrawal by Subject|0|||
19579621|NCT00941031|42028277|FG004|Maintenance Period|Withdrawal by Subject|6|||
19579622|NCT00941031|42028278|FG005|Maintenance Period|Withdrawal by Subject|2|||
19579623|NCT00941031|42028279|FG006|Maintenance Period|Withdrawal by Subject|13|||
19579624|NCT00941031|42028273|FG000|Maintenance Period|Administrative Problems|0|||
19579625|NCT00941031|42028274|FG001|Maintenance Period|Administrative Problems|0|||
19579626|NCT00941031|42028275|FG002|Maintenance Period|Administrative Problems|0|||
19579627|NCT00941031|42028276|FG003|Maintenance Period|Administrative Problems|0|||
19579628|NCT00941031|42028277|FG004|Maintenance Period|Administrative Problems|1|||
19579629|NCT00941031|42028278|FG005|Maintenance Period|Administrative Problems|0|||
19579630|NCT00941031|42028279|FG006|Maintenance Period|Administrative Problems|1|||
19579631|NCT00941031|42028273|FG000|Maintenance Period|Protocol Violation|0|||
19579632|NCT00941031|42028274|FG001|Maintenance Period|Protocol Violation|0|||
19579633|NCT00941031|42028275|FG002|Maintenance Period|Protocol Violation|0|||
19579634|NCT00941031|42028276|FG003|Maintenance Period|Protocol Violation|0|||
19579635|NCT00941031|42028277|FG004|Maintenance Period|Protocol Violation|0|||
19579636|NCT00941031|42028278|FG005|Maintenance Period|Protocol Violation|0|||
19579637|NCT00941031|42028279|FG006|Maintenance Period|Protocol Violation|1|||
19579638|NCT00941031|42028273|FG000|Maintenance Period|Adverse Event|0|||
19579639|NCT00941031|42028274|FG001|Maintenance Period|Adverse Event|0|||
19579640|NCT00941031|42028275|FG002|Maintenance Period|Adverse Event|0|||
19579641|NCT00941031|42028276|FG003|Maintenance Period|Adverse Event|0|||
19579642|NCT00941031|42028277|FG004|Maintenance Period|Adverse Event|0|||
19579643|NCT00941031|42028278|FG005|Maintenance Period|Adverse Event|2|||
19579644|NCT00941031|42028279|FG006|Maintenance Period|Adverse Event|8|||
19579645|NCT00941031|42028273|FG000|Maintenance Period|Lost to Follow-up|0|||
19579646|NCT00941031|42028274|FG001|Maintenance Period|Lost to Follow-up|0|||
19579647|NCT00941031|42028275|FG002|Maintenance Period|Lost to Follow-up|0|||
19579648|NCT00941031|42028276|FG003|Maintenance Period|Lost to Follow-up|0|||
19579649|NCT00941031|42028277|FG004|Maintenance Period|Lost to Follow-up|2|||
19579650|NCT00941031|42028278|FG005|Maintenance Period|Lost to Follow-up|2|||
19579651|NCT00941031|42028279|FG006|Maintenance Period|Lost to Follow-up|7|||
19579652|NCT00941031|42028273|FG000|Maintenance Period|Lack of Efficacy|0|||
19579653|NCT00941031|42028274|FG001|Maintenance Period|Lack of Efficacy|0|||
19579654|NCT00941031|42028275|FG002|Maintenance Period|Lack of Efficacy|0|||
19579655|NCT00941031|42028276|FG003|Maintenance Period|Lack of Efficacy|0|||
19579656|NCT00941031|42028277|FG004|Maintenance Period|Lack of Efficacy|0|||
19579657|NCT00941031|42028278|FG005|Maintenance Period|Lack of Efficacy|0|||
19579658|NCT00941031|42028279|FG006|Maintenance Period|Lack of Efficacy|13|||
19579659|NCT00886834|42028300|FG000|Overall Study|Protocol Violation|0|||
19579660|NCT00886834|42028301|FG001|Overall Study|Protocol Violation|3|||
19579661|NCT00880009|42028307|FG000|Overall Study|Study terminated by sponsor|14|||
19579662|NCT00880009|42028307|FG000|Overall Study|Withdrawal by Subject|1|||
19579663|NCT00880009|42028307|FG000|Overall Study|Protocol Violation|1|||
19579664|NCT01104636|42028314|FG000|Overall Study|Lack of Efficacy|43|||
19579665|NCT01104636|42028314|FG000|Overall Study|Lost to Follow-up|24|||
19579666|NCT01104636|42028314|FG000|Overall Study|Withdrawal by Subject|4|||
19579667|NCT01104636|42028314|FG000|Overall Study|Other|43|||
19579668|NCT01104636|42028314|FG000|Overall Study|Study terminated by sponsor|1|||
19579669|NCT01104636|42028314|FG000|Overall Study|Pregnancy|2|||
19579670|NCT01104636|42028314|FG000|Overall Study|Adverse Event|40|||
19579671|NCT01104636|42028314|FG000|Overall Study|Ongoing|21|||
19579672|NCT01104558|42028318|FG000|Overall Study|Protocol Violation|6|||
19579673|NCT01104558|42028318|FG000|Overall Study|Missing of primary efficacy assessment|10|||
19579674|NCT01104558|42028318|FG000|Overall Study|Missing of genetic analysis results|1|||
19579675|NCT00886288|42028324|FG000|Overall Study|no respect of the 12 weeks period|657|||
19579676|NCT00886288|42028325|FG001|Overall Study|no respect of the 12 weeks period|227|||
19579677|NCT00886288|42028324|FG000|Overall Study|Lost to Follow-up|86|||
19579678|NCT00886288|42028325|FG001|Overall Study|Lost to Follow-up|0|||
19579679|NCT01204658|42028337|FG000|Primary Phase|Adverse Event|0|||
19579680|NCT01204658|42028338|FG001|Primary Phase|Adverse Event|0|||
19579681|NCT01204658|42028339|FG002|Primary Phase|Adverse Event|1|||
19579682|NCT01204658|42028340|FG003|Primary Phase|Adverse Event|0|||
19579683|NCT00951483|42028355|FG000|Overall Study|Physician Decision|4|||
19579684|NCT00951483|42028356|FG001|Overall Study|Physician Decision|0|||
19579685|NCT00951483|42028355|FG000|Overall Study|Withdrawal by Subject|15|||
19579686|NCT00951483|42028356|FG001|Overall Study|Withdrawal by Subject|0|||
19579687|NCT01104246|42028364|FG000|Overall Study|Withdrawal by Subject|1|||
19579688|NCT01104246|42028364|FG000|Overall Study|did not meet inclusion criteria|4|||
19579689|NCT01103778|42028368|FG000|Overall Study|Lost to Follow-up|1|||
19579690|NCT01103778|42028368|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
19579691|NCT01103778|42028368|FG000|Overall Study|Screen failure|1|||
19579692|NCT01103466|42028374|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
19579693|NCT01103466|42028375|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
19579694|NCT01103466|42028376|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
19579695|NCT01103466|42028374|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
19579696|NCT01103466|42028375|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
19579697|NCT01103466|42028376|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
19579698|NCT01103466|42028374|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
19579699|NCT01103466|42028375|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
19579700|NCT01103466|42028376|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
19579701|NCT01103466|42028374|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
19745884|NCT03529773|42193170|FG014|Overall Study|No longer meets eligibility criteria|0|||
19745885|NCT03529773|42193171|FG015|Overall Study|No longer meets eligibility criteria|0|||
19745886|NCT03529773|42193172|FG016|Overall Study|No longer meets eligibility criteria|0|||
19745887|NCT03529773|42193173|FG017|Overall Study|No longer meets eligibility criteria|0|||
19745888|NCT03529773|42193174|FG018|Overall Study|No longer meets eligibility criteria|0|||
19745889|NCT03529773|42193175|FG019|Overall Study|No longer meets eligibility criteria|0|||
19745890|NCT03529773|42193176|FG020|Overall Study|No longer meets eligibility criteria|0|||
19579702|NCT01103466|42028375|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
19579703|NCT01103466|42028376|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
19579704|NCT01103466|42028374|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
19579705|NCT01103466|42028375|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
19579706|NCT01103466|42028376|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
19579707|NCT01103466|42028374|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
19579708|NCT01103466|42028375|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
19579709|NCT01103466|42028376|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
19579710|NCT00945945|42028386|FG000|Overall Study|Adverse Event|15|||
19579711|NCT00945945|42028387|FG001|Overall Study|Adverse Event|35|||
19579712|NCT00945945|42028386|FG000|Overall Study|Withdrawal by Subject|7|||
19579713|NCT00945945|42028387|FG001|Overall Study|Withdrawal by Subject|10|||
19579714|NCT00945945|42028386|FG000|Overall Study|Lost to Follow-up|4|||
19579715|NCT00945945|42028387|FG001|Overall Study|Lost to Follow-up|5|||
19579716|NCT00945945|42028386|FG000|Overall Study|Lack of Efficacy|6|||
19579717|NCT00945945|42028387|FG001|Overall Study|Lack of Efficacy|2|||
19579718|NCT00945945|42028386|FG000|Overall Study|Protocol Violation|4|||
19579719|NCT00945945|42028387|FG001|Overall Study|Protocol Violation|2|||
19579720|NCT00945945|42028386|FG000|Overall Study|Entry Criteria Not Met|0|||
19579721|NCT00945945|42028387|FG001|Overall Study|Entry Criteria Not Met|1|||
19579722|NCT01203956|42028393|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
19579723|NCT01203956|42028394|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
19579724|NCT01103232|42028403|FG000|Overall Study|Withdrawal by Subject|1|||
19579725|NCT01103232|42028404|FG001|Overall Study|Withdrawal by Subject|1|||
19579726|NCT01103232|42028403|FG000|Overall Study|Protocol Violation|0|||
19579727|NCT01103232|42028404|FG001|Overall Study|Protocol Violation|1|||
19579728|NCT01112982|42028410|FG000|Overall Study|Withdrawal by Subject|1|||
19579729|NCT01112982|42028410|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
19579730|NCT01203878|42028420|FG000|Overall Study|Withdrawal by Subject|0|||
19579731|NCT01203878|42028421|FG001|Overall Study|Withdrawal by Subject|0|||
19579732|NCT01203878|42028422|FG002|Overall Study|Withdrawal by Subject|1|||
19579733|NCT01203878|42028420|FG000|Overall Study|Adverse Event|0|||
19579734|NCT01203878|42028421|FG001|Overall Study|Adverse Event|0|||
19579735|NCT01203878|42028422|FG002|Overall Study|Adverse Event|2|||
19579736|NCT01112514|42028429|FG000|Overall Study|Lost to Follow-up|1|||
19579737|NCT01203098|42028436|FG000|Overall Study|Adverse Event|3|||
19579738|NCT01203098|42028437|FG001|Overall Study|Adverse Event|1|||
19579739|NCT01203098|42028438|FG002|Overall Study|Adverse Event|7|||
19579740|NCT01203098|42028436|FG000|Overall Study|Lost to Follow-up|0|||
19579741|NCT01203098|42028437|FG001|Overall Study|Lost to Follow-up|0|||
19579742|NCT01203098|42028438|FG002|Overall Study|Lost to Follow-up|1|||
19579743|NCT01203098|42028436|FG000|Overall Study|Physician Decision|2|||
19579744|NCT01203098|42028437|FG001|Overall Study|Physician Decision|2|||
19579745|NCT01203098|42028438|FG002|Overall Study|Physician Decision|0|||
19579746|NCT01203098|42028436|FG000|Overall Study|Withdrawal by Subject|1|||
19579747|NCT01203098|42028437|FG001|Overall Study|Withdrawal by Subject|1|||
19579748|NCT01203098|42028438|FG002|Overall Study|Withdrawal by Subject|3|||
19579749|NCT00945555|42028446|FG000|Overall Study|Referred to another hospital|5|||
19579750|NCT00945555|42028446|FG000|Overall Study|Worsening condition, intensive care unit|1|||
19579751|NCT00945555|42028446|FG000|Overall Study|Withdrawal by Subject|2|||
19579752|NCT00945555|42028446|FG000|Overall Study|Participant continued treatment at home|1|||
19579753|NCT00945555|42028446|FG000|Overall Study|Death|18|||
19579754|NCT00945555|42028446|FG000|Overall Study|Other|1|||
19579755|NCT01108458|42028450|FG000|Overall Study|Withdrawal by Subject|1|||
19579756|NCT01108068|42028456|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
19579757|NCT01108068|42028457|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
19579758|NCT01201850|42028464|FG000|Overall Study|Tumor progression|4|||
19579759|NCT00951171|42028470|FG000|Overall Study|Adverse Event|2|||
19579760|NCT00951171|42028471|FG001|Overall Study|Adverse Event|0|||
19579761|NCT01200992|42028479|FG000|Overall Study|Study terminated early|35|||
19579762|NCT01200992|42028480|FG001|Overall Study|Study terminated early|41|||
19579763|NCT01200992|42028479|FG000|Overall Study|Randomized but not treated|2|||
19579764|NCT01200992|42028480|FG001|Overall Study|Randomized but not treated|0|||
19579765|NCT00878215|42028492|FG000|Overall Study|Determined to be ineligible|0|||
19579766|NCT00878215|42028493|FG001|Overall Study|Determined to be ineligible|10|||
19579767|NCT00878215|42028494|FG002|Overall Study|Determined to be ineligible|0|||
19579768|NCT00878215|42028495|FG003|Overall Study|Determined to be ineligible|0|||
19579769|NCT01200758|42028507|FG000|Stage I|Death|0|||
19579770|NCT01200758|42028508|FG001|Stage I|Death|1|||
19579771|NCT01200758|42028509|FG002|Stage I|Death|0|||
19579772|NCT01200758|42028510|FG003|Stage I|Death|0|||
19579773|NCT01200758|42028507|FG000|Stage I|Physician Decision|1|||
19579774|NCT01200758|42028508|FG001|Stage I|Physician Decision|1|||
19579775|NCT01200758|42028509|FG002|Stage I|Physician Decision|0|||
19579776|NCT01200758|42028510|FG003|Stage I|Physician Decision|0|||
19579777|NCT01200758|42028507|FG000|Stage I|Lack of Efficacy|2|||
19579778|NCT01200758|42028508|FG001|Stage I|Lack of Efficacy|1|||
19579779|NCT01200758|42028509|FG002|Stage I|Lack of Efficacy|0|||
19579780|NCT01200758|42028510|FG003|Stage I|Lack of Efficacy|0|||
19579781|NCT01200758|42028507|FG000|Stage I|Adverse Event|5|||
19579782|NCT01200758|42028508|FG001|Stage I|Adverse Event|5|||
19579783|NCT01200758|42028509|FG002|Stage I|Adverse Event|0|||
19579784|NCT01200758|42028510|FG003|Stage I|Adverse Event|0|||
19579785|NCT01200758|42028507|FG000|Stage I|Withdrawal by Subject|1|||
19579786|NCT01200758|42028508|FG001|Stage I|Withdrawal by Subject|2|||
19579787|NCT01200758|42028509|FG002|Stage I|Withdrawal by Subject|0|||
19579788|NCT01200758|42028510|FG003|Stage I|Withdrawal by Subject|0|||
19579789|NCT01200758|42028507|FG000|Stage I|Disease Progression|9|||
19579790|NCT01200758|42028508|FG001|Stage I|Disease Progression|7|||
19579791|NCT01200758|42028509|FG002|Stage I|Disease Progression|0|||
19579792|NCT01200758|42028510|FG003|Stage I|Disease Progression|0|||
19579793|NCT01200758|42028507|FG000|Stage 2|Disease Progression|0|||
19579794|NCT01200758|42028508|FG001|Stage 2|Disease Progression|0|||
19579795|NCT01200758|42028509|FG002|Stage 2|Disease Progression|16|||
19579796|NCT01200758|42028510|FG003|Stage 2|Disease Progression|21|||
19579797|NCT01200758|42028507|FG000|Stage 2|Lack of Efficacy|0|||
19579798|NCT01200758|42028508|FG001|Stage 2|Lack of Efficacy|0|||
19579799|NCT01200758|42028509|FG002|Stage 2|Lack of Efficacy|4|||
19579800|NCT01200758|42028510|FG003|Stage 2|Lack of Efficacy|2|||
19579801|NCT01200758|42028507|FG000|Stage 2|Physician Decision|0|||
19579802|NCT01200758|42028508|FG001|Stage 2|Physician Decision|0|||
19579803|NCT01200758|42028509|FG002|Stage 2|Physician Decision|5|||
19579804|NCT01200758|42028510|FG003|Stage 2|Physician Decision|7|||
19579805|NCT01200758|42028507|FG000|Stage 2|Adverse Event|0|||
19579806|NCT01200758|42028508|FG001|Stage 2|Adverse Event|0|||
19579807|NCT01200758|42028509|FG002|Stage 2|Adverse Event|5|||
19579808|NCT01200758|42028510|FG003|Stage 2|Adverse Event|9|||
19579809|NCT01200758|42028507|FG000|Stage 2|Withdrawal by Subject|0|||
19579810|NCT01200758|42028508|FG001|Stage 2|Withdrawal by Subject|0|||
19579811|NCT01200758|42028509|FG002|Stage 2|Withdrawal by Subject|4|||
19579812|NCT01200758|42028510|FG003|Stage 2|Withdrawal by Subject|1|||
19579813|NCT01200758|42028507|FG000|Stage 2|Lost to Follow-up|0|||
19579814|NCT01200758|42028508|FG001|Stage 2|Lost to Follow-up|0|||
19579815|NCT01200758|42028509|FG002|Stage 2|Lost to Follow-up|3|||
19579816|NCT01200758|42028510|FG003|Stage 2|Lost to Follow-up|1|||
19579817|NCT01200758|42028507|FG000|Stage 2|Protocol Violation|0|||
19579818|NCT01200758|42028508|FG001|Stage 2|Protocol Violation|0|||
19579819|NCT01200758|42028509|FG002|Stage 2|Protocol Violation|1|||
19579820|NCT01200758|42028510|FG003|Stage 2|Protocol Violation|4|||
19579821|NCT01200758|42028507|FG000|Stage 2|Death|0|||
19579822|NCT01200758|42028508|FG001|Stage 2|Death|0|||
19579823|NCT01200758|42028509|FG002|Stage 2|Death|3|||
19579824|NCT01200758|42028510|FG003|Stage 2|Death|5|||
19579825|NCT00876343|42028525|FG000|Overall Study|Adverse Event|7|||
19579826|NCT00876343|42028526|FG001|Overall Study|Adverse Event|8|||
19579827|NCT00876343|42028527|FG002|Overall Study|Adverse Event|2|||
19579828|NCT00876343|42028525|FG000|Overall Study|Withdrawal by Subject|4|||
19579829|NCT00876343|42028526|FG001|Overall Study|Withdrawal by Subject|4|||
19579830|NCT00876343|42028527|FG002|Overall Study|Withdrawal by Subject|3|||
19579831|NCT00876343|42028525|FG000|Overall Study|Lack of Efficacy|0|||
19579832|NCT00876343|42028526|FG001|Overall Study|Lack of Efficacy|0|||
19579833|NCT00876343|42028527|FG002|Overall Study|Lack of Efficacy|1|||
19579834|NCT00876343|42028525|FG000|Overall Study|Protocol Violation|4|||
19579835|NCT00876343|42028526|FG001|Overall Study|Protocol Violation|1|||
19579836|NCT00876343|42028527|FG002|Overall Study|Protocol Violation|1|||
19579837|NCT00876343|42028525|FG000|Overall Study|Physician Decision|0|||
19579838|NCT00876343|42028526|FG001|Overall Study|Physician Decision|1|||
19579839|NCT00876343|42028527|FG002|Overall Study|Physician Decision|1|||
19579840|NCT00876343|42028525|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
19579841|NCT00876343|42028526|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
19579842|NCT00876343|42028527|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
19579843|NCT00876343|42028525|FG000|Overall Study|Change of residence or other commitments|2|||
19387834|NCT02560623|41631164|FG003|Overall Study|Unable to swallow sponge|0|||
19579844|NCT00876343|42028526|FG001|Overall Study|Change of residence or other commitments|2|||
19579845|NCT00876343|42028527|FG002|Overall Study|Change of residence or other commitments|3|||
19579846|NCT01107912|42028539|FG000|Period 1|Adverse Event|0|||
19579847|NCT01107912|42028540|FG001|Period 1|Adverse Event|0|||
19579848|NCT01107912|42028541|FG002|Period 1|Adverse Event|0|||
19579849|NCT01107912|42028542|FG003|Period 1|Adverse Event|0|||
19579850|NCT01107912|42028543|FG004|Period 1|Adverse Event|2|||
19579851|NCT01107912|42028544|FG005|Period 1|Adverse Event|0|||
19579852|NCT01107912|42028539|FG000|Period 1|Physician Decision|0|||
19579853|NCT01107912|42028540|FG001|Period 1|Physician Decision|0|||
19579854|NCT01107912|42028541|FG002|Period 1|Physician Decision|0|||
19579855|NCT01107912|42028542|FG003|Period 1|Physician Decision|0|||
19579856|NCT01107912|42028543|FG004|Period 1|Physician Decision|1|||
19579857|NCT01107912|42028544|FG005|Period 1|Physician Decision|0|||
19579858|NCT01107912|42028539|FG000|Period 1|Withdrawal by Subject|1|||
19579859|NCT01107912|42028540|FG001|Period 1|Withdrawal by Subject|0|||
19579860|NCT01107912|42028541|FG002|Period 1|Withdrawal by Subject|0|||
19579861|NCT01107912|42028542|FG003|Period 1|Withdrawal by Subject|0|||
19579862|NCT01107912|42028543|FG004|Period 1|Withdrawal by Subject|0|||
19579863|NCT01107912|42028544|FG005|Period 1|Withdrawal by Subject|0|||
19579864|NCT01107912|42028539|FG000|Period 2|Physician Decision|0|||
19579865|NCT01107912|42028540|FG001|Period 2|Physician Decision|0|||
19579866|NCT01107912|42028541|FG002|Period 2|Physician Decision|1|||
19579867|NCT01107912|42028542|FG003|Period 2|Physician Decision|0|||
19579868|NCT01107912|42028543|FG004|Period 2|Physician Decision|0|||
19579869|NCT01107912|42028544|FG005|Period 2|Physician Decision|0|||
19579870|NCT01107912|42028539|FG000|Period 3|Adverse Event|0|||
19579871|NCT01107912|42028540|FG001|Period 3|Adverse Event|1|||
19579872|NCT01107912|42028541|FG002|Period 3|Adverse Event|1|||
19579873|NCT01107912|42028542|FG003|Period 3|Adverse Event|0|||
19579874|NCT01107912|42028543|FG004|Period 3|Adverse Event|0|||
19579875|NCT01107912|42028544|FG005|Period 3|Adverse Event|0|||
19579876|NCT01107912|42028539|FG000|Period 3|Withdrawal by Subject|0|||
19579877|NCT01107912|42028540|FG001|Period 3|Withdrawal by Subject|0|||
19579878|NCT01107912|42028541|FG002|Period 3|Withdrawal by Subject|0|||
19579879|NCT01107912|42028542|FG003|Period 3|Withdrawal by Subject|1|||
19579880|NCT01107912|42028543|FG004|Period 3|Withdrawal by Subject|0|||
19579881|NCT01107912|42028544|FG005|Period 3|Withdrawal by Subject|0|||
19579882|NCT01200524|42028562|FG000|Overall Study|Withdrawal by Subject|1|||
19579883|NCT01200524|42028563|FG001|Overall Study|Withdrawal by Subject|1|||
19579884|NCT01200524|42028564|FG002|Overall Study|Withdrawal by Subject|3|||
19579885|NCT01200524|42028562|FG000|Overall Study|Adverse Event|1|||
19579886|NCT01200524|42028563|FG001|Overall Study|Adverse Event|0|||
19579887|NCT01200524|42028564|FG002|Overall Study|Adverse Event|0|||
19579888|NCT01200524|42028562|FG000|Overall Study|Non availability of study nurse|0|||
19579889|NCT01200524|42028563|FG001|Overall Study|Non availability of study nurse|0|||
19579890|NCT01200524|42028564|FG002|Overall Study|Non availability of study nurse|1|||
19579891|NCT01100034|42028572|FG000|Overall Study|Lost to Follow-up|11|||
19579892|NCT01100034|42028572|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
19579893|NCT01100034|42028572|FG000|Overall Study|Withdrawal by Subject|4|||
19579894|NCT01100034|42028572|FG000|Overall Study|Sponsor decision|21|||
19579895|NCT01100034|42028572|FG000|Overall Study|Participated in another clinical trial|1|||
19579896|NCT01100034|42028572|FG000|Overall Study|Participants moved to another hospital|4|||
19579897|NCT01100034|42028572|FG000|Overall Study|Site closed due to non-responsiveness|1|||
19579898|NCT00876265|42028576|FG000|Overall Study|Miscellaneous reasons|4|||
19579899|NCT00876265|42028576|FG000|Overall Study|Lost to Follow-up|6|||
19579900|NCT00876265|42028576|FG000|Overall Study|Withdrawal by Subject|2|||
19579901|NCT01107444|42028584|FG000|Overall Study|Withdrawal by Subject|8|||
19579902|NCT01107444|42028585|FG001|Overall Study|Withdrawal by Subject|12|||
19579903|NCT01107444|42028584|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
19579904|NCT01107444|42028585|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
19579905|NCT00876187|42028599|FG000|Overall Study|Adverse Event|14|||
19579906|NCT00876187|42028600|FG001|Overall Study|Adverse Event|12|||
19579907|NCT00876187|42028601|FG002|Overall Study|Adverse Event|19|||
19579908|NCT00876187|42028602|FG003|Overall Study|Adverse Event|29|||
19579909|NCT00876187|42028603|FG004|Overall Study|Adverse Event|10|||
19579910|NCT00876187|42028599|FG000|Overall Study|Lack of Efficacy|59|||
19579911|NCT00876187|42028600|FG001|Overall Study|Lack of Efficacy|34|||
19579912|NCT00876187|42028601|FG002|Overall Study|Lack of Efficacy|45|||
19579913|NCT00876187|42028602|FG003|Overall Study|Lack of Efficacy|34|||
19579914|NCT00876187|42028603|FG004|Overall Study|Lack of Efficacy|59|||
19579915|NCT00876187|42028599|FG000|Overall Study|Lost to Follow-up|9|||
19579916|NCT00876187|42028600|FG001|Overall Study|Lost to Follow-up|10|||
19579917|NCT00876187|42028601|FG002|Overall Study|Lost to Follow-up|8|||
19579918|NCT00876187|42028602|FG003|Overall Study|Lost to Follow-up|8|||
19579919|NCT00876187|42028603|FG004|Overall Study|Lost to Follow-up|11|||
19579920|NCT00876187|42028599|FG000|Overall Study|Protocol Violation|6|||
19579921|NCT00876187|42028600|FG001|Overall Study|Protocol Violation|7|||
19579922|NCT00876187|42028601|FG002|Overall Study|Protocol Violation|7|||
19579923|NCT00876187|42028602|FG003|Overall Study|Protocol Violation|6|||
19579924|NCT00876187|42028603|FG004|Overall Study|Protocol Violation|3|||
19579925|NCT00876187|42028599|FG000|Overall Study|Withdrawal by Subject|16|||
19579926|NCT00876187|42028600|FG001|Overall Study|Withdrawal by Subject|26|||
19579927|NCT00876187|42028601|FG002|Overall Study|Withdrawal by Subject|32|||
19579928|NCT00876187|42028602|FG003|Overall Study|Withdrawal by Subject|38|||
19579929|NCT00876187|42028603|FG004|Overall Study|Withdrawal by Subject|37|||
19579930|NCT00876187|42028599|FG000|Overall Study|Entered extension study|101|||
19579931|NCT00876187|42028600|FG001|Overall Study|Entered extension study|120|||
19579932|NCT00876187|42028601|FG002|Overall Study|Entered extension study|156|||
19579933|NCT00876187|42028602|FG003|Overall Study|Entered extension study|151|||
19579934|NCT00876187|42028603|FG004|Overall Study|Entered extension study|144|||
19579935|NCT00876187|42028599|FG000|Overall Study|Randomized but not treated|3|||
19579936|NCT00876187|42028600|FG001|Overall Study|Randomized but not treated|1|||
19579937|NCT00876187|42028601|FG002|Overall Study|Randomized but not treated|3|||
19579938|NCT00876187|42028602|FG003|Overall Study|Randomized but not treated|2|||
19579939|NCT00876187|42028603|FG004|Overall Study|Randomized but not treated|3|||
19579940|NCT00876187|42028599|FG000|Overall Study|Other|2|||
19579941|NCT00876187|42028600|FG001|Overall Study|Other|5|||
19579942|NCT00876187|42028601|FG002|Overall Study|Other|9|||
19579943|NCT00876187|42028602|FG003|Overall Study|Other|7|||
19579944|NCT00876187|42028603|FG004|Overall Study|Other|4|||
19579945|NCT01102374|42028620|FG000|Overall Study|Death|9|||
19579946|NCT01102374|42028621|FG001|Overall Study|Death|13|||
19579947|NCT01102374|42028620|FG000|Overall Study|Lost to Follow-up|7|||
19579948|NCT01102374|42028621|FG001|Overall Study|Lost to Follow-up|6|||
19579949|NCT01106976|42028627|FG000|Overall Study|Lost to Follow-up|8|||
19579950|NCT00875485|42028633|FG000|Challenge Dose Epoch|Pregnancy|1|||
19579951|NCT00875485|42028634|FG001|Challenge Dose Epoch|Pregnancy|0|||
19579952|NCT04547140|42028642|FG000|Overall Study|Adverse Event|0|||
19579953|NCT04547140|42028643|FG001|Overall Study|Adverse Event|1|||
19579954|NCT04547140|42028642|FG000|Overall Study|Withdrawal by Subject|0|||
19579955|NCT04547140|42028643|FG001|Overall Study|Withdrawal by Subject|1|||
19579956|NCT04547140|42028642|FG000|Overall Study|Lost to Follow-up|3|||
19579957|NCT04547140|42028643|FG001|Overall Study|Lost to Follow-up|1|||
19579958|NCT04547140|42028642|FG000|Overall Study|Death|2|||
19579959|NCT04547140|42028643|FG001|Overall Study|Death|1|||
19579960|NCT04547140|42028642|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
19579961|NCT04547140|42028643|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
19579962|NCT04547140|42028642|FG000|Overall Study|Pregnancy|1|||
19579963|NCT04547140|42028643|FG001|Overall Study|Pregnancy|0|||
19579964|NCT04547140|42028642|FG000|Overall Study|Reason Not Specified|4|||
19579965|NCT04547140|42028643|FG001|Overall Study|Reason Not Specified|1|||
19579966|NCT01098474|42028655|FG000|Active Phase|Other|0|||
19579967|NCT01098474|42028656|FG001|Active Phase|Other|0|||
19579968|NCT01098474|42028657|FG002|Active Phase|Other|3|||
19579969|NCT01098474|42028658|FG003|Active Phase|Other|0|||
19579970|NCT01098474|42028659|FG004|Active Phase|Other|0|||
19579971|NCT01098474|42028660|FG005|Active Phase|Other|0|||
19579972|NCT01098474|42028655|FG000|Active Phase|Withdrawal by Subject|1|||
19579973|NCT01098474|42028656|FG001|Active Phase|Withdrawal by Subject|1|||
19579974|NCT01098474|42028657|FG002|Active Phase|Withdrawal by Subject|2|||
19579975|NCT01098474|42028658|FG003|Active Phase|Withdrawal by Subject|0|||
19579976|NCT01098474|42028659|FG004|Active Phase|Withdrawal by Subject|0|||
19579977|NCT01098474|42028660|FG005|Active Phase|Withdrawal by Subject|0|||
19579978|NCT01098474|42028655|FG000|Active Phase|Lost to Follow-up|1|||
19579979|NCT01098474|42028656|FG001|Active Phase|Lost to Follow-up|0|||
19579980|NCT01098474|42028657|FG002|Active Phase|Lost to Follow-up|0|||
19579981|NCT01098474|42028658|FG003|Active Phase|Lost to Follow-up|0|||
19579982|NCT01098474|42028659|FG004|Active Phase|Lost to Follow-up|0|||
19579983|NCT01098474|42028660|FG005|Active Phase|Lost to Follow-up|0|||
19579984|NCT01098474|42028655|FG000|Follow Up Phase|Travelled out of study area|0|||
19579985|NCT01098474|42028656|FG001|Follow Up Phase|Travelled out of study area|0|||
19579986|NCT01098474|42028657|FG002|Follow Up Phase|Travelled out of study area|0|||
19579987|NCT01098474|42028658|FG003|Follow Up Phase|Travelled out of study area|0|||
19579988|NCT01098474|42028659|FG004|Follow Up Phase|Travelled out of study area|1|||
19579989|NCT01098474|42028660|FG005|Follow Up Phase|Travelled out of study area|0|||
19579990|NCT01098474|42028655|FG000|Follow Up Phase|Other|0|||
19579991|NCT01098474|42028656|FG001|Follow Up Phase|Other|0|||
19579992|NCT01098474|42028657|FG002|Follow Up Phase|Other|0|||
19579993|NCT01098474|42028658|FG003|Follow Up Phase|Other|0|||
19579994|NCT01098474|42028659|FG004|Follow Up Phase|Other|0|||
19579995|NCT01098474|42028660|FG005|Follow Up Phase|Other|4|||
19579996|NCT01098474|42028655|FG000|Follow Up Phase|Withdrawal by Subject|0|||
19579997|NCT01098474|42028656|FG001|Follow Up Phase|Withdrawal by Subject|0|||
19579998|NCT01098474|42028657|FG002|Follow Up Phase|Withdrawal by Subject|0|||
19579999|NCT01098474|42028658|FG003|Follow Up Phase|Withdrawal by Subject|2|||
19580000|NCT01098474|42028659|FG004|Follow Up Phase|Withdrawal by Subject|0|||
19580001|NCT01098474|42028660|FG005|Follow Up Phase|Withdrawal by Subject|1|||
19745891|NCT03529773|42193177|FG021|Overall Study|No longer meets eligibility criteria|0|||
19745892|NCT03529773|42193178|FG022|Overall Study|No longer meets eligibility criteria|1|||
19745893|NCT03529773|42193179|FG023|Overall Study|No longer meets eligibility criteria|0|||
19745894|NCT03529773|42193180|FG024|Overall Study|No longer meets eligibility criteria|0|||
19745895|NCT03529773|42193181|FG025|Overall Study|No longer meets eligibility criteria|0|||
19745896|NCT03529773|42193182|FG026|Overall Study|No longer meets eligibility criteria|0|||
19745897|NCT03529773|42193183|FG027|Overall Study|No longer meets eligibility criteria|0|||
19745898|NCT03529773|42193184|FG028|Overall Study|No longer meets eligibility criteria|0|||
19745899|NCT03529773|42193185|FG029|Overall Study|No longer meets eligibility criteria|0|||
19580002|NCT01098474|42028655|FG000|Follow Up Phase|Lost to Follow-up|0|||
19580003|NCT01098474|42028656|FG001|Follow Up Phase|Lost to Follow-up|0|||
19580004|NCT01098474|42028657|FG002|Follow Up Phase|Lost to Follow-up|0|||
19580005|NCT01098474|42028658|FG003|Follow Up Phase|Lost to Follow-up|0|||
19580006|NCT01098474|42028659|FG004|Follow Up Phase|Lost to Follow-up|1|||
19580007|NCT01098474|42028660|FG005|Follow Up Phase|Lost to Follow-up|0|||
19580008|NCT01106898|42028684|FG000|Overall Study|Adverse Event|6|||
19580009|NCT00876733|42028692|FG000|Overall Study|Adverse Event|34|||
19580010|NCT00876733|42028693|FG001|Overall Study|Adverse Event|20|||
19580011|NCT00876733|42028694|FG002|Overall Study|Adverse Event|10|||
19580012|NCT00876733|42028695|FG003|Overall Study|Adverse Event|3|||
19580013|NCT00876733|42028692|FG000|Overall Study|Lack of Efficacy|17|||
19580014|NCT00876733|42028693|FG001|Overall Study|Lack of Efficacy|9|||
19580015|NCT00876733|42028694|FG002|Overall Study|Lack of Efficacy|10|||
19580016|NCT00876733|42028695|FG003|Overall Study|Lack of Efficacy|1|||
19580017|NCT00876733|42028692|FG000|Overall Study|Lost to Follow-up|26|||
19580018|NCT00876733|42028693|FG001|Overall Study|Lost to Follow-up|10|||
19580019|NCT00876733|42028694|FG002|Overall Study|Lost to Follow-up|3|||
19580020|NCT00876733|42028695|FG003|Overall Study|Lost to Follow-up|2|||
19580021|NCT00876733|42028692|FG000|Overall Study|Data not available|14|||
19580022|NCT00876733|42028693|FG001|Overall Study|Data not available|3|||
19580023|NCT00876733|42028694|FG002|Overall Study|Data not available|7|||
19580024|NCT00876733|42028695|FG003|Overall Study|Data not available|1|||
19580025|NCT00875017|42028715|FG000|First Intervention|Withdrawal by Subject|1|||
19580026|NCT00875017|42028716|FG001|First Intervention|Withdrawal by Subject|0|||
19580027|NCT00875017|42028717|FG002|First Intervention|Withdrawal by Subject|1|||
19580028|NCT00875017|42028718|FG003|First Intervention|Withdrawal by Subject|0|||
19608699|NCT00539591|42057714|FG000|Overall Study|Disease progression|2|||
19580029|NCT00875017|42028719|FG004|First Intervention|Withdrawal by Subject|0|||
19580030|NCT00875017|42028720|FG005|First Intervention|Withdrawal by Subject|0|||
19580031|NCT00875017|42028715|FG000|First Intervention|Adverse Event|0|||
19580032|NCT00875017|42028716|FG001|First Intervention|Adverse Event|0|||
19580033|NCT00875017|42028717|FG002|First Intervention|Adverse Event|0|||
19580034|NCT00875017|42028718|FG003|First Intervention|Adverse Event|1|||
19580035|NCT00875017|42028719|FG004|First Intervention|Adverse Event|0|||
19580036|NCT00875017|42028720|FG005|First Intervention|Adverse Event|0|||
19580037|NCT00875017|42028715|FG000|First Intervention|Problems collecting rectal effluent|1|||
19580038|NCT00875017|42028716|FG001|First Intervention|Problems collecting rectal effluent|0|||
19580039|NCT00875017|42028717|FG002|First Intervention|Problems collecting rectal effluent|0|||
19580040|NCT00875017|42028718|FG003|First Intervention|Problems collecting rectal effluent|0|||
19580041|NCT00875017|42028719|FG004|First Intervention|Problems collecting rectal effluent|0|||
19580042|NCT00875017|42028720|FG005|First Intervention|Problems collecting rectal effluent|0|||
19580043|NCT00875017|42028715|FG000|First Intervention|Intolerance to nasogastric tube|0|||
19580044|NCT00875017|42028716|FG001|First Intervention|Intolerance to nasogastric tube|0|||
19580045|NCT00875017|42028717|FG002|First Intervention|Intolerance to nasogastric tube|0|||
19580046|NCT00875017|42028718|FG003|First Intervention|Intolerance to nasogastric tube|0|||
19580047|NCT00875017|42028719|FG004|First Intervention|Intolerance to nasogastric tube|1|||
19580048|NCT00875017|42028720|FG005|First Intervention|Intolerance to nasogastric tube|0|||
19580049|NCT00875017|42028715|FG000|Washout|Problem collecting rectal effluent|0|||
19580050|NCT00875017|42028716|FG001|Washout|Problem collecting rectal effluent|0|||
19580051|NCT00875017|42028717|FG002|Washout|Problem collecting rectal effluent|1|||
19580052|NCT00875017|42028718|FG003|Washout|Problem collecting rectal effluent|0|||
19580053|NCT00875017|42028719|FG004|Washout|Problem collecting rectal effluent|0|||
19580054|NCT00875017|42028720|FG005|Washout|Problem collecting rectal effluent|0|||
19580055|NCT00875017|42028715|FG000|Second Intervention|Adverse Event|0|||
19580056|NCT00875017|42028716|FG001|Second Intervention|Adverse Event|0|||
19580057|NCT00875017|42028717|FG002|Second Intervention|Adverse Event|0|||
19580058|NCT00875017|42028718|FG003|Second Intervention|Adverse Event|1|||
19580059|NCT00875017|42028719|FG004|Second Intervention|Adverse Event|0|||
19580060|NCT00875017|42028720|FG005|Second Intervention|Adverse Event|0|||
19580061|NCT00875017|42028715|FG000|Washout|Problems collecting rectal effluent|0|||
19580062|NCT00875017|42028716|FG001|Washout|Problems collecting rectal effluent|1|||
19580063|NCT00875017|42028717|FG002|Washout|Problems collecting rectal effluent|0|||
19580064|NCT00875017|42028718|FG003|Washout|Problems collecting rectal effluent|0|||
19580065|NCT00875017|42028719|FG004|Washout|Problems collecting rectal effluent|0|||
19580066|NCT00875017|42028720|FG005|Washout|Problems collecting rectal effluent|0|||
19580067|NCT00875017|42028715|FG000|Third Intervention|Adverse Event|0|||
19580068|NCT00875017|42028716|FG001|Third Intervention|Adverse Event|1|||
19580069|NCT00875017|42028717|FG002|Third Intervention|Adverse Event|1|||
19580070|NCT00875017|42028718|FG003|Third Intervention|Adverse Event|0|||
19580071|NCT00875017|42028719|FG004|Third Intervention|Adverse Event|0|||
19580072|NCT00875017|42028720|FG005|Third Intervention|Adverse Event|0|||
19580073|NCT00875017|42028715|FG000|Washout|Withdrawal by Subject|0|||
19580074|NCT00875017|42028716|FG001|Washout|Withdrawal by Subject|0|||
19580075|NCT00875017|42028717|FG002|Washout|Withdrawal by Subject|0|||
19580076|NCT00875017|42028718|FG003|Washout|Withdrawal by Subject|0|||
19580077|NCT00875017|42028719|FG004|Washout|Withdrawal by Subject|1|||
19580078|NCT00875017|42028720|FG005|Washout|Withdrawal by Subject|0|||
19580079|NCT00875017|42028715|FG000|Fourth Intervention|Inability to comply with fasting|0|||
19580080|NCT00875017|42028716|FG001|Fourth Intervention|Inability to comply with fasting|0|||
19580081|NCT00875017|42028717|FG002|Fourth Intervention|Inability to comply with fasting|0|||
19580082|NCT00875017|42028718|FG003|Fourth Intervention|Inability to comply with fasting|0|||
19580083|NCT00875017|42028719|FG004|Fourth Intervention|Inability to comply with fasting|0|||
19580084|NCT00875017|42028720|FG005|Fourth Intervention|Inability to comply with fasting|1|||
19580085|NCT00875797|42028745|FG000|Overall Study|Protocol Violation|6|||
19580086|NCT00875797|42028746|FG001|Overall Study|Protocol Violation|3|||
19580087|NCT00874939|42028772|FG000|Overall Study|Study terminated|4|||
19580088|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
19580089|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
19580090|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
19580091|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
19580092|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
19580093|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
19580094|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
19580095|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
19580096|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
19580097|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
19580098|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580099|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580100|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580101|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580102|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
19580103|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580104|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580105|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580106|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580107|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
19580108|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
19580109|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580110|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580111|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580112|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
19580113|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580114|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580115|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580116|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580117|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
19580118|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580119|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580120|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
19580121|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580122|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
19580123|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580124|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580125|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580126|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580127|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
19580128|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580129|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580130|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580131|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580132|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
19580133|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580134|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580135|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580136|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580137|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
19580138|NCT01185353|42028787|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
19580139|NCT01185353|42028788|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580140|NCT01185353|42028789|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580141|NCT01185353|42028790|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580142|NCT01185353|42028791|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
19580143|NCT01185353|42028792|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580144|NCT01185353|42028793|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580145|NCT01185353|42028794|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580146|NCT01185353|42028795|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580147|NCT01185353|42028796|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
19580148|NCT01185353|42028787|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580149|NCT01185353|42028788|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580150|NCT01185353|42028789|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
19580151|NCT01185353|42028790|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580152|NCT01185353|42028791|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580153|NCT01185353|42028792|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
19580154|NCT01185353|42028793|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580155|NCT01185353|42028794|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580156|NCT01185353|42028795|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580157|NCT01185353|42028796|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
19580158|NCT01185353|42028787|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580159|NCT01185353|42028788|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
19580160|NCT01185353|42028789|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580161|NCT01185353|42028790|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
19580162|NCT01185353|42028791|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580163|NCT01185353|42028792|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580164|NCT01185353|42028793|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580165|NCT01185353|42028794|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580166|NCT01185353|42028795|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580167|NCT01185353|42028796|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
19580168|NCT01185353|42028787|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580169|NCT01185353|42028788|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580170|NCT01185353|42028789|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580171|NCT01185353|42028790|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
19580172|NCT01185353|42028791|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580173|NCT01185353|42028792|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580174|NCT01185353|42028793|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
19580175|NCT01185353|42028794|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580176|NCT01185353|42028795|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580177|NCT01185353|42028796|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
19580178|NCT01185353|42028787|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580179|NCT01185353|42028788|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580180|NCT01185353|42028789|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
19580181|NCT01185353|42028790|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
19580182|NCT01185353|42028791|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580183|NCT01185353|42028792|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
19580184|NCT01185353|42028793|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
19580185|NCT01185353|42028794|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580186|NCT01185353|42028795|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580187|NCT01185353|42028796|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
19580188|NCT01185353|42028787|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580189|NCT01185353|42028788|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580190|NCT01185353|42028789|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580191|NCT01185353|42028790|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580192|NCT01185353|42028791|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580193|NCT01185353|42028792|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580194|NCT01185353|42028793|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
19580195|NCT01185353|42028794|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580196|NCT01185353|42028795|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580197|NCT01185353|42028796|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
19580198|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580199|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580200|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580201|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580202|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580203|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580204|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
19580205|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
19580206|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
19580207|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
19580208|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580209|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580210|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580211|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580212|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580213|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580214|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
19580215|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
19580216|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
19580217|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
19580218|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580219|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580220|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580221|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580222|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580223|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580224|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
19580225|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
19580226|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
19580227|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
19580228|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580229|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580230|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580231|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580232|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580233|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580234|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580235|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580236|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
19580237|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
19580238|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Death|0|||
19580239|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Death|0|||
19580240|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Death|0|||
19580241|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Death|0|||
19580242|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Death|0|||
19580243|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Death|0|||
19580244|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Death|0|||
19580245|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Death|0|||
19580246|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Death|0|||
19580247|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Death|1|||
19580248|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580249|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580250|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580251|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580252|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580253|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580254|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580255|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580256|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
19580257|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
19580258|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580259|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580260|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580261|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580262|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580263|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580264|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580265|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580266|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
19580267|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
19580268|NCT01185353|42028787|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580269|NCT01185353|42028788|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580270|NCT01185353|42028789|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580271|NCT01185353|42028790|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580272|NCT01185353|42028791|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580273|NCT01185353|42028792|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580274|NCT01185353|42028793|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580275|NCT01185353|42028794|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580276|NCT01185353|42028795|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
19580277|NCT01185353|42028796|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
19580278|NCT01185353|42028787|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19745900|NCT03529773|42193186|FG030|Overall Study|No longer meets eligibility criteria|0|||
19580279|NCT01185353|42028788|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580280|NCT01185353|42028789|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580281|NCT01185353|42028790|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580282|NCT01185353|42028791|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580283|NCT01185353|42028792|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580284|NCT01185353|42028793|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580285|NCT01185353|42028794|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
19580286|NCT01185353|42028795|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
19580287|NCT01185353|42028796|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
19580288|NCT01185353|42028787|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580289|NCT01185353|42028788|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580290|NCT01185353|42028789|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580291|NCT01185353|42028790|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580292|NCT01185353|42028791|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580293|NCT01185353|42028792|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580294|NCT01185353|42028793|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
19580295|NCT01185353|42028794|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
19580296|NCT01185353|42028795|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
19580297|NCT01185353|42028796|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
19580298|NCT01185353|42028787|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580299|NCT01185353|42028788|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580300|NCT01185353|42028789|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580301|NCT01185353|42028790|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580302|NCT01185353|42028791|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580303|NCT01185353|42028792|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580304|NCT01185353|42028793|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580305|NCT01185353|42028794|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
19580306|NCT01185353|42028795|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
19580307|NCT01185353|42028796|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
19580308|NCT00875563|42028835|FG000|Overall Study|Death|4|||
19580309|NCT00875563|42028835|FG000|Overall Study|Withdrawal by Subject|7|||
19580310|NCT00875563|42028835|FG000|Overall Study|No long-term (3-5 year) consent|6|||
19580311|NCT00875563|42028835|FG000|Overall Study|Still be eligible for follow-up|7|||
19580312|NCT01155869|42028841|FG000|Overall Study|Lost to Follow-up|3|||
19580313|NCT01155869|42028842|FG001|Overall Study|Lost to Follow-up|1|||
19580314|NCT01098240|42028848|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
19580315|NCT01098240|42028849|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
19580316|NCT01098240|42028850|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
19580317|NCT01098240|42028848|FG000|Open-Label Phase|Protocol Violation|4|||
19580318|NCT01098240|42028849|FG001|Open-Label Phase|Protocol Violation|0|||
19580319|NCT01098240|42028850|FG002|Open-Label Phase|Protocol Violation|0|||
19580320|NCT01098240|42028848|FG000|Open-Label Phase|Lost to Follow-up|13|||
19580321|NCT01098240|42028849|FG001|Open-Label Phase|Lost to Follow-up|0|||
19580322|NCT01098240|42028850|FG002|Open-Label Phase|Lost to Follow-up|0|||
19580323|NCT01098240|42028848|FG000|Open-Label Phase|Other|19|||
19580324|NCT01098240|42028849|FG001|Open-Label Phase|Other|0|||
19580325|NCT01098240|42028850|FG002|Open-Label Phase|Other|0|||
19580326|NCT01098240|42028848|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
19580327|NCT01098240|42028849|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
19580328|NCT01098240|42028850|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
19580329|NCT01098240|42028848|FG000|Open-Label Phase|Pregnancy|1|||
19580330|NCT01098240|42028849|FG001|Open-Label Phase|Pregnancy|0|||
19580331|NCT01098240|42028850|FG002|Open-Label Phase|Pregnancy|0|||
19580332|NCT01098240|42028848|FG000|Open-Label Phase|Withdrawal by Subject|9|||
19580333|NCT01098240|42028849|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19580334|NCT01098240|42028850|FG002|Open-Label Phase|Withdrawal by Subject|0|||
19580335|NCT01098240|42028848|FG000|Open-Label Phase|Adverse Event|12|||
19580336|NCT01098240|42028849|FG001|Open-Label Phase|Adverse Event|0|||
19580337|NCT01098240|42028850|FG002|Open-Label Phase|Adverse Event|0|||
19580338|NCT01098240|42028848|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
19580339|NCT01098240|42028849|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
19580340|NCT01098240|42028850|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
19580341|NCT01098240|42028848|FG000|Double-Blind Phase|Protocol Violation|0|||
19580342|NCT01098240|42028849|FG001|Double-Blind Phase|Protocol Violation|2|||
19580343|NCT01098240|42028850|FG002|Double-Blind Phase|Protocol Violation|4|||
19580344|NCT01098240|42028848|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19580345|NCT01098240|42028849|FG001|Double-Blind Phase|Lost to Follow-up|2|||
19580346|NCT01098240|42028850|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19580347|NCT01098240|42028848|FG000|Double-Blind Phase|Other|0|||
19580348|NCT01098240|42028849|FG001|Double-Blind Phase|Other|2|||
19580349|NCT01098240|42028850|FG002|Double-Blind Phase|Other|2|||
19580350|NCT01098240|42028848|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
19580351|NCT01098240|42028849|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
19580352|NCT01098240|42028850|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
19580353|NCT01098240|42028848|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
19580354|NCT01098240|42028849|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
19580355|NCT01098240|42028850|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
19580356|NCT01098240|42028848|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19580357|NCT01098240|42028849|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
19580358|NCT01098240|42028850|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
19580359|NCT01098240|42028848|FG000|Double-Blind Phase|Adverse Event|0|||
19580360|NCT01098240|42028849|FG001|Double-Blind Phase|Adverse Event|3|||
19580361|NCT01098240|42028850|FG002|Double-Blind Phase|Adverse Event|3|||
19580362|NCT01098162|42028857|FG000|Overall Study|Adverse Event|37|||
19580363|NCT01098162|42028857|FG000|Overall Study|Lack of Efficacy|4|||
19580364|NCT01098162|42028857|FG000|Overall Study|Wish of Patient|7|||
19580365|NCT01098162|42028857|FG000|Overall Study|Lost to Follow-up|9|||
19580366|NCT01098162|42028857|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
19580367|NCT01098162|42028857|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
19580368|NCT01098162|42028857|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
19580369|NCT01098162|42028857|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
19580370|NCT01098162|42028857|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
19580371|NCT01098162|42028857|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
19580372|NCT01098162|42028857|FG000|Overall Study|Other Reason|1|||
19580373|NCT01098162|42028857|FG000|Overall Study|Reason Unknown|26|||
19580374|NCT01097694|42028863|FG000|Overall Study|Adverse Event|5|||
19580375|NCT01097694|42028864|FG001|Overall Study|Adverse Event|0|||
19580376|NCT01097694|42028863|FG000|Overall Study|Lost to Follow-up|0|||
19580377|NCT01097694|42028864|FG001|Overall Study|Lost to Follow-up|3|||
19580378|NCT01097694|42028863|FG000|Overall Study|Withdrawal by Subject|3|||
19580379|NCT01097694|42028864|FG001|Overall Study|Withdrawal by Subject|1|||
19580380|NCT01102140|42028872|FG000|Overall Study|Lost to Follow-up|1|||
19580381|NCT01102140|42028873|FG001|Overall Study|Lost to Follow-up|0|||
19580382|NCT01102140|42028872|FG000|Overall Study|Investigator terminated study|2|||
19580383|NCT01102140|42028873|FG001|Overall Study|Investigator terminated study|2|||
19580384|NCT00874549|42028885|FG000|Overall Study|Adverse Event|0|||
19580385|NCT00874549|42028886|FG001|Overall Study|Adverse Event|0|||
19580386|NCT00874549|42028887|FG002|Overall Study|Adverse Event|1|||
19580387|NCT00874549|42028888|FG003|Overall Study|Adverse Event|0|||
19580388|NCT00874549|42028885|FG000|Overall Study|Protocol Violation|1|||
19580389|NCT00874549|42028886|FG001|Overall Study|Protocol Violation|0|||
19580390|NCT00874549|42028887|FG002|Overall Study|Protocol Violation|2|||
19580391|NCT00874549|42028888|FG003|Overall Study|Protocol Violation|1|||
19580392|NCT00874549|42028885|FG000|Overall Study|Lost to Follow-up|0|||
19580393|NCT00874549|42028886|FG001|Overall Study|Lost to Follow-up|0|||
19580394|NCT00874549|42028887|FG002|Overall Study|Lost to Follow-up|1|||
19580395|NCT00874549|42028888|FG003|Overall Study|Lost to Follow-up|0|||
19580396|NCT00874549|42028885|FG000|Overall Study|Withdrawal by Subject|0|||
19580397|NCT00874549|42028886|FG001|Overall Study|Withdrawal by Subject|1|||
19580398|NCT00874549|42028887|FG002|Overall Study|Withdrawal by Subject|0|||
19580399|NCT00874549|42028888|FG003|Overall Study|Withdrawal by Subject|1|||
19580400|NCT01155479|42028903|FG000|Part I|Adverse Event|13|||
19580401|NCT01155479|42028904|FG001|Part I|Adverse Event|8|||
19580402|NCT01155479|42028905|FG002|Part I|Adverse Event|18|||
19580403|NCT01155479|42028906|FG003|Part I|Adverse Event|7|||
19580404|NCT01155479|42028907|FG004|Part I|Adverse Event|6|||
19580405|NCT01155479|42028903|FG000|Part I|Administrative|2|||
19580406|NCT01155479|42028904|FG001|Part I|Administrative|2|||
19580407|NCT01155479|42028905|FG002|Part I|Administrative|2|||
19580408|NCT01155479|42028906|FG003|Part I|Administrative|0|||
19580409|NCT01155479|42028907|FG004|Part I|Administrative|0|||
19580410|NCT01155479|42028903|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
19580411|NCT01155479|42028904|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
19580412|NCT01155479|42028905|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
19580413|NCT01155479|42028906|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
19580414|NCT01155479|42028907|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
19580415|NCT01155479|42028903|FG000|Part I|Withdrawal by Subject|11|||
19580416|NCT01155479|42028904|FG001|Part I|Withdrawal by Subject|13|||
19580417|NCT01155479|42028905|FG002|Part I|Withdrawal by Subject|8|||
19580418|NCT01155479|42028906|FG003|Part I|Withdrawal by Subject|8|||
19580419|NCT01155479|42028907|FG004|Part I|Withdrawal by Subject|9|||
19580420|NCT01155479|42028903|FG000|Part I|Lost to Follow-up|0|||
19580421|NCT01155479|42028904|FG001|Part I|Lost to Follow-up|0|||
19580422|NCT01155479|42028905|FG002|Part I|Lost to Follow-up|1|||
19580423|NCT01155479|42028906|FG003|Part I|Lost to Follow-up|1|||
19580424|NCT01155479|42028907|FG004|Part I|Lost to Follow-up|0|||
19580425|NCT01155479|42028903|FG000|Part I|Treatment Failure|3|||
19580426|NCT01155479|42028904|FG001|Part I|Treatment Failure|0|||
19580427|NCT01155479|42028905|FG002|Part I|Treatment Failure|3|||
19580428|NCT01155479|42028906|FG003|Part I|Treatment Failure|1|||
19580429|NCT01155479|42028907|FG004|Part I|Treatment Failure|2|||
19580430|NCT01155479|42028903|FG000|Part I|Did Not Receive Treatment|4|||
19580431|NCT01155479|42028904|FG001|Part I|Did Not Receive Treatment|2|||
19580432|NCT01155479|42028905|FG002|Part I|Did Not Receive Treatment|2|||
19580433|NCT01155479|42028906|FG003|Part I|Did Not Receive Treatment|6|||
19580434|NCT01155479|42028907|FG004|Part I|Did Not Receive Treatment|1|||
19580435|NCT01155479|42028903|FG000|Part I|Non-Compliance with Protocol|2|||
19580436|NCT01155479|42028904|FG001|Part I|Non-Compliance with Protocol|1|||
19580437|NCT01155479|42028905|FG002|Part I|Non-Compliance with Protocol|3|||
19580438|NCT01155479|42028906|FG003|Part I|Non-Compliance with Protocol|3|||
19580439|NCT01155479|42028907|FG004|Part I|Non-Compliance with Protocol|2|||
19580440|NCT01155479|42028903|FG000|Part II|Adverse Event|7|||
19580441|NCT01155479|42028904|FG001|Part II|Adverse Event|6|||
19580442|NCT01155479|42028905|FG002|Part II|Adverse Event|8|||
19580443|NCT01155479|42028906|FG003|Part II|Adverse Event|3|||
19580444|NCT01155479|42028907|FG004|Part II|Adverse Event|4|||
19580445|NCT01155479|42028903|FG000|Part II|Administrative|43|||
19580446|NCT01155479|42028904|FG001|Part II|Administrative|49|||
19580447|NCT01155479|42028905|FG002|Part II|Administrative|36|||
19580448|NCT01155479|42028906|FG003|Part II|Administrative|38|||
19580449|NCT01155479|42028907|FG004|Part II|Administrative|46|||
19580450|NCT01155479|42028903|FG000|Part II|Withdrawal by Subject|8|||
19580451|NCT01155479|42028904|FG001|Part II|Withdrawal by Subject|4|||
19580452|NCT01155479|42028905|FG002|Part II|Withdrawal by Subject|12|||
19580453|NCT01155479|42028906|FG003|Part II|Withdrawal by Subject|7|||
19580454|NCT01155479|42028907|FG004|Part II|Withdrawal by Subject|3|||
19580455|NCT01155479|42028903|FG000|Part II|Lost to Follow-up|1|||
19580456|NCT01155479|42028904|FG001|Part II|Lost to Follow-up|0|||
19580457|NCT01155479|42028905|FG002|Part II|Lost to Follow-up|0|||
19580458|NCT01155479|42028906|FG003|Part II|Lost to Follow-up|0|||
19580459|NCT01155479|42028907|FG004|Part II|Lost to Follow-up|1|||
19580460|NCT01155479|42028903|FG000|Part II|Treatment Failure|0|||
19580461|NCT01155479|42028904|FG001|Part II|Treatment Failure|1|||
19580462|NCT01155479|42028905|FG002|Part II|Treatment Failure|2|||
19580463|NCT01155479|42028906|FG003|Part II|Treatment Failure|0|||
19580464|NCT01155479|42028907|FG004|Part II|Treatment Failure|1|||
19580465|NCT01155479|42028903|FG000|Part II|Non-Compliance with Protocol|0|||
19580466|NCT01155479|42028904|FG001|Part II|Non-Compliance with Protocol|1|||
19580467|NCT01155479|42028905|FG002|Part II|Non-Compliance with Protocol|0|||
19580468|NCT01155479|42028906|FG003|Part II|Non-Compliance with Protocol|2|||
19580469|NCT01155479|42028907|FG004|Part II|Non-Compliance with Protocol|0|||
19580470|NCT01155323|42028935|FG000|First Intervention|exclusion criteria|1|||
19580471|NCT01155323|42028936|FG001|First Intervention|exclusion criteria|1|||
19580472|NCT01155323|42028935|FG000|Second Intervention|Lost to Follow-up|1|||
19580473|NCT01155323|42028936|FG001|Second Intervention|Lost to Follow-up|1|||
19580474|NCT01155167|42028944|FG000|Overall Study|Insufficient ultrasound data|2|||
19580475|NCT01155167|42028945|FG001|Overall Study|Insufficient ultrasound data|0|||
19580476|NCT01155167|42028944|FG000|Overall Study|Access site changed to femoral artery|1|||
19580477|NCT01155167|42028945|FG001|Overall Study|Access site changed to femoral artery|0|||
19580478|NCT01106586|42028953|FG000|Overall Study|Adverse Event|9|||
19580479|NCT01106586|42028954|FG001|Overall Study|Adverse Event|15|||
19580480|NCT01106586|42028953|FG000|Overall Study|Death|1|||
19580481|NCT01106586|42028954|FG001|Overall Study|Death|3|||
19745901|NCT03529773|42193187|FG031|Overall Study|No longer meets eligibility criteria|0|||
19580482|NCT01106586|42028953|FG000|Overall Study|Pregnancy|2|||
19580483|NCT01106586|42028954|FG001|Overall Study|Pregnancy|2|||
19580484|NCT01106586|42028953|FG000|Overall Study|Lack of Efficacy|1|||
19580485|NCT01106586|42028954|FG001|Overall Study|Lack of Efficacy|0|||
19580486|NCT01106586|42028953|FG000|Overall Study|Investigator's Discretion|5|||
19580487|NCT01106586|42028954|FG001|Overall Study|Investigator's Discretion|8|||
19580488|NCT01106586|42028953|FG000|Overall Study|Withdrew Consent|18|||
19580489|NCT01106586|42028954|FG001|Overall Study|Withdrew Consent|30|||
19580490|NCT01106586|42028953|FG000|Overall Study|Lost to Follow-up|24|||
19580491|NCT01106586|42028954|FG001|Overall Study|Lost to Follow-up|20|||
19580492|NCT01106586|42028953|FG000|Overall Study|Participant Noncompliance|12|||
19580493|NCT01106586|42028954|FG001|Overall Study|Participant Noncompliance|10|||
19580494|NCT01106586|42028953|FG000|Overall Study|Protocol Violation|1|||
19580495|NCT01106586|42028954|FG001|Overall Study|Protocol Violation|0|||
19580496|NCT01106586|42028953|FG000|Overall Study|Participant Transferred to Another Study|212|||
19580497|NCT01106586|42028954|FG001|Overall Study|Participant Transferred to Another Study|197|||
19580498|NCT01155011|42028962|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
19580499|NCT01155011|42028963|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
19580500|NCT01155011|42028962|FG000|Baseline to 6 Months|investigator decision, moved|4|||
19580501|NCT01155011|42028963|FG001|Baseline to 6 Months|investigator decision, moved|5|||
19580502|NCT01155011|42028962|FG000|Baseline to 6 Months|Death|0|||
19580503|NCT01155011|42028963|FG001|Baseline to 6 Months|Death|1|||
19580504|NCT01155011|42028962|FG000|6 to 12 Months|Withdrawal by Subject|8|||
19580505|NCT01155011|42028963|FG001|6 to 12 Months|Withdrawal by Subject|5|||
19580506|NCT01155011|42028962|FG000|6 to 12 Months|Death|1|||
19580507|NCT01155011|42028963|FG001|6 to 12 Months|Death|5|||
19580508|NCT01106430|42028975|FG000|Overall Study|Adverse Event|8|||
19580509|NCT01106430|42028976|FG001|Overall Study|Adverse Event|10|||
19580510|NCT01106430|42028975|FG000|Overall Study|Lack of Efficacy|2|||
19580511|NCT01106430|42028976|FG001|Overall Study|Lack of Efficacy|13|||
19580512|NCT01106430|42028975|FG000|Overall Study|Lost to Follow-up|5|||
19580513|NCT01106430|42028976|FG001|Overall Study|Lost to Follow-up|1|||
19580514|NCT01106430|42028975|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
19580515|NCT01106430|42028976|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
19580516|NCT01106430|42028975|FG000|Overall Study|Moved Out Of State|0|||
19580517|NCT01106430|42028976|FG001|Overall Study|Moved Out Of State|1|||
19580518|NCT01106430|42028975|FG000|Overall Study|Refused To Take Medication|0|||
19580519|NCT01106430|42028976|FG001|Overall Study|Refused To Take Medication|1|||
19580520|NCT01106430|42028975|FG000|Overall Study|Noncompliance|0|||
19580521|NCT01106430|42028976|FG001|Overall Study|Noncompliance|1|||
19580522|NCT01106430|42028975|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
19580523|NCT01106430|42028976|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
19580524|NCT01106430|42028975|FG000|Overall Study|Previous Use Of Marijuana|1|||
19580525|NCT01106430|42028976|FG001|Overall Study|Previous Use Of Marijuana|0|||
19580526|NCT01106430|42028975|FG000|Overall Study|Protocol Violation|7|||
19580527|NCT01106430|42028976|FG001|Overall Study|Protocol Violation|2|||
19580528|NCT01106430|42028975|FG000|Overall Study|Withdrawal by Subject|8|||
19580529|NCT01106430|42028976|FG001|Overall Study|Withdrawal by Subject|4|||
19580530|NCT01154231|42028982|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
19580531|NCT01154231|42028982|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
19580532|NCT01154153|42028988|FG000|Overall Study|Poor compliance to protocol|2|||
19580533|NCT01154153|42028989|FG001|Overall Study|Poor compliance to protocol|0|||
19580534|NCT01154153|42028988|FG000|Overall Study|Unable to use labs|2|||
19580535|NCT01154153|42028989|FG001|Overall Study|Unable to use labs|3|||
19580536|NCT01154153|42028988|FG000|Overall Study|Withdrew consent|1|||
19580537|NCT01154153|42028989|FG001|Overall Study|Withdrew consent|0|||
19580538|NCT00874237|42028995|FG000|Overall Study|Physician Decision|0|||
19580539|NCT00874237|42028996|FG001|Overall Study|Physician Decision|1|||
19580540|NCT00874237|42028997|FG002|Overall Study|Physician Decision|0|||
19580541|NCT00874237|42028998|FG003|Overall Study|Physician Decision|0|||
19580542|NCT00874237|42028999|FG004|Overall Study|Physician Decision|0|||
19580543|NCT00874237|42029000|FG005|Overall Study|Physician Decision|0|||
19580544|NCT00874237|42028995|FG000|Overall Study|Withdrawal by Subject|0|||
19580545|NCT00874237|42028996|FG001|Overall Study|Withdrawal by Subject|0|||
19580546|NCT00874237|42028997|FG002|Overall Study|Withdrawal by Subject|1|||
19580547|NCT00874237|42028998|FG003|Overall Study|Withdrawal by Subject|0|||
19580548|NCT00874237|42028999|FG004|Overall Study|Withdrawal by Subject|0|||
19580549|NCT00874237|42029000|FG005|Overall Study|Withdrawal by Subject|0|||
19580550|NCT01153841|42029012|FG000|Overall Study|Adverse Event|1|||
19580551|NCT01153841|42029013|FG001|Overall Study|Adverse Event|0|||
19580552|NCT01153841|42029012|FG000|Overall Study|Withdrawal by Subject|1|||
19580553|NCT01153841|42029013|FG001|Overall Study|Withdrawal by Subject|0|||
19580554|NCT01153841|42029012|FG000|Overall Study|Protocol Violation|2|||
19580555|NCT01153841|42029013|FG001|Overall Study|Protocol Violation|0|||
19580556|NCT01153841|42029012|FG000|Overall Study|Lost to Follow-up|2|||
19580557|NCT01153841|42029013|FG001|Overall Study|Lost to Follow-up|0|||
19580558|NCT01153763|42029019|FG000|Overall Study|Study Closed|16|||
19580559|NCT01153763|42029019|FG000|Overall Study|Lost to Follow-up|1|||
19580560|NCT01153763|42029019|FG000|Overall Study|Physician Decision|2|||
19580561|NCT01153763|42029019|FG000|Overall Study|Withdrawal by Subject|2|||
19580562|NCT00871741|42029025|FG000|Overall Study|Premature study termination|9|||
19580563|NCT00871741|42029026|FG001|Overall Study|Premature study termination|7|||
19580564|NCT01152437|42029035|FG000|Overall Study|Other Adverse Event|8|||
19580565|NCT01152437|42029036|FG001|Overall Study|Other Adverse Event|1|||
19580566|NCT01152437|42029037|FG002|Overall Study|Other Adverse Event|7|||
19580567|NCT01152437|42029035|FG000|Overall Study|Not treated|0|||
19580568|NCT01152437|42029036|FG001|Overall Study|Not treated|1|||
19580569|NCT01152437|42029037|FG002|Overall Study|Not treated|2|||
19580570|NCT01152437|42029035|FG000|Overall Study|Progressive disease|27|||
19580571|NCT01152437|42029036|FG001|Overall Study|Progressive disease|13|||
19580572|NCT01152437|42029037|FG002|Overall Study|Progressive disease|32|||
19580573|NCT01152437|42029035|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
19580574|NCT01152437|42029036|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
19580575|NCT01152437|42029037|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
19580576|NCT01151579|42029049|FG000|Overall Study|Physician Decision|3|||
19580577|NCT01151579|42029050|FG001|Overall Study|Physician Decision|1|||
19580578|NCT01151579|42029049|FG000|Overall Study|Withdrawal by Subject|3|||
19580579|NCT01151579|42029050|FG001|Overall Study|Withdrawal by Subject|2|||
19580580|NCT01151579|42029049|FG000|Overall Study|Not meet inclusion criteria|6|||
19580581|NCT01151579|42029050|FG001|Overall Study|Not meet inclusion criteria|4|||
19580582|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
19580583|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
19580584|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
19580585|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19580586|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19580587|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19580588|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19580589|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
19580590|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
19580591|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
19580592|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
19580593|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19580594|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19580595|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19580596|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19580597|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
19580598|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
19580599|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
19580600|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
19580601|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19580602|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19580603|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19580604|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19580605|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
19580606|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
19580607|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
19580608|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580609|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580610|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580611|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580612|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580613|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
19580614|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
19580615|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
19580616|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
19580617|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19580618|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19580619|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19580620|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19580621|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
19580622|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
19580623|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
19580624|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580625|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580626|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580627|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580628|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580629|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
19580630|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
19580631|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
19580632|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580633|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580634|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580635|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580636|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580637|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
19580638|NCT01097616|42029059|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580639|NCT01097616|42029060|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580640|NCT01097616|42029061|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
19580641|NCT01097616|42029062|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580642|NCT01097616|42029063|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580643|NCT01097616|42029064|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580644|NCT01097616|42029065|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580645|NCT01097616|42029066|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
19580646|NCT01097616|42029059|FG000|Optional DB EXT Phase|Adverse Event|0|||
19580647|NCT01097616|42029060|FG001|Optional DB EXT Phase|Adverse Event|7|||
19580648|NCT01097616|42029061|FG002|Optional DB EXT Phase|Adverse Event|2|||
19580649|NCT01097616|42029062|FG003|Optional DB EXT Phase|Adverse Event|0|||
19580650|NCT01097616|42029063|FG004|Optional DB EXT Phase|Adverse Event|0|||
19580651|NCT01097616|42029064|FG005|Optional DB EXT Phase|Adverse Event|0|||
19580652|NCT01097616|42029065|FG006|Optional DB EXT Phase|Adverse Event|0|||
19580653|NCT01097616|42029066|FG007|Optional DB EXT Phase|Adverse Event|0|||
19580654|NCT01097616|42029059|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
19580655|NCT01097616|42029060|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
19580656|NCT01097616|42029061|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
19580657|NCT01097616|42029062|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
19580658|NCT01097616|42029063|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
19580659|NCT01097616|42029064|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
19580660|NCT01097616|42029065|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
19580661|NCT01097616|42029066|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
19580662|NCT01097616|42029059|FG000|Optional DB EXT Phase|Protocol Violation|0|||
19580663|NCT01097616|42029060|FG001|Optional DB EXT Phase|Protocol Violation|2|||
19580664|NCT01097616|42029061|FG002|Optional DB EXT Phase|Protocol Violation|3|||
19580665|NCT01097616|42029062|FG003|Optional DB EXT Phase|Protocol Violation|0|||
19580666|NCT01097616|42029063|FG004|Optional DB EXT Phase|Protocol Violation|0|||
19580667|NCT01097616|42029064|FG005|Optional DB EXT Phase|Protocol Violation|0|||
19580668|NCT01097616|42029065|FG006|Optional DB EXT Phase|Protocol Violation|0|||
19580669|NCT01097616|42029066|FG007|Optional DB EXT Phase|Protocol Violation|0|||
19580670|NCT01097616|42029059|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
19580671|NCT01097616|42029060|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
19580672|NCT01097616|42029061|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
19580673|NCT01097616|42029062|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
19580674|NCT01097616|42029063|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
19580675|NCT01097616|42029064|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
19580676|NCT01097616|42029065|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
19580677|NCT01097616|42029066|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
19580678|NCT01097616|42029059|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
19580679|NCT01097616|42029060|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
19580680|NCT01097616|42029061|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
19580681|NCT01097616|42029062|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
19580682|NCT01097616|42029063|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
19580683|NCT01097616|42029064|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
19580684|NCT01097616|42029065|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
19580685|NCT01097616|42029066|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
19580686|NCT01097616|42029059|FG000|Optional DB EXT Phase|Physician Decision|1|||
19580687|NCT01097616|42029060|FG001|Optional DB EXT Phase|Physician Decision|0|||
19580688|NCT01097616|42029061|FG002|Optional DB EXT Phase|Physician Decision|0|||
19580689|NCT01097616|42029062|FG003|Optional DB EXT Phase|Physician Decision|0|||
19580690|NCT01097616|42029063|FG004|Optional DB EXT Phase|Physician Decision|0|||
19580691|NCT01097616|42029064|FG005|Optional DB EXT Phase|Physician Decision|0|||
19580692|NCT01097616|42029065|FG006|Optional DB EXT Phase|Physician Decision|0|||
19580693|NCT01097616|42029066|FG007|Optional DB EXT Phase|Physician Decision|0|||
19580694|NCT01097616|42029059|FG000|DB RO Phase|Adverse Event|0|||
19580695|NCT01097616|42029060|FG001|DB RO Phase|Adverse Event|0|||
19580696|NCT01097616|42029061|FG002|DB RO Phase|Adverse Event|0|||
19580697|NCT01097616|42029062|FG003|DB RO Phase|Adverse Event|0|||
19580698|NCT01097616|42029063|FG004|DB RO Phase|Adverse Event|0|||
19580699|NCT01097616|42029064|FG005|DB RO Phase|Adverse Event|0|||
19580700|NCT01097616|42029065|FG006|DB RO Phase|Adverse Event|1|||
19580701|NCT01097616|42029066|FG007|DB RO Phase|Adverse Event|0|||
19580702|NCT01097616|42029059|FG000|DB RO Phase|Withdrawal by Subject|0|||
19580703|NCT01097616|42029060|FG001|DB RO Phase|Withdrawal by Subject|0|||
19580704|NCT01097616|42029061|FG002|DB RO Phase|Withdrawal by Subject|0|||
19580705|NCT01097616|42029062|FG003|DB RO Phase|Withdrawal by Subject|0|||
19580706|NCT01097616|42029063|FG004|DB RO Phase|Withdrawal by Subject|0|||
19580707|NCT01097616|42029064|FG005|DB RO Phase|Withdrawal by Subject|1|||
19580708|NCT01097616|42029065|FG006|DB RO Phase|Withdrawal by Subject|0|||
19580709|NCT01097616|42029066|FG007|DB RO Phase|Withdrawal by Subject|0|||
19580710|NCT01097616|42029059|FG000|DB RO Phase|Lost to Follow-up|0|||
19580711|NCT01097616|42029060|FG001|DB RO Phase|Lost to Follow-up|0|||
19580712|NCT01097616|42029061|FG002|DB RO Phase|Lost to Follow-up|0|||
19580713|NCT01097616|42029062|FG003|DB RO Phase|Lost to Follow-up|1|||
19580714|NCT01097616|42029063|FG004|DB RO Phase|Lost to Follow-up|1|||
19580715|NCT01097616|42029064|FG005|DB RO Phase|Lost to Follow-up|0|||
19580716|NCT01097616|42029065|FG006|DB RO Phase|Lost to Follow-up|0|||
19580717|NCT01097616|42029066|FG007|DB RO Phase|Lost to Follow-up|1|||
19580718|NCT01097616|42029059|FG000|DB RO Phase|Not Treated in RO|0|||
19580719|NCT01097616|42029060|FG001|DB RO Phase|Not Treated in RO|0|||
19580720|NCT01097616|42029061|FG002|DB RO Phase|Not Treated in RO|0|||
19580721|NCT01097616|42029062|FG003|DB RO Phase|Not Treated in RO|0|||
19580722|NCT01097616|42029063|FG004|DB RO Phase|Not Treated in RO|0|||
19580723|NCT01097616|42029064|FG005|DB RO Phase|Not Treated in RO|1|||
19580724|NCT01097616|42029065|FG006|DB RO Phase|Not Treated in RO|0|||
19580725|NCT01097616|42029066|FG007|DB RO Phase|Not Treated in RO|0|||
19580726|NCT00871429|42029092|FG000|Overall Study|Lost to Follow-up|6|||
19580727|NCT00871429|42029092|FG000|Overall Study|Withdrawal by Subject|17|||
19580728|NCT00871429|42029092|FG000|Overall Study|Questionnaire not completed|1|||
19580729|NCT01151345|42029100|FG000|First Intervention Period|Protocol Violation|0|||
19580730|NCT01151345|42029101|FG001|First Intervention Period|Protocol Violation|1|||
19580731|NCT00593827|42029109|FG000|Overall Study|On Active Treatment/Pending|0|||
19580732|NCT00593827|42029110|FG001|Overall Study|On Active Treatment/Pending|2|||
19580733|NCT01150097|42029119|FG000|Months 24 to 36 Post-transplantation|Death|2|||
19580734|NCT01150097|42029120|FG001|Months 24 to 36 Post-transplantation|Death|0|||
19580735|NCT01150097|42029121|FG002|Months 24 to 36 Post-transplantation|Death|0|||
19580736|NCT01150097|42029119|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
19580737|NCT01150097|42029120|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
19580738|NCT01150097|42029121|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
19580739|NCT01150097|42029119|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
19580740|NCT01150097|42029120|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
19580741|NCT01150097|42029121|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
19580742|NCT01150097|42029119|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
19580743|NCT01150097|42029120|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
19580744|NCT01150097|42029121|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
19580745|NCT01150097|42029119|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
19580746|NCT01150097|42029120|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
19580747|NCT01150097|42029121|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
19580748|NCT01150097|42029119|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
19580749|NCT01150097|42029120|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
19580750|NCT01150097|42029121|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
19580751|NCT01150097|42029119|FG000|Months 24 to 48 Post-transplantation|Death|2|||
19580752|NCT01150097|42029120|FG001|Months 24 to 48 Post-transplantation|Death|0|||
19580753|NCT01150097|42029121|FG002|Months 24 to 48 Post-transplantation|Death|0|||
19580754|NCT01149863|42029131|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
19580755|NCT01149473|42029137|FG000|First Intervention|Adverse Event|1|||
19580756|NCT01149473|42029138|FG001|First Intervention|Adverse Event|1|||
19580757|NCT01149473|42029137|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19580758|NCT01149473|42029138|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
19580759|NCT00872989|42029146|FG000|Overall Study|Adverse Event|7|||
19580760|NCT00872989|42029147|FG001|Overall Study|Adverse Event|15|||
19580761|NCT00872989|42029146|FG000|Overall Study|Withdrawal by Subject|8|||
19580762|NCT00872989|42029147|FG001|Overall Study|Withdrawal by Subject|5|||
19580763|NCT00872989|42029146|FG000|Overall Study|Progression/relapse|47|||
19580764|NCT00872989|42029147|FG001|Overall Study|Progression/relapse|35|||
19580765|NCT00872989|42029146|FG000|Overall Study|Not protocol specified|3|||
19580766|NCT00872989|42029147|FG001|Overall Study|Not protocol specified|8|||
19580767|NCT01148771|42029161|FG000|Washout Period|Withdrawal by Subject|0|||
19580768|NCT01148771|42029162|FG001|Washout Period|Withdrawal by Subject|1|||
19580769|NCT01148693|42029174|FG000|Overall Study|Attempts for cannulation were failed|13|||
19580770|NCT01148693|42029175|FG001|Overall Study|Attempts for cannulation were failed|10|||
19580771|NCT00872599|42029181|FG000|Second Washout Period|Adverse Event|1|||
19580772|NCT00872599|42029182|FG001|Second Washout Period|Adverse Event|1|||
19580773|NCT01148537|42029191|FG000|Overall Study|Withdrawal by Subject|1|||
19580774|NCT01148537|42029192|FG001|Overall Study|Withdrawal by Subject|0|||
19580775|NCT01148537|42029193|FG002|Overall Study|Withdrawal by Subject|2|||
19580776|NCT01148537|42029191|FG000|Overall Study|Adverse Event|2|||
19580777|NCT01148537|42029192|FG001|Overall Study|Adverse Event|0|||
19580778|NCT01148537|42029193|FG002|Overall Study|Adverse Event|1|||
19580779|NCT01148459|42029204|FG000|Overall Study|Serious Adverse Event|5|||
19580780|NCT01148459|42029205|FG001|Overall Study|Serious Adverse Event|4|||
19580781|NCT01148459|42029204|FG000|Overall Study|Withdrawal by Subject|1|||
19580782|NCT01148459|42029205|FG001|Overall Study|Withdrawal by Subject|0|||
19580783|NCT01148459|42029204|FG000|Overall Study|Migrated/moved from study area|3|||
19580784|NCT01148459|42029205|FG001|Overall Study|Migrated/moved from study area|6|||
19580785|NCT01148459|42029204|FG000|Overall Study|Lost to Follow-up|2|||
19580786|NCT01148459|42029205|FG001|Overall Study|Lost to Follow-up|0|||
19580787|NCT01148459|42029204|FG000|Overall Study|Refusal|1|||
19580788|NCT01148459|42029205|FG001|Overall Study|Refusal|0|||
19580789|NCT01148459|42029204|FG000|Overall Study|Failure to comply with study procedures|0|||
19580790|NCT01148459|42029205|FG001|Overall Study|Failure to comply with study procedures|1|||
19580791|NCT00872521|42029214|FG000|Completed PAD Induction|Patient choice|0|||
19580792|NCT00872521|42029215|FG001|Completed PAD Induction|Patient choice|1|||
19580793|NCT00872521|42029216|FG002|Completed PAD Induction|Patient choice|0|||
19580794|NCT00872521|42029214|FG000|Completed PAD Induction|Disease progression|0|||
19580795|NCT00872521|42029215|FG001|Completed PAD Induction|Disease progression|2|||
19580796|NCT00872521|42029216|FG002|Completed PAD Induction|Disease progression|0|||
19580797|NCT00872521|42029214|FG000|Completed PAD Induction|Adverse Event|4|||
19580798|NCT00872521|42029215|FG001|Completed PAD Induction|Adverse Event|0|||
19580799|NCT00872521|42029216|FG002|Completed PAD Induction|Adverse Event|0|||
19580800|NCT00872521|42029214|FG000|Completed PAD Induction|Death|1|||
19580801|NCT00872521|42029215|FG001|Completed PAD Induction|Death|1|||
19580802|NCT00872521|42029216|FG002|Completed PAD Induction|Death|0|||
19580803|NCT00872521|42029214|FG000|Primary Endpoint Analysis|Other|1|||
19580804|NCT00872521|42029215|FG001|Primary Endpoint Analysis|Other|2|||
19580805|NCT00872521|42029216|FG002|Primary Endpoint Analysis|Other|0|||
19580806|NCT00872521|42029214|FG000|Primary Endpoint Analysis|Patient choice|0|||
19580807|NCT00872521|42029215|FG001|Primary Endpoint Analysis|Patient choice|1|||
19580808|NCT00872521|42029216|FG002|Primary Endpoint Analysis|Patient choice|0|||
19580809|NCT00872521|42029214|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
19580810|NCT00872521|42029215|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
19580811|NCT00872521|42029216|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
19580812|NCT00872521|42029214|FG000|Primary Endpoint Analysis|Patient response missing|0|||
19580813|NCT00872521|42029215|FG001|Primary Endpoint Analysis|Patient response missing|0|||
19580814|NCT00872521|42029216|FG002|Primary Endpoint Analysis|Patient response missing|1|||
19580815|NCT00872521|42029214|FG000|Completed 3-month Follow up|Other|0|||
19580816|NCT00872521|42029215|FG001|Completed 3-month Follow up|Other|2|||
19580817|NCT00872521|42029216|FG002|Completed 3-month Follow up|Other|0|||
19580818|NCT00872521|42029214|FG000|Completed 3-month Follow up|Physician Decision|0|||
19580819|NCT00872521|42029215|FG001|Completed 3-month Follow up|Physician Decision|1|||
19580820|NCT00872521|42029216|FG002|Completed 3-month Follow up|Physician Decision|0|||
19580821|NCT00872521|42029214|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
19580822|NCT00872521|42029215|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
19580823|NCT00872521|42029216|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
19580824|NCT01148225|42029235|FG000|Overall Study|Other|185|||
19580825|NCT01190891|42029244|FG000|Overall Study|Protocol Violation|1|||
19580826|NCT01190891|42029245|FG001|Overall Study|Protocol Violation|0|||
19580827|NCT01190891|42029244|FG000|Overall Study|Withdrawal by Subject|5|||
19580828|NCT01190891|42029245|FG001|Overall Study|Withdrawal by Subject|0|||
19580829|NCT00871975|42029251|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
19580830|NCT00871975|42029251|FG000|Overall Study|Catheters could not be inserted|1|||
19580831|NCT00871975|42029251|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
19580832|NCT00871975|42029251|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
19580833|NCT01190813|42029257|FG000|Overall Study|Lost to Follow-up|1|||
19580834|NCT01190813|42029258|FG001|Overall Study|Lost to Follow-up|2|||
19580835|NCT01190813|42029257|FG000|Overall Study|Withdrawal by Subject|2|||
19580836|NCT01190813|42029258|FG001|Overall Study|Withdrawal by Subject|1|||
19580837|NCT01190813|42029257|FG000|Overall Study|Refused study treatment after randomized|1|||
19580838|NCT01190813|42029258|FG001|Overall Study|Refused study treatment after randomized|0|||
19580839|NCT01190813|42029257|FG000|Overall Study|Adverse Event|0|||
19580840|NCT01190813|42029258|FG001|Overall Study|Adverse Event|1|||
19580841|NCT00870727|42029280|FG000|Overall Study|Lost to Follow-up|0|||
19580842|NCT00870727|42029281|FG001|Overall Study|Lost to Follow-up|1|||
19580843|NCT00870727|42029280|FG000|Overall Study|Lack of Efficacy|1|||
19580844|NCT00870727|42029281|FG001|Overall Study|Lack of Efficacy|3|||
19580845|NCT00870727|42029280|FG000|Overall Study|Adverse Event|0|||
19580846|NCT00870727|42029281|FG001|Overall Study|Adverse Event|1|||
19580847|NCT01147055|42029287|FG000|First Intervention Period|Lost to Follow-up|1|||
19580848|NCT01147055|42029288|FG001|First Intervention Period|Lost to Follow-up|0|||
19580849|NCT01146665|42029296|FG000|Overall Study|Withdrawal by Subject|10|||
19580850|NCT01146665|42029297|FG001|Overall Study|Withdrawal by Subject|16|||
19580851|NCT01145885|42029312|FG000|Overall Study|Progressive Disease|7|||
19580852|NCT01190267|42029324|FG000|Overall Study|Adverse Event|10|||
19580853|NCT01190267|42029325|FG001|Overall Study|Adverse Event|0|||
19580854|NCT01190267|42029324|FG000|Overall Study|Treatment Failure|8|||
19580855|NCT01190267|42029325|FG001|Overall Study|Treatment Failure|2|||
19580856|NCT01190267|42029324|FG000|Overall Study|Lost to Follow-up|2|||
19580857|NCT01190267|42029325|FG001|Overall Study|Lost to Follow-up|0|||
19580858|NCT01190267|42029324|FG000|Overall Study|Withdrawal by Subject|13|||
19580859|NCT01190267|42029325|FG001|Overall Study|Withdrawal by Subject|1|||
19580860|NCT01190267|42029324|FG000|Overall Study|Protocol Violation|8|||
19580861|NCT01190267|42029325|FG001|Overall Study|Protocol Violation|1|||
19580862|NCT00869089|42029331|FG000|Overall Study|Lost to Follow-up|1|||
19580863|NCT00869089|42029331|FG000|Overall Study|Withdrawal by Subject|1|||
19580864|NCT00869089|42029331|FG000|Overall Study|Screen Fail|1|||
19580865|NCT01190189|42029335|FG000|Overall Study|Lost to Follow-up|4|||
19580866|NCT01190189|42029335|FG000|Overall Study|Withdrawal by Subject|1|||
19580867|NCT01190189|42029335|FG000|Overall Study|Migrated/moved from study area|1|||
19580868|NCT00871117|42029341|FG000|Overall Study|Lost to Follow-up|5|||
19580869|NCT00871117|42029342|FG001|Overall Study|Lost to Follow-up|6|||
19580870|NCT00871117|42029341|FG000|Overall Study|Other|0|||
19580871|NCT00871117|42029342|FG001|Overall Study|Other|4|||
19580872|NCT01145495|42029349|FG000|Overall Study|Adverse Event|6|||
19580873|NCT01145495|42029349|FG000|Overall Study|Withdrawal by Subject|5|||
19580874|NCT01145495|42029349|FG000|Overall Study|Disease progression after respone|1|||
19580875|NCT00870103|42029353|FG000|Overall Study|Physician Decision|2|||
19580876|NCT00870103|42029353|FG000|Overall Study|Lost to Follow-up|2|||
19580877|NCT01145417|42029372|FG000|Overall Study|Death|1|||
19580878|NCT01145417|42029373|FG001|Overall Study|Death|0|||
19580879|NCT01145417|42029372|FG000|Overall Study|Lost to Follow-up|2|||
19580880|NCT01145417|42029373|FG001|Overall Study|Lost to Follow-up|1|||
19580881|NCT01145417|42029372|FG000|Overall Study|Withdrawal by Subject|1|||
19580882|NCT01145417|42029373|FG001|Overall Study|Withdrawal by Subject|2|||
19580883|NCT01145417|42029372|FG000|Overall Study|Pregnancy|1|||
19580884|NCT01145417|42029373|FG001|Overall Study|Pregnancy|0|||
19580885|NCT01145417|42029372|FG000|Overall Study|Adverse Event|0|||
19580886|NCT01145417|42029373|FG001|Overall Study|Adverse Event|1|||
19580887|NCT01145417|42029372|FG000|Overall Study|Study terminated by sponsor|35|||
19580888|NCT01145417|42029373|FG001|Overall Study|Study terminated by sponsor|43|||
19580889|NCT01145417|42029372|FG000|Overall Study|Other|1|||
19580890|NCT01145417|42029373|FG001|Overall Study|Other|0|||
19580891|NCT01144715|42029381|FG000|Overall Study|Lost to Follow-up|2|||
19580892|NCT01144715|42029382|FG001|Overall Study|Lost to Follow-up|1|||
19580893|NCT01144715|42029381|FG000|Overall Study|Withdrawal by Subject|2|||
19580894|NCT01144715|42029382|FG001|Overall Study|Withdrawal by Subject|1|||
19580895|NCT01144715|42029381|FG000|Overall Study|Adverse Event|0|||
19580896|NCT01144715|42029382|FG001|Overall Study|Adverse Event|1|||
19580897|NCT01189487|42029388|FG000|Overall Study|Lack of Efficacy|2|||
19580898|NCT01189487|42029388|FG000|Overall Study|Adverse Event|1|||
19580899|NCT01106352|42029397|FG000|Overall Study|Subjects untreated|0|||
19580900|NCT01106352|42029398|FG001|Overall Study|Subjects untreated|0|||
19580901|NCT01106352|42029399|FG002|Overall Study|Subjects untreated|0|||
19580902|NCT01106352|42029400|FG003|Overall Study|Subjects untreated|3|||
19580903|NCT01106352|42029401|FG004|Overall Study|Subjects untreated|4|||
19580904|NCT01106352|42029397|FG000|Overall Study|Sponsor Decision|1|||
19580905|NCT01106352|42029398|FG001|Overall Study|Sponsor Decision|0|||
19580906|NCT01106352|42029399|FG002|Overall Study|Sponsor Decision|0|||
19580907|NCT01106352|42029400|FG003|Overall Study|Sponsor Decision|0|||
19580908|NCT01106352|42029401|FG004|Overall Study|Sponsor Decision|0|||
19580909|NCT01106352|42029397|FG000|Overall Study|Too ill to come in for the visit|0|||
19580910|NCT01106352|42029398|FG001|Overall Study|Too ill to come in for the visit|0|||
19580911|NCT01106352|42029399|FG002|Overall Study|Too ill to come in for the visit|1|||
19580912|NCT01106352|42029400|FG003|Overall Study|Too ill to come in for the visit|0|||
19580913|NCT01106352|42029401|FG004|Overall Study|Too ill to come in for the visit|0|||
19580914|NCT01106352|42029397|FG000|Overall Study|Lost to Follow-up|0|||
19580915|NCT01106352|42029398|FG001|Overall Study|Lost to Follow-up|0|||
19580916|NCT01106352|42029399|FG002|Overall Study|Lost to Follow-up|0|||
19580917|NCT01106352|42029400|FG003|Overall Study|Lost to Follow-up|0|||
19580918|NCT01106352|42029401|FG004|Overall Study|Lost to Follow-up|1|||
19580919|NCT01106352|42029397|FG000|Overall Study|Death|0|||
19580920|NCT01106352|42029398|FG001|Overall Study|Death|0|||
19580921|NCT01106352|42029399|FG002|Overall Study|Death|1|||
19580922|NCT01106352|42029400|FG003|Overall Study|Death|3|||
19580923|NCT01106352|42029401|FG004|Overall Study|Death|1|||
19580924|NCT01106352|42029397|FG000|Overall Study|Disease progression|0|||
19580925|NCT01106352|42029398|FG001|Overall Study|Disease progression|0|||
19580926|NCT01106352|42029399|FG002|Overall Study|Disease progression|0|||
19580927|NCT01106352|42029400|FG003|Overall Study|Disease progression|1|||
19580928|NCT01106352|42029401|FG004|Overall Study|Disease progression|0|||
19580929|NCT01106352|42029397|FG000|Overall Study|Withdrawal by Subject|0|||
19580930|NCT01106352|42029398|FG001|Overall Study|Withdrawal by Subject|0|||
19580931|NCT01106352|42029399|FG002|Overall Study|Withdrawal by Subject|0|||
19580932|NCT01106352|42029400|FG003|Overall Study|Withdrawal by Subject|3|||
19580933|NCT01106352|42029401|FG004|Overall Study|Withdrawal by Subject|2|||
19580934|NCT01106352|42029397|FG000|Overall Study|Went on hospice|0|||
19580935|NCT01106352|42029398|FG001|Overall Study|Went on hospice|0|||
19580936|NCT01106352|42029399|FG002|Overall Study|Went on hospice|0|||
19580937|NCT01106352|42029400|FG003|Overall Study|Went on hospice|1|||
19580938|NCT01106352|42029401|FG004|Overall Study|Went on hospice|0|||
19580939|NCT01106352|42029397|FG000|Overall Study|Subject entered hospice|0|||
19580940|NCT01106352|42029398|FG001|Overall Study|Subject entered hospice|0|||
19580941|NCT01106352|42029399|FG002|Overall Study|Subject entered hospice|0|||
19580942|NCT01106352|42029400|FG003|Overall Study|Subject entered hospice|1|||
19580943|NCT01106352|42029401|FG004|Overall Study|Subject entered hospice|0|||
19580944|NCT01106352|42029397|FG000|Overall Study|Home hospice since July 2013|0|||
19580945|NCT01106352|42029398|FG001|Overall Study|Home hospice since July 2013|0|||
19580946|NCT01106352|42029399|FG002|Overall Study|Home hospice since July 2013|0|||
19580947|NCT01106352|42029400|FG003|Overall Study|Home hospice since July 2013|1|||
19580948|NCT01106352|42029401|FG004|Overall Study|Home hospice since July 2013|0|||
19580949|NCT01144403|42029417|FG000|Overall Study|Lost to Follow-up|3|||
19580950|NCT01144403|42029417|FG000|Overall Study|Death|1|||
19580951|NCT01144403|42029417|FG000|Overall Study|Adverse Event|1|||
19580952|NCT01143389|42029424|FG000|Overall Study|Lost to Follow-up|26|||
19580953|NCT01143389|42029425|FG001|Overall Study|Lost to Follow-up|25|||
19580954|NCT00868231|42029431|FG000|Treatment Period 1|Adverse Event|0|||
19580955|NCT00868231|42029432|FG001|Treatment Period 1|Adverse Event|0|||
19580956|NCT00868231|42029433|FG002|Treatment Period 1|Adverse Event|0|||
19580957|NCT00868231|42029434|FG003|Treatment Period 1|Adverse Event|0|||
19580958|NCT00868231|42029435|FG004|Treatment Period 1|Adverse Event|1|||
19580959|NCT00868231|42029436|FG005|Treatment Period 1|Adverse Event|0|||
19580960|NCT00868231|42029431|FG000|Treatment Period 2|Adverse Event|1|||
19580961|NCT00868231|42029432|FG001|Treatment Period 2|Adverse Event|0|||
19580962|NCT00868231|42029433|FG002|Treatment Period 2|Adverse Event|0|||
19580963|NCT00868231|42029434|FG003|Treatment Period 2|Adverse Event|0|||
19580964|NCT00868231|42029435|FG004|Treatment Period 2|Adverse Event|0|||
19580965|NCT00868231|42029436|FG005|Treatment Period 2|Adverse Event|0|||
19580966|NCT00868231|42029431|FG000|Treatment Period 3|Adverse Event|0|||
19580967|NCT00868231|42029432|FG001|Treatment Period 3|Adverse Event|0|||
19580968|NCT00868231|42029433|FG002|Treatment Period 3|Adverse Event|1|||
19580969|NCT00868231|42029434|FG003|Treatment Period 3|Adverse Event|0|||
19580970|NCT00868231|42029435|FG004|Treatment Period 3|Adverse Event|0|||
19580971|NCT00868231|42029436|FG005|Treatment Period 3|Adverse Event|0|||
19580972|NCT01101438|42029446|FG000|Overall Study|Withdrawal by Subject|8|||
19580973|NCT01101438|42029447|FG001|Overall Study|Withdrawal by Subject|9|||
19580974|NCT01143077|42029460|FG000|Overall Study|Lack of Efficacy|0|||
19580975|NCT01143077|42029461|FG001|Overall Study|Lack of Efficacy|2|||
19580976|NCT01143077|42029462|FG002|Overall Study|Lack of Efficacy|1|||
19580977|NCT01143077|42029460|FG000|Overall Study|Adverse Event|5|||
19580978|NCT01143077|42029461|FG001|Overall Study|Adverse Event|6|||
19580979|NCT01143077|42029462|FG002|Overall Study|Adverse Event|5|||
19580980|NCT01143077|42029460|FG000|Overall Study|Lost to Follow-up|2|||
19580981|NCT01143077|42029461|FG001|Overall Study|Lost to Follow-up|3|||
19580982|NCT01143077|42029462|FG002|Overall Study|Lost to Follow-up|4|||
19580983|NCT01143077|42029460|FG000|Overall Study|Protocol Violation|2|||
19580984|NCT01143077|42029461|FG001|Overall Study|Protocol Violation|0|||
19580985|NCT01143077|42029462|FG002|Overall Study|Protocol Violation|0|||
19580986|NCT01143077|42029460|FG000|Overall Study|Withdrawal by Subject|4|||
19580987|NCT01143077|42029461|FG001|Overall Study|Withdrawal by Subject|3|||
19580988|NCT01143077|42029462|FG002|Overall Study|Withdrawal by Subject|3|||
19580989|NCT01143077|42029460|FG000|Overall Study|Non-compliance with study drug|0|||
19580990|NCT01143077|42029461|FG001|Overall Study|Non-compliance with study drug|1|||
19580991|NCT01143077|42029462|FG002|Overall Study|Non-compliance with study drug|1|||
19580992|NCT01143077|42029460|FG000|Overall Study|Administrative|1|||
19580993|NCT01143077|42029461|FG001|Overall Study|Administrative|0|||
19580994|NCT01143077|42029462|FG002|Overall Study|Administrative|0|||
19580995|NCT01143077|42029460|FG000|Overall Study|Principal Investigator Decision|2|||
19580996|NCT01143077|42029461|FG001|Overall Study|Principal Investigator Decision|0|||
19580997|NCT01143077|42029462|FG002|Overall Study|Principal Investigator Decision|1|||
19580998|NCT01096446|42029472|FG000|Overall Study|Death|1|||
19580999|NCT01096446|42029473|FG001|Overall Study|Death|0|||
19581000|NCT01096446|42029472|FG000|Overall Study|Protocol Violation|2|||
19581001|NCT01096446|42029473|FG001|Overall Study|Protocol Violation|0|||
19581002|NCT00864721|42029478|FG000|Overall Study|Patient request|11|||
19581003|NCT00864721|42029478|FG000|Overall Study|Hospitalized|1|||
19581004|NCT00864721|42029478|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
19581005|NCT00864721|42029478|FG000|Overall Study|Adverse Event|21|||
19581006|NCT01095666|42029485|FG000|Overall Study|Lack of Efficacy|0|||
19581007|NCT01095666|42029486|FG001|Overall Study|Lack of Efficacy|0|||
19581008|NCT01095666|42029487|FG002|Overall Study|Lack of Efficacy|1|||
19581009|NCT01095666|42029485|FG000|Overall Study|Adverse Event|2|||
19581010|NCT01095666|42029486|FG001|Overall Study|Adverse Event|1|||
19581011|NCT01095666|42029487|FG002|Overall Study|Adverse Event|3|||
19581012|NCT01095666|42029485|FG000|Overall Study|Lost to Follow-up|2|||
19581013|NCT01095666|42029486|FG001|Overall Study|Lost to Follow-up|2|||
19581014|NCT01095666|42029487|FG002|Overall Study|Lost to Follow-up|0|||
19581015|NCT01095666|42029485|FG000|Overall Study|Withdrawal by Subject|6|||
19581016|NCT01095666|42029486|FG001|Overall Study|Withdrawal by Subject|6|||
19581017|NCT01095666|42029487|FG002|Overall Study|Withdrawal by Subject|1|||
19581018|NCT01095666|42029485|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
19581019|NCT01095666|42029486|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
19581020|NCT01095666|42029487|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
19581021|NCT01100658|42029495|FG000|Overall Study|Withdrawal by Subject|1|||
19581022|NCT01100502|42029501|FG000|Overall Study|Withdrawal by Subject|18|||
19581023|NCT01100502|42029502|FG001|Overall Study|Withdrawal by Subject|25|||
19581024|NCT01100502|42029501|FG000|Overall Study|Lost to Follow-up|13|||
19581025|NCT01100502|42029502|FG001|Overall Study|Lost to Follow-up|28|||
19581026|NCT01100502|42029501|FG000|Overall Study|Site request to end participation in study|0|||
19581027|NCT01100502|42029502|FG001|Overall Study|Site request to end participation in study|1|||
19581028|NCT01100502|42029501|FG000|Overall Study|Death|45|||
19581029|NCT01100502|42029502|FG001|Overall Study|Death|40|||
19581030|NCT01094886|42029508|FG000|Overall Study|Adverse Event|2|||
19581031|NCT01094886|42029508|FG000|Overall Study|Withdrawal by Subject|5|||
19581032|NCT01094808|42029515|FG000|Overall Study|Withdrawal by Subject|1|||
19581033|NCT01094808|42029516|FG001|Overall Study|Withdrawal by Subject|1|||
19581034|NCT01094808|42029517|FG002|Overall Study|Withdrawal by Subject|0|||
19581035|NCT00864253|42029527|FG000|Overall Study|Adverse Event|56|||
19581036|NCT00864253|42029528|FG001|Overall Study|Adverse Event|11|||
19581037|NCT00864253|42029527|FG000|Overall Study|Unrelated Adverse Event|3|||
19581038|NCT00864253|42029528|FG001|Overall Study|Unrelated Adverse Event|1|||
19581039|NCT00864253|42029527|FG000|Overall Study|Physician Decision|11|||
19581040|NCT00864253|42029528|FG001|Overall Study|Physician Decision|15|||
19581041|NCT00864253|42029527|FG000|Overall Study|Protocol Violation|0|||
19581042|NCT00864253|42029528|FG001|Overall Study|Protocol Violation|2|||
19581043|NCT00864253|42029527|FG000|Overall Study|Lost to Follow-up|1|||
19581044|NCT00864253|42029528|FG001|Overall Study|Lost to Follow-up|1|||
19581045|NCT00864253|42029527|FG000|Overall Study|Withdrawal by Subject|18|||
19581046|NCT00864253|42029528|FG001|Overall Study|Withdrawal by Subject|18|||
19581047|NCT00864253|42029527|FG000|Overall Study|Death|1|||
19581048|NCT00864253|42029528|FG001|Overall Study|Death|0|||
19581049|NCT00864253|42029527|FG000|Overall Study|Ongoing|2|||
19581050|NCT00864253|42029528|FG001|Overall Study|Ongoing|3|||
19581051|NCT00864253|42029527|FG000|Overall Study|Untreated|7|||
19581052|NCT00864253|42029528|FG001|Overall Study|Untreated|7|||
19581053|NCT01094730|42029536|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
19581054|NCT01094730|42029537|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
19581055|NCT01094730|42029536|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
19581056|NCT01094730|42029537|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
19581057|NCT01094730|42029536|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
19581058|NCT01094730|42029537|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
19581059|NCT01094730|42029536|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
19581060|NCT01094730|42029537|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
19581061|NCT01094730|42029536|FG000|Period 2 (14 Days)|Protocol Violation|2|||
19581062|NCT01094730|42029537|FG001|Period 2 (14 Days)|Protocol Violation|0|||
19581063|NCT01094730|42029536|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
19581064|NCT01094730|42029537|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
19581065|NCT01094730|42029536|FG000|Period 2 (14 Days)|Adverse Event|0|||
19581066|NCT01094730|42029537|FG001|Period 2 (14 Days)|Adverse Event|1|||
19581067|NCT01094730|42029536|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
19581068|NCT01094730|42029537|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
19581069|NCT00864097|42029552|FG000|Overall Study|Death|0|||
19581070|NCT00864097|42029553|FG001|Overall Study|Death|1|||
19581071|NCT00864097|42029554|FG002|Overall Study|Death|0|||
19581072|NCT00864097|42029555|FG003|Overall Study|Death|0|||
19581073|NCT00864097|42029552|FG000|Overall Study|Adverse Event|6|||
19581074|NCT00864097|42029553|FG001|Overall Study|Adverse Event|8|||
19581075|NCT00864097|42029554|FG002|Overall Study|Adverse Event|11|||
19581076|NCT00864097|42029555|FG003|Overall Study|Adverse Event|9|||
19581077|NCT00864097|42029552|FG000|Overall Study|Lack of Efficacy|9|||
19581078|NCT00864097|42029553|FG001|Overall Study|Lack of Efficacy|3|||
19581079|NCT00864097|42029554|FG002|Overall Study|Lack of Efficacy|7|||
19581080|NCT00864097|42029555|FG003|Overall Study|Lack of Efficacy|2|||
19581081|NCT00864097|42029552|FG000|Overall Study|Lost to Follow-up|0|||
19581082|NCT00864097|42029553|FG001|Overall Study|Lost to Follow-up|1|||
19581083|NCT00864097|42029554|FG002|Overall Study|Lost to Follow-up|0|||
19581084|NCT00864097|42029555|FG003|Overall Study|Lost to Follow-up|1|||
19581085|NCT00864097|42029552|FG000|Overall Study|Withdrawal by Subject|15|||
19581086|NCT00864097|42029553|FG001|Overall Study|Withdrawal by Subject|11|||
19581087|NCT00864097|42029554|FG002|Overall Study|Withdrawal by Subject|11|||
19581088|NCT00864097|42029555|FG003|Overall Study|Withdrawal by Subject|12|||
19581089|NCT00864097|42029552|FG000|Overall Study|Protocol Violation|2|||
19581090|NCT00864097|42029553|FG001|Overall Study|Protocol Violation|1|||
19581091|NCT00864097|42029554|FG002|Overall Study|Protocol Violation|0|||
19581092|NCT00864097|42029555|FG003|Overall Study|Protocol Violation|1|||
19581093|NCT00864097|42029552|FG000|Overall Study|Terminated by sponsor|105|||
19581094|NCT00864097|42029553|FG001|Overall Study|Terminated by sponsor|112|||
19581095|NCT00864097|42029554|FG002|Overall Study|Terminated by sponsor|102|||
19581096|NCT00864097|42029555|FG003|Overall Study|Terminated by sponsor|99|||
19581097|NCT00864097|42029552|FG000|Overall Study|Randomized but not treated|2|||
19581098|NCT00864097|42029553|FG001|Overall Study|Randomized but not treated|0|||
19581099|NCT00864097|42029554|FG002|Overall Study|Randomized but not treated|1|||
19581100|NCT00864097|42029555|FG003|Overall Study|Randomized but not treated|0|||
19581101|NCT00864097|42029552|FG000|Overall Study|Other|0|||
19581102|NCT00864097|42029553|FG001|Overall Study|Other|0|||
19581103|NCT00864097|42029554|FG002|Overall Study|Other|0|||
19581104|NCT00864097|42029555|FG003|Overall Study|Other|1|||
19581105|NCT01183013|42029572|FG000|Overall Study|Adverse Event|6|||
19581106|NCT01183013|42029573|FG001|Overall Study|Adverse Event|8|||
19581107|NCT01183013|42029574|FG002|Overall Study|Adverse Event|5|||
19581108|NCT01183013|42029575|FG003|Overall Study|Adverse Event|5|||
19581109|NCT01183013|42029576|FG004|Overall Study|Adverse Event|10|||
19581110|NCT01183013|42029577|FG005|Overall Study|Adverse Event|10|||
19581111|NCT01183013|42029578|FG006|Overall Study|Adverse Event|6|||
19581112|NCT01183013|42029572|FG000|Overall Study|Lack of Efficacy|3|||
19581113|NCT01183013|42029573|FG001|Overall Study|Lack of Efficacy|2|||
19581114|NCT01183013|42029574|FG002|Overall Study|Lack of Efficacy|1|||
19581115|NCT01183013|42029575|FG003|Overall Study|Lack of Efficacy|2|||
19581116|NCT01183013|42029576|FG004|Overall Study|Lack of Efficacy|1|||
19581117|NCT01183013|42029577|FG005|Overall Study|Lack of Efficacy|2|||
19581118|NCT01183013|42029578|FG006|Overall Study|Lack of Efficacy|0|||
19581119|NCT01183013|42029572|FG000|Overall Study|Protocol Violation|5|||
19581120|NCT01183013|42029573|FG001|Overall Study|Protocol Violation|2|||
19581121|NCT01183013|42029574|FG002|Overall Study|Protocol Violation|4|||
19581122|NCT01183013|42029575|FG003|Overall Study|Protocol Violation|0|||
19581123|NCT01183013|42029576|FG004|Overall Study|Protocol Violation|4|||
19581124|NCT01183013|42029577|FG005|Overall Study|Protocol Violation|3|||
19581125|NCT01183013|42029578|FG006|Overall Study|Protocol Violation|3|||
19581126|NCT01183013|42029572|FG000|Overall Study|Lost to Follow-up|7|||
19581127|NCT01183013|42029573|FG001|Overall Study|Lost to Follow-up|3|||
19581128|NCT01183013|42029574|FG002|Overall Study|Lost to Follow-up|4|||
19581129|NCT01183013|42029575|FG003|Overall Study|Lost to Follow-up|3|||
19581130|NCT01183013|42029576|FG004|Overall Study|Lost to Follow-up|2|||
19581131|NCT01183013|42029577|FG005|Overall Study|Lost to Follow-up|6|||
19581132|NCT01183013|42029578|FG006|Overall Study|Lost to Follow-up|5|||
19581133|NCT01183013|42029572|FG000|Overall Study|Withdrawal by Subject|9|||
19581134|NCT01183013|42029573|FG001|Overall Study|Withdrawal by Subject|13|||
19581135|NCT01183013|42029574|FG002|Overall Study|Withdrawal by Subject|10|||
19581136|NCT01183013|42029575|FG003|Overall Study|Withdrawal by Subject|8|||
19581137|NCT01183013|42029576|FG004|Overall Study|Withdrawal by Subject|7|||
19581138|NCT01183013|42029577|FG005|Overall Study|Withdrawal by Subject|9|||
19581139|NCT01183013|42029578|FG006|Overall Study|Withdrawal by Subject|10|||
19581140|NCT01183013|42029572|FG000|Overall Study|Reasons other than stated above|15|||
19581141|NCT01183013|42029573|FG001|Overall Study|Reasons other than stated above|11|||
19581142|NCT01183013|42029574|FG002|Overall Study|Reasons other than stated above|17|||
19581143|NCT01183013|42029575|FG003|Overall Study|Reasons other than stated above|12|||
19581144|NCT01183013|42029576|FG004|Overall Study|Reasons other than stated above|12|||
19581145|NCT01183013|42029577|FG005|Overall Study|Reasons other than stated above|15|||
19581146|NCT01183013|42029578|FG006|Overall Study|Reasons other than stated above|13|||
19581147|NCT01141283|42029602|FG000|Overall Study|Adverse Event|56|||
19581148|NCT01141283|42029602|FG000|Overall Study|Lost to Follow-up|4|||
19581149|NCT01141283|42029602|FG000|Overall Study|Withdrawal by Subject|14|||
19581150|NCT01141283|42029602|FG000|Overall Study|Administrative|4|||
19581151|NCT01141283|42029602|FG000|Overall Study|Lack of Efficacy|10|||
19581152|NCT00863707|42029608|FG000|Overall Study|Randomized, but drug not received|4|||
19608700|NCT00539591|42057715|FG001|Overall Study|Disease progression|2|||
19581153|NCT00863707|42029609|FG001|Overall Study|Randomized, but drug not received|3|||
19581154|NCT01094184|42029617|FG000|Overall Study|Death|35|||
19581155|NCT01094184|42029618|FG001|Overall Study|Death|11|||
19581156|NCT01134731|42029627|FG000|Overall Study|Adverse Event|3|||
19581157|NCT01134731|42029628|FG001|Overall Study|Adverse Event|2|||
19581158|NCT01134731|42029629|FG002|Overall Study|Adverse Event|1|||
19581159|NCT01134731|42029627|FG000|Overall Study|Physician Decision|2|||
19581160|NCT01134731|42029628|FG001|Overall Study|Physician Decision|2|||
19581161|NCT01134731|42029629|FG002|Overall Study|Physician Decision|2|||
19581162|NCT01134731|42029627|FG000|Overall Study|Lack of Efficacy|0|||
19581163|NCT01134731|42029628|FG001|Overall Study|Lack of Efficacy|0|||
19581164|NCT01134731|42029629|FG002|Overall Study|Lack of Efficacy|1|||
19581165|NCT01134731|42029627|FG000|Overall Study|Withdrawal by Subject|3|||
19581166|NCT01134731|42029628|FG001|Overall Study|Withdrawal by Subject|3|||
19581167|NCT01134731|42029629|FG002|Overall Study|Withdrawal by Subject|1|||
19581168|NCT01134731|42029627|FG000|Overall Study|Lost to Follow-up|5|||
19581169|NCT01134731|42029628|FG001|Overall Study|Lost to Follow-up|4|||
19581170|NCT01134731|42029629|FG002|Overall Study|Lost to Follow-up|3|||
19581171|NCT01141205|42029640|FG000|Overall Study|Physician Decision|1|||
19581172|NCT01141205|42029641|FG001|Overall Study|Physician Decision|1|||
19581173|NCT01141205|42029640|FG000|Overall Study|Lost to Follow-up|1|||
19581174|NCT01141205|42029641|FG001|Overall Study|Lost to Follow-up|0|||
19581175|NCT01141205|42029640|FG000|Overall Study|Withdrawal by Subject|1|||
19581176|NCT01141205|42029641|FG001|Overall Study|Withdrawal by Subject|1|||
19581177|NCT01140503|42029651|FG000|Overall Study|Withdrawal by Subject|1|||
19581178|NCT00863317|42029657|FG000|Overall Study|Lost to Follow-up|8|||
19581179|NCT00863317|42029658|FG001|Overall Study|Lost to Follow-up|9|||
19581180|NCT01200368|42029667|FG000|Infant Series|Adverse Event|2|||
19581181|NCT01200368|42029668|FG001|Infant Series|Adverse Event|2|||
19581182|NCT01200368|42029669|FG002|Infant Series|Adverse Event|3|||
19581183|NCT01200368|42029667|FG000|Infant Series|Withdrawal by Subject|0|||
19581184|NCT01200368|42029668|FG001|Infant Series|Withdrawal by Subject|2|||
19581185|NCT01200368|42029669|FG002|Infant Series|Withdrawal by Subject|2|||
19581186|NCT01200368|42029667|FG000|Infant Series|Did not meet entrance criteria|0|||
19581187|NCT01200368|42029668|FG001|Infant Series|Did not meet entrance criteria|1|||
19581188|NCT01200368|42029669|FG002|Infant Series|Did not meet entrance criteria|0|||
19581189|NCT01200368|42029667|FG000|Infant Series|Randomized, not vaccinated|0|||
19581190|NCT01200368|42029668|FG001|Infant Series|Randomized, not vaccinated|1|||
19581191|NCT01200368|42029669|FG002|Infant Series|Randomized, not vaccinated|1|||
19581192|NCT01200368|42029667|FG000|Infant Series|Other|1|||
19581193|NCT01200368|42029668|FG001|Infant Series|Other|0|||
19581194|NCT01200368|42029669|FG002|Infant Series|Other|0|||
19581195|NCT01200368|42029667|FG000|After Infant Series|Adverse Event|6|||
19581196|NCT01200368|42029668|FG001|After Infant Series|Adverse Event|6|||
19581197|NCT01200368|42029669|FG002|After Infant Series|Adverse Event|3|||
19581198|NCT01200368|42029667|FG000|After Infant Series|Withdrawal by Subject|10|||
19581199|NCT01200368|42029668|FG001|After Infant Series|Withdrawal by Subject|8|||
19581200|NCT01200368|42029669|FG002|After Infant Series|Withdrawal by Subject|4|||
19581201|NCT01200368|42029667|FG000|After Infant Series|Lost to Follow-up|1|||
19581202|NCT01200368|42029668|FG001|After Infant Series|Lost to Follow-up|0|||
19581203|NCT01200368|42029669|FG002|After Infant Series|Lost to Follow-up|0|||
19581204|NCT01200368|42029667|FG000|After Infant Series|Other|1|||
19581205|NCT01200368|42029668|FG001|After Infant Series|Other|2|||
19581206|NCT01200368|42029669|FG002|After Infant Series|Other|2|||
19581207|NCT01200368|42029667|FG000|Toddler Dose|Adverse Event|0|||
19581208|NCT01200368|42029668|FG001|Toddler Dose|Adverse Event|3|||
19581209|NCT01200368|42029669|FG002|Toddler Dose|Adverse Event|1|||
19581210|NCT01079130|42029690|FG000|Overall Study|Adverse Event|1|||
19581211|NCT01079130|42029691|FG001|Overall Study|Adverse Event|1|||
19581212|NCT01079130|42029692|FG002|Overall Study|Adverse Event|0|||
19581213|NCT01079130|42029693|FG003|Overall Study|Adverse Event|1|||
19581214|NCT01079130|42029694|FG004|Overall Study|Adverse Event|5|||
19581215|NCT01079130|42029695|FG005|Overall Study|Adverse Event|1|||
19581216|NCT01079130|42029690|FG000|Overall Study|Administrative problems|1|||
19581217|NCT01079130|42029691|FG001|Overall Study|Administrative problems|3|||
19581218|NCT01079130|42029692|FG002|Overall Study|Administrative problems|0|||
19581219|NCT01079130|42029693|FG003|Overall Study|Administrative problems|0|||
19581220|NCT01079130|42029694|FG004|Overall Study|Administrative problems|0|||
19581221|NCT01079130|42029695|FG005|Overall Study|Administrative problems|1|||
19581222|NCT01079130|42029690|FG000|Overall Study|Withdrawal by Subject|0|||
19581223|NCT01079130|42029691|FG001|Overall Study|Withdrawal by Subject|1|||
19581224|NCT01079130|42029692|FG002|Overall Study|Withdrawal by Subject|0|||
19581225|NCT01079130|42029693|FG003|Overall Study|Withdrawal by Subject|0|||
19581226|NCT01079130|42029694|FG004|Overall Study|Withdrawal by Subject|1|||
19581227|NCT01079130|42029695|FG005|Overall Study|Withdrawal by Subject|3|||
19581228|NCT01079130|42029690|FG000|Overall Study|Protocol deviation|0|||
19581229|NCT01079130|42029691|FG001|Overall Study|Protocol deviation|2|||
19581230|NCT01079130|42029692|FG002|Overall Study|Protocol deviation|1|||
19581231|NCT01079130|42029693|FG003|Overall Study|Protocol deviation|2|||
19581232|NCT01079130|42029694|FG004|Overall Study|Protocol deviation|0|||
19581233|NCT01079130|42029695|FG005|Overall Study|Protocol deviation|0|||
19581234|NCT01079130|42029690|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19581235|NCT01079130|42029691|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19581236|NCT01079130|42029692|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19581237|NCT01079130|42029693|FG003|Overall Study|Abnormal test procedure result(s)|0|||
19581238|NCT01079130|42029694|FG004|Overall Study|Abnormal test procedure result(s)|1|||
19581239|NCT01079130|42029695|FG005|Overall Study|Abnormal test procedure result(s)|0|||
19581240|NCT01079130|42029690|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19581241|NCT01079130|42029691|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19581242|NCT01079130|42029692|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19581243|NCT01079130|42029693|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
19581244|NCT01079130|42029694|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
19581245|NCT01079130|42029695|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
19581246|NCT01079130|42029690|FG000|Overall Study|Lost to Follow-up|0|||
19581247|NCT01079130|42029691|FG001|Overall Study|Lost to Follow-up|0|||
19581248|NCT01079130|42029692|FG002|Overall Study|Lost to Follow-up|0|||
19581249|NCT01079130|42029693|FG003|Overall Study|Lost to Follow-up|0|||
19581250|NCT01079130|42029694|FG004|Overall Study|Lost to Follow-up|1|||
19581251|NCT01079130|42029695|FG005|Overall Study|Lost to Follow-up|0|||
19581252|NCT01078974|42029709|FG000|Overall Study|Adverse Event|3|||
19581253|NCT00869557|42029715|FG000|Randomized Phase|Lost to Follow-up|2|||
19581254|NCT00869557|42029716|FG001|Randomized Phase|Lost to Follow-up|1|||
19581255|NCT00869557|42029715|FG000|Randomized Phase|Investigator's Discretion|1|||
19581256|NCT00869557|42029716|FG001|Randomized Phase|Investigator's Discretion|0|||
19581257|NCT00869557|42029715|FG000|Randomized Phase|Withdrew Consent|0|||
19581258|NCT00869557|42029716|FG001|Randomized Phase|Withdrew Consent|1|||
19581259|NCT00869557|42029715|FG000|Extension Phase|Adverse Event|2|||
19581260|NCT00869557|42029716|FG001|Extension Phase|Adverse Event|2|||
19581261|NCT00869557|42029715|FG000|Extension Phase|Lack of Efficacy|1|||
19581262|NCT00869557|42029716|FG001|Extension Phase|Lack of Efficacy|0|||
19581263|NCT00869557|42029715|FG000|Extension Phase|Lost to Follow-up|3|||
19581264|NCT00869557|42029716|FG001|Extension Phase|Lost to Follow-up|1|||
19581265|NCT00869557|42029715|FG000|Extension Phase|Investigator's Discretion|2|||
19581266|NCT00869557|42029716|FG001|Extension Phase|Investigator's Discretion|0|||
19581267|NCT00869557|42029715|FG000|Extension Phase|Withdrew Consent|2|||
19581268|NCT00869557|42029716|FG001|Extension Phase|Withdrew Consent|0|||
19581269|NCT01200290|42029723|FG000|Treatment Period|Adverse Event|1|||
19581270|NCT01200290|42029723|FG000|Post-Treatment Follow-Up Period|Death|2|||
19581271|NCT01134263|42029732|FG000|Overall Study|Serious adverse event|2|||
19581272|NCT01134263|42029733|FG001|Overall Study|Serious adverse event|1|||
19581273|NCT01134263|42029734|FG002|Overall Study|Serious adverse event|1|||
19581274|NCT01134263|42029735|FG003|Overall Study|Serious adverse event|1|||
19581275|NCT01134263|42029736|FG004|Overall Study|Serious adverse event|1|||
19581276|NCT01134263|42029732|FG000|Overall Study|Other adverse event|1|||
19581277|NCT01134263|42029733|FG001|Overall Study|Other adverse event|2|||
19581278|NCT01134263|42029734|FG002|Overall Study|Other adverse event|5|||
19581279|NCT01134263|42029735|FG003|Overall Study|Other adverse event|3|||
19581280|NCT01134263|42029736|FG004|Overall Study|Other adverse event|0|||
19581281|NCT01134263|42029732|FG000|Overall Study|Protocol Violation|8|||
19581282|NCT01134263|42029733|FG001|Overall Study|Protocol Violation|7|||
19581283|NCT01134263|42029734|FG002|Overall Study|Protocol Violation|2|||
19581284|NCT01134263|42029735|FG003|Overall Study|Protocol Violation|4|||
19581285|NCT01134263|42029736|FG004|Overall Study|Protocol Violation|2|||
19581286|NCT01134263|42029732|FG000|Overall Study|Lost to Follow-up|4|||
19581287|NCT01134263|42029733|FG001|Overall Study|Lost to Follow-up|3|||
19581288|NCT01134263|42029734|FG002|Overall Study|Lost to Follow-up|5|||
19581289|NCT01134263|42029735|FG003|Overall Study|Lost to Follow-up|3|||
19581290|NCT01134263|42029736|FG004|Overall Study|Lost to Follow-up|1|||
19581291|NCT01134263|42029732|FG000|Overall Study|Withdrawal by Subject|8|||
19581292|NCT01134263|42029733|FG001|Overall Study|Withdrawal by Subject|6|||
19581293|NCT01134263|42029734|FG002|Overall Study|Withdrawal by Subject|16|||
19581294|NCT01134263|42029735|FG003|Overall Study|Withdrawal by Subject|7|||
19581295|NCT01134263|42029736|FG004|Overall Study|Withdrawal by Subject|5|||
19581296|NCT01134263|42029732|FG000|Overall Study|Enrolled, but not treated|1|||
19581297|NCT01134263|42029733|FG001|Overall Study|Enrolled, but not treated|1|||
19581298|NCT01134263|42029734|FG002|Overall Study|Enrolled, but not treated|0|||
19581299|NCT01134263|42029735|FG003|Overall Study|Enrolled, but not treated|1|||
19581300|NCT01134263|42029736|FG004|Overall Study|Enrolled, but not treated|0|||
19581301|NCT01199822|42029757|FG000|Overall Study|Investigator discontinued therapy|0|||
19581302|NCT01199822|42029758|FG001|Overall Study|Investigator discontinued therapy|1|||
19581303|NCT01199822|42029759|FG002|Overall Study|Investigator discontinued therapy|0|||
19581304|NCT01096056|42029776|FG000|Overall Study|Lost to Follow-up|0|||
19581305|NCT01096056|42029777|FG001|Overall Study|Lost to Follow-up|1|||
19387835|NCT02560623|41631161|FG000|Overall Study|Intervention prior to sponge administration|0|||
19387836|NCT02560623|41631162|FG001|Overall Study|Intervention prior to sponge administration|1|||
19581306|NCT00866359|42029785|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
19581307|NCT00866359|42029786|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
19581308|NCT00866359|42029787|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
19581309|NCT00866359|42029788|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
19581310|NCT00866359|42029785|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
19581311|NCT00866359|42029786|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
19581312|NCT00866359|42029787|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
19581313|NCT00866359|42029788|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
19581314|NCT00866359|42029785|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
19581315|NCT00866359|42029786|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
19581316|NCT00866359|42029787|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
19581317|NCT00866359|42029788|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
19581318|NCT00866359|42029785|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
19581319|NCT00866359|42029786|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
19581320|NCT00866359|42029787|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
19581321|NCT00866359|42029788|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
19581322|NCT00866359|42029785|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
19581323|NCT00866359|42029786|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
19581324|NCT00866359|42029787|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
19581325|NCT00866359|42029788|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
19581326|NCT00866359|42029785|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
19581327|NCT00866359|42029786|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
19581328|NCT00866359|42029787|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
19581329|NCT00866359|42029788|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
19581330|NCT01199198|42029817|FG000|Overall Study|Adverse Event|3|||
19581331|NCT01199198|42029818|FG001|Overall Study|Adverse Event|0|||
19581332|NCT01199198|42029817|FG000|Overall Study|Lost to Follow-up|1|||
19581333|NCT01199198|42029818|FG001|Overall Study|Lost to Follow-up|5|||
19581334|NCT01199198|42029817|FG000|Overall Study|Withdrawal by Subject|1|||
19581335|NCT01199198|42029818|FG001|Overall Study|Withdrawal by Subject|2|||
19581336|NCT01199198|42029817|FG000|Overall Study|ICU Transfer|1|||
19581337|NCT01199198|42029818|FG001|Overall Study|ICU Transfer|2|||
19581338|NCT01199198|42029817|FG000|Overall Study|Hospice-care transfer|1|||
19581339|NCT01199198|42029818|FG001|Overall Study|Hospice-care transfer|2|||
19581340|NCT01095978|42029824|FG000|Overall Study|Did not take Klacid SR|2|||
19373600|NCT02760407|41614833|FG000|Overall Study|Withdrawal by Subject|25|||
19373601|NCT02760407|41614834|FG001|Overall Study|Withdrawal by Subject|31|||
19373602|NCT02760407|41614835|FG002|Overall Study|Withdrawal by Subject|37|||
19373603|NCT02760407|41614836|FG003|Overall Study|Withdrawal by Subject|25|||
19373604|NCT02760407|41614833|FG000|Overall Study|Violation of Eligibility criteria|0|||
19373605|NCT02760407|41614834|FG001|Overall Study|Violation of Eligibility criteria|0|||
19373606|NCT02760407|41614835|FG002|Overall Study|Violation of Eligibility criteria|1|||
19373607|NCT02760407|41614836|FG003|Overall Study|Violation of Eligibility criteria|1|||
19373608|NCT02760407|41614833|FG000|Overall Study|Personal reasons|0|||
19373609|NCT02760407|41614834|FG001|Overall Study|Personal reasons|0|||
19373610|NCT02760407|41614835|FG002|Overall Study|Personal reasons|0|||
19373611|NCT02760407|41614836|FG003|Overall Study|Personal reasons|1|||
19581341|NCT01095978|42029824|FG000|Overall Study|Adverse Event|1|||
19581342|NCT01134107|42029832|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
19581343|NCT01134107|42029833|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
19581344|NCT01134107|42029832|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
19581345|NCT01134107|42029833|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
19387837|NCT02560623|41631163|FG002|Overall Study|Intervention prior to sponge administration|0|||
19387838|NCT02560623|41631164|FG003|Overall Study|Intervention prior to sponge administration|0|||
19387839|NCT02560389|41631177|FG000|Overall Study|Lost to Follow-up|1|||
19387840|NCT02560389|41631178|FG001|Overall Study|Lost to Follow-up|2|||
19373612|NCT02760407|41614833|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
19581346|NCT01134107|42029832|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
19581347|NCT01134107|42029833|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
19581348|NCT01134107|42029832|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
19581349|NCT01134107|42029833|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
19581350|NCT01134107|42029832|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
19581351|NCT01134107|42029833|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
19581352|NCT01134107|42029832|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
19581353|NCT01134107|42029833|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
19581354|NCT01134107|42029832|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
19581355|NCT01134107|42029833|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
19581356|NCT01199042|42029839|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
19581357|NCT01199042|42029839|FG000|At Home (3 Months)|Lost to Follow-up|1|||
19581358|NCT01198574|42029852|FG000|Overall Study|Resigned from schools|4|||
19581359|NCT01198574|42029853|FG001|Overall Study|Resigned from schools|1|||
19581360|NCT01198574|42029854|FG002|Overall Study|Resigned from schools|1|||
19581361|NCT01198574|42029855|FG003|Overall Study|Resigned from schools|4|||
19581362|NCT01198028|42029865|FG000|Overall Study|Adverse Event|5|||
19581363|NCT01198028|42029865|FG000|Overall Study|Death|3|||
19581364|NCT01198028|42029865|FG000|Overall Study|Physician Decision|2|||
19581365|NCT01197950|42029872|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
19581366|NCT01197950|42029873|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
19581367|NCT01197950|42029874|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
19581368|NCT01092780|42029882|FG000|Washout Period 1|Adverse Event|0|||
19581369|NCT01092780|42029883|FG001|Washout Period 1|Adverse Event|1|||
19373613|NCT02760407|41614834|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
19373614|NCT02760407|41614835|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
19373630|NCT02760407|41614835|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
19387841|NCT02560389|41631179|FG002|Overall Study|Lost to Follow-up|2|||
19581370|NCT01092780|42029884|FG002|Washout Period 1|Adverse Event|0|||
19581371|NCT01092780|42029885|FG003|Washout Period 1|Adverse Event|0|||
19581372|NCT01092780|42029882|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
19581373|NCT01092780|42029883|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
19581374|NCT01092780|42029884|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
19581375|NCT01092780|42029885|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
19581376|NCT01092780|42029882|FG000|Washout Period 2|Adverse Event|0|||
19581377|NCT01092780|42029883|FG001|Washout Period 2|Adverse Event|1|||
19581378|NCT01092780|42029884|FG002|Washout Period 2|Adverse Event|1|||
19581379|NCT01092780|42029885|FG003|Washout Period 2|Adverse Event|0|||
19581380|NCT01092702|42029895|FG000|Overall Study|Withdrawal by Subject|7|||
19581381|NCT01092702|42029895|FG000|Overall Study|Lost to Follow-up|2|||
19581382|NCT01092546|42029899|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
19581383|NCT01197794|42029910|FG000|Overall Study|Adverse Event|3|||
19581384|NCT01197794|42029911|FG001|Overall Study|Adverse Event|2|||
19581385|NCT01197794|42029912|FG002|Overall Study|Adverse Event|4|||
19581386|NCT01197794|42029913|FG003|Overall Study|Adverse Event|4|||
19581387|NCT01197794|42029914|FG004|Overall Study|Adverse Event|4|||
19581388|NCT01197794|42029915|FG005|Overall Study|Adverse Event|2|||
19581389|NCT01197794|42029916|FG006|Overall Study|Adverse Event|3|||
19581390|NCT01197794|42029910|FG000|Overall Study|Protocol Violation|0|||
19581391|NCT01197794|42029911|FG001|Overall Study|Protocol Violation|0|||
19581392|NCT01197794|42029912|FG002|Overall Study|Protocol Violation|0|||
19581393|NCT01197794|42029913|FG003|Overall Study|Protocol Violation|0|||
19581394|NCT01197794|42029914|FG004|Overall Study|Protocol Violation|2|||
19581395|NCT01197794|42029915|FG005|Overall Study|Protocol Violation|0|||
19581396|NCT01197794|42029916|FG006|Overall Study|Protocol Violation|1|||
19581397|NCT01197794|42029910|FG000|Overall Study|Development of study withdrawal criteria|3|||
19581398|NCT01197794|42029911|FG001|Overall Study|Development of study withdrawal criteria|0|||
19581399|NCT01197794|42029912|FG002|Overall Study|Development of study withdrawal criteria|0|||
19581400|NCT01197794|42029913|FG003|Overall Study|Development of study withdrawal criteria|1|||
19581401|NCT01197794|42029914|FG004|Overall Study|Development of study withdrawal criteria|0|||
19581402|NCT01197794|42029915|FG005|Overall Study|Development of study withdrawal criteria|0|||
19581403|NCT01197794|42029916|FG006|Overall Study|Development of study withdrawal criteria|1|||
19581404|NCT01197794|42029910|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
19581405|NCT01197794|42029911|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
19581406|NCT01197794|42029912|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
19581407|NCT01197794|42029913|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
19581408|NCT01197794|42029914|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
19581409|NCT01197794|42029915|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
19581410|NCT01197794|42029916|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
19581411|NCT01197794|42029910|FG000|Overall Study|Withdrawal by Subject|3|||
19581412|NCT01197794|42029911|FG001|Overall Study|Withdrawal by Subject|3|||
19581413|NCT01197794|42029912|FG002|Overall Study|Withdrawal by Subject|4|||
19581414|NCT01197794|42029913|FG003|Overall Study|Withdrawal by Subject|1|||
19581415|NCT01197794|42029914|FG004|Overall Study|Withdrawal by Subject|1|||
19581416|NCT01197794|42029915|FG005|Overall Study|Withdrawal by Subject|5|||
19581417|NCT01197794|42029916|FG006|Overall Study|Withdrawal by Subject|6|||
19581418|NCT01197794|42029910|FG000|Overall Study|Lost to Follow-up|1|||
19581419|NCT01197794|42029911|FG001|Overall Study|Lost to Follow-up|1|||
19581420|NCT01197794|42029912|FG002|Overall Study|Lost to Follow-up|0|||
19581421|NCT01197794|42029913|FG003|Overall Study|Lost to Follow-up|1|||
19581422|NCT01197794|42029914|FG004|Overall Study|Lost to Follow-up|0|||
19581423|NCT01197794|42029915|FG005|Overall Study|Lost to Follow-up|1|||
19581424|NCT01197794|42029916|FG006|Overall Study|Lost to Follow-up|0|||
19581425|NCT01197794|42029910|FG000|Overall Study|Other|1|||
19581426|NCT01197794|42029911|FG001|Overall Study|Other|1|||
19581427|NCT01197794|42029912|FG002|Overall Study|Other|3|||
19581428|NCT01197794|42029913|FG003|Overall Study|Other|0|||
19581429|NCT01197794|42029914|FG004|Overall Study|Other|2|||
19581430|NCT01197794|42029915|FG005|Overall Study|Other|2|||
19581431|NCT01197794|42029916|FG006|Overall Study|Other|4|||
19581432|NCT01078662|42029938|FG000|Overall Study|Death|41|||
19581433|NCT01078662|42029939|FG001|Overall Study|Death|103|||
19581434|NCT01078662|42029940|FG002|Overall Study|Death|18|||
19581435|NCT01078662|42029941|FG003|Overall Study|Death|5|||
19581436|NCT01078662|42029942|FG004|Overall Study|Death|8|||
19387842|NCT02560389|41631177|FG000|Overall Study|Tested positive for illicit substance|0|||
19581437|NCT01078662|42029938|FG000|Overall Study|Patients reached data cut-off|12|||
19581438|NCT01078662|42029939|FG001|Overall Study|Patients reached data cut-off|53|||
19581439|NCT01078662|42029940|FG002|Overall Study|Patients reached data cut-off|2|||
19581440|NCT01078662|42029941|FG003|Overall Study|Patients reached data cut-off|2|||
19581441|NCT01078662|42029942|FG004|Overall Study|Patients reached data cut-off|3|||
19581442|NCT01078662|42029938|FG000|Overall Study|Withdrawal by Subject|4|||
19581443|NCT01078662|42029939|FG001|Overall Study|Withdrawal by Subject|11|||
19581444|NCT01078662|42029940|FG002|Overall Study|Withdrawal by Subject|1|||
19581445|NCT01078662|42029941|FG003|Overall Study|Withdrawal by Subject|0|||
19581446|NCT01078662|42029942|FG004|Overall Study|Withdrawal by Subject|0|||
19581447|NCT01078662|42029938|FG000|Overall Study|Protocol Violation|0|||
19581448|NCT01078662|42029939|FG001|Overall Study|Protocol Violation|1|||
19581449|NCT01078662|42029940|FG002|Overall Study|Protocol Violation|0|||
19581450|NCT01078662|42029941|FG003|Overall Study|Protocol Violation|0|||
19581451|NCT01078662|42029942|FG004|Overall Study|Protocol Violation|0|||
19581452|NCT01078662|42029938|FG000|Overall Study|Lost to Follow-up|1|||
19581453|NCT01078662|42029939|FG001|Overall Study|Lost to Follow-up|0|||
19581454|NCT01078662|42029940|FG002|Overall Study|Lost to Follow-up|0|||
19581455|NCT01078662|42029941|FG003|Overall Study|Lost to Follow-up|0|||
19581456|NCT01078662|42029942|FG004|Overall Study|Lost to Follow-up|0|||
19581457|NCT01091454|42029951|FG000|Overall Study|Ineligible|1|||
19581458|NCT01140347|42029957|FG000|Overall Study|Lost to Follow-up|5|||
19581459|NCT01140347|42029958|FG001|Overall Study|Lost to Follow-up|6|||
19581460|NCT01140347|42029957|FG000|Overall Study|Withdrawal by Subject|13|||
19581461|NCT01140347|42029958|FG001|Overall Study|Withdrawal by Subject|8|||
19581462|NCT01197560|42029966|FG000|Overall Study|Adverse Event|6|||
19581463|NCT01197560|42029967|FG001|Overall Study|Adverse Event|8|||
19581464|NCT01197560|42029966|FG000|Overall Study|Death|3|||
19581465|NCT01197560|42029967|FG001|Overall Study|Death|5|||
19581466|NCT01197560|42029966|FG000|Overall Study|Withdrawal by Subject|1|||
19581467|NCT01197560|42029967|FG001|Overall Study|Withdrawal by Subject|1|||
19581468|NCT01197560|42029966|FG000|Overall Study|Disease progression|40|||
19581469|NCT01197560|42029967|FG001|Overall Study|Disease progression|35|||
19581470|NCT01197560|42029966|FG000|Overall Study|Miscellaneous|4|||
19581471|NCT01197560|42029967|FG001|Overall Study|Miscellaneous|3|||
19581472|NCT01197560|42029966|FG000|Overall Study|Missing|0|||
19581473|NCT01197560|42029967|FG001|Overall Study|Missing|1|||
19581474|NCT01133405|42029984|FG000|Period 1|Withdrawal by Subject|0|||
19581475|NCT01133405|42029985|FG001|Period 1|Withdrawal by Subject|1|||
19581476|NCT01133405|42029986|FG002|Period 1|Withdrawal by Subject|0|||
19581477|NCT01133405|42029987|FG003|Period 1|Withdrawal by Subject|1|||
19581478|NCT01133405|42029988|FG004|Period 1|Withdrawal by Subject|0|||
19581479|NCT01133405|42029989|FG005|Period 1|Withdrawal by Subject|1|||
19581480|NCT01133405|42029990|FG006|Period 1|Withdrawal by Subject|0|||
19581481|NCT01133405|42029991|FG007|Period 1|Withdrawal by Subject|0|||
19476962|NCT02790138|41755395|FG000|Overall Study|Voluntary Withdrawal|8|||
19476963|NCT02790138|41755396|FG001|Overall Study|Voluntary Withdrawal|9|||
19581482|NCT01133405|42029992|FG008|Period 1|Withdrawal by Subject|0|||
19581483|NCT01133405|42029993|FG009|Period 1|Withdrawal by Subject|0|||
19581484|NCT01133405|42029984|FG000|Period 1|Physician Decision|0|||
19581485|NCT01133405|42029985|FG001|Period 1|Physician Decision|0|||
19581486|NCT01133405|42029986|FG002|Period 1|Physician Decision|0|||
19581487|NCT01133405|42029987|FG003|Period 1|Physician Decision|1|||
19581488|NCT01133405|42029988|FG004|Period 1|Physician Decision|0|||
19581489|NCT01133405|42029989|FG005|Period 1|Physician Decision|0|||
19581490|NCT01133405|42029990|FG006|Period 1|Physician Decision|0|||
19581491|NCT01133405|42029991|FG007|Period 1|Physician Decision|0|||
19581492|NCT01133405|42029992|FG008|Period 1|Physician Decision|0|||
19581493|NCT01133405|42029993|FG009|Period 1|Physician Decision|0|||
19581494|NCT01133405|42029984|FG000|Period 1|Discontinued after randomization|1|||
19581495|NCT01133405|42029985|FG001|Period 1|Discontinued after randomization|0|||
19581496|NCT01133405|42029986|FG002|Period 1|Discontinued after randomization|0|||
19581497|NCT01133405|42029987|FG003|Period 1|Discontinued after randomization|0|||
19581498|NCT01133405|42029988|FG004|Period 1|Discontinued after randomization|0|||
19581499|NCT01133405|42029989|FG005|Period 1|Discontinued after randomization|0|||
19581500|NCT01133405|42029990|FG006|Period 1|Discontinued after randomization|1|||
19581501|NCT01133405|42029991|FG007|Period 1|Discontinued after randomization|0|||
19581502|NCT01133405|42029992|FG008|Period 1|Discontinued after randomization|0|||
19581503|NCT01133405|42029993|FG009|Period 1|Discontinued after randomization|0|||
19581504|NCT01133405|42029984|FG000|Period 1|Received drug only in period 2|0|||
19581505|NCT01133405|42029985|FG001|Period 1|Received drug only in period 2|1|||
19581506|NCT01133405|42029986|FG002|Period 1|Received drug only in period 2|0|||
19581507|NCT01133405|42029987|FG003|Period 1|Received drug only in period 2|2|||
19581508|NCT01133405|42029988|FG004|Period 1|Received drug only in period 2|0|||
19581509|NCT01133405|42029989|FG005|Period 1|Received drug only in period 2|1|||
19581510|NCT01133405|42029990|FG006|Period 1|Received drug only in period 2|0|||
19581511|NCT01133405|42029991|FG007|Period 1|Received drug only in period 2|0|||
19581512|NCT01133405|42029992|FG008|Period 1|Received drug only in period 2|0|||
19581513|NCT01133405|42029993|FG009|Period 1|Received drug only in period 2|0|||
19581514|NCT01133405|42029984|FG000|Period 1|Received drug only in period 3|0|||
19581515|NCT01133405|42029985|FG001|Period 1|Received drug only in period 3|1|||
19581516|NCT01133405|42029986|FG002|Period 1|Received drug only in period 3|1|||
19581517|NCT01133405|42029987|FG003|Period 1|Received drug only in period 3|0|||
19581518|NCT01133405|42029988|FG004|Period 1|Received drug only in period 3|0|||
19581519|NCT01133405|42029989|FG005|Period 1|Received drug only in period 3|0|||
19581520|NCT01133405|42029990|FG006|Period 1|Received drug only in period 3|0|||
19581521|NCT01133405|42029991|FG007|Period 1|Received drug only in period 3|0|||
19581522|NCT01133405|42029992|FG008|Period 1|Received drug only in period 3|0|||
19581523|NCT01133405|42029993|FG009|Period 1|Received drug only in period 3|0|||
19581524|NCT01133405|42029984|FG000|Period 2|Adverse Event|0|||
19581525|NCT01133405|42029985|FG001|Period 2|Adverse Event|0|||
19581526|NCT01133405|42029986|FG002|Period 2|Adverse Event|1|||
19581527|NCT01133405|42029987|FG003|Period 2|Adverse Event|0|||
19581528|NCT01133405|42029988|FG004|Period 2|Adverse Event|0|||
19581529|NCT01133405|42029989|FG005|Period 2|Adverse Event|0|||
19581530|NCT01133405|42029990|FG006|Period 2|Adverse Event|0|||
19581531|NCT01133405|42029991|FG007|Period 2|Adverse Event|0|||
19581532|NCT01133405|42029992|FG008|Period 2|Adverse Event|0|||
19581533|NCT01133405|42029993|FG009|Period 2|Adverse Event|0|||
19581534|NCT01133405|42029984|FG000|Period 2|Withdrawal by Subject|0|||
19581535|NCT01133405|42029985|FG001|Period 2|Withdrawal by Subject|0|||
19581536|NCT01133405|42029986|FG002|Period 2|Withdrawal by Subject|0|||
19581537|NCT01133405|42029987|FG003|Period 2|Withdrawal by Subject|1|||
19581538|NCT01133405|42029988|FG004|Period 2|Withdrawal by Subject|0|||
19581539|NCT01133405|42029989|FG005|Period 2|Withdrawal by Subject|1|||
19581540|NCT01133405|42029990|FG006|Period 2|Withdrawal by Subject|0|||
19581541|NCT01133405|42029991|FG007|Period 2|Withdrawal by Subject|0|||
19581542|NCT01133405|42029992|FG008|Period 2|Withdrawal by Subject|0|||
19581543|NCT01133405|42029993|FG009|Period 2|Withdrawal by Subject|0|||
19581544|NCT01133405|42029984|FG000|Period 2|Entry Criteria Not Met|0|||
19581545|NCT01133405|42029985|FG001|Period 2|Entry Criteria Not Met|1|||
19581546|NCT01133405|42029986|FG002|Period 2|Entry Criteria Not Met|0|||
19581547|NCT01133405|42029987|FG003|Period 2|Entry Criteria Not Met|0|||
19581548|NCT01133405|42029988|FG004|Period 2|Entry Criteria Not Met|0|||
19581549|NCT01133405|42029989|FG005|Period 2|Entry Criteria Not Met|0|||
19581550|NCT01133405|42029990|FG006|Period 2|Entry Criteria Not Met|0|||
19581551|NCT01133405|42029991|FG007|Period 2|Entry Criteria Not Met|0|||
19581552|NCT01133405|42029992|FG008|Period 2|Entry Criteria Not Met|0|||
19581553|NCT01133405|42029993|FG009|Period 2|Entry Criteria Not Met|0|||
19581554|NCT01133405|42029984|FG000|Period 2|Physician Decision|0|||
19581555|NCT01133405|42029985|FG001|Period 2|Physician Decision|0|||
19581556|NCT01133405|42029986|FG002|Period 2|Physician Decision|0|||
19581557|NCT01133405|42029987|FG003|Period 2|Physician Decision|0|||
19581558|NCT01133405|42029988|FG004|Period 2|Physician Decision|0|||
19581559|NCT01133405|42029989|FG005|Period 2|Physician Decision|1|||
19581560|NCT01133405|42029990|FG006|Period 2|Physician Decision|0|||
19581561|NCT01133405|42029991|FG007|Period 2|Physician Decision|0|||
19581562|NCT01133405|42029992|FG008|Period 2|Physician Decision|0|||
19581563|NCT01133405|42029993|FG009|Period 2|Physician Decision|0|||
19581564|NCT01196078|42030025|FG000|Overall Study|Withdrawal by Subject|3|||
19581565|NCT01196078|42030026|FG001|Overall Study|Withdrawal by Subject|5|||
19581566|NCT01196078|42030025|FG000|Overall Study|Adverse Event|4|||
19581567|NCT01196078|42030026|FG001|Overall Study|Adverse Event|4|||
19581568|NCT01196078|42030025|FG000|Overall Study|Protocol Violation|2|||
19581569|NCT01196078|42030026|FG001|Overall Study|Protocol Violation|1|||
19581570|NCT01196078|42030025|FG000|Overall Study|Lack of Efficacy|17|||
19581571|NCT01196078|42030026|FG001|Overall Study|Lack of Efficacy|23|||
19581572|NCT01196078|42030025|FG000|Overall Study|Lost to Follow-up|1|||
19581573|NCT01196078|42030026|FG001|Overall Study|Lost to Follow-up|0|||
19581574|NCT01196078|42030025|FG000|Overall Study|Death|6|||
19581575|NCT01196078|42030026|FG001|Overall Study|Death|4|||
19581576|NCT01078584|42030032|FG000|Overall Study|Final Status Unknown|1073|||
19581577|NCT01078584|42030032|FG000|Overall Study|Lost to Follow-up|670|||
19581578|NCT01078584|42030032|FG000|Overall Study|Non-serious Adverse Event|577|||
19581579|NCT01078584|42030032|FG000|Overall Study|Withdrawal of Consent|244|||
19581580|NCT01078584|42030032|FG000|Overall Study|Physician Withdrew from Study|90|||
19581581|NCT01078584|42030032|FG000|Overall Study|Non-compliance|67|||
19581582|NCT01078584|42030032|FG000|Overall Study|Blood Pressure Controlled|49|||
19581583|NCT01078584|42030032|FG000|Overall Study|Physician Switched Medication|26|||
19581584|NCT01078584|42030032|FG000|Overall Study|Physician Discontinued Patient|12|||
19581585|NCT01078584|42030032|FG000|Overall Study|Lack of Efficacy|98|||
19581586|NCT01078584|42030032|FG000|Overall Study|Protocol Violation|75|||
19581587|NCT01078584|42030032|FG000|Overall Study|Serious Adverse Event|27|||
19581588|NCT01078584|42030032|FG000|Overall Study|Multiple Reasons|2|||
19581589|NCT01133171|42030052|FG000|Overall Study|Withdrawal by Subject|1|||
19581590|NCT01133171|42030053|FG001|Overall Study|Withdrawal by Subject|2|||
19581591|NCT01133171|42030054|FG002|Overall Study|Withdrawal by Subject|0|||
19581592|NCT01195844|42030062|FG000|Overall Study|Fecal sample not collected|40|||
19581593|NCT01132547|42030078|FG000|Overall Study|Withdrawal by Subject|3|||
19581594|NCT01132547|42030079|FG001|Overall Study|Withdrawal by Subject|1|||
19581595|NCT01132547|42030078|FG000|Overall Study|Death|1|||
19581596|NCT01132547|42030079|FG001|Overall Study|Death|0|||
19581597|NCT01194830|42030087|FG000|Overall Study|Adverse Event|3|||
19581598|NCT01194830|42030088|FG001|Overall Study|Adverse Event|2|||
19581599|NCT01194830|42030087|FG000|Overall Study|Protocol Violation|5|||
19581600|NCT01194830|42030088|FG001|Overall Study|Protocol Violation|4|||
19581601|NCT01194830|42030087|FG000|Overall Study|Lost to Follow-up|9|||
19581602|NCT01194830|42030088|FG001|Overall Study|Lost to Follow-up|7|||
19581603|NCT01194830|42030087|FG000|Overall Study|Withdrawal by Subject|2|||
19581604|NCT01194830|42030088|FG001|Overall Study|Withdrawal by Subject|1|||
19581605|NCT01194830|42030087|FG000|Overall Study|Lack of Efficacy|1|||
19581606|NCT01194830|42030088|FG001|Overall Study|Lack of Efficacy|1|||
19581607|NCT01194830|42030087|FG000|Overall Study|Non-compliance issues|4|||
19581608|NCT01194830|42030088|FG001|Overall Study|Non-compliance issues|4|||
19581609|NCT01194830|42030087|FG000|Overall Study|Other Reason|12|||
19581610|NCT01194830|42030088|FG001|Overall Study|Other Reason|8|||
19581611|NCT01194440|42030094|FG000|Baseline (First Dose)|Reason not specified|4|||
19581612|NCT01194440|42030094|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
19581613|NCT01194440|42030094|FG000|Baseline (First Dose)|Change in therapy|1|||
19581614|NCT01194440|42030094|FG000|Baseline (First Dose)|Adverse Event|1|||
19581615|NCT01194440|42030094|FG000|6-months (2nd Dose)|Change in therapy|4|||
19581616|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Adverse Event|1|||
19581617|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Adverse Event|1|||
19581618|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Adverse Event|2|||
19581619|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Adverse Event|5|||
19581620|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Adverse Event|0|||
19581621|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
19581622|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
19581623|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
19581624|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
19581625|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
19581626|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
19581627|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
19581628|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
19581629|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
19581630|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
19581631|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
19581632|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
19581633|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
19581634|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
19581635|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
19581636|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
19581637|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
19581638|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
19581639|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
19581640|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
19581641|NCT00951015|42030103|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
19581642|NCT00951015|42030104|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
19581643|NCT00951015|42030105|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
19581644|NCT00951015|42030106|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
19581645|NCT00951015|42030107|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
19581646|NCT00951015|42030103|FG000|Open-label Phase|Adverse Event|0|||
19581647|NCT00951015|42030104|FG001|Open-label Phase|Adverse Event|0|||
19581648|NCT00951015|42030105|FG002|Open-label Phase|Adverse Event|0|||
19581649|NCT00951015|42030106|FG003|Open-label Phase|Adverse Event|0|||
19581650|NCT00951015|42030107|FG004|Open-label Phase|Adverse Event|3|||
19581651|NCT00951015|42030103|FG000|Open-label Phase|Lack of Efficacy|0|||
19581652|NCT00951015|42030104|FG001|Open-label Phase|Lack of Efficacy|0|||
19581653|NCT00951015|42030105|FG002|Open-label Phase|Lack of Efficacy|0|||
19581654|NCT00951015|42030106|FG003|Open-label Phase|Lack of Efficacy|0|||
19581655|NCT00951015|42030107|FG004|Open-label Phase|Lack of Efficacy|1|||
19581656|NCT00951015|42030103|FG000|Open-label Phase|Protocol Violation|0|||
19581657|NCT00951015|42030104|FG001|Open-label Phase|Protocol Violation|0|||
19581658|NCT00951015|42030105|FG002|Open-label Phase|Protocol Violation|0|||
19581659|NCT00951015|42030106|FG003|Open-label Phase|Protocol Violation|0|||
19581660|NCT00951015|42030107|FG004|Open-label Phase|Protocol Violation|12|||
19581661|NCT00951015|42030103|FG000|Open-label Phase|Lost to Follow-up|0|||
19581662|NCT00951015|42030104|FG001|Open-label Phase|Lost to Follow-up|0|||
19581663|NCT00951015|42030105|FG002|Open-label Phase|Lost to Follow-up|0|||
19581664|NCT00951015|42030106|FG003|Open-label Phase|Lost to Follow-up|0|||
19581665|NCT00951015|42030107|FG004|Open-label Phase|Lost to Follow-up|12|||
19581666|NCT00951015|42030103|FG000|Open-label Phase|Withdrawal by Subject|0|||
19581667|NCT00951015|42030104|FG001|Open-label Phase|Withdrawal by Subject|0|||
19581668|NCT00951015|42030105|FG002|Open-label Phase|Withdrawal by Subject|0|||
19581669|NCT00951015|42030106|FG003|Open-label Phase|Withdrawal by Subject|0|||
19581670|NCT00951015|42030107|FG004|Open-label Phase|Withdrawal by Subject|14|||
19581671|NCT00951015|42030103|FG000|Open-label Phase|Physician Decision|0|||
19581672|NCT00951015|42030104|FG001|Open-label Phase|Physician Decision|0|||
19581673|NCT00951015|42030105|FG002|Open-label Phase|Physician Decision|0|||
19581674|NCT00951015|42030106|FG003|Open-label Phase|Physician Decision|0|||
19581675|NCT00951015|42030107|FG004|Open-label Phase|Physician Decision|8|||
19581676|NCT01139021|42030136|FG000|Overall Study|Adverse Event|0|||
19581677|NCT01139021|42030137|FG001|Overall Study|Adverse Event|0|||
19581678|NCT01139021|42030138|FG002|Overall Study|Adverse Event|0|||
19581679|NCT01139021|42030139|FG003|Overall Study|Adverse Event|0|||
19581680|NCT01139021|42030140|FG004|Overall Study|Adverse Event|1|||
19581681|NCT01139021|42030141|FG005|Overall Study|Adverse Event|0|||
19581682|NCT01139021|42030136|FG000|Overall Study|Lost to Follow-up|0|||
19581683|NCT01139021|42030137|FG001|Overall Study|Lost to Follow-up|0|||
19581684|NCT01139021|42030138|FG002|Overall Study|Lost to Follow-up|0|||
19581685|NCT01139021|42030139|FG003|Overall Study|Lost to Follow-up|0|||
19581686|NCT01139021|42030140|FG004|Overall Study|Lost to Follow-up|2|||
19581687|NCT01139021|42030141|FG005|Overall Study|Lost to Follow-up|0|||
19581688|NCT01139021|42030136|FG000|Overall Study|Protocol Violation|1|||
19581689|NCT01139021|42030137|FG001|Overall Study|Protocol Violation|0|||
19581690|NCT01139021|42030138|FG002|Overall Study|Protocol Violation|0|||
19581691|NCT01139021|42030139|FG003|Overall Study|Protocol Violation|0|||
19581692|NCT01139021|42030140|FG004|Overall Study|Protocol Violation|2|||
19581693|NCT01139021|42030141|FG005|Overall Study|Protocol Violation|0|||
19581694|NCT01139021|42030136|FG000|Overall Study|Withdrawal by Subject|0|||
19581695|NCT01139021|42030137|FG001|Overall Study|Withdrawal by Subject|0|||
19581696|NCT01139021|42030138|FG002|Overall Study|Withdrawal by Subject|0|||
19581697|NCT01139021|42030139|FG003|Overall Study|Withdrawal by Subject|1|||
19581698|NCT01139021|42030140|FG004|Overall Study|Withdrawal by Subject|4|||
19581699|NCT01139021|42030141|FG005|Overall Study|Withdrawal by Subject|0|||
19581700|NCT01193660|42030159|FG000|Overall Study|Withdrawal by Subject|2|||
19581701|NCT01193660|42030160|FG001|Overall Study|Withdrawal by Subject|3|||
19581702|NCT01193660|42030161|FG002|Overall Study|Withdrawal by Subject|1|||
19581703|NCT01193660|42030159|FG000|Overall Study|Death|1|||
19581704|NCT01193660|42030160|FG001|Overall Study|Death|0|||
19581705|NCT01193660|42030161|FG002|Overall Study|Death|0|||
19581706|NCT01193660|42030159|FG000|Overall Study|Physician Decision|1|||
19581707|NCT01193660|42030160|FG001|Overall Study|Physician Decision|0|||
19581708|NCT01193660|42030161|FG002|Overall Study|Physician Decision|1|||
19581709|NCT01076166|42030169|FG000|Overall Study|Adverse Event|3|||
19581710|NCT01076166|42030169|FG000|Overall Study|Symptoms improved/resolved|6|||
19581711|NCT01193582|42030180|FG000|Vaccination Series|Withdrawal by Subject|11|||
19581712|NCT01193582|42030181|FG001|Vaccination Series|Withdrawal by Subject|13|||
19581713|NCT01193582|42030182|FG002|Vaccination Series|Withdrawal by Subject|8|||
19581714|NCT01193582|42030183|FG003|Vaccination Series|Withdrawal by Subject|3|||
19581715|NCT01193582|42030180|FG000|12 Month Follow-up|Death|0|||
19581716|NCT01193582|42030181|FG001|12 Month Follow-up|Death|0|||
19581717|NCT01193582|42030182|FG002|12 Month Follow-up|Death|1|||
19581718|NCT01193582|42030183|FG003|12 Month Follow-up|Death|0|||
19581719|NCT01193582|42030180|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
19581720|NCT01193582|42030181|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
19581721|NCT01193582|42030182|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
19581722|NCT01193582|42030183|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
19581723|NCT00945477|42030195|FG000|Overall Study|Adverse Event|3|||
19581724|NCT00945477|42030195|FG000|Overall Study|Lack of Efficacy|2|||
19581725|NCT00945477|42030195|FG000|Overall Study|Withdrawal by Subject|1|||
19581726|NCT01076088|42030206|FG000|Overall Study|Adverse Event|1|||
19581727|NCT01076088|42030207|FG001|Overall Study|Adverse Event|6|||
19581728|NCT01076088|42030208|FG002|Overall Study|Adverse Event|3|||
19581729|NCT01076088|42030209|FG003|Overall Study|Adverse Event|2|||
19581730|NCT01076088|42030210|FG004|Overall Study|Adverse Event|3|||
19581731|NCT01076088|42030211|FG005|Overall Study|Adverse Event|3|||
19581732|NCT01076088|42030206|FG000|Overall Study|Lost to Follow-up|1|||
19581733|NCT01076088|42030207|FG001|Overall Study|Lost to Follow-up|1|||
19581734|NCT01076088|42030208|FG002|Overall Study|Lost to Follow-up|0|||
19581735|NCT01076088|42030209|FG003|Overall Study|Lost to Follow-up|1|||
19581736|NCT01076088|42030210|FG004|Overall Study|Lost to Follow-up|1|||
19581737|NCT01076088|42030211|FG005|Overall Study|Lost to Follow-up|2|||
19581738|NCT01076088|42030206|FG000|Overall Study|Non-compliance with study drug|0|||
19581739|NCT01076088|42030207|FG001|Overall Study|Non-compliance with study drug|0|||
19581740|NCT01076088|42030208|FG002|Overall Study|Non-compliance with study drug|0|||
19581741|NCT01076088|42030209|FG003|Overall Study|Non-compliance with study drug|1|||
19581742|NCT01076088|42030210|FG004|Overall Study|Non-compliance with study drug|0|||
19581743|NCT01076088|42030211|FG005|Overall Study|Non-compliance with study drug|0|||
19581744|NCT01076088|42030206|FG000|Overall Study|Physician Decision|1|||
19581745|NCT01076088|42030207|FG001|Overall Study|Physician Decision|3|||
19581746|NCT01076088|42030208|FG002|Overall Study|Physician Decision|0|||
19581747|NCT01076088|42030209|FG003|Overall Study|Physician Decision|1|||
19581748|NCT01076088|42030210|FG004|Overall Study|Physician Decision|1|||
19581749|NCT01076088|42030211|FG005|Overall Study|Physician Decision|0|||
19581750|NCT01076088|42030206|FG000|Overall Study|Withdrawal by Subject|8|||
19581751|NCT01076088|42030207|FG001|Overall Study|Withdrawal by Subject|8|||
19581752|NCT01076088|42030208|FG002|Overall Study|Withdrawal by Subject|14|||
19581753|NCT01076088|42030209|FG003|Overall Study|Withdrawal by Subject|10|||
19581754|NCT01076088|42030210|FG004|Overall Study|Withdrawal by Subject|11|||
19581755|NCT01076088|42030211|FG005|Overall Study|Withdrawal by Subject|17|||
19581756|NCT01076088|42030206|FG000|Overall Study|Other protocol specified criteria|0|||
19581757|NCT01076088|42030207|FG001|Overall Study|Other protocol specified criteria|0|||
19581758|NCT01076088|42030208|FG002|Overall Study|Other protocol specified criteria|0|||
19581759|NCT01076088|42030209|FG003|Overall Study|Other protocol specified criteria|0|||
19581760|NCT01076088|42030210|FG004|Overall Study|Other protocol specified criteria|0|||
19581761|NCT01076088|42030211|FG005|Overall Study|Other protocol specified criteria|1|||
19581762|NCT01193348|42030226|FG000|Screening Period|Screen Failure|5|||
19581763|NCT01193348|42030226|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
19581764|NCT01193348|42030226|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
19581765|NCT01193348|42030226|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
19581766|NCT01193348|42030226|FG000|Extension Treatment Period|Physician Decision|1|||
19581767|NCT01193348|42030226|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
19581768|NCT00945321|42030235|FG000|Period 1|Adverse Event|0|||
19581769|NCT00945321|42030236|FG001|Period 1|Adverse Event|0|||
19581770|NCT00945321|42030237|FG002|Period 1|Adverse Event|0|||
19581771|NCT00945321|42030238|FG003|Period 1|Adverse Event|0|||
19581772|NCT00945321|42030239|FG004|Period 1|Adverse Event|1|||
19581773|NCT00945321|42030240|FG005|Period 1|Adverse Event|0|||
19581774|NCT00945321|42030235|FG000|Period 4|Lost to Follow-up|0|||
19581775|NCT00945321|42030236|FG001|Period 4|Lost to Follow-up|0|||
19581776|NCT00945321|42030237|FG002|Period 4|Lost to Follow-up|0|||
19581777|NCT00945321|42030238|FG003|Period 4|Lost to Follow-up|0|||
19581778|NCT00945321|42030239|FG004|Period 4|Lost to Follow-up|0|||
19581779|NCT00945321|42030240|FG005|Period 4|Lost to Follow-up|1|||
19581780|NCT00945243|42030258|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
19581781|NCT01192412|42030264|FG000|Overall Study|Lost to Follow-up|2|||
19581782|NCT01192412|42030265|FG001|Overall Study|Lost to Follow-up|1|||
19581783|NCT01192412|42030264|FG000|Overall Study|Withdrawal by Subject|2|||
19581784|NCT01192412|42030265|FG001|Overall Study|Withdrawal by Subject|1|||
19581785|NCT00944697|42030273|FG000|Overall Study|Withdrawal by Subject|1|||
19581786|NCT00944697|42030274|FG001|Overall Study|Withdrawal by Subject|1|||
19581787|NCT00944697|42030273|FG000|Overall Study|Adverse Event|0|||
19581788|NCT00944697|42030274|FG001|Overall Study|Adverse Event|3|||
19581789|NCT00944697|42030273|FG000|Overall Study|Administrative|1|||
19581790|NCT00944697|42030274|FG001|Overall Study|Administrative|1|||
19581791|NCT01192178|42030282|FG000|Overall Study|Withdrawal by Subject|6|||
19581792|NCT01192178|42030283|FG001|Overall Study|Withdrawal by Subject|10|||
19581793|NCT01192178|42030282|FG000|Overall Study|Protocol Violation|10|||
19581794|NCT01192178|42030283|FG001|Overall Study|Protocol Violation|3|||
19581795|NCT01192178|42030282|FG000|Overall Study|Physician Decision|2|||
19581796|NCT01192178|42030283|FG001|Overall Study|Physician Decision|4|||
19581797|NCT01192178|42030282|FG000|Overall Study|Lost to Follow-up|3|||
19581798|NCT01192178|42030283|FG001|Overall Study|Lost to Follow-up|3|||
19581799|NCT01192178|42030282|FG000|Overall Study|Adverse Event|2|||
19581800|NCT01192178|42030283|FG001|Overall Study|Adverse Event|1|||
19581801|NCT01192178|42030282|FG000|Overall Study|Lack of Efficacy|1|||
19581802|NCT01192178|42030283|FG001|Overall Study|Lack of Efficacy|2|||
19581803|NCT01192100|42030291|FG000|Overall Study|Withdrawal by Subject|0|||
19581804|NCT01192100|42030292|FG001|Overall Study|Withdrawal by Subject|0|||
19581805|NCT01192100|42030293|FG002|Overall Study|Withdrawal by Subject|0|||
19581806|NCT01192100|42030294|FG003|Overall Study|Withdrawal by Subject|0|||
19581807|NCT01192100|42030295|FG004|Overall Study|Withdrawal by Subject|1|||
19581808|NCT01192100|42030296|FG005|Overall Study|Withdrawal by Subject|0|||
19581809|NCT01192100|42030291|FG000|Overall Study|Protocol Violation|0|||
19581810|NCT01192100|42030292|FG001|Overall Study|Protocol Violation|0|||
19581811|NCT01192100|42030293|FG002|Overall Study|Protocol Violation|0|||
19581812|NCT01192100|42030294|FG003|Overall Study|Protocol Violation|1|||
19581813|NCT01192100|42030295|FG004|Overall Study|Protocol Violation|0|||
19581814|NCT01192100|42030296|FG005|Overall Study|Protocol Violation|0|||
19581815|NCT00869401|42030309|FG000|Overall Study|Withdrawal by Subject|0|||
19581816|NCT00869401|42030310|FG001|Overall Study|Withdrawal by Subject|0|||
19581817|NCT00869401|42030311|FG002|Overall Study|Withdrawal by Subject|0|||
19581818|NCT00869401|42030312|FG003|Overall Study|Withdrawal by Subject|5|||
19581819|NCT00869401|42030313|FG004|Overall Study|Withdrawal by Subject|3|||
19581820|NCT01076010|42030328|FG000|Overall Study|Death|15|||
19581821|NCT01076010|42030329|FG001|Overall Study|Death|1|||
19581822|NCT01076010|42030330|FG002|Overall Study|Death|0|||
19581823|NCT01076010|42030328|FG000|Overall Study|Adverse Event|7|||
19581824|NCT01076010|42030329|FG001|Overall Study|Adverse Event|2|||
19581825|NCT01076010|42030330|FG002|Overall Study|Adverse Event|0|||
19581826|NCT01076010|42030328|FG000|Overall Study|Progressive disease|90|||
19581827|NCT01076010|42030329|FG001|Overall Study|Progressive disease|30|||
19581828|NCT01076010|42030330|FG002|Overall Study|Progressive disease|1|||
19581829|NCT01076010|42030328|FG000|Overall Study|Lack of Efficacy|4|||
19581830|NCT01076010|42030329|FG001|Overall Study|Lack of Efficacy|0|||
19581831|NCT01076010|42030330|FG002|Overall Study|Lack of Efficacy|0|||
19581832|NCT01076010|42030328|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
19581833|NCT01076010|42030329|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
19581834|NCT01076010|42030330|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
19581835|NCT01076010|42030328|FG000|Overall Study|Significant Surgical Procedure|0|||
19581836|NCT01076010|42030329|FG001|Overall Study|Significant Surgical Procedure|1|||
19581837|NCT01076010|42030330|FG002|Overall Study|Significant Surgical Procedure|0|||
19581838|NCT01076010|42030328|FG000|Overall Study|Protocol Violation|0|||
19581839|NCT01076010|42030329|FG001|Overall Study|Protocol Violation|1|||
19581840|NCT01076010|42030330|FG002|Overall Study|Protocol Violation|0|||
19581841|NCT01076010|42030328|FG000|Overall Study|Noncompliance|1|||
19581842|NCT01076010|42030329|FG001|Overall Study|Noncompliance|1|||
19581843|NCT01076010|42030330|FG002|Overall Study|Noncompliance|0|||
19581844|NCT01076010|42030328|FG000|Overall Study|Withdrawal by Subject|3|||
19581845|NCT01076010|42030329|FG001|Overall Study|Withdrawal by Subject|0|||
19581846|NCT01076010|42030330|FG002|Overall Study|Withdrawal by Subject|1|||
19581847|NCT01076010|42030328|FG000|Overall Study|Other|5|||
19581848|NCT01076010|42030329|FG001|Overall Study|Other|2|||
19581849|NCT01076010|42030330|FG002|Overall Study|Other|0|||
19581850|NCT01075152|42030340|FG000|Overall Study|Withdrawal by Subject|1|||
19581851|NCT01075152|42030341|FG001|Overall Study|Withdrawal by Subject|0|||
19581852|NCT01078116|42030349|FG000|Overall Study|Lost to Follow-up|17|||
19581853|NCT01078116|42030349|FG000|Overall Study|Adverse Event|5|||
19581854|NCT01078116|42030349|FG000|Overall Study|Withdrawal by Subject|8|||
19581855|NCT01078116|42030349|FG000|Overall Study|Lack of effectiveness|15|||
19581856|NCT01078116|42030349|FG000|Overall Study|Case report form not completed|3|||
19581857|NCT00950859|42030355|FG000|Overall Study|Adverse Event|3|||
19581858|NCT00950859|42030356|FG001|Overall Study|Adverse Event|3|||
19581859|NCT00950859|42030355|FG000|Overall Study|Insufficient Viral Load Response|12|||
19581860|NCT00950859|42030356|FG001|Overall Study|Insufficient Viral Load Response|3|||
19581861|NCT00950859|42030355|FG000|Overall Study|Protocol Violation|1|||
19581862|NCT00950859|42030356|FG001|Overall Study|Protocol Violation|1|||
19581863|NCT00950859|42030355|FG000|Overall Study|Lost to Follow-up|0|||
19581864|NCT00950859|42030356|FG001|Overall Study|Lost to Follow-up|3|||
19581865|NCT00862849|42030362|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
19581866|NCT00862849|42030363|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
19581867|NCT00862849|42030364|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
19581868|NCT00862849|42030365|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
19581869|NCT00862849|42030366|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
19581870|NCT00862849|42030367|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
19581871|NCT00862849|42030362|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
19581872|NCT00862849|42030363|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
19581873|NCT00862849|42030364|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
19581874|NCT00862849|42030365|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
19581875|NCT00862849|42030366|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
19581876|NCT00862849|42030367|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
19581877|NCT01090050|42030377|FG000|Overall Study|Lost to Follow-up|0|||
19581878|NCT01090050|42030378|FG001|Overall Study|Lost to Follow-up|1|||
19581879|NCT01090050|42030377|FG000|Overall Study|Lack of Efficacy|1|||
19581880|NCT01090050|42030378|FG001|Overall Study|Lack of Efficacy|5|||
19581881|NCT01090050|42030377|FG000|Overall Study|Physician Decision|0|||
19581882|NCT01090050|42030378|FG001|Overall Study|Physician Decision|1|||
19581883|NCT00944229|42030388|FG000|Overall Study|Withdrawal by Subject|11|||
19581884|NCT00944229|42030388|FG000|Overall Study|Physician Decision|14|||
19581885|NCT01077960|42030392|FG000|Overall Study|Adverse Event|6|||
19581886|NCT01077960|42030392|FG000|Overall Study|Protocol Violation|3|||
19581887|NCT01077960|42030392|FG000|Overall Study|Lost to Follow-up|5|||
19581888|NCT01077960|42030392|FG000|Overall Study|Subject decision|1|||
19581889|NCT01077960|42030392|FG000|Overall Study|Reason unspecified|1|||
19581890|NCT01077804|42030396|FG000|Overall Study|Unreachable|102|||
19581891|NCT01077804|42030396|FG000|Overall Study|Refused to continue|79|||
19581892|NCT01077804|42030396|FG000|Overall Study|Other|18|||
19581893|NCT01075074|42030420|FG000|Overall Study|Surgeon changed to open incisional case|1|||
19581894|NCT01075074|42030421|FG001|Overall Study|Surgeon changed to open incisional case|2|||
19581895|NCT01075074|42030422|FG002|Overall Study|Surgeon changed to open incisional case|2|||
19581896|NCT00866281|42030436|FG000|Overall Study|Adverse Event|1|||
19581897|NCT00866281|42030437|FG001|Overall Study|Adverse Event|0|||
19581898|NCT00866281|42030436|FG000|Overall Study|Withdrawal by participants|3|||
19581899|NCT00866281|42030437|FG001|Overall Study|Withdrawal by participants|0|||
19581900|NCT00866281|42030436|FG000|Overall Study|Disease progression|3|||
19581901|NCT00866281|42030437|FG001|Overall Study|Disease progression|11|||
19581902|NCT00866281|42030436|FG000|Overall Study|New cancer therapy|0|||
19581903|NCT00866281|42030437|FG001|Overall Study|New cancer therapy|4|||
19581904|NCT01077258|42030446|FG000|Overall Study|Lost to Follow-up|1390|||
19581905|NCT01077258|42030446|FG000|Overall Study|Adverse drug reaction|218|||
19581906|NCT01077258|42030446|FG000|Overall Study|Lack of Efficacy|663|||
19581907|NCT01077258|42030446|FG000|Overall Study|Clinical remission|37|||
19581908|NCT01077258|42030446|FG000|Overall Study|Other reasons|260|||
19581909|NCT00943917|42030474|FG000|Stage I|Adverse Event|1|||
19581910|NCT00943917|42030475|FG001|Stage I|Adverse Event|2|||
19581911|NCT00943917|42030476|FG002|Stage I|Adverse Event|2|||
19581912|NCT00943917|42030477|FG003|Stage I|Adverse Event|0|||
19581913|NCT00943917|42030478|FG004|Stage I|Adverse Event|0|||
19581914|NCT00943917|42030479|FG005|Stage I|Adverse Event|0|||
19581915|NCT00943917|42030480|FG006|Stage I|Adverse Event|0|||
19581916|NCT00943917|42030481|FG007|Stage I|Adverse Event|0|||
19581917|NCT00943917|42030482|FG008|Stage I|Adverse Event|0|||
19581918|NCT00943917|42030483|FG009|Stage I|Adverse Event|0|||
19581919|NCT00943917|42030484|FG010|Stage I|Adverse Event|0|||
19581920|NCT00943917|42030485|FG011|Stage I|Adverse Event|0|||
19581921|NCT00943917|42030486|FG012|Stage I|Adverse Event|0|||
19581922|NCT00943917|42030487|FG013|Stage I|Adverse Event|0|||
19581923|NCT00943917|42030488|FG014|Stage I|Adverse Event|0|||
19581924|NCT00943917|42030474|FG000|Stage I|Lost to Follow-up|0|||
19581925|NCT00943917|42030475|FG001|Stage I|Lost to Follow-up|0|||
19581926|NCT00943917|42030476|FG002|Stage I|Lost to Follow-up|1|||
19581927|NCT00943917|42030477|FG003|Stage I|Lost to Follow-up|0|||
19581928|NCT00943917|42030478|FG004|Stage I|Lost to Follow-up|0|||
19581929|NCT00943917|42030479|FG005|Stage I|Lost to Follow-up|0|||
19581930|NCT00943917|42030480|FG006|Stage I|Lost to Follow-up|0|||
19581931|NCT00943917|42030481|FG007|Stage I|Lost to Follow-up|0|||
19581932|NCT00943917|42030482|FG008|Stage I|Lost to Follow-up|0|||
19581933|NCT00943917|42030483|FG009|Stage I|Lost to Follow-up|0|||
19581934|NCT00943917|42030484|FG010|Stage I|Lost to Follow-up|0|||
19581935|NCT00943917|42030485|FG011|Stage I|Lost to Follow-up|0|||
19581936|NCT00943917|42030486|FG012|Stage I|Lost to Follow-up|0|||
19581937|NCT00943917|42030487|FG013|Stage I|Lost to Follow-up|0|||
19581938|NCT00943917|42030488|FG014|Stage I|Lost to Follow-up|0|||
19581939|NCT00943917|42030474|FG000|Stage I|hyperglycemia|0|||
19581940|NCT00943917|42030475|FG001|Stage I|hyperglycemia|0|||
19581941|NCT00943917|42030476|FG002|Stage I|hyperglycemia|1|||
19581942|NCT00943917|42030477|FG003|Stage I|hyperglycemia|0|||
19581943|NCT00943917|42030478|FG004|Stage I|hyperglycemia|0|||
19581944|NCT00943917|42030479|FG005|Stage I|hyperglycemia|0|||
19581945|NCT00943917|42030480|FG006|Stage I|hyperglycemia|0|||
19581946|NCT00943917|42030481|FG007|Stage I|hyperglycemia|0|||
19581947|NCT00943917|42030482|FG008|Stage I|hyperglycemia|0|||
19581948|NCT00943917|42030483|FG009|Stage I|hyperglycemia|0|||
19581949|NCT00943917|42030484|FG010|Stage I|hyperglycemia|0|||
19581950|NCT00943917|42030485|FG011|Stage I|hyperglycemia|0|||
19581951|NCT00943917|42030486|FG012|Stage I|hyperglycemia|0|||
19581952|NCT00943917|42030487|FG013|Stage I|hyperglycemia|0|||
19581953|NCT00943917|42030488|FG014|Stage I|hyperglycemia|0|||
19581954|NCT00943917|42030474|FG000|Stage I|A1C elevation|1|||
19581955|NCT00943917|42030475|FG001|Stage I|A1C elevation|0|||
19581956|NCT00943917|42030476|FG002|Stage I|A1C elevation|0|||
19581957|NCT00943917|42030477|FG003|Stage I|A1C elevation|0|||
19581958|NCT00943917|42030478|FG004|Stage I|A1C elevation|0|||
19581959|NCT00943917|42030479|FG005|Stage I|A1C elevation|0|||
19581960|NCT00943917|42030480|FG006|Stage I|A1C elevation|0|||
19581961|NCT00943917|42030481|FG007|Stage I|A1C elevation|0|||
19581962|NCT00943917|42030482|FG008|Stage I|A1C elevation|0|||
19581963|NCT00943917|42030483|FG009|Stage I|A1C elevation|0|||
19581964|NCT00943917|42030484|FG010|Stage I|A1C elevation|0|||
19581965|NCT00943917|42030485|FG011|Stage I|A1C elevation|0|||
19581966|NCT00943917|42030486|FG012|Stage I|A1C elevation|0|||
19581967|NCT00943917|42030487|FG013|Stage I|A1C elevation|0|||
19581968|NCT00943917|42030488|FG014|Stage I|A1C elevation|0|||
19581969|NCT00943917|42030474|FG000|Stage I|Withdrawal by Subject|2|||
19581970|NCT00943917|42030475|FG001|Stage I|Withdrawal by Subject|1|||
19581971|NCT00943917|42030476|FG002|Stage I|Withdrawal by Subject|2|||
19581972|NCT00943917|42030477|FG003|Stage I|Withdrawal by Subject|0|||
19581973|NCT00943917|42030478|FG004|Stage I|Withdrawal by Subject|0|||
19581974|NCT00943917|42030479|FG005|Stage I|Withdrawal by Subject|0|||
19581975|NCT00943917|42030480|FG006|Stage I|Withdrawal by Subject|0|||
19581976|NCT00943917|42030481|FG007|Stage I|Withdrawal by Subject|0|||
19581977|NCT00943917|42030482|FG008|Stage I|Withdrawal by Subject|0|||
19581978|NCT00943917|42030483|FG009|Stage I|Withdrawal by Subject|0|||
19581979|NCT00943917|42030484|FG010|Stage I|Withdrawal by Subject|0|||
19581980|NCT00943917|42030485|FG011|Stage I|Withdrawal by Subject|0|||
19581981|NCT00943917|42030486|FG012|Stage I|Withdrawal by Subject|0|||
19581982|NCT00943917|42030487|FG013|Stage I|Withdrawal by Subject|0|||
19581983|NCT00943917|42030488|FG014|Stage I|Withdrawal by Subject|0|||
19581984|NCT00943917|42030474|FG000|Stage II|Adverse Event|0|||
19581985|NCT00943917|42030475|FG001|Stage II|Adverse Event|0|||
19581986|NCT00943917|42030476|FG002|Stage II|Adverse Event|0|||
19581987|NCT00943917|42030477|FG003|Stage II|Adverse Event|0|||
19581988|NCT00943917|42030478|FG004|Stage II|Adverse Event|0|||
19581989|NCT00943917|42030479|FG005|Stage II|Adverse Event|1|||
19581990|NCT00943917|42030480|FG006|Stage II|Adverse Event|3|||
19581991|NCT00943917|42030481|FG007|Stage II|Adverse Event|0|||
19581992|NCT00943917|42030482|FG008|Stage II|Adverse Event|1|||
19581993|NCT00943917|42030483|FG009|Stage II|Adverse Event|0|||
19581994|NCT00943917|42030484|FG010|Stage II|Adverse Event|0|||
19581995|NCT00943917|42030485|FG011|Stage II|Adverse Event|0|||
19581996|NCT00943917|42030486|FG012|Stage II|Adverse Event|0|||
19581997|NCT00943917|42030487|FG013|Stage II|Adverse Event|0|||
19581998|NCT00943917|42030488|FG014|Stage II|Adverse Event|0|||
19581999|NCT00943917|42030474|FG000|Stage II|Withdrawal by Subject|0|||
19582000|NCT00943917|42030475|FG001|Stage II|Withdrawal by Subject|0|||
19582001|NCT00943917|42030476|FG002|Stage II|Withdrawal by Subject|0|||
19582002|NCT00943917|42030477|FG003|Stage II|Withdrawal by Subject|0|||
19582003|NCT00943917|42030478|FG004|Stage II|Withdrawal by Subject|0|||
19582004|NCT00943917|42030479|FG005|Stage II|Withdrawal by Subject|1|||
19582005|NCT00943917|42030480|FG006|Stage II|Withdrawal by Subject|0|||
19582006|NCT00943917|42030481|FG007|Stage II|Withdrawal by Subject|0|||
19582007|NCT00943917|42030482|FG008|Stage II|Withdrawal by Subject|0|||
19582008|NCT00943917|42030483|FG009|Stage II|Withdrawal by Subject|0|||
19582009|NCT00943917|42030484|FG010|Stage II|Withdrawal by Subject|0|||
19582010|NCT00943917|42030485|FG011|Stage II|Withdrawal by Subject|0|||
19582011|NCT00943917|42030486|FG012|Stage II|Withdrawal by Subject|0|||
19582012|NCT00943917|42030487|FG013|Stage II|Withdrawal by Subject|0|||
19582013|NCT00943917|42030488|FG014|Stage II|Withdrawal by Subject|0|||
19582014|NCT00943917|42030474|FG000|Stage II|Pregnancy|0|||
19582015|NCT00943917|42030475|FG001|Stage II|Pregnancy|0|||
19582016|NCT00943917|42030476|FG002|Stage II|Pregnancy|0|||
19582017|NCT00943917|42030477|FG003|Stage II|Pregnancy|0|||
19582018|NCT00943917|42030478|FG004|Stage II|Pregnancy|0|||
19582019|NCT00943917|42030479|FG005|Stage II|Pregnancy|1|||
19582020|NCT00943917|42030480|FG006|Stage II|Pregnancy|0|||
19582021|NCT00943917|42030481|FG007|Stage II|Pregnancy|0|||
19582022|NCT00943917|42030482|FG008|Stage II|Pregnancy|0|||
19582023|NCT00943917|42030483|FG009|Stage II|Pregnancy|0|||
19582024|NCT00943917|42030484|FG010|Stage II|Pregnancy|0|||
19582025|NCT00943917|42030485|FG011|Stage II|Pregnancy|0|||
19582026|NCT00943917|42030486|FG012|Stage II|Pregnancy|0|||
19582027|NCT00943917|42030487|FG013|Stage II|Pregnancy|0|||
19582028|NCT00943917|42030488|FG014|Stage II|Pregnancy|0|||
19582029|NCT00943917|42030474|FG000|Stage II Continuation|Adverse Event|0|||
19582030|NCT00943917|42030475|FG001|Stage II Continuation|Adverse Event|0|||
19582031|NCT00943917|42030476|FG002|Stage II Continuation|Adverse Event|0|||
19582032|NCT00943917|42030477|FG003|Stage II Continuation|Adverse Event|0|||
19582033|NCT00943917|42030478|FG004|Stage II Continuation|Adverse Event|0|||
19582034|NCT00943917|42030479|FG005|Stage II Continuation|Adverse Event|0|||
19582035|NCT00943917|42030480|FG006|Stage II Continuation|Adverse Event|0|||
19582036|NCT00943917|42030481|FG007|Stage II Continuation|Adverse Event|0|||
19582037|NCT00943917|42030482|FG008|Stage II Continuation|Adverse Event|0|||
19582038|NCT00943917|42030483|FG009|Stage II Continuation|Adverse Event|0|||
19639253|NCT00723554|42088653|FG000|Overall Study|Lost to Follow-up|1|||
19639254|NCT00723554|42088653|FG000|Overall Study|Non-compliance|1|||
19582039|NCT00943917|42030484|FG010|Stage II Continuation|Adverse Event|0|||
19582040|NCT00943917|42030485|FG011|Stage II Continuation|Adverse Event|1|||
19582041|NCT00943917|42030486|FG012|Stage II Continuation|Adverse Event|2|||
19582042|NCT00943917|42030487|FG013|Stage II Continuation|Adverse Event|1|||
19582043|NCT00943917|42030488|FG014|Stage II Continuation|Adverse Event|1|||
19582044|NCT00943917|42030474|FG000|Stage II Continuation|Withdrawal by Subject|0|||
19582045|NCT00943917|42030475|FG001|Stage II Continuation|Withdrawal by Subject|0|||
19582046|NCT00943917|42030476|FG002|Stage II Continuation|Withdrawal by Subject|0|||
19582047|NCT00943917|42030477|FG003|Stage II Continuation|Withdrawal by Subject|0|||
19582048|NCT00943917|42030478|FG004|Stage II Continuation|Withdrawal by Subject|0|||
19582049|NCT00943917|42030479|FG005|Stage II Continuation|Withdrawal by Subject|0|||
19639255|NCT00687219|42088659|FG000|Overall Study|Adverse Event|8|||
19639256|NCT00687219|42088659|FG000|Overall Study|Discontinuance criteria met|7|||
19639257|NCT00687219|42088659|FG000|Overall Study|HCV-RNA positive conversion|34|||
19639258|NCT00687219|42088659|FG000|Overall Study|Withdrawal by Subject|1|||
19639259|NCT00687219|42088659|FG000|Overall Study|Lack of Efficacy|1|||
19639260|NCT00723398|42088668|FG000|Overall Study|Withdrawal by Subject|2|||
19639261|NCT00723398|42088669|FG001|Overall Study|Withdrawal by Subject|6|||
19639262|NCT00723398|42088670|FG002|Overall Study|Withdrawal by Subject|4|||
19582050|NCT00943917|42030480|FG006|Stage II Continuation|Withdrawal by Subject|0|||
19582051|NCT00943917|42030481|FG007|Stage II Continuation|Withdrawal by Subject|0|||
19582052|NCT00943917|42030482|FG008|Stage II Continuation|Withdrawal by Subject|0|||
19582053|NCT00943917|42030483|FG009|Stage II Continuation|Withdrawal by Subject|0|||
19582054|NCT00943917|42030484|FG010|Stage II Continuation|Withdrawal by Subject|0|||
19582055|NCT00943917|42030485|FG011|Stage II Continuation|Withdrawal by Subject|0|||
19582056|NCT00943917|42030486|FG012|Stage II Continuation|Withdrawal by Subject|0|||
19582057|NCT00943917|42030487|FG013|Stage II Continuation|Withdrawal by Subject|1|||
19582058|NCT00943917|42030488|FG014|Stage II Continuation|Withdrawal by Subject|3|||
19582059|NCT00943917|42030474|FG000|Stage II Continuation|Protocol Violation|0|||
19582060|NCT00943917|42030475|FG001|Stage II Continuation|Protocol Violation|0|||
19582061|NCT00943917|42030476|FG002|Stage II Continuation|Protocol Violation|0|||
19582062|NCT00943917|42030477|FG003|Stage II Continuation|Protocol Violation|0|||
19582063|NCT00943917|42030478|FG004|Stage II Continuation|Protocol Violation|0|||
19582064|NCT00943917|42030479|FG005|Stage II Continuation|Protocol Violation|0|||
19582065|NCT00943917|42030480|FG006|Stage II Continuation|Protocol Violation|0|||
19582066|NCT00943917|42030481|FG007|Stage II Continuation|Protocol Violation|0|||
19582067|NCT00943917|42030482|FG008|Stage II Continuation|Protocol Violation|0|||
19582068|NCT00943917|42030483|FG009|Stage II Continuation|Protocol Violation|1|||
19582069|NCT00943917|42030484|FG010|Stage II Continuation|Protocol Violation|0|||
19582070|NCT00943917|42030485|FG011|Stage II Continuation|Protocol Violation|1|||
19582071|NCT00943917|42030486|FG012|Stage II Continuation|Protocol Violation|0|||
19582072|NCT00943917|42030487|FG013|Stage II Continuation|Protocol Violation|0|||
19582073|NCT00943917|42030488|FG014|Stage II Continuation|Protocol Violation|0|||
19582074|NCT00943917|42030474|FG000|Stage II Continuation|hypoglycemia|0|||
19582075|NCT00943917|42030475|FG001|Stage II Continuation|hypoglycemia|0|||
19582076|NCT00943917|42030476|FG002|Stage II Continuation|hypoglycemia|0|||
19582077|NCT00943917|42030477|FG003|Stage II Continuation|hypoglycemia|0|||
19582078|NCT00943917|42030478|FG004|Stage II Continuation|hypoglycemia|0|||
19582079|NCT00943917|42030479|FG005|Stage II Continuation|hypoglycemia|0|||
19582080|NCT00943917|42030480|FG006|Stage II Continuation|hypoglycemia|0|||
19582081|NCT00943917|42030481|FG007|Stage II Continuation|hypoglycemia|0|||
19582082|NCT00943917|42030482|FG008|Stage II Continuation|hypoglycemia|0|||
19582083|NCT00943917|42030483|FG009|Stage II Continuation|hypoglycemia|0|||
19582084|NCT00943917|42030484|FG010|Stage II Continuation|hypoglycemia|0|||
19582085|NCT00943917|42030485|FG011|Stage II Continuation|hypoglycemia|0|||
19582086|NCT00943917|42030486|FG012|Stage II Continuation|hypoglycemia|1|||
19582087|NCT00943917|42030487|FG013|Stage II Continuation|hypoglycemia|0|||
19582088|NCT00943917|42030488|FG014|Stage II Continuation|hypoglycemia|0|||
19582089|NCT00943917|42030474|FG000|Stage II Continuation|A1C elevation|0|||
19582090|NCT00943917|42030475|FG001|Stage II Continuation|A1C elevation|0|||
19582091|NCT00943917|42030476|FG002|Stage II Continuation|A1C elevation|0|||
19582092|NCT00943917|42030477|FG003|Stage II Continuation|A1C elevation|0|||
19582093|NCT00943917|42030478|FG004|Stage II Continuation|A1C elevation|0|||
19582094|NCT00943917|42030479|FG005|Stage II Continuation|A1C elevation|0|||
19582095|NCT00943917|42030480|FG006|Stage II Continuation|A1C elevation|0|||
19582096|NCT00943917|42030481|FG007|Stage II Continuation|A1C elevation|0|||
19582097|NCT00943917|42030482|FG008|Stage II Continuation|A1C elevation|0|||
19582098|NCT00943917|42030483|FG009|Stage II Continuation|A1C elevation|0|||
19582099|NCT00943917|42030484|FG010|Stage II Continuation|A1C elevation|0|||
19582100|NCT00943917|42030485|FG011|Stage II Continuation|A1C elevation|0|||
19582101|NCT00943917|42030486|FG012|Stage II Continuation|A1C elevation|0|||
19582102|NCT00943917|42030487|FG013|Stage II Continuation|A1C elevation|1|||
19582103|NCT00943917|42030488|FG014|Stage II Continuation|A1C elevation|0|||
19582104|NCT01077024|42030523|FG000|Overall Study|Lost to Follow-up|20|||
19582105|NCT01077024|42030524|FG001|Overall Study|Lost to Follow-up|14|||
19582106|NCT01077024|42030523|FG000|Overall Study|Withdrawal by Subject|0|||
19582107|NCT01077024|42030524|FG001|Overall Study|Withdrawal by Subject|2|||
19582108|NCT01077024|42030523|FG000|Overall Study|Incarcerated|7|||
19582109|NCT01077024|42030524|FG001|Overall Study|Incarcerated|8|||
19582110|NCT01077024|42030523|FG000|Overall Study|Other|4|||
19582111|NCT01077024|42030524|FG001|Overall Study|Other|4|||
19582112|NCT01089582|42030530|FG000|Overall Study|Death|2|||
19582113|NCT01089582|42030530|FG000|Overall Study|Adverse Event|15|||
19582114|NCT01089582|42030530|FG000|Overall Study|Lost to Follow-up|8|||
19582115|NCT01089582|42030530|FG000|Overall Study|Other|4|||
19582116|NCT01089582|42030530|FG000|Overall Study|Withdrawal by Subject|1|||
19582117|NCT00862459|42030537|FG000|Overall Study|Lost to Follow-up|1|||
19582118|NCT00862459|42030538|FG001|Overall Study|Lost to Follow-up|2|||
19582119|NCT00862459|42030539|FG002|Overall Study|Lost to Follow-up|2|||
19582120|NCT00862459|42030537|FG000|Overall Study|Protocol Violation|1|||
19582121|NCT00862459|42030538|FG001|Overall Study|Protocol Violation|0|||
19582122|NCT00862459|42030539|FG002|Overall Study|Protocol Violation|0|||
19582123|NCT00862459|42030537|FG000|Overall Study|Withdrawal by Subject|1|||
19582124|NCT00862459|42030538|FG001|Overall Study|Withdrawal by Subject|1|||
19582125|NCT00862459|42030539|FG002|Overall Study|Withdrawal by Subject|3|||
19582126|NCT00862459|42030537|FG000|Overall Study|Adverse Event|0|||
19582127|NCT00862459|42030538|FG001|Overall Study|Adverse Event|1|||
19582128|NCT00862459|42030539|FG002|Overall Study|Adverse Event|0|||
19582129|NCT00862459|42030537|FG000|Overall Study|Personal reasons|1|||
19582130|NCT00862459|42030538|FG001|Overall Study|Personal reasons|0|||
19582131|NCT00862459|42030539|FG002|Overall Study|Personal reasons|0|||
19582132|NCT00862459|42030537|FG000|Overall Study|Operation|1|||
19582133|NCT00862459|42030538|FG001|Overall Study|Operation|1|||
19582134|NCT00862459|42030539|FG002|Overall Study|Operation|0|||
19582135|NCT00862459|42030537|FG000|Overall Study|Intravenous (IV) site problems|1|||
19582136|NCT00862459|42030538|FG001|Overall Study|Intravenous (IV) site problems|0|||
19582137|NCT00862459|42030539|FG002|Overall Study|Intravenous (IV) site problems|1|||
19582138|NCT00862459|42030537|FG000|Overall Study|Unable to hold still for imaging|0|||
19582139|NCT00862459|42030538|FG001|Overall Study|Unable to hold still for imaging|1|||
19582140|NCT00862459|42030539|FG002|Overall Study|Unable to hold still for imaging|0|||
19582141|NCT00862459|42030537|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
19582142|NCT00862459|42030538|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
19582143|NCT00862459|42030539|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
19582144|NCT00862459|42030537|FG000|Overall Study|Administrative problems|0|||
19582145|NCT00862459|42030538|FG001|Overall Study|Administrative problems|1|||
19582146|NCT00862459|42030539|FG002|Overall Study|Administrative problems|0|||
19582147|NCT00580047|42030551|FG000|Overall Study|Lost to Follow-up|1|||
19582148|NCT00580047|42030552|FG001|Overall Study|Lost to Follow-up|1|||
19582149|NCT00580047|42030553|FG002|Overall Study|Lost to Follow-up|0|||
19582150|NCT00580047|42030551|FG000|Overall Study|Withdrawal by Subject|1|||
19582151|NCT00580047|42030552|FG001|Overall Study|Withdrawal by Subject|1|||
19582152|NCT00580047|42030553|FG002|Overall Study|Withdrawal by Subject|2|||
19582153|NCT00580047|42030551|FG000|Overall Study|Withdrawal by Subject|1|||
19582154|NCT00580047|42030552|FG001|Overall Study|Withdrawal by Subject|0|||
19582155|NCT00580047|42030553|FG002|Overall Study|Withdrawal by Subject|0|||
19582156|NCT01074450|42030566|FG000|First Intervention|Emesis in Dosing Interval|0|||
19582157|NCT01074450|42030567|FG001|First Intervention|Emesis in Dosing Interval|2|||
19582158|NCT01074450|42030566|FG000|Second Intervention|Protocol Violation|1|||
19582159|NCT01074450|42030567|FG001|Second Intervention|Protocol Violation|0|||
19582160|NCT01074450|42030566|FG000|Second Intervention|Physician Decision|0|||
19387843|NCT02560389|41631178|FG001|Overall Study|Tested positive for illicit substance|1|||
19582161|NCT01074450|42030567|FG001|Second Intervention|Physician Decision|1|||
19582162|NCT00943761|42030575|FG000|Overall Study|Lost to Follow-up|2|||
19582163|NCT00943761|42030576|FG001|Overall Study|Lost to Follow-up|0|||
19582164|NCT00943761|42030575|FG000|Overall Study|Withdrawal by Subject|2|||
19582165|NCT00943761|42030576|FG001|Overall Study|Withdrawal by Subject|1|||
19582166|NCT00949533|42030584|FG000|Overall Study|Lost to Follow-up|0|||
19582167|NCT00949533|42030585|FG001|Overall Study|Lost to Follow-up|1|||
19582168|NCT00866047|42030591|FG000|Treatment Period|Progressive disease|13|||
19582169|NCT00866047|42030591|FG000|Treatment Period|Adverse Event|16|||
19582170|NCT00866047|42030591|FG000|Treatment Period|Physician Decision|14|||
19582171|NCT00866047|42030591|FG000|Treatment Period|Withdrawal by Subject|5|||
19582172|NCT00866047|42030591|FG000|Follow-up Period|Lost to Follow-up|5|||
19582173|NCT00869323|42030595|FG000|Maintenance Therapy|concurrent illness|1|||
19582174|NCT01192022|42030603|FG000|Overall Study|Withdrawal of Consent|3|||
19582175|NCT01192022|42030604|FG001|Overall Study|Withdrawal of Consent|1|||
19582176|NCT01192022|42030605|FG002|Overall Study|Withdrawal of Consent|0|||
19582177|NCT01192022|42030606|FG003|Overall Study|Withdrawal of Consent|0|||
19582178|NCT01192022|42030607|FG004|Overall Study|Withdrawal of Consent|0|||
19582179|NCT01192022|42030603|FG000|Overall Study|Lost to Follow-up|4|||
19582180|NCT01192022|42030604|FG001|Overall Study|Lost to Follow-up|2|||
19582181|NCT01192022|42030605|FG002|Overall Study|Lost to Follow-up|1|||
19582182|NCT01192022|42030606|FG003|Overall Study|Lost to Follow-up|1|||
19582183|NCT01192022|42030607|FG004|Overall Study|Lost to Follow-up|0|||
19582184|NCT01192022|42030603|FG000|Overall Study|Adverse Event|1|||
19582185|NCT01192022|42030604|FG001|Overall Study|Adverse Event|0|||
19582186|NCT01192022|42030605|FG002|Overall Study|Adverse Event|0|||
19582187|NCT01192022|42030606|FG003|Overall Study|Adverse Event|0|||
19582188|NCT01192022|42030607|FG004|Overall Study|Adverse Event|0|||
19582189|NCT01192022|42030603|FG000|Overall Study|Fatal Adverse Event|4|||
19582190|NCT01192022|42030604|FG001|Overall Study|Fatal Adverse Event|6|||
19582191|NCT01192022|42030605|FG002|Overall Study|Fatal Adverse Event|0|||
19582192|NCT01192022|42030606|FG003|Overall Study|Fatal Adverse Event|0|||
19582193|NCT01192022|42030607|FG004|Overall Study|Fatal Adverse Event|1|||
19582194|NCT01192022|42030603|FG000|Overall Study|Physician withdrew-patient hardship|1|||
19582195|NCT01192022|42030604|FG001|Overall Study|Physician withdrew-patient hardship|0|||
19582196|NCT01192022|42030605|FG002|Overall Study|Physician withdrew-patient hardship|0|||
19582197|NCT01192022|42030606|FG003|Overall Study|Physician withdrew-patient hardship|0|||
19582198|NCT01192022|42030607|FG004|Overall Study|Physician withdrew-patient hardship|0|||
19582199|NCT01192022|42030603|FG000|Overall Study|Patient too sick from chemotherapy|0|||
19582200|NCT01192022|42030604|FG001|Overall Study|Patient too sick from chemotherapy|1|||
19582201|NCT01192022|42030605|FG002|Overall Study|Patient too sick from chemotherapy|0|||
19582202|NCT01192022|42030606|FG003|Overall Study|Patient too sick from chemotherapy|0|||
19582203|NCT01192022|42030607|FG004|Overall Study|Patient too sick from chemotherapy|0|||
19582204|NCT01192022|42030603|FG000|Overall Study|Patient needed surgery|0|||
19582205|NCT01192022|42030604|FG001|Overall Study|Patient needed surgery|1|||
19582206|NCT01192022|42030605|FG002|Overall Study|Patient needed surgery|0|||
19582207|NCT01192022|42030606|FG003|Overall Study|Patient needed surgery|0|||
19582208|NCT01192022|42030607|FG004|Overall Study|Patient needed surgery|0|||
19582209|NCT01192022|42030603|FG000|Overall Study|Parents did not allow all follow up|0|||
19582210|NCT01192022|42030604|FG001|Overall Study|Parents did not allow all follow up|0|||
19582211|NCT01192022|42030605|FG002|Overall Study|Parents did not allow all follow up|0|||
19582212|NCT01192022|42030606|FG003|Overall Study|Parents did not allow all follow up|1|||
19582213|NCT01192022|42030607|FG004|Overall Study|Parents did not allow all follow up|0|||
19582214|NCT01191944|42030620|FG000|Overall Study|Adverse Event|11|||
19582215|NCT01191944|42030621|FG001|Overall Study|Adverse Event|12|||
19582216|NCT01191944|42030620|FG000|Overall Study|Protocol Violation|1|||
19582217|NCT01191944|42030621|FG001|Overall Study|Protocol Violation|2|||
19582218|NCT01191944|42030620|FG000|Overall Study|Withdrawal by Subject|4|||
19582219|NCT01191944|42030621|FG001|Overall Study|Withdrawal by Subject|2|||
19582220|NCT01191944|42030620|FG000|Overall Study|Other|1|||
19582221|NCT01191944|42030621|FG001|Overall Study|Other|3|||
19582222|NCT01191788|42030629|FG000|Overall Study|Lost to Follow-up|21|||
19582223|NCT01191788|42030630|FG001|Overall Study|Lost to Follow-up|22|||
19582224|NCT00940875|42030639|FG000|Treatment Phase|Adverse Event|9|||
19582225|NCT00940875|42030640|FG001|Treatment Phase|Adverse Event|3|||
19582226|NCT00940875|42030639|FG000|Treatment Phase|Death|3|||
19582227|NCT00940875|42030640|FG001|Treatment Phase|Death|5|||
19582228|NCT00940875|42030639|FG000|Treatment Phase|Lack of Efficacy|1|||
19582229|NCT00940875|42030640|FG001|Treatment Phase|Lack of Efficacy|0|||
19582230|NCT00940875|42030639|FG000|Treatment Phase|Withdrawal by Subject|3|||
19582231|NCT00940875|42030640|FG001|Treatment Phase|Withdrawal by Subject|0|||
19582232|NCT00940875|42030639|FG000|Treatment Phase|Disease progression|9|||
19582233|NCT00940875|42030640|FG001|Treatment Phase|Disease progression|11|||
19582234|NCT00940875|42030639|FG000|Treatment Phase|Physician Decision|1|||
19582235|NCT00940875|42030640|FG001|Treatment Phase|Physician Decision|0|||
19582236|NCT00940875|42030639|FG000|Post-Study Treatment|Death|0|||
19582237|NCT00940875|42030640|FG001|Post-Study Treatment|Death|1|||
19582238|NCT00940875|42030639|FG000|Post-Study Treatment|Disease Progression|0|||
19582239|NCT00940875|42030640|FG001|Post-Study Treatment|Disease Progression|2|||
19582240|NCT00940485|42030649|FG000|Overall Study|HBeAb positive at Baseline|3|||
19582241|NCT00940485|42030650|FG001|Overall Study|HBeAb positive at Baseline|2|||
19582242|NCT00940485|42030649|FG000|Overall Study|Lost to Follow-up|2|||
19582243|NCT00940485|42030650|FG001|Overall Study|Lost to Follow-up|3|||
19582244|NCT00940485|42030649|FG000|Overall Study|Adverse Event|8|||
19582245|NCT00940485|42030650|FG001|Overall Study|Adverse Event|0|||
19582246|NCT00940485|42030649|FG000|Overall Study|Withdrawal by Subject|1|||
19582247|NCT00940485|42030650|FG001|Overall Study|Withdrawal by Subject|1|||
19582248|NCT00940485|42030649|FG000|Overall Study|Others|1|||
19582249|NCT00940485|42030650|FG001|Overall Study|Others|1|||
19582250|NCT00943605|42030658|FG000|Overall Study|Study termination|30|||
19582251|NCT00943605|42030659|FG001|Overall Study|Study termination|30|||
19582252|NCT01132313|42030677|FG000|Overall Study|Lack of Efficacy|1|||
19582253|NCT01132313|42030678|FG001|Overall Study|Lack of Efficacy|0|||
19582254|NCT01132313|42030679|FG002|Overall Study|Lack of Efficacy|0|||
19582255|NCT01132313|42030680|FG003|Overall Study|Lack of Efficacy|0|||
19582256|NCT01132313|42030681|FG004|Overall Study|Lack of Efficacy|0|||
19582257|NCT01132313|42030682|FG005|Overall Study|Lack of Efficacy|0|||
19582258|NCT01132313|42030683|FG006|Overall Study|Lack of Efficacy|0|||
19582259|NCT01132313|42030684|FG007|Overall Study|Lack of Efficacy|3|||
19582260|NCT01132313|42030685|FG008|Overall Study|Lack of Efficacy|14|||
19582261|NCT01132313|42030686|FG009|Overall Study|Lack of Efficacy|16|||
19582262|NCT01132313|42030687|FG010|Overall Study|Lack of Efficacy|0|||
19582263|NCT01132313|42030688|FG011|Overall Study|Lack of Efficacy|0|||
19582264|NCT01132313|42030677|FG000|Overall Study|Not treated|2|||
19582265|NCT01132313|42030678|FG001|Overall Study|Not treated|0|||
19582266|NCT01132313|42030679|FG002|Overall Study|Not treated|0|||
19582267|NCT01132313|42030680|FG003|Overall Study|Not treated|0|||
19582268|NCT01132313|42030681|FG004|Overall Study|Not treated|2|||
19582269|NCT01132313|42030682|FG005|Overall Study|Not treated|1|||
19582270|NCT01132313|42030683|FG006|Overall Study|Not treated|3|||
19582271|NCT01132313|42030684|FG007|Overall Study|Not treated|0|||
19582272|NCT01132313|42030685|FG008|Overall Study|Not treated|0|||
19582273|NCT01132313|42030686|FG009|Overall Study|Not treated|0|||
19582274|NCT01132313|42030687|FG010|Overall Study|Not treated|0|||
19582275|NCT01132313|42030688|FG011|Overall Study|Not treated|0|||
19582276|NCT01132313|42030677|FG000|Overall Study|Adverse Event|0|||
19582277|NCT01132313|42030678|FG001|Overall Study|Adverse Event|0|||
19582278|NCT01132313|42030679|FG002|Overall Study|Adverse Event|4|||
19582279|NCT01132313|42030680|FG003|Overall Study|Adverse Event|10|||
19582280|NCT01132313|42030681|FG004|Overall Study|Adverse Event|19|||
19582281|NCT01132313|42030682|FG005|Overall Study|Adverse Event|6|||
19582282|NCT01132313|42030683|FG006|Overall Study|Adverse Event|5|||
19582283|NCT01132313|42030684|FG007|Overall Study|Adverse Event|3|||
19582284|NCT01132313|42030685|FG008|Overall Study|Adverse Event|7|||
19582285|NCT01132313|42030686|FG009|Overall Study|Adverse Event|2|||
19582286|NCT01132313|42030687|FG010|Overall Study|Adverse Event|0|||
19582287|NCT01132313|42030688|FG011|Overall Study|Adverse Event|0|||
19582288|NCT01132313|42030677|FG000|Overall Study|Protocol Violation|0|||
19582289|NCT01132313|42030678|FG001|Overall Study|Protocol Violation|0|||
19582290|NCT01132313|42030679|FG002|Overall Study|Protocol Violation|0|||
19582291|NCT01132313|42030680|FG003|Overall Study|Protocol Violation|1|||
19582292|NCT01132313|42030681|FG004|Overall Study|Protocol Violation|0|||
19582293|NCT01132313|42030682|FG005|Overall Study|Protocol Violation|0|||
19582294|NCT01132313|42030683|FG006|Overall Study|Protocol Violation|0|||
19582295|NCT01132313|42030684|FG007|Overall Study|Protocol Violation|0|||
19582296|NCT01132313|42030685|FG008|Overall Study|Protocol Violation|0|||
19582297|NCT01132313|42030686|FG009|Overall Study|Protocol Violation|0|||
19582298|NCT01132313|42030687|FG010|Overall Study|Protocol Violation|0|||
19582299|NCT01132313|42030688|FG011|Overall Study|Protocol Violation|0|||
19582300|NCT01132313|42030677|FG000|Overall Study|Lost to Follow-up|0|||
19582301|NCT01132313|42030678|FG001|Overall Study|Lost to Follow-up|0|||
19582302|NCT01132313|42030679|FG002|Overall Study|Lost to Follow-up|1|||
19582303|NCT01132313|42030680|FG003|Overall Study|Lost to Follow-up|0|||
19582304|NCT01132313|42030681|FG004|Overall Study|Lost to Follow-up|0|||
19582305|NCT01132313|42030682|FG005|Overall Study|Lost to Follow-up|0|||
19582306|NCT01132313|42030683|FG006|Overall Study|Lost to Follow-up|0|||
19582307|NCT01132313|42030684|FG007|Overall Study|Lost to Follow-up|1|||
19582308|NCT01132313|42030685|FG008|Overall Study|Lost to Follow-up|0|||
19582309|NCT01132313|42030686|FG009|Overall Study|Lost to Follow-up|0|||
19582310|NCT01132313|42030687|FG010|Overall Study|Lost to Follow-up|0|||
19582311|NCT01132313|42030688|FG011|Overall Study|Lost to Follow-up|0|||
19582312|NCT01132313|42030677|FG000|Overall Study|Withdrawal by Subject|0|||
19582313|NCT01132313|42030678|FG001|Overall Study|Withdrawal by Subject|0|||
19582314|NCT01132313|42030679|FG002|Overall Study|Withdrawal by Subject|3|||
19582315|NCT01132313|42030680|FG003|Overall Study|Withdrawal by Subject|3|||
19582316|NCT01132313|42030681|FG004|Overall Study|Withdrawal by Subject|6|||
19582317|NCT01132313|42030682|FG005|Overall Study|Withdrawal by Subject|0|||
19582318|NCT01132313|42030683|FG006|Overall Study|Withdrawal by Subject|1|||
19582319|NCT01132313|42030684|FG007|Overall Study|Withdrawal by Subject|0|||
19582320|NCT01132313|42030685|FG008|Overall Study|Withdrawal by Subject|0|||
19582321|NCT01132313|42030686|FG009|Overall Study|Withdrawal by Subject|2|||
19582322|NCT01132313|42030687|FG010|Overall Study|Withdrawal by Subject|0|||
19582323|NCT01132313|42030688|FG011|Overall Study|Withdrawal by Subject|0|||
19582324|NCT01132313|42030677|FG000|Overall Study|Lack of antiviral response|0|||
19582325|NCT01132313|42030678|FG001|Overall Study|Lack of antiviral response|0|||
19582326|NCT01132313|42030679|FG002|Overall Study|Lack of antiviral response|12|||
19582327|NCT01132313|42030680|FG003|Overall Study|Lack of antiviral response|18|||
19582328|NCT01132313|42030681|FG004|Overall Study|Lack of antiviral response|18|||
19582329|NCT01132313|42030682|FG005|Overall Study|Lack of antiviral response|18|||
19582330|NCT01132313|42030683|FG006|Overall Study|Lack of antiviral response|21|||
19582331|NCT01132313|42030684|FG007|Overall Study|Lack of antiviral response|0|||
19582332|NCT01132313|42030685|FG008|Overall Study|Lack of antiviral response|0|||
19582333|NCT01132313|42030686|FG009|Overall Study|Lack of antiviral response|0|||
19582334|NCT01132313|42030687|FG010|Overall Study|Lack of antiviral response|1|||
19582335|NCT01132313|42030688|FG011|Overall Study|Lack of antiviral response|0|||
19582336|NCT01132313|42030677|FG000|Overall Study|Other reason not defined above|0|||
19582337|NCT01132313|42030678|FG001|Overall Study|Other reason not defined above|0|||
19582338|NCT01132313|42030679|FG002|Overall Study|Other reason not defined above|0|||
19582339|NCT01132313|42030680|FG003|Overall Study|Other reason not defined above|0|||
19582340|NCT01132313|42030681|FG004|Overall Study|Other reason not defined above|0|||
19582341|NCT01132313|42030682|FG005|Overall Study|Other reason not defined above|0|||
19582342|NCT01132313|42030683|FG006|Overall Study|Other reason not defined above|0|||
19582343|NCT01132313|42030684|FG007|Overall Study|Other reason not defined above|1|||
19582344|NCT01132313|42030685|FG008|Overall Study|Other reason not defined above|0|||
19582345|NCT01132313|42030686|FG009|Overall Study|Other reason not defined above|0|||
19582346|NCT01132313|42030687|FG010|Overall Study|Other reason not defined above|0|||
19582347|NCT01132313|42030688|FG011|Overall Study|Other reason not defined above|0|||
19582348|NCT00861757|42030723|FG000|Overall Study|Adverse Event|1|||
19582349|NCT00861757|42030724|FG001|Overall Study|Adverse Event|5|||
19582350|NCT00861757|42030725|FG002|Overall Study|Adverse Event|7|||
19582351|NCT00861757|42030726|FG003|Overall Study|Adverse Event|2|||
19582352|NCT00861757|42030723|FG000|Overall Study|Entry Criteria Not Met|1|||
19582353|NCT00861757|42030724|FG001|Overall Study|Entry Criteria Not Met|2|||
19582354|NCT00861757|42030725|FG002|Overall Study|Entry Criteria Not Met|1|||
19582355|NCT00861757|42030726|FG003|Overall Study|Entry Criteria Not Met|1|||
19582356|NCT00861757|42030723|FG000|Overall Study|Lack of Efficacy|3|||
19582357|NCT00861757|42030724|FG001|Overall Study|Lack of Efficacy|1|||
19582358|NCT00861757|42030725|FG002|Overall Study|Lack of Efficacy|0|||
19582359|NCT00861757|42030726|FG003|Overall Study|Lack of Efficacy|1|||
19582360|NCT00861757|42030723|FG000|Overall Study|Lost to Follow-up|1|||
19582361|NCT00861757|42030724|FG001|Overall Study|Lost to Follow-up|0|||
19582362|NCT00861757|42030725|FG002|Overall Study|Lost to Follow-up|1|||
19582363|NCT00861757|42030726|FG003|Overall Study|Lost to Follow-up|1|||
19582364|NCT00861757|42030723|FG000|Overall Study|Physician Decision|0|||
19582365|NCT00861757|42030724|FG001|Overall Study|Physician Decision|0|||
19582366|NCT00861757|42030725|FG002|Overall Study|Physician Decision|0|||
19582367|NCT00861757|42030726|FG003|Overall Study|Physician Decision|1|||
19582368|NCT00861757|42030723|FG000|Overall Study|Protocol Violation|2|||
19582369|NCT00861757|42030724|FG001|Overall Study|Protocol Violation|2|||
19582370|NCT00861757|42030725|FG002|Overall Study|Protocol Violation|4|||
19582371|NCT00861757|42030726|FG003|Overall Study|Protocol Violation|1|||
19582372|NCT00861757|42030723|FG000|Overall Study|Withdrawal by Subject|1|||
19582373|NCT00861757|42030724|FG001|Overall Study|Withdrawal by Subject|5|||
19582374|NCT00861757|42030725|FG002|Overall Study|Withdrawal by Subject|5|||
19582375|NCT00861757|42030726|FG003|Overall Study|Withdrawal by Subject|2|||
19582376|NCT01131455|42030743|FG000|Overall Study|Death of PI|6|||
19582377|NCT01131455|42030744|FG001|Overall Study|Death of PI|4|||
19582378|NCT01131455|42030745|FG002|Overall Study|Death of PI|0|||
19582379|NCT01138007|42030756|FG000|Overall Study|Adverse Event|4|||
19582380|NCT01138007|42030757|FG001|Overall Study|Adverse Event|12|||
19582381|NCT01138007|42030758|FG002|Overall Study|Adverse Event|9|||
19582382|NCT01138007|42030756|FG000|Overall Study|Lack of Efficacy|2|||
19582383|NCT01138007|42030757|FG001|Overall Study|Lack of Efficacy|0|||
19582384|NCT01138007|42030758|FG002|Overall Study|Lack of Efficacy|6|||
19582385|NCT01138007|42030756|FG000|Overall Study|Protocol Violation|2|||
19582386|NCT01138007|42030757|FG001|Overall Study|Protocol Violation|3|||
19582387|NCT01138007|42030758|FG002|Overall Study|Protocol Violation|2|||
19582388|NCT01138007|42030756|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
19582389|NCT01138007|42030757|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
19582390|NCT01138007|42030758|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
19582391|NCT01138007|42030756|FG000|Overall Study|Lost to Follow-up|3|||
19582392|NCT01138007|42030757|FG001|Overall Study|Lost to Follow-up|3|||
19582393|NCT01138007|42030758|FG002|Overall Study|Lost to Follow-up|5|||
19582394|NCT01138007|42030756|FG000|Overall Study|Physician Decision|0|||
19582395|NCT01138007|42030757|FG001|Overall Study|Physician Decision|5|||
19582396|NCT01138007|42030758|FG002|Overall Study|Physician Decision|3|||
19582397|NCT01138007|42030756|FG000|Overall Study|Withdrawal by Subject|5|||
19582398|NCT01138007|42030757|FG001|Overall Study|Withdrawal by Subject|6|||
19582399|NCT01138007|42030758|FG002|Overall Study|Withdrawal by Subject|15|||
19582400|NCT00865345|42030768|FG000|Overall Study|Withdrawal by Subject|2|||
19582401|NCT01131299|42030772|FG000|Overall Study|Withdrawal by Subject|4|||
19582402|NCT01131299|42030773|FG001|Overall Study|Withdrawal by Subject|7|||
19582403|NCT01130831|42030778|FG000|Overall Study|Withdrawal by Subject|7|||
19582404|NCT01130831|42030778|FG000|Overall Study|Death|4|||
19582405|NCT01130831|42030778|FG000|Overall Study|Information was missing|3|||
19582406|NCT01130597|42030794|FG000|Overall Study|Protocol-specified (High K+)|1|||
19582407|NCT01130597|42030794|FG000|Overall Study|Adverse Event|4|||
19582408|NCT01130597|42030794|FG000|Overall Study|Death|1|||
19582409|NCT01130597|42030794|FG000|Overall Study|Protocol Violation|1|||
19582410|NCT00939003|42030800|FG000|Double-blind Treatment Period|Adverse Event|1|||
19582411|NCT00939003|42030801|FG001|Double-blind Treatment Period|Adverse Event|1|||
19582412|NCT00939003|42030800|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
19582413|NCT00939003|42030801|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
19582414|NCT00939003|42030800|FG000|Double-blind Treatment Period|Pregnancy|0|||
19582415|NCT00939003|42030801|FG001|Double-blind Treatment Period|Pregnancy|1|||
19582416|NCT00939003|42030800|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
19582417|NCT00939003|42030801|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
19582418|NCT00939003|42030800|FG000|Open-label Treatment Period|Adverse Event|4|||
19582419|NCT00939003|42030801|FG001|Open-label Treatment Period|Adverse Event|8|||
19582420|NCT00939003|42030800|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
19582421|NCT00939003|42030801|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
19582422|NCT00939003|42030800|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
19582423|NCT00939003|42030801|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
19582424|NCT00939003|42030800|FG000|Open-label Treatment Period|Pregnancy|1|||
19582425|NCT00939003|42030801|FG001|Open-label Treatment Period|Pregnancy|1|||
19582426|NCT00939003|42030800|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
19582427|NCT00939003|42030801|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
19582428|NCT00939003|42030800|FG000|Open-label Treatment Period|Site Closure|3|||
19582429|NCT00939003|42030801|FG001|Open-label Treatment Period|Site Closure|4|||
19582430|NCT01188668|42030810|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
19582431|NCT01188668|42030810|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
19582432|NCT01188668|42030810|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
19582433|NCT01130051|42030817|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
19582434|NCT01130051|42030818|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
19582435|NCT01130051|42030817|FG000|Washout Period of 14 Days|Protocol Violation|1|||
19582436|NCT01130051|42030818|FG001|Washout Period of 14 Days|Protocol Violation|1|||
19582437|NCT00865189|42030826|FG000|Overall Study|Other|1|||
19582438|NCT00865189|42030827|FG001|Overall Study|Other|2|||
19582439|NCT00865189|42030826|FG000|Overall Study|Death|4|||
19582440|NCT00865189|42030827|FG001|Overall Study|Death|11|||
19582441|NCT00865189|42030826|FG000|Overall Study|Lost to Follow-up|6|||
19582442|NCT00865189|42030827|FG001|Overall Study|Lost to Follow-up|6|||
19582443|NCT00865189|42030826|FG000|Overall Study|Withdrawal by Subject|1|||
19582444|NCT00865189|42030827|FG001|Overall Study|Withdrawal by Subject|0|||
19582445|NCT01182194|42030835|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
19582446|NCT01182194|42030836|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
19582447|NCT01181726|42030844|FG000|First Intervention|Adverse Event|1|||
19582448|NCT01181726|42030845|FG001|First Intervention|Adverse Event|0|||
19582449|NCT01137071|42030851|FG000|Overall Study|Disease Progression|11|||
19582450|NCT01137071|42030851|FG000|Overall Study|Withdrawal by Subject|2|||
19582451|NCT01137071|42030851|FG000|Overall Study|Wrongly Included|1|||
19582452|NCT00860743|42030866|FG000|Overall Study|Withdrawal by Subject|3|||
19582453|NCT00860743|42030867|FG001|Overall Study|Withdrawal by Subject|0|||
19582454|NCT01186796|42030875|FG000|Overall Study|Adverse Event|3|||
19582455|NCT01186796|42030876|FG001|Overall Study|Adverse Event|0|||
19582456|NCT01186796|42030875|FG000|Overall Study|Withdrawal by Subject|1|||
19582457|NCT01186796|42030876|FG001|Overall Study|Withdrawal by Subject|1|||
19582458|NCT01186796|42030875|FG000|Overall Study|Protocol Violation|0|||
19582459|NCT01186796|42030876|FG001|Overall Study|Protocol Violation|1|||
19582460|NCT01136915|42030884|FG000|Overall Study|Lost to Follow-up|2|||
19582461|NCT01136915|42030885|FG001|Overall Study|Lost to Follow-up|0|||
19582462|NCT01136915|42030884|FG000|Overall Study|Exclusion criterion met|0|||
19582463|NCT01136915|42030885|FG001|Overall Study|Exclusion criterion met|1|||
19582464|NCT00940017|42030893|FG000|Overall Study|did not meet entrance criteria|3|||
19582465|NCT00940017|42030893|FG000|Overall Study|Adverse Event|1|||
19582466|NCT01129583|42030899|FG000|Overall Study|Death|1|||
19582467|NCT01129583|42030900|FG001|Overall Study|Death|0|||
19582468|NCT01129583|42030899|FG000|Overall Study|Lost to Follow-up|1|||
19582469|NCT01129583|42030900|FG001|Overall Study|Lost to Follow-up|1|||
19582470|NCT01129583|42030899|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
19582471|NCT01129583|42030900|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
19582472|NCT01186328|42030906|FG000|Overall Study|Death|1|||
19582473|NCT01186328|42030907|FG001|Overall Study|Death|0|||
19582474|NCT01186328|42030908|FG002|Overall Study|Death|0|||
19582475|NCT00848497|42030915|FG000|Overall Study|Screen failure|2|||
19582476|NCT00848497|42030916|FG001|Overall Study|Screen failure|0|||
19582477|NCT00848497|42030915|FG000|Overall Study|Withdrawal by Subject|0|||
19582478|NCT00848497|42030916|FG001|Overall Study|Withdrawal by Subject|1|||
19582479|NCT00857623|42030926|FG000|Overall Study|Adverse Event|5|||
19582480|NCT00857623|42030927|FG001|Overall Study|Adverse Event|2|||
19582481|NCT00857623|42030926|FG000|Overall Study|Study-specific discontinuation criteria|5|||
19582482|NCT00857623|42030927|FG001|Overall Study|Study-specific discontinuation criteria|3|||
19582483|NCT00857623|42030926|FG000|Overall Study|Withdrawal by Subject|2|||
19582484|NCT00857623|42030927|FG001|Overall Study|Withdrawal by Subject|1|||
19582485|NCT00857623|42030926|FG000|Overall Study|Lack of Efficacy|1|||
19582486|NCT00857623|42030927|FG001|Overall Study|Lack of Efficacy|1|||
19582487|NCT00857623|42030926|FG000|Overall Study|Severe non-compliance to protocol|1|||
19582488|NCT00857623|42030927|FG001|Overall Study|Severe non-compliance to protocol|1|||
19582489|NCT00857623|42030926|FG000|Overall Study|Intake of prohibited medication|0|||
19582490|NCT00857623|42030927|FG001|Overall Study|Intake of prohibited medication|1|||
19582491|NCT00857623|42030926|FG000|Overall Study|Positive for HEP C|0|||
19582492|NCT00857623|42030927|FG001|Overall Study|Positive for HEP C|1|||
19582493|NCT01185782|42030935|FG000|Overall Study|Adverse Event|0|||
19582494|NCT01185782|42030936|FG001|Overall Study|Adverse Event|1|||
19582495|NCT01185782|42030935|FG000|Overall Study|Protocol Violation|1|||
19582496|NCT01185782|42030936|FG001|Overall Study|Protocol Violation|0|||
19582497|NCT01185782|42030935|FG000|Overall Study|Poor Response to Treatment|3|||
19582498|NCT01185782|42030936|FG001|Overall Study|Poor Response to Treatment|1|||
19582499|NCT01185782|42030935|FG000|Overall Study|Other|2|||
19582500|NCT01185782|42030936|FG001|Overall Study|Other|5|||
19582501|NCT01185782|42030935|FG000|Overall Study|Randomized but not treated|0|||
19582502|NCT01185782|42030936|FG001|Overall Study|Randomized but not treated|4|||
19582503|NCT01129115|42030946|FG000|Overall Study|Adverse Event|1|||
19582504|NCT01129115|42030947|FG001|Overall Study|Adverse Event|2|||
19582505|NCT01129115|42030948|FG002|Overall Study|Adverse Event|3|||
19582506|NCT01129115|42030949|FG003|Overall Study|Adverse Event|3|||
19582507|NCT01129115|42030946|FG000|Overall Study|Withdrawal by Subject|1|||
19582508|NCT01129115|42030947|FG001|Overall Study|Withdrawal by Subject|3|||
19582509|NCT01129115|42030948|FG002|Overall Study|Withdrawal by Subject|1|||
19582510|NCT01129115|42030949|FG003|Overall Study|Withdrawal by Subject|4|||
19582511|NCT01129115|42030946|FG000|Overall Study|Protocol Violation|0|||
19582512|NCT01129115|42030947|FG001|Overall Study|Protocol Violation|2|||
19582513|NCT01129115|42030948|FG002|Overall Study|Protocol Violation|2|||
19582514|NCT01129115|42030949|FG003|Overall Study|Protocol Violation|2|||
19582515|NCT01185704|42030961|FG000|Overall Study|Randomized but not treated|3|||
19582516|NCT01185704|42030962|FG001|Overall Study|Randomized but not treated|3|||
19582517|NCT01185704|42030961|FG000|Overall Study|Lack of ovarian response|5|||
19582518|NCT01185704|42030962|FG001|Overall Study|Lack of ovarian response|1|||
19582519|NCT01185704|42030961|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
19582520|NCT01185704|42030962|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
19582521|NCT01185704|42030961|FG000|Overall Study|Ectopic pregnancy|0|||
19582522|NCT01185704|42030962|FG001|Overall Study|Ectopic pregnancy|1|||
19582523|NCT01128959|42030968|FG000|Lead in Period|Adverse Event|3|||
19582524|NCT01128959|42030968|FG000|Treatment Period|Adverse Event|3|||
19582525|NCT01128959|42030968|FG000|Treatment Period|Withdrawal by Subject|1|||
19582526|NCT00859573|42030976|FG000|Overall Study|Withdrawal by Subject|4|||
19582527|NCT00859573|42030977|FG001|Overall Study|Withdrawal by Subject|1|||
19582528|NCT00859573|42030976|FG000|Overall Study|Physician Decision|1|||
19582529|NCT00859573|42030977|FG001|Overall Study|Physician Decision|1|||
19582530|NCT01136291|42030985|FG000|Overall Study|Lost to Follow-up|1|||
19582531|NCT01136291|42030986|FG001|Overall Study|Lost to Follow-up|1|||
19582532|NCT01185548|42030992|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
19476964|NCT02790138|41755395|FG000|Overall Study|Lack of Efficacy|6|||
19476965|NCT02790138|41755396|FG001|Overall Study|Lack of Efficacy|7|||
19476966|NCT02790138|41755395|FG000|Overall Study|Reason not Specified|1|||
19476967|NCT02790138|41755396|FG001|Overall Study|Reason not Specified|0|||
19582533|NCT01128569|42031005|FG000|Washout Period 1|Adverse Event|0|||
19582534|NCT01128569|42031006|FG001|Washout Period 1|Adverse Event|0|||
19582535|NCT01128569|42031007|FG002|Washout Period 1|Adverse Event|1|||
19582536|NCT01128569|42031008|FG003|Washout Period 1|Adverse Event|0|||
19582537|NCT01128569|42031009|FG004|Washout Period 1|Adverse Event|0|||
19582538|NCT01128569|42031010|FG005|Washout Period 1|Adverse Event|0|||
19582539|NCT01128569|42031005|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19582540|NCT01128569|42031006|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19582541|NCT01128569|42031007|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19582542|NCT01128569|42031008|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19582543|NCT01128569|42031009|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19582544|NCT01128569|42031010|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19582545|NCT01128413|42031020|FG000|Overall Study|Withdrawal by Subject|1|||
19582546|NCT01128413|42031021|FG001|Overall Study|Withdrawal by Subject|0|||
19582547|NCT01128413|42031020|FG000|Overall Study|NICOM Monitor Problems|2|||
19582548|NCT01128413|42031021|FG001|Overall Study|NICOM Monitor Problems|1|||
19582549|NCT01128413|42031020|FG000|Overall Study|Pt made DNR|1|||
19582550|NCT01128413|42031021|FG001|Overall Study|Pt made DNR|0|||
19582551|NCT01185080|42031030|FG000|Overall Study|Adverse Event|1|||
19582552|NCT01185080|42031031|FG001|Overall Study|Adverse Event|1|||
19582553|NCT01185080|42031032|FG002|Overall Study|Adverse Event|0|||
19582554|NCT01185080|42031030|FG000|Overall Study|Personal reasons|0|||
19582555|NCT01185080|42031031|FG001|Overall Study|Personal reasons|0|||
19582556|NCT01185080|42031032|FG002|Overall Study|Personal reasons|1|||
19582557|NCT01128179|42031042|FG000|Overall Study|Death|1|||
19582558|NCT01128179|42031043|FG001|Overall Study|Death|0|||
19582559|NCT01128179|42031042|FG000|Overall Study|Protocol Violation|1|||
19582560|NCT01128179|42031043|FG001|Overall Study|Protocol Violation|0|||
19582561|NCT01181102|42031051|FG000|Overall Study|Adverse Event|28|||
19582562|NCT01181102|42031052|FG001|Overall Study|Adverse Event|26|||
19582563|NCT01181102|42031051|FG000|Overall Study|Lack of Efficacy|3|||
19582564|NCT01181102|42031052|FG001|Overall Study|Lack of Efficacy|1|||
19582565|NCT01181102|42031051|FG000|Overall Study|Lost to Follow-up|2|||
19582566|NCT01181102|42031052|FG001|Overall Study|Lost to Follow-up|0|||
19582567|NCT01181102|42031051|FG000|Overall Study|Physician Decision|3|||
19582568|NCT01181102|42031052|FG001|Overall Study|Physician Decision|1|||
19582569|NCT01181102|42031051|FG000|Overall Study|Protocol Violation|5|||
19582570|NCT01181102|42031052|FG001|Overall Study|Protocol Violation|6|||
19582571|NCT01181102|42031051|FG000|Overall Study|Withdrawal by Subject|10|||
19582572|NCT01181102|42031052|FG001|Overall Study|Withdrawal by Subject|12|||
19582573|NCT00858637|42031060|FG000|Active Comparison Phase|Adverse Event|14|||
19582574|NCT00858637|42031061|FG001|Active Comparison Phase|Adverse Event|0|||
19582575|NCT00858637|42031062|FG002|Active Comparison Phase|Adverse Event|0|||
19582576|NCT00858637|42031063|FG003|Active Comparison Phase|Adverse Event|9|||
19582577|NCT00858637|42031064|FG004|Active Comparison Phase|Adverse Event|0|||
19582578|NCT00858637|42031065|FG005|Active Comparison Phase|Adverse Event|0|||
19582579|NCT00858637|42031060|FG000|Active Comparison Phase|Death|1|||
19582580|NCT00858637|42031061|FG001|Active Comparison Phase|Death|0|||
19582581|NCT00858637|42031062|FG002|Active Comparison Phase|Death|0|||
19582582|NCT00858637|42031063|FG003|Active Comparison Phase|Death|1|||
19582583|NCT00858637|42031064|FG004|Active Comparison Phase|Death|0|||
19582584|NCT00858637|42031065|FG005|Active Comparison Phase|Death|0|||
19582585|NCT00858637|42031060|FG000|Active Comparison Phase|Physician Decision|1|||
19582586|NCT00858637|42031061|FG001|Active Comparison Phase|Physician Decision|0|||
19582587|NCT00858637|42031062|FG002|Active Comparison Phase|Physician Decision|0|||
19582588|NCT00858637|42031063|FG003|Active Comparison Phase|Physician Decision|1|||
19582589|NCT00858637|42031064|FG004|Active Comparison Phase|Physician Decision|0|||
19582590|NCT00858637|42031065|FG005|Active Comparison Phase|Physician Decision|0|||
19582591|NCT00858637|42031060|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
19582592|NCT00858637|42031061|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
19582593|NCT00858637|42031062|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
19582594|NCT00858637|42031063|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
19582595|NCT00858637|42031064|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
19582596|NCT00858637|42031065|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
19582597|NCT00858637|42031060|FG000|Active Comparison Phase|Other Reasons|1|||
19582598|NCT00858637|42031061|FG001|Active Comparison Phase|Other Reasons|0|||
19582599|NCT00858637|42031062|FG002|Active Comparison Phase|Other Reasons|0|||
19582600|NCT00858637|42031063|FG003|Active Comparison Phase|Other Reasons|1|||
19582601|NCT00858637|42031064|FG004|Active Comparison Phase|Other Reasons|0|||
19582602|NCT00858637|42031065|FG005|Active Comparison Phase|Other Reasons|0|||
19582603|NCT00858637|42031060|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
19582604|NCT00858637|42031061|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
19582605|NCT00858637|42031062|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
19582606|NCT00858637|42031063|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
19582607|NCT00858637|42031064|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
19582608|NCT00858637|42031065|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
19582609|NCT00858637|42031060|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
19582610|NCT00858637|42031061|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
19582611|NCT00858637|42031062|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
19582612|NCT00858637|42031063|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
19582613|NCT00858637|42031064|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
19582614|NCT00858637|42031065|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
19582615|NCT00858403|42031075|FG000|Overall Study|Withdrawal by Subject|1|||
19582616|NCT00858403|42031075|FG000|Overall Study|Death|3|||
19582617|NCT00858403|42031075|FG000|Overall Study|Disease Progression|1|||
19582618|NCT00858247|42031081|FG000|Baseline Assessment|Withdrawal by Subject|1|||
19582619|NCT00858247|42031082|FG001|Baseline Assessment|Withdrawal by Subject|1|||
19582620|NCT00858247|42031081|FG000|Baseline Assessment|Poor IV access|1|||
19582621|NCT00858247|42031082|FG001|Baseline Assessment|Poor IV access|0|||
19582622|NCT00858247|42031081|FG000|Baseline Assessment|Protocol Violation|0|||
19582623|NCT00858247|42031082|FG001|Baseline Assessment|Protocol Violation|1|||
19582624|NCT00858247|42031081|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
19582625|NCT00858247|42031082|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
19582626|NCT00838435|42031088|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
19582627|NCT00838435|42031088|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
19582628|NCT00838435|42031088|FG000|Part 2 (7 Years)|Adverse Event|2|||
19582629|NCT00838435|42031088|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
19582630|NCT00838435|42031088|FG000|Part 2 (7 Years)|Physician Decision|1|||
19582631|NCT00838435|42031088|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
19582632|NCT00838435|42031088|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
19582633|NCT00838201|42031097|FG000|Overall Study|Investigator decision, or other reasons|2|||
19582634|NCT00838201|42031098|FG001|Overall Study|Investigator decision, or other reasons|3|||
19582635|NCT00838201|42031097|FG000|Overall Study|Noncompliance|0|||
19582636|NCT00838201|42031098|FG001|Overall Study|Noncompliance|1|||
19582637|NCT00838201|42031097|FG000|Overall Study|Administrative decision|1|||
19582638|NCT00838201|42031098|FG001|Overall Study|Administrative decision|2|||
19582639|NCT00838201|42031097|FG000|Overall Study|Disease progression|3|||
19582640|NCT00838201|42031098|FG001|Overall Study|Disease progression|3|||
19582641|NCT00838201|42031097|FG000|Overall Study|Consent withdrawn|16|||
19582642|NCT00838201|42031098|FG001|Overall Study|Consent withdrawn|19|||
19582643|NCT00838201|42031097|FG000|Overall Study|Lost to Follow-up|4|||
19582644|NCT00838201|42031098|FG001|Overall Study|Lost to Follow-up|3|||
19582645|NCT00838201|42031097|FG000|Overall Study|Adverse Event|5|||
19582646|NCT00838201|42031098|FG001|Overall Study|Adverse Event|9|||
19582647|NCT00838201|42031097|FG000|Overall Study|Death|11|||
19582648|NCT00838201|42031098|FG001|Overall Study|Death|13|||
19582649|NCT00837967|42031104|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
19582650|NCT00837967|42031105|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
19582651|NCT02756806|42031111|FG000|Overall Study|Study terminated early|5|||
19582652|NCT00942357|42031117|FG000|Overall Study|Ineligible|37|||
19582653|NCT00942357|42031118|FG001|Overall Study|Ineligible|40|||
19582654|NCT04583956|42031126|FG000|Overall Study|Death|9|||
19582655|NCT04583956|42031127|FG001|Overall Study|Death|11|||
19582656|NCT04583956|42031126|FG000|Overall Study|Lost to Follow-up|7|||
19582657|NCT04583956|42031127|FG001|Overall Study|Lost to Follow-up|9|||
19582658|NCT04583956|42031126|FG000|Overall Study|Protocol Violation|2|||
19582659|NCT04583956|42031127|FG001|Overall Study|Protocol Violation|0|||
19582660|NCT04583956|42031126|FG000|Overall Study|Withdrawal by Subject|0|||
19582661|NCT04583956|42031127|FG001|Overall Study|Withdrawal by Subject|2|||
19582662|NCT04583956|42031126|FG000|Overall Study|Randomized but not dosed|2|||
19582663|NCT04583956|42031127|FG001|Overall Study|Randomized but not dosed|3|||
19582664|NCT04583956|42031126|FG000|Overall Study|Withdrawal of consent before product administration|1|||
19582665|NCT04583956|42031127|FG001|Overall Study|Withdrawal of consent before product administration|0|||
19582666|NCT00939783|42031133|FG000|Overall Study|Death|6|||
19582667|NCT00939783|42031133|FG000|Overall Study|Adverse Event|39|||
19582668|NCT00939783|42031133|FG000|Overall Study|Study Terminated by Sponsor|498|||
19582669|NCT00939783|42031133|FG000|Overall Study|Withdrawal by Subject|78|||
19582670|NCT00939783|42031133|FG000|Overall Study|Other|16|||
19582671|NCT00939783|42031133|FG000|Overall Study|Lost to Follow-up|8|||
19582672|NCT00939783|42031133|FG000|Overall Study|Protocol Violation|3|||
19582673|NCT00939783|42031133|FG000|Overall Study|Enrolled but not treated|1|||
19582674|NCT00939627|42031139|FG000|Overall Study|Disease Progression|16|||
19582675|NCT00939627|42031140|FG001|Overall Study|Disease Progression|12|||
19582676|NCT00939627|42031141|FG002|Overall Study|Disease Progression|0|||
19582677|NCT00939627|42031139|FG000|Overall Study|Adverse Event|6|||
19387844|NCT02560389|41631179|FG002|Overall Study|Tested positive for illicit substance|0|||
19582678|NCT00939627|42031140|FG001|Overall Study|Adverse Event|7|||
19582679|NCT00939627|42031141|FG002|Overall Study|Adverse Event|0|||
19582680|NCT00939627|42031139|FG000|Overall Study|Death|0|||
19582681|NCT00939627|42031140|FG001|Overall Study|Death|2|||
19582682|NCT00939627|42031141|FG002|Overall Study|Death|0|||
19582683|NCT00939627|42031139|FG000|Overall Study|Withdrawal by Subject|2|||
19582684|NCT00939627|42031140|FG001|Overall Study|Withdrawal by Subject|4|||
19582685|NCT00939627|42031141|FG002|Overall Study|Withdrawal by Subject|0|||
19582686|NCT00939627|42031139|FG000|Overall Study|Other complicating disease|1|||
19582687|NCT00939627|42031140|FG001|Overall Study|Other complicating disease|1|||
19582688|NCT00939627|42031141|FG002|Overall Study|Other complicating disease|0|||
19582689|NCT00939627|42031139|FG000|Overall Study|Not compliant|2|||
19582690|NCT00939627|42031140|FG001|Overall Study|Not compliant|0|||
19582691|NCT00939627|42031141|FG002|Overall Study|Not compliant|0|||
19582692|NCT00939627|42031139|FG000|Overall Study|No off-tx reason given|0|||
19582693|NCT00939627|42031140|FG001|Overall Study|No off-tx reason given|2|||
19582694|NCT00939627|42031141|FG002|Overall Study|No off-tx reason given|0|||
19582695|NCT00937833|42031149|FG000|Overall Study|Protocol Violation|1|||
19582696|NCT00937833|42031150|FG001|Overall Study|Protocol Violation|2|||
19582697|NCT00937833|42031149|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
19582698|NCT00937833|42031150|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
19582699|NCT00937833|42031149|FG000|Overall Study|Lost to Follow-up|10|||
19582700|NCT00937833|42031150|FG001|Overall Study|Lost to Follow-up|8|||
19582701|NCT00937833|42031149|FG000|Overall Study|Withdrawal by Subject|4|||
19582702|NCT00937833|42031150|FG001|Overall Study|Withdrawal by Subject|6|||
19582703|NCT01135511|42031165|FG000|Overall Study|Adverse Event|0|||
19582704|NCT01135511|42031166|FG001|Overall Study|Adverse Event|1|||
19582705|NCT01135511|42031167|FG002|Overall Study|Adverse Event|2|||
19582706|NCT01135511|42031168|FG003|Overall Study|Adverse Event|0|||
19582707|NCT01135511|42031169|FG004|Overall Study|Adverse Event|0|||
19582708|NCT01135511|42031170|FG005|Overall Study|Adverse Event|1|||
19582709|NCT01135511|42031171|FG006|Overall Study|Adverse Event|0|||
19582710|NCT01135511|42031172|FG007|Overall Study|Adverse Event|1|||
19582711|NCT01135511|42031173|FG008|Overall Study|Adverse Event|0|||
19582712|NCT01135511|42031165|FG000|Overall Study|Lack of Efficacy|0|||
19582713|NCT01135511|42031166|FG001|Overall Study|Lack of Efficacy|1|||
19582714|NCT01135511|42031167|FG002|Overall Study|Lack of Efficacy|1|||
19582715|NCT01135511|42031168|FG003|Overall Study|Lack of Efficacy|2|||
19582716|NCT01135511|42031169|FG004|Overall Study|Lack of Efficacy|0|||
19582717|NCT01135511|42031170|FG005|Overall Study|Lack of Efficacy|0|||
19582718|NCT01135511|42031171|FG006|Overall Study|Lack of Efficacy|0|||
19582719|NCT01135511|42031172|FG007|Overall Study|Lack of Efficacy|0|||
19582720|NCT01135511|42031173|FG008|Overall Study|Lack of Efficacy|0|||
19582721|NCT01135511|42031165|FG000|Overall Study|Protocol Violation|0|||
19582722|NCT01135511|42031166|FG001|Overall Study|Protocol Violation|0|||
19582723|NCT01135511|42031167|FG002|Overall Study|Protocol Violation|3|||
19582724|NCT01135511|42031168|FG003|Overall Study|Protocol Violation|0|||
19582725|NCT01135511|42031169|FG004|Overall Study|Protocol Violation|0|||
19582726|NCT01135511|42031170|FG005|Overall Study|Protocol Violation|0|||
19582727|NCT01135511|42031171|FG006|Overall Study|Protocol Violation|0|||
19582728|NCT01135511|42031172|FG007|Overall Study|Protocol Violation|0|||
19582729|NCT01135511|42031173|FG008|Overall Study|Protocol Violation|0|||
19582730|NCT01135511|42031165|FG000|Overall Study|Pregnancy|0|||
19582731|NCT01135511|42031166|FG001|Overall Study|Pregnancy|0|||
19582732|NCT01135511|42031167|FG002|Overall Study|Pregnancy|0|||
19582733|NCT01135511|42031168|FG003|Overall Study|Pregnancy|1|||
19582734|NCT01135511|42031169|FG004|Overall Study|Pregnancy|0|||
19582735|NCT01135511|42031170|FG005|Overall Study|Pregnancy|0|||
19582736|NCT01135511|42031171|FG006|Overall Study|Pregnancy|0|||
19582737|NCT01135511|42031172|FG007|Overall Study|Pregnancy|0|||
19582738|NCT01135511|42031173|FG008|Overall Study|Pregnancy|0|||
19582739|NCT01135511|42031165|FG000|Overall Study|could not visit the clinic|0|||
19582740|NCT01135511|42031166|FG001|Overall Study|could not visit the clinic|1|||
19582741|NCT01135511|42031167|FG002|Overall Study|could not visit the clinic|2|||
19582742|NCT01135511|42031168|FG003|Overall Study|could not visit the clinic|0|||
19582743|NCT01135511|42031169|FG004|Overall Study|could not visit the clinic|0|||
19582744|NCT01135511|42031170|FG005|Overall Study|could not visit the clinic|0|||
19582745|NCT01135511|42031171|FG006|Overall Study|could not visit the clinic|0|||
19582746|NCT01135511|42031172|FG007|Overall Study|could not visit the clinic|0|||
19582747|NCT01135511|42031173|FG008|Overall Study|could not visit the clinic|0|||
19582748|NCT01135511|42031165|FG000|Overall Study|noncompliance with study drug taken|0|||
19582749|NCT01135511|42031166|FG001|Overall Study|noncompliance with study drug taken|0|||
19582750|NCT01135511|42031167|FG002|Overall Study|noncompliance with study drug taken|0|||
19582751|NCT01135511|42031168|FG003|Overall Study|noncompliance with study drug taken|0|||
19582752|NCT01135511|42031169|FG004|Overall Study|noncompliance with study drug taken|1|||
19582753|NCT01135511|42031170|FG005|Overall Study|noncompliance with study drug taken|0|||
19582754|NCT01135511|42031171|FG006|Overall Study|noncompliance with study drug taken|0|||
19582755|NCT01135511|42031172|FG007|Overall Study|noncompliance with study drug taken|0|||
19582756|NCT01135511|42031173|FG008|Overall Study|noncompliance with study drug taken|0|||
19582757|NCT01135511|42031165|FG000|Overall Study|Withdrawal by Subject|0|||
19582758|NCT01135511|42031166|FG001|Overall Study|Withdrawal by Subject|0|||
19582759|NCT01135511|42031167|FG002|Overall Study|Withdrawal by Subject|0|||
19582760|NCT01135511|42031168|FG003|Overall Study|Withdrawal by Subject|0|||
19582761|NCT01135511|42031169|FG004|Overall Study|Withdrawal by Subject|0|||
19582762|NCT01135511|42031170|FG005|Overall Study|Withdrawal by Subject|0|||
19582763|NCT01135511|42031171|FG006|Overall Study|Withdrawal by Subject|1|||
19582764|NCT01135511|42031172|FG007|Overall Study|Withdrawal by Subject|0|||
19582765|NCT01135511|42031173|FG008|Overall Study|Withdrawal by Subject|1|||
19582766|NCT01180790|42031209|FG000|Overall Study|Adverse Event|1|||
19582767|NCT01180790|42031210|FG001|Overall Study|Adverse Event|1|||
19582768|NCT01180790|42031211|FG002|Overall Study|Adverse Event|2|||
19582769|NCT01180790|42031212|FG003|Overall Study|Adverse Event|0|||
19582770|NCT01180790|42031213|FG004|Overall Study|Adverse Event|1|||
19582771|NCT01180790|42031214|FG005|Overall Study|Adverse Event|3|||
19582772|NCT01180790|42031215|FG006|Overall Study|Adverse Event|0|||
19582773|NCT01180790|42031209|FG000|Overall Study|Withdrawal by Subject|3|||
19582774|NCT01180790|42031210|FG001|Overall Study|Withdrawal by Subject|0|||
19582775|NCT01180790|42031211|FG002|Overall Study|Withdrawal by Subject|5|||
19582776|NCT01180790|42031212|FG003|Overall Study|Withdrawal by Subject|0|||
19582777|NCT01180790|42031213|FG004|Overall Study|Withdrawal by Subject|2|||
19582778|NCT01180790|42031214|FG005|Overall Study|Withdrawal by Subject|1|||
19582779|NCT01180790|42031215|FG006|Overall Study|Withdrawal by Subject|0|||
19582780|NCT01180790|42031209|FG000|Overall Study|Lost to Follow-up|3|||
19582781|NCT01180790|42031210|FG001|Overall Study|Lost to Follow-up|1|||
19582782|NCT01180790|42031211|FG002|Overall Study|Lost to Follow-up|0|||
19582783|NCT01180790|42031212|FG003|Overall Study|Lost to Follow-up|2|||
19582784|NCT01180790|42031213|FG004|Overall Study|Lost to Follow-up|1|||
19582785|NCT01180790|42031214|FG005|Overall Study|Lost to Follow-up|0|||
19582786|NCT01180790|42031215|FG006|Overall Study|Lost to Follow-up|1|||
19582787|NCT01180790|42031209|FG000|Overall Study|Physician Decision|1|||
19582788|NCT01180790|42031210|FG001|Overall Study|Physician Decision|0|||
19582789|NCT01180790|42031211|FG002|Overall Study|Physician Decision|0|||
19582790|NCT01180790|42031212|FG003|Overall Study|Physician Decision|1|||
19582791|NCT01180790|42031213|FG004|Overall Study|Physician Decision|0|||
19582792|NCT01180790|42031214|FG005|Overall Study|Physician Decision|0|||
19582793|NCT01180790|42031215|FG006|Overall Study|Physician Decision|0|||
19582794|NCT01180790|42031209|FG000|Overall Study|Lack of Efficacy|1|||
19582795|NCT01180790|42031210|FG001|Overall Study|Lack of Efficacy|2|||
19582796|NCT01180790|42031211|FG002|Overall Study|Lack of Efficacy|5|||
19582797|NCT01180790|42031212|FG003|Overall Study|Lack of Efficacy|6|||
19582798|NCT01180790|42031213|FG004|Overall Study|Lack of Efficacy|1|||
19582799|NCT01180790|42031214|FG005|Overall Study|Lack of Efficacy|3|||
19582800|NCT01180790|42031215|FG006|Overall Study|Lack of Efficacy|0|||
19582801|NCT01180790|42031209|FG000|Overall Study|compliance|0|||
19582802|NCT01180790|42031210|FG001|Overall Study|compliance|1|||
19582803|NCT01180790|42031211|FG002|Overall Study|compliance|0|||
19582804|NCT01180790|42031212|FG003|Overall Study|compliance|0|||
19582805|NCT01180790|42031213|FG004|Overall Study|compliance|0|||
19582806|NCT01180790|42031214|FG005|Overall Study|compliance|0|||
19582807|NCT01180790|42031215|FG006|Overall Study|compliance|0|||
19582808|NCT01180790|42031209|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582809|NCT01180790|42031210|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582810|NCT01180790|42031211|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
19582811|NCT01180790|42031212|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582812|NCT01180790|42031213|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582813|NCT01180790|42031214|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582814|NCT01180790|42031215|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
19582815|NCT01184846|42031259|FG000|Overall Study|Adverse Event|2|||
19582816|NCT01184846|42031259|FG000|Overall Study|Insufficient response|1|||
19582817|NCT01180400|42031267|FG000|Overall Study|Withdrawal by Subject|5|||
19582818|NCT01180400|42031268|FG001|Overall Study|Withdrawal by Subject|6|||
19582819|NCT01180400|42031267|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19582820|NCT01180400|42031268|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
19582821|NCT01180400|42031267|FG000|Overall Study|Adverse Event|12|||
19582822|NCT01180400|42031268|FG001|Overall Study|Adverse Event|10|||
19582823|NCT01180400|42031267|FG000|Overall Study|Severe non-compliance to protocol|1|||
19582824|NCT01180400|42031268|FG001|Overall Study|Severe non-compliance to protocol|2|||
19582825|NCT01180400|42031267|FG000|Overall Study|Condition under investigation worsened|2|||
19582826|NCT01180400|42031268|FG001|Overall Study|Condition under investigation worsened|1|||
19582827|NCT01180400|42031267|FG000|Overall Study|Lack of Efficacy|2|||
19582828|NCT01180400|42031268|FG001|Overall Study|Lack of Efficacy|0|||
19582829|NCT01180400|42031267|FG000|Overall Study|Study-specific withdrawal criteria|1|||
19582830|NCT01180400|42031268|FG001|Overall Study|Study-specific withdrawal criteria|2|||
19582831|NCT01180400|42031267|FG000|Overall Study|Lost to Follow-up|2|||
19582832|NCT01180400|42031268|FG001|Overall Study|Lost to Follow-up|3|||
19582833|NCT01180400|42031267|FG000|Overall Study|Other|0|||
19582834|NCT01180400|42031268|FG001|Overall Study|Other|1|||
19582835|NCT01180244|42031276|FG000|Overall Study|Lack of Efficacy|0|||
19582836|NCT01180244|42031277|FG001|Overall Study|Lack of Efficacy|7|||
19582837|NCT01180244|42031276|FG000|Overall Study|Physician Decision|3|||
19582838|NCT01180244|42031277|FG001|Overall Study|Physician Decision|0|||
19582839|NCT01180244|42031276|FG000|Overall Study|Adverse Event|1|||
19582840|NCT01180244|42031277|FG001|Overall Study|Adverse Event|0|||
19582841|NCT01180244|42031276|FG000|Overall Study|Withdrawal by Subject|0|||
19582842|NCT01180244|42031277|FG001|Overall Study|Withdrawal by Subject|1|||
19582843|NCT01180244|42031276|FG000|Overall Study|Protocol Violation|1|||
19582844|NCT01180244|42031277|FG001|Overall Study|Protocol Violation|0|||
19582845|NCT01180244|42031276|FG000|Overall Study|Lost to Follow-up|1|||
19582846|NCT01180244|42031277|FG001|Overall Study|Lost to Follow-up|0|||
19582847|NCT01191086|42031283|FG000|Overall Study|Adverse Event|20|||
19582848|NCT01191086|42031283|FG000|Overall Study|Lack of Efficacy|10|||
19582849|NCT01191086|42031283|FG000|Overall Study|Lost to Follow-up|4|||
19582850|NCT01191086|42031283|FG000|Overall Study|Physician Decision|2|||
19582851|NCT01191086|42031283|FG000|Overall Study|Withdrawal by Subject|24|||
19582852|NCT01191086|42031283|FG000|Overall Study|Discontinuation criterion met|1|||
19582853|NCT01191086|42031283|FG000|Overall Study|Other|1|||
19582854|NCT01191008|42031287|FG000|Overall Study|Protocol Violation|7|||
19582855|NCT01191008|42031287|FG000|Overall Study|Lost to Follow-up|8|||
19582856|NCT01088412|42031294|FG000|Overall Study|Adverse Event|38|||
19582857|NCT01088412|42031295|FG001|Overall Study|Adverse Event|0|||
19582858|NCT01088412|42031296|FG002|Overall Study|Adverse Event|0|||
19582859|NCT01088412|42031294|FG000|Overall Study|Death|42|||
19582860|NCT01088412|42031295|FG001|Overall Study|Death|6|||
19582861|NCT01088412|42031296|FG002|Overall Study|Death|0|||
19582862|NCT01088412|42031294|FG000|Overall Study|Other Reason per Case Report Form|2089|||
19582863|NCT01088412|42031295|FG001|Overall Study|Other Reason per Case Report Form|103|||
19582864|NCT01088412|42031296|FG002|Overall Study|Other Reason per Case Report Form|9|||
19582865|NCT01088412|42031294|FG000|Overall Study|Withdrawal by Subject|1761|||
19582866|NCT01088412|42031295|FG001|Overall Study|Withdrawal by Subject|25|||
19582867|NCT01088412|42031296|FG002|Overall Study|Withdrawal by Subject|1|||
19582868|NCT01088412|42031294|FG000|Overall Study|Received Another GH Product|79|||
19582869|NCT01088412|42031295|FG001|Overall Study|Received Another GH Product|0|||
19582870|NCT01088412|42031296|FG002|Overall Study|Received Another GH Product|0|||
19582871|NCT01088412|42031294|FG000|Overall Study|Participant Moved|601|||
19582872|NCT01088412|42031295|FG001|Overall Study|Participant Moved|21|||
19582873|NCT01088412|42031296|FG002|Overall Study|Participant Moved|2|||
19582874|NCT01088412|42031294|FG000|Overall Study|Physician Decision|1041|||
19582875|NCT01088412|42031295|FG001|Overall Study|Physician Decision|8|||
19582876|NCT01088412|42031296|FG002|Overall Study|Physician Decision|4|||
19582877|NCT01088412|42031294|FG000|Overall Study|Sponsor Decision|4467|||
19582878|NCT01088412|42031295|FG001|Overall Study|Sponsor Decision|79|||
19582879|NCT01088412|42031296|FG002|Overall Study|Sponsor Decision|23|||
19582880|NCT01088412|42031294|FG000|Overall Study|Third Party Required to Change Brand|487|||
19582881|NCT01088412|42031295|FG001|Overall Study|Third Party Required to Change Brand|0|||
19582882|NCT01088412|42031296|FG002|Overall Study|Third Party Required to Change Brand|0|||
19582883|NCT01088412|42031294|FG000|Overall Study|Lost to Follow-up|3052|||
19582884|NCT01088412|42031295|FG001|Overall Study|Lost to Follow-up|130|||
19582885|NCT01088412|42031296|FG002|Overall Study|Lost to Follow-up|11|||
19582886|NCT01088412|42031294|FG000|Overall Study|Study Summary Not Completed|4360|||
19582887|NCT01088412|42031295|FG001|Overall Study|Study Summary Not Completed|64|||
19582888|NCT01088412|42031296|FG002|Overall Study|Study Summary Not Completed|22|||
19582889|NCT01076400|42031307|FG000|Overall Study|Adverse Event|2|||
19582890|NCT01076400|42031308|FG001|Overall Study|Adverse Event|0|||
19582891|NCT01076400|42031309|FG002|Overall Study|Adverse Event|0|||
19582892|NCT01076400|42031307|FG000|Overall Study|Progressive Disease|5|||
19582893|NCT01076400|42031308|FG001|Overall Study|Progressive Disease|0|||
19582894|NCT01076400|42031309|FG002|Overall Study|Progressive Disease|0|||
19582895|NCT01086384|42031315|FG000|2-week Run-in Period|Adverse Event|1|||
19582896|NCT01086384|42031316|FG001|2-week Run-in Period|Adverse Event|0|||
19582897|NCT01086384|42031317|FG002|2-week Run-in Period|Adverse Event|0|||
19582898|NCT01086384|42031315|FG000|2-week Run-in Period|Protocol Violation|1|||
19582899|NCT01086384|42031316|FG001|2-week Run-in Period|Protocol Violation|0|||
19582900|NCT01086384|42031317|FG002|2-week Run-in Period|Protocol Violation|0|||
19582901|NCT01086384|42031315|FG000|2-week Run-in Period|Lost to Follow-up|1|||
19582902|NCT01086384|42031316|FG001|2-week Run-in Period|Lost to Follow-up|0|||
19582903|NCT01086384|42031317|FG002|2-week Run-in Period|Lost to Follow-up|0|||
19582904|NCT01086384|42031315|FG000|2-week Run-in Period|Physician Decision|6|||
19582905|NCT01086384|42031316|FG001|2-week Run-in Period|Physician Decision|0|||
19582906|NCT01086384|42031317|FG002|2-week Run-in Period|Physician Decision|0|||
19582907|NCT01086384|42031315|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
19582908|NCT01086384|42031316|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19582909|NCT01086384|42031317|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19582910|NCT01086384|42031315|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
19582911|NCT01086384|42031316|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
19582912|NCT01086384|42031317|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
19582913|NCT01086384|42031315|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
19582914|NCT01086384|42031316|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
19582915|NCT01086384|42031317|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
19582916|NCT01086384|42031315|FG000|2-week Run-in Period|Randomized in Error|1|||
19582917|NCT01086384|42031316|FG001|2-week Run-in Period|Randomized in Error|0|||
19582918|NCT01086384|42031317|FG002|2-week Run-in Period|Randomized in Error|0|||
19582919|NCT01086384|42031315|FG000|Treatment Period|Withdrawal by Subject|0|||
19582920|NCT01086384|42031316|FG001|Treatment Period|Withdrawal by Subject|53|||
19582921|NCT01086384|42031317|FG002|Treatment Period|Withdrawal by Subject|55|||
19582922|NCT01086384|42031315|FG000|Treatment Period|Protocol Violation|0|||
19582923|NCT01086384|42031316|FG001|Treatment Period|Protocol Violation|26|||
19582924|NCT01086384|42031317|FG002|Treatment Period|Protocol Violation|17|||
19582925|NCT01086384|42031315|FG000|Treatment Period|Lack of Efficacy|0|||
19582926|NCT01086384|42031316|FG001|Treatment Period|Lack of Efficacy|22|||
19582927|NCT01086384|42031317|FG002|Treatment Period|Lack of Efficacy|13|||
19582928|NCT01086384|42031315|FG000|Treatment Period|Adverse Event|0|||
19582929|NCT01086384|42031316|FG001|Treatment Period|Adverse Event|19|||
19582930|NCT01086384|42031317|FG002|Treatment Period|Adverse Event|15|||
19582931|NCT01086384|42031315|FG000|Treatment Period|Lost to Follow-up|0|||
19582932|NCT01086384|42031316|FG001|Treatment Period|Lost to Follow-up|11|||
19582933|NCT01086384|42031317|FG002|Treatment Period|Lost to Follow-up|9|||
19582934|NCT01086384|42031315|FG000|Treatment Period|Physician Decision|0|||
19582935|NCT01086384|42031316|FG001|Treatment Period|Physician Decision|9|||
19582936|NCT01086384|42031317|FG002|Treatment Period|Physician Decision|6|||
19582937|NCT01086384|42031315|FG000|Treatment Period|Study Closed/Terminated|0|||
19582938|NCT01086384|42031316|FG001|Treatment Period|Study Closed/Terminated|7|||
19582939|NCT01086384|42031317|FG002|Treatment Period|Study Closed/Terminated|8|||
19582940|NCT01086384|42031315|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
19582941|NCT01086384|42031316|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
19582942|NCT01086384|42031317|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
19582943|NCT01086384|42031315|FG000|Treatment Period|Received Treatment in Error|0|||
19582944|NCT01086384|42031316|FG001|Treatment Period|Received Treatment in Error|1|||
19582945|NCT01086384|42031317|FG002|Treatment Period|Received Treatment in Error|0|||
19582946|NCT01127633|42031338|FG000|Overall Study|Adverse Event|74|||
19582947|NCT01127633|42031339|FG001|Overall Study|Adverse Event|73|||
19582948|NCT01127633|42031338|FG000|Overall Study|Death|40|||
19582949|NCT01127633|42031339|FG001|Overall Study|Death|43|||
19582950|NCT01127633|42031338|FG000|Overall Study|Lost to Follow-up|4|||
19582951|NCT01127633|42031339|FG001|Overall Study|Lost to Follow-up|0|||
19582952|NCT01127633|42031338|FG000|Overall Study|Parent/Caregiver Decision|246|||
19582953|NCT01127633|42031339|FG001|Overall Study|Parent/Caregiver Decision|228|||
19582954|NCT01127633|42031338|FG000|Overall Study|Physician Decision|60|||
19582955|NCT01127633|42031339|FG001|Overall Study|Physician Decision|45|||
19582956|NCT01127633|42031338|FG000|Overall Study|Withdrawal by Subject|57|||
19582957|NCT01127633|42031339|FG001|Overall Study|Withdrawal by Subject|72|||
19582958|NCT01127633|42031338|FG000|Overall Study|Sponsor Decision|163|||
19582959|NCT01127633|42031339|FG001|Overall Study|Sponsor Decision|195|||
19582960|NCT01127633|42031338|FG000|Overall Study|Protocol Violation|8|||
19582961|NCT01127633|42031339|FG001|Overall Study|Protocol Violation|16|||
19582962|NCT01127633|42031338|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
19582963|NCT01127633|42031339|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
19582964|NCT01127633|42031338|FG000|Overall Study|Not treated|1|||
19582965|NCT01127633|42031339|FG001|Overall Study|Not treated|0|||
19582966|NCT01122173|42031345|FG000|Overall Study|Lost to Follow-up|3|||
19582967|NCT01122173|42031345|FG000|Overall Study|Withdrawal by Subject|3|||
19582968|NCT01122173|42031345|FG000|Overall Study|Left study for other reasons|3|||
19582969|NCT01127165|42031352|FG000|Overall Study|Adverse Event|2|||
19582970|NCT01127165|42031353|FG001|Overall Study|Adverse Event|2|||
19582971|NCT01127165|42031352|FG000|Overall Study|Lack of Efficacy|10|||
19582972|NCT01127165|42031353|FG001|Overall Study|Lack of Efficacy|8|||
19582973|NCT01127165|42031352|FG000|Overall Study|Lost to Follow-up|3|||
19582974|NCT01127165|42031353|FG001|Overall Study|Lost to Follow-up|5|||
19582975|NCT01127165|42031352|FG000|Overall Study|Withdrawal by Subject|1|||
19582976|NCT01127165|42031353|FG001|Overall Study|Withdrawal by Subject|3|||
19582977|NCT01127165|42031352|FG000|Overall Study|Protocol Violation|0|||
19582978|NCT01127165|42031353|FG001|Overall Study|Protocol Violation|1|||
19582979|NCT01126619|42031359|FG000|Overall Study|Not eligible for the study|2|||
19582980|NCT01126619|42031359|FG000|Overall Study|Investigator decision|4|||
19582981|NCT01126619|42031359|FG000|Overall Study|Serious adverse event|1|||
19582982|NCT01126619|42031359|FG000|Overall Study|Withdrawal by Subject|9|||
19582983|NCT01126619|42031359|FG000|Overall Study|Non-compliance|1|||
19582984|NCT00941733|42031367|FG000|Overall Study|Death|24|||
19582985|NCT00941733|42031368|FG001|Overall Study|Death|10|||
19582986|NCT00941733|42031367|FG000|Overall Study|Withdrawal by Subject|14|||
19582987|NCT00941733|42031368|FG001|Overall Study|Withdrawal by Subject|6|||
19582988|NCT00941733|42031367|FG000|Overall Study|Adverse Event|20|||
19582989|NCT00941733|42031368|FG001|Overall Study|Adverse Event|4|||
19582990|NCT00941733|42031367|FG000|Overall Study|Lost to Follow-up|1|||
19582991|NCT00941733|42031368|FG001|Overall Study|Lost to Follow-up|2|||
19582992|NCT00941733|42031367|FG000|Overall Study|Protocol Violation|15|||
19582993|NCT00941733|42031368|FG001|Overall Study|Protocol Violation|6|||
19582994|NCT00941655|42031376|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
19582995|NCT00941655|42031377|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
19582996|NCT00941655|42031376|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
19582997|NCT00941655|42031377|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
19582998|NCT00941655|42031376|FG000|Overall Study|progressed while on chemo|0|||
19582999|NCT00941655|42031377|FG001|Overall Study|progressed while on chemo|2|||
19583000|NCT00941655|42031376|FG000|Overall Study|refused further treatment|0|||
19583001|NCT00941655|42031377|FG001|Overall Study|refused further treatment|1|||
19583002|NCT00941655|42031376|FG000|Overall Study|withdrew consent|0|||
19583003|NCT00941655|42031377|FG001|Overall Study|withdrew consent|1|||
19583004|NCT00941655|42031376|FG000|Overall Study|non-compliant|0|||
19583005|NCT00941655|42031377|FG001|Overall Study|non-compliant|1|||
19583006|NCT00939393|42031386|FG000|Overall Study|Withdrawal by Subject|1|||
19583007|NCT00939393|42031387|FG001|Overall Study|Withdrawal by Subject|0|||
19583008|NCT00939393|42031386|FG000|Overall Study|Lost to Follow-up|3|||
19583009|NCT00939393|42031387|FG001|Overall Study|Lost to Follow-up|0|||
19583010|NCT00936117|42031404|FG000|Overall Study|Adverse Event|7|||
19583011|NCT00936117|42031404|FG000|Overall Study|Unable to continue oral medication|3|||
19583012|NCT04088500|42031409|FG000|Overall Study|Reason unknown|1|||
19583013|NCT04088500|42031409|FG000|Overall Study|Participant withdrew consent|1|||
19583014|NCT04088500|42031409|FG000|Overall Study|Disease progression|3|||
19583015|NCT01082874|42031417|FG000|Overall Study|Lost to Follow-up|10|||
19583016|NCT01082874|42031418|FG001|Overall Study|Lost to Follow-up|10|||
19583017|NCT01082874|42031419|FG002|Overall Study|Lost to Follow-up|6|||
19583018|NCT01082874|42031420|FG003|Overall Study|Lost to Follow-up|10|||
19583019|NCT01082874|42031417|FG000|Overall Study|Withdrawal by Subject|1|||
19583020|NCT01082874|42031418|FG001|Overall Study|Withdrawal by Subject|2|||
19583021|NCT01082874|42031419|FG002|Overall Study|Withdrawal by Subject|5|||
19583022|NCT01082874|42031420|FG003|Overall Study|Withdrawal by Subject|3|||
19583023|NCT00933543|42031432|FG000|Overall Study|Adverse Event|2|||
19583024|NCT00933543|42031433|FG001|Overall Study|Adverse Event|1|||
19583025|NCT00933543|42031432|FG000|Overall Study|Lost to Follow-up|0|||
19583026|NCT00933543|42031433|FG001|Overall Study|Lost to Follow-up|1|||
19583027|NCT00933543|42031432|FG000|Overall Study|Withdrawal by Subject|0|||
19583028|NCT00933543|42031433|FG001|Overall Study|Withdrawal by Subject|1|||
19583029|NCT00933543|42031432|FG000|Overall Study|Lack of Efficacy|0|||
19583030|NCT00933543|42031433|FG001|Overall Study|Lack of Efficacy|3|||
19583031|NCT00933543|42031432|FG000|Overall Study|Other|1|||
19583032|NCT00933543|42031433|FG001|Overall Study|Other|1|||
19583033|NCT01082328|42031439|FG000|Overall Study|Adverse Event|1|||
19583034|NCT01079988|42031448|FG000|Overall Study|Lost to Follow-up|0|||
19583035|NCT01079988|42031449|FG001|Overall Study|Lost to Follow-up|0|||
19583036|NCT01079988|42031450|FG002|Overall Study|Lost to Follow-up|0|||
19583037|NCT01079988|42031451|FG003|Overall Study|Lost to Follow-up|1|||
19583038|NCT01079988|42031452|FG004|Overall Study|Lost to Follow-up|0|||
19583039|NCT01079988|42031448|FG000|Overall Study|Lack of Efficacy|1|||
19583040|NCT01079988|42031449|FG001|Overall Study|Lack of Efficacy|0|||
19583041|NCT01079988|42031450|FG002|Overall Study|Lack of Efficacy|0|||
19583042|NCT01079988|42031451|FG003|Overall Study|Lack of Efficacy|0|||
19583043|NCT01079988|42031452|FG004|Overall Study|Lack of Efficacy|0|||
19583044|NCT01079988|42031448|FG000|Overall Study|Other|0|||
19583045|NCT01079988|42031449|FG001|Overall Study|Other|0|||
19583046|NCT01079988|42031450|FG002|Overall Study|Other|0|||
19583047|NCT01079988|42031451|FG003|Overall Study|Other|2|||
19583048|NCT01079988|42031452|FG004|Overall Study|Other|1|||
19583049|NCT01074216|42031464|FG000|Overall Study|Physician Decision|1|||
19583050|NCT01074216|42031464|FG000|Overall Study|Not Treated|12|||
19583051|NCT01079832|42031468|FG000|Overall Study|Withdrawal by Subject|1|||
19583052|NCT01072344|42031474|FG000|Overall Study|Relasped-reached end point|7|||
19583053|NCT01072344|42031475|FG001|Overall Study|Relasped-reached end point|12|||
19583054|NCT01072344|42031474|FG000|Overall Study|Protocol Violation|1|||
19583055|NCT01072344|42031475|FG001|Overall Study|Protocol Violation|2|||
19583056|NCT01072344|42031474|FG000|Overall Study|Lost to Follow-up|3|||
19583057|NCT01072344|42031475|FG001|Overall Study|Lost to Follow-up|4|||
19583058|NCT01071954|42031481|FG000|Overall Study|Noncompliance|4|||
19583059|NCT01071954|42031481|FG000|Overall Study|Adverse Event|1|||
19583060|NCT01071954|42031481|FG000|Overall Study|Withdrawal by Subject|11|||
19583061|NCT01071954|42031481|FG000|Overall Study|Requirement for Alternative Therapy|5|||
19583062|NCT01071954|42031481|FG000|Overall Study|Administrative Decision|5|||
19583063|NCT01071954|42031481|FG000|Overall Study|Protocol Specified Criteria|1|||
19583064|NCT00837811|42031488|FG000|Overall Study|Adverse Event|4|||
19583065|NCT00837811|42031489|FG001|Overall Study|Adverse Event|6|||
19583066|NCT00837811|42031490|FG002|Overall Study|Adverse Event|0|||
19583067|NCT00837811|42031488|FG000|Overall Study|Death|1|||
19583068|NCT00837811|42031489|FG001|Overall Study|Death|1|||
19583069|NCT00837811|42031490|FG002|Overall Study|Death|0|||
19583070|NCT00837811|42031488|FG000|Overall Study|Lack of Efficacy|0|||
19583071|NCT00837811|42031489|FG001|Overall Study|Lack of Efficacy|11|||
19583072|NCT00837811|42031490|FG002|Overall Study|Lack of Efficacy|0|||
19583073|NCT00837811|42031488|FG000|Overall Study|Lost to Follow-up|1|||
19583074|NCT00837811|42031489|FG001|Overall Study|Lost to Follow-up|3|||
19583075|NCT00837811|42031490|FG002|Overall Study|Lost to Follow-up|0|||
19583076|NCT00837811|42031488|FG000|Overall Study|Physician Decision|0|||
19583077|NCT00837811|42031489|FG001|Overall Study|Physician Decision|2|||
19583078|NCT00837811|42031490|FG002|Overall Study|Physician Decision|1|||
19583079|NCT00837811|42031488|FG000|Overall Study|Withdrawal by Subject|1|||
19583080|NCT00837811|42031489|FG001|Overall Study|Withdrawal by Subject|9|||
19583081|NCT00837811|42031490|FG002|Overall Study|Withdrawal by Subject|0|||
19583082|NCT00837811|42031488|FG000|Overall Study|Sponsor Decision|0|||
19583083|NCT00837811|42031489|FG001|Overall Study|Sponsor Decision|2|||
19583084|NCT00837811|42031490|FG002|Overall Study|Sponsor Decision|0|||
19583085|NCT00857389|42031507|FG000|Overall Study|Did not proceed to transplant|2|||
19583086|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
19583087|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
19583088|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Patient requirement|20|||
19583089|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Death|5|||
19583090|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Change of therapy|6|||
19583091|NCT01071798|42031511|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
19583092|NCT01071798|42031511|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
19583093|NCT01071798|42031511|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
19583094|NCT01071798|42031511|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
19583095|NCT01071798|42031511|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
19583096|NCT00857311|42031529|FG000|Overall Study|Lost to Follow-up|1|||
19583097|NCT00857311|42031530|FG001|Overall Study|Lost to Follow-up|0|||
19583098|NCT00857311|42031531|FG002|Overall Study|Lost to Follow-up|0|||
19583099|NCT00857311|42031532|FG003|Overall Study|Lost to Follow-up|0|||
19583100|NCT00857233|42031538|FG000|Overall Study|Adverse Event|24|||
19583101|NCT00857233|42031538|FG000|Overall Study|Lack of Efficacy|1|||
19583102|NCT00857233|42031538|FG000|Overall Study|Non-compliance|1|||
19583103|NCT00857233|42031538|FG000|Overall Study|Withdrawal of Consent|9|||
19583104|NCT00857233|42031538|FG000|Overall Study|Lost to Follow-up|4|||
19583105|NCT00857233|42031538|FG000|Overall Study|Nursing Home Placement|14|||
19583106|NCT00857233|42031538|FG000|Overall Study|Other Reasons|2|||
19583107|NCT00856999|42031542|FG000|Overall Study|Withdrawal by Subject|5|||
19583108|NCT01071252|42031552|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
19583109|NCT01071252|42031553|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
19583110|NCT01071252|42031554|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
19583111|NCT01071252|42031555|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
19583112|NCT01071252|42031556|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
19583113|NCT01071252|42031552|FG000|Overall Study|Withdrawal by Subject|8|||
19583114|NCT01071252|42031553|FG001|Overall Study|Withdrawal by Subject|2|||
19583115|NCT01071252|42031554|FG002|Overall Study|Withdrawal by Subject|1|||
19583116|NCT01071252|42031555|FG003|Overall Study|Withdrawal by Subject|2|||
19583117|NCT01071252|42031556|FG004|Overall Study|Withdrawal by Subject|3|||
19583118|NCT01071252|42031552|FG000|Overall Study|administrative problems|1|||
19583119|NCT01071252|42031553|FG001|Overall Study|administrative problems|1|||
19583120|NCT01071252|42031554|FG002|Overall Study|administrative problems|0|||
19583121|NCT01071252|42031555|FG003|Overall Study|administrative problems|2|||
19583122|NCT01071252|42031556|FG004|Overall Study|administrative problems|1|||
19583123|NCT01071252|42031552|FG000|Overall Study|Lost to Follow-up|1|||
19583124|NCT01071252|42031553|FG001|Overall Study|Lost to Follow-up|0|||
19583125|NCT01071252|42031554|FG002|Overall Study|Lost to Follow-up|1|||
19583126|NCT01071252|42031555|FG003|Overall Study|Lost to Follow-up|2|||
19583127|NCT01071252|42031556|FG004|Overall Study|Lost to Follow-up|0|||
19583128|NCT01071252|42031552|FG000|Overall Study|Adverse Event|1|||
19583129|NCT01071252|42031553|FG001|Overall Study|Adverse Event|1|||
19583130|NCT01071252|42031554|FG002|Overall Study|Adverse Event|0|||
19583131|NCT01071252|42031555|FG003|Overall Study|Adverse Event|1|||
19583132|NCT01071252|42031556|FG004|Overall Study|Adverse Event|0|||
19583133|NCT01071252|42031552|FG000|Overall Study|Death|0|||
19583134|NCT01071252|42031553|FG001|Overall Study|Death|0|||
19583135|NCT01071252|42031554|FG002|Overall Study|Death|0|||
19583136|NCT01071252|42031555|FG003|Overall Study|Death|0|||
19583137|NCT01071252|42031556|FG004|Overall Study|Death|1|||
19583138|NCT00856843|42031570|FG000|Overall Study|Withdrawal by Subject|1|||
19583139|NCT00856843|42031571|FG001|Overall Study|Withdrawal by Subject|5|||
19583140|NCT00856843|42031570|FG000|Overall Study|Lack of Efficacy|1|||
19583141|NCT00856843|42031571|FG001|Overall Study|Lack of Efficacy|0|||
19583142|NCT00856609|42031579|FG000|Overall Study|Adverse Event|1|||
19583143|NCT00856609|42031580|FG001|Overall Study|Adverse Event|0|||
19583144|NCT01071096|42031586|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
19583145|NCT01071096|42031587|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
19583146|NCT00856375|42031606|FG000|Overall Study|Other|0|||
19583147|NCT00856375|42031607|FG001|Overall Study|Other|1|||
19583148|NCT00856375|42031606|FG000|Overall Study|Death|32|||
19583149|NCT00856375|42031607|FG001|Overall Study|Death|30|||
19583150|NCT00856375|42031606|FG000|Overall Study|Sponsor Terminated Study|7|||
19583151|NCT00856375|42031607|FG001|Overall Study|Sponsor Terminated Study|7|||
19583152|NCT00856375|42031606|FG000|Overall Study|Withdrawal by Subject|2|||
19583153|NCT00856375|42031607|FG001|Overall Study|Withdrawal by Subject|1|||
19583154|NCT00856375|42031606|FG000|Overall Study|Lost to Follow-up|1|||
19583155|NCT00856375|42031607|FG001|Overall Study|Lost to Follow-up|2|||
19583156|NCT01070784|42031615|FG000|Overall Study|Withdrawal by Subject|6|||
19583157|NCT01070784|42031616|FG001|Overall Study|Withdrawal by Subject|9|||
19583158|NCT01070784|42031615|FG000|Overall Study|Adverse Event|14|||
19583159|NCT01070784|42031616|FG001|Overall Study|Adverse Event|9|||
19583160|NCT00837577|42031624|FG000|Double-blind Period|Clinical Adverse Event|1|||
19583161|NCT00837577|42031625|FG001|Double-blind Period|Clinical Adverse Event|0|||
19583162|NCT00837577|42031624|FG000|Double-blind Period|Withdrawal by Subject|1|||
19583163|NCT00837577|42031625|FG001|Double-blind Period|Withdrawal by Subject|0|||
19583164|NCT00837577|42031624|FG000|Open-label Period|Clinical Adverse Event|2|||
19583165|NCT00837577|42031625|FG001|Open-label Period|Clinical Adverse Event|2|||
19583166|NCT00837577|42031624|FG000|Open-label Period|Laboratory Adverse Event|0|||
19583167|NCT00837577|42031625|FG001|Open-label Period|Laboratory Adverse Event|1|||
19583168|NCT00837577|42031624|FG000|Open-label Period|Lack of Efficacy|4|||
19583169|NCT00837577|42031625|FG001|Open-label Period|Lack of Efficacy|3|||
19583170|NCT00837577|42031624|FG000|Open-label Period|Withdrawal by Subject|1|||
19583171|NCT00837577|42031625|FG001|Open-label Period|Withdrawal by Subject|2|||
19583172|NCT00837577|42031624|FG000|Open-label Period|Other Reason|1|||
19583173|NCT00837577|42031625|FG001|Open-label Period|Other Reason|1|||
19583174|NCT01070550|42031638|FG000|Overall Study|Adverse Event|43|||
19583175|NCT01070550|42031639|FG001|Overall Study|Adverse Event|1|||
19583176|NCT01070550|42031640|FG002|Overall Study|Adverse Event|3|||
19583177|NCT01070550|42031641|FG003|Overall Study|Adverse Event|0|||
19583178|NCT01070550|42031642|FG004|Overall Study|Adverse Event|0|||
19583179|NCT01070550|42031643|FG005|Overall Study|Adverse Event|0|||
19583180|NCT01070550|42031638|FG000|Overall Study|Death|20|||
19583181|NCT01070550|42031639|FG001|Overall Study|Death|4|||
19583182|NCT01070550|42031640|FG002|Overall Study|Death|3|||
19583183|NCT01070550|42031641|FG003|Overall Study|Death|0|||
19583184|NCT01070550|42031642|FG004|Overall Study|Death|0|||
19583185|NCT01070550|42031643|FG005|Overall Study|Death|0|||
19583186|NCT01070550|42031638|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
19583187|NCT01070550|42031639|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
19583188|NCT01070550|42031640|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
19583189|NCT01070550|42031641|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
19583190|NCT01070550|42031642|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
19583191|NCT01070550|42031643|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
19583192|NCT01070550|42031638|FG000|Overall Study|Early termination|3|||
19583193|NCT01070550|42031639|FG001|Overall Study|Early termination|0|||
19583194|NCT01070550|42031640|FG002|Overall Study|Early termination|0|||
19583195|NCT01070550|42031641|FG003|Overall Study|Early termination|0|||
19583196|NCT01070550|42031642|FG004|Overall Study|Early termination|0|||
19583197|NCT01070550|42031643|FG005|Overall Study|Early termination|0|||
19583198|NCT01070550|42031638|FG000|Overall Study|Failed to return|450|||
19583199|NCT01070550|42031639|FG001|Overall Study|Failed to return|33|||
19583200|NCT01070550|42031640|FG002|Overall Study|Failed to return|144|||
19583201|NCT01070550|42031641|FG003|Overall Study|Failed to return|40|||
19583202|NCT01070550|42031642|FG004|Overall Study|Failed to return|1|||
19583203|NCT01070550|42031643|FG005|Overall Study|Failed to return|2|||
19583204|NCT01070550|42031638|FG000|Overall Study|Incomplete treatment|2|||
19583205|NCT01070550|42031639|FG001|Overall Study|Incomplete treatment|0|||
19583206|NCT01070550|42031640|FG002|Overall Study|Incomplete treatment|0|||
19583207|NCT01070550|42031641|FG003|Overall Study|Incomplete treatment|0|||
19583208|NCT01070550|42031642|FG004|Overall Study|Incomplete treatment|0|||
19583209|NCT01070550|42031643|FG005|Overall Study|Incomplete treatment|0|||
19583210|NCT01070550|42031638|FG000|Overall Study|Lab test not done|22|||
19583211|NCT01070550|42031639|FG001|Overall Study|Lab test not done|3|||
19583212|NCT01070550|42031640|FG002|Overall Study|Lab test not done|4|||
19583213|NCT01070550|42031641|FG003|Overall Study|Lab test not done|1|||
19583214|NCT01070550|42031642|FG004|Overall Study|Lab test not done|0|||
19583215|NCT01070550|42031643|FG005|Overall Study|Lab test not done|1|||
19583216|NCT01070550|42031638|FG000|Overall Study|Lack of Efficacy|65|||
19583217|NCT01070550|42031639|FG001|Overall Study|Lack of Efficacy|1|||
19583218|NCT01070550|42031640|FG002|Overall Study|Lack of Efficacy|5|||
19583219|NCT01070550|42031641|FG003|Overall Study|Lack of Efficacy|5|||
19583220|NCT01070550|42031642|FG004|Overall Study|Lack of Efficacy|0|||
19583221|NCT01070550|42031643|FG005|Overall Study|Lack of Efficacy|1|||
19583222|NCT01070550|42031638|FG000|Overall Study|Miscellaneous|12|||
19583223|NCT01070550|42031639|FG001|Overall Study|Miscellaneous|2|||
19583224|NCT01070550|42031640|FG002|Overall Study|Miscellaneous|3|||
19583225|NCT01070550|42031641|FG003|Overall Study|Miscellaneous|1|||
19583226|NCT01070550|42031642|FG004|Overall Study|Miscellaneous|0|||
19583227|NCT01070550|42031643|FG005|Overall Study|Miscellaneous|0|||
19583228|NCT01070550|42031638|FG000|Overall Study|New treatment started|3|||
19583229|NCT01070550|42031639|FG001|Overall Study|New treatment started|1|||
19583230|NCT01070550|42031640|FG002|Overall Study|New treatment started|0|||
19583231|NCT01070550|42031641|FG003|Overall Study|New treatment started|2|||
19583232|NCT01070550|42031642|FG004|Overall Study|New treatment started|0|||
19583233|NCT01070550|42031643|FG005|Overall Study|New treatment started|0|||
19583234|NCT01070550|42031638|FG000|Overall Study|Non-responders|493|||
19583235|NCT01070550|42031639|FG001|Overall Study|Non-responders|4|||
19583236|NCT01070550|42031640|FG002|Overall Study|Non-responders|21|||
19583237|NCT01070550|42031641|FG003|Overall Study|Non-responders|20|||
19583238|NCT01070550|42031642|FG004|Overall Study|Non-responders|0|||
19583239|NCT01070550|42031643|FG005|Overall Study|Non-responders|2|||
19583240|NCT01070550|42031638|FG000|Overall Study|Not categorized|33|||
19583241|NCT01070550|42031639|FG001|Overall Study|Not categorized|2|||
19583242|NCT01070550|42031640|FG002|Overall Study|Not categorized|6|||
19583243|NCT01070550|42031641|FG003|Overall Study|Not categorized|1|||
19583244|NCT01070550|42031642|FG004|Overall Study|Not categorized|0|||
19583245|NCT01070550|42031643|FG005|Overall Study|Not categorized|1|||
19583246|NCT01070550|42031638|FG000|Overall Study|Protocol Violation|15|||
19583247|NCT01070550|42031639|FG001|Overall Study|Protocol Violation|1|||
19583248|NCT01070550|42031640|FG002|Overall Study|Protocol Violation|1|||
19583249|NCT01070550|42031641|FG003|Overall Study|Protocol Violation|1|||
19583250|NCT01070550|42031642|FG004|Overall Study|Protocol Violation|0|||
19583251|NCT01070550|42031643|FG005|Overall Study|Protocol Violation|0|||
19745902|NCT03529773|42193188|FG032|Overall Study|No longer meets eligibility criteria|0|||
19583252|NCT01070550|42031638|FG000|Overall Study|Relapse|44|||
19583253|NCT01070550|42031639|FG001|Overall Study|Relapse|5|||
19583254|NCT01070550|42031640|FG002|Overall Study|Relapse|14|||
19583255|NCT01070550|42031641|FG003|Overall Study|Relapse|4|||
19583256|NCT01070550|42031642|FG004|Overall Study|Relapse|0|||
19583257|NCT01070550|42031643|FG005|Overall Study|Relapse|0|||
19583258|NCT01070550|42031638|FG000|Overall Study|Result not available|3|||
19583259|NCT01070550|42031639|FG001|Overall Study|Result not available|1|||
19583260|NCT01070550|42031640|FG002|Overall Study|Result not available|3|||
19583261|NCT01070550|42031641|FG003|Overall Study|Result not available|0|||
19583262|NCT01070550|42031642|FG004|Overall Study|Result not available|0|||
19583263|NCT01070550|42031643|FG005|Overall Study|Result not available|0|||
19583264|NCT01070550|42031638|FG000|Overall Study|Screen failure|1|||
19583265|NCT01070550|42031639|FG001|Overall Study|Screen failure|0|||
19583266|NCT01070550|42031640|FG002|Overall Study|Screen failure|0|||
19583267|NCT01070550|42031641|FG003|Overall Study|Screen failure|0|||
19583268|NCT01070550|42031642|FG004|Overall Study|Screen failure|0|||
19583269|NCT01070550|42031643|FG005|Overall Study|Screen failure|0|||
19583270|NCT01070550|42031638|FG000|Overall Study|Sponsor decision|1|||
19583271|NCT01070550|42031639|FG001|Overall Study|Sponsor decision|0|||
19583272|NCT01070550|42031640|FG002|Overall Study|Sponsor decision|0|||
19583273|NCT01070550|42031641|FG003|Overall Study|Sponsor decision|0|||
19583274|NCT01070550|42031642|FG004|Overall Study|Sponsor decision|0|||
19583275|NCT01070550|42031643|FG005|Overall Study|Sponsor decision|0|||
19583276|NCT01070550|42031638|FG000|Overall Study|Treatment duration shortened|1|||
19583277|NCT01070550|42031639|FG001|Overall Study|Treatment duration shortened|0|||
19583278|NCT01070550|42031640|FG002|Overall Study|Treatment duration shortened|0|||
19583279|NCT01070550|42031641|FG003|Overall Study|Treatment duration shortened|0|||
19583280|NCT01070550|42031642|FG004|Overall Study|Treatment duration shortened|0|||
19583281|NCT01070550|42031643|FG005|Overall Study|Treatment duration shortened|0|||
19583282|NCT01070550|42031638|FG000|Overall Study|Treatment interrupted|7|||
19583283|NCT01070550|42031639|FG001|Overall Study|Treatment interrupted|0|||
19583284|NCT01070550|42031640|FG002|Overall Study|Treatment interrupted|1|||
19583285|NCT01070550|42031641|FG003|Overall Study|Treatment interrupted|1|||
19583286|NCT01070550|42031642|FG004|Overall Study|Treatment interrupted|0|||
19583287|NCT01070550|42031643|FG005|Overall Study|Treatment interrupted|0|||
19583288|NCT01070550|42031638|FG000|Overall Study|Treatment not started|14|||
19583289|NCT01070550|42031639|FG001|Overall Study|Treatment not started|2|||
19583290|NCT01070550|42031640|FG002|Overall Study|Treatment not started|4|||
19583291|NCT01070550|42031641|FG003|Overall Study|Treatment not started|0|||
19583292|NCT01070550|42031642|FG004|Overall Study|Treatment not started|0|||
19583293|NCT01070550|42031643|FG005|Overall Study|Treatment not started|0|||
19583294|NCT01070550|42031638|FG000|Overall Study|Treatment restarted|0|||
19583295|NCT01070550|42031639|FG001|Overall Study|Treatment restarted|1|||
19583296|NCT01070550|42031640|FG002|Overall Study|Treatment restarted|0|||
19583297|NCT01070550|42031641|FG003|Overall Study|Treatment restarted|0|||
19583298|NCT01070550|42031642|FG004|Overall Study|Treatment restarted|0|||
19583299|NCT01070550|42031643|FG005|Overall Study|Treatment restarted|0|||
19583300|NCT01070550|42031638|FG000|Overall Study|Treatment stopped|3|||
19583301|NCT01070550|42031639|FG001|Overall Study|Treatment stopped|0|||
19583302|NCT01070550|42031640|FG002|Overall Study|Treatment stopped|0|||
19583303|NCT01070550|42031641|FG003|Overall Study|Treatment stopped|0|||
19583304|NCT01070550|42031642|FG004|Overall Study|Treatment stopped|0|||
19583305|NCT01070550|42031643|FG005|Overall Study|Treatment stopped|0|||
19583306|NCT01070550|42031638|FG000|Overall Study|Treatment unavailable|1|||
19583307|NCT01070550|42031639|FG001|Overall Study|Treatment unavailable|0|||
19583308|NCT01070550|42031640|FG002|Overall Study|Treatment unavailable|0|||
19583309|NCT01070550|42031641|FG003|Overall Study|Treatment unavailable|0|||
19583310|NCT01070550|42031642|FG004|Overall Study|Treatment unavailable|0|||
19583311|NCT01070550|42031643|FG005|Overall Study|Treatment unavailable|0|||
19583312|NCT01070550|42031638|FG000|Overall Study|Treatment was stopped early|7|||
19583313|NCT01070550|42031639|FG001|Overall Study|Treatment was stopped early|0|||
19583314|NCT01070550|42031640|FG002|Overall Study|Treatment was stopped early|0|||
19583315|NCT01070550|42031641|FG003|Overall Study|Treatment was stopped early|0|||
19583316|NCT01070550|42031642|FG004|Overall Study|Treatment was stopped early|0|||
19583317|NCT01070550|42031643|FG005|Overall Study|Treatment was stopped early|0|||
19583318|NCT01070550|42031638|FG000|Overall Study|Other|5|||
19583319|NCT01070550|42031639|FG001|Overall Study|Other|0|||
19583320|NCT01070550|42031640|FG002|Overall Study|Other|0|||
19583321|NCT01070550|42031641|FG003|Overall Study|Other|1|||
19583322|NCT01070550|42031642|FG004|Overall Study|Other|0|||
19583323|NCT01070550|42031643|FG005|Overall Study|Other|0|||
19583324|NCT01070550|42031638|FG000|Overall Study|Withdrawal by Subject|35|||
19583325|NCT01070550|42031639|FG001|Overall Study|Withdrawal by Subject|0|||
19583326|NCT01070550|42031640|FG002|Overall Study|Withdrawal by Subject|3|||
19583327|NCT01070550|42031641|FG003|Overall Study|Withdrawal by Subject|0|||
19583328|NCT01070550|42031642|FG004|Overall Study|Withdrawal by Subject|0|||
19583329|NCT01070550|42031643|FG005|Overall Study|Withdrawal by Subject|0|||
19583330|NCT00848107|42031658|FG000|Overall Study|Lost to Follow-up|2|||
19583331|NCT00848107|42031658|FG000|Overall Study|Withdrawal by Subject|8|||
19583332|NCT00848107|42031658|FG000|Overall Study|Adverse Event|9|||
19745903|NCT03529773|42193189|FG033|Overall Study|No longer meets eligibility criteria|0|||
19745904|NCT03529773|42193190|FG034|Overall Study|No longer meets eligibility criteria|0|||
19583333|NCT00848107|42031658|FG000|Overall Study|Death|1|||
19583334|NCT00848107|42031658|FG000|Overall Study|Pregnancy|1|||
19583335|NCT00856297|42031667|FG000|Overall Study|Unable to classify|2|||
19583336|NCT00856297|42031668|FG001|Overall Study|Unable to classify|0|||
19583337|NCT00856297|42031669|FG002|Overall Study|Unable to classify|0|||
19583338|NCT00856297|42031670|FG003|Overall Study|Unable to classify|0|||
19583339|NCT00856297|42031671|FG004|Overall Study|Unable to classify|0|||
19583340|NCT01046136|42031690|FG000|Overall Study|Withdrawal by Subject|0|||
19583341|NCT01046136|42031691|FG001|Overall Study|Withdrawal by Subject|4|||
19583342|NCT01046136|42031690|FG000|Overall Study|Physician Decision|1|||
19583343|NCT01046136|42031691|FG001|Overall Study|Physician Decision|1|||
19583344|NCT01046136|42031690|FG000|Overall Study|Lost to Follow-up|3|||
19583345|NCT01046136|42031691|FG001|Overall Study|Lost to Follow-up|3|||
19583346|NCT01070394|42031699|FG000|Overall Study|Adverse Event|6|||
19583347|NCT01070394|42031699|FG000|Overall Study|Withdrawal by Subject|1|||
19583348|NCT00836953|42031705|FG000|Overall Study|Withdrawal by Subject|1|||
19583349|NCT00836953|42031705|FG000|Overall Study|Lost to Follow-up|1|||
19583350|NCT01070316|42031709|FG000|Extension Phase|Lack of Efficacy|3|||
19583351|NCT01070316|42031709|FG000|Extension Phase|Withdrawal by Subject|1|||
19583352|NCT01126541|42031716|FG000|Overall Study|Adverse Event|0|||
19583353|NCT01126541|42031717|FG001|Overall Study|Adverse Event|2|||
19583354|NCT01126541|42031718|FG002|Overall Study|Adverse Event|4|||
19583355|NCT01126541|42031716|FG000|Overall Study|Death|0|||
19583356|NCT01126541|42031717|FG001|Overall Study|Death|1|||
19583357|NCT01126541|42031718|FG002|Overall Study|Death|0|||
19583358|NCT01126541|42031716|FG000|Overall Study|Lack of Efficacy|6|||
19583359|NCT01126541|42031717|FG001|Overall Study|Lack of Efficacy|1|||
19583360|NCT01126541|42031718|FG002|Overall Study|Lack of Efficacy|11|||
19583361|NCT01126541|42031716|FG000|Overall Study|Lost to Follow-up|1|||
19583362|NCT01126541|42031717|FG001|Overall Study|Lost to Follow-up|2|||
19583363|NCT01126541|42031718|FG002|Overall Study|Lost to Follow-up|2|||
19583364|NCT01126541|42031716|FG000|Overall Study|Withdrawal by Subject|2|||
19583365|NCT01126541|42031717|FG001|Overall Study|Withdrawal by Subject|5|||
19583366|NCT01126541|42031718|FG002|Overall Study|Withdrawal by Subject|6|||
19583367|NCT01126541|42031716|FG000|Overall Study|Protocol Violation|0|||
19583368|NCT01126541|42031717|FG001|Overall Study|Protocol Violation|0|||
19583369|NCT01126541|42031718|FG002|Overall Study|Protocol Violation|1|||
19583370|NCT01126541|42031716|FG000|Overall Study|Administrative reason or other|1|||
19583371|NCT01126541|42031717|FG001|Overall Study|Administrative reason or other|1|||
19583372|NCT01126541|42031718|FG002|Overall Study|Administrative reason or other|2|||
19583373|NCT00836875|42031730|FG000|Overall Study|Death|3|||
19583374|NCT00836875|42031731|FG001|Overall Study|Death|2|||
19583375|NCT00836875|42031730|FG000|Overall Study|Withdrawal by Subject|0|||
19583376|NCT00836875|42031731|FG001|Overall Study|Withdrawal by Subject|1|||
19583377|NCT01125917|42031737|FG000|Overall Study|Adverse Event|43|||
19583378|NCT01125917|42031737|FG000|Overall Study|Lost to Follow-up|23|||
19583379|NCT01125917|42031737|FG000|Overall Study|Withdrawal by Subject|31|||
19583380|NCT01125917|42031737|FG000|Overall Study|Administrative|223|||
19583381|NCT01125917|42031737|FG000|Overall Study|Lack of Efficacy|19|||
19583382|NCT00847561|42031743|FG000|Overall Study|Withdrawal by Subject|4|||
19583383|NCT00847561|42031744|FG001|Overall Study|Withdrawal by Subject|3|||
19583384|NCT00847561|42031743|FG000|Overall Study|Unable to schedule|9|||
19583385|NCT00847561|42031744|FG001|Overall Study|Unable to schedule|1|||
19583386|NCT01121549|42031750|FG000|Overall Study|Adverse Event|10|||
19583387|NCT01121549|42031750|FG000|Overall Study|Lack of Efficacy|11|||
19583388|NCT01121549|42031750|FG000|Overall Study|Lost to Follow-up|12|||
19583389|NCT01121549|42031750|FG000|Overall Study|Did not meet entrance criteria|9|||
19583390|NCT01121549|42031750|FG000|Overall Study|Study terminated by sponsor|197|||
19583391|NCT01121549|42031750|FG000|Overall Study|Pregnancy|1|||
19387845|NCT02564211|41631187|FG000|Overall Study|Adverse Event|4|||
19387846|NCT02093026|41631191|FG000|Overall Study|Adverse Event|26|||
19387847|NCT02093026|41631191|FG000|Overall Study|Death|10|||
19387848|NCT02093026|41631191|FG000|Overall Study|Other|157|||
19387849|NCT02040844|41631199|FG000|Overall Study|Adverse Event|0|||
19387850|NCT02040844|41631200|FG001|Overall Study|Adverse Event|0|||
19387851|NCT02040844|41631201|FG002|Overall Study|Adverse Event|1|||
19387852|NCT02040844|41631199|FG000|Overall Study|Withdrawal by Subject|16|||
19387853|NCT02040844|41631200|FG001|Overall Study|Withdrawal by Subject|22|||
19387854|NCT02040844|41631201|FG002|Overall Study|Withdrawal by Subject|25|||
19387855|NCT02040844|41631199|FG000|Overall Study|Lost to Follow-up|12|||
19387856|NCT02040844|41631200|FG001|Overall Study|Lost to Follow-up|9|||
19387857|NCT02040844|41631201|FG002|Overall Study|Lost to Follow-up|13|||
19387858|NCT02040844|41631199|FG000|Overall Study|Missing|13|||
19387859|NCT02040844|41631200|FG001|Overall Study|Missing|3|||
19583392|NCT01121549|42031750|FG000|Overall Study|Protocol Violation|33|||
19583393|NCT01121549|42031750|FG000|Overall Study|Withdrawal by Subject|16|||
19583394|NCT01121549|42031750|FG000|Overall Study|Other|58|||
19583395|NCT00847405|42031756|FG000|First Intervention|Adverse Event|0|||
19387860|NCT02040844|41631201|FG002|Overall Study|Missing|2|||
19387861|NCT02040844|41631199|FG000|Overall Study|Non-specified|8|||
19583396|NCT00847405|42031757|FG001|First Intervention|Adverse Event|1|||
19583397|NCT00847405|42031756|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19583398|NCT00847405|42031757|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19583399|NCT00836095|42031763|FG000|Overall Study|Physician Decision|0|||
19387862|NCT02040844|41631200|FG001|Overall Study|Non-specified|2|||
19387863|NCT02040844|41631201|FG002|Overall Study|Non-specified|5|||
19583400|NCT00836095|42031764|FG001|Overall Study|Physician Decision|3|||
19583401|NCT00835237|42031781|FG000|Overall Study|Lost to Follow-up|4|||
19387864|NCT02040844|41631199|FG000|Overall Study|Concomitant medication|1|||
19387865|NCT02040844|41631200|FG001|Overall Study|Concomitant medication|3|||
19387866|NCT02040844|41631201|FG002|Overall Study|Concomitant medication|1|||
19387867|NCT02059174|41631209|FG000|Period 1|Withdrawal by Subject|0|||
19387868|NCT02059174|41631210|FG001|Period 1|Withdrawal by Subject|2|||
19387869|NCT02059174|41631209|FG000|Period 2|Withdrawal by Subject|0|||
19387870|NCT02059174|41631210|FG001|Period 2|Withdrawal by Subject|2|||
19387871|NCT02059174|41631209|FG000|Period 2|Protocol Violation|1|||
19387872|NCT02059174|41631210|FG001|Period 2|Protocol Violation|0|||
19387873|NCT02059174|41631209|FG000|Period 3|Physician Decision|1|||
19387874|NCT02059174|41631210|FG001|Period 3|Physician Decision|0|||
19387875|NCT02092324|41631218|FG000|Overall Study|Adverse Event|1|||
19387876|NCT02092324|41631218|FG000|Overall Study|Lack of Efficacy|6|||
19387877|NCT02092324|41631218|FG000|Overall Study|Proceed to Transplant|3|||
19387878|NCT02092324|41631218|FG000|Overall Study|Physician Decision|7|||
19387879|NCT02092324|41631218|FG000|Overall Study|Misdiagnosis|2|||
19387880|NCT02040766|41631230|FG000|Overall Study|Adverse Event|1|||
19583402|NCT00835237|42031782|FG001|Overall Study|Lost to Follow-up|0|||
19583403|NCT00835237|42031781|FG000|Overall Study|Withdrawal by Subject|2|||
19583404|NCT00835237|42031782|FG001|Overall Study|Withdrawal by Subject|0|||
19583405|NCT01072500|42031790|FG000|Overall Study|Death|2|||
19583406|NCT01072500|42031791|FG001|Overall Study|Death|2|||
19583407|NCT01072500|42031790|FG000|Overall Study|Lost to Follow-up|5|||
19583408|NCT01072500|42031791|FG001|Overall Study|Lost to Follow-up|2|||
19583409|NCT01072500|42031790|FG000|Overall Study|Withdrawal by Subject|17|||
19583410|NCT01072500|42031791|FG001|Overall Study|Withdrawal by Subject|10|||
19583411|NCT00847015|42031799|FG000|Overall Study|Withdrawal by Subject|1|||
19583412|NCT00847015|42031799|FG000|Overall Study|declined any surgery|1|||
19583413|NCT00847015|42031799|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
19583414|NCT00855595|42031805|FG000|Overall Study|Withdrawal by Subject|1|||
19583415|NCT00855595|42031806|FG001|Overall Study|Withdrawal by Subject|2|||
19583416|NCT00855595|42031805|FG000|Overall Study|Lost to Follow-up|3|||
19583417|NCT00855595|42031806|FG001|Overall Study|Lost to Follow-up|3|||
19583418|NCT00855595|42031805|FG000|Overall Study|Adverse Event|1|||
19583419|NCT00855595|42031806|FG001|Overall Study|Adverse Event|1|||
19583420|NCT00855595|42031805|FG000|Overall Study|patient moved out of state|1|||
19583421|NCT00855595|42031806|FG001|Overall Study|patient moved out of state|0|||
19583422|NCT00855595|42031805|FG000|Overall Study|patient left country|0|||
19583423|NCT00855595|42031806|FG001|Overall Study|patient left country|1|||
19583424|NCT00855439|42031814|FG000|Overall Study|Withdrawal by Subject|2|||
19583425|NCT00855439|42031815|FG001|Overall Study|Withdrawal by Subject|0|||
19583426|NCT00855439|42031814|FG000|Overall Study|Pregnancy|1|||
19583427|NCT00855439|42031815|FG001|Overall Study|Pregnancy|0|||
19583428|NCT01064856|42031823|FG000|Double-blind (DB) Period|Adverse Event|1|||
19583429|NCT01064856|42031824|FG001|Double-blind (DB) Period|Adverse Event|0|||
19583430|NCT01064856|42031825|FG002|Double-blind (DB) Period|Adverse Event|0|||
19583431|NCT01064856|42031826|FG003|Double-blind (DB) Period|Adverse Event|0|||
19583432|NCT01064856|42031823|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
19583433|NCT01064856|42031824|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
19583434|NCT01064856|42031825|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
19583435|NCT01064856|42031826|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
19583436|NCT01064856|42031823|FG000|Open-label (OL) Period|Adverse Event|0|||
19583437|NCT01064856|42031824|FG001|Open-label (OL) Period|Adverse Event|0|||
19583438|NCT01064856|42031825|FG002|Open-label (OL) Period|Adverse Event|12|||
19583439|NCT01064856|42031826|FG003|Open-label (OL) Period|Adverse Event|6|||
19583440|NCT01064856|42031823|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
19583441|NCT01064856|42031824|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
19583442|NCT01064856|42031825|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
19583443|NCT01064856|42031826|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
19583444|NCT01064856|42031823|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
19583445|NCT01064856|42031824|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
19583446|NCT01064856|42031825|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
19583447|NCT01064856|42031826|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
19583448|NCT01064856|42031823|FG000|Open-label (OL) Period|Other|0|||
19583449|NCT01064856|42031824|FG001|Open-label (OL) Period|Other|0|||
19583450|NCT01064856|42031825|FG002|Open-label (OL) Period|Other|7|||
19583451|NCT01064856|42031826|FG003|Open-label (OL) Period|Other|7|||
19583452|NCT00846391|42031836|FG000|Overall Study|Physician Decision|0|||
19583453|NCT00846391|42031837|FG001|Overall Study|Physician Decision|0|||
19583454|NCT00846391|42031838|FG002|Overall Study|Physician Decision|1|||
19583455|NCT00846391|42031836|FG000|Overall Study|Study Terminated by Sponsor|1|||
19583456|NCT00846391|42031837|FG001|Overall Study|Study Terminated by Sponsor|2|||
19583457|NCT00846391|42031838|FG002|Overall Study|Study Terminated by Sponsor|2|||
19387881|NCT02040766|41631231|FG001|Overall Study|Adverse Event|1|||
19387882|NCT02040766|41631232|FG002|Overall Study|Adverse Event|1|||
19387883|NCT02040766|41631233|FG003|Overall Study|Adverse Event|0|||
19387884|NCT02040766|41631234|FG004|Overall Study|Adverse Event|2|||
19583458|NCT01042392|42031848|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
19583459|NCT01042392|42031849|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
19583460|NCT01042392|42031850|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
19583461|NCT01042392|42031851|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
19387885|NCT02040766|41631230|FG000|Overall Study|Withdrawal by Subject|4|||
19583462|NCT01042392|42031848|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
19745905|NCT03529773|42193191|FG035|Overall Study|No longer meets eligibility criteria|0|||
19745906|NCT03529773|42193192|FG036|Overall Study|No longer meets eligibility criteria|0|||
19745907|NCT03529773|42193193|FG037|Overall Study|No longer meets eligibility criteria|0|||
19745908|NCT03529773|42193194|FG038|Overall Study|No longer meets eligibility criteria|1|||
19745909|NCT03529773|42193195|FG039|Overall Study|No longer meets eligibility criteria|0|||
19745910|NCT03529773|42193156|FG000|Overall Study|Other|0|||
19745911|NCT03529773|42193157|FG001|Overall Study|Other|0|||
19745912|NCT03529773|42193158|FG002|Overall Study|Other|0|||
19745913|NCT03529773|42193159|FG003|Overall Study|Other|0|||
19745914|NCT03529773|42193160|FG004|Overall Study|Other|0|||
19745915|NCT03529773|42193161|FG005|Overall Study|Other|0|||
19745916|NCT03529773|42193162|FG006|Overall Study|Other|0|||
19745917|NCT03529773|42193163|FG007|Overall Study|Other|0|||
19745918|NCT03529773|42193164|FG008|Overall Study|Other|0|||
19745919|NCT03529773|42193165|FG009|Overall Study|Other|0|||
19745920|NCT03529773|42193166|FG010|Overall Study|Other|0|||
19583463|NCT01042392|42031849|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
19583464|NCT01042392|42031850|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
19583465|NCT01042392|42031851|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
19583466|NCT01042392|42031848|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
19583467|NCT01042392|42031849|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
19583468|NCT01042392|42031850|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
19583469|NCT01042392|42031851|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
19583470|NCT01042392|42031848|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
19583471|NCT01042392|42031849|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
19583472|NCT01042392|42031850|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
19583473|NCT01042392|42031851|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
19583474|NCT01042392|42031848|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
19583475|NCT01042392|42031849|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
19583476|NCT01042392|42031850|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
19583477|NCT01042392|42031851|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
19583478|NCT01042392|42031848|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
19583479|NCT01042392|42031849|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
19583480|NCT01042392|42031850|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
19583481|NCT01042392|42031851|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
19583482|NCT01042392|42031848|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
19583483|NCT01042392|42031849|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
19583484|NCT01042392|42031850|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
19583485|NCT01042392|42031851|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
19583486|NCT01042392|42031848|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
19583487|NCT01042392|42031849|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
19583488|NCT01042392|42031850|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
19583489|NCT01042392|42031851|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
19583490|NCT01042392|42031848|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
19583491|NCT01042392|42031849|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
19583492|NCT01042392|42031850|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
19583493|NCT01042392|42031851|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
19583494|NCT01064310|42031865|FG000|Period 1|Adverse Event|7|||
19583495|NCT01064310|42031866|FG001|Period 1|Adverse Event|10|||
19583496|NCT01064310|42031867|FG002|Period 1|Adverse Event|0|||
19583497|NCT01064310|42031865|FG000|Period 1|Physician Decision|1|||
19583498|NCT01064310|42031866|FG001|Period 1|Physician Decision|0|||
19583499|NCT01064310|42031867|FG002|Period 1|Physician Decision|0|||
19583500|NCT01064310|42031865|FG000|Period 1|Withdrawal by Subject|2|||
19583501|NCT01064310|42031866|FG001|Period 1|Withdrawal by Subject|2|||
19583502|NCT01064310|42031867|FG002|Period 1|Withdrawal by Subject|0|||
19583503|NCT01064310|42031865|FG000|Period 1|Lack of Efficacy|3|||
19583504|NCT01064310|42031866|FG001|Period 1|Lack of Efficacy|5|||
19583505|NCT01064310|42031867|FG002|Period 1|Lack of Efficacy|0|||
19583506|NCT01064310|42031865|FG000|Period 1|Entered Open-label Period|1|||
19583507|NCT01064310|42031866|FG001|Period 1|Entered Open-label Period|1|||
19583508|NCT01064310|42031867|FG002|Period 1|Entered Open-label Period|0|||
19583509|NCT01064310|42031865|FG000|Period 2|Adverse Event|2|||
19583510|NCT01064310|42031866|FG001|Period 2|Adverse Event|1|||
19583511|NCT01064310|42031867|FG002|Period 2|Adverse Event|0|||
19583512|NCT01064310|42031865|FG000|Period 2|Physician Decision|0|||
19583513|NCT01064310|42031866|FG001|Period 2|Physician Decision|1|||
19583514|NCT01064310|42031867|FG002|Period 2|Physician Decision|0|||
19583515|NCT01064310|42031865|FG000|Period 2|Entered Open-label Period|1|||
19583516|NCT01064310|42031866|FG001|Period 2|Entered Open-label Period|0|||
19583517|NCT01064310|42031867|FG002|Period 2|Entered Open-label Period|0|||
19583518|NCT01064310|42031865|FG000|Period 2|Lack of Efficacy|1|||
19583519|NCT01064310|42031866|FG001|Period 2|Lack of Efficacy|4|||
19583520|NCT01064310|42031867|FG002|Period 2|Lack of Efficacy|0|||
19583521|NCT01064310|42031865|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
19583522|NCT01064310|42031866|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
19583523|NCT01064310|42031867|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
19583524|NCT01064310|42031865|FG000|Open Label Pazopinib|Adverse Event|0|||
19583525|NCT01064310|42031866|FG001|Open Label Pazopinib|Adverse Event|0|||
19583526|NCT01064310|42031867|FG002|Open Label Pazopinib|Adverse Event|12|||
19583527|NCT01064310|42031865|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
19583528|NCT01064310|42031866|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
19583529|NCT01064310|42031867|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
19583530|NCT01064310|42031865|FG000|Open Label Pazopinib|Physician Decision|0|||
19583531|NCT01064310|42031866|FG001|Open Label Pazopinib|Physician Decision|0|||
19583532|NCT01064310|42031867|FG002|Open Label Pazopinib|Physician Decision|20|||
19583533|NCT01037244|42031880|FG000|Overall Study|Adverse Event|3|||
19583534|NCT01037244|42031881|FG001|Overall Study|Adverse Event|2|||
19583535|NCT01037244|42031882|FG002|Overall Study|Adverse Event|6|||
19583536|NCT01037244|42031883|FG003|Overall Study|Adverse Event|3|||
19583537|NCT01037244|42031880|FG000|Overall Study|Lack of Efficacy|1|||
19583538|NCT01037244|42031881|FG001|Overall Study|Lack of Efficacy|1|||
19583539|NCT01037244|42031882|FG002|Overall Study|Lack of Efficacy|0|||
19583540|NCT01037244|42031883|FG003|Overall Study|Lack of Efficacy|1|||
19583541|NCT01037244|42031880|FG000|Overall Study|Lost to Follow-up|3|||
19583542|NCT01037244|42031881|FG001|Overall Study|Lost to Follow-up|3|||
19583543|NCT01037244|42031882|FG002|Overall Study|Lost to Follow-up|4|||
19583544|NCT01037244|42031883|FG003|Overall Study|Lost to Follow-up|4|||
19583545|NCT01037244|42031880|FG000|Overall Study|Withdrawal by Subject|1|||
19583546|NCT01037244|42031881|FG001|Overall Study|Withdrawal by Subject|5|||
19583547|NCT01037244|42031882|FG002|Overall Study|Withdrawal by Subject|3|||
19583548|NCT01037244|42031883|FG003|Overall Study|Withdrawal by Subject|5|||
19583549|NCT01037244|42031880|FG000|Overall Study|Partner Withdrew Consent|2|||
19583550|NCT01037244|42031881|FG001|Overall Study|Partner Withdrew Consent|1|||
19583551|NCT01037244|42031882|FG002|Overall Study|Partner Withdrew Consent|0|||
19583552|NCT01037244|42031883|FG003|Overall Study|Partner Withdrew Consent|0|||
19583553|NCT01037244|42031880|FG000|Overall Study|Various|3|||
19583554|NCT01037244|42031881|FG001|Overall Study|Various|2|||
19583555|NCT01037244|42031882|FG002|Overall Study|Various|1|||
19583556|NCT01037244|42031883|FG003|Overall Study|Various|1|||
19583557|NCT00833989|42031897|FG000|Overall Study|Physician Decision|0|||
19583558|NCT00833989|42031898|FG001|Overall Study|Physician Decision|0|||
19583559|NCT00833989|42031899|FG002|Overall Study|Physician Decision|0|||
19583560|NCT00833989|42031900|FG003|Overall Study|Physician Decision|1|||
19583561|NCT00833989|42031897|FG000|Overall Study|Withdrawal by Subject|3|||
19583562|NCT00833989|42031898|FG001|Overall Study|Withdrawal by Subject|0|||
19583563|NCT00833989|42031899|FG002|Overall Study|Withdrawal by Subject|1|||
19583564|NCT00833989|42031900|FG003|Overall Study|Withdrawal by Subject|1|||
19583565|NCT01037088|42031913|FG000|Overall Study|Withdrawal by Subject|3|||
19583566|NCT01042236|42031922|FG000|Treatment Period 1|Adverse Event|0|||
19583567|NCT01042236|42031923|FG001|Treatment Period 1|Adverse Event|1|||
19583568|NCT01042236|42031924|FG002|Treatment Period 1|Adverse Event|0|||
19583569|NCT01042236|42031925|FG003|Treatment Period 1|Adverse Event|0|||
19583570|NCT01042236|42031926|FG004|Treatment Period 1|Adverse Event|1|||
19583571|NCT01042236|42031927|FG005|Treatment Period 1|Adverse Event|0|||
19583572|NCT01042236|42031922|FG000|Treatment Period 3|Adverse Event|0|||
19583573|NCT01042236|42031923|FG001|Treatment Period 3|Adverse Event|0|||
19583574|NCT01042236|42031924|FG002|Treatment Period 3|Adverse Event|0|||
19583575|NCT01042236|42031925|FG003|Treatment Period 3|Adverse Event|1|||
19583576|NCT01042236|42031926|FG004|Treatment Period 3|Adverse Event|0|||
19583577|NCT01042236|42031927|FG005|Treatment Period 3|Adverse Event|0|||
19583578|NCT01042236|42031922|FG000|Treatment Period 3|Protocol Violation|0|||
19583579|NCT01042236|42031923|FG001|Treatment Period 3|Protocol Violation|0|||
19583580|NCT01042236|42031924|FG002|Treatment Period 3|Protocol Violation|0|||
19583581|NCT01042236|42031925|FG003|Treatment Period 3|Protocol Violation|1|||
19583582|NCT01042236|42031926|FG004|Treatment Period 3|Protocol Violation|0|||
19583583|NCT01042236|42031927|FG005|Treatment Period 3|Protocol Violation|0|||
19583584|NCT00592501|42031935|FG000|Overall Study|Withdrawal by Subject|1|||
19583585|NCT00592501|42031935|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
19583586|NCT01040832|42031941|FG000|Overall Study|Adverse Event|4|||
19583587|NCT01040832|42031942|FG001|Overall Study|Adverse Event|5|||
19583588|NCT01040832|42031941|FG000|Overall Study|Death|4|||
19583589|NCT01040832|42031942|FG001|Overall Study|Death|6|||
19583590|NCT01040832|42031941|FG000|Overall Study|Withdrawal by Subject|2|||
19583591|NCT01040832|42031942|FG001|Overall Study|Withdrawal by Subject|3|||
19583592|NCT01040832|42031941|FG000|Overall Study|Progressive disease|32|||
19583593|NCT01040832|42031942|FG001|Overall Study|Progressive disease|17|||
19583594|NCT01040832|42031941|FG000|Overall Study|Symptomatic deterioration|2|||
19583595|NCT01040832|42031942|FG001|Overall Study|Symptomatic deterioration|5|||
19583596|NCT01040832|42031941|FG000|Overall Study|Other|2|||
19583597|NCT01040832|42031942|FG001|Overall Study|Other|1|||
19583598|NCT00854581|42031948|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
19583599|NCT00854581|42031948|FG000|Induction (Up to Day 21)|Death|1|||
19583600|NCT00854581|42031948|FG000|Induction (Up to Day 21)|Physician Decision|1|||
19583601|NCT00854581|42031948|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
19583602|NCT00833911|42031957|FG000|Titration|Adverse Event|18|||
19583603|NCT00833911|42031957|FG000|Titration|Withdrawal by Subject|3|||
19583604|NCT00833911|42031957|FG000|Maintenance Phase I|Adverse Event|73|||
19583605|NCT00833911|42031957|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
19583606|NCT00833911|42031957|FG000|Maintenance Phase I|Physician Decision|10|||
19583607|NCT00833911|42031957|FG000|Maintenance Phase I|Lack of Efficacy|4|||
19583608|NCT00833911|42031957|FG000|Maintenance Phase II|Adverse Event|6|||
19583609|NCT00833911|42031957|FG000|Maintenance Phase II|Physician Decision|2|||
19583610|NCT00833911|42031957|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
19583611|NCT00833911|42031957|FG000|Maintenance Phase II|Lack of Efficacy|1|||
19583612|NCT01125293|42031971|FG000|Overall Study|Disease Progression|1|||
19583613|NCT01125293|42031972|FG001|Overall Study|Disease Progression|3|||
19583614|NCT01125293|42031973|FG002|Overall Study|Disease Progression|4|||
19583615|NCT01125293|42031974|FG003|Overall Study|Disease Progression|3|||
19583616|NCT01125293|42031975|FG004|Overall Study|Disease Progression|5|||
19583617|NCT01125293|42031976|FG005|Overall Study|Disease Progression|12|||
19583618|NCT01125293|42031971|FG000|Overall Study|Adverse Event|1|||
19583619|NCT01125293|42031972|FG001|Overall Study|Adverse Event|0|||
19583620|NCT01125293|42031973|FG002|Overall Study|Adverse Event|0|||
19583621|NCT01125293|42031974|FG003|Overall Study|Adverse Event|0|||
19583622|NCT01125293|42031975|FG004|Overall Study|Adverse Event|2|||
19583623|NCT01125293|42031976|FG005|Overall Study|Adverse Event|8|||
19583624|NCT01125293|42031971|FG000|Overall Study|Symptomatic Deterioration|1|||
19583625|NCT01125293|42031972|FG001|Overall Study|Symptomatic Deterioration|0|||
19583626|NCT01125293|42031973|FG002|Overall Study|Symptomatic Deterioration|0|||
19583627|NCT01125293|42031974|FG003|Overall Study|Symptomatic Deterioration|0|||
19583628|NCT01125293|42031975|FG004|Overall Study|Symptomatic Deterioration|0|||
19583629|NCT01125293|42031976|FG005|Overall Study|Symptomatic Deterioration|0|||
19583630|NCT01125293|42031971|FG000|Overall Study|Death|0|||
19583631|NCT01125293|42031972|FG001|Overall Study|Death|0|||
19583632|NCT01125293|42031973|FG002|Overall Study|Death|0|||
19583633|NCT01125293|42031974|FG003|Overall Study|Death|0|||
19583634|NCT01125293|42031975|FG004|Overall Study|Death|1|||
19583635|NCT01125293|42031976|FG005|Overall Study|Death|0|||
19583636|NCT01125293|42031971|FG000|Overall Study|Withdrawal by Subject|0|||
19583637|NCT01125293|42031972|FG001|Overall Study|Withdrawal by Subject|0|||
19583638|NCT01125293|42031973|FG002|Overall Study|Withdrawal by Subject|0|||
19583639|NCT01125293|42031974|FG003|Overall Study|Withdrawal by Subject|0|||
19583640|NCT01125293|42031975|FG004|Overall Study|Withdrawal by Subject|2|||
19583641|NCT01125293|42031976|FG005|Overall Study|Withdrawal by Subject|1|||
19583642|NCT01125293|42031971|FG000|Overall Study|Physician Decision|0|||
19583643|NCT01125293|42031972|FG001|Overall Study|Physician Decision|0|||
19583644|NCT01125293|42031973|FG002|Overall Study|Physician Decision|0|||
19583645|NCT01125293|42031974|FG003|Overall Study|Physician Decision|0|||
19583646|NCT01125293|42031975|FG004|Overall Study|Physician Decision|0|||
19583647|NCT01125293|42031976|FG005|Overall Study|Physician Decision|2|||
19583648|NCT01121393|42031995|FG000|Overall Study|Progressive disease|201|||
19583649|NCT01121393|42031996|FG001|Overall Study|Progressive disease|20|||
19583650|NCT01121393|42031995|FG000|Overall Study|Other Adverse events|24|||
19583651|NCT01121393|42031996|FG001|Overall Study|Other Adverse events|45|||
19583652|NCT01121393|42031995|FG000|Overall Study|Non-compliant with protocol|0|||
19583653|NCT01121393|42031996|FG001|Overall Study|Non-compliant with protocol|3|||
19583654|NCT01121393|42031995|FG000|Overall Study|Lost to Follow-up|1|||
19583655|NCT01121393|42031996|FG001|Overall Study|Lost to Follow-up|0|||
19583656|NCT01121393|42031995|FG000|Overall Study|Refused cont. medication|7|||
19583657|NCT01121393|42031996|FG001|Overall Study|Refused cont. medication|7|||
19583658|NCT01121393|42031995|FG000|Overall Study|Not treated|3|||
19583659|NCT01121393|42031996|FG001|Overall Study|Not treated|9|||
19583660|NCT01121393|42031995|FG000|Overall Study|Other than listed|6|||
19583661|NCT01121393|42031996|FG001|Overall Study|Other than listed|0|||
19583662|NCT00937521|42032034|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583663|NCT00937521|42032035|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583664|NCT00937521|42032036|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
19583665|NCT00937521|42032037|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583666|NCT00937521|42032038|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583667|NCT00937521|42032039|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583668|NCT00937521|42032040|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
19583669|NCT00937521|42032041|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
19583670|NCT00937521|42032034|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
19583671|NCT00937521|42032035|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
19583672|NCT00937521|42032036|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
19583673|NCT00937521|42032037|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
19583674|NCT00937521|42032038|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
19583675|NCT00937521|42032039|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
19583676|NCT00937521|42032040|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
19583677|NCT00937521|42032041|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
19583678|NCT00937521|42032034|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583679|NCT00937521|42032035|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583680|NCT00937521|42032036|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
19583681|NCT00937521|42032037|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
19583682|NCT00937521|42032038|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583683|NCT00937521|42032039|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583684|NCT00937521|42032040|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583685|NCT00937521|42032041|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
19583686|NCT00937521|42032034|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
19583687|NCT00937521|42032035|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
19583688|NCT00937521|42032036|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
19583689|NCT00937521|42032037|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
19583690|NCT00937521|42032038|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
19583691|NCT00937521|42032039|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
19583692|NCT00937521|42032040|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
19583693|NCT00937521|42032041|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
19583694|NCT00937521|42032034|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
19583695|NCT00937521|42032035|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583696|NCT00937521|42032036|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583697|NCT00937521|42032037|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583698|NCT00937521|42032038|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583699|NCT00937521|42032039|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583700|NCT00937521|42032040|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
19583701|NCT00937521|42032041|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
19583702|NCT00937521|42032034|FG000|Booster Phase|Adverse Event|0|||
19583703|NCT00937521|42032035|FG001|Booster Phase|Adverse Event|0|||
19583704|NCT00937521|42032036|FG002|Booster Phase|Adverse Event|0|||
19583705|NCT00937521|42032037|FG003|Booster Phase|Adverse Event|0|||
19583706|NCT00937521|42032038|FG004|Booster Phase|Adverse Event|0|||
19583707|NCT00937521|42032039|FG005|Booster Phase|Adverse Event|0|||
19583708|NCT00937521|42032040|FG006|Booster Phase|Adverse Event|1|||
19583709|NCT00937521|42032041|FG007|Booster Phase|Adverse Event|0|||
19583710|NCT00937521|42032034|FG000|Booster Phase|Withdrawal by Subject|1|||
19583711|NCT00937521|42032035|FG001|Booster Phase|Withdrawal by Subject|0|||
19583712|NCT00937521|42032036|FG002|Booster Phase|Withdrawal by Subject|0|||
19583713|NCT00937521|42032037|FG003|Booster Phase|Withdrawal by Subject|1|||
19583714|NCT00937521|42032038|FG004|Booster Phase|Withdrawal by Subject|0|||
19583715|NCT00937521|42032039|FG005|Booster Phase|Withdrawal by Subject|0|||
19583716|NCT00937521|42032040|FG006|Booster Phase|Withdrawal by Subject|0|||
19583717|NCT00937521|42032041|FG007|Booster Phase|Withdrawal by Subject|2|||
19583718|NCT00937521|42032034|FG000|Booster Phase|Lost to Follow-up|2|||
19583719|NCT00937521|42032035|FG001|Booster Phase|Lost to Follow-up|2|||
19583720|NCT00937521|42032036|FG002|Booster Phase|Lost to Follow-up|4|||
19583721|NCT00937521|42032037|FG003|Booster Phase|Lost to Follow-up|2|||
19583722|NCT00937521|42032038|FG004|Booster Phase|Lost to Follow-up|4|||
19583723|NCT00937521|42032039|FG005|Booster Phase|Lost to Follow-up|4|||
19583724|NCT00937521|42032040|FG006|Booster Phase|Lost to Follow-up|3|||
19583725|NCT00937521|42032041|FG007|Booster Phase|Lost to Follow-up|0|||
19608701|NCT00539591|42057716|FG002|Overall Study|Disease progression|3|||
19387886|NCT02040766|41631231|FG001|Overall Study|Withdrawal by Subject|3|||
19387887|NCT02040766|41631232|FG002|Overall Study|Withdrawal by Subject|2|||
19387888|NCT02040766|41631233|FG003|Overall Study|Withdrawal by Subject|3|||
19387889|NCT02040766|41631234|FG004|Overall Study|Withdrawal by Subject|2|||
19387890|NCT02040766|41631230|FG000|Overall Study|Non-compliance|0|||
19387891|NCT02040766|41631231|FG001|Overall Study|Non-compliance|1|||
19583726|NCT00937521|42032034|FG000|Booster Phase|Administrative Reason|0|||
19583727|NCT00937521|42032035|FG001|Booster Phase|Administrative Reason|0|||
19583728|NCT00937521|42032036|FG002|Booster Phase|Administrative Reason|1|||
19583729|NCT00937521|42032037|FG003|Booster Phase|Administrative Reason|0|||
19583730|NCT00937521|42032038|FG004|Booster Phase|Administrative Reason|1|||
19583731|NCT00937521|42032039|FG005|Booster Phase|Administrative Reason|1|||
19583732|NCT00937521|42032040|FG006|Booster Phase|Administrative Reason|0|||
19583733|NCT00937521|42032041|FG007|Booster Phase|Administrative Reason|0|||
19583734|NCT00937521|42032034|FG000|Booster Phase|Protocol Deviation|0|||
19583735|NCT00937521|42032035|FG001|Booster Phase|Protocol Deviation|0|||
19583736|NCT00937521|42032036|FG002|Booster Phase|Protocol Deviation|0|||
19583737|NCT00937521|42032037|FG003|Booster Phase|Protocol Deviation|0|||
19583738|NCT00937521|42032038|FG004|Booster Phase|Protocol Deviation|0|||
19583739|NCT00937521|42032039|FG005|Booster Phase|Protocol Deviation|0|||
19583740|NCT00937521|42032040|FG006|Booster Phase|Protocol Deviation|1|||
19583741|NCT00937521|42032041|FG007|Booster Phase|Protocol Deviation|0|||
19583742|NCT00935883|42032076|FG000|Treatment Period|Physician Decision|1|||
19583743|NCT00935883|42032077|FG001|Treatment Period|Physician Decision|0|||
19583744|NCT00935883|42032076|FG000|Treatment Period|Withdrawal by Subject|0|||
19583745|NCT00935883|42032077|FG001|Treatment Period|Withdrawal by Subject|2|||
19583746|NCT00936975|42032083|FG000|Overall Study|Withdrawal by Subject|1|||
19583747|NCT00936975|42032083|FG000|Overall Study|Disease progression|3|||
19583748|NCT00936975|42032083|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
19583749|NCT00936897|42032090|FG000|Overall Study|Withdrawal by Subject|9|||
19583750|NCT00936897|42032091|FG001|Overall Study|Withdrawal by Subject|19|||
19583751|NCT00936897|42032090|FG000|Overall Study|Adverse Event|4|||
19583752|NCT00936897|42032091|FG001|Overall Study|Adverse Event|13|||
19583753|NCT00936897|42032090|FG000|Overall Study|Other|3|||
19583754|NCT00936897|42032091|FG001|Overall Study|Other|9|||
19583755|NCT00936897|42032090|FG000|Overall Study|Lost to Follow-up|1|||
19583756|NCT00936897|42032091|FG001|Overall Study|Lost to Follow-up|10|||
19583757|NCT00936897|42032090|FG000|Overall Study|Administrative Decision|1|||
19583758|NCT00936897|42032091|FG001|Overall Study|Administrative Decision|2|||
19583759|NCT00936897|42032090|FG000|Overall Study|Protocol Violation|1|||
19583760|NCT00936897|42032091|FG001|Overall Study|Protocol Violation|1|||
19583761|NCT00936897|42032090|FG000|Overall Study|Ineligibility Determined|0|||
19583762|NCT00936897|42032091|FG001|Overall Study|Ineligibility Determined|3|||
19583763|NCT00936897|42032090|FG000|Overall Study|Noncompliance|0|||
19583764|NCT00936897|42032091|FG001|Overall Study|Noncompliance|2|||
19583765|NCT00936897|42032090|FG000|Overall Study|Death|0|||
19583766|NCT00936897|42032091|FG001|Overall Study|Death|1|||
19583767|NCT01120691|42032100|FG000|Overall Study|Adverse Event|59|||
19583768|NCT01120691|42032101|FG001|Overall Study|Adverse Event|67|||
19583769|NCT01120691|42032102|FG002|Overall Study|Adverse Event|47|||
19583770|NCT01120691|42032100|FG000|Overall Study|Subject withdrew consent|33|||
19583771|NCT01120691|42032101|FG001|Overall Study|Subject withdrew consent|50|||
19583772|NCT01120691|42032102|FG002|Overall Study|Subject withdrew consent|44|||
19583773|NCT01120691|42032100|FG000|Overall Study|Death|21|||
19583774|NCT01120691|42032101|FG001|Overall Study|Death|22|||
19583775|NCT01120691|42032102|FG002|Overall Study|Death|24|||
19583776|NCT01120691|42032100|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
19387892|NCT02040766|41631232|FG002|Overall Study|Non-compliance|0|||
19387893|NCT02040766|41631233|FG003|Overall Study|Non-compliance|0|||
19387894|NCT02040766|41631234|FG004|Overall Study|Non-compliance|0|||
19387895|NCT02040766|41631230|FG000|Overall Study|Protocol Violation|2|||
19387896|NCT02040766|41631231|FG001|Overall Study|Protocol Violation|1|||
19387897|NCT02040766|41631232|FG002|Overall Study|Protocol Violation|2|||
19387898|NCT02040766|41631233|FG003|Overall Study|Protocol Violation|3|||
19583777|NCT01120691|42032101|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
19583778|NCT01120691|42032102|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
19583779|NCT01120691|42032100|FG000|Overall Study|Administrative problems|15|||
19583780|NCT01120691|42032101|FG001|Overall Study|Administrative problems|8|||
19583781|NCT01120691|42032102|FG002|Overall Study|Administrative problems|9|||
19583782|NCT01120691|42032100|FG000|Overall Study|Protocol deviation|13|||
19583783|NCT01120691|42032101|FG001|Overall Study|Protocol deviation|12|||
19583784|NCT01120691|42032102|FG002|Overall Study|Protocol deviation|12|||
19583785|NCT01120691|42032100|FG000|Overall Study|Lost to Follow-up|5|||
19583786|NCT01120691|42032101|FG001|Overall Study|Lost to Follow-up|6|||
19583787|NCT01120691|42032102|FG002|Overall Study|Lost to Follow-up|4|||
19583788|NCT01120691|42032100|FG000|Overall Study|Abnormal test procedure result(s)|3|||
19583789|NCT01120691|42032101|FG001|Overall Study|Abnormal test procedure result(s)|2|||
19583790|NCT01120691|42032102|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19583791|NCT01120691|42032100|FG000|Overall Study|Patient's inability to use the device|3|||
19583792|NCT01120691|42032101|FG001|Overall Study|Patient's inability to use the device|1|||
19745921|NCT03529773|42193167|FG011|Overall Study|Other|0|||
19583793|NCT01120691|42032102|FG002|Overall Study|Patient's inability to use the device|0|||
19583794|NCT01120691|42032100|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19583795|NCT01120691|42032101|FG001|Overall Study|Abnormal laboratory value(s)|3|||
19583796|NCT01120691|42032102|FG002|Overall Study|Abnormal laboratory value(s)|4|||
19583797|NCT00935493|42032126|FG000|Overall Study|Lost to Follow-up|1|||
19583798|NCT00935493|42032127|FG001|Overall Study|Lost to Follow-up|1|||
19583799|NCT00935493|42032128|FG002|Overall Study|Lost to Follow-up|1|||
19583800|NCT00935493|42032126|FG000|Overall Study|Treatment Discontinued|0|||
19583801|NCT00935493|42032127|FG001|Overall Study|Treatment Discontinued|1|||
19583802|NCT00935493|42032128|FG002|Overall Study|Treatment Discontinued|0|||
19583803|NCT03856996|42032138|FG000|Overall Study|Withdrawal by Subject|1|||
19583804|NCT03856996|42032139|FG001|Overall Study|Withdrawal by Subject|0|||
19583805|NCT03856996|42032138|FG000|Overall Study|Lost to Follow-up|0|||
19583806|NCT03856996|42032139|FG001|Overall Study|Lost to Follow-up|1|||
19583807|NCT03856996|42032138|FG000|Overall Study|Adverse Event|1|||
19583808|NCT03856996|42032139|FG001|Overall Study|Adverse Event|1|||
19583809|NCT03856996|42032138|FG000|Overall Study|Other|1|||
19583810|NCT03856996|42032139|FG001|Overall Study|Other|0|||
19583811|NCT00935259|42032145|FG000|Period 1|Administrative (scheduling conflict)|1|||
19583812|NCT00935259|42032146|FG001|Period 1|Administrative (scheduling conflict)|1|||
19583813|NCT01120379|42032163|FG000|One Year Timepoint|Withdrawal by Subject|41|||
19583814|NCT01120379|42032163|FG000|One Year Timepoint|Lost to Follow-up|115|||
19583815|NCT01120379|42032163|FG000|One Year Timepoint|Death|108|||
19583816|NCT01120379|42032163|FG000|One Year Timepoint|Physician Decision|9|||
19583817|NCT01120379|42032163|FG000|One Year Timepoint|Any other reason for early termination|5|||
19583818|NCT01120379|42032163|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
19583819|NCT01120379|42032163|FG000|Two Year Timepoint|Lost to Follow-up|87|||
19583820|NCT01120379|42032163|FG000|Two Year Timepoint|Death|123|||
19583821|NCT01120379|42032163|FG000|Two Year Timepoint|Physician Decision|12|||
19583822|NCT01120379|42032163|FG000|Two Year Timepoint|Any other reason for early termination|4|||
19583823|NCT01120379|42032163|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
19583824|NCT01120379|42032163|FG000|Three Year Timepoint|Lost to Follow-up|43|||
19583825|NCT01120379|42032163|FG000|Three Year Timepoint|Death|120|||
19583826|NCT01120379|42032163|FG000|Three Year Timepoint|Physician Decision|9|||
19583827|NCT01120379|42032163|FG000|Three Year Timepoint|Any other reason for early termination|17|||
19583828|NCT01120379|42032163|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
19583829|NCT01120379|42032163|FG000|Four Year Timepoint|Lost to Follow-up|10|||
19583830|NCT01120379|42032163|FG000|Four Year Timepoint|Death|131|||
19583831|NCT01120379|42032163|FG000|Four Year Timepoint|Physician Decision|5|||
19583832|NCT01120379|42032163|FG000|Four Year Timepoint|Any other reason for early termination|217|||
19583833|NCT01120067|42032169|FG000|Overall Study|Lost to Follow-up|3|||
19583834|NCT01120067|42032170|FG001|Overall Study|Lost to Follow-up|1|||
19583835|NCT01120067|42032169|FG000|Overall Study|fail to engage >3 sessions|2|||
19583836|NCT01120067|42032170|FG001|Overall Study|fail to engage >3 sessions|0|||
19583837|NCT01124045|42032178|FG000|Overall Study|Lost to Follow-up|0|||
19583838|NCT01124045|42032179|FG001|Overall Study|Lost to Follow-up|1|||
19583839|NCT01124045|42032178|FG000|Overall Study|Physician Decision|0|||
19583840|NCT01124045|42032179|FG001|Overall Study|Physician Decision|2|||
19583841|NCT01123889|42032187|FG000|Overall Study|Lost to Follow-up|3|||
19583842|NCT01123889|42032188|FG001|Overall Study|Lost to Follow-up|1|||
19583843|NCT00934947|42032196|FG000|Overall Study|Adverse Event|0|||
19583844|NCT00934947|42032197|FG001|Overall Study|Adverse Event|2|||
19583845|NCT01123655|42032207|FG000|Overall Study|Medication for RA had to be changed|1|||
19583846|NCT01123655|42032208|FG001|Overall Study|Medication for RA had to be changed|0|||
19583847|NCT01123655|42032209|FG002|Overall Study|Medication for RA had to be changed|0|||
19583848|NCT01123655|42032207|FG000|Overall Study|new illness|0|||
19583849|NCT01123655|42032208|FG001|Overall Study|new illness|1|||
19583850|NCT01123655|42032209|FG002|Overall Study|new illness|0|||
19583851|NCT01123655|42032207|FG000|Overall Study|began prohibitive drug|0|||
19583852|NCT01123655|42032208|FG001|Overall Study|began prohibitive drug|0|||
19583853|NCT01123655|42032209|FG002|Overall Study|began prohibitive drug|1|||
19583854|NCT00934791|42032217|FG000|Overall Study|Withdrawal by Subject|1|||
19583855|NCT00934791|42032218|FG001|Overall Study|Withdrawal by Subject|0|||
19583856|NCT01119443|42032226|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
19583857|NCT01119443|42032227|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
19583858|NCT01111019|42032236|FG000|Overall Study|Withdrew Prematurely|2|||
19583859|NCT01111019|42032236|FG000|Overall Study|Other|1|||
19583860|NCT01119287|42032255|FG000|Overall Study|Patient Decision, not related to AE|0|||
19583861|NCT01119287|42032256|FG001|Overall Study|Patient Decision, not related to AE|0|||
19583862|NCT01119287|42032257|FG002|Overall Study|Patient Decision, not related to AE|2|||
19583863|NCT01119287|42032258|FG003|Overall Study|Patient Decision, not related to AE|2|||
19583864|NCT01119287|42032259|FG004|Overall Study|Patient Decision, not related to AE|1|||
19583865|NCT01119287|42032260|FG005|Overall Study|Patient Decision, not related to AE|0|||
19583866|NCT01110707|42032274|FG000|Overall Study|Protocol Violation|0|||
19583867|NCT01110707|42032275|FG001|Overall Study|Protocol Violation|3|||
19583868|NCT01119131|42032285|FG000|Overall Study|Adverse Event|1|||
19583869|NCT01119131|42032286|FG001|Overall Study|Adverse Event|1|||
19583870|NCT01119131|42032287|FG002|Overall Study|Adverse Event|1|||
19583871|NCT01119131|42032285|FG000|Overall Study|Non-Compliance|1|||
19583872|NCT01119131|42032286|FG001|Overall Study|Non-Compliance|0|||
19583873|NCT01119131|42032287|FG002|Overall Study|Non-Compliance|4|||
19583874|NCT01119131|42032285|FG000|Overall Study|Physician Decision|0|||
19583875|NCT01119131|42032286|FG001|Overall Study|Physician Decision|0|||
19583876|NCT01119131|42032287|FG002|Overall Study|Physician Decision|1|||
19583877|NCT01118975|42032297|FG000|Overall Study|Adverse Event|0|||
19583878|NCT01118975|42032298|FG001|Overall Study|Adverse Event|1|||
19583879|NCT01110239|42032308|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
19583880|NCT01110239|42032309|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
19583881|NCT01110239|42032310|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
19583882|NCT01110239|42032311|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
19583883|NCT01110239|42032308|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
19583884|NCT01110239|42032309|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
19583885|NCT01110239|42032310|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
19583886|NCT01110239|42032311|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
19583887|NCT01118663|42032324|FG000|Overall Study|Adverse Event|2|||
19583888|NCT01118663|42032325|FG001|Overall Study|Adverse Event|1|||
19583889|NCT01118663|42032324|FG000|Overall Study|Withdrawal by Subject|0|||
19583890|NCT01118663|42032325|FG001|Overall Study|Withdrawal by Subject|1|||
19583891|NCT01118351|42032331|FG000|Overall Study|Adverse Event|3|||
19583892|NCT01118351|42032331|FG000|Overall Study|Withdrawal by Subject|1|||
19583893|NCT01110005|42032337|FG000|Overall Study|ineligible|1|||
19583894|NCT01110005|42032338|FG001|Overall Study|ineligible|2|||
19583895|NCT01110005|42032337|FG000|Overall Study|missing consent|3|||
19583896|NCT01110005|42032338|FG001|Overall Study|missing consent|2|||
19583897|NCT01110005|42032337|FG000|Overall Study|Withdrawal by Subject|0|||
19583898|NCT01110005|42032338|FG001|Overall Study|Withdrawal by Subject|1|||
19583899|NCT01118117|42032361|FG000|Overall Study|Death|8|||
19583900|NCT01118117|42032362|FG001|Overall Study|Death|0|||
19583901|NCT01118117|42032361|FG000|Overall Study|Lost to Follow-up|6|||
19583902|NCT01118117|42032362|FG001|Overall Study|Lost to Follow-up|0|||
19387899|NCT02040766|41631234|FG004|Overall Study|Protocol Violation|0|||
19387900|NCT02040766|41631230|FG000|Overall Study|Lost to Follow-up|4|||
19387901|NCT02040766|41631231|FG001|Overall Study|Lost to Follow-up|1|||
19387902|NCT02040766|41631232|FG002|Overall Study|Lost to Follow-up|3|||
19387903|NCT02040766|41631233|FG003|Overall Study|Lost to Follow-up|1|||
19387904|NCT02040766|41631234|FG004|Overall Study|Lost to Follow-up|4|||
19387905|NCT02040766|41631230|FG000|Overall Study|Not reported|1|||
19387906|NCT02040766|41631231|FG001|Overall Study|Not reported|0|||
19387907|NCT02040766|41631232|FG002|Overall Study|Not reported|0|||
19387908|NCT02040766|41631233|FG003|Overall Study|Not reported|0|||
19387909|NCT02040766|41631234|FG004|Overall Study|Not reported|0|||
19387910|NCT02040766|41631230|FG000|Overall Study|Lack of Efficacy|6|||
19387911|NCT02040766|41631231|FG001|Overall Study|Lack of Efficacy|3|||
19387912|NCT02040766|41631232|FG002|Overall Study|Lack of Efficacy|4|||
19387913|NCT02040766|41631233|FG003|Overall Study|Lack of Efficacy|6|||
19387914|NCT02040766|41631234|FG004|Overall Study|Lack of Efficacy|5|||
19387915|NCT02040532|41631247|FG000|Overall Study|Lost to Follow-up|1|||
19387916|NCT02040532|41631247|FG000|Overall Study|Physician Decision|4|||
19387917|NCT02040532|41631247|FG000|Overall Study|Adverse Event|4|||
19583903|NCT01118117|42032361|FG000|Overall Study|Missed 12 Month Visit|7|||
19583904|NCT01118117|42032362|FG001|Overall Study|Missed 12 Month Visit|0|||
19583905|NCT01109849|42032370|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
19583906|NCT01109849|42032371|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
19583907|NCT01109849|42032372|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
19583908|NCT01109849|42032373|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
19387918|NCT02040532|41631247|FG000|Overall Study|Withdrawal by Subject|3|||
19387919|NCT02039908|41631251|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
19387920|NCT02039908|41631252|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
19387921|NCT02039908|41631253|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
19745922|NCT03529773|42193168|FG012|Overall Study|Other|1|||
19583909|NCT01109849|42032374|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
19583910|NCT01109849|42032370|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
19583911|NCT01109849|42032371|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
19583912|NCT01109849|42032372|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
19583913|NCT01109849|42032373|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
19583914|NCT01109849|42032374|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
19583915|NCT01109849|42032370|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
19583916|NCT01109849|42032371|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
19583917|NCT01109849|42032372|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
19583918|NCT01109849|42032373|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
19583919|NCT01109849|42032374|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
19583920|NCT01109849|42032370|FG000|Initial Randomization: ADHD Treatment|move away|2|||
19583921|NCT01109849|42032371|FG001|Initial Randomization: ADHD Treatment|move away|7|||
19583922|NCT01109849|42032372|FG002|Initial Randomization: ADHD Treatment|move away|0|||
19583923|NCT01109849|42032373|FG003|Initial Randomization: ADHD Treatment|move away|0|||
19583924|NCT01109849|42032374|FG004|Initial Randomization: ADHD Treatment|move away|0|||
19583925|NCT01109849|42032370|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
19583926|NCT01109849|42032371|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
19583927|NCT01109849|42032372|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
19583928|NCT01109849|42032373|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
19583929|NCT01109849|42032374|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
19583930|NCT01109849|42032370|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
19583931|NCT01109849|42032371|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
19583932|NCT01109849|42032372|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
19583933|NCT01109849|42032373|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
19583934|NCT01109849|42032374|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
19583935|NCT01061736|42032404|FG000|Overall Study|Dose regimen not selected|0|||
19583936|NCT01061736|42032405|FG001|Overall Study|Dose regimen not selected|0|||
19583937|NCT01061736|42032406|FG002|Overall Study|Dose regimen not selected|0|||
19583938|NCT01061736|42032407|FG003|Overall Study|Dose regimen not selected|0|||
19583939|NCT01061736|42032408|FG004|Overall Study|Dose regimen not selected|0|||
19583940|NCT01061736|42032409|FG005|Overall Study|Dose regimen not selected|0|||
19583941|NCT01061736|42032410|FG006|Overall Study|Dose regimen not selected|79|||
19583942|NCT01061736|42032411|FG007|Overall Study|Dose regimen not selected|0|||
19583943|NCT01061736|42032412|FG008|Overall Study|Dose regimen not selected|0|||
19583944|NCT01061736|42032413|FG009|Overall Study|Dose regimen not selected|0|||
19583945|NCT01061736|42032404|FG000|Overall Study|Adverse Event|13|||
19583946|NCT01061736|42032405|FG001|Overall Study|Adverse Event|1|||
19583947|NCT01061736|42032406|FG002|Overall Study|Adverse Event|3|||
19583948|NCT01061736|42032407|FG003|Overall Study|Adverse Event|2|||
19583949|NCT01061736|42032408|FG004|Overall Study|Adverse Event|4|||
19583950|NCT01061736|42032409|FG005|Overall Study|Adverse Event|1|||
19583951|NCT01061736|42032410|FG006|Overall Study|Adverse Event|4|||
19583952|NCT01061736|42032411|FG007|Overall Study|Adverse Event|63|||
19745923|NCT03529773|42193169|FG013|Overall Study|Other|0|||
19745924|NCT03529773|42193170|FG014|Overall Study|Other|2|||
19745925|NCT03529773|42193171|FG015|Overall Study|Other|0|||
19745926|NCT03529773|42193172|FG016|Overall Study|Other|0|||
19745927|NCT03529773|42193173|FG017|Overall Study|Other|3|||
19745928|NCT03529773|42193174|FG018|Overall Study|Other|0|||
19745929|NCT03529773|42193175|FG019|Overall Study|Other|0|||
19745930|NCT03529773|42193176|FG020|Overall Study|Other|1|||
19745931|NCT03529773|42193177|FG021|Overall Study|Other|0|||
19745932|NCT03529773|42193178|FG022|Overall Study|Other|1|||
19745933|NCT03529773|42193179|FG023|Overall Study|Other|0|||
19745934|NCT03529773|42193180|FG024|Overall Study|Other|3|||
19745935|NCT03529773|42193181|FG025|Overall Study|Other|2|||
19745936|NCT03529773|42193182|FG026|Overall Study|Other|2|||
19583953|NCT01061736|42032412|FG008|Overall Study|Adverse Event|67|||
19583954|NCT01061736|42032413|FG009|Overall Study|Adverse Event|34|||
19583955|NCT01061736|42032404|FG000|Overall Study|Lack of Efficacy|0|||
19583956|NCT01061736|42032405|FG001|Overall Study|Lack of Efficacy|2|||
19583957|NCT01061736|42032406|FG002|Overall Study|Lack of Efficacy|1|||
19583958|NCT01061736|42032407|FG003|Overall Study|Lack of Efficacy|1|||
19583959|NCT01061736|42032408|FG004|Overall Study|Lack of Efficacy|1|||
19583960|NCT01061736|42032409|FG005|Overall Study|Lack of Efficacy|2|||
19583961|NCT01061736|42032410|FG006|Overall Study|Lack of Efficacy|1|||
19583962|NCT01061736|42032411|FG007|Overall Study|Lack of Efficacy|9|||
19583963|NCT01061736|42032412|FG008|Overall Study|Lack of Efficacy|9|||
19583964|NCT01061736|42032413|FG009|Overall Study|Lack of Efficacy|10|||
19583965|NCT01061736|42032404|FG000|Overall Study|Poor compliance to protocol|0|||
19583966|NCT01061736|42032405|FG001|Overall Study|Poor compliance to protocol|0|||
19583967|NCT01061736|42032406|FG002|Overall Study|Poor compliance to protocol|0|||
19583968|NCT01061736|42032407|FG003|Overall Study|Poor compliance to protocol|0|||
19583969|NCT01061736|42032408|FG004|Overall Study|Poor compliance to protocol|0|||
19583970|NCT01061736|42032409|FG005|Overall Study|Poor compliance to protocol|0|||
19583971|NCT01061736|42032410|FG006|Overall Study|Poor compliance to protocol|0|||
19583972|NCT01061736|42032411|FG007|Overall Study|Poor compliance to protocol|2|||
19583973|NCT01061736|42032412|FG008|Overall Study|Poor compliance to protocol|5|||
19583974|NCT01061736|42032413|FG009|Overall Study|Poor compliance to protocol|9|||
19583975|NCT01061736|42032404|FG000|Overall Study|Not treated|0|||
19583976|NCT01061736|42032405|FG001|Overall Study|Not treated|0|||
19583977|NCT01061736|42032406|FG002|Overall Study|Not treated|0|||
19583978|NCT01061736|42032407|FG003|Overall Study|Not treated|0|||
19583979|NCT01061736|42032408|FG004|Overall Study|Not treated|1|||
19583980|NCT01061736|42032409|FG005|Overall Study|Not treated|0|||
19583981|NCT01061736|42032410|FG006|Overall Study|Not treated|0|||
19583982|NCT01061736|42032411|FG007|Overall Study|Not treated|2|||
19583983|NCT01061736|42032412|FG008|Overall Study|Not treated|1|||
19583984|NCT01061736|42032413|FG009|Overall Study|Not treated|0|||
19583985|NCT01061736|42032404|FG000|Overall Study|Other than specified above|0|||
19583986|NCT01061736|42032405|FG001|Overall Study|Other than specified above|1|||
19583987|NCT01061736|42032406|FG002|Overall Study|Other than specified above|2|||
19583988|NCT01061736|42032407|FG003|Overall Study|Other than specified above|0|||
19583989|NCT01061736|42032408|FG004|Overall Study|Other than specified above|1|||
19583990|NCT01061736|42032409|FG005|Overall Study|Other than specified above|0|||
19583991|NCT01061736|42032410|FG006|Overall Study|Other than specified above|0|||
19583992|NCT01061736|42032411|FG007|Overall Study|Other than specified above|18|||
19583993|NCT01061736|42032412|FG008|Overall Study|Other than specified above|15|||
19583994|NCT01061736|42032413|FG009|Overall Study|Other than specified above|21|||
19583995|NCT01117337|42032440|FG000|Overall Study|Lost to Follow-up|4|||
19583996|NCT01117337|42032441|FG001|Overall Study|Lost to Follow-up|0|||
19583997|NCT01108523|42032451|FG000|Overall Study|Protocol Violation|4|||
19583998|NCT01035606|42032458|FG000|Overall Study|change in health, job demands,family|3|||
19583999|NCT01035606|42032459|FG001|Overall Study|change in health, job demands,family|3|||
19584000|NCT01035606|42032460|FG002|Overall Study|change in health, job demands,family|4|||
19584001|NCT01117181|42032470|FG000|Overall Study|Lost to Follow-up|1|||
19584002|NCT01117181|42032471|FG001|Overall Study|Lost to Follow-up|0|||
19584003|NCT01117181|42032470|FG000|Overall Study|Withdrawal by Subject|0|||
19584004|NCT01117181|42032471|FG001|Overall Study|Withdrawal by Subject|2|||
19584005|NCT01040130|42032479|FG000|Overall Study|Adverse Event|1|||
19584006|NCT01040130|42032480|FG001|Overall Study|Adverse Event|1|||
19584007|NCT01040130|42032481|FG002|Overall Study|Adverse Event|0|||
19584008|NCT01040130|42032482|FG003|Overall Study|Adverse Event|5|||
19584009|NCT01040130|42032483|FG004|Overall Study|Adverse Event|0|||
19584010|NCT01040130|42032484|FG005|Overall Study|Adverse Event|3|||
19584011|NCT01040130|42032479|FG000|Overall Study|Protocol Violation|0|||
19584012|NCT01040130|42032480|FG001|Overall Study|Protocol Violation|0|||
19584013|NCT01040130|42032481|FG002|Overall Study|Protocol Violation|2|||
19584014|NCT01040130|42032482|FG003|Overall Study|Protocol Violation|0|||
19584015|NCT01040130|42032483|FG004|Overall Study|Protocol Violation|0|||
19584016|NCT01040130|42032484|FG005|Overall Study|Protocol Violation|0|||
19584017|NCT01040130|42032479|FG000|Overall Study|Withdrawal by Subject|0|||
19584018|NCT01040130|42032480|FG001|Overall Study|Withdrawal by Subject|2|||
19584019|NCT01040130|42032481|FG002|Overall Study|Withdrawal by Subject|0|||
19584020|NCT01040130|42032482|FG003|Overall Study|Withdrawal by Subject|0|||
19584021|NCT01040130|42032483|FG004|Overall Study|Withdrawal by Subject|0|||
19584022|NCT01040130|42032484|FG005|Overall Study|Withdrawal by Subject|1|||
19584023|NCT01040130|42032479|FG000|Overall Study|Other reasons not listed above|2|||
19584024|NCT01040130|42032480|FG001|Overall Study|Other reasons not listed above|0|||
19584025|NCT01040130|42032481|FG002|Overall Study|Other reasons not listed above|0|||
19584026|NCT01040130|42032482|FG003|Overall Study|Other reasons not listed above|0|||
19584027|NCT01040130|42032483|FG004|Overall Study|Other reasons not listed above|0|||
19584028|NCT01040130|42032484|FG005|Overall Study|Other reasons not listed above|0|||
19584029|NCT00932451|42032494|FG000|Overall Study|Withdrawal by Subject|69|||
19584030|NCT00932451|42032494|FG000|Overall Study|Lost to Follow-up|22|||
19584031|NCT00932451|42032494|FG000|Overall Study|Death|726|||
19584032|NCT00932451|42032494|FG000|Overall Study|Other reasons|5|||
19584033|NCT01039584|42032505|FG000|Overall Study|Withdrawal by Subject|4|||
19584034|NCT01039584|42032506|FG001|Overall Study|Withdrawal by Subject|2|||
19584035|NCT01039584|42032507|FG002|Overall Study|Withdrawal by Subject|1|||
19584036|NCT01039584|42032505|FG000|Overall Study|Protocol Violation|10|||
19584037|NCT01039584|42032506|FG001|Overall Study|Protocol Violation|4|||
19584038|NCT01039584|42032507|FG002|Overall Study|Protocol Violation|6|||
19584039|NCT01039584|42032505|FG000|Overall Study|Lost to Follow-up|5|||
19584040|NCT01039584|42032506|FG001|Overall Study|Lost to Follow-up|3|||
19584041|NCT01039584|42032507|FG002|Overall Study|Lost to Follow-up|4|||
19584042|NCT01039584|42032505|FG000|Overall Study|Negative Baseline culture for Candida|59|||
19584043|NCT01039584|42032506|FG001|Overall Study|Negative Baseline culture for Candida|59|||
19584044|NCT01039584|42032507|FG002|Overall Study|Negative Baseline culture for Candida|24|||
19584045|NCT01039584|42032505|FG000|Overall Study|Lack of Efficacy|7|||
19584046|NCT01039584|42032506|FG001|Overall Study|Lack of Efficacy|6|||
19584047|NCT01039584|42032507|FG002|Overall Study|Lack of Efficacy|10|||
19584048|NCT01039584|42032505|FG000|Overall Study|other|1|||
19584049|NCT01039584|42032506|FG001|Overall Study|other|3|||
19584050|NCT01039584|42032507|FG002|Overall Study|other|1|||
19584051|NCT01039584|42032505|FG000|Overall Study|Pap smear with significant pathology|10|||
19584052|NCT01039584|42032506|FG001|Overall Study|Pap smear with significant pathology|10|||
19584053|NCT01039584|42032507|FG002|Overall Study|Pap smear with significant pathology|3|||
19584054|NCT01039584|42032505|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
19584055|NCT01039584|42032506|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
19584056|NCT01039584|42032507|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
19584057|NCT01108055|42032515|FG000|Overall Study|Ineligible|11|||
19387922|NCT02039908|41631254|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
19387923|NCT02039908|41631251|FG000|Phase 1-Summer|Protocol Violation|6|||
19387924|NCT02039908|41631252|FG001|Phase 1-Summer|Protocol Violation|0|||
19387925|NCT02039908|41631253|FG002|Phase 1-Summer|Protocol Violation|0|||
19387926|NCT02039908|41631254|FG003|Phase 1-Summer|Protocol Violation|0|||
19387927|NCT02039908|41631251|FG000|Phase 2-School Year|Lost to Follow-up|0|||
19387928|NCT02039908|41631252|FG001|Phase 2-School Year|Lost to Follow-up|0|||
19387929|NCT02039908|41631253|FG002|Phase 2-School Year|Lost to Follow-up|1|||
19387930|NCT02039908|41631254|FG003|Phase 2-School Year|Lost to Follow-up|3|||
19387931|NCT02039908|41631251|FG000|Phase 2-School Year|Protocol Violation|0|||
19387932|NCT02039908|41631252|FG001|Phase 2-School Year|Protocol Violation|0|||
19387933|NCT02039908|41631253|FG002|Phase 2-School Year|Protocol Violation|3|||
19387934|NCT02039908|41631254|FG003|Phase 2-School Year|Protocol Violation|0|||
19584058|NCT01108055|42032515|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
19584059|NCT01107899|42032522|FG000|Overall Study|Physician Decision|5|||
19584060|NCT01107899|42032523|FG001|Overall Study|Physician Decision|0|||
19584061|NCT01107899|42032524|FG002|Overall Study|Physician Decision|3|||
19584062|NCT01107899|42032522|FG000|Overall Study|Withdrawal by Subject|0|||
19584063|NCT01107899|42032523|FG001|Overall Study|Withdrawal by Subject|0|||
19584064|NCT01107899|42032524|FG002|Overall Study|Withdrawal by Subject|1|||
19584065|NCT01115933|42032535|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
19584066|NCT01107743|42032592|FG000|Overall Study|Protocol Violation|46|||
19584067|NCT01059864|42032641|FG000|Open-Label Run-In Phase|Adverse Event|7|||
19584068|NCT01059864|42032642|FG001|Open-Label Run-In Phase|Adverse Event|0|||
19584069|NCT01059864|42032643|FG002|Open-Label Run-In Phase|Adverse Event|0|||
19584070|NCT01059864|42032641|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
19584071|NCT01059864|42032642|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
19584072|NCT01059864|42032643|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
19584073|NCT01059864|42032641|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
19584074|NCT01059864|42032642|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
19584075|NCT01059864|42032643|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
19584076|NCT01059864|42032641|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
19584077|NCT01059864|42032642|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
19584078|NCT01059864|42032643|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
19584079|NCT01059864|42032641|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
19584080|NCT01059864|42032642|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
19584081|NCT01059864|42032643|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
19584082|NCT01059864|42032641|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
19584083|NCT01059864|42032642|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
19584084|NCT01059864|42032643|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
19584085|NCT01035138|42032653|FG000|Overall Study|Adverse Event|4|||
19584086|NCT01035138|42032654|FG001|Overall Study|Adverse Event|0|||
19584087|NCT01035138|42032655|FG002|Overall Study|Adverse Event|2|||
19584088|NCT01035138|42032653|FG000|Overall Study|Caregiver Decision|2|||
19584089|NCT01035138|42032654|FG001|Overall Study|Caregiver Decision|0|||
19584090|NCT01035138|42032655|FG002|Overall Study|Caregiver Decision|1|||
19584091|NCT01035138|42032653|FG000|Overall Study|Withdrawal by Subject|1|||
19584092|NCT01035138|42032654|FG001|Overall Study|Withdrawal by Subject|0|||
19584093|NCT01035138|42032655|FG002|Overall Study|Withdrawal by Subject|0|||
19584094|NCT01035138|42032653|FG000|Overall Study|Physician Decision|0|||
19584095|NCT01035138|42032654|FG001|Overall Study|Physician Decision|0|||
19584096|NCT01035138|42032655|FG002|Overall Study|Physician Decision|1|||
19584097|NCT01035138|42032653|FG000|Overall Study|Sponsor Decision|66|||
19584098|NCT01035138|42032654|FG001|Overall Study|Sponsor Decision|60|||
19584099|NCT01035138|42032655|FG002|Overall Study|Sponsor Decision|42|||
19584100|NCT01035138|42032653|FG000|Overall Study|Lost to Follow-up|0|||
19584101|NCT01035138|42032654|FG001|Overall Study|Lost to Follow-up|0|||
19584102|NCT01035138|42032655|FG002|Overall Study|Lost to Follow-up|1|||
19584103|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
19584104|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
19584105|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
19584106|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
19584107|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
19584108|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
19584109|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
19584110|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
19584111|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
19584112|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
19584113|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
19584114|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
19584115|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
19584116|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
19584117|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
19584118|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
19584119|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Program Termination|3|||
19584120|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Program Termination|0|||
19584121|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Program Termination|1|||
19584122|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Program Termination|1|||
19584123|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
19584124|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
19584125|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
19584126|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
19584127|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
19584128|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
19584129|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
19584130|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
19584131|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
19584132|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
19584133|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
19584134|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
19584135|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
19584136|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
19584137|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
19584138|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
19584139|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
19584140|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
19584141|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
19584142|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
19584143|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
19584144|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
19584145|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
19584146|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
19584147|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
19584148|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
19584149|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
19584150|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
19584151|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
19584152|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
19584153|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
19584154|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
19584155|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
19584156|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
19584157|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
19584158|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
19584159|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
19584160|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
19584161|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
19584162|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
19584163|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
19584164|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
19584165|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
19584166|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
19584167|NCT03739840|42032669|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
19584168|NCT03739840|42032670|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
19584169|NCT03739840|42032671|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
19584170|NCT03739840|42032672|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
19584171|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
19584172|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
19584173|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
19584174|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
19584175|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
19584176|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
19584177|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
19584178|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
19584179|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
19584180|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
19745937|NCT03529773|42193183|FG027|Overall Study|Other|0|||
19584181|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
19584182|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
19584183|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
19584184|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
19584185|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
19584186|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
19584187|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
19584188|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
19584189|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
19584190|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
19584191|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
19584192|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
19584193|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
19584194|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
19584195|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
19584196|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
19584197|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
19584198|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
19584199|NCT03739840|42032669|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
19584200|NCT03739840|42032670|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
19584201|NCT03739840|42032671|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
19584202|NCT03739840|42032672|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
19584203|NCT01035060|42032696|FG000|Overall Study|Lost to Follow-up|0|||
19584204|NCT01035060|42032697|FG001|Overall Study|Lost to Follow-up|7|||
19584205|NCT01035060|42032696|FG000|Overall Study|Did not quality after 2nd screening|14|||
19584206|NCT01035060|42032697|FG001|Overall Study|Did not quality after 2nd screening|1|||
19584207|NCT01035060|42032696|FG000|Overall Study|Withdrawal by Subject|8|||
19584208|NCT01035060|42032697|FG001|Overall Study|Withdrawal by Subject|6|||
19584209|NCT01035060|42032696|FG000|Overall Study|Physician Decision|2|||
19584210|NCT01035060|42032697|FG001|Overall Study|Physician Decision|0|||
19584211|NCT01039428|42032705|FG000|Overall Study|Protocol Violation|1|||
19584212|NCT01039428|42032706|FG001|Overall Study|Protocol Violation|0|||
19584213|NCT01039428|42032705|FG000|Overall Study|Withdrawal by Subject|1|||
19584214|NCT01039428|42032706|FG001|Overall Study|Withdrawal by Subject|0|||
19584215|NCT01034358|42032712|FG000|Overall Study|Withdrawal by Subject|1|||
19584216|NCT01034358|42032712|FG000|Overall Study|Protocol Violation|1|||
19584217|NCT01033734|42032720|FG000|Overall Study|Withdrawal by Subject|1|||
19584218|NCT01115855|42032735|FG000|Overall Study|Adverse Event|16|||
19584219|NCT01115855|42032736|FG001|Overall Study|Adverse Event|18|||
19584220|NCT01115855|42032735|FG000|Overall Study|Death|6|||
19584221|NCT01115855|42032736|FG001|Overall Study|Death|5|||
19584222|NCT01115855|42032735|FG000|Overall Study|Lab Abnormality|1|||
19584223|NCT01115855|42032736|FG001|Overall Study|Lab Abnormality|1|||
19584224|NCT01115855|42032735|FG000|Overall Study|Protocol Violation|0|||
19584225|NCT01115855|42032736|FG001|Overall Study|Protocol Violation|1|||
19584226|NCT01115855|42032735|FG000|Overall Study|Withdrawal by Subject|5|||
19584227|NCT01115855|42032736|FG001|Overall Study|Withdrawal by Subject|5|||
19584228|NCT01115855|42032735|FG000|Overall Study|Other|8|||
19584229|NCT01115855|42032736|FG001|Overall Study|Other|6|||
19584230|NCT01115309|42032746|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
19584231|NCT01115309|42032746|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
19584232|NCT01115309|42032746|FG000|Long-term Follow-up|Lost to Follow-up|6|||
19584233|NCT03638128|42032754|FG000|Overall Study|Withdrawal by Subject|1|||
19584234|NCT03638128|42032755|FG001|Overall Study|Withdrawal by Subject|7|||
19584235|NCT03638128|42032756|FG002|Overall Study|Withdrawal by Subject|6|||
19584236|NCT03638128|42032754|FG000|Overall Study|Sponsor Decision|15|||
19584237|NCT03638128|42032755|FG001|Overall Study|Sponsor Decision|12|||
19584238|NCT03638128|42032756|FG002|Overall Study|Sponsor Decision|19|||
19584239|NCT03638128|42032754|FG000|Overall Study|Lost to Follow-up|0|||
19584240|NCT03638128|42032755|FG001|Overall Study|Lost to Follow-up|0|||
19584241|NCT03638128|42032756|FG002|Overall Study|Lost to Follow-up|1|||
19584242|NCT01059630|42032769|FG000|Overall Study|Death|100|||
19584243|NCT01059630|42032770|FG001|Overall Study|Death|84|||
19584244|NCT01059630|42032769|FG000|Overall Study|Lost to Follow-up|4|||
19584245|NCT01059630|42032770|FG001|Overall Study|Lost to Follow-up|1|||
19584246|NCT01059630|42032769|FG000|Overall Study|Physician Decision|2|||
19584247|NCT01059630|42032770|FG001|Overall Study|Physician Decision|4|||
19584248|NCT01059630|42032769|FG000|Overall Study|Withdrawal by Subject|21|||
19584249|NCT01059630|42032770|FG001|Overall Study|Withdrawal by Subject|14|||
19584250|NCT00932373|42032787|FG000|Overall Study|Progressive disease|3|||
19584251|NCT00932373|42032788|FG001|Overall Study|Progressive disease|1|||
19584252|NCT00932373|42032789|FG002|Overall Study|Progressive disease|0|||
19584253|NCT00932373|42032790|FG003|Overall Study|Progressive disease|0|||
19584254|NCT00932373|42032791|FG004|Overall Study|Progressive disease|10|||
19584255|NCT00932373|42032792|FG005|Overall Study|Progressive disease|1|||
19584256|NCT00932373|42032793|FG006|Overall Study|Progressive disease|0|||
19584257|NCT00932373|42032794|FG007|Overall Study|Progressive disease|2|||
19584258|NCT00932373|42032795|FG008|Overall Study|Progressive disease|1|||
19584259|NCT00932373|42032796|FG009|Overall Study|Progressive disease|9|||
19584260|NCT00932373|42032797|FG010|Overall Study|Progressive disease|2|||
19584261|NCT00932373|42032787|FG000|Overall Study|Adverse Event|0|||
19584262|NCT00932373|42032788|FG001|Overall Study|Adverse Event|0|||
19584263|NCT00932373|42032789|FG002|Overall Study|Adverse Event|0|||
19584264|NCT00932373|42032790|FG003|Overall Study|Adverse Event|0|||
19584265|NCT00932373|42032791|FG004|Overall Study|Adverse Event|2|||
19584266|NCT00932373|42032792|FG005|Overall Study|Adverse Event|1|||
19584267|NCT00932373|42032793|FG006|Overall Study|Adverse Event|0|||
19584268|NCT00932373|42032794|FG007|Overall Study|Adverse Event|1|||
19584269|NCT00932373|42032795|FG008|Overall Study|Adverse Event|0|||
19584270|NCT00932373|42032796|FG009|Overall Study|Adverse Event|2|||
19584271|NCT00932373|42032797|FG010|Overall Study|Adverse Event|1|||
19584272|NCT00932373|42032787|FG000|Overall Study|Physician Decision|0|||
19584273|NCT00932373|42032788|FG001|Overall Study|Physician Decision|0|||
19584274|NCT00932373|42032789|FG002|Overall Study|Physician Decision|1|||
19584275|NCT00932373|42032790|FG003|Overall Study|Physician Decision|0|||
19584276|NCT00932373|42032791|FG004|Overall Study|Physician Decision|2|||
19584277|NCT00932373|42032792|FG005|Overall Study|Physician Decision|0|||
19584278|NCT00932373|42032793|FG006|Overall Study|Physician Decision|0|||
19584279|NCT00932373|42032794|FG007|Overall Study|Physician Decision|0|||
19584280|NCT00932373|42032795|FG008|Overall Study|Physician Decision|0|||
19584281|NCT00932373|42032796|FG009|Overall Study|Physician Decision|1|||
19584282|NCT00932373|42032797|FG010|Overall Study|Physician Decision|0|||
19584283|NCT00932373|42032787|FG000|Overall Study|Dose limiting toxicity|0|||
19584284|NCT00932373|42032788|FG001|Overall Study|Dose limiting toxicity|0|||
19584285|NCT00932373|42032789|FG002|Overall Study|Dose limiting toxicity|0|||
19584286|NCT00932373|42032790|FG003|Overall Study|Dose limiting toxicity|0|||
19584287|NCT00932373|42032791|FG004|Overall Study|Dose limiting toxicity|0|||
19584288|NCT00932373|42032792|FG005|Overall Study|Dose limiting toxicity|1|||
19584289|NCT00932373|42032793|FG006|Overall Study|Dose limiting toxicity|0|||
19584290|NCT00932373|42032794|FG007|Overall Study|Dose limiting toxicity|0|||
19584291|NCT00932373|42032795|FG008|Overall Study|Dose limiting toxicity|0|||
19584292|NCT00932373|42032796|FG009|Overall Study|Dose limiting toxicity|0|||
19584293|NCT00932373|42032797|FG010|Overall Study|Dose limiting toxicity|0|||
19584294|NCT00932373|42032787|FG000|Overall Study|Withdrawal by Subject|0|||
19584295|NCT00932373|42032788|FG001|Overall Study|Withdrawal by Subject|0|||
19584296|NCT00932373|42032789|FG002|Overall Study|Withdrawal by Subject|0|||
19584297|NCT00932373|42032790|FG003|Overall Study|Withdrawal by Subject|0|||
19584298|NCT00932373|42032791|FG004|Overall Study|Withdrawal by Subject|0|||
19584299|NCT00932373|42032792|FG005|Overall Study|Withdrawal by Subject|0|||
19584300|NCT00932373|42032793|FG006|Overall Study|Withdrawal by Subject|0|||
19584301|NCT00932373|42032794|FG007|Overall Study|Withdrawal by Subject|0|||
19584302|NCT00932373|42032795|FG008|Overall Study|Withdrawal by Subject|1|||
19584303|NCT00932373|42032796|FG009|Overall Study|Withdrawal by Subject|0|||
19584304|NCT00932373|42032797|FG010|Overall Study|Withdrawal by Subject|0|||
19584305|NCT00932373|42032787|FG000|Overall Study|Clinical progression|0|||
19584306|NCT00932373|42032788|FG001|Overall Study|Clinical progression|0|||
19584307|NCT00932373|42032789|FG002|Overall Study|Clinical progression|0|||
19584308|NCT00932373|42032790|FG003|Overall Study|Clinical progression|0|||
19584309|NCT00932373|42032791|FG004|Overall Study|Clinical progression|0|||
19584310|NCT00932373|42032792|FG005|Overall Study|Clinical progression|0|||
19584311|NCT00932373|42032793|FG006|Overall Study|Clinical progression|1|||
19584312|NCT00932373|42032794|FG007|Overall Study|Clinical progression|0|||
19584313|NCT00932373|42032795|FG008|Overall Study|Clinical progression|0|||
19584314|NCT00932373|42032796|FG009|Overall Study|Clinical progression|0|||
19584315|NCT00932373|42032797|FG010|Overall Study|Clinical progression|0|||
19584316|NCT00932373|42032787|FG000|Overall Study|Lack of Efficacy|0|||
19584317|NCT00932373|42032788|FG001|Overall Study|Lack of Efficacy|0|||
19584318|NCT00932373|42032789|FG002|Overall Study|Lack of Efficacy|0|||
19584319|NCT00932373|42032790|FG003|Overall Study|Lack of Efficacy|0|||
19584320|NCT00932373|42032791|FG004|Overall Study|Lack of Efficacy|0|||
19584321|NCT00932373|42032792|FG005|Overall Study|Lack of Efficacy|0|||
19584322|NCT00932373|42032793|FG006|Overall Study|Lack of Efficacy|0|||
19584323|NCT00932373|42032794|FG007|Overall Study|Lack of Efficacy|0|||
19584324|NCT00932373|42032795|FG008|Overall Study|Lack of Efficacy|0|||
19584325|NCT00932373|42032796|FG009|Overall Study|Lack of Efficacy|1|||
19584326|NCT00932373|42032797|FG010|Overall Study|Lack of Efficacy|0|||
19584327|NCT01055496|42032831|FG000|Overall Study|Withdrawal by Subject|2|||
19584328|NCT01055496|42032832|FG001|Overall Study|Withdrawal by Subject|4|||
19584329|NCT01055496|42032831|FG000|Overall Study|Death|13|||
19584330|NCT01055496|42032832|FG001|Overall Study|Death|23|||
19584331|NCT01055496|42032831|FG000|Overall Study|Lost to Follow-up|0|||
19584332|NCT01055496|42032832|FG001|Overall Study|Lost to Follow-up|2|||
19584333|NCT01055496|42032831|FG000|Overall Study|Other - Unspecified|0|||
19584334|NCT01055496|42032832|FG001|Overall Study|Other - Unspecified|1|||
19584335|NCT01055262|42032859|FG000|Overall Study|Adverse Event|5|||
19584336|NCT01055262|42032859|FG000|Overall Study|Protocol Violation|3|||
19584337|NCT01055262|42032859|FG000|Overall Study|Uncooperativeness|1|||
19584338|NCT01052844|42032865|FG000|Overall Study|Adverse Event|0|||
19584339|NCT01052844|42032866|FG001|Overall Study|Adverse Event|1|||
19584340|NCT01049412|42032874|FG000|Period I|Withdrawal by Subject|4|||
19584341|NCT01049412|42032875|FG001|Period I|Withdrawal by Subject|6|||
19584342|NCT01049412|42032874|FG000|Period I|Lost to Follow-up|2|||
19584343|NCT01049412|42032875|FG001|Period I|Lost to Follow-up|2|||
19584344|NCT01049412|42032874|FG000|Period I|Physician Decision|0|||
19584345|NCT01049412|42032875|FG001|Period I|Physician Decision|3|||
19584346|NCT01049412|42032874|FG000|Period I|Protocol Violation|1|||
19584347|NCT01049412|42032875|FG001|Period I|Protocol Violation|2|||
19584348|NCT01049412|42032874|FG000|Period I|Adverse Event|1|||
19584349|NCT01049412|42032875|FG001|Period I|Adverse Event|0|||
19584350|NCT01049412|42032874|FG000|Period II|Withdrawal by Subject|2|||
19584351|NCT01049412|42032875|FG001|Period II|Withdrawal by Subject|3|||
19584352|NCT01049412|42032874|FG000|Period II|Adverse Event|1|||
19584353|NCT01049412|42032875|FG001|Period II|Adverse Event|0|||
19584354|NCT01049412|42032874|FG000|Period II|Lost to Follow-up|1|||
19584355|NCT01049412|42032875|FG001|Period II|Lost to Follow-up|0|||
19584356|NCT00934089|42032885|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
19584357|NCT00934089|42032886|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
19584358|NCT00934089|42032885|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
19584359|NCT00934089|42032886|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
19584360|NCT01032174|42032894|FG000|Overall Study|Adverse Event|0|||
19584361|NCT01032174|42032895|FG001|Overall Study|Adverse Event|1|||
19584362|NCT00933933|42032906|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
19584363|NCT00933933|42032907|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
19584364|NCT00933933|42032908|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
19584365|NCT00933933|42032906|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
19584366|NCT00933933|42032907|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
19584367|NCT00933933|42032908|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
19584368|NCT01032018|42032926|FG000|Overall Study|Lost to Follow-up|6|||
19584369|NCT01032018|42032927|FG001|Overall Study|Lost to Follow-up|5|||
19584370|NCT01032018|42032926|FG000|Overall Study|Death|0|||
19584371|NCT01032018|42032927|FG001|Overall Study|Death|1|||
19584372|NCT01031706|42032935|FG000|Overall Study|Adverse Event|1|||
19584373|NCT01031706|42032936|FG001|Overall Study|Adverse Event|0|||
19584374|NCT01031706|42032935|FG000|Overall Study|Withdrawal by Subject|1|||
19584375|NCT01031706|42032936|FG001|Overall Study|Withdrawal by Subject|1|||
19584376|NCT00927069|42032944|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
19584377|NCT00927069|42032945|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
19584378|NCT00927069|42032946|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
19584379|NCT00927069|42032947|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
19584380|NCT00927069|42032944|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
19584381|NCT00927069|42032945|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
19584382|NCT00927069|42032946|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
19584383|NCT00927069|42032947|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
19584384|NCT00927069|42032944|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
19584385|NCT00927069|42032945|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
19584386|NCT00927069|42032946|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
19584387|NCT00927069|42032947|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
19584388|NCT00927069|42032944|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
19584389|NCT00927069|42032945|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
19584390|NCT00927069|42032946|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
19584391|NCT00927069|42032947|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
19584392|NCT00927069|42032944|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
19584393|NCT00927069|42032945|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
19584394|NCT00927069|42032946|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
19584395|NCT00927069|42032947|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
19584396|NCT01031628|42032961|FG000|Overall Study|Study terminated early|0|||
19584397|NCT01031628|42032962|FG001|Overall Study|Study terminated early|1|||
19584398|NCT01031628|42032963|FG002|Overall Study|Study terminated early|3|||
19584399|NCT01031628|42032964|FG003|Overall Study|Study terminated early|0|||
19584400|NCT01031004|42032976|FG000|Overall Study|Protocol Violation|0|||
19584401|NCT01031004|42032977|FG001|Overall Study|Protocol Violation|1|||
19584402|NCT01031004|42032976|FG000|Overall Study|Lost to Follow-up|1|||
19584403|NCT01031004|42032977|FG001|Overall Study|Lost to Follow-up|0|||
19584404|NCT00931515|42032985|FG000|Overall Study|Lost to Follow-up|2|||
19584405|NCT00931515|42032986|FG001|Overall Study|Lost to Follow-up|5|||
19584406|NCT01029366|42032994|FG000|Overall Study|Withdrawal by Subject|1|||
19584407|NCT01029366|42032995|FG001|Overall Study|Withdrawal by Subject|0|||
19584408|NCT01029366|42032994|FG000|Overall Study|Death|1|||
19584409|NCT01029366|42032995|FG001|Overall Study|Death|1|||
19584410|NCT01029366|42032994|FG000|Overall Study|disease progression|2|||
19584411|NCT01029366|42032995|FG001|Overall Study|disease progression|0|||
19584412|NCT01029366|42032994|FG000|Overall Study|manufacturing failure|0|||
19584413|NCT01029366|42032995|FG001|Overall Study|manufacturing failure|1|||
19584414|NCT01028352|42033002|FG000|Overall Study|Ineligible due to baseline average pain|5|||
19584415|NCT01028352|42033002|FG000|Overall Study|Withdrawal by Subject|1|||
19584416|NCT00929643|42033019|FG000|Overall Study|Protocol Violation|2|||
19584417|NCT00926367|42033025|FG000|Overall Study|Withdrawal by Subject|0|||
19584418|NCT00926367|42033026|FG001|Overall Study|Withdrawal by Subject|1|||
19584419|NCT00926367|42033025|FG000|Overall Study|Lost to Follow-up|1|||
19584420|NCT00926367|42033026|FG001|Overall Study|Lost to Follow-up|0|||
19584421|NCT00926367|42033025|FG000|Overall Study|Skin Irritation|1|||
19584422|NCT00926367|42033026|FG001|Overall Study|Skin Irritation|2|||
19584423|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
19584424|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
19584425|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
19584426|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
19584427|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
19584428|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
19584429|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
19584430|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
19584431|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
19584432|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
19584433|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
19584434|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
19584435|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
19584436|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
19584437|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
19584438|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
19584439|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
19584440|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
19584441|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
19584442|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
19584443|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
19584444|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
19584445|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
19584446|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
19584447|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Death|2|||
19584448|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Death|1|||
19584449|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Death|2|||
19584450|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Graft loss|0|||
19584451|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Graft loss|2|||
19584452|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Graft loss|0|||
19584453|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
19584454|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
19584455|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
19584456|NCT01114529|42033037|FG000|Completed Study Medication at Month 24|Missing|2|||
19584457|NCT01114529|42033038|FG001|Completed Study Medication at Month 24|Missing|0|||
19584458|NCT01114529|42033039|FG002|Completed Study Medication at Month 24|Missing|0|||
19745938|NCT03529773|42193184|FG028|Overall Study|Other|0|||
19584459|NCT01114529|42033037|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
19584460|NCT01114529|42033038|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
19584461|NCT01114529|42033039|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
19584462|NCT01114529|42033037|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
19584463|NCT01114529|42033038|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
19584464|NCT01114529|42033039|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
19584465|NCT01114529|42033037|FG000|Completed Study Phase at Month 24|Death|8|||
19584466|NCT01114529|42033038|FG001|Completed Study Phase at Month 24|Death|5|||
19584467|NCT01114529|42033039|FG002|Completed Study Phase at Month 24|Death|4|||
19584468|NCT01114529|42033037|FG000|Completed Study Phase at Month 24|Other|2|||
19584469|NCT01114529|42033038|FG001|Completed Study Phase at Month 24|Other|0|||
19584470|NCT01114529|42033039|FG002|Completed Study Phase at Month 24|Other|0|||
19584471|NCT01114529|42033037|FG000|Completed Study Phase at Month 24|Missing|2|||
19584472|NCT01114529|42033038|FG001|Completed Study Phase at Month 24|Missing|0|||
19584473|NCT01114529|42033039|FG002|Completed Study Phase at Month 24|Missing|0|||
19584474|NCT00926289|42033051|FG000|Overall Study|Adverse Event|9|||
19584475|NCT00926289|42033052|FG001|Overall Study|Adverse Event|11|||
19584476|NCT00926289|42033051|FG000|Overall Study|Protocol Violation|8|||
19584477|NCT00926289|42033052|FG001|Overall Study|Protocol Violation|12|||
19584478|NCT00926289|42033051|FG000|Overall Study|Lost to Follow-up|3|||
19584479|NCT00926289|42033052|FG001|Overall Study|Lost to Follow-up|6|||
19584480|NCT00926289|42033051|FG000|Overall Study|Withdrawal by Subject|4|||
19584481|NCT00926289|42033052|FG001|Overall Study|Withdrawal by Subject|4|||
19584482|NCT00926289|42033051|FG000|Overall Study|Other|1|||
19584483|NCT00926289|42033052|FG001|Overall Study|Other|3|||
19584484|NCT03208036|42033077|FG000|Baseline Assessment|Withdrawal by Subject|1|||
19584485|NCT03208036|42033078|FG001|Baseline Assessment|Withdrawal by Subject|1|||
19584486|NCT03208036|42033077|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
19584487|NCT03208036|42033078|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
19584488|NCT03208036|42033077|FG000|Intervention|Withdrawal by Subject|3|||
19584489|NCT03208036|42033078|FG001|Intervention|Withdrawal by Subject|2|||
19584490|NCT03208036|42033077|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
19584491|NCT03208036|42033078|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
19584492|NCT00926211|42033084|FG000|Overall Study|Lost to Follow-up|1|||
19584493|NCT01114373|42033089|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
19584494|NCT01114373|42033090|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
19584495|NCT01114373|42033089|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
19584496|NCT01114373|42033090|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
19584497|NCT01114373|42033089|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
19584498|NCT01114373|42033090|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
19584499|NCT01114373|42033089|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
19584500|NCT01114373|42033090|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
19584501|NCT00925899|42033102|FG000|Part 1|Death|1|||
19584502|NCT00925899|42033103|FG001|Part 1|Death|2|||
19584503|NCT00925899|42033102|FG000|Part 1|Withdrawal by Subject|10|||
19584504|NCT00925899|42033103|FG001|Part 1|Withdrawal by Subject|9|||
19584505|NCT01114217|42033112|FG000|Overall Study|Adverse Event|5|||
19584506|NCT01114217|42033113|FG001|Overall Study|Adverse Event|3|||
19584507|NCT01114217|42033112|FG000|Overall Study|Lost to Follow-up|17|||
19584508|NCT01114217|42033113|FG001|Overall Study|Lost to Follow-up|33|||
19584509|NCT01114217|42033112|FG000|Overall Study|Withdrawal by Subject|21|||
19584510|NCT01114217|42033113|FG001|Overall Study|Withdrawal by Subject|28|||
19584511|NCT01114217|42033112|FG000|Overall Study|Other-Clerical Error|3|||
19584512|NCT01114217|42033113|FG001|Overall Study|Other-Clerical Error|0|||
19584513|NCT01114217|42033112|FG000|Overall Study|Other-Early termination|6|||
19584514|NCT01114217|42033113|FG001|Overall Study|Other-Early termination|10|||
19584515|NCT01114217|42033112|FG000|Overall Study|Other-Procedure|1|||
19584516|NCT01114217|42033113|FG001|Overall Study|Other-Procedure|1|||
19584517|NCT01114217|42033112|FG000|Overall Study|Other-Pregnancy|2|||
19584518|NCT01114217|42033113|FG001|Overall Study|Other-Pregnancy|4|||
19584519|NCT01114217|42033112|FG000|Overall Study|Other-Protocol Violation|1|||
19584520|NCT01114217|42033113|FG001|Overall Study|Other-Protocol Violation|3|||
19584521|NCT01114217|42033112|FG000|Overall Study|Other-Lack of Efficacy|1|||
19584522|NCT01114217|42033113|FG001|Overall Study|Other-Lack of Efficacy|0|||
19584523|NCT01114217|42033112|FG000|Overall Study|Other-Non Compliance|2|||
19584524|NCT01114217|42033113|FG001|Overall Study|Other-Non Compliance|0|||
19584525|NCT01114217|42033112|FG000|Overall Study|Other-Physician Decision|1|||
19584526|NCT01114217|42033113|FG001|Overall Study|Other-Physician Decision|1|||
19584527|NCT01114217|42033112|FG000|Overall Study|Other-Sponsor Decision|10|||
19584528|NCT01114217|42033113|FG001|Overall Study|Other-Sponsor Decision|12|||
19584529|NCT01114217|42033112|FG000|Overall Study|Other-Study Termination|0|||
19584530|NCT01114217|42033113|FG001|Overall Study|Other-Study Termination|1|||
19584531|NCT01114217|42033112|FG000|Overall Study|Other-Study Withdrawn|1|||
19745939|NCT03529773|42193185|FG029|Overall Study|Other|0|||
19745940|NCT03529773|42193186|FG030|Overall Study|Other|0|||
19584532|NCT01114217|42033113|FG001|Overall Study|Other-Study Withdrawn|1|||
19584533|NCT01114217|42033112|FG000|Overall Study|Other-Site Stopped Communicating|2|||
19584534|NCT01114217|42033113|FG001|Overall Study|Other-Site Stopped Communicating|0|||
19584535|NCT01114217|42033112|FG000|Overall Study|Other-Lost to Follow-up|1|||
19584536|NCT01114217|42033113|FG001|Overall Study|Other-Lost to Follow-up|0|||
19584537|NCT01114217|42033112|FG000|Overall Study|Other-Withdrawal by Subject|1|||
19584538|NCT01114217|42033113|FG001|Overall Study|Other-Withdrawal by Subject|1|||
19584539|NCT01030536|42033122|FG000|Overall Study|Withdrawal by Subject|0|||
19584540|NCT01030536|42033123|FG001|Overall Study|Withdrawal by Subject|0|||
19584541|NCT01030536|42033124|FG002|Overall Study|Withdrawal by Subject|1|||
19584542|NCT01030536|42033125|FG003|Overall Study|Withdrawal by Subject|0|||
19584543|NCT01030536|42033126|FG004|Overall Study|Withdrawal by Subject|0|||
19584544|NCT01030536|42033122|FG000|Overall Study|undefined|1|||
19584545|NCT01030536|42033123|FG001|Overall Study|undefined|0|||
19584546|NCT01030536|42033124|FG002|Overall Study|undefined|1|||
19584547|NCT01030536|42033125|FG003|Overall Study|undefined|1|||
19584548|NCT01030536|42033126|FG004|Overall Study|undefined|0|||
19584549|NCT01030536|42033122|FG000|Overall Study|Adverse Event|0|||
19584550|NCT01030536|42033123|FG001|Overall Study|Adverse Event|3|||
19584551|NCT01030536|42033124|FG002|Overall Study|Adverse Event|1|||
19584552|NCT01030536|42033125|FG003|Overall Study|Adverse Event|0|||
19584553|NCT01030536|42033126|FG004|Overall Study|Adverse Event|1|||
19584554|NCT01030536|42033122|FG000|Overall Study|Progressive disease|6|||
19584555|NCT01030536|42033123|FG001|Overall Study|Progressive disease|2|||
19584556|NCT01030536|42033124|FG002|Overall Study|Progressive disease|3|||
19584557|NCT01030536|42033125|FG003|Overall Study|Progressive disease|2|||
19584558|NCT01030536|42033126|FG004|Overall Study|Progressive disease|0|||
19584559|NCT01030536|42033122|FG000|Overall Study|Death|0|||
19584560|NCT01030536|42033123|FG001|Overall Study|Death|1|||
19584561|NCT01030536|42033124|FG002|Overall Study|Death|0|||
19584562|NCT01030536|42033125|FG003|Overall Study|Death|0|||
19584563|NCT01030536|42033126|FG004|Overall Study|Death|0|||
19584564|NCT01030458|42033144|FG000|Overall Study|Lost to Follow-up|9|||
19584565|NCT01030458|42033145|FG001|Overall Study|Lost to Follow-up|10|||
19584566|NCT01030458|42033144|FG000|Overall Study|Withdrawal by Subject|2|||
19584567|NCT01030458|42033145|FG001|Overall Study|Withdrawal by Subject|3|||
19584568|NCT01030458|42033144|FG000|Overall Study|Logistical reasons|9|||
19584569|NCT01030458|42033145|FG001|Overall Study|Logistical reasons|5|||
19584570|NCT01030458|42033144|FG000|Overall Study|Moved or changed job|6|||
19584571|NCT01030458|42033145|FG001|Overall Study|Moved or changed job|13|||
19584572|NCT01030458|42033144|FG000|Overall Study|Side effect of medication|1|||
19584573|NCT01030458|42033145|FG001|Overall Study|Side effect of medication|1|||
19584574|NCT00930969|42033151|FG000|Overall Study|Death|5|||
19584575|NCT00930969|42033151|FG000|Overall Study|Lost to Follow-up|1|||
19584576|NCT00930969|42033151|FG000|Overall Study|Physician Decision|13|||
19584577|NCT00930969|42033151|FG000|Overall Study|Withdrawal by Subject|19|||
19584578|NCT01114139|42033157|FG000|Overall Study|Adverse Event|3|||
19584579|NCT01114139|42033158|FG001|Overall Study|Adverse Event|2|||
19584580|NCT01114139|42033157|FG000|Overall Study|Lost to Follow-up|15|||
19584581|NCT01114139|42033158|FG001|Overall Study|Lost to Follow-up|3|||
19584582|NCT01114139|42033157|FG000|Overall Study|Withdrawal by Subject|17|||
19584583|NCT01114139|42033158|FG001|Overall Study|Withdrawal by Subject|6|||
19584584|NCT01114139|42033157|FG000|Overall Study|Other-Missed 1 visit|1|||
19584585|NCT01114139|42033158|FG001|Overall Study|Other-Missed 1 visit|0|||
19584586|NCT01114139|42033157|FG000|Overall Study|Other-Protocol Violation|1|||
19584587|NCT01114139|42033158|FG001|Overall Study|Other-Protocol Violation|0|||
19584588|NCT01114139|42033157|FG000|Overall Study|Other-Out of window for study drug dose|1|||
19584589|NCT01114139|42033158|FG001|Overall Study|Other-Out of window for study drug dose|0|||
19584590|NCT01114139|42033157|FG000|Overall Study|Other-Participant falsified records|0|||
19584591|NCT01114139|42033158|FG001|Overall Study|Other-Participant falsified records|1|||
19584592|NCT01114139|42033157|FG000|Overall Study|Other-Participant went on hospice|0|||
19584593|NCT01114139|42033158|FG001|Overall Study|Other-Participant went on hospice|1|||
19584594|NCT01114139|42033157|FG000|Overall Study|Other-Physician changed treatment|1|||
19584595|NCT01114139|42033158|FG001|Overall Study|Other-Physician changed treatment|0|||
19584596|NCT01114139|42033157|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
19584597|NCT01114139|42033158|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
19584598|NCT01027884|42033166|FG000|Overall Study|Adverse Event|2|||
19584599|NCT01027884|42033167|FG001|Overall Study|Adverse Event|1|||
19584600|NCT01027884|42033166|FG000|Overall Study|Protocol Violation|1|||
19584601|NCT01027884|42033167|FG001|Overall Study|Protocol Violation|0|||
19584602|NCT01027884|42033166|FG000|Overall Study|Non-compliance|1|||
19584603|NCT01027884|42033167|FG001|Overall Study|Non-compliance|1|||
19584604|NCT01027884|42033166|FG000|Overall Study|Withdrawal by Subject|0|||
19584605|NCT01027884|42033167|FG001|Overall Study|Withdrawal by Subject|1|||
19584606|NCT01027884|42033166|FG000|Overall Study|Lost to Follow-up|0|||
19584607|NCT01027884|42033167|FG001|Overall Study|Lost to Follow-up|1|||
19584608|NCT01027884|42033166|FG000|Overall Study|Spinal fixation surgery|0|||
19584609|NCT01027884|42033167|FG001|Overall Study|Spinal fixation surgery|3|||
19584610|NCT03387514|42033175|FG000|Overall Study|Withdrawal by Subject|2|||
19584611|NCT03387514|42033175|FG000|Overall Study|Physician Decision|1|||
19584612|NCT03387514|42033175|FG000|Overall Study|Lost to Follow-up|2|||
19584613|NCT01113749|42033190|FG000|Overall Study|Lost to Follow-up|1|||
19584614|NCT01113749|42033191|FG001|Overall Study|Lost to Follow-up|2|||
19584615|NCT01022580|42033199|FG000|Overall Study|Death|18|||
19584616|NCT01022580|42033200|FG001|Overall Study|Death|22|||
19584617|NCT01107353|42033214|FG000|Overall Study|Positive Drug Screen|1|||
19584618|NCT01107353|42033215|FG001|Overall Study|Positive Drug Screen|0|||
19584619|NCT01107197|42033223|FG000|Overall Study|Death|12|||
19584620|NCT01107197|42033224|FG001|Overall Study|Death|10|||
19584621|NCT01107197|42033223|FG000|Overall Study|Lost to Follow-up|5|||
19584622|NCT01107197|42033224|FG001|Overall Study|Lost to Follow-up|8|||
19584623|NCT01107197|42033223|FG000|Overall Study|Withdrawal by Subject|3|||
19584624|NCT01107197|42033224|FG001|Overall Study|Withdrawal by Subject|5|||
19584625|NCT01112579|42033241|FG000|Overall Study|Missed Visit|1|||
19584626|NCT01112579|42033242|FG001|Overall Study|Missed Visit|1|||
19584627|NCT01112579|42033241|FG000|Overall Study|Death|0|||
19584628|NCT01112579|42033242|FG001|Overall Study|Death|2|||
19584629|NCT01112267|42033250|FG000|Overall Study|Adverse Event|24|||
19584630|NCT01112267|42033251|FG001|Overall Study|Adverse Event|6|||
19584631|NCT01112267|42033250|FG000|Overall Study|Withdrawal by Subject|3|||
19584632|NCT01112267|42033251|FG001|Overall Study|Withdrawal by Subject|5|||
19584633|NCT01112267|42033250|FG000|Overall Study|Protocol Violation|5|||
19584634|NCT01112267|42033251|FG001|Overall Study|Protocol Violation|3|||
19584635|NCT01112267|42033250|FG000|Overall Study|Participants not compliant|1|||
19584636|NCT01112267|42033251|FG001|Overall Study|Participants not compliant|2|||
19584637|NCT01112267|42033250|FG000|Overall Study|Participants not receive any study drug|1|||
19584638|NCT01112267|42033251|FG001|Overall Study|Participants not receive any study drug|2|||
19584639|NCT00925587|42033259|FG000|Overall Study|Protocol Specified Criteria|6|||
19584640|NCT00925587|42033260|FG001|Overall Study|Protocol Specified Criteria|6|||
19584641|NCT00925587|42033259|FG000|Overall Study|Physician Decision|4|||
19584642|NCT00925587|42033260|FG001|Overall Study|Physician Decision|1|||
19584643|NCT00925587|42033259|FG000|Overall Study|Protocol Violation|6|||
19584644|NCT00925587|42033260|FG001|Overall Study|Protocol Violation|4|||
19584645|NCT00925587|42033259|FG000|Overall Study|Withdrawal by Subject|9|||
19584646|NCT00925587|42033260|FG001|Overall Study|Withdrawal by Subject|6|||
19584647|NCT00925587|42033259|FG000|Overall Study|Death|5|||
19584648|NCT00925587|42033260|FG001|Overall Study|Death|5|||
19584649|NCT00925587|42033259|FG000|Overall Study|Adverse Event|6|||
19584650|NCT00925587|42033260|FG001|Overall Study|Adverse Event|2|||
19584651|NCT00925587|42033259|FG000|Overall Study|Lost to Follow-up|0|||
19584652|NCT00925587|42033260|FG001|Overall Study|Lost to Follow-up|1|||
19584653|NCT00928707|42033272|FG000|Overall Study|Protocol Violation|1|||
19584654|NCT00928707|42033273|FG001|Overall Study|Protocol Violation|0|||
19584655|NCT00930813|42033281|FG000|Overall Study|Death|4|||
19584656|NCT00930813|42033282|FG001|Overall Study|Death|5|||
19584657|NCT00930813|42033281|FG000|Overall Study|Withdrawal by Subject|2|||
19584658|NCT00930813|42033282|FG001|Overall Study|Withdrawal by Subject|5|||
19584659|NCT00930813|42033281|FG000|Overall Study|Lost to Follow-up|2|||
19584660|NCT00930813|42033282|FG001|Overall Study|Lost to Follow-up|4|||
19584661|NCT00930579|42033290|FG000|Overall Study|Withdrawal by Subject|1|||
19584662|NCT00930579|42033290|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
19584663|NCT03367156|42033296|FG000|Overall Study|Lack of interest|3|||
19584664|NCT03367156|42033297|FG001|Overall Study|Lack of interest|1|||
19584665|NCT03367156|42033296|FG000|Overall Study|Death|2|||
19584666|NCT03367156|42033297|FG001|Overall Study|Death|0|||
19584667|NCT03367156|42033296|FG000|Overall Study|Lost to Follow-up|2|||
19584668|NCT03367156|42033297|FG001|Overall Study|Lost to Follow-up|1|||
19584669|NCT03367156|42033296|FG000|Overall Study|Became ineligible|1|||
19584670|NCT03367156|42033297|FG001|Overall Study|Became ineligible|2|||
19584671|NCT03367156|42033296|FG000|Overall Study|Hospitalization|1|||
19584672|NCT03367156|42033297|FG001|Overall Study|Hospitalization|0|||
19584673|NCT03367156|42033296|FG000|Overall Study|Concerned about Treatment|11|||
19584674|NCT03367156|42033297|FG001|Overall Study|Concerned about Treatment|3|||
19584675|NCT03367156|42033296|FG000|Overall Study|Started new treatment|4|||
19584676|NCT03367156|42033297|FG001|Overall Study|Started new treatment|1|||
19584677|NCT00925353|42033305|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
19584678|NCT01106651|42033329|FG000|Overall Study|Adverse Event|17|||
19584679|NCT01106651|42033330|FG001|Overall Study|Adverse Event|9|||
19387935|NCT02039908|41631251|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
19584680|NCT01106651|42033331|FG002|Overall Study|Adverse Event|23|||
19584681|NCT01106651|42033329|FG000|Overall Study|Lost to Follow-up|8|||
19584682|NCT01106651|42033330|FG001|Overall Study|Lost to Follow-up|2|||
19584683|NCT01106651|42033331|FG002|Overall Study|Lost to Follow-up|6|||
19584684|NCT01106651|42033329|FG000|Overall Study|Physician Decision|4|||
19584685|NCT01106651|42033330|FG001|Overall Study|Physician Decision|3|||
19584686|NCT01106651|42033331|FG002|Overall Study|Physician Decision|1|||
19584687|NCT01106651|42033329|FG000|Overall Study|Protocol Violation|1|||
19584688|NCT01106651|42033330|FG001|Overall Study|Protocol Violation|2|||
19584689|NCT01106651|42033331|FG002|Overall Study|Protocol Violation|1|||
19584690|NCT01106651|42033329|FG000|Overall Study|Withdrawal by Subject|14|||
19584691|NCT01106651|42033330|FG001|Overall Study|Withdrawal by Subject|7|||
19584692|NCT01106651|42033331|FG002|Overall Study|Withdrawal by Subject|4|||
19584693|NCT01106651|42033329|FG000|Overall Study|Noncompliance with study drug|1|||
19584694|NCT01106651|42033330|FG001|Overall Study|Noncompliance with study drug|0|||
19584695|NCT01106651|42033331|FG002|Overall Study|Noncompliance with study drug|2|||
19584696|NCT01106651|42033329|FG000|Overall Study|Other|34|||
19584697|NCT01106651|42033330|FG001|Overall Study|Other|31|||
19584698|NCT01106651|42033331|FG002|Overall Study|Other|21|||
19584699|NCT01106651|42033329|FG000|Overall Study|Death|0|||
19584700|NCT01106651|42033330|FG001|Overall Study|Death|3|||
19584701|NCT01106651|42033331|FG002|Overall Study|Death|0|||
19584702|NCT01027650|42033350|FG000|Overall Study|Personal Reasons|0|||
19584703|NCT01027650|42033351|FG001|Overall Study|Personal Reasons|0|||
19584704|NCT01027650|42033352|FG002|Overall Study|Personal Reasons|0|||
19584705|NCT01027650|42033353|FG003|Overall Study|Personal Reasons|0|||
19584706|NCT01027650|42033354|FG004|Overall Study|Personal Reasons|2|||
19584707|NCT01027650|42033355|FG005|Overall Study|Personal Reasons|1|||
19584708|NCT01027650|42033356|FG006|Overall Study|Personal Reasons|0|||
19584709|NCT01027650|42033357|FG007|Overall Study|Personal Reasons|0|||
19584710|NCT01027650|42033350|FG000|Overall Study|Lost to Follow-up|0|||
19584711|NCT01027650|42033351|FG001|Overall Study|Lost to Follow-up|0|||
19584712|NCT01027650|42033352|FG002|Overall Study|Lost to Follow-up|0|||
19584713|NCT01027650|42033353|FG003|Overall Study|Lost to Follow-up|0|||
19584714|NCT01027650|42033354|FG004|Overall Study|Lost to Follow-up|0|||
19584715|NCT01027650|42033355|FG005|Overall Study|Lost to Follow-up|0|||
19584716|NCT01027650|42033356|FG006|Overall Study|Lost to Follow-up|1|||
19584717|NCT01027650|42033357|FG007|Overall Study|Lost to Follow-up|0|||
19584718|NCT01027650|42033350|FG000|Overall Study|Lack of Efficacy|0|||
19584719|NCT01027650|42033351|FG001|Overall Study|Lack of Efficacy|0|||
19584720|NCT01027650|42033352|FG002|Overall Study|Lack of Efficacy|0|||
19584721|NCT01027650|42033353|FG003|Overall Study|Lack of Efficacy|0|||
19584722|NCT01027650|42033354|FG004|Overall Study|Lack of Efficacy|0|||
19584723|NCT01027650|42033355|FG005|Overall Study|Lack of Efficacy|1|||
19584724|NCT01027650|42033356|FG006|Overall Study|Lack of Efficacy|0|||
19584725|NCT01027650|42033357|FG007|Overall Study|Lack of Efficacy|0|||
19584726|NCT01106027|42033375|FG000|Overall Study|Lost graft early, discontinued|1|||
19584727|NCT00927927|42033394|FG000|Overall Study|Withdrawal by Subject|0|||
19584728|NCT00927927|42033395|FG001|Overall Study|Withdrawal by Subject|0|||
19584729|NCT00927927|42033396|FG002|Overall Study|Withdrawal by Subject|0|||
19584730|NCT00927927|42033397|FG003|Overall Study|Withdrawal by Subject|0|||
19584731|NCT00927927|42033398|FG004|Overall Study|Withdrawal by Subject|0|||
19584732|NCT00927927|42033399|FG005|Overall Study|Withdrawal by Subject|0|||
19584733|NCT00927927|42033400|FG006|Overall Study|Withdrawal by Subject|0|||
19584734|NCT00927927|42033401|FG007|Overall Study|Withdrawal by Subject|2|||
19584735|NCT00927927|42033402|FG008|Overall Study|Withdrawal by Subject|0|||
19584736|NCT00927927|42033403|FG009|Overall Study|Withdrawal by Subject|0|||
19584737|NCT00927927|42033404|FG010|Overall Study|Withdrawal by Subject|0|||
19584738|NCT00927927|42033405|FG011|Overall Study|Withdrawal by Subject|2|||
19584739|NCT00927927|42033406|FG012|Overall Study|Withdrawal by Subject|0|||
19584740|NCT00927927|42033407|FG013|Overall Study|Withdrawal by Subject|0|||
19584741|NCT00927927|42033408|FG014|Overall Study|Withdrawal by Subject|0|||
19584742|NCT01027416|42033442|FG000|Overall Study|Withdrawal by Subject|0|||
19584743|NCT01027416|42033443|FG001|Overall Study|Withdrawal by Subject|1|||
19584744|NCT01027416|42033442|FG000|Overall Study|Physician Decision|1|||
19584745|NCT01027416|42033443|FG001|Overall Study|Physician Decision|4|||
19584746|NCT00923559|42033451|FG000|Overall Study|Lost to Follow-up|2|||
19584747|NCT00923559|42033452|FG001|Overall Study|Lost to Follow-up|3|||
19584748|NCT01015638|42033462|FG000|Overall Study|Withdrawal by Subject|1|||
19584749|NCT01015638|42033463|FG001|Overall Study|Withdrawal by Subject|0|||
19584750|NCT01022502|42033469|FG000|Overall Study|Adverse Event|1|||
19584751|NCT01022502|42033469|FG000|Overall Study|employment related reasons|1|||
19584752|NCT01022502|42033469|FG000|Overall Study|Withdrawal by Subject|1|||
19584753|NCT01105091|42033477|FG000|Overall Study|Death|2|||
19584754|NCT01105091|42033478|FG001|Overall Study|Death|0|||
19584755|NCT00924729|42033488|FG000|Overall Study|insufficient volume for analysis|1|||
19584756|NCT00924729|42033489|FG001|Overall Study|insufficient volume for analysis|0|||
19584757|NCT00924729|42033488|FG000|Overall Study|Protocol Violation|1|||
19584758|NCT00924729|42033489|FG001|Overall Study|Protocol Violation|0|||
19584759|NCT01099709|42033497|FG000|Period 1|Withdrawal by Subject|0|||
19584760|NCT01099709|42033498|FG001|Period 1|Withdrawal by Subject|1|||
19584761|NCT01099709|42033497|FG000|Period 1|Positive cotinine test|0|||
19584762|NCT01099709|42033498|FG001|Period 1|Positive cotinine test|1|||
19584763|NCT01099709|42033497|FG000|Period 1|Adverse Event|1|||
19584764|NCT01099709|42033498|FG001|Period 1|Adverse Event|0|||
19584765|NCT01099397|42033505|FG000|Overall Study|Lost to Follow-up|4|||
19584766|NCT01099397|42033505|FG000|Overall Study|Protocol Violation|4|||
19584767|NCT01099397|42033505|FG000|Overall Study|Withdrawal by Subject|5|||
19584768|NCT01022424|42033510|FG000|Overall Study|Adverse Event|1|||
19584769|NCT01022424|42033510|FG000|Overall Study|Physician Decision|1|||
19584770|NCT01022424|42033510|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
19584771|NCT01098851|42033520|FG000|Overall Study|Equipment failure|1|||
19584772|NCT01098851|42033521|FG001|Overall Study|Equipment failure|0|||
19584773|NCT01026948|42033527|FG000|Overall Study|Physician Decision|8|||
19584774|NCT01104779|42033535|FG000|Overall Study|Protocol Violation|1|||
19584775|NCT01104779|42033536|FG001|Overall Study|Protocol Violation|2|||
19584776|NCT01104779|42033537|FG002|Overall Study|Protocol Violation|2|||
19584777|NCT01104779|42033535|FG000|Overall Study|Lack of Efficacy|26|||
19584778|NCT01104779|42033536|FG001|Overall Study|Lack of Efficacy|12|||
19584779|NCT01104779|42033537|FG002|Overall Study|Lack of Efficacy|13|||
19584780|NCT01104779|42033535|FG000|Overall Study|Adverse Event|13|||
19584781|NCT01104779|42033536|FG001|Overall Study|Adverse Event|14|||
19584782|NCT01104779|42033537|FG002|Overall Study|Adverse Event|13|||
19584783|NCT01104779|42033535|FG000|Overall Study|Did not meet inc/exc criteria|1|||
19584784|NCT01104779|42033536|FG001|Overall Study|Did not meet inc/exc criteria|1|||
19584785|NCT01104779|42033537|FG002|Overall Study|Did not meet inc/exc criteria|1|||
19584786|NCT01104779|42033535|FG000|Overall Study|Other reasons|0|||
19584787|NCT01104779|42033536|FG001|Overall Study|Other reasons|1|||
19584788|NCT01104779|42033537|FG002|Overall Study|Other reasons|0|||
19584789|NCT01104779|42033535|FG000|Overall Study|Lost to Follow-up|2|||
19584790|NCT01104779|42033536|FG001|Overall Study|Lost to Follow-up|0|||
19584791|NCT01104779|42033537|FG002|Overall Study|Lost to Follow-up|1|||
19584792|NCT01104779|42033535|FG000|Overall Study|Withdrawal by Subject|16|||
19584793|NCT01104779|42033536|FG001|Overall Study|Withdrawal by Subject|25|||
19584794|NCT01104779|42033537|FG002|Overall Study|Withdrawal by Subject|32|||
19584795|NCT00918957|42033547|FG000|Overall Study|Adverse Event|2|||
19584796|NCT00918957|42033548|FG001|Overall Study|Adverse Event|0|||
19584797|NCT00918957|42033547|FG000|Overall Study|Withdrawal by Subject|1|||
19584798|NCT00918957|42033548|FG001|Overall Study|Withdrawal by Subject|0|||
19584799|NCT01022268|42033556|FG000|Overall Study|Withdrawal by Subject|1|||
19584800|NCT01022268|42033557|FG001|Overall Study|Withdrawal by Subject|0|||
19584801|NCT01022268|42033556|FG000|Overall Study|Withdrawal by Subject|1|||
19584802|NCT01022268|42033557|FG001|Overall Study|Withdrawal by Subject|0|||
19584803|NCT01015560|42033563|FG000|Overall Study|Adverse Event|1|||
19584804|NCT01015560|42033563|FG000|Overall Study|Not protocol specified|1|||
19584805|NCT01015560|42033563|FG000|Overall Study|Withdrawal by Subject|1|||
19584806|NCT00918879|42033569|FG000|Overall Study|Withdrawal by Subject|4|||
19584807|NCT00918879|42033570|FG001|Overall Study|Withdrawal by Subject|4|||
19584808|NCT00918879|42033569|FG000|Overall Study|Lost to Follow-up|1|||
19584809|NCT00918879|42033570|FG001|Overall Study|Lost to Follow-up|1|||
19584810|NCT00918879|42033569|FG000|Overall Study|Severe non-compliance to protocol|1|||
19584811|NCT00918879|42033570|FG001|Overall Study|Severe non-compliance to protocol|1|||
19584812|NCT01026792|42033576|FG000|Overall Study|Protocol Violation|1|||
19584813|NCT01026324|42033583|FG000|Follow up/Survival|Withdrawal by Subject|1|||
19584814|NCT01026324|42033584|FG001|Follow up/Survival|Withdrawal by Subject|0|||
19584815|NCT01026324|42033585|FG002|Follow up/Survival|Withdrawal by Subject|0|||
19584816|NCT01098539|42033596|FG000|Overall Study|Adverse Event|26|||
19584817|NCT01098539|42033597|FG001|Overall Study|Adverse Event|26|||
19584818|NCT01098539|42033596|FG000|Overall Study|Protocol Violation|1|||
19584819|NCT01098539|42033597|FG001|Overall Study|Protocol Violation|4|||
19584820|NCT01098539|42033596|FG000|Overall Study|Noncompliance|3|||
19584821|NCT01098539|42033597|FG001|Overall Study|Noncompliance|5|||
19584822|NCT01098539|42033596|FG000|Overall Study|Lost to Follow-up|4|||
19584823|NCT01098539|42033597|FG001|Overall Study|Lost to Follow-up|4|||
19584824|NCT01098539|42033596|FG000|Overall Study|Withdrawal by Subject|12|||
19584825|NCT01098539|42033597|FG001|Overall Study|Withdrawal by Subject|26|||
19584826|NCT01098539|42033596|FG000|Overall Study|Physician Decision|5|||
19584827|NCT01098539|42033597|FG001|Overall Study|Physician Decision|3|||
19584828|NCT01098461|42033607|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
19584829|NCT01098461|42033608|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
19584830|NCT01098461|42033609|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
19584831|NCT01098461|42033610|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
19584832|NCT01098461|42033607|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
19584833|NCT01098461|42033608|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
19584834|NCT01098461|42033609|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
19584835|NCT01098461|42033610|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
19584836|NCT01098461|42033607|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
19584837|NCT01098461|42033608|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
19584838|NCT01098461|42033609|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
19584839|NCT01098461|42033610|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
19584840|NCT01098461|42033607|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
19584841|NCT01098461|42033608|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
19584842|NCT01098461|42033609|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
19584843|NCT01098461|42033610|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
19584844|NCT01098461|42033607|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
19584845|NCT01098461|42033608|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
19584846|NCT01098461|42033609|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
19584847|NCT01098461|42033610|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
19584848|NCT01098461|42033607|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
19584849|NCT01098461|42033608|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
19584850|NCT01098461|42033609|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
19584851|NCT01098461|42033610|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
19584852|NCT01098461|42033607|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
19584853|NCT01098461|42033608|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
19584854|NCT01098461|42033609|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
19584855|NCT01098461|42033610|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
19584856|NCT01098305|42033623|FG000|Overall Study|Lost to Follow-up|31|||
19584857|NCT01098305|42033624|FG001|Overall Study|Lost to Follow-up|33|||
19584858|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
19584859|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
19584860|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
19584861|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
19584862|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
19584863|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
19584864|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
19584865|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
19584866|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
19584867|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
19584868|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584869|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584870|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
19584871|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
19584872|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
19584873|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
19584874|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
19584875|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
19584876|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
19584877|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
19584878|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
19584879|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
19584880|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
19584881|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
19584882|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
19584883|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584884|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
19584885|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584886|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19387936|NCT02039908|41631252|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
19584887|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584888|NCT00833833|42033636|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
19584889|NCT00833833|42033637|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
19584890|NCT00833833|42033638|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
19584891|NCT00833833|42033639|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
19584892|NCT00833833|42033640|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
19584893|NCT00833833|42033641|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
19584894|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
19584895|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
19584896|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
19584897|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
19584898|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
19584899|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
19584900|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
19584901|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
19584902|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
19584903|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
19584904|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
19584905|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
19584906|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
19584907|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
19584908|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
19584909|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
19584910|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
19584911|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
19584912|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584913|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584914|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584915|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
19584916|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
19584917|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
19584918|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584919|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584920|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584921|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
19584922|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
19584923|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
19584924|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
19584925|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
19584926|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
19584927|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
19584928|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
19584929|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
19584930|NCT00833833|42033636|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
19584931|NCT00833833|42033637|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
19584932|NCT00833833|42033638|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
19584933|NCT00833833|42033639|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
19584934|NCT00833833|42033640|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
19584935|NCT00833833|42033641|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
19584936|NCT01098071|42033661|FG000|Overall Study|Surgery (adenoidectomy)|2|||
19584937|NCT01098071|42033661|FG000|Overall Study|Lost to Follow-up|13|||
19584938|NCT01097057|42033665|FG000|Overall Study|Physician Decision|3|||
19584939|NCT01022112|42033674|FG000|Overall Study|Adverse Event|1|||
19584940|NCT01022112|42033675|FG001|Overall Study|Adverse Event|2|||
19584941|NCT01022112|42033676|FG002|Overall Study|Adverse Event|0|||
19584942|NCT01022112|42033677|FG003|Overall Study|Adverse Event|1|||
19584943|NCT01022112|42033678|FG004|Overall Study|Adverse Event|0|||
19584944|NCT01022112|42033674|FG000|Overall Study|Lack of Efficacy|1|||
19584945|NCT01022112|42033675|FG001|Overall Study|Lack of Efficacy|0|||
19584946|NCT01022112|42033676|FG002|Overall Study|Lack of Efficacy|0|||
19584947|NCT01022112|42033677|FG003|Overall Study|Lack of Efficacy|0|||
19584948|NCT01022112|42033678|FG004|Overall Study|Lack of Efficacy|1|||
19584949|NCT01022112|42033674|FG000|Overall Study|Physician Decision|0|||
19584950|NCT01022112|42033675|FG001|Overall Study|Physician Decision|0|||
19584951|NCT01022112|42033676|FG002|Overall Study|Physician Decision|1|||
19584952|NCT01022112|42033677|FG003|Overall Study|Physician Decision|0|||
19584953|NCT01022112|42033678|FG004|Overall Study|Physician Decision|1|||
19584954|NCT01022112|42033674|FG000|Overall Study|Withdrawal by Subject|0|||
19584955|NCT01022112|42033675|FG001|Overall Study|Withdrawal by Subject|1|||
19584956|NCT01022112|42033676|FG002|Overall Study|Withdrawal by Subject|2|||
19584957|NCT01022112|42033677|FG003|Overall Study|Withdrawal by Subject|2|||
19584958|NCT01022112|42033678|FG004|Overall Study|Withdrawal by Subject|1|||
19584959|NCT01022112|42033674|FG000|Overall Study|Fasting plasma glucose level increased|1|||
19584960|NCT01022112|42033675|FG001|Overall Study|Fasting plasma glucose level increased|0|||
19584961|NCT01022112|42033676|FG002|Overall Study|Fasting plasma glucose level increased|0|||
19584962|NCT01022112|42033677|FG003|Overall Study|Fasting plasma glucose level increased|0|||
19584963|NCT01022112|42033678|FG004|Overall Study|Fasting plasma glucose level increased|7|||
19584964|NCT01096667|42033695|FG000|Overall Study|Lost to Follow-up|1|||
19584965|NCT01096667|42033696|FG001|Overall Study|Lost to Follow-up|1|||
19584966|NCT01096667|42033697|FG002|Overall Study|Lost to Follow-up|1|||
19584967|NCT01096667|42033698|FG003|Overall Study|Lost to Follow-up|0|||
19584968|NCT01096667|42033699|FG004|Overall Study|Lost to Follow-up|0|||
19584969|NCT01096667|42033695|FG000|Overall Study|Withdrawal by Subject|1|||
19584970|NCT01096667|42033696|FG001|Overall Study|Withdrawal by Subject|0|||
19584971|NCT01096667|42033697|FG002|Overall Study|Withdrawal by Subject|0|||
19584972|NCT01096667|42033698|FG003|Overall Study|Withdrawal by Subject|1|||
19584973|NCT01096667|42033699|FG004|Overall Study|Withdrawal by Subject|0|||
19584974|NCT01096667|42033695|FG000|Overall Study|Reason not available|0|||
19584975|NCT01096667|42033696|FG001|Overall Study|Reason not available|1|||
19584976|NCT01096667|42033697|FG002|Overall Study|Reason not available|1|||
19584977|NCT01096667|42033698|FG003|Overall Study|Reason not available|1|||
19584978|NCT01096667|42033699|FG004|Overall Study|Reason not available|0|||
19584979|NCT01096667|42033695|FG000|Overall Study|Protocol Violation|0|||
19584980|NCT01096667|42033696|FG001|Overall Study|Protocol Violation|0|||
19584981|NCT01096667|42033697|FG002|Overall Study|Protocol Violation|0|||
19584982|NCT01096667|42033698|FG003|Overall Study|Protocol Violation|1|||
19584983|NCT01096667|42033699|FG004|Overall Study|Protocol Violation|0|||
19584984|NCT01096667|42033695|FG000|Overall Study|Not treated|1|||
19584985|NCT01096667|42033696|FG001|Overall Study|Not treated|0|||
19584986|NCT01096667|42033697|FG002|Overall Study|Not treated|0|||
19584987|NCT01096667|42033698|FG003|Overall Study|Not treated|0|||
19584988|NCT01096667|42033699|FG004|Overall Study|Not treated|0|||
19584989|NCT01014624|42033714|FG000|Overall Study|Adverse Event|0|||
19584990|NCT01014624|42033715|FG001|Overall Study|Adverse Event|1|||
19584991|NCT01014624|42033714|FG000|Overall Study|Protocol Violation|1|||
19584992|NCT01014624|42033715|FG001|Overall Study|Protocol Violation|0|||
19584993|NCT01014624|42033714|FG000|Overall Study|Withdrawal by Subject|1|||
19584994|NCT01014624|42033715|FG001|Overall Study|Withdrawal by Subject|0|||
19584995|NCT01021878|42033725|FG000|Overall Study|Lost to Follow-up|4|||
19584996|NCT01021878|42033726|FG001|Overall Study|Lost to Follow-up|3|||
19584997|NCT01021878|42033725|FG000|Overall Study|Death|0|||
19584998|NCT01021878|42033726|FG001|Overall Study|Death|1|||
19584999|NCT01021878|42033725|FG000|Overall Study|Adverse Event|6|||
19585000|NCT01021878|42033726|FG001|Overall Study|Adverse Event|5|||
19585001|NCT01021878|42033725|FG000|Overall Study|Transplantation|6|||
19585002|NCT01021878|42033726|FG001|Overall Study|Transplantation|1|||
19585003|NCT00854113|42033746|FG000|Overall Study|Adverse Event|0|||
19585004|NCT00854113|42033747|FG001|Overall Study|Adverse Event|0|||
19585005|NCT00854113|42033748|FG002|Overall Study|Adverse Event|0|||
19585006|NCT00854113|42033749|FG003|Overall Study|Adverse Event|0|||
19585007|NCT00854113|42033750|FG004|Overall Study|Adverse Event|0|||
19585008|NCT00854113|42033751|FG005|Overall Study|Adverse Event|0|||
19585009|NCT00854113|42033752|FG006|Overall Study|Adverse Event|0|||
19585010|NCT00854113|42033753|FG007|Overall Study|Adverse Event|2|||
19585011|NCT00854113|42033754|FG008|Overall Study|Adverse Event|0|||
19585012|NCT00854113|42033755|FG009|Overall Study|Adverse Event|0|||
19585013|NCT00854113|42033756|FG010|Overall Study|Adverse Event|0|||
19585014|NCT00854113|42033746|FG000|Overall Study|Withdrawal by Subject|0|||
19585015|NCT00854113|42033747|FG001|Overall Study|Withdrawal by Subject|0|||
19585016|NCT00854113|42033748|FG002|Overall Study|Withdrawal by Subject|0|||
19585017|NCT00854113|42033749|FG003|Overall Study|Withdrawal by Subject|0|||
19585018|NCT00854113|42033750|FG004|Overall Study|Withdrawal by Subject|0|||
19585019|NCT00854113|42033751|FG005|Overall Study|Withdrawal by Subject|0|||
19585020|NCT00854113|42033752|FG006|Overall Study|Withdrawal by Subject|0|||
19585021|NCT00854113|42033753|FG007|Overall Study|Withdrawal by Subject|1|||
19585022|NCT00854113|42033754|FG008|Overall Study|Withdrawal by Subject|1|||
19585023|NCT00854113|42033755|FG009|Overall Study|Withdrawal by Subject|0|||
19585024|NCT00854113|42033756|FG010|Overall Study|Withdrawal by Subject|0|||
19585025|NCT00845845|42033782|FG000|Overall Study|Lost to Follow-up|0|||
19585026|NCT00845845|42033783|FG001|Overall Study|Lost to Follow-up|4|||
19585027|NCT01104701|42033793|FG000|Overall Study|Withdrawal by Subject|0|||
19585028|NCT01104701|42033794|FG001|Overall Study|Withdrawal by Subject|1|||
19585029|NCT01104701|42033795|FG002|Overall Study|Withdrawal by Subject|2|||
19585030|NCT01104701|42033796|FG003|Overall Study|Withdrawal by Subject|1|||
19585031|NCT01104701|42033793|FG000|Overall Study|Adverse Event|0|||
19585032|NCT01104701|42033794|FG001|Overall Study|Adverse Event|0|||
19585033|NCT01104701|42033795|FG002|Overall Study|Adverse Event|0|||
19585034|NCT01104701|42033796|FG003|Overall Study|Adverse Event|1|||
19585035|NCT01104701|42033793|FG000|Overall Study|Physician Decision|0|||
19585036|NCT01104701|42033794|FG001|Overall Study|Physician Decision|2|||
19585037|NCT01104701|42033795|FG002|Overall Study|Physician Decision|0|||
19585038|NCT01104701|42033796|FG003|Overall Study|Physician Decision|0|||
19585039|NCT00833755|42033810|FG000|Overall Study|Physician Decision|4|||
19585040|NCT00833755|42033811|FG001|Overall Study|Physician Decision|4|||
19585041|NCT00833755|42033812|FG002|Overall Study|Physician Decision|2|||
19585042|NCT00833755|42033813|FG003|Overall Study|Physician Decision|6|||
19585043|NCT00833755|42033810|FG000|Overall Study|Subject had scheduling issues|0|||
19585044|NCT00833755|42033811|FG001|Overall Study|Subject had scheduling issues|1|||
19585045|NCT00833755|42033812|FG002|Overall Study|Subject had scheduling issues|0|||
19585046|NCT00833755|42033813|FG003|Overall Study|Subject had scheduling issues|0|||
19585047|NCT01021332|42033824|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
19585048|NCT01021332|42033824|FG000|Overall Study|Adverse Event|43|||
19585049|NCT01021332|42033824|FG000|Overall Study|Lack of Efficacy|19|||
19585050|NCT01021332|42033824|FG000|Overall Study|Withdrawal of Consent|23|||
19585051|NCT01021332|42033824|FG000|Overall Study|Lost to Follow-up|4|||
19585052|NCT01021332|42033824|FG000|Overall Study|Protocol Violation|9|||
19585053|NCT01021332|42033824|FG000|Overall Study|Miscellaneous|3|||
19585054|NCT00923091|42033838|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
19585055|NCT00923091|42033839|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
19585056|NCT00923091|42033840|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
19585057|NCT00923091|42033841|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
19585058|NCT00923091|42033842|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
19585059|NCT00923091|42033843|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
19585060|NCT00923091|42033844|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
19585061|NCT00923091|42033845|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
19585062|NCT00923091|42033846|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
19585063|NCT00923091|42033847|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
19585064|NCT00923091|42033848|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
19585065|NCT00923091|42033849|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
19585066|NCT00923091|42033850|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
19585067|NCT00923091|42033838|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
19585068|NCT00923091|42033839|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
19585069|NCT00923091|42033840|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
19585070|NCT00923091|42033841|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
19585071|NCT00923091|42033842|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
19585072|NCT00923091|42033843|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
19585073|NCT00923091|42033844|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
19585074|NCT00923091|42033845|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
19585075|NCT00923091|42033846|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
19585076|NCT00923091|42033847|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
19585077|NCT00923091|42033848|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
19585078|NCT00923091|42033849|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
19585079|NCT00923091|42033850|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
19585080|NCT00923091|42033838|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
19585081|NCT00923091|42033839|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
19585082|NCT00923091|42033840|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
19585083|NCT00923091|42033841|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
19585084|NCT00923091|42033842|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
19585085|NCT00923091|42033843|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
19585086|NCT00923091|42033844|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
19585087|NCT00923091|42033845|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
19585088|NCT00923091|42033846|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
19585089|NCT00923091|42033847|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
19585090|NCT00923091|42033848|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
19585091|NCT00923091|42033849|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
19585092|NCT00923091|42033850|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
19585093|NCT00923091|42033838|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585094|NCT00923091|42033839|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585095|NCT00923091|42033840|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585096|NCT00923091|42033841|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585097|NCT00923091|42033842|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585098|NCT00923091|42033843|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
19585099|NCT00923091|42033844|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585100|NCT00923091|42033845|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585101|NCT00923091|42033846|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585102|NCT00923091|42033847|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585103|NCT00923091|42033848|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585104|NCT00923091|42033849|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585105|NCT00923091|42033850|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
19585106|NCT00923091|42033838|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585107|NCT00923091|42033839|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
19585108|NCT00923091|42033840|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585109|NCT00923091|42033841|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
19585110|NCT00923091|42033842|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585111|NCT00923091|42033843|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
19585112|NCT00923091|42033844|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585113|NCT00923091|42033845|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585114|NCT00923091|42033846|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585115|NCT00923091|42033847|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585116|NCT00923091|42033848|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585117|NCT00923091|42033849|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585118|NCT00923091|42033850|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
19585119|NCT00923091|42033838|FG000|Period III (Single-Blind)|Adverse Event|5|||
19585120|NCT00923091|42033839|FG001|Period III (Single-Blind)|Adverse Event|0|||
19585121|NCT00923091|42033840|FG002|Period III (Single-Blind)|Adverse Event|0|||
19585122|NCT00923091|42033841|FG003|Period III (Single-Blind)|Adverse Event|0|||
19585123|NCT00923091|42033842|FG004|Period III (Single-Blind)|Adverse Event|0|||
19585124|NCT00923091|42033843|FG005|Period III (Single-Blind)|Adverse Event|0|||
19585125|NCT00923091|42033844|FG006|Period III (Single-Blind)|Adverse Event|0|||
19585126|NCT00923091|42033845|FG007|Period III (Single-Blind)|Adverse Event|0|||
19585127|NCT00923091|42033846|FG008|Period III (Single-Blind)|Adverse Event|0|||
19585128|NCT00923091|42033847|FG009|Period III (Single-Blind)|Adverse Event|0|||
19585129|NCT00923091|42033848|FG010|Period III (Single-Blind)|Adverse Event|0|||
19585130|NCT00923091|42033849|FG011|Period III (Single-Blind)|Adverse Event|0|||
19585131|NCT00923091|42033850|FG012|Period III (Single-Blind)|Adverse Event|0|||
19585132|NCT00923091|42033838|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
19585133|NCT00923091|42033839|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585134|NCT00923091|42033840|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585135|NCT00923091|42033841|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585136|NCT00923091|42033842|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585137|NCT00923091|42033843|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585138|NCT00923091|42033844|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585139|NCT00923091|42033845|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585140|NCT00923091|42033846|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585141|NCT00923091|42033847|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585142|NCT00923091|42033848|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585143|NCT00923091|42033849|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585144|NCT00923091|42033850|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
19585145|NCT00923091|42033838|FG000|Period III (Single-Blind)|Protocol Violation|3|||
19585146|NCT00923091|42033839|FG001|Period III (Single-Blind)|Protocol Violation|0|||
19585147|NCT00923091|42033840|FG002|Period III (Single-Blind)|Protocol Violation|0|||
19585148|NCT00923091|42033841|FG003|Period III (Single-Blind)|Protocol Violation|0|||
19585149|NCT00923091|42033842|FG004|Period III (Single-Blind)|Protocol Violation|0|||
19585150|NCT00923091|42033843|FG005|Period III (Single-Blind)|Protocol Violation|0|||
19585151|NCT00923091|42033844|FG006|Period III (Single-Blind)|Protocol Violation|0|||
19585152|NCT00923091|42033845|FG007|Period III (Single-Blind)|Protocol Violation|0|||
19585153|NCT00923091|42033846|FG008|Period III (Single-Blind)|Protocol Violation|0|||
19585154|NCT00923091|42033847|FG009|Period III (Single-Blind)|Protocol Violation|0|||
19585155|NCT00923091|42033848|FG010|Period III (Single-Blind)|Protocol Violation|0|||
19585156|NCT00923091|42033849|FG011|Period III (Single-Blind)|Protocol Violation|0|||
19585157|NCT00923091|42033850|FG012|Period III (Single-Blind)|Protocol Violation|0|||
19585158|NCT00923091|42033838|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
19585159|NCT00923091|42033839|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
19585160|NCT00923091|42033840|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
19585161|NCT00923091|42033841|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
19585162|NCT00923091|42033842|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
19585163|NCT00923091|42033843|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
19585164|NCT00923091|42033844|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
19585165|NCT00923091|42033845|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
19585166|NCT00923091|42033846|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
19585167|NCT00923091|42033847|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
19585168|NCT00923091|42033848|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
19585169|NCT00923091|42033849|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
19585170|NCT00923091|42033850|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
19585171|NCT00923091|42033838|FG000|Period IV (Double-Blind)|Adverse Event|2|||
19585172|NCT00923091|42033839|FG001|Period IV (Double-Blind)|Adverse Event|0|||
19585173|NCT00923091|42033840|FG002|Period IV (Double-Blind)|Adverse Event|0|||
19585174|NCT00923091|42033841|FG003|Period IV (Double-Blind)|Adverse Event|0|||
19585175|NCT00923091|42033842|FG004|Period IV (Double-Blind)|Adverse Event|0|||
19585176|NCT00923091|42033843|FG005|Period IV (Double-Blind)|Adverse Event|0|||
19585177|NCT00923091|42033844|FG006|Period IV (Double-Blind)|Adverse Event|0|||
19585178|NCT00923091|42033845|FG007|Period IV (Double-Blind)|Adverse Event|0|||
19585179|NCT00923091|42033846|FG008|Period IV (Double-Blind)|Adverse Event|0|||
19585180|NCT00923091|42033847|FG009|Period IV (Double-Blind)|Adverse Event|0|||
19585181|NCT00923091|42033848|FG010|Period IV (Double-Blind)|Adverse Event|0|||
19585182|NCT00923091|42033849|FG011|Period IV (Double-Blind)|Adverse Event|0|||
19585183|NCT00923091|42033850|FG012|Period IV (Double-Blind)|Adverse Event|0|||
19585184|NCT00923091|42033838|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585185|NCT00923091|42033839|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
19585186|NCT00923091|42033840|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585187|NCT00923091|42033841|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585188|NCT00923091|42033842|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585189|NCT00923091|42033843|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585190|NCT00923091|42033844|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585191|NCT00923091|42033845|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585192|NCT00923091|42033846|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585193|NCT00923091|42033847|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585194|NCT00923091|42033848|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585195|NCT00923091|42033849|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585196|NCT00923091|42033850|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
19585197|NCT00923091|42033838|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
19585198|NCT00923091|42033839|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
19585199|NCT00923091|42033840|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
19585200|NCT00923091|42033841|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
19585201|NCT00923091|42033842|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
19585202|NCT00923091|42033843|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
19585203|NCT00923091|42033844|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
19585204|NCT00923091|42033845|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
19585205|NCT00923091|42033846|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
19585206|NCT00923091|42033847|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
19585207|NCT00923091|42033848|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
19585208|NCT00923091|42033849|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
19585209|NCT00923091|42033850|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
19585210|NCT00923091|42033838|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585211|NCT00923091|42033839|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585212|NCT00923091|42033840|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585213|NCT00923091|42033841|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585214|NCT00923091|42033842|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585215|NCT00923091|42033843|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585216|NCT00923091|42033844|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585217|NCT00923091|42033845|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585218|NCT00923091|42033846|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
19585219|NCT00923091|42033847|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585220|NCT00923091|42033848|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585221|NCT00923091|42033849|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
19585222|NCT00923091|42033850|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
19585223|NCT00923091|42033838|FG000|Period V (Double -Blind)|Protocol Violation|0|||
19585224|NCT00923091|42033839|FG001|Period V (Double -Blind)|Protocol Violation|0|||
19585225|NCT00923091|42033840|FG002|Period V (Double -Blind)|Protocol Violation|0|||
19585226|NCT00923091|42033841|FG003|Period V (Double -Blind)|Protocol Violation|0|||
19585227|NCT00923091|42033842|FG004|Period V (Double -Blind)|Protocol Violation|0|||
19585228|NCT00923091|42033843|FG005|Period V (Double -Blind)|Protocol Violation|0|||
19585229|NCT00923091|42033844|FG006|Period V (Double -Blind)|Protocol Violation|0|||
19585230|NCT00923091|42033845|FG007|Period V (Double -Blind)|Protocol Violation|0|||
19585231|NCT00923091|42033846|FG008|Period V (Double -Blind)|Protocol Violation|0|||
19585232|NCT00923091|42033847|FG009|Period V (Double -Blind)|Protocol Violation|0|||
19585233|NCT00923091|42033848|FG010|Period V (Double -Blind)|Protocol Violation|0|||
19585234|NCT00923091|42033849|FG011|Period V (Double -Blind)|Protocol Violation|0|||
19585235|NCT00923091|42033850|FG012|Period V (Double -Blind)|Protocol Violation|1|||
19585236|NCT00923091|42033838|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
19585237|NCT00923091|42033839|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
19585238|NCT00923091|42033840|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
19585239|NCT00923091|42033841|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
19585240|NCT00923091|42033842|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
19585241|NCT00923091|42033843|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
19585242|NCT00923091|42033844|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
19585243|NCT00923091|42033845|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
19585244|NCT00923091|42033846|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
19585245|NCT00923091|42033847|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
19585246|NCT00923091|42033848|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
19585247|NCT00923091|42033849|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
19585248|NCT00923091|42033850|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
19585249|NCT00923091|42033838|FG000|Period VI (Open-Label)|Adverse Event|17|||
19585250|NCT00923091|42033839|FG001|Period VI (Open-Label)|Adverse Event|0|||
19585251|NCT00923091|42033840|FG002|Period VI (Open-Label)|Adverse Event|4|||
19585252|NCT00923091|42033841|FG003|Period VI (Open-Label)|Adverse Event|1|||
19585253|NCT00923091|42033842|FG004|Period VI (Open-Label)|Adverse Event|1|||
19585254|NCT00923091|42033843|FG005|Period VI (Open-Label)|Adverse Event|0|||
19585255|NCT00923091|42033844|FG006|Period VI (Open-Label)|Adverse Event|0|||
19585256|NCT00923091|42033845|FG007|Period VI (Open-Label)|Adverse Event|0|||
19585257|NCT00923091|42033846|FG008|Period VI (Open-Label)|Adverse Event|0|||
19585258|NCT00923091|42033847|FG009|Period VI (Open-Label)|Adverse Event|0|||
19585259|NCT00923091|42033848|FG010|Period VI (Open-Label)|Adverse Event|0|||
19585260|NCT00923091|42033849|FG011|Period VI (Open-Label)|Adverse Event|0|||
19585261|NCT00923091|42033850|FG012|Period VI (Open-Label)|Adverse Event|0|||
19585262|NCT00923091|42033838|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
19585263|NCT00923091|42033839|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
19585264|NCT00923091|42033840|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
19585265|NCT00923091|42033841|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585266|NCT00923091|42033842|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
19585267|NCT00923091|42033843|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585268|NCT00923091|42033844|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585269|NCT00923091|42033845|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585270|NCT00923091|42033846|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585271|NCT00923091|42033847|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585272|NCT00923091|42033848|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585273|NCT00923091|42033849|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585274|NCT00923091|42033850|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
19585275|NCT00923091|42033838|FG000|Period VI (Open-Label)|Protocol Violation|6|||
19585276|NCT00923091|42033839|FG001|Period VI (Open-Label)|Protocol Violation|1|||
19585277|NCT00923091|42033840|FG002|Period VI (Open-Label)|Protocol Violation|3|||
19585278|NCT00923091|42033841|FG003|Period VI (Open-Label)|Protocol Violation|1|||
19585279|NCT00923091|42033842|FG004|Period VI (Open-Label)|Protocol Violation|4|||
19585280|NCT00923091|42033843|FG005|Period VI (Open-Label)|Protocol Violation|0|||
19585281|NCT00923091|42033844|FG006|Period VI (Open-Label)|Protocol Violation|0|||
19585282|NCT00923091|42033845|FG007|Period VI (Open-Label)|Protocol Violation|0|||
19585283|NCT00923091|42033846|FG008|Period VI (Open-Label)|Protocol Violation|0|||
19585284|NCT00923091|42033847|FG009|Period VI (Open-Label)|Protocol Violation|0|||
19585285|NCT00923091|42033848|FG010|Period VI (Open-Label)|Protocol Violation|0|||
19585286|NCT00923091|42033849|FG011|Period VI (Open-Label)|Protocol Violation|0|||
19585287|NCT00923091|42033850|FG012|Period VI (Open-Label)|Protocol Violation|0|||
19585288|NCT00923091|42033838|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
19585289|NCT00923091|42033839|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
19585290|NCT00923091|42033840|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
19585291|NCT00923091|42033841|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
19585292|NCT00923091|42033842|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
19585293|NCT00923091|42033843|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
19585294|NCT00923091|42033844|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
19585295|NCT00923091|42033845|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
19585296|NCT00923091|42033846|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
19585297|NCT00923091|42033847|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
19585298|NCT00923091|42033848|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
19585299|NCT00923091|42033849|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
19585300|NCT00923091|42033850|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
19585301|NCT00923091|42033838|FG000|Period VI (Open-Label)|Other Reason|0|||
19585302|NCT00923091|42033839|FG001|Period VI (Open-Label)|Other Reason|0|||
19585303|NCT00923091|42033840|FG002|Period VI (Open-Label)|Other Reason|0|||
19585304|NCT00923091|42033841|FG003|Period VI (Open-Label)|Other Reason|1|||
19585305|NCT00923091|42033842|FG004|Period VI (Open-Label)|Other Reason|1|||
19585306|NCT00923091|42033843|FG005|Period VI (Open-Label)|Other Reason|0|||
19585307|NCT00923091|42033844|FG006|Period VI (Open-Label)|Other Reason|0|||
19585308|NCT00923091|42033845|FG007|Period VI (Open-Label)|Other Reason|0|||
19585309|NCT00923091|42033846|FG008|Period VI (Open-Label)|Other Reason|0|||
19585310|NCT00923091|42033847|FG009|Period VI (Open-Label)|Other Reason|0|||
19585311|NCT00923091|42033848|FG010|Period VI (Open-Label)|Other Reason|0|||
19585312|NCT00923091|42033849|FG011|Period VI (Open-Label)|Other Reason|0|||
19585313|NCT00923091|42033850|FG012|Period VI (Open-Label)|Other Reason|0|||
19585314|NCT00853957|42033877|FG000|Overall Study|Adverse Event|9|||
19585315|NCT00853957|42033878|FG001|Overall Study|Adverse Event|3|||
19585316|NCT00853957|42033877|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19585317|NCT00853957|42033878|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19585318|NCT00853957|42033877|FG000|Overall Study|Subject withdrew consent|4|||
19585319|NCT00853957|42033878|FG001|Overall Study|Subject withdrew consent|5|||
19585320|NCT00853957|42033877|FG000|Overall Study|Lost to Follow-up|1|||
19585321|NCT00853957|42033878|FG001|Overall Study|Lost to Follow-up|6|||
19585322|NCT00853957|42033877|FG000|Overall Study|Protocol deviation|0|||
19585323|NCT00853957|42033878|FG001|Overall Study|Protocol deviation|3|||
19585324|NCT01021020|42033884|FG000|Period I|Protocol Violation|1|||
19585325|NCT01021020|42033884|FG000|Period I|Withdrawal by Subject|1|||
19585326|NCT01021020|42033884|FG000|14 Day Washout Period A|Physician Decision|1|||
19585327|NCT00833053|42033898|FG000|Overall Study|Adverse Event|4|||
19585328|NCT00833053|42033899|FG001|Overall Study|Adverse Event|0|||
19585329|NCT00833053|42033898|FG000|Overall Study|Treatment Failure|3|||
19585330|NCT00833053|42033899|FG001|Overall Study|Treatment Failure|1|||
19585331|NCT00833053|42033898|FG000|Overall Study|Withdrawal by Subject|0|||
19585332|NCT00833053|42033899|FG001|Overall Study|Withdrawal by Subject|1|||
19585333|NCT00833053|42033898|FG000|Overall Study|Protocol Violation|2|||
19585334|NCT00833053|42033899|FG001|Overall Study|Protocol Violation|1|||
19585335|NCT00832975|42033905|FG000|Overall Study|Lost to Follow-up|7|||
19585336|NCT00832975|42033905|FG000|Overall Study|Protocol Violation|6|||
19585337|NCT00832975|42033905|FG000|Overall Study|Death|5|||
19585338|NCT00832975|42033905|FG000|Overall Study|Physician Decision|4|||
19585339|NCT00832975|42033905|FG000|Overall Study|Withdrawal by Subject|3|||
19585340|NCT00832975|42033905|FG000|Overall Study|Other reasons|14|||
19585341|NCT01020786|42033909|FG000|Induction Period|Entry Criteria Not Met|2|||
19585342|NCT01020786|42033909|FG000|Induction Period|Adverse Event|10|||
19585343|NCT01020786|42033909|FG000|Induction Period|Progressive Disease|31|||
19585344|NCT01020786|42033909|FG000|Induction Period|Investigator Decision|3|||
19585345|NCT01020786|42033909|FG000|Induction Period|Withdrawal by Subject|3|||
19585346|NCT01020786|42033909|FG000|Maintenance Period|Adverse Event|8|||
19585347|NCT01020786|42033909|FG000|Maintenance Period|Progressive Disease|43|||
19585348|NCT01020786|42033909|FG000|Maintenance Period|Withdrawal by Subject|8|||
19585349|NCT01020786|42033909|FG000|Maintenance Period|Sponsor Decision|1|||
19585350|NCT00918645|42033914|FG000|Overall Study|Withdrawal by Subject|1|||
19585351|NCT00922935|42033921|FG000|Overall Study|Protocol Violation|0|||
19585352|NCT00922935|42033922|FG001|Overall Study|Protocol Violation|3|||
19585353|NCT00922935|42033923|FG002|Overall Study|Protocol Violation|0|||
19585354|NCT00922935|42033921|FG000|Overall Study|Physician Decision|1|||
19585355|NCT00922935|42033922|FG001|Overall Study|Physician Decision|1|||
19585356|NCT00922935|42033923|FG002|Overall Study|Physician Decision|0|||
19585357|NCT00922935|42033921|FG000|Overall Study|Lost to Follow-up|0|||
19585358|NCT00922935|42033922|FG001|Overall Study|Lost to Follow-up|1|||
19585359|NCT00922935|42033923|FG002|Overall Study|Lost to Follow-up|0|||
19585360|NCT01020474|42033933|FG000|Overall Study|Adverse Event|4|||
19585361|NCT01020474|42033934|FG001|Overall Study|Adverse Event|4|||
19585362|NCT01020474|42033933|FG000|Overall Study|Protocol Violation|0|||
19585363|NCT01020474|42033934|FG001|Overall Study|Protocol Violation|2|||
19585364|NCT01020474|42033933|FG000|Overall Study|Withdrawal by Subject|5|||
19585365|NCT01020474|42033934|FG001|Overall Study|Withdrawal by Subject|7|||
19585366|NCT01020474|42033933|FG000|Overall Study|Other Reasons|1|||
19585367|NCT01020474|42033934|FG001|Overall Study|Other Reasons|1|||
19585368|NCT01020474|42033933|FG000|Overall Study|Insufficient Clinical Response|0|||
19585369|NCT01020474|42033934|FG001|Overall Study|Insufficient Clinical Response|3|||
19585370|NCT00922779|42033940|FG000|Overall Study|Adverse Event|67|||
19585371|NCT00922779|42033940|FG000|Overall Study|Pregnancy|7|||
19585372|NCT00922779|42033940|FG000|Overall Study|Withdrawal by Subject|308|||
19585373|NCT00922779|42033940|FG000|Overall Study|Lost to Follow-up|44|||
19585374|NCT00922779|42033940|FG000|Overall Study|Other|27|||
19585375|NCT00922779|42033940|FG000|Overall Study|Missing|1874|||
19585376|NCT00924651|42033946|FG000|Overall Study|Chemo started too soon|2|||
19585377|NCT00924651|42033947|FG001|Overall Study|Chemo started too soon|3|||
19585378|NCT00924651|42033946|FG000|Overall Study|No Reason|3|||
19585379|NCT00924651|42033947|FG001|Overall Study|No Reason|7|||
19585380|NCT00924651|42033946|FG000|Overall Study|Overwhelmed|6|||
19585381|NCT00924651|42033947|FG001|Overall Study|Overwhelmed|6|||
19585382|NCT00924651|42033946|FG000|Overall Study|Noncompliant|1|||
19585383|NCT00924651|42033947|FG001|Overall Study|Noncompliant|4|||
19585384|NCT00924651|42033946|FG000|Overall Study|Medical|1|||
19585385|NCT00924651|42033947|FG001|Overall Study|Medical|3|||
19585386|NCT00924651|42033946|FG000|Overall Study|Changed Mind|10|||
19585387|NCT00924651|42033947|FG001|Overall Study|Changed Mind|1|||
19585388|NCT00924651|42033946|FG000|Overall Study|Incomplete Form|2|||
19585389|NCT00924651|42033947|FG001|Overall Study|Incomplete Form|1|||
19585390|NCT00922623|42033953|FG000|Overall Study|Other|4|||
19585391|NCT00922623|42033953|FG000|Overall Study|Lost to Follow-up|1|||
19585392|NCT01025232|42033961|FG000|Overall Study|Study drug no longer available|3|||
19585393|NCT01025232|42033962|FG001|Overall Study|Study drug no longer available|6|||
19585394|NCT01025154|42033968|FG000|Overall Study|Lost to Follow-up|1|||
19585395|NCT01025154|42033968|FG000|Overall Study|Withdrawal by Subject|1|||
19585396|NCT00832819|42033975|FG000|Overall Study|Adverse Event|0|||
19585397|NCT00832819|42033976|FG001|Overall Study|Adverse Event|1|||
19585398|NCT00832819|42033977|FG002|Overall Study|Adverse Event|0|||
19585399|NCT00832819|42033975|FG000|Overall Study|Protocol Violation|0|||
19585400|NCT00832819|42033976|FG001|Overall Study|Protocol Violation|0|||
19585401|NCT00832819|42033977|FG002|Overall Study|Protocol Violation|1|||
19585402|NCT00853723|42033986|FG000|Overall Study|Adverse Event|3|||
19585403|NCT00853723|42033987|FG001|Overall Study|Adverse Event|4|||
19585404|NCT00853723|42033988|FG002|Overall Study|Adverse Event|1|||
19585405|NCT00853723|42033986|FG000|Overall Study|Withdrawal by Subject|2|||
19585406|NCT00853723|42033987|FG001|Overall Study|Withdrawal by Subject|1|||
19585407|NCT00853723|42033988|FG002|Overall Study|Withdrawal by Subject|0|||
19585408|NCT00853723|42033986|FG000|Overall Study|Protocol Violation|1|||
19585409|NCT00853723|42033987|FG001|Overall Study|Protocol Violation|2|||
19585410|NCT00853723|42033988|FG002|Overall Study|Protocol Violation|1|||
19585411|NCT01104545|42034002|FG000|Overall Study|Adverse Event|0|||
19585412|NCT01104545|42034003|FG001|Overall Study|Adverse Event|1|||
19585413|NCT01104545|42034004|FG002|Overall Study|Adverse Event|2|||
19585414|NCT00918255|42034052|FG000|Overall Study|Adverse Event|1|||
19585415|NCT00918255|42034053|FG001|Overall Study|Adverse Event|0|||
19585416|NCT00918255|42034054|FG002|Overall Study|Adverse Event|0|||
19585417|NCT00918255|42034052|FG000|Overall Study|Withdrawal by Subject|1|||
19585418|NCT00918255|42034053|FG001|Overall Study|Withdrawal by Subject|0|||
19585419|NCT00918255|42034054|FG002|Overall Study|Withdrawal by Subject|2|||
19585420|NCT00918255|42034052|FG000|Overall Study|Lack of Efficacy|1|||
19585421|NCT00918255|42034053|FG001|Overall Study|Lack of Efficacy|0|||
19585422|NCT00918255|42034054|FG002|Overall Study|Lack of Efficacy|0|||
19585423|NCT00918255|42034052|FG000|Overall Study|Lost to Follow-up|1|||
19585424|NCT00918255|42034053|FG001|Overall Study|Lost to Follow-up|0|||
19585425|NCT00918255|42034054|FG002|Overall Study|Lost to Follow-up|2|||
19585426|NCT00918255|42034052|FG000|Overall Study|Exceeded allowed number of interventions|0|||
19585427|NCT00918255|42034053|FG001|Overall Study|Exceeded allowed number of interventions|0|||
19585428|NCT00918255|42034054|FG002|Overall Study|Exceeded allowed number of interventions|1|||
19585429|NCT00918255|42034052|FG000|Overall Study|Non-compliance|1|||
19585430|NCT00918255|42034053|FG001|Overall Study|Non-compliance|0|||
19585431|NCT00918255|42034054|FG002|Overall Study|Non-compliance|0|||
19585432|NCT00918255|42034052|FG000|Overall Study|Investigator discretion|1|||
19585433|NCT00918255|42034053|FG001|Overall Study|Investigator discretion|0|||
19585434|NCT00918255|42034054|FG002|Overall Study|Investigator discretion|0|||
19585435|NCT01096589|42034066|FG000|Overall Study|Adverse Event|2|||
19585436|NCT01096589|42034067|FG001|Overall Study|Adverse Event|1|||
19585437|NCT01096589|42034068|FG002|Overall Study|Adverse Event|2|||
19585438|NCT01096589|42034069|FG003|Overall Study|Adverse Event|1|||
19585439|NCT01096589|42034066|FG000|Overall Study|Withdrawal by Subject|2|||
19585440|NCT01096589|42034067|FG001|Overall Study|Withdrawal by Subject|1|||
19585441|NCT01096589|42034068|FG002|Overall Study|Withdrawal by Subject|1|||
19585442|NCT01096589|42034069|FG003|Overall Study|Withdrawal by Subject|1|||
19585443|NCT01096589|42034066|FG000|Overall Study|Compliance with protocol|0|||
19585444|NCT01096589|42034067|FG001|Overall Study|Compliance with protocol|0|||
19585445|NCT01096589|42034068|FG002|Overall Study|Compliance with protocol|1|||
19585446|NCT01096589|42034069|FG003|Overall Study|Compliance with protocol|0|||
19585447|NCT01096589|42034066|FG000|Overall Study|found treatment exhausting|0|||
19585448|NCT01096589|42034067|FG001|Overall Study|found treatment exhausting|0|||
19585449|NCT01096589|42034068|FG002|Overall Study|found treatment exhausting|0|||
19585450|NCT01096589|42034069|FG003|Overall Study|found treatment exhausting|1|||
19585451|NCT00845065|42034085|FG000|Overall Study|Adverse Event|3|||
19585452|NCT00845065|42034086|FG001|Overall Study|Adverse Event|23|||
19585453|NCT00845065|42034085|FG000|Overall Study|Lack of Efficacy|43|||
19585454|NCT00845065|42034086|FG001|Overall Study|Lack of Efficacy|21|||
19585455|NCT00845065|42034085|FG000|Overall Study|Non-Medical Reasons|1|||
19585456|NCT00845065|42034086|FG001|Overall Study|Non-Medical Reasons|11|||
19585457|NCT00832585|42034092|FG000|Overall Study|Withdrawal by Subject|1|||
19585458|NCT00832585|42034092|FG000|Overall Study|Lost to Follow-up|1|||
19585459|NCT00918567|42034098|FG000|Overall Study|Lack of Efficacy|3|||
19585460|NCT00918567|42034099|FG001|Overall Study|Lack of Efficacy|1|||
19585461|NCT00918567|42034098|FG000|Overall Study|Withdrawal by Subject|1|||
19585462|NCT00918567|42034099|FG001|Overall Study|Withdrawal by Subject|1|||
19585463|NCT00918567|42034098|FG000|Overall Study|Adverse Event|1|||
19585464|NCT00918567|42034099|FG001|Overall Study|Adverse Event|0|||
19585465|NCT01024920|42034107|FG000|Overall Study|Progressive disease|47|||
19585466|NCT01024920|42034108|FG001|Overall Study|Progressive disease|25|||
19585467|NCT01024920|42034107|FG000|Overall Study|Adverse Event|8|||
19585468|NCT01024920|42034108|FG001|Overall Study|Adverse Event|4|||
19585469|NCT01024920|42034107|FG000|Overall Study|Lost to Follow-up|0|||
19585470|NCT01024920|42034108|FG001|Overall Study|Lost to Follow-up|1|||
19585471|NCT01024920|42034107|FG000|Overall Study|Patient refusal to continue|4|||
19585472|NCT01024920|42034108|FG001|Overall Study|Patient refusal to continue|0|||
19585473|NCT01024920|42034107|FG000|Overall Study|Other than listed|5|||
19585474|NCT01024920|42034108|FG001|Overall Study|Other than listed|1|||
19585475|NCT01024920|42034107|FG000|Overall Study|Not treated|3|||
19585476|NCT01024920|42034108|FG001|Overall Study|Not treated|0|||
19585477|NCT01024920|42034107|FG000|Overall Study|Protocol Violation|0|||
19585478|NCT01024920|42034108|FG001|Overall Study|Protocol Violation|1|||
19585479|NCT00832117|42034116|FG000|Overall Study|Death|1|||
19585480|NCT00832117|42034116|FG000|Overall Study|Disease Progression|11|||
19585481|NCT01104311|42034125|FG000|Overall Study|Withdrawal by Subject|6|||
19585482|NCT01104311|42034126|FG001|Overall Study|Withdrawal by Subject|6|||
19585483|NCT01104311|42034125|FG000|Overall Study|Protocol Violation|0|||
19585484|NCT01104311|42034126|FG001|Overall Study|Protocol Violation|1|||
19585485|NCT01104311|42034125|FG000|Overall Study|Physician Decision|2|||
19585486|NCT01104311|42034126|FG001|Overall Study|Physician Decision|2|||
19585487|NCT01104311|42034125|FG000|Overall Study|low compliance|1|||
19585488|NCT01104311|42034126|FG001|Overall Study|low compliance|1|||
19585489|NCT01104311|42034125|FG000|Overall Study|Adverse Event|1|||
19585490|NCT01104311|42034126|FG001|Overall Study|Adverse Event|2|||
19585491|NCT00831493|42034136|FG000|Overall Study|Intractable nausea and vomiting|1|||
19585492|NCT00853567|42034143|FG000|Overall Study|Study prematurely terminated|71|||
19585493|NCT00853489|42034153|FG000|Overall Study|Lost to Follow-up|5|||
19585494|NCT00853489|42034154|FG001|Overall Study|Lost to Follow-up|2|||
19585495|NCT01104155|42034162|FG000|Overall Study|Adverse Event|15|||
19585496|NCT01104155|42034163|FG001|Overall Study|Adverse Event|8|||
19585497|NCT01104155|42034162|FG000|Overall Study|Participant choice|6|||
19585498|NCT01104155|42034163|FG001|Overall Study|Participant choice|5|||
19585499|NCT01104155|42034162|FG000|Overall Study|Withdrawal of consent|1|||
19585500|NCT01104155|42034163|FG001|Overall Study|Withdrawal of consent|1|||
19585501|NCT01104155|42034162|FG000|Overall Study|Other|3|||
19585502|NCT01104155|42034163|FG001|Overall Study|Other|4|||
19585503|NCT01019694|42034172|FG000|Overall Study|Adverse Event|12|||
19585504|NCT01019694|42034173|FG001|Overall Study|Adverse Event|16|||
19585505|NCT01019694|42034174|FG002|Overall Study|Adverse Event|19|||
19585506|NCT01019694|42034172|FG000|Overall Study|Protocol Violation|2|||
19585507|NCT01019694|42034173|FG001|Overall Study|Protocol Violation|6|||
19585508|NCT01019694|42034174|FG002|Overall Study|Protocol Violation|4|||
19585509|NCT01019694|42034172|FG000|Overall Study|Lost to Follow-up|5|||
19585510|NCT01019694|42034173|FG001|Overall Study|Lost to Follow-up|3|||
19585511|NCT01019694|42034174|FG002|Overall Study|Lost to Follow-up|3|||
19585512|NCT01019694|42034172|FG000|Overall Study|Withdrawal by Subject|4|||
19585513|NCT01019694|42034173|FG001|Overall Study|Withdrawal by Subject|6|||
19585514|NCT01019694|42034174|FG002|Overall Study|Withdrawal by Subject|12|||
19585515|NCT01019694|42034172|FG000|Overall Study|Not treated|0|||
19585516|NCT01019694|42034173|FG001|Overall Study|Not treated|2|||
19585517|NCT01019694|42034174|FG002|Overall Study|Not treated|3|||
19585518|NCT01019694|42034172|FG000|Overall Study|Other reason (not specified)|1|||
19585519|NCT01019694|42034173|FG001|Overall Study|Other reason (not specified)|5|||
19585520|NCT01019694|42034174|FG002|Overall Study|Other reason (not specified)|6|||
19585521|NCT00831415|42034182|FG000|Overall Study|Adverse Event|14|||
19585522|NCT00831415|42034182|FG000|Overall Study|Failed to return|3|||
19585523|NCT00831415|42034182|FG000|Overall Study|Physician Decision|6|||
19585524|NCT00831415|42034182|FG000|Overall Study|Lost to Follow-up|9|||
19585525|NCT00831415|42034182|FG000|Overall Study|Protocol Violation|3|||
19585526|NCT00831415|42034182|FG000|Overall Study|Withdrawal by Subject|35|||
19585527|NCT00831415|42034182|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
19585528|NCT00831415|42034182|FG000|Overall Study|Death|1|||
19585529|NCT01095653|42034189|FG000|Overall Study|Lack of Efficacy|3|||
19585530|NCT01095653|42034190|FG001|Overall Study|Lack of Efficacy|0|||
19585531|NCT01095653|42034191|FG002|Overall Study|Lack of Efficacy|0|||
19585532|NCT01095653|42034189|FG000|Overall Study|Adverse Event|1|||
19585533|NCT01095653|42034190|FG001|Overall Study|Adverse Event|4|||
19585534|NCT01095653|42034191|FG002|Overall Study|Adverse Event|4|||
19585535|NCT01095653|42034189|FG000|Overall Study|Lost to Follow-up|1|||
19585536|NCT01095653|42034190|FG001|Overall Study|Lost to Follow-up|0|||
19585537|NCT01095653|42034191|FG002|Overall Study|Lost to Follow-up|4|||
19585538|NCT01095653|42034189|FG000|Overall Study|Withdrawal by Subject|4|||
19585539|NCT01095653|42034190|FG001|Overall Study|Withdrawal by Subject|5|||
19585540|NCT01095653|42034191|FG002|Overall Study|Withdrawal by Subject|3|||
19585541|NCT01095653|42034189|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
19585542|NCT01095653|42034190|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
19585543|NCT01095653|42034191|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
19585544|NCT00920907|42034201|FG000|Induction Period|Adverse Event|0|||
19585545|NCT00920907|42034202|FG001|Induction Period|Adverse Event|2|||
19585546|NCT00920907|42034201|FG000|Induction Period|Death|1|||
19585547|NCT00920907|42034202|FG001|Induction Period|Death|1|||
19585548|NCT00920907|42034201|FG000|Induction Period|Disease Progression|12|||
19585549|NCT00920907|42034202|FG001|Induction Period|Disease Progression|11|||
19585550|NCT00920907|42034201|FG000|Induction Period|Study Drug Toxicity|8|||
19585551|NCT00920907|42034202|FG001|Induction Period|Study Drug Toxicity|6|||
19585552|NCT00920907|42034201|FG000|Induction Period|No longer meets study criteria|0|||
19585553|NCT00920907|42034202|FG001|Induction Period|No longer meets study criteria|1|||
19585554|NCT00920907|42034201|FG000|Induction Period|Withdrawal by Subject|1|||
19585555|NCT00920907|42034202|FG001|Induction Period|Withdrawal by Subject|1|||
19585556|NCT00920907|42034201|FG000|Maintenance Period|Disease Progression|3|||
19585557|NCT00920907|42034202|FG001|Maintenance Period|Disease Progression|7|||
19585558|NCT00920907|42034201|FG000|Maintenance Period|Administrative (study closure)|7|||
19585559|NCT00920907|42034202|FG001|Maintenance Period|Administrative (study closure)|2|||
19585560|NCT00920907|42034201|FG000|Maintenance Period|Study Drug Toxicity|0|||
19585561|NCT00920907|42034202|FG001|Maintenance Period|Study Drug Toxicity|2|||
19585562|NCT00920907|42034201|FG000|Maintenance Period|Death|1|||
19585563|NCT00920907|42034202|FG001|Maintenance Period|Death|1|||
19585564|NCT00920907|42034201|FG000|Maintenance Period|Withdrawal by Subject|1|||
19585565|NCT00920907|42034202|FG001|Maintenance Period|Withdrawal by Subject|0|||
19585566|NCT00920907|42034201|FG000|Maintenance Period|Adverse Event|0|||
19585567|NCT00920907|42034202|FG001|Maintenance Period|Adverse Event|1|||
19585568|NCT01103141|42034212|FG000|Overall Study|Death|0|||
19585569|NCT01103141|42034213|FG001|Overall Study|Death|1|||
19585570|NCT01103141|42034212|FG000|Overall Study|Lost to Follow-up|2|||
19585571|NCT01103141|42034213|FG001|Overall Study|Lost to Follow-up|1|||
19585572|NCT00844831|42034219|FG000|Overall Study|Withdrawal by Subject|4|||
19585573|NCT00844831|42034219|FG000|Overall Study|Adverse Event|1|||
19585574|NCT00844831|42034219|FG000|Overall Study|Physician Decision|1|||
19585575|NCT00920829|42034231|FG000|Allocation|No post randomization data|3|||
19585576|NCT00920829|42034232|FG001|Allocation|No post randomization data|1|||
19585577|NCT00920829|42034233|FG002|Allocation|No post randomization data|0|||
19585578|NCT00920829|42034234|FG003|Allocation|No post randomization data|2|||
19585579|NCT00920829|42034231|FG000|Available for Analysis|Withdrawal by Subject|6|||
19585580|NCT00920829|42034232|FG001|Available for Analysis|Withdrawal by Subject|6|||
19585581|NCT00920829|42034233|FG002|Available for Analysis|Withdrawal by Subject|6|||
19585582|NCT00920829|42034234|FG003|Available for Analysis|Withdrawal by Subject|10|||
19585583|NCT00920829|42034231|FG000|Available for Analysis|Required Medical Treatment|0|||
19585584|NCT00920829|42034232|FG001|Available for Analysis|Required Medical Treatment|1|||
19585585|NCT00920829|42034233|FG002|Available for Analysis|Required Medical Treatment|2|||
19585586|NCT00920829|42034234|FG003|Available for Analysis|Required Medical Treatment|0|||
19585587|NCT00920829|42034231|FG000|Available for Analysis|Adverse Event|1|||
19585588|NCT00920829|42034232|FG001|Available for Analysis|Adverse Event|2|||
19585589|NCT00920829|42034233|FG002|Available for Analysis|Adverse Event|1|||
19585590|NCT00920829|42034234|FG003|Available for Analysis|Adverse Event|0|||
19585591|NCT00920829|42034231|FG000|Available for Analysis|Death|1|||
19585592|NCT00920829|42034232|FG001|Available for Analysis|Death|0|||
19585593|NCT00920829|42034233|FG002|Available for Analysis|Death|0|||
19585594|NCT00920829|42034234|FG003|Available for Analysis|Death|0|||
19585595|NCT00920829|42034231|FG000|Available for Analysis|Protocol Violation|0|||
19585596|NCT00920829|42034232|FG001|Available for Analysis|Protocol Violation|0|||
19585597|NCT00920829|42034233|FG002|Available for Analysis|Protocol Violation|1|||
19585598|NCT00920829|42034234|FG003|Available for Analysis|Protocol Violation|0|||
19585599|NCT00920829|42034231|FG000|Available for Analysis|Required more treatment|0|||
19585600|NCT00920829|42034232|FG001|Available for Analysis|Required more treatment|2|||
19585601|NCT00920829|42034233|FG002|Available for Analysis|Required more treatment|0|||
19585602|NCT00920829|42034234|FG003|Available for Analysis|Required more treatment|1|||
19585603|NCT00831181|42034244|FG000|Overall Study|Adverse Event|12|||
19585604|NCT01023672|42034249|FG000|Overall Study|Worsening disease|2|||
19585605|NCT01023672|42034249|FG000|Overall Study|Death|1|||
19585606|NCT01094171|42034253|FG000|Overall Study|Lost to Follow-up|2|||
19585607|NCT01094171|42034253|FG000|Overall Study|Informed consent withdrawal|4|||
19585608|NCT01094171|42034253|FG000|Overall Study|Migration from the study area|3|||
19585609|NCT01094171|42034253|FG000|Overall Study|Other|1|||
19585610|NCT01093625|42034259|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
19585611|NCT01093625|42034260|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
19585612|NCT01093625|42034259|FG000|2-Week Visit|Withdrawal by Subject|1|||
19585613|NCT01093625|42034260|FG001|2-Week Visit|Withdrawal by Subject|0|||
19585614|NCT01093625|42034259|FG000|1-Month Visit|Lost to Follow-up|2|||
19585615|NCT01093625|42034260|FG001|1-Month Visit|Lost to Follow-up|0|||
19585616|NCT01093625|42034259|FG000|3-Month Visit|Lost to Follow-up|2|||
19585617|NCT01093625|42034260|FG001|3-Month Visit|Lost to Follow-up|0|||
19585618|NCT01093625|42034259|FG000|6-Month Visit|Withdrawal by Subject|6|||
19585619|NCT01093625|42034260|FG001|6-Month Visit|Withdrawal by Subject|7|||
19585620|NCT01093625|42034259|FG000|6-Month Visit|Lost to Follow-up|2|||
19585621|NCT01093625|42034260|FG001|6-Month Visit|Lost to Follow-up|2|||
19585622|NCT01093625|42034259|FG000|1-Year Visit|Lost to Follow-up|5|||
19585623|NCT01093625|42034260|FG001|1-Year Visit|Lost to Follow-up|3|||
19585624|NCT01023516|42034268|FG000|Overall Study|Voluntary discontinuation|7|||
19585625|NCT01023516|42034269|FG001|Overall Study|Voluntary discontinuation|5|||
19585626|NCT01023516|42034268|FG000|Overall Study|Adverse Event|9|||
19585627|NCT01023516|42034269|FG001|Overall Study|Adverse Event|6|||
19585628|NCT01023516|42034268|FG000|Overall Study|Safety reason|0|||
19585629|NCT01023516|42034269|FG001|Overall Study|Safety reason|3|||
19585630|NCT01023516|42034268|FG000|Overall Study|Study-specific criteria|4|||
19585631|NCT01023516|42034269|FG001|Overall Study|Study-specific criteria|2|||
19585632|NCT01023516|42034268|FG000|Overall Study|Incorrect enrolment|4|||
19585633|NCT01023516|42034269|FG001|Overall Study|Incorrect enrolment|2|||
19585634|NCT00844753|42034279|FG000|Overall Study|Lack of Efficacy|1|||
19585635|NCT00844753|42034280|FG001|Overall Study|Lack of Efficacy|0|||
19585636|NCT00844753|42034281|FG002|Overall Study|Lack of Efficacy|2|||
19585637|NCT00844753|42034282|FG003|Overall Study|Lack of Efficacy|2|||
19585638|NCT00844753|42034279|FG000|Overall Study|Adverse Event|3|||
19585639|NCT00844753|42034280|FG001|Overall Study|Adverse Event|2|||
19585640|NCT00844753|42034281|FG002|Overall Study|Adverse Event|5|||
19585641|NCT00844753|42034282|FG003|Overall Study|Adverse Event|5|||
19585642|NCT00844753|42034279|FG000|Overall Study|Lost to Follow-up|1|||
19585643|NCT00844753|42034280|FG001|Overall Study|Lost to Follow-up|1|||
19585644|NCT00844753|42034281|FG002|Overall Study|Lost to Follow-up|0|||
19585645|NCT00844753|42034282|FG003|Overall Study|Lost to Follow-up|1|||
19585646|NCT00844753|42034279|FG000|Overall Study|could not swallow medication|2|||
19585647|NCT00844753|42034280|FG001|Overall Study|could not swallow medication|0|||
19585648|NCT00844753|42034281|FG002|Overall Study|could not swallow medication|0|||
19585649|NCT00844753|42034282|FG003|Overall Study|could not swallow medication|0|||
19585650|NCT00844753|42034279|FG000|Overall Study|Withdrawal by Subject|1|||
19585651|NCT00844753|42034280|FG001|Overall Study|Withdrawal by Subject|0|||
19585652|NCT00844753|42034281|FG002|Overall Study|Withdrawal by Subject|0|||
19585653|NCT00844753|42034282|FG003|Overall Study|Withdrawal by Subject|3|||
19585654|NCT00830947|42034292|FG000|Overall Study|Lost to Follow-up|4|||
19585655|NCT00830947|42034293|FG001|Overall Study|Lost to Follow-up|4|||
19585656|NCT01018992|42034301|FG000|Overall Study|Adverse Event|8|||
19585657|NCT01018992|42034302|FG001|Overall Study|Adverse Event|3|||
19585658|NCT01018992|42034301|FG000|Overall Study|Withdrawal by Subject|3|||
19585659|NCT01018992|42034302|FG001|Overall Study|Withdrawal by Subject|8|||
19585660|NCT01018992|42034301|FG000|Overall Study|Protocol Violation|0|||
19585661|NCT01018992|42034302|FG001|Overall Study|Protocol Violation|4|||
19585662|NCT01018992|42034301|FG000|Overall Study|Lost to Follow-up|5|||
19585663|NCT01018992|42034302|FG001|Overall Study|Lost to Follow-up|1|||
19585664|NCT00917553|42034310|FG000|Overall Study|Lost to Follow-up|2|||
19585665|NCT00917553|42034311|FG001|Overall Study|Lost to Follow-up|1|||
19585666|NCT01018680|42034319|FG000|Overall Study|Adverse Event|23|||
19585667|NCT01018680|42034320|FG001|Overall Study|Adverse Event|40|||
19585668|NCT01018680|42034319|FG000|Overall Study|Withdrawal by Subject|10|||
19585669|NCT01018680|42034320|FG001|Overall Study|Withdrawal by Subject|10|||
19585670|NCT01018680|42034319|FG000|Overall Study|Protocol Violation|5|||
19585671|NCT01018680|42034320|FG001|Overall Study|Protocol Violation|8|||
19585672|NCT01018680|42034319|FG000|Overall Study|Sponsor Decision|6|||
19585673|NCT01018680|42034320|FG001|Overall Study|Sponsor Decision|7|||
19585674|NCT01018680|42034319|FG000|Overall Study|Lack of Efficacy|8|||
19585675|NCT01018680|42034320|FG001|Overall Study|Lack of Efficacy|2|||
19585676|NCT01018680|42034319|FG000|Overall Study|Lost to Follow-up|5|||
19585677|NCT01018680|42034320|FG001|Overall Study|Lost to Follow-up|3|||
19585678|NCT01018680|42034319|FG000|Overall Study|Entry Criteria Not Met|1|||
19585679|NCT01018680|42034320|FG001|Overall Study|Entry Criteria Not Met|4|||
19585680|NCT01018680|42034319|FG000|Overall Study|Physician Decision|3|||
19585681|NCT01018680|42034320|FG001|Overall Study|Physician Decision|1|||
19585682|NCT01012440|42034326|FG000|Overall Study|Withdrawal by Subject|2|||
19585683|NCT00916929|42034332|FG000|Overall Study|Lost to Follow-up|1|||
19585684|NCT00916929|42034333|FG001|Overall Study|Lost to Follow-up|3|||
19585685|NCT00916929|42034332|FG000|Overall Study|Death|5|||
19585686|NCT00916929|42034333|FG001|Overall Study|Death|10|||
19585687|NCT00916929|42034332|FG000|Overall Study|Withdrawal by Subject|1|||
19585688|NCT00916929|42034333|FG001|Overall Study|Withdrawal by Subject|5|||
19585689|NCT00916929|42034332|FG000|Overall Study|Left ventricular epicardial lead|1|||
19585690|NCT00916929|42034333|FG001|Overall Study|Left ventricular epicardial lead|2|||
19585691|NCT00916929|42034332|FG000|Overall Study|Transferred to hospice care|1|||
19585692|NCT00916929|42034333|FG001|Overall Study|Transferred to hospice care|1|||
19585693|NCT00916929|42034332|FG000|Overall Study|System explant|1|||
19585694|NCT00916929|42034333|FG001|Overall Study|System explant|0|||
19585695|NCT00916929|42034332|FG000|Overall Study|Moved to another state|0|||
19585696|NCT00916929|42034333|FG001|Overall Study|Moved to another state|1|||
19585697|NCT00916929|42034332|FG000|Overall Study|Device unable to process impedance data|0|||
19585698|NCT00916929|42034333|FG001|Overall Study|Device unable to process impedance data|7|||
19585699|NCT00844597|42034347|FG000|Overall Study|Adverse Event|0|||
19585700|NCT00844597|42034348|FG001|Overall Study|Adverse Event|0|||
19585701|NCT00844597|42034349|FG002|Overall Study|Adverse Event|0|||
19585702|NCT00844597|42034350|FG003|Overall Study|Adverse Event|1|||
19585703|NCT00844597|42034351|FG004|Overall Study|Adverse Event|0|||
19585704|NCT00844597|42034352|FG005|Overall Study|Adverse Event|0|||
19585705|NCT01017120|42034370|FG000|Overall Study|Adverse Event|9|||
19585706|NCT01017120|42034371|FG001|Overall Study|Adverse Event|0|||
19585707|NCT01017120|42034370|FG000|Overall Study|Lost to Follow-up|13|||
19585708|NCT01017120|42034371|FG001|Overall Study|Lost to Follow-up|11|||
19585709|NCT01017120|42034370|FG000|Overall Study|Lack of Efficacy|1|||
19585710|NCT01017120|42034371|FG001|Overall Study|Lack of Efficacy|0|||
19585711|NCT01017120|42034370|FG000|Overall Study|Withdrawal by Subject|39|||
19585712|NCT01017120|42034371|FG001|Overall Study|Withdrawal by Subject|21|||
19585713|NCT01017120|42034370|FG000|Overall Study|Pregnancy|1|||
19585714|NCT01017120|42034371|FG001|Overall Study|Pregnancy|1|||
19585715|NCT01017120|42034370|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
19585716|NCT01017120|42034371|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
19585717|NCT01017120|42034370|FG000|Overall Study|Relocated Out of Town|0|||
19585718|NCT01017120|42034371|FG001|Overall Study|Relocated Out of Town|2|||
19585719|NCT01017120|42034370|FG000|Overall Study|Protocol Violation|1|||
19585720|NCT01017120|42034371|FG001|Overall Study|Protocol Violation|0|||
19585721|NCT01017120|42034370|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
19585722|NCT01017120|42034371|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
19585723|NCT01016964|42034379|FG000|Overall Study|Lost to Follow-up|3|||
19585724|NCT01016964|42034380|FG001|Overall Study|Lost to Follow-up|3|||
19585725|NCT02996110|42034391|FG000|Pre-Treatment|Other Reasons|0|||
19585726|NCT02996110|42034392|FG001|Pre-Treatment|Other Reasons|1|||
19585727|NCT02996110|42034393|FG002|Pre-Treatment|Other Reasons|0|||
19585728|NCT02996110|42034394|FG003|Pre-Treatment|Other Reasons|0|||
19585729|NCT02996110|42034395|FG004|Pre-Treatment|Other Reasons|1|||
19585730|NCT02996110|42034391|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
19585731|NCT02996110|42034392|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
19585732|NCT02996110|42034393|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
19585733|NCT02996110|42034394|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
19585734|NCT02996110|42034395|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
19585735|NCT02996110|42034391|FG000|Track 1|Disease Progression|15|||
19585736|NCT02996110|42034392|FG001|Track 1|Disease Progression|17|||
19585737|NCT02996110|42034393|FG002|Track 1|Disease Progression|0|||
19387937|NCT02039908|41631253|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
19585738|NCT02996110|42034394|FG003|Track 1|Disease Progression|0|||
19585739|NCT02996110|42034395|FG004|Track 1|Disease Progression|0|||
19585740|NCT02996110|42034391|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
19585741|NCT02996110|42034392|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
19585742|NCT02996110|42034393|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
19585743|NCT02996110|42034394|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
19585744|NCT02996110|42034395|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
19585745|NCT02996110|42034391|FG000|Track 1|Study Drug Toxicity|5|||
19585746|NCT02996110|42034392|FG001|Track 1|Study Drug Toxicity|3|||
19585747|NCT02996110|42034393|FG002|Track 1|Study Drug Toxicity|0|||
19585748|NCT02996110|42034394|FG003|Track 1|Study Drug Toxicity|0|||
19585749|NCT02996110|42034395|FG004|Track 1|Study Drug Toxicity|0|||
19585750|NCT02996110|42034391|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
19585751|NCT02996110|42034392|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
19585752|NCT02996110|42034393|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
19585753|NCT02996110|42034394|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
19585754|NCT02996110|42034395|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
19585755|NCT02996110|42034391|FG000|Track 1|Administrative Reason by Sponsor|0|||
19585756|NCT02996110|42034392|FG001|Track 1|Administrative Reason by Sponsor|1|||
19585757|NCT02996110|42034393|FG002|Track 1|Administrative Reason by Sponsor|0|||
19585758|NCT02996110|42034394|FG003|Track 1|Administrative Reason by Sponsor|0|||
19585759|NCT02996110|42034395|FG004|Track 1|Administrative Reason by Sponsor|0|||
19585760|NCT02996110|42034391|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
19585761|NCT02996110|42034392|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
19585762|NCT02996110|42034393|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
19585763|NCT02996110|42034394|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
19585764|NCT02996110|42034395|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
19585765|NCT02996110|42034391|FG000|Track 2|Disease Progression|33|||
19585766|NCT02996110|42034392|FG001|Track 2|Disease Progression|26|||
19585767|NCT02996110|42034393|FG002|Track 2|Disease Progression|19|||
19585768|NCT02996110|42034394|FG003|Track 2|Disease Progression|16|||
19585769|NCT02996110|42034395|FG004|Track 2|Disease Progression|15|||
19585770|NCT02996110|42034391|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
19585771|NCT02996110|42034392|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
19585772|NCT02996110|42034393|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
19585773|NCT02996110|42034394|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
19585774|NCT02996110|42034395|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
19585775|NCT02996110|42034391|FG000|Track 2|Death|0|||
19585776|NCT02996110|42034392|FG001|Track 2|Death|0|||
19585777|NCT02996110|42034393|FG002|Track 2|Death|1|||
19585778|NCT02996110|42034394|FG003|Track 2|Death|0|||
19585779|NCT02996110|42034395|FG004|Track 2|Death|1|||
19585780|NCT02996110|42034391|FG000|Track 2|Study Drug Toxicity|4|||
19585781|NCT02996110|42034392|FG001|Track 2|Study Drug Toxicity|1|||
19585782|NCT02996110|42034393|FG002|Track 2|Study Drug Toxicity|4|||
19585783|NCT02996110|42034394|FG003|Track 2|Study Drug Toxicity|1|||
19585784|NCT02996110|42034395|FG004|Track 2|Study Drug Toxicity|0|||
19585785|NCT02996110|42034391|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
19585786|NCT02996110|42034392|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
19585787|NCT02996110|42034393|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
19585788|NCT02996110|42034394|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
19585789|NCT02996110|42034395|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
19585790|NCT02996110|42034391|FG000|Track 2|Participant Withdrew Consent|1|||
19585791|NCT02996110|42034392|FG001|Track 2|Participant Withdrew Consent|2|||
19585792|NCT02996110|42034393|FG002|Track 2|Participant Withdrew Consent|3|||
19585793|NCT02996110|42034394|FG003|Track 2|Participant Withdrew Consent|1|||
19585794|NCT02996110|42034395|FG004|Track 2|Participant Withdrew Consent|1|||
19585795|NCT02996110|42034391|FG000|Track 2|Other Reasons|0|||
19585796|NCT02996110|42034392|FG001|Track 2|Other Reasons|0|||
19585797|NCT02996110|42034393|FG002|Track 2|Other Reasons|1|||
19585798|NCT02996110|42034394|FG003|Track 2|Other Reasons|0|||
19585799|NCT02996110|42034395|FG004|Track 2|Other Reasons|1|||
19585800|NCT00916617|42034413|FG000|Overall Study|Adverse Event|3|||
19585801|NCT00916617|42034414|FG001|Overall Study|Adverse Event|2|||
19585802|NCT00916617|42034415|FG002|Overall Study|Adverse Event|6|||
19585803|NCT00916617|42034416|FG003|Overall Study|Adverse Event|3|||
19585804|NCT00916617|42034413|FG000|Overall Study|Withdrawal by Subject|3|||
19585805|NCT00916617|42034414|FG001|Overall Study|Withdrawal by Subject|2|||
19585806|NCT00916617|42034415|FG002|Overall Study|Withdrawal by Subject|0|||
19585807|NCT00916617|42034416|FG003|Overall Study|Withdrawal by Subject|1|||
19585808|NCT00916617|42034413|FG000|Overall Study|Caregiver Request|3|||
19585809|NCT00916617|42034414|FG001|Overall Study|Caregiver Request|2|||
19585810|NCT00916617|42034415|FG002|Overall Study|Caregiver Request|1|||
19585811|NCT00916617|42034416|FG003|Overall Study|Caregiver Request|0|||
19585812|NCT00916617|42034413|FG000|Overall Study|Physician Decision|1|||
19585813|NCT00916617|42034414|FG001|Overall Study|Physician Decision|1|||
19585814|NCT00916617|42034415|FG002|Overall Study|Physician Decision|0|||
19585815|NCT00916617|42034416|FG003|Overall Study|Physician Decision|0|||
19585816|NCT00916617|42034413|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
19585817|NCT00916617|42034414|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
19585818|NCT00916617|42034415|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
19585819|NCT00916617|42034416|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
19585820|NCT00916617|42034413|FG000|Overall Study|Lost to Follow-up|2|||
19585821|NCT00916617|42034414|FG001|Overall Study|Lost to Follow-up|1|||
19585822|NCT00916617|42034415|FG002|Overall Study|Lost to Follow-up|0|||
19585823|NCT00916617|42034416|FG003|Overall Study|Lost to Follow-up|0|||
19585824|NCT00916617|42034413|FG000|Overall Study|Lack of Efficacy|1|||
19585825|NCT00916617|42034414|FG001|Overall Study|Lack of Efficacy|0|||
19585826|NCT00916617|42034415|FG002|Overall Study|Lack of Efficacy|0|||
19585827|NCT00916617|42034416|FG003|Overall Study|Lack of Efficacy|0|||
19585828|NCT00916617|42034413|FG000|Overall Study|Other|2|||
19585829|NCT00916617|42034414|FG001|Overall Study|Other|0|||
19585830|NCT00916617|42034415|FG002|Overall Study|Other|0|||
19585831|NCT00916617|42034416|FG003|Overall Study|Other|2|||
19585832|NCT01103063|42034428|FG000|Overall Study|Adverse Event|3|||
19585833|NCT01103063|42034429|FG001|Overall Study|Adverse Event|1|||
19585834|NCT01103063|42034428|FG000|Overall Study|Lost to Follow-up|68|||
19585835|NCT01103063|42034429|FG001|Overall Study|Lost to Follow-up|51|||
19585836|NCT01103063|42034428|FG000|Overall Study|Withdrawal by Subject|60|||
19585837|NCT01103063|42034429|FG001|Overall Study|Withdrawal by Subject|15|||
19585838|NCT01103063|42034428|FG000|Overall Study|Other|16|||
19585839|NCT01103063|42034429|FG001|Overall Study|Other|11|||
19585840|NCT01103063|42034428|FG000|Overall Study|Protocol Violation|1|||
19585841|NCT01103063|42034429|FG001|Overall Study|Protocol Violation|0|||
19585842|NCT01103063|42034428|FG000|Overall Study|Study terminated by Sponsor|326|||
19585843|NCT01103063|42034429|FG001|Overall Study|Study terminated by Sponsor|342|||
19585844|NCT01103063|42034428|FG000|Overall Study|Death|3|||
19585845|NCT01103063|42034429|FG001|Overall Study|Death|1|||
19585846|NCT01091675|42034437|FG000|Overall Study|Adverse Event|7|||
19585847|NCT01091675|42034437|FG000|Overall Study|Lack of Efficacy|27|||
19585848|NCT01091519|42034443|FG000|Overall Study|Adverse Event|12|||
19585849|NCT01091519|42034444|FG001|Overall Study|Adverse Event|16|||
19585850|NCT01091519|42034443|FG000|Overall Study|Death|1|||
19585851|NCT01091519|42034444|FG001|Overall Study|Death|0|||
19585852|NCT01091519|42034443|FG000|Overall Study|Lack of Efficacy|16|||
19585853|NCT01091519|42034444|FG001|Overall Study|Lack of Efficacy|19|||
19585854|NCT01091519|42034443|FG000|Overall Study|Lost to Follow-up|14|||
19585855|NCT01091519|42034444|FG001|Overall Study|Lost to Follow-up|24|||
19585856|NCT01091519|42034443|FG000|Overall Study|Withdrawal by Subject|2|||
19585857|NCT01091519|42034444|FG001|Overall Study|Withdrawal by Subject|2|||
19585858|NCT01091519|42034443|FG000|Overall Study|Other|6|||
19585859|NCT01091519|42034444|FG001|Overall Study|Other|8|||
19585860|NCT01091519|42034443|FG000|Overall Study|Randomized not treated|4|||
19585861|NCT01091519|42034444|FG001|Overall Study|Randomized not treated|4|||
19585862|NCT01011738|42034453|FG000|Overall Study|Death|12|||
19585863|NCT01011738|42034454|FG001|Overall Study|Death|3|||
19585864|NCT01011738|42034455|FG002|Overall Study|Death|0|||
19585865|NCT01011738|42034453|FG000|Overall Study|Unknown reasons|312|||
19585866|NCT01011738|42034454|FG001|Overall Study|Unknown reasons|291|||
19585867|NCT01011738|42034455|FG002|Overall Study|Unknown reasons|17|||
19585868|NCT00918333|42034466|FG000|Overall Study|Drug not taken per protocol|1|||
19585869|NCT00918333|42034467|FG001|Overall Study|Drug not taken per protocol|0|||
19585870|NCT00918333|42034466|FG000|Overall Study|Inadequate amount of drugs provided|1|||
19585871|NCT00918333|42034467|FG001|Overall Study|Inadequate amount of drugs provided|4|||
19585872|NCT00918333|42034466|FG000|Overall Study|Ineligible|1|||
19585873|NCT00918333|42034467|FG001|Overall Study|Ineligible|0|||
19585874|NCT00918333|42034466|FG000|Overall Study|Withdrawal by Subject|0|||
19585875|NCT00918333|42034467|FG001|Overall Study|Withdrawal by Subject|1|||
19585876|NCT01091363|42034478|FG000|Overall Study|Withdrawal by Subject|11|||
19585877|NCT01091363|42034479|FG001|Overall Study|Withdrawal by Subject|15|||
19585878|NCT01091363|42034478|FG000|Overall Study|Lost to Follow-up|2|||
19585879|NCT01091363|42034479|FG001|Overall Study|Lost to Follow-up|2|||
19585880|NCT01090973|42034485|FG000|Overall Study|Disease progression|1|||
19585881|NCT01090739|42034489|FG000|Enrollment|Withdrawal by Subject|24|||
19585882|NCT01090739|42034489|FG000|Enrollment|Protocol Violation|14|||
19585883|NCT01090739|42034489|FG000|Enrollment|Lost to Follow-up|5|||
19585884|NCT01090739|42034489|FG000|Enrollment|Physician Decision|5|||
19585885|NCT01090739|42034489|FG000|Enrollment|Sponsor termination of site|4|||
19585886|NCT01090739|42034489|FG000|Enrollment|Study implant limit reached|2|||
19585887|NCT01090739|42034489|FG000|Enrollment|Adverse Event|1|||
19585888|NCT01090739|42034489|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
19585889|NCT01090739|42034489|FG000|12 Month Follow-up|Lost to Follow-up|1|||
19585890|NCT01090739|42034489|FG000|12 Month Follow-up|Physician Decision|1|||
19585891|NCT01090739|42034489|FG000|12 Month Follow-up|Death|1|||
19585892|NCT01090739|42034489|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
19585893|NCT01090739|42034489|FG000|24 Month Follow-up|Lost to Follow-up|1|||
19585894|NCT01090739|42034489|FG000|24 Month Follow-up|Death|1|||
19585895|NCT01090739|42034489|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
19585896|NCT01090739|42034489|FG000|36 Month Follow-up|Visit still pending|17|||
19585897|NCT00916383|42034507|FG000|Overall Study|Adverse Event|1|||
19585898|NCT00916383|42034507|FG000|Overall Study|Death|1|||
19585899|NCT00916383|42034507|FG000|Overall Study|Protocol Violation|1|||
19585900|NCT00916305|42034517|FG000|Overall Study|Lost to Follow-up|21|||
19585901|NCT00916305|42034518|FG001|Overall Study|Lost to Follow-up|27|||
19585902|NCT00916305|42034517|FG000|Overall Study|Withdrawal by Subject|0|||
19585903|NCT00916305|42034518|FG001|Overall Study|Withdrawal by Subject|1|||
19585904|NCT00916149|42034527|FG000|Overall Study|Lost to Follow-up|3|||
19585905|NCT00916149|42034528|FG001|Overall Study|Lost to Follow-up|2|||
19585906|NCT00916149|42034529|FG002|Overall Study|Lost to Follow-up|0|||
19585907|NCT00916149|42034527|FG000|Overall Study|Unable to place scalp EEG leads|1|||
19585908|NCT00916149|42034528|FG001|Overall Study|Unable to place scalp EEG leads|0|||
19585909|NCT00916149|42034529|FG002|Overall Study|Unable to place scalp EEG leads|0|||
19585910|NCT01090427|42034539|FG000|After Controlled Period|Death|0|||
19585911|NCT01090427|42034540|FG001|After Controlled Period|Death|0|||
19585912|NCT01090427|42034541|FG002|After Controlled Period|Death|0|||
19585913|NCT01090427|42034542|FG003|After Controlled Period|Death|0|||
19585914|NCT01090427|42034543|FG004|After Controlled Period|Death|0|||
19585915|NCT01090427|42034544|FG005|After Controlled Period|Death|1|||
19585916|NCT01090427|42034545|FG006|After Controlled Period|Death|0|||
19585917|NCT01090427|42034539|FG000|After Controlled Period|Lack of Efficacy|0|||
19585918|NCT01090427|42034540|FG001|After Controlled Period|Lack of Efficacy|0|||
19585919|NCT01090427|42034541|FG002|After Controlled Period|Lack of Efficacy|0|||
19585920|NCT01090427|42034542|FG003|After Controlled Period|Lack of Efficacy|0|||
19585921|NCT01090427|42034543|FG004|After Controlled Period|Lack of Efficacy|0|||
19585922|NCT01090427|42034544|FG005|After Controlled Period|Lack of Efficacy|3|||
19585923|NCT01090427|42034545|FG006|After Controlled Period|Lack of Efficacy|2|||
19585924|NCT01090427|42034539|FG000|After Controlled Period|Adverse Event|0|||
19585925|NCT01090427|42034540|FG001|After Controlled Period|Adverse Event|0|||
19585926|NCT01090427|42034541|FG002|After Controlled Period|Adverse Event|0|||
19585927|NCT01090427|42034542|FG003|After Controlled Period|Adverse Event|2|||
19585928|NCT01090427|42034543|FG004|After Controlled Period|Adverse Event|0|||
19585929|NCT01090427|42034544|FG005|After Controlled Period|Adverse Event|1|||
19585930|NCT01090427|42034545|FG006|After Controlled Period|Adverse Event|0|||
19585931|NCT01016262|42034560|FG000|Double-blind Phase|Adverse Event|0|||
19585932|NCT01016262|42034561|FG001|Double-blind Phase|Adverse Event|0|||
19585933|NCT01016262|42034562|FG002|Double-blind Phase|Adverse Event|1|||
19585934|NCT01016262|42034563|FG003|Double-blind Phase|Adverse Event|0|||
19585935|NCT01016262|42034564|FG004|Double-blind Phase|Adverse Event|0|||
19585936|NCT01016262|42034565|FG005|Double-blind Phase|Adverse Event|0|||
19585937|NCT01016262|42034560|FG000|Double-blind Phase|Lack of Efficacy|1|||
19585938|NCT01016262|42034561|FG001|Double-blind Phase|Lack of Efficacy|0|||
19585939|NCT01016262|42034562|FG002|Double-blind Phase|Lack of Efficacy|5|||
19585940|NCT01016262|42034563|FG003|Double-blind Phase|Lack of Efficacy|0|||
19585941|NCT01016262|42034564|FG004|Double-blind Phase|Lack of Efficacy|0|||
19585942|NCT01016262|42034565|FG005|Double-blind Phase|Lack of Efficacy|0|||
19585943|NCT01016262|42034560|FG000|Double-blind Phase|Disease Progression|0|||
19585944|NCT01016262|42034561|FG001|Double-blind Phase|Disease Progression|1|||
19585945|NCT01016262|42034562|FG002|Double-blind Phase|Disease Progression|2|||
19585946|NCT01016262|42034563|FG003|Double-blind Phase|Disease Progression|0|||
19585947|NCT01016262|42034564|FG004|Double-blind Phase|Disease Progression|0|||
19585948|NCT01016262|42034565|FG005|Double-blind Phase|Disease Progression|0|||
19387938|NCT02039908|41631254|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
19585949|NCT01016262|42034560|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
19585950|NCT01016262|42034561|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
19585951|NCT01016262|42034562|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
19585952|NCT01016262|42034563|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
19585953|NCT01016262|42034564|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
19585954|NCT01016262|42034565|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
19585955|NCT01016262|42034560|FG000|Open-Label Phase|Adverse Event|0|||
19585956|NCT01016262|42034561|FG001|Open-Label Phase|Adverse Event|0|||
19585957|NCT01016262|42034562|FG002|Open-Label Phase|Adverse Event|0|||
19585958|NCT01016262|42034563|FG003|Open-Label Phase|Adverse Event|1|||
19585959|NCT01016262|42034564|FG004|Open-Label Phase|Adverse Event|0|||
19585960|NCT01016262|42034565|FG005|Open-Label Phase|Adverse Event|0|||
19585961|NCT01016262|42034560|FG000|Open-Label Phase|Lost to Follow-up|0|||
19585962|NCT01016262|42034561|FG001|Open-Label Phase|Lost to Follow-up|0|||
19585963|NCT01016262|42034562|FG002|Open-Label Phase|Lost to Follow-up|0|||
19585964|NCT01016262|42034563|FG003|Open-Label Phase|Lost to Follow-up|0|||
19585965|NCT01016262|42034564|FG004|Open-Label Phase|Lost to Follow-up|1|||
19585966|NCT01016262|42034565|FG005|Open-Label Phase|Lost to Follow-up|0|||
19585967|NCT01016262|42034560|FG000|Open-Label Phase|Lack of Efficacy|0|||
19585968|NCT01016262|42034561|FG001|Open-Label Phase|Lack of Efficacy|0|||
19585969|NCT01016262|42034562|FG002|Open-Label Phase|Lack of Efficacy|0|||
19585970|NCT01016262|42034563|FG003|Open-Label Phase|Lack of Efficacy|1|||
19585971|NCT01016262|42034564|FG004|Open-Label Phase|Lack of Efficacy|0|||
19585972|NCT01016262|42034565|FG005|Open-Label Phase|Lack of Efficacy|0|||
19585973|NCT01016262|42034560|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
19585974|NCT01016262|42034561|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
19585975|NCT01016262|42034562|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
19585976|NCT01016262|42034563|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
19585977|NCT01016262|42034564|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
19585978|NCT01016262|42034565|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
19585979|NCT01001910|42034576|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
19585980|NCT01009554|42034582|FG000|Overall Study|Adverse Event|1|||
19585981|NCT01009554|42034583|FG001|Overall Study|Adverse Event|1|||
19585982|NCT01009554|42034582|FG000|Overall Study|Withdrawal by Subject|1|||
19585983|NCT01009554|42034583|FG001|Overall Study|Withdrawal by Subject|3|||
19585984|NCT01009554|42034582|FG000|Overall Study|Noncompliant with Study Product|0|||
19585985|NCT01009554|42034583|FG001|Overall Study|Noncompliant with Study Product|3|||
19585986|NCT01006590|42034591|FG000|Overall Study|Adverse Event|2|||
19585987|NCT01006590|42034592|FG001|Overall Study|Adverse Event|3|||
19585988|NCT01006590|42034591|FG000|Overall Study|Death|1|||
19585989|NCT01006590|42034592|FG001|Overall Study|Death|1|||
19585990|NCT01006590|42034591|FG000|Overall Study|Lost to Follow-up|1|||
19585991|NCT01006590|42034592|FG001|Overall Study|Lost to Follow-up|1|||
19585992|NCT01006590|42034591|FG000|Overall Study|Protocol Violation|1|||
19585993|NCT01006590|42034592|FG001|Overall Study|Protocol Violation|0|||
19585994|NCT01006590|42034591|FG000|Overall Study|Withdrawal by Subject|4|||
19585995|NCT01006590|42034592|FG001|Overall Study|Withdrawal by Subject|2|||
19585996|NCT01006590|42034591|FG000|Overall Study|Study specific discontinuation criteria|16|||
19585997|NCT01006590|42034592|FG001|Overall Study|Study specific discontinuation criteria|23|||
19585998|NCT01006590|42034591|FG000|Overall Study|Other|3|||
19585999|NCT01006590|42034592|FG001|Overall Study|Other|2|||
19586000|NCT01001832|42034600|FG000|Short-term Period|Adverse Event|2|||
19586001|NCT01001832|42034601|FG001|Short-term Period|Adverse Event|3|||
19586002|NCT01001832|42034600|FG000|Long-term Period|Adverse Event|2|||
19586003|NCT01001832|42034601|FG001|Long-term Period|Adverse Event|1|||
19586004|NCT01001832|42034600|FG000|Long-term Period|Withdrawal by Subject|1|||
19586005|NCT01001832|42034601|FG001|Long-term Period|Withdrawal by Subject|0|||
19586006|NCT01001832|42034600|FG000|Long-term Period|Lack of Efficacy|0|||
19586007|NCT01001832|42034601|FG001|Long-term Period|Lack of Efficacy|2|||
19586008|NCT01001832|42034600|FG000|Long-term Period|Other|1|||
19586009|NCT01001832|42034601|FG001|Long-term Period|Other|2|||
19586010|NCT01001832|42034600|FG000|Follow-up Period|Withdrawal by Subject|1|||
19586011|NCT01001832|42034601|FG001|Follow-up Period|Withdrawal by Subject|0|||
19586012|NCT01001832|42034600|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
19586013|NCT01001832|42034601|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
19586014|NCT01001832|42034600|FG000|Follow-up Period|Other|2|||
19586015|NCT01001832|42034601|FG001|Follow-up Period|Other|1|||
19586016|NCT01001598|42034610|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
19586017|NCT01001598|42034610|FG000|Overall Study|Adverse Event|1|||
19586018|NCT01006356|42034614|FG000|Overall Study|Adverse Event|6|||
19586019|NCT01006356|42034614|FG000|Overall Study|Physician Decision|1|||
19586020|NCT01006356|42034614|FG000|Overall Study|Paticipants did not cooperate|6|||
19586021|NCT01006356|42034614|FG000|Overall Study|Withdrawal by Subject|1|||
19586022|NCT01006356|42034614|FG000|Overall Study|Choice by participants|2|||
19586023|NCT01006356|42034614|FG000|Overall Study|Protocol Violation|3|||
19586024|NCT01006356|42034614|FG000|Overall Study|Other|23|||
19586025|NCT01089725|42034623|FG000|Overall Study|Adverse Event|1|||
19586026|NCT01089725|42034624|FG001|Overall Study|Adverse Event|1|||
19586027|NCT01089725|42034625|FG002|Overall Study|Adverse Event|0|||
19586028|NCT01089725|42034626|FG003|Overall Study|Adverse Event|0|||
19586029|NCT01089725|42034627|FG004|Overall Study|Adverse Event|2|||
19586030|NCT01089725|42034623|FG000|Overall Study|Lack of Efficacy|4|||
19586031|NCT01089725|42034624|FG001|Overall Study|Lack of Efficacy|3|||
19586032|NCT01089725|42034625|FG002|Overall Study|Lack of Efficacy|1|||
19586033|NCT01089725|42034626|FG003|Overall Study|Lack of Efficacy|0|||
19586034|NCT01089725|42034627|FG004|Overall Study|Lack of Efficacy|4|||
19586035|NCT01089725|42034623|FG000|Overall Study|Lost to Follow-up|2|||
19586036|NCT01089725|42034624|FG001|Overall Study|Lost to Follow-up|2|||
19586037|NCT01089725|42034625|FG002|Overall Study|Lost to Follow-up|0|||
19586038|NCT01089725|42034626|FG003|Overall Study|Lost to Follow-up|3|||
19586039|NCT01089725|42034627|FG004|Overall Study|Lost to Follow-up|0|||
19586040|NCT01089725|42034623|FG000|Overall Study|Protocol Violation|0|||
19586041|NCT01089725|42034624|FG001|Overall Study|Protocol Violation|0|||
19586042|NCT01089725|42034625|FG002|Overall Study|Protocol Violation|1|||
19586043|NCT01089725|42034626|FG003|Overall Study|Protocol Violation|1|||
19586044|NCT01089725|42034627|FG004|Overall Study|Protocol Violation|0|||
19586045|NCT01089725|42034623|FG000|Overall Study|Withdrawal by Subject|5|||
19586046|NCT01089725|42034624|FG001|Overall Study|Withdrawal by Subject|5|||
19586047|NCT01089725|42034625|FG002|Overall Study|Withdrawal by Subject|4|||
19586048|NCT01089725|42034626|FG003|Overall Study|Withdrawal by Subject|5|||
19586049|NCT01089725|42034627|FG004|Overall Study|Withdrawal by Subject|4|||
19586050|NCT01089725|42034623|FG000|Overall Study|Study Terminated by Sponsor|51|||
19586051|NCT01089725|42034624|FG001|Overall Study|Study Terminated by Sponsor|56|||
19586052|NCT01089725|42034625|FG002|Overall Study|Study Terminated by Sponsor|53|||
19586053|NCT01089725|42034626|FG003|Overall Study|Study Terminated by Sponsor|68|||
19586054|NCT01089725|42034627|FG004|Overall Study|Study Terminated by Sponsor|68|||
19586055|NCT01089725|42034623|FG000|Overall Study|Randomized, but not treated|0|||
19586056|NCT01089725|42034624|FG001|Overall Study|Randomized, but not treated|1|||
19586057|NCT01089725|42034625|FG002|Overall Study|Randomized, but not treated|2|||
19586058|NCT01089725|42034626|FG003|Overall Study|Randomized, but not treated|1|||
19586059|NCT01089725|42034627|FG004|Overall Study|Randomized, but not treated|2|||
19586060|NCT01089725|42034623|FG000|Overall Study|Other|3|||
19586061|NCT01089725|42034624|FG001|Overall Study|Other|0|||
19586062|NCT01089725|42034625|FG002|Overall Study|Other|0|||
19586063|NCT01089725|42034626|FG003|Overall Study|Other|1|||
19586064|NCT01089725|42034627|FG004|Overall Study|Other|0|||
19586065|NCT01190930|42034645|FG000|Induction|Adverse Event|17|||
19586066|NCT01190930|42034646|FG001|Induction|Adverse Event|0|||
19586067|NCT01190930|42034647|FG002|Induction|Adverse Event|0|||
19586068|NCT01190930|42034648|FG003|Induction|Adverse Event|0|||
19586069|NCT01190930|42034649|FG004|Induction|Adverse Event|0|||
19586070|NCT01190930|42034650|FG005|Induction|Adverse Event|0|||
19586071|NCT01190930|42034651|FG006|Induction|Adverse Event|0|||
19586072|NCT01190930|42034652|FG007|Induction|Adverse Event|0|||
19586073|NCT01190930|42034653|FG008|Induction|Adverse Event|0|||
19586074|NCT01190930|42034654|FG009|Induction|Adverse Event|0|||
19586075|NCT01190930|42034645|FG000|Induction|Death|34|||
19586076|NCT01190930|42034646|FG001|Induction|Death|0|||
19586077|NCT01190930|42034647|FG002|Induction|Death|0|||
19586078|NCT01190930|42034648|FG003|Induction|Death|0|||
19586079|NCT01190930|42034649|FG004|Induction|Death|0|||
19586080|NCT01190930|42034650|FG005|Induction|Death|0|||
19586081|NCT01190930|42034651|FG006|Induction|Death|0|||
19586082|NCT01190930|42034652|FG007|Induction|Death|0|||
19586083|NCT01190930|42034653|FG008|Induction|Death|0|||
19586084|NCT01190930|42034654|FG009|Induction|Death|0|||
19586085|NCT01190930|42034645|FG000|Induction|Lost to Follow-up|1|||
19586086|NCT01190930|42034646|FG001|Induction|Lost to Follow-up|0|||
19586087|NCT01190930|42034647|FG002|Induction|Lost to Follow-up|0|||
19586088|NCT01190930|42034648|FG003|Induction|Lost to Follow-up|0|||
19586089|NCT01190930|42034649|FG004|Induction|Lost to Follow-up|0|||
19586090|NCT01190930|42034650|FG005|Induction|Lost to Follow-up|0|||
19586091|NCT01190930|42034651|FG006|Induction|Lost to Follow-up|0|||
19586092|NCT01190930|42034652|FG007|Induction|Lost to Follow-up|0|||
19586093|NCT01190930|42034653|FG008|Induction|Lost to Follow-up|0|||
19586094|NCT01190930|42034654|FG009|Induction|Lost to Follow-up|0|||
19586095|NCT01190930|42034645|FG000|Induction|Physician Decision|125|||
19387939|NCT02058940|41631262|FG000|Overall Study|Discharged from Critical Care Unit|1|||
19387940|NCT02058628|41631268|FG000|Overall Study|Adverse Event|1|||
19387941|NCT02058628|41631269|FG001|Overall Study|Adverse Event|0|||
19387942|NCT02058628|41631268|FG000|Overall Study|Withdrawal by Subject|2|||
19387943|NCT02058628|41631269|FG001|Overall Study|Withdrawal by Subject|2|||
19387944|NCT02058628|41631268|FG000|Overall Study|Lost to Follow-up|2|||
19387945|NCT02058628|41631269|FG001|Overall Study|Lost to Follow-up|4|||
19387946|NCT02058628|41631268|FG000|Overall Study|Not in time schedule|0|||
19387947|NCT02058628|41631269|FG001|Overall Study|Not in time schedule|1|||
19586096|NCT01190930|42034646|FG001|Induction|Physician Decision|3|||
19586097|NCT01190930|42034647|FG002|Induction|Physician Decision|0|||
19586098|NCT01190930|42034648|FG003|Induction|Physician Decision|0|||
19586099|NCT01190930|42034649|FG004|Induction|Physician Decision|0|||
19586100|NCT01190930|42034650|FG005|Induction|Physician Decision|0|||
19586101|NCT01190930|42034651|FG006|Induction|Physician Decision|0|||
19586102|NCT01190930|42034652|FG007|Induction|Physician Decision|0|||
19586103|NCT01190930|42034653|FG008|Induction|Physician Decision|0|||
19586104|NCT01190930|42034654|FG009|Induction|Physician Decision|0|||
19586105|NCT01190930|42034645|FG000|Induction|Withdrawal by Subject|9|||
19586106|NCT01190930|42034646|FG001|Induction|Withdrawal by Subject|0|||
19586107|NCT01190930|42034647|FG002|Induction|Withdrawal by Subject|0|||
19586108|NCT01190930|42034648|FG003|Induction|Withdrawal by Subject|0|||
19586109|NCT01190930|42034649|FG004|Induction|Withdrawal by Subject|0|||
19586110|NCT01190930|42034650|FG005|Induction|Withdrawal by Subject|0|||
19586111|NCT01190930|42034651|FG006|Induction|Withdrawal by Subject|0|||
19586112|NCT01190930|42034652|FG007|Induction|Withdrawal by Subject|0|||
19586113|NCT01190930|42034653|FG008|Induction|Withdrawal by Subject|0|||
19586114|NCT01190930|42034654|FG009|Induction|Withdrawal by Subject|0|||
19586115|NCT01190930|42034645|FG000|Induction|Refusal|235|||
19586116|NCT01190930|42034646|FG001|Induction|Refusal|0|||
19586117|NCT01190930|42034647|FG002|Induction|Refusal|0|||
19586118|NCT01190930|42034648|FG003|Induction|Refusal|0|||
19586119|NCT01190930|42034649|FG004|Induction|Refusal|0|||
19586120|NCT01190930|42034650|FG005|Induction|Refusal|0|||
19586121|NCT01190930|42034651|FG006|Induction|Refusal|0|||
19586122|NCT01190930|42034652|FG007|Induction|Refusal|0|||
19586123|NCT01190930|42034653|FG008|Induction|Refusal|0|||
19586124|NCT01190930|42034654|FG009|Induction|Refusal|0|||
19586125|NCT01190930|42034645|FG000|Induction|Inevaluable|23|||
19586126|NCT01190930|42034646|FG001|Induction|Inevaluable|1|||
19586127|NCT01190930|42034647|FG002|Induction|Inevaluable|0|||
19586128|NCT01190930|42034648|FG003|Induction|Inevaluable|0|||
19586129|NCT01190930|42034649|FG004|Induction|Inevaluable|0|||
19586130|NCT01190930|42034650|FG005|Induction|Inevaluable|0|||
19586131|NCT01190930|42034651|FG006|Induction|Inevaluable|0|||
19586132|NCT01190930|42034652|FG007|Induction|Inevaluable|0|||
19586133|NCT01190930|42034653|FG008|Induction|Inevaluable|0|||
19586134|NCT01190930|42034654|FG009|Induction|Inevaluable|0|||
19586135|NCT01190930|42034645|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
19586136|NCT01190930|42034646|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586137|NCT01190930|42034647|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586138|NCT01190930|42034648|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586139|NCT01190930|42034649|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586140|NCT01190930|42034650|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586141|NCT01190930|42034651|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586142|NCT01190930|42034652|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586143|NCT01190930|42034653|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586144|NCT01190930|42034654|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
19586145|NCT01190930|42034645|FG000|Induction|High Risk Downs|80|||
19586146|NCT01190930|42034646|FG001|Induction|High Risk Downs|0|||
19586147|NCT01190930|42034647|FG002|Induction|High Risk Downs|0|||
19586148|NCT01190930|42034648|FG003|Induction|High Risk Downs|0|||
19586149|NCT01190930|42034649|FG004|Induction|High Risk Downs|0|||
19586150|NCT01190930|42034650|FG005|Induction|High Risk Downs|0|||
19586151|NCT01190930|42034651|FG006|Induction|High Risk Downs|0|||
19586152|NCT01190930|42034652|FG007|Induction|High Risk Downs|0|||
19586153|NCT01190930|42034653|FG008|Induction|High Risk Downs|0|||
19586154|NCT01190930|42034654|FG009|Induction|High Risk Downs|0|||
19586155|NCT01190930|42034645|FG000|Induction|Enrollment onto another COG Protocol|1|||
19586156|NCT01190930|42034646|FG001|Induction|Enrollment onto another COG Protocol|0|||
19586157|NCT01190930|42034647|FG002|Induction|Enrollment onto another COG Protocol|0|||
19586158|NCT01190930|42034648|FG003|Induction|Enrollment onto another COG Protocol|0|||
19586159|NCT01190930|42034649|FG004|Induction|Enrollment onto another COG Protocol|0|||
19586160|NCT01190930|42034650|FG005|Induction|Enrollment onto another COG Protocol|0|||
19586161|NCT01190930|42034651|FG006|Induction|Enrollment onto another COG Protocol|0|||
19586162|NCT01190930|42034652|FG007|Induction|Enrollment onto another COG Protocol|0|||
19586163|NCT01190930|42034653|FG008|Induction|Enrollment onto another COG Protocol|0|||
19586164|NCT01190930|42034654|FG009|Induction|Enrollment onto another COG Protocol|0|||
19586165|NCT01190930|42034645|FG000|Induction|Average Risk|1847|||
19586166|NCT01190930|42034646|FG001|Induction|Average Risk|0|||
19586167|NCT01190930|42034647|FG002|Induction|Average Risk|0|||
19586168|NCT01190930|42034648|FG003|Induction|Average Risk|0|||
19586169|NCT01190930|42034649|FG004|Induction|Average Risk|0|||
19586170|NCT01190930|42034650|FG005|Induction|Average Risk|0|||
19586171|NCT01190930|42034651|FG006|Induction|Average Risk|0|||
19586172|NCT01190930|42034652|FG007|Induction|Average Risk|0|||
19586173|NCT01190930|42034653|FG008|Induction|Average Risk|0|||
19586174|NCT01190930|42034654|FG009|Induction|Average Risk|0|||
19586175|NCT01190930|42034645|FG000|Induction|High Risk|1227|||
19586176|NCT01190930|42034646|FG001|Induction|High Risk|0|||
19586177|NCT01190930|42034647|FG002|Induction|High Risk|0|||
19586178|NCT01190930|42034648|FG003|Induction|High Risk|0|||
19586179|NCT01190930|42034649|FG004|Induction|High Risk|0|||
19476968|NCT01489189|41755551|FG000|Overall Study|Withdrawal by Subject|20|||
19586180|NCT01190930|42034650|FG005|Induction|High Risk|0|||
19586181|NCT01190930|42034651|FG006|Induction|High Risk|0|||
19586182|NCT01190930|42034652|FG007|Induction|High Risk|0|||
19586183|NCT01190930|42034653|FG008|Induction|High Risk|0|||
19586184|NCT01190930|42034654|FG009|Induction|High Risk|0|||
19586185|NCT01190930|42034645|FG000|Induction|Low Risk|443|||
19586186|NCT01190930|42034646|FG001|Induction|Low Risk|0|||
19586187|NCT01190930|42034647|FG002|Induction|Low Risk|0|||
19586188|NCT01190930|42034648|FG003|Induction|Low Risk|0|||
19586189|NCT01190930|42034649|FG004|Induction|Low Risk|0|||
19586190|NCT01190930|42034650|FG005|Induction|Low Risk|0|||
19586191|NCT01190930|42034651|FG006|Induction|Low Risk|0|||
19586192|NCT01190930|42034652|FG007|Induction|Low Risk|0|||
19586193|NCT01190930|42034653|FG008|Induction|Low Risk|0|||
19586194|NCT01190930|42034654|FG009|Induction|Low Risk|0|||
19586195|NCT01190930|42034645|FG000|Induction|Very High Risk|1012|||
19586196|NCT01190930|42034646|FG001|Induction|Very High Risk|0|||
19586197|NCT01190930|42034647|FG002|Induction|Very High Risk|0|||
19586198|NCT01190930|42034648|FG003|Induction|Very High Risk|0|||
19586199|NCT01190930|42034649|FG004|Induction|Very High Risk|0|||
19586200|NCT01190930|42034650|FG005|Induction|Very High Risk|0|||
19586201|NCT01190930|42034651|FG006|Induction|Very High Risk|0|||
19586202|NCT01190930|42034652|FG007|Induction|Very High Risk|0|||
19586203|NCT01190930|42034653|FG008|Induction|Very High Risk|0|||
19586204|NCT01190930|42034654|FG009|Induction|Very High Risk|0|||
19586205|NCT01190930|42034645|FG000|Induction|Philadelphia chromosome-positive|99|||
19586206|NCT01190930|42034646|FG001|Induction|Philadelphia chromosome-positive|0|||
19586207|NCT01190930|42034647|FG002|Induction|Philadelphia chromosome-positive|0|||
19586208|NCT01190930|42034648|FG003|Induction|Philadelphia chromosome-positive|0|||
19586209|NCT01190930|42034649|FG004|Induction|Philadelphia chromosome-positive|0|||
19586210|NCT01190930|42034650|FG005|Induction|Philadelphia chromosome-positive|0|||
19586211|NCT01190930|42034651|FG006|Induction|Philadelphia chromosome-positive|0|||
19586212|NCT01190930|42034652|FG007|Induction|Philadelphia chromosome-positive|0|||
19586213|NCT01190930|42034653|FG008|Induction|Philadelphia chromosome-positive|0|||
19586214|NCT01190930|42034654|FG009|Induction|Philadelphia chromosome-positive|0|||
19586215|NCT01190930|42034645|FG000|Induction|Incomplete Induction data|63|||
19586216|NCT01190930|42034646|FG001|Induction|Incomplete Induction data|0|||
19586217|NCT01190930|42034647|FG002|Induction|Incomplete Induction data|0|||
19586218|NCT01190930|42034648|FG003|Induction|Incomplete Induction data|0|||
19586219|NCT01190930|42034649|FG004|Induction|Incomplete Induction data|0|||
19586220|NCT01190930|42034650|FG005|Induction|Incomplete Induction data|0|||
19586221|NCT01190930|42034651|FG006|Induction|Incomplete Induction data|0|||
19586222|NCT01190930|42034652|FG007|Induction|Incomplete Induction data|0|||
19586223|NCT01190930|42034653|FG008|Induction|Incomplete Induction data|0|||
19586224|NCT01190930|42034654|FG009|Induction|Incomplete Induction data|0|||
19586225|NCT01190930|42034645|FG000|Induction|Progressive disease|0|||
19586226|NCT01190930|42034646|FG001|Induction|Progressive disease|1|||
19586227|NCT01190930|42034647|FG002|Induction|Progressive disease|0|||
19586228|NCT01190930|42034648|FG003|Induction|Progressive disease|0|||
19586229|NCT01190930|42034649|FG004|Induction|Progressive disease|0|||
19586230|NCT01190930|42034650|FG005|Induction|Progressive disease|0|||
19586231|NCT01190930|42034651|FG006|Induction|Progressive disease|0|||
19586232|NCT01190930|42034652|FG007|Induction|Progressive disease|0|||
19586233|NCT01190930|42034653|FG008|Induction|Progressive disease|0|||
19586234|NCT01190930|42034654|FG009|Induction|Progressive disease|0|||
19586235|NCT01190930|42034645|FG000|Induction|No treatment|3|||
19586236|NCT01190930|42034646|FG001|Induction|No treatment|0|||
19586237|NCT01190930|42034647|FG002|Induction|No treatment|0|||
19586238|NCT01190930|42034648|FG003|Induction|No treatment|0|||
19586239|NCT01190930|42034649|FG004|Induction|No treatment|0|||
19586240|NCT01190930|42034650|FG005|Induction|No treatment|0|||
19586241|NCT01190930|42034651|FG006|Induction|No treatment|0|||
19586242|NCT01190930|42034652|FG007|Induction|No treatment|0|||
19586243|NCT01190930|42034653|FG008|Induction|No treatment|0|||
19586244|NCT01190930|42034654|FG009|Induction|No treatment|0|||
19586245|NCT01190930|42034645|FG000|Induction|Ineligible|69|||
19586246|NCT01190930|42034646|FG001|Induction|Ineligible|4|||
19586247|NCT01190930|42034647|FG002|Induction|Ineligible|0|||
19586248|NCT01190930|42034648|FG003|Induction|Ineligible|0|||
19586249|NCT01190930|42034649|FG004|Induction|Ineligible|0|||
19586250|NCT01190930|42034650|FG005|Induction|Ineligible|0|||
19586251|NCT01190930|42034651|FG006|Induction|Ineligible|0|||
19586252|NCT01190930|42034652|FG007|Induction|Ineligible|0|||
19586253|NCT01190930|42034653|FG008|Induction|Ineligible|0|||
19586254|NCT01190930|42034654|FG009|Induction|Ineligible|0|||
19586255|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
19586256|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
19586257|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
19586258|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
19586259|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
19586260|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
19586261|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
19586262|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
19586263|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
19586264|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
19586265|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Death|0|||
19586266|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Death|0|||
19586267|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Death|8|||
19586268|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Death|4|||
19586269|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Death|0|||
19586270|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Death|0|||
19586271|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Death|0|||
19586272|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Death|0|||
19586273|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Death|0|||
19586274|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Death|0|||
19586275|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
19586276|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
19586277|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
19586278|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
19586279|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
19586280|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
19586281|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
19586282|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
19586283|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
19586284|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
19586285|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586286|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
19586287|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
19586288|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
19586289|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586290|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586291|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586292|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586293|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586294|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
19586295|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Refusal|0|||
19586296|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Refusal|2|||
19586297|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Refusal|694|||
19586298|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Refusal|4|||
19586299|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Refusal|0|||
19586300|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Refusal|3|||
19586301|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Refusal|0|||
19586302|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Refusal|0|||
19586303|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Refusal|0|||
19586304|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Refusal|0|||
19586305|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
19586306|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
19586307|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
19586308|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
19586309|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
19586310|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
19586311|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
19586312|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
19586313|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
19586314|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
19586315|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586316|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
19586317|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586318|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586319|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586320|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586321|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586322|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586323|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586324|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
19586325|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
19586326|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
19586327|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
19586328|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
19586329|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
19586330|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
19586331|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
19586332|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
19586333|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
19586334|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
19586335|NCT01190930|42034645|FG000|Post Induction Pre-Maintenance|Relapse|0|||
19586336|NCT01190930|42034646|FG001|Post Induction Pre-Maintenance|Relapse|0|||
19586337|NCT01190930|42034647|FG002|Post Induction Pre-Maintenance|Relapse|1|||
19586338|NCT01190930|42034648|FG003|Post Induction Pre-Maintenance|Relapse|0|||
19586339|NCT01190930|42034649|FG004|Post Induction Pre-Maintenance|Relapse|0|||
19586340|NCT01190930|42034650|FG005|Post Induction Pre-Maintenance|Relapse|0|||
19586341|NCT01190930|42034651|FG006|Post Induction Pre-Maintenance|Relapse|0|||
19586342|NCT01190930|42034652|FG007|Post Induction Pre-Maintenance|Relapse|0|||
19586343|NCT01190930|42034653|FG008|Post Induction Pre-Maintenance|Relapse|0|||
19586344|NCT01190930|42034654|FG009|Post Induction Pre-Maintenance|Relapse|0|||
19586345|NCT01190930|42034645|FG000|Maintenance|Adverse Event|0|||
19586346|NCT01190930|42034646|FG001|Maintenance|Adverse Event|0|||
19586347|NCT01190930|42034647|FG002|Maintenance|Adverse Event|0|||
19586348|NCT01190930|42034648|FG003|Maintenance|Adverse Event|0|||
19586349|NCT01190930|42034649|FG004|Maintenance|Adverse Event|0|||
19586350|NCT01190930|42034650|FG005|Maintenance|Adverse Event|1|||
19586351|NCT01190930|42034651|FG006|Maintenance|Adverse Event|1|||
19586352|NCT01190930|42034652|FG007|Maintenance|Adverse Event|3|||
19586353|NCT01190930|42034653|FG008|Maintenance|Adverse Event|3|||
19586354|NCT01190930|42034654|FG009|Maintenance|Adverse Event|0|||
19586355|NCT01190930|42034645|FG000|Maintenance|Death|0|||
19586356|NCT01190930|42034646|FG001|Maintenance|Death|0|||
19586357|NCT01190930|42034647|FG002|Maintenance|Death|0|||
19586358|NCT01190930|42034648|FG003|Maintenance|Death|1|||
19586359|NCT01190930|42034649|FG004|Maintenance|Death|0|||
19586360|NCT01190930|42034650|FG005|Maintenance|Death|0|||
19586361|NCT01190930|42034651|FG006|Maintenance|Death|2|||
19586362|NCT01190930|42034652|FG007|Maintenance|Death|2|||
19586363|NCT01190930|42034653|FG008|Maintenance|Death|2|||
19586364|NCT01190930|42034654|FG009|Maintenance|Death|2|||
19586365|NCT01190930|42034645|FG000|Maintenance|Lost to Follow-up|0|||
19586366|NCT01190930|42034646|FG001|Maintenance|Lost to Follow-up|0|||
19586367|NCT01190930|42034647|FG002|Maintenance|Lost to Follow-up|0|||
19586368|NCT01190930|42034648|FG003|Maintenance|Lost to Follow-up|0|||
19586369|NCT01190930|42034649|FG004|Maintenance|Lost to Follow-up|0|||
19586370|NCT01190930|42034650|FG005|Maintenance|Lost to Follow-up|0|||
19586371|NCT01190930|42034651|FG006|Maintenance|Lost to Follow-up|1|||
19586372|NCT01190930|42034652|FG007|Maintenance|Lost to Follow-up|1|||
19586373|NCT01190930|42034653|FG008|Maintenance|Lost to Follow-up|1|||
19586374|NCT01190930|42034654|FG009|Maintenance|Lost to Follow-up|0|||
19586375|NCT01190930|42034645|FG000|Maintenance|Physician Decision|0|||
19586376|NCT01190930|42034646|FG001|Maintenance|Physician Decision|1|||
19586377|NCT01190930|42034647|FG002|Maintenance|Physician Decision|0|||
19586378|NCT01190930|42034648|FG003|Maintenance|Physician Decision|5|||
19586379|NCT01190930|42034649|FG004|Maintenance|Physician Decision|9|||
19586380|NCT01190930|42034650|FG005|Maintenance|Physician Decision|4|||
19586381|NCT01190930|42034651|FG006|Maintenance|Physician Decision|8|||
19586382|NCT01190930|42034652|FG007|Maintenance|Physician Decision|8|||
19586383|NCT01190930|42034653|FG008|Maintenance|Physician Decision|10|||
19586384|NCT01190930|42034654|FG009|Maintenance|Physician Decision|17|||
19586385|NCT01190930|42034645|FG000|Maintenance|Withdrawal by Subject|0|||
19586386|NCT01190930|42034646|FG001|Maintenance|Withdrawal by Subject|0|||
19586387|NCT01190930|42034647|FG002|Maintenance|Withdrawal by Subject|0|||
19586388|NCT01190930|42034648|FG003|Maintenance|Withdrawal by Subject|0|||
19586389|NCT01190930|42034649|FG004|Maintenance|Withdrawal by Subject|0|||
19586390|NCT01190930|42034650|FG005|Maintenance|Withdrawal by Subject|0|||
19586391|NCT01190930|42034651|FG006|Maintenance|Withdrawal by Subject|2|||
19586392|NCT01190930|42034652|FG007|Maintenance|Withdrawal by Subject|1|||
19586393|NCT01190930|42034653|FG008|Maintenance|Withdrawal by Subject|4|||
19586394|NCT01190930|42034654|FG009|Maintenance|Withdrawal by Subject|1|||
19586395|NCT01190930|42034645|FG000|Maintenance|Refusal|0|||
19586396|NCT01190930|42034646|FG001|Maintenance|Refusal|1|||
19586397|NCT01190930|42034647|FG002|Maintenance|Refusal|0|||
19586398|NCT01190930|42034648|FG003|Maintenance|Refusal|2|||
19586399|NCT01190930|42034649|FG004|Maintenance|Refusal|0|||
19586400|NCT01190930|42034650|FG005|Maintenance|Refusal|4|||
19586401|NCT01190930|42034651|FG006|Maintenance|Refusal|5|||
19586402|NCT01190930|42034652|FG007|Maintenance|Refusal|17|||
19586403|NCT01190930|42034653|FG008|Maintenance|Refusal|13|||
19586404|NCT01190930|42034654|FG009|Maintenance|Refusal|6|||
19586405|NCT01190930|42034645|FG000|Maintenance|second malignant neoplasm|0|||
19586406|NCT01190930|42034646|FG001|Maintenance|second malignant neoplasm|0|||
19586407|NCT01190930|42034647|FG002|Maintenance|second malignant neoplasm|0|||
19586408|NCT01190930|42034648|FG003|Maintenance|second malignant neoplasm|1|||
19586409|NCT01190930|42034649|FG004|Maintenance|second malignant neoplasm|0|||
19586410|NCT01190930|42034650|FG005|Maintenance|second malignant neoplasm|1|||
19586411|NCT01190930|42034651|FG006|Maintenance|second malignant neoplasm|0|||
19586412|NCT01190930|42034652|FG007|Maintenance|second malignant neoplasm|0|||
19586413|NCT01190930|42034653|FG008|Maintenance|second malignant neoplasm|1|||
19586414|NCT01190930|42034654|FG009|Maintenance|second malignant neoplasm|0|||
19586415|NCT01190930|42034645|FG000|Maintenance|Inevaluable|0|||
19586416|NCT01190930|42034646|FG001|Maintenance|Inevaluable|0|||
19586417|NCT01190930|42034647|FG002|Maintenance|Inevaluable|0|||
19586418|NCT01190930|42034648|FG003|Maintenance|Inevaluable|0|||
19586419|NCT01190930|42034649|FG004|Maintenance|Inevaluable|0|||
19586420|NCT01190930|42034650|FG005|Maintenance|Inevaluable|1|||
19586421|NCT01190930|42034651|FG006|Maintenance|Inevaluable|1|||
19586422|NCT01190930|42034652|FG007|Maintenance|Inevaluable|1|||
19586423|NCT01190930|42034653|FG008|Maintenance|Inevaluable|0|||
19586424|NCT01190930|42034654|FG009|Maintenance|Inevaluable|0|||
19586425|NCT01190930|42034645|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
19586426|NCT01190930|42034646|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
19586427|NCT01190930|42034647|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
19586428|NCT01190930|42034648|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
19586429|NCT01190930|42034649|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
19586430|NCT01190930|42034650|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
19586431|NCT01190930|42034651|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
19586432|NCT01190930|42034652|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
19586433|NCT01190930|42034653|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
19586434|NCT01190930|42034654|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
19586435|NCT01190930|42034645|FG000|Maintenance|Relapse|0|||
19586436|NCT01190930|42034646|FG001|Maintenance|Relapse|0|||
19586437|NCT01190930|42034647|FG002|Maintenance|Relapse|0|||
19586438|NCT01190930|42034648|FG003|Maintenance|Relapse|2|||
19586439|NCT01190930|42034649|FG004|Maintenance|Relapse|0|||
19586440|NCT01190930|42034650|FG005|Maintenance|Relapse|1|||
19586441|NCT01190930|42034651|FG006|Maintenance|Relapse|6|||
19586442|NCT01190930|42034652|FG007|Maintenance|Relapse|13|||
19586443|NCT01190930|42034653|FG008|Maintenance|Relapse|11|||
19586444|NCT01190930|42034654|FG009|Maintenance|Relapse|11|||
19586445|NCT01190930|42034645|FG000|Maintenance|Still on therapy|0|||
19586446|NCT01190930|42034646|FG001|Maintenance|Still on therapy|8|||
19586447|NCT01190930|42034647|FG002|Maintenance|Still on therapy|0|||
19586448|NCT01190930|42034648|FG003|Maintenance|Still on therapy|29|||
19586449|NCT01190930|42034649|FG004|Maintenance|Still on therapy|0|||
19586450|NCT01190930|42034650|FG005|Maintenance|Still on therapy|0|||
19586451|NCT01190930|42034651|FG006|Maintenance|Still on therapy|0|||
19586452|NCT01190930|42034652|FG007|Maintenance|Still on therapy|0|||
19586453|NCT01190930|42034653|FG008|Maintenance|Still on therapy|0|||
19586454|NCT01190930|42034654|FG009|Maintenance|Still on therapy|0|||
19586455|NCT01101191|42034678|FG000|Period 1|Withdrawal by Subject|1|||
19586456|NCT01101191|42034679|FG001|Period 1|Withdrawal by Subject|0|||
19586457|NCT01101191|42034678|FG000|Period 1|Adverse Event|1|||
19586458|NCT01101191|42034679|FG001|Period 1|Adverse Event|2|||
19586459|NCT01178762|42034686|FG000|Overall Study|Lost to Follow-up|15|||
19586460|NCT01178294|42034690|FG000|Overall Study|Adverse Event|4|||
19586461|NCT01178294|42034690|FG000|Overall Study|Lost to Follow-up|2|||
19586462|NCT01178294|42034690|FG000|Overall Study|Lack of Efficacy|1|||
19586463|NCT01178294|42034690|FG000|Overall Study|Death|1|||
19586464|NCT01178294|42034690|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
19586465|NCT01178294|42034690|FG000|Overall Study|Subject status is terminal|1|||
19586466|NCT01178294|42034690|FG000|Overall Study|Completion status could not be verified|1|||
19586467|NCT01178138|42034694|FG000|Overall Study|Lost to Follow-up|8|||
19586468|NCT01178138|42034694|FG000|Overall Study|Withdrawal by Subject|7|||
19586469|NCT01178138|42034694|FG000|Overall Study|Physician Decision|8|||
19586470|NCT01177670|42034703|FG000|Overall Study|Study Terminated|115|||
19586471|NCT01177670|42034703|FG000|Overall Study|Physician Decision|50|||
19586472|NCT01177670|42034703|FG000|Overall Study|Withdrawal by Subject|4|||
19586473|NCT01190228|42034710|FG000|Overall Study|Protocol Violation|4|||
19586474|NCT01190228|42034711|FG001|Overall Study|Protocol Violation|0|||
19586475|NCT01190228|42034712|FG002|Overall Study|Protocol Violation|0|||
19586476|NCT01190228|42034710|FG000|Overall Study|Withdrawal by Subject|1|||
19586477|NCT01190228|42034711|FG001|Overall Study|Withdrawal by Subject|0|||
19586478|NCT01190228|42034712|FG002|Overall Study|Withdrawal by Subject|0|||
19586479|NCT01009086|42034725|FG000|Overall Study|Lack of Efficacy|16|||
19586480|NCT01009086|42034726|FG001|Overall Study|Lack of Efficacy|15|||
19586481|NCT01009086|42034727|FG002|Overall Study|Lack of Efficacy|9|||
19586482|NCT01009086|42034725|FG000|Overall Study|Lost to Follow-up|4|||
19586483|NCT01009086|42034726|FG001|Overall Study|Lost to Follow-up|5|||
19586484|NCT01009086|42034727|FG002|Overall Study|Lost to Follow-up|3|||
19586485|NCT01009086|42034725|FG000|Overall Study|Adverse Event|12|||
19586486|NCT01009086|42034726|FG001|Overall Study|Adverse Event|11|||
19586487|NCT01009086|42034727|FG002|Overall Study|Adverse Event|8|||
19586488|NCT01009086|42034725|FG000|Overall Study|Withdrawal by Subject|9|||
19586489|NCT01009086|42034726|FG001|Overall Study|Withdrawal by Subject|11|||
19586490|NCT01009086|42034727|FG002|Overall Study|Withdrawal by Subject|13|||
19586491|NCT01009086|42034725|FG000|Overall Study|Other|3|||
19586492|NCT01009086|42034726|FG001|Overall Study|Other|5|||
19586493|NCT01009086|42034727|FG002|Overall Study|Other|1|||
19586494|NCT01190150|42034742|FG000|First Treatment|Withdrawal by Subject|1|||
19586495|NCT01190150|42034743|FG001|First Treatment|Withdrawal by Subject|0|||
19586496|NCT01190150|42034742|FG000|Washout|Withdrawal by Subject|0|||
19586497|NCT01190150|42034743|FG001|Washout|Withdrawal by Subject|1|||
19586498|NCT01190150|42034742|FG000|Washout|Difficulty in adherence|0|||
19586499|NCT01190150|42034743|FG001|Washout|Difficulty in adherence|1|||
19586500|NCT01001520|42034749|FG000|Medication Period 1|Withdrawal by Subject|2|||
19586501|NCT01001520|42034750|FG001|Medication Period 1|Withdrawal by Subject|2|||
19586502|NCT01001520|42034749|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
19586503|NCT01001520|42034750|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
19586504|NCT01001520|42034749|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
19586505|NCT01001520|42034750|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
19586506|NCT01001520|42034749|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
19586507|NCT01001520|42034750|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
19586508|NCT01001520|42034749|FG000|Washout Period|Withdrawal by Subject|2|||
19586509|NCT01001520|42034750|FG001|Washout Period|Withdrawal by Subject|1|||
19586510|NCT01001520|42034749|FG000|Medication Period 2|Withdrawal by Subject|0|||
19586511|NCT01001520|42034750|FG001|Medication Period 2|Withdrawal by Subject|3|||
19586512|NCT01189604|42034774|FG000|Overall Study|Impossible to visit|0|||
19586513|NCT01189604|42034775|FG001|Overall Study|Impossible to visit|0|||
19586514|NCT01189604|42034776|FG002|Overall Study|Impossible to visit|0|||
19586515|NCT01189604|42034777|FG003|Overall Study|Impossible to visit|0|||
19586516|NCT01189604|42034778|FG004|Overall Study|Impossible to visit|0|||
19586517|NCT01189604|42034779|FG005|Overall Study|Impossible to visit|1|||
19586518|NCT01189604|42034780|FG006|Overall Study|Impossible to visit|0|||
19586519|NCT01189604|42034774|FG000|Overall Study|Adverse Event|0|||
19586520|NCT01189604|42034775|FG001|Overall Study|Adverse Event|1|||
19586521|NCT01189604|42034776|FG002|Overall Study|Adverse Event|0|||
19586522|NCT01189604|42034777|FG003|Overall Study|Adverse Event|0|||
19586523|NCT01189604|42034778|FG004|Overall Study|Adverse Event|2|||
19586524|NCT01189604|42034779|FG005|Overall Study|Adverse Event|0|||
19586525|NCT01189604|42034780|FG006|Overall Study|Adverse Event|1|||
19586526|NCT01189604|42034774|FG000|Overall Study|Withdrawal by Subject|1|||
19586527|NCT01189604|42034775|FG001|Overall Study|Withdrawal by Subject|0|||
19586528|NCT01189604|42034776|FG002|Overall Study|Withdrawal by Subject|0|||
19586529|NCT01189604|42034777|FG003|Overall Study|Withdrawal by Subject|0|||
19586530|NCT01189604|42034778|FG004|Overall Study|Withdrawal by Subject|0|||
19586531|NCT01189604|42034779|FG005|Overall Study|Withdrawal by Subject|0|||
19586532|NCT01189604|42034780|FG006|Overall Study|Withdrawal by Subject|0|||
19586533|NCT01008696|42034798|FG000|Overall Study|Participant's evasion of hospital visit|5|||
19586534|NCT01008696|42034799|FG001|Overall Study|Participant's evasion of hospital visit|4|||
19586535|NCT01008696|42034798|FG000|Overall Study|Withdrawal by Subject|2|||
19586536|NCT01008696|42034799|FG001|Overall Study|Withdrawal by Subject|4|||
19586537|NCT01008696|42034798|FG000|Overall Study|Physician Decision|5|||
19586538|NCT01008696|42034799|FG001|Overall Study|Physician Decision|1|||
19586539|NCT01008696|42034798|FG000|Overall Study|Adverse Event|1|||
19586540|NCT01008696|42034799|FG001|Overall Study|Adverse Event|0|||
19586541|NCT01008696|42034798|FG000|Overall Study|Participants' non-cooperation|2|||
19586542|NCT01008696|42034799|FG001|Overall Study|Participants' non-cooperation|3|||
19586543|NCT01008696|42034798|FG000|Overall Study|Other|2|||
19586544|NCT01008696|42034799|FG001|Overall Study|Other|3|||
19586545|NCT01008696|42034798|FG000|Overall Study|Other|0|||
19586546|NCT01008696|42034799|FG001|Overall Study|Other|2|||
19586547|NCT01176968|42034818|FG000|Overall Study|Adverse Event|10|||
19586548|NCT01176968|42034819|FG001|Overall Study|Adverse Event|11|||
19586549|NCT01176968|42034818|FG000|Overall Study|Death|2|||
19586550|NCT01176968|42034819|FG001|Overall Study|Death|3|||
19586551|NCT01176968|42034818|FG000|Overall Study|Lack of Efficacy|0|||
19586552|NCT01176968|42034819|FG001|Overall Study|Lack of Efficacy|1|||
19586553|NCT01176968|42034818|FG000|Overall Study|Lost to Follow-up|16|||
19586554|NCT01176968|42034819|FG001|Overall Study|Lost to Follow-up|14|||
19586555|NCT01176968|42034818|FG000|Overall Study|Withdrawal by Subject|48|||
19586556|NCT01176968|42034819|FG001|Overall Study|Withdrawal by Subject|48|||
19586557|NCT01176968|42034818|FG000|Overall Study|Protocol Violation|2|||
19586558|NCT01176968|42034819|FG001|Overall Study|Protocol Violation|1|||
19586559|NCT01176968|42034818|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
19586560|NCT01176968|42034819|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
19586561|NCT01176968|42034818|FG000|Overall Study|Study terminated by sponsor|0|||
19586562|NCT01176968|42034819|FG001|Overall Study|Study terminated by sponsor|1|||
19586563|NCT01176968|42034818|FG000|Overall Study|Reason not defined|5|||
19586564|NCT01176968|42034819|FG001|Overall Study|Reason not defined|3|||
19586565|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
19586566|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
19586567|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
19586568|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
19586569|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Pregnancy|0|||
19586570|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Pregnancy|1|||
19586571|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
19745941|NCT03529773|42193187|FG031|Overall Study|Other|0|||
19586572|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
19586573|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
19586574|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
19586575|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
19586576|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
19586577|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Other|3|||
19586578|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Other|0|||
19586579|NCT01006122|42034830|FG000|First Double-blind Intervention Period|Adverse Event|0|||
19586580|NCT01006122|42034831|FG001|First Double-blind Intervention Period|Adverse Event|4|||
19586581|NCT01006122|42034830|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
19586582|NCT01006122|42034831|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
19586583|NCT01006122|42034830|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
19586584|NCT01006122|42034831|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
19586585|NCT01006122|42034830|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
19586586|NCT01006122|42034831|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
19586587|NCT01006122|42034830|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
19586588|NCT01006122|42034831|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
19586589|NCT01006122|42034830|FG000|Second Double-blind Intervention Period|Death|0|||
19586590|NCT01006122|42034831|FG001|Second Double-blind Intervention Period|Death|1|||
19586591|NCT01005966|42034837|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
19586592|NCT01005966|42034838|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
19586593|NCT01005966|42034839|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
19586594|NCT01005966|42034840|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
19586595|NCT01005966|42034841|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
19586596|NCT01005966|42034837|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
19586597|NCT01005966|42034838|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
19586598|NCT01005966|42034839|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
19586599|NCT01005966|42034840|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
19586600|NCT01005966|42034841|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
19586601|NCT01005966|42034837|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
19586602|NCT01005966|42034838|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
19586603|NCT01005966|42034839|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
19586604|NCT01005966|42034840|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
19745942|NCT03529773|42193188|FG032|Overall Study|Other|0|||
19745943|NCT03529773|42193189|FG033|Overall Study|Other|0|||
19586605|NCT01005966|42034841|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
19586606|NCT01005966|42034837|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
19586607|NCT01005966|42034838|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
19586608|NCT01005966|42034839|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
19586609|NCT01005966|42034840|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
19586610|NCT01005966|42034841|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
19586611|NCT01005966|42034837|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19586612|NCT01005966|42034838|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19586613|NCT01005966|42034839|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19586614|NCT01005966|42034840|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
19586615|NCT01005966|42034841|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19586616|NCT01005966|42034837|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19586617|NCT01005966|42034838|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19586618|NCT01005966|42034839|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
19586619|NCT01005966|42034840|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19586620|NCT01005966|42034841|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19586621|NCT01005966|42034837|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
19586622|NCT01005966|42034838|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
19586623|NCT01005966|42034839|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
19586624|NCT01005966|42034840|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
19586625|NCT01005966|42034841|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
19586626|NCT01005966|42034837|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
19586627|NCT01005966|42034838|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
19586628|NCT01005966|42034839|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
19586629|NCT01005966|42034840|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
19586630|NCT01005966|42034841|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
19586631|NCT01005966|42034837|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
19586632|NCT01005966|42034838|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
19586633|NCT01005966|42034839|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
19586634|NCT01005966|42034840|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
19586635|NCT01005966|42034841|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
19586636|NCT01005732|42034867|FG000|Overall Study|Lost to Follow-up|10|||
19586637|NCT01005732|42034867|FG000|Overall Study|Death|1|||
19586638|NCT00603382|42034881|FG000|Overall Study|Adverse Event|0|||
19586639|NCT00603382|42034882|FG001|Overall Study|Adverse Event|1|||
19586640|NCT00603382|42034883|FG002|Overall Study|Adverse Event|1|||
19586641|NCT00603382|42034884|FG003|Overall Study|Adverse Event|2|||
19586642|NCT00603382|42034885|FG004|Overall Study|Adverse Event|1|||
19586643|NCT00603382|42034886|FG005|Overall Study|Adverse Event|2|||
19586644|NCT00603382|42034881|FG000|Overall Study|Lack of Efficacy|14|||
19586645|NCT00603382|42034882|FG001|Overall Study|Lack of Efficacy|9|||
19586646|NCT00603382|42034883|FG002|Overall Study|Lack of Efficacy|3|||
19586647|NCT00603382|42034884|FG003|Overall Study|Lack of Efficacy|6|||
19586648|NCT00603382|42034885|FG004|Overall Study|Lack of Efficacy|6|||
19586649|NCT00603382|42034886|FG005|Overall Study|Lack of Efficacy|11|||
19586650|NCT00603382|42034881|FG000|Overall Study|Protocol Violation|1|||
19586651|NCT00603382|42034882|FG001|Overall Study|Protocol Violation|0|||
19586652|NCT00603382|42034883|FG002|Overall Study|Protocol Violation|1|||
19586653|NCT00603382|42034884|FG003|Overall Study|Protocol Violation|2|||
19586654|NCT00603382|42034885|FG004|Overall Study|Protocol Violation|1|||
19586655|NCT00603382|42034886|FG005|Overall Study|Protocol Violation|0|||
19586656|NCT00603382|42034881|FG000|Overall Study|Lost to Follow-up|0|||
19586657|NCT00603382|42034882|FG001|Overall Study|Lost to Follow-up|1|||
19586658|NCT00603382|42034883|FG002|Overall Study|Lost to Follow-up|1|||
19586659|NCT00603382|42034884|FG003|Overall Study|Lost to Follow-up|1|||
19586660|NCT00603382|42034885|FG004|Overall Study|Lost to Follow-up|0|||
19586661|NCT00603382|42034886|FG005|Overall Study|Lost to Follow-up|1|||
19586662|NCT00603382|42034881|FG000|Overall Study|Physician Decision|0|||
19586663|NCT00603382|42034882|FG001|Overall Study|Physician Decision|0|||
19586664|NCT00603382|42034883|FG002|Overall Study|Physician Decision|2|||
19586665|NCT00603382|42034884|FG003|Overall Study|Physician Decision|0|||
19586666|NCT00603382|42034885|FG004|Overall Study|Physician Decision|1|||
19586667|NCT00603382|42034886|FG005|Overall Study|Physician Decision|3|||
19586668|NCT00603382|42034881|FG000|Overall Study|Withdrawal by Subject|3|||
19586669|NCT00603382|42034882|FG001|Overall Study|Withdrawal by Subject|3|||
19586670|NCT00603382|42034883|FG002|Overall Study|Withdrawal by Subject|1|||
19586671|NCT00603382|42034884|FG003|Overall Study|Withdrawal by Subject|1|||
19586672|NCT00603382|42034885|FG004|Overall Study|Withdrawal by Subject|0|||
19586673|NCT00603382|42034886|FG005|Overall Study|Withdrawal by Subject|1|||
19586674|NCT01176266|42034900|FG000|Overall Study|Death|6|||
19586675|NCT01176266|42034900|FG000|Overall Study|Withdrawal by Subject|3|||
19586676|NCT01182428|42034910|FG000|Overall Study|Physician Decision|1|||
19586677|NCT01182428|42034911|FG001|Overall Study|Physician Decision|0|||
19586678|NCT01182428|42034910|FG000|Overall Study|Lost to Follow-up|9|||
19586679|NCT01182428|42034911|FG001|Overall Study|Lost to Follow-up|1|||
19586680|NCT01182428|42034910|FG000|Overall Study|Withdrawal by Subject|1|||
19586681|NCT01182428|42034911|FG001|Overall Study|Withdrawal by Subject|0|||
19586682|NCT00603304|42034919|FG000|Overall Study|Lost to Follow-up|5|||
19586683|NCT00603304|42034920|FG001|Overall Study|Lost to Follow-up|7|||
19586684|NCT00603304|42034919|FG000|Overall Study|Withdrawal by Subject|8|||
19586685|NCT00603304|42034920|FG001|Overall Study|Withdrawal by Subject|5|||
19586686|NCT00603304|42034919|FG000|Overall Study|Protocol Violation|1|||
19586687|NCT00603304|42034920|FG001|Overall Study|Protocol Violation|0|||
19586688|NCT00603304|42034919|FG000|Overall Study|Adverse Event|4|||
19586689|NCT00603304|42034920|FG001|Overall Study|Adverse Event|2|||
19586690|NCT00603304|42034919|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
19586691|NCT00603304|42034920|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
19586692|NCT00603304|42034919|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
19586693|NCT00603304|42034920|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
19586694|NCT00603304|42034919|FG000|Overall Study|Exclusionary Medication|2|||
19586695|NCT00603304|42034920|FG001|Overall Study|Exclusionary Medication|3|||
19586696|NCT00603304|42034919|FG000|Overall Study|Non-Compliant|0|||
19586697|NCT00603304|42034920|FG001|Overall Study|Non-Compliant|1|||
19586698|NCT00603304|42034919|FG000|Overall Study|Moved Away|0|||
19586699|NCT00603304|42034920|FG001|Overall Study|Moved Away|2|||
19586700|NCT00603304|42034919|FG000|Overall Study|Other|2|||
19586701|NCT00603304|42034920|FG001|Overall Study|Other|0|||
19586702|NCT00603304|42034919|FG000|Overall Study|Patient Decision|2|||
19586703|NCT00603304|42034920|FG001|Overall Study|Patient Decision|0|||
19586704|NCT01176032|42034930|FG000|Overall Study|Adverse Event|1|||
19586705|NCT01176032|42034931|FG001|Overall Study|Adverse Event|0|||
19586706|NCT01176032|42034930|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19586707|NCT01176032|42034931|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19586708|NCT01176032|42034930|FG000|Overall Study|Protocol Violation|1|||
19586709|NCT01176032|42034931|FG001|Overall Study|Protocol Violation|0|||
19586710|NCT01176032|42034930|FG000|Overall Study|Informed consent withdrawn|3|||
19586711|NCT01176032|42034931|FG001|Overall Study|Informed consent withdrawn|0|||
19586712|NCT01176032|42034930|FG000|Overall Study|Other|1|||
19586713|NCT01176032|42034931|FG001|Overall Study|Other|0|||
19586714|NCT01208974|42034942|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
19586715|NCT01208974|42034943|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
19586716|NCT01208974|42034944|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
19586717|NCT01208974|42034945|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
19586718|NCT01208974|42034942|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
19586719|NCT01208974|42034943|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
19586720|NCT01208974|42034944|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
19586721|NCT01208974|42034945|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
19586722|NCT01208974|42034942|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
19586723|NCT01208974|42034943|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
19586724|NCT01208974|42034944|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
19586725|NCT01208974|42034945|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
19586726|NCT01008618|42034952|FG000|Period 1 (Titration Period)|Physician Decision|2|||
19586727|NCT01008618|42034953|FG001|Period 1 (Titration Period)|Physician Decision|0|||
19586728|NCT01008618|42034954|FG002|Period 1 (Titration Period)|Physician Decision|0|||
19586729|NCT01008618|42034952|FG000|Period 1 (Titration Period)|Adverse Event|33|||
19586730|NCT01008618|42034953|FG001|Period 1 (Titration Period)|Adverse Event|0|||
19586731|NCT01008618|42034954|FG002|Period 1 (Titration Period)|Adverse Event|0|||
19586732|NCT01008618|42034952|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
19586733|NCT01008618|42034953|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
19586734|NCT01008618|42034954|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
19586735|NCT01008618|42034952|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
19586736|NCT01008618|42034953|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
19586737|NCT01008618|42034954|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
19586738|NCT01008618|42034952|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
19586739|NCT01008618|42034953|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
19586740|NCT01008618|42034954|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
19586741|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
19586742|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
19586743|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
19586744|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
19586745|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
19586746|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
19586747|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
19586748|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
19586749|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
19586750|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
19586751|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
19586752|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
19586753|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
19586754|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
19586755|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
19586756|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
19586757|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
19586758|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
19586759|NCT01008618|42034952|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
19586760|NCT01008618|42034953|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
19586761|NCT01008618|42034954|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
19586762|NCT01001208|42034965|FG000|Overall Study|Adverse Event|10|||
19586763|NCT01001208|42034966|FG001|Overall Study|Adverse Event|5|||
19586764|NCT01001208|42034965|FG000|Overall Study|Lost to Follow-up|5|||
19586765|NCT01001208|42034966|FG001|Overall Study|Lost to Follow-up|9|||
19586766|NCT01001208|42034965|FG000|Overall Study|Physician Decision|1|||
19586767|NCT01001208|42034966|FG001|Overall Study|Physician Decision|0|||
19586768|NCT01001208|42034965|FG000|Overall Study|Withdrawal by Subject|4|||
19586769|NCT01001208|42034966|FG001|Overall Study|Withdrawal by Subject|5|||
19586770|NCT01001208|42034965|FG000|Overall Study|Ineligibility Determined|4|||
19586771|NCT01001208|42034966|FG001|Overall Study|Ineligibility Determined|2|||
19586772|NCT01001208|42034965|FG000|Overall Study|Noncompliance|4|||
19586773|NCT01001208|42034966|FG001|Overall Study|Noncompliance|7|||
19586774|NCT01001208|42034965|FG000|Overall Study|Disease Progression|0|||
19586775|NCT01001208|42034966|FG001|Overall Study|Disease Progression|3|||
19586776|NCT01001208|42034965|FG000|Overall Study|Other|0|||
19586777|NCT01001208|42034966|FG001|Overall Study|Other|2|||
19586778|NCT01000974|42034975|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
19586779|NCT01000974|42034976|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
19586780|NCT01000974|42034977|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
19586781|NCT01000974|42034975|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
19586782|NCT01000974|42034976|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
19586783|NCT01000974|42034977|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
19586784|NCT01000974|42034975|FG000|Primary Vaccination Phase|Protocol Violation|40|||
19586785|NCT01000974|42034976|FG001|Primary Vaccination Phase|Protocol Violation|3|||
19586786|NCT01000974|42034977|FG002|Primary Vaccination Phase|Protocol Violation|2|||
19586787|NCT01000974|42034975|FG000|Primary Vaccination Phase|Adverse Event|14|||
19586788|NCT01000974|42034976|FG001|Primary Vaccination Phase|Adverse Event|2|||
19586789|NCT01000974|42034977|FG002|Primary Vaccination Phase|Adverse Event|2|||
19586790|NCT01000974|42034975|FG000|Primary Vaccination Phase|Other|4|||
19586791|NCT01000974|42034976|FG001|Primary Vaccination Phase|Other|9|||
19586792|NCT01000974|42034977|FG002|Primary Vaccination Phase|Other|12|||
19586793|NCT01000974|42034975|FG000|Booster Vaccination Phase|Protocol Violation|0|||
19586794|NCT01000974|42034976|FG001|Booster Vaccination Phase|Protocol Violation|0|||
19586795|NCT01000974|42034977|FG002|Booster Vaccination Phase|Protocol Violation|2|||
19586796|NCT01000974|42034975|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
19586797|NCT01000974|42034976|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
19586798|NCT01000974|42034977|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
19586799|NCT01000974|42034975|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
19586800|NCT01000974|42034976|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
19586801|NCT01000974|42034977|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
19586802|NCT01000974|42034975|FG000|Booster Vaccination Phase|Other|24|||
19586803|NCT01000974|42034976|FG001|Booster Vaccination Phase|Other|6|||
19586804|NCT01000974|42034977|FG002|Booster Vaccination Phase|Other|4|||
19586805|NCT01193842|42034993|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
19586806|NCT01193842|42034994|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
19586807|NCT01193842|42034995|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
19586808|NCT01193842|42034996|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
19586809|NCT01193842|42034997|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
19586810|NCT01193842|42034993|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
19586811|NCT01193842|42034994|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
19586812|NCT01193842|42034995|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
19586813|NCT01193842|42034996|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
19586814|NCT01193842|42034997|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
19586815|NCT01193842|42034993|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
19586816|NCT01193842|42034994|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
19586817|NCT01193842|42034995|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
19586818|NCT01193842|42034996|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
19586819|NCT01193842|42034997|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
19586820|NCT01193842|42034993|FG000|Phase II: Randomized Groups|Death|0|||
19586821|NCT01193842|42034994|FG001|Phase II: Randomized Groups|Death|0|||
19586822|NCT01193842|42034995|FG002|Phase II: Randomized Groups|Death|0|||
19586823|NCT01193842|42034996|FG003|Phase II: Randomized Groups|Death|1|||
19586824|NCT01193842|42034997|FG004|Phase II: Randomized Groups|Death|1|||
19586825|NCT01193842|42034993|FG000|Phase II: Randomized Groups|Adverse Event|0|||
19586826|NCT01193842|42034994|FG001|Phase II: Randomized Groups|Adverse Event|0|||
19586827|NCT01193842|42034995|FG002|Phase II: Randomized Groups|Adverse Event|0|||
19586828|NCT01193842|42034996|FG003|Phase II: Randomized Groups|Adverse Event|5|||
19586829|NCT01193842|42034997|FG004|Phase II: Randomized Groups|Adverse Event|3|||
19586830|NCT01193842|42034993|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
19586831|NCT01193842|42034994|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
19586832|NCT01193842|42034995|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
19586833|NCT01193842|42034996|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
19586834|NCT01193842|42034997|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
19586835|NCT01193842|42034993|FG000|Phase II: Randomized Groups|Ineligible|0|||
19586836|NCT01193842|42034994|FG001|Phase II: Randomized Groups|Ineligible|0|||
19586837|NCT01193842|42034995|FG002|Phase II: Randomized Groups|Ineligible|0|||
19586838|NCT01193842|42034996|FG003|Phase II: Randomized Groups|Ineligible|0|||
19586839|NCT01193842|42034997|FG004|Phase II: Randomized Groups|Ineligible|1|||
19586840|NCT01193842|42034993|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
19586841|NCT01193842|42034994|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
19586842|NCT01193842|42034995|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
19586843|NCT01193842|42034996|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
19586844|NCT01193842|42034997|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
19586845|NCT01004406|42035016|FG000|Overall Study|Withdrawal by Subject|2|||
19586846|NCT01004406|42035017|FG001|Overall Study|Withdrawal by Subject|0|||
19586847|NCT01004406|42035016|FG000|Overall Study|Lost to Follow-up|1|||
19586848|NCT01004406|42035017|FG001|Overall Study|Lost to Follow-up|0|||
19586849|NCT01182350|42035032|FG000|Overall Study|Adverse Event|5|||
19586850|NCT01182350|42035033|FG001|Overall Study|Adverse Event|0|||
19586851|NCT01182350|42035034|FG002|Overall Study|Adverse Event|0|||
19586852|NCT01182350|42035035|FG003|Overall Study|Adverse Event|0|||
19586853|NCT01182350|42035036|FG004|Overall Study|Adverse Event|0|||
19586854|NCT01182350|42035032|FG000|Overall Study|Disease Progression|15|||
19586855|NCT01182350|42035033|FG001|Overall Study|Disease Progression|12|||
19586856|NCT01182350|42035034|FG002|Overall Study|Disease Progression|0|||
19586857|NCT01182350|42035035|FG003|Overall Study|Disease Progression|1|||
19586858|NCT01182350|42035036|FG004|Overall Study|Disease Progression|0|||
19586859|NCT01182350|42035032|FG000|Overall Study|Death|0|||
19586860|NCT01182350|42035033|FG001|Overall Study|Death|1|||
19586861|NCT01182350|42035034|FG002|Overall Study|Death|1|||
19586862|NCT01182350|42035035|FG003|Overall Study|Death|0|||
19586863|NCT01182350|42035036|FG004|Overall Study|Death|0|||
19586864|NCT01182350|42035032|FG000|Overall Study|Withdrawal by Subject|3|||
19586865|NCT01182350|42035033|FG001|Overall Study|Withdrawal by Subject|1|||
19586866|NCT01182350|42035034|FG002|Overall Study|Withdrawal by Subject|0|||
19586867|NCT01182350|42035035|FG003|Overall Study|Withdrawal by Subject|1|||
19586868|NCT01182350|42035036|FG004|Overall Study|Withdrawal by Subject|0|||
19586869|NCT01182350|42035032|FG000|Overall Study|Alternative Therapy|2|||
19586870|NCT01182350|42035033|FG001|Overall Study|Alternative Therapy|0|||
19586871|NCT01182350|42035034|FG002|Overall Study|Alternative Therapy|1|||
19586872|NCT01182350|42035035|FG003|Overall Study|Alternative Therapy|0|||
19586873|NCT01182350|42035036|FG004|Overall Study|Alternative Therapy|0|||
19586874|NCT01182350|42035032|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
19586875|NCT01182350|42035033|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
19586876|NCT01182350|42035034|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
19586877|NCT01182350|42035035|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
19586878|NCT01182350|42035036|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
19586879|NCT01182350|42035032|FG000|Overall Study|Unevaluable for Biopsy|0|||
19586880|NCT01182350|42035033|FG001|Overall Study|Unevaluable for Biopsy|0|||
19586881|NCT01182350|42035034|FG002|Overall Study|Unevaluable for Biopsy|0|||
19586882|NCT01182350|42035035|FG003|Overall Study|Unevaluable for Biopsy|0|||
19586883|NCT01182350|42035036|FG004|Overall Study|Unevaluable for Biopsy|3|||
19586884|NCT01163474|42035052|FG000|Overall Study|Withdrawal by Subject|1|||
19586885|NCT01163474|42035052|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
19586886|NCT01163474|42035052|FG000|Overall Study|Lost to Follow-up|3|||
19586887|NCT00603538|42035062|FG000|Overall Study|Adverse Event|0|||
19586888|NCT00603538|42035063|FG001|Overall Study|Adverse Event|4|||
19586889|NCT00603538|42035064|FG002|Overall Study|Adverse Event|2|||
19586890|NCT00603538|42035062|FG000|Overall Study|Objective progression or relapse|3|||
19586891|NCT00603538|42035063|FG001|Overall Study|Objective progression or relapse|0|||
19586892|NCT00603538|42035064|FG002|Overall Study|Objective progression or relapse|0|||
19586893|NCT01163318|42035075|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
19586894|NCT01163318|42035075|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
19586895|NCT01163318|42035075|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
19586896|NCT01163318|42035075|FG000|Overall Study|Participants Without Case Report Form|7|||
19586897|NCT01163318|42035075|FG000|Overall Study|Multiple Reasons Per Participant|224|||
19586898|NCT01162304|42035079|FG000|Overall Study|Beck scale to high|11|||
19586899|NCT04515394|42035085|FG000|Overall Study|Participant did not receive treatment|1|||
19586900|NCT01175018|42035091|FG000|Overall Study|Adverse Event|3|||
19586901|NCT01175018|42035092|FG001|Overall Study|Adverse Event|1|||
19586902|NCT01174784|42035100|FG000|Overall Study|Screen fails|4|||
19586903|NCT01174550|42035107|FG000|Overall Study|Death|75|||
19586904|NCT01174550|42035108|FG001|Overall Study|Death|74|||
19586905|NCT01174550|42035107|FG000|Overall Study|Lost to Follow-up|652|||
19586906|NCT01174550|42035108|FG001|Overall Study|Lost to Follow-up|510|||
19586907|NCT01174550|42035107|FG000|Overall Study|Withdrawal by Subject|543|||
19586908|NCT01174550|42035108|FG001|Overall Study|Withdrawal by Subject|289|||
19586909|NCT01008150|42035118|FG000|Overall Study|did not receive study drug|1|||
19586910|NCT01008150|42035119|FG001|Overall Study|did not receive study drug|1|||
19586911|NCT01008150|42035120|FG002|Overall Study|did not receive study drug|1|||
19586912|NCT01008150|42035121|FG003|Overall Study|did not receive study drug|0|||
19586913|NCT01007916|42035132|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
19586914|NCT01007916|42035133|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
19586915|NCT01007916|42035132|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
19586916|NCT01007916|42035133|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
19586917|NCT01007838|42035143|FG000|Overall Study|Withdrawal by Subject|1|||
19586918|NCT01007838|42035144|FG001|Overall Study|Withdrawal by Subject|0|||
19586919|NCT01007838|42035145|FG002|Overall Study|Withdrawal by Subject|0|||
19586920|NCT01007838|42035146|FG003|Overall Study|Withdrawal by Subject|0|||
19586921|NCT01007838|42035143|FG000|Overall Study|Physician Decision|1|||
19586922|NCT01007838|42035144|FG001|Overall Study|Physician Decision|0|||
19586923|NCT01007838|42035145|FG002|Overall Study|Physician Decision|0|||
19586924|NCT01007838|42035146|FG003|Overall Study|Physician Decision|0|||
19586925|NCT01007838|42035143|FG000|Overall Study|Started home haemodialysis|1|||
19586926|NCT01007838|42035144|FG001|Overall Study|Started home haemodialysis|0|||
19586927|NCT01007838|42035145|FG002|Overall Study|Started home haemodialysis|0|||
19586928|NCT01007838|42035146|FG003|Overall Study|Started home haemodialysis|0|||
19586929|NCT01007448|42035158|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
19586930|NCT01007448|42035159|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
19586931|NCT01007448|42035158|FG000|Overall Study|Staph Skin Infection Flare|1|||
19586932|NCT01007448|42035159|FG001|Overall Study|Staph Skin Infection Flare|0|||
19586933|NCT01007448|42035158|FG000|Overall Study|Participant Leaving the Country|1|||
19586934|NCT01007448|42035159|FG001|Overall Study|Participant Leaving the Country|0|||
19586935|NCT01007448|42035158|FG000|Overall Study|Participant Given Prohibited Medication|1|||
19586936|NCT01007448|42035159|FG001|Overall Study|Participant Given Prohibited Medication|0|||
19586937|NCT01007448|42035158|FG000|Overall Study|Progressive Disease|1|||
19586938|NCT01007448|42035159|FG001|Overall Study|Progressive Disease|2|||
19586939|NCT01007448|42035158|FG000|Overall Study|Lack of Efficacy|2|||
19586940|NCT01007448|42035159|FG001|Overall Study|Lack of Efficacy|0|||
19586941|NCT01007448|42035158|FG000|Overall Study|Withdrawal by Subject|2|||
19586942|NCT01007448|42035159|FG001|Overall Study|Withdrawal by Subject|3|||
19586943|NCT01007448|42035158|FG000|Overall Study|Adverse Event|1|||
19586944|NCT01007448|42035159|FG001|Overall Study|Adverse Event|4|||
19586945|NCT03538756|42035165|FG000|Long-Term Follow-up|Adverse Event|0|||
19586946|NCT03538756|42035166|FG001|Long-Term Follow-up|Adverse Event|0|||
19586947|NCT03538756|42035167|FG002|Long-Term Follow-up|Adverse Event|6|||
19586948|NCT03538756|42035165|FG000|Long-Term Follow-up|Death|0|||
19586949|NCT03538756|42035166|FG001|Long-Term Follow-up|Death|0|||
19586950|NCT03538756|42035167|FG002|Long-Term Follow-up|Death|1|||
19586951|NCT03538756|42035165|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
19586952|NCT03538756|42035166|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
19745944|NCT03529773|42193190|FG034|Overall Study|Other|1|||
19745945|NCT03529773|42193191|FG035|Overall Study|Other|1|||
19745946|NCT03529773|42193192|FG036|Overall Study|Other|0|||
19745947|NCT03529773|42193193|FG037|Overall Study|Other|0|||
19586953|NCT03538756|42035167|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
19586954|NCT03538756|42035165|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
19586955|NCT03538756|42035166|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
19586956|NCT03538756|42035167|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
19586957|NCT03538756|42035165|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
19586958|NCT03538756|42035166|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
19586959|NCT03538756|42035167|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
19586960|NCT01004250|42035177|FG000|Induction Therapy Period|Adverse Event|10|||
19586961|NCT01004250|42035177|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
19586962|NCT01004250|42035177|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
19586963|NCT01004250|42035177|FG000|Induction Therapy Period|Physician Decision|2|||
19586964|NCT01004250|42035177|FG000|Maintenance Therapy Period|Adverse Event|15|||
19387948|NCT02058628|41631268|FG000|Overall Study|The visit date was not in timeline|0|||
19586965|NCT01004250|42035177|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
19586966|NCT01004250|42035177|FG000|Maintenance Therapy Period|Protocol Violation|1|||
19586967|NCT01004250|42035177|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
19586968|NCT01004250|42035177|FG000|Maintenance Therapy Period|Physician Decision|4|||
19586969|NCT01004250|42035177|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
19586970|NCT01004172|42035185|FG000|Overall Study|Progressive Disease in CNS Only|16|||
19586971|NCT01004172|42035185|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
19586972|NCT01004172|42035185|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
19586973|NCT01004172|42035185|FG000|Overall Study|Adverse Event|1|||
19586974|NCT01004172|42035185|FG000|Overall Study|Physician Decision|1|||
19586975|NCT01004172|42035185|FG000|Overall Study|Symptomatic Deterioration|2|||
19586976|NCT01161524|42035192|FG000|Core Study (23 Weeks)|Adverse Event|3|||
19586977|NCT01161524|42035193|FG001|Core Study (23 Weeks)|Adverse Event|0|||
19586978|NCT01161524|42035194|FG002|Core Study (23 Weeks)|Adverse Event|0|||
19586979|NCT01161524|42035192|FG000|Core Study (23 Weeks)|Other|1|||
19586980|NCT01161524|42035193|FG001|Core Study (23 Weeks)|Other|0|||
19586981|NCT01161524|42035194|FG002|Core Study (23 Weeks)|Other|0|||
19586982|NCT01161524|42035192|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
19586983|NCT01161524|42035193|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
19586984|NCT01161524|42035194|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
19586985|NCT01161524|42035192|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
19586986|NCT01161524|42035193|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
19586987|NCT01161524|42035194|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
19586988|NCT01161524|42035192|FG000|Core Study (23 Weeks)|Subject Choice|3|||
19586989|NCT01161524|42035193|FG001|Core Study (23 Weeks)|Subject Choice|2|||
19586990|NCT01161524|42035194|FG002|Core Study (23 Weeks)|Subject Choice|0|||
19586991|NCT01161524|42035192|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
19586992|NCT01161524|42035193|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
19586993|NCT01161524|42035194|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
19586994|NCT01161524|42035192|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
19586995|NCT01161524|42035193|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
19586996|NCT01161524|42035194|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
19586997|NCT01161524|42035192|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
19586998|NCT01161524|42035193|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
19586999|NCT01161524|42035194|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
19587000|NCT01161524|42035192|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
19587001|NCT01161524|42035193|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
19587002|NCT01161524|42035194|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
19587003|NCT01161524|42035192|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
19587004|NCT01161524|42035193|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
19587005|NCT01161524|42035194|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
19587006|NCT01000506|42035207|FG000|Overall Study|Adverse Event|6|||
19587007|NCT01000506|42035208|FG001|Overall Study|Adverse Event|5|||
19587008|NCT01000506|42035209|FG002|Overall Study|Adverse Event|8|||
19587009|NCT01000506|42035210|FG003|Overall Study|Adverse Event|9|||
19587010|NCT01000506|42035207|FG000|Overall Study|Lack of Efficacy|8|||
19587011|NCT01000506|42035208|FG001|Overall Study|Lack of Efficacy|6|||
19587012|NCT01000506|42035209|FG002|Overall Study|Lack of Efficacy|4|||
19587013|NCT01000506|42035210|FG003|Overall Study|Lack of Efficacy|4|||
19587014|NCT01000506|42035207|FG000|Overall Study|Protocol Violation|1|||
19587015|NCT01000506|42035208|FG001|Overall Study|Protocol Violation|1|||
19587016|NCT01000506|42035209|FG002|Overall Study|Protocol Violation|0|||
19587017|NCT01000506|42035210|FG003|Overall Study|Protocol Violation|0|||
19587018|NCT01000506|42035207|FG000|Overall Study|Lost to Follow-up|1|||
19587019|NCT01000506|42035208|FG001|Overall Study|Lost to Follow-up|1|||
19587020|NCT01000506|42035209|FG002|Overall Study|Lost to Follow-up|4|||
19587021|NCT01000506|42035210|FG003|Overall Study|Lost to Follow-up|0|||
19587022|NCT01000506|42035207|FG000|Overall Study|Physician Decision|1|||
19587023|NCT01000506|42035208|FG001|Overall Study|Physician Decision|3|||
19587024|NCT01000506|42035209|FG002|Overall Study|Physician Decision|3|||
19587025|NCT01000506|42035210|FG003|Overall Study|Physician Decision|3|||
19587026|NCT01000506|42035207|FG000|Overall Study|Withdrawal by Subject|11|||
19587027|NCT01000506|42035208|FG001|Overall Study|Withdrawal by Subject|8|||
19587028|NCT01000506|42035209|FG002|Overall Study|Withdrawal by Subject|2|||
19587029|NCT01000506|42035210|FG003|Overall Study|Withdrawal by Subject|7|||
19587030|NCT01174238|42035220|FG000|Overall Study|Lost to Follow-up|2|||
19587031|NCT01174160|42035229|FG000|Overall Study|Adverse Event|1|||
19587032|NCT01174160|42035230|FG001|Overall Study|Adverse Event|0|||
19587033|NCT01174160|42035229|FG000|Overall Study|Lost to Follow-up|1|||
19587034|NCT01174160|42035230|FG001|Overall Study|Lost to Follow-up|0|||
19587035|NCT01174160|42035229|FG000|Overall Study|Physician Decision|1|||
19587036|NCT01174160|42035230|FG001|Overall Study|Physician Decision|0|||
19587037|NCT01174160|42035229|FG000|Overall Study|Protocol Violation|4|||
19587038|NCT01174160|42035230|FG001|Overall Study|Protocol Violation|6|||
19587039|NCT01174160|42035229|FG000|Overall Study|Withdrawal by Subject|1|||
19587040|NCT01174160|42035230|FG001|Overall Study|Withdrawal by Subject|0|||
19587041|NCT01161446|42035238|FG000|Overall Study|Lost to Follow-up|18|||
19587042|NCT01161446|42035239|FG001|Overall Study|Lost to Follow-up|14|||
19587043|NCT01161446|42035238|FG000|Overall Study|Withdrawal by Subject|0|||
19587044|NCT01161446|42035239|FG001|Overall Study|Withdrawal by Subject|1|||
19587045|NCT01174004|42035247|FG000|Overall Study|Adverse Event|2|||
19587046|NCT01174004|42035248|FG001|Overall Study|Adverse Event|10|||
19587047|NCT01174004|42035247|FG000|Overall Study|Withdrawal by Subject|2|||
19587048|NCT01174004|42035248|FG001|Overall Study|Withdrawal by Subject|3|||
19587049|NCT01174004|42035247|FG000|Overall Study|At Discretion of Sponsor|2|||
19587050|NCT01174004|42035248|FG001|Overall Study|At Discretion of Sponsor|2|||
19587051|NCT01174004|42035247|FG000|Overall Study|Protocol Violation|0|||
19587052|NCT01174004|42035248|FG001|Overall Study|Protocol Violation|1|||
19587053|NCT01174004|42035247|FG000|Overall Study|Physician Decision|1|||
19587054|NCT01174004|42035248|FG001|Overall Study|Physician Decision|0|||
19587055|NCT01173692|42035256|FG000|Overall Study|Adverse Event|1|||
19587056|NCT01173692|42035257|FG001|Overall Study|Adverse Event|2|||
19587057|NCT01173692|42035256|FG000|Overall Study|Withdrawal by Subject|1|||
19587058|NCT01173692|42035257|FG001|Overall Study|Withdrawal by Subject|3|||
19587059|NCT01101035|42035265|FG000|Overall Study|Adverse Event|191|||
19587060|NCT01101035|42035266|FG001|Overall Study|Adverse Event|172|||
19587061|NCT01101035|42035265|FG000|Overall Study|Major Protocol Deviation|52|||
19587062|NCT01101035|42035266|FG001|Overall Study|Major Protocol Deviation|46|||
19587063|NCT01101035|42035265|FG000|Overall Study|Lost to Follow-up|226|||
19587064|NCT01101035|42035266|FG001|Overall Study|Lost to Follow-up|223|||
19587065|NCT01101035|42035265|FG000|Overall Study|Voluntary Withdrawal|595|||
19587066|NCT01101035|42035266|FG001|Overall Study|Voluntary Withdrawal|587|||
19587067|NCT01101035|42035265|FG000|Overall Study|Reason not Specified|333|||
19587068|NCT01101035|42035266|FG001|Overall Study|Reason not Specified|363|||
19587069|NCT01100567|42035274|FG000|Overall Study|Withdrawal by Subject|5|||
19587070|NCT01100567|42035275|FG001|Overall Study|Withdrawal by Subject|8|||
19587071|NCT01100567|42035274|FG000|Overall Study|Early Hospital Discharge|6|||
19587072|NCT01100567|42035275|FG001|Overall Study|Early Hospital Discharge|4|||
19587073|NCT01100567|42035274|FG000|Overall Study|Lost to Follow-up|1|||
19587074|NCT01100567|42035275|FG001|Overall Study|Lost to Follow-up|2|||
19587075|NCT01100567|42035274|FG000|Overall Study|Physician Decision|0|||
19587076|NCT01100567|42035275|FG001|Overall Study|Physician Decision|1|||
19587077|NCT01100567|42035274|FG000|Overall Study|Deemed ineligible after consent|0|||
19587078|NCT01100567|42035275|FG001|Overall Study|Deemed ineligible after consent|1|||
19587079|NCT01160822|42035288|FG000|Overall Study|Adverse Event|0|||
19587080|NCT01160822|42035289|FG001|Overall Study|Adverse Event|0|||
19587081|NCT01160822|42035290|FG002|Overall Study|Adverse Event|0|||
19587082|NCT01160822|42035291|FG003|Overall Study|Adverse Event|0|||
19587083|NCT01160822|42035292|FG004|Overall Study|Adverse Event|1|||
19587084|NCT01160822|42035293|FG005|Overall Study|Adverse Event|2|||
19587085|NCT01160822|42035294|FG006|Overall Study|Adverse Event|5|||
19587086|NCT01160822|42035288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19587087|NCT01160822|42035289|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19587088|NCT01160822|42035290|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19587089|NCT01160822|42035291|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
19587090|NCT01160822|42035292|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
19587091|NCT01160822|42035293|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
19587092|NCT01160822|42035294|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
19587093|NCT01160822|42035288|FG000|Overall Study|Withdrawal by Subject|0|||
19587094|NCT01160822|42035289|FG001|Overall Study|Withdrawal by Subject|0|||
19587095|NCT01160822|42035290|FG002|Overall Study|Withdrawal by Subject|0|||
19587096|NCT01160822|42035291|FG003|Overall Study|Withdrawal by Subject|0|||
19587097|NCT01160822|42035292|FG004|Overall Study|Withdrawal by Subject|0|||
19587098|NCT01160822|42035293|FG005|Overall Study|Withdrawal by Subject|0|||
19587099|NCT01160822|42035294|FG006|Overall Study|Withdrawal by Subject|1|||
19587100|NCT01160822|42035288|FG000|Overall Study|Lost to Follow-up|0|||
19587101|NCT01160822|42035289|FG001|Overall Study|Lost to Follow-up|0|||
19587102|NCT01160822|42035290|FG002|Overall Study|Lost to Follow-up|0|||
19587103|NCT01160822|42035291|FG003|Overall Study|Lost to Follow-up|0|||
19587104|NCT01160822|42035292|FG004|Overall Study|Lost to Follow-up|1|||
19587105|NCT01160822|42035293|FG005|Overall Study|Lost to Follow-up|0|||
19587106|NCT01160822|42035294|FG006|Overall Study|Lost to Follow-up|0|||
19587107|NCT01160822|42035288|FG000|Overall Study|Administrative problems|0|||
19587108|NCT01160822|42035289|FG001|Overall Study|Administrative problems|0|||
19587109|NCT01160822|42035290|FG002|Overall Study|Administrative problems|0|||
19587110|NCT01160822|42035291|FG003|Overall Study|Administrative problems|0|||
19587111|NCT01160822|42035292|FG004|Overall Study|Administrative problems|1|||
19587112|NCT01160822|42035293|FG005|Overall Study|Administrative problems|0|||
19587113|NCT01160822|42035294|FG006|Overall Study|Administrative problems|0|||
19587114|NCT01160822|42035288|FG000|Overall Study|Protocol deviation|0|||
19587115|NCT01160822|42035289|FG001|Overall Study|Protocol deviation|0|||
19587116|NCT01160822|42035290|FG002|Overall Study|Protocol deviation|0|||
19587117|NCT01160822|42035291|FG003|Overall Study|Protocol deviation|0|||
19587118|NCT01160822|42035292|FG004|Overall Study|Protocol deviation|2|||
19587119|NCT01160822|42035293|FG005|Overall Study|Protocol deviation|0|||
19587120|NCT01160822|42035294|FG006|Overall Study|Protocol deviation|0|||
19587121|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
19587122|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
19587123|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
19587124|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
19587125|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Death|13|||
19587126|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Death|12|||
19587127|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Progression|257|||
19587128|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Progression|218|||
19587129|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
19587130|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
19587131|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
19587132|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
19587133|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
19587134|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
19587135|NCT01006980|42035313|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
19587136|NCT01006980|42035314|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
19587137|NCT01006980|42035313|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
19587138|NCT01006980|42035314|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
19587139|NCT01006980|42035313|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
19587140|NCT01006980|42035314|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
19587141|NCT01006980|42035313|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
19587142|NCT01006980|42035314|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
19587143|NCT01006980|42035313|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
19587144|NCT01006980|42035314|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
19587145|NCT01006980|42035313|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
19587146|NCT01006980|42035314|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
19587147|NCT00887926|42035325|FG000|Overall Study|Withdrawal by Subject|0|||
19587148|NCT00887926|42035326|FG001|Overall Study|Withdrawal by Subject|1|||
19587149|NCT00887926|42035327|FG002|Overall Study|Withdrawal by Subject|0|||
19587150|NCT00887926|42035328|FG003|Overall Study|Withdrawal by Subject|0|||
19587151|NCT00998400|42035346|FG000|Overall Study|Lack of interest/motivation|1|||
19587152|NCT00998400|42035347|FG001|Overall Study|Lack of interest/motivation|2|||
19587153|NCT00998400|42035346|FG000|Overall Study|Logistical problems|1|||
19587154|NCT00998400|42035347|FG001|Overall Study|Logistical problems|0|||
19587155|NCT00997386|42035354|FG000|Overall Study|Death|7|||
19587156|NCT00996996|42035358|FG000|Overall Study|Progressive Disease|10|||
19587157|NCT00996996|42035358|FG000|Overall Study|Non-compliance|8|||
19587158|NCT00996996|42035358|FG000|Overall Study|Lost to Follow-up|9|||
19587159|NCT00996996|42035358|FG000|Overall Study|Death|5|||
19587160|NCT00996996|42035358|FG000|Overall Study|Did Not Receive Study Medications|1|||
19587161|NCT00996918|42035367|FG000|Overall Study|Lack of Efficacy|1|||
19587162|NCT00996918|42035368|FG001|Overall Study|Lack of Efficacy|1|||
19587163|NCT00996918|42035369|FG002|Overall Study|Lack of Efficacy|2|||
19587164|NCT00996918|42035370|FG003|Overall Study|Lack of Efficacy|2|||
19587165|NCT00996918|42035371|FG004|Overall Study|Lack of Efficacy|0|||
19587166|NCT00996918|42035367|FG000|Overall Study|Adverse Event|2|||
19587167|NCT00996918|42035368|FG001|Overall Study|Adverse Event|5|||
19587168|NCT00996918|42035369|FG002|Overall Study|Adverse Event|2|||
19587169|NCT00996918|42035370|FG003|Overall Study|Adverse Event|6|||
19587170|NCT00996918|42035371|FG004|Overall Study|Adverse Event|0|||
19587171|NCT00996918|42035367|FG000|Overall Study|Withdrawal by Subject|1|||
19587172|NCT00996918|42035368|FG001|Overall Study|Withdrawal by Subject|4|||
19587173|NCT00996918|42035369|FG002|Overall Study|Withdrawal by Subject|3|||
19587174|NCT00996918|42035370|FG003|Overall Study|Withdrawal by Subject|3|||
19587175|NCT00996918|42035371|FG004|Overall Study|Withdrawal by Subject|2|||
19587176|NCT00996918|42035367|FG000|Overall Study|Physician Decision|1|||
19587177|NCT00996918|42035368|FG001|Overall Study|Physician Decision|0|||
19587178|NCT00996918|42035369|FG002|Overall Study|Physician Decision|0|||
19587179|NCT00996918|42035370|FG003|Overall Study|Physician Decision|0|||
19587180|NCT00996918|42035371|FG004|Overall Study|Physician Decision|0|||
19587181|NCT00996918|42035367|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
19587182|NCT00996918|42035368|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
19587183|NCT00996918|42035369|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
19587184|NCT00996918|42035370|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
19587185|NCT00996918|42035371|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
19587186|NCT00996918|42035367|FG000|Overall Study|Loss of Caregiver|0|||
19587187|NCT00996918|42035368|FG001|Overall Study|Loss of Caregiver|1|||
19587188|NCT00996918|42035369|FG002|Overall Study|Loss of Caregiver|0|||
19587189|NCT00996918|42035370|FG003|Overall Study|Loss of Caregiver|0|||
19587190|NCT00996918|42035371|FG004|Overall Study|Loss of Caregiver|0|||
19587191|NCT00996918|42035367|FG000|Overall Study|Other|3|||
19587192|NCT00996918|42035368|FG001|Overall Study|Other|1|||
19587193|NCT00996918|42035369|FG002|Overall Study|Other|0|||
19587194|NCT00996918|42035370|FG003|Overall Study|Other|0|||
19587195|NCT00996918|42035371|FG004|Overall Study|Other|0|||
19587196|NCT01160744|42035387|FG000|Overall Study|Withdrawal by Subject|11|||
19587197|NCT01160744|42035388|FG001|Overall Study|Withdrawal by Subject|5|||
19587198|NCT01160744|42035389|FG002|Overall Study|Withdrawal by Subject|6|||
19587199|NCT01160744|42035390|FG003|Overall Study|Withdrawal by Subject|4|||
19587200|NCT01160744|42035387|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
19587201|NCT01160744|42035388|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
19587202|NCT01160744|42035389|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
19587203|NCT01160744|42035390|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
19587204|NCT01160354|42035405|FG000|Overall Study|Death|0|||
19587205|NCT01160354|42035406|FG001|Overall Study|Death|1|||
19587206|NCT01160354|42035407|FG002|Overall Study|Death|1|||
19587207|NCT01160198|42035418|FG000|Overall Study|Withdrawal by Subject|2|||
19587208|NCT01160198|42035419|FG001|Overall Study|Withdrawal by Subject|1|||
19587209|NCT01160198|42035420|FG002|Overall Study|Withdrawal by Subject|0|||
19587210|NCT01160198|42035418|FG000|Overall Study|Adverse Event|0|||
19587211|NCT01160198|42035419|FG001|Overall Study|Adverse Event|1|||
19587212|NCT01160198|42035420|FG002|Overall Study|Adverse Event|0|||
19587213|NCT01160198|42035418|FG000|Overall Study|Lost to Follow-up|0|||
19587214|NCT01160198|42035419|FG001|Overall Study|Lost to Follow-up|1|||
19587215|NCT01160198|42035420|FG002|Overall Study|Lost to Follow-up|0|||
19587216|NCT01160198|42035418|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
19587217|NCT01160198|42035419|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
19587218|NCT01160198|42035420|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
19587219|NCT01159574|42035428|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
19587220|NCT01159574|42035428|FG000|Treatment Phase|Adverse Event|3|||
19587221|NCT01159574|42035428|FG000|Treatment Phase|Death|6|||
19587222|NCT01159574|42035428|FG000|Treatment Phase|Physician Decision|2|||
19587223|NCT01159574|42035428|FG000|Treatment Phase|Withdrawal by Subject|7|||
19587224|NCT01159574|42035428|FG000|Treatment Phase|still on treatment|2|||
19587225|NCT01159574|42035428|FG000|Follow Up Phase|Lost to Follow-up|2|||
19587226|NCT01159574|42035428|FG000|Follow Up Phase|still being followed for overall surviva|18|||
19587227|NCT01158950|42035432|FG000|1st Intervention (1 Day)|Physician Decision|1|||
19587228|NCT01158950|42035433|FG001|1st Intervention (1 Day)|Physician Decision|2|||
19587229|NCT01172288|42035440|FG000|Overall Study|Adverse Event|1|||
19587230|NCT01172288|42035441|FG001|Overall Study|Adverse Event|0|||
19587231|NCT01172288|42035440|FG000|Overall Study|Protocol Violation|0|||
19745948|NCT03529773|42193194|FG038|Overall Study|Other|0|||
19587232|NCT01172288|42035441|FG001|Overall Study|Protocol Violation|1|||
19587233|NCT00996840|42035452|FG000|Overall Study|Adverse Event|0|||
19587234|NCT00996840|42035453|FG001|Overall Study|Adverse Event|1|||
19587235|NCT00996840|42035454|FG002|Overall Study|Adverse Event|0|||
19587236|NCT00996840|42035455|FG003|Overall Study|Adverse Event|0|||
19587237|NCT00996840|42035456|FG004|Overall Study|Adverse Event|0|||
19587238|NCT00996840|42035452|FG000|Overall Study|Physician Decision|0|||
19587239|NCT00996840|42035453|FG001|Overall Study|Physician Decision|0|||
19587240|NCT00996840|42035454|FG002|Overall Study|Physician Decision|1|||
19587241|NCT00996840|42035455|FG003|Overall Study|Physician Decision|1|||
19587242|NCT00996840|42035456|FG004|Overall Study|Physician Decision|2|||
19587243|NCT00996840|42035452|FG000|Overall Study|Withdrawal by Subject|1|||
19745949|NCT03529773|42193195|FG039|Overall Study|Other|0|||
19587244|NCT00996840|42035453|FG001|Overall Study|Withdrawal by Subject|1|||
19587245|NCT00996840|42035454|FG002|Overall Study|Withdrawal by Subject|0|||
19587246|NCT00996840|42035455|FG003|Overall Study|Withdrawal by Subject|0|||
19587247|NCT00996840|42035456|FG004|Overall Study|Withdrawal by Subject|0|||
19587248|NCT00998946|42035472|FG000|Overall Study|Lost to Follow-up|1|||
19587249|NCT00998946|42035472|FG000|Overall Study|Withdrawal by Subject|1|||
19587250|NCT00998946|42035472|FG000|Overall Study|Death|2|||
19587251|NCT00998946|42035472|FG000|Overall Study|Reason Unspecified|3|||
19587252|NCT00998946|42035472|FG000|Overall Study|Enrolled but not Dosed|2|||
19587253|NCT01158404|42035484|FG000|Overall Study|Withdrawal by Subject|0|||
19587254|NCT01158404|42035485|FG001|Overall Study|Withdrawal by Subject|1|||
19587255|NCT01158404|42035486|FG002|Overall Study|Withdrawal by Subject|0|||
19587256|NCT01158404|42035487|FG003|Overall Study|Withdrawal by Subject|0|||
19587257|NCT01158404|42035488|FG004|Overall Study|Withdrawal by Subject|3|||
19587258|NCT01158404|42035489|FG005|Overall Study|Withdrawal by Subject|1|||
19587259|NCT01158404|42035490|FG006|Overall Study|Withdrawal by Subject|0|||
19587260|NCT01158404|42035491|FG007|Overall Study|Withdrawal by Subject|1|||
19587261|NCT01158404|42035484|FG000|Overall Study|Physician Decision|0|||
19587262|NCT01158404|42035485|FG001|Overall Study|Physician Decision|0|||
19587263|NCT01158404|42035486|FG002|Overall Study|Physician Decision|0|||
19587264|NCT01158404|42035487|FG003|Overall Study|Physician Decision|0|||
19587265|NCT01158404|42035488|FG004|Overall Study|Physician Decision|0|||
19587266|NCT01158404|42035489|FG005|Overall Study|Physician Decision|0|||
19587267|NCT01158404|42035490|FG006|Overall Study|Physician Decision|0|||
19587268|NCT01158404|42035491|FG007|Overall Study|Physician Decision|1|||
19587269|NCT01158404|42035484|FG000|Overall Study|Progressive Disease|0|||
19587270|NCT01158404|42035485|FG001|Overall Study|Progressive Disease|0|||
19587271|NCT01158404|42035486|FG002|Overall Study|Progressive Disease|0|||
19587272|NCT01158404|42035487|FG003|Overall Study|Progressive Disease|0|||
19587273|NCT01158404|42035488|FG004|Overall Study|Progressive Disease|0|||
19587274|NCT01158404|42035489|FG005|Overall Study|Progressive Disease|0|||
19587275|NCT01158404|42035490|FG006|Overall Study|Progressive Disease|1|||
19587276|NCT01158404|42035491|FG007|Overall Study|Progressive Disease|0|||
19587277|NCT00998790|42035511|FG000|Overall Study|Withdrawal by Subject|21|||
19587278|NCT01001988|42035515|FG000|Overall Study|Protocol Violation|84|||
19587279|NCT01001988|42035515|FG000|Overall Study|Withdrawal by Subject|18|||
19587280|NCT01001988|42035515|FG000|Overall Study|Lost to Follow-up|15|||
19587281|NCT00996606|42035519|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
19587282|NCT00996606|42035519|FG000|Overall Study|Insufficient Therapeutic Response|2|||
19587283|NCT00996606|42035519|FG000|Overall Study|Protocol Violation|1|||
19587284|NCT00996606|42035519|FG000|Overall Study|Withdrawal by Subject|3|||
19587285|NCT00995436|42035526|FG000|Overall Study|Withdrawal by Subject|2|||
19587286|NCT00995436|42035527|FG001|Overall Study|Withdrawal by Subject|5|||
19587287|NCT00995436|42035528|FG002|Overall Study|Withdrawal by Subject|0|||
19587288|NCT00994890|42035539|FG000|Overall Study|Adverse Event|13|||
19587289|NCT00994890|42035540|FG001|Overall Study|Adverse Event|9|||
19587290|NCT00994890|42035541|FG002|Overall Study|Adverse Event|11|||
19587291|NCT00994890|42035539|FG000|Overall Study|Lack of Efficacy|0|||
19587292|NCT00994890|42035540|FG001|Overall Study|Lack of Efficacy|0|||
19587293|NCT00994890|42035541|FG002|Overall Study|Lack of Efficacy|1|||
19587294|NCT00994890|42035539|FG000|Overall Study|Lost to Follow-up|6|||
19587295|NCT00994890|42035540|FG001|Overall Study|Lost to Follow-up|1|||
19587296|NCT00994890|42035541|FG002|Overall Study|Lost to Follow-up|3|||
19587297|NCT00994890|42035539|FG000|Overall Study|No longer willing to participate|8|||
19587298|NCT00994890|42035540|FG001|Overall Study|No longer willing to participate|5|||
19587299|NCT00994890|42035541|FG002|Overall Study|No longer willing to participate|13|||
19587300|NCT00994890|42035539|FG000|Overall Study|Protocol Violation|2|||
19587301|NCT00994890|42035540|FG001|Overall Study|Protocol Violation|4|||
19587302|NCT00994890|42035541|FG002|Overall Study|Protocol Violation|0|||
19587303|NCT00994890|42035539|FG000|Overall Study|Study terminated by sponsor|199|||
19587304|NCT00994890|42035540|FG001|Overall Study|Study terminated by sponsor|201|||
19587305|NCT00994890|42035541|FG002|Overall Study|Study terminated by sponsor|197|||
19587306|NCT00994890|42035539|FG000|Overall Study|Randomized, but not treated|1|||
19587307|NCT00994890|42035540|FG001|Overall Study|Randomized, but not treated|0|||
19587308|NCT00994890|42035541|FG002|Overall Study|Randomized, but not treated|0|||
19587309|NCT00994890|42035539|FG000|Overall Study|Other|2|||
19587310|NCT00994890|42035540|FG001|Overall Study|Other|2|||
19587311|NCT00994890|42035541|FG002|Overall Study|Other|1|||
19587312|NCT00994422|42035551|FG000|Overall Study|Lost to Follow-up|7|||
19587313|NCT00994422|42035552|FG001|Overall Study|Lost to Follow-up|1|||
19587314|NCT01171976|42035563|FG000|Overall Study|Protocol Violation|0|||
19587315|NCT01171976|42035564|FG001|Overall Study|Protocol Violation|0|||
19587316|NCT01171976|42035565|FG002|Overall Study|Protocol Violation|1|||
19587317|NCT01171976|42035563|FG000|Overall Study|Death|2|||
19587318|NCT01171976|42035564|FG001|Overall Study|Death|4|||
19587319|NCT01171976|42035565|FG002|Overall Study|Death|1|||
19587320|NCT01171976|42035563|FG000|Overall Study|Lost to Follow-up|4|||
19587321|NCT01171976|42035564|FG001|Overall Study|Lost to Follow-up|0|||
19587322|NCT01171976|42035565|FG002|Overall Study|Lost to Follow-up|2|||
19587323|NCT01171976|42035563|FG000|Overall Study|Withdrawal by Subject|1|||
19587324|NCT01171976|42035564|FG001|Overall Study|Withdrawal by Subject|5|||
19587325|NCT01171976|42035565|FG002|Overall Study|Withdrawal by Subject|6|||
19587326|NCT01171976|42035563|FG000|Overall Study|Abnormal test result|1|||
19587327|NCT01171976|42035564|FG001|Overall Study|Abnormal test result|0|||
19587328|NCT01171976|42035565|FG002|Overall Study|Abnormal test result|0|||
19587329|NCT01171976|42035563|FG000|Overall Study|Adverse Event|6|||
19587330|NCT01171976|42035564|FG001|Overall Study|Adverse Event|2|||
19587331|NCT01171976|42035565|FG002|Overall Study|Adverse Event|5|||
19587332|NCT00996216|42035573|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
19587333|NCT00996216|42035573|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
19587334|NCT00996216|42035573|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
19587335|NCT00830869|42035590|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
19587336|NCT00830869|42035591|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
19587337|NCT00830869|42035592|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
19587338|NCT00830869|42035593|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
19587339|NCT00830869|42035594|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
19587340|NCT00830869|42035595|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
19587341|NCT00830869|42035596|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
19587342|NCT00830869|42035597|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
19587343|NCT00830869|42035598|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
19587344|NCT00830869|42035599|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
19587345|NCT00830869|42035600|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
19587346|NCT00830869|42035601|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
19587347|NCT00830869|42035590|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
19587348|NCT00830869|42035591|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
19587349|NCT00830869|42035592|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
19587350|NCT00830869|42035593|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
19587351|NCT00830869|42035594|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
19587352|NCT00830869|42035595|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
19587353|NCT00830869|42035596|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
19587354|NCT00830869|42035597|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
19587355|NCT00830869|42035598|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
19587356|NCT00830869|42035599|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
19587357|NCT00830869|42035600|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
19587358|NCT00830869|42035601|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
19587359|NCT00830869|42035590|FG000|Period 1: Part 1|Adverse Event|0|||
19587360|NCT00830869|42035591|FG001|Period 1: Part 1|Adverse Event|0|||
19587361|NCT00830869|42035592|FG002|Period 1: Part 1|Adverse Event|0|||
19587362|NCT00830869|42035593|FG003|Period 1: Part 1|Adverse Event|0|||
19587363|NCT00830869|42035594|FG004|Period 1: Part 1|Adverse Event|0|||
19587364|NCT00830869|42035595|FG005|Period 1: Part 1|Adverse Event|1|||
19587365|NCT00830869|42035596|FG006|Period 1: Part 1|Adverse Event|1|||
19587366|NCT00830869|42035597|FG007|Period 1: Part 1|Adverse Event|0|||
19587367|NCT00830869|42035598|FG008|Period 1: Part 1|Adverse Event|0|||
19587368|NCT00830869|42035599|FG009|Period 1: Part 1|Adverse Event|0|||
19587369|NCT00830869|42035600|FG010|Period 1: Part 1|Adverse Event|0|||
19587370|NCT00830869|42035601|FG011|Period 1: Part 1|Adverse Event|0|||
19587371|NCT00830869|42035590|FG000|Period 1: Part 1|Progressive disease|1|||
19587372|NCT00830869|42035591|FG001|Period 1: Part 1|Progressive disease|0|||
19587373|NCT00830869|42035592|FG002|Period 1: Part 1|Progressive disease|1|||
19587374|NCT00830869|42035593|FG003|Period 1: Part 1|Progressive disease|6|||
19587375|NCT00830869|42035594|FG004|Period 1: Part 1|Progressive disease|4|||
19587376|NCT00830869|42035595|FG005|Period 1: Part 1|Progressive disease|4|||
19587377|NCT00830869|42035596|FG006|Period 1: Part 1|Progressive disease|1|||
19587378|NCT00830869|42035597|FG007|Period 1: Part 1|Progressive disease|0|||
19587379|NCT00830869|42035598|FG008|Period 1: Part 1|Progressive disease|0|||
19587380|NCT00830869|42035599|FG009|Period 1: Part 1|Progressive disease|0|||
19587381|NCT00830869|42035600|FG010|Period 1: Part 1|Progressive disease|0|||
19587382|NCT00830869|42035601|FG011|Period 1: Part 1|Progressive disease|0|||
19587383|NCT00830869|42035590|FG000|Period 2: Part 2|Protocol Violation|0|||
19587384|NCT00830869|42035591|FG001|Period 2: Part 2|Protocol Violation|0|||
19587385|NCT00830869|42035592|FG002|Period 2: Part 2|Protocol Violation|0|||
19587386|NCT00830869|42035593|FG003|Period 2: Part 2|Protocol Violation|0|||
19587387|NCT00830869|42035594|FG004|Period 2: Part 2|Protocol Violation|0|||
19587388|NCT00830869|42035595|FG005|Period 2: Part 2|Protocol Violation|0|||
19587389|NCT00830869|42035596|FG006|Period 2: Part 2|Protocol Violation|0|||
19587390|NCT00830869|42035597|FG007|Period 2: Part 2|Protocol Violation|1|||
19587391|NCT00830869|42035598|FG008|Period 2: Part 2|Protocol Violation|0|||
19587392|NCT00830869|42035599|FG009|Period 2: Part 2|Protocol Violation|1|||
19587393|NCT00830869|42035600|FG010|Period 2: Part 2|Protocol Violation|0|||
19587394|NCT00830869|42035601|FG011|Period 2: Part 2|Protocol Violation|0|||
19587395|NCT00830869|42035590|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
19587396|NCT00830869|42035591|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
19587397|NCT00830869|42035592|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
19745950|NCT03529773|42193156|FG000|Overall Study|Physician Decision|0|||
19745951|NCT03529773|42193157|FG001|Overall Study|Physician Decision|0|||
19745952|NCT03529773|42193158|FG002|Overall Study|Physician Decision|0|||
19745953|NCT03529773|42193159|FG003|Overall Study|Physician Decision|0|||
19745954|NCT03529773|42193160|FG004|Overall Study|Physician Decision|0|||
19587398|NCT00830869|42035593|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
19587399|NCT00830869|42035594|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
19587400|NCT00830869|42035595|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
19587401|NCT00830869|42035596|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
19587402|NCT00830869|42035597|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
19587403|NCT00830869|42035598|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
19587404|NCT00830869|42035599|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
19587405|NCT00830869|42035600|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
19587406|NCT00830869|42035601|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
19587407|NCT00830869|42035590|FG000|Period 2: Part 2|Adverse Event|0|||
19587408|NCT00830869|42035591|FG001|Period 2: Part 2|Adverse Event|0|||
19587409|NCT00830869|42035592|FG002|Period 2: Part 2|Adverse Event|0|||
19587410|NCT00830869|42035593|FG003|Period 2: Part 2|Adverse Event|0|||
19587411|NCT00830869|42035594|FG004|Period 2: Part 2|Adverse Event|0|||
19587412|NCT00830869|42035595|FG005|Period 2: Part 2|Adverse Event|0|||
19587413|NCT00830869|42035596|FG006|Period 2: Part 2|Adverse Event|0|||
19587414|NCT00830869|42035597|FG007|Period 2: Part 2|Adverse Event|4|||
19587415|NCT00830869|42035598|FG008|Period 2: Part 2|Adverse Event|3|||
19587416|NCT00830869|42035599|FG009|Period 2: Part 2|Adverse Event|2|||
19587417|NCT00830869|42035600|FG010|Period 2: Part 2|Adverse Event|2|||
19587418|NCT00830869|42035601|FG011|Period 2: Part 2|Adverse Event|0|||
19587419|NCT00830869|42035590|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
19587420|NCT00830869|42035591|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
19587421|NCT00830869|42035592|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
19587422|NCT00830869|42035593|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
19587423|NCT00830869|42035594|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
19587424|NCT00830869|42035595|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
19587425|NCT00830869|42035596|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
19587426|NCT00830869|42035597|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
19587427|NCT00830869|42035598|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
19587428|NCT00830869|42035599|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
19587429|NCT00830869|42035600|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
19587430|NCT00830869|42035601|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
19587431|NCT00830869|42035590|FG000|Period 2: Part 2|Progressive disease|0|||
19587432|NCT00830869|42035591|FG001|Period 2: Part 2|Progressive disease|0|||
19587433|NCT00830869|42035592|FG002|Period 2: Part 2|Progressive disease|0|||
19587434|NCT00830869|42035593|FG003|Period 2: Part 2|Progressive disease|0|||
19587435|NCT00830869|42035594|FG004|Period 2: Part 2|Progressive disease|0|||
19587436|NCT00830869|42035595|FG005|Period 2: Part 2|Progressive disease|0|||
19587437|NCT00830869|42035596|FG006|Period 2: Part 2|Progressive disease|0|||
19587438|NCT00830869|42035597|FG007|Period 2: Part 2|Progressive disease|14|||
19587439|NCT00830869|42035598|FG008|Period 2: Part 2|Progressive disease|11|||
19587440|NCT00830869|42035599|FG009|Period 2: Part 2|Progressive disease|12|||
19587441|NCT00830869|42035600|FG010|Period 2: Part 2|Progressive disease|8|||
19587442|NCT00830869|42035601|FG011|Period 2: Part 2|Progressive disease|15|||
19587443|NCT00830869|42035590|FG000|Period 2: Part 2|Other|0|||
19587444|NCT00830869|42035591|FG001|Period 2: Part 2|Other|0|||
19587445|NCT00830869|42035592|FG002|Period 2: Part 2|Other|0|||
19587446|NCT00830869|42035593|FG003|Period 2: Part 2|Other|0|||
19587447|NCT00830869|42035594|FG004|Period 2: Part 2|Other|0|||
19587448|NCT00830869|42035595|FG005|Period 2: Part 2|Other|0|||
19587449|NCT00830869|42035596|FG006|Period 2: Part 2|Other|0|||
19587450|NCT00830869|42035597|FG007|Period 2: Part 2|Other|0|||
19745955|NCT03529773|42193161|FG005|Overall Study|Physician Decision|0|||
19587451|NCT00830869|42035598|FG008|Period 2: Part 2|Other|0|||
19587452|NCT00830869|42035599|FG009|Period 2: Part 2|Other|1|||
19587453|NCT00830869|42035600|FG010|Period 2: Part 2|Other|0|||
19587454|NCT00830869|42035601|FG011|Period 2: Part 2|Other|0|||
19587455|NCT00844519|42035630|FG000|Overall Study|Withdrawal by Subject|1|||
19587456|NCT00844519|42035631|FG001|Overall Study|Withdrawal by Subject|1|||
19587457|NCT00844519|42035630|FG000|Overall Study|Adverse Event|1|||
19587458|NCT00844519|42035631|FG001|Overall Study|Adverse Event|0|||
19587459|NCT01171820|42035639|FG000|Overall Study|Death|3|||
19587460|NCT01171820|42035640|FG001|Overall Study|Death|3|||
19587461|NCT01171820|42035639|FG000|Overall Study|Lost to Follow-up|0|||
19587462|NCT01171820|42035640|FG001|Overall Study|Lost to Follow-up|1|||
19587463|NCT01171820|42035639|FG000|Overall Study|Withdrawal by Subject|2|||
19587464|NCT01171820|42035640|FG001|Overall Study|Withdrawal by Subject|0|||
19587465|NCT01171820|42035639|FG000|Overall Study|Physician Decision|0|||
19587466|NCT01171820|42035640|FG001|Overall Study|Physician Decision|1|||
19587467|NCT01171820|42035639|FG000|Overall Study|1-Year Missed Visit|1|||
19587468|NCT01171820|42035640|FG001|Overall Study|1-Year Missed Visit|1|||
19587469|NCT00994110|42035648|FG000|Overall Study|Withdrawal by Subject|9|||
19587470|NCT00994110|42035649|FG001|Overall Study|Withdrawal by Subject|9|||
19587471|NCT00994110|42035648|FG000|Overall Study|Not Treated|4|||
19587472|NCT00994110|42035649|FG001|Overall Study|Not Treated|8|||
19587473|NCT00994110|42035648|FG000|Overall Study|Adverse Event|1|||
19587474|NCT00994110|42035649|FG001|Overall Study|Adverse Event|0|||
19587475|NCT00994110|42035648|FG000|Overall Study|Patient not resected|41|||
19587476|NCT00994110|42035649|FG001|Overall Study|Patient not resected|52|||
19587477|NCT00994110|42035648|FG000|Overall Study|Pt not eligible|10|||
19587478|NCT00994110|42035649|FG001|Overall Study|Pt not eligible|5|||
19587479|NCT00993954|42035657|FG000|Overall Study|Protocol Violation|21|||
19587480|NCT00993954|42035658|FG001|Overall Study|Protocol Violation|2|||
19587481|NCT01157234|42035666|FG000|Overall Study|Withdrawal by Subject|1|||
19587482|NCT01157234|42035667|FG001|Overall Study|Withdrawal by Subject|0|||
19587483|NCT00991302|42035682|FG000|Overall Study|Death|0|||
19587484|NCT00991302|42035683|FG001|Overall Study|Death|1|||
19587485|NCT00991302|42035682|FG000|Overall Study|Lost to Follow-up|14|||
19587486|NCT00991302|42035683|FG001|Overall Study|Lost to Follow-up|12|||
19587487|NCT00995670|42035692|FG000|Overall Study|Failed arterial cannulation|1|||
19587488|NCT00995670|42035693|FG001|Overall Study|Failed arterial cannulation|0|||
19587489|NCT00995670|42035694|FG002|Overall Study|Failed arterial cannulation|3|||
19587490|NCT00601354|42035704|FG000|Overall Study|Lost to Follow-up|4|||
19587491|NCT00601354|42035705|FG001|Overall Study|Lost to Follow-up|5|||
19587492|NCT00853099|42035714|FG000|Double-blind Period|Adverse Event|7|||
19587493|NCT00853099|42035715|FG001|Double-blind Period|Adverse Event|9|||
19587494|NCT00853099|42035716|FG002|Double-blind Period|Adverse Event|13|||
19587495|NCT00853099|42035717|FG003|Double-blind Period|Adverse Event|0|||
19587496|NCT00853099|42035714|FG000|Double-blind Period|Withdrawal by Subject|2|||
19587497|NCT00853099|42035715|FG001|Double-blind Period|Withdrawal by Subject|3|||
19587498|NCT00853099|42035716|FG002|Double-blind Period|Withdrawal by Subject|0|||
19587499|NCT00853099|42035717|FG003|Double-blind Period|Withdrawal by Subject|0|||
19587500|NCT00853099|42035714|FG000|Double-blind Period|Lack of Efficacy|14|||
19587501|NCT00853099|42035715|FG001|Double-blind Period|Lack of Efficacy|17|||
19587502|NCT00853099|42035716|FG002|Double-blind Period|Lack of Efficacy|16|||
19587503|NCT00853099|42035717|FG003|Double-blind Period|Lack of Efficacy|0|||
19587504|NCT00853099|42035714|FG000|Double-blind Period|Other|0|||
19587505|NCT00853099|42035715|FG001|Double-blind Period|Other|0|||
19587506|NCT00853099|42035716|FG002|Double-blind Period|Other|1|||
19587507|NCT00853099|42035717|FG003|Double-blind Period|Other|0|||
19587508|NCT00853099|42035714|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
19587509|NCT00853099|42035715|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
19587510|NCT00853099|42035716|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
19587511|NCT00853099|42035717|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
19587512|NCT00853099|42035714|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
19587513|NCT00853099|42035715|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
19587514|NCT00853099|42035716|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
19587515|NCT00853099|42035717|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
19587516|NCT00853099|42035714|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
19587517|NCT00853099|42035715|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
19587518|NCT00853099|42035716|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
19587519|NCT00853099|42035717|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
19587520|NCT00853099|42035714|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
19587521|NCT00853099|42035715|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
19587522|NCT00853099|42035716|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
19587523|NCT00853099|42035717|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
19587524|NCT00853099|42035714|FG000|Double-blind + Open-label Periods|Other|0|||
19587525|NCT00853099|42035715|FG001|Double-blind + Open-label Periods|Other|0|||
19587526|NCT00853099|42035716|FG002|Double-blind + Open-label Periods|Other|0|||
19587527|NCT00853099|42035717|FG003|Double-blind + Open-label Periods|Other|6|||
19587528|NCT00992784|42035730|FG000|Overall Study|Adverse Event|2|||
19587529|NCT00992784|42035731|FG001|Overall Study|Adverse Event|1|||
19587530|NCT00992784|42035732|FG002|Overall Study|Adverse Event|0|||
19587531|NCT00992784|42035730|FG000|Overall Study|Withdrawal by Subject|1|||
19587532|NCT00992784|42035731|FG001|Overall Study|Withdrawal by Subject|1|||
19587533|NCT00992784|42035732|FG002|Overall Study|Withdrawal by Subject|1|||
19587534|NCT00830167|42035742|FG000|Overall Study|Lack of Efficacy|26|||
19587535|NCT00830167|42035743|FG001|Overall Study|Lack of Efficacy|10|||
19587536|NCT00830167|42035742|FG000|Overall Study|Adverse Event|8|||
19587537|NCT00830167|42035743|FG001|Overall Study|Adverse Event|24|||
19587538|NCT00830167|42035742|FG000|Overall Study|Not meeting entrance criteria|2|||
19587539|NCT00830167|42035743|FG001|Overall Study|Not meeting entrance criteria|5|||
19587540|NCT00830167|42035742|FG000|Overall Study|Withdrawal by Subject|2|||
19587541|NCT00830167|42035743|FG001|Overall Study|Withdrawal by Subject|0|||
19587542|NCT00830167|42035742|FG000|Overall Study|Lost to Follow-up|0|||
19587543|NCT00830167|42035743|FG001|Overall Study|Lost to Follow-up|1|||
19587544|NCT00830167|42035742|FG000|Overall Study|Protocol Violation|0|||
19587545|NCT00830167|42035743|FG001|Overall Study|Protocol Violation|1|||
19587546|NCT00830167|42035742|FG000|Overall Study|Other|2|||
19587547|NCT00830167|42035743|FG001|Overall Study|Other|2|||
19587548|NCT00992394|42035751|FG000|Overall Study|Lack of Efficacy|6|||
19587549|NCT00992394|42035752|FG001|Overall Study|Lack of Efficacy|3|||
19587550|NCT00992394|42035751|FG000|Overall Study|Adverse Event|4|||
19387949|NCT02058628|41631269|FG001|Overall Study|The visit date was not in timeline|1|||
19387950|NCT02058628|41631268|FG000|Overall Study|A lot of time for study for participant|1|||
19387951|NCT02058628|41631269|FG001|Overall Study|A lot of time for study for participant|0|||
19387952|NCT02058628|41631268|FG000|Overall Study|Non compliance|1|||
19587551|NCT00992394|42035752|FG001|Overall Study|Adverse Event|5|||
19587552|NCT00992394|42035751|FG000|Overall Study|Withdrawal by Subject|8|||
19587553|NCT00992394|42035752|FG001|Overall Study|Withdrawal by Subject|2|||
19587554|NCT00992394|42035751|FG000|Overall Study|Physician Decision|1|||
19587555|NCT00992394|42035752|FG001|Overall Study|Physician Decision|0|||
19587556|NCT00992394|42035751|FG000|Overall Study|Protocol Violation|2|||
19587557|NCT00992394|42035752|FG001|Overall Study|Protocol Violation|4|||
19587558|NCT00992394|42035751|FG000|Overall Study|Lost to Follow-up|2|||
19587559|NCT00992394|42035752|FG001|Overall Study|Lost to Follow-up|0|||
19587560|NCT00992394|42035751|FG000|Overall Study|Other event|1|||
19587561|NCT00992394|42035752|FG001|Overall Study|Other event|0|||
19587562|NCT00829933|42035762|FG000|Overall Study|Adverse Event|2|||
19587563|NCT00829933|42035763|FG001|Overall Study|Adverse Event|3|||
19587564|NCT00829933|42035764|FG002|Overall Study|Adverse Event|2|||
19587565|NCT00829933|42035765|FG003|Overall Study|Adverse Event|1|||
19587566|NCT00829933|42035762|FG000|Overall Study|Death|0|||
19587567|NCT00829933|42035763|FG001|Overall Study|Death|0|||
19587568|NCT00829933|42035764|FG002|Overall Study|Death|1|||
19587569|NCT00829933|42035765|FG003|Overall Study|Death|1|||
19587570|NCT00829933|42035762|FG000|Overall Study|Lack of Efficacy|0|||
19587571|NCT00829933|42035763|FG001|Overall Study|Lack of Efficacy|1|||
19587572|NCT00829933|42035764|FG002|Overall Study|Lack of Efficacy|0|||
19587573|NCT00829933|42035765|FG003|Overall Study|Lack of Efficacy|0|||
19587574|NCT00829933|42035762|FG000|Overall Study|Physician Decision|5|||
19587575|NCT00829933|42035763|FG001|Overall Study|Physician Decision|7|||
19587576|NCT00829933|42035764|FG002|Overall Study|Physician Decision|8|||
19387953|NCT02058628|41631269|FG001|Overall Study|Non compliance|0|||
19387954|NCT02058160|41631280|FG000|Overall Study|Randomized but not treated|2|||
19387955|NCT02058160|41631281|FG001|Overall Study|Randomized but not treated|4|||
19387956|NCT02058160|41631280|FG000|Overall Study|Poor compliance to protocol|4|||
19387957|NCT02058160|41631281|FG001|Overall Study|Poor compliance to protocol|1|||
19387958|NCT02058160|41631280|FG000|Overall Study|Adverse Event|12|||
19387959|NCT02058160|41631281|FG001|Overall Study|Adverse Event|3|||
19587577|NCT00829933|42035765|FG003|Overall Study|Physician Decision|1|||
19587578|NCT00829933|42035762|FG000|Overall Study|Pregnancy|0|||
19587579|NCT00829933|42035763|FG001|Overall Study|Pregnancy|0|||
19587580|NCT00829933|42035764|FG002|Overall Study|Pregnancy|0|||
19587581|NCT00829933|42035765|FG003|Overall Study|Pregnancy|2|||
19587582|NCT00829933|42035762|FG000|Overall Study|Protocol Violation|2|||
19587583|NCT00829933|42035763|FG001|Overall Study|Protocol Violation|1|||
19587584|NCT00829933|42035764|FG002|Overall Study|Protocol Violation|0|||
19587585|NCT00829933|42035765|FG003|Overall Study|Protocol Violation|0|||
19587586|NCT00829933|42035762|FG000|Overall Study|withdrew before treatment started|5|||
19587587|NCT00829933|42035763|FG001|Overall Study|withdrew before treatment started|1|||
19587588|NCT00829933|42035764|FG002|Overall Study|withdrew before treatment started|2|||
19587589|NCT00829933|42035765|FG003|Overall Study|withdrew before treatment started|9|||
19587590|NCT01170962|42035778|FG000|Treatment Period|Lack of Efficacy|96|||
19587591|NCT01170962|42035779|FG001|Treatment Period|Lack of Efficacy|91|||
19587592|NCT01170962|42035780|FG002|Treatment Period|Lack of Efficacy|7|||
19587593|NCT01170962|42035778|FG000|Treatment Period|Adverse Event|11|||
19587594|NCT01170962|42035779|FG001|Treatment Period|Adverse Event|12|||
19587595|NCT01170962|42035780|FG002|Treatment Period|Adverse Event|3|||
19587596|NCT01170962|42035778|FG000|Treatment Period|Withdrawal by Subject|2|||
19587597|NCT01170962|42035779|FG001|Treatment Period|Withdrawal by Subject|1|||
19587598|NCT01170962|42035780|FG002|Treatment Period|Withdrawal by Subject|0|||
19587599|NCT01170962|42035778|FG000|Treatment Period|Lost to Follow-up|1|||
19587600|NCT01170962|42035779|FG001|Treatment Period|Lost to Follow-up|1|||
19587601|NCT01170962|42035780|FG002|Treatment Period|Lost to Follow-up|1|||
19587602|NCT01170962|42035778|FG000|Treatment Period|Participant no longer meets criteria|0|||
19587603|NCT01170962|42035779|FG001|Treatment Period|Participant no longer meets criteria|1|||
19587604|NCT01170962|42035780|FG002|Treatment Period|Participant no longer meets criteria|0|||
19587605|NCT01170962|42035778|FG000|Treatment Period|Request to discontinue treatment|7|||
19587606|NCT01170962|42035779|FG001|Treatment Period|Request to discontinue treatment|3|||
19587607|NCT01170962|42035780|FG002|Treatment Period|Request to discontinue treatment|1|||
19587608|NCT01170962|42035778|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
19587609|NCT01170962|42035779|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
19587610|NCT01170962|42035780|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
19587611|NCT01170962|42035778|FG000|Follow up Period|Withdrawal by Subject|14|||
19587612|NCT01170962|42035779|FG001|Follow up Period|Withdrawal by Subject|10|||
19587613|NCT01170962|42035780|FG002|Follow up Period|Withdrawal by Subject|2|||
19587614|NCT01170962|42035778|FG000|Follow up Period|Lost to Follow-up|13|||
19587615|NCT01170962|42035779|FG001|Follow up Period|Lost to Follow-up|8|||
19587616|NCT01170962|42035780|FG002|Follow up Period|Lost to Follow-up|1|||
19587617|NCT01170962|42035778|FG000|Follow up Period|Death|2|||
19587618|NCT01170962|42035779|FG001|Follow up Period|Death|2|||
19587619|NCT01170962|42035780|FG002|Follow up Period|Death|0|||
19587620|NCT01170962|42035778|FG000|Follow up Period|Others|10|||
19587621|NCT01170962|42035779|FG001|Follow up Period|Others|7|||
19587622|NCT01170962|42035780|FG002|Follow up Period|Others|3|||
19587623|NCT00843193|42035799|FG000|Overall Study|Adverse Event|2|||
19587624|NCT00843193|42035800|FG001|Overall Study|Adverse Event|4|||
19587625|NCT00843193|42035799|FG000|Overall Study|Lack of Efficacy|1|||
19587626|NCT00843193|42035800|FG001|Overall Study|Lack of Efficacy|1|||
19587627|NCT00843193|42035799|FG000|Overall Study|Protocol Violation|1|||
19587628|NCT00843193|42035800|FG001|Overall Study|Protocol Violation|2|||
19587629|NCT00843193|42035799|FG000|Overall Study|Lost to Follow-up|1|||
19587630|NCT00843193|42035800|FG001|Overall Study|Lost to Follow-up|0|||
19587631|NCT00843193|42035799|FG000|Overall Study|Physician Decision|0|||
19587632|NCT00843193|42035800|FG001|Overall Study|Physician Decision|1|||
19587633|NCT00843193|42035799|FG000|Overall Study|Withdrawal by Subject|3|||
19587634|NCT00843193|42035800|FG001|Overall Study|Withdrawal by Subject|3|||
19587635|NCT00829621|42035809|FG000|Overall Study|Death|1|||
19587636|NCT00829621|42035810|FG001|Overall Study|Death|0|||
19587637|NCT00829621|42035809|FG000|Overall Study|Lost to Follow-up|3|||
19587638|NCT00829621|42035810|FG001|Overall Study|Lost to Follow-up|4|||
19587639|NCT01157078|42035818|FG000|Overall Study|Withdrawal by Subject|12|||
19587640|NCT01157078|42035819|FG001|Overall Study|Withdrawal by Subject|14|||
19587641|NCT01157078|42035818|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19587642|NCT01157078|42035819|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19587643|NCT01157078|42035818|FG000|Overall Study|Adverse Event|6|||
19587644|NCT01157078|42035819|FG001|Overall Study|Adverse Event|6|||
19587645|NCT01157078|42035818|FG000|Overall Study|Severe non-compliance to protocol|2|||
19587646|NCT01157078|42035819|FG001|Overall Study|Severe non-compliance to protocol|4|||
19587647|NCT01157078|42035818|FG000|Overall Study|Condition under investigation worsened|0|||
19587648|NCT01157078|42035819|FG001|Overall Study|Condition under investigation worsened|1|||
19587649|NCT01157078|42035818|FG000|Overall Study|Lack of Efficacy|2|||
19745956|NCT03529773|42193162|FG006|Overall Study|Physician Decision|0|||
19745957|NCT03529773|42193163|FG007|Overall Study|Physician Decision|0|||
19745958|NCT03529773|42193164|FG008|Overall Study|Physician Decision|0|||
19587650|NCT01157078|42035819|FG001|Overall Study|Lack of Efficacy|0|||
19587651|NCT01157078|42035818|FG000|Overall Study|Study-specific withdrawal criteria|2|||
19587652|NCT01157078|42035819|FG001|Overall Study|Study-specific withdrawal criteria|2|||
19587653|NCT01157078|42035818|FG000|Overall Study|Lost to Follow-up|7|||
19587654|NCT01157078|42035819|FG001|Overall Study|Lost to Follow-up|5|||
19587655|NCT01157078|42035818|FG000|Overall Study|Other|2|||
19587656|NCT01157078|42035819|FG001|Overall Study|Other|4|||
19587657|NCT00591721|42035827|FG000|Overall Study|Withdrawal by Subject|10|||
19587658|NCT00591721|42035828|FG001|Overall Study|Withdrawal by Subject|10|||
19587659|NCT00591721|42035827|FG000|Overall Study|Lost to Follow-up|1|||
19587660|NCT00591721|42035828|FG001|Overall Study|Lost to Follow-up|4|||
19587661|NCT00591721|42035827|FG000|Overall Study|Intervention not received|10|||
19587662|NCT00591721|42035828|FG001|Overall Study|Intervention not received|8|||
19587663|NCT01156844|42035838|FG000|Overall Study|Adverse Event|0|||
19587664|NCT01156844|42035839|FG001|Overall Study|Adverse Event|0|||
19587665|NCT01156844|42035840|FG002|Overall Study|Adverse Event|1|||
19587666|NCT01156844|42035841|FG003|Overall Study|Adverse Event|1|||
19587667|NCT01156844|42035838|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19587668|NCT01156844|42035839|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19587669|NCT01156844|42035840|FG002|Overall Study|Abnormal test procedure result(s)|2|||
19587670|NCT01156844|42035841|FG003|Overall Study|Abnormal test procedure result(s)|2|||
19587671|NCT01156844|42035838|FG000|Overall Study|Withdrawal by Subject|0|||
19587672|NCT01156844|42035839|FG001|Overall Study|Withdrawal by Subject|0|||
19587673|NCT01156844|42035840|FG002|Overall Study|Withdrawal by Subject|2|||
19587674|NCT01156844|42035841|FG003|Overall Study|Withdrawal by Subject|2|||
19587675|NCT01156844|42035838|FG000|Overall Study|Lost to Follow-up|0|||
19587676|NCT01156844|42035839|FG001|Overall Study|Lost to Follow-up|0|||
19587677|NCT01156844|42035840|FG002|Overall Study|Lost to Follow-up|1|||
19587678|NCT01156844|42035841|FG003|Overall Study|Lost to Follow-up|0|||
19587679|NCT01156844|42035838|FG000|Overall Study|Administrative problems|0|||
19587680|NCT01156844|42035839|FG001|Overall Study|Administrative problems|1|||
19587681|NCT01156844|42035840|FG002|Overall Study|Administrative problems|0|||
19587682|NCT01156844|42035841|FG003|Overall Study|Administrative problems|1|||
19587683|NCT01156844|42035838|FG000|Overall Study|Protocol deviation|2|||
19587684|NCT01156844|42035839|FG001|Overall Study|Protocol deviation|0|||
19587685|NCT01156844|42035840|FG002|Overall Study|Protocol deviation|0|||
19587686|NCT01156844|42035841|FG003|Overall Study|Protocol deviation|0|||
19587687|NCT00853021|42035854|FG000|Overall Study|Adverse Event|2|||
19587688|NCT00853021|42035854|FG000|Overall Study|Withdrawal by Subject|2|||
19587689|NCT00853021|42035854|FG000|Overall Study|Death|1|||
19587690|NCT01156532|42035858|FG000|Overall Study|Family Reasons|1|||
19587691|NCT01156532|42035858|FG000|Overall Study|Lost to Follow-up|1|||
19587692|NCT00843115|42035862|FG000|Overall Study|Death|4|||
19587693|NCT00843115|42035862|FG000|Overall Study|Adverse Event|30|||
19587694|NCT00843115|42035862|FG000|Overall Study|Lost to Follow-up|4|||
19587695|NCT00843115|42035862|FG000|Overall Study|Withdrawal by Subject|17|||
19587696|NCT00843115|42035862|FG000|Overall Study|Family wanted meds stopped|1|||
19587697|NCT00843115|42035862|FG000|Overall Study|Family does not want continuation|1|||
19587698|NCT00843115|42035862|FG000|Overall Study|Patient forgot to take meds|1|||
19587699|NCT00843115|42035862|FG000|Overall Study|Does not meet entrance criteria|1|||
19587700|NCT00843115|42035862|FG000|Overall Study|Physician Decision|1|||
19587701|NCT00843115|42035862|FG000|Overall Study|Family discontinued meds|1|||
19587702|NCT00843115|42035862|FG000|Overall Study|patient took for 2 days then stopped|1|||
19587703|NCT00843115|42035862|FG000|Overall Study|patient never took the medication|1|||
19587704|NCT00843115|42035862|FG000|Overall Study|hospitalized due to deterioration|1|||
19587705|NCT00843115|42035862|FG000|Overall Study|week 12 not done|1|||
19587706|NCT00843115|42035862|FG000|Overall Study|Syndrome De Glissement|1|||
19587707|NCT01156376|42035869|FG000|Overall Study|Adverse Event|1|||
19587708|NCT01156376|42035870|FG001|Overall Study|Adverse Event|0|||
19587709|NCT01156376|42035871|FG002|Overall Study|Adverse Event|1|||
19587710|NCT01156376|42035869|FG000|Overall Study|Withdrawal by Subject|0|||
19587711|NCT01156376|42035870|FG001|Overall Study|Withdrawal by Subject|0|||
19587712|NCT01156376|42035871|FG002|Overall Study|Withdrawal by Subject|3|||
19587713|NCT00829387|42035881|FG000|Overall Study|Withdrawal by Subject|2|||
19587714|NCT00829387|42035882|FG001|Overall Study|Withdrawal by Subject|3|||
19587715|NCT00829387|42035881|FG000|Overall Study|Disqualified by PI|1|||
19587716|NCT00829387|42035882|FG001|Overall Study|Disqualified by PI|0|||
19587717|NCT01156142|42035890|FG000|Overall Study|Withdrawal by Subject|8|||
19587718|NCT01156142|42035891|FG001|Overall Study|Withdrawal by Subject|6|||
19587719|NCT01156142|42035890|FG000|Overall Study|Ineligible|0|||
19587720|NCT01156142|42035891|FG001|Overall Study|Ineligible|1|||
19587721|NCT00842257|42035897|FG000|Overall Study|Adverse Event|1|||
19587722|NCT00852475|42035903|FG000|Overall Study|Lost to Follow-up|3|||
19587723|NCT00852475|42035904|FG001|Overall Study|Lost to Follow-up|4|||
19587724|NCT01155284|42035914|FG000|Overall Study|Withdrawal by Subject|4|||
19587725|NCT01155284|42035915|FG001|Overall Study|Withdrawal by Subject|3|||
19587726|NCT01155284|42035914|FG000|Overall Study|Lost to Follow-up|1|||
19587727|NCT01155284|42035915|FG001|Overall Study|Lost to Follow-up|2|||
19587728|NCT01155284|42035914|FG000|Overall Study|Physician Decision|1|||
19587729|NCT01155284|42035915|FG001|Overall Study|Physician Decision|0|||
19587730|NCT01155284|42035914|FG000|Overall Study|Adverse Event|1|||
19587731|NCT01155284|42035915|FG001|Overall Study|Adverse Event|0|||
19587732|NCT00852397|42035926|FG000|Overall Study|Adverse Event|4|||
19587733|NCT00852397|42035927|FG001|Overall Study|Adverse Event|6|||
19587734|NCT00852397|42035928|FG002|Overall Study|Adverse Event|4|||
19587735|NCT00852397|42035926|FG000|Overall Study|Death|0|||
19587736|NCT00852397|42035927|FG001|Overall Study|Death|0|||
19587737|NCT00852397|42035928|FG002|Overall Study|Death|1|||
19587738|NCT00852397|42035926|FG000|Overall Study|Withdrawal by Subject|4|||
19587739|NCT00852397|42035927|FG001|Overall Study|Withdrawal by Subject|1|||
19587740|NCT00852397|42035928|FG002|Overall Study|Withdrawal by Subject|2|||
19587741|NCT00852397|42035926|FG000|Overall Study|Study terminated by sponsor|2|||
19587742|NCT00852397|42035927|FG001|Overall Study|Study terminated by sponsor|1|||
19587743|NCT00852397|42035928|FG002|Overall Study|Study terminated by sponsor|6|||
19587744|NCT00852397|42035926|FG000|Overall Study|Difficulty in study site visit|1|||
19587745|NCT00852397|42035927|FG001|Overall Study|Difficulty in study site visit|0|||
19587746|NCT00852397|42035928|FG002|Overall Study|Difficulty in study site visit|0|||
19587747|NCT00852397|42035926|FG000|Overall Study|Protocol Violation|0|||
19587748|NCT00852397|42035927|FG001|Overall Study|Protocol Violation|0|||
19587749|NCT00852397|42035928|FG002|Overall Study|Protocol Violation|1|||
19587750|NCT00841321|42035938|FG000|Overall Study|Lost to Follow-up|1|||
19587751|NCT00841321|42035939|FG001|Overall Study|Lost to Follow-up|1|||
19587752|NCT00841321|42035938|FG000|Overall Study|Adverse Event|0|||
19587753|NCT00841321|42035939|FG001|Overall Study|Adverse Event|2|||
19587754|NCT00986232|42035951|FG000|Overall Study|Adverse Event|1|||
19587755|NCT00986232|42035952|FG001|Overall Study|Adverse Event|2|||
19587756|NCT00986232|42035953|FG002|Overall Study|Adverse Event|3|||
19587757|NCT00986232|42035954|FG003|Overall Study|Adverse Event|0|||
19587758|NCT00986232|42035951|FG000|Overall Study|Lost to Follow-up|19|||
19587759|NCT00986232|42035952|FG001|Overall Study|Lost to Follow-up|12|||
19587760|NCT00986232|42035953|FG002|Overall Study|Lost to Follow-up|12|||
19387960|NCT02058160|41631280|FG000|Overall Study|Lost to Follow-up|1|||
19387961|NCT02058160|41631281|FG001|Overall Study|Lost to Follow-up|0|||
19587761|NCT00986232|42035954|FG003|Overall Study|Lost to Follow-up|7|||
19587762|NCT00986232|42035951|FG000|Overall Study|Protocol Violation|2|||
19587763|NCT00986232|42035952|FG001|Overall Study|Protocol Violation|3|||
19587764|NCT00986232|42035953|FG002|Overall Study|Protocol Violation|0|||
19587765|NCT00986232|42035954|FG003|Overall Study|Protocol Violation|1|||
19587766|NCT00986232|42035951|FG000|Overall Study|Withdrawal by Subject|13|||
19587767|NCT00986232|42035952|FG001|Overall Study|Withdrawal by Subject|16|||
19587768|NCT00986232|42035953|FG002|Overall Study|Withdrawal by Subject|12|||
19587769|NCT00986232|42035954|FG003|Overall Study|Withdrawal by Subject|3|||
19587770|NCT00986232|42035951|FG000|Overall Study|Missed one or more bleeds|13|||
19587771|NCT00986232|42035952|FG001|Overall Study|Missed one or more bleeds|10|||
19587772|NCT00986232|42035953|FG002|Overall Study|Missed one or more bleeds|6|||
19587773|NCT00986232|42035954|FG003|Overall Study|Missed one or more bleeds|7|||
19587774|NCT00986232|42035951|FG000|Overall Study|Incomplete safety follow-up|3|||
19587775|NCT00986232|42035952|FG001|Overall Study|Incomplete safety follow-up|7|||
19587776|NCT00986232|42035953|FG002|Overall Study|Incomplete safety follow-up|2|||
19587777|NCT00986232|42035954|FG003|Overall Study|Incomplete safety follow-up|2|||
19587778|NCT00852241|42035970|FG000|Overall Study|Physician Decision|18|||
19587779|NCT01169636|42035979|FG000|Overall Study|Adverse Event|0|||
19587780|NCT01169636|42035980|FG001|Overall Study|Adverse Event|0|||
19587781|NCT01169636|42035981|FG002|Overall Study|Adverse Event|1|||
19587782|NCT01169636|42035982|FG003|Overall Study|Adverse Event|1|||
19587783|NCT01169636|42035983|FG004|Overall Study|Adverse Event|0|||
19587784|NCT01169636|42035979|FG000|Overall Study|Screen failure|0|||
19587785|NCT01169636|42035980|FG001|Overall Study|Screen failure|0|||
19587786|NCT01169636|42035981|FG002|Overall Study|Screen failure|2|||
19587787|NCT01169636|42035982|FG003|Overall Study|Screen failure|0|||
19587788|NCT01169636|42035983|FG004|Overall Study|Screen failure|0|||
19587789|NCT01169636|42035979|FG000|Overall Study|Withdrawal by Subject|0|||
19587790|NCT01169636|42035980|FG001|Overall Study|Withdrawal by Subject|0|||
19587791|NCT01169636|42035981|FG002|Overall Study|Withdrawal by Subject|0|||
19587792|NCT01169636|42035982|FG003|Overall Study|Withdrawal by Subject|0|||
19587793|NCT01169636|42035983|FG004|Overall Study|Withdrawal by Subject|3|||
19587794|NCT01169558|42035993|FG000|Overall Study|Disease progression|98|||
19587795|NCT01169558|42035993|FG000|Overall Study|Adverse Event|25|||
19587796|NCT01169558|42035993|FG000|Overall Study|Withdrawal of Consent|8|||
19587797|NCT01169558|42035993|FG000|Overall Study|Medical Decision|7|||
19587798|NCT01169558|42035993|FG000|Overall Study|Stable Disease|4|||
19587799|NCT01169558|42035993|FG000|Overall Study|Lost to Follow-up|4|||
19587800|NCT01169558|42035993|FG000|Overall Study|Need for Surgery|4|||
19587801|NCT01169558|42035993|FG000|Overall Study|Non-compliance|2|||
19587802|NCT01169558|42035993|FG000|Overall Study|Protocol Violation|2|||
19587803|NCT01169558|42035993|FG000|Overall Study|Partial response|2|||
19587804|NCT00840463|42035999|FG000|Overall Study|Adverse Event|1|||
19587805|NCT00840463|42036000|FG001|Overall Study|Adverse Event|0|||
19587806|NCT01155050|42036010|FG000|Overall Study|Lost to Follow-up|15|||
19587807|NCT01155050|42036011|FG001|Overall Study|Lost to Follow-up|20|||
19587808|NCT01155050|42036012|FG002|Overall Study|Lost to Follow-up|19|||
19587809|NCT01155050|42036013|FG003|Overall Study|Lost to Follow-up|22|||
19587810|NCT01168856|42036025|FG000|Overall Study|Lost to Follow-up|4|||
19587811|NCT01168856|42036026|FG001|Overall Study|Lost to Follow-up|34|||
19587812|NCT01168856|42036025|FG000|Overall Study|Withdrawal by Subject|6|||
19587813|NCT01168856|42036026|FG001|Overall Study|Withdrawal by Subject|8|||
19587814|NCT01168856|42036025|FG000|Overall Study|Physician Decision|2|||
19587815|NCT01168856|42036026|FG001|Overall Study|Physician Decision|1|||
19587816|NCT01168856|42036025|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
19587817|NCT01168856|42036026|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
19587818|NCT01168856|42036025|FG000|Overall Study|Participant received anti-HCV treatment|1|||
19587819|NCT01168856|42036026|FG001|Overall Study|Participant received anti-HCV treatment|0|||
19587820|NCT01168856|42036025|FG000|Overall Study|Death|0|||
19587821|NCT01168856|42036026|FG001|Overall Study|Death|2|||
19587822|NCT01168856|42036025|FG000|Overall Study|Other|1|||
19587823|NCT01168856|42036026|FG001|Overall Study|Other|291|||
19587824|NCT01168856|42036025|FG000|Overall Study|Protocol Violation|4|||
19587825|NCT01168856|42036026|FG001|Overall Study|Protocol Violation|6|||
19587826|NCT00828451|42036037|FG000|Overall Study|Death|2|||
19587827|NCT00828451|42036037|FG000|Overall Study|Lack of intravenous line|7|||
19587828|NCT00828451|42036037|FG000|Overall Study|Withdrawal by Subject|1|||
19587829|NCT00828451|42036037|FG000|Overall Study|Deterioration in clinical status|1|||
19587830|NCT00839917|42036043|FG000|Overall Study|Lost to Follow-up|1|||
19587831|NCT00839917|42036044|FG001|Overall Study|Lost to Follow-up|0|||
19587832|NCT00839917|42036043|FG000|Overall Study|Did not receive vaccine|0|||
19587833|NCT00839917|42036044|FG001|Overall Study|Did not receive vaccine|1|||
19587834|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
19587835|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
19587836|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
19587837|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
19587838|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
19587839|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
19587840|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
19587841|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
19587842|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
19587843|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
19587844|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
19587845|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
19587846|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
19587847|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
19587848|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
19587849|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
19587850|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
19587851|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
19587852|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
19745959|NCT03529773|42193165|FG009|Overall Study|Physician Decision|0|||
19745960|NCT03529773|42193166|FG010|Overall Study|Physician Decision|0|||
19587853|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
19587854|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
19587855|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
19587856|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
19587857|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
19587858|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
19587859|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
19587860|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
19587861|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
19587862|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
19587863|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
19587864|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
19587865|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
19587866|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
19587867|NCT00839527|42036053|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
19587868|NCT00839527|42036054|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
19587869|NCT00839527|42036055|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
19587870|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
19587871|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
19587872|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
19587873|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
19587874|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
19587875|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
19587876|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
19587877|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
19587878|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
19587879|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
19587880|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
19587881|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
19587882|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
19587883|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
19587884|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
19587885|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
19587886|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
19587887|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
19587888|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
19587889|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
19587890|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
19587891|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
19587892|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
19587893|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
19587894|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
19587895|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
19587896|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
19587897|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
19587898|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
19587899|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
19587900|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
19587901|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
19587902|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
19587903|NCT00839527|42036053|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
19587904|NCT00839527|42036054|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
19587905|NCT00839527|42036055|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
19587906|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
19587907|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
19587908|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
19587909|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
19587910|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
19587911|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
19587912|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
19587913|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
19587914|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
19587915|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
19587916|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
19587917|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
19587918|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
19587919|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
19587920|NCT00600886|42036067|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
19587921|NCT00600886|42036068|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
19587922|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
19587923|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
19587924|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
19587925|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
19587926|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
19587927|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
19587928|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
19587929|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
19587930|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
19587931|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
19587932|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
19587933|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
19587934|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Death|1|||
19587935|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Death|1|||
19587936|NCT00600886|42036067|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
19587937|NCT00600886|42036068|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
19587938|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
19587939|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
19587940|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
19587941|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
19587942|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
19587943|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
19587944|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
19587945|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
19587946|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
19587947|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
19587948|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
19587949|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
19587950|NCT00600886|42036067|FG000|Extension - After Crossover (CAS)|Death|1|||
19587951|NCT00600886|42036068|FG001|Extension - After Crossover (CAS)|Death|0|||
19587952|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
19587953|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
19587954|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
19587955|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
19587956|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
19587957|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
19587958|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
19587959|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
19587960|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
19587961|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
19587962|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
19587963|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
19587964|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
19587965|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
19587966|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
19587967|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
19587968|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
19587969|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
19587970|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
19587971|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
19587972|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
19587973|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
19587974|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
19587975|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
19587976|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
19587977|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
19587978|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
19587979|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
19587980|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
19587981|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
19587982|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
19587983|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
19587984|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
19587985|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
19587986|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
19587987|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
19587988|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
19587989|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
19587990|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
19587991|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
19587992|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
19587993|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
19587994|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
19587995|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
19587996|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
19587997|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
19587998|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
19587999|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
19588000|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
19588001|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
19588002|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
19588003|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
19588004|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Site closed|0|||
19588005|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Site closed|0|||
19588006|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Site closed|1|||
19588007|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Site closed|0|||
19588008|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
19588009|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
19588010|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
19588011|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
19588012|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
19588013|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
19588014|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
19588015|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
19588016|NCT00838903|42036092|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
19588017|NCT00838903|42036093|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
19588018|NCT00838903|42036094|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
19588019|NCT00838903|42036095|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
19588020|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
19588021|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
19588022|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
19588023|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
19588024|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
19588025|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
19588026|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
19588027|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
19588028|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
19588029|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
19588030|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
19588031|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
19588032|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
19588033|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
19588034|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
19588035|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
19588036|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
19588037|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
19588038|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
19588039|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
19588040|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
19588041|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
19588042|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
19588043|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
19588044|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
19588045|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
19588046|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
19588047|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
19588048|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
19588049|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
19588050|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
19588051|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
19588052|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
19588053|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
19588054|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
19588055|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
19588056|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
19588057|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
19588058|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
19588059|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
19588060|NCT00838903|42036092|FG000|Follow-up Period (8 Weeks)|Missing|1|||
19588061|NCT00838903|42036093|FG001|Follow-up Period (8 Weeks)|Missing|2|||
19588062|NCT00838903|42036094|FG002|Follow-up Period (8 Weeks)|Missing|1|||
19588063|NCT00838903|42036095|FG003|Follow-up Period (8 Weeks)|Missing|1|||
19588064|NCT00828139|42036109|FG000|Overall Study|Adverse Event|8|||
19588065|NCT00828139|42036110|FG001|Overall Study|Adverse Event|1|||
19588066|NCT00828139|42036111|FG002|Overall Study|Adverse Event|10|||
19588067|NCT00828139|42036112|FG003|Overall Study|Adverse Event|5|||
19588068|NCT00828139|42036109|FG000|Overall Study|Death|2|||
19588069|NCT00828139|42036110|FG001|Overall Study|Death|1|||
19588070|NCT00828139|42036111|FG002|Overall Study|Death|0|||
19588071|NCT00828139|42036112|FG003|Overall Study|Death|2|||
19588072|NCT00828139|42036109|FG000|Overall Study|Refusal unrelated to toxicity|3|||
19588073|NCT00828139|42036110|FG001|Overall Study|Refusal unrelated to toxicity|4|||
19588074|NCT00828139|42036111|FG002|Overall Study|Refusal unrelated to toxicity|5|||
19588075|NCT00828139|42036112|FG003|Overall Study|Refusal unrelated to toxicity|3|||
19588076|NCT00828139|42036109|FG000|Overall Study|Disease Progression|24|||
19588077|NCT00828139|42036110|FG001|Overall Study|Disease Progression|33|||
19588078|NCT00828139|42036111|FG002|Overall Study|Disease Progression|35|||
19588079|NCT00828139|42036112|FG003|Overall Study|Disease Progression|39|||
19588080|NCT00828139|42036109|FG000|Overall Study|Other|4|||
19588081|NCT00828139|42036110|FG001|Overall Study|Other|2|||
19588082|NCT00828139|42036111|FG002|Overall Study|Other|5|||
19588083|NCT00828139|42036112|FG003|Overall Study|Other|2|||
19588084|NCT00838513|42036122|FG000|Screening Period|Screen Failure|3|||
19588085|NCT00838513|42036122|FG000|Extension Treatment Period|Death|1|||
19588086|NCT00838513|42036122|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
19588087|NCT00600106|42036128|FG000|Overall Study|Withdrawal by Subject|1|||
19588088|NCT00600106|42036129|FG001|Overall Study|Withdrawal by Subject|1|||
19588089|NCT00850993|42036139|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
19588090|NCT00850993|42036140|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
19588091|NCT00850993|42036141|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
19588092|NCT00850993|42036142|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
19588093|NCT00818779|42036154|FG000|Overall Study|Protocol Violation|1|||
19588094|NCT00818779|42036155|FG001|Overall Study|Protocol Violation|0|||
19588095|NCT00818779|42036154|FG000|Overall Study|Lost to Follow-up|1|||
19588096|NCT00818779|42036155|FG001|Overall Study|Lost to Follow-up|0|||
19588097|NCT00818779|42036154|FG000|Overall Study|Adverse Event|4|||
19588098|NCT00818779|42036155|FG001|Overall Study|Adverse Event|1|||
19588099|NCT00850759|42036165|FG000|Overall Study|Lost to Follow-up|7|||
19588100|NCT00850759|42036166|FG001|Overall Study|Lost to Follow-up|5|||
19588101|NCT00850759|42036167|FG002|Overall Study|Lost to Follow-up|5|||
19588102|NCT00850759|42036168|FG003|Overall Study|Lost to Follow-up|3|||
19588103|NCT00827827|42036180|FG000|Overall Study|Lost to Follow-up|3|||
19588104|NCT00827827|42036181|FG001|Overall Study|Lost to Follow-up|0|||
19588105|NCT00827827|42036180|FG000|Overall Study|Fall at home- hospitalization|1|||
19588106|NCT00827827|42036181|FG001|Overall Study|Fall at home- hospitalization|0|||
19588107|NCT00827827|42036180|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
19588108|NCT00827827|42036181|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
19588109|NCT00827827|42036180|FG000|Overall Study|Gout|1|||
19588110|NCT00827827|42036181|FG001|Overall Study|Gout|0|||
19588111|NCT00827827|42036180|FG000|Overall Study|Transportation issues|1|||
19588112|NCT00827827|42036181|FG001|Overall Study|Transportation issues|0|||
19588113|NCT00827827|42036180|FG000|Overall Study|Burned with water at home|1|||
19588114|NCT00827827|42036181|FG001|Overall Study|Burned with water at home|0|||
19588115|NCT00600028|42036190|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
19588116|NCT00600028|42036191|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
19588117|NCT00600028|42036190|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
19588118|NCT00600028|42036191|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
19588119|NCT00600028|42036190|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
19588120|NCT00600028|42036191|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
19588121|NCT03542266|42036200|FG000|Treatment Phase|Withdrawal by Subject|1|||
19588122|NCT03542266|42036200|FG000|Treatment Phase|Adverse Event|1|||
19588123|NCT03542266|42036200|FG000|Treatment Phase|PD|1|||
19588124|NCT03201250|42036207|FG000|Overall Study|screen failures|3|||
19588125|NCT03201250|42036208|FG001|Overall Study|screen failures|0|||
19588126|NCT03201250|42036209|FG002|Overall Study|screen failures|0|||
19588127|NCT00818623|42036226|FG000|Overall Study|Adverse Event|1|||
19588128|NCT00818623|42036227|FG001|Overall Study|Adverse Event|0|||
19588129|NCT00818623|42036228|FG002|Overall Study|Adverse Event|1|||
19588130|NCT00818623|42036229|FG003|Overall Study|Adverse Event|0|||
19588131|NCT00818623|42036230|FG004|Overall Study|Adverse Event|0|||
19588132|NCT00818623|42036231|FG005|Overall Study|Adverse Event|1|||
19588133|NCT00818623|42036232|FG006|Overall Study|Adverse Event|0|||
19588134|NCT00818623|42036233|FG007|Overall Study|Adverse Event|0|||
19588135|NCT00818623|42036226|FG000|Overall Study|Bad prostate specific antigen response|0|||
19588136|NCT00818623|42036227|FG001|Overall Study|Bad prostate specific antigen response|3|||
19588137|NCT00818623|42036228|FG002|Overall Study|Bad prostate specific antigen response|2|||
19588138|NCT00818623|42036229|FG003|Overall Study|Bad prostate specific antigen response|5|||
19588139|NCT00818623|42036230|FG004|Overall Study|Bad prostate specific antigen response|0|||
19588140|NCT00818623|42036231|FG005|Overall Study|Bad prostate specific antigen response|1|||
19588141|NCT00818623|42036232|FG006|Overall Study|Bad prostate specific antigen response|0|||
19588142|NCT00818623|42036233|FG007|Overall Study|Bad prostate specific antigen response|0|||
19588143|NCT00818623|42036226|FG000|Overall Study|Withdrawal by Subject|0|||
19588144|NCT00818623|42036227|FG001|Overall Study|Withdrawal by Subject|1|||
19588145|NCT00818623|42036228|FG002|Overall Study|Withdrawal by Subject|1|||
19588146|NCT00818623|42036229|FG003|Overall Study|Withdrawal by Subject|0|||
19588147|NCT00818623|42036230|FG004|Overall Study|Withdrawal by Subject|0|||
19588148|NCT00818623|42036231|FG005|Overall Study|Withdrawal by Subject|1|||
19588149|NCT00818623|42036232|FG006|Overall Study|Withdrawal by Subject|1|||
19588150|NCT00818623|42036233|FG007|Overall Study|Withdrawal by Subject|1|||
19588151|NCT00818623|42036226|FG000|Overall Study|Protocol Violation|1|||
19588152|NCT00818623|42036227|FG001|Overall Study|Protocol Violation|0|||
19588153|NCT00818623|42036228|FG002|Overall Study|Protocol Violation|0|||
19588154|NCT00818623|42036229|FG003|Overall Study|Protocol Violation|0|||
19588155|NCT00818623|42036230|FG004|Overall Study|Protocol Violation|1|||
19588156|NCT00818623|42036231|FG005|Overall Study|Protocol Violation|0|||
19588157|NCT00818623|42036232|FG006|Overall Study|Protocol Violation|1|||
19588158|NCT00818623|42036233|FG007|Overall Study|Protocol Violation|0|||
19588159|NCT00818623|42036226|FG000|Overall Study|Need of additional treatment|0|||
19588160|NCT00818623|42036227|FG001|Overall Study|Need of additional treatment|0|||
19588161|NCT00818623|42036228|FG002|Overall Study|Need of additional treatment|0|||
19588162|NCT00818623|42036229|FG003|Overall Study|Need of additional treatment|0|||
19588163|NCT00818623|42036230|FG004|Overall Study|Need of additional treatment|1|||
19588164|NCT00818623|42036231|FG005|Overall Study|Need of additional treatment|0|||
19588165|NCT00818623|42036232|FG006|Overall Study|Need of additional treatment|0|||
19588166|NCT00818623|42036233|FG007|Overall Study|Need of additional treatment|0|||
19588167|NCT00818623|42036226|FG000|Overall Study|Lack of trial drug at site|0|||
19588168|NCT00818623|42036227|FG001|Overall Study|Lack of trial drug at site|0|||
19588169|NCT00818623|42036228|FG002|Overall Study|Lack of trial drug at site|0|||
19588170|NCT00818623|42036229|FG003|Overall Study|Lack of trial drug at site|0|||
19588171|NCT00818623|42036230|FG004|Overall Study|Lack of trial drug at site|2|||
19588172|NCT00818623|42036231|FG005|Overall Study|Lack of trial drug at site|0|||
19588173|NCT00818623|42036232|FG006|Overall Study|Lack of trial drug at site|1|||
19588174|NCT00818623|42036233|FG007|Overall Study|Lack of trial drug at site|0|||
19588175|NCT00818623|42036226|FG000|Overall Study|Disease progression|0|||
19588176|NCT00818623|42036227|FG001|Overall Study|Disease progression|0|||
19588177|NCT00818623|42036228|FG002|Overall Study|Disease progression|0|||
19588178|NCT00818623|42036229|FG003|Overall Study|Disease progression|0|||
19588179|NCT00818623|42036230|FG004|Overall Study|Disease progression|0|||
19588180|NCT00818623|42036231|FG005|Overall Study|Disease progression|0|||
19588181|NCT00818623|42036232|FG006|Overall Study|Disease progression|1|||
19588182|NCT00818623|42036233|FG007|Overall Study|Disease progression|0|||
19588183|NCT00827359|42036251|FG000|Overall Study|Progressive Diseas|19|||
19588184|NCT00827359|42036251|FG000|Overall Study|Unacceptable Toxicity|5|||
19588185|NCT00827359|42036251|FG000|Overall Study|Ineligible|1|||
19588186|NCT00818389|42036257|FG000|Overall Study|Death|1|||
19588187|NCT00818389|42036258|FG001|Overall Study|Death|3|||
19588188|NCT00818389|42036257|FG000|Overall Study|ALS Disease Progression|1|||
19588189|NCT00818389|42036258|FG001|Overall Study|ALS Disease Progression|0|||
19588190|NCT00818389|42036257|FG000|Overall Study|Withdrawal by Subject|2|||
19588191|NCT00818389|42036258|FG001|Overall Study|Withdrawal by Subject|2|||
19588192|NCT00818389|42036257|FG000|Overall Study|Adverse Event|0|||
19588193|NCT00818389|42036258|FG001|Overall Study|Adverse Event|1|||
19588194|NCT00850135|42036264|FG000|Overall Study|Physician Decision|1|||
19588195|NCT01154816|42036282|FG000|Overall Study|Withdrawal by Subject|1|||
19588196|NCT01154816|42036283|FG001|Overall Study|Withdrawal by Subject|0|||
19588197|NCT01154816|42036284|FG002|Overall Study|Withdrawal by Subject|0|||
19588198|NCT01154816|42036285|FG003|Overall Study|Withdrawal by Subject|1|||
19588199|NCT01154816|42036286|FG004|Overall Study|Withdrawal by Subject|0|||
19588200|NCT01154816|42036287|FG005|Overall Study|Withdrawal by Subject|0|||
19588201|NCT01154816|42036288|FG006|Overall Study|Withdrawal by Subject|0|||
19588202|NCT01154816|42036289|FG007|Overall Study|Withdrawal by Subject|0|||
19588203|NCT01154816|42036290|FG008|Overall Study|Withdrawal by Subject|1|||
19588204|NCT01154816|42036291|FG009|Overall Study|Withdrawal by Subject|3|||
19588205|NCT01154816|42036292|FG010|Overall Study|Withdrawal by Subject|0|||
19588206|NCT01154816|42036293|FG011|Overall Study|Withdrawal by Subject|0|||
19588207|NCT01154816|42036282|FG000|Overall Study|Progressive Disease|13|||
19588208|NCT01154816|42036283|FG001|Overall Study|Progressive Disease|8|||
19588209|NCT01154816|42036284|FG002|Overall Study|Progressive Disease|9|||
19588210|NCT01154816|42036285|FG003|Overall Study|Progressive Disease|9|||
19588211|NCT01154816|42036286|FG004|Overall Study|Progressive Disease|8|||
19588212|NCT01154816|42036287|FG005|Overall Study|Progressive Disease|8|||
19588213|NCT01154816|42036288|FG006|Overall Study|Progressive Disease|5|||
19588214|NCT01154816|42036289|FG007|Overall Study|Progressive Disease|6|||
19588215|NCT01154816|42036290|FG008|Overall Study|Progressive Disease|8|||
19588216|NCT01154816|42036291|FG009|Overall Study|Progressive Disease|6|||
19588217|NCT01154816|42036292|FG010|Overall Study|Progressive Disease|10|||
19588218|NCT01154816|42036293|FG011|Overall Study|Progressive Disease|3|||
19588219|NCT01154816|42036282|FG000|Overall Study|Physician Decision|1|||
19588220|NCT01154816|42036283|FG001|Overall Study|Physician Decision|0|||
19588221|NCT01154816|42036284|FG002|Overall Study|Physician Decision|1|||
19588222|NCT01154816|42036285|FG003|Overall Study|Physician Decision|0|||
19588223|NCT01154816|42036286|FG004|Overall Study|Physician Decision|2|||
19588224|NCT01154816|42036287|FG005|Overall Study|Physician Decision|0|||
19588225|NCT01154816|42036288|FG006|Overall Study|Physician Decision|0|||
19588226|NCT01154816|42036289|FG007|Overall Study|Physician Decision|0|||
19588227|NCT01154816|42036290|FG008|Overall Study|Physician Decision|0|||
19588228|NCT01154816|42036291|FG009|Overall Study|Physician Decision|1|||
19588229|NCT01154816|42036292|FG010|Overall Study|Physician Decision|1|||
19588230|NCT01154816|42036293|FG011|Overall Study|Physician Decision|1|||
19588231|NCT01154816|42036282|FG000|Overall Study|Adverse Event|5|||
19588232|NCT01154816|42036283|FG001|Overall Study|Adverse Event|2|||
19588233|NCT01154816|42036284|FG002|Overall Study|Adverse Event|0|||
19588234|NCT01154816|42036285|FG003|Overall Study|Adverse Event|0|||
19588235|NCT01154816|42036286|FG004|Overall Study|Adverse Event|0|||
19588236|NCT01154816|42036287|FG005|Overall Study|Adverse Event|0|||
19588237|NCT01154816|42036288|FG006|Overall Study|Adverse Event|1|||
19588238|NCT01154816|42036289|FG007|Overall Study|Adverse Event|1|||
19588239|NCT01154816|42036290|FG008|Overall Study|Adverse Event|0|||
19588240|NCT01154816|42036291|FG009|Overall Study|Adverse Event|0|||
19588241|NCT01154816|42036292|FG010|Overall Study|Adverse Event|0|||
19588242|NCT01154816|42036293|FG011|Overall Study|Adverse Event|0|||
19588243|NCT00849901|42036339|FG000|Acute Treatment Phase|Adverse Event|9|||
19588244|NCT00849901|42036340|FG001|Acute Treatment Phase|Adverse Event|1|||
19588245|NCT00849901|42036341|FG002|Acute Treatment Phase|Adverse Event|3|||
19588246|NCT00849901|42036339|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
19588247|NCT00849901|42036340|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
19588248|NCT00849901|42036341|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
19588249|NCT00849901|42036339|FG000|Acute Treatment Phase|Protocol Violation|0|||
19588250|NCT00849901|42036340|FG001|Acute Treatment Phase|Protocol Violation|2|||
19588251|NCT00849901|42036341|FG002|Acute Treatment Phase|Protocol Violation|1|||
19588252|NCT00849901|42036339|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
19588253|NCT00849901|42036340|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
19588254|NCT00849901|42036341|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
19588255|NCT00849901|42036339|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
19588256|NCT00849901|42036340|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
19588257|NCT00849901|42036341|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
19588258|NCT00849901|42036339|FG000|Acute Treatment Phase|Physician Decision|1|||
19588259|NCT00849901|42036340|FG001|Acute Treatment Phase|Physician Decision|1|||
19588260|NCT00849901|42036341|FG002|Acute Treatment Phase|Physician Decision|1|||
19588261|NCT00849901|42036339|FG000|Acute Treatment Phase|Sponsor Decision|1|||
19588262|NCT00849901|42036340|FG001|Acute Treatment Phase|Sponsor Decision|0|||
19588263|NCT00849901|42036341|FG002|Acute Treatment Phase|Sponsor Decision|0|||
19588264|NCT00849901|42036339|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
19588265|NCT00849901|42036340|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
19588266|NCT00849901|42036341|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
19588267|NCT00849901|42036339|FG000|Extension Phase|Adverse Event|2|||
19588268|NCT00849901|42036340|FG001|Extension Phase|Adverse Event|8|||
19588269|NCT00849901|42036341|FG002|Extension Phase|Adverse Event|4|||
19588270|NCT00849901|42036339|FG000|Extension Phase|Lost to Follow-up|3|||
19588271|NCT00849901|42036340|FG001|Extension Phase|Lost to Follow-up|0|||
19588272|NCT00849901|42036341|FG002|Extension Phase|Lost to Follow-up|1|||
19588273|NCT00849901|42036339|FG000|Extension Phase|Protocol Violation|2|||
19588274|NCT00849901|42036340|FG001|Extension Phase|Protocol Violation|2|||
19588275|NCT00849901|42036341|FG002|Extension Phase|Protocol Violation|4|||
19588276|NCT00849901|42036339|FG000|Extension Phase|Withdrawal by Subject|7|||
19588277|NCT00849901|42036340|FG001|Extension Phase|Withdrawal by Subject|6|||
19588278|NCT00849901|42036341|FG002|Extension Phase|Withdrawal by Subject|3|||
19588279|NCT00849901|42036339|FG000|Extension Phase|Parent or Caregiver Decision|10|||
19588280|NCT00849901|42036340|FG001|Extension Phase|Parent or Caregiver Decision|4|||
19588281|NCT00849901|42036341|FG002|Extension Phase|Parent or Caregiver Decision|4|||
19588282|NCT00849901|42036339|FG000|Extension Phase|Physician Decision|1|||
19588283|NCT00849901|42036340|FG001|Extension Phase|Physician Decision|2|||
19588284|NCT00849901|42036341|FG002|Extension Phase|Physician Decision|0|||
19588285|NCT00849901|42036339|FG000|Extension Phase|Lack of Efficacy|2|||
19588286|NCT00849901|42036340|FG001|Extension Phase|Lack of Efficacy|4|||
19588287|NCT00849901|42036341|FG002|Extension Phase|Lack of Efficacy|1|||
19588288|NCT01168232|42036355|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
19588289|NCT01168232|42036355|FG000|Overall Study|Ineligible- Wrong cell type|6|||
19588290|NCT01168232|42036355|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
19588291|NCT00817531|42036359|FG000|Overall Study|Adverse Event|1|||
19588292|NCT00817531|42036359|FG000|Overall Study|Lack of Efficacy|1|||
19588293|NCT00817063|42036365|FG000|Overall Study|Adverse Event|32|||
19588294|NCT00817063|42036366|FG001|Overall Study|Adverse Event|13|||
19588295|NCT00817063|42036365|FG000|Overall Study|Death|1|||
19588296|NCT00817063|42036366|FG001|Overall Study|Death|1|||
19588297|NCT00817063|42036365|FG000|Overall Study|Lack of Efficacy|33|||
19588298|NCT00817063|42036366|FG001|Overall Study|Lack of Efficacy|86|||
19588299|NCT00817063|42036365|FG000|Overall Study|Failure to Return|13|||
19588300|NCT00817063|42036366|FG001|Overall Study|Failure to Return|12|||
19588301|NCT00817063|42036365|FG000|Overall Study|Violation of Selection at Entry|7|||
19588302|NCT00817063|42036366|FG001|Overall Study|Violation of Selection at Entry|4|||
19588303|NCT00817063|42036365|FG000|Overall Study|Protocol Violation|3|||
19588304|NCT00817063|42036366|FG001|Overall Study|Protocol Violation|8|||
19588305|NCT00817063|42036365|FG000|Overall Study|Withdrawal by Subject|17|||
19588306|NCT00817063|42036366|FG001|Overall Study|Withdrawal by Subject|37|||
19588307|NCT00817063|42036365|FG000|Overall Study|Early Improvement|19|||
19588308|NCT00817063|42036366|FG001|Overall Study|Early Improvement|4|||
19588309|NCT00817063|42036365|FG000|Overall Study|Administrative|10|||
19588310|NCT00817063|42036366|FG001|Overall Study|Administrative|4|||
19588311|NCT00817063|42036365|FG000|Overall Study|Abnormality of Laboratory Test|2|||
19588312|NCT00817063|42036366|FG001|Overall Study|Abnormality of Laboratory Test|1|||
19588313|NCT01167140|42036372|FG000|Overall Study|Withdrawal by Subject|1|||
19588314|NCT01166750|42036378|FG000|Overall Study|Lost to Follow-up|1|||
19588315|NCT01166750|42036379|FG001|Overall Study|Lost to Follow-up|0|||
19588316|NCT00826267|42036388|FG000|Overall Study|Other Adverse Event|1|||
19588317|NCT00826267|42036389|FG001|Overall Study|Other Adverse Event|0|||
19588318|NCT00826267|42036390|FG002|Overall Study|Other Adverse Event|0|||
19588319|NCT00986154|42036401|FG000|Overall Study|Death|136|||
19588320|NCT00986154|42036402|FG001|Overall Study|Death|127|||
19588321|NCT00986154|42036401|FG000|Overall Study|Lost to Follow-up|7|||
19588322|NCT00986154|42036402|FG001|Overall Study|Lost to Follow-up|4|||
19588323|NCT00986154|42036401|FG000|Overall Study|Withdrawal by Subject|32|||
19588324|NCT00986154|42036402|FG001|Overall Study|Withdrawal by Subject|33|||
19588325|NCT00986154|42036401|FG000|Overall Study|investigator/subject decide not continue|6|||
19588326|NCT00986154|42036402|FG001|Overall Study|investigator/subject decide not continue|3|||
19588327|NCT00986154|42036401|FG000|Overall Study|never received study drug|25|||
19588328|NCT00986154|42036402|FG001|Overall Study|never received study drug|27|||
19588329|NCT00848965|42036408|FG000|Overall Study|Adverse Event|1|||
19588330|NCT00848965|42036408|FG000|Overall Study|Withdrawal by Subject|1|||
19588331|NCT01154036|42036427|FG000|Phase I|Physician Decision|0|||
19588332|NCT01154036|42036428|FG001|Phase I|Physician Decision|1|||
19588333|NCT01154036|42036429|FG002|Phase I|Physician Decision|0|||
19588334|NCT01154036|42036430|FG003|Phase I|Physician Decision|0|||
19588335|NCT01154036|42036431|FG004|Phase I|Physician Decision|0|||
19588336|NCT01154036|42036432|FG005|Phase I|Physician Decision|0|||
19588337|NCT01154036|42036433|FG006|Phase I|Physician Decision|0|||
19588338|NCT01154036|42036434|FG007|Phase I|Physician Decision|0|||
19588339|NCT01154036|42036427|FG000|Phase I|Lost to Follow-up|0|||
19588340|NCT01154036|42036428|FG001|Phase I|Lost to Follow-up|3|||
19588341|NCT01154036|42036429|FG002|Phase I|Lost to Follow-up|6|||
19588342|NCT01154036|42036430|FG003|Phase I|Lost to Follow-up|0|||
19588343|NCT01154036|42036431|FG004|Phase I|Lost to Follow-up|0|||
19588344|NCT01154036|42036432|FG005|Phase I|Lost to Follow-up|0|||
19588345|NCT01154036|42036433|FG006|Phase I|Lost to Follow-up|0|||
19588346|NCT01154036|42036434|FG007|Phase I|Lost to Follow-up|0|||
19588347|NCT01154036|42036427|FG000|Phase I|Protocol Violation|0|||
19588348|NCT01154036|42036428|FG001|Phase I|Protocol Violation|3|||
19588349|NCT01154036|42036429|FG002|Phase I|Protocol Violation|9|||
19588350|NCT01154036|42036430|FG003|Phase I|Protocol Violation|0|||
19588351|NCT01154036|42036431|FG004|Phase I|Protocol Violation|0|||
19588352|NCT01154036|42036432|FG005|Phase I|Protocol Violation|0|||
19588353|NCT01154036|42036433|FG006|Phase I|Protocol Violation|0|||
19588354|NCT01154036|42036434|FG007|Phase I|Protocol Violation|0|||
19588355|NCT01154036|42036427|FG000|Phase I|Withdrawal by Subject|2|||
19588356|NCT01154036|42036428|FG001|Phase I|Withdrawal by Subject|10|||
19588357|NCT01154036|42036429|FG002|Phase I|Withdrawal by Subject|29|||
19588358|NCT01154036|42036430|FG003|Phase I|Withdrawal by Subject|0|||
19588359|NCT01154036|42036431|FG004|Phase I|Withdrawal by Subject|0|||
19588360|NCT01154036|42036432|FG005|Phase I|Withdrawal by Subject|0|||
19588361|NCT01154036|42036433|FG006|Phase I|Withdrawal by Subject|0|||
19588362|NCT01154036|42036434|FG007|Phase I|Withdrawal by Subject|0|||
19588363|NCT01154036|42036427|FG000|Phase I|Adverse Event|1|||
19588364|NCT01154036|42036428|FG001|Phase I|Adverse Event|11|||
19588365|NCT01154036|42036429|FG002|Phase I|Adverse Event|12|||
19588366|NCT01154036|42036430|FG003|Phase I|Adverse Event|0|||
19588367|NCT01154036|42036431|FG004|Phase I|Adverse Event|0|||
19588368|NCT01154036|42036432|FG005|Phase I|Adverse Event|0|||
19588369|NCT01154036|42036433|FG006|Phase I|Adverse Event|0|||
19588370|NCT01154036|42036434|FG007|Phase I|Adverse Event|0|||
19588371|NCT01154036|42036427|FG000|Phase II|Adverse Event|0|||
19588372|NCT01154036|42036428|FG001|Phase II|Adverse Event|0|||
19588373|NCT01154036|42036429|FG002|Phase II|Adverse Event|0|||
19588374|NCT01154036|42036430|FG003|Phase II|Adverse Event|0|||
19588375|NCT01154036|42036431|FG004|Phase II|Adverse Event|1|||
19588376|NCT01154036|42036432|FG005|Phase II|Adverse Event|1|||
19588377|NCT01154036|42036433|FG006|Phase II|Adverse Event|1|||
19588378|NCT01154036|42036434|FG007|Phase II|Adverse Event|1|||
19588379|NCT01154036|42036427|FG000|Phase II|Physician Decision|0|||
19588380|NCT01154036|42036428|FG001|Phase II|Physician Decision|0|||
19588381|NCT01154036|42036429|FG002|Phase II|Physician Decision|0|||
19588382|NCT01154036|42036430|FG003|Phase II|Physician Decision|0|||
19588383|NCT01154036|42036431|FG004|Phase II|Physician Decision|0|||
19588384|NCT01154036|42036432|FG005|Phase II|Physician Decision|0|||
19588385|NCT01154036|42036433|FG006|Phase II|Physician Decision|1|||
19588386|NCT01154036|42036434|FG007|Phase II|Physician Decision|0|||
19588387|NCT01154036|42036427|FG000|Phase II|Lost to Follow-up|0|||
19588388|NCT01154036|42036428|FG001|Phase II|Lost to Follow-up|0|||
19588389|NCT01154036|42036429|FG002|Phase II|Lost to Follow-up|0|||
19588390|NCT01154036|42036430|FG003|Phase II|Lost to Follow-up|1|||
19588391|NCT01154036|42036431|FG004|Phase II|Lost to Follow-up|2|||
19588392|NCT01154036|42036432|FG005|Phase II|Lost to Follow-up|0|||
19588393|NCT01154036|42036433|FG006|Phase II|Lost to Follow-up|2|||
19588394|NCT01154036|42036434|FG007|Phase II|Lost to Follow-up|1|||
19588395|NCT01154036|42036427|FG000|Phase II|Protocol Violation|0|||
19588396|NCT01154036|42036428|FG001|Phase II|Protocol Violation|0|||
19588397|NCT01154036|42036429|FG002|Phase II|Protocol Violation|0|||
19588398|NCT01154036|42036430|FG003|Phase II|Protocol Violation|0|||
19588399|NCT01154036|42036431|FG004|Phase II|Protocol Violation|1|||
19588400|NCT01154036|42036432|FG005|Phase II|Protocol Violation|2|||
19588401|NCT01154036|42036433|FG006|Phase II|Protocol Violation|0|||
19588402|NCT01154036|42036434|FG007|Phase II|Protocol Violation|0|||
19588403|NCT01154036|42036427|FG000|Phase II|Withdrawal by Subject|0|||
19588404|NCT01154036|42036428|FG001|Phase II|Withdrawal by Subject|0|||
19588405|NCT01154036|42036429|FG002|Phase II|Withdrawal by Subject|0|||
19588406|NCT01154036|42036430|FG003|Phase II|Withdrawal by Subject|0|||
19588407|NCT01154036|42036431|FG004|Phase II|Withdrawal by Subject|4|||
19588408|NCT01154036|42036432|FG005|Phase II|Withdrawal by Subject|2|||
19588409|NCT01154036|42036433|FG006|Phase II|Withdrawal by Subject|5|||
19588410|NCT01154036|42036434|FG007|Phase II|Withdrawal by Subject|4|||
19588411|NCT00816595|42036456|FG000|Overall Study|Withdrawal by Subject|2|||
19588412|NCT00816595|42036457|FG001|Overall Study|Withdrawal by Subject|0|||
19588413|NCT01166438|42036467|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
19588414|NCT01166438|42036468|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
19588415|NCT01166438|42036467|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
19588416|NCT01166438|42036468|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
19588417|NCT01166438|42036467|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
19588418|NCT01166438|42036468|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
19588419|NCT01166438|42036467|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
19588420|NCT01166438|42036468|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
19588421|NCT01166438|42036467|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
19588422|NCT01166438|42036468|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
19588423|NCT01166438|42036467|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
19588424|NCT01166438|42036468|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
19588425|NCT01153958|42036477|FG000|Overall Study|Study Terminated|36|||
19588426|NCT01153958|42036478|FG001|Overall Study|Study Terminated|32|||
19588427|NCT00599638|42036488|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
19588428|NCT00599638|42036489|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
19588429|NCT00599638|42036490|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
19588430|NCT00599638|42036491|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
19588431|NCT00599638|42036488|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
19588432|NCT00599638|42036489|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
19588433|NCT00599638|42036490|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
19588434|NCT00599638|42036491|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
19588435|NCT00599638|42036488|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
19588436|NCT00599638|42036489|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
19588437|NCT00599638|42036490|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
19588438|NCT00599638|42036491|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
19588439|NCT00599638|42036488|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
19588440|NCT00599638|42036489|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
19588441|NCT00599638|42036490|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
19588442|NCT00599638|42036491|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
19588443|NCT00599638|42036488|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
19588444|NCT00599638|42036489|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
19588445|NCT00599638|42036490|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
19588446|NCT00599638|42036491|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
19588447|NCT00599638|42036488|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
19588448|NCT00599638|42036489|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
19588449|NCT00599638|42036490|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
19588450|NCT00599638|42036491|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
19588451|NCT00599638|42036488|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
19588452|NCT00599638|42036489|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
19588453|NCT00599638|42036490|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
19588454|NCT00599638|42036491|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
19588455|NCT00599638|42036488|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
19588456|NCT00599638|42036489|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
19588457|NCT00599638|42036490|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
19588458|NCT00599638|42036491|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
19588459|NCT00599638|42036488|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
19588460|NCT00599638|42036489|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
19588461|NCT00599638|42036490|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
19588462|NCT00599638|42036491|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
19588463|NCT01166282|42036501|FG000|Open-label Period|Adverse Event|0|||
19588464|NCT01166282|42036502|FG001|Open-label Period|Adverse Event|0|||
19588465|NCT01166282|42036503|FG002|Open-label Period|Adverse Event|6|||
19588466|NCT01166282|42036501|FG000|Open-label Period|Withdrawal by Subject|0|||
19588467|NCT01166282|42036502|FG001|Open-label Period|Withdrawal by Subject|0|||
19588468|NCT01166282|42036503|FG002|Open-label Period|Withdrawal by Subject|4|||
19588469|NCT01166282|42036501|FG000|Open-label Period|Lack of Efficacy|0|||
19588470|NCT01166282|42036502|FG001|Open-label Period|Lack of Efficacy|0|||
19588471|NCT01166282|42036503|FG002|Open-label Period|Lack of Efficacy|2|||
19588472|NCT01166282|42036501|FG000|Open-label Period|Remission|0|||
19588473|NCT01166282|42036502|FG001|Open-label Period|Remission|0|||
19588474|NCT01166282|42036503|FG002|Open-label Period|Remission|4|||
19588475|NCT01166282|42036501|FG000|Open-label Period|Irregular Compliance|0|||
19588476|NCT01166282|42036502|FG001|Open-label Period|Irregular Compliance|0|||
19588477|NCT01166282|42036503|FG002|Open-label Period|Irregular Compliance|1|||
19588478|NCT01153724|42036511|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19588479|NCT01153724|42036511|FG000|Treatment Period 2|Adverse Event|1|||
19588480|NCT01153724|42036511|FG000|Treatment Period 2|Other reason not defined above|1|||
19588481|NCT01152788|42036519|FG000|Overall Study|Withdrawal by Subject|0|||
19588482|NCT01152788|42036520|FG001|Overall Study|Withdrawal by Subject|3|||
19588483|NCT01152788|42036519|FG000|Overall Study|No treatment|0|||
19588484|NCT01152788|42036520|FG001|Overall Study|No treatment|1|||
19588485|NCT01165424|42036526|FG000|Overall Study|Clinical adverse experiences|1|||
19588486|NCT01165424|42036526|FG000|Overall Study|Laboratory adverse experiences|1|||
19588487|NCT01165424|42036526|FG000|Overall Study|Did not meet entry criteria|1|||
19588488|NCT01165424|42036526|FG000|Overall Study|Participant moved (relocated)|1|||
19588489|NCT01152554|42036532|FG000|Overall Study|Withdrawal by Subject|73|||
19588490|NCT01152554|42036533|FG001|Overall Study|Withdrawal by Subject|28|||
19588491|NCT01152554|42036532|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
19588492|NCT01152554|42036533|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
19588493|NCT01152554|42036532|FG000|Overall Study|Adverse Event|67|||
19588494|NCT01152554|42036533|FG001|Overall Study|Adverse Event|14|||
19588495|NCT01152554|42036532|FG000|Overall Study|Severe non-compliance to protocol|36|||
19588496|NCT01152554|42036533|FG001|Overall Study|Severe non-compliance to protocol|14|||
19588497|NCT01152554|42036532|FG000|Overall Study|Condition under investigation worsened|5|||
19588498|NCT01152554|42036533|FG001|Overall Study|Condition under investigation worsened|2|||
19588499|NCT01152554|42036532|FG000|Overall Study|Lack of Efficacy|20|||
19588500|NCT01152554|42036533|FG001|Overall Study|Lack of Efficacy|3|||
19588501|NCT01152554|42036532|FG000|Overall Study|Study-specific withdrawal criteria|17|||
19588502|NCT01152554|42036533|FG001|Overall Study|Study-specific withdrawal criteria|8|||
19588503|NCT01152554|42036532|FG000|Overall Study|Lost to Follow-up|87|||
19588504|NCT01152554|42036533|FG001|Overall Study|Lost to Follow-up|32|||
19588505|NCT01152554|42036532|FG000|Overall Study|Other|28|||
19588506|NCT01152554|42036533|FG001|Overall Study|Other|8|||
19588507|NCT01152554|42036532|FG000|Overall Study|Death|1|||
19588508|NCT01152554|42036533|FG001|Overall Study|Death|1|||
19588509|NCT00598702|42036547|FG000|Overall Study|Other|0|||
19588510|NCT00598702|42036548|FG001|Overall Study|Other|2|||
19588511|NCT00598702|42036549|FG002|Overall Study|Other|0|||
19588512|NCT00598702|42036550|FG003|Overall Study|Other|0|||
19588513|NCT00598702|42036551|FG004|Overall Study|Other|0|||
19588514|NCT00598702|42036552|FG005|Overall Study|Other|1|||
19588515|NCT00598702|42036553|FG006|Overall Study|Other|0|||
19588516|NCT00598702|42036554|FG007|Overall Study|Other|0|||
19588517|NCT00598702|42036547|FG000|Overall Study|Early discharge from hospital|0|||
19588518|NCT00598702|42036548|FG001|Overall Study|Early discharge from hospital|0|||
19588519|NCT00598702|42036549|FG002|Overall Study|Early discharge from hospital|2|||
19588520|NCT00598702|42036550|FG003|Overall Study|Early discharge from hospital|5|||
19588521|NCT00598702|42036551|FG004|Overall Study|Early discharge from hospital|0|||
19588522|NCT00598702|42036552|FG005|Overall Study|Early discharge from hospital|10|||
19588523|NCT00598702|42036553|FG006|Overall Study|Early discharge from hospital|1|||
19588524|NCT00598702|42036554|FG007|Overall Study|Early discharge from hospital|0|||
19588525|NCT00598702|42036547|FG000|Overall Study|Adverse Event|0|||
19588526|NCT00598702|42036548|FG001|Overall Study|Adverse Event|0|||
19588527|NCT00598702|42036549|FG002|Overall Study|Adverse Event|0|||
19588528|NCT00598702|42036550|FG003|Overall Study|Adverse Event|1|||
19588529|NCT00598702|42036551|FG004|Overall Study|Adverse Event|0|||
19588530|NCT00598702|42036552|FG005|Overall Study|Adverse Event|0|||
19588531|NCT00598702|42036553|FG006|Overall Study|Adverse Event|0|||
19588532|NCT00598702|42036554|FG007|Overall Study|Adverse Event|0|||
19588533|NCT00598702|42036547|FG000|Overall Study|Withdrawal by Subject|0|||
19588534|NCT00598702|42036548|FG001|Overall Study|Withdrawal by Subject|0|||
19588535|NCT00598702|42036549|FG002|Overall Study|Withdrawal by Subject|0|||
19588536|NCT00598702|42036550|FG003|Overall Study|Withdrawal by Subject|1|||
19588537|NCT00598702|42036551|FG004|Overall Study|Withdrawal by Subject|1|||
19588538|NCT00598702|42036552|FG005|Overall Study|Withdrawal by Subject|0|||
19588539|NCT00598702|42036553|FG006|Overall Study|Withdrawal by Subject|0|||
19588540|NCT00598702|42036554|FG007|Overall Study|Withdrawal by Subject|0|||
19588541|NCT00598702|42036547|FG000|Overall Study|Physician Decision|0|||
19588542|NCT00598702|42036548|FG001|Overall Study|Physician Decision|0|||
19588543|NCT00598702|42036549|FG002|Overall Study|Physician Decision|0|||
19588544|NCT00598702|42036550|FG003|Overall Study|Physician Decision|0|||
19588545|NCT00598702|42036551|FG004|Overall Study|Physician Decision|1|||
19588546|NCT00598702|42036552|FG005|Overall Study|Physician Decision|0|||
19588547|NCT00598702|42036553|FG006|Overall Study|Physician Decision|0|||
19588548|NCT00598702|42036554|FG007|Overall Study|Physician Decision|0|||
19588549|NCT00598702|42036547|FG000|Overall Study|Dose limiting toxicity|0|||
19588550|NCT00598702|42036548|FG001|Overall Study|Dose limiting toxicity|0|||
19588551|NCT00598702|42036549|FG002|Overall Study|Dose limiting toxicity|0|||
19588552|NCT00598702|42036550|FG003|Overall Study|Dose limiting toxicity|1|||
19588553|NCT00598702|42036551|FG004|Overall Study|Dose limiting toxicity|1|||
19588554|NCT00598702|42036552|FG005|Overall Study|Dose limiting toxicity|1|||
19588555|NCT00598702|42036553|FG006|Overall Study|Dose limiting toxicity|0|||
19588556|NCT00598702|42036554|FG007|Overall Study|Dose limiting toxicity|0|||
19588557|NCT01148810|42036574|FG000|Overall Study|Adverse Event|0|||
19588558|NCT01148810|42036575|FG001|Overall Study|Adverse Event|2|||
19588559|NCT01148810|42036574|FG000|Overall Study|Lack of Efficacy|0|||
19588560|NCT01148810|42036575|FG001|Overall Study|Lack of Efficacy|1|||
19588561|NCT01148810|42036574|FG000|Overall Study|Withdrawal by Subject|0|||
19588562|NCT01148810|42036575|FG001|Overall Study|Withdrawal by Subject|2|||
19588563|NCT01148810|42036574|FG000|Overall Study|Protocol Violation|1|||
19588564|NCT01148810|42036575|FG001|Overall Study|Protocol Violation|0|||
19588565|NCT01151618|42036582|FG000|Overall Study|Adverse Event|2|||
19588566|NCT01151618|42036582|FG000|Overall Study|Withdrawal by Subject|7|||
19588567|NCT01164956|42036586|FG000|Overall Study|Side Effects|1|||
19588568|NCT01164956|42036587|FG001|Overall Study|Side Effects|0|||
19588569|NCT01164956|42036588|FG002|Overall Study|Side Effects|1|||
19588570|NCT01164722|42036598|FG000|Overall Study|Adverse Event|0|||
19588571|NCT01164722|42036599|FG001|Overall Study|Adverse Event|1|||
19588572|NCT01164722|42036598|FG000|Overall Study|Withdrawal by Subject|3|||
19588573|NCT01164722|42036599|FG001|Overall Study|Withdrawal by Subject|4|||
19588574|NCT01164722|42036598|FG000|Overall Study|Lost to Follow-up|3|||
19588575|NCT01164722|42036599|FG001|Overall Study|Lost to Follow-up|6|||
19588576|NCT01164722|42036598|FG000|Overall Study|met protocol criteria for non-treatment|11|||
19588577|NCT01164722|42036599|FG001|Overall Study|met protocol criteria for non-treatment|1|||
19588578|NCT01164722|42036598|FG000|Overall Study|enrolled on other study, concomitant med|1|||
19588579|NCT01164722|42036599|FG001|Overall Study|enrolled on other study, concomitant med|3|||
19588580|NCT01151540|42036605|FG000|Overall Study|Other|2|||
19588581|NCT01151540|42036605|FG000|Overall Study|Adverse event, non-fatal|4|||
19588582|NCT01151540|42036605|FG000|Overall Study|Withdrawal by Subject|7|||
19588583|NCT01163786|42036609|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
19588584|NCT01163786|42036609|FG000|Treatment With Bortezomib|Adverse Event|2|||
19588585|NCT01163786|42036609|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
19588586|NCT00984282|42036615|FG000|Double Blind Treatment|Adverse Event|40|||
19588587|NCT00984282|42036616|FG001|Double Blind Treatment|Adverse Event|6|||
19588588|NCT00984282|42036615|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
19588589|NCT00984282|42036616|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
19588590|NCT00984282|42036615|FG000|Double Blind Treatment|Physician Decision|1|||
19588591|NCT00984282|42036616|FG001|Double Blind Treatment|Physician Decision|2|||
19588592|NCT00984282|42036615|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
19588593|NCT00984282|42036616|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
19588594|NCT00984282|42036615|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
19588595|NCT00984282|42036616|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
19588596|NCT00984282|42036615|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
19588597|NCT00984282|42036616|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
19588598|NCT00984282|42036615|FG000|Double Blind Treatment|Lost to Follow-up|3|||
19588599|NCT00984282|42036616|FG001|Double Blind Treatment|Lost to Follow-up|0|||
19588600|NCT00984282|42036615|FG000|Double Blind Treatment|Death|8|||
19588601|NCT00984282|42036616|FG001|Double Blind Treatment|Death|4|||
19588602|NCT00984282|42036615|FG000|Double Blind Treatment|Not treated|0|||
19588603|NCT00984282|42036616|FG001|Double Blind Treatment|Not treated|1|||
19588604|NCT00984282|42036615|FG000|Double Blind Treatment|Switched to commercial drug|6|||
19588605|NCT00984282|42036616|FG001|Double Blind Treatment|Switched to commercial drug|1|||
19588606|NCT00984282|42036615|FG000|Double Blind Treatment|protocol driven decision point|1|||
19588607|NCT00984282|42036616|FG001|Double Blind Treatment|protocol driven decision point|1|||
19588608|NCT00984282|42036615|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
19588609|NCT00984282|42036616|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
19588610|NCT00984282|42036615|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
19588611|NCT00984282|42036616|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
19588612|NCT00984282|42036615|FG000|Open-label Treatment|Adverse Event|20|||
19588613|NCT00984282|42036616|FG001|Open-label Treatment|Adverse Event|30|||
19588614|NCT00984282|42036615|FG000|Open-label Treatment|Withdrawal by Subject|6|||
19588615|NCT00984282|42036616|FG001|Open-label Treatment|Withdrawal by Subject|21|||
19588616|NCT00984282|42036615|FG000|Open-label Treatment|Death|7|||
19588617|NCT00984282|42036616|FG001|Open-label Treatment|Death|15|||
19588618|NCT00984282|42036615|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
19588619|NCT00984282|42036616|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
19588620|NCT00984282|42036615|FG000|Open-label Treatment|Lost to Follow-up|1|||
19588621|NCT00984282|42036616|FG001|Open-label Treatment|Lost to Follow-up|1|||
19588622|NCT00984282|42036615|FG000|Open-label Treatment|Patient convenience|1|||
19588623|NCT00984282|42036616|FG001|Open-label Treatment|Patient convenience|0|||
19588624|NCT00984282|42036615|FG000|Open-label Treatment|Non-compliant with study medication|1|||
19588625|NCT00984282|42036616|FG001|Open-label Treatment|Non-compliant with study medication|0|||
19588626|NCT00984282|42036615|FG000|Open-label Treatment|Target lesion removed|0|||
19588627|NCT00984282|42036616|FG001|Open-label Treatment|Target lesion removed|1|||
19588628|NCT00984282|42036615|FG000|Open-label Treatment|Protocol driven decision point|1|||
19588629|NCT00984282|42036616|FG001|Open-label Treatment|Protocol driven decision point|1|||
19588630|NCT00984282|42036615|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
19588631|NCT00984282|42036616|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
19588632|NCT00984282|42036615|FG000|Open-label Treatment|Switched to commercial drug|6|||
19588633|NCT00984282|42036616|FG001|Open-label Treatment|Switched to commercial drug|7|||
19588634|NCT00984282|42036615|FG000|Open-label Treatment|Physician Decision|1|||
19588635|NCT00984282|42036616|FG001|Open-label Treatment|Physician Decision|0|||
19588636|NCT00984282|42036615|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
19588637|NCT00984282|42036616|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
19588638|NCT00984282|42036615|FG000|Long Term Follow-up|Death|27|||
19588639|NCT00984282|42036616|FG001|Long Term Follow-up|Death|68|||
19588640|NCT00984282|42036615|FG000|Long Term Follow-up|Lost to Follow-up|3|||
19588641|NCT00984282|42036616|FG001|Long Term Follow-up|Lost to Follow-up|6|||
19588642|NCT00984282|42036615|FG000|Long Term Follow-up|Protocol driven decision point|25|||
19588643|NCT00984282|42036616|FG001|Long Term Follow-up|Protocol driven decision point|26|||
19588644|NCT00984282|42036615|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
19588645|NCT00984282|42036616|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
19588646|NCT00984282|42036615|FG000|Long Term Follow-up|Switched to commercial drug|4|||
19588647|NCT00984282|42036616|FG001|Long Term Follow-up|Switched to commercial drug|2|||
19588648|NCT00984282|42036615|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
19588649|NCT00984282|42036616|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
19588650|NCT01147874|42036624|FG000|Overall Study|Adverse Event|5|||
19588651|NCT01147874|42036624|FG000|Overall Study|Investigator's Request|1|||
19588652|NCT01147874|42036624|FG000|Overall Study|Lost to Follow-up|25|||
19588653|NCT01147874|42036624|FG000|Overall Study|Other|5|||
19588654|NCT01147874|42036624|FG000|Overall Study|Protocol Violation|5|||
19588655|NCT01147874|42036624|FG000|Overall Study|Sponsor's Decision|2|||
19588656|NCT01147874|42036624|FG000|Overall Study|Withdrawal by Subject|24|||
19588657|NCT01147640|42036630|FG000|Overall Study|Adverse Event|2|||
19588658|NCT01147640|42036631|FG001|Overall Study|Adverse Event|0|||
19588659|NCT01147640|42036630|FG000|Overall Study|Physician Decision|1|||
19588660|NCT01147640|42036631|FG001|Overall Study|Physician Decision|0|||
19588661|NCT01147640|42036630|FG000|Overall Study|Withdrawal by Subject|1|||
19588662|NCT01147640|42036631|FG001|Overall Study|Withdrawal by Subject|0|||
19588663|NCT01147640|42036630|FG000|Overall Study|Lost to Follow-up|0|||
19588664|NCT01147640|42036631|FG001|Overall Study|Lost to Follow-up|1|||
19588665|NCT01147640|42036630|FG000|Overall Study|Didn't meet eligibility criteria|1|||
19588666|NCT01147640|42036631|FG001|Overall Study|Didn't meet eligibility criteria|0|||
19588667|NCT01121900|42036637|FG000|First Intervention Period|Adverse Event|1|||
19588668|NCT01121900|42036638|FG001|First Intervention Period|Adverse Event|1|||
19588669|NCT01121900|42036637|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19588670|NCT01121900|42036638|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19588671|NCT01121666|42036646|FG000|Overall Study|Protocol Violation|29|||
19588672|NCT01121666|42036647|FG001|Overall Study|Protocol Violation|10|||
19588673|NCT00984126|42036657|FG000|Overall Study|Protocol Violation|0|||
19588674|NCT00984126|42036658|FG001|Overall Study|Protocol Violation|0|||
19588675|NCT00984126|42036659|FG002|Overall Study|Protocol Violation|1|||
19588676|NCT00984126|42036660|FG003|Overall Study|Protocol Violation|2|||
19588677|NCT00984126|42036657|FG000|Overall Study|Adverse Event|0|||
19588678|NCT00984126|42036658|FG001|Overall Study|Adverse Event|0|||
19588679|NCT00984126|42036659|FG002|Overall Study|Adverse Event|0|||
19588680|NCT00984126|42036660|FG003|Overall Study|Adverse Event|2|||
19588681|NCT00984126|42036657|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
19588682|NCT00984126|42036658|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
19588683|NCT00984126|42036659|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
19588684|NCT00984126|42036660|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
19588685|NCT00984126|42036657|FG000|Overall Study|Withdrawal criteria|0|||
19588686|NCT00984126|42036658|FG001|Overall Study|Withdrawal criteria|1|||
19588687|NCT00984126|42036659|FG002|Overall Study|Withdrawal criteria|3|||
19588688|NCT00984126|42036660|FG003|Overall Study|Withdrawal criteria|9|||
19588689|NCT00979602|42036681|FG000|Overall Study|Serious Adverse Event|5|||
19588690|NCT00979602|42036682|FG001|Overall Study|Serious Adverse Event|3|||
19588691|NCT00979602|42036681|FG000|Overall Study|Protocol Violation|3|||
19588692|NCT00979602|42036682|FG001|Overall Study|Protocol Violation|0|||
19588693|NCT00979602|42036681|FG000|Overall Study|Withdrawal by Subject|31|||
19588694|NCT00979602|42036682|FG001|Overall Study|Withdrawal by Subject|25|||
19588695|NCT00979602|42036681|FG000|Overall Study|Lost to Follow-up|100|||
19588696|NCT00979602|42036682|FG001|Overall Study|Lost to Follow-up|96|||
19588697|NCT00979602|42036681|FG000|Overall Study|Migrated/moved from study area|3|||
19588698|NCT00979602|42036682|FG001|Overall Study|Migrated/moved from study area|6|||
19588699|NCT00979602|42036681|FG000|Overall Study|Others|3|||
19588700|NCT00979602|42036682|FG001|Overall Study|Others|3|||
19588701|NCT00816361|42036707|FG000|Overall Study|Withdrawal by Subject|0|||
19588702|NCT00816361|42036708|FG001|Overall Study|Withdrawal by Subject|0|||
19588703|NCT00816361|42036709|FG002|Overall Study|Withdrawal by Subject|0|||
19588704|NCT00816361|42036710|FG003|Overall Study|Withdrawal by Subject|0|||
19588705|NCT00816361|42036711|FG004|Overall Study|Withdrawal by Subject|1|||
19588706|NCT00816361|42036712|FG005|Overall Study|Withdrawal by Subject|2|||
19588707|NCT00816361|42036713|FG006|Overall Study|Withdrawal by Subject|0|||
19588708|NCT00816361|42036714|FG007|Overall Study|Withdrawal by Subject|2|||
19588709|NCT00816361|42036715|FG008|Overall Study|Withdrawal by Subject|1|||
19588710|NCT00816361|42036707|FG000|Overall Study|Death|4|||
19588711|NCT00816361|42036708|FG001|Overall Study|Death|3|||
19588712|NCT00816361|42036709|FG002|Overall Study|Death|3|||
19588713|NCT00816361|42036710|FG003|Overall Study|Death|3|||
19588714|NCT00816361|42036711|FG004|Overall Study|Death|1|||
19588715|NCT00816361|42036712|FG005|Overall Study|Death|1|||
19588716|NCT00816361|42036713|FG006|Overall Study|Death|3|||
19588717|NCT00816361|42036714|FG007|Overall Study|Death|7|||
19588718|NCT00816361|42036715|FG008|Overall Study|Death|8|||
19588719|NCT00816361|42036707|FG000|Overall Study|Other|0|||
19588720|NCT00816361|42036708|FG001|Overall Study|Other|0|||
19588721|NCT00816361|42036709|FG002|Overall Study|Other|0|||
19588722|NCT00816361|42036710|FG003|Overall Study|Other|0|||
19588723|NCT00816361|42036711|FG004|Overall Study|Other|0|||
19588724|NCT00816361|42036712|FG005|Overall Study|Other|0|||
19588725|NCT00816361|42036713|FG006|Overall Study|Other|0|||
19588726|NCT00816361|42036714|FG007|Overall Study|Other|0|||
19588727|NCT00816361|42036715|FG008|Overall Study|Other|1|||
19588728|NCT00826111|42036738|FG000|Overall Study|Lost to Follow-up|0|||
19588729|NCT00826111|42036739|FG001|Overall Study|Lost to Follow-up|1|||
19588730|NCT00826111|42036738|FG000|Overall Study|Protocol Violation|1|||
19588731|NCT00826111|42036739|FG001|Overall Study|Protocol Violation|0|||
19588732|NCT00826111|42036738|FG000|Overall Study|Withdrawal by Subject|5|||
19588733|NCT00826111|42036739|FG001|Overall Study|Withdrawal by Subject|0|||
19588734|NCT00826111|42036738|FG000|Overall Study|Physician Decision|1|||
19588735|NCT00826111|42036739|FG001|Overall Study|Physician Decision|1|||
19588736|NCT00982644|42036750|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
19588737|NCT00982644|42036751|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
19588738|NCT00982644|42036750|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
19588739|NCT00982644|42036751|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
19588740|NCT00982644|42036750|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
19588741|NCT00982644|42036751|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
19588742|NCT00982644|42036750|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
19588743|NCT00982644|42036751|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
19588744|NCT00982644|42036750|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
19588745|NCT00982644|42036751|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
19588746|NCT00982644|42036750|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
19588747|NCT00982644|42036751|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
19588748|NCT00982644|42036750|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
19588749|NCT00982644|42036751|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
19588750|NCT00982644|42036750|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
19588751|NCT00982644|42036751|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
19588752|NCT00982644|42036750|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
19588753|NCT00982644|42036751|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
19588754|NCT00982644|42036750|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
19588755|NCT00982644|42036751|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
19588756|NCT00815659|42036757|FG000|Overall Study|Adverse Event|9|||
19588757|NCT00815659|42036757|FG000|Overall Study|Withdrawal by Subject|9|||
19588758|NCT00815659|42036757|FG000|Overall Study|Lost to Follow-up|4|||
19588759|NCT00815659|42036757|FG000|Overall Study|Protocol Violation|1|||
19588760|NCT00825175|42036763|FG000|Overall Study|Withdrawal by Subject|0|||
19588761|NCT00825175|42036764|FG001|Overall Study|Withdrawal by Subject|5|||
19588762|NCT00824473|42036772|FG000|Overall Study|Adverse Event|4|||
19588763|NCT00824473|42036773|FG001|Overall Study|Adverse Event|5|||
19588764|NCT00824473|42036772|FG000|Overall Study|Lack of Efficacy|2|||
19588765|NCT00824473|42036773|FG001|Overall Study|Lack of Efficacy|2|||
19588766|NCT00824473|42036772|FG000|Overall Study|Protocol Violation|2|||
19588767|NCT00824473|42036773|FG001|Overall Study|Protocol Violation|0|||
19588768|NCT00824473|42036772|FG000|Overall Study|Non-Compliance|4|||
19588769|NCT00824473|42036773|FG001|Overall Study|Non-Compliance|2|||
19588770|NCT00824473|42036772|FG000|Overall Study|Withdrawal by Subject|2|||
19588771|NCT00824473|42036773|FG001|Overall Study|Withdrawal by Subject|3|||
19588772|NCT00824473|42036772|FG000|Overall Study|Other|1|||
19588773|NCT00824473|42036773|FG001|Overall Study|Other|1|||
19588774|NCT00815191|42036785|FG000|Overall Study|Protocol Violation|1|||
19588775|NCT00815191|42036786|FG001|Overall Study|Protocol Violation|1|||
19588776|NCT00812929|42036792|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
19588777|NCT00812929|42036793|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
19588778|NCT00812929|42036794|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
19588779|NCT00812929|42036795|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
19588780|NCT00812929|42036796|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
19588781|NCT00812929|42036797|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
19588782|NCT00812929|42036798|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
19588783|NCT00812929|42036799|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
19588784|NCT00812929|42036800|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
19588785|NCT00812929|42036801|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
19588786|NCT00812929|42036792|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
19588787|NCT00812929|42036793|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
19588788|NCT00812929|42036794|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
19588789|NCT00812929|42036795|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
19588790|NCT00812929|42036796|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
19588791|NCT00812929|42036797|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
19588792|NCT00812929|42036798|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
19588793|NCT00812929|42036799|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
19588794|NCT00812929|42036800|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
19588795|NCT00812929|42036801|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
19588796|NCT00812929|42036792|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
19588797|NCT00812929|42036793|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
19588798|NCT00812929|42036794|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
19588799|NCT00812929|42036795|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
19588800|NCT00812929|42036796|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
19588801|NCT00812929|42036797|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
19588802|NCT00812929|42036798|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
19588803|NCT00812929|42036799|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
19588804|NCT00812929|42036800|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
19588805|NCT00812929|42036801|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
19588806|NCT00824161|42036818|FG000|Overall Study|Withdrawal by Subject|1|||
19588807|NCT00824161|42036818|FG000|Overall Study|Screen Failure|1|||
19588808|NCT00979134|42036827|FG000|Overall Study|Disease progression|18|||
19588809|NCT00979134|42036828|FG001|Overall Study|Disease progression|2|||
19588810|NCT00979134|42036829|FG002|Overall Study|Disease progression|5|||
19588811|NCT00979134|42036827|FG000|Overall Study|Adverse Event|0|||
19588812|NCT00979134|42036828|FG001|Overall Study|Adverse Event|0|||
19588813|NCT00979134|42036829|FG002|Overall Study|Adverse Event|2|||
19588814|NCT00979134|42036827|FG000|Overall Study|Withdrawal by Subject|1|||
19588815|NCT00979134|42036828|FG001|Overall Study|Withdrawal by Subject|1|||
19588816|NCT00979134|42036829|FG002|Overall Study|Withdrawal by Subject|2|||
19588817|NCT00979134|42036827|FG000|Overall Study|Lost to Follow-up|2|||
19588818|NCT00979134|42036828|FG001|Overall Study|Lost to Follow-up|2|||
19588819|NCT00979134|42036829|FG002|Overall Study|Lost to Follow-up|0|||
19588820|NCT00979134|42036827|FG000|Overall Study|Death|4|||
19588821|NCT00979134|42036828|FG001|Overall Study|Death|0|||
19588822|NCT00979134|42036829|FG002|Overall Study|Death|26|||
19588823|NCT00979134|42036827|FG000|Overall Study|Other|8|||
19588824|NCT00979134|42036828|FG001|Overall Study|Other|1|||
19588825|NCT00979134|42036829|FG002|Overall Study|Other|5|||
19588826|NCT00824005|42036844|FG000|Overall Study|Death|0|||
19588827|NCT00824005|42036845|FG001|Overall Study|Death|1|||
19588828|NCT00824005|42036844|FG000|Overall Study|Lost to Follow-up|0|||
19588829|NCT00824005|42036845|FG001|Overall Study|Lost to Follow-up|1|||
19588830|NCT00814879|42036853|FG000|By Week 24|Cancer Diagnosis|1|||
19588831|NCT00814879|42036854|FG001|By Week 24|Cancer Diagnosis|0|||
19588832|NCT00814879|42036853|FG000|By Week 24|Incarceration|0|||
19588833|NCT00814879|42036854|FG001|By Week 24|Incarceration|1|||
19588834|NCT00814879|42036853|FG000|By Week 48|Lost to Follow-up|2|||
19588835|NCT00814879|42036854|FG001|By Week 48|Lost to Follow-up|2|||
19387962|NCT02058160|41631280|FG000|Overall Study|Other than specified above|12|||
19588836|NCT00814879|42036853|FG000|By Week 48|Death|0|||
19588837|NCT00814879|42036854|FG001|By Week 48|Death|1|||
19588838|NCT03347422|42036863|FG000|Part A (26 Weeks)|Adverse Event|3|||
19588839|NCT03347422|42036864|FG001|Part A (26 Weeks)|Adverse Event|0|||
19588840|NCT03347422|42036863|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
19588841|NCT03347422|42036864|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
19588842|NCT03347422|42036863|FG000|Part B (149 Weeks)|Adverse Event|0|||
19588843|NCT03347422|42036864|FG001|Part B (149 Weeks)|Adverse Event|1|||
19588844|NCT03347422|42036863|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
19588845|NCT03347422|42036864|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
19588846|NCT03347422|42036863|FG000|Part B (149 Weeks)|Other|1|||
19588847|NCT03347422|42036864|FG001|Part B (149 Weeks)|Other|0|||
19588848|NCT00814801|42036880|FG000|Overall Study|Adverse Event|15|||
19588849|NCT00814801|42036881|FG001|Overall Study|Adverse Event|16|||
19588850|NCT00814801|42036882|FG002|Overall Study|Adverse Event|19|||
19588851|NCT00814801|42036880|FG000|Overall Study|Withdrawal by Subject|9|||
19588852|NCT00814801|42036881|FG001|Overall Study|Withdrawal by Subject|11|||
19588853|NCT00814801|42036882|FG002|Overall Study|Withdrawal by Subject|14|||
19588854|NCT00814801|42036880|FG000|Overall Study|Inappropriate as a subject|1|||
19588855|NCT00814801|42036881|FG001|Overall Study|Inappropriate as a subject|1|||
19588856|NCT00814801|42036882|FG002|Overall Study|Inappropriate as a subject|1|||
19588857|NCT00814801|42036880|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
19588858|NCT00814801|42036881|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
19588859|NCT00814801|42036882|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
19588860|NCT00814801|42036880|FG000|Overall Study|Missing or change of caregiver|6|||
19588861|NCT00814801|42036881|FG001|Overall Study|Missing or change of caregiver|2|||
19588862|NCT00814801|42036882|FG002|Overall Study|Missing or change of caregiver|4|||
19588863|NCT00814801|42036880|FG000|Overall Study|Non-compliance|0|||
19588864|NCT00814801|42036881|FG001|Overall Study|Non-compliance|1|||
19588865|NCT00814801|42036882|FG002|Overall Study|Non-compliance|1|||
19588866|NCT00814801|42036880|FG000|Overall Study|Other|2|||
19588867|NCT00814801|42036881|FG001|Overall Study|Other|6|||
19588868|NCT00814801|42036882|FG002|Overall Study|Other|4|||
19588869|NCT00823615|42036890|FG000|Period 2|Lost to Follow-up|2|||
19588870|NCT00823615|42036891|FG001|Period 2|Lost to Follow-up|0|||
19588871|NCT00823615|42036890|FG000|Period 2|Time/Job Conflict|1|||
19588872|NCT00823615|42036891|FG001|Period 2|Time/Job Conflict|2|||
19588873|NCT00812461|42036899|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
19588874|NCT00812461|42036900|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
19588875|NCT00812461|42036899|FG000|All Treated Patients|Adverse Event|8|||
19588876|NCT00812461|42036900|FG001|All Treated Patients|Adverse Event|15|||
19588877|NCT00812461|42036899|FG000|All Treated Patients|Lack of Efficacy|13|||
19588878|NCT00812461|42036900|FG001|All Treated Patients|Lack of Efficacy|7|||
19588879|NCT00812461|42036899|FG000|All Treated Patients|Non-compliance|6|||
19588880|NCT00812461|42036900|FG001|All Treated Patients|Non-compliance|9|||
19588881|NCT00812461|42036899|FG000|All Treated Patients|Protocol Violation|36|||
19588882|NCT00812461|42036900|FG001|All Treated Patients|Protocol Violation|27|||
19588883|NCT00812461|42036899|FG000|All Treated Patients|Withdrawal by Subject|45|||
19588884|NCT00812461|42036900|FG001|All Treated Patients|Withdrawal by Subject|54|||
19588885|NCT00812461|42036899|FG000|All Treated Patients|Lost to Follow-up|11|||
19588886|NCT00812461|42036900|FG001|All Treated Patients|Lost to Follow-up|14|||
19588887|NCT00812461|42036899|FG000|All Treated Patients|Other Reason|13|||
19588888|NCT00812461|42036900|FG001|All Treated Patients|Other Reason|21|||
19588889|NCT00599326|42036906|FG000|Overall Study|Lost to Follow-up|1|||
19588890|NCT00599326|42036906|FG000|Overall Study|Noncompliant|1|||
19588891|NCT00978432|42036913|FG000|Overall Study|Withdrawal by Subject|0|||
19588892|NCT00978432|42036914|FG001|Overall Study|Withdrawal by Subject|0|||
19588893|NCT00978432|42036915|FG002|Overall Study|Withdrawal by Subject|1|||
19588894|NCT00978432|42036913|FG000|Overall Study|Lack of Efficacy|1|||
19588895|NCT00978432|42036914|FG001|Overall Study|Lack of Efficacy|1|||
19588896|NCT00978432|42036915|FG002|Overall Study|Lack of Efficacy|3|||
19588897|NCT00978432|42036913|FG000|Overall Study|Adverse Event|2|||
19588898|NCT00978432|42036914|FG001|Overall Study|Adverse Event|0|||
19387963|NCT02058160|41631281|FG001|Overall Study|Other than specified above|6|||
19588899|NCT00978432|42036915|FG002|Overall Study|Adverse Event|1|||
19588900|NCT00975780|42036925|FG000|Follow Up|Death|88|||
19588901|NCT00975780|42036926|FG001|Follow Up|Death|122|||
19588902|NCT00975780|42036925|FG000|Follow Up|Facility Withdrawal|7|||
19588903|NCT00975780|42036926|FG001|Follow Up|Facility Withdrawal|23|||
19588904|NCT00975780|42036925|FG000|Follow Up|Discharged from Facility|7|||
19588905|NCT00975780|42036926|FG001|Follow Up|Discharged from Facility|12|||
19588906|NCT00814489|42036935|FG000|Overall Study|Other|2|||
19588907|NCT00814489|42036936|FG001|Overall Study|Other|0|||
19588908|NCT00814489|42036937|FG002|Overall Study|Other|1|||
19588909|NCT00814333|42036949|FG000|Enrollment|Lost to Follow-up|1|||
19588910|NCT00814333|42036950|FG001|Enrollment|Lost to Follow-up|0|||
19588911|NCT01147250|42036958|FG000|Overall Study|Lost to Follow-up|14|||
19588912|NCT01147250|42036959|FG001|Overall Study|Lost to Follow-up|11|||
19588913|NCT01147250|42036958|FG000|Overall Study|Withdrawal by Subject|83|||
19588914|NCT01147250|42036959|FG001|Overall Study|Withdrawal by Subject|88|||
19588915|NCT01147250|42036958|FG000|Overall Study|Site termination by sponsor|13|||
19588916|NCT01147250|42036959|FG001|Overall Study|Site termination by sponsor|5|||
19588917|NCT01147250|42036958|FG000|Overall Study|Other than specified|0|||
19588918|NCT01147250|42036959|FG001|Overall Study|Other than specified|1|||
19588919|NCT00813943|42036968|FG000|Overall Study|Ongoing at cut-off date|5|||
19588920|NCT00813943|42036969|FG001|Overall Study|Ongoing at cut-off date|5|||
19588921|NCT00813943|42036970|FG002|Overall Study|Ongoing at cut-off date|3|||
19588922|NCT00821509|42036982|FG000|Overall Study|Withdrawal by Subject|12|||
19588923|NCT00821509|42036983|FG001|Overall Study|Withdrawal by Subject|11|||
19588924|NCT00821509|42036984|FG002|Overall Study|Withdrawal by Subject|34|||
19588925|NCT00821431|42036994|FG000|Overall Study|Adverse Event|6|||
19588926|NCT00821431|42036995|FG001|Overall Study|Adverse Event|3|||
19588927|NCT00821431|42036994|FG000|Overall Study|Withdrawal by Subject|5|||
19588928|NCT00821431|42036995|FG001|Overall Study|Withdrawal by Subject|0|||
19588929|NCT00821431|42036994|FG000|Overall Study|Lost to Follow-up|1|||
19588930|NCT00821431|42036995|FG001|Overall Study|Lost to Follow-up|0|||
19588931|NCT00821431|42036994|FG000|Overall Study|Protocol Violation|3|||
19588932|NCT00821431|42036995|FG001|Overall Study|Protocol Violation|1|||
19588933|NCT00821431|42036994|FG000|Overall Study|Physician Decision|0|||
19588934|NCT00821431|42036995|FG001|Overall Study|Physician Decision|1|||
19588935|NCT01134614|42037003|FG000|Overall Study|Still on treatment as of March 2013|21|||
19588936|NCT01134614|42037004|FG001|Overall Study|Still on treatment as of March 2013|13|||
19588937|NCT01134614|42037003|FG000|Overall Study|Progressive disease|60|||
19588938|NCT01134614|42037004|FG001|Overall Study|Progressive disease|54|||
19588939|NCT01134614|42037003|FG000|Overall Study|Adverse Event|26|||
19588940|NCT01134614|42037004|FG001|Overall Study|Adverse Event|39|||
19588941|NCT01134614|42037003|FG000|Overall Study|Death|5|||
19588942|NCT01134614|42037004|FG001|Overall Study|Death|8|||
19588943|NCT01134614|42037003|FG000|Overall Study|Withdrawal by Subject|3|||
19588944|NCT01134614|42037004|FG001|Overall Study|Withdrawal by Subject|2|||
19588945|NCT01134614|42037003|FG000|Overall Study|Alternative therapy|2|||
19588946|NCT01134614|42037004|FG001|Overall Study|Alternative therapy|0|||
19588947|NCT01134614|42037003|FG000|Overall Study|Complicating disease|2|||
19588948|NCT01134614|42037004|FG001|Overall Study|Complicating disease|1|||
19588949|NCT01134614|42037003|FG000|Overall Study|Physician's decision|0|||
19588950|NCT01134614|42037004|FG001|Overall Study|Physician's decision|1|||
19588951|NCT01134614|42037003|FG000|Overall Study|Never started treatment|4|||
19588952|NCT01134614|42037004|FG001|Overall Study|Never started treatment|1|||
19588953|NCT01134614|42037003|FG000|Overall Study|Pt received tx not allowed on study|0|||
19588954|NCT01134614|42037004|FG001|Overall Study|Pt received tx not allowed on study|1|||
19588955|NCT01134614|42037003|FG000|Overall Study|Symptomatic deterioration|0|||
19588956|NCT01134614|42037004|FG001|Overall Study|Symptomatic deterioration|1|||
19588957|NCT01134614|42037003|FG000|Overall Study|Patient in hospice care|0|||
19588958|NCT01134614|42037004|FG001|Overall Study|Patient in hospice care|1|||
19588959|NCT03982368|42037013|FG000|Overall Study|Adverse Event|6|||
19588960|NCT03982368|42037014|FG001|Overall Study|Adverse Event|4|||
19588961|NCT03982368|42037015|FG002|Overall Study|Adverse Event|3|||
19588962|NCT03982368|42037013|FG000|Overall Study|Lost to Follow-up|2|||
19588963|NCT03982368|42037014|FG001|Overall Study|Lost to Follow-up|1|||
19588964|NCT03982368|42037015|FG002|Overall Study|Lost to Follow-up|0|||
19588965|NCT03982368|42037013|FG000|Overall Study|Withdrawal by Subject|1|||
19588966|NCT03982368|42037014|FG001|Overall Study|Withdrawal by Subject|2|||
19588967|NCT03982368|42037015|FG002|Overall Study|Withdrawal by Subject|0|||
19588968|NCT03982368|42037013|FG000|Overall Study|unknow|4|||
19588969|NCT03982368|42037014|FG001|Overall Study|unknow|0|||
19588970|NCT03982368|42037015|FG002|Overall Study|unknow|2|||
19588971|NCT00813865|42037026|FG000|Overall Study|Failure to Respond|3|||
19588972|NCT00813865|42037026|FG000|Overall Study|Lost to Follow-up|3|||
19588973|NCT00813865|42037026|FG000|Overall Study|Withdrawal by Subject|1|||
19588974|NCT01147172|42037030|FG000|Overall Study|Withdrawal by Subject|2|||
19588975|NCT01147172|42037030|FG000|Overall Study|Lost to Follow-up|2|||
19588976|NCT01120964|42037038|FG000|Overall Study|Did not receive full treatment|1|||
19588977|NCT01120964|42037039|FG001|Overall Study|Did not receive full treatment|0|||
19588978|NCT01146860|42037047|FG000|Overall Study|Withdrawal by Subject|0|||
19588979|NCT01146860|42037048|FG001|Overall Study|Withdrawal by Subject|1|||
19588980|NCT00591565|42037054|FG000|Overall Study|lost follow up, withdrawn|5|||
19588981|NCT01146782|42037058|FG000|Screening Cohort|Screen Failure|187|||
19588982|NCT01146782|42037058|FG000|Screening Cohort|Lost to Follow-up|4|||
19588983|NCT01146782|42037058|FG000|Screening Cohort|Physician Decision|1|||
19588984|NCT01146782|42037058|FG000|Screening Cohort|Withdrawal by Subject|29|||
19588985|NCT01146782|42037058|FG000|Safety Cohort|Screen Failure|61|||
19588986|NCT01146782|42037058|FG000|Safety Cohort|Withdrawal by Subject|4|||
19588987|NCT01146782|42037058|FG000|Safety Cohort|Control AHI <5|4|||
19588988|NCT01146782|42037058|FG000|Safety Cohort|TST <4 hrs|14|||
19588989|NCT01146782|42037058|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
19745961|NCT03529773|42193167|FG011|Overall Study|Physician Decision|0|||
19588990|NCT01146782|42037058|FG000|Primary Endpoint Cohort|Physician Decision|1|||
19588991|NCT00978120|42037067|FG000|Overall Study|Death|0|||
19588992|NCT00978120|42037068|FG001|Overall Study|Death|0|||
19588993|NCT00978120|42037069|FG002|Overall Study|Death|0|||
19588994|NCT00978120|42037070|FG003|Overall Study|Death|1|||
19588995|NCT00978120|42037067|FG000|Overall Study|Lost to Follow-up|0|||
19588996|NCT00978120|42037068|FG001|Overall Study|Lost to Follow-up|0|||
19588997|NCT00978120|42037069|FG002|Overall Study|Lost to Follow-up|3|||
19588998|NCT00978120|42037070|FG003|Overall Study|Lost to Follow-up|0|||
19588999|NCT00978120|42037067|FG000|Overall Study|Withdrawal by Subject|2|||
19589000|NCT00978120|42037068|FG001|Overall Study|Withdrawal by Subject|0|||
19589001|NCT00978120|42037069|FG002|Overall Study|Withdrawal by Subject|0|||
19589002|NCT00978120|42037070|FG003|Overall Study|Withdrawal by Subject|0|||
19589003|NCT00978120|42037067|FG000|Overall Study|Moved out of state|0|||
19589004|NCT00978120|42037068|FG001|Overall Study|Moved out of state|0|||
19589005|NCT00978120|42037069|FG002|Overall Study|Moved out of state|0|||
19589006|NCT00978120|42037070|FG003|Overall Study|Moved out of state|1|||
19589007|NCT01133756|42037087|FG000|Overall Study|Adverse Event|1|||
19589008|NCT01133756|42037088|FG001|Overall Study|Adverse Event|2|||
19589009|NCT01133756|42037089|FG002|Overall Study|Adverse Event|1|||
19589010|NCT01133756|42037087|FG000|Overall Study|Investigator Decision|1|||
19589011|NCT01133756|42037088|FG001|Overall Study|Investigator Decision|0|||
19589012|NCT01133756|42037089|FG002|Overall Study|Investigator Decision|0|||
19589013|NCT01133756|42037087|FG000|Overall Study|Withdrawal by Subject|0|||
19589014|NCT01133756|42037088|FG001|Overall Study|Withdrawal by Subject|1|||
19589015|NCT01133756|42037089|FG002|Overall Study|Withdrawal by Subject|0|||
19589016|NCT01133756|42037087|FG000|Overall Study|Progression of Disease|0|||
19589017|NCT01133756|42037088|FG001|Overall Study|Progression of Disease|0|||
19589018|NCT01133756|42037089|FG002|Overall Study|Progression of Disease|1|||
19589019|NCT00978042|42037099|FG000|Initial Treatment Period|Treated in Error|0|||
19589020|NCT00978042|42037100|FG001|Initial Treatment Period|Treated in Error|3|||
19589021|NCT00978042|42037099|FG000|Initial Treatment Period|Ineligibility|1|||
19589022|NCT00978042|42037100|FG001|Initial Treatment Period|Ineligibility|0|||
19589023|NCT00978042|42037099|FG000|Initial Treatment Period|Lost to Follow-up|21|||
19589024|NCT00978042|42037100|FG001|Initial Treatment Period|Lost to Follow-up|3|||
19589025|NCT00978042|42037099|FG000|Initial Treatment Period|Adverse Event|2|||
19589026|NCT00978042|42037100|FG001|Initial Treatment Period|Adverse Event|0|||
19589027|NCT00978042|42037099|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
19589028|NCT00978042|42037100|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
19589029|NCT00978042|42037099|FG000|Initial Treatment Period|Consent withdrawn|22|||
19589030|NCT00978042|42037100|FG001|Initial Treatment Period|Consent withdrawn|9|||
19589031|NCT00978042|42037099|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
19589032|NCT00978042|42037100|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
19589033|NCT01133678|42037108|FG000|Overall Study|Death|1|||
19589034|NCT01133678|42037109|FG001|Overall Study|Death|1|||
19589035|NCT01133522|42037132|FG000|Overall Study|Withdrawal by Subject|0|||
19589036|NCT01133522|42037133|FG001|Overall Study|Withdrawal by Subject|1|||
19589037|NCT01133522|42037134|FG002|Overall Study|Withdrawal by Subject|0|||
19589038|NCT01133522|42037135|FG003|Overall Study|Withdrawal by Subject|1|||
19589039|NCT01133522|42037136|FG004|Overall Study|Withdrawal by Subject|0|||
19589040|NCT01133522|42037137|FG005|Overall Study|Withdrawal by Subject|0|||
19589041|NCT01133522|42037138|FG006|Overall Study|Withdrawal by Subject|0|||
19589042|NCT01133522|42037139|FG007|Overall Study|Withdrawal by Subject|0|||
19589043|NCT01133522|42037140|FG008|Overall Study|Withdrawal by Subject|0|||
19589044|NCT01133522|42037141|FG009|Overall Study|Withdrawal by Subject|0|||
19589045|NCT01133522|42037132|FG000|Overall Study|Physician Decision|0|||
19589046|NCT01133522|42037133|FG001|Overall Study|Physician Decision|0|||
19589047|NCT01133522|42037134|FG002|Overall Study|Physician Decision|0|||
19589048|NCT01133522|42037135|FG003|Overall Study|Physician Decision|0|||
19589049|NCT01133522|42037136|FG004|Overall Study|Physician Decision|1|||
19589050|NCT01133522|42037137|FG005|Overall Study|Physician Decision|0|||
19589051|NCT01133522|42037138|FG006|Overall Study|Physician Decision|0|||
19589052|NCT01133522|42037139|FG007|Overall Study|Physician Decision|0|||
19589053|NCT01133522|42037140|FG008|Overall Study|Physician Decision|0|||
19589054|NCT01133522|42037141|FG009|Overall Study|Physician Decision|0|||
19589055|NCT01133288|42037170|FG000|Eligibility Assessment|met exclusion criteria|5|||
19589056|NCT01133288|42037170|FG000|Intervention Allocation|study terminated|2|||
19589057|NCT00883090|42037178|FG000|Overall Study|Sponsor's decision|1|||
19589058|NCT00883090|42037178|FG000|Overall Study|Withdrawal by Subject|1|||
19589059|NCT01132820|42037182|FG000|Overall Study|Ineligible: wrong cell type|1|||
19589060|NCT01132820|42037182|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
19589061|NCT01132820|42037182|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
19589062|NCT01132820|42037182|FG000|Overall Study|Never treated|1|||
19589063|NCT01132820|42037182|FG000|Overall Study|Inadequate data|1|||
19589064|NCT00885352|42037201|FG000|Overall Study|Adverse Event|2|||
19589065|NCT00885352|42037202|FG001|Overall Study|Adverse Event|3|||
19589066|NCT00885352|42037201|FG000|Overall Study|Lost to Follow-up|2|||
19589067|NCT00885352|42037202|FG001|Overall Study|Lost to Follow-up|2|||
19589068|NCT00885352|42037201|FG000|Overall Study|Physician Decision|0|||
19589069|NCT00885352|42037202|FG001|Overall Study|Physician Decision|3|||
19589070|NCT00885352|42037201|FG000|Overall Study|Protocol Violation|0|||
19589071|NCT00885352|42037202|FG001|Overall Study|Protocol Violation|2|||
19589072|NCT00885352|42037201|FG000|Overall Study|Withdrawal by Subject|1|||
19589073|NCT00885352|42037202|FG001|Overall Study|Withdrawal by Subject|5|||
19589074|NCT00885352|42037201|FG000|Overall Study|Contradiction to study medication|0|||
19589075|NCT00885352|42037202|FG001|Overall Study|Contradiction to study medication|2|||
19589076|NCT00885352|42037201|FG000|Overall Study|Excluded medication|2|||
19589077|NCT00885352|42037202|FG001|Overall Study|Excluded medication|2|||
19589078|NCT00885352|42037201|FG000|Overall Study|Lab abnormalities|1|||
19589079|NCT00885352|42037202|FG001|Overall Study|Lab abnormalities|1|||
19589080|NCT00885118|42037213|FG000|Overall Study|Adverse Event|1|||
19589081|NCT00885118|42037214|FG001|Overall Study|Adverse Event|0|||
19589082|NCT00885118|42037215|FG002|Overall Study|Adverse Event|0|||
19589083|NCT00885118|42037216|FG003|Overall Study|Adverse Event|0|||
19589084|NCT00885118|42037217|FG004|Overall Study|Adverse Event|0|||
19589085|NCT00885118|42037213|FG000|Overall Study|Withdrawal by Subject|0|||
19589086|NCT00885118|42037214|FG001|Overall Study|Withdrawal by Subject|0|||
19589087|NCT00885118|42037215|FG002|Overall Study|Withdrawal by Subject|0|||
19589088|NCT00885118|42037216|FG003|Overall Study|Withdrawal by Subject|0|||
19589089|NCT00885118|42037217|FG004|Overall Study|Withdrawal by Subject|1|||
19589090|NCT00885118|42037213|FG000|Overall Study|Other reason not defined above|0|||
19589091|NCT00885118|42037214|FG001|Overall Study|Other reason not defined above|0|||
19589092|NCT00885118|42037215|FG002|Overall Study|Other reason not defined above|1|||
19589093|NCT00885118|42037216|FG003|Overall Study|Other reason not defined above|0|||
19589094|NCT00885118|42037217|FG004|Overall Study|Other reason not defined above|0|||
19589095|NCT00880906|42037235|FG000|Overall Study|Lost to Follow-up|0|||
19589096|NCT00880906|42037236|FG001|Overall Study|Lost to Follow-up|1|||
19589097|NCT00880906|42037235|FG000|Overall Study|Did not meet criteria following patholog|12|||
19589098|NCT00880906|42037236|FG001|Overall Study|Did not meet criteria following patholog|6|||
19589099|NCT00882310|42037242|FG000|Overall Study|Screen Failure|10|||
19589100|NCT00882310|42037242|FG000|Overall Study|Never received treatment|1|||
19589101|NCT00882310|42037242|FG000|Overall Study|Death|6|||
19589102|NCT00882310|42037242|FG000|Overall Study|Progression of disease|4|||
19589103|NCT00882310|42037242|FG000|Overall Study|Adverse Event|1|||
19589104|NCT00884650|42037248|FG000|Overall Study|Did not return complete pain diaries|7|||
19589105|NCT00884650|42037249|FG001|Overall Study|Did not return complete pain diaries|7|||
19589106|NCT00884650|42037248|FG000|Overall Study|Admitted Post-Op|1|||
19589107|NCT00884650|42037249|FG001|Overall Study|Admitted Post-Op|0|||
19589108|NCT00884650|42037248|FG000|Overall Study|Femoral Stress Fracture|1|||
19589109|NCT00884650|42037249|FG001|Overall Study|Femoral Stress Fracture|0|||
19589110|NCT00884650|42037248|FG000|Overall Study|Pain Pump Complication|0|||
19589111|NCT00884650|42037249|FG001|Overall Study|Pain Pump Complication|1|||
19589112|NCT00881608|42037261|FG000|Overall Study|Study prematurely terminated|11|||
19589113|NCT01088399|42037276|FG000|Overall Study|Adverse Event|211|||
19589114|NCT01088399|42037277|FG001|Overall Study|Adverse Event|16|||
19589115|NCT01088399|42037278|FG002|Overall Study|Adverse Event|0|||
19589116|NCT01088399|42037276|FG000|Overall Study|Death|204|||
19589117|NCT01088399|42037277|FG001|Overall Study|Death|45|||
19589118|NCT01088399|42037278|FG002|Overall Study|Death|0|||
19589119|NCT01088399|42037276|FG000|Overall Study|Lack of Efficacy|298|||
19589120|NCT01088399|42037277|FG001|Overall Study|Lack of Efficacy|7|||
19589121|NCT01088399|42037278|FG002|Overall Study|Lack of Efficacy|5|||
19589122|NCT01088399|42037276|FG000|Overall Study|Lost to Follow-up|1070|||
19589123|NCT01088399|42037277|FG001|Overall Study|Lost to Follow-up|278|||
19589124|NCT01088399|42037278|FG002|Overall Study|Lost to Follow-up|58|||
19589125|NCT01088399|42037276|FG000|Overall Study|Physician Decision|531|||
19589126|NCT01088399|42037277|FG001|Overall Study|Physician Decision|88|||
19589127|NCT01088399|42037278|FG002|Overall Study|Physician Decision|16|||
19589128|NCT01088399|42037276|FG000|Overall Study|Withdrawal by Subject|544|||
19589129|NCT01088399|42037277|FG001|Overall Study|Withdrawal by Subject|195|||
19589130|NCT01088399|42037278|FG002|Overall Study|Withdrawal by Subject|33|||
19589131|NCT01088399|42037276|FG000|Overall Study|Change to or start of somatropin therapy|234|||
19589132|NCT01088399|42037277|FG001|Overall Study|Change to or start of somatropin therapy|17|||
19589133|NCT01088399|42037278|FG002|Overall Study|Change to or start of somatropin therapy|12|||
19589134|NCT01088399|42037276|FG000|Overall Study|Sponsor decision|1573|||
19589135|NCT01088399|42037277|FG001|Overall Study|Sponsor decision|298|||
19589136|NCT01088399|42037278|FG002|Overall Study|Sponsor decision|7|||
19589137|NCT01088399|42037276|FG000|Overall Study|Protocol Violation|10|||
19589138|NCT01088399|42037277|FG001|Overall Study|Protocol Violation|1|||
19589139|NCT01088399|42037278|FG002|Overall Study|Protocol Violation|0|||
19589140|NCT01088399|42037276|FG000|Overall Study|Enrollment criteria not met|48|||
19589141|NCT01088399|42037277|FG001|Overall Study|Enrollment criteria not met|119|||
19589142|NCT01088399|42037278|FG002|Overall Study|Enrollment criteria not met|70|||
19589143|NCT01088399|42037276|FG000|Overall Study|Study summary visit not completed|2398|||
19589144|NCT01088399|42037277|FG001|Overall Study|Study summary visit not completed|283|||
19589145|NCT01088399|42037278|FG002|Overall Study|Study summary visit not completed|80|||
19589146|NCT00598078|42037286|FG000|Period 2 (Day 2)|Adverse Event|1|||
19589147|NCT00598078|42037287|FG001|Period 2 (Day 2)|Adverse Event|0|||
19589148|NCT01079195|42037295|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
19589149|NCT01079195|42037295|FG000|Overall Study|No Documentation Available|437|||
19589150|NCT01079195|42037295|FG000|Overall Study|Adverse Event|157|||
19589151|NCT01079195|42037295|FG000|Overall Study|Reason Unknown|39|||
19589152|NCT01079195|42037295|FG000|Overall Study|Withdrawal by Subject|18|||
19589153|NCT01079195|42037295|FG000|Overall Study|Financial Reasons|15|||
19589154|NCT01079195|42037295|FG000|Overall Study|Lack of Effectiveness|12|||
19589155|NCT01079195|42037295|FG000|Overall Study|Physician Decision|4|||
19589156|NCT01079195|42037295|FG000|Overall Study|Improved Status of Participant|4|||
19589157|NCT01079195|42037295|FG000|Overall Study|No Follow-up Documentation Available|4|||
19589158|NCT01079195|42037295|FG000|Overall Study|Non-compliance|2|||
19589159|NCT00883558|42037299|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
19589160|NCT00883558|42037300|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
19589161|NCT00883558|42037301|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
19589162|NCT00883558|42037299|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
19589163|NCT00883558|42037300|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
19589164|NCT00883558|42037301|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
19589165|NCT00883558|42037299|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
19589166|NCT00883558|42037300|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
19589167|NCT00883558|42037301|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
19589168|NCT00883558|42037299|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
19589169|NCT00883558|42037300|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
19589170|NCT00883558|42037301|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
19589171|NCT00883558|42037299|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
19589172|NCT00883558|42037300|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
19589173|NCT00883558|42037301|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
19589174|NCT00880750|42037309|FG000|First Intervention|Adverse Event|1|||
19589175|NCT00880750|42037310|FG001|First Intervention|Adverse Event|0|||
19589176|NCT00880750|42037309|FG000|First Intervention|Unable to collect urine|4|||
19589177|NCT00880750|42037310|FG001|First Intervention|Unable to collect urine|0|||
19589178|NCT00880750|42037309|FG000|First Intervention|Non-compliance with meals|0|||
19589179|NCT00880750|42037310|FG001|First Intervention|Non-compliance with meals|1|||
19589180|NCT00880750|42037309|FG000|First Intervention|Withdrawal by Subject|2|||
19589181|NCT00880750|42037310|FG001|First Intervention|Withdrawal by Subject|0|||
19589182|NCT00880750|42037309|FG000|First Intervention|Lost to Follow-up|2|||
19589183|NCT00880750|42037310|FG001|First Intervention|Lost to Follow-up|0|||
19589184|NCT00880750|42037309|FG000|Second Intervention|Withdrawal by Subject|2|||
19589185|NCT00880750|42037310|FG001|Second Intervention|Withdrawal by Subject|2|||
19589186|NCT00880750|42037309|FG000|Second Intervention|Protocol Violation|1|||
19589187|NCT00880750|42037310|FG001|Second Intervention|Protocol Violation|0|||
19589188|NCT00880750|42037309|FG000|Second Intervention|Unable to collect urine|1|||
19589189|NCT00880750|42037310|FG001|Second Intervention|Unable to collect urine|0|||
19589190|NCT00597766|42037319|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
19589191|NCT00597766|42037320|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
19589192|NCT00597766|42037321|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
19589193|NCT00597766|42037319|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
19589194|NCT00597766|42037320|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
19589195|NCT00597766|42037321|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
19589196|NCT00979992|42037329|FG000|Overall Study|Ineligible - inadequate pathology|1|||
19589197|NCT00979992|42037329|FG000|Overall Study|Ineligible - wrong cell type|2|||
19589198|NCT00979992|42037329|FG000|Overall Study|Refused - Never Treated|2|||
19589199|NCT01079741|42037338|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
19589200|NCT01079741|42037339|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
19589201|NCT01079741|42037340|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
19589202|NCT01079741|42037341|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
19589203|NCT01079741|42037342|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
19589204|NCT01079741|42037338|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
19589205|NCT01079741|42037339|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
19589206|NCT01079741|42037340|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
19589207|NCT01079741|42037341|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
19589208|NCT01079741|42037342|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
19589209|NCT01079663|42037356|FG000|Overall Study|Adverse Event|0|||
19589210|NCT01079663|42037357|FG001|Overall Study|Adverse Event|2|||
19589211|NCT01079663|42037356|FG000|Overall Study|Protocol Violation|0|||
19589212|NCT01079663|42037357|FG001|Overall Study|Protocol Violation|2|||
19589213|NCT00879814|42037367|FG000|Overall Study|Adverse Event|0|||
19589214|NCT00879814|42037368|FG001|Overall Study|Adverse Event|1|||
19589215|NCT00879814|42037369|FG002|Overall Study|Adverse Event|0|||
19589216|NCT00879814|42037370|FG003|Overall Study|Adverse Event|0|||
19589217|NCT00879814|42037367|FG000|Overall Study|Lost to Follow-up|1|||
19589218|NCT00879814|42037368|FG001|Overall Study|Lost to Follow-up|0|||
19589219|NCT00879814|42037369|FG002|Overall Study|Lost to Follow-up|0|||
19589220|NCT00879814|42037370|FG003|Overall Study|Lost to Follow-up|2|||
19589221|NCT00879814|42037367|FG000|Overall Study|Participant Failed to Return|0|||
19589222|NCT00879814|42037368|FG001|Overall Study|Participant Failed to Return|0|||
19589223|NCT00879814|42037369|FG002|Overall Study|Participant Failed to Return|0|||
19589224|NCT00879814|42037370|FG003|Overall Study|Participant Failed to Return|1|||
19589225|NCT00879814|42037367|FG000|Overall Study|Withdrawal by Subject|3|||
19589226|NCT00879814|42037368|FG001|Overall Study|Withdrawal by Subject|1|||
19589227|NCT00879814|42037369|FG002|Overall Study|Withdrawal by Subject|1|||
19589228|NCT00879814|42037370|FG003|Overall Study|Withdrawal by Subject|2|||
19589229|NCT00879814|42037367|FG000|Overall Study|Physician Decision|0|||
19589230|NCT00879814|42037368|FG001|Overall Study|Physician Decision|0|||
19589231|NCT00879814|42037369|FG002|Overall Study|Physician Decision|1|||
19589232|NCT00879814|42037370|FG003|Overall Study|Physician Decision|0|||
19589233|NCT00879814|42037367|FG000|Overall Study|Other|0|||
19589234|NCT00879814|42037368|FG001|Overall Study|Other|0|||
19589235|NCT00879814|42037369|FG002|Overall Study|Other|1|||
19589236|NCT00879814|42037370|FG003|Overall Study|Other|0|||
19589237|NCT01132664|42037385|FG000|Phase lb|Adverse Event|0|||
19589238|NCT01132664|42037386|FG001|Phase lb|Adverse Event|1|||
19589239|NCT01132664|42037387|FG002|Phase lb|Adverse Event|0|||
19589240|NCT01132664|42037388|FG003|Phase lb|Adverse Event|0|||
19589241|NCT01132664|42037389|FG004|Phase lb|Adverse Event|0|||
19589242|NCT01132664|42037385|FG000|Phase lb|Withdrawal by Subject|1|||
19589243|NCT01132664|42037386|FG001|Phase lb|Withdrawal by Subject|2|||
19589244|NCT01132664|42037387|FG002|Phase lb|Withdrawal by Subject|0|||
19589245|NCT01132664|42037388|FG003|Phase lb|Withdrawal by Subject|0|||
19589246|NCT01132664|42037389|FG004|Phase lb|Withdrawal by Subject|0|||
19589247|NCT01132664|42037385|FG000|Phase lb|Disease Progression|4|||
19589248|NCT01132664|42037386|FG001|Phase lb|Disease Progression|9|||
19589249|NCT01132664|42037387|FG002|Phase lb|Disease Progression|0|||
19589250|NCT01132664|42037388|FG003|Phase lb|Disease Progression|0|||
19589251|NCT01132664|42037389|FG004|Phase lb|Disease Progression|0|||
19589252|NCT01132664|42037385|FG000|Phase ll|Death|0|||
19589253|NCT01132664|42037386|FG001|Phase ll|Death|0|||
19589254|NCT01132664|42037387|FG002|Phase ll|Death|2|||
19589255|NCT01132664|42037388|FG003|Phase ll|Death|0|||
19589256|NCT01132664|42037389|FG004|Phase ll|Death|0|||
19589257|NCT01132664|42037385|FG000|Phase ll|Adverse Event|0|||
19589258|NCT01132664|42037386|FG001|Phase ll|Adverse Event|0|||
19589259|NCT01132664|42037387|FG002|Phase ll|Adverse Event|10|||
19589260|NCT01132664|42037388|FG003|Phase ll|Adverse Event|0|||
19589261|NCT01132664|42037389|FG004|Phase ll|Adverse Event|0|||
19589262|NCT01132664|42037385|FG000|Phase ll|Withdrawal by Subject|0|||
19589263|NCT01132664|42037386|FG001|Phase ll|Withdrawal by Subject|0|||
19589264|NCT01132664|42037387|FG002|Phase ll|Withdrawal by Subject|3|||
19589265|NCT01132664|42037388|FG003|Phase ll|Withdrawal by Subject|0|||
19589266|NCT01132664|42037389|FG004|Phase ll|Withdrawal by Subject|0|||
19589267|NCT01132664|42037385|FG000|Phase ll|Disease progression|0|||
19589268|NCT01132664|42037386|FG001|Phase ll|Disease progression|0|||
19589269|NCT01132664|42037387|FG002|Phase ll|Disease progression|35|||
19589270|NCT01132664|42037388|FG003|Phase ll|Disease progression|0|||
19589271|NCT01132664|42037389|FG004|Phase ll|Disease progression|0|||
19589272|NCT01132664|42037385|FG000|BM Cohort|Disease progression|0|||
19589273|NCT01132664|42037386|FG001|BM Cohort|Disease progression|0|||
19589274|NCT01132664|42037387|FG002|BM Cohort|Disease progression|0|||
19387964|NCT02090764|41631289|FG000|Overall Study|Adverse Event|1|||
19589275|NCT01132664|42037388|FG003|BM Cohort|Disease progression|3|||
19589276|NCT01132664|42037389|FG004|BM Cohort|Disease progression|4|||
19589277|NCT01132664|42037385|FG000|BM Cohort|Adverse Event|0|||
19589278|NCT01132664|42037386|FG001|BM Cohort|Adverse Event|0|||
19589279|NCT01132664|42037387|FG002|BM Cohort|Adverse Event|0|||
19589280|NCT01132664|42037388|FG003|BM Cohort|Adverse Event|0|||
19589281|NCT01132664|42037389|FG004|BM Cohort|Adverse Event|1|||
19589282|NCT01132664|42037385|FG000|BM Cohort|Withdrawal by Subject|0|||
19589283|NCT01132664|42037386|FG001|BM Cohort|Withdrawal by Subject|0|||
19589284|NCT01132664|42037387|FG002|BM Cohort|Withdrawal by Subject|0|||
19589285|NCT01132664|42037388|FG003|BM Cohort|Withdrawal by Subject|0|||
19589286|NCT01132664|42037389|FG004|BM Cohort|Withdrawal by Subject|1|||
19589287|NCT00591409|42037411|FG000|Overall Study|Not Treated|0|||
19589288|NCT00591409|42037412|FG001|Overall Study|Not Treated|0|||
19589289|NCT00591409|42037413|FG002|Overall Study|Not Treated|0|||
19589290|NCT00591409|42037414|FG003|Overall Study|Not Treated|0|||
19589291|NCT00591409|42037415|FG004|Overall Study|Not Treated|1|||
19589292|NCT00591409|42037416|FG005|Overall Study|Not Treated|0|||
19589293|NCT00591409|42037417|FG006|Overall Study|Not Treated|0|||
19589294|NCT00591409|42037418|FG007|Overall Study|Not Treated|0|||
19589295|NCT00591409|42037419|FG008|Overall Study|Not Treated|0|||
19589296|NCT00591409|42037420|FG009|Overall Study|Not Treated|1|||
19589297|NCT01078805|42037442|FG000|Overall Study|Clinically significant abnormal lab|5|||
19589298|NCT01078805|42037442|FG000|Overall Study|Death|134|||
19589299|NCT01078805|42037442|FG000|Overall Study|Lost to Follow-up|676|||
19589300|NCT01078805|42037442|FG000|Overall Study|Physician Decision|169|||
19589301|NCT01078805|42037442|FG000|Overall Study|Serious adverse event|26|||
19589302|NCT01078805|42037442|FG000|Overall Study|Sponsor decision|46|||
19589303|NCT01078805|42037442|FG000|Overall Study|Withdrawal by Subject|739|||
19589304|NCT01078805|42037442|FG000|Overall Study|Other|173|||
19589305|NCT01078805|42037442|FG000|Overall Study|Didn't take study drug|82|||
19589306|NCT00820027|42037450|FG000|Overall Study|Adverse Event|15|||
19589307|NCT00820027|42037451|FG001|Overall Study|Adverse Event|8|||
19589308|NCT00820027|42037452|FG002|Overall Study|Adverse Event|10|||
19589309|NCT00820027|42037453|FG003|Overall Study|Adverse Event|5|||
19589310|NCT00820027|42037450|FG000|Overall Study|Lack of Efficacy|2|||
19589311|NCT00820027|42037451|FG001|Overall Study|Lack of Efficacy|1|||
19589312|NCT00820027|42037452|FG002|Overall Study|Lack of Efficacy|2|||
19589313|NCT00820027|42037453|FG003|Overall Study|Lack of Efficacy|2|||
19589314|NCT00820027|42037450|FG000|Overall Study|Physician Decision|0|||
19589315|NCT00820027|42037451|FG001|Overall Study|Physician Decision|1|||
19589316|NCT00820027|42037452|FG002|Overall Study|Physician Decision|1|||
19589317|NCT00820027|42037453|FG003|Overall Study|Physician Decision|0|||
19589318|NCT00820027|42037450|FG000|Overall Study|Protocol Violation|3|||
19589319|NCT00820027|42037451|FG001|Overall Study|Protocol Violation|0|||
19589320|NCT00820027|42037452|FG002|Overall Study|Protocol Violation|4|||
19589321|NCT00820027|42037453|FG003|Overall Study|Protocol Violation|0|||
19589322|NCT00820027|42037450|FG000|Overall Study|Withdrawal by Subject|6|||
19589323|NCT00820027|42037451|FG001|Overall Study|Withdrawal by Subject|4|||
19589324|NCT00820027|42037452|FG002|Overall Study|Withdrawal by Subject|4|||
19589325|NCT00820027|42037453|FG003|Overall Study|Withdrawal by Subject|6|||
19589326|NCT01076153|42037464|FG000|Overall Study|Symptoms improved/resolved|10|||
19589327|NCT01076153|42037464|FG000|Overall Study|Adverse Event|1|||
19589328|NCT01076075|42037474|FG000|Overall Study|Adverse Event|3|||
19589329|NCT01076075|42037475|FG001|Overall Study|Adverse Event|9|||
19589330|NCT01076075|42037474|FG000|Overall Study|Lack of Efficacy|5|||
19589331|NCT01076075|42037475|FG001|Overall Study|Lack of Efficacy|4|||
19589332|NCT01076075|42037474|FG000|Overall Study|Lost to Follow-up|6|||
19589333|NCT01076075|42037475|FG001|Overall Study|Lost to Follow-up|5|||
19589334|NCT01076075|42037474|FG000|Overall Study|other|19|||
19589335|NCT01076075|42037475|FG001|Overall Study|other|9|||
19589336|NCT01076075|42037474|FG000|Overall Study|Protocol Violation|0|||
19589337|NCT01076075|42037475|FG001|Overall Study|Protocol Violation|1|||
19589338|NCT01076075|42037474|FG000|Overall Study|Withdrawal by Subject|8|||
19589339|NCT01076075|42037475|FG001|Overall Study|Withdrawal by Subject|19|||
19589340|NCT01075763|42037486|FG000|Overall Study|Lost to Follow-up|2|||
19589341|NCT01075763|42037487|FG001|Overall Study|Lost to Follow-up|1|||
19589342|NCT01075763|42037486|FG000|Overall Study|Lack of Efficacy|0|||
19589343|NCT01075763|42037487|FG001|Overall Study|Lack of Efficacy|1|||
19589344|NCT01075763|42037486|FG000|Overall Study|Withdrawal by Subject|2|||
19589345|NCT01075763|42037487|FG001|Overall Study|Withdrawal by Subject|2|||
19589346|NCT00881530|42037499|FG000|Overall Study|Adverse Event|5|||
19589347|NCT00881530|42037500|FG001|Overall Study|Adverse Event|1|||
19589348|NCT00881530|42037501|FG002|Overall Study|Adverse Event|1|||
19589349|NCT00881530|42037502|FG003|Overall Study|Adverse Event|4|||
19589350|NCT00881530|42037503|FG004|Overall Study|Adverse Event|10|||
19589351|NCT00881530|42037504|FG005|Overall Study|Adverse Event|2|||
19589352|NCT00881530|42037499|FG000|Overall Study|Lack of Efficacy|1|||
19589353|NCT00881530|42037500|FG001|Overall Study|Lack of Efficacy|0|||
19589354|NCT00881530|42037501|FG002|Overall Study|Lack of Efficacy|0|||
19589355|NCT00881530|42037502|FG003|Overall Study|Lack of Efficacy|0|||
19589356|NCT00881530|42037503|FG004|Overall Study|Lack of Efficacy|1|||
19589357|NCT00881530|42037504|FG005|Overall Study|Lack of Efficacy|1|||
19589358|NCT00881530|42037499|FG000|Overall Study|Not compliant with the protocol|0|||
19589359|NCT00881530|42037500|FG001|Overall Study|Not compliant with the protocol|0|||
19589360|NCT00881530|42037501|FG002|Overall Study|Not compliant with the protocol|0|||
19589361|NCT00881530|42037502|FG003|Overall Study|Not compliant with the protocol|0|||
19589362|NCT00881530|42037503|FG004|Overall Study|Not compliant with the protocol|2|||
19589363|NCT00881530|42037504|FG005|Overall Study|Not compliant with the protocol|0|||
19589364|NCT00881530|42037499|FG000|Overall Study|Lost to Follow-up|0|||
19589365|NCT00881530|42037500|FG001|Overall Study|Lost to Follow-up|1|||
19589366|NCT00881530|42037501|FG002|Overall Study|Lost to Follow-up|1|||
19589367|NCT00881530|42037502|FG003|Overall Study|Lost to Follow-up|3|||
19589368|NCT00881530|42037503|FG004|Overall Study|Lost to Follow-up|1|||
19589369|NCT00881530|42037504|FG005|Overall Study|Lost to Follow-up|0|||
19589370|NCT00881530|42037499|FG000|Overall Study|Refused to continue medication|7|||
19589371|NCT00881530|42037500|FG001|Overall Study|Refused to continue medication|2|||
19589372|NCT00881530|42037501|FG002|Overall Study|Refused to continue medication|1|||
19589373|NCT00881530|42037502|FG003|Overall Study|Refused to continue medication|2|||
19589374|NCT00881530|42037503|FG004|Overall Study|Refused to continue medication|0|||
19589375|NCT00881530|42037504|FG005|Overall Study|Refused to continue medication|0|||
19589376|NCT00881530|42037499|FG000|Overall Study|Other reason not defined above|1|||
19589377|NCT00881530|42037500|FG001|Overall Study|Other reason not defined above|1|||
19589378|NCT00881530|42037501|FG002|Overall Study|Other reason not defined above|2|||
19589379|NCT00881530|42037502|FG003|Overall Study|Other reason not defined above|0|||
19589380|NCT00881530|42037503|FG004|Overall Study|Other reason not defined above|0|||
19589381|NCT00881530|42037504|FG005|Overall Study|Other reason not defined above|2|||
19589382|NCT01075685|42037520|FG000|Overall Study|Protocol Violation|9|||
19589383|NCT01075685|42037521|FG001|Overall Study|Protocol Violation|1|||
19589384|NCT01075685|42037520|FG000|Overall Study|Withdrawal by Subject|20|||
19589385|NCT01075685|42037521|FG001|Overall Study|Withdrawal by Subject|5|||
19589386|NCT01075685|42037520|FG000|Overall Study|Lost to Follow-up|563|||
19589387|NCT01075685|42037521|FG001|Overall Study|Lost to Follow-up|220|||
19589388|NCT01075217|42037529|FG000|Overall Study|Adverse Event|1|||
19589389|NCT01075217|42037530|FG001|Overall Study|Adverse Event|1|||
19589390|NCT01075217|42037529|FG000|Overall Study|Physician Decision|1|||
19589391|NCT01075217|42037530|FG001|Overall Study|Physician Decision|0|||
19589392|NCT01078571|42037544|FG000|Overall Study|Adverse Event|36|||
19589393|NCT01078571|42037544|FG000|Overall Study|Lack of effectiveness|36|||
19589394|NCT01078571|42037544|FG000|Overall Study|Reason not reported|21|||
19589395|NCT01078571|42037544|FG000|Overall Study|Withdrawal by Subject|12|||
19589396|NCT01078571|42037544|FG000|Overall Study|Lost to Follow-up|8|||
19589397|NCT01078571|42037544|FG000|Overall Study|Protocol Violation|2|||
19589398|NCT00977106|42037555|FG000|Overall Study|Adverse Event|5|||
19589399|NCT00977106|42037556|FG001|Overall Study|Adverse Event|6|||
19589400|NCT00977106|42037555|FG000|Overall Study|Withdrawal by Subject|2|||
19589401|NCT00977106|42037556|FG001|Overall Study|Withdrawal by Subject|2|||
19589402|NCT00977106|42037555|FG000|Overall Study|Lack of Efficacy|2|||
19589403|NCT00977106|42037556|FG001|Overall Study|Lack of Efficacy|2|||
19589404|NCT00977106|42037555|FG000|Overall Study|Protocol Violation|0|||
19589405|NCT00977106|42037556|FG001|Overall Study|Protocol Violation|1|||
19589406|NCT00977106|42037555|FG000|Overall Study|Other|1|||
19589407|NCT00977106|42037556|FG001|Overall Study|Other|0|||
19589408|NCT01077713|42037566|FG000|Overall Study|Withdrawal by Subject|1|||
19589409|NCT01077713|42037567|FG001|Overall Study|Withdrawal by Subject|2|||
19589410|NCT01077713|42037566|FG000|Overall Study|Progressive Disease (PD)|0|||
19589411|NCT01077713|42037567|FG001|Overall Study|Progressive Disease (PD)|1|||
19589412|NCT01077713|42037566|FG000|Overall Study|Death|28|||
19589413|NCT01077713|42037567|FG001|Overall Study|Death|29|||
19589414|NCT01077713|42037566|FG000|Overall Study|Lost to Follow-up|1|||
19589415|NCT01077713|42037567|FG001|Overall Study|Lost to Follow-up|1|||
19589416|NCT01077713|42037566|FG000|Overall Study|Adverse Event|2|||
19589417|NCT01077713|42037567|FG001|Overall Study|Adverse Event|1|||
19589418|NCT01077713|42037566|FG000|Overall Study|Other|4|||
19589419|NCT01077713|42037567|FG001|Overall Study|Other|2|||
19589420|NCT00813709|42037576|FG000|Double Blind Period|Adverse Event|4|||
19589421|NCT00813709|42037577|FG001|Double Blind Period|Adverse Event|1|||
19589422|NCT00813709|42037578|FG002|Double Blind Period|Adverse Event|4|||
19589423|NCT00813709|42037579|FG003|Double Blind Period|Adverse Event|0|||
19589424|NCT00813709|42037580|FG004|Double Blind Period|Adverse Event|0|||
19589425|NCT00813709|42037581|FG005|Double Blind Period|Adverse Event|0|||
19387965|NCT02090764|41631290|FG001|Overall Study|Adverse Event|3|||
19589426|NCT00813709|42037576|FG000|Double Blind Period|Lost to Follow-up|3|||
19589427|NCT00813709|42037577|FG001|Double Blind Period|Lost to Follow-up|2|||
19589428|NCT00813709|42037578|FG002|Double Blind Period|Lost to Follow-up|2|||
19589429|NCT00813709|42037579|FG003|Double Blind Period|Lost to Follow-up|0|||
19589430|NCT00813709|42037580|FG004|Double Blind Period|Lost to Follow-up|0|||
19589431|NCT00813709|42037581|FG005|Double Blind Period|Lost to Follow-up|0|||
19589432|NCT00813709|42037576|FG000|Double Blind Period|Switched to open label phase|9|||
19589433|NCT00813709|42037577|FG001|Double Blind Period|Switched to open label phase|26|||
19589434|NCT00813709|42037578|FG002|Double Blind Period|Switched to open label phase|18|||
19589435|NCT00813709|42037579|FG003|Double Blind Period|Switched to open label phase|0|||
19589436|NCT00813709|42037580|FG004|Double Blind Period|Switched to open label phase|0|||
19589437|NCT00813709|42037581|FG005|Double Blind Period|Switched to open label phase|0|||
19589438|NCT00813709|42037576|FG000|Double Blind Period|Randomized but not treated|1|||
19589439|NCT00813709|42037577|FG001|Double Blind Period|Randomized but not treated|3|||
19589440|NCT00813709|42037578|FG002|Double Blind Period|Randomized but not treated|1|||
19589441|NCT00813709|42037579|FG003|Double Blind Period|Randomized but not treated|0|||
19589442|NCT00813709|42037580|FG004|Double Blind Period|Randomized but not treated|0|||
19589443|NCT00813709|42037581|FG005|Double Blind Period|Randomized but not treated|0|||
19589444|NCT00813709|42037576|FG000|Double Blind Period|Other|14|||
19589445|NCT00813709|42037577|FG001|Double Blind Period|Other|9|||
19589446|NCT00813709|42037578|FG002|Double Blind Period|Other|6|||
19589447|NCT00813709|42037579|FG003|Double Blind Period|Other|0|||
19589448|NCT00813709|42037580|FG004|Double Blind Period|Other|0|||
19589449|NCT00813709|42037581|FG005|Double Blind Period|Other|0|||
19589450|NCT00813709|42037576|FG000|Open Label Period|Adverse Event|0|||
19589451|NCT00813709|42037577|FG001|Open Label Period|Adverse Event|0|||
19589452|NCT00813709|42037578|FG002|Open Label Period|Adverse Event|0|||
19589453|NCT00813709|42037579|FG003|Open Label Period|Adverse Event|5|||
19589454|NCT00813709|42037580|FG004|Open Label Period|Adverse Event|4|||
19589455|NCT00813709|42037581|FG005|Open Label Period|Adverse Event|3|||
19589456|NCT00813709|42037576|FG000|Open Label Period|Lack of Efficacy|0|||
19589457|NCT00813709|42037577|FG001|Open Label Period|Lack of Efficacy|0|||
19589458|NCT00813709|42037578|FG002|Open Label Period|Lack of Efficacy|0|||
19589459|NCT00813709|42037579|FG003|Open Label Period|Lack of Efficacy|3|||
19589460|NCT00813709|42037580|FG004|Open Label Period|Lack of Efficacy|1|||
19589461|NCT00813709|42037581|FG005|Open Label Period|Lack of Efficacy|1|||
19589462|NCT00813709|42037576|FG000|Open Label Period|Randomized but not treated|0|||
19589463|NCT00813709|42037577|FG001|Open Label Period|Randomized but not treated|0|||
19589464|NCT00813709|42037578|FG002|Open Label Period|Randomized but not treated|0|||
19589465|NCT00813709|42037579|FG003|Open Label Period|Randomized but not treated|1|||
19589466|NCT00813709|42037580|FG004|Open Label Period|Randomized but not treated|0|||
19589467|NCT00813709|42037581|FG005|Open Label Period|Randomized but not treated|1|||
19589468|NCT00813709|42037576|FG000|Open Label Period|Other|0|||
19589469|NCT00813709|42037577|FG001|Open Label Period|Other|0|||
19589470|NCT00813709|42037578|FG002|Open Label Period|Other|0|||
19589471|NCT00813709|42037579|FG003|Open Label Period|Other|11|||
19589472|NCT00813709|42037580|FG004|Open Label Period|Other|5|||
19589473|NCT00813709|42037581|FG005|Open Label Period|Other|6|||
19589474|NCT01077323|42037613|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
19589475|NCT01077323|42037614|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
19589476|NCT01077323|42037615|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
19589477|NCT01077323|42037613|FG000|Overall Study|Dispensing of drug in baseline period|0|||
19589478|NCT01077323|42037614|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
19589479|NCT01077323|42037615|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
19589480|NCT01077323|42037613|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
19589481|NCT01077323|42037614|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
19387966|NCT02090764|41631289|FG000|Overall Study|Lack of Efficacy|0|||
19387967|NCT02090764|41631290|FG001|Overall Study|Lack of Efficacy|13|||
19387968|NCT02090764|41631289|FG000|Overall Study|Withdrawal by Subject|2|||
19387969|NCT02090764|41631290|FG001|Overall Study|Withdrawal by Subject|1|||
19387970|NCT02090764|41631289|FG000|Overall Study|Intercurrent illness and other|1|||
19387971|NCT02090764|41631290|FG001|Overall Study|Intercurrent illness and other|1|||
19387972|NCT02090764|41631289|FG000|Overall Study|Lost to Follow-up|2|||
19387973|NCT02090764|41631290|FG001|Overall Study|Lost to Follow-up|2|||
19387974|NCT02057692|41631300|FG000|Overall Study|Adverse Event|1|||
19387975|NCT02057692|41631301|FG001|Overall Study|Adverse Event|0|||
19387976|NCT02057692|41631302|FG002|Overall Study|Adverse Event|0|||
19589482|NCT01077323|42037615|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
19589483|NCT00976950|42037623|FG000|Overall Study|Adverse Event|3|||
19589484|NCT00976950|42037623|FG000|Overall Study|Events with no relationship to Aptivus|3|||
19589485|NCT00976716|42037627|FG000|Overall Study|Adverse Event|1|||
19589486|NCT00819247|42037635|FG000|Overall Study|Adverse Event|0|||
19589487|NCT00819247|42037636|FG001|Overall Study|Adverse Event|5|||
19589488|NCT00819247|42037637|FG002|Overall Study|Adverse Event|3|||
19589489|NCT00819247|42037635|FG000|Overall Study|Insufficient testosterone response|5|||
19589490|NCT00819247|42037636|FG001|Overall Study|Insufficient testosterone response|8|||
19589491|NCT00819247|42037637|FG002|Overall Study|Insufficient testosterone response|10|||
19589492|NCT00819247|42037635|FG000|Overall Study|Withdrawal by Subject|1|||
19589493|NCT00819247|42037636|FG001|Overall Study|Withdrawal by Subject|0|||
19589494|NCT00819247|42037637|FG002|Overall Study|Withdrawal by Subject|0|||
19589495|NCT00819247|42037635|FG000|Overall Study|Protocol Violation|1|||
19589496|NCT00819247|42037636|FG001|Overall Study|Protocol Violation|0|||
19589497|NCT00819247|42037637|FG002|Overall Study|Protocol Violation|1|||
19589498|NCT00819247|42037635|FG000|Overall Study|Mistakenly withdrawn|0|||
19589499|NCT00819247|42037636|FG001|Overall Study|Mistakenly withdrawn|1|||
19589500|NCT00819247|42037637|FG002|Overall Study|Mistakenly withdrawn|0|||
19589501|NCT00819247|42037635|FG000|Overall Study|Bad prostate-specific antigen response|3|||
19589502|NCT00819247|42037636|FG001|Overall Study|Bad prostate-specific antigen response|2|||
19589503|NCT00819247|42037637|FG002|Overall Study|Bad prostate-specific antigen response|0|||
19589504|NCT00819247|42037635|FG000|Overall Study|Other|1|||
19589505|NCT00819247|42037636|FG001|Overall Study|Other|0|||
19589506|NCT00819247|42037637|FG002|Overall Study|Other|0|||
19589507|NCT00973674|42037647|FG000|Overall Study|Protocol Violation|2|||
19589508|NCT00973674|42037648|FG001|Overall Study|Protocol Violation|0|||
19589509|NCT00819091|42037657|FG000|Overall Study|Adverse Event|3|||
19589510|NCT00819091|42037658|FG001|Overall Study|Adverse Event|5|||
19589511|NCT00819091|42037657|FG000|Overall Study|Protocol Violation|0|||
19589512|NCT00819091|42037658|FG001|Overall Study|Protocol Violation|1|||
19589513|NCT00819091|42037657|FG000|Overall Study|Lost to Follow-up|2|||
19589514|NCT00819091|42037658|FG001|Overall Study|Lost to Follow-up|0|||
19589515|NCT00819091|42037657|FG000|Overall Study|Withdrawal by Subject|1|||
19589516|NCT00819091|42037658|FG001|Overall Study|Withdrawal by Subject|2|||
19589517|NCT00819091|42037657|FG000|Overall Study|Other|1|||
19589518|NCT00819091|42037658|FG001|Overall Study|Other|2|||
19589519|NCT00973362|42037666|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
19589520|NCT00973362|42037667|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
19589521|NCT00973362|42037666|FG000|Baseline Evaluation|No colposcopy visit|62|||
19589522|NCT00973362|42037667|FG001|Baseline Evaluation|No colposcopy visit|0|||
19589523|NCT00973362|42037666|FG000|Baseline Evaluation|Inevaluable|686|||
19589524|NCT00973362|42037667|FG001|Baseline Evaluation|Inevaluable|223|||
19589525|NCT00973362|42037666|FG000|3-Year Follow-up|Lost to Follow-up|17|||
19589526|NCT00973362|42037667|FG001|3-Year Follow-up|Lost to Follow-up|0|||
19589527|NCT00819013|42037680|FG000|Overall Study|Not meeting continuing study eligibility|2|||
19589528|NCT00819013|42037681|FG001|Overall Study|Not meeting continuing study eligibility|1|||
19589529|NCT00819013|42037682|FG002|Overall Study|Not meeting continuing study eligibility|2|||
19589530|NCT00819013|42037683|FG003|Overall Study|Not meeting continuing study eligibility|1|||
19589531|NCT00819013|42037680|FG000|Overall Study|Adverse Event|0|||
19589532|NCT00819013|42037681|FG001|Overall Study|Adverse Event|0|||
19589533|NCT00819013|42037682|FG002|Overall Study|Adverse Event|1|||
19589534|NCT00819013|42037683|FG003|Overall Study|Adverse Event|0|||
19589535|NCT00819013|42037680|FG000|Overall Study|Withdrawal by Subject|1|||
19589536|NCT00819013|42037681|FG001|Overall Study|Withdrawal by Subject|0|||
19589537|NCT00819013|42037682|FG002|Overall Study|Withdrawal by Subject|1|||
19589538|NCT00819013|42037683|FG003|Overall Study|Withdrawal by Subject|0|||
19589539|NCT00819013|42037680|FG000|Overall Study|Lost to Follow-up|0|||
19589540|NCT00819013|42037681|FG001|Overall Study|Lost to Follow-up|0|||
19589541|NCT00819013|42037682|FG002|Overall Study|Lost to Follow-up|1|||
19589542|NCT00819013|42037683|FG003|Overall Study|Lost to Follow-up|2|||
19589543|NCT00819013|42037680|FG000|Overall Study|Death|0|||
19589544|NCT00819013|42037681|FG001|Overall Study|Death|0|||
19589545|NCT00819013|42037682|FG002|Overall Study|Death|0|||
19589546|NCT00819013|42037683|FG003|Overall Study|Death|1|||
19589547|NCT00976560|42037695|FG000|Overall Study|Adverse Event|5|||
19589548|NCT00976560|42037696|FG001|Overall Study|Adverse Event|5|||
19589549|NCT00976560|42037695|FG000|Overall Study|Lack of Efficacy|3|||
19589550|NCT00976560|42037696|FG001|Overall Study|Lack of Efficacy|5|||
19589551|NCT00976560|42037695|FG000|Overall Study|Protocol Violation|1|||
19476969|NCT01489189|41755552|FG001|Overall Study|Withdrawal by Subject|23|||
19476970|NCT01489189|41755551|FG000|Overall Study|Death|10|||
19589552|NCT00976560|42037696|FG001|Overall Study|Protocol Violation|0|||
19589553|NCT00976560|42037695|FG000|Overall Study|Lost to Follow-up|1|||
19589554|NCT00976560|42037696|FG001|Overall Study|Lost to Follow-up|0|||
19589555|NCT00976560|42037695|FG000|Overall Study|Physician Decision|2|||
19589556|NCT00976560|42037696|FG001|Overall Study|Physician Decision|0|||
19589557|NCT00976560|42037695|FG000|Overall Study|Withdrawal by Subject|2|||
19589558|NCT00976560|42037696|FG001|Overall Study|Withdrawal by Subject|3|||
19589559|NCT00976482|42037702|FG000|Overall Study|Death|208|||
19589560|NCT00976482|42037702|FG000|Overall Study|Withdrawal by Subject|45|||
19589561|NCT00976482|42037702|FG000|Overall Study|Center terminated|1|||
19589562|NCT00976482|42037702|FG000|Overall Study|Protocol Violation|5|||
19589563|NCT00975156|42037708|FG000|Overall Study|Protocol Violation|0|||
19589564|NCT00975156|42037709|FG001|Overall Study|Protocol Violation|1|||
19589565|NCT00810043|42037721|FG000|Overall Study|Withdrawal by Subject|1|||
19589566|NCT00810043|42037722|FG001|Overall Study|Withdrawal by Subject|0|||
19589567|NCT00810043|42037723|FG002|Overall Study|Withdrawal by Subject|2|||
19589568|NCT00810043|42037721|FG000|Overall Study|Lost to Follow-up|1|||
19589569|NCT00810043|42037722|FG001|Overall Study|Lost to Follow-up|0|||
19589570|NCT00810043|42037723|FG002|Overall Study|Lost to Follow-up|0|||
19589571|NCT00810043|42037721|FG000|Overall Study|Physician Decision|0|||
19589572|NCT00810043|42037722|FG001|Overall Study|Physician Decision|0|||
19589573|NCT00810043|42037723|FG002|Overall Study|Physician Decision|2|||
19589574|NCT00810043|42037721|FG000|Overall Study|Death|2|||
19589575|NCT00810043|42037722|FG001|Overall Study|Death|0|||
19589576|NCT00810043|42037723|FG002|Overall Study|Death|0|||
19589577|NCT00810043|42037721|FG000|Overall Study|Unrelated medical problem|0|||
19589578|NCT00810043|42037722|FG001|Overall Study|Unrelated medical problem|1|||
19589579|NCT00810043|42037723|FG002|Overall Study|Unrelated medical problem|0|||
19589580|NCT00810043|42037721|FG000|Overall Study|Non-medical problem|0|||
19589581|NCT00810043|42037722|FG001|Overall Study|Non-medical problem|0|||
19589582|NCT00810043|42037723|FG002|Overall Study|Non-medical problem|1|||
19589583|NCT00810043|42037721|FG000|Overall Study|No longer met enrollment criteria|0|||
19589584|NCT00810043|42037722|FG001|Overall Study|No longer met enrollment criteria|0|||
19589585|NCT00810043|42037723|FG002|Overall Study|No longer met enrollment criteria|3|||
19589586|NCT01120184|42037735|FG000|Overall Study|Adverse Event|0|||
19589587|NCT01120184|42037736|FG001|Overall Study|Adverse Event|1|||
19589588|NCT01120184|42037737|FG002|Overall Study|Adverse Event|0|||
19589589|NCT01120184|42037735|FG000|Overall Study|Lost to Follow-up|13|||
19589590|NCT01120184|42037736|FG001|Overall Study|Lost to Follow-up|13|||
19589591|NCT01120184|42037737|FG002|Overall Study|Lost to Follow-up|11|||
19589592|NCT01120184|42037735|FG000|Overall Study|Physician Decision|9|||
19589593|NCT01120184|42037736|FG001|Overall Study|Physician Decision|1|||
19589594|NCT01120184|42037737|FG002|Overall Study|Physician Decision|3|||
19589595|NCT01120184|42037735|FG000|Overall Study|Reason not Specified|8|||
19589596|NCT01120184|42037736|FG001|Overall Study|Reason not Specified|3|||
19589597|NCT01120184|42037737|FG002|Overall Study|Reason not Specified|12|||
19589598|NCT01120184|42037735|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
19589599|NCT01120184|42037736|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
19589600|NCT01120184|42037737|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
19589601|NCT01120184|42037735|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
19589602|NCT01120184|42037736|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
19589603|NCT01120184|42037737|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
19589604|NCT01120184|42037735|FG000|Overall Study|Death|170|||
19589605|NCT01120184|42037736|FG001|Overall Study|Death|176|||
19589606|NCT01120184|42037737|FG002|Overall Study|Death|169|||
19589607|NCT01120028|42037749|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
19589608|NCT01120028|42037750|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
19589609|NCT01120028|42037751|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
19589610|NCT01120028|42037752|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
19589611|NCT01120028|42037749|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
19589612|NCT01120028|42037750|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
19589613|NCT01120028|42037751|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
19589614|NCT01120028|42037752|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
19589615|NCT00878800|42037768|FG000|Overall Study|Adverse Event|0|||
19589616|NCT00878800|42037769|FG001|Overall Study|Adverse Event|0|||
19589617|NCT00878800|42037770|FG002|Overall Study|Adverse Event|2|||
19589618|NCT00878800|42037771|FG003|Overall Study|Adverse Event|0|||
19589619|NCT00878800|42037772|FG004|Overall Study|Adverse Event|1|||
19589620|NCT00878800|42037768|FG000|Overall Study|Progressive disease|1|||
19589621|NCT00878800|42037769|FG001|Overall Study|Progressive disease|5|||
19589622|NCT00878800|42037770|FG002|Overall Study|Progressive disease|6|||
19589623|NCT00878800|42037771|FG003|Overall Study|Progressive disease|5|||
19589624|NCT00878800|42037772|FG004|Overall Study|Progressive disease|13|||
19589625|NCT00878800|42037768|FG000|Overall Study|Withdrew consent|1|||
19589626|NCT00878800|42037769|FG001|Overall Study|Withdrew consent|1|||
19589627|NCT00878800|42037770|FG002|Overall Study|Withdrew consent|0|||
19589628|NCT00878800|42037771|FG003|Overall Study|Withdrew consent|1|||
19589629|NCT00878800|42037772|FG004|Overall Study|Withdrew consent|1|||
19589630|NCT00878800|42037768|FG000|Overall Study|Death|0|||
19589631|NCT00878800|42037769|FG001|Overall Study|Death|0|||
19589632|NCT00878800|42037770|FG002|Overall Study|Death|1|||
19589633|NCT00878800|42037771|FG003|Overall Study|Death|0|||
19589634|NCT00878800|42037772|FG004|Overall Study|Death|0|||
19589635|NCT00878800|42037768|FG000|Overall Study|Other|1|||
19589636|NCT00878800|42037769|FG001|Overall Study|Other|1|||
19589637|NCT00878800|42037770|FG002|Overall Study|Other|0|||
19589638|NCT00878800|42037771|FG003|Overall Study|Other|0|||
19589639|NCT00878800|42037772|FG004|Overall Study|Other|1|||
19589640|NCT01119950|42037783|FG000|Overall Study|Adverse Event|25|||
19589641|NCT01119950|42037783|FG000|Overall Study|Withdrawal by Subject|9|||
19589642|NCT01119950|42037783|FG000|Overall Study|Protocol Violation|5|||
19589643|NCT01119950|42037783|FG000|Overall Study|Lost to Follow-up|4|||
19589644|NCT01119950|42037783|FG000|Overall Study|Administrative|2|||
19589645|NCT01119950|42037783|FG000|Overall Study|Abnormal lab value|1|||
19589646|NCT01119950|42037783|FG000|Overall Study|Death|1|||
19589647|NCT01145222|42037813|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
19589648|NCT01145222|42037814|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
19589649|NCT01145222|42037815|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
19589650|NCT01145222|42037816|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
19589651|NCT01145222|42037813|FG000|Overall Study|Poor bowel preparation|0|||
19589652|NCT01145222|42037814|FG001|Overall Study|Poor bowel preparation|0|||
19589653|NCT01145222|42037815|FG002|Overall Study|Poor bowel preparation|0|||
19589654|NCT01145222|42037816|FG003|Overall Study|Poor bowel preparation|1|||
19589655|NCT01145066|42037829|FG000|Overall Study|To resume NSAIDs|2|||
19589656|NCT01145066|42037830|FG001|Overall Study|To resume NSAIDs|2|||
19589657|NCT01145066|42037831|FG002|Overall Study|To resume NSAIDs|1|||
19589658|NCT01145066|42037829|FG000|Overall Study|Non-related surgery|0|||
19589659|NCT01145066|42037830|FG001|Overall Study|Non-related surgery|0|||
19589660|NCT01145066|42037831|FG002|Overall Study|Non-related surgery|1|||
19589661|NCT01145066|42037829|FG000|Overall Study|Withdrawal by Subject|0|||
19589662|NCT01145066|42037830|FG001|Overall Study|Withdrawal by Subject|0|||
19589663|NCT01145066|42037831|FG002|Overall Study|Withdrawal by Subject|2|||
19589664|NCT01145066|42037829|FG000|Overall Study|To start new med|1|||
19589665|NCT01145066|42037830|FG001|Overall Study|To start new med|0|||
19589666|NCT01145066|42037831|FG002|Overall Study|To start new med|0|||
19589667|NCT01145066|42037829|FG000|Overall Study|problems swallowing capsule|1|||
19589668|NCT01145066|42037830|FG001|Overall Study|problems swallowing capsule|0|||
19589669|NCT01145066|42037831|FG002|Overall Study|problems swallowing capsule|0|||
19589670|NCT01145066|42037829|FG000|Overall Study|Abdominal discomfort|0|||
19589671|NCT01145066|42037830|FG001|Overall Study|Abdominal discomfort|1|||
19589672|NCT01145066|42037831|FG002|Overall Study|Abdominal discomfort|0|||
19589673|NCT01145066|42037829|FG000|Overall Study|Low platelet count|0|||
19589674|NCT01145066|42037830|FG001|Overall Study|Low platelet count|1|||
19589675|NCT01145066|42037831|FG002|Overall Study|Low platelet count|0|||
19589676|NCT01132118|42037841|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
19589677|NCT01132118|42037842|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
19589678|NCT01132118|42037841|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
19589679|NCT01132118|42037842|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
19589680|NCT01132118|42037841|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
19589681|NCT01132118|42037842|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
19589682|NCT00972816|42037856|FG000|Overall Study|Adverse Event|0|||
19589683|NCT00972816|42037857|FG001|Overall Study|Adverse Event|0|||
19589684|NCT00972816|42037858|FG002|Overall Study|Adverse Event|1|||
19589685|NCT00972816|42037859|FG003|Overall Study|Adverse Event|0|||
19589686|NCT00972816|42037860|FG004|Overall Study|Adverse Event|0|||
19589687|NCT00972816|42037861|FG005|Overall Study|Adverse Event|0|||
19589688|NCT00972816|42037862|FG006|Overall Study|Adverse Event|0|||
19589689|NCT00972816|42037863|FG007|Overall Study|Adverse Event|0|||
19589690|NCT00972816|42037856|FG000|Overall Study|Withdrawal by Subject|4|||
19589691|NCT00972816|42037857|FG001|Overall Study|Withdrawal by Subject|2|||
19589692|NCT00972816|42037858|FG002|Overall Study|Withdrawal by Subject|1|||
19589693|NCT00972816|42037859|FG003|Overall Study|Withdrawal by Subject|3|||
19589694|NCT00972816|42037860|FG004|Overall Study|Withdrawal by Subject|0|||
19589695|NCT00972816|42037861|FG005|Overall Study|Withdrawal by Subject|1|||
19589696|NCT00972816|42037862|FG006|Overall Study|Withdrawal by Subject|1|||
19589697|NCT00972816|42037863|FG007|Overall Study|Withdrawal by Subject|2|||
19589698|NCT00972816|42037856|FG000|Overall Study|Lost to Follow-up|11|||
19589699|NCT00972816|42037857|FG001|Overall Study|Lost to Follow-up|9|||
19589700|NCT00972816|42037858|FG002|Overall Study|Lost to Follow-up|7|||
19589701|NCT00972816|42037859|FG003|Overall Study|Lost to Follow-up|5|||
19589702|NCT00972816|42037860|FG004|Overall Study|Lost to Follow-up|11|||
19589703|NCT00972816|42037861|FG005|Overall Study|Lost to Follow-up|10|||
19589704|NCT00972816|42037862|FG006|Overall Study|Lost to Follow-up|7|||
19589705|NCT00972816|42037863|FG007|Overall Study|Lost to Follow-up|7|||
19589706|NCT00972816|42037856|FG000|Overall Study|Inappropriate enrolment|0|||
19589707|NCT00972816|42037857|FG001|Overall Study|Inappropriate enrolment|0|||
19589708|NCT00972816|42037858|FG002|Overall Study|Inappropriate enrolment|0|||
19589709|NCT00972816|42037859|FG003|Overall Study|Inappropriate enrolment|0|||
19589710|NCT00972816|42037860|FG004|Overall Study|Inappropriate enrolment|0|||
19589711|NCT00972816|42037861|FG005|Overall Study|Inappropriate enrolment|0|||
19589712|NCT00972816|42037862|FG006|Overall Study|Inappropriate enrolment|2|||
19589713|NCT00972816|42037863|FG007|Overall Study|Inappropriate enrolment|0|||
19589714|NCT00972816|42037856|FG000|Overall Study|Unable to classify|2|||
19589715|NCT00972816|42037857|FG001|Overall Study|Unable to classify|0|||
19589716|NCT00972816|42037858|FG002|Overall Study|Unable to classify|0|||
19589717|NCT00972816|42037859|FG003|Overall Study|Unable to classify|0|||
19589718|NCT00972816|42037860|FG004|Overall Study|Unable to classify|1|||
19589719|NCT00972816|42037861|FG005|Overall Study|Unable to classify|0|||
19589720|NCT00972816|42037862|FG006|Overall Study|Unable to classify|0|||
19589721|NCT00972816|42037863|FG007|Overall Study|Unable to classify|0|||
19589722|NCT00969618|42037881|FG000|Overall Study|Adverse Event|29|||
19589723|NCT00969618|42037881|FG000|Overall Study|Entry Criteria Not Met|3|||
19589724|NCT00969618|42037881|FG000|Overall Study|Lack of Efficacy|2|||
19589725|NCT00969618|42037881|FG000|Overall Study|Lost to Follow-up|7|||
19589726|NCT00969618|42037881|FG000|Overall Study|Physician Decision|1|||
19589727|NCT00969618|42037881|FG000|Overall Study|Protocol Violation|9|||
19589728|NCT00969618|42037881|FG000|Overall Study|Withdrawal by Subject|27|||
19589729|NCT00969540|42037887|FG000|Overall Study|Lost to Follow-up|1|||
19589730|NCT00969540|42037888|FG001|Overall Study|Lost to Follow-up|1|||
19589731|NCT00975000|42037908|FG000|Overall Study|Other|1|||
19589732|NCT00975000|42037909|FG001|Overall Study|Other|0|||
19589733|NCT00975000|42037908|FG000|Overall Study|Adverse Event|1|||
19589734|NCT00975000|42037909|FG001|Overall Study|Adverse Event|1|||
19589735|NCT00975000|42037908|FG000|Overall Study|Withdrawal by Subject|2|||
19589736|NCT00975000|42037909|FG001|Overall Study|Withdrawal by Subject|2|||
19589737|NCT00975000|42037908|FG000|Overall Study|Lost to Follow-up|0|||
19589738|NCT00975000|42037909|FG001|Overall Study|Lost to Follow-up|1|||
19589739|NCT00975000|42037908|FG000|Overall Study|Protocol-specified Criteria|1|||
19589740|NCT00975000|42037909|FG001|Overall Study|Protocol-specified Criteria|0|||
19589741|NCT00975000|42037908|FG000|Overall Study|Non-compliance|0|||
19589742|NCT00975000|42037909|FG001|Overall Study|Non-compliance|1|||
19589743|NCT00974922|42037915|FG000|Overall Study|study terminated|24|||
19589744|NCT00972504|42037919|FG000|Overall Study|Adverse Event|2|||
19589745|NCT00972504|42037919|FG000|Overall Study|Investigator discretion|1|||
19589746|NCT00969228|42037931|FG000|Overall Study|Adverse Event|1|||
19589747|NCT00969228|42037932|FG001|Overall Study|Adverse Event|0|||
19589748|NCT00969228|42037931|FG000|Overall Study|Withdrawal by Subject|4|||
19589749|NCT00969228|42037932|FG001|Overall Study|Withdrawal by Subject|0|||
19589750|NCT00969228|42037931|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
19589751|NCT00969228|42037932|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
19589752|NCT00969150|42037940|FG000|Overall Study|Adverse Event|4|||
19589753|NCT00969150|42037941|FG001|Overall Study|Adverse Event|14|||
19589754|NCT00969150|42037940|FG000|Overall Study|Lack of Efficacy|1|||
19589755|NCT00969150|42037941|FG001|Overall Study|Lack of Efficacy|1|||
19589756|NCT00969150|42037940|FG000|Overall Study|Protocol Violation|9|||
19589757|NCT00969150|42037941|FG001|Overall Study|Protocol Violation|12|||
19589758|NCT00969150|42037940|FG000|Overall Study|Withdrawal by Subject|13|||
19589759|NCT00969150|42037941|FG001|Overall Study|Withdrawal by Subject|9|||
19589760|NCT00969150|42037940|FG000|Overall Study|Lost to Follow-up|5|||
19589761|NCT00969150|42037941|FG001|Overall Study|Lost to Follow-up|4|||
19589762|NCT00969150|42037940|FG000|Overall Study|Other reasons|1|||
19589763|NCT00969150|42037941|FG001|Overall Study|Other reasons|0|||
19589764|NCT00974220|42037949|FG000|Treatment Period 1|Adverse Event|2|||
19589765|NCT00974220|42037950|FG001|Treatment Period 1|Adverse Event|1|||
19589766|NCT00974220|42037949|FG000|Treatment Period 1|noncompliant subjects|0|||
19589767|NCT00974220|42037950|FG001|Treatment Period 1|noncompliant subjects|1|||
19589768|NCT00971178|42037959|FG000|Overall Study|Lost to Follow-up|2|||
19589769|NCT00971178|42037960|FG001|Overall Study|Lost to Follow-up|2|||
19589770|NCT00971178|42037961|FG002|Overall Study|Lost to Follow-up|2|||
19589771|NCT03670602|42037971|FG000|Overall Study|Lost to Follow-up|1|||
19589772|NCT03670602|42037972|FG001|Overall Study|Lost to Follow-up|0|||
19589773|NCT03670602|42037971|FG000|Overall Study|Withdrawal by Subject|0|||
19589774|NCT03670602|42037972|FG001|Overall Study|Withdrawal by Subject|3|||
19589775|NCT00968526|42037980|FG000|Overall Study|Adverse Event|2|||
19589776|NCT00968526|42037981|FG001|Overall Study|Adverse Event|0|||
19589777|NCT00968526|42037980|FG000|Overall Study|Migrated/moved from study area|1|||
19589778|NCT00968526|42037981|FG001|Overall Study|Migrated/moved from study area|0|||
19589779|NCT03664674|42037998|FG000|Overall Study|Adverse Event|1|||
19589780|NCT03664674|42037999|FG001|Overall Study|Adverse Event|1|||
19589781|NCT03664674|42037998|FG000|Overall Study|Physician Decision|0|||
19589782|NCT03664674|42037999|FG001|Overall Study|Physician Decision|1|||
19589783|NCT03664674|42037998|FG000|Overall Study|Withdrawal by Subject|2|||
19589784|NCT03664674|42037999|FG001|Overall Study|Withdrawal by Subject|0|||
19589785|NCT00967668|42038010|FG000|Overall Study|Withdrawal by Subject|13|||
19589786|NCT00967668|42038011|FG001|Overall Study|Withdrawal by Subject|8|||
19589787|NCT00967668|42038012|FG002|Overall Study|Withdrawal by Subject|8|||
19589788|NCT00967668|42038010|FG000|Overall Study|Death|0|||
19589789|NCT00967668|42038011|FG001|Overall Study|Death|2|||
19589790|NCT00967668|42038012|FG002|Overall Study|Death|4|||
19589791|NCT00967668|42038010|FG000|Overall Study|Removed due to behavior|1|||
19589792|NCT00967668|42038011|FG001|Overall Study|Removed due to behavior|1|||
19589793|NCT00967668|42038012|FG002|Overall Study|Removed due to behavior|2|||
19589794|NCT00967668|42038010|FG000|Overall Study|Refused Year 2|11|||
19387977|NCT02057692|41631303|FG003|Overall Study|Adverse Event|0|||
19589795|NCT00967668|42038011|FG001|Overall Study|Refused Year 2|6|||
19589796|NCT00967668|42038012|FG002|Overall Study|Refused Year 2|4|||
19589797|NCT00967668|42038010|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
19589798|NCT00967668|42038011|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
19589799|NCT00967668|42038012|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
19589800|NCT00967668|42038010|FG000|Overall Study|Lost to Follow-up|15|||
19589801|NCT00967668|42038011|FG001|Overall Study|Lost to Follow-up|9|||
19589802|NCT00967668|42038012|FG002|Overall Study|Lost to Follow-up|16|||
19589803|NCT00967668|42038010|FG000|Overall Study|Refused 12-mo assessment|3|||
19589804|NCT00967668|42038011|FG001|Overall Study|Refused 12-mo assessment|1|||
19589805|NCT00967668|42038012|FG002|Overall Study|Refused 12-mo assessment|9|||
19589806|NCT00967668|42038010|FG000|Overall Study|Pregnancy|1|||
19589807|NCT00967668|42038011|FG001|Overall Study|Pregnancy|0|||
19589808|NCT00967668|42038012|FG002|Overall Study|Pregnancy|0|||
19589809|NCT00970944|42038025|FG000|Overall Study|Death|1|||
19589810|NCT00970944|42038026|FG001|Overall Study|Death|0|||
19589811|NCT00970944|42038025|FG000|Overall Study|Physician Decision|0|||
19589812|NCT00970944|42038026|FG001|Overall Study|Physician Decision|2|||
19589813|NCT04839289|42038035|FG000|Overall Study|Withdrawal by Subject|1|||
19589814|NCT04839289|42038036|FG001|Overall Study|Withdrawal by Subject|0|||
19589815|NCT04440813|42038044|FG000|Overall Study|Lost to Follow-up|5|||
19589816|NCT04440813|42038045|FG001|Overall Study|Lost to Follow-up|5|||
19589817|NCT04233073|42038059|FG000|Overall Study|Death|5|||
19589818|NCT04120116|42038067|FG000|Overall Study|Lost to Follow-up|0|||
19589819|NCT04120116|42038068|FG001|Overall Study|Lost to Follow-up|1|||
19589820|NCT04120116|42038069|FG002|Overall Study|Lost to Follow-up|0|||
19589821|NCT04120116|42038070|FG003|Overall Study|Lost to Follow-up|2|||
19589822|NCT04120116|42038067|FG000|Overall Study|Withdrawal by Subject|1|||
19589823|NCT04120116|42038068|FG001|Overall Study|Withdrawal by Subject|0|||
19589824|NCT04120116|42038069|FG002|Overall Study|Withdrawal by Subject|1|||
19589825|NCT04120116|42038070|FG003|Overall Study|Withdrawal by Subject|1|||
19589826|NCT04120116|42038067|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
19589827|NCT04120116|42038068|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
19589828|NCT04120116|42038069|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
19589829|NCT04120116|42038070|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
19589830|NCT03657810|42038093|FG000|Overall Study|Adverse Event|0|||
19589831|NCT03657810|42038094|FG001|Overall Study|Adverse Event|1|||
19589832|NCT03657810|42038095|FG002|Overall Study|Adverse Event|0|||
19589833|NCT03657810|42038093|FG000|Overall Study|Lack of Efficacy|4|||
19589834|NCT03657810|42038094|FG001|Overall Study|Lack of Efficacy|1|||
19589835|NCT03657810|42038095|FG002|Overall Study|Lack of Efficacy|3|||
19589836|NCT03657810|42038093|FG000|Overall Study|Protocol Violation|1|||
19589837|NCT03657810|42038094|FG001|Overall Study|Protocol Violation|0|||
19589838|NCT03657810|42038095|FG002|Overall Study|Protocol Violation|0|||
19589839|NCT03657810|42038093|FG000|Overall Study|Lost to Follow-up|0|||
19589840|NCT03657810|42038094|FG001|Overall Study|Lost to Follow-up|1|||
19589841|NCT03657810|42038095|FG002|Overall Study|Lost to Follow-up|0|||
19589842|NCT03657810|42038093|FG000|Overall Study|Not provided|0|||
19589843|NCT03657810|42038094|FG001|Overall Study|Not provided|1|||
19589844|NCT03657810|42038095|FG002|Overall Study|Not provided|0|||
19589845|NCT03370341|42038121|FG000|Overall Study|Lost to Follow-up|0|||
19589846|NCT03370341|42038122|FG001|Overall Study|Lost to Follow-up|1|||
19589847|NCT02927301|42038182|FG000|Overall Study|Adverse Event|7|||
19589848|NCT02927301|42038182|FG000|Overall Study|Withdrawal by Subject|1|||
19589849|NCT02927301|42038182|FG000|Overall Study|Physician Decision|2|||
19589850|NCT02614066|42038199|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
19589851|NCT02614066|42038200|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
19589852|NCT02614066|42038201|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
19589853|NCT02614066|42038202|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
19589854|NCT02614066|42038199|FG000|Overall Study|Full Consent Withdrawn|0|||
19589855|NCT02614066|42038200|FG001|Overall Study|Full Consent Withdrawn|1|||
19589856|NCT02614066|42038201|FG002|Overall Study|Full Consent Withdrawn|0|||
19589857|NCT02614066|42038202|FG003|Overall Study|Full Consent Withdrawn|3|||
19589858|NCT02614066|42038199|FG000|Overall Study|Lost to Follow-up|0|||
19589859|NCT02614066|42038200|FG001|Overall Study|Lost to Follow-up|1|||
19589860|NCT02614066|42038201|FG002|Overall Study|Lost to Follow-up|0|||
19589861|NCT02614066|42038202|FG003|Overall Study|Lost to Follow-up|0|||
19589862|NCT02614066|42038199|FG000|Overall Study|Still on-study|1|||
19589863|NCT02614066|42038200|FG001|Overall Study|Still on-study|9|||
19589864|NCT02614066|42038201|FG002|Overall Study|Still on-study|5|||
19589865|NCT02614066|42038202|FG003|Overall Study|Still on-study|32|||
19589866|NCT02614066|42038199|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
19589867|NCT02614066|42038200|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
19589868|NCT02614066|42038201|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
19589869|NCT02614066|42038202|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
19589870|NCT02544074|42038231|FG000|Overall Study|Withdrawal by Subject|0|||
19589871|NCT02544074|42038232|FG001|Overall Study|Withdrawal by Subject|1|||
19589872|NCT02544074|42038233|FG002|Overall Study|Withdrawal by Subject|0|||
19589873|NCT02544074|42038234|FG003|Overall Study|Withdrawal by Subject|0|||
19589874|NCT02544074|42038235|FG004|Overall Study|Withdrawal by Subject|0|||
19589875|NCT02544074|42038236|FG005|Overall Study|Withdrawal by Subject|0|||
19589876|NCT02544074|42038237|FG006|Overall Study|Withdrawal by Subject|0|||
19589877|NCT02544074|42038238|FG007|Overall Study|Withdrawal by Subject|0|||
19589878|NCT02544074|42038239|FG008|Overall Study|Withdrawal by Subject|0|||
19589879|NCT02544074|42038240|FG009|Overall Study|Withdrawal by Subject|0|||
19589880|NCT02544074|42038241|FG010|Overall Study|Withdrawal by Subject|0|||
19589881|NCT02544074|42038242|FG011|Overall Study|Withdrawal by Subject|0|||
19589882|NCT02544074|42038243|FG012|Overall Study|Withdrawal by Subject|0|||
19589883|NCT02544074|42038244|FG013|Overall Study|Withdrawal by Subject|0|||
19589884|NCT02544074|42038245|FG014|Overall Study|Withdrawal by Subject|0|||
19589885|NCT02544074|42038246|FG015|Overall Study|Withdrawal by Subject|0|||
19589886|NCT02544074|42038247|FG016|Overall Study|Withdrawal by Subject|0|||
19589887|NCT02544074|42038248|FG017|Overall Study|Withdrawal by Subject|0|||
19589888|NCT02544074|42038249|FG018|Overall Study|Withdrawal by Subject|0|||
19589889|NCT02544074|42038250|FG019|Overall Study|Withdrawal by Subject|0|||
19589890|NCT02544074|42038251|FG020|Overall Study|Withdrawal by Subject|0|||
19589891|NCT02544074|42038231|FG000|Overall Study|Tablet error|0|||
19589892|NCT02544074|42038232|FG001|Overall Study|Tablet error|0|||
19589893|NCT02544074|42038233|FG002|Overall Study|Tablet error|0|||
19589894|NCT02544074|42038234|FG003|Overall Study|Tablet error|0|||
19589895|NCT02544074|42038235|FG004|Overall Study|Tablet error|0|||
19589896|NCT02544074|42038236|FG005|Overall Study|Tablet error|1|||
19589897|NCT02544074|42038237|FG006|Overall Study|Tablet error|0|||
19589898|NCT02544074|42038238|FG007|Overall Study|Tablet error|0|||
19589899|NCT02544074|42038239|FG008|Overall Study|Tablet error|0|||
19589900|NCT02544074|42038240|FG009|Overall Study|Tablet error|1|||
19589901|NCT02544074|42038241|FG010|Overall Study|Tablet error|0|||
19589902|NCT02544074|42038242|FG011|Overall Study|Tablet error|0|||
19589903|NCT02544074|42038243|FG012|Overall Study|Tablet error|0|||
19589904|NCT02544074|42038244|FG013|Overall Study|Tablet error|0|||
19589905|NCT02544074|42038245|FG014|Overall Study|Tablet error|0|||
19589906|NCT02544074|42038246|FG015|Overall Study|Tablet error|0|||
19589907|NCT02544074|42038247|FG016|Overall Study|Tablet error|0|||
19589908|NCT02544074|42038248|FG017|Overall Study|Tablet error|0|||
19589909|NCT02544074|42038249|FG018|Overall Study|Tablet error|0|||
19589910|NCT02544074|42038250|FG019|Overall Study|Tablet error|0|||
19589911|NCT02544074|42038251|FG020|Overall Study|Tablet error|0|||
19589912|NCT02502799|42038289|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
19589913|NCT02502799|42038290|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
19589914|NCT02502799|42038291|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
19589915|NCT02502799|42038292|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
19589916|NCT02502799|42038289|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
19589917|NCT02502799|42038290|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
19589918|NCT02502799|42038291|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
19589919|NCT02502799|42038292|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
19589920|NCT02502799|42038289|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
19589921|NCT02502799|42038290|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
19589922|NCT02502799|42038291|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
19589923|NCT02502799|42038292|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
19589924|NCT02502799|42038289|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
19589925|NCT02502799|42038290|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
19589926|NCT02502799|42038291|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
19589927|NCT02502799|42038292|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
19589928|NCT02502799|42038289|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
19589929|NCT02502799|42038290|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
19589930|NCT02502799|42038291|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
19589931|NCT02502799|42038292|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
19589932|NCT02086448|42038305|FG000|Overall Study|Withdrawal by Subject|1|||
19589933|NCT02086448|42038306|FG001|Overall Study|Withdrawal by Subject|0|||
19589934|NCT02086448|42038307|FG002|Overall Study|Withdrawal by Subject|0|||
19589935|NCT02086448|42038308|FG003|Overall Study|Withdrawal by Subject|2|||
19589936|NCT01993836|42038321|FG000|Overall Study|Surgery Cancelled|3|||
19589937|NCT01993836|42038322|FG001|Overall Study|Surgery Cancelled|0|||
19589938|NCT01993836|42038323|FG002|Overall Study|Surgery Cancelled|0|||
19589939|NCT01993836|42038321|FG000|Overall Study|Physician Decision|2|||
19589940|NCT01993836|42038322|FG001|Overall Study|Physician Decision|1|||
19589941|NCT01993836|42038323|FG002|Overall Study|Physician Decision|0|||
19589942|NCT01993836|42038321|FG000|Overall Study|Death|0|||
19589943|NCT01993836|42038322|FG001|Overall Study|Death|2|||
19589944|NCT01993836|42038323|FG002|Overall Study|Death|0|||
19589945|NCT01993836|42038321|FG000|Overall Study|Withdrawal by Subject|12|||
19589946|NCT01993836|42038322|FG001|Overall Study|Withdrawal by Subject|10|||
19589947|NCT01993836|42038323|FG002|Overall Study|Withdrawal by Subject|5|||
19589948|NCT00753545|42038338|FG000|Overall Study|Death|98|||
19589949|NCT00753545|42038339|FG001|Overall Study|Death|112|||
19589950|NCT00753545|42038338|FG000|Overall Study|Lost to Follow-up|2|||
19589951|NCT00753545|42038339|FG001|Overall Study|Lost to Follow-up|3|||
19589952|NCT00753545|42038338|FG000|Overall Study|Protocol Violation|1|||
19589953|NCT00753545|42038339|FG001|Overall Study|Protocol Violation|0|||
19589954|NCT00753545|42038338|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
19589955|NCT00753545|42038339|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
19589956|NCT00278915|42038354|FG000|Overall Study|Lack of Efficacy|1|||
19589957|NCT00970632|42038361|FG000|Overall Study|Adverse Event|2|||
19589958|NCT00970632|42038362|FG001|Overall Study|Adverse Event|2|||
19589959|NCT00970632|42038363|FG002|Overall Study|Adverse Event|1|||
19589960|NCT00970632|42038361|FG000|Overall Study|Lack of Efficacy|3|||
19589961|NCT00970632|42038362|FG001|Overall Study|Lack of Efficacy|0|||
19589962|NCT00970632|42038363|FG002|Overall Study|Lack of Efficacy|0|||
19589963|NCT00970632|42038361|FG000|Overall Study|Lost to Follow-up|3|||
19589964|NCT00970632|42038362|FG001|Overall Study|Lost to Follow-up|0|||
19589965|NCT00970632|42038363|FG002|Overall Study|Lost to Follow-up|2|||
19589966|NCT00970632|42038361|FG000|Overall Study|Protocol Violation|8|||
19589967|NCT00970632|42038362|FG001|Overall Study|Protocol Violation|5|||
19589968|NCT00970632|42038363|FG002|Overall Study|Protocol Violation|8|||
19589969|NCT00970632|42038361|FG000|Overall Study|Withdrawal by Subject|7|||
19589970|NCT00970632|42038362|FG001|Overall Study|Withdrawal by Subject|6|||
19589971|NCT00970632|42038363|FG002|Overall Study|Withdrawal by Subject|4|||
19589972|NCT00970632|42038361|FG000|Overall Study|Entry criteria not met|0|||
19589973|NCT00970632|42038362|FG001|Overall Study|Entry criteria not met|2|||
19589974|NCT00970632|42038363|FG002|Overall Study|Entry criteria not met|2|||
19589975|NCT00970632|42038361|FG000|Overall Study|Sponsor decision|1|||
19589976|NCT00970632|42038362|FG001|Overall Study|Sponsor decision|0|||
19589977|NCT00970632|42038363|FG002|Overall Study|Sponsor decision|1|||
19589978|NCT01144364|42038373|FG000|Induction Phase|Disease progression|14|||
19589979|NCT01144364|42038374|FG001|Induction Phase|Disease progression|0|||
19589980|NCT01144364|42038375|FG002|Induction Phase|Disease progression|0|||
19589981|NCT01144364|42038373|FG000|Induction Phase|Adverse Event|9|||
19589982|NCT01144364|42038374|FG001|Induction Phase|Adverse Event|0|||
19589983|NCT01144364|42038375|FG002|Induction Phase|Adverse Event|0|||
19589984|NCT01144364|42038373|FG000|Induction Phase|Death|1|||
19589985|NCT01144364|42038374|FG001|Induction Phase|Death|0|||
19589986|NCT01144364|42038375|FG002|Induction Phase|Death|0|||
19589987|NCT01144364|42038373|FG000|Induction Phase|Withdrawal by Subject|1|||
19589988|NCT01144364|42038374|FG001|Induction Phase|Withdrawal by Subject|0|||
19589989|NCT01144364|42038375|FG002|Induction Phase|Withdrawal by Subject|0|||
19589990|NCT01144364|42038373|FG000|Induction Phase|Lost to Follow-up|2|||
19589991|NCT01144364|42038374|FG001|Induction Phase|Lost to Follow-up|0|||
19589992|NCT01144364|42038375|FG002|Induction Phase|Lost to Follow-up|0|||
19589993|NCT01144364|42038373|FG000|Induction Phase|Physician Decision|1|||
19589994|NCT01144364|42038374|FG001|Induction Phase|Physician Decision|0|||
19589995|NCT01144364|42038375|FG002|Induction Phase|Physician Decision|0|||
19589996|NCT01144364|42038373|FG000|Induction Phase|Stable disease|2|||
19589997|NCT01144364|42038374|FG001|Induction Phase|Stable disease|0|||
19589998|NCT01144364|42038375|FG002|Induction Phase|Stable disease|0|||
19589999|NCT01144364|42038373|FG000|Induction Phase|Secondary neoplasia|1|||
19590000|NCT01144364|42038374|FG001|Induction Phase|Secondary neoplasia|0|||
19590001|NCT01144364|42038375|FG002|Induction Phase|Secondary neoplasia|0|||
19590002|NCT01144364|42038373|FG000|Induction Phase|Protocol Violation|1|||
19590003|NCT01144364|42038374|FG001|Induction Phase|Protocol Violation|0|||
19590004|NCT01144364|42038375|FG002|Induction Phase|Protocol Violation|0|||
19590005|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
19590006|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
19590007|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
19590008|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
19590009|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
19590010|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
19590011|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Death|0|||
19590012|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Death|2|||
19590013|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Death|0|||
19590014|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
19590015|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
19590016|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
19590017|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
19590018|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
19590019|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
19590020|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
19590021|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
19590022|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
19590023|NCT01144364|42038373|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
19590024|NCT01144364|42038374|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
19590025|NCT01144364|42038375|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
19590026|NCT01119248|42038385|FG000|Overall Study|Physician Decision|5|||
19590027|NCT01131494|42038390|FG000|Overall Study|Withdrawal by Subject|2|||
19590028|NCT01131260|42038397|FG000|Overall Study|Randomization error|5|||
19590029|NCT01131260|42038398|FG001|Overall Study|Randomization error|1|||
19590030|NCT01131260|42038397|FG000|Overall Study|Declined to continue participation|8|||
19590031|NCT01131260|42038398|FG001|Overall Study|Declined to continue participation|13|||
19590032|NCT01131260|42038397|FG000|Overall Study|Physician Decision|22|||
19590033|NCT01131260|42038398|FG001|Overall Study|Physician Decision|24|||
19590034|NCT01131260|42038397|FG000|Overall Study|Technical problems|7|||
19590035|NCT01131260|42038398|FG001|Overall Study|Technical problems|6|||
19590036|NCT01131260|42038397|FG000|Overall Study|Staff error|2|||
19590037|NCT01131260|42038398|FG001|Overall Study|Staff error|1|||
19590038|NCT01131260|42038397|FG000|Overall Study|Ineligible|0|||
19590039|NCT01131260|42038398|FG001|Overall Study|Ineligible|2|||
19590040|NCT00965094|42038408|FG000|Overall Study|Adverse Event|5|||
19590041|NCT00965094|42038409|FG001|Overall Study|Adverse Event|0|||
19590042|NCT00965094|42038408|FG000|Overall Study|Lost to Follow-up|0|||
19590043|NCT00965094|42038409|FG001|Overall Study|Lost to Follow-up|1|||
19590044|NCT01131182|42038418|FG000|Overall Study|Withdrawal by Subject|1|||
19590045|NCT01131182|42038419|FG001|Overall Study|Withdrawal by Subject|1|||
19590046|NCT01131182|42038418|FG000|Overall Study|Lost to Follow-up|14|||
19590047|NCT01131182|42038419|FG001|Overall Study|Lost to Follow-up|15|||
19590048|NCT01131182|42038418|FG000|Overall Study|Other Reason|1|||
19590049|NCT01131182|42038419|FG001|Overall Study|Other Reason|0|||
19590050|NCT00964860|42038427|FG000|Overall Study|Withdrawal by Subject|0|||
19590051|NCT00964860|42038428|FG001|Overall Study|Withdrawal by Subject|1|||
19590052|NCT01131104|42038434|FG000|Overall Study|Withdrawal by Subject|3|||
19590053|NCT01131104|42038434|FG000|Overall Study|Physician Decision|4|||
19590054|NCT01131104|42038434|FG000|Overall Study|Information Not Available|5|||
19590055|NCT01131104|42038434|FG000|Overall Study|No Information on Index Date of Onset|1|||
19590056|NCT01118780|42038440|FG000|Overall Study|Adverse Event|15|||
19590057|NCT01118780|42038441|FG001|Overall Study|Adverse Event|15|||
19590058|NCT01118780|42038440|FG000|Overall Study|Death|1|||
19590059|NCT01118780|42038441|FG001|Overall Study|Death|0|||
19590060|NCT01118780|42038440|FG000|Overall Study|Lack of Efficacy|2|||
19590061|NCT01118780|42038441|FG001|Overall Study|Lack of Efficacy|6|||
19590062|NCT01118780|42038440|FG000|Overall Study|Physician Decision|2|||
19590063|NCT01118780|42038441|FG001|Overall Study|Physician Decision|0|||
19590064|NCT01118780|42038440|FG000|Overall Study|Protocol Violation|3|||
19590065|NCT01118780|42038441|FG001|Overall Study|Protocol Violation|6|||
19590066|NCT01118780|42038440|FG000|Overall Study|Withdrawal by Subject|13|||
19590067|NCT01118780|42038441|FG001|Overall Study|Withdrawal by Subject|8|||
19590068|NCT00964782|42038452|FG000|Overall Study|Lost to Follow-up|1|||
19590069|NCT00964782|42038453|FG001|Overall Study|Lost to Follow-up|0|||
19590070|NCT00966654|42038461|FG000|Overall Study|Study was terminated,PI left institution|12|||
19590071|NCT03262116|42038473|FG000|Overall Study|Physician Decision|0|||
19590072|NCT03262116|42038474|FG001|Overall Study|Physician Decision|2|||
19590073|NCT03262116|42038475|FG002|Overall Study|Physician Decision|1|||
19590074|NCT03262116|42038476|FG003|Overall Study|Physician Decision|1|||
19590075|NCT03262116|42038477|FG004|Overall Study|Physician Decision|1|||
19590076|NCT03262116|42038478|FG005|Overall Study|Physician Decision|2|||
19590077|NCT01130168|42038486|FG000|Period 1|Withdrawal by Subject|0|||
19590078|NCT01130168|42038487|FG001|Period 1|Withdrawal by Subject|1|||
19590079|NCT01130168|42038488|FG002|Period 1|Withdrawal by Subject|0|||
19590080|NCT01130168|42038489|FG003|Period 1|Withdrawal by Subject|1|||
19590081|NCT01130168|42038490|FG004|Period 1|Withdrawal by Subject|0|||
19590082|NCT01130168|42038491|FG005|Period 1|Withdrawal by Subject|0|||
19590083|NCT01130168|42038486|FG000|Period 1|Discontinued For Other Reason|0|||
19590084|NCT01130168|42038487|FG001|Period 1|Discontinued For Other Reason|0|||
19590085|NCT01130168|42038488|FG002|Period 1|Discontinued For Other Reason|1|||
19590086|NCT01130168|42038489|FG003|Period 1|Discontinued For Other Reason|1|||
19590087|NCT01130168|42038490|FG004|Period 1|Discontinued For Other Reason|0|||
19590088|NCT01130168|42038491|FG005|Period 1|Discontinued For Other Reason|0|||
19590089|NCT01130168|42038486|FG000|Period 1|Adverse Event|0|||
19590090|NCT01130168|42038487|FG001|Period 1|Adverse Event|0|||
19590091|NCT01130168|42038488|FG002|Period 1|Adverse Event|0|||
19590092|NCT01130168|42038489|FG003|Period 1|Adverse Event|1|||
19590093|NCT01130168|42038490|FG004|Period 1|Adverse Event|0|||
19590094|NCT01130168|42038491|FG005|Period 1|Adverse Event|0|||
19590095|NCT01144052|42038502|FG000|Overall Study|Withdrawal by Subject|1|||
19590096|NCT01144052|42038503|FG001|Overall Study|Withdrawal by Subject|1|||
19590097|NCT01143896|42038513|FG000|Overall Study|Did not complete Baseline Interview|5|||
19590098|NCT01143896|42038514|FG001|Overall Study|Did not complete Baseline Interview|4|||
19590099|NCT01143896|42038513|FG000|Overall Study|Lost to Follow-up|18|||
19590100|NCT01143896|42038514|FG001|Overall Study|Lost to Follow-up|13|||
19590101|NCT01143896|42038513|FG000|Overall Study|Withdrawal by Subject|13|||
19590102|NCT01143896|42038514|FG001|Overall Study|Withdrawal by Subject|5|||
19590103|NCT01143896|42038513|FG000|Overall Study|Death|6|||
19590104|NCT01143896|42038514|FG001|Overall Study|Death|3|||
19590105|NCT01118312|42038523|FG000|Overall Study|Lost to Follow-up|33|||
19590106|NCT01118312|42038524|FG001|Overall Study|Lost to Follow-up|32|||
19590107|NCT01118312|42038523|FG000|Overall Study|Withdrawal by Subject|1|||
19590108|NCT01118312|42038524|FG001|Overall Study|Withdrawal by Subject|3|||
19590109|NCT01117766|42038530|FG000|First Intervention|Adverse Event|0|||
19590110|NCT01117766|42038531|FG001|First Intervention|Adverse Event|1|||
19590111|NCT01117766|42038530|FG000|First Intervention|Protocol Violation|1|||
19590112|NCT01117766|42038531|FG001|First Intervention|Protocol Violation|0|||
19590113|NCT01117766|42038530|FG000|Washout Period|Protocol Violation|0|||
19590114|NCT01117766|42038531|FG001|Washout Period|Protocol Violation|2|||
19590115|NCT01117766|42038530|FG000|Second Intervention|Lost to Follow-up|1|||
19590116|NCT01117766|42038531|FG001|Second Intervention|Lost to Follow-up|0|||
19590117|NCT01117766|42038530|FG000|Second Intervention|Other|1|||
19590118|NCT01117766|42038531|FG001|Second Intervention|Other|2|||
19590119|NCT01117766|42038530|FG000|Second Intervention|Adverse Event|0|||
19590120|NCT01117766|42038531|FG001|Second Intervention|Adverse Event|2|||
19590121|NCT01117766|42038530|FG000|Second Intervention|Withdrawal by Subject|0|||
19590122|NCT01117766|42038531|FG001|Second Intervention|Withdrawal by Subject|1|||
19590123|NCT01117454|42038539|FG000|Overall Study|Pregnancy|0|||
19590124|NCT01117454|42038540|FG001|Overall Study|Pregnancy|1|||
19590125|NCT01116440|42038548|FG000|Treatment|Withdrawal by Subject|2|||
19590126|NCT01116440|42038549|FG001|Treatment|Withdrawal by Subject|2|||
19590127|NCT01116440|42038548|FG000|Treatment|Lost to Follow-up|1|||
19590128|NCT01116440|42038549|FG001|Treatment|Lost to Follow-up|1|||
19590129|NCT01116440|42038548|FG000|Treatment|Protocol Violation|0|||
19590130|NCT01116440|42038549|FG001|Treatment|Protocol Violation|2|||
19590131|NCT01116440|42038548|FG000|Treatment|Lack of Efficacy|0|||
19590132|NCT01116440|42038549|FG001|Treatment|Lack of Efficacy|1|||
19590133|NCT01116440|42038548|FG000|Treatment|Adverse Event|0|||
19590134|NCT01116440|42038549|FG001|Treatment|Adverse Event|1|||
19590135|NCT01116440|42038548|FG000|Withdrawal|Withdrawal by Subject|0|||
19590136|NCT01116440|42038549|FG001|Withdrawal|Withdrawal by Subject|1|||
19590137|NCT01116440|42038548|FG000|Withdrawal|Lost to Follow-up|0|||
19590138|NCT01116440|42038549|FG001|Withdrawal|Lost to Follow-up|1|||
19590139|NCT01116440|42038548|FG000|Follow-up|Lost to Follow-up|0|||
19590140|NCT01116440|42038549|FG001|Follow-up|Lost to Follow-up|1|||
19590141|NCT01116440|42038548|FG000|Follow-up|Withdrawal by Subject|0|||
19590142|NCT01116440|42038549|FG001|Follow-up|Withdrawal by Subject|1|||
19590143|NCT01129622|42038557|FG000|Overall Study|Withdrawal by Subject|2|||
19590144|NCT01128842|42038562|FG000|Overall Study|Adverse Event|1|||
19590145|NCT01128842|42038562|FG000|Overall Study|Disease Progression|6|||
19590146|NCT03624036|42038571|FG000|Overall Study|Still on Study|5|||
19590147|NCT03624036|42038572|FG001|Overall Study|Still on Study|1|||
19590148|NCT03624036|42038573|FG002|Overall Study|Still on Study|3|||
19590149|NCT03624036|42038574|FG003|Overall Study|Still on Study|3|||
19590150|NCT03624036|42038571|FG000|Overall Study|Death|1|||
19590151|NCT03624036|42038572|FG001|Overall Study|Death|2|||
19590152|NCT03624036|42038573|FG002|Overall Study|Death|0|||
19590153|NCT03624036|42038574|FG003|Overall Study|Death|0|||
19590154|NCT03624036|42038571|FG000|Overall Study|Enrolled but Never Treated|1|||
19590155|NCT03624036|42038572|FG001|Overall Study|Enrolled but Never Treated|0|||
19590156|NCT03624036|42038573|FG002|Overall Study|Enrolled but Never Treated|0|||
19590157|NCT03624036|42038574|FG003|Overall Study|Enrolled but Never Treated|0|||
19590158|NCT01143038|42038584|FG000|Overall Study|Withdrawal by Subject|4|||
19590159|NCT01143038|42038584|FG000|Overall Study|Requirement for alternative therapy|5|||
19590160|NCT01143038|42038584|FG000|Overall Study|Adverse Event|3|||
19590161|NCT01143038|42038584|FG000|Overall Study|Lost to Follow-up|2|||
19590162|NCT01143038|42038584|FG000|Overall Study|Protocol Deviation|1|||
19590163|NCT01143038|42038584|FG000|Overall Study|Death|1|||
19590164|NCT00966264|42038590|FG000|Overall Study|Lost to Follow-up|4|||
19590165|NCT00966264|42038591|FG001|Overall Study|Lost to Follow-up|3|||
19590166|NCT00915525|42038599|FG000|Overall Study|Protocol Violation|9|||
19590167|NCT00915525|42038600|FG001|Overall Study|Protocol Violation|4|||
19590168|NCT00915525|42038599|FG000|Overall Study|Withdrawal by Subject|59|||
19590169|NCT00915525|42038600|FG001|Overall Study|Withdrawal by Subject|21|||
19590170|NCT00915525|42038599|FG000|Overall Study|Lost to Follow-up|27|||
19590171|NCT00915525|42038600|FG001|Overall Study|Lost to Follow-up|16|||
19590172|NCT00915525|42038599|FG000|Overall Study|Pregnancy|2|||
19590173|NCT00915525|42038600|FG001|Overall Study|Pregnancy|0|||
19590174|NCT00915525|42038599|FG000|Overall Study|Lack of Efficacy|15|||
19590175|NCT00915525|42038600|FG001|Overall Study|Lack of Efficacy|32|||
19590176|NCT00915525|42038599|FG000|Overall Study|Adverse Event|29|||
19590177|NCT00915525|42038600|FG001|Overall Study|Adverse Event|13|||
19590178|NCT00915525|42038599|FG000|Overall Study|Missing|12|||
19590179|NCT00915525|42038600|FG001|Overall Study|Missing|1|||
19590180|NCT00915525|42038599|FG000|Overall Study|Other Reason|35|||
19590181|NCT00915525|42038600|FG001|Overall Study|Other Reason|12|||
19590182|NCT00915525|42038599|FG000|Overall Study|Site Closed|27|||
19590183|NCT00915525|42038600|FG001|Overall Study|Site Closed|9|||
19590184|NCT00915525|42038599|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
19590185|NCT00915525|42038600|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
19590186|NCT00915525|42038599|FG000|Overall Study|Study Burden|28|||
19590187|NCT00915525|42038600|FG001|Overall Study|Study Burden|12|||
19590188|NCT00915525|42038599|FG000|Overall Study|Non-Compliance|3|||
19590189|NCT00915525|42038600|FG001|Overall Study|Non-Compliance|1|||
19590190|NCT00915525|42038599|FG000|Overall Study|Patient Moved|15|||
19590191|NCT00915525|42038600|FG001|Overall Study|Patient Moved|9|||
19590192|NCT01074047|42038628|FG000|Treatment Phase|Adverse Event|89|||
19590193|NCT01074047|42038629|FG001|Treatment Phase|Adverse Event|66|||
19590194|NCT01074047|42038628|FG000|Treatment Phase|Disease Progression|16|||
19590195|NCT01074047|42038629|FG001|Treatment Phase|Disease Progression|21|||
19590196|NCT01074047|42038628|FG000|Treatment Phase|Withdrawal by Subject|27|||
19590197|NCT01074047|42038629|FG001|Treatment Phase|Withdrawal by Subject|48|||
19590198|NCT01074047|42038628|FG000|Treatment Phase|Death|53|||
19590199|NCT01074047|42038629|FG001|Treatment Phase|Death|58|||
19590200|NCT01074047|42038628|FG000|Treatment Phase|Lost to Follow-up|0|||
19590201|NCT01074047|42038629|FG001|Treatment Phase|Lost to Follow-up|1|||
19590202|NCT01074047|42038628|FG000|Treatment Phase|Protocol Violation|0|||
19590203|NCT01074047|42038629|FG001|Treatment Phase|Protocol Violation|1|||
19590204|NCT01074047|42038628|FG000|Treatment Phase|Miscellaneous|32|||
19590205|NCT01074047|42038629|FG001|Treatment Phase|Miscellaneous|39|||
19590206|NCT01074047|42038628|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
19590207|NCT01074047|42038629|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
19590208|NCT01074047|42038628|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
19590209|NCT01074047|42038629|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
19590210|NCT01074047|42038628|FG000|Survival Follow-Up Phase|Death|116|||
19590211|NCT01074047|42038629|FG001|Survival Follow-Up Phase|Death|124|||
19590212|NCT01074047|42038628|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
19590213|NCT01074047|42038629|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
19590214|NCT01074047|42038628|FG000|Extension Phase|Physician Decision|1|||
19590215|NCT01074047|42038629|FG001|Extension Phase|Physician Decision|0|||
19590216|NCT01074047|42038628|FG000|Extension Phase|Adverse Event|5|||
19590217|NCT01074047|42038629|FG001|Extension Phase|Adverse Event|0|||
19590218|NCT01074047|42038628|FG000|Extension Phase|Disease Progression|9|||
19590219|NCT01074047|42038629|FG001|Extension Phase|Disease Progression|0|||
19590220|NCT01074047|42038628|FG000|Extension Phase|Withdrawal by Subject|2|||
19590221|NCT01074047|42038629|FG001|Extension Phase|Withdrawal by Subject|0|||
19590222|NCT01074047|42038628|FG000|Extension Phase|Death|5|||
19590223|NCT01074047|42038629|FG001|Extension Phase|Death|0|||
19590224|NCT01142726|42038645|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
19590225|NCT01142726|42038646|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
19590226|NCT01142726|42038647|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
19590227|NCT01142726|42038645|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
19590228|NCT01142726|42038646|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
19590229|NCT01142726|42038647|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
19590230|NCT01142726|42038645|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
19590231|NCT01142726|42038646|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
19590232|NCT01142726|42038647|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
19590233|NCT01142726|42038645|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
19590234|NCT01142726|42038646|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
19590235|NCT01142726|42038647|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
19590236|NCT01142726|42038645|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
19590237|NCT01142726|42038646|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
19590238|NCT01142726|42038647|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
19590239|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
19590240|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
19590241|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
19590242|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
19590243|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
19590244|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
19590245|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
19590246|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
19590247|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
19590248|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
19590249|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
19590250|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
19590251|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
19590252|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
19590253|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
19590254|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
19590255|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
19590256|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
19590257|NCT01142726|42038645|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
19590258|NCT01142726|42038646|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
19590259|NCT01142726|42038647|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
19590260|NCT01142726|42038645|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
19590261|NCT01142726|42038646|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
19590262|NCT01142726|42038647|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
19590263|NCT01142726|42038645|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
19590264|NCT01142726|42038646|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
19590265|NCT01142726|42038647|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
19590266|NCT01142726|42038645|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
19590267|NCT01142726|42038646|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
19590268|NCT01142726|42038647|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
19590269|NCT01142726|42038645|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
19590270|NCT01142726|42038646|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
19590271|NCT01142726|42038647|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
19590272|NCT01073267|42038663|FG000|Overall Study|Disease Progression|3|||
19590273|NCT01142336|42038669|FG000|Overall Study|Adverse Event|1|||
19590274|NCT01142336|42038670|FG001|Overall Study|Adverse Event|1|||
19590275|NCT01142336|42038669|FG000|Overall Study|Lost to Follow-up|0|||
19590276|NCT01142336|42038670|FG001|Overall Study|Lost to Follow-up|1|||
19590277|NCT00915681|42038679|FG000|Overall Study|Screening failures|46|||
19590278|NCT01128296|42038683|FG000|Overall Study|Physician Decision|0|||
19590279|NCT01128296|42038684|FG001|Overall Study|Physician Decision|0|||
19590280|NCT01128296|42038685|FG002|Overall Study|Physician Decision|0|||
19590281|NCT01128296|42038686|FG003|Overall Study|Physician Decision|0|||
19590282|NCT01128296|42038687|FG004|Overall Study|Physician Decision|0|||
19590283|NCT01128296|42038688|FG005|Overall Study|Physician Decision|3|||
19590284|NCT01128296|42038683|FG000|Overall Study|Withdrawal by Subject|0|||
19590285|NCT01128296|42038684|FG001|Overall Study|Withdrawal by Subject|0|||
19590286|NCT01128296|42038685|FG002|Overall Study|Withdrawal by Subject|0|||
19590287|NCT01128296|42038686|FG003|Overall Study|Withdrawal by Subject|0|||
19590288|NCT01128296|42038687|FG004|Overall Study|Withdrawal by Subject|0|||
19590289|NCT01128296|42038688|FG005|Overall Study|Withdrawal by Subject|2|||
19590290|NCT01115738|42038702|FG000|Overall Study|Death|1|||
19590291|NCT01115738|42038703|FG001|Overall Study|Death|0|||
19590292|NCT01115738|42038704|FG002|Overall Study|Death|0|||
19590293|NCT01115738|42038702|FG000|Overall Study|Lost to Follow-up|0|||
19590294|NCT01115738|42038703|FG001|Overall Study|Lost to Follow-up|0|||
19590295|NCT01115738|42038704|FG002|Overall Study|Lost to Follow-up|1|||
19590296|NCT01115738|42038702|FG000|Overall Study|Physician Decision|18|||
19590297|NCT01115738|42038703|FG001|Overall Study|Physician Decision|15|||
19590298|NCT01115738|42038704|FG002|Overall Study|Physician Decision|17|||
19590299|NCT01115738|42038702|FG000|Overall Study|Withdrawal by Subject|6|||
19590300|NCT01115738|42038703|FG001|Overall Study|Withdrawal by Subject|6|||
19590301|NCT01115738|42038704|FG002|Overall Study|Withdrawal by Subject|9|||
19590302|NCT01141478|42038722|FG000|Overall Study|Withdrawal by Subject|1|||
19590303|NCT01141478|42038723|FG001|Overall Study|Withdrawal by Subject|1|||
19590304|NCT01114880|42038731|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
19590305|NCT01114880|42038732|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
19590306|NCT01114880|42038731|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
19590307|NCT01114880|42038732|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
19590308|NCT01114880|42038731|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
19590309|NCT01114880|42038732|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
19590310|NCT01114880|42038731|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
19590311|NCT01114880|42038732|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
19590312|NCT01114880|42038731|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
19590313|NCT01114880|42038732|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
19590314|NCT01114880|42038731|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
19590315|NCT01114880|42038732|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
19590316|NCT01114724|42038740|FG000|Overall Study|Death|8|||
19590317|NCT01114724|42038740|FG000|Overall Study|Lost to Follow-up|1|||
19590318|NCT01114724|42038740|FG000|Overall Study|Withdrawal by Subject|1|||
19590319|NCT00964392|42038747|FG000|Overall Study|Withdrawal by Subject|4|||
19590320|NCT00964392|42038748|FG001|Overall Study|Withdrawal by Subject|6|||
19590321|NCT00964392|42038747|FG000|Overall Study|Lost to Follow-up|4|||
19590322|NCT00964392|42038748|FG001|Overall Study|Lost to Follow-up|10|||
19590323|NCT00964392|42038747|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
19590324|NCT00964392|42038748|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
19590325|NCT00964392|42038747|FG000|Overall Study|Not completed|44|||
19590326|NCT00964392|42038748|FG001|Overall Study|Not completed|168|||
19590327|NCT00965718|42038754|FG000|Overall Study|Withdrawal by Subject|4|||
19590328|NCT00914589|42038761|FG000|Overall Study|Adverse Event|1|||
19590329|NCT00914589|42038762|FG001|Overall Study|Adverse Event|0|||
19590330|NCT00914589|42038763|FG002|Overall Study|Adverse Event|1|||
19590331|NCT00914589|42038761|FG000|Overall Study|Protocol Violation|8|||
19590332|NCT00914589|42038762|FG001|Overall Study|Protocol Violation|6|||
19590333|NCT00914589|42038763|FG002|Overall Study|Protocol Violation|3|||
19590334|NCT00914589|42038761|FG000|Overall Study|unclassified|16|||
19590335|NCT00914589|42038762|FG001|Overall Study|unclassified|9|||
19590336|NCT00914589|42038763|FG002|Overall Study|unclassified|7|||
19590337|NCT00914589|42038761|FG000|Overall Study|Death|0|||
19590338|NCT00914589|42038762|FG001|Overall Study|Death|1|||
19590339|NCT00914589|42038763|FG002|Overall Study|Death|1|||
19590340|NCT00912405|42038771|FG000|Overall Study|Lost to Follow-up|5|||
19590341|NCT00878722|42038783|FG000|Overall Study|Progressive disease|3|||
19590342|NCT00878722|42038784|FG001|Overall Study|Progressive disease|3|||
19590343|NCT00878722|42038785|FG002|Overall Study|Progressive disease|3|||
19590344|NCT00878722|42038786|FG003|Overall Study|Progressive disease|7|||
19590345|NCT00878722|42038787|FG004|Overall Study|Progressive disease|7|||
19590346|NCT00878722|42038788|FG005|Overall Study|Progressive disease|1|||
19387978|NCT02057692|41631300|FG000|Overall Study|Lost to Follow-up|0|||
19387979|NCT02057692|41631301|FG001|Overall Study|Lost to Follow-up|0|||
19387980|NCT02057692|41631302|FG002|Overall Study|Lost to Follow-up|0|||
19590347|NCT00878722|42038789|FG006|Overall Study|Progressive disease|4|||
19590348|NCT00878722|42038790|FG007|Overall Study|Progressive disease|3|||
19590349|NCT00878722|42038783|FG000|Overall Study|Death|0|||
19590350|NCT00878722|42038784|FG001|Overall Study|Death|0|||
19590351|NCT00878722|42038785|FG002|Overall Study|Death|0|||
19590352|NCT00878722|42038786|FG003|Overall Study|Death|1|||
19590353|NCT00878722|42038787|FG004|Overall Study|Death|0|||
19590354|NCT00878722|42038788|FG005|Overall Study|Death|1|||
19590355|NCT00878722|42038789|FG006|Overall Study|Death|0|||
19590356|NCT00878722|42038790|FG007|Overall Study|Death|2|||
19590357|NCT00878722|42038783|FG000|Overall Study|Adverse Event|0|||
19590358|NCT00878722|42038784|FG001|Overall Study|Adverse Event|0|||
19590359|NCT00878722|42038785|FG002|Overall Study|Adverse Event|0|||
19590360|NCT00878722|42038786|FG003|Overall Study|Adverse Event|0|||
19590361|NCT00878722|42038787|FG004|Overall Study|Adverse Event|0|||
19590362|NCT00878722|42038788|FG005|Overall Study|Adverse Event|0|||
19590363|NCT00878722|42038789|FG006|Overall Study|Adverse Event|2|||
19590364|NCT00878722|42038790|FG007|Overall Study|Adverse Event|0|||
19590365|NCT00878722|42038783|FG000|Overall Study|Withdrawal by Subject|0|||
19590366|NCT00878722|42038784|FG001|Overall Study|Withdrawal by Subject|0|||
19590367|NCT00878722|42038785|FG002|Overall Study|Withdrawal by Subject|0|||
19590368|NCT00878722|42038786|FG003|Overall Study|Withdrawal by Subject|0|||
19590369|NCT00878722|42038787|FG004|Overall Study|Withdrawal by Subject|0|||
19590370|NCT00878722|42038788|FG005|Overall Study|Withdrawal by Subject|0|||
19590371|NCT00878722|42038789|FG006|Overall Study|Withdrawal by Subject|0|||
19590372|NCT00878722|42038790|FG007|Overall Study|Withdrawal by Subject|2|||
19590373|NCT00878722|42038783|FG000|Overall Study|Relapse|0|||
19590374|NCT00878722|42038784|FG001|Overall Study|Relapse|0|||
19590375|NCT00878722|42038785|FG002|Overall Study|Relapse|0|||
19590376|NCT00878722|42038786|FG003|Overall Study|Relapse|1|||
19590377|NCT00878722|42038787|FG004|Overall Study|Relapse|0|||
19590378|NCT00878722|42038788|FG005|Overall Study|Relapse|0|||
19590379|NCT00878722|42038789|FG006|Overall Study|Relapse|0|||
19590380|NCT00878722|42038790|FG007|Overall Study|Relapse|0|||
19590381|NCT00964158|42038818|FG000|Overall Study|Lost to Follow-up|0|||
19590382|NCT00964158|42038819|FG001|Overall Study|Lost to Follow-up|1|||
19590383|NCT00964158|42038820|FG002|Overall Study|Lost to Follow-up|2|||
19590384|NCT00964158|42038818|FG000|Overall Study|Withdrawal by Subject|0|||
19590385|NCT00964158|42038819|FG001|Overall Study|Withdrawal by Subject|0|||
19590386|NCT00964158|42038820|FG002|Overall Study|Withdrawal by Subject|6|||
19590387|NCT00961350|42038833|FG000|Overall Study|Adverse Event|18|||
19590388|NCT00961350|42038834|FG001|Overall Study|Adverse Event|33|||
19590389|NCT00961350|42038833|FG000|Overall Study|Withdrawal by Subject|10|||
19590390|NCT00961350|42038834|FG001|Overall Study|Withdrawal by Subject|10|||
19590391|NCT00961350|42038833|FG000|Overall Study|Lost to Follow-up|3|||
19590392|NCT00961350|42038834|FG001|Overall Study|Lost to Follow-up|3|||
19590393|NCT00961350|42038833|FG000|Overall Study|Misc|16|||
19590394|NCT00961350|42038834|FG001|Overall Study|Misc|21|||
19590395|NCT00963924|42038842|FG000|Overall Study|Adverse Event|1|||
19590396|NCT00963924|42038843|FG001|Overall Study|Adverse Event|0|||
19590397|NCT00963924|42038842|FG000|Overall Study|Withdrawal by Subject|0|||
19590398|NCT00963924|42038843|FG001|Overall Study|Withdrawal by Subject|1|||
19590399|NCT00963924|42038842|FG000|Overall Study|Changed antipsychotic|0|||
19590400|NCT00963924|42038843|FG001|Overall Study|Changed antipsychotic|1|||
19590401|NCT00963924|42038842|FG000|Overall Study|Lost to Follow-up|0|||
19590402|NCT00963924|42038843|FG001|Overall Study|Lost to Follow-up|1|||
19590403|NCT03265665|42038853|FG000|24-week Data Collection|Withdrawal by Subject|2|||
19590404|NCT03265665|42038854|FG001|24-week Data Collection|Withdrawal by Subject|2|||
19590405|NCT03265665|42038853|FG000|24-week Data Collection|Lost to Follow-up|4|||
19590406|NCT03265665|42038854|FG001|24-week Data Collection|Lost to Follow-up|5|||
19590407|NCT03265665|42038853|FG000|36-week Data Collection|Lost to Follow-up|6|||
19476971|NCT01489189|41755552|FG001|Overall Study|Death|8|||
19590408|NCT03265665|42038854|FG001|36-week Data Collection|Lost to Follow-up|8|||
19590409|NCT01126736|42038867|FG000|Overall Study|Death|2|||
19590410|NCT01126736|42038868|FG001|Overall Study|Death|2|||
19590411|NCT01126736|42038869|FG002|Overall Study|Death|1|||
19590412|NCT01126736|42038870|FG003|Overall Study|Death|19|||
19590413|NCT01126736|42038871|FG004|Overall Study|Death|19|||
19590414|NCT01126736|42038867|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
19590415|NCT01126736|42038868|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
19590416|NCT01126736|42038869|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
19590417|NCT01126736|42038870|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
19590418|NCT01126736|42038871|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
19590419|NCT01126736|42038867|FG000|Overall Study|Lost to Follow-up|0|||
19590420|NCT01126736|42038868|FG001|Overall Study|Lost to Follow-up|0|||
19590421|NCT01126736|42038869|FG002|Overall Study|Lost to Follow-up|0|||
19590422|NCT01126736|42038870|FG003|Overall Study|Lost to Follow-up|1|||
19590423|NCT01126736|42038871|FG004|Overall Study|Lost to Follow-up|1|||
19590424|NCT01126736|42038867|FG000|Overall Study|Administrative reasons|0|||
19590425|NCT01126736|42038868|FG001|Overall Study|Administrative reasons|0|||
19590426|NCT01126736|42038869|FG002|Overall Study|Administrative reasons|0|||
19590427|NCT01126736|42038870|FG003|Overall Study|Administrative reasons|0|||
19590428|NCT01126736|42038871|FG004|Overall Study|Administrative reasons|1|||
19590429|NCT01126736|42038867|FG000|Overall Study|Progressive disease|0|||
19590430|NCT01126736|42038868|FG001|Overall Study|Progressive disease|0|||
19590431|NCT01126736|42038869|FG002|Overall Study|Progressive disease|0|||
19590432|NCT01126736|42038870|FG003|Overall Study|Progressive disease|2|||
19590433|NCT01126736|42038871|FG004|Overall Study|Progressive disease|1|||
19590434|NCT01126736|42038867|FG000|Overall Study|Withdrawal by Subject|0|||
19590435|NCT01126736|42038868|FG001|Overall Study|Withdrawal by Subject|0|||
19590436|NCT01126736|42038869|FG002|Overall Study|Withdrawal by Subject|0|||
19590437|NCT01126736|42038870|FG003|Overall Study|Withdrawal by Subject|1|||
19590438|NCT01126736|42038871|FG004|Overall Study|Withdrawal by Subject|1|||
19590439|NCT01126736|42038867|FG000|Overall Study|Other|2|||
19590440|NCT01126736|42038868|FG001|Overall Study|Other|4|||
19590441|NCT01126736|42038869|FG002|Overall Study|Other|4|||
19590442|NCT01126736|42038870|FG003|Overall Study|Other|16|||
19590443|NCT01126736|42038871|FG004|Overall Study|Other|15|||
19590444|NCT01114646|42038885|FG000|Overall Study|Withdrawal by Subject|3|||
19590445|NCT01114646|42038886|FG001|Overall Study|Withdrawal by Subject|2|||
19590446|NCT00965562|42038895|FG000|Overall Study|Lost to Follow-up|1|||
19590447|NCT00965562|42038896|FG001|Overall Study|Lost to Follow-up|2|||
19590448|NCT00965562|42038897|FG002|Overall Study|Lost to Follow-up|3|||
19590449|NCT00965562|42038895|FG000|Overall Study|Withdrawal by Subject|2|||
19590450|NCT00965562|42038896|FG001|Overall Study|Withdrawal by Subject|2|||
19590451|NCT00965562|42038897|FG002|Overall Study|Withdrawal by Subject|0|||
19590452|NCT00912093|42038911|FG000|The Controlled Phase|Death|0|||
19590453|NCT00912093|42038912|FG001|The Controlled Phase|Death|1|||
19590454|NCT00912093|42038913|FG002|The Controlled Phase|Death|0|||
19590455|NCT00912093|42038914|FG003|The Controlled Phase|Death|0|||
19590456|NCT00912093|42038915|FG004|The Controlled Phase|Death|0|||
19590457|NCT00912093|42038911|FG000|The Controlled Phase|Medical Condition|0|||
19590458|NCT00912093|42038912|FG001|The Controlled Phase|Medical Condition|1|||
19590459|NCT00912093|42038913|FG002|The Controlled Phase|Medical Condition|0|||
19590460|NCT00912093|42038914|FG003|The Controlled Phase|Medical Condition|0|||
19590461|NCT00912093|42038915|FG004|The Controlled Phase|Medical Condition|0|||
19590462|NCT00912093|42038911|FG000|The Controlled Phase|Lost to Follow-up|0|||
19590463|NCT00912093|42038912|FG001|The Controlled Phase|Lost to Follow-up|0|||
19590464|NCT00912093|42038913|FG002|The Controlled Phase|Lost to Follow-up|0|||
19590465|NCT00912093|42038914|FG003|The Controlled Phase|Lost to Follow-up|0|||
19590466|NCT00912093|42038915|FG004|The Controlled Phase|Lost to Follow-up|1|||
19590467|NCT00965484|42038923|FG000|Overall Study|Protocol Violation|1|||
19590468|NCT00965484|42038923|FG000|Overall Study|Withdrawal by Subject|1|||
19590469|NCT00961116|42038927|FG000|Washout Period of 7 Days|Adverse Event|1|||
19590470|NCT00961116|42038928|FG001|Washout Period of 7 Days|Adverse Event|1|||
19590471|NCT00961116|42038927|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
19590472|NCT00961116|42038928|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19590473|NCT00961116|42038927|FG000|Washout Period of 7 Days|Protocol Violation|0|||
19590474|NCT00961116|42038928|FG001|Washout Period of 7 Days|Protocol Violation|1|||
19590475|NCT00912015|42038939|FG000|Overall Study|Lack of Efficacy|1|||
19590476|NCT00912015|42038940|FG001|Overall Study|Lack of Efficacy|0|||
19590477|NCT00912015|42038941|FG002|Overall Study|Lack of Efficacy|0|||
19590478|NCT00912015|42038942|FG003|Overall Study|Lack of Efficacy|0|||
19590479|NCT00912015|42038939|FG000|Overall Study|Withdrawal by Subject|8|||
19590480|NCT00912015|42038940|FG001|Overall Study|Withdrawal by Subject|8|||
19590481|NCT00912015|42038941|FG002|Overall Study|Withdrawal by Subject|3|||
19590482|NCT00912015|42038942|FG003|Overall Study|Withdrawal by Subject|0|||
19590483|NCT00912015|42038939|FG000|Overall Study|Protocol Violation|1|||
19590484|NCT00912015|42038940|FG001|Overall Study|Protocol Violation|0|||
19590485|NCT00912015|42038941|FG002|Overall Study|Protocol Violation|0|||
19590486|NCT00912015|42038942|FG003|Overall Study|Protocol Violation|1|||
19590487|NCT00912015|42038939|FG000|Overall Study|Adverse Event|6|||
19590488|NCT00912015|42038940|FG001|Overall Study|Adverse Event|0|||
19590489|NCT00912015|42038941|FG002|Overall Study|Adverse Event|0|||
19590490|NCT00912015|42038942|FG003|Overall Study|Adverse Event|1|||
19590491|NCT00960804|42038955|FG000|Overall Study|Adverse Event|1|||
19590492|NCT00960804|42038956|FG001|Overall Study|Adverse Event|0|||
19590493|NCT00960804|42038957|FG002|Overall Study|Adverse Event|0|||
19590494|NCT00960804|42038955|FG000|Overall Study|Withdrawal by Subject|1|||
19590495|NCT00960804|42038956|FG001|Overall Study|Withdrawal by Subject|0|||
19590496|NCT00960804|42038957|FG002|Overall Study|Withdrawal by Subject|0|||
19590497|NCT00960804|42038955|FG000|Overall Study|Study terminated by the sponsor|5|||
19590498|NCT00960804|42038956|FG001|Overall Study|Study terminated by the sponsor|4|||
19590499|NCT00960804|42038957|FG002|Overall Study|Study terminated by the sponsor|10|||
19590500|NCT01126580|42038968|FG000|Overall Study|Adverse Event|14|||
19590501|NCT01126580|42038969|FG001|Overall Study|Adverse Event|8|||
19590502|NCT01126580|42038970|FG002|Overall Study|Adverse Event|12|||
19590503|NCT01126580|42038968|FG000|Overall Study|Withdrawal by Subject|11|||
19590504|NCT01126580|42038969|FG001|Overall Study|Withdrawal by Subject|19|||
19590505|NCT01126580|42038970|FG002|Overall Study|Withdrawal by Subject|14|||
19590506|NCT01126580|42038968|FG000|Overall Study|Sponsor Decision|5|||
19590507|NCT01126580|42038969|FG001|Overall Study|Sponsor Decision|4|||
19590508|NCT01126580|42038970|FG002|Overall Study|Sponsor Decision|7|||
19590509|NCT01126580|42038968|FG000|Overall Study|Physician Decision|1|||
19590510|NCT01126580|42038969|FG001|Overall Study|Physician Decision|1|||
19590511|NCT01126580|42038970|FG002|Overall Study|Physician Decision|2|||
19590512|NCT01126580|42038968|FG000|Overall Study|Entry Criteria Not Met|1|||
19590513|NCT01126580|42038969|FG001|Overall Study|Entry Criteria Not Met|1|||
19590514|NCT01126580|42038970|FG002|Overall Study|Entry Criteria Not Met|2|||
19590515|NCT01126580|42038968|FG000|Overall Study|Lack of Efficacy|2|||
19590516|NCT01126580|42038969|FG001|Overall Study|Lack of Efficacy|3|||
19590517|NCT01126580|42038970|FG002|Overall Study|Lack of Efficacy|4|||
19590518|NCT01126580|42038968|FG000|Overall Study|Protocol Violation|0|||
19590519|NCT01126580|42038969|FG001|Overall Study|Protocol Violation|1|||
19590520|NCT01126580|42038970|FG002|Overall Study|Protocol Violation|2|||
19590521|NCT01126580|42038968|FG000|Overall Study|Lost to Follow-up|15|||
19590522|NCT01126580|42038969|FG001|Overall Study|Lost to Follow-up|13|||
19590523|NCT01126580|42038970|FG002|Overall Study|Lost to Follow-up|9|||
19590524|NCT01126580|42038968|FG000|Overall Study|Treatment Non-compliance|0|||
19590525|NCT01126580|42038969|FG001|Overall Study|Treatment Non-compliance|2|||
19590526|NCT01126580|42038970|FG002|Overall Study|Treatment Non-compliance|3|||
19590527|NCT00911157|42038981|FG000|Overall Study|Adverse Event|4|||
19590528|NCT00911157|42038982|FG001|Overall Study|Adverse Event|1|||
19590529|NCT00911157|42038981|FG000|Overall Study|Withdrawal by Subject|1|||
19590530|NCT00911157|42038982|FG001|Overall Study|Withdrawal by Subject|1|||
19590531|NCT00911157|42038981|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
19590532|NCT00911157|42038982|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
19590533|NCT00911157|42038981|FG000|Overall Study|Need to treat for lung cancer|1|||
19590534|NCT00911157|42038982|FG001|Overall Study|Need to treat for lung cancer|0|||
19590535|NCT00960570|42038988|FG000|21 Day Washout Period|Adverse Event|1|||
19590536|NCT00960570|42038988|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
19590537|NCT00960570|42038988|FG000|1 Day Period Between Dosing|Adverse Event|2|||
19590538|NCT00960570|42038988|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
19590539|NCT01126424|42039001|FG000|Overall Study|Adverse Event|0|||
19590540|NCT01126424|42039002|FG001|Overall Study|Adverse Event|0|||
19590541|NCT01126424|42039003|FG002|Overall Study|Adverse Event|0|||
19590542|NCT01126424|42039004|FG003|Overall Study|Adverse Event|0|||
19590543|NCT01126424|42039005|FG004|Overall Study|Adverse Event|1|||
19590544|NCT01126424|42039006|FG005|Overall Study|Adverse Event|0|||
19590545|NCT01126424|42039001|FG000|Overall Study|Withdrawal by Subject|0|||
19590546|NCT01126424|42039002|FG001|Overall Study|Withdrawal by Subject|0|||
19590547|NCT01126424|42039003|FG002|Overall Study|Withdrawal by Subject|1|||
19590548|NCT01126424|42039004|FG003|Overall Study|Withdrawal by Subject|3|||
19590549|NCT01126424|42039005|FG004|Overall Study|Withdrawal by Subject|1|||
19590550|NCT01126424|42039006|FG005|Overall Study|Withdrawal by Subject|0|||
19590551|NCT01126268|42039014|FG000|Overall Study|Adverse Event|1|||
19590552|NCT00879658|42039025|FG000|Overall Study|Abnormal laboratory value(s)|3|||
19590553|NCT00879658|42039026|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19590554|NCT00879658|42039027|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19590555|NCT00879658|42039028|FG003|Overall Study|Abnormal laboratory value(s)|1|||
19590556|NCT00879658|42039029|FG004|Overall Study|Abnormal laboratory value(s)|0|||
19590557|NCT00879658|42039030|FG005|Overall Study|Abnormal laboratory value(s)|0|||
19590558|NCT00879658|42039031|FG006|Overall Study|Abnormal laboratory value(s)|0|||
19590559|NCT00879658|42039025|FG000|Overall Study|Administrative problems|2|||
19590560|NCT00879658|42039026|FG001|Overall Study|Administrative problems|1|||
19476972|NCT01489189|41755551|FG000|Overall Study|Missed Visit|1|||
19590561|NCT00879658|42039027|FG002|Overall Study|Administrative problems|0|||
19590562|NCT00879658|42039028|FG003|Overall Study|Administrative problems|1|||
19590563|NCT00879658|42039029|FG004|Overall Study|Administrative problems|0|||
19590564|NCT00879658|42039030|FG005|Overall Study|Administrative problems|0|||
19590565|NCT00879658|42039031|FG006|Overall Study|Administrative problems|0|||
19590566|NCT00879658|42039025|FG000|Overall Study|Adverse Event|6|||
19590567|NCT00879658|42039026|FG001|Overall Study|Adverse Event|4|||
19590568|NCT00879658|42039027|FG002|Overall Study|Adverse Event|3|||
19590569|NCT00879658|42039028|FG003|Overall Study|Adverse Event|1|||
19590570|NCT00879658|42039029|FG004|Overall Study|Adverse Event|2|||
19590571|NCT00879658|42039030|FG005|Overall Study|Adverse Event|0|||
19590572|NCT00879658|42039031|FG006|Overall Study|Adverse Event|0|||
19590573|NCT00879658|42039025|FG000|Overall Study|Protocol Violation|1|||
19590574|NCT00879658|42039026|FG001|Overall Study|Protocol Violation|0|||
19590575|NCT00879658|42039027|FG002|Overall Study|Protocol Violation|0|||
19590576|NCT00879658|42039028|FG003|Overall Study|Protocol Violation|0|||
19590577|NCT00879658|42039029|FG004|Overall Study|Protocol Violation|0|||
19590578|NCT00879658|42039030|FG005|Overall Study|Protocol Violation|0|||
19590579|NCT00879658|42039031|FG006|Overall Study|Protocol Violation|0|||
19590580|NCT00879658|42039025|FG000|Overall Study|Withdrawal by Subject|3|||
19590581|NCT00879658|42039026|FG001|Overall Study|Withdrawal by Subject|0|||
19590582|NCT00879658|42039027|FG002|Overall Study|Withdrawal by Subject|2|||
19590583|NCT00879658|42039028|FG003|Overall Study|Withdrawal by Subject|0|||
19590584|NCT00879658|42039029|FG004|Overall Study|Withdrawal by Subject|0|||
19590585|NCT00879658|42039030|FG005|Overall Study|Withdrawal by Subject|1|||
19590586|NCT00879658|42039031|FG006|Overall Study|Withdrawal by Subject|0|||
19590587|NCT00879658|42039025|FG000|Overall Study|Lack of Efficacy|0|||
19590588|NCT00879658|42039026|FG001|Overall Study|Lack of Efficacy|0|||
19590589|NCT00879658|42039027|FG002|Overall Study|Lack of Efficacy|2|||
19590590|NCT00879658|42039028|FG003|Overall Study|Lack of Efficacy|0|||
19590591|NCT00879658|42039029|FG004|Overall Study|Lack of Efficacy|0|||
19590592|NCT00879658|42039030|FG005|Overall Study|Lack of Efficacy|0|||
19590593|NCT00879658|42039031|FG006|Overall Study|Lack of Efficacy|0|||
19590594|NCT00879658|42039025|FG000|Overall Study|misrandomized (never received study med)|0|||
19590595|NCT00879658|42039026|FG001|Overall Study|misrandomized (never received study med)|0|||
19590596|NCT00879658|42039027|FG002|Overall Study|misrandomized (never received study med)|0|||
19590597|NCT00879658|42039028|FG003|Overall Study|misrandomized (never received study med)|1|||
19590598|NCT00879658|42039029|FG004|Overall Study|misrandomized (never received study med)|0|||
19590599|NCT00879658|42039030|FG005|Overall Study|misrandomized (never received study med)|0|||
19590600|NCT00879658|42039031|FG006|Overall Study|misrandomized (never received study med)|0|||
19590601|NCT00959946|42039061|FG000|Overall Study|Adverse Event|0|||
19590602|NCT00959946|42039062|FG001|Overall Study|Adverse Event|0|||
19590603|NCT00959946|42039063|FG002|Overall Study|Adverse Event|2|||
19590604|NCT00959946|42039064|FG003|Overall Study|Adverse Event|1|||
19590605|NCT00959946|42039065|FG004|Overall Study|Adverse Event|0|||
19590606|NCT00959946|42039066|FG005|Overall Study|Adverse Event|1|||
19590607|NCT00959946|42039067|FG006|Overall Study|Adverse Event|0|||
19590608|NCT00959946|42039068|FG007|Overall Study|Adverse Event|0|||
19590609|NCT00959946|42039061|FG000|Overall Study|Death|0|||
19590610|NCT00959946|42039062|FG001|Overall Study|Death|0|||
19590611|NCT00959946|42039063|FG002|Overall Study|Death|0|||
19590612|NCT00959946|42039064|FG003|Overall Study|Death|0|||
19590613|NCT00959946|42039065|FG004|Overall Study|Death|0|||
19476973|NCT01489189|41755552|FG001|Overall Study|Missed Visit|4|||
19590614|NCT00959946|42039066|FG005|Overall Study|Death|1|||
19590615|NCT00959946|42039067|FG006|Overall Study|Death|0|||
19590616|NCT00959946|42039068|FG007|Overall Study|Death|0|||
19590617|NCT00959946|42039061|FG000|Overall Study|Disease Progression|2|||
19590618|NCT00959946|42039062|FG001|Overall Study|Disease Progression|4|||
19590619|NCT00959946|42039063|FG002|Overall Study|Disease Progression|2|||
19590620|NCT00959946|42039064|FG003|Overall Study|Disease Progression|4|||
19590621|NCT00959946|42039065|FG004|Overall Study|Disease Progression|4|||
19590622|NCT00959946|42039066|FG005|Overall Study|Disease Progression|6|||
19590623|NCT00959946|42039067|FG006|Overall Study|Disease Progression|2|||
19590624|NCT00959946|42039068|FG007|Overall Study|Disease Progression|2|||
19590625|NCT00959946|42039061|FG000|Overall Study|Withdrawal by Subject|0|||
19590626|NCT00959946|42039062|FG001|Overall Study|Withdrawal by Subject|0|||
19590627|NCT00959946|42039063|FG002|Overall Study|Withdrawal by Subject|0|||
19590628|NCT00959946|42039064|FG003|Overall Study|Withdrawal by Subject|0|||
19590629|NCT00959946|42039065|FG004|Overall Study|Withdrawal by Subject|0|||
19590630|NCT00959946|42039066|FG005|Overall Study|Withdrawal by Subject|1|||
19590631|NCT00959946|42039067|FG006|Overall Study|Withdrawal by Subject|0|||
19590632|NCT00959946|42039068|FG007|Overall Study|Withdrawal by Subject|0|||
19590633|NCT00911937|42039093|FG000|Overall Study|Death|1|||
19590634|NCT00911937|42039094|FG001|Overall Study|Death|0|||
19590635|NCT00911937|42039093|FG000|Overall Study|Lost to Follow-up|8|||
19590636|NCT00911937|42039094|FG001|Overall Study|Lost to Follow-up|5|||
19590637|NCT00911937|42039093|FG000|Overall Study|Withdrawal by Subject|10|||
19590638|NCT00911937|42039094|FG001|Overall Study|Withdrawal by Subject|7|||
19590639|NCT00911937|42039093|FG000|Overall Study|Withdrawn due to pregnancy|1|||
19590640|NCT00911937|42039094|FG001|Overall Study|Withdrawn due to pregnancy|0|||
19590641|NCT00911937|42039093|FG000|Overall Study|Adverse Event|11|||
19590642|NCT00911937|42039094|FG001|Overall Study|Adverse Event|25|||
19590643|NCT00911937|42039093|FG000|Overall Study|Lack of Efficacy|11|||
19590644|NCT00911937|42039094|FG001|Overall Study|Lack of Efficacy|6|||
19590645|NCT00911937|42039093|FG000|Overall Study|Did not meet inclusion criteria|9|||
19590646|NCT00911937|42039094|FG001|Overall Study|Did not meet inclusion criteria|11|||
19590647|NCT00911937|42039093|FG000|Overall Study|Protocol Violation|14|||
19590648|NCT00911937|42039094|FG001|Overall Study|Protocol Violation|23|||
19590649|NCT00911937|42039093|FG000|Overall Study|Randomized but not treated|13|||
19590650|NCT00911937|42039094|FG001|Overall Study|Randomized but not treated|13|||
19590651|NCT00911937|42039093|FG000|Overall Study|Other|9|||
19590652|NCT00911937|42039094|FG001|Overall Study|Other|5|||
19590653|NCT00880048|42039103|FG000|Overall Study|Adverse Event|2|||
19590654|NCT00880048|42039104|FG001|Overall Study|Adverse Event|3|||
19590655|NCT00880048|42039105|FG002|Overall Study|Adverse Event|5|||
19590656|NCT00880048|42039103|FG000|Overall Study|Lack of Efficacy|1|||
19590657|NCT00880048|42039104|FG001|Overall Study|Lack of Efficacy|2|||
19590658|NCT00880048|42039105|FG002|Overall Study|Lack of Efficacy|2|||
19590659|NCT00880048|42039103|FG000|Overall Study|Protocol Violation|4|||
19590660|NCT00880048|42039104|FG001|Overall Study|Protocol Violation|6|||
19590661|NCT00880048|42039105|FG002|Overall Study|Protocol Violation|5|||
19590662|NCT00880048|42039103|FG000|Overall Study|Lost to Follow-up|6|||
19590663|NCT00880048|42039104|FG001|Overall Study|Lost to Follow-up|6|||
19590664|NCT00880048|42039105|FG002|Overall Study|Lost to Follow-up|5|||
19590665|NCT00880048|42039103|FG000|Overall Study|Physician Decision|1|||
19590666|NCT00880048|42039104|FG001|Overall Study|Physician Decision|1|||
19590667|NCT00880048|42039105|FG002|Overall Study|Physician Decision|7|||
19590668|NCT00880048|42039103|FG000|Overall Study|Withdrawal by Subject|5|||
19590669|NCT00880048|42039104|FG001|Overall Study|Withdrawal by Subject|8|||
19590670|NCT00880048|42039105|FG002|Overall Study|Withdrawal by Subject|5|||
19590671|NCT00880048|42039103|FG000|Overall Study|Study closed/terminated|9|||
19590672|NCT00880048|42039104|FG001|Overall Study|Study closed/terminated|7|||
19590673|NCT00880048|42039105|FG002|Overall Study|Study closed/terminated|6|||
19590674|NCT00962208|42039115|FG000|Overall Study|Could not achieve good vision|9|||
19590675|NCT00962208|42039116|FG001|Overall Study|Could not achieve good vision|0|||
19590676|NCT00962208|42039115|FG000|Overall Study|Contraindicated to continue study|5|||
19590677|NCT00962208|42039116|FG001|Overall Study|Contraindicated to continue study|1|||
19590678|NCT00962208|42039115|FG000|Overall Study|Lost to Follow-up|0|||
19590679|NCT00962208|42039116|FG001|Overall Study|Lost to Follow-up|9|||
19590680|NCT01076543|42039128|FG000|Overall Study|Withdrawal by Subject|2|||
19590681|NCT01076543|42039129|FG001|Overall Study|Withdrawal by Subject|0|||
19590682|NCT01076543|42039130|FG002|Overall Study|Withdrawal by Subject|0|||
19590683|NCT01076543|42039131|FG003|Overall Study|Withdrawal by Subject|0|||
19590684|NCT01076543|42039132|FG004|Overall Study|Withdrawal by Subject|0|||
19590685|NCT01076543|42039133|FG005|Overall Study|Withdrawal by Subject|0|||
19590686|NCT01072877|42039153|FG000|Overall Study|Lost to Follow-up|1|||
19590687|NCT01072877|42039154|FG001|Overall Study|Lost to Follow-up|1|||
19590688|NCT01072877|42039155|FG002|Overall Study|Lost to Follow-up|0|||
19590689|NCT01072877|42039156|FG003|Overall Study|Lost to Follow-up|2|||
19590690|NCT01072877|42039157|FG004|Overall Study|Lost to Follow-up|0|||
19590691|NCT00961896|42039174|FG000|Overall Study|Abnormal laboratory value|0|||
19590692|NCT00961896|42039175|FG001|Overall Study|Abnormal laboratory value|0|||
19590693|NCT00961896|42039176|FG002|Overall Study|Abnormal laboratory value|1|||
19590694|NCT00957528|42039190|FG000|Overall Study|Protocol Violation|0|||
19590695|NCT00957528|42039191|FG001|Overall Study|Protocol Violation|1|||
19590696|NCT00957528|42039192|FG002|Overall Study|Protocol Violation|0|||
19590697|NCT00957528|42039190|FG000|Overall Study|Withdrawal by Subject|0|||
19590698|NCT00957528|42039191|FG001|Overall Study|Withdrawal by Subject|0|||
19590699|NCT00957528|42039192|FG002|Overall Study|Withdrawal by Subject|1|||
19590700|NCT00958776|42039202|FG000|Overall Study|Adverse Event|0|||
19590701|NCT00958776|42039203|FG001|Overall Study|Adverse Event|1|||
19590702|NCT00958776|42039202|FG000|Overall Study|Physician Decision|1|||
19590703|NCT00958776|42039203|FG001|Overall Study|Physician Decision|0|||
19590704|NCT00958776|42039202|FG000|Overall Study|Lost to Follow-up|2|||
19590705|NCT00958776|42039203|FG001|Overall Study|Lost to Follow-up|6|||
19590706|NCT00958776|42039202|FG000|Overall Study|Withdrawal by Subject|7|||
19590707|NCT00958776|42039203|FG001|Overall Study|Withdrawal by Subject|16|||
19590708|NCT00958776|42039202|FG000|Overall Study|Protocol Violation|1|||
19590709|NCT00958776|42039203|FG001|Overall Study|Protocol Violation|1|||
19590710|NCT00958776|42039202|FG000|Overall Study|Death|2|||
19590711|NCT00958776|42039203|FG001|Overall Study|Death|1|||
19590712|NCT00958776|42039202|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
19590713|NCT00958776|42039203|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
19590714|NCT00958776|42039202|FG000|Overall Study|Missing|1|||
19590715|NCT00958776|42039203|FG001|Overall Study|Missing|1|||
19590716|NCT00596830|42039212|FG000|Overall Study|Death|258|||
19590717|NCT00596830|42039213|FG001|Overall Study|Death|247|||
19590718|NCT00596830|42039212|FG000|Overall Study|Lost to Follow-up|7|||
19590719|NCT00596830|42039213|FG001|Overall Study|Lost to Follow-up|11|||
19590720|NCT00596830|42039212|FG000|Overall Study|Withdrawal by Subject|22|||
19590721|NCT00596830|42039213|FG001|Overall Study|Withdrawal by Subject|12|||
19590722|NCT00596830|42039212|FG000|Overall Study|Study terminated by sponsor|51|||
19590723|NCT00596830|42039213|FG001|Overall Study|Study terminated by sponsor|62|||
19590724|NCT00596830|42039212|FG000|Overall Study|Follow-up was discontinued|1|||
19590725|NCT00596830|42039213|FG001|Overall Study|Follow-up was discontinued|0|||
19590726|NCT00596830|42039212|FG000|Overall Study|Randomized but not treated|3|||
19590727|NCT00596830|42039213|FG001|Overall Study|Randomized but not treated|7|||
19590728|NCT00957372|42039222|FG000|PART I|Lost to Follow-up|0|||
19590729|NCT00957372|42039223|FG001|PART I|Lost to Follow-up|0|||
19590730|NCT00957372|42039224|FG002|PART I|Lost to Follow-up|1|||
19590731|NCT00957372|42039225|FG003|PART I|Lost to Follow-up|0|||
19590732|NCT00957372|42039222|FG000|PART II|Withdrawal by Subject|0|||
19590733|NCT00957372|42039223|FG001|PART II|Withdrawal by Subject|0|||
19590734|NCT00957372|42039224|FG002|PART II|Withdrawal by Subject|0|||
19590735|NCT00957372|42039225|FG003|PART II|Withdrawal by Subject|8|||
19590736|NCT00957372|42039222|FG000|PART II|Physician Decision|0|||
19590737|NCT00957372|42039223|FG001|PART II|Physician Decision|0|||
19590738|NCT00957372|42039224|FG002|PART II|Physician Decision|0|||
19590739|NCT00957372|42039225|FG003|PART II|Physician Decision|1|||
19590740|NCT00957372|42039222|FG000|PART II|Pregnancy|0|||
19590741|NCT00957372|42039223|FG001|PART II|Pregnancy|0|||
19590742|NCT00957372|42039224|FG002|PART II|Pregnancy|0|||
19590743|NCT00957372|42039225|FG003|PART II|Pregnancy|1|||
19590744|NCT00957372|42039222|FG000|PART II|Not Know|0|||
19590745|NCT00957372|42039223|FG001|PART II|Not Know|0|||
19590746|NCT00957372|42039224|FG002|PART II|Not Know|0|||
19590747|NCT00957372|42039225|FG003|PART II|Not Know|20|||
19590748|NCT00957372|42039222|FG000|PART II|Adverse Event|0|||
19590749|NCT00957372|42039223|FG001|PART II|Adverse Event|0|||
19590750|NCT00957372|42039224|FG002|PART II|Adverse Event|0|||
19590751|NCT00957372|42039225|FG003|PART II|Adverse Event|10|||
19590752|NCT00957372|42039222|FG000|PART II|Patient non-compliance|0|||
19590753|NCT00957372|42039223|FG001|PART II|Patient non-compliance|0|||
19590754|NCT00957372|42039224|FG002|PART II|Patient non-compliance|0|||
19590755|NCT00957372|42039225|FG003|PART II|Patient non-compliance|4|||
19590756|NCT00953160|42039241|FG000|Overall Study|Lost to Follow-up|23|||
19590757|NCT00953160|42039241|FG000|Overall Study|Withdrawal by Subject|4|||
19590758|NCT00952848|42039245|FG000|Overall Study|Withdrawal by Subject|4|||
19590759|NCT00952614|42039249|FG000|Overall Study|Death|3|||
19590760|NCT00952614|42039249|FG000|Overall Study|Lost to Follow-up|3|||
19590761|NCT00952614|42039249|FG000|Overall Study|other reason|1|||
19590762|NCT00911859|42039257|FG000|Treatment Period|Adverse Event|3|||
19590763|NCT00911859|42039258|FG001|Treatment Period|Adverse Event|3|||
19590764|NCT00911859|42039259|FG002|Treatment Period|Adverse Event|7|||
19590765|NCT00911859|42039257|FG000|Treatment Period|Death|1|||
19590766|NCT00911859|42039258|FG001|Treatment Period|Death|3|||
19590767|NCT00911859|42039259|FG002|Treatment Period|Death|5|||
19590768|NCT00911859|42039257|FG000|Treatment Period|Lack of Efficacy|1|||
19590769|NCT00911859|42039258|FG001|Treatment Period|Lack of Efficacy|7|||
19590770|NCT00911859|42039259|FG002|Treatment Period|Lack of Efficacy|5|||
19590771|NCT00911859|42039257|FG000|Treatment Period|Physician Decision|3|||
19590772|NCT00911859|42039258|FG001|Treatment Period|Physician Decision|3|||
19590773|NCT00911859|42039259|FG002|Treatment Period|Physician Decision|3|||
19590774|NCT00911859|42039257|FG000|Treatment Period|Withdrawal by Subject|0|||
19590775|NCT00911859|42039258|FG001|Treatment Period|Withdrawal by Subject|4|||
19590776|NCT00911859|42039259|FG002|Treatment Period|Withdrawal by Subject|5|||
19590777|NCT00911859|42039257|FG000|Treatment Period|Did not receive study treatment|0|||
19590778|NCT00911859|42039258|FG001|Treatment Period|Did not receive study treatment|1|||
19590779|NCT00911859|42039259|FG002|Treatment Period|Did not receive study treatment|0|||
19590780|NCT00911859|42039257|FG000|Maintainance Period|Lack of Efficacy|0|||
19590781|NCT00911859|42039258|FG001|Maintainance Period|Lack of Efficacy|0|||
19590782|NCT00911859|42039259|FG002|Maintainance Period|Lack of Efficacy|9|||
19590783|NCT00911859|42039257|FG000|Maintainance Period|Physician Decision|0|||
19590784|NCT00911859|42039258|FG001|Maintainance Period|Physician Decision|0|||
19590785|NCT00911859|42039259|FG002|Maintainance Period|Physician Decision|9|||
19590786|NCT00911859|42039257|FG000|Maintainance Period|Withdrawal by Subject|0|||
19590787|NCT00911859|42039258|FG001|Maintainance Period|Withdrawal by Subject|0|||
19590788|NCT00911859|42039259|FG002|Maintainance Period|Withdrawal by Subject|3|||
19590789|NCT00911859|42039257|FG000|Follow-up Period|Death|5|||
19590790|NCT00911859|42039258|FG001|Follow-up Period|Death|8|||
19590791|NCT00911859|42039259|FG002|Follow-up Period|Death|10|||
19590792|NCT00911859|42039257|FG000|Follow-up Period|Lost to Follow-up|1|||
19590793|NCT00911859|42039258|FG001|Follow-up Period|Lost to Follow-up|1|||
19590794|NCT00911859|42039259|FG002|Follow-up Period|Lost to Follow-up|0|||
19590795|NCT00911859|42039257|FG000|Follow-up Period|Withdrawal by Subject|0|||
19590796|NCT00911859|42039258|FG001|Follow-up Period|Withdrawal by Subject|4|||
19590797|NCT00911859|42039259|FG002|Follow-up Period|Withdrawal by Subject|4|||
19590798|NCT00911859|42039257|FG000|Follow-up Period|Study terminated by sponsor|5|||
19590799|NCT00911859|42039258|FG001|Follow-up Period|Study terminated by sponsor|33|||
19590800|NCT00911859|42039259|FG002|Follow-up Period|Study terminated by sponsor|27|||
19590801|NCT00956592|42039269|FG000|Overall Study|Protocol Violation|1|||
19590802|NCT00956592|42039270|FG001|Overall Study|Protocol Violation|3|||
19590803|NCT00955968|42039280|FG000|Overall Study|Death|2|||
19590804|NCT00955968|42039281|FG001|Overall Study|Death|4|||
19590805|NCT00955968|42039280|FG000|Overall Study|Withdrawal by Subject|35|||
19590806|NCT00955968|42039281|FG001|Overall Study|Withdrawal by Subject|31|||
19590807|NCT00955968|42039280|FG000|Overall Study|Lost to Follow-up|45|||
19590808|NCT00955968|42039281|FG001|Overall Study|Lost to Follow-up|39|||
19590809|NCT00955968|42039280|FG000|Overall Study|Site closed|55|||
19590810|NCT00955968|42039281|FG001|Overall Study|Site closed|52|||
19590811|NCT02725593|42039292|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
19590812|NCT02725593|42039293|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
19590813|NCT02725593|42039292|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
19590814|NCT02725593|42039293|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
19590815|NCT02725593|42039292|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
19590816|NCT02725593|42039293|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
19590817|NCT02725593|42039292|FG000|Long Term Extension|Withdrawal by Subject|1|||
19590818|NCT02725593|42039293|FG001|Long Term Extension|Withdrawal by Subject|3|||
19590819|NCT00911625|42039301|FG000|Overall Study|Lost to Follow-up|7|||
19590820|NCT00911625|42039302|FG001|Overall Study|Lost to Follow-up|0|||
19590821|NCT00596752|42039310|FG000|Overall Study|Other Reason|44|||
19590822|NCT00596752|42039311|FG001|Overall Study|Other Reason|49|||
19590823|NCT00596752|42039310|FG000|Overall Study|Adverse Event|34|||
19590824|NCT00596752|42039311|FG001|Overall Study|Adverse Event|34|||
19590825|NCT00596752|42039310|FG000|Overall Study|Lost to Follow-up|22|||
19590826|NCT00596752|42039311|FG001|Overall Study|Lost to Follow-up|38|||
19590827|NCT00596752|42039310|FG000|Overall Study|Withdrawal by Subject|12|||
19590828|NCT00596752|42039311|FG001|Overall Study|Withdrawal by Subject|9|||
19590829|NCT00596752|42039310|FG000|Overall Study|Unsatisfactory Compliance|9|||
19590830|NCT00596752|42039311|FG001|Overall Study|Unsatisfactory Compliance|6|||
19590831|NCT00596752|42039310|FG000|Overall Study|Lack of Efficacy|4|||
19590832|NCT00596752|42039311|FG001|Overall Study|Lack of Efficacy|7|||
19590833|NCT00596752|42039310|FG000|Overall Study|Protocol Violation|1|||
19590834|NCT00596752|42039311|FG001|Overall Study|Protocol Violation|0|||
19590835|NCT00958074|42039319|FG000|Overall Study|Withdrawal by Subject|0|||
19590836|NCT00958074|42039320|FG001|Overall Study|Withdrawal by Subject|1|||
19590837|NCT00809965|42039329|FG000|Overall Study|Death|194|||
19590838|NCT00809965|42039330|FG001|Overall Study|Death|147|||
19590839|NCT00809965|42039331|FG002|Overall Study|Death|196|||
19590840|NCT00809965|42039329|FG000|Overall Study|Lost to Follow-up|17|||
19590841|NCT00809965|42039330|FG001|Overall Study|Lost to Follow-up|10|||
19590842|NCT00809965|42039331|FG002|Overall Study|Lost to Follow-up|18|||
19590843|NCT00809965|42039329|FG000|Overall Study|Withdrawal by Subject|405|||
19590844|NCT00809965|42039330|FG001|Overall Study|Withdrawal by Subject|448|||
19590845|NCT00809965|42039331|FG002|Overall Study|Withdrawal by Subject|441|||
19590846|NCT00809965|42039329|FG000|Overall Study|Other Reason|167|||
19590847|NCT00809965|42039330|FG001|Overall Study|Other Reason|170|||
19590848|NCT00809965|42039331|FG002|Overall Study|Other Reason|189|||
19590849|NCT00597376|42039341|FG000|Overall Study|Withdrawal by Subject|4|||
19590850|NCT00597376|42039342|FG001|Overall Study|Withdrawal by Subject|3|||
19590851|NCT00597376|42039341|FG000|Overall Study|Adverse Event|4|||
19590852|NCT00597376|42039342|FG001|Overall Study|Adverse Event|1|||
19590853|NCT00910689|42039378|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
19590854|NCT00910689|42039379|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
19590855|NCT00910689|42039380|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
19590856|NCT00910689|42039381|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
19590857|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
19590858|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
19590859|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
19590860|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
19590861|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
19590862|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
19590863|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
19590864|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
19590865|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
19590866|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
19590867|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
19590868|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
19590869|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
19590870|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
19590871|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
19590872|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
19590873|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
19590874|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
19590875|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
19590876|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
19590877|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
19590878|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
19590879|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
19590880|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
19590881|NCT00910689|42039378|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
19590882|NCT00910689|42039379|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
19590883|NCT00910689|42039380|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
19590884|NCT00910689|42039381|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
19590885|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
19590886|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
19590887|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
19590888|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
19590889|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
19590890|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
19590891|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
19590892|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
19590893|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
19590894|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
19590895|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
19590896|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
19590897|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
19590898|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
19590899|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
19590900|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
19590901|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
19590902|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
19590903|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
19590904|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
19590905|NCT00910689|42039378|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
19590906|NCT00910689|42039379|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
19590907|NCT00910689|42039380|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
19590908|NCT00910689|42039381|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
19590909|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
19590910|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
19590911|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
19590912|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
19590913|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
19590914|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
19590915|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
19590916|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
19590917|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
19590918|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
19590919|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
19590920|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
19590921|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
19590922|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
19590923|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
19590924|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
19590925|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
19590926|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
19590927|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
19590928|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
19590929|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
19590930|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
19590931|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
19590932|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
19590933|NCT00910689|42039378|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
19590934|NCT00910689|42039379|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
19590935|NCT00910689|42039380|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
19590936|NCT00910689|42039381|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
19590937|NCT00807001|42039396|FG000|Overall Study|Non-compliance|0|||
19590938|NCT00807001|42039397|FG001|Overall Study|Non-compliance|1|||
19590939|NCT00807001|42039398|FG002|Overall Study|Non-compliance|0|||
19590940|NCT00807001|42039399|FG003|Overall Study|Non-compliance|0|||
19590941|NCT00807001|42039400|FG004|Overall Study|Non-compliance|0|||
19590942|NCT00809341|42039414|FG000|Overall Study|Physician Decision|0|||
19590943|NCT00809341|42039415|FG001|Overall Study|Physician Decision|1|||
19590944|NCT01125800|42039426|FG000|Phase I|Protocol Violation|0|||
19590945|NCT01125800|42039427|FG001|Phase I|Protocol Violation|3|||
19590946|NCT01125800|42039428|FG002|Phase I|Protocol Violation|1|||
19590947|NCT01125800|42039429|FG003|Phase I|Protocol Violation|1|||
19590948|NCT01125800|42039430|FG004|Phase I|Protocol Violation|0|||
19590949|NCT01125800|42039426|FG000|Phase I|Adverse Event|2|||
19590950|NCT01125800|42039427|FG001|Phase I|Adverse Event|2|||
19590951|NCT01125800|42039428|FG002|Phase I|Adverse Event|1|||
19590952|NCT01125800|42039429|FG003|Phase I|Adverse Event|7|||
19590953|NCT01125800|42039430|FG004|Phase I|Adverse Event|0|||
19590954|NCT01125800|42039426|FG000|Phase I|Administrative problems|1|||
19590955|NCT01125800|42039427|FG001|Phase I|Administrative problems|0|||
19590956|NCT01125800|42039428|FG002|Phase I|Administrative problems|0|||
19590957|NCT01125800|42039429|FG003|Phase I|Administrative problems|0|||
19590958|NCT01125800|42039430|FG004|Phase I|Administrative problems|0|||
19590959|NCT01125800|42039426|FG000|Phase I|Withdrawal by Subject|0|||
19590960|NCT01125800|42039427|FG001|Phase I|Withdrawal by Subject|0|||
19476974|NCT01549873|41755561|FG000|Overall Study|Physician Decision|0|||
19590961|NCT01125800|42039428|FG002|Phase I|Withdrawal by Subject|1|||
19590962|NCT01125800|42039429|FG003|Phase I|Withdrawal by Subject|0|||
19590963|NCT01125800|42039430|FG004|Phase I|Withdrawal by Subject|0|||
19590964|NCT01125800|42039426|FG000|Phase I|Disease progression|5|||
19590965|NCT01125800|42039427|FG001|Phase I|Disease progression|4|||
19590966|NCT01125800|42039428|FG002|Phase I|Disease progression|1|||
19590967|NCT01125800|42039429|FG003|Phase I|Disease progression|3|||
19590968|NCT01125800|42039430|FG004|Phase I|Disease progression|0|||
19590969|NCT01125800|42039426|FG000|Phase II|Protocol Violation|0|||
19590970|NCT01125800|42039427|FG001|Phase II|Protocol Violation|0|||
19590971|NCT01125800|42039428|FG002|Phase II|Protocol Violation|0|||
19590972|NCT01125800|42039429|FG003|Phase II|Protocol Violation|0|||
19590973|NCT01125800|42039430|FG004|Phase II|Protocol Violation|1|||
19590974|NCT01125800|42039426|FG000|Phase II|Adverse Event|0|||
19590975|NCT01125800|42039427|FG001|Phase II|Adverse Event|0|||
19590976|NCT01125800|42039428|FG002|Phase II|Adverse Event|0|||
19590977|NCT01125800|42039429|FG003|Phase II|Adverse Event|0|||
19590978|NCT01125800|42039430|FG004|Phase II|Adverse Event|2|||
19590979|NCT01125800|42039426|FG000|Phase II|Disease progression|0|||
19590980|NCT01125800|42039427|FG001|Phase II|Disease progression|0|||
19590981|NCT01125800|42039428|FG002|Phase II|Disease progression|0|||
19590982|NCT01125800|42039429|FG003|Phase II|Disease progression|1|||
19590983|NCT01125800|42039430|FG004|Phase II|Disease progression|8|||
19590984|NCT01125722|42039447|FG000|Overall Study|Withdrawal by Subject|2|||
19590985|NCT01125722|42039448|FG001|Overall Study|Withdrawal by Subject|1|||
19590986|NCT01125722|42039447|FG000|Overall Study|Lost to Follow-up|1|||
19590987|NCT01125722|42039448|FG001|Overall Study|Lost to Follow-up|0|||
19590988|NCT00811135|42039454|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
19590989|NCT00811135|42039454|FG000|Overall Study|Death|3|||
19590990|NCT00811135|42039454|FG000|Overall Study|Protocol Violation|2|||
19590991|NCT00811135|42039454|FG000|Overall Study|Violation of Selection Criteria|1|||
19590992|NCT00811135|42039454|FG000|Overall Study|Refused Treatment|1|||
19590993|NCT00811135|42039454|FG000|Overall Study|Withdrawal by Subject|3|||
19590994|NCT00811135|42039454|FG000|Overall Study|Administrative/Other Unspecified|11|||
19590995|NCT00811135|42039454|FG000|Overall Study|Ongoing|59|||
19590996|NCT00811057|42039461|FG000|Overall Study|Protocol Violation|5|||
19590997|NCT00811057|42039462|FG001|Overall Study|Protocol Violation|10|||
19590998|NCT00811057|42039463|FG002|Overall Study|Protocol Violation|10|||
19590999|NCT00879970|42039474|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
19591000|NCT00879970|42039475|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
19591001|NCT00879970|42039476|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
19591002|NCT00879970|42039477|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
19591003|NCT00879970|42039478|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
19591004|NCT00879970|42039474|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
19591005|NCT00879970|42039475|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
19591006|NCT00879970|42039476|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
19591007|NCT00879970|42039477|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
19476975|NCT01549873|41755562|FG001|Overall Study|Physician Decision|1|||
19591008|NCT00879970|42039478|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
19591009|NCT00879970|42039474|FG000|Period 1 TZD Randomization|Death|2|||
19591010|NCT00879970|42039475|FG001|Period 1 TZD Randomization|Death|1|||
19591011|NCT00879970|42039476|FG002|Period 1 TZD Randomization|Death|0|||
19591012|NCT00879970|42039477|FG003|Period 1 TZD Randomization|Death|0|||
19591013|NCT00879970|42039478|FG004|Period 1 TZD Randomization|Death|0|||
19591014|NCT00879970|42039474|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
19591015|NCT00879970|42039475|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
19591016|NCT00879970|42039476|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
19591017|NCT00879970|42039477|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
19591018|NCT00879970|42039478|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
19591019|NCT00879970|42039474|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
19591020|NCT00879970|42039475|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
19591021|NCT00879970|42039476|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
19591022|NCT00879970|42039477|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
19591023|NCT00879970|42039478|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
19591024|NCT00879970|42039474|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
19591025|NCT00879970|42039475|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
19591026|NCT00879970|42039476|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
19591027|NCT00879970|42039477|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
19591028|NCT00879970|42039478|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
19591029|NCT00879970|42039474|FG000|Period 2 Vitamin D Randomization|Death|0|||
19591030|NCT00879970|42039475|FG001|Period 2 Vitamin D Randomization|Death|0|||
19591031|NCT00879970|42039476|FG002|Period 2 Vitamin D Randomization|Death|0|||
19591032|NCT00879970|42039477|FG003|Period 2 Vitamin D Randomization|Death|2|||
19591033|NCT00879970|42039478|FG004|Period 2 Vitamin D Randomization|Death|0|||
19591034|NCT00808639|42039496|FG000|Overall Study|Disease progression before surgery.|1|||
19591035|NCT00810901|42039502|FG000|Overall Study|Lost to Follow-up|88|||
19591036|NCT00810901|42039503|FG001|Overall Study|Lost to Follow-up|58|||
19591037|NCT00910299|42039511|FG000|Overall Study|Withdrawal by Subject|16|||
19591038|NCT00910299|42039512|FG001|Overall Study|Withdrawal by Subject|13|||
19591039|NCT00910299|42039511|FG000|Overall Study|Sponsor Decision|58|||
19591040|NCT00910299|42039512|FG001|Overall Study|Sponsor Decision|60|||
19591041|NCT00910299|42039511|FG000|Overall Study|Didn't receive any study drug|2|||
19591042|NCT00910299|42039512|FG001|Overall Study|Didn't receive any study drug|1|||
19591043|NCT00595504|42039520|FG000|Overall Study|Withdrawal by Subject|1|||
19591044|NCT00595504|42039521|FG001|Overall Study|Withdrawal by Subject|3|||
19591045|NCT00595504|42039520|FG000|Overall Study|Physician Decision|1|||
19591046|NCT00595504|42039521|FG001|Overall Study|Physician Decision|0|||
19591047|NCT00808483|42039529|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
19591048|NCT00808483|42039530|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
19591049|NCT00808483|42039529|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
19591050|NCT00808483|42039530|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
19591051|NCT00808483|42039529|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
19591052|NCT00808483|42039530|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
19591053|NCT00810511|42039545|FG000|Overall Study|Protocol Violation|0|||
19591054|NCT00810511|42039546|FG001|Overall Study|Protocol Violation|1|||
19591055|NCT00810511|42039545|FG000|Overall Study|Lack of Efficacy|9|||
19591056|NCT00810511|42039546|FG001|Overall Study|Lack of Efficacy|1|||
19591057|NCT00810511|42039545|FG000|Overall Study|death in the family|0|||
19591058|NCT00810511|42039546|FG001|Overall Study|death in the family|1|||
19591059|NCT00810511|42039545|FG000|Overall Study|Lost to Follow-up|1|||
19591060|NCT00810511|42039546|FG001|Overall Study|Lost to Follow-up|0|||
19591061|NCT00810511|42039545|FG000|Overall Study|deposits on contact lens|0|||
19591062|NCT00810511|42039546|FG001|Overall Study|deposits on contact lens|1|||
19591063|NCT00596362|42039552|FG000|Overall Study|Progressive Disease|1|||
19591064|NCT00907803|42039559|FG000|Overall Study|Withdrawal of consent - long commute|1|||
19591065|NCT00907803|42039560|FG001|Overall Study|Withdrawal of consent - long commute|0|||
19591066|NCT00907803|42039561|FG002|Overall Study|Withdrawal of consent - long commute|0|||
19591067|NCT00907803|42039559|FG000|Overall Study|Adverse Event|2|||
19591068|NCT00907803|42039560|FG001|Overall Study|Adverse Event|0|||
19591069|NCT00907803|42039561|FG002|Overall Study|Adverse Event|0|||
19591070|NCT00907803|42039559|FG000|Overall Study|Withdrawal by Subject|0|||
19591071|NCT00907803|42039560|FG001|Overall Study|Withdrawal by Subject|1|||
19591072|NCT00907803|42039561|FG002|Overall Study|Withdrawal by Subject|0|||
19591073|NCT00907803|42039559|FG000|Overall Study|Lost to Follow-up|0|||
19591074|NCT00907803|42039560|FG001|Overall Study|Lost to Follow-up|1|||
19591075|NCT00907803|42039561|FG002|Overall Study|Lost to Follow-up|0|||
19591076|NCT00907803|42039559|FG000|Overall Study|Protocol Violation|0|||
19591077|NCT00907803|42039560|FG001|Overall Study|Protocol Violation|1|||
19591078|NCT00907803|42039561|FG002|Overall Study|Protocol Violation|0|||
19591079|NCT00808249|42039573|FG000|Overall Study|Adverse Event|4|||
19591080|NCT00808249|42039574|FG001|Overall Study|Adverse Event|7|||
19591081|NCT00808249|42039575|FG002|Overall Study|Adverse Event|10|||
19591082|NCT00808249|42039576|FG003|Overall Study|Adverse Event|6|||
19591083|NCT00808249|42039573|FG000|Overall Study|Lost to Follow-up|2|||
19591084|NCT00808249|42039574|FG001|Overall Study|Lost to Follow-up|3|||
19591085|NCT00808249|42039575|FG002|Overall Study|Lost to Follow-up|3|||
19591086|NCT00808249|42039576|FG003|Overall Study|Lost to Follow-up|5|||
19591087|NCT00808249|42039573|FG000|Overall Study|Withdrawal by Subject|4|||
19591088|NCT00808249|42039574|FG001|Overall Study|Withdrawal by Subject|0|||
19591089|NCT00808249|42039575|FG002|Overall Study|Withdrawal by Subject|2|||
19591090|NCT00808249|42039576|FG003|Overall Study|Withdrawal by Subject|4|||
19591091|NCT00808249|42039573|FG000|Overall Study|Protocol Violation|3|||
19591092|NCT00808249|42039574|FG001|Overall Study|Protocol Violation|3|||
19591093|NCT00808249|42039575|FG002|Overall Study|Protocol Violation|3|||
19591094|NCT00808249|42039576|FG003|Overall Study|Protocol Violation|0|||
19591095|NCT00808249|42039573|FG000|Overall Study|Lack of Efficacy|1|||
19591096|NCT00808249|42039574|FG001|Overall Study|Lack of Efficacy|1|||
19591097|NCT00808249|42039575|FG002|Overall Study|Lack of Efficacy|0|||
19591098|NCT00808249|42039576|FG003|Overall Study|Lack of Efficacy|0|||
19591099|NCT00808249|42039573|FG000|Overall Study|study specific discontinuation criteria|1|||
19591100|NCT00808249|42039574|FG001|Overall Study|study specific discontinuation criteria|0|||
19591101|NCT00808249|42039575|FG002|Overall Study|study specific discontinuation criteria|1|||
19591102|NCT00808249|42039576|FG003|Overall Study|study specific discontinuation criteria|0|||
19591103|NCT00808249|42039573|FG000|Overall Study|All other reasons|2|||
19591104|NCT00808249|42039574|FG001|Overall Study|All other reasons|1|||
19591105|NCT00808249|42039575|FG002|Overall Study|All other reasons|3|||
19591106|NCT00808249|42039576|FG003|Overall Study|All other reasons|1|||
19591107|NCT00908895|42039588|FG000|Overall Study|Lost to Follow-up|1|||
19591108|NCT00908895|42039589|FG001|Overall Study|Lost to Follow-up|3|||
19591109|NCT00908895|42039588|FG000|Overall Study|algodystrophy|2|||
19591110|NCT00908895|42039589|FG001|Overall Study|algodystrophy|2|||
19591111|NCT00908895|42039588|FG000|Overall Study|Adverse Event|1|||
19591112|NCT00908895|42039589|FG001|Overall Study|Adverse Event|1|||
19591113|NCT00591253|42039598|FG000|Overall Study|Adverse Event|3|||
19591114|NCT00591253|42039599|FG001|Overall Study|Adverse Event|3|||
19591115|NCT00591253|42039600|FG002|Overall Study|Adverse Event|1|||
19591116|NCT00591253|42039598|FG000|Overall Study|Protocol Violation|2|||
19591117|NCT00591253|42039599|FG001|Overall Study|Protocol Violation|2|||
19591118|NCT00591253|42039600|FG002|Overall Study|Protocol Violation|2|||
19591119|NCT00591253|42039598|FG000|Overall Study|Lost to Follow-up|2|||
19591120|NCT00591253|42039599|FG001|Overall Study|Lost to Follow-up|4|||
19591121|NCT00591253|42039600|FG002|Overall Study|Lost to Follow-up|0|||
19591122|NCT00591253|42039598|FG000|Overall Study|Withdrawal by Subject|1|||
19591123|NCT00591253|42039599|FG001|Overall Study|Withdrawal by Subject|7|||
19591124|NCT00591253|42039600|FG002|Overall Study|Withdrawal by Subject|6|||
19591125|NCT00591253|42039598|FG000|Overall Study|Lack of Efficacy|1|||
19591126|NCT00591253|42039599|FG001|Overall Study|Lack of Efficacy|0|||
19591127|NCT00591253|42039600|FG002|Overall Study|Lack of Efficacy|3|||
19591128|NCT00591253|42039598|FG000|Overall Study|Other|5|||
19591129|NCT00591253|42039599|FG001|Overall Study|Other|5|||
19591130|NCT00591253|42039600|FG002|Overall Study|Other|3|||
19591131|NCT00908583|42039608|FG000|Phase 1|Withdrawal by Subject|1|||
19591132|NCT00908583|42039608|FG000|Phase 1|Adverse Event|4|||
19591133|NCT00908583|42039608|FG000|Phase 2|Physician Decision|1|||
19591134|NCT00908583|42039608|FG000|Phase 2|Adverse Event|1|||
19591135|NCT00908583|42039608|FG000|Phase 3|Adverse Event|2|||
19591136|NCT00908583|42039608|FG000|Phase 4|Adverse Event|1|||
19591137|NCT00908583|42039608|FG000|Phase 4|Physician Decision|1|||
19591138|NCT00908583|42039608|FG000|Phase 5|Adverse Event|3|||
19591139|NCT00909363|42039629|FG000|Overall Study|Withdrawal by Subject|1|||
19591140|NCT00909363|42039630|FG001|Overall Study|Withdrawal by Subject|0|||
19591141|NCT00909363|42039631|FG002|Overall Study|Withdrawal by Subject|0|||
19591142|NCT00909363|42039629|FG000|Overall Study|Lack of Efficacy|1|||
19591143|NCT00909363|42039630|FG001|Overall Study|Lack of Efficacy|0|||
19591144|NCT00909363|42039631|FG002|Overall Study|Lack of Efficacy|0|||
19591145|NCT00810355|42039645|FG000|Overall Study|Lost to Follow-up|13|||
19591146|NCT00810355|42039646|FG001|Overall Study|Lost to Follow-up|17|||
19591147|NCT00810355|42039647|FG002|Overall Study|Lost to Follow-up|11|||
19591148|NCT00810355|42039645|FG000|Overall Study|Withdrawal by Subject|1|||
19591149|NCT00810355|42039646|FG001|Overall Study|Withdrawal by Subject|0|||
19591150|NCT00810355|42039647|FG002|Overall Study|Withdrawal by Subject|0|||
19591151|NCT00908349|42039655|FG000|Overall Study|Adverse Event|10|||
19387981|NCT02057692|41631303|FG003|Overall Study|Lost to Follow-up|1|||
19591152|NCT00908349|42039655|FG000|Overall Study|Withdrawal by Subject|9|||
19591153|NCT00908349|42039655|FG000|Overall Study|Physician Decision|5|||
19591154|NCT00908349|42039655|FG000|Overall Study|Lost to Follow-up|5|||
19591155|NCT00908349|42039655|FG000|Overall Study|Various|6|||
19591156|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
19591157|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
19591158|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
19591159|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
19591160|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
19591161|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
19591162|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
19591163|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
19591164|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
19591165|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
19591166|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
19591167|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
19591168|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
19591169|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
19591170|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
19591171|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
19591172|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
19591173|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
19591174|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
19591175|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
19591176|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
19591177|NCT01125566|42039661|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
19591178|NCT01125566|42039662|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
19591179|NCT01125566|42039663|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
19591180|NCT01125566|42039661|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
19591181|NCT01125566|42039662|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
19387982|NCT02038036|41631321|FG000|Core Study|Adverse Event|7|||
19591182|NCT01125566|42039663|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
19591183|NCT01125566|42039661|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
19591184|NCT01125566|42039662|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
19591185|NCT01125566|42039663|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
19591186|NCT01125566|42039661|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
19591187|NCT01125566|42039662|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
19591188|NCT01125566|42039663|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
19591189|NCT01125566|42039661|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
19591190|NCT01125566|42039662|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
19591191|NCT01125566|42039663|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
19591192|NCT00810277|42039670|FG000|Overall Study|Adverse Event|1|||
19591193|NCT00595582|42039674|FG000|Overall Study|Pilot study that PI terminated|2|||
19591194|NCT00595582|42039674|FG000|Overall Study|Lost to Follow-up|1|||
19591195|NCT00595582|42039674|FG000|Overall Study|Adverse Event|2|||
19591196|NCT00595582|42039674|FG000|Overall Study|Physician Decision|5|||
19591197|NCT00808015|42039678|FG000|Overall Study|Death|1|||
19591198|NCT00808015|42039678|FG000|Overall Study|Lack of Efficacy|58|||
19591199|NCT00808015|42039678|FG000|Overall Study|Lost to Follow-up|76|||
19591200|NCT00808015|42039678|FG000|Overall Study|Participants not willing to participate|158|||
19591201|NCT00808015|42039678|FG000|Overall Study|Adverse Event|22|||
19591202|NCT00808015|42039678|FG000|Overall Study|Other|25|||
19591203|NCT00808015|42039678|FG000|Overall Study|Enrolled but not treated|4|||
19591204|NCT00810199|42039684|FG000|Overall Study|Adverse Event|24|||
19591205|NCT00810199|42039685|FG001|Overall Study|Adverse Event|26|||
19591206|NCT00810199|42039684|FG000|Overall Study|Death|4|||
19591207|NCT00810199|42039685|FG001|Overall Study|Death|6|||
19591208|NCT00810199|42039684|FG000|Overall Study|Withdrew consent|9|||
19591209|NCT00810199|42039685|FG001|Overall Study|Withdrew consent|12|||
19591210|NCT00810199|42039684|FG000|Overall Study|Insufficient therapeutic response|5|||
19591211|NCT00810199|42039685|FG001|Overall Study|Insufficient therapeutic response|14|||
19591212|NCT00810199|42039684|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
19591213|NCT00810199|42039685|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
19591214|NCT00810199|42039684|FG000|Overall Study|Administrative/Other|5|||
19591215|NCT00810199|42039685|FG001|Overall Study|Administrative/Other|6|||
19745962|NCT03529773|42193168|FG012|Overall Study|Physician Decision|0|||
19387983|NCT02038036|41631322|FG001|Core Study|Adverse Event|7|||
19387984|NCT02038036|41631321|FG000|Core Study|Death|1|||
19591216|NCT00810199|42039684|FG000|Overall Study|Protocol Violation|2|||
19591217|NCT00810199|42039685|FG001|Overall Study|Protocol Violation|6|||
19591218|NCT00810199|42039684|FG000|Overall Study|Failure to return|1|||
19591219|NCT00810199|42039685|FG001|Overall Study|Failure to return|4|||
19591220|NCT00810199|42039684|FG000|Overall Study|Did not receive study drug|2|||
19591221|NCT00810199|42039685|FG001|Overall Study|Did not receive study drug|1|||
19591222|NCT00877006|42039699|FG000|Treatment Period|Death|2|||
19591223|NCT00877006|42039700|FG001|Treatment Period|Death|1|||
19591224|NCT00877006|42039699|FG000|Treatment Period|Adverse Event|10|||
19591225|NCT00877006|42039700|FG001|Treatment Period|Adverse Event|3|||
19591226|NCT00877006|42039699|FG000|Treatment Period|Withdrawal by Subject|2|||
19591227|NCT00877006|42039700|FG001|Treatment Period|Withdrawal by Subject|3|||
19591228|NCT00877006|42039699|FG000|Treatment Period|Protocol Violation|1|||
19591229|NCT00877006|42039700|FG001|Treatment Period|Protocol Violation|0|||
19591230|NCT00877006|42039699|FG000|Treatment Period|Lost to Follow-up|0|||
19591231|NCT00877006|42039700|FG001|Treatment Period|Lost to Follow-up|1|||
19591232|NCT00877006|42039699|FG000|Treatment Period|Disease Progression|1|||
19591233|NCT00877006|42039700|FG001|Treatment Period|Disease Progression|2|||
19591234|NCT00877006|42039699|FG000|Treatment Period|Started New Treatment Regimen|2|||
19591235|NCT00877006|42039700|FG001|Treatment Period|Started New Treatment Regimen|5|||
19591236|NCT00877006|42039699|FG000|Treatment Period|Other|4|||
19591237|NCT00877006|42039700|FG001|Treatment Period|Other|4|||
19591238|NCT00877006|42039699|FG000|Treatment Period|Randomized but Not Treated|3|||
19591239|NCT00877006|42039700|FG001|Treatment Period|Randomized but Not Treated|8|||
19591240|NCT00877006|42039699|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
19591241|NCT00877006|42039700|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
19591242|NCT00877006|42039699|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
19591243|NCT00877006|42039700|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
19591244|NCT00877006|42039699|FG000|Long-Term Follow-up Period|Death|26|||
19591245|NCT00877006|42039700|FG001|Long-Term Follow-up Period|Death|18|||
19591246|NCT00877006|42039699|FG000|Long-Term Follow-up Period|Other|7|||
19591247|NCT00877006|42039700|FG001|Long-Term Follow-up Period|Other|9|||
19591248|NCT00876928|42039710|FG000|Overall Study|Lost to Follow-up|2|||
19591249|NCT00876928|42039711|FG001|Overall Study|Lost to Follow-up|5|||
19591250|NCT00876928|42039710|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
19591251|NCT00876928|42039711|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
19591252|NCT00807937|42039721|FG000|Overall Study|Adverse Event|12|||
19591253|NCT00807937|42039722|FG001|Overall Study|Adverse Event|12|||
19591254|NCT00807937|42039723|FG002|Overall Study|Adverse Event|5|||
19591255|NCT00807937|42039724|FG003|Overall Study|Adverse Event|4|||
19591256|NCT00807937|42039721|FG000|Overall Study|Protocol Violation|4|||
19591257|NCT00807937|42039722|FG001|Overall Study|Protocol Violation|5|||
19591258|NCT00807937|42039723|FG002|Overall Study|Protocol Violation|3|||
19591259|NCT00807937|42039724|FG003|Overall Study|Protocol Violation|3|||
19591260|NCT00807937|42039721|FG000|Overall Study|Withdrawal by Subject|5|||
19591261|NCT00807937|42039722|FG001|Overall Study|Withdrawal by Subject|4|||
19591262|NCT00807937|42039723|FG002|Overall Study|Withdrawal by Subject|1|||
19591263|NCT00807937|42039724|FG003|Overall Study|Withdrawal by Subject|4|||
19591264|NCT00807937|42039721|FG000|Overall Study|Lost to Follow-up|4|||
19591265|NCT00807937|42039722|FG001|Overall Study|Lost to Follow-up|0|||
19591266|NCT00807937|42039723|FG002|Overall Study|Lost to Follow-up|2|||
19591267|NCT00807937|42039724|FG003|Overall Study|Lost to Follow-up|1|||
19591268|NCT00807937|42039721|FG000|Overall Study|Lack of Efficacy|0|||
19591269|NCT00807937|42039722|FG001|Overall Study|Lack of Efficacy|0|||
19591270|NCT00807937|42039723|FG002|Overall Study|Lack of Efficacy|1|||
19591271|NCT00807937|42039724|FG003|Overall Study|Lack of Efficacy|2|||
19591272|NCT00807937|42039721|FG000|Overall Study|Intake of prohibited medicine|0|||
19591273|NCT00807937|42039722|FG001|Overall Study|Intake of prohibited medicine|0|||
19591274|NCT00807937|42039723|FG002|Overall Study|Intake of prohibited medicine|2|||
19591275|NCT00807937|42039724|FG003|Overall Study|Intake of prohibited medicine|0|||
19591276|NCT00807937|42039721|FG000|Overall Study|All other reasons (not provided)|2|||
19591277|NCT00807937|42039722|FG001|Overall Study|All other reasons (not provided)|4|||
19591278|NCT00807937|42039723|FG002|Overall Study|All other reasons (not provided)|0|||
19591279|NCT00807937|42039724|FG003|Overall Study|All other reasons (not provided)|1|||
19591280|NCT00906945|42039739|FG000|Overall Study|Found to be not eligible|0|||
19591281|NCT00906945|42039740|FG001|Overall Study|Found to be not eligible|0|||
19591282|NCT00906945|42039741|FG002|Overall Study|Found to be not eligible|0|||
19591283|NCT00906945|42039742|FG003|Overall Study|Found to be not eligible|1|||
19591284|NCT00906945|42039743|FG004|Overall Study|Found to be not eligible|1|||
19591285|NCT00906945|42039744|FG005|Overall Study|Found to be not eligible|1|||
19591286|NCT00906945|42039739|FG000|Overall Study|Physician Decision|0|||
19591287|NCT00906945|42039740|FG001|Overall Study|Physician Decision|0|||
19591288|NCT00906945|42039741|FG002|Overall Study|Physician Decision|0|||
19591289|NCT00906945|42039742|FG003|Overall Study|Physician Decision|0|||
19591290|NCT00906945|42039743|FG004|Overall Study|Physician Decision|0|||
19591291|NCT00906945|42039744|FG005|Overall Study|Physician Decision|1|||
19591292|NCT00807235|42039762|FG000|Overall Study|Adverse Event|1|||
19591293|NCT00807235|42039763|FG001|Overall Study|Adverse Event|0|||
19591294|NCT00876694|42039771|FG000|Overall Study|Adverse Event|10|||
19591295|NCT00876694|42039772|FG001|Overall Study|Adverse Event|7|||
19591296|NCT00876694|42039771|FG000|Overall Study|Subject withdrew consent|6|||
19591297|NCT00876694|42039772|FG001|Overall Study|Subject withdrew consent|4|||
19591298|NCT00876694|42039771|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19591299|NCT00876694|42039772|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19591300|NCT00876694|42039771|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19591301|NCT00876694|42039772|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19591302|NCT00876694|42039771|FG000|Overall Study|Administrative problems|1|||
19591303|NCT00876694|42039772|FG001|Overall Study|Administrative problems|1|||
19591304|NCT00876694|42039771|FG000|Overall Study|Death|1|||
19591305|NCT00876694|42039772|FG001|Overall Study|Death|0|||
19591306|NCT00805441|42039780|FG000|Overall Study|Adverse Event|5|||
19591307|NCT00805441|42039781|FG001|Overall Study|Adverse Event|2|||
19591308|NCT00805441|42039780|FG000|Overall Study|Lack of Efficacy|0|||
19591309|NCT00805441|42039781|FG001|Overall Study|Lack of Efficacy|2|||
19591310|NCT00805441|42039780|FG000|Overall Study|Protocol Violation|4|||
19591311|NCT00805441|42039781|FG001|Overall Study|Protocol Violation|8|||
19591312|NCT00805441|42039780|FG000|Overall Study|Lost to Follow-up|10|||
19591313|NCT00805441|42039781|FG001|Overall Study|Lost to Follow-up|13|||
19591314|NCT00805441|42039780|FG000|Overall Study|Withdrawal by Subject|15|||
19591315|NCT00805441|42039781|FG001|Overall Study|Withdrawal by Subject|9|||
19591316|NCT00805441|42039780|FG000|Overall Study|Physician Decision|0|||
19591317|NCT00805441|42039781|FG001|Overall Study|Physician Decision|1|||
19591318|NCT00805441|42039780|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
19591319|NCT00805441|42039781|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
19591320|NCT00590317|42039789|FG000|Overall Study|Lack of Efficacy|1|||
19591321|NCT00590317|42039790|FG001|Overall Study|Lack of Efficacy|5|||
19591322|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
19591323|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
19591324|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
19591325|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
19591326|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
19591327|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
19591328|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
19591329|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
19591330|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
19591331|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
19591332|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
19591333|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
19591334|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
19591335|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
19591336|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
19591337|NCT01139762|42039799|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
19591338|NCT01139762|42039800|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
19591339|NCT01139762|42039801|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
19591340|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
19591341|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
19591342|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
19591343|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Death|0|||
19591344|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Death|1|||
19591345|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Death|1|||
19591346|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
19591347|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
19591348|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
19591349|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
19591350|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
19591351|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
19591352|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
19591353|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
19591354|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
19591355|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
19591356|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
19591357|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
19591358|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
19591359|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
19591360|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
19591361|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
19591362|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
19591363|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
19591364|NCT01139762|42039799|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
19591365|NCT01139762|42039800|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
19591366|NCT01139762|42039801|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
19591367|NCT00805285|42039808|FG000|Overall Study|Lack of Efficacy|1|||
19591368|NCT01139450|42039815|FG000|Overall Study|Withdrawal by Subject|7|||
19591369|NCT01139450|42039816|FG001|Overall Study|Withdrawal by Subject|10|||
19591370|NCT01139450|42039817|FG002|Overall Study|Withdrawal by Subject|13|||
19591371|NCT01139450|42039815|FG000|Overall Study|Lack of Efficacy|3|||
19591372|NCT01139450|42039816|FG001|Overall Study|Lack of Efficacy|1|||
19591373|NCT01139450|42039817|FG002|Overall Study|Lack of Efficacy|8|||
19591374|NCT01139450|42039815|FG000|Overall Study|Protocol Violation|6|||
19591375|NCT01139450|42039816|FG001|Overall Study|Protocol Violation|5|||
19591376|NCT01139450|42039817|FG002|Overall Study|Protocol Violation|2|||
19591377|NCT01139450|42039815|FG000|Overall Study|Lost to Follow-up|9|||
19591378|NCT01139450|42039816|FG001|Overall Study|Lost to Follow-up|7|||
19591379|NCT01139450|42039817|FG002|Overall Study|Lost to Follow-up|11|||
19591380|NCT01139450|42039815|FG000|Overall Study|Administrative|0|||
19591381|NCT01139450|42039816|FG001|Overall Study|Administrative|0|||
19591382|NCT01139450|42039817|FG002|Overall Study|Administrative|1|||
19591383|NCT01139450|42039815|FG000|Overall Study|Adverse Event|2|||
19591384|NCT01139450|42039816|FG001|Overall Study|Adverse Event|2|||
19591385|NCT01139450|42039817|FG002|Overall Study|Adverse Event|3|||
19591386|NCT00805207|42039834|FG000|Overall Study|Protocol Violation|0|||
19591387|NCT00805207|42039835|FG001|Overall Study|Protocol Violation|0|||
19591388|NCT00805207|42039836|FG002|Overall Study|Protocol Violation|1|||
19591389|NCT00805207|42039837|FG003|Overall Study|Protocol Violation|0|||
19591390|NCT00805207|42039838|FG004|Overall Study|Protocol Violation|0|||
19591391|NCT00805207|42039839|FG005|Overall Study|Protocol Violation|0|||
19591392|NCT00805207|42039840|FG006|Overall Study|Protocol Violation|0|||
19591393|NCT00805207|42039841|FG007|Overall Study|Protocol Violation|0|||
19591394|NCT00805207|42039842|FG008|Overall Study|Protocol Violation|0|||
19591395|NCT00805207|42039834|FG000|Overall Study|Physician Decision|0|||
19591396|NCT00805207|42039835|FG001|Overall Study|Physician Decision|1|||
19591397|NCT00805207|42039836|FG002|Overall Study|Physician Decision|0|||
19591398|NCT00805207|42039837|FG003|Overall Study|Physician Decision|0|||
19591399|NCT00805207|42039838|FG004|Overall Study|Physician Decision|0|||
19591400|NCT00805207|42039839|FG005|Overall Study|Physician Decision|1|||
19591401|NCT00805207|42039840|FG006|Overall Study|Physician Decision|0|||
19591402|NCT00805207|42039841|FG007|Overall Study|Physician Decision|0|||
19591403|NCT00805207|42039842|FG008|Overall Study|Physician Decision|0|||
19591404|NCT00805207|42039834|FG000|Overall Study|Withdrawal by Subject|0|||
19591405|NCT00805207|42039835|FG001|Overall Study|Withdrawal by Subject|1|||
19591406|NCT00805207|42039836|FG002|Overall Study|Withdrawal by Subject|0|||
19591407|NCT00805207|42039837|FG003|Overall Study|Withdrawal by Subject|0|||
19591408|NCT00805207|42039838|FG004|Overall Study|Withdrawal by Subject|1|||
19591409|NCT00805207|42039839|FG005|Overall Study|Withdrawal by Subject|2|||
19591410|NCT00805207|42039840|FG006|Overall Study|Withdrawal by Subject|0|||
19591411|NCT00805207|42039841|FG007|Overall Study|Withdrawal by Subject|0|||
19591412|NCT00805207|42039842|FG008|Overall Study|Withdrawal by Subject|0|||
19591413|NCT00805675|42039869|FG000|Overall Study|Adverse Event|0|||
19591414|NCT00805675|42039870|FG001|Overall Study|Adverse Event|0|||
19591415|NCT00805675|42039871|FG002|Overall Study|Adverse Event|1|||
19591416|NCT00589303|42039885|FG000|Overall Study|Withdrawal by Subject|2|||
19591417|NCT00589303|42039886|FG001|Overall Study|Withdrawal by Subject|1|||
19591418|NCT00952380|42039897|FG000|Overall Study|Other|0|||
19591419|NCT00952380|42039898|FG001|Overall Study|Other|0|||
19591420|NCT00952380|42039899|FG002|Overall Study|Other|0|||
19591421|NCT00952380|42039900|FG003|Overall Study|Other|0|||
19591422|NCT00952380|42039901|FG004|Overall Study|Other|1|||
19591423|NCT00952380|42039897|FG000|Overall Study|Withdrawal by Subject|0|||
19591424|NCT00952380|42039898|FG001|Overall Study|Withdrawal by Subject|0|||
19591425|NCT00952380|42039899|FG002|Overall Study|Withdrawal by Subject|1|||
19591426|NCT00952380|42039900|FG003|Overall Study|Withdrawal by Subject|0|||
19591427|NCT00952380|42039901|FG004|Overall Study|Withdrawal by Subject|2|||
19591428|NCT00952380|42039897|FG000|Overall Study|Adverse Event|0|||
19591429|NCT00952380|42039898|FG001|Overall Study|Adverse Event|1|||
19591430|NCT00952380|42039899|FG002|Overall Study|Adverse Event|0|||
19591431|NCT00952380|42039900|FG003|Overall Study|Adverse Event|0|||
19591432|NCT00952380|42039901|FG004|Overall Study|Adverse Event|3|||
19591433|NCT00952380|42039897|FG000|Overall Study|Physician Decision|0|||
19591434|NCT00952380|42039898|FG001|Overall Study|Physician Decision|0|||
19591435|NCT00952380|42039899|FG002|Overall Study|Physician Decision|1|||
19591436|NCT00952380|42039900|FG003|Overall Study|Physician Decision|2|||
19591437|NCT00952380|42039901|FG004|Overall Study|Physician Decision|0|||
19591438|NCT00952380|42039897|FG000|Overall Study|Non-compliant to protocol|0|||
19591439|NCT00952380|42039898|FG001|Overall Study|Non-compliant to protocol|0|||
19591440|NCT00952380|42039899|FG002|Overall Study|Non-compliant to protocol|0|||
19591441|NCT00952380|42039900|FG003|Overall Study|Non-compliant to protocol|1|||
19591442|NCT00952380|42039901|FG004|Overall Study|Non-compliant to protocol|0|||
19591443|NCT00803179|42039918|FG000|Overall Study|Lost to Follow-up|3|||
19591444|NCT00804193|42039925|FG000|Overall Study|Lack of baseline fungus|32|||
19591445|NCT00804193|42039926|FG001|Overall Study|Lack of baseline fungus|31|||
19591446|NCT00804193|42039927|FG002|Overall Study|Lack of baseline fungus|19|||
19591447|NCT00804193|42039925|FG000|Overall Study|Adverse Event|0|||
19591448|NCT00804193|42039926|FG001|Overall Study|Adverse Event|0|||
19591449|NCT00804193|42039927|FG002|Overall Study|Adverse Event|2|||
19591450|NCT00804193|42039925|FG000|Overall Study|Lack of Efficacy|1|||
19591451|NCT00804193|42039926|FG001|Overall Study|Lack of Efficacy|1|||
19591452|NCT00804193|42039927|FG002|Overall Study|Lack of Efficacy|3|||
19591453|NCT00804193|42039925|FG000|Overall Study|Protocol Violation|0|||
19591454|NCT00804193|42039926|FG001|Overall Study|Protocol Violation|8|||
19591455|NCT00804193|42039927|FG002|Overall Study|Protocol Violation|2|||
19591456|NCT00804193|42039925|FG000|Overall Study|Lost to Follow-up|3|||
19591457|NCT00804193|42039926|FG001|Overall Study|Lost to Follow-up|3|||
19591458|NCT00804193|42039927|FG002|Overall Study|Lost to Follow-up|4|||
19591459|NCT00804193|42039925|FG000|Overall Study|Withdrawal by Subject|3|||
19591460|NCT00804193|42039926|FG001|Overall Study|Withdrawal by Subject|1|||
19591461|NCT00804193|42039927|FG002|Overall Study|Withdrawal by Subject|2|||
19591462|NCT00957996|42039937|FG000|Overall Study|Death|4|||
19591463|NCT00957996|42039938|FG001|Overall Study|Death|10|||
19591464|NCT00957996|42039937|FG000|Overall Study|Lost to Follow-up|4|||
19591465|NCT00957996|42039938|FG001|Overall Study|Lost to Follow-up|7|||
19591466|NCT00957996|42039937|FG000|Overall Study|Withdrawal by Subject|9|||
19591467|NCT00957996|42039938|FG001|Overall Study|Withdrawal by Subject|2|||
19591468|NCT00957996|42039937|FG000|Overall Study|Adverse Event|2|||
19591469|NCT00957996|42039938|FG001|Overall Study|Adverse Event|1|||
19591470|NCT00957996|42039937|FG000|Overall Study|Physician Decision|1|||
19591471|NCT00957996|42039938|FG001|Overall Study|Physician Decision|1|||
19591472|NCT00957996|42039937|FG000|Overall Study|Influenza-related complication|0|||
19591473|NCT00957996|42039938|FG001|Overall Study|Influenza-related complication|1|||
19591474|NCT00957996|42039937|FG000|Overall Study|Missing|1|||
19591475|NCT00957996|42039938|FG001|Overall Study|Missing|0|||
19591476|NCT00957996|42039937|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
19591477|NCT00957996|42039938|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
19591478|NCT00589693|42039948|FG000|Overall Study|randomized in error|12|||
19591479|NCT00589693|42039949|FG001|Overall Study|randomized in error|6|||
19591480|NCT00589693|42039948|FG000|Overall Study|Adverse Event|4|||
19591481|NCT00589693|42039949|FG001|Overall Study|Adverse Event|4|||
19591482|NCT00589693|42039948|FG000|Overall Study|Death|26|||
19591483|NCT00589693|42039949|FG001|Overall Study|Death|16|||
19591484|NCT00589693|42039948|FG000|Overall Study|Lack of Efficacy|0|||
19591485|NCT00589693|42039949|FG001|Overall Study|Lack of Efficacy|1|||
19591486|NCT00589693|42039948|FG000|Overall Study|Lost to Follow-up|1|||
19591487|NCT00589693|42039949|FG001|Overall Study|Lost to Follow-up|0|||
19591488|NCT00589693|42039948|FG000|Overall Study|Physician Decision|0|||
19591489|NCT00589693|42039949|FG001|Overall Study|Physician Decision|1|||
19591490|NCT00589693|42039948|FG000|Overall Study|Protocol Violation|1|||
19591491|NCT00589693|42039949|FG001|Overall Study|Protocol Violation|1|||
19591492|NCT00803101|42039957|FG000|Overall Study|Death / Serious Adverse Event|4|||
19591493|NCT00803101|42039958|FG001|Overall Study|Death / Serious Adverse Event|6|||
19591494|NCT00803101|42039957|FG000|Overall Study|Withdrawal by Subject|6|||
19591495|NCT00803101|42039958|FG001|Overall Study|Withdrawal by Subject|4|||
19591496|NCT00803101|42039957|FG000|Overall Study|Lost to Follow-up|2|||
19591497|NCT00803101|42039958|FG001|Overall Study|Lost to Follow-up|2|||
19591498|NCT00803101|42039957|FG000|Overall Study|Protocol Violation|1|||
19591499|NCT00803101|42039958|FG001|Overall Study|Protocol Violation|7|||
19591500|NCT00803101|42039957|FG000|Overall Study|Surgery finished outside protocol window|1|||
19591501|NCT00803101|42039958|FG001|Overall Study|Surgery finished outside protocol window|1|||
19591502|NCT00803101|42039957|FG000|Overall Study|Patient died outside SAE report period|1|||
19591503|NCT00803101|42039958|FG001|Overall Study|Patient died outside SAE report period|0|||
19591504|NCT00803101|42039957|FG000|Overall Study|Patient did not attend scheduled visit|2|||
19591505|NCT00803101|42039958|FG001|Overall Study|Patient did not attend scheduled visit|1|||
19591506|NCT00803101|42039957|FG000|Overall Study|Patient did not have surgery|1|||
19591507|NCT00803101|42039958|FG001|Overall Study|Patient did not have surgery|1|||
19591508|NCT00801229|42039966|FG000|Signed Consent|Withdrawal by Subject|2|||
19591509|NCT00801229|42039967|FG001|Signed Consent|Withdrawal by Subject|2|||
19591510|NCT00801229|42039966|FG000|Signed Consent|Found Ineligible|1|||
19591511|NCT00801229|42039967|FG001|Signed Consent|Found Ineligible|1|||
19591512|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
19591513|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
19591514|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
19591515|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
19591516|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
19591517|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
19591518|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
19591519|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
19591520|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
19591521|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
19591522|NCT00801229|42039966|FG000|Received Study Drug/Placebo|Adverse Event|1|||
19591523|NCT00801229|42039967|FG001|Received Study Drug/Placebo|Adverse Event|1|||
19591524|NCT01964430|42039975|FG000|Overall Study|Adverse Event|71|||
19591525|NCT01964430|42039976|FG001|Overall Study|Adverse Event|37|||
19591526|NCT01964430|42039975|FG000|Overall Study|Withdrawal by Subject|36|||
19591527|NCT01964430|42039976|FG001|Overall Study|Withdrawal by Subject|27|||
19591528|NCT01964430|42039975|FG000|Overall Study|Death|1|||
19591529|NCT01964430|42039976|FG001|Overall Study|Death|3|||
19745963|NCT03529773|42193169|FG013|Overall Study|Physician Decision|0|||
19745964|NCT03529773|42193170|FG014|Overall Study|Physician Decision|0|||
19745965|NCT03529773|42193171|FG015|Overall Study|Physician Decision|0|||
19745966|NCT03529773|42193172|FG016|Overall Study|Physician Decision|0|||
19591530|NCT01964430|42039975|FG000|Overall Study|Protocol Deviation|0|||
19591531|NCT01964430|42039976|FG001|Overall Study|Protocol Deviation|1|||
19591532|NCT01964430|42039975|FG000|Overall Study|Physician Decision|5|||
19591533|NCT01964430|42039976|FG001|Overall Study|Physician Decision|4|||
19591534|NCT01964430|42039975|FG000|Overall Study|Disease Relapse|28|||
19591535|NCT01964430|42039976|FG001|Overall Study|Disease Relapse|38|||
19591536|NCT01964430|42039975|FG000|Overall Study|Miscellaneous|1|||
19591537|NCT01964430|42039976|FG001|Overall Study|Miscellaneous|3|||
19591538|NCT01964430|42039975|FG000|Overall Study|Randomized but not Treated|3|||
19591539|NCT01964430|42039976|FG001|Overall Study|Randomized but not Treated|11|||
19591540|NCT00948246|42039982|FG000|Overall Study|Lost to Follow-up|11|||
19591541|NCT00948246|42039982|FG000|Overall Study|Adverse Event|11|||
19745967|NCT03529773|42193173|FG017|Overall Study|Physician Decision|0|||
19745968|NCT03529773|42193174|FG018|Overall Study|Physician Decision|0|||
19745969|NCT03529773|42193175|FG019|Overall Study|Physician Decision|1|||
19745970|NCT03529773|42193176|FG020|Overall Study|Physician Decision|1|||
19745971|NCT03529773|42193177|FG021|Overall Study|Physician Decision|0|||
19745972|NCT03529773|42193178|FG022|Overall Study|Physician Decision|0|||
19745973|NCT03529773|42193179|FG023|Overall Study|Physician Decision|0|||
19745974|NCT03529773|42193180|FG024|Overall Study|Physician Decision|0|||
19591542|NCT00948246|42039982|FG000|Overall Study|Death|1|||
19591543|NCT00948246|42039982|FG000|Overall Study|Withdrawal by Subject|1|||
19591544|NCT00800683|42039988|FG000|Overall Study|Adverse Event|11|||
19591545|NCT00800683|42039989|FG001|Overall Study|Adverse Event|8|||
19591546|NCT00800683|42039988|FG000|Overall Study|Lost to Follow-up|3|||
19591547|NCT00800683|42039989|FG001|Overall Study|Lost to Follow-up|1|||
19591548|NCT00800683|42039988|FG000|Overall Study|Withdrawal by Subject|1|||
19591549|NCT00800683|42039989|FG001|Overall Study|Withdrawal by Subject|7|||
19591550|NCT00800683|42039988|FG000|Overall Study|Lack of Efficacy|1|||
19591551|NCT00800683|42039989|FG001|Overall Study|Lack of Efficacy|1|||
19591552|NCT00800683|42039988|FG000|Overall Study|Other|1|||
19591553|NCT00800683|42039989|FG001|Overall Study|Other|2|||
19591554|NCT01124864|42040001|FG000|Overall Study|Follow up phase competed as per protocol|18|||
19591555|NCT01124864|42040002|FG001|Overall Study|Follow up phase competed as per protocol|22|||
19591556|NCT01124864|42040003|FG002|Overall Study|Follow up phase competed as per protocol|24|||
19591557|NCT01124864|42040004|FG003|Overall Study|Follow up phase competed as per protocol|18|||
19591558|NCT01124864|42040005|FG004|Overall Study|Follow up phase competed as per protocol|26|||
19591559|NCT01124864|42040006|FG005|Overall Study|Follow up phase competed as per protocol|2|||
19745975|NCT03529773|42193181|FG025|Overall Study|Physician Decision|0|||
19591560|NCT01124864|42040001|FG000|Overall Study|Death|6|||
19591561|NCT01124864|42040002|FG001|Overall Study|Death|9|||
19591562|NCT01124864|42040003|FG002|Overall Study|Death|6|||
19591563|NCT01124864|42040004|FG003|Overall Study|Death|2|||
19591564|NCT01124864|42040005|FG004|Overall Study|Death|1|||
19591565|NCT01124864|42040006|FG005|Overall Study|Death|0|||
19591566|NCT01124864|42040001|FG000|Overall Study|Withdrawal by Subject|2|||
19591567|NCT01124864|42040002|FG001|Overall Study|Withdrawal by Subject|3|||
19591568|NCT01124864|42040003|FG002|Overall Study|Withdrawal by Subject|4|||
19591569|NCT01124864|42040004|FG003|Overall Study|Withdrawal by Subject|0|||
19591570|NCT01124864|42040005|FG004|Overall Study|Withdrawal by Subject|2|||
19591571|NCT01124864|42040006|FG005|Overall Study|Withdrawal by Subject|1|||
19591572|NCT01124864|42040001|FG000|Overall Study|Lost to Follow-up|1|||
19591573|NCT01124864|42040002|FG001|Overall Study|Lost to Follow-up|1|||
19591574|NCT01124864|42040003|FG002|Overall Study|Lost to Follow-up|0|||
19591575|NCT01124864|42040004|FG003|Overall Study|Lost to Follow-up|1|||
19591576|NCT01124864|42040005|FG004|Overall Study|Lost to Follow-up|0|||
19591577|NCT01124864|42040006|FG005|Overall Study|Lost to Follow-up|0|||
19591578|NCT01124864|42040001|FG000|Overall Study|Protocol Violation|1|||
19591579|NCT01124864|42040002|FG001|Overall Study|Protocol Violation|0|||
19591580|NCT01124864|42040003|FG002|Overall Study|Protocol Violation|0|||
19591581|NCT01124864|42040004|FG003|Overall Study|Protocol Violation|0|||
19591582|NCT01124864|42040005|FG004|Overall Study|Protocol Violation|1|||
19591583|NCT01124864|42040006|FG005|Overall Study|Protocol Violation|0|||
19591584|NCT01113710|42040022|FG000|Overall Study|Adverse Event|64|||
19591585|NCT01113710|42040022|FG000|Overall Study|Lack of Efficacy|41|||
19591586|NCT01113710|42040022|FG000|Overall Study|No Information Available|40|||
19591587|NCT01113710|42040022|FG000|Overall Study|Withdrawal by Subject|28|||
19591588|NCT01113710|42040022|FG000|Overall Study|Lost to Follow-up|20|||
19591589|NCT01113710|42040022|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
19591590|NCT01113710|42040022|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
19591591|NCT01113710|42040022|FG000|Overall Study|Lack of Patient's Compliance|8|||
19591592|NCT01113710|42040022|FG000|Overall Study|Other|7|||
19591593|NCT01113710|42040022|FG000|Overall Study|Adverse Event/Other|5|||
19591594|NCT01113710|42040022|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
19591595|NCT01113710|42040022|FG000|Overall Study|Lack of Efficacy/Other|4|||
19591596|NCT01113710|42040022|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
19591597|NCT01113710|42040022|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
19591598|NCT01113710|42040022|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
19591599|NCT01113710|42040022|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
19591600|NCT01113710|42040022|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
19591601|NCT01113710|42040022|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
19591602|NCT01113710|42040022|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
19591603|NCT01113710|42040022|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
19591604|NCT01113710|42040022|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
19591605|NCT01113710|42040022|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
19591606|NCT01113710|42040022|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
19591607|NCT01113710|42040022|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
19387985|NCT02038036|41631322|FG001|Core Study|Death|1|||
19591608|NCT01113710|42040022|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
19591609|NCT01124162|42040028|FG000|First Intervention|Adverse Event|2|||
19591610|NCT01124162|42040029|FG001|First Intervention|Adverse Event|0|||
19591611|NCT01124162|42040028|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19591612|NCT01124162|42040029|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19591613|NCT00906399|42040038|FG000|Year 1|Randomized But Not Treated|0|||
19591614|NCT00906399|42040039|FG001|Year 1|Randomized But Not Treated|1|||
19591615|NCT00906399|42040040|FG002|Year 1|Randomized But Not Treated|3|||
19745976|NCT03529773|42193182|FG026|Overall Study|Physician Decision|0|||
19745977|NCT03529773|42193183|FG027|Overall Study|Physician Decision|0|||
19745978|NCT03529773|42193184|FG028|Overall Study|Physician Decision|0|||
19745979|NCT03529773|42193185|FG029|Overall Study|Physician Decision|0|||
19745980|NCT03529773|42193186|FG030|Overall Study|Physician Decision|0|||
19745981|NCT03529773|42193187|FG031|Overall Study|Physician Decision|0|||
19745982|NCT03529773|42193188|FG032|Overall Study|Physician Decision|0|||
19745983|NCT03529773|42193189|FG033|Overall Study|Physician Decision|0|||
19745984|NCT03529773|42193190|FG034|Overall Study|Physician Decision|0|||
19745985|NCT03529773|42193191|FG035|Overall Study|Physician Decision|0|||
19745986|NCT03529773|42193192|FG036|Overall Study|Physician Decision|0|||
19745987|NCT03529773|42193193|FG037|Overall Study|Physician Decision|0|||
19745988|NCT03529773|42193194|FG038|Overall Study|Physician Decision|0|||
19745989|NCT03529773|42193195|FG039|Overall Study|Physician Decision|0|||
19745990|NCT03529773|42193156|FG000|Overall Study|Protocol Violation|0|||
19745991|NCT03529773|42193157|FG001|Overall Study|Protocol Violation|0|||
19745992|NCT03529773|42193158|FG002|Overall Study|Protocol Violation|0|||
19745993|NCT03529773|42193159|FG003|Overall Study|Protocol Violation|0|||
19745994|NCT03529773|42193160|FG004|Overall Study|Protocol Violation|0|||
19745995|NCT03529773|42193161|FG005|Overall Study|Protocol Violation|0|||
19591616|NCT00906399|42040041|FG003|Year 1|Randomized But Not Treated|0|||
19745996|NCT03529773|42193162|FG006|Overall Study|Protocol Violation|0|||
19745997|NCT03529773|42193163|FG007|Overall Study|Protocol Violation|0|||
19745998|NCT03529773|42193164|FG008|Overall Study|Protocol Violation|0|||
19745999|NCT03529773|42193165|FG009|Overall Study|Protocol Violation|0|||
19746000|NCT03529773|42193166|FG010|Overall Study|Protocol Violation|0|||
19746001|NCT03529773|42193167|FG011|Overall Study|Protocol Violation|0|||
19746002|NCT03529773|42193168|FG012|Overall Study|Protocol Violation|0|||
19746003|NCT03529773|42193169|FG013|Overall Study|Protocol Violation|0|||
19746004|NCT03529773|42193170|FG014|Overall Study|Protocol Violation|0|||
19591617|NCT00906399|42040042|FG004|Year 1|Randomized But Not Treated|0|||
19591618|NCT00906399|42040043|FG005|Year 1|Randomized But Not Treated|0|||
19591619|NCT00906399|42040044|FG006|Year 1|Randomized But Not Treated|0|||
19591620|NCT00906399|42040038|FG000|Year 1|Adverse Event|4|||
19591621|NCT00906399|42040039|FG001|Year 1|Adverse Event|22|||
19591622|NCT00906399|42040040|FG002|Year 1|Adverse Event|24|||
19591623|NCT00906399|42040041|FG003|Year 1|Adverse Event|0|||
19591624|NCT00906399|42040042|FG004|Year 1|Adverse Event|0|||
19591625|NCT00906399|42040043|FG005|Year 1|Adverse Event|0|||
19591626|NCT00906399|42040044|FG006|Year 1|Adverse Event|0|||
19591627|NCT00906399|42040038|FG000|Year 1|Lost to Follow-up|4|||
19591628|NCT00906399|42040039|FG001|Year 1|Lost to Follow-up|4|||
19591629|NCT00906399|42040040|FG002|Year 1|Lost to Follow-up|2|||
19591630|NCT00906399|42040041|FG003|Year 1|Lost to Follow-up|0|||
19591631|NCT00906399|42040042|FG004|Year 1|Lost to Follow-up|0|||
19591632|NCT00906399|42040043|FG005|Year 1|Lost to Follow-up|0|||
19591633|NCT00906399|42040044|FG006|Year 1|Lost to Follow-up|0|||
19591634|NCT00906399|42040038|FG000|Year 1|Withdrawal by Subject|30|||
19591635|NCT00906399|42040039|FG001|Year 1|Withdrawal by Subject|32|||
19591636|NCT00906399|42040040|FG002|Year 1|Withdrawal by Subject|36|||
19591637|NCT00906399|42040041|FG003|Year 1|Withdrawal by Subject|0|||
19591638|NCT00906399|42040042|FG004|Year 1|Withdrawal by Subject|0|||
19591639|NCT00906399|42040043|FG005|Year 1|Withdrawal by Subject|0|||
19591640|NCT00906399|42040044|FG006|Year 1|Withdrawal by Subject|0|||
19591641|NCT00906399|42040038|FG000|Year 1|Physician Decision|0|||
19591642|NCT00906399|42040039|FG001|Year 1|Physician Decision|1|||
19591643|NCT00906399|42040040|FG002|Year 1|Physician Decision|3|||
19591644|NCT00906399|42040041|FG003|Year 1|Physician Decision|0|||
19591645|NCT00906399|42040042|FG004|Year 1|Physician Decision|0|||
19591646|NCT00906399|42040043|FG005|Year 1|Physician Decision|0|||
19591647|NCT00906399|42040044|FG006|Year 1|Physician Decision|0|||
19591648|NCT00906399|42040038|FG000|Year 1|Death|2|||
19591649|NCT00906399|42040039|FG001|Year 1|Death|1|||
19591650|NCT00906399|42040040|FG002|Year 1|Death|1|||
19591651|NCT00906399|42040041|FG003|Year 1|Death|0|||
19591652|NCT00906399|42040042|FG004|Year 1|Death|0|||
19591653|NCT00906399|42040043|FG005|Year 1|Death|0|||
19591654|NCT00906399|42040044|FG006|Year 1|Death|0|||
19591655|NCT00906399|42040038|FG000|Year 1|Other|4|||
19746005|NCT03529773|42193171|FG015|Overall Study|Protocol Violation|0|||
19746006|NCT03529773|42193172|FG016|Overall Study|Protocol Violation|0|||
19591656|NCT00906399|42040039|FG001|Year 1|Other|2|||
19591657|NCT00906399|42040040|FG002|Year 1|Other|7|||
19591658|NCT00906399|42040041|FG003|Year 1|Other|0|||
19387986|NCT02038036|41631321|FG000|Core Study|Disease progression|2|||
19591659|NCT00906399|42040042|FG004|Year 1|Other|0|||
19591660|NCT00906399|42040043|FG005|Year 1|Other|0|||
19591661|NCT00906399|42040044|FG006|Year 1|Other|0|||
19591662|NCT00906399|42040038|FG000|Year 2|Adverse Event|0|||
19591663|NCT00906399|42040039|FG001|Year 2|Adverse Event|0|||
19591664|NCT00906399|42040040|FG002|Year 2|Adverse Event|0|||
19591665|NCT00906399|42040041|FG003|Year 2|Adverse Event|9|||
19591666|NCT00906399|42040042|FG004|Year 2|Adverse Event|8|||
19591667|NCT00906399|42040043|FG005|Year 2|Adverse Event|11|||
19591668|NCT00906399|42040044|FG006|Year 2|Adverse Event|6|||
19591669|NCT00906399|42040038|FG000|Year 2|Lost to Follow-up|0|||
19591670|NCT00906399|42040039|FG001|Year 2|Lost to Follow-up|0|||
19591671|NCT00906399|42040040|FG002|Year 2|Lost to Follow-up|0|||
19591672|NCT00906399|42040041|FG003|Year 2|Lost to Follow-up|1|||
19591673|NCT00906399|42040042|FG004|Year 2|Lost to Follow-up|4|||
19591674|NCT00906399|42040043|FG005|Year 2|Lost to Follow-up|2|||
19591675|NCT00906399|42040044|FG006|Year 2|Lost to Follow-up|4|||
19591676|NCT00906399|42040038|FG000|Year 2|Withdrawal by Subject|0|||
19591677|NCT00906399|42040039|FG001|Year 2|Withdrawal by Subject|0|||
19591678|NCT00906399|42040040|FG002|Year 2|Withdrawal by Subject|0|||
19591679|NCT00906399|42040041|FG003|Year 2|Withdrawal by Subject|17|||
19591680|NCT00906399|42040042|FG004|Year 2|Withdrawal by Subject|18|||
19591681|NCT00906399|42040043|FG005|Year 2|Withdrawal by Subject|27|||
19591682|NCT00906399|42040044|FG006|Year 2|Withdrawal by Subject|13|||
19591683|NCT00906399|42040038|FG000|Year 2|Physician Decision|0|||
19591684|NCT00906399|42040039|FG001|Year 2|Physician Decision|0|||
19591685|NCT00906399|42040040|FG002|Year 2|Physician Decision|0|||
19591686|NCT00906399|42040041|FG003|Year 2|Physician Decision|0|||
19591687|NCT00906399|42040042|FG004|Year 2|Physician Decision|2|||
19591688|NCT00906399|42040043|FG005|Year 2|Physician Decision|6|||
19591689|NCT00906399|42040044|FG006|Year 2|Physician Decision|3|||
19591690|NCT00906399|42040038|FG000|Year 2|Death|0|||
19591691|NCT00906399|42040039|FG001|Year 2|Death|0|||
19591692|NCT00906399|42040040|FG002|Year 2|Death|0|||
19591693|NCT00906399|42040041|FG003|Year 2|Death|1|||
19591694|NCT00906399|42040042|FG004|Year 2|Death|0|||
19591695|NCT00906399|42040043|FG005|Year 2|Death|0|||
19591696|NCT00906399|42040044|FG006|Year 2|Death|3|||
19591697|NCT00906399|42040038|FG000|Year 2|Other|0|||
19591698|NCT00906399|42040039|FG001|Year 2|Other|0|||
19591699|NCT00906399|42040040|FG002|Year 2|Other|0|||
19746007|NCT03529773|42193173|FG017|Overall Study|Protocol Violation|0|||
19746008|NCT03529773|42193174|FG018|Overall Study|Protocol Violation|0|||
19746009|NCT03529773|42193175|FG019|Overall Study|Protocol Violation|0|||
19591700|NCT00906399|42040041|FG003|Year 2|Other|2|||
19591701|NCT00906399|42040042|FG004|Year 2|Other|3|||
19591702|NCT00906399|42040043|FG005|Year 2|Other|1|||
19591703|NCT00906399|42040044|FG006|Year 2|Other|0|||
19591704|NCT01111838|42040056|FG000|Overall Study|Patient Ineligible|2|||
19591705|NCT01111838|42040056|FG000|Overall Study|Not Treated|3|||
19591706|NCT01111838|42040056|FG000|Overall Study|Clinical deterioration|1|||
19591707|NCT01111838|42040056|FG000|Overall Study|Other Complicating Disease|1|||
19591708|NCT00947856|42040062|FG000|Treatment Period|Progressive Disease|33|||
19591709|NCT00947856|42040063|FG001|Treatment Period|Progressive Disease|12|||
19591710|NCT00947856|42040062|FG000|Treatment Period|Adverse Event|15|||
19591711|NCT00947856|42040063|FG001|Treatment Period|Adverse Event|9|||
19591712|NCT00947856|42040062|FG000|Treatment Period|Physician Decision|14|||
19591713|NCT00947856|42040063|FG001|Treatment Period|Physician Decision|6|||
19591714|NCT00947856|42040062|FG000|Treatment Period|Study Stopped by Sponsor|4|||
19591715|NCT00947856|42040063|FG001|Treatment Period|Study Stopped by Sponsor|4|||
19591716|NCT00947856|42040062|FG000|Treatment Period|Withdrawal by Subject|12|||
19591717|NCT00947856|42040063|FG001|Treatment Period|Withdrawal by Subject|1|||
19591718|NCT00947856|42040062|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
19591719|NCT00947856|42040063|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
19591720|NCT00947856|42040062|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
19591721|NCT00947856|42040063|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
19591722|NCT00947856|42040062|FG000|Follow-up Period|Lost to Follow-up|7|||
19591723|NCT00947856|42040063|FG001|Follow-up Period|Lost to Follow-up|0|||
19591724|NCT00947856|42040062|FG000|Follow-up Period|Patient unavailable for site visits|1|||
19746010|NCT03529773|42193176|FG020|Overall Study|Protocol Violation|0|||
19591725|NCT00947856|42040063|FG001|Follow-up Period|Patient unavailable for site visits|0|||
19591726|NCT00947856|42040062|FG000|Follow-up Period|Withdrawal by Subject|1|||
19591727|NCT00947856|42040063|FG001|Follow-up Period|Withdrawal by Subject|0|||
19591728|NCT00947544|42040078|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
19591729|NCT00947544|42040079|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
19591730|NCT00907335|42040091|FG000|Overall Study|Withdrawal by Subject|2|||
19591731|NCT00907335|42040092|FG001|Overall Study|Withdrawal by Subject|0|||
19746011|NCT03529773|42193177|FG021|Overall Study|Protocol Violation|0|||
19591732|NCT00907335|42040091|FG000|Overall Study|Adverse Event|4|||
19591733|NCT00907335|42040092|FG001|Overall Study|Adverse Event|1|||
19591734|NCT00907335|42040091|FG000|Overall Study|Lost to Follow-up|2|||
19591735|NCT00907335|42040092|FG001|Overall Study|Lost to Follow-up|0|||
19746012|NCT03529773|42193178|FG022|Overall Study|Protocol Violation|0|||
19746013|NCT03529773|42193179|FG023|Overall Study|Protocol Violation|0|||
19746014|NCT03529773|42193180|FG024|Overall Study|Protocol Violation|0|||
19746015|NCT03529773|42193181|FG025|Overall Study|Protocol Violation|0|||
19746016|NCT03529773|42193182|FG026|Overall Study|Protocol Violation|0|||
19746017|NCT03529773|42193183|FG027|Overall Study|Protocol Violation|0|||
19591736|NCT00947154|42040098|FG000|Overall Study|Lost to Follow-up|1|||
19591737|NCT01124006|42040106|FG000|Overall Study|Withdrawal by Subject|2|||
19591738|NCT01124006|42040107|FG001|Overall Study|Withdrawal by Subject|2|||
19591739|NCT01124006|42040108|FG002|Overall Study|Withdrawal by Subject|0|||
19746018|NCT03529773|42193184|FG028|Overall Study|Protocol Violation|0|||
19591740|NCT01124006|42040106|FG000|Overall Study|Lost to Follow-up|1|||
19591741|NCT01124006|42040107|FG001|Overall Study|Lost to Follow-up|0|||
19746019|NCT03529773|42193185|FG029|Overall Study|Protocol Violation|0|||
19746020|NCT03529773|42193186|FG030|Overall Study|Protocol Violation|1|||
19746021|NCT03529773|42193187|FG031|Overall Study|Protocol Violation|0|||
19746022|NCT03529773|42193188|FG032|Overall Study|Protocol Violation|0|||
19591742|NCT01124006|42040108|FG002|Overall Study|Lost to Follow-up|1|||
19591743|NCT01124006|42040106|FG000|Overall Study|Other|0|||
19591744|NCT01124006|42040107|FG001|Overall Study|Other|0|||
19591745|NCT01124006|42040108|FG002|Overall Study|Other|1|||
19746023|NCT03529773|42193189|FG033|Overall Study|Protocol Violation|0|||
19746024|NCT03529773|42193190|FG034|Overall Study|Protocol Violation|0|||
19746025|NCT03529773|42193191|FG035|Overall Study|Protocol Violation|0|||
19746026|NCT03529773|42193192|FG036|Overall Study|Protocol Violation|0|||
19746027|NCT03529773|42193193|FG037|Overall Study|Protocol Violation|0|||
19746028|NCT03529773|42193194|FG038|Overall Study|Protocol Violation|0|||
19591746|NCT00952068|42040116|FG000|Overall Study|Adverse Event|3|||
19591747|NCT00952068|42040116|FG000|Overall Study|Withdrawal by Subject|4|||
19591748|NCT01123850|42040120|FG000|Overall Study|Slow enrollment|45|||
19591749|NCT01123382|42040126|FG000|Overall Study|Withdrawal by Subject|1|||
19591750|NCT01123382|42040127|FG001|Overall Study|Withdrawal by Subject|4|||
19591751|NCT01123382|42040126|FG000|Overall Study|Lost to Follow-up|1|||
19591752|NCT01123382|42040127|FG001|Overall Study|Lost to Follow-up|2|||
19591753|NCT00951912|42040136|FG000|Overall Study|Lack of Efficacy|1|||
19591754|NCT00951912|42040137|FG001|Overall Study|Lack of Efficacy|0|||
19591755|NCT00951912|42040138|FG002|Overall Study|Lack of Efficacy|0|||
19591756|NCT00951912|42040136|FG000|Overall Study|Adverse Event|0|||
19591757|NCT00951912|42040137|FG001|Overall Study|Adverse Event|1|||
19591758|NCT00951912|42040138|FG002|Overall Study|Adverse Event|1|||
19591759|NCT00951912|42040136|FG000|Overall Study|Lost to Follow-up|2|||
19591760|NCT00951912|42040137|FG001|Overall Study|Lost to Follow-up|2|||
19591761|NCT00951912|42040138|FG002|Overall Study|Lost to Follow-up|0|||
19591762|NCT00951912|42040136|FG000|Overall Study|Physician Decision|1|||
19591763|NCT00951912|42040137|FG001|Overall Study|Physician Decision|0|||
19591764|NCT00951912|42040138|FG002|Overall Study|Physician Decision|1|||
19591765|NCT00951912|42040136|FG000|Overall Study|Withdrawal by Subject|1|||
19591766|NCT00951912|42040137|FG001|Overall Study|Withdrawal by Subject|1|||
19591767|NCT00951912|42040138|FG002|Overall Study|Withdrawal by Subject|0|||
19591768|NCT00951912|42040136|FG000|Overall Study|Other:Depression|1|||
19591769|NCT00951912|42040137|FG001|Overall Study|Other:Depression|0|||
19591770|NCT00951912|42040138|FG002|Overall Study|Other:Depression|0|||
19591771|NCT00951912|42040136|FG000|Overall Study|Other: Colon cancer|1|||
19591772|NCT00951912|42040137|FG001|Overall Study|Other: Colon cancer|0|||
19591773|NCT00951912|42040138|FG002|Overall Study|Other: Colon cancer|0|||
19591774|NCT00951912|42040136|FG000|Overall Study|Other: Stroke|0|||
19591775|NCT00951912|42040137|FG001|Overall Study|Other: Stroke|1|||
19591776|NCT00951912|42040138|FG002|Overall Study|Other: Stroke|0|||
19591777|NCT01123148|42040146|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
19591778|NCT01123148|42040146|FG000|Overall Study|Didn't meet milestone criteria|1|||
19591779|NCT01123070|42040154|FG000|Part B Double Blind Period|Protocol Violation|0|||
19591780|NCT01123070|42040155|FG001|Part B Double Blind Period|Protocol Violation|0|||
19591781|NCT01123070|42040156|FG002|Part B Double Blind Period|Protocol Violation|0|||
19591782|NCT01123070|42040157|FG003|Part B Double Blind Period|Protocol Violation|1|||
19591783|NCT01123070|42040154|FG000|Part B Double Blind Period|Adverse Event|0|||
19591784|NCT01123070|42040155|FG001|Part B Double Blind Period|Adverse Event|0|||
19591785|NCT01123070|42040156|FG002|Part B Double Blind Period|Adverse Event|2|||
19746029|NCT03529773|42193195|FG039|Overall Study|Protocol Violation|0|||
19746030|NCT03529773|42193156|FG000|Overall Study|Withdrawal by Subject|0|||
19387987|NCT02038036|41631322|FG001|Core Study|Disease progression|2|||
19591786|NCT01123070|42040157|FG003|Part B Double Blind Period|Adverse Event|0|||
19591787|NCT01123070|42040154|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
19591788|NCT01123070|42040155|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
19591789|NCT01123070|42040156|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
19591790|NCT01123070|42040157|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
19746031|NCT03529773|42193157|FG001|Overall Study|Withdrawal by Subject|0|||
19591791|NCT01122680|42040168|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
19591792|NCT01122680|42040169|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
19746032|NCT03529773|42193158|FG002|Overall Study|Withdrawal by Subject|0|||
19746033|NCT03529773|42193159|FG003|Overall Study|Withdrawal by Subject|0|||
19746034|NCT03529773|42193160|FG004|Overall Study|Withdrawal by Subject|0|||
19746035|NCT03529773|42193161|FG005|Overall Study|Withdrawal by Subject|0|||
19746036|NCT03529773|42193162|FG006|Overall Study|Withdrawal by Subject|0|||
19746037|NCT03529773|42193163|FG007|Overall Study|Withdrawal by Subject|1|||
19746038|NCT03529773|42193164|FG008|Overall Study|Withdrawal by Subject|0|||
19746039|NCT03529773|42193165|FG009|Overall Study|Withdrawal by Subject|1|||
19746040|NCT03529773|42193166|FG010|Overall Study|Withdrawal by Subject|1|||
19746041|NCT03529773|42193167|FG011|Overall Study|Withdrawal by Subject|0|||
19746042|NCT03529773|42193168|FG012|Overall Study|Withdrawal by Subject|0|||
19746043|NCT03529773|42193169|FG013|Overall Study|Withdrawal by Subject|0|||
19746044|NCT03529773|42193170|FG014|Overall Study|Withdrawal by Subject|0|||
19746045|NCT03529773|42193171|FG015|Overall Study|Withdrawal by Subject|3|||
19746046|NCT03529773|42193172|FG016|Overall Study|Withdrawal by Subject|0|||
19746047|NCT03529773|42193173|FG017|Overall Study|Withdrawal by Subject|2|||
19746048|NCT03529773|42193174|FG018|Overall Study|Withdrawal by Subject|3|||
19746049|NCT03529773|42193175|FG019|Overall Study|Withdrawal by Subject|1|||
19746050|NCT03529773|42193176|FG020|Overall Study|Withdrawal by Subject|3|||
19746051|NCT03529773|42193177|FG021|Overall Study|Withdrawal by Subject|1|||
19746052|NCT03529773|42193178|FG022|Overall Study|Withdrawal by Subject|1|||
19746053|NCT03529773|42193179|FG023|Overall Study|Withdrawal by Subject|2|||
19746054|NCT03529773|42193180|FG024|Overall Study|Withdrawal by Subject|2|||
19746055|NCT03529773|42193181|FG025|Overall Study|Withdrawal by Subject|4|||
19746056|NCT03529773|42193182|FG026|Overall Study|Withdrawal by Subject|2|||
19746057|NCT03529773|42193183|FG027|Overall Study|Withdrawal by Subject|1|||
19746058|NCT03529773|42193184|FG028|Overall Study|Withdrawal by Subject|1|||
19746059|NCT03529773|42193185|FG029|Overall Study|Withdrawal by Subject|0|||
19746060|NCT03529773|42193186|FG030|Overall Study|Withdrawal by Subject|0|||
19746061|NCT03529773|42193187|FG031|Overall Study|Withdrawal by Subject|0|||
19746062|NCT03529773|42193188|FG032|Overall Study|Withdrawal by Subject|0|||
19746063|NCT03529773|42193189|FG033|Overall Study|Withdrawal by Subject|0|||
19746064|NCT03529773|42193190|FG034|Overall Study|Withdrawal by Subject|1|||
19746065|NCT03529773|42193191|FG035|Overall Study|Withdrawal by Subject|2|||
19746066|NCT03529773|42193192|FG036|Overall Study|Withdrawal by Subject|0|||
19746067|NCT03529773|42193193|FG037|Overall Study|Withdrawal by Subject|2|||
19746068|NCT03529773|42193194|FG038|Overall Study|Withdrawal by Subject|1|||
19746069|NCT03529773|42193195|FG039|Overall Study|Withdrawal by Subject|1|||
19746070|NCT03529773|42193156|FG000|Overall Study|Screen Failure|0|||
19746071|NCT03529773|42193157|FG001|Overall Study|Screen Failure|0|||
19746072|NCT03529773|42193158|FG002|Overall Study|Screen Failure|0|||
19746073|NCT03529773|42193159|FG003|Overall Study|Screen Failure|0|||
19746074|NCT03529773|42193160|FG004|Overall Study|Screen Failure|0|||
19746075|NCT03529773|42193161|FG005|Overall Study|Screen Failure|0|||
19746076|NCT03529773|42193162|FG006|Overall Study|Screen Failure|0|||
19746077|NCT03529773|42193163|FG007|Overall Study|Screen Failure|0|||
19746078|NCT03529773|42193164|FG008|Overall Study|Screen Failure|0|||
19591793|NCT01122680|42040170|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
19591794|NCT01122680|42040171|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
19591795|NCT01122680|42040168|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
19591796|NCT01122680|42040169|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
19591797|NCT01122680|42040170|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
19591798|NCT01122680|42040171|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
19591799|NCT01122680|42040168|FG000|Period 1 (4 Weeks)|Other|1|||
19591800|NCT01122680|42040169|FG001|Period 1 (4 Weeks)|Other|1|||
19591801|NCT01122680|42040170|FG002|Period 1 (4 Weeks)|Other|0|||
19591802|NCT01122680|42040171|FG003|Period 1 (4 Weeks)|Other|0|||
19591803|NCT01122680|42040168|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
19591804|NCT01122680|42040169|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
19591805|NCT01122680|42040170|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
19591806|NCT01122680|42040171|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
19591807|NCT01122680|42040168|FG000|Period 2 (4 Weeks)|Other|1|||
19591808|NCT01122680|42040169|FG001|Period 2 (4 Weeks)|Other|0|||
19591809|NCT01122680|42040170|FG002|Period 2 (4 Weeks)|Other|0|||
19591810|NCT01122680|42040171|FG003|Period 2 (4 Weeks)|Other|0|||
19591811|NCT01122680|42040168|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
19591812|NCT01122680|42040169|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
19591813|NCT01122680|42040170|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
19746079|NCT03529773|42193165|FG009|Overall Study|Screen Failure|0|||
19746080|NCT03529773|42193166|FG010|Overall Study|Screen Failure|0|||
19746081|NCT03529773|42193167|FG011|Overall Study|Screen Failure|0|||
19746082|NCT03529773|42193168|FG012|Overall Study|Screen Failure|0|||
19746083|NCT03529773|42193169|FG013|Overall Study|Screen Failure|0|||
19746084|NCT03529773|42193170|FG014|Overall Study|Screen Failure|0|||
19591814|NCT01122680|42040171|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
19591815|NCT01122680|42040168|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19591816|NCT01122680|42040169|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
19746085|NCT03529773|42193171|FG015|Overall Study|Screen Failure|0|||
19591817|NCT01122680|42040170|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19746086|NCT03529773|42193172|FG016|Overall Study|Screen Failure|0|||
19746087|NCT03529773|42193173|FG017|Overall Study|Screen Failure|0|||
19591818|NCT01122680|42040171|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
19591819|NCT00946998|42040183|FG000|Overall Study|Exited prior to first outcome assessment|5|||
19591820|NCT00946998|42040184|FG001|Overall Study|Exited prior to first outcome assessment|3|||
19591821|NCT01138826|42040190|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
19591822|NCT01138826|42040191|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
19591823|NCT01138826|42040192|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
19591824|NCT01138826|42040193|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
19591825|NCT01138826|42040194|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
19591826|NCT01138826|42040195|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
19591827|NCT00906087|42040203|FG000|Initial Washout|Withdrawal by Subject|1|||
19591828|NCT00906087|42040203|FG000|Initial Washout|Physician Decision|1|||
19591829|NCT00907257|42040212|FG000|Overall Study|Adverse Event|0|||
19591830|NCT00907257|42040213|FG001|Overall Study|Adverse Event|4|||
19591831|NCT00907257|42040212|FG000|Overall Study|Protocol Violation|1|||
19591832|NCT00907257|42040213|FG001|Overall Study|Protocol Violation|2|||
19591833|NCT00907257|42040212|FG000|Overall Study|Lost to Follow-up|3|||
19591834|NCT00907257|42040213|FG001|Overall Study|Lost to Follow-up|3|||
19591835|NCT00907257|42040212|FG000|Overall Study|Withdrawal by Subject|1|||
19591836|NCT00907257|42040213|FG001|Overall Study|Withdrawal by Subject|2|||
19591837|NCT00907257|42040212|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
19591838|NCT00907257|42040213|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
19591839|NCT00907257|42040212|FG000|Overall Study|Moved|1|||
19591840|NCT00907257|42040213|FG001|Overall Study|Moved|0|||
19591841|NCT00907257|42040212|FG000|Overall Study|Personal Reasons|6|||
19591842|NCT00907257|42040213|FG001|Overall Study|Personal Reasons|1|||
19591843|NCT01138046|42040219|FG000|Overall Study|Withdrawal due to death|6|||
19591844|NCT00876460|42040231|FG000|Combination Therapy Phase|Progressive disease|2|||
19591845|NCT00876460|42040232|FG001|Combination Therapy Phase|Progressive disease|3|||
19591846|NCT00876460|42040233|FG002|Combination Therapy Phase|Progressive disease|3|||
19591847|NCT00876460|42040234|FG003|Combination Therapy Phase|Progressive disease|3|||
19591848|NCT00876460|42040235|FG004|Combination Therapy Phase|Progressive disease|3|||
19591849|NCT00876460|42040236|FG005|Combination Therapy Phase|Progressive disease|1|||
19591850|NCT00876460|42040237|FG006|Combination Therapy Phase|Progressive disease|1|||
19591851|NCT00876460|42040238|FG007|Combination Therapy Phase|Progressive disease|1|||
19591852|NCT00876460|42040231|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
19591853|NCT00876460|42040232|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
19591854|NCT00876460|42040233|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
19591855|NCT00876460|42040234|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
19591856|NCT00876460|42040235|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
19591857|NCT00876460|42040236|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
19591858|NCT00876460|42040237|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
19591859|NCT00876460|42040238|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
19591860|NCT00876460|42040231|FG000|Combination Therapy Phase|Adverse Event|0|||
19591861|NCT00876460|42040232|FG001|Combination Therapy Phase|Adverse Event|2|||
19591862|NCT00876460|42040233|FG002|Combination Therapy Phase|Adverse Event|0|||
19591863|NCT00876460|42040234|FG003|Combination Therapy Phase|Adverse Event|2|||
19591864|NCT00876460|42040235|FG004|Combination Therapy Phase|Adverse Event|2|||
19591865|NCT00876460|42040236|FG005|Combination Therapy Phase|Adverse Event|0|||
19746088|NCT03529773|42193174|FG018|Overall Study|Screen Failure|0|||
19591866|NCT00876460|42040237|FG006|Combination Therapy Phase|Adverse Event|3|||
19591867|NCT00876460|42040238|FG007|Combination Therapy Phase|Adverse Event|2|||
19591868|NCT00876460|42040231|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
19591869|NCT00876460|42040232|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
19591870|NCT00876460|42040233|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
19746089|NCT03529773|42193175|FG019|Overall Study|Screen Failure|0|||
19591871|NCT00876460|42040234|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
19591872|NCT00876460|42040235|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
19591873|NCT00876460|42040236|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
19591874|NCT00876460|42040237|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
19591875|NCT00876460|42040238|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
19591876|NCT00876460|42040231|FG000|Combination Therapy Phase|Other reason not defined above|0|||
19591877|NCT00876460|42040232|FG001|Combination Therapy Phase|Other reason not defined above|0|||
19591878|NCT00876460|42040233|FG002|Combination Therapy Phase|Other reason not defined above|0|||
19591879|NCT00876460|42040234|FG003|Combination Therapy Phase|Other reason not defined above|0|||
19591880|NCT00876460|42040235|FG004|Combination Therapy Phase|Other reason not defined above|0|||
19591881|NCT00876460|42040236|FG005|Combination Therapy Phase|Other reason not defined above|0|||
19746090|NCT03529773|42193176|FG020|Overall Study|Screen Failure|0|||
19746091|NCT03529773|42193177|FG021|Overall Study|Screen Failure|0|||
19746092|NCT03529773|42193178|FG022|Overall Study|Screen Failure|0|||
19746093|NCT03529773|42193179|FG023|Overall Study|Screen Failure|0|||
19746094|NCT03529773|42193180|FG024|Overall Study|Screen Failure|0|||
19746095|NCT03529773|42193181|FG025|Overall Study|Screen Failure|0|||
19746096|NCT03529773|42193182|FG026|Overall Study|Screen Failure|0|||
19746097|NCT03529773|42193183|FG027|Overall Study|Screen Failure|0|||
19746098|NCT03529773|42193184|FG028|Overall Study|Screen Failure|0|||
19746099|NCT03529773|42193185|FG029|Overall Study|Screen Failure|0|||
19746100|NCT03529773|42193186|FG030|Overall Study|Screen Failure|0|||
19746101|NCT03529773|42193187|FG031|Overall Study|Screen Failure|0|||
19746102|NCT03529773|42193188|FG032|Overall Study|Screen Failure|0|||
19746103|NCT03529773|42193189|FG033|Overall Study|Screen Failure|0|||
19746104|NCT03529773|42193190|FG034|Overall Study|Screen Failure|0|||
19746105|NCT03529773|42193191|FG035|Overall Study|Screen Failure|0|||
19591882|NCT00876460|42040237|FG006|Combination Therapy Phase|Other reason not defined above|1|||
19591883|NCT00876460|42040238|FG007|Combination Therapy Phase|Other reason not defined above|2|||
19591884|NCT00876460|42040231|FG000|Combination Therapy Phase|Not treated|0|||
19746106|NCT03529773|42193192|FG036|Overall Study|Screen Failure|1|||
19746107|NCT03529773|42193193|FG037|Overall Study|Screen Failure|1|||
19746108|NCT03529773|42193194|FG038|Overall Study|Screen Failure|0|||
19746109|NCT03529773|42193195|FG039|Overall Study|Screen Failure|1|||
19746110|NCT03529773|42193156|FG000|Overall Study|Randomized but not vaccinated|0|||
19746111|NCT03529773|42193157|FG001|Overall Study|Randomized but not vaccinated|0|||
19746112|NCT03529773|42193158|FG002|Overall Study|Randomized but not vaccinated|0|||
19746113|NCT03529773|42193159|FG003|Overall Study|Randomized but not vaccinated|0|||
19746114|NCT03529773|42193160|FG004|Overall Study|Randomized but not vaccinated|0|||
19746115|NCT03529773|42193161|FG005|Overall Study|Randomized but not vaccinated|0|||
19746116|NCT03529773|42193162|FG006|Overall Study|Randomized but not vaccinated|0|||
19746117|NCT03529773|42193163|FG007|Overall Study|Randomized but not vaccinated|0|||
19746118|NCT03529773|42193164|FG008|Overall Study|Randomized but not vaccinated|0|||
19746119|NCT03529773|42193165|FG009|Overall Study|Randomized but not vaccinated|0|||
19746120|NCT03529773|42193166|FG010|Overall Study|Randomized but not vaccinated|0|||
19746121|NCT03529773|42193167|FG011|Overall Study|Randomized but not vaccinated|0|||
19746122|NCT03529773|42193168|FG012|Overall Study|Randomized but not vaccinated|0|||
19746123|NCT03529773|42193169|FG013|Overall Study|Randomized but not vaccinated|0|||
19746124|NCT03529773|42193170|FG014|Overall Study|Randomized but not vaccinated|0|||
19746125|NCT03529773|42193171|FG015|Overall Study|Randomized but not vaccinated|0|||
19591885|NCT00876460|42040232|FG001|Combination Therapy Phase|Not treated|0|||
19591886|NCT00876460|42040233|FG002|Combination Therapy Phase|Not treated|0|||
19591887|NCT00876460|42040234|FG003|Combination Therapy Phase|Not treated|0|||
19591888|NCT00876460|42040235|FG004|Combination Therapy Phase|Not treated|0|||
19591889|NCT00876460|42040236|FG005|Combination Therapy Phase|Not treated|0|||
19746126|NCT03529773|42193172|FG016|Overall Study|Randomized but not vaccinated|0|||
19746127|NCT03529773|42193173|FG017|Overall Study|Randomized but not vaccinated|1|||
19746128|NCT03529773|42193174|FG018|Overall Study|Randomized but not vaccinated|0|||
19591890|NCT00876460|42040237|FG006|Combination Therapy Phase|Not treated|1|||
19591891|NCT00876460|42040238|FG007|Combination Therapy Phase|Not treated|0|||
19591892|NCT00876460|42040231|FG000|Mono Therapy Phase|Progressive disease|0|||
19591893|NCT00876460|42040232|FG001|Mono Therapy Phase|Progressive disease|0|||
19591894|NCT00876460|42040233|FG002|Mono Therapy Phase|Progressive disease|0|||
19591895|NCT00876460|42040234|FG003|Mono Therapy Phase|Progressive disease|0|||
19591896|NCT00876460|42040235|FG004|Mono Therapy Phase|Progressive disease|2|||
19591897|NCT00876460|42040236|FG005|Mono Therapy Phase|Progressive disease|0|||
19591898|NCT00876460|42040237|FG006|Mono Therapy Phase|Progressive disease|1|||
19591899|NCT00876460|42040238|FG007|Mono Therapy Phase|Progressive disease|3|||
19591900|NCT00876460|42040231|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
19591901|NCT00876460|42040232|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
19591902|NCT00876460|42040233|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
19591903|NCT00876460|42040234|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
19591904|NCT00876460|42040235|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
19591905|NCT00876460|42040236|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
19591906|NCT00876460|42040237|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
19591907|NCT00876460|42040238|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
19591908|NCT00876460|42040231|FG000|Mono Therapy Phase|Adverse Event|0|||
19591909|NCT00876460|42040232|FG001|Mono Therapy Phase|Adverse Event|0|||
19591910|NCT00876460|42040233|FG002|Mono Therapy Phase|Adverse Event|0|||
19591911|NCT00876460|42040234|FG003|Mono Therapy Phase|Adverse Event|1|||
19591912|NCT00876460|42040235|FG004|Mono Therapy Phase|Adverse Event|0|||
19591913|NCT00876460|42040236|FG005|Mono Therapy Phase|Adverse Event|0|||
19746129|NCT03529773|42193175|FG019|Overall Study|Randomized but not vaccinated|0|||
19591914|NCT00876460|42040237|FG006|Mono Therapy Phase|Adverse Event|0|||
19591915|NCT00876460|42040238|FG007|Mono Therapy Phase|Adverse Event|0|||
19591916|NCT00908115|42040268|FG000|Overall Study|Other|14|||
19591917|NCT01137812|42040274|FG000|Overall Study|Adverse Event|21|||
19591918|NCT01137812|42040275|FG001|Overall Study|Adverse Event|14|||
19591919|NCT01137812|42040274|FG000|Overall Study|Lost to Follow-up|6|||
19591920|NCT01137812|42040275|FG001|Overall Study|Lost to Follow-up|8|||
19591921|NCT01137812|42040274|FG000|Overall Study|Physician Decision|25|||
19591922|NCT01137812|42040275|FG001|Overall Study|Physician Decision|17|||
19591923|NCT01137812|42040274|FG000|Overall Study|Protocol Violation|5|||
19591924|NCT01137812|42040275|FG001|Overall Study|Protocol Violation|4|||
19591925|NCT01137812|42040274|FG000|Overall Study|Withdrawal by Subject|5|||
19591926|NCT01137812|42040275|FG001|Overall Study|Withdrawal by Subject|13|||
19591927|NCT01137812|42040274|FG000|Overall Study|Death|2|||
19591928|NCT01137812|42040275|FG001|Overall Study|Death|0|||
19591929|NCT01137812|42040274|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
19591930|NCT01137812|42040275|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
19591931|NCT01137812|42040274|FG000|Overall Study|Other|19|||
19591932|NCT01137812|42040275|FG001|Overall Study|Other|27|||
19591933|NCT01137578|42040281|FG000|Overall Study|Participant requested to Discontinue|3|||
19591934|NCT01137578|42040282|FG001|Overall Study|Participant requested to Discontinue|0|||
19591935|NCT01137578|42040283|FG002|Overall Study|Participant requested to Discontinue|0|||
19591936|NCT01137578|42040281|FG000|Overall Study|Withdrawal by Subject|1|||
19591937|NCT01137578|42040282|FG001|Overall Study|Withdrawal by Subject|0|||
19591938|NCT01137578|42040283|FG002|Overall Study|Withdrawal by Subject|0|||
19591939|NCT01137578|42040281|FG000|Overall Study|Other|12|||
19591940|NCT01137578|42040282|FG001|Overall Study|Other|2|||
19591941|NCT01137578|42040283|FG002|Overall Study|Other|6|||
19591942|NCT00946920|42040313|FG000|Overall Study|Withdrawal by Subject|28|||
19591943|NCT00946920|42040314|FG001|Overall Study|Withdrawal by Subject|15|||
19591944|NCT00946920|42040313|FG000|Overall Study|Lost to Follow-up|2|||
19591945|NCT00946920|42040314|FG001|Overall Study|Lost to Follow-up|2|||
19591946|NCT00946920|42040313|FG000|Overall Study|Physician Decision|5|||
19591947|NCT00946920|42040314|FG001|Overall Study|Physician Decision|2|||
19591948|NCT00946920|42040313|FG000|Overall Study|Adverse Event|41|||
19591949|NCT00946920|42040314|FG001|Overall Study|Adverse Event|14|||
19591950|NCT00946920|42040313|FG000|Overall Study|Protocol Violation|16|||
19591951|NCT00946920|42040314|FG001|Overall Study|Protocol Violation|8|||
19591952|NCT00946920|42040313|FG000|Overall Study|Miscellaneous reasons|18|||
19591953|NCT00946920|42040314|FG001|Overall Study|Miscellaneous reasons|3|||
19591954|NCT00946530|42040324|FG000|Overall Study|Withdrawal by Subject|0|||
19591955|NCT00946530|42040325|FG001|Overall Study|Withdrawal by Subject|3|||
19591956|NCT00946530|42040326|FG002|Overall Study|Withdrawal by Subject|0|||
19591957|NCT00946530|42040327|FG003|Overall Study|Withdrawal by Subject|3|||
19591958|NCT00946530|42040324|FG000|Overall Study|Physician Decision|1|||
19591959|NCT00946530|42040325|FG001|Overall Study|Physician Decision|1|||
19591960|NCT00946530|42040326|FG002|Overall Study|Physician Decision|1|||
19591961|NCT00946530|42040327|FG003|Overall Study|Physician Decision|1|||
19591962|NCT00946296|42040343|FG000|Overall Study|Physician Decision|3|||
19591963|NCT00946296|42040344|FG001|Overall Study|Physician Decision|0|||
19591964|NCT00945906|42040350|FG000|Overall Study|Withdrawal by Subject|1|||
19591965|NCT00945906|42040350|FG000|Overall Study|Did not want to return for last visit|2|||
19591966|NCT00945906|42040350|FG000|Overall Study|Unable to return for last visit|2|||
19591967|NCT00945906|42040350|FG000|Overall Study|Moved to another country|2|||
19591968|NCT00594646|42040354|FG000|Overall Study|Withdrawal by Subject|1|||
19591969|NCT00594646|42040354|FG000|Overall Study|Lost to Follow-up|15|||
19591970|NCT01111604|42040362|FG000|Overall Study|Lost to Follow-up|0|||
19591971|NCT01111604|42040363|FG001|Overall Study|Lost to Follow-up|0|||
19591972|NCT01111604|42040364|FG002|Overall Study|Lost to Follow-up|1|||
19591973|NCT01111604|42040362|FG000|Overall Study|Withdrew Consent|3|||
19591974|NCT01111604|42040363|FG001|Overall Study|Withdrew Consent|0|||
19591975|NCT01111604|42040364|FG002|Overall Study|Withdrew Consent|2|||
19591976|NCT01111604|42040362|FG000|Overall Study|Withdrawal by Subject|2|||
19591977|NCT01111604|42040363|FG001|Overall Study|Withdrawal by Subject|0|||
19591978|NCT01111604|42040364|FG002|Overall Study|Withdrawal by Subject|0|||
19591979|NCT01111604|42040362|FG000|Overall Study|Death|1|||
19591980|NCT01111604|42040363|FG001|Overall Study|Death|0|||
19591981|NCT01111604|42040364|FG002|Overall Study|Death|0|||
19591982|NCT01111604|42040362|FG000|Overall Study|Met Exclusion Criteria|2|||
19591983|NCT01111604|42040363|FG001|Overall Study|Met Exclusion Criteria|0|||
19591984|NCT01111604|42040364|FG002|Overall Study|Met Exclusion Criteria|0|||
19591985|NCT00950742|42040392|FG000|Overall Study|Other Adverse Event|1|||
19591986|NCT00950742|42040393|FG001|Overall Study|Other Adverse Event|0|||
19591987|NCT00950742|42040392|FG000|Overall Study|Withdrawal by Subject|3|||
19591988|NCT00950742|42040393|FG001|Overall Study|Withdrawal by Subject|0|||
19591989|NCT00950742|42040392|FG000|Overall Study|Progressive Disease|6|||
19591990|NCT00950742|42040393|FG001|Overall Study|Progressive Disease|2|||
19591991|NCT00950742|42040392|FG000|Overall Study|Dose limiting toxicity|6|||
19591992|NCT00950742|42040393|FG001|Overall Study|Dose limiting toxicity|0|||
19591993|NCT00955110|42040403|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
19591994|NCT00955110|42040403|FG000|Treatment Phase|Adverse Event|2|||
19591995|NCT00955110|42040403|FG000|Treatment Phase|Administrative reasons|2|||
19591996|NCT00955110|42040403|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
19591997|NCT00955110|42040403|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
19591998|NCT00950664|42040417|FG000|First Intervention|Lost to Follow-up|1|||
19591999|NCT00950664|42040418|FG001|First Intervention|Lost to Follow-up|3|||
19592000|NCT00950664|42040417|FG000|First Intervention|Withdrawal by Subject|2|||
19592001|NCT00950664|42040418|FG001|First Intervention|Withdrawal by Subject|2|||
19592002|NCT01111526|42040424|FG000|Overall Study|GVHD Disease Progression|0|||
19592003|NCT01111526|42040425|FG001|Overall Study|GVHD Disease Progression|1|||
19592004|NCT01111526|42040426|FG002|Overall Study|GVHD Disease Progression|2|||
19592005|NCT01111292|42040432|FG000|Treatment|Physician Decision|1|||
19592006|NCT01111292|42040433|FG001|Treatment|Physician Decision|1|||
19592007|NCT00944658|42040441|FG000|Treatment 12 Weeks|Adverse Event|0|||
19592008|NCT00944658|42040442|FG001|Treatment 12 Weeks|Adverse Event|2|||
19592009|NCT01110200|42040450|FG000|Overall Study|Adverse Event|28|||
19592010|NCT01110200|42040451|FG001|Overall Study|Adverse Event|28|||
19592011|NCT01110200|42040450|FG000|Overall Study|Withdrawal by Subject|25|||
19592012|NCT01110200|42040451|FG001|Overall Study|Withdrawal by Subject|32|||
19592013|NCT01110200|42040450|FG000|Overall Study|Lack of Efficacy|16|||
19592014|NCT01110200|42040451|FG001|Overall Study|Lack of Efficacy|25|||
19592015|NCT01110200|42040450|FG000|Overall Study|Protocol Violation|14|||
19592016|NCT01110200|42040451|FG001|Overall Study|Protocol Violation|12|||
19592017|NCT01110200|42040450|FG000|Overall Study|Physician Decision|13|||
19592018|NCT01110200|42040451|FG001|Overall Study|Physician Decision|17|||
19592019|NCT01110200|42040450|FG000|Overall Study|Lost to Follow-up|10|||
19592020|NCT01110200|42040451|FG001|Overall Study|Lost to Follow-up|7|||
19592021|NCT01108796|42040461|FG000|Overall Study|Adverse Event|0|||
19592022|NCT01108796|42040462|FG001|Overall Study|Adverse Event|1|||
19592023|NCT01108796|42040461|FG000|Overall Study|Lost to Follow-up|7|||
19592024|NCT01108796|42040462|FG001|Overall Study|Lost to Follow-up|6|||
19592025|NCT01108718|42040472|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
19592026|NCT01108718|42040473|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
19592027|NCT01137110|42040480|FG000|Overall Study|Protocol Violation|1|||
19592028|NCT01137110|42040481|FG001|Overall Study|Protocol Violation|0|||
19592029|NCT01136954|42040489|FG000|Overall Study|Adverse Event|3|||
19592030|NCT01136954|42040490|FG001|Overall Study|Adverse Event|2|||
19592031|NCT01136954|42040489|FG000|Overall Study|Withdrawal by Subject|6|||
19592032|NCT01136954|42040490|FG001|Overall Study|Withdrawal by Subject|2|||
19592033|NCT01136954|42040489|FG000|Overall Study|Lack of Efficacy|14|||
19592034|NCT01136954|42040490|FG001|Overall Study|Lack of Efficacy|13|||
19592035|NCT01136954|42040489|FG000|Overall Study|Physician Decision|0|||
19592036|NCT01136954|42040490|FG001|Overall Study|Physician Decision|1|||
19592037|NCT01136954|42040489|FG000|Overall Study|Other|1|||
19592038|NCT01136954|42040490|FG001|Overall Study|Other|3|||
19592039|NCT01136876|42040499|FG000|Overall Study|Lost to Follow-up|0|||
19592040|NCT01136876|42040500|FG001|Overall Study|Lost to Follow-up|1|||
19592041|NCT01136876|42040499|FG000|Overall Study|Physician Decision|3|||
19592042|NCT01136876|42040500|FG001|Overall Study|Physician Decision|5|||
19592043|NCT01136876|42040499|FG000|Overall Study|Missing NGAL measurement|2|||
19592044|NCT01136876|42040500|FG001|Overall Study|Missing NGAL measurement|5|||
19592045|NCT01105130|42040511|FG000|Overall Study|Withdrawal by Subject|4|||
19592046|NCT01105130|42040512|FG001|Overall Study|Withdrawal by Subject|6|||
19746130|NCT03529773|42193176|FG020|Overall Study|Randomized but not vaccinated|0|||
19592047|NCT01105130|42040513|FG002|Overall Study|Withdrawal by Subject|2|||
19592048|NCT01105130|42040511|FG000|Overall Study|Never Started|2|||
19592049|NCT01105130|42040512|FG001|Overall Study|Never Started|2|||
19592050|NCT01105130|42040513|FG002|Overall Study|Never Started|4|||
19592051|NCT01105130|42040511|FG000|Overall Study|Toxicity|1|||
19592052|NCT01105130|42040512|FG001|Overall Study|Toxicity|3|||
19592053|NCT01105130|42040513|FG002|Overall Study|Toxicity|2|||
19592054|NCT01105130|42040511|FG000|Overall Study|Multiple Reasons|3|||
19592055|NCT01105130|42040512|FG001|Overall Study|Multiple Reasons|0|||
19592056|NCT01105130|42040513|FG002|Overall Study|Multiple Reasons|2|||
19592057|NCT01108094|42040525|FG000|Overall Study|Adverse Event|2|||
19592058|NCT01108094|42040526|FG001|Overall Study|Adverse Event|0|||
19592059|NCT01108094|42040527|FG002|Overall Study|Adverse Event|0|||
19592060|NCT01108094|42040528|FG003|Overall Study|Adverse Event|0|||
19592061|NCT01108094|42040525|FG000|Overall Study|Withdrawal by Subject|1|||
19592062|NCT01108094|42040526|FG001|Overall Study|Withdrawal by Subject|0|||
19592063|NCT01108094|42040527|FG002|Overall Study|Withdrawal by Subject|0|||
19592064|NCT01108094|42040528|FG003|Overall Study|Withdrawal by Subject|0|||
19592065|NCT00954174|42040545|FG000|Overall Study|Adverse Event|28|||
19592066|NCT00954174|42040546|FG001|Overall Study|Adverse Event|23|||
19592067|NCT00954174|42040547|FG002|Overall Study|Adverse Event|4|||
19592068|NCT00954174|42040548|FG003|Overall Study|Adverse Event|9|||
19592069|NCT00954174|42040545|FG000|Overall Study|Death|4|||
19592070|NCT00954174|42040546|FG001|Overall Study|Death|2|||
19592071|NCT00954174|42040547|FG002|Overall Study|Death|0|||
19592072|NCT00954174|42040548|FG003|Overall Study|Death|0|||
19592073|NCT00954174|42040545|FG000|Overall Study|Lack of Efficacy|32|||
19592074|NCT00954174|42040546|FG001|Overall Study|Lack of Efficacy|22|||
19592075|NCT00954174|42040547|FG002|Overall Study|Lack of Efficacy|8|||
19592076|NCT00954174|42040548|FG003|Overall Study|Lack of Efficacy|6|||
19592077|NCT00954174|42040545|FG000|Overall Study|Withdrawal by Subject|14|||
19592078|NCT00954174|42040546|FG001|Overall Study|Withdrawal by Subject|10|||
19592079|NCT00954174|42040547|FG002|Overall Study|Withdrawal by Subject|4|||
19592080|NCT00954174|42040548|FG003|Overall Study|Withdrawal by Subject|3|||
19592081|NCT00954174|42040545|FG000|Overall Study|Medical Reason|4|||
19592082|NCT00954174|42040546|FG001|Overall Study|Medical Reason|2|||
19592083|NCT00954174|42040547|FG002|Overall Study|Medical Reason|1|||
19592084|NCT00954174|42040548|FG003|Overall Study|Medical Reason|0|||
19592085|NCT00954174|42040545|FG000|Overall Study|Ineligible|40|||
19592086|NCT00954174|42040546|FG001|Overall Study|Ineligible|47|||
19592087|NCT00954174|42040547|FG002|Overall Study|Ineligible|7|||
19592088|NCT00954174|42040548|FG003|Overall Study|Ineligible|4|||
19592089|NCT00954174|42040545|FG000|Overall Study|Never Treated|4|||
19592090|NCT00954174|42040546|FG001|Overall Study|Never Treated|17|||
19592091|NCT00954174|42040547|FG002|Overall Study|Never Treated|0|||
19592092|NCT00954174|42040548|FG003|Overall Study|Never Treated|3|||
19592093|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
19592094|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
19592095|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
19592096|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
19592097|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Adverse Event|198|||
19592098|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Adverse Event|0|||
19592099|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Adverse Event|0|||
19592100|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Adverse Event|0|||
19592101|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Death|62|||
19592102|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Death|0|||
19592103|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Death|0|||
19592104|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Death|0|||
19592105|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
19592106|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
19592107|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
19592108|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
19592109|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Complicating disease|13|||
19592110|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Complicating disease|0|||
19592111|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Complicating disease|0|||
19592112|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Complicating disease|0|||
19592113|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
19592114|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
19592115|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
19592116|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
19592117|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
19592118|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
19592119|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
19592120|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
19592121|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Non-compliance|4|||
19592122|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Non-compliance|0|||
19592123|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Non-compliance|0|||
19592124|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Non-compliance|0|||
19592125|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Pain|4|||
19592126|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Pain|0|||
19592127|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Pain|0|||
19592128|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Pain|0|||
19592129|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
19592130|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
19592131|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
19592132|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
19592133|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Hospice care|1|||
19592134|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Hospice care|0|||
19592135|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Hospice care|0|||
19592136|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Hospice care|0|||
19592137|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Physician Decision|1|||
19592138|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Physician Decision|0|||
19592139|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Physician Decision|0|||
19592140|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Physician Decision|0|||
19592141|NCT01107626|42040565|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
19592142|NCT01107626|42040566|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
19592143|NCT01107626|42040567|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
19592144|NCT01107626|42040568|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
19592145|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
19592146|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
19592147|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
19592148|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
19592149|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
19592150|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
19592151|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
19592152|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
19592153|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Death|0|||
19592154|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Death|8|||
19592155|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Death|2|||
19592156|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Death|13|||
19592157|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
19592158|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
19592159|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
19592160|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
19592161|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
19592162|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
19592163|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
19592164|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
19592165|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
19592166|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
19592167|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
19592168|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
19592169|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
19592170|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
19592171|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
19592172|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
19592173|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
19592174|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
19592175|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
19592176|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
19592177|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
19592178|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
19592179|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
19592180|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
19592181|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
19592182|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
19592183|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
19592184|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
19592185|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
19592186|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
19592187|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
19592188|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
19592189|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
19387988|NCT02038036|41631321|FG000|Core Study|Lost to Follow-up|0|||
19387989|NCT02038036|41631322|FG001|Core Study|Lost to Follow-up|1|||
19746131|NCT03529773|42193177|FG021|Overall Study|Randomized but not vaccinated|0|||
19592190|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
19592191|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
19592192|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
19592193|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
19387990|NCT02038036|41631321|FG000|Core Study|Physician Decision|2|||
19592194|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
19592195|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
19592196|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
19592197|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Pain|0|||
19592198|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Pain|0|||
19592199|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Pain|0|||
19592200|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Pain|1|||
19592201|NCT01107626|42040565|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
19592202|NCT01107626|42040566|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
19592203|NCT01107626|42040567|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
19592204|NCT01107626|42040568|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
19592205|NCT01136408|42040580|FG000|Overall Study|Adverse Event|4|||
19592206|NCT01136408|42040581|FG001|Overall Study|Adverse Event|8|||
19592207|NCT01136408|42040582|FG002|Overall Study|Adverse Event|4|||
19592208|NCT01136408|42040580|FG000|Overall Study|Protocol Violation|1|||
19592209|NCT01136408|42040581|FG001|Overall Study|Protocol Violation|1|||
19592210|NCT01136408|42040582|FG002|Overall Study|Protocol Violation|1|||
19592211|NCT01136174|42040598|FG000|Overall Study|Adverse Event|0|||
19592212|NCT01136174|42040599|FG001|Overall Study|Adverse Event|0|||
19592213|NCT01136174|42040600|FG002|Overall Study|Adverse Event|0|||
19592214|NCT01136174|42040601|FG003|Overall Study|Adverse Event|4|||
19592215|NCT01135394|42040620|FG000|Screening|Lost to Follow-up|2|||
19592216|NCT01135394|42040620|FG000|Screening|Withdrawal by Subject|10|||
19592217|NCT01135394|42040620|FG000|Screening|Screening failure|16|||
19592218|NCT01135394|42040620|FG000|Screening|Physician Decision|5|||
19592219|NCT01135394|42040620|FG000|Baseline Assessment|Withdrawal by Subject|9|||
19592220|NCT01135394|42040620|FG000|Baseline Assessment|Physician Decision|3|||
19592221|NCT01135394|42040620|FG000|Baseline Assessment|Lost to Follow-up|2|||
19592222|NCT01135394|42040620|FG000|Baseline Assessment|Adverse Event|1|||
19592223|NCT01135394|42040620|FG000|Study Treatment|Withdrawal by Subject|1|||
19592224|NCT01135394|42040620|FG000|Study Treatment|Physician Decision|1|||
19592225|NCT01135394|42040620|FG000|Study Treatment|Adverse Event|2|||
19592226|NCT00949884|42040627|FG000|Overall Study|Adverse Event|14|||
19592227|NCT00949884|42040628|FG001|Overall Study|Adverse Event|3|||
19592228|NCT00949884|42040629|FG002|Overall Study|Adverse Event|12|||
19592229|NCT00949884|42040627|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
19592230|NCT00949884|42040628|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
19592231|NCT00949884|42040629|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
19592232|NCT00949884|42040627|FG000|Overall Study|Lost to Follow-up|7|||
19592233|NCT00949884|42040628|FG001|Overall Study|Lost to Follow-up|5|||
19592234|NCT00949884|42040629|FG002|Overall Study|Lost to Follow-up|5|||
19592235|NCT00949884|42040627|FG000|Overall Study|Physician Decision|5|||
19592236|NCT00949884|42040628|FG001|Overall Study|Physician Decision|0|||
19592237|NCT00949884|42040629|FG002|Overall Study|Physician Decision|6|||
19592238|NCT00949884|42040627|FG000|Overall Study|Treatment non-compliance|5|||
19592239|NCT00949884|42040628|FG001|Overall Study|Treatment non-compliance|0|||
19592240|NCT00949884|42040629|FG002|Overall Study|Treatment non-compliance|8|||
19592241|NCT00949884|42040627|FG000|Overall Study|Withdrawal by Subject|13|||
19592242|NCT00949884|42040628|FG001|Overall Study|Withdrawal by Subject|4|||
19592243|NCT00949884|42040629|FG002|Overall Study|Withdrawal by Subject|16|||
19592244|NCT00949884|42040627|FG000|Overall Study|Lack of Efficacy|4|||
19592245|NCT00949884|42040628|FG001|Overall Study|Lack of Efficacy|2|||
19592246|NCT00949884|42040629|FG002|Overall Study|Lack of Efficacy|7|||
19592247|NCT00949884|42040627|FG000|Overall Study|Study terminated by sponsor|0|||
19592248|NCT00949884|42040628|FG001|Overall Study|Study terminated by sponsor|0|||
19592249|NCT00949884|42040629|FG002|Overall Study|Study terminated by sponsor|1|||
19592250|NCT00949650|42040640|FG000|Overall Study|Progressive disease|188|||
19592251|NCT00949650|42040641|FG001|Overall Study|Progressive disease|19|||
19592252|NCT00949650|42040640|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
19592253|NCT00949650|42040641|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
19592254|NCT00949650|42040640|FG000|Overall Study|Other Adverse Event (AE)|28|||
19592255|NCT00949650|42040641|FG001|Overall Study|Other Adverse Event (AE)|17|||
19592256|NCT00949650|42040640|FG000|Overall Study|Protocol Violation|1|||
19592257|NCT00949650|42040641|FG001|Overall Study|Protocol Violation|4|||
19592258|NCT00949650|42040640|FG000|Overall Study|Refusal to continue medication|7|||
19592259|NCT00949650|42040641|FG001|Overall Study|Refusal to continue medication|11|||
19592260|NCT00949650|42040640|FG000|Overall Study|Not treated|1|||
19592261|NCT00949650|42040641|FG001|Overall Study|Not treated|4|||
19592262|NCT00949650|42040640|FG000|Overall Study|Other not specified above|5|||
19592263|NCT00949650|42040641|FG001|Overall Study|Other not specified above|0|||
19592264|NCT00908037|42040658|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592265|NCT00908037|42040659|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592266|NCT00908037|42040660|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592267|NCT00908037|42040661|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592268|NCT00908037|42040662|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
19592269|NCT00908037|42040663|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592270|NCT00908037|42040664|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
19592271|NCT00908037|42040665|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592272|NCT00908037|42040666|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
19592273|NCT00908037|42040667|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592274|NCT00908037|42040668|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592275|NCT00908037|42040669|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
19592276|NCT00908037|42040658|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19746132|NCT03529773|42193178|FG022|Overall Study|Randomized but not vaccinated|0|||
19746133|NCT03529773|42193179|FG023|Overall Study|Randomized but not vaccinated|0|||
19746134|NCT03529773|42193180|FG024|Overall Study|Randomized but not vaccinated|0|||
19746135|NCT03529773|42193181|FG025|Overall Study|Randomized but not vaccinated|0|||
19592277|NCT00908037|42040659|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592278|NCT00908037|42040660|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592279|NCT00908037|42040661|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592280|NCT00908037|42040662|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
19592281|NCT00908037|42040663|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592282|NCT00908037|42040664|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592283|NCT00908037|42040665|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592284|NCT00908037|42040666|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
19592285|NCT00908037|42040667|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592286|NCT00908037|42040668|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592287|NCT00908037|42040669|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
19592288|NCT00908037|42040658|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592289|NCT00908037|42040659|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592290|NCT00908037|42040660|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592291|NCT00908037|42040661|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
19592292|NCT00908037|42040662|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592293|NCT00908037|42040663|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592294|NCT00908037|42040664|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
19592295|NCT00908037|42040665|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592296|NCT00908037|42040666|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592297|NCT00908037|42040667|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592298|NCT00908037|42040668|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592299|NCT00908037|42040669|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
19592300|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592301|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592302|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592303|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592304|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592305|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592306|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592307|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592308|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592309|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592310|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
19592311|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
19592312|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592313|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592314|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592315|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592316|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592317|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592318|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592319|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592320|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592321|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
19592322|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
19592323|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
19592324|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592325|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592326|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592327|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19746136|NCT03529773|42193182|FG026|Overall Study|Randomized but not vaccinated|0|||
19746137|NCT03529773|42193183|FG027|Overall Study|Randomized but not vaccinated|1|||
19746138|NCT03529773|42193184|FG028|Overall Study|Randomized but not vaccinated|0|||
19592328|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592329|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592330|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592331|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592332|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592333|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
19592334|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592335|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
19592336|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592337|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592338|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592339|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592340|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592341|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592342|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592343|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592344|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592345|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592346|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
19592347|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
19592348|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592349|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592350|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592351|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592352|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592353|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592354|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592355|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592356|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592357|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
19592358|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592359|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
19592360|NCT00908037|42040658|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592361|NCT00908037|42040659|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592362|NCT00908037|42040660|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592363|NCT00908037|42040661|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592364|NCT00908037|42040662|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592365|NCT00908037|42040663|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592366|NCT00908037|42040664|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592367|NCT00908037|42040665|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592368|NCT00908037|42040666|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592369|NCT00908037|42040667|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592370|NCT00908037|42040668|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
19592371|NCT00908037|42040669|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
19592372|NCT00904215|42040721|FG000|Overall Study|Adverse Event|25|||
19592373|NCT00904215|42040721|FG000|Overall Study|Protocol Violation|10|||
19592374|NCT00904215|42040721|FG000|Overall Study|Lost to Follow-up|63|||
19592375|NCT00904215|42040721|FG000|Overall Study|Withdrawal by Subject|9|||
19592376|NCT00904215|42040721|FG000|Overall Study|Other|28|||
19592377|NCT00905307|42040731|FG000|Overall Study|Switched to Open Label Rescue|7|||
19592378|NCT00905307|42040732|FG001|Overall Study|Switched to Open Label Rescue|17|||
19592379|NCT00905307|42040733|FG002|Overall Study|Switched to Open Label Rescue|11|||
19592380|NCT00905307|42040734|FG003|Overall Study|Switched to Open Label Rescue|11|||
19592381|NCT00905307|42040735|FG004|Overall Study|Switched to Open Label Rescue|4|||
19592382|NCT00905307|42040736|FG005|Overall Study|Switched to Open Label Rescue|15|||
19592383|NCT00905307|42040731|FG000|Overall Study|Lost to Follow-up|0|||
19592384|NCT00905307|42040732|FG001|Overall Study|Lost to Follow-up|0|||
19592385|NCT00905307|42040733|FG002|Overall Study|Lost to Follow-up|0|||
19592386|NCT00905307|42040734|FG003|Overall Study|Lost to Follow-up|0|||
19592387|NCT00905307|42040735|FG004|Overall Study|Lost to Follow-up|1|||
19592388|NCT00905307|42040736|FG005|Overall Study|Lost to Follow-up|1|||
19592389|NCT00905307|42040731|FG000|Overall Study|Adverse Event|3|||
19592390|NCT00905307|42040732|FG001|Overall Study|Adverse Event|4|||
19592391|NCT00905307|42040733|FG002|Overall Study|Adverse Event|5|||
19592392|NCT00905307|42040734|FG003|Overall Study|Adverse Event|11|||
19592393|NCT00905307|42040735|FG004|Overall Study|Adverse Event|3|||
19592394|NCT00905307|42040736|FG005|Overall Study|Adverse Event|5|||
19592395|NCT00905307|42040731|FG000|Overall Study|Withdrawal by Subject|5|||
19592396|NCT00905307|42040732|FG001|Overall Study|Withdrawal by Subject|13|||
19592397|NCT00905307|42040733|FG002|Overall Study|Withdrawal by Subject|15|||
19592398|NCT00905307|42040734|FG003|Overall Study|Withdrawal by Subject|11|||
19592399|NCT00905307|42040735|FG004|Overall Study|Withdrawal by Subject|4|||
19592400|NCT00905307|42040736|FG005|Overall Study|Withdrawal by Subject|13|||
19592401|NCT00905307|42040731|FG000|Overall Study|Protocol Violation|1|||
19592402|NCT00905307|42040732|FG001|Overall Study|Protocol Violation|0|||
19592403|NCT00905307|42040733|FG002|Overall Study|Protocol Violation|1|||
19592404|NCT00905307|42040734|FG003|Overall Study|Protocol Violation|0|||
19592405|NCT00905307|42040735|FG004|Overall Study|Protocol Violation|0|||
19592406|NCT00905307|42040736|FG005|Overall Study|Protocol Violation|0|||
19592407|NCT00905307|42040731|FG000|Overall Study|Lack of Efficacy|6|||
19592408|NCT00905307|42040732|FG001|Overall Study|Lack of Efficacy|3|||
19592409|NCT00905307|42040733|FG002|Overall Study|Lack of Efficacy|5|||
19592410|NCT00905307|42040734|FG003|Overall Study|Lack of Efficacy|4|||
19592411|NCT00905307|42040735|FG004|Overall Study|Lack of Efficacy|4|||
19592412|NCT00905307|42040736|FG005|Overall Study|Lack of Efficacy|8|||
19592413|NCT00907881|42040763|FG000|Overall Study|Lost to Follow-up|59|||
19592414|NCT00907881|42040763|FG000|Overall Study|Noncompliance|5|||
19592415|NCT00907881|42040763|FG000|Overall Study|Withdrawal by Subject|5|||
19592416|NCT00907881|42040763|FG000|Overall Study|Protocol Violation|1|||
19592417|NCT00907881|42040763|FG000|Overall Study|Missing discontinuation information|15|||
19592418|NCT00904917|42040771|FG000|Overall Study|Lost to Follow-up|2|||
19592419|NCT00904917|42040772|FG001|Overall Study|Lost to Follow-up|2|||
19592420|NCT00904917|42040773|FG002|Overall Study|Lost to Follow-up|2|||
19592421|NCT00904917|42040774|FG003|Overall Study|Lost to Follow-up|2|||
19592422|NCT00904839|42040789|FG000|Overall Study|Adverse Event|0|||
19592423|NCT00904839|42040790|FG001|Overall Study|Adverse Event|5|||
19592424|NCT00904839|42040791|FG002|Overall Study|Adverse Event|4|||
19592425|NCT00904839|42040789|FG000|Overall Study|Protocol Violation|0|||
19592426|NCT00904839|42040790|FG001|Overall Study|Protocol Violation|1|||
19592427|NCT00904839|42040791|FG002|Overall Study|Protocol Violation|1|||
19592428|NCT00904839|42040789|FG000|Overall Study|Lost to Follow-up|0|||
19592429|NCT00904839|42040790|FG001|Overall Study|Lost to Follow-up|1|||
19592430|NCT00904839|42040791|FG002|Overall Study|Lost to Follow-up|2|||
19592431|NCT00904839|42040789|FG000|Overall Study|Withdrawal by Subject|0|||
19592432|NCT00904839|42040790|FG001|Overall Study|Withdrawal by Subject|2|||
19592433|NCT00904839|42040791|FG002|Overall Study|Withdrawal by Subject|0|||
19592434|NCT00904839|42040789|FG000|Overall Study|Not treated|1|||
19592435|NCT00904839|42040790|FG001|Overall Study|Not treated|0|||
19592436|NCT00904839|42040791|FG002|Overall Study|Not treated|1|||
19592437|NCT00904839|42040789|FG000|Overall Study|Other than above|0|||
19592438|NCT00904839|42040790|FG001|Overall Study|Other than above|9|||
19592439|NCT00904839|42040791|FG002|Overall Study|Other than above|7|||
19592440|NCT00903357|42040802|FG000|First Intervention|Withdrawal by Subject|5|||
19592441|NCT00903357|42040803|FG001|First Intervention|Withdrawal by Subject|3|||
19592442|NCT00903357|42040802|FG000|First Intervention|Flu|0|||
19592443|NCT00903357|42040803|FG001|First Intervention|Flu|1|||
19592444|NCT00903357|42040802|FG000|Wash Out Period of 2 Weeks|Flu|0|||
19592445|NCT00903357|42040803|FG001|Wash Out Period of 2 Weeks|Flu|1|||
19592446|NCT00903357|42040802|FG000|Second Intervention|Lost to Follow-up|1|||
19592447|NCT00903357|42040803|FG001|Second Intervention|Lost to Follow-up|0|||
19592448|NCT00904371|42040813|FG000|Overall Study|Adverse Event|2|||
19592449|NCT00904371|42040813|FG000|Overall Study|Lost to Follow-up|4|||
19592450|NCT00904371|42040813|FG000|Overall Study|Discontinued at target blood pressure|2|||
19592451|NCT00904371|42040813|FG000|Overall Study|Continued with Tritace|1|||
19592452|NCT01104662|42040825|FG000|Overall Study|Adverse Event|2|||
19592453|NCT01104662|42040826|FG001|Overall Study|Adverse Event|2|||
19592454|NCT01104662|42040827|FG002|Overall Study|Adverse Event|0|||
19592455|NCT01104662|42040828|FG003|Overall Study|Adverse Event|1|||
19592456|NCT01104662|42040829|FG004|Overall Study|Adverse Event|1|||
19592457|NCT01104662|42040830|FG005|Overall Study|Adverse Event|1|||
19592458|NCT01104662|42040831|FG006|Overall Study|Adverse Event|0|||
19592459|NCT01104662|42040832|FG007|Overall Study|Adverse Event|0|||
19592460|NCT01104662|42040825|FG000|Overall Study|Clinical Failure|1|||
19592461|NCT01104662|42040826|FG001|Overall Study|Clinical Failure|0|||
19592462|NCT01104662|42040827|FG002|Overall Study|Clinical Failure|0|||
19592463|NCT01104662|42040828|FG003|Overall Study|Clinical Failure|0|||
19592464|NCT01104662|42040829|FG004|Overall Study|Clinical Failure|0|||
19746139|NCT03529773|42193185|FG029|Overall Study|Randomized but not vaccinated|0|||
19746140|NCT03529773|42193186|FG030|Overall Study|Randomized but not vaccinated|0|||
19746141|NCT03529773|42193187|FG031|Overall Study|Randomized but not vaccinated|0|||
19592465|NCT01104662|42040830|FG005|Overall Study|Clinical Failure|1|||
19592466|NCT01104662|42040831|FG006|Overall Study|Clinical Failure|0|||
19592467|NCT01104662|42040832|FG007|Overall Study|Clinical Failure|0|||
19592468|NCT01104662|42040825|FG000|Overall Study|Participant left investigator's care|1|||
19592469|NCT01104662|42040826|FG001|Overall Study|Participant left investigator's care|1|||
19592470|NCT01104662|42040827|FG002|Overall Study|Participant left investigator's care|0|||
19592471|NCT01104662|42040828|FG003|Overall Study|Participant left investigator's care|0|||
19592472|NCT01104662|42040829|FG004|Overall Study|Participant left investigator's care|0|||
19592473|NCT01104662|42040830|FG005|Overall Study|Participant left investigator's care|0|||
19592474|NCT01104662|42040831|FG006|Overall Study|Participant left investigator's care|0|||
19592475|NCT01104662|42040832|FG007|Overall Study|Participant left investigator's care|0|||
19592476|NCT01104662|42040825|FG000|Overall Study|Reason not specified|3|||
19592477|NCT01104662|42040826|FG001|Overall Study|Reason not specified|3|||
19592478|NCT01104662|42040827|FG002|Overall Study|Reason not specified|0|||
19592479|NCT01104662|42040828|FG003|Overall Study|Reason not specified|0|||
19592480|NCT01104662|42040829|FG004|Overall Study|Reason not specified|0|||
19592481|NCT01104662|42040830|FG005|Overall Study|Reason not specified|1|||
19592482|NCT01104662|42040831|FG006|Overall Study|Reason not specified|0|||
19592483|NCT01104662|42040832|FG007|Overall Study|Reason not specified|0|||
19592484|NCT01104662|42040825|FG000|Overall Study|Randomized but not treated|3|||
19592485|NCT01104662|42040826|FG001|Overall Study|Randomized but not treated|4|||
19746142|NCT03529773|42193188|FG032|Overall Study|Randomized but not vaccinated|0|||
19746143|NCT03529773|42193189|FG033|Overall Study|Randomized but not vaccinated|0|||
19746144|NCT03529773|42193190|FG034|Overall Study|Randomized but not vaccinated|0|||
19746145|NCT03529773|42193191|FG035|Overall Study|Randomized but not vaccinated|0|||
19746146|NCT03529773|42193192|FG036|Overall Study|Randomized but not vaccinated|0|||
19592486|NCT01104662|42040827|FG002|Overall Study|Randomized but not treated|1|||
19592487|NCT01104662|42040828|FG003|Overall Study|Randomized but not treated|0|||
19592488|NCT01104662|42040829|FG004|Overall Study|Randomized but not treated|0|||
19592489|NCT01104662|42040830|FG005|Overall Study|Randomized but not treated|1|||
19592490|NCT01104662|42040831|FG006|Overall Study|Randomized but not treated|0|||
19592491|NCT01104662|42040832|FG007|Overall Study|Randomized but not treated|0|||
19592492|NCT01104584|42040851|FG000|Overall Study|Study drug never administered|21|||
19592493|NCT01104584|42040851|FG000|Overall Study|Study prematurely discontinued|2|||
19592494|NCT01103960|42040875|FG000|Overall Study|Adverse Event|2|||
19592495|NCT01103960|42040876|FG001|Overall Study|Adverse Event|1|||
19592496|NCT01103960|42040875|FG000|Overall Study|Withdrawal by Subject|2|||
19592497|NCT01103960|42040876|FG001|Overall Study|Withdrawal by Subject|1|||
19592498|NCT01103960|42040875|FG000|Overall Study|Other|1|||
19592499|NCT01103960|42040876|FG001|Overall Study|Other|0|||
19592500|NCT01107392|42040884|FG000|Overall Study|Adverse Event|2|||
19592501|NCT01107392|42040885|FG001|Overall Study|Adverse Event|0|||
19592502|NCT01107392|42040884|FG000|Overall Study|Personal Reasons|2|||
19592503|NCT01107392|42040885|FG001|Overall Study|Personal Reasons|3|||
19592504|NCT01107392|42040884|FG000|Overall Study|Administrative decision|1|||
19592505|NCT01107392|42040885|FG001|Overall Study|Administrative decision|0|||
19592506|NCT01106846|42040893|FG000|Overall Study|Change in surgical procedure|0|||
19592507|NCT01106846|42040894|FG001|Overall Study|Change in surgical procedure|1|||
19592508|NCT00902577|42040900|FG000|Overall Study|Withdrawal by Subject|6|||
19592509|NCT00902577|42040900|FG000|Overall Study|FMISO production failure|2|||
19746147|NCT03529773|42193193|FG037|Overall Study|Randomized but not vaccinated|0|||
19746148|NCT03529773|42193194|FG038|Overall Study|Randomized but not vaccinated|0|||
19746149|NCT03529773|42193195|FG039|Overall Study|Randomized but not vaccinated|0|||
19746150|NCT03799211|42193300|FG000|Overall Study|Lost to Follow-up|2|||
19746151|NCT03799211|42193301|FG001|Overall Study|Lost to Follow-up|13|||
19746152|NCT03799211|42193300|FG000|Overall Study|Withdrawal by Subject|2|||
19746153|NCT03799211|42193301|FG001|Overall Study|Withdrawal by Subject|0|||
19746154|NCT03349710|42193313|FG000|Treatment Period|Death|0|||
19746155|NCT03349710|42193314|FG001|Treatment Period|Death|0|||
19746156|NCT03349710|42193315|FG002|Treatment Period|Death|1|||
19746157|NCT03349710|42193316|FG003|Treatment Period|Death|0|||
19746158|NCT03349710|42193313|FG000|Treatment Period|Disease Progression|0|||
19746159|NCT03349710|42193314|FG001|Treatment Period|Disease Progression|2|||
19746160|NCT03349710|42193315|FG002|Treatment Period|Disease Progression|0|||
19746161|NCT03349710|42193316|FG003|Treatment Period|Disease Progression|1|||
19746162|NCT03349710|42193313|FG000|Treatment Period|Study Drug Toxicity|1|||
19746163|NCT03349710|42193314|FG001|Treatment Period|Study Drug Toxicity|0|||
19746164|NCT03349710|42193315|FG002|Treatment Period|Study Drug Toxicity|1|||
19746165|NCT03349710|42193316|FG003|Treatment Period|Study Drug Toxicity|1|||
19746166|NCT03349710|42193313|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
19746167|NCT03349710|42193314|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
19746168|NCT03349710|42193315|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
19746169|NCT03349710|42193316|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
19746170|NCT03349710|42193313|FG000|Treatment Period|admin reason by sponsor|0|||
19746171|NCT03349710|42193314|FG001|Treatment Period|admin reason by sponsor|7|||
19746172|NCT03349710|42193315|FG002|Treatment Period|admin reason by sponsor|0|||
19746173|NCT03349710|42193316|FG003|Treatment Period|admin reason by sponsor|19|||
19746174|NCT03349710|42193313|FG000|Treatment Period|Other Reason|2|||
19746175|NCT03349710|42193314|FG001|Treatment Period|Other Reason|0|||
19746176|NCT03349710|42193315|FG002|Treatment Period|Other Reason|2|||
19746177|NCT03349710|42193316|FG003|Treatment Period|Other Reason|1|||
19746178|NCT03349710|42193313|FG000|Treatment Period|completed|6|||
19746179|NCT03349710|42193314|FG001|Treatment Period|completed|0|||
19746180|NCT03349710|42193315|FG002|Treatment Period|completed|18|||
19592510|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
19592511|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
19592512|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
19592513|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
19592514|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
19592515|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
19592516|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
19592517|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
19592518|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
19592519|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
19592520|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
19592521|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
19592522|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
19592523|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
19592524|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
19592525|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19592526|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
19592527|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19592528|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
19592529|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19592530|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
19592531|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
19592532|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
19746181|NCT03349710|42193316|FG003|Treatment Period|completed|1|||
19746182|NCT03349710|42193313|FG000|Treatment Period|participant request to discontinue|0|||
19592533|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
19592534|NCT01106690|42040935|FG000|Core Period: Baseline to Week 26|Other|10|||
19592535|NCT01106690|42040936|FG001|Core Period: Baseline to Week 26|Other|2|||
19592536|NCT01106690|42040937|FG002|Core Period: Baseline to Week 26|Other|6|||
19592537|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19592538|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19592539|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
19592540|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19592541|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19592542|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19592543|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19746183|NCT03349710|42193314|FG001|Treatment Period|participant request to discontinue|0|||
19592544|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
19592545|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
19592546|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
19592547|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
19592548|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
19592549|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
19592550|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
19592551|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
19592552|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Other|8|||
19592553|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Other|3|||
19592554|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Other|4|||
19592555|NCT01106690|42040935|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
19592556|NCT01106690|42040936|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19592557|NCT01106690|42040937|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19592558|NCT01103180|42040967|FG000|Overall Study|Withdrawal by Subject|8|||
19592559|NCT01103180|42040968|FG001|Overall Study|Withdrawal by Subject|13|||
19592560|NCT01103180|42040967|FG000|Overall Study|Lost to Follow-up|13|||
19592561|NCT01103180|42040968|FG001|Overall Study|Lost to Follow-up|7|||
19592562|NCT01103180|42040967|FG000|Overall Study|Physician Decision|1|||
19592563|NCT01103180|42040968|FG001|Overall Study|Physician Decision|0|||
19592564|NCT01103180|42040967|FG000|Overall Study|Protocol Violation|0|||
19592565|NCT01103180|42040968|FG001|Overall Study|Protocol Violation|1|||
19592566|NCT00944034|42040986|FG000|Overall Study|Inappropriate enrollment|0|||
19592567|NCT00944034|42040987|FG001|Overall Study|Inappropriate enrollment|1|||
19592568|NCT00944034|42040988|FG002|Overall Study|Inappropriate enrollment|0|||
19592569|NCT00944034|42040989|FG003|Overall Study|Inappropriate enrollment|1|||
19592570|NCT00944034|42040990|FG004|Overall Study|Inappropriate enrollment|2|||
19592571|NCT00944034|42040991|FG005|Overall Study|Inappropriate enrollment|1|||
19592572|NCT00944034|42040992|FG006|Overall Study|Inappropriate enrollment|0|||
19592573|NCT00944034|42040993|FG007|Overall Study|Inappropriate enrollment|0|||
19592574|NCT00944034|42040994|FG008|Overall Study|Inappropriate enrollment|1|||
19592575|NCT00944034|42040995|FG009|Overall Study|Inappropriate enrollment|1|||
19592576|NCT00944034|42040996|FG010|Overall Study|Inappropriate enrollment|0|||
19592577|NCT00944034|42040997|FG011|Overall Study|Inappropriate enrollment|0|||
19592578|NCT00944034|42040986|FG000|Overall Study|Withdrawal by Subject|3|||
19592579|NCT00944034|42040987|FG001|Overall Study|Withdrawal by Subject|2|||
19592580|NCT00944034|42040988|FG002|Overall Study|Withdrawal by Subject|6|||
19592581|NCT00944034|42040989|FG003|Overall Study|Withdrawal by Subject|2|||
19592582|NCT00944034|42040990|FG004|Overall Study|Withdrawal by Subject|5|||
19592583|NCT00944034|42040991|FG005|Overall Study|Withdrawal by Subject|8|||
19592584|NCT00944034|42040992|FG006|Overall Study|Withdrawal by Subject|2|||
19592585|NCT00944034|42040993|FG007|Overall Study|Withdrawal by Subject|2|||
19592586|NCT00944034|42040994|FG008|Overall Study|Withdrawal by Subject|3|||
19592587|NCT00944034|42040995|FG009|Overall Study|Withdrawal by Subject|4|||
19592588|NCT00944034|42040996|FG010|Overall Study|Withdrawal by Subject|0|||
19592589|NCT00944034|42040997|FG011|Overall Study|Withdrawal by Subject|4|||
19592590|NCT00944034|42040986|FG000|Overall Study|Lost to Follow-up|0|||
19592591|NCT00944034|42040987|FG001|Overall Study|Lost to Follow-up|4|||
19592592|NCT00944034|42040988|FG002|Overall Study|Lost to Follow-up|2|||
19592593|NCT00944034|42040989|FG003|Overall Study|Lost to Follow-up|0|||
19592594|NCT00944034|42040990|FG004|Overall Study|Lost to Follow-up|5|||
19592595|NCT00944034|42040991|FG005|Overall Study|Lost to Follow-up|7|||
19592596|NCT00944034|42040992|FG006|Overall Study|Lost to Follow-up|0|||
19592597|NCT00944034|42040993|FG007|Overall Study|Lost to Follow-up|1|||
19592598|NCT00944034|42040994|FG008|Overall Study|Lost to Follow-up|5|||
19746184|NCT03349710|42193315|FG002|Treatment Period|participant request to discontinue|4|||
19746185|NCT03349710|42193316|FG003|Treatment Period|participant request to discontinue|0|||
19746186|NCT03349710|42193313|FG000|Treatment Period|participant withdrew consent|1|||
19746187|NCT03349710|42193314|FG001|Treatment Period|participant withdrew consent|0|||
19746188|NCT03349710|42193315|FG002|Treatment Period|participant withdrew consent|0|||
19746189|NCT03349710|42193316|FG003|Treatment Period|participant withdrew consent|0|||
19746190|NCT03511053|42193326|FG000|Overall Study|Withdrawal by Subject|1|||
19746191|NCT03377634|42193332|FG000|Study Period|Adverse Event|1|||
19592599|NCT00944034|42040995|FG009|Overall Study|Lost to Follow-up|1|||
19592600|NCT00944034|42040996|FG010|Overall Study|Lost to Follow-up|1|||
19592601|NCT00944034|42040997|FG011|Overall Study|Lost to Follow-up|0|||
19592602|NCT00944034|42040986|FG000|Overall Study|Death|0|||
19592603|NCT00944034|42040987|FG001|Overall Study|Death|0|||
19592604|NCT00944034|42040988|FG002|Overall Study|Death|1|||
19592605|NCT00944034|42040989|FG003|Overall Study|Death|0|||
19592606|NCT00944034|42040990|FG004|Overall Study|Death|0|||
19592607|NCT00944034|42040991|FG005|Overall Study|Death|0|||
19592608|NCT00944034|42040992|FG006|Overall Study|Death|0|||
19592609|NCT00944034|42040993|FG007|Overall Study|Death|0|||
19592610|NCT00944034|42040994|FG008|Overall Study|Death|0|||
19592611|NCT00944034|42040995|FG009|Overall Study|Death|0|||
19592612|NCT00944034|42040996|FG010|Overall Study|Death|0|||
19592613|NCT00944034|42040997|FG011|Overall Study|Death|0|||
19592614|NCT00944034|42040986|FG000|Overall Study|Protocol Violation|2|||
19592615|NCT00944034|42040987|FG001|Overall Study|Protocol Violation|0|||
19592616|NCT00944034|42040988|FG002|Overall Study|Protocol Violation|0|||
19592617|NCT00944034|42040989|FG003|Overall Study|Protocol Violation|1|||
19592618|NCT00944034|42040990|FG004|Overall Study|Protocol Violation|2|||
19592619|NCT00944034|42040991|FG005|Overall Study|Protocol Violation|3|||
19592620|NCT00944034|42040992|FG006|Overall Study|Protocol Violation|0|||
19592621|NCT00944034|42040993|FG007|Overall Study|Protocol Violation|1|||
19592622|NCT00944034|42040994|FG008|Overall Study|Protocol Violation|1|||
19592623|NCT00944034|42040995|FG009|Overall Study|Protocol Violation|4|||
19592624|NCT00944034|42040996|FG010|Overall Study|Protocol Violation|0|||
19592625|NCT00944034|42040997|FG011|Overall Study|Protocol Violation|0|||
19592626|NCT00944034|42040986|FG000|Overall Study|Unable to classify|0|||
19592627|NCT00944034|42040987|FG001|Overall Study|Unable to classify|0|||
19592628|NCT00944034|42040988|FG002|Overall Study|Unable to classify|0|||
19592629|NCT00944034|42040989|FG003|Overall Study|Unable to classify|0|||
19592630|NCT00944034|42040990|FG004|Overall Study|Unable to classify|0|||
19592631|NCT00944034|42040991|FG005|Overall Study|Unable to classify|1|||
19592632|NCT00944034|42040992|FG006|Overall Study|Unable to classify|1|||
19592633|NCT00944034|42040993|FG007|Overall Study|Unable to classify|1|||
19592634|NCT00944034|42040994|FG008|Overall Study|Unable to classify|0|||
19592635|NCT00944034|42040995|FG009|Overall Study|Unable to classify|0|||
19592636|NCT00944034|42040996|FG010|Overall Study|Unable to classify|0|||
19592637|NCT00944034|42040997|FG011|Overall Study|Unable to classify|0|||
19592638|NCT00944034|42040986|FG000|Overall Study|Administrative reason|0|||
19592639|NCT00944034|42040987|FG001|Overall Study|Administrative reason|0|||
19592640|NCT00944034|42040988|FG002|Overall Study|Administrative reason|0|||
19592641|NCT00944034|42040989|FG003|Overall Study|Administrative reason|0|||
19592642|NCT00944034|42040990|FG004|Overall Study|Administrative reason|0|||
19592643|NCT00944034|42040991|FG005|Overall Study|Administrative reason|0|||
19592644|NCT00944034|42040992|FG006|Overall Study|Administrative reason|1|||
19592645|NCT00944034|42040993|FG007|Overall Study|Administrative reason|0|||
19592646|NCT00944034|42040994|FG008|Overall Study|Administrative reason|0|||
19592647|NCT00944034|42040995|FG009|Overall Study|Administrative reason|0|||
19592648|NCT00944034|42040996|FG010|Overall Study|Administrative reason|0|||
19592649|NCT00944034|42040997|FG011|Overall Study|Administrative reason|0|||
19592650|NCT01106534|42041040|FG000|Overall Study|Withdrawal by Subject|18|||
19746192|NCT03377634|42193333|FG001|Study Period|Adverse Event|0|||
19746193|NCT03377634|42193332|FG000|Study Period|Withdrawal by Subject|1|||
19746194|NCT03377634|42193333|FG001|Study Period|Withdrawal by Subject|0|||
19592651|NCT01106534|42041040|FG000|Overall Study|Lost to Follow-up|2|||
19592652|NCT01106534|42041040|FG000|Overall Study|Death|16|||
19592653|NCT01106534|42041040|FG000|Overall Study|Physician Decision|1|||
19592654|NCT00941304|42041050|FG000|Overall Study|Lost to Follow-up|1|||
19592655|NCT00941304|42041051|FG001|Overall Study|Lost to Follow-up|0|||
19592656|NCT00941304|42041052|FG002|Overall Study|Lost to Follow-up|0|||
19592657|NCT00941304|42041053|FG003|Overall Study|Lost to Follow-up|0|||
19592658|NCT00941304|42041054|FG004|Overall Study|Lost to Follow-up|0|||
19592659|NCT00941070|42041066|FG000|Overall Study|Patient non-compliant|1|||
19592660|NCT01098812|42041075|FG000|Overall Study|Death|2|||
19592661|NCT01098812|42041076|FG001|Overall Study|Death|0|||
19592662|NCT01098812|42041077|FG002|Overall Study|Death|1|||
19592663|NCT01098812|42041075|FG000|Overall Study|Lost to Follow-up|0|||
19592664|NCT01098812|42041076|FG001|Overall Study|Lost to Follow-up|1|||
19592665|NCT01098812|42041077|FG002|Overall Study|Lost to Follow-up|0|||
19592666|NCT00903201|42041087|FG000|Overall Study|Adverse Event|1|||
19592667|NCT00903201|42041088|FG001|Overall Study|Adverse Event|4|||
19592668|NCT00903201|42041089|FG002|Overall Study|Adverse Event|0|||
19592669|NCT00903201|42041087|FG000|Overall Study|Protocol Violation|2|||
19592670|NCT00903201|42041088|FG001|Overall Study|Protocol Violation|1|||
19592671|NCT00903201|42041089|FG002|Overall Study|Protocol Violation|0|||
19592672|NCT00903201|42041087|FG000|Overall Study|Lost to Follow-up|0|||
19592673|NCT00903201|42041088|FG001|Overall Study|Lost to Follow-up|1|||
19592674|NCT00903201|42041089|FG002|Overall Study|Lost to Follow-up|0|||
19592675|NCT00903201|42041087|FG000|Overall Study|Physician Decision|1|||
19592676|NCT00903201|42041088|FG001|Overall Study|Physician Decision|0|||
19592677|NCT00903201|42041089|FG002|Overall Study|Physician Decision|1|||
19592678|NCT00903201|42041087|FG000|Overall Study|Withdrawal by Subject|1|||
19592679|NCT00903201|42041088|FG001|Overall Study|Withdrawal by Subject|0|||
19592680|NCT00903201|42041089|FG002|Overall Study|Withdrawal by Subject|1|||
19746195|NCT03528369|42193342|FG000|Overall Study|Withdrawal by Subject|2|||
19746196|NCT03528369|42193343|FG001|Overall Study|Withdrawal by Subject|0|||
19746197|NCT03528369|42193344|FG002|Overall Study|Withdrawal by Subject|0|||
19746198|NCT03528369|42193342|FG000|Overall Study|Lost to Follow-up|1|||
19746199|NCT03528369|42193343|FG001|Overall Study|Lost to Follow-up|0|||
19746200|NCT03528369|42193344|FG002|Overall Study|Lost to Follow-up|0|||
19746201|NCT03528369|42193342|FG000|Overall Study|Adverse Event|0|||
19746202|NCT03528369|42193343|FG001|Overall Study|Adverse Event|1|||
19746203|NCT03528369|42193344|FG002|Overall Study|Adverse Event|0|||
19746204|NCT00006011|42193355|FG000|Overall Study|Disease progression|13|||
19746205|NCT00006011|42193356|FG001|Overall Study|Disease progression|6|||
19746206|NCT00006011|42193357|FG002|Overall Study|Disease progression|26|||
19746207|NCT00006011|42193355|FG000|Overall Study|Refused further treatment|15|||
19592681|NCT00902265|42041099|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
19746208|NCT00006011|42193356|FG001|Overall Study|Refused further treatment|13|||
19746209|NCT00006011|42193357|FG002|Overall Study|Refused further treatment|26|||
19746210|NCT00006011|42193355|FG000|Overall Study|Adverse Event|15|||
19746211|NCT00006011|42193356|FG001|Overall Study|Adverse Event|39|||
19746212|NCT00006011|42193357|FG002|Overall Study|Adverse Event|5|||
19746213|NCT00006011|42193355|FG000|Overall Study|Death|0|||
19746214|NCT00006011|42193356|FG001|Overall Study|Death|1|||
19746215|NCT00006011|42193357|FG002|Overall Study|Death|2|||
19746216|NCT00006011|42193355|FG000|Overall Study|Other|4|||
19746217|NCT00006011|42193356|FG001|Overall Study|Other|2|||
19746218|NCT00006011|42193357|FG002|Overall Study|Other|5|||
19592682|NCT00902265|42041099|FG000|Overall Study|Adverse Event|2|||
19592683|NCT00902265|42041099|FG000|Overall Study|Lack of Efficacy|2|||
19592684|NCT00902265|42041099|FG000|Overall Study|Protocol Violation|1|||
19592685|NCT00943722|42041117|FG000|Base Study|Adverse Event|0|||
19746219|NCT00006011|42193355|FG000|Overall Study|Ineligible|18|||
19746220|NCT00006011|42193356|FG001|Overall Study|Ineligible|16|||
19746221|NCT00006011|42193357|FG002|Overall Study|Ineligible|9|||
19746222|NCT03377556|42193363|FG000|Overall Study|Adverse Event|5|||
19746223|NCT03377556|42193363|FG000|Overall Study|Refusal unrelated to adverse events|1|||
19746224|NCT03377556|42193363|FG000|Overall Study|Progression/relapse|38|||
19746225|NCT03377556|42193363|FG000|Overall Study|Death|3|||
19746226|NCT03750955|42193369|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
19746227|NCT03750955|42193370|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
19387991|NCT02038036|41631322|FG001|Core Study|Physician Decision|1|||
19387992|NCT02038036|41631321|FG000|Core Study|Subject/guardian decision|0|||
19592686|NCT00943722|42041118|FG001|Base Study|Adverse Event|0|||
19592687|NCT00943722|42041119|FG002|Base Study|Adverse Event|0|||
19592688|NCT00943722|42041120|FG003|Base Study|Adverse Event|1|||
19592689|NCT00943722|42041121|FG004|Base Study|Adverse Event|0|||
19592690|NCT00943722|42041122|FG005|Base Study|Adverse Event|0|||
19592691|NCT00943722|42041123|FG006|Base Study|Adverse Event|0|||
19592692|NCT00943722|42041117|FG000|Base Study|Lost to Follow-up|12|||
19592693|NCT00943722|42041118|FG001|Base Study|Lost to Follow-up|8|||
19592694|NCT00943722|42041119|FG002|Base Study|Lost to Follow-up|10|||
19592695|NCT00943722|42041120|FG003|Base Study|Lost to Follow-up|8|||
19592696|NCT00943722|42041121|FG004|Base Study|Lost to Follow-up|11|||
19746228|NCT03750955|42193369|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
19746229|NCT03750955|42193370|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
19592697|NCT00943722|42041122|FG005|Base Study|Lost to Follow-up|0|||
19592698|NCT00943722|42041123|FG006|Base Study|Lost to Follow-up|0|||
19592699|NCT00943722|42041117|FG000|Base Study|Physician Decision|1|||
19592700|NCT00943722|42041118|FG001|Base Study|Physician Decision|0|||
19387993|NCT02038036|41631322|FG001|Core Study|Subject/guardian decision|1|||
19592701|NCT00943722|42041119|FG002|Base Study|Physician Decision|0|||
19592702|NCT00943722|42041120|FG003|Base Study|Physician Decision|0|||
19592703|NCT00943722|42041121|FG004|Base Study|Physician Decision|1|||
19746230|NCT00005957|42193380|FG000|Overall Study|No treated|3|||
19746231|NCT00005957|42193381|FG001|Overall Study|No treated|9|||
19746232|NCT00005957|42193380|FG000|Overall Study|Crossover to the other arm|5|||
19746233|NCT00005957|42193381|FG001|Overall Study|Crossover to the other arm|19|||
19746234|NCT00005879|42193389|FG000|Overall Study|Withdrawal by Subject|8|||
19746235|NCT00005879|42193390|FG001|Overall Study|Withdrawal by Subject|10|||
19746236|NCT03527745|42193422|FG000|Overall Study|Lost to Follow-up|3|||
19746237|NCT03527745|42193423|FG001|Overall Study|Lost to Follow-up|6|||
19746238|NCT03527745|42193424|FG002|Overall Study|Lost to Follow-up|7|||
19746239|NCT03527745|42193425|FG003|Overall Study|Lost to Follow-up|9|||
19746240|NCT03527745|42193426|FG004|Overall Study|Lost to Follow-up|0|||
19746241|NCT03527745|42193427|FG005|Overall Study|Lost to Follow-up|2|||
19746242|NCT03527745|42193428|FG006|Overall Study|Lost to Follow-up|3|||
19746243|NCT03527745|42193429|FG007|Overall Study|Lost to Follow-up|2|||
19746244|NCT03527745|42193430|FG008|Overall Study|Lost to Follow-up|3|||
19746245|NCT03527745|42193431|FG009|Overall Study|Lost to Follow-up|2|||
19746246|NCT03527745|42193432|FG010|Overall Study|Lost to Follow-up|1|||
19746247|NCT03527745|42193433|FG011|Overall Study|Lost to Follow-up|1|||
19746248|NCT03527745|42193434|FG012|Overall Study|Lost to Follow-up|0|||
19746249|NCT03527745|42193435|FG013|Overall Study|Lost to Follow-up|0|||
19746250|NCT03527745|42193436|FG014|Overall Study|Lost to Follow-up|0|||
19746251|NCT03527745|42193437|FG015|Overall Study|Lost to Follow-up|0|||
19746252|NCT03527745|42193438|FG016|Overall Study|Lost to Follow-up|1|||
19746253|NCT03527745|42193439|FG017|Overall Study|Lost to Follow-up|0|||
19746254|NCT03527745|42193440|FG018|Overall Study|Lost to Follow-up|0|||
19746255|NCT03527745|42193441|FG019|Overall Study|Lost to Follow-up|1|||
19746256|NCT03527745|42193442|FG020|Overall Study|Lost to Follow-up|1|||
19746257|NCT03527745|42193443|FG021|Overall Study|Lost to Follow-up|5|||
19746258|NCT03527745|42193444|FG022|Overall Study|Lost to Follow-up|6|||
19746259|NCT03527745|42193445|FG023|Overall Study|Lost to Follow-up|8|||
19746260|NCT03527745|42193446|FG024|Overall Study|Lost to Follow-up|1|||
19746261|NCT03527745|42193447|FG025|Overall Study|Lost to Follow-up|3|||
19746262|NCT03583359|42193505|FG000|Overall Study|Withdrawal by Subject|15|||
19592704|NCT00943722|42041122|FG005|Base Study|Physician Decision|0|||
19592705|NCT00943722|42041123|FG006|Base Study|Physician Decision|0|||
19592706|NCT00943722|42041117|FG000|Base Study|Pregnancy|0|||
19592707|NCT00943722|42041118|FG001|Base Study|Pregnancy|0|||
19592708|NCT00943722|42041119|FG002|Base Study|Pregnancy|1|||
19592709|NCT00943722|42041120|FG003|Base Study|Pregnancy|0|||
19592710|NCT00943722|42041121|FG004|Base Study|Pregnancy|2|||
19592711|NCT00943722|42041122|FG005|Base Study|Pregnancy|0|||
19592712|NCT00943722|42041123|FG006|Base Study|Pregnancy|0|||
19592713|NCT00943722|42041117|FG000|Base Study|Protocol Violation|0|||
19592714|NCT00943722|42041118|FG001|Base Study|Protocol Violation|1|||
19592715|NCT00943722|42041119|FG002|Base Study|Protocol Violation|0|||
19592716|NCT00943722|42041120|FG003|Base Study|Protocol Violation|0|||
19592717|NCT00943722|42041121|FG004|Base Study|Protocol Violation|2|||
19592718|NCT00943722|42041122|FG005|Base Study|Protocol Violation|0|||
19592719|NCT00943722|42041123|FG006|Base Study|Protocol Violation|0|||
19592720|NCT00943722|42041117|FG000|Base Study|Withdrawal by Subject|12|||
19592721|NCT00943722|42041118|FG001|Base Study|Withdrawal by Subject|13|||
19592722|NCT00943722|42041119|FG002|Base Study|Withdrawal by Subject|2|||
19592723|NCT00943722|42041120|FG003|Base Study|Withdrawal by Subject|13|||
19592724|NCT00943722|42041121|FG004|Base Study|Withdrawal by Subject|8|||
19592725|NCT00943722|42041122|FG005|Base Study|Withdrawal by Subject|0|||
19592726|NCT00943722|42041123|FG006|Base Study|Withdrawal by Subject|0|||
19592727|NCT00943722|42041117|FG000|Base Study|Month 12 visit not completed|0|||
19592728|NCT00943722|42041118|FG001|Base Study|Month 12 visit not completed|0|||
19592729|NCT00943722|42041119|FG002|Base Study|Month 12 visit not completed|0|||
19592730|NCT00943722|42041120|FG003|Base Study|Month 12 visit not completed|0|||
19592731|NCT00943722|42041121|FG004|Base Study|Month 12 visit not completed|2|||
19592732|NCT00943722|42041122|FG005|Base Study|Month 12 visit not completed|0|||
19592733|NCT00943722|42041123|FG006|Base Study|Month 12 visit not completed|0|||
19592734|NCT00943722|42041117|FG000|First Extension Study: EXT 1|Adverse Event|0|||
19592735|NCT00943722|42041118|FG001|First Extension Study: EXT 1|Adverse Event|0|||
19746263|NCT03583359|42193506|FG001|Overall Study|Withdrawal by Subject|6|||
19746264|NCT03583359|42193505|FG000|Overall Study|Lost to Follow-up|12|||
19746265|NCT03583359|42193506|FG001|Overall Study|Lost to Follow-up|3|||
19746266|NCT03583359|42193505|FG000|Overall Study|Adverse Event|0|||
19746267|NCT03583359|42193506|FG001|Overall Study|Adverse Event|1|||
19746268|NCT03583359|42193505|FG000|Overall Study|Protocol Violation|0|||
19746269|NCT03583359|42193506|FG001|Overall Study|Protocol Violation|1|||
19746270|NCT03583359|42193505|FG000|Overall Study|Other|2|||
19592736|NCT00943722|42041119|FG002|First Extension Study: EXT 1|Adverse Event|0|||
19592737|NCT00943722|42041120|FG003|First Extension Study: EXT 1|Adverse Event|0|||
19592738|NCT00943722|42041121|FG004|First Extension Study: EXT 1|Adverse Event|0|||
19592739|NCT00943722|42041122|FG005|First Extension Study: EXT 1|Adverse Event|1|||
19592740|NCT00943722|42041123|FG006|First Extension Study: EXT 1|Adverse Event|0|||
19592741|NCT00943722|42041117|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
19592742|NCT00943722|42041118|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
19746271|NCT03583359|42193506|FG001|Overall Study|Other|1|||
19592743|NCT00943722|42041119|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
19592744|NCT00943722|42041120|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
19592745|NCT00943722|42041121|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
19592746|NCT00943722|42041122|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
19592747|NCT00943722|42041123|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
19592748|NCT00943722|42041117|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
19592749|NCT00943722|42041118|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
19592750|NCT00943722|42041119|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
19592751|NCT00943722|42041120|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
19592752|NCT00943722|42041121|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
19592753|NCT00943722|42041122|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
19592754|NCT00943722|42041123|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
19592755|NCT00943722|42041117|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
19592756|NCT00943722|42041118|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
19592757|NCT00943722|42041119|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
19592758|NCT00943722|42041120|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
19592759|NCT00943722|42041121|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
19592760|NCT00943722|42041122|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
19592761|NCT00943722|42041123|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
19592762|NCT00943722|42041117|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
19592763|NCT00943722|42041118|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
19592764|NCT00943722|42041119|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
19592765|NCT00943722|42041120|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
19592766|NCT00943722|42041121|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
19592767|NCT00943722|42041122|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
19592768|NCT00943722|42041123|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
19592769|NCT00943722|42041117|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
19592770|NCT00943722|42041118|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
19592771|NCT00943722|42041119|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
19592772|NCT00943722|42041120|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
19592773|NCT00943722|42041121|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
19592774|NCT00943722|42041122|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
19746272|NCT03510663|42193520|FG000|Overall Study|Withdrawal by Subject|0|||
19746273|NCT03510663|42193521|FG001|Overall Study|Withdrawal by Subject|1|||
19746274|NCT03510663|42193522|FG002|Overall Study|Withdrawal by Subject|0|||
19746275|NCT03510663|42193523|FG003|Overall Study|Withdrawal by Subject|0|||
19746276|NCT03510663|42193524|FG004|Overall Study|Withdrawal by Subject|0|||
19746277|NCT03510663|42193525|FG005|Overall Study|Withdrawal by Subject|0|||
19746278|NCT03510663|42193526|FG006|Overall Study|Withdrawal by Subject|0|||
19746279|NCT03510663|42193527|FG007|Overall Study|Withdrawal by Subject|0|||
19746280|NCT03510273|42193537|FG000|Overall Study|Withdrawal by Subject|2|||
19746281|NCT03510273|42193537|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
19746282|NCT03510273|42193537|FG000|Overall Study|Moved away from study area|4|||
19746283|NCT03582813|42193547|FG000|Overall Study|Lost to Follow-up|18|||
19746284|NCT03582813|42193548|FG001|Overall Study|Lost to Follow-up|21|||
19746285|NCT03582813|42193547|FG000|Overall Study|Withdrawal by Subject|1|||
19746286|NCT03582813|42193548|FG001|Overall Study|Withdrawal by Subject|0|||
19746287|NCT03480009|42193558|FG000|Overall Study|Lost to Follow-up|4|||
19746288|NCT03480009|42193559|FG001|Overall Study|Lost to Follow-up|5|||
19746289|NCT03480009|42193560|FG002|Overall Study|Lost to Follow-up|4|||
19746290|NCT03480009|42193561|FG003|Overall Study|Lost to Follow-up|0|||
19746291|NCT03399786|42193576|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19746292|NCT03399786|42193577|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19746293|NCT03399786|42193578|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19746294|NCT03399786|42193579|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19746295|NCT03399786|42193576|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
19746296|NCT03399786|42193577|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
19746297|NCT03399786|42193578|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
19746298|NCT03399786|42193579|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
19746299|NCT03399786|42193576|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
19746300|NCT03399786|42193577|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
19746301|NCT03399786|42193578|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
19746302|NCT03399786|42193579|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
19746303|NCT03505593|42193587|FG000|Overall Study|Withdrawal by Subject|1|||
19746304|NCT03505593|42193587|FG000|Overall Study|Died before procedure|1|||
19746305|NCT03505593|42193587|FG000|Overall Study|Anatomical abnormality|1|||
19746306|NCT03505593|42193587|FG000|Overall Study|Unable to pass through esophagus|1|||
19746307|NCT03505593|42193587|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
19746308|NCT03504189|42193591|FG000|Overall Study|Withdrawal by Subject|1|||
19746309|NCT03504189|42193591|FG000|Overall Study|Screening Failure|1|||
19592775|NCT00943722|42041123|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
19592776|NCT00943722|42041117|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
19592777|NCT00943722|42041118|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
19592778|NCT00943722|42041119|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
19592779|NCT00943722|42041120|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
19592780|NCT00943722|42041121|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
19592781|NCT00943722|42041122|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
19592782|NCT00943722|42041123|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
19592783|NCT00943722|42041117|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
19592784|NCT00943722|42041118|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
19592785|NCT00943722|42041119|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
19592786|NCT00943722|42041120|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
19592787|NCT00943722|42041121|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
19592788|NCT00943722|42041122|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
19592789|NCT00943722|42041123|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
19592790|NCT00943722|42041117|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
19592791|NCT00943722|42041118|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
19592792|NCT00943722|42041119|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
19592793|NCT00943722|42041120|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
19592794|NCT00943722|42041121|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
19592795|NCT00943722|42041122|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
19592796|NCT00943722|42041123|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
19592797|NCT00901485|42041146|FG000|Overall Study|Lack of Efficacy|0|||
19592798|NCT00901485|42041147|FG001|Overall Study|Lack of Efficacy|2|||
19592799|NCT00901485|42041146|FG000|Overall Study|Withdrawal by Subject|1|||
19592800|NCT00901485|42041147|FG001|Overall Study|Withdrawal by Subject|2|||
19592801|NCT00896337|42041153|FG000|Overall Study|Death|7|||
19592802|NCT00896337|42041153|FG000|Overall Study|Withdrawal by Subject|7|||
19592803|NCT00896337|42041153|FG000|Overall Study|Lost to Follow-up|11|||
19592804|NCT00953706|42041173|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
19592805|NCT00953706|42041174|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
19592806|NCT00953706|42041175|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
19592807|NCT00953706|42041176|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
19592808|NCT00953706|42041173|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
19592809|NCT00953706|42041174|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
19592810|NCT00953706|42041175|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
19592811|NCT00953706|42041176|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
19592812|NCT00953706|42041173|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
19592813|NCT00953706|42041174|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
19592814|NCT00953706|42041175|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
19592815|NCT00953706|42041176|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
19592816|NCT00953706|42041173|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
19592817|NCT00953706|42041174|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
19592818|NCT00953706|42041175|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
19592819|NCT00953706|42041176|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
19592820|NCT00953706|42041173|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
19592821|NCT00953706|42041174|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
19592822|NCT00953706|42041175|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
19592823|NCT00953706|42041176|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
19592824|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
19592825|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
19592826|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
19592827|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
19592828|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
19592829|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
19592830|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
19592831|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
19746310|NCT03504189|42193591|FG000|Overall Study|Device Failure|2|||
19592832|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
19592833|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
19592834|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
19592835|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
19746311|NCT03374358|42193602|FG000|Overall Study|Withdrawal by Subject|0|||
19592836|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
19592837|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
19592838|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
19592839|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
19592840|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
19592841|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
19592842|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
19592843|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
19592844|NCT00953706|42041173|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
19592845|NCT00953706|42041174|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
19592846|NCT00953706|42041175|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
19592847|NCT00953706|42041176|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
19746312|NCT03374358|42193603|FG001|Overall Study|Withdrawal by Subject|2|||
19746313|NCT03372096|42193609|FG000|Overall Study|Study Closed|8|||
19746314|NCT00004859|42193618|FG000|Overall Study|Lack of Efficacy|43|||
19746315|NCT00004859|42193619|FG001|Overall Study|Lack of Efficacy|113|||
19746316|NCT00004859|42193618|FG000|Overall Study|Adverse Event|31|||
19746317|NCT00004859|42193619|FG001|Overall Study|Adverse Event|93|||
19746318|NCT00004859|42193618|FG000|Overall Study|Death|5|||
19746319|NCT00004859|42193619|FG001|Overall Study|Death|5|||
19592848|NCT00940992|42041189|FG000|Overall Study|Adverse Event|2|||
19592849|NCT00940992|42041190|FG001|Overall Study|Adverse Event|0|||
19592850|NCT00940992|42041191|FG002|Overall Study|Adverse Event|1|||
19592851|NCT00940992|42041189|FG000|Overall Study|subject request|2|||
19592852|NCT00940992|42041190|FG001|Overall Study|subject request|1|||
19592853|NCT00940992|42041191|FG002|Overall Study|subject request|0|||
19746320|NCT00004859|42193618|FG000|Overall Study|Withdrawal by Subject|7|||
19746321|NCT00004859|42193619|FG001|Overall Study|Withdrawal by Subject|33|||
19746322|NCT00004859|42193618|FG000|Overall Study|Protocol Violation|2|||
19746323|NCT00004859|42193619|FG001|Overall Study|Protocol Violation|2|||
19746324|NCT00004859|42193618|FG000|Overall Study|other disease|0|||
19746325|NCT00004859|42193619|FG001|Overall Study|other disease|3|||
19746326|NCT00004859|42193618|FG000|Overall Study|error|3|||
19746327|NCT00004859|42193619|FG001|Overall Study|error|1|||
19746328|NCT00004859|42193618|FG000|Overall Study|missing data|14|||
19746329|NCT00004859|42193619|FG001|Overall Study|missing data|11|||
19592854|NCT00940992|42041189|FG000|Overall Study|Lost to Follow-up|0|||
19592855|NCT00940992|42041190|FG001|Overall Study|Lost to Follow-up|1|||
19592856|NCT00940992|42041191|FG002|Overall Study|Lost to Follow-up|1|||
19592857|NCT00938964|42041201|FG000|Overall Study|Death|3|||
19592858|NCT00938964|42041202|FG001|Overall Study|Death|3|||
19592859|NCT00938964|42041201|FG000|Overall Study|Lost to Follow-up|2|||
19592860|NCT00938964|42041202|FG001|Overall Study|Lost to Follow-up|3|||
19592861|NCT00938964|42041201|FG000|Overall Study|Withdrawal by Subject|22|||
19592862|NCT00938964|42041202|FG001|Overall Study|Withdrawal by Subject|18|||
19592863|NCT00938964|42041201|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
19592864|NCT00938964|42041202|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
19592865|NCT00938886|42041210|FG000|Overall Study|Death|0|||
19592866|NCT00938886|42041211|FG001|Overall Study|Death|1|||
19592867|NCT00938886|42041210|FG000|Overall Study|Withdrawal by Subject|4|||
19592868|NCT00938886|42041211|FG001|Overall Study|Withdrawal by Subject|7|||
19592869|NCT00938886|42041210|FG000|Overall Study|Lost to Follow-up|3|||
19592870|NCT00938886|42041211|FG001|Overall Study|Lost to Follow-up|2|||
19592871|NCT00938340|42041217|FG000|Overall Study|Withdrawal by Subject|3|||
19592872|NCT00938340|42041217|FG000|Overall Study|Protocol Violation|1|||
19592873|NCT00938340|42041217|FG000|Overall Study|Adverse Event|1|||
19592874|NCT00942708|42041263|FG000|Overall Study|Withdrawal by Subject|1|||
19592875|NCT00937950|42041268|FG000|Overall Study|Withdrawal by Subject|23|||
19592876|NCT00937950|42041268|FG000|Overall Study|Migrated/moved from study area|27|||
19592877|NCT00937950|42041268|FG000|Overall Study|Lost to Follow-up|144|||
19592878|NCT00937950|42041268|FG000|Overall Study|Missing confirmed|4|||
19592879|NCT00937950|42041268|FG000|Overall Study|Other|18|||
19592880|NCT00942162|42041275|FG000|Overall Study|Death|45|||
19592881|NCT00942162|42041276|FG001|Overall Study|Death|35|||
19592882|NCT00942162|42041277|FG002|Overall Study|Death|0|||
19592883|NCT00942162|42041275|FG000|Overall Study|Withdrawal by Subject|7|||
19592884|NCT00942162|42041276|FG001|Overall Study|Withdrawal by Subject|2|||
19592885|NCT00942162|42041277|FG002|Overall Study|Withdrawal by Subject|0|||
19592886|NCT00942162|42041275|FG000|Overall Study|Lost to Follow-up|4|||
19592887|NCT00942162|42041276|FG001|Overall Study|Lost to Follow-up|0|||
19592888|NCT00942162|42041277|FG002|Overall Study|Lost to Follow-up|0|||
19592889|NCT00942162|42041275|FG000|Overall Study|Other|14|||
19746330|NCT00004859|42193618|FG000|Overall Study|Other|13|||
19746331|NCT00004859|42193619|FG001|Overall Study|Other|21|||
19746332|NCT03500679|42193629|FG000|Overall Study|Lost to Follow-up|6|||
19746333|NCT03500679|42193630|FG001|Overall Study|Lost to Follow-up|3|||
19592890|NCT00942162|42041276|FG001|Overall Study|Other|13|||
19592891|NCT00942162|42041277|FG002|Overall Study|Other|2|||
19592892|NCT00942084|42041287|FG000|Overall Study|Death|2|||
19592893|NCT00941928|42041291|FG000|Overall Study|Withdrawal by Subject|1|||
19746334|NCT03500679|42193629|FG000|Overall Study|Withdrawal by Subject|3|||
19746335|NCT03500679|42193630|FG001|Overall Study|Withdrawal by Subject|0|||
19746336|NCT03348930|42193636|FG000|Washout (1 Week)|Lost to Follow-up|1|||
19746337|NCT03348930|42193637|FG001|Washout (1 Week)|Lost to Follow-up|1|||
19746338|NCT03500211|42193645|FG000|Overall Study|Withdrawal by Subject|1|||
19746339|NCT03500211|42193646|FG001|Overall Study|Withdrawal by Subject|1|||
19746340|NCT03478683|42193654|FG000|Overall Study|Adverse Event|5|||
19746341|NCT03478683|42193655|FG001|Overall Study|Adverse Event|3|||
19746342|NCT03478683|42193654|FG000|Overall Study|Lost to Follow-up|0|||
19746343|NCT03478683|42193655|FG001|Overall Study|Lost to Follow-up|5|||
19746344|NCT03478683|42193654|FG000|Overall Study|Physician Decision|1|||
19746345|NCT03478683|42193655|FG001|Overall Study|Physician Decision|3|||
19746346|NCT03478683|42193654|FG000|Overall Study|Withdrawal by Subject|7|||
19746347|NCT03478683|42193655|FG001|Overall Study|Withdrawal by Subject|7|||
19746348|NCT03478371|42193661|FG000|Overall Study|non-compliance|1|||
19746349|NCT03478371|42193661|FG000|Overall Study|Lost to Follow-up|4|||
19746350|NCT03477903|42193671|FG000|Overall Study|Study Terminated by Sponsor|1|||
19746351|NCT03475875|42193675|FG000|Period 1|Lost to Follow-up|1|||
19746352|NCT03475875|42193676|FG001|Period 1|Lost to Follow-up|0|||
19746353|NCT03475875|42193675|FG000|Period 1|Adverse Event|2|||
19746354|NCT03475875|42193676|FG001|Period 1|Adverse Event|1|||
19746355|NCT03475875|42193675|FG000|Period 2|Adverse Event|3|||
19746356|NCT03475875|42193676|FG001|Period 2|Adverse Event|0|||
19746357|NCT03475875|42193675|FG000|Period 2|Protocol Violation|0|||
19746358|NCT03475875|42193676|FG001|Period 2|Protocol Violation|1|||
19746359|NCT03474081|42193684|FG000|Overall Study|Adverse Event|6|||
19746360|NCT03474081|42193685|FG001|Overall Study|Adverse Event|3|||
19746361|NCT03474081|42193684|FG000|Overall Study|Lost to Follow-up|2|||
19746362|NCT03474081|42193685|FG001|Overall Study|Lost to Follow-up|1|||
19746363|NCT03474081|42193684|FG000|Overall Study|Physician Decision|3|||
19746364|NCT03474081|42193685|FG001|Overall Study|Physician Decision|2|||
19746365|NCT03474081|42193684|FG000|Overall Study|Withdrawal by Subject|5|||
19746366|NCT03474081|42193685|FG001|Overall Study|Withdrawal by Subject|7|||
19746367|NCT03474081|42193684|FG000|Overall Study|Investigator site closed|1|||
19746368|NCT03474081|42193685|FG001|Overall Study|Investigator site closed|0|||
19746369|NCT03346434|42193697|FG000|Overall Study|Randomized in Error|0|||
19592894|NCT00941928|42041291|FG000|Overall Study|Disease Progression|1|||
19592895|NCT00937560|42041295|FG000|Initial Treatment|Death|6|||
19592896|NCT00937560|42041295|FG000|Initial Treatment|Withdraw consent|3|||
19592897|NCT00937560|42041295|FG000|Initial Treatment|Adverse Event|1|||
19592898|NCT00937560|42041295|FG000|Initial Treatment|Lost to Follow-up|1|||
19592899|NCT00937560|42041295|FG000|Initial Treatment|No end of study page|10|||
19592900|NCT00937560|42041295|FG000|Maintenance Treatment|Death|12|||
19592901|NCT00937560|42041295|FG000|Maintenance Treatment|Withdraw consent|5|||
19592902|NCT00937560|42041295|FG000|Maintenance Treatment|According to protocol|1|||
19592903|NCT00594568|42041302|FG000|Initial Treatment|Adverse Event|51|||
19592904|NCT00594568|42041303|FG001|Initial Treatment|Adverse Event|121|||
19592905|NCT00594568|42041304|FG002|Initial Treatment|Adverse Event|144|||
19592906|NCT00594568|42041302|FG000|Initial Treatment|Death|6|||
19592907|NCT00594568|42041303|FG001|Initial Treatment|Death|11|||
19592908|NCT00594568|42041304|FG002|Initial Treatment|Death|15|||
19592909|NCT00594568|42041302|FG000|Initial Treatment|Lost to Follow-up|4|||
19592910|NCT00594568|42041303|FG001|Initial Treatment|Lost to Follow-up|1|||
19592911|NCT00594568|42041304|FG002|Initial Treatment|Lost to Follow-up|4|||
19592912|NCT00594568|42041302|FG000|Initial Treatment|Physician Decision|3|||
19592913|NCT00594568|42041303|FG001|Initial Treatment|Physician Decision|2|||
19592914|NCT00594568|42041304|FG002|Initial Treatment|Physician Decision|4|||
19592915|NCT00594568|42041302|FG000|Initial Treatment|Protocol Violation|2|||
19592916|NCT00594568|42041303|FG001|Initial Treatment|Protocol Violation|2|||
19592917|NCT00594568|42041304|FG002|Initial Treatment|Protocol Violation|5|||
19592918|NCT00594568|42041302|FG000|Initial Treatment|Withdrawal by Subject|25|||
19592919|NCT00594568|42041303|FG001|Initial Treatment|Withdrawal by Subject|31|||
19592920|NCT00594568|42041304|FG002|Initial Treatment|Withdrawal by Subject|46|||
19592921|NCT00594568|42041302|FG000|Initial Treatment|Sponsor decision|193|||
19592922|NCT00594568|42041303|FG001|Initial Treatment|Sponsor decision|142|||
19746370|NCT03346434|42193698|FG001|Overall Study|Randomized in Error|0|||
19746371|NCT03346434|42193699|FG002|Overall Study|Randomized in Error|0|||
19746372|NCT03346434|42193700|FG003|Overall Study|Randomized in Error|0|||
19746373|NCT03346434|42193701|FG004|Overall Study|Randomized in Error|1|||
19746374|NCT03346434|42193702|FG005|Overall Study|Randomized in Error|0|||
19746375|NCT03346434|42193697|FG000|Overall Study|Withdrawal by Subject|0|||
19746376|NCT03346434|42193698|FG001|Overall Study|Withdrawal by Subject|0|||
19746377|NCT03346434|42193699|FG002|Overall Study|Withdrawal by Subject|1|||
19746378|NCT03346434|42193700|FG003|Overall Study|Withdrawal by Subject|0|||
19746379|NCT03346434|42193701|FG004|Overall Study|Withdrawal by Subject|1|||
19592923|NCT00594568|42041304|FG002|Initial Treatment|Sponsor decision|147|||
19592924|NCT00594568|42041302|FG000|Initial Treatment|Caregiver decision|21|||
19592925|NCT00594568|42041303|FG001|Initial Treatment|Caregiver decision|36|||
19592926|NCT00594568|42041304|FG002|Initial Treatment|Caregiver decision|36|||
19592927|NCT00594568|42041302|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
19592928|NCT00594568|42041303|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
19592929|NCT00594568|42041304|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
19592930|NCT00594568|42041302|FG000|Initial Treatment|Entry criteria exclusion|0|||
19592931|NCT00594568|42041303|FG001|Initial Treatment|Entry criteria exclusion|1|||
19592932|NCT00594568|42041304|FG002|Initial Treatment|Entry criteria exclusion|1|||
19592933|NCT00594568|42041302|FG000|Delayed Start|Death|0|||
19592934|NCT00594568|42041303|FG001|Delayed Start|Death|0|||
19592935|NCT00594568|42041304|FG002|Delayed Start|Death|1|||
19592936|NCT00594568|42041302|FG000|Delayed Start|Adverse Event|12|||
19592937|NCT00594568|42041303|FG001|Delayed Start|Adverse Event|2|||
19592938|NCT00594568|42041304|FG002|Delayed Start|Adverse Event|2|||
19592939|NCT00594568|42041302|FG000|Delayed Start|Withdrawal by Subject|4|||
19592940|NCT00594568|42041303|FG001|Delayed Start|Withdrawal by Subject|3|||
19592941|NCT00594568|42041304|FG002|Delayed Start|Withdrawal by Subject|0|||
19592942|NCT00594568|42041302|FG000|Delayed Start|Physician Decision|0|||
19592943|NCT00594568|42041303|FG001|Delayed Start|Physician Decision|0|||
19592944|NCT00594568|42041304|FG002|Delayed Start|Physician Decision|1|||
19592945|NCT00594568|42041302|FG000|Delayed Start|Lost to Follow-up|0|||
19592946|NCT00594568|42041303|FG001|Delayed Start|Lost to Follow-up|0|||
19592947|NCT00594568|42041304|FG002|Delayed Start|Lost to Follow-up|1|||
19592948|NCT00594568|42041302|FG000|Delayed Start|Caregiver Decision|5|||
19592949|NCT00594568|42041303|FG001|Delayed Start|Caregiver Decision|6|||
19592950|NCT00594568|42041304|FG002|Delayed Start|Caregiver Decision|2|||
19592951|NCT00594568|42041302|FG000|Delayed Start|Sponsor Decision|77|||
19592952|NCT00594568|42041303|FG001|Delayed Start|Sponsor Decision|66|||
19592953|NCT00594568|42041304|FG002|Delayed Start|Sponsor Decision|59|||
19592954|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
19592955|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
19592956|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
19592957|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
19592958|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
19592959|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
19592960|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
19592961|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
19592962|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
19592963|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
19592964|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
19592965|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
19592966|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
19592967|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
19592968|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
19592969|NCT00594568|42041302|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
19592970|NCT00594568|42041303|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
19592971|NCT00594568|42041304|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
19592972|NCT00875056|42041332|FG000|Overall Study|Adverse Event|6|||
19592973|NCT00875056|42041333|FG001|Overall Study|Adverse Event|1|||
19592974|NCT00875056|42041334|FG002|Overall Study|Adverse Event|2|||
19592975|NCT00875056|42041332|FG000|Overall Study|Progressive Disease|14|||
19592976|NCT00875056|42041333|FG001|Overall Study|Progressive Disease|8|||
19592977|NCT00875056|42041334|FG002|Overall Study|Progressive Disease|3|||
19592978|NCT00875056|42041332|FG000|Overall Study|Withdrawal by Subject|3|||
19592979|NCT00875056|42041333|FG001|Overall Study|Withdrawal by Subject|0|||
19592980|NCT00875056|42041334|FG002|Overall Study|Withdrawal by Subject|1|||
19592981|NCT00940602|42041344|FG000|Overall Study|Administrative problems|1|||
19592982|NCT00940602|42041345|FG001|Overall Study|Administrative problems|1|||
19592983|NCT00940602|42041344|FG000|Overall Study|Patient/guardian decision|13|||
19592984|NCT00940602|42041345|FG001|Overall Study|Patient/guardian decision|28|||
19592985|NCT00940602|42041344|FG000|Overall Study|Physician Decision|8|||
19592986|NCT00940602|42041345|FG001|Overall Study|Physician Decision|5|||
19592987|NCT00940602|42041344|FG000|Overall Study|Pregnancy|1|||
19592988|NCT00940602|42041345|FG001|Overall Study|Pregnancy|0|||
19592989|NCT00940602|42041344|FG000|Overall Study|Protocol Deviation (untreated)|1|||
19592990|NCT00940602|42041345|FG001|Overall Study|Protocol Deviation (untreated)|0|||
19592991|NCT00940602|42041344|FG000|Overall Study|Disease progression|8|||
19592992|NCT00940602|42041345|FG001|Overall Study|Disease progression|2|||
19592993|NCT00940602|42041344|FG000|Overall Study|Death|38|||
19592994|NCT00940602|42041345|FG001|Overall Study|Death|19|||
19592995|NCT00940602|42041344|FG000|Overall Study|Lost to Follow-up|3|||
19592996|NCT00940602|42041345|FG001|Overall Study|Lost to Follow-up|1|||
19592997|NCT00940602|42041344|FG000|Overall Study|Patient withdrew consent|26|||
19592998|NCT00940602|42041345|FG001|Overall Study|Patient withdrew consent|13|||
19592999|NCT00940602|42041344|FG000|Overall Study|Adverse Event|7|||
19593000|NCT00940602|42041345|FG001|Overall Study|Adverse Event|2|||
19593001|NCT00940602|42041344|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
19593002|NCT00940602|42041345|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
19593003|NCT00874822|42041352|FG000|Overall Study|excluded by criteria|8|||
19593004|NCT00875524|42041358|FG000|Overall Study|Serious adverse event|0|||
19593005|NCT00875524|42041359|FG001|Overall Study|Serious adverse event|1|||
19593006|NCT00875524|42041358|FG000|Overall Study|Protocol Violation|4|||
19593007|NCT00875524|42041359|FG001|Overall Study|Protocol Violation|0|||
19593008|NCT00875524|42041358|FG000|Overall Study|Lost to Follow-up|1|||
19593009|NCT00875524|42041359|FG001|Overall Study|Lost to Follow-up|0|||
19593010|NCT00875524|42041358|FG000|Overall Study|Withdrawal by Subject|3|||
19593011|NCT00875524|42041359|FG001|Overall Study|Withdrawal by Subject|5|||
19593012|NCT01094288|42041373|FG000|Overall Study|Adverse Event|0|||
19593013|NCT01094288|42041374|FG001|Overall Study|Adverse Event|3|||
19593014|NCT01094288|42041375|FG002|Overall Study|Adverse Event|1|||
19593015|NCT01094288|42041376|FG003|Overall Study|Adverse Event|1|||
19593016|NCT01094288|42041377|FG004|Overall Study|Adverse Event|0|||
19593017|NCT01094288|42041378|FG005|Overall Study|Adverse Event|0|||
19593018|NCT01094288|42041379|FG006|Overall Study|Adverse Event|0|||
19593019|NCT01094288|42041380|FG007|Overall Study|Adverse Event|0|||
19593020|NCT01094288|42041373|FG000|Overall Study|Withdrawal by Subject|0|||
19593021|NCT01094288|42041374|FG001|Overall Study|Withdrawal by Subject|1|||
19593022|NCT01094288|42041375|FG002|Overall Study|Withdrawal by Subject|2|||
19593023|NCT01094288|42041376|FG003|Overall Study|Withdrawal by Subject|0|||
19593024|NCT01094288|42041377|FG004|Overall Study|Withdrawal by Subject|0|||
19593025|NCT01094288|42041378|FG005|Overall Study|Withdrawal by Subject|0|||
19593026|NCT01094288|42041379|FG006|Overall Study|Withdrawal by Subject|0|||
19593027|NCT01094288|42041380|FG007|Overall Study|Withdrawal by Subject|2|||
19593028|NCT01094288|42041373|FG000|Overall Study|Initiation of Alternative Therapy|0|||
19593029|NCT01094288|42041374|FG001|Overall Study|Initiation of Alternative Therapy|0|||
19593030|NCT01094288|42041375|FG002|Overall Study|Initiation of Alternative Therapy|1|||
19593031|NCT01094288|42041376|FG003|Overall Study|Initiation of Alternative Therapy|0|||
19746380|NCT03346434|42193702|FG005|Overall Study|Withdrawal by Subject|0|||
19746381|NCT03346434|42193697|FG000|Overall Study|Lost to Follow-up|0|||
19746382|NCT03346434|42193698|FG001|Overall Study|Lost to Follow-up|0|||
19746383|NCT03346434|42193699|FG002|Overall Study|Lost to Follow-up|0|||
19746384|NCT03346434|42193700|FG003|Overall Study|Lost to Follow-up|0|||
19746385|NCT03346434|42193701|FG004|Overall Study|Lost to Follow-up|1|||
19746386|NCT03346434|42193702|FG005|Overall Study|Lost to Follow-up|1|||
19746387|NCT03346434|42193697|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
19746388|NCT03346434|42193698|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
19746389|NCT03346434|42193699|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
19746390|NCT03346434|42193700|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
19746391|NCT03346434|42193701|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
19746392|NCT03346434|42193702|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
19746393|NCT03393000|42193720|FG000|Overall Study|Death|11|||
19746394|NCT03393000|42193720|FG000|Overall Study|Withdrawal by Subject|2|||
19746395|NCT03393000|42193720|FG000|Overall Study|Physician Decision|1|||
19746396|NCT03370770|42193724|FG000|Overall Study|Patient was followed in another hospital center|1|||
19746397|NCT03370770|42193724|FG000|Overall Study|Progressive Disease|98|||
19746398|NCT03370770|42193724|FG000|Overall Study|Adverse Event|2|||
19746399|NCT03370770|42193724|FG000|Overall Study|Death|5|||
19746400|NCT03473301|42193731|FG000|Overall Study|Protocol Violation|4|||
19746401|NCT03473301|42193732|FG001|Overall Study|Protocol Violation|0|||
19593032|NCT01094288|42041377|FG004|Overall Study|Initiation of Alternative Therapy|0|||
19746402|NCT03473301|42193733|FG002|Overall Study|Protocol Violation|0|||
19746403|NCT03473301|42193731|FG000|Overall Study|Withdrawal by Subject|0|||
19593033|NCT01094288|42041378|FG005|Overall Study|Initiation of Alternative Therapy|0|||
19593034|NCT01094288|42041379|FG006|Overall Study|Initiation of Alternative Therapy|0|||
19593035|NCT01094288|42041380|FG007|Overall Study|Initiation of Alternative Therapy|0|||
19593036|NCT01094288|42041373|FG000|Overall Study|Reason not Specified|2|||
19593037|NCT01094288|42041374|FG001|Overall Study|Reason not Specified|3|||
19593038|NCT01094288|42041375|FG002|Overall Study|Reason not Specified|0|||
19593039|NCT01094288|42041376|FG003|Overall Study|Reason not Specified|1|||
19593040|NCT01094288|42041377|FG004|Overall Study|Reason not Specified|0|||
19593041|NCT01094288|42041378|FG005|Overall Study|Reason not Specified|0|||
19593042|NCT01094288|42041379|FG006|Overall Study|Reason not Specified|0|||
19593043|NCT01094288|42041380|FG007|Overall Study|Reason not Specified|0|||
19593044|NCT01094288|42041373|FG000|Overall Study|Ongoing Participants|0|||
19593045|NCT01094288|42041374|FG001|Overall Study|Ongoing Participants|3|||
19593046|NCT01094288|42041375|FG002|Overall Study|Ongoing Participants|0|||
19593047|NCT01094288|42041376|FG003|Overall Study|Ongoing Participants|0|||
19593048|NCT01094288|42041377|FG004|Overall Study|Ongoing Participants|0|||
19593049|NCT01094288|42041378|FG005|Overall Study|Ongoing Participants|0|||
19593050|NCT01094288|42041379|FG006|Overall Study|Ongoing Participants|0|||
19593051|NCT01094288|42041380|FG007|Overall Study|Ongoing Participants|0|||
19593052|NCT00874120|42041404|FG000|First Intervention|Adverse Event|0|||
19593053|NCT00874120|42041405|FG001|First Intervention|Adverse Event|1|||
19593054|NCT00874120|42041404|FG000|First Intervention|Withdrawal by Subject|2|||
19593055|NCT00874120|42041405|FG001|First Intervention|Withdrawal by Subject|0|||
19593056|NCT00874120|42041404|FG000|First Intervention|Lost to Follow-up|0|||
19593057|NCT00874120|42041405|FG001|First Intervention|Lost to Follow-up|1|||
19593058|NCT00874120|42041404|FG000|First Intervention|Protocol Violation|3|||
19746404|NCT03473301|42193732|FG001|Overall Study|Withdrawal by Subject|1|||
19746405|NCT03473301|42193733|FG002|Overall Study|Withdrawal by Subject|0|||
19746406|NCT03473301|42193731|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
19746407|NCT03473301|42193732|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
19746408|NCT03473301|42193733|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
19746409|NCT03390426|42193745|FG000|Overall Study|Protocol Violation|0|||
19746410|NCT03390426|42193746|FG001|Overall Study|Protocol Violation|1|||
19746411|NCT03472521|42193754|FG000|Overall Study|Lost to Follow-up|3|||
19746412|NCT03472521|42193755|FG001|Overall Study|Lost to Follow-up|2|||
19746413|NCT03472521|42193754|FG000|Overall Study|Discontinued intervention|3|||
19746414|NCT03472521|42193755|FG001|Overall Study|Discontinued intervention|1|||
19746415|NCT02906020|42193771|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
19746416|NCT02906020|42193772|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
19746417|NCT02906020|42193773|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
19746418|NCT02906020|42193774|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
19746419|NCT02906020|42193775|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
19746420|NCT02906020|42193776|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
19746421|NCT02906020|42193777|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
19746422|NCT02906020|42193778|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
19746423|NCT02906020|42193779|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
19746424|NCT02906020|42193780|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
19746425|NCT02906020|42193781|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
19746426|NCT02906020|42193782|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
19746427|NCT02906020|42193783|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
19746428|NCT02906020|42193784|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
19593059|NCT00874120|42041405|FG001|First Intervention|Protocol Violation|0|||
19593060|NCT00874120|42041404|FG000|First Intervention|positive drug test|1|||
19593061|NCT00874120|42041405|FG001|First Intervention|positive drug test|0|||
19593062|NCT00874120|42041404|FG000|Second Intervention|Withdrawal by Subject|1|||
19593063|NCT00874120|42041405|FG001|Second Intervention|Withdrawal by Subject|0|||
19593064|NCT00874120|42041404|FG000|Second Intervention|Protocol Violation|1|||
19593065|NCT00874120|42041405|FG001|Second Intervention|Protocol Violation|0|||
19593066|NCT00939822|42041413|FG000|Overall Study|Lost to Follow-up|1|||
19593067|NCT00939822|42041414|FG001|Overall Study|Lost to Follow-up|0|||
19593068|NCT00939822|42041413|FG000|Overall Study|withdrew from study due to busy schedule|1|||
19593069|NCT00939822|42041414|FG001|Overall Study|withdrew from study due to busy schedule|1|||
19593070|NCT00939822|42041413|FG000|Overall Study|Mental health issues|0|||
19593071|NCT00939822|42041414|FG001|Overall Study|Mental health issues|2|||
19593072|NCT00939510|42041420|FG000|Overall Study|Withdrawal by Subject|1|||
19593073|NCT01098266|42041426|FG000|Overall Study|Physician Decision|1|||
19593074|NCT01098266|42041427|FG001|Overall Study|Physician Decision|0|||
19593075|NCT01098266|42041426|FG000|Overall Study|Death|3|||
19593076|NCT01098266|42041427|FG001|Overall Study|Death|2|||
19593077|NCT01098266|42041426|FG000|Overall Study|Withdrawal by Subject|3|||
19593078|NCT01098266|42041427|FG001|Overall Study|Withdrawal by Subject|5|||
19593079|NCT00935532|42041435|FG000|Overall Study|Adverse Event|11|||
19593080|NCT00935532|42041436|FG001|Overall Study|Adverse Event|6|||
19593081|NCT00935532|42041435|FG000|Overall Study|Death|1|||
19746429|NCT02906020|42193785|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
19387994|NCT02038036|41631321|FG000|Core Study|Withdrawal by Subject|3|||
19593082|NCT00935532|42041436|FG001|Overall Study|Death|0|||
19593083|NCT00935532|42041435|FG000|Overall Study|Lost to Follow-up|1|||
19593084|NCT00935532|42041436|FG001|Overall Study|Lost to Follow-up|0|||
19593085|NCT00935532|42041435|FG000|Overall Study|Physician Decision|1|||
19593086|NCT00935532|42041436|FG001|Overall Study|Physician Decision|2|||
19746430|NCT02906020|42193786|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
19746431|NCT02906020|42193771|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746432|NCT02906020|42193772|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746433|NCT02906020|42193773|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746434|NCT02906020|42193774|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746435|NCT02906020|42193775|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746436|NCT02906020|42193776|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746437|NCT02906020|42193777|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746438|NCT02906020|42193778|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746439|NCT02906020|42193779|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
19593087|NCT00935532|42041435|FG000|Overall Study|Protocol Violation|2|||
19593088|NCT00935532|42041436|FG001|Overall Study|Protocol Violation|1|||
19593089|NCT00935532|42041435|FG000|Overall Study|Subject Decision|2|||
19593090|NCT00935532|42041436|FG001|Overall Study|Subject Decision|1|||
19593091|NCT00935532|42041435|FG000|Overall Study|Sponsor Decision|0|||
19593092|NCT00935532|42041436|FG001|Overall Study|Sponsor Decision|1|||
19593093|NCT00935532|42041435|FG000|Overall Study|Loss Glucose Control|4|||
19593094|NCT00935532|42041436|FG001|Overall Study|Loss Glucose Control|0|||
19593095|NCT01093586|42041442|FG000|Overall Study|Failed to engraft|3|||
19593096|NCT00937404|42041446|FG000|Overall Study|Protocol Violation|1|||
19593097|NCT00937404|42041446|FG000|Overall Study|Withdrawal by Subject|1|||
19593098|NCT01098110|42041453|FG000|Overall Study|Withdrawal by Subject|14|||
19593099|NCT01098110|42041454|FG001|Overall Study|Withdrawal by Subject|24|||
19593100|NCT01098110|42041455|FG002|Overall Study|Withdrawal by Subject|19|||
19593101|NCT01098110|42041453|FG000|Overall Study|Adverse Event|30|||
19593102|NCT01098110|42041454|FG001|Overall Study|Adverse Event|32|||
19593103|NCT01098110|42041455|FG002|Overall Study|Adverse Event|43|||
19593104|NCT01098110|42041453|FG000|Overall Study|Lack of Efficacy|13|||
19593105|NCT01098110|42041454|FG001|Overall Study|Lack of Efficacy|9|||
19593106|NCT01098110|42041455|FG002|Overall Study|Lack of Efficacy|27|||
19593107|NCT01098110|42041453|FG000|Overall Study|Other|4|||
19593108|NCT01098110|42041454|FG001|Overall Study|Other|7|||
19593109|NCT01098110|42041455|FG002|Overall Study|Other|5|||
19593110|NCT01098110|42041453|FG000|Overall Study|Untreated|1|||
19593111|NCT01098110|42041454|FG001|Overall Study|Untreated|1|||
19593112|NCT01098110|42041455|FG002|Overall Study|Untreated|0|||
19593113|NCT01092728|42041465|FG000|Overall Study|Withdrawal by Subject|2|||
19593114|NCT01092728|42041466|FG001|Overall Study|Withdrawal by Subject|0|||
19593115|NCT01092728|42041465|FG000|Overall Study|Adverse Event|0|||
19593116|NCT01092728|42041466|FG001|Overall Study|Adverse Event|1|||
19593117|NCT01092728|42041465|FG000|Overall Study|Disease Progression|1|||
19593118|NCT01092728|42041466|FG001|Overall Study|Disease Progression|13|||
19593119|NCT01092728|42041465|FG000|Overall Study|Prohibited Concomitant Medications|1|||
19593120|NCT01092728|42041466|FG001|Overall Study|Prohibited Concomitant Medications|0|||
19593121|NCT01096550|42041474|FG000|Overall Study|discontinued site|10|||
19593122|NCT01096550|42041475|FG001|Overall Study|discontinued site|11|||
19593123|NCT01096550|42041474|FG000|Overall Study|non-regular treatment track at clinic|1|||
19593124|NCT01096550|42041475|FG001|Overall Study|non-regular treatment track at clinic|1|||
19593125|NCT01096550|42041474|FG000|Overall Study|clinic readmission|1|||
19593126|NCT01096550|42041475|FG001|Overall Study|clinic readmission|1|||
19593127|NCT01096550|42041474|FG000|Overall Study|Withdrawal by Subject|0|||
19593128|NCT01096550|42041475|FG001|Overall Study|Withdrawal by Subject|1|||
19593129|NCT01096550|42041474|FG000|Overall Study|non-African American participant|13|||
19593130|NCT01096550|42041475|FG001|Overall Study|non-African American participant|6|||
19593131|NCT01096550|42041474|FG000|Overall Study|Lost to Follow-up|12|||
19593132|NCT01096550|42041475|FG001|Overall Study|Lost to Follow-up|9|||
19593133|NCT01101542|42041481|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
19593134|NCT01101542|42041481|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
19593135|NCT01101542|42041481|FG000|Year 4 Surveillance Period|Other|287|||
19593136|NCT01101542|42041481|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
19593137|NCT01101542|42041481|FG000|Year 5 Surveillance Period|Pregnancy|1|||
19593138|NCT01101542|42041481|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
19593139|NCT01101542|42041481|FG000|Year 6 Surveillance Period|Pregnancy|1|||
19593140|NCT01101542|42041481|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
19593141|NCT00937326|42041490|FG000|Overall Study|Adverse Event|0|||
19593142|NCT00937326|42041491|FG001|Overall Study|Adverse Event|3|||
19593143|NCT00937326|42041492|FG002|Overall Study|Adverse Event|1|||
19593144|NCT00937326|42041493|FG003|Overall Study|Adverse Event|1|||
19593145|NCT00937326|42041494|FG004|Overall Study|Adverse Event|2|||
19593146|NCT00937326|42041490|FG000|Overall Study|Death|0|||
19593147|NCT00937326|42041491|FG001|Overall Study|Death|0|||
19593148|NCT00937326|42041492|FG002|Overall Study|Death|1|||
19593149|NCT00937326|42041493|FG003|Overall Study|Death|0|||
19593150|NCT00937326|42041494|FG004|Overall Study|Death|0|||
19593151|NCT00937326|42041490|FG000|Overall Study|Withdrawal by Subject|3|||
19593152|NCT00937326|42041491|FG001|Overall Study|Withdrawal by Subject|4|||
19593153|NCT00937326|42041492|FG002|Overall Study|Withdrawal by Subject|1|||
19593154|NCT00937326|42041493|FG003|Overall Study|Withdrawal by Subject|4|||
19593155|NCT00937326|42041494|FG004|Overall Study|Withdrawal by Subject|3|||
19593156|NCT00937326|42041490|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
19593157|NCT00937326|42041491|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
19593158|NCT00937326|42041492|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
19593159|NCT00937326|42041493|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
19593160|NCT00937326|42041494|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
19593161|NCT00873730|42041513|FG000|Overall Study|Protocol Deviation|5|||
19593162|NCT00873730|42041514|FG001|Overall Study|Protocol Deviation|2|||
19593163|NCT00873730|42041513|FG000|Overall Study|Adverse Event|0|||
19593164|NCT00873730|42041514|FG001|Overall Study|Adverse Event|2|||
19593165|NCT00873730|42041513|FG000|Overall Study|Withdrawal by Subject|0|||
19593166|NCT00873730|42041514|FG001|Overall Study|Withdrawal by Subject|1|||
19593167|NCT00873730|42041513|FG000|Overall Study|Sponsor decision|1|||
19593168|NCT00873730|42041514|FG001|Overall Study|Sponsor decision|0|||
19593169|NCT01092416|42041520|FG000|Enrollment|Atherectomy device not inserted|3|||
19593170|NCT01092416|42041520|FG000|30-Day Follow-up|Death|2|||
19593171|NCT01092416|42041520|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
19593172|NCT01092416|42041520|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
19593173|NCT01092416|42041520|FG000|12-Month Follow-up|Death|16|||
19593174|NCT01092416|42041520|FG000|12-Month Follow-up|Lost to Follow-up|4|||
19593175|NCT01092416|42041520|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
19593176|NCT01092416|42041520|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
19593177|NCT01092416|42041520|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
19593178|NCT00874432|42041531|FG000|Overall Study|Withdrawal by Subject|1|||
19593179|NCT00874432|42041532|FG001|Overall Study|Withdrawal by Subject|0|||
19593180|NCT00874432|42041533|FG002|Overall Study|Withdrawal by Subject|0|||
19593181|NCT00874432|42041534|FG003|Overall Study|Withdrawal by Subject|0|||
19593182|NCT00874432|42041531|FG000|Overall Study|Physician Decision|1|||
19593183|NCT00874432|42041532|FG001|Overall Study|Physician Decision|0|||
19593184|NCT00874432|42041533|FG002|Overall Study|Physician Decision|0|||
19593185|NCT00874432|42041534|FG003|Overall Study|Physician Decision|0|||
19593186|NCT00874432|42041531|FG000|Overall Study|Other|1|||
19593187|NCT00874432|42041532|FG001|Overall Study|Other|2|||
19593188|NCT00874432|42041533|FG002|Overall Study|Other|8|||
19593189|NCT00874432|42041534|FG003|Overall Study|Other|3|||
19593190|NCT00935220|42041546|FG000|Overall Study|Adverse Event|1|||
19593191|NCT00935220|42041546|FG000|Overall Study|Other reason (not specified)|1|||
19593192|NCT00874276|42041552|FG000|Overall Study|Withdrawal by Subject|1|||
19387995|NCT02038036|41631322|FG001|Core Study|Withdrawal by Subject|1|||
19593193|NCT00874276|42041553|FG001|Overall Study|Withdrawal by Subject|1|||
19593194|NCT00594958|42041564|FG000|Overall Study|Withdrawal by Subject|1|||
19593195|NCT00594958|42041565|FG001|Overall Study|Withdrawal by Subject|0|||
19593196|NCT00594958|42041566|FG002|Overall Study|Withdrawal by Subject|1|||
19593197|NCT00594958|42041564|FG000|Overall Study|Adverse Event|4|||
19593198|NCT00594958|42041565|FG001|Overall Study|Adverse Event|1|||
19593199|NCT00594958|42041566|FG002|Overall Study|Adverse Event|2|||
19593200|NCT00594958|42041564|FG000|Overall Study|Pregnancy|0|||
19593201|NCT00594958|42041565|FG001|Overall Study|Pregnancy|2|||
19593202|NCT00594958|42041566|FG002|Overall Study|Pregnancy|0|||
19593203|NCT00594958|42041564|FG000|Overall Study|Protocol Violation|1|||
19593204|NCT00594958|42041565|FG001|Overall Study|Protocol Violation|0|||
19593205|NCT00594958|42041566|FG002|Overall Study|Protocol Violation|2|||
19593206|NCT00594958|42041564|FG000|Overall Study|Lost to Follow-up|5|||
19593207|NCT00594958|42041565|FG001|Overall Study|Lost to Follow-up|0|||
19593208|NCT00594958|42041566|FG002|Overall Study|Lost to Follow-up|3|||
19593209|NCT00594958|42041564|FG000|Overall Study|administrative|3|||
19593210|NCT00594958|42041565|FG001|Overall Study|administrative|0|||
19593211|NCT00594958|42041566|FG002|Overall Study|administrative|2|||
19593212|NCT00594880|42041576|FG000|Overall Study|Withdrawal by Subject|1|||
19593213|NCT00594880|42041577|FG001|Overall Study|Withdrawal by Subject|1|||
19593214|NCT00594880|42041576|FG000|Overall Study|Lost to Follow-up|1|||
19593215|NCT00594880|42041577|FG001|Overall Study|Lost to Follow-up|0|||
19593216|NCT00871858|42041589|FG000|Overall Study|Protocol Violation|3|||
19593217|NCT00871858|42041590|FG001|Overall Study|Protocol Violation|4|||
19593218|NCT00871858|42041589|FG000|Overall Study|Adverse Event|1|||
19593219|NCT00871858|42041590|FG001|Overall Study|Adverse Event|1|||
19593220|NCT00871858|42041589|FG000|Overall Study|Withdrawal by Subject|1|||
19593221|NCT00871858|42041590|FG001|Overall Study|Withdrawal by Subject|1|||
19593222|NCT00871858|42041589|FG000|Overall Study|Lost to Follow-up|0|||
19593223|NCT00871858|42041590|FG001|Overall Study|Lost to Follow-up|1|||
19593224|NCT00871780|42041596|FG000|Overall Study|Enrolled But Not Treated|6|||
19593225|NCT00871780|42041596|FG000|Overall Study|Withdrawal by Subject|9|||
19593226|NCT00871780|42041596|FG000|Overall Study|Adverse Event|6|||
19593227|NCT00871780|42041596|FG000|Overall Study|Voluntary Discontinuation|4|||
19593228|NCT00871780|42041596|FG000|Overall Study|Death|1|||
19593229|NCT00871780|42041596|FG000|Overall Study|Physician Decision|1|||
19593230|NCT00594178|42041603|FG000|Overall Study|Physician Decision|5|||
19593231|NCT00933270|42041607|FG000|Overall Study|Withdrawal by Subject|26|||
19593232|NCT00933270|42041607|FG000|Overall Study|Insufficient Follow-up|10|||
19593233|NCT00933270|42041607|FG000|Overall Study|Lost to Follow-up|14|||
19593234|NCT00933270|42041607|FG000|Overall Study|Adverse Event|1|||
19593235|NCT00933270|42041607|FG000|Overall Study|Missed Visit|2|||
19593236|NCT00933270|42041607|FG000|Overall Study|Death|24|||
19593237|NCT00933270|42041607|FG000|Overall Study|Moved or would not return|10|||
19593238|NCT00936858|42041612|FG000|Overall Study|Death|3|||
19593239|NCT00936858|42041612|FG000|Overall Study|Progression|29|||
19593240|NCT00936858|42041612|FG000|Overall Study|Withdrawal by Subject|5|||
19593241|NCT00936858|42041612|FG000|Overall Study|Adverse Event|1|||
19593242|NCT00936858|42041612|FG000|Overall Study|Physician Decision|7|||
19593243|NCT00936858|42041612|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
19593244|NCT00936858|42041612|FG000|Overall Study|Lost to Follow-up|1|||
19593245|NCT00872170|42041619|FG000|Overall Study|Adverse Event|1|||
19593246|NCT00872170|42041620|FG001|Overall Study|Adverse Event|0|||
19593247|NCT00936702|42041625|FG000|Overall Study|Disease progression|34|||
19593248|NCT00936702|42041625|FG000|Overall Study|Adverse Event|8|||
19593249|NCT00936702|42041625|FG000|Overall Study|Withdrawal by Subject|2|||
19593250|NCT00936702|42041625|FG000|Overall Study|Alternative Treatment|1|||
19593251|NCT00936702|42041625|FG000|Overall Study|Other|1|||
19593252|NCT00594100|42041629|FG000|Procedure|Technical Failure|9|||
19593253|NCT00594100|42041629|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
19593254|NCT00594100|42041629|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
19593255|NCT00594100|42041629|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
19593256|NCT01092182|42041636|FG000|Overall Study|Death|0|||
19593257|NCT01092182|42041637|FG001|Overall Study|Death|5|||
19593258|NCT01092182|42041638|FG002|Overall Study|Death|3|||
19593259|NCT01092182|42041636|FG000|Overall Study|participant safety|1|||
19593260|NCT01092182|42041637|FG001|Overall Study|participant safety|2|||
19593261|NCT01092182|42041638|FG002|Overall Study|participant safety|0|||
19593262|NCT01092182|42041636|FG000|Overall Study|Physician Decision|0|||
19593263|NCT01092182|42041637|FG001|Overall Study|Physician Decision|6|||
19593264|NCT01092182|42041638|FG002|Overall Study|Physician Decision|0|||
19593265|NCT01092182|42041636|FG000|Overall Study|Did not meet criteria|0|||
19593266|NCT01092182|42041637|FG001|Overall Study|Did not meet criteria|0|||
19593267|NCT01092182|42041638|FG002|Overall Study|Did not meet criteria|25|||
19593268|NCT01092182|42041636|FG000|Overall Study|Non-compliance|0|||
19593269|NCT01092182|42041637|FG001|Overall Study|Non-compliance|3|||
19593270|NCT01092182|42041638|FG002|Overall Study|Non-compliance|0|||
19593271|NCT01092182|42041636|FG000|Overall Study|Participant refused follow-up|0|||
19387996|NCT02038036|41631321|FG000|Crossover Period|Withdrawal by Subject|0|||
19387997|NCT02038036|41631322|FG001|Crossover Period|Withdrawal by Subject|3|||
19387998|NCT02038036|41631321|FG000|Crossover Period|Adverse Event|0|||
19593272|NCT01092182|42041637|FG001|Overall Study|Participant refused follow-up|2|||
19593273|NCT01092182|42041638|FG002|Overall Study|Participant refused follow-up|0|||
19593274|NCT00932646|42041646|FG000|Overall Study|Adverse Event|2|||
19593275|NCT00932646|42041647|FG001|Overall Study|Adverse Event|1|||
19593276|NCT00932646|42041648|FG002|Overall Study|Adverse Event|1|||
19593277|NCT00932646|42041649|FG003|Overall Study|Adverse Event|1|||
19593278|NCT00932646|42041646|FG000|Overall Study|Lost to Follow-up|2|||
19593279|NCT00932646|42041647|FG001|Overall Study|Lost to Follow-up|1|||
19593280|NCT00932646|42041648|FG002|Overall Study|Lost to Follow-up|0|||
19593281|NCT00932646|42041649|FG003|Overall Study|Lost to Follow-up|0|||
19593282|NCT00932646|42041646|FG000|Overall Study|Withdrawal by Subject|1|||
19593283|NCT00932646|42041647|FG001|Overall Study|Withdrawal by Subject|1|||
19593284|NCT00932646|42041648|FG002|Overall Study|Withdrawal by Subject|3|||
19593285|NCT00932646|42041649|FG003|Overall Study|Withdrawal by Subject|0|||
19593286|NCT00871234|42041663|FG000|Overall Study|Adverse Event|2|||
19593287|NCT00871234|42041663|FG000|Overall Study|Lost to Follow-up|3|||
19593288|NCT01091246|42041670|FG000|Overall Study|Lost to Follow-up|23|||
19593289|NCT01091246|42041671|FG001|Overall Study|Lost to Follow-up|11|||
19593290|NCT01091246|42041672|FG002|Overall Study|Lost to Follow-up|7|||
19593291|NCT01091246|42041670|FG000|Overall Study|Adverse Event|1|||
19593292|NCT01091246|42041671|FG001|Overall Study|Adverse Event|0|||
19593293|NCT01091246|42041672|FG002|Overall Study|Adverse Event|1|||
19593294|NCT01091246|42041670|FG000|Overall Study|Withdrawal by Subject|9|||
19593295|NCT01091246|42041671|FG001|Overall Study|Withdrawal by Subject|5|||
19593296|NCT01091246|42041672|FG002|Overall Study|Withdrawal by Subject|4|||
19746440|NCT02906020|42193780|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
19593297|NCT01091246|42041670|FG000|Overall Study|Subject not dosed|2|||
19593298|NCT01091246|42041671|FG001|Overall Study|Subject not dosed|0|||
19593299|NCT01091246|42041672|FG002|Overall Study|Subject not dosed|1|||
19593300|NCT01097330|42041684|FG000|Overall Study|Study terminated early|7|||
19593301|NCT01097330|42041685|FG001|Overall Study|Study terminated early|5|||
19387999|NCT02038036|41631322|FG001|Crossover Period|Adverse Event|9|||
19593302|NCT00934440|42041691|FG000|Overall Study|Lost to Follow-up|1|||
19593303|NCT00934362|42041698|FG000|Overall Study|Adverse Event|1|||
19593304|NCT00934362|42041699|FG001|Overall Study|Adverse Event|0|||
19593305|NCT00934128|42041707|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
19593306|NCT00934128|42041708|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
19593307|NCT00934128|42041707|FG000|First Intervention (2 Hours)|Adverse Event|4|||
19593308|NCT00934128|42041708|FG001|First Intervention (2 Hours)|Adverse Event|1|||
19593309|NCT00934128|42041707|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
19593310|NCT00934128|42041708|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
19593311|NCT00934128|42041707|FG000|Washout Period (1 Hour)|Patient preference|1|||
19593312|NCT00934128|42041708|FG001|Washout Period (1 Hour)|Patient preference|3|||
19593313|NCT00934128|42041707|FG000|Washout Period (1 Hour)|Pain|1|||
19593314|NCT00934128|42041708|FG001|Washout Period (1 Hour)|Pain|0|||
19593315|NCT00934128|42041707|FG000|Washout Period (1 Hour)|Too tired|1|||
19593316|NCT00934128|42041708|FG001|Washout Period (1 Hour)|Too tired|0|||
19593317|NCT00934128|42041707|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
19593318|NCT00934128|42041708|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
19593319|NCT00934128|42041707|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
19593320|NCT00934128|42041708|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
19593321|NCT00871000|42041716|FG000|Overall Study|Withdrawal by Subject|1|||
19593322|NCT00871000|42041717|FG001|Overall Study|Withdrawal by Subject|0|||
19593323|NCT01096784|42041725|FG000|Overall Study|Withdrawal by Subject|2|||
19593324|NCT01096784|42041726|FG001|Overall Study|Withdrawal by Subject|1|||
19593325|NCT01096784|42041725|FG000|Overall Study|Adverse Event|11|||
19593326|NCT01096784|42041726|FG001|Overall Study|Adverse Event|9|||
19593327|NCT01096784|42041725|FG000|Overall Study|Protocol Deviation|2|||
19593328|NCT01096784|42041726|FG001|Overall Study|Protocol Deviation|2|||
19593329|NCT01096784|42041725|FG000|Overall Study|Administrative Decision|0|||
19593330|NCT01096784|42041726|FG001|Overall Study|Administrative Decision|1|||
19593331|NCT01096784|42041725|FG000|Overall Study|Other Unspecified|0|||
19593332|NCT01096784|42041726|FG001|Overall Study|Other Unspecified|1|||
19593333|NCT00934050|42041740|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
19593334|NCT00934050|42041741|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
19593335|NCT00934050|42041742|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
19593336|NCT00934050|42041743|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
19593337|NCT00934050|42041744|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
19593338|NCT00934050|42041745|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
19593339|NCT00934050|42041740|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
19593340|NCT00934050|42041741|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
19593341|NCT00934050|42041742|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
19593342|NCT00934050|42041743|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
19593343|NCT00934050|42041744|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
19593344|NCT00934050|42041745|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
19593345|NCT00934050|42041740|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
19593346|NCT00934050|42041741|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
19593347|NCT00934050|42041742|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
19388000|NCT02038036|41631321|FG000|Crossover Period|Death|0|||
19593348|NCT00934050|42041743|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
19593349|NCT00934050|42041744|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
19593350|NCT00934050|42041745|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
19593351|NCT00934050|42041740|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
19593352|NCT00934050|42041741|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
19593353|NCT00934050|42041742|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
19593354|NCT00934050|42041743|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
19593355|NCT00934050|42041744|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
19593356|NCT00934050|42041745|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
19593357|NCT00934050|42041740|FG000|Enrolled After 15 Dec 2009|Death|0|||
19593358|NCT00934050|42041741|FG001|Enrolled After 15 Dec 2009|Death|0|||
19593359|NCT00934050|42041742|FG002|Enrolled After 15 Dec 2009|Death|0|||
19593360|NCT00934050|42041743|FG003|Enrolled After 15 Dec 2009|Death|0|||
19593361|NCT00934050|42041744|FG004|Enrolled After 15 Dec 2009|Death|0|||
19593362|NCT00934050|42041745|FG005|Enrolled After 15 Dec 2009|Death|1|||
19746441|NCT02906020|42193781|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746442|NCT02906020|42193782|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746443|NCT02906020|42193783|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746444|NCT02906020|42193784|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746445|NCT02906020|42193785|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746446|NCT02906020|42193786|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
19746447|NCT02906020|42193771|FG000|Part 2: Double-blind Treatment Period|Other|0|||
19746448|NCT02906020|42193772|FG001|Part 2: Double-blind Treatment Period|Other|0|||
19746449|NCT02906020|42193773|FG002|Part 2: Double-blind Treatment Period|Other|0|||
19746450|NCT02906020|42193774|FG003|Part 2: Double-blind Treatment Period|Other|0|||
19388001|NCT02038036|41631322|FG001|Crossover Period|Death|2|||
19388002|NCT02038036|41631321|FG000|Crossover Period|Disease progression|0|||
19593363|NCT00934050|42041740|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
19593364|NCT00934050|42041741|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
19593365|NCT00934050|42041742|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
19593366|NCT00934050|42041743|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
19593367|NCT00934050|42041744|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
19593368|NCT00934050|42041745|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
19593369|NCT00934050|42041740|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
19593370|NCT00934050|42041741|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
19593371|NCT00934050|42041742|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
19593372|NCT00934050|42041743|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
19593373|NCT00934050|42041744|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
19593374|NCT00934050|42041745|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
19593375|NCT01091168|42041757|FG000|Overall Study|Progressive disease|250|||
19593376|NCT01091168|42041758|FG001|Overall Study|Progressive disease|234|||
19593377|NCT01091168|42041757|FG000|Overall Study|Adverse Event|21|||
19593378|NCT01091168|42041758|FG001|Overall Study|Adverse Event|24|||
19593379|NCT01091168|42041757|FG000|Overall Study|Lost to Follow-up|0|||
19593380|NCT01091168|42041758|FG001|Overall Study|Lost to Follow-up|1|||
19593381|NCT01091168|42041757|FG000|Overall Study|Physician, patient's decision, other|27|||
19593382|NCT01091168|42041758|FG001|Overall Study|Physician, patient's decision, other|37|||
19593383|NCT00864916|42041766|FG000|Overall Study|Lost to Follow-up|4|||
19593384|NCT00864916|42041767|FG001|Overall Study|Lost to Follow-up|4|||
19593385|NCT00864916|42041766|FG000|Overall Study|Protocol Violation|1|||
19593386|NCT00864916|42041767|FG001|Overall Study|Protocol Violation|0|||
19593387|NCT00864916|42041766|FG000|Overall Study|Withdrawal by Subject|1|||
19593388|NCT00864916|42041767|FG001|Overall Study|Withdrawal by Subject|0|||
19593389|NCT00864682|42041776|FG000|Overall Study|Protocol Violation|2|||
19593390|NCT00864682|42041777|FG001|Overall Study|Protocol Violation|1|||
19593391|NCT00864682|42041778|FG002|Overall Study|Protocol Violation|2|||
19593392|NCT00931944|42041786|FG000|Overall Study|Adverse Event|4|||
19593393|NCT00931944|42041786|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
19593394|NCT00931944|42041786|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
19593395|NCT00931944|42041786|FG000|Overall Study|Death|28|||
19593396|NCT00931944|42041786|FG000|Overall Study|Other|2|||
19593397|NCT00929994|42041790|FG000|Overall Study|Withdrawal by Subject|1|||
19593398|NCT00929994|42041790|FG000|Overall Study|medical issue unrelated to intervention|4|||
19593399|NCT00929994|42041790|FG000|Overall Study|employment|1|||
19593400|NCT01090310|42041801|FG000|Core Study|Adverse Event|2|||
19593401|NCT01090310|42041802|FG001|Core Study|Adverse Event|2|||
19593402|NCT01090310|42041803|FG002|Core Study|Adverse Event|1|||
19593403|NCT01090310|42041804|FG003|Core Study|Adverse Event|1|||
19593404|NCT01090310|42041801|FG000|Core Study|Subject withdrew consent|0|||
19593405|NCT01090310|42041802|FG001|Core Study|Subject withdrew consent|3|||
19593406|NCT01090310|42041803|FG002|Core Study|Subject withdrew consent|1|||
19593407|NCT01090310|42041804|FG003|Core Study|Subject withdrew consent|1|||
19593408|NCT01090310|42041801|FG000|Core Study|Abnormal test procedure result|0|||
19593409|NCT01090310|42041802|FG001|Core Study|Abnormal test procedure result|0|||
19593410|NCT01090310|42041803|FG002|Core Study|Abnormal test procedure result|1|||
19593411|NCT01090310|42041804|FG003|Core Study|Abnormal test procedure result|0|||
19593412|NCT01090310|42041801|FG000|Core Study|Administrative reasons|5|||
19593413|NCT01090310|42041802|FG001|Core Study|Administrative reasons|6|||
19593414|NCT01090310|42041803|FG002|Core Study|Administrative reasons|4|||
19593415|NCT01090310|42041804|FG003|Core Study|Administrative reasons|4|||
19593416|NCT01090310|42041801|FG000|Core Study|Protocol deviation|1|||
19593417|NCT01090310|42041802|FG001|Core Study|Protocol deviation|0|||
19593418|NCT01090310|42041803|FG002|Core Study|Protocol deviation|0|||
19593419|NCT01090310|42041804|FG003|Core Study|Protocol deviation|1|||
19593420|NCT01090310|42041801|FG000|Extension Study|Aministrative problems|13|||
19593421|NCT01090310|42041802|FG001|Extension Study|Aministrative problems|15|||
19593422|NCT01090310|42041803|FG002|Extension Study|Aministrative problems|14|||
19593423|NCT01090310|42041804|FG003|Extension Study|Aministrative problems|18|||
19593424|NCT01090310|42041801|FG000|Extension Study|Adverse Event|0|||
19593425|NCT01090310|42041802|FG001|Extension Study|Adverse Event|0|||
19593426|NCT01090310|42041803|FG002|Extension Study|Adverse Event|0|||
19593427|NCT01090310|42041804|FG003|Extension Study|Adverse Event|1|||
19593428|NCT01090310|42041801|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
19746451|NCT02906020|42193775|FG004|Part 2: Double-blind Treatment Period|Other|0|||
19746452|NCT02906020|42193776|FG005|Part 2: Double-blind Treatment Period|Other|0|||
19746453|NCT02906020|42193777|FG006|Part 2: Double-blind Treatment Period|Other|0|||
19746454|NCT02906020|42193778|FG007|Part 2: Double-blind Treatment Period|Other|0|||
19746455|NCT02906020|42193779|FG008|Part 2: Double-blind Treatment Period|Other|6|||
19746456|NCT02906020|42193780|FG009|Part 2: Double-blind Treatment Period|Other|10|||
19746457|NCT02906020|42193781|FG010|Part 2: Double-blind Treatment Period|Other|0|||
19746458|NCT02906020|42193782|FG011|Part 2: Double-blind Treatment Period|Other|0|||
19746459|NCT02906020|42193783|FG012|Part 2: Double-blind Treatment Period|Other|0|||
19746460|NCT02906020|42193784|FG013|Part 2: Double-blind Treatment Period|Other|0|||
19593429|NCT01090310|42041802|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
19593430|NCT01090310|42041803|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
19593431|NCT01090310|42041804|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
19593432|NCT01090310|42041801|FG000|Extension Study|Subject withdrew consent|0|||
19593433|NCT01090310|42041802|FG001|Extension Study|Subject withdrew consent|1|||
19593434|NCT01090310|42041803|FG002|Extension Study|Subject withdrew consent|0|||
19593435|NCT01090310|42041804|FG003|Extension Study|Subject withdrew consent|0|||
19593436|NCT01090076|42041816|FG000|Overall Study|Death|1|||
19593437|NCT01090076|42041817|FG001|Overall Study|Death|1|||
19593438|NCT01090076|42041816|FG000|Overall Study|Withdrawal by Subject|0|||
19593439|NCT01090076|42041817|FG001|Overall Study|Withdrawal by Subject|1|||
19593440|NCT00869050|42041825|FG000|Overall Study|Screen Failure|3|||
19593441|NCT00927186|42041831|FG000|12 Months Primary Study|Adverse Event|5|||
19593442|NCT00927186|42041832|FG001|12 Months Primary Study|Adverse Event|2|||
19593443|NCT00927186|42041831|FG000|12 Months Primary Study|Lost to Follow-up|1|||
19593444|NCT00927186|42041832|FG001|12 Months Primary Study|Lost to Follow-up|0|||
19593445|NCT00927186|42041831|FG000|12 Months Primary Study|Protocol Violation|0|||
19593446|NCT00927186|42041832|FG001|12 Months Primary Study|Protocol Violation|1|||
19593447|NCT00927186|42041831|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
19746461|NCT02906020|42193785|FG014|Part 2: Double-blind Treatment Period|Other|0|||
19746462|NCT02906020|42193786|FG015|Part 2: Double-blind Treatment Period|Other|0|||
19746463|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746464|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746465|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746466|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746467|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746468|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746469|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746470|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746471|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746472|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19593448|NCT00927186|42041832|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
19593449|NCT00593554|42041843|FG000|Overall Study|Death|1|||
19593450|NCT00593554|42041844|FG001|Overall Study|Death|2|||
19593451|NCT00593554|42041843|FG000|Overall Study|Physician Decision|0|||
19593452|NCT00593554|42041844|FG001|Overall Study|Physician Decision|1|||
19593453|NCT00593554|42041843|FG000|Overall Study|Withdrawal by Subject|1|||
19593454|NCT00593554|42041844|FG001|Overall Study|Withdrawal by Subject|0|||
19593455|NCT00593554|42041843|FG000|Overall Study|Disease Progression|1|||
19593456|NCT00593554|42041844|FG001|Overall Study|Disease Progression|2|||
19593457|NCT01101308|42041850|FG000|Period 1|Adverse Event|2|||
19593458|NCT01101308|42041851|FG001|Period 1|Adverse Event|1|||
19746473|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746474|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19593459|NCT01101308|42041850|FG000|Period 1|Positive for cotinine|1|||
19593460|NCT01101308|42041851|FG001|Period 1|Positive for cotinine|0|||
19593461|NCT00926796|42041860|FG000|Overall Study|Did not receive randomized treatment|4|||
19593462|NCT00926796|42041861|FG001|Overall Study|Did not receive randomized treatment|7|||
19593463|NCT00926796|42041860|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
19593464|NCT00926796|42041861|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
19593465|NCT00926796|42041860|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
19593466|NCT00926796|42041861|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
19593467|NCT00926796|42041860|FG000|Overall Study|Adverse Event|7|||
19593468|NCT00926796|42041861|FG001|Overall Study|Adverse Event|14|||
19593469|NCT00926796|42041860|FG000|Overall Study|Lost to Follow-up|22|||
19593470|NCT00926796|42041861|FG001|Overall Study|Lost to Follow-up|13|||
19593471|NCT00926796|42041860|FG000|Overall Study|Protocol Violation|15|||
19593472|NCT00926796|42041861|FG001|Overall Study|Protocol Violation|11|||
19593473|NCT00926796|42041860|FG000|Overall Study|Withdrawal by Subject|1|||
19593474|NCT00926796|42041861|FG001|Overall Study|Withdrawal by Subject|0|||
19593475|NCT01087736|42041871|FG000|Overall Study|Lost to Follow-up|1|||
19593476|NCT01087736|42041872|FG001|Overall Study|Lost to Follow-up|0|||
19593477|NCT01087736|42041871|FG000|Overall Study|Death|0|||
19593478|NCT01087736|42041872|FG001|Overall Study|Death|1|||
19593479|NCT01087736|42041871|FG000|Overall Study|Withdrawal by Subject|0|||
19593480|NCT01087736|42041872|FG001|Overall Study|Withdrawal by Subject|1|||
19593481|NCT01079936|42041882|FG000|Phase I: MTD|First Remission Status|2|||
19593482|NCT01079936|42041883|FG001|Phase I: MTD|First Remission Status|0|||
19593483|NCT01079936|42041884|FG002|Phase I: MTD|First Remission Status|0|||
19593484|NCT01079936|42041885|FG003|Phase I: MTD|First Remission Status|0|||
19593485|NCT01079936|42041886|FG004|Phase I: MTD|First Remission Status|0|||
19593486|NCT01079936|42041882|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
19593487|NCT01079936|42041883|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
19593488|NCT01079936|42041884|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
19593489|NCT01079936|42041885|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
19593490|NCT01079936|42041886|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
19593491|NCT01079936|42041882|FG000|Phase II|Adverse Event|0|||
19593492|NCT01079936|42041883|FG001|Phase II|Adverse Event|0|||
19593493|NCT01079936|42041884|FG002|Phase II|Adverse Event|1|||
19593494|NCT01079936|42041885|FG003|Phase II|Adverse Event|0|||
19593495|NCT01079936|42041886|FG004|Phase II|Adverse Event|0|||
19593496|NCT01079936|42041882|FG000|Phase II|Insurance Issue|0|||
19593497|NCT01079936|42041883|FG001|Phase II|Insurance Issue|0|||
19593498|NCT01079936|42041884|FG002|Phase II|Insurance Issue|0|||
19593499|NCT01079936|42041885|FG003|Phase II|Insurance Issue|0|||
19593500|NCT01079936|42041886|FG004|Phase II|Insurance Issue|1|||
19593501|NCT00931710|42041899|FG000|Overall Study|Adverse Event|16|||
19593502|NCT00931710|42041900|FG001|Overall Study|Adverse Event|10|||
19593503|NCT00931710|42041899|FG000|Overall Study|Abnormal test procedure results|2|||
19593504|NCT00931710|42041900|FG001|Overall Study|Abnormal test procedure results|0|||
19593505|NCT00931710|42041899|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
19593506|NCT00931710|42041900|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
19593507|NCT00931710|42041899|FG000|Overall Study|Patient withdrew consent|4|||
19593508|NCT00931710|42041900|FG001|Overall Study|Patient withdrew consent|9|||
19593509|NCT00931710|42041899|FG000|Overall Study|Lost to Follow-up|6|||
19593510|NCT00931710|42041900|FG001|Overall Study|Lost to Follow-up|5|||
19593511|NCT00931710|42041899|FG000|Overall Study|Protocol deviation|1|||
19593512|NCT00931710|42041900|FG001|Overall Study|Protocol deviation|2|||
19593513|NCT01100528|42041906|FG000|Overall Study|Death|1|||
19593514|NCT01100528|42041906|FG000|Overall Study|Withdrawal by Subject|2|||
19593515|NCT01079234|42041913|FG000|Main: Week 0 to 26|Adverse Event|5|||
19593516|NCT01079234|42041914|FG001|Main: Week 0 to 26|Adverse Event|4|||
19593517|NCT01079234|42041915|FG002|Main: Week 0 to 26|Adverse Event|1|||
19593518|NCT01079234|42041916|FG003|Main: Week 0 to 26|Adverse Event|0|||
19593519|NCT01079234|42041913|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
19593520|NCT01079234|42041914|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
19593521|NCT01079234|42041915|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
19593522|NCT01079234|42041916|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
19593523|NCT01079234|42041913|FG000|Main: Week 0 to 26|Protocol Violation|6|||
19593524|NCT01079234|42041914|FG001|Main: Week 0 to 26|Protocol Violation|2|||
19388003|NCT02038036|41631322|FG001|Crossover Period|Disease progression|3|||
19593525|NCT01079234|42041915|FG002|Main: Week 0 to 26|Protocol Violation|4|||
19593526|NCT01079234|42041916|FG003|Main: Week 0 to 26|Protocol Violation|0|||
19593527|NCT01079234|42041913|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
19593528|NCT01079234|42041914|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
19593529|NCT01079234|42041915|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
19593530|NCT01079234|42041916|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
19593531|NCT01079234|42041913|FG000|Main: Week 0 to 26|Unclassified|7|||
19593532|NCT01079234|42041914|FG001|Main: Week 0 to 26|Unclassified|13|||
19593533|NCT01079234|42041915|FG002|Main: Week 0 to 26|Unclassified|4|||
19593534|NCT01079234|42041916|FG003|Main: Week 0 to 26|Unclassified|0|||
19593535|NCT01079234|42041913|FG000|Extension: Week 27 to 52|Adverse Event|0|||
19593536|NCT01079234|42041914|FG001|Extension: Week 27 to 52|Adverse Event|0|||
19593537|NCT01079234|42041915|FG002|Extension: Week 27 to 52|Adverse Event|1|||
19593538|NCT01079234|42041916|FG003|Extension: Week 27 to 52|Adverse Event|0|||
19593539|NCT01079234|42041913|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
19593540|NCT01079234|42041914|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
19593541|NCT01079234|42041915|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
19593542|NCT01079234|42041916|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
19593543|NCT01079234|42041913|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
19593544|NCT01079234|42041914|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
19593545|NCT01079234|42041915|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
19593546|NCT01079234|42041916|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
19593547|NCT01079234|42041913|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
19746475|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
19593548|NCT01079234|42041914|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
19593549|NCT01079234|42041915|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
19593550|NCT01079234|42041916|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
19593551|NCT01079234|42041913|FG000|Extension: Week 27 to 52|Unclassified|0|||
19593552|NCT01079234|42041914|FG001|Extension: Week 27 to 52|Unclassified|0|||
19593553|NCT01079234|42041915|FG002|Extension: Week 27 to 52|Unclassified|4|||
19593554|NCT01079234|42041916|FG003|Extension: Week 27 to 52|Unclassified|7|||
19593555|NCT00931632|42041927|FG000|Overall Study|Withdrawal by Subject|2|||
19593556|NCT00931632|42041928|FG001|Overall Study|Withdrawal by Subject|3|||
19593557|NCT00931632|42041927|FG000|Overall Study|Adverse Event|19|||
19593558|NCT00931632|42041928|FG001|Overall Study|Adverse Event|15|||
19593559|NCT01078922|42041934|FG000|Overall Study|Adverse Event|1|||
19593560|NCT00863746|42041941|FG000|Treatment|Not treated|4|||
19593561|NCT00863746|42041942|FG001|Treatment|Not treated|2|||
19593562|NCT00863746|42041941|FG000|Treatment|Adverse Event|41|||
19593563|NCT00863746|42041942|FG001|Treatment|Adverse Event|16|||
19593564|NCT00863746|42041941|FG000|Treatment|non-compliant with study medication|4|||
19593565|NCT00863746|42041942|FG001|Treatment|non-compliant with study medication|0|||
19593566|NCT00863746|42041941|FG000|Treatment|Consent withdrawn|15|||
19593567|NCT00863746|42041942|FG001|Treatment|Consent withdrawn|14|||
19593568|NCT00863746|42041941|FG000|Treatment|Lost to Follow-up|1|||
19593569|NCT00863746|42041942|FG001|Treatment|Lost to Follow-up|0|||
19593570|NCT00863746|42041941|FG000|Treatment|Protocol Violation|5|||
19593571|NCT00863746|42041942|FG001|Treatment|Protocol Violation|3|||
19593572|NCT00863746|42041941|FG000|Treatment|Other|1|||
19593573|NCT00863746|42041942|FG001|Treatment|Other|0|||
19593574|NCT00863746|42041941|FG000|Survival Follow up|Death|244|||
19593575|NCT00863746|42041942|FG001|Survival Follow up|Death|271|||
19593576|NCT00863746|42041941|FG000|Survival Follow up|Lost to Follow-up|2|||
19593577|NCT00863746|42041942|FG001|Survival Follow up|Lost to Follow-up|1|||
19593578|NCT00863746|42041941|FG000|Survival Follow up|Consent Withdrawn|7|||
19593579|NCT00863746|42041942|FG001|Survival Follow up|Consent Withdrawn|8|||
19593580|NCT00926328|42041950|FG000|Overall Study|Lost to Follow-up|12|||
19593581|NCT00926328|42041951|FG001|Overall Study|Lost to Follow-up|14|||
19593582|NCT00863512|42041959|FG000|Overall Study|Adverse Event|2|||
19593583|NCT00863512|42041960|FG001|Overall Study|Adverse Event|0|||
19593584|NCT00863512|42041959|FG000|Overall Study|Withdrawal by Subject|11|||
19746476|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
19746477|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19593585|NCT00863512|42041960|FG001|Overall Study|Withdrawal by Subject|0|||
19593586|NCT00863512|42041959|FG000|Overall Study|Physician Decision|1|||
19746478|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
19746479|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746480|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746481|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19593587|NCT00863512|42041960|FG001|Overall Study|Physician Decision|0|||
19593588|NCT00868192|42041966|FG000|Overall Study|Ineligible|4|||
19593589|NCT00867568|42041970|FG000|Overall Study|Lack of Efficacy|10|||
19593590|NCT00867568|42041970|FG000|Overall Study|Adverse Event|4|||
19593591|NCT00867568|42041970|FG000|Overall Study|Withdrawal by Subject|1|||
19593592|NCT00930930|42041976|FG000|Overall Study|Death|1|||
19593593|NCT00930930|42041977|FG001|Overall Study|Death|0|||
19593594|NCT00930930|42041976|FG000|Overall Study|Physician Decision|1|||
19593595|NCT00930930|42041977|FG001|Overall Study|Physician Decision|0|||
19593596|NCT00930930|42041976|FG000|Overall Study|Adverse Event|13|||
19593597|NCT00930930|42041977|FG001|Overall Study|Adverse Event|3|||
19593598|NCT00930930|42041976|FG000|Overall Study|Withdrawal by Subject|3|||
19593599|NCT00930930|42041977|FG001|Overall Study|Withdrawal by Subject|1|||
19593600|NCT00930930|42041976|FG000|Overall Study|Disease progression|2|||
19593601|NCT00930930|42041977|FG001|Overall Study|Disease progression|3|||
19593602|NCT00930930|42041976|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
19593603|NCT00930930|42041977|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
19593604|NCT00930930|42041976|FG000|Overall Study|patients not compliant|1|||
19593605|NCT00930930|42041977|FG001|Overall Study|patients not compliant|1|||
19593606|NCT00862654|42041987|FG000|Overall Study|Lack of Efficacy|1|||
19593607|NCT00862654|42041988|FG001|Overall Study|Lack of Efficacy|0|||
19593608|NCT00862654|42041989|FG002|Overall Study|Lack of Efficacy|1|||
19593609|NCT00862654|42041990|FG003|Overall Study|Lack of Efficacy|0|||
19593610|NCT00862654|42041987|FG000|Overall Study|Lost to Follow-up|1|||
19593611|NCT00862654|42041988|FG001|Overall Study|Lost to Follow-up|2|||
19593612|NCT00862654|42041989|FG002|Overall Study|Lost to Follow-up|1|||
19593613|NCT00862654|42041990|FG003|Overall Study|Lost to Follow-up|3|||
19593614|NCT00862654|42041987|FG000|Overall Study|Adverse Event|0|||
19593615|NCT00862654|42041988|FG001|Overall Study|Adverse Event|1|||
19593616|NCT00862654|42041989|FG002|Overall Study|Adverse Event|1|||
19593617|NCT00862654|42041990|FG003|Overall Study|Adverse Event|0|||
19593618|NCT00862654|42041987|FG000|Overall Study|Pregnancy|1|||
19593619|NCT00862654|42041988|FG001|Overall Study|Pregnancy|1|||
19593620|NCT00862654|42041989|FG002|Overall Study|Pregnancy|0|||
19593621|NCT00862654|42041990|FG003|Overall Study|Pregnancy|0|||
19593622|NCT00862654|42041987|FG000|Overall Study|Withdrawal by Subject|2|||
19593623|NCT00862654|42041988|FG001|Overall Study|Withdrawal by Subject|2|||
19593624|NCT00862654|42041989|FG002|Overall Study|Withdrawal by Subject|2|||
19593625|NCT00862654|42041990|FG003|Overall Study|Withdrawal by Subject|3|||
19593626|NCT00862654|42041987|FG000|Overall Study|Subject mistake|0|||
19593627|NCT00862654|42041988|FG001|Overall Study|Subject mistake|1|||
19593628|NCT00862654|42041989|FG002|Overall Study|Subject mistake|0|||
19593629|NCT00862654|42041990|FG003|Overall Study|Subject mistake|0|||
19593630|NCT00862654|42041987|FG000|Overall Study|Familly constraint|0|||
19593631|NCT00862654|42041988|FG001|Overall Study|Familly constraint|1|||
19593632|NCT00862654|42041989|FG002|Overall Study|Familly constraint|0|||
19593633|NCT00862654|42041990|FG003|Overall Study|Familly constraint|0|||
19593634|NCT00862654|42041987|FG000|Overall Study|Never used study drugs|1|||
19593635|NCT00862654|42041988|FG001|Overall Study|Never used study drugs|0|||
19593636|NCT00862654|42041989|FG002|Overall Study|Never used study drugs|0|||
19593637|NCT00862654|42041990|FG003|Overall Study|Never used study drugs|0|||
19593638|NCT00862654|42041987|FG000|Overall Study|Included after end of inclusions|0|||
19593639|NCT00862654|42041988|FG001|Overall Study|Included after end of inclusions|0|||
19593640|NCT00862654|42041989|FG002|Overall Study|Included after end of inclusions|1|||
19593641|NCT00862654|42041990|FG003|Overall Study|Included after end of inclusions|0|||
19593642|NCT00867490|42042000|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
19593643|NCT00867490|42042000|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
19593644|NCT00867490|42042000|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
19593645|NCT00867490|42042000|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
19593646|NCT00867490|42042000|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
19593647|NCT00930774|42042011|FG000|Overall Study|Withdrawal by Subject|1|||
19593648|NCT00930774|42042012|FG001|Overall Study|Withdrawal by Subject|9|||
19593649|NCT00930774|42042013|FG002|Overall Study|Withdrawal by Subject|2|||
19593650|NCT00930774|42042014|FG003|Overall Study|Withdrawal by Subject|0|||
19593651|NCT00867334|42042027|FG000|Overall Study|Withdrawal by Subject|0|||
19593652|NCT00867334|42042028|FG001|Overall Study|Withdrawal by Subject|1|||
19593653|NCT00867334|42042027|FG000|Overall Study|Withdrawal by Subject|1|||
19593654|NCT00867334|42042028|FG001|Overall Study|Withdrawal by Subject|0|||
19593655|NCT00867334|42042027|FG000|Overall Study|Withdrawal by Subject|1|||
19593656|NCT00867334|42042028|FG001|Overall Study|Withdrawal by Subject|0|||
19593657|NCT00925704|42042040|FG000|First Intervention|Withdrew consent|0|||
19593658|NCT00925704|42042041|FG001|First Intervention|Withdrew consent|0|||
19593659|NCT00925704|42042042|FG002|First Intervention|Withdrew consent|0|||
19593660|NCT00925704|42042043|FG003|First Intervention|Withdrew consent|1|||
19593661|NCT00925704|42042044|FG004|First Intervention|Withdrew consent|1|||
19593662|NCT00925704|42042045|FG005|First Intervention|Withdrew consent|0|||
19593663|NCT00925704|42042040|FG000|Second Intervention|Withdrawal by Subject|1|||
19593664|NCT00925704|42042041|FG001|Second Intervention|Withdrawal by Subject|0|||
19593665|NCT00925704|42042042|FG002|Second Intervention|Withdrawal by Subject|0|||
19593666|NCT00925704|42042043|FG003|Second Intervention|Withdrawal by Subject|0|||
19593667|NCT00925704|42042044|FG004|Second Intervention|Withdrawal by Subject|1|||
19593668|NCT00925704|42042045|FG005|Second Intervention|Withdrawal by Subject|0|||
19593669|NCT00925704|42042040|FG000|Third Intervention|Withdrew consent|0|||
19593670|NCT00925704|42042041|FG001|Third Intervention|Withdrew consent|0|||
19593671|NCT00925704|42042042|FG002|Third Intervention|Withdrew consent|0|||
19593672|NCT00925704|42042043|FG003|Third Intervention|Withdrew consent|0|||
19593673|NCT00925704|42042044|FG004|Third Intervention|Withdrew consent|0|||
19746482|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746483|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746484|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746485|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746486|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746487|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746488|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746489|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746490|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19746491|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
19746492|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
19746493|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
19593674|NCT00925704|42042045|FG005|Third Intervention|Withdrew consent|1|||
19593675|NCT01076192|42042056|FG000|Overall Study|Other|197|||
19593676|NCT01076036|42042061|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
19593677|NCT01075958|42042065|FG000|Overall Study|Blood sample could not be obtained|44|||
19593678|NCT01096316|42042071|FG000|Overall Study|Lost to Follow-up|15|||
19593679|NCT01096316|42042072|FG001|Overall Study|Lost to Follow-up|9|||
19593680|NCT00925548|42042080|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
19593681|NCT00925548|42042081|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
19593682|NCT00866788|42042092|FG000|Overall Study|Adverse Event|0|||
19593683|NCT00866788|42042093|FG001|Overall Study|Adverse Event|2|||
19593684|NCT00866788|42042094|FG002|Overall Study|Adverse Event|0|||
19593685|NCT00866788|42042095|FG003|Overall Study|Adverse Event|1|||
19593686|NCT00866788|42042092|FG000|Overall Study|Lost to Follow-up|1|||
19593687|NCT00866788|42042093|FG001|Overall Study|Lost to Follow-up|1|||
19593688|NCT00866788|42042094|FG002|Overall Study|Lost to Follow-up|0|||
19593689|NCT00866788|42042095|FG003|Overall Study|Lost to Follow-up|2|||
19593690|NCT00866788|42042092|FG000|Overall Study|Withdrawal by Subject|2|||
19593691|NCT00866788|42042093|FG001|Overall Study|Withdrawal by Subject|1|||
19593692|NCT00866788|42042094|FG002|Overall Study|Withdrawal by Subject|0|||
19593693|NCT00866788|42042095|FG003|Overall Study|Withdrawal by Subject|1|||
19593694|NCT00866788|42042092|FG000|Overall Study|Pregnancy|0|||
19593695|NCT00866788|42042093|FG001|Overall Study|Pregnancy|1|||
19593696|NCT00866788|42042094|FG002|Overall Study|Pregnancy|0|||
19593697|NCT00866788|42042095|FG003|Overall Study|Pregnancy|0|||
19593698|NCT00866788|42042092|FG000|Overall Study|Disease progression|3|||
19593699|NCT00866788|42042093|FG001|Overall Study|Disease progression|1|||
19593700|NCT00866788|42042094|FG002|Overall Study|Disease progression|1|||
19593701|NCT00866788|42042095|FG003|Overall Study|Disease progression|0|||
19593702|NCT00866788|42042092|FG000|Overall Study|Physician Decision|0|||
19593703|NCT00866788|42042093|FG001|Overall Study|Physician Decision|0|||
19593704|NCT00866788|42042094|FG002|Overall Study|Physician Decision|1|||
19593705|NCT00866788|42042095|FG003|Overall Study|Physician Decision|1|||
19593706|NCT00860470|42042110|FG000|Overall Study|Death|6|||
19593707|NCT00860470|42042111|FG001|Overall Study|Death|10|||
19593708|NCT00860470|42042110|FG000|Overall Study|Moved away|8|||
19593709|NCT00860470|42042111|FG001|Overall Study|Moved away|10|||
19593710|NCT00860470|42042110|FG000|Overall Study|Lost to Follow-up|34|||
19593711|NCT00860470|42042111|FG001|Overall Study|Lost to Follow-up|39|||
19593712|NCT00923364|42042117|FG000|Overall Study|Death|3|||
19593713|NCT00923364|42042118|FG001|Overall Study|Death|0|||
19593714|NCT00923364|42042117|FG000|Overall Study|Did not go to transplant|1|||
19593715|NCT00923364|42042118|FG001|Overall Study|Did not go to transplant|0|||
19593716|NCT01096160|42042133|FG000|Overall Study|Adverse Event|0|||
19593717|NCT01096160|42042134|FG001|Overall Study|Adverse Event|0|||
19593718|NCT01096160|42042135|FG002|Overall Study|Adverse Event|1|||
19593719|NCT01096160|42042136|FG003|Overall Study|Adverse Event|0|||
19593720|NCT01096160|42042137|FG004|Overall Study|Adverse Event|0|||
19593721|NCT01096160|42042138|FG005|Overall Study|Adverse Event|0|||
19593722|NCT01096160|42042139|FG006|Overall Study|Adverse Event|0|||
19593723|NCT01096160|42042140|FG007|Overall Study|Adverse Event|0|||
19746494|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
19746495|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19593724|NCT01096160|42042141|FG008|Overall Study|Adverse Event|0|||
19593725|NCT01096160|42042142|FG009|Overall Study|Adverse Event|1|||
19593726|NCT01096160|42042133|FG000|Overall Study|Met stopping criteria per protocol|0|||
19593727|NCT01096160|42042134|FG001|Overall Study|Met stopping criteria per protocol|0|||
19746496|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746497|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19593728|NCT01096160|42042135|FG002|Overall Study|Met stopping criteria per protocol|0|||
19593729|NCT01096160|42042136|FG003|Overall Study|Met stopping criteria per protocol|0|||
19593730|NCT01096160|42042137|FG004|Overall Study|Met stopping criteria per protocol|1|||
19593731|NCT01096160|42042138|FG005|Overall Study|Met stopping criteria per protocol|0|||
19593732|NCT01096160|42042139|FG006|Overall Study|Met stopping criteria per protocol|2|||
19593733|NCT01096160|42042140|FG007|Overall Study|Met stopping criteria per protocol|0|||
19593734|NCT01096160|42042141|FG008|Overall Study|Met stopping criteria per protocol|2|||
19593735|NCT01096160|42042142|FG009|Overall Study|Met stopping criteria per protocol|0|||
19593736|NCT00860158|42042177|FG000|Overall Study|Study Terminated|1|||
19593737|NCT00929526|42042183|FG000|Overall Study|Withdrawal by Subject|1|||
19593738|NCT00929526|42042184|FG001|Overall Study|Withdrawal by Subject|11|||
19593739|NCT00929526|42042183|FG000|Overall Study|Lost to Follow-up|8|||
19593740|NCT00929526|42042184|FG001|Overall Study|Lost to Follow-up|12|||
19593741|NCT00929526|42042183|FG000|Overall Study|Other|8|||
19593742|NCT00929526|42042184|FG001|Overall Study|Other|6|||
19593743|NCT00859456|42042190|FG000|Overall Study|Adverse Event|3|||
19593744|NCT00859456|42042190|FG000|Overall Study|Progressive disease|2|||
19593745|NCT00859456|42042190|FG000|Overall Study|Non-compliance|3|||
19593746|NCT01075646|42042198|FG000|Overall Study|Lost to Follow-up|4|||
19593747|NCT01075646|42042199|FG001|Overall Study|Lost to Follow-up|3|||
19593748|NCT01075646|42042200|FG002|Overall Study|Lost to Follow-up|1|||
19593749|NCT01075646|42042201|FG003|Overall Study|Lost to Follow-up|2|||
19593750|NCT01075412|42042213|FG000|Overall Study|Withdrawal by Subject|0|||
19593751|NCT01075412|42042214|FG001|Overall Study|Withdrawal by Subject|1|||
19593752|NCT00799903|42042221|FG000|Overall Study|Investigator Site Closed|25|||
19593753|NCT00799903|42042222|FG001|Overall Study|Investigator Site Closed|23|||
19593754|NCT00799903|42042221|FG000|Overall Study|Withdrawal by Subject|179|||
19593755|NCT00799903|42042222|FG001|Overall Study|Withdrawal by Subject|175|||
19746498|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746499|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746500|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746501|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746502|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746503|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746504|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19593756|NCT00799903|42042221|FG000|Overall Study|Lost to Follow-up|69|||
19593757|NCT00799903|42042222|FG001|Overall Study|Lost to Follow-up|80|||
19593758|NCT01075256|42042231|FG000|Overall Study|Withdrawal by Subject|1|||
19593759|NCT01075256|42042232|FG001|Overall Study|Withdrawal by Subject|0|||
19593760|NCT01075256|42042233|FG002|Overall Study|Withdrawal by Subject|0|||
19593761|NCT00923130|42042246|FG000|Overall Study|Stopped treatment due to progression|17|||
19593762|NCT00923130|42042246|FG000|Overall Study|Death|1|||
19593763|NCT00923130|42042246|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
19593764|NCT00923130|42042246|FG000|Overall Study|Switched to alternative treatment|2|||
19593765|NCT00923130|42042246|FG000|Overall Study|Refused further treatment|2|||
19593766|NCT03253627|42042252|FG000|Overall Study|Lost to Follow-up|1|||
19593767|NCT03253627|42042253|FG001|Overall Study|Lost to Follow-up|2|||
19593768|NCT03253627|42042252|FG000|Overall Study|Withdrawal by Subject|0|||
19593769|NCT03253627|42042253|FG001|Overall Study|Withdrawal by Subject|2|||
19593770|NCT03253627|42042252|FG000|Overall Study|Inability to complete MRI|1|||
19593771|NCT03253627|42042253|FG001|Overall Study|Inability to complete MRI|0|||
19593772|NCT01075178|42042261|FG000|Subject Matching|eligible but not matched|130|||
19593773|NCT01075178|42042262|FG001|Subject Matching|eligible but not matched|403|||
19593774|NCT01075178|42042261|FG000|Subject Chart Review|died before chart review period|0|||
19593775|NCT01075178|42042262|FG001|Subject Chart Review|died before chart review period|2|||
19593776|NCT01075178|42042261|FG000|Subject Chart Review|no data collected due to site closure|3|||
19746505|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19593777|NCT01075178|42042262|FG001|Subject Chart Review|no data collected due to site closure|4|||
19593778|NCT01075178|42042261|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
19593779|NCT01075178|42042262|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
19593780|NCT00799825|42042268|FG000|Overall Study|Adverse Event|1|||
19593781|NCT00799825|42042268|FG000|Overall Study|Withdrawal by Subject|6|||
19593782|NCT00799825|42042268|FG000|Overall Study|Lost to Follow-up|38|||
19593783|NCT00799825|42042268|FG000|Overall Study|Pregnancy|3|||
19593784|NCT00799591|42042272|FG000|Overall Study|De-escalation of doses|20|||
19593785|NCT00799591|42042272|FG000|Overall Study|Death|14|||
19593786|NCT00799591|42042272|FG000|Overall Study|Technical failure|12|||
19593787|NCT00799591|42042272|FG000|Overall Study|Resistant germ|11|||
19593788|NCT00799591|42042272|FG000|Overall Study|New infection|4|||
19593789|NCT00799591|42042272|FG000|Overall Study|Resistance germ and technical failure|2|||
19593790|NCT00799591|42042272|FG000|Overall Study|Persistance of fever undetermined origin|1|||
19593791|NCT00799591|42042272|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
19593792|NCT00799591|42042272|FG000|Overall Study|Infectious origin not probable|1|||
19593793|NCT01075100|42042278|FG000|Overall Study|Adverse Event|15|||
19593794|NCT01075100|42042279|FG001|Overall Study|Adverse Event|18|||
19593795|NCT01075100|42042278|FG000|Overall Study|Patient Request|4|||
19593796|NCT01075100|42042279|FG001|Overall Study|Patient Request|4|||
19593797|NCT01075100|42042278|FG000|Overall Study|Investigator Request|2|||
19593798|NCT01075100|42042279|FG001|Overall Study|Investigator Request|1|||
19593799|NCT01075100|42042278|FG000|Overall Study|Disease Progression|25|||
19593800|NCT01075100|42042279|FG001|Overall Study|Disease Progression|29|||
19593801|NCT01075100|42042278|FG000|Overall Study|Other|3|||
19593802|NCT01075100|42042279|FG001|Overall Study|Other|1|||
19593803|NCT00803023|42042291|FG000|Overall Study|Adverse Event|5|||
19593804|NCT00803023|42042292|FG001|Overall Study|Adverse Event|4|||
19593805|NCT00803023|42042293|FG002|Overall Study|Adverse Event|8|||
19593806|NCT00803023|42042294|FG003|Overall Study|Adverse Event|6|||
19593807|NCT00803023|42042291|FG000|Overall Study|Withdrawal by Subject|0|||
19593808|NCT00803023|42042292|FG001|Overall Study|Withdrawal by Subject|2|||
19593809|NCT00803023|42042293|FG002|Overall Study|Withdrawal by Subject|0|||
19593810|NCT00803023|42042294|FG003|Overall Study|Withdrawal by Subject|0|||
19593811|NCT00803023|42042291|FG000|Overall Study|Lost to Follow-up|0|||
19593812|NCT00803023|42042292|FG001|Overall Study|Lost to Follow-up|1|||
19593813|NCT00803023|42042293|FG002|Overall Study|Lost to Follow-up|2|||
19593814|NCT00803023|42042294|FG003|Overall Study|Lost to Follow-up|1|||
19593815|NCT00803023|42042291|FG000|Overall Study|Lack of Efficacy|0|||
19593816|NCT00803023|42042292|FG001|Overall Study|Lack of Efficacy|1|||
19593817|NCT00803023|42042293|FG002|Overall Study|Lack of Efficacy|1|||
19593818|NCT00803023|42042294|FG003|Overall Study|Lack of Efficacy|1|||
19593819|NCT00859222|42042307|FG000|Overall Study|Adverse Event|2|||
19593820|NCT00859222|42042308|FG001|Overall Study|Adverse Event|3|||
19593821|NCT00859222|42042309|FG002|Overall Study|Adverse Event|6|||
19593822|NCT00859222|42042310|FG003|Overall Study|Adverse Event|24|||
19593823|NCT00859222|42042311|FG004|Overall Study|Adverse Event|15|||
19593824|NCT00859222|42042307|FG000|Overall Study|DLT|1|||
19593825|NCT00859222|42042308|FG001|Overall Study|DLT|0|||
19593826|NCT00859222|42042309|FG002|Overall Study|DLT|0|||
19593827|NCT00859222|42042310|FG003|Overall Study|DLT|0|||
19593828|NCT00859222|42042311|FG004|Overall Study|DLT|0|||
19593829|NCT01072448|42042328|FG000|Overall Study|Adverse Event|9|||
19593830|NCT01072448|42042329|FG001|Overall Study|Adverse Event|10|||
19593831|NCT01072448|42042328|FG000|Overall Study|Subject withdrew consent|4|||
19593832|NCT01072448|42042329|FG001|Overall Study|Subject withdrew consent|9|||
19593833|NCT01072448|42042328|FG000|Overall Study|Protocol deviation|3|||
19593834|NCT01072448|42042329|FG001|Overall Study|Protocol deviation|4|||
19593835|NCT01072448|42042328|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19593836|NCT01072448|42042329|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19593837|NCT01072448|42042328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19593838|NCT01072448|42042329|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19593839|NCT01072448|42042328|FG000|Overall Study|Lost to Follow-up|1|||
19593840|NCT01072448|42042329|FG001|Overall Study|Lost to Follow-up|1|||
19593841|NCT01072448|42042328|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19593842|NCT01072448|42042329|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19593843|NCT01072448|42042328|FG000|Overall Study|Death|0|||
19593844|NCT01072448|42042329|FG001|Overall Study|Death|2|||
19593845|NCT00922974|42042338|FG000|Phase II Component|Protocol Violation|2|||
19593846|NCT00922974|42042339|FG001|Phase II Component|Protocol Violation|0|||
19593847|NCT00922974|42042338|FG000|Phase II Component|Not evaluable for treatment review|5|||
19593848|NCT00922974|42042339|FG001|Phase II Component|Not evaluable for treatment review|0|||
19593849|NCT00922974|42042338|FG000|Phase III Component|Protocol Violation|8|||
19593850|NCT00922974|42042339|FG001|Phase III Component|Protocol Violation|6|||
19593851|NCT00858988|42042349|FG000|Analysis|Lactulose unable to be detected in urine|2|||
19593852|NCT00858988|42042350|FG001|Analysis|Lactulose unable to be detected in urine|1|||
19593853|NCT00858832|42042358|FG000|Overall Study|became ineligible: delivered vaginally|1|||
19593854|NCT00858832|42042359|FG001|Overall Study|became ineligible: delivered vaginally|0|||
19593855|NCT00858832|42042358|FG000|Overall Study|Adverse Event|0|||
19593856|NCT00858832|42042359|FG001|Overall Study|Adverse Event|1|||
19593857|NCT01071512|42042365|FG000|Overall Study|Adverse Event|1|||
19593858|NCT01071512|42042365|FG000|Overall Study|Development of antibodies to drug|2|||
19593859|NCT01071512|42042365|FG000|Overall Study|positive anti-JC virus antibody test|2|||
19746506|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746507|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
19746508|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
19746509|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19593860|NCT00858442|42042371|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
19593861|NCT00858442|42042372|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
19593862|NCT01071278|42042379|FG000|Overall Study|Premature Discontinuation|254|||
19593863|NCT01071278|42042379|FG000|Overall Study|Completion Status Unknown|459|||
19746510|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
19746511|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746512|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746513|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746514|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746515|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746516|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746517|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746518|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746519|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746520|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746521|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746522|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746523|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
19746524|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
19746525|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746526|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
19746527|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746528|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746529|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746530|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746531|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746532|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746533|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746534|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746535|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746536|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746537|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746538|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
19746539|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
19746540|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
19746541|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
19746542|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
19746543|NCT02906020|42193771|FG000|Part 2: Long-term Follow-up Period|Other|0|||
19746544|NCT02906020|42193772|FG001|Part 2: Long-term Follow-up Period|Other|0|||
19746545|NCT02906020|42193773|FG002|Part 2: Long-term Follow-up Period|Other|0|||
19746546|NCT02906020|42193774|FG003|Part 2: Long-term Follow-up Period|Other|0|||
19746547|NCT02906020|42193775|FG004|Part 2: Long-term Follow-up Period|Other|0|||
19746548|NCT02906020|42193776|FG005|Part 2: Long-term Follow-up Period|Other|0|||
19746549|NCT02906020|42193777|FG006|Part 2: Long-term Follow-up Period|Other|0|||
19746550|NCT02906020|42193778|FG007|Part 2: Long-term Follow-up Period|Other|0|||
19746551|NCT02906020|42193779|FG008|Part 2: Long-term Follow-up Period|Other|0|||
19746552|NCT02906020|42193780|FG009|Part 2: Long-term Follow-up Period|Other|0|||
19746553|NCT02906020|42193781|FG010|Part 2: Long-term Follow-up Period|Other|0|||
19746554|NCT02906020|42193782|FG011|Part 2: Long-term Follow-up Period|Other|0|||
19746555|NCT02906020|42193783|FG012|Part 2: Long-term Follow-up Period|Other|13|||
19746556|NCT02906020|42193784|FG013|Part 2: Long-term Follow-up Period|Other|8|||
19746557|NCT02906020|42193785|FG014|Part 2: Long-term Follow-up Period|Other|3|||
19746558|NCT02906020|42193786|FG015|Part 2: Long-term Follow-up Period|Other|2|||
19746559|NCT03499353|42193814|FG000|Treatment|Adverse Event|3|||
19746560|NCT03499353|42193814|FG000|Treatment|Progressive Disease|10|||
19746561|NCT03499353|42193814|FG000|Treatment|Other|1|||
19746562|NCT03499353|42193814|FG000|Treatment|Withdrawal by Subject|2|||
19746563|NCT03499353|42193814|FG000|Long-Term Follow-up|Death|2|||
19593864|NCT00858208|42042385|FG000|Overall Study|Adverse Event|3|||
19593865|NCT00858208|42042385|FG000|Overall Study|Lost to Follow-up|26|||
19593866|NCT00858208|42042385|FG000|Overall Study|Participant refused|40|||
19593867|NCT00858208|42042385|FG000|Overall Study|Other|10|||
19593868|NCT01071200|42042391|FG000|Overall Study|Lack of ovarian response|1|||
19746564|NCT03499353|42193814|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
19746565|NCT03499353|42193814|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
19746566|NCT03368664|42193818|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
19746567|NCT03368664|42193818|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
19746568|NCT03368664|42193818|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
19746569|NCT03368664|42193818|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
19746570|NCT00004259|42193830|FG000|Overall Study|Protocol Violation|1|||
19593869|NCT01071200|42042392|FG001|Overall Study|Lack of ovarian response|1|||
19593870|NCT01071200|42042391|FG000|Overall Study|No fertilization|4|||
19593871|NCT01071200|42042392|FG001|Overall Study|No fertilization|0|||
19593872|NCT01071200|42042391|FG000|Overall Study|No oocytes retrieved|1|||
19593873|NCT01071200|42042392|FG001|Overall Study|No oocytes retrieved|1|||
19593874|NCT01071200|42042391|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
19593875|NCT01071200|42042392|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
19593876|NCT01071200|42042391|FG000|Overall Study|No viable embryos|0|||
19593877|NCT01071200|42042392|FG001|Overall Study|No viable embryos|1|||
19593878|NCT02207569|42042398|FG000|1-Month|Death|6|||
19593879|NCT02207569|42042398|FG000|1-Month|Withdrawal by Subject|2|||
19593880|NCT02207569|42042398|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
19593881|NCT02207569|42042398|FG000|6-Month|Death|8|||
19593882|NCT02207569|42042398|FG000|6-Month|Withdrawal by Subject|2|||
19593883|NCT02207569|42042398|FG000|12-Month|Death|14|||
19593884|NCT02207569|42042398|FG000|12-Month|Withdrawal by Subject|2|||
19593885|NCT02207569|42042398|FG000|24-Month|Death|23|||
19593886|NCT02207569|42042398|FG000|24-Month|Withdrawal by Subject|3|||
19593887|NCT02207569|42042398|FG000|36-Month|Death|23|||
19593888|NCT02207569|42042398|FG000|36-Month|Withdrawal by Subject|4|||
19593889|NCT02207569|42042398|FG000|48-Month|Death|25|||
19593890|NCT02207569|42042398|FG000|48-Month|Withdrawal by Subject|2|||
19593891|NCT02207569|42042398|FG000|48-Month|Lost to Follow-up|4|||
19593892|NCT02207569|42042398|FG000|60-Month|Death|1|||
19593893|NCT02207569|42042398|FG000|60-Month|Lost to Follow-up|1|||
19593894|NCT02207569|42042398|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
19593895|NCT02207569|42042398|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
19593896|NCT01070966|42042402|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
19593897|NCT01070966|42042402|FG000|Participants for Safety Evaluation|Off-label use|9|||
19593898|NCT01070966|42042402|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
19593899|NCT01070966|42042402|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
19593900|NCT01070966|42042402|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
19593901|NCT01070966|42042402|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
19593902|NCT01070966|42042402|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
19593903|NCT01070966|42042402|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
19593904|NCT01070888|42042415|FG000|First Intervention (14 Days)|Adverse Event|0|||
19593905|NCT01070888|42042416|FG001|First Intervention (14 Days)|Adverse Event|1|||
19593906|NCT01070888|42042415|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
19593907|NCT01070888|42042416|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
19593908|NCT01070888|42042415|FG000|Washout (14 Days)|Physician Decision|1|||
19593909|NCT01070888|42042416|FG001|Washout (14 Days)|Physician Decision|0|||
19593910|NCT00857896|42042422|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
19593911|NCT00857818|42042429|FG000|Overall Study|Lack of Efficacy|1|||
19593912|NCT00857818|42042430|FG001|Overall Study|Lack of Efficacy|0|||
19593913|NCT00857818|42042429|FG000|Overall Study|Adverse Event|3|||
19593914|NCT00857818|42042430|FG001|Overall Study|Adverse Event|0|||
19476976|NCT01489111|41755568|FG000|Overall Study|Withdrawal criterion|1|||
19593915|NCT00857818|42042429|FG000|Overall Study|Withdrawal by Subject|0|||
19593916|NCT00857818|42042430|FG001|Overall Study|Withdrawal by Subject|4|||
19593917|NCT00857818|42042429|FG000|Overall Study|Sponsor terminated study|6|||
19593918|NCT00857818|42042430|FG001|Overall Study|Sponsor terminated study|4|||
19593919|NCT00857818|42042429|FG000|Overall Study|Investigator decision|1|||
19593920|NCT00857818|42042430|FG001|Overall Study|Investigator decision|0|||
19593921|NCT01074944|42042436|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
19593922|NCT01074944|42042437|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
19593923|NCT01074944|42042438|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
19593924|NCT01074944|42042439|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
19593925|NCT01074944|42042440|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
19593926|NCT01074944|42042436|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
19593927|NCT01074944|42042437|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
19593928|NCT01074944|42042438|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
19593929|NCT01074944|42042439|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
19593930|NCT01074944|42042440|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
19593931|NCT01074944|42042436|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
19593932|NCT01074944|42042437|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
19593933|NCT01074944|42042438|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
19593934|NCT01074944|42042439|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
19593935|NCT01074944|42042440|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
19593936|NCT01074944|42042436|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
19593937|NCT01074944|42042437|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
19746571|NCT00004259|42193831|FG001|Overall Study|Protocol Violation|2|||
19388004|NCT02038036|41631321|FG000|Crossover Period|Lost to Follow-up|0|||
19593938|NCT01074944|42042438|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
19746572|NCT00004259|42193832|FG002|Overall Study|Protocol Violation|0|||
19593939|NCT01074944|42042439|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
19593940|NCT01074944|42042440|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
19593941|NCT01074944|42042436|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
19593942|NCT01074944|42042437|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
19593943|NCT01074944|42042438|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
19593944|NCT01074944|42042439|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
19593945|NCT01074944|42042440|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
19593946|NCT01074944|42042436|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
19593947|NCT01074944|42042437|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
19593948|NCT01074944|42042438|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
19593949|NCT01074944|42042439|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
19593950|NCT01074944|42042440|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
19593951|NCT01074944|42042436|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
19593952|NCT01074944|42042437|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
19593953|NCT01074944|42042438|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
19593954|NCT01074944|42042439|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
19593955|NCT01074944|42042440|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
19593956|NCT01074944|42042436|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
19593957|NCT01074944|42042437|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
19593958|NCT01074944|42042438|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
19593959|NCT01074944|42042439|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
19593960|NCT01074944|42042440|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
19593961|NCT01074944|42042436|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
19593962|NCT01074944|42042437|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
19593963|NCT01074944|42042438|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
19593964|NCT01074944|42042439|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
19593965|NCT01074944|42042440|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
19593966|NCT01074944|42042436|FG000|Long Term Treatment|Adverse Event|0|||
19593967|NCT01074944|42042437|FG001|Long Term Treatment|Adverse Event|0|||
19593968|NCT01074944|42042438|FG002|Long Term Treatment|Adverse Event|0|||
19593969|NCT01074944|42042439|FG003|Long Term Treatment|Adverse Event|3|||
19593970|NCT01074944|42042440|FG004|Long Term Treatment|Adverse Event|0|||
19593971|NCT01074944|42042436|FG000|Long Term Treatment|Lost to Follow-up|0|||
19593972|NCT01074944|42042437|FG001|Long Term Treatment|Lost to Follow-up|0|||
19593973|NCT01074944|42042438|FG002|Long Term Treatment|Lost to Follow-up|0|||
19593974|NCT01074944|42042439|FG003|Long Term Treatment|Lost to Follow-up|2|||
19593975|NCT01074944|42042440|FG004|Long Term Treatment|Lost to Follow-up|0|||
19593976|NCT01074944|42042436|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
19593977|NCT01074944|42042437|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
19593978|NCT01074944|42042438|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
19593979|NCT01074944|42042439|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
19593980|NCT01074944|42042440|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
19593981|NCT01074944|42042436|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
19593982|NCT01074944|42042437|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
19593983|NCT01074944|42042438|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
19593984|NCT01074944|42042439|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
19593985|NCT01074944|42042440|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
19593986|NCT01074944|42042436|FG000|Long Term Treatment|Withdrawal by Subject|0|||
19593987|NCT01074944|42042437|FG001|Long Term Treatment|Withdrawal by Subject|0|||
19593988|NCT01074944|42042438|FG002|Long Term Treatment|Withdrawal by Subject|0|||
19593989|NCT01074944|42042439|FG003|Long Term Treatment|Withdrawal by Subject|2|||
19593990|NCT01074944|42042440|FG004|Long Term Treatment|Withdrawal by Subject|0|||
19593991|NCT01074944|42042436|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
19593992|NCT01074944|42042437|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
19593993|NCT01074944|42042438|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
19593994|NCT01074944|42042439|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
19593995|NCT01074944|42042440|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
19593996|NCT01074944|42042436|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
19593997|NCT01074944|42042437|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
19593998|NCT01074944|42042438|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
19593999|NCT01074944|42042439|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
19594000|NCT01074944|42042440|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
19594001|NCT00802945|42042450|FG000|Overall Study|Death|27|||
19594002|NCT00802945|42042451|FG001|Overall Study|Death|23|||
19746573|NCT00004259|42193833|FG003|Overall Study|Protocol Violation|0|||
19746574|NCT00004259|42193830|FG000|Overall Study|Withdrawal by Subject|0|||
19594003|NCT00802945|42042450|FG000|Overall Study|Terminated by sponsor|8|||
19594004|NCT00802945|42042451|FG001|Overall Study|Terminated by sponsor|12|||
19594005|NCT01074554|42042461|FG000|Overall Study|Adverse Event|3|||
19594006|NCT01074554|42042462|FG001|Overall Study|Adverse Event|3|||
19594007|NCT01074554|42042461|FG000|Overall Study|Lost to Follow-up|0|||
19594008|NCT01074554|42042462|FG001|Overall Study|Lost to Follow-up|1|||
19594009|NCT00857584|42042470|FG000|Overall Study|Lack of Efficacy|1|||
19594010|NCT00857584|42042471|FG001|Overall Study|Lack of Efficacy|2|||
19594011|NCT00857584|42042470|FG000|Overall Study|Adverse Event|2|||
19746575|NCT00004259|42193831|FG001|Overall Study|Withdrawal by Subject|2|||
19594012|NCT00857584|42042471|FG001|Overall Study|Adverse Event|2|||
19594013|NCT00857584|42042470|FG000|Overall Study|Physician Decision|1|||
19594014|NCT00857584|42042471|FG001|Overall Study|Physician Decision|1|||
19594015|NCT00798967|42042479|FG000|Overall Study|Adverse Event|2|||
19594016|NCT00798967|42042480|FG001|Overall Study|Adverse Event|3|||
19594017|NCT00798967|42042479|FG000|Overall Study|Withdrawal by Subject|0|||
19594018|NCT00798967|42042480|FG001|Overall Study|Withdrawal by Subject|1|||
19594019|NCT00798967|42042479|FG000|Overall Study|Physician Decision|1|||
19594020|NCT00798967|42042480|FG001|Overall Study|Physician Decision|0|||
19594021|NCT00798967|42042479|FG000|Overall Study|Randomized in error by site|1|||
19594022|NCT00798967|42042480|FG001|Overall Study|Randomized in error by site|0|||
19594023|NCT01074242|42042487|FG000|Overall Study|Case report before date of contract|40|||
19594024|NCT01074242|42042487|FG000|Overall Study|Lost to Follow-up|1|||
19594025|NCT01074242|42042487|FG000|Overall Study|Case report unclear|6|||
19594026|NCT01074242|42042487|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
19594027|NCT01074242|42042487|FG000|Overall Study|Duplicate Case Report Form|5|||
19594028|NCT00798889|42042491|FG000|Overall Study|Adverse Event|53|||
19594029|NCT00798889|42042491|FG000|Overall Study|Protocol Violation|2|||
19594030|NCT00798889|42042491|FG000|Overall Study|Withdrawal by Subject|31|||
19594031|NCT00798889|42042491|FG000|Overall Study|Lost to Follow-up|1|||
19594032|NCT00798889|42042491|FG000|Overall Study|Lack of Efficacy|213|||
19594033|NCT00798889|42042491|FG000|Overall Study|Decision of Sponsor|11|||
19594034|NCT00798889|42042491|FG000|Overall Study|Enrolled, Not treated|3|||
19746576|NCT00004259|42193832|FG002|Overall Study|Withdrawal by Subject|0|||
19594035|NCT00796861|42042495|FG000|Overall Study|Withdrawal by Subject|2|||
19594036|NCT00796861|42042495|FG000|Overall Study|Death|2|||
19594037|NCT00802867|42042499|FG000|Overall Study|Lost to Follow-up|6|||
19594038|NCT00802867|42042499|FG000|Overall Study|Protocol Violation|6|||
19594039|NCT00802867|42042499|FG000|Overall Study|Withdrawal by Subject|1|||
19594040|NCT00798655|42042503|FG000|Overall Study|Did not receive at least one dose of pan|2|||
19594041|NCT00796549|42042507|FG000|Overall Study|Adverse Event|11|||
19594042|NCT00796549|42042507|FG000|Overall Study|not entered|149|||
19594043|NCT00796549|42042507|FG000|Overall Study|Other|2|||
19594044|NCT00796549|42042507|FG000|Overall Study|Progressive disease|56|||
19594045|NCT00856492|42042516|FG000|Overall Study|Ineligible or withdrew consent|1|||
19594046|NCT00856492|42042517|FG001|Overall Study|Ineligible or withdrew consent|1|||
19594047|NCT00856492|42042518|FG002|Overall Study|Ineligible or withdrew consent|2|||
19594048|NCT00856180|42042529|FG000|Overall Study|Adverse Event|4|||
19594049|NCT00856180|42042529|FG000|Overall Study|Progressive Disease|16|||
19594050|NCT00900627|42042541|FG000|Overall Study|Condition under investigation worsened|4|||
19594051|NCT00900627|42042542|FG001|Overall Study|Condition under investigation worsened|0|||
19594052|NCT00900627|42042543|FG002|Overall Study|Condition under investigation worsened|5|||
19594053|NCT00900627|42042544|FG003|Overall Study|Condition under investigation worsened|3|||
19594054|NCT00900627|42042545|FG004|Overall Study|Condition under investigation worsened|0|||
19594055|NCT00900627|42042546|FG005|Overall Study|Condition under investigation worsened|0|||
19594056|NCT00900627|42042541|FG000|Overall Study|Withdrawal by Subject|1|||
19594057|NCT00900627|42042542|FG001|Overall Study|Withdrawal by Subject|0|||
19594058|NCT00900627|42042543|FG002|Overall Study|Withdrawal by Subject|1|||
19594059|NCT00900627|42042544|FG003|Overall Study|Withdrawal by Subject|0|||
19594060|NCT00900627|42042545|FG004|Overall Study|Withdrawal by Subject|1|||
19594061|NCT00900627|42042546|FG005|Overall Study|Withdrawal by Subject|2|||
19594062|NCT00900627|42042541|FG000|Overall Study|Adverse Event|1|||
19594063|NCT00900627|42042542|FG001|Overall Study|Adverse Event|2|||
19594064|NCT00900627|42042543|FG002|Overall Study|Adverse Event|0|||
19594065|NCT00900627|42042544|FG003|Overall Study|Adverse Event|3|||
19594066|NCT00900627|42042545|FG004|Overall Study|Adverse Event|0|||
19594067|NCT00900627|42042546|FG005|Overall Study|Adverse Event|0|||
19746577|NCT00004259|42193833|FG003|Overall Study|Withdrawal by Subject|0|||
19594068|NCT00900627|42042541|FG000|Overall Study|Death|0|||
19594069|NCT00900627|42042542|FG001|Overall Study|Death|0|||
19594070|NCT00900627|42042543|FG002|Overall Study|Death|0|||
19594071|NCT00900627|42042544|FG003|Overall Study|Death|0|||
19594072|NCT00900627|42042545|FG004|Overall Study|Death|28|||
19594073|NCT00900627|42042546|FG005|Overall Study|Death|24|||
19594074|NCT00866320|42042560|FG000|Overall Study|Withdrawal by Subject|4|||
19594075|NCT00866320|42042560|FG000|Overall Study|Death|2|||
19746578|NCT03365934|42193857|FG000|Overall Study|Adverse Event|1|||
19746579|NCT03365934|42193857|FG000|Overall Study|Withdrawal by Subject|1|||
19746580|NCT03468855|42193866|FG000|Overall Study|Adverse Event|2|||
19594076|NCT00869518|42042568|FG000|Overall Study|Lost to Follow-up|1|||
19594077|NCT00869518|42042569|FG001|Overall Study|Lost to Follow-up|1|||
19594078|NCT00797563|42042575|FG000|Overall Study|Adverse Event|1|||
19594079|NCT00869440|42042583|FG000|Overall Study|Withdrawal by Subject|1|||
19594080|NCT00869440|42042584|FG001|Overall Study|Withdrawal by Subject|0|||
19594081|NCT00869440|42042585|FG002|Overall Study|Withdrawal by Subject|0|||
19594082|NCT00869440|42042586|FG003|Overall Study|Withdrawal by Subject|0|||
19594083|NCT00869440|42042583|FG000|Overall Study|Physician Decision|1|||
19594084|NCT00869440|42042584|FG001|Overall Study|Physician Decision|1|||
19594085|NCT00869440|42042585|FG002|Overall Study|Physician Decision|0|||
19594086|NCT00869440|42042586|FG003|Overall Study|Physician Decision|0|||
19594087|NCT00895947|42042598|FG000|Overall Study|Adverse Event|3|||
19594088|NCT00895947|42042599|FG001|Overall Study|Adverse Event|4|||
19594089|NCT00895947|42042598|FG000|Overall Study|Lost to Follow-up|3|||
19594090|NCT00895947|42042599|FG001|Overall Study|Lost to Follow-up|4|||
19594091|NCT00895947|42042598|FG000|Overall Study|Protocol Violation|4|||
19594092|NCT00895947|42042599|FG001|Overall Study|Protocol Violation|2|||
19594093|NCT00895947|42042598|FG000|Overall Study|Withdrawal by Subject|2|||
19594094|NCT00895947|42042599|FG001|Overall Study|Withdrawal by Subject|0|||
19594095|NCT00869362|42042607|FG000|Overall Study|Death|0|||
19594096|NCT00869362|42042608|FG001|Overall Study|Death|2|||
19594097|NCT00869362|42042607|FG000|Overall Study|Lost to Follow-up|1|||
19594098|NCT00869362|42042608|FG001|Overall Study|Lost to Follow-up|3|||
19594099|NCT00588445|42042615|FG000|Overall Study|Protocol Violation|1|||
19594100|NCT00588445|42042615|FG000|Overall Study|Withdrawal by Subject|3|||
19594101|NCT00588445|42042615|FG000|Overall Study|Disease Progression|1|||
19594102|NCT00588445|42042615|FG000|Overall Study|Not Treated|10|||
19594103|NCT00796315|42042621|FG000|Overall Study|Protocol Violation|0|||
19594104|NCT00796315|42042622|FG001|Overall Study|Protocol Violation|1|||
19594105|NCT00796315|42042623|FG002|Overall Study|Protocol Violation|0|||
19594106|NCT00855166|42042636|FG000|Overall Study|Adverse Event|0|||
19746581|NCT03468855|42193866|FG000|Overall Study|Lost to Follow-up|5|||
19746582|NCT03468855|42193866|FG000|Overall Study|Withdrawal by Subject|3|||
19594107|NCT00855166|42042637|FG001|Overall Study|Adverse Event|2|||
19594108|NCT00855166|42042636|FG000|Overall Study|Death|0|||
19594109|NCT00855166|42042637|FG001|Overall Study|Death|1|||
19594110|NCT00855166|42042636|FG000|Overall Study|Withdrawal by Subject|1|||
19594111|NCT00855166|42042637|FG001|Overall Study|Withdrawal by Subject|4|||
19594112|NCT00855166|42042636|FG000|Overall Study|Poor/non-compliance|2|||
19594113|NCT00855166|42042637|FG001|Overall Study|Poor/non-compliance|0|||
19594114|NCT00855166|42042636|FG000|Overall Study|Administrative reasons by sponsor|1|||
19594115|NCT00855166|42042637|FG001|Overall Study|Administrative reasons by sponsor|0|||
19594116|NCT00855166|42042636|FG000|Overall Study|Subject no longer meets study criteria|1|||
19594117|NCT00855166|42042637|FG001|Overall Study|Subject no longer meets study criteria|1|||
19594118|NCT00587587|42042647|FG000|Overall Study|Lost to Follow-up|6|||
19594119|NCT00587587|42042648|FG001|Overall Study|Lost to Follow-up|1|||
19594120|NCT00854620|42042656|FG000|Overall Study|Adverse Event|1|||
19594121|NCT00793585|42042662|FG000|Overall Study|Adverse Event|1|||
19594122|NCT00793585|42042663|FG001|Overall Study|Adverse Event|1|||
19594123|NCT00793585|42042662|FG000|Overall Study|Protocol Violation|1|||
19594124|NCT00793585|42042663|FG001|Overall Study|Protocol Violation|2|||
19594125|NCT00898443|42042671|FG000|Overall Study|Withdrawal by Subject|1|||
19594126|NCT00898443|42042672|FG001|Overall Study|Withdrawal by Subject|0|||
19594127|NCT00900159|42042680|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
19594128|NCT00900159|42042681|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
19594129|NCT00854308|42042700|FG000|Overall Study|Disease progression|42|||
19594130|NCT00854308|42042701|FG001|Overall Study|Disease progression|50|||
19594131|NCT00854308|42042700|FG000|Overall Study|Adverse Event|8|||
19594132|NCT00854308|42042701|FG001|Overall Study|Adverse Event|3|||
19594133|NCT00854308|42042700|FG000|Overall Study|Death|2|||
19594134|NCT00854308|42042701|FG001|Overall Study|Death|5|||
19594135|NCT00854308|42042700|FG000|Overall Study|Physician Decision|6|||
19594136|NCT00854308|42042701|FG001|Overall Study|Physician Decision|6|||
19594137|NCT00854308|42042700|FG000|Overall Study|Withdrawal by Subject|4|||
19594138|NCT00854308|42042701|FG001|Overall Study|Withdrawal by Subject|2|||
19594139|NCT00854308|42042700|FG000|Overall Study|Sponsor's decision to terminate study|0|||
19594140|NCT00854308|42042701|FG001|Overall Study|Sponsor's decision to terminate study|1|||
19594141|NCT00592852|42042707|FG000|Overall Study|Non-compliance|1|||
19594142|NCT00592852|42042707|FG000|Overall Study|Adverse Event|3|||
19594143|NCT00592852|42042707|FG000|Overall Study|Found ineligible|1|||
19594144|NCT00592852|42042707|FG000|Overall Study|Withdrawal by Subject|1|||
19594145|NCT00895245|42042711|FG000|Overall Study|Lack of Efficacy|6|||
19746583|NCT03468855|42193866|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
19594146|NCT00865306|42042717|FG000|Controlled Trial|Lost to Follow-up|1|||
19594147|NCT00865306|42042718|FG001|Controlled Trial|Lost to Follow-up|1|||
19594148|NCT00865306|42042717|FG000|Controlled Trial|Difficulty commuting|2|||
19594149|NCT00865306|42042718|FG001|Controlled Trial|Difficulty commuting|0|||
19594150|NCT00865306|42042717|FG000|Controlled Trial|Improved btw baseline and first session|1|||
19594151|NCT00865306|42042718|FG001|Controlled Trial|Improved btw baseline and first session|0|||
19594152|NCT00865306|42042717|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
19594153|NCT00865306|42042718|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
19594154|NCT00865306|42042717|FG000|Controlled Trial|Withdrawal by Subject|0|||
19594155|NCT00865306|42042718|FG001|Controlled Trial|Withdrawal by Subject|1|||
19594156|NCT00896649|42042724|FG000|Overall Study|Physician Decision|1|||
19594157|NCT00896649|42042724|FG000|Overall Study|Pregnancy|1|||
19594158|NCT00896649|42042724|FG000|Overall Study|missing documentation|1|||
19594159|NCT00896649|42042724|FG000|Overall Study|technical difficulties|2|||
19594160|NCT00796003|42042731|FG000|Overall Study|Disease Progression|2|||
19594161|NCT00796003|42042732|FG001|Overall Study|Disease Progression|13|||
19594162|NCT00796003|42042731|FG000|Overall Study|Adverse Event|1|||
19594163|NCT00796003|42042732|FG001|Overall Study|Adverse Event|7|||
19594164|NCT00796003|42042731|FG000|Overall Study|Specified organ function not met|0|||
19594165|NCT00796003|42042732|FG001|Overall Study|Specified organ function not met|1|||
19594166|NCT00796003|42042731|FG000|Overall Study|Physician Decision|0|||
19594167|NCT00796003|42042732|FG001|Overall Study|Physician Decision|4|||
19594168|NCT00796003|42042731|FG000|Overall Study|Withdrawal by Subject|0|||
19388005|NCT02038036|41631322|FG001|Crossover Period|Lost to Follow-up|1|||
19388006|NCT02038036|41631321|FG000|Crossover Period|Physician Decision|0|||
19388007|NCT02038036|41631322|FG001|Crossover Period|Physician Decision|2|||
19476977|NCT01488487|41755572|FG000|Overall Study|Adverse Event|6|||
19388008|NCT02037568|41631333|FG000|Overall Study|Withdrawal by Subject|17|||
19594169|NCT00796003|42042732|FG001|Overall Study|Withdrawal by Subject|1|||
19594170|NCT00796003|42042731|FG000|Overall Study|Other|0|||
19594171|NCT00796003|42042732|FG001|Overall Study|Other|1|||
19594172|NCT00796003|42042731|FG000|Overall Study|Participants Not treated|0|||
19594173|NCT00796003|42042732|FG001|Overall Study|Participants Not treated|2|||
19594174|NCT00895011|42042744|FG000|Overall Study|Withdrawal by Subject|14|||
19594175|NCT00895011|42042745|FG001|Overall Study|Withdrawal by Subject|7|||
19594176|NCT00895011|42042746|FG002|Overall Study|Withdrawal by Subject|2|||
19594177|NCT00895011|42042744|FG000|Overall Study|Lost to Follow-up|5|||
19594178|NCT00895011|42042745|FG001|Overall Study|Lost to Follow-up|4|||
19594179|NCT00895011|42042746|FG002|Overall Study|Lost to Follow-up|1|||
19594180|NCT00895011|42042744|FG000|Overall Study|Protocol Violation|3|||
19594181|NCT00895011|42042745|FG001|Overall Study|Protocol Violation|1|||
19594182|NCT00895011|42042746|FG002|Overall Study|Protocol Violation|3|||
19594183|NCT00895011|42042744|FG000|Overall Study|Adverse Event|1|||
19594184|NCT00895011|42042745|FG001|Overall Study|Adverse Event|2|||
19594185|NCT00895011|42042746|FG002|Overall Study|Adverse Event|2|||
19594186|NCT00895011|42042744|FG000|Overall Study|schedule conflict|1|||
19594187|NCT00895011|42042745|FG001|Overall Study|schedule conflict|0|||
19594188|NCT00895011|42042746|FG002|Overall Study|schedule conflict|0|||
19594189|NCT00899847|42042755|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
19594190|NCT00795535|42042761|FG000|Overall Study|incomplete data and technical problems|20|||
19594191|NCT00853762|42042769|FG000|Overall Study|Premature Termination|16|||
19594192|NCT00853762|42042770|FG001|Overall Study|Premature Termination|15|||
19594193|NCT00853762|42042771|FG002|Overall Study|Premature Termination|14|||
19594194|NCT00853762|42042772|FG003|Overall Study|Premature Termination|21|||
19594195|NCT00853762|42042769|FG000|Overall Study|Protocol Violation|0|||
19594196|NCT00853762|42042770|FG001|Overall Study|Protocol Violation|0|||
19594197|NCT00853762|42042771|FG002|Overall Study|Protocol Violation|0|||
19594198|NCT00853762|42042772|FG003|Overall Study|Protocol Violation|1|||
19594199|NCT00853762|42042769|FG000|Overall Study|Withdrawal by Subject|0|||
19594200|NCT00853762|42042770|FG001|Overall Study|Withdrawal by Subject|0|||
19594201|NCT00853762|42042771|FG002|Overall Study|Withdrawal by Subject|1|||
19594202|NCT00853762|42042772|FG003|Overall Study|Withdrawal by Subject|0|||
19594203|NCT00853762|42042769|FG000|Overall Study|Other|0|||
19594204|NCT00853762|42042770|FG001|Overall Study|Other|2|||
19594205|NCT00853762|42042771|FG002|Overall Study|Other|0|||
19594206|NCT00853762|42042772|FG003|Overall Study|Other|0|||
19594207|NCT00853762|42042769|FG000|Overall Study|Randomised but not Treated|0|||
19594208|NCT00853762|42042770|FG001|Overall Study|Randomised but not Treated|2|||
19594209|NCT00853762|42042771|FG002|Overall Study|Randomised but not Treated|2|||
19594210|NCT00853762|42042772|FG003|Overall Study|Randomised but not Treated|0|||
19594211|NCT00789529|42042784|FG000|Overall Study|Withdrawal by Subject|0|||
19594212|NCT00789529|42042785|FG001|Overall Study|Withdrawal by Subject|1|||
19594213|NCT00789529|42042784|FG000|Overall Study|Other Reason|1|||
19594214|NCT00789529|42042785|FG001|Overall Study|Other Reason|0|||
19594215|NCT00894933|42042791|FG000|Overall Study|Lost to Follow-up|2|||
19594216|NCT00894933|42042791|FG000|Overall Study|Cancelled Procedure|1|||
19594217|NCT00894933|42042791|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
19594218|NCT00792805|42042798|FG000|Overall Study|Adverse Event|12|||
19594219|NCT00792805|42042799|FG001|Overall Study|Adverse Event|10|||
19594220|NCT00792805|42042800|FG002|Overall Study|Adverse Event|10|||
19594221|NCT00792805|42042798|FG000|Overall Study|Subject withdrew consent|5|||
19594222|NCT00792805|42042799|FG001|Overall Study|Subject withdrew consent|6|||
19594223|NCT00792805|42042800|FG002|Overall Study|Subject withdrew consent|5|||
19594224|NCT00792805|42042798|FG000|Overall Study|Administrative problems|2|||
19594225|NCT00792805|42042799|FG001|Overall Study|Administrative problems|0|||
19746584|NCT03738865|42193872|FG000|Overall Study|Withdrawal by Subject|3|||
19746585|NCT03738865|42193873|FG001|Overall Study|Withdrawal by Subject|3|||
19594226|NCT00792805|42042800|FG002|Overall Study|Administrative problems|4|||
19594227|NCT00792805|42042798|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19594228|NCT00792805|42042799|FG001|Overall Study|Abnormal test procedure result(s)|2|||
19594229|NCT00792805|42042800|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19594230|NCT00792805|42042798|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19594231|NCT00792805|42042799|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
19594232|NCT00792805|42042800|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
19594233|NCT00792805|42042798|FG000|Overall Study|Lost to Follow-up|1|||
19594234|NCT00792805|42042799|FG001|Overall Study|Lost to Follow-up|1|||
19594235|NCT00792805|42042800|FG002|Overall Study|Lost to Follow-up|6|||
19594236|NCT00792805|42042798|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19594237|NCT00792805|42042799|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19594238|NCT00792805|42042800|FG002|Overall Study|Abnormal laboratory value(s)|1|||
19594239|NCT00792805|42042798|FG000|Overall Study|Protocol deviation|0|||
19594240|NCT00792805|42042799|FG001|Overall Study|Protocol deviation|1|||
19594241|NCT00792805|42042800|FG002|Overall Study|Protocol deviation|1|||
19594242|NCT00925002|42042811|FG000|Overall Study|Other|1|||
19594243|NCT00925002|42042812|FG001|Overall Study|Other|4|||
19594244|NCT00925002|42042813|FG002|Overall Study|Other|0|||
19594245|NCT00925002|42042811|FG000|Overall Study|Death|1|||
19594246|NCT00925002|42042812|FG001|Overall Study|Death|1|||
19594247|NCT00925002|42042813|FG002|Overall Study|Death|5|||
19594248|NCT00925002|42042811|FG000|Overall Study|Adverse Event|3|||
19594249|NCT00925002|42042812|FG001|Overall Study|Adverse Event|1|||
19594250|NCT00925002|42042813|FG002|Overall Study|Adverse Event|2|||
19594251|NCT00925002|42042811|FG000|Overall Study|Participant withdrew consent|1|||
19594252|NCT00925002|42042812|FG001|Overall Study|Participant withdrew consent|3|||
19594253|NCT00925002|42042813|FG002|Overall Study|Participant withdrew consent|3|||
19594254|NCT00928746|42042822|FG000|Overall Study|Adverse Event|2|||
19594255|NCT00928746|42042822|FG000|Overall Study|Protocol Violation|1|||
19594256|NCT00928746|42042822|FG000|Overall Study|Withdrawal by Subject|1|||
19594257|NCT00928746|42042822|FG000|Overall Study|Other|2|||
19594258|NCT00922428|42042828|FG000|Overall Study|retrospective/extremely implausible data|2|||
19594259|NCT00922428|42042828|FG000|Overall Study|no medication use or questionable use|13|||
19594260|NCT00894543|42042840|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
19594261|NCT00894543|42042841|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
19594262|NCT00894543|42042840|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
19594263|NCT00894543|42042841|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
19594264|NCT00922272|42042847|FG000|Open-label Phase|Adverse Event|5|||
19594265|NCT00922272|42042848|FG001|Open-label Phase|Adverse Event|0|||
19594266|NCT00922272|42042847|FG000|Open-label Phase|Protocol Violation|1|||
19594267|NCT00922272|42042848|FG001|Open-label Phase|Protocol Violation|0|||
19594268|NCT00922272|42042847|FG000|Open-label Phase|Withdrawal by Subject|11|||
19594269|NCT00922272|42042848|FG001|Open-label Phase|Withdrawal by Subject|0|||
19594270|NCT00922272|42042847|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
19746586|NCT03738865|42193872|FG000|Overall Study|Adverse Event|2|||
19746587|NCT03738865|42193873|FG001|Overall Study|Adverse Event|0|||
19746588|NCT03738865|42193872|FG000|Overall Study|Physician Decision|0|||
19746589|NCT03738865|42193873|FG001|Overall Study|Physician Decision|1|||
19746590|NCT03524157|42193882|FG000|Overall Study|cytology not readable|0|||
19746591|NCT03524157|42193883|FG001|Overall Study|cytology not readable|0|||
19746592|NCT03524157|42193884|FG002|Overall Study|cytology not readable|1|||
19746593|NCT03437733|42193898|FG000|Overall Study|Eligibility criteria not met|0|||
19746594|NCT03437733|42193899|FG001|Overall Study|Eligibility criteria not met|3|||
19746595|NCT03468543|42193907|FG000|Overall Study|Protocol stopping rules met|3|||
19746596|NCT03467763|42193911|FG000|Overall Study|Lost to Follow-up|1|||
19746597|NCT03467763|42193911|FG000|Overall Study|Protocol Violation|2|||
19746598|NCT00004031|42193919|FG000|Overall Study|Adverse Event|5|||
19746599|NCT00004031|42193920|FG001|Overall Study|Adverse Event|0|||
19746600|NCT00004031|42193919|FG000|Overall Study|Refusal unrelated to adverse events|2|||
19746601|NCT00004031|42193920|FG001|Overall Study|Refusal unrelated to adverse events|11|||
19746602|NCT00004031|42193919|FG000|Overall Study|Progression/relapse|9|||
19388009|NCT02037568|41631334|FG001|Overall Study|Withdrawal by Subject|24|||
19594271|NCT00922272|42042848|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
19594272|NCT00922272|42042847|FG000|Open-label Phase|Withdrawal criteria met|5|||
19594273|NCT00922272|42042848|FG001|Open-label Phase|Withdrawal criteria met|0|||
19476978|NCT01488487|41755572|FG000|Overall Study|Death|1|||
19594274|NCT00922272|42042847|FG000|Double-blind Phase|Adverse Event|1|||
19594275|NCT00922272|42042848|FG001|Double-blind Phase|Adverse Event|1|||
19594276|NCT00922272|42042847|FG000|Double-blind Phase|Withdrawal by Subject|1|||
19594277|NCT00922272|42042848|FG001|Double-blind Phase|Withdrawal by Subject|1|||
19594278|NCT00922272|42042847|FG000|Double-blind Phase|Lost to Follow-up|2|||
19594279|NCT00922272|42042848|FG001|Double-blind Phase|Lost to Follow-up|1|||
19746603|NCT00004031|42193920|FG001|Overall Study|Progression/relapse|4|||
19746604|NCT00004031|42193919|FG000|Overall Study|Death|3|||
19746605|NCT00004031|42193920|FG001|Overall Study|Death|1|||
19746606|NCT00004031|42193919|FG000|Overall Study|Other- not protocol specified|3|||
19746607|NCT00004031|42193920|FG001|Overall Study|Other- not protocol specified|3|||
19746608|NCT00004031|42193919|FG000|Overall Study|Reason under review|3|||
19746609|NCT00004031|42193920|FG001|Overall Study|Reason under review|2|||
19746610|NCT03467217|42193930|FG000|Overall Study|Trial stopped early|5|||
19746611|NCT03467217|42193931|FG001|Overall Study|Trial stopped early|2|||
19746612|NCT03467217|42193930|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
19594280|NCT00922272|42042847|FG000|Double-blind Phase|Withdrawal criteria met|1|||
19594281|NCT00922272|42042848|FG001|Double-blind Phase|Withdrawal criteria met|1|||
19594282|NCT00922272|42042847|FG000|Double-blind Phase|Noncompliance|1|||
19594283|NCT00922272|42042848|FG001|Double-blind Phase|Noncompliance|1|||
19594284|NCT00922272|42042847|FG000|Double-blind Phase|Positive urine drug screen|1|||
19746613|NCT03467217|42193931|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
19746614|NCT03467217|42193930|FG000|Overall Study|Lost to Follow-up|0|||
19746615|NCT03467217|42193931|FG001|Overall Study|Lost to Follow-up|2|||
19594285|NCT00922272|42042848|FG001|Double-blind Phase|Positive urine drug screen|1|||
19594286|NCT00853372|42042858|FG000|Overall Study|Death|30|||
19594287|NCT00853372|42042859|FG001|Overall Study|Death|26|||
19594288|NCT00853372|42042858|FG000|Overall Study|Lost to Follow-up|1|||
19594289|NCT00853372|42042859|FG001|Overall Study|Lost to Follow-up|2|||
19594290|NCT00853372|42042858|FG000|Overall Study|Full Consent Withdrawn|1|||
19594291|NCT00853372|42042859|FG001|Overall Study|Full Consent Withdrawn|1|||
19594292|NCT00848536|42042867|FG000|Overall Study|Adverse Event|2|||
19594293|NCT00848536|42042868|FG001|Overall Study|Adverse Event|2|||
19746616|NCT00003875|42193937|FG000|Overall Study|Screen Failed|1|||
19746617|NCT03495453|42193943|FG000|Overall Study|Withdrawal by Subject|0|||
19746618|NCT03495453|42193944|FG001|Overall Study|Withdrawal by Subject|1|||
19746619|NCT03364686|42193950|FG000|Overall Study|Physician Decision|2|||
19746620|NCT03437577|42193957|FG000|Pre-Randomization|Withdrawal by Subject|0|||
19746621|NCT03437577|42193958|FG001|Pre-Randomization|Withdrawal by Subject|0|||
19746622|NCT03437577|42193959|FG002|Pre-Randomization|Withdrawal by Subject|10|||
19746623|NCT03437577|42193957|FG000|Post-Randomization|Physician Decision|0|||
19746624|NCT03437577|42193958|FG001|Post-Randomization|Physician Decision|2|||
19746625|NCT03437577|42193959|FG002|Post-Randomization|Physician Decision|0|||
19746626|NCT03336528|42193967|FG000|Overall Study|Protocol Violation|1|||
19746627|NCT03336528|42193968|FG001|Overall Study|Protocol Violation|1|||
19746628|NCT03336528|42193967|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
19594294|NCT00848536|42042867|FG000|Overall Study|Withdrawal by Subject|0|||
19594295|NCT00848536|42042868|FG001|Overall Study|Withdrawal by Subject|1|||
19594296|NCT00848536|42042867|FG000|Overall Study|Protocol Violation|0|||
19594297|NCT00848536|42042868|FG001|Overall Study|Protocol Violation|1|||
19594298|NCT00848536|42042867|FG000|Overall Study|Noncompliance|1|||
19594299|NCT00848536|42042868|FG001|Overall Study|Noncompliance|0|||
19746629|NCT03336528|42193968|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
19746630|NCT03336528|42193967|FG000|Overall Study|Did not receive study medication|1|||
19746631|NCT03336528|42193968|FG001|Overall Study|Did not receive study medication|2|||
19746632|NCT03364608|42193976|FG000|Overall Study|Withdrawal by Subject|4|||
19746633|NCT03364608|42193976|FG000|Overall Study|Protocol Violation|2|||
19746634|NCT03364608|42193976|FG000|Overall Study|Lost to Follow-up|2|||
19746635|NCT00003869|42193990|FG000|Overall Study|Adverse Event|14|||
19746636|NCT00003869|42193991|FG001|Overall Study|Adverse Event|3|||
19746637|NCT00003869|42193990|FG000|Overall Study|Withdrawal by Subject|21|||
19746638|NCT00003869|42193991|FG001|Overall Study|Withdrawal by Subject|3|||
19746639|NCT00003869|42193990|FG000|Overall Study|Death|1|||
19746640|NCT00003869|42193991|FG001|Overall Study|Death|2|||
19746641|NCT00003869|42193990|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
19746642|NCT00003869|42193991|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
19594300|NCT00848536|42042867|FG000|Overall Study|Inadequate Control of IOP|1|||
19594301|NCT00848536|42042868|FG001|Overall Study|Inadequate Control of IOP|1|||
19594302|NCT00848536|42042867|FG000|Overall Study|Patient Moved|0|||
19594303|NCT00848536|42042868|FG001|Overall Study|Patient Moved|2|||
19746643|NCT03344640|42193999|FG000|Overall Study|Adverse Event|1|||
19746644|NCT03344640|42194000|FG001|Overall Study|Adverse Event|0|||
19594304|NCT00922116|42042874|FG000|Overall Study|Adverse Event|4|||
19594305|NCT00922116|42042874|FG000|Overall Study|Death|1|||
19594306|NCT00922116|42042874|FG000|Overall Study|Lost to Follow-up|1|||
19594307|NCT00922116|42042874|FG000|Overall Study|Withdrawal by Subject|4|||
19594308|NCT00922116|42042874|FG000|Overall Study|Other|5|||
19594309|NCT00921024|42042880|FG000|Overall Study|Lost to Follow-up|2|||
19746645|NCT03344640|42193999|FG000|Overall Study|Physician Decision|1|||
19746646|NCT03344640|42194000|FG001|Overall Study|Physician Decision|1|||
19746647|NCT03344640|42193999|FG000|Overall Study|Withdrawal by Subject|1|||
19746648|NCT03344640|42194000|FG001|Overall Study|Withdrawal by Subject|2|||
19746649|NCT03344640|42193999|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
19746650|NCT03344640|42194000|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
19594310|NCT00921024|42042881|FG001|Overall Study|Lost to Follow-up|0|||
19594311|NCT00921024|42042880|FG000|Overall Study|Received concomittant therapy|2|||
19594312|NCT00921024|42042881|FG001|Overall Study|Received concomittant therapy|0|||
19594313|NCT00921024|42042880|FG000|Overall Study|Withdrawal by Subject|0|||
19594314|NCT00921024|42042881|FG001|Overall Study|Withdrawal by Subject|3|||
19594315|NCT00928668|42042887|FG000|Overall Study|Adverse Event|1|||
19594316|NCT00928668|42042888|FG001|Overall Study|Adverse Event|0|||
19746651|NCT03344562|42194008|FG000|Overall Study|Withdrawal by Subject|2|||
19746652|NCT03344562|42194009|FG001|Overall Study|Withdrawal by Subject|0|||
19746653|NCT00003659|42194015|FG000|Overall Study|Withdrawal by Subject|3|||
19746654|NCT03494985|42194023|FG000|Overall Study|Adverse Event|3|||
19746655|NCT03494985|42194024|FG001|Overall Study|Adverse Event|2|||
19746656|NCT03494985|42194025|FG002|Overall Study|Adverse Event|3|||
19746657|NCT03494985|42194026|FG003|Overall Study|Adverse Event|0|||
19746658|NCT03494985|42194023|FG000|Overall Study|Other (Withdrawal of consent)|2|||
19746659|NCT03494985|42194024|FG001|Overall Study|Other (Withdrawal of consent)|3|||
19746660|NCT03494985|42194025|FG002|Overall Study|Other (Withdrawal of consent)|2|||
19594317|NCT00928668|42042889|FG002|Overall Study|Adverse Event|0|||
19594318|NCT00928668|42042890|FG003|Overall Study|Adverse Event|0|||
19594319|NCT00928668|42042891|FG004|Overall Study|Adverse Event|0|||
19594320|NCT00928668|42042887|FG000|Overall Study|Protocol Violation|0|||
19594321|NCT00928668|42042888|FG001|Overall Study|Protocol Violation|0|||
19594322|NCT00928668|42042889|FG002|Overall Study|Protocol Violation|0|||
19594323|NCT00928668|42042890|FG003|Overall Study|Protocol Violation|0|||
19594324|NCT00928668|42042891|FG004|Overall Study|Protocol Violation|1|||
19594325|NCT00928668|42042887|FG000|Overall Study|Withdrawal by Subject|0|||
19594326|NCT00928668|42042888|FG001|Overall Study|Withdrawal by Subject|1|||
19594327|NCT00928668|42042889|FG002|Overall Study|Withdrawal by Subject|1|||
19594328|NCT00928668|42042890|FG003|Overall Study|Withdrawal by Subject|0|||
19594329|NCT00928668|42042891|FG004|Overall Study|Withdrawal by Subject|0|||
19594330|NCT00928668|42042887|FG000|Overall Study|Other reasons not listed above|0|||
19594331|NCT00928668|42042888|FG001|Overall Study|Other reasons not listed above|0|||
19594332|NCT00928668|42042889|FG002|Overall Study|Other reasons not listed above|0|||
19594333|NCT00928668|42042890|FG003|Overall Study|Other reasons not listed above|1|||
19594334|NCT00928668|42042891|FG004|Overall Study|Other reasons not listed above|0|||
19594335|NCT00592774|42042913|FG000|Overall Study|Adverse Event|5|||
19594336|NCT00592774|42042914|FG001|Overall Study|Adverse Event|19|||
19594337|NCT00592774|42042915|FG002|Overall Study|Adverse Event|2|||
19594338|NCT00592774|42042916|FG003|Overall Study|Adverse Event|14|||
19594339|NCT00592774|42042917|FG004|Overall Study|Adverse Event|8|||
19594340|NCT00592774|42042913|FG000|Overall Study|Protocol Violation|0|||
19594341|NCT00592774|42042914|FG001|Overall Study|Protocol Violation|1|||
19594342|NCT00592774|42042915|FG002|Overall Study|Protocol Violation|0|||
19594343|NCT00592774|42042916|FG003|Overall Study|Protocol Violation|0|||
19594344|NCT00592774|42042917|FG004|Overall Study|Protocol Violation|1|||
19594345|NCT00592774|42042913|FG000|Overall Study|Withdrawal by Subject|3|||
19594346|NCT00592774|42042914|FG001|Overall Study|Withdrawal by Subject|7|||
19594347|NCT00592774|42042915|FG002|Overall Study|Withdrawal by Subject|0|||
19594348|NCT00592774|42042916|FG003|Overall Study|Withdrawal by Subject|0|||
19594349|NCT00592774|42042917|FG004|Overall Study|Withdrawal by Subject|0|||
19594350|NCT00592774|42042913|FG000|Overall Study|Lack of Efficacy|3|||
19594351|NCT00592774|42042914|FG001|Overall Study|Lack of Efficacy|3|||
19594352|NCT00592774|42042915|FG002|Overall Study|Lack of Efficacy|0|||
19594353|NCT00592774|42042916|FG003|Overall Study|Lack of Efficacy|0|||
19594354|NCT00592774|42042917|FG004|Overall Study|Lack of Efficacy|2|||
19594355|NCT00592774|42042913|FG000|Overall Study|Physician Decision|0|||
19594356|NCT00592774|42042914|FG001|Overall Study|Physician Decision|1|||
19594357|NCT00592774|42042915|FG002|Overall Study|Physician Decision|1|||
19594358|NCT00592774|42042916|FG003|Overall Study|Physician Decision|0|||
19594359|NCT00592774|42042917|FG004|Overall Study|Physician Decision|1|||
19594360|NCT00592774|42042913|FG000|Overall Study|Other|0|||
19594361|NCT00592774|42042914|FG001|Overall Study|Other|1|||
19594362|NCT00592774|42042915|FG002|Overall Study|Other|1|||
19594363|NCT00592774|42042916|FG003|Overall Study|Other|0|||
19594364|NCT00592774|42042917|FG004|Overall Study|Other|2|||
19594365|NCT00837694|42042935|FG000|Overall Study|Lost to Follow-up|2|||
19594366|NCT00837694|42042936|FG001|Overall Study|Lost to Follow-up|0|||
19594367|NCT00837694|42042937|FG002|Overall Study|Lost to Follow-up|2|||
19594368|NCT00837694|42042938|FG003|Overall Study|Lost to Follow-up|1|||
19594369|NCT00837694|42042939|FG004|Overall Study|Lost to Follow-up|1|||
19594370|NCT00837694|42042940|FG005|Overall Study|Lost to Follow-up|1|||
19594371|NCT00852202|42042957|FG000|Overall Study|Adverse Event|2|||
19594372|NCT00852202|42042958|FG001|Overall Study|Adverse Event|3|||
19594373|NCT00852202|42042959|FG002|Overall Study|Adverse Event|7|||
19594374|NCT00852202|42042957|FG000|Overall Study|Lack of Efficacy|4|||
19594375|NCT00852202|42042958|FG001|Overall Study|Lack of Efficacy|1|||
19594376|NCT00852202|42042959|FG002|Overall Study|Lack of Efficacy|2|||
19746661|NCT03494985|42194026|FG003|Overall Study|Other (Withdrawal of consent)|5|||
19746662|NCT03494985|42194023|FG000|Overall Study|Other (Not specified)|0|||
19594377|NCT00852202|42042957|FG000|Overall Study|Protocol Violation|2|||
19594378|NCT00852202|42042958|FG001|Overall Study|Protocol Violation|2|||
19746663|NCT03494985|42194024|FG001|Overall Study|Other (Not specified)|1|||
19746664|NCT03494985|42194025|FG002|Overall Study|Other (Not specified)|1|||
19746665|NCT03494985|42194026|FG003|Overall Study|Other (Not specified)|0|||
19746666|NCT03437265|42194036|FG000|Overall Study|Protocol Violation|6|||
19746667|NCT00003509|42194040|FG000|Overall Study|Not evaluable|5|||
19746668|NCT03344172|42194046|FG000|Overall Study|Received <1 dose of treatment|1|||
19746669|NCT03344172|42194047|FG001|Overall Study|Received <1 dose of treatment|0|||
19746670|NCT03465891|42194055|FG000|Overall Study|Withdrawal by Subject|0|||
19746671|NCT03465891|42194056|FG001|Overall Study|Withdrawal by Subject|1|||
19746672|NCT03465891|42194055|FG000|Overall Study|Disease progression|1|||
19746673|NCT03465891|42194056|FG001|Overall Study|Disease progression|0|||
19746674|NCT03363906|42194062|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
19746675|NCT03363906|42194063|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
19746676|NCT03363906|42194062|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
19746677|NCT03363906|42194063|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
19746678|NCT03363906|42194062|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
19746679|NCT03363906|42194063|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
19746680|NCT03363906|42194062|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
19746681|NCT03363906|42194063|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
19746682|NCT00003473|42194069|FG000|Overall Study|Three patients were not evaluable.|3|||
19746683|NCT03343626|42194081|FG000|Overall Study|Lost to Follow-up|4|||
19746684|NCT03343626|42194082|FG001|Overall Study|Lost to Follow-up|3|||
19746685|NCT03343626|42194083|FG002|Overall Study|Lost to Follow-up|2|||
19746686|NCT03343626|42194084|FG003|Overall Study|Lost to Follow-up|5|||
19746687|NCT03343626|42194085|FG004|Overall Study|Lost to Follow-up|4|||
19746688|NCT03343626|42194086|FG005|Overall Study|Lost to Follow-up|4|||
19746689|NCT03343626|42194087|FG006|Overall Study|Lost to Follow-up|4|||
19746690|NCT03343626|42194088|FG007|Overall Study|Lost to Follow-up|7|||
19746691|NCT03343626|42194081|FG000|Overall Study|Withdrawal of Consent|2|||
19746692|NCT03343626|42194082|FG001|Overall Study|Withdrawal of Consent|1|||
19746693|NCT03343626|42194083|FG002|Overall Study|Withdrawal of Consent|0|||
19746694|NCT03343626|42194084|FG003|Overall Study|Withdrawal of Consent|3|||
19746695|NCT03343626|42194085|FG004|Overall Study|Withdrawal of Consent|3|||
19746696|NCT03343626|42194086|FG005|Overall Study|Withdrawal of Consent|1|||
19746697|NCT03343626|42194087|FG006|Overall Study|Withdrawal of Consent|1|||
19746698|NCT03343626|42194088|FG007|Overall Study|Withdrawal of Consent|2|||
19746699|NCT03343626|42194081|FG000|Overall Study|Reason not Specified|0|||
19746700|NCT03343626|42194082|FG001|Overall Study|Reason not Specified|1|||
19746701|NCT03343626|42194083|FG002|Overall Study|Reason not Specified|0|||
19746702|NCT03343626|42194084|FG003|Overall Study|Reason not Specified|0|||
19746703|NCT03343626|42194085|FG004|Overall Study|Reason not Specified|0|||
19746704|NCT03343626|42194086|FG005|Overall Study|Reason not Specified|0|||
19594379|NCT00852202|42042959|FG002|Overall Study|Protocol Violation|7|||
19594380|NCT00852202|42042957|FG000|Overall Study|Withdrawal by Subject|3|||
19594381|NCT00852202|42042958|FG001|Overall Study|Withdrawal by Subject|1|||
19594382|NCT00852202|42042959|FG002|Overall Study|Withdrawal by Subject|2|||
19594383|NCT00852202|42042957|FG000|Overall Study|Lost to Follow-up|5|||
19594384|NCT00852202|42042958|FG001|Overall Study|Lost to Follow-up|5|||
19594385|NCT00852202|42042959|FG002|Overall Study|Lost to Follow-up|6|||
19594386|NCT00852202|42042957|FG000|Overall Study|pregnancy,moving away and surgery|1|||
19594387|NCT00852202|42042958|FG001|Overall Study|pregnancy,moving away and surgery|0|||
19594388|NCT00852202|42042959|FG002|Overall Study|pregnancy,moving away and surgery|2|||
19594389|NCT01074008|42042977|FG000|Overall Study|Adverse Event|0|||
19594390|NCT01074008|42042978|FG001|Overall Study|Adverse Event|1|||
19594391|NCT01074008|42042979|FG002|Overall Study|Adverse Event|0|||
19594392|NCT01074008|42042980|FG003|Overall Study|Adverse Event|0|||
19594393|NCT01074008|42042981|FG004|Overall Study|Adverse Event|0|||
19594394|NCT01074008|42042982|FG005|Overall Study|Adverse Event|0|||
19594395|NCT01074008|42042983|FG006|Overall Study|Adverse Event|0|||
19594396|NCT01074008|42042984|FG007|Overall Study|Adverse Event|0|||
19594397|NCT01074008|42042985|FG008|Overall Study|Adverse Event|0|||
19594398|NCT01074008|42042977|FG000|Overall Study|Withdrawal by Subject|1|||
19594399|NCT01074008|42042978|FG001|Overall Study|Withdrawal by Subject|1|||
19594400|NCT01074008|42042979|FG002|Overall Study|Withdrawal by Subject|1|||
19594401|NCT01074008|42042980|FG003|Overall Study|Withdrawal by Subject|0|||
19594402|NCT01074008|42042981|FG004|Overall Study|Withdrawal by Subject|1|||
19594403|NCT01074008|42042982|FG005|Overall Study|Withdrawal by Subject|0|||
19746705|NCT03343626|42194087|FG006|Overall Study|Reason not Specified|0|||
19746706|NCT03343626|42194088|FG007|Overall Study|Reason not Specified|1|||
19746707|NCT03343626|42194081|FG000|Overall Study|Data Entry Error|0|||
19746708|NCT03343626|42194082|FG001|Overall Study|Data Entry Error|0|||
19746709|NCT03343626|42194083|FG002|Overall Study|Data Entry Error|0|||
19594404|NCT01074008|42042983|FG006|Overall Study|Withdrawal by Subject|0|||
19594405|NCT01074008|42042984|FG007|Overall Study|Withdrawal by Subject|0|||
19594406|NCT01074008|42042985|FG008|Overall Study|Withdrawal by Subject|0|||
19594407|NCT01074008|42042977|FG000|Overall Study|Lost to Follow-up|0|||
19594408|NCT01074008|42042978|FG001|Overall Study|Lost to Follow-up|1|||
19594409|NCT01074008|42042979|FG002|Overall Study|Lost to Follow-up|1|||
19594410|NCT01074008|42042980|FG003|Overall Study|Lost to Follow-up|1|||
19594411|NCT01074008|42042981|FG004|Overall Study|Lost to Follow-up|1|||
19594412|NCT01074008|42042982|FG005|Overall Study|Lost to Follow-up|0|||
19594413|NCT01074008|42042983|FG006|Overall Study|Lost to Follow-up|1|||
19594414|NCT01074008|42042984|FG007|Overall Study|Lost to Follow-up|0|||
19594415|NCT01074008|42042985|FG008|Overall Study|Lost to Follow-up|4|||
19594416|NCT01073930|42043016|FG000|Overall Study|Withdrawal by Subject|3|||
19594417|NCT01073930|42043017|FG001|Overall Study|Withdrawal by Subject|2|||
19594418|NCT01073930|42043016|FG000|Overall Study|Lost to Follow-up|0|||
19594419|NCT01073930|42043017|FG001|Overall Study|Lost to Follow-up|1|||
19594420|NCT01073930|42043016|FG000|Overall Study|Adverse Event|0|||
19594421|NCT01073930|42043017|FG001|Overall Study|Adverse Event|1|||
19594422|NCT01073930|42043016|FG000|Overall Study|Noncompliance with study drug|0|||
19594423|NCT01073930|42043017|FG001|Overall Study|Noncompliance with study drug|1|||
19594424|NCT01073930|42043016|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
19746710|NCT03343626|42194084|FG003|Overall Study|Data Entry Error|0|||
19746711|NCT03343626|42194085|FG004|Overall Study|Data Entry Error|0|||
19746712|NCT03343626|42194086|FG005|Overall Study|Data Entry Error|0|||
19746713|NCT03343626|42194087|FG006|Overall Study|Data Entry Error|0|||
19594425|NCT01073930|42043017|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
19594426|NCT01073618|42043023|FG000|Overall Study|Death|208|||
19746714|NCT03343626|42194088|FG007|Overall Study|Data Entry Error|1|||
19746715|NCT03334422|42194113|FG000|Overall Study|Adverse Event|1|||
19746716|NCT03334422|42194114|FG001|Overall Study|Adverse Event|3|||
19746717|NCT03334422|42194115|FG002|Overall Study|Adverse Event|2|||
19746718|NCT03334422|42194116|FG003|Overall Study|Adverse Event|2|||
19746719|NCT03334422|42194113|FG000|Overall Study|Lack of Efficacy|10|||
19746720|NCT03334422|42194114|FG001|Overall Study|Lack of Efficacy|2|||
19746721|NCT03334422|42194115|FG002|Overall Study|Lack of Efficacy|7|||
19746722|NCT03334422|42194116|FG003|Overall Study|Lack of Efficacy|3|||
19746723|NCT03334422|42194113|FG000|Overall Study|Withdrawal by Subject|8|||
19746724|NCT03334422|42194114|FG001|Overall Study|Withdrawal by Subject|3|||
19746725|NCT03334422|42194115|FG002|Overall Study|Withdrawal by Subject|1|||
19746726|NCT03334422|42194116|FG003|Overall Study|Withdrawal by Subject|0|||
19746727|NCT03334422|42194113|FG000|Overall Study|Lost to Follow-up|0|||
19746728|NCT03334422|42194114|FG001|Overall Study|Lost to Follow-up|0|||
19746729|NCT03334422|42194115|FG002|Overall Study|Lost to Follow-up|0|||
19746730|NCT03334422|42194116|FG003|Overall Study|Lost to Follow-up|1|||
19746731|NCT03334422|42194113|FG000|Overall Study|Inability to obtain laboratory samples|0|||
19746732|NCT03334422|42194114|FG001|Overall Study|Inability to obtain laboratory samples|1|||
19746733|NCT03334422|42194115|FG002|Overall Study|Inability to obtain laboratory samples|0|||
19746734|NCT03334422|42194116|FG003|Overall Study|Inability to obtain laboratory samples|0|||
19746735|NCT03334422|42194113|FG000|Overall Study|Pregnancy|0|||
19746736|NCT03334422|42194114|FG001|Overall Study|Pregnancy|1|||
19746737|NCT03334422|42194115|FG002|Overall Study|Pregnancy|0|||
19746738|NCT03334422|42194116|FG003|Overall Study|Pregnancy|0|||
19746739|NCT00003389|42194133|FG000|Overall Study|Disease progression|6|||
19746740|NCT00003389|42194134|FG001|Overall Study|Disease progression|1|||
19746741|NCT00003389|42194133|FG000|Overall Study|Adverse Event|13|||
19746742|NCT00003389|42194134|FG001|Overall Study|Adverse Event|2|||
19746743|NCT00003389|42194133|FG000|Overall Study|Death|0|||
19746744|NCT00003389|42194134|FG001|Overall Study|Death|3|||
19746745|NCT00003389|42194133|FG000|Overall Study|Withdrawal by Subject|12|||
19594427|NCT01073618|42043023|FG000|Overall Study|Adverse Event|19|||
19594428|NCT01073618|42043023|FG000|Overall Study|Other|80|||
19746746|NCT00003389|42194134|FG001|Overall Study|Withdrawal by Subject|5|||
19746747|NCT00003389|42194133|FG000|Overall Study|Alternative therapy|2|||
19594429|NCT01073462|42043027|FG000|Overall Study|Death|14|||
19594430|NCT01073462|42043027|FG000|Overall Study|Kidney transplant|10|||
19594431|NCT01073462|42043027|FG000|Overall Study|Low parathyroid hormone levels|8|||
19594432|NCT01073462|42043027|FG000|Overall Study|Serious adverse event|2|||
19594433|NCT01073462|42043027|FG000|Overall Study|Lost to Follow-up|7|||
19594434|NCT00789373|42043031|FG000|Induction|Adverse Event|64|||
19746748|NCT00003389|42194134|FG001|Overall Study|Alternative therapy|1|||
19746749|NCT00003389|42194133|FG000|Overall Study|Complicating disease|1|||
19746750|NCT00003389|42194134|FG001|Overall Study|Complicating disease|0|||
19746751|NCT00003389|42194133|FG000|Overall Study|Off-treatment reason missing|31|||
19594435|NCT00789373|42043032|FG001|Induction|Adverse Event|0|||
19746752|NCT00003389|42194134|FG001|Overall Study|Off-treatment reason missing|21|||
19746753|NCT00003389|42194133|FG000|Overall Study|Ineligible|33|||
19746754|NCT00003389|42194134|FG001|Overall Study|Ineligible|27|||
19746755|NCT03362190|42194144|FG000|Overall Study|Adverse Event|0|||
19594436|NCT00789373|42043033|FG002|Induction|Adverse Event|0|||
19594437|NCT00789373|42043031|FG000|Induction|Death Due to study disease|24|||
19594438|NCT00789373|42043032|FG001|Induction|Death Due to study disease|0|||
19594439|NCT00789373|42043033|FG002|Induction|Death Due to study disease|0|||
19594440|NCT00789373|42043031|FG000|Induction|Death due to adverse event|19|||
19594441|NCT00789373|42043032|FG001|Induction|Death due to adverse event|0|||
19594442|NCT00789373|42043033|FG002|Induction|Death due to adverse event|0|||
19594443|NCT00789373|42043031|FG000|Induction|Death due to toxicity|11|||
19746756|NCT03362190|42194145|FG001|Overall Study|Adverse Event|0|||
19746757|NCT03362190|42194146|FG002|Overall Study|Adverse Event|0|||
19746758|NCT03362190|42194147|FG003|Overall Study|Adverse Event|1|||
19746759|NCT03362190|42194144|FG000|Overall Study|Withdrawal by Subject|0|||
19746760|NCT03362190|42194145|FG001|Overall Study|Withdrawal by Subject|0|||
19746761|NCT03362190|42194146|FG002|Overall Study|Withdrawal by Subject|0|||
19746762|NCT03362190|42194147|FG003|Overall Study|Withdrawal by Subject|1|||
19746763|NCT02323126|42194163|FG000|Overall Study|Patient / guardian decision|0|||
19746764|NCT02323126|42194164|FG001|Overall Study|Patient / guardian decision|1|||
19746765|NCT02323126|42194165|FG002|Overall Study|Patient / guardian decision|2|||
19746766|NCT02323126|42194163|FG000|Overall Study|Progressive disease|14|||
19746767|NCT02323126|42194164|FG001|Overall Study|Progressive disease|8|||
19746768|NCT02323126|42194165|FG002|Overall Study|Progressive disease|14|||
19746769|NCT02323126|42194163|FG000|Overall Study|Physician Decision|0|||
19746770|NCT02323126|42194164|FG001|Overall Study|Physician Decision|1|||
19746771|NCT02323126|42194165|FG002|Overall Study|Physician Decision|3|||
19746772|NCT02323126|42194163|FG000|Overall Study|Death|1|||
19746773|NCT02323126|42194164|FG001|Overall Study|Death|1|||
19746774|NCT02323126|42194165|FG002|Overall Study|Death|4|||
19746775|NCT02323126|42194163|FG000|Overall Study|Adverse Event|3|||
19746776|NCT02323126|42194164|FG001|Overall Study|Adverse Event|5|||
19746777|NCT02323126|42194165|FG002|Overall Study|Adverse Event|7|||
19746778|NCT03491553|42194182|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
19746779|NCT03491553|42194183|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
19746780|NCT03491553|42194184|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
19746781|NCT03491553|42194185|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
19746782|NCT03491553|42194186|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
19746783|NCT03491553|42194187|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
19746784|NCT03491553|42194182|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
19746785|NCT03491553|42194183|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
19746786|NCT03491553|42194184|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
19746787|NCT03491553|42194185|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
19746788|NCT03491553|42194186|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
19746789|NCT03491553|42194187|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
19746790|NCT00003377|42194208|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
19746791|NCT00003377|42194209|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
19746792|NCT00003377|42194210|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
19746793|NCT00003377|42194211|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
19746794|NCT00003377|42194212|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
19746795|NCT00003377|42194208|FG000|Period II|Ureteral stent complications|0|||
19746796|NCT00003377|42194209|FG001|Period II|Ureteral stent complications|0|||
19746797|NCT00003377|42194210|FG002|Period II|Ureteral stent complications|0|||
19388010|NCT02037568|41631333|FG000|Overall Study|Lost to Follow-up|16|||
19594444|NCT00789373|42043032|FG001|Induction|Death due to toxicity|0|||
19594445|NCT00789373|42043033|FG002|Induction|Death due to toxicity|0|||
19594446|NCT00789373|42043031|FG000|Induction|Death due to procedure|1|||
19594447|NCT00789373|42043032|FG001|Induction|Death due to procedure|0|||
19594448|NCT00789373|42043033|FG002|Induction|Death due to procedure|0|||
19594449|NCT00789373|42043031|FG000|Induction|Investigator decision|7|||
19594450|NCT00789373|42043032|FG001|Induction|Investigator decision|0|||
19594451|NCT00789373|42043033|FG002|Induction|Investigator decision|0|||
19594452|NCT00789373|42043031|FG000|Induction|Protocol entry criteria not met|9|||
19594453|NCT00789373|42043032|FG001|Induction|Protocol entry criteria not met|0|||
19594454|NCT00789373|42043033|FG002|Induction|Protocol entry criteria not met|0|||
19594455|NCT00789373|42043031|FG000|Induction|Lost to Follow-up|6|||
19594456|NCT00789373|42043032|FG001|Induction|Lost to Follow-up|0|||
19594457|NCT00789373|42043033|FG002|Induction|Lost to Follow-up|0|||
19594458|NCT00789373|42043031|FG000|Induction|Protocol Violation|1|||
19594459|NCT00789373|42043032|FG001|Induction|Protocol Violation|0|||
19594460|NCT00789373|42043033|FG002|Induction|Protocol Violation|0|||
19594461|NCT00789373|42043031|FG000|Induction|Progressive Disease|220|||
19746798|NCT00003377|42194211|FG003|Period II|Ureteral stent complications|0|||
19746799|NCT00003377|42194212|FG004|Period II|Ureteral stent complications|1|||
19746800|NCT00651742|42194225|FG000|Overall Study|Objective Disease Progression|22|||
19746801|NCT00651742|42194225|FG000|Overall Study|Toxicity|3|||
19746802|NCT00651742|42194225|FG000|Overall Study|Investigator Judgment|1|||
19746803|NCT00651742|42194225|FG000|Overall Study|Withdrawal of Consent|1|||
19388011|NCT02037568|41631334|FG001|Overall Study|Lost to Follow-up|13|||
19594462|NCT00789373|42043032|FG001|Induction|Progressive Disease|0|||
19746804|NCT00651742|42194225|FG000|Overall Study|Enrolled but not treated|1|||
19594463|NCT00789373|42043033|FG002|Induction|Progressive Disease|0|||
19594464|NCT00789373|42043031|FG000|Induction|Withdrawal by Subject|37|||
19594465|NCT00789373|42043032|FG001|Induction|Withdrawal by Subject|0|||
19594466|NCT00789373|42043033|FG002|Induction|Withdrawal by Subject|0|||
19594467|NCT00789373|42043031|FG000|Maintenance|Adverse Event|0|||
19594468|NCT00789373|42043032|FG001|Maintenance|Adverse Event|65|||
19594469|NCT00789373|42043033|FG002|Maintenance|Adverse Event|12|||
19594470|NCT00789373|42043031|FG000|Maintenance|Death due to study disease|0|||
19594471|NCT00789373|42043032|FG001|Maintenance|Death due to study disease|3|||
19594472|NCT00789373|42043033|FG002|Maintenance|Death due to study disease|1|||
19594473|NCT00789373|42043031|FG000|Maintenance|Death due to adverse event|0|||
19594474|NCT00789373|42043032|FG001|Maintenance|Death due to adverse event|4|||
19594475|NCT00789373|42043033|FG002|Maintenance|Death due to adverse event|1|||
19594476|NCT00789373|42043031|FG000|Maintenance|Death due to toxicity|0|||
19594477|NCT00789373|42043032|FG001|Maintenance|Death due to toxicity|1|||
19594478|NCT00789373|42043033|FG002|Maintenance|Death due to toxicity|2|||
19594479|NCT00789373|42043031|FG000|Maintenance|Investigator Decision|0|||
19594480|NCT00789373|42043032|FG001|Maintenance|Investigator Decision|4|||
19594481|NCT00789373|42043033|FG002|Maintenance|Investigator Decision|2|||
19594482|NCT00789373|42043031|FG000|Maintenance|Protocol entry criteria not met|0|||
19594483|NCT00789373|42043032|FG001|Maintenance|Protocol entry criteria not met|2|||
19594484|NCT00789373|42043033|FG002|Maintenance|Protocol entry criteria not met|0|||
19594485|NCT00789373|42043031|FG000|Maintenance|Lost to Follow-up|0|||
19594486|NCT00789373|42043032|FG001|Maintenance|Lost to Follow-up|2|||
19594487|NCT00789373|42043033|FG002|Maintenance|Lost to Follow-up|0|||
19594488|NCT00789373|42043031|FG000|Maintenance|Progressive Disease|0|||
19594489|NCT00789373|42043032|FG001|Maintenance|Progressive Disease|253|||
19594490|NCT00789373|42043033|FG002|Maintenance|Progressive Disease|152|||
19594491|NCT00789373|42043031|FG000|Maintenance|Withdrawal by Subject|0|||
19594492|NCT00789373|42043032|FG001|Maintenance|Withdrawal by Subject|21|||
19594493|NCT00789373|42043033|FG002|Maintenance|Withdrawal by Subject|8|||
19594494|NCT00789373|42043031|FG000|Maintenance|Sponsor Decision|0|||
19594495|NCT00789373|42043032|FG001|Maintenance|Sponsor Decision|0|||
19594496|NCT00789373|42043033|FG002|Maintenance|Sponsor Decision|2|||
19594497|NCT00789373|42043031|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
19388012|NCT02037568|41631333|FG000|Overall Study|Screen Failure|3|||
19594498|NCT00789373|42043032|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
19594499|NCT00789373|42043033|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
19594500|NCT00851890|42043048|FG000|Overall Study|Lost to Follow-up|0|||
19594501|NCT00851890|42043049|FG001|Overall Study|Lost to Follow-up|1|||
19594502|NCT00851890|42043050|FG002|Overall Study|Lost to Follow-up|0|||
19594503|NCT00851890|42043051|FG003|Overall Study|Lost to Follow-up|1|||
19594504|NCT00788827|42043061|FG000|Overall Study|Lack of Efficacy|2|||
19594505|NCT00592072|42043067|FG000|Wash Out Period|Lost to Follow-up|1|||
19594506|NCT00592072|42043068|FG001|Wash Out Period|Lost to Follow-up|1|||
19594507|NCT00792571|42043074|FG000|Overall Study|Death|1|||
19594508|NCT00792571|42043074|FG000|Overall Study|Adverse Event|4|||
19594509|NCT00792571|42043074|FG000|Overall Study|Withdrawal by Subject|1|||
19594510|NCT00792571|42043074|FG000|Overall Study|Other|4|||
19746805|NCT00002651|42194231|FG000|Induction|Adverse Event|44|||
19746806|NCT00002651|42194232|FG001|Induction|Adverse Event|0|||
19594511|NCT01069484|42043080|FG000|Overall Study|Death-in-near-family|1|||
19594512|NCT01069484|42043081|FG001|Overall Study|Death-in-near-family|0|||
19594513|NCT01069484|42043080|FG000|Overall Study|No specific reason|8|||
19594514|NCT01069484|42043081|FG001|Overall Study|No specific reason|2|||
19594515|NCT01069484|42043080|FG000|Overall Study|Illness mother or child|3|||
19594516|NCT01069484|42043081|FG001|Overall Study|Illness mother or child|1|||
19594517|NCT00794365|42043088|FG000|Overall Study|Lost to Follow-up|38|||
19594518|NCT00794365|42043088|FG000|Overall Study|Other|17|||
19594519|NCT00794365|42043088|FG000|Overall Study|Poor Compliance|11|||
19594520|NCT00794365|42043088|FG000|Overall Study|Adverse Event|10|||
19594521|NCT00794365|42043088|FG000|Overall Study|Lack of Efficacy|3|||
19594522|NCT01067144|42043094|FG000|Treatment|Did not receive allocated intervention|4|||
19594523|NCT01067144|42043095|FG001|Treatment|Did not receive allocated intervention|7|||
19594524|NCT01067144|42043094|FG000|Follow-up|Lost to Follow-up|22|||
19594525|NCT01067144|42043095|FG001|Follow-up|Lost to Follow-up|12|||
19594526|NCT01067144|42043094|FG000|Follow-up|Censored owing to second surgery|19|||
19594527|NCT01067144|42043095|FG001|Follow-up|Censored owing to second surgery|28|||
19746807|NCT00002651|42194233|FG002|Induction|Adverse Event|0|||
19746808|NCT00002651|42194231|FG000|Induction|Refusal unrelated to adverse event|50|||
19746809|NCT00002651|42194232|FG001|Induction|Refusal unrelated to adverse event|0|||
19746810|NCT00002651|42194233|FG002|Induction|Refusal unrelated to adverse event|0|||
19594528|NCT01067144|42043094|FG000|Follow-up|Withdrawal by Subject|18|||
19594529|NCT01067144|42043095|FG001|Follow-up|Withdrawal by Subject|14|||
19594530|NCT01067144|42043094|FG000|Follow-up|Surgery cancelled|0|||
19594531|NCT01067144|42043095|FG001|Follow-up|Surgery cancelled|1|||
19594532|NCT01067144|42043094|FG000|Follow-up|Death|0|||
19594533|NCT01067144|42043095|FG001|Follow-up|Death|1|||
19594534|NCT01078298|42043103|FG000|Overall Study|Lost to Follow-up|12|||
19594535|NCT01078298|42043104|FG001|Overall Study|Lost to Follow-up|13|||
19594536|NCT01078298|42043103|FG000|Overall Study|Withdrawal by Subject|31|||
19594537|NCT01078298|42043104|FG001|Overall Study|Withdrawal by Subject|33|||
19594538|NCT01078298|42043103|FG000|Overall Study|Protocol Violation|6|||
19594539|NCT01078298|42043104|FG001|Overall Study|Protocol Violation|6|||
19594540|NCT01078298|42043103|FG000|Overall Study|Adverse Event|6|||
19594541|NCT01078298|42043104|FG001|Overall Study|Adverse Event|5|||
19594542|NCT01078298|42043103|FG000|Overall Study|Death|2|||
19746811|NCT00002651|42194231|FG000|Induction|Progression/relapse|274|||
19746812|NCT00002651|42194232|FG001|Induction|Progression/relapse|0|||
19594543|NCT01078298|42043104|FG001|Overall Study|Death|0|||
19746813|NCT00002651|42194233|FG002|Induction|Progression/relapse|0|||
19746814|NCT00002651|42194231|FG000|Induction|Death|62|||
19594544|NCT01078298|42043103|FG000|Overall Study|Did not meet entrance criteria|0|||
19746815|NCT00002651|42194232|FG001|Induction|Death|0|||
19746816|NCT00002651|42194233|FG002|Induction|Death|0|||
19746817|NCT00002651|42194231|FG000|Induction|Other|823|||
19594545|NCT01078298|42043104|FG001|Overall Study|Did not meet entrance criteria|1|||
19594546|NCT01078298|42043103|FG000|Overall Study|Other|24|||
19594547|NCT01078298|42043104|FG001|Overall Study|Other|32|||
19594548|NCT00788593|42043110|FG000|Placebo Run-in Phase|Adverse Event|2|||
19594549|NCT00788593|42043111|FG001|Placebo Run-in Phase|Adverse Event|0|||
19594550|NCT00788593|42043112|FG002|Placebo Run-in Phase|Adverse Event|0|||
19594551|NCT00788593|42043110|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
19594552|NCT00788593|42043111|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
19594553|NCT00788593|42043112|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
19594554|NCT00788593|42043110|FG000|Placebo Run-in Phase|Protocol Violation|2|||
19594555|NCT00788593|42043111|FG001|Placebo Run-in Phase|Protocol Violation|0|||
19594556|NCT00788593|42043112|FG002|Placebo Run-in Phase|Protocol Violation|0|||
19594557|NCT00788593|42043110|FG000|First Intervention Period|Adverse Event|0|||
19594558|NCT00788593|42043111|FG001|First Intervention Period|Adverse Event|1|||
19746818|NCT00002651|42194232|FG001|Induction|Other|0|||
19746819|NCT00002651|42194233|FG002|Induction|Other|0|||
19388013|NCT02037568|41631334|FG001|Overall Study|Screen Failure|1|||
19388014|NCT02037568|41631333|FG000|Overall Study|Patient did not receive transplant|0|||
19388015|NCT02037568|41631334|FG001|Overall Study|Patient did not receive transplant|1|||
19388016|NCT02088034|41631343|FG000|Overall Study|Lost to Follow-up|1|||
19388017|NCT02088034|41631344|FG001|Overall Study|Lost to Follow-up|1|||
19388018|NCT02088034|41631345|FG002|Overall Study|Lost to Follow-up|0|||
19388019|NCT02088034|41631343|FG000|Overall Study|Pregnancy|2|||
19388020|NCT02088034|41631344|FG001|Overall Study|Pregnancy|1|||
19388021|NCT02088034|41631345|FG002|Overall Study|Pregnancy|2|||
19388022|NCT02037256|41631355|FG000|Overall Study|Protocol Violation|0|||
19388023|NCT02037256|41631356|FG001|Overall Study|Protocol Violation|1|||
19594559|NCT00788593|42043112|FG002|First Intervention Period|Adverse Event|0|||
19746820|NCT00002651|42194231|FG000|Induction|not eligible|90|||
19594560|NCT00788593|42043110|FG000|Second Intervention Period|Lost to Follow-up|0|||
19594561|NCT00788593|42043111|FG001|Second Intervention Period|Lost to Follow-up|1|||
19594562|NCT00788593|42043112|FG002|Second Intervention Period|Lost to Follow-up|0|||
19594563|NCT00788593|42043110|FG000|Second Intervention Period|Other|0|||
19594564|NCT00788593|42043111|FG001|Second Intervention Period|Other|0|||
19594565|NCT00788593|42043112|FG002|Second Intervention Period|Other|1|||
19594566|NCT00793819|42043124|FG000|Overall Study|Adverse Event|8|||
19594567|NCT00793819|42043125|FG001|Overall Study|Adverse Event|4|||
19594568|NCT00793819|42043124|FG000|Overall Study|Lack of Efficacy|1|||
19594569|NCT00793819|42043125|FG001|Overall Study|Lack of Efficacy|1|||
19594570|NCT00793819|42043124|FG000|Overall Study|Withdrawal by Subject|4|||
19594571|NCT00793819|42043125|FG001|Overall Study|Withdrawal by Subject|3|||
19594572|NCT00793819|42043124|FG000|Overall Study|Lost to Follow-up|1|||
19594573|NCT00793819|42043125|FG001|Overall Study|Lost to Follow-up|1|||
19594574|NCT00792259|42043134|FG000|Overall Study|Poor Quality Scans|1|||
19594575|NCT00792259|42043135|FG001|Overall Study|Poor Quality Scans|0|||
19594576|NCT00792259|42043136|FG002|Overall Study|Poor Quality Scans|0|||
19594577|NCT00894387|42043146|FG000|Overall Study|Adverse Event|44|||
19594578|NCT00894387|42043147|FG001|Overall Study|Adverse Event|45|||
19594579|NCT00894387|42043146|FG000|Overall Study|Abnormal Laboratory values|2|||
19388024|NCT02037256|41631355|FG000|Overall Study|Withdrawn prior to Velcade|0|||
19594580|NCT00894387|42043147|FG001|Overall Study|Abnormal Laboratory values|2|||
19594581|NCT00894387|42043146|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19594582|NCT00894387|42043147|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19594583|NCT00894387|42043146|FG000|Overall Study|Lost to Follow-up|3|||
19594584|NCT00894387|42043147|FG001|Overall Study|Lost to Follow-up|5|||
19594585|NCT00894387|42043146|FG000|Overall Study|Administrative problems|2|||
19594586|NCT00894387|42043147|FG001|Overall Study|Administrative problems|2|||
19594587|NCT00894387|42043146|FG000|Overall Study|Death|77|||
19594588|NCT00894387|42043147|FG001|Overall Study|Death|76|||
19594589|NCT00894387|42043146|FG000|Overall Study|Protocol Deviation|4|||
19388025|NCT02037256|41631356|FG001|Overall Study|Withdrawn prior to Velcade|2|||
19388026|NCT02035696|41631368|FG000|Overall Study|Lost to Follow-up|0|||
19388027|NCT02035696|41631369|FG001|Overall Study|Lost to Follow-up|3|||
19388028|NCT02035696|41631370|FG002|Overall Study|Lost to Follow-up|1|||
19388029|NCT02035696|41631371|FG003|Overall Study|Lost to Follow-up|2|||
19388030|NCT02035696|41631368|FG000|Overall Study|Withdrawal by Subject|3|||
19388031|NCT02035696|41631369|FG001|Overall Study|Withdrawal by Subject|0|||
19388032|NCT02035696|41631370|FG002|Overall Study|Withdrawal by Subject|2|||
19594590|NCT00894387|42043147|FG001|Overall Study|Protocol Deviation|0|||
19594591|NCT00894387|42043146|FG000|Overall Study|Patient's request|25|||
19594592|NCT00894387|42043147|FG001|Overall Study|Patient's request|30|||
19594593|NCT00894387|42043146|FG000|Overall Study|Other (Missing)|5|||
19746821|NCT00002651|42194232|FG001|Induction|not eligible|0|||
19388033|NCT02035696|41631371|FG003|Overall Study|Withdrawal by Subject|1|||
19746822|NCT00002651|42194233|FG002|Induction|not eligible|0|||
19594594|NCT00894387|42043147|FG001|Overall Study|Other (Missing)|3|||
19594595|NCT00894387|42043146|FG000|Overall Study|Mis-randomized|13|||
19746823|NCT00002651|42194231|FG000|Consolidation and Randomization|Adverse Event|0|||
19388034|NCT02057458|41631385|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
19388035|NCT02057458|41631386|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
19388036|NCT02057458|41631387|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
19388037|NCT02057458|41631385|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
19388038|NCT02057458|41631386|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
19388039|NCT02057458|41631387|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
19388040|NCT02057458|41631385|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
19388041|NCT02057458|41631386|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
19388042|NCT02057458|41631387|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
19388043|NCT02057068|41631419|FG000|Overall Study|Withdrawal by Subject|2|||
19388044|NCT02057068|41631420|FG001|Overall Study|Withdrawal by Subject|2|||
19388045|NCT02057068|41631419|FG000|Overall Study|Caregiver (CG) Health|0|||
19388046|NCT02057068|41631420|FG001|Overall Study|Caregiver (CG) Health|2|||
19388047|NCT02057068|41631419|FG000|Overall Study|Carepartner (CP) Health|4|||
19388048|NCT02057068|41631420|FG001|Overall Study|Carepartner (CP) Health|2|||
19388049|NCT02057068|41631419|FG000|Overall Study|Lost to Follow-up|2|||
19388050|NCT02057068|41631420|FG001|Overall Study|Lost to Follow-up|2|||
19388051|NCT02056834|41631428|FG000|Overall Study|Lost to Follow-up|7|||
19388052|NCT02087176|41631433|FG000|Overall Study|Withdrawal by Subject|1|||
19388053|NCT02087176|41631433|FG000|Overall Study|Death|10|||
19388054|NCT02087176|41631433|FG000|Overall Study|Censored|19|||
19388055|NCT02087176|41631433|FG000|Overall Study|Study Terminated by Sponsor|2|||
19388056|NCT02056288|41631439|FG000|In-Hospital Data|Surgery cancelled|1|||
19388057|NCT02056288|41631440|FG001|In-Hospital Data|Surgery cancelled|0|||
19388058|NCT02056288|41631439|FG000|In-Hospital Data|Protocol Violation|3|||
19388059|NCT02056288|41631440|FG001|In-Hospital Data|Protocol Violation|0|||
19388060|NCT02056288|41631439|FG000|In-Hospital Data|Physician Decision|1|||
19388061|NCT02056288|41631440|FG001|In-Hospital Data|Physician Decision|0|||
19388062|NCT02056288|41631439|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
19388063|NCT02056288|41631440|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
19594596|NCT00894387|42043147|FG001|Overall Study|Mis-randomized|9|||
19594597|NCT00894387|42043146|FG000|Overall Study|GCP non-compliance|0|||
19594598|NCT00894387|42043147|FG001|Overall Study|GCP non-compliance|2|||
19594599|NCT00928512|42043158|FG000|Overall Study|Adverse Event|4|||
19746824|NCT00002651|42194232|FG001|Consolidation and Randomization|Adverse Event|36|||
19388064|NCT02086162|41631448|FG000|Overall Study|Withdrawal by Subject|4|||
19594600|NCT00928512|42043159|FG001|Overall Study|Adverse Event|3|||
19594601|NCT00928512|42043160|FG002|Overall Study|Adverse Event|2|||
19594602|NCT00928512|42043161|FG003|Overall Study|Adverse Event|8|||
19746825|NCT00002651|42194233|FG002|Consolidation and Randomization|Adverse Event|14|||
19746826|NCT00002651|42194231|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
19746827|NCT00002651|42194232|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
19746828|NCT00002651|42194233|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
19746829|NCT00002651|42194231|FG000|Consolidation and Randomization|Progression/relapse|0|||
19746830|NCT00002651|42194232|FG001|Consolidation and Randomization|Progression/relapse|295|||
19746831|NCT00002651|42194233|FG002|Consolidation and Randomization|Progression/relapse|298|||
19746832|NCT00002651|42194231|FG000|Consolidation and Randomization|Death|0|||
19746833|NCT00002651|42194232|FG001|Consolidation and Randomization|Death|38|||
19746834|NCT00002651|42194233|FG002|Consolidation and Randomization|Death|48|||
19746835|NCT00002651|42194231|FG000|Consolidation and Randomization|Other|0|||
19746836|NCT00002651|42194232|FG001|Consolidation and Randomization|Other|314|||
19746837|NCT00002651|42194233|FG002|Consolidation and Randomization|Other|313|||
19746838|NCT00002651|42194231|FG000|Consolidation and Randomization|not eligible|0|||
19746839|NCT00002651|42194232|FG001|Consolidation and Randomization|not eligible|102|||
19746840|NCT00002651|42194233|FG002|Consolidation and Randomization|not eligible|112|||
19594603|NCT00928512|42043162|FG004|Overall Study|Adverse Event|6|||
19594604|NCT00928512|42043158|FG000|Overall Study|Lack of Efficacy|2|||
19594605|NCT00928512|42043159|FG001|Overall Study|Lack of Efficacy|0|||
19594606|NCT00928512|42043160|FG002|Overall Study|Lack of Efficacy|4|||
19594607|NCT00928512|42043161|FG003|Overall Study|Lack of Efficacy|7|||
19594608|NCT00928512|42043162|FG004|Overall Study|Lack of Efficacy|3|||
19594609|NCT00928512|42043158|FG000|Overall Study|Protocol Violation|0|||
19594610|NCT00928512|42043159|FG001|Overall Study|Protocol Violation|1|||
19594611|NCT00928512|42043160|FG002|Overall Study|Protocol Violation|0|||
19594612|NCT00928512|42043161|FG003|Overall Study|Protocol Violation|1|||
19594613|NCT00928512|42043162|FG004|Overall Study|Protocol Violation|3|||
19594614|NCT00928512|42043158|FG000|Overall Study|Withdrawal by Subject|3|||
19594615|NCT00928512|42043159|FG001|Overall Study|Withdrawal by Subject|0|||
19594616|NCT00928512|42043160|FG002|Overall Study|Withdrawal by Subject|3|||
19594617|NCT00928512|42043161|FG003|Overall Study|Withdrawal by Subject|4|||
19594618|NCT00928512|42043162|FG004|Overall Study|Withdrawal by Subject|0|||
19594619|NCT00928512|42043158|FG000|Overall Study|Lost to Follow-up|1|||
19594620|NCT00928512|42043159|FG001|Overall Study|Lost to Follow-up|1|||
19594621|NCT00928512|42043160|FG002|Overall Study|Lost to Follow-up|2|||
19594622|NCT00928512|42043161|FG003|Overall Study|Lost to Follow-up|1|||
19594623|NCT00928512|42043162|FG004|Overall Study|Lost to Follow-up|3|||
19594624|NCT00928512|42043158|FG000|Overall Study|Administrative Problems|0|||
19594625|NCT00928512|42043159|FG001|Overall Study|Administrative Problems|1|||
19594626|NCT00928512|42043160|FG002|Overall Study|Administrative Problems|0|||
19594627|NCT00928512|42043161|FG003|Overall Study|Administrative Problems|0|||
19594628|NCT00928512|42043162|FG004|Overall Study|Administrative Problems|0|||
19594629|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
19594630|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
19594631|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
19594632|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
19594633|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
19594634|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
19594635|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
19594636|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
19594637|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
19594638|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
19594639|NCT00787891|42043180|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
19594640|NCT00787891|42043181|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
19594641|NCT00787891|42043180|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
19594642|NCT00787891|42043181|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
19594643|NCT00787891|42043180|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
19594644|NCT00787891|42043181|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
19594645|NCT00787891|42043180|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
19594646|NCT00787891|42043181|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
19594647|NCT00787891|42043180|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
19594648|NCT00787891|42043181|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
19594649|NCT00892437|42043191|FG000|Randomized Phase|Randomized but not treated|6|||
19594650|NCT00892437|42043192|FG001|Randomized Phase|Randomized but not treated|0|||
19594651|NCT00892437|42043191|FG000|Randomized Phase|Adverse Event|2|||
19594652|NCT00892437|42043192|FG001|Randomized Phase|Adverse Event|2|||
19594653|NCT00892437|42043191|FG000|Randomized Phase|Lost to Follow-up|1|||
19594654|NCT00892437|42043192|FG001|Randomized Phase|Lost to Follow-up|3|||
19594655|NCT00892437|42043191|FG000|Randomized Phase|Investigator's Discretion|1|||
19594656|NCT00892437|42043192|FG001|Randomized Phase|Investigator's Discretion|0|||
19594657|NCT00892437|42043191|FG000|Randomized Phase|Withdrew Consent|1|||
19594658|NCT00892437|42043192|FG001|Randomized Phase|Withdrew Consent|0|||
19594659|NCT00892437|42043191|FG000|Open-Label Extension Phase|Adverse Event|4|||
19594660|NCT00892437|42043192|FG001|Open-Label Extension Phase|Adverse Event|2|||
19594661|NCT00892437|42043191|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
19594662|NCT00892437|42043192|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
19594663|NCT00892437|42043191|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
19594664|NCT00892437|42043192|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
19594665|NCT00892437|42043191|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
19594666|NCT00892437|42043192|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
19594667|NCT00892437|42043191|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
19594668|NCT00892437|42043192|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
19594669|NCT00792103|42043199|FG000|Overall Study|Enrolled, not treated|15|||
19594670|NCT00792103|42043199|FG000|Overall Study|Lost to Follow-up|17|||
19594671|NCT00792103|42043199|FG000|Overall Study|Adverse Event|25|||
19594672|NCT00792103|42043199|FG000|Overall Study|Withdrawal by Subject|52|||
19594673|NCT00792103|42043199|FG000|Overall Study|Protocol Violation|10|||
19594674|NCT00792103|42043199|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
19594675|NCT00892281|42043205|FG000|Overall Study|Adverse Event|65|||
19594676|NCT00892281|42043206|FG001|Overall Study|Adverse Event|8|||
19594677|NCT00892281|42043205|FG000|Overall Study|Lost to Follow-up|81|||
19746841|NCT00002597|42194243|FG000|Overall Study|Protocol Violation|19|||
19746842|NCT00002597|42194244|FG001|Overall Study|Protocol Violation|17|||
19746843|NCT00002597|42194243|FG000|Overall Study|Withdrawal by Subject|7|||
19746844|NCT00002597|42194244|FG001|Overall Study|Withdrawal by Subject|6|||
19746845|NCT03435081|42194253|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
19746846|NCT03435081|42194254|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
19746847|NCT03435081|42194255|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
19746848|NCT03435081|42194253|FG000|Week 0 to Week 16|Adverse Event|2|||
19746849|NCT03435081|42194254|FG001|Week 0 to Week 16|Adverse Event|2|||
19746850|NCT03435081|42194255|FG002|Week 0 to Week 16|Adverse Event|2|||
19746851|NCT03435081|42194253|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
19746852|NCT03435081|42194254|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
19594678|NCT00892281|42043206|FG001|Overall Study|Lost to Follow-up|8|||
19746853|NCT03435081|42194255|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
19746854|NCT03435081|42194253|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
19746855|NCT03435081|42194254|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
19746856|NCT03435081|42194255|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
19746857|NCT03435081|42194253|FG000|Week 0 to Week 16|Pregnancy|1|||
19746858|NCT03435081|42194254|FG001|Week 0 to Week 16|Pregnancy|0|||
19746859|NCT03435081|42194255|FG002|Week 0 to Week 16|Pregnancy|0|||
19594679|NCT00892281|42043205|FG000|Overall Study|Pregnancy|1|||
19594680|NCT00892281|42043206|FG001|Overall Study|Pregnancy|0|||
19746860|NCT03435081|42194253|FG000|Week 0 to Week 16|Non-compliance|1|||
19746861|NCT03435081|42194254|FG001|Week 0 to Week 16|Non-compliance|0|||
19746862|NCT03435081|42194255|FG002|Week 0 to Week 16|Non-compliance|2|||
19746863|NCT03435081|42194253|FG000|Week 0 to Week 16|Inadequate Response|0|||
19594681|NCT00892281|42043205|FG000|Overall Study|Protocol Violation|7|||
19594682|NCT00892281|42043206|FG001|Overall Study|Protocol Violation|2|||
19594683|NCT00892281|42043205|FG000|Overall Study|Withdrawal by Subject|86|||
19594684|NCT00892281|42043206|FG001|Overall Study|Withdrawal by Subject|14|||
19594685|NCT00892281|42043205|FG000|Overall Study|Subject failed to return for final visit|2|||
19594686|NCT00892281|42043206|FG001|Overall Study|Subject failed to return for final visit|0|||
19594687|NCT00892281|42043205|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
19594688|NCT00892281|42043206|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
19594689|NCT00892281|42043205|FG000|Overall Study|Final visit completed 4 weeks late|0|||
19594690|NCT00892281|42043206|FG001|Overall Study|Final visit completed 4 weeks late|1|||
19594691|NCT00892281|42043205|FG000|Overall Study|Subject completed day after study closed|1|||
19594692|NCT00892281|42043206|FG001|Overall Study|Subject completed day after study closed|0|||
19594693|NCT00892281|42043205|FG000|Overall Study|Family emergency|1|||
19594694|NCT00892281|42043206|FG001|Overall Study|Family emergency|0|||
19594695|NCT00892281|42043205|FG000|Overall Study|Last visit not done - death in family|1|||
19594696|NCT00892281|42043206|FG001|Overall Study|Last visit not done - death in family|0|||
19594697|NCT00892281|42043205|FG000|Overall Study|Did not meet incl/excl criteria|1|||
19594698|NCT00892281|42043206|FG001|Overall Study|Did not meet incl/excl criteria|0|||
19594699|NCT00892281|42043205|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
19594700|NCT00892281|42043206|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
19594701|NCT00892281|42043205|FG000|Overall Study|Unable to redeem the drug voucher|1|||
19594702|NCT00892281|42043206|FG001|Overall Study|Unable to redeem the drug voucher|0|||
19594703|NCT00892281|42043205|FG000|Overall Study|Subject not good candidate for study|1|||
19594704|NCT00892281|42043206|FG001|Overall Study|Subject not good candidate for study|0|||
19594705|NCT00892281|42043205|FG000|Overall Study|Subject did not return for any visits|1|||
19594706|NCT00892281|42043206|FG001|Overall Study|Subject did not return for any visits|0|||
19594707|NCT00892281|42043205|FG000|Overall Study|Subject missed several visits/lost meds|1|||
19594708|NCT00892281|42043206|FG001|Overall Study|Subject missed several visits/lost meds|0|||
19594709|NCT00892281|42043205|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
19594710|NCT00892281|42043206|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
19594711|NCT00892281|42043205|FG000|Overall Study|Scheduled for knee replacement|0|||
19594712|NCT00892281|42043206|FG001|Overall Study|Scheduled for knee replacement|1|||
19594713|NCT00892281|42043205|FG000|Overall Study|PI complained of inadequate compensation|3|||
19594714|NCT00892281|42043206|FG001|Overall Study|PI complained of inadequate compensation|0|||
19594715|NCT00892281|42043205|FG000|Overall Study|Subject lost interest in program|0|||
19594716|NCT00892281|42043206|FG001|Overall Study|Subject lost interest in program|1|||
19594717|NCT00892281|42043205|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
19594718|NCT00892281|42043206|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
19594719|NCT00892281|42043205|FG000|Overall Study|Death in family|1|||
19594720|NCT00892281|42043206|FG001|Overall Study|Death in family|0|||
19594721|NCT00892281|42043205|FG000|Overall Study|Lack of efficacy of study product|2|||
19594722|NCT00892281|42043206|FG001|Overall Study|Lack of efficacy of study product|0|||
19594723|NCT00892281|42043205|FG000|Overall Study|Subject not seen by PI at final visit|1|||
19594724|NCT00892281|42043206|FG001|Overall Study|Subject not seen by PI at final visit|0|||
19594725|NCT00892281|42043205|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
19594726|NCT00892281|42043206|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
19594727|NCT00892281|42043205|FG000|Overall Study|Missed multiple visits|1|||
19594728|NCT00892281|42043206|FG001|Overall Study|Missed multiple visits|0|||
19594729|NCT00892281|42043205|FG000|Overall Study|Missed visits rescheduled out of window|1|||
19594730|NCT00892281|42043206|FG001|Overall Study|Missed visits rescheduled out of window|0|||
19594731|NCT00892281|42043205|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
19594732|NCT00892281|42043206|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
19594733|NCT00892281|42043205|FG000|Overall Study|Subject had history of drug abuse|1|||
19594734|NCT00892281|42043206|FG001|Overall Study|Subject had history of drug abuse|0|||
19594735|NCT00892281|42043205|FG000|Overall Study|Rash on hand|1|||
19594736|NCT00892281|42043206|FG001|Overall Study|Rash on hand|0|||
19594737|NCT00892281|42043205|FG000|Overall Study|Visit 4 date out of window|1|||
19594738|NCT00892281|42043206|FG001|Overall Study|Visit 4 date out of window|0|||
19594739|NCT00784693|42043214|FG000|Overall Study|Lost to Follow-up|0|||
19594740|NCT00784693|42043215|FG001|Overall Study|Lost to Follow-up|1|||
19594741|NCT00784693|42043214|FG000|Overall Study|Lack of Efficacy|1|||
19594742|NCT00784693|42043215|FG001|Overall Study|Lack of Efficacy|1|||
19594743|NCT00784693|42043214|FG000|Overall Study|Withdrawal by Subject|0|||
19594744|NCT00784693|42043215|FG001|Overall Study|Withdrawal by Subject|4|||
19594745|NCT00784693|42043214|FG000|Overall Study|Randomized but not Treated|1|||
19594746|NCT00784693|42043215|FG001|Overall Study|Randomized but not Treated|0|||
19594747|NCT00784693|42043214|FG000|Overall Study|Other|1|||
19594748|NCT00784693|42043215|FG001|Overall Study|Other|0|||
19594749|NCT00893763|42043223|FG000|Overall Study|extubated|110|||
19594750|NCT00893763|42043224|FG001|Overall Study|extubated|110|||
19594751|NCT00892047|42043234|FG000|Overall Study|Adverse Event|2|||
19594752|NCT00892047|42043235|FG001|Overall Study|Adverse Event|2|||
19594753|NCT00892047|42043234|FG000|Overall Study|subject burden|2|||
19594754|NCT00892047|42043235|FG001|Overall Study|subject burden|3|||
19594755|NCT00892047|42043234|FG000|Overall Study|Lack of Efficacy|0|||
19594756|NCT00892047|42043235|FG001|Overall Study|Lack of Efficacy|2|||
19594757|NCT00787267|42043243|FG000|Overall Study|Screen failure/Ineligible|10|||
19594758|NCT00787267|42043243|FG000|Overall Study|No Reason Provided|1|||
19594759|NCT00787267|42043243|FG000|Overall Study|Withdrawal by Subject|1|||
19594760|NCT00928434|42043250|FG000|Overall Study|Adverse Event|14|||
19594761|NCT00928434|42043251|FG001|Overall Study|Adverse Event|5|||
19594762|NCT00928434|42043252|FG002|Overall Study|Adverse Event|18|||
19594763|NCT00928434|42043250|FG000|Overall Study|Protocol Violation|5|||
19594764|NCT00928434|42043251|FG001|Overall Study|Protocol Violation|0|||
19594765|NCT00928434|42043252|FG002|Overall Study|Protocol Violation|8|||
19594766|NCT00928434|42043250|FG000|Overall Study|Physician Decision|2|||
19594767|NCT00928434|42043251|FG001|Overall Study|Physician Decision|0|||
19594768|NCT00928434|42043252|FG002|Overall Study|Physician Decision|3|||
19594769|NCT00928434|42043250|FG000|Overall Study|Lost to Follow-up|1|||
19594770|NCT00928434|42043251|FG001|Overall Study|Lost to Follow-up|0|||
19594771|NCT00928434|42043252|FG002|Overall Study|Lost to Follow-up|3|||
19594772|NCT00928434|42043250|FG000|Overall Study|Withdrawal by Subject|5|||
19476979|NCT01488487|41755572|FG000|Overall Study|Withdrawal by Subject|2|||
19594773|NCT00928434|42043251|FG001|Overall Study|Withdrawal by Subject|3|||
19594774|NCT00928434|42043252|FG002|Overall Study|Withdrawal by Subject|2|||
19594775|NCT00928434|42043250|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
19594776|NCT00928434|42043251|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
19594777|NCT00928434|42043252|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
19594778|NCT00928434|42043250|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
19594779|NCT00928434|42043251|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
19594780|NCT00928434|42043252|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
19594781|NCT00928434|42043250|FG000|Overall Study|Other (not meeting above criteria)|5|||
19594782|NCT00928434|42043251|FG001|Overall Study|Other (not meeting above criteria)|1|||
19594783|NCT00928434|42043252|FG002|Overall Study|Other (not meeting above criteria)|2|||
19594784|NCT00787189|42043270|FG000|Overall Study|Lost to Follow-up|2|||
19594785|NCT00787189|42043271|FG001|Overall Study|Lost to Follow-up|2|||
19594786|NCT00784459|42043279|FG000|Overall Study|Adverse Event|0|||
19594787|NCT00784459|42043280|FG001|Overall Study|Adverse Event|2|||
19594788|NCT00786799|42043288|FG000|Overall Study|Lost to Follow-up|1|||
19594789|NCT00786799|42043289|FG001|Overall Study|Lost to Follow-up|1|||
19594790|NCT00786565|42043300|FG000|Enrollment Prior to Surgery|Site Closed|3|||
19594791|NCT00786565|42043300|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
19594792|NCT00786565|42043300|FG000|Post Surgery|Abnormal macular pucker|1|||
19594793|NCT00786565|42043300|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
19594794|NCT00784147|42043308|FG000|Overall Study|Lost to Follow-up|2|||
19594795|NCT00784147|42043309|FG001|Overall Study|Lost to Follow-up|4|||
19594796|NCT00784147|42043308|FG000|Overall Study|Withdrawal by Subject|1|||
19594797|NCT00784147|42043309|FG001|Overall Study|Withdrawal by Subject|3|||
19594798|NCT00784147|42043308|FG000|Overall Study|Physician Decision|2|||
19594799|NCT00784147|42043309|FG001|Overall Study|Physician Decision|1|||
19594800|NCT00784147|42043308|FG000|Overall Study|Protocol Violation|1|||
19594801|NCT00784147|42043309|FG001|Overall Study|Protocol Violation|1|||
19594802|NCT00784147|42043308|FG000|Overall Study|Death|2|||
19594803|NCT00784147|42043309|FG001|Overall Study|Death|0|||
19594804|NCT00891813|42043315|FG000|Overall Study|Adverse Event|3|||
19594805|NCT00891813|42043315|FG000|Overall Study|Withdrawal by Subject|1|||
19594806|NCT00891813|42043315|FG000|Overall Study|Patient Noncompliance|6|||
19594807|NCT00891813|42043315|FG000|Overall Study|Protocol Violation|2|||
19594808|NCT00783835|42043319|FG000|Overall Study|Adverse Event|3|||
19594809|NCT00783835|42043319|FG000|Overall Study|Medical Criteria|1|||
19594810|NCT00783835|42043319|FG000|Overall Study|Withdrawal by Subject|2|||
19594811|NCT00783835|42043319|FG000|Overall Study|Lost to Follow-up|1|||
19594812|NCT00783835|42043319|FG000|Overall Study|Participant not Adherent|3|||
19594813|NCT00783289|42043327|FG000|Overall Study|Protocol Violation|0|||
19594814|NCT00783289|42043328|FG001|Overall Study|Protocol Violation|1|||
19594815|NCT00783289|42043329|FG002|Overall Study|Protocol Violation|0|||
19594816|NCT00783289|42043330|FG003|Overall Study|Protocol Violation|0|||
19594817|NCT00847912|42043345|FG000|Overall Study|Protocol Violation|6|||
19594818|NCT00847912|42043346|FG001|Overall Study|Protocol Violation|7|||
19594819|NCT00847912|42043345|FG000|Overall Study|Withdrawal by Subject|3|||
19594820|NCT00847912|42043346|FG001|Overall Study|Withdrawal by Subject|6|||
19594821|NCT00850564|42043353|FG000|Overall Study|Withdrawal by Subject|2|||
19594822|NCT00837148|42043357|FG000|Overall Study|Adverse Event|1|||
19388065|NCT02086162|41631449|FG001|Overall Study|Withdrawal by Subject|4|||
19476980|NCT01488097|41755576|FG000|Overall Study|Lost to Follow-up|1|||
19594823|NCT00837148|42043357|FG000|Overall Study|Death|1|||
19594824|NCT00849940|42043361|FG000|Overall Study|Physician Decision|4|||
19594825|NCT00849472|42043365|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
19594826|NCT00849472|42043365|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
19594827|NCT00849472|42043365|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
19594828|NCT00849472|42043365|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
19594829|NCT00849472|42043365|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
19594830|NCT00849472|42043365|FG000|Weekly Paclitaxel|Disease Progression|1|||
19594831|NCT00849472|42043365|FG000|Weekly Paclitaxel|Adverse Event|11|||
19594832|NCT00849472|42043365|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
19594833|NCT00849472|42043365|FG000|Weekly Paclitaxel|Physician Decision|3|||
19594834|NCT00849472|42043365|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
19594835|NCT00849472|42043365|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
19594836|NCT00849472|42043365|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
19594837|NCT00849472|42043365|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
19594838|NCT00849472|42043365|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
19594839|NCT00849472|42043365|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
19594840|NCT00849472|42043365|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
19594841|NCT00849472|42043365|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
19594842|NCT00782509|42043373|FG000|Overall Study|Adverse Event|20|||
19594843|NCT00782509|42043374|FG001|Overall Study|Adverse Event|10|||
19594844|NCT00782509|42043375|FG002|Overall Study|Adverse Event|20|||
19594845|NCT00782509|42043373|FG000|Overall Study|Lost to Follow-up|1|||
19594846|NCT00782509|42043374|FG001|Overall Study|Lost to Follow-up|2|||
19594847|NCT00782509|42043375|FG002|Overall Study|Lost to Follow-up|3|||
19594848|NCT00782509|42043373|FG000|Overall Study|Withdrawal by Subject|3|||
19594849|NCT00782509|42043374|FG001|Overall Study|Withdrawal by Subject|5|||
19594850|NCT00782509|42043375|FG002|Overall Study|Withdrawal by Subject|8|||
19594851|NCT00782509|42043373|FG000|Overall Study|Non compliance with protocol|2|||
19594852|NCT00782509|42043374|FG001|Overall Study|Non compliance with protocol|0|||
19594853|NCT00782509|42043375|FG002|Overall Study|Non compliance with protocol|0|||
19594854|NCT00782509|42043373|FG000|Overall Study|Other reasons not stated above|5|||
19594855|NCT00782509|42043374|FG001|Overall Study|Other reasons not stated above|2|||
19594856|NCT00782509|42043375|FG002|Overall Study|Other reasons not stated above|3|||
19594857|NCT00782509|42043373|FG000|Overall Study|Lack of Efficacy|10|||
19594858|NCT00782509|42043374|FG001|Overall Study|Lack of Efficacy|5|||
19594859|NCT00782509|42043375|FG002|Overall Study|Lack of Efficacy|2|||
19594860|NCT00927810|42043394|FG000|Overall Study|Withdrawal by Subject|0|||
19594861|NCT00927810|42043395|FG001|Overall Study|Withdrawal by Subject|3|||
19594862|NCT00927810|42043396|FG002|Overall Study|Withdrawal by Subject|0|||
19594863|NCT00927810|42043397|FG003|Overall Study|Withdrawal by Subject|1|||
19594864|NCT00927810|42043394|FG000|Overall Study|Lost to Follow-up|0|||
19388066|NCT02086162|41631448|FG000|Overall Study|moved|1|||
19594865|NCT00927810|42043395|FG001|Overall Study|Lost to Follow-up|2|||
19594866|NCT00927810|42043396|FG002|Overall Study|Lost to Follow-up|1|||
19594867|NCT00927810|42043397|FG003|Overall Study|Lost to Follow-up|1|||
19594868|NCT00927810|42043394|FG000|Overall Study|Death|0|||
19594869|NCT00927810|42043395|FG001|Overall Study|Death|2|||
19594870|NCT00927810|42043396|FG002|Overall Study|Death|0|||
19594871|NCT00927810|42043397|FG003|Overall Study|Death|0|||
19594872|NCT00927810|42043394|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19594873|NCT00927810|42043395|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19594874|NCT00927810|42043396|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19594875|NCT00927810|42043397|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19594876|NCT00848926|42043415|FG000|Treatment Period|Progressive disease|45|||
19594877|NCT00848926|42043415|FG000|Treatment Period|Adverse Event|20|||
19594878|NCT00848926|42043415|FG000|Treatment Period|Physician Decision|12|||
19594879|NCT00848926|42043415|FG000|Treatment Period|Withdrawal by Subject|7|||
19594880|NCT00848926|42043415|FG000|Follow-up Period|Lost to Follow-up|7|||
19594881|NCT00848926|42043415|FG000|Follow-up Period|Withdrawal by Subject|3|||
19594882|NCT00848926|42043415|FG000|Follow-up Period|Other|2|||
19594883|NCT00847132|42043421|FG000|Overall Study|Death|1|||
19594884|NCT00847132|42043422|FG001|Overall Study|Death|1|||
19594885|NCT00918138|42043430|FG000|Overall Study|Subject withdrew consent|1|||
19594886|NCT00918138|42043431|FG001|Overall Study|Subject withdrew consent|1|||
19594887|NCT00918138|42043430|FG000|Overall Study|Death|1|||
19594888|NCT00918138|42043431|FG001|Overall Study|Death|0|||
19594889|NCT00782275|42043437|FG000|Overall Study|Adverse Event|11|||
19594890|NCT00782275|42043437|FG000|Overall Study|Withdrawal by Subject|1|||
19594891|NCT00782275|42043437|FG000|Overall Study|Progressive Disease|21|||
19594892|NCT00782275|42043437|FG000|Overall Study|Physician Decision|4|||
19594893|NCT00782275|42043437|FG000|Overall Study|Not started treatment|1|||
19594894|NCT00782275|42043437|FG000|Overall Study|Other|3|||
19594895|NCT00791557|42043441|FG000|Overall Study|Adverse Event|1|||
19594896|NCT00920790|42043445|FG000|Overall Study|aggravation of general condition|14|||
19594897|NCT00781963|42043451|FG000|Overall Study|Death|3|||
19594898|NCT00781963|42043452|FG001|Overall Study|Death|0|||
19594899|NCT00781963|42043451|FG000|Overall Study|Lost to Follow-up|2|||
19594900|NCT00781963|42043452|FG001|Overall Study|Lost to Follow-up|1|||
19594901|NCT00781963|42043451|FG000|Overall Study|Withdrawal by Subject|3|||
19594902|NCT00781963|42043452|FG001|Overall Study|Withdrawal by Subject|1|||
19594903|NCT00781963|42043451|FG000|Overall Study|Refused follow-up|9|||
19594904|NCT00781963|42043452|FG001|Overall Study|Refused follow-up|0|||
19594905|NCT00920556|42043458|FG000|Overall Study|Adverse Event|16|||
19594906|NCT00920556|42043458|FG000|Overall Study|Physician Decision|7|||
19594907|NCT00920556|42043458|FG000|Overall Study|Withdrawal by Subject|1|||
19476981|NCT01516879|41755582|FG000|Overall Study|Withdrawal by Subject|9|||
19594908|NCT00781885|42043466|FG000|Overall Study|Physician Decision|1|||
19594909|NCT00918684|42043470|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
19594910|NCT00918684|42043470|FG000|Treatment Phase|Lack of Efficacy|6|||
19594911|NCT00918684|42043470|FG000|Treatment Phase|Lost to Follow-up|2|||
19594912|NCT00918684|42043470|FG000|Treatment Phase|Physician Decision|8|||
19594913|NCT00918684|42043470|FG000|Treatment Phase|Protocol Violation|1|||
19594914|NCT00918684|42043470|FG000|Treatment Phase|Withdrawal by Subject|8|||
19594915|NCT00786409|42043474|FG000|Overall Study|Withdrawal by Subject|2|||
19594916|NCT00786409|42043474|FG000|Overall Study|Adverse Event|2|||
19594917|NCT00786409|42043474|FG000|Overall Study|Pregnancy|2|||
19594918|NCT00786409|42043474|FG000|Overall Study|Lost to Follow-up|1|||
19594919|NCT00919854|42043478|FG000|Overall Study|Adverse Event|1|||
19594920|NCT00891735|42043486|FG000|Overall Study|Adverse Event|2|||
19594921|NCT00891735|42043487|FG001|Overall Study|Adverse Event|0|||
19594922|NCT00891735|42043488|FG002|Overall Study|Adverse Event|2|||
19594923|NCT00891735|42043489|FG003|Overall Study|Adverse Event|0|||
19594924|NCT00891735|42043486|FG000|Overall Study|Death|8|||
19594925|NCT00891735|42043487|FG001|Overall Study|Death|5|||
19594926|NCT00891735|42043488|FG002|Overall Study|Death|4|||
19594927|NCT00891735|42043489|FG003|Overall Study|Death|5|||
19594928|NCT00891735|42043486|FG000|Overall Study|Lost to Follow-up|2|||
19594929|NCT00891735|42043487|FG001|Overall Study|Lost to Follow-up|2|||
19594930|NCT00891735|42043488|FG002|Overall Study|Lost to Follow-up|2|||
19594931|NCT00891735|42043489|FG003|Overall Study|Lost to Follow-up|2|||
19594932|NCT00891735|42043486|FG000|Overall Study|Physician's decision to withdraw patient|1|||
19594933|NCT00891735|42043487|FG001|Overall Study|Physician's decision to withdraw patient|0|||
19594934|NCT00891735|42043488|FG002|Overall Study|Physician's decision to withdraw patient|0|||
19594935|NCT00891735|42043489|FG003|Overall Study|Physician's decision to withdraw patient|0|||
19594936|NCT00891735|42043486|FG000|Overall Study|Patient's decision to withdraw|4|||
19594937|NCT00891735|42043487|FG001|Overall Study|Patient's decision to withdraw|9|||
19594938|NCT00891735|42043488|FG002|Overall Study|Patient's decision to withdraw|4|||
19594939|NCT00891735|42043489|FG003|Overall Study|Patient's decision to withdraw|8|||
19594940|NCT00891657|42043501|FG000|Overall Study|Withdrawal by Subject|1|||
19594941|NCT00891657|42043502|FG001|Overall Study|Withdrawal by Subject|1|||
19594942|NCT00917124|42043510|FG000|Overall Study|Protocol Violation|4|||
19594943|NCT00917124|42043511|FG001|Overall Study|Protocol Violation|6|||
19594944|NCT00889863|42043517|FG000|Part I: Open Label|Death|1|||
19476982|NCT01516879|41755583|FG001|Overall Study|Withdrawal by Subject|11|||
19476983|NCT01516879|41755582|FG000|Overall Study|Death|0|||
19594945|NCT00889863|42043518|FG001|Part I: Open Label|Death|0|||
19594946|NCT00889863|42043517|FG000|Part I: Open Label|Adverse Event|4|||
19594947|NCT00889863|42043518|FG001|Part I: Open Label|Adverse Event|0|||
19594948|NCT00889863|42043517|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
19594949|NCT00889863|42043518|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
19594950|NCT00889863|42043517|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
19594951|NCT00889863|42043518|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
19594952|NCT00889863|42043517|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
19594953|NCT00889863|42043518|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
19594954|NCT00889863|42043517|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
19594955|NCT00889863|42043518|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
19746864|NCT03435081|42194254|FG001|Week 0 to Week 16|Inadequate Response|1|||
19594956|NCT00889863|42043517|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
19594957|NCT00889863|42043518|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
19594958|NCT00915018|42043528|FG000|Overall Study|Death|75|||
19594959|NCT00915018|42043529|FG001|Overall Study|Death|70|||
19594960|NCT00915018|42043528|FG000|Overall Study|Lost to Follow-up|10|||
19594961|NCT00915018|42043529|FG001|Overall Study|Lost to Follow-up|5|||
19594962|NCT00915018|42043528|FG000|Overall Study|Withdrawal by Subject|38|||
19594963|NCT00915018|42043529|FG001|Overall Study|Withdrawal by Subject|27|||
19594964|NCT00915018|42043528|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
19594965|NCT00915018|42043529|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
19594966|NCT00916578|42043535|FG000|Overall Study|Physician Decision|2|||
19594967|NCT00916578|42043535|FG000|Overall Study|Withdrawal by Subject|3|||
19594968|NCT00916578|42043535|FG000|Overall Study|Insurance Denial|2|||
19594969|NCT00889707|42043541|FG000|Overall Study|Adverse Event|1|||
19594970|NCT00889707|42043542|FG001|Overall Study|Adverse Event|0|||
19594971|NCT00889707|42043541|FG000|Overall Study|Withdrawal by Subject|4|||
19594972|NCT00889707|42043542|FG001|Overall Study|Withdrawal by Subject|3|||
19594973|NCT00889707|42043541|FG000|Overall Study|Lost to Follow-up|0|||
19594974|NCT00889707|42043542|FG001|Overall Study|Lost to Follow-up|2|||
19594975|NCT00889707|42043541|FG000|Overall Study|Lack of Efficacy|2|||
19594976|NCT00889707|42043542|FG001|Overall Study|Lack of Efficacy|5|||
19594977|NCT00914940|42043548|FG000|D0 to D100 Post-transplant|Death|2|||
19594978|NCT00914940|42043548|FG000|D101 to 2 Years Post-transplant|Death|8|||
19594979|NCT00914940|42043548|FG000|2 Years to 5 Years Post-transplant|Death|3|||
19594980|NCT00835978|42043556|FG000|Overall Study|Death|33|||
19594981|NCT00835978|42043557|FG001|Overall Study|Death|40|||
19594982|NCT00835978|42043558|FG002|Overall Study|Death|49|||
19594983|NCT00835978|42043559|FG003|Overall Study|Death|4|||
19594984|NCT00835978|42043556|FG000|Overall Study|Lost to Follow-up|3|||
19594985|NCT00835978|42043557|FG001|Overall Study|Lost to Follow-up|4|||
19594986|NCT00835978|42043558|FG002|Overall Study|Lost to Follow-up|2|||
19594987|NCT00835978|42043559|FG003|Overall Study|Lost to Follow-up|1|||
19594988|NCT00835978|42043556|FG000|Overall Study|Other|5|||
19594989|NCT00835978|42043557|FG001|Overall Study|Other|1|||
19594990|NCT00835978|42043558|FG002|Overall Study|Other|8|||
19594991|NCT00835978|42043559|FG003|Overall Study|Other|0|||
19594992|NCT00835978|42043556|FG000|Overall Study|Objective progression or relapse|2|||
19594993|NCT00835978|42043557|FG001|Overall Study|Objective progression or relapse|0|||
19594994|NCT00835978|42043558|FG002|Overall Study|Objective progression or relapse|1|||
19594995|NCT00835978|42043559|FG003|Overall Study|Objective progression or relapse|0|||
19594996|NCT00835978|42043556|FG000|Overall Study|Adverse Event|1|||
19594997|NCT00835978|42043557|FG001|Overall Study|Adverse Event|0|||
19594998|NCT00835978|42043558|FG002|Overall Study|Adverse Event|1|||
19594999|NCT00835978|42043559|FG003|Overall Study|Adverse Event|0|||
19595000|NCT00835978|42043556|FG000|Overall Study|Withdrawal by Subject|0|||
19595001|NCT00835978|42043557|FG001|Overall Study|Withdrawal by Subject|3|||
19595002|NCT00835978|42043558|FG002|Overall Study|Withdrawal by Subject|0|||
19595003|NCT00835978|42043559|FG003|Overall Study|Withdrawal by Subject|5|||
19595004|NCT00835978|42043556|FG000|Overall Study|Study terminated by sponsor|12|||
19595005|NCT00835978|42043557|FG001|Overall Study|Study terminated by sponsor|8|||
19595006|NCT00835978|42043558|FG002|Overall Study|Study terminated by sponsor|30|||
19595007|NCT00835978|42043559|FG003|Overall Study|Study terminated by sponsor|0|||
19595008|NCT00914628|42043576|FG000|Overall Study|Death|35|||
19595009|NCT00914628|42043577|FG001|Overall Study|Death|17|||
19595010|NCT00914628|42043576|FG000|Overall Study|Medical decision|4|||
19595011|NCT00914628|42043577|FG001|Overall Study|Medical decision|0|||
19595012|NCT00914628|42043576|FG000|Overall Study|Protocol Violation|1|||
19595013|NCT00914628|42043577|FG001|Overall Study|Protocol Violation|0|||
19595014|NCT00914628|42043576|FG000|Overall Study|Lack of Efficacy|1|||
19595015|NCT00914628|42043577|FG001|Overall Study|Lack of Efficacy|0|||
19595016|NCT00914628|42043576|FG000|Overall Study|non-randomized|1|||
19595017|NCT00914628|42043577|FG001|Overall Study|non-randomized|0|||
19595018|NCT00914628|42043576|FG000|Overall Study|Relapse|1|||
19595019|NCT00914628|42043577|FG001|Overall Study|Relapse|2|||
19595020|NCT00914628|42043576|FG000|Overall Study|Study terminated by Sponsor|14|||
19595021|NCT00914628|42043577|FG001|Overall Study|Study terminated by Sponsor|8|||
19595022|NCT00914628|42043576|FG000|Overall Study|Patients who did not receive a single dose|7|||
19595023|NCT00914628|42043577|FG001|Overall Study|Patients who did not receive a single dose|1|||
19595024|NCT01077518|42043589|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
19595025|NCT01077518|42043590|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
19595026|NCT01077518|42043591|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
19595027|NCT01077518|42043589|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
19595028|NCT01077518|42043590|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
19595029|NCT01077518|42043591|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
19595030|NCT01077518|42043589|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
19595031|NCT01077518|42043590|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
19595032|NCT01077518|42043591|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
19595033|NCT01077518|42043589|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
19595034|NCT01077518|42043590|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
19595035|NCT01077518|42043591|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
19595036|NCT01077518|42043589|FG000|Optional Ofa Phase|Physician Decision|0|||
19595037|NCT01077518|42043590|FG001|Optional Ofa Phase|Physician Decision|0|||
19595038|NCT01077518|42043591|FG002|Optional Ofa Phase|Physician Decision|1|||
19595039|NCT01077518|42043589|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
19595040|NCT01077518|42043590|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
19595041|NCT01077518|42043591|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
19595042|NCT01077518|42043589|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
19595043|NCT01077518|42043590|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
19595044|NCT01077518|42043591|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
19595045|NCT00835120|42043600|FG000|Overall Study|Lack of Efficacy|1|||
19595046|NCT00835120|42043600|FG000|Overall Study|Lost to Follow-up|3|||
19595047|NCT00835120|42043600|FG000|Overall Study|Adverse Event|2|||
19595048|NCT00835120|42043600|FG000|Overall Study|Withdrawal by Subject|2|||
19595049|NCT00914316|42043608|FG000|Phase 1|Physician Decision|4|||
19595050|NCT00914316|42043609|FG001|Phase 1|Physician Decision|0|||
19595051|NCT00914316|42043610|FG002|Phase 1|Physician Decision|1|||
19595052|NCT00914316|42043611|FG003|Phase 1|Physician Decision|2|||
19595053|NCT00914316|42043608|FG000|Phase 1|Withdrawal by Subject|0|||
19595054|NCT00914316|42043609|FG001|Phase 1|Withdrawal by Subject|2|||
19595055|NCT00914316|42043610|FG002|Phase 1|Withdrawal by Subject|4|||
19746865|NCT03435081|42194255|FG002|Week 0 to Week 16|Inadequate Response|0|||
19746866|NCT03435081|42194253|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
19746867|NCT03435081|42194254|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
19746868|NCT03435081|42194255|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
19746869|NCT03435081|42194253|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
19746870|NCT03435081|42194254|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
19746871|NCT03435081|42194255|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
19595056|NCT00914316|42043611|FG003|Phase 1|Withdrawal by Subject|0|||
19595057|NCT00914316|42043608|FG000|Phase 1|Adverse Event|1|||
19595058|NCT00914316|42043609|FG001|Phase 1|Adverse Event|0|||
19595059|NCT00914316|42043610|FG002|Phase 1|Adverse Event|0|||
19595060|NCT00914316|42043611|FG003|Phase 1|Adverse Event|0|||
19595061|NCT00914316|42043608|FG000|Phase 2|Withdrawal by Subject|1|||
19595062|NCT00914316|42043609|FG001|Phase 2|Withdrawal by Subject|0|||
19595063|NCT00914316|42043610|FG002|Phase 2|Withdrawal by Subject|1|||
19595064|NCT00914316|42043611|FG003|Phase 2|Withdrawal by Subject|0|||
19595065|NCT00827632|42043623|FG000|Overall Study|Lost to Follow-up|8|||
19595066|NCT00827632|42043624|FG001|Overall Study|Lost to Follow-up|12|||
19595067|NCT00827632|42043623|FG000|Overall Study|Early withdrawal|14|||
19595068|NCT00827632|42043624|FG001|Overall Study|Early withdrawal|11|||
19595069|NCT00827242|42043632|FG000|Overall Study|Withdrawal by Subject|2|||
19595070|NCT00827242|42043633|FG001|Overall Study|Withdrawal by Subject|4|||
19595071|NCT00827242|42043632|FG000|Overall Study|Protocol Violation|1|||
19595072|NCT00827242|42043633|FG001|Overall Study|Protocol Violation|3|||
19595073|NCT00827242|42043632|FG000|Overall Study|Lost to Follow-up|0|||
19595074|NCT00827242|42043633|FG001|Overall Study|Lost to Follow-up|3|||
19595075|NCT00827242|42043632|FG000|Overall Study|Adverse Event Excluding Death|2|||
19595076|NCT00827242|42043633|FG001|Overall Study|Adverse Event Excluding Death|1|||
19595077|NCT00827242|42043632|FG000|Overall Study|Entry Criteria Not Met|4|||
19746872|NCT03435081|42194253|FG000|Week 16 to Week 104|Adverse Event|1|||
19746873|NCT03435081|42194254|FG001|Week 16 to Week 104|Adverse Event|0|||
19746874|NCT03435081|42194255|FG002|Week 16 to Week 104|Adverse Event|2|||
19746875|NCT03435081|42194253|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
19746876|NCT03435081|42194254|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
19746877|NCT03435081|42194255|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
19746878|NCT03435081|42194253|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
19746879|NCT03435081|42194254|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
19746880|NCT03435081|42194255|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
19746881|NCT03435081|42194253|FG000|Week 16 to Week 104|Non--Compliance|0|||
19746882|NCT03435081|42194254|FG001|Week 16 to Week 104|Non--Compliance|0|||
19746883|NCT03435081|42194255|FG002|Week 16 to Week 104|Non--Compliance|1|||
19746884|NCT02738008|42194270|FG000|Overall Study|Study Terminated by Sponsor|1|||
19746885|NCT02738008|42194271|FG001|Overall Study|Study Terminated by Sponsor|5|||
19746886|NCT02738008|42194272|FG002|Overall Study|Study Terminated by Sponsor|3|||
19595078|NCT00827242|42043633|FG001|Overall Study|Entry Criteria Not Met|1|||
19595079|NCT00827242|42043632|FG000|Overall Study|Physician Decision|2|||
19595080|NCT00827242|42043633|FG001|Overall Study|Physician Decision|0|||
19595081|NCT00827242|42043632|FG000|Overall Study|Death|1|||
19595082|NCT00827242|42043633|FG001|Overall Study|Death|0|||
19595083|NCT00827242|42043632|FG000|Overall Study|Lack of Efficacy|1|||
19595084|NCT00827242|42043633|FG001|Overall Study|Lack of Efficacy|0|||
19595085|NCT01077362|42043642|FG000|Overall Study|Lack of Efficacy|13|||
19595086|NCT01077362|42043643|FG001|Overall Study|Lack of Efficacy|8|||
19746887|NCT02738008|42194270|FG000|Overall Study|Adverse Event|0|||
19595087|NCT01077362|42043644|FG002|Overall Study|Lack of Efficacy|10|||
19595088|NCT01077362|42043642|FG000|Overall Study|Lost to Follow-up|1|||
19595089|NCT01077362|42043643|FG001|Overall Study|Lost to Follow-up|0|||
19595090|NCT01077362|42043644|FG002|Overall Study|Lost to Follow-up|3|||
19595091|NCT01077362|42043642|FG000|Overall Study|Adverse Event|12|||
19595092|NCT01077362|42043643|FG001|Overall Study|Adverse Event|7|||
19595093|NCT01077362|42043644|FG002|Overall Study|Adverse Event|4|||
19595094|NCT01077362|42043642|FG000|Overall Study|Withdrawal by Subject|5|||
19595095|NCT01077362|42043643|FG001|Overall Study|Withdrawal by Subject|3|||
19595096|NCT01077362|42043644|FG002|Overall Study|Withdrawal by Subject|5|||
19595097|NCT01077362|42043642|FG000|Overall Study|Other|0|||
19595098|NCT01077362|42043643|FG001|Overall Study|Other|1|||
19595099|NCT01077362|42043644|FG002|Overall Study|Other|2|||
19595100|NCT00846586|42043659|FG000|Overall Study|Adverse Event|20|||
19595101|NCT00846586|42043660|FG001|Overall Study|Adverse Event|10|||
19595102|NCT00846586|42043659|FG000|Overall Study|Subject withdrew consent|8|||
19595103|NCT00846586|42043660|FG001|Overall Study|Subject withdrew consent|10|||
19595104|NCT00846586|42043659|FG000|Overall Study|Administrative problems|5|||
19595105|NCT00846586|42043660|FG001|Overall Study|Administrative problems|4|||
19595106|NCT00846586|42043659|FG000|Overall Study|Death|2|||
19595107|NCT00846586|42043660|FG001|Overall Study|Death|0|||
19595108|NCT00846586|42043659|FG000|Overall Study|Protocol deviation|2|||
19388067|NCT02086162|41631449|FG001|Overall Study|moved|1|||
19388068|NCT02086162|41631448|FG000|Overall Study|Lost to Follow-up|4|||
19388069|NCT02086162|41631449|FG001|Overall Study|Lost to Follow-up|2|||
19388070|NCT02086162|41631448|FG000|Overall Study|Death|1|||
19388071|NCT02086162|41631449|FG001|Overall Study|Death|0|||
19595109|NCT00846586|42043660|FG001|Overall Study|Protocol deviation|6|||
19595110|NCT00846586|42043659|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19595111|NCT00846586|42043660|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19595112|NCT00846586|42043659|FG000|Overall Study|Lost to Follow-up|1|||
19595113|NCT00846586|42043660|FG001|Overall Study|Lost to Follow-up|4|||
19595114|NCT00846586|42043659|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19595115|NCT00846586|42043660|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19595116|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
19595117|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
19595118|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Adverse Event|31|||
19595119|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Adverse Event|21|||
19595120|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
19595121|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
19595122|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
19595123|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
19595124|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
19595125|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
19595126|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
19595127|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
19595128|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Administrative problems|3|||
19595129|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Administrative problems|3|||
19595130|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Death|5|||
19595131|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Death|8|||
19595132|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Disease progression|139|||
19595133|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Disease progression|119|||
19595134|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
19595135|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
19595136|NCT00785785|42043668|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
19595137|NCT00785785|42043669|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
19595138|NCT00785785|42043668|FG000|Optional Extension Phase|Adverse Event|4|||
19595139|NCT00785785|42043669|FG001|Optional Extension Phase|Adverse Event|5|||
19595140|NCT00785785|42043668|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
19595141|NCT00785785|42043669|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
19595142|NCT00785785|42043668|FG000|Optional Extension Phase|Lost to Follow-up|1|||
19595143|NCT00785785|42043669|FG001|Optional Extension Phase|Lost to Follow-up|0|||
19476984|NCT01516879|41755583|FG001|Overall Study|Death|2|||
19595144|NCT00785785|42043668|FG000|Optional Extension Phase|Administrative problems|2|||
19595145|NCT00785785|42043669|FG001|Optional Extension Phase|Administrative problems|0|||
19595146|NCT00785785|42043668|FG000|Optional Extension Phase|Death|1|||
19595147|NCT00785785|42043669|FG001|Optional Extension Phase|Death|5|||
19595148|NCT00785785|42043668|FG000|Optional Extension Phase|Disease progression|22|||
19595149|NCT00785785|42043669|FG001|Optional Extension Phase|Disease progression|70|||
19595150|NCT00785785|42043668|FG000|Optional Extension Phase|Protocol deviation|0|||
19595151|NCT00785785|42043669|FG001|Optional Extension Phase|Protocol deviation|2|||
19595152|NCT00785785|42043668|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
19595153|NCT00785785|42043669|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
19595154|NCT01077284|42043680|FG000|Overall Study|Adverse Event|2|||
19595155|NCT01077284|42043681|FG001|Overall Study|Adverse Event|0|||
19595156|NCT01077284|42043682|FG002|Overall Study|Adverse Event|1|||
19595157|NCT01077284|42043680|FG000|Overall Study|Lost to Follow-up|1|||
19595158|NCT01077284|42043681|FG001|Overall Study|Lost to Follow-up|2|||
19595159|NCT01077284|42043682|FG002|Overall Study|Lost to Follow-up|0|||
19595160|NCT01077284|42043680|FG000|Overall Study|Withdrawal by Subject|2|||
19595161|NCT01077284|42043681|FG001|Overall Study|Withdrawal by Subject|3|||
19595162|NCT01077284|42043682|FG002|Overall Study|Withdrawal by Subject|1|||
19595163|NCT01077284|42043680|FG000|Overall Study|Other|0|||
19595164|NCT01077284|42043681|FG001|Overall Study|Other|0|||
19595165|NCT01077284|42043682|FG002|Overall Study|Other|1|||
19595166|NCT00826618|42043690|FG000|Overall Study|Withdrawal by Subject|1|||
19595167|NCT01077128|42043694|FG000|Overall Study|Adverse Event|8|||
19595168|NCT01077128|42043694|FG000|Overall Study|Lack of Efficacy|1|||
19595169|NCT01077128|42043694|FG000|Overall Study|Disease exacerbation|1|||
19595170|NCT01077128|42043694|FG000|Overall Study|Adverse event and consent withdrawal|1|||
19595171|NCT01077128|42043694|FG000|Overall Study|Adverse event and disease exacerbation|1|||
19595172|NCT01077128|42043694|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
19595173|NCT01077128|42043694|FG000|Overall Study|Other|54|||
19595174|NCT00826540|42043748|FG000|Overall Study|ineligible|3|||
19595175|NCT00826540|42043748|FG000|Overall Study|Withdrawal by Subject|1|||
19595176|NCT01077050|42043752|FG000|Overall Study|Subjects signed ICF could not be located|1|||
19595177|NCT01077050|42043752|FG000|Overall Study|Screen failure|8|||
19595178|NCT00592384|42043758|FG000|Overall Study|Withdrawal by Subject|5|||
19595179|NCT00592384|42043759|FG001|Overall Study|Withdrawal by Subject|6|||
19595180|NCT00846040|42043768|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
19595181|NCT00846040|42043769|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
19595182|NCT00846040|42043770|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
19595183|NCT00846040|42043768|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
19595184|NCT00846040|42043769|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
19595185|NCT00846040|42043770|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
19595186|NCT00826228|42043779|FG000|Overall Study|Withdrawal by Subject|1|||
19595187|NCT00825994|42043784|FG000|Overall Study|Withdrawal by Subject|2|||
19595188|NCT00825994|42043784|FG000|Overall Study|Lost to Follow-up|1|||
19595189|NCT00825994|42043784|FG000|Overall Study|Protocol Violation|1|||
19595190|NCT00825994|42043784|FG000|Overall Study|Placebo Responder at V2|1|||
19595191|NCT00825916|42043791|FG000|Overall Study|Lost to Follow-up|4|||
19595192|NCT00825916|42043792|FG001|Overall Study|Lost to Follow-up|2|||
19595193|NCT00825916|42043793|FG002|Overall Study|Lost to Follow-up|1|||
19595194|NCT00791479|42043840|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
19595195|NCT00791479|42043841|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
19595196|NCT00791479|42043842|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
19595197|NCT00791479|42043843|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
19595198|NCT00791479|42043844|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
19595199|NCT00791479|42043845|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
19595200|NCT00791479|42043840|FG000|Overall Study|Adverse Event|0|||
19595201|NCT00791479|42043841|FG001|Overall Study|Adverse Event|1|||
19595202|NCT00791479|42043842|FG002|Overall Study|Adverse Event|0|||
19595203|NCT00791479|42043843|FG003|Overall Study|Adverse Event|2|||
19595204|NCT00791479|42043844|FG004|Overall Study|Adverse Event|0|||
19595205|NCT00791479|42043845|FG005|Overall Study|Adverse Event|1|||
19595206|NCT00791479|42043840|FG000|Overall Study|Lost to Follow-up|0|||
19595207|NCT00791479|42043841|FG001|Overall Study|Lost to Follow-up|1|||
19595208|NCT00791479|42043842|FG002|Overall Study|Lost to Follow-up|0|||
19595209|NCT00791479|42043843|FG003|Overall Study|Lost to Follow-up|0|||
19595210|NCT00791479|42043844|FG004|Overall Study|Lost to Follow-up|0|||
19595211|NCT00791479|42043845|FG005|Overall Study|Lost to Follow-up|1|||
19595212|NCT00791479|42043840|FG000|Overall Study|Protocol Violation|2|||
19595213|NCT00791479|42043841|FG001|Overall Study|Protocol Violation|1|||
19595214|NCT00791479|42043842|FG002|Overall Study|Protocol Violation|0|||
19595215|NCT00791479|42043843|FG003|Overall Study|Protocol Violation|1|||
19595216|NCT00791479|42043844|FG004|Overall Study|Protocol Violation|0|||
19595217|NCT00791479|42043845|FG005|Overall Study|Protocol Violation|0|||
19595218|NCT00791479|42043840|FG000|Overall Study|Withdrawal by Subject|0|||
19595219|NCT00791479|42043841|FG001|Overall Study|Withdrawal by Subject|0|||
19595220|NCT00791479|42043842|FG002|Overall Study|Withdrawal by Subject|0|||
19595221|NCT00791479|42043843|FG003|Overall Study|Withdrawal by Subject|1|||
19595222|NCT00791479|42043844|FG004|Overall Study|Withdrawal by Subject|0|||
19595223|NCT00791479|42043845|FG005|Overall Study|Withdrawal by Subject|1|||
19595224|NCT00890097|42043869|FG000|Overall Study|Adverse Event|21|||
19595225|NCT00890097|42043870|FG001|Overall Study|Adverse Event|32|||
19595226|NCT00890097|42043871|FG002|Overall Study|Adverse Event|28|||
19595227|NCT00890097|42043869|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
19595228|NCT00890097|42043870|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
19595229|NCT00890097|42043871|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
19595230|NCT00890097|42043869|FG000|Overall Study|Withdrew Consent|9|||
19595231|NCT00890097|42043870|FG001|Overall Study|Withdrew Consent|6|||
19595232|NCT00890097|42043871|FG002|Overall Study|Withdrew Consent|9|||
19595233|NCT00890097|42043869|FG000|Overall Study|Lost to Follow-up|5|||
19595234|NCT00890097|42043870|FG001|Overall Study|Lost to Follow-up|5|||
19595235|NCT00890097|42043871|FG002|Overall Study|Lost to Follow-up|5|||
19595236|NCT00890097|42043869|FG000|Overall Study|Noncompliance|0|||
19595237|NCT00890097|42043870|FG001|Overall Study|Noncompliance|4|||
19595238|NCT00890097|42043871|FG002|Overall Study|Noncompliance|4|||
19595239|NCT00890097|42043869|FG000|Overall Study|Sponsor Decision|7|||
19595240|NCT00890097|42043870|FG001|Overall Study|Sponsor Decision|11|||
19595241|NCT00890097|42043871|FG002|Overall Study|Sponsor Decision|7|||
19595242|NCT00890097|42043869|FG000|Overall Study|Did not attend final visit|2|||
19595243|NCT00890097|42043870|FG001|Overall Study|Did not attend final visit|3|||
19595244|NCT00890097|42043871|FG002|Overall Study|Did not attend final visit|0|||
19595245|NCT00890097|42043869|FG000|Overall Study|Subject Decision|3|||
19595246|NCT00890097|42043870|FG001|Overall Study|Subject Decision|2|||
19595247|NCT00890097|42043871|FG002|Overall Study|Subject Decision|6|||
19595248|NCT00890097|42043869|FG000|Overall Study|Randomization Error|2|||
19595249|NCT00890097|42043870|FG001|Overall Study|Randomization Error|0|||
19595250|NCT00890097|42043871|FG002|Overall Study|Randomization Error|0|||
19595251|NCT00890097|42043869|FG000|Overall Study|Failed inclusion criteria|3|||
19595252|NCT00890097|42043870|FG001|Overall Study|Failed inclusion criteria|4|||
19595253|NCT00890097|42043871|FG002|Overall Study|Failed inclusion criteria|0|||
19595254|NCT00890097|42043869|FG000|Overall Study|Transportation|0|||
19595255|NCT00890097|42043870|FG001|Overall Study|Transportation|2|||
19595256|NCT00890097|42043871|FG002|Overall Study|Transportation|0|||
19595257|NCT00890097|42043869|FG000|Overall Study|Subject Moved|0|||
19595258|NCT00890097|42043870|FG001|Overall Study|Subject Moved|4|||
19595259|NCT00890097|42043871|FG002|Overall Study|Subject Moved|0|||
19595260|NCT00890097|42043869|FG000|Overall Study|Protocol Deviation|1|||
19595261|NCT00890097|42043870|FG001|Overall Study|Protocol Deviation|1|||
19595262|NCT00890097|42043871|FG002|Overall Study|Protocol Deviation|1|||
19595263|NCT00913458|42043879|FG000|Phase 1|Non-Responder|54|||
19595264|NCT00913458|42043880|FG001|Phase 1|Non-Responder|0|||
19595265|NCT00913458|42043881|FG002|Phase 1|Non-Responder|0|||
19595266|NCT00913458|42043882|FG003|Phase 1|Non-Responder|0|||
19595267|NCT00913458|42043883|FG004|Phase 1|Non-Responder|0|||
19595268|NCT00913458|42043884|FG005|Phase 1|Non-Responder|0|||
19595269|NCT00913458|42043885|FG006|Phase 1|Non-Responder|0|||
19595270|NCT00913458|42043879|FG000|Phase 1|Subject Request|17|||
19595271|NCT00913458|42043880|FG001|Phase 1|Subject Request|0|||
19595272|NCT00913458|42043881|FG002|Phase 1|Subject Request|0|||
19595273|NCT00913458|42043882|FG003|Phase 1|Subject Request|0|||
19595274|NCT00913458|42043883|FG004|Phase 1|Subject Request|0|||
19595275|NCT00913458|42043884|FG005|Phase 1|Subject Request|0|||
19595276|NCT00913458|42043885|FG006|Phase 1|Subject Request|0|||
19595277|NCT00913458|42043879|FG000|Phase 1|Adverse Event|20|||
19595278|NCT00913458|42043880|FG001|Phase 1|Adverse Event|0|||
19595279|NCT00913458|42043881|FG002|Phase 1|Adverse Event|0|||
19595280|NCT00913458|42043882|FG003|Phase 1|Adverse Event|0|||
19595281|NCT00913458|42043883|FG004|Phase 1|Adverse Event|0|||
19595282|NCT00913458|42043884|FG005|Phase 1|Adverse Event|0|||
19595283|NCT00913458|42043885|FG006|Phase 1|Adverse Event|0|||
19595284|NCT00913458|42043879|FG000|Phase 1|Lost to Follow-up|2|||
19595285|NCT00913458|42043880|FG001|Phase 1|Lost to Follow-up|0|||
19595286|NCT00913458|42043881|FG002|Phase 1|Lost to Follow-up|0|||
19595287|NCT00913458|42043882|FG003|Phase 1|Lost to Follow-up|0|||
19595288|NCT00913458|42043883|FG004|Phase 1|Lost to Follow-up|0|||
19595289|NCT00913458|42043884|FG005|Phase 1|Lost to Follow-up|0|||
19595290|NCT00913458|42043885|FG006|Phase 1|Lost to Follow-up|0|||
19595291|NCT00913458|42043879|FG000|Phase 1|Protocol Violation|10|||
19595292|NCT00913458|42043880|FG001|Phase 1|Protocol Violation|0|||
19595293|NCT00913458|42043881|FG002|Phase 1|Protocol Violation|0|||
19595294|NCT00913458|42043882|FG003|Phase 1|Protocol Violation|0|||
19595295|NCT00913458|42043883|FG004|Phase 1|Protocol Violation|0|||
19595296|NCT00913458|42043884|FG005|Phase 1|Protocol Violation|0|||
19595297|NCT00913458|42043885|FG006|Phase 1|Protocol Violation|0|||
19595298|NCT00913458|42043879|FG000|Phase 1|Sponsor|2|||
19595299|NCT00913458|42043880|FG001|Phase 1|Sponsor|0|||
19595300|NCT00913458|42043881|FG002|Phase 1|Sponsor|0|||
19595301|NCT00913458|42043882|FG003|Phase 1|Sponsor|0|||
19595302|NCT00913458|42043883|FG004|Phase 1|Sponsor|0|||
19595303|NCT00913458|42043884|FG005|Phase 1|Sponsor|0|||
19595304|NCT00913458|42043885|FG006|Phase 1|Sponsor|0|||
19595305|NCT00913458|42043879|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
19595306|NCT00913458|42043880|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
19595307|NCT00913458|42043881|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
19595308|NCT00913458|42043882|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
19595309|NCT00913458|42043883|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
19595310|NCT00913458|42043884|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
19595311|NCT00913458|42043885|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
19595312|NCT00913458|42043879|FG000|Phase 2|Non-Responder|0|||
19595313|NCT00913458|42043880|FG001|Phase 2|Non-Responder|5|||
19595314|NCT00913458|42043881|FG002|Phase 2|Non-Responder|7|||
19595315|NCT00913458|42043882|FG003|Phase 2|Non-Responder|12|||
19595316|NCT00913458|42043883|FG004|Phase 2|Non-Responder|0|||
19595317|NCT00913458|42043884|FG005|Phase 2|Non-Responder|0|||
19595318|NCT00913458|42043885|FG006|Phase 2|Non-Responder|0|||
19595319|NCT00913458|42043879|FG000|Phase 2|Subject Request|0|||
19595320|NCT00913458|42043880|FG001|Phase 2|Subject Request|0|||
19595321|NCT00913458|42043881|FG002|Phase 2|Subject Request|1|||
19595322|NCT00913458|42043882|FG003|Phase 2|Subject Request|2|||
19595323|NCT00913458|42043883|FG004|Phase 2|Subject Request|0|||
19595324|NCT00913458|42043884|FG005|Phase 2|Subject Request|0|||
19595325|NCT00913458|42043885|FG006|Phase 2|Subject Request|0|||
19595326|NCT00913458|42043879|FG000|Phase 2|Adverse Event|0|||
19595327|NCT00913458|42043880|FG001|Phase 2|Adverse Event|3|||
19595328|NCT00913458|42043881|FG002|Phase 2|Adverse Event|0|||
19595329|NCT00913458|42043882|FG003|Phase 2|Adverse Event|1|||
19595330|NCT00913458|42043883|FG004|Phase 2|Adverse Event|0|||
19595331|NCT00913458|42043884|FG005|Phase 2|Adverse Event|0|||
19595332|NCT00913458|42043885|FG006|Phase 2|Adverse Event|0|||
19595333|NCT00913458|42043879|FG000|Phase 2|Lost to Follow-up|0|||
19595334|NCT00913458|42043880|FG001|Phase 2|Lost to Follow-up|0|||
19595335|NCT00913458|42043881|FG002|Phase 2|Lost to Follow-up|0|||
19595336|NCT00913458|42043882|FG003|Phase 2|Lost to Follow-up|1|||
19595337|NCT00913458|42043883|FG004|Phase 2|Lost to Follow-up|0|||
19595338|NCT00913458|42043884|FG005|Phase 2|Lost to Follow-up|0|||
19595339|NCT00913458|42043885|FG006|Phase 2|Lost to Follow-up|0|||
19595340|NCT00913458|42043879|FG000|Phase 2|Protocol Violation|0|||
19595341|NCT00913458|42043880|FG001|Phase 2|Protocol Violation|2|||
19595342|NCT00913458|42043881|FG002|Phase 2|Protocol Violation|0|||
19595343|NCT00913458|42043882|FG003|Phase 2|Protocol Violation|0|||
19595344|NCT00913458|42043883|FG004|Phase 2|Protocol Violation|0|||
19595345|NCT00913458|42043884|FG005|Phase 2|Protocol Violation|0|||
19595346|NCT00913458|42043885|FG006|Phase 2|Protocol Violation|0|||
19595347|NCT00913458|42043879|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
19595348|NCT00913458|42043880|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
19595349|NCT00913458|42043881|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
19595350|NCT00913458|42043882|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
19595351|NCT00913458|42043883|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
19595352|NCT00913458|42043884|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
19595353|NCT00913458|42043885|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
19595354|NCT00913458|42043879|FG000|Phase 3|Adverse Event|0|||
19595355|NCT00913458|42043880|FG001|Phase 3|Adverse Event|0|||
19595356|NCT00913458|42043881|FG002|Phase 3|Adverse Event|0|||
19595357|NCT00913458|42043882|FG003|Phase 3|Adverse Event|0|||
19595358|NCT00913458|42043883|FG004|Phase 3|Adverse Event|5|||
19595359|NCT00913458|42043884|FG005|Phase 3|Adverse Event|4|||
19595360|NCT00913458|42043885|FG006|Phase 3|Adverse Event|1|||
19595361|NCT00913458|42043879|FG000|Phase 3|Lost to Follow-up|0|||
19595362|NCT00913458|42043880|FG001|Phase 3|Lost to Follow-up|0|||
19595363|NCT00913458|42043881|FG002|Phase 3|Lost to Follow-up|0|||
19595364|NCT00913458|42043882|FG003|Phase 3|Lost to Follow-up|0|||
19595365|NCT00913458|42043883|FG004|Phase 3|Lost to Follow-up|2|||
19595366|NCT00913458|42043884|FG005|Phase 3|Lost to Follow-up|0|||
19595367|NCT00913458|42043885|FG006|Phase 3|Lost to Follow-up|0|||
19595368|NCT00913458|42043879|FG000|Phase 3|Non-Responder|0|||
19595369|NCT00913458|42043880|FG001|Phase 3|Non-Responder|0|||
19595370|NCT00913458|42043881|FG002|Phase 3|Non-Responder|0|||
19595371|NCT00913458|42043882|FG003|Phase 3|Non-Responder|0|||
19595372|NCT00913458|42043883|FG004|Phase 3|Non-Responder|0|||
19595373|NCT00913458|42043884|FG005|Phase 3|Non-Responder|1|||
19595374|NCT00913458|42043885|FG006|Phase 3|Non-Responder|3|||
19595375|NCT00913458|42043879|FG000|Phase 3|Withdrawal by Subject|0|||
19595376|NCT00913458|42043880|FG001|Phase 3|Withdrawal by Subject|0|||
19595377|NCT00913458|42043881|FG002|Phase 3|Withdrawal by Subject|0|||
19595378|NCT00913458|42043882|FG003|Phase 3|Withdrawal by Subject|0|||
19595379|NCT00913458|42043883|FG004|Phase 3|Withdrawal by Subject|1|||
19595380|NCT00913458|42043884|FG005|Phase 3|Withdrawal by Subject|2|||
19595381|NCT00913458|42043885|FG006|Phase 3|Withdrawal by Subject|0|||
19595382|NCT00913458|42043879|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
19595383|NCT00913458|42043880|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
19595384|NCT00913458|42043881|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
19595385|NCT00913458|42043882|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
19595386|NCT00913458|42043883|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
19746888|NCT02738008|42194271|FG001|Overall Study|Adverse Event|1|||
19746889|NCT02738008|42194272|FG002|Overall Study|Adverse Event|2|||
19595387|NCT00913458|42043884|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
19595388|NCT00913458|42043885|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
19595389|NCT00785707|42043902|FG000|Overall Study|Lost to Follow-up|7|||
19595390|NCT00913380|42043908|FG000|Clinical Outcomes|Lost to Follow-up|6|||
19746890|NCT00002525|42194282|FG000|Overall Study|Adverse Event|36|||
19595391|NCT00913380|42043909|FG001|Clinical Outcomes|Lost to Follow-up|6|||
19595392|NCT00785629|42043919|FG000|Overall Study|Adverse Event|2|||
19595393|NCT00785629|42043920|FG001|Overall Study|Adverse Event|1|||
19595394|NCT00785629|42043921|FG002|Overall Study|Adverse Event|1|||
19595395|NCT00785629|42043922|FG003|Overall Study|Adverse Event|5|||
19595396|NCT00785629|42043919|FG000|Overall Study|Protocol Violation|1|||
19746891|NCT00002525|42194283|FG001|Overall Study|Adverse Event|0|||
19595397|NCT00785629|42043920|FG001|Overall Study|Protocol Violation|2|||
19595398|NCT00785629|42043921|FG002|Overall Study|Protocol Violation|4|||
19595399|NCT00785629|42043922|FG003|Overall Study|Protocol Violation|5|||
19595400|NCT00785629|42043919|FG000|Overall Study|administrative decision|5|||
19595401|NCT00785629|42043920|FG001|Overall Study|administrative decision|1|||
19595402|NCT00785629|42043921|FG002|Overall Study|administrative decision|3|||
19595403|NCT00785629|42043922|FG003|Overall Study|administrative decision|4|||
19595404|NCT00785629|42043919|FG000|Overall Study|Withdrawal by Subject|0|||
19595405|NCT00785629|42043920|FG001|Overall Study|Withdrawal by Subject|1|||
19595406|NCT00785629|42043921|FG002|Overall Study|Withdrawal by Subject|2|||
19595407|NCT00785629|42043922|FG003|Overall Study|Withdrawal by Subject|2|||
19595408|NCT00916344|42043930|FG000|Overall Study|Death|2|||
19595409|NCT00916344|42043930|FG000|Overall Study|ICD upgrade|1|||
19595410|NCT00916344|42043930|FG000|Overall Study|Drop-out|5|||
19595411|NCT00913770|42043937|FG000|Overall Study|Unable to contact|24|||
19595412|NCT00913770|42043938|FG001|Overall Study|Unable to contact|19|||
19595413|NCT00913770|42043939|FG002|Overall Study|Unable to contact|13|||
19595414|NCT00913770|42043937|FG000|Overall Study|Refused|11|||
19595415|NCT00913770|42043938|FG001|Overall Study|Refused|10|||
19595416|NCT00913770|42043939|FG002|Overall Study|Refused|8|||
19595417|NCT00780559|42043949|FG000|Overall Study|Lost to Follow-up|2|||
19595418|NCT00780559|42043950|FG001|Overall Study|Lost to Follow-up|7|||
19595419|NCT00780559|42043949|FG000|Overall Study|Death|1|||
19595420|NCT00780559|42043950|FG001|Overall Study|Death|0|||
19595421|NCT00912912|42043958|FG000|Overall Study|Withdrawal by Subject|1|||
19595422|NCT00912912|42043958|FG000|Overall Study|Disease Progression|3|||
19595423|NCT00889005|42043964|FG000|Overall Study|Lost to Follow-up|4|||
19595424|NCT00889005|42043965|FG001|Overall Study|Lost to Follow-up|2|||
19595425|NCT00889005|42043964|FG000|Overall Study|Withdrawal by Subject|4|||
19595426|NCT00889005|42043965|FG001|Overall Study|Withdrawal by Subject|0|||
19595427|NCT00779857|42043971|FG000|Overall Study|Death|1|||
19595428|NCT00779857|42043971|FG000|Overall Study|Withdrawal by Subject|3|||
19746892|NCT00002525|42194282|FG000|Overall Study|Death|5|||
19746893|NCT00002525|42194283|FG001|Overall Study|Death|0|||
19746894|NCT00002525|42194282|FG000|Overall Study|Withdrawal by Subject|11|||
19746895|NCT00002525|42194283|FG001|Overall Study|Withdrawal by Subject|0|||
19746896|NCT00002525|42194282|FG000|Overall Study|Start non-protocol therapy|1|||
19746897|NCT00002525|42194283|FG001|Overall Study|Start non-protocol therapy|0|||
19746898|NCT00002525|42194282|FG000|Overall Study|Other complicating disease|1|||
19746899|NCT00002525|42194283|FG001|Overall Study|Other complicating disease|0|||
19746900|NCT00002525|42194282|FG000|Overall Study|Duke's A, B1, D disease|92|||
19746901|NCT00002525|42194283|FG001|Overall Study|Duke's A, B1, D disease|0|||
19595429|NCT00779857|42043971|FG000|Overall Study|Missed Visit|2|||
19595430|NCT00913692|42043975|FG000|Screening (4 Months)|Physician Decision|3|||
19595431|NCT00913692|42043975|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
19595432|NCT00913692|42043975|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
19595433|NCT00784927|42043982|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
19595434|NCT00784927|42043982|FG000|Overall Study|Protocol Violation|1|||
19746902|NCT00002525|42194282|FG000|Overall Study|Error|6|||
19746903|NCT00002525|42194283|FG001|Overall Study|Error|0|||
19746904|NCT00002525|42194282|FG000|Overall Study|Other|26|||
19746905|NCT00002525|42194283|FG001|Overall Study|Other|0|||
19746906|NCT00002525|42194282|FG000|Overall Study|Never start protocol therapy|8|||
19746907|NCT00002525|42194283|FG001|Overall Study|Never start protocol therapy|0|||
19746908|NCT03489369|42194295|FG000|Overall Study|Documented Progressive Disease|3|||
19746909|NCT03489369|42194296|FG001|Overall Study|Documented Progressive Disease|2|||
19746910|NCT03489369|42194297|FG002|Overall Study|Documented Progressive Disease|3|||
19746911|NCT03489369|42194298|FG003|Overall Study|Documented Progressive Disease|6|||
19746912|NCT03489369|42194295|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
19746913|NCT03489369|42194296|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
19746914|NCT03489369|42194297|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
19746915|NCT03489369|42194298|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
19746916|NCT03257254|42194308|FG000|Overall Study|Withdrawal by Subject|7|||
19746917|NCT03257254|42194308|FG000|Overall Study|Lost to Follow-up|9|||
19746918|NCT03257254|42194308|FG000|Overall Study|Study discontinued by sponsor|5|||
19746919|NCT03738475|42194314|FG000|Overall Study|Participant Non-Compliance|1|||
19746920|NCT03738475|42194315|FG001|Overall Study|Participant Non-Compliance|0|||
19746921|NCT03084718|42194326|FG000|Overall Study|Withdrawal by Subject|4|||
19746922|NCT03084718|42194327|FG001|Overall Study|Withdrawal by Subject|3|||
19746923|NCT03084718|42194328|FG002|Overall Study|Withdrawal by Subject|4|||
19746924|NCT03084718|42194329|FG003|Overall Study|Withdrawal by Subject|0|||
19746925|NCT03084718|42194330|FG004|Overall Study|Withdrawal by Subject|0|||
19746926|NCT03084718|42194326|FG000|Overall Study|Physician Decision|1|||
19595435|NCT00784927|42043982|FG000|Overall Study|Ineligible|1|||
19746927|NCT03084718|42194327|FG001|Overall Study|Physician Decision|0|||
19746928|NCT03084718|42194328|FG002|Overall Study|Physician Decision|0|||
19746929|NCT03084718|42194329|FG003|Overall Study|Physician Decision|0|||
19746930|NCT03084718|42194330|FG004|Overall Study|Physician Decision|0|||
19746931|NCT03084718|42194326|FG000|Overall Study|Adverse Event|3|||
19746932|NCT03084718|42194327|FG001|Overall Study|Adverse Event|5|||
19746933|NCT03084718|42194328|FG002|Overall Study|Adverse Event|5|||
19746934|NCT03084718|42194329|FG003|Overall Study|Adverse Event|8|||
19746935|NCT03084718|42194330|FG004|Overall Study|Adverse Event|2|||
19746936|NCT03084718|42194326|FG000|Overall Study|Lack of Efficacy|2|||
19746937|NCT03084718|42194327|FG001|Overall Study|Lack of Efficacy|0|||
19595436|NCT00779779|42043987|FG000|Overall Study|Adverse Event|1|||
19595437|NCT00779779|42043987|FG000|Overall Study|Protocol Violation|14|||
19595438|NCT00779779|42043987|FG000|Overall Study|Withdrawal by Subject|4|||
19595439|NCT00779779|42043987|FG000|Overall Study|Lost to Follow-up|5|||
19595440|NCT00845728|42043993|FG000|Overall Study|Abnormal laboratory value (s)|2|||
19595441|NCT00845728|42043994|FG001|Overall Study|Abnormal laboratory value (s)|2|||
19595442|NCT00845728|42043993|FG000|Overall Study|Patient's inability to use the device|4|||
19476985|NCT01516879|41755582|FG000|Overall Study|Lost to Follow-up|2|||
19595443|NCT00845728|42043994|FG001|Overall Study|Patient's inability to use the device|6|||
19595444|NCT00845728|42043993|FG000|Overall Study|Abnormal test procedure result (s)|7|||
19595445|NCT00845728|42043994|FG001|Overall Study|Abnormal test procedure result (s)|2|||
19595446|NCT00845728|42043993|FG000|Overall Study|Lost to Follow-up|22|||
19595447|NCT00845728|42043994|FG001|Overall Study|Lost to Follow-up|13|||
19595448|NCT00845728|42043993|FG000|Overall Study|Death|24|||
19595449|NCT00845728|42043994|FG001|Overall Study|Death|26|||
19595450|NCT00845728|42043993|FG000|Overall Study|Administrative Problems|34|||
19595451|NCT00845728|42043994|FG001|Overall Study|Administrative Problems|26|||
19595452|NCT00845728|42043993|FG000|Overall Study|Protocol Violation|36|||
19595453|NCT00845728|42043994|FG001|Overall Study|Protocol Violation|24|||
19595454|NCT00845728|42043993|FG000|Overall Study|Lack of Efficacy|51|||
19595455|NCT00845728|42043994|FG001|Overall Study|Lack of Efficacy|39|||
19595456|NCT00845728|42043993|FG000|Overall Study|Adverse Event|101|||
19595457|NCT00845728|42043994|FG001|Overall Study|Adverse Event|96|||
19595458|NCT00845728|42043993|FG000|Overall Study|Withdrawal by Subject|105|||
19595459|NCT00845728|42043994|FG001|Overall Study|Withdrawal by Subject|108|||
19595460|NCT00779467|42044004|FG000|Overall Study|Lack of Efficacy|11|||
19595461|NCT00779467|42044005|FG001|Overall Study|Lack of Efficacy|2|||
19595462|NCT00779467|42044006|FG002|Overall Study|Lack of Efficacy|6|||
19595463|NCT00779467|42044007|FG003|Overall Study|Lack of Efficacy|11|||
19595464|NCT00779467|42044004|FG000|Overall Study|failed inclusion criteria|3|||
19595465|NCT00779467|42044005|FG001|Overall Study|failed inclusion criteria|3|||
19595466|NCT00779467|42044006|FG002|Overall Study|failed inclusion criteria|1|||
19595467|NCT00779467|42044007|FG003|Overall Study|failed inclusion criteria|2|||
19595468|NCT00779467|42044004|FG000|Overall Study|missing data|1|||
19595469|NCT00779467|42044005|FG001|Overall Study|missing data|0|||
19595470|NCT00779467|42044006|FG002|Overall Study|missing data|1|||
19595471|NCT00779467|42044007|FG003|Overall Study|missing data|4|||
19595472|NCT00779467|42044004|FG000|Overall Study|technical issue|0|||
19595473|NCT00779467|42044005|FG001|Overall Study|technical issue|0|||
19595474|NCT00779467|42044006|FG002|Overall Study|technical issue|2|||
19595475|NCT00779467|42044007|FG003|Overall Study|technical issue|1|||
19595476|NCT00779467|42044004|FG000|Overall Study|unavailable research staff|0|||
19595477|NCT00779467|42044005|FG001|Overall Study|unavailable research staff|0|||
19595478|NCT00779467|42044006|FG002|Overall Study|unavailable research staff|0|||
19595479|NCT00779467|42044007|FG003|Overall Study|unavailable research staff|1|||
19595480|NCT00778921|42044020|FG000|Overall Study|Adverse Event|9|||
19595481|NCT00778921|42044021|FG001|Overall Study|Adverse Event|10|||
19595482|NCT00778921|42044022|FG002|Overall Study|Adverse Event|14|||
19746938|NCT03084718|42194328|FG002|Overall Study|Lack of Efficacy|1|||
19595483|NCT00778921|42044020|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
19595484|NCT00778921|42044021|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
19595485|NCT00778921|42044022|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
19595486|NCT00778921|42044020|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
19595487|NCT00778921|42044021|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
19595488|NCT00778921|42044022|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
19595489|NCT00778921|42044020|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
19595490|NCT00778921|42044021|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
19595491|NCT00778921|42044022|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
19595492|NCT00778921|42044020|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
19595493|NCT00778921|42044021|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
19595494|NCT00778921|42044022|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
19595495|NCT00778921|42044020|FG000|Overall Study|Patient withdrew request|3|||
19595496|NCT00778921|42044021|FG001|Overall Study|Patient withdrew request|1|||
19595497|NCT00778921|42044022|FG002|Overall Study|Patient withdrew request|6|||
19595498|NCT00778921|42044020|FG000|Overall Study|Lost to Follow-up|0|||
19595499|NCT00778921|42044021|FG001|Overall Study|Lost to Follow-up|2|||
19595500|NCT00778921|42044022|FG002|Overall Study|Lost to Follow-up|1|||
19595501|NCT00778921|42044020|FG000|Overall Study|Administrative Problems|1|||
19595502|NCT00778921|42044021|FG001|Overall Study|Administrative Problems|2|||
19746939|NCT03084718|42194329|FG003|Overall Study|Lack of Efficacy|4|||
19595503|NCT00778921|42044022|FG002|Overall Study|Administrative Problems|0|||
19595504|NCT00778921|42044020|FG000|Overall Study|Protocol Violation|3|||
19595505|NCT00778921|42044021|FG001|Overall Study|Protocol Violation|0|||
19595506|NCT00778921|42044022|FG002|Overall Study|Protocol Violation|2|||
19595507|NCT00778921|42044020|FG000|Overall Study|Not treated|0|||
19595508|NCT00778921|42044021|FG001|Overall Study|Not treated|2|||
19595509|NCT00778921|42044022|FG002|Overall Study|Not treated|2|||
19595510|NCT00915876|42044032|FG000|Overall Study|Adverse Event|0|||
19595511|NCT00915876|42044033|FG001|Overall Study|Adverse Event|1|||
19595512|NCT00587431|42044041|FG000|Overall Study|Adverse Event|1|||
19595513|NCT00587431|42044042|FG001|Overall Study|Adverse Event|0|||
19595514|NCT00587431|42044041|FG000|Overall Study|Withdrawal by Subject|0|||
19595515|NCT00587431|42044042|FG001|Overall Study|Withdrawal by Subject|1|||
19595516|NCT00776659|42044051|FG000|Overall Study|Lost to Follow-up|15|||
19595517|NCT00776659|42044051|FG000|Overall Study|Withdrawal by Subject|10|||
19595518|NCT00776659|42044051|FG000|Overall Study|Study Terminated by Sponsor|1|||
19595519|NCT00825682|42044057|FG000|Overall Study|personal reasons/ inconvenience|13|||
19595520|NCT00825682|42044058|FG001|Overall Study|personal reasons/ inconvenience|5|||
19595521|NCT00833794|42044067|FG000|Open-label Phase|Adverse Event|225|||
19595522|NCT00833794|42044068|FG001|Open-label Phase|Adverse Event|0|||
19595523|NCT00833794|42044067|FG000|Open-label Phase|Lack of Efficacy|28|||
19595524|NCT00833794|42044068|FG001|Open-label Phase|Lack of Efficacy|0|||
19595525|NCT00833794|42044067|FG000|Open-label Phase|Withdrawal by Subject|48|||
19595526|NCT00833794|42044068|FG001|Open-label Phase|Withdrawal by Subject|0|||
19595527|NCT00833794|42044067|FG000|Open-label Phase|Physician Decision|20|||
19595528|NCT00833794|42044068|FG001|Open-label Phase|Physician Decision|0|||
19595529|NCT00833794|42044067|FG000|Open-label Phase|Administrative reason|1|||
19595530|NCT00833794|42044068|FG001|Open-label Phase|Administrative reason|0|||
19595531|NCT00833794|42044067|FG000|Open-label Phase|Protocol Violation|47|||
19595532|NCT00833794|42044068|FG001|Open-label Phase|Protocol Violation|0|||
19595533|NCT00833794|42044067|FG000|Open-label Phase|Did not complete wash-out period|12|||
19595534|NCT00833794|42044068|FG001|Open-label Phase|Did not complete wash-out period|0|||
19595535|NCT00833794|42044067|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
19595536|NCT00833794|42044068|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
19595537|NCT00833794|42044067|FG000|Double-blind Phase|Adverse Event|44|||
19595538|NCT00833794|42044068|FG001|Double-blind Phase|Adverse Event|11|||
19595539|NCT00833794|42044067|FG000|Double-blind Phase|Lack of Efficacy|34|||
19595540|NCT00833794|42044068|FG001|Double-blind Phase|Lack of Efficacy|22|||
19595541|NCT00833794|42044067|FG000|Double-blind Phase|Withdrawal by Subject|23|||
19595542|NCT00833794|42044068|FG001|Double-blind Phase|Withdrawal by Subject|6|||
19595543|NCT00833794|42044067|FG000|Double-blind Phase|Physician Decision|4|||
19595544|NCT00833794|42044068|FG001|Double-blind Phase|Physician Decision|7|||
19746940|NCT03084718|42194330|FG004|Overall Study|Lack of Efficacy|0|||
19595545|NCT00833794|42044067|FG000|Double-blind Phase|Administrative reason|1|||
19595546|NCT00833794|42044068|FG001|Double-blind Phase|Administrative reason|3|||
19595547|NCT00912288|42044078|FG000|Overall Study|Death|0|||
19595548|NCT00912288|42044079|FG001|Overall Study|Death|1|||
19595549|NCT00912288|42044078|FG000|Overall Study|Adverse Event|1|||
19595550|NCT00912288|42044079|FG001|Overall Study|Adverse Event|1|||
19595551|NCT00912288|42044078|FG000|Overall Study|Lost to Follow-up|1|||
19595552|NCT00912288|42044079|FG001|Overall Study|Lost to Follow-up|0|||
19595553|NCT00912288|42044078|FG000|Overall Study|Protocol Violation|1|||
19595554|NCT00912288|42044079|FG001|Overall Study|Protocol Violation|0|||
19595555|NCT00912288|42044078|FG000|Overall Study|Withdrawal by Subject|3|||
19595556|NCT00912288|42044079|FG001|Overall Study|Withdrawal by Subject|3|||
19595557|NCT00912288|42044078|FG000|Overall Study|Study terminated by sponsor|34|||
19595558|NCT00912288|42044079|FG001|Overall Study|Study terminated by sponsor|35|||
19595559|NCT00912288|42044078|FG000|Overall Study|Other|1|||
19595560|NCT00912288|42044079|FG001|Overall Study|Other|0|||
19595561|NCT00778375|42044085|FG000|Overall Study|Ineligible|3|||
19595562|NCT00777829|42044091|FG000|Overall Study|Withdrawal by Subject|0|||
19595563|NCT00777829|42044092|FG001|Overall Study|Withdrawal by Subject|2|||
19595564|NCT00775021|42044100|FG000|First Intervention|Lost to Follow-up|1|||
19595565|NCT00775021|42044101|FG001|First Intervention|Lost to Follow-up|0|||
19595566|NCT00775021|42044100|FG000|Second Intervention|Adverse Event|0|||
19595567|NCT00775021|42044101|FG001|Second Intervention|Adverse Event|1|||
19595568|NCT00777205|42044109|FG000|Overall Study|Lost to Follow-up|25|||
19595569|NCT00777205|42044110|FG001|Overall Study|Lost to Follow-up|9|||
19595570|NCT00777205|42044109|FG000|Overall Study|Withdrawal by Subject|6|||
19595571|NCT00777205|42044110|FG001|Overall Study|Withdrawal by Subject|4|||
19595572|NCT00777205|42044109|FG000|Overall Study|Death|0|||
19595573|NCT00777205|42044110|FG001|Overall Study|Death|2|||
19595574|NCT00777205|42044109|FG000|Overall Study|Protocol Violation|0|||
19595575|NCT00777205|42044110|FG001|Overall Study|Protocol Violation|56|||
19595576|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
19595577|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
19595578|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
19595579|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
19595580|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
19595581|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
19595582|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
19595583|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
19595584|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
19595585|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
19595586|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
19595587|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
19595588|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
19595589|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
19595590|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
19595591|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
19595592|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
19595593|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
19595594|NCT00833638|42044121|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
19595595|NCT00833638|42044122|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
19595596|NCT00833638|42044123|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
19595597|NCT00833638|42044121|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
19595598|NCT00833638|42044122|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
19595599|NCT00833638|42044123|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
19595600|NCT00833638|42044121|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
19595601|NCT00833638|42044122|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
19595602|NCT00833638|42044123|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
19595603|NCT01041404|42044141|FG000|Overall Study|Adverse Event|45|||
19595604|NCT01041404|42044142|FG001|Overall Study|Adverse Event|35|||
19595605|NCT01041404|42044141|FG000|Overall Study|Lack of Efficacy|200|||
19595606|NCT01041404|42044142|FG001|Overall Study|Lack of Efficacy|210|||
19595607|NCT01041404|42044141|FG000|Overall Study|Violation of Selection Criteria|0|||
19595608|NCT01041404|42044142|FG001|Overall Study|Violation of Selection Criteria|1|||
19595609|NCT01041404|42044141|FG000|Overall Study|Protocol Violation|4|||
19595610|NCT01041404|42044142|FG001|Overall Study|Protocol Violation|0|||
19595611|NCT01041404|42044141|FG000|Overall Study|Withdrawal by Subject|29|||
19595612|NCT01041404|42044142|FG001|Overall Study|Withdrawal by Subject|23|||
19595613|NCT01041404|42044141|FG000|Overall Study|Failure to Return|1|||
19595614|NCT01041404|42044142|FG001|Overall Study|Failure to Return|2|||
19595615|NCT01041404|42044141|FG000|Overall Study|Other|11|||
19595616|NCT01041404|42044142|FG001|Overall Study|Other|23|||
19595617|NCT00777049|42044153|FG000|Overall Study|Withdrawal by Subject|1|||
19595618|NCT00777049|42044154|FG001|Overall Study|Withdrawal by Subject|0|||
19595619|NCT00777049|42044153|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
19595620|NCT00777049|42044154|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
19595621|NCT00774787|42044160|FG000|Overall Study|Lost to Follow-up|1|||
19595622|NCT00888927|42044168|FG000|Overall Study|Adverse Event|0|||
19595623|NCT00888927|42044169|FG001|Overall Study|Adverse Event|0|||
19595624|NCT00888927|42044170|FG002|Overall Study|Adverse Event|0|||
19595625|NCT00888927|42044171|FG003|Overall Study|Adverse Event|1|||
19595626|NCT00888927|42044168|FG000|Overall Study|Withdrawal of consent|0|||
19595627|NCT00888927|42044169|FG001|Overall Study|Withdrawal of consent|0|||
19595628|NCT00888927|42044170|FG002|Overall Study|Withdrawal of consent|0|||
19595629|NCT00888927|42044171|FG003|Overall Study|Withdrawal of consent|1|||
19595630|NCT01040780|42044183|FG000|Overall Study|Protocol Violation|1|||
19595631|NCT01040780|42044184|FG001|Overall Study|Protocol Violation|3|||
19595632|NCT00888849|42044195|FG000|Overall Study|Death|4|||
19595633|NCT00888849|42044196|FG001|Overall Study|Death|7|||
19595634|NCT00888849|42044195|FG000|Overall Study|Lost to Follow-up|1|||
19595635|NCT00888849|42044196|FG001|Overall Study|Lost to Follow-up|2|||
19595636|NCT01059812|42044204|FG000|Overall Study|Adverse Event|9|||
19595637|NCT01059812|42044205|FG001|Overall Study|Adverse Event|5|||
19595638|NCT01059812|42044204|FG000|Overall Study|Lack of Efficacy|2|||
19595639|NCT01059812|42044205|FG001|Overall Study|Lack of Efficacy|2|||
19595640|NCT01059812|42044204|FG000|Overall Study|Protocol Violation|3|||
19595641|NCT01059812|42044205|FG001|Overall Study|Protocol Violation|1|||
19595642|NCT01059812|42044204|FG000|Overall Study|Withdrawal Criteria|9|||
19595643|NCT01059812|42044205|FG001|Overall Study|Withdrawal Criteria|4|||
19595644|NCT01059812|42044204|FG000|Overall Study|Unclassified|14|||
19595645|NCT01059812|42044205|FG001|Overall Study|Unclassified|4|||
19595646|NCT00888615|42044211|FG000|Overall Study|No treatment|2|||
19595647|NCT00845650|42044221|FG000|Overall Study|Withdrawal by Subject|0|||
19595648|NCT00845650|42044222|FG001|Overall Study|Withdrawal by Subject|0|||
19595649|NCT00845650|42044223|FG002|Overall Study|Withdrawal by Subject|0|||
19595650|NCT00845650|42044224|FG003|Overall Study|Withdrawal by Subject|0|||
19595651|NCT00845650|42044225|FG004|Overall Study|Withdrawal by Subject|2|||
19595652|NCT00845650|42044226|FG005|Overall Study|Withdrawal by Subject|0|||
19595653|NCT00845650|42044221|FG000|Overall Study|Lost to Follow-up|0|||
19595654|NCT00845650|42044222|FG001|Overall Study|Lost to Follow-up|0|||
19595655|NCT00845650|42044223|FG002|Overall Study|Lost to Follow-up|3|||
19595656|NCT00845650|42044224|FG003|Overall Study|Lost to Follow-up|1|||
19595657|NCT00845650|42044225|FG004|Overall Study|Lost to Follow-up|0|||
19595658|NCT00845650|42044226|FG005|Overall Study|Lost to Follow-up|1|||
19595659|NCT00845650|42044221|FG000|Overall Study|Sponsor hold on dosing|0|||
19595660|NCT00845650|42044222|FG001|Overall Study|Sponsor hold on dosing|0|||
19595661|NCT00845650|42044223|FG002|Overall Study|Sponsor hold on dosing|0|||
19595662|NCT00845650|42044224|FG003|Overall Study|Sponsor hold on dosing|0|||
19595663|NCT00845650|42044225|FG004|Overall Study|Sponsor hold on dosing|1|||
19595664|NCT00845650|42044226|FG005|Overall Study|Sponsor hold on dosing|1|||
19595665|NCT00845650|42044221|FG000|Overall Study|Unable to access IV line|1|||
19595666|NCT00845650|42044222|FG001|Overall Study|Unable to access IV line|0|||
19595667|NCT00845650|42044223|FG002|Overall Study|Unable to access IV line|0|||
19595668|NCT00845650|42044224|FG003|Overall Study|Unable to access IV line|0|||
19595669|NCT00845650|42044225|FG004|Overall Study|Unable to access IV line|0|||
19595670|NCT00845650|42044226|FG005|Overall Study|Unable to access IV line|0|||
19595671|NCT00888381|42044244|FG000|Overall Study|Lost to Follow-up|0|||
19595672|NCT00888381|42044245|FG001|Overall Study|Lost to Follow-up|1|||
19746941|NCT03084718|42194326|FG000|Overall Study|Lost to Follow-up|0|||
19595673|NCT00887913|42044251|FG000|Overall Study|Withdrawal by Subject|6|||
19595674|NCT00833560|42044255|FG000|Overall Study|Toxicity|13|||
19595675|NCT00833560|42044255|FG000|Overall Study|Adverse Event|11|||
19595676|NCT00833560|42044255|FG000|Overall Study|Protocol Violation|6|||
19595677|NCT00833560|42044255|FG000|Overall Study|Lack of Efficacy|4|||
19595678|NCT00833560|42044255|FG000|Overall Study|Death|2|||
19595679|NCT00833560|42044255|FG000|Overall Study|Pregression of other disease|1|||
19595680|NCT00833560|42044255|FG000|Overall Study|Other|5|||
19595681|NCT00887679|42044259|FG000|Overall Study|Withdrawal by Subject|1|||
19746942|NCT03084718|42194327|FG001|Overall Study|Lost to Follow-up|1|||
19746943|NCT03084718|42194328|FG002|Overall Study|Lost to Follow-up|0|||
19746944|NCT03084718|42194329|FG003|Overall Study|Lost to Follow-up|0|||
19746945|NCT03084718|42194330|FG004|Overall Study|Lost to Follow-up|2|||
19746946|NCT03084718|42194326|FG000|Overall Study|Protocol Violation|0|||
19746947|NCT03084718|42194327|FG001|Overall Study|Protocol Violation|0|||
19595682|NCT00887679|42044259|FG000|Overall Study|Lost to Follow-up|4|||
19595683|NCT00887679|42044259|FG000|Overall Study|Physician Decision|5|||
19595684|NCT00833482|42044266|FG000|Days 11-20|Adverse Event|0|||
19595685|NCT00833482|42044267|FG001|Days 11-20|Adverse Event|2|||
19595686|NCT00833482|42044268|FG002|Days 11-20|Adverse Event|0|||
19595687|NCT00833482|42044269|FG003|Days 11-20|Adverse Event|0|||
19595688|NCT00833482|42044270|FG004|Days 11-20|Adverse Event|0|||
19595689|NCT00833482|42044271|FG005|Days 11-20|Adverse Event|0|||
19595690|NCT00833482|42044266|FG000|Days 11-20|Withdrawal by Subject|0|||
19595691|NCT00833482|42044267|FG001|Days 11-20|Withdrawal by Subject|1|||
19595692|NCT00833482|42044268|FG002|Days 11-20|Withdrawal by Subject|0|||
19595693|NCT00833482|42044269|FG003|Days 11-20|Withdrawal by Subject|0|||
19595694|NCT00833482|42044270|FG004|Days 11-20|Withdrawal by Subject|0|||
19595695|NCT00833482|42044271|FG005|Days 11-20|Withdrawal by Subject|0|||
19746948|NCT03084718|42194328|FG002|Overall Study|Protocol Violation|1|||
19746949|NCT03084718|42194329|FG003|Overall Study|Protocol Violation|0|||
19595696|NCT00833482|42044266|FG000|Days 21-30|Adverse Event|0|||
19595697|NCT00833482|42044267|FG001|Days 21-30|Adverse Event|0|||
19595698|NCT00833482|42044268|FG002|Days 21-30|Adverse Event|1|||
19595699|NCT00833482|42044269|FG003|Days 21-30|Adverse Event|0|||
19595700|NCT00833482|42044270|FG004|Days 21-30|Adverse Event|0|||
19595701|NCT00833482|42044271|FG005|Days 21-30|Adverse Event|0|||
19746950|NCT03084718|42194330|FG004|Overall Study|Protocol Violation|0|||
19746951|NCT03084718|42194326|FG000|Overall Study|Death|0|||
19746952|NCT03084718|42194327|FG001|Overall Study|Death|1|||
19746953|NCT03084718|42194328|FG002|Overall Study|Death|0|||
19746954|NCT03084718|42194329|FG003|Overall Study|Death|0|||
19746955|NCT03084718|42194330|FG004|Overall Study|Death|0|||
19595702|NCT00833482|42044266|FG000|Days 21-30|Withdrawal by Subject|0|||
19595703|NCT00833482|42044267|FG001|Days 21-30|Withdrawal by Subject|0|||
19746956|NCT03084718|42194326|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
19746957|NCT03084718|42194327|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
19746958|NCT03084718|42194328|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
19746959|NCT03084718|42194329|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
19746960|NCT03084718|42194330|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
19746961|NCT04321252|42194354|FG000|Overall Study|Withdrawal by Subject|0|||
19746962|NCT04321252|42194355|FG001|Overall Study|Withdrawal by Subject|0|||
19746963|NCT04321252|42194356|FG002|Overall Study|Withdrawal by Subject|0|||
19746964|NCT04321252|42194357|FG003|Overall Study|Withdrawal by Subject|0|||
19746965|NCT04321252|42194358|FG004|Overall Study|Withdrawal by Subject|0|||
19746966|NCT04321252|42194359|FG005|Overall Study|Withdrawal by Subject|1|||
19595704|NCT00833482|42044268|FG002|Days 21-30|Withdrawal by Subject|0|||
19595705|NCT00833482|42044269|FG003|Days 21-30|Withdrawal by Subject|0|||
19595706|NCT00833482|42044270|FG004|Days 21-30|Withdrawal by Subject|1|||
19595707|NCT00833482|42044271|FG005|Days 21-30|Withdrawal by Subject|0|||
19595708|NCT00845182|42044296|FG000|Overall Study|Lost to Follow-up|3|||
19595709|NCT00845182|42044297|FG001|Overall Study|Lost to Follow-up|3|||
19595710|NCT00845182|42044298|FG002|Overall Study|Lost to Follow-up|4|||
19595711|NCT00845182|42044296|FG000|Overall Study|Adverse Event|0|||
19595712|NCT00845182|42044297|FG001|Overall Study|Adverse Event|1|||
19595713|NCT00845182|42044298|FG002|Overall Study|Adverse Event|1|||
19595714|NCT00845182|42044296|FG000|Overall Study|Physician Decision|0|||
19595715|NCT00845182|42044297|FG001|Overall Study|Physician Decision|0|||
19595716|NCT00845182|42044298|FG002|Overall Study|Physician Decision|1|||
19595717|NCT00833248|42044312|FG000|Overall Study|Adverse Event|3|||
19595718|NCT00833248|42044313|FG001|Overall Study|Adverse Event|0|||
19595719|NCT00833248|42044312|FG000|Overall Study|Protocol Violation|1|||
19476986|NCT01516879|41755583|FG001|Overall Study|Lost to Follow-up|11|||
19595720|NCT00833248|42044313|FG001|Overall Study|Protocol Violation|2|||
19595721|NCT00833248|42044312|FG000|Overall Study|Withdrawal by Subject|0|||
19476987|NCT01516879|41755582|FG000|Overall Study|Other|5|||
19476988|NCT01516879|41755583|FG001|Overall Study|Other|10|||
19476989|NCT01515865|41755589|FG000|Part A (Open-label)|Other|3|||
19476990|NCT01515865|41755590|FG001|Part A (Open-label)|Other|0|||
19476991|NCT01515865|41755591|FG002|Part A (Open-label)|Other|0|||
19476992|NCT01515865|41755589|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
19476993|NCT01515865|41755590|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
19476994|NCT01515865|41755591|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
19476995|NCT01515865|41755589|FG000|Part B (Open-label)|Other|1|||
19476996|NCT01515865|41755590|FG001|Part B (Open-label)|Other|0|||
19476997|NCT01515865|41755591|FG002|Part B (Open-label)|Other|0|||
19476998|NCT01547299|41755601|FG000|Overall Study|Withdrawal by Subject|2|||
19476999|NCT01547299|41755602|FG001|Overall Study|Withdrawal by Subject|2|||
19477000|NCT01515475|41755612|FG000|Overall Study|Lost to Follow-up|20|||
19477001|NCT01515475|41755613|FG001|Overall Study|Lost to Follow-up|15|||
19477002|NCT01515475|41755614|FG002|Overall Study|Lost to Follow-up|12|||
19477003|NCT01515475|41755615|FG003|Overall Study|Lost to Follow-up|12|||
19477004|NCT01515319|41755701|FG000|Overall Study|Withdrawal by Subject|0|||
19477005|NCT01515319|41755702|FG001|Overall Study|Withdrawal by Subject|0|||
19477006|NCT01515319|41755703|FG002|Overall Study|Withdrawal by Subject|0|||
19477007|NCT01515319|41755704|FG003|Overall Study|Withdrawal by Subject|0|||
19477008|NCT01515319|41755705|FG004|Overall Study|Withdrawal by Subject|0|||
19477009|NCT01515319|41755706|FG005|Overall Study|Withdrawal by Subject|0|||
19477010|NCT01515319|41755707|FG006|Overall Study|Withdrawal by Subject|1|||
19477011|NCT01515319|41755708|FG007|Overall Study|Withdrawal by Subject|0|||
19477012|NCT01515319|41755709|FG008|Overall Study|Withdrawal by Subject|0|||
19477013|NCT01515319|41755710|FG009|Overall Study|Withdrawal by Subject|0|||
19477014|NCT01515319|41755701|FG000|Overall Study|Adverse Event|0|||
19477015|NCT01515319|41755702|FG001|Overall Study|Adverse Event|0|||
19477016|NCT01515319|41755703|FG002|Overall Study|Adverse Event|0|||
19477017|NCT01515319|41755704|FG003|Overall Study|Adverse Event|0|||
19477018|NCT01515319|41755705|FG004|Overall Study|Adverse Event|0|||
19477019|NCT01515319|41755706|FG005|Overall Study|Adverse Event|0|||
19595722|NCT00833248|42044313|FG001|Overall Study|Withdrawal by Subject|1|||
19595723|NCT00887289|42044319|FG000|Overall Study|Lack of Efficacy|14|||
19595724|NCT00887289|42044319|FG000|Overall Study|Adverse Event|27|||
19595725|NCT00887289|42044319|FG000|Overall Study|Withdrawal by Subject|26|||
19595726|NCT00887289|42044319|FG000|Overall Study|Lost to Follow-up|8|||
19595727|NCT00887289|42044319|FG000|Overall Study|Other|20|||
19595728|NCT00833092|42044325|FG000|Overall Study|Withdrawal by Subject|2|||
19595729|NCT00833092|42044326|FG001|Overall Study|Withdrawal by Subject|3|||
19595730|NCT00833092|42044325|FG000|Overall Study|Protocol Violation|2|||
19595731|NCT00833092|42044326|FG001|Overall Study|Protocol Violation|1|||
19595732|NCT00833092|42044325|FG000|Overall Study|Diarrhea|0|||
19595733|NCT00833092|42044326|FG001|Overall Study|Diarrhea|2|||
19595734|NCT00833092|42044325|FG000|Overall Study|constipation|0|||
19595735|NCT00833092|42044326|FG001|Overall Study|constipation|1|||
19595736|NCT00823264|42044334|FG000|Overall Study|Protocol Violation|2|||
19595737|NCT00823264|42044335|FG001|Overall Study|Protocol Violation|0|||
19595738|NCT00832780|42044341|FG000|Overall Study|Death|16|||
19477020|NCT01515319|41755707|FG006|Overall Study|Adverse Event|0|||
19595739|NCT00832780|42044341|FG000|Overall Study|Lost to Follow-up|4|||
19595740|NCT00832780|42044341|FG000|Overall Study|no reason given|2|||
19595741|NCT00832780|42044341|FG000|Overall Study|other complicating condition|2|||
19595742|NCT00832780|42044341|FG000|Overall Study|Physician Decision|1|||
19595743|NCT00591838|42044350|FG000|Overall Study|Withdrawal by Subject|0|||
19595744|NCT00591838|42044351|FG001|Overall Study|Withdrawal by Subject|0|||
19595745|NCT00591838|42044352|FG002|Overall Study|Withdrawal by Subject|0|||
19595746|NCT00591838|42044353|FG003|Overall Study|Withdrawal by Subject|1|||
19595747|NCT00591838|42044354|FG004|Overall Study|Withdrawal by Subject|0|||
19595748|NCT00832624|42044367|FG000|Overall Study|Study Terminated|10|||
19595749|NCT00832078|42044371|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
19595750|NCT00832078|42044372|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
19595751|NCT00832078|42044371|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
19595752|NCT00832078|42044372|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
19595753|NCT00822172|42044380|FG000|Overall Study|Adverse Event|10|||
19595754|NCT00822172|42044381|FG001|Overall Study|Adverse Event|12|||
19595755|NCT00822172|42044380|FG000|Overall Study|Death|1|||
19595756|NCT00822172|42044381|FG001|Overall Study|Death|0|||
19595757|NCT00822172|42044380|FG000|Overall Study|Lost to Follow-up|3|||
19595758|NCT00822172|42044381|FG001|Overall Study|Lost to Follow-up|1|||
19595759|NCT00822172|42044380|FG000|Overall Study|Withdrawal by Subject|1|||
19595760|NCT00822172|42044381|FG001|Overall Study|Withdrawal by Subject|4|||
19595761|NCT00822172|42044380|FG000|Overall Study|site closed|0|||
19595762|NCT00822172|42044381|FG001|Overall Study|site closed|1|||
19595763|NCT00822172|42044380|FG000|Overall Study|Other|0|||
19595764|NCT00822172|42044381|FG001|Overall Study|Other|1|||
19595765|NCT00832000|42044387|FG000|Overall Study|Adverse Event|2|||
19595766|NCT00832000|42044388|FG001|Overall Study|Adverse Event|0|||
19595767|NCT00832000|42044387|FG000|Overall Study|Withdrawal by Subject|1|||
19595768|NCT00832000|42044388|FG001|Overall Study|Withdrawal by Subject|0|||
19595769|NCT00832000|42044387|FG000|Overall Study|No calls to IVR in either period|1|||
19595770|NCT00832000|42044388|FG001|Overall Study|No calls to IVR in either period|1|||
19595771|NCT00832000|42044387|FG000|Overall Study|No calls to IVR in period 2|2|||
19595772|NCT00832000|42044388|FG001|Overall Study|No calls to IVR in period 2|0|||
19595773|NCT00911508|42044425|FG000|Overall Study|Lost to Follow-up|27|||
19595774|NCT00911508|42044426|FG001|Overall Study|Lost to Follow-up|18|||
19595775|NCT00911508|42044425|FG000|Overall Study|Withdrawal by Subject|79|||
19595776|NCT00911508|42044426|FG001|Overall Study|Withdrawal by Subject|112|||
19595777|NCT00774397|42044452|FG000|Overall Study|Adverse Event|1|||
19595778|NCT00774397|42044453|FG001|Overall Study|Adverse Event|3|||
19595779|NCT00774397|42044454|FG002|Overall Study|Adverse Event|16|||
19595780|NCT00774397|42044455|FG003|Overall Study|Adverse Event|8|||
19595781|NCT00774397|42044456|FG004|Overall Study|Adverse Event|8|||
19595782|NCT00774397|42044457|FG005|Overall Study|Adverse Event|3|||
19595783|NCT00774397|42044458|FG006|Overall Study|Adverse Event|16|||
19595784|NCT00774397|42044452|FG000|Overall Study|Lack of Efficacy|11|||
19595785|NCT00774397|42044453|FG001|Overall Study|Lack of Efficacy|4|||
19595786|NCT00774397|42044454|FG002|Overall Study|Lack of Efficacy|5|||
19595787|NCT00774397|42044455|FG003|Overall Study|Lack of Efficacy|3|||
19595788|NCT00774397|42044456|FG004|Overall Study|Lack of Efficacy|27|||
19746967|NCT04321252|42194360|FG006|Overall Study|Withdrawal by Subject|0|||
19746968|NCT04321252|42194361|FG007|Overall Study|Withdrawal by Subject|0|||
19746969|NCT04321252|42194362|FG008|Overall Study|Withdrawal by Subject|0|||
19746970|NCT03433677|42194394|FG000|Period 1|Protocol Violation|1|||
19746971|NCT03433677|42194395|FG001|Period 1|Protocol Violation|0|||
19746972|NCT03433677|42194394|FG000|Period 2|Withdrawal by Subject|1|||
19746973|NCT03433677|42194395|FG001|Period 2|Withdrawal by Subject|1|||
19746974|NCT02492711|42194405|FG000|Overall Study|Adverse Event|9|||
19746975|NCT02492711|42194406|FG001|Overall Study|Adverse Event|9|||
19746976|NCT02492711|42194407|FG002|Overall Study|Adverse Event|2|||
19746977|NCT02492711|42194405|FG000|Overall Study|Death|3|||
19746978|NCT02492711|42194406|FG001|Overall Study|Death|3|||
19746979|NCT02492711|42194407|FG002|Overall Study|Death|0|||
19746980|NCT02492711|42194405|FG000|Overall Study|Withdrawal by Subject|10|||
19746981|NCT02492711|42194406|FG001|Overall Study|Withdrawal by Subject|16|||
19595789|NCT00774397|42044457|FG005|Overall Study|Lack of Efficacy|15|||
19595790|NCT00774397|42044458|FG006|Overall Study|Lack of Efficacy|9|||
19595791|NCT00774397|42044452|FG000|Overall Study|Protocol Violation|0|||
19595792|NCT00774397|42044453|FG001|Overall Study|Protocol Violation|1|||
19595793|NCT00774397|42044454|FG002|Overall Study|Protocol Violation|3|||
19595794|NCT00774397|42044455|FG003|Overall Study|Protocol Violation|1|||
19595795|NCT00774397|42044456|FG004|Overall Study|Protocol Violation|2|||
19595796|NCT00774397|42044457|FG005|Overall Study|Protocol Violation|1|||
19595797|NCT00774397|42044458|FG006|Overall Study|Protocol Violation|0|||
19595798|NCT00774397|42044452|FG000|Overall Study|Lost to Follow-up|0|||
19595799|NCT00774397|42044453|FG001|Overall Study|Lost to Follow-up|1|||
19595800|NCT00774397|42044454|FG002|Overall Study|Lost to Follow-up|1|||
19595801|NCT00774397|42044455|FG003|Overall Study|Lost to Follow-up|1|||
19595802|NCT00774397|42044456|FG004|Overall Study|Lost to Follow-up|0|||
19595803|NCT00774397|42044457|FG005|Overall Study|Lost to Follow-up|1|||
19746982|NCT02492711|42194407|FG002|Overall Study|Withdrawal by Subject|5|||
19746983|NCT02492711|42194405|FG000|Overall Study|Physician Decision|10|||
19595804|NCT00774397|42044458|FG006|Overall Study|Lost to Follow-up|0|||
19595805|NCT00774397|42044452|FG000|Overall Study|Refused to continue trial medication|1|||
19595806|NCT00774397|42044453|FG001|Overall Study|Refused to continue trial medication|3|||
19595807|NCT00774397|42044454|FG002|Overall Study|Refused to continue trial medication|2|||
19595808|NCT00774397|42044455|FG003|Overall Study|Refused to continue trial medication|2|||
19595809|NCT00774397|42044456|FG004|Overall Study|Refused to continue trial medication|6|||
19595810|NCT00774397|42044457|FG005|Overall Study|Refused to continue trial medication|2|||
19595811|NCT00774397|42044458|FG006|Overall Study|Refused to continue trial medication|3|||
19595812|NCT00774397|42044452|FG000|Overall Study|Not treated|0|||
19595813|NCT00774397|42044453|FG001|Overall Study|Not treated|0|||
19595814|NCT00774397|42044454|FG002|Overall Study|Not treated|0|||
19595815|NCT00774397|42044455|FG003|Overall Study|Not treated|0|||
19595816|NCT00774397|42044456|FG004|Overall Study|Not treated|1|||
19595817|NCT00774397|42044457|FG005|Overall Study|Not treated|0|||
19595818|NCT00774397|42044458|FG006|Overall Study|Not treated|1|||
19595819|NCT00774397|42044452|FG000|Overall Study|Other than those stated above|1|||
19595820|NCT00774397|42044453|FG001|Overall Study|Other than those stated above|1|||
19595821|NCT00774397|42044454|FG002|Overall Study|Other than those stated above|3|||
19595822|NCT00774397|42044455|FG003|Overall Study|Other than those stated above|2|||
19595823|NCT00774397|42044456|FG004|Overall Study|Other than those stated above|2|||
19595824|NCT00774397|42044457|FG005|Overall Study|Other than those stated above|0|||
19595825|NCT00774397|42044458|FG006|Overall Study|Other than those stated above|1|||
19595826|NCT00909870|42044513|FG000|Overall Study|Adverse Event|13|||
19595827|NCT00909870|42044514|FG001|Overall Study|Adverse Event|7|||
19595828|NCT00909870|42044513|FG000|Overall Study|Protocol Violation|1|||
19595829|NCT00909870|42044514|FG001|Overall Study|Protocol Violation|2|||
19595830|NCT00909870|42044513|FG000|Overall Study|Withdrawal by Subject|5|||
19595831|NCT00909870|42044514|FG001|Overall Study|Withdrawal by Subject|8|||
19595832|NCT00909870|42044513|FG000|Overall Study|Lost to Follow-up|3|||
19595833|NCT00909870|42044514|FG001|Overall Study|Lost to Follow-up|3|||
19595834|NCT00909870|42044513|FG000|Overall Study|Physician Decision|0|||
19595835|NCT00909870|42044514|FG001|Overall Study|Physician Decision|2|||
19595836|NCT00909870|42044513|FG000|Overall Study|Other|1|||
19595837|NCT00909870|42044514|FG001|Overall Study|Other|5|||
19595838|NCT00768469|42044523|FG000|Overall Study|Adverse Event|0|||
19595839|NCT00768469|42044524|FG001|Overall Study|Adverse Event|2|||
19595840|NCT00768469|42044523|FG000|Overall Study|Disease Progression|3|||
19595841|NCT00768469|42044524|FG001|Overall Study|Disease Progression|4|||
19595842|NCT00768469|42044523|FG000|Overall Study|Withdrawal by Subject|0|||
19595843|NCT00768469|42044524|FG001|Overall Study|Withdrawal by Subject|1|||
19595844|NCT00886821|42044545|FG000|Stage 2|Adverse Event|0|||
19595845|NCT00886821|42044546|FG001|Stage 2|Adverse Event|0|||
19595846|NCT00886821|42044547|FG002|Stage 2|Adverse Event|0|||
19595847|NCT00886821|42044548|FG003|Stage 2|Adverse Event|0|||
19595848|NCT00886821|42044549|FG004|Stage 2|Adverse Event|0|||
19595849|NCT00886821|42044550|FG005|Stage 2|Adverse Event|0|||
19595850|NCT00886821|42044551|FG006|Stage 2|Adverse Event|0|||
19595851|NCT00886821|42044552|FG007|Stage 2|Adverse Event|0|||
19595852|NCT00886821|42044553|FG008|Stage 2|Adverse Event|0|||
19595853|NCT00886821|42044554|FG009|Stage 2|Adverse Event|0|||
19595854|NCT00886821|42044555|FG010|Stage 2|Adverse Event|0|||
19595855|NCT00886821|42044556|FG011|Stage 2|Adverse Event|1|||
19595856|NCT00886821|42044557|FG012|Stage 2|Adverse Event|3|||
19595857|NCT00886821|42044558|FG013|Stage 2|Adverse Event|0|||
19746984|NCT02492711|42194406|FG001|Overall Study|Physician Decision|6|||
19746985|NCT02492711|42194407|FG002|Overall Study|Physician Decision|4|||
19746986|NCT02492711|42194405|FG000|Overall Study|Lost to Follow-up|0|||
19746987|NCT02492711|42194406|FG001|Overall Study|Lost to Follow-up|0|||
19746988|NCT02492711|42194407|FG002|Overall Study|Lost to Follow-up|1|||
19746989|NCT02492711|42194405|FG000|Overall Study|study treatment delay|2|||
19595858|NCT00886821|42044545|FG000|Stage 2|Lost to Follow-up|0|||
19595859|NCT00886821|42044546|FG001|Stage 2|Lost to Follow-up|0|||
19595860|NCT00886821|42044547|FG002|Stage 2|Lost to Follow-up|0|||
19595861|NCT00886821|42044548|FG003|Stage 2|Lost to Follow-up|0|||
19595862|NCT00886821|42044549|FG004|Stage 2|Lost to Follow-up|0|||
19595863|NCT00886821|42044550|FG005|Stage 2|Lost to Follow-up|0|||
19595864|NCT00886821|42044551|FG006|Stage 2|Lost to Follow-up|0|||
19595865|NCT00886821|42044552|FG007|Stage 2|Lost to Follow-up|0|||
19595866|NCT00886821|42044553|FG008|Stage 2|Lost to Follow-up|0|||
19595867|NCT00886821|42044554|FG009|Stage 2|Lost to Follow-up|0|||
19595868|NCT00886821|42044555|FG010|Stage 2|Lost to Follow-up|0|||
19595869|NCT00886821|42044556|FG011|Stage 2|Lost to Follow-up|0|||
19595870|NCT00886821|42044557|FG012|Stage 2|Lost to Follow-up|2|||
19595871|NCT00886821|42044558|FG013|Stage 2|Lost to Follow-up|1|||
19595872|NCT00886743|42044602|FG000|Overall Study|Adverse Event|3|||
19746990|NCT02492711|42194406|FG001|Overall Study|study treatment delay|1|||
19746991|NCT02492711|42194407|FG002|Overall Study|study treatment delay|0|||
19595873|NCT00886743|42044602|FG000|Overall Study|Other|1|||
19595874|NCT00886587|42044608|FG000|Overall Study|Adverse Event|2|||
19595875|NCT00886587|42044609|FG001|Overall Study|Adverse Event|1|||
19595876|NCT00886587|42044608|FG000|Overall Study|Protocol Violation|2|||
19746992|NCT02492711|42194405|FG000|Overall Study|change in chemotherapy|0|||
19746993|NCT02492711|42194406|FG001|Overall Study|change in chemotherapy|1|||
19746994|NCT02492711|42194407|FG002|Overall Study|change in chemotherapy|0|||
19746995|NCT02492711|42194405|FG000|Overall Study|never treated|2|||
19746996|NCT02492711|42194406|FG001|Overall Study|never treated|4|||
19746997|NCT02492711|42194407|FG002|Overall Study|never treated|0|||
19746998|NCT02492711|42194405|FG000|Overall Study|Other|0|||
19477021|NCT01515319|41755708|FG007|Overall Study|Adverse Event|0|||
19595877|NCT00886587|42044609|FG001|Overall Study|Protocol Violation|0|||
19595878|NCT00886587|42044608|FG000|Overall Study|Withdrawal by Subject|0|||
19595879|NCT00886587|42044609|FG001|Overall Study|Withdrawal by Subject|1|||
19595880|NCT00886119|42044615|FG000|Period 1|Did not meet inclusion criteria|1|||
19595881|NCT00886119|42044616|FG001|Period 1|Did not meet inclusion criteria|0|||
19595882|NCT00768079|42044625|FG000|Overall Study|Lost to Follow-up|2|||
19595883|NCT00768079|42044626|FG001|Overall Study|Lost to Follow-up|0|||
19595884|NCT00768079|42044627|FG002|Overall Study|Lost to Follow-up|4|||
19595885|NCT00768079|42044625|FG000|Overall Study|Participant incarcerated|0|||
19595886|NCT00768079|42044626|FG001|Overall Study|Participant incarcerated|1|||
19595887|NCT00768079|42044627|FG002|Overall Study|Participant incarcerated|0|||
19595888|NCT00767455|42044637|FG000|Overall Study|Investigator error|19|||
19477022|NCT01515319|41755709|FG008|Overall Study|Adverse Event|3|||
19477023|NCT01515319|41755710|FG009|Overall Study|Adverse Event|0|||
19477024|NCT01515319|41755701|FG000|Overall Study|Protocol Violation|0|||
19477025|NCT01515319|41755702|FG001|Overall Study|Protocol Violation|0|||
19477026|NCT01515319|41755703|FG002|Overall Study|Protocol Violation|0|||
19477027|NCT01515319|41755704|FG003|Overall Study|Protocol Violation|0|||
19595889|NCT00766831|42044643|FG000|Overall Study|Withdrawal by Subject|4|||
19595890|NCT00766831|42044643|FG000|Overall Study|Lost to Follow-up|3|||
19477028|NCT01515319|41755705|FG004|Overall Study|Protocol Violation|0|||
19477029|NCT01515319|41755706|FG005|Overall Study|Protocol Violation|0|||
19477030|NCT01515319|41755707|FG006|Overall Study|Protocol Violation|0|||
19477031|NCT01515319|41755708|FG007|Overall Study|Protocol Violation|0|||
19595891|NCT00766831|42044643|FG000|Overall Study|Adverse Event|20|||
19595892|NCT00766831|42044643|FG000|Overall Study|Protocol Violation|15|||
19595893|NCT00766831|42044643|FG000|Overall Study|Physician Decision|5|||
19595894|NCT00766831|42044643|FG000|Overall Study|Withdrawal of consent|26|||
19595895|NCT00766831|42044643|FG000|Overall Study|Non cooperation by participants|14|||
19595896|NCT00766831|42044643|FG000|Overall Study|Other|28|||
19595897|NCT00766675|42044647|FG000|Overall Study|Adverse Event|16|||
19595898|NCT00766675|42044647|FG000|Overall Study|Lost to Follow-up|2|||
19595899|NCT00766675|42044647|FG000|Overall Study|Withdrawal by Subject|11|||
19595900|NCT00766675|42044647|FG000|Overall Study|Protocol Violation|8|||
19595901|NCT00766675|42044647|FG000|Overall Study|Participant took prohibited medication|1|||
19595902|NCT00766675|42044647|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
19595903|NCT00766675|42044647|FG000|Overall Study|Insufficient therapy|1|||
19595904|NCT00766597|42044651|FG000|Overall Study|Unexpected closure of study|4|||
19595905|NCT00766597|42044651|FG000|Overall Study|Without CCR5-tropic virus|5|||
19595906|NCT00910962|42044660|FG000|Overall Study|Adverse Event|5|||
19595907|NCT00910962|42044661|FG001|Overall Study|Adverse Event|20|||
19595908|NCT00910962|42044662|FG002|Overall Study|Adverse Event|17|||
19595909|NCT00910962|42044660|FG000|Overall Study|Protocol Violation|1|||
19595910|NCT00910962|42044661|FG001|Overall Study|Protocol Violation|3|||
19595911|NCT00910962|42044662|FG002|Overall Study|Protocol Violation|3|||
19595912|NCT00910962|42044660|FG000|Overall Study|Lost to Follow-up|0|||
19595913|NCT00910962|42044661|FG001|Overall Study|Lost to Follow-up|3|||
19595914|NCT00910962|42044662|FG002|Overall Study|Lost to Follow-up|1|||
19595915|NCT00910962|42044660|FG000|Overall Study|Physician Decision|0|||
19595916|NCT00910962|42044661|FG001|Overall Study|Physician Decision|6|||
19595917|NCT00910962|42044662|FG002|Overall Study|Physician Decision|6|||
19595918|NCT00910962|42044660|FG000|Overall Study|Withdrawal by Subject|25|||
19595919|NCT00910962|42044661|FG001|Overall Study|Withdrawal by Subject|32|||
19595920|NCT00910962|42044662|FG002|Overall Study|Withdrawal by Subject|32|||
19595921|NCT00910962|42044660|FG000|Overall Study|Reached defined stopping criteria|12|||
19595922|NCT00910962|42044661|FG001|Overall Study|Reached defined stopping criteria|14|||
19595923|NCT00910962|42044662|FG002|Overall Study|Reached defined stopping criteria|17|||
19595924|NCT00773461|42044674|FG000|Overall Study|Adverse Event|1|||
19595925|NCT00773461|42044675|FG001|Overall Study|Adverse Event|3|||
19595926|NCT00773461|42044674|FG000|Overall Study|Withdrawal by Subject|4|||
19595927|NCT00773461|42044675|FG001|Overall Study|Withdrawal by Subject|1|||
19595928|NCT00773383|42044682|FG000|Overall Study|Adverse Event|4|||
19595929|NCT00773383|42044682|FG000|Overall Study|Death|1|||
19595930|NCT00773383|42044682|FG000|Overall Study|Progression of Disease|23|||
19595931|NCT00773383|42044682|FG000|Overall Study|Other|2|||
19595932|NCT00773383|42044682|FG000|Overall Study|No study dose received|1|||
19595933|NCT00757003|42044690|FG000|Overall Study|Death|33|||
19595934|NCT00757003|42044690|FG000|Overall Study|Lost to Follow-up|9|||
19595935|NCT00757003|42044690|FG000|Overall Study|Withdrawal by Subject|4|||
19477032|NCT01515319|41755709|FG008|Overall Study|Protocol Violation|2|||
19477033|NCT01515319|41755710|FG009|Overall Study|Protocol Violation|0|||
19595936|NCT00757003|42044690|FG000|Overall Study|Surgically explanted|2|||
19595937|NCT00757003|42044690|FG000|Overall Study|Not implanted|1|||
19595938|NCT00766363|42044699|FG000|Overall Study|Withdrawal by Subject|1|||
19595939|NCT00766363|42044700|FG001|Overall Study|Withdrawal by Subject|0|||
19595940|NCT00766363|42044701|FG002|Overall Study|Withdrawal by Subject|0|||
19595941|NCT00766363|42044702|FG003|Overall Study|Withdrawal by Subject|0|||
19595942|NCT00766363|42044699|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
19595943|NCT00766363|42044700|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
19595944|NCT00766363|42044701|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
19595945|NCT00766363|42044702|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
19595946|NCT02636946|42044715|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
19595947|NCT02636946|42044716|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
19595948|NCT02636946|42044715|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
19595949|NCT02636946|42044716|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
19595950|NCT02636946|42044715|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
19595951|NCT02636946|42044716|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
19595952|NCT02636946|42044715|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
19595953|NCT02636946|42044716|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
19595954|NCT02636946|42044715|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
19595955|NCT02636946|42044716|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
19595956|NCT02636946|42044715|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
19595957|NCT02636946|42044716|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
19595958|NCT00766051|42044724|FG000|Overall Study|Withdrawal by Subject|2|||
19595959|NCT00766051|42044725|FG001|Overall Study|Withdrawal by Subject|0|||
19595960|NCT00909792|42044733|FG000|Period 1|Did not meet inclusion criteria|0|||
19595961|NCT00909792|42044734|FG001|Period 1|Did not meet inclusion criteria|1|||
19595962|NCT00909792|42044733|FG000|Period 2|Biomicroscopy|1|||
19595963|NCT00909792|42044734|FG001|Period 2|Biomicroscopy|0|||
19595964|NCT00909792|42044733|FG000|Period 2|Lost to Follow-up|0|||
19595965|NCT00909792|42044734|FG001|Period 2|Lost to Follow-up|1|||
19595966|NCT00765817|42044742|FG000|Overall Study|Adverse Event|13|||
19595967|NCT00765817|42044743|FG001|Overall Study|Adverse Event|1|||
19595968|NCT00765817|42044742|FG000|Overall Study|Death|0|||
19595969|NCT00765817|42044743|FG001|Overall Study|Death|1|||
19595970|NCT00765817|42044742|FG000|Overall Study|Entry criteria not met|2|||
19595971|NCT00765817|42044743|FG001|Overall Study|Entry criteria not met|2|||
19595972|NCT00765817|42044742|FG000|Overall Study|Loss of glucose control|0|||
19595973|NCT00765817|42044743|FG001|Overall Study|Loss of glucose control|2|||
19595974|NCT00765817|42044742|FG000|Overall Study|Lost to Follow-up|1|||
19595975|NCT00765817|42044743|FG001|Overall Study|Lost to Follow-up|3|||
19595976|NCT00765817|42044742|FG000|Overall Study|Physician Decision|2|||
19595977|NCT00765817|42044743|FG001|Overall Study|Physician Decision|1|||
19595978|NCT00765817|42044742|FG000|Overall Study|Protocol Violation|1|||
19595979|NCT00765817|42044743|FG001|Overall Study|Protocol Violation|1|||
19595980|NCT00765817|42044742|FG000|Overall Study|Subject decision|7|||
19595981|NCT00765817|42044743|FG001|Overall Study|Subject decision|11|||
19595982|NCT00772603|42044752|FG000|Overall Study|Withdrawal by Subject|11|||
19595983|NCT00772603|42044753|FG001|Overall Study|Withdrawal by Subject|10|||
19595984|NCT00772603|42044754|FG002|Overall Study|Withdrawal by Subject|6|||
19595985|NCT00772603|42044752|FG000|Overall Study|Adverse Event|37|||
19595986|NCT00772603|42044753|FG001|Overall Study|Adverse Event|18|||
19595987|NCT00772603|42044754|FG002|Overall Study|Adverse Event|10|||
19595988|NCT00772603|42044752|FG000|Overall Study|Subject Non-compliance|1|||
19595989|NCT00772603|42044753|FG001|Overall Study|Subject Non-compliance|6|||
19595990|NCT00772603|42044754|FG002|Overall Study|Subject Non-compliance|4|||
19595991|NCT00772603|42044752|FG000|Overall Study|Protocol Violation|0|||
19595992|NCT00772603|42044753|FG001|Overall Study|Protocol Violation|1|||
19595993|NCT00772603|42044754|FG002|Overall Study|Protocol Violation|1|||
19595994|NCT00772603|42044752|FG000|Overall Study|Lost to Follow-up|1|||
19595995|NCT00772603|42044753|FG001|Overall Study|Lost to Follow-up|5|||
19595996|NCT00772603|42044754|FG002|Overall Study|Lost to Follow-up|2|||
19595997|NCT00772603|42044752|FG000|Overall Study|Physician Decision|0|||
19595998|NCT00772603|42044753|FG001|Overall Study|Physician Decision|0|||
19595999|NCT00772603|42044754|FG002|Overall Study|Physician Decision|1|||
19596000|NCT00772603|42044752|FG000|Overall Study|Other|2|||
19596001|NCT00772603|42044753|FG001|Overall Study|Other|0|||
19596002|NCT00772603|42044754|FG002|Overall Study|Other|2|||
19596003|NCT00772447|42044767|FG000|Overall Study|Withdrawal by Subject|9|||
19596004|NCT00772447|42044768|FG001|Overall Study|Withdrawal by Subject|5|||
19596005|NCT00772447|42044767|FG000|Overall Study|Physician Decision|4|||
19596006|NCT00772447|42044768|FG001|Overall Study|Physician Decision|8|||
19596007|NCT00772447|42044767|FG000|Overall Study|Lost to Follow-up|2|||
19596008|NCT00772447|42044768|FG001|Overall Study|Lost to Follow-up|4|||
19596009|NCT00772447|42044767|FG000|Overall Study|incorrect enrolment|3|||
19596010|NCT00772447|42044768|FG001|Overall Study|incorrect enrolment|4|||
19596011|NCT00772447|42044767|FG000|Overall Study|Protocol Violation|0|||
19596012|NCT00772447|42044768|FG001|Overall Study|Protocol Violation|1|||
19596013|NCT00772447|42044767|FG000|Overall Study|all others|2|||
19596014|NCT00772447|42044768|FG001|Overall Study|all others|2|||
19596015|NCT00765037|42044775|FG000|Overall Study|Lost to Follow-up|5|||
19596016|NCT00765037|42044775|FG000|Overall Study|Adverse Event|1|||
19596017|NCT00831844|42044789|FG000|Overall Study|Adverse Event|2|||
19596018|NCT00831844|42044790|FG001|Overall Study|Adverse Event|0|||
19596019|NCT00831844|42044791|FG002|Overall Study|Adverse Event|0|||
19596020|NCT00831844|42044792|FG003|Overall Study|Adverse Event|0|||
19596021|NCT00831844|42044793|FG004|Overall Study|Adverse Event|1|||
19596022|NCT00831844|42044794|FG005|Overall Study|Adverse Event|1|||
19596023|NCT00831844|42044795|FG006|Overall Study|Adverse Event|2|||
19596024|NCT00831844|42044796|FG007|Overall Study|Adverse Event|0|||
19596025|NCT00831844|42044797|FG008|Overall Study|Adverse Event|0|||
19596026|NCT00831844|42044798|FG009|Overall Study|Adverse Event|0|||
19596027|NCT00831844|42044789|FG000|Overall Study|Death|0|||
19596028|NCT00831844|42044790|FG001|Overall Study|Death|0|||
19596029|NCT00831844|42044791|FG002|Overall Study|Death|0|||
19596030|NCT00831844|42044792|FG003|Overall Study|Death|1|||
19596031|NCT00831844|42044793|FG004|Overall Study|Death|0|||
19596032|NCT00831844|42044794|FG005|Overall Study|Death|0|||
19596033|NCT00831844|42044795|FG006|Overall Study|Death|0|||
19596034|NCT00831844|42044796|FG007|Overall Study|Death|0|||
19596035|NCT00831844|42044797|FG008|Overall Study|Death|0|||
19596036|NCT00831844|42044798|FG009|Overall Study|Death|0|||
19596037|NCT00831844|42044789|FG000|Overall Study|Lack of Efficacy|8|||
19596038|NCT00831844|42044790|FG001|Overall Study|Lack of Efficacy|10|||
19596039|NCT00831844|42044791|FG002|Overall Study|Lack of Efficacy|15|||
19746999|NCT02492711|42194406|FG001|Overall Study|Other|0|||
19747000|NCT02492711|42194407|FG002|Overall Study|Other|1|||
19747001|NCT01147822|42194422|FG000|Overall Study|Death|66|||
19747002|NCT01147822|42194423|FG001|Overall Study|Death|59|||
19747003|NCT01147822|42194422|FG000|Overall Study|Protocol Violation|0|||
19747004|NCT01147822|42194423|FG001|Overall Study|Protocol Violation|1|||
19747005|NCT01147822|42194422|FG000|Overall Study|Lost to Follow-up|3|||
19747006|NCT01147822|42194423|FG001|Overall Study|Lost to Follow-up|2|||
19596040|NCT00831844|42044792|FG003|Overall Study|Lack of Efficacy|8|||
19596041|NCT00831844|42044793|FG004|Overall Study|Lack of Efficacy|11|||
19596042|NCT00831844|42044794|FG005|Overall Study|Lack of Efficacy|17|||
19596043|NCT00831844|42044795|FG006|Overall Study|Lack of Efficacy|8|||
19596044|NCT00831844|42044796|FG007|Overall Study|Lack of Efficacy|9|||
19596045|NCT00831844|42044797|FG008|Overall Study|Lack of Efficacy|7|||
19596046|NCT00831844|42044798|FG009|Overall Study|Lack of Efficacy|0|||
19596047|NCT00831844|42044789|FG000|Overall Study|Physician Decision|0|||
19596048|NCT00831844|42044790|FG001|Overall Study|Physician Decision|1|||
19596049|NCT00831844|42044791|FG002|Overall Study|Physician Decision|3|||
19596050|NCT00831844|42044792|FG003|Overall Study|Physician Decision|1|||
19596051|NCT00831844|42044793|FG004|Overall Study|Physician Decision|1|||
19596052|NCT00831844|42044794|FG005|Overall Study|Physician Decision|1|||
19596053|NCT00831844|42044795|FG006|Overall Study|Physician Decision|0|||
19596054|NCT00831844|42044796|FG007|Overall Study|Physician Decision|0|||
19596055|NCT00831844|42044797|FG008|Overall Study|Physician Decision|1|||
19596056|NCT00831844|42044798|FG009|Overall Study|Physician Decision|0|||
19596057|NCT00831844|42044789|FG000|Overall Study|Withdrawal by Subject|0|||
19596058|NCT00831844|42044790|FG001|Overall Study|Withdrawal by Subject|0|||
19596059|NCT00831844|42044791|FG002|Overall Study|Withdrawal by Subject|1|||
19596060|NCT00831844|42044792|FG003|Overall Study|Withdrawal by Subject|0|||
19596061|NCT00831844|42044793|FG004|Overall Study|Withdrawal by Subject|0|||
19596062|NCT00831844|42044794|FG005|Overall Study|Withdrawal by Subject|0|||
19596063|NCT00831844|42044795|FG006|Overall Study|Withdrawal by Subject|0|||
19596064|NCT00831844|42044796|FG007|Overall Study|Withdrawal by Subject|1|||
19596065|NCT00831844|42044797|FG008|Overall Study|Withdrawal by Subject|1|||
19596066|NCT00831844|42044798|FG009|Overall Study|Withdrawal by Subject|0|||
19596067|NCT00831844|42044789|FG000|Overall Study|Ineligible|0|||
19596068|NCT00831844|42044790|FG001|Overall Study|Ineligible|1|||
19596069|NCT00831844|42044791|FG002|Overall Study|Ineligible|1|||
19596070|NCT00831844|42044792|FG003|Overall Study|Ineligible|0|||
19596071|NCT00831844|42044793|FG004|Overall Study|Ineligible|1|||
19596072|NCT00831844|42044794|FG005|Overall Study|Ineligible|0|||
19596073|NCT00831844|42044795|FG006|Overall Study|Ineligible|0|||
19596074|NCT00831844|42044796|FG007|Overall Study|Ineligible|0|||
19596075|NCT00831844|42044797|FG008|Overall Study|Ineligible|0|||
19596076|NCT00831844|42044798|FG009|Overall Study|Ineligible|0|||
19747007|NCT01147822|42194422|FG000|Overall Study|Physician Decision|0|||
19596077|NCT00764881|42044822|FG000|Overall Study|Adverse Event|5|||
19596078|NCT00764881|42044823|FG001|Overall Study|Adverse Event|1|||
19596079|NCT00764881|42044822|FG000|Overall Study|Withdrawal by Subject|1|||
19747008|NCT01147822|42194423|FG001|Overall Study|Physician Decision|2|||
19596080|NCT00764881|42044823|FG001|Overall Study|Withdrawal by Subject|3|||
19596081|NCT00764881|42044822|FG000|Overall Study|Protocol Violation|2|||
19596082|NCT00764881|42044823|FG001|Overall Study|Protocol Violation|2|||
19596083|NCT00764881|42044822|FG000|Overall Study|Lost to Follow-up|2|||
19596084|NCT00764881|42044823|FG001|Overall Study|Lost to Follow-up|0|||
19596085|NCT00764881|42044822|FG000|Overall Study|Noncompliant|1|||
19596086|NCT00764881|42044823|FG001|Overall Study|Noncompliant|0|||
19596087|NCT00764881|42044822|FG000|Overall Study|Accidentally discontinued study drug|1|||
19596088|NCT00764881|42044823|FG001|Overall Study|Accidentally discontinued study drug|0|||
19596089|NCT00764881|42044822|FG000|Overall Study|Wished to become pregnant|1|||
19596090|NCT00764881|42044823|FG001|Overall Study|Wished to become pregnant|0|||
19596091|NCT00764881|42044822|FG000|Overall Study|Carcinoma detected|1|||
19596092|NCT00764881|42044823|FG001|Overall Study|Carcinoma detected|0|||
19596093|NCT00764881|42044822|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
19596094|NCT00764881|42044823|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
19596095|NCT00764881|42044822|FG000|Overall Study|no treatment or no observation|2|||
19596096|NCT00764881|42044823|FG001|Overall Study|no treatment or no observation|2|||
19596097|NCT00844558|42044831|FG000|Overall Study|Withdrawal by Subject|9|||
19596098|NCT00844558|42044832|FG001|Overall Study|Withdrawal by Subject|2|||
19596099|NCT00844558|42044831|FG000|Overall Study|Death|1|||
19596100|NCT00844558|42044832|FG001|Overall Study|Death|0|||
19596101|NCT00844558|42044831|FG000|Overall Study|Protocol Violation|1|||
19596102|NCT00844558|42044832|FG001|Overall Study|Protocol Violation|1|||
19596103|NCT00844558|42044831|FG000|Overall Study|Lost to Follow-up|0|||
19596104|NCT00844558|42044832|FG001|Overall Study|Lost to Follow-up|1|||
19596105|NCT00844558|42044831|FG000|Overall Study|Physician Decision|1|||
19596106|NCT00844558|42044832|FG001|Overall Study|Physician Decision|0|||
19596107|NCT00772369|42044843|FG000|Overall Study|Did not return record release form|1|||
19596108|NCT00821236|42044850|FG000|Overall Study|Lost to Follow-up|3|||
19596109|NCT00756457|42044860|FG000|Overall Study|Lost to Follow-up|1|||
19596110|NCT00756457|42044861|FG001|Overall Study|Lost to Follow-up|2|||
19596111|NCT00844480|42044885|FG000|Overall Study|Withdrawal by Subject|2|||
19596112|NCT00844480|42044886|FG001|Overall Study|Withdrawal by Subject|3|||
19596113|NCT00771901|42044895|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
19596114|NCT00771901|42044896|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
19596115|NCT00771901|42044897|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
19596116|NCT00843856|42044907|FG000|Overall Study|Lost to Follow-up|1|||
19596117|NCT00843856|42044908|FG001|Overall Study|Lost to Follow-up|2|||
19596118|NCT00764491|42044916|FG000|Overall Study|Lost to Follow-up|35|||
19596119|NCT00764491|42044917|FG001|Overall Study|Lost to Follow-up|17|||
19596120|NCT00843778|42044923|FG000|Overall Study|Adverse Event|15|||
19596121|NCT00843778|42044923|FG000|Overall Study|Lack of Efficacy|14|||
19596122|NCT00843778|42044923|FG000|Overall Study|Loss of efficacy|2|||
19596123|NCT00843778|42044923|FG000|Overall Study|Withdrawal by Subject|4|||
19596124|NCT00591370|42044927|FG000|Overall Study|Not Treated|2|||
19596125|NCT00910728|42044940|FG000|Overall Study|Lack of Efficacy|2|||
19596126|NCT00910728|42044941|FG001|Overall Study|Lack of Efficacy|3|||
19596127|NCT00910728|42044942|FG002|Overall Study|Lack of Efficacy|1|||
19596128|NCT00910728|42044943|FG003|Overall Study|Lack of Efficacy|2|||
19596129|NCT00910728|42044944|FG004|Overall Study|Lack of Efficacy|1|||
19596130|NCT00910728|42044945|FG005|Overall Study|Lack of Efficacy|0|||
19596131|NCT00910728|42044946|FG006|Overall Study|Lack of Efficacy|2|||
19596132|NCT00910728|42044947|FG007|Overall Study|Lack of Efficacy|2|||
19596133|NCT00910728|42044948|FG008|Overall Study|Lack of Efficacy|2|||
19596134|NCT00910728|42044940|FG000|Overall Study|Withdrawal by Subject|0|||
19596135|NCT00910728|42044941|FG001|Overall Study|Withdrawal by Subject|0|||
19596136|NCT00910728|42044942|FG002|Overall Study|Withdrawal by Subject|0|||
19596137|NCT00910728|42044943|FG003|Overall Study|Withdrawal by Subject|0|||
19596138|NCT00910728|42044944|FG004|Overall Study|Withdrawal by Subject|3|||
19596139|NCT00910728|42044945|FG005|Overall Study|Withdrawal by Subject|1|||
19596140|NCT00910728|42044946|FG006|Overall Study|Withdrawal by Subject|2|||
19596141|NCT00910728|42044947|FG007|Overall Study|Withdrawal by Subject|0|||
19596142|NCT00910728|42044948|FG008|Overall Study|Withdrawal by Subject|0|||
19596143|NCT00910728|42044940|FG000|Overall Study|(not specified)|2|||
19596144|NCT00910728|42044941|FG001|Overall Study|(not specified)|0|||
19596145|NCT00910728|42044942|FG002|Overall Study|(not specified)|1|||
19596146|NCT00910728|42044943|FG003|Overall Study|(not specified)|0|||
19596147|NCT00910728|42044944|FG004|Overall Study|(not specified)|1|||
19596148|NCT00910728|42044945|FG005|Overall Study|(not specified)|0|||
19596149|NCT00910728|42044946|FG006|Overall Study|(not specified)|0|||
19596150|NCT00910728|42044947|FG007|Overall Study|(not specified)|0|||
19596151|NCT00910728|42044948|FG008|Overall Study|(not specified)|0|||
19596152|NCT00910728|42044940|FG000|Overall Study|Adverse Event|2|||
19596153|NCT00910728|42044941|FG001|Overall Study|Adverse Event|0|||
19596154|NCT00910728|42044942|FG002|Overall Study|Adverse Event|1|||
19596155|NCT00910728|42044943|FG003|Overall Study|Adverse Event|1|||
19596156|NCT00910728|42044944|FG004|Overall Study|Adverse Event|0|||
19596157|NCT00910728|42044945|FG005|Overall Study|Adverse Event|0|||
19596158|NCT00910728|42044946|FG006|Overall Study|Adverse Event|2|||
19596159|NCT00910728|42044947|FG007|Overall Study|Adverse Event|1|||
19596160|NCT00910728|42044948|FG008|Overall Study|Adverse Event|1|||
19596161|NCT00820222|42044970|FG000|Overall Study|Lost to Follow-up|10|||
19596162|NCT00820222|42044971|FG001|Overall Study|Lost to Follow-up|9|||
19596163|NCT00820222|42044970|FG000|Overall Study|Withdrawal by Subject|19|||
19596164|NCT00820222|42044971|FG001|Overall Study|Withdrawal by Subject|21|||
19596165|NCT00820222|42044970|FG000|Overall Study|Physician Decision|93|||
19596166|NCT00820222|42044971|FG001|Overall Study|Physician Decision|88|||
19596167|NCT00820222|42044970|FG000|Overall Study|Sponsor Terminated Study|43|||
19596168|NCT00820222|42044971|FG001|Overall Study|Sponsor Terminated Study|65|||
19596169|NCT00820222|42044970|FG000|Overall Study|Unkown|11|||
19596170|NCT00820222|42044971|FG001|Overall Study|Unkown|7|||
19596171|NCT01039688|42044980|FG000|Overall Study|Adverse Event|38|||
19596172|NCT01039688|42044981|FG001|Overall Study|Adverse Event|39|||
19596173|NCT01039688|42044982|FG002|Overall Study|Adverse Event|24|||
19596174|NCT01039688|42044980|FG000|Overall Study|Lack of Efficacy|20|||
19596175|NCT01039688|42044981|FG001|Overall Study|Lack of Efficacy|11|||
19596176|NCT01039688|42044982|FG002|Overall Study|Lack of Efficacy|26|||
19596177|NCT01039688|42044980|FG000|Overall Study|Lost to Follow-up|11|||
19596178|NCT01039688|42044981|FG001|Overall Study|Lost to Follow-up|9|||
19596179|NCT01039688|42044982|FG002|Overall Study|Lost to Follow-up|5|||
19747009|NCT01147822|42194422|FG000|Overall Study|Withdrawal by Subject|8|||
19747010|NCT01147822|42194423|FG001|Overall Study|Withdrawal by Subject|13|||
19747011|NCT01147822|42194422|FG000|Overall Study|Not Completed/Ongoing|111|||
19747012|NCT01147822|42194423|FG001|Overall Study|Not Completed/Ongoing|102|||
19596180|NCT01039688|42044980|FG000|Overall Study|Other|13|||
19596181|NCT01039688|42044981|FG001|Overall Study|Other|25|||
19596182|NCT01039688|42044982|FG002|Overall Study|Other|12|||
19596183|NCT01039688|42044980|FG000|Overall Study|Withdrawal by Subject|23|||
19596184|NCT01039688|42044981|FG001|Overall Study|Withdrawal by Subject|27|||
19596185|NCT01039688|42044982|FG002|Overall Study|Withdrawal by Subject|13|||
19596186|NCT01039688|42044980|FG000|Overall Study|Death|2|||
19596187|NCT01039688|42044981|FG001|Overall Study|Death|0|||
19596188|NCT01039688|42044982|FG002|Overall Study|Death|0|||
19596189|NCT02237508|42045003|FG000|Overall Study|Withdrawal by Subject|0|||
19596190|NCT02237508|42045004|FG001|Overall Study|Withdrawal by Subject|2|||
19596191|NCT02237508|42045005|FG002|Overall Study|Withdrawal by Subject|0|||
19596192|NCT02237508|42045006|FG003|Overall Study|Withdrawal by Subject|1|||
19596193|NCT02237508|42045007|FG004|Overall Study|Withdrawal by Subject|0|||
19596194|NCT02237508|42045008|FG005|Overall Study|Withdrawal by Subject|1|||
19596195|NCT02237508|42045009|FG006|Overall Study|Withdrawal by Subject|1|||
19596196|NCT02237508|42045010|FG007|Overall Study|Withdrawal by Subject|0|||
19596197|NCT02237508|42045011|FG008|Overall Study|Withdrawal by Subject|1|||
19596198|NCT02237508|42045012|FG009|Overall Study|Withdrawal by Subject|0|||
19596199|NCT02237508|42045003|FG000|Overall Study|Physician Decision|0|||
19596200|NCT02237508|42045004|FG001|Overall Study|Physician Decision|1|||
19596201|NCT02237508|42045005|FG002|Overall Study|Physician Decision|0|||
19596202|NCT02237508|42045006|FG003|Overall Study|Physician Decision|0|||
19596203|NCT02237508|42045007|FG004|Overall Study|Physician Decision|0|||
19596204|NCT02237508|42045008|FG005|Overall Study|Physician Decision|0|||
19596205|NCT02237508|42045009|FG006|Overall Study|Physician Decision|0|||
19596206|NCT02237508|42045010|FG007|Overall Study|Physician Decision|0|||
19596207|NCT02237508|42045011|FG008|Overall Study|Physician Decision|0|||
19596208|NCT02237508|42045012|FG009|Overall Study|Physician Decision|0|||
19596209|NCT02237508|42045003|FG000|Overall Study|Protocol Violation|0|||
19596210|NCT02237508|42045004|FG001|Overall Study|Protocol Violation|0|||
19596211|NCT02237508|42045005|FG002|Overall Study|Protocol Violation|1|||
19596212|NCT02237508|42045006|FG003|Overall Study|Protocol Violation|0|||
19596213|NCT02237508|42045007|FG004|Overall Study|Protocol Violation|0|||
19596214|NCT02237508|42045008|FG005|Overall Study|Protocol Violation|0|||
19596215|NCT02237508|42045009|FG006|Overall Study|Protocol Violation|0|||
19596216|NCT02237508|42045010|FG007|Overall Study|Protocol Violation|0|||
19596217|NCT02237508|42045011|FG008|Overall Study|Protocol Violation|0|||
19596218|NCT02237508|42045012|FG009|Overall Study|Protocol Violation|0|||
19596219|NCT00909090|42045032|FG000|Overall Study|Lost to Follow-up|17|||
19596220|NCT00909090|42045033|FG001|Overall Study|Lost to Follow-up|17|||
19596221|NCT00909480|42045044|FG000|Overall Study|Adverse Event|5|||
19596222|NCT00909480|42045045|FG001|Overall Study|Adverse Event|3|||
19596223|NCT00909480|42045044|FG000|Overall Study|Protocol Violation|6|||
19596224|NCT00909480|42045045|FG001|Overall Study|Protocol Violation|8|||
19596225|NCT00909480|42045044|FG000|Overall Study|Withdrawal criteria|9|||
19596226|NCT00909480|42045045|FG001|Overall Study|Withdrawal criteria|11|||
19596227|NCT00909480|42045044|FG000|Overall Study|Unclassified|18|||
19596228|NCT00909480|42045045|FG001|Overall Study|Unclassified|19|||
19596229|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Adverse Event|11|||
19596230|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Adverse Event|15|||
19596231|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
19596232|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
19596233|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
19596234|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
19596235|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
19596236|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
19596237|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
19596238|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
19596239|NCT01058096|42045053|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
19596240|NCT01058096|42045054|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
19596241|NCT01057862|42045062|FG000|Overall Study|Withdrawal by Subject|1|||
19596242|NCT01057862|42045063|FG001|Overall Study|Withdrawal by Subject|2|||
19596243|NCT01038128|42045069|FG000|Overall Study|Lack of Efficacy|1|||
19596244|NCT01038128|42045069|FG000|Overall Study|Lost to Follow-up|1|||
19596245|NCT01038128|42045069|FG000|Overall Study|Withdrawal by Subject|2|||
19596246|NCT00842530|42045090|FG000|Overall Study|Serious adverse event|0|||
19596247|NCT00842530|42045091|FG001|Overall Study|Serious adverse event|6|||
19596248|NCT00842530|42045090|FG000|Overall Study|Other adverse event|6|||
19596249|NCT00842530|42045091|FG001|Overall Study|Other adverse event|1|||
19596250|NCT00842530|42045090|FG000|Overall Study|Protocol Violation|32|||
19596251|NCT00842530|42045091|FG001|Overall Study|Protocol Violation|14|||
19596252|NCT00842530|42045090|FG000|Overall Study|Lost to Follow-up|6|||
19596253|NCT00842530|42045091|FG001|Overall Study|Lost to Follow-up|8|||
19596254|NCT00842530|42045090|FG000|Overall Study|Withdrawal by Subject|73|||
19596255|NCT00842530|42045091|FG001|Overall Study|Withdrawal by Subject|28|||
19596256|NCT00819910|42045102|FG000|Overall Study|Adverse Event|0|||
19747013|NCT03431337|42194431|FG000|Overall Study|Lost to Follow-up|21|||
19747014|NCT03431337|42194432|FG001|Overall Study|Lost to Follow-up|19|||
19596257|NCT00819910|42045103|FG001|Overall Study|Adverse Event|0|||
19596258|NCT00819910|42045104|FG002|Overall Study|Adverse Event|2|||
19596259|NCT00819910|42045105|FG003|Overall Study|Adverse Event|1|||
19596260|NCT00819910|42045102|FG000|Overall Study|Withdrawal by Subject|1|||
19596261|NCT00819910|42045103|FG001|Overall Study|Withdrawal by Subject|1|||
19596262|NCT00819910|42045104|FG002|Overall Study|Withdrawal by Subject|1|||
19596263|NCT00819910|42045105|FG003|Overall Study|Withdrawal by Subject|0|||
19747015|NCT03431337|42194431|FG000|Overall Study|Withdrawal by Subject|8|||
19747016|NCT03431337|42194432|FG001|Overall Study|Withdrawal by Subject|3|||
19747017|NCT03738241|42194452|FG000|Overall Study|Withdrawal by Subject|0|||
19596264|NCT00819910|42045102|FG000|Overall Study|Lost to Follow-up|1|||
19596265|NCT00819910|42045103|FG001|Overall Study|Lost to Follow-up|0|||
19596266|NCT00819910|42045104|FG002|Overall Study|Lost to Follow-up|0|||
19596267|NCT00819910|42045105|FG003|Overall Study|Lost to Follow-up|0|||
19596268|NCT00830518|42045133|FG000|Overall Study|Progressive Disease|18|||
19596269|NCT00830518|42045134|FG001|Overall Study|Progressive Disease|8|||
19596270|NCT00830518|42045133|FG000|Overall Study|Symptomatic Deterioration|4|||
19596271|NCT00830518|42045134|FG001|Overall Study|Symptomatic Deterioration|1|||
19596272|NCT00830518|42045133|FG000|Overall Study|Adverse Event|14|||
19596273|NCT00830518|42045134|FG001|Overall Study|Adverse Event|1|||
19747018|NCT03738241|42194453|FG001|Overall Study|Withdrawal by Subject|0|||
19747019|NCT03738241|42194454|FG002|Overall Study|Withdrawal by Subject|0|||
19747020|NCT03738241|42194455|FG003|Overall Study|Withdrawal by Subject|0|||
19747021|NCT03738241|42194456|FG004|Overall Study|Withdrawal by Subject|0|||
19747022|NCT03738241|42194457|FG005|Overall Study|Withdrawal by Subject|0|||
19747023|NCT03738241|42194458|FG006|Overall Study|Withdrawal by Subject|0|||
19747024|NCT03738241|42194459|FG007|Overall Study|Withdrawal by Subject|0|||
19747025|NCT03738241|42194460|FG008|Overall Study|Withdrawal by Subject|0|||
19747026|NCT03738241|42194461|FG009|Overall Study|Withdrawal by Subject|1|||
19747027|NCT03738241|42194452|FG000|Overall Study|Physician Decision|0|||
19747028|NCT03738241|42194453|FG001|Overall Study|Physician Decision|0|||
19747029|NCT03738241|42194454|FG002|Overall Study|Physician Decision|0|||
19747030|NCT03738241|42194455|FG003|Overall Study|Physician Decision|0|||
19747031|NCT03738241|42194456|FG004|Overall Study|Physician Decision|0|||
19747032|NCT03738241|42194457|FG005|Overall Study|Physician Decision|0|||
19747033|NCT03738241|42194458|FG006|Overall Study|Physician Decision|0|||
19747034|NCT03738241|42194459|FG007|Overall Study|Physician Decision|0|||
19596274|NCT00830518|42045133|FG000|Overall Study|Withdrawal by Patient|2|||
19596275|NCT00830518|42045134|FG001|Overall Study|Withdrawal by Patient|0|||
19596276|NCT00830518|42045133|FG000|Overall Study|Reason not Specified|8|||
19747035|NCT03738241|42194460|FG008|Overall Study|Physician Decision|1|||
19747036|NCT03738241|42194461|FG009|Overall Study|Physician Decision|0|||
19747037|NCT03738241|42194452|FG000|Overall Study|Adverse Event|1|||
19747038|NCT03738241|42194453|FG001|Overall Study|Adverse Event|0|||
19747039|NCT03738241|42194454|FG002|Overall Study|Adverse Event|0|||
19596277|NCT00830518|42045134|FG001|Overall Study|Reason not Specified|1|||
19596278|NCT00908544|42045143|FG000|Overall Study|Withdrawal by Subject|2|||
19596279|NCT00908544|42045144|FG001|Overall Study|Withdrawal by Subject|4|||
19596280|NCT00908544|42045143|FG000|Overall Study|Lack of Efficacy|0|||
19596281|NCT00908544|42045144|FG001|Overall Study|Lack of Efficacy|1|||
19596282|NCT00908544|42045143|FG000|Overall Study|Pregnancy|1|||
19596283|NCT00908544|42045144|FG001|Overall Study|Pregnancy|0|||
19596284|NCT00908544|42045143|FG000|Overall Study|Relocation abroad|1|||
19596285|NCT00908544|42045144|FG001|Overall Study|Relocation abroad|1|||
19596286|NCT00908544|42045143|FG000|Overall Study|Unable to visit sutdy center|1|||
19596287|NCT00908544|42045144|FG001|Overall Study|Unable to visit sutdy center|0|||
19596288|NCT00830440|42045152|FG000|Overall Study|Protocol Violation|1|||
19596289|NCT00830440|42045153|FG001|Overall Study|Protocol Violation|0|||
19596290|NCT00830440|42045152|FG000|Overall Study|Withdrawal by Subject|1|||
19596291|NCT00830440|42045153|FG001|Overall Study|Withdrawal by Subject|0|||
19596292|NCT00830440|42045152|FG000|Overall Study|unsuccessful procedure|4|||
19596293|NCT00830440|42045153|FG001|Overall Study|unsuccessful procedure|0|||
19596294|NCT00830440|42045152|FG000|Overall Study|Adverse Event|2|||
19596295|NCT00830440|42045153|FG001|Overall Study|Adverse Event|0|||
19596296|NCT00908310|42045160|FG000|Overall Study|Death|37|||
19596297|NCT00908310|42045160|FG000|Overall Study|Withdrawal by Subject|7|||
19596298|NCT00908310|42045160|FG000|Overall Study|Lost to Follow-up|7|||
19596299|NCT00908310|42045160|FG000|Overall Study|Screening failure|5|||
19596300|NCT00908310|42045160|FG000|Overall Study|Other reasons|4|||
19596301|NCT00830128|42045164|FG000|Overall Study|Adverse Event|5|||
19596302|NCT00830128|42045164|FG000|Overall Study|Lack of Efficacy|7|||
19596303|NCT00830128|42045164|FG000|Overall Study|Protocol Violation|1|||
19596304|NCT00830128|42045164|FG000|Overall Study|Withdrawal by Subject|2|||
19596305|NCT00830128|42045164|FG000|Overall Study|Family obligation|1|||
19747040|NCT03738241|42194455|FG003|Overall Study|Adverse Event|0|||
19747041|NCT03738241|42194456|FG004|Overall Study|Adverse Event|0|||
19747042|NCT03738241|42194457|FG005|Overall Study|Adverse Event|0|||
19747043|NCT03738241|42194458|FG006|Overall Study|Adverse Event|0|||
19747044|NCT03738241|42194459|FG007|Overall Study|Adverse Event|0|||
19747045|NCT03738241|42194460|FG008|Overall Study|Adverse Event|0|||
19747046|NCT03738241|42194461|FG009|Overall Study|Adverse Event|0|||
19596306|NCT00830128|42045164|FG000|Overall Study|Relocation|1|||
19596307|NCT00830128|42045164|FG000|Overall Study|Work obligation|1|||
19596308|NCT00830128|42045164|FG000|Overall Study|Operating a vehicle|1|||
19596309|NCT00841906|42045170|FG000|Overall Study|Withdrawal by Subject|2|||
19596310|NCT00841906|42045171|FG001|Overall Study|Withdrawal by Subject|0|||
19596311|NCT00771667|42045183|FG000|Induction Phase|Adverse Event|5|||
19747047|NCT03430245|42194483|FG000|Overall Study|Withdrawal by Subject|6|||
19747048|NCT03430245|42194483|FG000|Overall Study|Lost to Follow-up|1|||
19747049|NCT03461289|42194487|FG000|Overall Study|Death|1|||
19747050|NCT03428997|42194491|FG000|Overall Study|Sponsor decision.|1|||
19747051|NCT03428997|42194491|FG000|Overall Study|Withdrawal by Subject|3|||
19747052|NCT03428997|42194491|FG000|Overall Study|Lost to Follow-up|4|||
19747053|NCT03452943|42194499|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
19747054|NCT03452943|42194500|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
19747055|NCT03452943|42194499|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
19747056|NCT03452943|42194500|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
19747057|NCT03452943|42194499|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
19596312|NCT00771667|42045184|FG001|Induction Phase|Adverse Event|2|||
19596313|NCT00771667|42045185|FG002|Induction Phase|Adverse Event|4|||
19596314|NCT00771667|42045186|FG003|Induction Phase|Adverse Event|1|||
19596315|NCT00771667|42045187|FG004|Induction Phase|Adverse Event|0|||
19596316|NCT00771667|42045188|FG005|Induction Phase|Adverse Event|0|||
19596317|NCT00771667|42045189|FG006|Induction Phase|Adverse Event|0|||
19596318|NCT00771667|42045190|FG007|Induction Phase|Adverse Event|0|||
19596319|NCT00771667|42045191|FG008|Induction Phase|Adverse Event|0|||
19596320|NCT00771667|42045192|FG009|Induction Phase|Adverse Event|0|||
19596321|NCT00771667|42045183|FG000|Induction Phase|Lack of Efficacy|9|||
19596322|NCT00771667|42045184|FG001|Induction Phase|Lack of Efficacy|2|||
19596323|NCT00771667|42045185|FG002|Induction Phase|Lack of Efficacy|4|||
19596324|NCT00771667|42045186|FG003|Induction Phase|Lack of Efficacy|3|||
19596325|NCT00771667|42045187|FG004|Induction Phase|Lack of Efficacy|0|||
19596326|NCT00771667|42045188|FG005|Induction Phase|Lack of Efficacy|0|||
19596327|NCT00771667|42045189|FG006|Induction Phase|Lack of Efficacy|0|||
19596328|NCT00771667|42045190|FG007|Induction Phase|Lack of Efficacy|0|||
19747058|NCT03452943|42194500|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
19747059|NCT03452943|42194499|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
19596329|NCT00771667|42045191|FG008|Induction Phase|Lack of Efficacy|0|||
19596330|NCT00771667|42045192|FG009|Induction Phase|Lack of Efficacy|0|||
19596331|NCT00771667|42045183|FG000|Induction Phase|Lost to Follow-up|1|||
19596332|NCT00771667|42045184|FG001|Induction Phase|Lost to Follow-up|0|||
19596333|NCT00771667|42045185|FG002|Induction Phase|Lost to Follow-up|1|||
19596334|NCT00771667|42045186|FG003|Induction Phase|Lost to Follow-up|0|||
19596335|NCT00771667|42045187|FG004|Induction Phase|Lost to Follow-up|0|||
19596336|NCT00771667|42045188|FG005|Induction Phase|Lost to Follow-up|0|||
19596337|NCT00771667|42045189|FG006|Induction Phase|Lost to Follow-up|0|||
19596338|NCT00771667|42045190|FG007|Induction Phase|Lost to Follow-up|0|||
19596339|NCT00771667|42045191|FG008|Induction Phase|Lost to Follow-up|0|||
19596340|NCT00771667|42045192|FG009|Induction Phase|Lost to Follow-up|0|||
19747060|NCT03452943|42194500|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
19596341|NCT00771667|42045183|FG000|Induction Phase|Other|4|||
19596342|NCT00771667|42045184|FG001|Induction Phase|Other|6|||
19596343|NCT00771667|42045185|FG002|Induction Phase|Other|3|||
19596344|NCT00771667|42045186|FG003|Induction Phase|Other|4|||
19596345|NCT00771667|42045187|FG004|Induction Phase|Other|0|||
19596346|NCT00771667|42045188|FG005|Induction Phase|Other|0|||
19596347|NCT00771667|42045189|FG006|Induction Phase|Other|0|||
19596348|NCT00771667|42045190|FG007|Induction Phase|Other|0|||
19596349|NCT00771667|42045191|FG008|Induction Phase|Other|0|||
19596350|NCT00771667|42045192|FG009|Induction Phase|Other|0|||
19596351|NCT00771667|42045183|FG000|Maintenance Phase|Adverse Event|0|||
19596352|NCT00771667|42045184|FG001|Maintenance Phase|Adverse Event|0|||
19596353|NCT00771667|42045185|FG002|Maintenance Phase|Adverse Event|0|||
19596354|NCT00771667|42045186|FG003|Maintenance Phase|Adverse Event|0|||
19596355|NCT00771667|42045187|FG004|Maintenance Phase|Adverse Event|1|||
19596356|NCT00771667|42045188|FG005|Maintenance Phase|Adverse Event|3|||
19596357|NCT00771667|42045189|FG006|Maintenance Phase|Adverse Event|5|||
19596358|NCT00771667|42045190|FG007|Maintenance Phase|Adverse Event|1|||
19596359|NCT00771667|42045191|FG008|Maintenance Phase|Adverse Event|8|||
19596360|NCT00771667|42045192|FG009|Maintenance Phase|Adverse Event|7|||
19596361|NCT00771667|42045183|FG000|Maintenance Phase|Lack of Efficacy|0|||
19596362|NCT00771667|42045184|FG001|Maintenance Phase|Lack of Efficacy|0|||
19596363|NCT00771667|42045185|FG002|Maintenance Phase|Lack of Efficacy|0|||
19596364|NCT00771667|42045186|FG003|Maintenance Phase|Lack of Efficacy|0|||
19596365|NCT00771667|42045187|FG004|Maintenance Phase|Lack of Efficacy|1|||
19596366|NCT00771667|42045188|FG005|Maintenance Phase|Lack of Efficacy|3|||
19596367|NCT00771667|42045189|FG006|Maintenance Phase|Lack of Efficacy|3|||
19596368|NCT00771667|42045190|FG007|Maintenance Phase|Lack of Efficacy|2|||
19596369|NCT00771667|42045191|FG008|Maintenance Phase|Lack of Efficacy|11|||
19596370|NCT00771667|42045192|FG009|Maintenance Phase|Lack of Efficacy|7|||
19596371|NCT00771667|42045183|FG000|Maintenance Phase|Other|0|||
19596372|NCT00771667|42045184|FG001|Maintenance Phase|Other|0|||
19596373|NCT00771667|42045185|FG002|Maintenance Phase|Other|0|||
19596374|NCT00771667|42045186|FG003|Maintenance Phase|Other|0|||
19596375|NCT00771667|42045187|FG004|Maintenance Phase|Other|0|||
19596376|NCT00771667|42045188|FG005|Maintenance Phase|Other|1|||
19596377|NCT00771667|42045189|FG006|Maintenance Phase|Other|2|||
19747061|NCT03452943|42194499|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
19747062|NCT03452943|42194500|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
19747063|NCT03452943|42194499|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
19747064|NCT03452943|42194500|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
19747065|NCT03481725|42194508|FG000|Overall Study|Withdrawal by Subject|1|||
19596378|NCT00771667|42045190|FG007|Maintenance Phase|Other|2|||
19596379|NCT00771667|42045191|FG008|Maintenance Phase|Other|3|||
19596380|NCT00771667|42045192|FG009|Maintenance Phase|Other|3|||
19596381|NCT00770965|42045214|FG000|Safety Set|Withdrawal by Subject|0|||
19596382|NCT00770965|42045215|FG001|Safety Set|Withdrawal by Subject|0|||
19596383|NCT00770965|42045216|FG002|Safety Set|Withdrawal by Subject|0|||
19596384|NCT00770965|42045217|FG003|Safety Set|Withdrawal by Subject|1|||
19596385|NCT00770965|42045214|FG000|Safety Set|Protocol deviation|0|||
19596386|NCT00770965|42045215|FG001|Safety Set|Protocol deviation|0|||
19596387|NCT00770965|42045216|FG002|Safety Set|Protocol deviation|1|||
19596388|NCT00770965|42045217|FG003|Safety Set|Protocol deviation|0|||
19596389|NCT00770965|42045214|FG000|Excluded Set|Administrative problems|14|||
19596390|NCT00770965|42045215|FG001|Excluded Set|Administrative problems|12|||
19596391|NCT00770965|42045216|FG002|Excluded Set|Administrative problems|12|||
19596392|NCT00770965|42045217|FG003|Excluded Set|Administrative problems|10|||
19596393|NCT00770965|42045214|FG000|Excluded Set|Withdrawal by Subject|1|||
19596394|NCT00770965|42045215|FG001|Excluded Set|Withdrawal by Subject|1|||
19596395|NCT00770965|42045216|FG002|Excluded Set|Withdrawal by Subject|2|||
19596396|NCT00770965|42045217|FG003|Excluded Set|Withdrawal by Subject|3|||
19747066|NCT03481725|42194509|FG001|Overall Study|Withdrawal by Subject|0|||
19747067|NCT03480243|42194517|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
19596397|NCT00763555|42045229|FG000|Overall Study|Adverse Event|2|||
19596398|NCT00763555|42045230|FG001|Overall Study|Adverse Event|1|||
19596399|NCT00763555|42045229|FG000|Overall Study|Withdrawal by Subject|2|||
19596400|NCT00763555|42045230|FG001|Overall Study|Withdrawal by Subject|6|||
19747068|NCT03480243|42194517|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
19747069|NCT03426345|42194532|FG000|Overall Study|Adverse Event|4|||
19747070|NCT03426345|42194533|FG001|Overall Study|Adverse Event|4|||
19596401|NCT00763555|42045229|FG000|Overall Study|Lost to Follow-up|0|||
19596402|NCT00763555|42045230|FG001|Overall Study|Lost to Follow-up|3|||
19596403|NCT00763321|42045239|FG000|Open-label Period|Adverse Event|24|||
19596404|NCT00763321|42045240|FG001|Open-label Period|Adverse Event|0|||
19596405|NCT00763321|42045241|FG002|Open-label Period|Adverse Event|0|||
19596406|NCT00763321|42045239|FG000|Open-label Period|Lost to Follow-up|14|||
19596407|NCT00763321|42045240|FG001|Open-label Period|Lost to Follow-up|0|||
19596408|NCT00763321|42045241|FG002|Open-label Period|Lost to Follow-up|0|||
19596409|NCT00763321|42045239|FG000|Open-label Period|Withdrawal by Subject|7|||
19596410|NCT00763321|42045240|FG001|Open-label Period|Withdrawal by Subject|0|||
19596411|NCT00763321|42045241|FG002|Open-label Period|Withdrawal by Subject|0|||
19596412|NCT00763321|42045239|FG000|Open-label Period|Subject noncompliant|7|||
19596413|NCT00763321|42045240|FG001|Open-label Period|Subject noncompliant|0|||
19596414|NCT00763321|42045241|FG002|Open-label Period|Subject noncompliant|0|||
19596415|NCT00763321|42045239|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
19596416|NCT00763321|42045240|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
19596417|NCT00763321|42045241|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
19596418|NCT00763321|42045239|FG000|Open-label Period|Lack of Efficacy|2|||
19596419|NCT00763321|42045240|FG001|Open-label Period|Lack of Efficacy|0|||
19596420|NCT00763321|42045241|FG002|Open-label Period|Lack of Efficacy|0|||
19596421|NCT00763321|42045239|FG000|Open-label Period|Other|4|||
19596422|NCT00763321|42045240|FG001|Open-label Period|Other|0|||
19596423|NCT00763321|42045241|FG002|Open-label Period|Other|0|||
19596424|NCT00763321|42045239|FG000|Double-blind Period|Lack of Efficacy|0|||
19596425|NCT00763321|42045240|FG001|Double-blind Period|Lack of Efficacy|9|||
19596426|NCT00763321|42045241|FG002|Double-blind Period|Lack of Efficacy|17|||
19596427|NCT00763321|42045239|FG000|Double-blind Period|Adverse Event|0|||
19596428|NCT00763321|42045240|FG001|Double-blind Period|Adverse Event|4|||
19596429|NCT00763321|42045241|FG002|Double-blind Period|Adverse Event|4|||
19596430|NCT00763321|42045239|FG000|Double-blind Period|Lost to Follow-up|0|||
19596431|NCT00763321|42045240|FG001|Double-blind Period|Lost to Follow-up|4|||
19596432|NCT00763321|42045241|FG002|Double-blind Period|Lost to Follow-up|2|||
19596433|NCT00763321|42045239|FG000|Double-blind Period|Withdrawal by Subject|0|||
19596434|NCT00763321|42045240|FG001|Double-blind Period|Withdrawal by Subject|2|||
19596435|NCT00763321|42045241|FG002|Double-blind Period|Withdrawal by Subject|3|||
19596436|NCT00763321|42045239|FG000|Double-blind Period|Other|0|||
19596437|NCT00763321|42045240|FG001|Double-blind Period|Other|2|||
19596438|NCT00763321|42045241|FG002|Double-blind Period|Other|3|||
19596439|NCT00770653|42045250|FG000|Overall Study|Adverse Event|13|||
19596440|NCT00770653|42045251|FG001|Overall Study|Adverse Event|5|||
19596441|NCT00770653|42045250|FG000|Overall Study|Protocol Violation|8|||
19596442|NCT00770653|42045251|FG001|Overall Study|Protocol Violation|6|||
19596443|NCT00770653|42045250|FG000|Overall Study|Withdrawal by Subject|4|||
19596444|NCT00770653|42045251|FG001|Overall Study|Withdrawal by Subject|7|||
19596445|NCT00770653|42045250|FG000|Overall Study|Lack of Compliance|1|||
19596446|NCT00770653|42045251|FG001|Overall Study|Lack of Compliance|4|||
19596447|NCT00770653|42045250|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
19596448|NCT00770653|42045251|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
19596449|NCT00770653|42045250|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
19596450|NCT00770653|42045251|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
19596451|NCT00770653|42045250|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
19596452|NCT00770653|42045251|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
19596453|NCT00770653|42045250|FG000|Overall Study|Lost to Follow-up|1|||
19596454|NCT00770653|42045251|FG001|Overall Study|Lost to Follow-up|2|||
19596455|NCT00770653|42045250|FG000|Overall Study|Physician Decision|1|||
19596456|NCT00770653|42045251|FG001|Overall Study|Physician Decision|0|||
19596457|NCT00819052|42045259|FG000|Overall Study|Adverse Event|0|||
19596458|NCT00819052|42045260|FG001|Overall Study|Adverse Event|5|||
19596459|NCT00819052|42045259|FG000|Overall Study|Protocol Violation|1|||
19596460|NCT00819052|42045260|FG001|Overall Study|Protocol Violation|2|||
19596461|NCT00819052|42045259|FG000|Overall Study|Lost to Follow-up|1|||
19596462|NCT00819052|42045260|FG001|Overall Study|Lost to Follow-up|2|||
19596463|NCT00819052|42045259|FG000|Overall Study|Withdrawal by Subject|1|||
19596464|NCT00819052|42045260|FG001|Overall Study|Withdrawal by Subject|2|||
19596465|NCT00819052|42045259|FG000|Overall Study|Lack of Efficacy|1|||
19596466|NCT00819052|42045260|FG001|Overall Study|Lack of Efficacy|1|||
19596467|NCT00819052|42045259|FG000|Overall Study|Pregnancy|1|||
19596468|NCT00819052|42045260|FG001|Overall Study|Pregnancy|2|||
19596469|NCT00819052|42045259|FG000|Overall Study|Death or events leading to death|1|||
19596470|NCT00819052|42045260|FG001|Overall Study|Death or events leading to death|0|||
19596471|NCT00763009|42045269|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
19596472|NCT00841672|42045276|FG000|Overall Study|Adverse Event|7|||
19596473|NCT00841672|42045277|FG001|Overall Study|Adverse Event|16|||
19596474|NCT00841672|42045276|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19596475|NCT00841672|42045277|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19596476|NCT00841672|42045276|FG000|Overall Study|Subject withdrew consent|2|||
19596477|NCT00841672|42045277|FG001|Overall Study|Subject withdrew consent|4|||
19596478|NCT00841672|42045276|FG000|Overall Study|Lost to Follow-up|1|||
19596479|NCT00841672|42045277|FG001|Overall Study|Lost to Follow-up|1|||
19596480|NCT00841672|42045276|FG000|Overall Study|Administrative problems|9|||
19596481|NCT00841672|42045277|FG001|Overall Study|Administrative problems|9|||
19596482|NCT00841672|42045276|FG000|Overall Study|Misrandomized|1|||
19596483|NCT00841672|42045277|FG001|Overall Study|Misrandomized|0|||
19596484|NCT00841672|42045276|FG000|Overall Study|Protocol Deviation|0|||
19596485|NCT00841672|42045277|FG001|Overall Study|Protocol Deviation|1|||
19596486|NCT00908232|42045283|FG000|Cycle 1 to 4|Death|5|||
19596487|NCT00908232|42045284|FG001|Cycle 1 to 4|Death|0|||
19596488|NCT00908232|42045285|FG002|Cycle 1 to 4|Death|0|||
19596489|NCT00908232|42045286|FG003|Cycle 1 to 4|Death|0|||
19596490|NCT00908232|42045283|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
19596491|NCT00908232|42045284|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
19596492|NCT00908232|42045285|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
19596493|NCT00908232|42045286|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
19596494|NCT00908232|42045283|FG000|Cycle 1 to 4|Progressive Disease|6|||
19596495|NCT00908232|42045284|FG001|Cycle 1 to 4|Progressive Disease|0|||
19596496|NCT00908232|42045285|FG002|Cycle 1 to 4|Progressive Disease|0|||
19596497|NCT00908232|42045286|FG003|Cycle 1 to 4|Progressive Disease|0|||
19596498|NCT00908232|42045283|FG000|Cycle 1 to 4|Adverse Event|12|||
19596499|NCT00908232|42045284|FG001|Cycle 1 to 4|Adverse Event|0|||
19596500|NCT00908232|42045285|FG002|Cycle 1 to 4|Adverse Event|0|||
19596501|NCT00908232|42045286|FG003|Cycle 1 to 4|Adverse Event|0|||
19596502|NCT00908232|42045283|FG000|Cycle 1 to 4|Other|1|||
19596503|NCT00908232|42045284|FG001|Cycle 1 to 4|Other|0|||
19596504|NCT00908232|42045285|FG002|Cycle 1 to 4|Other|0|||
19596505|NCT00908232|42045286|FG003|Cycle 1 to 4|Other|0|||
19596506|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
19596507|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
19596508|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
19596509|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
19747071|NCT03426345|42194532|FG000|Overall Study|Lack of Efficacy|1|||
19747072|NCT03426345|42194533|FG001|Overall Study|Lack of Efficacy|0|||
19747073|NCT03426345|42194532|FG000|Overall Study|Withdrawal by Subject|5|||
19747074|NCT03426345|42194533|FG001|Overall Study|Withdrawal by Subject|6|||
19747075|NCT03426345|42194532|FG000|Overall Study|Lost to Follow-up|3|||
19747076|NCT03426345|42194533|FG001|Overall Study|Lost to Follow-up|1|||
19747077|NCT03426345|42194532|FG000|Overall Study|Protocol Deviation|3|||
19747078|NCT03426345|42194533|FG001|Overall Study|Protocol Deviation|4|||
19747079|NCT03426345|42194532|FG000|Overall Study|Reason Not Specified|1|||
19747080|NCT03426345|42194533|FG001|Overall Study|Reason Not Specified|2|||
19596510|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
19596511|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
19596512|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
19596513|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
19596514|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
19596515|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
19596516|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
19596517|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
19596518|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
19596519|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
19596520|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
19596521|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
19747081|NCT03426345|42194532|FG000|Overall Study|Missing Completion Status|1|||
19596522|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
19596523|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
19596524|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
19596525|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
19747082|NCT03426345|42194533|FG001|Overall Study|Missing Completion Status|0|||
19596526|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
19596527|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
19596528|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
19596529|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
19596530|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
19596531|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
19596532|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
19596533|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
19596534|NCT00908232|42045283|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
19596535|NCT00908232|42045284|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
19596536|NCT00908232|42045285|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
19596537|NCT00908232|42045286|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
19596538|NCT00770341|42045295|FG000|Overall Study|Did not meet eligibility criteria|1|||
19596539|NCT00770341|42045296|FG001|Overall Study|Did not meet eligibility criteria|0|||
19596540|NCT00770341|42045297|FG002|Overall Study|Did not meet eligibility criteria|0|||
19596541|NCT00770341|42045295|FG000|Overall Study|Withdrawal by Subject|0|||
19596542|NCT00770341|42045296|FG001|Overall Study|Withdrawal by Subject|1|||
19596543|NCT00770341|42045297|FG002|Overall Study|Withdrawal by Subject|0|||
19596544|NCT00770341|42045295|FG000|Overall Study|Clinical Adverse Event|3|||
19596545|NCT00770341|42045296|FG001|Overall Study|Clinical Adverse Event|1|||
19596546|NCT00770341|42045297|FG002|Overall Study|Clinical Adverse Event|2|||
19596547|NCT00770341|42045295|FG000|Overall Study|Laboratory adverse event|3|||
19596548|NCT00770341|42045296|FG001|Overall Study|Laboratory adverse event|3|||
19596549|NCT00770341|42045297|FG002|Overall Study|Laboratory adverse event|0|||
19596550|NCT00770341|42045295|FG000|Overall Study|Lack of Efficacy|3|||
19596551|NCT00770341|42045296|FG001|Overall Study|Lack of Efficacy|0|||
19596552|NCT00770341|42045297|FG002|Overall Study|Lack of Efficacy|1|||
19596553|NCT00770341|42045295|FG000|Overall Study|Other|1|||
19596554|NCT00770341|42045296|FG001|Overall Study|Other|0|||
19596555|NCT00770341|42045297|FG002|Overall Study|Other|0|||
19596556|NCT00770341|42045295|FG000|Overall Study|Not treated|1|||
19596557|NCT00770341|42045296|FG001|Overall Study|Not treated|0|||
19596558|NCT00770341|42045297|FG002|Overall Study|Not treated|0|||
19596559|NCT00762463|42045314|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
19596560|NCT00762463|42045315|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
19596561|NCT00762463|42045316|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
19596562|NCT00762463|42045317|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
19596563|NCT00762463|42045314|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
19596564|NCT00762463|42045315|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
19596565|NCT00762463|42045316|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
19596566|NCT00762463|42045317|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
19596567|NCT00762463|42045314|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
19596568|NCT00762463|42045315|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
19596569|NCT00762463|42045316|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
19596570|NCT00762463|42045317|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
19596571|NCT00762463|42045314|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
19596572|NCT00762463|42045315|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
19596573|NCT00762463|42045316|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
19596574|NCT00762463|42045317|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
19596575|NCT00762463|42045314|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
19596576|NCT00762463|42045315|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
19596577|NCT00762463|42045316|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
19596578|NCT00762463|42045317|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
19596579|NCT00762463|42045314|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
19596580|NCT00762463|42045315|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
19596581|NCT00762463|42045316|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
19596582|NCT00762463|42045317|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
19596583|NCT00762463|42045314|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
19596584|NCT00762463|42045315|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
19596585|NCT00762463|42045316|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
19596586|NCT00762463|42045317|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
19596587|NCT00762463|42045314|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
19596588|NCT00762463|42045315|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
19596589|NCT00762463|42045316|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
19596590|NCT00762463|42045317|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
19596591|NCT00762385|42045330|FG000|First Intervention|Lens Issue|1|||
19596592|NCT00762385|42045331|FG001|First Intervention|Lens Issue|1|||
19596593|NCT00762385|42045330|FG000|First Intervention|Lost to Follow-up|0|||
19596594|NCT00762385|42045331|FG001|First Intervention|Lost to Follow-up|2|||
19596595|NCT00762385|42045330|FG000|First Intervention|Ineligible|1|||
19596596|NCT00762385|42045331|FG001|First Intervention|Ineligible|0|||
19596597|NCT00762385|42045330|FG000|First Intervention|Protocol Violation|0|||
19596598|NCT00762385|42045331|FG001|First Intervention|Protocol Violation|1|||
19596599|NCT00762385|42045330|FG000|Second Intervention|Protocol Violation|3|||
19596600|NCT00762385|42045331|FG001|Second Intervention|Protocol Violation|3|||
19596601|NCT00906282|42045340|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
19596602|NCT00906282|42045340|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
19596603|NCT00906282|42045340|FG000|Preoperative Chemotherapy|Progressive disease|6|||
19596604|NCT00906282|42045340|FG000|Preoperative Chemotherapy|Toxicity|1|||
19596605|NCT00762229|42045347|FG000|Overall Study|Lost to Follow-up|1|||
19596606|NCT00762229|42045348|FG001|Overall Study|Lost to Follow-up|1|||
19596607|NCT00762229|42045347|FG000|Overall Study|did not recveive intervention|0|||
19596608|NCT00762229|42045348|FG001|Overall Study|did not recveive intervention|1|||
19596609|NCT00907374|42045356|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
19596610|NCT00907374|42045357|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
19596611|NCT00818662|42045367|FG000|Overall Study|Adverse Event|5|||
19596612|NCT00818662|42045368|FG001|Overall Study|Adverse Event|14|||
19596613|NCT00818662|42045369|FG002|Overall Study|Adverse Event|4|||
19596614|NCT00818662|42045370|FG003|Overall Study|Adverse Event|3|||
19596615|NCT00818662|42045367|FG000|Overall Study|Withdrawal by Subject|5|||
19596616|NCT00818662|42045368|FG001|Overall Study|Withdrawal by Subject|4|||
19596617|NCT00818662|42045369|FG002|Overall Study|Withdrawal by Subject|2|||
19596618|NCT00818662|42045370|FG003|Overall Study|Withdrawal by Subject|2|||
19596619|NCT00818662|42045367|FG000|Overall Study|Death|1|||
19596620|NCT00818662|42045368|FG001|Overall Study|Death|3|||
19596621|NCT00818662|42045369|FG002|Overall Study|Death|0|||
19596622|NCT00818662|42045370|FG003|Overall Study|Death|0|||
19596623|NCT00818662|42045367|FG000|Overall Study|Physician Decision|1|||
19596624|NCT00818662|42045368|FG001|Overall Study|Physician Decision|0|||
19596625|NCT00818662|42045369|FG002|Overall Study|Physician Decision|0|||
19596626|NCT00818662|42045370|FG003|Overall Study|Physician Decision|0|||
19596627|NCT00818662|42045367|FG000|Overall Study|Lost to Follow-up|0|||
19596628|NCT00818662|42045368|FG001|Overall Study|Lost to Follow-up|0|||
19596629|NCT00818662|42045369|FG002|Overall Study|Lost to Follow-up|0|||
19596630|NCT00818662|42045370|FG003|Overall Study|Lost to Follow-up|1|||
19596631|NCT00818662|42045367|FG000|Overall Study|Unwilling or Unable to Participate|4|||
19596632|NCT00818662|42045368|FG001|Overall Study|Unwilling or Unable to Participate|6|||
19596633|NCT00818662|42045369|FG002|Overall Study|Unwilling or Unable to Participate|2|||
19596634|NCT00818662|42045370|FG003|Overall Study|Unwilling or Unable to Participate|4|||
19596635|NCT00818662|42045367|FG000|Overall Study|Protocol Violation|1|||
19596636|NCT00818662|42045368|FG001|Overall Study|Protocol Violation|1|||
19596637|NCT00818662|42045369|FG002|Overall Study|Protocol Violation|0|||
19596638|NCT00818662|42045370|FG003|Overall Study|Protocol Violation|0|||
19596639|NCT00818662|42045367|FG000|Overall Study|Requires a Prohibited Medication|1|||
19596640|NCT00818662|42045368|FG001|Overall Study|Requires a Prohibited Medication|0|||
19596641|NCT00818662|42045369|FG002|Overall Study|Requires a Prohibited Medication|0|||
19596642|NCT00818662|42045370|FG003|Overall Study|Requires a Prohibited Medication|0|||
19596643|NCT00818662|42045367|FG000|Overall Study|Safety Risk|1|||
19596644|NCT00818662|42045368|FG001|Overall Study|Safety Risk|1|||
19596645|NCT00818662|42045369|FG002|Overall Study|Safety Risk|0|||
19596646|NCT00818662|42045370|FG003|Overall Study|Safety Risk|1|||
19596647|NCT00818662|42045367|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
19596648|NCT00818662|42045368|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
19596649|NCT00818662|42045369|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
19596650|NCT00818662|42045370|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
19596651|NCT00818662|42045367|FG000|Overall Study|Participant's health declined|0|||
19596652|NCT00818662|42045368|FG001|Overall Study|Participant's health declined|0|||
19596653|NCT00818662|42045369|FG002|Overall Study|Participant's health declined|0|||
19596654|NCT00818662|42045370|FG003|Overall Study|Participant's health declined|1|||
19596655|NCT00818662|42045367|FG000|Overall Study|Caregiver to pursue other treatment|0|||
19596656|NCT00818662|42045368|FG001|Overall Study|Caregiver to pursue other treatment|1|||
19596657|NCT00818662|42045369|FG002|Overall Study|Caregiver to pursue other treatment|0|||
19596658|NCT00818662|42045370|FG003|Overall Study|Caregiver to pursue other treatment|0|||
19747083|NCT03426267|42194542|FG000|Overall Study|Physician Decision|1|||
19596659|NCT00818662|42045367|FG000|Overall Study|Moving out of state|0|||
19596660|NCT00818662|42045368|FG001|Overall Study|Moving out of state|0|||
19596661|NCT00818662|42045369|FG002|Overall Study|Moving out of state|0|||
19596662|NCT00818662|42045370|FG003|Overall Study|Moving out of state|1|||
19596663|NCT00818662|42045367|FG000|Overall Study|Declined move to another study site|1|||
19596664|NCT00818662|42045368|FG001|Overall Study|Declined move to another study site|0|||
19596665|NCT00818662|42045369|FG002|Overall Study|Declined move to another study site|0|||
19596666|NCT00818662|42045370|FG003|Overall Study|Declined move to another study site|0|||
19596667|NCT00818662|42045367|FG000|Overall Study|Change in living situation|0|||
19596668|NCT00818662|42045368|FG001|Overall Study|Change in living situation|0|||
19596669|NCT00818662|42045369|FG002|Overall Study|Change in living situation|0|||
19596670|NCT00818662|42045370|FG003|Overall Study|Change in living situation|1|||
19596671|NCT00818662|42045367|FG000|Overall Study|Study partner decision|0|||
19596672|NCT00818662|42045368|FG001|Overall Study|Study partner decision|0|||
19596673|NCT00818662|42045369|FG002|Overall Study|Study partner decision|0|||
19596674|NCT00818662|42045370|FG003|Overall Study|Study partner decision|1|||
19596675|NCT00818662|42045367|FG000|Overall Study|Admitted to long term nursing care|0|||
19596676|NCT00818662|42045368|FG001|Overall Study|Admitted to long term nursing care|1|||
19596677|NCT00818662|42045369|FG002|Overall Study|Admitted to long term nursing care|0|||
19596678|NCT00818662|42045370|FG003|Overall Study|Admitted to long term nursing care|0|||
19596679|NCT00903786|42045381|FG000|Overall Study|Physician Decision|6|||
19596680|NCT00903786|42045381|FG000|Overall Study|Lack of Efficacy|5|||
19596681|NCT00903786|42045381|FG000|Overall Study|Reason other than lack of efficacy|4|||
19596682|NCT00762073|42045390|FG000|Overall Study|Lack of Efficacy|1|||
19596683|NCT00762073|42045391|FG001|Overall Study|Lack of Efficacy|1|||
19596684|NCT00762073|42045392|FG002|Overall Study|Lack of Efficacy|0|||
19596685|NCT00762073|42045393|FG003|Overall Study|Lack of Efficacy|0|||
19596686|NCT00762073|42045390|FG000|Overall Study|Adverse Event|1|||
19596687|NCT00762073|42045391|FG001|Overall Study|Adverse Event|0|||
19596688|NCT00762073|42045392|FG002|Overall Study|Adverse Event|1|||
19596689|NCT00762073|42045393|FG003|Overall Study|Adverse Event|1|||
19596690|NCT00762073|42045390|FG000|Overall Study|Significant Subject Noncompliance|0|||
19596691|NCT00762073|42045391|FG001|Overall Study|Significant Subject Noncompliance|1|||
19596692|NCT00762073|42045392|FG002|Overall Study|Significant Subject Noncompliance|0|||
19596693|NCT00762073|42045393|FG003|Overall Study|Significant Subject Noncompliance|1|||
19596694|NCT00762073|42045390|FG000|Overall Study|Withdrawal by Subject|1|||
19596695|NCT00762073|42045391|FG001|Overall Study|Withdrawal by Subject|2|||
19596696|NCT00762073|42045392|FG002|Overall Study|Withdrawal by Subject|1|||
19596697|NCT00762073|42045393|FG003|Overall Study|Withdrawal by Subject|1|||
19596698|NCT00762073|42045390|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
19596699|NCT00762073|42045391|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
19596700|NCT00762073|42045392|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
19596701|NCT00762073|42045393|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
19596702|NCT00761761|42045412|FG000|Overall Study|Lost to Follow-up|3|||
19596703|NCT00761761|42045413|FG001|Overall Study|Lost to Follow-up|1|||
19596704|NCT00761761|42045412|FG000|Overall Study|Withdrawal by Subject|3|||
19596705|NCT00761761|42045413|FG001|Overall Study|Withdrawal by Subject|0|||
19596706|NCT00761605|42045421|FG000|Overall Study|Adverse Event|26|||
19596707|NCT00761605|42045421|FG000|Overall Study|Death|2|||
19596708|NCT00761605|42045421|FG000|Overall Study|Lack of Efficacy|26|||
19596709|NCT00761605|42045421|FG000|Overall Study|Lost to Follow-up|29|||
19596710|NCT00761605|42045421|FG000|Overall Study|Withdrawal by Subject|37|||
19596711|NCT00761605|42045421|FG000|Overall Study|Other|21|||
19596712|NCT00761527|42045429|FG000|Overall Study|Adverse Event|3|||
19596713|NCT00761527|42045429|FG000|Overall Study|Poor Compliance|8|||
19596714|NCT00761527|42045429|FG000|Overall Study|Lost to Follow-up|9|||
19596715|NCT00761527|42045429|FG000|Overall Study|Unknown reason|2|||
19596716|NCT00770029|42045435|FG000|Overall Study|Lost to Follow-up|2|||
19596717|NCT00770029|42045436|FG001|Overall Study|Lost to Follow-up|0|||
19596718|NCT00770029|42045435|FG000|Overall Study|Withdrawal by Subject|3|||
19596719|NCT00770029|42045436|FG001|Overall Study|Withdrawal by Subject|3|||
19596720|NCT00770029|42045435|FG000|Overall Study|Adverse Event|1|||
19596721|NCT00770029|42045436|FG001|Overall Study|Adverse Event|0|||
19596722|NCT00817414|42045447|FG000|Overall Study|Adverse Event|1|||
19596723|NCT00817414|42045448|FG001|Overall Study|Adverse Event|1|||
19596724|NCT00817414|42045449|FG002|Overall Study|Adverse Event|1|||
19596725|NCT00817414|42045450|FG003|Overall Study|Adverse Event|0|||
19596726|NCT00817414|42045451|FG004|Overall Study|Adverse Event|0|||
19596727|NCT00817414|42045447|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
19596728|NCT00817414|42045448|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
19596729|NCT00817414|42045449|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
19596730|NCT00817414|42045450|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
19596731|NCT00817414|42045451|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
19596732|NCT00817414|42045447|FG000|Overall Study|Withdrawal by Subject|1|||
19596733|NCT00817414|42045448|FG001|Overall Study|Withdrawal by Subject|1|||
19596734|NCT00817414|42045449|FG002|Overall Study|Withdrawal by Subject|0|||
19596735|NCT00817414|42045450|FG003|Overall Study|Withdrawal by Subject|0|||
19596736|NCT00817414|42045451|FG004|Overall Study|Withdrawal by Subject|0|||
19596737|NCT00817414|42045447|FG000|Overall Study|Lost to Follow-up|0|||
19596738|NCT00817414|42045448|FG001|Overall Study|Lost to Follow-up|0|||
19596739|NCT00817414|42045449|FG002|Overall Study|Lost to Follow-up|1|||
19596740|NCT00817414|42045450|FG003|Overall Study|Lost to Follow-up|1|||
19596741|NCT00817414|42045451|FG004|Overall Study|Lost to Follow-up|1|||
19596742|NCT00817414|42045447|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
19596743|NCT00817414|42045448|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
19596744|NCT00817414|42045449|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
19596745|NCT00817414|42045450|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
19596746|NCT00817414|42045451|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
19596747|NCT00817414|42045447|FG000|Overall Study|Protocol Violation|0|||
19596748|NCT00817414|42045448|FG001|Overall Study|Protocol Violation|0|||
19596749|NCT00817414|42045449|FG002|Overall Study|Protocol Violation|0|||
19596750|NCT00817414|42045450|FG003|Overall Study|Protocol Violation|0|||
19596751|NCT00817414|42045451|FG004|Overall Study|Protocol Violation|1|||
19596752|NCT00769561|42045470|FG000|Overall Study|Withdrawal by Subject|2|||
19596753|NCT00769561|42045471|FG001|Overall Study|Withdrawal by Subject|2|||
19596754|NCT00769561|42045470|FG000|Overall Study|Lost to Follow-up|1|||
19596755|NCT00769561|42045471|FG001|Overall Study|Lost to Follow-up|3|||
19596756|NCT00817336|42045479|FG000|Overall Study|Withdrawal by Subject|1|||
19596757|NCT00817336|42045480|FG001|Overall Study|Withdrawal by Subject|1|||
19596758|NCT00761215|42045488|FG000|Overall Study|Randomized but didn't receive drug|1|||
19596759|NCT00761215|42045489|FG001|Overall Study|Randomized but didn't receive drug|1|||
19596760|NCT00761215|42045490|FG002|Overall Study|Randomized but didn't receive drug|2|||
19596761|NCT00761215|42045488|FG000|Overall Study|Lost to Follow-up|6|||
19596762|NCT00761215|42045489|FG001|Overall Study|Lost to Follow-up|3|||
19596763|NCT00761215|42045490|FG002|Overall Study|Lost to Follow-up|6|||
19596764|NCT00761215|42045488|FG000|Overall Study|Withdrawal by Subject|1|||
19596765|NCT00761215|42045489|FG001|Overall Study|Withdrawal by Subject|0|||
19596766|NCT00761215|42045490|FG002|Overall Study|Withdrawal by Subject|0|||
19596767|NCT00761215|42045488|FG000|Overall Study|Bacteremia|1|||
19596768|NCT00761215|42045489|FG001|Overall Study|Bacteremia|0|||
19596769|NCT00761215|42045490|FG002|Overall Study|Bacteremia|0|||
19596770|NCT05101122|42045523|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
19596771|NCT05101122|42045523|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
19596772|NCT05101122|42045523|FG000|AD313 80/5|Withdrawal by Subject|1|||
19596773|NCT05101122|42045523|FG000|AD313 80/10|Physician Decision|1|||
19596774|NCT05038163|42045545|FG000|Stage 1|Did not complete survey|2186|||
19596775|NCT05038163|42045546|FG001|Stage 1|Did not complete survey|0|||
19596776|NCT05038163|42045547|FG002|Stage 1|Did not complete survey|0|||
19596777|NCT05038163|42045548|FG003|Stage 1|Did not complete survey|0|||
19596778|NCT05038163|42045549|FG004|Stage 1|Did not complete survey|0|||
19596779|NCT05038163|42045545|FG000|Stage 2|Did not complete Stage 2 survey|0|||
19596780|NCT05038163|42045546|FG001|Stage 2|Did not complete Stage 2 survey|74|||
19596781|NCT05038163|42045547|FG002|Stage 2|Did not complete Stage 2 survey|86|||
19596782|NCT05038163|42045548|FG003|Stage 2|Did not complete Stage 2 survey|96|||
19596783|NCT05038163|42045549|FG004|Stage 2|Did not complete Stage 2 survey|78|||
19596784|NCT04516746|42045576|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
19596785|NCT04516746|42045577|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
19596786|NCT04516746|42045576|FG000|Overall Study|Withdrawal by Subject|362|||
19596787|NCT04516746|42045577|FG001|Overall Study|Withdrawal by Subject|408|||
19596788|NCT04516746|42045576|FG000|Overall Study|Lost to Follow-up|157|||
19596789|NCT04516746|42045577|FG001|Overall Study|Lost to Follow-up|86|||
19596790|NCT04516746|42045576|FG000|Overall Study|Protocol deviation|18|||
19596791|NCT04516746|42045577|FG001|Overall Study|Protocol deviation|7|||
19596792|NCT04516746|42045576|FG000|Overall Study|Death|8|||
19596793|NCT04516746|42045577|FG001|Overall Study|Death|7|||
19596794|NCT04516746|42045576|FG000|Overall Study|Physician Decision|0|||
19596795|NCT04516746|42045577|FG001|Overall Study|Physician Decision|2|||
19596796|NCT04516746|42045576|FG000|Overall Study|Other|0|||
19596797|NCT04516746|42045577|FG001|Overall Study|Other|1|||
19596798|NCT04413617|42045607|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
19596799|NCT04413617|42045608|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
19596800|NCT04413617|42045609|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
19596801|NCT04413617|42045610|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
19596802|NCT04413617|42045611|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
19596803|NCT04413617|42045607|FG000|Overall Study|Protocol Violation|0|||
19596804|NCT04413617|42045608|FG001|Overall Study|Protocol Violation|1|||
19596805|NCT04413617|42045609|FG002|Overall Study|Protocol Violation|0|||
19596806|NCT04413617|42045610|FG003|Overall Study|Protocol Violation|0|||
19596807|NCT04413617|42045611|FG004|Overall Study|Protocol Violation|1|||
19596808|NCT04413617|42045607|FG000|Overall Study|Lack of Efficacy|2|||
19596809|NCT04413617|42045608|FG001|Overall Study|Lack of Efficacy|0|||
19596810|NCT04413617|42045609|FG002|Overall Study|Lack of Efficacy|2|||
19596811|NCT04413617|42045610|FG003|Overall Study|Lack of Efficacy|1|||
19596812|NCT04413617|42045611|FG004|Overall Study|Lack of Efficacy|0|||
19596813|NCT04413617|42045607|FG000|Overall Study|Withdrawal by Subject|3|||
19596814|NCT04413617|42045608|FG001|Overall Study|Withdrawal by Subject|4|||
19596815|NCT04413617|42045609|FG002|Overall Study|Withdrawal by Subject|2|||
19596816|NCT04413617|42045610|FG003|Overall Study|Withdrawal by Subject|5|||
19596817|NCT04413617|42045611|FG004|Overall Study|Withdrawal by Subject|3|||
19596818|NCT04413617|42045607|FG000|Overall Study|Death|1|||
19596819|NCT04413617|42045608|FG001|Overall Study|Death|0|||
19596820|NCT04413617|42045609|FG002|Overall Study|Death|0|||
19596821|NCT04413617|42045610|FG003|Overall Study|Death|0|||
19596822|NCT04413617|42045611|FG004|Overall Study|Death|0|||
19596823|NCT04413617|42045607|FG000|Overall Study|Adverse Event|1|||
19596824|NCT04413617|42045608|FG001|Overall Study|Adverse Event|0|||
19596825|NCT04413617|42045609|FG002|Overall Study|Adverse Event|0|||
19596826|NCT04413617|42045610|FG003|Overall Study|Adverse Event|1|||
19596827|NCT04413617|42045611|FG004|Overall Study|Adverse Event|1|||
19596828|NCT04413617|42045607|FG000|Overall Study|COVID-19|0|||
19596829|NCT04413617|42045608|FG001|Overall Study|COVID-19|1|||
19596830|NCT04413617|42045609|FG002|Overall Study|COVID-19|0|||
19596831|NCT04413617|42045610|FG003|Overall Study|COVID-19|0|||
19596832|NCT04413617|42045611|FG004|Overall Study|COVID-19|0|||
19596833|NCT04055116|42045647|FG000|First Intervention|Physician Decision|2|||
19596834|NCT04055116|42045648|FG001|First Intervention|Physician Decision|7|||
19596835|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
19596836|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
19596837|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
19596838|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
19596839|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
19596840|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
19596841|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
19596842|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
19596843|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
19596844|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
19596845|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
19596846|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
19596847|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
19596848|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
19596849|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
19596850|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
19596851|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
19596852|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
19596853|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
19596854|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
19596855|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
19596856|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
19596857|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
19596858|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
19596859|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
19596860|NCT03536884|42045698|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
19596861|NCT03536884|42045699|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
19596862|NCT03536884|42045700|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
19596863|NCT03536884|42045701|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
19596864|NCT03536884|42045702|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
19596865|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
19596866|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
19596867|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
19388087|NCT02700815|41631479|FG000|Overall Study|Adverse Event|0|||
19388088|NCT02700815|41631480|FG001|Overall Study|Adverse Event|6|||
19388089|NCT02700815|41631481|FG002|Overall Study|Adverse Event|2|||
19388090|NCT02700815|41631482|FG003|Overall Study|Adverse Event|3|||
19388091|NCT02700815|41631479|FG000|Overall Study|Lack of Efficacy|0|||
19388092|NCT02700815|41631480|FG001|Overall Study|Lack of Efficacy|0|||
19388093|NCT02700815|41631481|FG002|Overall Study|Lack of Efficacy|1|||
19388094|NCT02700815|41631482|FG003|Overall Study|Lack of Efficacy|2|||
19388095|NCT02700815|41631479|FG000|Overall Study|Lost to Follow-up|1|||
19388096|NCT02700815|41631480|FG001|Overall Study|Lost to Follow-up|0|||
19388097|NCT02700815|41631481|FG002|Overall Study|Lost to Follow-up|0|||
19388098|NCT02700815|41631482|FG003|Overall Study|Lost to Follow-up|1|||
19388099|NCT02700815|41631479|FG000|Overall Study|Refusal to continue medication|0|||
19388100|NCT02700815|41631480|FG001|Overall Study|Refusal to continue medication|1|||
19388101|NCT02700815|41631481|FG002|Overall Study|Refusal to continue medication|0|||
19596868|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
19596869|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
19596870|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
19596871|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
19596872|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
19747084|NCT03426267|42194543|FG001|Overall Study|Physician Decision|4|||
19747085|NCT03426267|42194542|FG000|Overall Study|Lost to Follow-up|1|||
19747086|NCT03426267|42194543|FG001|Overall Study|Lost to Follow-up|0|||
19747087|NCT03426267|42194542|FG000|Overall Study|Withdrawal by Subject|4|||
19747088|NCT03426267|42194543|FG001|Overall Study|Withdrawal by Subject|10|||
19747089|NCT03426267|42194542|FG000|Overall Study|Protocol Violation|1|||
19747090|NCT03426267|42194543|FG001|Overall Study|Protocol Violation|3|||
19747091|NCT03426267|42194542|FG000|Overall Study|Adverse Event|9|||
19747092|NCT03426267|42194543|FG001|Overall Study|Adverse Event|27|||
19747093|NCT03426267|42194542|FG000|Overall Study|Prohibited Treatment Intake|2|||
19747094|NCT03426267|42194543|FG001|Overall Study|Prohibited Treatment Intake|3|||
19747095|NCT03426267|42194542|FG000|Overall Study|Lack of Efficacy|0|||
19747096|NCT03426267|42194543|FG001|Overall Study|Lack of Efficacy|25|||
19747097|NCT03426267|42194542|FG000|Overall Study|other|3|||
19747098|NCT03426267|42194543|FG001|Overall Study|other|0|||
19747099|NCT03412929|42194549|FG000|Overall Study|Protocol Violation|3|||
19747100|NCT03451773|42194555|FG000|Overall Study|Death on study|1|||
19747101|NCT03451773|42194556|FG001|Overall Study|Death on study|5|||
19747102|NCT03451773|42194555|FG000|Overall Study|Death during follow-up period|0|||
19747103|NCT03451773|42194556|FG001|Overall Study|Death during follow-up period|1|||
19747104|NCT03425253|42194563|FG000|Overall Study|Adverse Event|2|||
19747105|NCT03425253|42194563|FG000|Overall Study|Lost to Follow-up|3|||
19747106|NCT03425253|42194563|FG000|Overall Study|Withdrew Consent|6|||
19747107|NCT03425253|42194563|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
19747108|NCT03424239|42194568|FG000|Overall Study|Withdrawal by Subject|2|||
19747109|NCT03451071|42194572|FG000|First Vaccine|Withdrawal by Subject|1|||
19388102|NCT02700815|41631482|FG003|Overall Study|Refusal to continue medication|1|||
19388103|NCT02700815|41631479|FG000|Overall Study|Withdrawal by Subject|0|||
19596873|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
19747110|NCT03451071|42194572|FG000|Second Vaccine|Lost to Follow-up|19|||
19747111|NCT03451071|42194572|FG000|Third Vaccine|Lost to Follow-up|22|||
19747112|NCT03451071|42194572|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
19747113|NCT03449979|42194580|FG000|Overall Study|Technical difficulty|0|||
19596874|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
19596875|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
19596876|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
19596877|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
19596878|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
19596879|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
19596880|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
19596881|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
19596882|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
19596883|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
19596884|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
19596885|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
19596886|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
19596887|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
19596888|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
19596889|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
19596890|NCT03536884|42045698|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
19596891|NCT03536884|42045699|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
19596892|NCT03536884|42045700|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
19596893|NCT03536884|42045701|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
19596894|NCT03536884|42045702|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
19596895|NCT03512262|42045719|FG000|Overall Study|Adverse Event|8|||
19596896|NCT03512262|42045720|FG001|Overall Study|Adverse Event|3|||
19596897|NCT03512262|42045719|FG000|Overall Study|Death (non-treatment emergent)|1|||
19596898|NCT03512262|42045720|FG001|Overall Study|Death (non-treatment emergent)|0|||
19596899|NCT03512262|42045719|FG000|Overall Study|Withdrawal by Subject|17|||
19596900|NCT03512262|42045720|FG001|Overall Study|Withdrawal by Subject|9|||
19596901|NCT03512262|42045719|FG000|Overall Study|Lost to Follow-up|7|||
19596902|NCT03512262|42045720|FG001|Overall Study|Lost to Follow-up|1|||
19596903|NCT03512262|42045719|FG000|Overall Study|Other than Specified|2|||
19596904|NCT03512262|42045720|FG001|Overall Study|Other than Specified|2|||
19596905|NCT03499600|42045728|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
19596906|NCT03499600|42045729|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
19596907|NCT03007979|42045743|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
19596908|NCT02960893|42045749|FG000|Randomization Phase (8-week)|Adverse Event|5|||
19596909|NCT02960893|42045750|FG001|Randomization Phase (8-week)|Adverse Event|0|||
19596910|NCT02960893|42045749|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
19747114|NCT03449979|42194581|FG001|Overall Study|Technical difficulty|0|||
19747115|NCT03449979|42194582|FG002|Overall Study|Technical difficulty|0|||
19747116|NCT03449979|42194583|FG003|Overall Study|Technical difficulty|1|||
19747117|NCT03449199|42194596|FG000|Overall Study|Lost to Follow-up|1|||
19747118|NCT03449199|42194597|FG001|Overall Study|Lost to Follow-up|1|||
19747119|NCT03449199|42194598|FG002|Overall Study|Lost to Follow-up|0|||
19747120|NCT03449199|42194596|FG000|Overall Study|Protocol Deviation|0|||
19747121|NCT03449199|42194597|FG001|Overall Study|Protocol Deviation|0|||
19747122|NCT03449199|42194598|FG002|Overall Study|Protocol Deviation|1|||
19747123|NCT03449199|42194596|FG000|Overall Study|Withdrawal by Subject|0|||
19747124|NCT03449199|42194597|FG001|Overall Study|Withdrawal by Subject|0|||
19747125|NCT03449199|42194598|FG002|Overall Study|Withdrawal by Subject|1|||
19747126|NCT03421431|42194612|FG000|Overall Study|Adverse Event|2|||
19747127|NCT03421431|42194613|FG001|Overall Study|Adverse Event|1|||
19747128|NCT03421431|42194614|FG002|Overall Study|Adverse Event|12|||
19747129|NCT03421431|42194612|FG000|Overall Study|Lost to Follow-up|1|||
19747130|NCT03421431|42194613|FG001|Overall Study|Lost to Follow-up|1|||
19747131|NCT03421431|42194614|FG002|Overall Study|Lost to Follow-up|1|||
19747132|NCT03421431|42194612|FG000|Overall Study|Withdrawal by Subject|3|||
19747133|NCT03421431|42194613|FG001|Overall Study|Withdrawal by Subject|2|||
19747134|NCT03421431|42194614|FG002|Overall Study|Withdrawal by Subject|1|||
19747135|NCT03421431|42194612|FG000|Overall Study|Protocol Violation|0|||
19747136|NCT03421431|42194613|FG001|Overall Study|Protocol Violation|1|||
19747137|NCT03421431|42194614|FG002|Overall Study|Protocol Violation|0|||
19747138|NCT03421431|42194612|FG000|Overall Study|Participant met Stopping Rules|0|||
19747139|NCT03421431|42194613|FG001|Overall Study|Participant met Stopping Rules|1|||
19596911|NCT02960893|42045750|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
19747140|NCT03421431|42194614|FG002|Overall Study|Participant met Stopping Rules|0|||
19747141|NCT03448419|42194626|FG000|Overall Study|Adverse Event|10|||
19747142|NCT03448419|42194627|FG001|Overall Study|Adverse Event|9|||
19747143|NCT03448419|42194626|FG000|Overall Study|Lost to Follow-up|0|||
19747144|NCT03448419|42194627|FG001|Overall Study|Lost to Follow-up|2|||
19747145|NCT03448419|42194626|FG000|Overall Study|Withdrawal by Subject|3|||
19596912|NCT02960893|42045749|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
19596913|NCT02960893|42045750|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
19596914|NCT02960893|42045749|FG000|Extension Phase (48-week)|Adverse Event|2|||
19596915|NCT02960893|42045750|FG001|Extension Phase (48-week)|Adverse Event|3|||
19596916|NCT02960893|42045749|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
19596917|NCT02960893|42045750|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
19596918|NCT02960893|42045749|FG000|Extension Phase (48-week)|Other Reason|2|||
19596919|NCT02960893|42045750|FG001|Extension Phase (48-week)|Other Reason|1|||
19596920|NCT02960893|42045749|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
19596921|NCT02960893|42045750|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
19596922|NCT02960893|42045749|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
19596923|NCT02960893|42045750|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
19596924|NCT02867813|42045765|FG000|Overall Study|Withdrawal by Subject|57|||
19596925|NCT02867813|42045766|FG001|Overall Study|Withdrawal by Subject|56|||
19596926|NCT02867813|42045765|FG000|Overall Study|Decision by Sponsor|7|||
19596927|NCT02867813|42045766|FG001|Overall Study|Decision by Sponsor|7|||
19596928|NCT02867813|42045765|FG000|Overall Study|Lost to Follow-up|91|||
19596929|NCT02867813|42045766|FG001|Overall Study|Lost to Follow-up|78|||
19747146|NCT03448419|42194627|FG001|Overall Study|Withdrawal by Subject|1|||
19747147|NCT03448419|42194626|FG000|Overall Study|Not treated|0|||
19747148|NCT03448419|42194627|FG001|Overall Study|Not treated|1|||
19747149|NCT03448419|42194626|FG000|Overall Study|Patient did not attend all visits|0|||
19596930|NCT02867813|42045765|FG000|Overall Study|Missing|2|||
19596931|NCT02867813|42045766|FG001|Overall Study|Missing|1|||
19596932|NCT02867813|42045765|FG000|Overall Study|Death|294|||
19596933|NCT02867813|42045766|FG001|Overall Study|Death|268|||
19596934|NCT02278055|42045778|FG000|Overall Study|Adverse Event|1|||
19596935|NCT02278055|42045778|FG000|Overall Study|Lost to Follow-up|1|||
19596936|NCT02278055|42045778|FG000|Overall Study|Withdrawal by Subject|2|||
19596937|NCT02278055|42045778|FG000|Overall Study|Progressive Disease|4|||
19596938|NCT02231879|42045784|FG000|Overall Study|Adverse Event|2|||
19596939|NCT02231879|42045785|FG001|Overall Study|Adverse Event|1|||
19596940|NCT02231879|42045784|FG000|Overall Study|Lack of Efficacy|0|||
19596941|NCT02231879|42045785|FG001|Overall Study|Lack of Efficacy|1|||
19596942|NCT01833806|42045815|FG000|Overall Study|Alternative treatment|2|||
19596943|NCT01833806|42045815|FG000|Overall Study|Death|5|||
19596944|NCT01833806|42045815|FG000|Overall Study|Physician Decision|1|||
19747150|NCT03448419|42194627|FG001|Overall Study|Patient did not attend all visits|2|||
19747151|NCT03448419|42194626|FG000|Overall Study|Withdrawn by Sponsor|0|||
19747152|NCT03448419|42194627|FG001|Overall Study|Withdrawn by Sponsor|1|||
19747153|NCT03419403|42194638|FG000|Overall Study|Withdrawal by Subject|5|||
19747154|NCT03419403|42194639|FG001|Overall Study|Withdrawal by Subject|2|||
19747155|NCT03419403|42194640|FG002|Overall Study|Withdrawal by Subject|5|||
19747156|NCT03419403|42194641|FG003|Overall Study|Withdrawal by Subject|1|||
19747157|NCT03419403|42194638|FG000|Overall Study|Progressive disease (per protocol)|0|||
19747158|NCT03419403|42194639|FG001|Overall Study|Progressive disease (per protocol)|2|||
19747159|NCT03419403|42194640|FG002|Overall Study|Progressive disease (per protocol)|2|||
19747160|NCT03419403|42194641|FG003|Overall Study|Progressive disease (per protocol)|0|||
19747161|NCT03419403|42194638|FG000|Overall Study|Other, not specified|6|||
19747162|NCT03419403|42194639|FG001|Overall Study|Other, not specified|4|||
19747163|NCT03419403|42194640|FG002|Overall Study|Other, not specified|5|||
19747164|NCT03419403|42194641|FG003|Overall Study|Other, not specified|1|||
19747165|NCT03419403|42194638|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
19747166|NCT03419403|42194639|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
19747167|NCT03419403|42194640|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
19747168|NCT03419403|42194641|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
19747169|NCT03447249|42194651|FG000|Overall Study|Adverse Event|1|||
19747170|NCT03447249|42194652|FG001|Overall Study|Adverse Event|0|||
19747171|NCT03447249|42194651|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
19747172|NCT03447249|42194652|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
19596945|NCT01833806|42045815|FG000|Overall Study|Lost to Follow-up|1|||
19596946|NCT01712490|42045821|FG000|Overall Study|Ongoing|601|||
19596947|NCT01712490|42045822|FG001|Overall Study|Ongoing|586|||
19596948|NCT01712490|42045821|FG000|Overall Study|Other|11|||
19596949|NCT01712490|42045822|FG001|Overall Study|Other|11|||
19596950|NCT01712490|42045821|FG000|Overall Study|Withdrawal by Subject|36|||
19596951|NCT01712490|42045822|FG001|Overall Study|Withdrawal by Subject|44|||
19747173|NCT03447249|42194651|FG000|Overall Study|Other|3|||
19747174|NCT03447249|42194652|FG001|Overall Study|Other|0|||
19747175|NCT03418545|42194662|FG000|Overall Study|Withdrawal by Participant|2|||
19747176|NCT03418545|42194663|FG001|Overall Study|Withdrawal by Participant|4|||
19747177|NCT03418545|42194662|FG000|Overall Study|Lost to Follow-up|3|||
19747178|NCT03418545|42194663|FG001|Overall Study|Lost to Follow-up|5|||
19747179|NCT03418545|42194662|FG000|Overall Study|Reason Not Specified|0|||
19747180|NCT03418545|42194663|FG001|Overall Study|Reason Not Specified|1|||
19747181|NCT03418545|42194662|FG000|Overall Study|Missing Completion Status|0|||
19747182|NCT03418545|42194663|FG001|Overall Study|Missing Completion Status|1|||
19596952|NCT01712490|42045821|FG000|Overall Study|Lost to Follow-up|16|||
19596953|NCT01712490|42045822|FG001|Overall Study|Lost to Follow-up|29|||
19596954|NCT01439802|42045828|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
19596955|NCT01439802|42045828|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
19596956|NCT00816556|42045839|FG000|Overall Study|Adverse Event|1|||
19596957|NCT00816556|42045840|FG001|Overall Study|Adverse Event|1|||
19596958|NCT00816556|42045841|FG002|Overall Study|Adverse Event|1|||
19596959|NCT00816556|42045839|FG000|Overall Study|Withdrawal by Subject|1|||
19596960|NCT00816556|42045840|FG001|Overall Study|Withdrawal by Subject|1|||
19596961|NCT00816556|42045841|FG002|Overall Study|Withdrawal by Subject|1|||
19596962|NCT00816556|42045839|FG000|Overall Study|Lost to Follow-up|0|||
19596963|NCT00816556|42045840|FG001|Overall Study|Lost to Follow-up|0|||
19596964|NCT00816556|42045841|FG002|Overall Study|Lost to Follow-up|1|||
19596965|NCT00760747|42045851|FG000|Study Period II|Adverse Event|3|||
19596966|NCT00760747|42045852|FG001|Study Period II|Adverse Event|4|||
19596967|NCT00760747|42045851|FG000|Study Period II|Lack of Efficacy|0|||
19596968|NCT00760747|42045852|FG001|Study Period II|Lack of Efficacy|6|||
19596969|NCT00760747|42045851|FG000|Study Period II|Parent/Caregiver Decision|3|||
19596970|NCT00760747|42045852|FG001|Study Period II|Parent/Caregiver Decision|0|||
19596971|NCT00760747|42045851|FG000|Study Period II|Protocol Violation|6|||
19596972|NCT00760747|42045852|FG001|Study Period II|Protocol Violation|3|||
19596973|NCT00760747|42045851|FG000|Study Period II|Withdrawal by Subject|1|||
19596974|NCT00760747|42045852|FG001|Study Period II|Withdrawal by Subject|0|||
19596975|NCT00760747|42045851|FG000|Study Period II|No drug administered|0|||
19596976|NCT00760747|42045852|FG001|Study Period II|No drug administered|1|||
19596977|NCT00760747|42045851|FG000|Study Period III|Adverse Event|1|||
19596978|NCT00760747|42045852|FG001|Study Period III|Adverse Event|0|||
19596979|NCT00760747|42045851|FG000|Study Period III|Lack of Efficacy|1|||
19596980|NCT00760747|42045852|FG001|Study Period III|Lack of Efficacy|0|||
19596981|NCT00760747|42045851|FG000|Study Period III|Parent/Caregiver Decision|0|||
19596982|NCT00760747|42045852|FG001|Study Period III|Parent/Caregiver Decision|1|||
19596983|NCT00760747|42045851|FG000|Study Period III|Protocol Violation|1|||
19596984|NCT00760747|42045852|FG001|Study Period III|Protocol Violation|1|||
19596985|NCT00760747|42045851|FG000|Study Period III|Physician Decision|0|||
19596986|NCT00760747|42045852|FG001|Study Period III|Physician Decision|1|||
19596987|NCT00760669|42045858|FG000|Overall Study|Not assessed for overall improvement|18|||
19596988|NCT00760669|42045858|FG000|Overall Study|Participants missing efficacy assessment|6|||
19596989|NCT00760669|42045858|FG000|Overall Study|Participants with overlapping cases|1|||
19596990|NCT00760669|42045858|FG000|Overall Study|Took drug before entering in contract|5|||
19596991|NCT00769483|42045868|FG000|Overall Study|Withdrawal by Subject|0|||
19596992|NCT00769483|42045869|FG001|Overall Study|Withdrawal by Subject|1|||
19596993|NCT00769483|42045870|FG002|Overall Study|Withdrawal by Subject|0|||
19596994|NCT00769483|42045871|FG003|Overall Study|Withdrawal by Subject|0|||
19596995|NCT00769483|42045872|FG004|Overall Study|Withdrawal by Subject|1|||
19596996|NCT00769483|42045873|FG005|Overall Study|Withdrawal by Subject|0|||
19596997|NCT00760513|42045891|FG000|Overall Study|Withdrawal by Subject|5|||
19596998|NCT00760513|42045892|FG001|Overall Study|Withdrawal by Subject|7|||
19596999|NCT00907296|42045910|FG000|Overall Study|Ineligibility Determined|1|||
19597000|NCT00907296|42045911|FG001|Overall Study|Ineligibility Determined|0|||
19597001|NCT00907296|42045912|FG002|Overall Study|Ineligibility Determined|0|||
19597002|NCT00907296|42045913|FG003|Overall Study|Ineligibility Determined|1|||
19597003|NCT00907296|42045914|FG004|Overall Study|Ineligibility Determined|0|||
19597004|NCT00907296|42045915|FG005|Overall Study|Ineligibility Determined|0|||
19597005|NCT00907296|42045916|FG006|Overall Study|Ineligibility Determined|0|||
19597006|NCT00907296|42045917|FG007|Overall Study|Ineligibility Determined|1|||
19597007|NCT00907296|42045918|FG008|Overall Study|Ineligibility Determined|0|||
19597008|NCT00907296|42045919|FG009|Overall Study|Ineligibility Determined|0|||
19597009|NCT00907296|42045910|FG000|Overall Study|Protocol Deviation|0|||
19597010|NCT00907296|42045911|FG001|Overall Study|Protocol Deviation|1|||
19597011|NCT00907296|42045912|FG002|Overall Study|Protocol Deviation|0|||
19597012|NCT00907296|42045913|FG003|Overall Study|Protocol Deviation|0|||
19597013|NCT00907296|42045914|FG004|Overall Study|Protocol Deviation|0|||
19597014|NCT00907296|42045915|FG005|Overall Study|Protocol Deviation|0|||
19597015|NCT00907296|42045916|FG006|Overall Study|Protocol Deviation|0|||
19597016|NCT00907296|42045917|FG007|Overall Study|Protocol Deviation|0|||
19597017|NCT00907296|42045918|FG008|Overall Study|Protocol Deviation|0|||
19597018|NCT00907296|42045919|FG009|Overall Study|Protocol Deviation|0|||
19597019|NCT00907296|42045910|FG000|Overall Study|Noncompliance|1|||
19597020|NCT00907296|42045911|FG001|Overall Study|Noncompliance|1|||
19597021|NCT00907296|42045912|FG002|Overall Study|Noncompliance|1|||
19597022|NCT00907296|42045913|FG003|Overall Study|Noncompliance|0|||
19597023|NCT00907296|42045914|FG004|Overall Study|Noncompliance|0|||
19597024|NCT00907296|42045915|FG005|Overall Study|Noncompliance|1|||
19597025|NCT00907296|42045916|FG006|Overall Study|Noncompliance|0|||
19597026|NCT00907296|42045917|FG007|Overall Study|Noncompliance|2|||
19597027|NCT00907296|42045918|FG008|Overall Study|Noncompliance|0|||
19597028|NCT00907296|42045919|FG009|Overall Study|Noncompliance|0|||
19597029|NCT00907296|42045910|FG000|Overall Study|Adverse Event|2|||
19597030|NCT00907296|42045911|FG001|Overall Study|Adverse Event|0|||
19597031|NCT00907296|42045912|FG002|Overall Study|Adverse Event|0|||
19597032|NCT00907296|42045913|FG003|Overall Study|Adverse Event|0|||
19747183|NCT03409731|42194672|FG000|Overall Study|Withdrawal by Subject|1|||
19747184|NCT03409731|42194672|FG000|Overall Study|Death|2|||
19747185|NCT03446781|42194678|FG000|Overall Study|Lost to Follow-up|11|||
19747186|NCT03446781|42194679|FG001|Overall Study|Lost to Follow-up|5|||
19747187|NCT03446781|42194678|FG000|Overall Study|Withdrawal by Subject|9|||
19747188|NCT03446781|42194679|FG001|Overall Study|Withdrawal by Subject|7|||
19747189|NCT03446781|42194678|FG000|Overall Study|Adverse Event|8|||
19747190|NCT03446781|42194679|FG001|Overall Study|Adverse Event|2|||
19597033|NCT00907296|42045914|FG004|Overall Study|Adverse Event|0|||
19597034|NCT00907296|42045915|FG005|Overall Study|Adverse Event|0|||
19597035|NCT00907296|42045916|FG006|Overall Study|Adverse Event|1|||
19597036|NCT00907296|42045917|FG007|Overall Study|Adverse Event|0|||
19597037|NCT00907296|42045918|FG008|Overall Study|Adverse Event|0|||
19597038|NCT00907296|42045919|FG009|Overall Study|Adverse Event|1|||
19597039|NCT00907296|42045910|FG000|Overall Study|Withdrawal by Subject|7|||
19597040|NCT00907296|42045911|FG001|Overall Study|Withdrawal by Subject|2|||
19597041|NCT00907296|42045912|FG002|Overall Study|Withdrawal by Subject|1|||
19597042|NCT00907296|42045913|FG003|Overall Study|Withdrawal by Subject|1|||
19597043|NCT00907296|42045914|FG004|Overall Study|Withdrawal by Subject|1|||
19597044|NCT00907296|42045915|FG005|Overall Study|Withdrawal by Subject|5|||
19597045|NCT00907296|42045916|FG006|Overall Study|Withdrawal by Subject|3|||
19597046|NCT00907296|42045917|FG007|Overall Study|Withdrawal by Subject|2|||
19597047|NCT00907296|42045918|FG008|Overall Study|Withdrawal by Subject|4|||
19597048|NCT00907296|42045919|FG009|Overall Study|Withdrawal by Subject|2|||
19597049|NCT00907296|42045910|FG000|Overall Study|Lost to Follow-up|9|||
19747191|NCT03446781|42194678|FG000|Overall Study|Protocol Violation|0|||
19747192|NCT03446781|42194679|FG001|Overall Study|Protocol Violation|3|||
19747193|NCT03445065|42194711|FG000|Overall Study|Withdrawal by Subject|3|||
19747194|NCT03445065|42194712|FG001|Overall Study|Withdrawal by Subject|6|||
19747195|NCT03445065|42194713|FG002|Overall Study|Withdrawal by Subject|2|||
19747196|NCT03445065|42194714|FG003|Overall Study|Withdrawal by Subject|2|||
19597050|NCT00907296|42045911|FG001|Overall Study|Lost to Follow-up|1|||
19597051|NCT00907296|42045912|FG002|Overall Study|Lost to Follow-up|0|||
19747197|NCT03445065|42194711|FG000|Overall Study|Other|4|||
19747198|NCT03445065|42194712|FG001|Overall Study|Other|3|||
19747199|NCT03445065|42194713|FG002|Overall Study|Other|3|||
19597052|NCT00907296|42045913|FG003|Overall Study|Lost to Follow-up|2|||
19597053|NCT00907296|42045914|FG004|Overall Study|Lost to Follow-up|0|||
19597054|NCT00907296|42045915|FG005|Overall Study|Lost to Follow-up|3|||
19597055|NCT00907296|42045916|FG006|Overall Study|Lost to Follow-up|2|||
19597056|NCT00907296|42045917|FG007|Overall Study|Lost to Follow-up|2|||
19597057|NCT00907296|42045918|FG008|Overall Study|Lost to Follow-up|0|||
19597058|NCT00907296|42045919|FG009|Overall Study|Lost to Follow-up|4|||
19597059|NCT00816400|42045950|FG000|Overall Study|Death|2|||
19597060|NCT00816400|42045951|FG001|Overall Study|Death|3|||
19597061|NCT00816400|42045952|FG002|Overall Study|Death|3|||
19747200|NCT03445065|42194714|FG003|Overall Study|Other|1|||
19747201|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Death|3|||
19597062|NCT00816400|42045953|FG003|Overall Study|Death|3|||
19597063|NCT00816400|42045954|FG004|Overall Study|Death|2|||
19597064|NCT00816400|42045955|FG005|Overall Study|Death|3|||
19597065|NCT00816400|42045956|FG006|Overall Study|Death|2|||
19597066|NCT00816400|42045957|FG007|Overall Study|Death|5|||
19597067|NCT00816400|42045958|FG008|Overall Study|Death|6|||
19597068|NCT00816400|42045950|FG000|Overall Study|In hospice care at the end of the study|0|||
19747202|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Death|0|||
19747203|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Death|0|||
19747204|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Death|0|||
19747205|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Death|0|||
19747206|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
19747207|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
19747208|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
19747209|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
19747210|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
19747211|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
19747212|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
19747213|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
19747214|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
19747215|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
19747216|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Other|0|||
19747217|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Other|0|||
19747218|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Other|1|||
19747219|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Other|0|||
19747220|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Other|0|||
19597069|NCT00816400|42045951|FG001|Overall Study|In hospice care at the end of the study|0|||
19597070|NCT00816400|42045952|FG002|Overall Study|In hospice care at the end of the study|2|||
19597071|NCT00816400|42045953|FG003|Overall Study|In hospice care at the end of the study|0|||
19597072|NCT00816400|42045954|FG004|Overall Study|In hospice care at the end of the study|0|||
19597073|NCT00816400|42045955|FG005|Overall Study|In hospice care at the end of the study|0|||
19597074|NCT00816400|42045956|FG006|Overall Study|In hospice care at the end of the study|0|||
19597075|NCT00816400|42045957|FG007|Overall Study|In hospice care at the end of the study|0|||
19597076|NCT00816400|42045958|FG008|Overall Study|In hospice care at the end of the study|0|||
19597077|NCT00906204|42045981|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
19597078|NCT00906204|42045982|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
19597079|NCT00906204|42045981|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
19597080|NCT00906204|42045982|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
19597081|NCT00906204|42045981|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
19597082|NCT00906204|42045982|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
19597083|NCT00906204|42045981|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
19597084|NCT00906204|42045982|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
19597085|NCT00906204|42045981|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
19597086|NCT00906204|42045982|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
19597087|NCT00905424|42046023|FG000|Overall Study|Lost to Follow-up|3|||
19597088|NCT00905424|42046024|FG001|Overall Study|Lost to Follow-up|3|||
19597089|NCT00905424|42046023|FG000|Overall Study|Withdrawal by Subject|1|||
19597090|NCT00905424|42046024|FG001|Overall Study|Withdrawal by Subject|2|||
19597091|NCT00905424|42046023|FG000|Overall Study|Adverse Event|4|||
19597092|NCT00905424|42046024|FG001|Overall Study|Adverse Event|2|||
19597093|NCT00905424|42046023|FG000|Overall Study|Non-compliance with study medication|2|||
19597094|NCT00905424|42046024|FG001|Overall Study|Non-compliance with study medication|0|||
19597095|NCT00905424|42046023|FG000|Overall Study|Sponsor decision|1|||
19597096|NCT00905424|42046024|FG001|Overall Study|Sponsor decision|0|||
19597097|NCT00905424|42046023|FG000|Overall Study|Positive urine drug screen|0|||
19597098|NCT00905424|42046024|FG001|Overall Study|Positive urine drug screen|1|||
19597099|NCT00905424|42046023|FG000|Overall Study|Non-adherence to visit schedule|0|||
19597100|NCT00905424|42046024|FG001|Overall Study|Non-adherence to visit schedule|1|||
19597101|NCT00816166|42046034|FG000|Overall Study|Lost to Follow-up|6|||
19597102|NCT00816166|42046035|FG001|Overall Study|Lost to Follow-up|10|||
19597103|NCT00816166|42046034|FG000|Overall Study|Death|4|||
19597104|NCT00816166|42046035|FG001|Overall Study|Death|2|||
19597105|NCT00815308|42046045|FG000|Overall Study|Adverse Event|4|||
19597106|NCT00815308|42046045|FG000|Overall Study|Withdrawal by Subject|0|||
19597107|NCT00815308|42046045|FG000|Overall Study|Protocol Violation|6|||
19597108|NCT01039376|42046051|FG000|Overall Study|Lost to Follow-up|5|||
19597109|NCT01039376|42046052|FG001|Overall Study|Lost to Follow-up|12|||
19597110|NCT01039376|42046051|FG000|Overall Study|Physician Decision|15|||
19597111|NCT01039376|42046052|FG001|Overall Study|Physician Decision|10|||
19597112|NCT01039376|42046051|FG000|Overall Study|Withdrawal by Subject|20|||
19597113|NCT01039376|42046052|FG001|Overall Study|Withdrawal by Subject|32|||
19597114|NCT01039376|42046051|FG000|Overall Study|Study terminated by Sponsor|90|||
19597115|NCT01039376|42046052|FG001|Overall Study|Study terminated by Sponsor|72|||
19597116|NCT00905034|42046059|FG000|Overall Study|Withdrawal by Subject|1|||
19597117|NCT00828568|42046066|FG000|Randomized|Withdrawal by Subject|1|||
19597118|NCT00828568|42046067|FG001|Randomized|Withdrawal by Subject|0|||
19597119|NCT00828568|42046068|FG002|Randomized|Withdrawal by Subject|2|||
19597120|NCT00828568|42046066|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
19597121|NCT00828568|42046067|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
19597122|NCT00828568|42046068|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
19597123|NCT00828568|42046066|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
19747221|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
19747222|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
19747223|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
19747224|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
19747225|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
19747226|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
19747227|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
19747228|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
19747229|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
19747230|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
19747231|NCT01224106|42194739|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
19747232|NCT01224106|42194740|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19747233|NCT01224106|42194741|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
19747234|NCT01224106|42194742|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19747235|NCT01224106|42194743|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19597124|NCT00828568|42046067|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
19597125|NCT00828568|42046068|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
19597126|NCT00828568|42046066|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
19597127|NCT00828568|42046067|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
19747236|NCT01224106|42194739|FG000|Open-Label Extension (OLE) Phase|Death|0|||
19747237|NCT01224106|42194740|FG001|Open-Label Extension (OLE) Phase|Death|0|||
19747238|NCT01224106|42194741|FG002|Open-Label Extension (OLE) Phase|Death|0|||
19747239|NCT01224106|42194742|FG003|Open-Label Extension (OLE) Phase|Death|1|||
19747240|NCT01224106|42194743|FG004|Open-Label Extension (OLE) Phase|Death|3|||
19747241|NCT01224106|42194739|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
19747242|NCT01224106|42194740|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
19747243|NCT01224106|42194741|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
19747244|NCT01224106|42194742|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
19747245|NCT01224106|42194743|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
19747246|NCT01224106|42194739|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
19747247|NCT01224106|42194740|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
19747248|NCT01224106|42194741|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
19747249|NCT01224106|42194742|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
19747250|NCT01224106|42194743|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
19747251|NCT01224106|42194739|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
19747252|NCT01224106|42194740|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
19747253|NCT01224106|42194741|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
19747254|NCT01224106|42194742|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
19747255|NCT01224106|42194743|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
19747256|NCT01224106|42194739|FG000|Open-Label Extension (OLE) Phase|Other|0|||
19747257|NCT01224106|42194740|FG001|Open-Label Extension (OLE) Phase|Other|0|||
19747258|NCT01224106|42194741|FG002|Open-Label Extension (OLE) Phase|Other|0|||
19747259|NCT01224106|42194742|FG003|Open-Label Extension (OLE) Phase|Other|5|||
19747260|NCT01224106|42194743|FG004|Open-Label Extension (OLE) Phase|Other|3|||
19747261|NCT03409107|42194763|FG000|Overall Study|Withdrawal by Subject|4|||
19597128|NCT00828568|42046068|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
19597129|NCT00828568|42046066|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
19597130|NCT00828568|42046067|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
19597131|NCT00828568|42046068|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
19597132|NCT01038752|42046079|FG000|Overall Study|Tumor Progression|2|||
19597133|NCT01038752|42046080|FG001|Overall Study|Tumor Progression|2|||
19597134|NCT01038752|42046079|FG000|Overall Study|Lost to Follow-up|3|||
19597135|NCT01038752|42046080|FG001|Overall Study|Lost to Follow-up|3|||
19597136|NCT00903630|42046089|FG000|Phase 2|Adverse Event|0|||
19597137|NCT00903630|42046090|FG001|Phase 2|Adverse Event|0|||
19747262|NCT03409107|42194764|FG001|Overall Study|Withdrawal by Subject|2|||
19747263|NCT03409107|42194763|FG000|Overall Study|Physician Decision|1|||
19597138|NCT00903630|42046091|FG002|Phase 2|Adverse Event|1|||
19597139|NCT01037114|42046101|FG000|Year 20|Others|1|||
19597140|NCT00840970|42046105|FG000|Overall Study|Adverse Event|0|||
19597141|NCT00840970|42046106|FG001|Overall Study|Adverse Event|0|||
19597142|NCT00840970|42046107|FG002|Overall Study|Adverse Event|1|||
19597143|NCT01054820|42046117|FG000|Overall Study|Withdrawal by Subject|2|||
19597144|NCT00840658|42046125|FG000|Overall Study|Death|2|||
19597145|NCT00840658|42046126|FG001|Overall Study|Death|2|||
19597146|NCT00840658|42046127|FG002|Overall Study|Death|3|||
19597147|NCT00840658|42046128|FG003|Overall Study|Death|3|||
19597148|NCT00840658|42046125|FG000|Overall Study|Lost to Follow-up|3|||
19597149|NCT00840658|42046126|FG001|Overall Study|Lost to Follow-up|1|||
19597150|NCT00840658|42046127|FG002|Overall Study|Lost to Follow-up|2|||
19597151|NCT00840658|42046128|FG003|Overall Study|Lost to Follow-up|1|||
19597152|NCT01036724|42046144|FG000|Overall Study|Adverse Event|1|||
19597153|NCT01036724|42046145|FG001|Overall Study|Adverse Event|2|||
19597154|NCT01036724|42046144|FG000|Overall Study|Lack of Efficacy|1|||
19597155|NCT01036724|42046145|FG001|Overall Study|Lack of Efficacy|1|||
19597156|NCT01036724|42046144|FG000|Overall Study|Protocol Violation|4|||
19597157|NCT01036724|42046145|FG001|Overall Study|Protocol Violation|5|||
19597158|NCT01052714|42046153|FG000|Overall Study|Adverse Event|6|||
19597159|NCT01052714|42046154|FG001|Overall Study|Adverse Event|3|||
19597160|NCT01052714|42046155|FG002|Overall Study|Adverse Event|0|||
19597161|NCT01052714|42046153|FG000|Overall Study|Death|1|||
19597162|NCT01052714|42046154|FG001|Overall Study|Death|2|||
19597163|NCT01052714|42046155|FG002|Overall Study|Death|0|||
19597164|NCT01052714|42046153|FG000|Overall Study|Lost to Follow-up|2|||
19597165|NCT01052714|42046154|FG001|Overall Study|Lost to Follow-up|3|||
19597166|NCT01052714|42046155|FG002|Overall Study|Lost to Follow-up|0|||
19597167|NCT01052714|42046153|FG000|Overall Study|Physician Decision|9|||
19597168|NCT01052714|42046154|FG001|Overall Study|Physician Decision|9|||
19597169|NCT01052714|42046155|FG002|Overall Study|Physician Decision|1|||
19597170|NCT01052714|42046153|FG000|Overall Study|Withdrawal by Subject|7|||
19597171|NCT01052714|42046154|FG001|Overall Study|Withdrawal by Subject|12|||
19597172|NCT01052714|42046155|FG002|Overall Study|Withdrawal by Subject|1|||
19597173|NCT01052480|42046172|FG000|Overall Study|Lost to Follow-up|3|||
19597174|NCT01052480|42046173|FG001|Overall Study|Lost to Follow-up|3|||
19597175|NCT01052480|42046172|FG000|Overall Study|Protocol Violation|1|||
19597176|NCT01052480|42046173|FG001|Overall Study|Protocol Violation|0|||
19597177|NCT01052480|42046172|FG000|Overall Study|Withdrawal by Subject|3|||
19597178|NCT01052480|42046173|FG001|Overall Study|Withdrawal by Subject|7|||
19597179|NCT01052480|42046172|FG000|Overall Study|Physician Decision|0|||
19597180|NCT01052480|42046173|FG001|Overall Study|Physician Decision|2|||
19597181|NCT01052480|42046172|FG000|Overall Study|Death|1|||
19597182|NCT01052480|42046173|FG001|Overall Study|Death|5|||
19597183|NCT00904722|42046179|FG000|Overall Study|Physician Decision|1|||
19597184|NCT01029782|42046185|FG000|Overall Study|Lost to Follow-up|2|||
19597185|NCT01029782|42046186|FG001|Overall Study|Lost to Follow-up|2|||
19597186|NCT01029782|42046185|FG000|Overall Study|Diagnosis changed|1|||
19597187|NCT01029782|42046186|FG001|Overall Study|Diagnosis changed|1|||
19597188|NCT01029782|42046185|FG000|Overall Study|Adverse Event|0|||
19597189|NCT01029782|42046186|FG001|Overall Study|Adverse Event|1|||
19597190|NCT01029782|42046185|FG000|Overall Study|Physician Decision|0|||
19597191|NCT01029782|42046186|FG001|Overall Study|Physician Decision|1|||
19597192|NCT01029782|42046185|FG000|Overall Study|Protocol Violation|0|||
19597193|NCT01029782|42046186|FG001|Overall Study|Protocol Violation|2|||
19597194|NCT01029782|42046185|FG000|Overall Study|Withdrawal by Subject|0|||
19597195|NCT01029782|42046186|FG001|Overall Study|Withdrawal by Subject|1|||
19597196|NCT01029704|42046201|FG000|Overall Study|Adverse Event|0|||
19597197|NCT01029704|42046202|FG001|Overall Study|Adverse Event|0|||
19597198|NCT01029704|42046203|FG002|Overall Study|Adverse Event|0|||
19597199|NCT01029704|42046204|FG003|Overall Study|Adverse Event|0|||
19597200|NCT01029704|42046205|FG004|Overall Study|Adverse Event|0|||
19597201|NCT01029704|42046206|FG005|Overall Study|Adverse Event|0|||
19597202|NCT01029704|42046207|FG006|Overall Study|Adverse Event|1|||
19597203|NCT01029704|42046208|FG007|Overall Study|Adverse Event|1|||
19597204|NCT01029704|42046209|FG008|Overall Study|Adverse Event|0|||
19597205|NCT01029704|42046201|FG000|Overall Study|Withdrawal by Subject|0|||
19597206|NCT01029704|42046202|FG001|Overall Study|Withdrawal by Subject|0|||
19597207|NCT01029704|42046203|FG002|Overall Study|Withdrawal by Subject|0|||
19597208|NCT01029704|42046204|FG003|Overall Study|Withdrawal by Subject|0|||
19597209|NCT01029704|42046205|FG004|Overall Study|Withdrawal by Subject|2|||
19597210|NCT01029704|42046206|FG005|Overall Study|Withdrawal by Subject|1|||
19597211|NCT01029704|42046207|FG006|Overall Study|Withdrawal by Subject|1|||
19597212|NCT01029704|42046208|FG007|Overall Study|Withdrawal by Subject|1|||
19597213|NCT01029704|42046209|FG008|Overall Study|Withdrawal by Subject|0|||
19597214|NCT01029704|42046201|FG000|Overall Study|Lost to Follow-up|0|||
19597215|NCT01029704|42046202|FG001|Overall Study|Lost to Follow-up|0|||
19597216|NCT01029704|42046203|FG002|Overall Study|Lost to Follow-up|0|||
19597217|NCT01029704|42046204|FG003|Overall Study|Lost to Follow-up|0|||
19597218|NCT01029704|42046205|FG004|Overall Study|Lost to Follow-up|0|||
19597219|NCT01029704|42046206|FG005|Overall Study|Lost to Follow-up|0|||
19597220|NCT01029704|42046207|FG006|Overall Study|Lost to Follow-up|1|||
19597221|NCT01029704|42046208|FG007|Overall Study|Lost to Follow-up|1|||
19597222|NCT01029704|42046209|FG008|Overall Study|Lost to Follow-up|1|||
19597223|NCT01029704|42046201|FG000|Overall Study|Lack of Efficacy|0|||
19597224|NCT01029704|42046202|FG001|Overall Study|Lack of Efficacy|0|||
19597225|NCT01029704|42046203|FG002|Overall Study|Lack of Efficacy|0|||
19597226|NCT01029704|42046204|FG003|Overall Study|Lack of Efficacy|0|||
19597227|NCT01029704|42046205|FG004|Overall Study|Lack of Efficacy|2|||
19597228|NCT01029704|42046206|FG005|Overall Study|Lack of Efficacy|3|||
19597229|NCT01029704|42046207|FG006|Overall Study|Lack of Efficacy|1|||
19597230|NCT01029704|42046208|FG007|Overall Study|Lack of Efficacy|2|||
19597231|NCT01029704|42046209|FG008|Overall Study|Lack of Efficacy|0|||
19597232|NCT01029704|42046201|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
19597233|NCT01029704|42046202|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
19597234|NCT01029704|42046203|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
19597235|NCT01029704|42046204|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
19597236|NCT01029704|42046205|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
19597237|NCT01029704|42046206|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
19597238|NCT01029704|42046207|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
19597239|NCT01029704|42046208|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
19597240|NCT01029704|42046209|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
19597241|NCT00840034|42046231|FG000|Acute Treatment Phase|Adverse Event|6|||
19597242|NCT00840034|42046232|FG001|Acute Treatment Phase|Adverse Event|8|||
19597243|NCT00840034|42046231|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
19597244|NCT00840034|42046232|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
19597245|NCT00840034|42046231|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
19597246|NCT00840034|42046232|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
19597247|NCT00840034|42046231|FG000|Acute Treatment Phase|Physician Decision|0|||
19597248|NCT00840034|42046232|FG001|Acute Treatment Phase|Physician Decision|1|||
19747264|NCT03409107|42194764|FG001|Overall Study|Physician Decision|0|||
19747265|NCT03409107|42194763|FG000|Overall Study|Lost to Follow-up|7|||
19747266|NCT03409107|42194764|FG001|Overall Study|Lost to Follow-up|2|||
19747267|NCT03409107|42194763|FG000|Overall Study|Adverse Event|5|||
19597249|NCT00840034|42046231|FG000|Acute Treatment Phase|Protocol Violation|2|||
19597250|NCT00840034|42046232|FG001|Acute Treatment Phase|Protocol Violation|4|||
19597251|NCT00840034|42046231|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
19597252|NCT00840034|42046232|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
19597253|NCT00840034|42046231|FG000|Taper Phase|Adverse Event|1|||
19597254|NCT00840034|42046232|FG001|Taper Phase|Adverse Event|0|||
19597255|NCT00840034|42046231|FG000|Taper Phase|Lost to Follow-up|1|||
19597256|NCT00840034|42046232|FG001|Taper Phase|Lost to Follow-up|1|||
19597257|NCT00840034|42046231|FG000|Taper Phase|Withdrawal by Subject|1|||
19597258|NCT00840034|42046232|FG001|Taper Phase|Withdrawal by Subject|1|||
19597259|NCT00813904|42046240|FG000|Overall Study|Death|1|||
19597260|NCT00839956|42046244|FG000|Overall Study|Adverse Event|2|||
19597261|NCT00839956|42046244|FG000|Overall Study|Lack of Efficacy|6|||
19597262|NCT00839956|42046244|FG000|Overall Study|Physician Decision|1|||
19597263|NCT00839956|42046244|FG000|Overall Study|Withdrawal by Subject|3|||
19597264|NCT00839800|42046250|FG000|Overall Study|Adverse Event|8|||
19597265|NCT00839800|42046251|FG001|Overall Study|Adverse Event|12|||
19597266|NCT00839800|42046250|FG000|Overall Study|Lost to Follow-up|31|||
19597267|NCT00839800|42046251|FG001|Overall Study|Lost to Follow-up|26|||
19597268|NCT00839800|42046250|FG000|Overall Study|Withdrawal by Subject|28|||
19597269|NCT00839800|42046251|FG001|Overall Study|Withdrawal by Subject|34|||
19597270|NCT00839800|42046250|FG000|Overall Study|Incorrect Enrolment|3|||
19747268|NCT03409107|42194764|FG001|Overall Study|Adverse Event|3|||
19747269|NCT03408873|42194778|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
19747270|NCT03408873|42194778|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
19747271|NCT03408873|42194778|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
19747272|NCT03408873|42194778|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
19747273|NCT03408873|42194778|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
19747274|NCT03408873|42194778|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
19747275|NCT03780959|42194785|FG000|Part 1|Adverse Event|1|||
19747276|NCT03780959|42194786|FG001|Part 1|Adverse Event|0|||
19747277|NCT03780959|42194787|FG002|Part 1|Adverse Event|0|||
19747278|NCT03780959|42194785|FG000|Part 1|Withdrawal by Subject|1|||
19747279|NCT03780959|42194786|FG001|Part 1|Withdrawal by Subject|0|||
19597271|NCT00839800|42046251|FG001|Overall Study|Incorrect Enrolment|3|||
19747280|NCT03780959|42194787|FG002|Part 1|Withdrawal by Subject|0|||
19747281|NCT03780959|42194785|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
19747282|NCT03780959|42194786|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
19597272|NCT00839800|42046250|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
19597273|NCT00839800|42046251|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
19597274|NCT00839800|42046250|FG000|Overall Study|Safety Reasons|2|||
19597275|NCT00839800|42046251|FG001|Overall Study|Safety Reasons|1|||
19597276|NCT00839800|42046250|FG000|Overall Study|Other|8|||
19597277|NCT00839800|42046251|FG001|Overall Study|Other|14|||
19597278|NCT00839800|42046250|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
19597279|NCT00839800|42046251|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
19597280|NCT00753415|42046285|FG000|Part A|Disease progression|1|||
19597281|NCT00753415|42046286|FG001|Part A|Disease progression|0|||
19597282|NCT00753415|42046287|FG002|Part A|Disease progression|1|||
19597283|NCT00753415|42046288|FG003|Part A|Disease progression|2|||
19597284|NCT00753415|42046289|FG004|Part A|Disease progression|0|||
19597285|NCT00753415|42046290|FG005|Part A|Disease progression|0|||
19597286|NCT00753415|42046291|FG006|Part A|Disease progression|0|||
19597287|NCT00753415|42046292|FG007|Part A|Disease progression|0|||
19597288|NCT00753415|42046293|FG008|Part A|Disease progression|0|||
19597289|NCT00753415|42046294|FG009|Part A|Disease progression|0|||
19597290|NCT00753415|42046285|FG000|Part A|Withdrawal by Subject|0|||
19597291|NCT00753415|42046286|FG001|Part A|Withdrawal by Subject|0|||
19597292|NCT00753415|42046287|FG002|Part A|Withdrawal by Subject|1|||
19597293|NCT00753415|42046288|FG003|Part A|Withdrawal by Subject|0|||
19597294|NCT00753415|42046289|FG004|Part A|Withdrawal by Subject|0|||
19597295|NCT00753415|42046290|FG005|Part A|Withdrawal by Subject|0|||
19597296|NCT00753415|42046291|FG006|Part A|Withdrawal by Subject|0|||
19597297|NCT00753415|42046292|FG007|Part A|Withdrawal by Subject|0|||
19597298|NCT00753415|42046293|FG008|Part A|Withdrawal by Subject|0|||
19597299|NCT00753415|42046294|FG009|Part A|Withdrawal by Subject|0|||
19597300|NCT00753415|42046285|FG000|Part B|Lost to Follow-up|0|||
19597301|NCT00753415|42046286|FG001|Part B|Lost to Follow-up|0|||
19597302|NCT00753415|42046287|FG002|Part B|Lost to Follow-up|0|||
19597303|NCT00753415|42046288|FG003|Part B|Lost to Follow-up|0|||
19597304|NCT00753415|42046289|FG004|Part B|Lost to Follow-up|0|||
19597305|NCT00753415|42046290|FG005|Part B|Lost to Follow-up|0|||
19597306|NCT00753415|42046291|FG006|Part B|Lost to Follow-up|0|||
19597307|NCT00753415|42046292|FG007|Part B|Lost to Follow-up|1|||
19597308|NCT00753415|42046293|FG008|Part B|Lost to Follow-up|1|||
19597309|NCT00753415|42046294|FG009|Part B|Lost to Follow-up|0|||
19597310|NCT00753415|42046285|FG000|Part B|Disease progression|0|||
19597311|NCT00753415|42046286|FG001|Part B|Disease progression|0|||
19597312|NCT00753415|42046287|FG002|Part B|Disease progression|0|||
19597313|NCT00753415|42046288|FG003|Part B|Disease progression|0|||
19597314|NCT00753415|42046289|FG004|Part B|Disease progression|0|||
19597315|NCT00753415|42046290|FG005|Part B|Disease progression|0|||
19597316|NCT00753415|42046291|FG006|Part B|Disease progression|0|||
19597317|NCT00753415|42046292|FG007|Part B|Disease progression|0|||
19597318|NCT00753415|42046293|FG008|Part B|Disease progression|2|||
19597319|NCT00753415|42046294|FG009|Part B|Disease progression|1|||
19597320|NCT00754741|42046321|FG000|Overall Study|Died or disenrolled|57|||
19597321|NCT00754741|42046322|FG001|Overall Study|Died or disenrolled|69|||
19597322|NCT00754741|42046323|FG002|Overall Study|Died or disenrolled|54|||
19597323|NCT00752791|42046331|FG000|Overall Study|Adverse Event|7|||
19597324|NCT00752791|42046331|FG000|Overall Study|Withdrawal by Subject|1|||
19597325|NCT00752791|42046331|FG000|Overall Study|Physician Decision|1|||
19597326|NCT00752791|42046331|FG000|Overall Study|Death|1|||
19597327|NCT00752791|42046331|FG000|Overall Study|Renal transplant|3|||
19597328|NCT00752791|42046331|FG000|Overall Study|Switched to hemodialysis|2|||
19597329|NCT00752791|42046331|FG000|Overall Study|Protocol deviation|1|||
19597330|NCT00902304|42046342|FG000|Overall Study|Adverse Event|4|||
19597331|NCT00902304|42046343|FG001|Overall Study|Adverse Event|10|||
19597332|NCT00902304|42046344|FG002|Overall Study|Adverse Event|25|||
19597333|NCT00902304|42046342|FG000|Overall Study|Investigator discretion|3|||
19597334|NCT00902304|42046343|FG001|Overall Study|Investigator discretion|5|||
19597335|NCT00902304|42046344|FG002|Overall Study|Investigator discretion|13|||
19747283|NCT03780959|42194787|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
19747284|NCT03780959|42194785|FG000|Part 1|Response Status|2|||
19597336|NCT00902304|42046342|FG000|Overall Study|Lost to Follow-up|7|||
19597337|NCT00902304|42046343|FG001|Overall Study|Lost to Follow-up|7|||
19747285|NCT03780959|42194786|FG001|Part 1|Response Status|0|||
19597338|NCT00902304|42046344|FG002|Overall Study|Lost to Follow-up|7|||
19597339|NCT00902304|42046342|FG000|Overall Study|Protocol Violation|9|||
19597340|NCT00902304|42046343|FG001|Overall Study|Protocol Violation|18|||
19597341|NCT00902304|42046344|FG002|Overall Study|Protocol Violation|20|||
19597342|NCT00902304|42046342|FG000|Overall Study|Withdrawal by Subject|32|||
19597343|NCT00902304|42046343|FG001|Overall Study|Withdrawal by Subject|22|||
19597344|NCT00902304|42046344|FG002|Overall Study|Withdrawal by Subject|43|||
19597345|NCT00902304|42046342|FG000|Overall Study|includes pregnancy|3|||
19597346|NCT00902304|42046343|FG001|Overall Study|includes pregnancy|9|||
19597347|NCT00902304|42046344|FG002|Overall Study|includes pregnancy|2|||
19597348|NCT00759109|42046355|FG000|Overall Study|Adverse Event|17|||
19597349|NCT00759109|42046356|FG001|Overall Study|Adverse Event|12|||
19597350|NCT00759109|42046355|FG000|Overall Study|Inability to comply|1|||
19597351|NCT00759109|42046356|FG001|Overall Study|Inability to comply|1|||
19597352|NCT00759109|42046355|FG000|Overall Study|Withdrawal by Subject|9|||
19597353|NCT00759109|42046356|FG001|Overall Study|Withdrawal by Subject|5|||
19747286|NCT03780959|42194787|FG002|Part 1|Response Status|0|||
19747287|NCT03780959|42194785|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
19747288|NCT03780959|42194786|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
19747289|NCT03780959|42194787|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
19747290|NCT03780959|42194785|FG000|Part 2|Response Status|0|||
19747291|NCT03780959|42194786|FG001|Part 2|Response Status|18|||
19747292|NCT03780959|42194787|FG002|Part 2|Response Status|6|||
19597354|NCT00759109|42046355|FG000|Overall Study|Death|4|||
19597355|NCT00759109|42046356|FG001|Overall Study|Death|3|||
19597356|NCT00759109|42046355|FG000|Overall Study|Lost to Follow-up|4|||
19597357|NCT00759109|42046356|FG001|Overall Study|Lost to Follow-up|6|||
19597358|NCT00759109|42046355|FG000|Overall Study|Started new therapy|2|||
19597359|NCT00759109|42046356|FG001|Overall Study|Started new therapy|6|||
19597360|NCT00759109|42046355|FG000|Overall Study|HCV RNA negative|1|||
19597361|NCT00759109|42046356|FG001|Overall Study|HCV RNA negative|0|||
19597362|NCT00759109|42046355|FG000|Overall Study|Participant moved to a different city|0|||
19597363|NCT00759109|42046356|FG001|Overall Study|Participant moved to a different city|1|||
19597364|NCT00759109|42046355|FG000|Overall Study|Participant had a liver transplant|0|||
19597365|NCT00759109|42046356|FG001|Overall Study|Participant had a liver transplant|1|||
19597366|NCT00759109|42046355|FG000|Overall Study|Lost during study|1|||
19597367|NCT00759109|42046356|FG001|Overall Study|Lost during study|0|||
19597368|NCT00759031|42046364|FG000|First Intervention (1 Day)|Physician Decision|1|||
19597369|NCT00759031|42046365|FG001|First Intervention (1 Day)|Physician Decision|0|||
19597370|NCT00759031|42046364|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
19597371|NCT00759031|42046365|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
19597372|NCT00759031|42046364|FG000|First Intervention (1 Day)|Screening failure|1|||
19597373|NCT00759031|42046365|FG001|First Intervention (1 Day)|Screening failure|0|||
19597374|NCT00758485|42046373|FG000|Overall Study|Lost to Follow-up|0|||
19597375|NCT00758485|42046374|FG001|Overall Study|Lost to Follow-up|1|||
19597376|NCT00758485|42046373|FG000|Overall Study|Not Treated|1|||
19597377|NCT00758485|42046374|FG001|Overall Study|Not Treated|2|||
19597378|NCT00757783|42046383|FG000|Overall Study|Adverse Event|0|||
19597379|NCT00757783|42046384|FG001|Overall Study|Adverse Event|2|||
19597380|NCT00757783|42046383|FG000|Overall Study|Lost to Follow-up|1|||
19597381|NCT00757783|42046384|FG001|Overall Study|Lost to Follow-up|1|||
19597382|NCT00757783|42046383|FG000|Overall Study|Protocol Violation|1|||
19597383|NCT00757783|42046384|FG001|Overall Study|Protocol Violation|0|||
19597384|NCT00757783|42046383|FG000|Overall Study|Withdrawal by Subject|2|||
19597385|NCT00757783|42046384|FG001|Overall Study|Withdrawal by Subject|1|||
19597386|NCT00757783|42046383|FG000|Overall Study|Other|1|||
19597387|NCT00757783|42046384|FG001|Overall Study|Other|2|||
19597388|NCT00757705|42046390|FG000|Overall Study|Adverse Event|19|||
19597389|NCT00757705|42046390|FG000|Overall Study|Lost to Follow-up|16|||
19597390|NCT00757705|42046390|FG000|Overall Study|Withdrawal by Subject|25|||
19597391|NCT00757705|42046390|FG000|Overall Study|Insufficient Response|26|||
19597392|NCT00757705|42046390|FG000|Overall Study|Ineligible to continue|8|||
19597393|NCT00757705|42046390|FG000|Overall Study|Non-compliant|9|||
19597394|NCT00757705|42046390|FG000|Overall Study|Other|18|||
19597395|NCT00757627|42046394|FG000|Overall Study|Adverse Event|15|||
19597396|NCT00757627|42046394|FG000|Overall Study|Lack of Efficacy|10|||
19597397|NCT00757627|42046394|FG000|Overall Study|Lost to Follow-up|28|||
19597398|NCT00757627|42046394|FG000|Overall Study|Withdrawal by Subject|27|||
19597399|NCT00757627|42046394|FG000|Overall Study|Other|1|||
19597400|NCT01023308|42046405|FG000|Overall Study|Abnormal test proceedure results|3|||
19597401|NCT01023308|42046406|FG001|Overall Study|Abnormal test proceedure results|8|||
19597402|NCT01023308|42046405|FG000|Overall Study|Administrative problems|2|||
19597403|NCT01023308|42046406|FG001|Overall Study|Administrative problems|1|||
19597404|NCT01023308|42046405|FG000|Overall Study|Adverse Event|130|||
19597405|NCT01023308|42046406|FG001|Overall Study|Adverse Event|66|||
19597406|NCT01023308|42046405|FG000|Overall Study|Death|21|||
19747293|NCT03408639|42194799|FG000|Overall Study|Death|5|||
19597407|NCT01023308|42046406|FG001|Overall Study|Death|17|||
19597408|NCT01023308|42046405|FG000|Overall Study|Disease progression|82|||
19597409|NCT01023308|42046406|FG001|Overall Study|Disease progression|153|||
19597410|NCT01023308|42046405|FG000|Overall Study|New Cancer therapy|4|||
19597411|NCT01023308|42046406|FG001|Overall Study|New Cancer therapy|7|||
19747294|NCT03408639|42194800|FG001|Overall Study|Death|5|||
19747295|NCT03408639|42194799|FG000|Overall Study|Lost to Follow-up|1|||
19597412|NCT01023308|42046405|FG000|Overall Study|Protocol Violation|3|||
19597413|NCT01023308|42046406|FG001|Overall Study|Protocol Violation|4|||
19597414|NCT01023308|42046405|FG000|Overall Study|Untreated|5|||
19597415|NCT01023308|42046406|FG001|Overall Study|Untreated|5|||
19597416|NCT01023308|42046405|FG000|Overall Study|Lost to Follow-up|1|||
19597417|NCT01023308|42046406|FG001|Overall Study|Lost to Follow-up|0|||
19597418|NCT01023308|42046405|FG000|Overall Study|Withdrawal by Subject|34|||
19597419|NCT01023308|42046406|FG001|Overall Study|Withdrawal by Subject|18|||
19597420|NCT01022996|42046412|FG000|Overall Study|Adverse Event|14|||
19597421|NCT01022996|42046412|FG000|Overall Study|Withdrawal by Subject|3|||
19597422|NCT01022996|42046412|FG000|Overall Study|Lost to Follow-up|1|||
19597423|NCT01022996|42046412|FG000|Overall Study|Administrative problems|6|||
19597424|NCT01022996|42046412|FG000|Overall Study|Disease Progression|32|||
19597425|NCT01022996|42046412|FG000|Overall Study|Protocol Violation|1|||
19597426|NCT00757237|42046418|FG000|Overall Study|Lost to Follow-up|0|||
19597427|NCT00757237|42046419|FG001|Overall Study|Lost to Follow-up|1|||
19597428|NCT00757237|42046418|FG000|Overall Study|Protocol Violation|0|||
19597429|NCT00757237|42046419|FG001|Overall Study|Protocol Violation|2|||
19597430|NCT00757237|42046418|FG000|Overall Study|Physician Decision|2|||
19597431|NCT00757237|42046419|FG001|Overall Study|Physician Decision|3|||
19597432|NCT00757237|42046418|FG000|Overall Study|Withdrawal by Subject|8|||
19597433|NCT00757237|42046419|FG001|Overall Study|Withdrawal by Subject|12|||
19597434|NCT00757237|42046418|FG000|Overall Study|Safety or Tolerability|3|||
19597435|NCT00757237|42046419|FG001|Overall Study|Safety or Tolerability|5|||
19597436|NCT00757237|42046418|FG000|Overall Study|Other|0|||
19597437|NCT00757237|42046419|FG001|Overall Study|Other|2|||
19597438|NCT01029392|42046427|FG000|Overall Study|Withdrawal by Subject|18|||
19597439|NCT01029392|42046428|FG001|Overall Study|Withdrawal by Subject|11|||
19597440|NCT01029392|42046427|FG000|Overall Study|Physician Decision|2|||
19597441|NCT01029392|42046428|FG001|Overall Study|Physician Decision|0|||
19597442|NCT00903006|42046440|FG000|Overall Study|Withdrawal by Subject|2|||
19597443|NCT00903006|42046441|FG001|Overall Study|Withdrawal by Subject|0|||
19597444|NCT00903006|42046442|FG002|Overall Study|Withdrawal by Subject|0|||
19597445|NCT00903006|42046443|FG003|Overall Study|Withdrawal by Subject|0|||
19597446|NCT00903006|42046440|FG000|Overall Study|Progressive Disease|0|||
19597447|NCT00903006|42046441|FG001|Overall Study|Progressive Disease|3|||
19597448|NCT00903006|42046442|FG002|Overall Study|Progressive Disease|1|||
19597449|NCT00903006|42046443|FG003|Overall Study|Progressive Disease|0|||
19597450|NCT00839332|42046456|FG000|Phase 1|Disease Progression|38|||
19597451|NCT00839332|42046457|FG001|Phase 1|Disease Progression|0|||
19597452|NCT00839332|42046458|FG002|Phase 1|Disease Progression|0|||
19597453|NCT00839332|42046456|FG000|Phase 1|Adverse Event|6|||
19597454|NCT00839332|42046457|FG001|Phase 1|Adverse Event|0|||
19597455|NCT00839332|42046458|FG002|Phase 1|Adverse Event|0|||
19597456|NCT00839332|42046456|FG000|Phase 1|Withdrawal by Subject|4|||
19747296|NCT03408639|42194800|FG001|Overall Study|Lost to Follow-up|4|||
19747297|NCT03408639|42194799|FG000|Overall Study|Withdrawal by Subject|2|||
19747298|NCT03408639|42194800|FG001|Overall Study|Withdrawal by Subject|7|||
19747299|NCT03408639|42194799|FG000|Overall Study|Physician Decision|3|||
19747300|NCT03408639|42194800|FG001|Overall Study|Physician Decision|6|||
19747301|NCT03810235|42194808|FG000|Overall Study|Withdrawal by Subject|2|||
19597457|NCT00839332|42046457|FG001|Phase 1|Withdrawal by Subject|0|||
19597458|NCT00839332|42046458|FG002|Phase 1|Withdrawal by Subject|0|||
19597459|NCT00839332|42046456|FG000|Phase 1|Physician Decision|2|||
19597460|NCT00839332|42046457|FG001|Phase 1|Physician Decision|0|||
19597461|NCT00839332|42046458|FG002|Phase 1|Physician Decision|0|||
19597462|NCT00839332|42046456|FG000|Phase 2|Protocol Violation|0|||
19597463|NCT00839332|42046457|FG001|Phase 2|Protocol Violation|1|||
19597464|NCT00839332|42046458|FG002|Phase 2|Protocol Violation|0|||
19597465|NCT00839332|42046456|FG000|Phase 2|Disease Progression|0|||
19597466|NCT00839332|42046457|FG001|Phase 2|Disease Progression|46|||
19597467|NCT00839332|42046458|FG002|Phase 2|Disease Progression|21|||
19597468|NCT00839332|42046456|FG000|Phase 2|Adverse Event|0|||
19597469|NCT00839332|42046457|FG001|Phase 2|Adverse Event|8|||
19597470|NCT00839332|42046458|FG002|Phase 2|Adverse Event|6|||
19597471|NCT00839332|42046456|FG000|Phase 2|Death|0|||
19597472|NCT00839332|42046457|FG001|Phase 2|Death|4|||
19597473|NCT00839332|42046458|FG002|Phase 2|Death|2|||
19597474|NCT00839332|42046456|FG000|Phase 2|Withdrawal by Subject|0|||
19597475|NCT00839332|42046457|FG001|Phase 2|Withdrawal by Subject|5|||
19597476|NCT00839332|42046458|FG002|Phase 2|Withdrawal by Subject|8|||
19597477|NCT00839332|42046456|FG000|Phase 2|Physician Decision|0|||
19597478|NCT00839332|42046457|FG001|Phase 2|Physician Decision|4|||
19597479|NCT00839332|42046458|FG002|Phase 2|Physician Decision|1|||
19747302|NCT03810235|42194809|FG001|Overall Study|Withdrawal by Subject|0|||
19747303|NCT03408483|42194818|FG000|Overall Study|Physician Decision|3|||
19597480|NCT00839332|42046456|FG000|Phase 2|Lost to Follow-up|0|||
19597481|NCT00839332|42046457|FG001|Phase 2|Lost to Follow-up|0|||
19597482|NCT00839332|42046458|FG002|Phase 2|Lost to Follow-up|1|||
19597483|NCT00902850|42046469|FG000|Overall Study|Physician Decision|2|||
19597484|NCT00902850|42046470|FG001|Overall Study|Physician Decision|2|||
19597485|NCT00902538|42046479|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
19597486|NCT00902538|42046480|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
19597487|NCT00902538|42046481|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
19597488|NCT00902538|42046482|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
19597489|NCT00902538|42046483|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
19597490|NCT00902538|42046484|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
19597491|NCT00902538|42046479|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
19597492|NCT00902538|42046480|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
19597493|NCT00902538|42046481|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
19597494|NCT00902538|42046482|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
19597495|NCT00902538|42046483|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
19597496|NCT00902538|42046484|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
19597497|NCT00902538|42046479|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
19597498|NCT00902538|42046480|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
19597499|NCT00902538|42046481|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
19597500|NCT00902538|42046482|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
19597501|NCT00902538|42046483|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
19597502|NCT00902538|42046484|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
19597503|NCT00902538|42046479|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
19597504|NCT00902538|42046480|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
19597505|NCT00902538|42046481|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
19597506|NCT00902538|42046482|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
19597507|NCT00902538|42046483|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
19597508|NCT00902538|42046484|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
19597509|NCT00902538|42046479|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
19597510|NCT00902538|42046480|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
19597511|NCT00902538|42046481|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
19597512|NCT00902538|42046482|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
19597513|NCT00902538|42046483|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
19597514|NCT00902538|42046484|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
19597515|NCT00902538|42046479|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
19597516|NCT00902538|42046480|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
19597517|NCT00902538|42046481|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
19597518|NCT00902538|42046482|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
19597519|NCT00902538|42046483|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
19597520|NCT00902538|42046484|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
19597521|NCT00902538|42046479|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
19597522|NCT00902538|42046480|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
19597523|NCT00902538|42046481|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
19597524|NCT00902538|42046482|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
19597525|NCT00902538|42046483|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
19597526|NCT00902538|42046484|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
19597527|NCT00902538|42046479|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
19597528|NCT00902538|42046480|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
19597529|NCT00902538|42046481|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
19597530|NCT00902538|42046482|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
19597531|NCT00902538|42046483|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
19597532|NCT00902538|42046484|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
19597533|NCT00902538|42046479|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
19597534|NCT00902538|42046480|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
19597535|NCT00902538|42046481|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
19747304|NCT03408483|42194819|FG001|Overall Study|Physician Decision|3|||
19597536|NCT00902538|42046482|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
19597537|NCT00902538|42046483|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
19597538|NCT00902538|42046484|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
19597539|NCT00902538|42046479|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
19597540|NCT00902538|42046480|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
19597541|NCT00902538|42046481|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
19597542|NCT00902538|42046482|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
19597543|NCT00902538|42046483|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
19597544|NCT00902538|42046484|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
19597545|NCT00902538|42046479|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
19597546|NCT00902538|42046480|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
19597547|NCT00902538|42046481|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
19597548|NCT00902538|42046482|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
19597549|NCT00902538|42046483|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
19597550|NCT00902538|42046484|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
19597551|NCT00902538|42046479|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
19597552|NCT00902538|42046480|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
19597553|NCT00902538|42046481|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
19597554|NCT00902538|42046482|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
19597555|NCT00902538|42046483|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
19597556|NCT00902538|42046484|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
19597557|NCT00902538|42046479|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
19747305|NCT03408483|42194818|FG000|Overall Study|Lost to Follow-up|3|||
19747306|NCT03408483|42194819|FG001|Overall Study|Lost to Follow-up|0|||
19747307|NCT03777917|42194827|FG000|Overall Study|Withdrawal by Subject|1|||
19747308|NCT03777917|42194828|FG001|Overall Study|Withdrawal by Subject|0|||
19597558|NCT00902538|42046480|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
19597559|NCT00902538|42046481|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
19597560|NCT00902538|42046482|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
19597561|NCT00902538|42046483|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
19597562|NCT00902538|42046484|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
19597563|NCT00902538|42046479|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
19597564|NCT00902538|42046480|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
19597565|NCT00902538|42046481|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
19597566|NCT00902538|42046482|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
19597567|NCT00902538|42046483|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
19597568|NCT00902538|42046484|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
19597569|NCT00902538|42046479|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
19597570|NCT00902538|42046480|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
19597571|NCT00902538|42046481|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
19597572|NCT00902538|42046482|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
19597573|NCT00902538|42046483|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
19597574|NCT00902538|42046484|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
19597575|NCT00902538|42046479|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
19597576|NCT00902538|42046480|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
19597577|NCT00902538|42046481|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
19597578|NCT00902538|42046482|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
19597579|NCT00902538|42046483|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
19597580|NCT00902538|42046484|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
19597581|NCT00902538|42046479|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
19597582|NCT00902538|42046480|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
19597583|NCT00902538|42046481|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
19597584|NCT00902538|42046482|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
19597585|NCT00902538|42046483|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
19597586|NCT00902538|42046484|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
19597587|NCT01036022|42046506|FG000|Overall Study|Adverse Event|1|||
19597588|NCT01036022|42046507|FG001|Overall Study|Adverse Event|3|||
19597589|NCT01036022|42046508|FG002|Overall Study|Adverse Event|2|||
19597590|NCT01036022|42046509|FG003|Overall Study|Adverse Event|1|||
19597591|NCT01036022|42046510|FG004|Overall Study|Adverse Event|0|||
19597592|NCT01036022|42046511|FG005|Overall Study|Adverse Event|2|||
19597593|NCT01036022|42046506|FG000|Overall Study|Lack of Efficacy|1|||
19597594|NCT01036022|42046507|FG001|Overall Study|Lack of Efficacy|1|||
19597595|NCT01036022|42046508|FG002|Overall Study|Lack of Efficacy|1|||
19597596|NCT01036022|42046509|FG003|Overall Study|Lack of Efficacy|0|||
19597597|NCT01036022|42046510|FG004|Overall Study|Lack of Efficacy|1|||
19597598|NCT01036022|42046511|FG005|Overall Study|Lack of Efficacy|1|||
19597599|NCT01036022|42046506|FG000|Overall Study|Physician Decision|0|||
19597600|NCT01036022|42046507|FG001|Overall Study|Physician Decision|0|||
19597601|NCT01036022|42046508|FG002|Overall Study|Physician Decision|1|||
19597602|NCT01036022|42046509|FG003|Overall Study|Physician Decision|0|||
19747309|NCT03777917|42194827|FG000|Overall Study|Physician Decision|1|||
19597603|NCT01036022|42046510|FG004|Overall Study|Physician Decision|0|||
19597604|NCT01036022|42046511|FG005|Overall Study|Physician Decision|0|||
19597605|NCT01036022|42046506|FG000|Overall Study|Withdrawal by Subject|0|||
19597606|NCT01036022|42046507|FG001|Overall Study|Withdrawal by Subject|0|||
19597607|NCT01036022|42046508|FG002|Overall Study|Withdrawal by Subject|0|||
19597608|NCT01036022|42046509|FG003|Overall Study|Withdrawal by Subject|1|||
19597609|NCT01036022|42046510|FG004|Overall Study|Withdrawal by Subject|2|||
19597610|NCT01036022|42046511|FG005|Overall Study|Withdrawal by Subject|0|||
19597611|NCT00752557|42046536|FG000|Overall Study|Withdrawal by Subject|4|||
19597612|NCT00752557|42046537|FG001|Overall Study|Withdrawal by Subject|3|||
19597613|NCT00752557|42046538|FG002|Overall Study|Withdrawal by Subject|3|||
19597614|NCT00752557|42046536|FG000|Overall Study|Unspecified resaons|0|||
19597615|NCT00752557|42046537|FG001|Overall Study|Unspecified resaons|2|||
19597616|NCT00752557|42046538|FG002|Overall Study|Unspecified resaons|2|||
19597617|NCT00752557|42046536|FG000|Overall Study|Lost to Follow-up|1|||
19597618|NCT00752557|42046537|FG001|Overall Study|Lost to Follow-up|0|||
19597619|NCT00752557|42046538|FG002|Overall Study|Lost to Follow-up|1|||
19597620|NCT00747643|42046550|FG000|Overall Study|Withdrawal by Subject|36|||
19597621|NCT00747643|42046551|FG001|Overall Study|Withdrawal by Subject|27|||
19597622|NCT01022762|42046559|FG000|Overall Study|Adverse Event|3|||
19597623|NCT01022762|42046560|FG001|Overall Study|Adverse Event|1|||
19597624|NCT01022762|42046559|FG000|Overall Study|Lack of Efficacy|0|||
19597625|NCT01022762|42046560|FG001|Overall Study|Lack of Efficacy|1|||
19597626|NCT01022762|42046559|FG000|Overall Study|Protocol Violation|7|||
19597627|NCT01022762|42046560|FG001|Overall Study|Protocol Violation|6|||
19597628|NCT01022762|42046559|FG000|Overall Study|Unclassified|12|||
19597629|NCT01022762|42046560|FG001|Overall Study|Unclassified|20|||
19597630|NCT01028378|42046566|FG000|Overall Study|Lost to Follow-up|12|||
19597631|NCT01028378|42046566|FG000|Overall Study|Withdrawal by Subject|1|||
19597632|NCT01028378|42046566|FG000|Overall Study|Adminstrative Reasons|4|||
19597633|NCT00747565|42046572|FG000|Overall Study|Withdrawal by Subject|10|||
19597634|NCT00747565|42046573|FG001|Overall Study|Withdrawal by Subject|6|||
19597635|NCT00747565|42046572|FG000|Overall Study|Lost to Follow-up|4|||
19597636|NCT00747565|42046573|FG001|Overall Study|Lost to Follow-up|1|||
19597637|NCT01028300|42046579|FG000|Overall Study|Study Terminated|4|||
19597638|NCT00752089|42046583|FG000|Overall Study|Adverse Event|1|||
19597639|NCT00752089|42046583|FG000|Overall Study|Protocol Deviation|2|||
19597640|NCT00752089|42046583|FG000|Overall Study|Could not attend visit 9|1|||
19597641|NCT00752089|42046583|FG000|Overall Study|Not capable of wearing partial denture|1|||
19597642|NCT00752089|42046583|FG000|Overall Study|Cannot continue the study|1|||
19597643|NCT00751933|42046594|FG000|Overall Study|Withdrawal by Subject|0|||
19597644|NCT00751933|42046595|FG001|Overall Study|Withdrawal by Subject|1|||
19597645|NCT00751933|42046596|FG002|Overall Study|Withdrawal by Subject|0|||
19597646|NCT00751933|42046597|FG003|Overall Study|Withdrawal by Subject|0|||
19597647|NCT00751933|42046594|FG000|Overall Study|Physician Decision|0|||
19597648|NCT00751933|42046595|FG001|Overall Study|Physician Decision|0|||
19597649|NCT00751933|42046596|FG002|Overall Study|Physician Decision|1|||
19597650|NCT00751933|42046597|FG003|Overall Study|Physician Decision|1|||
19597651|NCT00751621|42046601|FG000|Overall Study|Adverse Event|1|||
19597652|NCT00751621|42046601|FG000|Overall Study|Withdrawal by Subject|1|||
19597653|NCT00751621|42046601|FG000|Overall Study|Subject moved to another country|1|||
19597654|NCT00751621|42046601|FG000|Overall Study|Poor adherence to asthma treatment|1|||
19597655|NCT01028222|42046609|FG000|Overall Study|Protocol deviation|1|||
19597656|NCT01028222|42046610|FG001|Overall Study|Protocol deviation|0|||
19597657|NCT01028222|42046609|FG000|Overall Study|Disease progression|33|||
19597658|NCT01028222|42046610|FG001|Overall Study|Disease progression|9|||
19597659|NCT01028222|42046609|FG000|Overall Study|Administrative problems|1|||
19597660|NCT01028222|42046610|FG001|Overall Study|Administrative problems|1|||
19597661|NCT01028222|42046609|FG000|Overall Study|Lost to Follow-up|0|||
19597662|NCT01028222|42046610|FG001|Overall Study|Lost to Follow-up|1|||
19597663|NCT01028222|42046609|FG000|Overall Study|Withdrawal by Subject|1|||
19597664|NCT01028222|42046610|FG001|Overall Study|Withdrawal by Subject|0|||
19597665|NCT01028222|42046609|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
19597666|NCT01028222|42046610|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
19597667|NCT01028222|42046609|FG000|Overall Study|Adverse Event|2|||
19597668|NCT01028222|42046610|FG001|Overall Study|Adverse Event|0|||
19597669|NCT00586495|42046617|FG000|Treatment Period|Adverse Event|11|||
19597670|NCT00586495|42046617|FG000|Treatment Period|Death|1|||
19597671|NCT00586495|42046617|FG000|Treatment Period|Protocol Violation|1|||
19597672|NCT00586495|42046617|FG000|Treatment Period|Withdrawal by Subject|1|||
19597673|NCT00586495|42046617|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
19597674|NCT00586495|42046617|FG000|Treatment Period|Switch to commercial drug|10|||
19597675|NCT00586495|42046617|FG000|Follow-up|Death|40|||
19597676|NCT00586495|42046617|FG000|Follow-up|Lost to Follow-up|1|||
19597677|NCT00586495|42046617|FG000|Follow-up|Withdrawal by Subject|4|||
19597678|NCT00586495|42046617|FG000|Follow-up|Protocol driven decision point|37|||
19597679|NCT00586495|42046617|FG000|Follow-up|Switch to commercial drug|10|||
19747310|NCT03777917|42194828|FG001|Overall Study|Physician Decision|0|||
19597680|NCT01027754|42046623|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
19597681|NCT01027754|42046624|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
19597682|NCT01027754|42046623|FG000|Overall Study|Withdrawal by Subject|0|||
19597683|NCT01027754|42046624|FG001|Overall Study|Withdrawal by Subject|5|||
19597684|NCT01034540|42046636|FG000|Overall Study|Adverse Event|0|||
19597685|NCT01034540|42046637|FG001|Overall Study|Adverse Event|1|||
19597686|NCT00774930|42046647|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
19597687|NCT00774930|42046648|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
19597688|NCT00774930|42046647|FG000|DB Phase|Adverse Event|1|||
19597689|NCT00774930|42046648|FG001|DB Phase|Adverse Event|2|||
19597690|NCT00774930|42046647|FG000|DB Phase|Subject Decision|1|||
19597691|NCT00774930|42046648|FG001|DB Phase|Subject Decision|5|||
19597692|NCT00774930|42046647|FG000|DB Phase|Sponsor Decision|0|||
19597693|NCT00774930|42046648|FG001|DB Phase|Sponsor Decision|1|||
19597694|NCT00774930|42046647|FG000|DB Phase|Disease Progression|1|||
19597695|NCT00774930|42046648|FG001|DB Phase|Disease Progression|1|||
19597696|NCT00774930|42046647|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
19597697|NCT00774930|42046648|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
19597698|NCT00774930|42046647|FG000|IOL Phase|Adverse Event|1|||
19597699|NCT00774930|42046648|FG001|IOL Phase|Adverse Event|1|||
19597700|NCT00774930|42046647|FG000|IOL Phase|Subject Decision|4|||
19597701|NCT00774930|42046648|FG001|IOL Phase|Subject Decision|3|||
19597702|NCT00774930|42046647|FG000|IOL Phase|Physician Decision|3|||
19597703|NCT00774930|42046648|FG001|IOL Phase|Physician Decision|2|||
19597704|NCT00774930|42046647|FG000|IOL Phase|Sponsor Decision|1|||
19747311|NCT03777917|42194827|FG000|Overall Study|Lost to Follow-up|6|||
19747312|NCT03777917|42194828|FG001|Overall Study|Lost to Follow-up|2|||
19747313|NCT03777917|42194827|FG000|Overall Study|Other|1|||
19597705|NCT00774930|42046648|FG001|IOL Phase|Sponsor Decision|0|||
19597706|NCT00774930|42046647|FG000|IOL Phase|Disease Progression|2|||
19597707|NCT00774930|42046648|FG001|IOL Phase|Disease Progression|1|||
19597708|NCT00774930|42046647|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
19597709|NCT00774930|42046648|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
19597710|NCT00774930|42046647|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
19597711|NCT00774930|42046648|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
19597712|NCT00774930|42046647|FG000|IOL Phase|Other|1|||
19597713|NCT00774930|42046648|FG001|IOL Phase|Other|0|||
19597714|NCT00774930|42046647|FG000|IOL Phase|Brain radiation|0|||
19597715|NCT00774930|42046648|FG001|IOL Phase|Brain radiation|1|||
19597716|NCT00774930|42046647|FG000|LTOLE Phase|Adverse Event|7|||
19597717|NCT00774930|42046648|FG001|LTOLE Phase|Adverse Event|3|||
19597718|NCT00774930|42046647|FG000|LTOLE Phase|Subject decision|0|||
19597719|NCT00774930|42046648|FG001|LTOLE Phase|Subject decision|5|||
19597720|NCT00774930|42046647|FG000|LTOLE Phase|Physician Decision|4|||
19597721|NCT00774930|42046648|FG001|LTOLE Phase|Physician Decision|1|||
19597722|NCT00774930|42046647|FG000|LTOLE Phase|Sponsor decision|2|||
19597723|NCT00774930|42046648|FG001|LTOLE Phase|Sponsor decision|1|||
19597724|NCT00774930|42046647|FG000|LTOLE Phase|Disease Progression|2|||
19597725|NCT00774930|42046648|FG001|LTOLE Phase|Disease Progression|5|||
19597726|NCT00774930|42046647|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
19597727|NCT00774930|42046648|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
19597728|NCT00774930|42046647|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
19597729|NCT00774930|42046648|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
19597730|NCT01027364|42046669|FG000|Overall Study|Adverse Event|1|||
19597731|NCT01027364|42046670|FG001|Overall Study|Adverse Event|0|||
19597732|NCT01027364|42046671|FG002|Overall Study|Adverse Event|1|||
19747314|NCT03777917|42194828|FG001|Overall Study|Other|0|||
19747315|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
19747316|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
19747317|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
19747318|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
19747319|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
19747320|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
19747321|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
19747322|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
19597733|NCT01027364|42046672|FG003|Overall Study|Adverse Event|0|||
19597734|NCT01027364|42046669|FG000|Overall Study|Lost to Follow-up|1|||
19597735|NCT01027364|42046670|FG001|Overall Study|Lost to Follow-up|0|||
19597736|NCT01027364|42046671|FG002|Overall Study|Lost to Follow-up|0|||
19597737|NCT01027364|42046672|FG003|Overall Study|Lost to Follow-up|0|||
19597738|NCT01027364|42046669|FG000|Overall Study|Protocol Violation|1|||
19597739|NCT01027364|42046670|FG001|Overall Study|Protocol Violation|0|||
19597740|NCT01027364|42046671|FG002|Overall Study|Protocol Violation|0|||
19747323|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
19597741|NCT01027364|42046672|FG003|Overall Study|Protocol Violation|1|||
19597742|NCT01027364|42046669|FG000|Overall Study|Withdrawal by Subject|1|||
19597743|NCT01027364|42046670|FG001|Overall Study|Withdrawal by Subject|2|||
19597744|NCT01027364|42046671|FG002|Overall Study|Withdrawal by Subject|0|||
19597745|NCT01027364|42046672|FG003|Overall Study|Withdrawal by Subject|0|||
19597746|NCT01027286|42046700|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
19597747|NCT01027286|42046701|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
19597748|NCT01027286|42046700|FG000|Overall Study|Lost to Follow-up|0|||
19597749|NCT01027286|42046701|FG001|Overall Study|Lost to Follow-up|1|||
19597750|NCT01026974|42046711|FG000|Overall Study|Withdrawal by Subject|0|||
19597751|NCT01026974|42046712|FG001|Overall Study|Withdrawal by Subject|1|||
19597752|NCT01026974|42046713|FG002|Overall Study|Withdrawal by Subject|7|||
19597753|NCT01026974|42046714|FG003|Overall Study|Withdrawal by Subject|2|||
19597754|NCT01026974|42046711|FG000|Overall Study|Lost to Follow-up|1|||
19597755|NCT01026974|42046712|FG001|Overall Study|Lost to Follow-up|1|||
19597756|NCT01026974|42046713|FG002|Overall Study|Lost to Follow-up|4|||
19597757|NCT01026974|42046714|FG003|Overall Study|Lost to Follow-up|0|||
19597758|NCT01026974|42046711|FG000|Overall Study|Adverse Event|0|||
19597759|NCT01026974|42046712|FG001|Overall Study|Adverse Event|0|||
19597760|NCT01026974|42046713|FG002|Overall Study|Adverse Event|0|||
19597761|NCT01026974|42046714|FG003|Overall Study|Adverse Event|1|||
19597762|NCT01026974|42046711|FG000|Overall Study|Inappropriate enrollment|0|||
19597763|NCT01026974|42046712|FG001|Overall Study|Inappropriate enrollment|0|||
19597764|NCT01026974|42046713|FG002|Overall Study|Inappropriate enrollment|1|||
19597765|NCT01026974|42046714|FG003|Overall Study|Inappropriate enrollment|0|||
19597766|NCT00897390|42046729|FG000|Overall Study|Adverse Event|2|||
19597767|NCT00897390|42046729|FG000|Overall Study|No Longer Met Study Criteria|1|||
19597768|NCT00897390|42046729|FG000|Overall Study|Personal Reasons|1|||
19597769|NCT00897390|42046729|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
19597770|NCT01034462|42046742|FG000|Overall Study|Adverse Event|7|||
19597771|NCT01034462|42046743|FG001|Overall Study|Adverse Event|17|||
19597772|NCT01034462|42046742|FG000|Overall Study|Lack of Efficacy|4|||
19597773|NCT01034462|42046743|FG001|Overall Study|Lack of Efficacy|4|||
19597774|NCT01034462|42046742|FG000|Overall Study|Protocol Violation|10|||
19597775|NCT01034462|42046743|FG001|Overall Study|Protocol Violation|7|||
19597776|NCT01034462|42046742|FG000|Overall Study|Withdrawal by Subject|9|||
19597777|NCT01034462|42046743|FG001|Overall Study|Withdrawal by Subject|8|||
19597778|NCT01034462|42046742|FG000|Overall Study|Lost to Follow-up|14|||
19597779|NCT01034462|42046743|FG001|Overall Study|Lost to Follow-up|16|||
19597780|NCT01034462|42046742|FG000|Overall Study|Other reasons|1|||
19597781|NCT01034462|42046743|FG001|Overall Study|Other reasons|2|||
19597782|NCT01033448|42046751|FG000|Overall Study|Withdrawal by Subject|4|||
19597783|NCT01033448|42046751|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
19597784|NCT01033448|42046751|FG000|Overall Study|Lost to Follow-up|3|||
19597785|NCT01033448|42046751|FG000|Overall Study|Withdrew due to other reasons|3|||
19597786|NCT01033448|42046751|FG000|Overall Study|Unknown disposition|1|||
19597787|NCT00746941|42046761|FG000|Overall Study|Death|2|||
19597788|NCT00746941|42046762|FG001|Overall Study|Death|0|||
19597789|NCT00746941|42046763|FG002|Overall Study|Death|0|||
19597790|NCT00746941|42046764|FG003|Overall Study|Death|6|||
19597791|NCT00746941|42046761|FG000|Overall Study|Physician Decision|0|||
19597792|NCT00746941|42046762|FG001|Overall Study|Physician Decision|0|||
19597793|NCT00746941|42046763|FG002|Overall Study|Physician Decision|2|||
19597794|NCT00746941|42046764|FG003|Overall Study|Physician Decision|0|||
19597795|NCT00746941|42046761|FG000|Overall Study|Withdrawal by Subject|3|||
19597796|NCT00746941|42046762|FG001|Overall Study|Withdrawal by Subject|0|||
19597797|NCT00746941|42046763|FG002|Overall Study|Withdrawal by Subject|0|||
19597798|NCT00746941|42046764|FG003|Overall Study|Withdrawal by Subject|2|||
19597799|NCT00746941|42046761|FG000|Overall Study|Other, reason not provided|2|||
19597800|NCT00746941|42046762|FG001|Overall Study|Other, reason not provided|4|||
19597801|NCT00746941|42046763|FG002|Overall Study|Other, reason not provided|0|||
19597802|NCT00746941|42046764|FG003|Overall Study|Other, reason not provided|4|||
19597803|NCT00746941|42046761|FG000|Overall Study|Adverse Event|0|||
19597804|NCT00746941|42046762|FG001|Overall Study|Adverse Event|0|||
19597805|NCT00746941|42046763|FG002|Overall Study|Adverse Event|0|||
19597806|NCT00746941|42046764|FG003|Overall Study|Adverse Event|1|||
19597807|NCT00746785|42046776|FG000|Overall Study|Lost to Follow-up|29|||
19597808|NCT00746785|42046777|FG001|Overall Study|Lost to Follow-up|25|||
19597809|NCT00746785|42046778|FG002|Overall Study|Lost to Follow-up|27|||
19597810|NCT00750919|42046786|FG000|Overall Study|Adverse Event|9|||
19597811|NCT00750919|42046786|FG000|Overall Study|Withdrawal by Subject|1|||
19597812|NCT00750919|42046786|FG000|Overall Study|Lack of Efficacy|8|||
19597813|NCT00750919|42046786|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
19597814|NCT00750919|42046786|FG000|Overall Study|Other|36|||
19597815|NCT00746551|42046792|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
19597816|NCT00746551|42046793|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
19597817|NCT00746551|42046792|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
19597818|NCT00746551|42046793|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
19597819|NCT00746551|42046792|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
19597820|NCT00746551|42046793|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
19597821|NCT00753649|42046801|FG000|Overall Study|Migrated/moved from study area|1|||
19597822|NCT00753649|42046802|FG001|Overall Study|Migrated/moved from study area|0|||
19597823|NCT00753649|42046801|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
19597824|NCT00753649|42046802|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
19747324|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
19597825|NCT00753649|42046801|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
19597826|NCT00753649|42046802|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
19597827|NCT00753649|42046801|FG000|Overall Study|Protocol Violation|2|||
19747325|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
19747326|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
19747327|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
19747328|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
19747329|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
19747330|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
19747331|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
19747332|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
19747333|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
19747334|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
19747335|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
19747336|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
19747337|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
19747338|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
19747339|NCT03777059|42194839|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
19747340|NCT03777059|42194840|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
19747341|NCT03777059|42194841|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
19747342|NCT03777059|42194842|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
19747343|NCT03777059|42194839|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
19747344|NCT03777059|42194840|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
19747345|NCT03777059|42194841|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
19747346|NCT03777059|42194842|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
19747347|NCT03777059|42194839|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
19747348|NCT03777059|42194840|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
19747349|NCT03777059|42194841|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
19747350|NCT03777059|42194842|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
19747351|NCT03777059|42194839|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
19747352|NCT03777059|42194840|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
19747353|NCT03777059|42194841|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
19747354|NCT03777059|42194842|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
19747355|NCT03777059|42194839|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
19747356|NCT03777059|42194840|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
19597828|NCT00753649|42046802|FG001|Overall Study|Protocol Violation|0|||
19597829|NCT00750139|42046812|FG000|Overall Study|Adverse Event|1|||
19597830|NCT00750139|42046813|FG001|Overall Study|Adverse Event|2|||
19597831|NCT00750139|42046814|FG002|Overall Study|Adverse Event|0|||
19597832|NCT00750139|42046815|FG003|Overall Study|Adverse Event|1|||
19747357|NCT03777059|42194841|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
19597833|NCT00750139|42046812|FG000|Overall Study|Lost to Follow-up|17|||
19597834|NCT00750139|42046813|FG001|Overall Study|Lost to Follow-up|12|||
19597835|NCT00750139|42046814|FG002|Overall Study|Lost to Follow-up|15|||
19597836|NCT00750139|42046815|FG003|Overall Study|Lost to Follow-up|6|||
19597837|NCT00750139|42046812|FG000|Overall Study|Withdrawal by Subject|3|||
19747358|NCT03777059|42194842|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
19597838|NCT00750139|42046813|FG001|Overall Study|Withdrawal by Subject|2|||
19597839|NCT00750139|42046814|FG002|Overall Study|Withdrawal by Subject|6|||
19597840|NCT00750139|42046815|FG003|Overall Study|Withdrawal by Subject|2|||
19597841|NCT00750139|42046812|FG000|Overall Study|Physician Decision|1|||
19597842|NCT00750139|42046813|FG001|Overall Study|Physician Decision|1|||
19597843|NCT00750139|42046814|FG002|Overall Study|Physician Decision|0|||
19597844|NCT00750139|42046815|FG003|Overall Study|Physician Decision|0|||
19597845|NCT00750139|42046812|FG000|Overall Study|Non-compliance|1|||
19597846|NCT00750139|42046813|FG001|Overall Study|Non-compliance|0|||
19597847|NCT00750139|42046814|FG002|Overall Study|Non-compliance|1|||
19747359|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19388104|NCT02700815|41631480|FG001|Overall Study|Withdrawal by Subject|0|||
19597848|NCT00750139|42046815|FG003|Overall Study|Non-compliance|3|||
19597849|NCT00750139|42046812|FG000|Overall Study|Termination by sponsor|4|||
19597850|NCT00750139|42046813|FG001|Overall Study|Termination by sponsor|0|||
19597851|NCT00750139|42046814|FG002|Overall Study|Termination by sponsor|0|||
19597852|NCT00750139|42046815|FG003|Overall Study|Termination by sponsor|1|||
19597853|NCT00750139|42046812|FG000|Overall Study|Non-specific|62|||
19597854|NCT00750139|42046813|FG001|Overall Study|Non-specific|42|||
19597855|NCT00750139|42046814|FG002|Overall Study|Non-specific|79|||
19597856|NCT00750139|42046815|FG003|Overall Study|Non-specific|33|||
19597857|NCT00750061|42046829|FG000|Overall Study|Adverse Event|2|||
19597858|NCT00750061|42046830|FG001|Overall Study|Adverse Event|0|||
19597859|NCT00750061|42046829|FG000|Overall Study|Withdrawal by Subject|0|||
19597860|NCT00750061|42046830|FG001|Overall Study|Withdrawal by Subject|1|||
19597861|NCT00750061|42046829|FG000|Overall Study|Physician Decision|0|||
19597862|NCT00750061|42046830|FG001|Overall Study|Physician Decision|1|||
19597863|NCT00744757|42046836|FG000|Overall Study|Objective disease progression|7|||
19747360|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747361|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
19597864|NCT00744757|42046836|FG000|Overall Study|Physician Decision|5|||
19597865|NCT00744757|42046836|FG000|Overall Study|Withdrawal by Subject|1|||
19597866|NCT00744757|42046836|FG000|Overall Study|Death|6|||
19597867|NCT00744757|42046836|FG000|Overall Study|Adverse Event|2|||
19597868|NCT00745849|42046840|FG000|First Intervention|Withdrawal by Subject|0|||
19597869|NCT00745849|42046841|FG001|First Intervention|Withdrawal by Subject|1|||
19597870|NCT00745849|42046840|FG000|First Intervention|Lost to Follow-up|1|||
19597871|NCT00745849|42046841|FG001|First Intervention|Lost to Follow-up|1|||
19597872|NCT00745849|42046840|FG000|Second Intervention|Lost to Follow-up|2|||
19597873|NCT00745849|42046841|FG001|Second Intervention|Lost to Follow-up|1|||
19597874|NCT00749203|42046849|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
19597875|NCT00749203|42046850|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
19597876|NCT00749203|42046849|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
19597877|NCT00749203|42046850|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
19597878|NCT00749203|42046849|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
19597879|NCT00749203|42046850|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
19597880|NCT00749203|42046849|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
19597881|NCT00749203|42046850|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
19597882|NCT00749203|42046849|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
19597883|NCT00749203|42046850|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
19597884|NCT00749203|42046849|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
19597885|NCT00749203|42046850|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
19597886|NCT00748969|42046858|FG000|Overall Study|Withdrawal by Subject|1|||
19597887|NCT00748969|42046859|FG001|Overall Study|Withdrawal by Subject|0|||
19597888|NCT00748969|42046858|FG000|Overall Study|Withdrawal by Subject|0|||
19597889|NCT00748969|42046859|FG001|Overall Study|Withdrawal by Subject|1|||
19597890|NCT00745615|42046869|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
19597891|NCT00745615|42046870|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
19597892|NCT00745615|42046871|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
19597893|NCT00745615|42046872|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
19597894|NCT00745615|42046873|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
19597895|NCT00745615|42046874|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
19597896|NCT00745615|42046869|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
19597897|NCT00745615|42046870|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
19597898|NCT00745615|42046871|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
19597899|NCT00745615|42046872|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
19597900|NCT00745615|42046873|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
19597901|NCT00745615|42046874|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
19597902|NCT00745615|42046869|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
19597903|NCT00745615|42046870|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
19597904|NCT00745615|42046871|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
19597905|NCT00745615|42046872|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
19597906|NCT00745615|42046873|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
19597907|NCT00745615|42046874|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
19597908|NCT00745615|42046869|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
19597909|NCT00745615|42046870|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
19597910|NCT00745615|42046871|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
19597911|NCT00745615|42046872|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
19597912|NCT00745615|42046873|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
19597913|NCT00745615|42046874|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
19747362|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
19597914|NCT00745615|42046869|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
19597915|NCT00745615|42046870|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
19747363|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
19597916|NCT00745615|42046871|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
19597917|NCT00745615|42046872|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
19597918|NCT00745615|42046873|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
19597919|NCT00745615|42046874|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
19597920|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
19597921|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
19597922|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
19597923|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
19597924|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
19597925|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
19597926|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
19597927|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
19597928|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
19597929|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
19597930|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
19597931|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
19597932|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
19597933|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
19597934|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
19597935|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
19597936|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
19597937|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
19597938|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
19597939|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
19597940|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
19597941|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
19597942|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
19597943|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
19597944|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
19597945|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
19597946|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
19747364|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747365|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
19747366|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
19747367|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
19747368|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747369|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747370|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747371|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
19747372|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
19747373|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
19747374|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
19747375|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
19747376|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
19747377|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
19747378|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
19747379|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
19747380|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
19747381|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
19747382|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
19747383|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
19747384|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
19747385|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747386|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
19747387|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
19747388|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747389|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747390|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
19747391|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
19747392|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747393|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747394|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747395|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747396|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747397|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
19747398|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747399|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
19747400|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
19747401|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19597947|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
19597948|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
19597949|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
19597950|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
19597951|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
19597952|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
19597953|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
19597954|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
19597955|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
19597956|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
19597957|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
19597958|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
19597959|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
19597960|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
19597961|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
19747402|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747403|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747404|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
19747405|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747406|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
19747407|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747408|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747409|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747410|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
19747411|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747412|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747413|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747414|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
19747415|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747416|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747417|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747418|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
19747419|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19597962|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
19597963|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
19597964|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
19597965|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
19597966|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
19597967|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
19597968|NCT00745615|42046869|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
19597969|NCT00745615|42046870|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
19597970|NCT00745615|42046871|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
19597971|NCT00745615|42046872|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
19597972|NCT00745615|42046873|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
19597973|NCT00745615|42046874|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
19597974|NCT00744523|42046888|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
19597975|NCT00744523|42046889|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
19597976|NCT04517253|42046900|FG000|Overall Study|Adverse Event|1|||
19597977|NCT04517253|42046901|FG001|Overall Study|Adverse Event|0|||
19597978|NCT04517253|42046902|FG002|Overall Study|Adverse Event|0|||
19597979|NCT04517253|42046900|FG000|Overall Study|Death|0|||
19597980|NCT04517253|42046901|FG001|Overall Study|Death|1|||
19597981|NCT04517253|42046902|FG002|Overall Study|Death|0|||
19597982|NCT00744991|42046912|FG000|Overall Study|Progressive Disease|11|||
19597983|NCT00744991|42046912|FG000|Overall Study|Withdrawal by Subject|8|||
19597984|NCT00744991|42046912|FG000|Overall Study|Physician Decision|3|||
19597985|NCT00744991|42046912|FG000|Overall Study|Adverse Event|2|||
19597986|NCT00744991|42046912|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
19597987|NCT00839254|42046936|FG000|Overall Study|Protocol Violation|0|||
19597988|NCT00839254|42046937|FG001|Overall Study|Protocol Violation|1|||
19597989|NCT00839254|42046938|FG002|Overall Study|Protocol Violation|1|||
19597990|NCT00839254|42046939|FG003|Overall Study|Protocol Violation|1|||
19747420|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747421|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19597991|NCT00839254|42046940|FG004|Overall Study|Protocol Violation|0|||
19597992|NCT00839254|42046941|FG005|Overall Study|Protocol Violation|0|||
19747422|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747423|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
19747424|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747425|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747426|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747427|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
19747428|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747429|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747430|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
19597993|NCT00839254|42046942|FG006|Overall Study|Protocol Violation|1|||
19597994|NCT00839254|42046943|FG007|Overall Study|Protocol Violation|2|||
19597995|NCT00839254|42046936|FG000|Overall Study|Physician Decision|0|||
19597996|NCT00839254|42046937|FG001|Overall Study|Physician Decision|1|||
19597997|NCT00839254|42046938|FG002|Overall Study|Physician Decision|0|||
19597998|NCT00839254|42046939|FG003|Overall Study|Physician Decision|0|||
19597999|NCT00839254|42046940|FG004|Overall Study|Physician Decision|0|||
19598000|NCT00839254|42046941|FG005|Overall Study|Physician Decision|0|||
19598001|NCT00839254|42046942|FG006|Overall Study|Physician Decision|0|||
19598002|NCT00839254|42046943|FG007|Overall Study|Physician Decision|1|||
19598003|NCT00839254|42046936|FG000|Overall Study|Wrong treatment number allocation|0|||
19598004|NCT00839254|42046937|FG001|Overall Study|Wrong treatment number allocation|1|||
19598005|NCT00839254|42046938|FG002|Overall Study|Wrong treatment number allocation|0|||
19598006|NCT00839254|42046939|FG003|Overall Study|Wrong treatment number allocation|0|||
19598007|NCT00839254|42046940|FG004|Overall Study|Wrong treatment number allocation|0|||
19598008|NCT00839254|42046941|FG005|Overall Study|Wrong treatment number allocation|1|||
19598009|NCT00839254|42046942|FG006|Overall Study|Wrong treatment number allocation|0|||
19598010|NCT00839254|42046943|FG007|Overall Study|Wrong treatment number allocation|0|||
19598011|NCT00839254|42046936|FG000|Overall Study|Adverse Event|12|||
19598012|NCT00839254|42046937|FG001|Overall Study|Adverse Event|6|||
19598013|NCT00839254|42046938|FG002|Overall Study|Adverse Event|3|||
19598014|NCT00839254|42046939|FG003|Overall Study|Adverse Event|5|||
19598015|NCT00839254|42046940|FG004|Overall Study|Adverse Event|2|||
19598016|NCT00839254|42046941|FG005|Overall Study|Adverse Event|1|||
19598017|NCT00839254|42046942|FG006|Overall Study|Adverse Event|0|||
19598018|NCT00839254|42046943|FG007|Overall Study|Adverse Event|1|||
19598019|NCT00839254|42046936|FG000|Overall Study|Withdrawal by Subject|87|||
19598020|NCT00839254|42046937|FG001|Overall Study|Withdrawal by Subject|53|||
19747431|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19598021|NCT00839254|42046938|FG002|Overall Study|Withdrawal by Subject|54|||
19598022|NCT00839254|42046939|FG003|Overall Study|Withdrawal by Subject|32|||
19598023|NCT00839254|42046940|FG004|Overall Study|Withdrawal by Subject|27|||
19598024|NCT00839254|42046941|FG005|Overall Study|Withdrawal by Subject|15|||
19598025|NCT00839254|42046942|FG006|Overall Study|Withdrawal by Subject|22|||
19598026|NCT00839254|42046943|FG007|Overall Study|Withdrawal by Subject|9|||
19598027|NCT00839254|42046936|FG000|Overall Study|Wrong group allocation|0|||
19598028|NCT00839254|42046937|FG001|Overall Study|Wrong group allocation|0|||
19598029|NCT00839254|42046938|FG002|Overall Study|Wrong group allocation|0|||
19598030|NCT00839254|42046939|FG003|Overall Study|Wrong group allocation|0|||
19598031|NCT00839254|42046940|FG004|Overall Study|Wrong group allocation|0|||
19598032|NCT00839254|42046941|FG005|Overall Study|Wrong group allocation|0|||
19598033|NCT00839254|42046942|FG006|Overall Study|Wrong group allocation|1|||
19598034|NCT00839254|42046943|FG007|Overall Study|Wrong group allocation|0|||
19598035|NCT00839254|42046936|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
19598036|NCT00839254|42046937|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598037|NCT00839254|42046938|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598038|NCT00839254|42046939|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598039|NCT00839254|42046940|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598040|NCT00839254|42046941|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
19598041|NCT00839254|42046942|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598042|NCT00839254|42046943|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
19598043|NCT00839254|42046936|FG000|Overall Study|Withdrawn due to non-compliance|2|||
19598044|NCT00839254|42046937|FG001|Overall Study|Withdrawn due to non-compliance|0|||
19598045|NCT00839254|42046938|FG002|Overall Study|Withdrawn due to non-compliance|0|||
19598046|NCT00839254|42046939|FG003|Overall Study|Withdrawn due to non-compliance|0|||
19598047|NCT00839254|42046940|FG004|Overall Study|Withdrawn due to non-compliance|0|||
19598048|NCT00839254|42046941|FG005|Overall Study|Withdrawn due to non-compliance|0|||
19598049|NCT00839254|42046942|FG006|Overall Study|Withdrawn due to non-compliance|0|||
19598050|NCT00839254|42046943|FG007|Overall Study|Withdrawn due to non-compliance|0|||
19598051|NCT00839254|42046936|FG000|Overall Study|Lost to Follow-up|51|||
19598052|NCT00839254|42046937|FG001|Overall Study|Lost to Follow-up|30|||
19598053|NCT00839254|42046938|FG002|Overall Study|Lost to Follow-up|32|||
19598054|NCT00839254|42046939|FG003|Overall Study|Lost to Follow-up|24|||
19598055|NCT00839254|42046940|FG004|Overall Study|Lost to Follow-up|8|||
19598056|NCT00839254|42046941|FG005|Overall Study|Lost to Follow-up|8|||
19598057|NCT00839254|42046942|FG006|Overall Study|Lost to Follow-up|4|||
19598058|NCT00839254|42046943|FG007|Overall Study|Lost to Follow-up|2|||
19598059|NCT00586339|42046995|FG000|Overall Study|Withdrawal by Subject|1|||
19598060|NCT00586339|42046996|FG001|Overall Study|Withdrawal by Subject|3|||
19598061|NCT00586339|42046997|FG002|Overall Study|Withdrawal by Subject|1|||
19598062|NCT00586339|42046995|FG000|Overall Study|Migrated/moved from study area|3|||
19373631|NCT02760407|41614836|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
19598063|NCT00586339|42046996|FG001|Overall Study|Migrated/moved from study area|2|||
19598064|NCT00586339|42046997|FG002|Overall Study|Migrated/moved from study area|4|||
19598065|NCT00586339|42046995|FG000|Overall Study|Lost to Follow-up|3|||
19598066|NCT00586339|42046996|FG001|Overall Study|Lost to Follow-up|2|||
19598067|NCT00586339|42046997|FG002|Overall Study|Lost to Follow-up|1|||
19598068|NCT00812968|42047005|FG000|Overall Study|Relapse after erythroid response|6|||
19598069|NCT00812968|42047005|FG000|Overall Study|Disease progression|1|||
19598070|NCT00812968|42047005|FG000|Overall Study|No further treatment required|1|||
19598071|NCT00812968|42047005|FG000|Overall Study|Study closed due to marketing approval|3|||
19598072|NCT00839098|42047014|FG000|Overall Study|Withdrawal by Subject|2|||
19598073|NCT00839098|42047015|FG001|Overall Study|Withdrawal by Subject|1|||
19598074|NCT00839098|42047016|FG002|Overall Study|Withdrawal by Subject|7|||
19598075|NCT00813748|42047026|FG000|Skin Test Substudy|Physician Decision|0|||
19598076|NCT00813748|42047027|FG001|Skin Test Substudy|Physician Decision|1|||
19598077|NCT00813592|42047035|FG000|Overall Study|Disease assessment was not completed per|2|||
19598078|NCT00813358|42047040|FG000|Overall Study|Death|32|||
19598079|NCT00813358|42047040|FG000|Overall Study|Lost to Follow-up|12|||
19598080|NCT00813358|42047040|FG000|Overall Study|other endpoints|5|||
19598081|NCT00813358|42047040|FG000|Overall Study|Withdrawal by Subject|20|||
19598082|NCT00812812|42047046|FG000|Overall Study|Adverse Event|2|||
19598083|NCT00812812|42047047|FG001|Overall Study|Adverse Event|1|||
19598084|NCT00812812|42047046|FG000|Overall Study|Lack of Efficacy|1|||
19598085|NCT00812812|42047047|FG001|Overall Study|Lack of Efficacy|0|||
19598086|NCT00812812|42047046|FG000|Overall Study|Lost to Follow-up|0|||
19598087|NCT00812812|42047047|FG001|Overall Study|Lost to Follow-up|1|||
19598088|NCT00812812|42047046|FG000|Overall Study|Withdrawal by Subject|0|||
19598089|NCT00812812|42047047|FG001|Overall Study|Withdrawal by Subject|2|||
19598090|NCT00810082|42047057|FG000|Overall Study|Lost to Follow-up|0|||
19598091|NCT00810082|42047058|FG001|Overall Study|Lost to Follow-up|4|||
19598092|NCT00748189|42047066|FG000|Overall Study|Death|99|||
19598093|NCT00748189|42047067|FG001|Overall Study|Death|84|||
19598094|NCT00748189|42047066|FG000|Overall Study|Withdrawal by Subject|23|||
19598095|NCT00748189|42047067|FG001|Overall Study|Withdrawal by Subject|29|||
19598096|NCT00748189|42047066|FG000|Overall Study|Physician Decision|16|||
19598097|NCT00748189|42047067|FG001|Overall Study|Physician Decision|5|||
19598098|NCT00748189|42047066|FG000|Overall Study|Lost to Follow-up|8|||
19598099|NCT00748189|42047067|FG001|Overall Study|Lost to Follow-up|15|||
19598100|NCT00748189|42047066|FG000|Overall Study|Study terminated by Sponsor|70|||
19598101|NCT00748189|42047067|FG001|Overall Study|Study terminated by Sponsor|79|||
19598102|NCT00744055|42047080|FG000|Overall Study|Withdrawal by Subject|6|||
19598103|NCT00744055|42047081|FG001|Overall Study|Withdrawal by Subject|9|||
19598104|NCT00744055|42047080|FG000|Overall Study|Lack of Efficacy|0|||
19598105|NCT00744055|42047081|FG001|Overall Study|Lack of Efficacy|1|||
19598106|NCT00744055|42047080|FG000|Overall Study|Physician Decision|0|||
19598107|NCT00744055|42047081|FG001|Overall Study|Physician Decision|2|||
19598108|NCT00744055|42047080|FG000|Overall Study|Protocol Violation|1|||
19598109|NCT00744055|42047081|FG001|Overall Study|Protocol Violation|1|||
19598110|NCT00744055|42047080|FG000|Overall Study|Lost to Follow-up|0|||
19598111|NCT00744055|42047081|FG001|Overall Study|Lost to Follow-up|1|||
19598112|NCT00748033|42047089|FG000|Overall Study|Adverse Event|0|||
19598113|NCT00748033|42047090|FG001|Overall Study|Adverse Event|1|||
19598114|NCT00735553|42047107|FG000|Overall Study|Study prematurely terminated|77|||
19598115|NCT00740779|42047118|FG000|Overall Study|Adverse Event|4|||
19598116|NCT00740779|42047119|FG001|Overall Study|Adverse Event|6|||
19598117|NCT00740779|42047120|FG002|Overall Study|Adverse Event|3|||
19598118|NCT00740779|42047118|FG000|Overall Study|Protocol Violation|1|||
19598119|NCT00740779|42047119|FG001|Overall Study|Protocol Violation|1|||
19598120|NCT00740779|42047120|FG002|Overall Study|Protocol Violation|1|||
19598121|NCT00740779|42047118|FG000|Overall Study|Lack of Efficacy|0|||
19598122|NCT00740779|42047119|FG001|Overall Study|Lack of Efficacy|0|||
19598123|NCT00740779|42047120|FG002|Overall Study|Lack of Efficacy|2|||
19598124|NCT00740779|42047118|FG000|Overall Study|Withdrawal by Subject|2|||
19598125|NCT00740779|42047119|FG001|Overall Study|Withdrawal by Subject|4|||
19598126|NCT00740779|42047120|FG002|Overall Study|Withdrawal by Subject|2|||
19598127|NCT00740779|42047118|FG000|Overall Study|Lost to Follow-up|2|||
19598128|NCT00740779|42047119|FG001|Overall Study|Lost to Follow-up|3|||
19598129|NCT00740779|42047120|FG002|Overall Study|Lost to Follow-up|5|||
19598130|NCT00735475|42047130|FG000|Overall Study|Adverse Event|0|||
19598131|NCT00735475|42047131|FG001|Overall Study|Adverse Event|1|||
19598132|NCT00735475|42047130|FG000|Overall Study|Death|1|||
19598133|NCT00735475|42047131|FG001|Overall Study|Death|1|||
19598134|NCT00735475|42047130|FG000|Overall Study|Lost to Follow-up|3|||
19598135|NCT00735475|42047131|FG001|Overall Study|Lost to Follow-up|3|||
19598136|NCT00735475|42047130|FG000|Overall Study|Physician Decision|0|||
19598137|NCT00735475|42047131|FG001|Overall Study|Physician Decision|1|||
19598138|NCT00735475|42047130|FG000|Overall Study|Withdrawal by Subject|4|||
19598139|NCT00735475|42047131|FG001|Overall Study|Withdrawal by Subject|5|||
19598140|NCT01026818|42047140|FG000|Screening Period|Entry Criteria Not Met|105|||
19598141|NCT01026818|42047141|FG001|Screening Period|Entry Criteria Not Met|0|||
19598142|NCT01026818|42047142|FG002|Screening Period|Entry Criteria Not Met|0|||
19598143|NCT01026818|42047143|FG003|Screening Period|Entry Criteria Not Met|0|||
19598144|NCT01026818|42047140|FG000|Screening Period|Withdrawal by Subject|49|||
19598145|NCT01026818|42047141|FG001|Screening Period|Withdrawal by Subject|0|||
19598146|NCT01026818|42047142|FG002|Screening Period|Withdrawal by Subject|0|||
19598147|NCT01026818|42047143|FG003|Screening Period|Withdrawal by Subject|0|||
19598148|NCT01026818|42047140|FG000|Screening Period|Protocol Deviation|3|||
19598149|NCT01026818|42047141|FG001|Screening Period|Protocol Deviation|0|||
19598150|NCT01026818|42047142|FG002|Screening Period|Protocol Deviation|0|||
19598151|NCT01026818|42047143|FG003|Screening Period|Protocol Deviation|0|||
19598152|NCT01026818|42047140|FG000|Screening Period|Adverse Event|2|||
19598153|NCT01026818|42047141|FG001|Screening Period|Adverse Event|0|||
19598154|NCT01026818|42047142|FG002|Screening Period|Adverse Event|0|||
19598155|NCT01026818|42047143|FG003|Screening Period|Adverse Event|0|||
19598156|NCT01026818|42047140|FG000|Screening Period|Physician Decision|1|||
19598157|NCT01026818|42047141|FG001|Screening Period|Physician Decision|0|||
19598158|NCT01026818|42047142|FG002|Screening Period|Physician Decision|0|||
19598159|NCT01026818|42047143|FG003|Screening Period|Physician Decision|0|||
19598160|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
19598161|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
19598162|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
19598163|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
19598164|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
19598165|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
19598166|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
19598167|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
19598168|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
19598169|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
19598170|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
19598171|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
19598172|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
19598173|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
19598174|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
19598175|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
19598176|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
19598177|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
19598178|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
19598179|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
19598180|NCT01026818|42047140|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
19598181|NCT01026818|42047141|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
19598182|NCT01026818|42047142|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
19598183|NCT01026818|42047143|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
19598184|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
19598185|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
19598186|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
19598187|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
19598188|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
19598189|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
19598190|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
19598191|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
19598192|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
19598193|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
19598194|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
19598195|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
19598196|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
19598197|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
19598198|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
19598199|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
19598200|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
19598201|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
19598202|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
19598203|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
19598204|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
19598205|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
19598206|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
19598207|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
19598208|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
19598209|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
19598210|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
19598211|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
19598212|NCT01026818|42047140|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
19598213|NCT01026818|42047141|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
19598214|NCT01026818|42047142|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
19598215|NCT01026818|42047143|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
19598216|NCT01026818|42047140|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
19598217|NCT01026818|42047141|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
19598218|NCT01026818|42047142|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
19598219|NCT01026818|42047143|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
19598220|NCT01026818|42047140|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
19598221|NCT01026818|42047141|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
19598222|NCT01026818|42047142|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
19598223|NCT01026818|42047143|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
19598224|NCT01026818|42047140|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
19598225|NCT01026818|42047141|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
19598226|NCT01026818|42047142|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
19598227|NCT01026818|42047143|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
19598228|NCT01026818|42047140|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
19598229|NCT01026818|42047141|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
19598230|NCT01026818|42047142|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
19598231|NCT01026818|42047143|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
19598232|NCT01026818|42047140|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
19598233|NCT01026818|42047141|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
19598234|NCT01026818|42047142|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
19598235|NCT01026818|42047143|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
19598236|NCT00735397|42047155|FG000|Overall Study|Adverse Event|194|||
19598237|NCT00735397|42047155|FG000|Overall Study|Lost to Follow-up|33|||
19598238|NCT00735397|42047155|FG000|Overall Study|Participant choice|252|||
19598239|NCT00735397|42047155|FG000|Overall Study|Inadequate therapeutic effect|202|||
19598240|NCT00735397|42047155|FG000|Overall Study|Administrative/Other|502|||
19598241|NCT00735007|42047162|FG000|Overall Study|Adverse Event|4|||
19598242|NCT00735007|42047162|FG000|Overall Study|Protocol Violation|1|||
19598243|NCT00743509|42047166|FG000|Overall Study|Withdrawal by Subject|2|||
19598244|NCT00734929|42047172|FG000|Overall Study|Lost to Follow-up|1|||
19598245|NCT00734929|42047173|FG001|Overall Study|Lost to Follow-up|2|||
19598246|NCT00734929|42047172|FG000|Overall Study|No intervention/ screen fail|5|||
19598247|NCT00734929|42047173|FG001|Overall Study|No intervention/ screen fail|3|||
19598248|NCT00734851|42047181|FG000|Overall Study|Withdrawal by Subject|2|||
19598249|NCT00734851|42047181|FG000|Overall Study|Lost to Follow-up|1|||
19598250|NCT00734851|42047181|FG000|Overall Study|Physician Decision|18|||
19598251|NCT00734617|42047187|FG000|Overall Study|Adverse Event|4|||
19598252|NCT00734617|42047188|FG001|Overall Study|Adverse Event|7|||
19598253|NCT00734617|42047187|FG000|Overall Study|Withdrawal by Subject|103|||
19598254|NCT00734617|42047188|FG001|Overall Study|Withdrawal by Subject|95|||
19598255|NCT00743431|42047194|FG000|Overall Study|Toxicity|6|||
19598256|NCT00743431|42047194|FG000|Overall Study|Tumor progression|56|||
19598257|NCT00743431|42047194|FG000|Overall Study|Withdrawal by Subject|13|||
19598258|NCT00743431|42047194|FG000|Overall Study|Death|9|||
19598259|NCT00743431|42047194|FG000|Overall Study|Reason for discontinuation not specified|29|||
19598260|NCT00743431|42047194|FG000|Overall Study|No documentation available|13|||
19598261|NCT03593655|42047200|FG000|First Product Use Period|Withdrawal by Subject|1|||
19598262|NCT03593655|42047201|FG001|First Product Use Period|Withdrawal by Subject|1|||
19598263|NCT03593655|42047200|FG000|First Product Use Period|Lost to Follow-up|1|||
19598264|NCT03593655|42047201|FG001|First Product Use Period|Lost to Follow-up|3|||
19598265|NCT03593655|42047200|FG000|Second Product Use Period|Withdrawal by Subject|1|||
19598266|NCT03593655|42047201|FG001|Second Product Use Period|Withdrawal by Subject|1|||
19598267|NCT03593655|42047200|FG000|Second Product Use Period|Lost to Follow-up|1|||
19598268|NCT03593655|42047201|FG001|Second Product Use Period|Lost to Follow-up|0|||
19598269|NCT03593655|42047200|FG000|Third Product Use Period|Lost to Follow-up|1|||
19598270|NCT03593655|42047201|FG001|Third Product Use Period|Lost to Follow-up|2|||
19598271|NCT03593655|42047200|FG000|Third Product Use Period|Physician Decision|0|||
19598272|NCT03593655|42047201|FG001|Third Product Use Period|Physician Decision|1|||
19598273|NCT03593655|42047200|FG000|Third Product Use Period|Withdrawal by Subject|0|||
19598274|NCT03593655|42047201|FG001|Third Product Use Period|Withdrawal by Subject|1|||
19598275|NCT00734539|42047212|FG000|Main Study|Death|33|||
19598276|NCT00734539|42047213|FG001|Main Study|Death|32|||
19598277|NCT00734539|42047212|FG000|Main Study|Physician Decision|2|||
19598278|NCT00734539|42047213|FG001|Main Study|Physician Decision|0|||
19598279|NCT00734539|42047212|FG000|Main Study|Withdrawal by Subject|1|||
19598280|NCT00734539|42047213|FG001|Main Study|Withdrawal by Subject|3|||
19598281|NCT00734539|42047212|FG000|Main Study|Enrolled in error; ineligible|1|||
19598282|NCT00734539|42047213|FG001|Main Study|Enrolled in error; ineligible|0|||
19598283|NCT00743275|42047224|FG000|Overall Study|Protocol Violation|0|||
19598284|NCT00743275|42047225|FG001|Overall Study|Protocol Violation|1|||
19598285|NCT00734149|42047231|FG000|Overall Study|Withdrawal by Subject|1|||
19598286|NCT00743197|42047239|FG000|Overall Study|Study terminated due to departure of PI.|1|||
19598287|NCT00743197|42047240|FG001|Overall Study|Study terminated due to departure of PI.|2|||
19598288|NCT00734071|42047248|FG000|Overall Study|Adverse Event|4|||
19598289|NCT00734071|42047249|FG001|Overall Study|Adverse Event|3|||
19598290|NCT00734071|42047248|FG000|Overall Study|Lack of Efficacy|3|||
19598291|NCT00734071|42047249|FG001|Overall Study|Lack of Efficacy|1|||
19598292|NCT00734071|42047248|FG000|Overall Study|Noncompliance|2|||
19598293|NCT00734071|42047249|FG001|Overall Study|Noncompliance|2|||
19598294|NCT00734071|42047248|FG000|Overall Study|Protocol Deviations|3|||
19598295|NCT00734071|42047249|FG001|Overall Study|Protocol Deviations|4|||
19598296|NCT00734071|42047248|FG000|Overall Study|Voluntary Withdrawal|9|||
19598297|NCT00734071|42047249|FG001|Overall Study|Voluntary Withdrawal|7|||
19598298|NCT00734071|42047248|FG000|Overall Study|Lost to Follow-up|16|||
19598299|NCT00734071|42047249|FG001|Overall Study|Lost to Follow-up|8|||
19598300|NCT00734071|42047248|FG000|Overall Study|Other|1|||
19598301|NCT00734071|42047249|FG001|Overall Study|Other|2|||
19598302|NCT00739297|42047255|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
19598303|NCT00739297|42047256|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
19598304|NCT00739297|42047257|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
19598305|NCT00739297|42047258|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
19598306|NCT00739297|42047259|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
19598307|NCT00739297|42047260|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
19598308|NCT00739297|42047261|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
19598309|NCT00739297|42047255|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
19598310|NCT00739297|42047256|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
19598311|NCT00739297|42047257|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
19598312|NCT00739297|42047258|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
19598313|NCT00739297|42047259|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
19598314|NCT00739297|42047260|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
19598315|NCT00739297|42047261|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
19747432|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19598316|NCT00739063|42047277|FG000|Overall Study|Screen failures|8|||
19598317|NCT01026194|42047283|FG000|Period 1：Double Blind Period|Adverse Event|2|||
19598318|NCT01026194|42047284|FG001|Period 1：Double Blind Period|Adverse Event|1|||
19598319|NCT01026194|42047283|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
19598320|NCT01026194|42047284|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
19598321|NCT01026194|42047283|FG000|Period 1：Double Blind Period|Physician Decision|0|||
19598322|NCT01026194|42047284|FG001|Period 1：Double Blind Period|Physician Decision|4|||
19598323|NCT01026194|42047283|FG000|Period 2：Open-label Period|Adverse Event|4|||
19598324|NCT01026194|42047284|FG001|Period 2：Open-label Period|Adverse Event|5|||
19598325|NCT01026194|42047283|FG000|Period 2：Open-label Period|Physician Decision|3|||
19598326|NCT01026194|42047284|FG001|Period 2：Open-label Period|Physician Decision|1|||
19598327|NCT01026194|42047283|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
19598328|NCT01026194|42047284|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
19598329|NCT01033136|42047294|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
19598330|NCT01033136|42047295|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
19598331|NCT00738673|42047305|FG000|Overall Study|Adverse Event|1|||
19598332|NCT00738673|42047306|FG001|Overall Study|Adverse Event|0|||
19598333|NCT00738673|42047305|FG000|Overall Study|Lack of Efficacy|19|||
19598334|NCT00738673|42047306|FG001|Overall Study|Lack of Efficacy|8|||
19598335|NCT00738673|42047305|FG000|Overall Study|Protocol Violation|1|||
19598336|NCT00738673|42047306|FG001|Overall Study|Protocol Violation|2|||
19598337|NCT00738673|42047305|FG000|Overall Study|Withdrawal by Subject|3|||
19598338|NCT00738673|42047306|FG001|Overall Study|Withdrawal by Subject|1|||
19598339|NCT00811954|42047315|FG000|Overall Study|Death|10|||
19598340|NCT00811954|42047316|FG001|Overall Study|Death|6|||
19598341|NCT00811954|42047317|FG002|Overall Study|Death|13|||
19598342|NCT00811954|42047315|FG000|Overall Study|Lost to Follow-up|29|||
19598343|NCT00811954|42047316|FG001|Overall Study|Lost to Follow-up|23|||
19598344|NCT00811954|42047317|FG002|Overall Study|Lost to Follow-up|34|||
19598345|NCT00811954|42047315|FG000|Overall Study|Not able to get to clinic|28|||
19598346|NCT00811954|42047316|FG001|Overall Study|Not able to get to clinic|35|||
19598347|NCT00811954|42047317|FG002|Overall Study|Not able to get to clinic|30|||
19598348|NCT00811954|42047315|FG000|Overall Study|Not willing to adhere to requirements|12|||
19598349|NCT00811954|42047316|FG001|Overall Study|Not willing to adhere to requirements|2|||
19598350|NCT00811954|42047317|FG002|Overall Study|Not willing to adhere to requirements|16|||
19598351|NCT00811954|42047315|FG000|Overall Study|Withdraw consent prior study completion|4|||
19598352|NCT00811954|42047316|FG001|Overall Study|Withdraw consent prior study completion|6|||
19598353|NCT00811954|42047317|FG002|Overall Study|Withdraw consent prior study completion|5|||
19598354|NCT00811954|42047315|FG000|Overall Study|Site Closure|4|||
19598355|NCT00811954|42047316|FG001|Overall Study|Site Closure|0|||
19598356|NCT00811954|42047317|FG002|Overall Study|Site Closure|1|||
19598357|NCT00811954|42047315|FG000|Overall Study|Severe Debilitation|2|||
19598358|NCT00811954|42047316|FG001|Overall Study|Severe Debilitation|0|||
19598359|NCT00811954|42047317|FG002|Overall Study|Severe Debilitation|1|||
19598360|NCT00811954|42047315|FG000|Overall Study|Complete Protocol: No follow-up|0|||
19598361|NCT00811954|42047316|FG001|Overall Study|Complete Protocol: No follow-up|0|||
19598362|NCT00811954|42047317|FG002|Overall Study|Complete Protocol: No follow-up|1|||
19598363|NCT01032200|42047327|FG000|Overall Study|Death|1|||
19598364|NCT01032200|42047328|FG001|Overall Study|Death|1|||
19598365|NCT01032200|42047327|FG000|Overall Study|Withdrawal by Subject|1|||
19598366|NCT01032200|42047328|FG001|Overall Study|Withdrawal by Subject|3|||
19598367|NCT01032200|42047327|FG000|Overall Study|Toxicity|0|||
19598368|NCT01032200|42047328|FG001|Overall Study|Toxicity|2|||
19598369|NCT01032200|42047327|FG000|Overall Study|Progression|1|||
19598370|NCT01032200|42047328|FG001|Overall Study|Progression|0|||
19598371|NCT01032200|42047327|FG000|Overall Study|Multiple|1|||
19598372|NCT01032200|42047328|FG001|Overall Study|Multiple|1|||
19598373|NCT00738283|42047334|FG000|Overall Study|Death|1|||
19598374|NCT00738283|42047334|FG000|Overall Study|Transfer to another facility|2|||
19598375|NCT00738283|42047334|FG000|Overall Study|Discharge home prior to end of study|1|||
19598376|NCT00586105|42047347|FG000|Overall Study|Adverse Event|4|||
19598377|NCT00586105|42047347|FG000|Overall Study|Death|2|||
19598378|NCT00586105|42047347|FG000|Overall Study|Protocol Violation|1|||
19598379|NCT00586105|42047347|FG000|Overall Study|Withdrawal by Subject|3|||
19598380|NCT00586105|42047347|FG000|Overall Study|Disease progression|19|||
19598381|NCT00586105|42047347|FG000|Overall Study|Switched to commercial drug|9|||
19598382|NCT00586105|42047347|FG000|Overall Study|Reason not reported|1|||
19598383|NCT00743119|42047351|FG000|Overall Study|unreliable|3|||
19598384|NCT00743119|42047351|FG000|Overall Study|Withdrawal by Subject|1|||
19598385|NCT00733369|42047365|FG000|Overall Study|Lost to Follow-up|2|||
19598386|NCT00733369|42047366|FG001|Overall Study|Lost to Follow-up|1|||
19598387|NCT00733369|42047365|FG000|Overall Study|Adverse Event|4|||
19598388|NCT00733369|42047366|FG001|Overall Study|Adverse Event|4|||
19598389|NCT00733369|42047365|FG000|Overall Study|Protocol Violation|4|||
19598390|NCT00733369|42047366|FG001|Overall Study|Protocol Violation|4|||
19598391|NCT00813124|42047372|FG000|Overall Study|Death|2|||
19598392|NCT00813124|42047372|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
19598393|NCT00813124|42047372|FG000|Overall Study|Withdrawal by Subject|1|||
19598394|NCT00733291|42047378|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
19598395|NCT00733291|42047379|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
19598396|NCT00733291|42047380|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
19598397|NCT00733291|42047381|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
19598398|NCT00732199|42047394|FG000|Overall Study|Withdrawal by Subject|25|||
19598399|NCT00732199|42047395|FG001|Overall Study|Withdrawal by Subject|18|||
19598400|NCT00732199|42047394|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
19598401|NCT00732199|42047395|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
19598402|NCT00807040|42047406|FG000|Overall Study|Death|24|||
19598403|NCT00807040|42047407|FG001|Overall Study|Death|29|||
19598404|NCT00807040|42047406|FG000|Overall Study|Withdrawal by Subject|8|||
19598405|NCT00807040|42047407|FG001|Overall Study|Withdrawal by Subject|6|||
19598406|NCT00807040|42047406|FG000|Overall Study|Lost to Follow-up|4|||
19598407|NCT00807040|42047407|FG001|Overall Study|Lost to Follow-up|6|||
19598408|NCT00811720|42047415|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
19598409|NCT00811720|42047416|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
19598410|NCT00811720|42047415|FG000|All Treated Patients|Adverse Event|20|||
19598411|NCT00811720|42047416|FG001|All Treated Patients|Adverse Event|62|||
19598412|NCT00811720|42047415|FG000|All Treated Patients|Lack of Efficacy|22|||
19598413|NCT00811720|42047416|FG001|All Treated Patients|Lack of Efficacy|18|||
19598414|NCT00811720|42047415|FG000|All Treated Patients|Non-compliance|0|||
19598415|NCT00811720|42047416|FG001|All Treated Patients|Non-compliance|14|||
19598416|NCT00811720|42047415|FG000|All Treated Patients|Protocol Violation|9|||
19598417|NCT00811720|42047416|FG001|All Treated Patients|Protocol Violation|16|||
19598418|NCT00811720|42047415|FG000|All Treated Patients|Withdrawal by Subject|28|||
19598419|NCT00811720|42047416|FG001|All Treated Patients|Withdrawal by Subject|34|||
19598420|NCT00811720|42047415|FG000|All Treated Patients|Lost to Follow-up|10|||
19598421|NCT00811720|42047416|FG001|All Treated Patients|Lost to Follow-up|16|||
19598422|NCT00811720|42047415|FG000|All Treated Patients|Other Reason|7|||
19598423|NCT00811720|42047416|FG001|All Treated Patients|Other Reason|4|||
19598424|NCT04202679|42047424|FG000|Overall Study|Adverse Event|2|||
19598425|NCT04202679|42047425|FG001|Overall Study|Adverse Event|0|||
19598426|NCT04202679|42047424|FG000|Overall Study|Poor compliance to protocol|1|||
19598427|NCT04202679|42047425|FG001|Overall Study|Poor compliance to protocol|0|||
19598428|NCT04202679|42047424|FG000|Overall Study|Withdrawal by Subject|23|||
19598429|NCT04202679|42047425|FG001|Overall Study|Withdrawal by Subject|6|||
19598430|NCT00811642|42047432|FG000|Overall Study|Adverse Event|3|||
19598431|NCT00811642|42047432|FG000|Overall Study|Protocol Violation|1|||
19598432|NCT00811642|42047432|FG000|Overall Study|Death|2|||
19598433|NCT00811642|42047432|FG000|Overall Study|Withdrawal by Subject|7|||
19598434|NCT00811642|42047432|FG000|Overall Study|Cumulative use of antifungal agent|2|||
19598435|NCT00809926|42047438|FG000|Overall Study|Adverse Event|18|||
19598436|NCT00809926|42047439|FG001|Overall Study|Adverse Event|10|||
19598437|NCT00809926|42047438|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
19598438|NCT00809926|42047439|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19598439|NCT00809926|42047438|FG000|Overall Study|Patient withdrew consent|8|||
19598440|NCT00809926|42047439|FG001|Overall Study|Patient withdrew consent|6|||
19598441|NCT00809926|42047438|FG000|Overall Study|Lost to Follow-up|2|||
19598442|NCT00809926|42047439|FG001|Overall Study|Lost to Follow-up|1|||
19598443|NCT00809926|42047438|FG000|Overall Study|Administrative Problems|0|||
19598444|NCT00809926|42047439|FG001|Overall Study|Administrative Problems|1|||
19598445|NCT00809926|42047438|FG000|Overall Study|Protocol deviation|0|||
19598446|NCT00809926|42047439|FG001|Overall Study|Protocol deviation|2|||
19747433|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747434|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747435|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19747436|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
19598447|NCT00590980|42047445|FG000|Overall Study|Did not meet all inclusion criteria|10|||
19747437|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747438|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
19747439|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747440|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747441|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747442|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747443|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747444|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747445|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19598448|NCT00590902|42047449|FG000|Overall Study|Death|1|||
19598449|NCT00590824|42047457|FG000|Overall Study|Disease could not be resected|0|||
19598450|NCT00590824|42047458|FG001|Overall Study|Disease could not be resected|2|||
19598451|NCT00590824|42047459|FG002|Overall Study|Disease could not be resected|1|||
19598452|NCT00590824|42047460|FG003|Overall Study|Disease could not be resected|0|||
19598453|NCT00590824|42047457|FG000|Overall Study|Adverse Event|0|||
19598454|NCT00590824|42047458|FG001|Overall Study|Adverse Event|0|||
19598455|NCT00590824|42047459|FG002|Overall Study|Adverse Event|0|||
19598456|NCT00590824|42047460|FG003|Overall Study|Adverse Event|1|||
19598457|NCT00590590|42047473|FG000|Overall Study|Lack of Efficacy|1|||
19598458|NCT00590590|42047474|FG001|Overall Study|Lack of Efficacy|2|||
19598459|NCT00590590|42047475|FG002|Overall Study|Lack of Efficacy|0|||
19598460|NCT00590590|42047473|FG000|Overall Study|Adverse Event|1|||
19598461|NCT00590590|42047474|FG001|Overall Study|Adverse Event|0|||
19598462|NCT00590590|42047475|FG002|Overall Study|Adverse Event|0|||
19598463|NCT00590590|42047473|FG000|Overall Study|Protocol Violation|0|||
19598464|NCT00590590|42047474|FG001|Overall Study|Protocol Violation|0|||
19598465|NCT00590590|42047475|FG002|Overall Study|Protocol Violation|2|||
19747446|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19598466|NCT00590590|42047473|FG000|Overall Study|Lost to Follow-up|4|||
19598467|NCT00590590|42047474|FG001|Overall Study|Lost to Follow-up|1|||
19598468|NCT00590590|42047475|FG002|Overall Study|Lost to Follow-up|2|||
19598469|NCT00590590|42047473|FG000|Overall Study|Withdrawal by Subject|0|||
19598470|NCT00590590|42047474|FG001|Overall Study|Withdrawal by Subject|1|||
19598471|NCT00590590|42047475|FG002|Overall Study|Withdrawal by Subject|1|||
19598472|NCT00590590|42047473|FG000|Overall Study|Did not complete due to study closure|1|||
19598473|NCT00590590|42047474|FG001|Overall Study|Did not complete due to study closure|1|||
19598474|NCT00590590|42047475|FG002|Overall Study|Did not complete due to study closure|1|||
19598475|NCT00590590|42047473|FG000|Overall Study|Did not complete study|0|||
19598476|NCT00590590|42047474|FG001|Overall Study|Did not complete study|1|||
19598477|NCT00590590|42047475|FG002|Overall Study|Did not complete study|0|||
19598478|NCT00809614|42047485|FG000|Overall Study|Lack of Efficacy|2|||
19598479|NCT00809614|42047486|FG001|Overall Study|Lack of Efficacy|3|||
19598480|NCT00809614|42047485|FG000|Overall Study|Withdrawal by Subject|1|||
19598481|NCT00809614|42047486|FG001|Overall Study|Withdrawal by Subject|1|||
19598482|NCT00731731|42047495|FG000|Overall Study|Protocol Violation|0|||
19598483|NCT00731731|42047496|FG001|Overall Study|Protocol Violation|0|||
19598484|NCT00731731|42047497|FG002|Overall Study|Protocol Violation|1|||
19598485|NCT00731731|42047495|FG000|Overall Study|Cancel prior to treatment|0|||
19598486|NCT00731731|42047496|FG001|Overall Study|Cancel prior to treatment|0|||
19598487|NCT00731731|42047497|FG002|Overall Study|Cancel prior to treatment|2|||
19598488|NCT00806494|42047510|FG000|Overall Study|Adverse Event|29|||
19598489|NCT00806494|42047510|FG000|Overall Study|Lack of Efficacy|6|||
19598490|NCT00806494|42047510|FG000|Overall Study|Lost to Follow-up|10|||
19598491|NCT00806494|42047510|FG000|Overall Study|Other|30|||
19598492|NCT00806494|42047510|FG000|Overall Study|Withdrawal by Subject|5|||
19598493|NCT00806416|42047517|FG000|Period 1 - Part I|Adverse Event|0|||
19598494|NCT00806416|42047518|FG001|Period 1 - Part I|Adverse Event|1|||
19598495|NCT00806416|42047519|FG002|Period 1 - Part I|Adverse Event|0|||
19598496|NCT00806416|42047520|FG003|Period 1 - Part I|Adverse Event|0|||
19598497|NCT00806416|42047517|FG000|Period 1 - Part I|Lost to Follow-up|0|||
19747447|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747448|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747449|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
19747450|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
19598498|NCT00806416|42047518|FG001|Period 1 - Part I|Lost to Follow-up|2|||
19598499|NCT00806416|42047519|FG002|Period 1 - Part I|Lost to Follow-up|0|||
19598500|NCT00806416|42047520|FG003|Period 1 - Part I|Lost to Follow-up|0|||
19598501|NCT00806416|42047517|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
19598502|NCT00806416|42047518|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
19598503|NCT00806416|42047519|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
19598504|NCT00806416|42047520|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
19598505|NCT00806416|42047517|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
19598506|NCT00806416|42047518|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
19747451|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747452|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747453|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747454|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747455|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747456|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747457|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747458|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747459|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747460|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747461|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19598507|NCT00806416|42047519|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
19598508|NCT00806416|42047520|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
19598509|NCT02724969|42047530|FG000|Overall Study|Lost to Follow-up|12|||
19598510|NCT02724969|42047531|FG001|Overall Study|Lost to Follow-up|6|||
19598511|NCT02724969|42047530|FG000|Overall Study|Withdrawal by Subject|3|||
19598512|NCT02724969|42047531|FG001|Overall Study|Withdrawal by Subject|3|||
19598513|NCT02724969|42047530|FG000|Overall Study|Infant demise|0|||
19598514|NCT02724969|42047531|FG001|Overall Study|Infant demise|2|||
19598515|NCT00811252|42047540|FG000|Overall Study|Adverse Event|6|||
19598516|NCT00811252|42047541|FG001|Overall Study|Adverse Event|10|||
19598517|NCT00811252|42047542|FG002|Overall Study|Adverse Event|15|||
19598518|NCT00811252|42047540|FG000|Overall Study|Lack of Efficacy|7|||
19598519|NCT00811252|42047541|FG001|Overall Study|Lack of Efficacy|2|||
19598520|NCT00811252|42047542|FG002|Overall Study|Lack of Efficacy|0|||
19598521|NCT00811252|42047540|FG000|Overall Study|Protocol Violation|3|||
19598522|NCT00811252|42047541|FG001|Overall Study|Protocol Violation|3|||
19598523|NCT00811252|42047542|FG002|Overall Study|Protocol Violation|2|||
19598524|NCT00811252|42047540|FG000|Overall Study|Withdrawal of Consent|1|||
19598525|NCT00811252|42047541|FG001|Overall Study|Withdrawal of Consent|2|||
19598526|NCT00811252|42047542|FG002|Overall Study|Withdrawal of Consent|2|||
19598527|NCT00811252|42047540|FG000|Overall Study|Lost to Follow-up|0|||
19598528|NCT00811252|42047541|FG001|Overall Study|Lost to Follow-up|0|||
19598529|NCT00811252|42047542|FG002|Overall Study|Lost to Follow-up|2|||
19598530|NCT00811252|42047540|FG000|Overall Study|Administrative or Other Reasons|0|||
19598531|NCT00811252|42047541|FG001|Overall Study|Administrative or Other Reasons|3|||
19598532|NCT00811252|42047542|FG002|Overall Study|Administrative or Other Reasons|2|||
19598533|NCT00736957|42047559|FG000|Overall Study|Adverse Event|43|||
19598534|NCT00736957|42047559|FG000|Overall Study|Withdrawal by Subject|49|||
19598535|NCT00736957|42047559|FG000|Overall Study|violation of eligibility criteria|2|||
19598536|NCT00736957|42047559|FG000|Overall Study|did not attend hospital appointments|1|||
19598537|NCT00736957|42047559|FG000|Overall Study|not eligible for Treatment Period I|22|||
19598538|NCT00736957|42047559|FG000|Overall Study|Physician Decision|5|||
19598539|NCT00736879|42047567|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
19598540|NCT00736879|42047568|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
19598541|NCT00736879|42047569|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
19598542|NCT00736879|42047570|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
19598543|NCT00736879|42047567|FG000|Double Blind Treatment Period|Adverse Event|0|||
19598544|NCT00736879|42047568|FG001|Double Blind Treatment Period|Adverse Event|1|||
19598545|NCT00736879|42047569|FG002|Double Blind Treatment Period|Adverse Event|1|||
19598546|NCT00736879|42047570|FG003|Double Blind Treatment Period|Adverse Event|0|||
19598547|NCT00736879|42047567|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
19598548|NCT00736879|42047568|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
19598549|NCT00736879|42047569|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
19598550|NCT00736879|42047570|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
19598551|NCT00736879|42047567|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
19598552|NCT00736879|42047568|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
19598553|NCT00736879|42047569|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
19598554|NCT00736879|42047570|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
19598555|NCT00736879|42047567|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
19598556|NCT00736879|42047568|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
19598557|NCT00736879|42047569|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
19598558|NCT00736879|42047570|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
19598559|NCT00736879|42047567|FG000|Double Blind Treatment Period|No longer met criteria|0|||
19598560|NCT00736879|42047568|FG001|Double Blind Treatment Period|No longer met criteria|1|||
19598561|NCT00736879|42047569|FG002|Double Blind Treatment Period|No longer met criteria|0|||
19598562|NCT00736879|42047570|FG003|Double Blind Treatment Period|No longer met criteria|0|||
19598563|NCT00736879|42047567|FG000|Double Blind Treatment Period|non-specified|0|||
19598564|NCT00736879|42047568|FG001|Double Blind Treatment Period|non-specified|1|||
19598565|NCT00736879|42047569|FG002|Double Blind Treatment Period|non-specified|0|||
19747462|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
19747463|NCT03100058|42194861|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747464|NCT03100058|42194862|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19598566|NCT00736879|42047570|FG003|Double Blind Treatment Period|non-specified|0|||
19598567|NCT00736879|42047567|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
19598568|NCT00736879|42047568|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
19598569|NCT00736879|42047569|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
19598570|NCT00736879|42047570|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
19598571|NCT00736879|42047567|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
19598572|NCT00736879|42047568|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
19598573|NCT00736879|42047569|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
19598574|NCT00736879|42047570|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
19598575|NCT00806260|42047589|FG000|Period 1 (1 Day)|Adverse Event|0|||
19598576|NCT00806260|42047590|FG001|Period 1 (1 Day)|Adverse Event|0|||
19598577|NCT00806260|42047591|FG002|Period 1 (1 Day)|Adverse Event|0|||
19598578|NCT00806260|42047592|FG003|Period 1 (1 Day)|Adverse Event|0|||
19598579|NCT00806260|42047593|FG004|Period 1 (1 Day)|Adverse Event|3|||
19598580|NCT00806260|42047594|FG005|Period 1 (1 Day)|Adverse Event|0|||
19598581|NCT00806260|42047589|FG000|Period 2|Adverse Event|0|||
19598582|NCT00806260|42047590|FG001|Period 2|Adverse Event|0|||
19598583|NCT00806260|42047591|FG002|Period 2|Adverse Event|0|||
19598584|NCT00806260|42047592|FG003|Period 2|Adverse Event|1|||
19598585|NCT00806260|42047593|FG004|Period 2|Adverse Event|0|||
19598586|NCT00806260|42047594|FG005|Period 2|Adverse Event|0|||
19598587|NCT00806260|42047589|FG000|Period 2|Protocol Violation|1|||
19598588|NCT00806260|42047590|FG001|Period 2|Protocol Violation|0|||
19598589|NCT00806260|42047591|FG002|Period 2|Protocol Violation|1|||
19598590|NCT00806260|42047592|FG003|Period 2|Protocol Violation|0|||
19598591|NCT00806260|42047593|FG004|Period 2|Protocol Violation|0|||
19598592|NCT00806260|42047594|FG005|Period 2|Protocol Violation|0|||
19598593|NCT00806260|42047589|FG000|Period 2|Need to take concomitant medication|1|||
19598594|NCT00806260|42047590|FG001|Period 2|Need to take concomitant medication|0|||
19598595|NCT00806260|42047591|FG002|Period 2|Need to take concomitant medication|0|||
19598596|NCT00806260|42047592|FG003|Period 2|Need to take concomitant medication|0|||
19598597|NCT00806260|42047593|FG004|Period 2|Need to take concomitant medication|0|||
19598598|NCT00806260|42047594|FG005|Period 2|Need to take concomitant medication|0|||
19598599|NCT00806260|42047589|FG000|Period 2|sponsor request|0|||
19598600|NCT00806260|42047590|FG001|Period 2|sponsor request|0|||
19598601|NCT00806260|42047591|FG002|Period 2|sponsor request|1|||
19598602|NCT00806260|42047592|FG003|Period 2|sponsor request|1|||
19598603|NCT00806260|42047593|FG004|Period 2|sponsor request|0|||
19598604|NCT00806260|42047594|FG005|Period 2|sponsor request|0|||
19598605|NCT00806260|42047589|FG000|Period 3|Protocol Violation|0|||
19598606|NCT00806260|42047590|FG001|Period 3|Protocol Violation|1|||
19598607|NCT00806260|42047591|FG002|Period 3|Protocol Violation|1|||
19598608|NCT00806260|42047592|FG003|Period 3|Protocol Violation|0|||
19598609|NCT00806260|42047593|FG004|Period 3|Protocol Violation|0|||
19598610|NCT00806260|42047594|FG005|Period 3|Protocol Violation|0|||
19598611|NCT00806260|42047589|FG000|Period 3|Pregnancy|1|||
19598612|NCT00806260|42047590|FG001|Period 3|Pregnancy|0|||
19598613|NCT00806260|42047591|FG002|Period 3|Pregnancy|0|||
19598614|NCT00806260|42047592|FG003|Period 3|Pregnancy|0|||
19598615|NCT00806260|42047593|FG004|Period 3|Pregnancy|0|||
19598616|NCT00806260|42047594|FG005|Period 3|Pregnancy|0|||
19598617|NCT00742885|42047608|FG000|Overall Study|Lost to Follow-up|1|||
19598618|NCT00742885|42047609|FG001|Overall Study|Lost to Follow-up|0|||
19598619|NCT00811174|42047618|FG000|Overall Study|Protocol Violation|2|||
19598620|NCT00811174|42047618|FG000|Overall Study|Sponsors Decision|1|||
19598621|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
19598622|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
19598623|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
19747465|NCT03100058|42194863|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747466|NCT03100058|42194864|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747467|NCT03100058|42194865|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747468|NCT03100058|42194866|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747469|NCT03100058|42194867|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
19747470|NCT03100058|42194868|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747471|NCT03100058|42194869|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747472|NCT03100058|42194870|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747473|NCT03100058|42194871|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747474|NCT03100058|42194872|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747475|NCT03100058|42194873|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
19747476|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747477|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747478|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747479|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747480|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747481|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747482|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19598624|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
19598625|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
19598626|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
19598627|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
19598628|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
19598629|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
19598630|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
19598631|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
19598632|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
19598633|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
19598634|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
19598635|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
19598636|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
19598637|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
19598638|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
19598639|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
19598640|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
19598641|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
19598642|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
19598643|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
19598644|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
19598645|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
19598646|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
19747483|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747484|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747485|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
19747486|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
19747487|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
19747488|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
19747489|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747490|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747491|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747492|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747493|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747494|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747495|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747496|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19598647|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
19747497|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747498|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747499|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
19747500|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
19747501|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
19747502|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747503|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747504|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19598648|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
19598649|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
19598650|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
19598651|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
19598652|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
19598653|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
19598654|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
19598655|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
19598656|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
19598657|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
19598658|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
19598659|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
19598660|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
19598661|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
19598662|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
19598663|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
19598664|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
19598665|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
19598666|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
19598667|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
19598668|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
19598669|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
19598670|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
19598671|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
19598672|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
19598673|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
19598674|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
19598675|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
19598676|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
19598677|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
19598678|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
19598679|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
19598680|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
19598681|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
19598682|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
19598683|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
19598684|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
19598685|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
19598686|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
19598687|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
19598688|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
19598689|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
19598690|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
19598691|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Change of location|0|||
19598692|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Change of location|0|||
19598693|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Change of location|0|||
19598694|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Change of location|1|||
19598695|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Change of location|0|||
19598696|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
19598697|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
19598698|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
19598699|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
19598700|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
19598701|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
19598702|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
19598703|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
19598704|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
19598705|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
19598706|NCT00730405|42047627|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
19598707|NCT00730405|42047628|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
19598708|NCT00730405|42047629|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
19598709|NCT00730405|42047630|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
19598710|NCT00730405|42047631|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
19598711|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
19598712|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
19598713|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
19598714|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
19598715|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
19598716|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
19598717|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
19598718|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
19598719|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
19598720|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
19598721|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
19598722|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
19598723|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
19598724|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
19598725|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
19598726|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Death|0|||
19598727|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Death|1|||
19598728|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Death|0|||
19598729|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Death|1|||
19598730|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Death|0|||
19598731|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Change of location|1|||
19598732|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Change of location|1|||
19598733|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Change of location|0|||
19598734|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Change of location|1|||
19598735|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Change of location|0|||
19598736|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
19598737|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
19598738|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
19598739|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
19598740|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
19598741|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
19598742|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
19598743|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
19598744|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
19598745|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
19598746|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
19598747|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
19598748|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
19598749|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
19598750|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
19598751|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
19598752|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
19598753|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
19598754|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
19598755|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
19598756|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
19598757|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
19598758|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
19598759|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
19598760|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
19598761|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
19598762|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
19598763|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
19598764|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
19598765|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
19598766|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
19598767|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
19598768|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
19598769|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
19598770|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
19598771|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
19598772|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
19598773|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
19598774|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
19598775|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
19747505|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747506|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747507|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747508|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19598776|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
19598777|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
19598778|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
19598779|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
19598780|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
19598781|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
19598782|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
19598783|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
19598784|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
19598785|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
19598786|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Missing|0|||
19598787|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Missing|0|||
19598788|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Missing|2|||
19598789|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Missing|0|||
19598790|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Missing|0|||
19598791|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
19598792|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
19598793|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
19598794|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
19598795|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
19598796|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
19598797|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
19598798|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
19598799|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
19598800|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
19598801|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
19598802|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
19598803|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
19598804|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
19598805|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
19598806|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
19598807|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
19598808|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
19598809|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
19598810|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
19598811|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
19598812|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
19598813|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
19598814|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
19598815|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
19747509|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19598816|NCT00730405|42047627|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
19598817|NCT00730405|42047628|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
19598818|NCT00730405|42047629|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
19598819|NCT00730405|42047630|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
19598820|NCT00730405|42047631|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
19598821|NCT00736723|42047647|FG000|Overall Study|Withdrawal by Subject|4|||
19598822|NCT00736723|42047648|FG001|Overall Study|Withdrawal by Subject|3|||
19598823|NCT00736645|42047658|FG000|Overall Study|Adverse Event|0|||
19598824|NCT00736645|42047659|FG001|Overall Study|Adverse Event|2|||
19747510|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747511|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
19747512|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
19747513|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
19747514|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
19747515|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19598825|NCT00736645|42047660|FG002|Overall Study|Adverse Event|0|||
19598826|NCT00736645|42047661|FG003|Overall Study|Adverse Event|0|||
19598827|NCT00736489|42047671|FG000|Period 1|Lost to Follow-up|1|||
19598828|NCT00736489|42047672|FG001|Period 1|Lost to Follow-up|0|||
19598829|NCT00736489|42047673|FG002|Period 1|Lost to Follow-up|0|||
19598830|NCT00736489|42047674|FG003|Period 1|Lost to Follow-up|0|||
19598831|NCT00736489|42047675|FG004|Period 1|Lost to Follow-up|0|||
19598832|NCT00736489|42047676|FG005|Period 1|Lost to Follow-up|0|||
19598833|NCT00736489|42047671|FG000|Period 1|Withdrawal by Subject|0|||
19598834|NCT00736489|42047672|FG001|Period 1|Withdrawal by Subject|0|||
19747516|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747517|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747518|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747519|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747520|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19598835|NCT00736489|42047673|FG002|Period 1|Withdrawal by Subject|0|||
19598836|NCT00736489|42047674|FG003|Period 1|Withdrawal by Subject|0|||
19598837|NCT00736489|42047675|FG004|Period 1|Withdrawal by Subject|0|||
19598838|NCT00736489|42047676|FG005|Period 1|Withdrawal by Subject|1|||
19598839|NCT00730327|42047708|FG000|Overall Study|Lost to Follow-up|14|||
19598840|NCT00730327|42047709|FG001|Overall Study|Lost to Follow-up|16|||
19598841|NCT00730327|42047708|FG000|Overall Study|Adverse Event|8|||
19598842|NCT00730327|42047709|FG001|Overall Study|Adverse Event|1|||
19598843|NCT00730327|42047708|FG000|Overall Study|Withdrawal by Subject|3|||
19598844|NCT00730327|42047709|FG001|Overall Study|Withdrawal by Subject|13|||
19598845|NCT00730327|42047708|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
19598846|NCT00730327|42047709|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
19598847|NCT00742417|42047724|FG000|Randomized|Withdrawal by legal representative|0|||
19598848|NCT00742417|42047725|FG001|Randomized|Withdrawal by legal representative|1|||
19598849|NCT00742417|42047724|FG000|Randomized|Withdrawal by Subject|1|||
19598850|NCT00742417|42047725|FG001|Randomized|Withdrawal by Subject|0|||
19598851|NCT00742417|42047724|FG000|Randomized|Physician Decision|1|||
19598852|NCT00742417|42047725|FG001|Randomized|Physician Decision|0|||
19598853|NCT00742417|42047724|FG000|Intensive Period|Withdrawal by Subject|1|||
19598854|NCT00742417|42047725|FG001|Intensive Period|Withdrawal by Subject|1|||
19598855|NCT00742417|42047724|FG000|Intensive Period|Adverse Event|2|||
19598856|NCT00742417|42047725|FG001|Intensive Period|Adverse Event|0|||
19598857|NCT00811018|42047733|FG000|Overall Study|Additional Chronic Treatment|31|||
19598858|NCT00811018|42047733|FG000|Overall Study|Adverse Event|79|||
19598859|NCT00811018|42047733|FG000|Overall Study|Death|147|||
19598860|NCT00811018|42047733|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
19598861|NCT00811018|42047733|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
19598862|NCT00811018|42047733|FG000|Overall Study|Investigator Decision|57|||
19598863|NCT00811018|42047733|FG000|Overall Study|Lost to Follow-up|19|||
19747521|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747522|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747523|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747524|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747525|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
19747526|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19598864|NCT00811018|42047733|FG000|Overall Study|Pregnancy|6|||
19598865|NCT00811018|42047733|FG000|Overall Study|Sponsor Decision|450|||
19598866|NCT00811018|42047733|FG000|Overall Study|Withdrawal by Subject|70|||
19598867|NCT00811018|42047733|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
19598868|NCT00811018|42047733|FG000|Overall Study|Other|26|||
19598869|NCT00730171|42047742|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
19598870|NCT00730171|42047742|FG000|Overall Study|Adverse Event|193|||
19598871|NCT00730171|42047742|FG000|Overall Study|Protocol Violation|48|||
19747527|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
19747528|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747529|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747530|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747531|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747532|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747533|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747534|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747535|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747536|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747537|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747538|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747539|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
19747540|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
19747541|NCT03100058|42194861|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747542|NCT03100058|42194862|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19598872|NCT00730171|42047742|FG000|Overall Study|Withdrawal by Subject|202|||
19598873|NCT00730171|42047742|FG000|Overall Study|Lost to Follow-up|121|||
19598874|NCT00730171|42047742|FG000|Overall Study|Insufficient Therapeutic Response|141|||
19598875|NCT00730171|42047742|FG000|Overall Study|Other|61|||
19598876|NCT00730015|42047753|FG000|Overall Study|Adverse Event|11|||
19598877|NCT00730015|42047754|FG001|Overall Study|Adverse Event|10|||
19598878|NCT00730015|42047755|FG002|Overall Study|Adverse Event|8|||
19598879|NCT00730015|42047753|FG000|Overall Study|Protocol Violation|2|||
19598880|NCT00730015|42047754|FG001|Overall Study|Protocol Violation|6|||
19598881|NCT00730015|42047755|FG002|Overall Study|Protocol Violation|4|||
19598882|NCT00730015|42047753|FG000|Overall Study|Withdrawal by Subject|12|||
19598883|NCT00730015|42047754|FG001|Overall Study|Withdrawal by Subject|12|||
19598884|NCT00730015|42047755|FG002|Overall Study|Withdrawal by Subject|8|||
19598885|NCT00730015|42047753|FG000|Overall Study|Lost to Follow-up|4|||
19598886|NCT00730015|42047754|FG001|Overall Study|Lost to Follow-up|10|||
19598887|NCT00730015|42047755|FG002|Overall Study|Lost to Follow-up|3|||
19598888|NCT00730015|42047753|FG000|Overall Study|Lack of Efficacy|1|||
19598889|NCT00730015|42047754|FG001|Overall Study|Lack of Efficacy|2|||
19598890|NCT00730015|42047755|FG002|Overall Study|Lack of Efficacy|8|||
19598891|NCT00730015|42047753|FG000|Overall Study|Other Reason|1|||
19598892|NCT00730015|42047754|FG001|Overall Study|Other Reason|0|||
19598893|NCT00730015|42047755|FG002|Overall Study|Other Reason|1|||
19598894|NCT00806026|42047774|FG000|Overall Study|Death|0|||
19598895|NCT00806026|42047775|FG001|Overall Study|Death|0|||
19598896|NCT00806026|42047776|FG002|Overall Study|Death|0|||
19598897|NCT00806026|42047777|FG003|Overall Study|Death|1|||
19598898|NCT00806026|42047778|FG004|Overall Study|Death|0|||
19598899|NCT00806026|42047779|FG005|Overall Study|Death|0|||
19598900|NCT00806026|42047774|FG000|Overall Study|Did not meet entrance criteria|4|||
19598901|NCT00806026|42047775|FG001|Overall Study|Did not meet entrance criteria|1|||
19598902|NCT00806026|42047776|FG002|Overall Study|Did not meet entrance criteria|2|||
19598903|NCT00806026|42047777|FG003|Overall Study|Did not meet entrance criteria|1|||
19598904|NCT00806026|42047778|FG004|Overall Study|Did not meet entrance criteria|0|||
19598905|NCT00806026|42047779|FG005|Overall Study|Did not meet entrance criteria|0|||
19598906|NCT00806026|42047774|FG000|Overall Study|Lack of Efficacy|5|||
19598907|NCT00806026|42047775|FG001|Overall Study|Lack of Efficacy|18|||
19598908|NCT00806026|42047776|FG002|Overall Study|Lack of Efficacy|13|||
19598909|NCT00806026|42047777|FG003|Overall Study|Lack of Efficacy|4|||
19598910|NCT00806026|42047778|FG004|Overall Study|Lack of Efficacy|8|||
19598911|NCT00806026|42047779|FG005|Overall Study|Lack of Efficacy|7|||
19598912|NCT00806026|42047774|FG000|Overall Study|Lost to Follow-up|8|||
19598913|NCT00806026|42047775|FG001|Overall Study|Lost to Follow-up|15|||
19598914|NCT00806026|42047776|FG002|Overall Study|Lost to Follow-up|8|||
19598915|NCT00806026|42047777|FG003|Overall Study|Lost to Follow-up|2|||
19598916|NCT00806026|42047778|FG004|Overall Study|Lost to Follow-up|6|||
19598917|NCT00806026|42047779|FG005|Overall Study|Lost to Follow-up|6|||
19598918|NCT00806026|42047774|FG000|Overall Study|Withdrawal by Subject|14|||
19598919|NCT00806026|42047775|FG001|Overall Study|Withdrawal by Subject|17|||
19598920|NCT00806026|42047776|FG002|Overall Study|Withdrawal by Subject|9|||
19598921|NCT00806026|42047777|FG003|Overall Study|Withdrawal by Subject|2|||
19598922|NCT00806026|42047778|FG004|Overall Study|Withdrawal by Subject|5|||
19598923|NCT00806026|42047779|FG005|Overall Study|Withdrawal by Subject|3|||
19598924|NCT00806026|42047774|FG000|Overall Study|Other|3|||
19747543|NCT03100058|42194863|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19598925|NCT00806026|42047775|FG001|Overall Study|Other|6|||
19598926|NCT00806026|42047776|FG002|Overall Study|Other|8|||
19598927|NCT00806026|42047777|FG003|Overall Study|Other|2|||
19598928|NCT00806026|42047778|FG004|Overall Study|Other|0|||
19598929|NCT00806026|42047779|FG005|Overall Study|Other|4|||
19598930|NCT00806026|42047774|FG000|Overall Study|Protocol Violation|6|||
19598931|NCT00806026|42047775|FG001|Overall Study|Protocol Violation|9|||
19598932|NCT00806026|42047776|FG002|Overall Study|Protocol Violation|9|||
19598933|NCT00806026|42047777|FG003|Overall Study|Protocol Violation|0|||
19598934|NCT00806026|42047778|FG004|Overall Study|Protocol Violation|2|||
19598935|NCT00806026|42047779|FG005|Overall Study|Protocol Violation|3|||
19598936|NCT00806026|42047774|FG000|Overall Study|Adverse Event|52|||
19598937|NCT00806026|42047775|FG001|Overall Study|Adverse Event|35|||
19598938|NCT00806026|42047776|FG002|Overall Study|Adverse Event|44|||
19598939|NCT00806026|42047777|FG003|Overall Study|Adverse Event|17|||
19598940|NCT00806026|42047778|FG004|Overall Study|Adverse Event|9|||
19598941|NCT00806026|42047779|FG005|Overall Study|Adverse Event|9|||
19598942|NCT04026165|42047794|FG000|Run-in Placebo Period|Enrollment Error|13|||
19598943|NCT04026165|42047795|FG001|Run-in Placebo Period|Enrollment Error|0|||
19598944|NCT04026165|42047796|FG002|Run-in Placebo Period|Enrollment Error|0|||
19598945|NCT04026165|42047797|FG003|Run-in Placebo Period|Enrollment Error|0|||
19598946|NCT04026165|42047794|FG000|Run-in Placebo Period|Run-in Failure|4|||
19598947|NCT04026165|42047795|FG001|Run-in Placebo Period|Run-in Failure|0|||
19598948|NCT04026165|42047796|FG002|Run-in Placebo Period|Run-in Failure|0|||
19598949|NCT04026165|42047797|FG003|Run-in Placebo Period|Run-in Failure|0|||
19598950|NCT04026165|42047794|FG000|Run-in Placebo Period|Protocol Violation|2|||
19598951|NCT04026165|42047795|FG001|Run-in Placebo Period|Protocol Violation|0|||
19639263|NCT00723398|42088671|FG003|Overall Study|Withdrawal by Subject|4|||
19639264|NCT00723398|42088672|FG004|Overall Study|Withdrawal by Subject|4|||
19639265|NCT00723398|42088668|FG000|Overall Study|Protocol Violation|2|||
19639266|NCT00723398|42088669|FG001|Overall Study|Protocol Violation|1|||
19639267|NCT00723398|42088670|FG002|Overall Study|Protocol Violation|5|||
19639268|NCT00723398|42088671|FG003|Overall Study|Protocol Violation|0|||
19639269|NCT00723398|42088672|FG004|Overall Study|Protocol Violation|0|||
19639270|NCT00723398|42088668|FG000|Overall Study|Physician Decision|2|||
19639271|NCT00723398|42088669|FG001|Overall Study|Physician Decision|2|||
19639272|NCT00723398|42088670|FG002|Overall Study|Physician Decision|5|||
19639273|NCT00723398|42088671|FG003|Overall Study|Physician Decision|0|||
19639274|NCT00723398|42088672|FG004|Overall Study|Physician Decision|1|||
19639275|NCT00723398|42088668|FG000|Overall Study|Adverse Event|0|||
19639276|NCT00723398|42088669|FG001|Overall Study|Adverse Event|5|||
19639277|NCT00723398|42088670|FG002|Overall Study|Adverse Event|3|||
19639278|NCT00723398|42088671|FG003|Overall Study|Adverse Event|1|||
19639279|NCT00723398|42088672|FG004|Overall Study|Adverse Event|4|||
19639280|NCT00723398|42088668|FG000|Overall Study|Lost to Follow-up|0|||
19639281|NCT00723398|42088669|FG001|Overall Study|Lost to Follow-up|1|||
19747544|NCT03100058|42194864|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747545|NCT03100058|42194865|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19598952|NCT04026165|42047796|FG002|Run-in Placebo Period|Protocol Violation|0|||
19598953|NCT04026165|42047797|FG003|Run-in Placebo Period|Protocol Violation|0|||
19598954|NCT04026165|42047794|FG000|Run-in Placebo Period|Withdrew Consent|2|||
19598955|NCT04026165|42047795|FG001|Run-in Placebo Period|Withdrew Consent|0|||
19598956|NCT04026165|42047796|FG002|Run-in Placebo Period|Withdrew Consent|0|||
19639282|NCT00723398|42088670|FG002|Overall Study|Lost to Follow-up|0|||
19639283|NCT00723398|42088671|FG003|Overall Study|Lost to Follow-up|0|||
19639284|NCT00723398|42088672|FG004|Overall Study|Lost to Follow-up|0|||
19639285|NCT00716456|42088687|FG000|Overall Study|Adverse Event|0|||
19747546|NCT03100058|42194866|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747547|NCT03100058|42194867|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19639286|NCT00716456|42088688|FG001|Overall Study|Adverse Event|2|||
19639287|NCT00716456|42088689|FG002|Overall Study|Adverse Event|0|||
19639288|NCT00684645|42088697|FG000|Overall Study|Death|2|||
19639289|NCT00684645|42088697|FG000|Overall Study|Progressive disease|67|||
19639290|NCT00684645|42088697|FG000|Overall Study|Adverse Event|27|||
19639291|NCT00684645|42088697|FG000|Overall Study|Lost to Follow-up|3|||
19639292|NCT00684645|42088697|FG000|Overall Study|Other|15|||
19639293|NCT00716144|42088705|FG000|Overall Study|Withdrawal by Subject|4|||
19639294|NCT00716144|42088706|FG001|Overall Study|Withdrawal by Subject|2|||
19639295|NCT00716144|42088707|FG002|Overall Study|Withdrawal by Subject|6|||
19639296|NCT00716144|42088708|FG003|Overall Study|Withdrawal by Subject|6|||
19639297|NCT00716144|42088705|FG000|Overall Study|Lost to Follow-up|2|||
19747548|NCT03100058|42194868|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19477034|NCT01492361|41755747|FG000|Overall Study|Withdrawal by Subject|281|||
19477035|NCT01492361|41755748|FG001|Overall Study|Withdrawal by Subject|297|||
19598957|NCT04026165|42047797|FG003|Run-in Placebo Period|Withdrew Consent|0|||
19598958|NCT04026165|42047794|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
19598959|NCT04026165|42047795|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
19639298|NCT00716144|42088706|FG001|Overall Study|Lost to Follow-up|2|||
19639299|NCT00716144|42088707|FG002|Overall Study|Lost to Follow-up|1|||
19639300|NCT00716144|42088708|FG003|Overall Study|Lost to Follow-up|2|||
19598960|NCT04026165|42047796|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
19598961|NCT04026165|42047797|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
19598962|NCT04026165|42047794|FG000|Run-in SEL Period|Run-in Failure|0|||
19598963|NCT04026165|42047795|FG001|Run-in SEL Period|Run-in Failure|26|||
19598964|NCT04026165|42047796|FG002|Run-in SEL Period|Run-in Failure|0|||
19598965|NCT04026165|42047797|FG003|Run-in SEL Period|Run-in Failure|0|||
19598966|NCT04026165|42047794|FG000|Run-in SEL Period|Withdrew Consent|0|||
19598967|NCT04026165|42047795|FG001|Run-in SEL Period|Withdrew Consent|10|||
19598968|NCT04026165|42047796|FG002|Run-in SEL Period|Withdrew Consent|0|||
19598969|NCT04026165|42047797|FG003|Run-in SEL Period|Withdrew Consent|0|||
19598970|NCT04026165|42047794|FG000|Run-in SEL Period|Enrollment Error|0|||
19598971|NCT04026165|42047795|FG001|Run-in SEL Period|Enrollment Error|4|||
19598972|NCT04026165|42047796|FG002|Run-in SEL Period|Enrollment Error|0|||
19598973|NCT04026165|42047797|FG003|Run-in SEL Period|Enrollment Error|0|||
19598974|NCT04026165|42047794|FG000|Run-in SEL Period|Protocol Violation|0|||
19598975|NCT04026165|42047795|FG001|Run-in SEL Period|Protocol Violation|3|||
19598976|NCT04026165|42047796|FG002|Run-in SEL Period|Protocol Violation|0|||
19598977|NCT04026165|42047797|FG003|Run-in SEL Period|Protocol Violation|0|||
19598978|NCT04026165|42047794|FG000|Run-in SEL Period|Investigator's Discretion|0|||
19598979|NCT04026165|42047795|FG001|Run-in SEL Period|Investigator's Discretion|2|||
19598980|NCT04026165|42047796|FG002|Run-in SEL Period|Investigator's Discretion|0|||
19598981|NCT04026165|42047797|FG003|Run-in SEL Period|Investigator's Discretion|0|||
19598982|NCT04026165|42047794|FG000|Run-in SEL Period|Death|0|||
19598983|NCT04026165|42047795|FG001|Run-in SEL Period|Death|1|||
19598984|NCT04026165|42047796|FG002|Run-in SEL Period|Death|0|||
19598985|NCT04026165|42047797|FG003|Run-in SEL Period|Death|0|||
19598986|NCT04026165|42047794|FG000|Randomized Period|Withdrew Consent|0|||
19598987|NCT04026165|42047795|FG001|Randomized Period|Withdrew Consent|0|||
19598988|NCT04026165|42047796|FG002|Randomized Period|Withdrew Consent|5|||
19598989|NCT04026165|42047797|FG003|Randomized Period|Withdrew Consent|8|||
19598990|NCT04026165|42047794|FG000|Randomized Period|Death|0|||
19598991|NCT04026165|42047795|FG001|Randomized Period|Death|0|||
19598992|NCT04026165|42047796|FG002|Randomized Period|Death|5|||
19598993|NCT04026165|42047797|FG003|Randomized Period|Death|7|||
19747549|NCT03100058|42194869|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19598994|NCT04026165|42047794|FG000|Randomized Period|Investigator's Discretion|0|||
19598995|NCT04026165|42047795|FG001|Randomized Period|Investigator's Discretion|0|||
19598996|NCT04026165|42047796|FG002|Randomized Period|Investigator's Discretion|2|||
19747550|NCT03100058|42194870|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
19747551|NCT03100058|42194871|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747552|NCT03100058|42194872|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747553|NCT03100058|42194873|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
19747554|NCT02871778|42194919|FG000|Part A: Treatment Period 1|Adverse Event|1|||
19747555|NCT02871778|42194920|FG001|Part A: Treatment Period 1|Adverse Event|1|||
19747556|NCT02871778|42194921|FG002|Part A: Treatment Period 1|Adverse Event|1|||
19747557|NCT02871778|42194922|FG003|Part A: Treatment Period 1|Adverse Event|0|||
19747558|NCT02871778|42194923|FG004|Part A: Treatment Period 1|Adverse Event|0|||
19747559|NCT02871778|42194924|FG005|Part A: Treatment Period 1|Adverse Event|0|||
19747560|NCT02871778|42194925|FG006|Part A: Treatment Period 1|Adverse Event|0|||
19747561|NCT02871778|42194926|FG007|Part A: Treatment Period 1|Adverse Event|0|||
19747562|NCT02871778|42194919|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
19747563|NCT02871778|42194920|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
19747564|NCT02871778|42194921|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
19747565|NCT02871778|42194922|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
19747566|NCT02871778|42194923|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
19747567|NCT02871778|42194924|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
19747568|NCT02871778|42194925|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
19747569|NCT02871778|42194926|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
19747570|NCT02871778|42194919|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747571|NCT02871778|42194920|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747572|NCT02871778|42194921|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
19747573|NCT02871778|42194922|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747574|NCT02871778|42194923|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747575|NCT02871778|42194924|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747576|NCT02871778|42194925|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19747577|NCT02871778|42194926|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
19598997|NCT04026165|42047797|FG003|Randomized Period|Investigator's Discretion|2|||
19747578|NCT02871778|42194919|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19747579|NCT02871778|42194920|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19747580|NCT02871778|42194921|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
19747581|NCT02871778|42194922|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19598998|NCT04026165|42047794|FG000|Randomized Period|Lost to Follow-up|0|||
19598999|NCT04026165|42047795|FG001|Randomized Period|Lost to Follow-up|0|||
19599000|NCT04026165|42047796|FG002|Randomized Period|Lost to Follow-up|2|||
19599001|NCT04026165|42047797|FG003|Randomized Period|Lost to Follow-up|2|||
19599002|NCT00805792|42047805|FG000|Overall Study|Death|3|||
19599003|NCT00805792|42047805|FG000|Overall Study|Lost to Follow-up|2|||
19599004|NCT00590044|42047811|FG000|Overall Study|Withdrawal by Subject|2|||
19599005|NCT00590044|42047812|FG001|Overall Study|Withdrawal by Subject|2|||
19599006|NCT00590044|42047811|FG000|Overall Study|wrong insulin arm assigned|1|||
19599007|NCT00590044|42047812|FG001|Overall Study|wrong insulin arm assigned|0|||
19599008|NCT00590044|42047811|FG000|Overall Study|Protocol Violation|1|||
19599009|NCT00590044|42047812|FG001|Overall Study|Protocol Violation|0|||
19599010|NCT00805480|42047825|FG000|Overall Study|Withdrawal by Subject|13|||
19599011|NCT00805480|42047826|FG001|Overall Study|Withdrawal by Subject|5|||
19599012|NCT00805480|42047827|FG002|Overall Study|Withdrawal by Subject|11|||
19599013|NCT00805480|42047828|FG003|Overall Study|Withdrawal by Subject|5|||
19599014|NCT00805480|42047825|FG000|Overall Study|Lost to Follow-up|1|||
19599015|NCT00805480|42047826|FG001|Overall Study|Lost to Follow-up|2|||
19599016|NCT00805480|42047827|FG002|Overall Study|Lost to Follow-up|0|||
19599017|NCT00805480|42047828|FG003|Overall Study|Lost to Follow-up|0|||
19747582|NCT02871778|42194923|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19747583|NCT02871778|42194924|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19747584|NCT02871778|42194925|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19599018|NCT00805480|42047825|FG000|Overall Study|Adverse Event|0|||
19599019|NCT00805480|42047826|FG001|Overall Study|Adverse Event|0|||
19599020|NCT00805480|42047827|FG002|Overall Study|Adverse Event|1|||
19599021|NCT00805480|42047828|FG003|Overall Study|Adverse Event|0|||
19599022|NCT00729937|42047844|FG000|Overall Study|Lost to Follow-up|49|||
19599023|NCT00729937|42047845|FG001|Overall Study|Lost to Follow-up|58|||
19599024|NCT00729937|42047846|FG002|Overall Study|Lost to Follow-up|18|||
19599025|NCT00729937|42047847|FG003|Overall Study|Lost to Follow-up|33|||
19599026|NCT00729937|42047848|FG004|Overall Study|Lost to Follow-up|18|||
19599027|NCT00729937|42047849|FG005|Overall Study|Lost to Follow-up|23|||
19599028|NCT00729937|42047844|FG000|Overall Study|Physician Decision|7|||
19599029|NCT00729937|42047845|FG001|Overall Study|Physician Decision|16|||
19599030|NCT00729937|42047846|FG002|Overall Study|Physician Decision|2|||
19599031|NCT00729937|42047847|FG003|Overall Study|Physician Decision|0|||
19599032|NCT00729937|42047848|FG004|Overall Study|Physician Decision|5|||
19599033|NCT00729937|42047849|FG005|Overall Study|Physician Decision|8|||
19599034|NCT00729937|42047844|FG000|Overall Study|Death|1|||
19599035|NCT00729937|42047845|FG001|Overall Study|Death|0|||
19599036|NCT00729937|42047846|FG002|Overall Study|Death|1|||
19599037|NCT00729937|42047847|FG003|Overall Study|Death|0|||
19599038|NCT00729937|42047848|FG004|Overall Study|Death|0|||
19599039|NCT00729937|42047849|FG005|Overall Study|Death|1|||
19599040|NCT00729937|42047844|FG000|Overall Study|Withdrawal by Subject|3|||
19599041|NCT00729937|42047845|FG001|Overall Study|Withdrawal by Subject|5|||
19599042|NCT00729937|42047846|FG002|Overall Study|Withdrawal by Subject|6|||
19599043|NCT00729937|42047847|FG003|Overall Study|Withdrawal by Subject|0|||
19599044|NCT00729937|42047848|FG004|Overall Study|Withdrawal by Subject|4|||
19599045|NCT00729937|42047849|FG005|Overall Study|Withdrawal by Subject|2|||
19599046|NCT00729937|42047844|FG000|Overall Study|Randomized but not treated|12|||
19599047|NCT00729937|42047845|FG001|Overall Study|Randomized but not treated|6|||
19599048|NCT00729937|42047846|FG002|Overall Study|Randomized but not treated|1|||
19599049|NCT00729937|42047847|FG003|Overall Study|Randomized but not treated|0|||
19599050|NCT00729937|42047848|FG004|Overall Study|Randomized but not treated|1|||
19599051|NCT00729937|42047849|FG005|Overall Study|Randomized but not treated|3|||
19599052|NCT00729937|42047844|FG000|Overall Study|Did not meet eligibility criteria|2|||
19599053|NCT00729937|42047845|FG001|Overall Study|Did not meet eligibility criteria|1|||
19599054|NCT00729937|42047846|FG002|Overall Study|Did not meet eligibility criteria|0|||
19599055|NCT00729937|42047847|FG003|Overall Study|Did not meet eligibility criteria|0|||
19599056|NCT00729937|42047848|FG004|Overall Study|Did not meet eligibility criteria|0|||
19599057|NCT00729937|42047849|FG005|Overall Study|Did not meet eligibility criteria|0|||
19599058|NCT00729937|42047844|FG000|Overall Study|Incarcerated|0|||
19599059|NCT00729937|42047845|FG001|Overall Study|Incarcerated|2|||
19599060|NCT00729937|42047846|FG002|Overall Study|Incarcerated|1|||
19599061|NCT00729937|42047847|FG003|Overall Study|Incarcerated|1|||
19599062|NCT00729937|42047848|FG004|Overall Study|Incarcerated|0|||
19388105|NCT02700815|41631481|FG002|Overall Study|Withdrawal by Subject|1|||
19599063|NCT00729937|42047849|FG005|Overall Study|Incarcerated|0|||
19599064|NCT00729859|42047866|FG000|Overall Study|Adverse Event|0|||
19599065|NCT00729859|42047867|FG001|Overall Study|Adverse Event|1|||
19599066|NCT00729859|42047868|FG002|Overall Study|Adverse Event|0|||
19599067|NCT00729859|42047866|FG000|Overall Study|Withdrawal by Subject|0|||
19599068|NCT00729859|42047867|FG001|Overall Study|Withdrawal by Subject|1|||
19599069|NCT00729859|42047868|FG002|Overall Study|Withdrawal by Subject|0|||
19599070|NCT00810394|42047884|FG000|Overall Study|Withdrawal by Subject|3|||
19599071|NCT00736333|42047888|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
19599072|NCT00736333|42047888|FG000|Overall Study|Data Missing|2|||
19599073|NCT00736333|42047888|FG000|Overall Study|Tumor Progression|75|||
19599074|NCT00736333|42047888|FG000|Overall Study|Toxicity|6|||
19599075|NCT00736333|42047888|FG000|Overall Study|Withdrawal by Subject|10|||
19599076|NCT00736333|42047888|FG000|Overall Study|Death|7|||
19599077|NCT00736333|42047888|FG000|Overall Study|Other|4|||
19599078|NCT00736255|42047894|FG000|Overall Study|Adverse Event|1|||
19599079|NCT00736255|42047895|FG001|Overall Study|Adverse Event|0|||
19599080|NCT00736255|42047894|FG000|Overall Study|Physician Decision|1|||
19599081|NCT00736255|42047895|FG001|Overall Study|Physician Decision|0|||
19599082|NCT00736255|42047894|FG000|Overall Study|Non-compliance|1|||
19599083|NCT00736255|42047895|FG001|Overall Study|Non-compliance|1|||
19599084|NCT03920254|42047904|FG000|Overall Study|Adverse Event|1|||
19599085|NCT03920254|42047905|FG001|Overall Study|Adverse Event|0|||
19599086|NCT03920254|42047906|FG002|Overall Study|Adverse Event|0|||
19599087|NCT03920254|42047904|FG000|Overall Study|Physician Decision|0|||
19599088|NCT03920254|42047905|FG001|Overall Study|Physician Decision|1|||
19599089|NCT03920254|42047906|FG002|Overall Study|Physician Decision|2|||
19599090|NCT03920254|42047904|FG000|Overall Study|Study Terminated By Sponsor|12|||
19599091|NCT03920254|42047905|FG001|Overall Study|Study Terminated By Sponsor|17|||
19599092|NCT03920254|42047906|FG002|Overall Study|Study Terminated By Sponsor|12|||
19599093|NCT03920254|42047904|FG000|Overall Study|Withdrawal by Subject|0|||
19599094|NCT03920254|42047905|FG001|Overall Study|Withdrawal by Subject|0|||
19599095|NCT03920254|42047906|FG002|Overall Study|Withdrawal by Subject|1|||
19599096|NCT00729469|42047916|FG000|Overall Study|Adverse Event|14|||
19599097|NCT00729469|42047917|FG001|Overall Study|Adverse Event|25|||
19599098|NCT00729469|42047916|FG000|Overall Study|Lost to Follow-up|9|||
19599099|NCT00729469|42047917|FG001|Overall Study|Lost to Follow-up|9|||
19599100|NCT00729469|42047916|FG000|Overall Study|Protocol Violation|2|||
19599101|NCT00729469|42047917|FG001|Overall Study|Protocol Violation|1|||
19599102|NCT00729469|42047916|FG000|Overall Study|Withdrawal by Subject|19|||
19599103|NCT00729469|42047917|FG001|Overall Study|Withdrawal by Subject|8|||
19599104|NCT00729469|42047916|FG000|Overall Study|Other-Not mentioned|9|||
19599105|NCT00729469|42047917|FG001|Overall Study|Other-Not mentioned|4|||
19599106|NCT00742183|42047925|FG000|Overall Study|Adverse Event|2|||
19599107|NCT00742183|42047926|FG001|Overall Study|Adverse Event|2|||
19599108|NCT00742183|42047925|FG000|Overall Study|Death|1|||
19599109|NCT00742183|42047926|FG001|Overall Study|Death|0|||
19599110|NCT00742183|42047925|FG000|Overall Study|Physician Decision|0|||
19599111|NCT00742183|42047926|FG001|Overall Study|Physician Decision|2|||
19599112|NCT00742183|42047925|FG000|Overall Study|Lost to Follow-up|4|||
19599113|NCT00742183|42047926|FG001|Overall Study|Lost to Follow-up|4|||
19599114|NCT00742183|42047925|FG000|Overall Study|Required skin-graft|1|||
19599115|NCT00742183|42047926|FG001|Overall Study|Required skin-graft|1|||
19599116|NCT00742183|42047925|FG000|Overall Study|Withdrawal by Subject|1|||
19599117|NCT00742183|42047926|FG001|Overall Study|Withdrawal by Subject|0|||
19599118|NCT00742183|42047925|FG000|Overall Study|Lack of Efficacy|0|||
19599119|NCT00742183|42047926|FG001|Overall Study|Lack of Efficacy|3|||
19599120|NCT00808444|42047934|FG000|Overall Study|Withdrawal by Subject|1|||
19599121|NCT00808444|42047935|FG001|Overall Study|Withdrawal by Subject|0|||
19599122|NCT00808444|42047934|FG000|Overall Study|Lost to Follow-up|0|||
19599123|NCT00808444|42047935|FG001|Overall Study|Lost to Follow-up|1|||
19599124|NCT00742027|42047941|FG000|Overall Study|Disease Progression|76|||
19599125|NCT00742027|42047941|FG000|Overall Study|New Cancer Therapy|19|||
19599126|NCT00742027|42047941|FG000|Overall Study|Withdrawal by Subject|18|||
19599127|NCT00742027|42047941|FG000|Overall Study|Death|7|||
19599128|NCT00742027|42047941|FG000|Overall Study|Lost to Follow-up|4|||
19599129|NCT00742027|42047941|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
19599130|NCT00742027|42047941|FG000|Overall Study|Missing|2|||
19599131|NCT00742027|42047941|FG000|Overall Study|Administrative Problems|1|||
19599132|NCT03996369|42047947|FG000|Overall Study|Protocol deviation|1|||
19599133|NCT03996369|42047948|FG001|Overall Study|Protocol deviation|1|||
19599134|NCT03996369|42047947|FG000|Overall Study|Physician Decision|4|||
19599135|NCT03996369|42047948|FG001|Overall Study|Physician Decision|2|||
19599136|NCT03996369|42047947|FG000|Overall Study|Participant decision|0|||
19599137|NCT03996369|42047948|FG001|Overall Study|Participant decision|1|||
19599138|NCT03996369|42047947|FG000|Overall Study|Lack of Efficacy|4|||
19599139|NCT03996369|42047948|FG001|Overall Study|Lack of Efficacy|0|||
19599140|NCT03996369|42047947|FG000|Overall Study|Adverse Event|9|||
19599141|NCT03996369|42047948|FG001|Overall Study|Adverse Event|0|||
19599142|NCT03996369|42047947|FG000|Overall Study|Withdrawal by Subject|6|||
19599143|NCT03996369|42047948|FG001|Overall Study|Withdrawal by Subject|8|||
19747585|NCT02871778|42194926|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
19599144|NCT03996369|42047947|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
19599145|NCT03996369|42047948|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
19599146|NCT03996369|42047947|FG000|Overall Study|Lost to Follow-up|0|||
19599147|NCT03996369|42047948|FG001|Overall Study|Lost to Follow-up|1|||
19599148|NCT00808210|42047956|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
19599149|NCT00808210|42047957|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
19599150|NCT00808210|42047956|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
19599151|NCT00808210|42047957|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
19599152|NCT00808210|42047956|FG000|Double-Blind TX Period|Adverse Event|0|||
19599153|NCT00808210|42047957|FG001|Double-Blind TX Period|Adverse Event|1|||
19599154|NCT00808210|42047956|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
19599155|NCT00808210|42047957|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
19599156|NCT00808210|42047956|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
19599157|NCT00808210|42047957|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
19599158|NCT00808210|42047956|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
19599159|NCT00808210|42047957|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
19599160|NCT00736099|42047965|FG000|Overall Study|Adverse Event|61|||
19599161|NCT00736099|42047966|FG001|Overall Study|Adverse Event|18|||
19599162|NCT00736099|42047965|FG000|Overall Study|Protocol Violation|10|||
19599163|NCT00736099|42047966|FG001|Overall Study|Protocol Violation|4|||
19599164|NCT00736099|42047965|FG000|Overall Study|Lost to Follow-up|12|||
19599165|NCT00736099|42047966|FG001|Overall Study|Lost to Follow-up|5|||
19599166|NCT00736099|42047965|FG000|Overall Study|Withdrawal by Subject|42|||
19599167|NCT00736099|42047966|FG001|Overall Study|Withdrawal by Subject|13|||
19599168|NCT00736099|42047965|FG000|Overall Study|Lack of Efficacy|15|||
19599169|NCT00736099|42047966|FG001|Overall Study|Lack of Efficacy|8|||
19599170|NCT00736099|42047965|FG000|Overall Study|Other reason|43|||
19599171|NCT00736099|42047966|FG001|Overall Study|Other reason|10|||
19599172|NCT00735943|42047972|FG000|Overall Study|Lost to Follow-up|1|||
19599173|NCT00735943|42047972|FG000|Overall Study|Adverse Event|1|||
19599174|NCT00735709|42047980|FG000|Overall Study|Adverse Event|2|||
19599175|NCT00735709|42047981|FG001|Overall Study|Adverse Event|3|||
19599176|NCT00735709|42047982|FG002|Overall Study|Adverse Event|1|||
19599177|NCT00735709|42047983|FG003|Overall Study|Adverse Event|5|||
19599178|NCT00735709|42047980|FG000|Overall Study|Lack of Efficacy|8|||
19599179|NCT00735709|42047981|FG001|Overall Study|Lack of Efficacy|4|||
19599180|NCT00735709|42047982|FG002|Overall Study|Lack of Efficacy|2|||
19599181|NCT00735709|42047983|FG003|Overall Study|Lack of Efficacy|3|||
19599182|NCT00735709|42047980|FG000|Overall Study|Noncompliance|0|||
19599183|NCT00735709|42047981|FG001|Overall Study|Noncompliance|0|||
19599184|NCT00735709|42047982|FG002|Overall Study|Noncompliance|1|||
19599185|NCT00735709|42047983|FG003|Overall Study|Noncompliance|0|||
19599186|NCT00735709|42047980|FG000|Overall Study|Protocol deviations|1|||
19599187|NCT00735709|42047981|FG001|Overall Study|Protocol deviations|2|||
19599188|NCT00735709|42047982|FG002|Overall Study|Protocol deviations|1|||
19599189|NCT00735709|42047983|FG003|Overall Study|Protocol deviations|1|||
19599190|NCT00735709|42047980|FG000|Overall Study|Voluntary Withdrawal|1|||
19599191|NCT00735709|42047981|FG001|Overall Study|Voluntary Withdrawal|3|||
19599192|NCT00735709|42047982|FG002|Overall Study|Voluntary Withdrawal|5|||
19599193|NCT00735709|42047983|FG003|Overall Study|Voluntary Withdrawal|7|||
19599194|NCT00735709|42047980|FG000|Overall Study|Lost to Follow-up|0|||
19599195|NCT00735709|42047981|FG001|Overall Study|Lost to Follow-up|1|||
19599196|NCT00735709|42047982|FG002|Overall Study|Lost to Follow-up|1|||
19599197|NCT00735709|42047983|FG003|Overall Study|Lost to Follow-up|1|||
19599198|NCT00735709|42047980|FG000|Overall Study|Excluded medication|1|||
19599199|NCT00735709|42047981|FG001|Overall Study|Excluded medication|0|||
19599200|NCT00735709|42047982|FG002|Overall Study|Excluded medication|0|||
19599201|NCT00735709|42047983|FG003|Overall Study|Excluded medication|1|||
19599202|NCT00729157|42047993|FG000|Overall Study|Withdrawal by Subject|1|||
19599203|NCT00728689|42047999|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
19599204|NCT00728689|42048000|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
19599205|NCT00727909|42048008|FG000|Overall Study|Withdrawal by Subject|5|||
19599206|NCT00727909|42048009|FG001|Overall Study|Withdrawal by Subject|11|||
19599207|NCT00727909|42048010|FG002|Overall Study|Withdrawal by Subject|8|||
19599208|NCT00727909|42048011|FG003|Overall Study|Withdrawal by Subject|5|||
19599209|NCT00727909|42048008|FG000|Overall Study|Death|0|||
19599210|NCT00727909|42048009|FG001|Overall Study|Death|0|||
19599211|NCT00727909|42048010|FG002|Overall Study|Death|1|||
19599212|NCT00727909|42048011|FG003|Overall Study|Death|0|||
19599213|NCT00726895|42048015|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19599214|NCT00726895|42048016|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19599215|NCT00585325|42048025|FG000|Overall Study|Withdrawal by Subject|1|||
19599216|NCT00585325|42048026|FG001|Overall Study|Withdrawal by Subject|1|||
19599217|NCT00726661|42048034|FG000|Overall Study|Lost to Follow-up|36|||
19599218|NCT00726661|42048035|FG001|Overall Study|Lost to Follow-up|11|||
19599219|NCT00726661|42048034|FG000|Overall Study|Withdrawal by Subject|17|||
19599220|NCT00726661|42048035|FG001|Overall Study|Withdrawal by Subject|13|||
19599221|NCT00726661|42048034|FG000|Overall Study|Trial terminated by sponsor|214|||
19599222|NCT00726661|42048035|FG001|Overall Study|Trial terminated by sponsor|187|||
19599223|NCT00726661|42048034|FG000|Overall Study|Death|475|||
19599224|NCT00726661|42048035|FG001|Overall Study|Death|159|||
19599225|NCT00726661|42048034|FG000|Overall Study|Physician Decision|25|||
19599226|NCT00726661|42048035|FG001|Overall Study|Physician Decision|13|||
19599227|NCT00726661|42048034|FG000|Overall Study|Other|47|||
19599228|NCT00726661|42048035|FG001|Overall Study|Other|35|||
19599229|NCT00741091|42048051|FG000|Overall Study|Death|13|||
19599230|NCT00741091|42048051|FG000|Overall Study|Lost to Follow-up|16|||
19599231|NCT00741091|42048051|FG000|Overall Study|Withdrawal by Subject|6|||
19747586|NCT02871778|42194919|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747587|NCT02871778|42194920|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
19747588|NCT02871778|42194921|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747589|NCT02871778|42194922|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747590|NCT02871778|42194923|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747591|NCT02871778|42194924|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747592|NCT02871778|42194925|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747593|NCT02871778|42194926|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
19747594|NCT02871778|42194919|FG000|Part A: Treatment Period 2|Adverse Event|2|||
19747595|NCT02871778|42194920|FG001|Part A: Treatment Period 2|Adverse Event|2|||
19747596|NCT02871778|42194921|FG002|Part A: Treatment Period 2|Adverse Event|0|||
19747597|NCT02871778|42194922|FG003|Part A: Treatment Period 2|Adverse Event|0|||
19747598|NCT02871778|42194923|FG004|Part A: Treatment Period 2|Adverse Event|0|||
19747599|NCT02871778|42194924|FG005|Part A: Treatment Period 2|Adverse Event|0|||
19747600|NCT02871778|42194925|FG006|Part A: Treatment Period 2|Adverse Event|0|||
19747601|NCT02871778|42194926|FG007|Part A: Treatment Period 2|Adverse Event|0|||
19747602|NCT02871778|42194919|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747603|NCT02871778|42194920|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747604|NCT02871778|42194921|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747605|NCT02871778|42194922|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
19747606|NCT02871778|42194923|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747607|NCT02871778|42194924|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747608|NCT02871778|42194925|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747609|NCT02871778|42194926|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
19747610|NCT02871778|42194919|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
19747611|NCT02871778|42194920|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747612|NCT02871778|42194921|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
19747613|NCT02871778|42194922|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747614|NCT02871778|42194923|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747615|NCT02871778|42194924|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747616|NCT02871778|42194925|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747617|NCT02871778|42194926|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
19747618|NCT02871778|42194919|FG000|Part B: Treatment Period 3|Adverse Event|0|||
19747619|NCT02871778|42194920|FG001|Part B: Treatment Period 3|Adverse Event|0|||
19747620|NCT02871778|42194921|FG002|Part B: Treatment Period 3|Adverse Event|0|||
19747621|NCT02871778|42194922|FG003|Part B: Treatment Period 3|Adverse Event|0|||
19747622|NCT02871778|42194923|FG004|Part B: Treatment Period 3|Adverse Event|1|||
19747623|NCT02871778|42194924|FG005|Part B: Treatment Period 3|Adverse Event|1|||
19747624|NCT02871778|42194925|FG006|Part B: Treatment Period 3|Adverse Event|1|||
19747625|NCT02871778|42194926|FG007|Part B: Treatment Period 3|Adverse Event|0|||
19747626|NCT01471444|42194959|FG000|Overall Study|Physician Decision|3|||
19747627|NCT01471444|42194960|FG001|Overall Study|Physician Decision|2|||
19747628|NCT01471444|42194959|FG000|Overall Study|Withdrawal by Subject|0|||
19747629|NCT01471444|42194960|FG001|Overall Study|Withdrawal by Subject|1|||
19747630|NCT03443427|42194978|FG000|Overall Study|Adverse Event|2|||
19747631|NCT03443427|42194979|FG001|Overall Study|Adverse Event|3|||
19747632|NCT03443427|42194978|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
19599232|NCT00741091|42048051|FG000|Overall Study|Missed Visit|22|||
19599233|NCT00741013|42048058|FG000|Overall Study|Adverse Event|1|||
19599234|NCT00741013|42048059|FG001|Overall Study|Adverse Event|0|||
19599235|NCT00741013|42048060|FG002|Overall Study|Adverse Event|0|||
19599236|NCT00741013|42048058|FG000|Overall Study|Withdrawal by Subject|0|||
19747633|NCT03443427|42194979|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
19747634|NCT03443427|42194978|FG000|Overall Study|Other|4|||
19747635|NCT03443427|42194979|FG001|Overall Study|Other|6|||
19747636|NCT03417219|42194987|FG000|Overall Study|Lost to Follow-up|0|||
19747637|NCT03417219|42194988|FG001|Overall Study|Lost to Follow-up|3|||
19747638|NCT02953821|42194996|FG000|Overall Study|Adverse Event|0|||
19747639|NCT02953821|42194997|FG001|Overall Study|Adverse Event|4|||
19747640|NCT02953821|42194996|FG000|Overall Study|Death|1|||
19599237|NCT00741013|42048059|FG001|Overall Study|Withdrawal by Subject|0|||
19747641|NCT02953821|42194997|FG001|Overall Study|Death|0|||
19747642|NCT02953821|42194996|FG000|Overall Study|Progressive Disease|5|||
19747643|NCT02953821|42194997|FG001|Overall Study|Progressive Disease|1|||
19747644|NCT02953821|42194996|FG000|Overall Study|Lost to Follow-up|2|||
19747645|NCT02953821|42194997|FG001|Overall Study|Lost to Follow-up|0|||
19747646|NCT02953821|42194996|FG000|Overall Study|Physician Decision|1|||
19747647|NCT02953821|42194997|FG001|Overall Study|Physician Decision|1|||
19747648|NCT02953821|42194996|FG000|Overall Study|Withdrawal by Subject|3|||
19747649|NCT02953821|42194997|FG001|Overall Study|Withdrawal by Subject|3|||
19747650|NCT02953821|42194996|FG000|Overall Study|Change of address|0|||
19747651|NCT02953821|42194997|FG001|Overall Study|Change of address|1|||
19747652|NCT02953821|42194996|FG000|Overall Study|Lack of Efficacy|1|||
19599238|NCT00741013|42048060|FG002|Overall Study|Withdrawal by Subject|1|||
19599239|NCT00741013|42048058|FG000|Overall Study|Discovered failed screen after enrolled|0|||
19599240|NCT00741013|42048059|FG001|Overall Study|Discovered failed screen after enrolled|2|||
19599241|NCT00741013|42048060|FG002|Overall Study|Discovered failed screen after enrolled|0|||
19599242|NCT00740857|42048071|FG000|Overall Study|Withdrawal by Subject|1|||
19599243|NCT00740857|42048072|FG001|Overall Study|Withdrawal by Subject|0|||
19599244|NCT00740857|42048073|FG002|Overall Study|Withdrawal by Subject|0|||
19599245|NCT00808132|42048086|FG000|Overall Study|Adverse Event|34|||
19599246|NCT00808132|42048087|FG001|Overall Study|Adverse Event|33|||
19599247|NCT00808132|42048088|FG002|Overall Study|Adverse Event|16|||
19599248|NCT00808132|42048089|FG003|Overall Study|Adverse Event|31|||
19599249|NCT00808132|42048090|FG004|Overall Study|Adverse Event|33|||
19599250|NCT00808132|42048086|FG000|Overall Study|Death|0|||
19599251|NCT00808132|42048087|FG001|Overall Study|Death|0|||
19599252|NCT00808132|42048088|FG002|Overall Study|Death|0|||
19599253|NCT00808132|42048089|FG003|Overall Study|Death|0|||
19599254|NCT00808132|42048090|FG004|Overall Study|Death|1|||
19599255|NCT00808132|42048086|FG000|Overall Study|Physician Decision|0|||
19599256|NCT00808132|42048087|FG001|Overall Study|Physician Decision|1|||
19599257|NCT00808132|42048088|FG002|Overall Study|Physician Decision|0|||
19599258|NCT00808132|42048089|FG003|Overall Study|Physician Decision|0|||
19599259|NCT00808132|42048090|FG004|Overall Study|Physician Decision|0|||
19599260|NCT00808132|42048086|FG000|Overall Study|Lost to Follow-up|8|||
19599261|NCT00808132|42048087|FG001|Overall Study|Lost to Follow-up|10|||
19599262|NCT00808132|42048088|FG002|Overall Study|Lost to Follow-up|11|||
19599263|NCT00808132|42048089|FG003|Overall Study|Lost to Follow-up|8|||
19599264|NCT00808132|42048090|FG004|Overall Study|Lost to Follow-up|9|||
19599265|NCT00808132|42048086|FG000|Overall Study|Protocol Violation|8|||
19599266|NCT00808132|42048087|FG001|Overall Study|Protocol Violation|9|||
19599267|NCT00808132|42048088|FG002|Overall Study|Protocol Violation|4|||
19599268|NCT00808132|42048089|FG003|Overall Study|Protocol Violation|9|||
19599269|NCT00808132|42048090|FG004|Overall Study|Protocol Violation|5|||
19599270|NCT00808132|42048086|FG000|Overall Study|Withdrawal by Subject|27|||
19599271|NCT00808132|42048087|FG001|Overall Study|Withdrawal by Subject|18|||
19599272|NCT00808132|42048088|FG002|Overall Study|Withdrawal by Subject|2|||
19599273|NCT00808132|42048089|FG003|Overall Study|Withdrawal by Subject|7|||
19599274|NCT00808132|42048090|FG004|Overall Study|Withdrawal by Subject|16|||
19599275|NCT00808132|42048086|FG000|Overall Study|Other|6|||
19599276|NCT00808132|42048087|FG001|Overall Study|Other|4|||
19599277|NCT00808132|42048088|FG002|Overall Study|Other|6|||
19599278|NCT00808132|42048089|FG003|Overall Study|Other|2|||
19599279|NCT00808132|42048090|FG004|Overall Study|Other|15|||
19599280|NCT00808132|42048086|FG000|Overall Study|Randomized, but not treated|10|||
19599281|NCT00808132|42048087|FG001|Overall Study|Randomized, but not treated|7|||
19599282|NCT00808132|42048088|FG002|Overall Study|Randomized, but not treated|9|||
19599283|NCT00808132|42048089|FG003|Overall Study|Randomized, but not treated|8|||
19599284|NCT00808132|42048090|FG004|Overall Study|Randomized, but not treated|9|||
19599285|NCT00808132|42048086|FG000|Overall Study|Unsatisfactory response|5|||
19599286|NCT00808132|42048087|FG001|Overall Study|Unsatisfactory response|6|||
19599287|NCT00808132|42048088|FG002|Overall Study|Unsatisfactory response|6|||
19599288|NCT00808132|42048089|FG003|Overall Study|Unsatisfactory response|4|||
19599289|NCT00808132|42048090|FG004|Overall Study|Unsatisfactory response|12|||
19599290|NCT00727441|42048105|FG000|Overall Study|Disease Progression|11|||
19599291|NCT00727441|42048106|FG001|Overall Study|Disease Progression|14|||
19599292|NCT00727441|42048107|FG002|Overall Study|Disease Progression|17|||
19599293|NCT00727441|42048105|FG000|Overall Study|Eligibility|7|||
19599294|NCT00727441|42048106|FG001|Overall Study|Eligibility|5|||
19747653|NCT02953821|42194997|FG001|Overall Study|Lack of Efficacy|0|||
19599295|NCT00727441|42048107|FG002|Overall Study|Eligibility|7|||
19599296|NCT00727441|42048105|FG000|Overall Study|Death|0|||
19599297|NCT00727441|42048106|FG001|Overall Study|Death|1|||
19599298|NCT00727441|42048107|FG002|Overall Study|Death|1|||
19599299|NCT00727441|42048105|FG000|Overall Study|Physician Decision|0|||
19599300|NCT00727441|42048106|FG001|Overall Study|Physician Decision|1|||
19599301|NCT00727441|42048107|FG002|Overall Study|Physician Decision|0|||
19599302|NCT00727441|42048105|FG000|Overall Study|Withdrawal by Subject|0|||
19599303|NCT00727441|42048106|FG001|Overall Study|Withdrawal by Subject|1|||
19599304|NCT00727441|42048107|FG002|Overall Study|Withdrawal by Subject|0|||
19599305|NCT00717769|42048121|FG000|Overall Study|Adverse Event|9|||
19599306|NCT00717769|42048122|FG001|Overall Study|Adverse Event|6|||
19599307|NCT00717769|42048123|FG002|Overall Study|Adverse Event|1|||
19599308|NCT00717769|42048121|FG000|Overall Study|Lack of compliance|0|||
19599309|NCT00717769|42048122|FG001|Overall Study|Lack of compliance|2|||
19599310|NCT00717769|42048123|FG002|Overall Study|Lack of compliance|0|||
19599311|NCT00717769|42048121|FG000|Overall Study|Lost to Follow-up|3|||
19599312|NCT00717769|42048122|FG001|Overall Study|Lost to Follow-up|4|||
19599313|NCT00717769|42048123|FG002|Overall Study|Lost to Follow-up|0|||
19599314|NCT00717769|42048121|FG000|Overall Study|Lack of Efficacy|1|||
19599315|NCT00717769|42048122|FG001|Overall Study|Lack of Efficacy|2|||
19599316|NCT00717769|42048123|FG002|Overall Study|Lack of Efficacy|0|||
19599317|NCT00717769|42048121|FG000|Overall Study|Protocol Violation|0|||
19599318|NCT00717769|42048122|FG001|Overall Study|Protocol Violation|2|||
19599319|NCT00717769|42048123|FG002|Overall Study|Protocol Violation|0|||
19599320|NCT00717769|42048121|FG000|Overall Study|Sponsor decision|1|||
19599321|NCT00717769|42048122|FG001|Overall Study|Sponsor decision|0|||
19599322|NCT00717769|42048123|FG002|Overall Study|Sponsor decision|10|||
19599323|NCT00717769|42048121|FG000|Overall Study|Withdrew consent|2|||
19599324|NCT00717769|42048122|FG001|Overall Study|Withdrew consent|2|||
19599325|NCT00717769|42048123|FG002|Overall Study|Withdrew consent|0|||
19599326|NCT04153929|42048141|FG000|Overall Study|Other than listed|2|||
19599327|NCT04153929|42048142|FG001|Overall Study|Other than listed|2|||
19599328|NCT04153929|42048143|FG002|Overall Study|Other than listed|0|||
19599329|NCT04153929|42048144|FG003|Overall Study|Other than listed|1|||
19599330|NCT04153929|42048145|FG004|Overall Study|Other than listed|0|||
19599331|NCT04153929|42048146|FG005|Overall Study|Other than listed|2|||
19599332|NCT04153929|42048147|FG006|Overall Study|Other than listed|2|||
19599333|NCT04153929|42048148|FG007|Overall Study|Other than listed|1|||
19599334|NCT04153929|42048141|FG000|Overall Study|Lost to Follow-up|2|||
19599335|NCT04153929|42048142|FG001|Overall Study|Lost to Follow-up|1|||
19599336|NCT04153929|42048143|FG002|Overall Study|Lost to Follow-up|0|||
19599337|NCT04153929|42048144|FG003|Overall Study|Lost to Follow-up|1|||
19599338|NCT04153929|42048145|FG004|Overall Study|Lost to Follow-up|1|||
19599339|NCT04153929|42048146|FG005|Overall Study|Lost to Follow-up|0|||
19599340|NCT04153929|42048147|FG006|Overall Study|Lost to Follow-up|0|||
19599341|NCT04153929|42048148|FG007|Overall Study|Lost to Follow-up|0|||
19599342|NCT04153929|42048141|FG000|Overall Study|Withdrawal by Subject|3|||
19599343|NCT04153929|42048142|FG001|Overall Study|Withdrawal by Subject|1|||
19599344|NCT04153929|42048143|FG002|Overall Study|Withdrawal by Subject|0|||
19599345|NCT04153929|42048144|FG003|Overall Study|Withdrawal by Subject|3|||
19599346|NCT04153929|42048145|FG004|Overall Study|Withdrawal by Subject|1|||
19599347|NCT04153929|42048146|FG005|Overall Study|Withdrawal by Subject|0|||
19599348|NCT04153929|42048147|FG006|Overall Study|Withdrawal by Subject|1|||
19599349|NCT04153929|42048148|FG007|Overall Study|Withdrawal by Subject|0|||
19599350|NCT04153929|42048141|FG000|Overall Study|Protocol Violation|0|||
19599351|NCT04153929|42048142|FG001|Overall Study|Protocol Violation|0|||
19599352|NCT04153929|42048143|FG002|Overall Study|Protocol Violation|0|||
19599353|NCT04153929|42048144|FG003|Overall Study|Protocol Violation|0|||
19599354|NCT04153929|42048145|FG004|Overall Study|Protocol Violation|0|||
19599355|NCT04153929|42048146|FG005|Overall Study|Protocol Violation|0|||
19599356|NCT04153929|42048147|FG006|Overall Study|Protocol Violation|1|||
19599357|NCT04153929|42048148|FG007|Overall Study|Protocol Violation|2|||
19599358|NCT04153929|42048141|FG000|Overall Study|Adverse Event|3|||
19599359|NCT04153929|42048142|FG001|Overall Study|Adverse Event|5|||
19599360|NCT04153929|42048143|FG002|Overall Study|Adverse Event|5|||
19599361|NCT04153929|42048144|FG003|Overall Study|Adverse Event|11|||
19599362|NCT04153929|42048145|FG004|Overall Study|Adverse Event|15|||
19599363|NCT04153929|42048146|FG005|Overall Study|Adverse Event|4|||
19599364|NCT04153929|42048147|FG006|Overall Study|Adverse Event|8|||
19599365|NCT04153929|42048148|FG007|Overall Study|Adverse Event|2|||
19599366|NCT04153929|42048141|FG000|Overall Study|Not treated|1|||
19599367|NCT04153929|42048142|FG001|Overall Study|Not treated|0|||
19639301|NCT00716144|42088705|FG000|Overall Study|Adverse Event|0|||
19639302|NCT00716144|42088706|FG001|Overall Study|Adverse Event|0|||
19639303|NCT00716144|42088707|FG002|Overall Study|Adverse Event|0|||
19639304|NCT00716144|42088708|FG003|Overall Study|Adverse Event|2|||
19599368|NCT04153929|42048143|FG002|Overall Study|Not treated|0|||
19599369|NCT04153929|42048144|FG003|Overall Study|Not treated|0|||
19599370|NCT04153929|42048145|FG004|Overall Study|Not treated|0|||
19599371|NCT04153929|42048146|FG005|Overall Study|Not treated|0|||
19599372|NCT04153929|42048147|FG006|Overall Study|Not treated|1|||
19599373|NCT04153929|42048148|FG007|Overall Study|Not treated|0|||
19599374|NCT00591214|42048166|FG000|Overall Study|Physician Decision|7|||
19599375|NCT00591214|42048166|FG000|Overall Study|Withdrawal by Subject|1|||
19599376|NCT00725725|42048173|FG000|Overall Study|Adverse Event|1|||
19599377|NCT00725725|42048174|FG001|Overall Study|Adverse Event|3|||
19599378|NCT00725725|42048175|FG002|Overall Study|Adverse Event|2|||
19599379|NCT00725725|42048173|FG000|Overall Study|Lost to Follow-up|2|||
19599380|NCT00725725|42048174|FG001|Overall Study|Lost to Follow-up|0|||
19599381|NCT00725725|42048175|FG002|Overall Study|Lost to Follow-up|2|||
19599382|NCT00725725|42048173|FG000|Overall Study|Withdrawal by Subject|1|||
19599383|NCT00725725|42048174|FG001|Overall Study|Withdrawal by Subject|0|||
19599384|NCT00725725|42048175|FG002|Overall Study|Withdrawal by Subject|1|||
19599385|NCT00725725|42048173|FG000|Overall Study|Protocol Violation|0|||
19599386|NCT00725725|42048174|FG001|Overall Study|Protocol Violation|1|||
19599387|NCT00725725|42048175|FG002|Overall Study|Protocol Violation|0|||
19599388|NCT00725101|42048183|FG000|Overall Study|Death|3|||
19599389|NCT00725101|42048183|FG000|Overall Study|Lost to Follow-up|353|||
19599390|NCT00725101|42048183|FG000|Overall Study|Protocol Violation|1|||
19599391|NCT00725101|42048183|FG000|Overall Study|Withdrawal by Subject|127|||
19599392|NCT00725101|42048183|FG000|Overall Study|not specified/no reason given|11|||
19599393|NCT00585169|42048187|FG000|Overall Study|Withdrawal by Subject|1|||
19599394|NCT00807742|42048195|FG000|Overall Study|Death|9|||
19599395|NCT00807742|42048196|FG001|Overall Study|Death|2|||
19599396|NCT00807742|42048195|FG000|Overall Study|Withdrawal by Subject|2|||
19599397|NCT00807742|42048196|FG001|Overall Study|Withdrawal by Subject|1|||
19599398|NCT00807742|42048195|FG000|Overall Study|Lost to Follow-up|35|||
19599399|NCT00807742|42048196|FG001|Overall Study|Lost to Follow-up|51|||
19599400|NCT00724945|42048202|FG000|Period 1|non-compliance|1|||
19599401|NCT00724945|42048203|FG001|Period 1|non-compliance|0|||
19599402|NCT00724945|42048202|FG000|Period 1|Adverse Event|1|||
19599403|NCT00724945|42048203|FG001|Period 1|Adverse Event|1|||
19599404|NCT00724945|42048202|FG000|Period 1|Lost to Follow-up|1|||
19599405|NCT00724945|42048203|FG001|Period 1|Lost to Follow-up|0|||
19599406|NCT00724945|42048202|FG000|Period 2|lens comfort issue|3|||
19599407|NCT00724945|42048203|FG001|Period 2|lens comfort issue|0|||
19599408|NCT00724945|42048202|FG000|Period 2|lens physiology issue|1|||
19599409|NCT00724945|42048203|FG001|Period 2|lens physiology issue|0|||
19599410|NCT00803452|42048211|FG000|Overall Study|Adverse Event|0|||
19599411|NCT00803452|42048212|FG001|Overall Study|Adverse Event|2|||
19599412|NCT00803452|42048211|FG000|Overall Study|Lost to Follow-up|0|||
19599413|NCT00803452|42048212|FG001|Overall Study|Lost to Follow-up|3|||
19599414|NCT00589108|42048221|FG000|Overall Study|Lost to Follow-up|1|||
19599415|NCT00589108|42048222|FG001|Overall Study|Lost to Follow-up|1|||
19599416|NCT00589108|42048223|FG002|Overall Study|Lost to Follow-up|1|||
19599417|NCT00589108|42048221|FG000|Overall Study|Death|3|||
19599418|NCT00589108|42048222|FG001|Overall Study|Death|3|||
19599419|NCT00589108|42048223|FG002|Overall Study|Death|4|||
19599420|NCT00717067|42048236|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
19599421|NCT00717067|42048237|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
19599422|NCT00717067|42048238|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
19599423|NCT00717067|42048239|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
19599424|NCT00717067|42048240|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
19599425|NCT00802438|42048262|FG000|Overall Study|Screen Failure|20|||
19599426|NCT00802438|42048262|FG000|Overall Study|Withdrawal by Subject|7|||
19599427|NCT00802438|42048262|FG000|Overall Study|Physician Decision|1|||
19599428|NCT00588952|42048272|FG000|Overall Study|Adverse Event|0|||
19599429|NCT00588952|42048273|FG001|Overall Study|Adverse Event|2|||
19599430|NCT00588952|42048272|FG000|Overall Study|Withdrawal by Subject|3|||
19747654|NCT02953821|42194996|FG000|Overall Study|Out of state for indeterminate time|0|||
19747655|NCT02953821|42194997|FG001|Overall Study|Out of state for indeterminate time|1|||
19599431|NCT00588952|42048273|FG001|Overall Study|Withdrawal by Subject|5|||
19599432|NCT01021748|42048288|FG000|Overall Study|Adverse Event|2|||
19599433|NCT01021748|42048289|FG001|Overall Study|Adverse Event|1|||
19599434|NCT01021748|42048290|FG002|Overall Study|Adverse Event|2|||
19599435|NCT01021748|42048291|FG003|Overall Study|Adverse Event|0|||
19747656|NCT02953821|42194996|FG000|Overall Study|No improvement|0|||
19747657|NCT02953821|42194997|FG001|Overall Study|No improvement|1|||
19747658|NCT02953821|42194996|FG000|Overall Study|Refused follow-up visit|2|||
19747659|NCT02953821|42194997|FG001|Overall Study|Refused follow-up visit|1|||
19747660|NCT03783923|42195007|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
19747661|NCT03783923|42195008|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
19747662|NCT03783923|42195007|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
19747663|NCT03783923|42195008|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
19747664|NCT03783923|42195007|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
19747665|NCT03783923|42195008|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
19747666|NCT03783923|42195007|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
19747667|NCT03783923|42195008|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
19747668|NCT03783923|42195007|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
19747669|NCT03783923|42195008|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
19747670|NCT03417141|42195012|FG000|Overall Study|Withdrawal by Subject|1|||
19747671|NCT03417141|42195012|FG000|Overall Study|Protocol Violation|3|||
19599436|NCT01021748|42048292|FG004|Overall Study|Adverse Event|2|||
19747672|NCT03724981|42195020|FG000|First Device|Protocol Violation|1|||
19747673|NCT03724981|42195021|FG001|First Device|Protocol Violation|1|||
19747674|NCT03442569|42195029|FG000|Overall Study|Subject was ineligible after enrollment|1|||
19747675|NCT01347879|42195035|FG000|Overall Study|Adverse Event|0|||
19747676|NCT01347879|42195036|FG001|Overall Study|Adverse Event|12|||
19747677|NCT01347879|42195035|FG000|Overall Study|Lost to Follow-up|2|||
19747678|NCT01347879|42195036|FG001|Overall Study|Lost to Follow-up|0|||
19747679|NCT01347879|42195035|FG000|Overall Study|Withdrawal by Subject|3|||
19747680|NCT01347879|42195036|FG001|Overall Study|Withdrawal by Subject|2|||
19747681|NCT01347879|42195035|FG000|Overall Study|Other|2|||
19747682|NCT01347879|42195036|FG001|Overall Study|Other|3|||
19747683|NCT03441789|42195053|FG000|Overall Study|Withdrawal by Subject|1|||
19747684|NCT03441789|42195054|FG001|Overall Study|Withdrawal by Subject|1|||
19747685|NCT03441789|42195053|FG000|Overall Study|Adverse Event|0|||
19747686|NCT03441789|42195054|FG001|Overall Study|Adverse Event|1|||
19747687|NCT03441789|42195053|FG000|Overall Study|Protocol Violation|0|||
19747688|NCT03441789|42195054|FG001|Overall Study|Protocol Violation|1|||
19747689|NCT03441789|42195053|FG000|Overall Study|Lost to Follow-up|0|||
19747690|NCT03441789|42195054|FG001|Overall Study|Lost to Follow-up|1|||
19747691|NCT03387735|42195071|FG000|Overall Study|Lost to Follow-up|4|||
19747692|NCT03387735|42195072|FG001|Overall Study|Lost to Follow-up|8|||
19747693|NCT03387735|42195071|FG000|Overall Study|Death|4|||
19747694|NCT03387735|42195072|FG001|Overall Study|Death|8|||
19747695|NCT03439137|42195080|FG000|Overall Study|Adverse Event|16|||
19747696|NCT03439137|42195081|FG001|Overall Study|Adverse Event|12|||
19747697|NCT03439137|42195080|FG000|Overall Study|Physician Decision|0|||
19747698|NCT03439137|42195081|FG001|Overall Study|Physician Decision|5|||
19747699|NCT03439137|42195080|FG000|Overall Study|Withdrawal by Subject|14|||
19747700|NCT03439137|42195081|FG001|Overall Study|Withdrawal by Subject|4|||
19747701|NCT03439137|42195080|FG000|Overall Study|Conducting rescue therapy|2|||
19747702|NCT03439137|42195081|FG001|Overall Study|Conducting rescue therapy|1|||
19747703|NCT03439137|42195080|FG000|Overall Study|Difficult to control Hb|10|||
19747704|NCT03439137|42195081|FG001|Overall Study|Difficult to control Hb|2|||
19747705|NCT03439137|42195080|FG000|Overall Study|Initiation of a renal transplant|0|||
19747706|NCT03439137|42195081|FG001|Overall Study|Initiation of a renal transplant|2|||
19747707|NCT04055090|42195089|FG000|Overall Study|screen failure|1|||
19747708|NCT04055090|42195090|FG001|Overall Study|screen failure|0|||
19747709|NCT04055090|42195089|FG000|Overall Study|Withdrawal by Subject|1|||
19747710|NCT04055090|42195090|FG001|Overall Study|Withdrawal by Subject|0|||
19747711|NCT03403413|42195113|FG000|Overall Study|Lack of Efficacy|2|||
19747712|NCT03354663|42195128|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
19747713|NCT03354663|42195128|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
19747714|NCT03354663|42195128|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
19747715|NCT03354663|42195128|FG000|Completed 30-day Visit|Missed Visit|1|||
19747716|NCT03721705|42195138|FG000|Overall Study|Adverse Event|2|||
19747717|NCT03721705|42195139|FG001|Overall Study|Adverse Event|0|||
19747718|NCT03721705|42195138|FG000|Overall Study|Withdrawal by Subject|4|||
19747719|NCT03721705|42195139|FG001|Overall Study|Withdrawal by Subject|10|||
19747720|NCT03721705|42195138|FG000|Overall Study|No Suitable Study Partner|1|||
19747721|NCT03721705|42195139|FG001|Overall Study|No Suitable Study Partner|0|||
19747722|NCT03721705|42195138|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
19747723|NCT03721705|42195139|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
19747724|NCT03721705|42195138|FG000|Overall Study|Death|0|||
19747725|NCT03721705|42195139|FG001|Overall Study|Death|1|||
19747726|NCT03720847|42195145|FG000|Washout|Physician Decision|1|||
19747727|NCT03720847|42195146|FG001|Washout|Physician Decision|2|||
19747728|NCT02631070|42195155|FG000|Overall Study|Withdrawal by Subject|35|||
19747729|NCT02631070|42195156|FG001|Overall Study|Withdrawal by Subject|13|||
19747730|NCT02631070|42195155|FG000|Overall Study|Death|45|||
19747731|NCT02631070|42195156|FG001|Overall Study|Death|24|||
19747732|NCT02631070|42195155|FG000|Overall Study|Lost to Follow-up|5|||
19747733|NCT02631070|42195156|FG001|Overall Study|Lost to Follow-up|1|||
19747734|NCT02631070|42195155|FG000|Overall Study|Transition to rollover protocol|52|||
19747735|NCT02631070|42195156|FG001|Overall Study|Transition to rollover protocol|21|||
19747736|NCT02631070|42195155|FG000|Overall Study|Other reasons|12|||
19747737|NCT02631070|42195156|FG001|Overall Study|Other reasons|5|||
19747738|NCT00741988|42195164|FG000|Overall Study|Adverse Event|2|||
19747739|NCT00741988|42195165|FG001|Overall Study|Adverse Event|4|||
19747740|NCT00741988|42195164|FG000|Overall Study|Lack of Efficacy|2|||
19747741|NCT00741988|42195165|FG001|Overall Study|Lack of Efficacy|0|||
19747742|NCT03354429|42195173|FG000|Overall Study|Withdrawal by Subject|8|||
19747743|NCT03354429|42195174|FG001|Overall Study|Withdrawal by Subject|7|||
19747744|NCT03354429|42195173|FG000|Overall Study|Lost to Follow-up|1|||
19747745|NCT03354429|42195174|FG001|Overall Study|Lost to Follow-up|0|||
19747746|NCT03352713|42195180|FG000|Overall Study|Lost to Follow-up|8|||
19747747|NCT03352713|42195180|FG000|Overall Study|Withdrawn by investigator|5|||
19747748|NCT03352713|42195180|FG000|Overall Study|Completed 0 EMAs|8|||
19747749|NCT03352713|42195180|FG000|Overall Study|Device incompatible/stolen|5|||
19747750|NCT03901144|42195184|FG000|Overall Study|Lost to Follow-up|1|||
19747751|NCT03901144|42195185|FG001|Overall Study|Lost to Follow-up|1|||
19747752|NCT03901144|42195186|FG002|Overall Study|Lost to Follow-up|1|||
19747753|NCT03901144|42195187|FG003|Overall Study|Lost to Follow-up|1|||
19747754|NCT02952261|42195199|FG000|Overall Study|Withdrawal by Subject|4|||
19747755|NCT02952261|42195200|FG001|Overall Study|Withdrawal by Subject|5|||
19747756|NCT02952261|42195199|FG000|Overall Study|Protocol Violation|1|||
19747757|NCT02952261|42195200|FG001|Overall Study|Protocol Violation|0|||
19747758|NCT03384693|42195206|FG000|Overall Study|Adverse Event|3|||
19747759|NCT03718429|42195218|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
19747760|NCT03718429|42195219|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
19747761|NCT03718429|42195220|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
19747762|NCT03718429|42195221|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
19747763|NCT01285102|42195241|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
19747764|NCT03382899|42195275|FG000|Overall Study|Ineligibility Determined|0|||
19747765|NCT03382899|42195276|FG001|Overall Study|Ineligibility Determined|1|||
19747766|NCT03382899|42195275|FG000|Overall Study|Lost to Follow-up|0|||
19747767|NCT03382899|42195276|FG001|Overall Study|Lost to Follow-up|1|||
19747768|NCT03382899|42195275|FG000|Overall Study|Sponsor's decision|31|||
19747769|NCT03382899|42195276|FG001|Overall Study|Sponsor's decision|28|||
19747770|NCT03382899|42195275|FG000|Overall Study|Withdrawal by Subject|0|||
19747771|NCT03382899|42195276|FG001|Overall Study|Withdrawal by Subject|5|||
19747772|NCT00709852|42195282|FG000|Period 1|Adverse Event|2|||
19747773|NCT00709852|42195283|FG001|Period 1|Adverse Event|0|||
19747774|NCT00709852|42195282|FG000|Period 1|Withdrawal by Subject|4|||
19747775|NCT00709852|42195283|FG001|Period 1|Withdrawal by Subject|2|||
19747776|NCT00709852|42195282|FG000|Period 1|Protocol Violation|1|||
19747777|NCT00709852|42195283|FG001|Period 1|Protocol Violation|0|||
19747778|NCT00709852|42195282|FG000|Period 1|Defective scanner|0|||
19747779|NCT00709852|42195283|FG001|Period 1|Defective scanner|1|||
19747780|NCT00709852|42195282|FG000|Period 1|Lost to Follow-up|1|||
19747781|NCT00709852|42195283|FG001|Period 1|Lost to Follow-up|0|||
19747782|NCT00709852|42195282|FG000|Period 2|Protocol Violation|4|||
19747783|NCT00709852|42195283|FG001|Period 2|Protocol Violation|1|||
19747784|NCT00709852|42195282|FG000|Period 2|Adverse Event|1|||
19747785|NCT00709852|42195283|FG001|Period 2|Adverse Event|1|||
19747786|NCT00709852|42195282|FG000|Period 2|Lost to Follow-up|1|||
19747787|NCT00709852|42195283|FG001|Period 2|Lost to Follow-up|0|||
19747788|NCT00709852|42195282|FG000|Period 2|No 72-hour follow-up|3|||
19747789|NCT00709852|42195283|FG001|Period 2|No 72-hour follow-up|0|||
19747790|NCT03382041|42195300|FG000|Overall Study|Consent Form Lost|2|||
19747791|NCT03382041|42195301|FG001|Overall Study|Consent Form Lost|1|||
19747792|NCT03382041|42195300|FG000|Overall Study|Withdrawal by Subject|1|||
19747793|NCT03382041|42195301|FG001|Overall Study|Withdrawal by Subject|4|||
19747794|NCT03382041|42195300|FG000|Overall Study|Lost to Follow-up|1|||
19747795|NCT03382041|42195301|FG001|Overall Study|Lost to Follow-up|4|||
19747796|NCT03351231|42195307|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
19747797|NCT03351231|42195307|FG000|Combination Therapy Period|Disease progression|2|||
19747798|NCT03351231|42195307|FG000|Combination Therapy Period|Study drug toxicity|1|||
19747799|NCT03351231|42195307|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
19747800|NCT03351231|42195307|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
19747801|NCT03351231|42195307|FG000|Safety Follow-Up Period|Other reason|2|||
19747802|NCT03381339|42195313|FG000|Overall Study|Protocol Violation|4|||
19747803|NCT03381339|42195314|FG001|Overall Study|Protocol Violation|3|||
19747804|NCT03381339|42195313|FG000|Overall Study|Lost to Follow-up|0|||
19747805|NCT03381339|42195314|FG001|Overall Study|Lost to Follow-up|1|||
19747806|NCT03401229|42195322|FG000|Overall Study|Lost to Follow-up|2|||
19747807|NCT03401229|42195323|FG001|Overall Study|Lost to Follow-up|1|||
19747808|NCT03401229|42195322|FG000|Overall Study|Other|1|||
19747809|NCT03401229|42195323|FG001|Overall Study|Other|3|||
19747810|NCT03401229|42195322|FG000|Overall Study|Adverse Event|8|||
19747811|NCT03401229|42195323|FG001|Overall Study|Adverse Event|6|||
19747812|NCT03401229|42195322|FG000|Overall Study|Withdrawal by Subject|29|||
19747813|NCT03401229|42195323|FG001|Overall Study|Withdrawal by Subject|26|||
19747814|NCT03401229|42195322|FG000|Overall Study|COVID-19|0|||
19747815|NCT03401229|42195323|FG001|Overall Study|COVID-19|1|||
19747816|NCT03349515|42195331|FG000|Overall Study|Lack of Efficacy|2|||
19747817|NCT03349515|42195332|FG001|Overall Study|Lack of Efficacy|0|||
19747818|NCT03349515|42195331|FG000|Overall Study|Physician Decision|3|||
19747819|NCT03349515|42195332|FG001|Overall Study|Physician Decision|1|||
19747820|NCT03349437|42195338|FG000|Screening|Screen Fail|4|||
19747821|NCT03349437|42195339|FG001|Screening|Screen Fail|0|||
19747822|NCT03349437|42195340|FG002|Screening|Screen Fail|0|||
19747823|NCT03349437|42195338|FG000|Screening|Withdrawn|1|||
19747824|NCT03349437|42195339|FG001|Screening|Withdrawn|0|||
19747825|NCT03349437|42195340|FG002|Screening|Withdrawn|0|||
19747826|NCT03380091|42195349|FG000|Overall Study|Withdrawal by Subject|2|||
19747827|NCT03380091|42195350|FG001|Overall Study|Withdrawal by Subject|1|||
19747828|NCT03379233|42195360|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
19747829|NCT03379233|42195361|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
19747830|NCT01377922|42195369|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
19747831|NCT01377922|42195370|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
19747832|NCT03372603|42195376|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
19747833|NCT03372603|42195377|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
19747834|NCT03372603|42195376|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
19747835|NCT03372603|42195377|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
19747836|NCT01377844|42195385|FG000|Overall Study|Withdrawal by Subject|25|||
19747837|NCT01377844|42195386|FG001|Overall Study|Withdrawal by Subject|28|||
19747838|NCT01377844|42195385|FG000|Overall Study|Protocol Violation|2|||
19747839|NCT01377844|42195386|FG001|Overall Study|Protocol Violation|3|||
19747840|NCT01377844|42195385|FG000|Overall Study|Adverse Event|3|||
19747841|NCT01377844|42195386|FG001|Overall Study|Adverse Event|0|||
19747842|NCT01377844|42195385|FG000|Overall Study|Physician Decision|6|||
19747843|NCT01377844|42195386|FG001|Overall Study|Physician Decision|3|||
19747844|NCT01377844|42195385|FG000|Overall Study|Study terminated by Sponsor|0|||
19747845|NCT01377844|42195386|FG001|Overall Study|Study terminated by Sponsor|1|||
19747846|NCT03372369|42195395|FG000|Qualification Period|Withdrawal by Subject|16|||
19747847|NCT03372369|42195396|FG001|Qualification Period|Withdrawal by Subject|13|||
19747848|NCT03372369|42195395|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
19747849|NCT03372369|42195396|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
19747850|NCT03372369|42195395|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
19747851|NCT03372369|42195396|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
19747852|NCT03371355|42195406|FG000|Overall Study|Investigator judgment|0|||
19747853|NCT03371355|42195407|FG001|Overall Study|Investigator judgment|0|||
19747854|NCT03371355|42195408|FG002|Overall Study|Investigator judgment|1|||
19747855|NCT03371355|42195409|FG003|Overall Study|Investigator judgment|1|||
19747856|NCT03371355|42195406|FG000|Overall Study|Voluntary withdrawal|1|||
19747857|NCT03371355|42195407|FG001|Overall Study|Voluntary withdrawal|0|||
19747858|NCT03371355|42195408|FG002|Overall Study|Voluntary withdrawal|1|||
19747859|NCT03371355|42195409|FG003|Overall Study|Voluntary withdrawal|2|||
19599437|NCT01021748|42048293|FG005|Overall Study|Adverse Event|0|||
19599438|NCT01021748|42048294|FG006|Overall Study|Adverse Event|1|||
19599439|NCT01021748|42048295|FG007|Overall Study|Adverse Event|0|||
19599440|NCT01021748|42048296|FG008|Overall Study|Adverse Event|7|||
19599441|NCT01021748|42048288|FG000|Overall Study|Physician Decision|1|||
19599442|NCT01021748|42048289|FG001|Overall Study|Physician Decision|0|||
19599443|NCT01021748|42048290|FG002|Overall Study|Physician Decision|1|||
19599444|NCT01021748|42048291|FG003|Overall Study|Physician Decision|1|||
19599445|NCT01021748|42048292|FG004|Overall Study|Physician Decision|0|||
19599446|NCT01021748|42048293|FG005|Overall Study|Physician Decision|0|||
19599447|NCT01021748|42048294|FG006|Overall Study|Physician Decision|1|||
19599448|NCT01021748|42048295|FG007|Overall Study|Physician Decision|1|||
19599449|NCT01021748|42048296|FG008|Overall Study|Physician Decision|2|||
19599450|NCT01021748|42048288|FG000|Overall Study|Progressive Disease|3|||
19599451|NCT01021748|42048289|FG001|Overall Study|Progressive Disease|3|||
19599452|NCT01021748|42048290|FG002|Overall Study|Progressive Disease|4|||
19599453|NCT01021748|42048291|FG003|Overall Study|Progressive Disease|6|||
19599454|NCT01021748|42048292|FG004|Overall Study|Progressive Disease|7|||
19599455|NCT01021748|42048293|FG005|Overall Study|Progressive Disease|3|||
19599456|NCT01021748|42048294|FG006|Overall Study|Progressive Disease|0|||
19599457|NCT01021748|42048295|FG007|Overall Study|Progressive Disease|5|||
19599458|NCT01021748|42048296|FG008|Overall Study|Progressive Disease|6|||
19599459|NCT01021748|42048288|FG000|Overall Study|Withdrawal by Subject|0|||
19599460|NCT01021748|42048289|FG001|Overall Study|Withdrawal by Subject|0|||
19599461|NCT01021748|42048290|FG002|Overall Study|Withdrawal by Subject|0|||
19599462|NCT01021748|42048291|FG003|Overall Study|Withdrawal by Subject|0|||
19599463|NCT01021748|42048292|FG004|Overall Study|Withdrawal by Subject|0|||
19599464|NCT01021748|42048293|FG005|Overall Study|Withdrawal by Subject|0|||
19599465|NCT01021748|42048294|FG006|Overall Study|Withdrawal by Subject|1|||
19599466|NCT01021748|42048295|FG007|Overall Study|Withdrawal by Subject|0|||
19599467|NCT01021748|42048296|FG008|Overall Study|Withdrawal by Subject|1|||
19599468|NCT01021748|42048288|FG000|Overall Study|Not Treated|0|||
19599469|NCT01021748|42048289|FG001|Overall Study|Not Treated|1|||
19599470|NCT01021748|42048290|FG002|Overall Study|Not Treated|0|||
19599471|NCT01021748|42048291|FG003|Overall Study|Not Treated|0|||
19599472|NCT01021748|42048292|FG004|Overall Study|Not Treated|0|||
19599473|NCT01021748|42048293|FG005|Overall Study|Not Treated|0|||
19599474|NCT01021748|42048294|FG006|Overall Study|Not Treated|0|||
19599475|NCT01021748|42048295|FG007|Overall Study|Not Treated|0|||
19599476|NCT01021748|42048296|FG008|Overall Study|Not Treated|0|||
19599477|NCT00802360|42048320|FG000|Overall Study|Stimulation failure|4|||
19599478|NCT00802360|42048321|FG001|Overall Study|Stimulation failure|0|||
19599479|NCT00802360|42048322|FG002|Overall Study|Stimulation failure|3|||
19599480|NCT00802360|42048323|FG003|Overall Study|Stimulation failure|3|||
19599481|NCT00802360|42048320|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
19599482|NCT00802360|42048321|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
19599483|NCT00802360|42048322|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
19599484|NCT00802360|42048323|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
19599485|NCT00802360|42048320|FG000|Overall Study|Cycle cancelled|0|||
19639305|NCT00716144|42088705|FG000|Overall Study|Non-compliance|1|||
19639306|NCT00716144|42088706|FG001|Overall Study|Non-compliance|0|||
19639307|NCT00716144|42088707|FG002|Overall Study|Non-compliance|0|||
19639308|NCT00716144|42088708|FG003|Overall Study|Non-compliance|0|||
19639309|NCT00716144|42088705|FG000|Overall Study|Protocol Violation|2|||
19639310|NCT00716144|42088706|FG001|Overall Study|Protocol Violation|0|||
19639311|NCT00716144|42088707|FG002|Overall Study|Protocol Violation|1|||
19639312|NCT00716144|42088708|FG003|Overall Study|Protocol Violation|0|||
19639313|NCT00716144|42088705|FG000|Overall Study|Physician Decision|0|||
19599486|NCT00802360|42048321|FG001|Overall Study|Cycle cancelled|1|||
19599487|NCT00802360|42048322|FG002|Overall Study|Cycle cancelled|1|||
19599488|NCT00802360|42048323|FG003|Overall Study|Cycle cancelled|1|||
19599489|NCT00802360|42048320|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
19599490|NCT00802360|42048321|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
19599491|NCT00802360|42048322|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
19599492|NCT00802360|42048323|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
19599493|NCT00802360|42048320|FG000|Overall Study|No positive serum pregnancy|17|||
19599494|NCT00802360|42048321|FG001|Overall Study|No positive serum pregnancy|20|||
19599495|NCT00802360|42048322|FG002|Overall Study|No positive serum pregnancy|14|||
19639314|NCT00716144|42088706|FG001|Overall Study|Physician Decision|1|||
19639315|NCT00716144|42088707|FG002|Overall Study|Physician Decision|2|||
19639316|NCT00716144|42088708|FG003|Overall Study|Physician Decision|2|||
19639317|NCT00716144|42088705|FG000|Overall Study|Intercurrent illness|0|||
19639318|NCT00716144|42088706|FG001|Overall Study|Intercurrent illness|0|||
19639319|NCT00716144|42088707|FG002|Overall Study|Intercurrent illness|1|||
19639320|NCT00716144|42088708|FG003|Overall Study|Intercurrent illness|0|||
19639321|NCT00716144|42088705|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
19639322|NCT00716144|42088706|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
19639323|NCT00716144|42088707|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
19639324|NCT00716144|42088708|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
19639325|NCT00716144|42088705|FG000|Overall Study|Adverse event: left foot pain|0|||
19639326|NCT00716144|42088706|FG001|Overall Study|Adverse event: left foot pain|1|||
19639327|NCT00716144|42088707|FG002|Overall Study|Adverse event: left foot pain|0|||
19639328|NCT00716144|42088708|FG003|Overall Study|Adverse event: left foot pain|0|||
19639329|NCT00716144|42088705|FG000|Overall Study|Clinical Depression|0|||
19639330|NCT00716144|42088706|FG001|Overall Study|Clinical Depression|1|||
19639331|NCT00716144|42088707|FG002|Overall Study|Clinical Depression|0|||
19639332|NCT00716144|42088708|FG003|Overall Study|Clinical Depression|0|||
19639333|NCT00576381|42088718|FG000|Overall Study|Reoperation|3|||
19639334|NCT00576381|42088718|FG000|Overall Study|Adverse Event|4|||
19639335|NCT00684567|42088722|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
19639336|NCT00684567|42088722|FG000|Monotherapy Period|Adverse Event|2|||
19639337|NCT00684567|42088722|FG000|Monotherapy Period|Death|1|||
19639338|NCT00684567|42088722|FG000|Monotherapy Period|Progression of primary disease|11|||
19639339|NCT00684411|42088726|FG000|Overall Study|New Primary Cancer|1|||
19639340|NCT00684411|42088726|FG000|Overall Study|Disease Progression|10|||
19639341|NCT00684411|42088726|FG000|Overall Study|Adverse Event|1|||
19639342|NCT00686829|42088730|FG000|Overall Study|Adverse Event|5|||
19639343|NCT00686829|42088730|FG000|Overall Study|Lack of Efficacy|6|||
19639344|NCT00686829|42088730|FG000|Overall Study|Lost to Follow-up|4|||
19639345|NCT00686829|42088730|FG000|Overall Study|Withdrawal by Subject|14|||
19639346|NCT00686829|42088730|FG000|Overall Study|Protocol Violation|3|||
19639347|NCT00686829|42088730|FG000|Overall Study|Sponsor discontinued VCV|47|||
19639348|NCT00687297|42088736|FG000|Randomization|Withdrawal by Subject|2|||
19639349|NCT00687297|42088737|FG001|Randomization|Withdrawal by Subject|0|||
19639350|NCT00687297|42088736|FG000|Randomization|Withdrew before treatment, ineligible|1|||
19639351|NCT00687297|42088737|FG001|Randomization|Withdrew before treatment, ineligible|1|||
19639352|NCT00687297|42088736|FG000|Induction|Withdrawal by Subject|4|||
19639353|NCT00687297|42088737|FG001|Induction|Withdrawal by Subject|4|||
19639354|NCT00687297|42088736|FG000|Induction|Adverse Event|16|||
19639355|NCT00687297|42088737|FG001|Induction|Adverse Event|15|||
19639356|NCT00687297|42088736|FG000|Induction|Death|7|||
19639357|NCT00687297|42088737|FG001|Induction|Death|11|||
19639358|NCT00687297|42088736|FG000|Induction|Lack of Efficacy|17|||
19639359|NCT00687297|42088737|FG001|Induction|Lack of Efficacy|21|||
19639360|NCT00687297|42088736|FG000|Induction|Ineligible|0|||
19639361|NCT00687297|42088737|FG001|Induction|Ineligible|1|||
19639362|NCT00687297|42088736|FG000|Induction|Patient Noncompliance|1|||
19639363|NCT00687297|42088737|FG001|Induction|Patient Noncompliance|0|||
19639364|NCT00687297|42088736|FG000|Induction|Physician Decision|0|||
19599496|NCT00802360|42048323|FG003|Overall Study|No positive serum pregnancy|10|||
19639365|NCT00687297|42088737|FG001|Induction|Physician Decision|2|||
19639366|NCT00687297|42088736|FG000|Induction|Other|0|||
19639367|NCT00687297|42088737|FG001|Induction|Other|1|||
19639368|NCT00684177|42088747|FG000|Overall Study|Adverse Event|4|||
19639369|NCT00684177|42088748|FG001|Overall Study|Adverse Event|3|||
19639370|NCT00684177|42088747|FG000|Overall Study|Lack of Efficacy|10|||
19639371|NCT00684177|42088748|FG001|Overall Study|Lack of Efficacy|15|||
19639372|NCT00684177|42088747|FG000|Overall Study|Protocol Violation|1|||
19639373|NCT00684177|42088748|FG001|Overall Study|Protocol Violation|0|||
19639374|NCT00684177|42088747|FG000|Overall Study|Lost to Follow-up|2|||
19639375|NCT00684177|42088748|FG001|Overall Study|Lost to Follow-up|1|||
19639376|NCT00684177|42088747|FG000|Overall Study|Physician Decision|2|||
19639377|NCT00684177|42088748|FG001|Overall Study|Physician Decision|0|||
19639378|NCT00684177|42088747|FG000|Overall Study|Withdrawal by Subject|1|||
19639379|NCT00684177|42088748|FG001|Overall Study|Withdrawal by Subject|2|||
19599497|NCT00802360|42048320|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
19599498|NCT00802360|42048321|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
19639380|NCT00684177|42088747|FG000|Overall Study|Other|1|||
19639381|NCT00684177|42088748|FG001|Overall Study|Other|2|||
19639382|NCT00684021|42088758|FG000|Overall Study|MRI Contraindicated|1|||
19639383|NCT00684021|42088759|FG001|Overall Study|MRI Contraindicated|1|||
19599499|NCT00802360|42048322|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
19639384|NCT00684021|42088760|FG002|Overall Study|MRI Contraindicated|1|||
19639385|NCT00684021|42088761|FG003|Overall Study|MRI Contraindicated|0|||
19639386|NCT00684021|42088758|FG000|Overall Study|MRI not performed|0|||
19639387|NCT00684021|42088759|FG001|Overall Study|MRI not performed|1|||
19639388|NCT00684021|42088760|FG002|Overall Study|MRI not performed|1|||
19639389|NCT00684021|42088761|FG003|Overall Study|MRI not performed|2|||
19639390|NCT00684021|42088758|FG000|Overall Study|Death|1|||
19639391|NCT00684021|42088759|FG001|Overall Study|Death|0|||
19639392|NCT00684021|42088760|FG002|Overall Study|Death|0|||
19639393|NCT00684021|42088761|FG003|Overall Study|Death|0|||
19639394|NCT00686595|42088771|FG000|Overall Study|Adverse Event|3|||
19639395|NCT00686595|42088771|FG000|Overall Study|Protocol Violation|1|||
19639396|NCT00686595|42088771|FG000|Overall Study|Lost to Follow-up|1|||
19639397|NCT00686595|42088771|FG000|Overall Study|Lack of Efficacy|1|||
19639398|NCT00686595|42088771|FG000|Overall Study|Poor Compliance|1|||
19639399|NCT00576303|42088775|FG000|Dose Titration Period|Early withdrawal|17|||
19639400|NCT00576303|42088775|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
19639401|NCT00576303|42088775|FG000|Long Term Safety Period|Early withdrawal|16|||
19639402|NCT00686517|42088782|FG000|Treatment|Serious Adverse Event|1|||
19639403|NCT00686517|42088783|FG001|Treatment|Serious Adverse Event|2|||
19639404|NCT00686517|42088784|FG002|Treatment|Serious Adverse Event|1|||
19639405|NCT00686517|42088782|FG000|Treatment|Adverse Event|2|||
19639406|NCT00686517|42088783|FG001|Treatment|Adverse Event|0|||
19639407|NCT00686517|42088784|FG002|Treatment|Adverse Event|0|||
19639408|NCT00686517|42088782|FG000|Treatment|Poor Protocol Compliance|1|||
19639409|NCT00686517|42088783|FG001|Treatment|Poor Protocol Compliance|0|||
19639410|NCT00686517|42088784|FG002|Treatment|Poor Protocol Compliance|0|||
19639411|NCT00686517|42088782|FG000|Treatment|Protocol Violation|2|||
19639412|NCT00686517|42088783|FG001|Treatment|Protocol Violation|1|||
19639413|NCT00686517|42088784|FG002|Treatment|Protocol Violation|0|||
19639414|NCT00686205|42088794|FG000|Overall Study|Protocol Violation|127|||
19639415|NCT00686205|42088795|FG001|Overall Study|Protocol Violation|0|||
19639416|NCT00686205|42088794|FG000|Overall Study|Withdrawal by Subject|2|||
19639417|NCT00686205|42088795|FG001|Overall Study|Withdrawal by Subject|0|||
19639418|NCT00686205|42088794|FG000|Overall Study|Specimen handling procedure altered|5878|||
19639419|NCT00686205|42088795|FG001|Overall Study|Specimen handling procedure altered|0|||
19599500|NCT00802360|42048323|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
19599501|NCT00802360|42048320|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
19599502|NCT00802360|42048321|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
19599503|NCT00802360|42048322|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
19639420|NCT00686205|42088794|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
19639421|NCT00686205|42088795|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
19639422|NCT00571701|42088803|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
19639423|NCT00571701|42088804|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
19599504|NCT00802360|42048323|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
19599505|NCT00802360|42048320|FG000|Overall Study|Other|2|||
19639424|NCT00571701|42088803|FG000|First Intervention 12 Months|Death|1|||
19639425|NCT00571701|42088804|FG001|First Intervention 12 Months|Death|0|||
19639426|NCT00571701|42088803|FG000|Second Intervention 12 Months|Adverse Event|0|||
19639427|NCT00571701|42088804|FG001|Second Intervention 12 Months|Adverse Event|1|||
19639428|NCT00571701|42088803|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
19639429|NCT00571701|42088804|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
19639430|NCT00686127|42088830|FG000|Overall Study|Withdrawal by Subject|14|||
19639431|NCT00686127|42088831|FG001|Overall Study|Withdrawal by Subject|6|||
19639432|NCT00718718|42088844|FG000|Prior to Week 12|Adverse Event|0|||
19639433|NCT00718718|42088845|FG001|Prior to Week 12|Adverse Event|0|||
19639434|NCT00718718|42088846|FG002|Prior to Week 12|Adverse Event|0|||
19639435|NCT00718718|42088847|FG003|Prior to Week 12|Adverse Event|0|||
19639436|NCT00718718|42088848|FG004|Prior to Week 12|Adverse Event|0|||
19639437|NCT00718718|42088849|FG005|Prior to Week 12|Adverse Event|0|||
19639438|NCT00718718|42088850|FG006|Prior to Week 12|Adverse Event|0|||
19639439|NCT00718718|42088851|FG007|Prior to Week 12|Adverse Event|1|||
19639440|NCT00718718|42088852|FG008|Prior to Week 12|Adverse Event|1|||
19639441|NCT00718718|42088853|FG009|Prior to Week 12|Adverse Event|0|||
19639442|NCT00718718|42088844|FG000|Prior to Week 12|Withdrawal by Subject|0|||
19639443|NCT00718718|42088845|FG001|Prior to Week 12|Withdrawal by Subject|0|||
19639444|NCT00718718|42088846|FG002|Prior to Week 12|Withdrawal by Subject|0|||
19639445|NCT00718718|42088847|FG003|Prior to Week 12|Withdrawal by Subject|0|||
19639446|NCT00718718|42088848|FG004|Prior to Week 12|Withdrawal by Subject|3|||
19639447|NCT00718718|42088849|FG005|Prior to Week 12|Withdrawal by Subject|0|||
19639448|NCT00718718|42088850|FG006|Prior to Week 12|Withdrawal by Subject|1|||
19639449|NCT00718718|42088851|FG007|Prior to Week 12|Withdrawal by Subject|1|||
19639450|NCT00718718|42088852|FG008|Prior to Week 12|Withdrawal by Subject|1|||
19639451|NCT00718718|42088853|FG009|Prior to Week 12|Withdrawal by Subject|0|||
19639452|NCT00718718|42088844|FG000|Prior to Week 12|Other|1|||
19639453|NCT00718718|42088845|FG001|Prior to Week 12|Other|0|||
19639454|NCT00718718|42088846|FG002|Prior to Week 12|Other|1|||
19639455|NCT00718718|42088847|FG003|Prior to Week 12|Other|0|||
19639456|NCT00718718|42088848|FG004|Prior to Week 12|Other|0|||
19639457|NCT00718718|42088849|FG005|Prior to Week 12|Other|0|||
19639458|NCT00718718|42088850|FG006|Prior to Week 12|Other|0|||
19639459|NCT00718718|42088851|FG007|Prior to Week 12|Other|0|||
19639460|NCT00718718|42088852|FG008|Prior to Week 12|Other|0|||
19639461|NCT00718718|42088853|FG009|Prior to Week 12|Other|0|||
19639462|NCT00718718|42088844|FG000|Week 12 to End of Study|Adverse Event|0|||
19639463|NCT00718718|42088845|FG001|Week 12 to End of Study|Adverse Event|0|||
19639464|NCT00718718|42088846|FG002|Week 12 to End of Study|Adverse Event|0|||
19639465|NCT00718718|42088847|FG003|Week 12 to End of Study|Adverse Event|0|||
19639466|NCT00718718|42088848|FG004|Week 12 to End of Study|Adverse Event|0|||
19639467|NCT00718718|42088849|FG005|Week 12 to End of Study|Adverse Event|0|||
19639468|NCT00718718|42088850|FG006|Week 12 to End of Study|Adverse Event|0|||
19639469|NCT00718718|42088851|FG007|Week 12 to End of Study|Adverse Event|1|||
19639470|NCT00718718|42088852|FG008|Week 12 to End of Study|Adverse Event|0|||
19639471|NCT00718718|42088853|FG009|Week 12 to End of Study|Adverse Event|0|||
19639472|NCT00718718|42088844|FG000|Week 12 to End of Study|Death|0|||
19639473|NCT00718718|42088845|FG001|Week 12 to End of Study|Death|0|||
19639474|NCT00718718|42088846|FG002|Week 12 to End of Study|Death|0|||
19639475|NCT00718718|42088847|FG003|Week 12 to End of Study|Death|0|||
19639476|NCT00718718|42088848|FG004|Week 12 to End of Study|Death|0|||
19639477|NCT00718718|42088849|FG005|Week 12 to End of Study|Death|1|||
19639478|NCT00718718|42088850|FG006|Week 12 to End of Study|Death|0|||
19639479|NCT00718718|42088851|FG007|Week 12 to End of Study|Death|0|||
19639480|NCT00718718|42088852|FG008|Week 12 to End of Study|Death|0|||
19639481|NCT00718718|42088853|FG009|Week 12 to End of Study|Death|0|||
19639482|NCT00718718|42088844|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
19639483|NCT00718718|42088845|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
19639484|NCT00718718|42088846|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
19639485|NCT00718718|42088847|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
19639486|NCT00718718|42088848|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
19639487|NCT00718718|42088849|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
19639488|NCT00718718|42088850|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
19388106|NCT02700815|41631482|FG003|Overall Study|Withdrawal by Subject|0|||
19599506|NCT00802360|42048321|FG001|Overall Study|Other|3|||
19599507|NCT00802360|42048322|FG002|Overall Study|Other|6|||
19599508|NCT00802360|42048323|FG003|Overall Study|Other|3|||
19599509|NCT01026038|42048338|FG000|Overall Study|Lost to Follow-up|1|||
19599510|NCT01026038|42048339|FG001|Overall Study|Lost to Follow-up|1|||
19599511|NCT01026038|42048340|FG002|Overall Study|Lost to Follow-up|0|||
19599512|NCT00801892|42048359|FG000|Main Study Period|Withdrawal by Subject|0|||
19599513|NCT00801892|42048360|FG001|Main Study Period|Withdrawal by Subject|1|||
19639489|NCT00718718|42088851|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
19639490|NCT00718718|42088852|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
19747860|NCT03371355|42195406|FG000|Overall Study|Adverse Event|0|||
19639491|NCT00718718|42088853|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
19599514|NCT00801892|42048359|FG000|Sham Crossover Period|Lost to Follow-up|0|||
19599515|NCT00801892|42048360|FG001|Sham Crossover Period|Lost to Follow-up|2|||
19599516|NCT02680587|42048374|FG000|Overall Study|Withdrawal by Subject|1|||
19639492|NCT00718718|42088844|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
19639493|NCT00718718|42088845|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
19639494|NCT00718718|42088846|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
19639495|NCT00718718|42088847|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
19599517|NCT02680587|42048375|FG001|Overall Study|Withdrawal by Subject|0|||
19639496|NCT00718718|42088848|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
19639497|NCT00718718|42088849|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
19639498|NCT00718718|42088850|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
19639499|NCT00718718|42088851|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
19639500|NCT00718718|42088852|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
19639501|NCT00718718|42088853|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
19639502|NCT00718718|42088844|FG000|Week 12 to End of Study|Other|0|||
19639503|NCT00718718|42088845|FG001|Week 12 to End of Study|Other|1|||
19639504|NCT00718718|42088846|FG002|Week 12 to End of Study|Other|0|||
19639505|NCT00718718|42088847|FG003|Week 12 to End of Study|Other|1|||
19599518|NCT00589420|42048385|FG000|Overall Study|screen failure|1|||
19599519|NCT01025336|42048394|FG000|Overall Study|Protocol Violation|0|||
19599520|NCT01025336|42048395|FG001|Overall Study|Protocol Violation|0|||
19599521|NCT01025336|42048396|FG002|Overall Study|Protocol Violation|0|||
19599522|NCT01025336|42048397|FG003|Overall Study|Protocol Violation|2|||
19599523|NCT01025336|42048398|FG004|Overall Study|Protocol Violation|0|||
19599524|NCT00796978|42048432|FG000|Overall Study|Cardiac adverse event|5|||
19599525|NCT00796978|42048432|FG000|Overall Study|Adverse Event|4|||
19599526|NCT00796978|42048432|FG000|Overall Study|Withdrawal by Subject|3|||
19639506|NCT00718718|42088848|FG004|Week 12 to End of Study|Other|0|||
19639507|NCT00718718|42088849|FG005|Week 12 to End of Study|Other|0|||
19639508|NCT00718718|42088850|FG006|Week 12 to End of Study|Other|1|||
19639509|NCT00718718|42088851|FG007|Week 12 to End of Study|Other|0|||
19639510|NCT00718718|42088852|FG008|Week 12 to End of Study|Other|0|||
19639511|NCT00718718|42088853|FG009|Week 12 to End of Study|Other|0|||
19639512|NCT00683787|42088882|FG000|Overall Study|Progression|3|||
19639513|NCT00683787|42088883|FG001|Overall Study|Progression|3|||
19639514|NCT00683787|42088884|FG002|Overall Study|Progression|0|||
19639515|NCT00683787|42088882|FG000|Overall Study|Adverse Event|0|||
19639516|NCT00683787|42088883|FG001|Overall Study|Adverse Event|0|||
19639517|NCT00683787|42088884|FG002|Overall Study|Adverse Event|2|||
19639518|NCT00723008|42088894|FG000|Enrollment|Lost to Follow-up|1|||
19639519|NCT00723008|42088895|FG001|Enrollment|Lost to Follow-up|0|||
19639520|NCT00723008|42088894|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
19639521|NCT00723008|42088895|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
19639522|NCT00723008|42088894|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
19747861|NCT03371355|42195407|FG001|Overall Study|Adverse Event|1|||
19747862|NCT03371355|42195408|FG002|Overall Study|Adverse Event|2|||
19747863|NCT03371355|42195409|FG003|Overall Study|Adverse Event|3|||
19747864|NCT03371355|42195406|FG000|Overall Study|Reason not Specified|0|||
19747865|NCT03371355|42195407|FG001|Overall Study|Reason not Specified|1|||
19747866|NCT03371355|42195408|FG002|Overall Study|Reason not Specified|0|||
19747867|NCT03371355|42195409|FG003|Overall Study|Reason not Specified|1|||
19747868|NCT03370419|42195423|FG000|Overall Study|Lost to Follow-up|16|||
19747869|NCT03369951|42195431|FG000|Overall Study|Withdrawal by Subject|3|||
19747870|NCT03369951|42195431|FG000|Overall Study|Death|1|||
19747871|NCT03369951|42195431|FG000|Overall Study|Lost to Follow-up|1|||
19747872|NCT03369951|42195431|FG000|Overall Study|Protocol Violation|1|||
19747873|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
19747874|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
19747875|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
19747876|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
19747877|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
19747878|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
19747879|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
19747880|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
19747881|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
19747882|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
19747883|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
19747884|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
19747885|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
19747886|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
19599527|NCT00796822|42048438|FG000|Overall Study|Lost to Follow-up|2|||
19639523|NCT00723008|42088895|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
19639524|NCT00723008|42088894|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
19639525|NCT00723008|42088895|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
19639526|NCT00723008|42088894|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
19639527|NCT00723008|42088895|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
19639528|NCT00723008|42088894|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
19639529|NCT00723008|42088895|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
19747887|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
19747888|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
19747889|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
19747890|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
19747891|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
19747892|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
19747893|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
19747894|NCT04040192|42195435|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
19747895|NCT04040192|42195436|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
19747896|NCT04040192|42195437|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
19747897|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
19747898|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
19747899|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
19747900|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
19747901|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
19747902|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
19747903|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
19639530|NCT00718640|42088909|FG000|Overall Study|Adverse Event|4|||
19639531|NCT00718640|42088909|FG000|Overall Study|Death|1|||
19747904|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
19747905|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
19747906|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
19747907|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
19747908|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
19747909|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
19747910|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
19747911|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
19747912|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
19747913|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
19747914|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
19747915|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
19747916|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
19747917|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
19747918|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
19747919|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
19639532|NCT00718640|42088909|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
19639533|NCT00715910|42088917|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
19639534|NCT00715910|42088918|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
19639535|NCT00715910|42088919|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
19639536|NCT00715910|42088920|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
19639537|NCT00715910|42088921|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
19639538|NCT00715910|42088922|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
19639539|NCT00715910|42088917|FG000|Booster and ESFU Phase|Other|0|||
19639540|NCT00715910|42088918|FG001|Booster and ESFU Phase|Other|0|||
19639541|NCT00715910|42088919|FG002|Booster and ESFU Phase|Other|0|||
19639542|NCT00715910|42088920|FG003|Booster and ESFU Phase|Other|5|||
19639543|NCT00715910|42088921|FG004|Booster and ESFU Phase|Other|1|||
19639544|NCT00715910|42088922|FG005|Booster and ESFU Phase|Other|0|||
19639545|NCT00715676|42088941|FG000|Overall Study|Adverse Event|3|||
19639546|NCT00715676|42088942|FG001|Overall Study|Adverse Event|5|||
19639547|NCT00715676|42088943|FG002|Overall Study|Adverse Event|21|||
19639548|NCT00715676|42088941|FG000|Overall Study|Withdrawal by Subject|1|||
19599528|NCT00796822|42048439|FG001|Overall Study|Lost to Follow-up|0|||
19599529|NCT00796822|42048438|FG000|Overall Study|Adverse Event|1|||
19599530|NCT00796822|42048439|FG001|Overall Study|Adverse Event|0|||
19599531|NCT01020812|42048445|FG000|Overall Study|Physician Decision|1|||
19599532|NCT01020812|42048445|FG000|Overall Study|Withdrawal by Subject|1|||
19599533|NCT01020812|42048445|FG000|Overall Study|Protocol Violation|1|||
19599534|NCT01032044|42048451|FG000|Overall Study|Protocol Violation|14|||
19599535|NCT01032044|42048452|FG001|Overall Study|Protocol Violation|8|||
19599536|NCT01032044|42048451|FG000|Overall Study|Adverse Event|0|||
19599537|NCT01032044|42048452|FG001|Overall Study|Adverse Event|1|||
19599538|NCT01032044|42048451|FG000|Overall Study|Lost to Follow-up|11|||
19599539|NCT01032044|42048452|FG001|Overall Study|Lost to Follow-up|11|||
19639549|NCT00715676|42088942|FG001|Overall Study|Withdrawal by Subject|3|||
19639550|NCT00715676|42088943|FG002|Overall Study|Withdrawal by Subject|8|||
19599540|NCT01024946|42048458|FG000|Overall Study|Screen Failure|3|||
19599541|NCT01024946|42048458|FG000|Overall Study|Withdrawal by Subject|1|||
19599542|NCT01024946|42048458|FG000|Overall Study|Adverse Event|1|||
19639551|NCT00715676|42088941|FG000|Overall Study|Lost to Follow-up|1|||
19599543|NCT00724867|42048462|FG000|Overall Study|Adverse Event|25|||
19599544|NCT00724867|42048462|FG000|Overall Study|Lack of Efficacy|14|||
19599545|NCT00724867|42048462|FG000|Overall Study|Lost to Follow-up|12|||
19599546|NCT00724867|42048462|FG000|Overall Study|Non-compliance with study drug|6|||
19599547|NCT00724867|42048462|FG000|Overall Study|Physician Decision|17|||
19599548|NCT00724867|42048462|FG000|Overall Study|Protocol Violation|1|||
19639552|NCT00715676|42088942|FG001|Overall Study|Lost to Follow-up|2|||
19639553|NCT00715676|42088943|FG002|Overall Study|Lost to Follow-up|1|||
19639554|NCT00715676|42088941|FG000|Overall Study|Terminated by Sponsor|1|||
19639555|NCT00715676|42088942|FG001|Overall Study|Terminated by Sponsor|0|||
19639556|NCT00715676|42088943|FG002|Overall Study|Terminated by Sponsor|0|||
19639557|NCT00715676|42088941|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
19639558|NCT00715676|42088942|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
19639559|NCT00715676|42088943|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
19599549|NCT00724867|42048462|FG000|Overall Study|Withdrawal by Subject|31|||
19599550|NCT00724867|42048462|FG000|Overall Study|Sponsor decision to end study|14|||
19599551|NCT00724867|42048462|FG000|Overall Study|Subject incarcerated|1|||
19599552|NCT00724867|42048462|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
19599553|NCT00724867|42048462|FG000|Overall Study|Subject moved out of state|1|||
19599554|NCT00724867|42048462|FG000|Overall Study|Elected to exit due to site closure|2|||
19639560|NCT00715676|42088941|FG000|Overall Study|Use of Exclusionary Medication|0|||
19639561|NCT00715676|42088942|FG001|Overall Study|Use of Exclusionary Medication|0|||
19599555|NCT00724711|42048471|FG000|Overall Study|Adverse Event|7|||
19599556|NCT00724711|42048472|FG001|Overall Study|Adverse Event|3|||
19599557|NCT00724711|42048471|FG000|Overall Study|Pregnancy|0|||
19599558|NCT00724711|42048472|FG001|Overall Study|Pregnancy|1|||
19599559|NCT00724711|42048471|FG000|Overall Study|Lack of Efficacy|0|||
19599560|NCT00724711|42048472|FG001|Overall Study|Lack of Efficacy|1|||
19639562|NCT00715676|42088943|FG002|Overall Study|Use of Exclusionary Medication|1|||
19639563|NCT00715676|42088941|FG000|Overall Study|Elevated Blood Glucose|0|||
19639564|NCT00715676|42088942|FG001|Overall Study|Elevated Blood Glucose|1|||
19639565|NCT00715676|42088943|FG002|Overall Study|Elevated Blood Glucose|0|||
19639566|NCT00718328|42088953|FG000|Overall Study|Lost to Follow-up|1|||
19639567|NCT00718328|42088954|FG001|Overall Study|Lost to Follow-up|0|||
19639568|NCT00715520|42088963|FG000|Overall Study|Screen failure|8|||
19639569|NCT00715520|42088964|FG001|Overall Study|Screen failure|1|||
19639570|NCT00715520|42088965|FG002|Overall Study|Screen failure|1|||
19639571|NCT00715520|42088963|FG000|Overall Study|Withdrawal by Subject|2|||
19639572|NCT00715520|42088964|FG001|Overall Study|Withdrawal by Subject|0|||
19639573|NCT00715520|42088965|FG002|Overall Study|Withdrawal by Subject|1|||
19639574|NCT00680901|42088975|FG000|Overall Study|Lost to Follow-up|8|||
19639575|NCT00680901|42088976|FG001|Overall Study|Lost to Follow-up|8|||
19599561|NCT00724711|42048471|FG000|Overall Study|Physician Decision|0|||
19599562|NCT00724711|42048472|FG001|Overall Study|Physician Decision|3|||
19599563|NCT00724711|42048471|FG000|Overall Study|Withdrawal by Subject|5|||
19599564|NCT00724711|42048472|FG001|Overall Study|Withdrawal by Subject|4|||
19639576|NCT00680901|42088975|FG000|Overall Study|Withdrawal by Subject|4|||
19639577|NCT00680901|42088976|FG001|Overall Study|Withdrawal by Subject|13|||
19639578|NCT00680901|42088975|FG000|Overall Study|Physician Decision|0|||
19639579|NCT00680901|42088976|FG001|Overall Study|Physician Decision|1|||
19639580|NCT00680901|42088975|FG000|Overall Study|Ongoing: On Study Treatment|16|||
19639581|NCT00680901|42088976|FG001|Overall Study|Ongoing: On Study Treatment|13|||
19639582|NCT00680901|42088975|FG000|Overall Study|Ongoing: In Follow Up|45|||
19639583|NCT00680901|42088976|FG001|Overall Study|Ongoing: In Follow Up|41|||
19639584|NCT00790205|42088984|FG000|Overall Study|Lost to Follow-up|61|||
19639585|NCT00790205|42088985|FG001|Overall Study|Lost to Follow-up|71|||
19639586|NCT00790205|42088984|FG000|Overall Study|Withdrawal by Subject|299|||
19639587|NCT00790205|42088985|FG001|Overall Study|Withdrawal by Subject|363|||
19639588|NCT00715208|42088993|FG000|Overall Study|Withdrawal by Subject|1|||
19639589|NCT00715208|42088994|FG001|Overall Study|Withdrawal by Subject|1|||
19639590|NCT00715208|42088993|FG000|Overall Study|Adverse Event|0|||
19639591|NCT00715208|42088994|FG001|Overall Study|Adverse Event|6|||
19639592|NCT00715208|42088993|FG000|Overall Study|Lack of Efficacy|0|||
19639593|NCT00715208|42088994|FG001|Overall Study|Lack of Efficacy|2|||
19639594|NCT00775463|42089002|FG000|Overall Study|Withdrawal by Subject|0|||
19639595|NCT00775463|42089003|FG001|Overall Study|Withdrawal by Subject|1|||
19599565|NCT00724711|42048471|FG000|Overall Study|Lost to Follow-up|4|||
19599566|NCT00724711|42048472|FG001|Overall Study|Lost to Follow-up|5|||
19599567|NCT00724711|42048471|FG000|Overall Study|Protocol Violation|1|||
19639596|NCT00775463|42089002|FG000|Overall Study|Adverse Event|7|||
19639597|NCT00775463|42089003|FG001|Overall Study|Adverse Event|9|||
19639598|NCT00775463|42089002|FG000|Overall Study|Protocol Violation|2|||
19639599|NCT00775463|42089003|FG001|Overall Study|Protocol Violation|2|||
19639600|NCT00775463|42089002|FG000|Overall Study|Lost to Follow-up|1|||
19639601|NCT00775463|42089003|FG001|Overall Study|Lost to Follow-up|0|||
19639602|NCT00775463|42089002|FG000|Overall Study|Lack of Efficacy|1|||
19599568|NCT00724711|42048472|FG001|Overall Study|Protocol Violation|0|||
19639603|NCT00775463|42089003|FG001|Overall Study|Lack of Efficacy|1|||
19639604|NCT00587795|42089018|FG000|Overall Study|Withdrawal by Subject|1|||
19639605|NCT00587795|42089019|FG001|Overall Study|Withdrawal by Subject|0|||
19639606|NCT00587639|42089025|FG000|Overall Study|Withdrawal by Subject|1|||
19639607|NCT00774995|42089033|FG000|Overall Study|Protocol Violation|0|||
19639608|NCT00774995|42089034|FG001|Overall Study|Protocol Violation|0|||
19639609|NCT00774995|42089035|FG002|Overall Study|Protocol Violation|1|||
19639610|NCT00774995|42089036|FG003|Overall Study|Protocol Violation|0|||
19639611|NCT00713648|42089046|FG000|Overall Study|Adverse Event|1|||
19639612|NCT00713648|42089046|FG000|Overall Study|Unclassified|2|||
19639613|NCT00713648|42089046|FG000|Overall Study|According to Protocol|2|||
19639614|NCT00713648|42089046|FG000|Overall Study|Development of antibodies|3|||
19639615|NCT00768053|42089050|FG000|Overall Study|Adverse Event|10|||
19639616|NCT00768053|42089050|FG000|Overall Study|Lost to Follow-up|1|||
19639617|NCT00683475|42089056|FG000|Overall Study|Withdrawal by Subject|1|||
19639618|NCT00683475|42089057|FG001|Overall Study|Withdrawal by Subject|0|||
19639619|NCT00683475|42089056|FG000|Overall Study|Never Treated: Adverse Event|2|||
19639620|NCT00683475|42089057|FG001|Overall Study|Never Treated: Adverse Event|3|||
19639621|NCT00683475|42089056|FG000|Overall Study|Never Treated: Progressive Disease|1|||
19639622|NCT00683475|42089057|FG001|Overall Study|Never Treated: Progressive Disease|0|||
19639623|NCT00685035|42089064|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
19639624|NCT00685035|42089065|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
19639625|NCT00773747|42089091|FG000|Overall Study|Lack of Efficacy|112|||
19639626|NCT00773747|42089092|FG001|Overall Study|Lack of Efficacy|144|||
19639627|NCT00773747|42089091|FG000|Overall Study|Physician Decision|26|||
19639628|NCT00773747|42089092|FG001|Overall Study|Physician Decision|18|||
19639629|NCT00773747|42089091|FG000|Overall Study|Lost to Follow-up|0|||
19639630|NCT00773747|42089092|FG001|Overall Study|Lost to Follow-up|1|||
19639631|NCT00773747|42089091|FG000|Overall Study|Protocol Violation|2|||
19639632|NCT00773747|42089092|FG001|Overall Study|Protocol Violation|2|||
19639633|NCT00773747|42089091|FG000|Overall Study|Withdrawal by Subject|89|||
19639634|NCT00773747|42089092|FG001|Overall Study|Withdrawal by Subject|61|||
19639635|NCT00773747|42089091|FG000|Overall Study|Adverse Event|61|||
19639636|NCT00773747|42089092|FG001|Overall Study|Adverse Event|62|||
19639637|NCT00773747|42089091|FG000|Overall Study|Death|5|||
19639638|NCT00773747|42089092|FG001|Overall Study|Death|8|||
19639639|NCT00773747|42089091|FG000|Overall Study|Not Treated|2|||
19639640|NCT00773747|42089092|FG001|Overall Study|Not Treated|0|||
19639641|NCT00784277|42089102|FG000|IR Treatment|Adverse Event|4|||
19639642|NCT00784277|42089103|FG001|IR Treatment|Adverse Event|8|||
19639643|NCT00784277|42089104|FG002|IR Treatment|Adverse Event|19|||
19639644|NCT00784277|42089105|FG003|IR Treatment|Adverse Event|35|||
19639645|NCT00784277|42089106|FG004|IR Treatment|Adverse Event|0|||
19639646|NCT00784277|42089107|FG005|IR Treatment|Adverse Event|0|||
19639647|NCT00784277|42089108|FG006|IR Treatment|Adverse Event|0|||
19639648|NCT00784277|42089102|FG000|IR Treatment|Lack of Efficacy|4|||
19639649|NCT00784277|42089103|FG001|IR Treatment|Lack of Efficacy|4|||
19639650|NCT00784277|42089104|FG002|IR Treatment|Lack of Efficacy|1|||
19639651|NCT00784277|42089105|FG003|IR Treatment|Lack of Efficacy|0|||
19639652|NCT00784277|42089106|FG004|IR Treatment|Lack of Efficacy|0|||
19639653|NCT00784277|42089107|FG005|IR Treatment|Lack of Efficacy|0|||
19639654|NCT00784277|42089108|FG006|IR Treatment|Lack of Efficacy|0|||
19639655|NCT00784277|42089102|FG000|IR Treatment|Lost to Follow-up|1|||
19639656|NCT00784277|42089103|FG001|IR Treatment|Lost to Follow-up|0|||
19639657|NCT00784277|42089104|FG002|IR Treatment|Lost to Follow-up|1|||
19639658|NCT00784277|42089105|FG003|IR Treatment|Lost to Follow-up|0|||
19639659|NCT00784277|42089106|FG004|IR Treatment|Lost to Follow-up|0|||
19639660|NCT00784277|42089107|FG005|IR Treatment|Lost to Follow-up|0|||
19639661|NCT00784277|42089108|FG006|IR Treatment|Lost to Follow-up|0|||
19639662|NCT00784277|42089102|FG000|IR Treatment|Withdrawal by Subject|5|||
19639663|NCT00784277|42089103|FG001|IR Treatment|Withdrawal by Subject|1|||
19639664|NCT00784277|42089104|FG002|IR Treatment|Withdrawal by Subject|4|||
19639665|NCT00784277|42089105|FG003|IR Treatment|Withdrawal by Subject|6|||
19639666|NCT00784277|42089106|FG004|IR Treatment|Withdrawal by Subject|0|||
19639667|NCT00784277|42089107|FG005|IR Treatment|Withdrawal by Subject|0|||
19639668|NCT00784277|42089108|FG006|IR Treatment|Withdrawal by Subject|0|||
19639669|NCT00784277|42089102|FG000|IR Treatment|Resolution Of Pain|0|||
19639670|NCT00784277|42089103|FG001|IR Treatment|Resolution Of Pain|1|||
19639671|NCT00784277|42089104|FG002|IR Treatment|Resolution Of Pain|0|||
19639672|NCT00784277|42089105|FG003|IR Treatment|Resolution Of Pain|0|||
19639673|NCT00784277|42089106|FG004|IR Treatment|Resolution Of Pain|0|||
19639674|NCT00784277|42089107|FG005|IR Treatment|Resolution Of Pain|0|||
19639675|NCT00784277|42089108|FG006|IR Treatment|Resolution Of Pain|0|||
19639676|NCT00784277|42089102|FG000|IR Treatment|Other|2|||
19639677|NCT00784277|42089103|FG001|IR Treatment|Other|3|||
19639678|NCT00784277|42089104|FG002|IR Treatment|Other|3|||
19639679|NCT00784277|42089105|FG003|IR Treatment|Other|2|||
19639680|NCT00784277|42089106|FG004|IR Treatment|Other|0|||
19639681|NCT00784277|42089107|FG005|IR Treatment|Other|0|||
19639682|NCT00784277|42089108|FG006|IR Treatment|Other|0|||
19639683|NCT00784277|42089102|FG000|ER Treatment|Adverse Event|0|||
19639684|NCT00784277|42089103|FG001|ER Treatment|Adverse Event|0|||
19639685|NCT00784277|42089104|FG002|ER Treatment|Adverse Event|0|||
19639686|NCT00784277|42089105|FG003|ER Treatment|Adverse Event|0|||
19639687|NCT00784277|42089106|FG004|ER Treatment|Adverse Event|1|||
19639688|NCT00784277|42089107|FG005|ER Treatment|Adverse Event|7|||
19639689|NCT00784277|42089108|FG006|ER Treatment|Adverse Event|7|||
19639690|NCT00784277|42089102|FG000|ER Treatment|Lack of Efficacy|0|||
19639691|NCT00784277|42089103|FG001|ER Treatment|Lack of Efficacy|0|||
19639692|NCT00784277|42089104|FG002|ER Treatment|Lack of Efficacy|0|||
19639693|NCT00784277|42089105|FG003|ER Treatment|Lack of Efficacy|0|||
19639694|NCT00784277|42089106|FG004|ER Treatment|Lack of Efficacy|3|||
19639695|NCT00784277|42089107|FG005|ER Treatment|Lack of Efficacy|4|||
19639696|NCT00784277|42089108|FG006|ER Treatment|Lack of Efficacy|0|||
19639697|NCT00784277|42089102|FG000|ER Treatment|Lost to Follow-up|0|||
19639698|NCT00784277|42089103|FG001|ER Treatment|Lost to Follow-up|0|||
19639699|NCT00784277|42089104|FG002|ER Treatment|Lost to Follow-up|0|||
19639700|NCT00784277|42089105|FG003|ER Treatment|Lost to Follow-up|0|||
19639701|NCT00784277|42089106|FG004|ER Treatment|Lost to Follow-up|0|||
19639702|NCT00784277|42089107|FG005|ER Treatment|Lost to Follow-up|2|||
19639703|NCT00784277|42089108|FG006|ER Treatment|Lost to Follow-up|0|||
19639704|NCT00784277|42089102|FG000|ER Treatment|Withdrawal by Subject|0|||
19639705|NCT00784277|42089103|FG001|ER Treatment|Withdrawal by Subject|0|||
19639706|NCT00784277|42089104|FG002|ER Treatment|Withdrawal by Subject|0|||
19639707|NCT00784277|42089105|FG003|ER Treatment|Withdrawal by Subject|0|||
19747920|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
19599569|NCT01024244|42048483|FG000|Overall Study|Adverse Event|1|||
19599570|NCT01024244|42048484|FG001|Overall Study|Adverse Event|2|||
19599571|NCT01024244|42048485|FG002|Overall Study|Adverse Event|0|||
19599572|NCT01024244|42048486|FG003|Overall Study|Adverse Event|1|||
19599573|NCT01024244|42048487|FG004|Overall Study|Adverse Event|2|||
19599574|NCT01024244|42048483|FG000|Overall Study|Entry Criteria Not Met|0|||
19599575|NCT01024244|42048484|FG001|Overall Study|Entry Criteria Not Met|1|||
19599576|NCT01024244|42048485|FG002|Overall Study|Entry Criteria Not Met|0|||
19599577|NCT01024244|42048486|FG003|Overall Study|Entry Criteria Not Met|0|||
19639708|NCT00784277|42089106|FG004|ER Treatment|Withdrawal by Subject|2|||
19639709|NCT00784277|42089107|FG005|ER Treatment|Withdrawal by Subject|5|||
19639710|NCT00784277|42089108|FG006|ER Treatment|Withdrawal by Subject|3|||
19639711|NCT00784277|42089102|FG000|ER Treatment|Study Medication Non-Compliant|0|||
19639712|NCT00784277|42089103|FG001|ER Treatment|Study Medication Non-Compliant|0|||
19639713|NCT00784277|42089104|FG002|ER Treatment|Study Medication Non-Compliant|0|||
19639714|NCT00784277|42089105|FG003|ER Treatment|Study Medication Non-Compliant|0|||
19639715|NCT00784277|42089106|FG004|ER Treatment|Study Medication Non-Compliant|2|||
19639716|NCT00784277|42089107|FG005|ER Treatment|Study Medication Non-Compliant|3|||
19639717|NCT00784277|42089108|FG006|ER Treatment|Study Medication Non-Compliant|3|||
19639718|NCT00784277|42089102|FG000|ER Treatment|Other|0|||
19639719|NCT00784277|42089103|FG001|ER Treatment|Other|0|||
19639720|NCT00784277|42089104|FG002|ER Treatment|Other|0|||
19639721|NCT00784277|42089105|FG003|ER Treatment|Other|0|||
19639722|NCT00784277|42089106|FG004|ER Treatment|Other|1|||
19639723|NCT00784277|42089107|FG005|ER Treatment|Other|3|||
19639724|NCT00784277|42089108|FG006|ER Treatment|Other|2|||
19639725|NCT00682929|42089124|FG000|Overall Study|Adverse Event|4|||
19599578|NCT01024244|42048487|FG004|Overall Study|Entry Criteria Not Met|0|||
19639726|NCT00682929|42089125|FG001|Overall Study|Adverse Event|1|||
19639727|NCT00682929|42089126|FG002|Overall Study|Adverse Event|1|||
19639728|NCT00682929|42089124|FG000|Overall Study|Withdrawal by Subject|1|||
19639729|NCT00682929|42089125|FG001|Overall Study|Withdrawal by Subject|2|||
19639730|NCT00682929|42089126|FG002|Overall Study|Withdrawal by Subject|1|||
19639731|NCT00682929|42089124|FG000|Overall Study|dosing compliance < 80%|0|||
19639732|NCT00682929|42089125|FG001|Overall Study|dosing compliance < 80%|2|||
19747921|NCT04040192|42195435|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
19599579|NCT01024244|42048483|FG000|Overall Study|Lack of Efficacy|1|||
19639733|NCT00682929|42089126|FG002|Overall Study|dosing compliance < 80%|0|||
19639734|NCT00682929|42089124|FG000|Overall Study|lag in DEA renewal|1|||
19639735|NCT00682929|42089125|FG001|Overall Study|lag in DEA renewal|0|||
19639736|NCT00682929|42089126|FG002|Overall Study|lag in DEA renewal|0|||
19639737|NCT00680745|42089138|FG000|Overall Study|Withdrawal by Subject|8|||
19639738|NCT00680745|42089139|FG001|Overall Study|Withdrawal by Subject|3|||
19639739|NCT00680745|42089140|FG002|Overall Study|Withdrawal by Subject|2|||
19639740|NCT00680745|42089141|FG003|Overall Study|Withdrawal by Subject|8|||
19639741|NCT00680745|42089138|FG000|Overall Study|Lost to Follow-up|0|||
19639742|NCT00680745|42089139|FG001|Overall Study|Lost to Follow-up|1|||
19639743|NCT00680745|42089140|FG002|Overall Study|Lost to Follow-up|1|||
19747922|NCT04040192|42195436|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
19747923|NCT04040192|42195437|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
19747924|NCT03368859|42195461|FG000|Overall Study|Withdrew Consent|5|||
19747925|NCT03368859|42195462|FG001|Overall Study|Withdrew Consent|4|||
19747926|NCT03368859|42195461|FG000|Overall Study|Death|12|||
19747927|NCT03368859|42195462|FG001|Overall Study|Death|6|||
19747928|NCT03368859|42195461|FG000|Overall Study|Study terminated by Sponsor|18|||
19747929|NCT03368859|42195462|FG001|Overall Study|Study terminated by Sponsor|23|||
19747930|NCT03368859|42195461|FG000|Overall Study|Other|1|||
19747931|NCT03368859|42195462|FG001|Overall Study|Other|1|||
19639744|NCT00680745|42089141|FG003|Overall Study|Lost to Follow-up|0|||
19639745|NCT00680745|42089138|FG000|Overall Study|Death|1|||
19639746|NCT00680745|42089139|FG001|Overall Study|Death|0|||
19639747|NCT00680745|42089140|FG002|Overall Study|Death|1|||
19639748|NCT00680745|42089141|FG003|Overall Study|Death|0|||
19639749|NCT00680745|42089138|FG000|Overall Study|Adverse Event|5|||
19639750|NCT00680745|42089139|FG001|Overall Study|Adverse Event|3|||
19639751|NCT00680745|42089140|FG002|Overall Study|Adverse Event|3|||
19639752|NCT00680745|42089141|FG003|Overall Study|Adverse Event|3|||
19639753|NCT00680745|42089138|FG000|Overall Study|Poor/Non-compliance|0|||
19639754|NCT00680745|42089139|FG001|Overall Study|Poor/Non-compliance|3|||
19639755|NCT00680745|42089140|FG002|Overall Study|Poor/Non-compliance|0|||
19639756|NCT00680745|42089141|FG003|Overall Study|Poor/Non-compliance|0|||
19639757|NCT00680745|42089138|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
19639758|NCT00680745|42089139|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
19639759|NCT00680745|42089140|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
19639760|NCT00680745|42089141|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
19639761|NCT00680745|42089138|FG000|Overall Study|False Treatment|0|||
19639762|NCT00680745|42089139|FG001|Overall Study|False Treatment|1|||
19639763|NCT00680745|42089140|FG002|Overall Study|False Treatment|3|||
19639764|NCT00680745|42089141|FG003|Overall Study|False Treatment|0|||
19639765|NCT00680121|42089154|FG000|Overall Study|Lost to Follow-up|27|||
19639766|NCT00680121|42089155|FG001|Overall Study|Lost to Follow-up|23|||
19639767|NCT00767819|42089164|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
19747932|NCT03096314|42195476|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
19747933|NCT03096314|42195477|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
19747934|NCT03335163|42195483|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
19747935|NCT03335163|42195483|FG000|Overall Study|Withdrawal by Subject|18|||
19747936|NCT03364335|42195509|FG000|Overall Study|Adverse Event|3|||
19747937|NCT03364335|42195510|FG001|Overall Study|Adverse Event|4|||
19747938|NCT03364335|42195511|FG002|Overall Study|Adverse Event|1|||
19747939|NCT03364335|42195512|FG003|Overall Study|Adverse Event|2|||
19747940|NCT03364335|42195513|FG004|Overall Study|Adverse Event|0|||
19747941|NCT03364335|42195509|FG000|Overall Study|Lost to Follow-up|7|||
19747942|NCT03364335|42195510|FG001|Overall Study|Lost to Follow-up|7|||
19747943|NCT03364335|42195511|FG002|Overall Study|Lost to Follow-up|10|||
19747944|NCT03364335|42195512|FG003|Overall Study|Lost to Follow-up|11|||
19747945|NCT03364335|42195513|FG004|Overall Study|Lost to Follow-up|11|||
19747946|NCT03334695|42195536|FG000|Overall Study|Lost to Follow-up|3|||
19747947|NCT03334695|42195537|FG001|Overall Study|Lost to Follow-up|3|||
19747948|NCT03334695|42195536|FG000|Overall Study|Physician Decision|1|||
19747949|NCT03334695|42195537|FG001|Overall Study|Physician Decision|2|||
19747950|NCT03334695|42195536|FG000|Overall Study|Protocol Violation|0|||
19747951|NCT03334695|42195537|FG001|Overall Study|Protocol Violation|1|||
19747952|NCT03364023|42195545|FG000|Overall Study|Lost to Follow-up|3|||
19747953|NCT03364023|42195545|FG000|Overall Study|Death|14|||
19747954|NCT03764813|42195569|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
19747955|NCT03764813|42195570|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
19747956|NCT03764813|42195571|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
19639768|NCT00767819|42089165|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
19639769|NCT00767819|42089166|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19639770|NCT00767819|42089164|FG000|Overall Study|Withdrawal by Subject|1|||
19639771|NCT00767819|42089165|FG001|Overall Study|Withdrawal by Subject|1|||
19639772|NCT00767819|42089166|FG002|Overall Study|Withdrawal by Subject|0|||
19639773|NCT00767819|42089164|FG000|Overall Study|Administrative problems|0|||
19639774|NCT00767819|42089165|FG001|Overall Study|Administrative problems|1|||
19639775|NCT00767819|42089166|FG002|Overall Study|Administrative problems|0|||
19639776|NCT00767819|42089164|FG000|Overall Study|Death|2|||
19747957|NCT03764813|42195572|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
19747958|NCT03363321|42195593|FG000|Overall Study|Withdrawal by Subject|0|||
19747959|NCT03363321|42195594|FG001|Overall Study|Withdrawal by Subject|1|||
19747960|NCT03363321|42195595|FG002|Overall Study|Withdrawal by Subject|0|||
19639777|NCT00767819|42089165|FG001|Overall Study|Death|3|||
19639778|NCT00767819|42089166|FG002|Overall Study|Death|0|||
19639779|NCT00767819|42089164|FG000|Overall Study|Adverse Event|2|||
19639780|NCT00767819|42089165|FG001|Overall Study|Adverse Event|0|||
19639781|NCT00767819|42089166|FG002|Overall Study|Adverse Event|0|||
19639782|NCT00767819|42089164|FG000|Overall Study|Abnormal lab values|1|||
19639783|NCT00767819|42089165|FG001|Overall Study|Abnormal lab values|0|||
19639784|NCT00767819|42089166|FG002|Overall Study|Abnormal lab values|0|||
19639785|NCT00767819|42089164|FG000|Overall Study|Lost to Follow-up|1|||
19639786|NCT00767819|42089165|FG001|Overall Study|Lost to Follow-up|0|||
19639787|NCT00767819|42089166|FG002|Overall Study|Lost to Follow-up|0|||
19639788|NCT00584870|42089177|FG000|Overall Study|Adverse Event|4|||
19639789|NCT00584870|42089178|FG001|Overall Study|Adverse Event|3|||
19639790|NCT00584870|42089179|FG002|Overall Study|Adverse Event|2|||
19639791|NCT00584870|42089177|FG000|Overall Study|Lost to Follow-up|4|||
19639792|NCT00584870|42089178|FG001|Overall Study|Lost to Follow-up|1|||
19639793|NCT00584870|42089179|FG002|Overall Study|Lost to Follow-up|1|||
19639794|NCT00584870|42089177|FG000|Overall Study|Lack of Efficacy|7|||
19639795|NCT00584870|42089178|FG001|Overall Study|Lack of Efficacy|14|||
19639796|NCT00584870|42089179|FG002|Overall Study|Lack of Efficacy|8|||
19639797|NCT00584870|42089177|FG000|Overall Study|Withdrawal by Subject|10|||
19639798|NCT00584870|42089178|FG001|Overall Study|Withdrawal by Subject|5|||
19639799|NCT00584870|42089179|FG002|Overall Study|Withdrawal by Subject|3|||
19639800|NCT00584870|42089177|FG000|Overall Study|Protocol Violation|1|||
19639801|NCT00584870|42089178|FG001|Overall Study|Protocol Violation|1|||
19639802|NCT00584870|42089179|FG002|Overall Study|Protocol Violation|2|||
19639803|NCT00584870|42089177|FG000|Overall Study|Did not met entrance criteria|1|||
19639804|NCT00584870|42089178|FG001|Overall Study|Did not met entrance criteria|0|||
19639805|NCT00584870|42089179|FG002|Overall Study|Did not met entrance criteria|0|||
19639806|NCT00584870|42089177|FG000|Overall Study|Other|2|||
19639807|NCT00584870|42089178|FG001|Overall Study|Other|0|||
19639808|NCT00584870|42089179|FG002|Overall Study|Other|0|||
19639809|NCT00584870|42089177|FG000|Overall Study|Randomized but not treated|0|||
19639810|NCT00584870|42089178|FG001|Overall Study|Randomized but not treated|1|||
19639811|NCT00584870|42089179|FG002|Overall Study|Randomized but not treated|2|||
19639812|NCT00679341|42089189|FG000|Overall Study|Disease progression|42|||
19639813|NCT00679341|42089190|FG001|Overall Study|Disease progression|36|||
19639814|NCT00679341|42089189|FG000|Overall Study|Adverse Event|5|||
19639815|NCT00679341|42089190|FG001|Overall Study|Adverse Event|6|||
19639816|NCT00679341|42089189|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
19639817|NCT00679341|42089190|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
19639818|NCT00679341|42089189|FG000|Overall Study|Death|1|||
19639819|NCT00679341|42089190|FG001|Overall Study|Death|1|||
19639820|NCT00679341|42089189|FG000|Overall Study|Other|1|||
19639821|NCT00679341|42089190|FG001|Overall Study|Other|0|||
19639822|NCT00679341|42089189|FG000|Overall Study|Physician Decision|1|||
19639823|NCT00679341|42089190|FG001|Overall Study|Physician Decision|0|||
19639824|NCT00679341|42089189|FG000|Overall Study|Not treated|0|||
19639825|NCT00679341|42089190|FG001|Overall Study|Not treated|2|||
19639826|NCT00679341|42089189|FG000|Overall Study|Physician/patient decision to withdraw|0|||
19639827|NCT00679341|42089190|FG001|Overall Study|Physician/patient decision to withdraw|6|||
19639828|NCT00679263|42089200|FG000|Visit 2/Dose 1|Adverse Event|1|||
19639829|NCT00679263|42089201|FG001|Visit 2/Dose 1|Adverse Event|0|||
19639830|NCT00679263|42089202|FG002|Visit 2/Dose 1|Adverse Event|0|||
19639831|NCT00679263|42089200|FG000|Visit 2/Dose 1|subject not compliance|1|||
19639832|NCT00679263|42089201|FG001|Visit 2/Dose 1|subject not compliance|1|||
19639833|NCT00679263|42089202|FG002|Visit 2/Dose 1|subject not compliance|0|||
19639834|NCT00680043|42089213|FG000|Overall Study|Withdrawal by Subject|1|||
19639835|NCT00680043|42089214|FG001|Overall Study|Withdrawal by Subject|0|||
19639836|NCT00680043|42089215|FG002|Overall Study|Withdrawal by Subject|0|||
19639837|NCT00680043|42089213|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
19639838|NCT00680043|42089214|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
19639839|NCT00680043|42089215|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
19639840|NCT00680043|42089213|FG000|Overall Study|Renal Transplant|1|||
19639841|NCT00680043|42089214|FG001|Overall Study|Renal Transplant|0|||
19639842|NCT00680043|42089215|FG002|Overall Study|Renal Transplant|4|||
19639843|NCT00682539|42089226|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
19639844|NCT00682539|42089227|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
19639845|NCT00682539|42089228|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
19639846|NCT00682539|42089226|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
19639847|NCT00682539|42089227|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
19747961|NCT03363321|42195596|FG003|Overall Study|Withdrawal by Subject|1|||
19639848|NCT00682539|42089228|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
19639849|NCT00682461|42089238|FG000|Overall Study|Adverse Event|5|||
19639850|NCT00682461|42089239|FG001|Overall Study|Adverse Event|7|||
19639851|NCT00682461|42089238|FG000|Overall Study|Lost to Follow-up|8|||
19639852|NCT00682461|42089239|FG001|Overall Study|Lost to Follow-up|5|||
19639853|NCT00682461|42089238|FG000|Overall Study|Withdrawal by Subject|12|||
19639854|NCT00682461|42089239|FG001|Overall Study|Withdrawal by Subject|19|||
19639855|NCT00679029|42089246|FG000|Overall Study|Adverse Event|3|||
19639856|NCT00679029|42089246|FG000|Overall Study|Withdrawal by Subject|1|||
19639857|NCT00679029|42089246|FG000|Overall Study|Lost to Follow-up|1|||
19639858|NCT00677235|42089252|FG000|Overall Study|Withdrawal by Subject|1|||
19639859|NCT00677235|42089253|FG001|Overall Study|Withdrawal by Subject|1|||
19639860|NCT00677235|42089252|FG000|Overall Study|Lost to Follow-up|2|||
19639861|NCT00677235|42089253|FG001|Overall Study|Lost to Follow-up|1|||
19639862|NCT00677235|42089252|FG000|Overall Study|Death|37|||
19639863|NCT00677235|42089253|FG001|Overall Study|Death|36|||
19639864|NCT00677235|42089252|FG000|Overall Study|Adverse Experience|1|||
19639865|NCT00677235|42089253|FG001|Overall Study|Adverse Experience|0|||
19639866|NCT00676689|42089259|FG000|Overall Study|Screen Failure|2|||
19639867|NCT00676689|42089259|FG000|Overall Study|Death|2|||
19639868|NCT00676689|42089259|FG000|Overall Study|Lost to Follow-up|4|||
19639869|NCT00676689|42089259|FG000|Overall Study|Physician Decision|1|||
19639870|NCT00676689|42089259|FG000|Overall Study|Withdrawal by Subject|3|||
19639871|NCT00676689|42089259|FG000|Overall Study|Continuing FU|49|||
19639872|NCT00678795|42089265|FG000|Overall Study|Adverse Event|7|||
19639873|NCT00678795|42089266|FG001|Overall Study|Adverse Event|3|||
19639874|NCT00678795|42089265|FG000|Overall Study|Withdrawal by Subject|3|||
19639875|NCT00678795|42089266|FG001|Overall Study|Withdrawal by Subject|0|||
19639876|NCT00678795|42089265|FG000|Overall Study|Protocol Violation|0|||
19639877|NCT00678795|42089266|FG001|Overall Study|Protocol Violation|1|||
19639878|NCT00678795|42089265|FG000|Overall Study|Lost to Follow-up|0|||
19639879|NCT00678795|42089266|FG001|Overall Study|Lost to Follow-up|1|||
19639880|NCT00678795|42089265|FG000|Overall Study|Lack of Efficacy|1|||
19639881|NCT00678795|42089266|FG001|Overall Study|Lack of Efficacy|1|||
19747962|NCT03363321|42195597|FG004|Overall Study|Withdrawal by Subject|0|||
19747963|NCT03361605|42195610|FG000|Overall Study|Analyzable data not available|3|||
19747964|NCT03829046|42195616|FG000|Overall Study|Withdrawal by Subject|1|||
19747965|NCT03829046|42195617|FG001|Overall Study|Withdrawal by Subject|0|||
19747966|NCT03361293|42195625|FG000|Overall Study|Lost to Follow-up|0|||
19639882|NCT00678639|42089274|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
19639883|NCT00678639|42089275|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
19747967|NCT03361293|42195626|FG001|Overall Study|Lost to Follow-up|2|||
19747968|NCT03361293|42195625|FG000|Overall Study|Withdrawal by Subject|1|||
19639884|NCT00678561|42089325|FG000|Overall Study|Adverse Event|0|||
19639885|NCT00678561|42089326|FG001|Overall Study|Adverse Event|1|||
19639886|NCT00678561|42089327|FG002|Overall Study|Adverse Event|1|||
19639887|NCT00678561|42089328|FG003|Overall Study|Adverse Event|0|||
19639888|NCT00678561|42089329|FG004|Overall Study|Adverse Event|1|||
19747969|NCT03361293|42195626|FG001|Overall Study|Withdrawal by Subject|3|||
19747970|NCT03361137|42195637|FG000|Overall Study|Reason not specified|1|||
19747971|NCT03361137|42195638|FG001|Overall Study|Reason not specified|0|||
19747972|NCT03361137|42195639|FG002|Overall Study|Reason not specified|0|||
19747973|NCT03361137|42195640|FG003|Overall Study|Reason not specified|0|||
19747974|NCT03361137|42195641|FG004|Overall Study|Reason not specified|0|||
19747975|NCT03360747|42195655|FG000|Overall Study|Voluntary Withdrawal|1|||
19747976|NCT03359811|42195661|FG000|Overall Study|Protocol Violation|2|||
19747977|NCT03359811|42195662|FG001|Overall Study|Protocol Violation|0|||
19747978|NCT03728426|42195669|FG000|Overall Study|Death|3|||
19747979|NCT02095678|42195675|FG000|Overall Study|Withdrawal by Subject|0|||
19747980|NCT02095678|42195676|FG001|Overall Study|Withdrawal by Subject|1|||
19747981|NCT02095678|42195675|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
19747982|NCT02095678|42195676|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
19747983|NCT02095678|42195675|FG000|Overall Study|lesion impacted by previous treatment|1|||
19747984|NCT02095678|42195676|FG001|Overall Study|lesion impacted by previous treatment|1|||
19747985|NCT02095678|42195675|FG000|Overall Study|No Confirmed Diagnosis|0|||
19747986|NCT02095678|42195676|FG001|Overall Study|No Confirmed Diagnosis|3|||
19747987|NCT02095678|42195675|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
19747988|NCT02095678|42195676|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
19747989|NCT02095678|42195675|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
19747990|NCT02095678|42195676|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
19747991|NCT03763877|42195689|FG000|Overall Study|Withdrawal by Subject|3|||
19747992|NCT03763877|42195690|FG001|Overall Study|Withdrawal by Subject|1|||
19747993|NCT03763877|42195691|FG002|Overall Study|Withdrawal by Subject|3|||
19747994|NCT03763877|42195692|FG003|Overall Study|Withdrawal by Subject|4|||
19747995|NCT03763877|42195689|FG000|Overall Study|Adverse Event|1|||
19747996|NCT03763877|42195690|FG001|Overall Study|Adverse Event|1|||
19747997|NCT03763877|42195691|FG002|Overall Study|Adverse Event|3|||
19747998|NCT03763877|42195692|FG003|Overall Study|Adverse Event|1|||
19747999|NCT03763877|42195689|FG000|Overall Study|Protocol Violation|1|||
19748000|NCT03763877|42195690|FG001|Overall Study|Protocol Violation|1|||
19748001|NCT03763877|42195691|FG002|Overall Study|Protocol Violation|0|||
19748002|NCT03763877|42195692|FG003|Overall Study|Protocol Violation|0|||
19748003|NCT03763877|42195689|FG000|Overall Study|Lost to Follow-up|0|||
19748004|NCT03763877|42195690|FG001|Overall Study|Lost to Follow-up|1|||
19748005|NCT03763877|42195691|FG002|Overall Study|Lost to Follow-up|1|||
19748006|NCT03763877|42195692|FG003|Overall Study|Lost to Follow-up|0|||
19748007|NCT03358407|42195725|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748008|NCT03358407|42195726|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748009|NCT03358407|42195727|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
19748010|NCT03358407|42195728|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748011|NCT03358407|42195729|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748012|NCT03358407|42195730|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748013|NCT03358407|42195731|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748014|NCT03358407|42195732|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748015|NCT03358407|42195733|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748016|NCT03358407|42195734|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
19748017|NCT03358407|42195725|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748018|NCT03358407|42195726|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748019|NCT03358407|42195727|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748020|NCT03358407|42195728|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748021|NCT03358407|42195729|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
19748022|NCT03358407|42195730|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748023|NCT03358407|42195731|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748024|NCT03358407|42195732|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748025|NCT03358407|42195733|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748026|NCT03358407|42195734|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748027|NCT03358407|42195725|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748028|NCT03358407|42195726|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748029|NCT03358407|42195727|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748030|NCT03358407|42195728|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748031|NCT03358407|42195729|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748032|NCT03358407|42195730|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
19748033|NCT03358407|42195731|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748034|NCT03358407|42195732|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
19748035|NCT03358407|42195733|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748036|NCT03358407|42195734|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
19748037|NCT03358407|42195725|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748038|NCT03358407|42195726|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748039|NCT03358407|42195727|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748040|NCT03358407|42195728|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748041|NCT03358407|42195729|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748042|NCT03358407|42195730|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
19639889|NCT00678561|42089330|FG005|Overall Study|Adverse Event|0|||
19639890|NCT00678561|42089331|FG006|Overall Study|Adverse Event|0|||
19639891|NCT00678561|42089332|FG007|Overall Study|Adverse Event|0|||
19639892|NCT00678561|42089325|FG000|Overall Study|Protocol Violation|0|||
19639893|NCT00678561|42089326|FG001|Overall Study|Protocol Violation|0|||
19639894|NCT00678561|42089327|FG002|Overall Study|Protocol Violation|0|||
19639895|NCT00678561|42089328|FG003|Overall Study|Protocol Violation|0|||
19639896|NCT00678561|42089329|FG004|Overall Study|Protocol Violation|1|||
19639897|NCT00678561|42089330|FG005|Overall Study|Protocol Violation|1|||
19639898|NCT00678561|42089331|FG006|Overall Study|Protocol Violation|0|||
19639899|NCT00678561|42089332|FG007|Overall Study|Protocol Violation|0|||
19639900|NCT00678561|42089325|FG000|Overall Study|Withdrawal by Subject|0|||
19639901|NCT00678561|42089326|FG001|Overall Study|Withdrawal by Subject|0|||
19639902|NCT00678561|42089327|FG002|Overall Study|Withdrawal by Subject|0|||
19639903|NCT00678561|42089328|FG003|Overall Study|Withdrawal by Subject|0|||
19639904|NCT00678561|42089329|FG004|Overall Study|Withdrawal by Subject|0|||
19639905|NCT00678561|42089330|FG005|Overall Study|Withdrawal by Subject|0|||
19639906|NCT00678561|42089331|FG006|Overall Study|Withdrawal by Subject|0|||
19639907|NCT00678561|42089332|FG007|Overall Study|Withdrawal by Subject|1|||
19639908|NCT00676143|42089359|FG000|Overall Study|Adverse Event|34|||
19599580|NCT01024244|42048484|FG001|Overall Study|Lack of Efficacy|0|||
19599581|NCT01024244|42048485|FG002|Overall Study|Lack of Efficacy|0|||
19599582|NCT01024244|42048486|FG003|Overall Study|Lack of Efficacy|0|||
19599583|NCT01024244|42048487|FG004|Overall Study|Lack of Efficacy|0|||
19599584|NCT01024244|42048483|FG000|Overall Study|Protocol Violation|1|||
19599585|NCT01024244|42048484|FG001|Overall Study|Protocol Violation|0|||
19599586|NCT01024244|42048485|FG002|Overall Study|Protocol Violation|0|||
19599587|NCT01024244|42048486|FG003|Overall Study|Protocol Violation|0|||
19599588|NCT01024244|42048487|FG004|Overall Study|Protocol Violation|2|||
19599589|NCT01024244|42048483|FG000|Overall Study|Sponsor Decision|14|||
19599590|NCT01024244|42048484|FG001|Overall Study|Sponsor Decision|7|||
19599591|NCT01024244|42048485|FG002|Overall Study|Sponsor Decision|14|||
19599592|NCT01024244|42048486|FG003|Overall Study|Sponsor Decision|12|||
19599593|NCT01024244|42048487|FG004|Overall Study|Sponsor Decision|10|||
19599594|NCT01024244|42048483|FG000|Overall Study|Withdrawal by Subject|0|||
19599595|NCT01024244|42048484|FG001|Overall Study|Withdrawal by Subject|1|||
19599596|NCT01024244|42048485|FG002|Overall Study|Withdrawal by Subject|0|||
19599597|NCT01024244|42048486|FG003|Overall Study|Withdrawal by Subject|0|||
19599598|NCT01024244|42048487|FG004|Overall Study|Withdrawal by Subject|0|||
19599599|NCT00721279|42048501|FG000|Overall Study|Lack of Efficacy|6|||
19599600|NCT00721279|42048502|FG001|Overall Study|Lack of Efficacy|3|||
19599601|NCT00721279|42048501|FG000|Overall Study|Tolerability insufficient|5|||
19599602|NCT00721279|42048502|FG001|Overall Study|Tolerability insufficient|2|||
19599603|NCT00721279|42048501|FG000|Overall Study|Withdrawal by Subject|13|||
19599604|NCT00721279|42048502|FG001|Overall Study|Withdrawal by Subject|3|||
19599605|NCT00721279|42048501|FG000|Overall Study|Other|12|||
19599606|NCT00721279|42048502|FG001|Overall Study|Other|16|||
19599607|NCT01030952|42048511|FG000|Overall Study|Protocol Violation|0|||
19599608|NCT01030952|42048512|FG001|Overall Study|Protocol Violation|1|||
19599609|NCT01030952|42048511|FG000|Overall Study|Informed consent withdrawal|1|||
19599610|NCT01030952|42048512|FG001|Overall Study|Informed consent withdrawal|0|||
19599611|NCT01030952|42048511|FG000|Overall Study|Lost to Follow-up|0|||
19599612|NCT01030952|42048512|FG001|Overall Study|Lost to Follow-up|1|||
19599613|NCT01030952|42048511|FG000|Overall Study|Unexplained|1|||
19599614|NCT01030952|42048512|FG001|Overall Study|Unexplained|1|||
19599615|NCT01030874|42048522|FG000|Overall Study|Withdrawal by Subject|1|||
19599616|NCT01030874|42048523|FG001|Overall Study|Withdrawal by Subject|0|||
19599617|NCT01030874|42048522|FG000|Overall Study|Discharged in first 2 weeks|17|||
19599618|NCT01030874|42048523|FG001|Overall Study|Discharged in first 2 weeks|16|||
19599619|NCT03611751|42048532|FG000|Pre-treatment|Randomized but not treated|1|||
19599620|NCT03611751|42048533|FG001|Pre-treatment|Randomized but not treated|1|||
19599621|NCT03611751|42048534|FG002|Pre-treatment|Randomized but not treated|0|||
19599622|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
19599623|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
19599624|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
19599625|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
19599626|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
19639909|NCT00676143|42089360|FG001|Overall Study|Adverse Event|60|||
19639910|NCT00676143|42089359|FG000|Overall Study|Death|4|||
19639911|NCT00676143|42089360|FG001|Overall Study|Death|4|||
19639912|NCT00676143|42089359|FG000|Overall Study|Lack of Efficacy|0|||
19639913|NCT00676143|42089360|FG001|Overall Study|Lack of Efficacy|6|||
19599627|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
19599628|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
19599629|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
19599630|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
19599631|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
19599632|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
19599633|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
19599634|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
19599635|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
19599636|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
19599637|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
19599638|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
19599639|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
19599640|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
19599641|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
19599642|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
19599643|NCT03611751|42048532|FG000|Treatment Week 0 - Week 16|Death|0|||
19599644|NCT03611751|42048533|FG001|Treatment Week 0 - Week 16|Death|0|||
19599645|NCT03611751|42048534|FG002|Treatment Week 0 - Week 16|Death|1|||
19599646|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
19599647|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
19599648|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
19599649|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
19599650|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
19599651|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
19599652|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
19599653|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
19748043|NCT03358407|42195731|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748044|NCT03358407|42195732|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
19748045|NCT03358407|42195733|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748046|NCT03358407|42195734|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
19748047|NCT03358407|42195725|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19599654|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
19599655|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
19599656|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
19599657|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
19599658|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
19599659|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
19599660|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
19599661|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
19599662|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
19599663|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
19599664|NCT03611751|42048532|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
19599665|NCT03611751|42048533|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
19599666|NCT03611751|42048534|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
19599667|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
19599668|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
19599669|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
19599670|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
19599671|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
19599672|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
19599673|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
19599674|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
19599675|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
19599676|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
19599677|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
19639914|NCT00676143|42089359|FG000|Overall Study|Lost to Follow-up|0|||
19639915|NCT00676143|42089360|FG001|Overall Study|Lost to Follow-up|13|||
19639916|NCT00676143|42089359|FG000|Overall Study|Physician Decision|5|||
19639917|NCT00676143|42089360|FG001|Overall Study|Physician Decision|8|||
19639918|NCT00676143|42089359|FG000|Overall Study|Protocol Violation|4|||
19639919|NCT00676143|42089360|FG001|Overall Study|Protocol Violation|8|||
19639920|NCT00676143|42089359|FG000|Overall Study|Withdrawal by Subject|24|||
19639921|NCT00676143|42089360|FG001|Overall Study|Withdrawal by Subject|42|||
19639922|NCT00676143|42089359|FG000|Overall Study|Discontinuation of study by sponsor|65|||
19639923|NCT00676143|42089360|FG001|Overall Study|Discontinuation of study by sponsor|88|||
19639924|NCT00676143|42089359|FG000|Overall Study|Failed to return|2|||
19599678|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
19599679|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
19639925|NCT00676143|42089360|FG001|Overall Study|Failed to return|1|||
19639926|NCT00676143|42089359|FG000|Overall Study|Loss of caregiver|5|||
19639927|NCT00676143|42089360|FG001|Overall Study|Loss of caregiver|3|||
19639928|NCT00676143|42089359|FG000|Overall Study|Other|11|||
19639929|NCT00676143|42089360|FG001|Overall Study|Other|20|||
19639930|NCT00676143|42089359|FG000|Overall Study|Participant participation unknown|1|||
19639931|NCT00676143|42089360|FG001|Overall Study|Participant participation unknown|4|||
19639932|NCT00676143|42089359|FG000|Overall Study|Vasogenic edema recurrence|1|||
19639933|NCT00676143|42089360|FG001|Overall Study|Vasogenic edema recurrence|3|||
19639934|NCT00675597|42089385|FG000|Overall Study|Withdrawal by Subject|3|||
19639935|NCT00675441|42089393|FG000|Overall Study|Withdrawal by Subject|2|||
19639936|NCT00675441|42089393|FG000|Overall Study|Death|1|||
19639937|NCT00674973|42089408|FG000|Overall Study|Insufficient Therapeutic Response|77|||
19639938|NCT00674973|42089409|FG001|Overall Study|Insufficient Therapeutic Response|72|||
19639939|NCT00674973|42089408|FG000|Overall Study|Refused Treatment|1|||
19639940|NCT00674973|42089409|FG001|Overall Study|Refused Treatment|5|||
19639941|NCT00674973|42089408|FG000|Overall Study|Failure to Return|1|||
19639942|NCT00674973|42089409|FG001|Overall Study|Failure to Return|0|||
19639943|NCT00674973|42089408|FG000|Overall Study|Adverse Event|2|||
19639944|NCT00674973|42089409|FG001|Overall Study|Adverse Event|9|||
19639945|NCT00674973|42089408|FG000|Overall Study|Death|19|||
19639946|NCT00674973|42089409|FG001|Overall Study|Death|15|||
19639947|NCT00674973|42089408|FG000|Overall Study|Protocol Violation|0|||
19639948|NCT00674973|42089409|FG001|Overall Study|Protocol Violation|1|||
19639949|NCT00673179|42089417|FG000|Overall Study|Toxicity/Complications|3|||
19639950|NCT00673179|42089418|FG001|Overall Study|Toxicity/Complications|0|||
19639951|NCT00584012|42089424|FG000|Overall Study|Withdrawal by Subject|1|||
19639952|NCT00674817|42089428|FG000|Period 1|Withdrawal by Subject|2|||
19639953|NCT00674817|42089428|FG000|Period 1|Protocol Violation|1|||
19639954|NCT00674817|42089428|FG000|Period 3|Adverse Event|1|||
19639955|NCT00674817|42089428|FG000|Period 3|Protocol Violation|1|||
19639956|NCT00674817|42089428|FG000|Period 4|Adverse Event|1|||
19639957|NCT00672633|42089444|FG000|Overall Study|Withdrawal by Subject|0|||
19639958|NCT00672633|42089445|FG001|Overall Study|Withdrawal by Subject|1|||
19639959|NCT00672555|42089451|FG000|Overall Study|Lost to Follow-up|4|||
19639960|NCT00672555|42089451|FG000|Overall Study|Did not want to answer questionnaire|2|||
19639961|NCT00672477|42089457|FG000|Overall Study|Adverse Event|10|||
19639962|NCT00672477|42089458|FG001|Overall Study|Adverse Event|7|||
19639963|NCT00672477|42089457|FG000|Overall Study|Death|7|||
19639964|NCT00672477|42089458|FG001|Overall Study|Death|11|||
19639965|NCT00672477|42089457|FG000|Overall Study|Physician Decision|2|||
19639966|NCT00672477|42089458|FG001|Overall Study|Physician Decision|0|||
19639967|NCT00672477|42089457|FG000|Overall Study|Protocol Violation|1|||
19639968|NCT00672477|42089458|FG001|Overall Study|Protocol Violation|1|||
19639969|NCT00672477|42089457|FG000|Overall Study|Withdrawal by Subject|5|||
19639970|NCT00672477|42089458|FG001|Overall Study|Withdrawal by Subject|3|||
19639971|NCT00672477|42089457|FG000|Overall Study|Lack of Efficacy|1|||
19639972|NCT00672477|42089458|FG001|Overall Study|Lack of Efficacy|1|||
19639973|NCT00672477|42089457|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
19639974|NCT00672477|42089458|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
19639975|NCT00674661|42089466|FG000|Overall Study|Other|5|||
19639976|NCT00674661|42089467|FG001|Overall Study|Other|7|||
19639977|NCT00674661|42089466|FG000|Overall Study|Lost to Follow-up|6|||
19639978|NCT00674661|42089467|FG001|Overall Study|Lost to Follow-up|3|||
19639979|NCT00674661|42089466|FG000|Overall Study|Withdrawal by Subject|0|||
19639980|NCT00674661|42089467|FG001|Overall Study|Withdrawal by Subject|5|||
19639981|NCT00671931|42089482|FG000|Overall Study|Physician Decision|1|||
19639982|NCT00671931|42089483|FG001|Overall Study|Physician Decision|0|||
19639983|NCT00671931|42089484|FG002|Overall Study|Physician Decision|0|||
19639984|NCT00671931|42089485|FG003|Overall Study|Physician Decision|2|||
19639985|NCT00671931|42089486|FG004|Overall Study|Physician Decision|1|||
19639986|NCT00673881|42089502|FG000|Overall Study|Withdrawal by Subject|1|||
19639987|NCT00671853|42089508|FG000|Overall Study|Lack of Efficacy|3|||
19639988|NCT00671853|42089509|FG001|Overall Study|Lack of Efficacy|7|||
19639989|NCT00671853|42089508|FG000|Overall Study|Adverse Event|7|||
19639990|NCT00671853|42089509|FG001|Overall Study|Adverse Event|1|||
19639991|NCT00671853|42089508|FG000|Overall Study|Withdrawal by Subject|1|||
19639992|NCT00671853|42089509|FG001|Overall Study|Withdrawal by Subject|5|||
19639993|NCT00671853|42089508|FG000|Overall Study|Lost to Follow-up|8|||
19748048|NCT03358407|42195726|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19388107|NCT00708305|41631492|FG000|Period 1|Protocol Violation|1|||
19639994|NCT00671853|42089509|FG001|Overall Study|Lost to Follow-up|8|||
19639995|NCT00671853|42089508|FG000|Overall Study|Physician Decision|0|||
19639996|NCT00671853|42089509|FG001|Overall Study|Physician Decision|2|||
19639997|NCT00671853|42089508|FG000|Overall Study|Non-adherence with study procedures|1|||
19639998|NCT00671853|42089509|FG001|Overall Study|Non-adherence with study procedures|4|||
19639999|NCT00570921|42089517|FG000|Overall Study|Protocol Violation|1|||
19640000|NCT00570921|42089517|FG000|Overall Study|Physician Decision|1|||
19640001|NCT00670449|42089525|FG000|Overall Study|Adverse Event|6|||
19640002|NCT00670449|42089526|FG001|Overall Study|Adverse Event|2|||
19640003|NCT00670449|42089527|FG002|Overall Study|Adverse Event|8|||
19640004|NCT00670449|42089528|FG003|Overall Study|Adverse Event|5|||
19640005|NCT00670449|42089525|FG000|Overall Study|Protocol Deviation|1|||
19640006|NCT00670449|42089526|FG001|Overall Study|Protocol Deviation|2|||
19640007|NCT00670449|42089527|FG002|Overall Study|Protocol Deviation|0|||
19640008|NCT00670449|42089528|FG003|Overall Study|Protocol Deviation|1|||
19640009|NCT00670449|42089525|FG000|Overall Study|Administrative Problems|0|||
19640010|NCT00670449|42089526|FG001|Overall Study|Administrative Problems|2|||
19640011|NCT00670449|42089527|FG002|Overall Study|Administrative Problems|0|||
19640012|NCT00670449|42089528|FG003|Overall Study|Administrative Problems|1|||
19640013|NCT00670449|42089525|FG000|Overall Study|Subject Withdrew Consent|0|||
19640014|NCT00670449|42089526|FG001|Overall Study|Subject Withdrew Consent|2|||
19640015|NCT00670449|42089527|FG002|Overall Study|Subject Withdrew Consent|0|||
19640016|NCT00670449|42089528|FG003|Overall Study|Subject Withdrew Consent|1|||
19640017|NCT00670449|42089525|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
19640018|NCT00670449|42089526|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19640019|NCT00670449|42089527|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
19640020|NCT00670449|42089528|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19640021|NCT00670449|42089525|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
19640022|NCT00670449|42089526|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
19640023|NCT00670449|42089527|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
19640024|NCT00670449|42089528|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
19640025|NCT04349072|42089539|FG000|Randomization Period|Found ineligible post enrollment|0|||
19640026|NCT04349072|42089540|FG001|Randomization Period|Found ineligible post enrollment|1|||
19640027|NCT04349072|42089539|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
19640028|NCT04349072|42089540|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
19640029|NCT04349072|42089539|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
19640030|NCT04349072|42089540|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
19640031|NCT04349072|42089539|FG000|Treatment Period|Physician Decision|0|||
19640032|NCT04349072|42089540|FG001|Treatment Period|Physician Decision|1|||
19640033|NCT04349072|42089539|FG000|Treatment Period|Protocol Violation|0|||
19640034|NCT04349072|42089540|FG001|Treatment Period|Protocol Violation|1|||
19640035|NCT04349072|42089539|FG000|Treatment Period|Withdrawal by Subject|1|||
19640036|NCT04349072|42089540|FG001|Treatment Period|Withdrawal by Subject|1|||
19640037|NCT00668733|42089548|FG000|Overall Study|Lost to Follow-up|2|||
19640038|NCT00668733|42089549|FG001|Overall Study|Lost to Follow-up|3|||
19640039|NCT00668733|42089548|FG000|Overall Study|Withdrawal by Subject|0|||
19640040|NCT00668733|42089549|FG001|Overall Study|Withdrawal by Subject|4|||
19640041|NCT00673257|42089555|FG000|Overall Study|Withdrawal by Subject|4|||
19640042|NCT00673257|42089555|FG000|Overall Study|Unable to obtain specimen|1|||
19748049|NCT03358407|42195727|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19640043|NCT00667875|42089562|FG000|Overall Study|Adverse Event|0|||
19640044|NCT00667875|42089563|FG001|Overall Study|Adverse Event|2|||
19640045|NCT00667875|42089564|FG002|Overall Study|Adverse Event|6|||
19640046|NCT00667875|42089562|FG000|Overall Study|Withdrawal by Subject|10|||
19640047|NCT00667875|42089563|FG001|Overall Study|Withdrawal by Subject|9|||
19640048|NCT00667875|42089564|FG002|Overall Study|Withdrawal by Subject|7|||
19640049|NCT03468998|42089584|FG000|Overall Study|Withdrawal by Subject|1|||
19640050|NCT03468998|42089585|FG001|Overall Study|Withdrawal by Subject|1|||
19640051|NCT03468998|42089586|FG002|Overall Study|Withdrawal by Subject|0|||
19640052|NCT03468998|42089587|FG003|Overall Study|Withdrawal by Subject|4|||
19640053|NCT03468998|42089588|FG004|Overall Study|Withdrawal by Subject|1|||
19640054|NCT03468998|42089589|FG005|Overall Study|Withdrawal by Subject|0|||
19640055|NCT00667251|42089603|FG000|Overall Study|Adverse Event|13|||
19640056|NCT00667251|42089604|FG001|Overall Study|Adverse Event|4|||
19640057|NCT00667251|42089603|FG000|Overall Study|Withdrawal by Subject|6|||
19640058|NCT00667251|42089604|FG001|Overall Study|Withdrawal by Subject|2|||
19640059|NCT00667251|42089603|FG000|Overall Study|Other/missing|46|||
19640060|NCT00667251|42089604|FG001|Overall Study|Other/missing|84|||
19640061|NCT00667251|42089603|FG000|Overall Study|Intercurrent Illness|4|||
19640062|NCT00667251|42089604|FG001|Overall Study|Intercurrent Illness|3|||
19640063|NCT00667251|42089603|FG000|Overall Study|Symptomatic progression|1|||
19640064|NCT00667251|42089604|FG001|Overall Study|Symptomatic progression|2|||
19640065|NCT00669903|42089622|FG000|Overall Study|Adverse Event|0|||
19640066|NCT00669903|42089623|FG001|Overall Study|Adverse Event|1|||
19640067|NCT00669903|42089624|FG002|Overall Study|Adverse Event|3|||
19640068|NCT00669903|42089625|FG003|Overall Study|Adverse Event|1|||
19640069|NCT00669903|42089622|FG000|Overall Study|Withdrawal by Subject|0|||
19640070|NCT00669903|42089623|FG001|Overall Study|Withdrawal by Subject|2|||
19640071|NCT00669903|42089624|FG002|Overall Study|Withdrawal by Subject|2|||
19640072|NCT00669903|42089625|FG003|Overall Study|Withdrawal by Subject|2|||
19640073|NCT00669903|42089622|FG000|Overall Study|Lost to Follow-up|1|||
19640074|NCT00669903|42089623|FG001|Overall Study|Lost to Follow-up|1|||
19640075|NCT00669903|42089624|FG002|Overall Study|Lost to Follow-up|0|||
19640076|NCT00669903|42089625|FG003|Overall Study|Lost to Follow-up|1|||
19640077|NCT00669903|42089622|FG000|Overall Study|Protocol Violation|0|||
19640078|NCT00669903|42089623|FG001|Overall Study|Protocol Violation|1|||
19640079|NCT00669903|42089624|FG002|Overall Study|Protocol Violation|0|||
19640080|NCT00669903|42089625|FG003|Overall Study|Protocol Violation|0|||
19640081|NCT03759392|42089637|FG000|Overall Study|Adverse Event|12|||
19640082|NCT03759392|42089638|FG001|Overall Study|Adverse Event|4|||
19640083|NCT03759392|42089637|FG000|Overall Study|Death|2|||
19640084|NCT03759392|42089638|FG001|Overall Study|Death|1|||
19640085|NCT03759392|42089637|FG000|Overall Study|Withdrawal by Subject|2|||
19640086|NCT03759392|42089638|FG001|Overall Study|Withdrawal by Subject|0|||
19640087|NCT03759392|42089637|FG000|Overall Study|Protocol Violation|2|||
19640088|NCT03759392|42089638|FG001|Overall Study|Protocol Violation|0|||
19640089|NCT03759392|42089637|FG000|Overall Study|Physician Decision|0|||
19640090|NCT03759392|42089638|FG001|Overall Study|Physician Decision|1|||
19640091|NCT03759392|42089637|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
19640092|NCT03759392|42089638|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
19640093|NCT03759392|42089637|FG000|Overall Study|No longer able to take medicines|1|||
19640094|NCT03759392|42089638|FG001|Overall Study|No longer able to take medicines|0|||
19640095|NCT03759392|42089637|FG000|Overall Study|Stopped taking study drug|1|||
19640096|NCT03759392|42089638|FG001|Overall Study|Stopped taking study drug|0|||
19640097|NCT00667719|42089644|FG000|Overall Study|Adverse Event|39|||
19640098|NCT00667719|42089644|FG000|Overall Study|Abnormal Test Procedure|1|||
19640099|NCT00667719|42089644|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19640100|NCT00667719|42089644|FG000|Overall Study|Protocol Violation|3|||
19640101|NCT00667719|42089644|FG000|Overall Study|Withdrawal by Subject|17|||
19640102|NCT00667719|42089644|FG000|Overall Study|Lost to Follow-up|8|||
19640103|NCT00669669|42089653|FG000|Overall Study|To late to start treatment|1|||
19640104|NCT00467779|42089672|FG000|Stage 1|Adverse Event|1|||
19640105|NCT00467779|42089673|FG001|Stage 1|Adverse Event|0|||
19640106|NCT00467779|42089674|FG002|Stage 1|Adverse Event|0|||
19640107|NCT00467779|42089675|FG003|Stage 1|Adverse Event|0|||
19640108|NCT00467779|42089676|FG004|Stage 1|Adverse Event|0|||
19640109|NCT00467779|42089677|FG005|Stage 1|Adverse Event|1|||
19640110|NCT00467779|42089678|FG006|Stage 1|Adverse Event|2|||
19640111|NCT00467779|42089679|FG007|Stage 1|Adverse Event|1|||
19640112|NCT00467779|42089680|FG008|Stage 1|Adverse Event|0|||
19640113|NCT00467779|42089681|FG009|Stage 1|Adverse Event|0|||
19640114|NCT00467779|42089682|FG010|Stage 1|Adverse Event|0|||
19640115|NCT00467779|42089683|FG011|Stage 1|Adverse Event|0|||
19640116|NCT00467779|42089684|FG012|Stage 1|Adverse Event|0|||
19640117|NCT00467779|42089685|FG013|Stage 1|Adverse Event|0|||
19640118|NCT00467779|42089686|FG014|Stage 1|Adverse Event|0|||
19640119|NCT00467779|42089672|FG000|Stage 1|Disease Progression|2|||
19640120|NCT00467779|42089673|FG001|Stage 1|Disease Progression|2|||
19640121|NCT00467779|42089674|FG002|Stage 1|Disease Progression|2|||
19640122|NCT00467779|42089675|FG003|Stage 1|Disease Progression|3|||
19640123|NCT00467779|42089676|FG004|Stage 1|Disease Progression|2|||
19640124|NCT00467779|42089677|FG005|Stage 1|Disease Progression|2|||
19640125|NCT00467779|42089678|FG006|Stage 1|Disease Progression|4|||
19640126|NCT00467779|42089679|FG007|Stage 1|Disease Progression|5|||
19640127|NCT00467779|42089680|FG008|Stage 1|Disease Progression|0|||
19640128|NCT00467779|42089681|FG009|Stage 1|Disease Progression|0|||
19640129|NCT00467779|42089682|FG010|Stage 1|Disease Progression|0|||
19640130|NCT00467779|42089683|FG011|Stage 1|Disease Progression|0|||
19640131|NCT00467779|42089684|FG012|Stage 1|Disease Progression|0|||
19640132|NCT00467779|42089685|FG013|Stage 1|Disease Progression|0|||
19640133|NCT00467779|42089686|FG014|Stage 1|Disease Progression|0|||
19640134|NCT00467779|42089672|FG000|Stage 1|Unspecified Reason|1|||
19640135|NCT00467779|42089673|FG001|Stage 1|Unspecified Reason|0|||
19640136|NCT00467779|42089674|FG002|Stage 1|Unspecified Reason|1|||
19640137|NCT00467779|42089675|FG003|Stage 1|Unspecified Reason|0|||
19640138|NCT00467779|42089676|FG004|Stage 1|Unspecified Reason|1|||
19640139|NCT00467779|42089677|FG005|Stage 1|Unspecified Reason|2|||
19640140|NCT00467779|42089678|FG006|Stage 1|Unspecified Reason|0|||
19640141|NCT00467779|42089679|FG007|Stage 1|Unspecified Reason|0|||
19640142|NCT00467779|42089680|FG008|Stage 1|Unspecified Reason|0|||
19640143|NCT00467779|42089681|FG009|Stage 1|Unspecified Reason|0|||
19640144|NCT00467779|42089682|FG010|Stage 1|Unspecified Reason|0|||
19640145|NCT00467779|42089683|FG011|Stage 1|Unspecified Reason|0|||
19640146|NCT00467779|42089684|FG012|Stage 1|Unspecified Reason|0|||
19640147|NCT00467779|42089685|FG013|Stage 1|Unspecified Reason|0|||
19640148|NCT00467779|42089686|FG014|Stage 1|Unspecified Reason|0|||
19640149|NCT00467779|42089672|FG000|Stage 1|Physician Decision|0|||
19640150|NCT00467779|42089673|FG001|Stage 1|Physician Decision|1|||
19640151|NCT00467779|42089674|FG002|Stage 1|Physician Decision|0|||
19640152|NCT00467779|42089675|FG003|Stage 1|Physician Decision|0|||
19640153|NCT00467779|42089676|FG004|Stage 1|Physician Decision|0|||
19640154|NCT00467779|42089677|FG005|Stage 1|Physician Decision|0|||
19640155|NCT00467779|42089678|FG006|Stage 1|Physician Decision|0|||
19640156|NCT00467779|42089679|FG007|Stage 1|Physician Decision|0|||
19640157|NCT00467779|42089680|FG008|Stage 1|Physician Decision|0|||
19640158|NCT00467779|42089681|FG009|Stage 1|Physician Decision|0|||
19640159|NCT00467779|42089682|FG010|Stage 1|Physician Decision|0|||
19640160|NCT00467779|42089683|FG011|Stage 1|Physician Decision|0|||
19640161|NCT00467779|42089684|FG012|Stage 1|Physician Decision|0|||
19640162|NCT00467779|42089685|FG013|Stage 1|Physician Decision|0|||
19640163|NCT00467779|42089686|FG014|Stage 1|Physician Decision|0|||
19640164|NCT00467779|42089672|FG000|Stage 1|Withdrawal by Subject|0|||
19640165|NCT00467779|42089673|FG001|Stage 1|Withdrawal by Subject|0|||
19640166|NCT00467779|42089674|FG002|Stage 1|Withdrawal by Subject|0|||
19640167|NCT00467779|42089675|FG003|Stage 1|Withdrawal by Subject|0|||
19640168|NCT00467779|42089676|FG004|Stage 1|Withdrawal by Subject|0|||
19640169|NCT00467779|42089677|FG005|Stage 1|Withdrawal by Subject|0|||
19640170|NCT00467779|42089678|FG006|Stage 1|Withdrawal by Subject|1|||
19640171|NCT00467779|42089679|FG007|Stage 1|Withdrawal by Subject|1|||
19640172|NCT00467779|42089680|FG008|Stage 1|Withdrawal by Subject|0|||
19640173|NCT00467779|42089681|FG009|Stage 1|Withdrawal by Subject|0|||
19640174|NCT00467779|42089682|FG010|Stage 1|Withdrawal by Subject|0|||
19640175|NCT00467779|42089683|FG011|Stage 1|Withdrawal by Subject|0|||
19640176|NCT00467779|42089684|FG012|Stage 1|Withdrawal by Subject|0|||
19640177|NCT00467779|42089685|FG013|Stage 1|Withdrawal by Subject|0|||
19640178|NCT00467779|42089686|FG014|Stage 1|Withdrawal by Subject|0|||
19640179|NCT00467779|42089672|FG000|Stage 1A|Adverse Event|0|||
19640180|NCT00467779|42089673|FG001|Stage 1A|Adverse Event|0|||
19640181|NCT00467779|42089674|FG002|Stage 1A|Adverse Event|0|||
19748050|NCT03358407|42195728|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19640182|NCT00467779|42089675|FG003|Stage 1A|Adverse Event|0|||
19640183|NCT00467779|42089676|FG004|Stage 1A|Adverse Event|0|||
19640184|NCT00467779|42089677|FG005|Stage 1A|Adverse Event|0|||
19640185|NCT00467779|42089678|FG006|Stage 1A|Adverse Event|0|||
19640186|NCT00467779|42089679|FG007|Stage 1A|Adverse Event|0|||
19640187|NCT00467779|42089680|FG008|Stage 1A|Adverse Event|0|||
19640188|NCT00467779|42089681|FG009|Stage 1A|Adverse Event|0|||
19640189|NCT00467779|42089682|FG010|Stage 1A|Adverse Event|0|||
19640190|NCT00467779|42089683|FG011|Stage 1A|Adverse Event|0|||
19640191|NCT00467779|42089684|FG012|Stage 1A|Adverse Event|1|||
19640192|NCT00467779|42089685|FG013|Stage 1A|Adverse Event|0|||
19640193|NCT00467779|42089686|FG014|Stage 1A|Adverse Event|0|||
19640194|NCT00467779|42089672|FG000|Stage 1A|Death|0|||
19640195|NCT00467779|42089673|FG001|Stage 1A|Death|0|||
19640196|NCT00467779|42089674|FG002|Stage 1A|Death|0|||
19640197|NCT00467779|42089675|FG003|Stage 1A|Death|0|||
19640198|NCT00467779|42089676|FG004|Stage 1A|Death|0|||
19640199|NCT00467779|42089677|FG005|Stage 1A|Death|0|||
19640200|NCT00467779|42089678|FG006|Stage 1A|Death|0|||
19640201|NCT00467779|42089679|FG007|Stage 1A|Death|0|||
19640202|NCT00467779|42089680|FG008|Stage 1A|Death|0|||
19640203|NCT00467779|42089681|FG009|Stage 1A|Death|0|||
19640204|NCT00467779|42089682|FG010|Stage 1A|Death|0|||
19640205|NCT00467779|42089683|FG011|Stage 1A|Death|1|||
19640206|NCT00467779|42089684|FG012|Stage 1A|Death|1|||
19640207|NCT00467779|42089685|FG013|Stage 1A|Death|0|||
19640208|NCT00467779|42089686|FG014|Stage 1A|Death|0|||
19640209|NCT00467779|42089672|FG000|Stage 1A|Disease Progression|0|||
19640210|NCT00467779|42089673|FG001|Stage 1A|Disease Progression|0|||
19640211|NCT00467779|42089674|FG002|Stage 1A|Disease Progression|0|||
19640212|NCT00467779|42089675|FG003|Stage 1A|Disease Progression|0|||
19640213|NCT00467779|42089676|FG004|Stage 1A|Disease Progression|0|||
19640214|NCT00467779|42089677|FG005|Stage 1A|Disease Progression|0|||
19599680|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
19599681|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
19599682|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
19599683|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
19599684|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
19599685|NCT03611751|42048532|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
19599686|NCT03611751|42048533|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
19599687|NCT03611751|42048534|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
19640215|NCT00467779|42089678|FG006|Stage 1A|Disease Progression|0|||
19640216|NCT00467779|42089679|FG007|Stage 1A|Disease Progression|0|||
19640217|NCT00467779|42089680|FG008|Stage 1A|Disease Progression|0|||
19640218|NCT00467779|42089681|FG009|Stage 1A|Disease Progression|2|||
19640219|NCT00467779|42089682|FG010|Stage 1A|Disease Progression|2|||
19640220|NCT00467779|42089683|FG011|Stage 1A|Disease Progression|5|||
19640221|NCT00467779|42089684|FG012|Stage 1A|Disease Progression|2|||
19640222|NCT00467779|42089685|FG013|Stage 1A|Disease Progression|0|||
19640223|NCT00467779|42089686|FG014|Stage 1A|Disease Progression|0|||
19640224|NCT00467779|42089672|FG000|Stage 1A|Physician Decision|0|||
19640225|NCT00467779|42089673|FG001|Stage 1A|Physician Decision|0|||
19640226|NCT00467779|42089674|FG002|Stage 1A|Physician Decision|0|||
19640227|NCT00467779|42089675|FG003|Stage 1A|Physician Decision|0|||
19640228|NCT00467779|42089676|FG004|Stage 1A|Physician Decision|0|||
19640229|NCT00467779|42089677|FG005|Stage 1A|Physician Decision|0|||
19640230|NCT00467779|42089678|FG006|Stage 1A|Physician Decision|0|||
19640231|NCT00467779|42089679|FG007|Stage 1A|Physician Decision|0|||
19640232|NCT00467779|42089680|FG008|Stage 1A|Physician Decision|0|||
19640233|NCT00467779|42089681|FG009|Stage 1A|Physician Decision|1|||
19640234|NCT00467779|42089682|FG010|Stage 1A|Physician Decision|0|||
19640235|NCT00467779|42089683|FG011|Stage 1A|Physician Decision|0|||
19640236|NCT00467779|42089684|FG012|Stage 1A|Physician Decision|0|||
19640237|NCT00467779|42089685|FG013|Stage 1A|Physician Decision|0|||
19640238|NCT00467779|42089686|FG014|Stage 1A|Physician Decision|0|||
19640239|NCT00467779|42089672|FG000|Stage 1A|Withdrawal by Subject|0|||
19640240|NCT00467779|42089673|FG001|Stage 1A|Withdrawal by Subject|0|||
19640241|NCT00467779|42089674|FG002|Stage 1A|Withdrawal by Subject|0|||
19640242|NCT00467779|42089675|FG003|Stage 1A|Withdrawal by Subject|0|||
19640243|NCT00467779|42089676|FG004|Stage 1A|Withdrawal by Subject|0|||
19640244|NCT00467779|42089677|FG005|Stage 1A|Withdrawal by Subject|0|||
19640245|NCT00467779|42089678|FG006|Stage 1A|Withdrawal by Subject|0|||
19640246|NCT00467779|42089679|FG007|Stage 1A|Withdrawal by Subject|0|||
19640247|NCT00467779|42089680|FG008|Stage 1A|Withdrawal by Subject|0|||
19640248|NCT00467779|42089681|FG009|Stage 1A|Withdrawal by Subject|0|||
19640249|NCT00467779|42089682|FG010|Stage 1A|Withdrawal by Subject|1|||
19640250|NCT00467779|42089683|FG011|Stage 1A|Withdrawal by Subject|1|||
19640251|NCT00467779|42089684|FG012|Stage 1A|Withdrawal by Subject|1|||
19640252|NCT00467779|42089685|FG013|Stage 1A|Withdrawal by Subject|0|||
19640253|NCT00467779|42089686|FG014|Stage 1A|Withdrawal by Subject|0|||
19640254|NCT00467779|42089672|FG000|Stage 1A|Unspecified Reason|0|||
19640255|NCT00467779|42089673|FG001|Stage 1A|Unspecified Reason|0|||
19640256|NCT00467779|42089674|FG002|Stage 1A|Unspecified Reason|0|||
19640257|NCT00467779|42089675|FG003|Stage 1A|Unspecified Reason|0|||
19640258|NCT00467779|42089676|FG004|Stage 1A|Unspecified Reason|0|||
19640259|NCT00467779|42089677|FG005|Stage 1A|Unspecified Reason|0|||
19599688|NCT00721123|42048551|FG000|Overall Study|Adverse Event|96|||
19599689|NCT00721123|42048551|FG000|Overall Study|Death|10|||
19640260|NCT00467779|42089678|FG006|Stage 1A|Unspecified Reason|0|||
19640261|NCT00467779|42089679|FG007|Stage 1A|Unspecified Reason|0|||
19640262|NCT00467779|42089680|FG008|Stage 1A|Unspecified Reason|0|||
19640263|NCT00467779|42089681|FG009|Stage 1A|Unspecified Reason|0|||
19640264|NCT00467779|42089682|FG010|Stage 1A|Unspecified Reason|0|||
19640265|NCT00467779|42089683|FG011|Stage 1A|Unspecified Reason|1|||
19640266|NCT00467779|42089684|FG012|Stage 1A|Unspecified Reason|1|||
19640267|NCT00467779|42089685|FG013|Stage 1A|Unspecified Reason|0|||
19640268|NCT00467779|42089686|FG014|Stage 1A|Unspecified Reason|0|||
19640269|NCT00467779|42089672|FG000|Stage 2|Adverse Event|0|||
19640270|NCT00467779|42089673|FG001|Stage 2|Adverse Event|0|||
19640271|NCT00467779|42089674|FG002|Stage 2|Adverse Event|0|||
19640272|NCT00467779|42089675|FG003|Stage 2|Adverse Event|0|||
19640273|NCT00467779|42089676|FG004|Stage 2|Adverse Event|0|||
19640274|NCT00467779|42089677|FG005|Stage 2|Adverse Event|0|||
19640275|NCT00467779|42089678|FG006|Stage 2|Adverse Event|0|||
19640276|NCT00467779|42089679|FG007|Stage 2|Adverse Event|0|||
19640277|NCT00467779|42089680|FG008|Stage 2|Adverse Event|1|||
19640278|NCT00467779|42089681|FG009|Stage 2|Adverse Event|0|||
19640279|NCT00467779|42089682|FG010|Stage 2|Adverse Event|0|||
19640280|NCT00467779|42089683|FG011|Stage 2|Adverse Event|0|||
19640281|NCT00467779|42089684|FG012|Stage 2|Adverse Event|0|||
19640282|NCT00467779|42089685|FG013|Stage 2|Adverse Event|0|||
19599690|NCT00721123|42048551|FG000|Overall Study|Insufficient Therapeutic Response|21|||
19599691|NCT00721123|42048551|FG000|Overall Study|Protocol Violation|1|||
19599692|NCT00721123|42048551|FG000|Overall Study|Refused Treatment|41|||
19599693|NCT00721123|42048551|FG000|Overall Study|Failure to Return|9|||
19599694|NCT00721123|42048551|FG000|Overall Study|Withdrawal by Subject|5|||
19599695|NCT00720499|42048571|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
19599696|NCT00720499|42048572|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19599697|NCT00720499|42048571|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
19599698|NCT00720499|42048572|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
19599699|NCT00720499|42048571|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
19599700|NCT00720499|42048572|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
19599701|NCT00724243|42048579|FG000|Overall Study|Lack of Efficacy|10|||
19748051|NCT03358407|42195729|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748052|NCT03358407|42195730|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
19748053|NCT03358407|42195731|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
19748054|NCT03358407|42195732|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748055|NCT03358407|42195733|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748056|NCT03358407|42195734|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
19748057|NCT03358407|42195725|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748058|NCT03358407|42195726|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748059|NCT03358407|42195727|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748060|NCT03358407|42195728|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748061|NCT03358407|42195729|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748062|NCT03358407|42195730|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
19748063|NCT03358407|42195731|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
19748064|NCT03358407|42195732|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
19748065|NCT03358407|42195733|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748066|NCT03358407|42195734|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
19748067|NCT02950545|42195776|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
19748068|NCT02950545|42195777|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
19748069|NCT02950545|42195778|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
19748070|NCT02950545|42195779|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
19748071|NCT02950545|42195780|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
19748072|NCT02950545|42195781|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
19748073|NCT02950545|42195776|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
19748074|NCT02950545|42195777|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
19748075|NCT02950545|42195778|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
19640283|NCT00467779|42089686|FG014|Stage 2|Adverse Event|0|||
19640284|NCT00467779|42089672|FG000|Stage 2|Death|0|||
19640285|NCT00467779|42089673|FG001|Stage 2|Death|0|||
19640286|NCT00467779|42089674|FG002|Stage 2|Death|0|||
19748076|NCT02950545|42195779|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
19748077|NCT02950545|42195780|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
19748078|NCT02950545|42195781|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
19599702|NCT00724243|42048579|FG000|Overall Study|Adverse Event|5|||
19599703|NCT00720343|42048583|FG000|Overall Study|Physician Decision|3|||
19599704|NCT00720343|42048583|FG000|Overall Study|No data|3|||
19599705|NCT00720109|42048589|FG000|Induction Period|Did not meet eligibility criteria|3|||
19599706|NCT00720109|42048590|FG001|Induction Period|Did not meet eligibility criteria|0|||
19599707|NCT00720109|42048591|FG002|Induction Period|Did not meet eligibility criteria|0|||
19599708|NCT00720109|42048589|FG000|Induction Period|Bone Marrow Transplant|2|||
19599709|NCT00720109|42048590|FG001|Induction Period|Bone Marrow Transplant|0|||
19599710|NCT00720109|42048591|FG002|Induction Period|Bone Marrow Transplant|0|||
19640287|NCT00467779|42089675|FG003|Stage 2|Death|0|||
19640288|NCT00467779|42089676|FG004|Stage 2|Death|0|||
19640289|NCT00467779|42089677|FG005|Stage 2|Death|0|||
19640290|NCT00467779|42089678|FG006|Stage 2|Death|0|||
19640291|NCT00467779|42089679|FG007|Stage 2|Death|0|||
19640292|NCT00467779|42089680|FG008|Stage 2|Death|1|||
19640293|NCT00467779|42089681|FG009|Stage 2|Death|0|||
19640294|NCT00467779|42089682|FG010|Stage 2|Death|0|||
19640295|NCT00467779|42089683|FG011|Stage 2|Death|0|||
19640296|NCT00467779|42089684|FG012|Stage 2|Death|0|||
19640297|NCT00467779|42089685|FG013|Stage 2|Death|0|||
19640298|NCT00467779|42089686|FG014|Stage 2|Death|0|||
19640299|NCT00467779|42089672|FG000|Stage 2|Disease Progression|0|||
19640300|NCT00467779|42089673|FG001|Stage 2|Disease Progression|0|||
19640301|NCT00467779|42089674|FG002|Stage 2|Disease Progression|0|||
19640302|NCT00467779|42089675|FG003|Stage 2|Disease Progression|0|||
19640303|NCT00467779|42089676|FG004|Stage 2|Disease Progression|0|||
19640304|NCT00467779|42089677|FG005|Stage 2|Disease Progression|0|||
19640305|NCT00467779|42089678|FG006|Stage 2|Disease Progression|0|||
19640306|NCT00467779|42089679|FG007|Stage 2|Disease Progression|0|||
19640307|NCT00467779|42089680|FG008|Stage 2|Disease Progression|16|||
19640308|NCT00467779|42089681|FG009|Stage 2|Disease Progression|0|||
19640309|NCT00467779|42089682|FG010|Stage 2|Disease Progression|0|||
19640310|NCT00467779|42089683|FG011|Stage 2|Disease Progression|0|||
19640311|NCT00467779|42089684|FG012|Stage 2|Disease Progression|0|||
19640312|NCT00467779|42089685|FG013|Stage 2|Disease Progression|0|||
19640313|NCT00467779|42089686|FG014|Stage 2|Disease Progression|0|||
19640314|NCT00467779|42089672|FG000|Stage 2|Unspecified Reason|0|||
19640315|NCT00467779|42089673|FG001|Stage 2|Unspecified Reason|0|||
19640316|NCT00467779|42089674|FG002|Stage 2|Unspecified Reason|0|||
19640317|NCT00467779|42089675|FG003|Stage 2|Unspecified Reason|0|||
19640318|NCT00467779|42089676|FG004|Stage 2|Unspecified Reason|0|||
19640319|NCT00467779|42089677|FG005|Stage 2|Unspecified Reason|0|||
19640320|NCT00467779|42089678|FG006|Stage 2|Unspecified Reason|0|||
19640321|NCT00467779|42089679|FG007|Stage 2|Unspecified Reason|0|||
19640322|NCT00467779|42089680|FG008|Stage 2|Unspecified Reason|3|||
19640323|NCT00467779|42089681|FG009|Stage 2|Unspecified Reason|0|||
19640324|NCT00467779|42089682|FG010|Stage 2|Unspecified Reason|0|||
19640325|NCT00467779|42089683|FG011|Stage 2|Unspecified Reason|0|||
19640326|NCT00467779|42089684|FG012|Stage 2|Unspecified Reason|0|||
19640327|NCT00467779|42089685|FG013|Stage 2|Unspecified Reason|0|||
19640328|NCT00467779|42089686|FG014|Stage 2|Unspecified Reason|0|||
19640329|NCT00467779|42089672|FG000|Stage 2A|Adverse Event|0|||
19640330|NCT00467779|42089673|FG001|Stage 2A|Adverse Event|0|||
19640331|NCT00467779|42089674|FG002|Stage 2A|Adverse Event|0|||
19640332|NCT00467779|42089675|FG003|Stage 2A|Adverse Event|0|||
19640333|NCT00467779|42089676|FG004|Stage 2A|Adverse Event|0|||
19640334|NCT00467779|42089677|FG005|Stage 2A|Adverse Event|0|||
19640335|NCT00467779|42089678|FG006|Stage 2A|Adverse Event|0|||
19640336|NCT00467779|42089679|FG007|Stage 2A|Adverse Event|0|||
19640337|NCT00467779|42089680|FG008|Stage 2A|Adverse Event|0|||
19640338|NCT00467779|42089681|FG009|Stage 2A|Adverse Event|0|||
19640339|NCT00467779|42089682|FG010|Stage 2A|Adverse Event|0|||
19748079|NCT02950545|42195776|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
19748080|NCT02950545|42195777|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
19748081|NCT02950545|42195778|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
19748082|NCT02950545|42195779|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
19748083|NCT02950545|42195780|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
19748084|NCT02950545|42195781|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
19748085|NCT02950545|42195776|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
19748086|NCT02950545|42195777|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
19748087|NCT02950545|42195778|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
19748088|NCT02950545|42195779|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
19748089|NCT02950545|42195780|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
19748090|NCT02950545|42195781|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
19748091|NCT02950545|42195776|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
19748092|NCT02950545|42195777|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
19748093|NCT02950545|42195778|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
19748094|NCT02950545|42195779|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
19748095|NCT02950545|42195780|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
19748096|NCT02950545|42195781|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
19640340|NCT00467779|42089683|FG011|Stage 2A|Adverse Event|0|||
19640341|NCT00467779|42089684|FG012|Stage 2A|Adverse Event|0|||
19640342|NCT00467779|42089685|FG013|Stage 2A|Adverse Event|2|||
19640343|NCT00467779|42089686|FG014|Stage 2A|Adverse Event|0|||
19640344|NCT00467779|42089672|FG000|Stage 2A|Death|0|||
19640345|NCT00467779|42089673|FG001|Stage 2A|Death|0|||
19640346|NCT00467779|42089674|FG002|Stage 2A|Death|0|||
19640347|NCT00467779|42089675|FG003|Stage 2A|Death|0|||
19640348|NCT00467779|42089676|FG004|Stage 2A|Death|0|||
19640349|NCT00467779|42089677|FG005|Stage 2A|Death|0|||
19640350|NCT00467779|42089678|FG006|Stage 2A|Death|0|||
19640351|NCT00467779|42089679|FG007|Stage 2A|Death|0|||
19640352|NCT00467779|42089680|FG008|Stage 2A|Death|0|||
19640353|NCT00467779|42089681|FG009|Stage 2A|Death|0|||
19640354|NCT00467779|42089682|FG010|Stage 2A|Death|0|||
19640355|NCT00467779|42089683|FG011|Stage 2A|Death|0|||
19748097|NCT03358329|42195787|FG000|Overall Study|Lost to Follow-up|2|||
19748098|NCT03358329|42195787|FG000|Overall Study|Withdrawal by Subject|2|||
19748099|NCT03357471|42195803|FG000|Overall Study|Adverse Event|1|||
19748100|NCT03357471|42195804|FG001|Overall Study|Adverse Event|0|||
19748101|NCT03357471|42195803|FG000|Overall Study|Lost to Follow-up|1|||
19748102|NCT03357471|42195804|FG001|Overall Study|Lost to Follow-up|0|||
19748103|NCT03356145|42195812|FG000|Overall Study|Withdrawal by Subject|2|||
19748104|NCT03356145|42195813|FG001|Overall Study|Withdrawal by Subject|1|||
19599711|NCT00720109|42048589|FG000|Induction Period|Physician Decision|1|||
19599712|NCT00720109|42048590|FG001|Induction Period|Physician Decision|0|||
19599713|NCT00720109|42048591|FG002|Induction Period|Physician Decision|0|||
19599714|NCT00720109|42048589|FG000|Risk Stratification Period|Adverse Event|0|||
19599715|NCT00720109|42048590|FG001|Risk Stratification Period|Adverse Event|1|||
19599716|NCT00720109|42048591|FG002|Risk Stratification Period|Adverse Event|0|||
19599717|NCT00720109|42048589|FG000|Risk Stratification Period|Physician Decision|0|||
19599718|NCT00720109|42048590|FG001|Risk Stratification Period|Physician Decision|2|||
19599719|NCT00720109|42048591|FG002|Risk Stratification Period|Physician Decision|1|||
19599720|NCT00720109|42048589|FG000|Risk Stratification Period|Bone marrow transplant|0|||
19599721|NCT00720109|42048590|FG001|Risk Stratification Period|Bone marrow transplant|9|||
19599722|NCT00720109|42048591|FG002|Risk Stratification Period|Bone marrow transplant|7|||
19599723|NCT00720109|42048589|FG000|Risk Stratification Period|Disease progression or relapse|0|||
19599724|NCT00720109|42048590|FG001|Risk Stratification Period|Disease progression or relapse|2|||
19599725|NCT00720109|42048591|FG002|Risk Stratification Period|Disease progression or relapse|0|||
19599726|NCT00720109|42048589|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
19599727|NCT00720109|42048590|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
19599728|NCT00720109|42048591|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
19599729|NCT01705977|42048602|FG000|Overall Study|Withdrawal by Subject|128|||
19599730|NCT01705977|42048603|FG001|Overall Study|Withdrawal by Subject|128|||
19599731|NCT01705977|42048602|FG000|Overall Study|Adverse Event|57|||
19599732|NCT01705977|42048603|FG001|Overall Study|Adverse Event|49|||
19599733|NCT01705977|42048602|FG000|Overall Study|Protocol Violation|2|||
19599734|NCT01705977|42048603|FG001|Overall Study|Protocol Violation|4|||
19599735|NCT01705977|42048602|FG000|Overall Study|Site closure|3|||
19599736|NCT01705977|42048603|FG001|Overall Study|Site closure|2|||
19599737|NCT01705977|42048602|FG000|Overall Study|Lost to Follow-up|33|||
19599738|NCT01705977|42048603|FG001|Overall Study|Lost to Follow-up|37|||
19599739|NCT01705977|42048602|FG000|Overall Study|Physician Decision|48|||
19640356|NCT00467779|42089684|FG012|Stage 2A|Death|0|||
19640357|NCT00467779|42089685|FG013|Stage 2A|Death|1|||
19640358|NCT00467779|42089686|FG014|Stage 2A|Death|0|||
19640359|NCT00467779|42089672|FG000|Stage 2A|Disease Progression|0|||
19640360|NCT00467779|42089673|FG001|Stage 2A|Disease Progression|0|||
19640361|NCT00467779|42089674|FG002|Stage 2A|Disease Progression|0|||
19640362|NCT00467779|42089675|FG003|Stage 2A|Disease Progression|0|||
19640363|NCT00467779|42089676|FG004|Stage 2A|Disease Progression|0|||
19640364|NCT00467779|42089677|FG005|Stage 2A|Disease Progression|0|||
19640365|NCT00467779|42089678|FG006|Stage 2A|Disease Progression|0|||
19599740|NCT01705977|42048603|FG001|Overall Study|Physician Decision|38|||
19599741|NCT01705977|42048602|FG000|Overall Study|Missing study conclusion form|2|||
19640366|NCT00467779|42089679|FG007|Stage 2A|Disease Progression|0|||
19640367|NCT00467779|42089680|FG008|Stage 2A|Disease Progression|0|||
19640368|NCT00467779|42089681|FG009|Stage 2A|Disease Progression|0|||
19640369|NCT00467779|42089682|FG010|Stage 2A|Disease Progression|0|||
19640370|NCT00467779|42089683|FG011|Stage 2A|Disease Progression|0|||
19599742|NCT01705977|42048603|FG001|Overall Study|Missing study conclusion form|2|||
19599743|NCT01015118|42048611|FG000|Overall Study|Protocol Violation|5|||
19599744|NCT01015118|42048612|FG001|Overall Study|Protocol Violation|6|||
19599745|NCT01015118|42048611|FG000|Overall Study|Withdrawal by Subject|103|||
19599746|NCT01015118|42048612|FG001|Overall Study|Withdrawal by Subject|27|||
19599747|NCT01015118|42048611|FG000|Overall Study|Other Adverse Event (AE)|141|||
19599748|NCT01015118|42048612|FG001|Overall Study|Other Adverse Event (AE)|33|||
19599749|NCT01015118|42048611|FG000|Overall Study|Worsening or AE of underlying disease|5|||
19599750|NCT01015118|42048612|FG001|Overall Study|Worsening or AE of underlying disease|4|||
19599751|NCT01015118|42048611|FG000|Overall Study|Progressive disease|364|||
19599752|NCT01015118|42048612|FG001|Overall Study|Progressive disease|229|||
19599753|NCT01015118|42048611|FG000|Overall Study|Not treated|9|||
19599754|NCT01015118|42048612|FG001|Overall Study|Not treated|5|||
19599755|NCT01015118|42048611|FG000|Overall Study|Other than stated above|42|||
19640371|NCT00467779|42089684|FG012|Stage 2A|Disease Progression|0|||
19640372|NCT00467779|42089685|FG013|Stage 2A|Disease Progression|10|||
19599756|NCT01015118|42048612|FG001|Overall Study|Other than stated above|23|||
19599757|NCT00800176|42048624|FG000|Overall Study|Adverse Event|2|||
19640373|NCT00467779|42089686|FG014|Stage 2A|Disease Progression|0|||
19640374|NCT00467779|42089672|FG000|Stage 2A|Unspecified Reason|0|||
19640375|NCT00467779|42089673|FG001|Stage 2A|Unspecified Reason|0|||
19640376|NCT00467779|42089674|FG002|Stage 2A|Unspecified Reason|0|||
19748105|NCT03356145|42195812|FG000|Overall Study|Did not meet inclusion criteria|1|||
19640377|NCT00467779|42089675|FG003|Stage 2A|Unspecified Reason|0|||
19640378|NCT00467779|42089676|FG004|Stage 2A|Unspecified Reason|0|||
19640379|NCT00467779|42089677|FG005|Stage 2A|Unspecified Reason|0|||
19640380|NCT00467779|42089678|FG006|Stage 2A|Unspecified Reason|0|||
19640381|NCT00467779|42089679|FG007|Stage 2A|Unspecified Reason|0|||
19640382|NCT00467779|42089680|FG008|Stage 2A|Unspecified Reason|0|||
19640383|NCT00467779|42089681|FG009|Stage 2A|Unspecified Reason|0|||
19640384|NCT00467779|42089682|FG010|Stage 2A|Unspecified Reason|0|||
19640385|NCT00467779|42089683|FG011|Stage 2A|Unspecified Reason|0|||
19640386|NCT00467779|42089684|FG012|Stage 2A|Unspecified Reason|0|||
19640387|NCT00467779|42089685|FG013|Stage 2A|Unspecified Reason|7|||
19640388|NCT00467779|42089686|FG014|Stage 2A|Unspecified Reason|0|||
19640389|NCT00467779|42089672|FG000|Stage 2A|Withdrawal by Subject|0|||
19640390|NCT00467779|42089673|FG001|Stage 2A|Withdrawal by Subject|0|||
19640391|NCT00467779|42089674|FG002|Stage 2A|Withdrawal by Subject|0|||
19640392|NCT00467779|42089675|FG003|Stage 2A|Withdrawal by Subject|0|||
19640393|NCT00467779|42089676|FG004|Stage 2A|Withdrawal by Subject|0|||
19640394|NCT00467779|42089677|FG005|Stage 2A|Withdrawal by Subject|0|||
19640395|NCT00467779|42089678|FG006|Stage 2A|Withdrawal by Subject|0|||
19640396|NCT00467779|42089679|FG007|Stage 2A|Withdrawal by Subject|0|||
19640397|NCT00467779|42089680|FG008|Stage 2A|Withdrawal by Subject|0|||
19640398|NCT00467779|42089681|FG009|Stage 2A|Withdrawal by Subject|0|||
19640399|NCT00467779|42089682|FG010|Stage 2A|Withdrawal by Subject|0|||
19640400|NCT00467779|42089683|FG011|Stage 2A|Withdrawal by Subject|0|||
19640401|NCT00467779|42089684|FG012|Stage 2A|Withdrawal by Subject|0|||
19640402|NCT00467779|42089685|FG013|Stage 2A|Withdrawal by Subject|1|||
19640403|NCT00467779|42089686|FG014|Stage 2A|Withdrawal by Subject|0|||
19748106|NCT03356145|42195813|FG001|Overall Study|Did not meet inclusion criteria|0|||
19748107|NCT03342963|42195823|FG000|Overall Study|Adverse Event|1|||
19748108|NCT03342963|42195824|FG001|Overall Study|Adverse Event|2|||
19748109|NCT03342963|42195825|FG002|Overall Study|Adverse Event|0|||
19640404|NCT00467779|42089672|FG000|Stage 3|Adverse Event|0|||
19640405|NCT00467779|42089673|FG001|Stage 3|Adverse Event|0|||
19640406|NCT00467779|42089674|FG002|Stage 3|Adverse Event|0|||
19640407|NCT00467779|42089675|FG003|Stage 3|Adverse Event|0|||
19640408|NCT00467779|42089676|FG004|Stage 3|Adverse Event|0|||
19640409|NCT00467779|42089677|FG005|Stage 3|Adverse Event|0|||
19640410|NCT00467779|42089678|FG006|Stage 3|Adverse Event|0|||
19640411|NCT00467779|42089679|FG007|Stage 3|Adverse Event|0|||
19640412|NCT00467779|42089680|FG008|Stage 3|Adverse Event|0|||
19640413|NCT00467779|42089681|FG009|Stage 3|Adverse Event|0|||
19640414|NCT00467779|42089682|FG010|Stage 3|Adverse Event|0|||
19640415|NCT00467779|42089683|FG011|Stage 3|Adverse Event|0|||
19640416|NCT00467779|42089684|FG012|Stage 3|Adverse Event|0|||
19640417|NCT00467779|42089685|FG013|Stage 3|Adverse Event|0|||
19640418|NCT00467779|42089686|FG014|Stage 3|Adverse Event|2|||
19640419|NCT00467779|42089672|FG000|Stage 3|Death|0|||
19640420|NCT00467779|42089673|FG001|Stage 3|Death|0|||
19640421|NCT00467779|42089674|FG002|Stage 3|Death|0|||
19640422|NCT00467779|42089675|FG003|Stage 3|Death|0|||
19640423|NCT00467779|42089676|FG004|Stage 3|Death|0|||
19640424|NCT00467779|42089677|FG005|Stage 3|Death|0|||
19640425|NCT00467779|42089678|FG006|Stage 3|Death|0|||
19640426|NCT00467779|42089679|FG007|Stage 3|Death|0|||
19640427|NCT00467779|42089680|FG008|Stage 3|Death|0|||
19640428|NCT00467779|42089681|FG009|Stage 3|Death|0|||
19640429|NCT00467779|42089682|FG010|Stage 3|Death|0|||
19640430|NCT00467779|42089683|FG011|Stage 3|Death|0|||
19748110|NCT03342963|42195826|FG003|Overall Study|Adverse Event|0|||
19640431|NCT00467779|42089684|FG012|Stage 3|Death|0|||
19640432|NCT00467779|42089685|FG013|Stage 3|Death|0|||
19640433|NCT00467779|42089686|FG014|Stage 3|Death|1|||
19640434|NCT00467779|42089672|FG000|Stage 3|Disease Progression|0|||
19640435|NCT00467779|42089673|FG001|Stage 3|Disease Progression|0|||
19640436|NCT00467779|42089674|FG002|Stage 3|Disease Progression|0|||
19640437|NCT00467779|42089675|FG003|Stage 3|Disease Progression|0|||
19640438|NCT00467779|42089676|FG004|Stage 3|Disease Progression|0|||
19640439|NCT00467779|42089677|FG005|Stage 3|Disease Progression|0|||
19640440|NCT00467779|42089678|FG006|Stage 3|Disease Progression|0|||
19640441|NCT00467779|42089679|FG007|Stage 3|Disease Progression|0|||
19640442|NCT00467779|42089680|FG008|Stage 3|Disease Progression|0|||
19640443|NCT00467779|42089681|FG009|Stage 3|Disease Progression|0|||
19640444|NCT00467779|42089682|FG010|Stage 3|Disease Progression|0|||
19640445|NCT00467779|42089683|FG011|Stage 3|Disease Progression|0|||
19640446|NCT00467779|42089684|FG012|Stage 3|Disease Progression|0|||
19640447|NCT00467779|42089685|FG013|Stage 3|Disease Progression|0|||
19640448|NCT00467779|42089686|FG014|Stage 3|Disease Progression|9|||
19748111|NCT03342963|42195823|FG000|Overall Study|Withdrawal by Subject|1|||
19640449|NCT00467779|42089672|FG000|Stage 3|Unspecified Reason|0|||
19640450|NCT00467779|42089673|FG001|Stage 3|Unspecified Reason|0|||
19640451|NCT00467779|42089674|FG002|Stage 3|Unspecified Reason|0|||
19640452|NCT00467779|42089675|FG003|Stage 3|Unspecified Reason|0|||
19640453|NCT00467779|42089676|FG004|Stage 3|Unspecified Reason|0|||
19640454|NCT00467779|42089677|FG005|Stage 3|Unspecified Reason|0|||
19640455|NCT00467779|42089678|FG006|Stage 3|Unspecified Reason|0|||
19640456|NCT00467779|42089679|FG007|Stage 3|Unspecified Reason|0|||
19640457|NCT00467779|42089680|FG008|Stage 3|Unspecified Reason|0|||
19640458|NCT00467779|42089681|FG009|Stage 3|Unspecified Reason|0|||
19640459|NCT00467779|42089682|FG010|Stage 3|Unspecified Reason|0|||
19640460|NCT00467779|42089683|FG011|Stage 3|Unspecified Reason|0|||
19640461|NCT00467779|42089684|FG012|Stage 3|Unspecified Reason|0|||
19640462|NCT00467779|42089685|FG013|Stage 3|Unspecified Reason|0|||
19640463|NCT00467779|42089686|FG014|Stage 3|Unspecified Reason|5|||
19640464|NCT00570687|42089726|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640465|NCT00570687|42089727|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640466|NCT00570687|42089728|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640467|NCT00570687|42089729|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640468|NCT00570687|42089730|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
19640469|NCT00570687|42089731|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
19640470|NCT00570687|42089732|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
19640471|NCT00570687|42089733|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
19640472|NCT00570687|42089734|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
19640473|NCT00570687|42089735|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
19640474|NCT00570687|42089726|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640475|NCT00570687|42089727|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640476|NCT00570687|42089728|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640477|NCT00570687|42089729|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640478|NCT00570687|42089730|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640479|NCT00570687|42089731|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640480|NCT00570687|42089732|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640481|NCT00570687|42089733|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640482|NCT00570687|42089734|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
19640483|NCT00570687|42089735|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640484|NCT00570687|42089726|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640485|NCT00570687|42089727|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640486|NCT00570687|42089728|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640487|NCT00570687|42089729|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640488|NCT00570687|42089730|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640489|NCT00570687|42089731|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640490|NCT00570687|42089732|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
19640491|NCT00570687|42089733|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640492|NCT00570687|42089734|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640493|NCT00570687|42089735|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
19640494|NCT03836677|42089749|FG000|Period 1|Adverse Event|0|||
19640495|NCT03836677|42089750|FG001|Period 1|Adverse Event|1|||
19640496|NCT03836677|42089749|FG000|Period 2|Severe non-compliance to protocol|1|||
19640497|NCT03836677|42089750|FG001|Period 2|Severe non-compliance to protocol|0|||
19640498|NCT00434161|42089781|FG000|Overall Study|Adverse Event|5|||
19477036|NCT01492361|41755747|FG000|Overall Study|Physician Decision|12|||
19599758|NCT00800176|42048625|FG001|Overall Study|Adverse Event|1|||
19599759|NCT00800176|42048626|FG002|Overall Study|Adverse Event|0|||
19599760|NCT00800176|42048627|FG003|Overall Study|Adverse Event|2|||
19599761|NCT00800176|42048628|FG004|Overall Study|Adverse Event|1|||
19599762|NCT00800176|42048629|FG005|Overall Study|Adverse Event|1|||
19599763|NCT00800176|42048624|FG000|Overall Study|Refused treatment|3|||
19599764|NCT00800176|42048625|FG001|Overall Study|Refused treatment|2|||
19599765|NCT00800176|42048626|FG002|Overall Study|Refused treatment|0|||
19599766|NCT00800176|42048627|FG003|Overall Study|Refused treatment|0|||
19599767|NCT00800176|42048628|FG004|Overall Study|Refused treatment|1|||
19599768|NCT00800176|42048629|FG005|Overall Study|Refused treatment|4|||
19599769|NCT00800176|42048624|FG000|Overall Study|Failure to return|3|||
19640499|NCT00434161|42089782|FG001|Overall Study|Adverse Event|1|||
19477037|NCT01492361|41755748|FG001|Overall Study|Physician Decision|12|||
19640500|NCT00434161|42089783|FG002|Overall Study|Adverse Event|4|||
19640501|NCT00434161|42089781|FG000|Overall Study|Lost to Follow-up|0|||
19640502|NCT00434161|42089782|FG001|Overall Study|Lost to Follow-up|1|||
19640503|NCT00434161|42089783|FG002|Overall Study|Lost to Follow-up|0|||
19599770|NCT00800176|42048625|FG001|Overall Study|Failure to return|3|||
19599771|NCT00800176|42048626|FG002|Overall Study|Failure to return|0|||
19599772|NCT00800176|42048627|FG003|Overall Study|Failure to return|2|||
19599773|NCT00800176|42048628|FG004|Overall Study|Failure to return|0|||
19599774|NCT00800176|42048629|FG005|Overall Study|Failure to return|0|||
19599775|NCT00800176|42048624|FG000|Overall Study|Other|1|||
19477038|NCT01492361|41755747|FG000|Overall Study|Lost to Follow-up|6|||
19599776|NCT00800176|42048625|FG001|Overall Study|Other|0|||
19599777|NCT00800176|42048626|FG002|Overall Study|Other|0|||
19599778|NCT00800176|42048627|FG003|Overall Study|Other|0|||
19599779|NCT00800176|42048628|FG004|Overall Study|Other|2|||
19599780|NCT00800176|42048629|FG005|Overall Study|Other|0|||
19599781|NCT00715429|42048645|FG000|Overall Study|Did not complete the study diary|0|||
19599782|NCT00715429|42048646|FG001|Overall Study|Did not complete the study diary|1|||
19599783|NCT00715117|42048668|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
19599784|NCT00715117|42048669|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
19599785|NCT00723229|42048682|FG000|First Intervention|Lost to Follow-up|7|||
19599786|NCT00723229|42048683|FG001|First Intervention|Lost to Follow-up|3|||
19599787|NCT01030718|42048698|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
19599788|NCT01030718|42048699|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
19599789|NCT01030718|42048700|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
19599790|NCT01030718|42048698|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
19599791|NCT01030718|42048699|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
19599792|NCT01030718|42048700|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
19599793|NCT01030718|42048698|FG000|Studies CA180-031 and -036 Combined|Death|0|||
19599794|NCT01030718|42048699|FG001|Studies CA180-031 and -036 Combined|Death|1|||
19599795|NCT01030718|42048700|FG002|Studies CA180-031 and -036 Combined|Death|0|||
19599796|NCT01030718|42048698|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
19599797|NCT01030718|42048699|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
19599798|NCT01030718|42048700|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
19599799|NCT01030718|42048698|FG000|Study CA180-036 Only|insufficient effect|1|||
19599800|NCT01030718|42048699|FG001|Study CA180-036 Only|insufficient effect|1|||
19599801|NCT01030718|42048700|FG002|Study CA180-036 Only|insufficient effect|5|||
19599802|NCT01030718|42048698|FG000|Study CA180-036 Only|Adverse Event|2|||
19599803|NCT01030718|42048699|FG001|Study CA180-036 Only|Adverse Event|3|||
19599804|NCT01030718|42048700|FG002|Study CA180-036 Only|Adverse Event|0|||
19599805|NCT01030718|42048698|FG000|Study CA180-036 Only|Death|0|||
19599806|NCT01030718|42048699|FG001|Study CA180-036 Only|Death|1|||
19599807|NCT01030718|42048700|FG002|Study CA180-036 Only|Death|0|||
19599808|NCT01030718|42048698|FG000|Study CA180-036 Only|Other Reasons|0|||
19599809|NCT01030718|42048699|FG001|Study CA180-036 Only|Other Reasons|2|||
19599810|NCT01030718|42048700|FG002|Study CA180-036 Only|Other Reasons|0|||
19599811|NCT00722761|42048720|FG000|Overall Study|Lost to Follow-up|1|||
19599812|NCT00722761|42048721|FG001|Overall Study|Lost to Follow-up|4|||
19599813|NCT00722761|42048720|FG000|Overall Study|Withdrawal by Subject|5|||
19599814|NCT00722761|42048721|FG001|Overall Study|Withdrawal by Subject|2|||
19599815|NCT00719953|42048727|FG000|Overall Study|Adverse Event|4|||
19599816|NCT01019486|42048734|FG000|Overall Study|Withdrawal by Subject|1|||
19599817|NCT01019486|42048735|FG001|Overall Study|Withdrawal by Subject|1|||
19599818|NCT01019486|42048736|FG002|Overall Study|Withdrawal by Subject|1|||
19599819|NCT00714493|42048745|FG000|Overall Study|Adverse Event|11|||
19599820|NCT00714493|42048745|FG000|Overall Study|Death|3|||
19599821|NCT00714493|42048745|FG000|Overall Study|Lack of Efficacy|10|||
19599822|NCT00714493|42048745|FG000|Overall Study|Lost to Follow-up|3|||
19599823|NCT00714493|42048745|FG000|Overall Study|Protocol Violation|12|||
19599824|NCT00714493|42048745|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
19599825|NCT00714493|42048745|FG000|Overall Study|OTHER|2|||
19599826|NCT01019252|42048751|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
19599827|NCT01019252|42048752|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
19599828|NCT01019252|42048751|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
19599829|NCT01019252|42048752|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
19599830|NCT01019252|42048751|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
19599831|NCT01019252|42048752|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
19599832|NCT01019252|42048751|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
19599833|NCT01019252|42048752|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
19599834|NCT01013870|42048760|FG000|Overall Study|Lost to Follow-up|1|||
19599835|NCT01013870|42048761|FG001|Overall Study|Lost to Follow-up|3|||
19599836|NCT01013792|42048769|FG000|Overall Study|Study suspended|2|||
19599837|NCT01013792|42048770|FG001|Overall Study|Study suspended|1|||
19599838|NCT01013792|42048769|FG000|Overall Study|Adverse Event|0|||
19599839|NCT01013792|42048770|FG001|Overall Study|Adverse Event|3|||
19640504|NCT00434161|42089781|FG000|Overall Study|Death|1|||
19640505|NCT00434161|42089782|FG001|Overall Study|Death|0|||
19640506|NCT00434161|42089783|FG002|Overall Study|Death|1|||
19640507|NCT00434161|42089781|FG000|Overall Study|Non-Compliance|1|||
19640508|NCT00434161|42089782|FG001|Overall Study|Non-Compliance|1|||
19640509|NCT00434161|42089783|FG002|Overall Study|Non-Compliance|0|||
19640510|NCT00434161|42089781|FG000|Overall Study|Withdrawal by Subject|2|||
19640511|NCT00434161|42089782|FG001|Overall Study|Withdrawal by Subject|0|||
19640512|NCT00434161|42089783|FG002|Overall Study|Withdrawal by Subject|3|||
19640513|NCT00434161|42089781|FG000|Overall Study|Logistical error study assessments|1|||
19640514|NCT00434161|42089782|FG001|Overall Study|Logistical error study assessments|0|||
19640515|NCT00434161|42089783|FG002|Overall Study|Logistical error study assessments|3|||
19640516|NCT00441103|42089800|FG000|Overall Study|Adverse Event|2|||
19640517|NCT00441103|42089801|FG001|Overall Study|Adverse Event|1|||
19640518|NCT00441103|42089800|FG000|Overall Study|Death|1|||
19640519|NCT00441103|42089801|FG001|Overall Study|Death|0|||
19640520|NCT00441103|42089800|FG000|Overall Study|Disease Progression|2|||
19640521|NCT00441103|42089801|FG001|Overall Study|Disease Progression|0|||
19640522|NCT00441103|42089800|FG000|Overall Study|Lost to Follow-up|1|||
19640523|NCT00441103|42089801|FG001|Overall Study|Lost to Follow-up|0|||
19640524|NCT00441103|42089800|FG000|Overall Study|Protocol Violation|1|||
19640525|NCT00441103|42089801|FG001|Overall Study|Protocol Violation|0|||
19640526|NCT00441103|42089800|FG000|Overall Study|Participant unable to use Rebiject II|1|||
19640527|NCT00441103|42089801|FG001|Overall Study|Participant unable to use Rebiject II|0|||
19640528|NCT00441103|42089800|FG000|Overall Study|Participant refused MRI|1|||
19640529|NCT00441103|42089801|FG001|Overall Study|Participant refused MRI|0|||
19640530|NCT00441103|42089800|FG000|Overall Study|Inclusion criteria absent|1|||
19640531|NCT00441103|42089801|FG001|Overall Study|Inclusion criteria absent|0|||
19640532|NCT00441103|42089800|FG000|Overall Study|Non-compliant|0|||
19640533|NCT00441103|42089801|FG001|Overall Study|Non-compliant|1|||
19640534|NCT00441103|42089800|FG000|Overall Study|Participant decided to withdraw|1|||
19640535|NCT00441103|42089801|FG001|Overall Study|Participant decided to withdraw|0|||
19640536|NCT00441103|42089800|FG000|Overall Study|Participant's reason|0|||
19640537|NCT00441103|42089801|FG001|Overall Study|Participant's reason|1|||
19640538|NCT00441103|42089800|FG000|Overall Study|Participant decided to stop|0|||
19640539|NCT00441103|42089801|FG001|Overall Study|Participant decided to stop|1|||
19640540|NCT00433771|42089808|FG000|Overall Study|screen fail|14|||
19640541|NCT00433771|42089808|FG000|Overall Study|Treated and later found to be ineligible|2|||
19640542|NCT00433771|42089808|FG000|Overall Study|Death|2|||
19640543|NCT00433771|42089808|FG000|Overall Study|Failure to deploy stent|1|||
19640544|NCT00433537|42089812|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
19640545|NCT00433537|42089813|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
19640546|NCT00433537|42089814|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
19640547|NCT00433537|42089812|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
19640548|NCT00433537|42089813|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
19640549|NCT00433537|42089814|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
19640550|NCT00433537|42089812|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
19640551|NCT00433537|42089813|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
19640552|NCT00433537|42089814|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
19640553|NCT00433537|42089812|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
19640554|NCT00433537|42089813|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
19748112|NCT03342963|42195824|FG001|Overall Study|Withdrawal by Subject|0|||
19748113|NCT03342963|42195825|FG002|Overall Study|Withdrawal by Subject|0|||
19748114|NCT03342963|42195826|FG003|Overall Study|Withdrawal by Subject|0|||
19748115|NCT03361956|42195841|FG000|Overall Study|Adverse Event|1|||
19748116|NCT03361956|42195842|FG001|Overall Study|Adverse Event|0|||
19748117|NCT03361956|42195843|FG002|Overall Study|Adverse Event|1|||
19748118|NCT03361956|42195844|FG003|Overall Study|Adverse Event|1|||
19748119|NCT03361956|42195845|FG004|Overall Study|Adverse Event|0|||
19748120|NCT03361956|42195841|FG000|Overall Study|Other|0|||
19748121|NCT03361956|42195842|FG001|Overall Study|Other|0|||
19748122|NCT03361956|42195843|FG002|Overall Study|Other|0|||
19748123|NCT03361956|42195844|FG003|Overall Study|Other|1|||
19748124|NCT03361956|42195845|FG004|Overall Study|Other|0|||
19748125|NCT03361956|42195841|FG000|Overall Study|Withdrawal by Subject|2|||
19748126|NCT03361956|42195842|FG001|Overall Study|Withdrawal by Subject|2|||
19748127|NCT03361956|42195843|FG002|Overall Study|Withdrawal by Subject|2|||
19477039|NCT01492361|41755748|FG001|Overall Study|Lost to Follow-up|13|||
19640555|NCT00433537|42089814|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
19640556|NCT00433537|42089812|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
19640557|NCT00433537|42089813|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
19640558|NCT00433537|42089814|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
19640559|NCT00433537|42089812|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
19748128|NCT03361956|42195844|FG003|Overall Study|Withdrawal by Subject|0|||
19748129|NCT03361956|42195845|FG004|Overall Study|Withdrawal by Subject|3|||
19748130|NCT03361956|42195841|FG000|Overall Study|Disease Relapse|0|||
19748131|NCT03361956|42195842|FG001|Overall Study|Disease Relapse|0|||
19748132|NCT03361956|42195843|FG002|Overall Study|Disease Relapse|1|||
19748133|NCT03361956|42195844|FG003|Overall Study|Disease Relapse|0|||
19748134|NCT03361956|42195845|FG004|Overall Study|Disease Relapse|0|||
19748135|NCT03361956|42195841|FG000|Overall Study|Physician Decision|0|||
19748136|NCT03361956|42195842|FG001|Overall Study|Physician Decision|2|||
19748137|NCT03361956|42195843|FG002|Overall Study|Physician Decision|0|||
19748138|NCT03361956|42195844|FG003|Overall Study|Physician Decision|1|||
19748139|NCT03361956|42195845|FG004|Overall Study|Physician Decision|0|||
19640560|NCT00433537|42089813|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
19640561|NCT00433537|42089814|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
19640562|NCT00433537|42089812|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
19640563|NCT00433537|42089813|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
19640564|NCT00433537|42089814|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
19640565|NCT00433537|42089812|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
19640566|NCT00433537|42089813|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
19640567|NCT00433537|42089814|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
19640568|NCT00433537|42089812|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
19640569|NCT00433537|42089813|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
19640570|NCT00433537|42089814|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
19640571|NCT00570765|42089824|FG000|DB Phase|Withdrawal by Subject|1|||
19640572|NCT00570765|42089825|FG001|DB Phase|Withdrawal by Subject|0|||
19640573|NCT00570765|42089826|FG002|DB Phase|Withdrawal by Subject|0|||
19640574|NCT00570765|42089827|FG003|DB Phase|Withdrawal by Subject|0|||
19640575|NCT00570765|42089824|FG000|DB Phase|Protocol Violation|0|||
19640576|NCT00570765|42089825|FG001|DB Phase|Protocol Violation|1|||
19640577|NCT00570765|42089826|FG002|DB Phase|Protocol Violation|0|||
19640578|NCT00570765|42089827|FG003|DB Phase|Protocol Violation|0|||
19640579|NCT00570765|42089824|FG000|DB Phase|Adverse Event|3|||
19640580|NCT00570765|42089825|FG001|DB Phase|Adverse Event|6|||
19640581|NCT00570765|42089826|FG002|DB Phase|Adverse Event|0|||
19640582|NCT00570765|42089827|FG003|DB Phase|Adverse Event|0|||
19640583|NCT00570765|42089824|FG000|DB Phase|Did Not Receive Study Drug|0|||
19640584|NCT00570765|42089825|FG001|DB Phase|Did Not Receive Study Drug|0|||
19599840|NCT01013792|42048769|FG000|Overall Study|Lost to Follow-up|0|||
19599841|NCT01013792|42048770|FG001|Overall Study|Lost to Follow-up|1|||
19599842|NCT01018862|42048779|FG000|Overall Study|Adverse Event|2|||
19599843|NCT01018862|42048780|FG001|Overall Study|Adverse Event|0|||
19599844|NCT01018862|42048781|FG002|Overall Study|Adverse Event|6|||
19599845|NCT01018862|42048779|FG000|Overall Study|Lack of Efficacy|1|||
19599846|NCT01018862|42048780|FG001|Overall Study|Lack of Efficacy|0|||
19599847|NCT01018862|42048781|FG002|Overall Study|Lack of Efficacy|2|||
19599848|NCT01018862|42048779|FG000|Overall Study|Lost to Follow-up|3|||
19599849|NCT01018862|42048780|FG001|Overall Study|Lost to Follow-up|1|||
19599850|NCT01018862|42048781|FG002|Overall Study|Lost to Follow-up|0|||
19599851|NCT01018862|42048779|FG000|Overall Study|Protocol Violation|1|||
19599852|NCT01018862|42048780|FG001|Overall Study|Protocol Violation|3|||
19599853|NCT01018862|42048781|FG002|Overall Study|Protocol Violation|3|||
19599854|NCT01018862|42048779|FG000|Overall Study|Withdrawal by Subject|1|||
19599855|NCT01018862|42048780|FG001|Overall Study|Withdrawal by Subject|2|||
19599856|NCT01018862|42048781|FG002|Overall Study|Withdrawal by Subject|1|||
19599857|NCT01018862|42048779|FG000|Overall Study|administrative problems|5|||
19599858|NCT01018862|42048780|FG001|Overall Study|administrative problems|4|||
19599859|NCT01018862|42048781|FG002|Overall Study|administrative problems|4|||
19599860|NCT01018394|42048791|FG000|Overall Study|Withdrawal by Subject|5|||
19599861|NCT01018394|42048792|FG001|Overall Study|Withdrawal by Subject|5|||
19599862|NCT01018394|42048791|FG000|Overall Study|Lost to Follow-up|4|||
19599863|NCT01018394|42048792|FG001|Overall Study|Lost to Follow-up|3|||
19599864|NCT01017146|42048800|FG000|Overall Study|Adverse Event|11|||
19599865|NCT01017146|42048801|FG001|Overall Study|Adverse Event|1|||
19599866|NCT01017146|42048800|FG000|Overall Study|Lost to Follow-up|14|||
19599867|NCT01017146|42048801|FG001|Overall Study|Lost to Follow-up|14|||
19599868|NCT01017146|42048800|FG000|Overall Study|Noncompliance with Study Product|1|||
19599869|NCT01017146|42048801|FG001|Overall Study|Noncompliance with Study Product|1|||
19599870|NCT01017146|42048800|FG000|Overall Study|Withdrawal by Subject|32|||
19640585|NCT00570765|42089826|FG002|DB Phase|Did Not Receive Study Drug|1|||
19640586|NCT00570765|42089827|FG003|DB Phase|Did Not Receive Study Drug|0|||
19640587|NCT00570765|42089824|FG000|LTSE Phase|Withdrawal by Subject|0|||
19640588|NCT00570765|42089825|FG001|LTSE Phase|Withdrawal by Subject|0|||
19640589|NCT00570765|42089826|FG002|LTSE Phase|Withdrawal by Subject|0|||
19748140|NCT03361956|42195841|FG000|Overall Study|Lost to Follow-up|0|||
19748141|NCT03361956|42195842|FG001|Overall Study|Lost to Follow-up|0|||
19599871|NCT01017146|42048801|FG001|Overall Study|Withdrawal by Subject|16|||
19748142|NCT03361956|42195843|FG002|Overall Study|Lost to Follow-up|1|||
19599872|NCT01017146|42048800|FG000|Overall Study|Relocation|0|||
19599873|NCT01017146|42048801|FG001|Overall Study|Relocation|4|||
19599874|NCT01017146|42048800|FG000|Overall Study|Pregnancy|2|||
19599875|NCT01017146|42048801|FG001|Overall Study|Pregnancy|1|||
19599876|NCT01017146|42048800|FG000|Overall Study|Protocol Violation|2|||
19599877|NCT01017146|42048801|FG001|Overall Study|Protocol Violation|0|||
19599878|NCT01017146|42048800|FG000|Overall Study|Took Excluded Medication|2|||
19599879|NCT01017146|42048801|FG001|Overall Study|Took Excluded Medication|0|||
19599880|NCT01017146|42048800|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
19599881|NCT01017146|42048801|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
19599882|NCT01017146|42048800|FG000|Overall Study|Change in Work Situation|1|||
19599883|NCT01017146|42048801|FG001|Overall Study|Change in Work Situation|0|||
19599884|NCT01010750|42048813|FG000|Second Intervention|Adverse Event|0|||
19640590|NCT00570765|42089827|FG003|LTSE Phase|Withdrawal by Subject|1|||
19640591|NCT00570765|42089824|FG000|LTSE Phase|Adverse Event|0|||
19640592|NCT00570765|42089825|FG001|LTSE Phase|Adverse Event|0|||
19640593|NCT00570765|42089826|FG002|LTSE Phase|Adverse Event|0|||
19640594|NCT00570765|42089827|FG003|LTSE Phase|Adverse Event|7|||
19640595|NCT00570765|42089824|FG000|LTSE Phase|Physician Decision|0|||
19640596|NCT00570765|42089825|FG001|LTSE Phase|Physician Decision|0|||
19640597|NCT00570765|42089826|FG002|LTSE Phase|Physician Decision|0|||
19640598|NCT00570765|42089827|FG003|LTSE Phase|Physician Decision|4|||
19640599|NCT00667563|42089838|FG000|Overall Study|Protocol Violation|24|||
19640600|NCT00667095|42089844|FG000|Overall Study|Withdrawal by Subject|0|||
19640601|NCT00667095|42089845|FG001|Overall Study|Withdrawal by Subject|1|||
19640602|NCT00433381|42089853|FG000|Overall Study|Ineligible / no protocol treatment|3|||
19640603|NCT00433381|42089854|FG001|Overall Study|Ineligible / no protocol treatment|3|||
19640604|NCT00667017|42089868|FG000|Overall Study|Withdrawal by Subject|1|||
19640605|NCT00666705|42089872|FG000|Overall Study|Withdrawal by Subject|1|||
19640606|NCT00433147|42089885|FG000|Overall Study|Adverse Event|0|||
19640607|NCT00433147|42089886|FG001|Overall Study|Adverse Event|1|||
19640608|NCT00433147|42089887|FG002|Overall Study|Adverse Event|0|||
19640609|NCT00433147|42089888|FG003|Overall Study|Adverse Event|0|||
19640610|NCT00666237|42089900|FG000|Overall Study|Death|5|||
19640611|NCT00666237|42089901|FG001|Overall Study|Death|5|||
19640612|NCT00666237|42089900|FG000|Overall Study|Lost to Follow-up|29|||
19640613|NCT00666237|42089901|FG001|Overall Study|Lost to Follow-up|25|||
19640614|NCT00662025|42089907|FG000|Overall Study|Objective progression or relapse|51|||
19640615|NCT00662025|42089907|FG000|Overall Study|Adverse Event|7|||
19640616|NCT00662025|42089907|FG000|Overall Study|Withdrawal by Subject|1|||
19640617|NCT00662025|42089907|FG000|Overall Study|Results of other clinical study|2|||
19640618|NCT00662025|42089907|FG000|Overall Study|Target lesion cannot be evaluated|1|||
19640619|NCT00662025|42089907|FG000|Overall Study|Domestic circumstances|1|||
19640620|NCT00440947|42089911|FG000|36-Week Induction Phase|Adverse Event|16|||
19640621|NCT00440947|42089912|FG001|36-Week Induction Phase|Adverse Event|0|||
19640622|NCT00440947|42089913|FG002|36-Week Induction Phase|Adverse Event|0|||
19640623|NCT00440947|42089914|FG003|36-Week Induction Phase|Adverse Event|0|||
19640624|NCT00440947|42089915|FG004|36-Week Induction Phase|Adverse Event|0|||
19640625|NCT00440947|42089911|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
19640626|NCT00440947|42089912|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
19640627|NCT00440947|42089913|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
19640628|NCT00440947|42089914|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
19640629|NCT00440947|42089915|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
19748143|NCT03361956|42195844|FG003|Overall Study|Lost to Follow-up|1|||
19640630|NCT00440947|42089911|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
19640631|NCT00440947|42089912|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
19599885|NCT01010750|42048814|FG001|Second Intervention|Adverse Event|1|||
19599886|NCT01010750|42048815|FG002|Second Intervention|Adverse Event|0|||
19599887|NCT01010750|42048816|FG003|Second Intervention|Adverse Event|0|||
19599888|NCT01010750|42048817|FG004|Second Intervention|Adverse Event|0|||
19599889|NCT01010750|42048818|FG005|Second Intervention|Adverse Event|0|||
19599890|NCT01012622|42048826|FG000|Overall Study|Withdrawal by Subject|6|||
19599891|NCT01012622|42048826|FG000|Overall Study|Lost to Follow-up|5|||
19599892|NCT01012622|42048826|FG000|Overall Study|Adverse Event|7|||
19640632|NCT00440947|42089913|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
19640633|NCT00440947|42089914|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
19640634|NCT00440947|42089915|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
19640635|NCT00440947|42089911|FG000|36-Week Induction Phase|Non-compliance|10|||
19599893|NCT01012622|42048826|FG000|Overall Study|non-compliance with the drug|9|||
19640636|NCT00440947|42089912|FG001|36-Week Induction Phase|Non-compliance|0|||
19640637|NCT00440947|42089913|FG002|36-Week Induction Phase|Non-compliance|0|||
19640638|NCT00440947|42089914|FG003|36-Week Induction Phase|Non-compliance|0|||
19640639|NCT00440947|42089915|FG004|36-Week Induction Phase|Non-compliance|0|||
19640640|NCT00440947|42089911|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
19640641|NCT00440947|42089912|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
19748144|NCT03361956|42195845|FG004|Overall Study|Lost to Follow-up|2|||
19388108|NCT00708305|41631493|FG001|Period 1|Protocol Violation|0|||
19599894|NCT01012622|42048826|FG000|Overall Study|Other|1|||
19599895|NCT01012622|42048826|FG000|Overall Study|screening failure|1|||
19599896|NCT01012622|42048826|FG000|Overall Study|withdrawal of consent by a parent|2|||
19599897|NCT00722371|42048837|FG000|Overall Study|Adverse Event|6|||
19599898|NCT00722371|42048838|FG001|Overall Study|Adverse Event|13|||
19599899|NCT00722371|42048839|FG002|Overall Study|Adverse Event|9|||
19599900|NCT00722371|42048840|FG003|Overall Study|Adverse Event|10|||
19599901|NCT00722371|42048841|FG004|Overall Study|Adverse Event|6|||
19599902|NCT00722371|42048842|FG005|Overall Study|Adverse Event|8|||
19599903|NCT00722371|42048843|FG006|Overall Study|Adverse Event|4|||
19599904|NCT00722371|42048837|FG000|Overall Study|Contraindication|0|||
19599905|NCT00722371|42048838|FG001|Overall Study|Contraindication|0|||
19599906|NCT00722371|42048839|FG002|Overall Study|Contraindication|1|||
19599907|NCT00722371|42048840|FG003|Overall Study|Contraindication|0|||
19599908|NCT00722371|42048841|FG004|Overall Study|Contraindication|0|||
19599909|NCT00722371|42048842|FG005|Overall Study|Contraindication|0|||
19640642|NCT00440947|42089913|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
19640643|NCT00440947|42089914|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
19599910|NCT00722371|42048843|FG006|Overall Study|Contraindication|0|||
19599911|NCT00722371|42048837|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
19599912|NCT00722371|42048838|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
19599913|NCT00722371|42048839|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
19640644|NCT00440947|42089915|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
19640645|NCT00440947|42089911|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
19640646|NCT00440947|42089912|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
19640647|NCT00440947|42089913|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
19640648|NCT00440947|42089914|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
19640649|NCT00440947|42089915|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
19640650|NCT00440947|42089911|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
19640651|NCT00440947|42089912|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
19640652|NCT00440947|42089913|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
19640653|NCT00440947|42089914|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
19640654|NCT00440947|42089915|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
19640655|NCT00440947|42089911|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
19640656|NCT00440947|42089912|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
19640657|NCT00440947|42089913|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
19640658|NCT00440947|42089914|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
19640659|NCT00440947|42089915|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
19640660|NCT00440947|42089911|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
19640661|NCT00440947|42089912|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
19640662|NCT00440947|42089913|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
19640663|NCT00440947|42089914|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
19640664|NCT00440947|42089915|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
19640665|NCT00440947|42089911|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
19640666|NCT00440947|42089912|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
19640667|NCT00440947|42089913|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
19640668|NCT00440947|42089914|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
19640669|NCT00440947|42089915|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
19640670|NCT00440947|42089911|FG000|36-Week Induction Phase|Incarceration|3|||
19640671|NCT00440947|42089912|FG001|36-Week Induction Phase|Incarceration|0|||
19640672|NCT00440947|42089913|FG002|36-Week Induction Phase|Incarceration|0|||
19640673|NCT00440947|42089914|FG003|36-Week Induction Phase|Incarceration|0|||
19640674|NCT00440947|42089915|FG004|36-Week Induction Phase|Incarceration|0|||
19640675|NCT00440947|42089911|FG000|36-Week Induction Phase|Pregnancy|1|||
19640676|NCT00440947|42089912|FG001|36-Week Induction Phase|Pregnancy|0|||
19640677|NCT00440947|42089913|FG002|36-Week Induction Phase|Pregnancy|0|||
19640678|NCT00440947|42089914|FG003|36-Week Induction Phase|Pregnancy|0|||
19640679|NCT00440947|42089915|FG004|36-Week Induction Phase|Pregnancy|0|||
19640680|NCT00440947|42089911|FG000|48-Week Randomization Phase|Adverse Event|0|||
19640681|NCT00440947|42089912|FG001|48-Week Randomization Phase|Adverse Event|2|||
19640682|NCT00440947|42089913|FG002|48-Week Randomization Phase|Adverse Event|5|||
19640683|NCT00440947|42089914|FG003|48-Week Randomization Phase|Adverse Event|0|||
19640684|NCT00440947|42089915|FG004|48-Week Randomization Phase|Adverse Event|0|||
19640685|NCT00440947|42089911|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
19640686|NCT00440947|42089912|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
19640687|NCT00440947|42089913|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
19640688|NCT00440947|42089914|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
19640689|NCT00440947|42089915|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
19640690|NCT00440947|42089911|FG000|48-Week Randomization Phase|Non-compliance|0|||
19640691|NCT00440947|42089912|FG001|48-Week Randomization Phase|Non-compliance|3|||
19599914|NCT00722371|42048840|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
19640692|NCT00440947|42089913|FG002|48-Week Randomization Phase|Non-compliance|4|||
19640693|NCT00440947|42089914|FG003|48-Week Randomization Phase|Non-compliance|0|||
19640694|NCT00440947|42089915|FG004|48-Week Randomization Phase|Non-compliance|0|||
19640695|NCT00440947|42089911|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
19640696|NCT00440947|42089912|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
19640697|NCT00440947|42089913|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
19640698|NCT00440947|42089914|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
19640699|NCT00440947|42089915|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
19640700|NCT00440947|42089911|FG000|48-Week Randomization Phase|Protocol Violation|0|||
19640701|NCT00440947|42089912|FG001|48-Week Randomization Phase|Protocol Violation|0|||
19640702|NCT00440947|42089913|FG002|48-Week Randomization Phase|Protocol Violation|1|||
19640703|NCT00440947|42089914|FG003|48-Week Randomization Phase|Protocol Violation|0|||
19640704|NCT00440947|42089915|FG004|48-Week Randomization Phase|Protocol Violation|0|||
19640705|NCT00440947|42089911|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
19640706|NCT00440947|42089912|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
19640707|NCT00440947|42089913|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
19640708|NCT00440947|42089914|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
19640709|NCT00440947|42089915|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
19640710|NCT00440947|42089911|FG000|48-Week Randomization Phase|Pregnancy|0|||
19640711|NCT00440947|42089912|FG001|48-Week Randomization Phase|Pregnancy|0|||
19640712|NCT00440947|42089913|FG002|48-Week Randomization Phase|Pregnancy|1|||
19640713|NCT00440947|42089914|FG003|48-Week Randomization Phase|Pregnancy|0|||
19640714|NCT00440947|42089915|FG004|48-Week Randomization Phase|Pregnancy|0|||
19640715|NCT00440947|42089911|FG000|48-Week Randomization Phase|Incarceration|0|||
19640716|NCT00440947|42089912|FG001|48-Week Randomization Phase|Incarceration|3|||
19640717|NCT00440947|42089913|FG002|48-Week Randomization Phase|Incarceration|0|||
19640718|NCT00440947|42089914|FG003|48-Week Randomization Phase|Incarceration|0|||
19640719|NCT00440947|42089915|FG004|48-Week Randomization Phase|Incarceration|0|||
19640720|NCT00440947|42089911|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
19640721|NCT00440947|42089912|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
19640722|NCT00440947|42089913|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
19640723|NCT00440947|42089914|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
19640724|NCT00440947|42089915|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
19640725|NCT00440947|42089911|FG000|48-Week Randomization Phase|Physician Decision|0|||
19640726|NCT00440947|42089912|FG001|48-Week Randomization Phase|Physician Decision|2|||
19640727|NCT00440947|42089913|FG002|48-Week Randomization Phase|Physician Decision|0|||
19640728|NCT00440947|42089914|FG003|48-Week Randomization Phase|Physician Decision|0|||
19640729|NCT00440947|42089915|FG004|48-Week Randomization Phase|Physician Decision|0|||
19640730|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
19640731|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
19640732|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
19640733|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
19640734|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
19640735|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
19748145|NCT03361176|42195916|FG000|Overall Study|Lost to Follow-up|1|||
19748146|NCT03361176|42195917|FG001|Overall Study|Lost to Follow-up|2|||
19748147|NCT03361176|42195916|FG000|Overall Study|Adverse Event|0|||
19748148|NCT03361176|42195917|FG001|Overall Study|Adverse Event|2|||
19748149|NCT03361176|42195916|FG000|Overall Study|Withdrawal by Subject|0|||
19748150|NCT03361176|42195917|FG001|Overall Study|Withdrawal by Subject|1|||
19748151|NCT05283499|42195925|FG000|Overall Study|Did not receive intervention|1|||
19748152|NCT05283499|42195926|FG001|Overall Study|Did not receive intervention|2|||
19748153|NCT05271175|42195935|FG000|One Week Follow up|Lost to Follow-up|10|||
19748154|NCT05271175|42195936|FG001|One Week Follow up|Lost to Follow-up|7|||
19748155|NCT05271175|42195937|FG002|One Week Follow up|Lost to Follow-up|5|||
19748156|NCT05271175|42195935|FG000|One Month Follow up|Lost to Follow-up|12|||
19748157|NCT05271175|42195936|FG001|One Month Follow up|Lost to Follow-up|7|||
19640736|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
19640737|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
19640738|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
19640739|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
19640740|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
19640741|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
19640742|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
19640743|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
19640744|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
19748158|NCT05271175|42195937|FG002|One Month Follow up|Lost to Follow-up|9|||
19748159|NCT05271175|42195935|FG000|Six Months Follow up|Lost to Follow-up|8|||
19640745|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
19640746|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
19640747|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
19640748|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
19640749|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
19640750|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
19640751|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
19640752|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
19640753|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
19640754|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
19640755|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
19640756|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
19640757|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
19640758|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
19640759|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
19640760|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
19640761|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
19640762|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
19640763|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
19640764|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
19640765|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
19640766|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
19640767|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
19640768|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
19640769|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
19640770|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
19640771|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
19640772|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
19640773|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
19640774|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
19640775|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
19640776|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
19640777|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
19640778|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
19640779|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
19640780|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
19640781|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
19640782|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
19640783|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
19640784|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
19640785|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Other|0|||
19640786|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Other|0|||
19748160|NCT05271175|42195936|FG001|Six Months Follow up|Lost to Follow-up|2|||
19748161|NCT05271175|42195937|FG002|Six Months Follow up|Lost to Follow-up|2|||
19640787|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Other|0|||
19640788|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Other|1|||
19640789|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Other|0|||
19640790|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
19640791|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
19640792|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
19640793|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
19640794|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
19640795|NCT00440947|42089911|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
19748162|NCT03098030|42195949|FG000|Overall Study|Death|10|||
19599915|NCT00722371|42048841|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
19599916|NCT00722371|42048842|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
19599917|NCT00722371|42048843|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
19599918|NCT00722371|42048837|FG000|Overall Study|Excluded medication|0|||
19599919|NCT00722371|42048838|FG001|Overall Study|Excluded medication|1|||
19599920|NCT00722371|42048839|FG002|Overall Study|Excluded medication|1|||
19599921|NCT00722371|42048840|FG003|Overall Study|Excluded medication|0|||
19599922|NCT00722371|42048841|FG004|Overall Study|Excluded medication|0|||
19599923|NCT00722371|42048842|FG005|Overall Study|Excluded medication|0|||
19599924|NCT00722371|42048843|FG006|Overall Study|Excluded medication|1|||
19599925|NCT00722371|42048837|FG000|Overall Study|Hyperglycemia|2|||
19599926|NCT00722371|42048838|FG001|Overall Study|Hyperglycemia|6|||
19640796|NCT00440947|42089912|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
19748163|NCT03098030|42195950|FG001|Overall Study|Death|156|||
19748164|NCT03098030|42195951|FG002|Overall Study|Death|156|||
19599927|NCT00722371|42048839|FG002|Overall Study|Hyperglycemia|4|||
19599928|NCT00722371|42048840|FG003|Overall Study|Hyperglycemia|2|||
19599929|NCT00722371|42048841|FG004|Overall Study|Hyperglycemia|5|||
19599930|NCT00722371|42048842|FG005|Overall Study|Hyperglycemia|1|||
19599931|NCT00722371|42048843|FG006|Overall Study|Hyperglycemia|1|||
19599932|NCT00722371|42048837|FG000|Overall Study|Hypoglycemia|1|||
19599933|NCT00722371|42048838|FG001|Overall Study|Hypoglycemia|0|||
19599934|NCT00722371|42048839|FG002|Overall Study|Hypoglycemia|0|||
19599935|NCT00722371|42048840|FG003|Overall Study|Hypoglycemia|0|||
19599936|NCT00722371|42048841|FG004|Overall Study|Hypoglycemia|0|||
19599937|NCT00722371|42048842|FG005|Overall Study|Hypoglycemia|0|||
19599938|NCT00722371|42048843|FG006|Overall Study|Hypoglycemia|0|||
19599939|NCT00722371|42048837|FG000|Overall Study|Lack of Efficacy|4|||
19599940|NCT00722371|42048838|FG001|Overall Study|Lack of Efficacy|6|||
19599941|NCT00722371|42048839|FG002|Overall Study|Lack of Efficacy|6|||
19599942|NCT00722371|42048840|FG003|Overall Study|Lack of Efficacy|6|||
19599943|NCT00722371|42048841|FG004|Overall Study|Lack of Efficacy|2|||
19599944|NCT00722371|42048842|FG005|Overall Study|Lack of Efficacy|3|||
19599945|NCT00722371|42048843|FG006|Overall Study|Lack of Efficacy|0|||
19599946|NCT00722371|42048837|FG000|Overall Study|Lost to Follow-up|11|||
19599947|NCT00722371|42048838|FG001|Overall Study|Lost to Follow-up|14|||
19599948|NCT00722371|42048839|FG002|Overall Study|Lost to Follow-up|21|||
19599949|NCT00722371|42048840|FG003|Overall Study|Lost to Follow-up|13|||
19599950|NCT00722371|42048841|FG004|Overall Study|Lost to Follow-up|8|||
19599951|NCT00722371|42048842|FG005|Overall Study|Lost to Follow-up|16|||
19599952|NCT00722371|42048843|FG006|Overall Study|Lost to Follow-up|13|||
19599953|NCT00722371|42048837|FG000|Overall Study|Physician Decision|5|||
19599954|NCT00722371|42048838|FG001|Overall Study|Physician Decision|2|||
19599955|NCT00722371|42048839|FG002|Overall Study|Physician Decision|2|||
19599956|NCT00722371|42048840|FG003|Overall Study|Physician Decision|5|||
19599957|NCT00722371|42048841|FG004|Overall Study|Physician Decision|2|||
19599958|NCT00722371|42048842|FG005|Overall Study|Physician Decision|3|||
19599959|NCT00722371|42048843|FG006|Overall Study|Physician Decision|4|||
19599960|NCT00722371|42048837|FG000|Overall Study|Pregnancy|1|||
19599961|NCT00722371|42048838|FG001|Overall Study|Pregnancy|1|||
19599962|NCT00722371|42048839|FG002|Overall Study|Pregnancy|0|||
19599963|NCT00722371|42048840|FG003|Overall Study|Pregnancy|0|||
19599964|NCT00722371|42048841|FG004|Overall Study|Pregnancy|0|||
19599965|NCT00722371|42048842|FG005|Overall Study|Pregnancy|1|||
19599966|NCT00722371|42048843|FG006|Overall Study|Pregnancy|0|||
19599967|NCT00722371|42048837|FG000|Overall Study|Protocol Violation|6|||
19599968|NCT00722371|42048838|FG001|Overall Study|Protocol Violation|1|||
19599969|NCT00722371|42048839|FG002|Overall Study|Protocol Violation|0|||
19599970|NCT00722371|42048840|FG003|Overall Study|Protocol Violation|1|||
19599971|NCT00722371|42048841|FG004|Overall Study|Protocol Violation|4|||
19599972|NCT00722371|42048842|FG005|Overall Study|Protocol Violation|2|||
19599973|NCT00722371|42048843|FG006|Overall Study|Protocol Violation|1|||
19599974|NCT00722371|42048837|FG000|Overall Study|Withdrawal by Subject|18|||
19599975|NCT00722371|42048838|FG001|Overall Study|Withdrawal by Subject|27|||
19599976|NCT00722371|42048839|FG002|Overall Study|Withdrawal by Subject|19|||
19599977|NCT00722371|42048840|FG003|Overall Study|Withdrawal by Subject|23|||
19599978|NCT00722371|42048841|FG004|Overall Study|Withdrawal by Subject|19|||
19599979|NCT00722371|42048842|FG005|Overall Study|Withdrawal by Subject|18|||
19599980|NCT00722371|42048843|FG006|Overall Study|Withdrawal by Subject|26|||
19640797|NCT00440947|42089913|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
19640798|NCT00440947|42089914|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
19640799|NCT00440947|42089915|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
19640800|NCT00664521|42089938|FG000|Overall Study|Adverse Event|4|||
19640801|NCT00664521|42089939|FG001|Overall Study|Adverse Event|1|||
19640802|NCT00664521|42089938|FG000|Overall Study|Lost to Follow-up|1|||
19640803|NCT00664521|42089939|FG001|Overall Study|Lost to Follow-up|0|||
19599981|NCT00722137|42048861|FG000|Overall Study|Overt Disease Progression|5|||
19640804|NCT00664521|42089938|FG000|Overall Study|Other|1|||
19640805|NCT00664521|42089939|FG001|Overall Study|Other|0|||
19599982|NCT00722137|42048862|FG001|Overall Study|Overt Disease Progression|4|||
19599983|NCT00722137|42048861|FG000|Overall Study|Adverse Event|17|||
19599984|NCT00722137|42048862|FG001|Overall Study|Adverse Event|21|||
19599985|NCT00722137|42048861|FG000|Overall Study|Death|12|||
19599986|NCT00722137|42048862|FG001|Overall Study|Death|7|||
19599987|NCT00722137|42048861|FG000|Overall Study|Withdrawal by Subject|6|||
19599988|NCT00722137|42048862|FG001|Overall Study|Withdrawal by Subject|9|||
19599989|NCT00722137|42048861|FG000|Overall Study|Other Reason Unknown|3|||
19640806|NCT00664209|42089945|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
19640807|NCT00664209|42089945|FG000|Study Treatment Period|Physician Decision|4|||
19640808|NCT00664209|42089945|FG000|Study Treatment Period|Withdrawal by Subject|2|||
19599990|NCT00722137|42048862|FG001|Overall Study|Other Reason Unknown|4|||
19599991|NCT00722137|42048861|FG000|Overall Study|Randomized But Not Treated|2|||
19599992|NCT00722137|42048862|FG001|Overall Study|Randomized But Not Treated|3|||
19599993|NCT02281084|42048872|FG000|Overall Study|Adverse Event|1|||
19640809|NCT00440557|42089953|FG000|Overall Study|Withdrawal by Subject|10|||
19640810|NCT00440557|42089954|FG001|Overall Study|Withdrawal by Subject|5|||
19640811|NCT00440557|42089955|FG002|Overall Study|Withdrawal by Subject|11|||
19640812|NCT00440557|42089953|FG000|Overall Study|Lost to Follow-up|1|||
19640813|NCT00440557|42089954|FG001|Overall Study|Lost to Follow-up|2|||
19640814|NCT00440557|42089955|FG002|Overall Study|Lost to Follow-up|6|||
19640815|NCT00440557|42089953|FG000|Overall Study|Adverse Event|3|||
19640816|NCT00440557|42089954|FG001|Overall Study|Adverse Event|3|||
19640817|NCT00440557|42089955|FG002|Overall Study|Adverse Event|5|||
19640818|NCT00440557|42089953|FG000|Overall Study|Death|2|||
19640819|NCT00440557|42089954|FG001|Overall Study|Death|6|||
19640820|NCT00440557|42089955|FG002|Overall Study|Death|3|||
19640821|NCT00440557|42089953|FG000|Overall Study|Began Dialysis|4|||
19640822|NCT00440557|42089954|FG001|Overall Study|Began Dialysis|1|||
19640823|NCT00440557|42089955|FG002|Overall Study|Began Dialysis|4|||
19640824|NCT00440557|42089953|FG000|Overall Study|Principal Investigator decision|0|||
19640825|NCT00440557|42089954|FG001|Overall Study|Principal Investigator decision|3|||
19640826|NCT00440557|42089955|FG002|Overall Study|Principal Investigator decision|1|||
19640827|NCT00440557|42089953|FG000|Overall Study|Patient moved|1|||
19640828|NCT00440557|42089954|FG001|Overall Study|Patient moved|2|||
19640829|NCT00440557|42089955|FG002|Overall Study|Patient moved|1|||
19640830|NCT00440557|42089953|FG000|Overall Study|Principal Investigator's office closed|3|||
19640831|NCT00440557|42089954|FG001|Overall Study|Principal Investigator's office closed|6|||
19640832|NCT00440557|42089955|FG002|Overall Study|Principal Investigator's office closed|4|||
19640833|NCT00440557|42089953|FG000|Overall Study|Patient transferred to nursing home|0|||
19640834|NCT00440557|42089954|FG001|Overall Study|Patient transferred to nursing home|1|||
19640835|NCT00440557|42089955|FG002|Overall Study|Patient transferred to nursing home|0|||
19640836|NCT00440557|42089953|FG000|Overall Study|Patient had surgery|1|||
19640837|NCT00440557|42089954|FG001|Overall Study|Patient had surgery|0|||
19640838|NCT00440557|42089955|FG002|Overall Study|Patient had surgery|0|||
19640839|NCT00582608|42090015|FG000|Overall Study|Not Treated|7|||
19640840|NCT00582608|42090015|FG000|Overall Study|Patient Ineligible|1|||
19640841|NCT00582608|42090015|FG000|Overall Study|Lack of accrual|4|||
19640842|NCT03014570|42090021|FG000|Overall Study|COVID-19 Restrictions|38|||
19640843|NCT03014570|42090022|FG001|Overall Study|COVID-19 Restrictions|24|||
19640844|NCT03014570|42090021|FG000|Overall Study|Death|70|||
19640845|NCT03014570|42090022|FG001|Overall Study|Death|79|||
19640846|NCT03014570|42090021|FG000|Overall Study|Transfer from facility|11|||
19640847|NCT03014570|42090022|FG001|Overall Study|Transfer from facility|14|||
19640848|NCT03014570|42090021|FG000|Overall Study|Hospitalized|5|||
19640849|NCT03014570|42090022|FG001|Overall Study|Hospitalized|3|||
19640850|NCT03014570|42090021|FG000|Overall Study|Transfer within facility|1|||
19640851|NCT03014570|42090022|FG001|Overall Study|Transfer within facility|0|||
19640852|NCT03014570|42090021|FG000|Overall Study|Site refusal|0|||
19640853|NCT03014570|42090022|FG001|Overall Study|Site refusal|11|||
19640854|NCT00427999|42090029|FG000|Overall Study|Adverse Event|6|||
19640855|NCT00427999|42090029|FG000|Overall Study|Abnormal laboratory values|1|||
19640856|NCT00427999|42090029|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
19640857|NCT00427999|42090029|FG000|Overall Study|Protocol Violation|2|||
19640858|NCT00427999|42090029|FG000|Overall Study|Withdrawal by Subject|9|||
19640859|NCT00427999|42090029|FG000|Overall Study|Death|1|||
19640860|NCT00661713|42090042|FG000|Overall Study|Death|1|||
19640861|NCT00661713|42090043|FG001|Overall Study|Death|0|||
19640862|NCT00661713|42090044|FG002|Overall Study|Death|0|||
19640863|NCT00661713|42090045|FG003|Overall Study|Death|0|||
19640864|NCT00661713|42090046|FG004|Overall Study|Death|1|||
19640865|NCT00661713|42090047|FG005|Overall Study|Death|0|||
19640866|NCT00661713|42090048|FG006|Overall Study|Death|0|||
19640867|NCT00661713|42090049|FG007|Overall Study|Death|0|||
19640868|NCT00661713|42090042|FG000|Overall Study|Unable to Classify|1|||
19640869|NCT00661713|42090043|FG001|Overall Study|Unable to Classify|0|||
19640870|NCT00661713|42090044|FG002|Overall Study|Unable to Classify|0|||
19640871|NCT00661713|42090045|FG003|Overall Study|Unable to Classify|0|||
19640872|NCT00661713|42090046|FG004|Overall Study|Unable to Classify|0|||
19640873|NCT00661713|42090047|FG005|Overall Study|Unable to Classify|0|||
19640874|NCT00661713|42090048|FG006|Overall Study|Unable to Classify|0|||
19640875|NCT00661713|42090049|FG007|Overall Study|Unable to Classify|0|||
19640876|NCT00661713|42090042|FG000|Overall Study|Protocol Violation|1|||
19748165|NCT03098030|42195952|FG003|Overall Study|Death|82|||
19640877|NCT00661713|42090043|FG001|Overall Study|Protocol Violation|6|||
19640878|NCT00661713|42090044|FG002|Overall Study|Protocol Violation|3|||
19640879|NCT00661713|42090045|FG003|Overall Study|Protocol Violation|3|||
19640880|NCT00661713|42090046|FG004|Overall Study|Protocol Violation|0|||
19640881|NCT00661713|42090047|FG005|Overall Study|Protocol Violation|2|||
19640882|NCT00661713|42090048|FG006|Overall Study|Protocol Violation|2|||
19640883|NCT00661713|42090049|FG007|Overall Study|Protocol Violation|1|||
19640884|NCT00661713|42090042|FG000|Overall Study|Withdrawal by Subject|11|||
19640885|NCT00661713|42090043|FG001|Overall Study|Withdrawal by Subject|25|||
19640886|NCT00661713|42090044|FG002|Overall Study|Withdrawal by Subject|12|||
19640887|NCT00661713|42090045|FG003|Overall Study|Withdrawal by Subject|21|||
19640888|NCT00661713|42090046|FG004|Overall Study|Withdrawal by Subject|12|||
19640889|NCT00661713|42090047|FG005|Overall Study|Withdrawal by Subject|26|||
19640890|NCT00661713|42090048|FG006|Overall Study|Withdrawal by Subject|45|||
19640891|NCT00661713|42090049|FG007|Overall Study|Withdrawal by Subject|9|||
19640892|NCT00661713|42090042|FG000|Overall Study|Lost to Follow-up|2|||
19640893|NCT00661713|42090043|FG001|Overall Study|Lost to Follow-up|7|||
19640894|NCT00661713|42090044|FG002|Overall Study|Lost to Follow-up|2|||
19640895|NCT00661713|42090045|FG003|Overall Study|Lost to Follow-up|2|||
19640896|NCT00661713|42090046|FG004|Overall Study|Lost to Follow-up|5|||
19640897|NCT00661713|42090047|FG005|Overall Study|Lost to Follow-up|7|||
19640898|NCT00661713|42090048|FG006|Overall Study|Lost to Follow-up|14|||
19640899|NCT00661713|42090049|FG007|Overall Study|Lost to Follow-up|1|||
19640900|NCT00661713|42090042|FG000|Overall Study|Administrative Reason|0|||
19640901|NCT00661713|42090043|FG001|Overall Study|Administrative Reason|1|||
19640902|NCT00661713|42090044|FG002|Overall Study|Administrative Reason|0|||
19640903|NCT00661713|42090045|FG003|Overall Study|Administrative Reason|2|||
19640904|NCT00661713|42090046|FG004|Overall Study|Administrative Reason|2|||
19640905|NCT00661713|42090047|FG005|Overall Study|Administrative Reason|2|||
19640906|NCT00661713|42090048|FG006|Overall Study|Administrative Reason|1|||
19640907|NCT00661713|42090049|FG007|Overall Study|Administrative Reason|0|||
19640908|NCT00661713|42090042|FG000|Overall Study|Adverse Event|0|||
19640909|NCT00661713|42090043|FG001|Overall Study|Adverse Event|0|||
19640910|NCT00661713|42090044|FG002|Overall Study|Adverse Event|0|||
19640911|NCT00661713|42090045|FG003|Overall Study|Adverse Event|0|||
19640912|NCT00661713|42090046|FG004|Overall Study|Adverse Event|0|||
19640913|NCT00661713|42090047|FG005|Overall Study|Adverse Event|0|||
19640914|NCT00661713|42090048|FG006|Overall Study|Adverse Event|1|||
19640915|NCT00661713|42090049|FG007|Overall Study|Adverse Event|0|||
19640916|NCT00661713|42090042|FG000|Overall Study|Inappropriate Enrollment|0|||
19640917|NCT00661713|42090043|FG001|Overall Study|Inappropriate Enrollment|0|||
19640918|NCT00661713|42090044|FG002|Overall Study|Inappropriate Enrollment|0|||
19640919|NCT00661713|42090045|FG003|Overall Study|Inappropriate Enrollment|0|||
19640920|NCT00661713|42090046|FG004|Overall Study|Inappropriate Enrollment|0|||
19640921|NCT00661713|42090047|FG005|Overall Study|Inappropriate Enrollment|0|||
19640922|NCT00661713|42090048|FG006|Overall Study|Inappropriate Enrollment|1|||
19640923|NCT00661713|42090049|FG007|Overall Study|Inappropriate Enrollment|0|||
19640924|NCT03835975|42090074|FG000|Overall Study|Lost to Follow-up|1|||
19748166|NCT03098030|42195949|FG000|Overall Study|Withdrawal by Subject|0|||
19748167|NCT03098030|42195950|FG001|Overall Study|Withdrawal by Subject|7|||
19748168|NCT03098030|42195951|FG002|Overall Study|Withdrawal by Subject|8|||
19748169|NCT03098030|42195952|FG003|Overall Study|Withdrawal by Subject|2|||
19599994|NCT02281084|42048873|FG001|Overall Study|Adverse Event|0|||
19599995|NCT02281084|42048874|FG002|Overall Study|Adverse Event|0|||
19599996|NCT02281084|42048875|FG003|Overall Study|Adverse Event|0|||
19599997|NCT02281084|42048872|FG000|Overall Study|Withdrawal by Subject|1|||
19640925|NCT03835975|42090075|FG001|Overall Study|Lost to Follow-up|1|||
19640926|NCT03835975|42090076|FG002|Overall Study|Lost to Follow-up|0|||
19640927|NCT03835975|42090077|FG003|Overall Study|Lost to Follow-up|0|||
19640928|NCT03835975|42090078|FG004|Overall Study|Lost to Follow-up|0|||
19640929|NCT03835975|42090074|FG000|Overall Study|No longer met eligibility criteria|0|||
19640930|NCT03835975|42090075|FG001|Overall Study|No longer met eligibility criteria|1|||
19640931|NCT03835975|42090076|FG002|Overall Study|No longer met eligibility criteria|0|||
19640932|NCT03835975|42090077|FG003|Overall Study|No longer met eligibility criteria|0|||
19640933|NCT03835975|42090078|FG004|Overall Study|No longer met eligibility criteria|0|||
19640934|NCT03835975|42090074|FG000|Overall Study|Protocol Violation|1|||
19640935|NCT03835975|42090075|FG001|Overall Study|Protocol Violation|1|||
19640936|NCT03835975|42090076|FG002|Overall Study|Protocol Violation|2|||
19640937|NCT03835975|42090077|FG003|Overall Study|Protocol Violation|0|||
19640938|NCT03835975|42090078|FG004|Overall Study|Protocol Violation|0|||
19640939|NCT03835975|42090074|FG000|Overall Study|Withdrawal by Subject|1|||
19640940|NCT03835975|42090075|FG001|Overall Study|Withdrawal by Subject|0|||
19599998|NCT02281084|42048873|FG001|Overall Study|Withdrawal by Subject|2|||
19599999|NCT02281084|42048874|FG002|Overall Study|Withdrawal by Subject|0|||
19600000|NCT02281084|42048875|FG003|Overall Study|Withdrawal by Subject|0|||
19600001|NCT02281084|42048872|FG000|Overall Study|Death|20|||
19600002|NCT02281084|42048873|FG001|Overall Study|Death|16|||
19600003|NCT02281084|42048874|FG002|Overall Study|Death|3|||
19600004|NCT02281084|42048875|FG003|Overall Study|Death|5|||
19600005|NCT02281084|42048872|FG000|Overall Study|Physician Decision|0|||
19600006|NCT02281084|42048873|FG001|Overall Study|Physician Decision|0|||
19600007|NCT02281084|42048874|FG002|Overall Study|Physician Decision|1|||
19640941|NCT03835975|42090076|FG002|Overall Study|Withdrawal by Subject|1|||
19640942|NCT03835975|42090077|FG003|Overall Study|Withdrawal by Subject|1|||
19640943|NCT03835975|42090078|FG004|Overall Study|Withdrawal by Subject|0|||
19640944|NCT00427921|42090092|FG000|Overall Study|Adverse Event|26|||
19640945|NCT00427921|42090092|FG000|Overall Study|Withdrawal by Subject|4|||
19600008|NCT02281084|42048875|FG003|Overall Study|Physician Decision|0|||
19640946|NCT00427921|42090092|FG000|Overall Study|Lost to Follow-up|2|||
19640947|NCT00427921|42090092|FG000|Overall Study|Other reason not specified|10|||
19640948|NCT00427921|42090092|FG000|Overall Study|Adverse Event + Hospitalization|1|||
19640949|NCT00427921|42090092|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
19640950|NCT00427921|42090092|FG000|Overall Study|Adverse Event + No Response|1|||
19640951|NCT00427921|42090092|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
19748170|NCT03098030|42195949|FG000|Overall Study|Lost to Follow-up|0|||
19748171|NCT03098030|42195950|FG001|Overall Study|Lost to Follow-up|0|||
19748172|NCT03098030|42195951|FG002|Overall Study|Lost to Follow-up|2|||
19748173|NCT03098030|42195952|FG003|Overall Study|Lost to Follow-up|1|||
19748174|NCT03341637|42195963|FG000|Overall Study|Lost to Follow-up|1|||
19748175|NCT03341637|42195964|FG001|Overall Study|Lost to Follow-up|0|||
19748176|NCT03341637|42195963|FG000|Overall Study|Withdrawal by Subject|3|||
19748177|NCT03341637|42195964|FG001|Overall Study|Withdrawal by Subject|3|||
19748178|NCT03341637|42195963|FG000|Overall Study|Reason not Specified|1|||
19748179|NCT03341637|42195964|FG001|Overall Study|Reason not Specified|1|||
19748180|NCT01378858|42195972|FG000|Overall Study|Withdrawal by Subject|4|||
19748181|NCT01378858|42195973|FG001|Overall Study|Withdrawal by Subject|4|||
19748182|NCT02891850|42195981|FG000|Overall Study|Adverse Event|3|||
19748183|NCT02891850|42195982|FG001|Overall Study|Adverse Event|0|||
19748184|NCT02891850|42195981|FG000|Overall Study|Death|0|||
19748185|NCT02891850|42195982|FG001|Overall Study|Death|4|||
19748186|NCT02891850|42195981|FG000|Overall Study|Physician Decision|1|||
19748187|NCT02891850|42195982|FG001|Overall Study|Physician Decision|0|||
19748188|NCT02891850|42195981|FG000|Overall Study|Pregnancy|1|||
19748189|NCT02891850|42195982|FG001|Overall Study|Pregnancy|0|||
19748190|NCT02891850|42195981|FG000|Overall Study|Withdrawal by Subject|2|||
19748191|NCT02891850|42195982|FG001|Overall Study|Withdrawal by Subject|3|||
19748192|NCT02949219|42195988|FG000|Overall Study|Withdrawal by Subject|1|||
19748193|NCT05594173|42195992|FG000|Overall Study|Adverse Event|1|||
19748194|NCT05594173|42195992|FG000|Overall Study|COVID-19 Pandemic|2|||
19748195|NCT03339999|42196005|FG000|Overall Study|Adverse Event|1|||
19748196|NCT03339999|42196006|FG001|Overall Study|Adverse Event|2|||
19748197|NCT03339999|42196007|FG002|Overall Study|Adverse Event|2|||
19748198|NCT03339999|42196008|FG003|Overall Study|Adverse Event|1|||
19748199|NCT03339999|42196005|FG000|Overall Study|Lack of Efficacy|0|||
19748200|NCT03339999|42196006|FG001|Overall Study|Lack of Efficacy|1|||
19748201|NCT03339999|42196007|FG002|Overall Study|Lack of Efficacy|0|||
19748202|NCT03339999|42196008|FG003|Overall Study|Lack of Efficacy|0|||
19748203|NCT03339999|42196005|FG000|Overall Study|Lost to Follow-up|0|||
19748204|NCT03339999|42196006|FG001|Overall Study|Lost to Follow-up|0|||
19748205|NCT03339999|42196007|FG002|Overall Study|Lost to Follow-up|0|||
19748206|NCT03339999|42196008|FG003|Overall Study|Lost to Follow-up|1|||
19748207|NCT03339999|42196005|FG000|Overall Study|Study Terminated by Sponsor|6|||
19748208|NCT03339999|42196006|FG001|Overall Study|Study Terminated by Sponsor|3|||
19748209|NCT03339999|42196007|FG002|Overall Study|Study Terminated by Sponsor|4|||
19748210|NCT03339999|42196008|FG003|Overall Study|Study Terminated by Sponsor|3|||
19748211|NCT03097328|42196021|FG000|Overall Study|Still on Therapy|2|||
19748212|NCT03097328|42196021|FG000|Overall Study|Progressive Disease|29|||
19748213|NCT03097328|42196021|FG000|Overall Study|Adverse Event|4|||
19748214|NCT03097328|42196021|FG000|Overall Study|Withdrawal by Subject|1|||
19748215|NCT03097328|42196021|FG000|Overall Study|Physician Decision|1|||
19748216|NCT03097328|42196021|FG000|Overall Study|Patient Decision|1|||
19748217|NCT03097328|42196021|FG000|Overall Study|Ineligible for Study Drug|1|||
19748218|NCT03339453|42196025|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
19748219|NCT03339453|42196026|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
19748220|NCT03761056|42196051|FG000|Overall Study|Still on Study|34|||
19748221|NCT03761056|42196051|FG000|Overall Study|Death|6|||
19748222|NCT03761056|42196051|FG000|Overall Study|Investigator Decision|1|||
19748223|NCT03761056|42196051|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
19748224|NCT03359850|42196076|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
19748225|NCT03359850|42196077|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
19748226|NCT03359850|42196076|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
19748227|NCT03359850|42196077|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
19748228|NCT03359850|42196076|FG000|Extension Phase (Up to 28 Months)|Death|2|||
19748229|NCT03359850|42196077|FG001|Extension Phase (Up to 28 Months)|Death|4|||
19748230|NCT03359850|42196076|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
19748231|NCT03359850|42196077|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
19748232|NCT03359850|42196076|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
19748233|NCT03359850|42196077|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
19748234|NCT00114140|42196096|FG000|Overall Study|Protocol Violation|7|||
19748235|NCT03342690|42196107|FG000|Overall Study|Missing Information|9|||
19748236|NCT03342690|42196107|FG000|Overall Study|Protocol Violation|16|||
19748237|NCT03712345|42196114|FG000|Overall Study|Failure to meet randomization criteria|0|||
19748238|NCT03712345|42196115|FG001|Overall Study|Failure to meet randomization criteria|0|||
19748239|NCT03712345|42196116|FG002|Overall Study|Failure to meet randomization criteria|1|||
19748240|NCT03358290|42196129|FG000|Overall Study|Study discontinued by Sponsor|0|||
19640952|NCT00427921|42090092|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
19640953|NCT00427921|42090092|FG000|Overall Study|Adverse Event + Lost Response|1|||
19640954|NCT00427921|42090092|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
19640955|NCT00427921|42090092|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
19640956|NCT00432991|42090098|FG000|Overall Study|Protocol Violation|7|||
19640957|NCT00432991|42090099|FG001|Overall Study|Protocol Violation|12|||
19640958|NCT00432835|42090107|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
19640959|NCT00432835|42090108|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
19640960|NCT00580970|42090116|FG000|Pre-treatment|Non-compliance|1|||
19640961|NCT00580970|42090116|FG000|Treatment (Lovastatin)|Non-compliance|6|||
19640962|NCT00580970|42090116|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
19640963|NCT00580970|42090116|FG000|Treatment (Lovastatin)|Physician Decision|4|||
19640964|NCT00580970|42090116|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
19640965|NCT00580970|42090116|FG000|Treatment (Lovastatin)|Death|1|||
19640966|NCT00665925|42090124|FG000|Overall Study|Lack of Efficacy|10|||
19640967|NCT00665925|42090125|FG001|Overall Study|Lack of Efficacy|8|||
19748241|NCT03358290|42196130|FG001|Overall Study|Study discontinued by Sponsor|1|||
19748242|NCT03358290|42196131|FG002|Overall Study|Study discontinued by Sponsor|1|||
19748243|NCT03358290|42196132|FG003|Overall Study|Study discontinued by Sponsor|0|||
19748244|NCT03358290|42196133|FG004|Overall Study|Study discontinued by Sponsor|0|||
19748245|NCT03358290|42196129|FG000|Overall Study|Adverse Event|0|||
19748246|NCT03358290|42196130|FG001|Overall Study|Adverse Event|0|||
19748247|NCT03358290|42196131|FG002|Overall Study|Adverse Event|1|||
19748248|NCT03358290|42196132|FG003|Overall Study|Adverse Event|2|||
19748249|NCT03358290|42196133|FG004|Overall Study|Adverse Event|0|||
19748250|NCT03358290|42196129|FG000|Overall Study|Withdrawal by Subject|0|||
19748251|NCT03358290|42196130|FG001|Overall Study|Withdrawal by Subject|0|||
19748252|NCT03358290|42196131|FG002|Overall Study|Withdrawal by Subject|0|||
19748253|NCT03358290|42196132|FG003|Overall Study|Withdrawal by Subject|0|||
19748254|NCT03358290|42196133|FG004|Overall Study|Withdrawal by Subject|1|||
19748255|NCT03089216|42196149|FG000|Overall Study|Adverse Event|0|||
19748256|NCT03089216|42196150|FG001|Overall Study|Adverse Event|0|||
19748257|NCT03089216|42196151|FG002|Overall Study|Adverse Event|0|||
19748258|NCT03089216|42196152|FG003|Overall Study|Adverse Event|1|||
19748259|NCT03339726|42196169|FG000|Overall Study|Withdrawal by Subject|1|||
19748260|NCT03339726|42196170|FG001|Overall Study|Withdrawal by Subject|0|||
19748261|NCT03339726|42196171|FG002|Overall Study|Withdrawal by Subject|0|||
19748262|NCT03339726|42196169|FG000|Overall Study|Lost to Follow-up|0|||
19748263|NCT03339726|42196170|FG001|Overall Study|Lost to Follow-up|1|||
19748264|NCT03339726|42196171|FG002|Overall Study|Lost to Follow-up|0|||
19748265|NCT03339297|42196181|FG000|Overall Study|Relapse of Hematologic Disease|1|||
19600009|NCT00796666|42048893|FG000|Overall Study|Death|2|||
19600010|NCT00796666|42048894|FG001|Overall Study|Death|4|||
19600011|NCT00796666|42048893|FG000|Overall Study|Withdrawal by Subject|2|||
19600012|NCT00796666|42048894|FG001|Overall Study|Withdrawal by Subject|0|||
19748266|NCT03339297|42196182|FG001|Overall Study|Relapse of Hematologic Disease|0|||
19748267|NCT03339297|42196181|FG000|Overall Study|Death|10|||
19748268|NCT03339297|42196182|FG001|Overall Study|Death|7|||
19748269|NCT03339297|42196181|FG000|Overall Study|Hepatic Candidosis|1|||
19748270|NCT03339297|42196182|FG001|Overall Study|Hepatic Candidosis|0|||
19748271|NCT03339297|42196181|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
19748272|NCT03339297|42196182|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
19748273|NCT03339297|42196181|FG000|Overall Study|Consent Withdrawn by Participant|3|||
19748274|NCT03339297|42196182|FG001|Overall Study|Consent Withdrawn by Participant|3|||
19748275|NCT03339297|42196181|FG000|Overall Study|Disease Relapse|2|||
19748276|NCT03339297|42196182|FG001|Overall Study|Disease Relapse|0|||
19748277|NCT03339297|42196181|FG000|Overall Study|Physician Decision|1|||
19748278|NCT03339297|42196182|FG001|Overall Study|Physician Decision|1|||
19748279|NCT03339297|42196181|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
19600013|NCT00796666|42048893|FG000|Overall Study|Adverse Event|7|||
19600014|NCT00796666|42048894|FG001|Overall Study|Adverse Event|5|||
19600015|NCT00796666|42048893|FG000|Overall Study|Protocol Violation|1|||
19600016|NCT00796666|42048894|FG001|Overall Study|Protocol Violation|0|||
19600017|NCT00796666|42048893|FG000|Overall Study|Other|1|||
19600018|NCT00796666|42048894|FG001|Overall Study|Other|0|||
19600019|NCT00796666|42048893|FG000|Overall Study|Terminated by sponsor|53|||
19600020|NCT00796666|42048894|FG001|Overall Study|Terminated by sponsor|55|||
19600021|NCT00796666|42048893|FG000|Overall Study|Randomized and not treated|1|||
19600022|NCT00796666|42048894|FG001|Overall Study|Randomized and not treated|0|||
19600023|NCT00799708|42048903|FG000|Overall Study|non-compliance|1|||
19600024|NCT00799708|42048904|FG001|Overall Study|non-compliance|0|||
19640968|NCT00665925|42090126|FG002|Overall Study|Lack of Efficacy|9|||
19640969|NCT00665925|42090127|FG003|Overall Study|Lack of Efficacy|8|||
19748280|NCT03339297|42196182|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
19600025|NCT00799708|42048905|FG002|Overall Study|non-compliance|0|||
19600026|NCT00796510|42048917|FG000|Overall Study|Death|1|||
19600027|NCT00796510|42048918|FG001|Overall Study|Death|0|||
19640970|NCT00665925|42090124|FG000|Overall Study|Lost to Follow-up|1|||
19640971|NCT00665925|42090125|FG001|Overall Study|Lost to Follow-up|2|||
19640972|NCT00665925|42090126|FG002|Overall Study|Lost to Follow-up|2|||
19640973|NCT00665925|42090127|FG003|Overall Study|Lost to Follow-up|2|||
19640974|NCT00665925|42090124|FG000|Overall Study|Withdrawal by Subject|2|||
19640975|NCT00665925|42090125|FG001|Overall Study|Withdrawal by Subject|2|||
19640976|NCT00665925|42090126|FG002|Overall Study|Withdrawal by Subject|3|||
19640977|NCT00665925|42090127|FG003|Overall Study|Withdrawal by Subject|2|||
19640978|NCT00665925|42090124|FG000|Overall Study|Physician Decision|0|||
19640979|NCT00665925|42090125|FG001|Overall Study|Physician Decision|0|||
19640980|NCT00665925|42090126|FG002|Overall Study|Physician Decision|1|||
19748281|NCT03339297|42196181|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
19748282|NCT03339297|42196182|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
19748283|NCT03339297|42196181|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
19748284|NCT03339297|42196182|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
19748285|NCT03339297|42196181|FG000|Overall Study|Adverse Event, Non-fatal|1|||
19748286|NCT03339297|42196182|FG001|Overall Study|Adverse Event, Non-fatal|0|||
19748287|NCT03339297|42196181|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
19748288|NCT03339297|42196182|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
19600028|NCT00796510|42048917|FG000|Overall Study|Study Terminated|2|||
19600029|NCT00796510|42048918|FG001|Overall Study|Study Terminated|0|||
19600030|NCT00588640|42048924|FG000|Overall Study|Physician Decision|1|||
19600031|NCT00588640|42048924|FG000|Overall Study|Ineligible Patient|1|||
19600032|NCT01016912|42048933|FG000|End of Treatment Period|Lack of Efficacy|0|||
19600033|NCT01016912|42048934|FG001|End of Treatment Period|Lack of Efficacy|1|||
19600034|NCT01016912|42048935|FG002|End of Treatment Period|Lack of Efficacy|0|||
19600035|NCT01016912|42048936|FG003|End of Treatment Period|Lack of Efficacy|4|||
19600036|NCT01016912|42048937|FG004|End of Treatment Period|Lack of Efficacy|4|||
19640981|NCT00665925|42090127|FG003|Overall Study|Physician Decision|2|||
19640982|NCT00665925|42090124|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
19640983|NCT00665925|42090125|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
19640984|NCT00665925|42090126|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
19640985|NCT00665925|42090127|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
19640986|NCT00665925|42090124|FG000|Overall Study|Adverse Event|1|||
19640987|NCT00665925|42090125|FG001|Overall Study|Adverse Event|5|||
19640988|NCT00665925|42090126|FG002|Overall Study|Adverse Event|10|||
19640989|NCT00665925|42090127|FG003|Overall Study|Adverse Event|5|||
19640990|NCT00665925|42090124|FG000|Overall Study|Enrolled by mistake|0|||
19640991|NCT00665925|42090125|FG001|Overall Study|Enrolled by mistake|0|||
19640992|NCT00665925|42090126|FG002|Overall Study|Enrolled by mistake|0|||
19640993|NCT00665925|42090127|FG003|Overall Study|Enrolled by mistake|1|||
19748289|NCT03339297|42196181|FG000|Overall Study|Patient Was Not Eligible|1|||
19748290|NCT03339297|42196182|FG001|Overall Study|Patient Was Not Eligible|0|||
19748291|NCT03713281|42196208|FG000|Overall Study|Lens handling difficuluties|2|||
19748292|NCT03713281|42196208|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
19748293|NCT03339219|42196212|FG000|Overall Study|Death|12|||
19748294|NCT03339219|42196212|FG000|Overall Study|Site Terminated by Sponsor|22|||
19748295|NCT03339219|42196212|FG000|Overall Study|Withdrawal by Subject|1|||
19748296|NCT03338673|42196218|FG000|Overall Study|Lost to Follow-up|1|||
19748297|NCT03338673|42196219|FG001|Overall Study|Lost to Follow-up|1|||
19640994|NCT00665925|42090124|FG000|Overall Study|Due to exclusion criteria|1|||
19640995|NCT00665925|42090125|FG001|Overall Study|Due to exclusion criteria|0|||
19640996|NCT00665925|42090126|FG002|Overall Study|Due to exclusion criteria|0|||
19640997|NCT00665925|42090127|FG003|Overall Study|Due to exclusion criteria|0|||
19640998|NCT00426751|42090140|FG000|Overall Study|Adverse Event|8|||
19640999|NCT00426751|42090141|FG001|Overall Study|Adverse Event|1|||
19641000|NCT00426751|42090140|FG000|Overall Study|Lost to Follow-up|7|||
19641001|NCT00426751|42090141|FG001|Overall Study|Lost to Follow-up|6|||
19641002|NCT00426751|42090140|FG000|Overall Study|Consent Withdrawn|0|||
19641003|NCT00426751|42090141|FG001|Overall Study|Consent Withdrawn|1|||
19641004|NCT00426751|42090140|FG000|Overall Study|Other Reasons|7|||
19641005|NCT00426751|42090141|FG001|Overall Study|Other Reasons|12|||
19641006|NCT00440401|42090149|FG000|Overall Study|Adverse Event|2|||
19641007|NCT00440401|42090150|FG001|Overall Study|Adverse Event|1|||
19641008|NCT00440401|42090149|FG000|Overall Study|Other|2|||
19641009|NCT00440401|42090150|FG001|Overall Study|Other|5|||
19641010|NCT02598960|42090169|FG000|Treatment Period|Disease Progression|4|||
19641011|NCT02598960|42090170|FG001|Treatment Period|Disease Progression|4|||
19600037|NCT01016912|42048933|FG000|End of Treatment Period|Adverse Event|0|||
19641012|NCT02598960|42090171|FG002|Treatment Period|Disease Progression|4|||
19641013|NCT02598960|42090172|FG003|Treatment Period|Disease Progression|6|||
19641014|NCT02598960|42090173|FG004|Treatment Period|Disease Progression|8|||
19641015|NCT02598960|42090174|FG005|Treatment Period|Disease Progression|2|||
19641016|NCT02598960|42090175|FG006|Treatment Period|Disease Progression|2|||
19641017|NCT02598960|42090176|FG007|Treatment Period|Disease Progression|3|||
19641018|NCT02598960|42090177|FG008|Treatment Period|Disease Progression|7|||
19641019|NCT02598960|42090178|FG009|Treatment Period|Disease Progression|9|||
19641020|NCT02598960|42090179|FG010|Treatment Period|Disease Progression|7|||
19641021|NCT02598960|42090180|FG011|Treatment Period|Disease Progression|143|||
19641022|NCT02598960|42090181|FG012|Treatment Period|Disease Progression|23|||
19641023|NCT02598960|42090169|FG000|Treatment Period|Study drug toxicity|0|||
19641024|NCT02598960|42090170|FG001|Treatment Period|Study drug toxicity|0|||
19641025|NCT02598960|42090171|FG002|Treatment Period|Study drug toxicity|0|||
19600038|NCT01016912|42048934|FG001|End of Treatment Period|Adverse Event|1|||
19600039|NCT01016912|42048935|FG002|End of Treatment Period|Adverse Event|1|||
19600040|NCT01016912|42048936|FG003|End of Treatment Period|Adverse Event|0|||
19600041|NCT01016912|42048937|FG004|End of Treatment Period|Adverse Event|0|||
19600042|NCT01016912|42048933|FG000|End of Treatment Period|Completed double-blind period only|0|||
19600043|NCT01016912|42048934|FG001|End of Treatment Period|Completed double-blind period only|1|||
19641026|NCT02598960|42090172|FG003|Treatment Period|Study drug toxicity|0|||
19641027|NCT02598960|42090173|FG004|Treatment Period|Study drug toxicity|0|||
19641028|NCT02598960|42090174|FG005|Treatment Period|Study drug toxicity|0|||
19641029|NCT02598960|42090175|FG006|Treatment Period|Study drug toxicity|0|||
19600044|NCT01016912|42048935|FG002|End of Treatment Period|Completed double-blind period only|0|||
19600045|NCT01016912|42048936|FG003|End of Treatment Period|Completed double-blind period only|0|||
19600046|NCT01016912|42048937|FG004|End of Treatment Period|Completed double-blind period only|0|||
19600047|NCT01016912|42048933|FG000|Follow-up Period|Other reason|0|||
19600048|NCT01016912|42048934|FG001|Follow-up Period|Other reason|0|||
19600049|NCT01016912|42048935|FG002|Follow-up Period|Other reason|1|||
19641030|NCT02598960|42090176|FG007|Treatment Period|Study drug toxicity|0|||
19641031|NCT02598960|42090177|FG008|Treatment Period|Study drug toxicity|0|||
19641032|NCT02598960|42090178|FG009|Treatment Period|Study drug toxicity|1|||
19641033|NCT02598960|42090179|FG010|Treatment Period|Study drug toxicity|0|||
19641034|NCT02598960|42090180|FG011|Treatment Period|Study drug toxicity|3|||
19641035|NCT02598960|42090181|FG012|Treatment Period|Study drug toxicity|0|||
19641036|NCT02598960|42090169|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
19641037|NCT02598960|42090170|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
19641038|NCT02598960|42090171|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
19641039|NCT02598960|42090172|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
19641040|NCT02598960|42090173|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
19641041|NCT02598960|42090174|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
19641042|NCT02598960|42090175|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
19641043|NCT02598960|42090176|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
19641044|NCT02598960|42090177|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
19641045|NCT02598960|42090178|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
19641046|NCT02598960|42090179|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
19641047|NCT02598960|42090180|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
19641048|NCT02598960|42090181|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
19748298|NCT02949024|42196227|FG000|Overall Study|Withdrawal by Subject|0|||
19600050|NCT01016912|42048936|FG003|Follow-up Period|Other reason|1|||
19600051|NCT01016912|42048937|FG004|Follow-up Period|Other reason|0|||
19600052|NCT00802672|42048972|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
19600053|NCT00802672|42048973|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
19600054|NCT00802672|42048974|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
19600055|NCT00802672|42048972|FG000|Overall Study|Adverse Event|1|||
19600056|NCT00802672|42048973|FG001|Overall Study|Adverse Event|1|||
19600057|NCT00802672|42048974|FG002|Overall Study|Adverse Event|1|||
19600058|NCT00802672|42048972|FG000|Overall Study|Protocol Violation|2|||
19600059|NCT00802672|42048973|FG001|Overall Study|Protocol Violation|1|||
19600060|NCT00802672|42048974|FG002|Overall Study|Protocol Violation|1|||
19600061|NCT00802672|42048972|FG000|Overall Study|Lost to Follow-up|5|||
19600062|NCT00802672|42048973|FG001|Overall Study|Lost to Follow-up|5|||
19600063|NCT00802672|42048974|FG002|Overall Study|Lost to Follow-up|3|||
19600064|NCT00802672|42048972|FG000|Overall Study|Withdrawal by Subject|1|||
19600065|NCT00802672|42048973|FG001|Overall Study|Withdrawal by Subject|1|||
19600066|NCT00802672|42048974|FG002|Overall Study|Withdrawal by Subject|2|||
19600067|NCT00802672|42048972|FG000|Overall Study|other|3|||
19600068|NCT00802672|42048973|FG001|Overall Study|other|1|||
19600069|NCT00802672|42048974|FG002|Overall Study|other|2|||
19600070|NCT00714415|42048984|FG000|Overall Study|Lack of Efficacy|1|||
19600071|NCT00714415|42048985|FG001|Overall Study|Lack of Efficacy|0|||
19600072|NCT00714415|42048984|FG000|Overall Study|Death|1|||
19600073|NCT00714415|42048985|FG001|Overall Study|Death|0|||
19600074|NCT00714259|42048991|FG000|Overall Study|Death|2|||
19600075|NCT00796120|42048997|FG000|Overall Study|Death|3|||
19600076|NCT00796120|42048998|FG001|Overall Study|Death|0|||
19600077|NCT00796120|42048997|FG000|Overall Study|Adverse Event|11|||
19600078|NCT00796120|42048998|FG001|Overall Study|Adverse Event|6|||
19600079|NCT00796120|42048997|FG000|Overall Study|Progressive disease|22|||
19600080|NCT00796120|42048998|FG001|Overall Study|Progressive disease|13|||
19600081|NCT00796120|42048997|FG000|Overall Study|Participant refusal|3|||
19641049|NCT02598960|42090169|FG000|Treatment Period|participant request to discontinue|0|||
19641050|NCT02598960|42090170|FG001|Treatment Period|participant request to discontinue|1|||
19641051|NCT02598960|42090171|FG002|Treatment Period|participant request to discontinue|0|||
19641052|NCT02598960|42090172|FG003|Treatment Period|participant request to discontinue|0|||
19641053|NCT02598960|42090173|FG004|Treatment Period|participant request to discontinue|1|||
19641054|NCT02598960|42090174|FG005|Treatment Period|participant request to discontinue|0|||
19641055|NCT02598960|42090175|FG006|Treatment Period|participant request to discontinue|0|||
19641056|NCT02598960|42090176|FG007|Treatment Period|participant request to discontinue|0|||
19641057|NCT02598960|42090177|FG008|Treatment Period|participant request to discontinue|0|||
19600082|NCT00796120|42048998|FG001|Overall Study|Participant refusal|4|||
19600083|NCT00796120|42048997|FG000|Overall Study|Other|6|||
19600084|NCT00796120|42048998|FG001|Overall Study|Other|17|||
19600085|NCT00796120|42048997|FG000|Overall Study|Physician Decision|16|||
19600086|NCT00796120|42048998|FG001|Overall Study|Physician Decision|17|||
19600087|NCT00796120|42048997|FG000|Overall Study|Randomized but not treated|0|||
19600088|NCT00796120|42048998|FG001|Overall Study|Randomized but not treated|3|||
19641058|NCT02598960|42090178|FG009|Treatment Period|participant request to discontinue|0|||
19641059|NCT02598960|42090179|FG010|Treatment Period|participant request to discontinue|1|||
19641060|NCT02598960|42090180|FG011|Treatment Period|participant request to discontinue|4|||
19641061|NCT02598960|42090181|FG012|Treatment Period|participant request to discontinue|0|||
19641062|NCT02598960|42090169|FG000|Treatment Period|participant withdrew consent|0|||
19641063|NCT02598960|42090170|FG001|Treatment Period|participant withdrew consent|0|||
19641064|NCT02598960|42090171|FG002|Treatment Period|participant withdrew consent|0|||
19641065|NCT02598960|42090172|FG003|Treatment Period|participant withdrew consent|0|||
19641066|NCT02598960|42090173|FG004|Treatment Period|participant withdrew consent|0|||
19641067|NCT02598960|42090174|FG005|Treatment Period|participant withdrew consent|0|||
19641068|NCT02598960|42090175|FG006|Treatment Period|participant withdrew consent|0|||
19641069|NCT02598960|42090176|FG007|Treatment Period|participant withdrew consent|0|||
19641070|NCT02598960|42090177|FG008|Treatment Period|participant withdrew consent|0|||
19641071|NCT02598960|42090178|FG009|Treatment Period|participant withdrew consent|0|||
19641072|NCT02598960|42090179|FG010|Treatment Period|participant withdrew consent|0|||
19641073|NCT02598960|42090180|FG011|Treatment Period|participant withdrew consent|3|||
19641074|NCT02598960|42090181|FG012|Treatment Period|participant withdrew consent|0|||
19641075|NCT02598960|42090169|FG000|Treatment Period|No longer meets study criteria|0|||
19641076|NCT02598960|42090170|FG001|Treatment Period|No longer meets study criteria|0|||
19641077|NCT02598960|42090171|FG002|Treatment Period|No longer meets study criteria|0|||
19641078|NCT02598960|42090172|FG003|Treatment Period|No longer meets study criteria|0|||
19641079|NCT02598960|42090173|FG004|Treatment Period|No longer meets study criteria|0|||
19641080|NCT02598960|42090174|FG005|Treatment Period|No longer meets study criteria|0|||
19641081|NCT02598960|42090175|FG006|Treatment Period|No longer meets study criteria|0|||
19641082|NCT02598960|42090176|FG007|Treatment Period|No longer meets study criteria|0|||
19641083|NCT02598960|42090177|FG008|Treatment Period|No longer meets study criteria|0|||
19641084|NCT02598960|42090178|FG009|Treatment Period|No longer meets study criteria|0|||
19641085|NCT02598960|42090179|FG010|Treatment Period|No longer meets study criteria|0|||
19641086|NCT02598960|42090180|FG011|Treatment Period|No longer meets study criteria|1|||
19641087|NCT02598960|42090181|FG012|Treatment Period|No longer meets study criteria|0|||
19641088|NCT02598960|42090169|FG000|Treatment Period|Other Reasons|0|||
19641089|NCT02598960|42090170|FG001|Treatment Period|Other Reasons|0|||
19641090|NCT02598960|42090171|FG002|Treatment Period|Other Reasons|0|||
19641091|NCT02598960|42090172|FG003|Treatment Period|Other Reasons|0|||
19641092|NCT02598960|42090173|FG004|Treatment Period|Other Reasons|0|||
19641093|NCT02598960|42090174|FG005|Treatment Period|Other Reasons|0|||
19641094|NCT02598960|42090175|FG006|Treatment Period|Other Reasons|0|||
19641095|NCT02598960|42090176|FG007|Treatment Period|Other Reasons|0|||
19641096|NCT02598960|42090177|FG008|Treatment Period|Other Reasons|0|||
19641097|NCT02598960|42090178|FG009|Treatment Period|Other Reasons|0|||
19641098|NCT02598960|42090179|FG010|Treatment Period|Other Reasons|0|||
19641099|NCT02598960|42090180|FG011|Treatment Period|Other Reasons|0|||
19641100|NCT02598960|42090181|FG012|Treatment Period|Other Reasons|1|||
19641101|NCT02598960|42090169|FG000|Participants Entering Follow Up Period|Death|1|||
19641102|NCT02598960|42090170|FG001|Participants Entering Follow Up Period|Death|0|||
19641103|NCT02598960|42090171|FG002|Participants Entering Follow Up Period|Death|0|||
19641104|NCT02598960|42090172|FG003|Participants Entering Follow Up Period|Death|0|||
19600089|NCT00795886|42049004|FG000|Overall Study|Death|10|||
19600090|NCT00719563|42049011|FG000|Overall Study|Adverse Event|16|||
19600091|NCT00719563|42049012|FG001|Overall Study|Adverse Event|13|||
19600092|NCT00719563|42049011|FG000|Overall Study|Medical condition changed|3|||
19600093|NCT00719563|42049012|FG001|Overall Study|Medical condition changed|5|||
19600094|NCT00719563|42049011|FG000|Overall Study|Lack of Efficacy|3|||
19600095|NCT00719563|42049012|FG001|Overall Study|Lack of Efficacy|7|||
19600096|NCT00719563|42049011|FG000|Overall Study|Personal reasons|6|||
19600097|NCT00719563|42049012|FG001|Overall Study|Personal reasons|7|||
19641105|NCT02598960|42090173|FG004|Participants Entering Follow Up Period|Death|0|||
19641106|NCT02598960|42090174|FG005|Participants Entering Follow Up Period|Death|0|||
19641107|NCT02598960|42090175|FG006|Participants Entering Follow Up Period|Death|0|||
19641108|NCT02598960|42090176|FG007|Participants Entering Follow Up Period|Death|0|||
19641109|NCT02598960|42090177|FG008|Participants Entering Follow Up Period|Death|0|||
19641110|NCT02598960|42090178|FG009|Participants Entering Follow Up Period|Death|1|||
19641111|NCT02598960|42090179|FG010|Participants Entering Follow Up Period|Death|0|||
19641112|NCT02598960|42090180|FG011|Participants Entering Follow Up Period|Death|11|||
19641113|NCT02598960|42090181|FG012|Participants Entering Follow Up Period|Death|2|||
19641114|NCT02598960|42090169|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641115|NCT02598960|42090170|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641116|NCT02598960|42090171|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641117|NCT02598960|42090172|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641118|NCT02598960|42090173|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
19388109|NCT00708305|41631494|FG002|Period 1|Protocol Violation|1|||
19388110|NCT00708305|41631495|FG003|Period 1|Protocol Violation|0|||
19600098|NCT00719563|42049011|FG000|Overall Study|Unknown reasons|4|||
19641119|NCT02598960|42090174|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641120|NCT02598960|42090175|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641121|NCT02598960|42090176|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
19748299|NCT02949024|42196228|FG001|Overall Study|Withdrawal by Subject|1|||
19748300|NCT03093428|42196238|FG000|Overall Study|Not eligible for treatment|2|||
19748301|NCT03093428|42196239|FG001|Overall Study|Not eligible for treatment|1|||
19748302|NCT03093428|42196238|FG000|Overall Study|Progression|14|||
19748303|NCT03093428|42196239|FG001|Overall Study|Progression|4|||
19748304|NCT03093428|42196238|FG000|Overall Study|Death|1|||
19600099|NCT00719563|42049012|FG001|Overall Study|Unknown reasons|6|||
19600100|NCT00719563|42049011|FG000|Overall Study|Noncompliant|1|||
19600101|NCT00719563|42049012|FG001|Overall Study|Noncompliant|1|||
19600102|NCT00719563|42049011|FG000|Overall Study|Lost to Follow-up|5|||
19748305|NCT03093428|42196239|FG001|Overall Study|Death|0|||
19748306|NCT03093428|42196238|FG000|Overall Study|Adverse Event|1|||
19748307|NCT03093428|42196239|FG001|Overall Study|Adverse Event|0|||
19748308|NCT03093428|42196238|FG000|Overall Study|Withdrawal by Subject|1|||
19748309|NCT03093428|42196239|FG001|Overall Study|Withdrawal by Subject|1|||
19748310|NCT02735980|42196248|FG000|Overall Study|Adverse Event|0|||
19748311|NCT02735980|42196249|FG001|Overall Study|Adverse Event|4|||
19748312|NCT02735980|42196250|FG002|Overall Study|Adverse Event|1|||
19748313|NCT02735980|42196248|FG000|Overall Study|Death|5|||
19748314|NCT02735980|42196249|FG001|Overall Study|Death|4|||
19748315|NCT02735980|42196250|FG002|Overall Study|Death|0|||
19748316|NCT02735980|42196248|FG000|Overall Study|Physician Decision|3|||
19748317|NCT02735980|42196249|FG001|Overall Study|Physician Decision|1|||
19748318|NCT02735980|42196250|FG002|Overall Study|Physician Decision|0|||
19748319|NCT02735980|42196248|FG000|Overall Study|Screen failure|1|||
19748320|NCT02735980|42196249|FG001|Overall Study|Screen failure|0|||
19748321|NCT02735980|42196250|FG002|Overall Study|Screen failure|0|||
19748322|NCT02735980|42196248|FG000|Overall Study|Withdrawal by Subject|1|||
19600103|NCT00719563|42049012|FG001|Overall Study|Lost to Follow-up|3|||
19600104|NCT00795184|42049019|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
19600105|NCT00795184|42049020|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
19600106|NCT00718861|42049031|FG000|Overall Study|Withdrawal by Subject|15|||
19600107|NCT00718861|42049032|FG001|Overall Study|Withdrawal by Subject|10|||
19600108|NCT00718861|42049031|FG000|Overall Study|Adverse Event|2|||
19748323|NCT02735980|42196249|FG001|Overall Study|Withdrawal by Subject|2|||
19748324|NCT02735980|42196250|FG002|Overall Study|Withdrawal by Subject|0|||
19748325|NCT03338400|42196265|FG000|Overall Study|Lost to Follow-up|1|||
19748326|NCT03338400|42196266|FG001|Overall Study|Lost to Follow-up|2|||
19748327|NCT03337113|42196284|FG000|Overall Study|Adverse Event|1|||
19748328|NCT03337113|42196285|FG001|Overall Study|Adverse Event|1|||
19748329|NCT03337113|42196286|FG002|Overall Study|Adverse Event|0|||
19748330|NCT03337113|42196287|FG003|Overall Study|Adverse Event|1|||
19748331|NCT03337113|42196284|FG000|Overall Study|Physician Decision|0|||
19748332|NCT03337113|42196285|FG001|Overall Study|Physician Decision|2|||
19748333|NCT03337113|42196286|FG002|Overall Study|Physician Decision|0|||
19388111|NCT00708305|41631492|FG000|Period 1|Other Reason|0|||
19600109|NCT00718861|42049032|FG001|Overall Study|Adverse Event|1|||
19748334|NCT03337113|42196287|FG003|Overall Study|Physician Decision|1|||
19748335|NCT03337113|42196284|FG000|Overall Study|Withdrawal by Subject|0|||
19748336|NCT03337113|42196285|FG001|Overall Study|Withdrawal by Subject|0|||
19641122|NCT02598960|42090177|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641123|NCT02598960|42090178|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641124|NCT02598960|42090179|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641125|NCT02598960|42090180|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
19600110|NCT00718861|42049031|FG000|Overall Study|Lost to Follow-up|2|||
19600111|NCT00718861|42049032|FG001|Overall Study|Lost to Follow-up|1|||
19600112|NCT00718861|42049031|FG000|Overall Study|Administrative Problems|1|||
19600113|NCT00718861|42049032|FG001|Overall Study|Administrative Problems|1|||
19600114|NCT00718861|42049031|FG000|Overall Study|Death|1|||
19600115|NCT00718861|42049032|FG001|Overall Study|Death|5|||
19600116|NCT01016600|42049042|FG000|Overall Study|Did not start treatment|1|||
19600117|NCT01016600|42049043|FG001|Overall Study|Did not start treatment|0|||
19600118|NCT01016600|42049044|FG002|Overall Study|Did not start treatment|0|||
19641126|NCT02598960|42090181|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
19641127|NCT02598960|42090169|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
19641128|NCT02598960|42090170|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
19641129|NCT02598960|42090171|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
19641130|NCT02598960|42090172|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
19641131|NCT02598960|42090173|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
19641132|NCT02598960|42090174|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
19641133|NCT02598960|42090175|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
19641134|NCT02598960|42090176|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
19641135|NCT02598960|42090177|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
19641136|NCT02598960|42090178|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
19641137|NCT02598960|42090179|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
19641138|NCT02598960|42090180|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
19641139|NCT02598960|42090181|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
19641140|NCT02598960|42090169|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19748337|NCT03337113|42196286|FG002|Overall Study|Withdrawal by Subject|1|||
19748338|NCT03337113|42196287|FG003|Overall Study|Withdrawal by Subject|0|||
19388112|NCT00708305|41631493|FG001|Period 1|Other Reason|0|||
19641141|NCT02598960|42090170|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641142|NCT02598960|42090171|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641143|NCT02598960|42090172|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641144|NCT02598960|42090173|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641145|NCT02598960|42090174|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641146|NCT02598960|42090175|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641147|NCT02598960|42090176|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641148|NCT02598960|42090177|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641149|NCT02598960|42090178|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641150|NCT02598960|42090179|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641151|NCT02598960|42090180|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
19641152|NCT02598960|42090181|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
19641153|NCT02598960|42090169|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
19641154|NCT02598960|42090170|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
19641155|NCT02598960|42090171|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
19641156|NCT02598960|42090172|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
19641157|NCT02598960|42090173|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
19641158|NCT02598960|42090174|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
19641159|NCT02598960|42090175|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
19641160|NCT02598960|42090176|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
19641161|NCT02598960|42090177|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
19641162|NCT02598960|42090178|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
19641163|NCT02598960|42090179|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
19641164|NCT02598960|42090180|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
19641165|NCT02598960|42090181|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
19641166|NCT00426361|42090212|FG000|Overall Study|Lost to Follow-up|3|||
19748339|NCT03092726|42196299|FG000|Overall Study|Adverse Event|3|||
19388113|NCT00708305|41631494|FG002|Period 1|Other Reason|0|||
19600119|NCT01016600|42049045|FG003|Overall Study|Did not start treatment|0|||
19600120|NCT01016132|42049056|FG000|Overall Study|Discomfort|1|||
19600121|NCT01015820|42049062|FG000|Overall Study|Suboptimal measurements|1|||
19388114|NCT00708305|41631495|FG003|Period 1|Other Reason|2|||
19641167|NCT00426361|42090213|FG001|Overall Study|Lost to Follow-up|2|||
19641168|NCT00426361|42090214|FG002|Overall Study|Lost to Follow-up|5|||
19641169|NCT00426361|42090212|FG000|Overall Study|Withdrawal by Subject|1|||
19641170|NCT00426361|42090213|FG001|Overall Study|Withdrawal by Subject|3|||
19641171|NCT00426361|42090214|FG002|Overall Study|Withdrawal by Subject|0|||
19641172|NCT00665847|42090222|FG000|Overall Study|Adverse Event|8|||
19641173|NCT00665847|42090222|FG000|Overall Study|Withdrawal by Subject|2|||
19600122|NCT01015820|42049063|FG001|Overall Study|Suboptimal measurements|0|||
19600123|NCT01010204|42049086|FG000|Overall Study|Lost to Follow-up|2|||
19600124|NCT01010204|42049087|FG001|Overall Study|Lost to Follow-up|2|||
19600125|NCT01010204|42049086|FG000|Overall Study|Adverse Event|1|||
19600126|NCT01010204|42049087|FG001|Overall Study|Adverse Event|3|||
19600127|NCT01010204|42049086|FG000|Overall Study|Withdrawal by Subject|2|||
19600128|NCT01010204|42049087|FG001|Overall Study|Withdrawal by Subject|3|||
19600129|NCT01010204|42049086|FG000|Overall Study|psychiatric hospitalization|2|||
19600130|NCT01010204|42049087|FG001|Overall Study|psychiatric hospitalization|1|||
19600131|NCT00718549|42049093|FG000|Induction Phase|Disease Progression|1|||
19641174|NCT00665847|42090222|FG000|Overall Study|Subject non-compliant|8|||
19600132|NCT00718549|42049094|FG001|Induction Phase|Disease Progression|0|||
19600133|NCT00718549|42049095|FG002|Induction Phase|Disease Progression|0|||
19641175|NCT00665847|42090222|FG000|Overall Study|Subject reached a virologic endpoint|4|||
19641176|NCT00665847|42090222|FG000|Overall Study|Resistance to TMC125|1|||
19641177|NCT00665847|42090222|FG000|Overall Study|Subject ineligible to continue the trial|1|||
19641178|NCT00665847|42090222|FG000|Overall Study|Switch to Commercial Medication|1|||
19641179|NCT00426127|42090226|FG000|Overall Study|Adverse Event|1|||
19641180|NCT00426127|42090226|FG000|Overall Study|Removed due to disease progression|1|||
19641181|NCT00425503|42090230|FG000|Overall Study|Adverse Event|2|||
19641182|NCT00425503|42090230|FG000|Overall Study|Protocol Violation|1|||
19641183|NCT00425269|42090236|FG000|Overall Study|Pregnancy|5|||
19641184|NCT00425269|42090237|FG001|Overall Study|Pregnancy|7|||
19641185|NCT00425269|42090236|FG000|Overall Study|Lost to Follow-up|9|||
19641186|NCT00425269|42090237|FG001|Overall Study|Lost to Follow-up|9|||
19641187|NCT00425269|42090236|FG000|Overall Study|moved or medical reason|5|||
19641188|NCT00425269|42090237|FG001|Overall Study|moved or medical reason|4|||
19641189|NCT00430573|42090243|FG000|Overall Study|Withdrawal by Subject|5|||
19641190|NCT02075840|42090267|FG000|Overall Study|Withdrawal by Subject|13|||
19641191|NCT02075840|42090268|FG001|Overall Study|Withdrawal by Subject|22|||
19641192|NCT02075840|42090267|FG000|Overall Study|Reason not specified|1|||
19641193|NCT02075840|42090268|FG001|Overall Study|Reason not specified|0|||
19641194|NCT02075840|42090267|FG000|Overall Study|Adverse Event|0|||
19641195|NCT02075840|42090268|FG001|Overall Study|Adverse Event|2|||
19641196|NCT02075840|42090267|FG000|Overall Study|Death|35|||
19641197|NCT02075840|42090268|FG001|Overall Study|Death|40|||
19641198|NCT02075840|42090267|FG000|Overall Study|Lost to Follow-up|3|||
19641199|NCT02075840|42090268|FG001|Overall Study|Lost to Follow-up|2|||
19641200|NCT02075840|42090267|FG000|Overall Study|Physician Decision|1|||
19641201|NCT02075840|42090268|FG001|Overall Study|Physician Decision|3|||
19641202|NCT02075840|42090267|FG000|Overall Study|Ongoing at CCOD|99|||
19641203|NCT02075840|42090268|FG001|Overall Study|Ongoing at CCOD|82|||
19641204|NCT00430495|42090278|FG000|Overall Study|Adverse Event|2|||
19641205|NCT00430495|42090279|FG001|Overall Study|Adverse Event|3|||
19748340|NCT03092726|42196300|FG001|Overall Study|Adverse Event|10|||
19748341|NCT03092726|42196299|FG000|Overall Study|Lack of Efficacy|0|||
19748342|NCT03092726|42196300|FG001|Overall Study|Lack of Efficacy|1|||
19748343|NCT03092726|42196299|FG000|Overall Study|Lost to Follow-up|1|||
19748344|NCT03092726|42196300|FG001|Overall Study|Lost to Follow-up|0|||
19748345|NCT03092726|42196299|FG000|Overall Study|Withdrawal by Subject|5|||
19748346|NCT03092726|42196300|FG001|Overall Study|Withdrawal by Subject|3|||
19748347|NCT03338010|42196308|FG000|Overall Study|Withdrawal by Subject|14|||
19748348|NCT03338010|42196309|FG001|Overall Study|Withdrawal by Subject|8|||
19748349|NCT03338010|42196308|FG000|Overall Study|Lost to Follow-up|4|||
19748350|NCT03338010|42196309|FG001|Overall Study|Lost to Follow-up|2|||
19748351|NCT03338010|42196308|FG000|Overall Study|Adverse Event|3|||
19388115|NCT00708305|41631492|FG000|Period 2|Lost to Follow-up|0|||
19600134|NCT00718549|42049093|FG000|Induction Phase|Eligibility Criteria Violation|2|||
19600135|NCT00718549|42049094|FG001|Induction Phase|Eligibility Criteria Violation|0|||
19600136|NCT00718549|42049095|FG002|Induction Phase|Eligibility Criteria Violation|0|||
19641206|NCT00430495|42090280|FG002|Overall Study|Adverse Event|2|||
19641207|NCT00430495|42090281|FG003|Overall Study|Adverse Event|0|||
19641208|NCT00430495|42090278|FG000|Overall Study|Death|0|||
19641209|NCT00430495|42090279|FG001|Overall Study|Death|0|||
19641210|NCT00430495|42090280|FG002|Overall Study|Death|1|||
19641211|NCT00430495|42090281|FG003|Overall Study|Death|0|||
19641212|NCT00430495|42090278|FG000|Overall Study|Lost to Follow-up|0|||
19641213|NCT00430495|42090279|FG001|Overall Study|Lost to Follow-up|1|||
19641214|NCT00430495|42090280|FG002|Overall Study|Lost to Follow-up|4|||
19641215|NCT00430495|42090281|FG003|Overall Study|Lost to Follow-up|0|||
19748352|NCT03338010|42196309|FG001|Overall Study|Adverse Event|2|||
19748353|NCT03338010|42196308|FG000|Overall Study|Physician Decision|2|||
19641216|NCT00430495|42090278|FG000|Overall Study|Protocol Violation|1|||
19641217|NCT00430495|42090279|FG001|Overall Study|Protocol Violation|0|||
19641218|NCT00430495|42090280|FG002|Overall Study|Protocol Violation|1|||
19641219|NCT00430495|42090281|FG003|Overall Study|Protocol Violation|0|||
19641220|NCT00430495|42090278|FG000|Overall Study|Disease Progression|1|||
19641221|NCT00430495|42090279|FG001|Overall Study|Disease Progression|1|||
19641222|NCT00430495|42090280|FG002|Overall Study|Disease Progression|0|||
19641223|NCT00430495|42090281|FG003|Overall Study|Disease Progression|0|||
19641224|NCT00430495|42090278|FG000|Overall Study|Other|8|||
19641225|NCT00430495|42090279|FG001|Overall Study|Other|2|||
19641226|NCT00430495|42090280|FG002|Overall Study|Other|5|||
19641227|NCT00430495|42090281|FG003|Overall Study|Other|4|||
19641228|NCT00430495|42090278|FG000|Overall Study|Randomized but not Treated|2|||
19641229|NCT00430495|42090279|FG001|Overall Study|Randomized but not Treated|0|||
19641230|NCT00430495|42090280|FG002|Overall Study|Randomized but not Treated|0|||
19641231|NCT00430495|42090281|FG003|Overall Study|Randomized but not Treated|0|||
19641232|NCT00425113|42090293|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
19641233|NCT00425113|42090294|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
19641234|NCT00425113|42090293|FG000|Overall Study|diagnosis of abdominal TB|0|||
19641235|NCT00425113|42090294|FG001|Overall Study|diagnosis of abdominal TB|1|||
19641236|NCT00425113|42090293|FG000|Overall Study|missing study drug more than 14 days|0|||
19641237|NCT00425113|42090294|FG001|Overall Study|missing study drug more than 14 days|1|||
19641238|NCT00425113|42090293|FG000|Overall Study|Withdrawal by Subject|1|||
19641239|NCT00425113|42090294|FG001|Overall Study|Withdrawal by Subject|0|||
19641240|NCT00440011|42090303|FG000|Overall Study|Adverse Event|2|||
19641241|NCT00440011|42090304|FG001|Overall Study|Adverse Event|0|||
19641242|NCT00440011|42090303|FG000|Overall Study|Lost to Follow-up|0|||
19641243|NCT00440011|42090304|FG001|Overall Study|Lost to Follow-up|2|||
19641244|NCT00440011|42090303|FG000|Overall Study|Protocol Violation|1|||
19641245|NCT00440011|42090304|FG001|Overall Study|Protocol Violation|1|||
19641246|NCT00440011|42090303|FG000|Overall Study|Withdrawal by Subject|1|||
19641247|NCT00440011|42090304|FG001|Overall Study|Withdrawal by Subject|0|||
19641248|NCT00663117|42090341|FG000|Overall Study|Lack of Efficacy|1|||
19641249|NCT00663117|42090342|FG001|Overall Study|Lack of Efficacy|0|||
19641250|NCT02410902|42090365|FG000|Overall Study|Adverse Event|2|||
19641251|NCT02410902|42090366|FG001|Overall Study|Adverse Event|3|||
19641252|NCT02410902|42090365|FG000|Overall Study|Lost to Follow-up|4|||
19641253|NCT02410902|42090366|FG001|Overall Study|Lost to Follow-up|1|||
19641254|NCT02410902|42090365|FG000|Overall Study|Protocol Violation|1|||
19641255|NCT02410902|42090366|FG001|Overall Study|Protocol Violation|4|||
19641256|NCT02410902|42090365|FG000|Overall Study|Withdrawal by Subject|6|||
19641257|NCT02410902|42090366|FG001|Overall Study|Withdrawal by Subject|8|||
19641258|NCT02410902|42090365|FG000|Overall Study|Non-Compliance|8|||
19641259|NCT02410902|42090366|FG001|Overall Study|Non-Compliance|2|||
19641260|NCT00570141|42090374|FG000|Overall Study|Adverse Event|1|||
19641261|NCT00570141|42090374|FG000|Overall Study|Missed visits|1|||
19641262|NCT00570141|42090374|FG000|Overall Study|Lost to Follow-up|1|||
19641263|NCT00579254|42090378|FG000|Overall Study|Lost to Follow-up|39|||
19641264|NCT00579254|42090378|FG000|Overall Study|Discontinued when study terminated|73|||
19641265|NCT00661089|42090384|FG000|Overall Study|1 subject withdrawal|0|||
19641266|NCT00661089|42090385|FG001|Overall Study|1 subject withdrawal|1|||
19641267|NCT00661089|42090384|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
19641268|NCT00661089|42090385|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
19641269|NCT00582426|42090394|FG000|Overall Study|Lost to Follow-up|0|||
19641270|NCT00582426|42090395|FG001|Overall Study|Lost to Follow-up|2|||
19641271|NCT00582426|42090394|FG000|Overall Study|Adverse Event|4|||
19748354|NCT03338010|42196309|FG001|Overall Study|Physician Decision|2|||
19641272|NCT00582426|42090395|FG001|Overall Study|Adverse Event|2|||
19641273|NCT00582426|42090394|FG000|Overall Study|Protocol Violation|6|||
19388116|NCT00708305|41631493|FG001|Period 2|Lost to Follow-up|1|||
19388117|NCT00708305|41631494|FG002|Period 2|Lost to Follow-up|0|||
19388118|NCT00708305|41631495|FG003|Period 2|Lost to Follow-up|0|||
19388119|NCT00708305|41631492|FG000|Period 2|Protocol Violation|0|||
19388120|NCT00708305|41631493|FG001|Period 2|Protocol Violation|1|||
19388121|NCT00708305|41631494|FG002|Period 2|Protocol Violation|0|||
19388122|NCT00708305|41631495|FG003|Period 2|Protocol Violation|0|||
19388123|NCT00708305|41631492|FG000|Period 2|Other Reason|1|||
19388124|NCT00708305|41631493|FG001|Period 2|Other Reason|0|||
19388125|NCT00708305|41631494|FG002|Period 2|Other Reason|0|||
19388126|NCT00708305|41631495|FG003|Period 2|Other Reason|1|||
19388127|NCT00708305|41631492|FG000|Period 3|Protocol Violation|0|||
19388128|NCT00708305|41631493|FG001|Period 3|Protocol Violation|2|||
19388129|NCT00708305|41631494|FG002|Period 3|Protocol Violation|0|||
19388130|NCT00708305|41631495|FG003|Period 3|Protocol Violation|0|||
19388131|NCT00708305|41631492|FG000|Period 3|Other Reason|1|||
19388132|NCT00708305|41631493|FG001|Period 3|Other Reason|0|||
19388133|NCT00708305|41631494|FG002|Period 3|Other Reason|0|||
19388134|NCT00708305|41631495|FG003|Period 3|Other Reason|0|||
19388135|NCT02055976|41631517|FG000|Overall Study|Other|0|||
19641274|NCT00582426|42090395|FG001|Overall Study|Protocol Violation|2|||
19641275|NCT00582426|42090394|FG000|Overall Study|Death|4|||
19641276|NCT00582426|42090395|FG001|Overall Study|Death|3|||
19641277|NCT00582426|42090394|FG000|Overall Study|Withdrawal by Subject|3|||
19641278|NCT00582426|42090395|FG001|Overall Study|Withdrawal by Subject|2|||
19641279|NCT00582426|42090394|FG000|Overall Study|Disease Progression|2|||
19641280|NCT00582426|42090395|FG001|Overall Study|Disease Progression|2|||
19641281|NCT00582426|42090394|FG000|Overall Study|Use of illicit drugs|1|||
19641282|NCT00582426|42090395|FG001|Overall Study|Use of illicit drugs|0|||
19641283|NCT02387970|42090403|FG000|Overall Study|Did not complete 1-year follow up|1|||
19641284|NCT02387970|42090404|FG001|Overall Study|Did not complete 1-year follow up|2|||
19641285|NCT00580034|42090410|FG000|Overall Study|Toxicity|10|||
19641286|NCT00580034|42090411|FG001|Overall Study|Toxicity|0|||
19641287|NCT00773513|42090417|FG000|Overall Study|Renal Transplant|254|||
19641288|NCT00773513|42090418|FG001|Overall Study|Renal Transplant|263|||
19641289|NCT00773513|42090417|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
19641290|NCT00773513|42090418|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
19641291|NCT00773513|42090417|FG000|Overall Study|Withdrew Consent|68|||
19641292|NCT00773513|42090418|FG001|Overall Study|Withdrew Consent|69|||
19641293|NCT00773513|42090417|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
19641294|NCT00773513|42090418|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
19641295|NCT00773513|42090417|FG000|Overall Study|Failure to Return|22|||
19641296|NCT00773513|42090418|FG001|Overall Study|Failure to Return|8|||
19641297|NCT00773513|42090417|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19641298|NCT00773513|42090418|FG001|Overall Study|Insufficient Therapeutic Response|18|||
19641299|NCT00773513|42090417|FG000|Overall Study|Reason Not Specified|159|||
19641300|NCT00773513|42090418|FG001|Overall Study|Reason Not Specified|126|||
19641301|NCT00773513|42090417|FG000|Overall Study|Death|531|||
19641302|NCT00773513|42090418|FG001|Overall Study|Death|545|||
19641303|NCT00581828|42090424|FG000|Overall Study|Protocol Violation|1|||
19641304|NCT00767039|42090430|FG000|Overall Study|Death|5|||
19641305|NCT00767039|42090431|FG001|Overall Study|Death|2|||
19641306|NCT00662649|42090441|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
19641307|NCT00662649|42090442|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
19641308|NCT00662649|42090443|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
19641309|NCT00662649|42090444|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
19641310|NCT00662649|42090445|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
19388136|NCT02055976|41631518|FG001|Overall Study|Other|0|||
19388137|NCT02055976|41631519|FG002|Overall Study|Other|1|||
19388138|NCT02055976|41631520|FG003|Overall Study|Other|0|||
19388139|NCT02055976|41631521|FG004|Overall Study|Other|0|||
19600137|NCT00718549|42049093|FG000|Induction Phase|Early Termination - No Additional Info|59|||
19600138|NCT00718549|42049094|FG001|Induction Phase|Early Termination - No Additional Info|0|||
19600139|NCT00718549|42049095|FG002|Induction Phase|Early Termination - No Additional Info|0|||
19600140|NCT00718549|42049093|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
19600141|NCT00718549|42049094|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
19600142|NCT00718549|42049095|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
19600143|NCT00718549|42049093|FG000|Maintenance/ Observation Phase|Death|0|||
19600144|NCT00718549|42049094|FG001|Maintenance/ Observation Phase|Death|1|||
19600145|NCT00718549|42049095|FG002|Maintenance/ Observation Phase|Death|2|||
19600146|NCT00718549|42049093|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
19600147|NCT00718549|42049094|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
19641311|NCT00662649|42090441|FG000|Core Study (24 Months)|Adverse Event|22|||
19641312|NCT00662649|42090442|FG001|Core Study (24 Months)|Adverse Event|13|||
19388140|NCT02055976|41631522|FG005|Overall Study|Other|0|||
19388141|NCT02055976|41631523|FG006|Overall Study|Other|0|||
19388142|NCT02055976|41631524|FG007|Overall Study|Other|0|||
19600148|NCT00718549|42049095|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
19600149|NCT00718549|42049093|FG000|Maintenance/ Observation Phase|Progression|0|||
19600150|NCT00718549|42049094|FG001|Maintenance/ Observation Phase|Progression|5|||
19600151|NCT00718549|42049095|FG002|Maintenance/ Observation Phase|Progression|14|||
19600152|NCT00718549|42049093|FG000|Maintenance/ Observation Phase|Relapse|0|||
19600153|NCT00718549|42049094|FG001|Maintenance/ Observation Phase|Relapse|3|||
19600154|NCT00718549|42049095|FG002|Maintenance/ Observation Phase|Relapse|2|||
19641313|NCT00662649|42090443|FG002|Core Study (24 Months)|Adverse Event|18|||
19641314|NCT00662649|42090444|FG003|Core Study (24 Months)|Adverse Event|0|||
19641315|NCT00662649|42090445|FG004|Core Study (24 Months)|Adverse Event|0|||
19748355|NCT03338010|42196308|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19748356|NCT03338010|42196309|FG001|Overall Study|Non-Compliance with Study Drug|3|||
19748357|NCT03338010|42196308|FG000|Overall Study|Protocol Violation|0|||
19748358|NCT03338010|42196309|FG001|Overall Study|Protocol Violation|1|||
19748359|NCT03337542|42196315|FG000|Overall Study|Withdrew Consent|17|||
19748360|NCT03337542|42196315|FG000|Overall Study|Allergic Adverse Event|1|||
19748361|NCT03337542|42196315|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
19748362|NCT03337542|42196315|FG000|Overall Study|Lost to Follow-up|1|||
19748363|NCT03337542|42196315|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
19748364|NCT01328548|42196322|FG000|Overall Study|Death|3|||
19748365|NCT01328548|42196323|FG001|Overall Study|Death|0|||
19748366|NCT01328548|42196322|FG000|Overall Study|Protocol Violation|1|||
19748367|NCT01328548|42196323|FG001|Overall Study|Protocol Violation|0|||
19748368|NCT03337308|42196361|FG000|Overall Study|Adverse Event|2|||
19748369|NCT03337308|42196362|FG001|Overall Study|Adverse Event|3|||
19748370|NCT03337308|42196363|FG002|Overall Study|Adverse Event|3|||
19748371|NCT03337308|42196364|FG003|Overall Study|Adverse Event|1|||
19748372|NCT03337308|42196361|FG000|Overall Study|Lost to Follow-up|1|||
19748373|NCT03337308|42196362|FG001|Overall Study|Lost to Follow-up|2|||
19748374|NCT03337308|42196363|FG002|Overall Study|Lost to Follow-up|0|||
19748375|NCT03337308|42196364|FG003|Overall Study|Lost to Follow-up|0|||
19748376|NCT03337308|42196361|FG000|Overall Study|Withdrawal by Subject|2|||
19748377|NCT03337308|42196362|FG001|Overall Study|Withdrawal by Subject|1|||
19748378|NCT03337308|42196363|FG002|Overall Study|Withdrawal by Subject|2|||
19748379|NCT03337308|42196364|FG003|Overall Study|Withdrawal by Subject|1|||
19748380|NCT03337308|42196361|FG000|Overall Study|Protocol Violation|0|||
19748381|NCT03337308|42196362|FG001|Overall Study|Protocol Violation|1|||
19748382|NCT03337308|42196363|FG002|Overall Study|Protocol Violation|0|||
19748383|NCT03337308|42196364|FG003|Overall Study|Protocol Violation|0|||
19748384|NCT02948829|42196374|FG000|Overall Study|Lost to Follow-up|2|||
19600155|NCT00793624|42049112|FG000|Overall Study|Adverse Event|18|||
19748385|NCT02948829|42196374|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
19748386|NCT02948829|42196374|FG000|Overall Study|Pregnancy|1|||
19748387|NCT02948829|42196374|FG000|Overall Study|Other: Reason not Specified|8|||
19748388|NCT03337152|42196395|FG000|Overall Study|Physician Decision|1|||
19388143|NCT02055976|41631525|FG008|Overall Study|Other|0|||
19600156|NCT00793624|42049113|FG001|Overall Study|Adverse Event|16|||
19600157|NCT00793624|42049114|FG002|Overall Study|Adverse Event|15|||
19600158|NCT00793624|42049115|FG003|Overall Study|Adverse Event|20|||
19600159|NCT00793624|42049112|FG000|Overall Study|Lost to Follow-up|2|||
19600160|NCT00793624|42049113|FG001|Overall Study|Lost to Follow-up|2|||
19600161|NCT00793624|42049114|FG002|Overall Study|Lost to Follow-up|4|||
19600162|NCT00793624|42049115|FG003|Overall Study|Lost to Follow-up|0|||
19600163|NCT00793624|42049112|FG000|Overall Study|Withdrawal by Subject|20|||
19600164|NCT00793624|42049113|FG001|Overall Study|Withdrawal by Subject|9|||
19600165|NCT00793624|42049114|FG002|Overall Study|Withdrawal by Subject|11|||
19600166|NCT00793624|42049115|FG003|Overall Study|Withdrawal by Subject|14|||
19600167|NCT00793624|42049112|FG000|Overall Study|Lack of Efficacy|9|||
19600168|NCT00793624|42049113|FG001|Overall Study|Lack of Efficacy|2|||
19600169|NCT00793624|42049114|FG002|Overall Study|Lack of Efficacy|1|||
19600170|NCT00793624|42049115|FG003|Overall Study|Lack of Efficacy|3|||
19600171|NCT00793624|42049112|FG000|Overall Study|Non compliance with protocol|2|||
19600172|NCT00793624|42049113|FG001|Overall Study|Non compliance with protocol|3|||
19600173|NCT00793624|42049114|FG002|Overall Study|Non compliance with protocol|2|||
19600174|NCT00793624|42049115|FG003|Overall Study|Non compliance with protocol|3|||
19600175|NCT00793624|42049112|FG000|Overall Study|Other reason not described above|6|||
19600176|NCT00793624|42049113|FG001|Overall Study|Other reason not described above|4|||
19600177|NCT00793624|42049114|FG002|Overall Study|Other reason not described above|6|||
19600178|NCT00793624|42049115|FG003|Overall Study|Other reason not described above|3|||
19600179|NCT00794950|42049133|FG000|BCG Induction|Withdrawal by Subject|2|||
19600180|NCT00794950|42049133|FG000|BCG Induction|ineligible|3|||
19600181|NCT00794950|42049133|FG000|BCG Induction|noncompliant w. BCG|1|||
19600182|NCT00794950|42049133|FG000|BCG Induction|Adverse Event|1|||
19600183|NCT00794950|42049133|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
19748389|NCT03337152|42196396|FG001|Overall Study|Physician Decision|0|||
19748390|NCT03337152|42196395|FG000|Overall Study|Lost to Follow-up|1|||
19748391|NCT03337152|42196396|FG001|Overall Study|Lost to Follow-up|3|||
19641316|NCT00662649|42090441|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
19641317|NCT00662649|42090442|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
19641318|NCT00662649|42090443|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
19641319|NCT00662649|42090444|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
19641320|NCT00662649|42090445|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
19641321|NCT00662649|42090441|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
19641322|NCT00662649|42090442|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
19641323|NCT00662649|42090443|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
19641324|NCT00662649|42090444|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
19641325|NCT00662649|42090445|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
19641326|NCT00662649|42090441|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
19641327|NCT00662649|42090442|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
19641328|NCT00662649|42090443|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
19641329|NCT00662649|42090444|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
19641330|NCT00662649|42090445|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
19641331|NCT00662649|42090441|FG000|Core Study (24 Months)|Protocol Violation|5|||
19641332|NCT00662649|42090442|FG001|Core Study (24 Months)|Protocol Violation|5|||
19641333|NCT00662649|42090443|FG002|Core Study (24 Months)|Protocol Violation|4|||
19748392|NCT03337152|42196395|FG000|Overall Study|Adverse Event|3|||
19748393|NCT03337152|42196396|FG001|Overall Study|Adverse Event|1|||
19748394|NCT03337152|42196395|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
19748395|NCT03337152|42196396|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
19748396|NCT03710161|42196410|FG000|Overall Study|Study halted due to COVID pandemic|3|||
19748397|NCT03710161|42196411|FG001|Overall Study|Study halted due to COVID pandemic|2|||
19748398|NCT03091400|42196419|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
19748399|NCT03091400|42196420|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
19641334|NCT00662649|42090444|FG003|Core Study (24 Months)|Protocol Violation|0|||
19641335|NCT00662649|42090445|FG004|Core Study (24 Months)|Protocol Violation|0|||
19641336|NCT00662649|42090441|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
19641337|NCT00662649|42090442|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
19641338|NCT00662649|42090443|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
19641339|NCT00662649|42090444|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
19641340|NCT00662649|42090445|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
19641341|NCT00662649|42090441|FG000|Core Study (24 Months)|Death|1|||
19641342|NCT00662649|42090442|FG001|Core Study (24 Months)|Death|0|||
19641343|NCT00662649|42090443|FG002|Core Study (24 Months)|Death|2|||
19641344|NCT00662649|42090444|FG003|Core Study (24 Months)|Death|0|||
19641345|NCT00662649|42090445|FG004|Core Study (24 Months)|Death|0|||
19641346|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
19641347|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
19641348|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
19641349|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
19641350|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
19641351|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
19641352|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
19641353|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
19641354|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
19641355|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
19641356|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
19641357|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
19641358|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
19641359|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
19641360|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
19641361|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
19641362|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
19641363|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
19641364|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
19641365|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
19641366|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
19641367|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
19641368|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
19641369|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
19641370|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
19641371|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
19641372|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
19748400|NCT01318993|42196426|FG000|Overall Study|Adverse Event|53|||
19641373|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
19748401|NCT01318993|42196426|FG000|Overall Study|Lack of Efficacy|121|||
19641374|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
19641375|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
19641376|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
19641377|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
19641378|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
19641379|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
19641380|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
19641381|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
19641382|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
19600184|NCT00794950|42049133|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
19600185|NCT00794950|42049133|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
19600186|NCT00794950|42049133|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
19600187|NCT00793546|42049140|FG000|Overall Study|Death|3|||
19600188|NCT00793546|42049141|FG001|Overall Study|Death|0|||
19600189|NCT00793546|42049140|FG000|Overall Study|Lost to Follow-up|1|||
19600190|NCT00793546|42049141|FG001|Overall Study|Lost to Follow-up|0|||
19600191|NCT00793546|42049140|FG000|Overall Study|Withdrawal by Subject|1|||
19600192|NCT00793546|42049141|FG001|Overall Study|Withdrawal by Subject|1|||
19600193|NCT00793546|42049140|FG000|Overall Study|Study Terminated by Sponsor|8|||
19600194|NCT00793546|42049141|FG001|Overall Study|Study Terminated by Sponsor|27|||
19600195|NCT00793546|42049140|FG000|Overall Study|Other|1|||
19641383|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
19641384|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
19641385|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
19641386|NCT00662649|42090441|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
19748402|NCT01318993|42196426|FG000|Overall Study|Protocol Violation|3|||
19600196|NCT00793546|42049141|FG001|Overall Study|Other|0|||
19600197|NCT00798694|42049151|FG000|Overall Study|Lost to Follow-up|1|||
19600198|NCT00798694|42049152|FG001|Overall Study|Lost to Follow-up|1|||
19600199|NCT00798694|42049151|FG000|Overall Study|Physician Decision|1|||
19600200|NCT00798694|42049152|FG001|Overall Study|Physician Decision|0|||
19600201|NCT00718315|42049167|FG000|Overall Study|Adverse Event|1|||
19600202|NCT00718315|42049168|FG001|Overall Study|Adverse Event|2|||
19600203|NCT00718315|42049169|FG002|Overall Study|Adverse Event|3|||
19600204|NCT00718315|42049167|FG000|Overall Study|Death|6|||
19600205|NCT00718315|42049168|FG001|Overall Study|Death|6|||
19600206|NCT00718315|42049169|FG002|Overall Study|Death|5|||
19600207|NCT00718315|42049167|FG000|Overall Study|Lost to Follow-up|2|||
19600208|NCT00718315|42049168|FG001|Overall Study|Lost to Follow-up|3|||
19600209|NCT00718315|42049169|FG002|Overall Study|Lost to Follow-up|4|||
19600210|NCT00718315|42049167|FG000|Overall Study|Protocol Violation|5|||
19600211|NCT00718315|42049168|FG001|Overall Study|Protocol Violation|5|||
19600212|NCT00718315|42049169|FG002|Overall Study|Protocol Violation|3|||
19600213|NCT00718315|42049167|FG000|Overall Study|Erlotinib dose decreased|4|||
19600214|NCT00718315|42049168|FG001|Overall Study|Erlotinib dose decreased|3|||
19600215|NCT00718315|42049169|FG002|Overall Study|Erlotinib dose decreased|1|||
19600216|NCT00718315|42049167|FG000|Overall Study|Use of Minocyclin|1|||
19600217|NCT00718315|42049168|FG001|Overall Study|Use of Minocyclin|1|||
19600218|NCT00718315|42049169|FG002|Overall Study|Use of Minocyclin|1|||
19600219|NCT00718315|42049167|FG000|Overall Study|Disease progression|0|||
19600220|NCT00718315|42049168|FG001|Overall Study|Disease progression|1|||
19600221|NCT00718315|42049169|FG002|Overall Study|Disease progression|1|||
19600222|NCT00718315|42049167|FG000|Overall Study|Other|0|||
19600223|NCT00718315|42049168|FG001|Overall Study|Other|0|||
19600224|NCT00718315|42049169|FG002|Overall Study|Other|1|||
19600225|NCT00718315|42049167|FG000|Overall Study|Use of ATB and Corticoids|0|||
19600226|NCT00718315|42049168|FG001|Overall Study|Use of ATB and Corticoids|1|||
19600227|NCT00718315|42049169|FG002|Overall Study|Use of ATB and Corticoids|2|||
19600228|NCT00798304|42049180|FG000|Overall Study|Adverse Event|0|||
19600229|NCT00798304|42049181|FG001|Overall Study|Adverse Event|1|||
19600230|NCT00798304|42049182|FG002|Overall Study|Adverse Event|1|||
19600231|NCT00798304|42049180|FG000|Overall Study|Discontinuation by Sponsor|14|||
19600232|NCT00798304|42049181|FG001|Overall Study|Discontinuation by Sponsor|21|||
19600233|NCT00798304|42049182|FG002|Overall Study|Discontinuation by Sponsor|9|||
19600234|NCT00718237|42049192|FG000|Overall Study|Adverse Event|1|||
19600235|NCT00718237|42049193|FG001|Overall Study|Adverse Event|3|||
19600236|NCT00718237|42049192|FG000|Overall Study|Lost to Follow-up|2|||
19600237|NCT00718237|42049193|FG001|Overall Study|Lost to Follow-up|2|||
19600238|NCT00718237|42049192|FG000|Overall Study|Physician Decision|1|||
19600239|NCT00718237|42049193|FG001|Overall Study|Physician Decision|0|||
19748403|NCT01318993|42196426|FG000|Overall Study|Protocol based stopping criteria|6|||
19600240|NCT00718237|42049192|FG000|Overall Study|Withdrawal by Subject|9|||
19600241|NCT00718237|42049193|FG001|Overall Study|Withdrawal by Subject|10|||
19600242|NCT00793780|42049203|FG000|Overall Study|Withdrawal by Subject|2|||
19600243|NCT00793780|42049204|FG001|Overall Study|Withdrawal by Subject|1|||
19600244|NCT02643303|42049219|FG000|Overall Study|Progressive Disease|4|||
19600245|NCT02643303|42049220|FG001|Overall Study|Progressive Disease|4|||
19600246|NCT02643303|42049221|FG002|Overall Study|Progressive Disease|1|||
19600247|NCT02643303|42049222|FG003|Overall Study|Progressive Disease|12|||
19600248|NCT02643303|42049223|FG004|Overall Study|Progressive Disease|6|||
19600249|NCT02643303|42049224|FG005|Overall Study|Progressive Disease|4|||
19600250|NCT02643303|42049225|FG006|Overall Study|Progressive Disease|8|||
19600251|NCT02643303|42049226|FG007|Overall Study|Progressive Disease|2|||
19600252|NCT02643303|42049227|FG008|Overall Study|Progressive Disease|6|||
19600253|NCT02643303|42049219|FG000|Overall Study|Adverse Event|0|||
19600254|NCT02643303|42049220|FG001|Overall Study|Adverse Event|1|||
19600255|NCT02643303|42049221|FG002|Overall Study|Adverse Event|0|||
19641387|NCT00662649|42090442|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
19641388|NCT00662649|42090443|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
19641389|NCT00662649|42090444|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
19641390|NCT00662649|42090445|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
19641391|NCT00766493|42090459|FG000|30 Days Post-Procedure|Discontinued|7|||
19641392|NCT00766493|42090459|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
19641393|NCT00766493|42090459|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
19641394|NCT03070392|42090465|FG000|Overall Study|Not Treated|7|||
19641395|NCT03070392|42090466|FG001|Overall Study|Not Treated|0|||
19641396|NCT03070392|42090467|FG002|Overall Study|Not Treated|3|||
19641397|NCT03070392|42090468|FG003|Overall Study|Not Treated|12|||
19641398|NCT03070392|42090465|FG000|Overall Study|Death|3|||
19641399|NCT03070392|42090466|FG001|Overall Study|Death|0|||
19641400|NCT03070392|42090467|FG002|Overall Study|Death|0|||
19641401|NCT03070392|42090468|FG003|Overall Study|Death|1|||
19641402|NCT03070392|42090465|FG000|Overall Study|Withdrawal by Subject|7|||
19641403|NCT03070392|42090466|FG001|Overall Study|Withdrawal by Subject|0|||
19641404|NCT03070392|42090467|FG002|Overall Study|Withdrawal by Subject|0|||
19641405|NCT03070392|42090468|FG003|Overall Study|Withdrawal by Subject|3|||
19641406|NCT03070392|42090465|FG000|Overall Study|Physician Decision|1|||
19748404|NCT01318993|42196426|FG000|Overall Study|Study closed or terminated|174|||
19748405|NCT01318993|42196426|FG000|Overall Study|Lost to Follow-up|4|||
19748406|NCT01318993|42196426|FG000|Overall Study|Physician Decision|13|||
19600256|NCT02643303|42049222|FG003|Overall Study|Adverse Event|0|||
19600257|NCT02643303|42049223|FG004|Overall Study|Adverse Event|1|||
19748407|NCT01318993|42196426|FG000|Overall Study|Withdrawal by Subject|24|||
19748408|NCT03090152|42196433|FG000|Overall Study|Withdrawal by Subject|0|||
19748409|NCT03090152|42196434|FG001|Overall Study|Withdrawal by Subject|2|||
19600258|NCT02643303|42049224|FG005|Overall Study|Adverse Event|0|||
19600259|NCT02643303|42049225|FG006|Overall Study|Adverse Event|0|||
19641407|NCT03070392|42090466|FG001|Overall Study|Physician Decision|0|||
19641408|NCT03070392|42090467|FG002|Overall Study|Physician Decision|0|||
19641409|NCT03070392|42090468|FG003|Overall Study|Physician Decision|2|||
19641410|NCT03070392|42090465|FG000|Overall Study|Progressive Disease|154|||
19641411|NCT03070392|42090466|FG001|Overall Study|Progressive Disease|6|||
19641412|NCT03070392|42090467|FG002|Overall Study|Progressive Disease|2|||
19641413|NCT03070392|42090468|FG003|Overall Study|Progressive Disease|70|||
19641414|NCT03070392|42090465|FG000|Overall Study|Adverse Event|6|||
19641415|NCT03070392|42090466|FG001|Overall Study|Adverse Event|1|||
19641416|NCT03070392|42090467|FG002|Overall Study|Adverse Event|1|||
19641417|NCT03070392|42090468|FG003|Overall Study|Adverse Event|3|||
19641418|NCT03070392|42090465|FG000|Overall Study|Alternate anticancer treatment|1|||
19641419|NCT03070392|42090466|FG001|Overall Study|Alternate anticancer treatment|0|||
19641420|NCT03070392|42090467|FG002|Overall Study|Alternate anticancer treatment|0|||
19641421|NCT03070392|42090468|FG003|Overall Study|Alternate anticancer treatment|1|||
19641422|NCT03070392|42090465|FG000|Overall Study|Ongoing|73|||
19641423|NCT03070392|42090466|FG001|Overall Study|Ongoing|0|||
19641424|NCT03070392|42090467|FG002|Overall Study|Ongoing|0|||
19641425|NCT03070392|42090468|FG003|Overall Study|Ongoing|11|||
19641426|NCT00784043|42090476|FG000|Overall Study|Withdrawal by Subject|8|||
19641427|NCT00784043|42090477|FG001|Overall Study|Withdrawal by Subject|5|||
19641428|NCT00784043|42090476|FG000|Overall Study|Protocol Terminated|23|||
19641429|NCT00784043|42090477|FG001|Overall Study|Protocol Terminated|1|||
19641430|NCT00773279|42090483|FG000|Period 1|Adverse Event|2|||
19641431|NCT00773279|42090484|FG001|Period 1|Adverse Event|1|||
19641432|NCT00773279|42090483|FG000|Period 1|Lack of Efficacy|0|||
19748410|NCT03090152|42196435|FG002|Overall Study|Withdrawal by Subject|1|||
19388144|NCT02055976|41631517|FG000|Overall Study|Adverse Event|0|||
19600260|NCT02643303|42049226|FG007|Overall Study|Adverse Event|0|||
19600261|NCT02643303|42049227|FG008|Overall Study|Adverse Event|0|||
19600262|NCT02643303|42049219|FG000|Overall Study|Withdrawal by Subject|0|||
19600263|NCT02643303|42049220|FG001|Overall Study|Withdrawal by Subject|0|||
19641433|NCT00773279|42090484|FG001|Period 1|Lack of Efficacy|2|||
19641434|NCT00773279|42090483|FG000|Period 1|Unclassified|5|||
19641435|NCT00773279|42090484|FG001|Period 1|Unclassified|1|||
19641436|NCT00773279|42090483|FG000|Period 2|Adverse Event|0|||
19641437|NCT00773279|42090484|FG001|Period 2|Adverse Event|1|||
19748411|NCT03090152|42196433|FG000|Overall Study|Surgery Canceled|1|||
19748412|NCT03090152|42196434|FG001|Overall Study|Surgery Canceled|0|||
19748413|NCT03090152|42196435|FG002|Overall Study|Surgery Canceled|0|||
19748414|NCT03090152|42196433|FG000|Overall Study|Epidural catheter could not be placed|0|||
19748415|NCT03090152|42196434|FG001|Overall Study|Epidural catheter could not be placed|2|||
19748416|NCT03090152|42196435|FG002|Overall Study|Epidural catheter could not be placed|0|||
19748417|NCT04252287|42196445|FG000|Overall Study|Death|5|||
19748418|NCT04252287|42196446|FG001|Overall Study|Death|3|||
19748419|NCT04252287|42196445|FG000|Overall Study|Lost to Follow-up|4|||
19748420|NCT04252287|42196446|FG001|Overall Study|Lost to Follow-up|6|||
19748421|NCT04252287|42196445|FG000|Overall Study|Withdrawal by Subject|19|||
19748422|NCT04252287|42196446|FG001|Overall Study|Withdrawal by Subject|16|||
19748423|NCT04252287|42196445|FG000|Overall Study|Protocol Violation|3|||
19748424|NCT04252287|42196446|FG001|Overall Study|Protocol Violation|4|||
19748425|NCT02735200|42196458|FG000|Overall Study|Lost to Follow-up|0|||
19748426|NCT02735200|42196459|FG001|Overall Study|Lost to Follow-up|5|||
19748427|NCT02735200|42196458|FG000|Overall Study|Withdrawal by Subject|8|||
19748428|NCT02735200|42196459|FG001|Overall Study|Withdrawal by Subject|0|||
19748429|NCT02946918|42196467|FG000|Overall Study|Patient unblinded himself|1|||
19748430|NCT02946918|42196468|FG001|Overall Study|Patient unblinded himself|0|||
19748431|NCT02946918|42196467|FG000|Overall Study|Physician Decision|0|||
19748432|NCT02946918|42196468|FG001|Overall Study|Physician Decision|2|||
19748433|NCT02946918|42196467|FG000|Overall Study|Ran out of study medication|0|||
19748434|NCT02946918|42196468|FG001|Overall Study|Ran out of study medication|1|||
19748435|NCT02734810|42196489|FG000|Overall Study|Adverse Event|1|||
19748436|NCT02734810|42196490|FG001|Overall Study|Adverse Event|0|||
19748437|NCT02734810|42196489|FG000|Overall Study|Lack of Efficacy|1|||
19748438|NCT02734810|42196490|FG001|Overall Study|Lack of Efficacy|0|||
19477040|NCT01492361|41755747|FG000|Overall Study|Other than specified above|106|||
19477041|NCT01492361|41755748|FG001|Overall Study|Other than specified above|138|||
19477042|NCT01514461|41755827|FG000|Overall Study|Adverse Event|2|||
19477043|NCT01514461|41755828|FG001|Overall Study|Adverse Event|1|||
19477044|NCT01514461|41755829|FG002|Overall Study|Adverse Event|3|||
19477045|NCT01514461|41755827|FG000|Overall Study|Physician Decision|1|||
19477046|NCT01514461|41755828|FG001|Overall Study|Physician Decision|1|||
19477047|NCT01514461|41755829|FG002|Overall Study|Physician Decision|0|||
19477048|NCT01514461|41755827|FG000|Overall Study|Patient/guardian decision|1|||
19477049|NCT01514461|41755828|FG001|Overall Study|Patient/guardian decision|1|||
19600264|NCT02643303|42049221|FG002|Overall Study|Withdrawal by Subject|0|||
19600265|NCT02643303|42049222|FG003|Overall Study|Withdrawal by Subject|1|||
19600266|NCT02643303|42049223|FG004|Overall Study|Withdrawal by Subject|0|||
19600267|NCT02643303|42049224|FG005|Overall Study|Withdrawal by Subject|0|||
19600268|NCT02643303|42049225|FG006|Overall Study|Withdrawal by Subject|1|||
19600269|NCT02643303|42049226|FG007|Overall Study|Withdrawal by Subject|1|||
19641438|NCT00773279|42090483|FG000|Period 2|Lack of Efficacy|1|||
19641439|NCT00773279|42090484|FG001|Period 2|Lack of Efficacy|0|||
19641440|NCT00773279|42090483|FG000|Period 2|Protocol Violation|0|||
19641441|NCT00773279|42090484|FG001|Period 2|Protocol Violation|3|||
19641442|NCT00773279|42090483|FG000|Period 2|Unclassified|2|||
19641443|NCT00773279|42090484|FG001|Period 2|Unclassified|2|||
19641444|NCT00766415|42090493|FG000|Overall Study|Withdrawal by Subject|0|||
19641445|NCT00766415|42090494|FG001|Overall Study|Withdrawal by Subject|1|||
19600270|NCT02643303|42049227|FG008|Overall Study|Withdrawal by Subject|1|||
19600271|NCT00790036|42049253|FG000|Overall Study|Abnormal lab values|3|||
19600272|NCT00790036|42049254|FG001|Overall Study|Abnormal lab values|2|||
19600273|NCT00790036|42049253|FG000|Overall Study|Administrative problems|5|||
19600274|NCT00790036|42049254|FG001|Overall Study|Administrative problems|9|||
19600275|NCT00790036|42049253|FG000|Overall Study|Adverse Event|113|||
19641446|NCT00772967|42090500|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
19641447|NCT00772967|42090501|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
19641448|NCT00772967|42090502|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
19641449|NCT00772967|42090503|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
19641450|NCT00772967|42090504|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
19641451|NCT00772967|42090505|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
19477050|NCT01514461|41755829|FG002|Overall Study|Patient/guardian decision|1|||
19477051|NCT01514461|41755827|FG000|Overall Study|Death|1|||
19600276|NCT00790036|42049254|FG001|Overall Study|Adverse Event|44|||
19477052|NCT01514461|41755828|FG001|Overall Study|Death|0|||
19477053|NCT01514461|41755829|FG002|Overall Study|Death|0|||
19477054|NCT01491737|41755875|FG000|Overall Study|Withdrawal by Subject|20|||
19477055|NCT01491737|41755876|FG001|Overall Study|Withdrawal by Subject|17|||
19477056|NCT01491737|41755875|FG000|Overall Study|Lost to Follow-up|2|||
19477057|NCT01491737|41755876|FG001|Overall Study|Lost to Follow-up|10|||
19477058|NCT01491737|41755875|FG000|Overall Study|Death|63|||
19641452|NCT00772967|42090500|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
19748439|NCT03656068|42196515|FG000|Overall Study|Withdrawal by Subject|4|||
19748440|NCT03656068|42196515|FG000|Overall Study|Adverse Event|1|||
19748441|NCT02944383|42196522|FG000|Overall Study|Lost to Follow-up|0|||
19748442|NCT02944383|42196523|FG001|Overall Study|Lost to Follow-up|0|||
19600277|NCT00790036|42049253|FG000|Overall Study|Death|1|||
19600278|NCT00790036|42049254|FG001|Overall Study|Death|0|||
19641453|NCT00772967|42090501|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
19641454|NCT00772967|42090502|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
19641455|NCT00772967|42090503|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
19748443|NCT02944383|42196524|FG002|Overall Study|Lost to Follow-up|1|||
19748444|NCT02944383|42196522|FG000|Overall Study|Withdrawal by Subject|1|||
19748445|NCT02944383|42196523|FG001|Overall Study|Withdrawal by Subject|0|||
19748446|NCT02944383|42196524|FG002|Overall Study|Withdrawal by Subject|0|||
19748447|NCT02096588|42196536|FG000|Overall Study|Lack of Efficacy|2|||
19748448|NCT02096588|42196537|FG001|Overall Study|Lack of Efficacy|0|||
19748449|NCT02096588|42196536|FG000|Overall Study|Withdrawal by Subject|0|||
19748450|NCT02096588|42196537|FG001|Overall Study|Withdrawal by Subject|1|||
19748451|NCT03768089|42196561|FG000|Part A|Lost to Follow-up|0|||
19748452|NCT03768089|42196562|FG001|Part A|Lost to Follow-up|0|||
19641456|NCT00772967|42090504|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
19641457|NCT00772967|42090505|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
19641458|NCT00772967|42090500|FG000|Crossover Treatment 3|Adverse Event|0|||
19641459|NCT00772967|42090501|FG001|Crossover Treatment 3|Adverse Event|0|||
19641460|NCT00772967|42090502|FG002|Crossover Treatment 3|Adverse Event|0|||
19641461|NCT00772967|42090503|FG003|Crossover Treatment 3|Adverse Event|0|||
19641462|NCT00772967|42090504|FG004|Crossover Treatment 3|Adverse Event|1|||
19641463|NCT00772967|42090505|FG005|Crossover Treatment 3|Adverse Event|0|||
19641464|NCT00662259|42090528|FG000|Overall Study|Adverse Event|2|||
19641465|NCT00662259|42090529|FG001|Overall Study|Adverse Event|0|||
19641466|NCT00660699|42090535|FG000|Overall Study|Withdrawal by Subject|2|||
19641467|NCT00582114|42090541|FG000|Overall Study|Death|4|||
19641468|NCT00582114|42090542|FG001|Overall Study|Death|4|||
19641469|NCT00582114|42090541|FG000|Overall Study|Kidney Transplant|3|||
19641470|NCT00582114|42090542|FG001|Overall Study|Kidney Transplant|1|||
19641471|NCT00582114|42090541|FG000|Overall Study|Lost to Follow-up|7|||
19748453|NCT03768089|42196563|FG002|Part A|Lost to Follow-up|0|||
19748454|NCT03768089|42196564|FG003|Part A|Lost to Follow-up|0|||
19748455|NCT03768089|42196565|FG004|Part A|Lost to Follow-up|1|||
19748456|NCT03768089|42196566|FG005|Part A|Lost to Follow-up|0|||
19748457|NCT03768089|42196567|FG006|Part A|Lost to Follow-up|0|||
19748458|NCT03768089|42196568|FG007|Part A|Lost to Follow-up|0|||
19748459|NCT03768089|42196569|FG008|Part A|Lost to Follow-up|0|||
19748460|NCT03768089|42196570|FG009|Part A|Lost to Follow-up|0|||
19748461|NCT03768089|42196571|FG010|Part A|Lost to Follow-up|0|||
19748462|NCT03768089|42196572|FG011|Part A|Lost to Follow-up|0|||
19748463|NCT03768089|42196573|FG012|Part A|Lost to Follow-up|0|||
19748464|NCT03768089|42196574|FG013|Part A|Lost to Follow-up|0|||
19748465|NCT03768089|42196575|FG014|Part A|Lost to Follow-up|0|||
19748466|NCT03768089|42196576|FG015|Part A|Lost to Follow-up|0|||
19748467|NCT03768089|42196577|FG016|Part A|Lost to Follow-up|0|||
19748468|NCT03768089|42196578|FG017|Part A|Lost to Follow-up|0|||
19748469|NCT03768089|42196561|FG000|Part C|Randomized, Never Dosed|0|||
19748470|NCT03768089|42196562|FG001|Part C|Randomized, Never Dosed|0|||
19748471|NCT03768089|42196563|FG002|Part C|Randomized, Never Dosed|0|||
19748472|NCT03768089|42196564|FG003|Part C|Randomized, Never Dosed|0|||
19748473|NCT03768089|42196565|FG004|Part C|Randomized, Never Dosed|0|||
19748474|NCT03768089|42196566|FG005|Part C|Randomized, Never Dosed|0|||
19748475|NCT03768089|42196567|FG006|Part C|Randomized, Never Dosed|0|||
19748476|NCT03768089|42196568|FG007|Part C|Randomized, Never Dosed|0|||
19600279|NCT00790036|42049253|FG000|Overall Study|Disease progression|24|||
19600280|NCT00790036|42049254|FG001|Overall Study|Disease progression|48|||
19600281|NCT00790036|42049253|FG000|Overall Study|Lost to Follow-up|1|||
19600282|NCT00790036|42049254|FG001|Overall Study|Lost to Follow-up|2|||
19600283|NCT00790036|42049253|FG000|Overall Study|Protocol Violation|10|||
19600284|NCT00790036|42049254|FG001|Overall Study|Protocol Violation|2|||
19600285|NCT00790036|42049253|FG000|Overall Study|Withdrawal by Subject|18|||
19600286|NCT00790036|42049254|FG001|Overall Study|Withdrawal by Subject|7|||
19600287|NCT00790036|42049253|FG000|Overall Study|Subject/guardian decision|20|||
19600288|NCT00790036|42049254|FG001|Overall Study|Subject/guardian decision|7|||
19600289|NCT00789958|42049261|FG000|Overall Study|Adverse Event|3|||
19600290|NCT00789958|42049261|FG000|Overall Study|Withdrawal by Subject|4|||
19600291|NCT00789958|42049261|FG000|Overall Study|Progression|3|||
19600292|NCT00789958|42049261|FG000|Overall Study|not protocol specified|1|||
19600293|NCT00789958|42049261|FG000|Overall Study|Not eligible/not analyzable|26|||
19748477|NCT03768089|42196569|FG008|Part C|Randomized, Never Dosed|0|||
19748478|NCT03768089|42196570|FG009|Part C|Randomized, Never Dosed|0|||
19748479|NCT03768089|42196571|FG010|Part C|Randomized, Never Dosed|0|||
19748480|NCT03768089|42196572|FG011|Part C|Randomized, Never Dosed|0|||
19748481|NCT03768089|42196573|FG012|Part C|Randomized, Never Dosed|0|||
19748482|NCT03768089|42196574|FG013|Part C|Randomized, Never Dosed|0|||
19600294|NCT00789880|42049273|FG000|Overall Study|Adverse Event|0|||
19641472|NCT00582114|42090542|FG001|Overall Study|Lost to Follow-up|6|||
19748483|NCT03768089|42196575|FG014|Part C|Randomized, Never Dosed|1|||
19748484|NCT03768089|42196576|FG015|Part C|Randomized, Never Dosed|0|||
19748485|NCT03768089|42196577|FG016|Part C|Randomized, Never Dosed|0|||
19641473|NCT00582114|42090541|FG000|Overall Study|Withdrawal by Subject|8|||
19641474|NCT00582114|42090542|FG001|Overall Study|Withdrawal by Subject|16|||
19641475|NCT00582114|42090541|FG000|Overall Study|Adverse Event|1|||
19641476|NCT00582114|42090542|FG001|Overall Study|Adverse Event|1|||
19641477|NCT00582114|42090541|FG000|Overall Study|Physician Decision|0|||
19641478|NCT00582114|42090542|FG001|Overall Study|Physician Decision|6|||
19641479|NCT00582114|42090541|FG000|Overall Study|Stopped by data safety monitoring board|19|||
19641480|NCT00582114|42090542|FG001|Overall Study|Stopped by data safety monitoring board|20|||
19641481|NCT00582036|42090550|FG000|Overall Study|Withdrawal by Subject|0|||
19641482|NCT00582036|42090551|FG001|Overall Study|Withdrawal by Subject|1|||
19641483|NCT00581360|42090557|FG000|Overall Study|Withdrawal by Subject|1|||
19641484|NCT00660387|42090563|FG000|Overall Study|Adverse Event|1|||
19641485|NCT00660387|42090564|FG001|Overall Study|Adverse Event|2|||
19641486|NCT00660387|42090563|FG000|Overall Study|Lack of Efficacy|0|||
19748486|NCT03768089|42196578|FG017|Part C|Randomized, Never Dosed|0|||
19748487|NCT03086330|42196639|FG000|Overall Study|Withdrawal by Subject|3|||
19748488|NCT03086330|42196640|FG001|Overall Study|Withdrawal by Subject|2|||
19748489|NCT03086330|42196639|FG000|Overall Study|Lost to Follow-up|1|||
19748490|NCT03086330|42196640|FG001|Overall Study|Lost to Follow-up|2|||
19748491|NCT02943993|42196672|FG000|Overall Study|Withdrawal by Subject|52|||
19748492|NCT02943993|42196672|FG000|Overall Study|Transfer to another institution|6|||
19748493|NCT02943993|42196672|FG000|Overall Study|Lost to Follow-up|135|||
19748494|NCT02943993|42196672|FG000|Overall Study|Death|98|||
19748495|NCT02943993|42196672|FG000|Overall Study|Other reason for premature termination|32|||
19748496|NCT02943993|42196672|FG000|Overall Study|Missing reason for termination|7|||
19748497|NCT02943447|42196696|FG000|Blinded Study Phase|Withdrew Consent|1|||
19748498|NCT02943447|42196697|FG001|Blinded Study Phase|Withdrew Consent|2|||
19748499|NCT02943447|42196698|FG002|Blinded Study Phase|Withdrew Consent|1|||
19748500|NCT02943447|42196696|FG000|Blinded Study Phase|Adverse Event|3|||
19748501|NCT02943447|42196697|FG001|Blinded Study Phase|Adverse Event|0|||
19748502|NCT02943447|42196698|FG002|Blinded Study Phase|Adverse Event|0|||
19748503|NCT02943447|42196696|FG000|Blinded Study Phase|Investigator's discretion|1|||
19748504|NCT02943447|42196697|FG001|Blinded Study Phase|Investigator's discretion|0|||
19748505|NCT02943447|42196698|FG002|Blinded Study Phase|Investigator's discretion|0|||
19748506|NCT02943447|42196696|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
19748507|NCT02943447|42196697|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
19748508|NCT02943447|42196698|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
19748509|NCT02943447|42196696|FG000|Open-Label Extension Phase|Adverse Event|4|||
19748510|NCT02943447|42196697|FG001|Open-Label Extension Phase|Adverse Event|7|||
19748511|NCT02943447|42196698|FG002|Open-Label Extension Phase|Adverse Event|3|||
19748512|NCT02943447|42196696|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
19748513|NCT02943447|42196697|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
19748514|NCT02943447|42196698|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
19748515|NCT02943447|42196696|FG000|Open-Label Extension Phase|Withdrew consent|1|||
19748516|NCT02943447|42196697|FG001|Open-Label Extension Phase|Withdrew consent|1|||
19748517|NCT02943447|42196698|FG002|Open-Label Extension Phase|Withdrew consent|1|||
19748518|NCT02943447|42196696|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
19748519|NCT02943447|42196697|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
19641487|NCT00660387|42090564|FG001|Overall Study|Lack of Efficacy|1|||
19641488|NCT00660387|42090563|FG000|Overall Study|Protocol Violation|1|||
19641489|NCT00660387|42090564|FG001|Overall Study|Protocol Violation|0|||
19641490|NCT00582738|42090572|FG000|Overall Study|Administrative Problems|7|||
19641491|NCT00582738|42090573|FG001|Overall Study|Administrative Problems|8|||
19641492|NCT00582738|42090572|FG000|Overall Study|Adverse Event|0|||
19641493|NCT00582738|42090573|FG001|Overall Study|Adverse Event|5|||
19641494|NCT00582738|42090572|FG000|Overall Study|Graft Lost|0|||
19641495|NCT00582738|42090573|FG001|Overall Study|Graft Lost|1|||
19641496|NCT00582738|42090572|FG000|Overall Study|Other|1|||
19641497|NCT00582738|42090573|FG001|Overall Study|Other|0|||
19641498|NCT00582738|42090572|FG000|Overall Study|Protocol Violation|1|||
19641499|NCT00582738|42090573|FG001|Overall Study|Protocol Violation|1|||
19641500|NCT00582738|42090572|FG000|Overall Study|Withdrawal by Subject|0|||
19641501|NCT00582738|42090573|FG001|Overall Study|Withdrawal by Subject|3|||
19641502|NCT00772889|42090588|FG000|Overall Study|Adverse Event|7|||
19641503|NCT00772889|42090589|FG001|Overall Study|Adverse Event|4|||
19641504|NCT00772889|42090590|FG002|Overall Study|Adverse Event|0|||
19641505|NCT00772889|42090588|FG000|Overall Study|Withdrawal by Subject|9|||
19748520|NCT02943447|42196698|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
19748521|NCT02844777|42196727|FG000|Overall Study|Withdrawal by Subject|2|||
19748522|NCT02844777|42196728|FG001|Overall Study|Withdrawal by Subject|0|||
19748523|NCT02844777|42196729|FG002|Overall Study|Withdrawal by Subject|0|||
19748524|NCT04003142|42196740|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
19748525|NCT04003142|42196741|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
19641506|NCT00772889|42090589|FG001|Overall Study|Withdrawal by Subject|8|||
19641507|NCT00772889|42090590|FG002|Overall Study|Withdrawal by Subject|9|||
19641508|NCT00772889|42090588|FG000|Overall Study|Lost to Follow-up|6|||
19641509|NCT00772889|42090589|FG001|Overall Study|Lost to Follow-up|6|||
19641510|NCT00772889|42090590|FG002|Overall Study|Lost to Follow-up|7|||
19641511|NCT01247324|42090600|FG000|Overall Study|Death|1|||
19641512|NCT01247324|42090601|FG001|Overall Study|Death|0|||
19641513|NCT01247324|42090600|FG000|Overall Study|Physician Decision|0|||
19641514|NCT01247324|42090601|FG001|Overall Study|Physician Decision|1|||
19641515|NCT01247324|42090600|FG000|Overall Study|Non-compliance with study drug|3|||
19641516|NCT01247324|42090601|FG001|Overall Study|Non-compliance with study drug|0|||
19641517|NCT01247324|42090600|FG000|Overall Study|Lack of Efficacy|12|||
19641518|NCT01247324|42090601|FG001|Overall Study|Lack of Efficacy|8|||
19641519|NCT01247324|42090600|FG000|Overall Study|Non-compliance|2|||
19641520|NCT01247324|42090601|FG001|Overall Study|Non-compliance|0|||
19641521|NCT01247324|42090600|FG000|Overall Study|Pregnancy|2|||
19641522|NCT01247324|42090601|FG001|Overall Study|Pregnancy|3|||
19641523|NCT01247324|42090600|FG000|Overall Study|Protocol Violation|1|||
19641524|NCT01247324|42090601|FG001|Overall Study|Protocol Violation|2|||
19641525|NCT01247324|42090600|FG000|Overall Study|Reason not specified|11|||
19641526|NCT01247324|42090601|FG001|Overall Study|Reason not specified|8|||
19641527|NCT01247324|42090600|FG000|Overall Study|Consent withdrawn by participant|13|||
19641528|NCT01247324|42090601|FG001|Overall Study|Consent withdrawn by participant|8|||
19641529|NCT01247324|42090600|FG000|Overall Study|Adverse Event|25|||
19641530|NCT01247324|42090601|FG001|Overall Study|Adverse Event|13|||
19641531|NCT01247324|42090600|FG000|Overall Study|Lost to Follow-up|1|||
19641532|NCT01247324|42090601|FG001|Overall Study|Lost to Follow-up|1|||
19641533|NCT00772577|42090610|FG000|Overall Study|Adverse Event|6|||
19641534|NCT00772577|42090611|FG001|Overall Study|Adverse Event|3|||
19641535|NCT00772577|42090610|FG000|Overall Study|Abnormal laboratory values|0|||
19641536|NCT00772577|42090611|FG001|Overall Study|Abnormal laboratory values|1|||
19641537|NCT00772577|42090610|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19641538|NCT00772577|42090611|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
19641539|NCT00772577|42090610|FG000|Overall Study|Patient withdrew consent|8|||
19641540|NCT00772577|42090611|FG001|Overall Study|Patient withdrew consent|5|||
19641541|NCT00772577|42090610|FG000|Overall Study|Lost to Follow-up|4|||
19641542|NCT00772577|42090611|FG001|Overall Study|Lost to Follow-up|3|||
19641543|NCT00772577|42090610|FG000|Overall Study|Administrative problems|2|||
19641544|NCT00772577|42090611|FG001|Overall Study|Administrative problems|1|||
19641545|NCT00772577|42090610|FG000|Overall Study|Protocol Deviation|3|||
19641546|NCT00772577|42090611|FG001|Overall Study|Protocol Deviation|2|||
19641547|NCT02345850|42090620|FG000|Overall Study|Not transplanted|10|||
19641548|NCT02345850|42090621|FG001|Overall Study|Not transplanted|5|||
19641549|NCT02345850|42090622|FG002|Overall Study|Not transplanted|4|||
19641550|NCT02345850|42090620|FG000|Overall Study|Lost to Follow-up|2|||
19641551|NCT02345850|42090621|FG001|Overall Study|Lost to Follow-up|3|||
19641552|NCT02345850|42090622|FG002|Overall Study|Lost to Follow-up|2|||
19641553|NCT02345850|42090620|FG000|Overall Study|Withdrawal by Subject|1|||
19641554|NCT02345850|42090621|FG001|Overall Study|Withdrawal by Subject|0|||
19641555|NCT02345850|42090622|FG002|Overall Study|Withdrawal by Subject|0|||
19641556|NCT00659607|42090630|FG000|Overall Study|No blood pressure recorded|147|||
19641557|NCT00659607|42090630|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
19641558|NCT00659607|42090630|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
19641559|NCT00659607|42090630|FG000|Overall Study|No recorded efficacy data|15|||
19641560|NCT00659607|42090630|FG000|Overall Study|Inconsistent BP measuring date|2|||
19641561|NCT02848092|42090638|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
19641562|NCT02848092|42090639|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
19641563|NCT02848092|42090638|FG000|1-month Post-training Follow-up|Adverse Event|2|||
19641564|NCT02848092|42090639|FG001|1-month Post-training Follow-up|Adverse Event|1|||
19641565|NCT02848092|42090638|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
19641566|NCT02848092|42090639|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
19641567|NCT02848092|42090638|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
19641568|NCT02848092|42090639|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
19641569|NCT02848092|42090638|FG000|1-month Post-training Follow-up|fatigue|0|||
19641570|NCT02848092|42090639|FG001|1-month Post-training Follow-up|fatigue|1|||
19641571|NCT02848092|42090638|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
19641572|NCT02848092|42090639|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
19641573|NCT02848092|42090638|FG000|6-month Post-training Follow-up|Adverse Event|1|||
19641574|NCT02848092|42090639|FG001|6-month Post-training Follow-up|Adverse Event|1|||
19641575|NCT02848092|42090638|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
19641576|NCT02848092|42090639|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
19641577|NCT02848092|42090638|FG000|6-month Post-training Follow-up|frustrated with task|1|||
19641578|NCT02848092|42090639|FG001|6-month Post-training Follow-up|frustrated with task|0|||
19641579|NCT02848092|42090638|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
19641580|NCT02848092|42090639|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
19641581|NCT02848092|42090638|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
19641582|NCT02848092|42090639|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
19641583|NCT00660309|42090647|FG000|Overall Study|Adverse Event|2|||
19641584|NCT00660309|42090648|FG001|Overall Study|Adverse Event|0|||
19641585|NCT00660309|42090647|FG000|Overall Study|Withdrawal by Subject|0|||
19641586|NCT00660309|42090648|FG001|Overall Study|Withdrawal by Subject|3|||
19641587|NCT00581100|42090657|FG000|Overall Study|Death|1|||
19748526|NCT04003142|42196742|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
19748527|NCT04003142|42196743|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
19748528|NCT04003142|42196744|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
19748529|NCT04003142|42196740|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
19748530|NCT04003142|42196741|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
19748531|NCT04003142|42196742|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
19748532|NCT04003142|42196743|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
19748533|NCT04003142|42196744|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
19600295|NCT00789880|42049274|FG001|Overall Study|Adverse Event|0|||
19600296|NCT00789880|42049275|FG002|Overall Study|Adverse Event|0|||
19600297|NCT00789880|42049276|FG003|Overall Study|Adverse Event|0|||
19600298|NCT00789880|42049277|FG004|Overall Study|Adverse Event|1|||
19600299|NCT00789880|42049278|FG005|Overall Study|Adverse Event|0|||
19600300|NCT00789880|42049273|FG000|Overall Study|Protocol Violation|0|||
19600301|NCT00789880|42049274|FG001|Overall Study|Protocol Violation|1|||
19600302|NCT00789880|42049275|FG002|Overall Study|Protocol Violation|0|||
19641588|NCT00581100|42090658|FG001|Overall Study|Death|0|||
19641589|NCT00581100|42090657|FG000|Overall Study|Adverse Event|2|||
19641590|NCT00581100|42090658|FG001|Overall Study|Adverse Event|1|||
19641591|NCT00581100|42090657|FG000|Overall Study|Withdrawal by Subject|1|||
19641592|NCT00581100|42090658|FG001|Overall Study|Withdrawal by Subject|4|||
19641593|NCT00581100|42090657|FG000|Overall Study|Other|3|||
19641594|NCT00581100|42090658|FG001|Overall Study|Other|0|||
19641595|NCT00579098|42090666|FG000|Overall Study|Lost to Follow-up|2|||
19641596|NCT00579098|42090667|FG001|Overall Study|Lost to Follow-up|0|||
19641597|NCT00579098|42090666|FG000|Overall Study|Adverse Event|2|||
19641598|NCT00579098|42090667|FG001|Overall Study|Adverse Event|3|||
19641599|NCT00579098|42090666|FG000|Overall Study|Withdrawal by Subject|2|||
19641600|NCT00579098|42090667|FG001|Overall Study|Withdrawal by Subject|3|||
19641601|NCT00579098|42090666|FG000|Overall Study|AF returned after ablation|3|||
19641602|NCT00579098|42090667|FG001|Overall Study|AF returned after ablation|2|||
19641603|NCT00772109|42090677|FG000|Overall Study|Serious adverse event|1|||
19641604|NCT00772109|42090678|FG001|Overall Study|Serious adverse event|0|||
19641605|NCT00772109|42090679|FG002|Overall Study|Serious adverse event|1|||
19641606|NCT00772109|42090680|FG003|Overall Study|Serious adverse event|0|||
19600303|NCT00789880|42049276|FG003|Overall Study|Protocol Violation|1|||
19600304|NCT00789880|42049277|FG004|Overall Study|Protocol Violation|0|||
19600305|NCT00789880|42049278|FG005|Overall Study|Protocol Violation|0|||
19600306|NCT00789880|42049273|FG000|Overall Study|Withdrawal by Subject|1|||
19600307|NCT00789880|42049274|FG001|Overall Study|Withdrawal by Subject|0|||
19600308|NCT00789880|42049275|FG002|Overall Study|Withdrawal by Subject|0|||
19600309|NCT00789880|42049276|FG003|Overall Study|Withdrawal by Subject|0|||
19600310|NCT00789880|42049277|FG004|Overall Study|Withdrawal by Subject|2|||
19600311|NCT00789880|42049278|FG005|Overall Study|Withdrawal by Subject|0|||
19600312|NCT00792298|42049292|FG000|Treatment Period 1|Adverse Event|0|||
19600313|NCT00792298|42049293|FG001|Treatment Period 1|Adverse Event|1|||
19600314|NCT00792298|42049294|FG002|Treatment Period 1|Adverse Event|0|||
19600315|NCT00792298|42049295|FG003|Treatment Period 1|Adverse Event|1|||
19641607|NCT00772109|42090677|FG000|Overall Study|Protocol Violation|5|||
19641608|NCT00772109|42090678|FG001|Overall Study|Protocol Violation|8|||
19641609|NCT00772109|42090679|FG002|Overall Study|Protocol Violation|7|||
19641610|NCT00772109|42090680|FG003|Overall Study|Protocol Violation|6|||
19641611|NCT00772109|42090677|FG000|Overall Study|Lost to Follow-up|7|||
19641612|NCT00772109|42090678|FG001|Overall Study|Lost to Follow-up|3|||
19641613|NCT00772109|42090679|FG002|Overall Study|Lost to Follow-up|5|||
19748534|NCT04003142|42196740|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
19641614|NCT00772109|42090680|FG003|Overall Study|Lost to Follow-up|9|||
19641615|NCT00772109|42090677|FG000|Overall Study|Withdrawal by Subject|8|||
19641616|NCT00772109|42090678|FG001|Overall Study|Withdrawal by Subject|8|||
19641617|NCT00772109|42090679|FG002|Overall Study|Withdrawal by Subject|6|||
19641618|NCT00772109|42090680|FG003|Overall Study|Withdrawal by Subject|16|||
19641619|NCT00772031|42090692|FG000|Overall Study|Early termination of trial|12|||
19748535|NCT04003142|42196741|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
19600316|NCT00792298|42049296|FG004|Treatment Period 1|Adverse Event|0|||
19600317|NCT00792298|42049297|FG005|Treatment Period 1|Adverse Event|1|||
19600318|NCT00792298|42049298|FG006|Treatment Period 1|Adverse Event|1|||
19600319|NCT00792298|42049299|FG007|Treatment Period 1|Adverse Event|0|||
19600320|NCT00792298|42049292|FG000|Treatment Period 1|Lack of Efficacy|0|||
19600321|NCT00792298|42049293|FG001|Treatment Period 1|Lack of Efficacy|0|||
19641620|NCT00772031|42090693|FG001|Overall Study|Early termination of trial|10|||
19641621|NCT00772031|42090692|FG000|Overall Study|Lost to Follow-up|20|||
19641622|NCT00772031|42090693|FG001|Overall Study|Lost to Follow-up|33|||
19641623|NCT00580866|42090707|FG000|Overall Study|Lost to Follow-up|2|||
19641624|NCT00580866|42090708|FG001|Overall Study|Lost to Follow-up|2|||
19641625|NCT00771953|42090716|FG000|Overall Study|Adverse Event|5|||
19641626|NCT00771953|42090717|FG001|Overall Study|Adverse Event|3|||
19641627|NCT00771953|42090716|FG000|Overall Study|Death|2|||
19641628|NCT00771953|42090717|FG001|Overall Study|Death|2|||
19641629|NCT00771953|42090716|FG000|Overall Study|Progression before active Tx|1|||
19641630|NCT00771953|42090717|FG001|Overall Study|Progression before active Tx|2|||
19641631|NCT00771953|42090716|FG000|Overall Study|Sponsor decision|1|||
19600322|NCT00792298|42049294|FG002|Treatment Period 1|Lack of Efficacy|1|||
19600323|NCT00792298|42049295|FG003|Treatment Period 1|Lack of Efficacy|0|||
19600324|NCT00792298|42049296|FG004|Treatment Period 1|Lack of Efficacy|0|||
19600325|NCT00792298|42049297|FG005|Treatment Period 1|Lack of Efficacy|0|||
19600326|NCT00792298|42049298|FG006|Treatment Period 1|Lack of Efficacy|0|||
19600327|NCT00792298|42049299|FG007|Treatment Period 1|Lack of Efficacy|0|||
19641632|NCT00771953|42090717|FG001|Overall Study|Sponsor decision|0|||
19641633|NCT00771953|42090716|FG000|Overall Study|Other complicating disease|1|||
19641634|NCT00771953|42090717|FG001|Overall Study|Other complicating disease|0|||
19641635|NCT00771953|42090716|FG000|Overall Study|Withdrawal by Subject|0|||
19600328|NCT00792298|42049292|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19600329|NCT00792298|42049293|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19600330|NCT00792298|42049294|FG002|Treatment Period 1|Withdrawal by Subject|1|||
19600331|NCT00792298|42049295|FG003|Treatment Period 1|Withdrawal by Subject|2|||
19641636|NCT00771953|42090717|FG001|Overall Study|Withdrawal by Subject|3|||
19641637|NCT00621244|42090729|FG000|Overall Study|Withdrawal by Subject|7|||
19641638|NCT00621244|42090730|FG001|Overall Study|Withdrawal by Subject|3|||
19641639|NCT00621244|42090731|FG002|Overall Study|Withdrawal by Subject|3|||
19641640|NCT00621244|42090732|FG003|Overall Study|Withdrawal by Subject|3|||
19641641|NCT00621244|42090729|FG000|Overall Study|Disease progression|44|||
19641642|NCT00621244|42090730|FG001|Overall Study|Disease progression|20|||
19641643|NCT00621244|42090731|FG002|Overall Study|Disease progression|20|||
19641644|NCT00621244|42090732|FG003|Overall Study|Disease progression|15|||
19641645|NCT00621244|42090729|FG000|Overall Study|Death|3|||
19641646|NCT00621244|42090730|FG001|Overall Study|Death|3|||
19641647|NCT00621244|42090731|FG002|Overall Study|Death|1|||
19641648|NCT00621244|42090732|FG003|Overall Study|Death|1|||
19748536|NCT04003142|42196742|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
19748537|NCT04003142|42196743|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
19748538|NCT04003142|42196744|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
19748539|NCT04003142|42196740|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
19748540|NCT04003142|42196741|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
19748541|NCT04003142|42196742|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
19748542|NCT04003142|42196743|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
19748543|NCT04003142|42196744|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
19748544|NCT04003142|42196740|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
19748545|NCT04003142|42196741|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
19748546|NCT04003142|42196742|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
19748547|NCT04003142|42196743|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
19748548|NCT04003142|42196744|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
19748549|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
19748550|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
19748551|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
19748552|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
19748553|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
19748554|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Death|0|||
19748555|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Death|0|||
19748556|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Death|0|||
19748557|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Death|0|||
19748558|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Death|1|||
19748559|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
19748560|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
19748561|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
19748562|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
19748563|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
19748564|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
19641649|NCT00621244|42090729|FG000|Overall Study|Adverse Event|27|||
19641650|NCT00621244|42090730|FG001|Overall Study|Adverse Event|7|||
19748565|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
19748566|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
19600332|NCT00792298|42049296|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19600333|NCT00792298|42049297|FG005|Treatment Period 1|Withdrawal by Subject|2|||
19600334|NCT00792298|42049298|FG006|Treatment Period 1|Withdrawal by Subject|1|||
19641651|NCT00621244|42090731|FG002|Overall Study|Adverse Event|9|||
19748567|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
19748568|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
19748569|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
19748570|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
19748571|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
19748572|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
19748573|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
19748574|NCT04003142|42196740|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
19748575|NCT04003142|42196741|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
19748576|NCT04003142|42196742|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
19748577|NCT04003142|42196743|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
19748578|NCT04003142|42196744|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
19748579|NCT02612337|42196764|FG000|Overall Study|Lack of Efficacy|1|||
19748580|NCT02612337|42196765|FG001|Overall Study|Lack of Efficacy|0|||
19748581|NCT02612337|42196764|FG000|Overall Study|Withdrawal by Subject|2|||
19748582|NCT02612337|42196765|FG001|Overall Study|Withdrawal by Subject|2|||
19748583|NCT02612337|42196764|FG000|Overall Study|Did not receive study drug|0|||
19748584|NCT02612337|42196765|FG001|Overall Study|Did not receive study drug|1|||
19748585|NCT03532451|42196779|FG000|Overall Study|Withdrawal by Subject|0|||
19748586|NCT03532451|42196780|FG001|Overall Study|Withdrawal by Subject|1|||
19748587|NCT03532451|42196779|FG000|Overall Study|Progression prior to the surgery|1|||
19748588|NCT03532451|42196780|FG001|Overall Study|Progression prior to the surgery|0|||
19748589|NCT03562767|42196789|FG000|Overall Study|Physician Decision|2|||
19748590|NCT03562767|42196790|FG001|Overall Study|Physician Decision|0|||
19748591|NCT03562767|42196791|FG002|Overall Study|Physician Decision|0|||
19748592|NCT03562767|42196789|FG000|Overall Study|Logistic Reason|1|||
19748593|NCT03562767|42196790|FG001|Overall Study|Logistic Reason|3|||
19748594|NCT03562767|42196791|FG002|Overall Study|Logistic Reason|0|||
19388145|NCT02055976|41631518|FG001|Overall Study|Adverse Event|0|||
19388146|NCT02055976|41631519|FG002|Overall Study|Adverse Event|0|||
19748595|NCT03085238|42196803|FG000|Overall Study|Adverse Event|2|||
19748596|NCT03085238|42196803|FG000|Overall Study|Death|2|||
19748597|NCT03383666|42196816|FG000|Overall Study|Withdrawal by Subject|2|||
19748598|NCT03383666|42196816|FG000|Overall Study|Lost to Follow-up|2|||
19748599|NCT03086018|42196820|FG000|Final Testing for End of Trial|Adverse Event|1|||
19748600|NCT03086018|42196820|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
19748601|NCT03319953|42196830|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
19748602|NCT03319953|42196831|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
19748603|NCT03319953|42196832|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
19748604|NCT03319953|42196833|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
19748605|NCT03319953|42196830|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
19748606|NCT03319953|42196831|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
19748607|NCT03319953|42196832|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
19748608|NCT03319953|42196833|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
19748609|NCT02927834|42196844|FG000|Overall Study|Lost to Follow-up|1|||
19748610|NCT02927834|42196845|FG001|Overall Study|Lost to Follow-up|2|||
19748611|NCT02927834|42196846|FG002|Overall Study|Lost to Follow-up|2|||
19748612|NCT01964547|42196860|FG000|Overall Study|Adverse Event|8|||
19748613|NCT01964547|42196861|FG001|Overall Study|Adverse Event|2|||
19388147|NCT02055976|41631520|FG003|Overall Study|Adverse Event|0|||
19388148|NCT02055976|41631521|FG004|Overall Study|Adverse Event|0|||
19388149|NCT02055976|41631522|FG005|Overall Study|Adverse Event|1|||
19388150|NCT02055976|41631523|FG006|Overall Study|Adverse Event|1|||
19388151|NCT02055976|41631524|FG007|Overall Study|Adverse Event|0|||
19388152|NCT02055976|41631525|FG008|Overall Study|Adverse Event|0|||
19388153|NCT02055976|41631517|FG000|Overall Study|Does not meet entrance criteria|0|||
19388154|NCT02055976|41631518|FG001|Overall Study|Does not meet entrance criteria|0|||
19388155|NCT02055976|41631519|FG002|Overall Study|Does not meet entrance criteria|0|||
19388156|NCT02055976|41631520|FG003|Overall Study|Does not meet entrance criteria|0|||
19641652|NCT00621244|42090732|FG003|Overall Study|Adverse Event|2|||
19748614|NCT01964547|42196860|FG000|Overall Study|Withdrawal by Subject|4|||
19748615|NCT01964547|42196861|FG001|Overall Study|Withdrawal by Subject|7|||
19748616|NCT01964547|42196860|FG000|Overall Study|Lost to Follow-up|0|||
19748617|NCT01964547|42196861|FG001|Overall Study|Lost to Follow-up|1|||
19388157|NCT02055976|41631521|FG004|Overall Study|Does not meet entrance criteria|0|||
19388158|NCT02055976|41631522|FG005|Overall Study|Does not meet entrance criteria|0|||
19388159|NCT02055976|41631523|FG006|Overall Study|Does not meet entrance criteria|1|||
19388160|NCT02055976|41631524|FG007|Overall Study|Does not meet entrance criteria|0|||
19388161|NCT02055976|41631525|FG008|Overall Study|Does not meet entrance criteria|0|||
19388162|NCT02055976|41631517|FG000|Overall Study|Lost to Follow-up|0|||
19388163|NCT02055976|41631518|FG001|Overall Study|Lost to Follow-up|0|||
19388164|NCT02055976|41631519|FG002|Overall Study|Lost to Follow-up|0|||
19388165|NCT02055976|41631520|FG003|Overall Study|Lost to Follow-up|1|||
19748618|NCT01964547|42196860|FG000|Overall Study|Withdrawal by Investigator|0|||
19748619|NCT01964547|42196861|FG001|Overall Study|Withdrawal by Investigator|1|||
19748620|NCT03319719|42196867|FG000|Overall Study|Lost to Follow-up|1|||
19748621|NCT03318783|42196875|FG000|Overall Study|Withdrawal by Subject|0|||
19748622|NCT03318783|42196876|FG001|Overall Study|Withdrawal by Subject|1|||
19748623|NCT03318783|42196875|FG000|Overall Study|Death|0|||
19748624|NCT03318783|42196876|FG001|Overall Study|Death|1|||
19748625|NCT01313689|42196887|FG000|24-Week Randomization 1|Adverse Event|10|||
19748626|NCT01313689|42196888|FG001|24-Week Randomization 1|Adverse Event|5|||
19748627|NCT01313689|42196889|FG002|24-Week Randomization 1|Adverse Event|0|||
19748628|NCT01313689|42196890|FG003|24-Week Randomization 1|Adverse Event|0|||
19748629|NCT01313689|42196891|FG004|24-Week Randomization 1|Adverse Event|0|||
19748630|NCT01313689|42196887|FG000|24-Week Randomization 1|Physician Decision|4|||
19748631|NCT01313689|42196888|FG001|24-Week Randomization 1|Physician Decision|5|||
19748632|NCT01313689|42196889|FG002|24-Week Randomization 1|Physician Decision|0|||
19748633|NCT01313689|42196890|FG003|24-Week Randomization 1|Physician Decision|0|||
19748634|NCT01313689|42196891|FG004|24-Week Randomization 1|Physician Decision|0|||
19748635|NCT01313689|42196887|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
19748636|NCT01313689|42196888|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
19748637|NCT01313689|42196889|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
19748638|NCT01313689|42196890|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
19748639|NCT01313689|42196891|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
19748640|NCT01313689|42196887|FG000|24-Week Randomization 2|Adverse Event|0|||
19748641|NCT01313689|42196888|FG001|24-Week Randomization 2|Adverse Event|0|||
19748642|NCT01313689|42196889|FG002|24-Week Randomization 2|Adverse Event|2|||
19748643|NCT01313689|42196890|FG003|24-Week Randomization 2|Adverse Event|0|||
19748644|NCT01313689|42196891|FG004|24-Week Randomization 2|Adverse Event|8|||
19748645|NCT01313689|42196887|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
19748646|NCT01313689|42196888|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
19748647|NCT01313689|42196889|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
19748648|NCT01313689|42196890|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
19748649|NCT01313689|42196891|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
19748650|NCT01313689|42196887|FG000|24-Week Randomization 2|Physician Decision|0|||
19748651|NCT01313689|42196888|FG001|24-Week Randomization 2|Physician Decision|0|||
19748652|NCT01313689|42196889|FG002|24-Week Randomization 2|Physician Decision|0|||
19748653|NCT01313689|42196890|FG003|24-Week Randomization 2|Physician Decision|0|||
19748654|NCT01313689|42196891|FG004|24-Week Randomization 2|Physician Decision|4|||
19748655|NCT03318315|42196913|FG000|Overall Study|Lost to Follow-up|3|||
19748656|NCT03318315|42196914|FG001|Overall Study|Lost to Follow-up|2|||
19748657|NCT03318315|42196915|FG002|Overall Study|Lost to Follow-up|1|||
19748658|NCT03318315|42196913|FG000|Overall Study|Protocol Violation|1|||
19748659|NCT03318315|42196914|FG001|Overall Study|Protocol Violation|1|||
19748660|NCT03318315|42196915|FG002|Overall Study|Protocol Violation|1|||
19748661|NCT03318315|42196913|FG000|Overall Study|Withdrawal by Subject|0|||
19748662|NCT03318315|42196914|FG001|Overall Study|Withdrawal by Subject|0|||
19748663|NCT03318315|42196915|FG002|Overall Study|Withdrawal by Subject|2|||
19748664|NCT04460183|42196926|FG000|Overall Study|Lost to Follow-up|3|||
19748665|NCT04460183|42196927|FG001|Overall Study|Lost to Follow-up|1|||
19748666|NCT04460183|42196926|FG000|Overall Study|Withdrawal by Subject|1|||
19748667|NCT04460183|42196927|FG001|Overall Study|Withdrawal by Subject|0|||
19748668|NCT03710083|42196933|FG000|Overall Study|Withdrawal by Subject|2|||
19748669|NCT03710083|42196933|FG000|Overall Study|Unsuccessful Procedure|1|||
19748670|NCT03318003|42196939|FG000|Overall Study|Withdrawal by Subject|1|||
19748671|NCT03318003|42196940|FG001|Overall Study|Withdrawal by Subject|1|||
19748672|NCT03318003|42196939|FG000|Overall Study|fetal loss|0|||
19748673|NCT03318003|42196940|FG001|Overall Study|fetal loss|1|||
19748674|NCT03317379|42196949|FG000|Overall Study|Lost to Follow-up|0|||
19748675|NCT03317379|42196950|FG001|Overall Study|Lost to Follow-up|3|||
19748676|NCT03317379|42196951|FG002|Overall Study|Lost to Follow-up|2|||
19748677|NCT03316911|42196961|FG000|Overall Study|Lost to Follow-up|33|||
19748678|NCT03316911|42196962|FG001|Overall Study|Lost to Follow-up|29|||
19748679|NCT01106391|42196968|FG000|Overall Study|Death|12|||
19748680|NCT01106391|42196968|FG000|Overall Study|Withdrawal by Subject|7|||
19748681|NCT03316131|42196972|FG000|Treatment Period 2|Protocol deviation|1|||
19748682|NCT03316131|42196973|FG001|Treatment Period 2|Protocol deviation|0|||
19748683|NCT03301415|42196979|FG000|Overall Study|Lost to Follow-up|2|||
19388166|NCT02055976|41631521|FG004|Overall Study|Lost to Follow-up|0|||
19388167|NCT02055976|41631522|FG005|Overall Study|Lost to Follow-up|0|||
19748684|NCT03301415|42196979|FG000|Overall Study|Unable to comply with visit schedule|2|||
19748685|NCT02732938|42196985|FG000|Overall Study|Death|0|||
19748686|NCT02732938|42196986|FG001|Overall Study|Death|11|||
19748687|NCT02732938|42196987|FG002|Overall Study|Death|0|||
19748688|NCT02732938|42196985|FG000|Overall Study|Randomized but did not receive treatment|0|||
19748689|NCT02732938|42196986|FG001|Overall Study|Randomized but did not receive treatment|1|||
19748690|NCT02732938|42196987|FG002|Overall Study|Randomized but did not receive treatment|0|||
19748691|NCT02732938|42196985|FG000|Overall Study|Refused further follow-up|1|||
19748692|NCT02732938|42196986|FG001|Overall Study|Refused further follow-up|0|||
19748693|NCT02732938|42196987|FG002|Overall Study|Refused further follow-up|0|||
19748694|NCT02732938|42196985|FG000|Overall Study|Study terminated by sponsor|3|||
19748695|NCT02732938|42196986|FG001|Overall Study|Study terminated by sponsor|6|||
19748696|NCT02732938|42196987|FG002|Overall Study|Study terminated by sponsor|0|||
19748697|NCT04647721|42196995|FG000|Overall Study|Withdrawal by Subject|0|||
19748698|NCT04647721|42196996|FG001|Overall Study|Withdrawal by Subject|2|||
19748699|NCT04647721|42196995|FG000|Overall Study|Lost to Follow-up|2|||
19748700|NCT04647721|42196996|FG001|Overall Study|Lost to Follow-up|0|||
19748701|NCT05159362|42197011|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
19748702|NCT05159362|42197012|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
19748703|NCT05159362|42197013|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
19748704|NCT03718000|42197029|FG000|Overall Study|Relocation|2|||
19748705|NCT03718000|42197030|FG001|Overall Study|Relocation|4|||
19748706|NCT03718000|42197029|FG000|Overall Study|Pregnancy|0|||
19748707|NCT03718000|42197030|FG001|Overall Study|Pregnancy|1|||
19748708|NCT03063203|42197037|FG000|Overall Study|Chose alternative therapy|3|||
19748709|NCT03063203|42197037|FG000|Overall Study|Death|2|||
19748710|NCT03063203|42197037|FG000|Overall Study|Disease progression|4|||
19748711|NCT03063203|42197037|FG000|Overall Study|Physician Decision|5|||
19748712|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
19748713|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
19748714|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
19748715|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748716|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748717|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748718|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748719|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748720|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748721|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748722|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748723|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748724|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748725|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748726|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748727|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
19748728|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
19748729|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
19748730|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748731|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748732|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748733|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748734|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748735|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748736|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748737|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748738|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748739|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748740|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748741|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748742|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748743|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
19748744|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748745|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748746|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748747|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
19748748|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748749|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748750|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748751|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748752|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748753|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748754|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748755|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748756|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19388168|NCT02055976|41631523|FG006|Overall Study|Lost to Follow-up|0|||
19748757|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748758|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748759|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
19748760|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748761|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19600335|NCT00792298|42049299|FG007|Treatment Period 1|Withdrawal by Subject|0|||
19600336|NCT00792298|42049292|FG000|Treatment Period 1|Lost to Follow-up|0|||
19600337|NCT00792298|42049293|FG001|Treatment Period 1|Lost to Follow-up|0|||
19641653|NCT00621244|42090729|FG000|Overall Study|Administrative problems|5|||
19641654|NCT00621244|42090730|FG001|Overall Study|Administrative problems|1|||
19641655|NCT00621244|42090731|FG002|Overall Study|Administrative problems|0|||
19641656|NCT00621244|42090732|FG003|Overall Study|Administrative problems|2|||
19641657|NCT00659529|42090806|FG000|Overall Study|Withdrawal by Subject|4|||
19641658|NCT00659529|42090806|FG000|Overall Study|Protocol Violation|3|||
19641659|NCT00659529|42090806|FG000|Overall Study|Screen failure|9|||
19641660|NCT00578942|42090810|FG000|Overall Study|Lost to Follow-up|1|||
19641661|NCT00765245|42090816|FG000|Overall Study|disease progression|3|||
19641662|NCT00765245|42090817|FG001|Overall Study|disease progression|2|||
19641663|NCT00765245|42090816|FG000|Overall Study|Withdrawal by Subject|3|||
19600338|NCT00792298|42049294|FG002|Treatment Period 1|Lost to Follow-up|0|||
19600339|NCT00792298|42049295|FG003|Treatment Period 1|Lost to Follow-up|0|||
19600340|NCT00792298|42049296|FG004|Treatment Period 1|Lost to Follow-up|0|||
19600341|NCT00792298|42049297|FG005|Treatment Period 1|Lost to Follow-up|0|||
19641664|NCT00765245|42090817|FG001|Overall Study|Withdrawal by Subject|0|||
19641665|NCT00765245|42090816|FG000|Overall Study|Adverse Event|5|||
19748762|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
19641666|NCT00765245|42090817|FG001|Overall Study|Adverse Event|0|||
19641667|NCT00765245|42090816|FG000|Overall Study|Physician Decision|1|||
19641668|NCT00765245|42090817|FG001|Overall Study|Physician Decision|0|||
19641669|NCT00765245|42090816|FG000|Overall Study|Death|1|||
19641670|NCT00765245|42090817|FG001|Overall Study|Death|0|||
19641671|NCT00782795|42090825|FG000|Overall Study|Withdrawal by Subject|1|||
19641672|NCT00782795|42090826|FG001|Overall Study|Withdrawal by Subject|2|||
19641673|NCT00656799|42090832|FG000|Overall Study|Death|2|||
19641674|NCT00764699|42090836|FG000|Overall Study|PI left and study terminated|3|||
19641675|NCT00782717|42090842|FG000|Overall Study|Adverse Event|2|||
19641676|NCT00782717|42090843|FG001|Overall Study|Adverse Event|5|||
19641677|NCT00782717|42090842|FG000|Overall Study|Patient decision unrelated to AE|6|||
19641678|NCT00782717|42090843|FG001|Overall Study|Patient decision unrelated to AE|3|||
19641679|NCT00782717|42090842|FG000|Overall Study|Noncompliance|2|||
19641680|NCT00782717|42090843|FG001|Overall Study|Noncompliance|1|||
19641681|NCT00782717|42090842|FG000|Overall Study|Treatment failure|3|||
19641682|NCT00782717|42090843|FG001|Overall Study|Treatment failure|14|||
19641683|NCT00782717|42090842|FG000|Overall Study|Enrollment close prior to surgery|1|||
19641684|NCT00782717|42090843|FG001|Overall Study|Enrollment close prior to surgery|0|||
19641685|NCT00782717|42090842|FG000|Overall Study|Did not meet entrance criteria|1|||
19641686|NCT00782717|42090843|FG001|Overall Study|Did not meet entrance criteria|3|||
19641687|NCT00782717|42090842|FG000|Overall Study|Exited in error|0|||
19641688|NCT00782717|42090843|FG001|Overall Study|Exited in error|2|||
19641689|NCT00656175|42090851|FG000|Overall Study|Adverse Event|1|||
19641690|NCT00656175|42090852|FG001|Overall Study|Adverse Event|0|||
19641691|NCT00656175|42090851|FG000|Overall Study|Transportation issues|0|||
19641692|NCT00656175|42090852|FG001|Overall Study|Transportation issues|1|||
19641693|NCT00620776|42090860|FG000|Overall Study|Did not receive treatment|3|||
19641694|NCT00620776|42090861|FG001|Overall Study|Did not receive treatment|5|||
19641695|NCT00620776|42090860|FG000|Overall Study|Adverse Event|2|||
19641696|NCT00620776|42090861|FG001|Overall Study|Adverse Event|3|||
19641697|NCT00620776|42090860|FG000|Overall Study|Lack of Efficacy|2|||
19641698|NCT00620776|42090861|FG001|Overall Study|Lack of Efficacy|1|||
19641699|NCT00620776|42090860|FG000|Overall Study|Lost to Follow-up|2|||
19641700|NCT00620776|42090861|FG001|Overall Study|Lost to Follow-up|5|||
19641701|NCT00620776|42090860|FG000|Overall Study|Withdrawal by Subject|3|||
19641702|NCT00620776|42090861|FG001|Overall Study|Withdrawal by Subject|2|||
19748763|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748764|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748765|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748766|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19388169|NCT02055976|41631524|FG007|Overall Study|Lost to Follow-up|0|||
19600342|NCT00792298|42049298|FG006|Treatment Period 1|Lost to Follow-up|1|||
19641703|NCT00656019|42090871|FG000|Overall Study|Not Eligible|10|||
19641704|NCT00656019|42090872|FG001|Overall Study|Not Eligible|0|||
19641705|NCT00656019|42090873|FG002|Overall Study|Not Eligible|0|||
19641706|NCT00656019|42090874|FG003|Overall Study|Not Eligible|0|||
19641707|NCT00656019|42090871|FG000|Overall Study|Withdrawal by Subject|2|||
19641708|NCT00656019|42090872|FG001|Overall Study|Withdrawal by Subject|0|||
19600343|NCT00792298|42049299|FG007|Treatment Period 1|Lost to Follow-up|0|||
19748767|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748768|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748769|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748770|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748771|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748772|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748773|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748774|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748775|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
19748776|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748777|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748778|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748779|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
19748780|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748781|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748782|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748783|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748784|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748785|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748786|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748787|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748788|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748789|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748790|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748791|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
19748792|NCT02891226|42197052|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748793|NCT02891226|42197053|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748794|NCT02891226|42197054|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748795|NCT02891226|42197055|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
19748796|NCT02891226|42197056|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748797|NCT02891226|42197057|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748798|NCT02891226|42197058|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748799|NCT02891226|42197059|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748800|NCT02891226|42197060|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748801|NCT02891226|42197061|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748802|NCT02891226|42197062|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748803|NCT02891226|42197063|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748804|NCT02891226|42197064|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748805|NCT02891226|42197065|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748806|NCT02891226|42197066|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748807|NCT02891226|42197067|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
19748808|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748809|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748810|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748811|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748812|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748813|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748814|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
19748815|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
19748816|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
19748817|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
19748818|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748819|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748820|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748821|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748822|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748823|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
19748824|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748825|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748826|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748827|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748828|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748829|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
19600344|NCT00792298|42049292|FG000|Treatment Period 1|Physician Decision|0|||
19600345|NCT00792298|42049293|FG001|Treatment Period 1|Physician Decision|0|||
19748830|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748831|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748832|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19600346|NCT00792298|42049294|FG002|Treatment Period 1|Physician Decision|0|||
19748833|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
19748834|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748835|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748836|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748837|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748838|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748839|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
19748840|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748841|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748842|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748843|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748844|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19600347|NCT00792298|42049295|FG003|Treatment Period 1|Physician Decision|1|||
19600348|NCT00792298|42049296|FG004|Treatment Period 1|Physician Decision|0|||
19600349|NCT00792298|42049297|FG005|Treatment Period 1|Physician Decision|0|||
19600350|NCT00792298|42049298|FG006|Treatment Period 1|Physician Decision|1|||
19600351|NCT00792298|42049299|FG007|Treatment Period 1|Physician Decision|0|||
19600352|NCT00792298|42049292|FG000|Treatment Period 1|Protocol Violation|0|||
19600353|NCT00792298|42049293|FG001|Treatment Period 1|Protocol Violation|0|||
19748845|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748846|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
19748847|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
19600354|NCT00792298|42049294|FG002|Treatment Period 1|Protocol Violation|0|||
19600355|NCT00792298|42049295|FG003|Treatment Period 1|Protocol Violation|0|||
19600356|NCT00792298|42049296|FG004|Treatment Period 1|Protocol Violation|0|||
19600357|NCT00792298|42049297|FG005|Treatment Period 1|Protocol Violation|0|||
19600358|NCT00792298|42049298|FG006|Treatment Period 1|Protocol Violation|0|||
19600359|NCT00792298|42049299|FG007|Treatment Period 1|Protocol Violation|1|||
19600360|NCT00792298|42049292|FG000|Washout|Adverse Event|0|||
19600361|NCT00792298|42049293|FG001|Washout|Adverse Event|0|||
19600362|NCT00792298|42049294|FG002|Washout|Adverse Event|0|||
19600363|NCT00792298|42049295|FG003|Washout|Adverse Event|0|||
19600364|NCT00792298|42049296|FG004|Washout|Adverse Event|0|||
19600365|NCT00792298|42049297|FG005|Washout|Adverse Event|1|||
19600366|NCT00792298|42049298|FG006|Washout|Adverse Event|0|||
19600367|NCT00792298|42049299|FG007|Washout|Adverse Event|0|||
19600368|NCT00792298|42049292|FG000|Washout|Withdrawal by Subject|0|||
19600369|NCT00792298|42049293|FG001|Washout|Withdrawal by Subject|0|||
19600370|NCT00792298|42049294|FG002|Washout|Withdrawal by Subject|1|||
19600371|NCT00792298|42049295|FG003|Washout|Withdrawal by Subject|0|||
19600372|NCT00792298|42049296|FG004|Washout|Withdrawal by Subject|0|||
19600373|NCT00792298|42049297|FG005|Washout|Withdrawal by Subject|1|||
19600374|NCT00792298|42049298|FG006|Washout|Withdrawal by Subject|0|||
19600375|NCT00792298|42049299|FG007|Washout|Withdrawal by Subject|0|||
19600376|NCT00792298|42049292|FG000|Treatment Period 2|Lack of Efficacy|0|||
19600377|NCT00792298|42049293|FG001|Treatment Period 2|Lack of Efficacy|0|||
19600378|NCT00792298|42049294|FG002|Treatment Period 2|Lack of Efficacy|0|||
19600379|NCT00792298|42049295|FG003|Treatment Period 2|Lack of Efficacy|0|||
19600380|NCT00792298|42049296|FG004|Treatment Period 2|Lack of Efficacy|1|||
19600381|NCT00792298|42049297|FG005|Treatment Period 2|Lack of Efficacy|0|||
19600382|NCT00792298|42049298|FG006|Treatment Period 2|Lack of Efficacy|0|||
19600383|NCT00792298|42049299|FG007|Treatment Period 2|Lack of Efficacy|0|||
19600384|NCT00792298|42049292|FG000|Treatment Period 2|Physician Decision|0|||
19600385|NCT00792298|42049293|FG001|Treatment Period 2|Physician Decision|0|||
19600386|NCT00792298|42049294|FG002|Treatment Period 2|Physician Decision|0|||
19600387|NCT00792298|42049295|FG003|Treatment Period 2|Physician Decision|0|||
19600388|NCT00792298|42049296|FG004|Treatment Period 2|Physician Decision|0|||
19600389|NCT00792298|42049297|FG005|Treatment Period 2|Physician Decision|0|||
19600390|NCT00792298|42049298|FG006|Treatment Period 2|Physician Decision|1|||
19600391|NCT00792298|42049299|FG007|Treatment Period 2|Physician Decision|0|||
19600392|NCT00792298|42049292|FG000|Treatment Period 2|Pregnancy|0|||
19600393|NCT00792298|42049293|FG001|Treatment Period 2|Pregnancy|0|||
19600394|NCT00792298|42049294|FG002|Treatment Period 2|Pregnancy|1|||
19600395|NCT00792298|42049295|FG003|Treatment Period 2|Pregnancy|0|||
19600396|NCT00792298|42049296|FG004|Treatment Period 2|Pregnancy|0|||
19600397|NCT00792298|42049297|FG005|Treatment Period 2|Pregnancy|0|||
19600398|NCT00792298|42049298|FG006|Treatment Period 2|Pregnancy|0|||
19600399|NCT00792298|42049299|FG007|Treatment Period 2|Pregnancy|0|||
19600400|NCT00792298|42049292|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19600401|NCT00792298|42049293|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19600402|NCT00792298|42049294|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19600403|NCT00792298|42049295|FG003|Treatment Period 2|Withdrawal by Subject|2|||
19600404|NCT00792298|42049296|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19600405|NCT00792298|42049297|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19600406|NCT00792298|42049298|FG006|Treatment Period 2|Withdrawal by Subject|0|||
19600407|NCT00792298|42049299|FG007|Treatment Period 2|Withdrawal by Subject|2|||
19600408|NCT00718159|42049323|FG000|Overall Study|Progressive Disease|3|||
19600409|NCT00718159|42049324|FG001|Overall Study|Progressive Disease|3|||
19600410|NCT00718159|42049325|FG002|Overall Study|Progressive Disease|2|||
19600411|NCT00718159|42049326|FG003|Overall Study|Progressive Disease|0|||
19748848|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
19641709|NCT00656019|42090873|FG002|Overall Study|Withdrawal by Subject|0|||
19641710|NCT00656019|42090874|FG003|Overall Study|Withdrawal by Subject|0|||
19641711|NCT00656019|42090871|FG000|Overall Study|Lost to Follow-up|2|||
19641712|NCT00656019|42090872|FG001|Overall Study|Lost to Follow-up|1|||
19641713|NCT00656019|42090873|FG002|Overall Study|Lost to Follow-up|0|||
19641714|NCT00656019|42090874|FG003|Overall Study|Lost to Follow-up|0|||
19641715|NCT00782483|42090884|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
19641716|NCT00782171|42090890|FG000|Overall Study|Lost to Follow-up|2|||
19641717|NCT00782171|42090891|FG001|Overall Study|Lost to Follow-up|2|||
19641718|NCT00782171|42090890|FG000|Overall Study|Withdrawal by Subject|2|||
19641719|NCT00782171|42090891|FG001|Overall Study|Withdrawal by Subject|1|||
19641720|NCT00782171|42090890|FG000|Overall Study|complications|3|||
19641721|NCT00782171|42090891|FG001|Overall Study|complications|1|||
19641722|NCT00782171|42090890|FG000|Overall Study|others|7|||
19641723|NCT00782171|42090891|FG001|Overall Study|others|9|||
19641724|NCT00782171|42090890|FG000|Overall Study|not eligible|8|||
19641725|NCT00782171|42090891|FG001|Overall Study|not eligible|6|||
19641726|NCT00764465|42090903|FG000|Overall Study|Adverse Event|2|||
19641727|NCT00764465|42090904|FG001|Overall Study|Adverse Event|0|||
19641728|NCT00764465|42090905|FG002|Overall Study|Adverse Event|0|||
19641729|NCT00764465|42090906|FG003|Overall Study|Adverse Event|1|||
19641730|NCT00764465|42090907|FG004|Overall Study|Adverse Event|1|||
19641731|NCT00764465|42090908|FG005|Overall Study|Adverse Event|1|||
19641732|NCT00764465|42090903|FG000|Overall Study|Withdrawal by Subject|0|||
19641733|NCT00764465|42090904|FG001|Overall Study|Withdrawal by Subject|1|||
19641734|NCT00764465|42090905|FG002|Overall Study|Withdrawal by Subject|1|||
19641735|NCT00764465|42090906|FG003|Overall Study|Withdrawal by Subject|0|||
19641736|NCT00764465|42090907|FG004|Overall Study|Withdrawal by Subject|0|||
19641737|NCT00764465|42090908|FG005|Overall Study|Withdrawal by Subject|0|||
19641738|NCT00655863|42090928|FG000|Overall Study|Lost to Follow-up|0|||
19641739|NCT00655863|42090929|FG001|Overall Study|Lost to Follow-up|0|||
19641740|NCT00655863|42090930|FG002|Overall Study|Lost to Follow-up|1|||
19641741|NCT00781937|42090940|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
19641742|NCT00781937|42090941|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
19641743|NCT00781937|42090940|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
19641744|NCT00781937|42090941|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
19641745|NCT00781937|42090940|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
19641746|NCT00781937|42090941|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
19641747|NCT00781937|42090940|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
19641748|NCT00781937|42090941|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
19641749|NCT00781937|42090940|FG000|Main Trial Period Through Week 56|Unclassified|10|||
19641750|NCT00781937|42090941|FG001|Main Trial Period Through Week 56|Unclassified|15|||
19641751|NCT00781937|42090940|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
19641752|NCT00781937|42090941|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
19641753|NCT00781937|42090940|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
19641754|NCT00781937|42090941|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
19641755|NCT00659373|42090949|FG000|Overall Study|Withdrawal by Subject|3|||
19641756|NCT00659373|42090950|FG001|Overall Study|Withdrawal by Subject|5|||
19641757|NCT00659373|42090949|FG000|Overall Study|Assessment Missed|2|||
19641758|NCT00659373|42090950|FG001|Overall Study|Assessment Missed|2|||
19641759|NCT00439777|42090958|FG000|Treatment Period|Death|29|||
19641760|NCT00439777|42090959|FG001|Treatment Period|Death|21|||
19641761|NCT00439777|42090958|FG000|Treatment Period|Study terminated by sponsor|125|||
19641762|NCT00439777|42090959|FG001|Treatment Period|Study terminated by sponsor|132|||
19641763|NCT00439777|42090958|FG000|Treatment Period|Site closed by investigator|0|||
19641764|NCT00439777|42090959|FG001|Treatment Period|Site closed by investigator|1|||
19641765|NCT00439777|42090958|FG000|Treatment Period|Did not take study treatment|7|||
19641766|NCT00439777|42090959|FG001|Treatment Period|Did not take study treatment|8|||
19641767|NCT00439777|42090958|FG000|Treatment Period|Adverse Event|111|||
19748849|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
19748850|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748851|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748852|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748853|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748854|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748855|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
19748856|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748857|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748858|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19477059|NCT01491737|41755876|FG001|Overall Study|Death|57|||
19641768|NCT00439777|42090959|FG001|Treatment Period|Adverse Event|92|||
19641769|NCT00439777|42090958|FG000|Treatment Period|Protocol Violation|23|||
19641770|NCT00439777|42090959|FG001|Treatment Period|Protocol Violation|30|||
19641771|NCT00439777|42090958|FG000|Treatment Period|Withdrawal by Subject|66|||
19748859|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748860|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
19748861|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748862|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748863|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748864|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748865|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748866|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748867|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748868|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748869|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748870|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748871|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
19748872|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748873|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748874|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748875|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748876|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748877|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748878|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
19748879|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748880|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748881|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748882|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748883|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748884|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19641772|NCT00439777|42090959|FG001|Treatment Period|Withdrawal by Subject|118|||
19641773|NCT00439777|42090958|FG000|Treatment Period|Lack of Efficacy|1|||
19641774|NCT00439777|42090959|FG001|Treatment Period|Lack of Efficacy|4|||
19641775|NCT00439777|42090958|FG000|Treatment Period|Lost to Follow-up|8|||
19641776|NCT00439777|42090959|FG001|Treatment Period|Lost to Follow-up|10|||
19641777|NCT00439777|42090958|FG000|Treatment Period|Protocol driven decision point|1|||
19641778|NCT00439777|42090959|FG001|Treatment Period|Protocol driven decision point|3|||
19641779|NCT00439777|42090958|FG000|Treatment Period|Physician Decision|7|||
19641780|NCT00439777|42090959|FG001|Treatment Period|Physician Decision|18|||
19641781|NCT00439777|42090958|FG000|Treatment Period|Clinical endpoint reached|26|||
19641782|NCT00439777|42090959|FG001|Treatment Period|Clinical endpoint reached|13|||
19641783|NCT00439777|42090958|FG000|Treatment Period|Technical problems|3|||
19641784|NCT00439777|42090959|FG001|Treatment Period|Technical problems|1|||
19641785|NCT00439777|42090958|FG000|Treatment Period|Participant convenience|12|||
19641786|NCT00439777|42090959|FG001|Treatment Period|Participant convenience|8|||
19641787|NCT00439777|42090958|FG000|Observational Period|Protocol Violation|0|||
19641788|NCT00439777|42090959|FG001|Observational Period|Protocol Violation|2|||
19641789|NCT00439777|42090958|FG000|Observational Period|Withdrawal by Subject|9|||
19641790|NCT00439777|42090959|FG001|Observational Period|Withdrawal by Subject|5|||
19641791|NCT00439777|42090958|FG000|Observational Period|Lost to Follow-up|1|||
19641792|NCT00439777|42090959|FG001|Observational Period|Lost to Follow-up|11|||
19641793|NCT00439777|42090958|FG000|Observational Period|Death|27|||
19641794|NCT00439777|42090959|FG001|Observational Period|Death|20|||
19641795|NCT00439777|42090958|FG000|Observational Period|Study terminated by sponsor|3|||
19641796|NCT00439777|42090959|FG001|Observational Period|Study terminated by sponsor|1|||
19641797|NCT00439777|42090958|FG000|Observational Period|Protocol driven decision point|0|||
19641798|NCT00439777|42090959|FG001|Observational Period|Protocol driven decision point|1|||
19641799|NCT00439777|42090958|FG000|Observational Period|Lack of Efficacy|1|||
19641800|NCT00439777|42090959|FG001|Observational Period|Lack of Efficacy|0|||
19641801|NCT00439777|42090958|FG000|Observational Period|Technical problems|0|||
19641802|NCT00439777|42090959|FG001|Observational Period|Technical problems|1|||
19641803|NCT00620854|42090971|FG000|Washout 1|Withdrawal by Subject|0|||
19641804|NCT00620854|42090972|FG001|Washout 1|Withdrawal by Subject|0|||
19641805|NCT00620854|42090973|FG002|Washout 1|Withdrawal by Subject|1|||
19641806|NCT00620854|42090974|FG003|Washout 1|Withdrawal by Subject|1|||
19641807|NCT00620854|42090975|FG004|Washout 1|Withdrawal by Subject|0|||
19641808|NCT00620854|42090976|FG005|Washout 1|Withdrawal by Subject|0|||
19641809|NCT00430027|42090987|FG000|Overall Study|Study terminated|8|||
19641810|NCT00792948|42090991|FG000|Overall Study|Adverse Event|6|||
19641811|NCT00792948|42090991|FG000|Overall Study|Death|4|||
19641812|NCT00792948|42090991|FG000|Overall Study|Withdrawal by Subject|3|||
19641813|NCT00792948|42090991|FG000|Overall Study|Ineligible|2|||
19641814|NCT00792948|42090991|FG000|Overall Study|Insurance denial - not treated|1|||
19641815|NCT00792948|42090991|FG000|Overall Study|Physician Decision|11|||
19641816|NCT00792948|42090991|FG000|Overall Study|Protocol Violation|1|||
19641817|NCT00429793|42090998|FG000|Overall Study|Improper pre-protocol treatment|3|||
19641818|NCT00429793|42090998|FG000|Overall Study|Required test not done|1|||
19641819|NCT00429793|42090998|FG000|Overall Study|Never treated|1|||
19641820|NCT00429793|42090998|FG000|Overall Study|Non-measurable|1|||
19641821|NCT00424645|42091009|FG000|Overall Study|Death|1|||
19641822|NCT00424645|42091010|FG001|Overall Study|Death|0|||
19641823|NCT00763451|42091020|FG000|Overall Study|Adverse Event|4|||
19641824|NCT00763451|42091021|FG001|Overall Study|Adverse Event|6|||
19641825|NCT00763451|42091022|FG002|Overall Study|Adverse Event|19|||
19641826|NCT00763451|42091023|FG003|Overall Study|Adverse Event|14|||
19641827|NCT00763451|42091020|FG000|Overall Study|Lack of Efficacy|1|||
19641828|NCT00763451|42091021|FG001|Overall Study|Lack of Efficacy|4|||
19641829|NCT00763451|42091022|FG002|Overall Study|Lack of Efficacy|3|||
19641830|NCT00763451|42091023|FG003|Overall Study|Lack of Efficacy|2|||
19641831|NCT00763451|42091020|FG000|Overall Study|Withdrawal by Subject|1|||
19641832|NCT00763451|42091021|FG001|Overall Study|Withdrawal by Subject|6|||
19641833|NCT00763451|42091022|FG002|Overall Study|Withdrawal by Subject|9|||
19641834|NCT00763451|42091023|FG003|Overall Study|Withdrawal by Subject|7|||
19641835|NCT00763451|42091020|FG000|Overall Study|Protocol Violation|0|||
19641836|NCT00763451|42091021|FG001|Overall Study|Protocol Violation|0|||
19641837|NCT00763451|42091022|FG002|Overall Study|Protocol Violation|1|||
19641838|NCT00763451|42091023|FG003|Overall Study|Protocol Violation|0|||
19641839|NCT00763451|42091020|FG000|Overall Study|Poor Compliance to Protocol|1|||
19641840|NCT00763451|42091021|FG001|Overall Study|Poor Compliance to Protocol|1|||
19641841|NCT00763451|42091022|FG002|Overall Study|Poor Compliance to Protocol|2|||
19641842|NCT00763451|42091023|FG003|Overall Study|Poor Compliance to Protocol|2|||
19641843|NCT00763451|42091020|FG000|Overall Study|Familial and Personal Reasons|5|||
19641844|NCT00763451|42091021|FG001|Overall Study|Familial and Personal Reasons|3|||
19641845|NCT00763451|42091022|FG002|Overall Study|Familial and Personal Reasons|5|||
19641846|NCT00763451|42091023|FG003|Overall Study|Familial and Personal Reasons|4|||
19641847|NCT00763451|42091020|FG000|Overall Study|Randomized but not Treated|1|||
19641848|NCT00763451|42091021|FG001|Overall Study|Randomized but not Treated|1|||
19641849|NCT00763451|42091022|FG002|Overall Study|Randomized but not Treated|0|||
19641850|NCT00763451|42091023|FG003|Overall Study|Randomized but not Treated|0|||
19641851|NCT00763451|42091020|FG000|Overall Study|Study Site Reason|0|||
19641852|NCT00763451|42091021|FG001|Overall Study|Study Site Reason|1|||
19641853|NCT00763451|42091022|FG002|Overall Study|Study Site Reason|1|||
19641854|NCT00763451|42091023|FG003|Overall Study|Study Site Reason|1|||
19641855|NCT00762762|42091036|FG000|Overall Study|Did not return for appointments|6|||
19641856|NCT00762762|42091037|FG001|Overall Study|Did not return for appointments|8|||
19641857|NCT00424489|42091045|FG000|Overall Study|Death|3|||
19641858|NCT00578864|42091051|FG000|Overall Study|Death|1|||
19641859|NCT00578864|42091052|FG001|Overall Study|Death|0|||
19641860|NCT00770315|42091075|FG000|Overall Study|Adverse Event|11|||
19641861|NCT00770315|42091076|FG001|Overall Study|Adverse Event|17|||
19641862|NCT00770315|42091077|FG002|Overall Study|Adverse Event|16|||
19641863|NCT00770315|42091078|FG003|Overall Study|Adverse Event|6|||
19641864|NCT00770315|42091075|FG000|Overall Study|Lost to Follow-up|9|||
19641865|NCT00770315|42091076|FG001|Overall Study|Lost to Follow-up|5|||
19641866|NCT00770315|42091077|FG002|Overall Study|Lost to Follow-up|10|||
19641867|NCT00770315|42091078|FG003|Overall Study|Lost to Follow-up|3|||
19641868|NCT00770315|42091075|FG000|Overall Study|Withdrawal by Subject|13|||
19641869|NCT00770315|42091076|FG001|Overall Study|Withdrawal by Subject|17|||
19641870|NCT00770315|42091077|FG002|Overall Study|Withdrawal by Subject|24|||
19641871|NCT00770315|42091078|FG003|Overall Study|Withdrawal by Subject|20|||
19641872|NCT00770315|42091075|FG000|Overall Study|Noncompliance with Protocol|7|||
19641873|NCT00770315|42091076|FG001|Overall Study|Noncompliance with Protocol|4|||
19641874|NCT00770315|42091077|FG002|Overall Study|Noncompliance with Protocol|7|||
19641875|NCT00770315|42091078|FG003|Overall Study|Noncompliance with Protocol|9|||
19641876|NCT00587171|42091090|FG000|Overall Study|Lost to Follow-up|1|||
19641877|NCT00587171|42091091|FG001|Overall Study|Lost to Follow-up|1|||
19641878|NCT00763139|42091097|FG000|Overall Study|Adverse Event|4|||
19641879|NCT00763139|42091098|FG001|Overall Study|Adverse Event|2|||
19641880|NCT00763139|42091097|FG000|Overall Study|Withdrawal by Subject|0|||
19641881|NCT00763139|42091098|FG001|Overall Study|Withdrawal by Subject|1|||
19641882|NCT00763139|42091097|FG000|Overall Study|med change not allowed by protocol|1|||
19641883|NCT00763139|42091098|FG001|Overall Study|med change not allowed by protocol|0|||
19641884|NCT01366092|42091109|FG000|Overall Study|Progressive cGVHD|2|||
19641885|NCT01366092|42091109|FG000|Overall Study|Physician Decision|1|||
19641886|NCT01366092|42091109|FG000|Overall Study|Withdrawal by Subject|1|||
19477060|NCT01491737|41755875|FG000|Overall Study|Study Termination by Sponsor|36|||
19641887|NCT00781859|42091115|FG000|Overall Study|Adverse Event|2|||
19641888|NCT00781859|42091116|FG001|Overall Study|Adverse Event|2|||
19641889|NCT00781859|42091115|FG000|Overall Study|Withdrawal by Subject|8|||
19641890|NCT00781859|42091116|FG001|Overall Study|Withdrawal by Subject|4|||
19641891|NCT00781859|42091115|FG000|Overall Study|Lost to Follow-up|6|||
19641892|NCT00781859|42091116|FG001|Overall Study|Lost to Follow-up|3|||
19641893|NCT00781859|42091115|FG000|Overall Study|Death|3|||
19641894|NCT00781859|42091116|FG001|Overall Study|Death|0|||
19641895|NCT00580788|42091126|FG000|Overall Study|Adverse Event|0|||
19641896|NCT00580788|42091127|FG001|Overall Study|Adverse Event|0|||
19641897|NCT00580788|42091128|FG002|Overall Study|Adverse Event|0|||
19641898|NCT00580788|42091129|FG003|Overall Study|Adverse Event|1|||
19641899|NCT00417079|42091148|FG000|Overall Study|Disease progression|267|||
19641900|NCT00417079|42091149|FG001|Overall Study|Disease progression|180|||
19641901|NCT00417079|42091148|FG000|Overall Study|Adverse Event|32|||
19641902|NCT00417079|42091149|FG001|Overall Study|Adverse Event|67|||
19641903|NCT00417079|42091148|FG000|Overall Study|Non-compliance to protocol|0|||
19641904|NCT00417079|42091149|FG001|Overall Study|Non-compliance to protocol|1|||
19641905|NCT00417079|42091148|FG000|Overall Study|Lost to Follow-up|2|||
19641906|NCT00417079|42091149|FG001|Overall Study|Lost to Follow-up|0|||
19641907|NCT00417079|42091148|FG000|Overall Study|Withdrawal by Subject|17|||
19641908|NCT00417079|42091149|FG001|Overall Study|Withdrawal by Subject|8|||
19641909|NCT00417079|42091148|FG000|Overall Study|Not treated|6|||
19641910|NCT00417079|42091149|FG001|Overall Study|Not treated|7|||
19641911|NCT00417079|42091148|FG000|Overall Study|Screened failure|2|||
19641912|NCT00417079|42091149|FG001|Overall Study|Screened failure|1|||
19641913|NCT00417079|42091148|FG000|Overall Study|Investigator's decision|1|||
19641914|NCT00417079|42091149|FG001|Overall Study|Investigator's decision|4|||
19641915|NCT00417079|42091148|FG000|Overall Study|Non-confirmed Disease progression|1|||
19641916|NCT00417079|42091149|FG001|Overall Study|Non-confirmed Disease progression|1|||
19641917|NCT00417079|42091148|FG000|Overall Study|Clinical deterioration|1|||
19641918|NCT00417079|42091149|FG001|Overall Study|Clinical deterioration|0|||
19641919|NCT00417079|42091148|FG000|Overall Study|Screening error|2|||
19641920|NCT00417079|42091149|FG001|Overall Study|Screening error|1|||
19641921|NCT00417079|42091148|FG000|Overall Study|Withdrawal by subject's family|0|||
19641922|NCT00417079|42091149|FG001|Overall Study|Withdrawal by subject's family|1|||
19641923|NCT00417079|42091148|FG000|Overall Study|Patient unable to come to the clinic|0|||
19641924|NCT00417079|42091149|FG001|Overall Study|Patient unable to come to the clinic|1|||
19641925|NCT00417079|42091148|FG000|Overall Study|abnormal liver function tests|0|||
19641926|NCT00417079|42091149|FG001|Overall Study|abnormal liver function tests|1|||
19641927|NCT00429169|42091157|FG000|Overall Study|Lost to Follow-up|0|||
19641928|NCT00429169|42091158|FG001|Overall Study|Lost to Follow-up|1|||
19641929|NCT00429169|42091157|FG000|Overall Study|Ineligibility discovered after entry|2|||
19641930|NCT00429169|42091158|FG001|Overall Study|Ineligibility discovered after entry|1|||
19641931|NCT01188096|42091166|FG000|Overall Study|progression of disease|4|||
19641932|NCT01188096|42091166|FG000|Overall Study|Withdrawal by Subject|2|||
19641933|NCT00416455|42091172|FG000|Overall Study|PET / CT not done|3|||
19641934|NCT00416455|42091173|FG001|Overall Study|PET / CT not done|5|||
19641935|NCT00416455|42091172|FG000|Overall Study|PET / CT poor quality|2|||
19641936|NCT00416455|42091173|FG001|Overall Study|PET / CT poor quality|1|||
19641937|NCT00416455|42091172|FG000|Overall Study|Inadequate pathology|11|||
19641938|NCT00416455|42091173|FG001|Overall Study|Inadequate pathology|2|||
19641939|NCT00415909|42091190|FG000|Overall Study|Withdrawal by Subject|2|||
19641940|NCT00415909|42091190|FG000|Overall Study|Death|1|||
19641941|NCT00415597|42091194|FG000|Enrollment|Withdrawal by Subject|1|||
19641942|NCT00415597|42091194|FG000|Enrollment|Protocol Violation|1|||
19641943|NCT00415597|42091194|FG000|Treatment|Adverse Event|110|||
19641944|NCT00415597|42091194|FG000|Treatment|Lack of Efficacy|39|||
19641945|NCT00415597|42091194|FG000|Treatment|Protocol Violation|67|||
19641946|NCT00415597|42091194|FG000|Treatment|Physician Decision|3|||
19388170|NCT02055976|41631525|FG008|Overall Study|Lost to Follow-up|0|||
19641947|NCT00415597|42091194|FG000|Treatment|Withdrawal by Subject|51|||
19641948|NCT00415597|42091194|FG000|Treatment|Lost to Follow-up|28|||
19641949|NCT00415597|42091194|FG000|Treatment|Drug Screen|2|||
19641950|NCT00415597|42091194|FG000|Treatment|Administrative|3|||
19641951|NCT00415597|42091194|FG000|Treatment|Sponsor Decision|1|||
19641952|NCT00415597|42091194|FG000|Treatment|Multiple Reasons|1|||
19641953|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
19641954|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
19641955|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
19641956|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
19641957|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
19641958|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
19641959|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
19641960|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
19641961|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
19641962|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
19641963|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
19641964|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
19641965|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
19641966|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
19641967|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
19641968|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
19641969|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
19641970|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
19641971|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
19641972|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
19641973|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
19641974|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
19641975|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
19641976|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
19641977|NCT00620542|42091200|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
19641978|NCT00620542|42091201|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
19641979|NCT00620542|42091202|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
19641980|NCT00620542|42091203|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
19641981|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
19641982|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
19641983|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
19641984|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
19641985|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
19641986|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
19641987|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
19641988|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
19641989|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
19641990|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
19641991|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
19641992|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
19641993|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
19641994|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
19641995|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
19641996|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
19641997|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
19641998|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
19641999|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
19642000|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
19642001|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
19642002|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
19642003|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
19642004|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
19642005|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
19642006|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
19642007|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
19642008|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
19642009|NCT00620542|42091200|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
19642010|NCT00620542|42091201|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
19642011|NCT00620542|42091202|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
19642012|NCT00620542|42091203|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
19642013|NCT05096208|42091224|FG000|Overall Study|Lost to Follow-up|3|||
19642014|NCT05096208|42091225|FG001|Overall Study|Lost to Follow-up|5|||
19642015|NCT05096208|42091226|FG002|Overall Study|Lost to Follow-up|5|||
19642016|NCT05096208|42091227|FG003|Overall Study|Lost to Follow-up|2|||
19642017|NCT05096208|42091224|FG000|Overall Study|Withdrawal by Subject|0|||
19642018|NCT05096208|42091225|FG001|Overall Study|Withdrawal by Subject|1|||
19642019|NCT05096208|42091226|FG002|Overall Study|Withdrawal by Subject|2|||
19642020|NCT05096208|42091227|FG003|Overall Study|Withdrawal by Subject|3|||
19642021|NCT05096208|42091224|FG000|Overall Study|No longer met eligibility criteria|1|||
19642022|NCT05096208|42091225|FG001|Overall Study|No longer met eligibility criteria|0|||
19642023|NCT05096208|42091226|FG002|Overall Study|No longer met eligibility criteria|0|||
19642024|NCT05096208|42091227|FG003|Overall Study|No longer met eligibility criteria|0|||
19642025|NCT05096208|42091224|FG000|Overall Study|Other|0|||
19642026|NCT05096208|42091225|FG001|Overall Study|Other|0|||
19642027|NCT05096208|42091226|FG002|Overall Study|Other|1|||
19642028|NCT05096208|42091227|FG003|Overall Study|Other|0|||
19642029|NCT04555616|42091246|FG000|Overall Study|Death|1|||
19642030|NCT04555616|42091247|FG001|Overall Study|Death|0|||
19642031|NCT04555616|42091248|FG002|Overall Study|Death|1|||
19642032|NCT04555616|42091246|FG000|Overall Study|Withdrawal by Subject|2|||
19642033|NCT04555616|42091247|FG001|Overall Study|Withdrawal by Subject|1|||
19642034|NCT04555616|42091248|FG002|Overall Study|Withdrawal by Subject|0|||
19642035|NCT04177758|42091272|FG000|Overall Study|Lost to Follow-up|19|||
19642036|NCT04177758|42091273|FG001|Overall Study|Lost to Follow-up|11|||
19642037|NCT04003103|42091282|FG000|Overall Study|Death|1|||
19642038|NCT04003103|42091283|FG001|Overall Study|Death|0|||
19642039|NCT04003103|42091284|FG002|Overall Study|Death|0|||
19642040|NCT04003103|42091282|FG000|Overall Study|Lost to Follow-up|4|||
19642041|NCT04003103|42091283|FG001|Overall Study|Lost to Follow-up|3|||
19642042|NCT04003103|42091284|FG002|Overall Study|Lost to Follow-up|2|||
19642043|NCT04003103|42091282|FG000|Overall Study|Withdrawal by Subject|10|||
19642044|NCT04003103|42091283|FG001|Overall Study|Withdrawal by Subject|1|||
19642045|NCT04003103|42091284|FG002|Overall Study|Withdrawal by Subject|1|||
19642046|NCT04003103|42091282|FG000|Overall Study|Status not recorded|0|||
19642047|NCT04003103|42091283|FG001|Overall Study|Status not recorded|2|||
19642048|NCT04003103|42091284|FG002|Overall Study|Status not recorded|0|||
19642049|NCT03921528|42091333|FG000|Overall Study|Withdrawal by Subject|0|||
19642050|NCT03921528|42091334|FG001|Overall Study|Withdrawal by Subject|1|||
19642051|NCT03921528|42091335|FG002|Overall Study|Withdrawal by Subject|0|||
19642052|NCT03921528|42091336|FG003|Overall Study|Withdrawal by Subject|0|||
19642053|NCT03921528|42091337|FG004|Overall Study|Withdrawal by Subject|0|||
19642054|NCT03832322|42091355|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
19642055|NCT03832322|42091356|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
19642056|NCT03642990|42091372|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
19642057|NCT03642990|42091372|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
19642058|NCT03639311|42091378|FG000|Overall Study|Ongoing at the time of analysis|88|||
19642059|NCT03639311|42091379|FG001|Overall Study|Ongoing at the time of analysis|0|||
19642060|NCT03639311|42091378|FG000|Overall Study|Lost to Follow-up|1|||
19642061|NCT03639311|42091379|FG001|Overall Study|Lost to Follow-up|0|||
19642062|NCT03639311|42091378|FG000|Overall Study|Adverse Event|1|||
19642063|NCT03639311|42091379|FG001|Overall Study|Adverse Event|0|||
19642064|NCT03633825|42091390|FG000|Enrollment|Did not post on network|5066|||
19642065|NCT03633825|42091391|FG001|Enrollment|Did not post on network|5080|||
19642066|NCT03633825|42091390|FG000|Enrollment|Post not classified as crisis|13967|||
19642067|NCT03633825|42091391|FG001|Enrollment|Post not classified as crisis|13757|||
19642068|NCT03633825|42091390|FG000|Follow up|Lost to Follow-up|478|||
19642069|NCT03633825|42091391|FG001|Follow up|Lost to Follow-up|450|||
19642070|NCT03465540|42091403|FG000|Overall Study|Withdrawal by Subject|0|||
19642071|NCT03465540|42091404|FG001|Overall Study|Withdrawal by Subject|0|||
19642072|NCT03465540|42091405|FG002|Overall Study|Withdrawal by Subject|1|||
19642073|NCT03465540|42091406|FG003|Overall Study|Withdrawal by Subject|1|||
19642074|NCT03465540|42091407|FG004|Overall Study|Withdrawal by Subject|1|||
19642075|NCT03465540|42091408|FG005|Overall Study|Withdrawal by Subject|0|||
19642076|NCT03465540|42091403|FG000|Overall Study|Lost to Follow-up|0|||
19642077|NCT03465540|42091404|FG001|Overall Study|Lost to Follow-up|1|||
19642078|NCT03465540|42091405|FG002|Overall Study|Lost to Follow-up|0|||
19642079|NCT03465540|42091406|FG003|Overall Study|Lost to Follow-up|0|||
19642080|NCT03465540|42091407|FG004|Overall Study|Lost to Follow-up|1|||
19642081|NCT03465540|42091408|FG005|Overall Study|Lost to Follow-up|0|||
19642082|NCT03465540|42091403|FG000|Overall Study|Death|1|||
19642083|NCT03465540|42091404|FG001|Overall Study|Death|1|||
19642084|NCT03465540|42091405|FG002|Overall Study|Death|0|||
19642085|NCT03465540|42091406|FG003|Overall Study|Death|2|||
19642086|NCT03465540|42091407|FG004|Overall Study|Death|0|||
19642087|NCT03465540|42091408|FG005|Overall Study|Death|2|||
19642088|NCT03465540|42091403|FG000|Overall Study|Protocol specified criteria|0|||
19642089|NCT03465540|42091404|FG001|Overall Study|Protocol specified criteria|2|||
19642090|NCT03465540|42091405|FG002|Overall Study|Protocol specified criteria|2|||
19642091|NCT03465540|42091406|FG003|Overall Study|Protocol specified criteria|0|||
19642092|NCT03465540|42091407|FG004|Overall Study|Protocol specified criteria|2|||
19642093|NCT03465540|42091408|FG005|Overall Study|Protocol specified criteria|0|||
19642094|NCT03246061|42091433|FG000|Overall Study|Still in follow-up|15|||
19642095|NCT03246061|42091434|FG001|Overall Study|Still in follow-up|21|||
19642096|NCT03194646|42091446|FG000|Overall Study|Adverse Event|24|||
19642097|NCT03194646|42091447|FG001|Overall Study|Adverse Event|25|||
19642098|NCT03194646|42091448|FG002|Overall Study|Adverse Event|14|||
19642099|NCT03194646|42091449|FG003|Overall Study|Adverse Event|17|||
19642100|NCT03194646|42091446|FG000|Overall Study|Lack of Efficacy|4|||
19642101|NCT03194646|42091447|FG001|Overall Study|Lack of Efficacy|2|||
19642102|NCT03194646|42091448|FG002|Overall Study|Lack of Efficacy|2|||
19642103|NCT03194646|42091449|FG003|Overall Study|Lack of Efficacy|12|||
19642104|NCT03194646|42091446|FG000|Overall Study|Lost to Follow-up|30|||
19642105|NCT03194646|42091447|FG001|Overall Study|Lost to Follow-up|22|||
19642106|NCT03194646|42091448|FG002|Overall Study|Lost to Follow-up|12|||
19642107|NCT03194646|42091449|FG003|Overall Study|Lost to Follow-up|35|||
19642108|NCT03194646|42091446|FG000|Overall Study|Non-compliance with study drug|4|||
19642109|NCT03194646|42091447|FG001|Overall Study|Non-compliance with study drug|0|||
19642110|NCT03194646|42091448|FG002|Overall Study|Non-compliance with study drug|1|||
19642111|NCT03194646|42091449|FG003|Overall Study|Non-compliance with study drug|1|||
19642112|NCT03194646|42091446|FG000|Overall Study|Other|87|||
19642113|NCT03194646|42091447|FG001|Overall Study|Other|67|||
19642114|NCT03194646|42091448|FG002|Overall Study|Other|34|||
19642115|NCT03194646|42091449|FG003|Overall Study|Other|31|||
19642116|NCT03194646|42091446|FG000|Overall Study|Physician Decision|7|||
19642117|NCT03194646|42091447|FG001|Overall Study|Physician Decision|9|||
19642118|NCT03194646|42091448|FG002|Overall Study|Physician Decision|5|||
19642119|NCT03194646|42091449|FG003|Overall Study|Physician Decision|4|||
19642120|NCT03194646|42091446|FG000|Overall Study|Pregnancy|4|||
19642121|NCT03194646|42091447|FG001|Overall Study|Pregnancy|5|||
19642122|NCT03194646|42091448|FG002|Overall Study|Pregnancy|1|||
19642123|NCT03194646|42091449|FG003|Overall Study|Pregnancy|2|||
19642124|NCT03194646|42091446|FG000|Overall Study|Protocol Violation|4|||
19642125|NCT03194646|42091447|FG001|Overall Study|Protocol Violation|2|||
19642126|NCT03194646|42091448|FG002|Overall Study|Protocol Violation|1|||
19642127|NCT03194646|42091449|FG003|Overall Study|Protocol Violation|1|||
19642128|NCT03194646|42091446|FG000|Overall Study|Site terminated by sponsor|0|||
19642129|NCT03194646|42091447|FG001|Overall Study|Site terminated by sponsor|0|||
19642130|NCT03194646|42091448|FG002|Overall Study|Site terminated by sponsor|2|||
19642131|NCT03194646|42091449|FG003|Overall Study|Site terminated by sponsor|0|||
19642132|NCT03194646|42091446|FG000|Overall Study|Study terminated by sponsor|60|||
19642133|NCT03194646|42091447|FG001|Overall Study|Study terminated by sponsor|61|||
19642134|NCT03194646|42091448|FG002|Overall Study|Study terminated by sponsor|30|||
19642135|NCT03194646|42091449|FG003|Overall Study|Study terminated by sponsor|34|||
19642136|NCT03194646|42091446|FG000|Overall Study|Withdrawal by Subject|74|||
19642137|NCT03194646|42091447|FG001|Overall Study|Withdrawal by Subject|75|||
19642138|NCT03194646|42091448|FG002|Overall Study|Withdrawal by Subject|36|||
19642139|NCT03194646|42091449|FG003|Overall Study|Withdrawal by Subject|131|||
19642140|NCT03194646|42091446|FG000|Overall Study|Missing|4|||
19642141|NCT03194646|42091447|FG001|Overall Study|Missing|0|||
19642142|NCT03194646|42091448|FG002|Overall Study|Missing|1|||
19642143|NCT03194646|42091449|FG003|Overall Study|Missing|12|||
19642144|NCT03055832|42091489|FG000|Week 2|Withdrawal by Subject|1|||
19642145|NCT03055832|42091490|FG001|Week 2|Withdrawal by Subject|0|||
19642146|NCT03052049|42091510|FG000|Overall Study|Withdrawal by Subject|2|||
19642147|NCT02771275|42091535|FG000|Overall Study|Reoperation|2|||
19642148|NCT02771275|42091535|FG000|Overall Study|On Study|11|||
19642149|NCT02768870|42091539|FG000|Overall Study|Not Implanted with Device|2|||
19748885|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748886|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748887|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
19748888|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19600412|NCT00718159|42049327|FG004|Overall Study|Progressive Disease|6|||
19600413|NCT00718159|42049328|FG005|Overall Study|Progressive Disease|0|||
19600414|NCT00718159|42049329|FG006|Overall Study|Progressive Disease|0|||
19600415|NCT00718159|42049323|FG000|Overall Study|Death due to Adverse Event|0|||
19600416|NCT00718159|42049324|FG001|Overall Study|Death due to Adverse Event|0|||
19600417|NCT00718159|42049325|FG002|Overall Study|Death due to Adverse Event|0|||
19600418|NCT00718159|42049326|FG003|Overall Study|Death due to Adverse Event|2|||
19600419|NCT00718159|42049327|FG004|Overall Study|Death due to Adverse Event|2|||
19600420|NCT00718159|42049328|FG005|Overall Study|Death due to Adverse Event|0|||
19600421|NCT00718159|42049329|FG006|Overall Study|Death due to Adverse Event|0|||
19600422|NCT00718159|42049323|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
19600423|NCT00718159|42049324|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
19600424|NCT00718159|42049325|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
19600425|NCT00718159|42049326|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
19600426|NCT00718159|42049327|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
19600427|NCT00718159|42049328|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
19600428|NCT00718159|42049329|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
19600429|NCT00718159|42049323|FG000|Overall Study|Investigator Decision|0|||
19600430|NCT00718159|42049324|FG001|Overall Study|Investigator Decision|0|||
19642150|NCT02768870|42091539|FG000|Overall Study|Death|1|||
19642151|NCT02768870|42091539|FG000|Overall Study|Reoperation|4|||
19642152|NCT02768870|42091539|FG000|Overall Study|On Study|19|||
19642153|NCT02750618|42091543|FG000|Overall Study|Withdrawal by Subject|1|||
19642154|NCT02632409|42091549|FG000|Randomized|AE unrelated to study Drug|0|||
19642155|NCT02632409|42091550|FG001|Randomized|AE unrelated to study Drug|1|||
19642156|NCT02632409|42091549|FG000|Randomized|Participant withdrew consent|2|||
19642157|NCT02632409|42091550|FG001|Randomized|Participant withdrew consent|1|||
19642158|NCT02632409|42091549|FG000|Randomized|No Longer meets study criteria|5|||
19642159|NCT02632409|42091550|FG001|Randomized|No Longer meets study criteria|0|||
19642160|NCT02632409|42091549|FG000|Randomized|other reasons|1|||
19642161|NCT02632409|42091550|FG001|Randomized|other reasons|0|||
19600431|NCT00718159|42049325|FG002|Overall Study|Investigator Decision|0|||
19600432|NCT00718159|42049326|FG003|Overall Study|Investigator Decision|0|||
19642162|NCT02632409|42091549|FG000|Treatment Period|Ongoing Treatment|20|||
19642163|NCT02632409|42091550|FG001|Treatment Period|Ongoing Treatment|21|||
19642164|NCT02632409|42091549|FG000|Treatment Period|Disease Recurrence|147|||
19642165|NCT02632409|42091550|FG001|Treatment Period|Disease Recurrence|90|||
19642166|NCT02632409|42091549|FG000|Treatment Period|Study Drug Toxicity|8|||
19642167|NCT02632409|42091550|FG001|Treatment Period|Study Drug Toxicity|49|||
19642168|NCT02632409|42091549|FG000|Treatment Period|Death|1|||
19642169|NCT02632409|42091550|FG001|Treatment Period|Death|0|||
19642170|NCT02632409|42091549|FG000|Treatment Period|AE unrelated to study drug|15|||
19642171|NCT02632409|42091550|FG001|Treatment Period|AE unrelated to study drug|16|||
19642172|NCT02632409|42091549|FG000|Treatment Period|Request to discontinue treatment|4|||
19642173|NCT02632409|42091550|FG001|Treatment Period|Request to discontinue treatment|19|||
19642174|NCT02632409|42091549|FG000|Treatment Period|Participant withdrew consent|7|||
19642175|NCT02632409|42091550|FG001|Treatment Period|Participant withdrew consent|5|||
19642176|NCT02632409|42091549|FG000|Treatment Period|Lost to Follow-up|0|||
19642177|NCT02632409|42091550|FG001|Treatment Period|Lost to Follow-up|1|||
19642178|NCT02632409|42091549|FG000|Treatment Period|Maximum clinical benefit|1|||
19642179|NCT02632409|42091550|FG001|Treatment Period|Maximum clinical benefit|0|||
19642180|NCT02632409|42091549|FG000|Treatment Period|No longer meets study criteria|3|||
19642181|NCT02632409|42091550|FG001|Treatment Period|No longer meets study criteria|0|||
19642182|NCT02632409|42091549|FG000|Treatment Period|Administrative Reason by sponsor|0|||
19642183|NCT02632409|42091550|FG001|Treatment Period|Administrative Reason by sponsor|1|||
19642184|NCT02632409|42091549|FG000|Treatment Period|Other Reasons|10|||
19642185|NCT02632409|42091550|FG001|Treatment Period|Other Reasons|6|||
19642186|NCT02537431|42091556|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
19642187|NCT02526160|42091562|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
19642188|NCT02526160|42091563|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
19642189|NCT02526160|42091562|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
19642190|NCT02526160|42091563|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
19642191|NCT02526160|42091562|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
19642192|NCT02526160|42091563|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
19642193|NCT02526160|42091562|FG000|Open-Label Treatment Extension Period I|Death|0|||
19642194|NCT02526160|42091563|FG001|Open-Label Treatment Extension Period I|Death|1|||
19642195|NCT02526160|42091562|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
19642196|NCT02526160|42091563|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
19642197|NCT02526160|42091562|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
19642198|NCT02526160|42091563|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
19642199|NCT02526160|42091562|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
19642200|NCT02526160|42091563|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
19642201|NCT02526160|42091562|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
19642202|NCT02526160|42091563|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
19642203|NCT02432196|42091574|FG000|Overall Study|Not Implanted with Device|1|||
19642204|NCT02432196|42091574|FG000|Overall Study|Death|2|||
19642205|NCT02432196|42091574|FG000|Overall Study|Reoperation|3|||
19642206|NCT02432196|42091574|FG000|Overall Study|On Study|20|||
19642207|NCT02157610|42091598|FG000|Overall Study|Death|4|||
19642208|NCT02157610|42091599|FG001|Overall Study|Death|4|||
19642209|NCT02115282|42091607|FG000|Overall Study|Disease progression during treatment|216|||
19642210|NCT02115282|42091608|FG001|Overall Study|Disease progression during treatment|229|||
19642211|NCT02115282|42091607|FG000|Overall Study|Adverse Event|49|||
19642212|NCT02115282|42091608|FG001|Overall Study|Adverse Event|23|||
19642213|NCT02115282|42091607|FG000|Overall Study|Death|1|||
19642214|NCT02115282|42091608|FG001|Overall Study|Death|3|||
19642215|NCT02115282|42091607|FG000|Overall Study|Alternative therapy|1|||
19642216|NCT02115282|42091608|FG001|Overall Study|Alternative therapy|1|||
19642217|NCT02115282|42091607|FG000|Overall Study|Complicating disease|0|||
19642218|NCT02115282|42091608|FG001|Overall Study|Complicating disease|3|||
19642219|NCT02115282|42091607|FG000|Overall Study|Withdrawal by Subject|12|||
19642220|NCT02115282|42091608|FG001|Overall Study|Withdrawal by Subject|10|||
19642221|NCT02115282|42091607|FG000|Overall Study|Symptomatic progression/deterioration|7|||
19642222|NCT02115282|42091608|FG001|Overall Study|Symptomatic progression/deterioration|18|||
19642223|NCT02115282|42091607|FG000|Overall Study|Non-compliance|5|||
19642224|NCT02115282|42091608|FG001|Overall Study|Non-compliance|1|||
19642225|NCT02115282|42091607|FG000|Overall Study|Protocol Violation|2|||
19642226|NCT02115282|42091608|FG001|Overall Study|Protocol Violation|2|||
19642227|NCT02115282|42091607|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
19642228|NCT02115282|42091608|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
19642229|NCT02115282|42091607|FG000|Overall Study|Not start protocol therapy|9|||
19642230|NCT02115282|42091608|FG001|Overall Study|Not start protocol therapy|10|||
19642231|NCT01511250|42091653|FG000|Overall Study|Withdrawal of Consent|1|||
19642232|NCT01511250|42091654|FG001|Overall Study|Withdrawal of Consent|0|||
19642233|NCT01511250|42091655|FG002|Overall Study|Withdrawal of Consent|0|||
19642234|NCT01511250|42091656|FG003|Overall Study|Withdrawal of Consent|0|||
19642235|NCT01511250|42091657|FG004|Overall Study|Withdrawal of Consent|0|||
19748889|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748890|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748891|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748892|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748893|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748894|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748895|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
19748896|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
19642236|NCT01511250|42091658|FG005|Overall Study|Withdrawal of Consent|0|||
19642237|NCT01511250|42091659|FG006|Overall Study|Withdrawal of Consent|0|||
19642238|NCT01511250|42091660|FG007|Overall Study|Withdrawal of Consent|1|||
19642239|NCT01511250|42091661|FG008|Overall Study|Withdrawal of Consent|1|||
19642240|NCT01511250|42091662|FG009|Overall Study|Withdrawal of Consent|0|||
19642241|NCT01511250|42091653|FG000|Overall Study|Sponsor/Investigator Decision|1|||
19642242|NCT01511250|42091654|FG001|Overall Study|Sponsor/Investigator Decision|0|||
19642243|NCT01511250|42091655|FG002|Overall Study|Sponsor/Investigator Decision|0|||
19642244|NCT01511250|42091656|FG003|Overall Study|Sponsor/Investigator Decision|0|||
19642245|NCT01511250|42091657|FG004|Overall Study|Sponsor/Investigator Decision|0|||
19642246|NCT01511250|42091658|FG005|Overall Study|Sponsor/Investigator Decision|0|||
19642247|NCT01511250|42091659|FG006|Overall Study|Sponsor/Investigator Decision|0|||
19642248|NCT01511250|42091660|FG007|Overall Study|Sponsor/Investigator Decision|0|||
19642249|NCT01511250|42091661|FG008|Overall Study|Sponsor/Investigator Decision|0|||
19642250|NCT01511250|42091662|FG009|Overall Study|Sponsor/Investigator Decision|0|||
19642251|NCT01511250|42091653|FG000|Overall Study|Lost to Follow-up|7|||
19642252|NCT01511250|42091654|FG001|Overall Study|Lost to Follow-up|3|||
19642253|NCT01511250|42091655|FG002|Overall Study|Lost to Follow-up|3|||
19642254|NCT01511250|42091656|FG003|Overall Study|Lost to Follow-up|3|||
19642255|NCT01511250|42091657|FG004|Overall Study|Lost to Follow-up|0|||
19642256|NCT01511250|42091658|FG005|Overall Study|Lost to Follow-up|0|||
19642257|NCT01511250|42091659|FG006|Overall Study|Lost to Follow-up|2|||
19642258|NCT01511250|42091660|FG007|Overall Study|Lost to Follow-up|3|||
19642259|NCT01511250|42091661|FG008|Overall Study|Lost to Follow-up|13|||
19642260|NCT01511250|42091662|FG009|Overall Study|Lost to Follow-up|5|||
19642261|NCT01511250|42091653|FG000|Overall Study|Protocol Violation|0|||
19642262|NCT01511250|42091654|FG001|Overall Study|Protocol Violation|2|||
19642263|NCT01511250|42091655|FG002|Overall Study|Protocol Violation|1|||
19642264|NCT01511250|42091656|FG003|Overall Study|Protocol Violation|0|||
19642265|NCT01511250|42091657|FG004|Overall Study|Protocol Violation|0|||
19642266|NCT01511250|42091658|FG005|Overall Study|Protocol Violation|0|||
19642267|NCT01511250|42091659|FG006|Overall Study|Protocol Violation|0|||
19642268|NCT01511250|42091660|FG007|Overall Study|Protocol Violation|0|||
19642269|NCT01511250|42091661|FG008|Overall Study|Protocol Violation|0|||
19642270|NCT01511250|42091662|FG009|Overall Study|Protocol Violation|0|||
19642271|NCT01424566|42091684|FG000|Single-blind Treatment|Adverse Event|71|||
19642272|NCT01424566|42091685|FG001|Single-blind Treatment|Adverse Event|0|||
19642273|NCT01424566|42091686|FG002|Single-blind Treatment|Adverse Event|0|||
19642274|NCT01424566|42091684|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
19642275|NCT01424566|42091685|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
19642276|NCT01424566|42091686|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
19642277|NCT01424566|42091684|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
19642278|NCT01424566|42091685|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
19642279|NCT01424566|42091686|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
19642280|NCT01424566|42091684|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
19642281|NCT01424566|42091685|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
19642282|NCT01424566|42091686|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
19642283|NCT01424566|42091684|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
19642284|NCT01424566|42091685|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
19642285|NCT01424566|42091686|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
19642286|NCT01424566|42091684|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
19642287|NCT01424566|42091685|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
19642288|NCT01424566|42091686|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
19642289|NCT01424566|42091684|FG000|Double-blind Treatment|Adverse Event|0|||
19642290|NCT01424566|42091685|FG001|Double-blind Treatment|Adverse Event|21|||
19748897|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
19642291|NCT01424566|42091686|FG002|Double-blind Treatment|Adverse Event|13|||
19642292|NCT01424566|42091684|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
19642293|NCT01424566|42091685|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
19642294|NCT01424566|42091686|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
19600433|NCT00718159|42049327|FG004|Overall Study|Investigator Decision|0|||
19600434|NCT00718159|42049328|FG005|Overall Study|Investigator Decision|1|||
19600435|NCT00718159|42049329|FG006|Overall Study|Investigator Decision|1|||
19600436|NCT00718081|42049348|FG000|Overall Study|Adverse Event|0|||
19600437|NCT00718081|42049349|FG001|Overall Study|Adverse Event|1|||
19600438|NCT00718081|42049350|FG002|Overall Study|Adverse Event|0|||
19600439|NCT00718081|42049348|FG000|Overall Study|Lack of Efficacy|7|||
19600440|NCT00718081|42049349|FG001|Overall Study|Lack of Efficacy|3|||
19600441|NCT00718081|42049350|FG002|Overall Study|Lack of Efficacy|21|||
19600442|NCT00788710|42049361|FG000|Overall Study|Adverse Event|1|||
19600443|NCT00788710|42049362|FG001|Overall Study|Adverse Event|3|||
19600444|NCT00788710|42049363|FG002|Overall Study|Adverse Event|4|||
19600445|NCT00788710|42049361|FG000|Overall Study|Lack of Efficacy|0|||
19600446|NCT00788710|42049362|FG001|Overall Study|Lack of Efficacy|0|||
19600447|NCT00788710|42049363|FG002|Overall Study|Lack of Efficacy|1|||
19600448|NCT00788710|42049361|FG000|Overall Study|Lost to Follow-up|0|||
19600449|NCT00788710|42049362|FG001|Overall Study|Lost to Follow-up|1|||
19600450|NCT00788710|42049363|FG002|Overall Study|Lost to Follow-up|0|||
19600451|NCT00788710|42049361|FG000|Overall Study|Physician Decision|2|||
19600452|NCT00788710|42049362|FG001|Overall Study|Physician Decision|1|||
19748898|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748899|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748900|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748901|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748902|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748903|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
19748904|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748905|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748906|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748907|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19642295|NCT01424566|42091684|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
19642296|NCT01424566|42091685|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
19642297|NCT01424566|42091686|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
19642298|NCT01424566|42091684|FG000|Double-blind Treatment|Lack of Efficacy|0|||
19642299|NCT01424566|42091685|FG001|Double-blind Treatment|Lack of Efficacy|1|||
19642300|NCT01424566|42091686|FG002|Double-blind Treatment|Lack of Efficacy|1|||
19642301|NCT01361607|42091695|FG000|Overall Study|Adverse Event|38|||
19642302|NCT01361607|42091696|FG001|Overall Study|Adverse Event|29|||
19642303|NCT01361607|42091695|FG000|Overall Study|Withdrawal by Subject|19|||
19642304|NCT01361607|42091696|FG001|Overall Study|Withdrawal by Subject|8|||
19642305|NCT01361607|42091695|FG000|Overall Study|Withdrawal by Investigator|5|||
19642306|NCT01361607|42091696|FG001|Overall Study|Withdrawal by Investigator|3|||
19642307|NCT01361607|42091695|FG000|Overall Study|Lost to Follow-up|1|||
19642308|NCT01361607|42091696|FG001|Overall Study|Lost to Follow-up|0|||
19642309|NCT01361607|42091695|FG000|Overall Study|Met Withdrawal Criteria|1|||
19642310|NCT01361607|42091696|FG001|Overall Study|Met Withdrawal Criteria|1|||
19642311|NCT01337089|42091703|FG000|Overall Study|Adverse Event|237|||
19642312|NCT01337089|42091703|FG000|Overall Study|Withdrawal by Subject|129|||
19642313|NCT01337089|42091703|FG000|Overall Study|Withdrawal by Investigator|33|||
19642314|NCT01337089|42091703|FG000|Overall Study|Met Withdrawal Criteria|3|||
19642315|NCT01337089|42091703|FG000|Overall Study|Lost to Follow-up|2|||
19642316|NCT01274338|42091717|FG000|Overall Study|Lack of Efficacy|72|||
19642317|NCT01274338|42091718|FG001|Overall Study|Lack of Efficacy|108|||
19642318|NCT01274338|42091719|FG002|Overall Study|Lack of Efficacy|116|||
19642319|NCT01274338|42091720|FG003|Overall Study|Lack of Efficacy|0|||
19642320|NCT01274338|42091721|FG004|Overall Study|Lack of Efficacy|0|||
19642321|NCT01274338|42091722|FG005|Overall Study|Lack of Efficacy|0|||
19642322|NCT01274338|42091717|FG000|Overall Study|Adverse Event|272|||
19642323|NCT01274338|42091718|FG001|Overall Study|Adverse Event|105|||
19642324|NCT01274338|42091719|FG002|Overall Study|Adverse Event|180|||
19642325|NCT01274338|42091720|FG003|Overall Study|Adverse Event|1|||
19642326|NCT01274338|42091721|FG004|Overall Study|Adverse Event|0|||
19642327|NCT01274338|42091722|FG005|Overall Study|Adverse Event|0|||
19642328|NCT01274338|42091717|FG000|Overall Study|Death|8|||
19642329|NCT01274338|42091718|FG001|Overall Study|Death|1|||
19642330|NCT01274338|42091719|FG002|Overall Study|Death|0|||
19642331|NCT01274338|42091720|FG003|Overall Study|Death|0|||
19642332|NCT01274338|42091721|FG004|Overall Study|Death|0|||
19642333|NCT01274338|42091722|FG005|Overall Study|Death|0|||
19642334|NCT01274338|42091717|FG000|Overall Study|Withdrawal by Subject|27|||
19642335|NCT01274338|42091718|FG001|Overall Study|Withdrawal by Subject|99|||
19642336|NCT01274338|42091719|FG002|Overall Study|Withdrawal by Subject|17|||
19748908|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748909|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748910|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19600453|NCT00788710|42049363|FG002|Overall Study|Physician Decision|0|||
19600454|NCT00788710|42049361|FG000|Overall Study|Protocol Violation|0|||
19600455|NCT00788710|42049362|FG001|Overall Study|Protocol Violation|1|||
19642337|NCT01274338|42091720|FG003|Overall Study|Withdrawal by Subject|0|||
19642338|NCT01274338|42091721|FG004|Overall Study|Withdrawal by Subject|0|||
19642339|NCT01274338|42091722|FG005|Overall Study|Withdrawal by Subject|0|||
19642340|NCT01274338|42091717|FG000|Overall Study|Did not start treatment|8|||
19642341|NCT01274338|42091718|FG001|Overall Study|Did not start treatment|116|||
19642342|NCT01274338|42091719|FG002|Overall Study|Did not start treatment|7|||
19642343|NCT01274338|42091720|FG003|Overall Study|Did not start treatment|0|||
19748911|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
19642344|NCT01274338|42091721|FG004|Overall Study|Did not start treatment|0|||
19642345|NCT01274338|42091722|FG005|Overall Study|Did not start treatment|0|||
19642346|NCT01274338|42091717|FG000|Overall Study|Alternative therapy|0|||
19642347|NCT01274338|42091718|FG001|Overall Study|Alternative therapy|1|||
19642348|NCT01274338|42091719|FG002|Overall Study|Alternative therapy|0|||
19642349|NCT01274338|42091720|FG003|Overall Study|Alternative therapy|0|||
19642350|NCT01274338|42091721|FG004|Overall Study|Alternative therapy|0|||
19642351|NCT01274338|42091722|FG005|Overall Study|Alternative therapy|0|||
19642352|NCT01274338|42091717|FG000|Overall Study|Other complicating diseases|0|||
19642353|NCT01274338|42091718|FG001|Overall Study|Other complicating diseases|3|||
19642354|NCT01274338|42091719|FG002|Overall Study|Other complicating diseases|1|||
19642355|NCT01274338|42091720|FG003|Overall Study|Other complicating diseases|0|||
19642356|NCT01274338|42091721|FG004|Overall Study|Other complicating diseases|0|||
19642357|NCT01274338|42091722|FG005|Overall Study|Other complicating diseases|0|||
19748912|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748913|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748914|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748915|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748916|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748917|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19642358|NCT01274338|42091717|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
19642359|NCT01274338|42091718|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
19642360|NCT01274338|42091719|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
19642361|NCT01274338|42091720|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
19642362|NCT01274338|42091721|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
19642363|NCT01274338|42091722|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
19642364|NCT01274338|42091717|FG000|Overall Study|Pregnancy|0|||
19642365|NCT01274338|42091718|FG001|Overall Study|Pregnancy|0|||
19642366|NCT01274338|42091719|FG002|Overall Study|Pregnancy|1|||
19642367|NCT01274338|42091720|FG003|Overall Study|Pregnancy|0|||
19642368|NCT01274338|42091721|FG004|Overall Study|Pregnancy|0|||
19600456|NCT00788710|42049363|FG002|Overall Study|Protocol Violation|1|||
19600457|NCT00788710|42049361|FG000|Overall Study|Withdrawal by Subject|2|||
19600458|NCT00788710|42049362|FG001|Overall Study|Withdrawal by Subject|2|||
19642369|NCT01274338|42091722|FG005|Overall Study|Pregnancy|0|||
19642370|NCT01274338|42091717|FG000|Overall Study|Reason not reported|12|||
19642371|NCT01274338|42091718|FG001|Overall Study|Reason not reported|21|||
19642372|NCT01274338|42091719|FG002|Overall Study|Reason not reported|3|||
19642373|NCT01274338|42091720|FG003|Overall Study|Reason not reported|0|||
19642374|NCT01274338|42091721|FG004|Overall Study|Reason not reported|1|||
19642375|NCT01274338|42091722|FG005|Overall Study|Reason not reported|0|||
19642376|NCT00114530|42091758|FG000|Overall Study|Death|3|||
19642377|NCT00114530|42091759|FG001|Overall Study|Death|11|||
19642378|NCT00114530|42091758|FG000|Overall Study|Lost to Follow-up|1|||
19642379|NCT00114530|42091759|FG001|Overall Study|Lost to Follow-up|1|||
19642380|NCT00114530|42091758|FG000|Overall Study|Physician Decision|1|||
19642381|NCT00114530|42091759|FG001|Overall Study|Physician Decision|1|||
19642382|NCT00114530|42091758|FG000|Overall Study|Withdrawal by Subject|2|||
19642383|NCT00114530|42091759|FG001|Overall Study|Withdrawal by Subject|6|||
19642384|NCT00114530|42091758|FG000|Overall Study|Breast Cancer|1|||
19642385|NCT00114530|42091759|FG001|Overall Study|Breast Cancer|0|||
19642386|NCT00114530|42091758|FG000|Overall Study|Subject decision after endpoint failure|0|||
19642387|NCT00114530|42091759|FG001|Overall Study|Subject decision after endpoint failure|1|||
19642388|NCT00114530|42091758|FG000|Overall Study|Ineligible|1|||
19642389|NCT00114530|42091759|FG001|Overall Study|Ineligible|0|||
19642390|NCT00618982|42091782|FG000|Overall Study|Adverse Event|23|||
19642391|NCT00618982|42091782|FG000|Overall Study|Withdrawal by Subject|1|||
19642392|NCT00618982|42091782|FG000|Overall Study|Protocol Violation|1|||
19642393|NCT00618982|42091782|FG000|Overall Study|ongoing, still treated with study med.|25|||
19477061|NCT01491737|41755876|FG001|Overall Study|Study Termination by Sponsor|36|||
19642394|NCT00578786|42091792|FG000|Overall Study|Adverse Event|27|||
19600459|NCT00788710|42049363|FG002|Overall Study|Withdrawal by Subject|0|||
19600460|NCT00787930|42049371|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
19600461|NCT00588094|42049381|FG000|Overall Study|Adverse Event|3|||
19600462|NCT00588094|42049381|FG000|Overall Study|Progression of Disease|2|||
19600463|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
19600464|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
19642395|NCT00578786|42091793|FG001|Overall Study|Adverse Event|37|||
19642396|NCT00578786|42091794|FG002|Overall Study|Adverse Event|17|||
19642397|NCT00578786|42091792|FG000|Overall Study|Lack of Efficacy|2|||
19642398|NCT00578786|42091793|FG001|Overall Study|Lack of Efficacy|5|||
19642399|NCT00578786|42091794|FG002|Overall Study|Lack of Efficacy|2|||
19642400|NCT00578786|42091792|FG000|Overall Study|Early Escape from Prior Study|2|||
19642401|NCT00578786|42091793|FG001|Overall Study|Early Escape from Prior Study|1|||
19642402|NCT00578786|42091794|FG002|Overall Study|Early Escape from Prior Study|2|||
19642403|NCT00578786|42091792|FG000|Overall Study|Withdrawal by Subject|7|||
19642404|NCT00578786|42091793|FG001|Overall Study|Withdrawal by Subject|8|||
19642405|NCT00578786|42091794|FG002|Overall Study|Withdrawal by Subject|5|||
19642406|NCT00578786|42091792|FG000|Overall Study|Protocol Violation|0|||
19642407|NCT00578786|42091793|FG001|Overall Study|Protocol Violation|3|||
19642408|NCT00578786|42091794|FG002|Overall Study|Protocol Violation|1|||
19642409|NCT00578786|42091792|FG000|Overall Study|Physician Decision|1|||
19642410|NCT00578786|42091793|FG001|Overall Study|Physician Decision|0|||
19642411|NCT00578786|42091794|FG002|Overall Study|Physician Decision|1|||
19642412|NCT00578786|42091792|FG000|Overall Study|Sponsor Decision|0|||
19642413|NCT00578786|42091793|FG001|Overall Study|Sponsor Decision|0|||
19642414|NCT00578786|42091794|FG002|Overall Study|Sponsor Decision|1|||
19642415|NCT00578786|42091792|FG000|Overall Study|Lost to Follow-up|0|||
19642416|NCT00578786|42091793|FG001|Overall Study|Lost to Follow-up|4|||
19642417|NCT00578786|42091794|FG002|Overall Study|Lost to Follow-up|0|||
19642418|NCT00578786|42091792|FG000|Overall Study|Pregnancy|0|||
19642419|NCT00578786|42091793|FG001|Overall Study|Pregnancy|1|||
19642420|NCT00578786|42091794|FG002|Overall Study|Pregnancy|0|||
19642421|NCT00578786|42091792|FG000|Overall Study|Not Otherwise Specified|0|||
19642422|NCT00578786|42091793|FG001|Overall Study|Not Otherwise Specified|4|||
19642423|NCT00578786|42091794|FG002|Overall Study|Not Otherwise Specified|1|||
19642424|NCT00578786|42091792|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
19642425|NCT00578786|42091793|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
19642426|NCT00578786|42091794|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
19642427|NCT00424255|42091814|FG000|Overall Study|Death|115|||
19642428|NCT00424255|42091815|FG001|Overall Study|Death|111|||
19642429|NCT00424255|42091814|FG000|Overall Study|Lost to Follow-up|26|||
19642430|NCT00424255|42091815|FG001|Overall Study|Lost to Follow-up|20|||
19642431|NCT00424255|42091814|FG000|Overall Study|Protocol Violation|0|||
19600465|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
19600466|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
19600467|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
19600468|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
19600469|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
19600470|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
19600471|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
19600472|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
19642432|NCT00424255|42091815|FG001|Overall Study|Protocol Violation|1|||
19600473|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
19642433|NCT00424255|42091814|FG000|Overall Study|Withdrawal by Subject|34|||
19600474|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
19600475|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
19600476|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
19600477|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
19600478|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
19600479|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
19600480|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
19600481|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
19600482|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
19600483|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
19642434|NCT00424255|42091815|FG001|Overall Study|Withdrawal by Subject|38|||
19642435|NCT00424255|42091814|FG000|Overall Study|Physician Decision|3|||
19642436|NCT00424255|42091815|FG001|Overall Study|Physician Decision|7|||
19642437|NCT00424255|42091814|FG000|Overall Study|Cognitive Disturbance|1|||
19642438|NCT00424255|42091815|FG001|Overall Study|Cognitive Disturbance|0|||
19600484|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
19600485|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
19600486|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
19600487|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
19600488|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
19600489|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
19600490|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
19642439|NCT00424255|42091814|FG000|Overall Study|Non-compliance by Participants|1|||
19642440|NCT00424255|42091815|FG001|Overall Study|Non-compliance by Participants|0|||
19642441|NCT00424255|42091814|FG000|Overall Study|Fatigue|1|||
19642442|NCT00424255|42091815|FG001|Overall Study|Fatigue|0|||
19642443|NCT00424255|42091814|FG000|Overall Study|Disease Progression|0|||
19642444|NCT00424255|42091815|FG001|Overall Study|Disease Progression|2|||
19642445|NCT00424255|42091814|FG000|Overall Study|Sponsor Terminated Study|161|||
19642446|NCT00424255|42091815|FG001|Overall Study|Sponsor Terminated Study|167|||
19642447|NCT00620074|42091821|FG000|Overall Study|Adverse Event|1|||
19642448|NCT00424177|42091825|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
19642449|NCT00424177|42091825|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
19642450|NCT00424177|42091825|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
19748918|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19748919|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
19600491|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
19600492|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
19600493|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
19600494|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
19600495|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
19600496|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
19600497|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
19600498|NCT03373383|42049390|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
19600499|NCT03373383|42049391|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
19600500|NCT03373383|42049392|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
19600501|NCT03373383|42049393|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
19600502|NCT03373383|42049394|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
19600503|NCT03373383|42049390|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
19600504|NCT03373383|42049391|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
19600505|NCT03373383|42049392|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
19600506|NCT03373383|42049393|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
19600507|NCT03373383|42049394|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
19600508|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
19600509|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
19600510|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
19600511|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
19600512|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
19600513|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
19600514|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
19600515|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
19600516|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
19600517|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
19600518|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
19600519|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
19600520|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
19600521|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
19600522|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
19600523|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
19600524|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
19600525|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
19600526|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
19600527|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
19600528|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
19600529|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
19600530|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
19600531|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
19600532|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
19600533|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
19600534|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
19600535|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
19600536|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
19600537|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
19600538|NCT00784654|42049421|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
19600539|NCT00784654|42049422|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
19600540|NCT00784654|42049423|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
19600541|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
19600542|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
19600543|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
19600544|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
19600545|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
19600546|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
19600547|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19600548|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
19600549|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
19600550|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
19600551|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
19600552|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
19600553|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Adverse Event|0|||
19600554|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Adverse Event|1|||
19600555|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Adverse Event|1|||
19600556|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
19600557|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
19600558|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
19600559|NCT00784654|42049421|FG000|Randomized Withdrawal Period|Family reasons|0|||
19600560|NCT00784654|42049422|FG001|Randomized Withdrawal Period|Family reasons|0|||
19600561|NCT00784654|42049423|FG002|Randomized Withdrawal Period|Family reasons|1|||
19600562|NCT00787150|42049437|FG000|Overall Study|Adverse Event|4|||
19600563|NCT00787150|42049438|FG001|Overall Study|Adverse Event|4|||
19600564|NCT00787150|42049439|FG002|Overall Study|Adverse Event|4|||
19600565|NCT00787150|42049437|FG000|Overall Study|Physician Decision|1|||
19600566|NCT00787150|42049438|FG001|Overall Study|Physician Decision|2|||
19600567|NCT00787150|42049439|FG002|Overall Study|Physician Decision|1|||
19600568|NCT00787150|42049437|FG000|Overall Study|Withdrawal by Subject|2|||
19600569|NCT00787150|42049438|FG001|Overall Study|Withdrawal by Subject|1|||
19600570|NCT00787150|42049439|FG002|Overall Study|Withdrawal by Subject|0|||
19600571|NCT00787150|42049437|FG000|Overall Study|Dosing incorrect study durg|2|||
19600572|NCT00787150|42049438|FG001|Overall Study|Dosing incorrect study durg|0|||
19600573|NCT00787150|42049439|FG002|Overall Study|Dosing incorrect study durg|0|||
19600574|NCT00786838|42049449|FG000|Overall Study|Physician Decision|4|||
19600575|NCT00786838|42049449|FG000|Overall Study|Death|4|||
19600576|NCT00786838|42049449|FG000|Overall Study|Adverse Event|6|||
19600577|NCT00786838|42049449|FG000|Overall Study|Progressive disease|31|||
19600578|NCT00786838|42049449|FG000|Overall Study|Withdrawal by Subject|4|||
19600579|NCT00785980|42049458|FG000|7 Day Washout Period|Protocol Violation|3|||
19600580|NCT00791518|42049465|FG000|Overall Study|Protocol Violation|93|||
19600581|NCT00785512|42049486|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
19600582|NCT00785512|42049487|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
19600583|NCT00785512|42049486|FG000|Overall Study|Adverse Event|0|||
19600584|NCT00785512|42049487|FG001|Overall Study|Adverse Event|0|||
19600585|NCT00785512|42049486|FG000|Overall Study|Lack of Efficacy|0|||
19600586|NCT00785512|42049487|FG001|Overall Study|Lack of Efficacy|2|||
19600587|NCT00785512|42049486|FG000|Overall Study|Withdrawal by Subject|0|||
19600588|NCT00785512|42049487|FG001|Overall Study|Withdrawal by Subject|1|||
19600589|NCT00785512|42049486|FG000|Overall Study|Lost to Follow-up|3|||
19600590|NCT00785512|42049487|FG001|Overall Study|Lost to Follow-up|0|||
19600591|NCT00785512|42049486|FG000|Overall Study|Precedure Refused|0|||
19600592|NCT00785512|42049487|FG001|Overall Study|Precedure Refused|0|||
19600593|NCT00785512|42049486|FG000|Overall Study|IVRS Programing Error|0|||
19600594|NCT00785512|42049487|FG001|Overall Study|IVRS Programing Error|0|||
19600595|NCT00785512|42049486|FG000|Overall Study|Physician Decision|0|||
19600596|NCT00785512|42049487|FG001|Overall Study|Physician Decision|0|||
19600597|NCT00785512|42049486|FG000|Overall Study|Lack of compliance|0|||
19600598|NCT00785512|42049487|FG001|Overall Study|Lack of compliance|1|||
19600599|NCT00785356|42049497|FG000|Overall Study|Study prematurely terminated|8|||
19600600|NCT00785044|42049505|FG000|Overall Study|Dosed at non-participating sites|152|||
19642451|NCT00424177|42091825|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
19642452|NCT00424177|42091825|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
19642453|NCT00424177|42091825|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
19642454|NCT00424177|42091825|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
19642455|NCT00424177|42091825|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
19642456|NCT00424177|42091825|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
19642457|NCT00424177|42091825|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
19642458|NCT00618826|42091837|FG000|Overall Study|Adverse Event|1|||
19642459|NCT00578448|42091842|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
19642460|NCT00578448|42091842|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
19642461|NCT00578448|42091842|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
19642462|NCT00578448|42091842|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
19748920|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19477062|NCT01491737|41755875|FG000|Overall Study|Reason Not Specified|8|||
19477063|NCT01491737|41755876|FG001|Overall Study|Reason Not Specified|9|||
19600601|NCT00785044|42049505|FG000|Overall Study|Death|77|||
19600602|NCT00785044|42049505|FG000|Overall Study|Lost to Follow-up|266|||
19642463|NCT00578318|42091850|FG000|Overall Study|Lost to Follow-up|2|||
19600603|NCT00785044|42049505|FG000|Overall Study|Withdrawal by Subject|1|||
19600604|NCT00784810|42049512|FG000|Overall Study|Adverse Event|32|||
19600605|NCT00784810|42049513|FG001|Overall Study|Adverse Event|20|||
19600606|NCT00784810|42049512|FG000|Overall Study|Lack of Efficacy|14|||
19600607|NCT00784810|42049513|FG001|Overall Study|Lack of Efficacy|11|||
19600608|NCT00784810|42049512|FG000|Overall Study|Withdrawal by Subject|11|||
19600609|NCT00784810|42049513|FG001|Overall Study|Withdrawal by Subject|9|||
19642464|NCT00578318|42091851|FG001|Overall Study|Lost to Follow-up|0|||
19642465|NCT00578318|42091850|FG000|Overall Study|Physician Decision|1|||
19642466|NCT00578318|42091851|FG001|Overall Study|Physician Decision|0|||
19642467|NCT00618748|42091860|FG000|Overall Study|Adverse Event|4|||
19642468|NCT00618748|42091861|FG001|Overall Study|Adverse Event|3|||
19642469|NCT00618748|42091862|FG002|Overall Study|Adverse Event|8|||
19642470|NCT00618748|42091860|FG000|Overall Study|Physician Decision|3|||
19642471|NCT00618748|42091861|FG001|Overall Study|Physician Decision|1|||
19642472|NCT00618748|42091862|FG002|Overall Study|Physician Decision|1|||
19642473|NCT00618748|42091860|FG000|Overall Study|Withdrawal by Subject|4|||
19642474|NCT00618748|42091861|FG001|Overall Study|Withdrawal by Subject|1|||
19600610|NCT00784810|42049512|FG000|Overall Study|Administrative|5|||
19600611|NCT00784810|42049513|FG001|Overall Study|Administrative|8|||
19600612|NCT00784810|42049512|FG000|Overall Study|Lost to Follow-up|1|||
19600613|NCT00784810|42049513|FG001|Overall Study|Lost to Follow-up|1|||
19600614|NCT00791128|42049519|FG000|Overall Study|Adverse Event|4|||
19600615|NCT00791128|42049519|FG000|Overall Study|Device migration|2|||
19600616|NCT00791128|42049519|FG000|Overall Study|non-compliance by subject|2|||
19600617|NCT00791128|42049519|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
19600618|NCT00776230|42049539|FG000|Overall Study|Lost to Follow-up|2|||
19600619|NCT00776230|42049540|FG001|Overall Study|Lost to Follow-up|1|||
19600620|NCT00776230|42049541|FG002|Overall Study|Lost to Follow-up|5|||
19600621|NCT00776230|42049539|FG000|Overall Study|Not vaccinated at Day 0|1|||
19600622|NCT00776230|42049540|FG001|Overall Study|Not vaccinated at Day 0|0|||
19642475|NCT00618748|42091862|FG002|Overall Study|Withdrawal by Subject|5|||
19642476|NCT00658359|42091873|FG000|Overall Study|Death|3|||
19642477|NCT00658359|42091874|FG001|Overall Study|Death|1|||
19642478|NCT00658359|42091875|FG002|Overall Study|Death|2|||
19642479|NCT00658359|42091873|FG000|Overall Study|Adverse Event|13|||
19642480|NCT00658359|42091874|FG001|Overall Study|Adverse Event|6|||
19642481|NCT00658359|42091875|FG002|Overall Study|Adverse Event|9|||
19642482|NCT00658359|42091873|FG000|Overall Study|Protocol Violation|1|||
19642483|NCT00658359|42091874|FG001|Overall Study|Protocol Violation|0|||
19642484|NCT00658359|42091875|FG002|Overall Study|Protocol Violation|0|||
19642485|NCT00658359|42091873|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
19642486|NCT00658359|42091874|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
19642487|NCT00658359|42091875|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
19642488|NCT00658359|42091873|FG000|Overall Study|Withdrawal by Subject|7|||
19642489|NCT00658359|42091874|FG001|Overall Study|Withdrawal by Subject|4|||
19642490|NCT00658359|42091875|FG002|Overall Study|Withdrawal by Subject|2|||
19642491|NCT00658359|42091873|FG000|Overall Study|Lost to Follow-up|2|||
19642492|NCT00658359|42091874|FG001|Overall Study|Lost to Follow-up|2|||
19642493|NCT00658359|42091875|FG002|Overall Study|Lost to Follow-up|4|||
19642494|NCT00658359|42091873|FG000|Overall Study|Lack of Efficacy|0|||
19642495|NCT00658359|42091874|FG001|Overall Study|Lack of Efficacy|1|||
19642496|NCT00658359|42091875|FG002|Overall Study|Lack of Efficacy|0|||
19642497|NCT00619918|42091887|FG000|Overall Study|Withdrawal by Subject|4|||
19642498|NCT00619918|42091888|FG001|Overall Study|Withdrawal by Subject|3|||
19642499|NCT00619918|42091887|FG000|Overall Study|Physician Decision|8|||
19642500|NCT00619918|42091888|FG001|Overall Study|Physician Decision|8|||
19642501|NCT00619918|42091887|FG000|Overall Study|Transfer to outside facility|3|||
19642502|NCT00619918|42091888|FG001|Overall Study|Transfer to outside facility|3|||
19642503|NCT00619918|42091887|FG000|Overall Study|Left before receiving first dose|5|||
19642504|NCT00619918|42091888|FG001|Overall Study|Left before receiving first dose|8|||
19642505|NCT01005914|42091894|FG000|Overall Study|Adverse Event|4|||
19642506|NCT01005914|42091894|FG000|Overall Study|Death|4|||
19642507|NCT01005914|42091894|FG000|Overall Study|Lack of Efficacy|1|||
19642508|NCT01005914|42091894|FG000|Overall Study|Withdrawal by Subject|1|||
19642509|NCT00618514|42091905|FG000|Overall Study|Lost to Follow-up|11|||
19642510|NCT00618514|42091906|FG001|Overall Study|Lost to Follow-up|12|||
19642511|NCT00618514|42091907|FG002|Overall Study|Lost to Follow-up|4|||
19642512|NCT00578292|42091913|FG000|Overall Study|Death|1|||
19642513|NCT00578292|42091913|FG000|Overall Study|Graft failure|2|||
19642514|NCT00655629|42091919|FG000|Overall Study|Adverse Event|4|||
19642515|NCT00655629|42091920|FG001|Overall Study|Adverse Event|1|||
19642516|NCT00655629|42091919|FG000|Overall Study|Lack of Efficacy|2|||
19600623|NCT00776230|42049541|FG002|Overall Study|Not vaccinated at Day 0|0|||
19642517|NCT00655629|42091920|FG001|Overall Study|Lack of Efficacy|12|||
19642518|NCT00655629|42091919|FG000|Overall Study|Lost to Follow-up|4|||
19642519|NCT00655629|42091920|FG001|Overall Study|Lost to Follow-up|3|||
19642520|NCT00655629|42091919|FG000|Overall Study|Protocol Violation|5|||
19642521|NCT00655629|42091920|FG001|Overall Study|Protocol Violation|3|||
19642522|NCT00655629|42091919|FG000|Overall Study|consent withdrawn|6|||
19642523|NCT00655629|42091920|FG001|Overall Study|consent withdrawn|4|||
19642524|NCT00570063|42091928|FG000|Overall Study|Adverse Event|4|||
19642525|NCT00570063|42091929|FG001|Overall Study|Adverse Event|1|||
19642526|NCT00570063|42091928|FG000|Overall Study|Lack of Efficacy|0|||
19642527|NCT00570063|42091929|FG001|Overall Study|Lack of Efficacy|1|||
19642528|NCT00570063|42091928|FG000|Overall Study|Withdrawal by Subject|4|||
19642529|NCT00570063|42091929|FG001|Overall Study|Withdrawal by Subject|3|||
19642530|NCT00570063|42091928|FG000|Overall Study|Sponsor's Decision|7|||
19642531|NCT00570063|42091929|FG001|Overall Study|Sponsor's Decision|3|||
19642532|NCT00577772|42091946|FG000|Overall Study|Lost to Follow-up|0|||
19642533|NCT00577772|42091947|FG001|Overall Study|Lost to Follow-up|1|||
19642534|NCT00578136|42091955|FG000|Overall Study|Not given intervention|1|||
19642535|NCT00578136|42091956|FG001|Overall Study|Not given intervention|1|||
19642536|NCT00655551|42091965|FG000|All Periods Combined|Adverse Event|0|||
19642537|NCT00655551|42091966|FG001|All Periods Combined|Adverse Event|3|||
19642538|NCT00655551|42091967|FG002|All Periods Combined|Adverse Event|4|||
19642539|NCT00655551|42091965|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
19642540|NCT00655551|42091966|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
19642541|NCT00655551|42091967|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
19642542|NCT00655551|42091965|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
19642543|NCT00655551|42091966|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
19642544|NCT00655551|42091967|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
19642545|NCT00655551|42091965|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
19642546|NCT00655551|42091966|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
19642547|NCT00655551|42091967|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
19642548|NCT00312728|42091975|FG000|Overall Study|Progressive disease|53|||
19642549|NCT00312728|42091975|FG000|Overall Study|Adverse Event|32|||
19642550|NCT00312728|42091975|FG000|Overall Study|Withdrawal by Subject|10|||
19642551|NCT00312728|42091975|FG000|Overall Study|Required non-protocol cancer treatment|2|||
19642552|NCT00312728|42091975|FG000|Overall Study|Protocol Violation|2|||
19642553|NCT00312728|42091975|FG000|Overall Study|Other|10|||
19642554|NCT00312728|42091975|FG000|Overall Study|Other|1|||
19642555|NCT00577824|42091982|FG000|Overall Study|Adverse Event|6|||
19642556|NCT00577824|42091983|FG001|Overall Study|Adverse Event|18|||
19642557|NCT00577824|42091984|FG002|Overall Study|Adverse Event|1|||
19642558|NCT00577824|42091982|FG000|Overall Study|Patient decision|0|||
19642559|NCT00577824|42091983|FG001|Overall Study|Patient decision|1|||
19642560|NCT00577824|42091984|FG002|Overall Study|Patient decision|1|||
19642561|NCT00577824|42091982|FG000|Overall Study|Protocol Violation|1|||
19642562|NCT00577824|42091983|FG001|Overall Study|Protocol Violation|1|||
19642563|NCT00577824|42091984|FG002|Overall Study|Protocol Violation|0|||
19642564|NCT00617344|42091995|FG000|Overall Study|Serious adverse event|1|||
19642565|NCT00617344|42091996|FG001|Overall Study|Serious adverse event|0|||
19642566|NCT00617344|42091997|FG002|Overall Study|Serious adverse event|0|||
19642567|NCT00617344|42091995|FG000|Overall Study|Other Adverse Event|1|||
19642568|NCT00617344|42091996|FG001|Overall Study|Other Adverse Event|1|||
19642569|NCT00617344|42091997|FG002|Overall Study|Other Adverse Event|0|||
19642570|NCT00617344|42091995|FG000|Overall Study|Protocol Violation|10|||
19642571|NCT00617344|42091996|FG001|Overall Study|Protocol Violation|8|||
19642572|NCT00617344|42091997|FG002|Overall Study|Protocol Violation|5|||
19642573|NCT00617344|42091995|FG000|Overall Study|Lost to Follow-up|5|||
19642574|NCT00617344|42091996|FG001|Overall Study|Lost to Follow-up|4|||
19642575|NCT00617344|42091997|FG002|Overall Study|Lost to Follow-up|1|||
19642576|NCT00617344|42091995|FG000|Overall Study|Withdrawal by Subject|8|||
19642577|NCT00617344|42091996|FG001|Overall Study|Withdrawal by Subject|9|||
19642578|NCT00617344|42091997|FG002|Overall Study|Withdrawal by Subject|2|||
19642579|NCT00654381|42092065|FG000|1st Stage|Adverse Event|3|||
19642580|NCT00654381|42092066|FG001|1st Stage|Adverse Event|3|||
19642581|NCT00654381|42092067|FG002|1st Stage|Adverse Event|3|||
19642582|NCT00654381|42092068|FG003|1st Stage|Adverse Event|3|||
19642583|NCT00654381|42092069|FG004|1st Stage|Adverse Event|2|||
19642584|NCT00654381|42092070|FG005|1st Stage|Adverse Event|1|||
19642585|NCT00654381|42092065|FG000|1st Stage|Withdrawal by Subject|0|||
19642586|NCT00654381|42092066|FG001|1st Stage|Withdrawal by Subject|0|||
19642587|NCT00654381|42092067|FG002|1st Stage|Withdrawal by Subject|0|||
19642588|NCT00654381|42092068|FG003|1st Stage|Withdrawal by Subject|1|||
19642589|NCT00654381|42092069|FG004|1st Stage|Withdrawal by Subject|0|||
19642590|NCT00654381|42092070|FG005|1st Stage|Withdrawal by Subject|1|||
19642591|NCT00654381|42092065|FG000|1st Stage|Investigator's decision|0|||
19642592|NCT00654381|42092066|FG001|1st Stage|Investigator's decision|0|||
19642593|NCT00654381|42092067|FG002|1st Stage|Investigator's decision|0|||
19642594|NCT00654381|42092068|FG003|1st Stage|Investigator's decision|1|||
19642595|NCT00654381|42092069|FG004|1st Stage|Investigator's decision|0|||
19642596|NCT00654381|42092070|FG005|1st Stage|Investigator's decision|0|||
19642597|NCT00654381|42092065|FG000|2nd Stage|Adverse Event|2|||
19642598|NCT00654381|42092066|FG001|2nd Stage|Adverse Event|0|||
19642599|NCT00654381|42092067|FG002|2nd Stage|Adverse Event|2|||
19642600|NCT00654381|42092068|FG003|2nd Stage|Adverse Event|3|||
19642601|NCT00654381|42092069|FG004|2nd Stage|Adverse Event|7|||
19642602|NCT00654381|42092070|FG005|2nd Stage|Adverse Event|2|||
19642603|NCT00654381|42092065|FG000|2nd Stage|Withdrawal by Subject|0|||
19642604|NCT00654381|42092066|FG001|2nd Stage|Withdrawal by Subject|0|||
19642605|NCT00654381|42092067|FG002|2nd Stage|Withdrawal by Subject|0|||
19642606|NCT00654381|42092068|FG003|2nd Stage|Withdrawal by Subject|0|||
19642607|NCT00654381|42092069|FG004|2nd Stage|Withdrawal by Subject|1|||
19642608|NCT00654381|42092070|FG005|2nd Stage|Withdrawal by Subject|1|||
19642609|NCT00654381|42092065|FG000|2nd Stage|Investigator's decision|0|||
19642610|NCT00654381|42092066|FG001|2nd Stage|Investigator's decision|0|||
19748921|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748922|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748923|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19642611|NCT00654381|42092067|FG002|2nd Stage|Investigator's decision|1|||
19642612|NCT00654381|42092068|FG003|2nd Stage|Investigator's decision|1|||
19642613|NCT00654381|42092069|FG004|2nd Stage|Investigator's decision|0|||
19642614|NCT00654381|42092070|FG005|2nd Stage|Investigator's decision|0|||
19642615|NCT00654381|42092065|FG000|Extension Stage|Adverse Event|1|||
19642616|NCT00654381|42092066|FG001|Extension Stage|Adverse Event|2|||
19642617|NCT00654381|42092067|FG002|Extension Stage|Adverse Event|9|||
19642618|NCT00654381|42092068|FG003|Extension Stage|Adverse Event|7|||
19642619|NCT00654381|42092069|FG004|Extension Stage|Adverse Event|1|||
19642620|NCT00654381|42092070|FG005|Extension Stage|Adverse Event|1|||
19642621|NCT00654381|42092065|FG000|Extension Stage|Protocol Violation|0|||
19642622|NCT00654381|42092066|FG001|Extension Stage|Protocol Violation|0|||
19642623|NCT00654381|42092067|FG002|Extension Stage|Protocol Violation|0|||
19642624|NCT00654381|42092068|FG003|Extension Stage|Protocol Violation|1|||
19642625|NCT00654381|42092069|FG004|Extension Stage|Protocol Violation|0|||
19642626|NCT00654381|42092070|FG005|Extension Stage|Protocol Violation|0|||
19642627|NCT00654381|42092065|FG000|Extension Stage|Lack of Efficacy|0|||
19642628|NCT00654381|42092066|FG001|Extension Stage|Lack of Efficacy|0|||
19642629|NCT00654381|42092067|FG002|Extension Stage|Lack of Efficacy|1|||
19642630|NCT00654381|42092068|FG003|Extension Stage|Lack of Efficacy|0|||
19642631|NCT00654381|42092069|FG004|Extension Stage|Lack of Efficacy|0|||
19642632|NCT00654381|42092070|FG005|Extension Stage|Lack of Efficacy|0|||
19642633|NCT00654381|42092065|FG000|Extension Stage|Withdrawal by Subject|0|||
19642634|NCT00654381|42092066|FG001|Extension Stage|Withdrawal by Subject|0|||
19642635|NCT00654381|42092067|FG002|Extension Stage|Withdrawal by Subject|1|||
19642636|NCT00654381|42092068|FG003|Extension Stage|Withdrawal by Subject|1|||
19642637|NCT00654381|42092069|FG004|Extension Stage|Withdrawal by Subject|1|||
19642638|NCT00654381|42092070|FG005|Extension Stage|Withdrawal by Subject|1|||
19642639|NCT00654381|42092065|FG000|Extension Stage|Closure of the trial site|0|||
19642640|NCT00654381|42092066|FG001|Extension Stage|Closure of the trial site|0|||
19642641|NCT00654381|42092067|FG002|Extension Stage|Closure of the trial site|0|||
19642642|NCT00654381|42092068|FG003|Extension Stage|Closure of the trial site|0|||
19642643|NCT00654381|42092069|FG004|Extension Stage|Closure of the trial site|1|||
19642644|NCT00654381|42092070|FG005|Extension Stage|Closure of the trial site|1|||
19642645|NCT00657267|42092087|FG000|Overall Study|Progressive disease|45|||
19642646|NCT00657267|42092087|FG000|Overall Study|Adverse Event|9|||
19642647|NCT00653991|42092095|FG000|3 Month Follow-up|Participant would not respond|150|||
19642648|NCT00653991|42092096|FG001|3 Month Follow-up|Participant would not respond|157|||
19642649|NCT00653991|42092095|FG000|6 Month Follow-up|Participant would not respond|133|||
19642650|NCT00653991|42092096|FG001|6 Month Follow-up|Participant would not respond|141|||
19642651|NCT00652899|42092104|FG000|Overall Study|Death|1|||
19642652|NCT00652899|42092104|FG000|Overall Study|Treating physician decision|1|||
19748924|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748925|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748926|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748927|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748928|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
19748929|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748930|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748931|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748932|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748933|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748934|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748935|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
19748936|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748937|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748938|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748939|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748940|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19642653|NCT00617890|42092116|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
19642654|NCT00617890|42092117|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
19642655|NCT00617890|42092118|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
19642656|NCT00617890|42092119|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
19642657|NCT00617890|42092116|FG000|Overall Study|Lack of Efficacy|23|||
19642658|NCT00617890|42092117|FG001|Overall Study|Lack of Efficacy|26|||
19642659|NCT00617890|42092118|FG002|Overall Study|Lack of Efficacy|30|||
19642660|NCT00617890|42092119|FG003|Overall Study|Lack of Efficacy|97|||
19642661|NCT00617890|42092116|FG000|Overall Study|Lost to Follow-up|0|||
19642662|NCT00617890|42092117|FG001|Overall Study|Lost to Follow-up|0|||
19642663|NCT00617890|42092118|FG002|Overall Study|Lost to Follow-up|1|||
19642664|NCT00617890|42092119|FG003|Overall Study|Lost to Follow-up|2|||
19642665|NCT00617890|42092116|FG000|Overall Study|Withdrawal by Subject|4|||
19642666|NCT00617890|42092117|FG001|Overall Study|Withdrawal by Subject|1|||
19642667|NCT00617890|42092118|FG002|Overall Study|Withdrawal by Subject|0|||
19642668|NCT00617890|42092119|FG003|Overall Study|Withdrawal by Subject|2|||
19642669|NCT00617890|42092116|FG000|Overall Study|Protocol Violation|2|||
19642670|NCT00617890|42092117|FG001|Overall Study|Protocol Violation|1|||
19642671|NCT00617890|42092118|FG002|Overall Study|Protocol Violation|0|||
19642672|NCT00617890|42092119|FG003|Overall Study|Protocol Violation|0|||
19642673|NCT00617890|42092116|FG000|Overall Study|Adverse Event|1|||
19642674|NCT00617890|42092117|FG001|Overall Study|Adverse Event|0|||
19642675|NCT00617890|42092118|FG002|Overall Study|Adverse Event|3|||
19642676|NCT00617890|42092119|FG003|Overall Study|Adverse Event|8|||
19642677|NCT00617890|42092116|FG000|Overall Study|Not treated|1|||
19642678|NCT00617890|42092117|FG001|Overall Study|Not treated|0|||
19642679|NCT00617890|42092118|FG002|Overall Study|Not treated|1|||
19642680|NCT00617890|42092119|FG003|Overall Study|Not treated|1|||
19642681|NCT00712166|42092134|FG000|Overall Study|Noncompliance|0|||
19642682|NCT00712166|42092135|FG001|Overall Study|Noncompliance|1|||
19642683|NCT00652743|42092146|FG000|Months 12-18|Lost to Follow-up|1|||
19642684|NCT00652743|42092147|FG001|Months 12-18|Lost to Follow-up|2|||
19642685|NCT00652743|42092148|FG002|Months 12-18|Lost to Follow-up|7|||
19642686|NCT00652743|42092146|FG000|Months 24-30|Other|5|||
19642687|NCT00652743|42092147|FG001|Months 24-30|Other|1|||
19642688|NCT00652743|42092148|FG002|Months 24-30|Other|11|||
19642689|NCT00652743|42092146|FG000|Months 36-42|Serious Adverse Events|0|||
19642690|NCT00652743|42092147|FG001|Months 36-42|Serious Adverse Events|1|||
19642691|NCT00652743|42092148|FG002|Months 36-42|Serious Adverse Events|1|||
19642692|NCT00652743|42092146|FG000|Months 36-42|Withdrawal by Subject|1|||
19642693|NCT00652743|42092147|FG001|Months 36-42|Withdrawal by Subject|1|||
19642694|NCT00652743|42092148|FG002|Months 36-42|Withdrawal by Subject|0|||
19642695|NCT00652743|42092146|FG000|Months 36-42|Lost to Follow-up|0|||
19642696|NCT00652743|42092147|FG001|Months 36-42|Lost to Follow-up|1|||
19642697|NCT00652743|42092148|FG002|Months 36-42|Lost to Follow-up|0|||
19642698|NCT00652743|42092146|FG000|Months 36-42|Migrated/moved from study area|1|||
19642699|NCT00652743|42092147|FG001|Months 36-42|Migrated/moved from study area|0|||
19748941|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19642700|NCT00652743|42092148|FG002|Months 36-42|Migrated/moved from study area|0|||
19642701|NCT00652743|42092146|FG000|Months 36-42|Other|4|||
19642702|NCT00652743|42092147|FG001|Months 36-42|Other|2|||
19642703|NCT00652743|42092148|FG002|Months 36-42|Other|8|||
19642704|NCT00712010|42092159|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
19642705|NCT00653523|42092175|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
19642706|NCT00653523|42092175|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
19748942|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748943|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748944|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748945|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
19748946|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748947|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748948|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748949|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748950|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748951|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
19748952|NCT02891226|42197052|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748953|NCT02891226|42197053|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748954|NCT02891226|42197054|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748955|NCT02891226|42197055|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19642707|NCT00653523|42092175|FG000|Overall Study|Adverse Event|7|||
19642708|NCT00653523|42092175|FG000|Overall Study|Withdrawal by Subject|6|||
19642709|NCT00653523|42092175|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
19642710|NCT00653523|42092175|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
19642711|NCT02717442|42092181|FG000|Overall Study|Study Terminated by Sponsor|31|||
19642712|NCT02717442|42092182|FG001|Overall Study|Study Terminated by Sponsor|29|||
19642713|NCT02717442|42092181|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
19642714|NCT02717442|42092182|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
19642715|NCT02717442|42092181|FG000|Overall Study|Other - Not Specified|2|||
19642716|NCT02717442|42092182|FG001|Overall Study|Other - Not Specified|0|||
19642717|NCT00616018|42092195|FG000|Overall Study|Protocol Violation|3|||
19642718|NCT00424021|42092204|FG000|NCT00046319 Study Period|Adverse Event|1|||
19642719|NCT00424021|42092205|FG001|NCT00046319 Study Period|Adverse Event|0|||
19642720|NCT00424021|42092206|FG002|NCT00046319 Study Period|Adverse Event|1|||
19748956|NCT02891226|42197056|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748957|NCT02891226|42197057|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748958|NCT02891226|42197058|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748959|NCT02891226|42197059|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748960|NCT02891226|42197060|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748961|NCT02891226|42197061|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
19748962|NCT02891226|42197062|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748963|NCT02891226|42197063|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748964|NCT02891226|42197064|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748965|NCT02891226|42197065|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748966|NCT02891226|42197066|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748967|NCT02891226|42197067|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
19748968|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748969|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19642721|NCT00424021|42092207|FG003|NCT00046319 Study Period|Adverse Event|1|||
19642722|NCT00424021|42092204|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
19642723|NCT00424021|42092205|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
19642724|NCT00424021|42092206|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
19642725|NCT00424021|42092207|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
19642726|NCT00424021|42092204|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
19642727|NCT00424021|42092205|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
19642728|NCT00424021|42092206|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
19642729|NCT00424021|42092207|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
19642730|NCT00424021|42092204|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
19642731|NCT00424021|42092205|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
19642732|NCT00424021|42092206|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
19748970|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748971|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748972|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748973|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19600624|NCT00776230|42049539|FG000|Overall Study|Withdrawal by Subject|0|||
19600625|NCT00776230|42049540|FG001|Overall Study|Withdrawal by Subject|1|||
19600626|NCT00776230|42049541|FG002|Overall Study|Withdrawal by Subject|0|||
19642733|NCT00424021|42092207|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
19642734|NCT00424021|42092204|FG000|AMB-220-E Study Period|Adverse Event|1|||
19642735|NCT00424021|42092205|FG001|AMB-220-E Study Period|Adverse Event|1|||
19642736|NCT00424021|42092206|FG002|AMB-220-E Study Period|Adverse Event|3|||
19642737|NCT00424021|42092207|FG003|AMB-220-E Study Period|Adverse Event|7|||
19642738|NCT00424021|42092204|FG000|AMB-220-E Study Period|Death|0|||
19600627|NCT00776230|42049539|FG000|Overall Study|Subject missed Visit 4|0|||
19600628|NCT00776230|42049540|FG001|Overall Study|Subject missed Visit 4|1|||
19600629|NCT00776230|42049541|FG002|Overall Study|Subject missed Visit 4|0|||
19600630|NCT00775606|42049551|FG000|Overall Study|Study sponsor terminated funding|3|||
19600631|NCT00775606|42049552|FG001|Overall Study|Study sponsor terminated funding|0|||
19600632|NCT02960763|42049565|FG000|Step 1|Withdrawal by Subject|10|||
19642739|NCT00424021|42092205|FG001|AMB-220-E Study Period|Death|0|||
19642740|NCT00424021|42092206|FG002|AMB-220-E Study Period|Death|1|||
19642741|NCT00424021|42092207|FG003|AMB-220-E Study Period|Death|1|||
19600633|NCT02960763|42049566|FG001|Step 1|Withdrawal by Subject|8|||
19600634|NCT02960763|42049567|FG002|Step 1|Withdrawal by Subject|13|||
19600635|NCT02960763|42049568|FG003|Step 1|Withdrawal by Subject|0|||
19600636|NCT02960763|42049569|FG004|Step 1|Withdrawal by Subject|0|||
19600637|NCT02960763|42049565|FG000|Step 1|Lost to Follow-up|7|||
19600638|NCT02960763|42049566|FG001|Step 1|Lost to Follow-up|9|||
19600639|NCT02960763|42049567|FG002|Step 1|Lost to Follow-up|12|||
19600640|NCT02960763|42049568|FG003|Step 1|Lost to Follow-up|0|||
19600641|NCT02960763|42049569|FG004|Step 1|Lost to Follow-up|0|||
19600642|NCT02960763|42049565|FG000|Step 1|Death|1|||
19600643|NCT02960763|42049566|FG001|Step 1|Death|1|||
19642742|NCT00424021|42092204|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
19748974|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748975|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19600644|NCT02960763|42049567|FG002|Step 1|Death|1|||
19600645|NCT02960763|42049568|FG003|Step 1|Death|0|||
19600646|NCT02960763|42049569|FG004|Step 1|Death|0|||
19600647|NCT02960763|42049565|FG000|Step 1|Investigator discretion|1|||
19600648|NCT02960763|42049566|FG001|Step 1|Investigator discretion|0|||
19600649|NCT02960763|42049567|FG002|Step 1|Investigator discretion|1|||
19600650|NCT02960763|42049568|FG003|Step 1|Investigator discretion|0|||
19600651|NCT02960763|42049569|FG004|Step 1|Investigator discretion|0|||
19600652|NCT02960763|42049565|FG000|Step 1|Other|0|||
19642743|NCT00424021|42092205|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
19642744|NCT00424021|42092206|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
19642745|NCT00424021|42092207|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
19600653|NCT02960763|42049566|FG001|Step 1|Other|0|||
19600654|NCT02960763|42049567|FG002|Step 1|Other|1|||
19600655|NCT02960763|42049568|FG003|Step 1|Other|0|||
19600656|NCT02960763|42049569|FG004|Step 1|Other|0|||
19600657|NCT02960763|42049565|FG000|Step 2|Withdrawal by Subject|0|||
19600658|NCT02960763|42049566|FG001|Step 2|Withdrawal by Subject|0|||
19600659|NCT02960763|42049567|FG002|Step 2|Withdrawal by Subject|0|||
19600660|NCT02960763|42049568|FG003|Step 2|Withdrawal by Subject|7|||
19600661|NCT02960763|42049569|FG004|Step 2|Withdrawal by Subject|3|||
19600662|NCT02960763|42049565|FG000|Step 2|Lost to Follow-up|0|||
19600663|NCT02960763|42049566|FG001|Step 2|Lost to Follow-up|0|||
19600664|NCT02960763|42049567|FG002|Step 2|Lost to Follow-up|0|||
19600665|NCT02960763|42049568|FG003|Step 2|Lost to Follow-up|4|||
19600666|NCT02960763|42049569|FG004|Step 2|Lost to Follow-up|1|||
19642746|NCT00424021|42092204|FG000|AMB-220-E Study Period|Physician Decision|0|||
19642747|NCT00424021|42092205|FG001|AMB-220-E Study Period|Physician Decision|0|||
19642748|NCT00424021|42092206|FG002|AMB-220-E Study Period|Physician Decision|0|||
19642749|NCT00424021|42092207|FG003|AMB-220-E Study Period|Physician Decision|1|||
19642750|NCT00617734|42092226|FG000|Overall Study|Withdrew Consent|2|||
19642751|NCT00617734|42092227|FG001|Overall Study|Withdrew Consent|0|||
19642752|NCT00617734|42092226|FG000|Overall Study|Adverse Event|4|||
19642753|NCT00617734|42092227|FG001|Overall Study|Adverse Event|1|||
19642754|NCT00617734|42092226|FG000|Overall Study|Protocol Violation|1|||
19642755|NCT00617734|42092227|FG001|Overall Study|Protocol Violation|0|||
19642756|NCT00617734|42092226|FG000|Overall Study|Found Ineligible After Randomization|1|||
19642757|NCT00617734|42092227|FG001|Overall Study|Found Ineligible After Randomization|4|||
19642758|NCT00617734|42092226|FG000|Overall Study|Lost to Follow-up|0|||
19642759|NCT00617734|42092227|FG001|Overall Study|Lost to Follow-up|1|||
19642760|NCT00577460|42092236|FG000|Overall Study|Adverse Event|11|||
19642761|NCT00577460|42092237|FG001|Overall Study|Adverse Event|7|||
19642762|NCT00577460|42092238|FG002|Overall Study|Adverse Event|14|||
19642763|NCT00577460|42092236|FG000|Overall Study|Protocol Violation|0|||
19642764|NCT00577460|42092237|FG001|Overall Study|Protocol Violation|1|||
19642765|NCT00577460|42092238|FG002|Overall Study|Protocol Violation|1|||
19642766|NCT00577460|42092236|FG000|Overall Study|Lost to Follow-up|0|||
19642767|NCT00577460|42092237|FG001|Overall Study|Lost to Follow-up|3|||
19642768|NCT00577460|42092238|FG002|Overall Study|Lost to Follow-up|4|||
19642769|NCT00577460|42092236|FG000|Overall Study|Withdrawal by Subject|5|||
19642770|NCT00577460|42092237|FG001|Overall Study|Withdrawal by Subject|5|||
19642771|NCT00577460|42092238|FG002|Overall Study|Withdrawal by Subject|6|||
19642772|NCT00577460|42092236|FG000|Overall Study|Other|0|||
19642773|NCT00577460|42092237|FG001|Overall Study|Other|3|||
19642774|NCT00577460|42092238|FG002|Overall Study|Other|2|||
19642775|NCT00415519|42092255|FG000|Overall Study|Adverse Event|1|||
19642776|NCT00415519|42092256|FG001|Overall Study|Adverse Event|0|||
19642777|NCT00415519|42092255|FG000|Overall Study|Withdrawal by Subject|2|||
19642778|NCT00415519|42092256|FG001|Overall Study|Withdrawal by Subject|0|||
19642779|NCT00415519|42092255|FG000|Overall Study|Patient's convenience|1|||
19642780|NCT00415519|42092256|FG001|Overall Study|Patient's convenience|0|||
19642781|NCT00423943|42092264|FG000|Overall Study|Withdrawal by Subject|3|||
19642782|NCT00423943|42092265|FG001|Overall Study|Withdrawal by Subject|1|||
19642783|NCT00428389|42092273|FG000|Core Phase|Adverse Event|6|||
19642784|NCT00428389|42092274|FG001|Core Phase|Adverse Event|4|||
19642785|NCT00428389|42092273|FG000|Core Phase|Lack of Efficacy|2|||
19642786|NCT00428389|42092274|FG001|Core Phase|Lack of Efficacy|0|||
19642787|NCT00428389|42092273|FG000|Core Phase|Abnormal test procedure result(s)|0|||
19642788|NCT00428389|42092274|FG001|Core Phase|Abnormal test procedure result(s)|1|||
19642789|NCT00428389|42092273|FG000|Core Phase|Withdrawal by Subject|3|||
19642790|NCT00428389|42092274|FG001|Core Phase|Withdrawal by Subject|4|||
19600667|NCT02960763|42049565|FG000|Step 2|Investigator discretion|0|||
19600668|NCT02960763|42049566|FG001|Step 2|Investigator discretion|0|||
19600669|NCT02960763|42049567|FG002|Step 2|Investigator discretion|0|||
19600670|NCT02960763|42049568|FG003|Step 2|Investigator discretion|0|||
19600671|NCT02960763|42049569|FG004|Step 2|Investigator discretion|1|||
19600672|NCT00775528|42049581|FG000|Overall Study|Protocol Violation|1|||
19642791|NCT00428389|42092273|FG000|Core Phase|Protocol deviation|0|||
19642792|NCT00428389|42092274|FG001|Core Phase|Protocol deviation|2|||
19642793|NCT00428389|42092273|FG000|Extension Phase|Adverse Event|17|||
19642794|NCT00428389|42092274|FG001|Extension Phase|Adverse Event|11|||
19642795|NCT00428389|42092273|FG000|Extension Phase|Lack of Efficacy|4|||
19642796|NCT00428389|42092274|FG001|Extension Phase|Lack of Efficacy|3|||
19642797|NCT00428389|42092273|FG000|Extension Phase|Withdrawal by Subject|6|||
19642798|NCT00428389|42092274|FG001|Extension Phase|Withdrawal by Subject|6|||
19642799|NCT00428389|42092273|FG000|Extension Phase|Lost to Follow-up|0|||
19642800|NCT00428389|42092274|FG001|Extension Phase|Lost to Follow-up|3|||
19642801|NCT00428389|42092273|FG000|Extension Phase|Death|1|||
19600673|NCT00775450|42049590|FG000|Overall Study|Serious Adverse Event|2|||
19600674|NCT00775450|42049591|FG001|Overall Study|Serious Adverse Event|0|||
19600675|NCT00775450|42049592|FG002|Overall Study|Serious Adverse Event|0|||
19600676|NCT00775450|42049593|FG003|Overall Study|Serious Adverse Event|0|||
19600677|NCT00775450|42049594|FG004|Overall Study|Serious Adverse Event|0|||
19600678|NCT00775450|42049590|FG000|Overall Study|Protocol Violation|0|||
19642802|NCT00428389|42092274|FG001|Extension Phase|Death|0|||
19642803|NCT00428389|42092273|FG000|Extension Phase|Protocol Violation|3|||
19642804|NCT00428389|42092274|FG001|Extension Phase|Protocol Violation|2|||
19642805|NCT00428389|42092273|FG000|Extension Phase|Administrative problems|1|||
19642806|NCT00428389|42092274|FG001|Extension Phase|Administrative problems|1|||
19642807|NCT00616642|42092282|FG000|Overall Study|Withdrawal by Subject|0|||
19642808|NCT00616642|42092283|FG001|Overall Study|Withdrawal by Subject|1|||
19642809|NCT00406315|42092289|FG000|Overall Study|Death|1|||
19642810|NCT00406315|42092289|FG000|Overall Study|Adverse Event|39|||
19642811|NCT00406315|42092289|FG000|Overall Study|Laboratory Abnormality|4|||
19642812|NCT00406315|42092289|FG000|Overall Study|Lack of Efficacy|13|||
19642813|NCT00406315|42092289|FG000|Overall Study|Other|33|||
19642814|NCT00406315|42092289|FG000|Overall Study|Lost to Follow-up|21|||
19642815|NCT00406315|42092289|FG000|Overall Study|Withdrawal by Subject|30|||
19642816|NCT00711594|42092297|FG000|Overall Study|Progressive disease|2|||
19642817|NCT00711594|42092298|FG001|Overall Study|Progressive disease|2|||
19642818|NCT00711594|42092299|FG002|Overall Study|Progressive disease|6|||
19642819|NCT00711594|42092300|FG003|Overall Study|Progressive disease|44|||
19642820|NCT00711594|42092297|FG000|Overall Study|Other Adverse Event|1|||
19642821|NCT00711594|42092298|FG001|Overall Study|Other Adverse Event|0|||
19642822|NCT00711594|42092299|FG002|Overall Study|Other Adverse Event|0|||
19642823|NCT00711594|42092300|FG003|Overall Study|Other Adverse Event|16|||
19642824|NCT00711594|42092297|FG000|Overall Study|Withdrawal by Subject|0|||
19642825|NCT00711594|42092298|FG001|Overall Study|Withdrawal by Subject|1|||
19642826|NCT00711594|42092299|FG002|Overall Study|Withdrawal by Subject|0|||
19642827|NCT00711594|42092300|FG003|Overall Study|Withdrawal by Subject|2|||
19642828|NCT00710762|42092314|FG000|Overall Study|Progressive disease|27|||
19642829|NCT00710762|42092315|FG001|Overall Study|Progressive disease|30|||
19748976|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748977|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748978|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
19748979|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748980|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748981|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19642830|NCT00710762|42092314|FG000|Overall Study|Adverse Event other disease worsening|2|||
19642831|NCT00710762|42092315|FG001|Overall Study|Adverse Event other disease worsening|1|||
19642832|NCT00710762|42092314|FG000|Overall Study|Other Adverse Event|7|||
19748982|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748983|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
19748984|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748985|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748986|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748987|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748988|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748989|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748990|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748991|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748992|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748993|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19477064|NCT01487863|41755888|FG000|Overall Study|Death|19|||
19600679|NCT00775450|42049591|FG001|Overall Study|Protocol Violation|0|||
19600680|NCT00775450|42049592|FG002|Overall Study|Protocol Violation|0|||
19600681|NCT00775450|42049593|FG003|Overall Study|Protocol Violation|0|||
19600682|NCT00775450|42049594|FG004|Overall Study|Protocol Violation|1|||
19600683|NCT00775450|42049590|FG000|Overall Study|Withdrawal by Subject|1|||
19600684|NCT00775450|42049591|FG001|Overall Study|Withdrawal by Subject|0|||
19600685|NCT00775450|42049592|FG002|Overall Study|Withdrawal by Subject|0|||
19600686|NCT00775450|42049593|FG003|Overall Study|Withdrawal by Subject|0|||
19642833|NCT00710762|42092315|FG001|Overall Study|Other Adverse Event|7|||
19642834|NCT00710762|42092314|FG000|Overall Study|Lost to Follow-up|1|||
19748994|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
19748995|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748996|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748997|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748998|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19748999|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
19749000|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749001|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749002|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749003|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749004|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749005|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749006|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749007|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749008|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749009|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749010|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
19749011|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749012|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749013|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749014|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749015|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
19749016|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749017|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749018|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749019|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749020|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749021|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749022|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749023|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749024|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749025|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749026|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
19749027|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749028|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749029|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749030|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749031|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
19749032|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749033|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749034|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749035|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749036|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749037|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749038|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749039|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749040|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749041|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749042|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
19749043|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749044|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749045|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749046|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749047|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
19749048|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749049|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749050|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749051|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749052|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749053|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749054|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749055|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749056|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749057|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749058|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
19749059|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749060|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749061|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749062|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749063|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
19749064|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749065|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749066|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749067|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749068|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749069|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749070|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749071|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749072|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749073|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749074|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
19749075|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749076|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749077|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749078|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749079|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
19749080|NCT02891226|42197052|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749081|NCT02891226|42197053|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749082|NCT02891226|42197054|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749083|NCT02891226|42197055|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749084|NCT02891226|42197056|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749085|NCT02891226|42197057|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749086|NCT02891226|42197058|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749087|NCT02891226|42197059|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749088|NCT02891226|42197060|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749089|NCT02891226|42197061|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749090|NCT02891226|42197062|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
19749091|NCT02891226|42197063|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749092|NCT02891226|42197064|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19642835|NCT00710762|42092315|FG001|Overall Study|Lost to Follow-up|0|||
19642836|NCT00710762|42092314|FG000|Overall Study|Reason other than listed above|2|||
19749093|NCT02891226|42197065|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749094|NCT02891226|42197066|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749095|NCT02891226|42197067|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
19749096|NCT02891226|42197052|FG000|Follow-up Period|Withdrawal by Subject|0|||
19749097|NCT02891226|42197053|FG001|Follow-up Period|Withdrawal by Subject|0|||
19749098|NCT02891226|42197054|FG002|Follow-up Period|Withdrawal by Subject|0|||
19749099|NCT02891226|42197055|FG003|Follow-up Period|Withdrawal by Subject|0|||
19749100|NCT02891226|42197056|FG004|Follow-up Period|Withdrawal by Subject|0|||
19749101|NCT02891226|42197057|FG005|Follow-up Period|Withdrawal by Subject|0|||
19749102|NCT02891226|42197058|FG006|Follow-up Period|Withdrawal by Subject|0|||
19749103|NCT02891226|42197059|FG007|Follow-up Period|Withdrawal by Subject|0|||
19749104|NCT02891226|42197060|FG008|Follow-up Period|Withdrawal by Subject|0|||
19749105|NCT02891226|42197061|FG009|Follow-up Period|Withdrawal by Subject|0|||
19749106|NCT02891226|42197062|FG010|Follow-up Period|Withdrawal by Subject|0|||
19642837|NCT00710762|42092315|FG001|Overall Study|Reason other than listed above|2|||
19642838|NCT00573430|42092324|FG000|Overall Study|Incorrect enrollment of randomization|0|||
19642839|NCT00573430|42092325|FG001|Overall Study|Incorrect enrollment of randomization|4|||
19642840|NCT00573430|42092326|FG002|Overall Study|Incorrect enrollment of randomization|3|||
19642841|NCT00573430|42092324|FG000|Overall Study|Adverse Event|0|||
19642842|NCT00573430|42092325|FG001|Overall Study|Adverse Event|0|||
19642843|NCT00573430|42092326|FG002|Overall Study|Adverse Event|2|||
19749107|NCT02891226|42197063|FG011|Follow-up Period|Withdrawal by Subject|1|||
19749108|NCT02891226|42197064|FG012|Follow-up Period|Withdrawal by Subject|0|||
19749109|NCT02891226|42197065|FG013|Follow-up Period|Withdrawal by Subject|0|||
19749110|NCT02891226|42197066|FG014|Follow-up Period|Withdrawal by Subject|1|||
19642844|NCT00573430|42092324|FG000|Overall Study|Withdrawal by Subject|1|||
19749111|NCT02891226|42197067|FG015|Follow-up Period|Withdrawal by Subject|1|||
19749112|NCT03612856|42197094|FG000|Pre-dose Period|Physician Decision|0|||
19749113|NCT03612856|42197095|FG001|Pre-dose Period|Physician Decision|1|||
19749114|NCT03612856|42197096|FG002|Pre-dose Period|Physician Decision|1|||
19749115|NCT03612856|42197094|FG000|Pre-dose Period|Withdrawal by Subject|0|||
19749116|NCT03612856|42197095|FG001|Pre-dose Period|Withdrawal by Subject|1|||
19749117|NCT03612856|42197096|FG002|Pre-dose Period|Withdrawal by Subject|0|||
19749118|NCT03333837|42197109|FG000|Overall Study|Adverse Event|2|||
19749119|NCT03333837|42197110|FG001|Overall Study|Adverse Event|1|||
19749120|NCT03333837|42197111|FG002|Overall Study|Adverse Event|1|||
19749121|NCT03333837|42197112|FG003|Overall Study|Adverse Event|1|||
19749122|NCT03333837|42197113|FG004|Overall Study|Adverse Event|0|||
19749123|NCT03333837|42197109|FG000|Overall Study|Caregiver withdrew|0|||
19749124|NCT03333837|42197110|FG001|Overall Study|Caregiver withdrew|2|||
19749125|NCT03333837|42197111|FG002|Overall Study|Caregiver withdrew|1|||
19749126|NCT03333837|42197112|FG003|Overall Study|Caregiver withdrew|0|||
19749127|NCT03333837|42197113|FG004|Overall Study|Caregiver withdrew|0|||
19749128|NCT03333837|42197109|FG000|Overall Study|Withdrawal by Subject|0|||
19749129|NCT03333837|42197110|FG001|Overall Study|Withdrawal by Subject|0|||
19749130|NCT03333837|42197111|FG002|Overall Study|Withdrawal by Subject|1|||
19749131|NCT03333837|42197112|FG003|Overall Study|Withdrawal by Subject|1|||
19749132|NCT03333837|42197113|FG004|Overall Study|Withdrawal by Subject|3|||
19749133|NCT03333837|42197109|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
19749134|NCT03333837|42197110|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
19749135|NCT03333837|42197111|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
19749136|NCT03333837|42197112|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
19749137|NCT03333837|42197113|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
19749138|NCT03708211|42197131|FG000|Overall Study|Progressive Disease|10|||
19749139|NCT03708211|42197132|FG001|Overall Study|Progressive Disease|7|||
19749140|NCT03708211|42197131|FG000|Overall Study|Withdrawal by Subject|0|||
19749141|NCT03708211|42197132|FG001|Overall Study|Withdrawal by Subject|1|||
19749142|NCT03708211|42197131|FG000|Overall Study|Other|2|||
19749143|NCT03708211|42197132|FG001|Overall Study|Other|0|||
19749144|NCT02948634|42197142|FG000|Overall Study|Lack of efficacy and study suspended|10|||
19749145|NCT02948634|42197143|FG001|Overall Study|Lack of efficacy and study suspended|2|||
19749146|NCT02945046|42197152|FG000|Overall Study|Adverse Event|1|||
19749147|NCT02945046|42197153|FG001|Overall Study|Adverse Event|0|||
19749148|NCT02945046|42197154|FG002|Overall Study|Adverse Event|2|||
19749149|NCT02945046|42197152|FG000|Overall Study|Withdrawal by Subject|3|||
19749150|NCT02945046|42197153|FG001|Overall Study|Withdrawal by Subject|3|||
19749151|NCT02945046|42197154|FG002|Overall Study|Withdrawal by Subject|3|||
19642845|NCT00573430|42092325|FG001|Overall Study|Withdrawal by Subject|0|||
19642846|NCT00573430|42092326|FG002|Overall Study|Withdrawal by Subject|1|||
19642847|NCT00573430|42092324|FG000|Overall Study|Protocol Violation|0|||
19642848|NCT00573430|42092325|FG001|Overall Study|Protocol Violation|1|||
19642849|NCT00573430|42092326|FG002|Overall Study|Protocol Violation|1|||
19642850|NCT00573430|42092324|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19642851|NCT00573430|42092325|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19749152|NCT02945046|42197152|FG000|Overall Study|Protocol Violation|2|||
19749153|NCT02945046|42197153|FG001|Overall Study|Protocol Violation|3|||
19749154|NCT02945046|42197154|FG002|Overall Study|Protocol Violation|2|||
19749155|NCT02945046|42197152|FG000|Overall Study|Lost to Follow-up|1|||
19749156|NCT02945046|42197153|FG001|Overall Study|Lost to Follow-up|1|||
19749157|NCT02945046|42197154|FG002|Overall Study|Lost to Follow-up|0|||
19749158|NCT02945046|42197152|FG000|Overall Study|Lack of Efficacy|1|||
19749159|NCT02945046|42197153|FG001|Overall Study|Lack of Efficacy|2|||
19749160|NCT02945046|42197154|FG002|Overall Study|Lack of Efficacy|1|||
19749161|NCT02945046|42197152|FG000|Overall Study|Other than specified|5|||
19749162|NCT02945046|42197153|FG001|Overall Study|Other than specified|4|||
19749163|NCT02945046|42197154|FG002|Overall Study|Other than specified|7|||
19642852|NCT00573430|42092326|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
19749164|NCT03705793|42197164|FG000|Overall Study|Lost to Follow-up|3|||
19749165|NCT03705793|42197165|FG001|Overall Study|Lost to Follow-up|4|||
19749166|NCT03705793|42197164|FG000|Overall Study|Withdrawal by Subject|2|||
19749167|NCT03705793|42197165|FG001|Overall Study|Withdrawal by Subject|1|||
19749168|NCT02944968|42197184|FG000|Overall Study|Subject excluded before study procedure|1|||
19642853|NCT00711516|42092336|FG000|Overall Study|Adverse Event|1|||
19749169|NCT02944968|42197184|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
19749170|NCT03761797|42197188|FG000|Overall Study|Changing hospital|11|||
19749171|NCT03761797|42197188|FG000|Overall Study|Improvement/remission|6|||
19749172|NCT03761797|42197188|FG000|Overall Study|Withdrawal by Subject|19|||
19749173|NCT03761797|42197188|FG000|Overall Study|Lost to Follow-up|33|||
19749174|NCT03761797|42197188|FG000|Overall Study|Adverse Event|37|||
19749175|NCT03761797|42197188|FG000|Overall Study|Case report form (CRF) not collected|5|||
19749176|NCT03761797|42197188|FG000|Overall Study|No patient visit after entry|13|||
19749177|NCT03761797|42197188|FG000|Overall Study|Switch to other diabetes medication|10|||
19749178|NCT03761797|42197188|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
19749179|NCT03761797|42197188|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
19749180|NCT03761797|42197188|FG000|Overall Study|Insufficient effectives|2|||
19749181|NCT03761797|42197188|FG000|Overall Study|Excessive alcohol intake|1|||
19749182|NCT02944656|42197194|FG000|Overall Study|No longer eligible|3|||
19749183|NCT02944656|42197195|FG001|Overall Study|No longer eligible|0|||
19749184|NCT02944656|42197194|FG000|Overall Study|Lost to Follow-up|7|||
19749185|NCT02944656|42197195|FG001|Overall Study|Lost to Follow-up|10|||
19749186|NCT02713529|42197208|FG000|Overall Study|Withdrawal by Subject|3|||
19749187|NCT02713529|42197209|FG001|Overall Study|Withdrawal by Subject|1|||
19749188|NCT02713529|42197210|FG002|Overall Study|Withdrawal by Subject|4|||
19749189|NCT02713529|42197211|FG003|Overall Study|Withdrawal by Subject|2|||
19749190|NCT02713529|42197212|FG004|Overall Study|Withdrawal by Subject|0|||
19749191|NCT02713529|42197213|FG005|Overall Study|Withdrawal by Subject|1|||
19749192|NCT02713529|42197214|FG006|Overall Study|Withdrawal by Subject|1|||
19749193|NCT02713529|42197208|FG000|Overall Study|Lost to Follow-up|1|||
19749194|NCT02713529|42197209|FG001|Overall Study|Lost to Follow-up|0|||
19749195|NCT02713529|42197210|FG002|Overall Study|Lost to Follow-up|1|||
19749196|NCT02713529|42197211|FG003|Overall Study|Lost to Follow-up|0|||
19749197|NCT02713529|42197212|FG004|Overall Study|Lost to Follow-up|0|||
19749198|NCT02713529|42197213|FG005|Overall Study|Lost to Follow-up|0|||
19749199|NCT02713529|42197214|FG006|Overall Study|Lost to Follow-up|0|||
19749200|NCT02713529|42197208|FG000|Overall Study|Death|3|||
19749201|NCT02713529|42197209|FG001|Overall Study|Death|3|||
19749202|NCT02713529|42197210|FG002|Overall Study|Death|26|||
19749203|NCT02713529|42197211|FG003|Overall Study|Death|27|||
19749204|NCT02713529|42197212|FG004|Overall Study|Death|3|||
19749205|NCT02713529|42197213|FG005|Overall Study|Death|13|||
19749206|NCT02713529|42197214|FG006|Overall Study|Death|3|||
19600687|NCT00775450|42049594|FG004|Overall Study|Withdrawal by Subject|1|||
19600688|NCT00775138|42049610|FG000|Overall Study|Withdrawal by Subject|0|||
19600689|NCT00775138|42049611|FG001|Overall Study|Withdrawal by Subject|0|||
19600690|NCT00775138|42049612|FG002|Overall Study|Withdrawal by Subject|2|||
19600691|NCT00775138|42049613|FG003|Overall Study|Withdrawal by Subject|2|||
19600692|NCT00775138|42049610|FG000|Overall Study|Adverse Event|0|||
19600693|NCT00775138|42049611|FG001|Overall Study|Adverse Event|0|||
19600694|NCT00775138|42049612|FG002|Overall Study|Adverse Event|1|||
19600695|NCT00775138|42049613|FG003|Overall Study|Adverse Event|0|||
19600696|NCT04605991|42049625|FG000|Overall Study|Adverse Event|5|||
19642854|NCT00711516|42092337|FG001|Overall Study|Adverse Event|1|||
19642855|NCT00711516|42092336|FG000|Overall Study|Withdrawal by Subject|0|||
19642856|NCT00711516|42092337|FG001|Overall Study|Withdrawal by Subject|1|||
19749207|NCT03707821|42197240|FG000|Overall Study|Protocol Violation|0|||
19749208|NCT03707821|42197241|FG001|Overall Study|Protocol Violation|1|||
19749209|NCT03707821|42197240|FG000|Overall Study|Unsatisfactory Visual Response|1|||
19749210|NCT03707821|42197241|FG001|Overall Study|Unsatisfactory Visual Response|0|||
19749211|NCT03707821|42197240|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
19749212|NCT03707821|42197241|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
19749213|NCT04546581|42197249|FG000|Overall Study|Adverse Event|9|||
19749214|NCT04546581|42197250|FG001|Overall Study|Adverse Event|3|||
19749215|NCT04546581|42197249|FG000|Overall Study|Physician Decision|0|||
19600697|NCT04605991|42049625|FG000|Overall Study|Lack of Efficacy|1|||
19642857|NCT00711516|42092336|FG000|Overall Study|Protocol Violation|0|||
19642858|NCT00711516|42092337|FG001|Overall Study|Protocol Violation|1|||
19642859|NCT00615550|42092345|FG000|Overall Study|Lost to Follow-up|6|||
19642860|NCT00615550|42092346|FG001|Overall Study|Lost to Follow-up|1|||
19600698|NCT04605991|42049625|FG000|Overall Study|Lost to Follow-up|8|||
19600699|NCT04605991|42049625|FG000|Overall Study|Physician Decision|4|||
19600700|NCT04605991|42049625|FG000|Overall Study|Withdrawal by Subject|14|||
19600701|NCT04605991|42049625|FG000|Overall Study|Non-compliance with study|1|||
19642861|NCT00186888|42092355|FG000|Overall Study|Toxicity|0|||
19749216|NCT04546581|42197250|FG001|Overall Study|Physician Decision|1|||
19749217|NCT04546581|42197249|FG000|Overall Study|Protocol Violation|1|||
19600702|NCT00783796|42049629|FG000|Overall Study|Did not receive any stent|4|||
19600703|NCT00783796|42049629|FG000|Overall Study|Received non-XIENCE V stent|1|||
19600704|NCT00783796|42049629|FG000|Overall Study|Received commercial XIENCE V stent|1|||
19600705|NCT00783718|42049638|FG000|Induction Phase|Adverse Event|4|||
19642862|NCT00186888|42092356|FG001|Overall Study|Toxicity|1|||
19749218|NCT04546581|42197250|FG001|Overall Study|Protocol Violation|2|||
19749219|NCT04546581|42197249|FG000|Overall Study|Withdrawal by Subject|3|||
19600706|NCT00783718|42049639|FG001|Induction Phase|Adverse Event|0|||
19600707|NCT00783718|42049640|FG002|Induction Phase|Adverse Event|7|||
19600708|NCT00783718|42049641|FG003|Induction Phase|Adverse Event|0|||
19600709|NCT00783718|42049642|FG004|Induction Phase|Adverse Event|0|||
19600710|NCT00783718|42049643|FG005|Induction Phase|Adverse Event|0|||
19600711|NCT00783718|42049644|FG006|Induction Phase|Adverse Event|0|||
19600712|NCT00783718|42049638|FG000|Induction Phase|Protocol Violation|1|||
19600713|NCT00783718|42049639|FG001|Induction Phase|Protocol Violation|1|||
19600714|NCT00783718|42049640|FG002|Induction Phase|Protocol Violation|6|||
19600715|NCT00783718|42049641|FG003|Induction Phase|Protocol Violation|0|||
19600716|NCT00783718|42049642|FG004|Induction Phase|Protocol Violation|0|||
19600717|NCT00783718|42049643|FG005|Induction Phase|Protocol Violation|0|||
19600718|NCT00783718|42049644|FG006|Induction Phase|Protocol Violation|0|||
19600719|NCT00783718|42049638|FG000|Induction Phase|Lack of Efficacy|5|||
19600720|NCT00783718|42049639|FG001|Induction Phase|Lack of Efficacy|2|||
19600721|NCT00783718|42049640|FG002|Induction Phase|Lack of Efficacy|14|||
19600722|NCT00783718|42049641|FG003|Induction Phase|Lack of Efficacy|0|||
19600723|NCT00783718|42049642|FG004|Induction Phase|Lack of Efficacy|0|||
19600724|NCT00783718|42049643|FG005|Induction Phase|Lack of Efficacy|0|||
19600725|NCT00783718|42049644|FG006|Induction Phase|Lack of Efficacy|0|||
19600726|NCT00783718|42049638|FG000|Induction Phase|Withdrawal by Subject|3|||
19642863|NCT00186888|42092357|FG002|Overall Study|Toxicity|0|||
19642864|NCT00186888|42092355|FG000|Overall Study|Relapse or progression of disease|4|||
19642865|NCT00186888|42092356|FG001|Overall Study|Relapse or progression of disease|2|||
19642866|NCT00186888|42092357|FG002|Overall Study|Relapse or progression of disease|0|||
19642867|NCT00577382|42092394|FG000|Overall Study|Adverse Event|0|||
19642868|NCT00577382|42092395|FG001|Overall Study|Adverse Event|6|||
19749220|NCT04546581|42197250|FG001|Overall Study|Withdrawal by Subject|7|||
19749221|NCT03707587|42197258|FG000|Overall Study|Death|0|||
19749222|NCT03707587|42197259|FG001|Overall Study|Death|1|||
19600727|NCT00783718|42049639|FG001|Induction Phase|Withdrawal by Subject|4|||
19600728|NCT00783718|42049640|FG002|Induction Phase|Withdrawal by Subject|8|||
19642869|NCT00577382|42092394|FG000|Overall Study|Withdrawal by Subject|0|||
19642870|NCT00577382|42092395|FG001|Overall Study|Withdrawal by Subject|1|||
19642871|NCT00577382|42092394|FG000|Overall Study|Progressive Disease|17|||
19642872|NCT00577382|42092395|FG001|Overall Study|Progressive Disease|19|||
19642873|NCT00577382|42092394|FG000|Overall Study|Intercurrent Illness|1|||
19642874|NCT00577382|42092395|FG001|Overall Study|Intercurrent Illness|2|||
19642875|NCT00577382|42092394|FG000|Overall Study|Death|1|||
19642876|NCT00577382|42092395|FG001|Overall Study|Death|1|||
19642877|NCT00577382|42092394|FG000|Overall Study|Lost to Follow-up|2|||
19642878|NCT00577382|42092395|FG001|Overall Study|Lost to Follow-up|2|||
19642879|NCT00614926|42092403|FG000|Overall Study|Burden of travel|1|||
19642880|NCT00614926|42092404|FG001|Overall Study|Burden of travel|0|||
19642881|NCT00614926|42092403|FG000|Overall Study|Adverse Event|3|||
19642882|NCT00614926|42092404|FG001|Overall Study|Adverse Event|0|||
19642883|NCT00423319|42092417|FG000|Overall Study|Death|2|||
19642884|NCT00423319|42092418|FG001|Overall Study|Death|0|||
19642885|NCT00423319|42092417|FG000|Overall Study|Adverse Event|93|||
19642886|NCT00423319|42092418|FG001|Overall Study|Adverse Event|112|||
19642887|NCT00423319|42092417|FG000|Overall Study|Withdrawal by Subject|86|||
19642888|NCT00423319|42092418|FG001|Overall Study|Withdrawal by Subject|99|||
19642889|NCT00423319|42092417|FG000|Overall Study|Lost to Follow-up|4|||
19642890|NCT00423319|42092418|FG001|Overall Study|Lost to Follow-up|3|||
19642891|NCT00423319|42092417|FG000|Overall Study|Poor compliance or noncompliance|1|||
19642892|NCT00423319|42092418|FG001|Overall Study|Poor compliance or noncompliance|1|||
19642893|NCT00423319|42092417|FG000|Overall Study|No longer meets study criteria|15|||
19642894|NCT00423319|42092418|FG001|Overall Study|No longer meets study criteria|15|||
19642895|NCT00423319|42092417|FG000|Overall Study|Other|23|||
19642896|NCT00423319|42092418|FG001|Overall Study|Other|22|||
19642897|NCT00710684|42092428|FG000|Overall Study|Adverse Event|11|||
19642898|NCT00710684|42092429|FG001|Overall Study|Adverse Event|19|||
19642899|NCT00710684|42092430|FG002|Overall Study|Adverse Event|16|||
19642900|NCT00710684|42092428|FG000|Overall Study|Lack of Efficacy|4|||
19642901|NCT00710684|42092429|FG001|Overall Study|Lack of Efficacy|3|||
19642902|NCT00710684|42092430|FG002|Overall Study|Lack of Efficacy|5|||
19642903|NCT00710684|42092428|FG000|Overall Study|Protocol Violation|5|||
19600729|NCT00783718|42049641|FG003|Induction Phase|Withdrawal by Subject|0|||
19600730|NCT00783718|42049642|FG004|Induction Phase|Withdrawal by Subject|0|||
19600731|NCT00783718|42049643|FG005|Induction Phase|Withdrawal by Subject|0|||
19600732|NCT00783718|42049644|FG006|Induction Phase|Withdrawal by Subject|0|||
19642904|NCT00710684|42092429|FG001|Overall Study|Protocol Violation|5|||
19642905|NCT00710684|42092430|FG002|Overall Study|Protocol Violation|5|||
19642906|NCT00710684|42092428|FG000|Overall Study|Lost to Follow-up|4|||
19642907|NCT00710684|42092429|FG001|Overall Study|Lost to Follow-up|6|||
19642908|NCT00710684|42092430|FG002|Overall Study|Lost to Follow-up|7|||
19642909|NCT00710684|42092428|FG000|Overall Study|Physician Decision|0|||
19642910|NCT00710684|42092429|FG001|Overall Study|Physician Decision|2|||
19642911|NCT00710684|42092430|FG002|Overall Study|Physician Decision|4|||
19642912|NCT00710684|42092428|FG000|Overall Study|Withdrawal by Subject|24|||
19642913|NCT00710684|42092429|FG001|Overall Study|Withdrawal by Subject|18|||
19642914|NCT00710684|42092430|FG002|Overall Study|Withdrawal by Subject|11|||
19642915|NCT00710684|42092428|FG000|Overall Study|Missing|1|||
19642916|NCT00710684|42092429|FG001|Overall Study|Missing|0|||
19642917|NCT00710684|42092430|FG002|Overall Study|Missing|0|||
19642918|NCT00710684|42092428|FG000|Overall Study|Did not continue after week 24|25|||
19642919|NCT00710684|42092429|FG001|Overall Study|Did not continue after week 24|21|||
19642920|NCT00710684|42092430|FG002|Overall Study|Did not continue after week 24|16|||
19642921|NCT00710606|42092446|FG000|Overall Study|Adverse Event|0|||
19642922|NCT00710606|42092447|FG001|Overall Study|Adverse Event|2|||
19642923|NCT00713544|42092461|FG000|Overall Study|Adverse Event|5|||
19642924|NCT00713544|42092462|FG001|Overall Study|Adverse Event|3|||
19642925|NCT00713544|42092463|FG002|Overall Study|Adverse Event|7|||
19642926|NCT00713544|42092464|FG003|Overall Study|Adverse Event|7|||
19642927|NCT00713544|42092465|FG004|Overall Study|Adverse Event|3|||
19642928|NCT00713544|42092466|FG005|Overall Study|Adverse Event|5|||
19642929|NCT00713544|42092461|FG000|Overall Study|Withdrawal by Subject|2|||
19642930|NCT00713544|42092462|FG001|Overall Study|Withdrawal by Subject|0|||
19642931|NCT00713544|42092463|FG002|Overall Study|Withdrawal by Subject|3|||
19642932|NCT00713544|42092464|FG003|Overall Study|Withdrawal by Subject|2|||
19642933|NCT00713544|42092465|FG004|Overall Study|Withdrawal by Subject|3|||
19642934|NCT00713544|42092466|FG005|Overall Study|Withdrawal by Subject|1|||
19642935|NCT00713544|42092461|FG000|Overall Study|Protocol Violation|0|||
19642936|NCT00713544|42092462|FG001|Overall Study|Protocol Violation|0|||
19642937|NCT00713544|42092463|FG002|Overall Study|Protocol Violation|0|||
19642938|NCT00713544|42092464|FG003|Overall Study|Protocol Violation|0|||
19642939|NCT00713544|42092465|FG004|Overall Study|Protocol Violation|0|||
19642940|NCT00713544|42092466|FG005|Overall Study|Protocol Violation|1|||
19642941|NCT00713544|42092461|FG000|Overall Study|Physician Decision|0|||
19642942|NCT00713544|42092462|FG001|Overall Study|Physician Decision|0|||
19642943|NCT00713544|42092463|FG002|Overall Study|Physician Decision|0|||
19642944|NCT00713544|42092464|FG003|Overall Study|Physician Decision|0|||
19642945|NCT00713544|42092465|FG004|Overall Study|Physician Decision|0|||
19642946|NCT00713544|42092466|FG005|Overall Study|Physician Decision|2|||
19642947|NCT00713544|42092461|FG000|Overall Study|Lack of Efficacy|0|||
19642948|NCT00713544|42092462|FG001|Overall Study|Lack of Efficacy|1|||
19642949|NCT00713544|42092463|FG002|Overall Study|Lack of Efficacy|0|||
19642950|NCT00713544|42092464|FG003|Overall Study|Lack of Efficacy|1|||
19642951|NCT00713544|42092465|FG004|Overall Study|Lack of Efficacy|1|||
19600733|NCT00783718|42049638|FG000|Induction Phase|Lost to Follow-up|1|||
19600734|NCT00783718|42049639|FG001|Induction Phase|Lost to Follow-up|0|||
19600735|NCT00783718|42049640|FG002|Induction Phase|Lost to Follow-up|1|||
19600736|NCT00783718|42049641|FG003|Induction Phase|Lost to Follow-up|0|||
19600737|NCT00783718|42049642|FG004|Induction Phase|Lost to Follow-up|0|||
19600738|NCT00783718|42049643|FG005|Induction Phase|Lost to Follow-up|0|||
19600739|NCT00783718|42049644|FG006|Induction Phase|Lost to Follow-up|0|||
19600740|NCT00783718|42049638|FG000|Maintenance Phase|Adverse Event|12|||
19600741|NCT00783718|42049639|FG001|Maintenance Phase|Adverse Event|0|||
19600742|NCT00783718|42049640|FG002|Maintenance Phase|Adverse Event|0|||
19600743|NCT00783718|42049641|FG003|Maintenance Phase|Adverse Event|15|||
19600744|NCT00783718|42049642|FG004|Maintenance Phase|Adverse Event|7|||
19600745|NCT00783718|42049643|FG005|Maintenance Phase|Adverse Event|6|||
19600746|NCT00783718|42049644|FG006|Maintenance Phase|Adverse Event|16|||
19600747|NCT00783718|42049638|FG000|Maintenance Phase|Protocol Violation|1|||
19600748|NCT00783718|42049639|FG001|Maintenance Phase|Protocol Violation|0|||
19600749|NCT00783718|42049640|FG002|Maintenance Phase|Protocol Violation|0|||
19600750|NCT00783718|42049641|FG003|Maintenance Phase|Protocol Violation|0|||
19600751|NCT00783718|42049642|FG004|Maintenance Phase|Protocol Violation|0|||
19600752|NCT00783718|42049643|FG005|Maintenance Phase|Protocol Violation|0|||
19600753|NCT00783718|42049644|FG006|Maintenance Phase|Protocol Violation|2|||
19600754|NCT00783718|42049638|FG000|Maintenance Phase|Lack of Efficacy|83|||
19600755|NCT00783718|42049639|FG001|Maintenance Phase|Lack of Efficacy|0|||
19600756|NCT00783718|42049640|FG002|Maintenance Phase|Lack of Efficacy|0|||
19600757|NCT00783718|42049641|FG003|Maintenance Phase|Lack of Efficacy|61|||
19600758|NCT00783718|42049642|FG004|Maintenance Phase|Lack of Efficacy|31|||
19600759|NCT00783718|42049643|FG005|Maintenance Phase|Lack of Efficacy|33|||
19600760|NCT00783718|42049644|FG006|Maintenance Phase|Lack of Efficacy|155|||
19600761|NCT00783718|42049638|FG000|Maintenance Phase|Withdrawal by Subject|6|||
19600762|NCT00783718|42049639|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19642952|NCT00713544|42092466|FG005|Overall Study|Lack of Efficacy|0|||
19600763|NCT00783718|42049640|FG002|Maintenance Phase|Withdrawal by Subject|0|||
19600764|NCT00783718|42049641|FG003|Maintenance Phase|Withdrawal by Subject|2|||
19600765|NCT00783718|42049642|FG004|Maintenance Phase|Withdrawal by Subject|5|||
19642953|NCT00713544|42092461|FG000|Overall Study|Lost to Follow-up|0|||
19642954|NCT00713544|42092462|FG001|Overall Study|Lost to Follow-up|0|||
19642955|NCT00713544|42092463|FG002|Overall Study|Lost to Follow-up|1|||
19642956|NCT00713544|42092464|FG003|Overall Study|Lost to Follow-up|0|||
19642957|NCT00713544|42092465|FG004|Overall Study|Lost to Follow-up|0|||
19642958|NCT00713544|42092466|FG005|Overall Study|Lost to Follow-up|0|||
19642959|NCT00713544|42092461|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
19642960|NCT00713544|42092462|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
19642961|NCT00713544|42092463|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
19642962|NCT00713544|42092464|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
19749223|NCT03312933|42197265|FG000|Overall Study|Protocol Violation|15|||
19749224|NCT03312933|42197265|FG000|Overall Study|Lost to Follow-up|36|||
19642963|NCT00713544|42092465|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
19642964|NCT00713544|42092466|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
19642965|NCT00713544|42092461|FG000|Overall Study|Incorrect enrollment|0|||
19642966|NCT00713544|42092462|FG001|Overall Study|Incorrect enrollment|1|||
19642967|NCT00713544|42092463|FG002|Overall Study|Incorrect enrollment|0|||
19642968|NCT00713544|42092464|FG003|Overall Study|Incorrect enrollment|0|||
19642969|NCT00713544|42092465|FG004|Overall Study|Incorrect enrollment|0|||
19642970|NCT00713544|42092466|FG005|Overall Study|Incorrect enrollment|0|||
19749225|NCT03312933|42197265|FG000|Overall Study|Withdrawal by Subject|3|||
19749226|NCT02561273|42197271|FG000|Overall Study|Protocol Violation|1|||
19749227|NCT02561273|42197272|FG001|Overall Study|Protocol Violation|0|||
19749228|NCT03312543|42197282|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
19642971|NCT00713544|42092461|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
19642972|NCT00713544|42092462|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
19642973|NCT00713544|42092463|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
19642974|NCT00713544|42092464|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
19749229|NCT03312543|42197283|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
19749230|NCT03312543|42197282|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
19749231|NCT03312543|42197283|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
19749232|NCT03312543|42197282|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
19749233|NCT03312543|42197283|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
19749234|NCT03312543|42197282|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
19642975|NCT00713544|42092465|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
19642976|NCT00713544|42092466|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
19642977|NCT00415363|42092482|FG000|Overall Study|Withdrawal by Subject|4|||
19642978|NCT00415363|42092483|FG001|Overall Study|Withdrawal by Subject|4|||
19642979|NCT00415363|42092482|FG000|Overall Study|Adverse Event|4|||
19749235|NCT03312543|42197283|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
19749236|NCT03312543|42197282|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
19749237|NCT03312543|42197283|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
19749238|NCT03312543|42197282|FG000|Regression (Week 12 to Week 24)|Death|0|||
19749239|NCT03312543|42197283|FG001|Regression (Week 12 to Week 24)|Death|1|||
19749240|NCT02392559|42197291|FG000|Overall Study|Withdrawal by Subject|0|||
19749241|NCT02392559|42197292|FG001|Overall Study|Withdrawal by Subject|1|||
19749242|NCT03332589|42197306|FG000|Overall Study|Lack of Efficacy|2|||
19749243|NCT03332589|42197307|FG001|Overall Study|Lack of Efficacy|0|||
19749244|NCT03332589|42197308|FG002|Overall Study|Lack of Efficacy|0|||
19749245|NCT03332589|42197306|FG000|Overall Study|Adverse Event|1|||
19642980|NCT00415363|42092483|FG001|Overall Study|Adverse Event|4|||
19642981|NCT00415363|42092482|FG000|Overall Study|Lost to Follow-up|2|||
19642982|NCT00415363|42092483|FG001|Overall Study|Lost to Follow-up|1|||
19749246|NCT03332589|42197307|FG001|Overall Study|Adverse Event|0|||
19749247|NCT03332589|42197308|FG002|Overall Study|Adverse Event|0|||
19749248|NCT03332589|42197306|FG000|Overall Study|Death|1|||
19749249|NCT03332589|42197307|FG001|Overall Study|Death|0|||
19749250|NCT03332589|42197308|FG002|Overall Study|Death|0|||
19749251|NCT00458003|42197318|FG000|Overall Study|Non protocol spinal anesthesia|1|||
19749252|NCT00458003|42197319|FG001|Overall Study|Non protocol spinal anesthesia|1|||
19749253|NCT02061293|42197329|FG000|Overall Study|Elevated Blood Pressure|1|||
19749254|NCT02061293|42197330|FG001|Overall Study|Elevated Blood Pressure|1|||
19749255|NCT02913612|42197340|FG000|Overall Study|Lost to Follow-up|6|||
19749256|NCT02913612|42197341|FG001|Overall Study|Lost to Follow-up|5|||
19749257|NCT02913612|42197342|FG002|Overall Study|Lost to Follow-up|2|||
19642983|NCT00415363|42092482|FG000|Overall Study|Physician Decision|3|||
19642984|NCT00415363|42092483|FG001|Overall Study|Physician Decision|1|||
19642985|NCT00415363|42092482|FG000|Overall Study|Death|16|||
19642986|NCT00415363|42092483|FG001|Overall Study|Death|12|||
19642987|NCT00415363|42092482|FG000|Overall Study|Progressive disease|26|||
19642988|NCT00415363|42092483|FG001|Overall Study|Progressive disease|32|||
19642989|NCT00415051|42092490|FG000|Overall Study|Protocol Violation|1|||
19642990|NCT00713258|42092496|FG000|Overall Study|Adverse Event|2|||
19642991|NCT00713258|42092497|FG001|Overall Study|Adverse Event|4|||
19642992|NCT00713258|42092496|FG000|Overall Study|Non-Compliance|2|||
19642993|NCT00713258|42092497|FG001|Overall Study|Non-Compliance|1|||
19642994|NCT00713258|42092496|FG000|Overall Study|Other|1|||
19642995|NCT00713258|42092497|FG001|Overall Study|Other|1|||
19642996|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
19642997|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
19642998|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
19642999|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
19643000|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
19643001|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
19643002|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
19643003|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
19643004|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
19643005|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
19643006|NCT00710034|42092505|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
19643007|NCT00710034|42092506|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
19643008|NCT00710034|42092505|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
19643009|NCT00710034|42092506|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
19643010|NCT00710034|42092505|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
19643011|NCT00710034|42092506|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
19643012|NCT00710034|42092505|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
19643013|NCT00710034|42092506|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
19643014|NCT00710034|42092505|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
19643015|NCT00710034|42092506|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
19643016|NCT00710034|42092505|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
19643017|NCT00710034|42092506|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
19643018|NCT00414973|42092516|FG000|Overall Study|Withdrawal by Subject|14|||
19643019|NCT00414973|42092517|FG001|Overall Study|Withdrawal by Subject|4|||
19643020|NCT00414973|42092518|FG002|Overall Study|Withdrawal by Subject|1|||
19643021|NCT00414973|42092519|FG003|Overall Study|Withdrawal by Subject|0|||
19643022|NCT00414973|42092516|FG000|Overall Study|Adverse Event|10|||
19643023|NCT00414973|42092517|FG001|Overall Study|Adverse Event|0|||
19643024|NCT00414973|42092518|FG002|Overall Study|Adverse Event|1|||
19643025|NCT00414973|42092519|FG003|Overall Study|Adverse Event|0|||
19643026|NCT00414973|42092516|FG000|Overall Study|Protocol Violation|3|||
19643027|NCT00414973|42092517|FG001|Overall Study|Protocol Violation|4|||
19643028|NCT00414973|42092518|FG002|Overall Study|Protocol Violation|0|||
19643029|NCT00414973|42092519|FG003|Overall Study|Protocol Violation|0|||
19643030|NCT00414973|42092516|FG000|Overall Study|Lost to Follow-up|0|||
19643031|NCT00414973|42092517|FG001|Overall Study|Lost to Follow-up|2|||
19643032|NCT00414973|42092518|FG002|Overall Study|Lost to Follow-up|0|||
19643033|NCT00414973|42092519|FG003|Overall Study|Lost to Follow-up|0|||
19643034|NCT00414973|42092516|FG000|Overall Study|Sponsor Decision|1|||
19643035|NCT00414973|42092517|FG001|Overall Study|Sponsor Decision|0|||
19749258|NCT02913612|42197343|FG003|Overall Study|Lost to Follow-up|0|||
19749259|NCT02913612|42197340|FG000|Overall Study|Physician Decision|1|||
19643036|NCT00414973|42092518|FG002|Overall Study|Sponsor Decision|0|||
19643037|NCT00414973|42092519|FG003|Overall Study|Sponsor Decision|0|||
19643038|NCT00414973|42092516|FG000|Overall Study|Death|0|||
19643039|NCT00414973|42092517|FG001|Overall Study|Death|0|||
19643040|NCT00414973|42092518|FG002|Overall Study|Death|1|||
19643041|NCT00414973|42092519|FG003|Overall Study|Death|0|||
19643042|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
19749260|NCT02913612|42197341|FG001|Overall Study|Physician Decision|4|||
19643043|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
19643044|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
19643045|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
19643046|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
19643047|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
19643048|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
19643049|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19643050|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
19643051|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
19643052|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
19643053|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
19643054|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
19643055|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
19643056|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
19643057|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
19643058|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
19643059|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
19643060|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
19643061|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
19643062|NCT00423085|42092532|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
19643063|NCT00423085|42092533|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
19643064|NCT00423085|42092534|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
19643065|NCT00423085|42092535|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
19643066|NCT00423085|42092532|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
19643067|NCT00423085|42092533|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
19643068|NCT00423085|42092534|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
19643069|NCT00423085|42092535|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
19643070|NCT00423085|42092532|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
19643071|NCT00423085|42092533|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
19643072|NCT00423085|42092534|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
19643073|NCT00423085|42092535|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
19643074|NCT00423085|42092532|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
19643075|NCT00423085|42092533|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
19643076|NCT00423085|42092534|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
19643077|NCT00423085|42092535|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
19643078|NCT00423085|42092532|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
19643079|NCT00423085|42092533|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
19643080|NCT00423085|42092534|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
19643081|NCT00423085|42092535|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
19643082|NCT00423085|42092532|FG000|52-Week Open-Label Extension Phase|Death|0|||
19643083|NCT00423085|42092533|FG001|52-Week Open-Label Extension Phase|Death|0|||
19643084|NCT00423085|42092534|FG002|52-Week Open-Label Extension Phase|Death|0|||
19643085|NCT00423085|42092535|FG003|52-Week Open-Label Extension Phase|Death|2|||
19643086|NCT00414661|42092549|FG000|Overall Study|Death|2|||
19643087|NCT00414661|42092550|FG001|Overall Study|Death|5|||
19643088|NCT00414661|42092551|FG002|Overall Study|Death|0|||
19643089|NCT00414661|42092552|FG003|Overall Study|Death|0|||
19643090|NCT00414661|42092549|FG000|Overall Study|Lost to Follow-up|1|||
19643091|NCT00414661|42092550|FG001|Overall Study|Lost to Follow-up|4|||
19643092|NCT00414661|42092551|FG002|Overall Study|Lost to Follow-up|0|||
19643093|NCT00414661|42092552|FG003|Overall Study|Lost to Follow-up|1|||
19643094|NCT00414661|42092549|FG000|Overall Study|Withdrawal by Subject|5|||
19643095|NCT00414661|42092550|FG001|Overall Study|Withdrawal by Subject|2|||
19643096|NCT00414661|42092551|FG002|Overall Study|Withdrawal by Subject|2|||
19643097|NCT00414661|42092552|FG003|Overall Study|Withdrawal by Subject|2|||
19643098|NCT00414661|42092549|FG000|Overall Study|Other|6|||
19643099|NCT00414661|42092550|FG001|Overall Study|Other|3|||
19643100|NCT00414661|42092551|FG002|Overall Study|Other|0|||
19643101|NCT00414661|42092552|FG003|Overall Study|Other|0|||
19643102|NCT00405067|42092565|FG000|Overall Study|Adverse Event|4|||
19643103|NCT00405067|42092566|FG001|Overall Study|Adverse Event|9|||
19643104|NCT00405067|42092567|FG002|Overall Study|Adverse Event|4|||
19643105|NCT00405067|42092565|FG000|Overall Study|Lost to Follow-up|0|||
19643106|NCT00405067|42092566|FG001|Overall Study|Lost to Follow-up|0|||
19749261|NCT02913612|42197342|FG002|Overall Study|Physician Decision|1|||
19749262|NCT02913612|42197343|FG003|Overall Study|Physician Decision|0|||
19749263|NCT02913612|42197340|FG000|Overall Study|Withdrawal by Subject|2|||
19643107|NCT00405067|42092567|FG002|Overall Study|Lost to Follow-up|1|||
19643108|NCT00708708|42092575|FG000|Overall Study|Another therapy instead of Enbrel|141|||
19643109|NCT00708708|42092575|FG000|Overall Study|Lost to Follow-up|52|||
19643110|NCT00708708|42092575|FG000|Overall Study|Withdrawal by Subject|51|||
19643111|NCT00708708|42092575|FG000|Overall Study|Intolerance|42|||
19643112|NCT00708708|42092575|FG000|Overall Study|Another therapy along with Enbrel|15|||
19643113|NCT00708708|42092575|FG000|Overall Study|Other unspecified|11|||
19643114|NCT00708708|42092575|FG000|Overall Study|Good effectiveness|9|||
19643115|NCT00708708|42092575|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
19643116|NCT00708708|42092575|FG000|Overall Study|Administrative reasons|7|||
19643117|NCT00708708|42092575|FG000|Overall Study|Lack of effectiveness|4|||
19643118|NCT00708708|42092575|FG000|Overall Study|Lack of compliance|3|||
19643119|NCT00708708|42092575|FG000|Overall Study|Pregnancy|3|||
19643120|NCT00708708|42092575|FG000|Overall Study|Adverse Event|3|||
19643121|NCT00708708|42092575|FG000|Overall Study|Missing values|392|||
19643122|NCT00404755|42092582|FG000|Phase I (Bupropion)|Adverse Event|3|||
19643123|NCT00404755|42092582|FG000|Phase I (Bupropion)|Other|1|||
19643124|NCT00404755|42092582|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
19643125|NCT00614614|42092592|FG000|Primary Vaccination Phase|Adverse Event|6|||
19643126|NCT00614614|42092593|FG001|Primary Vaccination Phase|Adverse Event|0|||
19643127|NCT00614614|42092594|FG002|Primary Vaccination Phase|Adverse Event|0|||
19643128|NCT00614614|42092595|FG003|Primary Vaccination Phase|Adverse Event|0|||
19643129|NCT00614614|42092596|FG004|Primary Vaccination Phase|Adverse Event|0|||
19643130|NCT00614614|42092592|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
19643131|NCT00614614|42092593|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
19643132|NCT00614614|42092594|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
19643133|NCT00614614|42092595|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
19643134|NCT00614614|42092596|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
19643135|NCT00614614|42092592|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
19643136|NCT00614614|42092593|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
19643137|NCT00614614|42092594|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
19643138|NCT00614614|42092595|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
19643139|NCT00614614|42092596|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
19643140|NCT00614614|42092592|FG000|Primary Vaccination Phase|Protocol Violation|9|||
19643141|NCT00614614|42092593|FG001|Primary Vaccination Phase|Protocol Violation|3|||
19643142|NCT00614614|42092594|FG002|Primary Vaccination Phase|Protocol Violation|0|||
19643143|NCT00614614|42092595|FG003|Primary Vaccination Phase|Protocol Violation|0|||
19643144|NCT00614614|42092596|FG004|Primary Vaccination Phase|Protocol Violation|0|||
19643145|NCT00614614|42092592|FG000|Primary Vaccination Phase|Other|4|||
19643146|NCT00614614|42092593|FG001|Primary Vaccination Phase|Other|0|||
19643147|NCT00614614|42092594|FG002|Primary Vaccination Phase|Other|0|||
19643148|NCT00614614|42092595|FG003|Primary Vaccination Phase|Other|0|||
19643149|NCT00614614|42092596|FG004|Primary Vaccination Phase|Other|0|||
19643150|NCT00614614|42092592|FG000|Booster Vaccination Phase|Adverse Event|0|||
19643151|NCT00614614|42092593|FG001|Booster Vaccination Phase|Adverse Event|0|||
19643152|NCT00614614|42092594|FG002|Booster Vaccination Phase|Adverse Event|1|||
19643153|NCT00614614|42092595|FG003|Booster Vaccination Phase|Adverse Event|1|||
19643154|NCT00614614|42092596|FG004|Booster Vaccination Phase|Adverse Event|0|||
19643155|NCT00614614|42092592|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
19643156|NCT00614614|42092593|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
19643157|NCT00614614|42092594|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
19643158|NCT00614614|42092595|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
19643159|NCT00614614|42092596|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
19643160|NCT00614614|42092592|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
19643161|NCT00614614|42092593|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
19643162|NCT00614614|42092594|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
19643163|NCT00614614|42092595|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
19643164|NCT00614614|42092596|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
19643165|NCT00614614|42092592|FG000|Booster Vaccination Phase|Protocol Violation|0|||
19643166|NCT00614614|42092593|FG001|Booster Vaccination Phase|Protocol Violation|0|||
19643167|NCT00614614|42092594|FG002|Booster Vaccination Phase|Protocol Violation|2|||
19643168|NCT00614614|42092595|FG003|Booster Vaccination Phase|Protocol Violation|3|||
19643169|NCT00614614|42092596|FG004|Booster Vaccination Phase|Protocol Violation|0|||
19643170|NCT00614614|42092592|FG000|Booster Vaccination Phase|Other|0|||
19643171|NCT00614614|42092593|FG001|Booster Vaccination Phase|Other|1|||
19643172|NCT00614614|42092594|FG002|Booster Vaccination Phase|Other|3|||
19643173|NCT00614614|42092595|FG003|Booster Vaccination Phase|Other|2|||
19643174|NCT00614614|42092596|FG004|Booster Vaccination Phase|Other|1|||
19643175|NCT00713310|42092613|FG000|Overall Study|Adverse Event|5|||
19643176|NCT00713310|42092614|FG001|Overall Study|Adverse Event|2|||
19643177|NCT00713310|42092613|FG000|Overall Study|Lack of Efficacy|0|||
19643178|NCT00713310|42092614|FG001|Overall Study|Lack of Efficacy|2|||
19643179|NCT00713310|42092613|FG000|Overall Study|Withdrawal by Subject|0|||
19643180|NCT00713310|42092614|FG001|Overall Study|Withdrawal by Subject|2|||
19643181|NCT00422461|42092624|FG000|Overall Study|Adverse Event|1|||
19643182|NCT00422461|42092625|FG001|Overall Study|Adverse Event|2|||
19643183|NCT00422461|42092626|FG002|Overall Study|Adverse Event|1|||
19643184|NCT00422461|42092627|FG003|Overall Study|Adverse Event|1|||
19643185|NCT00422461|42092624|FG000|Overall Study|Other|0|||
19643186|NCT00422461|42092625|FG001|Overall Study|Other|0|||
19643187|NCT00422461|42092626|FG002|Overall Study|Other|0|||
19643188|NCT00422461|42092627|FG003|Overall Study|Other|2|||
19643189|NCT00422461|42092624|FG000|Overall Study|Participants no longer willing to participate in study|1|||
19643190|NCT00422461|42092625|FG001|Overall Study|Participants no longer willing to participate in study|0|||
19643191|NCT00422461|42092626|FG002|Overall Study|Participants no longer willing to participate in study|0|||
19643192|NCT00422461|42092627|FG003|Overall Study|Participants no longer willing to participate in study|0|||
19643193|NCT00422461|42092624|FG000|Overall Study|Randomized but not treated|1|||
19643194|NCT00422461|42092625|FG001|Overall Study|Randomized but not treated|1|||
19643195|NCT00422461|42092626|FG002|Overall Study|Randomized but not treated|0|||
19643196|NCT00422461|42092627|FG003|Overall Study|Randomized but not treated|0|||
19643197|NCT00712920|42092640|FG000|Overall Study|Adverse Event|3|||
19643198|NCT00712920|42092641|FG001|Overall Study|Adverse Event|4|||
19643199|NCT00712920|42092642|FG002|Overall Study|Adverse Event|7|||
19643200|NCT00712920|42092640|FG000|Overall Study|Withdrawal by Subject|4|||
19643201|NCT00712920|42092641|FG001|Overall Study|Withdrawal by Subject|2|||
19643202|NCT00712920|42092642|FG002|Overall Study|Withdrawal by Subject|1|||
19643203|NCT00712920|42092640|FG000|Overall Study|Lost to Follow-up|1|||
19643204|NCT00712920|42092641|FG001|Overall Study|Lost to Follow-up|4|||
19643205|NCT00712920|42092642|FG002|Overall Study|Lost to Follow-up|0|||
19643206|NCT00712920|42092640|FG000|Overall Study|Lack of Efficacy|1|||
19643207|NCT00712920|42092641|FG001|Overall Study|Lack of Efficacy|0|||
19643208|NCT00712920|42092642|FG002|Overall Study|Lack of Efficacy|1|||
19643209|NCT00712920|42092640|FG000|Overall Study|Other|5|||
19643210|NCT00712920|42092641|FG001|Overall Study|Other|7|||
19643211|NCT00712920|42092642|FG002|Overall Study|Other|3|||
19643212|NCT00712920|42092640|FG000|Overall Study|Non-compliance|3|||
19643213|NCT00712920|42092641|FG001|Overall Study|Non-compliance|0|||
19643214|NCT00712920|42092642|FG002|Overall Study|Non-compliance|0|||
19643215|NCT00710424|42092661|FG000|Overall Study|Adverse Event|30|||
19643216|NCT00710424|42092662|FG001|Overall Study|Adverse Event|12|||
19643217|NCT00710424|42092661|FG000|Overall Study|Lack of Efficacy|4|||
19643218|NCT00710424|42092662|FG001|Overall Study|Lack of Efficacy|5|||
19643219|NCT00710424|42092661|FG000|Overall Study|Withdrawal by Subject|5|||
19643220|NCT00710424|42092662|FG001|Overall Study|Withdrawal by Subject|3|||
19643221|NCT00710424|42092661|FG000|Overall Study|Lost to Follow-up|0|||
19643222|NCT00710424|42092662|FG001|Overall Study|Lost to Follow-up|1|||
19643223|NCT00710424|42092661|FG000|Overall Study|Refused medication, no side effects|1|||
19643224|NCT00710424|42092662|FG001|Overall Study|Refused medication, no side effects|0|||
19643225|NCT00710424|42092661|FG000|Overall Study|Non-compliance with stable analgesia|1|||
19643226|NCT00710424|42092662|FG001|Overall Study|Non-compliance with stable analgesia|0|||
19643227|NCT00710424|42092661|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
19643228|NCT00710424|42092662|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
19643229|NCT00710424|42092661|FG000|Overall Study|Subject thought medication changed|1|||
19643230|NCT00710424|42092662|FG001|Overall Study|Subject thought medication changed|0|||
19643231|NCT00710424|42092661|FG000|Overall Study|Ceased treatment due to travel|1|||
19643232|NCT00710424|42092662|FG001|Overall Study|Ceased treatment due to travel|0|||
19643233|NCT00710424|42092661|FG000|Overall Study|Subject preferred paracetamol|0|||
19643234|NCT00710424|42092662|FG001|Overall Study|Subject preferred paracetamol|1|||
19643235|NCT00710424|42092661|FG000|Overall Study|Felt good so stopped treatment|0|||
19643236|NCT00710424|42092662|FG001|Overall Study|Felt good so stopped treatment|1|||
19643237|NCT00612586|42092670|FG000|Overall Study|Adverse Event|6|||
19643238|NCT00612586|42092671|FG001|Overall Study|Adverse Event|2|||
19643239|NCT00612586|42092670|FG000|Overall Study|Death|1|||
19643240|NCT00612586|42092671|FG001|Overall Study|Death|0|||
19643241|NCT00612586|42092670|FG000|Overall Study|Entry Criteria Not Met|0|||
19643242|NCT00612586|42092671|FG001|Overall Study|Entry Criteria Not Met|2|||
19643243|NCT00612586|42092670|FG000|Overall Study|Withdrawal by Subject|7|||
19643244|NCT00612586|42092671|FG001|Overall Study|Withdrawal by Subject|9|||
19643245|NCT00612586|42092670|FG000|Overall Study|Physician Decision|1|||
19643246|NCT00612586|42092671|FG001|Overall Study|Physician Decision|2|||
19643247|NCT00612586|42092670|FG000|Overall Study|Sponsor Decision|1|||
19643248|NCT00612586|42092671|FG001|Overall Study|Sponsor Decision|1|||
19643249|NCT00612586|42092670|FG000|Overall Study|Progressive Disease|26|||
19643250|NCT00612586|42092671|FG001|Overall Study|Progressive Disease|24|||
19643251|NCT00612586|42092670|FG000|Overall Study|Randomized and Not Treated|1|||
19643252|NCT00612586|42092671|FG001|Overall Study|Randomized and Not Treated|1|||
19643253|NCT00614380|42092682|FG000|Overall Study|Adverse Event|14|||
19643254|NCT00614380|42092683|FG001|Overall Study|Adverse Event|4|||
19643255|NCT00614380|42092684|FG002|Overall Study|Adverse Event|0|||
19643256|NCT00614380|42092685|FG003|Overall Study|Adverse Event|0|||
19643257|NCT00614380|42092682|FG000|Overall Study|Lost to Follow-up|6|||
19749264|NCT02913612|42197341|FG001|Overall Study|Withdrawal by Subject|4|||
19643258|NCT00614380|42092683|FG001|Overall Study|Lost to Follow-up|1|||
19643259|NCT00614380|42092684|FG002|Overall Study|Lost to Follow-up|0|||
19643260|NCT00614380|42092685|FG003|Overall Study|Lost to Follow-up|0|||
19643261|NCT00614380|42092682|FG000|Overall Study|Non compliant with the protocol|12|||
19643262|NCT00614380|42092683|FG001|Overall Study|Non compliant with the protocol|2|||
19643263|NCT00614380|42092684|FG002|Overall Study|Non compliant with the protocol|1|||
19643264|NCT00614380|42092685|FG003|Overall Study|Non compliant with the protocol|2|||
19643265|NCT00614380|42092682|FG000|Overall Study|Consent withdrawn|3|||
19643266|NCT00614380|42092683|FG001|Overall Study|Consent withdrawn|1|||
19643267|NCT00614380|42092684|FG002|Overall Study|Consent withdrawn|0|||
19643268|NCT00614380|42092685|FG003|Overall Study|Consent withdrawn|0|||
19643269|NCT00612508|42092702|FG000|Overall Study|Withdrawal by Subject|3|||
19643270|NCT00612508|42092703|FG001|Overall Study|Withdrawal by Subject|4|||
19643271|NCT00613834|42092713|FG000|Overall Study|Withdrawal by Subject|0|||
19643272|NCT00613834|42092714|FG001|Overall Study|Withdrawal by Subject|3|||
19643273|NCT00613366|42092728|FG000|Overall Study|Withdrawal by Subject|3|||
19643274|NCT00613366|42092729|FG001|Overall Study|Withdrawal by Subject|2|||
19643275|NCT00612352|42092737|FG000|Overall Study|Adverse Event|1|||
19643276|NCT00612352|42092738|FG001|Overall Study|Adverse Event|0|||
19643277|NCT00612352|42092737|FG000|Overall Study|Withdrawal by Subject|3|||
19643278|NCT00612352|42092738|FG001|Overall Study|Withdrawal by Subject|5|||
19643279|NCT00612352|42092737|FG000|Overall Study|moved out of state|1|||
19643280|NCT00612352|42092738|FG001|Overall Study|moved out of state|0|||
19643281|NCT00612352|42092737|FG000|Overall Study|didn't return calls/show up on test date|4|||
19643282|NCT00612352|42092738|FG001|Overall Study|didn't return calls/show up on test date|1|||
19643283|NCT00704730|42092746|FG000|Overall Study|Adverse Event|35|||
19643284|NCT00704730|42092747|FG001|Overall Study|Adverse Event|9|||
19643285|NCT00704730|42092746|FG000|Overall Study|Death|11|||
19643286|NCT00704730|42092747|FG001|Overall Study|Death|5|||
19643287|NCT00704730|42092746|FG000|Overall Study|Physician Decision|2|||
19643288|NCT00704730|42092747|FG001|Overall Study|Physician Decision|0|||
19643289|NCT00704730|42092746|FG000|Overall Study|Did not receive drug|5|||
19643290|NCT00704730|42092747|FG001|Overall Study|Did not receive drug|2|||
19643291|NCT00704730|42092746|FG000|Overall Study|Disease progression per PI|58|||
19643292|NCT00704730|42092747|FG001|Overall Study|Disease progression per PI|67|||
19643293|NCT00704730|42092746|FG000|Overall Study|data unavailable|1|||
19643294|NCT00704730|42092747|FG001|Overall Study|data unavailable|0|||
19643295|NCT00704730|42092746|FG000|Overall Study|Withdrawal by Subject|9|||
19643296|NCT00704730|42092747|FG001|Overall Study|Withdrawal by Subject|13|||
19643297|NCT00651261|42092756|FG000|Overall Study|Adverse Event|32|||
19643298|NCT00651261|42092757|FG001|Overall Study|Adverse Event|22|||
19643299|NCT00651261|42092756|FG000|Overall Study|Death|18|||
19643300|NCT00651261|42092757|FG001|Overall Study|Death|18|||
19643301|NCT00651261|42092756|FG000|Overall Study|Withdrawal by Subject|22|||
19643302|NCT00651261|42092757|FG001|Overall Study|Withdrawal by Subject|40|||
19643303|NCT00651261|42092756|FG000|Overall Study|Induction failure|24|||
19643304|NCT00651261|42092757|FG001|Overall Study|Induction failure|35|||
19643305|NCT00651261|42092756|FG000|Overall Study|Disease progression|58|||
19643306|NCT00651261|42092757|FG001|Overall Study|Disease progression|58|||
19643307|NCT00651261|42092756|FG000|Overall Study|Alternative therapy|109|||
19643308|NCT00651261|42092757|FG001|Overall Study|Alternative therapy|107|||
19643309|NCT00651261|42092756|FG000|Overall Study|Other disease or participant decisions|23|||
19643310|NCT00651261|42092757|FG001|Overall Study|Other disease or participant decisions|23|||
19643311|NCT00651261|42092756|FG000|Overall Study|Never treated|5|||
19643312|NCT00651261|42092757|FG001|Overall Study|Never treated|3|||
19643313|NCT00651183|42092765|FG000|Overall Study|Lack of Efficacy|1|||
19643314|NCT00651183|42092766|FG001|Overall Study|Lack of Efficacy|0|||
19643315|NCT00651183|42092765|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
19643316|NCT00651183|42092766|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
19643317|NCT00651183|42092765|FG000|Overall Study|Tolerability insufficient|5|||
19643318|NCT00651183|42092766|FG001|Overall Study|Tolerability insufficient|2|||
19643319|NCT00651183|42092765|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
19643320|NCT00651183|42092766|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
19643321|NCT00651183|42092765|FG000|Overall Study|Withdrawal by Subject|6|||
19643322|NCT00651183|42092766|FG001|Overall Study|Withdrawal by Subject|3|||
19643323|NCT00651183|42092765|FG000|Overall Study|Lost to Follow-up|3|||
19643324|NCT00651183|42092766|FG001|Overall Study|Lost to Follow-up|1|||
19643325|NCT00651183|42092765|FG000|Overall Study|Other reasons|4|||
19643326|NCT00651183|42092766|FG001|Overall Study|Other reasons|2|||
19643327|NCT00651183|42092765|FG000|Overall Study|missing|1|||
19643328|NCT00651183|42092766|FG001|Overall Study|missing|0|||
19643329|NCT00699972|42092775|FG000|Overall Study|Adverse Event|7|||
19643330|NCT00699972|42092776|FG001|Overall Study|Adverse Event|9|||
19643331|NCT00699972|42092777|FG002|Overall Study|Adverse Event|24|||
19643332|NCT00699972|42092775|FG000|Overall Study|Lost to Follow-up|0|||
19643333|NCT00699972|42092776|FG001|Overall Study|Lost to Follow-up|2|||
19643334|NCT00699972|42092777|FG002|Overall Study|Lost to Follow-up|0|||
19643335|NCT00699972|42092775|FG000|Overall Study|Withdrawal by Subject|3|||
19643336|NCT00699972|42092776|FG001|Overall Study|Withdrawal by Subject|7|||
19643337|NCT00699972|42092777|FG002|Overall Study|Withdrawal by Subject|4|||
19643338|NCT00699972|42092775|FG000|Overall Study|Lack of Efficacy|2|||
19643339|NCT00699972|42092776|FG001|Overall Study|Lack of Efficacy|0|||
19643340|NCT00699972|42092777|FG002|Overall Study|Lack of Efficacy|2|||
19643341|NCT00699972|42092775|FG000|Overall Study|Administrative/Other|3|||
19643342|NCT00699972|42092776|FG001|Overall Study|Administrative/Other|1|||
19643343|NCT00699972|42092777|FG002|Overall Study|Administrative/Other|4|||
19643344|NCT00699972|42092775|FG000|Overall Study|Randomized, Not Treated|1|||
19643345|NCT00699972|42092776|FG001|Overall Study|Randomized, Not Treated|0|||
19643346|NCT00699972|42092777|FG002|Overall Study|Randomized, Not Treated|1|||
19643347|NCT00642759|42092785|FG000|Overall Study|Protocol Violation|1|||
19643348|NCT00611026|42092793|FG000|Randomized to Double-blind Treatment|Not treated|2|||
19643349|NCT00611026|42092794|FG001|Randomized to Double-blind Treatment|Not treated|1|||
19643350|NCT00611026|42092795|FG002|Randomized to Double-blind Treatment|Not treated|3|||
19643351|NCT00611026|42092793|FG000|Double-blind Treatment Period|Death|1|||
19643352|NCT00611026|42092794|FG001|Double-blind Treatment Period|Death|0|||
19643353|NCT00611026|42092795|FG002|Double-blind Treatment Period|Death|0|||
19643354|NCT00611026|42092793|FG000|Double-blind Treatment Period|Adverse Event|9|||
19643355|NCT00611026|42092794|FG001|Double-blind Treatment Period|Adverse Event|28|||
19643356|NCT00611026|42092795|FG002|Double-blind Treatment Period|Adverse Event|46|||
19643357|NCT00611026|42092793|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
19643358|NCT00611026|42092794|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
19643359|NCT00611026|42092795|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
19643360|NCT00611026|42092793|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
19643361|NCT00611026|42092794|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
19643362|NCT00611026|42092795|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
19643363|NCT00611026|42092793|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
19643364|NCT00611026|42092794|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
19643365|NCT00611026|42092795|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
19643366|NCT00611026|42092793|FG000|Double-blind Treatment Period|Other|13|||
19643367|NCT00611026|42092794|FG001|Double-blind Treatment Period|Other|20|||
19643368|NCT00611026|42092795|FG002|Double-blind Treatment Period|Other|18|||
19643369|NCT00646113|42092805|FG000|Overall Study|Lost to Follow-up|5|||
19643370|NCT00646113|42092805|FG000|Overall Study|Adverse Event|3|||
19643371|NCT00422383|42092814|FG000|Overall Study|Adverse Event|5|||
19643372|NCT00422383|42092815|FG001|Overall Study|Adverse Event|3|||
19643373|NCT00422383|42092816|FG002|Overall Study|Adverse Event|1|||
19643374|NCT00422383|42092817|FG003|Overall Study|Adverse Event|1|||
19643375|NCT00422383|42092818|FG004|Overall Study|Adverse Event|0|||
19643376|NCT00422383|42092814|FG000|Overall Study|Lack of Efficacy|4|||
19643377|NCT00422383|42092815|FG001|Overall Study|Lack of Efficacy|4|||
19643378|NCT00422383|42092816|FG002|Overall Study|Lack of Efficacy|2|||
19643379|NCT00422383|42092817|FG003|Overall Study|Lack of Efficacy|1|||
19643380|NCT00422383|42092818|FG004|Overall Study|Lack of Efficacy|1|||
19643381|NCT00422383|42092814|FG000|Overall Study|Lost to Follow-up|0|||
19643382|NCT00422383|42092815|FG001|Overall Study|Lost to Follow-up|1|||
19643383|NCT00422383|42092816|FG002|Overall Study|Lost to Follow-up|0|||
19643384|NCT00422383|42092817|FG003|Overall Study|Lost to Follow-up|0|||
19643385|NCT00422383|42092818|FG004|Overall Study|Lost to Follow-up|1|||
19643386|NCT00422383|42092814|FG000|Overall Study|Protocol Violation|1|||
19643387|NCT00422383|42092815|FG001|Overall Study|Protocol Violation|1|||
19643388|NCT00422383|42092816|FG002|Overall Study|Protocol Violation|1|||
19643389|NCT00422383|42092817|FG003|Overall Study|Protocol Violation|0|||
19643390|NCT00422383|42092818|FG004|Overall Study|Protocol Violation|0|||
19749265|NCT02913612|42197342|FG002|Overall Study|Withdrawal by Subject|0|||
19643391|NCT00422383|42092814|FG000|Overall Study|Withdrawal by Subject|5|||
19643392|NCT00422383|42092815|FG001|Overall Study|Withdrawal by Subject|5|||
19643393|NCT00422383|42092816|FG002|Overall Study|Withdrawal by Subject|0|||
19643394|NCT00422383|42092817|FG003|Overall Study|Withdrawal by Subject|0|||
19643395|NCT00422383|42092818|FG004|Overall Study|Withdrawal by Subject|1|||
19643396|NCT00612040|42092839|FG000|Overall Study|Adverse Event|0|||
19643397|NCT00612040|42092840|FG001|Overall Study|Adverse Event|2|||
19643398|NCT00612040|42092841|FG002|Overall Study|Adverse Event|1|||
19643399|NCT00612040|42092839|FG000|Overall Study|Protocol Violation|1|||
19643400|NCT00612040|42092840|FG001|Overall Study|Protocol Violation|2|||
19643401|NCT00612040|42092841|FG002|Overall Study|Protocol Violation|1|||
19643402|NCT00612040|42092839|FG000|Overall Study|Lack of Efficacy|2|||
19643403|NCT00612040|42092840|FG001|Overall Study|Lack of Efficacy|1|||
19643404|NCT00612040|42092841|FG002|Overall Study|Lack of Efficacy|0|||
19643405|NCT00612040|42092839|FG000|Overall Study|Unclassified|2|||
19643406|NCT00612040|42092840|FG001|Overall Study|Unclassified|2|||
19643407|NCT00612040|42092841|FG002|Overall Study|Unclassified|5|||
19643408|NCT00422227|42092851|FG000|Overall Study|Adverse Event|3|||
19643409|NCT00422227|42092852|FG001|Overall Study|Adverse Event|8|||
19643410|NCT00422227|42092851|FG000|Overall Study|Lost to Follow-up|1|||
19643411|NCT00422227|42092852|FG001|Overall Study|Lost to Follow-up|3|||
19643412|NCT00422227|42092851|FG000|Overall Study|Withdrawal by Subject|0|||
19643413|NCT00422227|42092852|FG001|Overall Study|Withdrawal by Subject|4|||
19643414|NCT00421993|42092862|FG000|Overall Study|Withdrawal by Subject|22|||
19643415|NCT00421993|42092863|FG001|Overall Study|Withdrawal by Subject|23|||
19643416|NCT00421993|42092864|FG002|Overall Study|Withdrawal by Subject|23|||
19643417|NCT00421993|42092865|FG003|Overall Study|Withdrawal by Subject|24|||
19643418|NCT00421993|42092862|FG000|Overall Study|Lost to Follow-up|18|||
19643419|NCT00421993|42092863|FG001|Overall Study|Lost to Follow-up|19|||
19643420|NCT00421993|42092864|FG002|Overall Study|Lost to Follow-up|22|||
19643421|NCT00421993|42092865|FG003|Overall Study|Lost to Follow-up|20|||
19643422|NCT00421993|42092862|FG000|Overall Study|Adverse Event|11|||
19643423|NCT00421993|42092863|FG001|Overall Study|Adverse Event|1|||
19643424|NCT00421993|42092864|FG002|Overall Study|Adverse Event|6|||
19643425|NCT00421993|42092865|FG003|Overall Study|Adverse Event|4|||
19643426|NCT00421993|42092862|FG000|Overall Study|Protocol Violation|2|||
19643427|NCT00421993|42092863|FG001|Overall Study|Protocol Violation|2|||
19643428|NCT00421993|42092864|FG002|Overall Study|Protocol Violation|0|||
19643429|NCT00421993|42092865|FG003|Overall Study|Protocol Violation|1|||
19643430|NCT00421993|42092862|FG000|Overall Study|Lack of Efficacy|0|||
19643431|NCT00421993|42092863|FG001|Overall Study|Lack of Efficacy|3|||
19643432|NCT00421993|42092864|FG002|Overall Study|Lack of Efficacy|0|||
19643433|NCT00421993|42092865|FG003|Overall Study|Lack of Efficacy|5|||
19643434|NCT00421993|42092862|FG000|Overall Study|Pregnancy|0|||
19643435|NCT00421993|42092863|FG001|Overall Study|Pregnancy|1|||
19643436|NCT00421993|42092864|FG002|Overall Study|Pregnancy|1|||
19749266|NCT02913612|42197343|FG003|Overall Study|Withdrawal by Subject|0|||
19749267|NCT02913612|42197340|FG000|Overall Study|Hemangioma resolved|1|||
19749268|NCT02913612|42197341|FG001|Overall Study|Hemangioma resolved|0|||
19749269|NCT02913612|42197342|FG002|Overall Study|Hemangioma resolved|0|||
19749270|NCT02913612|42197343|FG003|Overall Study|Hemangioma resolved|0|||
19749271|NCT02913612|42197340|FG000|Overall Study|Local IRB decision|1|||
19643437|NCT00421993|42092865|FG003|Overall Study|Pregnancy|2|||
19643438|NCT00421993|42092862|FG000|Overall Study|Subject transportation issues|0|||
19643439|NCT00421993|42092863|FG001|Overall Study|Subject transportation issues|0|||
19643440|NCT00421993|42092864|FG002|Overall Study|Subject transportation issues|0|||
19643441|NCT00421993|42092865|FG003|Overall Study|Subject transportation issues|1|||
19643442|NCT00413959|42092875|FG000|Overall Study|Pt had only one cycle.|1|||
19643443|NCT00645567|42092879|FG000|Overall Study|Adverse Event|1|||
19643444|NCT00611884|42092891|FG000|Overall Study|Adverse Event|1|||
19643445|NCT00611884|42092892|FG001|Overall Study|Adverse Event|0|||
19643446|NCT00611884|42092893|FG002|Overall Study|Adverse Event|0|||
19643447|NCT00611884|42092894|FG003|Overall Study|Adverse Event|1|||
19643448|NCT00611884|42092891|FG000|Overall Study|Non-Compliance|1|||
19643449|NCT00611884|42092892|FG001|Overall Study|Non-Compliance|4|||
19643450|NCT00611884|42092893|FG002|Overall Study|Non-Compliance|2|||
19643451|NCT00611884|42092894|FG003|Overall Study|Non-Compliance|2|||
19643452|NCT00611884|42092891|FG000|Overall Study|Lack of Efficacy|0|||
19643453|NCT00611884|42092892|FG001|Overall Study|Lack of Efficacy|1|||
19643454|NCT00611884|42092893|FG002|Overall Study|Lack of Efficacy|0|||
19643455|NCT00611884|42092894|FG003|Overall Study|Lack of Efficacy|0|||
19643456|NCT00611884|42092891|FG000|Overall Study|Unclassified|7|||
19643457|NCT00611884|42092892|FG001|Overall Study|Unclassified|4|||
19643458|NCT00611884|42092893|FG002|Overall Study|Unclassified|2|||
19643459|NCT00611884|42092894|FG003|Overall Study|Unclassified|3|||
19643460|NCT00420745|42092906|FG000|Overall Study|Adverse Event|2|||
19643461|NCT00420745|42092907|FG001|Overall Study|Adverse Event|2|||
19749272|NCT02913612|42197341|FG001|Overall Study|Local IRB decision|0|||
19749273|NCT02913612|42197342|FG002|Overall Study|Local IRB decision|0|||
19749274|NCT02913612|42197343|FG003|Overall Study|Local IRB decision|0|||
19749275|NCT02913612|42197340|FG000|Overall Study|Study drug non-compliance|1|||
19749276|NCT02913612|42197341|FG001|Overall Study|Study drug non-compliance|1|||
19749277|NCT02913612|42197342|FG002|Overall Study|Study drug non-compliance|0|||
19749278|NCT02913612|42197343|FG003|Overall Study|Study drug non-compliance|0|||
19749279|NCT02913612|42197340|FG000|Overall Study|Insurance issues|0|||
19749280|NCT02913612|42197341|FG001|Overall Study|Insurance issues|1|||
19749281|NCT02913612|42197342|FG002|Overall Study|Insurance issues|0|||
19749282|NCT02913612|42197343|FG003|Overall Study|Insurance issues|0|||
19749283|NCT02913612|42197340|FG000|Overall Study|Needed to treat second hemangioma|0|||
19749284|NCT02913612|42197341|FG001|Overall Study|Needed to treat second hemangioma|1|||
19749285|NCT02913612|42197342|FG002|Overall Study|Needed to treat second hemangioma|0|||
19749286|NCT02913612|42197343|FG003|Overall Study|Needed to treat second hemangioma|0|||
19749287|NCT02913612|42197340|FG000|Overall Study|Study completion criteria not met|0|||
19749288|NCT02913612|42197341|FG001|Overall Study|Study completion criteria not met|1|||
19749289|NCT02913612|42197342|FG002|Overall Study|Study completion criteria not met|0|||
19749290|NCT02913612|42197343|FG003|Overall Study|Study completion criteria not met|0|||
19749291|NCT02913612|42197340|FG000|Overall Study|Ineligible|0|||
19749292|NCT02913612|42197341|FG001|Overall Study|Ineligible|1|||
19749293|NCT02913612|42197342|FG002|Overall Study|Ineligible|0|||
19749294|NCT02913612|42197343|FG003|Overall Study|Ineligible|0|||
19749295|NCT03312231|42197357|FG000|Overall Study|Lost to Follow-up|2|||
19749296|NCT03312231|42197358|FG001|Overall Study|Lost to Follow-up|6|||
19749297|NCT03312231|42197359|FG002|Overall Study|Lost to Follow-up|1|||
19749298|NCT03312231|42197360|FG003|Overall Study|Lost to Follow-up|3|||
19749299|NCT03312231|42197361|FG004|Overall Study|Lost to Follow-up|1|||
19749300|NCT03312231|42197357|FG000|Overall Study|Withdrawal by Subject|0|||
19749301|NCT03312231|42197358|FG001|Overall Study|Withdrawal by Subject|3|||
19749302|NCT03312231|42197359|FG002|Overall Study|Withdrawal by Subject|1|||
19749303|NCT03312231|42197360|FG003|Overall Study|Withdrawal by Subject|0|||
19749304|NCT03312231|42197361|FG004|Overall Study|Withdrawal by Subject|0|||
19749305|NCT03312231|42197357|FG000|Overall Study|Death|0|||
19749306|NCT03312231|42197358|FG001|Overall Study|Death|1|||
19749307|NCT03312231|42197359|FG002|Overall Study|Death|1|||
19749308|NCT03312231|42197360|FG003|Overall Study|Death|0|||
19749309|NCT03312231|42197361|FG004|Overall Study|Death|0|||
19749310|NCT03312231|42197357|FG000|Overall Study|Study Vaccination not Received|1|||
19749311|NCT03312231|42197358|FG001|Overall Study|Study Vaccination not Received|1|||
19749312|NCT03312231|42197359|FG002|Overall Study|Study Vaccination not Received|1|||
19749313|NCT03312231|42197360|FG003|Overall Study|Study Vaccination not Received|0|||
19749314|NCT03312231|42197361|FG004|Overall Study|Study Vaccination not Received|0|||
19749315|NCT03323736|42197376|FG000|Overall Study|Screen Failure|14|||
19749316|NCT03323736|42197377|FG001|Overall Study|Screen Failure|9|||
19749317|NCT03323736|42197378|FG002|Overall Study|Screen Failure|1|||
19749318|NCT03323736|42197376|FG000|Overall Study|Withdrawal Before Treatment|3|||
19749319|NCT03323736|42197377|FG001|Overall Study|Withdrawal Before Treatment|1|||
19749320|NCT03323736|42197378|FG002|Overall Study|Withdrawal Before Treatment|1|||
19749321|NCT03323736|42197376|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
19749322|NCT03323736|42197377|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
19749323|NCT03323736|42197378|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
19749324|NCT03311841|42197393|FG000|14-day Wash-out|Adverse Event|0|||
19643462|NCT00420745|42092906|FG000|Overall Study|Lost to Follow-up|10|||
19749325|NCT03311841|42197394|FG001|14-day Wash-out|Adverse Event|1|||
19643463|NCT00420745|42092907|FG001|Overall Study|Lost to Follow-up|2|||
19749326|NCT03311841|42197395|FG002|14-day Wash-out|Adverse Event|0|||
19749327|NCT03311841|42197396|FG003|14-day Wash-out|Adverse Event|0|||
19749328|NCT03311841|42197397|FG004|14-day Wash-out|Adverse Event|0|||
19749329|NCT03311841|42197393|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
19749330|NCT03311841|42197394|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
19749331|NCT03311841|42197395|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
19749332|NCT03311841|42197396|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
19749333|NCT03311841|42197397|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
19749334|NCT03311373|42197430|FG000|Overall Study|Adverse Event|1|||
19749335|NCT03311373|42197430|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
19749336|NCT03311373|42197430|FG000|Overall Study|Lost to Follow-up|1|||
19749337|NCT03311373|42197430|FG000|Overall Study|Physician Decision|1|||
19749338|NCT03311373|42197430|FG000|Overall Study|Withdrawal by Subject|3|||
19749339|NCT01155375|42197442|FG000|Overall Study|Adverse Event|1|||
19749340|NCT01155375|42197443|FG001|Overall Study|Adverse Event|0|||
19749341|NCT00628095|42197452|FG000|Overall Study|Adverse Event|5|||
19749342|NCT00628095|42197453|FG001|Overall Study|Adverse Event|3|||
19749343|NCT00628095|42197452|FG000|Overall Study|Lack of Efficacy|0|||
19749344|NCT00628095|42197453|FG001|Overall Study|Lack of Efficacy|3|||
19749345|NCT00628095|42197452|FG000|Overall Study|Withdrawal by Subject|2|||
19749346|NCT00628095|42197453|FG001|Overall Study|Withdrawal by Subject|0|||
19749347|NCT00628095|42197452|FG000|Overall Study|Other|0|||
19749348|NCT00628095|42197453|FG001|Overall Study|Other|1|||
19749349|NCT02889861|42197461|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
19749350|NCT03325881|42197472|FG000|Overall Study|Protocol Violation|0|||
19749351|NCT03325881|42197473|FG001|Overall Study|Protocol Violation|1|||
19749352|NCT03325881|42197472|FG000|Overall Study|Withdrawal by Subject|0|||
19749353|NCT03325881|42197473|FG001|Overall Study|Withdrawal by Subject|2|||
19749354|NCT03325881|42197472|FG000|Overall Study|Lack of Efficacy|2|||
19749355|NCT03325881|42197473|FG001|Overall Study|Lack of Efficacy|0|||
19749356|NCT03325881|42197472|FG000|Overall Study|Not treated|1|||
19749357|NCT03325881|42197473|FG001|Overall Study|Not treated|0|||
19749358|NCT02887989|42197483|FG000|Overall Study|Withdrawal by Subject|8|||
19749359|NCT02887989|42197484|FG001|Overall Study|Withdrawal by Subject|11|||
19643464|NCT00420745|42092906|FG000|Overall Study|Protocol Violation|1|||
19643465|NCT00420745|42092907|FG001|Overall Study|Protocol Violation|0|||
19643466|NCT00420745|42092906|FG000|Overall Study|Physician Decision|1|||
19643467|NCT00420745|42092907|FG001|Overall Study|Physician Decision|1|||
19643468|NCT00420745|42092906|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
19643469|NCT00420745|42092907|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
19643470|NCT00420745|42092906|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
19643471|NCT00420745|42092907|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
19643472|NCT00611806|42092915|FG000|Overall Study|Withdrawal by Subject|8|||
19643473|NCT00611806|42092916|FG001|Overall Study|Withdrawal by Subject|2|||
19643474|NCT00611806|42092915|FG000|Overall Study|Adverse Event|2|||
19643475|NCT00611806|42092916|FG001|Overall Study|Adverse Event|1|||
19643476|NCT00611806|42092915|FG000|Overall Study|Lost to Follow-up|6|||
19643477|NCT00611806|42092916|FG001|Overall Study|Lost to Follow-up|0|||
19643478|NCT00413413|42092925|FG000|Single-Blind|Adverse Event|0|||
19643479|NCT00413413|42092926|FG001|Single-Blind|Adverse Event|9|||
19643480|NCT00413413|42092927|FG002|Single-Blind|Adverse Event|0|||
19643481|NCT00413413|42092925|FG000|Single-Blind|Lack of Efficacy|0|||
19643482|NCT00413413|42092926|FG001|Single-Blind|Lack of Efficacy|5|||
19643483|NCT00413413|42092927|FG002|Single-Blind|Lack of Efficacy|0|||
19643484|NCT00413413|42092925|FG000|Single-Blind|Subject no longer requires study drug|0|||
19643485|NCT00413413|42092926|FG001|Single-Blind|Subject no longer requires study drug|151|||
19643486|NCT00413413|42092927|FG002|Single-Blind|Subject no longer requires study drug|0|||
19643487|NCT00413413|42092925|FG000|Single-Blind|Protocol Violation|0|||
19643488|NCT00413413|42092926|FG001|Single-Blind|Protocol Violation|16|||
19643489|NCT00413413|42092927|FG002|Single-Blind|Protocol Violation|0|||
19643490|NCT00413413|42092925|FG000|Single-Blind|Withdrawal by Subject|0|||
19643491|NCT00413413|42092926|FG001|Single-Blind|Withdrawal by Subject|27|||
19643492|NCT00413413|42092927|FG002|Single-Blind|Withdrawal by Subject|0|||
19643493|NCT00413413|42092925|FG000|Single-Blind|Lost to Follow-up|0|||
19643494|NCT00413413|42092926|FG001|Single-Blind|Lost to Follow-up|8|||
19643495|NCT00413413|42092927|FG002|Single-Blind|Lost to Follow-up|0|||
19643496|NCT00413413|42092925|FG000|Double-Blind|Adverse Event|6|||
19643497|NCT00413413|42092926|FG001|Double-Blind|Adverse Event|0|||
19643498|NCT00413413|42092927|FG002|Double-Blind|Adverse Event|5|||
19643499|NCT00413413|42092925|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
19643500|NCT00413413|42092926|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
19643501|NCT00413413|42092927|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
19643502|NCT00413413|42092925|FG000|Double-Blind|Protocol deviation|1|||
19643503|NCT00413413|42092926|FG001|Double-Blind|Protocol deviation|2|||
19643504|NCT00413413|42092927|FG002|Double-Blind|Protocol deviation|1|||
19643505|NCT00413413|42092925|FG000|Double-Blind|Subject withdrew consent|4|||
19749360|NCT02887989|42197483|FG000|Overall Study|Death|1|||
19749361|NCT02887989|42197484|FG001|Overall Study|Death|0|||
19749362|NCT02887521|42197492|FG000|Overall Study|Withdrawal by Subject|0|||
19749363|NCT02887521|42197493|FG001|Overall Study|Withdrawal by Subject|3|||
19749364|NCT03305055|42197501|FG000|Overall Study|Withdrawal by Subject|0|||
19749365|NCT03305055|42197502|FG001|Overall Study|Withdrawal by Subject|1|||
19749366|NCT03305055|42197501|FG000|Overall Study|Adverse Event|1|||
19749367|NCT03305055|42197502|FG001|Overall Study|Adverse Event|1|||
19749368|NCT02763189|42197510|FG000|Overall Study|Device failure|0|||
19749369|NCT02763189|42197511|FG001|Overall Study|Device failure|2|||
19749370|NCT03273387|42197519|FG000|Overall Study|Death|2|||
19749371|NCT03273387|42197520|FG001|Overall Study|Death|2|||
19749372|NCT03273387|42197519|FG000|Overall Study|Withdrawal by Subject|1|||
19749373|NCT03273387|42197520|FG001|Overall Study|Withdrawal by Subject|1|||
19749374|NCT01328080|42197526|FG000|Overall Study|Lost to Follow-up|5|||
19749375|NCT02649946|42197545|FG000|Overall Study|Withdrawal by Subject|1|||
19749376|NCT02649946|42197546|FG001|Overall Study|Withdrawal by Subject|1|||
19749377|NCT02649946|42197545|FG000|Overall Study|Death|7|||
19749378|NCT02649946|42197546|FG001|Overall Study|Death|9|||
19749379|NCT02649946|42197545|FG000|Overall Study|Physician Decision|1|||
19749380|NCT02649946|42197546|FG001|Overall Study|Physician Decision|0|||
19749381|NCT02649946|42197545|FG000|Overall Study|Lost to Follow-up|2|||
19749382|NCT02649946|42197546|FG001|Overall Study|Lost to Follow-up|1|||
19749383|NCT02649946|42197545|FG000|Overall Study|Erroneously enrolled|1|||
19643506|NCT00413413|42092926|FG001|Double-Blind|Subject withdrew consent|6|||
19643507|NCT00413413|42092927|FG002|Double-Blind|Subject withdrew consent|9|||
19643508|NCT00413413|42092925|FG000|Double-Blind|Lost to Follow-up|3|||
19643509|NCT00413413|42092926|FG001|Double-Blind|Lost to Follow-up|4|||
19643510|NCT00413413|42092927|FG002|Double-Blind|Lost to Follow-up|2|||
19643511|NCT00610714|42092937|FG000|Overall Study|Adverse Event|3|||
19643512|NCT00610714|42092938|FG001|Overall Study|Adverse Event|1|||
19643513|NCT00610714|42092937|FG000|Overall Study|Death|12|||
19643514|NCT00610714|42092938|FG001|Overall Study|Death|18|||
19643515|NCT00610714|42092937|FG000|Overall Study|Withdrawal by Subject|9|||
19643516|NCT00610714|42092938|FG001|Overall Study|Withdrawal by Subject|3|||
19643517|NCT00610714|42092937|FG000|Overall Study|Study completion at 120 PFS events|2|||
19643518|NCT00610714|42092938|FG001|Overall Study|Study completion at 120 PFS events|2|||
19643519|NCT00403585|42092944|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
19643520|NCT00403585|42092944|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
19643521|NCT00403585|42092944|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
19643522|NCT00645411|42092952|FG000|Overall Study|Adverse Event|0|||
19643523|NCT00645411|42092953|FG001|Overall Study|Adverse Event|0|||
19643524|NCT00645411|42092954|FG002|Overall Study|Adverse Event|0|||
19643525|NCT00645411|42092955|FG003|Overall Study|Adverse Event|2|||
19643526|NCT00645411|42092952|FG000|Overall Study|Withdrawal by Subject|2|||
19643527|NCT00645411|42092953|FG001|Overall Study|Withdrawal by Subject|1|||
19643528|NCT00645411|42092954|FG002|Overall Study|Withdrawal by Subject|19|||
19643529|NCT00645411|42092955|FG003|Overall Study|Withdrawal by Subject|21|||
19643530|NCT00645411|42092952|FG000|Overall Study|Lost to Follow-up|10|||
19643531|NCT00645411|42092953|FG001|Overall Study|Lost to Follow-up|5|||
19643532|NCT00645411|42092954|FG002|Overall Study|Lost to Follow-up|124|||
19643533|NCT00645411|42092955|FG003|Overall Study|Lost to Follow-up|75|||
19643534|NCT00645411|42092952|FG000|Overall Study|Protocol Violation|1|||
19643535|NCT00645411|42092953|FG001|Overall Study|Protocol Violation|0|||
19643536|NCT00645411|42092954|FG002|Overall Study|Protocol Violation|1|||
19643537|NCT00645411|42092955|FG003|Overall Study|Protocol Violation|0|||
19643538|NCT00645411|42092952|FG000|Overall Study|Inappropriate enrollment|0|||
19643539|NCT00645411|42092953|FG001|Overall Study|Inappropriate enrollment|0|||
19643540|NCT00645411|42092954|FG002|Overall Study|Inappropriate enrollment|4|||
19643541|NCT00645411|42092955|FG003|Overall Study|Inappropriate enrollment|1|||
19643542|NCT00645411|42092952|FG000|Overall Study|Unable to classify|0|||
19643543|NCT00645411|42092953|FG001|Overall Study|Unable to classify|0|||
19643544|NCT00645411|42092954|FG002|Overall Study|Unable to classify|3|||
19643545|NCT00645411|42092955|FG003|Overall Study|Unable to classify|4|||
19643546|NCT00403273|42092974|FG000|Overall Study|Lost to Follow-up|3|||
19643547|NCT00403273|42092975|FG001|Overall Study|Lost to Follow-up|2|||
19477065|NCT01487863|41755889|FG001|Overall Study|Death|19|||
19643548|NCT00403273|42092974|FG000|Overall Study|Physician Decision|0|||
19643549|NCT00403273|42092975|FG001|Overall Study|Physician Decision|1|||
19643550|NCT00403273|42092974|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
19643551|NCT00403273|42092975|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
19643552|NCT00402727|42092998|FG000|Overall Study|Adverse Event|10|||
19643553|NCT00402727|42092999|FG001|Overall Study|Adverse Event|6|||
19643554|NCT00402727|42092998|FG000|Overall Study|Death|1|||
19643555|NCT00402727|42092999|FG001|Overall Study|Death|0|||
19643556|NCT00402727|42092998|FG000|Overall Study|Lack of Efficacy|1|||
19643557|NCT00402727|42092999|FG001|Overall Study|Lack of Efficacy|3|||
19643558|NCT00402727|42092998|FG000|Overall Study|Lost to Follow-up|24|||
19643559|NCT00402727|42092999|FG001|Overall Study|Lost to Follow-up|11|||
19643560|NCT00402727|42092998|FG000|Overall Study|Physician Decision|1|||
19643561|NCT00402727|42092999|FG001|Overall Study|Physician Decision|1|||
19643562|NCT00402727|42092998|FG000|Overall Study|Protocol Violation|0|||
19643563|NCT00402727|42092999|FG001|Overall Study|Protocol Violation|4|||
19643564|NCT00402727|42092998|FG000|Overall Study|Withdrawal by Subject|3|||
19643565|NCT00402727|42092999|FG001|Overall Study|Withdrawal by Subject|7|||
19643566|NCT00402727|42092998|FG000|Overall Study|supply problems|2|||
19643567|NCT00402727|42092999|FG001|Overall Study|supply problems|1|||
19749384|NCT02649946|42197546|FG001|Overall Study|Erroneously enrolled|0|||
19643568|NCT00402727|42092998|FG000|Overall Study|non-compliance|0|||
19643569|NCT00402727|42092999|FG001|Overall Study|non-compliance|1|||
19643570|NCT00402649|42093005|FG000|Overall Study|Lost to Follow-up|1|||
19643571|NCT00402649|42093005|FG000|Overall Study|Withdrawal by Subject|1|||
19643572|NCT00402337|42093014|FG000|Overall Study|Adverse Event|0|||
19643573|NCT00402337|42093015|FG001|Overall Study|Adverse Event|2|||
19643574|NCT00402337|42093016|FG002|Overall Study|Adverse Event|2|||
19643575|NCT00402337|42093017|FG003|Overall Study|Adverse Event|3|||
19643576|NCT00402337|42093018|FG004|Overall Study|Adverse Event|2|||
19643577|NCT00402337|42093014|FG000|Overall Study|Noncompliance|0|||
19643578|NCT00402337|42093015|FG001|Overall Study|Noncompliance|0|||
19643579|NCT00402337|42093016|FG002|Overall Study|Noncompliance|0|||
19643580|NCT00402337|42093017|FG003|Overall Study|Noncompliance|0|||
19643581|NCT00402337|42093018|FG004|Overall Study|Noncompliance|2|||
19643582|NCT00402337|42093014|FG000|Overall Study|Withdrawal by Subject|5|||
19643583|NCT00402337|42093015|FG001|Overall Study|Withdrawal by Subject|3|||
19643584|NCT00402337|42093016|FG002|Overall Study|Withdrawal by Subject|1|||
19643585|NCT00402337|42093017|FG003|Overall Study|Withdrawal by Subject|6|||
19643586|NCT00402337|42093018|FG004|Overall Study|Withdrawal by Subject|4|||
19643587|NCT00402337|42093014|FG000|Overall Study|Lost to Follow-up|0|||
19643588|NCT00402337|42093015|FG001|Overall Study|Lost to Follow-up|0|||
19643589|NCT00402337|42093016|FG002|Overall Study|Lost to Follow-up|1|||
19643590|NCT00402337|42093017|FG003|Overall Study|Lost to Follow-up|2|||
19643591|NCT00402337|42093018|FG004|Overall Study|Lost to Follow-up|0|||
19643592|NCT00402337|42093014|FG000|Overall Study|Physician Decision|0|||
19643593|NCT00402337|42093015|FG001|Overall Study|Physician Decision|0|||
19643594|NCT00402337|42093016|FG002|Overall Study|Physician Decision|0|||
19643595|NCT00402337|42093017|FG003|Overall Study|Physician Decision|1|||
19643596|NCT00402337|42093018|FG004|Overall Study|Physician Decision|0|||
19643597|NCT00402337|42093014|FG000|Overall Study|Other Reason|0|||
19643598|NCT00402337|42093015|FG001|Overall Study|Other Reason|1|||
19643599|NCT00402337|42093016|FG002|Overall Study|Other Reason|0|||
19643600|NCT00402337|42093017|FG003|Overall Study|Other Reason|0|||
19643601|NCT00402337|42093018|FG004|Overall Study|Other Reason|0|||
19749385|NCT02649946|42197545|FG000|Overall Study|Missed 6-month follow-up visit|0|||
19749386|NCT02649946|42197546|FG001|Overall Study|Missed 6-month follow-up visit|4|||
19749387|NCT03273153|42197554|FG000|Overall Study|Adverse Event|1|||
19749388|NCT03273153|42197555|FG001|Overall Study|Adverse Event|2|||
19749389|NCT03273153|42197554|FG000|Overall Study|Missing|0|||
19749390|NCT03273153|42197555|FG001|Overall Study|Missing|2|||
19643602|NCT00650091|42093032|FG000|Amended Study Design|Withdrawal by Subject|12|||
19643603|NCT00650091|42093033|FG001|Amended Study Design|Withdrawal by Subject|11|||
19643604|NCT00650091|42093034|FG002|Amended Study Design|Withdrawal by Subject|0|||
19643605|NCT00650091|42093032|FG000|Amended Study Design|Physician Decision|5|||
19643606|NCT00650091|42093033|FG001|Amended Study Design|Physician Decision|0|||
19643607|NCT00650091|42093034|FG002|Amended Study Design|Physician Decision|0|||
19643608|NCT00650091|42093032|FG000|Amended Study Design|Adverse Event|1|||
19643609|NCT00650091|42093033|FG001|Amended Study Design|Adverse Event|4|||
19749391|NCT03273153|42197554|FG000|Overall Study|Other|3|||
19749392|NCT03273153|42197555|FG001|Overall Study|Other|2|||
19643610|NCT00650091|42093034|FG002|Amended Study Design|Adverse Event|0|||
19643611|NCT00650091|42093032|FG000|Amended Study Design|Lung transplantation|4|||
19643612|NCT00650091|42093033|FG001|Amended Study Design|Lung transplantation|2|||
19643613|NCT00650091|42093034|FG002|Amended Study Design|Lung transplantation|0|||
19643614|NCT00650091|42093032|FG000|Amended Study Design|Other|1|||
19643615|NCT00650091|42093033|FG001|Amended Study Design|Other|3|||
19643616|NCT00650091|42093034|FG002|Amended Study Design|Other|0|||
19643617|NCT00642369|42093044|FG000|Overall Study|Adverse Event|2|||
19643618|NCT00642369|42093045|FG001|Overall Study|Adverse Event|3|||
19643619|NCT00642369|42093044|FG000|Overall Study|Withdrawal by Subject|1|||
19643620|NCT00642369|42093045|FG001|Overall Study|Withdrawal by Subject|0|||
19643621|NCT00642369|42093044|FG000|Overall Study|misdiagnosis|0|||
19643622|NCT00642369|42093045|FG001|Overall Study|misdiagnosis|1|||
19643623|NCT00642369|42093044|FG000|Overall Study|Lack of Efficacy|2|||
19643624|NCT00642369|42093045|FG001|Overall Study|Lack of Efficacy|2|||
19643625|NCT00645099|42093070|FG000|Overall Study|Lack of Efficacy|15|||
19643626|NCT00645099|42093071|FG001|Overall Study|Lack of Efficacy|6|||
19643627|NCT00645099|42093070|FG000|Overall Study|Withdrawal by Subject|30|||
19643628|NCT00645099|42093071|FG001|Overall Study|Withdrawal by Subject|22|||
19643629|NCT00645099|42093070|FG000|Overall Study|Lost to Follow-up|6|||
19643630|NCT00645099|42093071|FG001|Overall Study|Lost to Follow-up|4|||
19643631|NCT00645099|42093070|FG000|Overall Study|Adverse Event|11|||
19643632|NCT00645099|42093071|FG001|Overall Study|Adverse Event|5|||
19643633|NCT00645099|42093070|FG000|Overall Study|Other|9|||
19643634|NCT00645099|42093071|FG001|Overall Study|Other|5|||
19643635|NCT00420511|42093079|FG000|Overall Study|Adverse Event|1|||
19643636|NCT00420511|42093080|FG001|Overall Study|Adverse Event|1|||
19643637|NCT00420511|42093079|FG000|Overall Study|Lost to Follow-up|1|||
19643638|NCT00420511|42093080|FG001|Overall Study|Lost to Follow-up|0|||
19643639|NCT00420199|42093090|FG000|Overall Study|Participant no longer met study criteria|1|||
19643640|NCT00420199|42093091|FG001|Overall Study|Participant no longer met study criteria|0|||
19643641|NCT00649389|42093106|FG000|Overall Study|Adverse Event|22|||
19643642|NCT00649389|42093107|FG001|Overall Study|Adverse Event|46|||
19643643|NCT00649389|42093108|FG002|Overall Study|Adverse Event|38|||
19643644|NCT00649389|42093109|FG003|Overall Study|Adverse Event|48|||
19643645|NCT00649389|42093106|FG000|Overall Study|Lost to Follow-up|15|||
19643646|NCT00649389|42093107|FG001|Overall Study|Lost to Follow-up|17|||
19643647|NCT00649389|42093108|FG002|Overall Study|Lost to Follow-up|21|||
19643648|NCT00649389|42093109|FG003|Overall Study|Lost to Follow-up|26|||
19643649|NCT00649389|42093106|FG000|Overall Study|Protocol Violation|11|||
19643650|NCT00649389|42093107|FG001|Overall Study|Protocol Violation|13|||
19643651|NCT00649389|42093108|FG002|Overall Study|Protocol Violation|9|||
19643652|NCT00649389|42093109|FG003|Overall Study|Protocol Violation|8|||
19643653|NCT00649389|42093106|FG000|Overall Study|Withdrawal by Subject|20|||
19643654|NCT00649389|42093107|FG001|Overall Study|Withdrawal by Subject|21|||
19643655|NCT00649389|42093108|FG002|Overall Study|Withdrawal by Subject|19|||
19643656|NCT00649389|42093109|FG003|Overall Study|Withdrawal by Subject|23|||
19643657|NCT00649389|42093106|FG000|Overall Study|Other|3|||
19643658|NCT00649389|42093107|FG001|Overall Study|Other|9|||
19643659|NCT00649389|42093108|FG002|Overall Study|Other|1|||
19643660|NCT00649389|42093109|FG003|Overall Study|Other|6|||
19643661|NCT00402103|42093121|FG000|Overall Study|Adverse Event|60|||
19643662|NCT00402103|42093122|FG001|Overall Study|Adverse Event|7|||
19643663|NCT00402103|42093121|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19643664|NCT00402103|42093122|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19643665|NCT00402103|42093121|FG000|Overall Study|Condition no longer requires study drug|2|||
19643666|NCT00402103|42093122|FG001|Overall Study|Condition no longer requires study drug|0|||
19643667|NCT00402103|42093121|FG000|Overall Study|Protocol Deviation|8|||
19643668|NCT00402103|42093122|FG001|Overall Study|Protocol Deviation|0|||
19643669|NCT00402103|42093121|FG000|Overall Study|Patient withdrew consent|12|||
19643670|NCT00402103|42093122|FG001|Overall Study|Patient withdrew consent|1|||
19643671|NCT00402103|42093121|FG000|Overall Study|Lost to Follow-up|6|||
19643672|NCT00402103|42093122|FG001|Overall Study|Lost to Follow-up|3|||
19643673|NCT00402103|42093121|FG000|Overall Study|Administrative problems|2|||
19643674|NCT00402103|42093122|FG001|Overall Study|Administrative problems|0|||
19643675|NCT00641667|42093132|FG000|Overall Study|Withdrawal by Subject|1|||
19643676|NCT00641667|42093132|FG000|Overall Study|Adverse Event|1|||
19643677|NCT00641667|42093132|FG000|Overall Study|Physician Decision|1|||
19643678|NCT00641667|42093132|FG000|Overall Study|Worsening of underlying disease|3|||
19643679|NCT00704184|42093141|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
19643680|NCT00704184|42093142|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
19643681|NCT00704184|42093143|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
19643682|NCT00704184|42093144|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
19643683|NCT00704184|42093145|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
19643684|NCT00704184|42093141|FG000|Open-Label Treatment|Adverse Event|0|||
19643685|NCT00704184|42093142|FG001|Open-Label Treatment|Adverse Event|0|||
19749393|NCT03273153|42197554|FG000|Overall Study|Symptomatic Deterioration|0|||
19643686|NCT00704184|42093143|FG002|Open-Label Treatment|Adverse Event|2|||
19643687|NCT00704184|42093144|FG003|Open-Label Treatment|Adverse Event|0|||
19643688|NCT00704184|42093145|FG004|Open-Label Treatment|Adverse Event|1|||
19643689|NCT00704184|42093141|FG000|Open-Label Treatment|Lack of Efficacy|0|||
19643690|NCT00704184|42093142|FG001|Open-Label Treatment|Lack of Efficacy|2|||
19643691|NCT00704184|42093143|FG002|Open-Label Treatment|Lack of Efficacy|2|||
19643692|NCT00704184|42093144|FG003|Open-Label Treatment|Lack of Efficacy|2|||
19643693|NCT00704184|42093145|FG004|Open-Label Treatment|Lack of Efficacy|1|||
19643694|NCT00704184|42093141|FG000|Open-Label Treatment|Physician Decision|0|||
19643695|NCT00704184|42093142|FG001|Open-Label Treatment|Physician Decision|0|||
19643696|NCT00704184|42093143|FG002|Open-Label Treatment|Physician Decision|0|||
19643697|NCT00704184|42093144|FG003|Open-Label Treatment|Physician Decision|0|||
19643698|NCT00704184|42093145|FG004|Open-Label Treatment|Physician Decision|1|||
19643699|NCT00704184|42093141|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
19643700|NCT00704184|42093142|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
19643701|NCT00704184|42093143|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
19643702|NCT00704184|42093144|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
19643703|NCT00704184|42093145|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
19643704|NCT00641043|42093159|FG000|Overall Study|Adverse Event|6|||
19643705|NCT00641043|42093160|FG001|Overall Study|Adverse Event|4|||
19643706|NCT00641043|42093159|FG000|Overall Study|Protocol Violation|2|||
19643707|NCT00641043|42093160|FG001|Overall Study|Protocol Violation|3|||
19643708|NCT00641043|42093159|FG000|Overall Study|Lost to Follow-up|3|||
19749394|NCT03273153|42197555|FG001|Overall Study|Symptomatic Deterioration|1|||
19749395|NCT03273153|42197554|FG000|Overall Study|Progressive Disease|6|||
19749396|NCT03273153|42197555|FG001|Overall Study|Progressive Disease|5|||
19749397|NCT03273153|42197554|FG000|Overall Study|Physician Decision|1|||
19749398|NCT03273153|42197555|FG001|Overall Study|Physician Decision|3|||
19749399|NCT03273153|42197554|FG000|Overall Study|Study Terminated by Sponsor|112|||
19749400|NCT03273153|42197555|FG001|Overall Study|Study Terminated by Sponsor|102|||
19749401|NCT03273153|42197554|FG000|Overall Study|Withdrawal by Subject|26|||
19749402|NCT03273153|42197555|FG001|Overall Study|Withdrawal by Subject|25|||
19749403|NCT03273153|42197554|FG000|Overall Study|Protocol Deviation|3|||
19643709|NCT00641043|42093160|FG001|Overall Study|Lost to Follow-up|2|||
19643710|NCT00641043|42093159|FG000|Overall Study|Withdrawal by Subject|4|||
19643711|NCT00641043|42093160|FG001|Overall Study|Withdrawal by Subject|4|||
19643712|NCT00641043|42093159|FG000|Overall Study|Other incl. lack of efficacy|4|||
19643713|NCT00641043|42093160|FG001|Overall Study|Other incl. lack of efficacy|2|||
19643714|NCT00402025|42093169|FG000|Overall Study|Adverse Event|0|||
19643715|NCT00402025|42093170|FG001|Overall Study|Adverse Event|0|||
19643716|NCT00402025|42093171|FG002|Overall Study|Adverse Event|2|||
19643717|NCT00402025|42093169|FG000|Overall Study|Death|0|||
19643718|NCT00402025|42093170|FG001|Overall Study|Death|1|||
19643719|NCT00402025|42093171|FG002|Overall Study|Death|5|||
19643720|NCT00402025|42093169|FG000|Overall Study|Disease Progression|1|||
19643721|NCT00402025|42093170|FG001|Overall Study|Disease Progression|1|||
19643722|NCT00402025|42093171|FG002|Overall Study|Disease Progression|2|||
19643723|NCT00402025|42093169|FG000|Overall Study|Physician Decision|1|||
19643724|NCT00402025|42093170|FG001|Overall Study|Physician Decision|1|||
19643725|NCT00402025|42093171|FG002|Overall Study|Physician Decision|0|||
19643726|NCT00402025|42093169|FG000|Overall Study|Participant Decision|0|||
19643727|NCT00402025|42093170|FG001|Overall Study|Participant Decision|0|||
19643728|NCT00402025|42093171|FG002|Overall Study|Participant Decision|1|||
19643729|NCT00609622|42093181|FG000|Overall Study|Adverse Event|14|||
19643730|NCT00609622|42093182|FG001|Overall Study|Adverse Event|10|||
19643731|NCT00609622|42093181|FG000|Overall Study|Withdrawal by Subject|4|||
19643732|NCT00609622|42093182|FG001|Overall Study|Withdrawal by Subject|20|||
19477066|NCT01487161|41755908|FG000|Overall Study|Adverse Event|1|||
19643733|NCT00609622|42093181|FG000|Overall Study|Death|1|||
19643734|NCT00609622|42093182|FG001|Overall Study|Death|4|||
19643735|NCT00609622|42093181|FG000|Overall Study|Protocol Violation|1|||
19643736|NCT00609622|42093182|FG001|Overall Study|Protocol Violation|1|||
19643737|NCT00609622|42093181|FG000|Overall Study|Objective progression or relapse|47|||
19643738|NCT00609622|42093182|FG001|Overall Study|Objective progression or relapse|41|||
19643739|NCT00609622|42093181|FG000|Overall Study|Study terminated by sponsor|16|||
19643740|NCT00609622|42093182|FG001|Overall Study|Study terminated by sponsor|3|||
19643741|NCT00609622|42093181|FG000|Overall Study|Other|7|||
19643742|NCT00609622|42093182|FG001|Overall Study|Other|14|||
19643743|NCT00609622|42093181|FG000|Overall Study|Global deterioration of health status|6|||
19643744|NCT00609622|42093182|FG001|Overall Study|Global deterioration of health status|2|||
19643745|NCT00699816|42093190|FG000|Overall Study|Protocol Violation|1|||
19643746|NCT00699816|42093191|FG001|Overall Study|Protocol Violation|3|||
19643747|NCT00699660|42093199|FG000|Overall Study|Lost to Follow-up|4|||
19643748|NCT00699660|42093200|FG001|Overall Study|Lost to Follow-up|2|||
19643749|NCT00699660|42093199|FG000|Overall Study|missing reports and recording failures|10|||
19643750|NCT00699660|42093200|FG001|Overall Study|missing reports and recording failures|6|||
19643751|NCT00627705|42093208|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
19749404|NCT03273153|42197555|FG001|Overall Study|Protocol Deviation|0|||
19749405|NCT03273153|42197554|FG000|Overall Study|Lost to Follow-up|6|||
19749406|NCT03273153|42197555|FG001|Overall Study|Lost to Follow-up|11|||
19643752|NCT00627705|42093209|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
19643753|NCT00627705|42093208|FG000|Overall Study|Adverse Event|1|||
19643754|NCT00627705|42093209|FG001|Overall Study|Adverse Event|0|||
19643755|NCT00627705|42093208|FG000|Overall Study|Withdrawal by Subject|0|||
19643756|NCT00627705|42093209|FG001|Overall Study|Withdrawal by Subject|2|||
19643757|NCT00627705|42093208|FG000|Overall Study|Lost to Follow-up|0|||
19643758|NCT00627705|42093209|FG001|Overall Study|Lost to Follow-up|1|||
19643759|NCT00610168|42093217|FG000|Overall Study|Withdrawal by Subject|2|||
19643760|NCT00610168|42093218|FG001|Overall Study|Withdrawal by Subject|0|||
19643761|NCT00644787|42093224|FG000|Period 1: Titration Phase|Adverse Event|11|||
19643762|NCT00644787|42093225|FG001|Period 1: Titration Phase|Adverse Event|0|||
19643763|NCT00644787|42093226|FG002|Period 1: Titration Phase|Adverse Event|0|||
19643764|NCT00644787|42093224|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
19643765|NCT00644787|42093225|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
19749407|NCT03273153|42197554|FG000|Overall Study|Death|66|||
19749408|NCT03273153|42197555|FG001|Overall Study|Death|69|||
19749409|NCT03323034|42197567|FG000|Overall Study|Lack of Efficacy|5|||
19749410|NCT03323034|42197568|FG001|Overall Study|Lack of Efficacy|5|||
19643766|NCT00644787|42093226|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
19643767|NCT00644787|42093224|FG000|Period 1: Titration Phase|Physician Decision|1|||
19643768|NCT00644787|42093225|FG001|Period 1: Titration Phase|Physician Decision|0|||
19643769|NCT00644787|42093226|FG002|Period 1: Titration Phase|Physician Decision|0|||
19643770|NCT00644787|42093224|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
19643771|NCT00644787|42093225|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
19643772|NCT00644787|42093226|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
19643773|NCT00644787|42093224|FG000|Period 1: Titration Phase|Worsening of complications|1|||
19643774|NCT00644787|42093225|FG001|Period 1: Titration Phase|Worsening of complications|0|||
19643775|NCT00644787|42093226|FG002|Period 1: Titration Phase|Worsening of complications|0|||
19643776|NCT00644787|42093224|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
19643777|NCT00644787|42093225|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
19643778|NCT00644787|42093226|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
19643779|NCT00644787|42093224|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
19643780|NCT00644787|42093225|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
19643781|NCT00644787|42093226|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
19643782|NCT00644787|42093224|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
19643783|NCT00644787|42093225|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
19643784|NCT00644787|42093226|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
19643785|NCT00644787|42093224|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
19643786|NCT00644787|42093225|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
19643787|NCT00644787|42093226|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
19643788|NCT00644787|42093224|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
19643789|NCT00644787|42093225|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
19643790|NCT00644787|42093226|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
19643791|NCT00644787|42093224|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
19643792|NCT00644787|42093225|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
19643793|NCT00644787|42093226|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
19643794|NCT00644787|42093224|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
19643795|NCT00644787|42093225|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
19643796|NCT00644787|42093226|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
19643797|NCT00699582|42093237|FG000|Overall Study|Adverse Event|4|||
19643798|NCT00699582|42093238|FG001|Overall Study|Adverse Event|11|||
19643799|NCT00699582|42093239|FG002|Overall Study|Adverse Event|23|||
19643800|NCT00699582|42093237|FG000|Overall Study|Withdrawal by Subject|6|||
19643801|NCT00699582|42093238|FG001|Overall Study|Withdrawal by Subject|7|||
19643802|NCT00699582|42093239|FG002|Overall Study|Withdrawal by Subject|4|||
19643803|NCT00699582|42093237|FG000|Overall Study|Lack of Efficacy|1|||
19643804|NCT00699582|42093238|FG001|Overall Study|Lack of Efficacy|0|||
19643805|NCT00699582|42093239|FG002|Overall Study|Lack of Efficacy|1|||
19643806|NCT00699582|42093237|FG000|Overall Study|Progressive Disease|1|||
19643807|NCT00699582|42093238|FG001|Overall Study|Progressive Disease|0|||
19643808|NCT00699582|42093239|FG002|Overall Study|Progressive Disease|0|||
19643809|NCT00699582|42093237|FG000|Overall Study|Administrative/Other|4|||
19643810|NCT00699582|42093238|FG001|Overall Study|Administrative/Other|3|||
19643811|NCT00699582|42093239|FG002|Overall Study|Administrative/Other|0|||
19643812|NCT00699582|42093237|FG000|Overall Study|Randomized, Not Treated|2|||
19643813|NCT00699582|42093238|FG001|Overall Study|Randomized, Not Treated|1|||
19643814|NCT00699582|42093239|FG002|Overall Study|Randomized, Not Treated|0|||
19749411|NCT03323034|42197569|FG002|Overall Study|Lack of Efficacy|6|||
19749412|NCT03323034|42197570|FG003|Overall Study|Lack of Efficacy|5|||
19643815|NCT00640341|42093250|FG000|Overall Study|Adverse Event|0|||
19643816|NCT00640341|42093251|FG001|Overall Study|Adverse Event|0|||
19643817|NCT00640341|42093252|FG002|Overall Study|Adverse Event|1|||
19643818|NCT00640341|42093250|FG000|Overall Study|Positive Slit Lamp Findings|0|||
19643819|NCT00640341|42093251|FG001|Overall Study|Positive Slit Lamp Findings|0|||
19643820|NCT00640341|42093252|FG002|Overall Study|Positive Slit Lamp Findings|1|||
19643821|NCT00640341|42093250|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
19643822|NCT00640341|42093251|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
19643823|NCT00640341|42093252|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
19643824|NCT00640341|42093250|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
19643825|NCT00640341|42093251|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
19643826|NCT00640341|42093252|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
19643827|NCT00640341|42093250|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
19643828|NCT00640341|42093251|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
19643829|NCT00640341|42093252|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
19643830|NCT00640341|42093250|FG000|Overall Study|Lost to Follow-up|2|||
19643831|NCT00640341|42093251|FG001|Overall Study|Lost to Follow-up|0|||
19643832|NCT00640341|42093252|FG002|Overall Study|Lost to Follow-up|0|||
19643833|NCT00640341|42093250|FG000|Overall Study|Withdrawal by Subject|4|||
19643834|NCT00640341|42093251|FG001|Overall Study|Withdrawal by Subject|0|||
19643835|NCT00640341|42093252|FG002|Overall Study|Withdrawal by Subject|1|||
19643836|NCT00640341|42093250|FG000|Overall Study|Unacceptable Lens Movement|1|||
19643837|NCT00640341|42093251|FG001|Overall Study|Unacceptable Lens Movement|0|||
19643838|NCT00640341|42093252|FG002|Overall Study|Unacceptable Lens Movement|0|||
19643839|NCT00640341|42093250|FG000|Overall Study|Poor fit/Uncomfortable|4|||
19643840|NCT00640341|42093251|FG001|Overall Study|Poor fit/Uncomfortable|0|||
19643841|NCT00640341|42093252|FG002|Overall Study|Poor fit/Uncomfortable|0|||
19643842|NCT00640341|42093250|FG000|Overall Study|Ineligable at Baseline|5|||
19643843|NCT00640341|42093251|FG001|Overall Study|Ineligable at Baseline|3|||
19643844|NCT00640341|42093252|FG002|Overall Study|Ineligable at Baseline|2|||
19643845|NCT00640341|42093250|FG000|Overall Study|Adverse event and positive slit lamp|1|||
19643846|NCT00640341|42093251|FG001|Overall Study|Adverse event and positive slit lamp|0|||
19643847|NCT00640341|42093252|FG002|Overall Study|Adverse event and positive slit lamp|0|||
19643848|NCT00699348|42093260|FG000|Overall Study|Death|6|||
19643849|NCT00699348|42093260|FG000|Overall Study|Adverse Event|15|||
19643850|NCT00699348|42093260|FG000|Overall Study|Withdrawal by Subject|11|||
19643851|NCT00699348|42093260|FG000|Overall Study|Protocol Violation|10|||
19643852|NCT00699348|42093260|FG000|Overall Study|Lack of Efficacy|8|||
19643853|NCT00699348|42093260|FG000|Overall Study|Failure to return|1|||
19643854|NCT00699348|42093260|FG000|Overall Study|Blood transfusion|24|||
19643855|NCT00699348|42093260|FG000|Overall Study|Renal transplantation|10|||
19643856|NCT00699348|42093260|FG000|Overall Study|Other|5|||
19643857|NCT00643851|42093267|FG000|Overall Study|Death|0|||
19643858|NCT00643851|42093268|FG001|Overall Study|Death|1|||
19643859|NCT00643851|42093269|FG002|Overall Study|Death|0|||
19643860|NCT00643851|42093267|FG000|Overall Study|Lack of Efficacy|0|||
19643861|NCT00643851|42093268|FG001|Overall Study|Lack of Efficacy|1|||
19643862|NCT00643851|42093269|FG002|Overall Study|Lack of Efficacy|0|||
19749413|NCT03323034|42197571|FG004|Overall Study|Lack of Efficacy|5|||
19643863|NCT00643851|42093267|FG000|Overall Study|Adverse Event|2|||
19643864|NCT00643851|42093268|FG001|Overall Study|Adverse Event|6|||
19643865|NCT00643851|42093269|FG002|Overall Study|Adverse Event|6|||
19643866|NCT00643851|42093267|FG000|Overall Study|Lost to Follow-up|4|||
19643867|NCT00643851|42093268|FG001|Overall Study|Lost to Follow-up|6|||
19749414|NCT03323034|42197567|FG000|Overall Study|Physician Decision|0|||
19749415|NCT03323034|42197568|FG001|Overall Study|Physician Decision|0|||
19643868|NCT00643851|42093269|FG002|Overall Study|Lost to Follow-up|9|||
19643869|NCT00643851|42093267|FG000|Overall Study|Withdrawal by Subject|8|||
19643870|NCT00643851|42093268|FG001|Overall Study|Withdrawal by Subject|15|||
19643871|NCT00643851|42093269|FG002|Overall Study|Withdrawal by Subject|9|||
19749416|NCT03323034|42197569|FG002|Overall Study|Physician Decision|0|||
19749417|NCT03323034|42197570|FG003|Overall Study|Physician Decision|0|||
19749418|NCT03323034|42197571|FG004|Overall Study|Physician Decision|1|||
19749419|NCT03323034|42197567|FG000|Overall Study|Withdrawal by Subject|1|||
19749420|NCT03323034|42197568|FG001|Overall Study|Withdrawal by Subject|1|||
19749421|NCT03323034|42197569|FG002|Overall Study|Withdrawal by Subject|0|||
19749422|NCT03323034|42197570|FG003|Overall Study|Withdrawal by Subject|1|||
19749423|NCT03323034|42197571|FG004|Overall Study|Withdrawal by Subject|0|||
19749424|NCT03270657|42197602|FG000|Overall Study|Withdrawal by Subject|1|||
19749425|NCT03303417|42197606|FG000|Overall Study|Withdrawal by Subject|1|||
19749426|NCT03303417|42197607|FG001|Overall Study|Withdrawal by Subject|1|||
19643872|NCT00643851|42093267|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
19643873|NCT00643851|42093268|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
19643874|NCT00643851|42093269|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
19643875|NCT03667690|42093279|FG000|Overall Study|Adverse Event|0|||
19643876|NCT03667690|42093280|FG001|Overall Study|Adverse Event|3|||
19643877|NCT03667690|42093279|FG000|Overall Study|Death|22|||
19643878|NCT03667690|42093280|FG001|Overall Study|Death|21|||
19643879|NCT03667690|42093279|FG000|Overall Study|Lost to Follow-up|4|||
19643880|NCT03667690|42093280|FG001|Overall Study|Lost to Follow-up|5|||
19643881|NCT03667690|42093279|FG000|Overall Study|Withdrawal by Subject|7|||
19643882|NCT03667690|42093280|FG001|Overall Study|Withdrawal by Subject|8|||
19643883|NCT03667690|42093279|FG000|Overall Study|Subject could not return for additional investigational product|1|||
19643884|NCT03667690|42093280|FG001|Overall Study|Subject could not return for additional investigational product|0|||
19643885|NCT03667690|42093279|FG000|Overall Study|Subject discharged to hospice care|2|||
19643886|NCT03667690|42093280|FG001|Overall Study|Subject discharged to hospice care|0|||
19643887|NCT03667690|42093279|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
19643888|NCT03667690|42093280|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
19643889|NCT03667690|42093279|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
19643890|NCT03667690|42093280|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
19643891|NCT03667690|42093279|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
19643892|NCT03667690|42093280|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
19643893|NCT03667690|42093279|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
19643894|NCT03667690|42093280|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
19643895|NCT03667690|42093279|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
19643896|NCT03667690|42093280|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
19643897|NCT00627393|42093288|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
19643898|NCT00627393|42093289|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
19643899|NCT00627393|42093288|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
19643900|NCT00627393|42093289|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
19643901|NCT00627393|42093288|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
19643902|NCT00627393|42093289|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
19643903|NCT00627393|42093288|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
19643904|NCT00627393|42093289|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
19643905|NCT00577122|42093299|FG000|Overall Study|Adverse Event|0|||
19643906|NCT00577122|42093300|FG001|Overall Study|Adverse Event|2|||
19643907|NCT00577122|42093299|FG000|Overall Study|Progression, relapse during active trt|6|||
19643908|NCT00577122|42093300|FG001|Overall Study|Progression, relapse during active trt|8|||
19643909|NCT00577122|42093299|FG000|Overall Study|Prog, refract disease during active trt|8|||
19643910|NCT00577122|42093300|FG001|Overall Study|Prog, refract disease during active trt|5|||
19643911|NCT00577122|42093299|FG000|Overall Study|Alternative Therapy|0|||
19643912|NCT00577122|42093300|FG001|Overall Study|Alternative Therapy|1|||
19643913|NCT00696774|42093310|FG000|Period II|Adverse Event|0|||
19643914|NCT00696774|42093311|FG001|Period II|Adverse Event|0|||
19643915|NCT00696774|42093312|FG002|Period II|Adverse Event|15|||
19643916|NCT00696774|42093310|FG000|Period II|Lost to Follow-up|0|||
19643917|NCT00696774|42093311|FG001|Period II|Lost to Follow-up|0|||
19643918|NCT00696774|42093312|FG002|Period II|Lost to Follow-up|4|||
19643919|NCT00696774|42093310|FG000|Period II|Protocol Violation|0|||
19643920|NCT00696774|42093311|FG001|Period II|Protocol Violation|0|||
19643921|NCT00696774|42093312|FG002|Period II|Protocol Violation|11|||
19643922|NCT00696774|42093310|FG000|Period II|Withdrawal by Subject|0|||
19643923|NCT00696774|42093311|FG001|Period II|Withdrawal by Subject|0|||
19643924|NCT00696774|42093312|FG002|Period II|Withdrawal by Subject|4|||
19643925|NCT00696774|42093310|FG000|Period II|Sponsor Decision|0|||
19643926|NCT00696774|42093311|FG001|Period II|Sponsor Decision|0|||
19643927|NCT00696774|42093312|FG002|Period II|Sponsor Decision|0|||
19643928|NCT00696774|42093310|FG000|Period II|Lack of Efficacy|0|||
19643929|NCT00696774|42093311|FG001|Period II|Lack of Efficacy|0|||
19643930|NCT00696774|42093312|FG002|Period II|Lack of Efficacy|2|||
19643931|NCT00696774|42093310|FG000|Period III|Adverse Event|1|||
19643932|NCT00696774|42093311|FG001|Period III|Adverse Event|1|||
19643933|NCT00696774|42093312|FG002|Period III|Adverse Event|0|||
19643934|NCT00696774|42093310|FG000|Period III|Lost to Follow-up|2|||
19643935|NCT00696774|42093311|FG001|Period III|Lost to Follow-up|1|||
19643936|NCT00696774|42093312|FG002|Period III|Lost to Follow-up|0|||
19749427|NCT02943564|42197616|FG000|Overall Study|Miscellaneous Reasons|0|||
19643937|NCT00696774|42093310|FG000|Period III|Protocol Violation|1|||
19643938|NCT00696774|42093311|FG001|Period III|Protocol Violation|1|||
19643939|NCT00696774|42093312|FG002|Period III|Protocol Violation|0|||
19643940|NCT00696774|42093310|FG000|Period III|Withdrawal by Subject|1|||
19643941|NCT00696774|42093311|FG001|Period III|Withdrawal by Subject|2|||
19643942|NCT00696774|42093312|FG002|Period III|Withdrawal by Subject|0|||
19643943|NCT00696774|42093310|FG000|Period III|Sponsor Decision|2|||
19643944|NCT00696774|42093311|FG001|Period III|Sponsor Decision|0|||
19643945|NCT00696774|42093312|FG002|Period III|Sponsor Decision|0|||
19643946|NCT00696774|42093310|FG000|Period III|Lack of Efficacy|0|||
19643947|NCT00696774|42093311|FG001|Period III|Lack of Efficacy|2|||
19643948|NCT00696774|42093312|FG002|Period III|Lack of Efficacy|0|||
19643949|NCT00608842|42093324|FG000|Overall Study|Participant's Request|0|||
19643950|NCT00608842|42093325|FG001|Overall Study|Participant's Request|1|||
19643951|NCT00608842|42093326|FG002|Overall Study|Participant's Request|2|||
19643952|NCT00608842|42093327|FG003|Overall Study|Participant's Request|1|||
19643953|NCT00608842|42093324|FG000|Overall Study|Lost to Follow-up|1|||
19643954|NCT00608842|42093325|FG001|Overall Study|Lost to Follow-up|0|||
19643955|NCT00608842|42093326|FG002|Overall Study|Lost to Follow-up|0|||
19643956|NCT00608842|42093327|FG003|Overall Study|Lost to Follow-up|0|||
19643957|NCT00626925|42093339|FG000|Overall Study|Lost to Follow-up|1|||
19643958|NCT00626925|42093340|FG001|Overall Study|Lost to Follow-up|2|||
19643959|NCT00626925|42093339|FG000|Overall Study|relapse|1|||
19643960|NCT00626925|42093340|FG001|Overall Study|relapse|0|||
19643961|NCT00626925|42093339|FG000|Overall Study|Adverse effect|6|||
19643962|NCT00626925|42093340|FG001|Overall Study|Adverse effect|2|||
19643963|NCT00626925|42093339|FG000|Overall Study|Lack of Efficacy|1|||
19643964|NCT00626925|42093340|FG001|Overall Study|Lack of Efficacy|4|||
19643965|NCT00626925|42093339|FG000|Overall Study|Time constraints|3|||
19643966|NCT00626925|42093340|FG001|Overall Study|Time constraints|1|||
19643967|NCT00698646|42093363|FG000|Overall Study|Adverse Event|8|||
19643968|NCT00698646|42093364|FG001|Overall Study|Adverse Event|7|||
19643969|NCT00698646|42093365|FG002|Overall Study|Adverse Event|8|||
19643970|NCT00698646|42093363|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
19643971|NCT00698646|42093364|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
19643972|NCT00698646|42093365|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
19643973|NCT00698646|42093363|FG000|Overall Study|Protocol Deviation|6|||
19643974|NCT00698646|42093364|FG001|Overall Study|Protocol Deviation|2|||
19643975|NCT00698646|42093365|FG002|Overall Study|Protocol Deviation|3|||
19643976|NCT00698646|42093363|FG000|Overall Study|Withdrawal by Subject|10|||
19643977|NCT00698646|42093364|FG001|Overall Study|Withdrawal by Subject|11|||
19643978|NCT00698646|42093365|FG002|Overall Study|Withdrawal by Subject|8|||
19643979|NCT00698646|42093363|FG000|Overall Study|Lost to Follow-up|0|||
19643980|NCT00698646|42093364|FG001|Overall Study|Lost to Follow-up|0|||
19643981|NCT00698646|42093365|FG002|Overall Study|Lost to Follow-up|2|||
19643982|NCT00698646|42093363|FG000|Overall Study|Administrative problems|1|||
19643983|NCT00698646|42093364|FG001|Overall Study|Administrative problems|0|||
19643984|NCT00698646|42093365|FG002|Overall Study|Administrative problems|1|||
19643985|NCT00609466|42093376|FG000|Overall Study|Withdrawal by Subject|0|||
19643986|NCT00609466|42093377|FG001|Overall Study|Withdrawal by Subject|1|||
19643987|NCT00609466|42093378|FG002|Overall Study|Withdrawal by Subject|1|||
19643988|NCT00609466|42093376|FG000|Overall Study|Adverse Event|2|||
19643989|NCT00609466|42093377|FG001|Overall Study|Adverse Event|3|||
19643990|NCT00609466|42093378|FG002|Overall Study|Adverse Event|1|||
19643991|NCT00609466|42093376|FG000|Overall Study|Lack of Efficacy|0|||
19643992|NCT00609466|42093377|FG001|Overall Study|Lack of Efficacy|2|||
19643993|NCT00609466|42093378|FG002|Overall Study|Lack of Efficacy|2|||
19643994|NCT00608530|42093390|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
19643995|NCT00608530|42093391|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
19643996|NCT00608530|42093392|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
19643997|NCT00608530|42093393|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
19643998|NCT00608530|42093390|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
19643999|NCT00608530|42093391|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
19644000|NCT00608530|42093392|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
19644001|NCT00608530|42093393|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
19644002|NCT00608530|42093390|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
19644003|NCT00608530|42093391|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
19644004|NCT00608530|42093392|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
19644005|NCT00608530|42093393|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
19644006|NCT00608530|42093390|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
19644007|NCT00608530|42093391|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
19644008|NCT00608530|42093392|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
19644009|NCT00608530|42093393|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
19644010|NCT00608530|42093390|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
19644011|NCT00608530|42093391|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
19644012|NCT00608530|42093392|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
19644013|NCT00608530|42093393|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
19644014|NCT00608530|42093390|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
19644015|NCT00608530|42093391|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
19644016|NCT00608530|42093392|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
19644017|NCT00608530|42093393|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
19644018|NCT00642993|42093410|FG000|Overall Study|Adverse Event|85|||
19644019|NCT00642993|42093411|FG001|Overall Study|Adverse Event|4|||
19644020|NCT00642993|42093410|FG000|Overall Study|Lost to Follow-up|8|||
19644021|NCT00642993|42093411|FG001|Overall Study|Lost to Follow-up|4|||
19644022|NCT00642993|42093410|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
19644023|NCT00642993|42093411|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
19644024|NCT00642993|42093410|FG000|Overall Study|Protocol Violation|1|||
19644025|NCT00642993|42093411|FG001|Overall Study|Protocol Violation|4|||
19644026|NCT00642993|42093410|FG000|Overall Study|Did not meet protocol eligibility|0|||
19644027|NCT00642993|42093411|FG001|Overall Study|Did not meet protocol eligibility|1|||
19644028|NCT00642993|42093410|FG000|Overall Study|Administrative|1|||
19644029|NCT00642993|42093411|FG001|Overall Study|Administrative|0|||
19644030|NCT00696696|42093417|FG000|Overall Study|Adverse Event|5|||
19644031|NCT00696696|42093417|FG000|Overall Study|Withdrawal by Subject|8|||
19644032|NCT00696696|42093417|FG000|Overall Study|Physician Decision|2|||
19644033|NCT00696696|42093417|FG000|Overall Study|Death|3|||
19644034|NCT00699192|42093424|FG000|Overall Study|Missing|1|||
19644035|NCT00699192|42093425|FG001|Overall Study|Missing|1|||
19644036|NCT00699192|42093426|FG002|Overall Study|Missing|1|||
19644037|NCT00699192|42093424|FG000|Overall Study|Adverse Event|9|||
19644038|NCT00699192|42093425|FG001|Overall Study|Adverse Event|4|||
19644039|NCT00699192|42093426|FG002|Overall Study|Adverse Event|3|||
19644040|NCT00699192|42093424|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19644041|NCT00699192|42093425|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19644042|NCT00699192|42093426|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19644043|NCT00699192|42093424|FG000|Overall Study|Lack of Efficacy|0|||
19644044|NCT00699192|42093425|FG001|Overall Study|Lack of Efficacy|0|||
19644045|NCT00699192|42093426|FG002|Overall Study|Lack of Efficacy|1|||
19644046|NCT00699192|42093424|FG000|Overall Study|Withdrawal by Subject|3|||
19644047|NCT00699192|42093425|FG001|Overall Study|Withdrawal by Subject|2|||
19644048|NCT00699192|42093426|FG002|Overall Study|Withdrawal by Subject|4|||
19644049|NCT00699192|42093424|FG000|Overall Study|Administrative problems|1|||
19644050|NCT00699192|42093425|FG001|Overall Study|Administrative problems|3|||
19644051|NCT00699192|42093426|FG002|Overall Study|Administrative problems|1|||
19644052|NCT00699192|42093424|FG000|Overall Study|Protocol Violation|2|||
19644053|NCT00699192|42093425|FG001|Overall Study|Protocol Violation|2|||
19644054|NCT00699192|42093426|FG002|Overall Study|Protocol Violation|0|||
19698909|NCT00313586|42143713|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
19698910|NCT00313586|42143714|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
19698911|NCT00313586|42143715|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
19698912|NCT00313586|42143716|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
19698913|NCT00313586|42143713|FG000|Overall Study|Lost insurance|0|||
19698914|NCT00313586|42143714|FG001|Overall Study|Lost insurance|1|||
19698915|NCT00313586|42143715|FG002|Overall Study|Lost insurance|0|||
19698916|NCT00313586|42143716|FG003|Overall Study|Lost insurance|0|||
19698917|NCT00313586|42143713|FG000|Overall Study|Moved|0|||
19749428|NCT02943564|42197617|FG001|Overall Study|Miscellaneous Reasons|0|||
19749429|NCT02943564|42197618|FG002|Overall Study|Miscellaneous Reasons|3|||
19749430|NCT02943564|42197616|FG000|Overall Study|Site terminated by sponsor|0|||
19698918|NCT00313586|42143714|FG001|Overall Study|Moved|1|||
19698919|NCT00313586|42143715|FG002|Overall Study|Moved|0|||
19644055|NCT00401245|42093442|FG000|Double Blind Titration Phase|Adverse Event|3|||
19644056|NCT00401245|42093443|FG001|Double Blind Titration Phase|Adverse Event|2|||
19644057|NCT00401245|42093444|FG002|Double Blind Titration Phase|Adverse Event|5|||
19644058|NCT00401245|42093445|FG003|Double Blind Titration Phase|Adverse Event|12|||
19644059|NCT00401245|42093446|FG004|Double Blind Titration Phase|Adverse Event|0|||
19644060|NCT00401245|42093447|FG005|Double Blind Titration Phase|Adverse Event|0|||
19644061|NCT00401245|42093448|FG006|Double Blind Titration Phase|Adverse Event|0|||
19644062|NCT00401245|42093449|FG007|Double Blind Titration Phase|Adverse Event|0|||
19644063|NCT00401245|42093442|FG000|Double Blind Titration Phase|Other|0|||
19644064|NCT00401245|42093443|FG001|Double Blind Titration Phase|Other|0|||
19644065|NCT00401245|42093444|FG002|Double Blind Titration Phase|Other|1|||
19644066|NCT00401245|42093445|FG003|Double Blind Titration Phase|Other|0|||
19644067|NCT00401245|42093446|FG004|Double Blind Titration Phase|Other|0|||
19644068|NCT00401245|42093447|FG005|Double Blind Titration Phase|Other|0|||
19644069|NCT00401245|42093448|FG006|Double Blind Titration Phase|Other|0|||
19644070|NCT00401245|42093449|FG007|Double Blind Titration Phase|Other|0|||
19644071|NCT00401245|42093442|FG000|Double Blind Titration Phase|Protocol Violation|0|||
19644072|NCT00401245|42093443|FG001|Double Blind Titration Phase|Protocol Violation|0|||
19644073|NCT00401245|42093444|FG002|Double Blind Titration Phase|Protocol Violation|0|||
19644074|NCT00401245|42093445|FG003|Double Blind Titration Phase|Protocol Violation|1|||
19644075|NCT00401245|42093446|FG004|Double Blind Titration Phase|Protocol Violation|0|||
19644076|NCT00401245|42093447|FG005|Double Blind Titration Phase|Protocol Violation|0|||
19644077|NCT00401245|42093448|FG006|Double Blind Titration Phase|Protocol Violation|0|||
19644078|NCT00401245|42093449|FG007|Double Blind Titration Phase|Protocol Violation|0|||
19644079|NCT00401245|42093442|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
19644080|NCT00401245|42093443|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
19644081|NCT00401245|42093444|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
19644082|NCT00401245|42093445|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
19644083|NCT00401245|42093446|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
19644084|NCT00401245|42093447|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
19644085|NCT00401245|42093448|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
19644086|NCT00401245|42093449|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
19644087|NCT00401245|42093442|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19600766|NCT00783718|42049643|FG005|Maintenance Phase|Withdrawal by Subject|2|||
19600767|NCT00783718|42049644|FG006|Maintenance Phase|Withdrawal by Subject|20|||
19600768|NCT00783718|42049638|FG000|Maintenance Phase|Lost to Follow-up|3|||
19600769|NCT00783718|42049639|FG001|Maintenance Phase|Lost to Follow-up|0|||
19600770|NCT00783718|42049640|FG002|Maintenance Phase|Lost to Follow-up|0|||
19600771|NCT00783718|42049641|FG003|Maintenance Phase|Lost to Follow-up|0|||
19600772|NCT00783718|42049642|FG004|Maintenance Phase|Lost to Follow-up|2|||
19600773|NCT00783718|42049643|FG005|Maintenance Phase|Lost to Follow-up|0|||
19600774|NCT00783718|42049644|FG006|Maintenance Phase|Lost to Follow-up|2|||
19600775|NCT00774748|42049663|FG000|Overall Study|Lost to Follow-up|3|||
19608702|NCT00978341|42057752|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
19608703|NCT00978341|42057753|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
19608704|NCT00978029|42057763|FG000|Overall Study|Adverse Event|1|||
19608705|NCT00978029|42057764|FG001|Overall Study|Adverse Event|2|||
19608706|NCT00978029|42057765|FG002|Overall Study|Adverse Event|5|||
19608707|NCT00978029|42057763|FG000|Overall Study|Withdrawal by Subject|0|||
19608708|NCT00978029|42057764|FG001|Overall Study|Withdrawal by Subject|0|||
19608709|NCT00978029|42057765|FG002|Overall Study|Withdrawal by Subject|1|||
19608710|NCT00978029|42057763|FG000|Overall Study|Protocol Violation|0|||
19608711|NCT00978029|42057764|FG001|Overall Study|Protocol Violation|1|||
19608712|NCT00978029|42057765|FG002|Overall Study|Protocol Violation|0|||
19608713|NCT00871377|42057773|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
19608714|NCT00871377|42057774|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
19608715|NCT00871377|42057775|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
19608716|NCT00871377|42057776|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
19608717|NCT00871377|42057777|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
19608718|NCT00871377|42057778|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
19608719|NCT00871377|42057773|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
19608720|NCT00871377|42057774|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
19608721|NCT00871377|42057775|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
19608722|NCT00871377|42057776|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
19608723|NCT00871377|42057777|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
19608724|NCT00871377|42057778|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
19608725|NCT00871377|42057773|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
19644088|NCT00401245|42093443|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
19608726|NCT00871377|42057774|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608727|NCT00871377|42057775|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608728|NCT00871377|42057776|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
19644089|NCT00401245|42093444|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19644090|NCT00401245|42093445|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
19644091|NCT00401245|42093446|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19644092|NCT00401245|42093447|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19644093|NCT00401245|42093448|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19644094|NCT00401245|42093449|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
19644095|NCT00401245|42093442|FG000|Open Label Phase|Adverse Event|5|||
19644096|NCT00401245|42093443|FG001|Open Label Phase|Adverse Event|14|||
19644097|NCT00401245|42093444|FG002|Open Label Phase|Adverse Event|6|||
19644098|NCT00401245|42093445|FG003|Open Label Phase|Adverse Event|7|||
19644099|NCT00401245|42093446|FG004|Open Label Phase|Adverse Event|0|||
19644100|NCT00401245|42093447|FG005|Open Label Phase|Adverse Event|0|||
19644101|NCT00401245|42093448|FG006|Open Label Phase|Adverse Event|0|||
19644102|NCT00401245|42093449|FG007|Open Label Phase|Adverse Event|0|||
19644103|NCT00401245|42093442|FG000|Open Label Phase|Lost to Follow-up|5|||
19644104|NCT00401245|42093443|FG001|Open Label Phase|Lost to Follow-up|7|||
19644105|NCT00401245|42093444|FG002|Open Label Phase|Lost to Follow-up|5|||
19644106|NCT00401245|42093445|FG003|Open Label Phase|Lost to Follow-up|4|||
19644107|NCT00401245|42093446|FG004|Open Label Phase|Lost to Follow-up|0|||
19644108|NCT00401245|42093447|FG005|Open Label Phase|Lost to Follow-up|0|||
19644109|NCT00401245|42093448|FG006|Open Label Phase|Lost to Follow-up|0|||
19644110|NCT00401245|42093449|FG007|Open Label Phase|Lost to Follow-up|0|||
19644111|NCT00401245|42093442|FG000|Open Label Phase|Other|4|||
19644112|NCT00401245|42093443|FG001|Open Label Phase|Other|8|||
19644113|NCT00401245|42093444|FG002|Open Label Phase|Other|7|||
19644114|NCT00401245|42093445|FG003|Open Label Phase|Other|8|||
19644115|NCT00401245|42093446|FG004|Open Label Phase|Other|0|||
19644116|NCT00401245|42093447|FG005|Open Label Phase|Other|0|||
19644117|NCT00401245|42093448|FG006|Open Label Phase|Other|0|||
19644118|NCT00401245|42093449|FG007|Open Label Phase|Other|0|||
19644119|NCT00401245|42093442|FG000|Open Label Phase|Protocol Violation|0|||
19644120|NCT00401245|42093443|FG001|Open Label Phase|Protocol Violation|1|||
19644121|NCT00401245|42093444|FG002|Open Label Phase|Protocol Violation|0|||
19644122|NCT00401245|42093445|FG003|Open Label Phase|Protocol Violation|1|||
19644123|NCT00401245|42093446|FG004|Open Label Phase|Protocol Violation|0|||
19644124|NCT00401245|42093447|FG005|Open Label Phase|Protocol Violation|0|||
19644125|NCT00401245|42093448|FG006|Open Label Phase|Protocol Violation|0|||
19644126|NCT00401245|42093449|FG007|Open Label Phase|Protocol Violation|0|||
19644127|NCT00401245|42093442|FG000|Open Label Phase|Withdrawal by Subject|3|||
19644128|NCT00401245|42093443|FG001|Open Label Phase|Withdrawal by Subject|3|||
19644129|NCT00401245|42093444|FG002|Open Label Phase|Withdrawal by Subject|2|||
19644130|NCT00401245|42093445|FG003|Open Label Phase|Withdrawal by Subject|1|||
19644131|NCT00401245|42093446|FG004|Open Label Phase|Withdrawal by Subject|0|||
19644132|NCT00401245|42093447|FG005|Open Label Phase|Withdrawal by Subject|0|||
19644133|NCT00401245|42093448|FG006|Open Label Phase|Withdrawal by Subject|0|||
19644134|NCT00401245|42093449|FG007|Open Label Phase|Withdrawal by Subject|0|||
19644135|NCT00401245|42093442|FG000|Open Label Phase|Lack of Efficacy|4|||
19644136|NCT00401245|42093443|FG001|Open Label Phase|Lack of Efficacy|2|||
19644137|NCT00401245|42093444|FG002|Open Label Phase|Lack of Efficacy|3|||
19644138|NCT00401245|42093445|FG003|Open Label Phase|Lack of Efficacy|0|||
19644139|NCT00401245|42093446|FG004|Open Label Phase|Lack of Efficacy|0|||
19644140|NCT00401245|42093447|FG005|Open Label Phase|Lack of Efficacy|0|||
19644141|NCT00401245|42093448|FG006|Open Label Phase|Lack of Efficacy|0|||
19644142|NCT00401245|42093449|FG007|Open Label Phase|Lack of Efficacy|0|||
19749431|NCT02943564|42197617|FG001|Overall Study|Site terminated by sponsor|1|||
19749432|NCT02943564|42197618|FG002|Overall Study|Site terminated by sponsor|0|||
19749433|NCT02943564|42197616|FG000|Overall Study|Non-compliance with study drug|0|||
19749434|NCT02943564|42197617|FG001|Overall Study|Non-compliance with study drug|1|||
19644143|NCT00401245|42093442|FG000|Double Blind Tapering Phase|Adverse Event|0|||
19644144|NCT00401245|42093443|FG001|Double Blind Tapering Phase|Adverse Event|0|||
19644145|NCT00401245|42093444|FG002|Double Blind Tapering Phase|Adverse Event|0|||
19644146|NCT00401245|42093445|FG003|Double Blind Tapering Phase|Adverse Event|0|||
19644147|NCT00401245|42093446|FG004|Double Blind Tapering Phase|Adverse Event|1|||
19644148|NCT00401245|42093447|FG005|Double Blind Tapering Phase|Adverse Event|1|||
19644149|NCT00401245|42093448|FG006|Double Blind Tapering Phase|Adverse Event|2|||
19644150|NCT00401245|42093449|FG007|Double Blind Tapering Phase|Adverse Event|4|||
19644151|NCT00401245|42093442|FG000|Double Blind Tapering Phase|Investigator request|0|||
19644152|NCT00401245|42093443|FG001|Double Blind Tapering Phase|Investigator request|0|||
19644153|NCT00401245|42093444|FG002|Double Blind Tapering Phase|Investigator request|0|||
19644154|NCT00401245|42093445|FG003|Double Blind Tapering Phase|Investigator request|0|||
19644155|NCT00401245|42093446|FG004|Double Blind Tapering Phase|Investigator request|0|||
19644156|NCT00401245|42093447|FG005|Double Blind Tapering Phase|Investigator request|0|||
19644157|NCT00401245|42093448|FG006|Double Blind Tapering Phase|Investigator request|0|||
19644158|NCT00401245|42093449|FG007|Double Blind Tapering Phase|Investigator request|1|||
19644159|NCT00401245|42093442|FG000|Double Blind Tapering Phase|Other|0|||
19644160|NCT00401245|42093443|FG001|Double Blind Tapering Phase|Other|0|||
19644161|NCT00401245|42093444|FG002|Double Blind Tapering Phase|Other|0|||
19644162|NCT00401245|42093445|FG003|Double Blind Tapering Phase|Other|0|||
19644163|NCT00401245|42093446|FG004|Double Blind Tapering Phase|Other|1|||
19644164|NCT00401245|42093447|FG005|Double Blind Tapering Phase|Other|0|||
19644165|NCT00401245|42093448|FG006|Double Blind Tapering Phase|Other|2|||
19749435|NCT02943564|42197618|FG002|Overall Study|Non-compliance with study drug|0|||
19749436|NCT02943564|42197616|FG000|Overall Study|Pregnancy|0|||
19749437|NCT02943564|42197617|FG001|Overall Study|Pregnancy|1|||
19749438|NCT02943564|42197618|FG002|Overall Study|Pregnancy|1|||
19749439|NCT02943564|42197616|FG000|Overall Study|Protocol Violation|2|||
19749440|NCT02943564|42197617|FG001|Overall Study|Protocol Violation|2|||
19749441|NCT02943564|42197618|FG002|Overall Study|Protocol Violation|2|||
19749442|NCT02943564|42197616|FG000|Overall Study|Lost to Follow-up|1|||
19749443|NCT02943564|42197617|FG001|Overall Study|Lost to Follow-up|0|||
19749444|NCT02943564|42197618|FG002|Overall Study|Lost to Follow-up|0|||
19749445|NCT02943564|42197616|FG000|Overall Study|Withdrawal by Subject|6|||
19749446|NCT02943564|42197617|FG001|Overall Study|Withdrawal by Subject|5|||
19749447|NCT02943564|42197618|FG002|Overall Study|Withdrawal by Subject|2|||
19749448|NCT02943564|42197616|FG000|Overall Study|Adverse Event|1|||
19749449|NCT02943564|42197617|FG001|Overall Study|Adverse Event|2|||
19749450|NCT02943564|42197618|FG002|Overall Study|Adverse Event|1|||
19749451|NCT02943564|42197616|FG000|Overall Study|Lack of Efficacy|0|||
19749452|NCT02943564|42197617|FG001|Overall Study|Lack of Efficacy|1|||
19749453|NCT02943564|42197618|FG002|Overall Study|Lack of Efficacy|0|||
19749454|NCT03268941|42197630|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749455|NCT03268941|42197631|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749456|NCT03268941|42197632|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749457|NCT03268941|42197633|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
19749458|NCT03268941|42197634|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749459|NCT03268941|42197635|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749460|NCT03268941|42197636|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
19749461|NCT03268941|42197630|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749462|NCT03268941|42197631|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749463|NCT03268941|42197632|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749464|NCT03268941|42197633|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
19749465|NCT03268941|42197634|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749466|NCT03268941|42197635|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749467|NCT03268941|42197636|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
19749468|NCT03268941|42197630|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
19749469|NCT03268941|42197631|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749470|NCT03268941|42197632|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749471|NCT03268941|42197633|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749472|NCT03268941|42197634|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749473|NCT03268941|42197635|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749474|NCT03268941|42197636|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
19749475|NCT03268941|42197630|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
19749476|NCT03268941|42197631|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
19749477|NCT03268941|42197632|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
19749478|NCT03268941|42197633|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
19749479|NCT03268941|42197634|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
19749480|NCT03268941|42197635|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
19749481|NCT03268941|42197636|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
19749482|NCT03268941|42197630|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19749483|NCT03268941|42197631|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19749484|NCT03268941|42197632|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19749485|NCT03268941|42197633|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19749486|NCT03268941|42197634|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19644166|NCT00401245|42093449|FG007|Double Blind Tapering Phase|Other|2|||
19644167|NCT00401245|42093442|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
19644168|NCT00401245|42093443|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
19644169|NCT00401245|42093444|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
19644170|NCT00401245|42093445|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
19749487|NCT03268941|42197635|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
19749488|NCT03268941|42197636|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
19749489|NCT03245619|42197713|FG000|Part A (Up to Day 22)|Physician Decision|4|||
19749490|NCT03245619|42197714|FG001|Part A (Up to Day 22)|Physician Decision|6|||
19644171|NCT00401245|42093446|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
19644172|NCT00401245|42093447|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
19749491|NCT03245619|42197715|FG002|Part A (Up to Day 22)|Physician Decision|6|||
19749492|NCT03245619|42197716|FG003|Part A (Up to Day 22)|Physician Decision|0|||
19749493|NCT03245619|42197717|FG004|Part A (Up to Day 22)|Physician Decision|0|||
19749494|NCT03245619|42197718|FG005|Part A (Up to Day 22)|Physician Decision|0|||
19749495|NCT03245619|42197719|FG006|Part A (Up to Day 22)|Physician Decision|0|||
19749496|NCT03245619|42197720|FG007|Part A (Up to Day 22)|Physician Decision|0|||
19644173|NCT00401245|42093448|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
19644174|NCT00401245|42093449|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
19749497|NCT03245619|42197721|FG008|Part A (Up to Day 22)|Physician Decision|0|||
19749498|NCT03245619|42197722|FG009|Part A (Up to Day 22)|Physician Decision|0|||
19749499|NCT03245619|42197723|FG010|Part A (Up to Day 22)|Physician Decision|0|||
19749500|NCT03245619|42197724|FG011|Part A (Up to Day 22)|Physician Decision|0|||
19749501|NCT03245619|42197725|FG012|Part A (Up to Day 22)|Physician Decision|0|||
19749502|NCT03245619|42197726|FG013|Part A (Up to Day 22)|Physician Decision|0|||
19749503|NCT03245619|42197727|FG014|Part A (Up to Day 22)|Physician Decision|0|||
19749504|NCT03245619|42197728|FG015|Part A (Up to Day 22)|Physician Decision|0|||
19749505|NCT03245619|42197729|FG016|Part A (Up to Day 22)|Physician Decision|0|||
19749506|NCT04472650|42197790|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
19749507|NCT04472650|42197791|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
19749508|NCT02606461|42197803|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
19749509|NCT02606461|42197804|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
19749510|NCT02606461|42197805|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
19749511|NCT02606461|42197806|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
19644175|NCT00401245|42093442|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644176|NCT00401245|42093443|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644177|NCT00401245|42093444|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644178|NCT00401245|42093445|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644179|NCT00401245|42093446|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644180|NCT00401245|42093447|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
19644181|NCT00401245|42093448|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644182|NCT00401245|42093449|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
19644183|NCT00696384|42093469|FG000|Open Label Phase|Adverse Event|27|||
19644184|NCT00696384|42093470|FG001|Open Label Phase|Adverse Event|0|||
19644185|NCT00696384|42093471|FG002|Open Label Phase|Adverse Event|0|||
19644186|NCT00696384|42093469|FG000|Open Label Phase|Protocol Violation|18|||
19644187|NCT00696384|42093470|FG001|Open Label Phase|Protocol Violation|0|||
19644188|NCT00696384|42093471|FG002|Open Label Phase|Protocol Violation|0|||
19644189|NCT00696384|42093469|FG000|Open Label Phase|Lost to Follow-up|24|||
19644190|NCT00696384|42093470|FG001|Open Label Phase|Lost to Follow-up|0|||
19644191|NCT00696384|42093471|FG002|Open Label Phase|Lost to Follow-up|0|||
19644192|NCT00696384|42093469|FG000|Open Label Phase|Withdrawal by Subject|37|||
19644193|NCT00696384|42093470|FG001|Open Label Phase|Withdrawal by Subject|0|||
19644194|NCT00696384|42093471|FG002|Open Label Phase|Withdrawal by Subject|0|||
19644195|NCT00696384|42093469|FG000|Open Label Phase|Other|6|||
19644196|NCT00696384|42093470|FG001|Open Label Phase|Other|0|||
19644197|NCT00696384|42093471|FG002|Open Label Phase|Other|0|||
19644198|NCT00696384|42093469|FG000|Open Label Phase|Lack of Efficacy|3|||
19749512|NCT02606461|42197807|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
19644199|NCT00696384|42093470|FG001|Open Label Phase|Lack of Efficacy|0|||
19644200|NCT00696384|42093471|FG002|Open Label Phase|Lack of Efficacy|0|||
19644201|NCT00696384|42093469|FG000|Open Label Phase|Physician Decision|4|||
19644202|NCT00696384|42093470|FG001|Open Label Phase|Physician Decision|0|||
19644203|NCT00696384|42093471|FG002|Open Label Phase|Physician Decision|0|||
19644204|NCT00696384|42093469|FG000|Double Blind Phase|Adverse Event|0|||
19644205|NCT00696384|42093470|FG001|Double Blind Phase|Adverse Event|2|||
19644206|NCT00696384|42093471|FG002|Double Blind Phase|Adverse Event|2|||
19644207|NCT00696384|42093469|FG000|Double Blind Phase|Lost to Follow-up|0|||
19644208|NCT00696384|42093470|FG001|Double Blind Phase|Lost to Follow-up|2|||
19644209|NCT00696384|42093471|FG002|Double Blind Phase|Lost to Follow-up|1|||
19644210|NCT00696384|42093469|FG000|Double Blind Phase|Withdrawal by Subject|0|||
19644211|NCT00696384|42093470|FG001|Double Blind Phase|Withdrawal by Subject|4|||
19644212|NCT00696384|42093471|FG002|Double Blind Phase|Withdrawal by Subject|3|||
19644213|NCT00696384|42093469|FG000|Double Blind Phase|Lack of Efficacy|0|||
19644214|NCT00696384|42093470|FG001|Double Blind Phase|Lack of Efficacy|1|||
19644215|NCT00696384|42093471|FG002|Double Blind Phase|Lack of Efficacy|0|||
19644216|NCT00696384|42093469|FG000|Double Blind Phase|Physician Decision|0|||
19644217|NCT00696384|42093470|FG001|Double Blind Phase|Physician Decision|2|||
19644218|NCT00696384|42093471|FG002|Double Blind Phase|Physician Decision|0|||
19644219|NCT00636675|42093482|FG000|Overall Study|Lost to Follow-up|121|||
19644220|NCT00636675|42093483|FG001|Overall Study|Lost to Follow-up|31|||
19644221|NCT00636675|42093482|FG000|Overall Study|Withdrawal by Subject|19|||
19644222|NCT00636675|42093483|FG001|Overall Study|Withdrawal by Subject|10|||
19644223|NCT00699998|42093493|FG000|Overall Study|Withdrawal by Subject|194|||
19644224|NCT00699998|42093494|FG001|Overall Study|Withdrawal by Subject|83|||
19644225|NCT00699998|42093495|FG002|Overall Study|Withdrawal by Subject|202|||
19477067|NCT01487161|41755909|FG001|Overall Study|Adverse Event|0|||
19644226|NCT00699998|42093496|FG003|Overall Study|Withdrawal by Subject|80|||
19644227|NCT00699998|42093493|FG000|Overall Study|Physician Decision|3|||
19644228|NCT00699998|42093494|FG001|Overall Study|Physician Decision|2|||
19644229|NCT00699998|42093495|FG002|Overall Study|Physician Decision|1|||
19644230|NCT00699998|42093496|FG003|Overall Study|Physician Decision|1|||
19644231|NCT00699998|42093493|FG000|Overall Study|Lost to Follow-up|2|||
19644232|NCT00699998|42093494|FG001|Overall Study|Lost to Follow-up|1|||
19644233|NCT00699998|42093495|FG002|Overall Study|Lost to Follow-up|3|||
19644234|NCT00699998|42093496|FG003|Overall Study|Lost to Follow-up|1|||
19644235|NCT00696072|42093513|FG000|Overall Study|continuing active treatment|10|||
19644236|NCT00696072|42093514|FG001|Overall Study|continuing active treatment|13|||
19644237|NCT00696072|42093513|FG000|Overall Study|Adverse Event|10|||
19644238|NCT00696072|42093514|FG001|Overall Study|Adverse Event|6|||
19644239|NCT00696072|42093513|FG000|Overall Study|Patient Request|3|||
19644240|NCT00696072|42093514|FG001|Overall Study|Patient Request|7|||
19644241|NCT00696072|42093513|FG000|Overall Study|Investigator Request|1|||
19644242|NCT00696072|42093514|FG001|Overall Study|Investigator Request|4|||
19644243|NCT00696072|42093513|FG000|Overall Study|Sponsor Request|0|||
19644244|NCT00696072|42093514|FG001|Overall Study|Sponsor Request|1|||
19644245|NCT00696072|42093513|FG000|Overall Study|Disease Progression|32|||
19644246|NCT00696072|42093514|FG001|Overall Study|Disease Progression|30|||
19644247|NCT00696072|42093513|FG000|Overall Study|Non-specified|1|||
19644248|NCT00696072|42093514|FG001|Overall Study|Non-specified|2|||
19644249|NCT00634647|42093521|FG000|Overall Study|death on study|3|||
19644250|NCT00634647|42093521|FG000|Overall Study|refused further treatment|3|||
19644251|NCT00634647|42093521|FG000|Overall Study|declined to participate before treatment|1|||
19644252|NCT00576732|42093528|FG000|DOUBLE BLIND|Adverse Event|0|||
19644253|NCT00576732|42093529|FG001|DOUBLE BLIND|Adverse Event|0|||
19644254|NCT00576732|42093530|FG002|DOUBLE BLIND|Adverse Event|1|||
19644255|NCT00576732|42093531|FG003|DOUBLE BLIND|Adverse Event|0|||
19644256|NCT00576732|42093532|FG004|DOUBLE BLIND|Adverse Event|0|||
19644257|NCT00576732|42093533|FG005|DOUBLE BLIND|Adverse Event|0|||
19644258|NCT00576732|42093528|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
19644259|NCT00576732|42093529|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
19644260|NCT00576732|42093530|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
19644261|NCT00576732|42093531|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
19644262|NCT00576732|42093532|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
19644263|NCT00576732|42093533|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
19644264|NCT00576732|42093528|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
19644265|NCT00576732|42093529|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
19644266|NCT00576732|42093530|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
19644267|NCT00576732|42093531|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
19644268|NCT00576732|42093532|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
19644269|NCT00576732|42093533|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
19644270|NCT00576732|42093528|FG000|DOUBLE BLIND|OTHER|0|||
19644271|NCT00576732|42093529|FG001|DOUBLE BLIND|OTHER|2|||
19644272|NCT00576732|42093530|FG002|DOUBLE BLIND|OTHER|1|||
19644273|NCT00576732|42093531|FG003|DOUBLE BLIND|OTHER|0|||
19644274|NCT00576732|42093532|FG004|DOUBLE BLIND|OTHER|0|||
19644275|NCT00576732|42093533|FG005|DOUBLE BLIND|OTHER|0|||
19644276|NCT00576732|42093528|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
19644277|NCT00576732|42093529|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
19644278|NCT00576732|42093530|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
19644279|NCT00576732|42093531|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
19644280|NCT00576732|42093532|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
19644281|NCT00576732|42093533|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
19644282|NCT00576732|42093528|FG000|DOUBLE BLIND|Protocol Violation|1|||
19644283|NCT00576732|42093529|FG001|DOUBLE BLIND|Protocol Violation|0|||
19644284|NCT00576732|42093530|FG002|DOUBLE BLIND|Protocol Violation|0|||
19644285|NCT00576732|42093531|FG003|DOUBLE BLIND|Protocol Violation|0|||
19644286|NCT00576732|42093532|FG004|DOUBLE BLIND|Protocol Violation|0|||
19644287|NCT00576732|42093533|FG005|DOUBLE BLIND|Protocol Violation|0|||
19644288|NCT00576732|42093528|FG000|OPEN LABEL|Adverse Event|0|||
19644289|NCT00576732|42093529|FG001|OPEN LABEL|Adverse Event|0|||
19644290|NCT00576732|42093530|FG002|OPEN LABEL|Adverse Event|0|||
19644291|NCT00576732|42093531|FG003|OPEN LABEL|Adverse Event|4|||
19749513|NCT02606461|42197808|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
19749514|NCT03321396|42197823|FG000|Overall Study|Physician Decision|1|||
19749515|NCT03244917|42197829|FG000|Overall Study|Lost to Follow-up|2|||
19749516|NCT03244917|42197830|FG001|Overall Study|Lost to Follow-up|2|||
19644292|NCT00576732|42093532|FG004|OPEN LABEL|Adverse Event|0|||
19644293|NCT00576732|42093533|FG005|OPEN LABEL|Adverse Event|1|||
19644294|NCT00576732|42093528|FG000|OPEN LABEL|Lost to Follow-up|0|||
19644295|NCT00576732|42093529|FG001|OPEN LABEL|Lost to Follow-up|0|||
19644296|NCT00576732|42093530|FG002|OPEN LABEL|Lost to Follow-up|0|||
19644297|NCT00576732|42093531|FG003|OPEN LABEL|Lost to Follow-up|2|||
19644298|NCT00576732|42093532|FG004|OPEN LABEL|Lost to Follow-up|1|||
19644299|NCT00576732|42093533|FG005|OPEN LABEL|Lost to Follow-up|1|||
19644300|NCT00576732|42093528|FG000|OPEN LABEL|Withdrawal by Subject|0|||
19644301|NCT00576732|42093529|FG001|OPEN LABEL|Withdrawal by Subject|0|||
19644302|NCT00576732|42093530|FG002|OPEN LABEL|Withdrawal by Subject|0|||
19749517|NCT03321006|42197838|FG000|Overall Study|Death|1|||
19749518|NCT03321006|42197839|FG001|Overall Study|Death|0|||
19749519|NCT03321006|42197838|FG000|Overall Study|Lack of Efficacy|1|||
19749520|NCT03321006|42197839|FG001|Overall Study|Lack of Efficacy|0|||
19749521|NCT02593123|42197856|FG000|Overall Study|Physician Decision|2|||
19644303|NCT00576732|42093531|FG003|OPEN LABEL|Withdrawal by Subject|1|||
19644304|NCT00576732|42093532|FG004|OPEN LABEL|Withdrawal by Subject|0|||
19644305|NCT00576732|42093533|FG005|OPEN LABEL|Withdrawal by Subject|1|||
19644306|NCT00576732|42093528|FG000|OPEN LABEL|OTHER|0|||
19644307|NCT00576732|42093529|FG001|OPEN LABEL|OTHER|0|||
19644308|NCT00576732|42093530|FG002|OPEN LABEL|OTHER|0|||
19644309|NCT00576732|42093531|FG003|OPEN LABEL|OTHER|0|||
19644310|NCT00576732|42093532|FG004|OPEN LABEL|OTHER|0|||
19644311|NCT00576732|42093533|FG005|OPEN LABEL|OTHER|2|||
19644312|NCT00576732|42093528|FG000|OPEN LABEL|Lack of Efficacy|0|||
19644313|NCT00576732|42093529|FG001|OPEN LABEL|Lack of Efficacy|0|||
19644314|NCT00576732|42093530|FG002|OPEN LABEL|Lack of Efficacy|0|||
19644315|NCT00576732|42093531|FG003|OPEN LABEL|Lack of Efficacy|2|||
19644316|NCT00576732|42093532|FG004|OPEN LABEL|Lack of Efficacy|2|||
19644317|NCT00576732|42093533|FG005|OPEN LABEL|Lack of Efficacy|3|||
19644318|NCT00576732|42093528|FG000|OPEN LABEL|Protocol Violation|0|||
19644319|NCT00576732|42093529|FG001|OPEN LABEL|Protocol Violation|0|||
19644320|NCT00576732|42093530|FG002|OPEN LABEL|Protocol Violation|0|||
19644321|NCT00576732|42093531|FG003|OPEN LABEL|Protocol Violation|2|||
19477068|NCT01487161|41755910|FG002|Overall Study|Adverse Event|0|||
19644322|NCT00576732|42093532|FG004|OPEN LABEL|Protocol Violation|1|||
19644323|NCT00576732|42093533|FG005|OPEN LABEL|Protocol Violation|0|||
19644324|NCT00697788|42093545|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644325|NCT00697788|42093546|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
19644326|NCT00697788|42093547|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644327|NCT00697788|42093548|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644328|NCT00697788|42093549|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644329|NCT00697788|42093550|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644330|NCT00697788|42093551|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644331|NCT00697788|42093552|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
19644332|NCT00697788|42093545|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644333|NCT00697788|42093546|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644334|NCT00697788|42093547|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644335|NCT00697788|42093548|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644336|NCT00697788|42093549|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
19644337|NCT00697788|42093550|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644338|NCT00697788|42093551|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644339|NCT00697788|42093552|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
19644340|NCT00400153|42093582|FG000|Overall Study|AE due to study disease worsening|14|||
19644341|NCT00400153|42093583|FG001|Overall Study|AE due to study disease worsening|19|||
19644342|NCT00400153|42093584|FG002|Overall Study|AE due to study disease worsening|20|||
19644343|NCT00400153|42093582|FG000|Overall Study|AE due to other disease worsening|2|||
19644344|NCT00400153|42093583|FG001|Overall Study|AE due to other disease worsening|1|||
19644345|NCT00400153|42093584|FG002|Overall Study|AE due to other disease worsening|0|||
19644346|NCT00400153|42093582|FG000|Overall Study|AE due to other condition|3|||
19644347|NCT00400153|42093583|FG001|Overall Study|AE due to other condition|14|||
19644348|NCT00400153|42093584|FG002|Overall Study|AE due to other condition|15|||
19644349|NCT00400153|42093582|FG000|Overall Study|Protocol Violation|7|||
19644350|NCT00400153|42093583|FG001|Overall Study|Protocol Violation|4|||
19644351|NCT00400153|42093584|FG002|Overall Study|Protocol Violation|9|||
19644352|NCT00400153|42093582|FG000|Overall Study|Lost to Follow-up|2|||
19644353|NCT00400153|42093583|FG001|Overall Study|Lost to Follow-up|1|||
19644354|NCT00400153|42093584|FG002|Overall Study|Lost to Follow-up|4|||
19644355|NCT00400153|42093582|FG000|Overall Study|Withdrawal by Subject|12|||
19644356|NCT00400153|42093583|FG001|Overall Study|Withdrawal by Subject|11|||
19644357|NCT00400153|42093584|FG002|Overall Study|Withdrawal by Subject|10|||
19644358|NCT00400153|42093582|FG000|Overall Study|Other reasons - not mentioned above|8|||
19644359|NCT00400153|42093583|FG001|Overall Study|Other reasons - not mentioned above|5|||
19644360|NCT00400153|42093584|FG002|Overall Study|Other reasons - not mentioned above|3|||
19644361|NCT00631917|42093599|FG000|Overall Study|Adverse Event|34|||
19644362|NCT00631917|42093600|FG001|Overall Study|Adverse Event|45|||
19644363|NCT00631917|42093599|FG000|Overall Study|Abnormal laboratory value(s)|2|||
19644364|NCT00631917|42093600|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19644365|NCT00631917|42093599|FG000|Overall Study|Abnormal test procedure result(s)|3|||
19644366|NCT00631917|42093600|FG001|Overall Study|Abnormal test procedure result(s)|2|||
19644367|NCT00631917|42093599|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
19644368|NCT00631917|42093600|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
19644369|NCT00631917|42093599|FG000|Overall Study|No longer required study drug|0|||
19644370|NCT00631917|42093600|FG001|Overall Study|No longer required study drug|1|||
19749522|NCT02593123|42197857|FG001|Overall Study|Physician Decision|1|||
19644371|NCT00631917|42093599|FG000|Overall Study|Protocol deviation|6|||
19644372|NCT00631917|42093600|FG001|Overall Study|Protocol deviation|5|||
19644373|NCT00631917|42093599|FG000|Overall Study|Subject withdrew consent|25|||
19644374|NCT00631917|42093600|FG001|Overall Study|Subject withdrew consent|33|||
19644375|NCT00631917|42093599|FG000|Overall Study|Lost to Follow-up|7|||
19644376|NCT00631917|42093600|FG001|Overall Study|Lost to Follow-up|7|||
19644377|NCT00631917|42093599|FG000|Overall Study|Administrative problems|2|||
19644378|NCT00631917|42093600|FG001|Overall Study|Administrative problems|0|||
19644379|NCT00631917|42093599|FG000|Overall Study|Death|1|||
19644380|NCT00631917|42093600|FG001|Overall Study|Death|0|||
19644381|NCT00419341|42093617|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
19644382|NCT00419341|42093617|FG000|Wash in/Wash Out Period|Adverse Event|2|||
19644383|NCT00419341|42093617|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
19644384|NCT00419341|42093617|FG000|Efficacy Period|Withdrawal by Subject|6|||
19644385|NCT00419341|42093617|FG000|Efficacy Period|Protocol Violation|1|||
19644386|NCT00419341|42093617|FG000|Efficacy Period|Lost to Follow-up|1|||
19644387|NCT00419341|42093617|FG000|Efficacy Period|Non-compliance|1|||
19644388|NCT00419341|42093617|FG000|Efficacy Period|Termination of study site|1|||
19644389|NCT00694122|42093623|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
19644390|NCT00694122|42093624|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
19644391|NCT00694122|42093623|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
19644392|NCT00694122|42093624|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
19644393|NCT00694122|42093623|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
19644394|NCT00694122|42093624|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
19644395|NCT03922620|42093637|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
19644396|NCT03922620|42093638|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
19644397|NCT00419263|42093647|FG000|Overall Study|Lost to Follow-up|2|||
19644398|NCT00419263|42093648|FG001|Overall Study|Lost to Follow-up|1|||
19644399|NCT00419263|42093649|FG002|Overall Study|Lost to Follow-up|1|||
19644400|NCT00419263|42093647|FG000|Overall Study|Randomized in Error, Not Treated|1|||
19644401|NCT00419263|42093648|FG001|Overall Study|Randomized in Error, Not Treated|1|||
19644402|NCT00419263|42093649|FG002|Overall Study|Randomized in Error, Not Treated|0|||
19644403|NCT00419263|42093647|FG000|Overall Study|Adverse Event|0|||
19644404|NCT00419263|42093648|FG001|Overall Study|Adverse Event|0|||
19644405|NCT00419263|42093649|FG002|Overall Study|Adverse Event|1|||
19644406|NCT00419263|42093647|FG000|Overall Study|Withdrawal by Subject|0|||
19644407|NCT00419263|42093648|FG001|Overall Study|Withdrawal by Subject|0|||
19644408|NCT00419263|42093649|FG002|Overall Study|Withdrawal by Subject|1|||
19644409|NCT00399763|42093660|FG000|Overall Study|Lost to Follow-up|2|||
19644410|NCT00399763|42093661|FG001|Overall Study|Lost to Follow-up|3|||
19644411|NCT00699842|42093670|FG000|Overall Study|Death|0|||
19644412|NCT00699842|42093671|FG001|Overall Study|Death|1|||
19644413|NCT00699842|42093672|FG002|Overall Study|Death|0|||
19644414|NCT00399529|42093680|FG000|Overall Study|Off Study Prior to Treatment|2|||
19644415|NCT00712712|42093685|FG000|Overall Study|Protocol Violation|11|||
19644416|NCT00712712|42093685|FG000|Overall Study|Radiofrequency not done|3|||
19644417|NCT00712712|42093685|FG000|Overall Study|Death|8|||
19644418|NCT00712712|42093685|FG000|Overall Study|Withdrawal by Subject|1|||
19644419|NCT00411151|42093689|FG000|Overall Study|Death|38|||
19644420|NCT00411151|42093689|FG000|Overall Study|Withdrawal by Subject|2|||
19644421|NCT00411151|42093689|FG000|Overall Study|Lost to Follow-up|2|||
19644422|NCT00411151|42093689|FG000|Overall Study|Protocol Violation|1|||
19644423|NCT00411151|42093689|FG000|Overall Study|Trial prematurely closed|4|||
19644424|NCT00607048|42093695|FG000|Overall Study|Adverse Event|0|||
19644425|NCT00607048|42093696|FG001|Overall Study|Adverse Event|1|||
19644426|NCT00607048|42093697|FG002|Overall Study|Adverse Event|0|||
19644427|NCT00607048|42093698|FG003|Overall Study|Adverse Event|0|||
19644428|NCT00607048|42093699|FG004|Overall Study|Adverse Event|4|||
19644429|NCT00607048|42093700|FG005|Overall Study|Adverse Event|0|||
19644430|NCT00607048|42093695|FG000|Overall Study|Global deterioration of health|1|||
19644431|NCT00607048|42093696|FG001|Overall Study|Global deterioration of health|0|||
19644432|NCT00607048|42093697|FG002|Overall Study|Global deterioration of health|0|||
19644433|NCT00607048|42093698|FG003|Overall Study|Global deterioration of health|0|||
19644434|NCT00607048|42093699|FG004|Overall Study|Global deterioration of health|0|||
19644435|NCT00607048|42093700|FG005|Overall Study|Global deterioration of health|0|||
19644436|NCT00607048|42093695|FG000|Overall Study|Objective disease progression - relapse|1|||
19644437|NCT00607048|42093696|FG001|Overall Study|Objective disease progression - relapse|2|||
19644438|NCT00607048|42093697|FG002|Overall Study|Objective disease progression - relapse|4|||
19644439|NCT00607048|42093698|FG003|Overall Study|Objective disease progression - relapse|2|||
19644440|NCT00607048|42093699|FG004|Overall Study|Objective disease progression - relapse|2|||
19644441|NCT00607048|42093700|FG005|Overall Study|Objective disease progression - relapse|2|||
19644442|NCT00607048|42093695|FG000|Overall Study|Withdrawal by Subject|0|||
19644443|NCT00607048|42093696|FG001|Overall Study|Withdrawal by Subject|0|||
19477069|NCT01487161|41755911|FG003|Overall Study|Adverse Event|0|||
19644444|NCT00607048|42093697|FG002|Overall Study|Withdrawal by Subject|0|||
19644445|NCT00607048|42093698|FG003|Overall Study|Withdrawal by Subject|1|||
19644446|NCT00607048|42093699|FG004|Overall Study|Withdrawal by Subject|0|||
19644447|NCT00607048|42093700|FG005|Overall Study|Withdrawal by Subject|2|||
19644448|NCT00607048|42093695|FG000|Overall Study|Other|1|||
19644449|NCT00607048|42093696|FG001|Overall Study|Other|1|||
19644450|NCT00607048|42093697|FG002|Overall Study|Other|0|||
19644451|NCT00607048|42093698|FG003|Overall Study|Other|0|||
19644452|NCT00607048|42093699|FG004|Overall Study|Other|0|||
19644453|NCT00607048|42093700|FG005|Overall Study|Other|1|||
19644454|NCT00699608|42093716|FG000|First Intervention|Withdrawal by Subject|0|||
19644455|NCT00699608|42093717|FG001|First Intervention|Withdrawal by Subject|0|||
19644456|NCT00699608|42093718|FG002|First Intervention|Withdrawal by Subject|1|||
19644457|NCT00699608|42093719|FG003|First Intervention|Withdrawal by Subject|0|||
19644458|NCT00699608|42093720|FG004|First Intervention|Withdrawal by Subject|0|||
19644459|NCT00699608|42093721|FG005|First Intervention|Withdrawal by Subject|0|||
19644460|NCT00699608|42093716|FG000|First Intervention|Protocol Violation|0|||
19644461|NCT00699608|42093717|FG001|First Intervention|Protocol Violation|0|||
19644462|NCT00699608|42093718|FG002|First Intervention|Protocol Violation|0|||
19644463|NCT00699608|42093719|FG003|First Intervention|Protocol Violation|0|||
19644464|NCT00699608|42093720|FG004|First Intervention|Protocol Violation|1|||
19644465|NCT00699608|42093721|FG005|First Intervention|Protocol Violation|0|||
19644466|NCT00699608|42093716|FG000|Second Intervention|Adverse Event|0|||
19749523|NCT02593123|42197856|FG000|Overall Study|Relapse|1|||
19749524|NCT02593123|42197857|FG001|Overall Study|Relapse|1|||
19749525|NCT03302559|42197865|FG000|Overall Study|Adverse Event|2|||
19749526|NCT03302559|42197865|FG000|Overall Study|Lost to Follow-up|1|||
19644467|NCT00699608|42093717|FG001|Second Intervention|Adverse Event|0|||
19644468|NCT00699608|42093718|FG002|Second Intervention|Adverse Event|1|||
19644469|NCT00699608|42093719|FG003|Second Intervention|Adverse Event|0|||
19644470|NCT00699608|42093720|FG004|Second Intervention|Adverse Event|0|||
19749527|NCT03302559|42197865|FG000|Overall Study|Withdrew Consent|3|||
19644471|NCT00699608|42093721|FG005|Second Intervention|Adverse Event|0|||
19749528|NCT03302247|42197869|FG000|Overall Study|the study has closed prematurely|2|||
19749529|NCT03302247|42197869|FG000|Overall Study|Death|1|||
19749530|NCT04993339|42197875|FG000|Overall Study|Lost to Follow-up|0|||
19749531|NCT04993339|42197876|FG001|Overall Study|Lost to Follow-up|1|||
19749532|NCT04993339|42197875|FG000|Overall Study|no MRI scan|3|||
19749533|NCT04993339|42197876|FG001|Overall Study|no MRI scan|1|||
19644472|NCT00699608|42093716|FG000|Second Intervention|Withdrawal by Subject|0|||
19644473|NCT00699608|42093717|FG001|Second Intervention|Withdrawal by Subject|0|||
19644474|NCT00699608|42093718|FG002|Second Intervention|Withdrawal by Subject|0|||
19644475|NCT00699608|42093719|FG003|Second Intervention|Withdrawal by Subject|1|||
19644476|NCT00699608|42093720|FG004|Second Intervention|Withdrawal by Subject|0|||
19644477|NCT00699608|42093721|FG005|Second Intervention|Withdrawal by Subject|0|||
19644478|NCT03823404|42093732|FG000|Overall Study|Lost to Follow-up|1|||
19644479|NCT03823404|42093733|FG001|Overall Study|Lost to Follow-up|2|||
19644480|NCT03823404|42093734|FG002|Overall Study|Lost to Follow-up|3|||
19644481|NCT03823404|42093732|FG000|Overall Study|Protocol Violation|2|||
19644482|NCT03823404|42093733|FG001|Overall Study|Protocol Violation|0|||
19644483|NCT03823404|42093734|FG002|Overall Study|Protocol Violation|2|||
19644484|NCT03823404|42093732|FG000|Overall Study|Adverse Event|35|||
19644485|NCT03823404|42093733|FG001|Overall Study|Adverse Event|38|||
19644486|NCT03823404|42093734|FG002|Overall Study|Adverse Event|8|||
19644487|NCT03823404|42093732|FG000|Overall Study|Withdrawal by Subject|38|||
19644488|NCT03823404|42093733|FG001|Overall Study|Withdrawal by Subject|40|||
19644489|NCT03823404|42093734|FG002|Overall Study|Withdrawal by Subject|35|||
19644490|NCT03823404|42093732|FG000|Overall Study|Death|4|||
19644491|NCT03823404|42093733|FG001|Overall Study|Death|0|||
19644492|NCT03823404|42093734|FG002|Overall Study|Death|0|||
19644493|NCT03823404|42093732|FG000|Overall Study|Other: Various reasons provided|5|||
19644494|NCT03823404|42093733|FG001|Overall Study|Other: Various reasons provided|5|||
19644495|NCT03823404|42093734|FG002|Overall Study|Other: Various reasons provided|6|||
19644496|NCT00706706|42093742|FG000|Overall Study|Death|53|||
19644497|NCT00706706|42093742|FG000|Overall Study|Lost to Follow-up|7|||
19644498|NCT00706706|42093742|FG000|Overall Study|Study endpoint had reached|45|||
19644499|NCT00410761|42093748|FG000|Overall Study|Adverse Event|29|||
19644500|NCT00410761|42093749|FG001|Overall Study|Adverse Event|3|||
19644501|NCT00410761|42093748|FG000|Overall Study|objective disease progression|71|||
19644502|NCT00410761|42093749|FG001|Overall Study|objective disease progression|55|||
19644503|NCT00410761|42093748|FG000|Overall Study|Withdrawal by Subject|8|||
19644504|NCT00410761|42093749|FG001|Overall Study|Withdrawal by Subject|4|||
19644505|NCT00410761|42093748|FG000|Overall Study|Other|12|||
19644506|NCT00410761|42093749|FG001|Overall Study|Other|9|||
19644507|NCT00410761|42093748|FG000|Overall Study|Never received randomised treatment|0|||
19644508|NCT00410761|42093749|FG001|Overall Study|Never received randomised treatment|1|||
19644509|NCT00410605|42093755|FG000|Overall Study|Adverse Event|12|||
19644510|NCT00410605|42093755|FG000|Overall Study|Physician Decision|3|||
19644511|NCT00410605|42093755|FG000|Overall Study|Withdrawal by Subject|5|||
19644512|NCT00410605|42093755|FG000|Overall Study|Started Non-Protocol Therapy|3|||
19644513|NCT00410605|42093755|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
19644514|NCT00410605|42093755|FG000|Overall Study|Transferred to another Institution|1|||
19644515|NCT00418717|42093759|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
19644516|NCT00418717|42093759|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
19644517|NCT00572572|42093765|FG000|Overall Study|Withdrawal by Subject|3|||
19644518|NCT00572572|42093766|FG001|Overall Study|Withdrawal by Subject|6|||
19644519|NCT00418561|42093775|FG000|Overall Study|Participant's (guardian's) decision|0|||
19644520|NCT00418561|42093776|FG001|Overall Study|Participant's (guardian's) decision|1|||
19644521|NCT00418561|42093777|FG002|Overall Study|Participant's (guardian's) decision|0|||
19644522|NCT00398047|42093785|FG000|Overall Study|all patient progressed before completion|3|||
19644523|NCT00631371|42093792|FG000|Overall Study|Lost to Follow-up|24|||
19644524|NCT00631371|42093793|FG001|Overall Study|Lost to Follow-up|19|||
19644525|NCT00631371|42093792|FG000|Overall Study|Other reason|5|||
19644526|NCT00631371|42093793|FG001|Overall Study|Other reason|12|||
19644527|NCT00631371|42093792|FG000|Overall Study|subject request|38|||
19644528|NCT00631371|42093793|FG001|Overall Study|subject request|45|||
19644529|NCT00631371|42093792|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
19644530|NCT00631371|42093793|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
19644531|NCT00631371|42093792|FG000|Overall Study|Death|263|||
19644532|NCT00631371|42093793|FG001|Overall Study|Death|239|||
19644533|NCT00409747|42093799|FG000|Overall Study|Withdrawal by Subject|1|||
19749534|NCT04974697|42197884|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
19644534|NCT00630747|42093803|FG000|Overall Study|Death|1|||
19644535|NCT00630747|42093803|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
19644536|NCT00630747|42093803|FG000|Overall Study|Returned to country of origin|1|||
19749535|NCT04974697|42197884|FG000|Overall Study|Lens discomfort|1|||
19644537|NCT00397891|42093812|FG000|Overall Study|Withdrawal by Subject|1|||
19644538|NCT00397891|42093813|FG001|Overall Study|Withdrawal by Subject|0|||
19644539|NCT00397891|42093814|FG002|Overall Study|Withdrawal by Subject|0|||
19644540|NCT00397891|42093815|FG003|Overall Study|Withdrawal by Subject|0|||
19644541|NCT00397891|42093816|FG004|Overall Study|Withdrawal by Subject|1|||
19644542|NCT00397189|42093830|FG000|3 Weeks Period|Lost to Follow-up|5|||
19644543|NCT00397189|42093831|FG001|3 Weeks Period|Lost to Follow-up|4|||
19644544|NCT00397189|42093830|FG000|3 Weeks Period|Adverse Event|3|||
19644545|NCT00397189|42093831|FG001|3 Weeks Period|Adverse Event|2|||
19644546|NCT00397189|42093830|FG000|3 Weeks Period|Withdrawal by Subject|13|||
19644547|NCT00397189|42093831|FG001|3 Weeks Period|Withdrawal by Subject|9|||
19644548|NCT00397189|42093830|FG000|3 Weeks Period|Physician Decision|0|||
19644549|NCT00397189|42093831|FG001|3 Weeks Period|Physician Decision|2|||
19644550|NCT00397189|42093830|FG000|3 Weeks Period|Protocol Violation|0|||
19644551|NCT00397189|42093831|FG001|3 Weeks Period|Protocol Violation|3|||
19644552|NCT00397189|42093830|FG000|3 Weeks Period|Other|0|||
19644553|NCT00397189|42093831|FG001|3 Weeks Period|Other|2|||
19644554|NCT00606034|42093839|FG000|Overall Study|incarceration|1|||
19644555|NCT00397033|42093848|FG000|Overall Study|Adverse Event|7|||
19644556|NCT00397033|42093849|FG001|Overall Study|Adverse Event|10|||
19644557|NCT00397033|42093850|FG002|Overall Study|Adverse Event|4|||
19644558|NCT00397033|42093848|FG000|Overall Study|Lack of Efficacy|22|||
19644559|NCT00397033|42093849|FG001|Overall Study|Lack of Efficacy|12|||
19644560|NCT00397033|42093850|FG002|Overall Study|Lack of Efficacy|9|||
19644561|NCT00397033|42093848|FG000|Overall Study|Lost to Follow-up|3|||
19644562|NCT00397033|42093849|FG001|Overall Study|Lost to Follow-up|3|||
19644563|NCT00397033|42093850|FG002|Overall Study|Lost to Follow-up|3|||
19644564|NCT00397033|42093848|FG000|Overall Study|Withdrawal by Subject|12|||
19644565|NCT00397033|42093849|FG001|Overall Study|Withdrawal by Subject|7|||
19644566|NCT00397033|42093850|FG002|Overall Study|Withdrawal by Subject|5|||
19644567|NCT00397033|42093848|FG000|Overall Study|Other|0|||
19644568|NCT00397033|42093849|FG001|Overall Study|Other|5|||
19644569|NCT00397033|42093850|FG002|Overall Study|Other|2|||
19644570|NCT00572728|42093858|FG000|Overall Study|Withdrawal by Subject|10|||
19644571|NCT00572728|42093858|FG000|Overall Study|Ineligible|3|||
19644572|NCT00572728|42093858|FG000|Overall Study|Enrolled under Amendment 4|5|||
19644573|NCT00572728|42093858|FG000|Overall Study|Offstudy due to complicating disease|1|||
19644574|NCT00572728|42093858|FG000|Overall Study|FLT1 not completed|4|||
19644575|NCT00572728|42093858|FG000|Overall Study|First Chemotherapy not initiated|2|||
19644576|NCT00572728|42093858|FG000|Overall Study|FLT2 not completed|5|||
19644577|NCT00572728|42093858|FG000|Overall Study|Second chemotherapy not initiated|1|||
19644578|NCT00572728|42093858|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
19644579|NCT00572728|42093858|FG000|Overall Study|Pathology missing|1|||
19644580|NCT00699374|42093866|FG000|Overall Study|Death|93|||
19644581|NCT00699374|42093867|FG001|Overall Study|Death|83|||
19644582|NCT00699374|42093866|FG000|Overall Study|Adverse Event|70|||
19644583|NCT00699374|42093867|FG001|Overall Study|Adverse Event|67|||
19644584|NCT00699374|42093866|FG000|Overall Study|Global deterioration of health status|7|||
19644585|NCT00699374|42093867|FG001|Overall Study|Global deterioration of health status|8|||
19644586|NCT00699374|42093866|FG000|Overall Study|Lost to Follow-up|3|||
19644587|NCT00699374|42093867|FG001|Overall Study|Lost to Follow-up|5|||
19644588|NCT00699374|42093866|FG000|Overall Study|Withdrawal by Subject|34|||
19644589|NCT00699374|42093867|FG001|Overall Study|Withdrawal by Subject|44|||
19644590|NCT00699374|42093866|FG000|Overall Study|Objective progression or relapse|281|||
19644591|NCT00699374|42093867|FG001|Overall Study|Objective progression or relapse|277|||
19644592|NCT00699374|42093866|FG000|Overall Study|Other|18|||
19644593|NCT00699374|42093867|FG001|Overall Study|Other|15|||
19644594|NCT00699374|42093866|FG000|Overall Study|Protocol Violation|2|||
19644595|NCT00699374|42093867|FG001|Overall Study|Protocol Violation|6|||
19644596|NCT00699374|42093866|FG000|Overall Study|Study terminated by sponsor|13|||
19644597|NCT00699374|42093867|FG001|Overall Study|Study terminated by sponsor|28|||
19644598|NCT00699374|42093866|FG000|Overall Study|Randomized but not treated|4|||
19644599|NCT00699374|42093867|FG001|Overall Study|Randomized but not treated|2|||
19644600|NCT00699374|42093866|FG000|Overall Study|Died 28 days after last dose|5|||
19644601|NCT00699374|42093867|FG001|Overall Study|Died 28 days after last dose|9|||
19644602|NCT00606892|42093873|FG000|First Intervention|Protocol Violation|1|||
19644603|NCT00606892|42093874|FG001|First Intervention|Protocol Violation|4|||
19644604|NCT00625443|42093909|FG000|Overall Study|Adverse Event|1|||
19644605|NCT00625443|42093910|FG001|Overall Study|Adverse Event|4|||
19644606|NCT00625443|42093911|FG002|Overall Study|Adverse Event|0|||
19644607|NCT00625443|42093909|FG000|Overall Study|Non-compliance with protocol|0|||
19644608|NCT00625443|42093910|FG001|Overall Study|Non-compliance with protocol|1|||
19644609|NCT00625443|42093911|FG002|Overall Study|Non-compliance with protocol|0|||
19644610|NCT00625443|42093909|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
19644611|NCT00625443|42093910|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
19644612|NCT00625443|42093911|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
19644613|NCT00625443|42093909|FG000|Overall Study|Withdrawal by Subject|0|||
19644614|NCT00625443|42093910|FG001|Overall Study|Withdrawal by Subject|1|||
19644615|NCT00625443|42093911|FG002|Overall Study|Withdrawal by Subject|2|||
19644616|NCT00625443|42093909|FG000|Overall Study|Physician Decision|0|||
19644617|NCT00625443|42093910|FG001|Overall Study|Physician Decision|4|||
19644618|NCT00625443|42093911|FG002|Overall Study|Physician Decision|2|||
19644619|NCT00625443|42093909|FG000|Overall Study|Other|0|||
19644620|NCT00625443|42093910|FG001|Overall Study|Other|1|||
19644621|NCT00625443|42093911|FG002|Overall Study|Other|1|||
19644622|NCT00625365|42093922|FG000|Overall Study|Withdrawal by Subject|1|||
19644623|NCT00625365|42093922|FG000|Overall Study|No IV access|5|||
19644624|NCT00625365|42093922|FG000|Overall Study|VSD|1|||
19644625|NCT00606580|42093929|FG000|Overall Study|Lost to Follow-up|1|||
19644626|NCT00606580|42093930|FG001|Overall Study|Lost to Follow-up|1|||
19644627|NCT00606580|42093931|FG002|Overall Study|Lost to Follow-up|4|||
19644628|NCT00606580|42093929|FG000|Overall Study|Clinical failures|1|||
19644629|NCT00606580|42093930|FG001|Overall Study|Clinical failures|0|||
19644630|NCT00606580|42093931|FG002|Overall Study|Clinical failures|12|||
19644631|NCT00606580|42093929|FG000|Overall Study|Withdrawal by investigator|0|||
19644632|NCT00606580|42093930|FG001|Overall Study|Withdrawal by investigator|1|||
19644633|NCT00606580|42093931|FG002|Overall Study|Withdrawal by investigator|6|||
19644634|NCT00606580|42093929|FG000|Overall Study|Withdrawal by Subject|0|||
19644635|NCT00606580|42093930|FG001|Overall Study|Withdrawal by Subject|1|||
19644636|NCT00606580|42093931|FG002|Overall Study|Withdrawal by Subject|0|||
19644637|NCT00625131|42093941|FG000|Overall Study|Lost to Follow-up|3|||
19644638|NCT00625131|42093942|FG001|Overall Study|Lost to Follow-up|2|||
19644639|NCT00625131|42093943|FG002|Overall Study|Lost to Follow-up|0|||
19644640|NCT00625131|42093941|FG000|Overall Study|Withdrawal by Subject|1|||
19644641|NCT00625131|42093942|FG001|Overall Study|Withdrawal by Subject|0|||
19644642|NCT00625131|42093943|FG002|Overall Study|Withdrawal by Subject|5|||
19644643|NCT00629265|42093951|FG000|Overall Study|Lost to Follow-up|4|||
19644644|NCT00629265|42093952|FG001|Overall Study|Lost to Follow-up|5|||
19644645|NCT00629265|42093951|FG000|Overall Study|Withdrawal by Subject|11|||
19644646|NCT00629265|42093952|FG001|Overall Study|Withdrawal by Subject|8|||
19644647|NCT00629265|42093951|FG000|Overall Study|Death|1|||
19644648|NCT00629265|42093952|FG001|Overall Study|Death|0|||
19644649|NCT00629265|42093951|FG000|Overall Study|Adverse Event|2|||
19644650|NCT00629265|42093952|FG001|Overall Study|Adverse Event|0|||
19644651|NCT00629265|42093951|FG000|Overall Study|HNC Recurrence|4|||
19644652|NCT00629265|42093952|FG001|Overall Study|HNC Recurrence|0|||
19644653|NCT00629265|42093951|FG000|Overall Study|Other CA Requiring Treatment|1|||
19644654|NCT00629265|42093952|FG001|Overall Study|Other CA Requiring Treatment|3|||
19644655|NCT00629265|42093951|FG000|Overall Study|Needed Esophageal Dilation|4|||
19644656|NCT00629265|42093952|FG001|Overall Study|Needed Esophageal Dilation|1|||
19644657|NCT00629265|42093951|FG000|Overall Study|Unrelated Medical Complications|3|||
19644658|NCT00629265|42093952|FG001|Overall Study|Unrelated Medical Complications|1|||
19644659|NCT00629265|42093951|FG000|Overall Study|Unknown Reason|2|||
19644660|NCT00629265|42093952|FG001|Overall Study|Unknown Reason|2|||
19644661|NCT00606502|42093960|FG000|Randomization|Randomized but not treated|3|||
19644662|NCT00606502|42093961|FG001|Randomization|Randomized but not treated|0|||
19644663|NCT00606502|42093960|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
19644664|NCT00606502|42093961|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
19644665|NCT00605722|42093967|FG000|Overall Study|Adverse Event|6|||
19644666|NCT00605722|42093967|FG000|Overall Study|Insufficient therapeutic response|44|||
19749536|NCT03265119|42197892|FG000|Overall Study|Adverse Event|2|||
19749537|NCT03265119|42197893|FG001|Overall Study|Adverse Event|1|||
19644667|NCT00605722|42093967|FG000|Overall Study|Failure to return|1|||
19644668|NCT00605566|42093971|FG000|Overall Study|Adverse Event|1|||
19644669|NCT00605566|42093971|FG000|Overall Study|Clinical deterioration|1|||
19644670|NCT00605566|42093971|FG000|Overall Study|Poor compliance in run-in period|1|||
19644671|NCT00396877|42093977|FG000|Overall Study|Lost to Follow-up|2|||
19644672|NCT00396877|42093978|FG001|Overall Study|Lost to Follow-up|1|||
19644673|NCT00396877|42093977|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
19644674|NCT00396877|42093978|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
19749538|NCT03265119|42197892|FG000|Overall Study|Lack of Efficacy|3|||
19749539|NCT03265119|42197893|FG001|Overall Study|Lack of Efficacy|0|||
19749540|NCT03265119|42197892|FG000|Overall Study|Protocol Violation|1|||
19644675|NCT00628251|42093987|FG000|Randomised Part|Withdrawal by Subject|0|||
19644676|NCT00628251|42093988|FG001|Randomised Part|Withdrawal by Subject|0|||
19644677|NCT00628251|42093989|FG002|Randomised Part|Withdrawal by Subject|1|||
19644678|NCT00628251|42093987|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
19644679|NCT00628251|42093988|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
19644680|NCT00628251|42093989|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
19644681|NCT00628251|42093987|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
19644682|NCT00628251|42093988|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
19644683|NCT00628251|42093989|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
19749541|NCT03265119|42197893|FG001|Overall Study|Protocol Violation|2|||
19644684|NCT00628251|42093987|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
19644685|NCT00628251|42093988|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
19644686|NCT00628251|42093989|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
19644687|NCT00628251|42093987|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
19644688|NCT00628251|42093988|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
19644689|NCT00628251|42093989|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
19644690|NCT00628251|42093987|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
19644691|NCT00628251|42093988|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
19644692|NCT00628251|42093989|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
19644693|NCT00408499|42093999|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
19644694|NCT00408499|42094000|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
19644695|NCT00408499|42094001|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
19644696|NCT00408499|42094002|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
19644697|NCT00408499|42094003|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
19644698|NCT00408499|42093999|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
19644699|NCT00408499|42094000|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
19644700|NCT00408499|42094001|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
19644701|NCT00408499|42094002|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
19644702|NCT00408499|42094003|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
19644703|NCT00408499|42093999|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
19644704|NCT00408499|42094000|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
19644705|NCT00408499|42094001|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
19644706|NCT00408499|42094002|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
19749542|NCT03265119|42197892|FG000|Overall Study|Withdrawal by Subject|2|||
19749543|NCT03265119|42197893|FG001|Overall Study|Withdrawal by Subject|4|||
19644707|NCT00408499|42094003|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
19644708|NCT00408499|42093999|FG000|Phase II- MTD Expansion|Adverse Event|0|||
19644709|NCT00408499|42094000|FG001|Phase II- MTD Expansion|Adverse Event|0|||
19644710|NCT00408499|42094001|FG002|Phase II- MTD Expansion|Adverse Event|0|||
19644711|NCT00408499|42094002|FG003|Phase II- MTD Expansion|Adverse Event|0|||
19644712|NCT00408499|42094003|FG004|Phase II- MTD Expansion|Adverse Event|9|||
19749544|NCT03265119|42197892|FG000|Overall Study|Lost to Follow-up|1|||
19749545|NCT03265119|42197893|FG001|Overall Study|Lost to Follow-up|0|||
19749546|NCT03265119|42197892|FG000|Overall Study|Lack of Compliance|1|||
19749547|NCT03265119|42197893|FG001|Overall Study|Lack of Compliance|0|||
19749548|NCT04952701|42197899|FG000|Control Lens|Physician Decision|4|||
19749549|NCT04952701|42197899|FG000|Test Lens|Physician Decision|1|||
19749550|NCT04723173|42197905|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
19749551|NCT04919317|42197919|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
19749552|NCT04919317|42197920|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
19749553|NCT04919317|42197919|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
19749554|NCT04919317|42197920|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
19749555|NCT04919161|42197928|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
19749556|NCT04919161|42197929|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
19749557|NCT04919161|42197928|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
19749558|NCT04919161|42197929|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
19749559|NCT04919161|42197928|FG000|Overall Study|Acute ankle sprain after session 1|0|||
19749560|NCT04919161|42197929|FG001|Overall Study|Acute ankle sprain after session 1|1|||
19749561|NCT03262389|42197957|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
19749562|NCT03262389|42197957|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
19749563|NCT03262389|42197957|FG000|Overall Study|opted out of PET/MR|1|||
19749564|NCT03262233|42197965|FG000|Overall Study|Withdrawal by Subject|12|||
19749565|NCT03262233|42197966|FG001|Overall Study|Withdrawal by Subject|8|||
19749566|NCT03262233|42197967|FG002|Overall Study|Withdrawal by Subject|21|||
19749567|NCT03262233|42197968|FG003|Overall Study|Withdrawal by Subject|13|||
19749568|NCT03262233|42197965|FG000|Overall Study|Declined due to shock|1|||
19749569|NCT03262233|42197966|FG001|Overall Study|Declined due to shock|2|||
19749570|NCT03262233|42197967|FG002|Overall Study|Declined due to shock|2|||
19749571|NCT03262233|42197968|FG003|Overall Study|Declined due to shock|3|||
19600776|NCT00587860|42049673|FG000|Overall Study|Lost to Follow-up|2|||
19600777|NCT00587860|42049674|FG001|Overall Study|Lost to Follow-up|2|||
19600778|NCT00587860|42049673|FG000|Overall Study|Withdrawal by Subject|3|||
19600779|NCT00587860|42049674|FG001|Overall Study|Withdrawal by Subject|3|||
19600780|NCT00583453|42049682|FG000|Overall Study|discontinued intervention|0|||
19600781|NCT00583453|42049683|FG001|Overall Study|discontinued intervention|2|||
19600782|NCT00583219|42049691|FG000|Phase 2|Withdrawal by Subject|1|||
19600783|NCT01072175|42049711|FG000|Part A (Drug-Drug Interaction)|Death|1|||
19600784|NCT01072175|42049712|FG001|Part A (Drug-Drug Interaction)|Death|0|||
19600785|NCT01072175|42049713|FG002|Part A (Drug-Drug Interaction)|Death|0|||
19600786|NCT01072175|42049714|FG003|Part A (Drug-Drug Interaction)|Death|0|||
19644713|NCT00408499|42093999|FG000|Phase II- MTD Expansion|Death|0|||
19644714|NCT00408499|42094000|FG001|Phase II- MTD Expansion|Death|0|||
19644715|NCT00408499|42094001|FG002|Phase II- MTD Expansion|Death|0|||
19644716|NCT00408499|42094002|FG003|Phase II- MTD Expansion|Death|0|||
19644717|NCT00408499|42094003|FG004|Phase II- MTD Expansion|Death|2|||
19644718|NCT00408499|42093999|FG000|Phase II- MTD Expansion|Physician Decision|0|||
19644719|NCT00408499|42094000|FG001|Phase II- MTD Expansion|Physician Decision|0|||
19644720|NCT00408499|42094001|FG002|Phase II- MTD Expansion|Physician Decision|0|||
19644721|NCT00408499|42094002|FG003|Phase II- MTD Expansion|Physician Decision|0|||
19644722|NCT00408499|42094003|FG004|Phase II- MTD Expansion|Physician Decision|1|||
19644723|NCT00408499|42093999|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
19644724|NCT00408499|42094000|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
19749572|NCT03262233|42197965|FG000|Overall Study|Protocol Violation|5|||
19749573|NCT03262233|42197966|FG001|Overall Study|Protocol Violation|10|||
19749574|NCT03262233|42197967|FG002|Overall Study|Protocol Violation|2|||
19749575|NCT03262233|42197968|FG003|Overall Study|Protocol Violation|13|||
19749576|NCT03262233|42197965|FG000|Overall Study|data collection artifact|0|||
19749577|NCT03262233|42197966|FG001|Overall Study|data collection artifact|1|||
19749578|NCT03262233|42197967|FG002|Overall Study|data collection artifact|0|||
19749579|NCT03262233|42197968|FG003|Overall Study|data collection artifact|0|||
19749580|NCT03261531|42197979|FG000|Overall Study|Withdrawal by Subject|4|||
19749581|NCT04151290|42197983|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
19749582|NCT03260205|42198002|FG000|Overall Study|Adverse Event|2|||
19749583|NCT03260205|42198003|FG001|Overall Study|Adverse Event|0|||
19749584|NCT03260205|42198004|FG002|Overall Study|Adverse Event|2|||
19749585|NCT03260205|42198005|FG003|Overall Study|Adverse Event|2|||
19749586|NCT03260205|42198006|FG004|Overall Study|Adverse Event|4|||
19749587|NCT03260205|42198002|FG000|Overall Study|Lost to Follow-up|2|||
19749588|NCT03260205|42198003|FG001|Overall Study|Lost to Follow-up|2|||
19749589|NCT03260205|42198004|FG002|Overall Study|Lost to Follow-up|1|||
19749590|NCT03260205|42198005|FG003|Overall Study|Lost to Follow-up|1|||
19749591|NCT03260205|42198006|FG004|Overall Study|Lost to Follow-up|5|||
19749592|NCT03260205|42198002|FG000|Overall Study|Protocol Violation|0|||
19749593|NCT03260205|42198003|FG001|Overall Study|Protocol Violation|0|||
19749594|NCT03260205|42198004|FG002|Overall Study|Protocol Violation|2|||
19749595|NCT03260205|42198005|FG003|Overall Study|Protocol Violation|0|||
19749596|NCT03260205|42198006|FG004|Overall Study|Protocol Violation|1|||
19749597|NCT03260205|42198002|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
19749598|NCT03260205|42198003|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
19749599|NCT03260205|42198004|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
19749600|NCT03260205|42198005|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
19749601|NCT03260205|42198006|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
19749602|NCT03260205|42198002|FG000|Overall Study|Other: Unspecified|0|||
19749603|NCT03260205|42198003|FG001|Overall Study|Other: Unspecified|0|||
19749604|NCT03260205|42198004|FG002|Overall Study|Other: Unspecified|3|||
19749605|NCT03260205|42198005|FG003|Overall Study|Other: Unspecified|1|||
19749606|NCT03260205|42198006|FG004|Overall Study|Other: Unspecified|1|||
19749607|NCT03260205|42198002|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
19749608|NCT03260205|42198003|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
19749609|NCT03260205|42198004|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
19749610|NCT03260205|42198005|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
19749611|NCT03260205|42198006|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
19749612|NCT04666441|42198031|FG000|Overall Study|Lost to Follow-up|1|||
19749613|NCT04666441|42198032|FG001|Overall Study|Lost to Follow-up|4|||
19749614|NCT04666441|42198033|FG002|Overall Study|Lost to Follow-up|1|||
19749615|NCT04666441|42198034|FG003|Overall Study|Lost to Follow-up|3|||
19749616|NCT04666441|42198035|FG004|Overall Study|Lost to Follow-up|0|||
19749617|NCT04666441|42198036|FG005|Overall Study|Lost to Follow-up|2|||
19749618|NCT04666441|42198037|FG006|Overall Study|Lost to Follow-up|2|||
19749619|NCT04666441|42198038|FG007|Overall Study|Lost to Follow-up|2|||
19749620|NCT04666441|42198031|FG000|Overall Study|Subject Decision|1|||
19749621|NCT04666441|42198032|FG001|Overall Study|Subject Decision|1|||
19749622|NCT04666441|42198033|FG002|Overall Study|Subject Decision|3|||
19749623|NCT04666441|42198034|FG003|Overall Study|Subject Decision|1|||
19749624|NCT04666441|42198035|FG004|Overall Study|Subject Decision|0|||
19749625|NCT04666441|42198036|FG005|Overall Study|Subject Decision|1|||
19749626|NCT04666441|42198037|FG006|Overall Study|Subject Decision|3|||
19644725|NCT00408499|42094001|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
19749627|NCT04666441|42198038|FG007|Overall Study|Subject Decision|2|||
19749628|NCT03320850|42198075|FG000|Overall Study|Lost to Follow-up|0|||
19749629|NCT03320850|42198076|FG001|Overall Study|Lost to Follow-up|0|||
19749630|NCT03320850|42198077|FG002|Overall Study|Lost to Follow-up|0|||
19749631|NCT03320850|42198078|FG003|Overall Study|Lost to Follow-up|0|||
19749632|NCT03320850|42198079|FG004|Overall Study|Lost to Follow-up|1|||
19644726|NCT00408499|42094002|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
19644727|NCT00408499|42094003|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
19644728|NCT00408499|42093999|FG000|Phase II- MTD Expansion|treatment delay|0|||
19644729|NCT00408499|42094000|FG001|Phase II- MTD Expansion|treatment delay|0|||
19644730|NCT00408499|42094001|FG002|Phase II- MTD Expansion|treatment delay|0|||
19644731|NCT00408499|42094002|FG003|Phase II- MTD Expansion|treatment delay|0|||
19644732|NCT00408499|42094003|FG004|Phase II- MTD Expansion|treatment delay|3|||
19644733|NCT00621777|42094014|FG000|Open Phase|Adverse Event|20|||
19644734|NCT00621777|42094015|FG001|Open Phase|Adverse Event|0|||
19644735|NCT00621777|42094014|FG000|Open Phase|Did not abstain during open phase|56|||
19644736|NCT00621777|42094015|FG001|Open Phase|Did not abstain during open phase|0|||
19644737|NCT00621777|42094014|FG000|Open Phase|Withdrawal by Subject|17|||
19644738|NCT00621777|42094015|FG001|Open Phase|Withdrawal by Subject|0|||
19644739|NCT00621777|42094014|FG000|Open Phase|administrative|13|||
19644740|NCT00621777|42094015|FG001|Open Phase|administrative|0|||
19644741|NCT00621777|42094014|FG000|Open Phase|Lost to Follow-up|10|||
19644742|NCT00621777|42094015|FG001|Open Phase|Lost to Follow-up|0|||
19644743|NCT00621777|42094014|FG000|Randomized Phase|Adverse Event|3|||
19644744|NCT00621777|42094015|FG001|Randomized Phase|Adverse Event|3|||
19644745|NCT00621777|42094014|FG000|Randomized Phase|Lost to Follow-up|3|||
19644746|NCT00621777|42094015|FG001|Randomized Phase|Lost to Follow-up|3|||
19644747|NCT00621777|42094014|FG000|Randomized Phase|Withdrawal by Subject|1|||
19644748|NCT00621777|42094015|FG001|Randomized Phase|Withdrawal by Subject|9|||
19644749|NCT00621777|42094014|FG000|Randomized Phase|administrative|0|||
19644750|NCT00621777|42094015|FG001|Randomized Phase|administrative|3|||
19749633|NCT03320850|42198080|FG005|Overall Study|Lost to Follow-up|2|||
19749634|NCT03320850|42198081|FG006|Overall Study|Lost to Follow-up|2|||
19749635|NCT03320850|42198082|FG007|Overall Study|Lost to Follow-up|0|||
19749636|NCT03320850|42198083|FG008|Overall Study|Lost to Follow-up|6|||
19749637|NCT03320850|42198084|FG009|Overall Study|Lost to Follow-up|4|||
19749638|NCT03320850|42198075|FG000|Overall Study|Withdrawal by Subject|0|||
19749639|NCT03320850|42198076|FG001|Overall Study|Withdrawal by Subject|0|||
19749640|NCT03320850|42198077|FG002|Overall Study|Withdrawal by Subject|0|||
19749641|NCT03320850|42198078|FG003|Overall Study|Withdrawal by Subject|0|||
19749642|NCT03320850|42198079|FG004|Overall Study|Withdrawal by Subject|1|||
19749643|NCT03320850|42198080|FG005|Overall Study|Withdrawal by Subject|2|||
19749644|NCT03320850|42198081|FG006|Overall Study|Withdrawal by Subject|4|||
19644751|NCT00621777|42094014|FG000|Randomized Phase|Death|0|||
19644752|NCT00621777|42094015|FG001|Randomized Phase|Death|1|||
19644753|NCT00408421|42094025|FG000|Treatment Initial Randomization|Adverse Event|5|||
19644754|NCT00408421|42094026|FG001|Treatment Initial Randomization|Adverse Event|9|||
19644755|NCT00408421|42094027|FG002|Treatment Initial Randomization|Adverse Event|0|||
19644756|NCT00408421|42094025|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
19644757|NCT00408421|42094026|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
19644758|NCT00408421|42094027|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
19644759|NCT00408421|42094025|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
19644760|NCT00408421|42094026|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
19644761|NCT00408421|42094027|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
19644762|NCT00408421|42094025|FG000|Treatment Initial Randomization|Physician Decision|1|||
19644763|NCT00408421|42094026|FG001|Treatment Initial Randomization|Physician Decision|0|||
19644764|NCT00408421|42094027|FG002|Treatment Initial Randomization|Physician Decision|0|||
19644765|NCT00408421|42094025|FG000|Treatment Initial Randomization|Protocol Violation|0|||
19644766|NCT00408421|42094026|FG001|Treatment Initial Randomization|Protocol Violation|1|||
19644767|NCT00408421|42094027|FG002|Treatment Initial Randomization|Protocol Violation|0|||
19644768|NCT00408421|42094025|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
19644769|NCT00408421|42094026|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
19644770|NCT00408421|42094027|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
19644771|NCT00408421|42094025|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
19749645|NCT03320850|42198082|FG007|Overall Study|Withdrawal by Subject|5|||
19749646|NCT03320850|42198083|FG008|Overall Study|Withdrawal by Subject|2|||
19749647|NCT03320850|42198084|FG009|Overall Study|Withdrawal by Subject|1|||
19749648|NCT03320850|42198075|FG000|Overall Study|Lack of Efficacy|0|||
19749649|NCT03320850|42198076|FG001|Overall Study|Lack of Efficacy|0|||
19644772|NCT00408421|42094026|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
19644773|NCT00408421|42094027|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
19644774|NCT00408421|42094025|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
19644775|NCT00408421|42094026|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
19644776|NCT00408421|42094027|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
19644777|NCT00408421|42094025|FG000|Treatment Re-Randomization|Adverse Event|2|||
19644778|NCT00408421|42094026|FG001|Treatment Re-Randomization|Adverse Event|2|||
19749650|NCT03320850|42198077|FG002|Overall Study|Lack of Efficacy|0|||
19749651|NCT03320850|42198078|FG003|Overall Study|Lack of Efficacy|1|||
19644779|NCT00408421|42094027|FG002|Treatment Re-Randomization|Adverse Event|4|||
19644780|NCT00408421|42094025|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
19644781|NCT00408421|42094026|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
19644782|NCT00408421|42094027|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
19644783|NCT00408421|42094025|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
19644784|NCT00408421|42094026|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
19644785|NCT00408421|42094027|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
19644786|NCT00408421|42094025|FG000|Treatment Re-Randomization|Physician Decision|1|||
19644787|NCT00408421|42094026|FG001|Treatment Re-Randomization|Physician Decision|3|||
19644788|NCT00408421|42094027|FG002|Treatment Re-Randomization|Physician Decision|0|||
19644789|NCT00408421|42094025|FG000|Treatment Re-Randomization|Protocol Violation|1|||
19644790|NCT00408421|42094026|FG001|Treatment Re-Randomization|Protocol Violation|1|||
19644791|NCT00408421|42094027|FG002|Treatment Re-Randomization|Protocol Violation|0|||
19644792|NCT00408421|42094025|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
19644793|NCT00408421|42094026|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
19644794|NCT00408421|42094027|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
19644795|NCT00604786|42094037|FG000|Overall Study|Lost to Follow-up|2|||
19644796|NCT00604786|42094038|FG001|Overall Study|Lost to Follow-up|0|||
19644797|NCT00604708|42094046|FG000|Overall Study|Withdrawal by Subject|9|||
19644798|NCT00604708|42094047|FG001|Overall Study|Withdrawal by Subject|10|||
19644799|NCT00604708|42094046|FG000|Overall Study|Protocol Violation|2|||
19644800|NCT00604708|42094047|FG001|Overall Study|Protocol Violation|8|||
19644801|NCT00604708|42094046|FG000|Overall Study|Lost to Follow-up|5|||
19644802|NCT00604708|42094047|FG001|Overall Study|Lost to Follow-up|5|||
19644803|NCT00604708|42094046|FG000|Overall Study|administrative reasons|9|||
19644804|NCT00604708|42094047|FG001|Overall Study|administrative reasons|11|||
19749652|NCT03320850|42198079|FG004|Overall Study|Lack of Efficacy|0|||
19749653|NCT03320850|42198080|FG005|Overall Study|Lack of Efficacy|1|||
19644805|NCT00604708|42094046|FG000|Overall Study|Adverse Event|6|||
19644806|NCT00604708|42094047|FG001|Overall Study|Adverse Event|6|||
19644807|NCT00407797|42094053|FG000|Overall Study|Lost to Follow-up|2|||
19644808|NCT00407797|42094053|FG000|Overall Study|Adverse Event|6|||
19644809|NCT00407797|42094053|FG000|Overall Study|Other|7|||
19644810|NCT00407797|42094053|FG000|Overall Study|Withdrawal by Subject|3|||
19644811|NCT00568126|42094059|FG000|Overall Study|Adverse Event|3|||
19644812|NCT00568126|42094060|FG001|Overall Study|Adverse Event|0|||
19644813|NCT00568126|42094059|FG000|Overall Study|Withdrawal by Subject|2|||
19644814|NCT00568126|42094060|FG001|Overall Study|Withdrawal by Subject|3|||
19644815|NCT00568126|42094059|FG000|Overall Study|Lost to Follow-up|4|||
19644816|NCT00568126|42094060|FG001|Overall Study|Lost to Follow-up|3|||
19644817|NCT00568126|42094059|FG000|Overall Study|Lack of Efficacy|0|||
19644818|NCT00568126|42094060|FG001|Overall Study|Lack of Efficacy|1|||
19749654|NCT03320850|42198081|FG006|Overall Study|Lack of Efficacy|0|||
19749655|NCT03320850|42198082|FG007|Overall Study|Lack of Efficacy|2|||
19749656|NCT03320850|42198083|FG008|Overall Study|Lack of Efficacy|0|||
19749657|NCT03320850|42198084|FG009|Overall Study|Lack of Efficacy|3|||
19749658|NCT03320850|42198075|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
19749659|NCT03320850|42198076|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
19749660|NCT03320850|42198077|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
19749661|NCT03320850|42198078|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
19749662|NCT03320850|42198079|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
19749663|NCT03320850|42198080|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
19749664|NCT03320850|42198081|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
19749665|NCT03320850|42198082|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
19749666|NCT03320850|42198083|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
19749667|NCT03320850|42198084|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
19749668|NCT03320850|42198075|FG000|Overall Study|Adverse Event|0|||
19749669|NCT03320850|42198076|FG001|Overall Study|Adverse Event|0|||
19749670|NCT03320850|42198077|FG002|Overall Study|Adverse Event|0|||
19749671|NCT03320850|42198078|FG003|Overall Study|Adverse Event|0|||
19749672|NCT03320850|42198079|FG004|Overall Study|Adverse Event|0|||
19749673|NCT03320850|42198080|FG005|Overall Study|Adverse Event|2|||
19644819|NCT00568126|42094059|FG000|Overall Study|Physician Decision|2|||
19644820|NCT00568126|42094060|FG001|Overall Study|Physician Decision|2|||
19644821|NCT00407563|42094066|FG000|Overall Study|Patient continues on treatment|1|||
19644822|NCT00567892|42094072|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
19644823|NCT00567892|42094073|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
19644824|NCT00567892|42094074|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
19644825|NCT00567892|42094075|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
19644826|NCT00567892|42094072|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
19644827|NCT00567892|42094073|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
19644828|NCT00567892|42094074|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
19749674|NCT03320850|42198081|FG006|Overall Study|Adverse Event|1|||
19749675|NCT03320850|42198082|FG007|Overall Study|Adverse Event|0|||
19644829|NCT00567892|42094075|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
19644830|NCT00623103|42094089|FG000|Overall Study|Adverse Event|70|||
19644831|NCT00623103|42094090|FG001|Overall Study|Adverse Event|60|||
19644832|NCT00623103|42094089|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19644833|NCT00623103|42094090|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
19644834|NCT00623103|42094089|FG000|Overall Study|Withdrawal by Subject|18|||
19644835|NCT00623103|42094090|FG001|Overall Study|Withdrawal by Subject|24|||
19644836|NCT00623103|42094089|FG000|Overall Study|Lost to Follow-up|4|||
19644837|NCT00623103|42094090|FG001|Overall Study|Lost to Follow-up|1|||
19644838|NCT00623103|42094089|FG000|Overall Study|Administrative problems|2|||
19644839|NCT00623103|42094090|FG001|Overall Study|Administrative problems|4|||
19644840|NCT00623103|42094089|FG000|Overall Study|Death|11|||
19644841|NCT00623103|42094090|FG001|Overall Study|Death|11|||
19644842|NCT00623103|42094089|FG000|Overall Study|Protocol deviation|2|||
19644843|NCT00623103|42094090|FG001|Overall Study|Protocol deviation|1|||
19644844|NCT00396565|42094099|FG000|Overall Study|Physician Decision|3|||
19644845|NCT00396565|42094100|FG001|Overall Study|Physician Decision|1|||
19644846|NCT00396565|42094101|FG002|Overall Study|Physician Decision|2|||
19644847|NCT00396565|42094099|FG000|Overall Study|Adverse Event|5|||
19644848|NCT00396565|42094100|FG001|Overall Study|Adverse Event|13|||
19644849|NCT00396565|42094101|FG002|Overall Study|Adverse Event|3|||
19644850|NCT00396565|42094099|FG000|Overall Study|Withdrawal by Subject|8|||
19644851|NCT00396565|42094100|FG001|Overall Study|Withdrawal by Subject|13|||
19644852|NCT00396565|42094101|FG002|Overall Study|Withdrawal by Subject|1|||
19644853|NCT00396565|42094099|FG000|Overall Study|Lack of Efficacy|32|||
19644854|NCT00396565|42094100|FG001|Overall Study|Lack of Efficacy|64|||
19644855|NCT00396565|42094101|FG002|Overall Study|Lack of Efficacy|11|||
19644856|NCT00394771|42094113|FG000|Overall Study|Did not meet protocol requirements|1|||
19644857|NCT00394771|42094114|FG001|Overall Study|Did not meet protocol requirements|0|||
19644858|NCT00394771|42094115|FG002|Overall Study|Did not meet protocol requirements|2|||
19644859|NCT00394771|42094116|FG003|Overall Study|Did not meet protocol requirements|0|||
19644860|NCT00394771|42094113|FG000|Overall Study|Protocol Violation|2|||
19644861|NCT00394771|42094114|FG001|Overall Study|Protocol Violation|4|||
19644862|NCT00394771|42094115|FG002|Overall Study|Protocol Violation|9|||
19644863|NCT00394771|42094116|FG003|Overall Study|Protocol Violation|7|||
19644864|NCT00394771|42094113|FG000|Overall Study|Withdrawal by Subject|10|||
19644865|NCT00394771|42094114|FG001|Overall Study|Withdrawal by Subject|6|||
19644866|NCT00394771|42094115|FG002|Overall Study|Withdrawal by Subject|8|||
19644867|NCT00394771|42094116|FG003|Overall Study|Withdrawal by Subject|12|||
19644868|NCT00394771|42094113|FG000|Overall Study|Adverse Event|10|||
19644869|NCT00394771|42094114|FG001|Overall Study|Adverse Event|5|||
19644870|NCT00394771|42094115|FG002|Overall Study|Adverse Event|12|||
19644871|NCT00394771|42094116|FG003|Overall Study|Adverse Event|8|||
19644872|NCT00394771|42094113|FG000|Overall Study|Participant pregnant|0|||
19644873|NCT00394771|42094114|FG001|Overall Study|Participant pregnant|1|||
19644874|NCT00394771|42094115|FG002|Overall Study|Participant pregnant|2|||
19644875|NCT00394771|42094116|FG003|Overall Study|Participant pregnant|2|||
19644876|NCT00394771|42094113|FG000|Overall Study|Lost to Follow-up|15|||
19644877|NCT00394771|42094114|FG001|Overall Study|Lost to Follow-up|15|||
19644878|NCT00394771|42094115|FG002|Overall Study|Lost to Follow-up|13|||
19644879|NCT00394771|42094116|FG003|Overall Study|Lost to Follow-up|10|||
19644880|NCT00394771|42094113|FG000|Overall Study|Other|3|||
19644881|NCT00394771|42094114|FG001|Overall Study|Other|3|||
19644882|NCT00394771|42094115|FG002|Overall Study|Other|1|||
19644883|NCT00394771|42094116|FG003|Overall Study|Other|0|||
19644884|NCT00396409|42094128|FG000|Period 1 - 2007|Adverse Event|0|||
19644885|NCT00396409|42094129|FG001|Period 1 - 2007|Adverse Event|1|||
19644886|NCT00396409|42094128|FG000|Period 1 - 2007|Lack of Efficacy|0|||
19644887|NCT00396409|42094129|FG001|Period 1 - 2007|Lack of Efficacy|1|||
19644888|NCT00396409|42094128|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
19644889|NCT00396409|42094129|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
19644890|NCT00396409|42094128|FG000|Period 1 - 2007|Lost to Follow-up|2|||
19644891|NCT00396409|42094129|FG001|Period 1 - 2007|Lost to Follow-up|3|||
19644892|NCT00396409|42094128|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
19644893|NCT00396409|42094129|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
19644894|NCT00396409|42094128|FG000|Period 2 - 2008|Protocol Violation|1|||
19644895|NCT00396409|42094129|FG001|Period 2 - 2008|Protocol Violation|0|||
19644896|NCT00396409|42094128|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
19644897|NCT00396409|42094129|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
19644898|NCT00396409|42094128|FG000|Period 2 - 2008|Lost to Follow-up|3|||
19644899|NCT00396409|42094129|FG001|Period 2 - 2008|Lost to Follow-up|1|||
19644900|NCT02924376|42094141|FG000|Overall Study|Progressive Disease|4|||
19644901|NCT02924376|42094142|FG001|Overall Study|Progressive Disease|0|||
19644902|NCT02924376|42094143|FG002|Overall Study|Progressive Disease|1|||
19644903|NCT02924376|42094144|FG003|Overall Study|Progressive Disease|0|||
19644904|NCT02924376|42094141|FG000|Overall Study|Death|73|||
19644905|NCT02924376|42094142|FG001|Overall Study|Death|18|||
19644906|NCT02924376|42094143|FG002|Overall Study|Death|15|||
19644907|NCT02924376|42094144|FG003|Overall Study|Death|2|||
19644908|NCT02924376|42094141|FG000|Overall Study|Lost to Follow-up|3|||
19644909|NCT02924376|42094142|FG001|Overall Study|Lost to Follow-up|0|||
19644910|NCT02924376|42094143|FG002|Overall Study|Lost to Follow-up|0|||
19644911|NCT02924376|42094144|FG003|Overall Study|Lost to Follow-up|0|||
19644912|NCT02924376|42094141|FG000|Overall Study|Study Terminated by Sponsor|19|||
19644913|NCT02924376|42094142|FG001|Overall Study|Study Terminated by Sponsor|0|||
19644914|NCT02924376|42094143|FG002|Overall Study|Study Terminated by Sponsor|0|||
19644915|NCT02924376|42094144|FG003|Overall Study|Study Terminated by Sponsor|0|||
19644916|NCT02924376|42094141|FG000|Overall Study|Physician Decision|1|||
19644917|NCT02924376|42094142|FG001|Overall Study|Physician Decision|0|||
19644918|NCT02924376|42094143|FG002|Overall Study|Physician Decision|0|||
19644919|NCT02924376|42094144|FG003|Overall Study|Physician Decision|0|||
19644920|NCT02924376|42094141|FG000|Overall Study|Withdrawal by Subject|7|||
19644921|NCT02924376|42094142|FG001|Overall Study|Withdrawal by Subject|2|||
19644922|NCT02924376|42094143|FG002|Overall Study|Withdrawal by Subject|1|||
19644923|NCT02924376|42094144|FG003|Overall Study|Withdrawal by Subject|0|||
19644924|NCT02924376|42094141|FG000|Overall Study|Rolled Over to Another Study|1|||
19644925|NCT02924376|42094142|FG001|Overall Study|Rolled Over to Another Study|0|||
19644926|NCT02924376|42094143|FG002|Overall Study|Rolled Over to Another Study|0|||
19644927|NCT02924376|42094144|FG003|Overall Study|Rolled Over to Another Study|0|||
19644928|NCT00693420|42094159|FG000|Overall Study|Adverse Event|4|||
19644929|NCT00693420|42094160|FG001|Overall Study|Adverse Event|4|||
19644930|NCT00693420|42094159|FG000|Overall Study|Lost to Follow-up|0|||
19644931|NCT00693420|42094160|FG001|Overall Study|Lost to Follow-up|3|||
19644932|NCT00693420|42094159|FG000|Overall Study|Withdrawal by Subject|1|||
19644933|NCT00693420|42094160|FG001|Overall Study|Withdrawal by Subject|0|||
19644934|NCT00693420|42094159|FG000|Overall Study|Protocol Violation|0|||
19644935|NCT00693420|42094160|FG001|Overall Study|Protocol Violation|2|||
19644936|NCT00693420|42094159|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
19644937|NCT00693420|42094160|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
19644938|NCT00693420|42094159|FG000|Overall Study|Personal Reasons|1|||
19644939|NCT00693420|42094160|FG001|Overall Study|Personal Reasons|4|||
19644940|NCT00695136|42094166|FG000|Overall Study|Withdrawal by Subject|1|||
19644941|NCT00695136|42094166|FG000|Overall Study|unrelated adverse event|1|||
19644942|NCT00605176|42094182|FG000|Overall Study|Adverse Event|2|||
19644943|NCT00605176|42094183|FG001|Overall Study|Adverse Event|1|||
19644944|NCT00605176|42094184|FG002|Overall Study|Adverse Event|3|||
19644945|NCT00605176|42094182|FG000|Overall Study|Withdrawal by Subject|4|||
19644946|NCT00605176|42094183|FG001|Overall Study|Withdrawal by Subject|2|||
19644947|NCT00605176|42094184|FG002|Overall Study|Withdrawal by Subject|4|||
19644948|NCT00605176|42094182|FG000|Overall Study|Lost to Follow-up|2|||
19644949|NCT00605176|42094183|FG001|Overall Study|Lost to Follow-up|2|||
19644950|NCT00605176|42094184|FG002|Overall Study|Lost to Follow-up|1|||
19644951|NCT00605176|42094182|FG000|Overall Study|Non-complicance with study procedures|1|||
19644952|NCT00605176|42094183|FG001|Overall Study|Non-complicance with study procedures|0|||
19644953|NCT00605176|42094184|FG002|Overall Study|Non-complicance with study procedures|0|||
19644954|NCT00605176|42094182|FG000|Overall Study|Use of concomitant therapy|1|||
19644955|NCT00605176|42094183|FG001|Overall Study|Use of concomitant therapy|0|||
19644956|NCT00605176|42094184|FG002|Overall Study|Use of concomitant therapy|1|||
19644957|NCT00605176|42094182|FG000|Overall Study|Other (not due to AE)|1|||
19644958|NCT00605176|42094183|FG001|Overall Study|Other (not due to AE)|1|||
19644959|NCT00605176|42094184|FG002|Overall Study|Other (not due to AE)|0|||
19644960|NCT00694356|42094195|FG000|Overall Study|Adverse Event|1|||
19644961|NCT00694356|42094196|FG001|Overall Study|Adverse Event|0|||
19644962|NCT00694356|42094197|FG002|Overall Study|Adverse Event|0|||
19644963|NCT00694356|42094195|FG000|Overall Study|Progressive Disease|2|||
19644964|NCT00694356|42094196|FG001|Overall Study|Progressive Disease|6|||
19644965|NCT00694356|42094197|FG002|Overall Study|Progressive Disease|6|||
19644966|NCT00692406|42094205|FG000|Overall Study|PI dropped, bad data|57|||
19644967|NCT00567502|42094222|FG000|Overall Study|Lost to Follow-up|91|||
19644968|NCT00567502|42094223|FG001|Overall Study|Lost to Follow-up|14|||
19644969|NCT00567502|42094224|FG002|Overall Study|Lost to Follow-up|351|||
19644970|NCT00567502|42094225|FG003|Overall Study|Lost to Follow-up|2|||
19644971|NCT00567502|42094222|FG000|Overall Study|Death|65|||
19644972|NCT00567502|42094223|FG001|Overall Study|Death|16|||
19644973|NCT00567502|42094224|FG002|Overall Study|Death|360|||
19644974|NCT00567502|42094225|FG003|Overall Study|Death|5|||
19644975|NCT00567502|42094222|FG000|Overall Study|Other|64|||
19644976|NCT00567502|42094223|FG001|Overall Study|Other|2|||
19644977|NCT00567502|42094224|FG002|Overall Study|Other|134|||
19644978|NCT00567502|42094225|FG003|Overall Study|Other|6|||
19644979|NCT00567502|42094222|FG000|Overall Study|Participant request|12|||
19644980|NCT00567502|42094223|FG001|Overall Study|Participant request|1|||
19644981|NCT00567502|42094224|FG002|Overall Study|Participant request|33|||
19644982|NCT00567502|42094225|FG003|Overall Study|Participant request|1|||
19644983|NCT00567502|42094222|FG000|Overall Study|Sponsor request|9|||
19644984|NCT00567502|42094223|FG001|Overall Study|Sponsor request|0|||
19644985|NCT00567502|42094224|FG002|Overall Study|Sponsor request|30|||
19644986|NCT00567502|42094225|FG003|Overall Study|Sponsor request|1|||
19644987|NCT00567502|42094222|FG000|Overall Study|Never Initiated Treatment|0|||
19644988|NCT00567502|42094223|FG001|Overall Study|Never Initiated Treatment|0|||
19644989|NCT00567502|42094224|FG002|Overall Study|Never Initiated Treatment|0|||
19644990|NCT00567502|42094225|FG003|Overall Study|Never Initiated Treatment|72|||
19644991|NCT00396331|42094250|FG000|Overall Study|Failed to mobilize - no transplant|8|||
19644992|NCT00396331|42094250|FG000|Overall Study|Did not go on to transplant|5|||
19644993|NCT00396331|42094250|FG000|Overall Study|Lost to Follow-up|3|||
19644994|NCT00396331|42094250|FG000|Overall Study|Death|16|||
19644995|NCT00396253|42094262|FG000|Overall Study|Protocol Violation|1|||
19644996|NCT00396253|42094262|FG000|Overall Study|Withdrawal by Subject|7|||
19644997|NCT00396253|42094262|FG000|Overall Study|Death|3|||
19644998|NCT00396253|42094262|FG000|Overall Study|Physician Decision|1|||
19644999|NCT00396253|42094262|FG000|Overall Study|Change in eligibility status|1|||
19645000|NCT00604162|42094266|FG000|Overall Study|Physician Decision|3|||
19645001|NCT00604162|42094266|FG000|Overall Study|Withdrawal by Subject|1|||
19645002|NCT00396097|42094275|FG000|Overall Study|Withdrawal by Subject|17|||
19645003|NCT00396097|42094276|FG001|Overall Study|Withdrawal by Subject|17|||
19645004|NCT00396097|42094275|FG000|Overall Study|Lost to Follow-up|4|||
19645005|NCT00396097|42094276|FG001|Overall Study|Lost to Follow-up|9|||
19645006|NCT00396097|42094275|FG000|Overall Study|Other|3|||
19645007|NCT00396097|42094276|FG001|Overall Study|Other|5|||
19645008|NCT00396097|42094275|FG000|Overall Study|Protocol Violation|0|||
19645009|NCT00396097|42094276|FG001|Overall Study|Protocol Violation|6|||
19645010|NCT00396097|42094275|FG000|Overall Study|Adverse Event|1|||
19645011|NCT00396097|42094276|FG001|Overall Study|Adverse Event|5|||
19645012|NCT00396097|42094275|FG000|Overall Study|Insufficient Clinical Response|1|||
19645013|NCT00396097|42094276|FG001|Overall Study|Insufficient Clinical Response|4|||
19645014|NCT00375505|42094288|FG000|Overall Study|Adverse Event|1|||
19645015|NCT00375505|42094289|FG001|Overall Study|Adverse Event|2|||
19645016|NCT00375427|42094297|FG000|Overall Study|Adverse Event|21|||
19645017|NCT00375427|42094298|FG001|Overall Study|Adverse Event|27|||
19645018|NCT00375427|42094297|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19645019|NCT00375427|42094298|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19645020|NCT00375427|42094297|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19645021|NCT00375427|42094298|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19645022|NCT00375427|42094297|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19749676|NCT03320850|42198083|FG008|Overall Study|Adverse Event|2|||
19749677|NCT03320850|42198084|FG009|Overall Study|Adverse Event|0|||
19749678|NCT03320850|42198075|FG000|Overall Study|Reason Not Specified|0|||
19749679|NCT03320850|42198076|FG001|Overall Study|Reason Not Specified|0|||
19749680|NCT03320850|42198077|FG002|Overall Study|Reason Not Specified|0|||
19749681|NCT03320850|42198078|FG003|Overall Study|Reason Not Specified|0|||
19749682|NCT03320850|42198079|FG004|Overall Study|Reason Not Specified|0|||
19749683|NCT03320850|42198080|FG005|Overall Study|Reason Not Specified|1|||
19749684|NCT03320850|42198081|FG006|Overall Study|Reason Not Specified|0|||
19749685|NCT03320850|42198082|FG007|Overall Study|Reason Not Specified|0|||
19749686|NCT03320850|42198083|FG008|Overall Study|Reason Not Specified|0|||
19749687|NCT03320850|42198084|FG009|Overall Study|Reason Not Specified|1|||
19749688|NCT03301623|42198113|FG000|Overall Study|Death|3|||
19749689|NCT03301623|42198114|FG001|Overall Study|Death|1|||
19749690|NCT03301623|42198113|FG000|Overall Study|Withdrawal by Subject|11|||
19749691|NCT03301623|42198114|FG001|Overall Study|Withdrawal by Subject|13|||
19645023|NCT00375427|42094298|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19645024|NCT00375427|42094297|FG000|Overall Study|Patient no longer requires study drug|3|||
19645025|NCT00375427|42094298|FG001|Overall Study|Patient no longer requires study drug|7|||
19645026|NCT00375427|42094297|FG000|Overall Study|Protocol Violation|10|||
19645027|NCT00375427|42094298|FG001|Overall Study|Protocol Violation|8|||
19645028|NCT00375427|42094297|FG000|Overall Study|Withdrawal by Subject|9|||
19645029|NCT00375427|42094298|FG001|Overall Study|Withdrawal by Subject|13|||
19749692|NCT03301623|42198113|FG000|Overall Study|Lost to Follow-up|3|||
19749693|NCT03301623|42198114|FG001|Overall Study|Lost to Follow-up|1|||
19749694|NCT03319212|42198122|FG000|Overall Study|Discontinued as moving out of local area|0|||
19749695|NCT03319212|42198123|FG001|Overall Study|Discontinued as moving out of local area|1|||
19645030|NCT00375427|42094297|FG000|Overall Study|Lost to Follow-up|1|||
19645031|NCT00375427|42094298|FG001|Overall Study|Lost to Follow-up|1|||
19645032|NCT00375427|42094297|FG000|Overall Study|Administrative reasons|0|||
19645033|NCT00375427|42094298|FG001|Overall Study|Administrative reasons|1|||
19645034|NCT00375427|42094297|FG000|Overall Study|Death|11|||
19645035|NCT00375427|42094298|FG001|Overall Study|Death|10|||
19645036|NCT00393913|42094304|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
19749696|NCT03319212|42198122|FG000|Overall Study|Adverse Event|2|||
19749697|NCT03319212|42198123|FG001|Overall Study|Adverse Event|2|||
19749698|NCT03319212|42198122|FG000|Overall Study|Withdrawal by Subject|0|||
19749699|NCT03319212|42198123|FG001|Overall Study|Withdrawal by Subject|1|||
19749700|NCT03319212|42198122|FG000|Overall Study|Lost to Follow-up|0|||
19749701|NCT03319212|42198123|FG001|Overall Study|Lost to Follow-up|1|||
19749702|NCT03319212|42198122|FG000|Overall Study|Physician Decision|1|||
19749703|NCT03319212|42198123|FG001|Overall Study|Physician Decision|0|||
19749704|NCT04656691|42198128|FG000|Overall Study|Adverse Event|1|||
19749705|NCT03301155|42198134|FG000|Overall Study|Сompliance with exclusion criteria|8|||
19749706|NCT03301155|42198135|FG001|Overall Study|Сompliance with exclusion criteria|7|||
19749707|NCT01952730|42198141|FG000|Overall Study|FDA shut down core lab used by study|1|||
19749708|NCT03316170|42198147|FG000|Overall Study|Death|1|||
19749709|NCT03316170|42198148|FG001|Overall Study|Death|0|||
19749710|NCT03316170|42198147|FG000|Overall Study|Lost to Follow-up|6|||
19749711|NCT03316170|42198148|FG001|Overall Study|Lost to Follow-up|7|||
19749712|NCT03257865|42198157|FG000|Overall Study|Adverse Event|4|||
19749713|NCT03257865|42198158|FG001|Overall Study|Adverse Event|8|||
19749714|NCT03257865|42198157|FG000|Overall Study|Lack of Efficacy|1|||
19749715|NCT03257865|42198158|FG001|Overall Study|Lack of Efficacy|2|||
19749716|NCT03257865|42198157|FG000|Overall Study|Non-compliance with Study Drug|0|||
19749717|NCT03257865|42198158|FG001|Overall Study|Non-compliance with Study Drug|2|||
19749718|NCT03257865|42198157|FG000|Overall Study|Withdrawal by Subject|23|||
19749719|NCT03257865|42198158|FG001|Overall Study|Withdrawal by Subject|17|||
19749720|NCT03257865|42198157|FG000|Overall Study|Physician Decision|3|||
19600787|NCT01072175|42049715|FG004|Part A (Drug-Drug Interaction)|Death|0|||
19600788|NCT01072175|42049716|FG005|Part A (Drug-Drug Interaction)|Death|0|||
19600789|NCT01072175|42049717|FG006|Part A (Drug-Drug Interaction)|Death|0|||
19600790|NCT01072175|42049718|FG007|Part A (Drug-Drug Interaction)|Death|0|||
19600791|NCT01072175|42049719|FG008|Part A (Drug-Drug Interaction)|Death|0|||
19600792|NCT01072175|42049720|FG009|Part A (Drug-Drug Interaction)|Death|0|||
19600793|NCT01072175|42049721|FG010|Part A (Drug-Drug Interaction)|Death|0|||
19600794|NCT01072175|42049722|FG011|Part A (Drug-Drug Interaction)|Death|0|||
19600795|NCT01072175|42049723|FG012|Part A (Drug-Drug Interaction)|Death|0|||
19600796|NCT01072175|42049711|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
19600797|NCT01072175|42049712|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600798|NCT01072175|42049713|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600799|NCT01072175|42049714|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600800|NCT01072175|42049715|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600801|NCT01072175|42049716|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600802|NCT01072175|42049717|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600803|NCT01072175|42049718|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600804|NCT01072175|42049719|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600805|NCT01072175|42049720|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600806|NCT01072175|42049721|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600807|NCT01072175|42049722|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600808|NCT01072175|42049723|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
19600809|NCT01072175|42049711|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
19600810|NCT01072175|42049712|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600811|NCT01072175|42049713|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600812|NCT01072175|42049714|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600813|NCT01072175|42049715|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600814|NCT01072175|42049716|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600815|NCT01072175|42049717|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600816|NCT01072175|42049718|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600817|NCT01072175|42049719|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600818|NCT01072175|42049720|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600819|NCT01072175|42049721|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600820|NCT01072175|42049722|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600821|NCT01072175|42049723|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
19600822|NCT01072175|42049711|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
19600823|NCT01072175|42049712|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
19600824|NCT01072175|42049713|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
19600825|NCT01072175|42049714|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
19600826|NCT01072175|42049715|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
19600827|NCT01072175|42049716|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
19600828|NCT01072175|42049717|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
19600829|NCT01072175|42049718|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
19600830|NCT01072175|42049719|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
19600831|NCT01072175|42049720|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
19600832|NCT01072175|42049721|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
19749721|NCT03257865|42198158|FG001|Overall Study|Physician Decision|1|||
19749722|NCT03257865|42198157|FG000|Overall Study|Other|0|||
19749723|NCT03257865|42198158|FG001|Overall Study|Other|1|||
19749724|NCT03257865|42198157|FG000|Overall Study|Lost to Follow-up|4|||
19749725|NCT03257865|42198158|FG001|Overall Study|Lost to Follow-up|4|||
19645037|NCT00393913|42094304|FG000|Initial Assessment|Withdrawal by Subject|16|||
19645038|NCT00393913|42094304|FG000|CPAP|Withdrawal by Subject|3|||
19645039|NCT00393913|42094304|FG000|CPAP|Physician Decision|1|||
19645040|NCT00393913|42094304|FG000|CPAP|TEchnical problem with CPAP|3|||
19645041|NCT00567268|42094309|FG000|Overall Study|Protocol Violation|7|||
19645042|NCT00567268|42094309|FG000|Overall Study|Lost to Follow-up|36|||
19645043|NCT00567268|42094309|FG000|Overall Study|No Visit After First Day of Treatment|2|||
19645044|NCT00567268|42094309|FG000|Overall Study|No Drug Administration|4|||
19645045|NCT00567268|42094309|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
19645046|NCT03976648|42094350|FG000|Overall Study|Adverse Event|0|||
19645047|NCT03976648|42094351|FG001|Overall Study|Adverse Event|2|||
19645048|NCT03976648|42094350|FG000|Overall Study|Study terminated by sponsor|21|||
19645049|NCT03976648|42094351|FG001|Overall Study|Study terminated by sponsor|8|||
19645050|NCT00566254|42094359|FG000|Overall Study|Adverse Event|3|||
19645051|NCT00566254|42094360|FG001|Overall Study|Adverse Event|1|||
19645052|NCT00566254|42094359|FG000|Overall Study|Protocol Violation|1|||
19645053|NCT00566254|42094360|FG001|Overall Study|Protocol Violation|3|||
19645054|NCT00566254|42094359|FG000|Overall Study|Withdrawal by Subject|1|||
19645055|NCT00566254|42094360|FG001|Overall Study|Withdrawal by Subject|2|||
19645056|NCT00566254|42094359|FG000|Overall Study|Lack of Efficacy|5|||
19645057|NCT00566254|42094360|FG001|Overall Study|Lack of Efficacy|6|||
19645058|NCT00566254|42094359|FG000|Overall Study|Other|0|||
19645059|NCT00566254|42094360|FG001|Overall Study|Other|2|||
19645060|NCT00393523|42094371|FG000|Overall Study|Lost to Follow-up|0|||
19645061|NCT00393523|42094372|FG001|Overall Study|Lost to Follow-up|0|||
19645062|NCT00393523|42094373|FG002|Overall Study|Lost to Follow-up|0|||
19645063|NCT00393523|42094374|FG003|Overall Study|Lost to Follow-up|2|||
19645064|NCT00393523|42094375|FG004|Overall Study|Lost to Follow-up|1|||
19645065|NCT00393523|42094371|FG000|Overall Study|Protocol Violation|6|||
19645066|NCT00393523|42094372|FG001|Overall Study|Protocol Violation|2|||
19645067|NCT00393523|42094373|FG002|Overall Study|Protocol Violation|0|||
19645068|NCT00393523|42094374|FG003|Overall Study|Protocol Violation|1|||
19645069|NCT00393523|42094375|FG004|Overall Study|Protocol Violation|0|||
19388171|NCT02055898|41631554|FG000|First Intervention (5 Days)|Physician Decision|2|||
19388172|NCT02055898|41631555|FG001|First Intervention (5 Days)|Physician Decision|0|||
19388173|NCT02055898|41631554|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
19645070|NCT00393523|42094371|FG000|Overall Study|Withdrawal by Subject|6|||
19645071|NCT00393523|42094372|FG001|Overall Study|Withdrawal by Subject|7|||
19645072|NCT00393523|42094373|FG002|Overall Study|Withdrawal by Subject|2|||
19645073|NCT00393523|42094374|FG003|Overall Study|Withdrawal by Subject|3|||
19645074|NCT00393523|42094375|FG004|Overall Study|Withdrawal by Subject|0|||
19645075|NCT00393523|42094371|FG000|Overall Study|Difficulties in specimen collection|0|||
19645076|NCT00393523|42094372|FG001|Overall Study|Difficulties in specimen collection|0|||
19645077|NCT00393523|42094373|FG002|Overall Study|Difficulties in specimen collection|1|||
19645078|NCT00393523|42094374|FG003|Overall Study|Difficulties in specimen collection|0|||
19645079|NCT00393523|42094375|FG004|Overall Study|Difficulties in specimen collection|0|||
19645080|NCT00393523|42094371|FG000|Overall Study|Vaccine supply issue|0|||
19645081|NCT00393523|42094372|FG001|Overall Study|Vaccine supply issue|0|||
19645082|NCT00393523|42094373|FG002|Overall Study|Vaccine supply issue|1|||
19645083|NCT00393523|42094374|FG003|Overall Study|Vaccine supply issue|0|||
19645084|NCT00393523|42094375|FG004|Overall Study|Vaccine supply issue|0|||
19645085|NCT00393367|42094388|FG000|Overall Study|Protocol Violation|2|||
19645086|NCT00393367|42094389|FG001|Overall Study|Protocol Violation|5|||
19645087|NCT00393367|42094388|FG000|Overall Study|Withdrawal by Subject|0|||
19645088|NCT00393367|42094389|FG001|Overall Study|Withdrawal by Subject|2|||
19749726|NCT04617847|42198166|FG000|Overall Study|Withdrawal by Subject|1|||
19645089|NCT00395863|42094399|FG000|Overall Study|Patients did not complete both exams|2|||
19645090|NCT00395863|42094400|FG001|Overall Study|Patients did not complete both exams|3|||
19645091|NCT00395629|42094412|FG000|Core Study|Adverse Event|0|||
19645092|NCT00395629|42094413|FG001|Core Study|Adverse Event|3|||
19645093|NCT00395629|42094414|FG002|Core Study|Adverse Event|4|||
19645094|NCT00395629|42094412|FG000|Core Study|Abnormal laboratory value(s)|0|||
19645095|NCT00395629|42094413|FG001|Core Study|Abnormal laboratory value(s)|0|||
19645096|NCT00395629|42094414|FG002|Core Study|Abnormal laboratory value(s)|1|||
19645097|NCT00395629|42094412|FG000|Core Study|Protocol Violation|1|||
19645098|NCT00395629|42094413|FG001|Core Study|Protocol Violation|0|||
19645099|NCT00395629|42094414|FG002|Core Study|Protocol Violation|0|||
19645100|NCT00395629|42094412|FG000|Core Study|Withdrawal by Subject|0|||
19645101|NCT00395629|42094413|FG001|Core Study|Withdrawal by Subject|1|||
19645102|NCT00395629|42094414|FG002|Core Study|Withdrawal by Subject|1|||
19645103|NCT00395629|42094412|FG000|Core Study|Lost to Follow-up|0|||
19645104|NCT00395629|42094413|FG001|Core Study|Lost to Follow-up|0|||
19645105|NCT00395629|42094414|FG002|Core Study|Lost to Follow-up|1|||
19645106|NCT00395629|42094412|FG000|Extension Study|Adverse Event|0|||
19645107|NCT00395629|42094413|FG001|Extension Study|Adverse Event|0|||
19645108|NCT00395629|42094414|FG002|Extension Study|Adverse Event|2|||
19645109|NCT00395629|42094412|FG000|Extension Study|Administrative problems|0|||
19645110|NCT00395629|42094413|FG001|Extension Study|Administrative problems|0|||
19645111|NCT00395629|42094414|FG002|Extension Study|Administrative problems|1|||
19645112|NCT00392665|42094427|FG000|Overall Study|Death|16|||
19645113|NCT00392665|42094428|FG001|Overall Study|Death|14|||
19645114|NCT00392665|42094427|FG000|Overall Study|Lost to Follow-up|1|||
19645115|NCT00392665|42094428|FG001|Overall Study|Lost to Follow-up|1|||
19645116|NCT00622869|42094437|FG000|Overall Study|Subject Withdrew Consent|13|||
19645117|NCT00622869|42094438|FG001|Overall Study|Subject Withdrew Consent|17|||
19645118|NCT00622869|42094439|FG002|Overall Study|Subject Withdrew Consent|11|||
19645119|NCT00622869|42094437|FG000|Overall Study|Administrative Problems|11|||
19645120|NCT00622869|42094438|FG001|Overall Study|Administrative Problems|17|||
19645121|NCT00622869|42094439|FG002|Overall Study|Administrative Problems|13|||
19645122|NCT00622869|42094437|FG000|Overall Study|Death|12|||
19645123|NCT00622869|42094438|FG001|Overall Study|Death|15|||
19645124|NCT00622869|42094439|FG002|Overall Study|Death|10|||
19645125|NCT00622869|42094437|FG000|Overall Study|Lost to Follow-up|2|||
19645126|NCT00622869|42094438|FG001|Overall Study|Lost to Follow-up|4|||
19645127|NCT00622869|42094439|FG002|Overall Study|Lost to Follow-up|2|||
19645128|NCT00622869|42094437|FG000|Overall Study|Graft Loss|5|||
19645129|NCT00622869|42094438|FG001|Overall Study|Graft Loss|3|||
19645130|NCT00622869|42094439|FG002|Overall Study|Graft Loss|2|||
19645131|NCT00622869|42094437|FG000|Overall Study|Missing|0|||
19645132|NCT00622869|42094438|FG001|Overall Study|Missing|1|||
19645133|NCT00622869|42094439|FG002|Overall Study|Missing|1|||
19645134|NCT00395083|42094449|FG000|Overall Study|Withdrawal by Subject|6|||
19645135|NCT00395083|42094450|FG001|Overall Study|Withdrawal by Subject|5|||
19645136|NCT00395083|42094449|FG000|Overall Study|Developed another disease|4|||
19645137|NCT00395083|42094450|FG001|Overall Study|Developed another disease|3|||
19645138|NCT00366457|42094456|FG000|Overall Study|never began study therapy|2|||
19645139|NCT00624819|42094464|FG000|Follow-up Period: Year 4|Parents decision|0|||
19645140|NCT00624819|42094465|FG001|Follow-up Period: Year 4|Parents decision|0|||
19645141|NCT00624819|42094466|FG002|Follow-up Period: Year 4|Parents decision|1|||
19645142|NCT00624819|42094467|FG003|Follow-up Period: Year 4|Parents decision|0|||
19645143|NCT00624819|42094464|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
19645144|NCT00624819|42094465|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
19645145|NCT00624819|42094466|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
19645146|NCT00624819|42094467|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
19645147|NCT03832387|42094479|FG000|Overall Study|Protocol Violation|2|||
19645148|NCT03832387|42094480|FG001|Overall Study|Protocol Violation|6|||
19645149|NCT03832387|42094479|FG000|Overall Study|EXCLUSION CRITERIA|3|||
19645150|NCT03832387|42094480|FG001|Overall Study|EXCLUSION CRITERIA|1|||
19645151|NCT00366301|42094490|FG000|Overall Study|Lost to Follow-up|4|||
19645152|NCT00366301|42094491|FG001|Overall Study|Lost to Follow-up|4|||
19645153|NCT00366301|42094492|FG002|Overall Study|Lost to Follow-up|3|||
19645154|NCT00366301|42094493|FG003|Overall Study|Lost to Follow-up|7|||
19645155|NCT00366301|42094490|FG000|Overall Study|Withdrawal by Subject|4|||
19645156|NCT00366301|42094491|FG001|Overall Study|Withdrawal by Subject|2|||
19645157|NCT00366301|42094492|FG002|Overall Study|Withdrawal by Subject|1|||
19388174|NCT02055898|41631555|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
19388175|NCT02564055|41631567|FG000|Overall Study|Adverse Event|1|||
19388176|NCT02564055|41631568|FG001|Overall Study|Adverse Event|0|||
19388177|NCT02564055|41631569|FG002|Overall Study|Adverse Event|4|||
19388178|NCT02564055|41631570|FG003|Overall Study|Adverse Event|1|||
19388179|NCT02564055|41631571|FG004|Overall Study|Adverse Event|4|||
19388180|NCT02564055|41631572|FG005|Overall Study|Adverse Event|1|||
19388181|NCT02564055|41631567|FG000|Overall Study|Protocol Violation|1|||
19388182|NCT02564055|41631568|FG001|Overall Study|Protocol Violation|0|||
19388183|NCT02564055|41631569|FG002|Overall Study|Protocol Violation|0|||
19388184|NCT02564055|41631570|FG003|Overall Study|Protocol Violation|0|||
19388185|NCT02564055|41631571|FG004|Overall Study|Protocol Violation|0|||
19645158|NCT00366301|42094493|FG003|Overall Study|Withdrawal by Subject|1|||
19645159|NCT00365989|42094503|FG000|Overall Study|Withdrawal by Subject|1|||
19645160|NCT00365989|42094503|FG000|Overall Study|Non-compliance|1|||
19645161|NCT00622713|42094508|FG000|Overall Study|Adverse Event|35|||
19645162|NCT00622713|42094508|FG000|Overall Study|Administrative problems|4|||
19645163|NCT00622713|42094508|FG000|Overall Study|Withdrawal by Subject|11|||
19645164|NCT00622713|42094508|FG000|Overall Study|Lost to Follow-up|5|||
19645165|NCT00622713|42094508|FG000|Overall Study|Death|2|||
19645166|NCT00622713|42094508|FG000|Overall Study|Subject no longer required study drug|1|||
19645167|NCT00622713|42094508|FG000|Overall Study|Did not meet eligibility criteria|1|||
19645168|NCT00392197|42094514|FG000|Overall Study|Adverse Event|4|||
19645169|NCT00392197|42094515|FG001|Overall Study|Adverse Event|12|||
19645170|NCT00392197|42094514|FG000|Overall Study|Lack of Efficacy|3|||
19645171|NCT00392197|42094515|FG001|Overall Study|Lack of Efficacy|4|||
19645172|NCT00392197|42094514|FG000|Overall Study|Lost to Follow-up|0|||
19645173|NCT00392197|42094515|FG001|Overall Study|Lost to Follow-up|1|||
19645174|NCT00392197|42094514|FG000|Overall Study|Physician Decision|3|||
19645175|NCT00392197|42094515|FG001|Overall Study|Physician Decision|2|||
19645176|NCT00392197|42094514|FG000|Overall Study|Protocol Violation|7|||
19749727|NCT04617847|42198167|FG001|Overall Study|Withdrawal by Subject|0|||
19388186|NCT02564055|41631572|FG005|Overall Study|Protocol Violation|0|||
19645177|NCT00392197|42094515|FG001|Overall Study|Protocol Violation|5|||
19645178|NCT00392197|42094514|FG000|Overall Study|Withdrawal by Subject|4|||
19645179|NCT00392197|42094515|FG001|Overall Study|Withdrawal by Subject|6|||
19645180|NCT00391807|42094521|FG000|Overall Study|Did not receive study medication|23|||
19645181|NCT00391807|42094521|FG000|Overall Study|Adverse Event|177|||
19645182|NCT00391807|42094521|FG000|Overall Study|Pregnancy|25|||
19645183|NCT00391807|42094521|FG000|Overall Study|Lost to Follow-up|227|||
19645184|NCT00391807|42094521|FG000|Overall Study|Withdrawal by Subject|147|||
19645185|NCT00391807|42094521|FG000|Overall Study|Protocol Violation|20|||
19645186|NCT00391807|42094521|FG000|Overall Study|Various|96|||
19645187|NCT00624585|42094525|FG000|Overall Study|Death|3|||
19645188|NCT00624585|42094525|FG000|Overall Study|Disease Progression|6|||
19645189|NCT00624585|42094525|FG000|Overall Study|Adverse Event|3|||
19645190|NCT00622635|42094529|FG000|Treatment Period 1|Adverse Event|0|||
19645191|NCT00622635|42094530|FG001|Treatment Period 1|Adverse Event|0|||
19645192|NCT00622635|42094531|FG002|Treatment Period 1|Adverse Event|1|||
19645193|NCT00622635|42094532|FG003|Treatment Period 1|Adverse Event|0|||
19645194|NCT00622635|42094533|FG004|Treatment Period 1|Adverse Event|0|||
19645195|NCT00622635|42094534|FG005|Treatment Period 1|Adverse Event|0|||
19645196|NCT00622635|42094529|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19645197|NCT00622635|42094530|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19645198|NCT00622635|42094531|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19645199|NCT00622635|42094532|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19645200|NCT00622635|42094533|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19645201|NCT00622635|42094534|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19645202|NCT00622635|42094529|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
19645203|NCT00622635|42094530|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
19388187|NCT02564055|41631567|FG000|Overall Study|Reached stopping criteria|0|||
19388188|NCT02564055|41631568|FG001|Overall Study|Reached stopping criteria|0|||
19645204|NCT00622635|42094531|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
19645205|NCT00622635|42094532|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
19645206|NCT00622635|42094533|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
19698920|NCT00313586|42143716|FG003|Overall Study|Moved|0|||
19698921|NCT00313586|42143713|FG000|Overall Study|Death before starting treatment|1|||
19698922|NCT00313586|42143714|FG001|Overall Study|Death before starting treatment|0|||
19698923|NCT00313586|42143715|FG002|Overall Study|Death before starting treatment|0|||
19698924|NCT00313586|42143716|FG003|Overall Study|Death before starting treatment|0|||
19698925|NCT00312572|42143726|FG000|Overall Study|Adverse Event|10|||
19698926|NCT00312572|42143727|FG001|Overall Study|Adverse Event|16|||
19645207|NCT00622635|42094534|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
19645208|NCT00622635|42094529|FG000|Treatment Period 2|Adverse Event|1|||
19645209|NCT00622635|42094530|FG001|Treatment Period 2|Adverse Event|0|||
19645210|NCT00622635|42094531|FG002|Treatment Period 2|Adverse Event|0|||
19645211|NCT00622635|42094532|FG003|Treatment Period 2|Adverse Event|0|||
19645212|NCT00622635|42094533|FG004|Treatment Period 2|Adverse Event|0|||
19645213|NCT00622635|42094534|FG005|Treatment Period 2|Adverse Event|0|||
19645214|NCT00622635|42094529|FG000|Treatment Period 3|Adverse Event|0|||
19645215|NCT00622635|42094530|FG001|Treatment Period 3|Adverse Event|0|||
19645216|NCT00622635|42094531|FG002|Treatment Period 3|Adverse Event|0|||
19645217|NCT00622635|42094532|FG003|Treatment Period 3|Adverse Event|2|||
19645218|NCT00622635|42094533|FG004|Treatment Period 3|Adverse Event|0|||
19645219|NCT00622635|42094534|FG005|Treatment Period 3|Adverse Event|0|||
19645220|NCT00622635|42094529|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19645221|NCT00622635|42094530|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19645222|NCT00622635|42094531|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19645223|NCT00622635|42094532|FG003|Treatment Period 3|Withdrawal by Subject|1|||
19645224|NCT00622635|42094533|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19645225|NCT00622635|42094534|FG005|Treatment Period 3|Withdrawal by Subject|0|||
19645226|NCT00391027|42094544|FG000|Overall Study|Adverse Event|8|||
19645227|NCT00391027|42094545|FG001|Overall Study|Adverse Event|8|||
19645228|NCT00391027|42094544|FG000|Overall Study|Lack of Efficacy|3|||
19645229|NCT00391027|42094545|FG001|Overall Study|Lack of Efficacy|0|||
19645230|NCT00391027|42094544|FG000|Overall Study|Withdrawal by Subject|10|||
19645231|NCT00391027|42094545|FG001|Overall Study|Withdrawal by Subject|1|||
19645232|NCT00391027|42094544|FG000|Overall Study|Other|4|||
19645233|NCT00391027|42094545|FG001|Overall Study|Other|3|||
19645234|NCT00622401|42094554|FG000|Overall Study|Disease progression prior to treatment|3|||
19645235|NCT00622401|42094555|FG001|Overall Study|Disease progression prior to treatment|2|||
19645236|NCT00622401|42094556|FG002|Overall Study|Disease progression prior to treatment|0|||
19645237|NCT00621621|42094566|FG000|Overall Study|Subjects were exited at EP study|30|||
19645238|NCT00621621|42094567|FG001|Overall Study|Subjects were exited at EP study|0|||
19645239|NCT00621543|42094575|FG000|Overall Study|Lost to Follow-up|23|||
19645240|NCT00623805|42094581|FG000|Overall Study|Adverse Event|9|||
19645241|NCT00623805|42094582|FG001|Overall Study|Adverse Event|6|||
19645242|NCT00623805|42094581|FG000|Overall Study|Death|2|||
19645243|NCT00623805|42094582|FG001|Overall Study|Death|0|||
19645244|NCT00623805|42094581|FG000|Overall Study|Lack of Efficacy|3|||
19645245|NCT00623805|42094582|FG001|Overall Study|Lack of Efficacy|7|||
19645246|NCT00623805|42094581|FG000|Overall Study|Lost to Follow-up|2|||
19645247|NCT00623805|42094582|FG001|Overall Study|Lost to Follow-up|2|||
19645248|NCT00623805|42094581|FG000|Overall Study|Protocol Violation|1|||
19645249|NCT00623805|42094582|FG001|Overall Study|Protocol Violation|1|||
19645250|NCT00623805|42094581|FG000|Overall Study|Reason not Specified|3|||
19645251|NCT00623805|42094582|FG001|Overall Study|Reason not Specified|6|||
19645252|NCT00621309|42094588|FG000|Overall Study|Withdrawal by Subject|2|||
19645253|NCT00621309|42094589|FG001|Overall Study|Withdrawal by Subject|0|||
19749728|NCT04617847|42198166|FG000|Overall Study|Adverse Event|0|||
19749729|NCT04617847|42198167|FG001|Overall Study|Adverse Event|2|||
19749730|NCT04617847|42198166|FG000|Overall Study|Death|0|||
19749731|NCT04617847|42198167|FG001|Overall Study|Death|1|||
19749732|NCT04617847|42198166|FG000|Overall Study|Termination of Study by Sponsor|2|||
19645254|NCT00621309|42094590|FG002|Overall Study|Withdrawal by Subject|1|||
19645255|NCT00621309|42094591|FG003|Overall Study|Withdrawal by Subject|1|||
19645256|NCT00621309|42094592|FG004|Overall Study|Withdrawal by Subject|1|||
19645257|NCT00621309|42094593|FG005|Overall Study|Withdrawal by Subject|1|||
19645258|NCT00567190|42094601|FG000|Overall Study|Death|235|||
19645259|NCT00567190|42094602|FG001|Overall Study|Death|280|||
19645260|NCT00567190|42094601|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
19645261|NCT00567190|42094602|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
19645262|NCT00691938|42094620|FG000|Overall Study|QTc prolongation|1|||
19645263|NCT00691938|42094621|FG001|Overall Study|QTc prolongation|0|||
19645264|NCT00691938|42094622|FG002|Overall Study|QTc prolongation|0|||
19645265|NCT00691938|42094623|FG003|Overall Study|QTc prolongation|0|||
19645266|NCT00691938|42094624|FG004|Overall Study|QTc prolongation|0|||
19645267|NCT00691938|42094625|FG005|Overall Study|QTc prolongation|0|||
19645268|NCT00691938|42094626|FG006|Overall Study|QTc prolongation|0|||
19645269|NCT00365365|42094640|FG000|Overall Study|Randomized but not treated|0|||
19645270|NCT00365365|42094641|FG001|Overall Study|Randomized but not treated|2|||
19645271|NCT00365365|42094642|FG002|Overall Study|Randomized but not treated|0|||
19645272|NCT00365365|42094640|FG000|Overall Study|Poor compliance to protocol|0|||
19645273|NCT00365365|42094641|FG001|Overall Study|Poor compliance to protocol|1|||
19645274|NCT00365365|42094642|FG002|Overall Study|Poor compliance to protocol|0|||
19645275|NCT00365365|42094640|FG000|Overall Study|Lost to Follow-up|3|||
19645276|NCT00365365|42094641|FG001|Overall Study|Lost to Follow-up|3|||
19645277|NCT00365365|42094642|FG002|Overall Study|Lost to Follow-up|3|||
19645278|NCT00365365|42094640|FG000|Overall Study|Death|1|||
19645279|NCT00365365|42094641|FG001|Overall Study|Death|3|||
19645280|NCT00365365|42094642|FG002|Overall Study|Death|0|||
19645281|NCT00365365|42094640|FG000|Overall Study|Subject's request|11|||
19645282|NCT00365365|42094641|FG001|Overall Study|Subject's request|13|||
19645283|NCT00365365|42094642|FG002|Overall Study|Subject's request|1|||
19645284|NCT00365365|42094640|FG000|Overall Study|Disease progression/relapse|9|||
19645285|NCT00365365|42094641|FG001|Overall Study|Disease progression/relapse|6|||
19645286|NCT00365365|42094642|FG002|Overall Study|Disease progression/relapse|7|||
19645287|NCT00365365|42094640|FG000|Overall Study|Adverse Event|6|||
19645288|NCT00365365|42094641|FG001|Overall Study|Adverse Event|6|||
19645289|NCT00365365|42094642|FG002|Overall Study|Adverse Event|3|||
19645290|NCT00365365|42094640|FG000|Overall Study|Moved|2|||
19645291|NCT00365365|42094641|FG001|Overall Study|Moved|0|||
19645292|NCT00365365|42094642|FG002|Overall Study|Moved|0|||
19645293|NCT00365365|42094640|FG000|Overall Study|New cancer|1|||
19645294|NCT00365365|42094641|FG001|Overall Study|New cancer|0|||
19645295|NCT00365365|42094642|FG002|Overall Study|New cancer|0|||
19645296|NCT00365365|42094640|FG000|Overall Study|Withdrew consent|1|||
19645297|NCT00365365|42094641|FG001|Overall Study|Withdrew consent|1|||
19645298|NCT00365365|42094642|FG002|Overall Study|Withdrew consent|0|||
19645299|NCT00365365|42094640|FG000|Overall Study|Second malignancy|0|||
19645300|NCT00365365|42094641|FG001|Overall Study|Second malignancy|1|||
19645301|NCT00365365|42094642|FG002|Overall Study|Second malignancy|0|||
19645302|NCT00365365|42094640|FG000|Overall Study|Patient/physician decision|0|||
19645303|NCT00365365|42094641|FG001|Overall Study|Patient/physician decision|0|||
19645304|NCT00365365|42094642|FG002|Overall Study|Patient/physician decision|1|||
19645305|NCT00623727|42094652|FG000|Double Blind (DB)|Adverse Event|1|||
19645306|NCT00623727|42094653|FG001|Double Blind (DB)|Adverse Event|3|||
19645307|NCT00623727|42094652|FG000|Double Blind (DB)|Physician Decision|0|||
19645308|NCT00623727|42094653|FG001|Double Blind (DB)|Physician Decision|1|||
19645309|NCT00623727|42094652|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
19645310|NCT00623727|42094653|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
19645311|NCT00623727|42094652|FG000|Double Blind (DB)|Lack of Efficacy|2|||
19645312|NCT00623727|42094653|FG001|Double Blind (DB)|Lack of Efficacy|2|||
19645313|NCT00623727|42094652|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
19645314|NCT00623727|42094653|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
19645315|NCT00623727|42094652|FG000|Double Blind (DB)|Lost to Follow-up|1|||
19645316|NCT00623727|42094653|FG001|Double Blind (DB)|Lost to Follow-up|1|||
19645317|NCT00623727|42094652|FG000|Double Blind (DB)|Protocol Violation|2|||
19645318|NCT00623727|42094653|FG001|Double Blind (DB)|Protocol Violation|2|||
19645319|NCT00623727|42094652|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
19645320|NCT00623727|42094653|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
19645321|NCT00623727|42094652|FG000|Open Label Follow-up|Study termination|0|||
19645322|NCT00623727|42094653|FG001|Open Label Follow-up|Study termination|6|||
19645323|NCT00623727|42094652|FG000|Open Label Follow-up|Participant convenience|0|||
19645324|NCT00623727|42094653|FG001|Open Label Follow-up|Participant convenience|1|||
19645325|NCT00372775|42094661|FG000|Overall Study|Adverse Event|8|||
19645326|NCT00372775|42094661|FG000|Overall Study|Death|15|||
19645327|NCT00372775|42094661|FG000|Overall Study|Objective progression or relapse|30|||
19645328|NCT00372775|42094661|FG000|Overall Study|Global deterioration of health status|6|||
19645329|NCT00372775|42094661|FG000|Overall Study|Withdrawal by Subject|1|||
19645330|NCT00372775|42094661|FG000|Overall Study|Other|1|||
19645331|NCT00372775|42094661|FG000|Overall Study|Not Treated|2|||
19645332|NCT00372697|42094667|FG000|Overall Study|Protocol Violation|1|||
19645333|NCT00372697|42094668|FG001|Overall Study|Protocol Violation|1|||
19645334|NCT00566098|42094674|FG000|Collection of MILs|Withdrawal by Subject|1|||
19645335|NCT00566098|42094674|FG000|Collection of MILs|Relapsed|1|||
19645336|NCT00566098|42094674|FG000|Generation of MILs Product|Relapsed|1|||
19645337|NCT00566098|42094674|FG000|Administration of ASCT+MILs|Death|10|||
19645338|NCT00566098|42094674|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
19645339|NCT00690378|42094685|FG000|Overall Study|Adverse Event|1|||
19645340|NCT00690378|42094686|FG001|Overall Study|Adverse Event|0|||
19645341|NCT00690378|42094685|FG000|Overall Study|Withdrawal by Subject|2|||
19645342|NCT00690378|42094686|FG001|Overall Study|Withdrawal by Subject|0|||
19645343|NCT00690378|42094685|FG000|Overall Study|Protocol Violation|1|||
19645344|NCT00690378|42094686|FG001|Overall Study|Protocol Violation|0|||
19645345|NCT00690378|42094685|FG000|Overall Study|Lost to Follow-up|2|||
19645346|NCT00690378|42094686|FG001|Overall Study|Lost to Follow-up|3|||
19645347|NCT00690378|42094685|FG000|Overall Study|Did not meet inc/exc criteria|13|||
19645348|NCT00690378|42094686|FG001|Overall Study|Did not meet inc/exc criteria|11|||
19645349|NCT00690378|42094685|FG000|Overall Study|Social problem|1|||
19645350|NCT00690378|42094686|FG001|Overall Study|Social problem|0|||
19645351|NCT00574275|42094694|FG000|Overall Study|Randomized but not treated|2|||
19645352|NCT00574275|42094695|FG001|Overall Study|Randomized but not treated|3|||
19645353|NCT00574275|42094694|FG000|Overall Study|Adverse Event|32|||
19645354|NCT00574275|42094695|FG001|Overall Study|Adverse Event|76|||
19645355|NCT00574275|42094694|FG000|Overall Study|Disease progression|160|||
19645356|NCT00574275|42094695|FG001|Overall Study|Disease progression|146|||
19645357|NCT00574275|42094694|FG000|Overall Study|Lost to Follow-up|2|||
19645358|NCT00574275|42094695|FG001|Overall Study|Lost to Follow-up|1|||
19645359|NCT00574275|42094694|FG000|Overall Study|Study stopped based on DMC decision|62|||
19645360|NCT00574275|42094695|FG001|Overall Study|Study stopped based on DMC decision|23|||
19645361|NCT00574275|42094694|FG000|Overall Study|Withdrawal by Subject|15|||
19645362|NCT00574275|42094695|FG001|Overall Study|Withdrawal by Subject|17|||
19645363|NCT00574275|42094694|FG000|Overall Study|Error calculating tumor measurement|1|||
19645364|NCT00574275|42094695|FG001|Overall Study|Error calculating tumor measurement|0|||
19645365|NCT00574275|42094694|FG000|Overall Study|Physician Decision|1|||
19645366|NCT00574275|42094695|FG001|Overall Study|Physician Decision|1|||
19645367|NCT00574275|42094694|FG000|Overall Study|Protocol Violation|0|||
19645368|NCT00574275|42094695|FG001|Overall Study|Protocol Violation|1|||
19645369|NCT00574275|42094694|FG000|Overall Study|Patient and Investigator decision|0|||
19645370|NCT00574275|42094695|FG001|Overall Study|Patient and Investigator decision|1|||
19645371|NCT00574275|42094694|FG000|Overall Study|Insurance change|0|||
19645372|NCT00574275|42094695|FG001|Overall Study|Insurance change|1|||
19645373|NCT00574275|42094694|FG000|Overall Study|Operation for curative intent|0|||
19645374|NCT00574275|42094695|FG001|Overall Study|Operation for curative intent|1|||
19645375|NCT00567112|42094701|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
19645376|NCT00567112|42094702|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
19645377|NCT00567112|42094703|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
19645378|NCT00567112|42094701|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
19645379|NCT00567112|42094702|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
19645380|NCT00567112|42094703|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
19645381|NCT00567112|42094701|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
19645382|NCT00567112|42094702|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
19645383|NCT00567112|42094703|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
19645384|NCT01618656|42094723|FG000|Overall Study|Withdrawal by Subject|7|||
19645385|NCT01618656|42094724|FG001|Overall Study|Withdrawal by Subject|3|||
19645386|NCT01618656|42094723|FG000|Overall Study|Physician Decision|1|||
19645387|NCT01618656|42094724|FG001|Overall Study|Physician Decision|1|||
19645388|NCT03978832|42094730|FG000|Overall Study|Adverse Event|1|||
19645389|NCT03978832|42094730|FG000|Overall Study|Lost to Follow-up|1|||
19645390|NCT03978832|42094730|FG000|Overall Study|Withdrawal by Subject|6|||
19645391|NCT03978832|42094730|FG000|Overall Study|Physician Decision|2|||
19645392|NCT03978832|42094730|FG000|Overall Study|did not pass screening criteria|44|||
19645393|NCT00566722|42094737|FG000|Overall Study|Adverse Event|0|||
19645394|NCT00566722|42094738|FG001|Overall Study|Adverse Event|1|||
19645395|NCT00566722|42094739|FG002|Overall Study|Adverse Event|0|||
19645396|NCT00566722|42094737|FG000|Overall Study|Withdrawal by Subject|0|||
19645397|NCT00566722|42094738|FG001|Overall Study|Withdrawal by Subject|0|||
19645398|NCT00566722|42094739|FG002|Overall Study|Withdrawal by Subject|1|||
19645399|NCT00566722|42094737|FG000|Overall Study|Lost to Follow-up|1|||
19645400|NCT00566722|42094738|FG001|Overall Study|Lost to Follow-up|1|||
19645401|NCT00566722|42094739|FG002|Overall Study|Lost to Follow-up|1|||
19645402|NCT00566722|42094737|FG000|Overall Study|Lack of Efficacy|1|||
19645403|NCT00566722|42094738|FG001|Overall Study|Lack of Efficacy|2|||
19645404|NCT00566722|42094739|FG002|Overall Study|Lack of Efficacy|4|||
19645405|NCT00566722|42094737|FG000|Overall Study|Did not meet exclusion criteria|0|||
19645406|NCT00566722|42094738|FG001|Overall Study|Did not meet exclusion criteria|0|||
19645407|NCT00566722|42094739|FG002|Overall Study|Did not meet exclusion criteria|2|||
19645408|NCT00566722|42094737|FG000|Overall Study|Serious adverse event|0|||
19645409|NCT00566722|42094738|FG001|Overall Study|Serious adverse event|1|||
19645410|NCT00566722|42094739|FG002|Overall Study|Serious adverse event|0|||
19645411|NCT00566722|42094737|FG000|Overall Study|Noncompliant with drug administration|0|||
19645412|NCT00566722|42094738|FG001|Overall Study|Noncompliant with drug administration|0|||
19645413|NCT00566722|42094739|FG002|Overall Study|Noncompliant with drug administration|1|||
19645414|NCT00691704|42094750|FG000|Induction Therapy|Disease Progression|1|||
19645415|NCT00691704|42094750|FG000|Induction Therapy|Active Hepatitis|1|||
19645416|NCT00691704|42094750|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
19645417|NCT00691704|42094750|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
19645418|NCT00691704|42094750|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
19698927|NCT00312572|42143726|FG000|Overall Study|Lost to Follow-up|1|||
19645419|NCT00566020|42094754|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
19645420|NCT00566020|42094755|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
19645421|NCT00566020|42094754|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
19645422|NCT00566020|42094755|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
19645423|NCT00566020|42094754|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
19645424|NCT00566020|42094755|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
19645425|NCT00566020|42094754|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
19645426|NCT00566020|42094755|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
19645427|NCT00566020|42094754|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
19645428|NCT00566020|42094755|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
19645429|NCT00566020|42094754|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
19645430|NCT00566020|42094755|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
19645431|NCT00564070|42094762|FG000|Overall Study|Lost to Follow-up|9|||
19645432|NCT00564070|42094763|FG001|Overall Study|Lost to Follow-up|7|||
19645433|NCT00564070|42094762|FG000|Overall Study|Worsening depression, referred to care|3|||
19645434|NCT00564070|42094763|FG001|Overall Study|Worsening depression, referred to care|0|||
19645435|NCT00690612|42094769|FG000|Overall Study|Adverse Event|1|||
19645436|NCT00690612|42094769|FG000|Overall Study|Withdrawal by Subject|2|||
19645437|NCT00621153|42094775|FG000|Overall Study|Safety Reason|8|||
19645438|NCT00621153|42094776|FG001|Overall Study|Safety Reason|7|||
19645439|NCT00621153|42094775|FG000|Overall Study|Adverse Event|3|||
19645440|NCT00621153|42094776|FG001|Overall Study|Adverse Event|2|||
19645441|NCT00621153|42094775|FG000|Overall Study|Lost to Follow-up|5|||
19645442|NCT00621153|42094776|FG001|Overall Study|Lost to Follow-up|1|||
19645443|NCT00621153|42094775|FG000|Overall Study|Withdrawal by Subject|4|||
19645444|NCT00621153|42094776|FG001|Overall Study|Withdrawal by Subject|5|||
19645445|NCT00574119|42094782|FG000|Overall Study|Adverse Event|1|||
19749733|NCT04617847|42198167|FG001|Overall Study|Termination of Study by Sponsor|21|||
19749734|NCT04615507|42198177|FG000|Period 1|Covid-19 exposure|2|||
19749735|NCT04615507|42198178|FG001|Period 1|Covid-19 exposure|1|||
19749736|NCT04615507|42198177|FG000|Period 2|Covid-19 exposure|0|||
19749737|NCT04615507|42198178|FG001|Period 2|Covid-19 exposure|1|||
19749738|NCT04615507|42198177|FG000|Period 2|Protocol Violation|1|||
19749739|NCT04615507|42198178|FG001|Period 2|Protocol Violation|0|||
19749740|NCT04615507|42198177|FG000|Period 2|Withdrawal by Subject|1|||
19749741|NCT04615507|42198178|FG001|Period 2|Withdrawal by Subject|0|||
19749742|NCT04615507|42198177|FG000|Period 2|Adverse Event|0|||
19749743|NCT04615507|42198178|FG001|Period 2|Adverse Event|1|||
19749744|NCT04615507|42198177|FG000|Period 3|Covid-19 exposure|0|||
19749745|NCT04615507|42198178|FG001|Period 3|Covid-19 exposure|1|||
19749746|NCT04120233|42198190|FG000|Overall Study|Adverse Event|0|||
19749747|NCT04120233|42198191|FG001|Overall Study|Adverse Event|0|||
19749748|NCT04120233|42198192|FG002|Overall Study|Adverse Event|0|||
19749749|NCT04120233|42198193|FG003|Overall Study|Adverse Event|0|||
19749750|NCT04120233|42198194|FG004|Overall Study|Adverse Event|1|||
19749751|NCT04120233|42198195|FG005|Overall Study|Adverse Event|0|||
19749752|NCT01610700|42198211|FG000|Overall Study|Adverse Event|3|||
19749753|NCT01610700|42198212|FG001|Overall Study|Adverse Event|1|||
19749754|NCT01610700|42198211|FG000|Overall Study|Withdrawal by Subject|0|||
19749755|NCT01610700|42198212|FG001|Overall Study|Withdrawal by Subject|1|||
19749756|NCT01610700|42198211|FG000|Overall Study|subject took one dose of street cannabis|0|||
19749757|NCT01610700|42198212|FG001|Overall Study|subject took one dose of street cannabis|1|||
19749758|NCT03256851|42198221|FG000|Overall Study|Withdrawal by Subject|1|||
19645446|NCT00574119|42094782|FG000|Overall Study|Protocol Violation|1|||
19645447|NCT00574119|42094782|FG000|Overall Study|Withdrawal by Subject|1|||
19645448|NCT00574119|42094782|FG000|Overall Study|Physician Decision|1|||
19645449|NCT00705614|42094788|FG000|Initial Intervention|Adverse Event|40|||
19698928|NCT00312572|42143727|FG001|Overall Study|Lost to Follow-up|1|||
19698929|NCT00312572|42143726|FG000|Overall Study|Administrative|4|||
19698930|NCT00312572|42143727|FG001|Overall Study|Administrative|2|||
19698931|NCT00312572|42143726|FG000|Overall Study|Lack of Efficacy|1|||
19698932|NCT00312572|42143727|FG001|Overall Study|Lack of Efficacy|2|||
19698933|NCT00290888|42143737|FG000|Overall Study|Physician Decision|3|||
19698934|NCT00290888|42143738|FG001|Overall Study|Physician Decision|1|||
19698935|NCT00290732|42143747|FG000|Overall Study|Inability to instill drug intraductally.|0|||
19698936|NCT00290732|42143748|FG001|Overall Study|Inability to instill drug intraductally.|1|||
19698937|NCT00290732|42143749|FG002|Overall Study|Inability to instill drug intraductally.|1|||
19698938|NCT00290732|42143750|FG003|Overall Study|Inability to instill drug intraductally.|0|||
19698939|NCT00290732|42143751|FG004|Overall Study|Inability to instill drug intraductally.|0|||
19698940|NCT00312494|42143767|FG000|Overall Study|Randomized; not treated with study drug|9|||
19698941|NCT00312494|42143768|FG001|Overall Study|Randomized; not treated with study drug|10|||
19698942|NCT00312494|42143769|FG002|Overall Study|Randomized; not treated with study drug|5|||
19698943|NCT00312494|42143767|FG000|Overall Study|Adverse Event|33|||
19698944|NCT00312494|42143768|FG001|Overall Study|Adverse Event|15|||
19645450|NCT00705614|42094789|FG001|Initial Intervention|Adverse Event|21|||
19645451|NCT00705614|42094788|FG000|Initial Intervention|Lost to Follow-up|310|||
19645452|NCT00705614|42094789|FG001|Initial Intervention|Lost to Follow-up|191|||
19645453|NCT00705614|42094788|FG000|Initial Intervention|Withdrawal by Subject|114|||
19645454|NCT00705614|42094789|FG001|Initial Intervention|Withdrawal by Subject|71|||
19645455|NCT00705614|42094788|FG000|Initial Intervention|Administrative Reason|51|||
19645456|NCT00705614|42094789|FG001|Initial Intervention|Administrative Reason|38|||
19645457|NCT00705614|42094788|FG000|Initial Intervention|Status completion unknown|3|||
19645458|NCT00705614|42094789|FG001|Initial Intervention|Status completion unknown|0|||
19645459|NCT00705614|42094788|FG000|Switch to Remicade|Adverse Event|0|||
19645460|NCT00705614|42094789|FG001|Switch to Remicade|Adverse Event|5|||
19645461|NCT00705614|42094788|FG000|Switch to Remicade|Lost to Follow-up|0|||
19645462|NCT00705614|42094789|FG001|Switch to Remicade|Lost to Follow-up|23|||
19645463|NCT00705614|42094788|FG000|Switch to Remicade|Withdrawal by Subject|0|||
19645464|NCT00705614|42094789|FG001|Switch to Remicade|Withdrawal by Subject|12|||
19645465|NCT00705614|42094788|FG000|Switch to Remicade|Administrative Reason|0|||
19645466|NCT00705614|42094789|FG001|Switch to Remicade|Administrative Reason|9|||
19645467|NCT00620763|42094797|FG000|Period: First Intervention|Withdrawal by Subject|0|||
19645468|NCT00620763|42094798|FG001|Period: First Intervention|Withdrawal by Subject|2|||
19645469|NCT00620763|42094797|FG000|Period: First Intervention|Protocol Violation|0|||
19645470|NCT00620763|42094798|FG001|Period: First Intervention|Protocol Violation|3|||
19645471|NCT00620763|42094797|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
19645472|NCT00620763|42094798|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
19645473|NCT00562978|42094806|FG000|Overall Study|Patient had imaging dose only|1|||
19645474|NCT00562978|42094807|FG001|Overall Study|Patient had imaging dose only|11|||
19645475|NCT00620373|42094813|FG000|Overall Study|Unverified cancer status|33|||
19645476|NCT00372619|42094827|FG000|Overall Study|Ineligible|0|||
19645477|NCT00372619|42094828|FG001|Overall Study|Ineligible|0|||
19645478|NCT00372619|42094829|FG002|Overall Study|Ineligible|0|||
19645479|NCT00372619|42094830|FG003|Overall Study|Ineligible|0|||
19645480|NCT00372619|42094831|FG004|Overall Study|Ineligible|0|||
19645481|NCT00372619|42094832|FG005|Overall Study|Ineligible|2|||
19645482|NCT00372619|42094833|FG006|Overall Study|Ineligible|0|||
19645483|NCT00372619|42094827|FG000|Overall Study|Inevaluable|0|||
19645484|NCT00372619|42094828|FG001|Overall Study|Inevaluable|0|||
19645485|NCT00372619|42094829|FG002|Overall Study|Inevaluable|0|||
19645486|NCT00372619|42094830|FG003|Overall Study|Inevaluable|0|||
19645487|NCT00372619|42094831|FG004|Overall Study|Inevaluable|0|||
19645488|NCT00372619|42094832|FG005|Overall Study|Inevaluable|1|||
19645489|NCT00372619|42094833|FG006|Overall Study|Inevaluable|0|||
19645490|NCT00562588|42094851|FG000|Overall Study|Adverse Event|40|||
19645491|NCT00562588|42094852|FG001|Overall Study|Adverse Event|58|||
19645492|NCT00562588|42094851|FG000|Overall Study|Protocol Violation|30|||
19645493|NCT00562588|42094852|FG001|Overall Study|Protocol Violation|26|||
19645494|NCT00562588|42094851|FG000|Overall Study|Lost to Follow-up|12|||
19645495|NCT00562588|42094852|FG001|Overall Study|Lost to Follow-up|4|||
19645496|NCT00562588|42094851|FG000|Overall Study|Withdrawal by Subject|10|||
19645497|NCT00562588|42094852|FG001|Overall Study|Withdrawal by Subject|9|||
19645498|NCT00562588|42094851|FG000|Overall Study|Other|0|||
19645499|NCT00562588|42094852|FG001|Overall Study|Other|2|||
19645500|NCT00622167|42094858|FG000|Overall Study|Did not meet angiographic criteria|20|||
19645501|NCT00562354|42094864|FG000|Overall Study|Physician Decision|0|||
19645502|NCT00562354|42094865|FG001|Overall Study|Physician Decision|1|||
19645503|NCT00562354|42094864|FG000|Overall Study|Lost to Follow-up|0|||
19645504|NCT00562354|42094865|FG001|Overall Study|Lost to Follow-up|1|||
19645505|NCT00372385|42094877|FG000|Overall Study|Adverse Event|6|||
19645506|NCT00372385|42094878|FG001|Overall Study|Adverse Event|11|||
19645507|NCT00372385|42094879|FG002|Overall Study|Adverse Event|9|||
19645508|NCT00372385|42094880|FG003|Overall Study|Adverse Event|7|||
19645509|NCT00372385|42094877|FG000|Overall Study|Noncompliance|0|||
19645510|NCT00372385|42094878|FG001|Overall Study|Noncompliance|1|||
19645511|NCT00372385|42094879|FG002|Overall Study|Noncompliance|1|||
19645512|NCT00372385|42094880|FG003|Overall Study|Noncompliance|1|||
19645513|NCT00372385|42094877|FG000|Overall Study|Physician Decision|1|||
19645514|NCT00372385|42094878|FG001|Overall Study|Physician Decision|0|||
19645515|NCT00372385|42094879|FG002|Overall Study|Physician Decision|0|||
19645516|NCT00372385|42094880|FG003|Overall Study|Physician Decision|0|||
19645517|NCT00372385|42094877|FG000|Overall Study|Lost to Follow-up|2|||
19645518|NCT00372385|42094878|FG001|Overall Study|Lost to Follow-up|0|||
19645519|NCT00372385|42094879|FG002|Overall Study|Lost to Follow-up|0|||
19645520|NCT00372385|42094880|FG003|Overall Study|Lost to Follow-up|0|||
19645521|NCT00372385|42094877|FG000|Overall Study|Withdrawal by Subject|2|||
19645522|NCT00372385|42094878|FG001|Overall Study|Withdrawal by Subject|1|||
19645523|NCT00372385|42094879|FG002|Overall Study|Withdrawal by Subject|0|||
19645524|NCT00372385|42094880|FG003|Overall Study|Withdrawal by Subject|0|||
19645525|NCT00372385|42094877|FG000|Overall Study|Refusal of Treatment|3|||
19645526|NCT00372385|42094878|FG001|Overall Study|Refusal of Treatment|6|||
19645527|NCT00372385|42094879|FG002|Overall Study|Refusal of Treatment|0|||
19645528|NCT00372385|42094880|FG003|Overall Study|Refusal of Treatment|0|||
19645529|NCT00372385|42094877|FG000|Overall Study|No Response|1|||
19645530|NCT00372385|42094878|FG001|Overall Study|No Response|1|||
19645531|NCT00372385|42094879|FG002|Overall Study|No Response|0|||
19645532|NCT00372385|42094880|FG003|Overall Study|No Response|0|||
19645533|NCT00372385|42094877|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
19645534|NCT00372385|42094878|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
19645535|NCT00372385|42094879|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
19645536|NCT00372385|42094880|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
19645537|NCT00372385|42094877|FG000|Overall Study|Virologic Stopping Rule|17|||
19645538|NCT00372385|42094878|FG001|Overall Study|Virologic Stopping Rule|0|||
19645539|NCT00372385|42094879|FG002|Overall Study|Virologic Stopping Rule|0|||
19645540|NCT00372385|42094880|FG003|Overall Study|Virologic Stopping Rule|0|||
19645541|NCT03830281|42094893|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
19645542|NCT03830281|42094894|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
19645543|NCT03830281|42094893|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
19645544|NCT03830281|42094894|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
19645545|NCT03830281|42094893|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
19645546|NCT03830281|42094894|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
19749759|NCT03256851|42198222|FG001|Overall Study|Withdrawal by Subject|0|||
19749760|NCT04837807|42198228|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
19749761|NCT04837807|42198229|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
19749762|NCT03256695|42198235|FG000|Overall Study|Adverse Event|8|||
19749763|NCT03256695|42198235|FG000|Overall Study|Death|2|||
19749764|NCT03256695|42198235|FG000|Overall Study|Withdrawal by Subject|14|||
19749765|NCT03256695|42198235|FG000|Overall Study|Non-compliance with study drug|1|||
19749766|NCT03256695|42198235|FG000|Overall Study|Lost to Follow-up|3|||
19749767|NCT03256695|42198235|FG000|Overall Study|Lack of Efficacy|3|||
19749768|NCT03256695|42198235|FG000|Overall Study|Protocol Violation|5|||
19749769|NCT03256695|42198235|FG000|Overall Study|Other than specified|3|||
19749770|NCT03305016|42198239|FG000|Overall Study|Withdrawal by Subject|2|||
19749771|NCT03297021|42198246|FG000|Overall Study|Incomplete/illegible data sheet|4|||
19749772|NCT03297021|42198247|FG001|Overall Study|Incomplete/illegible data sheet|2|||
19749773|NCT03297021|42198248|FG002|Overall Study|Incomplete/illegible data sheet|3|||
19645547|NCT03830281|42094893|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
19645548|NCT03830281|42094894|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
19645549|NCT03830281|42094893|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
19645550|NCT03830281|42094894|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
19645551|NCT03830281|42094893|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
19645552|NCT03830281|42094894|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
19645553|NCT03830281|42094893|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
19645554|NCT03830281|42094894|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
19645555|NCT03830281|42094893|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
19645556|NCT03830281|42094894|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
19645557|NCT03830281|42094893|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
19645558|NCT03830281|42094894|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
19749774|NCT03297021|42198246|FG000|Overall Study|Missing Post-Op Data|1|||
19749775|NCT03297021|42198247|FG001|Overall Study|Missing Post-Op Data|2|||
19749776|NCT03297021|42198248|FG002|Overall Study|Missing Post-Op Data|1|||
19749777|NCT04820491|42198267|FG000|Overall Study|Withdrawal by Subject|1|||
19749778|NCT04820491|42198268|FG001|Overall Study|Withdrawal by Subject|0|||
19749779|NCT01988571|42198276|FG000|Overall Study|Death|3|||
19645559|NCT00563368|42094908|FG000|Overall Study|Lost to Follow-up|14|||
19645560|NCT00563368|42094909|FG001|Overall Study|Lost to Follow-up|14|||
19645561|NCT00563368|42094910|FG002|Overall Study|Lost to Follow-up|12|||
19645562|NCT00563368|42094911|FG003|Overall Study|Lost to Follow-up|6|||
19645563|NCT00563368|42094912|FG004|Overall Study|Lost to Follow-up|9|||
19645564|NCT00563368|42094913|FG005|Overall Study|Lost to Follow-up|8|||
19645565|NCT00563368|42094914|FG006|Overall Study|Lost to Follow-up|9|||
19645566|NCT00563368|42094908|FG000|Overall Study|Adverse Event|3|||
19645567|NCT00563368|42094909|FG001|Overall Study|Adverse Event|4|||
19645568|NCT00563368|42094910|FG002|Overall Study|Adverse Event|5|||
19645569|NCT00563368|42094911|FG003|Overall Study|Adverse Event|9|||
19645570|NCT00563368|42094912|FG004|Overall Study|Adverse Event|6|||
19645571|NCT00563368|42094913|FG005|Overall Study|Adverse Event|10|||
19645572|NCT00563368|42094914|FG006|Overall Study|Adverse Event|17|||
19645573|NCT00563368|42094908|FG000|Overall Study|Withdrawal by Subject|11|||
19645574|NCT00563368|42094909|FG001|Overall Study|Withdrawal by Subject|6|||
19645575|NCT00563368|42094910|FG002|Overall Study|Withdrawal by Subject|5|||
19749780|NCT01988571|42198277|FG001|Overall Study|Death|1|||
19749781|NCT01988571|42198276|FG000|Overall Study|Physician Decision|2|||
19749782|NCT01988571|42198277|FG001|Overall Study|Physician Decision|1|||
19749783|NCT01988571|42198276|FG000|Overall Study|Lost to Follow-up|3|||
19749784|NCT01988571|42198277|FG001|Overall Study|Lost to Follow-up|0|||
19645576|NCT00563368|42094911|FG003|Overall Study|Withdrawal by Subject|7|||
19645577|NCT00563368|42094912|FG004|Overall Study|Withdrawal by Subject|8|||
19645578|NCT00563368|42094913|FG005|Overall Study|Withdrawal by Subject|5|||
19645579|NCT00563368|42094914|FG006|Overall Study|Withdrawal by Subject|4|||
19645580|NCT00563368|42094908|FG000|Overall Study|protocol non-compliance|1|||
19645581|NCT00563368|42094909|FG001|Overall Study|protocol non-compliance|1|||
19645582|NCT00563368|42094910|FG002|Overall Study|protocol non-compliance|2|||
19645583|NCT00563368|42094911|FG003|Overall Study|protocol non-compliance|1|||
19645584|NCT00563368|42094912|FG004|Overall Study|protocol non-compliance|0|||
19645585|NCT00563368|42094913|FG005|Overall Study|protocol non-compliance|1|||
19645586|NCT00563368|42094914|FG006|Overall Study|protocol non-compliance|3|||
19645587|NCT00563368|42094908|FG000|Overall Study|Pregnancy|1|||
19645588|NCT00563368|42094909|FG001|Overall Study|Pregnancy|0|||
19645589|NCT00563368|42094910|FG002|Overall Study|Pregnancy|1|||
19645590|NCT00563368|42094911|FG003|Overall Study|Pregnancy|2|||
19645591|NCT00563368|42094912|FG004|Overall Study|Pregnancy|1|||
19645592|NCT00563368|42094913|FG005|Overall Study|Pregnancy|2|||
19749785|NCT01988571|42198276|FG000|Overall Study|Withdrawal by Subject|31|||
19749786|NCT01988571|42198277|FG001|Overall Study|Withdrawal by Subject|33|||
19749787|NCT04794751|42198283|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
19749788|NCT04794751|42198284|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
19749789|NCT04794751|42198283|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
19749790|NCT04794751|42198284|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
19645593|NCT00563368|42094914|FG006|Overall Study|Pregnancy|0|||
19645594|NCT00563368|42094908|FG000|Overall Study|requirement for restricted medication|0|||
19645595|NCT00563368|42094909|FG001|Overall Study|requirement for restricted medication|0|||
19645596|NCT00563368|42094910|FG002|Overall Study|requirement for restricted medication|2|||
19645597|NCT00563368|42094911|FG003|Overall Study|requirement for restricted medication|0|||
19645598|NCT00563368|42094912|FG004|Overall Study|requirement for restricted medication|0|||
19645599|NCT00563368|42094913|FG005|Overall Study|requirement for restricted medication|0|||
19645600|NCT00563368|42094914|FG006|Overall Study|requirement for restricted medication|0|||
19645601|NCT00563368|42094908|FG000|Overall Study|Other|5|||
19645602|NCT00563368|42094909|FG001|Overall Study|Other|5|||
19645603|NCT00563368|42094910|FG002|Overall Study|Other|3|||
19645604|NCT00563368|42094911|FG003|Overall Study|Other|4|||
19645605|NCT00563368|42094912|FG004|Overall Study|Other|4|||
19645606|NCT00563368|42094913|FG005|Overall Study|Other|4|||
19645607|NCT00563368|42094914|FG006|Overall Study|Other|0|||
19645608|NCT00390013|42094933|FG000|Phase 1|tired|0|||
19645609|NCT00390013|42094934|FG001|Phase 1|tired|0|||
19645610|NCT00390013|42094935|FG002|Phase 1|tired|0|||
19645611|NCT00390013|42094936|FG003|Phase 1|tired|1|||
19645612|NCT00390013|42094933|FG000|Phase 2 First Treatment|tired|1|||
19645613|NCT00390013|42094934|FG001|Phase 2 First Treatment|tired|0|||
19645614|NCT00390013|42094935|FG002|Phase 2 First Treatment|tired|0|||
19645615|NCT00390013|42094936|FG003|Phase 2 First Treatment|tired|0|||
19645616|NCT00390013|42094933|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
19645617|NCT00390013|42094934|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
19645618|NCT00390013|42094935|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
19645619|NCT00390013|42094936|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
19645620|NCT00561652|42094944|FG000|Overall Study|Withdrawal by Subject|0|||
19645621|NCT00561652|42094945|FG001|Overall Study|Withdrawal by Subject|1|||
19645622|NCT00697346|42094954|FG000|Overall Study|Adverse Event|4|||
19645623|NCT00697346|42094955|FG001|Overall Study|Adverse Event|5|||
19749791|NCT04794751|42198283|FG000|Period 1|Protocol Violation|0|||
19749792|NCT04794751|42198284|FG001|Period 1|Protocol Violation|2|||
19749793|NCT04794751|42198283|FG000|Period 1|Withdrawal by Subject|0|||
19749794|NCT04794751|42198284|FG001|Period 1|Withdrawal by Subject|1|||
19749795|NCT04794751|42198283|FG000|Period 2|Withdrawal by Subject|0|||
19749796|NCT04794751|42198284|FG001|Period 2|Withdrawal by Subject|1|||
19749797|NCT04794751|42198283|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
19749798|NCT04794751|42198284|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
19749799|NCT04794751|42198283|FG000|Period 2|Protocol Violation|1|||
19749800|NCT04794751|42198284|FG001|Period 2|Protocol Violation|0|||
19749801|NCT04578457|42198299|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
19645624|NCT00697346|42094956|FG002|Overall Study|Adverse Event|0|||
19645625|NCT00697346|42094954|FG000|Overall Study|Progressive Disease|19|||
19645626|NCT00697346|42094955|FG001|Overall Study|Progressive Disease|18|||
19645627|NCT00697346|42094956|FG002|Overall Study|Progressive Disease|0|||
19645628|NCT00697346|42094954|FG000|Overall Study|Symptomatic Deterioration|0|||
19645629|NCT00697346|42094955|FG001|Overall Study|Symptomatic Deterioration|1|||
19645630|NCT00697346|42094956|FG002|Overall Study|Symptomatic Deterioration|0|||
19645631|NCT00697346|42094954|FG000|Overall Study|Withdrawal by Subject|2|||
19645632|NCT00697346|42094955|FG001|Overall Study|Withdrawal by Subject|2|||
19645633|NCT00697346|42094956|FG002|Overall Study|Withdrawal by Subject|0|||
19645634|NCT00697346|42094954|FG000|Overall Study|Reason not Specified|3|||
19645635|NCT00697346|42094955|FG001|Overall Study|Reason not Specified|0|||
19749802|NCT04578457|42198299|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
19645636|NCT00697346|42094956|FG002|Overall Study|Reason not Specified|1|||
19645637|NCT00562120|42094983|FG000|First Intervention Period|Adverse Event|1|||
19645638|NCT00562120|42094984|FG001|First Intervention Period|Adverse Event|0|||
19645639|NCT00562120|42094985|FG002|First Intervention Period|Adverse Event|0|||
19645640|NCT00562120|42094986|FG003|First Intervention Period|Adverse Event|0|||
19645641|NCT00562120|42094983|FG000|First Intervention Period|Randomized but not Treated|1|||
19645642|NCT00562120|42094984|FG001|First Intervention Period|Randomized but not Treated|0|||
19645643|NCT00562120|42094985|FG002|First Intervention Period|Randomized but not Treated|0|||
19645644|NCT00562120|42094986|FG003|First Intervention Period|Randomized but not Treated|0|||
19645645|NCT00561730|42094996|FG000|Overall Study|Adverse Event|2|||
19645646|NCT00561730|42094996|FG000|Overall Study|Handling of the drug|1|||
19645647|NCT00561730|42094996|FG000|Overall Study|Lost to Follow-up|5|||
19645648|NCT00561730|42094996|FG000|Overall Study|Not specified reasons|1|||
19645649|NCT00697112|42095002|FG000|Overall Study|Adverse Event|8|||
19645650|NCT00697112|42095002|FG000|Overall Study|Lost to Follow-up|1|||
19645651|NCT00697112|42095002|FG000|Overall Study|Did not meet inclusion criteria|1|||
19645652|NCT00621855|42095011|FG000|Overall Study|Adverse Event|32|||
19645653|NCT00621855|42095012|FG001|Overall Study|Adverse Event|31|||
19645654|NCT00621855|42095013|FG002|Overall Study|Adverse Event|48|||
19645655|NCT00621855|42095014|FG003|Overall Study|Adverse Event|34|||
19645656|NCT00621855|42095015|FG004|Overall Study|Adverse Event|31|||
19645657|NCT00621855|42095011|FG000|Overall Study|Lost to Follow-up|0|||
19645658|NCT00621855|42095012|FG001|Overall Study|Lost to Follow-up|1|||
19645659|NCT00621855|42095013|FG002|Overall Study|Lost to Follow-up|3|||
19645660|NCT00621855|42095014|FG003|Overall Study|Lost to Follow-up|4|||
19645661|NCT00621855|42095015|FG004|Overall Study|Lost to Follow-up|1|||
19645662|NCT00621855|42095011|FG000|Overall Study|Protocol Violation|16|||
19645663|NCT00621855|42095012|FG001|Overall Study|Protocol Violation|8|||
19645664|NCT00621855|42095013|FG002|Overall Study|Protocol Violation|6|||
19645665|NCT00621855|42095014|FG003|Overall Study|Protocol Violation|7|||
19645666|NCT00621855|42095015|FG004|Overall Study|Protocol Violation|8|||
19645667|NCT00621855|42095011|FG000|Overall Study|Withdrawal by Subject|16|||
19645668|NCT00621855|42095012|FG001|Overall Study|Withdrawal by Subject|11|||
19645669|NCT00621855|42095013|FG002|Overall Study|Withdrawal by Subject|13|||
19645670|NCT00621855|42095014|FG003|Overall Study|Withdrawal by Subject|13|||
19645671|NCT00621855|42095015|FG004|Overall Study|Withdrawal by Subject|9|||
19645672|NCT00621855|42095011|FG000|Overall Study|Other|9|||
19645673|NCT00621855|42095012|FG001|Overall Study|Other|7|||
19645674|NCT00621855|42095013|FG002|Overall Study|Other|6|||
19645675|NCT00621855|42095014|FG003|Overall Study|Other|5|||
19645676|NCT00621855|42095015|FG004|Overall Study|Other|4|||
19645677|NCT00621855|42095011|FG000|Overall Study|Patients did not receive study drug|3|||
19645678|NCT00621855|42095012|FG001|Overall Study|Patients did not receive study drug|3|||
19645679|NCT00621855|42095013|FG002|Overall Study|Patients did not receive study drug|5|||
19645680|NCT00621855|42095014|FG003|Overall Study|Patients did not receive study drug|4|||
19645681|NCT00621855|42095015|FG004|Overall Study|Patients did not receive study drug|2|||
19645682|NCT04222088|42095029|FG000|Overall Study|Lost to Follow-up|5|||
19645683|NCT04222088|42095030|FG001|Overall Study|Lost to Follow-up|1|||
19645684|NCT04222088|42095029|FG000|Overall Study|Withdrawal by Subject|4|||
19645685|NCT04222088|42095030|FG001|Overall Study|Withdrawal by Subject|0|||
19645686|NCT00561574|42095038|FG000|Overall Study|Adverse Event|21|||
19645687|NCT00561574|42095039|FG001|Overall Study|Adverse Event|24|||
19645688|NCT00561574|42095038|FG000|Overall Study|Lack of Efficacy|11|||
19645689|NCT00561574|42095039|FG001|Overall Study|Lack of Efficacy|21|||
19645690|NCT00561574|42095038|FG000|Overall Study|Withdrawal by Subject|4|||
19645691|NCT00561574|42095039|FG001|Overall Study|Withdrawal by Subject|4|||
19749803|NCT04578457|42198299|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
19749804|NCT04578457|42198299|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
19645692|NCT00561574|42095038|FG000|Overall Study|Reason Unrelated to Trial|6|||
19645693|NCT00561574|42095039|FG001|Overall Study|Reason Unrelated to Trial|2|||
19645694|NCT00561574|42095038|FG000|Overall Study|Lost to Follow-up|1|||
19645695|NCT00561574|42095039|FG001|Overall Study|Lost to Follow-up|0|||
19645696|NCT00561574|42095038|FG000|Overall Study|Other|5|||
19645697|NCT00561574|42095039|FG001|Overall Study|Other|7|||
19645698|NCT00619827|42095047|FG000|Overall Study|Adverse Event|1|||
19645699|NCT00619827|42095048|FG001|Overall Study|Adverse Event|2|||
19645700|NCT00619827|42095047|FG000|Overall Study|Withdrawal by Subject|2|||
19645701|NCT00619827|42095048|FG001|Overall Study|Withdrawal by Subject|2|||
19645702|NCT00687804|42095057|FG000|Core Study|Adverse Event|5|||
19645703|NCT00687804|42095058|FG001|Core Study|Adverse Event|3|||
19645704|NCT00687804|42095059|FG002|Core Study|Adverse Event|3|||
19645705|NCT00687804|42095057|FG000|Core Study|Abnormal laboratory value(s)|1|||
19645706|NCT00687804|42095058|FG001|Core Study|Abnormal laboratory value(s)|0|||
19645707|NCT00687804|42095059|FG002|Core Study|Abnormal laboratory value(s)|0|||
19645708|NCT00687804|42095057|FG000|Core Study|Lack of Efficacy|1|||
19645709|NCT00687804|42095058|FG001|Core Study|Lack of Efficacy|1|||
19645710|NCT00687804|42095059|FG002|Core Study|Lack of Efficacy|1|||
19645711|NCT00687804|42095057|FG000|Core Study|Withdrawal by Subject|4|||
19645712|NCT00687804|42095058|FG001|Core Study|Withdrawal by Subject|7|||
19645713|NCT00687804|42095059|FG002|Core Study|Withdrawal by Subject|7|||
19645714|NCT00687804|42095057|FG000|Core Study|Lost to Follow-up|0|||
19645715|NCT00687804|42095058|FG001|Core Study|Lost to Follow-up|1|||
19645716|NCT00687804|42095059|FG002|Core Study|Lost to Follow-up|0|||
19645717|NCT00687804|42095057|FG000|Core Study|Death|2|||
19645718|NCT00687804|42095058|FG001|Core Study|Death|2|||
19645719|NCT00687804|42095059|FG002|Core Study|Death|2|||
19645720|NCT00687804|42095057|FG000|Core Study|Protocol Violation|1|||
19645721|NCT00687804|42095058|FG001|Core Study|Protocol Violation|1|||
19645722|NCT00687804|42095059|FG002|Core Study|Protocol Violation|0|||
19645723|NCT00687804|42095057|FG000|Open-Label Extension Study|Adverse Event|2|||
19645724|NCT00687804|42095058|FG001|Open-Label Extension Study|Adverse Event|2|||
19645725|NCT00687804|42095059|FG002|Open-Label Extension Study|Adverse Event|2|||
19645726|NCT00687804|42095057|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
19645727|NCT00687804|42095058|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
19645728|NCT00687804|42095059|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
19645729|NCT00687804|42095057|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
19645730|NCT00687804|42095058|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
19645731|NCT00687804|42095059|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
19645732|NCT00687804|42095057|FG000|Open-Label Extension Study|Administrative problems|1|||
19645733|NCT00687804|42095058|FG001|Open-Label Extension Study|Administrative problems|1|||
19645734|NCT00687804|42095059|FG002|Open-Label Extension Study|Administrative problems|0|||
19645735|NCT00687804|42095057|FG000|Open-Label Extension Study|Death|2|||
19645736|NCT00687804|42095058|FG001|Open-Label Extension Study|Death|3|||
19645737|NCT00687804|42095059|FG002|Open-Label Extension Study|Death|3|||
19645738|NCT00689052|42095086|FG000|Overall Study|Adverse Event|4|||
19645739|NCT00689052|42095087|FG001|Overall Study|Adverse Event|6|||
19645740|NCT00689052|42095086|FG000|Overall Study|Protocol Violation|1|||
19645741|NCT00689052|42095087|FG001|Overall Study|Protocol Violation|0|||
19645742|NCT00689052|42095086|FG000|Overall Study|Lost to Follow-up|2|||
19645743|NCT00689052|42095087|FG001|Overall Study|Lost to Follow-up|0|||
19645744|NCT00689052|42095086|FG000|Overall Study|Withdrawal by Subject|2|||
19645745|NCT00689052|42095087|FG001|Overall Study|Withdrawal by Subject|0|||
19645746|NCT00689052|42095086|FG000|Overall Study|Early termination of the trial|22|||
19645747|NCT00689052|42095087|FG001|Overall Study|Early termination of the trial|24|||
19645748|NCT00560950|42095097|FG000|Overall Study|Lost to Follow-up|1|||
19749805|NCT03334188|42198309|FG000|Overall Study|Withdrawal by Subject|0|||
19749806|NCT03334188|42198310|FG001|Overall Study|Withdrawal by Subject|1|||
19749807|NCT03334188|42198309|FG000|Overall Study|Death|1|||
19749808|NCT03334188|42198310|FG001|Overall Study|Death|0|||
19749809|NCT03334188|42198309|FG000|Overall Study|Never had qualifying clinic visit|7|||
19749810|NCT03334188|42198310|FG001|Overall Study|Never had qualifying clinic visit|7|||
19749811|NCT03333876|42198319|FG000|Screening Period|Screen Failure|4|||
19749812|NCT03333876|42198319|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
19645749|NCT00560950|42095098|FG001|Overall Study|Lost to Follow-up|0|||
19645750|NCT00576758|42095108|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
19645751|NCT00576758|42095109|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
19645752|NCT00576758|42095108|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
19645753|NCT00576758|42095109|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
19645754|NCT00576758|42095108|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
19645755|NCT00576758|42095109|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
19645756|NCT00576758|42095108|FG000|Induction Treatment Period|Death|1|||
19645757|NCT00576758|42095109|FG001|Induction Treatment Period|Death|0|||
19645758|NCT00576758|42095108|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
19645759|NCT00576758|42095109|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
19645760|NCT00576758|42095108|FG000|Induction Treatment Period|Withdrew consent|1|||
19645761|NCT00576758|42095109|FG001|Induction Treatment Period|Withdrew consent|0|||
19645762|NCT00576758|42095108|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
19645763|NCT00576758|42095109|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
19645764|NCT00576758|42095108|FG000|Extension Treatment Period|Death|1|||
19645765|NCT00576758|42095109|FG001|Extension Treatment Period|Death|1|||
19645766|NCT00576758|42095108|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
19645767|NCT00576758|42095109|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
19645768|NCT00576758|42095108|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
19645769|NCT00576758|42095109|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
19645770|NCT00576758|42095108|FG000|Extension Treatment Period|Administrative/Other|3|||
19645771|NCT00576758|42095109|FG001|Extension Treatment Period|Administrative/Other|1|||
19645772|NCT00576758|42095108|FG000|Follow-up Period|Administrative/Other|6|||
19645773|NCT00576758|42095109|FG001|Follow-up Period|Administrative/Other|8|||
19645774|NCT00576758|42095108|FG000|Follow-up Period|Death|3|||
19645775|NCT00576758|42095109|FG001|Follow-up Period|Death|3|||
19645776|NCT00576758|42095108|FG000|Follow-up Period|Insufficient therapeutic response|16|||
19645777|NCT00576758|42095109|FG001|Follow-up Period|Insufficient therapeutic response|5|||
19645778|NCT00576758|42095108|FG000|Follow-up Period|Withdrew consent|2|||
19645779|NCT00576758|42095109|FG001|Follow-up Period|Withdrew consent|1|||
19645780|NCT00560794|42095116|FG000|Overall Study|Adverse Event|2|||
19645781|NCT00560794|42095116|FG000|Overall Study|Patient was not Compliant|1|||
19645782|NCT00560794|42095116|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
19645783|NCT00560794|42095116|FG000|Overall Study|Hematological Relapse|1|||
19645784|NCT00560794|42095116|FG000|Overall Study|Received Bone Marrow Transplant|6|||
19645785|NCT00619359|42095124|FG000|Overall Study|Adverse Event|32|||
19645786|NCT00619359|42095125|FG001|Overall Study|Adverse Event|36|||
19645787|NCT00619359|42095124|FG000|Overall Study|Lost to Follow-up|12|||
19645788|NCT00619359|42095125|FG001|Overall Study|Lost to Follow-up|16|||
19645789|NCT00619359|42095124|FG000|Overall Study|Physician Decision|0|||
19645790|NCT00619359|42095125|FG001|Overall Study|Physician Decision|7|||
19645791|NCT00619359|42095124|FG000|Overall Study|Protocol Violation|1|||
19645792|NCT00619359|42095125|FG001|Overall Study|Protocol Violation|1|||
19645793|NCT00619359|42095124|FG000|Overall Study|Withdrawal by Subject|19|||
19645794|NCT00619359|42095125|FG001|Overall Study|Withdrawal by Subject|20|||
19645795|NCT00619359|42095124|FG000|Overall Study|Progressive Disease|3|||
19645796|NCT00619359|42095125|FG001|Overall Study|Progressive Disease|1|||
19645797|NCT00372229|42095133|FG000|Study Phase|Graft loss|0|||
19645798|NCT00372229|42095134|FG001|Study Phase|Graft loss|3|||
19645799|NCT00372229|42095133|FG000|Study Phase|Protocol Violation|3|||
19645800|NCT00372229|42095134|FG001|Study Phase|Protocol Violation|4|||
19645801|NCT00372229|42095133|FG000|Study Phase|Consent withdrawn|16|||
19645802|NCT00372229|42095134|FG001|Study Phase|Consent withdrawn|14|||
19645803|NCT00372229|42095133|FG000|Study Phase|Refused treatment/did not cooperate|3|||
19645804|NCT00372229|42095134|FG001|Study Phase|Refused treatment/did not cooperate|1|||
19645805|NCT00372229|42095133|FG000|Study Phase|Death|3|||
19749813|NCT03333876|42198319|FG000|Mandibular Advancement|Adverse Event|2|||
19749814|NCT03333876|42198319|FG000|Mandibular Advancement|Product Damage|2|||
19749815|NCT03294681|42198332|FG000|Overall Study|Withdrawal by Subject|1|||
19749816|NCT01140867|42198336|FG000|Overall Study|Adverse Event|22|||
19645806|NCT00372229|42095134|FG001|Study Phase|Death|2|||
19645807|NCT00372229|42095133|FG000|Study Phase|Reason not specified|3|||
19645808|NCT00372229|42095134|FG001|Study Phase|Reason not specified|2|||
19645809|NCT00372229|42095133|FG000|Study Phase|Lost to Follow-up|3|||
19645810|NCT00372229|42095134|FG001|Study Phase|Lost to Follow-up|3|||
19645811|NCT00372229|42095133|FG000|Follow-Up Phase|Graft loss|8|||
19645812|NCT00372229|42095134|FG001|Follow-Up Phase|Graft loss|7|||
19645813|NCT00372229|42095133|FG000|Follow-Up Phase|Consent withdrawn|13|||
19645814|NCT00372229|42095134|FG001|Follow-Up Phase|Consent withdrawn|19|||
19645815|NCT00372229|42095133|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
19645816|NCT00372229|42095134|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
19645817|NCT00372229|42095133|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
19645818|NCT00372229|42095134|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
19645819|NCT00372229|42095133|FG000|Follow-Up Phase|Death|9|||
19645820|NCT00372229|42095134|FG001|Follow-Up Phase|Death|12|||
19645821|NCT00372229|42095133|FG000|Follow-Up Phase|Administrative|1|||
19645822|NCT00372229|42095134|FG001|Follow-Up Phase|Administrative|0|||
19645823|NCT00372229|42095133|FG000|Follow-Up Phase|Reason not specified|2|||
19645824|NCT00372229|42095134|FG001|Follow-Up Phase|Reason not specified|3|||
19645825|NCT00372229|42095133|FG000|Follow-Up Phase|Lost to Follow-up|12|||
19645826|NCT00372229|42095134|FG001|Follow-Up Phase|Lost to Follow-up|10|||
19645827|NCT00698828|42095147|FG000|Overall Study|Adverse Event|3|||
19645828|NCT00698828|42095148|FG001|Overall Study|Adverse Event|4|||
19645829|NCT00698828|42095149|FG002|Overall Study|Adverse Event|4|||
19749817|NCT01140867|42198336|FG000|Overall Study|Lack of Efficacy|3|||
19749818|NCT01140867|42198336|FG000|Overall Study|Lost to Follow-up|2|||
19749819|NCT01140867|42198336|FG000|Overall Study|Withdrawal by Subject|1|||
19749820|NCT01140867|42198336|FG000|Overall Study|Protocol Violation|1|||
19749821|NCT01140867|42198336|FG000|Overall Study|Uncooperative patient|2|||
19749822|NCT01140867|42198336|FG000|Overall Study|Medication Noncompliance|2|||
19749823|NCT04572997|42198340|FG000|Overall Study|Adverse Event|1|||
19749824|NCT02943096|42198350|FG000|Overall Study|Lack of Efficacy|0|||
19749825|NCT02943096|42198351|FG001|Overall Study|Lack of Efficacy|1|||
19749826|NCT04571515|42198362|FG000|Overall Study|Physician Decision|0|||
19749827|NCT04571515|42198363|FG001|Overall Study|Physician Decision|0|||
19749828|NCT04571515|42198364|FG002|Overall Study|Physician Decision|0|||
19645830|NCT00698828|42095147|FG000|Overall Study|Death|0|||
19645831|NCT00698828|42095148|FG001|Overall Study|Death|0|||
19645832|NCT00698828|42095149|FG002|Overall Study|Death|1|||
19645833|NCT00698828|42095147|FG000|Overall Study|Exacerbation of COPD|1|||
19645834|NCT00698828|42095148|FG001|Overall Study|Exacerbation of COPD|3|||
19645835|NCT00698828|42095149|FG002|Overall Study|Exacerbation of COPD|0|||
19645836|NCT00698828|42095147|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
19645837|NCT00698828|42095148|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
19645838|NCT00698828|42095149|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
19645839|NCT00698828|42095147|FG000|Overall Study|Investigator/Sponsor decision|1|||
19645840|NCT00698828|42095148|FG001|Overall Study|Investigator/Sponsor decision|0|||
19645841|NCT00698828|42095149|FG002|Overall Study|Investigator/Sponsor decision|2|||
19645842|NCT00698828|42095147|FG000|Overall Study|Lost to Follow-up|1|||
19645843|NCT00698828|42095148|FG001|Overall Study|Lost to Follow-up|1|||
19645844|NCT00698828|42095149|FG002|Overall Study|Lost to Follow-up|0|||
19645845|NCT00698828|42095147|FG000|Overall Study|Withdrew consent|0|||
19645846|NCT00698828|42095148|FG001|Overall Study|Withdrew consent|7|||
19645847|NCT00698828|42095149|FG002|Overall Study|Withdrew consent|4|||
19645848|NCT00698828|42095147|FG000|Overall Study|Withdrew consent (not treated)|2|||
19749829|NCT04571515|42198365|FG003|Overall Study|Physician Decision|0|||
19749830|NCT04571515|42198366|FG004|Overall Study|Physician Decision|1|||
19749831|NCT04571515|42198362|FG000|Overall Study|Withdrawal by Subject|0|||
19749832|NCT04571515|42198363|FG001|Overall Study|Withdrawal by Subject|0|||
19749833|NCT04571515|42198364|FG002|Overall Study|Withdrawal by Subject|0|||
19749834|NCT04571515|42198365|FG003|Overall Study|Withdrawal by Subject|0|||
19749835|NCT04571515|42198366|FG004|Overall Study|Withdrawal by Subject|1|||
19749836|NCT04571515|42198362|FG000|Overall Study|insufficient pain|1|||
19749837|NCT04571515|42198363|FG001|Overall Study|insufficient pain|0|||
19749838|NCT04571515|42198364|FG002|Overall Study|insufficient pain|0|||
19749839|NCT04571515|42198365|FG003|Overall Study|insufficient pain|0|||
19749840|NCT04571515|42198366|FG004|Overall Study|insufficient pain|1|||
19749841|NCT03292653|42198381|FG000|Overall Study|Adverse Event|0|||
19749842|NCT03292653|42198382|FG001|Overall Study|Adverse Event|0|||
19749843|NCT03292653|42198383|FG002|Overall Study|Adverse Event|1|||
19749844|NCT03292653|42198381|FG000|Overall Study|Did not Receive Treatment|1|||
19749845|NCT03292653|42198382|FG001|Overall Study|Did not Receive Treatment|0|||
19645849|NCT00698828|42095148|FG001|Overall Study|Withdrew consent (not treated)|0|||
19749846|NCT03292653|42198383|FG002|Overall Study|Did not Receive Treatment|0|||
19749847|NCT03858634|42198394|FG000|Overall Study|Withdrawal by Subject|1|||
19749848|NCT03858634|42198395|FG001|Overall Study|Withdrawal by Subject|0|||
19749849|NCT03858634|42198394|FG000|Overall Study|Adverse Event|1|||
19749850|NCT03858634|42198395|FG001|Overall Study|Adverse Event|0|||
19388189|NCT02564055|41631569|FG002|Overall Study|Reached stopping criteria|0|||
19388190|NCT02564055|41631570|FG003|Overall Study|Reached stopping criteria|0|||
19645850|NCT00698828|42095149|FG002|Overall Study|Withdrew consent (not treated)|0|||
19645851|NCT00619515|42095157|FG000|Overall Study|Study Termination by IRB|73|||
19645852|NCT03167606|42095163|FG000|Overall Study|Lost to Follow-up|73|||
19645853|NCT03167606|42095164|FG001|Overall Study|Lost to Follow-up|64|||
19645854|NCT03167606|42095163|FG000|Overall Study|Withdrawal by Subject|6|||
19749851|NCT03858634|42198394|FG000|Overall Study|Lost to Follow-up|0|||
19749852|NCT03858634|42198395|FG001|Overall Study|Lost to Follow-up|1|||
19749853|NCT03858634|42198394|FG000|Overall Study|Other, Not Specified|1|||
19645855|NCT03167606|42095164|FG001|Overall Study|Withdrawal by Subject|5|||
19645856|NCT03167606|42095163|FG000|Overall Study|Withdrawal by Investigator|0|||
19645857|NCT03167606|42095164|FG001|Overall Study|Withdrawal by Investigator|2|||
19645858|NCT00688740|42095172|FG000|Overall Study|Adverse Event|45|||
19645859|NCT00688740|42095173|FG001|Overall Study|Adverse Event|8|||
19645860|NCT00688740|42095172|FG000|Overall Study|Death|2|||
19645861|NCT00688740|42095173|FG001|Overall Study|Death|2|||
19645862|NCT00688740|42095172|FG000|Overall Study|Lost to Follow-up|0|||
19645863|NCT00688740|42095173|FG001|Overall Study|Lost to Follow-up|1|||
19645864|NCT00688740|42095172|FG000|Overall Study|Consent Withdrawn|17|||
19645865|NCT00688740|42095173|FG001|Overall Study|Consent Withdrawn|17|||
19645866|NCT00688740|42095172|FG000|Overall Study|Breast Cancer Relapse|1|||
19645867|NCT00688740|42095173|FG001|Overall Study|Breast Cancer Relapse|4|||
19645868|NCT00688740|42095172|FG000|Overall Study|Violation of Inclusion Criteria|1|||
19645869|NCT00688740|42095173|FG001|Overall Study|Violation of Inclusion Criteria|3|||
19645870|NCT00552760|42095181|FG000|Overall Study|Adverse Event|3|||
19645871|NCT00552760|42095182|FG001|Overall Study|Adverse Event|5|||
19645872|NCT00552760|42095181|FG000|Overall Study|Relapsed- Depressed Event|10|||
19645873|NCT00552760|42095182|FG001|Overall Study|Relapsed- Depressed Event|16|||
19645874|NCT00552760|42095181|FG000|Overall Study|Relapse- Manic Event|3|||
19645875|NCT00552760|42095182|FG001|Overall Study|Relapse- Manic Event|3|||
19645876|NCT00552760|42095181|FG000|Overall Study|Relapsed- Mixed Event|3|||
19645877|NCT00552760|42095182|FG001|Overall Study|Relapsed- Mixed Event|5|||
19645878|NCT00552760|42095181|FG000|Overall Study|Protocol Violation|0|||
19645879|NCT00552760|42095182|FG001|Overall Study|Protocol Violation|1|||
19645880|NCT00552760|42095181|FG000|Overall Study|Lost to Follow-up|1|||
19645881|NCT00552760|42095182|FG001|Overall Study|Lost to Follow-up|1|||
19645882|NCT00552760|42095181|FG000|Overall Study|Non-compliance|1|||
19645883|NCT00552760|42095182|FG001|Overall Study|Non-compliance|1|||
19645884|NCT00552760|42095181|FG000|Overall Study|Medical Condition|1|||
19645885|NCT00552760|42095182|FG001|Overall Study|Medical Condition|1|||
19645886|NCT00552760|42095181|FG000|Overall Study|Withdrawal by Subject|3|||
19749854|NCT03858634|42198395|FG001|Overall Study|Other, Not Specified|1|||
19749855|NCT02891070|42198411|FG000|Overall Study|Adverse Event|1|||
19749856|NCT02891070|42198412|FG001|Overall Study|Adverse Event|0|||
19749857|NCT02891070|42198411|FG000|Overall Study|Physician Decision|0|||
19749858|NCT02891070|42198412|FG001|Overall Study|Physician Decision|1|||
19749859|NCT02891070|42198411|FG000|Overall Study|Lost to Follow-up|4|||
19749860|NCT02891070|42198412|FG001|Overall Study|Lost to Follow-up|4|||
19749861|NCT02891070|42198411|FG000|Overall Study|Other|1|||
19749862|NCT02891070|42198412|FG001|Overall Study|Other|0|||
19749863|NCT02891070|42198411|FG000|Overall Study|Protocol Violation|0|||
19749864|NCT02891070|42198412|FG001|Overall Study|Protocol Violation|1|||
19749865|NCT02891070|42198411|FG000|Overall Study|Withdrawal by Subject|1|||
19749866|NCT02891070|42198412|FG001|Overall Study|Withdrawal by Subject|2|||
19749867|NCT02891070|42198411|FG000|Overall Study|Death|3|||
19749868|NCT02891070|42198412|FG001|Overall Study|Death|0|||
19749869|NCT03255291|42198424|FG000|Overall Study|Determined to be ineligible|10|||
19749870|NCT03255291|42198425|FG001|Overall Study|Determined to be ineligible|12|||
19749871|NCT03255291|42198426|FG002|Overall Study|Determined to be ineligible|6|||
19749872|NCT03255291|42198427|FG003|Overall Study|Determined to be ineligible|6|||
19749873|NCT03255291|42198428|FG004|Overall Study|Determined to be ineligible|5|||
19749874|NCT03255291|42198429|FG005|Overall Study|Determined to be ineligible|10|||
19749875|NCT03255291|42198424|FG000|Overall Study|Baseline data collection issues|3|||
19749876|NCT03255291|42198425|FG001|Overall Study|Baseline data collection issues|0|||
19749877|NCT03255291|42198426|FG002|Overall Study|Baseline data collection issues|0|||
19749878|NCT03255291|42198427|FG003|Overall Study|Baseline data collection issues|0|||
19749879|NCT03255291|42198428|FG004|Overall Study|Baseline data collection issues|2|||
19749880|NCT03255291|42198429|FG005|Overall Study|Baseline data collection issues|0|||
19749881|NCT00381381|42198447|FG000|Overall Study|Adverse Event|3|||
19749882|NCT00381381|42198447|FG000|Overall Study|Lost to Follow-up|52|||
19749883|NCT00381381|42198447|FG000|Overall Study|Withdrawal by Subject|9|||
19749884|NCT02939937|42198453|FG000|Overall Study|Adverse Event|5|||
19749885|NCT02939937|42198454|FG001|Overall Study|Adverse Event|0|||
19749886|NCT02939937|42198453|FG000|Overall Study|Lost to Follow-up|1|||
19749887|NCT02939937|42198454|FG001|Overall Study|Lost to Follow-up|3|||
19749888|NCT02939079|42198462|FG000|Overall Study|Adverse Event|2|||
19749889|NCT02939079|42198463|FG001|Overall Study|Adverse Event|1|||
19749890|NCT02939079|42198462|FG000|Overall Study|Lost to Follow-up|0|||
19645887|NCT00552760|42095182|FG001|Overall Study|Withdrawal by Subject|0|||
19645888|NCT00552760|42095181|FG000|Overall Study|Medication Change|1|||
19645889|NCT00552760|42095182|FG001|Overall Study|Medication Change|0|||
19749891|NCT02939079|42198463|FG001|Overall Study|Lost to Follow-up|2|||
19749892|NCT02939079|42198462|FG000|Overall Study|Protocol Violation|1|||
19749893|NCT02939079|42198463|FG001|Overall Study|Protocol Violation|0|||
19749894|NCT02939079|42198462|FG000|Overall Study|Withdrawal by Subject|0|||
19749895|NCT02939079|42198463|FG001|Overall Study|Withdrawal by Subject|1|||
19749896|NCT02939079|42198462|FG000|Overall Study|relapse during the study|1|||
19749897|NCT02939079|42198463|FG001|Overall Study|relapse during the study|1|||
19749898|NCT04562155|42198473|FG000|Overall Study|COVID-19 pandemic|0|||
19749899|NCT04562155|42198474|FG001|Overall Study|COVID-19 pandemic|0|||
19749900|NCT04562155|42198475|FG002|Overall Study|COVID-19 pandemic|0|||
19749901|NCT04562155|42198476|FG003|Overall Study|COVID-19 pandemic|1|||
19645890|NCT00686790|42095188|FG000|Overall Study|Adverse Event|2|||
19645891|NCT00686790|42095188|FG000|Overall Study|Withdrawal by Subject|1|||
19645892|NCT00686790|42095188|FG000|Overall Study|Death|1|||
19645893|NCT00686790|42095188|FG000|Overall Study|Lost to Follow-up|12|||
19645894|NCT00686712|42095195|FG000|Overall Study|Protocol Violation|8|||
19645895|NCT00686712|42095196|FG001|Overall Study|Protocol Violation|8|||
19645896|NCT00686712|42095197|FG002|Overall Study|Protocol Violation|10|||
19645897|NCT00686712|42095195|FG000|Overall Study|Lost to Follow-up|1|||
19645898|NCT00686712|42095196|FG001|Overall Study|Lost to Follow-up|2|||
19645899|NCT00686712|42095197|FG002|Overall Study|Lost to Follow-up|3|||
19749902|NCT04562155|42198473|FG000|Overall Study|Adverse Event|7|||
19749903|NCT04562155|42198474|FG001|Overall Study|Adverse Event|3|||
19749904|NCT04562155|42198475|FG002|Overall Study|Adverse Event|8|||
19749905|NCT04562155|42198476|FG003|Overall Study|Adverse Event|1|||
19749906|NCT04562155|42198473|FG000|Overall Study|Withdrawal by Subject|3|||
19749907|NCT04562155|42198474|FG001|Overall Study|Withdrawal by Subject|6|||
19749908|NCT04562155|42198475|FG002|Overall Study|Withdrawal by Subject|3|||
19749909|NCT04562155|42198476|FG003|Overall Study|Withdrawal by Subject|3|||
19645900|NCT00686712|42095195|FG000|Overall Study|Adverse Event|1|||
19645901|NCT00686712|42095196|FG001|Overall Study|Adverse Event|1|||
19645902|NCT00686712|42095197|FG002|Overall Study|Adverse Event|0|||
19645903|NCT00686634|42095208|FG000|Overall Study|Protocol Violation|6|||
19645904|NCT00560404|42095215|FG000|Overall Study|Adverse Event|2|||
19645905|NCT00560404|42095216|FG001|Overall Study|Adverse Event|3|||
19645906|NCT00560404|42095215|FG000|Overall Study|Death|3|||
19645907|NCT00560404|42095216|FG001|Overall Study|Death|3|||
19645908|NCT00560404|42095215|FG000|Overall Study|Protocol Violation|12|||
19645909|NCT00560404|42095216|FG001|Overall Study|Protocol Violation|7|||
19645910|NCT00560404|42095215|FG000|Overall Study|Administrative Reasons|1|||
19645911|NCT00560404|42095216|FG001|Overall Study|Administrative Reasons|1|||
19645912|NCT00560404|42095215|FG000|Overall Study|Withdrew Consent|4|||
19645913|NCT00560404|42095216|FG001|Overall Study|Withdrew Consent|0|||
19645914|NCT00560404|42095215|FG000|Overall Study|Failure to return|1|||
19645915|NCT00560404|42095216|FG001|Overall Study|Failure to return|2|||
19645916|NCT00560404|42095215|FG000|Overall Study|Other withdrawal reason|13|||
19645917|NCT00560404|42095216|FG001|Overall Study|Other withdrawal reason|5|||
19645918|NCT03967444|42095224|FG000|Overall Study|Lost to Follow-up|1|||
19645919|NCT03967444|42095225|FG001|Overall Study|Lost to Follow-up|2|||
19645920|NCT00619983|42095235|FG000|Test Drug Alone|Withdrawal by Subject|1|||
19645921|NCT00619983|42095236|FG001|Test Drug Alone|Withdrawal by Subject|0|||
19645922|NCT00619983|42095237|FG002|Test Drug Alone|Withdrawal by Subject|0|||
19645923|NCT00619983|42095238|FG003|Test Drug Alone|Withdrawal by Subject|1|||
19645924|NCT00619983|42095235|FG000|Test Drug Alone|Failure of daily diary device|1|||
19645925|NCT00619983|42095236|FG001|Test Drug Alone|Failure of daily diary device|1|||
19645926|NCT00619983|42095237|FG002|Test Drug Alone|Failure of daily diary device|2|||
19645927|NCT00619983|42095238|FG003|Test Drug Alone|Failure of daily diary device|2|||
19645928|NCT00576420|42095251|FG000|Overall Study|Death|0|||
19645929|NCT00576420|42095252|FG001|Overall Study|Death|0|||
19645930|NCT00576420|42095253|FG002|Overall Study|Death|1|||
19645931|NCT03961204|42095302|FG000|Overall Study|Withdrawal by Subject|2|||
19645932|NCT03961204|42095302|FG000|Overall Study|Lost to Follow-up|3|||
19645933|NCT03961204|42095302|FG000|Overall Study|Other|1|||
19645934|NCT03961204|42095302|FG000|Overall Study|Missing|1|||
19645935|NCT00364351|42095308|FG000|Overall Study|Adverse Event|90|||
19645936|NCT00364351|42095309|FG001|Overall Study|Adverse Event|44|||
19645937|NCT00364351|42095308|FG000|Overall Study|Condition under investigation worsened|469|||
19645938|NCT00364351|42095309|FG001|Overall Study|Condition under investigation worsened|497|||
19645939|NCT00364351|42095308|FG000|Overall Study|Prohibited concomitant medication|0|||
19645940|NCT00364351|42095309|FG001|Overall Study|Prohibited concomitant medication|2|||
19645941|NCT00364351|42095308|FG000|Overall Study|Lost to Follow-up|1|||
19645942|NCT00364351|42095309|FG001|Overall Study|Lost to Follow-up|1|||
19645943|NCT00364351|42095308|FG000|Overall Study|Withdrawal by Subject|30|||
19645944|NCT00364351|42095309|FG001|Overall Study|Withdrawal by Subject|29|||
19645945|NCT00364351|42095308|FG000|Overall Study|Incorrect enrollment|1|||
19645946|NCT00364351|42095309|FG001|Overall Study|Incorrect enrollment|1|||
19645947|NCT00364351|42095308|FG000|Overall Study|Sponsor decision|1|||
19749910|NCT04562155|42198473|FG000|Overall Study|Participant personal reason|1|||
19645948|NCT00364351|42095309|FG001|Overall Study|Sponsor decision|0|||
19645949|NCT00364351|42095308|FG000|Overall Study|Poor treatment compliance|0|||
19645950|NCT00364351|42095309|FG001|Overall Study|Poor treatment compliance|3|||
19645951|NCT00364351|42095308|FG000|Overall Study|Investigator error|0|||
19645952|NCT00364351|42095309|FG001|Overall Study|Investigator error|2|||
19749911|NCT04562155|42198474|FG001|Overall Study|Participant personal reason|0|||
19645953|NCT00364351|42095308|FG000|Overall Study|Patient could not travel to site|0|||
19645954|NCT00364351|42095309|FG001|Overall Study|Patient could not travel to site|1|||
19645955|NCT00364351|42095308|FG000|Overall Study|Randomised treatment not started|0|||
19645956|NCT00364351|42095309|FG001|Overall Study|Randomised treatment not started|3|||
19645957|NCT00388297|42095319|FG000|Overall Study|Lost to Follow-up|16|||
19645958|NCT00388297|42095320|FG001|Overall Study|Lost to Follow-up|12|||
19645959|NCT00388297|42095321|FG002|Overall Study|Lost to Follow-up|11|||
19645960|NCT00388297|42095322|FG003|Overall Study|Lost to Follow-up|8|||
19645961|NCT00686166|42095332|FG000|Overall Study|Adverse Event|7|||
19645962|NCT00686166|42095332|FG000|Overall Study|Withdrawal by Subject|1|||
19645963|NCT00686166|42095332|FG000|Overall Study|Progression/Relapse|1|||
19645964|NCT00686166|42095332|FG000|Overall Study|Death|1|||
19749912|NCT04562155|42198475|FG002|Overall Study|Participant personal reason|2|||
19645965|NCT00686166|42095332|FG000|Overall Study|Not Protocol Specified|1|||
19749913|NCT04562155|42198476|FG003|Overall Study|Participant personal reason|1|||
19749914|NCT02896257|42198490|FG000|Providers|Without eligible patients|21|||
19749915|NCT02896257|42198491|FG001|Providers|Without eligible patients|28|||
19749916|NCT02896257|42198490|FG000|Patients|PFT entry criteria not met|43|||
19749917|NCT02896257|42198491|FG001|Patients|PFT entry criteria not met|50|||
19749918|NCT02896257|42198490|FG000|Patients|No capacity to review|8|||
19749919|NCT02896257|42198491|FG001|Patients|No capacity to review|11|||
19749920|NCT02896257|42198490|FG000|Patients|Appointment rescheduled/cancelled|5|||
19749921|NCT02896257|42198491|FG001|Patients|Appointment rescheduled/cancelled|7|||
19749922|NCT02896257|42198490|FG000|Patients|PCP not assigned a clinic|4|||
19749923|NCT02896257|42198491|FG001|Patients|PCP not assigned a clinic|0|||
19749924|NCT02896257|42198490|FG000|Patients|No history of COPD|0|||
19749925|NCT02896257|42198491|FG001|Patients|No history of COPD|1|||
19749926|NCT02896257|42198490|FG000|Patients|Deceased between review and index date|0|||
19749927|NCT02896257|42198491|FG001|Patients|Deceased between review and index date|1|||
19749928|NCT02896257|42198490|FG000|Patients|No ICS Rx upon review|1|||
19749929|NCT02896257|42198491|FG001|Patients|No ICS Rx upon review|1|||
19749930|NCT02896257|42198490|FG000|Patients|Protocol Violation|2|||
19749931|NCT02896257|42198491|FG001|Patients|Protocol Violation|1|||
19749932|NCT02896257|42198490|FG000|Patients|Hospice care|0|||
19749933|NCT02896257|42198491|FG001|Patients|Hospice care|1|||
19749934|NCT03313050|42198502|FG000|Stage 2: 12 Months|Adverse Event|0|||
19749935|NCT03313050|42198503|FG001|Stage 2: 12 Months|Adverse Event|0|||
19749936|NCT03313050|42198504|FG002|Stage 2: 12 Months|Adverse Event|0|||
19749937|NCT03313050|42198505|FG003|Stage 2: 12 Months|Adverse Event|1|||
19749938|NCT03313050|42198502|FG000|Stage 2: 12 Months|Death|0|||
19749939|NCT03313050|42198503|FG001|Stage 2: 12 Months|Death|0|||
19749940|NCT03313050|42198504|FG002|Stage 2: 12 Months|Death|3|||
19749941|NCT03313050|42198505|FG003|Stage 2: 12 Months|Death|0|||
19749942|NCT03313050|42198502|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
19749943|NCT03313050|42198503|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
19749944|NCT03313050|42198504|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
19749945|NCT03313050|42198505|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
19749946|NCT03313050|42198502|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
19749947|NCT03313050|42198503|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
19749948|NCT03313050|42198504|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
19749949|NCT03313050|42198505|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
19749950|NCT03313050|42198502|FG000|Stage 2: 12 Months|Protocol deviation|0|||
19749951|NCT03313050|42198503|FG001|Stage 2: 12 Months|Protocol deviation|0|||
19749952|NCT03313050|42198504|FG002|Stage 2: 12 Months|Protocol deviation|7|||
19749953|NCT03313050|42198505|FG003|Stage 2: 12 Months|Protocol deviation|7|||
19749954|NCT03313050|42198502|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
19749955|NCT03313050|42198503|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
19749956|NCT03313050|42198504|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
19749957|NCT03313050|42198505|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
19749958|NCT03313050|42198502|FG000|Stage 2: 12 Months|Other|0|||
19749959|NCT03313050|42198503|FG001|Stage 2: 12 Months|Other|0|||
19749960|NCT03313050|42198504|FG002|Stage 2: 12 Months|Other|0|||
19749961|NCT03313050|42198505|FG003|Stage 2: 12 Months|Other|1|||
19749962|NCT04755595|42198524|FG000|Overall Study|Lost to Follow-up|1|||
19749963|NCT04749745|42198529|FG000|Overall Study|Withdrawal by Subject|1|||
19749964|NCT04749745|42198530|FG001|Overall Study|Withdrawal by Subject|0|||
19749965|NCT03257436|42198536|FG000|Overall Study|Withdrawal by Subject|76|||
19645966|NCT00686166|42095332|FG000|Overall Study|Ineligible|5|||
19749966|NCT03257436|42198536|FG000|Overall Study|Death|19|||
19749967|NCT04748341|42198542|FG000|Overall Study|Lost to Follow-up|1|||
19749968|NCT04748341|42198543|FG001|Overall Study|Lost to Follow-up|1|||
19749969|NCT01328002|42198549|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
19749970|NCT01328002|42198550|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
19749971|NCT01328002|42198549|FG000|Open-Label Period|Adverse Event|8|||
19749972|NCT01328002|42198550|FG001|Open-Label Period|Adverse Event|0|||
19749973|NCT01328002|42198549|FG000|Open-Label Period|Lack of Efficacy|3|||
19749974|NCT01328002|42198550|FG001|Open-Label Period|Lack of Efficacy|0|||
19749975|NCT01328002|42198549|FG000|Open-Label Period|Protocol Violation|2|||
19749976|NCT01328002|42198550|FG001|Open-Label Period|Protocol Violation|0|||
19749977|NCT01328002|42198549|FG000|Open-Label Period|Withdrawal by Subject|9|||
19645967|NCT00686166|42095332|FG000|Overall Study|Did not begin protocol therapy|4|||
19645968|NCT00363649|42095343|FG000|Overall Study|Withdrawal by Subject|1|||
19645969|NCT00363649|42095344|FG001|Overall Study|Withdrawal by Subject|1|||
19645970|NCT00363649|42095343|FG000|Overall Study|Adverse Event|6|||
19645971|NCT00363649|42095344|FG001|Overall Study|Adverse Event|0|||
19645972|NCT00684060|42095352|FG000|Overall Study|Lost to Follow-up|1|||
19645973|NCT00684060|42095353|FG001|Overall Study|Lost to Follow-up|0|||
19645974|NCT00684060|42095352|FG000|Overall Study|New stenosis identified|1|||
19645975|NCT00684060|42095353|FG001|Overall Study|New stenosis identified|0|||
19645976|NCT00684060|42095352|FG000|Overall Study|Unable to collect MRI|1|||
19645977|NCT00684060|42095353|FG001|Overall Study|Unable to collect MRI|2|||
19645978|NCT00684060|42095352|FG000|Overall Study|Death|0|||
19645979|NCT00684060|42095353|FG001|Overall Study|Death|1|||
19645980|NCT03131648|42095361|FG000|Initial Treatment Period|Not dosed|2|||
19645981|NCT03131648|42095362|FG001|Initial Treatment Period|Not dosed|2|||
19645982|NCT03131648|42095363|FG002|Initial Treatment Period|Not dosed|0|||
19645983|NCT03131648|42095364|FG003|Initial Treatment Period|Not dosed|0|||
19645984|NCT03131648|42095365|FG004|Initial Treatment Period|Not dosed|0|||
19645985|NCT03131648|42095366|FG005|Initial Treatment Period|Not dosed|0|||
19645986|NCT03131648|42095367|FG006|Initial Treatment Period|Not dosed|0|||
19645987|NCT03131648|42095368|FG007|Initial Treatment Period|Not dosed|0|||
19645988|NCT03131648|42095361|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
19645989|NCT03131648|42095362|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
19645990|NCT03131648|42095363|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645991|NCT03131648|42095364|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645992|NCT03131648|42095365|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645993|NCT03131648|42095366|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645994|NCT03131648|42095367|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645995|NCT03131648|42095368|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19645996|NCT03131648|42095361|FG000|Open-label Treatment|Discontinued IMP|0|||
19645997|NCT03131648|42095362|FG001|Open-label Treatment|Discontinued IMP|0|||
19645998|NCT03131648|42095363|FG002|Open-label Treatment|Discontinued IMP|0|||
19645999|NCT03131648|42095364|FG003|Open-label Treatment|Discontinued IMP|0|||
19646000|NCT03131648|42095365|FG004|Open-label Treatment|Discontinued IMP|0|||
19646001|NCT03131648|42095366|FG005|Open-label Treatment|Discontinued IMP|0|||
19646002|NCT03131648|42095367|FG006|Open-label Treatment|Discontinued IMP|112|||
19646003|NCT03131648|42095368|FG007|Open-label Treatment|Discontinued IMP|0|||
19646004|NCT03131648|42095361|FG000|Open-label Treatment|Completed Week 50|0|||
19646005|NCT03131648|42095362|FG001|Open-label Treatment|Completed Week 50|0|||
19646006|NCT03131648|42095363|FG002|Open-label Treatment|Completed Week 50|0|||
19646007|NCT03131648|42095364|FG003|Open-label Treatment|Completed Week 50|0|||
19646008|NCT03131648|42095365|FG004|Open-label Treatment|Completed Week 50|0|||
19646009|NCT03131648|42095366|FG005|Open-label Treatment|Completed Week 50|0|||
19646010|NCT03131648|42095367|FG006|Open-label Treatment|Completed Week 50|6|||
19646011|NCT03131648|42095368|FG007|Open-label Treatment|Completed Week 50|0|||
19646012|NCT03131648|42095361|FG000|Maintenance Treatment Period|Not dosed|0|||
19646013|NCT03131648|42095362|FG001|Maintenance Treatment Period|Not dosed|0|||
19646014|NCT03131648|42095363|FG002|Maintenance Treatment Period|Not dosed|3|||
19646015|NCT03131648|42095364|FG003|Maintenance Treatment Period|Not dosed|2|||
19646016|NCT03131648|42095365|FG004|Maintenance Treatment Period|Not dosed|1|||
19646017|NCT03131648|42095366|FG005|Maintenance Treatment Period|Not dosed|0|||
19646018|NCT03131648|42095367|FG006|Maintenance Treatment Period|Not dosed|0|||
19646019|NCT03131648|42095368|FG007|Maintenance Treatment Period|Not dosed|0|||
19646020|NCT03131648|42095361|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
19646021|NCT03131648|42095362|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
19646022|NCT03131648|42095363|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
19646023|NCT03131648|42095364|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
19646024|NCT03131648|42095365|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
19646025|NCT03131648|42095366|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
19646026|NCT03131648|42095367|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
19646027|NCT03131648|42095368|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
19646028|NCT03131648|42095361|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19646029|NCT03131648|42095362|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19646030|NCT03131648|42095363|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
19646031|NCT03131648|42095364|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
19646032|NCT03131648|42095365|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
19646033|NCT03131648|42095366|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
19646034|NCT03131648|42095367|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19646035|NCT03131648|42095368|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19646036|NCT03131648|42095361|FG000|Maintenance Treatment Period|Completed Week 50|0|||
19646037|NCT03131648|42095362|FG001|Maintenance Treatment Period|Completed Week 50|0|||
19646038|NCT03131648|42095363|FG002|Maintenance Treatment Period|Completed Week 50|0|||
19646039|NCT03131648|42095364|FG003|Maintenance Treatment Period|Completed Week 50|0|||
19646040|NCT03131648|42095365|FG004|Maintenance Treatment Period|Completed Week 50|1|||
19646041|NCT03131648|42095366|FG005|Maintenance Treatment Period|Completed Week 50|0|||
19646042|NCT03131648|42095367|FG006|Maintenance Treatment Period|Completed Week 50|0|||
19646043|NCT03131648|42095368|FG007|Maintenance Treatment Period|Completed Week 50|0|||
19646044|NCT03131648|42095361|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646045|NCT03131648|42095362|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646046|NCT03131648|42095363|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646047|NCT03131648|42095364|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646048|NCT03131648|42095365|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646049|NCT03131648|42095366|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646050|NCT03131648|42095367|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
19646051|NCT03131648|42095368|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
19646052|NCT00618813|42095385|FG000|Overall Study|Lack of Efficacy|1|||
19646053|NCT00618813|42095385|FG000|Overall Study|Physician Decision|2|||
19646054|NCT00618813|42095385|FG000|Overall Study|Withdrawal by Subject|1|||
19646055|NCT00554788|42095392|FG000|Overall Study|Adverse Event|0|||
19646056|NCT00554788|42095393|FG001|Overall Study|Adverse Event|1|||
19646057|NCT00554788|42095394|FG002|Overall Study|Adverse Event|2|||
19646058|NCT00554788|42095392|FG000|Overall Study|Lost to Follow-up|4|||
19646059|NCT00554788|42095393|FG001|Overall Study|Lost to Follow-up|3|||
19646060|NCT00554788|42095394|FG002|Overall Study|Lost to Follow-up|3|||
19646061|NCT00554788|42095392|FG000|Overall Study|Physician Decision|1|||
19646062|NCT00554788|42095393|FG001|Overall Study|Physician Decision|1|||
19646063|NCT00554788|42095394|FG002|Overall Study|Physician Decision|3|||
19646064|NCT00554788|42095392|FG000|Overall Study|Withdrawal by Subject|0|||
19646065|NCT00554788|42095393|FG001|Overall Study|Withdrawal by Subject|0|||
19646066|NCT00554788|42095394|FG002|Overall Study|Withdrawal by Subject|1|||
19646067|NCT00554788|42095392|FG000|Overall Study|Refusal of further protocol therapy|0|||
19646068|NCT00554788|42095393|FG001|Overall Study|Refusal of further protocol therapy|1|||
19646069|NCT00554788|42095394|FG002|Overall Study|Refusal of further protocol therapy|1|||
19646070|NCT00554788|42095392|FG000|Overall Study|Progressive disease|0|||
19646071|NCT00554788|42095393|FG001|Overall Study|Progressive disease|0|||
19646072|NCT00554788|42095394|FG002|Overall Study|Progressive disease|3|||
19646073|NCT00554788|42095392|FG000|Overall Study|Ineligible|2|||
19646074|NCT00554788|42095393|FG001|Overall Study|Ineligible|0|||
19646075|NCT00554788|42095394|FG002|Overall Study|Ineligible|1|||
19646076|NCT00685698|42095403|FG000|Overall Study|Withdrawal by Subject|1|||
19646077|NCT00685698|42095403|FG000|Overall Study|Protocol Violation|6|||
19646078|NCT00685698|42095403|FG000|Overall Study|Adverse Event|3|||
19646079|NCT00685698|42095403|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
19646080|NCT00685698|42095403|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
19646081|NCT00685698|42095403|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
19646082|NCT00549328|42095419|FG000|Overall Study|Adverse Event|2|||
19646083|NCT00549328|42095419|FG000|Overall Study|Disease Progression|10|||
19646084|NCT00549328|42095419|FG000|Overall Study|Death|1|||
19646085|NCT00549328|42095419|FG000|Overall Study|Use of Prohibited Medication|1|||
19646086|NCT00696410|42095425|FG000|Overall Study|Lost to Follow-up|2|||
19646087|NCT00696410|42095426|FG001|Overall Study|Lost to Follow-up|0|||
19646088|NCT00696410|42095425|FG000|Overall Study|Withdrawal by Subject|8|||
19646089|NCT00696410|42095426|FG001|Overall Study|Withdrawal by Subject|0|||
19646090|NCT00696410|42095425|FG000|Overall Study|Physician Decision|3|||
19646091|NCT00696410|42095426|FG001|Overall Study|Physician Decision|0|||
19646092|NCT00683904|42095439|FG000|Dose Level 1|Disease progression|2|||
19646093|NCT00683904|42095440|FG001|Dose Level 1|Disease progression|0|||
19646094|NCT00683904|42095439|FG000|Dose Level 1|Adverse Event|1|||
19646095|NCT00683904|42095440|FG001|Dose Level 1|Adverse Event|0|||
19646096|NCT00683904|42095439|FG000|Dose Level 2|Adverse Event|0|||
19749978|NCT01328002|42198550|FG001|Open-Label Period|Withdrawal by Subject|0|||
19749979|NCT01328002|42198549|FG000|Open-Label Period|Lost to Follow-up|6|||
19749980|NCT01328002|42198550|FG001|Open-Label Period|Lost to Follow-up|0|||
19749981|NCT01328002|42198549|FG000|Open-Label Period|Other Reason|2|||
19749982|NCT01328002|42198550|FG001|Open-Label Period|Other Reason|0|||
19646097|NCT00683904|42095440|FG001|Dose Level 2|Adverse Event|2|||
19646098|NCT00363415|42095454|FG000|Overall Study|Progressive Disease|196|||
19646099|NCT00363415|42095455|FG001|Overall Study|Progressive Disease|107|||
19646100|NCT00363415|42095454|FG000|Overall Study|Sponsor Decision|67|||
19646101|NCT00363415|42095455|FG001|Overall Study|Sponsor Decision|31|||
19646102|NCT00363415|42095454|FG000|Overall Study|Death|32|||
19646103|NCT00363415|42095455|FG001|Overall Study|Death|29|||
19646104|NCT00363415|42095454|FG000|Overall Study|Adverse Event|24|||
19646105|NCT00363415|42095455|FG001|Overall Study|Adverse Event|15|||
19646106|NCT00363415|42095454|FG000|Overall Study|Physician Decision|18|||
19749983|NCT01328002|42198549|FG000|Double-Blind Period|Adverse Event|1|||
19646107|NCT00363415|42095455|FG001|Overall Study|Physician Decision|35|||
19646108|NCT00363415|42095454|FG000|Overall Study|Entry Criteria Not Met|11|||
19646109|NCT00363415|42095455|FG001|Overall Study|Entry Criteria Not Met|10|||
19646110|NCT00363415|42095454|FG000|Overall Study|Withdrawal by Subject|9|||
19646111|NCT00363415|42095455|FG001|Overall Study|Withdrawal by Subject|15|||
19646112|NCT00363415|42095454|FG000|Overall Study|Lost to Follow-up|3|||
19646113|NCT00363415|42095455|FG001|Overall Study|Lost to Follow-up|3|||
19646114|NCT00363415|42095454|FG000|Overall Study|Protocol Violation|1|||
19646115|NCT00363415|42095455|FG001|Overall Study|Protocol Violation|4|||
19646116|NCT00696020|42095465|FG000|Overall Study|Adverse Event|3|||
19646117|NCT00696020|42095466|FG001|Overall Study|Adverse Event|1|||
19749984|NCT01328002|42198550|FG001|Double-Blind Period|Adverse Event|0|||
19646118|NCT00696020|42095467|FG002|Overall Study|Adverse Event|2|||
19646119|NCT00696020|42095468|FG003|Overall Study|Adverse Event|1|||
19646120|NCT00696020|42095465|FG000|Overall Study|Lack of Efficacy|1|||
19646121|NCT00696020|42095466|FG001|Overall Study|Lack of Efficacy|0|||
19646122|NCT00696020|42095467|FG002|Overall Study|Lack of Efficacy|0|||
19646123|NCT00696020|42095468|FG003|Overall Study|Lack of Efficacy|0|||
19646124|NCT00696020|42095465|FG000|Overall Study|Protocol Violation|0|||
19646125|NCT00696020|42095466|FG001|Overall Study|Protocol Violation|0|||
19646126|NCT00696020|42095467|FG002|Overall Study|Protocol Violation|0|||
19646127|NCT00696020|42095468|FG003|Overall Study|Protocol Violation|1|||
19646128|NCT00696020|42095465|FG000|Overall Study|Withdrawal by Subject|0|||
19646129|NCT00696020|42095466|FG001|Overall Study|Withdrawal by Subject|1|||
19646130|NCT00696020|42095467|FG002|Overall Study|Withdrawal by Subject|0|||
19646131|NCT00696020|42095468|FG003|Overall Study|Withdrawal by Subject|1|||
19646132|NCT00696020|42095465|FG000|Overall Study|Other not stated above|0|||
19646133|NCT00696020|42095466|FG001|Overall Study|Other not stated above|0|||
19646134|NCT00696020|42095467|FG002|Overall Study|Other not stated above|1|||
19646135|NCT00696020|42095468|FG003|Overall Study|Other not stated above|1|||
19646136|NCT00576576|42095480|FG000|Overall Study|Lost to Follow-up|6|||
19646137|NCT00576576|42095480|FG000|Overall Study|Protocol Violation|1|||
19646138|NCT00695864|42095499|FG000|Placebo|Withdrawal by Subject|1|||
19646139|NCT00695864|42095499|FG000|Placebo|Physician Decision|4|||
19646140|NCT00684996|42095505|FG000|Overall Study|Adverse Event|1|||
19646141|NCT00684996|42095505|FG000|Overall Study|Refusal unrelated to adverse event|1|||
19646142|NCT00684996|42095505|FG000|Overall Study|Progression/relapse|2|||
19646143|NCT00684996|42095505|FG000|Overall Study|Other reasons not protocol specified|1|||
19646144|NCT00684762|42095512|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
19646145|NCT00684762|42095513|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
19646146|NCT00695786|42095523|FG000|Overall Study|Adverse Event|0|||
19646147|NCT00695786|42095524|FG001|Overall Study|Adverse Event|3|||
19646148|NCT00695786|42095525|FG002|Overall Study|Adverse Event|4|||
19749985|NCT01328002|42198549|FG000|Double-Blind Period|Lack of Efficacy|1|||
19749986|NCT01328002|42198550|FG001|Double-Blind Period|Lack of Efficacy|0|||
19749987|NCT02579265|42198559|FG000|Overall Study|Weaned off earlier than 28 days|44|||
19749988|NCT02579265|42198560|FG001|Overall Study|Weaned off earlier than 28 days|43|||
19749989|NCT02579265|42198559|FG000|Overall Study|Adverse Event|2|||
19749990|NCT02579265|42198560|FG001|Overall Study|Adverse Event|0|||
19749991|NCT02579265|42198559|FG000|Overall Study|Any other reason not specified|0|||
19749992|NCT02579265|42198560|FG001|Overall Study|Any other reason not specified|2|||
19749993|NCT02579265|42198559|FG000|Overall Study|Withdrawal by Subject|2|||
19749994|NCT02579265|42198560|FG001|Overall Study|Withdrawal by Subject|0|||
19749995|NCT02579265|42198559|FG000|Overall Study|Physician Decision|1|||
19749996|NCT02579265|42198560|FG001|Overall Study|Physician Decision|0|||
19749997|NCT02579265|42198559|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
19749998|NCT02579265|42198560|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
19749999|NCT03289533|42198566|FG000|Overall Study|Death|12|||
19750000|NCT03289533|42198566|FG000|Overall Study|Terminated from study by sponsor|10|||
19750001|NCT04727749|42198572|FG000|Overall Study|Lost to Follow-up|10|||
19750002|NCT04727749|42198573|FG001|Overall Study|Lost to Follow-up|3|||
19646149|NCT00695786|42095526|FG003|Overall Study|Adverse Event|2|||
19646150|NCT00695786|42095523|FG000|Overall Study|Lost to Follow-up|0|||
19646151|NCT00695786|42095524|FG001|Overall Study|Lost to Follow-up|5|||
19646152|NCT00695786|42095525|FG002|Overall Study|Lost to Follow-up|1|||
19646153|NCT00695786|42095526|FG003|Overall Study|Lost to Follow-up|1|||
19646154|NCT00695786|42095523|FG000|Overall Study|Withdrawal by Subject|0|||
19646155|NCT00695786|42095524|FG001|Overall Study|Withdrawal by Subject|4|||
19646156|NCT00695786|42095525|FG002|Overall Study|Withdrawal by Subject|3|||
19646157|NCT00695786|42095526|FG003|Overall Study|Withdrawal by Subject|1|||
19646158|NCT00695786|42095523|FG000|Overall Study|Deemed Ineligible|1|||
19646159|NCT00695786|42095524|FG001|Overall Study|Deemed Ineligible|0|||
19646160|NCT00695786|42095525|FG002|Overall Study|Deemed Ineligible|0|||
19646161|NCT00695786|42095526|FG003|Overall Study|Deemed Ineligible|0|||
19646162|NCT00695786|42095523|FG000|Overall Study|Lack of Efficacy|0|||
19646163|NCT00695786|42095524|FG001|Overall Study|Lack of Efficacy|0|||
19646164|NCT00695786|42095525|FG002|Overall Study|Lack of Efficacy|0|||
19646165|NCT00695786|42095526|FG003|Overall Study|Lack of Efficacy|4|||
19646166|NCT00387127|42095538|FG000|Overall Study|Lost to Follow-up|0|||
19646167|NCT00387127|42095539|FG001|Overall Study|Lost to Follow-up|4|||
19646168|NCT00387127|42095538|FG000|Overall Study|Death|16|||
19646169|NCT00387127|42095539|FG001|Overall Study|Death|16|||
19646170|NCT00387127|42095538|FG000|Overall Study|Physician Decision|0|||
19646171|NCT00387127|42095539|FG001|Overall Study|Physician Decision|1|||
19646172|NCT00387127|42095538|FG000|Overall Study|Withdrawal by Subject|3|||
19646173|NCT00387127|42095539|FG001|Overall Study|Withdrawal by Subject|2|||
19750003|NCT04547023|42198583|FG000|Overall Study|Did Not Receive Intervention|3|||
19646174|NCT00387127|42095538|FG000|Overall Study|Required by Protocol Amendment #4|12|||
19750004|NCT04547023|42198584|FG001|Overall Study|Did Not Receive Intervention|2|||
19646175|NCT00387127|42095539|FG001|Overall Study|Required by Protocol Amendment #4|10|||
19646176|NCT00387127|42095538|FG000|Overall Study|Serious Adverse Event|1|||
19646177|NCT00387127|42095539|FG001|Overall Study|Serious Adverse Event|1|||
19646178|NCT00387127|42095538|FG000|Overall Study|Sponsor Unblinded|1|||
19646179|NCT00387127|42095539|FG001|Overall Study|Sponsor Unblinded|0|||
19646180|NCT00683592|42095549|FG000|Overall Study|Adverse Event|12|||
19646181|NCT00683592|42095550|FG001|Overall Study|Adverse Event|4|||
19646182|NCT00683592|42095549|FG000|Overall Study|Withdrawal by Subject|11|||
19646183|NCT00683592|42095550|FG001|Overall Study|Withdrawal by Subject|11|||
19646184|NCT00683592|42095549|FG000|Overall Study|Lost to Follow-up|17|||
19646185|NCT00683592|42095550|FG001|Overall Study|Lost to Follow-up|17|||
19646186|NCT00683592|42095549|FG000|Overall Study|Lack of Efficacy|3|||
19646187|NCT00683592|42095550|FG001|Overall Study|Lack of Efficacy|7|||
19646188|NCT00683592|42095549|FG000|Overall Study|Physician Decision|0|||
19646189|NCT00683592|42095550|FG001|Overall Study|Physician Decision|1|||
19646190|NCT00683592|42095549|FG000|Overall Study|Non-compliance|3|||
19646191|NCT00683592|42095550|FG001|Overall Study|Non-compliance|5|||
19646192|NCT00683592|42095549|FG000|Overall Study|Other|1|||
19646193|NCT00683592|42095550|FG001|Overall Study|Other|1|||
19646194|NCT00695396|42095559|FG000|Overall Study|Study Closed Prematurely|5|||
19646195|NCT00695396|42095560|FG001|Overall Study|Study Closed Prematurely|6|||
19646196|NCT00695396|42095561|FG002|Overall Study|Study Closed Prematurely|8|||
19646197|NCT00695396|42095559|FG000|Overall Study|Withdrawal by Subject|2|||
19646198|NCT00695396|42095560|FG001|Overall Study|Withdrawal by Subject|2|||
19646199|NCT00695396|42095561|FG002|Overall Study|Withdrawal by Subject|0|||
19646200|NCT02656706|42095569|FG000|Overall Study|Insurance Denial|1|||
19646201|NCT00575328|42095575|FG000|Overall Study|Adverse Event|1|||
19646202|NCT00575328|42095576|FG001|Overall Study|Adverse Event|1|||
19646203|NCT00575328|42095575|FG000|Overall Study|Lost to Follow-up|2|||
19646204|NCT00575328|42095576|FG001|Overall Study|Lost to Follow-up|1|||
19646205|NCT00575094|42095582|FG000|Overall Study|Adverse Event|2|||
19646206|NCT00575094|42095582|FG000|Overall Study|Withdrawal by Subject|1|||
19646207|NCT00553696|42095590|FG000|Overall Study|Adverse Event|2|||
19646208|NCT00553696|42095591|FG001|Overall Study|Adverse Event|4|||
19646209|NCT00553696|42095592|FG002|Overall Study|Adverse Event|0|||
19646210|NCT00553696|42095593|FG003|Overall Study|Adverse Event|1|||
19646211|NCT00553696|42095590|FG000|Overall Study|Global deterioration of health status|0|||
19646212|NCT00553696|42095591|FG001|Overall Study|Global deterioration of health status|2|||
19646213|NCT00553696|42095592|FG002|Overall Study|Global deterioration of health status|0|||
19750005|NCT04547023|42198583|FG000|Overall Study|Lost to Follow-up|1|||
19750006|NCT04547023|42198584|FG001|Overall Study|Lost to Follow-up|1|||
19646214|NCT00553696|42095593|FG003|Overall Study|Global deterioration of health status|0|||
19646215|NCT00553696|42095590|FG000|Overall Study|Objective progression or relapse|2|||
19646216|NCT00553696|42095591|FG001|Overall Study|Objective progression or relapse|9|||
19646217|NCT00553696|42095592|FG002|Overall Study|Objective progression or relapse|6|||
19646218|NCT00553696|42095593|FG003|Overall Study|Objective progression or relapse|0|||
19646219|NCT00553696|42095590|FG000|Overall Study|Withdrawal by Subject|0|||
19646220|NCT00553696|42095591|FG001|Overall Study|Withdrawal by Subject|1|||
19646221|NCT00553696|42095592|FG002|Overall Study|Withdrawal by Subject|0|||
19646222|NCT00553696|42095593|FG003|Overall Study|Withdrawal by Subject|0|||
19646223|NCT00553540|42095608|FG000|Overall Study|discharged after first visit|2|||
19646224|NCT00553540|42095609|FG001|Overall Study|discharged after first visit|5|||
19646225|NCT00617409|42095618|FG000|Overall Study|Withdrawal by Subject|4|||
19646226|NCT00617409|42095619|FG001|Overall Study|Withdrawal by Subject|1|||
19646227|NCT00617409|42095620|FG002|Overall Study|Withdrawal by Subject|2|||
19646228|NCT00617409|42095618|FG000|Overall Study|Adverse Event|0|||
19646229|NCT00617409|42095619|FG001|Overall Study|Adverse Event|2|||
19646230|NCT00617409|42095620|FG002|Overall Study|Adverse Event|3|||
19646231|NCT00617409|42095618|FG000|Overall Study|Disease Progression|8|||
19646232|NCT00617409|42095619|FG001|Overall Study|Disease Progression|8|||
19646233|NCT00617409|42095620|FG002|Overall Study|Disease Progression|18|||
19646234|NCT00617409|42095618|FG000|Overall Study|Death|3|||
19646235|NCT00617409|42095619|FG001|Overall Study|Death|5|||
19646236|NCT00617409|42095620|FG002|Overall Study|Death|4|||
19646237|NCT00617409|42095618|FG000|Overall Study|Alternative Therapy|1|||
19646238|NCT00617409|42095619|FG001|Overall Study|Alternative Therapy|2|||
19646239|NCT00617409|42095620|FG002|Overall Study|Alternative Therapy|0|||
19646240|NCT00695318|42095631|FG000|Overall Study|Lost to Follow-up|1|||
19646241|NCT00695318|42095632|FG001|Overall Study|Lost to Follow-up|0|||
19646242|NCT00695318|42095631|FG000|Overall Study|Withdrawal by Subject|2|||
19646243|NCT00695318|42095632|FG001|Overall Study|Withdrawal by Subject|0|||
19646244|NCT00695318|42095631|FG000|Overall Study|Death|1|||
19646245|NCT00695318|42095632|FG001|Overall Study|Death|1|||
19646246|NCT00695318|42095631|FG000|Overall Study|Study Terminated|1|||
19646247|NCT00695318|42095632|FG001|Overall Study|Study Terminated|0|||
19646248|NCT00386425|42095646|FG000|Overall Study|Physician Decision|3|||
19646249|NCT00386425|42095647|FG001|Overall Study|Physician Decision|0|||
19646250|NCT00386425|42095648|FG002|Overall Study|Physician Decision|0|||
19646251|NCT00386425|42095646|FG000|Overall Study|Withdrawal by Subject|0|||
19646252|NCT00386425|42095647|FG001|Overall Study|Withdrawal by Subject|1|||
19646253|NCT00386425|42095648|FG002|Overall Study|Withdrawal by Subject|0|||
19646254|NCT00694304|42095660|FG000|Overall Study|Adverse Event|42|||
19646255|NCT00694304|42095660|FG000|Overall Study|Lack of Efficacy|35|||
19646256|NCT00694304|42095660|FG000|Overall Study|Non-compliance With Study Product|16|||
19646257|NCT00694304|42095660|FG000|Overall Study|Protocol Violation|6|||
19646258|NCT00694304|42095660|FG000|Overall Study|Withdrawal of Consent|61|||
19646259|NCT00694304|42095660|FG000|Overall Study|Lost to Follow-up|15|||
19646260|NCT00694304|42095660|FG000|Overall Study|Administrative or Other Reasons|32|||
19646261|NCT00371839|42095667|FG000|Overall Study|Death|4|||
19646262|NCT00371839|42095668|FG001|Overall Study|Death|0|||
19646263|NCT00371839|42095669|FG002|Overall Study|Death|0|||
19646264|NCT00371839|42095667|FG000|Overall Study|Withdrawal by Subject|7|||
19646265|NCT00371839|42095668|FG001|Overall Study|Withdrawal by Subject|4|||
19646266|NCT00371839|42095669|FG002|Overall Study|Withdrawal by Subject|0|||
19646267|NCT00371839|42095667|FG000|Overall Study|Lost to Follow-up|6|||
19646268|NCT00371839|42095668|FG001|Overall Study|Lost to Follow-up|3|||
19646269|NCT00371839|42095669|FG002|Overall Study|Lost to Follow-up|2|||
19646270|NCT00682890|42095677|FG000|Overall Study|Lost to Follow-up|1|||
19646271|NCT00682890|42095678|FG001|Overall Study|Lost to Follow-up|1|||
19646272|NCT00682890|42095677|FG000|Overall Study|subject moved away|0|||
19646273|NCT00682890|42095678|FG001|Overall Study|subject moved away|1|||
19646274|NCT00682890|42095677|FG000|Overall Study|heavy menstrual bleeding|1|||
19646275|NCT00682890|42095678|FG001|Overall Study|heavy menstrual bleeding|0|||
19646276|NCT00385723|42095687|FG000|Overall Study|Lost to Follow-up|1|||
19646277|NCT00385723|42095688|FG001|Overall Study|Lost to Follow-up|1|||
19646278|NCT00385723|42095689|FG002|Overall Study|Lost to Follow-up|0|||
19750007|NCT03697993|42198594|FG000|Overall Study|Became Ineligible after Enrollment|1|||
19750008|NCT03697993|42198595|FG001|Overall Study|Became Ineligible after Enrollment|3|||
19646279|NCT00385723|42095687|FG000|Overall Study|Withdrawal by Subject|1|||
19646280|NCT00385723|42095688|FG001|Overall Study|Withdrawal by Subject|0|||
19646281|NCT00385723|42095689|FG002|Overall Study|Withdrawal by Subject|2|||
19646282|NCT00698516|42095697|FG000|Overall Study|Study Termination|2|||
19646283|NCT00698516|42095697|FG000|Overall Study|Withdrawal by Subject|3|||
19646284|NCT00679302|42095707|FG000|Overall Study|Lost to Follow-up|8|||
19646285|NCT00679302|42095708|FG001|Overall Study|Lost to Follow-up|4|||
19646286|NCT00690482|42095737|FG000|Overall Study|Adverse Event|2|||
19646287|NCT00690482|42095738|FG001|Overall Study|Adverse Event|1|||
19646288|NCT00690482|42095737|FG000|Overall Study|Incorrect enrolment|0|||
19646289|NCT00690482|42095738|FG001|Overall Study|Incorrect enrolment|1|||
19646290|NCT00690482|42095737|FG000|Overall Study|Study-specific discontinuation criteria|1|||
19646291|NCT00690482|42095738|FG001|Overall Study|Study-specific discontinuation criteria|0|||
19750009|NCT03697993|42198594|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
19646292|NCT00690482|42095737|FG000|Overall Study|Intake of prohibited medicine|1|||
19646293|NCT00690482|42095738|FG001|Overall Study|Intake of prohibited medicine|0|||
19750010|NCT03697993|42198595|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
19750011|NCT03697993|42198594|FG000|Overall Study|Lost to Follow-up|3|||
19750012|NCT03697993|42198595|FG001|Overall Study|Lost to Follow-up|0|||
19750013|NCT03697993|42198594|FG000|Overall Study|Physician Decision|4|||
19750014|NCT03697993|42198595|FG001|Overall Study|Physician Decision|0|||
19750015|NCT03697993|42198594|FG000|Overall Study|Initial Urine Culture Negative|0|||
19646294|NCT00690482|42095737|FG000|Overall Study|withdrew consent at rand.day|0|||
19646295|NCT00690482|42095738|FG001|Overall Study|withdrew consent at rand.day|1|||
19646296|NCT00385255|42095746|FG000|Overall Study|Serious Adverse Event|1|||
19646297|NCT00385255|42095747|FG001|Overall Study|Serious Adverse Event|2|||
19646298|NCT00385255|42095746|FG000|Overall Study|Protocol Violation|0|||
19646299|NCT00385255|42095747|FG001|Overall Study|Protocol Violation|4|||
19646300|NCT00385255|42095746|FG000|Overall Study|Withdrawal by Subject|0|||
19646301|NCT00385255|42095747|FG001|Overall Study|Withdrawal by Subject|8|||
19646302|NCT00385255|42095746|FG000|Overall Study|Migrated/moved from study area|0|||
19646303|NCT00385255|42095747|FG001|Overall Study|Migrated/moved from study area|1|||
19646304|NCT00385255|42095746|FG000|Overall Study|Lost to Follow-up|20|||
19646305|NCT00385255|42095747|FG001|Overall Study|Lost to Follow-up|58|||
19646306|NCT00571662|42095757|FG000|Overall Study|Withdrawal by Subject|2|||
19646307|NCT00571662|42095757|FG000|Overall Study|psychiatric instability|1|||
19646308|NCT00571662|42095757|FG000|Overall Study|Adverse Event|5|||
19646309|NCT00698204|42095765|FG000|Overall Study|Withdrawal by Subject|1|||
19646310|NCT00698204|42095766|FG001|Overall Study|Withdrawal by Subject|0|||
19646311|NCT00549718|42095778|FG000|Overall Study|Insufficient clinical response|20|||
19750016|NCT03697993|42198595|FG001|Overall Study|Initial Urine Culture Negative|1|||
19750017|NCT03289455|42198605|FG000|Overall Study|Death|1|||
19646312|NCT00549718|42095779|FG001|Overall Study|Insufficient clinical response|7|||
19646313|NCT00549718|42095780|FG002|Overall Study|Insufficient clinical response|18|||
19646314|NCT00549718|42095781|FG003|Overall Study|Insufficient clinical response|32|||
19646315|NCT00549718|42095778|FG000|Overall Study|Adverse Event|6|||
19750018|NCT03289455|42198606|FG001|Overall Study|Death|0|||
19750019|NCT03289455|42198607|FG002|Overall Study|Death|0|||
19750020|NCT03289455|42198605|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
19750021|NCT03289455|42198606|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
19750022|NCT03289455|42198607|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
19750023|NCT03289455|42198605|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
19750024|NCT03289455|42198606|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
19750025|NCT03289455|42198607|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
19750026|NCT03289455|42198605|FG000|Overall Study|Progressive disease|3|||
19750027|NCT03289455|42198606|FG001|Overall Study|Progressive disease|4|||
19750028|NCT03289455|42198607|FG002|Overall Study|Progressive disease|5|||
19750029|NCT04484857|42198616|FG000|Overall Study|Adverse Event|2|||
19750030|NCT04484857|42198616|FG000|Overall Study|Death|10|||
19750031|NCT04484857|42198616|FG000|Overall Study|Withdrawal by Subject|3|||
19646316|NCT00549718|42095779|FG001|Overall Study|Adverse Event|8|||
19646317|NCT00549718|42095780|FG002|Overall Study|Adverse Event|7|||
19646318|NCT00549718|42095781|FG003|Overall Study|Adverse Event|3|||
19646319|NCT00549718|42095778|FG000|Overall Study|Lost to Follow-up|4|||
19750032|NCT04484857|42198616|FG000|Overall Study|Transferred/Relocation|5|||
19750033|NCT04484857|42198616|FG000|Overall Study|Kidney Transplant|7|||
19750034|NCT04484857|42198616|FG000|Overall Study|Other than specified|4|||
19750035|NCT04484857|42198616|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
19750036|NCT04095793|42198620|FG000|Overall Study|Adverse Event|3|||
19750037|NCT04095793|42198620|FG000|Overall Study|Study Terminated by Sponsor|103|||
19646320|NCT00549718|42095779|FG001|Overall Study|Lost to Follow-up|2|||
19646321|NCT00549718|42095780|FG002|Overall Study|Lost to Follow-up|0|||
19646322|NCT00549718|42095781|FG003|Overall Study|Lost to Follow-up|6|||
19646323|NCT00549718|42095778|FG000|Overall Study|Withdrawal by Subject|9|||
19646324|NCT00549718|42095779|FG001|Overall Study|Withdrawal by Subject|18|||
19646325|NCT00549718|42095780|FG002|Overall Study|Withdrawal by Subject|12|||
19646326|NCT00549718|42095781|FG003|Overall Study|Withdrawal by Subject|13|||
19646327|NCT00549718|42095778|FG000|Overall Study|Administrative|2|||
19646328|NCT00549718|42095779|FG001|Overall Study|Administrative|2|||
19646329|NCT00549718|42095780|FG002|Overall Study|Administrative|2|||
19646330|NCT00549718|42095781|FG003|Overall Study|Administrative|1|||
19646331|NCT00371761|42095793|FG000|Overall Study|Adverse Event|1|||
19646332|NCT00371761|42095794|FG001|Overall Study|Adverse Event|1|||
19646333|NCT00371761|42095793|FG000|Overall Study|Withdrawal by Subject|1|||
19646334|NCT00371761|42095794|FG001|Overall Study|Withdrawal by Subject|3|||
19646335|NCT00371761|42095793|FG000|Overall Study|Investigator Judgment|2|||
19646336|NCT00371761|42095794|FG001|Overall Study|Investigator Judgment|3|||
19646337|NCT00371761|42095793|FG000|Overall Study|Study termination|4|||
19646338|NCT00371761|42095794|FG001|Overall Study|Study termination|3|||
19646339|NCT00549640|42095802|FG000|Overall Study|Withdrawal by Subject|6|||
19646340|NCT00549640|42095803|FG001|Overall Study|Withdrawal by Subject|12|||
19646341|NCT00549640|42095802|FG000|Overall Study|Adverse Event|5|||
19646342|NCT00549640|42095803|FG001|Overall Study|Adverse Event|0|||
19646343|NCT00549640|42095802|FG000|Overall Study|Lost to Follow-up|7|||
19646344|NCT00549640|42095803|FG001|Overall Study|Lost to Follow-up|4|||
19646345|NCT00549562|42095825|FG000|Overall Study|Adverse Event|1|||
19646346|NCT00549562|42095825|FG000|Overall Study|Lack of Efficacy|1|||
19646347|NCT00681564|42095831|FG000|Overall Study|Lost to Follow-up|6|||
19646348|NCT00681564|42095832|FG001|Overall Study|Lost to Follow-up|6|||
19646349|NCT00681564|42095831|FG000|Overall Study|Withdrawal by Subject|0|||
19646350|NCT00681564|42095832|FG001|Overall Study|Withdrawal by Subject|1|||
19646351|NCT00681564|42095831|FG000|Overall Study|Death|0|||
19646352|NCT00681564|42095832|FG001|Overall Study|Death|1|||
19646353|NCT00677352|42095840|FG000|Treatment Phase|Adverse Event|14|||
19646354|NCT00677352|42095841|FG001|Treatment Phase|Adverse Event|22|||
19750038|NCT04095793|42198620|FG000|Overall Study|Withdrawal by Subject|4|||
19750039|NCT04482439|42198624|FG000|Overall Study|Lost to Follow-up|1|||
19646355|NCT00677352|42095840|FG000|Treatment Phase|Lack of Efficacy|2|||
19646356|NCT00677352|42095841|FG001|Treatment Phase|Lack of Efficacy|3|||
19646357|NCT00677352|42095840|FG000|Treatment Phase|Lost to Follow-up|0|||
19646358|NCT00677352|42095841|FG001|Treatment Phase|Lost to Follow-up|1|||
19646359|NCT00677352|42095840|FG000|Treatment Phase|Withdrawal by Subject|7|||
19646360|NCT00677352|42095841|FG001|Treatment Phase|Withdrawal by Subject|7|||
19646361|NCT00677352|42095840|FG000|Treatment Phase|Physician Decision|1|||
19646362|NCT00677352|42095841|FG001|Treatment Phase|Physician Decision|0|||
19646363|NCT00677352|42095840|FG000|Treatment Phase|Pregnancy|0|||
19646364|NCT00677352|42095841|FG001|Treatment Phase|Pregnancy|1|||
19646365|NCT00677352|42095840|FG000|Treatment Phase|Protocol Violation|1|||
19750040|NCT04482439|42198624|FG000|Overall Study|Unrelated illness|1|||
19750041|NCT04535947|42198631|FG000|Overall Study|Adverse Event|1|||
19750042|NCT04535947|42198632|FG001|Overall Study|Adverse Event|4|||
19646366|NCT00677352|42095841|FG001|Treatment Phase|Protocol Violation|1|||
19750043|NCT04535947|42198631|FG000|Overall Study|Other reasons not specified|2|||
19750044|NCT04535947|42198632|FG001|Overall Study|Other reasons not specified|0|||
19750045|NCT04535947|42198631|FG000|Overall Study|Withdrawal by Subject|1|||
19750046|NCT04535947|42198632|FG001|Overall Study|Withdrawal by Subject|1|||
19750047|NCT04474405|42198644|FG000|Overall Study|Withdrawal by Subject|0|||
19750048|NCT04474405|42198645|FG001|Overall Study|Withdrawal by Subject|0|||
19750049|NCT04474405|42198646|FG002|Overall Study|Withdrawal by Subject|1|||
19750050|NCT04474405|42198647|FG003|Overall Study|Withdrawal by Subject|0|||
19750051|NCT04474405|42198648|FG004|Overall Study|Withdrawal by Subject|1|||
19750052|NCT04474405|42198649|FG005|Overall Study|Withdrawal by Subject|0|||
19750053|NCT04474405|42198644|FG000|Overall Study|Other|0|||
19750054|NCT04474405|42198645|FG001|Overall Study|Other|0|||
19750055|NCT04474405|42198646|FG002|Overall Study|Other|0|||
19750056|NCT04474405|42198647|FG003|Overall Study|Other|0|||
19750057|NCT04474405|42198648|FG004|Overall Study|Other|3|||
19750058|NCT04474405|42198649|FG005|Overall Study|Other|0|||
19750059|NCT04531813|42198663|FG000|Overall Study|Protocol Violation|1|||
19750060|NCT04531813|42198663|FG000|Overall Study|Withdrawal by Subject|1|||
19750061|NCT03538444|42198669|FG000|Overall Study|opioid withdrawal|1|||
19750062|NCT03538444|42198670|FG001|Overall Study|opioid withdrawal|0|||
19646367|NCT00677352|42095840|FG000|Treatment Phase|Transference or work related matter|0|||
19646368|NCT00677352|42095841|FG001|Treatment Phase|Transference or work related matter|5|||
19646369|NCT00677352|42095840|FG000|Treatment Phase|Not treated|0|||
19646370|NCT00677352|42095841|FG001|Treatment Phase|Not treated|2|||
19750063|NCT01199302|42198680|FG000|Overall Study|Adverse Event|1|||
19750064|NCT01199302|42198681|FG001|Overall Study|Adverse Event|1|||
19750065|NCT01199302|42198682|FG002|Overall Study|Adverse Event|2|||
19750066|NCT01199302|42198683|FG003|Overall Study|Adverse Event|0|||
19646371|NCT00677352|42095840|FG000|Tapering Phase|Adverse Event|1|||
19646372|NCT00677352|42095841|FG001|Tapering Phase|Adverse Event|5|||
19646373|NCT00677352|42095840|FG000|Tapering Phase|Withdrawal by Subject|5|||
19646374|NCT00677352|42095841|FG001|Tapering Phase|Withdrawal by Subject|3|||
19646375|NCT00677352|42095840|FG000|Tapering Phase|Pregnancy|0|||
19646376|NCT00677352|42095841|FG001|Tapering Phase|Pregnancy|1|||
19646377|NCT00677352|42095840|FG000|Tapering Phase|Job transfer|0|||
19646378|NCT00677352|42095841|FG001|Tapering Phase|Job transfer|1|||
19646379|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|Death|1|||
19646380|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|Death|1|||
19646381|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
19646382|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
19646383|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
19646384|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
19646385|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
19646386|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
19646387|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
19646388|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
19646389|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
19646390|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
19646391|NCT00371683|42095854|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
19646392|NCT00371683|42095855|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
19646393|NCT00371683|42095854|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
19646394|NCT00371683|42095855|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
19646395|NCT00371683|42095854|FG000|Follow-Up Period - Randomized Patients|Death|0|||
19646396|NCT00371683|42095855|FG001|Follow-Up Period - Randomized Patients|Death|2|||
19646397|NCT00371683|42095854|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
19646398|NCT00371683|42095855|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
19646399|NCT00371683|42095854|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
19750067|NCT01199302|42198680|FG000|Overall Study|Withdrawal by Subject|2|||
19750068|NCT01199302|42198681|FG001|Overall Study|Withdrawal by Subject|2|||
19646400|NCT00371683|42095855|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
19646401|NCT03951766|42095871|FG000|Treatment Phase|Lost to Follow-up|1|||
19646402|NCT03951766|42095871|FG000|Follow-up Phase|Lost to Follow-up|10|||
19646403|NCT00371137|42095880|FG000|Overall Study|Adverse Event|20|||
19750069|NCT01199302|42198682|FG002|Overall Study|Withdrawal by Subject|3|||
19750070|NCT01199302|42198683|FG003|Overall Study|Withdrawal by Subject|0|||
19750071|NCT01199302|42198680|FG000|Overall Study|Disease Progression|3|||
19646404|NCT00371137|42095881|FG001|Overall Study|Adverse Event|35|||
19750072|NCT01199302|42198681|FG001|Overall Study|Disease Progression|4|||
19750073|NCT01199302|42198682|FG002|Overall Study|Disease Progression|4|||
19646405|NCT00371137|42095882|FG002|Overall Study|Adverse Event|42|||
19646406|NCT00371137|42095880|FG000|Overall Study|Withdrawal by Subject|11|||
19646407|NCT00371137|42095881|FG001|Overall Study|Withdrawal by Subject|10|||
19646408|NCT00371137|42095882|FG002|Overall Study|Withdrawal by Subject|15|||
19646409|NCT00371137|42095880|FG000|Overall Study|Lost to Follow-up|6|||
19646410|NCT00371137|42095881|FG001|Overall Study|Lost to Follow-up|3|||
19646411|NCT00371137|42095882|FG002|Overall Study|Lost to Follow-up|5|||
19646412|NCT00371137|42095880|FG000|Overall Study|Lack of Efficacy|30|||
19646413|NCT00371137|42095881|FG001|Overall Study|Lack of Efficacy|12|||
19646414|NCT00371137|42095882|FG002|Overall Study|Lack of Efficacy|13|||
19646415|NCT00371137|42095880|FG000|Overall Study|Sponsor Decision|2|||
19646416|NCT00371137|42095881|FG001|Overall Study|Sponsor Decision|1|||
19646417|NCT00371137|42095882|FG002|Overall Study|Sponsor Decision|2|||
19646418|NCT00371137|42095880|FG000|Overall Study|Physician Decision|1|||
19646419|NCT00371137|42095881|FG001|Overall Study|Physician Decision|1|||
19646420|NCT00371137|42095882|FG002|Overall Study|Physician Decision|1|||
19646421|NCT00371137|42095880|FG000|Overall Study|Protocol Violation|2|||
19646422|NCT00371137|42095881|FG001|Overall Study|Protocol Violation|1|||
19646423|NCT00371137|42095882|FG002|Overall Study|Protocol Violation|1|||
19646424|NCT00616239|42095890|FG000|Overall Study|Withdrawal by Subject|2|||
19646425|NCT00547534|42095894|FG000|Overall Study|Adverse Event|7|||
19646426|NCT00547534|42095894|FG000|Overall Study|Disease Progression|4|||
19477070|NCT01487161|41755908|FG000|Overall Study|Withdrawal by Subject|1|||
19477071|NCT01487161|41755909|FG001|Overall Study|Withdrawal by Subject|1|||
19477072|NCT01487161|41755910|FG002|Overall Study|Withdrawal by Subject|1|||
19477073|NCT01487161|41755911|FG003|Overall Study|Withdrawal by Subject|2|||
19477074|NCT01487161|41755908|FG000|Overall Study|missing data|0|||
19477075|NCT01487161|41755909|FG001|Overall Study|missing data|1|||
19477076|NCT01487161|41755910|FG002|Overall Study|missing data|0|||
19477077|NCT01487161|41755911|FG003|Overall Study|missing data|0|||
19477078|NCT01491035|41755966|FG000|Overall Study|Lost to Follow-up|0|||
19646427|NCT00384397|42095902|FG000|Overall Study|Adverse Event|0|||
19646428|NCT00384397|42095903|FG001|Overall Study|Adverse Event|1|||
19646429|NCT00384397|42095904|FG002|Overall Study|Adverse Event|2|||
19646430|NCT00384397|42095902|FG000|Overall Study|Protocol Violation|7|||
19646431|NCT00384397|42095903|FG001|Overall Study|Protocol Violation|15|||
19646432|NCT00384397|42095904|FG002|Overall Study|Protocol Violation|13|||
19646433|NCT00384397|42095902|FG000|Overall Study|Lost to Follow-up|11|||
19646434|NCT00384397|42095903|FG001|Overall Study|Lost to Follow-up|13|||
19646435|NCT00384397|42095904|FG002|Overall Study|Lost to Follow-up|3|||
19646436|NCT00384397|42095902|FG000|Overall Study|Withdrawal by Subject|14|||
19646437|NCT00384397|42095903|FG001|Overall Study|Withdrawal by Subject|17|||
19646438|NCT00384397|42095904|FG002|Overall Study|Withdrawal by Subject|15|||
19646439|NCT00384085|42095915|FG000|Overall Study|Adverse Event|5|||
19646440|NCT00384085|42095916|FG001|Overall Study|Adverse Event|5|||
19646441|NCT00384085|42095917|FG002|Overall Study|Adverse Event|4|||
19646442|NCT00384085|42095915|FG000|Overall Study|Lack of Efficacy|0|||
19646443|NCT00384085|42095916|FG001|Overall Study|Lack of Efficacy|3|||
19646444|NCT00384085|42095917|FG002|Overall Study|Lack of Efficacy|2|||
19646445|NCT00384085|42095915|FG000|Overall Study|No longer Requires Study Treatment|1|||
19646446|NCT00384085|42095916|FG001|Overall Study|No longer Requires Study Treatment|0|||
19646447|NCT00384085|42095917|FG002|Overall Study|No longer Requires Study Treatment|1|||
19646448|NCT00384085|42095915|FG000|Overall Study|Protocol Violation|2|||
19646449|NCT00384085|42095916|FG001|Overall Study|Protocol Violation|2|||
19646450|NCT00384085|42095917|FG002|Overall Study|Protocol Violation|2|||
19750074|NCT01199302|42198683|FG003|Overall Study|Disease Progression|2|||
19750075|NCT01199302|42198680|FG000|Overall Study|Study Termination|13|||
19750076|NCT01199302|42198681|FG001|Overall Study|Study Termination|8|||
19750077|NCT01199302|42198682|FG002|Overall Study|Study Termination|11|||
19750078|NCT01199302|42198683|FG003|Overall Study|Study Termination|9|||
19750079|NCT01199302|42198680|FG000|Overall Study|Lost to Follow-up|0|||
19646451|NCT00384085|42095915|FG000|Overall Study|Lost to Follow-up|9|||
19646452|NCT00384085|42095916|FG001|Overall Study|Lost to Follow-up|9|||
19750080|NCT01199302|42198681|FG001|Overall Study|Lost to Follow-up|1|||
19477079|NCT01491035|41755967|FG001|Overall Study|Lost to Follow-up|0|||
19646453|NCT00384085|42095917|FG002|Overall Study|Lost to Follow-up|10|||
19646454|NCT00384085|42095915|FG000|Overall Study|Progressive Disease|0|||
19646455|NCT00384085|42095916|FG001|Overall Study|Progressive Disease|1|||
19646456|NCT00384085|42095917|FG002|Overall Study|Progressive Disease|0|||
19646457|NCT00384085|42095915|FG000|Overall Study|Withdrawal by Subject|14|||
19646458|NCT00384085|42095916|FG001|Overall Study|Withdrawal by Subject|19|||
19646459|NCT00384085|42095917|FG002|Overall Study|Withdrawal by Subject|29|||
19646460|NCT00384085|42095915|FG000|Overall Study|Patient non-compliant|4|||
19750081|NCT01199302|42198682|FG002|Overall Study|Lost to Follow-up|0|||
19646461|NCT00384085|42095916|FG001|Overall Study|Patient non-compliant|4|||
19646462|NCT00384085|42095917|FG002|Overall Study|Patient non-compliant|5|||
19646463|NCT00384085|42095915|FG000|Overall Study|Physician Decision|1|||
19646464|NCT00384085|42095916|FG001|Overall Study|Physician Decision|0|||
19646465|NCT00384085|42095917|FG002|Overall Study|Physician Decision|0|||
19646466|NCT00384085|42095915|FG000|Overall Study|Loss of site personnel|1|||
19646467|NCT00384085|42095916|FG001|Overall Study|Loss of site personnel|0|||
19646468|NCT00384085|42095917|FG002|Overall Study|Loss of site personnel|1|||
19600833|NCT01072175|42049722|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
19600834|NCT01072175|42049723|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
19600835|NCT01072175|42049711|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600836|NCT01072175|42049712|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19646469|NCT00384085|42095915|FG000|Overall Study|Sponsor decision|1|||
19646470|NCT00384085|42095916|FG001|Overall Study|Sponsor decision|2|||
19646471|NCT00384085|42095917|FG002|Overall Study|Sponsor decision|1|||
19600837|NCT01072175|42049713|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
19646472|NCT00384085|42095915|FG000|Overall Study|Patient moved|1|||
19646473|NCT00384085|42095916|FG001|Overall Study|Patient moved|0|||
19646474|NCT00384085|42095917|FG002|Overall Study|Patient moved|1|||
19646475|NCT00384085|42095915|FG000|Overall Study|Patient required surgery|0|||
19646476|NCT00384085|42095916|FG001|Overall Study|Patient required surgery|1|||
19646477|NCT00384085|42095917|FG002|Overall Study|Patient required surgery|0|||
19646478|NCT00361231|42095927|FG000|Overall Study|Physician Decision|3|||
19646479|NCT00361231|42095927|FG000|Overall Study|Symptomatic deterioration|5|||
19646480|NCT00361231|42095927|FG000|Overall Study|Radiographic disease progression|16|||
19646481|NCT00361231|42095927|FG000|Overall Study|Withdrawal by Subject|4|||
19646482|NCT00361231|42095927|FG000|Overall Study|Adverse Event|6|||
19646483|NCT00676650|42095933|FG000|Overall Study|Death|45|||
19646484|NCT00676650|42095934|FG001|Overall Study|Death|14|||
19646485|NCT00676650|42095933|FG000|Overall Study|Adverse Event|159|||
19646486|NCT00676650|42095934|FG001|Overall Study|Adverse Event|21|||
19646487|NCT00676650|42095933|FG000|Overall Study|Global deterioration of health status|66|||
19646488|NCT00676650|42095934|FG001|Overall Study|Global deterioration of health status|31|||
19646489|NCT00676650|42095933|FG000|Overall Study|Lost to Follow-up|0|||
19646490|NCT00676650|42095934|FG001|Overall Study|Lost to Follow-up|1|||
19646491|NCT00676650|42095933|FG000|Overall Study|Objective progression or relapse|189|||
19646492|NCT00676650|42095934|FG001|Overall Study|Objective progression or relapse|140|||
19646493|NCT00676650|42095933|FG000|Overall Study|Other|14|||
19646494|NCT00676650|42095934|FG001|Overall Study|Other|10|||
19646495|NCT00676650|42095933|FG000|Overall Study|Protocol Violation|3|||
19646496|NCT00676650|42095934|FG001|Overall Study|Protocol Violation|1|||
19646497|NCT00676650|42095933|FG000|Overall Study|Study terminated by sponsor|57|||
19646498|NCT00676650|42095934|FG001|Overall Study|Study terminated by sponsor|43|||
19646499|NCT00676650|42095933|FG000|Overall Study|Withdrawal by Subject|48|||
19646500|NCT00676650|42095934|FG001|Overall Study|Withdrawal by Subject|24|||
19646501|NCT00676650|42095933|FG000|Overall Study|Randomized but not treated|3|||
19646502|NCT00676650|42095934|FG001|Overall Study|Randomized but not treated|4|||
19646503|NCT00573183|42095942|FG000|Overall Study|Lost to Follow-up|52|||
19750082|NCT01199302|42198683|FG003|Overall Study|Lost to Follow-up|0|||
19600838|NCT01072175|42049714|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600839|NCT01072175|42049715|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
19600840|NCT01072175|42049716|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600841|NCT01072175|42049717|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600842|NCT01072175|42049718|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600843|NCT01072175|42049719|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19646504|NCT00573183|42095943|FG001|Overall Study|Lost to Follow-up|50|||
19646505|NCT00573183|42095942|FG000|Overall Study|Withdrawal by Subject|8|||
19646506|NCT00573183|42095943|FG001|Overall Study|Withdrawal by Subject|2|||
19646507|NCT00573183|42095942|FG000|Overall Study|Death|0|||
19646508|NCT00573183|42095943|FG001|Overall Study|Death|1|||
19646509|NCT00573183|42095942|FG000|Overall Study|Adverse Event|2|||
19646510|NCT00573183|42095943|FG001|Overall Study|Adverse Event|0|||
19646511|NCT00573183|42095942|FG000|Overall Study|Incarceration|5|||
19646512|NCT00573183|42095943|FG001|Overall Study|Incarceration|8|||
19646513|NCT00573183|42095942|FG000|Overall Study|Other|5|||
19646514|NCT00573183|42095943|FG001|Overall Study|Other|2|||
19646515|NCT00615459|42095951|FG000|Period I|Adverse Event|2|||
19646516|NCT00615459|42095952|FG001|Period I|Adverse Event|0|||
19646517|NCT00615459|42095953|FG002|Period I|Adverse Event|1|||
19646518|NCT00615459|42095954|FG003|Period I|Adverse Event|0|||
19646519|NCT00615459|42095951|FG000|Period I|Subject withdrew consent|1|||
19646520|NCT00615459|42095952|FG001|Period I|Subject withdrew consent|0|||
19646521|NCT00615459|42095953|FG002|Period I|Subject withdrew consent|0|||
19646522|NCT00615459|42095954|FG003|Period I|Subject withdrew consent|1|||
19646523|NCT00615459|42095951|FG000|Period I|Abnormal test procedure results|1|||
19646524|NCT00615459|42095952|FG001|Period I|Abnormal test procedure results|1|||
19646525|NCT00615459|42095953|FG002|Period I|Abnormal test procedure results|1|||
19646526|NCT00615459|42095954|FG003|Period I|Abnormal test procedure results|0|||
19646527|NCT00615459|42095951|FG000|Period II|Adverse Event|1|||
19646528|NCT00615459|42095952|FG001|Period II|Adverse Event|0|||
19646529|NCT00615459|42095953|FG002|Period II|Adverse Event|0|||
19646530|NCT00615459|42095954|FG003|Period II|Adverse Event|0|||
19646531|NCT00615459|42095951|FG000|Period II|Lost to Follow-up|0|||
19646532|NCT00615459|42095952|FG001|Period II|Lost to Follow-up|0|||
19646533|NCT00615459|42095953|FG002|Period II|Lost to Follow-up|0|||
19646534|NCT00615459|42095954|FG003|Period II|Lost to Follow-up|1|||
19646535|NCT00615459|42095951|FG000|Period III|Adverse Event|0|||
19646536|NCT00615459|42095952|FG001|Period III|Adverse Event|1|||
19646537|NCT00615459|42095953|FG002|Period III|Adverse Event|0|||
19646538|NCT00615459|42095954|FG003|Period III|Adverse Event|0|||
19646539|NCT00615459|42095951|FG000|Period III|Administrative problems|0|||
19646540|NCT00615459|42095952|FG001|Period III|Administrative problems|1|||
19646541|NCT00615459|42095953|FG002|Period III|Administrative problems|1|||
19646542|NCT00615459|42095954|FG003|Period III|Administrative problems|0|||
19646543|NCT00615459|42095951|FG000|Period III|Unsatisfactory therapeutic effect|0|||
19646544|NCT00615459|42095952|FG001|Period III|Unsatisfactory therapeutic effect|1|||
19646545|NCT00615459|42095953|FG002|Period III|Unsatisfactory therapeutic effect|0|||
19646546|NCT00615459|42095954|FG003|Period III|Unsatisfactory therapeutic effect|0|||
19646547|NCT00383149|42095968|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
19646548|NCT00383149|42095968|FG000|Overall Study|Death|2|||
19646549|NCT00383149|42095968|FG000|Overall Study|Disease Progression|38|||
19646550|NCT00383149|42095968|FG000|Overall Study|Lost to Follow-up|1|||
19646551|NCT00383149|42095968|FG000|Overall Study|Other|1|||
19646552|NCT00383149|42095968|FG000|Overall Study|Study Drug Toxicity|4|||
19646553|NCT00383149|42095968|FG000|Overall Study|Request to Discontinue Treatment|4|||
19646554|NCT00383149|42095968|FG000|Overall Study|Participant Withdrew Consent|1|||
19646555|NCT00382993|42095974|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
19646556|NCT00382993|42095975|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
19646557|NCT00382993|42095974|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
19646558|NCT00382993|42095975|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
19646559|NCT00382993|42095974|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
19646560|NCT00382993|42095975|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
19646561|NCT00382993|42095974|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
19646562|NCT00382993|42095975|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
19646563|NCT00382993|42095974|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
19646564|NCT00382993|42095975|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
19646565|NCT00382993|42095974|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
19646566|NCT00382993|42095975|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
19646567|NCT00382993|42095974|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
19646568|NCT00382993|42095975|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
19646569|NCT00382993|42095974|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
19646570|NCT00382993|42095975|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
19646571|NCT00382993|42095974|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
19646572|NCT00382993|42095975|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
19646573|NCT00382993|42095974|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
19646574|NCT00382993|42095975|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
19646575|NCT00369967|42095983|FG000|Overall Study|Lost to Follow-up|23|||
19646576|NCT00369967|42095984|FG001|Overall Study|Lost to Follow-up|12|||
19646577|NCT00616629|42095999|FG000|Overall Study|Protocol Violation|1|||
19646578|NCT00616629|42096000|FG001|Overall Study|Protocol Violation|2|||
19646579|NCT00616629|42096001|FG002|Overall Study|Protocol Violation|1|||
19646580|NCT00616629|42096002|FG003|Overall Study|Protocol Violation|0|||
19646581|NCT00616629|42096003|FG004|Overall Study|Protocol Violation|0|||
19646582|NCT00616629|42095999|FG000|Overall Study|AV-block|1|||
19646583|NCT00616629|42096000|FG001|Overall Study|AV-block|0|||
19646584|NCT00616629|42096001|FG002|Overall Study|AV-block|0|||
19646585|NCT00616629|42096002|FG003|Overall Study|AV-block|0|||
19646586|NCT00616629|42096003|FG004|Overall Study|AV-block|0|||
19698945|NCT00312494|42143769|FG002|Overall Study|Adverse Event|11|||
19646587|NCT00369655|42096015|FG000|Overall Study|Refusal of further treatment|2|||
19646588|NCT00615069|42096019|FG000|Overall Study|Death|10|||
19646589|NCT00615069|42096019|FG000|Overall Study|Physician Decision|2|||
19646590|NCT00615069|42096019|FG000|Overall Study|Withdrawal by Subject|4|||
19646591|NCT00676338|42096027|FG000|Overall Study|Adverse Event|6|||
19646592|NCT00676338|42096028|FG001|Overall Study|Adverse Event|6|||
19646593|NCT00676338|42096029|FG002|Overall Study|Adverse Event|5|||
19646594|NCT00676338|42096030|FG003|Overall Study|Adverse Event|1|||
19646595|NCT00676338|42096027|FG000|Overall Study|Lost to Follow-up|4|||
19646596|NCT00676338|42096028|FG001|Overall Study|Lost to Follow-up|1|||
19646597|NCT00676338|42096029|FG002|Overall Study|Lost to Follow-up|3|||
19646598|NCT00676338|42096030|FG003|Overall Study|Lost to Follow-up|4|||
19646599|NCT00676338|42096027|FG000|Overall Study|Physician Decision|3|||
19646600|NCT00676338|42096028|FG001|Overall Study|Physician Decision|3|||
19646601|NCT00676338|42096029|FG002|Overall Study|Physician Decision|2|||
19646602|NCT00676338|42096030|FG003|Overall Study|Physician Decision|3|||
19646603|NCT00676338|42096027|FG000|Overall Study|Protocol Violation|5|||
19646604|NCT00676338|42096028|FG001|Overall Study|Protocol Violation|9|||
19646605|NCT00676338|42096029|FG002|Overall Study|Protocol Violation|2|||
19646606|NCT00676338|42096030|FG003|Overall Study|Protocol Violation|5|||
19646607|NCT00676338|42096027|FG000|Overall Study|Withdrawal by Subject|17|||
19646608|NCT00676338|42096028|FG001|Overall Study|Withdrawal by Subject|9|||
19646609|NCT00676338|42096029|FG002|Overall Study|Withdrawal by Subject|12|||
19646610|NCT00676338|42096030|FG003|Overall Study|Withdrawal by Subject|6|||
19646611|NCT00676338|42096027|FG000|Overall Study|Entry Criteria Not Met|0|||
19646612|NCT00676338|42096028|FG001|Overall Study|Entry Criteria Not Met|2|||
19646613|NCT00676338|42096029|FG002|Overall Study|Entry Criteria Not Met|1|||
19646614|NCT00676338|42096030|FG003|Overall Study|Entry Criteria Not Met|1|||
19646615|NCT00676338|42096027|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
19646616|NCT00676338|42096028|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
19646617|NCT00676338|42096029|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
19646618|NCT00676338|42096030|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
19646619|NCT00382291|42096043|FG000|Overall Study|Adverse Event|1|||
19750083|NCT01199302|42198680|FG000|Overall Study|Other|1|||
19750084|NCT01199302|42198681|FG001|Overall Study|Other|0|||
19750085|NCT01199302|42198682|FG002|Overall Study|Other|0|||
19750086|NCT01199302|42198683|FG003|Overall Study|Other|0|||
19750087|NCT03332784|42198710|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750088|NCT03332784|42198711|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
19750089|NCT03332784|42198712|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750090|NCT03332784|42198713|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750091|NCT03332784|42198714|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750092|NCT03332784|42198715|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750093|NCT03332784|42198716|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750094|NCT03332784|42198717|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19646620|NCT00382291|42096044|FG001|Overall Study|Adverse Event|2|||
19646621|NCT00382291|42096045|FG002|Overall Study|Adverse Event|2|||
19646622|NCT00382291|42096043|FG000|Overall Study|Protocol Violation|1|||
19646623|NCT00382291|42096044|FG001|Overall Study|Protocol Violation|0|||
19646624|NCT00382291|42096045|FG002|Overall Study|Protocol Violation|0|||
19646625|NCT00382291|42096043|FG000|Overall Study|Temporary study suspension|2|||
19646626|NCT00382291|42096044|FG001|Overall Study|Temporary study suspension|2|||
19646627|NCT00382291|42096045|FG002|Overall Study|Temporary study suspension|5|||
19646628|NCT00382291|42096043|FG000|Overall Study|Withdrawal by Subject|0|||
19646629|NCT00382291|42096044|FG001|Overall Study|Withdrawal by Subject|2|||
19646630|NCT00382291|42096045|FG002|Overall Study|Withdrawal by Subject|0|||
19646631|NCT00382291|42096043|FG000|Overall Study|Physician Decision|0|||
19646632|NCT00382291|42096044|FG001|Overall Study|Physician Decision|1|||
19646633|NCT00382291|42096045|FG002|Overall Study|Physician Decision|0|||
19646634|NCT00382291|42096043|FG000|Overall Study|Lack of Efficacy|0|||
19646635|NCT00382291|42096044|FG001|Overall Study|Lack of Efficacy|0|||
19646636|NCT00382291|42096045|FG002|Overall Study|Lack of Efficacy|1|||
19646637|NCT00547378|42096067|FG000|Randomized Cohort|Withdrawal by Subject|7|||
19646638|NCT00547378|42096068|FG001|Randomized Cohort|Withdrawal by Subject|5|||
19646639|NCT00547378|42096069|FG002|Randomized Cohort|Withdrawal by Subject|0|||
19646640|NCT00547378|42096067|FG000|Randomized Cohort|Death|0|||
19750095|NCT03332784|42198718|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750096|NCT03332784|42198719|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750097|NCT03332784|42198720|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19646641|NCT00547378|42096068|FG001|Randomized Cohort|Death|1|||
19646642|NCT00547378|42096069|FG002|Randomized Cohort|Death|0|||
19646643|NCT00547378|42096067|FG000|Randomized Cohort|Lost to Follow-up|1|||
19646644|NCT00547378|42096068|FG001|Randomized Cohort|Lost to Follow-up|0|||
19646645|NCT00547378|42096069|FG002|Randomized Cohort|Lost to Follow-up|0|||
19646646|NCT00547378|42096067|FG000|Randomized Cohort|Adverse Event|1|||
19646647|NCT00547378|42096068|FG001|Randomized Cohort|Adverse Event|0|||
19646648|NCT00547378|42096069|FG002|Randomized Cohort|Adverse Event|0|||
19646649|NCT00547378|42096067|FG000|Randomized Cohort|Other reasons|2|||
19750098|NCT03332784|42198721|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750099|NCT03332784|42198722|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750100|NCT03332784|42198723|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750101|NCT03332784|42198724|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
19646650|NCT00547378|42096068|FG001|Randomized Cohort|Other reasons|0|||
19646651|NCT00547378|42096069|FG002|Randomized Cohort|Other reasons|0|||
19646652|NCT00547378|42096067|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
19646653|NCT00547378|42096068|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
19646654|NCT00547378|42096069|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
19646655|NCT00547378|42096067|FG000|All Implanted Cohort|Adverse Event|4|||
19646656|NCT00547378|42096068|FG001|All Implanted Cohort|Adverse Event|10|||
19646657|NCT00547378|42096069|FG002|All Implanted Cohort|Adverse Event|17|||
19646658|NCT00547378|42096067|FG000|All Implanted Cohort|Lost to Follow-up|0|||
19646659|NCT00547378|42096068|FG001|All Implanted Cohort|Lost to Follow-up|1|||
19646660|NCT00547378|42096069|FG002|All Implanted Cohort|Lost to Follow-up|14|||
19646661|NCT00547378|42096067|FG000|All Implanted Cohort|Death|3|||
19646662|NCT00547378|42096068|FG001|All Implanted Cohort|Death|1|||
19646663|NCT00547378|42096069|FG002|All Implanted Cohort|Death|4|||
19646664|NCT00547378|42096067|FG000|All Implanted Cohort|Physician Decision|0|||
19646665|NCT00547378|42096068|FG001|All Implanted Cohort|Physician Decision|2|||
19646666|NCT00547378|42096069|FG002|All Implanted Cohort|Physician Decision|6|||
19646667|NCT00547378|42096067|FG000|All Implanted Cohort|Site closure|2|||
19646668|NCT00547378|42096068|FG001|All Implanted Cohort|Site closure|0|||
19646669|NCT00547378|42096069|FG002|All Implanted Cohort|Site closure|1|||
19646670|NCT00547378|42096067|FG000|All Implanted Cohort|Other reasons|1|||
19646671|NCT00547378|42096068|FG001|All Implanted Cohort|Other reasons|0|||
19646672|NCT00547378|42096069|FG002|All Implanted Cohort|Other reasons|1|||
19646673|NCT00381043|42096079|FG000|Overall Study|Lost to Follow-up|8|||
19646674|NCT00381043|42096080|FG001|Overall Study|Lost to Follow-up|6|||
19646675|NCT00381043|42096079|FG000|Overall Study|Withdrawal by Subject|3|||
19646676|NCT00381043|42096080|FG001|Overall Study|Withdrawal by Subject|1|||
19646677|NCT00381043|42096079|FG000|Overall Study|wanted more care|0|||
19646678|NCT00381043|42096080|FG001|Overall Study|wanted more care|1|||
19646679|NCT00381043|42096079|FG000|Overall Study|incarcerated|1|||
19646680|NCT00381043|42096080|FG001|Overall Study|incarcerated|0|||
19646681|NCT00614991|42096092|FG000|Overall Study|Adverse Event|3|||
19646682|NCT00614991|42096093|FG001|Overall Study|Adverse Event|3|||
19646683|NCT00614991|42096094|FG002|Overall Study|Adverse Event|0|||
19646684|NCT00614991|42096095|FG003|Overall Study|Adverse Event|0|||
19646685|NCT00614991|42096096|FG004|Overall Study|Adverse Event|1|||
19646686|NCT00614991|42096097|FG005|Overall Study|Adverse Event|0|||
19750102|NCT03332784|42198725|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750103|NCT03332784|42198726|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750104|NCT03332784|42198727|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750105|NCT03332784|42198728|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19750106|NCT03332784|42198729|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
19646687|NCT00360529|42096119|FG000|Overall Study|Adverse Event|10|||
19646688|NCT00360529|42096120|FG001|Overall Study|Adverse Event|23|||
19646689|NCT00360529|42096121|FG002|Overall Study|Adverse Event|33|||
19646690|NCT00360529|42096119|FG000|Overall Study|Protocol Violation|3|||
19646691|NCT00360529|42096120|FG001|Overall Study|Protocol Violation|3|||
19646692|NCT00360529|42096121|FG002|Overall Study|Protocol Violation|11|||
19646693|NCT00360529|42096119|FG000|Overall Study|Lost to Follow-up|14|||
19646694|NCT00360529|42096120|FG001|Overall Study|Lost to Follow-up|10|||
19646695|NCT00360529|42096121|FG002|Overall Study|Lost to Follow-up|13|||
19646696|NCT00360529|42096119|FG000|Overall Study|Withdrawal by Subject|22|||
19646697|NCT00360529|42096120|FG001|Overall Study|Withdrawal by Subject|14|||
19646698|NCT00360529|42096121|FG002|Overall Study|Withdrawal by Subject|18|||
19646699|NCT00360529|42096119|FG000|Overall Study|Lack of Efficacy|8|||
19646700|NCT00360529|42096120|FG001|Overall Study|Lack of Efficacy|6|||
19646701|NCT00360529|42096121|FG002|Overall Study|Lack of Efficacy|5|||
19646702|NCT00360529|42096119|FG000|Overall Study|Reason discontinued not explained above|4|||
19646703|NCT00360529|42096120|FG001|Overall Study|Reason discontinued not explained above|9|||
19646704|NCT00360529|42096121|FG002|Overall Study|Reason discontinued not explained above|11|||
19646705|NCT00369577|42096136|FG000|Overall Study|Withdrawal by Subject|0|||
19646706|NCT00369577|42096137|FG001|Overall Study|Withdrawal by Subject|0|||
19646707|NCT00369577|42096138|FG002|Overall Study|Withdrawal by Subject|1|||
19646708|NCT00678288|42096148|FG000|Overall Study|Adverse Event|0|||
19646709|NCT00678288|42096149|FG001|Overall Study|Adverse Event|2|||
19750107|NCT04465357|42198793|FG000|Overall Study|Adverse Event|2|||
19646710|NCT00678288|42096148|FG000|Overall Study|Withdrawal by Subject|1|||
19646711|NCT00678288|42096149|FG001|Overall Study|Withdrawal by Subject|1|||
19646712|NCT00678288|42096148|FG000|Overall Study|Study terminated by the sponsor|2|||
19646713|NCT00678288|42096149|FG001|Overall Study|Study terminated by the sponsor|0|||
19646714|NCT00678288|42096148|FG000|Overall Study|Not compliant with study medication|0|||
19646715|NCT00678288|42096149|FG001|Overall Study|Not compliant with study medication|1|||
19646716|NCT00678288|42096148|FG000|Overall Study|Switch to commercial drug|0|||
19646717|NCT00678288|42096149|FG001|Overall Study|Switch to commercial drug|1|||
19646718|NCT00678288|42096148|FG000|Overall Study|Reason not reported|1|||
19646719|NCT00678288|42096149|FG001|Overall Study|Reason not reported|0|||
19646720|NCT00678288|42096148|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
19646721|NCT00678288|42096149|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
19646722|NCT00369343|42096157|FG000|Double-blind Phase|Adverse Event|19|||
19646723|NCT00369343|42096158|FG001|Double-blind Phase|Adverse Event|4|||
19646724|NCT00369343|42096157|FG000|Double-blind Phase|Failed to return|2|||
19646725|NCT00369343|42096158|FG001|Double-blind Phase|Failed to return|0|||
19646726|NCT00369343|42096157|FG000|Double-blind Phase|Lost to Follow-up|9|||
19646727|NCT00369343|42096158|FG001|Double-blind Phase|Lost to Follow-up|2|||
19646728|NCT00369343|42096157|FG000|Double-blind Phase|Protocol Violation|2|||
19646729|NCT00369343|42096158|FG001|Double-blind Phase|Protocol Violation|0|||
19646730|NCT00369343|42096157|FG000|Double-blind Phase|Withdrawal by Subject|8|||
19646731|NCT00369343|42096158|FG001|Double-blind Phase|Withdrawal by Subject|6|||
19646732|NCT00369343|42096157|FG000|Double-blind Phase|Lack of Efficacy|0|||
19646733|NCT00369343|42096158|FG001|Double-blind Phase|Lack of Efficacy|4|||
19646734|NCT00369343|42096157|FG000|Double-blind Phase|Protocol deviation|4|||
19646735|NCT00369343|42096158|FG001|Double-blind Phase|Protocol deviation|0|||
19646736|NCT00369343|42096157|FG000|Open-label Phase|Adverse Event|19|||
19646737|NCT00369343|42096158|FG001|Open-label Phase|Adverse Event|7|||
19646738|NCT00369343|42096157|FG000|Open-label Phase|Failed to return|4|||
19646739|NCT00369343|42096158|FG001|Open-label Phase|Failed to return|0|||
19646740|NCT00369343|42096157|FG000|Open-label Phase|Physician Decision|2|||
19646741|NCT00369343|42096158|FG001|Open-label Phase|Physician Decision|0|||
19646742|NCT00369343|42096157|FG000|Open-label Phase|Lost to Follow-up|5|||
19646743|NCT00369343|42096158|FG001|Open-label Phase|Lost to Follow-up|3|||
19646744|NCT00369343|42096157|FG000|Open-label Phase|inadvertently reported study completers|3|||
19646745|NCT00369343|42096158|FG001|Open-label Phase|inadvertently reported study completers|2|||
19646746|NCT00369343|42096157|FG000|Open-label Phase|Protocol Violation|1|||
19646747|NCT00369343|42096158|FG001|Open-label Phase|Protocol Violation|3|||
19646748|NCT00369343|42096157|FG000|Open-label Phase|Withdrawal by Subject|15|||
19646749|NCT00369343|42096158|FG001|Open-label Phase|Withdrawal by Subject|6|||
19646750|NCT00369343|42096157|FG000|Open-label Phase|Lack of Efficacy|4|||
19646751|NCT00369343|42096158|FG001|Open-label Phase|Lack of Efficacy|3|||
19646752|NCT00369343|42096157|FG000|Open-label Phase|Lack of continuance tolerability|3|||
19646753|NCT00369343|42096158|FG001|Open-label Phase|Lack of continuance tolerability|4|||
19646754|NCT00369343|42096157|FG000|Open-label Phase|did not take study drug|1|||
19646755|NCT00369343|42096158|FG001|Open-label Phase|did not take study drug|2|||
19646756|NCT00369265|42096173|FG000|Overall Study|Study terminated|4|||
19646757|NCT00369265|42096174|FG001|Overall Study|Study terminated|7|||
19646758|NCT00368875|42096180|FG000|Overall Study|Adverse Event|0|||
19646759|NCT00368875|42096181|FG001|Overall Study|Adverse Event|12|||
19646760|NCT00368875|42096180|FG000|Overall Study|Progressive disease|3|||
19646761|NCT00368875|42096181|FG001|Overall Study|Progressive disease|27|||
19646762|NCT00368875|42096180|FG000|Overall Study|Withdrawal by Subject|2|||
19646763|NCT00368875|42096181|FG001|Overall Study|Withdrawal by Subject|6|||
19646764|NCT00368875|42096180|FG000|Overall Study|Other Reason|0|||
19646765|NCT00368875|42096181|FG001|Overall Study|Other Reason|2|||
19646766|NCT00368875|42096180|FG000|Overall Study|Alternative Therapy|1|||
19646767|NCT00368875|42096181|FG001|Overall Study|Alternative Therapy|1|||
19646768|NCT00614055|42096190|FG000|Overall Study|Adverse Event|1|||
19646769|NCT00614055|42096191|FG001|Overall Study|Adverse Event|0|||
19646770|NCT00614055|42096192|FG002|Overall Study|Adverse Event|0|||
19646771|NCT00614055|42096190|FG000|Overall Study|Protocol Violation|2|||
19646772|NCT00614055|42096191|FG001|Overall Study|Protocol Violation|2|||
19646773|NCT00614055|42096192|FG002|Overall Study|Protocol Violation|1|||
19646774|NCT00614055|42096190|FG000|Overall Study|Lack of Efficacy|0|||
19646775|NCT00614055|42096191|FG001|Overall Study|Lack of Efficacy|0|||
19646776|NCT00614055|42096192|FG002|Overall Study|Lack of Efficacy|2|||
19646777|NCT00614055|42096190|FG000|Overall Study|Unclassified|1|||
19646778|NCT00614055|42096191|FG001|Overall Study|Unclassified|4|||
19646779|NCT00614055|42096192|FG002|Overall Study|Unclassified|2|||
19646780|NCT00613821|42096205|FG000|Overall Study|Withdrawal by Subject|1|||
19646781|NCT00613821|42096206|FG001|Overall Study|Withdrawal by Subject|0|||
19646782|NCT00613821|42096205|FG000|Overall Study|Physician Decision|1|||
19646783|NCT00613821|42096206|FG001|Overall Study|Physician Decision|1|||
19750108|NCT04465357|42198793|FG000|Overall Study|Lack of Efficacy|1|||
19646784|NCT00548548|42096214|FG000|Overall Study|Death|345|||
19646785|NCT00548548|42096215|FG001|Overall Study|Death|348|||
19646786|NCT00548548|42096214|FG000|Overall Study|Lost to Follow-up|17|||
19646787|NCT00548548|42096215|FG001|Overall Study|Lost to Follow-up|18|||
19646788|NCT00613509|42096223|FG000|Cycle 1|Adverse Event|2|||
19646789|NCT00613509|42096224|FG001|Cycle 1|Adverse Event|1|||
19646790|NCT00613509|42096223|FG000|Cycle 1|Disease Progression|2|||
19646791|NCT00613509|42096224|FG001|Cycle 1|Disease Progression|6|||
19646792|NCT00613509|42096223|FG000|Cycle 1|Unacceptable Toxicity|1|||
19646793|NCT00613509|42096224|FG001|Cycle 1|Unacceptable Toxicity|0|||
19646794|NCT00613509|42096223|FG000|Cycle 1|Other administrative reason|0|||
19646795|NCT00613509|42096224|FG001|Cycle 1|Other administrative reason|1|||
19646796|NCT00547300|42096249|FG000|Overall Study|Study was Administratively Terminated|25|||
19646797|NCT00547300|42096250|FG001|Overall Study|Study was Administratively Terminated|24|||
19646798|NCT00547300|42096249|FG000|Overall Study|Did not Meet Entry Criteria|0|||
19646799|NCT00547300|42096250|FG001|Overall Study|Did not Meet Entry Criteria|2|||
19646800|NCT00612807|42096258|FG000|Overall Study|Withdrawal by Subject|2|||
19646801|NCT00612807|42096259|FG001|Overall Study|Withdrawal by Subject|0|||
19646802|NCT00678210|42096269|FG000|Overall Study|Adverse Event|1|||
19646803|NCT00678210|42096270|FG001|Overall Study|Adverse Event|2|||
19646804|NCT00678210|42096271|FG002|Overall Study|Adverse Event|3|||
19646805|NCT00678210|42096272|FG003|Overall Study|Adverse Event|3|||
19646806|NCT00678210|42096269|FG000|Overall Study|Lack of Efficacy|2|||
19646807|NCT00678210|42096270|FG001|Overall Study|Lack of Efficacy|3|||
19646808|NCT00678210|42096271|FG002|Overall Study|Lack of Efficacy|1|||
19646809|NCT00678210|42096272|FG003|Overall Study|Lack of Efficacy|9|||
19646810|NCT00678210|42096269|FG000|Overall Study|Lost to Follow-up|4|||
19646811|NCT00678210|42096270|FG001|Overall Study|Lost to Follow-up|2|||
19646812|NCT00678210|42096271|FG002|Overall Study|Lost to Follow-up|0|||
19646813|NCT00678210|42096272|FG003|Overall Study|Lost to Follow-up|1|||
19646814|NCT00678210|42096269|FG000|Overall Study|Withdrawal by Subject|3|||
19646815|NCT00678210|42096270|FG001|Overall Study|Withdrawal by Subject|4|||
19646816|NCT00678210|42096271|FG002|Overall Study|Withdrawal by Subject|1|||
19646817|NCT00678210|42096272|FG003|Overall Study|Withdrawal by Subject|7|||
19646818|NCT00678210|42096269|FG000|Overall Study|Other|1|||
19646819|NCT00678210|42096270|FG001|Overall Study|Other|0|||
19646820|NCT00678210|42096271|FG002|Overall Study|Other|1|||
19646821|NCT00678210|42096272|FG003|Overall Study|Other|0|||
19646822|NCT00611715|42096284|FG000|Overall Study|Disease Progression|24|||
19646823|NCT00611715|42096285|FG001|Overall Study|Disease Progression|4|||
19646824|NCT00611715|42096284|FG000|Overall Study|Withdrawal by Subject|5|||
19646825|NCT00611715|42096285|FG001|Overall Study|Withdrawal by Subject|1|||
19646826|NCT00611715|42096284|FG000|Overall Study|Adverse Event|9|||
19646827|NCT00611715|42096285|FG001|Overall Study|Adverse Event|1|||
19646828|NCT00611715|42096284|FG000|Overall Study|Death|1|||
19750109|NCT04465357|42198793|FG000|Overall Study|Lost to Follow-up|2|||
19750110|NCT04465357|42198793|FG000|Overall Study|Withdrawal by Subject|6|||
19750111|NCT04465357|42198793|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
19750112|NCT03332628|42198797|FG000|Overall Study|Physician Decision|2|||
19750113|NCT02761694|42198814|FG000|Overall Study|Lack of Efficacy|0|||
19750114|NCT02761694|42198815|FG001|Overall Study|Lack of Efficacy|0|||
19750115|NCT02761694|42198816|FG002|Overall Study|Lack of Efficacy|0|||
19750116|NCT02761694|42198817|FG003|Overall Study|Lack of Efficacy|0|||
19750117|NCT02761694|42198818|FG004|Overall Study|Lack of Efficacy|0|||
19750118|NCT02761694|42198819|FG005|Overall Study|Lack of Efficacy|0|||
19750119|NCT02761694|42198820|FG006|Overall Study|Lack of Efficacy|6|||
19750120|NCT02761694|42198821|FG007|Overall Study|Lack of Efficacy|0|||
19646829|NCT00611715|42096285|FG001|Overall Study|Death|0|||
19646830|NCT00611715|42096284|FG000|Overall Study|two patients are still on treatment|2|||
19646831|NCT00611715|42096285|FG001|Overall Study|two patients are still on treatment|0|||
19646832|NCT00677820|42096299|FG000|Overall Study|Lost to Follow-up|1|||
19646833|NCT00677820|42096300|FG001|Overall Study|Lost to Follow-up|0|||
19646834|NCT00611559|42096309|FG000|Overall Study|Lost to Follow-up|0|||
19750121|NCT02761694|42198822|FG008|Overall Study|Lack of Efficacy|0|||
19750122|NCT02761694|42198823|FG009|Overall Study|Lack of Efficacy|1|||
19750123|NCT02761694|42198824|FG010|Overall Study|Lack of Efficacy|1|||
19750124|NCT02761694|42198825|FG011|Overall Study|Lack of Efficacy|4|||
19750125|NCT02761694|42198814|FG000|Overall Study|Death|0|||
19750126|NCT02761694|42198815|FG001|Overall Study|Death|0|||
19750127|NCT02761694|42198816|FG002|Overall Study|Death|0|||
19750128|NCT02761694|42198817|FG003|Overall Study|Death|0|||
19750129|NCT02761694|42198818|FG004|Overall Study|Death|0|||
19750130|NCT02761694|42198819|FG005|Overall Study|Death|0|||
19750131|NCT02761694|42198820|FG006|Overall Study|Death|2|||
19750132|NCT02761694|42198821|FG007|Overall Study|Death|0|||
19646835|NCT00611559|42096310|FG001|Overall Study|Lost to Follow-up|1|||
19646836|NCT00611559|42096311|FG002|Overall Study|Lost to Follow-up|0|||
19750133|NCT02761694|42198822|FG008|Overall Study|Death|2|||
19750134|NCT02761694|42198823|FG009|Overall Study|Death|2|||
19750135|NCT02761694|42198824|FG010|Overall Study|Death|1|||
19750136|NCT02761694|42198825|FG011|Overall Study|Death|0|||
19750137|NCT02761694|42198814|FG000|Overall Study|Physician Decision|0|||
19646837|NCT00611559|42096309|FG000|Overall Study|Protocol Violation|1|||
19646838|NCT00611559|42096310|FG001|Overall Study|Protocol Violation|0|||
19646839|NCT00611559|42096311|FG002|Overall Study|Protocol Violation|1|||
19646840|NCT00611247|42096321|FG000|Overall Study|Death|1|||
19646841|NCT00611247|42096322|FG001|Overall Study|Death|5|||
19646842|NCT00611247|42096321|FG000|Overall Study|Lack of Efficacy|1|||
19750138|NCT02761694|42198815|FG001|Overall Study|Physician Decision|0|||
19646843|NCT00611247|42096322|FG001|Overall Study|Lack of Efficacy|16|||
19646844|NCT00675948|42096331|FG000|Overall Study|Adverse Event|23|||
19646845|NCT00675948|42096332|FG001|Overall Study|Adverse Event|1|||
19646846|NCT00675948|42096331|FG000|Overall Study|Lack of Efficacy|3|||
19646847|NCT00675948|42096332|FG001|Overall Study|Lack of Efficacy|0|||
19646848|NCT00675948|42096331|FG000|Overall Study|Withdrawal by Subject|7|||
19646849|NCT00675948|42096332|FG001|Overall Study|Withdrawal by Subject|0|||
19646850|NCT00675948|42096331|FG000|Overall Study|Lost to Follow-up|2|||
19646851|NCT00675948|42096332|FG001|Overall Study|Lost to Follow-up|0|||
19646852|NCT00675948|42096331|FG000|Overall Study|Protocol Violation|1|||
19646853|NCT00675948|42096332|FG001|Overall Study|Protocol Violation|0|||
19646854|NCT00675948|42096331|FG000|Overall Study|Pain under control|1|||
19646855|NCT00675948|42096332|FG001|Overall Study|Pain under control|0|||
19646856|NCT00675948|42096331|FG000|Overall Study|Sponsor decision|0|||
19646857|NCT00675948|42096332|FG001|Overall Study|Sponsor decision|1|||
19646858|NCT00675948|42096331|FG000|Overall Study|Patient died|1|||
19646859|NCT00675948|42096332|FG001|Overall Study|Patient died|0|||
19646860|NCT00675948|42096331|FG000|Overall Study|Patient unable to comply with diaries|1|||
19646861|NCT00675948|42096332|FG001|Overall Study|Patient unable to comply with diaries|0|||
19646862|NCT00675948|42096331|FG000|Overall Study|Patient feels unable to take medication|0|||
19646863|NCT00675948|42096332|FG001|Overall Study|Patient feels unable to take medication|1|||
19646864|NCT00610935|42096341|FG000|Overall Study|Lost to Follow-up|0|||
19646865|NCT00610935|42096342|FG001|Overall Study|Lost to Follow-up|1|||
19646866|NCT00610935|42096341|FG000|Overall Study|Withdrawal by Subject|0|||
19646867|NCT00610935|42096342|FG001|Overall Study|Withdrawal by Subject|2|||
19646868|NCT00610935|42096341|FG000|Overall Study|Sponsor Discontinuation|1|||
19646869|NCT00610935|42096342|FG001|Overall Study|Sponsor Discontinuation|0|||
19646870|NCT00610857|42096357|FG000|Overall Study|Not evaluable for response|2|||
19646871|NCT00672984|42096364|FG000|First Intervention|Adverse Event|5|||
19646872|NCT00672984|42096365|FG001|First Intervention|Adverse Event|0|||
19646873|NCT00672984|42096366|FG002|First Intervention|Adverse Event|0|||
19646874|NCT00672984|42096364|FG000|First Intervention|Withdrawal by Subject|1|||
19646875|NCT00672984|42096365|FG001|First Intervention|Withdrawal by Subject|2|||
19646876|NCT00672984|42096366|FG002|First Intervention|Withdrawal by Subject|2|||
19750139|NCT02761694|42198816|FG002|Overall Study|Physician Decision|0|||
19750140|NCT02761694|42198817|FG003|Overall Study|Physician Decision|0|||
19750141|NCT02761694|42198818|FG004|Overall Study|Physician Decision|0|||
19750142|NCT02761694|42198819|FG005|Overall Study|Physician Decision|0|||
19750143|NCT02761694|42198820|FG006|Overall Study|Physician Decision|1|||
19750144|NCT02761694|42198821|FG007|Overall Study|Physician Decision|0|||
19646877|NCT00672984|42096364|FG000|First Intervention|Sponsor decision|3|||
19646878|NCT00672984|42096365|FG001|First Intervention|Sponsor decision|0|||
19646879|NCT00672984|42096366|FG002|First Intervention|Sponsor decision|0|||
19646880|NCT00672984|42096364|FG000|Second Intervention|Non-compliance with facility policies|0|||
19646881|NCT00672984|42096365|FG001|Second Intervention|Non-compliance with facility policies|2|||
19646882|NCT00672984|42096366|FG002|Second Intervention|Non-compliance with facility policies|0|||
19646883|NCT00672984|42096364|FG000|Second Intervention|Withdrawal by Subject|0|||
19646884|NCT00672984|42096365|FG001|Second Intervention|Withdrawal by Subject|3|||
19646885|NCT00672984|42096366|FG002|Second Intervention|Withdrawal by Subject|0|||
19646886|NCT00672984|42096364|FG000|Second Intervention|Protocol Violation|0|||
19646887|NCT00672984|42096365|FG001|Second Intervention|Protocol Violation|1|||
19646888|NCT00672984|42096366|FG002|Second Intervention|Protocol Violation|1|||
19646889|NCT00672984|42096364|FG000|Third Intervention|Adverse Event|1|||
19646890|NCT00672984|42096365|FG001|Third Intervention|Adverse Event|0|||
19646891|NCT00672984|42096366|FG002|Third Intervention|Adverse Event|1|||
19646892|NCT00546364|42096379|FG000|Overall Study|Disease progression|5|||
19646893|NCT00546364|42096380|FG001|Overall Study|Disease progression|11|||
19646894|NCT00546364|42096381|FG002|Overall Study|Disease progression|8|||
19646895|NCT00546364|42096379|FG000|Overall Study|Completed and off treatment|1|||
19646896|NCT00546364|42096380|FG001|Overall Study|Completed and off treatment|0|||
19646897|NCT00546364|42096381|FG002|Overall Study|Completed and off treatment|2|||
19646898|NCT00546364|42096379|FG000|Overall Study|Administrative reason by sponsor|1|||
19646899|NCT00546364|42096380|FG001|Overall Study|Administrative reason by sponsor|0|||
19646900|NCT00546364|42096381|FG002|Overall Study|Administrative reason by sponsor|0|||
19646901|NCT00546364|42096379|FG000|Overall Study|Poor compliance/noncompliance|0|||
19646902|NCT00546364|42096380|FG001|Overall Study|Poor compliance/noncompliance|0|||
19646903|NCT00546364|42096381|FG002|Overall Study|Poor compliance/noncompliance|1|||
19646904|NCT00546364|42096379|FG000|Overall Study|No longer meets study criteria|1|||
19646905|NCT00546364|42096380|FG001|Overall Study|No longer meets study criteria|1|||
19646906|NCT00546364|42096381|FG002|Overall Study|No longer meets study criteria|0|||
19646907|NCT00546364|42096379|FG000|Overall Study|Withdrawal by Subject|5|||
19646908|NCT00546364|42096380|FG001|Overall Study|Withdrawal by Subject|6|||
19750145|NCT02761694|42198822|FG008|Overall Study|Physician Decision|0|||
19646909|NCT00546364|42096381|FG002|Overall Study|Withdrawal by Subject|3|||
19646910|NCT00546364|42096379|FG000|Overall Study|Prior taxotere|1|||
19646911|NCT00546364|42096380|FG001|Overall Study|Prior taxotere|0|||
19646912|NCT00546364|42096381|FG002|Overall Study|Prior taxotere|0|||
19646913|NCT00546364|42096379|FG000|Overall Study|Mixed response|1|||
19646914|NCT00546364|42096380|FG001|Overall Study|Mixed response|0|||
19646915|NCT00546364|42096381|FG002|Overall Study|Mixed response|0|||
19646916|NCT00546364|42096379|FG000|Overall Study|Palliative treatment|1|||
19646917|NCT00546364|42096380|FG001|Overall Study|Palliative treatment|0|||
19646918|NCT00546364|42096381|FG002|Overall Study|Palliative treatment|1|||
19646919|NCT00546364|42096379|FG000|Overall Study|Target lesions resected|1|||
19646920|NCT00546364|42096380|FG001|Overall Study|Target lesions resected|0|||
19646921|NCT00546364|42096381|FG002|Overall Study|Target lesions resected|0|||
19646922|NCT00546364|42096379|FG000|Overall Study|Physician Decision|0|||
19646923|NCT00546364|42096380|FG001|Overall Study|Physician Decision|0|||
19646924|NCT00546364|42096381|FG002|Overall Study|Physician Decision|1|||
19646925|NCT00546364|42096379|FG000|Overall Study|Sponsor decision|0|||
19646926|NCT00546364|42096380|FG001|Overall Study|Sponsor decision|0|||
19646927|NCT00546364|42096381|FG002|Overall Study|Sponsor decision|1|||
19646928|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
19646929|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
19646930|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
19646931|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
19646932|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
19646933|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
19646934|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
19646935|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
19646936|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
19646937|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
19646938|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
19646939|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
19646940|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
19646941|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
19646942|NCT00612105|42096391|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
19646943|NCT00612105|42096392|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
19646944|NCT00612105|42096391|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
19646945|NCT00612105|42096392|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
19646946|NCT00612105|42096391|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
19646947|NCT00612105|42096392|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
19646948|NCT00612105|42096391|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
19646949|NCT00612105|42096392|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
19646950|NCT00612105|42096391|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
19646951|NCT00612105|42096392|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
19646952|NCT00546052|42096398|FG000|Overall Study|Adverse Event|47|||
19646953|NCT00546052|42096398|FG000|Overall Study|Lost to Follow-up|144|||
19646954|NCT00546052|42096398|FG000|Overall Study|Protocol Violation|9|||
19750146|NCT02761694|42198823|FG009|Overall Study|Physician Decision|0|||
19750147|NCT02761694|42198824|FG010|Overall Study|Physician Decision|0|||
19750148|NCT02761694|42198825|FG011|Overall Study|Physician Decision|0|||
19750149|NCT02761694|42198814|FG000|Overall Study|Withdrawal by Subject|0|||
19750150|NCT02761694|42198815|FG001|Overall Study|Withdrawal by Subject|0|||
19646955|NCT00546052|42096398|FG000|Overall Study|Withdrawal by Subject|20|||
19646956|NCT00546052|42096398|FG000|Overall Study|Non Compliance|7|||
19646957|NCT00673920|42096413|FG000|Baseline up to Week 48|Withdrew consent|1|||
19646958|NCT00673920|42096414|FG001|Baseline up to Week 48|Withdrew consent|0|||
19750151|NCT02761694|42198816|FG002|Overall Study|Withdrawal by Subject|0|||
19646959|NCT00673920|42096415|FG002|Baseline up to Week 48|Withdrew consent|2|||
19646960|NCT00673920|42096416|FG003|Baseline up to Week 48|Withdrew consent|0|||
19646961|NCT00673920|42096417|FG004|Baseline up to Week 48|Withdrew consent|0|||
19646962|NCT00673920|42096418|FG005|Baseline up to Week 48|Withdrew consent|0|||
19646963|NCT00673920|42096419|FG006|Baseline up to Week 48|Withdrew consent|0|||
19646964|NCT00673920|42096420|FG007|Baseline up to Week 48|Withdrew consent|0|||
19646965|NCT00673920|42096413|FG000|Baseline up to Week 48|Refused treatment|1|||
19646966|NCT00673920|42096414|FG001|Baseline up to Week 48|Refused treatment|0|||
19646967|NCT00673920|42096415|FG002|Baseline up to Week 48|Refused treatment|0|||
19646968|NCT00673920|42096416|FG003|Baseline up to Week 48|Refused treatment|0|||
19646969|NCT00673920|42096417|FG004|Baseline up to Week 48|Refused treatment|0|||
19750152|NCT02761694|42198817|FG003|Overall Study|Withdrawal by Subject|1|||
19750153|NCT02761694|42198818|FG004|Overall Study|Withdrawal by Subject|0|||
19646970|NCT00673920|42096418|FG005|Baseline up to Week 48|Refused treatment|0|||
19646971|NCT00673920|42096419|FG006|Baseline up to Week 48|Refused treatment|0|||
19646972|NCT00673920|42096420|FG007|Baseline up to Week 48|Refused treatment|0|||
19646973|NCT00673920|42096413|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
19646974|NCT00673920|42096414|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
19646975|NCT00673920|42096415|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646976|NCT00673920|42096416|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646977|NCT00673920|42096417|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646978|NCT00673920|42096418|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646979|NCT00673920|42096419|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646980|NCT00673920|42096420|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
19646981|NCT00673920|42096413|FG000|Baseline up to Week 48|Protocol Violation|0|||
19646982|NCT00673920|42096414|FG001|Baseline up to Week 48|Protocol Violation|0|||
19646983|NCT00673920|42096415|FG002|Baseline up to Week 48|Protocol Violation|1|||
19646984|NCT00673920|42096416|FG003|Baseline up to Week 48|Protocol Violation|0|||
19646985|NCT00673920|42096417|FG004|Baseline up to Week 48|Protocol Violation|0|||
19646986|NCT00673920|42096418|FG005|Baseline up to Week 48|Protocol Violation|0|||
19646987|NCT00673920|42096419|FG006|Baseline up to Week 48|Protocol Violation|0|||
19646988|NCT00673920|42096420|FG007|Baseline up to Week 48|Protocol Violation|0|||
19646989|NCT00673920|42096413|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646990|NCT00673920|42096414|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646991|NCT00673920|42096415|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
19646992|NCT00673920|42096416|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646993|NCT00673920|42096417|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646994|NCT00673920|42096418|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646995|NCT00673920|42096419|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646996|NCT00673920|42096420|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
19646997|NCT00673920|42096413|FG000|Baseline up to Week 48|Administrative/Other|0|||
19646998|NCT00673920|42096414|FG001|Baseline up to Week 48|Administrative/Other|1|||
19646999|NCT00673920|42096415|FG002|Baseline up to Week 48|Administrative/Other|2|||
19647000|NCT00673920|42096416|FG003|Baseline up to Week 48|Administrative/Other|0|||
19647001|NCT00673920|42096417|FG004|Baseline up to Week 48|Administrative/Other|0|||
19647002|NCT00673920|42096418|FG005|Baseline up to Week 48|Administrative/Other|0|||
19647003|NCT00673920|42096419|FG006|Baseline up to Week 48|Administrative/Other|0|||
19647004|NCT00673920|42096420|FG007|Baseline up to Week 48|Administrative/Other|0|||
19647005|NCT00673920|42096413|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647006|NCT00673920|42096414|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
19647007|NCT00673920|42096415|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
19647008|NCT00673920|42096416|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647009|NCT00673920|42096417|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647010|NCT00673920|42096418|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647011|NCT00673920|42096419|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647012|NCT00673920|42096420|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
19647013|NCT00673920|42096413|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647014|NCT00673920|42096414|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647015|NCT00673920|42096415|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647016|NCT00673920|42096416|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647017|NCT00673920|42096417|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647018|NCT00673920|42096418|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647019|NCT00673920|42096419|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
19647020|NCT00673920|42096420|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
19647021|NCT00673920|42096413|FG000|Week 24 to Week 48|Failure to return|0|||
19647022|NCT00673920|42096414|FG001|Week 24 to Week 48|Failure to return|0|||
19647023|NCT00673920|42096415|FG002|Week 24 to Week 48|Failure to return|0|||
19647024|NCT00673920|42096416|FG003|Week 24 to Week 48|Failure to return|0|||
19647025|NCT00673920|42096417|FG004|Week 24 to Week 48|Failure to return|0|||
19647026|NCT00673920|42096418|FG005|Week 24 to Week 48|Failure to return|1|||
19647027|NCT00673920|42096419|FG006|Week 24 to Week 48|Failure to return|0|||
19750154|NCT02761694|42198819|FG005|Overall Study|Withdrawal by Subject|0|||
19750155|NCT02761694|42198820|FG006|Overall Study|Withdrawal by Subject|4|||
19750156|NCT02761694|42198821|FG007|Overall Study|Withdrawal by Subject|0|||
19750157|NCT02761694|42198822|FG008|Overall Study|Withdrawal by Subject|2|||
19750158|NCT02761694|42198823|FG009|Overall Study|Withdrawal by Subject|1|||
19750159|NCT02761694|42198824|FG010|Overall Study|Withdrawal by Subject|0|||
19750160|NCT02761694|42198825|FG011|Overall Study|Withdrawal by Subject|0|||
19750161|NCT02761694|42198814|FG000|Overall Study|Lost to Follow-up|0|||
19750162|NCT02761694|42198815|FG001|Overall Study|Lost to Follow-up|0|||
19750163|NCT02761694|42198816|FG002|Overall Study|Lost to Follow-up|0|||
19750164|NCT02761694|42198817|FG003|Overall Study|Lost to Follow-up|0|||
19750165|NCT02761694|42198818|FG004|Overall Study|Lost to Follow-up|0|||
19647028|NCT00673920|42096420|FG007|Week 24 to Week 48|Failure to return|0|||
19647029|NCT00673920|42096413|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647030|NCT00673920|42096414|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647031|NCT00673920|42096415|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647032|NCT00673920|42096416|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647033|NCT00673920|42096417|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647034|NCT00673920|42096418|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
19647035|NCT00673920|42096419|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647036|NCT00673920|42096420|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
19647037|NCT00673920|42096413|FG000|Week 24 to Week 48|Death|0|||
19647038|NCT00673920|42096414|FG001|Week 24 to Week 48|Death|0|||
19647039|NCT00673920|42096415|FG002|Week 24 to Week 48|Death|0|||
19647040|NCT00673920|42096416|FG003|Week 24 to Week 48|Death|0|||
19647041|NCT00673920|42096417|FG004|Week 24 to Week 48|Death|0|||
19647042|NCT00673920|42096418|FG005|Week 24 to Week 48|Death|1|||
19647043|NCT00673920|42096419|FG006|Week 24 to Week 48|Death|0|||
19647044|NCT00673920|42096420|FG007|Week 24 to Week 48|Death|0|||
19647045|NCT00673920|42096413|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
19647046|NCT00673920|42096414|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
19647047|NCT00673920|42096415|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
19647048|NCT00673920|42096416|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
19647049|NCT00673920|42096417|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
19647050|NCT00673920|42096418|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
19647051|NCT00673920|42096419|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
19647052|NCT00673920|42096420|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
19647053|NCT00379795|42096447|FG000|Overall Study|Death|31|||
19647054|NCT00379795|42096448|FG001|Overall Study|Death|8|||
19647055|NCT00379795|42096449|FG002|Overall Study|Death|6|||
19647056|NCT00379795|42096450|FG003|Overall Study|Death|4|||
19647057|NCT00379795|42096451|FG004|Overall Study|Death|7|||
19647058|NCT00379795|42096447|FG000|Overall Study|Adverse Event|17|||
19647059|NCT00379795|42096448|FG001|Overall Study|Adverse Event|3|||
19647060|NCT00379795|42096449|FG002|Overall Study|Adverse Event|3|||
19647061|NCT00379795|42096450|FG003|Overall Study|Adverse Event|1|||
19647062|NCT00379795|42096451|FG004|Overall Study|Adverse Event|4|||
19647063|NCT00379795|42096447|FG000|Overall Study|Lost to Follow-up|8|||
19647064|NCT00379795|42096448|FG001|Overall Study|Lost to Follow-up|1|||
19647065|NCT00379795|42096449|FG002|Overall Study|Lost to Follow-up|2|||
19647066|NCT00379795|42096450|FG003|Overall Study|Lost to Follow-up|1|||
19647067|NCT00379795|42096451|FG004|Overall Study|Lost to Follow-up|4|||
19647068|NCT00379795|42096447|FG000|Overall Study|Physician Decision|25|||
19647069|NCT00379795|42096448|FG001|Overall Study|Physician Decision|0|||
19647070|NCT00379795|42096449|FG002|Overall Study|Physician Decision|2|||
19647071|NCT00379795|42096450|FG003|Overall Study|Physician Decision|2|||
19750166|NCT02761694|42198819|FG005|Overall Study|Lost to Follow-up|0|||
19750167|NCT02761694|42198820|FG006|Overall Study|Lost to Follow-up|1|||
19750168|NCT02761694|42198821|FG007|Overall Study|Lost to Follow-up|0|||
19750169|NCT02761694|42198822|FG008|Overall Study|Lost to Follow-up|0|||
19750170|NCT02761694|42198823|FG009|Overall Study|Lost to Follow-up|0|||
19750171|NCT02761694|42198824|FG010|Overall Study|Lost to Follow-up|0|||
19750172|NCT02761694|42198825|FG011|Overall Study|Lost to Follow-up|1|||
19750173|NCT02761694|42198814|FG000|Overall Study|Adverse Event|0|||
19750174|NCT02761694|42198815|FG001|Overall Study|Adverse Event|0|||
19750175|NCT02761694|42198816|FG002|Overall Study|Adverse Event|0|||
19750176|NCT02761694|42198817|FG003|Overall Study|Adverse Event|0|||
19750177|NCT02761694|42198818|FG004|Overall Study|Adverse Event|0|||
19750178|NCT02761694|42198819|FG005|Overall Study|Adverse Event|0|||
19750179|NCT02761694|42198820|FG006|Overall Study|Adverse Event|1|||
19750180|NCT02761694|42198821|FG007|Overall Study|Adverse Event|0|||
19750181|NCT02761694|42198822|FG008|Overall Study|Adverse Event|1|||
19750182|NCT02761694|42198823|FG009|Overall Study|Adverse Event|0|||
19750183|NCT02761694|42198824|FG010|Overall Study|Adverse Event|0|||
19750184|NCT02761694|42198825|FG011|Overall Study|Adverse Event|1|||
19750185|NCT02761694|42198814|FG000|Overall Study|Other|4|||
19750186|NCT02761694|42198815|FG001|Overall Study|Other|4|||
19750187|NCT02761694|42198816|FG002|Overall Study|Other|1|||
19750188|NCT02761694|42198817|FG003|Overall Study|Other|2|||
19750189|NCT02761694|42198818|FG004|Overall Study|Other|3|||
19750190|NCT02761694|42198819|FG005|Overall Study|Other|3|||
19750191|NCT02761694|42198820|FG006|Overall Study|Other|18|||
19750192|NCT02761694|42198821|FG007|Overall Study|Other|8|||
19750193|NCT02761694|42198822|FG008|Overall Study|Other|0|||
19647072|NCT00379795|42096451|FG004|Overall Study|Physician Decision|2|||
19750194|NCT02761694|42198823|FG009|Overall Study|Other|1|||
19647073|NCT00379795|42096447|FG000|Overall Study|Withdrawal by Subject|94|||
19647074|NCT00379795|42096448|FG001|Overall Study|Withdrawal by Subject|11|||
19647075|NCT00379795|42096449|FG002|Overall Study|Withdrawal by Subject|19|||
19647076|NCT00379795|42096450|FG003|Overall Study|Withdrawal by Subject|7|||
19647077|NCT00379795|42096451|FG004|Overall Study|Withdrawal by Subject|14|||
19750195|NCT02761694|42198824|FG010|Overall Study|Other|1|||
19750196|NCT02761694|42198825|FG011|Overall Study|Other|0|||
19750197|NCT04516759|42198854|FG000|Overall Study|Withdrawal by Subject|1|||
19750198|NCT04516759|42198855|FG001|Overall Study|Withdrawal by Subject|1|||
19750199|NCT04516759|42198854|FG000|Overall Study|Other|0|||
19750200|NCT04516759|42198855|FG001|Overall Study|Other|1|||
19750201|NCT03332160|42198863|FG000|Overall Study|Withdrawal by Subject|1|||
19750202|NCT03332160|42198864|FG001|Overall Study|Withdrawal by Subject|1|||
19750203|NCT03332160|42198863|FG000|Overall Study|Adverse Event|0|||
19750204|NCT03332160|42198864|FG001|Overall Study|Adverse Event|1|||
19750205|NCT03332160|42198863|FG000|Overall Study|Developed Exclusion Criteria|0|||
19750206|NCT03332160|42198864|FG001|Overall Study|Developed Exclusion Criteria|1|||
19750207|NCT03332160|42198863|FG000|Overall Study|Non-adherence to treatment|0|||
19750208|NCT03332160|42198864|FG001|Overall Study|Non-adherence to treatment|2|||
19750209|NCT03312114|42198871|FG000|Overall Study|All the five enrolled dropped out of the|5|||
19647078|NCT00379795|42096447|FG000|Overall Study|Subject non-compliance|7|||
19647079|NCT00379795|42096448|FG001|Overall Study|Subject non-compliance|2|||
19647080|NCT00379795|42096449|FG002|Overall Study|Subject non-compliance|0|||
19647081|NCT00379795|42096450|FG003|Overall Study|Subject non-compliance|0|||
19647082|NCT00379795|42096451|FG004|Overall Study|Subject non-compliance|1|||
19647083|NCT00379795|42096447|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
19647084|NCT00379795|42096448|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
19647085|NCT00379795|42096449|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
19647086|NCT00379795|42096450|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
19750210|NCT03694327|42198878|FG000|Overall Study|Lost to Follow-up|13|||
19750211|NCT03694327|42198879|FG001|Overall Study|Lost to Follow-up|23|||
19750212|NCT03330288|42198887|FG000|Overall Study|Other reason|1|||
19750213|NCT03330288|42198888|FG001|Overall Study|Other reason|1|||
19647087|NCT00379795|42096451|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
19647088|NCT00379795|42096447|FG000|Overall Study|Subjects condition mandated intervention|34|||
19647089|NCT00379795|42096448|FG001|Overall Study|Subjects condition mandated intervention|9|||
19647090|NCT00379795|42096449|FG002|Overall Study|Subjects condition mandated intervention|7|||
19647091|NCT00379795|42096450|FG003|Overall Study|Subjects condition mandated intervention|5|||
19647092|NCT00379795|42096451|FG004|Overall Study|Subjects condition mandated intervention|7|||
19750214|NCT03330288|42198887|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
19750215|NCT03330288|42198888|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
19750216|NCT03330288|42198887|FG000|Overall Study|Adverse Event|1|||
19750217|NCT03330288|42198888|FG001|Overall Study|Adverse Event|0|||
19750218|NCT03330288|42198887|FG000|Overall Study|Withdrawal by Subject|1|||
19750219|NCT03330288|42198888|FG001|Overall Study|Withdrawal by Subject|0|||
19647093|NCT00379795|42096447|FG000|Overall Study|Sponsor's decision|257|||
19647094|NCT00379795|42096448|FG001|Overall Study|Sponsor's decision|17|||
19647095|NCT00379795|42096449|FG002|Overall Study|Sponsor's decision|54|||
19647096|NCT00379795|42096450|FG003|Overall Study|Sponsor's decision|47|||
19647097|NCT00379795|42096451|FG004|Overall Study|Sponsor's decision|10|||
19647098|NCT00610155|42096466|FG000|Period 1|Withdrawal by Subject|0|||
19647099|NCT00610155|42096467|FG001|Period 1|Withdrawal by Subject|0|||
19647100|NCT00610155|42096468|FG002|Period 1|Withdrawal by Subject|1|||
19647101|NCT00610155|42096469|FG003|Period 1|Withdrawal by Subject|0|||
19647102|NCT00610155|42096470|FG004|Period 1|Withdrawal by Subject|0|||
19647103|NCT00610155|42096471|FG005|Period 1|Withdrawal by Subject|0|||
19647104|NCT00610155|42096466|FG000|Period 3|Adverse Event|1|||
19647105|NCT00610155|42096467|FG001|Period 3|Adverse Event|0|||
19647106|NCT00610155|42096468|FG002|Period 3|Adverse Event|0|||
19647107|NCT00610155|42096469|FG003|Period 3|Adverse Event|0|||
19647108|NCT00610155|42096470|FG004|Period 3|Adverse Event|0|||
19750220|NCT03330288|42198887|FG000|Overall Study|Lost to Follow-up|26|||
19750221|NCT03330288|42198888|FG001|Overall Study|Lost to Follow-up|7|||
19750222|NCT03084536|42198897|FG000|Overall Study|Determined to be ineligible|0|||
19750223|NCT03084536|42198898|FG001|Overall Study|Determined to be ineligible|0|||
19750224|NCT03084536|42198899|FG002|Overall Study|Determined to be ineligible|16|||
19750225|NCT03084536|42198897|FG000|Overall Study|Withdrawal by Subject|0|||
19750226|NCT03084536|42198898|FG001|Overall Study|Withdrawal by Subject|0|||
19477080|NCT01491035|41755968|FG002|Overall Study|Lost to Follow-up|0|||
19647109|NCT00610155|42096471|FG005|Period 3|Adverse Event|0|||
19647110|NCT00674700|42096482|FG000|Year 1|Adverse Event|17|||
19647111|NCT00674700|42096483|FG001|Year 1|Adverse Event|20|||
19750227|NCT03084536|42198899|FG002|Overall Study|Withdrawal by Subject|4|||
19750228|NCT03084536|42198897|FG000|Overall Study|Physician Decision|0|||
19750229|NCT03084536|42198898|FG001|Overall Study|Physician Decision|0|||
19750230|NCT03084536|42198899|FG002|Overall Study|Physician Decision|3|||
19750231|NCT03084536|42198897|FG000|Overall Study|Death|0|||
19750232|NCT03084536|42198898|FG001|Overall Study|Death|0|||
19750233|NCT03084536|42198899|FG002|Overall Study|Death|1|||
19750234|NCT03084536|42198897|FG000|Overall Study|Lost to Follow-up|0|||
19750235|NCT03084536|42198898|FG001|Overall Study|Lost to Follow-up|0|||
19647112|NCT00674700|42096484|FG002|Year 1|Adverse Event|5|||
19647113|NCT00674700|42096482|FG000|Year 1|Withdrawal by Subject|7|||
19750236|NCT03084536|42198899|FG002|Overall Study|Lost to Follow-up|1|||
19750237|NCT03084536|42198897|FG000|Overall Study|Protocol Violation|0|||
19750238|NCT03084536|42198898|FG001|Overall Study|Protocol Violation|0|||
19750239|NCT03084536|42198899|FG002|Overall Study|Protocol Violation|1|||
19750240|NCT03084536|42198897|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
19750241|NCT03084536|42198898|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
19750242|NCT03084536|42198899|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
19750243|NCT03289143|42198910|FG000|Overall Study|Caregiver Unavailability|1|||
19750244|NCT03289143|42198911|FG001|Overall Study|Caregiver Unavailability|1|||
19750245|NCT03289143|42198912|FG002|Overall Study|Caregiver Unavailability|0|||
19750246|NCT03289143|42198913|FG003|Overall Study|Caregiver Unavailability|0|||
19750247|NCT03289143|42198910|FG000|Overall Study|Research Department Closure|0|||
19750248|NCT03289143|42198911|FG001|Overall Study|Research Department Closure|0|||
19750249|NCT03289143|42198912|FG002|Overall Study|Research Department Closure|1|||
19750250|NCT03289143|42198913|FG003|Overall Study|Research Department Closure|0|||
19750251|NCT03289143|42198910|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
19750252|NCT03289143|42198911|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
19750253|NCT03289143|42198912|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
19750254|NCT03289143|42198913|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
19750255|NCT03289143|42198910|FG000|Overall Study|Medical Monitor Decision|1|||
19750256|NCT03289143|42198911|FG001|Overall Study|Medical Monitor Decision|0|||
19750257|NCT03289143|42198912|FG002|Overall Study|Medical Monitor Decision|0|||
19750258|NCT03289143|42198913|FG003|Overall Study|Medical Monitor Decision|0|||
19750259|NCT03289143|42198910|FG000|Overall Study|Participant Non-Compliance|0|||
19750260|NCT03289143|42198911|FG001|Overall Study|Participant Non-Compliance|0|||
19750261|NCT03289143|42198912|FG002|Overall Study|Participant Non-Compliance|1|||
19750262|NCT03289143|42198913|FG003|Overall Study|Participant Non-Compliance|0|||
19750263|NCT03289143|42198910|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
19750264|NCT03289143|42198911|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
19750265|NCT03289143|42198912|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
19750266|NCT03289143|42198913|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
19750267|NCT03289143|42198910|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
19750268|NCT03289143|42198911|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
19647114|NCT00674700|42096483|FG001|Year 1|Withdrawal by Subject|7|||
19647115|NCT00674700|42096484|FG002|Year 1|Withdrawal by Subject|6|||
19647116|NCT00674700|42096482|FG000|Year 1|Any other reason not above-mentioned|7|||
19647117|NCT00674700|42096483|FG001|Year 1|Any other reason not above-mentioned|7|||
19647118|NCT00674700|42096484|FG002|Year 1|Any other reason not above-mentioned|6|||
19647119|NCT00674700|42096482|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
19647120|NCT00674700|42096483|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
19647121|NCT00674700|42096484|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
19647122|NCT00674700|42096482|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
19647123|NCT00674700|42096483|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
19647124|NCT00674700|42096484|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
19647125|NCT00674700|42096482|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
19647126|NCT00674700|42096483|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
19647127|NCT00674700|42096484|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
19647128|NCT00546910|42096494|FG000|Overall Study|Adverse Event|2|||
19647129|NCT00546910|42096495|FG001|Overall Study|Adverse Event|3|||
19647130|NCT00546910|42096494|FG000|Overall Study|Lack of Efficacy|5|||
19647131|NCT00546910|42096495|FG001|Overall Study|Lack of Efficacy|7|||
19647132|NCT00546910|42096494|FG000|Overall Study|Physician Decision|0|||
19647133|NCT00546910|42096495|FG001|Overall Study|Physician Decision|1|||
19647134|NCT00546910|42096494|FG000|Overall Study|Withdrawal by Subject|2|||
19647135|NCT00546910|42096495|FG001|Overall Study|Withdrawal by Subject|0|||
19647136|NCT00379639|42096506|FG000|Overall Study|Disease Progression|3|||
19647137|NCT00379639|42096507|FG001|Overall Study|Disease Progression|3|||
19647138|NCT00379639|42096508|FG002|Overall Study|Disease Progression|3|||
19647139|NCT00379639|42096509|FG003|Overall Study|Disease Progression|4|||
19647140|NCT00379639|42096510|FG004|Overall Study|Disease Progression|4|||
19647141|NCT00379639|42096506|FG000|Overall Study|Physician Decision|0|||
19647142|NCT00379639|42096507|FG001|Overall Study|Physician Decision|2|||
19647143|NCT00379639|42096508|FG002|Overall Study|Physician Decision|1|||
19647144|NCT00379639|42096509|FG003|Overall Study|Physician Decision|1|||
19647145|NCT00379639|42096510|FG004|Overall Study|Physician Decision|0|||
19647146|NCT00379639|42096506|FG000|Overall Study|Symptomatic Deterioration|0|||
19647147|NCT00379639|42096507|FG001|Overall Study|Symptomatic Deterioration|0|||
19647148|NCT00379639|42096508|FG002|Overall Study|Symptomatic Deterioration|1|||
19750269|NCT03289143|42198912|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
19647149|NCT00379639|42096509|FG003|Overall Study|Symptomatic Deterioration|0|||
19647150|NCT00379639|42096510|FG004|Overall Study|Symptomatic Deterioration|1|||
19647151|NCT00379639|42096506|FG000|Overall Study|Adverse Event|0|||
19647152|NCT00379639|42096507|FG001|Overall Study|Adverse Event|0|||
19647153|NCT00379639|42096508|FG002|Overall Study|Adverse Event|1|||
19647154|NCT00379639|42096509|FG003|Overall Study|Adverse Event|0|||
19647155|NCT00379639|42096510|FG004|Overall Study|Adverse Event|1|||
19647156|NCT00379639|42096506|FG000|Overall Study|Lost to Follow-up|0|||
19647157|NCT00379639|42096507|FG001|Overall Study|Lost to Follow-up|0|||
19647158|NCT00379639|42096508|FG002|Overall Study|Lost to Follow-up|0|||
19647159|NCT00379639|42096509|FG003|Overall Study|Lost to Follow-up|1|||
19647160|NCT00379639|42096510|FG004|Overall Study|Lost to Follow-up|0|||
19647161|NCT00379639|42096506|FG000|Overall Study|Other|0|||
19647162|NCT00379639|42096507|FG001|Overall Study|Other|0|||
19647163|NCT00379639|42096508|FG002|Overall Study|Other|3|||
19647164|NCT00379639|42096509|FG003|Overall Study|Other|0|||
19647165|NCT00379639|42096510|FG004|Overall Study|Other|0|||
19647166|NCT03948334|42096524|FG000|Overall Study|Adverse Event|1|||
19647167|NCT03948334|42096525|FG001|Overall Study|Adverse Event|4|||
19647168|NCT03948334|42096524|FG000|Overall Study|Lack of Efficacy|2|||
19647169|NCT03948334|42096525|FG001|Overall Study|Lack of Efficacy|0|||
19647170|NCT03948334|42096524|FG000|Overall Study|Lost to Follow-up|1|||
19647171|NCT03948334|42096525|FG001|Overall Study|Lost to Follow-up|0|||
19647172|NCT03948334|42096524|FG000|Overall Study|Physician Decision|1|||
19647173|NCT03948334|42096525|FG001|Overall Study|Physician Decision|0|||
19647174|NCT03948334|42096524|FG000|Overall Study|Pregnancy|0|||
19750270|NCT03289143|42198913|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
19750271|NCT03289143|42198910|FG000|Overall Study|Caregiver Passed Away|1|||
19750272|NCT03289143|42198911|FG001|Overall Study|Caregiver Passed Away|0|||
19647175|NCT03948334|42096525|FG001|Overall Study|Pregnancy|1|||
19647176|NCT03948334|42096524|FG000|Overall Study|Protocol Deviation|1|||
19647177|NCT03948334|42096525|FG001|Overall Study|Protocol Deviation|0|||
19647178|NCT03948334|42096524|FG000|Overall Study|Study terminated by Sponsor|50|||
19647179|NCT03948334|42096525|FG001|Overall Study|Study terminated by Sponsor|51|||
19647180|NCT03948334|42096524|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
19647181|NCT03948334|42096525|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
19647182|NCT00609765|42096539|FG000|Overall Study|Study ended prior to 12 months|1|||
19750273|NCT03289143|42198912|FG002|Overall Study|Caregiver Passed Away|0|||
19750274|NCT03289143|42198913|FG003|Overall Study|Caregiver Passed Away|0|||
19750275|NCT03289143|42198910|FG000|Overall Study|Physician Decision|0|||
19647183|NCT00608829|42096543|FG000|Overall Study|Death|6|||
19647184|NCT00608829|42096543|FG000|Overall Study|Withdrawal by Subject|4|||
19647185|NCT00608829|42096543|FG000|Overall Study|Subject refuses to follow up or return.|5|||
19647186|NCT00545818|42096549|FG000|Overall Study|Protocol Violation|1|||
19647187|NCT00545818|42096550|FG001|Overall Study|Protocol Violation|0|||
19647188|NCT00545818|42096549|FG000|Overall Study|Adverse Event|1|||
19647189|NCT00545818|42096550|FG001|Overall Study|Adverse Event|1|||
19647190|NCT00545818|42096549|FG000|Overall Study|Lost to Follow-up|1|||
19647191|NCT00545818|42096550|FG001|Overall Study|Lost to Follow-up|6|||
19647192|NCT00674154|42096558|FG000|Overall Study|Withdrawal by Subject|3|||
19647193|NCT00674154|42096559|FG001|Overall Study|Withdrawal by Subject|1|||
19647194|NCT00674154|42096558|FG000|Overall Study|Did not want parathyroidectomy|0|||
19647195|NCT00674154|42096559|FG001|Overall Study|Did not want parathyroidectomy|2|||
19647196|NCT00608517|42096568|FG000|Overall Study|Death|1|||
19750276|NCT03289143|42198911|FG001|Overall Study|Physician Decision|2|||
19750277|NCT03289143|42198912|FG002|Overall Study|Physician Decision|2|||
19750278|NCT03289143|42198913|FG003|Overall Study|Physician Decision|2|||
19647197|NCT00608517|42096569|FG001|Overall Study|Death|0|||
19647198|NCT00608517|42096570|FG002|Overall Study|Death|0|||
19647199|NCT00608205|42096581|FG000|Overall Study|Adverse Event|3|||
19647200|NCT00608205|42096582|FG001|Overall Study|Adverse Event|2|||
19647201|NCT00608205|42096581|FG000|Overall Study|Patient non-compliant|0|||
19647202|NCT00608205|42096582|FG001|Overall Study|Patient non-compliant|1|||
19647203|NCT00670800|42096592|FG000|Overall Study|2 controls were insulin resistant|0|||
19647204|NCT00670800|42096593|FG001|Overall Study|2 controls were insulin resistant|2|||
19647205|NCT00607893|42096603|FG000|Overall Study|Lost to Follow-up|4|||
19647206|NCT00607893|42096604|FG001|Overall Study|Lost to Follow-up|0|||
19647207|NCT00607893|42096603|FG000|Overall Study|withdrew due to loss of interest|0|||
19750279|NCT03289143|42198910|FG000|Overall Study|Protocol Deviation|2|||
19647208|NCT00607893|42096604|FG001|Overall Study|withdrew due to loss of interest|1|||
19647209|NCT00607893|42096603|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
19647210|NCT00607893|42096604|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
19647211|NCT00607893|42096603|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
19647212|NCT00607893|42096604|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
19647213|NCT00607893|42096603|FG000|Overall Study|Declined to be treated|1|||
19647214|NCT00607893|42096604|FG001|Overall Study|Declined to be treated|0|||
19647215|NCT00607893|42096603|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
19647216|NCT00607893|42096604|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
19647217|NCT00571038|42096614|FG000|Overall Study|Lost to Follow-up|1|||
19647218|NCT00571038|42096615|FG001|Overall Study|Lost to Follow-up|4|||
19647219|NCT00571038|42096614|FG000|Overall Study|Death|7|||
19750280|NCT03289143|42198911|FG001|Overall Study|Protocol Deviation|1|||
19750281|NCT03289143|42198912|FG002|Overall Study|Protocol Deviation|3|||
19750282|NCT03289143|42198913|FG003|Overall Study|Protocol Deviation|1|||
19750283|NCT03289143|42198910|FG000|Overall Study|Study Terminated By Sponsor|101|||
19750284|NCT03289143|42198911|FG001|Overall Study|Study Terminated By Sponsor|75|||
19750285|NCT03289143|42198912|FG002|Overall Study|Study Terminated By Sponsor|100|||
19750286|NCT03289143|42198913|FG003|Overall Study|Study Terminated By Sponsor|69|||
19750287|NCT03289143|42198910|FG000|Overall Study|Withdrawal by Subject|14|||
19750288|NCT03289143|42198911|FG001|Overall Study|Withdrawal by Subject|6|||
19750289|NCT03289143|42198912|FG002|Overall Study|Withdrawal by Subject|14|||
19750290|NCT03289143|42198913|FG003|Overall Study|Withdrawal by Subject|12|||
19750291|NCT03289143|42198910|FG000|Overall Study|Adverse Event|10|||
19750292|NCT03289143|42198911|FG001|Overall Study|Adverse Event|7|||
19750293|NCT03289143|42198912|FG002|Overall Study|Adverse Event|6|||
19750294|NCT03289143|42198913|FG003|Overall Study|Adverse Event|5|||
19750295|NCT03289143|42198910|FG000|Overall Study|Death|2|||
19750296|NCT03289143|42198911|FG001|Overall Study|Death|0|||
19647220|NCT00571038|42096615|FG001|Overall Study|Death|5|||
19647221|NCT00571038|42096614|FG000|Overall Study|Withdrawal by Subject|1|||
19647222|NCT00571038|42096615|FG001|Overall Study|Withdrawal by Subject|3|||
19647223|NCT00571038|42096614|FG000|Overall Study|Moved out of state|2|||
19647224|NCT00571038|42096615|FG001|Overall Study|Moved out of state|2|||
19647225|NCT00545740|42096625|FG000|Overall Study|Lack of Efficacy|34|||
19647226|NCT00545740|42096626|FG001|Overall Study|Lack of Efficacy|35|||
19647227|NCT00545740|42096627|FG002|Overall Study|Lack of Efficacy|47|||
19647228|NCT00545740|42096628|FG003|Overall Study|Lack of Efficacy|36|||
19647229|NCT00545740|42096625|FG000|Overall Study|Withdrawal by Subject|17|||
19647230|NCT00545740|42096626|FG001|Overall Study|Withdrawal by Subject|15|||
19647231|NCT00545740|42096627|FG002|Overall Study|Withdrawal by Subject|16|||
19647232|NCT00545740|42096628|FG003|Overall Study|Withdrawal by Subject|18|||
19647233|NCT00545740|42096625|FG000|Overall Study|Adverse Event|10|||
19647234|NCT00545740|42096626|FG001|Overall Study|Adverse Event|18|||
19647235|NCT00545740|42096627|FG002|Overall Study|Adverse Event|19|||
19647236|NCT00545740|42096628|FG003|Overall Study|Adverse Event|9|||
19647237|NCT00545740|42096625|FG000|Overall Study|Lost to Follow-up|7|||
19647238|NCT00545740|42096626|FG001|Overall Study|Lost to Follow-up|5|||
19647239|NCT00545740|42096627|FG002|Overall Study|Lost to Follow-up|5|||
19647240|NCT00545740|42096628|FG003|Overall Study|Lost to Follow-up|6|||
19647241|NCT00545740|42096625|FG000|Overall Study|Protocol Violation|1|||
19647242|NCT00545740|42096626|FG001|Overall Study|Protocol Violation|3|||
19647243|NCT00545740|42096627|FG002|Overall Study|Protocol Violation|1|||
19647244|NCT00545740|42096628|FG003|Overall Study|Protocol Violation|0|||
19647245|NCT00545740|42096625|FG000|Overall Study|Non-compliance|0|||
19647246|NCT00545740|42096626|FG001|Overall Study|Non-compliance|2|||
19750297|NCT03289143|42198912|FG002|Overall Study|Death|2|||
19750298|NCT03289143|42198913|FG003|Overall Study|Death|1|||
19750299|NCT03289143|42198910|FG000|Overall Study|Lost to Follow-up|2|||
19750300|NCT03289143|42198911|FG001|Overall Study|Lost to Follow-up|1|||
19750301|NCT03289143|42198912|FG002|Overall Study|Lost to Follow-up|1|||
19647247|NCT00545740|42096627|FG002|Overall Study|Non-compliance|1|||
19647248|NCT00545740|42096628|FG003|Overall Study|Non-compliance|0|||
19647249|NCT00545740|42096625|FG000|Overall Study|Moved|2|||
19647250|NCT00545740|42096626|FG001|Overall Study|Moved|0|||
19647251|NCT00545740|42096627|FG002|Overall Study|Moved|1|||
19647252|NCT00545740|42096628|FG003|Overall Study|Moved|0|||
19647253|NCT00545740|42096625|FG000|Overall Study|Diverticulitis attack|0|||
19750302|NCT03289143|42198913|FG003|Overall Study|Lost to Follow-up|0|||
19647254|NCT00545740|42096626|FG001|Overall Study|Diverticulitis attack|0|||
19647255|NCT00545740|42096627|FG002|Overall Study|Diverticulitis attack|1|||
19647256|NCT00545740|42096628|FG003|Overall Study|Diverticulitis attack|1|||
19647257|NCT00545740|42096625|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
19647258|NCT00545740|42096626|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
19647259|NCT00545740|42096627|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
19647260|NCT00545740|42096628|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
19647261|NCT00545740|42096625|FG000|Overall Study|Site closure|1|||
19647262|NCT00545740|42096626|FG001|Overall Study|Site closure|0|||
19647263|NCT00545740|42096627|FG002|Overall Study|Site closure|0|||
19647264|NCT00545740|42096628|FG003|Overall Study|Site closure|0|||
19647265|NCT00545740|42096625|FG000|Overall Study|Missed visit|1|||
19647266|NCT00545740|42096626|FG001|Overall Study|Missed visit|0|||
19647267|NCT00545740|42096627|FG002|Overall Study|Missed visit|0|||
19647268|NCT00545740|42096628|FG003|Overall Study|Missed visit|0|||
19647269|NCT00545740|42096625|FG000|Overall Study|Physician Decision|0|||
19647270|NCT00545740|42096626|FG001|Overall Study|Physician Decision|0|||
19647271|NCT00545740|42096627|FG002|Overall Study|Physician Decision|3|||
19647272|NCT00545740|42096628|FG003|Overall Study|Physician Decision|0|||
19647273|NCT00545740|42096625|FG000|Overall Study|Accepted only monthly telephone calls|1|||
19647274|NCT00545740|42096626|FG001|Overall Study|Accepted only monthly telephone calls|0|||
19647275|NCT00545740|42096627|FG002|Overall Study|Accepted only monthly telephone calls|0|||
19647276|NCT00545740|42096628|FG003|Overall Study|Accepted only monthly telephone calls|0|||
19647277|NCT00545740|42096625|FG000|Overall Study|Sponsor decision|0|||
19647278|NCT00545740|42096626|FG001|Overall Study|Sponsor decision|1|||
19647279|NCT00545740|42096627|FG002|Overall Study|Sponsor decision|0|||
19647280|NCT00545740|42096628|FG003|Overall Study|Sponsor decision|0|||
19647281|NCT00545740|42096625|FG000|Overall Study|Lack of time|0|||
19647282|NCT00545740|42096626|FG001|Overall Study|Lack of time|1|||
19647283|NCT00545740|42096627|FG002|Overall Study|Lack of time|0|||
19647284|NCT00545740|42096628|FG003|Overall Study|Lack of time|0|||
19647285|NCT00545740|42096625|FG000|Overall Study|Non-adherence to visits|0|||
19647286|NCT00545740|42096626|FG001|Overall Study|Non-adherence to visits|1|||
19647287|NCT00545740|42096627|FG002|Overall Study|Non-adherence to visits|0|||
19647288|NCT00545740|42096628|FG003|Overall Study|Non-adherence to visits|0|||
19647289|NCT00545740|42096625|FG000|Overall Study|Patient difficulties|0|||
19647290|NCT00545740|42096626|FG001|Overall Study|Patient difficulties|1|||
19647291|NCT00545740|42096627|FG002|Overall Study|Patient difficulties|0|||
19647292|NCT00545740|42096628|FG003|Overall Study|Patient difficulties|0|||
19647293|NCT00545740|42096625|FG000|Overall Study|Husband against study|0|||
19647294|NCT00545740|42096626|FG001|Overall Study|Husband against study|0|||
19647295|NCT00545740|42096627|FG002|Overall Study|Husband against study|1|||
19647296|NCT00545740|42096628|FG003|Overall Study|Husband against study|0|||
19647297|NCT00609609|42096640|FG000|Overall Study|Withdrawal by Subject|2|||
19647298|NCT00609609|42096641|FG001|Overall Study|Withdrawal by Subject|0|||
19647299|NCT00609609|42096640|FG000|Overall Study|Progression|4|||
19647300|NCT00609609|42096641|FG001|Overall Study|Progression|2|||
19647301|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Adverse Event|41|||
19647302|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Adverse Event|24|||
19647303|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
19647304|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
19647305|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
19647306|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
19647307|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Physician Decision|0|||
19647308|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Physician Decision|6|||
19647309|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
19647310|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
19647311|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
19647312|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
19647313|NCT00673452|42096649|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
19647314|NCT00673452|42096650|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
19647315|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
19647316|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
19647317|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
19647318|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
19750303|NCT03289143|42198910|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
19477081|NCT01491035|41755969|FG003|Overall Study|Lost to Follow-up|0|||
19647319|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
19647320|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
19647321|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
19647322|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
19647323|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
19647324|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
19647325|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
19647326|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
19647327|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
19647328|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
19647329|NCT00673452|42096649|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
19647330|NCT00673452|42096650|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
19647331|NCT00545584|42096659|FG000|Overall Study|Only one reason for discontinuation|62|||
19647332|NCT00545584|42096660|FG001|Overall Study|Only one reason for discontinuation|61|||
19647333|NCT00545584|42096661|FG002|Overall Study|Only one reason for discontinuation|48|||
19647334|NCT00545584|42096659|FG000|Overall Study|Two or more reasons for discontinuation|17|||
19647335|NCT00545584|42096660|FG001|Overall Study|Two or more reasons for discontinuation|19|||
19647336|NCT00545584|42096661|FG002|Overall Study|Two or more reasons for discontinuation|8|||
19647337|NCT00378703|42096673|FG000|Overall Study|Disease progression|59|||
19647338|NCT00378703|42096674|FG001|Overall Study|Disease progression|43|||
19647339|NCT00378703|42096675|FG002|Overall Study|Disease progression|48|||
19647340|NCT00378703|42096676|FG003|Overall Study|Disease progression|49|||
19647341|NCT00378703|42096673|FG000|Overall Study|Adverse Event|11|||
19647342|NCT00378703|42096674|FG001|Overall Study|Adverse Event|17|||
19647343|NCT00378703|42096675|FG002|Overall Study|Adverse Event|20|||
19647344|NCT00378703|42096676|FG003|Overall Study|Adverse Event|18|||
19647345|NCT00378703|42096673|FG000|Overall Study|Death|2|||
19647346|NCT00378703|42096674|FG001|Overall Study|Death|2|||
19647347|NCT00378703|42096675|FG002|Overall Study|Death|4|||
19647348|NCT00378703|42096676|FG003|Overall Study|Death|3|||
19647349|NCT00378703|42096673|FG000|Overall Study|Withdrawal by Subject|4|||
19647350|NCT00378703|42096674|FG001|Overall Study|Withdrawal by Subject|8|||
19647351|NCT00378703|42096675|FG002|Overall Study|Withdrawal by Subject|5|||
19647352|NCT00378703|42096676|FG003|Overall Study|Withdrawal by Subject|7|||
19647353|NCT00378703|42096673|FG000|Overall Study|Physician Decision|1|||
19647354|NCT00378703|42096674|FG001|Overall Study|Physician Decision|4|||
19647355|NCT00378703|42096675|FG002|Overall Study|Physician Decision|1|||
19647356|NCT00378703|42096676|FG003|Overall Study|Physician Decision|0|||
19647357|NCT00378703|42096673|FG000|Overall Study|Alternative therapy|4|||
19647358|NCT00378703|42096674|FG001|Overall Study|Alternative therapy|2|||
19647359|NCT00378703|42096675|FG002|Overall Study|Alternative therapy|0|||
19647360|NCT00378703|42096676|FG003|Overall Study|Alternative therapy|0|||
19647361|NCT00378703|42096673|FG000|Overall Study|Other complicated disease|0|||
19647362|NCT00378703|42096674|FG001|Overall Study|Other complicated disease|2|||
19647363|NCT00378703|42096675|FG002|Overall Study|Other complicated disease|2|||
19647364|NCT00378703|42096676|FG003|Overall Study|Other complicated disease|0|||
19647365|NCT00378703|42096673|FG000|Overall Study|Symptomatic deterioration|0|||
19647366|NCT00378703|42096674|FG001|Overall Study|Symptomatic deterioration|1|||
19647367|NCT00378703|42096675|FG002|Overall Study|Symptomatic deterioration|0|||
19647368|NCT00378703|42096676|FG003|Overall Study|Symptomatic deterioration|2|||
19647369|NCT00378703|42096673|FG000|Overall Study|Surgery|1|||
19647370|NCT00378703|42096674|FG001|Overall Study|Surgery|0|||
19647371|NCT00378703|42096675|FG002|Overall Study|Surgery|0|||
19647372|NCT00378703|42096676|FG003|Overall Study|Surgery|1|||
19647373|NCT00378703|42096673|FG000|Overall Study|Joint decision of physician and patient|1|||
19647374|NCT00378703|42096674|FG001|Overall Study|Joint decision of physician and patient|0|||
19647375|NCT00378703|42096675|FG002|Overall Study|Joint decision of physician and patient|0|||
19647376|NCT00378703|42096676|FG003|Overall Study|Joint decision of physician and patient|0|||
19647377|NCT00378703|42096673|FG000|Overall Study|Adverse events and progressive disease|0|||
19647378|NCT00378703|42096674|FG001|Overall Study|Adverse events and progressive disease|0|||
19647379|NCT00378703|42096675|FG002|Overall Study|Adverse events and progressive disease|0|||
19647380|NCT00378703|42096676|FG003|Overall Study|Adverse events and progressive disease|1|||
19647381|NCT00378703|42096673|FG000|Overall Study|Relocation|0|||
19647382|NCT00378703|42096674|FG001|Overall Study|Relocation|0|||
19647383|NCT00378703|42096675|FG002|Overall Study|Relocation|1|||
19750304|NCT03289143|42198911|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
19647384|NCT00378703|42096676|FG003|Overall Study|Relocation|0|||
19647385|NCT00378703|42096673|FG000|Overall Study|Ineligible|4|||
19647386|NCT00378703|42096674|FG001|Overall Study|Ineligible|7|||
19647387|NCT00378703|42096675|FG002|Overall Study|Ineligible|7|||
19647388|NCT00378703|42096676|FG003|Overall Study|Ineligible|7|||
19647389|NCT00378703|42096673|FG000|Overall Study|Never started treatment|1|||
19647390|NCT00378703|42096674|FG001|Overall Study|Never started treatment|4|||
19647391|NCT00378703|42096675|FG002|Overall Study|Never started treatment|0|||
19647392|NCT00378703|42096676|FG003|Overall Study|Never started treatment|0|||
19750305|NCT03289143|42198912|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
19750306|NCT03289143|42198913|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
19750307|NCT03289143|42198910|FG000|Overall Study|Withdrawal by Caregiver|0|||
19750308|NCT03289143|42198911|FG001|Overall Study|Withdrawal by Caregiver|1|||
19750309|NCT03289143|42198912|FG002|Overall Study|Withdrawal by Caregiver|0|||
19750310|NCT03289143|42198913|FG003|Overall Study|Withdrawal by Caregiver|0|||
19750311|NCT03289143|42198910|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
19750312|NCT03289143|42198911|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
19750313|NCT03289143|42198912|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
19750314|NCT03289143|42198913|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
19750315|NCT03289143|42198910|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
19750316|NCT03289143|42198911|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
19750317|NCT03289143|42198912|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
19750318|NCT03289143|42198913|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
19750319|NCT03311724|42198932|FG000|Overall Study|Physician Decision|0|||
19750320|NCT03311724|42198933|FG001|Overall Study|Physician Decision|0|||
19750321|NCT03311724|42198934|FG002|Overall Study|Physician Decision|0|||
19750322|NCT03311724|42198935|FG003|Overall Study|Physician Decision|1|||
19750323|NCT03311724|42198932|FG000|Overall Study|Protocol Violation|1|||
19750324|NCT03311724|42198933|FG001|Overall Study|Protocol Violation|0|||
19750325|NCT03311724|42198934|FG002|Overall Study|Protocol Violation|1|||
19750326|NCT03311724|42198935|FG003|Overall Study|Protocol Violation|0|||
19750327|NCT03311724|42198932|FG000|Overall Study|Withdrawal by Subject|1|||
19750328|NCT03311724|42198933|FG001|Overall Study|Withdrawal by Subject|1|||
19750329|NCT03311724|42198934|FG002|Overall Study|Withdrawal by Subject|0|||
19750330|NCT03311724|42198935|FG003|Overall Study|Withdrawal by Subject|0|||
19750331|NCT03311724|42198932|FG000|Overall Study|Lost to Follow-up|1|||
19750332|NCT03311724|42198933|FG001|Overall Study|Lost to Follow-up|0|||
19750333|NCT03311724|42198934|FG002|Overall Study|Lost to Follow-up|0|||
19750334|NCT03311724|42198935|FG003|Overall Study|Lost to Follow-up|0|||
19647393|NCT00378703|42096673|FG000|Overall Study|Other|1|||
19647394|NCT00378703|42096674|FG001|Overall Study|Other|1|||
19647395|NCT00378703|42096675|FG002|Overall Study|Other|2|||
19647396|NCT00378703|42096676|FG003|Overall Study|Other|3|||
19647397|NCT00368641|42096692|FG000|Overall Study|Adverse Event|2|||
19647398|NCT00368641|42096693|FG001|Overall Study|Adverse Event|1|||
19647399|NCT00368641|42096692|FG000|Overall Study|Death|1|||
19647400|NCT00368641|42096693|FG001|Overall Study|Death|0|||
19647401|NCT00368641|42096692|FG000|Overall Study|Withdrawal by Subject|1|||
19647402|NCT00368641|42096693|FG001|Overall Study|Withdrawal by Subject|0|||
19647403|NCT00368641|42096692|FG000|Overall Study|Sponsor decision to terminate study|2|||
19647404|NCT00368641|42096693|FG001|Overall Study|Sponsor decision to terminate study|5|||
19647405|NCT00608985|42096703|FG000|Overall Study|Adverse Event|2|||
19647406|NCT00608985|42096704|FG001|Overall Study|Adverse Event|7|||
19647407|NCT00608985|42096705|FG002|Overall Study|Adverse Event|4|||
19647408|NCT00608985|42096706|FG003|Overall Study|Adverse Event|6|||
19647409|NCT00608985|42096703|FG000|Overall Study|Administrative/Other|7|||
19647410|NCT00608985|42096704|FG001|Overall Study|Administrative/Other|4|||
19647411|NCT00608985|42096705|FG002|Overall Study|Administrative/Other|1|||
19647412|NCT00608985|42096706|FG003|Overall Study|Administrative/Other|2|||
19647413|NCT00608985|42096703|FG000|Overall Study|Withdrawal of Consent|5|||
19647414|NCT00608985|42096704|FG001|Overall Study|Withdrawal of Consent|1|||
19647415|NCT00608985|42096705|FG002|Overall Study|Withdrawal of Consent|1|||
19647416|NCT00608985|42096706|FG003|Overall Study|Withdrawal of Consent|1|||
19647417|NCT00608985|42096703|FG000|Overall Study|Lost to Follow-up|2|||
19647418|NCT00608985|42096704|FG001|Overall Study|Lost to Follow-up|1|||
19647419|NCT00608985|42096705|FG002|Overall Study|Lost to Follow-up|0|||
19647420|NCT00608985|42096706|FG003|Overall Study|Lost to Follow-up|0|||
19647421|NCT00368251|42096719|FG000|Overall Study|SAE, non-fatal|1|||
19647422|NCT00368251|42096720|FG001|Overall Study|SAE, non-fatal|0|||
19647423|NCT00368251|42096721|FG002|Overall Study|SAE, non-fatal|0|||
19647424|NCT00368251|42096719|FG000|Overall Study|AE, non-serious non-fatal|0|||
19647425|NCT00368251|42096720|FG001|Overall Study|AE, non-serious non-fatal|0|||
19647426|NCT00368251|42096721|FG002|Overall Study|AE, non-serious non-fatal|1|||
19647427|NCT00378079|42096732|FG000|Overall Study|Lost to Follow-up|6|||
19750335|NCT03311724|42198932|FG000|Overall Study|Sponsor Decision|0|||
19750336|NCT03311724|42198933|FG001|Overall Study|Sponsor Decision|0|||
19647428|NCT00378079|42096733|FG001|Overall Study|Lost to Follow-up|1|||
19647429|NCT00378079|42096734|FG002|Overall Study|Lost to Follow-up|0|||
19647430|NCT03936244|42096744|FG000|Overall Study|Lost to Follow-up|5|||
19647431|NCT03936244|42096745|FG001|Overall Study|Lost to Follow-up|1|||
19647432|NCT03936244|42096744|FG000|Overall Study|Physician Decision|7|||
19647433|NCT03936244|42096745|FG001|Overall Study|Physician Decision|3|||
19750337|NCT03311724|42198934|FG002|Overall Study|Sponsor Decision|1|||
19647434|NCT03923530|42096752|FG000|Overall Study|Withdrawal by Subject|1|||
19647435|NCT03923530|42096752|FG000|Overall Study|screen failure|3|||
19647436|NCT00608907|42096759|FG000|Overall Study|Adverse Event|6|||
19647437|NCT00608907|42096760|FG001|Overall Study|Adverse Event|0|||
19647438|NCT00608907|42096761|FG002|Overall Study|Adverse Event|1|||
19647439|NCT00608907|42096759|FG000|Overall Study|Death|1|||
19647440|NCT00608907|42096760|FG001|Overall Study|Death|0|||
19647441|NCT00608907|42096761|FG002|Overall Study|Death|0|||
19647442|NCT00608907|42096759|FG000|Overall Study|Withdrawal by Subject|4|||
19647443|NCT00608907|42096760|FG001|Overall Study|Withdrawal by Subject|0|||
19647444|NCT00608907|42096761|FG002|Overall Study|Withdrawal by Subject|0|||
19647445|NCT00608907|42096759|FG000|Overall Study|Progressive Disease|1|||
19647446|NCT00608907|42096760|FG001|Overall Study|Progressive Disease|0|||
19647447|NCT00608907|42096761|FG002|Overall Study|Progressive Disease|0|||
19647448|NCT00377611|42096771|FG000|Overall Study|Adverse Event|2|||
19647449|NCT00377611|42096772|FG001|Overall Study|Adverse Event|9|||
19647450|NCT00377611|42096771|FG000|Overall Study|Protocol Violation|2|||
19647451|NCT00377611|42096772|FG001|Overall Study|Protocol Violation|0|||
19647452|NCT00377611|42096771|FG000|Overall Study|Withdrawal by Subject|0|||
19647453|NCT00377611|42096772|FG001|Overall Study|Withdrawal by Subject|5|||
19647454|NCT00377611|42096771|FG000|Overall Study|Lost to Follow-up|18|||
19647455|NCT00377611|42096772|FG001|Overall Study|Lost to Follow-up|16|||
19647456|NCT00377611|42096771|FG000|Overall Study|Other|0|||
19647457|NCT00377611|42096772|FG001|Overall Study|Other|3|||
19647458|NCT00545272|42096785|FG000|Overall Study|Protocol deviation|0|||
19647459|NCT00545272|42096786|FG001|Overall Study|Protocol deviation|1|||
19647460|NCT00545272|42096787|FG002|Overall Study|Protocol deviation|0|||
19647461|NCT00545272|42096788|FG003|Overall Study|Protocol deviation|1|||
19750338|NCT03311724|42198935|FG003|Overall Study|Sponsor Decision|0|||
19750339|NCT03311646|42198957|FG000|Overall Study|Physician Decision|1|||
19750340|NCT03311646|42198957|FG000|Overall Study|Withdrawal by Subject|5|||
19750341|NCT03311646|42198957|FG000|Overall Study|Lost to Follow-up|5|||
19647462|NCT00545272|42096789|FG004|Overall Study|Protocol deviation|0|||
19647463|NCT00545272|42096790|FG005|Overall Study|Protocol deviation|1|||
19647464|NCT00545272|42096785|FG000|Overall Study|Adverse Event|0|||
19647465|NCT00545272|42096786|FG001|Overall Study|Adverse Event|0|||
19647466|NCT00545272|42096787|FG002|Overall Study|Adverse Event|1|||
19647467|NCT00545272|42096788|FG003|Overall Study|Adverse Event|0|||
19647468|NCT00545272|42096789|FG004|Overall Study|Adverse Event|0|||
19647469|NCT00545272|42096790|FG005|Overall Study|Adverse Event|1|||
19647470|NCT00545272|42096785|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19647471|NCT00545272|42096786|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19647472|NCT00545272|42096787|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19647473|NCT00545272|42096788|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19647474|NCT00545272|42096789|FG004|Overall Study|Abnormal laboratory value(s)|0|||
19647475|NCT00545272|42096790|FG005|Overall Study|Abnormal laboratory value(s)|1|||
19647476|NCT00545272|42096785|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19647477|NCT00545272|42096786|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19647478|NCT00545272|42096787|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19647479|NCT00545272|42096788|FG003|Overall Study|Abnormal test procedure result(s)|0|||
19647480|NCT00545272|42096789|FG004|Overall Study|Abnormal test procedure result(s)|1|||
19647481|NCT00545272|42096790|FG005|Overall Study|Abnormal test procedure result(s)|0|||
19647482|NCT00545272|42096785|FG000|Overall Study|Lost to Follow-up|0|||
19647483|NCT00545272|42096786|FG001|Overall Study|Lost to Follow-up|0|||
19647484|NCT00545272|42096787|FG002|Overall Study|Lost to Follow-up|0|||
19647485|NCT00545272|42096788|FG003|Overall Study|Lost to Follow-up|0|||
19647486|NCT00545272|42096789|FG004|Overall Study|Lost to Follow-up|1|||
19647487|NCT00545272|42096790|FG005|Overall Study|Lost to Follow-up|0|||
19647488|NCT00377455|42096804|FG000|Overall Study|Withdrawal by Subject|1|||
19647489|NCT00377299|42096810|FG000|Overall Study|Lost to Follow-up|14|||
19647490|NCT00377299|42096811|FG001|Overall Study|Lost to Follow-up|19|||
19647491|NCT00377299|42096810|FG000|Overall Study|Adverse Event|0|||
19647492|NCT00377299|42096811|FG001|Overall Study|Adverse Event|1|||
19750342|NCT03311646|42198957|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
19750343|NCT01672892|42198964|FG000|Overall Study|Protocol Violation|7|||
19647493|NCT00377299|42096810|FG000|Overall Study|Withdrawal by Subject|5|||
19647494|NCT00377299|42096811|FG001|Overall Study|Withdrawal by Subject|4|||
19647495|NCT00376675|42096820|FG000|Overall Study|Withdrawal by Subject|9|||
19647496|NCT00376675|42096821|FG001|Overall Study|Withdrawal by Subject|2|||
19647497|NCT00376675|42096820|FG000|Overall Study|Adverse Event|10|||
19647498|NCT00376675|42096821|FG001|Overall Study|Adverse Event|5|||
19647499|NCT00376675|42096820|FG000|Overall Study|Other Reason|1|||
19647500|NCT00376675|42096821|FG001|Overall Study|Other Reason|7|||
19647501|NCT03931330|42096827|FG000|Overall Study|Physician Decision|1|||
19647502|NCT00367237|42096834|FG000|Overall Study|Adverse Event|7|||
19647503|NCT00367237|42096835|FG001|Overall Study|Adverse Event|2|||
19647504|NCT00367237|42096834|FG000|Overall Study|Lost to Follow-up|1|||
19647505|NCT00367237|42096835|FG001|Overall Study|Lost to Follow-up|0|||
19647506|NCT00367237|42096834|FG000|Overall Study|Withdrawal by Subject|0|||
19750344|NCT01672892|42198965|FG001|Overall Study|Protocol Violation|3|||
19647507|NCT00367237|42096835|FG001|Overall Study|Withdrawal by Subject|4|||
19647508|NCT00367237|42096834|FG000|Overall Study|Protocol Violation|2|||
19647509|NCT00367237|42096835|FG001|Overall Study|Protocol Violation|5|||
19647510|NCT00544882|42096843|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
19647511|NCT00544882|42096844|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
19647512|NCT00544882|42096845|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
19647513|NCT00544882|42096843|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
19647514|NCT00544882|42096844|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
19750345|NCT03288987|42198976|FG000|Overall Study|Protocol Violation|10|||
19750346|NCT03288987|42198977|FG001|Overall Study|Protocol Violation|4|||
19750347|NCT02939781|42198983|FG000|Overall Study|Protocol Violation|8|||
19750348|NCT02939781|42198983|FG000|Overall Study|Withdrawal by Subject|1|||
19750349|NCT03083990|42198999|FG000|Overall Study|Adverse Event|1|||
19750350|NCT03083990|42199000|FG001|Overall Study|Adverse Event|0|||
19750351|NCT03252015|42199010|FG000|Overall Study|Withdrawal by Subject|0|||
19750352|NCT03252015|42199011|FG001|Overall Study|Withdrawal by Subject|1|||
19750353|NCT03252015|42199012|FG002|Overall Study|Withdrawal by Subject|1|||
19750354|NCT03252015|42199013|FG003|Overall Study|Withdrawal by Subject|0|||
19750355|NCT03252015|42199010|FG000|Overall Study|Adverse Event|1|||
19750356|NCT03252015|42199011|FG001|Overall Study|Adverse Event|0|||
19750357|NCT03252015|42199012|FG002|Overall Study|Adverse Event|0|||
19750358|NCT03252015|42199013|FG003|Overall Study|Adverse Event|1|||
19750359|NCT03083132|42199039|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
19750360|NCT03083132|42199040|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
19750361|NCT03083132|42199039|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
19750362|NCT03083132|42199040|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
19750363|NCT03083132|42199039|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
19750364|NCT03083132|42199040|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
19750365|NCT03683823|42199048|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
19750366|NCT03683823|42199049|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
19750367|NCT03683823|42199048|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
19750368|NCT03683823|42199049|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
19750369|NCT03683823|42199048|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
19750370|NCT03683823|42199049|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
19750371|NCT03285711|42199057|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
19750372|NCT03285711|42199058|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
19750373|NCT03285711|42199059|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
19750374|NCT03285711|42199060|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
19750375|NCT03285711|42199057|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
19750376|NCT03285711|42199058|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
19750377|NCT03285711|42199059|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
19647515|NCT00544882|42096845|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
19647516|NCT00544882|42096843|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
19647517|NCT00544882|42096844|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
19647518|NCT00544882|42096845|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
19647519|NCT00544882|42096843|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
19647520|NCT00544882|42096844|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
19647521|NCT00544882|42096845|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
19647522|NCT00544882|42096843|FG000|Cycle 3: Follow-up|Noncompliance|0|||
19647523|NCT00544882|42096844|FG001|Cycle 3: Follow-up|Noncompliance|1|||
19647524|NCT00544882|42096845|FG002|Cycle 3: Follow-up|Noncompliance|0|||
19647525|NCT00544882|42096843|FG000|Cycle 3: Follow-up|Pregnancy|0|||
19647526|NCT00544882|42096844|FG001|Cycle 3: Follow-up|Pregnancy|1|||
19647527|NCT00544882|42096845|FG002|Cycle 3: Follow-up|Pregnancy|0|||
19647528|NCT00606801|42096853|FG000|Intervention|Protocol Violation|3|||
19647529|NCT00606801|42096854|FG001|Intervention|Protocol Violation|3|||
19647530|NCT00606177|42096866|FG000|Overall Study|Adverse Event|9|||
19647531|NCT00606177|42096867|FG001|Overall Study|Adverse Event|5|||
19647532|NCT00606177|42096866|FG000|Overall Study|Lack of Efficacy|3|||
19647533|NCT00606177|42096867|FG001|Overall Study|Lack of Efficacy|7|||
19647534|NCT00606177|42096866|FG000|Overall Study|Physician Decision|1|||
19750378|NCT03285711|42199060|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
19750379|NCT03285711|42199057|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
19750380|NCT03285711|42199058|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
19750381|NCT03285711|42199059|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
19750382|NCT03285711|42199060|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
19750383|NCT03285711|42199057|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
19647535|NCT00606177|42096867|FG001|Overall Study|Physician Decision|0|||
19647536|NCT00606177|42096866|FG000|Overall Study|Protocol Violation|1|||
19647537|NCT00606177|42096867|FG001|Overall Study|Protocol Violation|4|||
19647538|NCT00606177|42096866|FG000|Overall Study|Withdrawal by Subject|5|||
19647539|NCT00606177|42096867|FG001|Overall Study|Withdrawal by Subject|6|||
19750384|NCT03285711|42199058|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
19647540|NCT00606177|42096866|FG000|Overall Study|Progression to depressive phase|6|||
19647541|NCT00606177|42096867|FG001|Overall Study|Progression to depressive phase|1|||
19647542|NCT00606177|42096866|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
19647543|NCT00606177|42096867|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
19647544|NCT00606177|42096866|FG000|Overall Study|Change of residence or other commitments|1|||
19647545|NCT00606177|42096867|FG001|Overall Study|Change of residence or other commitments|1|||
19647546|NCT00359281|42096882|FG000|Overall Study|Adverse Event|1|||
19647547|NCT00359281|42096883|FG001|Overall Study|Adverse Event|0|||
19647548|NCT00359281|42096884|FG002|Overall Study|Adverse Event|0|||
19647549|NCT00359281|42096885|FG003|Overall Study|Adverse Event|0|||
19647550|NCT00359281|42096886|FG004|Overall Study|Adverse Event|0|||
19647551|NCT00359281|42096887|FG005|Overall Study|Adverse Event|0|||
19647552|NCT00359281|42096888|FG006|Overall Study|Adverse Event|1|||
19647553|NCT00359281|42096889|FG007|Overall Study|Adverse Event|0|||
19647554|NCT00359281|42096890|FG008|Overall Study|Adverse Event|0|||
19647555|NCT00359281|42096882|FG000|Overall Study|Withdrawal by Subject|0|||
19647556|NCT00359281|42096883|FG001|Overall Study|Withdrawal by Subject|0|||
19647557|NCT00359281|42096884|FG002|Overall Study|Withdrawal by Subject|0|||
19647558|NCT00359281|42096885|FG003|Overall Study|Withdrawal by Subject|0|||
19647559|NCT00359281|42096886|FG004|Overall Study|Withdrawal by Subject|0|||
19647560|NCT00359281|42096887|FG005|Overall Study|Withdrawal by Subject|0|||
19647561|NCT00359281|42096888|FG006|Overall Study|Withdrawal by Subject|1|||
19647562|NCT00359281|42096889|FG007|Overall Study|Withdrawal by Subject|0|||
19647563|NCT00359281|42096890|FG008|Overall Study|Withdrawal by Subject|0|||
19647564|NCT00366535|42096919|FG000|First Phase: 12 Weeks|Adverse Event|1|||
19647565|NCT00366535|42096920|FG001|First Phase: 12 Weeks|Adverse Event|3|||
19647566|NCT00366535|42096919|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
19647567|NCT00366535|42096920|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
19647568|NCT00366535|42096919|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
19647569|NCT00366535|42096920|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
19647570|NCT00366535|42096919|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
19647571|NCT00366535|42096920|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
19647572|NCT00350545|42096934|FG000|Overall Study|Withdrawal by Subject|2|||
19647573|NCT00349921|42096942|FG000|First Spinal Injection|Physician Decision|1|||
19647574|NCT00349921|42096943|FG001|First Spinal Injection|Physician Decision|0|||
19647575|NCT00349921|42096944|FG002|First Spinal Injection|Physician Decision|0|||
19647576|NCT00349921|42096945|FG003|First Spinal Injection|Physician Decision|0|||
19647577|NCT00349921|42096942|FG000|First Spinal Injection|Adverse Event|0|||
19647578|NCT00349921|42096943|FG001|First Spinal Injection|Adverse Event|0|||
19647579|NCT00349921|42096944|FG002|First Spinal Injection|Adverse Event|1|||
19647580|NCT00349921|42096945|FG003|First Spinal Injection|Adverse Event|0|||
19647581|NCT00606021|42096956|FG000|Induction Phase|Death|73|||
19647582|NCT00606021|42096957|FG001|Induction Phase|Death|0|||
19647583|NCT00606021|42096958|FG002|Induction Phase|Death|0|||
19647584|NCT00606021|42096956|FG000|Induction Phase|Physician Decision|2|||
19647585|NCT00606021|42096957|FG001|Induction Phase|Physician Decision|0|||
19647586|NCT00606021|42096958|FG002|Induction Phase|Physician Decision|0|||
19647587|NCT00606021|42096956|FG000|Induction Phase|Withdrawal by Subject|2|||
19647588|NCT00606021|42096957|FG001|Induction Phase|Withdrawal by Subject|0|||
19647589|NCT00606021|42096958|FG002|Induction Phase|Withdrawal by Subject|0|||
19647590|NCT00606021|42096956|FG000|Induction Phase|Lost to Follow-up|10|||
19647591|NCT00606021|42096957|FG001|Induction Phase|Lost to Follow-up|0|||
19647592|NCT00606021|42096958|FG002|Induction Phase|Lost to Follow-up|0|||
19647593|NCT00606021|42096956|FG000|Maintenance Phase|Death|0|||
19647594|NCT00606021|42096957|FG001|Maintenance Phase|Death|17|||
19647595|NCT00606021|42096958|FG002|Maintenance Phase|Death|15|||
19647596|NCT00606021|42096956|FG000|Maintenance Phase|Physician Decision|0|||
19647597|NCT00606021|42096957|FG001|Maintenance Phase|Physician Decision|1|||
19647598|NCT00606021|42096958|FG002|Maintenance Phase|Physician Decision|0|||
19647599|NCT00606021|42096956|FG000|Maintenance Phase|Lost to Follow-up|0|||
19647600|NCT00606021|42096957|FG001|Maintenance Phase|Lost to Follow-up|5|||
19388191|NCT02564055|41631571|FG004|Overall Study|Reached stopping criteria|0|||
19647601|NCT00606021|42096958|FG002|Maintenance Phase|Lost to Follow-up|2|||
19647602|NCT00337675|42096969|FG000|Overall Study|Adverse Event|10|||
19647603|NCT00337675|42096970|FG001|Overall Study|Adverse Event|9|||
19647604|NCT00337675|42096971|FG002|Overall Study|Adverse Event|19|||
19647605|NCT00337675|42096969|FG000|Overall Study|Lack of Efficacy|10|||
19647606|NCT00337675|42096970|FG001|Overall Study|Lack of Efficacy|7|||
19647607|NCT00337675|42096971|FG002|Overall Study|Lack of Efficacy|9|||
19647608|NCT00337675|42096969|FG000|Overall Study|Lost to Follow-up|22|||
19647609|NCT00337675|42096970|FG001|Overall Study|Lost to Follow-up|19|||
19647610|NCT00337675|42096971|FG002|Overall Study|Lost to Follow-up|17|||
19647611|NCT00337675|42096969|FG000|Overall Study|Physician Decision|9|||
19647612|NCT00337675|42096970|FG001|Overall Study|Physician Decision|17|||
19647613|NCT00337675|42096971|FG002|Overall Study|Physician Decision|14|||
19750385|NCT03285711|42199059|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
19750386|NCT03285711|42199060|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
19750387|NCT03341936|42199070|FG000|Overall Study|Ineligible|1|||
19750388|NCT03341936|42199070|FG000|Overall Study|Disease Progression|2|||
19750389|NCT03341936|42199070|FG000|Overall Study|Withdrew Consent|4|||
19750390|NCT03341936|42199070|FG000|Overall Study|Non-Compliance|1|||
19750391|NCT03341936|42199070|FG000|Overall Study|Physician Decision|1|||
19750392|NCT03341936|42199070|FG000|Overall Study|Withdrawal by Subject|1|||
19750393|NCT03341936|42199070|FG000|Overall Study|Other|1|||
19750394|NCT02927366|42199076|FG000|Overall Study|Adverse Event|1|||
19750395|NCT02927366|42199077|FG001|Overall Study|Adverse Event|0|||
19750396|NCT02927366|42199076|FG000|Overall Study|Patient schedule|1|||
19750397|NCT02927366|42199077|FG001|Overall Study|Patient schedule|0|||
19750398|NCT03249909|42199086|FG000|Overall Study|Withdrawal by Subject|3|||
19750399|NCT03249909|42199087|FG001|Overall Study|Withdrawal by Subject|0|||
19750400|NCT03249909|42199088|FG002|Overall Study|Withdrawal by Subject|0|||
19750401|NCT03249909|42199086|FG000|Overall Study|Adverse Event|3|||
19750402|NCT03249909|42199087|FG001|Overall Study|Adverse Event|0|||
19750403|NCT03249909|42199088|FG002|Overall Study|Adverse Event|0|||
19750404|NCT03249909|42199086|FG000|Overall Study|Lost to Follow-up|0|||
19750405|NCT03249909|42199087|FG001|Overall Study|Lost to Follow-up|1|||
19750406|NCT03249909|42199088|FG002|Overall Study|Lost to Follow-up|0|||
19750407|NCT03081884|42199099|FG000|Overall Study|deferred prostate cancer treatment|1|||
19750408|NCT03081884|42199099|FG000|Overall Study|metastasis managed with systemic therapy|3|||
19750409|NCT03077438|42199106|FG000|Overall Study|Protocol Violation|3|||
19750410|NCT03077438|42199107|FG001|Overall Study|Protocol Violation|5|||
19750411|NCT03077438|42199106|FG000|Overall Study|Withdrawal by Subject|3|||
19750412|NCT03077438|42199107|FG001|Overall Study|Withdrawal by Subject|6|||
19750413|NCT03077438|42199106|FG000|Overall Study|Lost to Follow-up|6|||
19750414|NCT03077438|42199107|FG001|Overall Study|Lost to Follow-up|3|||
19750415|NCT03076970|42199117|FG000|Washout Period 2|Adverse Event|0|||
19750416|NCT03076970|42199118|FG001|Washout Period 2|Adverse Event|0|||
19750417|NCT03076970|42199119|FG002|Washout Period 2|Adverse Event|0|||
19750418|NCT03076970|42199120|FG003|Washout Period 2|Adverse Event|0|||
19750419|NCT03076970|42199121|FG004|Washout Period 2|Adverse Event|1|||
19750420|NCT03076970|42199122|FG005|Washout Period 2|Adverse Event|0|||
19750421|NCT03076970|42199117|FG000|Period 3|Withdrawal by Subject|0|||
19750422|NCT03076970|42199118|FG001|Period 3|Withdrawal by Subject|0|||
19750423|NCT03076970|42199119|FG002|Period 3|Withdrawal by Subject|0|||
19750424|NCT03076970|42199120|FG003|Period 3|Withdrawal by Subject|0|||
19750425|NCT03076970|42199121|FG004|Period 3|Withdrawal by Subject|0|||
19750426|NCT03076970|42199122|FG005|Period 3|Withdrawal by Subject|1|||
19750427|NCT03076970|42199117|FG000|Period 3|Failure to meet I/E criteria|0|||
19750428|NCT03076970|42199118|FG001|Period 3|Failure to meet I/E criteria|0|||
19750429|NCT03076970|42199119|FG002|Period 3|Failure to meet I/E criteria|0|||
19750430|NCT03076970|42199120|FG003|Period 3|Failure to meet I/E criteria|0|||
19750431|NCT03076970|42199121|FG004|Period 3|Failure to meet I/E criteria|1|||
19750432|NCT03076970|42199122|FG005|Period 3|Failure to meet I/E criteria|0|||
19750433|NCT00726596|42199135|FG000|Overall Study|Adverse Event|2|||
19750434|NCT00726596|42199136|FG001|Overall Study|Adverse Event|1|||
19750435|NCT00726596|42199135|FG000|Overall Study|Withdrawal by Subject|3|||
19750436|NCT00726596|42199136|FG001|Overall Study|Withdrawal by Subject|3|||
19750437|NCT02890992|42199159|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750438|NCT02890992|42199160|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
19750439|NCT02890992|42199161|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750440|NCT02890992|42199162|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750441|NCT02890992|42199163|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750442|NCT02890992|42199164|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750443|NCT02890992|42199165|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750444|NCT02890992|42199166|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
19750445|NCT02890992|42199159|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750446|NCT02890992|42199160|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750447|NCT02890992|42199161|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750448|NCT02890992|42199162|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750449|NCT02890992|42199163|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750450|NCT02890992|42199164|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
19750451|NCT02890992|42199165|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
19750452|NCT02890992|42199166|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
19750453|NCT02890992|42199159|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750454|NCT02890992|42199160|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
19750455|NCT02890992|42199161|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750456|NCT02890992|42199162|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
19477082|NCT01491035|41755970|FG004|Overall Study|Lost to Follow-up|1|||
19750457|NCT02890992|42199163|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750458|NCT02890992|42199164|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750459|NCT02890992|42199165|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750460|NCT02890992|42199166|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
19750461|NCT03076190|42199211|FG000|Overall Study|Lost to Follow-up|9|||
19750462|NCT03076190|42199212|FG001|Overall Study|Lost to Follow-up|34|||
19750463|NCT03076190|42199211|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
19750464|NCT03076190|42199212|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
19750465|NCT03329196|42199223|FG000|Overall Study|Adverse Event|10|||
19750466|NCT03329196|42199224|FG001|Overall Study|Adverse Event|5|||
19750467|NCT03329196|42199223|FG000|Overall Study|Physician Decision|2|||
19750468|NCT03329196|42199224|FG001|Overall Study|Physician Decision|2|||
19750469|NCT03329196|42199223|FG000|Overall Study|Withdrawal by Subject|11|||
19750470|NCT03329196|42199224|FG001|Overall Study|Withdrawal by Subject|3|||
19750471|NCT03329196|42199223|FG000|Overall Study|Hepatic function abnormalities|0|||
19750472|NCT03329196|42199224|FG001|Overall Study|Hepatic function abnormalities|1|||
19750473|NCT03329196|42199223|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
19750474|NCT03329196|42199224|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
19750475|NCT03329196|42199223|FG000|Overall Study|Difficult to control Hb|2|||
19750476|NCT03329196|42199224|FG001|Overall Study|Difficult to control Hb|3|||
19750477|NCT03329196|42199223|FG000|Overall Study|Dialysis or renal transplant|13|||
19750478|NCT03329196|42199224|FG001|Overall Study|Dialysis or renal transplant|15|||
19750479|NCT03328182|42199230|FG000|Overall Study|Withdrawal by Subject|1|||
19750480|NCT03328182|42199230|FG000|Overall Study|Protocol Violation|2|||
19750481|NCT03328182|42199230|FG000|Overall Study|No Product Evaluated|1|||
19750482|NCT03327402|42199234|FG000|Overall Study|Withdrawal by Subject|1|||
19750483|NCT03327402|42199234|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
19750484|NCT03075878|42199238|FG000|Overall Study|Physician Decision|1|||
19750485|NCT03326856|42199247|FG000|Overall Study|Lost to Follow-up|1|||
19750486|NCT03326856|42199248|FG001|Overall Study|Lost to Follow-up|1|||
19750487|NCT03326856|42199249|FG002|Overall Study|Lost to Follow-up|0|||
19750488|NCT03326856|42199250|FG003|Overall Study|Lost to Follow-up|0|||
19750489|NCT03326856|42199251|FG004|Overall Study|Lost to Follow-up|0|||
19750490|NCT03309696|42199265|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
19750491|NCT03309696|42199266|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
19477083|NCT01491035|41755971|FG005|Overall Study|Lost to Follow-up|0|||
19647614|NCT00337675|42096969|FG000|Overall Study|Protocol Violation|21|||
19647615|NCT00337675|42096970|FG001|Overall Study|Protocol Violation|24|||
19647616|NCT00337675|42096971|FG002|Overall Study|Protocol Violation|19|||
19647617|NCT00337675|42096969|FG000|Overall Study|Withdrawal by Subject|25|||
19647618|NCT00337675|42096970|FG001|Overall Study|Withdrawal by Subject|25|||
19647619|NCT00337675|42096971|FG002|Overall Study|Withdrawal by Subject|19|||
19647620|NCT00337675|42096969|FG000|Overall Study|Progressive Disease|0|||
19647621|NCT00337675|42096970|FG001|Overall Study|Progressive Disease|2|||
19647622|NCT00337675|42096971|FG002|Overall Study|Progressive Disease|0|||
19647623|NCT00337675|42096969|FG000|Overall Study|Trial Terminated|0|||
19647624|NCT00337675|42096970|FG001|Overall Study|Trial Terminated|0|||
19647625|NCT00337675|42096971|FG002|Overall Study|Trial Terminated|2|||
19647626|NCT00337285|42096979|FG000|Overall Study|Withdrawal by Subject|42|||
19647627|NCT00337285|42096979|FG000|Overall Study|Lost to Follow-up|41|||
19647628|NCT00337285|42096979|FG000|Overall Study|Adverse Event|28|||
19647629|NCT00337285|42096979|FG000|Overall Study|Protocol Violation|27|||
19647630|NCT00337285|42096979|FG000|Overall Study|Lack of Efficacy|11|||
19647631|NCT00337285|42096979|FG000|Overall Study|Death|1|||
19647632|NCT00337285|42096979|FG000|Overall Study|Physician Decision|1|||
19647633|NCT00337285|42096979|FG000|Overall Study|Lack of protocol compliance|7|||
19647634|NCT00605865|42096983|FG000|Overall Study|Protocol Violation|115|||
19647635|NCT00348673|42097023|FG000|Stage 1|Randomized but not Treated|0|||
19647636|NCT00348673|42097024|FG001|Stage 1|Randomized but not Treated|0|||
19647637|NCT00348673|42097025|FG002|Stage 1|Randomized but not Treated|1|||
19647638|NCT00348673|42097026|FG003|Stage 1|Randomized but not Treated|0|||
19647639|NCT00348673|42097027|FG004|Stage 1|Randomized but not Treated|0|||
19647640|NCT00348673|42097028|FG005|Stage 1|Randomized but not Treated|0|||
19647641|NCT00348673|42097029|FG006|Stage 1|Randomized but not Treated|0|||
19647642|NCT00348673|42097030|FG007|Stage 1|Randomized but not Treated|0|||
19647643|NCT00348673|42097031|FG008|Stage 1|Randomized but not Treated|0|||
19647644|NCT00337207|42097049|FG000|Overall Study|Withdrawal by Subject|3|||
19647645|NCT00604695|42097056|FG000|Overall Study|Did not receive first bolus.|0|||
19647646|NCT00604695|42097057|FG001|Overall Study|Did not receive first bolus.|4|||
19647647|NCT00348595|42097065|FG000|Overall Study|Adverse Event|5|||
19647648|NCT00348595|42097066|FG001|Overall Study|Adverse Event|8|||
19647649|NCT00337129|42097072|FG000|Overall Study|Adverse Event|4|||
19647650|NCT00337129|42097072|FG000|Overall Study|Withdrawal by Subject|1|||
19647651|NCT00337129|42097072|FG000|Overall Study|Lack of Efficacy|32|||
19647652|NCT00337129|42097072|FG000|Overall Study|Death|2|||
19750492|NCT03309696|42199267|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
19647653|NCT00337129|42097072|FG000|Overall Study|not protocol specified|1|||
19647654|NCT00605085|42097078|FG000|Overall Study|Withdrawal by Subject|8|||
19647655|NCT00605085|42097079|FG001|Overall Study|Withdrawal by Subject|5|||
19647656|NCT00605085|42097078|FG000|Overall Study|Adverse Event|9|||
19647657|NCT00605085|42097079|FG001|Overall Study|Adverse Event|5|||
19647658|NCT00605085|42097078|FG000|Overall Study|Pregnancy|2|||
19647659|NCT00605085|42097079|FG001|Overall Study|Pregnancy|0|||
19647660|NCT00605085|42097078|FG000|Overall Study|Protocol Violation|3|||
19750493|NCT03309696|42199268|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
19750494|NCT03075644|42199282|FG000|Overall Study|Withdrawal by Subject|1|||
19750495|NCT03075644|42199283|FG001|Overall Study|Withdrawal by Subject|1|||
19750496|NCT03075410|42199299|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
19750497|NCT03075410|42199300|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750498|NCT03075410|42199301|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
19750499|NCT03075410|42199302|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750500|NCT03075410|42199303|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750501|NCT03075410|42199304|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750502|NCT03075410|42199305|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750503|NCT03075410|42199306|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750504|NCT03075410|42199307|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
19750505|NCT03075410|42199299|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
19750506|NCT03075410|42199300|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750507|NCT03075410|42199301|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750508|NCT03075410|42199302|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750509|NCT03075410|42199303|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750510|NCT03075410|42199304|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750511|NCT03075410|42199305|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750512|NCT03075410|42199306|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750513|NCT03075410|42199307|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
19750514|NCT02100722|42199351|FG000|Overall Study|Withdrawal pre-procedure|4|||
19750515|NCT02100722|42199352|FG001|Overall Study|Withdrawal pre-procedure|9|||
19750516|NCT02100722|42199351|FG000|Overall Study|Withdrawal post-procedure|0|||
19750517|NCT02100722|42199352|FG001|Overall Study|Withdrawal post-procedure|3|||
19750518|NCT02100722|42199351|FG000|Overall Study|Lost to Follow-up|2|||
19750519|NCT02100722|42199352|FG001|Overall Study|Lost to Follow-up|2|||
19750520|NCT02100722|42199351|FG000|Overall Study|Continuing on study|751|||
19750521|NCT02100722|42199352|FG001|Overall Study|Continuing on study|729|||
19750522|NCT03071276|42199359|FG000|Overall Study|Adverse Event|1|||
19750523|NCT03071276|42199359|FG000|Overall Study|Lack of Efficacy|14|||
19750524|NCT03074162|42199369|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
19750525|NCT03074162|42199370|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
19750526|NCT03074162|42199371|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
19750527|NCT03074162|42199372|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
19750528|NCT03074162|42199373|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
19647661|NCT00605085|42097079|FG001|Overall Study|Protocol Violation|2|||
19647662|NCT00605085|42097078|FG000|Overall Study|Lost to Follow-up|10|||
19647663|NCT00605085|42097079|FG001|Overall Study|Lost to Follow-up|5|||
19647664|NCT00605085|42097078|FG000|Overall Study|administrative reasons|18|||
19647665|NCT00605085|42097079|FG001|Overall Study|administrative reasons|8|||
19647666|NCT00348283|42097087|FG000|Induction|Adverse Event|0|||
19647667|NCT00348283|42097088|FG001|Induction|Adverse Event|2|||
19647668|NCT00348283|42097087|FG000|Induction|Protocol Violation|0|||
19647669|NCT00348283|42097088|FG001|Induction|Protocol Violation|4|||
19647670|NCT00348283|42097087|FG000|Double Blind|Adverse Event|2|||
19647671|NCT00348283|42097088|FG001|Double Blind|Adverse Event|5|||
19647672|NCT00348283|42097087|FG000|Double Blind|Withdrawal by Subject|1|||
19647673|NCT00348283|42097088|FG001|Double Blind|Withdrawal by Subject|1|||
19647674|NCT00348283|42097087|FG000|Double Blind|Protocol Violation|0|||
19647675|NCT00348283|42097088|FG001|Double Blind|Protocol Violation|1|||
19647676|NCT00348283|42097087|FG000|Double Blind|Lack of Efficacy|2|||
19647677|NCT00348283|42097088|FG001|Double Blind|Lack of Efficacy|2|||
19647678|NCT00348283|42097087|FG000|Double Blind|Pregnancy|0|||
19647679|NCT00348283|42097088|FG001|Double Blind|Pregnancy|1|||
19647680|NCT00348283|42097087|FG000|Open Label|Adverse Event|0|||
19647681|NCT00348283|42097088|FG001|Open Label|Adverse Event|8|||
19647682|NCT00348283|42097087|FG000|Open Label|Withdrawal by Subject|0|||
19647683|NCT00348283|42097088|FG001|Open Label|Withdrawal by Subject|4|||
19647684|NCT00348283|42097087|FG000|Open Label|Lost to Follow-up|0|||
19647685|NCT00348283|42097088|FG001|Open Label|Lost to Follow-up|1|||
19647686|NCT00348283|42097087|FG000|Open Label|Lack of Efficacy|0|||
19647687|NCT00348283|42097088|FG001|Open Label|Lack of Efficacy|13|||
19647688|NCT00348283|42097087|FG000|Open Label|Administrative reasons|0|||
19647689|NCT00348283|42097088|FG001|Open Label|Administrative reasons|5|||
19750529|NCT03074162|42199374|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
19750530|NCT03074162|42199369|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
19647690|NCT00348283|42097087|FG000|Open Label|Subject moved to the United States|0|||
19647691|NCT00348283|42097088|FG001|Open Label|Subject moved to the United States|1|||
19647692|NCT00348283|42097087|FG000|Open Label|Pregnancy|0|||
19647693|NCT00348283|42097088|FG001|Open Label|Pregnancy|1|||
19647694|NCT00348283|42097087|FG000|Open Label|Sponsor decision|0|||
19647695|NCT00348283|42097088|FG001|Open Label|Sponsor decision|1|||
19647696|NCT00336895|42097094|FG000|Overall Study|diarrhea|1|||
19647697|NCT00336895|42097094|FG000|Overall Study|nausea and upset stomach|1|||
19647698|NCT00336895|42097094|FG000|Overall Study|Physician Decision|1|||
19647699|NCT00336895|42097094|FG000|Overall Study|screen failed|1|||
19647700|NCT00336583|42097098|FG000|Overall Study|Lost to Follow-up|1|||
19647701|NCT00336583|42097098|FG000|Overall Study|Death|1|||
19647702|NCT00336505|42097104|FG000|Overall Study|Adverse Event|10|||
19647703|NCT00336505|42097105|FG001|Overall Study|Adverse Event|9|||
19647704|NCT00336505|42097104|FG000|Overall Study|Lack of Efficacy|8|||
19647705|NCT00336505|42097105|FG001|Overall Study|Lack of Efficacy|4|||
19647706|NCT00336505|42097104|FG000|Overall Study|Lost to Follow-up|7|||
19647707|NCT00336505|42097105|FG001|Overall Study|Lost to Follow-up|4|||
19647708|NCT00336505|42097104|FG000|Overall Study|Withdrawal by Subject|5|||
19647709|NCT00336505|42097105|FG001|Overall Study|Withdrawal by Subject|3|||
19647710|NCT00336505|42097104|FG000|Overall Study|Other|7|||
19647711|NCT00336505|42097105|FG001|Overall Study|Other|7|||
19750531|NCT03074162|42199370|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
19750532|NCT03074162|42199371|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
19750533|NCT03074162|42199372|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
19750534|NCT03074162|42199373|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
19750535|NCT03074162|42199374|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
19750536|NCT03074162|42199369|FG000|Period 3|Withdrawal by Subject|1|||
19750537|NCT03074162|42199370|FG001|Period 3|Withdrawal by Subject|0|||
19750538|NCT03074162|42199371|FG002|Period 3|Withdrawal by Subject|0|||
19750539|NCT03074162|42199372|FG003|Period 3|Withdrawal by Subject|0|||
19750540|NCT03074162|42199373|FG004|Period 3|Withdrawal by Subject|1|||
19750541|NCT03074162|42199374|FG005|Period 3|Withdrawal by Subject|0|||
19600844|NCT01072175|42049720|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600845|NCT01072175|42049721|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600846|NCT01072175|42049722|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600847|NCT01072175|42049723|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
19600848|NCT01072175|42049711|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600849|NCT01072175|42049712|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
19600850|NCT01072175|42049713|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600851|NCT01072175|42049714|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
19600852|NCT01072175|42049715|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
19647712|NCT00357877|42097113|FG000|Overall Study|Death|2|||
19647713|NCT00357877|42097114|FG001|Overall Study|Death|1|||
19750542|NCT03070964|42199382|FG000|Overall Study|Progressive disease|8|||
19750543|NCT03070964|42199382|FG000|Overall Study|Treatment-unrelated adverse event|2|||
19750544|NCT03070964|42199382|FG000|Overall Study|Never treated|1|||
19750545|NCT03070964|42199382|FG000|Overall Study|Physician Decision|1|||
19750546|NCT03070964|42199382|FG000|Overall Study|Withdrawal by Subject|1|||
19750547|NCT03070964|42199382|FG000|Overall Study|Adverse Event|1|||
19750548|NCT04065074|42199386|FG000|Overall Study|Adverse Event|1|||
19750549|NCT04065074|42199386|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
19647714|NCT00357877|42097113|FG000|Overall Study|Lost to Follow-up|20|||
19647715|NCT00357877|42097114|FG001|Overall Study|Lost to Follow-up|23|||
19647716|NCT00357877|42097113|FG000|Overall Study|Withdrawal by Subject|3|||
19750550|NCT02888106|42199396|FG000|Overall Study|Withdrawal by Subject|1|||
19750551|NCT02888106|42199397|FG001|Overall Study|Withdrawal by Subject|2|||
19750552|NCT02888106|42199398|FG002|Overall Study|Withdrawal by Subject|0|||
19750553|NCT02888106|42199399|FG003|Overall Study|Withdrawal by Subject|1|||
19750554|NCT02888106|42199400|FG004|Overall Study|Withdrawal by Subject|0|||
19750555|NCT02888106|42199401|FG005|Overall Study|Withdrawal by Subject|0|||
19750556|NCT02888106|42199396|FG000|Overall Study|Lost to Follow-up|1|||
19647717|NCT00357877|42097114|FG001|Overall Study|Withdrawal by Subject|3|||
19647718|NCT00357877|42097113|FG000|Overall Study|Administrative withdrawal|1|||
19647719|NCT00357877|42097114|FG001|Overall Study|Administrative withdrawal|1|||
19647720|NCT00357877|42097113|FG000|Overall Study|Other|0|||
19647721|NCT00357877|42097114|FG001|Overall Study|Other|2|||
19647722|NCT00335959|42097122|FG000|Overall Study|Adverse Event|2|||
19647723|NCT00335959|42097122|FG000|Overall Study|Ineligible|1|||
19647724|NCT00670488|42097137|FG000|Overall Study|Adverse Event|0|||
19647725|NCT00670488|42097138|FG001|Overall Study|Adverse Event|7|||
19647726|NCT00670488|42097139|FG002|Overall Study|Adverse Event|0|||
19647727|NCT00670488|42097140|FG003|Overall Study|Adverse Event|3|||
19647728|NCT00670488|42097141|FG004|Overall Study|Adverse Event|1|||
19647729|NCT00670488|42097142|FG005|Overall Study|Adverse Event|1|||
19647730|NCT00670488|42097143|FG006|Overall Study|Adverse Event|5|||
19647731|NCT00670488|42097144|FG007|Overall Study|Adverse Event|1|||
19647732|NCT00670488|42097145|FG008|Overall Study|Adverse Event|0|||
19647733|NCT00670488|42097146|FG009|Overall Study|Adverse Event|1|||
19647734|NCT00670488|42097137|FG000|Overall Study|Physician Decision|1|||
19750557|NCT02888106|42199397|FG001|Overall Study|Lost to Follow-up|0|||
19647735|NCT00670488|42097138|FG001|Overall Study|Physician Decision|9|||
19647736|NCT00670488|42097139|FG002|Overall Study|Physician Decision|0|||
19647737|NCT00670488|42097140|FG003|Overall Study|Physician Decision|1|||
19647738|NCT00670488|42097141|FG004|Overall Study|Physician Decision|0|||
19647739|NCT00670488|42097142|FG005|Overall Study|Physician Decision|0|||
19647740|NCT00670488|42097143|FG006|Overall Study|Physician Decision|0|||
19647741|NCT00670488|42097144|FG007|Overall Study|Physician Decision|0|||
19647742|NCT00670488|42097145|FG008|Overall Study|Physician Decision|0|||
19750558|NCT02888106|42199398|FG002|Overall Study|Lost to Follow-up|0|||
19750559|NCT02888106|42199399|FG003|Overall Study|Lost to Follow-up|1|||
19750560|NCT02888106|42199400|FG004|Overall Study|Lost to Follow-up|0|||
19750561|NCT02888106|42199401|FG005|Overall Study|Lost to Follow-up|1|||
19750562|NCT02888106|42199396|FG000|Overall Study|Adverse Event|2|||
19750563|NCT02888106|42199397|FG001|Overall Study|Adverse Event|0|||
19750564|NCT02888106|42199398|FG002|Overall Study|Adverse Event|0|||
19750565|NCT02888106|42199399|FG003|Overall Study|Adverse Event|0|||
19750566|NCT02888106|42199400|FG004|Overall Study|Adverse Event|0|||
19750567|NCT02888106|42199401|FG005|Overall Study|Adverse Event|0|||
19750568|NCT02888106|42199396|FG000|Overall Study|Withdrawal of consent|0|||
19750569|NCT02888106|42199397|FG001|Overall Study|Withdrawal of consent|0|||
19750570|NCT02888106|42199398|FG002|Overall Study|Withdrawal of consent|0|||
19750571|NCT02888106|42199399|FG003|Overall Study|Withdrawal of consent|0|||
19750572|NCT02888106|42199400|FG004|Overall Study|Withdrawal of consent|1|||
19750573|NCT02888106|42199401|FG005|Overall Study|Withdrawal of consent|0|||
19750574|NCT02888106|42199396|FG000|Overall Study|Pregnancy|1|||
19750575|NCT02888106|42199397|FG001|Overall Study|Pregnancy|0|||
19750576|NCT02888106|42199398|FG002|Overall Study|Pregnancy|0|||
19647743|NCT00670488|42097146|FG009|Overall Study|Physician Decision|0|||
19750577|NCT02888106|42199399|FG003|Overall Study|Pregnancy|0|||
19647744|NCT00670488|42097137|FG000|Overall Study|Progressive Disease|2|||
19647745|NCT00670488|42097138|FG001|Overall Study|Progressive Disease|41|||
19647746|NCT00670488|42097139|FG002|Overall Study|Progressive Disease|3|||
19647747|NCT00670488|42097140|FG003|Overall Study|Progressive Disease|2|||
19647748|NCT00670488|42097141|FG004|Overall Study|Progressive Disease|2|||
19477084|NCT01491035|41755972|FG006|Overall Study|Lost to Follow-up|0|||
19647749|NCT00670488|42097142|FG005|Overall Study|Progressive Disease|4|||
19750578|NCT02888106|42199400|FG004|Overall Study|Pregnancy|0|||
19750579|NCT02888106|42199401|FG005|Overall Study|Pregnancy|0|||
19750580|NCT03793010|42199423|FG000|Overall Study|Withdrawal by Subject|5|||
19750581|NCT03793010|42199424|FG001|Overall Study|Withdrawal by Subject|7|||
19647750|NCT00670488|42097143|FG006|Overall Study|Progressive Disease|11|||
19647751|NCT00670488|42097144|FG007|Overall Study|Progressive Disease|2|||
19647752|NCT00670488|42097145|FG008|Overall Study|Progressive Disease|2|||
19647753|NCT00670488|42097146|FG009|Overall Study|Progressive Disease|1|||
19647754|NCT00670488|42097137|FG000|Overall Study|Withdrawal by Subject|0|||
19647755|NCT00670488|42097138|FG001|Overall Study|Withdrawal by Subject|1|||
19647756|NCT00670488|42097139|FG002|Overall Study|Withdrawal by Subject|0|||
19647757|NCT00670488|42097140|FG003|Overall Study|Withdrawal by Subject|1|||
19647758|NCT00670488|42097141|FG004|Overall Study|Withdrawal by Subject|0|||
19647759|NCT00670488|42097142|FG005|Overall Study|Withdrawal by Subject|0|||
19647760|NCT00670488|42097143|FG006|Overall Study|Withdrawal by Subject|1|||
19647761|NCT00670488|42097144|FG007|Overall Study|Withdrawal by Subject|0|||
19647762|NCT00670488|42097145|FG008|Overall Study|Withdrawal by Subject|1|||
19647763|NCT00670488|42097146|FG009|Overall Study|Withdrawal by Subject|0|||
19647764|NCT00671658|42097168|FG000|Overall Study|Physician Decision|5|||
19647765|NCT00542386|42097178|FG000|Overall Study|Adverse Event|1|||
19647766|NCT00542386|42097179|FG001|Overall Study|Adverse Event|7|||
19647767|NCT00542386|42097180|FG002|Overall Study|Adverse Event|7|||
19647768|NCT00542386|42097181|FG003|Overall Study|Adverse Event|8|||
19647769|NCT00542386|42097182|FG004|Overall Study|Adverse Event|13|||
19647770|NCT00542386|42097183|FG005|Overall Study|Adverse Event|4|||
19647771|NCT00542386|42097178|FG000|Overall Study|Death|0|||
19647772|NCT00542386|42097179|FG001|Overall Study|Death|0|||
19647773|NCT00542386|42097180|FG002|Overall Study|Death|1|||
19647774|NCT00542386|42097181|FG003|Overall Study|Death|2|||
19647775|NCT00542386|42097182|FG004|Overall Study|Death|1|||
19647776|NCT00542386|42097183|FG005|Overall Study|Death|2|||
19647777|NCT00542386|42097178|FG000|Overall Study|Lack of Efficacy|32|||
19647778|NCT00542386|42097179|FG001|Overall Study|Lack of Efficacy|12|||
19647779|NCT00542386|42097180|FG002|Overall Study|Lack of Efficacy|10|||
19647780|NCT00542386|42097181|FG003|Overall Study|Lack of Efficacy|13|||
19647781|NCT00542386|42097182|FG004|Overall Study|Lack of Efficacy|7|||
19647782|NCT00542386|42097183|FG005|Overall Study|Lack of Efficacy|31|||
19647783|NCT00542386|42097178|FG000|Overall Study|Physician Decision|1|||
19647784|NCT00542386|42097179|FG001|Overall Study|Physician Decision|0|||
19647785|NCT00542386|42097180|FG002|Overall Study|Physician Decision|0|||
19647786|NCT00542386|42097181|FG003|Overall Study|Physician Decision|1|||
19647787|NCT00542386|42097182|FG004|Overall Study|Physician Decision|0|||
19647788|NCT00542386|42097183|FG005|Overall Study|Physician Decision|0|||
19647789|NCT00542386|42097178|FG000|Overall Study|Protocol Violation|0|||
19647790|NCT00542386|42097179|FG001|Overall Study|Protocol Violation|0|||
19647791|NCT00542386|42097180|FG002|Overall Study|Protocol Violation|1|||
19647792|NCT00542386|42097181|FG003|Overall Study|Protocol Violation|0|||
19647793|NCT00542386|42097182|FG004|Overall Study|Protocol Violation|0|||
19647794|NCT00542386|42097183|FG005|Overall Study|Protocol Violation|4|||
19647795|NCT00542386|42097178|FG000|Overall Study|Withdrawal by Subject|5|||
19647796|NCT00542386|42097179|FG001|Overall Study|Withdrawal by Subject|8|||
19647797|NCT00542386|42097180|FG002|Overall Study|Withdrawal by Subject|10|||
19647798|NCT00542386|42097181|FG003|Overall Study|Withdrawal by Subject|11|||
19647799|NCT00542386|42097182|FG004|Overall Study|Withdrawal by Subject|15|||
19647800|NCT00542386|42097183|FG005|Overall Study|Withdrawal by Subject|7|||
19647801|NCT00542386|42097178|FG000|Overall Study|Other Reasons|4|||
19647802|NCT00542386|42097179|FG001|Overall Study|Other Reasons|1|||
19647803|NCT00542386|42097180|FG002|Overall Study|Other Reasons|4|||
19647804|NCT00542386|42097181|FG003|Overall Study|Other Reasons|3|||
19647805|NCT00542386|42097182|FG004|Overall Study|Other Reasons|4|||
19647806|NCT00542386|42097183|FG005|Overall Study|Other Reasons|2|||
19647807|NCT00604383|42097199|FG000|Overall Study|Withdrawal by Subject|33|||
19647808|NCT00604383|42097200|FG001|Overall Study|Withdrawal by Subject|31|||
19647809|NCT00604383|42097199|FG000|Overall Study|Lost to Follow-up|24|||
19647810|NCT00604383|42097200|FG001|Overall Study|Lost to Follow-up|19|||
19750582|NCT03793010|42199423|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
19750583|NCT03793010|42199424|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
19647811|NCT00604383|42097199|FG000|Overall Study|Death|14|||
19647812|NCT00604383|42097200|FG001|Overall Study|Death|22|||
19647813|NCT00604383|42097199|FG000|Overall Study|Adverse Event|16|||
19647814|NCT00604383|42097200|FG001|Overall Study|Adverse Event|9|||
19647815|NCT00604383|42097199|FG000|Overall Study|Physician Decision|0|||
19647816|NCT00604383|42097200|FG001|Overall Study|Physician Decision|3|||
19647817|NCT00333775|42097209|FG000|Overall Study|Death|144|||
19647818|NCT00333775|42097210|FG001|Overall Study|Death|149|||
19647819|NCT00333775|42097211|FG002|Overall Study|Death|143|||
19647820|NCT00333775|42097209|FG000|Overall Study|In Follow-up When Study Stopped|87|||
19647821|NCT00333775|42097210|FG001|Overall Study|In Follow-up When Study Stopped|92|||
19647822|NCT00333775|42097211|FG002|Overall Study|In Follow-up When Study Stopped|96|||
19647823|NCT00333775|42097209|FG000|Overall Study|Lost to Follow-up|10|||
19647824|NCT00333775|42097210|FG001|Overall Study|Lost to Follow-up|7|||
19647825|NCT00333775|42097211|FG002|Overall Study|Lost to Follow-up|8|||
19647826|NCT00605475|42097229|FG000|Overall Study|Abnormal Laboratory Values|0|||
19647827|NCT00605475|42097230|FG001|Overall Study|Abnormal Laboratory Values|0|||
19647828|NCT00605475|42097231|FG002|Overall Study|Abnormal Laboratory Values|0|||
19647829|NCT00605475|42097232|FG003|Overall Study|Abnormal Laboratory Values|0|||
19647830|NCT00605475|42097233|FG004|Overall Study|Abnormal Laboratory Values|0|||
19647831|NCT00605475|42097234|FG005|Overall Study|Abnormal Laboratory Values|0|||
19647832|NCT00605475|42097235|FG006|Overall Study|Abnormal Laboratory Values|0|||
19647833|NCT00605475|42097236|FG007|Overall Study|Abnormal Laboratory Values|0|||
19647834|NCT00605475|42097237|FG008|Overall Study|Abnormal Laboratory Values|1|||
19647835|NCT00605475|42097238|FG009|Overall Study|Abnormal Laboratory Values|0|||
19647836|NCT00605475|42097229|FG000|Overall Study|Administrative problems|0|||
19647837|NCT00605475|42097230|FG001|Overall Study|Administrative problems|0|||
19647838|NCT00605475|42097231|FG002|Overall Study|Administrative problems|0|||
19647839|NCT00605475|42097232|FG003|Overall Study|Administrative problems|0|||
19647840|NCT00605475|42097233|FG004|Overall Study|Administrative problems|0|||
19647841|NCT00605475|42097234|FG005|Overall Study|Administrative problems|0|||
19647842|NCT00605475|42097235|FG006|Overall Study|Administrative problems|1|||
19647843|NCT00605475|42097236|FG007|Overall Study|Administrative problems|0|||
19647844|NCT00605475|42097237|FG008|Overall Study|Administrative problems|0|||
19647845|NCT00605475|42097238|FG009|Overall Study|Administrative problems|0|||
19647846|NCT00605475|42097229|FG000|Overall Study|Lost to Follow-up|0|||
19647847|NCT00605475|42097230|FG001|Overall Study|Lost to Follow-up|0|||
19647848|NCT00605475|42097231|FG002|Overall Study|Lost to Follow-up|0|||
19647849|NCT00605475|42097232|FG003|Overall Study|Lost to Follow-up|0|||
19647850|NCT00605475|42097233|FG004|Overall Study|Lost to Follow-up|0|||
19647851|NCT00605475|42097234|FG005|Overall Study|Lost to Follow-up|0|||
19647852|NCT00605475|42097235|FG006|Overall Study|Lost to Follow-up|0|||
19647853|NCT00605475|42097236|FG007|Overall Study|Lost to Follow-up|0|||
19647854|NCT00605475|42097237|FG008|Overall Study|Lost to Follow-up|1|||
19647855|NCT00605475|42097238|FG009|Overall Study|Lost to Follow-up|1|||
19647856|NCT00605475|42097229|FG000|Overall Study|Protocol Violation|0|||
19647857|NCT00605475|42097230|FG001|Overall Study|Protocol Violation|0|||
19647858|NCT00605475|42097231|FG002|Overall Study|Protocol Violation|0|||
19647859|NCT00605475|42097232|FG003|Overall Study|Protocol Violation|0|||
19647860|NCT00605475|42097233|FG004|Overall Study|Protocol Violation|1|||
19647861|NCT00605475|42097234|FG005|Overall Study|Protocol Violation|0|||
19647862|NCT00605475|42097235|FG006|Overall Study|Protocol Violation|0|||
19647863|NCT00605475|42097236|FG007|Overall Study|Protocol Violation|0|||
19647864|NCT00605475|42097237|FG008|Overall Study|Protocol Violation|0|||
19647865|NCT00605475|42097238|FG009|Overall Study|Protocol Violation|0|||
19647866|NCT00605475|42097229|FG000|Overall Study|Withdrawal by Subject|0|||
19647867|NCT00605475|42097230|FG001|Overall Study|Withdrawal by Subject|0|||
19647868|NCT00605475|42097231|FG002|Overall Study|Withdrawal by Subject|0|||
19647869|NCT00605475|42097232|FG003|Overall Study|Withdrawal by Subject|0|||
19647870|NCT00605475|42097233|FG004|Overall Study|Withdrawal by Subject|0|||
19647871|NCT00605475|42097234|FG005|Overall Study|Withdrawal by Subject|2|||
19647872|NCT00605475|42097235|FG006|Overall Study|Withdrawal by Subject|0|||
19647873|NCT00605475|42097236|FG007|Overall Study|Withdrawal by Subject|0|||
19647874|NCT00605475|42097237|FG008|Overall Study|Withdrawal by Subject|0|||
19647875|NCT00605475|42097238|FG009|Overall Study|Withdrawal by Subject|1|||
19647876|NCT00333619|42097283|FG000|Overall Study|Death|12|||
19647877|NCT00333619|42097284|FG001|Overall Study|Death|6|||
19647878|NCT00333619|42097283|FG000|Overall Study|Withdrawal by Subject|6|||
19647879|NCT00333619|42097284|FG001|Overall Study|Withdrawal by Subject|1|||
19647880|NCT00333619|42097283|FG000|Overall Study|Lost to Follow-up|3|||
19647881|NCT00333619|42097284|FG001|Overall Study|Lost to Follow-up|3|||
19647882|NCT00605319|42097292|FG000|Overall Study|Adverse Event|6|||
19647883|NCT00333229|42097304|FG000|Overall Study|Lack of Efficacy|0|||
19647884|NCT00333229|42097305|FG001|Overall Study|Lack of Efficacy|1|||
19647885|NCT00332839|42097313|FG000|Core (Months 0 - 12)|Administrative problems|1|||
19647886|NCT00332839|42097314|FG001|Core (Months 0 - 12)|Administrative problems|1|||
19647887|NCT00332839|42097313|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
19647888|NCT00332839|42097314|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
19647889|NCT00332839|42097313|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
19647890|NCT00332839|42097314|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
19647891|NCT00332839|42097313|FG000|Core (Months 0 - 12)|Adverse Event|5|||
19647892|NCT00332839|42097314|FG001|Core (Months 0 - 12)|Adverse Event|15|||
19647893|NCT00332839|42097313|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
19647894|NCT00332839|42097314|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
19647895|NCT00332839|42097313|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
19647896|NCT00332839|42097314|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
19647897|NCT00332839|42097313|FG000|Follow-up (Months 12 - 60)|Death|1|||
19647898|NCT00332839|42097314|FG001|Follow-up (Months 12 - 60)|Death|1|||
19647899|NCT00357097|42097322|FG000|Overall Study|Did not meet inclusion criteria|5|||
19647900|NCT00357097|42097323|FG001|Overall Study|Did not meet inclusion criteria|3|||
19647901|NCT00357097|42097322|FG000|Overall Study|Adverse Event|34|||
19647902|NCT00357097|42097323|FG001|Overall Study|Adverse Event|6|||
19647903|NCT00357097|42097322|FG000|Overall Study|Withdrawal by Subject|8|||
19647904|NCT00357097|42097323|FG001|Overall Study|Withdrawal by Subject|7|||
19647905|NCT00357097|42097322|FG000|Overall Study|Non-compliance|1|||
19647906|NCT00357097|42097323|FG001|Overall Study|Non-compliance|2|||
19647907|NCT00357097|42097322|FG000|Overall Study|Lack of Efficacy|2|||
19647908|NCT00357097|42097323|FG001|Overall Study|Lack of Efficacy|8|||
19647909|NCT00357097|42097322|FG000|Overall Study|Met Exclusion Criteria|3|||
19647910|NCT00357097|42097323|FG001|Overall Study|Met Exclusion Criteria|1|||
19647911|NCT00357097|42097322|FG000|Overall Study|Other|1|||
19647912|NCT00357097|42097323|FG001|Overall Study|Other|1|||
19647913|NCT00357097|42097322|FG000|Overall Study|Increase of RLS Symptoms|0|||
19647914|NCT00357097|42097323|FG001|Overall Study|Increase of RLS Symptoms|1|||
19647915|NCT00356863|42097331|FG000|Overall Study|Death|16|||
19750584|NCT03793010|42199423|FG000|Overall Study|Lost to Follow-up|1|||
19750585|NCT03793010|42199424|FG001|Overall Study|Lost to Follow-up|2|||
19750586|NCT03793010|42199423|FG000|Overall Study|Patient couldn't sit still for injection|1|||
19750587|NCT03793010|42199424|FG001|Overall Study|Patient couldn't sit still for injection|0|||
19750588|NCT03793010|42199423|FG000|Overall Study|Withdrew to pursue other treatment|1|||
19750589|NCT03793010|42199424|FG001|Overall Study|Withdrew to pursue other treatment|0|||
19750590|NCT03793010|42199423|FG000|Overall Study|Did not meet eligibility criteria|1|||
19750591|NCT03793010|42199424|FG001|Overall Study|Did not meet eligibility criteria|0|||
19750592|NCT03304626|42199432|FG000|Overall Study|Adverse Event|1|||
19750593|NCT03304626|42199433|FG001|Overall Study|Adverse Event|0|||
19750594|NCT03304626|42199432|FG000|Overall Study|Lack of Efficacy|1|||
19750595|NCT03304626|42199433|FG001|Overall Study|Lack of Efficacy|1|||
19750596|NCT03274986|42199442|FG000|Overall Study|Withdrawal by Subject|0|||
19750597|NCT03274986|42199443|FG001|Overall Study|Withdrawal by Subject|1|||
19750598|NCT03274986|42199442|FG000|Overall Study|Lost to Follow-up|0|||
19750599|NCT03274986|42199443|FG001|Overall Study|Lost to Follow-up|1|||
19750600|NCT02919306|42199458|FG000|Overall Study|Withdrawal by Subject|1|||
19750601|NCT02919306|42199459|FG001|Overall Study|Withdrawal by Subject|0|||
19750602|NCT02919306|42199458|FG000|Overall Study|Protocol Violation|1|||
19750603|NCT02919306|42199459|FG001|Overall Study|Protocol Violation|0|||
19750604|NCT03274440|42199465|FG000|Overall Study|Time commitment too great|1|||
19750605|NCT03274440|42199466|FG001|Overall Study|Time commitment too great|0|||
19750606|NCT03274440|42199467|FG002|Overall Study|Time commitment too great|0|||
19647916|NCT00356863|42097332|FG001|Overall Study|Death|32|||
19647917|NCT00356863|42097331|FG000|Overall Study|Lost to Follow-up|76|||
19647918|NCT00356863|42097332|FG001|Overall Study|Lost to Follow-up|43|||
19647919|NCT00355615|42097355|FG000|Randomized Double Blind Period|Adverse Event|1|||
19647920|NCT00355615|42097356|FG001|Randomized Double Blind Period|Adverse Event|0|||
19647921|NCT00355615|42097357|FG002|Randomized Double Blind Period|Adverse Event|0|||
19647922|NCT00355615|42097358|FG003|Randomized Double Blind Period|Adverse Event|0|||
19647923|NCT00355615|42097359|FG004|Randomized Double Blind Period|Adverse Event|0|||
19647924|NCT00355615|42097355|FG000|Randomized Double Blind Period|Protocol Violation|0|||
19647925|NCT00355615|42097356|FG001|Randomized Double Blind Period|Protocol Violation|0|||
19647926|NCT00355615|42097357|FG002|Randomized Double Blind Period|Protocol Violation|1|||
19647927|NCT00355615|42097358|FG003|Randomized Double Blind Period|Protocol Violation|1|||
19750607|NCT03274440|42199468|FG003|Overall Study|Time commitment too great|1|||
19647928|NCT00355615|42097359|FG004|Randomized Double Blind Period|Protocol Violation|0|||
19647929|NCT00355615|42097355|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
19647930|NCT00355615|42097356|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
19647931|NCT00355615|42097357|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
19647932|NCT00355615|42097358|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
19647933|NCT00355615|42097359|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
19647934|NCT00355615|42097355|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
19647935|NCT00355615|42097356|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
19750608|NCT03274440|42199469|FG004|Overall Study|Time commitment too great|0|||
19750609|NCT03274440|42199470|FG005|Overall Study|Time commitment too great|0|||
19750610|NCT03268746|42199478|FG000|Overall Study|Withdrawal by Subject|1|||
19750611|NCT03268590|42199489|FG000|Overall Study|Previously unknown exclusion criteria|1|||
19750612|NCT03267576|42199498|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
19750613|NCT03267576|42199499|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
19750614|NCT03267576|42199498|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
19750615|NCT03267576|42199499|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
19647936|NCT00355615|42097357|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
19647937|NCT00355615|42097358|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
19647938|NCT00355615|42097359|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
19647939|NCT00355615|42097355|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
19647940|NCT00355615|42097356|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
19647941|NCT00355615|42097357|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
19647942|NCT00355615|42097358|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
19647943|NCT00355615|42097359|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
19647944|NCT00355615|42097355|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
19647945|NCT00355615|42097356|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
19647946|NCT00355615|42097357|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
19647947|NCT00355615|42097358|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
19647948|NCT00355615|42097359|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
19647949|NCT00347269|42097372|FG000|Overall Study|Lost to Follow-up|74|||
19647950|NCT00347269|42097373|FG001|Overall Study|Lost to Follow-up|65|||
19647951|NCT00347269|42097372|FG000|Overall Study|Withdrawal by Subject|18|||
19647952|NCT00347269|42097373|FG001|Overall Study|Withdrawal by Subject|38|||
19647953|NCT00347269|42097372|FG000|Overall Study|Death|2|||
19647954|NCT00347269|42097373|FG001|Overall Study|Death|3|||
19647955|NCT00544648|42097381|FG000|Overall Study|Withdrawal by Subject|1|||
19647956|NCT00544648|42097382|FG001|Overall Study|Withdrawal by Subject|0|||
19647957|NCT00544648|42097381|FG000|Overall Study|Adverse Event|1|||
19647958|NCT00544648|42097382|FG001|Overall Study|Adverse Event|1|||
19647959|NCT00544648|42097381|FG000|Overall Study|progression of disease|1|||
19750616|NCT03267264|42199509|FG000|Overall Study|Withdrawal by Subject|1|||
19750617|NCT03267264|42199510|FG001|Overall Study|Withdrawal by Subject|0|||
19750618|NCT03267264|42199511|FG002|Overall Study|Withdrawal by Subject|2|||
19750619|NCT03267264|42199512|FG003|Overall Study|Withdrawal by Subject|4|||
19750620|NCT03244800|42199529|FG000|Overall Study|Adverse Event|0|||
19750621|NCT03244800|42199530|FG001|Overall Study|Adverse Event|1|||
19750622|NCT03244800|42199531|FG002|Overall Study|Adverse Event|0|||
19750623|NCT03244800|42199532|FG003|Overall Study|Adverse Event|1|||
19750624|NCT03244800|42199529|FG000|Overall Study|Withdrew treatment|0|||
19750625|NCT03244800|42199530|FG001|Overall Study|Withdrew treatment|0|||
19750626|NCT03244800|42199531|FG002|Overall Study|Withdrew treatment|0|||
19647960|NCT00544648|42097382|FG001|Overall Study|progression of disease|0|||
19647961|NCT00346333|42097392|FG000|Overall Study|Death|1|||
19647962|NCT00346333|42097393|FG001|Overall Study|Death|0|||
19647963|NCT00346333|42097392|FG000|Overall Study|unwilling or unable to continue|4|||
19750627|NCT03244800|42199532|FG003|Overall Study|Withdrew treatment|1|||
19647964|NCT00346333|42097393|FG001|Overall Study|unwilling or unable to continue|8|||
19647965|NCT00330967|42097403|FG000|Overall Study|Withdrawal by Subject|0|||
19647966|NCT00330967|42097404|FG001|Overall Study|Withdrawal by Subject|5|||
19647967|NCT00330967|42097403|FG000|Overall Study|Physician Decision|0|||
19647968|NCT00330967|42097404|FG001|Overall Study|Physician Decision|9|||
19647969|NCT00330343|42097410|FG000|Overall Study|Lost to Follow-up|5|||
19647970|NCT00330187|42097418|FG000|Overall Study|Lost to Follow-up|12|||
19647971|NCT00330187|42097419|FG001|Overall Study|Lost to Follow-up|13|||
19647972|NCT00330187|42097420|FG002|Overall Study|Lost to Follow-up|14|||
19647973|NCT00330187|42097421|FG003|Overall Study|Lost to Follow-up|10|||
19647974|NCT00330187|42097418|FG000|Overall Study|Withdrawal by Subject|8|||
19647975|NCT00330187|42097419|FG001|Overall Study|Withdrawal by Subject|5|||
19647976|NCT00330187|42097420|FG002|Overall Study|Withdrawal by Subject|4|||
19647977|NCT00330187|42097421|FG003|Overall Study|Withdrawal by Subject|4|||
19647978|NCT03914950|42097431|FG000|Overall Study|Physician Decision|54|||
19647979|NCT00329797|42097443|FG000|Overall Study|Protocol Violation|1|||
19647980|NCT00329797|42097444|FG001|Overall Study|Protocol Violation|0|||
19647981|NCT00329797|42097443|FG000|Overall Study|Withdrawal by Subject|6|||
19647982|NCT00329797|42097444|FG001|Overall Study|Withdrawal by Subject|6|||
19647983|NCT00541450|42097452|FG000|Phase A|Adverse Event|3|||
19647984|NCT00541450|42097453|FG001|Phase A|Adverse Event|0|||
19647985|NCT00541450|42097452|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
19647986|NCT00541450|42097453|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
19647987|NCT00541450|42097452|FG000|Phase A|Hyperglycemia|0|||
19647988|NCT00541450|42097453|FG001|Phase A|Hyperglycemia|1|||
19647989|NCT00541450|42097452|FG000|Phase A|Lost to Follow-up|6|||
19647990|NCT00541450|42097453|FG001|Phase A|Lost to Follow-up|4|||
19647991|NCT00541450|42097452|FG000|Phase A|Physician Decision|2|||
19647992|NCT00541450|42097453|FG001|Phase A|Physician Decision|0|||
19647993|NCT00541450|42097452|FG000|Phase A|Protocol Violation|2|||
19647994|NCT00541450|42097453|FG001|Phase A|Protocol Violation|3|||
19647995|NCT00541450|42097452|FG000|Phase A|Withdrawal by Subject|7|||
19647996|NCT00541450|42097453|FG001|Phase A|Withdrawal by Subject|7|||
19647997|NCT00541450|42097452|FG000|Phase B|Adverse Event|6|||
19647998|NCT00541450|42097453|FG001|Phase B|Adverse Event|6|||
19647999|NCT00541450|42097452|FG000|Phase B|Hyperglycemia|10|||
19648000|NCT00541450|42097453|FG001|Phase B|Hyperglycemia|9|||
19648001|NCT00541450|42097452|FG000|Phase B|Lost to Follow-up|6|||
19648002|NCT00541450|42097453|FG001|Phase B|Lost to Follow-up|4|||
19648003|NCT00541450|42097452|FG000|Phase B|Physician Decision|4|||
19648004|NCT00541450|42097453|FG001|Phase B|Physician Decision|2|||
19648005|NCT00541450|42097452|FG000|Phase B|Pregnancy|0|||
19648006|NCT00541450|42097453|FG001|Phase B|Pregnancy|1|||
19648007|NCT00541450|42097452|FG000|Phase B|Protocol Violation|3|||
19648008|NCT00541450|42097453|FG001|Phase B|Protocol Violation|3|||
19648009|NCT00541450|42097452|FG000|Phase B|Withdrawal by Subject|8|||
19648010|NCT00541450|42097453|FG001|Phase B|Withdrawal by Subject|6|||
19648011|NCT00355147|42097465|FG000|Overall Study|Lost to Follow-up|10|||
19648012|NCT00355147|42097466|FG001|Overall Study|Lost to Follow-up|8|||
19648013|NCT00355147|42097465|FG000|Overall Study|Withdrawal by Subject|8|||
19648014|NCT00355147|42097466|FG001|Overall Study|Withdrawal by Subject|12|||
19648015|NCT03909100|42097476|FG000|Overall Study|Protocol Deviation|2|||
19648016|NCT03909100|42097476|FG000|Overall Study|Technical Problems|4|||
19648017|NCT03909100|42097476|FG000|Overall Study|Withdrawal by Subject|4|||
19648018|NCT03909100|42097476|FG000|Overall Study|Lost to Follow-up|1|||
19648019|NCT03909100|42097476|FG000|Overall Study|Reason not Specified|4|||
19648020|NCT00540124|42097486|FG000|Overall Study|Adverse Event|0|||
19648021|NCT00540124|42097487|FG001|Overall Study|Adverse Event|2|||
19648022|NCT00540124|42097488|FG002|Overall Study|Adverse Event|1|||
19648023|NCT00540124|42097486|FG000|Overall Study|Entry Criteria Not Met|2|||
19648024|NCT00540124|42097487|FG001|Overall Study|Entry Criteria Not Met|0|||
19648025|NCT00540124|42097488|FG002|Overall Study|Entry Criteria Not Met|0|||
19648026|NCT00540124|42097486|FG000|Overall Study|Lack of Efficacy|1|||
19648027|NCT00540124|42097487|FG001|Overall Study|Lack of Efficacy|0|||
19648028|NCT00540124|42097488|FG002|Overall Study|Lack of Efficacy|0|||
19648029|NCT00540124|42097486|FG000|Overall Study|Withdrawal by Subject|1|||
19648030|NCT00540124|42097487|FG001|Overall Study|Withdrawal by Subject|1|||
19648031|NCT00540124|42097488|FG002|Overall Study|Withdrawal by Subject|0|||
19648032|NCT00540046|42097498|FG000|Overall Study|Lost to Follow-up|33|||
19648033|NCT00540046|42097499|FG001|Overall Study|Lost to Follow-up|23|||
19648034|NCT00689936|42097510|FG000|Active Treatment Phase|Adverse Event|68|||
19648035|NCT00689936|42097511|FG001|Active Treatment Phase|Adverse Event|71|||
19648036|NCT00689936|42097512|FG002|Active Treatment Phase|Adverse Event|76|||
19648037|NCT00689936|42097510|FG000|Active Treatment Phase|Disease Progression|273|||
19648038|NCT00689936|42097511|FG001|Active Treatment Phase|Disease Progression|362|||
19648039|NCT00689936|42097512|FG002|Active Treatment Phase|Disease Progression|339|||
19648040|NCT00689936|42097510|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
19648041|NCT00689936|42097511|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
19648042|NCT00689936|42097512|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
19648043|NCT00689936|42097510|FG000|Active Treatment Phase|Death|60|||
19648044|NCT00689936|42097511|FG001|Active Treatment Phase|Death|28|||
19648045|NCT00689936|42097512|FG002|Active Treatment Phase|Death|37|||
19648046|NCT00689936|42097510|FG000|Active Treatment Phase|Lost to Follow-up|0|||
19648047|NCT00689936|42097511|FG001|Active Treatment Phase|Lost to Follow-up|2|||
19648048|NCT00689936|42097512|FG002|Active Treatment Phase|Lost to Follow-up|2|||
19648049|NCT00689936|42097510|FG000|Active Treatment Phase|Protocol Violation|2|||
19648050|NCT00689936|42097511|FG001|Active Treatment Phase|Protocol Violation|2|||
19648051|NCT00689936|42097512|FG002|Active Treatment Phase|Protocol Violation|4|||
19648052|NCT00689936|42097510|FG000|Active Treatment Phase|Study Close Out|64|||
19648053|NCT00689936|42097511|FG001|Active Treatment Phase|Study Close Out|26|||
19648054|NCT00689936|42097512|FG002|Active Treatment Phase|Study Close Out|21|||
19648055|NCT00689936|42097510|FG000|Active Treatment Phase|Miscellaneous|52|||
19648056|NCT00689936|42097511|FG001|Active Treatment Phase|Miscellaneous|34|||
19648057|NCT00689936|42097512|FG002|Active Treatment Phase|Miscellaneous|47|||
19648058|NCT00689936|42097510|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
19648059|NCT00689936|42097511|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
19648060|NCT00689936|42097512|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
19648061|NCT00671034|42097523|FG000|Overall Study|Adverse Event|5|||
19648062|NCT00671034|42097524|FG001|Overall Study|Adverse Event|7|||
19648063|NCT00671034|42097525|FG002|Overall Study|Adverse Event|1|||
19648064|NCT00671034|42097523|FG000|Overall Study|Death|3|||
19648065|NCT00671034|42097524|FG001|Overall Study|Death|2|||
19648066|NCT00671034|42097525|FG002|Overall Study|Death|1|||
19648067|NCT00671034|42097523|FG000|Overall Study|Physician Decision|12|||
19648068|NCT00671034|42097524|FG001|Overall Study|Physician Decision|4|||
19648069|NCT00671034|42097525|FG002|Overall Study|Physician Decision|5|||
19648070|NCT00671034|42097523|FG000|Overall Study|VHR ALL feature|8|||
19648071|NCT00671034|42097524|FG001|Overall Study|VHR ALL feature|3|||
19648072|NCT00671034|42097525|FG002|Overall Study|VHR ALL feature|5|||
19648073|NCT00671034|42097523|FG000|Overall Study|Refusal|5|||
19648074|NCT00671034|42097524|FG001|Overall Study|Refusal|3|||
19648075|NCT00671034|42097525|FG002|Overall Study|Refusal|5|||
19648076|NCT00671034|42097523|FG000|Overall Study|includes Alternative therapy, etc.|6|||
19648077|NCT00671034|42097524|FG001|Overall Study|includes Alternative therapy, etc.|1|||
19600853|NCT01072175|42049716|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600854|NCT01072175|42049717|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600855|NCT01072175|42049718|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600856|NCT01072175|42049719|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600857|NCT01072175|42049720|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600858|NCT01072175|42049721|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600859|NCT01072175|42049722|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600860|NCT01072175|42049723|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
19600861|NCT01072175|42049711|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600862|NCT01072175|42049712|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600863|NCT01072175|42049713|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
19600864|NCT01072175|42049714|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
19600865|NCT01072175|42049715|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
19600866|NCT01072175|42049716|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600867|NCT01072175|42049717|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600868|NCT01072175|42049718|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600869|NCT01072175|42049719|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600870|NCT01072175|42049720|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600871|NCT01072175|42049721|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600872|NCT01072175|42049722|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600873|NCT01072175|42049723|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
19600874|NCT01072175|42049711|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600875|NCT01072175|42049712|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
19600876|NCT01072175|42049713|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600877|NCT01072175|42049714|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
19648078|NCT00671034|42097525|FG002|Overall Study|includes Alternative therapy, etc.|7|||
19648079|NCT04404478|42097536|FG000|Overall Study|Withdrawal by Subject|1|||
19648080|NCT04404478|42097537|FG001|Overall Study|Withdrawal by Subject|3|||
19648081|NCT00539734|42097545|FG000|Overall Study|Protocol Violation|1|||
19648082|NCT03907072|42097552|FG000|Overall Study|Study Terminated by Sponsor|2|||
19648083|NCT03907072|42097553|FG001|Overall Study|Study Terminated by Sponsor|2|||
19648084|NCT03907072|42097554|FG002|Overall Study|Study Terminated by Sponsor|2|||
19648085|NCT00329719|42097579|FG000|Overall Study|Lost to Follow-up|0|||
19648086|NCT00329719|42097580|FG001|Overall Study|Lost to Follow-up|0|||
19648087|NCT00329719|42097581|FG002|Overall Study|Lost to Follow-up|0|||
19648088|NCT00329719|42097582|FG003|Overall Study|Lost to Follow-up|1|||
19648089|NCT00329641|42097592|FG000|Overall Study|Did not start treatment|1|||
19648090|NCT00329641|42097592|FG000|Overall Study|Not eligible|1|||
19648091|NCT00329641|42097592|FG000|Overall Study|Adverse Event|3|||
19648092|NCT00329641|42097592|FG000|Overall Study|Other reason, not protocol specified|1|||
19648093|NCT00329407|42097606|FG000|Overall Study|Withdrawal by Subject|1|||
19648094|NCT00328783|42097610|FG000|Overall Study|Could not tolerate ABC|21|||
19648095|NCT00328783|42097610|FG000|Overall Study|No heart in RT field|4|||
19648096|NCT00328783|42097610|FG000|Overall Study|Withdrawal by Subject|1|||
19648097|NCT00567489|42097618|FG000|Overall Study|Adverse Event|6|||
19648098|NCT00567489|42097619|FG001|Overall Study|Adverse Event|14|||
19648099|NCT00567489|42097618|FG000|Overall Study|Physician Decision|0|||
19648100|NCT00567489|42097619|FG001|Overall Study|Physician Decision|4|||
19648101|NCT00567489|42097618|FG000|Overall Study|Withdrawal by Subject|0|||
19648102|NCT00567489|42097619|FG001|Overall Study|Withdrawal by Subject|2|||
19648103|NCT00567489|42097618|FG000|Overall Study|Renal Transplantation|0|||
19648104|NCT00567489|42097619|FG001|Overall Study|Renal Transplantation|3|||
19648105|NCT00567489|42097618|FG000|Overall Study|Other|1|||
19648106|NCT00567489|42097619|FG001|Overall Study|Other|0|||
19648107|NCT00669942|42097637|FG000|Parts 2 and 3|Adverse Event|0|||
19648108|NCT00669942|42097638|FG001|Parts 2 and 3|Adverse Event|0|||
19648109|NCT00669942|42097639|FG002|Parts 2 and 3|Adverse Event|0|||
19648110|NCT00669942|42097640|FG003|Parts 2 and 3|Adverse Event|0|||
19648111|NCT00669942|42097641|FG004|Parts 2 and 3|Adverse Event|0|||
19648112|NCT00669942|42097642|FG005|Parts 2 and 3|Adverse Event|0|||
19648113|NCT00669942|42097643|FG006|Parts 2 and 3|Adverse Event|0|||
19648114|NCT00669942|42097644|FG007|Parts 2 and 3|Adverse Event|2|||
19648115|NCT00669942|42097645|FG008|Parts 2 and 3|Adverse Event|1|||
19648116|NCT00669942|42097646|FG009|Parts 2 and 3|Adverse Event|0|||
19648117|NCT00669942|42097647|FG010|Parts 2 and 3|Adverse Event|0|||
19648118|NCT00669942|42097648|FG011|Parts 2 and 3|Adverse Event|0|||
19648119|NCT00669942|42097637|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
19648120|NCT00669942|42097638|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
19648121|NCT00669942|42097639|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
19648122|NCT00669942|42097640|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
19648123|NCT00669942|42097641|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
19648124|NCT00669942|42097642|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
19648125|NCT00669942|42097643|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
19648126|NCT00669942|42097644|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
19648127|NCT00669942|42097645|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
19648128|NCT00669942|42097646|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
19750628|NCT04516291|42199553|FG000|Treatment Period (24 Weeks)|Other|1|||
19750629|NCT04516291|42199554|FG001|Treatment Period (24 Weeks)|Other|0|||
19750630|NCT04516291|42199555|FG002|Treatment Period (24 Weeks)|Other|0|||
19750631|NCT04516291|42199556|FG003|Treatment Period (24 Weeks)|Other|2|||
19750632|NCT04516291|42199557|FG004|Treatment Period (24 Weeks)|Other|2|||
19750633|NCT04516291|42199558|FG005|Treatment Period (24 Weeks)|Other|4|||
19750634|NCT04516291|42199559|FG006|Treatment Period (24 Weeks)|Other|2|||
19750635|NCT04516291|42199560|FG007|Treatment Period (24 Weeks)|Other|0|||
19600878|NCT01072175|42049715|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
19600879|NCT01072175|42049716|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600880|NCT01072175|42049717|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600881|NCT01072175|42049718|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600882|NCT01072175|42049719|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600883|NCT01072175|42049720|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600884|NCT01072175|42049721|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600885|NCT01072175|42049722|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19600886|NCT01072175|42049723|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
19750636|NCT04516291|42199553|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19750637|NCT04516291|42199554|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
19750638|NCT04516291|42199555|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
19750639|NCT04516291|42199556|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19750640|NCT04516291|42199557|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
19750641|NCT04516291|42199558|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19750642|NCT04516291|42199559|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19750643|NCT04516291|42199560|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19477085|NCT01491035|41755973|FG007|Overall Study|Lost to Follow-up|0|||
19477086|NCT01488071|41755997|FG000|Overall Study|Adverse Event|15|||
19648129|NCT00669942|42097647|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
19648130|NCT00669942|42097648|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
19648131|NCT00669942|42097637|FG000|Parts 2 and 3|Protocol Violation|0|||
19648132|NCT00669942|42097638|FG001|Parts 2 and 3|Protocol Violation|0|||
19648133|NCT00669942|42097639|FG002|Parts 2 and 3|Protocol Violation|0|||
19648134|NCT00669942|42097640|FG003|Parts 2 and 3|Protocol Violation|0|||
19648135|NCT00669942|42097641|FG004|Parts 2 and 3|Protocol Violation|0|||
19648136|NCT00669942|42097642|FG005|Parts 2 and 3|Protocol Violation|1|||
19750644|NCT04516291|42199553|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750645|NCT04516291|42199554|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750646|NCT04516291|42199555|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750647|NCT04516291|42199556|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
19750648|NCT04516291|42199557|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750649|NCT04516291|42199558|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750650|NCT04516291|42199559|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750651|NCT04516291|42199560|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
19750652|NCT04516291|42199553|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750653|NCT04516291|42199554|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
19750654|NCT04516291|42199555|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750655|NCT04516291|42199556|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750656|NCT04516291|42199557|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750657|NCT04516291|42199558|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750658|NCT04516291|42199559|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750659|NCT04516291|42199560|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19750660|NCT04516291|42199553|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
19648137|NCT00669942|42097643|FG006|Parts 2 and 3|Protocol Violation|0|||
19648138|NCT00669942|42097644|FG007|Parts 2 and 3|Protocol Violation|0|||
19648139|NCT00669942|42097645|FG008|Parts 2 and 3|Protocol Violation|0|||
19648140|NCT00669942|42097646|FG009|Parts 2 and 3|Protocol Violation|0|||
19648141|NCT00669942|42097647|FG010|Parts 2 and 3|Protocol Violation|0|||
19648142|NCT00669942|42097648|FG011|Parts 2 and 3|Protocol Violation|0|||
19648143|NCT00669864|42097671|FG000|Overall Study|Lost to Follow-up|2|||
19648144|NCT00669864|42097671|FG000|Overall Study|Protocol Violation|2|||
19648145|NCT00669864|42097671|FG000|Overall Study|Withdrawal by Subject|3|||
19648146|NCT00669864|42097671|FG000|Overall Study|Other|2|||
19648147|NCT00668148|42097675|FG000|Overall Study|Adverse Event|5|||
19648148|NCT00668148|42097675|FG000|Overall Study|Subject Non-compliance|1|||
19648149|NCT00668148|42097675|FG000|Overall Study|Progressive Disease Before Treatment|2|||
19648150|NCT00668148|42097675|FG000|Overall Study|Withdrawal of Consent|2|||
19648151|NCT00667992|42097692|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
19648152|NCT00667992|42097693|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
19648153|NCT00667992|42097692|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
19648154|NCT00667992|42097693|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
19648155|NCT00667992|42097692|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
19648156|NCT00667992|42097693|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
19648157|NCT00667992|42097692|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
19648158|NCT00667992|42097693|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
19648159|NCT00667992|42097692|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
19648160|NCT00667992|42097693|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
19648161|NCT00667992|42097692|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
19648162|NCT00667992|42097693|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
19648163|NCT00667992|42097692|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
19648164|NCT00667992|42097693|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
19648165|NCT00667992|42097692|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
19648166|NCT00667992|42097693|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
19648167|NCT00667992|42097692|FG000|Wash-out|Not within one doubling dilution|4|||
19648168|NCT00667992|42097693|FG001|Wash-out|Not within one doubling dilution|3|||
19648169|NCT00667992|42097692|FG000|Wash-out|Failure to wash-out|2|||
19648170|NCT00667992|42097693|FG001|Wash-out|Failure to wash-out|2|||
19648171|NCT00667992|42097692|FG000|Wash-out|Withdrawal by Subject|1|||
19648172|NCT00667992|42097693|FG001|Wash-out|Withdrawal by Subject|0|||
19648173|NCT00667992|42097692|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
19648174|NCT00667992|42097693|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
19648175|NCT00667992|42097692|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
19648176|NCT00667992|42097693|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
19648177|NCT00669396|42097711|FG000|Overall Study|Lost to Follow-up|10|||
19648178|NCT00669396|42097712|FG001|Overall Study|Lost to Follow-up|12|||
19648179|NCT00669318|42097718|FG000|Overall Study|Withdrawal by Subject|2|||
19648180|NCT00669240|42097722|FG000|Overall Study|Lack of Efficacy|33|||
19648181|NCT00669240|42097722|FG000|Overall Study|Withdrawal by Subject|42|||
19750661|NCT04516291|42199554|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
19750662|NCT04516291|42199555|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
19750663|NCT04516291|42199556|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
19750664|NCT04516291|42199557|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
19750665|NCT04516291|42199558|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
19750666|NCT04516291|42199559|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
19750667|NCT04516291|42199560|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
19648182|NCT00669240|42097722|FG000|Overall Study|Lost to Follow-up|34|||
19750668|NCT04516291|42199553|FG000|Follow-up Period (12 Weeks)|Other|0|||
19750669|NCT04516291|42199554|FG001|Follow-up Period (12 Weeks)|Other|1|||
19750670|NCT04516291|42199555|FG002|Follow-up Period (12 Weeks)|Other|0|||
19750671|NCT04516291|42199556|FG003|Follow-up Period (12 Weeks)|Other|2|||
19750672|NCT04516291|42199557|FG004|Follow-up Period (12 Weeks)|Other|0|||
19750673|NCT04516291|42199558|FG005|Follow-up Period (12 Weeks)|Other|0|||
19750674|NCT04516291|42199559|FG006|Follow-up Period (12 Weeks)|Other|0|||
19750675|NCT04516291|42199560|FG007|Follow-up Period (12 Weeks)|Other|0|||
19750676|NCT04516291|42199553|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750677|NCT04516291|42199554|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750678|NCT04516291|42199555|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750679|NCT04516291|42199556|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750680|NCT04516291|42199557|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
19750681|NCT04516291|42199558|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750682|NCT04516291|42199559|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750683|NCT04516291|42199560|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19750684|NCT04516291|42199553|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750685|NCT04516291|42199554|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750686|NCT04516291|42199555|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
19750687|NCT04516291|42199556|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750688|NCT04516291|42199557|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
19750689|NCT04516291|42199558|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750690|NCT04516291|42199559|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750691|NCT04516291|42199560|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
19750692|NCT03243630|42199578|FG000|Overall Study|Protocol Violation|1|||
19750693|NCT03243630|42199578|FG000|Overall Study|Physician Decision|1|||
19750694|NCT04450381|42199586|FG000|Overall Study|Protocol Violation|4|||
19750695|NCT04450381|42199586|FG000|Overall Study|Wrong device setting|2|||
19750696|NCT03068468|42199592|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
19750697|NCT03068468|42199593|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
19750698|NCT03068468|42199594|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
19750699|NCT03068468|42199595|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
19750700|NCT03068468|42199592|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
19750701|NCT03068468|42199593|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
19750702|NCT03068468|42199594|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
19750703|NCT03068468|42199595|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
19750704|NCT03068468|42199592|FG000|Placebo-Controlled Period|Adverse Event|16|||
19750705|NCT03068468|42199593|FG001|Placebo-Controlled Period|Adverse Event|21|||
19750706|NCT03068468|42199594|FG002|Placebo-Controlled Period|Adverse Event|0|||
19750707|NCT03068468|42199595|FG003|Placebo-Controlled Period|Adverse Event|0|||
19750708|NCT03068468|42199592|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
19750709|NCT03068468|42199593|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
19750710|NCT03068468|42199594|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
19750711|NCT03068468|42199595|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
19750712|NCT03068468|42199592|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
19750713|NCT03068468|42199593|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
19750714|NCT03068468|42199594|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19750715|NCT03068468|42199595|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19750716|NCT03068468|42199592|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
19750717|NCT03068468|42199593|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
19750718|NCT03068468|42199594|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
19750719|NCT03068468|42199595|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
19750720|NCT03068468|42199592|FG000|Placebo-Controlled Period|Death|0|||
19750721|NCT03068468|42199593|FG001|Placebo-Controlled Period|Death|1|||
19750722|NCT03068468|42199594|FG002|Placebo-Controlled Period|Death|0|||
19750723|NCT03068468|42199595|FG003|Placebo-Controlled Period|Death|0|||
19750724|NCT03068468|42199592|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
19750725|NCT03068468|42199593|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
19750726|NCT03068468|42199594|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
19750727|NCT03068468|42199595|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
19750728|NCT03068468|42199592|FG000|Open-Label Extension Period|Adverse Event|0|||
19750729|NCT03068468|42199593|FG001|Open-Label Extension Period|Adverse Event|0|||
19750730|NCT03068468|42199594|FG002|Open-Label Extension Period|Adverse Event|13|||
19750731|NCT03068468|42199595|FG003|Open-Label Extension Period|Adverse Event|17|||
19750732|NCT03068468|42199592|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
19750733|NCT03068468|42199593|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
19750734|NCT03068468|42199594|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
19750735|NCT03068468|42199595|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
19750736|NCT03068468|42199592|FG000|Open-Label Extension Period|Death|0|||
19750737|NCT03068468|42199593|FG001|Open-Label Extension Period|Death|0|||
19750738|NCT03068468|42199594|FG002|Open-Label Extension Period|Death|0|||
19750739|NCT03068468|42199595|FG003|Open-Label Extension Period|Death|1|||
19477087|NCT01488071|41755998|FG001|Overall Study|Adverse Event|23|||
19750740|NCT03068468|42199592|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
19750741|NCT03068468|42199593|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
19750742|NCT03068468|42199594|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
19750743|NCT03068468|42199595|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
19648183|NCT00669240|42097722|FG000|Overall Study|Adverse Event|21|||
19648184|NCT00669240|42097722|FG000|Overall Study|Other|19|||
19648185|NCT00669240|42097722|FG000|Overall Study|Enrolled but not treated|15|||
19648186|NCT00669240|42097722|FG000|Overall Study|Enrolled but no dosing record|1|||
19648187|NCT00669162|42097726|FG000|Overall Study|Withdrawal by Subject|1|||
19648188|NCT00400946|42097735|FG000|Overall Study|Ineligible|0|||
19648189|NCT00400946|42097736|FG001|Overall Study|Ineligible|0|||
19648190|NCT00400946|42097737|FG002|Overall Study|Ineligible|0|||
19648191|NCT00400946|42097738|FG003|Overall Study|Ineligible|5|||
19648192|NCT00400946|42097739|FG004|Overall Study|Ineligible|1|||
19648193|NCT00400946|42097735|FG000|Overall Study|Induction Failure|0|||
19648194|NCT00400946|42097736|FG001|Overall Study|Induction Failure|0|||
19648195|NCT00400946|42097737|FG002|Overall Study|Induction Failure|0|||
19750744|NCT03068468|42199592|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
19750745|NCT03068468|42199593|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
19750746|NCT03068468|42199594|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
19750747|NCT03068468|42199595|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
19750748|NCT03068468|42199592|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
19750749|NCT03068468|42199593|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
19750750|NCT03068468|42199594|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
19750751|NCT03068468|42199595|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
19750752|NCT03068468|42199592|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
19750753|NCT03068468|42199593|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
19750754|NCT03068468|42199594|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
19750755|NCT03068468|42199595|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
19750756|NCT03068468|42199592|FG000|Open-Label Extension Period|Reason not Specified|0|||
19750757|NCT03068468|42199593|FG001|Open-Label Extension Period|Reason not Specified|0|||
19750758|NCT03068468|42199594|FG002|Open-Label Extension Period|Reason not Specified|1|||
19750759|NCT03068468|42199595|FG003|Open-Label Extension Period|Reason not Specified|4|||
19750760|NCT04512001|42199605|FG000|Overall Study|Adverse Event|14|||
19750761|NCT04512001|42199606|FG001|Overall Study|Adverse Event|10|||
19750762|NCT04512001|42199605|FG000|Overall Study|Death|0|||
19750763|NCT04512001|42199606|FG001|Overall Study|Death|2|||
19750764|NCT04512001|42199605|FG000|Overall Study|Withdrawal by Subject|16|||
19750765|NCT04512001|42199606|FG001|Overall Study|Withdrawal by Subject|9|||
19750766|NCT04512001|42199605|FG000|Overall Study|Discontinued treatment prior to Week 24|4|||
19750767|NCT04512001|42199606|FG001|Overall Study|Discontinued treatment prior to Week 24|4|||
19750768|NCT04512001|42199605|FG000|Overall Study|Withdrawal By Sponsor's Decision|1|||
19750769|NCT04512001|42199606|FG001|Overall Study|Withdrawal By Sponsor's Decision|0|||
19750770|NCT04512001|42199605|FG000|Overall Study|Subject Did Not Meet Eligibility At Week 24|0|||
19750771|NCT04512001|42199606|FG001|Overall Study|Subject Did Not Meet Eligibility At Week 24|1|||
19750772|NCT04447417|42199614|FG000|Overall Study|Withdrawal by Subject|1|||
19750773|NCT04447417|42199615|FG001|Overall Study|Withdrawal by Subject|0|||
19750774|NCT04447417|42199614|FG000|Overall Study|Failure to meet inclusion criteria|1|||
19750775|NCT04447417|42199615|FG001|Overall Study|Failure to meet inclusion criteria|0|||
19750776|NCT04447417|42199614|FG000|Overall Study|Lost to Follow-up|1|||
19750777|NCT04447417|42199615|FG001|Overall Study|Lost to Follow-up|0|||
19750778|NCT02787044|42199623|FG000|Overall Study|Lost to Follow-up|15|||
19750779|NCT02787044|42199624|FG001|Overall Study|Lost to Follow-up|19|||
19750780|NCT01345019|42199636|FG000|Blinded Treatment Phase|Death|147|||
19750781|NCT01345019|42199637|FG001|Blinded Treatment Phase|Death|137|||
19750782|NCT01345019|42199636|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
19750783|NCT01345019|42199637|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
19750784|NCT01345019|42199636|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
19750785|NCT01345019|42199637|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
19750786|NCT01345019|42199636|FG000|Blinded Treatment Phase|Disease Progression|12|||
19750787|NCT01345019|42199637|FG001|Blinded Treatment Phase|Disease Progression|10|||
19750788|NCT01345019|42199636|FG000|Blinded Treatment Phase|Adverse Event|6|||
19750789|NCT01345019|42199637|FG001|Blinded Treatment Phase|Adverse Event|13|||
19750790|NCT01345019|42199636|FG000|Blinded Treatment Phase|Administrative Decision|10|||
19750791|NCT01345019|42199637|FG001|Blinded Treatment Phase|Administrative Decision|8|||
19750792|NCT01345019|42199636|FG000|Blinded Treatment Phase|Noncompliance|5|||
19750793|NCT01345019|42199637|FG001|Blinded Treatment Phase|Noncompliance|3|||
19750794|NCT01345019|42199636|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
19750795|NCT01345019|42199637|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
19648196|NCT00400946|42097738|FG003|Overall Study|Induction Failure|11|||
19648197|NCT00400946|42097739|FG004|Overall Study|Induction Failure|8|||
19648198|NCT00400946|42097735|FG000|Overall Study|Induction Death|0|||
19648199|NCT00400946|42097736|FG001|Overall Study|Induction Death|0|||
19648200|NCT00400946|42097737|FG002|Overall Study|Induction Death|0|||
19648201|NCT00400946|42097738|FG003|Overall Study|Induction Death|13|||
19648202|NCT00400946|42097739|FG004|Overall Study|Induction Death|3|||
19648203|NCT00400946|42097735|FG000|Overall Study|Lost to Follow-up|1|||
19648204|NCT00400946|42097736|FG001|Overall Study|Lost to Follow-up|1|||
19648205|NCT00400946|42097737|FG002|Overall Study|Lost to Follow-up|0|||
19648206|NCT00400946|42097738|FG003|Overall Study|Lost to Follow-up|0|||
19648207|NCT00400946|42097739|FG004|Overall Study|Lost to Follow-up|1|||
19648208|NCT00400946|42097735|FG000|Overall Study|Remission Death|1|||
19648209|NCT00400946|42097736|FG001|Overall Study|Remission Death|1|||
19648210|NCT00400946|42097737|FG002|Overall Study|Remission Death|0|||
19648211|NCT00400946|42097738|FG003|Overall Study|Remission Death|0|||
19750796|NCT01345019|42199636|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
19750797|NCT01345019|42199637|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
19750798|NCT01345019|42199636|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
19750799|NCT01345019|42199637|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
19750800|NCT01345019|42199636|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
19750801|NCT01345019|42199637|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
19750802|NCT01345019|42199636|FG000|Open Label Treatment Phase|Death|49|||
19750803|NCT01345019|42199637|FG001|Open Label Treatment Phase|Death|48|||
19750804|NCT01345019|42199636|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
19750805|NCT01345019|42199637|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
19750806|NCT01345019|42199636|FG000|Open Label Treatment Phase|Adverse Event|30|||
19750807|NCT01345019|42199637|FG001|Open Label Treatment Phase|Adverse Event|51|||
19750808|NCT01345019|42199636|FG000|Open Label Treatment Phase|Administrative Decision|30|||
19750809|NCT01345019|42199637|FG001|Open Label Treatment Phase|Administrative Decision|15|||
19648212|NCT00400946|42097739|FG004|Overall Study|Remission Death|1|||
19648213|NCT00400946|42097735|FG000|Overall Study|Relapse|9|||
19750810|NCT01345019|42199636|FG000|Open Label Treatment Phase|Disease Progression|17|||
19750811|NCT01345019|42199637|FG001|Open Label Treatment Phase|Disease Progression|18|||
19750812|NCT01345019|42199636|FG000|Open Label Treatment Phase|Noncompliance|5|||
19750813|NCT01345019|42199637|FG001|Open Label Treatment Phase|Noncompliance|4|||
19648214|NCT00400946|42097736|FG001|Overall Study|Relapse|2|||
19648215|NCT00400946|42097737|FG002|Overall Study|Relapse|1|||
19648216|NCT00400946|42097738|FG003|Overall Study|Relapse|1|||
19648217|NCT00400946|42097739|FG004|Overall Study|Relapse|5|||
19648218|NCT00400946|42097735|FG000|Overall Study|Transplant in CR1|0|||
19648219|NCT00400946|42097736|FG001|Overall Study|Transplant in CR1|0|||
19648220|NCT00400946|42097737|FG002|Overall Study|Transplant in CR1|0|||
19648221|NCT00400946|42097738|FG003|Overall Study|Transplant in CR1|10|||
19648222|NCT00400946|42097739|FG004|Overall Study|Transplant in CR1|1|||
19648223|NCT00400946|42097735|FG000|Overall Study|Withdrawal by Subject|2|||
19388192|NCT02564055|41631572|FG005|Overall Study|Reached stopping criteria|1|||
19648224|NCT00400946|42097736|FG001|Overall Study|Withdrawal by Subject|5|||
19648225|NCT00400946|42097737|FG002|Overall Study|Withdrawal by Subject|1|||
19648226|NCT00400946|42097738|FG003|Overall Study|Withdrawal by Subject|5|||
19648227|NCT00400946|42097739|FG004|Overall Study|Withdrawal by Subject|8|||
19648228|NCT00400946|42097735|FG000|Overall Study|Clinical|1|||
19648229|NCT00400946|42097736|FG001|Overall Study|Clinical|2|||
19648230|NCT00400946|42097737|FG002|Overall Study|Clinical|0|||
19648231|NCT00400946|42097738|FG003|Overall Study|Clinical|2|||
19648232|NCT00400946|42097739|FG004|Overall Study|Clinical|9|||
19750814|NCT01345019|42199636|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
19750815|NCT01345019|42199637|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
19750816|NCT01345019|42199636|FG000|Open Label Treatment Phase|Pregnancy|1|||
19750817|NCT01345019|42199637|FG001|Open Label Treatment Phase|Pregnancy|0|||
19750818|NCT01345019|42199636|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
19750819|NCT01345019|42199637|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
19750820|NCT01345019|42199636|FG000|Open Label Treatment Phase|Protocol Violation|0|||
19750821|NCT01345019|42199637|FG001|Open Label Treatment Phase|Protocol Violation|1|||
19750822|NCT04507867|42199647|FG000|Overall Study|Death|7|||
19750823|NCT04507867|42199648|FG001|Overall Study|Death|1|||
19750824|NCT03069716|42199672|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
19750825|NCT03069716|42199673|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
19750826|NCT03069716|42199674|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
19648233|NCT00400946|42097735|FG000|Overall Study|Other|0|||
19648234|NCT00400946|42097736|FG001|Overall Study|Other|0|||
19648235|NCT00400946|42097737|FG002|Overall Study|Other|0|||
19648236|NCT00400946|42097738|FG003|Overall Study|Other|0|||
19648237|NCT00400946|42097739|FG004|Overall Study|Other|1|||
19648238|NCT00666588|42097770|FG000|Overall Study|ineligible|2|||
19648239|NCT00666588|42097771|FG001|Overall Study|ineligible|0|||
19750827|NCT03069716|42199672|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
19750828|NCT03069716|42199673|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
19648240|NCT00666588|42097772|FG002|Overall Study|ineligible|0|||
19648241|NCT00666588|42097773|FG003|Overall Study|ineligible|2|||
19648242|NCT00666588|42097770|FG000|Overall Study|inevaluable|2|||
19648243|NCT00666588|42097771|FG001|Overall Study|inevaluable|0|||
19648244|NCT00666588|42097772|FG002|Overall Study|inevaluable|0|||
19648245|NCT00666588|42097773|FG003|Overall Study|inevaluable|0|||
19648246|NCT00689390|42097785|FG000|Overall Study|Adverse Event|19|||
19648247|NCT00689390|42097786|FG001|Overall Study|Adverse Event|0|||
19648248|NCT00689390|42097785|FG000|Overall Study|Lost to Follow-up|179|||
19648249|NCT00689390|42097786|FG001|Overall Study|Lost to Follow-up|7|||
19648250|NCT00689390|42097785|FG000|Overall Study|Withdrawal by Subject|117|||
19648251|NCT00689390|42097786|FG001|Overall Study|Withdrawal by Subject|3|||
19648252|NCT00689390|42097785|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
19648253|NCT00689390|42097786|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
19648254|NCT00689390|42097785|FG000|Overall Study|Non-Compliance With Protocol|21|||
19648255|NCT00689390|42097786|FG001|Overall Study|Non-Compliance With Protocol|0|||
19648256|NCT00689390|42097785|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
19648257|NCT00689390|42097786|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
19648258|NCT00689390|42097785|FG000|Overall Study|Administrative|37|||
19648259|NCT00689390|42097786|FG001|Overall Study|Administrative|0|||
19648260|NCT00567879|42097803|FG000|Overall Study|Adverse Event|2|||
19648261|NCT00567879|42097804|FG001|Overall Study|Adverse Event|0|||
19648262|NCT00567879|42097805|FG002|Overall Study|Adverse Event|1|||
19648263|NCT00567879|42097806|FG003|Overall Study|Adverse Event|0|||
19648264|NCT00567879|42097807|FG004|Overall Study|Adverse Event|1|||
19648265|NCT00567879|42097808|FG005|Overall Study|Adverse Event|0|||
19648266|NCT00567879|42097803|FG000|Overall Study|Abnormal test procedure(s)|0|||
19648267|NCT00567879|42097804|FG001|Overall Study|Abnormal test procedure(s)|0|||
19648268|NCT00567879|42097805|FG002|Overall Study|Abnormal test procedure(s)|1|||
19648269|NCT00567879|42097806|FG003|Overall Study|Abnormal test procedure(s)|0|||
19648270|NCT00567879|42097807|FG004|Overall Study|Abnormal test procedure(s)|0|||
19648271|NCT00567879|42097808|FG005|Overall Study|Abnormal test procedure(s)|0|||
19648272|NCT00567879|42097803|FG000|Overall Study|Withdrawal by Subject|0|||
19648273|NCT00567879|42097804|FG001|Overall Study|Withdrawal by Subject|0|||
19648274|NCT00567879|42097805|FG002|Overall Study|Withdrawal by Subject|3|||
19648275|NCT00567879|42097806|FG003|Overall Study|Withdrawal by Subject|1|||
19648276|NCT00567879|42097807|FG004|Overall Study|Withdrawal by Subject|0|||
19648277|NCT00567879|42097808|FG005|Overall Study|Withdrawal by Subject|0|||
19648278|NCT00567879|42097803|FG000|Overall Study|New cancer therapy|0|||
19648279|NCT00567879|42097804|FG001|Overall Study|New cancer therapy|0|||
19648280|NCT00567879|42097805|FG002|Overall Study|New cancer therapy|1|||
19648281|NCT00567879|42097806|FG003|Overall Study|New cancer therapy|0|||
19648282|NCT00567879|42097807|FG004|Overall Study|New cancer therapy|0|||
19648283|NCT00567879|42097808|FG005|Overall Study|New cancer therapy|0|||
19648284|NCT00567879|42097803|FG000|Overall Study|Disease progression|5|||
19648285|NCT00567879|42097804|FG001|Overall Study|Disease progression|7|||
19648286|NCT00567879|42097805|FG002|Overall Study|Disease progression|15|||
19648287|NCT00567879|42097806|FG003|Overall Study|Disease progression|5|||
19648288|NCT00567879|42097807|FG004|Overall Study|Disease progression|11|||
19648289|NCT00567879|42097808|FG005|Overall Study|Disease progression|3|||
19648290|NCT00603915|42097826|FG000|Overall Study|Physician Decision|1|||
19648291|NCT00603837|42097832|FG000|Overall Study|Physician Decision|3|||
19648292|NCT00603837|42097833|FG001|Overall Study|Physician Decision|0|||
19648293|NCT00667602|42097842|FG000|Overall Study|Withdrawal by Subject|4|||
19750829|NCT03069716|42199674|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
19750830|NCT03069716|42199672|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
19648294|NCT00667602|42097843|FG001|Overall Study|Withdrawal by Subject|9|||
19648295|NCT00667602|42097844|FG002|Overall Study|Withdrawal by Subject|10|||
19648296|NCT00667602|42097842|FG000|Overall Study|Lost to Follow-up|4|||
19648297|NCT00667602|42097843|FG001|Overall Study|Lost to Follow-up|5|||
19648298|NCT00667602|42097844|FG002|Overall Study|Lost to Follow-up|6|||
19648299|NCT00667602|42097842|FG000|Overall Study|Administrative reason|0|||
19648300|NCT00667602|42097843|FG001|Overall Study|Administrative reason|0|||
19648301|NCT00667602|42097844|FG002|Overall Study|Administrative reason|2|||
19648302|NCT00667602|42097842|FG000|Overall Study|Protocol Violation|0|||
19648303|NCT00667602|42097843|FG001|Overall Study|Protocol Violation|1|||
19648304|NCT00667602|42097844|FG002|Overall Study|Protocol Violation|0|||
19648305|NCT00691028|42097860|FG000|Open-label Period|Adverse Event|0|||
19648306|NCT00691028|42097861|FG001|Open-label Period|Adverse Event|0|||
19648307|NCT00691028|42097862|FG002|Open-label Period|Adverse Event|0|||
19648308|NCT00691028|42097863|FG003|Open-label Period|Adverse Event|16|||
19648309|NCT00691028|42097860|FG000|Open-label Period|Withdrawal by Subject|0|||
19648310|NCT00691028|42097861|FG001|Open-label Period|Withdrawal by Subject|0|||
19648311|NCT00691028|42097862|FG002|Open-label Period|Withdrawal by Subject|0|||
19750831|NCT03069716|42199673|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
19750832|NCT03069716|42199674|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
19750833|NCT03069716|42199672|FG000|Randomized Treatment|Withdrawal by Subject|0|||
19750834|NCT03069716|42199673|FG001|Randomized Treatment|Withdrawal by Subject|2|||
19750835|NCT03069716|42199674|FG002|Randomized Treatment|Withdrawal by Subject|0|||
19750836|NCT03693625|42199687|FG000|Overall Study|Adverse Event|2|||
19750837|NCT03693625|42199688|FG001|Overall Study|Adverse Event|0|||
19750838|NCT03693625|42199687|FG000|Overall Study|Study Terminated By Sponsor|20|||
19750839|NCT03693625|42199688|FG001|Overall Study|Study Terminated By Sponsor|7|||
19648312|NCT00691028|42097863|FG003|Open-label Period|Withdrawal by Subject|3|||
19648313|NCT00691028|42097860|FG000|Open-label Period|not come to a hospital|0|||
19648314|NCT00691028|42097861|FG001|Open-label Period|not come to a hospital|0|||
19648315|NCT00691028|42097862|FG002|Open-label Period|not come to a hospital|0|||
19648316|NCT00691028|42097863|FG003|Open-label Period|not come to a hospital|1|||
19648317|NCT00691028|42097860|FG000|Double-blind Period|Adverse Event|8|||
19648318|NCT00691028|42097861|FG001|Double-blind Period|Adverse Event|9|||
19648319|NCT00691028|42097862|FG002|Double-blind Period|Adverse Event|6|||
19648320|NCT00691028|42097863|FG003|Double-blind Period|Adverse Event|0|||
19648321|NCT00691028|42097860|FG000|Double-blind Period|Lack of Efficacy|4|||
19648322|NCT00691028|42097861|FG001|Double-blind Period|Lack of Efficacy|3|||
19648323|NCT00691028|42097862|FG002|Double-blind Period|Lack of Efficacy|2|||
19648324|NCT00691028|42097863|FG003|Double-blind Period|Lack of Efficacy|0|||
19648325|NCT00691028|42097860|FG000|Double-blind Period|Withdrawal by Subject|1|||
19648326|NCT00691028|42097861|FG001|Double-blind Period|Withdrawal by Subject|0|||
19648327|NCT00691028|42097862|FG002|Double-blind Period|Withdrawal by Subject|1|||
19648328|NCT00691028|42097863|FG003|Double-blind Period|Withdrawal by Subject|0|||
19648329|NCT00691028|42097860|FG000|Double-blind Period|not come to a hospital.|0|||
19648330|NCT00691028|42097861|FG001|Double-blind Period|not come to a hospital.|1|||
19648331|NCT00691028|42097862|FG002|Double-blind Period|not come to a hospital.|0|||
19648332|NCT00691028|42097863|FG003|Double-blind Period|not come to a hospital.|0|||
19648333|NCT00690794|42097877|FG000|Overall Study|Adverse Event|12|||
19648334|NCT00690794|42097878|FG001|Overall Study|Adverse Event|10|||
19648335|NCT00690794|42097877|FG000|Overall Study|Lost to Follow-up|1|||
19648336|NCT00690794|42097878|FG001|Overall Study|Lost to Follow-up|4|||
19648337|NCT00690794|42097877|FG000|Overall Study|Withdrawal by Subject|0|||
19648338|NCT00690794|42097878|FG001|Overall Study|Withdrawal by Subject|9|||
19648339|NCT00690794|42097877|FG000|Overall Study|Protocol Violation|6|||
19648340|NCT00690794|42097878|FG001|Overall Study|Protocol Violation|7|||
19648341|NCT00690794|42097877|FG000|Overall Study|Noncompliance|1|||
19648342|NCT00690794|42097878|FG001|Overall Study|Noncompliance|2|||
19648343|NCT00690794|42097877|FG000|Overall Study|Other not specified|1|||
19648344|NCT00690794|42097878|FG001|Overall Study|Other not specified|3|||
19648345|NCT00666276|42097884|FG000|Overall Study|Protocol Violation|34|||
19648346|NCT00567255|42097909|FG000|Overall Study|Adverse Event|241|||
19750840|NCT03693625|42199687|FG000|Overall Study|Withdrawal by Subject|1|||
19750841|NCT03693625|42199688|FG001|Overall Study|Withdrawal by Subject|1|||
19750842|NCT01265537|42199696|FG000|Overall Study|Adverse Event|2|||
19648347|NCT00567255|42097910|FG001|Overall Study|Adverse Event|68|||
19648348|NCT00567255|42097909|FG000|Overall Study|Lost to Follow-up|77|||
19648349|NCT00567255|42097910|FG001|Overall Study|Lost to Follow-up|48|||
19648350|NCT00567255|42097909|FG000|Overall Study|Withdrawal by Subject|75|||
19648351|NCT00567255|42097910|FG001|Overall Study|Withdrawal by Subject|56|||
19648352|NCT00567255|42097909|FG000|Overall Study|Lack of Efficacy|19|||
19648353|NCT00567255|42097910|FG001|Overall Study|Lack of Efficacy|33|||
19648354|NCT00567255|42097909|FG000|Overall Study|Protocol Violation|20|||
19648355|NCT00567255|42097910|FG001|Overall Study|Protocol Violation|8|||
19648356|NCT00567255|42097909|FG000|Overall Study|Pregnancy|6|||
19648357|NCT00567255|42097910|FG001|Overall Study|Pregnancy|0|||
19648358|NCT00567255|42097909|FG000|Overall Study|Drug noncompliance,moved,other|25|||
19648359|NCT00567255|42097910|FG001|Overall Study|Drug noncompliance,moved,other|15|||
19648360|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
19648361|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
19648362|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Other|2|||
19648363|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Other|2|||
19648364|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Personal reasons|2|||
19648365|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Personal reasons|2|||
19648366|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
19648367|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
19648368|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
19648369|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
19648370|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
19648371|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
19648372|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
19750843|NCT01265537|42199697|FG001|Overall Study|Adverse Event|1|||
19750844|NCT01265537|42199696|FG000|Overall Study|Physician Decision|0|||
19750845|NCT01265537|42199697|FG001|Overall Study|Physician Decision|1|||
19750846|NCT04396639|42199703|FG000|Overall Study|Withdrawal by Subject|1|||
19750847|NCT04396639|42199703|FG000|Overall Study|Other|1|||
19750848|NCT04432298|42199709|FG000|Overall Study|Other than specified|1|||
19750849|NCT04432298|42199710|FG001|Overall Study|Other than specified|0|||
19750850|NCT04432298|42199709|FG000|Overall Study|Lost to Follow-up|0|||
19648373|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
19648374|NCT00667446|42097918|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
19648375|NCT00667446|42097919|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
19750851|NCT04432298|42199710|FG001|Overall Study|Lost to Follow-up|1|||
19648376|NCT00667446|42097918|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
19648377|NCT00667446|42097919|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
19648378|NCT00688844|42097925|FG000|Overall Study|Lost to Follow-up|10|||
19648379|NCT00667368|42097931|FG000|Overall Study|Lost to Follow-up|176|||
19648380|NCT00667368|42097932|FG001|Overall Study|Lost to Follow-up|155|||
19648381|NCT00667368|42097931|FG000|Overall Study|Discontinued early|24|||
19648382|NCT00667368|42097932|FG001|Overall Study|Discontinued early|17|||
19648383|NCT00567567|42097941|FG000|Overall Study|Adverse Event|0|||
19648384|NCT00567567|42097942|FG001|Overall Study|Adverse Event|2|||
19648385|NCT00567567|42097943|FG002|Overall Study|Adverse Event|5|||
19648386|NCT00567567|42097941|FG000|Overall Study|Death|8|||
19648387|NCT00567567|42097942|FG001|Overall Study|Death|1|||
19648388|NCT00567567|42097943|FG002|Overall Study|Death|5|||
19648389|NCT00567567|42097941|FG000|Overall Study|Lack of Efficacy|16|||
19648390|NCT00567567|42097942|FG001|Overall Study|Lack of Efficacy|17|||
19648391|NCT00567567|42097943|FG002|Overall Study|Lack of Efficacy|48|||
19648392|NCT00567567|42097941|FG000|Overall Study|Lost to Follow-up|0|||
19648393|NCT00567567|42097942|FG001|Overall Study|Lost to Follow-up|0|||
19648394|NCT00567567|42097943|FG002|Overall Study|Lost to Follow-up|1|||
19648395|NCT00567567|42097941|FG000|Overall Study|Physician Decision|16|||
19600887|NCT01072175|42049711|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
19600888|NCT01072175|42049712|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
19600889|NCT01072175|42049713|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
19600890|NCT01072175|42049714|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
19600891|NCT01072175|42049715|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
19600892|NCT01072175|42049716|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
19600893|NCT01072175|42049717|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
19600894|NCT01072175|42049718|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
19600895|NCT01072175|42049719|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
19600896|NCT01072175|42049720|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
19600897|NCT01072175|42049721|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
19600898|NCT01072175|42049722|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
19600899|NCT01072175|42049723|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
19600900|NCT01072175|42049711|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600901|NCT01072175|42049712|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600902|NCT01072175|42049713|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19648396|NCT00567567|42097942|FG001|Overall Study|Physician Decision|18|||
19648397|NCT00567567|42097943|FG002|Overall Study|Physician Decision|84|||
19648398|NCT00567567|42097941|FG000|Overall Study|Withdrawal by Subject|0|||
19648399|NCT00567567|42097942|FG001|Overall Study|Withdrawal by Subject|0|||
19648400|NCT00567567|42097943|FG002|Overall Study|Withdrawal by Subject|2|||
19648401|NCT00567567|42097941|FG000|Overall Study|Ineligible|4|||
19648402|NCT00567567|42097942|FG001|Overall Study|Ineligible|0|||
19648403|NCT00567567|42097943|FG002|Overall Study|Ineligible|9|||
19648404|NCT00567567|42097941|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
19648405|NCT00567567|42097942|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
19648406|NCT00567567|42097943|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
19648407|NCT00567567|42097941|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
19648408|NCT00567567|42097942|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
19648409|NCT00567567|42097943|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
19648410|NCT00567567|42097941|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
19648411|NCT00567567|42097942|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
19648412|NCT00567567|42097943|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
19648413|NCT00666198|42097953|FG000|Overall Study|Protocol Violation|10|||
19648414|NCT00666198|42097953|FG000|Overall Study|No Visit After First Day of Treatment|13|||
19648415|NCT00666198|42097953|FG000|Overall Study|Safety Not Assessable|6|||
19648416|NCT00666198|42097953|FG000|Overall Study|No Drug Administration|4|||
19648417|NCT00664560|42097960|FG000|Overall Study|Adverse Event|19|||
19648418|NCT00664560|42097961|FG001|Overall Study|Adverse Event|16|||
19648419|NCT00664560|42097962|FG002|Overall Study|Adverse Event|7|||
19648420|NCT00664560|42097960|FG000|Overall Study|Withdrawal by Subject|9|||
19648421|NCT00664560|42097961|FG001|Overall Study|Withdrawal by Subject|13|||
19648422|NCT00664560|42097962|FG002|Overall Study|Withdrawal by Subject|7|||
19648423|NCT00664560|42097960|FG000|Overall Study|Lost to Follow-up|0|||
19648424|NCT00664560|42097961|FG001|Overall Study|Lost to Follow-up|2|||
19648425|NCT00664560|42097962|FG002|Overall Study|Lost to Follow-up|0|||
19648426|NCT00664560|42097960|FG000|Overall Study|Other|11|||
19648427|NCT00664560|42097961|FG001|Overall Study|Other|4|||
19648428|NCT00664560|42097962|FG002|Overall Study|Other|5|||
19648429|NCT00566709|42097972|FG000|Overall Study|Protocol Violation|5|||
19648430|NCT00566709|42097973|FG001|Overall Study|Protocol Violation|0|||
19648431|NCT00688688|42097982|FG000|Overall Study|Eligibility criterion not met|7|||
19648432|NCT00688688|42097983|FG001|Overall Study|Eligibility criterion not met|7|||
19648433|NCT00688688|42097984|FG002|Overall Study|Eligibility criterion not met|10|||
19648434|NCT00688688|42097982|FG000|Overall Study|Adverse Event|52|||
19648435|NCT00688688|42097983|FG001|Overall Study|Adverse Event|51|||
19648436|NCT00688688|42097984|FG002|Overall Study|Adverse Event|50|||
19648437|NCT00688688|42097982|FG000|Overall Study|Lack of Efficacy|34|||
19648438|NCT00688688|42097983|FG001|Overall Study|Lack of Efficacy|25|||
19648439|NCT00688688|42097984|FG002|Overall Study|Lack of Efficacy|45|||
19648440|NCT00688688|42097982|FG000|Overall Study|Withdrawal by Subject|66|||
19648441|NCT00688688|42097983|FG001|Overall Study|Withdrawal by Subject|75|||
19648442|NCT00688688|42097984|FG002|Overall Study|Withdrawal by Subject|65|||
19648443|NCT00688688|42097982|FG000|Overall Study|Lost to Follow-up|14|||
19648444|NCT00688688|42097983|FG001|Overall Study|Lost to Follow-up|7|||
19648445|NCT00688688|42097984|FG002|Overall Study|Lost to Follow-up|7|||
19648446|NCT00688688|42097982|FG000|Overall Study|Protocol Violation|6|||
19648447|NCT00688688|42097983|FG001|Overall Study|Protocol Violation|9|||
19648448|NCT00688688|42097984|FG002|Overall Study|Protocol Violation|11|||
19648449|NCT00688688|42097982|FG000|Overall Study|Randomized but never received study drug|1|||
19648450|NCT00688688|42097983|FG001|Overall Study|Randomized but never received study drug|0|||
19648451|NCT00688688|42097984|FG002|Overall Study|Randomized but never received study drug|0|||
19648452|NCT00688688|42097982|FG000|Overall Study|Non-compliance with study procedures|5|||
19648453|NCT00688688|42097983|FG001|Overall Study|Non-compliance with study procedures|3|||
19648454|NCT00688688|42097984|FG002|Overall Study|Non-compliance with study procedures|4|||
19648455|NCT00688688|42097982|FG000|Overall Study|Taking exclusionary medications|1|||
19648456|NCT00688688|42097983|FG001|Overall Study|Taking exclusionary medications|0|||
19648457|NCT00688688|42097984|FG002|Overall Study|Taking exclusionary medications|0|||
19648458|NCT00688688|42097982|FG000|Overall Study|Site closure|0|||
19648459|NCT00688688|42097983|FG001|Overall Study|Site closure|1|||
19648460|NCT00688688|42097984|FG002|Overall Study|Site closure|0|||
19648461|NCT00688688|42097982|FG000|Overall Study|Violation of exclusion criterion|0|||
19648462|NCT00688688|42097983|FG001|Overall Study|Violation of exclusion criterion|1|||
19648463|NCT00688688|42097984|FG002|Overall Study|Violation of exclusion criterion|0|||
19648464|NCT00664326|42097992|FG000|Overall Study|Adverse Event|14|||
19648465|NCT00664326|42097992|FG000|Overall Study|Noncompliance with study medication|3|||
19648466|NCT00664326|42097992|FG000|Overall Study|Withdrawal by Subject|1|||
19648467|NCT00664326|42097992|FG000|Overall Study|Physician Decision|1|||
19648468|NCT00664326|42097992|FG000|Overall Study|Other Reasons|3|||
19648469|NCT00664326|42097992|FG000|Overall Study|Death|2|||
19648470|NCT00664326|42097992|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
19648471|NCT00686972|42097996|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
19648472|NCT00665652|42098000|FG000|Overall Study|Adverse Event|4|||
19648473|NCT00665652|42098000|FG000|Overall Study|Death|1|||
19648474|NCT00665652|42098000|FG000|Overall Study|No longer met inclusion criteria.|1|||
19648475|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
19648476|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
19648477|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
19648478|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
19648479|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
19750852|NCT04432298|42199709|FG000|Overall Study|Death|3|||
19750853|NCT04432298|42199710|FG001|Overall Study|Death|2|||
19750854|NCT04432298|42199709|FG000|Overall Study|Withdrawal by Subject|2|||
19750855|NCT04432298|42199710|FG001|Overall Study|Withdrawal by Subject|0|||
19750856|NCT04167085|42199718|FG000|Baseline|Withdrawal by Subject|2|||
19750857|NCT04167085|42199719|FG001|Baseline|Withdrawal by Subject|1|||
19750858|NCT04167085|42199718|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
19750859|NCT04167085|42199719|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
19648480|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
19648481|NCT00566631|42098004|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
19648482|NCT00566631|42098004|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
19648483|NCT00566631|42098004|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
19648484|NCT00566631|42098004|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
19750860|NCT04162795|42199725|FG000|Overall Study|Other|16|||
19750861|NCT04162795|42199725|FG000|Overall Study|Screen failures|10|||
19750862|NCT03069482|42199731|FG000|Overall Study|Lost to Follow-up|0|||
19750863|NCT03069482|42199732|FG001|Overall Study|Lost to Follow-up|1|||
19750864|NCT03069482|42199731|FG000|Overall Study|Physician Decision|1|||
19750865|NCT03069482|42199732|FG001|Overall Study|Physician Decision|0|||
19750866|NCT03266172|42199744|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
19750867|NCT03266172|42199745|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
19750868|NCT03266172|42199746|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
19750869|NCT03266172|42199744|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
19750870|NCT03266172|42199745|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
19750871|NCT03266172|42199746|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
19750872|NCT03266172|42199744|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
19750873|NCT03266172|42199745|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
19750874|NCT03266172|42199746|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
19750875|NCT03266172|42199744|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
19750876|NCT03266172|42199745|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
19750877|NCT03266172|42199746|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
19750878|NCT03266172|42199744|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
19750879|NCT03266172|42199745|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
19750880|NCT03266172|42199746|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
19750881|NCT03266172|42199744|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
19750882|NCT03266172|42199745|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
19750883|NCT03266172|42199746|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
19750884|NCT04356937|42199798|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
19750885|NCT04356937|42199799|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
19750886|NCT03301740|42199811|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
19750887|NCT03301740|42199812|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
19750888|NCT03301740|42199811|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
19750889|NCT03301740|42199812|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
19750890|NCT04355767|42199820|FG000|Overall Study|Withdrawal by Subject|2|||
19750891|NCT04355767|42199821|FG001|Overall Study|Withdrawal by Subject|2|||
19750892|NCT04355767|42199820|FG000|Overall Study|Death|5|||
19750893|NCT04355767|42199821|FG001|Overall Study|Death|1|||
19750894|NCT00882050|42199830|FG000|Overall Study|Physician Decision|1|||
19750895|NCT00882050|42199831|FG001|Overall Study|Physician Decision|0|||
19750896|NCT00882050|42199832|FG002|Overall Study|Physician Decision|0|||
19750897|NCT03266094|42199840|FG000|Overall Study|Lost to Follow-up|1|||
19750898|NCT03266094|42199840|FG000|Overall Study|Withdrawal by Subject|1|||
19750899|NCT04161079|42199846|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
19648485|NCT00566631|42098004|FG000|Part 2: Extension Phase|Adverse Event|11|||
19648486|NCT00566631|42098004|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
19648487|NCT00566631|42098004|FG000|Part 2: Extension Phase|Death|1|||
19648488|NCT00566631|42098004|FG000|Part 2: Extension Phase|Other|5|||
19648489|NCT00661830|42098010|FG000|Overall Study|Death|37|||
19648490|NCT00661830|42098011|FG001|Overall Study|Death|33|||
19648491|NCT00661830|42098010|FG000|Overall Study|Lost to Follow-up|1|||
19648492|NCT00661830|42098011|FG001|Overall Study|Lost to Follow-up|3|||
19648493|NCT00661830|42098010|FG000|Overall Study|Withdrawal by Subject|1|||
19648494|NCT00661830|42098011|FG001|Overall Study|Withdrawal by Subject|1|||
19648495|NCT00661830|42098010|FG000|Overall Study|Other reason|1|||
19648496|NCT00661830|42098011|FG001|Overall Study|Other reason|5|||
19648497|NCT00540592|42098027|FG000|Overall Study|Adverse Event|0|||
19648498|NCT00540592|42098028|FG001|Overall Study|Adverse Event|1|||
19648499|NCT00540592|42098029|FG002|Overall Study|Adverse Event|0|||
19648500|NCT00540592|42098030|FG003|Overall Study|Adverse Event|0|||
19648501|NCT00540592|42098031|FG004|Overall Study|Adverse Event|1|||
19648502|NCT00540592|42098032|FG005|Overall Study|Adverse Event|0|||
19648503|NCT00540592|42098033|FG006|Overall Study|Adverse Event|0|||
19648504|NCT00540592|42098034|FG007|Overall Study|Adverse Event|1|||
19648505|NCT00540592|42098035|FG008|Overall Study|Adverse Event|1|||
19648506|NCT00540592|42098036|FG009|Overall Study|Adverse Event|2|||
19648507|NCT00540592|42098027|FG000|Overall Study|Lost to Follow-up|2|||
19648508|NCT00540592|42098028|FG001|Overall Study|Lost to Follow-up|0|||
19648509|NCT00540592|42098029|FG002|Overall Study|Lost to Follow-up|0|||
19648510|NCT00540592|42098030|FG003|Overall Study|Lost to Follow-up|0|||
19648511|NCT00540592|42098031|FG004|Overall Study|Lost to Follow-up|0|||
19648512|NCT00540592|42098032|FG005|Overall Study|Lost to Follow-up|0|||
19648513|NCT00540592|42098033|FG006|Overall Study|Lost to Follow-up|0|||
19648514|NCT00540592|42098034|FG007|Overall Study|Lost to Follow-up|0|||
19648515|NCT00540592|42098035|FG008|Overall Study|Lost to Follow-up|0|||
19750900|NCT03243084|42199856|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
19648516|NCT00540592|42098036|FG009|Overall Study|Lost to Follow-up|0|||
19648517|NCT00540592|42098027|FG000|Overall Study|Withdrawal by Subject|0|||
19648518|NCT00540592|42098028|FG001|Overall Study|Withdrawal by Subject|0|||
19648519|NCT00540592|42098029|FG002|Overall Study|Withdrawal by Subject|1|||
19648520|NCT00540592|42098030|FG003|Overall Study|Withdrawal by Subject|1|||
19648521|NCT00540592|42098031|FG004|Overall Study|Withdrawal by Subject|0|||
19648522|NCT00540592|42098032|FG005|Overall Study|Withdrawal by Subject|0|||
19648523|NCT00540592|42098033|FG006|Overall Study|Withdrawal by Subject|0|||
19648524|NCT00540592|42098034|FG007|Overall Study|Withdrawal by Subject|0|||
19648525|NCT00540592|42098035|FG008|Overall Study|Withdrawal by Subject|0|||
19648526|NCT00540592|42098036|FG009|Overall Study|Withdrawal by Subject|0|||
19648527|NCT03970395|42098060|FG000|Overall Study|Withdrawal by Subject|3|||
19648528|NCT03970395|42098061|FG001|Overall Study|Withdrawal by Subject|4|||
19648529|NCT03970395|42098060|FG000|Overall Study|Lost to Follow-up|4|||
19648530|NCT03970395|42098061|FG001|Overall Study|Lost to Follow-up|8|||
19648531|NCT00565773|42098071|FG000|Overall Study|Withdrawal by Subject|1|||
19648532|NCT00565773|42098071|FG000|Overall Study|Physician Decision|1|||
19648533|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
19750901|NCT03243084|42199857|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
19750902|NCT04353817|42199866|FG000|Overall Study|Adverse Event|0|||
19648534|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
19648535|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
19648536|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
19648537|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
19648538|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
19648539|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
19648540|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
19648541|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
19648542|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
19648543|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
19648544|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
19648545|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
19648546|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
19648547|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
19648548|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
19648549|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
19648550|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
19648551|NCT00570492|42098077|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
19648552|NCT00570492|42098078|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
19648553|NCT00570492|42098079|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
19648554|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19648555|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
19648556|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
19648557|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
19648558|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
19648559|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
19648560|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
19648561|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
19648562|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
19698946|NCT00312494|42143767|FG000|Overall Study|Lack of Efficacy|4|||
19698947|NCT00312494|42143768|FG001|Overall Study|Lack of Efficacy|6|||
19698948|NCT00312494|42143769|FG002|Overall Study|Lack of Efficacy|8|||
19648563|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
19648564|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
19648565|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
19648566|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
19648567|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
19648568|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
19648569|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
19648570|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
19648571|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
19648572|NCT00570492|42098077|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
19648573|NCT00570492|42098078|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
19648574|NCT00570492|42098079|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
19648575|NCT00571922|42098087|FG000|Overall Study|Completion unknown|36|||
19648576|NCT00571922|42098088|FG001|Overall Study|Completion unknown|36|||
19648577|NCT00686894|42098094|FG000|Overall Study|Relapse|2|||
19648578|NCT00686894|42098094|FG000|Overall Study|Protocol Violation|4|||
19648579|NCT00328627|42098110|FG000|Overall Study|Hyperglycemic Rescue|41|||
19648580|NCT00328627|42098111|FG001|Overall Study|Hyperglycemic Rescue|18|||
19648581|NCT00328627|42098112|FG002|Overall Study|Hyperglycemic Rescue|16|||
19648582|NCT00328627|42098113|FG003|Overall Study|Hyperglycemic Rescue|13|||
19648583|NCT00328627|42098114|FG004|Overall Study|Hyperglycemic Rescue|6|||
19648584|NCT00328627|42098115|FG005|Overall Study|Hyperglycemic Rescue|5|||
19648585|NCT00328627|42098116|FG006|Overall Study|Hyperglycemic Rescue|19|||
19648586|NCT00328627|42098117|FG007|Overall Study|Hyperglycemic Rescue|6|||
19648587|NCT00328627|42098118|FG008|Overall Study|Hyperglycemic Rescue|6|||
19648588|NCT00328627|42098119|FG009|Overall Study|Hyperglycemic Rescue|11|||
19648589|NCT00328627|42098120|FG010|Overall Study|Hyperglycemic Rescue|3|||
19648590|NCT00328627|42098121|FG011|Overall Study|Hyperglycemic Rescue|2|||
19648591|NCT00328627|42098110|FG000|Overall Study|Adverse Event|3|||
19648592|NCT00328627|42098111|FG001|Overall Study|Adverse Event|1|||
19648593|NCT00328627|42098112|FG002|Overall Study|Adverse Event|2|||
19648594|NCT00328627|42098113|FG003|Overall Study|Adverse Event|3|||
19648595|NCT00328627|42098114|FG004|Overall Study|Adverse Event|1|||
19648596|NCT00328627|42098115|FG005|Overall Study|Adverse Event|2|||
19648597|NCT00328627|42098116|FG006|Overall Study|Adverse Event|1|||
19648598|NCT00328627|42098117|FG007|Overall Study|Adverse Event|2|||
19648599|NCT00328627|42098118|FG008|Overall Study|Adverse Event|0|||
19648600|NCT00328627|42098119|FG009|Overall Study|Adverse Event|7|||
19648601|NCT00328627|42098120|FG010|Overall Study|Adverse Event|5|||
19648602|NCT00328627|42098121|FG011|Overall Study|Adverse Event|4|||
19648603|NCT00328627|42098110|FG000|Overall Study|Protocol Violation|2|||
19648604|NCT00328627|42098111|FG001|Overall Study|Protocol Violation|2|||
19648605|NCT00328627|42098112|FG002|Overall Study|Protocol Violation|2|||
19648606|NCT00328627|42098113|FG003|Overall Study|Protocol Violation|8|||
19648607|NCT00328627|42098114|FG004|Overall Study|Protocol Violation|5|||
19648608|NCT00328627|42098115|FG005|Overall Study|Protocol Violation|5|||
19648609|NCT00328627|42098116|FG006|Overall Study|Protocol Violation|6|||
19648610|NCT00328627|42098117|FG007|Overall Study|Protocol Violation|2|||
19648611|NCT00328627|42098118|FG008|Overall Study|Protocol Violation|1|||
19648612|NCT00328627|42098119|FG009|Overall Study|Protocol Violation|4|||
19648613|NCT00328627|42098120|FG010|Overall Study|Protocol Violation|6|||
19648614|NCT00328627|42098121|FG011|Overall Study|Protocol Violation|2|||
19750903|NCT04353817|42199867|FG001|Overall Study|Adverse Event|1|||
19648615|NCT00328627|42098110|FG000|Overall Study|Lost to Follow-up|4|||
19648616|NCT00328627|42098111|FG001|Overall Study|Lost to Follow-up|2|||
19648617|NCT00328627|42098112|FG002|Overall Study|Lost to Follow-up|2|||
19648618|NCT00328627|42098113|FG003|Overall Study|Lost to Follow-up|4|||
19648619|NCT00328627|42098114|FG004|Overall Study|Lost to Follow-up|0|||
19648620|NCT00328627|42098115|FG005|Overall Study|Lost to Follow-up|2|||
19648621|NCT00328627|42098116|FG006|Overall Study|Lost to Follow-up|3|||
19648622|NCT00328627|42098117|FG007|Overall Study|Lost to Follow-up|0|||
19648623|NCT00328627|42098118|FG008|Overall Study|Lost to Follow-up|3|||
19648624|NCT00328627|42098119|FG009|Overall Study|Lost to Follow-up|2|||
19648625|NCT00328627|42098120|FG010|Overall Study|Lost to Follow-up|0|||
19648626|NCT00328627|42098121|FG011|Overall Study|Lost to Follow-up|1|||
19648627|NCT00328627|42098110|FG000|Overall Study|Withdrawal by Subject|5|||
19648628|NCT00328627|42098111|FG001|Overall Study|Withdrawal by Subject|4|||
19648629|NCT00328627|42098112|FG002|Overall Study|Withdrawal by Subject|5|||
19648630|NCT00328627|42098113|FG003|Overall Study|Withdrawal by Subject|6|||
19648631|NCT00328627|42098114|FG004|Overall Study|Withdrawal by Subject|2|||
19648632|NCT00328627|42098115|FG005|Overall Study|Withdrawal by Subject|5|||
19648633|NCT00328627|42098116|FG006|Overall Study|Withdrawal by Subject|4|||
19648634|NCT00328627|42098117|FG007|Overall Study|Withdrawal by Subject|4|||
19648635|NCT00328627|42098118|FG008|Overall Study|Withdrawal by Subject|4|||
19648636|NCT00328627|42098119|FG009|Overall Study|Withdrawal by Subject|5|||
19648637|NCT00328627|42098120|FG010|Overall Study|Withdrawal by Subject|2|||
19648638|NCT00328627|42098121|FG011|Overall Study|Withdrawal by Subject|7|||
19648639|NCT00328627|42098110|FG000|Overall Study|Pregnancy|0|||
19648640|NCT00328627|42098111|FG001|Overall Study|Pregnancy|1|||
19648641|NCT00328627|42098112|FG002|Overall Study|Pregnancy|0|||
19648642|NCT00328627|42098113|FG003|Overall Study|Pregnancy|0|||
19648643|NCT00328627|42098114|FG004|Overall Study|Pregnancy|0|||
19648644|NCT00328627|42098115|FG005|Overall Study|Pregnancy|0|||
19648645|NCT00328627|42098116|FG006|Overall Study|Pregnancy|0|||
19648646|NCT00328627|42098117|FG007|Overall Study|Pregnancy|0|||
19648647|NCT00328627|42098118|FG008|Overall Study|Pregnancy|0|||
19648648|NCT00328627|42098119|FG009|Overall Study|Pregnancy|0|||
19648649|NCT00328627|42098120|FG010|Overall Study|Pregnancy|0|||
19648650|NCT00328627|42098121|FG011|Overall Study|Pregnancy|0|||
19648651|NCT00328627|42098110|FG000|Overall Study|Physician Decision|4|||
19648652|NCT00328627|42098111|FG001|Overall Study|Physician Decision|3|||
19648653|NCT00328627|42098112|FG002|Overall Study|Physician Decision|1|||
19648654|NCT00328627|42098113|FG003|Overall Study|Physician Decision|2|||
19648655|NCT00328627|42098114|FG004|Overall Study|Physician Decision|1|||
19648656|NCT00328627|42098115|FG005|Overall Study|Physician Decision|1|||
19648657|NCT00328627|42098116|FG006|Overall Study|Physician Decision|1|||
19648658|NCT00328627|42098117|FG007|Overall Study|Physician Decision|0|||
19648659|NCT00328627|42098118|FG008|Overall Study|Physician Decision|3|||
19648660|NCT00328627|42098119|FG009|Overall Study|Physician Decision|2|||
19648661|NCT00328627|42098120|FG010|Overall Study|Physician Decision|1|||
19648662|NCT00328627|42098121|FG011|Overall Study|Physician Decision|0|||
19648663|NCT00328627|42098110|FG000|Overall Study|Other|0|||
19648664|NCT00328627|42098111|FG001|Overall Study|Other|0|||
19648665|NCT00328627|42098112|FG002|Overall Study|Other|0|||
19648666|NCT00328627|42098113|FG003|Overall Study|Other|1|||
19648667|NCT00328627|42098114|FG004|Overall Study|Other|0|||
19648668|NCT00328627|42098115|FG005|Overall Study|Other|0|||
19648669|NCT00328627|42098116|FG006|Overall Study|Other|1|||
19648670|NCT00328627|42098117|FG007|Overall Study|Other|0|||
19648671|NCT00328627|42098118|FG008|Overall Study|Other|0|||
19648672|NCT00328627|42098119|FG009|Overall Study|Other|1|||
19648673|NCT00328627|42098120|FG010|Overall Study|Other|1|||
19648674|NCT00328627|42098121|FG011|Overall Study|Other|0|||
19648675|NCT03977727|42098157|FG000|Second Treatment|Lost to Follow-up|0|||
19648676|NCT03977727|42098158|FG001|Second Treatment|Lost to Follow-up|3|||
19648677|NCT00663858|42098167|FG000|Overall Study|Adverse Event|9|||
19750904|NCT00159588|42199876|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
19750905|NCT00159588|42199877|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
19648678|NCT00663858|42098168|FG001|Overall Study|Adverse Event|1|||
19648679|NCT00663858|42098169|FG002|Overall Study|Adverse Event|6|||
19648680|NCT00663858|42098167|FG000|Overall Study|Lack of Efficacy|5|||
19648681|NCT00663858|42098168|FG001|Overall Study|Lack of Efficacy|1|||
19648682|NCT00663858|42098169|FG002|Overall Study|Lack of Efficacy|3|||
19648683|NCT00663858|42098167|FG000|Overall Study|Withdrawal by Subject|7|||
19648684|NCT00663858|42098168|FG001|Overall Study|Withdrawal by Subject|3|||
19648685|NCT00663858|42098169|FG002|Overall Study|Withdrawal by Subject|3|||
19648686|NCT00663858|42098167|FG000|Overall Study|Protocol Violation|5|||
19648687|NCT00663858|42098168|FG001|Overall Study|Protocol Violation|3|||
19648688|NCT00663858|42098169|FG002|Overall Study|Protocol Violation|4|||
19648689|NCT00663858|42098167|FG000|Overall Study|Other|8|||
19648690|NCT00663858|42098168|FG001|Overall Study|Other|2|||
19648691|NCT00663858|42098169|FG002|Overall Study|Other|4|||
19648692|NCT00659880|42098177|FG000|Overall Study|Lost to Follow-up|5|||
19648693|NCT00683774|42098184|FG000|Overall Study|Withdrawal by Subject|0|||
19648694|NCT00683774|42098185|FG001|Overall Study|Withdrawal by Subject|1|||
19648695|NCT00683774|42098184|FG000|Overall Study|Physician Decision|3|||
19648696|NCT00683774|42098185|FG001|Overall Study|Physician Decision|0|||
19648697|NCT00354679|42098191|FG000|Overall Study|Patient Not Treated|1|||
19648698|NCT00683696|42098197|FG000|Overall Study|Withdrawn due to study closure|337|||
19648699|NCT00683696|42098198|FG001|Overall Study|Withdrawn due to study closure|338|||
19648700|NCT00683696|42098197|FG000|Overall Study|Withdrawn prior to study closure|13|||
19648701|NCT00683696|42098198|FG001|Overall Study|Withdrawn prior to study closure|28|||
19648702|NCT00683696|42098197|FG000|Overall Study|Lost to Follow-up|5|||
19648703|NCT00683696|42098198|FG001|Overall Study|Lost to Follow-up|6|||
19648704|NCT00683696|42098197|FG000|Overall Study|Vital status follow-up only|3|||
19648705|NCT00683696|42098198|FG001|Overall Study|Vital status follow-up only|3|||
19648706|NCT00683696|42098197|FG000|Overall Study|Death|46|||
19648707|NCT00683696|42098198|FG001|Overall Study|Death|30|||
19648708|NCT00345631|42098208|FG000|Overall Study|Withdrawal by Subject|1|||
19648709|NCT00345631|42098209|FG001|Overall Study|Withdrawal by Subject|0|||
19648710|NCT00345631|42098210|FG002|Overall Study|Withdrawal by Subject|1|||
19648711|NCT00345631|42098208|FG000|Overall Study|Adverse Event|0|||
19648712|NCT00345631|42098209|FG001|Overall Study|Adverse Event|1|||
19648713|NCT00345631|42098210|FG002|Overall Study|Adverse Event|0|||
19648714|NCT00345631|42098208|FG000|Overall Study|Lost to Follow-up|3|||
19648715|NCT00345631|42098209|FG001|Overall Study|Lost to Follow-up|7|||
19648716|NCT00345631|42098210|FG002|Overall Study|Lost to Follow-up|4|||
19648717|NCT00345631|42098208|FG000|Overall Study|Other reasons|0|||
19750906|NCT00159588|42199878|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
19750907|NCT03265938|42199889|FG000|Overall Study|Withdrawal by Subject|1|||
19750908|NCT03265938|42199889|FG000|Overall Study|Physician Decision|1|||
19750909|NCT03265938|42199889|FG000|Overall Study|friable mass|6|||
19648718|NCT00345631|42098209|FG001|Overall Study|Other reasons|0|||
19648719|NCT00345631|42098210|FG002|Overall Study|Other reasons|1|||
19648720|NCT00540514|42098222|FG000|Overall Study|Still on treatment|3|||
19648721|NCT00540514|42098223|FG001|Overall Study|Still on treatment|0|||
19648722|NCT00540514|42098222|FG000|Overall Study|Unacceptable Toxicity|61|||
19648723|NCT00540514|42098223|FG001|Overall Study|Unacceptable Toxicity|62|||
19750910|NCT04353037|42199898|FG000|Overall Study|Lost to Follow-up|0|||
19750911|NCT04353037|42199899|FG001|Overall Study|Lost to Follow-up|1|||
19750912|NCT04353037|42199900|FG002|Overall Study|Lost to Follow-up|2|||
19750913|NCT04353037|42199901|FG003|Overall Study|Lost to Follow-up|3|||
19750914|NCT04353037|42199898|FG000|Overall Study|Withdrawal by Subject|0|||
19750915|NCT04353037|42199899|FG001|Overall Study|Withdrawal by Subject|2|||
19750916|NCT04353037|42199900|FG002|Overall Study|Withdrawal by Subject|3|||
19750917|NCT04353037|42199901|FG003|Overall Study|Withdrawal by Subject|5|||
19750918|NCT04353037|42199898|FG000|Overall Study|Adverse Event|0|||
19750919|NCT04353037|42199899|FG001|Overall Study|Adverse Event|0|||
19750920|NCT04353037|42199900|FG002|Overall Study|Adverse Event|2|||
19750921|NCT04353037|42199901|FG003|Overall Study|Adverse Event|0|||
19750922|NCT04353037|42199898|FG000|Overall Study|Exposure Change|0|||
19750923|NCT04353037|42199899|FG001|Overall Study|Exposure Change|0|||
19750924|NCT04353037|42199900|FG002|Overall Study|Exposure Change|0|||
19750925|NCT04353037|42199901|FG003|Overall Study|Exposure Change|2|||
19750926|NCT04349917|42199915|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
19750927|NCT04349917|42199916|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
19750928|NCT04349917|42199915|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
19750929|NCT04349917|42199916|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
19750930|NCT04156399|42199923|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
19750931|NCT04156399|42199923|FG000|Overall Study|study suspension due to COVID pandemic|3|||
19750932|NCT03300570|42199929|FG000|Overall Study|Adverse Event|0|||
19648724|NCT00540514|42098222|FG000|Overall Study|Adverse Event|20|||
19750933|NCT03300570|42199930|FG001|Overall Study|Adverse Event|1|||
19750934|NCT03300570|42199929|FG000|Overall Study|Withdrawal by Subject|1|||
19750935|NCT03300570|42199930|FG001|Overall Study|Withdrawal by Subject|0|||
19750936|NCT03300570|42199929|FG000|Overall Study|Inadequate bowel prep|1|||
19648725|NCT00540514|42098223|FG001|Overall Study|Adverse Event|24|||
19648726|NCT00540514|42098222|FG000|Overall Study|Physician Decision|86|||
19648727|NCT00540514|42098223|FG001|Overall Study|Physician Decision|99|||
19648728|NCT00540514|42098222|FG000|Overall Study|Protocol Deviation|3|||
19648729|NCT00540514|42098223|FG001|Overall Study|Protocol Deviation|4|||
19750937|NCT03300570|42199930|FG001|Overall Study|Inadequate bowel prep|0|||
19750938|NCT04154605|42199939|FG000|Overall Study|Procedure Canceled|1|||
19750939|NCT04154605|42199940|FG001|Overall Study|Procedure Canceled|1|||
19750940|NCT04154605|42199939|FG000|Overall Study|Missed follow up|1|||
19750941|NCT04154605|42199940|FG001|Overall Study|Missed follow up|1|||
19750942|NCT04154605|42199939|FG000|Overall Study|Withdrawal by Subject|1|||
19750943|NCT04154605|42199940|FG001|Overall Study|Withdrawal by Subject|0|||
19750944|NCT03264456|42199946|FG000|Overall Study|Withdrawal by Subject|3|||
19750945|NCT03264456|42199946|FG000|Overall Study|Lost to Follow-up|1|||
19750946|NCT03853694|42199953|FG000|Overall Study|Protocol Violation|3|||
19750947|NCT03853694|42199954|FG001|Overall Study|Protocol Violation|5|||
19750948|NCT03853694|42199955|FG002|Overall Study|Protocol Violation|3|||
19750949|NCT03853694|42199953|FG000|Overall Study|Delivered early|0|||
19750950|NCT03853694|42199954|FG001|Overall Study|Delivered early|1|||
19750951|NCT03853694|42199955|FG002|Overall Study|Delivered early|0|||
19750952|NCT03853694|42199953|FG000|Overall Study|not suitable to proceed|0|||
19750953|NCT03853694|42199954|FG001|Overall Study|not suitable to proceed|1|||
19750954|NCT03853694|42199955|FG002|Overall Study|not suitable to proceed|0|||
19750955|NCT03853694|42199953|FG000|Overall Study|difficult surgery|0|||
19750956|NCT03853694|42199954|FG001|Overall Study|difficult surgery|0|||
19750957|NCT03853694|42199955|FG002|Overall Study|difficult surgery|1|||
19750958|NCT03853694|42199953|FG000|Overall Study|Lost to Follow-up|0|||
19750959|NCT03853694|42199954|FG001|Overall Study|Lost to Follow-up|1|||
19750960|NCT03853694|42199955|FG002|Overall Study|Lost to Follow-up|0|||
19750961|NCT03853694|42199953|FG000|Overall Study|Withdrawal by Subject|0|||
19750962|NCT03853694|42199954|FG001|Overall Study|Withdrawal by Subject|1|||
19750963|NCT03853694|42199955|FG002|Overall Study|Withdrawal by Subject|0|||
19648730|NCT00540514|42098222|FG000|Overall Study|Lost to Follow-up|1|||
19648731|NCT00540514|42098223|FG001|Overall Study|Lost to Follow-up|1|||
19648732|NCT00540514|42098222|FG000|Overall Study|Withdrawal by Subject|65|||
19648733|NCT00540514|42098223|FG001|Overall Study|Withdrawal by Subject|67|||
19648734|NCT00540514|42098222|FG000|Overall Study|Excluded prior to treatment|7|||
19648735|NCT00540514|42098223|FG001|Overall Study|Excluded prior to treatment|7|||
19648736|NCT00540514|42098222|FG000|Overall Study|Paclitaxel not available|0|||
19648737|NCT00540514|42098223|FG001|Overall Study|Paclitaxel not available|2|||
19648738|NCT00663702|42098232|FG000|Overall Study|Adverse Event|8|||
19648739|NCT00663702|42098233|FG001|Overall Study|Adverse Event|4|||
19648740|NCT00663702|42098232|FG000|Overall Study|Withdrawal by Subject|3|||
19648741|NCT00663702|42098233|FG001|Overall Study|Withdrawal by Subject|1|||
19648742|NCT00663702|42098232|FG000|Overall Study|Pregnancy|0|||
19648743|NCT00663702|42098233|FG001|Overall Study|Pregnancy|1|||
19648744|NCT00663702|42098232|FG000|Overall Study|Lost to Follow-up|3|||
19648745|NCT00663702|42098233|FG001|Overall Study|Lost to Follow-up|0|||
19648746|NCT00663702|42098232|FG000|Overall Study|Death|1|||
19648747|NCT00663702|42098233|FG001|Overall Study|Death|1|||
19750964|NCT04154293|42199966|FG000|Overall Study|Withdrawal by Subject|2|||
19750965|NCT04154293|42199967|FG001|Overall Study|Withdrawal by Subject|3|||
19750966|NCT04154293|42199968|FG002|Overall Study|Withdrawal by Subject|1|||
19750967|NCT04154293|42199966|FG000|Overall Study|Physician Decision|0|||
19750968|NCT04154293|42199967|FG001|Overall Study|Physician Decision|0|||
19750969|NCT04154293|42199968|FG002|Overall Study|Physician Decision|1|||
19750970|NCT04342897|42199978|FG000|Overall Study|Death|7|||
19750971|NCT04342897|42199979|FG001|Overall Study|Death|4|||
19750972|NCT04342897|42199978|FG000|Overall Study|Lost to Follow-up|6|||
19648748|NCT00663702|42098232|FG000|Overall Study|Lack of Efficacy|3|||
19648749|NCT00663702|42098233|FG001|Overall Study|Lack of Efficacy|3|||
19648750|NCT00683618|42098242|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
19648751|NCT00683618|42098243|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
19750973|NCT04342897|42199979|FG001|Overall Study|Lost to Follow-up|6|||
19750974|NCT04342897|42199978|FG000|Overall Study|Withdrawal by Subject|1|||
19750975|NCT04342897|42199979|FG001|Overall Study|Withdrawal by Subject|2|||
19750976|NCT04340557|42199987|FG000|Overall Study|Transferred to ICU and/or death|1|||
19750977|NCT04340557|42199988|FG001|Overall Study|Transferred to ICU and/or death|2|||
19750978|NCT04382053|42199996|FG000|Overall Study|Death|6|||
19750979|NCT04382053|42199997|FG001|Overall Study|Death|8|||
19750980|NCT04382053|42199996|FG000|Overall Study|Lost to Follow-up|0|||
19750981|NCT04382053|42199997|FG001|Overall Study|Lost to Follow-up|2|||
19750982|NCT04382053|42199996|FG000|Overall Study|Protocol Deviation|1|||
19750983|NCT04382053|42199997|FG001|Overall Study|Protocol Deviation|2|||
19750984|NCT04382053|42199996|FG000|Overall Study|Withdrawal by Subject|2|||
19750985|NCT04382053|42199997|FG001|Overall Study|Withdrawal by Subject|1|||
19750986|NCT03066830|42200006|FG000|Overall Study|At the Participant's own Request|16|||
19648752|NCT00683618|42098244|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
19750987|NCT03066830|42200007|FG001|Overall Study|At the Participant's own Request|17|||
19750988|NCT03066830|42200006|FG000|Overall Study|Other|3|||
19648753|NCT00683618|42098242|FG000|Randomised Treatment Period|Protocol Violation|0|||
19750989|NCT03066830|42200007|FG001|Overall Study|Other|0|||
19750990|NCT03066830|42200006|FG000|Overall Study|Poor Compliance to Protocol|1|||
19750991|NCT03066830|42200007|FG001|Overall Study|Poor Compliance to Protocol|0|||
19648754|NCT00683618|42098243|FG001|Randomised Treatment Period|Protocol Violation|1|||
19648755|NCT00683618|42098244|FG002|Randomised Treatment Period|Protocol Violation|0|||
19648756|NCT00683618|42098242|FG000|Randomised Treatment Period|Adverse Event|2|||
19648757|NCT00683618|42098243|FG001|Randomised Treatment Period|Adverse Event|0|||
19648758|NCT00683618|42098244|FG002|Randomised Treatment Period|Adverse Event|2|||
19648759|NCT00683618|42098242|FG000|Randomised Treatment Period|Reason not provided|0|||
19648760|NCT00683618|42098243|FG001|Randomised Treatment Period|Reason not provided|0|||
19648761|NCT00683618|42098244|FG002|Randomised Treatment Period|Reason not provided|2|||
19648762|NCT00683618|42098242|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
19648763|NCT00683618|42098243|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
19648764|NCT00683618|42098244|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
19648765|NCT00683618|42098242|FG000|Extension Treatment Period|Adverse Event|1|||
19648766|NCT00683618|42098243|FG001|Extension Treatment Period|Adverse Event|0|||
19648767|NCT00683618|42098244|FG002|Extension Treatment Period|Adverse Event|0|||
19648768|NCT00683618|42098242|FG000|Extension Treatment Period|Protocol Violation|1|||
19648769|NCT00683618|42098243|FG001|Extension Treatment Period|Protocol Violation|0|||
19648770|NCT00683618|42098244|FG002|Extension Treatment Period|Protocol Violation|0|||
19648771|NCT00688064|42098256|FG000|Overall Study|Protocol Violation|0|||
19648772|NCT00688064|42098257|FG001|Overall Study|Protocol Violation|1|||
19648773|NCT00688064|42098256|FG000|Overall Study|Adverse Event|2|||
19648774|NCT00688064|42098257|FG001|Overall Study|Adverse Event|4|||
19648775|NCT00688064|42098256|FG000|Overall Study|Withdrawal by Subject|7|||
19648776|NCT00688064|42098257|FG001|Overall Study|Withdrawal by Subject|7|||
19648777|NCT00688064|42098256|FG000|Overall Study|Lost to Follow-up|10|||
19648778|NCT00688064|42098257|FG001|Overall Study|Lost to Follow-up|10|||
19648779|NCT00688064|42098256|FG000|Overall Study|Lack of Efficacy|0|||
19750992|NCT03066830|42200006|FG000|Overall Study|Adverse Event|2|||
19750993|NCT03066830|42200007|FG001|Overall Study|Adverse Event|2|||
19750994|NCT03066830|42200006|FG000|Overall Study|Lost to Follow-up|11|||
19750995|NCT03066830|42200007|FG001|Overall Study|Lost to Follow-up|3|||
19750996|NCT04380961|42200016|FG000|Overall Study|Lost to Follow-up|17|||
19750997|NCT04380961|42200017|FG001|Overall Study|Lost to Follow-up|11|||
19750998|NCT04380961|42200016|FG000|Overall Study|Withdrawal by Subject|3|||
19750999|NCT04380961|42200017|FG001|Overall Study|Withdrawal by Subject|0|||
19751000|NCT04380961|42200016|FG000|Overall Study|Death|22|||
19751001|NCT04380961|42200017|FG001|Overall Study|Death|16|||
19751002|NCT04380961|42200016|FG000|Overall Study|Other|1|||
19751003|NCT04380961|42200017|FG001|Overall Study|Other|0|||
19751004|NCT04380961|42200016|FG000|Overall Study|Randomized but Not Treated|1|||
19751005|NCT04380961|42200017|FG001|Overall Study|Randomized but Not Treated|2|||
19751006|NCT04331899|42200027|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
19751007|NCT04331899|42200028|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
19751008|NCT03063632|42200036|FG000|Overall Study|Death|3|||
19751009|NCT03063632|42200037|FG001|Overall Study|Death|6|||
19751010|NCT03063632|42200036|FG000|Overall Study|Lost to Follow-up|0|||
19751011|NCT03063632|42200037|FG001|Overall Study|Lost to Follow-up|1|||
19751012|NCT03063632|42200036|FG000|Overall Study|Withdrawal by Subject|0|||
19751013|NCT03063632|42200037|FG001|Overall Study|Withdrawal by Subject|2|||
19751014|NCT03063632|42200036|FG000|Overall Study|Physician Decision|2|||
19751015|NCT03063632|42200037|FG001|Overall Study|Physician Decision|0|||
19751016|NCT03063632|42200036|FG000|Overall Study|Other: Disease progression; starting another treatment|2|||
19751017|NCT03063632|42200037|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
19751018|NCT04328467|42200046|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
19751019|NCT04328467|42200047|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
19751020|NCT04328467|42200048|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
19751021|NCT04328077|42200060|FG000|Overall Study|Lost to Follow-up|0|||
19751022|NCT04328077|42200061|FG001|Overall Study|Lost to Follow-up|1|||
19751023|NCT04328077|42200062|FG002|Overall Study|Lost to Follow-up|0|||
19751024|NCT04328077|42200063|FG003|Overall Study|Lost to Follow-up|0|||
19648780|NCT00688064|42098257|FG001|Overall Study|Lack of Efficacy|1|||
19648781|NCT00688064|42098256|FG000|Overall Study|Pregnancy|1|||
19648782|NCT00688064|42098257|FG001|Overall Study|Pregnancy|0|||
19751025|NCT04328077|42200060|FG000|Overall Study|Withdrawal by Subject|0|||
19751026|NCT04328077|42200061|FG001|Overall Study|Withdrawal by Subject|1|||
19751027|NCT04328077|42200062|FG002|Overall Study|Withdrawal by Subject|1|||
19648783|NCT00688064|42098256|FG000|Overall Study|Any other reasons|1|||
19648784|NCT00688064|42098257|FG001|Overall Study|Any other reasons|3|||
19648785|NCT00663234|42098263|FG000|Overall Study|Not willing to adhere to requirements|1|||
19648786|NCT00683384|42098271|FG000|Overall Study|Death|1|||
19648787|NCT00683384|42098271|FG000|Overall Study|Adverse Event|1|||
19648788|NCT00326911|42098277|FG000|Overall Study|Hospitalization prior to treatment|0|||
19648789|NCT00326911|42098278|FG001|Overall Study|Hospitalization prior to treatment|1|||
19648790|NCT00326911|42098277|FG000|Overall Study|Physician decision prior to treatment|1|||
19648791|NCT00326911|42098278|FG001|Overall Study|Physician decision prior to treatment|0|||
19751028|NCT04328077|42200063|FG003|Overall Study|Withdrawal by Subject|3|||
19751029|NCT03691831|42200081|FG000|Overall Study|Lost to Follow-up|16|||
19648792|NCT00326911|42098277|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
19751030|NCT03691831|42200082|FG001|Overall Study|Lost to Follow-up|12|||
19751031|NCT03691831|42200081|FG000|Overall Study|Withdrawal by Subject|9|||
19751032|NCT03691831|42200082|FG001|Overall Study|Withdrawal by Subject|17|||
19751033|NCT03691831|42200081|FG000|Overall Study|Investigator Decision|2|||
19751034|NCT03691831|42200082|FG001|Overall Study|Investigator Decision|2|||
19751035|NCT04320745|42200099|FG000|Overall Study|Adverse Event|26|||
19751036|NCT04320745|42200099|FG000|Overall Study|Withdrawal by Subject|4|||
19648793|NCT00326911|42098278|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
19648794|NCT00540436|42098284|FG000|First 12-Week Treatment Period|Adverse Event|1|||
19648795|NCT00540436|42098284|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
19648796|NCT00540436|42098284|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
19648797|NCT00540436|42098284|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
19648798|NCT00687440|42098288|FG000|Overall Study|Adverse Event|3|||
19648799|NCT00687440|42098288|FG000|Overall Study|Lost to Follow-up|3|||
19648800|NCT00687440|42098288|FG000|Overall Study|Lack of Efficacy|2|||
19648801|NCT00687440|42098288|FG000|Overall Study|Death|2|||
19648802|NCT00687440|42098288|FG000|Overall Study|Other|1|||
19648803|NCT00687440|42098288|FG000|Overall Study|Missing|1|||
19648804|NCT00659490|42098295|FG000|Overall Study|Lost to Follow-up|2|||
19648805|NCT00659490|42098296|FG001|Overall Study|Lost to Follow-up|0|||
19648806|NCT00659490|42098297|FG002|Overall Study|Lost to Follow-up|1|||
19648807|NCT00539500|42098305|FG000|Overall Study|Disease Progression|1|||
19648808|NCT00539500|42098305|FG000|Overall Study|Lost to Follow-up|2|||
19648809|NCT00662532|42098311|FG000|Overall Study|Adverse Event|0|||
19648810|NCT00662532|42098312|FG001|Overall Study|Adverse Event|1|||
19648811|NCT00662532|42098311|FG000|Overall Study|Lost to Follow-up|0|||
19648812|NCT00662532|42098312|FG001|Overall Study|Lost to Follow-up|1|||
19648813|NCT00686036|42098320|FG000|Overall Study|Adverse Event|3|||
19648814|NCT00686036|42098321|FG001|Overall Study|Adverse Event|0|||
19648815|NCT00686036|42098320|FG000|Overall Study|Withdrawal by Subject|3|||
19648816|NCT00686036|42098321|FG001|Overall Study|Withdrawal by Subject|1|||
19648817|NCT00686036|42098320|FG000|Overall Study|Study terminated by AstraZeneca|2|||
19648818|NCT00686036|42098321|FG001|Overall Study|Study terminated by AstraZeneca|1|||
19648819|NCT00686036|42098320|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
19648820|NCT00686036|42098321|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
19648821|NCT00686036|42098320|FG000|Overall Study|Other reasons not identified|0|||
19648822|NCT00686036|42098321|FG001|Overall Study|Other reasons not identified|4|||
19648823|NCT00682448|42098329|FG000|Overall Study|Adverse Event|1|||
19648824|NCT00682448|42098330|FG001|Overall Study|Adverse Event|2|||
19648825|NCT00682448|42098329|FG000|Overall Study|Lack of Efficacy|1|||
19648826|NCT00682448|42098330|FG001|Overall Study|Lack of Efficacy|0|||
19648827|NCT00682448|42098329|FG000|Overall Study|Lost to Follow-up|1|||
19648828|NCT00682448|42098330|FG001|Overall Study|Lost to Follow-up|3|||
19648829|NCT00682448|42098329|FG000|Overall Study|Pregnancy|0|||
19648830|NCT00682448|42098330|FG001|Overall Study|Pregnancy|1|||
19648831|NCT00682448|42098329|FG000|Overall Study|Withdrawal by Subject|2|||
19648832|NCT00682448|42098330|FG001|Overall Study|Withdrawal by Subject|0|||
19648833|NCT00681824|42098339|FG000|Overall Study|withdrawn by investigator|0|||
19648834|NCT00681824|42098340|FG001|Overall Study|withdrawn by investigator|0|||
19648835|NCT00681824|42098341|FG002|Overall Study|withdrawn by investigator|1|||
19648836|NCT00681824|42098339|FG000|Overall Study|scheduling conflict|1|||
19648837|NCT00681824|42098340|FG001|Overall Study|scheduling conflict|0|||
19648838|NCT00681824|42098341|FG002|Overall Study|scheduling conflict|0|||
19648839|NCT00681824|42098339|FG000|Overall Study|Death|0|||
19648840|NCT00681824|42098340|FG001|Overall Study|Death|1|||
19648841|NCT00681824|42098341|FG002|Overall Study|Death|0|||
19648842|NCT00681668|42098349|FG000|Overall Study|Protocol Violation|1|||
19648843|NCT00681668|42098349|FG000|Overall Study|Withdrawal by Subject|1|||
19648844|NCT00539188|42098355|FG000|Overall Study|Withdrawal by Subject|1|||
19648845|NCT00539188|42098356|FG001|Overall Study|Withdrawal by Subject|0|||
19648846|NCT00539188|42098355|FG000|Overall Study|Lost to Follow-up|2|||
19648847|NCT00539188|42098356|FG001|Overall Study|Lost to Follow-up|1|||
19648848|NCT00681590|42098364|FG000|Overall Study|Withdrawal by Subject|2|||
19648849|NCT00681590|42098365|FG001|Overall Study|Withdrawal by Subject|12|||
19648850|NCT04980456|42098373|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
19648851|NCT04980456|42098374|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
19751037|NCT04320745|42200099|FG000|Overall Study|Lost to Follow-up|12|||
19648852|NCT04980456|42098373|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
19648853|NCT04980456|42098374|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
19648854|NCT04980456|42098373|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
19648855|NCT04980456|42098374|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
19648856|NCT04980456|42098373|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
19648857|NCT04980456|42098374|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
19648858|NCT00326599|42098387|FG000|Overall Study|Withdrawal by Subject|1|||
19648859|NCT00326599|42098388|FG001|Overall Study|Withdrawal by Subject|0|||
19648860|NCT00326599|42098389|FG002|Overall Study|Withdrawal by Subject|5|||
19648861|NCT00326599|42098390|FG003|Overall Study|Withdrawal by Subject|2|||
19648862|NCT00326599|42098387|FG000|Overall Study|Adverse Event|1|||
19648863|NCT00326599|42098388|FG001|Overall Study|Adverse Event|0|||
19648864|NCT00326599|42098389|FG002|Overall Study|Adverse Event|32|||
19648865|NCT00326599|42098390|FG003|Overall Study|Adverse Event|3|||
19648866|NCT00326599|42098387|FG000|Overall Study|Disease Progression|3|||
19648867|NCT00326599|42098388|FG001|Overall Study|Disease Progression|1|||
19648868|NCT00326599|42098389|FG002|Overall Study|Disease Progression|13|||
19648869|NCT00326599|42098390|FG003|Overall Study|Disease Progression|11|||
19648870|NCT00326599|42098387|FG000|Overall Study|Alternate Treatment|1|||
19648871|NCT00326599|42098388|FG001|Overall Study|Alternate Treatment|0|||
19648872|NCT00326599|42098389|FG002|Overall Study|Alternate Treatment|0|||
19648873|NCT00326599|42098390|FG003|Overall Study|Alternate Treatment|0|||
19648874|NCT00326599|42098387|FG000|Overall Study|Death|0|||
19648875|NCT00326599|42098388|FG001|Overall Study|Death|0|||
19648876|NCT00326599|42098389|FG002|Overall Study|Death|1|||
19648877|NCT00326599|42098390|FG003|Overall Study|Death|2|||
19648878|NCT00326599|42098387|FG000|Overall Study|Other Unspecified Reason|0|||
19648879|NCT00326599|42098388|FG001|Overall Study|Other Unspecified Reason|0|||
19648880|NCT00326599|42098389|FG002|Overall Study|Other Unspecified Reason|2|||
19648881|NCT00326599|42098390|FG003|Overall Study|Other Unspecified Reason|1|||
19648882|NCT00539032|42098401|FG000|Overall Study|Withdrawal by Subject|2|||
19648883|NCT00539032|42098402|FG001|Overall Study|Withdrawal by Subject|1|||
19648884|NCT00685802|42098408|FG000|Washout Period of 7 Days|Protocol Violation|2|||
19648885|NCT00685802|42098409|FG001|Washout Period of 7 Days|Protocol Violation|0|||
19600903|NCT01072175|42049714|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600904|NCT01072175|42049715|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600905|NCT01072175|42049716|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
19600906|NCT01072175|42049717|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
19600907|NCT01072175|42049718|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
19600908|NCT01072175|42049719|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600909|NCT01072175|42049720|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19648886|NCT00685802|42098408|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19648887|NCT00685802|42098409|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19648888|NCT00354601|42098415|FG000|Overall Study|Protocol Violation|1|||
19648889|NCT00354601|42098415|FG000|Overall Study|progression|1|||
19648890|NCT03827473|42098421|FG000|Overall Study|Withdrawal by Subject|1|||
19648891|NCT03827473|42098422|FG001|Overall Study|Withdrawal by Subject|0|||
19648892|NCT00345397|42098428|FG000|Overall Study|Death|1|||
19648893|NCT00326209|42098433|FG000|Overall Study|Adverse Event|28|||
19648894|NCT00326209|42098433|FG000|Overall Study|Withdrawal by Subject|22|||
19648895|NCT00326209|42098433|FG000|Overall Study|Lack of Efficacy|31|||
19648896|NCT00326209|42098433|FG000|Overall Study|Lost to Follow-up|18|||
19648897|NCT00326209|42098433|FG000|Overall Study|Participant non-compliant|6|||
19648898|NCT00326209|42098433|FG000|Overall Study|Sponsor closed study|173|||
19648899|NCT00326209|42098433|FG000|Overall Study|Prohibited medication use|1|||
19648900|NCT00326209|42098433|FG000|Overall Study|Violation of entry criteria|1|||
19648901|NCT00326209|42098433|FG000|Overall Study|Withdrawn in error|1|||
19648902|NCT00326209|42098433|FG000|Overall Study|Pregnancy|1|||
19648903|NCT00537940|42098439|FG000|Overall Study|Adverse Event|20|||
19648904|NCT00537940|42098440|FG001|Overall Study|Adverse Event|19|||
19648905|NCT00537940|42098439|FG000|Overall Study|Lack of Efficacy|8|||
19648906|NCT00537940|42098440|FG001|Overall Study|Lack of Efficacy|16|||
19648907|NCT00537940|42098439|FG000|Overall Study|Lost to Follow-up|23|||
19648908|NCT00537940|42098440|FG001|Overall Study|Lost to Follow-up|29|||
19648909|NCT00537940|42098439|FG000|Overall Study|Withdrawal by Subject|113|||
19648910|NCT00537940|42098440|FG001|Overall Study|Withdrawal by Subject|95|||
19648911|NCT00537940|42098439|FG000|Overall Study|Protocol Violation|6|||
19648912|NCT00537940|42098440|FG001|Overall Study|Protocol Violation|4|||
19648913|NCT00537940|42098439|FG000|Overall Study|Pregnancy|1|||
19648914|NCT00537940|42098440|FG001|Overall Study|Pregnancy|1|||
19648915|NCT00537940|42098439|FG000|Overall Study|Study terminated by sponsor|2|||
19648916|NCT00537940|42098440|FG001|Overall Study|Study terminated by sponsor|3|||
19648917|NCT00537940|42098439|FG000|Overall Study|Other|10|||
19648918|NCT00537940|42098440|FG001|Overall Study|Other|12|||
19648919|NCT00661362|42098448|FG000|Overall Study|Adverse Event|5|||
19648920|NCT00661362|42098449|FG001|Overall Study|Adverse Event|4|||
19648921|NCT00661362|42098448|FG000|Overall Study|Incorrect enrollment|2|||
19648922|NCT00661362|42098449|FG001|Overall Study|Incorrect enrollment|0|||
19648923|NCT00661362|42098448|FG000|Overall Study|Study specific discontinuation criteria|4|||
19648924|NCT00661362|42098449|FG001|Overall Study|Study specific discontinuation criteria|11|||
19648925|NCT00661362|42098448|FG000|Overall Study|Withdrawal by Subject|13|||
19648926|NCT00661362|42098449|FG001|Overall Study|Withdrawal by Subject|23|||
19648927|NCT00661362|42098448|FG000|Overall Study|Lost to Follow-up|3|||
19648928|NCT00661362|42098449|FG001|Overall Study|Lost to Follow-up|1|||
19648929|NCT00661362|42098448|FG000|Overall Study|Severe non-compliance to protocol|0|||
19648930|NCT00661362|42098449|FG001|Overall Study|Severe non-compliance to protocol|1|||
19648931|NCT00661362|42098448|FG000|Overall Study|Safety reasons|1|||
19648932|NCT00661362|42098449|FG001|Overall Study|Safety reasons|0|||
19648933|NCT00661362|42098448|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
19648934|NCT00661362|42098449|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
19648935|NCT00325897|42098457|FG000|Overall Study|Lost to Follow-up|12|||
19648936|NCT00325897|42098458|FG001|Overall Study|Lost to Follow-up|13|||
19648937|NCT00344773|42098467|FG000|Overall Study|Adverse Event|2|||
19648938|NCT00344773|42098467|FG000|Overall Study|Objective Disease Progression|16|||
19648939|NCT00344773|42098467|FG000|Overall Study|Withdrawal by Subject|1|||
19648940|NCT00344773|42098467|FG000|Overall Study|Not Eligible for the study|2|||
19648941|NCT00325819|42098473|FG000|Overall Study|Study product lost in mail|2|||
19648942|NCT00325819|42098474|FG001|Overall Study|Study product lost in mail|1|||
19648943|NCT00325819|42098473|FG000|Overall Study|Did not take a dose of study product|4|||
19648944|NCT00325819|42098474|FG001|Overall Study|Did not take a dose of study product|9|||
19648945|NCT00325819|42098473|FG000|Overall Study|Lost to Follow-up|3|||
19648946|NCT00325819|42098474|FG001|Overall Study|Lost to Follow-up|3|||
19648947|NCT00687362|42098482|FG000|Overall Study|Protocol Violation|2|||
19648948|NCT00687362|42098482|FG000|Overall Study|Withdrawal by Subject|1|||
19648949|NCT00325195|42098489|FG000|Randomized|Not dosed|5|||
19648950|NCT00325195|42098490|FG001|Randomized|Not dosed|5|||
19648951|NCT00325195|42098491|FG002|Randomized|Not dosed|3|||
19648952|NCT00325195|42098489|FG000|Received Intervention: ITT Population|Adverse Event|15|||
19648953|NCT00325195|42098490|FG001|Received Intervention: ITT Population|Adverse Event|17|||
19648954|NCT00325195|42098491|FG002|Received Intervention: ITT Population|Adverse Event|1|||
19648955|NCT00325195|42098489|FG000|Received Intervention: ITT Population|Death|3|||
19648956|NCT00325195|42098490|FG001|Received Intervention: ITT Population|Death|1|||
19648957|NCT00325195|42098491|FG002|Received Intervention: ITT Population|Death|0|||
19648958|NCT00325195|42098489|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
19648959|NCT00325195|42098490|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
19648960|NCT00325195|42098491|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
19648961|NCT00325195|42098489|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
19648962|NCT00325195|42098490|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
19648963|NCT00325195|42098491|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
19648964|NCT00325195|42098489|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
19648965|NCT00325195|42098490|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
19648966|NCT00325195|42098491|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
19648967|NCT03976401|42098505|FG000|Overall Study|Adverse Event|2|||
19648968|NCT03976401|42098506|FG001|Overall Study|Adverse Event|0|||
19648969|NCT03976401|42098507|FG002|Overall Study|Adverse Event|4|||
19648970|NCT03976401|42098508|FG003|Overall Study|Adverse Event|1|||
19648971|NCT03976401|42098509|FG004|Overall Study|Adverse Event|1|||
19648972|NCT03976401|42098510|FG005|Overall Study|Adverse Event|0|||
19648973|NCT03976401|42098505|FG000|Overall Study|Withdrawal by Subject|0|||
19648974|NCT03976401|42098506|FG001|Overall Study|Withdrawal by Subject|1|||
19648975|NCT03976401|42098507|FG002|Overall Study|Withdrawal by Subject|0|||
19600910|NCT01072175|42049721|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600911|NCT01072175|42049722|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600912|NCT01072175|42049723|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
19600913|NCT01072175|42049711|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600914|NCT01072175|42049712|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600915|NCT01072175|42049713|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600916|NCT01072175|42049714|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600917|NCT01072175|42049715|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600918|NCT01072175|42049716|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600919|NCT01072175|42049717|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
19600920|NCT01072175|42049718|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
19600921|NCT01072175|42049719|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600922|NCT01072175|42049720|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600923|NCT01072175|42049721|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600924|NCT01072175|42049722|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600925|NCT01072175|42049723|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
19600926|NCT01072175|42049711|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600927|NCT01072175|42049712|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600928|NCT01072175|42049713|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600929|NCT01072175|42049714|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600930|NCT01072175|42049715|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600931|NCT01072175|42049716|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
19600932|NCT01072175|42049717|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
19600933|NCT01072175|42049718|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
19600934|NCT01072175|42049719|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600935|NCT01072175|42049720|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600936|NCT01072175|42049721|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600937|NCT01072175|42049722|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19600938|NCT01072175|42049723|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
19648976|NCT03976401|42098508|FG003|Overall Study|Withdrawal by Subject|0|||
19648977|NCT03976401|42098509|FG004|Overall Study|Withdrawal by Subject|0|||
19648978|NCT03976401|42098510|FG005|Overall Study|Withdrawal by Subject|1|||
19648979|NCT03976401|42098505|FG000|Overall Study|Physician Decision|0|||
19648980|NCT03976401|42098506|FG001|Overall Study|Physician Decision|0|||
19648981|NCT03976401|42098507|FG002|Overall Study|Physician Decision|1|||
19648982|NCT03976401|42098508|FG003|Overall Study|Physician Decision|0|||
19648983|NCT03976401|42098509|FG004|Overall Study|Physician Decision|0|||
19648984|NCT03976401|42098510|FG005|Overall Study|Physician Decision|0|||
19648985|NCT03976401|42098505|FG000|Overall Study|Lost to Follow-up|1|||
19648986|NCT03976401|42098506|FG001|Overall Study|Lost to Follow-up|2|||
19648987|NCT03976401|42098507|FG002|Overall Study|Lost to Follow-up|0|||
19648988|NCT03976401|42098508|FG003|Overall Study|Lost to Follow-up|0|||
19648989|NCT03976401|42098509|FG004|Overall Study|Lost to Follow-up|0|||
19648990|NCT03976401|42098510|FG005|Overall Study|Lost to Follow-up|0|||
19648991|NCT03976401|42098505|FG000|Overall Study|Protocol Violation|0|||
19648992|NCT03976401|42098506|FG001|Overall Study|Protocol Violation|1|||
19751038|NCT04320745|42200099|FG000|Overall Study|Protocol Deviation|2|||
19751039|NCT04320745|42200099|FG000|Overall Study|Non-compliance With Study Drug|2|||
19751040|NCT04320745|42200099|FG000|Overall Study|Reason Not Specified|1|||
19751041|NCT03063086|42200103|FG000|Overall Study|technical problems|1|||
19751042|NCT03063086|42200104|FG001|Overall Study|technical problems|0|||
19751043|NCT03063086|42200105|FG002|Overall Study|technical problems|0|||
19751044|NCT03063086|42200106|FG003|Overall Study|technical problems|0|||
19751045|NCT03063086|42200107|FG004|Overall Study|technical problems|0|||
19751046|NCT03063086|42200108|FG005|Overall Study|technical problems|0|||
19751047|NCT03063086|42200103|FG000|Overall Study|Adverse Event|1|||
19751048|NCT03063086|42200104|FG001|Overall Study|Adverse Event|1|||
19751049|NCT03063086|42200105|FG002|Overall Study|Adverse Event|1|||
19751050|NCT03063086|42200106|FG003|Overall Study|Adverse Event|1|||
19751051|NCT03063086|42200107|FG004|Overall Study|Adverse Event|0|||
19600939|NCT01072175|42049711|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600940|NCT01072175|42049712|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600941|NCT01072175|42049713|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600942|NCT01072175|42049714|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600943|NCT01072175|42049715|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600944|NCT01072175|42049716|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
19600945|NCT01072175|42049717|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
19600946|NCT01072175|42049718|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600947|NCT01072175|42049719|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19648993|NCT03976401|42098507|FG002|Overall Study|Protocol Violation|0|||
19648994|NCT03976401|42098508|FG003|Overall Study|Protocol Violation|0|||
19648995|NCT03976401|42098509|FG004|Overall Study|Protocol Violation|0|||
19648996|NCT03976401|42098510|FG005|Overall Study|Protocol Violation|0|||
19648997|NCT03976401|42098505|FG000|Overall Study|Withdrew Consent|0|||
19648998|NCT03976401|42098506|FG001|Overall Study|Withdrew Consent|0|||
19751052|NCT03063086|42200108|FG005|Overall Study|Adverse Event|0|||
19751053|NCT03063086|42200103|FG000|Overall Study|subject/guardian decision|1|||
19751054|NCT03063086|42200104|FG001|Overall Study|subject/guardian decision|0|||
19648999|NCT03976401|42098507|FG002|Overall Study|Withdrew Consent|0|||
19649000|NCT03976401|42098508|FG003|Overall Study|Withdrew Consent|1|||
19649001|NCT03976401|42098509|FG004|Overall Study|Withdrew Consent|0|||
19649002|NCT03976401|42098510|FG005|Overall Study|Withdrew Consent|0|||
19649003|NCT00660816|42098526|FG000|Overall Study|Adverse Event|1|||
19649004|NCT00660816|42098527|FG001|Overall Study|Adverse Event|2|||
19649005|NCT00660816|42098526|FG000|Overall Study|Withdrawal by Subject|1|||
19649006|NCT00660816|42098527|FG001|Overall Study|Withdrawal by Subject|0|||
19649007|NCT00660816|42098526|FG000|Overall Study|Death|0|||
19649008|NCT00660816|42098527|FG001|Overall Study|Death|2|||
19649009|NCT00660816|42098526|FG000|Overall Study|Lack of Efficacy|1|||
19649010|NCT00660816|42098527|FG001|Overall Study|Lack of Efficacy|0|||
19649011|NCT00660816|42098526|FG000|Overall Study|Physician Decision|0|||
19649012|NCT00660816|42098527|FG001|Overall Study|Physician Decision|2|||
19649013|NCT00660816|42098526|FG000|Overall Study|Protocol Violation|1|||
19649014|NCT00660816|42098527|FG001|Overall Study|Protocol Violation|0|||
19649015|NCT00660816|42098526|FG000|Overall Study|Disease Progression|16|||
19649016|NCT00660816|42098527|FG001|Overall Study|Disease Progression|12|||
19649017|NCT00660816|42098526|FG000|Overall Study|Complicating Disease|0|||
19649018|NCT00660816|42098527|FG001|Overall Study|Complicating Disease|1|||
19649019|NCT00685334|42098535|FG000|Overall Study|Withdrawal by Subject|5|||
19649020|NCT00685334|42098536|FG001|Overall Study|Withdrawal by Subject|6|||
19649021|NCT00685334|42098535|FG000|Overall Study|Lost to Follow-up|4|||
19649022|NCT00685334|42098536|FG001|Overall Study|Lost to Follow-up|0|||
19649023|NCT00685334|42098535|FG000|Overall Study|Chose to enter hospital|1|||
19649024|NCT00685334|42098536|FG001|Overall Study|Chose to enter hospital|1|||
19649025|NCT00325039|42098544|FG000|Overall Study|Lost to Follow-up|18|||
19649026|NCT00325039|42098545|FG001|Overall Study|Lost to Follow-up|14|||
19649027|NCT00344461|42098551|FG000|Overall Study|Adverse Event|6|||
19649028|NCT00344461|42098551|FG000|Overall Study|Death|1|||
19649029|NCT00344461|42098551|FG000|Overall Study|Lack of Efficacy|2|||
19649030|NCT00344461|42098551|FG000|Overall Study|Lost to Follow-up|2|||
19649031|NCT00344461|42098551|FG000|Overall Study|Physician Decision|2|||
19649032|NCT00344461|42098551|FG000|Overall Study|Protocol Violation|6|||
19649033|NCT00344461|42098551|FG000|Overall Study|Withdrawal by Subject|2|||
19649034|NCT00685178|42098560|FG000|Overall Study|Adverse Event|1|||
19649035|NCT00685178|42098561|FG001|Overall Study|Adverse Event|5|||
19649036|NCT00685178|42098562|FG002|Overall Study|Adverse Event|2|||
19649037|NCT00685178|42098563|FG003|Overall Study|Adverse Event|4|||
19649038|NCT00685178|42098560|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
19649039|NCT00685178|42098561|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
19649040|NCT00685178|42098562|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
19649041|NCT00685178|42098563|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
19649042|NCT00685178|42098560|FG000|Overall Study|voluntary study discharge|4|||
19649043|NCT00685178|42098561|FG001|Overall Study|voluntary study discharge|5|||
19649044|NCT00685178|42098562|FG002|Overall Study|voluntary study discharge|1|||
19649045|NCT00685178|42098563|FG003|Overall Study|voluntary study discharge|1|||
19649046|NCT00685178|42098560|FG000|Overall Study|incarcerated|1|||
19649047|NCT00685178|42098561|FG001|Overall Study|incarcerated|3|||
19649048|NCT00685178|42098562|FG002|Overall Study|incarcerated|7|||
19649049|NCT00685178|42098563|FG003|Overall Study|incarcerated|0|||
19649050|NCT00685178|42098560|FG000|Overall Study|administrative (disciplinary) discharge|0|||
19649051|NCT00685178|42098561|FG001|Overall Study|administrative (disciplinary) discharge|1|||
19649052|NCT00685178|42098562|FG002|Overall Study|administrative (disciplinary) discharge|0|||
19649053|NCT00685178|42098563|FG003|Overall Study|administrative (disciplinary) discharge|2|||
19649054|NCT00685178|42098560|FG000|Overall Study|Pregnancy|0|||
19649055|NCT00685178|42098561|FG001|Overall Study|Pregnancy|0|||
19649056|NCT00685178|42098562|FG002|Overall Study|Pregnancy|0|||
19649057|NCT00685178|42098563|FG003|Overall Study|Pregnancy|1|||
19649058|NCT00537394|42098576|FG000|First Year of Follow-up|Death|7|||
19649059|NCT00537394|42098577|FG001|First Year of Follow-up|Death|0|||
19649060|NCT00537394|42098578|FG002|First Year of Follow-up|Death|0|||
19649061|NCT00537394|42098576|FG000|First Year of Follow-up|Severe debilitation|1|||
19649062|NCT00537394|42098577|FG001|First Year of Follow-up|Severe debilitation|0|||
19649063|NCT00537394|42098578|FG002|First Year of Follow-up|Severe debilitation|1|||
19649064|NCT00537394|42098576|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
19649065|NCT00537394|42098577|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
19649066|NCT00537394|42098578|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
19649067|NCT00537394|42098576|FG000|First Year of Follow-up|Lost to Follow-up|1|||
19649068|NCT00537394|42098577|FG001|First Year of Follow-up|Lost to Follow-up|5|||
19649069|NCT00537394|42098578|FG002|First Year of Follow-up|Lost to Follow-up|1|||
19649070|NCT00537394|42098576|FG000|2nd Year of Follow-up|Death|4|||
19649071|NCT00537394|42098577|FG001|2nd Year of Follow-up|Death|1|||
19649072|NCT00537394|42098578|FG002|2nd Year of Follow-up|Death|2|||
19649073|NCT00537394|42098576|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
19751055|NCT03063086|42200105|FG002|Overall Study|subject/guardian decision|0|||
19751056|NCT03063086|42200106|FG003|Overall Study|subject/guardian decision|0|||
19751057|NCT03063086|42200107|FG004|Overall Study|subject/guardian decision|0|||
19751058|NCT03063086|42200108|FG005|Overall Study|subject/guardian decision|0|||
19600948|NCT01072175|42049720|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600949|NCT01072175|42049721|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600950|NCT01072175|42049722|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600951|NCT01072175|42049723|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
19600952|NCT01072175|42049711|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600953|NCT01072175|42049712|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600954|NCT01072175|42049713|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600955|NCT01072175|42049714|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600956|NCT01072175|42049715|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600957|NCT01072175|42049716|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600958|NCT01072175|42049717|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600959|NCT01072175|42049718|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600960|NCT01072175|42049719|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
19600961|NCT01072175|42049720|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600962|NCT01072175|42049721|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600963|NCT01072175|42049722|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600964|NCT01072175|42049723|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
19600965|NCT01072175|42049711|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600966|NCT01072175|42049712|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600967|NCT01072175|42049713|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600968|NCT01072175|42049714|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600969|NCT01072175|42049715|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600970|NCT01072175|42049716|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600971|NCT01072175|42049717|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600972|NCT01072175|42049718|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600973|NCT01072175|42049719|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
19600974|NCT01072175|42049720|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600975|NCT01072175|42049721|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600976|NCT01072175|42049722|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600977|NCT01072175|42049723|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
19600978|NCT01072175|42049711|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600979|NCT01072175|42049712|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600980|NCT01072175|42049713|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600981|NCT01072175|42049714|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600982|NCT01072175|42049715|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600983|NCT01072175|42049716|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600984|NCT01072175|42049717|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600985|NCT01072175|42049718|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19751059|NCT03063086|42200103|FG000|Overall Study|Non-compliance with study treatment|0|||
19751060|NCT03063086|42200104|FG001|Overall Study|Non-compliance with study treatment|0|||
19751061|NCT03063086|42200105|FG002|Overall Study|Non-compliance with study treatment|0|||
19649074|NCT00537394|42098577|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
19649075|NCT00537394|42098578|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
19649076|NCT00537394|42098576|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
19649077|NCT00537394|42098577|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
19649078|NCT00537394|42098578|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
19649079|NCT00537394|42098576|FG000|2nd Year of Follow-up|Clinic site closure|1|||
19649080|NCT00537394|42098577|FG001|2nd Year of Follow-up|Clinic site closure|0|||
19649081|NCT00537394|42098578|FG002|2nd Year of Follow-up|Clinic site closure|0|||
19649082|NCT00352885|42098586|FG000|Overall Study|Withdrawal by Subject|0|||
19649083|NCT00352885|42098587|FG001|Overall Study|Withdrawal by Subject|3|||
19649084|NCT00352885|42098586|FG000|Overall Study|Development of major depression|0|||
19649085|NCT00352885|42098587|FG001|Overall Study|Development of major depression|1|||
19649086|NCT00352885|42098586|FG000|Overall Study|Progression of metastatic melanoma|5|||
19649087|NCT00352885|42098587|FG001|Overall Study|Progression of metastatic melanoma|3|||
19649088|NCT00352885|42098586|FG000|Overall Study|Side effects of IL-2 administration|1|||
19649089|NCT00352885|42098587|FG001|Overall Study|Side effects of IL-2 administration|0|||
19649090|NCT00660660|42098595|FG000|Overall Study|Adverse Event|1|||
19649091|NCT00660660|42098596|FG001|Overall Study|Adverse Event|0|||
19649092|NCT00660660|42098595|FG000|Overall Study|Lost to Follow-up|0|||
19649093|NCT00660660|42098596|FG001|Overall Study|Lost to Follow-up|6|||
19649094|NCT00660660|42098595|FG000|Overall Study|Lack of Efficacy|0|||
19649095|NCT00660660|42098596|FG001|Overall Study|Lack of Efficacy|2|||
19649096|NCT00660660|42098595|FG000|Overall Study|Withdrawal by Subject|3|||
19649097|NCT00660660|42098596|FG001|Overall Study|Withdrawal by Subject|0|||
19649098|NCT00660660|42098595|FG000|Overall Study|Incorrect enrollment and other|0|||
19649099|NCT00660660|42098596|FG001|Overall Study|Incorrect enrollment and other|1|||
19649100|NCT00660660|42098595|FG000|Overall Study|New medication after randomization|1|||
19649101|NCT00660660|42098596|FG001|Overall Study|New medication after randomization|0|||
19649102|NCT00344305|42098604|FG000|Overall Study|Lost to Follow-up|2|||
19649103|NCT00344305|42098605|FG001|Overall Study|Lost to Follow-up|0|||
19649104|NCT00344305|42098604|FG000|Overall Study|Participant was not contacted in window|0|||
19649105|NCT00344305|42098605|FG001|Overall Study|Participant was not contacted in window|1|||
19649106|NCT00576056|42098612|FG000|Overall Study|Adverse Event|1|||
19649107|NCT00576056|42098612|FG000|Overall Study|Death|1|||
19649108|NCT00576056|42098612|FG000|Overall Study|Lack of Efficacy|1|||
19649109|NCT00576056|42098612|FG000|Overall Study|Withdrawal by Subject|2|||
19649110|NCT00576056|42098612|FG000|Overall Study|did not meet eligibility criteria|8|||
19649111|NCT00576056|42098612|FG000|Overall Study|Physician Decision|1|||
19649112|NCT00575510|42098619|FG000|Overall Study|Lost to Follow-up|4|||
19649113|NCT00575510|42098620|FG001|Overall Study|Lost to Follow-up|6|||
19649114|NCT00575510|42098621|FG002|Overall Study|Lost to Follow-up|9|||
19649115|NCT00575510|42098619|FG000|Overall Study|Withdrawal by Subject|1|||
19649116|NCT00575510|42098620|FG001|Overall Study|Withdrawal by Subject|0|||
19649117|NCT00575510|42098621|FG002|Overall Study|Withdrawal by Subject|0|||
19649118|NCT00575510|42098619|FG000|Overall Study|Clinic Called Patient|7|||
19649119|NCT00575510|42098620|FG001|Overall Study|Clinic Called Patient|7|||
19649120|NCT00575510|42098621|FG002|Overall Study|Clinic Called Patient|7|||
19649121|NCT00575510|42098619|FG000|Overall Study|Pregnancy|0|||
19649122|NCT00575510|42098620|FG001|Overall Study|Pregnancy|0|||
19649123|NCT00575510|42098621|FG002|Overall Study|Pregnancy|1|||
19649124|NCT02636439|42098632|FG000|Overall Study|Adverse Event|2|||
19649125|NCT02636439|42098633|FG001|Overall Study|Adverse Event|2|||
19649126|NCT02636439|42098632|FG000|Overall Study|Lost to Follow-up|1|||
19649127|NCT02636439|42098633|FG001|Overall Study|Lost to Follow-up|0|||
19649128|NCT02636439|42098632|FG000|Overall Study|Non-compliance|1|||
19649129|NCT02636439|42098633|FG001|Overall Study|Non-compliance|1|||
19649130|NCT02636439|42098632|FG000|Overall Study|Personal reasons|2|||
19649131|NCT02636439|42098633|FG001|Overall Study|Personal reasons|0|||
19751062|NCT03063086|42200106|FG003|Overall Study|Non-compliance with study treatment|1|||
19649132|NCT00343915|42098641|FG000|Primary Study|Withdrawal by Subject|1|||
19649133|NCT00343915|42098642|FG001|Primary Study|Withdrawal by Subject|0|||
19649134|NCT00343915|42098641|FG000|Primary Study|Lost to Follow-up|2|||
19649135|NCT00343915|42098642|FG001|Primary Study|Lost to Follow-up|3|||
19649136|NCT00343915|42098641|FG000|Primary Study|Other|1|||
19649137|NCT00343915|42098642|FG001|Primary Study|Other|0|||
19649138|NCT00575666|42098653|FG000|Overall Study|Withdrawal by Subject|3|||
19649139|NCT00575666|42098654|FG001|Overall Study|Withdrawal by Subject|2|||
19649140|NCT00575666|42098653|FG000|Overall Study|Physician Decision|1|||
19649141|NCT00575666|42098654|FG001|Overall Study|Physician Decision|1|||
19649142|NCT00658632|42098662|FG000|Overall Study|Adverse Event|13|||
19649143|NCT00658632|42098663|FG001|Overall Study|Adverse Event|11|||
19751063|NCT03063086|42200107|FG004|Overall Study|Non-compliance with study treatment|0|||
19751064|NCT03063086|42200108|FG005|Overall Study|Non-compliance with study treatment|1|||
19751065|NCT03063086|42200103|FG000|Overall Study|Physician Decision|0|||
19751066|NCT03063086|42200104|FG001|Overall Study|Physician Decision|0|||
19751067|NCT03063086|42200105|FG002|Overall Study|Physician Decision|0|||
19751068|NCT03063086|42200106|FG003|Overall Study|Physician Decision|1|||
19649144|NCT00658632|42098662|FG000|Overall Study|Lost to Follow-up|25|||
19649145|NCT00658632|42098663|FG001|Overall Study|Lost to Follow-up|23|||
19649146|NCT00658632|42098662|FG000|Overall Study|Withdrawal by Subject|10|||
19649147|NCT00658632|42098663|FG001|Overall Study|Withdrawal by Subject|7|||
19649148|NCT00658632|42098662|FG000|Overall Study|Lack of Efficacy|0|||
19649149|NCT00658632|42098663|FG001|Overall Study|Lack of Efficacy|1|||
19649150|NCT00658632|42098662|FG000|Overall Study|Withdrawal of consent|8|||
19649151|NCT00658632|42098663|FG001|Overall Study|Withdrawal of consent|14|||
19649152|NCT00658632|42098662|FG000|Overall Study|Pregnancy|1|||
19649153|NCT00658632|42098663|FG001|Overall Study|Pregnancy|1|||
19649154|NCT00658632|42098662|FG000|Overall Study|Other|7|||
19649155|NCT00658632|42098663|FG001|Overall Study|Other|8|||
19751069|NCT03063086|42200107|FG004|Overall Study|Physician Decision|0|||
19751070|NCT03063086|42200108|FG005|Overall Study|Physician Decision|0|||
19751071|NCT04128007|42200119|FG000|Overall Study|Withdrawal by Subject|9|||
19649156|NCT00677534|42098669|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
19649157|NCT00677534|42098669|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
19649158|NCT00677534|42098669|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
19649159|NCT00660348|42098675|FG000|Overall Study|Withdrawal by Subject|1|||
19649160|NCT00660348|42098676|FG001|Overall Study|Withdrawal by Subject|0|||
19649161|NCT00660192|42098684|FG000|Overall Study|Lost to Follow-up|2|||
19649162|NCT00660192|42098685|FG001|Overall Study|Lost to Follow-up|3|||
19649163|NCT00571688|42098693|FG000|Overall Study|Lost to Follow-up|3|||
19649164|NCT00571688|42098694|FG001|Overall Study|Lost to Follow-up|6|||
19649165|NCT00571688|42098693|FG000|Overall Study|subject did not tolerate Consta|1|||
19649166|NCT00571688|42098694|FG001|Overall Study|subject did not tolerate Consta|0|||
19649167|NCT00571688|42098693|FG000|Overall Study|subject moved out of the area|1|||
19649168|NCT00571688|42098694|FG001|Overall Study|subject moved out of the area|0|||
19649169|NCT00343291|42098702|FG000|Overall Study|Adverse Event|13|||
19649170|NCT00343291|42098703|FG001|Overall Study|Adverse Event|13|||
19649171|NCT00343291|42098702|FG000|Overall Study|Death|3|||
19649172|NCT00343291|42098703|FG001|Overall Study|Death|2|||
19649173|NCT00343291|42098702|FG000|Overall Study|Progressive disease|33|||
19649174|NCT00343291|42098703|FG001|Overall Study|Progressive disease|34|||
19649175|NCT00343291|42098702|FG000|Overall Study|Withdrawal by Subject|0|||
19649176|NCT00343291|42098703|FG001|Overall Study|Withdrawal by Subject|2|||
19649177|NCT00343291|42098702|FG000|Overall Study|Other|8|||
19649178|NCT00343291|42098703|FG001|Overall Study|Other|5|||
19649179|NCT00658788|42098709|FG000|Overall Study|Adverse Event|11|||
19649180|NCT00658788|42098709|FG000|Overall Study|Withdrawal by Subject|13|||
19649181|NCT00658788|42098709|FG000|Overall Study|Lost to Follow-up|18|||
19649182|NCT00658788|42098709|FG000|Overall Study|Treatment Discontinuation|32|||
19649183|NCT04829214|42098724|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
19649184|NCT04829214|42098725|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
19649185|NCT04829214|42098724|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
19649186|NCT04829214|42098725|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
19649187|NCT00562965|42098735|FG000|Overall Study|Withdrawal by Subject|0|||
19649188|NCT00562965|42098736|FG001|Overall Study|Withdrawal by Subject|1|||
19649189|NCT00562965|42098735|FG000|Overall Study|Death|2|||
19649190|NCT00562965|42098736|FG001|Overall Study|Death|4|||
19649191|NCT00562965|42098735|FG000|Overall Study|Lost to Follow-up|1|||
19649192|NCT00562965|42098736|FG001|Overall Study|Lost to Follow-up|0|||
19649193|NCT00562965|42098735|FG000|Overall Study|Other|0|||
19649194|NCT00562965|42098736|FG001|Overall Study|Other|1|||
19649195|NCT00537082|42098745|FG000|Overall Study|Adverse Event|6|||
19649196|NCT00537082|42098746|FG001|Overall Study|Adverse Event|6|||
19649197|NCT00537082|42098747|FG002|Overall Study|Adverse Event|3|||
19649198|NCT00537082|42098745|FG000|Overall Study|Protocol Violation|0|||
19751072|NCT04128007|42200120|FG001|Overall Study|Withdrawal by Subject|6|||
19649199|NCT00537082|42098746|FG001|Overall Study|Protocol Violation|2|||
19649200|NCT00537082|42098747|FG002|Overall Study|Protocol Violation|1|||
19649201|NCT00537082|42098745|FG000|Overall Study|Lack of Efficacy|0|||
19649202|NCT00537082|42098746|FG001|Overall Study|Lack of Efficacy|0|||
19649203|NCT00537082|42098747|FG002|Overall Study|Lack of Efficacy|2|||
19649204|NCT00537082|42098745|FG000|Overall Study|Withdrawal by Subject|0|||
19649205|NCT00537082|42098746|FG001|Overall Study|Withdrawal by Subject|1|||
19649206|NCT00537082|42098747|FG002|Overall Study|Withdrawal by Subject|0|||
19649207|NCT00537082|42098745|FG000|Overall Study|Discontinued before initiating treatment|3|||
19649208|NCT00537082|42098746|FG001|Overall Study|Discontinued before initiating treatment|0|||
19649209|NCT00537082|42098747|FG002|Overall Study|Discontinued before initiating treatment|0|||
19649210|NCT03828487|42098755|FG000|Overall Study|Physician Decision|1|||
19649211|NCT00324961|42098759|FG000|Overall Study|Adverse Event|5|||
19649212|NCT00324961|42098759|FG000|Overall Study|Consent Withdrawn|11|||
19649213|NCT00324961|42098759|FG000|Overall Study|Lost to Follow-up|22|||
19649214|NCT00324961|42098759|FG000|Overall Study|Protocol Violation|3|||
19649215|NCT00324961|42098759|FG000|Overall Study|Other|2|||
19649216|NCT00324649|42098767|FG000|Overall Study|Adverse Event|1|||
19649217|NCT00324649|42098768|FG001|Overall Study|Adverse Event|4|||
19649218|NCT00324649|42098767|FG000|Overall Study|Withdrawal by Subject|0|||
19649219|NCT00324649|42098768|FG001|Overall Study|Withdrawal by Subject|1|||
19649220|NCT00324649|42098767|FG000|Overall Study|Noncompliance|1|||
19649221|NCT00324649|42098768|FG001|Overall Study|Noncompliance|0|||
19649222|NCT00656370|42098774|FG000|Overall Study|Screen Failures|7|||
19649223|NCT00656370|42098774|FG000|Overall Study|Alternates|3|||
19649224|NCT00680186|42098782|FG000|Overall Study|Adverse Event|47|||
19649225|NCT00680186|42098783|FG001|Overall Study|Adverse Event|44|||
19649226|NCT00680186|42098782|FG000|Overall Study|Protocol Violation|31|||
19649227|NCT00680186|42098783|FG001|Overall Study|Protocol Violation|26|||
19649228|NCT00680186|42098782|FG000|Overall Study|Lost to Follow-up|11|||
19649229|NCT00680186|42098783|FG001|Overall Study|Lost to Follow-up|6|||
19649230|NCT00680186|42098782|FG000|Overall Study|Withdrawal by Subject|32|||
19649231|NCT00680186|42098783|FG001|Overall Study|Withdrawal by Subject|39|||
19649232|NCT00680186|42098782|FG000|Overall Study|Other|4|||
19649233|NCT00680186|42098783|FG001|Overall Study|Other|1|||
19751073|NCT04128007|42200119|FG000|Overall Study|Protocol Violation|1|||
19751074|NCT04128007|42200120|FG001|Overall Study|Protocol Violation|0|||
19751075|NCT04128007|42200119|FG000|Overall Study|Lost to Follow-up|8|||
19751076|NCT04128007|42200120|FG001|Overall Study|Lost to Follow-up|7|||
19751077|NCT04128007|42200119|FG000|Overall Study|Adverse Event|5|||
19751078|NCT04128007|42200120|FG001|Overall Study|Adverse Event|2|||
19751079|NCT04128007|42200119|FG000|Overall Study|Not reported|0|||
19751080|NCT04128007|42200120|FG001|Overall Study|Not reported|2|||
19751081|NCT04318093|42200128|FG000|Overall Study|Adverse Event|2|||
19751082|NCT04318093|42200129|FG001|Overall Study|Adverse Event|2|||
19751083|NCT04318093|42200128|FG000|Overall Study|Participant withdrew consent|1|||
19751084|NCT04318093|42200129|FG001|Overall Study|Participant withdrew consent|0|||
19649234|NCT00656292|42098791|FG000|Overall Study|Withdrawal by Subject|2|||
19649235|NCT00656292|42098792|FG001|Overall Study|Withdrawal by Subject|3|||
19751085|NCT04318093|42200128|FG000|Overall Study|Other reasons|0|||
19751086|NCT04318093|42200129|FG001|Overall Study|Other reasons|1|||
19649236|NCT00656292|42098791|FG000|Overall Study|Screen failure|1|||
19649237|NCT00656292|42098792|FG001|Overall Study|Screen failure|2|||
19649238|NCT00352417|42098800|FG000|Overall Study|Adverse Event|1|||
19649239|NCT00352417|42098801|FG001|Overall Study|Adverse Event|0|||
19649240|NCT00352417|42098800|FG000|Overall Study|Protocol Violation|0|||
19649241|NCT00352417|42098801|FG001|Overall Study|Protocol Violation|2|||
19649242|NCT00352417|42098800|FG000|Overall Study|Withdrawal by Subject|1|||
19649243|NCT00352417|42098801|FG001|Overall Study|Withdrawal by Subject|2|||
19649244|NCT00352417|42098800|FG000|Overall Study|Lost to Follow-up|1|||
19649245|NCT00352417|42098801|FG001|Overall Study|Lost to Follow-up|0|||
19649246|NCT00352417|42098800|FG000|Overall Study|Schedule Change|2|||
19649247|NCT00352417|42098801|FG001|Overall Study|Schedule Change|1|||
19649248|NCT00323869|42098807|FG000|Overall Study|Death|1|||
19649249|NCT00323557|42098813|FG000|Overall Study|Physician Decision|1|||
19649250|NCT00323557|42098814|FG001|Overall Study|Physician Decision|0|||
19649251|NCT00558363|42098823|FG000|Overall Study|Physician Decision|18|||
19649252|NCT00558363|42098824|FG001|Overall Study|Physician Decision|4|||
19649253|NCT00558363|42098823|FG000|Overall Study|Withdrawal by Subject|11|||
19649254|NCT00558363|42098824|FG001|Overall Study|Withdrawal by Subject|4|||
19649255|NCT00558363|42098823|FG000|Overall Study|Adverse Event|5|||
19649256|NCT00558363|42098824|FG001|Overall Study|Adverse Event|5|||
19649257|NCT00558363|42098823|FG000|Overall Study|Lack of Efficacy|2|||
19649258|NCT00558363|42098824|FG001|Overall Study|Lack of Efficacy|2|||
19649259|NCT00558363|42098823|FG000|Overall Study|Protocol Violation|2|||
19649260|NCT00558363|42098824|FG001|Overall Study|Protocol Violation|1|||
19649261|NCT00558363|42098823|FG000|Overall Study|Lost to Follow-up|0|||
19649262|NCT00558363|42098824|FG001|Overall Study|Lost to Follow-up|1|||
19649263|NCT00558363|42098823|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
19649264|NCT00558363|42098824|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
19649265|NCT00558363|42098823|FG000|Overall Study|Randomized in Error|1|||
19649266|NCT00558363|42098824|FG001|Overall Study|Randomized in Error|2|||
19649267|NCT00558363|42098823|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
19649268|NCT00558363|42098824|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
19649269|NCT00323479|42098830|FG000|Overall Study|Adverse Event|2|||
19649270|NCT00323479|42098830|FG000|Overall Study|Withdrawal by Subject|2|||
19649271|NCT00323479|42098830|FG000|Overall Study|Protocol Violation|3|||
19649272|NCT00323479|42098830|FG000|Overall Study|house moving|1|||
19649273|NCT00352105|42098834|FG000|Overall Study|Death|5|||
19649274|NCT00352105|42098834|FG000|Overall Study|Withdrawal by Subject|5|||
19751087|NCT04123405|42200140|FG000|Overall Study|Adverse Event|1|||
19751088|NCT04123405|42200141|FG001|Overall Study|Adverse Event|2|||
19751089|NCT04123405|42200142|FG002|Overall Study|Adverse Event|3|||
19649275|NCT00352105|42098834|FG000|Overall Study|Lack of Efficacy|9|||
19649276|NCT00352105|42098834|FG000|Overall Study|Adverse Event|19|||
19649277|NCT00352105|42098834|FG000|Overall Study|Protocol Violation|2|||
19649278|NCT00350779|42098840|FG000|Overall Study|Adverse Event|4|||
19649279|NCT00350779|42098841|FG001|Overall Study|Adverse Event|2|||
19649280|NCT00350779|42098840|FG000|Overall Study|Lack of Efficacy|0|||
19649281|NCT00350779|42098841|FG001|Overall Study|Lack of Efficacy|4|||
19649282|NCT00350779|42098840|FG000|Overall Study|Lost to Follow-up|2|||
19649283|NCT00350779|42098841|FG001|Overall Study|Lost to Follow-up|0|||
19649284|NCT00350779|42098840|FG000|Overall Study|Physician Decision|2|||
19649285|NCT00350779|42098841|FG001|Overall Study|Physician Decision|4|||
19649286|NCT00350779|42098840|FG000|Overall Study|Protocol Violation|3|||
19649287|NCT00350779|42098841|FG001|Overall Study|Protocol Violation|1|||
19649288|NCT00350779|42098840|FG000|Overall Study|Withdrawal by Subject|9|||
19649289|NCT00350779|42098841|FG001|Overall Study|Withdrawal by Subject|8|||
19649290|NCT00350779|42098840|FG000|Overall Study|Patient Moved|2|||
19649291|NCT00350779|42098841|FG001|Overall Study|Patient Moved|1|||
19649292|NCT00350779|42098840|FG000|Overall Study|Non-compliance with study procedures|0|||
19649293|NCT00350779|42098841|FG001|Overall Study|Non-compliance with study procedures|1|||
19649294|NCT00350623|42098852|FG000|Overall Study|Lost to Follow-up|8|||
19649295|NCT00350623|42098853|FG001|Overall Study|Lost to Follow-up|3|||
19649296|NCT00350623|42098854|FG002|Overall Study|Lost to Follow-up|4|||
19649297|NCT00350623|42098852|FG000|Overall Study|Withdrawal by Subject|0|||
19649298|NCT00350623|42098853|FG001|Overall Study|Withdrawal by Subject|1|||
19649299|NCT00350623|42098854|FG002|Overall Study|Withdrawal by Subject|1|||
19649300|NCT00350623|42098852|FG000|Overall Study|patient traveling outside the country|0|||
19649301|NCT00350623|42098853|FG001|Overall Study|patient traveling outside the country|0|||
19649302|NCT00350623|42098854|FG002|Overall Study|patient traveling outside the country|1|||
19649303|NCT00656136|42098864|FG000|Overall Study|Progressive disease|177|||
19649304|NCT00656136|42098865|FG001|Overall Study|Progressive disease|322|||
19649305|NCT00656136|42098864|FG000|Overall Study|Other Adverse Event|5|||
19649306|NCT00656136|42098865|FG001|Overall Study|Other Adverse Event|51|||
19649307|NCT00656136|42098864|FG000|Overall Study|Protocol Violation|2|||
19649308|NCT00656136|42098865|FG001|Overall Study|Protocol Violation|3|||
19649309|NCT00656136|42098864|FG000|Overall Study|Patient refused to take study medication|7|||
19649310|NCT00656136|42098865|FG001|Overall Study|Patient refused to take study medication|10|||
19649311|NCT00656136|42098864|FG000|Overall Study|Unknown and others|4|||
19649312|NCT00656136|42098865|FG001|Overall Study|Unknown and others|4|||
19649313|NCT00676520|42098871|FG000|Overall Study|Withdrawal by Subject|163|||
19649314|NCT00676520|42098871|FG000|Overall Study|Lost to Follow-up|162|||
19649315|NCT00676520|42098871|FG000|Overall Study|Death|159|||
19649316|NCT00676520|42098871|FG000|Overall Study|Physician Decision|20|||
19649317|NCT00676520|42098871|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
19649318|NCT00676520|42098871|FG000|Overall Study|Other Reason|18|||
19649319|NCT00652938|42098883|FG000|Overall Study|Adverse Event|1|||
19649320|NCT00652938|42098884|FG001|Overall Study|Adverse Event|0|||
19649321|NCT00652938|42098885|FG002|Overall Study|Adverse Event|2|||
19649322|NCT00652938|42098883|FG000|Overall Study|Withdrawal by Subject|0|||
19649323|NCT00652938|42098884|FG001|Overall Study|Withdrawal by Subject|6|||
19649324|NCT00652938|42098885|FG002|Overall Study|Withdrawal by Subject|1|||
19649325|NCT00652938|42098883|FG000|Overall Study|Lost to Follow-up|0|||
19649326|NCT00652938|42098884|FG001|Overall Study|Lost to Follow-up|0|||
19649327|NCT00652938|42098885|FG002|Overall Study|Lost to Follow-up|2|||
19649328|NCT00652938|42098883|FG000|Overall Study|fear of blood sampling|0|||
19649329|NCT00652938|42098884|FG001|Overall Study|fear of blood sampling|1|||
19649330|NCT00652938|42098885|FG002|Overall Study|fear of blood sampling|0|||
19649331|NCT00322621|42098893|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
19649332|NCT00322621|42098894|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
19649333|NCT00322621|42098895|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
19649334|NCT00322621|42098893|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
19649335|NCT00322621|42098894|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
19649336|NCT00322621|42098895|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
19649337|NCT00322621|42098893|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
19649338|NCT00322621|42098894|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
19649339|NCT00322621|42098895|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
19649340|NCT00322621|42098893|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
19649341|NCT00322621|42098894|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
19649342|NCT00322621|42098895|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
19649343|NCT00322621|42098893|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
19649344|NCT00322621|42098894|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
19649345|NCT00322621|42098895|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
19649346|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
19649347|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
19649348|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
19751090|NCT04123405|42200143|FG003|Overall Study|Adverse Event|3|||
19649349|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
19649350|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
19649351|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
19649352|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
19649353|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
19649354|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
19649355|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
19649356|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
19649357|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
19649358|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
19649359|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
19649360|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
19649361|NCT00322621|42098893|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
19649362|NCT00322621|42098894|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
19649363|NCT00322621|42098895|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
19649364|NCT00575042|42098908|FG000|Overall Study|Adverse Event|2|||
19649365|NCT00575042|42098908|FG000|Overall Study|Lost to Follow-up|1|||
19649366|NCT00676208|42098915|FG000|Overall Study|Lost to Follow-up|0|||
19649367|NCT00676208|42098916|FG001|Overall Study|Lost to Follow-up|2|||
19649368|NCT00676208|42098915|FG000|Overall Study|Incomplete data|2|||
19649369|NCT00676208|42098916|FG001|Overall Study|Incomplete data|4|||
19649370|NCT00656058|42098924|FG000|Overall Study|Withdrawal by Subject|2|||
19649371|NCT00656058|42098924|FG000|Overall Study|Withdrawal by Subject|4|||
19649372|NCT00537316|42098934|FG000|Part 1|Adverse Event|7|||
19649373|NCT00537316|42098935|FG001|Part 1|Adverse Event|11|||
19649374|NCT00537316|42098936|FG002|Part 1|Adverse Event|8|||
19649375|NCT00537316|42098937|FG003|Part 1|Adverse Event|0|||
19649376|NCT00537316|42098938|FG004|Part 1|Adverse Event|0|||
19649377|NCT00537316|42098939|FG005|Part 1|Adverse Event|0|||
19649378|NCT00537316|42098940|FG006|Part 1|Adverse Event|0|||
19649379|NCT00537316|42098934|FG000|Part 1|Protocol defined clinical event|1|||
19649380|NCT00537316|42098935|FG001|Part 1|Protocol defined clinical event|0|||
19649381|NCT00537316|42098936|FG002|Part 1|Protocol defined clinical event|0|||
19649382|NCT00537316|42098937|FG003|Part 1|Protocol defined clinical event|0|||
19649383|NCT00537316|42098938|FG004|Part 1|Protocol defined clinical event|0|||
19649384|NCT00537316|42098939|FG005|Part 1|Protocol defined clinical event|0|||
19649385|NCT00537316|42098940|FG006|Part 1|Protocol defined clinical event|0|||
19649386|NCT00537316|42098934|FG000|Part 1|Lost to Follow-up|1|||
19649387|NCT00537316|42098935|FG001|Part 1|Lost to Follow-up|0|||
19649388|NCT00537316|42098936|FG002|Part 1|Lost to Follow-up|0|||
19649389|NCT00537316|42098937|FG003|Part 1|Lost to Follow-up|0|||
19649390|NCT00537316|42098938|FG004|Part 1|Lost to Follow-up|0|||
19649391|NCT00537316|42098939|FG005|Part 1|Lost to Follow-up|0|||
19649392|NCT00537316|42098940|FG006|Part 1|Lost to Follow-up|0|||
19649393|NCT00537316|42098934|FG000|Part 1|Withdrawal by Subject|3|||
19649394|NCT00537316|42098935|FG001|Part 1|Withdrawal by Subject|8|||
19649395|NCT00537316|42098936|FG002|Part 1|Withdrawal by Subject|4|||
19649396|NCT00537316|42098937|FG003|Part 1|Withdrawal by Subject|0|||
19649397|NCT00537316|42098938|FG004|Part 1|Withdrawal by Subject|0|||
19649398|NCT00537316|42098939|FG005|Part 1|Withdrawal by Subject|0|||
19649399|NCT00537316|42098940|FG006|Part 1|Withdrawal by Subject|0|||
19649400|NCT00537316|42098934|FG000|Part 1|Protocol Violation|1|||
19649401|NCT00537316|42098935|FG001|Part 1|Protocol Violation|5|||
19649402|NCT00537316|42098936|FG002|Part 1|Protocol Violation|1|||
19649403|NCT00537316|42098937|FG003|Part 1|Protocol Violation|0|||
19649404|NCT00537316|42098938|FG004|Part 1|Protocol Violation|0|||
19649405|NCT00537316|42098939|FG005|Part 1|Protocol Violation|0|||
19649406|NCT00537316|42098940|FG006|Part 1|Protocol Violation|0|||
19649407|NCT00537316|42098934|FG000|Part 1|Did not meet protocol eligibility|1|||
19649408|NCT00537316|42098935|FG001|Part 1|Did not meet protocol eligibility|3|||
19649409|NCT00537316|42098936|FG002|Part 1|Did not meet protocol eligibility|2|||
19649410|NCT00537316|42098937|FG003|Part 1|Did not meet protocol eligibility|0|||
19649411|NCT00537316|42098938|FG004|Part 1|Did not meet protocol eligibility|0|||
19649412|NCT00537316|42098939|FG005|Part 1|Did not meet protocol eligibility|0|||
19649413|NCT00537316|42098940|FG006|Part 1|Did not meet protocol eligibility|0|||
19649414|NCT00537316|42098934|FG000|Part 1|Administrative|0|||
19649415|NCT00537316|42098935|FG001|Part 1|Administrative|0|||
19649416|NCT00537316|42098936|FG002|Part 1|Administrative|2|||
19649417|NCT00537316|42098937|FG003|Part 1|Administrative|0|||
19649418|NCT00537316|42098938|FG004|Part 1|Administrative|0|||
19649419|NCT00537316|42098939|FG005|Part 1|Administrative|0|||
19649420|NCT00537316|42098940|FG006|Part 1|Administrative|0|||
19649421|NCT00537316|42098934|FG000|Part 2|Never entered follow-up|0|||
19649422|NCT00537316|42098935|FG001|Part 2|Never entered follow-up|0|||
19649423|NCT00537316|42098936|FG002|Part 2|Never entered follow-up|0|||
19649424|NCT00537316|42098937|FG003|Part 2|Never entered follow-up|0|||
19649425|NCT00537316|42098938|FG004|Part 2|Never entered follow-up|0|||
19649426|NCT00537316|42098939|FG005|Part 2|Never entered follow-up|0|||
19649427|NCT00537316|42098940|FG006|Part 2|Never entered follow-up|1|||
19649428|NCT00537316|42098934|FG000|Part 2|Adverse Event|4|||
19649429|NCT00537316|42098935|FG001|Part 2|Adverse Event|0|||
19649430|NCT00537316|42098936|FG002|Part 2|Adverse Event|2|||
19649431|NCT00537316|42098937|FG003|Part 2|Adverse Event|0|||
19649432|NCT00537316|42098938|FG004|Part 2|Adverse Event|0|||
19649433|NCT00537316|42098939|FG005|Part 2|Adverse Event|0|||
19649434|NCT00537316|42098940|FG006|Part 2|Adverse Event|0|||
19649435|NCT00537316|42098934|FG000|Part 2|Lost to Follow-up|1|||
19649436|NCT00537316|42098935|FG001|Part 2|Lost to Follow-up|0|||
19649437|NCT00537316|42098936|FG002|Part 2|Lost to Follow-up|2|||
19649438|NCT00537316|42098937|FG003|Part 2|Lost to Follow-up|0|||
19649439|NCT00537316|42098938|FG004|Part 2|Lost to Follow-up|0|||
19649440|NCT00537316|42098939|FG005|Part 2|Lost to Follow-up|0|||
19649441|NCT00537316|42098940|FG006|Part 2|Lost to Follow-up|0|||
19649442|NCT00537316|42098934|FG000|Part 2|Withdrawal by Subject|5|||
19649443|NCT00537316|42098935|FG001|Part 2|Withdrawal by Subject|1|||
19649444|NCT00537316|42098936|FG002|Part 2|Withdrawal by Subject|4|||
19649445|NCT00537316|42098937|FG003|Part 2|Withdrawal by Subject|0|||
19649446|NCT00537316|42098938|FG004|Part 2|Withdrawal by Subject|0|||
19649447|NCT00537316|42098939|FG005|Part 2|Withdrawal by Subject|0|||
19649448|NCT00537316|42098940|FG006|Part 2|Withdrawal by Subject|0|||
19649449|NCT00537316|42098934|FG000|Part 2|Administrative|16|||
19649450|NCT00537316|42098935|FG001|Part 2|Administrative|8|||
19649451|NCT00537316|42098936|FG002|Part 2|Administrative|24|||
19649452|NCT00537316|42098937|FG003|Part 2|Administrative|3|||
19649453|NCT00537316|42098938|FG004|Part 2|Administrative|1|||
19649454|NCT00537316|42098939|FG005|Part 2|Administrative|4|||
19649455|NCT00537316|42098940|FG006|Part 2|Administrative|1|||
19649456|NCT03827395|42098961|FG000|Overall Study|Lost to Follow-up|1|||
19649457|NCT03827395|42098962|FG001|Overall Study|Lost to Follow-up|0|||
19649458|NCT03827395|42098961|FG000|Overall Study|Protocol Violation|1|||
19649459|NCT03827395|42098962|FG001|Overall Study|Protocol Violation|0|||
19649460|NCT03827395|42098961|FG000|Overall Study|Became ineligible after enrollment|1|||
19649461|NCT03827395|42098962|FG001|Overall Study|Became ineligible after enrollment|2|||
19649462|NCT00655980|42098971|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
19649463|NCT00655980|42098972|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
19649464|NCT00655980|42098973|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
19649465|NCT00679172|42098989|FG000|Overall Study|Non-compliance|1|||
19649466|NCT00679172|42098990|FG001|Overall Study|Non-compliance|1|||
19649467|NCT00679172|42098991|FG002|Overall Study|Non-compliance|0|||
19649468|NCT00679172|42098992|FG003|Overall Study|Non-compliance|1|||
19751091|NCT04123405|42200140|FG000|Overall Study|Exclusion criteria met|1|||
19751092|NCT04123405|42200141|FG001|Overall Study|Exclusion criteria met|2|||
19751093|NCT04123405|42200142|FG002|Overall Study|Exclusion criteria met|0|||
19751094|NCT04123405|42200143|FG003|Overall Study|Exclusion criteria met|2|||
19751095|NCT04123405|42200140|FG000|Overall Study|Withdrawal by Subject|1|||
19751096|NCT04123405|42200141|FG001|Overall Study|Withdrawal by Subject|3|||
19751097|NCT04123405|42200142|FG002|Overall Study|Withdrawal by Subject|0|||
19751098|NCT04123405|42200143|FG003|Overall Study|Withdrawal by Subject|2|||
19751099|NCT04123405|42200140|FG000|Overall Study|Contact to subject lost|0|||
19751100|NCT04123405|42200141|FG001|Overall Study|Contact to subject lost|0|||
19751101|NCT04123405|42200142|FG002|Overall Study|Contact to subject lost|0|||
19751102|NCT04123405|42200143|FG003|Overall Study|Contact to subject lost|1|||
19751103|NCT04123405|42200140|FG000|Overall Study|screening failure|1|||
19751104|NCT04123405|42200141|FG001|Overall Study|screening failure|0|||
19751105|NCT04123405|42200142|FG002|Overall Study|screening failure|0|||
19751106|NCT04123405|42200143|FG003|Overall Study|screening failure|0|||
19751107|NCT04314037|42200172|FG000|Treatment Period 2|Adverse Event|1|||
19751108|NCT04314037|42200173|FG001|Treatment Period 2|Adverse Event|0|||
19751109|NCT04314037|42200172|FG000|Treatment Period 3|Protocol Violation|1|||
19751110|NCT04314037|42200173|FG001|Treatment Period 3|Protocol Violation|0|||
19751111|NCT04314037|42200172|FG000|Treatment Period 3|Adverse Event|0|||
19751112|NCT04314037|42200173|FG001|Treatment Period 3|Adverse Event|1|||
19751113|NCT03056300|42200189|FG000|Overall Study|Surgical reason per study protocol|3|||
19751114|NCT03061214|42200196|FG000|Overall Study|Withdrawal by Subject|21|||
19751115|NCT03061214|42200197|FG001|Overall Study|Withdrawal by Subject|26|||
19751116|NCT03061214|42200198|FG002|Overall Study|Withdrawal by Subject|9|||
19751117|NCT03061214|42200196|FG000|Overall Study|Lost to Follow-up|3|||
19751118|NCT03061214|42200197|FG001|Overall Study|Lost to Follow-up|1|||
19751119|NCT03061214|42200198|FG002|Overall Study|Lost to Follow-up|1|||
19649469|NCT00679172|42098993|FG004|Overall Study|Non-compliance|0|||
19649470|NCT00679172|42098989|FG000|Overall Study|Other not specified|0|||
19649471|NCT00679172|42098990|FG001|Overall Study|Other not specified|0|||
19649472|NCT00679172|42098991|FG002|Overall Study|Other not specified|1|||
19649473|NCT00679172|42098992|FG003|Overall Study|Other not specified|0|||
19649474|NCT00679172|42098993|FG004|Overall Study|Other not specified|0|||
19649475|NCT00676130|42099010|FG000|Overall Study|Lost to Follow-up|0|||
19649476|NCT00676130|42099011|FG001|Overall Study|Lost to Follow-up|1|||
19751120|NCT03061214|42200196|FG000|Overall Study|Death|1|||
19751121|NCT03061214|42200197|FG001|Overall Study|Death|1|||
19751122|NCT03061214|42200198|FG002|Overall Study|Death|0|||
19649477|NCT00676130|42099010|FG000|Overall Study|Found ineligible|3|||
19649478|NCT00676130|42099011|FG001|Overall Study|Found ineligible|2|||
19649479|NCT00676130|42099010|FG000|Overall Study|Withdrawal by Subject|0|||
19649480|NCT00676130|42099011|FG001|Overall Study|Withdrawal by Subject|1|||
19649481|NCT00676052|42099023|FG000|Overall Study|Adverse Event|0|||
19649482|NCT00676052|42099024|FG001|Overall Study|Adverse Event|1|||
19649483|NCT00676052|42099025|FG002|Overall Study|Adverse Event|1|||
19649484|NCT00676052|42099026|FG003|Overall Study|Adverse Event|2|||
19649485|NCT00676052|42099027|FG004|Overall Study|Adverse Event|2|||
19649486|NCT00676052|42099028|FG005|Overall Study|Adverse Event|2|||
19649487|NCT00676052|42099023|FG000|Overall Study|Lack of Efficacy|2|||
19649488|NCT00676052|42099024|FG001|Overall Study|Lack of Efficacy|2|||
19649489|NCT00676052|42099025|FG002|Overall Study|Lack of Efficacy|1|||
19649490|NCT00676052|42099026|FG003|Overall Study|Lack of Efficacy|1|||
19649491|NCT00676052|42099027|FG004|Overall Study|Lack of Efficacy|2|||
19649492|NCT00676052|42099028|FG005|Overall Study|Lack of Efficacy|1|||
19649493|NCT00676052|42099023|FG000|Overall Study|Protocol Violation|5|||
19649494|NCT00676052|42099024|FG001|Overall Study|Protocol Violation|3|||
19649495|NCT00676052|42099025|FG002|Overall Study|Protocol Violation|2|||
19649496|NCT00676052|42099026|FG003|Overall Study|Protocol Violation|2|||
19649497|NCT00676052|42099027|FG004|Overall Study|Protocol Violation|1|||
19649498|NCT00676052|42099028|FG005|Overall Study|Protocol Violation|2|||
19649499|NCT00676052|42099023|FG000|Overall Study|Lost to Follow-up|0|||
19649500|NCT00676052|42099024|FG001|Overall Study|Lost to Follow-up|0|||
19649501|NCT00676052|42099025|FG002|Overall Study|Lost to Follow-up|0|||
19649502|NCT00676052|42099026|FG003|Overall Study|Lost to Follow-up|0|||
19649503|NCT00676052|42099027|FG004|Overall Study|Lost to Follow-up|1|||
19649504|NCT00676052|42099028|FG005|Overall Study|Lost to Follow-up|0|||
19649505|NCT00676052|42099023|FG000|Overall Study|Physician Decision|1|||
19649506|NCT00676052|42099024|FG001|Overall Study|Physician Decision|1|||
19649507|NCT00676052|42099025|FG002|Overall Study|Physician Decision|1|||
19649508|NCT00676052|42099026|FG003|Overall Study|Physician Decision|0|||
19649509|NCT00676052|42099027|FG004|Overall Study|Physician Decision|0|||
19649510|NCT00676052|42099028|FG005|Overall Study|Physician Decision|1|||
19649511|NCT00676052|42099023|FG000|Overall Study|Withdrawal by Subject|1|||
19649512|NCT00676052|42099024|FG001|Overall Study|Withdrawal by Subject|0|||
19649513|NCT00676052|42099025|FG002|Overall Study|Withdrawal by Subject|1|||
19649514|NCT00676052|42099026|FG003|Overall Study|Withdrawal by Subject|0|||
19649515|NCT00676052|42099027|FG004|Overall Study|Withdrawal by Subject|0|||
19649516|NCT00676052|42099028|FG005|Overall Study|Withdrawal by Subject|0|||
19649517|NCT00535288|42099047|FG000|Overall Study|Adverse Event|20|||
19649518|NCT00535288|42099048|FG001|Overall Study|Adverse Event|19|||
19649519|NCT00535288|42099049|FG002|Overall Study|Adverse Event|25|||
19649520|NCT00535288|42099050|FG003|Overall Study|Adverse Event|20|||
19649521|NCT00535288|42099051|FG004|Overall Study|Adverse Event|30|||
19649522|NCT00535288|42099047|FG000|Overall Study|Lost to Follow-up|0|||
19649523|NCT00535288|42099048|FG001|Overall Study|Lost to Follow-up|3|||
19649524|NCT00535288|42099049|FG002|Overall Study|Lost to Follow-up|0|||
19649525|NCT00535288|42099050|FG003|Overall Study|Lost to Follow-up|0|||
19649526|NCT00535288|42099051|FG004|Overall Study|Lost to Follow-up|0|||
19649527|NCT00535288|42099047|FG000|Overall Study|Lack of Efficacy|26|||
19649528|NCT00535288|42099048|FG001|Overall Study|Lack of Efficacy|3|||
19649529|NCT00535288|42099049|FG002|Overall Study|Lack of Efficacy|4|||
19649530|NCT00535288|42099050|FG003|Overall Study|Lack of Efficacy|4|||
19600986|NCT01072175|42049719|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
19600987|NCT01072175|42049720|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600988|NCT01072175|42049721|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600989|NCT01072175|42049722|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600990|NCT01072175|42049723|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
19600991|NCT01072175|42049711|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19649531|NCT00535288|42099051|FG004|Overall Study|Lack of Efficacy|7|||
19649532|NCT00535288|42099047|FG000|Overall Study|Unwilling to cooperate|6|||
19649533|NCT00535288|42099048|FG001|Overall Study|Unwilling to cooperate|6|||
19649534|NCT00535288|42099049|FG002|Overall Study|Unwilling to cooperate|3|||
19649535|NCT00535288|42099050|FG003|Overall Study|Unwilling to cooperate|3|||
19649536|NCT00535288|42099051|FG004|Overall Study|Unwilling to cooperate|4|||
19649537|NCT00535288|42099047|FG000|Overall Study|Other|2|||
19649538|NCT00535288|42099048|FG001|Overall Study|Other|1|||
19649539|NCT00535288|42099049|FG002|Overall Study|Other|1|||
19649540|NCT00535288|42099050|FG003|Overall Study|Other|2|||
19649541|NCT00535288|42099051|FG004|Overall Study|Other|1|||
19649542|NCT03904420|42099070|FG000|Overall Study|Study terminated|2|||
19649543|NCT03904420|42099071|FG001|Overall Study|Study terminated|2|||
19649544|NCT00675506|42099079|FG000|Overall Study|Lost to Follow-up|1|||
19649545|NCT00675506|42099080|FG001|Overall Study|Lost to Follow-up|5|||
19751123|NCT04115839|42200209|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
19649546|NCT00675506|42099079|FG000|Overall Study|Lost interest|3|||
19649547|NCT00675506|42099080|FG001|Overall Study|Lost interest|5|||
19649548|NCT00675506|42099079|FG000|Overall Study|Elevated fasting glucose|2|||
19649549|NCT00675506|42099080|FG001|Overall Study|Elevated fasting glucose|1|||
19649550|NCT00675506|42099079|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
19649551|NCT00675506|42099080|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
19649552|NCT00675506|42099079|FG000|Overall Study|Elevated IGF-1|2|||
19649553|NCT00675506|42099080|FG001|Overall Study|Elevated IGF-1|0|||
19649554|NCT00675506|42099079|FG000|Overall Study|Hypersensitivity Reaction|1|||
19649555|NCT00675506|42099080|FG001|Overall Study|Hypersensitivity Reaction|0|||
19649556|NCT00675506|42099079|FG000|Overall Study|Disclosed history of cancer|1|||
19649557|NCT00675506|42099080|FG001|Overall Study|Disclosed history of cancer|0|||
19649558|NCT00675506|42099079|FG000|Overall Study|Declined participation|1|||
19649559|NCT00675506|42099080|FG001|Overall Study|Declined participation|0|||
19649560|NCT00675506|42099079|FG000|Overall Study|Schedule conflict|0|||
19649561|NCT00675506|42099080|FG001|Overall Study|Schedule conflict|1|||
19649562|NCT03895840|42099087|FG000|Overall Study|Withdrawal by Subject|21|||
19649563|NCT00310375|42099093|FG000|Primary Reporting Phase|Adverse Event|28|||
19649564|NCT00310375|42099094|FG001|Primary Reporting Phase|Adverse Event|22|||
19649565|NCT00310375|42099095|FG002|Primary Reporting Phase|Adverse Event|0|||
19649566|NCT00310375|42099093|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
19649567|NCT00310375|42099094|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
19649568|NCT00310375|42099095|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
19649569|NCT00310375|42099093|FG000|Primary Reporting Phase|Pregnancy|2|||
19649570|NCT00310375|42099094|FG001|Primary Reporting Phase|Pregnancy|2|||
19649571|NCT00310375|42099095|FG002|Primary Reporting Phase|Pregnancy|0|||
19649572|NCT00310375|42099093|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
19649573|NCT00310375|42099094|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
19649574|NCT00310375|42099095|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
19649575|NCT00310375|42099093|FG000|Primary Reporting Phase|Protocol Violation|8|||
19649576|NCT00310375|42099094|FG001|Primary Reporting Phase|Protocol Violation|5|||
19649577|NCT00310375|42099095|FG002|Primary Reporting Phase|Protocol Violation|0|||
19649578|NCT00310375|42099093|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
19649579|NCT00310375|42099094|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
19649580|NCT00310375|42099095|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
19649581|NCT00310375|42099093|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
19649582|NCT00310375|42099094|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
19649583|NCT00310375|42099095|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
19649584|NCT00310375|42099093|FG000|Primary Reporting Phase|Physician Decision|5|||
19649585|NCT00310375|42099094|FG001|Primary Reporting Phase|Physician Decision|3|||
19649586|NCT00310375|42099095|FG002|Primary Reporting Phase|Physician Decision|0|||
19649587|NCT00310375|42099093|FG000|Primary Reporting Phase|Request of the sponsor|2|||
19649588|NCT00310375|42099094|FG001|Primary Reporting Phase|Request of the sponsor|2|||
19649589|NCT00310375|42099095|FG002|Primary Reporting Phase|Request of the sponsor|0|||
19649590|NCT00310375|42099093|FG000|Primary Reporting Phase|Failed to return|1|||
19649591|NCT00310375|42099094|FG001|Primary Reporting Phase|Failed to return|3|||
19649592|NCT00310375|42099095|FG002|Primary Reporting Phase|Failed to return|0|||
19649593|NCT00310375|42099093|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
19649594|NCT00310375|42099094|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
19649595|NCT00310375|42099095|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
19649596|NCT00310375|42099093|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
19649597|NCT00310375|42099094|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
19649598|NCT00310375|42099095|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
19649599|NCT00310375|42099093|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
19649600|NCT00310375|42099094|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
19649601|NCT00310375|42099095|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
19649602|NCT00310375|42099093|FG000|Primary Reporting Phase|Site closure|3|||
19649603|NCT00310375|42099094|FG001|Primary Reporting Phase|Site closure|0|||
19649604|NCT00310375|42099095|FG002|Primary Reporting Phase|Site closure|0|||
19649605|NCT00310375|42099093|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
19649606|NCT00310375|42099094|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
19649607|NCT00310375|42099095|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
19649608|NCT00310375|42099093|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
19649609|NCT00310375|42099094|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
19649610|NCT00310375|42099095|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
19649611|NCT00310375|42099093|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
19751124|NCT04115839|42200210|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
19649612|NCT00310375|42099094|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
19649613|NCT00310375|42099095|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
19649614|NCT00310375|42099093|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
19649615|NCT00310375|42099094|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
19649616|NCT00310375|42099095|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
19649617|NCT00309907|42099104|FG000|Overall Study|Death|4|||
19649618|NCT00309907|42099104|FG000|Overall Study|Physician Decision|1|||
19649619|NCT00309907|42099104|FG000|Overall Study|Ineligible|11|||
19649620|NCT00309907|42099104|FG000|Overall Study|Major infectious event|4|||
19649621|NCT00655824|42099109|FG000|Overall Study|Adverse Event|3|||
19649622|NCT00655824|42099109|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
19649623|NCT00655824|42099109|FG000|Overall Study|Protocol Violation|1|||
19649624|NCT00655824|42099109|FG000|Overall Study|Withdrawal by Subject|4|||
19649625|NCT00655824|42099109|FG000|Overall Study|Deterioration of Trial Disease|2|||
19649626|NCT00575588|42099115|FG000|Overall Study|Adverse Event|11|||
19649627|NCT00575588|42099116|FG001|Overall Study|Adverse Event|13|||
19649628|NCT00575588|42099115|FG000|Overall Study|Withdrawal by Subject|27|||
19649629|NCT00575588|42099116|FG001|Overall Study|Withdrawal by Subject|31|||
19649630|NCT00575588|42099115|FG000|Overall Study|Lost to Follow-up|1|||
19649631|NCT00575588|42099116|FG001|Overall Study|Lost to Follow-up|3|||
19649632|NCT00575588|42099115|FG000|Overall Study|Death|4|||
19649633|NCT00575588|42099116|FG001|Overall Study|Death|2|||
19649634|NCT00575588|42099115|FG000|Overall Study|Incorrect enrollment|8|||
19649635|NCT00575588|42099116|FG001|Overall Study|Incorrect enrollment|4|||
19649636|NCT00575588|42099115|FG000|Overall Study|Study specific discontinuation criteria|203|||
19649637|NCT00575588|42099116|FG001|Overall Study|Study specific discontinuation criteria|218|||
19649638|NCT00575588|42099115|FG000|Overall Study|Severe non-compliance to protocol|5|||
19649639|NCT00575588|42099116|FG001|Overall Study|Severe non-compliance to protocol|7|||
19649640|NCT00575588|42099115|FG000|Overall Study|Safety reasons|2|||
19649641|NCT00575588|42099116|FG001|Overall Study|Safety reasons|1|||
19649642|NCT00575588|42099115|FG000|Overall Study|Elevated triglyceride|1|||
19751125|NCT04115839|42200211|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
19751126|NCT04115839|42200212|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
19649643|NCT00575588|42099116|FG001|Overall Study|Elevated triglyceride|0|||
19649644|NCT00575588|42099115|FG000|Overall Study|Patient moved|1|||
19649645|NCT00575588|42099116|FG001|Overall Study|Patient moved|3|||
19649646|NCT00575588|42099115|FG000|Overall Study|Impossible to determine HbA1c|0|||
19649647|NCT00575588|42099116|FG001|Overall Study|Impossible to determine HbA1c|1|||
19649648|NCT00675428|42099124|FG000|Overall Study|Disease Progression|2|||
19649649|NCT00675428|42099125|FG001|Overall Study|Disease Progression|2|||
19649650|NCT00675428|42099124|FG000|Overall Study|No Disease Response After Cycle 6|0|||
19649651|NCT00675428|42099125|FG001|Overall Study|No Disease Response After Cycle 6|1|||
19649652|NCT00675428|42099124|FG000|Overall Study|Physician Decision|1|||
19649653|NCT00675428|42099125|FG001|Overall Study|Physician Decision|0|||
19649654|NCT00557505|42099149|FG000|Overall Study|Death|0|||
19649655|NCT00557505|42099150|FG001|Overall Study|Death|0|||
19649656|NCT00557505|42099151|FG002|Overall Study|Death|0|||
19649657|NCT00557505|42099152|FG003|Overall Study|Death|0|||
19649658|NCT00557505|42099153|FG004|Overall Study|Death|0|||
19751127|NCT04115839|42200213|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
19751128|NCT04115839|42200214|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
19751129|NCT04115839|42200215|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
19751130|NCT04115839|42200209|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
19751131|NCT04115839|42200210|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
19649659|NCT00557505|42099154|FG005|Overall Study|Death|0|||
19649660|NCT00557505|42099155|FG006|Overall Study|Death|0|||
19649661|NCT00557505|42099156|FG007|Overall Study|Death|0|||
19649662|NCT00557505|42099157|FG008|Overall Study|Death|1|||
19649663|NCT00557505|42099149|FG000|Overall Study|Adverse Event|0|||
19649664|NCT00557505|42099150|FG001|Overall Study|Adverse Event|0|||
19649665|NCT00557505|42099151|FG002|Overall Study|Adverse Event|1|||
19649666|NCT00557505|42099152|FG003|Overall Study|Adverse Event|0|||
19649667|NCT00557505|42099153|FG004|Overall Study|Adverse Event|0|||
19649668|NCT00557505|42099154|FG005|Overall Study|Adverse Event|0|||
19649669|NCT00557505|42099155|FG006|Overall Study|Adverse Event|1|||
19649670|NCT00557505|42099156|FG007|Overall Study|Adverse Event|0|||
19649671|NCT00557505|42099157|FG008|Overall Study|Adverse Event|0|||
19649672|NCT00557505|42099149|FG000|Overall Study|Global deterioration of health|1|||
19649673|NCT00557505|42099150|FG001|Overall Study|Global deterioration of health|0|||
19649674|NCT00557505|42099151|FG002|Overall Study|Global deterioration of health|0|||
19649675|NCT00557505|42099152|FG003|Overall Study|Global deterioration of health|0|||
19649676|NCT00557505|42099153|FG004|Overall Study|Global deterioration of health|0|||
19649677|NCT00557505|42099154|FG005|Overall Study|Global deterioration of health|0|||
19649678|NCT00557505|42099155|FG006|Overall Study|Global deterioration of health|0|||
19649679|NCT00557505|42099156|FG007|Overall Study|Global deterioration of health|0|||
19649680|NCT00557505|42099157|FG008|Overall Study|Global deterioration of health|0|||
19649681|NCT00557505|42099149|FG000|Overall Study|Objective progression or relapse|2|||
19649682|NCT00557505|42099150|FG001|Overall Study|Objective progression or relapse|3|||
19649683|NCT00557505|42099151|FG002|Overall Study|Objective progression or relapse|3|||
19649684|NCT00557505|42099152|FG003|Overall Study|Objective progression or relapse|2|||
19649685|NCT00557505|42099153|FG004|Overall Study|Objective progression or relapse|2|||
19649686|NCT00557505|42099154|FG005|Overall Study|Objective progression or relapse|3|||
19649687|NCT00557505|42099155|FG006|Overall Study|Objective progression or relapse|2|||
19649688|NCT00557505|42099156|FG007|Overall Study|Objective progression or relapse|5|||
19649689|NCT00557505|42099157|FG008|Overall Study|Objective progression or relapse|15|||
19649690|NCT00557505|42099149|FG000|Overall Study|Withdrawal by Subject|0|||
19649691|NCT00557505|42099150|FG001|Overall Study|Withdrawal by Subject|0|||
19649692|NCT00557505|42099151|FG002|Overall Study|Withdrawal by Subject|0|||
19649693|NCT00557505|42099152|FG003|Overall Study|Withdrawal by Subject|1|||
19649694|NCT00557505|42099153|FG004|Overall Study|Withdrawal by Subject|0|||
19649695|NCT00557505|42099154|FG005|Overall Study|Withdrawal by Subject|0|||
19649696|NCT00557505|42099155|FG006|Overall Study|Withdrawal by Subject|0|||
19649697|NCT00557505|42099156|FG007|Overall Study|Withdrawal by Subject|0|||
19649698|NCT00557505|42099157|FG008|Overall Study|Withdrawal by Subject|1|||
19649699|NCT00674570|42099183|FG000|Overall Study|Withdrawal by Subject|0|||
19649700|NCT00674570|42099184|FG001|Overall Study|Withdrawal by Subject|2|||
19649701|NCT00674570|42099185|FG002|Overall Study|Withdrawal by Subject|0|||
19649702|NCT00561951|42099196|FG000|Overall Study|Adverse Event|11|||
19649703|NCT00561951|42099197|FG001|Overall Study|Adverse Event|14|||
19649704|NCT00561951|42099198|FG002|Overall Study|Adverse Event|14|||
19649705|NCT00561951|42099196|FG000|Overall Study|Lack of Efficacy|5|||
19649706|NCT00561951|42099197|FG001|Overall Study|Lack of Efficacy|3|||
19649707|NCT00561951|42099198|FG002|Overall Study|Lack of Efficacy|2|||
19649708|NCT00561951|42099196|FG000|Overall Study|Lost to Follow-up|1|||
19649709|NCT00561951|42099197|FG001|Overall Study|Lost to Follow-up|1|||
19649710|NCT00561951|42099198|FG002|Overall Study|Lost to Follow-up|0|||
19649711|NCT00561951|42099196|FG000|Overall Study|Withdrawal by Subject|10|||
19649712|NCT00561951|42099197|FG001|Overall Study|Withdrawal by Subject|9|||
19649713|NCT00561951|42099198|FG002|Overall Study|Withdrawal by Subject|10|||
19649714|NCT00561951|42099196|FG000|Overall Study|Protocol Violation|4|||
19751132|NCT04115839|42200211|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
19751133|NCT04115839|42200212|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
19751134|NCT04115839|42200213|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
19751135|NCT04115839|42200214|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
19751136|NCT04115839|42200215|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
19751137|NCT04115839|42200209|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
19751138|NCT04115839|42200210|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19751139|NCT04115839|42200211|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19751140|NCT04115839|42200212|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19649715|NCT00561951|42099197|FG001|Overall Study|Protocol Violation|3|||
19649716|NCT00561951|42099198|FG002|Overall Study|Protocol Violation|4|||
19751141|NCT04115839|42200213|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19649717|NCT00561951|42099196|FG000|Overall Study|Physician Decision|1|||
19649718|NCT00561951|42099197|FG001|Overall Study|Physician Decision|0|||
19649719|NCT00561951|42099198|FG002|Overall Study|Physician Decision|0|||
19649720|NCT00561951|42099196|FG000|Overall Study|Pregnancy|0|||
19649721|NCT00561951|42099197|FG001|Overall Study|Pregnancy|1|||
19649722|NCT00561951|42099198|FG002|Overall Study|Pregnancy|0|||
19649723|NCT00561951|42099196|FG000|Overall Study|Meet Withdrawal Criterion|0|||
19649724|NCT00561951|42099197|FG001|Overall Study|Meet Withdrawal Criterion|1|||
19649725|NCT00561951|42099198|FG002|Overall Study|Meet Withdrawal Criterion|1|||
19649726|NCT00561951|42099196|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
19649727|NCT00561951|42099197|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
19649728|NCT00561951|42099198|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
19649729|NCT00322387|42099208|FG000|Treatment Period|Adverse Event|0|||
19649730|NCT00322387|42099209|FG001|Treatment Period|Adverse Event|1|||
19649731|NCT00322387|42099208|FG000|Follow-up Period|Final assessment not done|1|||
19649732|NCT00322387|42099209|FG001|Follow-up Period|Final assessment not done|3|||
19649733|NCT00322387|42099208|FG000|Follow-up Period|Death|1|||
19649734|NCT00322387|42099209|FG001|Follow-up Period|Death|0|||
19649735|NCT00561015|42099232|FG000|Overall Study|Adverse Event|0|||
19649736|NCT00561015|42099233|FG001|Overall Study|Adverse Event|0|||
19649737|NCT00561015|42099234|FG002|Overall Study|Adverse Event|0|||
19649738|NCT00561015|42099235|FG003|Overall Study|Adverse Event|0|||
19649739|NCT00561015|42099236|FG004|Overall Study|Adverse Event|1|||
19649740|NCT00561015|42099237|FG005|Overall Study|Adverse Event|0|||
19649741|NCT00561015|42099232|FG000|Overall Study|Lost to Follow-up|2|||
19649742|NCT00561015|42099233|FG001|Overall Study|Lost to Follow-up|0|||
19649743|NCT00561015|42099234|FG002|Overall Study|Lost to Follow-up|0|||
19649744|NCT00561015|42099235|FG003|Overall Study|Lost to Follow-up|1|||
19649745|NCT00561015|42099236|FG004|Overall Study|Lost to Follow-up|0|||
19649746|NCT00561015|42099237|FG005|Overall Study|Lost to Follow-up|3|||
19649747|NCT00561015|42099232|FG000|Overall Study|Participant non-compliance|2|||
19649748|NCT00561015|42099233|FG001|Overall Study|Participant non-compliance|0|||
19649749|NCT00561015|42099234|FG002|Overall Study|Participant non-compliance|0|||
19649750|NCT00561015|42099235|FG003|Overall Study|Participant non-compliance|0|||
19649751|NCT00561015|42099236|FG004|Overall Study|Participant non-compliance|0|||
19649752|NCT00561015|42099237|FG005|Overall Study|Participant non-compliance|0|||
19649753|NCT00560937|42099257|FG000|Overall Study|Withdrawal by Subject|0|||
19649754|NCT00560937|42099258|FG001|Overall Study|Withdrawal by Subject|1|||
19649755|NCT00560937|42099257|FG000|Overall Study|Physician Decision|1|||
19649756|NCT00560937|42099258|FG001|Overall Study|Physician Decision|1|||
19649757|NCT00561795|42099266|FG000|Overall Study|Adverse Event|3|||
19649758|NCT00561795|42099267|FG001|Overall Study|Adverse Event|3|||
19649759|NCT00561795|42099268|FG002|Overall Study|Adverse Event|0|||
19649760|NCT00561795|42099269|FG003|Overall Study|Adverse Event|0|||
19649761|NCT00561795|42099266|FG000|Overall Study|Study Closed/Terminated|0|||
19649762|NCT00561795|42099267|FG001|Overall Study|Study Closed/Terminated|3|||
19649763|NCT00561795|42099268|FG002|Overall Study|Study Closed/Terminated|0|||
19649764|NCT00561795|42099269|FG003|Overall Study|Study Closed/Terminated|0|||
19649765|NCT00561795|42099266|FG000|Overall Study|Physician Decision|1|||
19649766|NCT00561795|42099267|FG001|Overall Study|Physician Decision|0|||
19649767|NCT00561795|42099268|FG002|Overall Study|Physician Decision|0|||
19649768|NCT00561795|42099269|FG003|Overall Study|Physician Decision|0|||
19649769|NCT00652626|42099284|FG000|Initial Treatment Phase|Adverse Event|0|||
19649770|NCT00652626|42099285|FG001|Initial Treatment Phase|Adverse Event|0|||
19649771|NCT00652626|42099286|FG002|Initial Treatment Phase|Adverse Event|0|||
19649772|NCT00652626|42099287|FG003|Initial Treatment Phase|Adverse Event|0|||
19649773|NCT00652626|42099288|FG004|Initial Treatment Phase|Adverse Event|1|||
19649774|NCT00652626|42099289|FG005|Initial Treatment Phase|Adverse Event|0|||
19649775|NCT00652626|42099290|FG006|Initial Treatment Phase|Adverse Event|0|||
19649776|NCT00652626|42099284|FG000|Initial Treatment Phase|Protocol Violation|0|||
19649777|NCT00652626|42099285|FG001|Initial Treatment Phase|Protocol Violation|0|||
19649778|NCT00652626|42099286|FG002|Initial Treatment Phase|Protocol Violation|0|||
19649779|NCT00652626|42099287|FG003|Initial Treatment Phase|Protocol Violation|1|||
19649780|NCT00652626|42099288|FG004|Initial Treatment Phase|Protocol Violation|0|||
19649781|NCT00652626|42099289|FG005|Initial Treatment Phase|Protocol Violation|0|||
19649782|NCT00652626|42099290|FG006|Initial Treatment Phase|Protocol Violation|0|||
19649783|NCT00652626|42099284|FG000|Initial Treatment Phase|Physician Decision|0|||
19649784|NCT00652626|42099285|FG001|Initial Treatment Phase|Physician Decision|0|||
19751142|NCT04115839|42200214|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19649785|NCT00652626|42099286|FG002|Initial Treatment Phase|Physician Decision|0|||
19649786|NCT00652626|42099287|FG003|Initial Treatment Phase|Physician Decision|0|||
19649787|NCT00652626|42099288|FG004|Initial Treatment Phase|Physician Decision|1|||
19649788|NCT00652626|42099289|FG005|Initial Treatment Phase|Physician Decision|0|||
19649789|NCT00652626|42099290|FG006|Initial Treatment Phase|Physician Decision|0|||
19649790|NCT00652626|42099284|FG000|Initial Treatment Phase|Sponsor Request|0|||
19649791|NCT00652626|42099285|FG001|Initial Treatment Phase|Sponsor Request|0|||
19649792|NCT00652626|42099286|FG002|Initial Treatment Phase|Sponsor Request|1|||
19649793|NCT00652626|42099287|FG003|Initial Treatment Phase|Sponsor Request|0|||
19649794|NCT00652626|42099288|FG004|Initial Treatment Phase|Sponsor Request|0|||
19649795|NCT00652626|42099289|FG005|Initial Treatment Phase|Sponsor Request|0|||
19649796|NCT00652626|42099290|FG006|Initial Treatment Phase|Sponsor Request|0|||
19649797|NCT00652626|42099284|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
19649798|NCT00652626|42099285|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
19649799|NCT00652626|42099286|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
19649800|NCT00652626|42099287|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
19649801|NCT00652626|42099288|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
19649802|NCT00652626|42099289|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
19649803|NCT00652626|42099290|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
19649804|NCT00652626|42099284|FG000|Extension Phase|Withdrawal by Subject|0|||
19649805|NCT00652626|42099285|FG001|Extension Phase|Withdrawal by Subject|0|||
19649806|NCT00652626|42099286|FG002|Extension Phase|Withdrawal by Subject|0|||
19649807|NCT00652626|42099287|FG003|Extension Phase|Withdrawal by Subject|0|||
19649808|NCT00652626|42099288|FG004|Extension Phase|Withdrawal by Subject|0|||
19649809|NCT00652626|42099289|FG005|Extension Phase|Withdrawal by Subject|2|||
19649810|NCT00652626|42099290|FG006|Extension Phase|Withdrawal by Subject|0|||
19649811|NCT00652626|42099284|FG000|Extension Phase|Adverse Event|0|||
19649812|NCT00652626|42099285|FG001|Extension Phase|Adverse Event|0|||
19649813|NCT00652626|42099286|FG002|Extension Phase|Adverse Event|0|||
19649814|NCT00652626|42099287|FG003|Extension Phase|Adverse Event|0|||
19649815|NCT00652626|42099288|FG004|Extension Phase|Adverse Event|0|||
19649816|NCT00652626|42099289|FG005|Extension Phase|Adverse Event|2|||
19649817|NCT00652626|42099290|FG006|Extension Phase|Adverse Event|1|||
19649818|NCT00652626|42099284|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649819|NCT00652626|42099285|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649820|NCT00652626|42099286|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649821|NCT00652626|42099287|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649822|NCT00652626|42099288|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649823|NCT00652626|42099289|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
19477088|NCT01488071|41755997|FG000|Overall Study|Lack of Efficacy|11|||
19600992|NCT01072175|42049712|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600993|NCT01072175|42049713|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600994|NCT01072175|42049714|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600995|NCT01072175|42049715|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600996|NCT01072175|42049716|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600997|NCT01072175|42049717|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600998|NCT01072175|42049718|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19600999|NCT01072175|42049719|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
19649824|NCT00652626|42099290|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
19649825|NCT00652626|42099284|FG000|Extension Phase|Physician Decision|0|||
19649826|NCT00652626|42099285|FG001|Extension Phase|Physician Decision|0|||
19649827|NCT00652626|42099286|FG002|Extension Phase|Physician Decision|0|||
19649828|NCT00652626|42099287|FG003|Extension Phase|Physician Decision|0|||
19649829|NCT00652626|42099288|FG004|Extension Phase|Physician Decision|0|||
19649830|NCT00652626|42099289|FG005|Extension Phase|Physician Decision|1|||
19649831|NCT00652626|42099290|FG006|Extension Phase|Physician Decision|1|||
19649832|NCT00652626|42099284|FG000|Extension Phase|Death|0|||
19649833|NCT00652626|42099285|FG001|Extension Phase|Death|0|||
19649834|NCT00652626|42099286|FG002|Extension Phase|Death|0|||
19751143|NCT04115839|42200215|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
19649835|NCT00652626|42099287|FG003|Extension Phase|Death|0|||
19649836|NCT00652626|42099288|FG004|Extension Phase|Death|0|||
19649837|NCT00652626|42099289|FG005|Extension Phase|Death|1|||
19649838|NCT00652626|42099290|FG006|Extension Phase|Death|1|||
19649839|NCT00560703|42099310|FG000|Overall Study|Adverse Event|0|||
19649840|NCT00560703|42099311|FG001|Overall Study|Adverse Event|2|||
19649841|NCT00560703|42099310|FG000|Overall Study|Protocol Violation|0|||
19649842|NCT00560703|42099311|FG001|Overall Study|Protocol Violation|2|||
19649843|NCT00560703|42099310|FG000|Overall Study|Withdrawal by Subject|0|||
19649844|NCT00560703|42099311|FG001|Overall Study|Withdrawal by Subject|1|||
19649845|NCT00560703|42099310|FG000|Overall Study|non-compliance|0|||
19649846|NCT00560703|42099311|FG001|Overall Study|non-compliance|1|||
19649847|NCT00308737|42099320|FG000|Overall Study|Adverse Event|104|||
19649848|NCT00308737|42099321|FG001|Overall Study|Adverse Event|9|||
19649849|NCT00308737|42099322|FG002|Overall Study|Adverse Event|0|||
19649850|NCT00308737|42099320|FG000|Overall Study|Death|4|||
19649851|NCT00308737|42099321|FG001|Overall Study|Death|3|||
19649852|NCT00308737|42099322|FG002|Overall Study|Death|0|||
19649853|NCT00308737|42099320|FG000|Overall Study|Lost to Follow-up|56|||
19649854|NCT00308737|42099321|FG001|Overall Study|Lost to Follow-up|80|||
19649855|NCT00308737|42099322|FG002|Overall Study|Lost to Follow-up|5|||
19649856|NCT00308737|42099320|FG000|Overall Study|Physician Decision|15|||
19649857|NCT00308737|42099321|FG001|Overall Study|Physician Decision|2|||
19649858|NCT00308737|42099322|FG002|Overall Study|Physician Decision|1|||
19649859|NCT00308737|42099320|FG000|Overall Study|Protocol Violation|34|||
19649860|NCT00308737|42099321|FG001|Overall Study|Protocol Violation|9|||
19649861|NCT00308737|42099322|FG002|Overall Study|Protocol Violation|5|||
19649862|NCT00308737|42099320|FG000|Overall Study|Withdrawal by Subject|218|||
19649863|NCT00308737|42099321|FG001|Overall Study|Withdrawal by Subject|166|||
19649864|NCT00308737|42099322|FG002|Overall Study|Withdrawal by Subject|18|||
19649865|NCT00308737|42099320|FG000|Overall Study|Various|32|||
19649866|NCT00308737|42099321|FG001|Overall Study|Various|20|||
19649867|NCT00308737|42099322|FG002|Overall Study|Various|8|||
19649868|NCT00655746|42099330|FG000|Overall Study|Withdrawal by Subject|1|||
19649869|NCT00338455|42099340|FG000|Overall Study|Death|2|||
19649870|NCT00338455|42099341|FG001|Overall Study|Death|1|||
19649871|NCT00338455|42099340|FG000|Overall Study|Physician Decision|1|||
19649872|NCT00338455|42099341|FG001|Overall Study|Physician Decision|0|||
19649873|NCT00651924|42099349|FG000|Overall Study|Withdrawal by PI|0|||
19649874|NCT00651924|42099350|FG001|Overall Study|Withdrawal by PI|2|||
19649875|NCT00651924|42099349|FG000|Overall Study|Withdrawal by Subject|0|||
19649876|NCT00651924|42099350|FG001|Overall Study|Withdrawal by Subject|5|||
19649877|NCT00678392|42099358|FG000|Overall Study|Adverse Event|0|||
19649878|NCT00678392|42099359|FG001|Overall Study|Adverse Event|6|||
19649879|NCT00678392|42099358|FG000|Overall Study|Death|280|||
19649880|NCT00678392|42099359|FG001|Overall Study|Death|269|||
19649881|NCT00678392|42099358|FG000|Overall Study|Lost to Follow-up|15|||
19649882|NCT00678392|42099359|FG001|Overall Study|Lost to Follow-up|13|||
19649883|NCT00678392|42099358|FG000|Overall Study|Objective Progression or Relapse|3|||
19649884|NCT00678392|42099359|FG001|Overall Study|Objective Progression or Relapse|8|||
19649885|NCT00678392|42099358|FG000|Overall Study|Sponsor's Decision|1|||
19649886|NCT00678392|42099359|FG001|Overall Study|Sponsor's Decision|2|||
19649887|NCT00678392|42099358|FG000|Overall Study|Withdrawal by Subject|4|||
19649888|NCT00678392|42099359|FG001|Overall Study|Withdrawal by Subject|4|||
19649889|NCT00678392|42099358|FG000|Overall Study|Randomized But Not Treated|2|||
19649890|NCT00678392|42099359|FG001|Overall Study|Randomized But Not Treated|7|||
19649891|NCT00678392|42099358|FG000|Overall Study|Other|56|||
19649892|NCT00678392|42099359|FG001|Overall Study|Other|53|||
19649893|NCT00308581|42099365|FG000|Induction Phase|Adverse Event|0|||
19649894|NCT00308581|42099366|FG001|Induction Phase|Adverse Event|0|||
19649895|NCT00308581|42099367|FG002|Induction Phase|Adverse Event|37|||
19649896|NCT00308581|42099365|FG000|Induction Phase|Lack of Efficacy|0|||
19649897|NCT00308581|42099366|FG001|Induction Phase|Lack of Efficacy|0|||
19649898|NCT00308581|42099367|FG002|Induction Phase|Lack of Efficacy|121|||
19649899|NCT00308581|42099365|FG000|Induction Phase|Withdrawal by Subject|0|||
19649900|NCT00308581|42099366|FG001|Induction Phase|Withdrawal by Subject|0|||
19649901|NCT00308581|42099367|FG002|Induction Phase|Withdrawal by Subject|5|||
19649902|NCT00308581|42099365|FG000|Induction Phase|Unknown reason|0|||
19649903|NCT00308581|42099366|FG001|Induction Phase|Unknown reason|0|||
19649904|NCT00308581|42099367|FG002|Induction Phase|Unknown reason|3|||
19649905|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Adverse Event|10|||
19751144|NCT04115839|42200209|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751145|NCT04115839|42200210|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751146|NCT04115839|42200211|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
19751147|NCT04115839|42200212|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751148|NCT04115839|42200213|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751149|NCT04115839|42200214|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751150|NCT04115839|42200215|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
19751151|NCT04115839|42200209|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
19751152|NCT04115839|42200210|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
19751153|NCT04115839|42200211|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
19751154|NCT04115839|42200212|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
19751155|NCT04115839|42200213|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
19751156|NCT04115839|42200214|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
19751157|NCT04115839|42200215|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
19751158|NCT04115839|42200209|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
19751159|NCT04115839|42200210|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
19751160|NCT04115839|42200211|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
19751161|NCT04115839|42200212|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
19751162|NCT04115839|42200213|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
19751163|NCT04115839|42200214|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
19751164|NCT04115839|42200215|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
19751165|NCT01561430|42200244|FG000|Overall Study|Adverse Event|0|||
19751166|NCT01561430|42200245|FG001|Overall Study|Adverse Event|0|||
19751167|NCT01561430|42200246|FG002|Overall Study|Adverse Event|3|||
19751168|NCT01561430|42200247|FG003|Overall Study|Adverse Event|1|||
19751169|NCT01561430|42200244|FG000|Overall Study|Withdrawal by Subject|0|||
19751170|NCT01561430|42200245|FG001|Overall Study|Withdrawal by Subject|0|||
19751171|NCT01561430|42200246|FG002|Overall Study|Withdrawal by Subject|1|||
19751172|NCT01561430|42200247|FG003|Overall Study|Withdrawal by Subject|0|||
19751173|NCT01561430|42200244|FG000|Overall Study|Physician Decision|0|||
19751174|NCT01561430|42200245|FG001|Overall Study|Physician Decision|1|||
19751175|NCT01561430|42200246|FG002|Overall Study|Physician Decision|0|||
19751176|NCT01561430|42200247|FG003|Overall Study|Physician Decision|0|||
19751177|NCT01561430|42200244|FG000|Overall Study|Sponsor Decision|1|||
19751178|NCT01561430|42200245|FG001|Overall Study|Sponsor Decision|14|||
19751179|NCT01561430|42200246|FG002|Overall Study|Sponsor Decision|13|||
19751180|NCT01561430|42200247|FG003|Overall Study|Sponsor Decision|12|||
19751181|NCT03000530|42200283|FG000|Overall Study|Adverse Event|0|||
19751182|NCT03000530|42200284|FG001|Overall Study|Adverse Event|0|||
19751183|NCT03000530|42200285|FG002|Overall Study|Adverse Event|2|||
19751184|NCT03000530|42200283|FG000|Overall Study|Lost to Follow-up|0|||
19751185|NCT03000530|42200284|FG001|Overall Study|Lost to Follow-up|3|||
19751186|NCT03000530|42200285|FG002|Overall Study|Lost to Follow-up|1|||
19751187|NCT03000530|42200283|FG000|Overall Study|Withdrawal by Subject|0|||
19477089|NCT01488071|41755998|FG001|Overall Study|Lack of Efficacy|17|||
19751188|NCT03000530|42200284|FG001|Overall Study|Withdrawal by Subject|2|||
19751189|NCT03000530|42200285|FG002|Overall Study|Withdrawal by Subject|1|||
19751190|NCT03060512|42200298|FG000|Overall Study|Adverse Event|4|||
19751191|NCT03060512|42200299|FG001|Overall Study|Adverse Event|6|||
19751192|NCT03060512|42200298|FG000|Overall Study|Lost to Follow-up|1|||
19751193|NCT03060512|42200299|FG001|Overall Study|Lost to Follow-up|1|||
19751194|NCT03060512|42200298|FG000|Overall Study|Withdrawal by Subject|1|||
19751195|NCT03060512|42200299|FG001|Overall Study|Withdrawal by Subject|0|||
19751196|NCT03060512|42200298|FG000|Overall Study|Non-compliance with study medication|1|||
19649906|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Adverse Event|17|||
19649907|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Adverse Event|0|||
19649908|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
19649909|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
19649910|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
19649911|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
19649912|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
19649913|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
19649914|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
19649915|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
19649916|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
19649917|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
19649918|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
19649919|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
19649920|NCT00308581|42099365|FG000|Randomized Maintenance Phase|Unknown reason|3|||
19649921|NCT00308581|42099366|FG001|Randomized Maintenance Phase|Unknown reason|0|||
19649922|NCT00308581|42099367|FG002|Randomized Maintenance Phase|Unknown reason|0|||
19649923|NCT00678080|42099377|FG000|Overall Study|Physician Decision|2|||
19649924|NCT00678080|42099378|FG001|Overall Study|Physician Decision|0|||
19649925|NCT00678080|42099377|FG000|Overall Study|Lost to Follow-up|1|||
19649926|NCT00678080|42099378|FG001|Overall Study|Lost to Follow-up|0|||
19649927|NCT00678080|42099377|FG000|Overall Study|Withdrawal by Subject|0|||
19649928|NCT00678080|42099378|FG001|Overall Study|Withdrawal by Subject|1|||
19649929|NCT00658320|42099386|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
19649930|NCT00658320|42099387|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
19649931|NCT00658320|42099386|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
19649932|NCT00658320|42099387|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
19649933|NCT00658320|42099386|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
19649934|NCT00658320|42099387|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
19649935|NCT00658320|42099386|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
19649936|NCT00658320|42099387|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
19649937|NCT00322153|42099397|FG000|Overall Study|Adverse Event|21|||
19649938|NCT00322153|42099398|FG001|Overall Study|Adverse Event|34|||
19649939|NCT00322153|42099397|FG000|Overall Study|Protocol Violation|6|||
19649940|NCT00322153|42099398|FG001|Overall Study|Protocol Violation|14|||
19649941|NCT00322153|42099397|FG000|Overall Study|Withdrawal by Subject|18|||
19649942|NCT00322153|42099398|FG001|Overall Study|Withdrawal by Subject|10|||
19649943|NCT00322153|42099397|FG000|Overall Study|Lack of Efficacy|8|||
19649944|NCT00322153|42099398|FG001|Overall Study|Lack of Efficacy|3|||
19649945|NCT00322153|42099397|FG000|Overall Study|Lost to Follow-up|5|||
19649946|NCT00322153|42099398|FG001|Overall Study|Lost to Follow-up|4|||
19649947|NCT00322153|42099397|FG000|Overall Study|Withdrawn for other reasons|5|||
19649948|NCT00322153|42099398|FG001|Overall Study|Withdrawn for other reasons|4|||
19649949|NCT00657618|42099404|FG000|Overall Study|Adverse Event|32|||
19649950|NCT00657618|42099404|FG000|Overall Study|Withdrawal by Subject|8|||
19649951|NCT00657618|42099404|FG000|Overall Study|negative for leishmaniasis|2|||
19649952|NCT00657618|42099404|FG000|Overall Study|didn't start due to schedule conflicts|1|||
19649953|NCT00657540|42099410|FG000|Overall Study|Lost to Follow-up|1|||
19649954|NCT00657540|42099411|FG001|Overall Study|Lost to Follow-up|4|||
19649955|NCT00672620|42099421|FG000|Overall Study|Adverse Event|7|||
19649956|NCT00672620|42099422|FG001|Overall Study|Adverse Event|7|||
19649957|NCT00672620|42099423|FG002|Overall Study|Adverse Event|12|||
19649958|NCT00672620|42099424|FG003|Overall Study|Adverse Event|17|||
19649959|NCT00672620|42099421|FG000|Overall Study|Lack of Efficacy|1|||
19649960|NCT00672620|42099422|FG001|Overall Study|Lack of Efficacy|2|||
19649961|NCT00672620|42099423|FG002|Overall Study|Lack of Efficacy|2|||
19649962|NCT00672620|42099424|FG003|Overall Study|Lack of Efficacy|0|||
19649963|NCT00672620|42099421|FG000|Overall Study|Noncompliance with Study Drug|3|||
19649964|NCT00672620|42099422|FG001|Overall Study|Noncompliance with Study Drug|4|||
19649965|NCT00672620|42099423|FG002|Overall Study|Noncompliance with Study Drug|0|||
19649966|NCT00672620|42099424|FG003|Overall Study|Noncompliance with Study Drug|2|||
19649967|NCT00672620|42099421|FG000|Overall Study|Protocol Deviations|5|||
19649968|NCT00672620|42099422|FG001|Overall Study|Protocol Deviations|7|||
19649969|NCT00672620|42099423|FG002|Overall Study|Protocol Deviations|2|||
19649970|NCT00672620|42099424|FG003|Overall Study|Protocol Deviations|5|||
19649971|NCT00672620|42099421|FG000|Overall Study|Withdrawal of Consent|6|||
19649972|NCT00672620|42099422|FG001|Overall Study|Withdrawal of Consent|12|||
19649973|NCT00672620|42099423|FG002|Overall Study|Withdrawal of Consent|5|||
19649974|NCT00672620|42099424|FG003|Overall Study|Withdrawal of Consent|6|||
19649975|NCT00672620|42099421|FG000|Overall Study|Lost to Follow-up|8|||
19649976|NCT00672620|42099422|FG001|Overall Study|Lost to Follow-up|19|||
19649977|NCT00672620|42099423|FG002|Overall Study|Lost to Follow-up|8|||
19649978|NCT00672620|42099424|FG003|Overall Study|Lost to Follow-up|11|||
19649979|NCT00672620|42099421|FG000|Overall Study|Reason not Specified|3|||
19649980|NCT00672620|42099422|FG001|Overall Study|Reason not Specified|3|||
19649981|NCT00672620|42099423|FG002|Overall Study|Reason not Specified|2|||
19649982|NCT00672620|42099424|FG003|Overall Study|Reason not Specified|1|||
19649983|NCT00673790|42099437|FG000|Overall Study|Adverse Event|23|||
19649984|NCT00673790|42099438|FG001|Overall Study|Adverse Event|14|||
19649985|NCT00673790|42099439|FG002|Overall Study|Adverse Event|2|||
19649986|NCT00673790|42099437|FG000|Overall Study|Lack of Efficacy|2|||
19649987|NCT00673790|42099438|FG001|Overall Study|Lack of Efficacy|2|||
19649988|NCT00673790|42099439|FG002|Overall Study|Lack of Efficacy|2|||
19649989|NCT00673790|42099437|FG000|Overall Study|Protocol Violation|6|||
19649990|NCT00673790|42099438|FG001|Overall Study|Protocol Violation|9|||
19649991|NCT00673790|42099439|FG002|Overall Study|Protocol Violation|1|||
19649992|NCT00673790|42099437|FG000|Overall Study|Withdrawal by Subject|7|||
19649993|NCT00673790|42099438|FG001|Overall Study|Withdrawal by Subject|4|||
19649994|NCT00673790|42099439|FG002|Overall Study|Withdrawal by Subject|1|||
19649995|NCT00673790|42099437|FG000|Overall Study|Lost to Follow-up|6|||
19649996|NCT00673790|42099438|FG001|Overall Study|Lost to Follow-up|6|||
19649997|NCT00673790|42099439|FG002|Overall Study|Lost to Follow-up|5|||
19649998|NCT00673790|42099437|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
19649999|NCT00673790|42099438|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
19650000|NCT00673790|42099439|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
19650001|NCT00673790|42099437|FG000|Overall Study|Poor compliance|1|||
19650002|NCT00673790|42099438|FG001|Overall Study|Poor compliance|0|||
19650003|NCT00673790|42099439|FG002|Overall Study|Poor compliance|0|||
19650004|NCT00673790|42099437|FG000|Overall Study|Participated in two Nebivolol studies|0|||
19650005|NCT00673790|42099438|FG001|Overall Study|Participated in two Nebivolol studies|0|||
19650006|NCT00673790|42099439|FG002|Overall Study|Participated in two Nebivolol studies|1|||
19650007|NCT00673790|42099437|FG000|Overall Study|Unconfirmed pregnancy|0|||
19650008|NCT00673790|42099438|FG001|Overall Study|Unconfirmed pregnancy|1|||
19650009|NCT00673790|42099439|FG002|Overall Study|Unconfirmed pregnancy|0|||
19650010|NCT00673790|42099437|FG000|Overall Study|Randomization criteria not met|0|||
19650011|NCT00673790|42099438|FG001|Overall Study|Randomization criteria not met|1|||
19650012|NCT00673790|42099439|FG002|Overall Study|Randomization criteria not met|0|||
19650013|NCT00657150|42099450|FG000|Overall Study|Adverse Event|19|||
19650014|NCT00657150|42099451|FG001|Overall Study|Adverse Event|10|||
19650015|NCT00657150|42099450|FG000|Overall Study|Non-compliant with protocol|5|||
19650016|NCT00657150|42099451|FG001|Overall Study|Non-compliant with protocol|9|||
19650017|NCT00657150|42099450|FG000|Overall Study|Lost to Follow-up|2|||
19650018|NCT00657150|42099451|FG001|Overall Study|Lost to Follow-up|0|||
19650019|NCT00657150|42099450|FG000|Overall Study|Withdrawal by Subject|51|||
19650020|NCT00657150|42099451|FG001|Overall Study|Withdrawal by Subject|36|||
19650021|NCT00657150|42099450|FG000|Overall Study|Other|38|||
19650022|NCT00657150|42099451|FG001|Overall Study|Other|38|||
19650023|NCT00657150|42099450|FG000|Treatment|Adverse Event|60|||
19650024|NCT00657150|42099451|FG001|Treatment|Adverse Event|53|||
19650025|NCT00657150|42099450|FG000|Treatment|Non-compliant with protocol|10|||
19650026|NCT00657150|42099451|FG001|Treatment|Non-compliant with protocol|9|||
19650027|NCT00657150|42099450|FG000|Treatment|Lost to Follow-up|1|||
19650028|NCT00657150|42099451|FG001|Treatment|Lost to Follow-up|0|||
19650029|NCT00657150|42099450|FG000|Treatment|Withdrawal by Subject|23|||
19650030|NCT00657150|42099451|FG001|Treatment|Withdrawal by Subject|20|||
19650031|NCT00657150|42099450|FG000|Treatment|Other|13|||
19650032|NCT00657150|42099451|FG001|Treatment|Other|15|||
19650033|NCT00670748|42099461|FG000|Overall Study|Death during treatment|1|||
19650034|NCT00670748|42099462|FG001|Overall Study|Death during treatment|1|||
19650035|NCT00670748|42099463|FG002|Overall Study|Death during treatment|1|||
19650036|NCT00670748|42099464|FG003|Overall Study|Death during treatment|0|||
19650037|NCT00670748|42099461|FG000|Overall Study|Not off study|2|||
19650038|NCT00670748|42099462|FG001|Overall Study|Not off study|1|||
19650039|NCT00670748|42099463|FG002|Overall Study|Not off study|1|||
19650040|NCT00670748|42099464|FG003|Overall Study|Not off study|1|||
19650041|NCT00646776|42099476|FG000|Overall Study|Adverse Event|1|||
19650042|NCT00646776|42099477|FG001|Overall Study|Adverse Event|9|||
19751197|NCT03060512|42200299|FG001|Overall Study|Non-compliance with study medication|2|||
19751198|NCT02539160|42200387|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
19751199|NCT02539160|42200388|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
19751200|NCT02539160|42200389|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
19751201|NCT02539160|42200390|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
19751202|NCT02539160|42200387|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
19751203|NCT02539160|42200388|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
19751204|NCT02539160|42200389|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
19751205|NCT02539160|42200390|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
19751206|NCT02539160|42200387|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
19751207|NCT02539160|42200388|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
19751208|NCT02539160|42200389|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
19751209|NCT02539160|42200390|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
19751210|NCT04292899|42200404|FG000|Overall Study|Death|21|||
19751211|NCT04292899|42200405|FG001|Overall Study|Death|28|||
19751212|NCT04292899|42200406|FG002|Overall Study|Death|188|||
19751213|NCT04292899|42200407|FG003|Overall Study|Death|371|||
19751214|NCT04292899|42200404|FG000|Overall Study|Lost to Follow-up|8|||
19751215|NCT04292899|42200405|FG001|Overall Study|Lost to Follow-up|4|||
19751216|NCT04292899|42200406|FG002|Overall Study|Lost to Follow-up|22|||
19751217|NCT04292899|42200407|FG003|Overall Study|Lost to Follow-up|235|||
19751218|NCT04292899|42200404|FG000|Overall Study|Withdrew consent|1|||
19751219|NCT04292899|42200405|FG001|Overall Study|Withdrew consent|0|||
19650043|NCT00646776|42099476|FG000|Overall Study|Investigator discretion|0|||
19650044|NCT00646776|42099477|FG001|Overall Study|Investigator discretion|4|||
19751220|NCT04292899|42200406|FG002|Overall Study|Withdrew consent|11|||
19650045|NCT00655668|42099486|FG000|Overall Study|Adverse Event|6|||
19650046|NCT00655668|42099486|FG000|Overall Study|Death|5|||
19751221|NCT04292899|42200407|FG003|Overall Study|Withdrew consent|32|||
19751222|NCT04292899|42200404|FG000|Overall Study|Adverse Event|2|||
19751223|NCT04292899|42200405|FG001|Overall Study|Adverse Event|1|||
19751224|NCT04292899|42200406|FG002|Overall Study|Adverse Event|2|||
19751225|NCT04292899|42200407|FG003|Overall Study|Adverse Event|2|||
19751226|NCT04292899|42200404|FG000|Overall Study|Investigator's Discretion|0|||
19650047|NCT00655668|42099486|FG000|Overall Study|Disease Progression|27|||
19650048|NCT00655668|42099486|FG000|Overall Study|Study Terminated|9|||
19650049|NCT00655668|42099486|FG000|Overall Study|Other|1|||
19650050|NCT00655668|42099486|FG000|Overall Study|New Lymphoma Treatment Started|4|||
19650051|NCT00655668|42099486|FG000|Overall Study|Withdrawal by Subject|2|||
19650052|NCT00569166|42099493|FG000|Overall Study|Withdrawal by Subject|7|||
19650053|NCT00569166|42099494|FG001|Overall Study|Withdrawal by Subject|5|||
19650054|NCT00569166|42099495|FG002|Overall Study|Withdrawal by Subject|3|||
19650055|NCT00569166|42099493|FG000|Overall Study|Lost to Follow-up|2|||
19650056|NCT00569166|42099494|FG001|Overall Study|Lost to Follow-up|1|||
19650057|NCT00569166|42099495|FG002|Overall Study|Lost to Follow-up|1|||
19650058|NCT00655356|42099505|FG000|Overall Study|Withdrawal by Subject|3|||
19650059|NCT00655356|42099506|FG001|Overall Study|Withdrawal by Subject|4|||
19650060|NCT00655356|42099505|FG000|Overall Study|Sponsor Request|10|||
19650061|NCT00655356|42099506|FG001|Overall Study|Sponsor Request|4|||
19650062|NCT00655356|42099505|FG000|Overall Study|Adverse Event|1|||
19650063|NCT00655356|42099506|FG001|Overall Study|Adverse Event|1|||
19650064|NCT00655356|42099505|FG000|Overall Study|Protocol Violation|2|||
19650065|NCT00655356|42099506|FG001|Overall Study|Protocol Violation|1|||
19650066|NCT00655356|42099505|FG000|Overall Study|Other Reason|1|||
19650067|NCT00655356|42099506|FG001|Overall Study|Other Reason|0|||
19650068|NCT00571064|42099512|FG000|Overall Study|Adverse Event|13|||
19650069|NCT00571064|42099512|FG000|Overall Study|Protocol Violation|4|||
19650070|NCT00571064|42099512|FG000|Overall Study|Withdrawal by Subject|2|||
19650071|NCT00571064|42099512|FG000|Overall Study|Other|2|||
19650072|NCT03895372|42099525|FG000|Investigational Treatment Period|Adverse Event|1|||
19650073|NCT03895372|42099526|FG001|Investigational Treatment Period|Adverse Event|0|||
19650074|NCT03895372|42099527|FG002|Investigational Treatment Period|Adverse Event|0|||
19650075|NCT03895372|42099528|FG003|Investigational Treatment Period|Adverse Event|0|||
19650076|NCT03895372|42099529|FG004|Investigational Treatment Period|Adverse Event|0|||
19650077|NCT03895372|42099530|FG005|Investigational Treatment Period|Adverse Event|0|||
19650078|NCT03895372|42099531|FG006|Investigational Treatment Period|Adverse Event|4|||
19650079|NCT03895372|42099532|FG007|Investigational Treatment Period|Adverse Event|3|||
19650080|NCT03895372|42099525|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
19650081|NCT03895372|42099526|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
19650082|NCT03895372|42099527|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
19650083|NCT03895372|42099528|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
19650084|NCT03895372|42099529|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
19650085|NCT03895372|42099530|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
19650086|NCT03895372|42099531|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
19650087|NCT03895372|42099532|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
19650088|NCT03895372|42099525|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
19650089|NCT03895372|42099526|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
19650090|NCT03895372|42099527|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
19650091|NCT03895372|42099528|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
19650092|NCT03895372|42099529|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
19650093|NCT03895372|42099530|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
19751227|NCT04292899|42200405|FG001|Overall Study|Investigator's Discretion|0|||
19751228|NCT04292899|42200406|FG002|Overall Study|Investigator's Discretion|0|||
19388193|NCT02564055|41631567|FG000|Overall Study|Lost to Follow-up|0|||
19388194|NCT02564055|41631568|FG001|Overall Study|Lost to Follow-up|1|||
19388195|NCT02564055|41631569|FG002|Overall Study|Lost to Follow-up|4|||
19388196|NCT02564055|41631570|FG003|Overall Study|Lost to Follow-up|2|||
19388197|NCT02564055|41631571|FG004|Overall Study|Lost to Follow-up|1|||
19388198|NCT02564055|41631572|FG005|Overall Study|Lost to Follow-up|0|||
19388199|NCT02564055|41631567|FG000|Overall Study|Physician Decision|0|||
19388200|NCT02564055|41631568|FG001|Overall Study|Physician Decision|0|||
19388201|NCT02564055|41631569|FG002|Overall Study|Physician Decision|1|||
19388202|NCT02564055|41631570|FG003|Overall Study|Physician Decision|0|||
19388203|NCT02564055|41631571|FG004|Overall Study|Physician Decision|0|||
19388204|NCT02564055|41631572|FG005|Overall Study|Physician Decision|0|||
19388205|NCT02564055|41631567|FG000|Overall Study|Withdrawal by Subject|4|||
19388206|NCT02564055|41631568|FG001|Overall Study|Withdrawal by Subject|4|||
19388207|NCT02564055|41631569|FG002|Overall Study|Withdrawal by Subject|3|||
19388208|NCT02564055|41631570|FG003|Overall Study|Withdrawal by Subject|3|||
19388209|NCT02564055|41631571|FG004|Overall Study|Withdrawal by Subject|10|||
19388210|NCT02564055|41631572|FG005|Overall Study|Withdrawal by Subject|10|||
19388211|NCT02563899|41631590|FG000|Overall Study|Protocol Violation|1|||
19388212|NCT02563899|41631591|FG001|Overall Study|Protocol Violation|0|||
19388213|NCT02563899|41631592|FG002|Overall Study|Protocol Violation|0|||
19388214|NCT02563899|41631593|FG003|Overall Study|Protocol Violation|0|||
19388215|NCT02563899|41631590|FG000|Overall Study|Withdrawal by Subject|0|||
19388216|NCT02563899|41631591|FG001|Overall Study|Withdrawal by Subject|0|||
19388217|NCT02563899|41631592|FG002|Overall Study|Withdrawal by Subject|1|||
19388218|NCT02563899|41631593|FG003|Overall Study|Withdrawal by Subject|0|||
19388219|NCT02699099|41631607|FG000|Overall Study|Adverse Event|1|||
19388220|NCT02699099|41631608|FG001|Overall Study|Adverse Event|0|||
19650094|NCT03895372|42099531|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
19650095|NCT03895372|42099532|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
19650096|NCT03895372|42099525|FG000|Investigational Treatment Period|Other|0|||
19650097|NCT03895372|42099526|FG001|Investigational Treatment Period|Other|0|||
19650098|NCT03895372|42099527|FG002|Investigational Treatment Period|Other|0|||
19650099|NCT03895372|42099528|FG003|Investigational Treatment Period|Other|0|||
19650100|NCT03895372|42099529|FG004|Investigational Treatment Period|Other|0|||
19650101|NCT03895372|42099530|FG005|Investigational Treatment Period|Other|1|||
19650102|NCT03895372|42099531|FG006|Investigational Treatment Period|Other|0|||
19650103|NCT03895372|42099532|FG007|Investigational Treatment Period|Other|2|||
19650104|NCT03895372|42099525|FG000|Investigational Treatment Period|Protocol Violation|0|||
19650105|NCT03895372|42099526|FG001|Investigational Treatment Period|Protocol Violation|0|||
19650106|NCT03895372|42099527|FG002|Investigational Treatment Period|Protocol Violation|0|||
19650107|NCT03895372|42099528|FG003|Investigational Treatment Period|Protocol Violation|1|||
19650108|NCT03895372|42099529|FG004|Investigational Treatment Period|Protocol Violation|0|||
19650109|NCT03895372|42099530|FG005|Investigational Treatment Period|Protocol Violation|0|||
19650110|NCT03895372|42099531|FG006|Investigational Treatment Period|Protocol Violation|0|||
19650111|NCT03895372|42099532|FG007|Investigational Treatment Period|Protocol Violation|0|||
19650112|NCT03895372|42099525|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
19650113|NCT03895372|42099526|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
19650114|NCT03895372|42099527|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
19388221|NCT02699099|41631609|FG002|Overall Study|Adverse Event|2|||
19388222|NCT02699099|41631607|FG000|Overall Study|Lost to Follow-up|0|||
19388223|NCT02699099|41631608|FG001|Overall Study|Lost to Follow-up|1|||
19388224|NCT02699099|41631609|FG002|Overall Study|Lost to Follow-up|0|||
19650115|NCT03895372|42099528|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
19650116|NCT03895372|42099529|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
19650117|NCT03895372|42099530|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
19650118|NCT03895372|42099531|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
19650119|NCT03895372|42099532|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
19650120|NCT03895372|42099525|FG000|Extension Treatment Period|Adverse Event|0|||
19650121|NCT03895372|42099526|FG001|Extension Treatment Period|Adverse Event|1|||
19650122|NCT03895372|42099527|FG002|Extension Treatment Period|Adverse Event|0|||
19650123|NCT03895372|42099528|FG003|Extension Treatment Period|Adverse Event|1|||
19650124|NCT03895372|42099529|FG004|Extension Treatment Period|Adverse Event|0|||
19650125|NCT03895372|42099530|FG005|Extension Treatment Period|Adverse Event|0|||
19650126|NCT03895372|42099531|FG006|Extension Treatment Period|Adverse Event|3|||
19650127|NCT03895372|42099532|FG007|Extension Treatment Period|Adverse Event|3|||
19650128|NCT03895372|42099525|FG000|Extension Treatment Period|Other|1|||
19650129|NCT03895372|42099526|FG001|Extension Treatment Period|Other|3|||
19650130|NCT03895372|42099527|FG002|Extension Treatment Period|Other|0|||
19650131|NCT03895372|42099528|FG003|Extension Treatment Period|Other|0|||
19650132|NCT03895372|42099529|FG004|Extension Treatment Period|Other|1|||
19650133|NCT03895372|42099530|FG005|Extension Treatment Period|Other|0|||
19650134|NCT03895372|42099531|FG006|Extension Treatment Period|Other|0|||
19650135|NCT03895372|42099532|FG007|Extension Treatment Period|Other|2|||
19650136|NCT03895372|42099525|FG000|Extension Treatment Period|Pregnancy|0|||
19650137|NCT03895372|42099526|FG001|Extension Treatment Period|Pregnancy|0|||
19650138|NCT03895372|42099527|FG002|Extension Treatment Period|Pregnancy|0|||
19650139|NCT03895372|42099528|FG003|Extension Treatment Period|Pregnancy|0|||
19650140|NCT03895372|42099529|FG004|Extension Treatment Period|Pregnancy|1|||
19650141|NCT03895372|42099530|FG005|Extension Treatment Period|Pregnancy|0|||
19650142|NCT03895372|42099531|FG006|Extension Treatment Period|Pregnancy|0|||
19650143|NCT03895372|42099532|FG007|Extension Treatment Period|Pregnancy|0|||
19650144|NCT03895372|42099525|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
19650145|NCT03895372|42099526|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
19650146|NCT03895372|42099527|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
19388225|NCT02699099|41631607|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
19388226|NCT02699099|41631608|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
19388227|NCT02699099|41631609|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
19388228|NCT02698865|41631621|FG000|Overall Study|Other|11|||
19388229|NCT02698865|41631622|FG001|Overall Study|Other|11|||
19388230|NCT02698865|41631621|FG000|Overall Study|Withdrawal by Subject|20|||
19650147|NCT03895372|42099528|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
19650148|NCT03895372|42099529|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
19751229|NCT04292899|42200407|FG003|Overall Study|Investigator's Discretion|3|||
19388231|NCT02698865|41631622|FG001|Overall Study|Withdrawal by Subject|16|||
19650149|NCT03895372|42099530|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
19650150|NCT03895372|42099531|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
19650151|NCT03895372|42099532|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
19650152|NCT00669110|42099557|FG000|Overall Study|Adverse Event|4|||
19650153|NCT00669110|42099558|FG001|Overall Study|Adverse Event|3|||
19650154|NCT00669110|42099557|FG000|Overall Study|Caregiver request|3|||
19650155|NCT00669110|42099558|FG001|Overall Study|Caregiver request|2|||
19650156|NCT00669110|42099557|FG000|Overall Study|Physician Decision|0|||
19650157|NCT00669110|42099558|FG001|Overall Study|Physician Decision|1|||
19650158|NCT00669110|42099557|FG000|Overall Study|Lost to Follow-up|1|||
19650159|NCT00669110|42099558|FG001|Overall Study|Lost to Follow-up|0|||
19751230|NCT04292899|42200404|FG000|Overall Study|Non-compliance With Study Drug|0|||
19751231|NCT04292899|42200405|FG001|Overall Study|Non-compliance With Study Drug|0|||
19751232|NCT04292899|42200406|FG002|Overall Study|Non-compliance With Study Drug|0|||
19751233|NCT04292899|42200407|FG003|Overall Study|Non-compliance With Study Drug|1|||
19650160|NCT00669110|42099557|FG000|Overall Study|Protocol Violation|0|||
19650161|NCT00669110|42099558|FG001|Overall Study|Protocol Violation|5|||
19650162|NCT00669110|42099557|FG000|Overall Study|Withdrawal by Subject|0|||
19650163|NCT00669110|42099558|FG001|Overall Study|Withdrawal by Subject|2|||
19650164|NCT00654732|42099566|FG000|Overall Study|Adverse Event|4|||
19650165|NCT00654732|42099567|FG001|Overall Study|Adverse Event|6|||
19650166|NCT00649428|42099575|FG000|Overall Study|Adverse Event|2|||
19650167|NCT00649428|42099576|FG001|Overall Study|Adverse Event|2|||
19751234|NCT04292899|42200404|FG000|Overall Study|Protocol Violation|0|||
19751235|NCT04292899|42200405|FG001|Overall Study|Protocol Violation|0|||
19751236|NCT04292899|42200406|FG002|Overall Study|Protocol Violation|0|||
19751237|NCT04292899|42200407|FG003|Overall Study|Protocol Violation|1|||
19751238|NCT03241173|42200426|FG000|Overall Study|Death|3|||
19650168|NCT00649428|42099575|FG000|Overall Study|Withdrawal by Subject|6|||
19650169|NCT00649428|42099576|FG001|Overall Study|Withdrawal by Subject|6|||
19751239|NCT03241173|42200427|FG001|Overall Study|Death|2|||
19650170|NCT00649428|42099575|FG000|Overall Study|Lost to Follow-up|1|||
19650171|NCT00649428|42099576|FG001|Overall Study|Lost to Follow-up|3|||
19650172|NCT00649428|42099575|FG000|Overall Study|Insufficient manufacturing yield|5|||
19650173|NCT00649428|42099576|FG001|Overall Study|Insufficient manufacturing yield|1|||
19650174|NCT00649428|42099575|FG000|Overall Study|Protocol Violation|6|||
19650175|NCT00649428|42099576|FG001|Overall Study|Protocol Violation|2|||
19650176|NCT00649428|42099575|FG000|Overall Study|Physician Decision|0|||
19650177|NCT00649428|42099576|FG001|Overall Study|Physician Decision|1|||
19650178|NCT00669032|42099585|FG000|Overall Study|Lost to Follow-up|6|||
19650179|NCT00669032|42099586|FG001|Overall Study|Lost to Follow-up|5|||
19650180|NCT00669032|42099585|FG000|Overall Study|Lack of Efficacy|8|||
19650181|NCT00669032|42099586|FG001|Overall Study|Lack of Efficacy|19|||
19650182|NCT00669032|42099585|FG000|Overall Study|Withdrawal by Subject|12|||
19650183|NCT00669032|42099586|FG001|Overall Study|Withdrawal by Subject|13|||
19650184|NCT00669032|42099585|FG000|Overall Study|Adverse Event|12|||
19650185|NCT00669032|42099586|FG001|Overall Study|Adverse Event|16|||
19650186|NCT00669032|42099585|FG000|Overall Study|Physician Decision|1|||
19650187|NCT00669032|42099586|FG001|Overall Study|Physician Decision|1|||
19751240|NCT03241173|42200428|FG002|Overall Study|Death|4|||
19751241|NCT03241173|42200429|FG003|Overall Study|Death|4|||
19751242|NCT03241173|42200430|FG004|Overall Study|Death|2|||
19650188|NCT00669032|42099585|FG000|Overall Study|No fulfilment of the selection criteria|5|||
19650189|NCT00669032|42099586|FG001|Overall Study|No fulfilment of the selection criteria|5|||
19650190|NCT00654498|42099594|FG000|Overall Study|Not Treated|1|||
19650191|NCT00654498|42099595|FG001|Overall Study|Not Treated|0|||
19650192|NCT00654498|42099594|FG000|Overall Study|Adverse Event|6|||
19650193|NCT00654498|42099595|FG001|Overall Study|Adverse Event|1|||
19650194|NCT00654498|42099594|FG000|Overall Study|Protocol Violation|1|||
19650195|NCT00654498|42099595|FG001|Overall Study|Protocol Violation|1|||
19650196|NCT00654498|42099594|FG000|Overall Study|Lost to Follow-up|1|||
19650197|NCT00654498|42099595|FG001|Overall Study|Lost to Follow-up|5|||
19650198|NCT00654498|42099594|FG000|Overall Study|Withdrawal by Subject|1|||
19650199|NCT00654498|42099595|FG001|Overall Study|Withdrawal by Subject|0|||
19650200|NCT00654498|42099594|FG000|Overall Study|Other reason not defined above|4|||
19650201|NCT00654498|42099595|FG001|Overall Study|Other reason not defined above|5|||
19650202|NCT00670046|42099603|FG000|Overall Study|Lost to Follow-up|1|||
19650203|NCT00670046|42099604|FG001|Overall Study|Lost to Follow-up|1|||
19650204|NCT00670046|42099603|FG000|Overall Study|Withdrawal by Subject|0|||
19650205|NCT00670046|42099604|FG001|Overall Study|Withdrawal by Subject|1|||
19650206|NCT00321919|42099612|FG000|Overall Study|Adverse Event|17|||
19751243|NCT03241173|42200431|FG005|Overall Study|Death|2|||
19751244|NCT03241173|42200432|FG006|Overall Study|Death|3|||
19751245|NCT03241173|42200433|FG007|Overall Study|Death|1|||
19650207|NCT00321919|42099613|FG001|Overall Study|Adverse Event|10|||
19650208|NCT00321919|42099612|FG000|Overall Study|Death|21|||
19751246|NCT03241173|42200434|FG008|Overall Study|Death|0|||
19751247|NCT03241173|42200435|FG009|Overall Study|Death|5|||
19751248|NCT03241173|42200436|FG010|Overall Study|Death|4|||
19751249|NCT03241173|42200437|FG011|Overall Study|Death|3|||
19751250|NCT03241173|42200438|FG012|Overall Study|Death|0|||
19751251|NCT03241173|42200439|FG013|Overall Study|Death|0|||
19751252|NCT03241173|42200440|FG014|Overall Study|Death|0|||
19751253|NCT03241173|42200426|FG000|Overall Study|Withdrawal by Subject|0|||
19751254|NCT03241173|42200427|FG001|Overall Study|Withdrawal by Subject|0|||
19650209|NCT00321919|42099613|FG001|Overall Study|Death|17|||
19650210|NCT00321919|42099612|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19650211|NCT00321919|42099613|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19650212|NCT00321919|42099612|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
19650213|NCT00321919|42099613|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19650214|NCT00321919|42099612|FG000|Overall Study|Refused Treatment|23|||
19650215|NCT00321919|42099613|FG001|Overall Study|Refused Treatment|14|||
19650216|NCT00321919|42099612|FG000|Overall Study|Other Protocol Violation|2|||
19650217|NCT00321919|42099613|FG001|Overall Study|Other Protocol Violation|3|||
19650218|NCT00321919|42099612|FG000|Overall Study|Failure to Return|3|||
19650219|NCT00321919|42099613|FG001|Overall Study|Failure to Return|1|||
19650220|NCT00321919|42099612|FG000|Overall Study|Other withdrawal reason|7|||
19650221|NCT00321919|42099613|FG001|Overall Study|Other withdrawal reason|6|||
19650222|NCT00560391|42099625|FG000|Overall Study|Still on treatment|0|||
19650223|NCT00560391|42099626|FG001|Overall Study|Still on treatment|0|||
19650224|NCT00560391|42099627|FG002|Overall Study|Still on treatment|0|||
19650225|NCT00560391|42099628|FG003|Overall Study|Still on treatment|1|||
19650226|NCT00560391|42099629|FG004|Overall Study|Still on treatment|2|||
19650227|NCT00537238|42099644|FG000|Overall Study|Death|1|||
19650228|NCT00537238|42099645|FG001|Overall Study|Death|2|||
19650229|NCT00537238|42099644|FG000|Overall Study|Adverse Event|31|||
19650230|NCT00537238|42099645|FG001|Overall Study|Adverse Event|22|||
19650231|NCT00537238|42099644|FG000|Overall Study|Lack of Efficacy|20|||
19650232|NCT00537238|42099645|FG001|Overall Study|Lack of Efficacy|21|||
19650233|NCT00537238|42099644|FG000|Overall Study|Lost to Follow-up|12|||
19650234|NCT00537238|42099645|FG001|Overall Study|Lost to Follow-up|8|||
19650235|NCT00537238|42099644|FG000|Overall Study|Withdrawal by Subject|51|||
19650236|NCT00537238|42099645|FG001|Overall Study|Withdrawal by Subject|47|||
19650237|NCT00537238|42099644|FG000|Overall Study|Protocol Violation|15|||
19650238|NCT00537238|42099645|FG001|Overall Study|Protocol Violation|19|||
19650239|NCT00537238|42099644|FG000|Overall Study|Does not meet entrance criteria|0|||
19650240|NCT00537238|42099645|FG001|Overall Study|Does not meet entrance criteria|2|||
19650241|NCT00537238|42099644|FG000|Overall Study|Other|44|||
19751255|NCT03241173|42200428|FG002|Overall Study|Withdrawal by Subject|1|||
19751256|NCT03241173|42200429|FG003|Overall Study|Withdrawal by Subject|0|||
19751257|NCT03241173|42200430|FG004|Overall Study|Withdrawal by Subject|0|||
19751258|NCT03241173|42200431|FG005|Overall Study|Withdrawal by Subject|1|||
19751259|NCT03241173|42200432|FG006|Overall Study|Withdrawal by Subject|0|||
19751260|NCT03241173|42200433|FG007|Overall Study|Withdrawal by Subject|0|||
19751261|NCT03241173|42200434|FG008|Overall Study|Withdrawal by Subject|0|||
19751262|NCT03241173|42200435|FG009|Overall Study|Withdrawal by Subject|0|||
19751263|NCT03241173|42200436|FG010|Overall Study|Withdrawal by Subject|0|||
19751264|NCT03241173|42200437|FG011|Overall Study|Withdrawal by Subject|0|||
19751265|NCT03241173|42200438|FG012|Overall Study|Withdrawal by Subject|0|||
19751266|NCT03241173|42200439|FG013|Overall Study|Withdrawal by Subject|0|||
19751267|NCT03241173|42200440|FG014|Overall Study|Withdrawal by Subject|0|||
19751268|NCT03241173|42200426|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
19650242|NCT00537238|42099645|FG001|Overall Study|Other|52|||
19650243|NCT03966885|42099653|FG000|Overall Study|Death|1|||
19650244|NCT03966885|42099654|FG001|Overall Study|Death|0|||
19650245|NCT03966885|42099653|FG000|Overall Study|Lost to Follow-up|1|||
19751269|NCT03241173|42200427|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
19751270|NCT03241173|42200428|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19751271|NCT03241173|42200429|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
19650246|NCT03966885|42099654|FG001|Overall Study|Lost to Follow-up|2|||
19650247|NCT03966885|42099653|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
19650248|NCT03966885|42099654|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
19650249|NCT03966885|42099653|FG000|Overall Study|Moved from study area.|0|||
19650250|NCT03966885|42099654|FG001|Overall Study|Moved from study area.|2|||
19650251|NCT03965403|42099661|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
19650252|NCT00552669|42099667|FG000|Overall Study|Death|3|||
19650253|NCT00552669|42099668|FG001|Overall Study|Death|7|||
19650254|NCT00552513|42099676|FG000|Overall Study|Lost to Follow-up|5|||
19650255|NCT00552513|42099677|FG001|Overall Study|Lost to Follow-up|1|||
19650256|NCT00560313|42099685|FG000|Overall Study|Adverse Events or Death|2|||
19650257|NCT00560313|42099685|FG000|Overall Study|Withdrawal by Subject|2|||
19650258|NCT00560313|42099685|FG000|Overall Study|Lost to Follow-up|1|||
19650259|NCT00560313|42099685|FG000|Overall Study|Protocol Violation|1|||
19650260|NCT00667862|42099704|FG000|Overall Study|Adverse Event|9|||
19650261|NCT00667862|42099704|FG000|Overall Study|Death|1|||
19650262|NCT00667862|42099704|FG000|Overall Study|Disease Progression|22|||
19650263|NCT00667862|42099704|FG000|Overall Study|Withdrawal by Subject|3|||
19650264|NCT00535132|42099710|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
19650265|NCT00535132|42099711|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
19650266|NCT00535132|42099710|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
19650267|NCT00535132|42099711|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
19650268|NCT00570908|42099719|FG000|Overall Study|Adverse Event|5|||
19650269|NCT00570908|42099719|FG000|Overall Study|Withdrawal by Subject|2|||
19650270|NCT00781391|42099726|FG000|Overall Study|never received study drug|24|||
19650271|NCT00781391|42099727|FG001|Overall Study|never received study drug|23|||
19650272|NCT00781391|42099728|FG002|Overall Study|never received study drug|32|||
19650273|NCT00781391|42099726|FG000|Overall Study|Protocol Violation|19|||
19650274|NCT00781391|42099727|FG001|Overall Study|Protocol Violation|17|||
19650275|NCT00781391|42099728|FG002|Overall Study|Protocol Violation|20|||
19650276|NCT00781391|42099726|FG000|Overall Study|Death|789|||
19650277|NCT00781391|42099727|FG001|Overall Study|Death|730|||
19650278|NCT00781391|42099728|FG002|Overall Study|Death|706|||
19650279|NCT00781391|42099726|FG000|Overall Study|Withdrawal by Subject|47|||
19650280|NCT00781391|42099727|FG001|Overall Study|Withdrawal by Subject|37|||
19650281|NCT00781391|42099728|FG002|Overall Study|Withdrawal by Subject|25|||
19650282|NCT00781391|42099726|FG000|Overall Study|Lost to Follow-up|0|||
19650283|NCT00781391|42099727|FG001|Overall Study|Lost to Follow-up|0|||
19650284|NCT00781391|42099728|FG002|Overall Study|Lost to Follow-up|1|||
19650285|NCT00534976|42099738|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
19650286|NCT00534976|42099739|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
19650287|NCT00534976|42099738|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
19650288|NCT00534976|42099739|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
19650289|NCT00534976|42099738|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
19650290|NCT00534976|42099739|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
19650291|NCT00321763|42099749|FG000|Overall Study|Adverse Event|1|||
19650292|NCT00321763|42099750|FG001|Overall Study|Adverse Event|1|||
19650293|NCT00321763|42099751|FG002|Overall Study|Adverse Event|0|||
19650294|NCT00321763|42099752|FG003|Overall Study|Adverse Event|1|||
19650295|NCT00321763|42099749|FG000|Overall Study|Withdrawal by Subject|2|||
19650296|NCT00321763|42099750|FG001|Overall Study|Withdrawal by Subject|0|||
19650297|NCT00321763|42099751|FG002|Overall Study|Withdrawal by Subject|1|||
19650298|NCT00321763|42099752|FG003|Overall Study|Withdrawal by Subject|0|||
19650299|NCT00321763|42099749|FG000|Overall Study|Lost to Follow-up|3|||
19650300|NCT00321763|42099750|FG001|Overall Study|Lost to Follow-up|1|||
19650301|NCT00321763|42099751|FG002|Overall Study|Lost to Follow-up|5|||
19751272|NCT03241173|42200430|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
19751273|NCT03241173|42200431|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
19751274|NCT03241173|42200432|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
19751275|NCT03241173|42200433|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
19751276|NCT03241173|42200434|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19751277|NCT03241173|42200435|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19751278|NCT03241173|42200436|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
19751279|NCT03241173|42200437|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
19650302|NCT00321763|42099752|FG003|Overall Study|Lost to Follow-up|4|||
19650303|NCT00308113|42099768|FG000|Overall Study|Protocol closure|0|||
19751280|NCT03241173|42200438|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19751281|NCT03241173|42200439|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19650304|NCT00308113|42099769|FG001|Overall Study|Protocol closure|0|||
19650305|NCT00308113|42099770|FG002|Overall Study|Protocol closure|0|||
19650306|NCT00308113|42099771|FG003|Overall Study|Protocol closure|1|||
19650307|NCT00307801|42099787|FG000|Overall Study|Adverse Event|12|||
19650308|NCT00307801|42099788|FG001|Overall Study|Adverse Event|4|||
19650309|NCT00307801|42099787|FG000|Overall Study|Withdrawal by Subject|9|||
19650310|NCT00307801|42099788|FG001|Overall Study|Withdrawal by Subject|4|||
19650311|NCT00307801|42099787|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
19650312|NCT00307801|42099788|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
19650313|NCT00307801|42099787|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
19650314|NCT00307801|42099788|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
19650315|NCT00307801|42099787|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
19650316|NCT00307801|42099788|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
19650317|NCT00307801|42099787|FG000|Overall Study|Wrong Randomization|1|||
19650318|NCT00307801|42099788|FG001|Overall Study|Wrong Randomization|0|||
19650319|NCT00307801|42099787|FG000|Overall Study|Lack of Efficacy|0|||
19650320|NCT00307801|42099788|FG001|Overall Study|Lack of Efficacy|2|||
19650321|NCT00307801|42099787|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
19650322|NCT00307801|42099788|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
19650323|NCT00307801|42099787|FG000|Overall Study|Frustration with e-diary|1|||
19650324|NCT00307801|42099788|FG001|Overall Study|Frustration with e-diary|0|||
19650325|NCT00307801|42099787|FG000|Overall Study|Protocol Violation|3|||
19650326|NCT00307801|42099788|FG001|Overall Study|Protocol Violation|2|||
19650327|NCT00307801|42099787|FG000|Overall Study|No reason specified|2|||
19650328|NCT00307801|42099788|FG001|Overall Study|No reason specified|0|||
19650329|NCT00307801|42099787|FG000|Overall Study|Pregnancy|0|||
19650330|NCT00307801|42099788|FG001|Overall Study|Pregnancy|1|||
19650331|NCT00671060|42099797|FG000|Overall Study|Protocol Violation|1|||
19650332|NCT00671060|42099798|FG001|Overall Study|Protocol Violation|0|||
19650333|NCT00671060|42099797|FG000|Overall Study|Physician Decision|0|||
19650334|NCT00671060|42099798|FG001|Overall Study|Physician Decision|1|||
19650335|NCT00654420|42099808|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
19650336|NCT00654420|42099809|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
19650337|NCT00654420|42099810|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
19650338|NCT00654420|42099811|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
19650339|NCT00654420|42099808|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
19650340|NCT00654420|42099809|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
19650341|NCT00654420|42099810|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
19650342|NCT00654420|42099811|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
19650343|NCT00654420|42099808|FG000|Phase II|Adverse Event|0|||
19650344|NCT00654420|42099809|FG001|Phase II|Adverse Event|0|||
19650345|NCT00654420|42099810|FG002|Phase II|Adverse Event|3|||
19650346|NCT00654420|42099811|FG003|Phase II|Adverse Event|3|||
19650347|NCT00654420|42099808|FG000|Phase II|Lost to Follow-up|0|||
19388232|NCT02698865|41631621|FG000|Overall Study|Physician Decision|0|||
19650348|NCT00654420|42099809|FG001|Phase II|Lost to Follow-up|0|||
19650349|NCT00654420|42099810|FG002|Phase II|Lost to Follow-up|0|||
19650350|NCT00654420|42099811|FG003|Phase II|Lost to Follow-up|1|||
19650351|NCT00654420|42099808|FG000|Phase II|Physician Decision|0|||
19650352|NCT00654420|42099809|FG001|Phase II|Physician Decision|0|||
19650353|NCT00654420|42099810|FG002|Phase II|Physician Decision|0|||
19650354|NCT00654420|42099811|FG003|Phase II|Physician Decision|4|||
19650355|NCT00654420|42099808|FG000|Phase II|Progressive Disease|0|||
19650356|NCT00654420|42099809|FG001|Phase II|Progressive Disease|0|||
19650357|NCT00654420|42099810|FG002|Phase II|Progressive Disease|29|||
19650358|NCT00654420|42099811|FG003|Phase II|Progressive Disease|29|||
19650359|NCT00654420|42099808|FG000|Phase II|Withdrawal by Subject|0|||
19650360|NCT00654420|42099809|FG001|Phase II|Withdrawal by Subject|0|||
19650361|NCT00654420|42099810|FG002|Phase II|Withdrawal by Subject|4|||
19650362|NCT00654420|42099811|FG003|Phase II|Withdrawal by Subject|1|||
19650363|NCT00654420|42099808|FG000|Phase II|Missing Disposition Record|0|||
19650364|NCT00654420|42099809|FG001|Phase II|Missing Disposition Record|0|||
19650365|NCT00654420|42099810|FG002|Phase II|Missing Disposition Record|1|||
19650366|NCT00654420|42099811|FG003|Phase II|Missing Disposition Record|0|||
19650367|NCT00307489|42099823|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
19650368|NCT00307489|42099824|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
19650369|NCT00307489|42099823|FG000|Baseline Through Week 48|Physician Decision|1|||
19650370|NCT00307489|42099824|FG001|Baseline Through Week 48|Physician Decision|0|||
19650371|NCT00307489|42099823|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
19650372|NCT00307489|42099824|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
19650373|NCT00307489|42099823|FG000|Week 48 Through Week 168|Adverse Event|1|||
19650374|NCT00307489|42099824|FG001|Week 48 Through Week 168|Adverse Event|0|||
19650375|NCT00307489|42099823|FG000|Week 48 Through Week 168|Physician Decision|1|||
19650376|NCT00307489|42099824|FG001|Week 48 Through Week 168|Physician Decision|0|||
19751282|NCT03241173|42200440|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
19751283|NCT03241173|42200426|FG000|Overall Study|Lost to Follow-up|0|||
19650377|NCT00307489|42099823|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
19650378|NCT00307489|42099824|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
19650379|NCT00307489|42099823|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
19650380|NCT00307489|42099824|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
19751284|NCT03241173|42200427|FG001|Overall Study|Lost to Follow-up|0|||
19751285|NCT03241173|42200428|FG002|Overall Study|Lost to Follow-up|0|||
19751286|NCT03241173|42200429|FG003|Overall Study|Lost to Follow-up|0|||
19751287|NCT03241173|42200430|FG004|Overall Study|Lost to Follow-up|1|||
19751288|NCT03241173|42200431|FG005|Overall Study|Lost to Follow-up|0|||
19751289|NCT03241173|42200432|FG006|Overall Study|Lost to Follow-up|0|||
19751290|NCT03241173|42200433|FG007|Overall Study|Lost to Follow-up|0|||
19751291|NCT03241173|42200434|FG008|Overall Study|Lost to Follow-up|0|||
19751292|NCT03241173|42200435|FG009|Overall Study|Lost to Follow-up|1|||
19751293|NCT03241173|42200436|FG010|Overall Study|Lost to Follow-up|0|||
19751294|NCT03241173|42200437|FG011|Overall Study|Lost to Follow-up|0|||
19751295|NCT03241173|42200438|FG012|Overall Study|Lost to Follow-up|0|||
19751296|NCT03241173|42200439|FG013|Overall Study|Lost to Follow-up|0|||
19751297|NCT03241173|42200440|FG014|Overall Study|Lost to Follow-up|0|||
19751298|NCT03264066|42200474|FG000|Overall Study|Adverse Event|1|||
19751299|NCT03264066|42200475|FG001|Overall Study|Adverse Event|1|||
19751300|NCT03264066|42200476|FG002|Overall Study|Adverse Event|0|||
19751301|NCT03264066|42200477|FG003|Overall Study|Adverse Event|0|||
19751302|NCT03264066|42200478|FG004|Overall Study|Adverse Event|0|||
19751303|NCT03264066|42200479|FG005|Overall Study|Adverse Event|0|||
19751304|NCT03264066|42200474|FG000|Overall Study|Death|12|||
19751305|NCT03264066|42200475|FG001|Overall Study|Death|12|||
19751306|NCT03264066|42200476|FG002|Overall Study|Death|8|||
19751307|NCT03264066|42200477|FG003|Overall Study|Death|10|||
19650381|NCT00307489|42099823|FG000|Week 48 Through Week 168|Death|0|||
19650382|NCT00307489|42099824|FG001|Week 48 Through Week 168|Death|1|||
19650383|NCT00307489|42099823|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
19650384|NCT00307489|42099824|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
19650385|NCT00307489|42099823|FG000|Week 48 Through Week 168|Seroconversion|1|||
19650386|NCT00307489|42099824|FG001|Week 48 Through Week 168|Seroconversion|0|||
19650387|NCT00667628|42099832|FG000|Overall Study|Lost to Follow-up|1|||
19650388|NCT00667628|42099833|FG001|Overall Study|Lost to Follow-up|0|||
19650389|NCT00667628|42099832|FG000|Overall Study|Death|6|||
19650390|NCT00667628|42099833|FG001|Overall Study|Death|6|||
19650391|NCT00667628|42099832|FG000|Overall Study|Investigator Considers in Best Interest|1|||
19388233|NCT02698865|41631622|FG001|Overall Study|Physician Decision|4|||
19650392|NCT00667628|42099833|FG001|Overall Study|Investigator Considers in Best Interest|0|||
19650393|NCT00667628|42099832|FG000|Overall Study|Sponsor Terminated Study|17|||
19650394|NCT00667628|42099833|FG001|Overall Study|Sponsor Terminated Study|21|||
19650395|NCT00645840|42099839|FG000|Overall Study|Protocol Violation|3|||
19751308|NCT03264066|42200478|FG004|Overall Study|Death|6|||
19751309|NCT03264066|42200479|FG005|Overall Study|Death|1|||
19751310|NCT03264066|42200474|FG000|Overall Study|Lost to Follow-up|1|||
19751311|NCT03264066|42200475|FG001|Overall Study|Lost to Follow-up|0|||
19650396|NCT00307333|42099845|FG000|Overall Study|Lost to Follow-up|11|||
19650397|NCT00307333|42099846|FG001|Overall Study|Lost to Follow-up|3|||
19650398|NCT00762359|42099854|FG000|Overall Study|Adverse Event|20|||
19650399|NCT00762359|42099855|FG001|Overall Study|Adverse Event|23|||
19650400|NCT00762359|42099854|FG000|Overall Study|Protocol Violation|21|||
19650401|NCT00762359|42099855|FG001|Overall Study|Protocol Violation|13|||
19650402|NCT00762359|42099854|FG000|Overall Study|Withdrawal by Subject|13|||
19650403|NCT00762359|42099855|FG001|Overall Study|Withdrawal by Subject|10|||
19650404|NCT00762359|42099854|FG000|Overall Study|Lack of Efficacy|0|||
19650405|NCT00762359|42099855|FG001|Overall Study|Lack of Efficacy|4|||
19650406|NCT00762359|42099854|FG000|Overall Study|Institution closed|2|||
19650407|NCT00762359|42099855|FG001|Overall Study|Institution closed|3|||
19650408|NCT00762359|42099854|FG000|Overall Study|Physician Decision|2|||
19650409|NCT00762359|42099855|FG001|Overall Study|Physician Decision|3|||
19650410|NCT00762359|42099854|FG000|Overall Study|Removal|0|||
19650411|NCT00762359|42099855|FG001|Overall Study|Removal|1|||
19650412|NCT00762359|42099854|FG000|Overall Study|Withdrew consent|1|||
19650413|NCT00762359|42099855|FG001|Overall Study|Withdrew consent|0|||
19650414|NCT00654186|42099861|FG000|Overall Study|Withdrawal by Subject|5|||
19650415|NCT00761969|42099867|FG000|Overall Study|Death|112|||
19650416|NCT00761969|42099868|FG001|Overall Study|Death|47|||
19650417|NCT00761969|42099867|FG000|Overall Study|Lost to Follow-up|88|||
19650418|NCT00761969|42099868|FG001|Overall Study|Lost to Follow-up|93|||
19650419|NCT00761891|42099879|FG000|Overall Study|Withdrawal by Subject|10|||
19650420|NCT00321685|42099884|FG000|Overall Study|Adverse Event|18|||
19650421|NCT00321685|42099884|FG000|Overall Study|Death|2|||
19650422|NCT00321685|42099884|FG000|Overall Study|Withdrawal by Subject|8|||
19650423|NCT00321685|42099884|FG000|Overall Study|Alternative therapy|1|||
19650424|NCT00321685|42099884|FG000|Overall Study|Complicating disese|1|||
19751312|NCT03264066|42200476|FG002|Overall Study|Lost to Follow-up|0|||
19751313|NCT03264066|42200477|FG003|Overall Study|Lost to Follow-up|0|||
19751314|NCT03264066|42200478|FG004|Overall Study|Lost to Follow-up|0|||
19751315|NCT03264066|42200479|FG005|Overall Study|Lost to Follow-up|0|||
19751316|NCT03264066|42200474|FG000|Overall Study|Progressive Disease|0|||
19751317|NCT03264066|42200475|FG001|Overall Study|Progressive Disease|2|||
19751318|NCT03264066|42200476|FG002|Overall Study|Progressive Disease|1|||
19751319|NCT03264066|42200477|FG003|Overall Study|Progressive Disease|0|||
19650425|NCT00321685|42099884|FG000|Overall Study|Other|5|||
19650426|NCT00321685|42099884|FG000|Overall Study|Not start protocol therapy|2|||
19650427|NCT00321685|42099884|FG000|Overall Study|Ineligible|2|||
19650428|NCT03902392|42099890|FG000|Overall Study|Lost to Follow-up|7|||
19650429|NCT03902392|42099891|FG001|Overall Study|Lost to Follow-up|7|||
19650430|NCT00306787|42099899|FG000|Overall Study|Discontinued without taking study drug|208|||
19650431|NCT00306787|42099900|FG001|Overall Study|Discontinued without taking study drug|215|||
19650432|NCT00306787|42099899|FG000|Overall Study|Adverse Event|1|||
19650433|NCT00306787|42099900|FG001|Overall Study|Adverse Event|1|||
19650434|NCT00306787|42099899|FG000|Overall Study|Lack of Efficacy|1|||
19650435|NCT00306787|42099900|FG001|Overall Study|Lack of Efficacy|0|||
19650436|NCT00306787|42099899|FG000|Overall Study|Protocol Violation|8|||
19650437|NCT00306787|42099900|FG001|Overall Study|Protocol Violation|10|||
19650438|NCT00306787|42099899|FG000|Overall Study|Withdrawal by Subject|2|||
19650439|NCT00306787|42099900|FG001|Overall Study|Withdrawal by Subject|9|||
19650440|NCT00306787|42099899|FG000|Overall Study|Lost to Follow-up|9|||
19650441|NCT00306787|42099900|FG001|Overall Study|Lost to Follow-up|6|||
19751320|NCT03264066|42200478|FG004|Overall Study|Progressive Disease|0|||
19751321|NCT03264066|42200479|FG005|Overall Study|Progressive Disease|0|||
19751322|NCT03264066|42200474|FG000|Overall Study|Study Terminated by Sponsor|5|||
19751323|NCT03264066|42200475|FG001|Overall Study|Study Terminated by Sponsor|5|||
19751324|NCT03264066|42200476|FG002|Overall Study|Study Terminated by Sponsor|8|||
19751325|NCT03264066|42200477|FG003|Overall Study|Study Terminated by Sponsor|5|||
19751326|NCT03264066|42200478|FG004|Overall Study|Study Terminated by Sponsor|1|||
19751327|NCT03264066|42200479|FG005|Overall Study|Study Terminated by Sponsor|2|||
19650442|NCT00306787|42099899|FG000|Overall Study|Administrative problems|4|||
19650443|NCT00306787|42099900|FG001|Overall Study|Administrative problems|0|||
19650444|NCT00306787|42099899|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19650445|NCT00306787|42099900|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19751328|NCT03264066|42200474|FG000|Overall Study|Withdrawal by Subject|1|||
19751329|NCT03264066|42200475|FG001|Overall Study|Withdrawal by Subject|0|||
19650446|NCT00769067|42099908|FG000|Overall Study|Death|89|||
19650447|NCT00769067|42099909|FG001|Overall Study|Death|86|||
19650448|NCT00769067|42099908|FG000|Overall Study|Lost to Follow-up|3|||
19650449|NCT00769067|42099909|FG001|Overall Study|Lost to Follow-up|1|||
19650450|NCT00769067|42099908|FG000|Overall Study|Study terminated by sponsor|1|||
19650451|NCT00769067|42099909|FG001|Overall Study|Study terminated by sponsor|3|||
19650452|NCT00769067|42099908|FG000|Overall Study|Other|1|||
19650453|NCT00769067|42099909|FG001|Overall Study|Other|3|||
19650454|NCT00769067|42099908|FG000|Overall Study|Withdrawal by Subject|0|||
19650455|NCT00769067|42099909|FG001|Overall Study|Withdrawal by Subject|1|||
19751330|NCT03264066|42200476|FG002|Overall Study|Withdrawal by Subject|0|||
19650456|NCT00321373|42099919|FG000|Overall Study|Adverse Event|0|||
19650457|NCT00321373|42099920|FG001|Overall Study|Adverse Event|0|||
19650458|NCT00321373|42099921|FG002|Overall Study|Adverse Event|1|||
19751331|NCT03264066|42200477|FG003|Overall Study|Withdrawal by Subject|5|||
19650459|NCT00321373|42099919|FG000|Overall Study|Lost to Follow-up|1|||
19650460|NCT00321373|42099920|FG001|Overall Study|Lost to Follow-up|0|||
19650461|NCT00321373|42099921|FG002|Overall Study|Lost to Follow-up|1|||
19650462|NCT00321373|42099919|FG000|Overall Study|Withdrawal by Subject|1|||
19650463|NCT00321373|42099920|FG001|Overall Study|Withdrawal by Subject|0|||
19650464|NCT00321373|42099921|FG002|Overall Study|Withdrawal by Subject|0|||
19650465|NCT00321373|42099919|FG000|Overall Study|Other|0|||
19650466|NCT00321373|42099920|FG001|Overall Study|Other|0|||
19650467|NCT00321373|42099921|FG002|Overall Study|Other|1|||
19650468|NCT00667394|42099931|FG000|Overall Study|Adverse Event|3|||
19650469|NCT00667394|42099932|FG001|Overall Study|Adverse Event|0|||
19650470|NCT00667394|42099931|FG000|Overall Study|Progressive disease|1|||
19650471|NCT00667394|42099932|FG001|Overall Study|Progressive disease|0|||
19650472|NCT00761735|42099938|FG000|Overall Study|Lost to Follow-up|6|||
19650473|NCT00761735|42099938|FG000|Overall Study|Withdrawal by Subject|6|||
19650474|NCT00761735|42099938|FG000|Overall Study|Non-compliance with protocol|1|||
19650475|NCT00761735|42099938|FG000|Overall Study|Administrative|1|||
19650476|NCT00569946|42099946|FG000|Overall Study|Adverse Event|16|||
19650477|NCT00569946|42099946|FG000|Overall Study|Objective Progression or Relapse|42|||
19650478|NCT00569946|42099946|FG000|Overall Study|Global Deterioration of Health Status|1|||
19650479|NCT00645528|42099950|FG000|Overall Study|Did not show up for Visit 2|7|||
19650480|NCT00295633|42099957|FG000|Overall Study|Lack of Efficacy|19|||
19650481|NCT00295633|42099958|FG001|Overall Study|Lack of Efficacy|7|||
19650482|NCT00295633|42099959|FG002|Overall Study|Lack of Efficacy|16|||
19650483|NCT00295633|42099957|FG000|Overall Study|Withdrawal of consent by subject|16|||
19650484|NCT00295633|42099958|FG001|Overall Study|Withdrawal of consent by subject|16|||
19650485|NCT00295633|42099959|FG002|Overall Study|Withdrawal of consent by subject|26|||
19650486|NCT00295633|42099957|FG000|Overall Study|Adverse Event|9|||
19650487|NCT00295633|42099958|FG001|Overall Study|Adverse Event|17|||
19650488|NCT00295633|42099959|FG002|Overall Study|Adverse Event|9|||
19650489|NCT00295633|42099957|FG000|Overall Study|Lost to Follow-up|6|||
19650490|NCT00295633|42099958|FG001|Overall Study|Lost to Follow-up|11|||
19650491|NCT00295633|42099959|FG002|Overall Study|Lost to Follow-up|7|||
19650492|NCT00295633|42099957|FG000|Overall Study|Physician Decision|9|||
19650493|NCT00295633|42099958|FG001|Overall Study|Physician Decision|10|||
19650494|NCT00295633|42099959|FG002|Overall Study|Physician Decision|8|||
19650495|NCT00295633|42099957|FG000|Overall Study|Poor/Noncompliance|2|||
19650496|NCT00295633|42099958|FG001|Overall Study|Poor/Noncompliance|2|||
19650497|NCT00295633|42099959|FG002|Overall Study|Poor/Noncompliance|6|||
19650498|NCT00295633|42099957|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
19650499|NCT00295633|42099958|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
19650500|NCT00295633|42099959|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
19650501|NCT00295633|42099957|FG000|Overall Study|Death|1|||
19650502|NCT00295633|42099958|FG001|Overall Study|Death|1|||
19650503|NCT00295633|42099959|FG002|Overall Study|Death|0|||
19650504|NCT00295633|42099957|FG000|Overall Study|Administrative reason by sponsor|0|||
19650505|NCT00295633|42099958|FG001|Overall Study|Administrative reason by sponsor|0|||
19650506|NCT00295633|42099959|FG002|Overall Study|Administrative reason by sponsor|1|||
19650507|NCT00570674|42099967|FG000|Overall Study|Withdrawal by Subject|0|||
19650508|NCT00570674|42099968|FG001|Overall Study|Withdrawal by Subject|0|||
19650509|NCT00570674|42099969|FG002|Overall Study|Withdrawal by Subject|1|||
19650510|NCT00570674|42099970|FG003|Overall Study|Withdrawal by Subject|0|||
19650511|NCT00570674|42099971|FG004|Overall Study|Withdrawal by Subject|0|||
19650512|NCT00570674|42099972|FG005|Overall Study|Withdrawal by Subject|0|||
19650513|NCT00570674|42099973|FG006|Overall Study|Withdrawal by Subject|0|||
19650514|NCT00768989|42099986|FG000|Prior to Week 24|Withdrawal by Subject|1|||
19650515|NCT00768989|42099987|FG001|Prior to Week 24|Withdrawal by Subject|0|||
19650516|NCT00768989|42099986|FG000|Prior to Week 24|Adverse Event|3|||
19650517|NCT00768989|42099987|FG001|Prior to Week 24|Adverse Event|0|||
19650518|NCT00768989|42099986|FG000|Prior to Week 24|Lost to Follow-up|0|||
19650519|NCT00768989|42099987|FG001|Prior to Week 24|Lost to Follow-up|1|||
19650520|NCT00768989|42099986|FG000|Prior to Week 24|Protocol Violation|0|||
19650521|NCT00768989|42099987|FG001|Prior to Week 24|Protocol Violation|2|||
19650522|NCT00768989|42099986|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
19650523|NCT00768989|42099987|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
19650524|NCT00768989|42099986|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
19650525|NCT00768989|42099987|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
19650526|NCT00768989|42099986|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
19650527|NCT00768989|42099987|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
19650528|NCT00768989|42099986|FG000|On or After Week 36|Lack of Efficacy|1|||
19650529|NCT00768989|42099987|FG001|On or After Week 36|Lack of Efficacy|0|||
19650530|NCT00768989|42099986|FG000|On or After Week 36|Adverse Event|0|||
19650531|NCT00768989|42099987|FG001|On or After Week 36|Adverse Event|1|||
19650532|NCT00768989|42099986|FG000|On or After Week 36|Lost to Follow-up|1|||
19650533|NCT00768989|42099987|FG001|On or After Week 36|Lost to Follow-up|0|||
19650534|NCT00768989|42099986|FG000|On or After Week 36|Poor Compliance|1|||
19751332|NCT03264066|42200478|FG004|Overall Study|Withdrawal by Subject|0|||
19751333|NCT03264066|42200479|FG005|Overall Study|Withdrawal by Subject|0|||
19751334|NCT03759041|42200497|FG000|Overall Study|Withdrawal by Subject|4|||
19751335|NCT03759041|42200498|FG001|Overall Study|Withdrawal by Subject|10|||
19751336|NCT03759041|42200499|FG002|Overall Study|Withdrawal by Subject|10|||
19751337|NCT03759041|42200497|FG000|Overall Study|Adverse Event|1|||
19751338|NCT03759041|42200498|FG001|Overall Study|Adverse Event|3|||
19751339|NCT03759041|42200499|FG002|Overall Study|Adverse Event|4|||
19751340|NCT03759041|42200497|FG000|Overall Study|Lack of Efficacy|0|||
19751341|NCT03759041|42200498|FG001|Overall Study|Lack of Efficacy|0|||
19751342|NCT03759041|42200499|FG002|Overall Study|Lack of Efficacy|1|||
19751343|NCT03759041|42200497|FG000|Overall Study|Study Terminated by Sponsor|15|||
19751344|NCT03759041|42200498|FG001|Overall Study|Study Terminated by Sponsor|16|||
19751345|NCT03759041|42200499|FG002|Overall Study|Study Terminated by Sponsor|10|||
19751346|NCT03759041|42200497|FG000|Overall Study|Other reason for discontinuation|0|||
19751347|NCT03759041|42200498|FG001|Overall Study|Other reason for discontinuation|2|||
19751348|NCT03759041|42200499|FG002|Overall Study|Other reason for discontinuation|1|||
19751349|NCT03759041|42200497|FG000|Overall Study|Lost to Follow-up|7|||
19650535|NCT00768989|42099987|FG001|On or After Week 36|Poor Compliance|0|||
19650536|NCT00768989|42099986|FG000|On or After Week 36|Protocol Violation|1|||
19650537|NCT00768989|42099987|FG001|On or After Week 36|Protocol Violation|0|||
19650538|NCT00768989|42099986|FG000|On or After Week 36|Did not attend termination visit|2|||
19650539|NCT00768989|42099987|FG001|On or After Week 36|Did not attend termination visit|0|||
19650540|NCT00768989|42099986|FG000|On or After Week 36|Sponsor Termination|45|||
19650541|NCT00768989|42099987|FG001|On or After Week 36|Sponsor Termination|26|||
19751350|NCT03759041|42200498|FG001|Overall Study|Lost to Follow-up|2|||
19751351|NCT03759041|42200499|FG002|Overall Study|Lost to Follow-up|2|||
19751352|NCT03759041|42200497|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
19751353|NCT03759041|42200498|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
19650542|NCT00305773|42099997|FG000|Overall Study|Death|3|||
19650543|NCT00305773|42099998|FG001|Overall Study|Death|2|||
19650544|NCT00305773|42099997|FG000|Overall Study|Adverse Event|1|||
19650545|NCT00305773|42099998|FG001|Overall Study|Adverse Event|2|||
19650546|NCT00305773|42099997|FG000|Overall Study|Alternative Treatment|4|||
19650547|NCT00305773|42099998|FG001|Overall Study|Alternative Treatment|4|||
19650548|NCT00305773|42099997|FG000|Overall Study|Physician Decision|1|||
19650549|NCT00305773|42099998|FG001|Overall Study|Physician Decision|1|||
19650550|NCT00305773|42099997|FG000|Overall Study|Withdrawal by Subject|1|||
19650551|NCT00305773|42099998|FG001|Overall Study|Withdrawal by Subject|4|||
19650552|NCT00305773|42099997|FG000|Overall Study|Disease Progression|1|||
19650553|NCT00305773|42099998|FG001|Overall Study|Disease Progression|3|||
19650554|NCT00305773|42099997|FG000|Overall Study|All other reasons|3|||
19650555|NCT00305773|42099998|FG001|Overall Study|All other reasons|2|||
19650556|NCT00305695|42100006|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
19650557|NCT00305695|42100007|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
19650558|NCT00305695|42100006|FG000|Overall Study|Did not have baseline scan|1|||
19650559|NCT00305695|42100007|FG001|Overall Study|Did not have baseline scan|1|||
19650560|NCT00647556|42100015|FG000|Overall Study|Adverse Event|0|||
19650561|NCT00647556|42100016|FG001|Overall Study|Adverse Event|1|||
19650562|NCT00647556|42100015|FG000|Overall Study|Lost to Follow-up|1|||
19650563|NCT00647556|42100016|FG001|Overall Study|Lost to Follow-up|0|||
19650564|NCT00647556|42100015|FG000|Overall Study|Protocol Violation|0|||
19650565|NCT00647556|42100016|FG001|Overall Study|Protocol Violation|1|||
19650566|NCT00647556|42100015|FG000|Overall Study|Withdrawal by Subject|1|||
19650567|NCT00647556|42100016|FG001|Overall Study|Withdrawal by Subject|0|||
19650568|NCT00647556|42100015|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
19650569|NCT00647556|42100016|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
19650570|NCT00320593|42100024|FG000|Overall Study|Lost to Follow-up|3|||
19650571|NCT00320593|42100025|FG001|Overall Study|Lost to Follow-up|0|||
19751354|NCT03759041|42200499|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
19751355|NCT04110145|42200512|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
19650572|NCT00320593|42100024|FG000|Overall Study|Moved to another state|1|||
19650573|NCT00320593|42100025|FG001|Overall Study|Moved to another state|0|||
19650574|NCT00320593|42100024|FG000|Overall Study|Withdrawal by Subject|2|||
19650575|NCT00320593|42100025|FG001|Overall Study|Withdrawal by Subject|1|||
19650576|NCT00320593|42100024|FG000|Overall Study|Withdrawal by clinical center|1|||
19650577|NCT00320593|42100025|FG001|Overall Study|Withdrawal by clinical center|0|||
19650578|NCT00320515|42100031|FG000|Overall Study|Death|33|||
19650579|NCT00320515|42100031|FG000|Overall Study|Lost to Follow-up|6|||
19650580|NCT00320515|42100031|FG000|Overall Study|Physician Decision|2|||
19650581|NCT00320515|42100031|FG000|Overall Study|Withdrawal by Subject|8|||
19650582|NCT00662012|42100035|FG000|Overall Study|Lost to Follow-up|85|||
19650583|NCT00662012|42100035|FG000|Overall Study|Death|1|||
19650584|NCT00662012|42100035|FG000|Overall Study|Withdrawal by Subject|1|||
19650585|NCT00661778|42100039|FG000|Overall Study|Disease Progression|23|||
19650586|NCT00661778|42100039|FG000|Overall Study|Adverse Event|18|||
19650587|NCT00661778|42100039|FG000|Overall Study|Reason not Specified|6|||
19650588|NCT00661778|42100039|FG000|Overall Study|Protocol Violation|2|||
19650589|NCT00661778|42100039|FG000|Overall Study|Withdrawal of Consent|1|||
19650590|NCT00319735|42100043|FG000|Overall Study|Death|2|||
19650591|NCT00653328|42100048|FG000|Overall Study|Withdrawal by Subject|1|||
19650592|NCT00653328|42100048|FG000|Overall Study|Adverse Event|2|||
19650593|NCT00653328|42100048|FG000|Overall Study|Disease progression|10|||
19650594|NCT00653328|42100048|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
19650595|NCT00642642|42100061|FG000|Treatment & Follow Up|Adverse Event|2|||
19650596|NCT00642642|42100061|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
19650597|NCT00642642|42100061|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
19650598|NCT00534352|42100071|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
19650599|NCT00534352|42100071|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
19650600|NCT00534352|42100071|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
19650601|NCT00534352|42100071|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
19650602|NCT00534352|42100071|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
19650603|NCT00534352|42100071|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
19650604|NCT00642174|42100086|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
19650605|NCT00642174|42100087|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
19650606|NCT00665366|42100095|FG000|Overall Study|Lack of Efficacy|11|||
19650607|NCT00665366|42100096|FG001|Overall Study|Lack of Efficacy|10|||
19650608|NCT00665366|42100095|FG000|Overall Study|Adverse Event|25|||
19650609|NCT00665366|42100096|FG001|Overall Study|Adverse Event|23|||
19650610|NCT00665366|42100095|FG000|Overall Study|Withdrawal by Subject|11|||
19650611|NCT00665366|42100096|FG001|Overall Study|Withdrawal by Subject|14|||
19650612|NCT00665366|42100095|FG000|Overall Study|Lost to Follow-up|3|||
19650613|NCT00665366|42100096|FG001|Overall Study|Lost to Follow-up|5|||
19650614|NCT00665366|42100095|FG000|Overall Study|Poor compliance/noncompliance|3|||
19650615|NCT00665366|42100096|FG001|Overall Study|Poor compliance/noncompliance|5|||
19650616|NCT00665366|42100095|FG000|Overall Study|Pregnancy|1|||
19650617|NCT00665366|42100096|FG001|Overall Study|Pregnancy|0|||
19650618|NCT00665366|42100095|FG000|Overall Study|No longer meets study criteria|0|||
19650619|NCT00665366|42100096|FG001|Overall Study|No longer meets study criteria|1|||
19650620|NCT00665366|42100095|FG000|Overall Study|Other reasons|4|||
19650621|NCT00665366|42100096|FG001|Overall Study|Other reasons|1|||
19650622|NCT00642018|42100126|FG000|Overall Study|Adverse Event|11|||
19650623|NCT00642018|42100127|FG001|Overall Study|Adverse Event|36|||
19650624|NCT00642018|42100126|FG000|Overall Study|Withdrawal by Subject|4|||
19650625|NCT00642018|42100127|FG001|Overall Study|Withdrawal by Subject|10|||
19650626|NCT00642018|42100126|FG000|Overall Study|Progressive Disease|13|||
19650627|NCT00642018|42100127|FG001|Overall Study|Progressive Disease|18|||
19650628|NCT00642018|42100126|FG000|Overall Study|Physician Decision|0|||
19650629|NCT00642018|42100127|FG001|Overall Study|Physician Decision|10|||
19650630|NCT00642018|42100126|FG000|Overall Study|Protocol Violation|0|||
19650631|NCT00642018|42100127|FG001|Overall Study|Protocol Violation|1|||
19650632|NCT00642018|42100126|FG000|Overall Study|Death|0|||
19650633|NCT00642018|42100127|FG001|Overall Study|Death|3|||
19650634|NCT00642018|42100126|FG000|Overall Study|Entry Criteria Not Met|0|||
19650635|NCT00642018|42100127|FG001|Overall Study|Entry Criteria Not Met|1|||
19650636|NCT00532948|42100137|FG000|Overall Study|Protocol Violation|1|||
19650637|NCT00532948|42100138|FG001|Overall Study|Protocol Violation|0|||
19650638|NCT00532948|42100139|FG002|Overall Study|Protocol Violation|0|||
19650639|NCT00532948|42100137|FG000|Overall Study|Death|3|||
19650640|NCT00532948|42100138|FG001|Overall Study|Death|3|||
19650641|NCT00532948|42100139|FG002|Overall Study|Death|4|||
19650642|NCT00532948|42100137|FG000|Overall Study|Violation of selection criteria at entry|0|||
19650643|NCT00532948|42100138|FG001|Overall Study|Violation of selection criteria at entry|1|||
19650644|NCT00532948|42100139|FG002|Overall Study|Violation of selection criteria at entry|0|||
19650645|NCT00532948|42100137|FG000|Overall Study|Failure to return|0|||
19650646|NCT00532948|42100138|FG001|Overall Study|Failure to return|1|||
19650647|NCT00532948|42100139|FG002|Overall Study|Failure to return|0|||
19650648|NCT00641706|42100153|FG000|Overall Study|Adverse Event|2|||
19650649|NCT00641706|42100154|FG001|Overall Study|Adverse Event|1|||
19650650|NCT00641706|42100153|FG000|Overall Study|Withdrawal by Subject|6|||
19650651|NCT00641706|42100154|FG001|Overall Study|Withdrawal by Subject|1|||
19650652|NCT00641706|42100153|FG000|Overall Study|Clinical Decline|1|||
19650653|NCT00641706|42100154|FG001|Overall Study|Clinical Decline|0|||
19650654|NCT00641706|42100153|FG000|Overall Study|Lead Investigator Decision|0|||
19650655|NCT00641706|42100154|FG001|Overall Study|Lead Investigator Decision|1|||
19650656|NCT00644358|42100160|FG000|Overall Study|Adverse Event|124|||
19650657|NCT00644358|42100160|FG000|Overall Study|Lost to Follow-up|105|||
19650658|NCT00644358|42100160|FG000|Overall Study|Consent Withdrawal|64|||
19650659|NCT00644358|42100160|FG000|Overall Study|Lack of Effectiveness|39|||
19650660|NCT00644358|42100160|FG000|Overall Study|Protocol Violation|5|||
19650661|NCT00644358|42100160|FG000|Overall Study|Noncompliance|14|||
19650662|NCT00644358|42100160|FG000|Overall Study|Other Unspecified|11|||
19650663|NCT00640926|42100167|FG000|Overall Study|Adverse Event|2|||
19650664|NCT00640926|42100168|FG001|Overall Study|Adverse Event|3|||
19650665|NCT00640926|42100169|FG002|Overall Study|Adverse Event|2|||
19650666|NCT00640926|42100167|FG000|Overall Study|Lack of Efficacy|0|||
19650667|NCT00640926|42100168|FG001|Overall Study|Lack of Efficacy|2|||
19650668|NCT00640926|42100169|FG002|Overall Study|Lack of Efficacy|1|||
19650669|NCT00640926|42100167|FG000|Overall Study|Protocol Violation|2|||
19650670|NCT00640926|42100168|FG001|Overall Study|Protocol Violation|0|||
19650671|NCT00640926|42100169|FG002|Overall Study|Protocol Violation|2|||
19650672|NCT00640926|42100167|FG000|Overall Study|Lost to Follow-up|3|||
19650673|NCT00640926|42100168|FG001|Overall Study|Lost to Follow-up|1|||
19650674|NCT00640926|42100169|FG002|Overall Study|Lost to Follow-up|2|||
19650675|NCT00640926|42100167|FG000|Overall Study|Withdrawal by Subject|1|||
19650676|NCT00640926|42100168|FG001|Overall Study|Withdrawal by Subject|0|||
19650677|NCT00640926|42100169|FG002|Overall Study|Withdrawal by Subject|1|||
19650678|NCT03892564|42100177|FG000|Overall Study|Withdrawal by Subject|2|||
19650679|NCT03891862|42100184|FG000|Open-label Period|Adverse Event|2|||
19650680|NCT03891862|42100185|FG001|Open-label Period|Adverse Event|0|||
19650681|NCT03891862|42100186|FG002|Open-label Period|Adverse Event|0|||
19650682|NCT03891862|42100184|FG000|Open-label Period|Protocol Violation|5|||
19650683|NCT03891862|42100185|FG001|Open-label Period|Protocol Violation|0|||
19650684|NCT03891862|42100186|FG002|Open-label Period|Protocol Violation|0|||
19650685|NCT03891862|42100184|FG000|Open-label Period|Withdrawal by Subject|6|||
19650686|NCT03891862|42100185|FG001|Open-label Period|Withdrawal by Subject|0|||
19650687|NCT03891862|42100186|FG002|Open-label Period|Withdrawal by Subject|0|||
19650688|NCT03891862|42100184|FG000|Open-label Period|Death|1|||
19650689|NCT03891862|42100185|FG001|Open-label Period|Death|0|||
19650690|NCT03891862|42100186|FG002|Open-label Period|Death|0|||
19650691|NCT03891862|42100184|FG000|Open-label Period|Lost to Follow-up|2|||
19650692|NCT03891862|42100185|FG001|Open-label Period|Lost to Follow-up|0|||
19650693|NCT03891862|42100186|FG002|Open-label Period|Lost to Follow-up|0|||
19650694|NCT03891862|42100184|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
19650695|NCT03891862|42100185|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
19650696|NCT03891862|42100186|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
19650697|NCT03891862|42100184|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
19650698|NCT03891862|42100185|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
19650699|NCT03891862|42100186|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
19650700|NCT03891862|42100184|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
19650701|NCT03891862|42100185|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
19650702|NCT03891862|42100186|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
19650703|NCT03891862|42100184|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
19650704|NCT03891862|42100185|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
19650705|NCT03891862|42100186|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
19650706|NCT00640614|42100195|FG000|Overall Study|Lost to Follow-up|1|||
19650707|NCT00640614|42100196|FG001|Overall Study|Lost to Follow-up|0|||
19650708|NCT00761657|42100234|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
19650709|NCT00761657|42100235|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
19650710|NCT00761657|42100236|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
19650711|NCT00761657|42100237|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
19650712|NCT00761657|42100238|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
19650713|NCT00761657|42100239|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
19650714|NCT00761657|42100240|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
19650715|NCT00761657|42100241|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
19650716|NCT00761657|42100242|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
19650717|NCT00761657|42100234|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650718|NCT00761657|42100235|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650719|NCT00761657|42100236|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
19650720|NCT00761657|42100237|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
19650721|NCT00761657|42100238|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650722|NCT00761657|42100239|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650723|NCT00761657|42100240|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650724|NCT00761657|42100241|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650725|NCT00761657|42100242|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
19650726|NCT00761657|42100234|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
19650727|NCT00761657|42100235|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
19650728|NCT00761657|42100236|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
19650729|NCT00761657|42100237|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
19650730|NCT00761657|42100238|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
19650731|NCT00761657|42100239|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
19650732|NCT00761657|42100240|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
19650733|NCT00761657|42100241|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
19650734|NCT00761657|42100242|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
19650735|NCT00761657|42100234|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
19650736|NCT00761657|42100235|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
19650737|NCT00761657|42100236|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
19650738|NCT00761657|42100237|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
19650739|NCT00761657|42100238|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
19650740|NCT00761657|42100239|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
19650741|NCT00761657|42100240|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
19650742|NCT00761657|42100241|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
19601000|NCT01072175|42049720|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19601001|NCT01072175|42049721|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19601002|NCT01072175|42049722|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19601003|NCT01072175|42049723|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
19601004|NCT01072175|42049711|FG000|Part D (HPMC Capsules)|Death|0|||
19601005|NCT01072175|42049712|FG001|Part D (HPMC Capsules)|Death|0|||
19601006|NCT01072175|42049713|FG002|Part D (HPMC Capsules)|Death|0|||
19601007|NCT01072175|42049714|FG003|Part D (HPMC Capsules)|Death|0|||
19601008|NCT01072175|42049715|FG004|Part D (HPMC Capsules)|Death|0|||
19601009|NCT01072175|42049716|FG005|Part D (HPMC Capsules)|Death|0|||
19601010|NCT01072175|42049717|FG006|Part D (HPMC Capsules)|Death|0|||
19601011|NCT01072175|42049718|FG007|Part D (HPMC Capsules)|Death|0|||
19601012|NCT01072175|42049719|FG008|Part D (HPMC Capsules)|Death|0|||
19601013|NCT01072175|42049720|FG009|Part D (HPMC Capsules)|Death|10|||
19601014|NCT01072175|42049721|FG010|Part D (HPMC Capsules)|Death|12|||
19601015|NCT01072175|42049722|FG011|Part D (HPMC Capsules)|Death|28|||
19601016|NCT01072175|42049723|FG012|Part D (HPMC Capsules)|Death|26|||
19601017|NCT01072175|42049711|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
19601018|NCT01072175|42049712|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
19601019|NCT01072175|42049713|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
19601020|NCT01072175|42049714|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
19601021|NCT01072175|42049715|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
19601022|NCT01072175|42049716|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
19601023|NCT01072175|42049717|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
19601024|NCT01072175|42049718|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
19601025|NCT01072175|42049719|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
19601026|NCT01072175|42049720|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
19601027|NCT01072175|42049721|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
19601028|NCT01072175|42049722|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
19601029|NCT01072175|42049723|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
19601030|NCT01072175|42049711|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601031|NCT01072175|42049712|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601032|NCT01072175|42049713|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601033|NCT01072175|42049714|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601034|NCT01072175|42049715|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601035|NCT01072175|42049716|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601036|NCT01072175|42049717|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19650743|NCT00761657|42100242|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
19650744|NCT00319501|42100274|FG000|Double-blind Period|Withdrawal by Subject|0|||
19650745|NCT00319501|42100275|FG001|Double-blind Period|Withdrawal by Subject|3|||
19650746|NCT00319501|42100274|FG000|Double-blind Period|Sponsor Request|1|||
19650747|NCT00319501|42100275|FG001|Double-blind Period|Sponsor Request|0|||
19650748|NCT00319501|42100274|FG000|Double-blind Period|Did not receive treatment|42|||
19650749|NCT00319501|42100275|FG001|Double-blind Period|Did not receive treatment|29|||
19650750|NCT00319501|42100274|FG000|Open-label Period|Adverse Event|5|||
19650751|NCT00319501|42100275|FG001|Open-label Period|Adverse Event|0|||
19650752|NCT00319501|42100274|FG000|Open-label Period|Protocol Violation|6|||
19650753|NCT00319501|42100275|FG001|Open-label Period|Protocol Violation|0|||
19650754|NCT00319501|42100274|FG000|Open-label Period|Withdrawal by Subject|38|||
19650755|NCT00319501|42100275|FG001|Open-label Period|Withdrawal by Subject|0|||
19650756|NCT00319501|42100274|FG000|Open-label Period|Principal Investigator decision|6|||
19650757|NCT00319501|42100275|FG001|Open-label Period|Principal Investigator decision|0|||
19650758|NCT00319501|42100274|FG000|Open-label Period|Sponsor request|12|||
19650759|NCT00319501|42100275|FG001|Open-label Period|Sponsor request|0|||
19650760|NCT00319501|42100274|FG000|Open-label Period|Lost to Follow-up|5|||
19650761|NCT00319501|42100275|FG001|Open-label Period|Lost to Follow-up|0|||
19650762|NCT00319501|42100274|FG000|Open-label Period|Did not receive treatment|33|||
19650763|NCT00319501|42100275|FG001|Open-label Period|Did not receive treatment|0|||
19650764|NCT00319501|42100274|FG000|Open-label Period|Other|11|||
19650765|NCT00319501|42100275|FG001|Open-label Period|Other|0|||
19650766|NCT00319501|42100274|FG000|Open-label Extension Period|Adverse Event|2|||
19650767|NCT00319501|42100275|FG001|Open-label Extension Period|Adverse Event|0|||
19650768|NCT00319501|42100274|FG000|Open-label Extension Period|Did not receive treatment|18|||
19650769|NCT00319501|42100275|FG001|Open-label Extension Period|Did not receive treatment|0|||
19650770|NCT00319501|42100274|FG000|Open-label Extension Period|Other|1|||
19650771|NCT00319501|42100275|FG001|Open-label Extension Period|Other|0|||
19650772|NCT00319501|42100274|FG000|Open-label Extension Period|Principal investigator decision|2|||
19650773|NCT00319501|42100275|FG001|Open-label Extension Period|Principal investigator decision|0|||
19650774|NCT00319501|42100274|FG000|Open-label Extension Period|Sponsor request|26|||
19650775|NCT00319501|42100275|FG001|Open-label Extension Period|Sponsor request|0|||
19650776|NCT00319501|42100274|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
19601037|NCT01072175|42049718|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601038|NCT01072175|42049719|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19601039|NCT01072175|42049720|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
19650777|NCT00319501|42100275|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
19650778|NCT00761579|42100286|FG000|Overall Study|Adverse Event|10|||
19650779|NCT00761579|42100286|FG000|Overall Study|Death|2|||
19650780|NCT00761579|42100286|FG000|Overall Study|Lack of Efficacy|21|||
19650781|NCT00761579|42100286|FG000|Overall Study|Lost to Follow-up|16|||
19650782|NCT00761579|42100286|FG000|Overall Study|Pregnancy|1|||
19650783|NCT00761579|42100286|FG000|Overall Study|Withdrawal by Subject|34|||
19650784|NCT00761579|42100286|FG000|Overall Study|Lack of compliance|2|||
19650785|NCT00761579|42100286|FG000|Overall Study|Protocol deviation|1|||
19650786|NCT00761579|42100286|FG000|Overall Study|Drug overdose|1|||
19650787|NCT00761579|42100286|FG000|Overall Study|Aggravation of depression|1|||
19650788|NCT00761579|42100286|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
19650789|NCT00761579|42100286|FG000|Overall Study|Lost survey form|1|||
19650790|NCT00761579|42100286|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
19650791|NCT00627042|42100292|FG000|Overall Study|Withdrawal by Subject|2|||
19601040|NCT01072175|42049721|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
19601041|NCT01072175|42049722|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
19601042|NCT01072175|42049723|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
19601043|NCT01072175|42049711|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601044|NCT01072175|42049712|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601045|NCT01072175|42049713|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601046|NCT01072175|42049714|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601047|NCT01072175|42049715|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601048|NCT01072175|42049716|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601049|NCT01072175|42049717|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601050|NCT01072175|42049718|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601051|NCT01072175|42049719|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
19601052|NCT01072175|42049720|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
19601053|NCT01072175|42049721|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
19601054|NCT01072175|42049722|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
19601055|NCT01072175|42049723|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
19601056|NCT01072175|42049711|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601057|NCT01072175|42049712|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601058|NCT01072175|42049713|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601059|NCT01072175|42049714|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601060|NCT01072175|42049715|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601061|NCT01072175|42049716|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601062|NCT01072175|42049717|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601063|NCT01072175|42049718|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601064|NCT01072175|42049719|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601065|NCT01072175|42049720|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601066|NCT01072175|42049721|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
19601067|NCT01072175|42049722|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
19601068|NCT01072175|42049723|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
19601069|NCT01071317|42049757|FG000|Overall Study|Lost to Follow-up|2|||
19601070|NCT01071317|42049758|FG001|Overall Study|Lost to Follow-up|2|||
19601071|NCT00783094|42049775|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
19601072|NCT00783094|42049776|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
19601073|NCT00783094|42049777|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
19601074|NCT00783094|42049775|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
19601075|NCT00783094|42049776|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
19601076|NCT00783094|42049777|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
19601077|NCT00783094|42049775|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
19601078|NCT00783094|42049776|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
19601079|NCT00783094|42049777|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
19650792|NCT00319111|42100296|FG000|Overall Study|Adverse Event|20|||
19650793|NCT00319111|42100296|FG000|Overall Study|Withdrawal of consent|11|||
19650794|NCT00319111|42100296|FG000|Overall Study|Death|9|||
19650795|NCT00319111|42100296|FG000|Overall Study|Lack of clinical improvement|4|||
19650796|NCT00319111|42100296|FG000|Overall Study|Administrative|2|||
19650797|NCT00319111|42100296|FG000|Overall Study|Treatment failure|1|||
19650798|NCT00640224|42100304|FG000|Overall Study|Lost to Follow-up|5|||
19650799|NCT00640224|42100305|FG001|Overall Study|Lost to Follow-up|2|||
19650800|NCT00640224|42100306|FG002|Overall Study|Lost to Follow-up|0|||
19650801|NCT00640224|42100307|FG003|Overall Study|Lost to Follow-up|0|||
19650802|NCT00640224|42100304|FG000|Overall Study|Withdrawal by Subject|1|||
19650803|NCT00640224|42100305|FG001|Overall Study|Withdrawal by Subject|0|||
19650804|NCT00640224|42100306|FG002|Overall Study|Withdrawal by Subject|0|||
19650805|NCT00640224|42100307|FG003|Overall Study|Withdrawal by Subject|0|||
19650806|NCT00640224|42100304|FG000|Overall Study|Headaches|0|||
19650807|NCT00640224|42100305|FG001|Overall Study|Headaches|1|||
19650808|NCT00640224|42100306|FG002|Overall Study|Headaches|0|||
19650809|NCT00640224|42100307|FG003|Overall Study|Headaches|0|||
19650810|NCT00318643|42100322|FG000|Overall Study|Adverse Event|0|||
19650811|NCT00318643|42100323|FG001|Overall Study|Adverse Event|0|||
19650812|NCT00318643|42100324|FG002|Overall Study|Adverse Event|0|||
19650813|NCT00318643|42100325|FG003|Overall Study|Adverse Event|0|||
19650814|NCT00318643|42100326|FG004|Overall Study|Adverse Event|1|||
19650815|NCT00318643|42100322|FG000|Overall Study|Participant's Decision|0|||
19650816|NCT00318643|42100323|FG001|Overall Study|Participant's Decision|0|||
19650817|NCT00318643|42100324|FG002|Overall Study|Participant's Decision|0|||
19650818|NCT00318643|42100325|FG003|Overall Study|Participant's Decision|0|||
19650819|NCT00318643|42100326|FG004|Overall Study|Participant's Decision|1|||
19650820|NCT00318643|42100322|FG000|Overall Study|Investigator's Decision|0|||
19650821|NCT00318643|42100323|FG001|Overall Study|Investigator's Decision|0|||
19650822|NCT00318643|42100324|FG002|Overall Study|Investigator's Decision|0|||
19650823|NCT00318643|42100325|FG003|Overall Study|Investigator's Decision|0|||
19650824|NCT00318643|42100326|FG004|Overall Study|Investigator's Decision|1|||
19650825|NCT00318565|42100339|FG000|Overall Study|Excluded per protocol|24|||
19650826|NCT00304915|42100345|FG000|Overall Study|Lost to Follow-up|11|||
19650827|NCT00304915|42100346|FG001|Overall Study|Lost to Follow-up|11|||
19650828|NCT00304915|42100345|FG000|Overall Study|Death|4|||
19650829|NCT00304915|42100346|FG001|Overall Study|Death|5|||
19650830|NCT00304915|42100345|FG000|Overall Study|Withdrawal by Subject|3|||
19650831|NCT00304915|42100346|FG001|Overall Study|Withdrawal by Subject|0|||
19650832|NCT03687970|42100354|FG000|Overall Study|visit scheduling conflicts|2|||
19650833|NCT03687970|42100355|FG001|Overall Study|visit scheduling conflicts|0|||
19650834|NCT00530920|42100366|FG000|Overall Study|Randomized but not treated|0|||
19650835|NCT00530920|42100367|FG001|Overall Study|Randomized but not treated|2|||
19650836|NCT00530920|42100368|FG002|Overall Study|Randomized but not treated|0|||
19650837|NCT00530920|42100366|FG000|Overall Study|Adverse Event|0|||
19650838|NCT00530920|42100367|FG001|Overall Study|Adverse Event|0|||
19650839|NCT00530920|42100368|FG002|Overall Study|Adverse Event|3|||
19751356|NCT04110145|42200513|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
19650840|NCT00530920|42100366|FG000|Overall Study|Withdrawal by Subject|0|||
19650841|NCT00530920|42100367|FG001|Overall Study|Withdrawal by Subject|0|||
19650842|NCT00530920|42100368|FG002|Overall Study|Withdrawal by Subject|1|||
19650843|NCT03878758|42100377|FG000|Overall Study|Withdrawal by Subject|1|||
19650844|NCT03878758|42100377|FG000|Overall Study|Protocol defined|2|||
19650845|NCT03878758|42100377|FG000|Overall Study|Improper consent documentation|1|||
19650846|NCT03878602|42100392|FG000|Overall Study|cord blood donation|7|||
19650847|NCT03878602|42100393|FG001|Overall Study|cord blood donation|1|||
19650848|NCT03878602|42100392|FG000|Overall Study|incomplete data collection|2|||
19650849|NCT03878602|42100393|FG001|Overall Study|incomplete data collection|0|||
19650850|NCT00768755|42100405|FG000|Phase 1|Death|6|||
19650851|NCT00768755|42100406|FG001|Phase 1|Death|0|||
19650852|NCT00768755|42100407|FG002|Phase 1|Death|0|||
19650853|NCT00768755|42100408|FG003|Phase 1|Death|0|||
19650854|NCT00768755|42100405|FG000|Phase 1|Other|4|||
19650855|NCT00768755|42100406|FG001|Phase 1|Other|0|||
19650856|NCT00768755|42100407|FG002|Phase 1|Other|0|||
19650857|NCT00768755|42100408|FG003|Phase 1|Other|0|||
19650858|NCT00768755|42100405|FG000|Phase 2|Death|0|||
19650859|NCT00768755|42100406|FG001|Phase 2|Death|37|||
19650860|NCT00768755|42100407|FG002|Phase 2|Death|48|||
19650861|NCT00768755|42100408|FG003|Phase 2|Death|31|||
19650862|NCT00768755|42100405|FG000|Phase 2|Protocol Violation|0|||
19650863|NCT00768755|42100406|FG001|Phase 2|Protocol Violation|2|||
19650864|NCT00768755|42100407|FG002|Phase 2|Protocol Violation|0|||
19650865|NCT00768755|42100408|FG003|Phase 2|Protocol Violation|1|||
19650866|NCT00768755|42100405|FG000|Phase 2|Lost to Follow-up|0|||
19650867|NCT00768755|42100406|FG001|Phase 2|Lost to Follow-up|1|||
19650868|NCT00768755|42100407|FG002|Phase 2|Lost to Follow-up|1|||
19650869|NCT00768755|42100408|FG003|Phase 2|Lost to Follow-up|4|||
19650870|NCT00768755|42100405|FG000|Phase 2|Withdrawal by Subject|0|||
19650871|NCT00768755|42100406|FG001|Phase 2|Withdrawal by Subject|1|||
19650872|NCT00768755|42100407|FG002|Phase 2|Withdrawal by Subject|0|||
19650873|NCT00768755|42100408|FG003|Phase 2|Withdrawal by Subject|1|||
19650874|NCT00768755|42100405|FG000|Phase 2|Other|0|||
19650875|NCT00768755|42100406|FG001|Phase 2|Other|1|||
19751357|NCT04110145|42200514|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
19751358|NCT04110145|42200515|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
19751359|NCT04110145|42200516|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
19751360|NCT02477618|42200530|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
19751361|NCT02477618|42200531|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
19751362|NCT02477618|42200530|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
19650876|NCT00768755|42100407|FG002|Phase 2|Other|2|||
19650877|NCT00768755|42100408|FG003|Phase 2|Other|4|||
19650878|NCT00768755|42100405|FG000|Phase 2|Study Terminated by Sponsor|0|||
19650879|NCT00768755|42100406|FG001|Phase 2|Study Terminated by Sponsor|13|||
19650880|NCT00768755|42100407|FG002|Phase 2|Study Terminated by Sponsor|7|||
19751363|NCT02477618|42200531|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
19751364|NCT02477618|42200530|FG000|Overall Study|Adverse Event|1|||
19751365|NCT02477618|42200531|FG001|Overall Study|Adverse Event|1|||
19751366|NCT02477618|42200530|FG000|Overall Study|Transferred Away from Study Site|1|||
19751367|NCT02477618|42200531|FG001|Overall Study|Transferred Away from Study Site|0|||
19751368|NCT02477618|42200530|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
19751369|NCT02477618|42200531|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
19601080|NCT00783094|42049775|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
19601081|NCT00783094|42049776|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
19601082|NCT00783094|42049777|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
19601083|NCT00783094|42049775|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
19601084|NCT00783094|42049776|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
19601085|NCT00783094|42049777|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
19601086|NCT00783094|42049775|FG000|Open-Label Extension Period|Adverse Event|12|||
19601087|NCT00783094|42049776|FG001|Open-Label Extension Period|Adverse Event|7|||
19601088|NCT00783094|42049777|FG002|Open-Label Extension Period|Adverse Event|16|||
19601089|NCT00783094|42049775|FG000|Open-Label Extension Period|Death|0|||
19601090|NCT00783094|42049776|FG001|Open-Label Extension Period|Death|0|||
19601091|NCT00783094|42049777|FG002|Open-Label Extension Period|Death|1|||
19601092|NCT00783094|42049775|FG000|Open-Label Extension Period|Protocol Violation|4|||
19601093|NCT00783094|42049776|FG001|Open-Label Extension Period|Protocol Violation|5|||
19601094|NCT00783094|42049777|FG002|Open-Label Extension Period|Protocol Violation|7|||
19650881|NCT00768755|42100408|FG003|Phase 2|Study Terminated by Sponsor|14|||
19650882|NCT00768755|42100405|FG000|Phase 2|Randomized but not treated|0|||
19650883|NCT00768755|42100406|FG001|Phase 2|Randomized but not treated|0|||
19650884|NCT00768755|42100407|FG002|Phase 2|Randomized but not treated|0|||
19650885|NCT00768755|42100408|FG003|Phase 2|Randomized but not treated|2|||
19601095|NCT00783094|42049775|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
19601096|NCT00783094|42049776|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
19650886|NCT00530842|42100419|FG000|Overall Study|Adverse Event|10|||
19650887|NCT00530842|42100420|FG001|Overall Study|Adverse Event|6|||
19650888|NCT00530842|42100419|FG000|Overall Study|Lack of Efficacy|2|||
19650889|NCT00530842|42100420|FG001|Overall Study|Lack of Efficacy|1|||
19650890|NCT00530842|42100419|FG000|Overall Study|Lost to Follow-up|0|||
19751370|NCT04102501|42200539|FG000|Overall Study|Withdrawal by Subject|7|||
19751371|NCT04102501|42200540|FG001|Overall Study|Withdrawal by Subject|9|||
19751372|NCT04102501|42200539|FG000|Overall Study|Adverse Event|1|||
19751373|NCT04102501|42200540|FG001|Overall Study|Adverse Event|3|||
19751374|NCT03285477|42200550|FG000|Treatment and Response Assessment Period|Death|1|||
19751375|NCT03285477|42200551|FG001|Treatment and Response Assessment Period|Death|0|||
19751376|NCT03285477|42200550|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
19751377|NCT03285477|42200551|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
19751378|NCT03285477|42200550|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
19751379|NCT03285477|42200551|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
19751380|NCT03285477|42200550|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
19751381|NCT03285477|42200551|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
19751382|NCT03285477|42200550|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
19751383|NCT03285477|42200551|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
19751384|NCT04289623|42200568|FG000|Wave 1 Emails|Email was not delivered|268|||
19751385|NCT04289623|42200569|FG001|Wave 1 Emails|Email was not delivered|257|||
19751386|NCT04289623|42200570|FG002|Wave 1 Emails|Email was not delivered|0|||
19751387|NCT04289623|42200571|FG003|Wave 1 Emails|Email was not delivered|0|||
19751388|NCT04289623|42200572|FG004|Wave 1 Emails|Email was not delivered|0|||
19751389|NCT04289623|42200573|FG005|Wave 1 Emails|Email was not delivered|0|||
19751390|NCT03248037|42200589|FG000|Overall Study|Withdrawal by Subject|6|||
19751391|NCT03248037|42200590|FG001|Overall Study|Withdrawal by Subject|9|||
19751392|NCT03248037|42200589|FG000|Overall Study|Adverse Event|15|||
19751393|NCT03248037|42200590|FG001|Overall Study|Adverse Event|0|||
19751394|NCT04287517|42200605|FG000|Overall Study|Withdrawal by Subject|1|||
19751395|NCT04287517|42200606|FG001|Overall Study|Withdrawal by Subject|1|||
19751396|NCT03284229|42200612|FG000|Overall Study|Lost to Follow-up|3|||
19751397|NCT03242928|42200619|FG000|Overall Study|Adverse Event|2|||
19751398|NCT03242928|42200620|FG001|Overall Study|Adverse Event|1|||
19751399|NCT03242928|42200619|FG000|Overall Study|Lost to Follow-up|2|||
19751400|NCT03242928|42200620|FG001|Overall Study|Lost to Follow-up|0|||
19751401|NCT03242928|42200619|FG000|Overall Study|Physician Decision|0|||
19751402|NCT03242928|42200620|FG001|Overall Study|Physician Decision|1|||
19751403|NCT03242928|42200619|FG000|Overall Study|Withdrawal by Subject|5|||
19751404|NCT03242928|42200620|FG001|Overall Study|Withdrawal by Subject|3|||
19751405|NCT03300024|42200628|FG000|Overall Study|Physician Decision|4|||
19751406|NCT03300024|42200629|FG001|Overall Study|Physician Decision|6|||
19751407|NCT04276207|42200637|FG000|Period 1|Withdrawal by Subject|0|||
19751408|NCT04276207|42200638|FG001|Period 1|Withdrawal by Subject|1|||
19751409|NCT03240081|42200646|FG000|Overall Study|Withdrawal by Subject|0|||
19751410|NCT03240081|42200647|FG001|Overall Study|Withdrawal by Subject|2|||
19751411|NCT03240081|42200646|FG000|Overall Study|Lost to Follow-up|0|||
19751412|NCT03240081|42200647|FG001|Overall Study|Lost to Follow-up|1|||
19751413|NCT03282357|42200653|FG000|Overall Study|Lost to Follow-up|3|||
19751414|NCT03282357|42200653|FG000|Overall Study|Withdrawal by Subject|4|||
19751415|NCT03282357|42200653|FG000|Overall Study|Adverse Event|1|||
19751416|NCT03282357|42200653|FG000|Overall Study|Other|9|||
19751417|NCT04272775|42200660|FG000|Overall Study|Study Terminated by Sponsor|1|||
19751418|NCT04272775|42200661|FG001|Overall Study|Study Terminated by Sponsor|0|||
19751419|NCT04272775|42200660|FG000|Overall Study|Protocol Violation|0|||
19751420|NCT04272775|42200661|FG001|Overall Study|Protocol Violation|1|||
19751421|NCT04272775|42200660|FG000|Overall Study|Symptomatic Deterioration|1|||
19751422|NCT04272775|42200661|FG001|Overall Study|Symptomatic Deterioration|1|||
19751423|NCT04272775|42200660|FG000|Overall Study|Withdrawal by Subject|1|||
19751424|NCT04272775|42200661|FG001|Overall Study|Withdrawal by Subject|2|||
19751425|NCT04272775|42200660|FG000|Overall Study|Adverse Event|1|||
19751426|NCT04272775|42200661|FG001|Overall Study|Adverse Event|2|||
19751427|NCT04272775|42200660|FG000|Overall Study|Progressive Disease|3|||
19751428|NCT04272775|42200661|FG001|Overall Study|Progressive Disease|1|||
19751429|NCT03232983|42200667|FG000|Period 1|Physician Decision|0|||
19751430|NCT03232983|42200668|FG001|Period 1|Physician Decision|0|||
19751431|NCT03232983|42200669|FG002|Period 1|Physician Decision|1|||
19751432|NCT03232983|42200670|FG003|Period 1|Physician Decision|0|||
19751433|NCT03232983|42200667|FG000|Washout Period 2|Physician Decision|0|||
19751434|NCT03232983|42200668|FG001|Washout Period 2|Physician Decision|0|||
19751435|NCT03232983|42200669|FG002|Washout Period 2|Physician Decision|1|||
19751436|NCT03232983|42200670|FG003|Washout Period 2|Physician Decision|0|||
19751437|NCT03232983|42200667|FG000|Washout Period 2|Withdrawal by Subject|0|||
19751438|NCT03232983|42200668|FG001|Washout Period 2|Withdrawal by Subject|0|||
19751439|NCT03232983|42200669|FG002|Washout Period 2|Withdrawal by Subject|0|||
19751440|NCT03232983|42200670|FG003|Washout Period 2|Withdrawal by Subject|1|||
19751441|NCT03232983|42200667|FG000|Period 4|Withdrawal by Subject|1|||
19751442|NCT03232983|42200668|FG001|Period 4|Withdrawal by Subject|0|||
19751443|NCT03232983|42200669|FG002|Period 4|Withdrawal by Subject|0|||
19751444|NCT03232983|42200670|FG003|Period 4|Withdrawal by Subject|0|||
19751445|NCT04102345|42200684|FG000|Overall Study|Withdrawal by Subject|1|||
19751446|NCT04102345|42200685|FG001|Overall Study|Withdrawal by Subject|0|||
19751447|NCT04271605|42200691|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
19751448|NCT03299244|42200697|FG000|Overall Study|Withdrawal by Subject|34|||
19751449|NCT03299244|42200698|FG001|Overall Study|Withdrawal by Subject|29|||
19751450|NCT03299244|42200697|FG000|Overall Study|Decision by Sponsor|4|||
19751451|NCT03299244|42200698|FG001|Overall Study|Decision by Sponsor|5|||
19650891|NCT00530842|42100420|FG001|Overall Study|Lost to Follow-up|4|||
19650892|NCT00530842|42100419|FG000|Overall Study|Protocol Violation|3|||
19650893|NCT00530842|42100420|FG001|Overall Study|Protocol Violation|2|||
19650894|NCT00530842|42100419|FG000|Overall Study|Withdrawal by Subject|4|||
19650895|NCT00530842|42100420|FG001|Overall Study|Withdrawal by Subject|5|||
19650896|NCT00530842|42100419|FG000|Overall Study|Individual different reasons|4|||
19650897|NCT00530842|42100420|FG001|Overall Study|Individual different reasons|3|||
19650898|NCT00530842|42100419|FG000|Period 1|Adverse Event|7|||
19650899|NCT00530842|42100420|FG001|Period 1|Adverse Event|3|||
19650900|NCT00530842|42100419|FG000|Period 1|Lack of Efficacy|1|||
19601097|NCT00783094|42049777|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
19601098|NCT00783094|42049775|FG000|Open-Label Extension Period|Physician Decision|4|||
19601099|NCT00783094|42049776|FG001|Open-Label Extension Period|Physician Decision|2|||
19601100|NCT00783094|42049777|FG002|Open-Label Extension Period|Physician Decision|3|||
19601101|NCT00783094|42049775|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
19601102|NCT00783094|42049776|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
19601103|NCT00783094|42049777|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
19601104|NCT00790582|42049790|FG000|Overall Study|Death|14|||
19601105|NCT00790582|42049791|FG001|Overall Study|Death|32|||
19601106|NCT00790582|42049790|FG000|Overall Study|Physician Decision|7|||
19601107|NCT00790582|42049791|FG001|Overall Study|Physician Decision|1|||
19601108|NCT00790582|42049790|FG000|Overall Study|Lost to Follow-up|3|||
19601109|NCT00790582|42049791|FG001|Overall Study|Lost to Follow-up|3|||
19601110|NCT00790582|42049790|FG000|Overall Study|Withdrawal by Subject|7|||
19601111|NCT00790582|42049791|FG001|Overall Study|Withdrawal by Subject|51|||
19601112|NCT01048541|42049799|FG000|Overall Study|Withdrawal by Subject|1|||
19650901|NCT00530842|42100420|FG001|Period 1|Lack of Efficacy|1|||
19650902|NCT00530842|42100419|FG000|Period 1|Protocol Violation|2|||
19650903|NCT00530842|42100420|FG001|Period 1|Protocol Violation|1|||
19650904|NCT00530842|42100419|FG000|Period 1|Withdrawal by Subject|2|||
19650905|NCT00530842|42100420|FG001|Period 1|Withdrawal by Subject|3|||
19650906|NCT00530842|42100419|FG000|Period 1|Individual different reasons|2|||
19650907|NCT00530842|42100420|FG001|Period 1|Individual different reasons|3|||
19650908|NCT00530842|42100419|FG000|Period 2|Adverse Event|3|||
19650909|NCT00530842|42100420|FG001|Period 2|Adverse Event|3|||
19650910|NCT00530842|42100419|FG000|Period 2|Lack of Efficacy|1|||
19650911|NCT00530842|42100420|FG001|Period 2|Lack of Efficacy|0|||
19650912|NCT00530842|42100419|FG000|Period 2|Lost to Follow-up|0|||
19650913|NCT00530842|42100420|FG001|Period 2|Lost to Follow-up|4|||
19601113|NCT01048541|42049800|FG001|Overall Study|Withdrawal by Subject|0|||
19650914|NCT00530842|42100419|FG000|Period 2|Protocol Violation|1|||
19650915|NCT00530842|42100420|FG001|Period 2|Protocol Violation|0|||
19650916|NCT00530842|42100419|FG000|Period 2|Withdrawal by Subject|1|||
19650917|NCT00530842|42100420|FG001|Period 2|Withdrawal by Subject|2|||
19650918|NCT00530842|42100419|FG000|Period 2|Individual different reasons|2|||
19650919|NCT00530842|42100420|FG001|Period 2|Individual different reasons|0|||
19650920|NCT03882424|42100431|FG000|Overall Study|Lost to Follow-up|3|||
19650921|NCT03882424|42100432|FG001|Overall Study|Lost to Follow-up|0|||
19650922|NCT03882424|42100433|FG002|Overall Study|Lost to Follow-up|0|||
19650923|NCT03882424|42100431|FG000|Overall Study|schedule conflict|1|||
19650924|NCT03882424|42100432|FG001|Overall Study|schedule conflict|0|||
19650925|NCT03882424|42100433|FG002|Overall Study|schedule conflict|0|||
19650926|NCT03879772|42100446|FG000|Overall Study|Adverse Event|2|||
19650927|NCT03879772|42100447|FG001|Overall Study|Adverse Event|2|||
19650928|NCT03879772|42100448|FG002|Overall Study|Adverse Event|3|||
19650929|NCT03879772|42100449|FG003|Overall Study|Adverse Event|4|||
19650930|NCT03879772|42100450|FG004|Overall Study|Adverse Event|3|||
19650931|NCT03879772|42100446|FG000|Overall Study|Treatment Failure|1|||
19650932|NCT03879772|42100447|FG001|Overall Study|Treatment Failure|0|||
19650933|NCT03879772|42100448|FG002|Overall Study|Treatment Failure|0|||
19650934|NCT03879772|42100449|FG003|Overall Study|Treatment Failure|2|||
19751452|NCT03299244|42200697|FG000|Overall Study|Death|9|||
19751453|NCT03299244|42200698|FG001|Overall Study|Death|4|||
19751454|NCT03757715|42200707|FG000|Overall Study|Lost to Follow-up|4|||
19650935|NCT03879772|42100450|FG004|Overall Study|Treatment Failure|1|||
19650936|NCT03879772|42100446|FG000|Overall Study|Lost to Follow-up|0|||
19650937|NCT03879772|42100447|FG001|Overall Study|Lost to Follow-up|0|||
19650938|NCT03879772|42100448|FG002|Overall Study|Lost to Follow-up|0|||
19650939|NCT03879772|42100449|FG003|Overall Study|Lost to Follow-up|0|||
19650940|NCT03879772|42100450|FG004|Overall Study|Lost to Follow-up|1|||
19650941|NCT03879772|42100446|FG000|Overall Study|Withdrawal by Subject|0|||
19650942|NCT03879772|42100447|FG001|Overall Study|Withdrawal by Subject|1|||
19650943|NCT03879772|42100448|FG002|Overall Study|Withdrawal by Subject|3|||
19650944|NCT03879772|42100449|FG003|Overall Study|Withdrawal by Subject|1|||
19650945|NCT03879772|42100450|FG004|Overall Study|Withdrawal by Subject|1|||
19650946|NCT03879772|42100446|FG000|Overall Study|Protocol Violation|0|||
19650947|NCT03879772|42100447|FG001|Overall Study|Protocol Violation|0|||
19601114|NCT00774046|42049806|FG000|Screening|Not eligible|56|||
19601115|NCT00774046|42049806|FG000|Enrollment|Desired other therapy/refused|28|||
19601116|NCT00774046|42049806|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
19601117|NCT01046903|42049810|FG000|Overall Study|Lost to Follow-up|16|||
19601118|NCT01046903|42049810|FG000|Overall Study|Adverse Event|4|||
19601119|NCT01046903|42049810|FG000|Overall Study|Withdrawal by Subject|3|||
19601120|NCT01046903|42049810|FG000|Overall Study|Other|5|||
19601121|NCT00773968|42049814|FG000|Overall Study|Adverse Event|2|||
19601122|NCT00773968|42049814|FG000|Overall Study|Death|1|||
19601123|NCT00773968|42049814|FG000|Overall Study|Failure to Return|2|||
19601124|NCT00773968|42049814|FG000|Overall Study|Lack of Efficacy|3|||
19601125|NCT00773968|42049814|FG000|Overall Study|Protocol Violation|1|||
19601126|NCT00773968|42049814|FG000|Overall Study|Withdrawal by Subject|11|||
19601127|NCT00773968|42049814|FG000|Overall Study|Screen Failure|17|||
19601128|NCT00773968|42049814|FG000|Overall Study|Other|8|||
19601129|NCT00782626|42049818|FG000|Overall Study|Adverse Event|1|||
19601130|NCT00782626|42049818|FG000|Overall Study|Progressive Disease|5|||
19601131|NCT00782626|42049818|FG000|Overall Study|Other Complicating Disease|1|||
19601132|NCT01071083|42049827|FG000|Overall Study|Adverse Event|1|||
19601133|NCT01071083|42049828|FG001|Overall Study|Adverse Event|0|||
19601134|NCT01071083|42049829|FG002|Overall Study|Adverse Event|1|||
19601135|NCT01071083|42049830|FG003|Overall Study|Adverse Event|0|||
19601136|NCT01071083|42049831|FG004|Overall Study|Adverse Event|1|||
19601137|NCT01071083|42049827|FG000|Overall Study|Withdrawal by Subject|3|||
19601138|NCT01071083|42049828|FG001|Overall Study|Withdrawal by Subject|0|||
19601139|NCT01071083|42049829|FG002|Overall Study|Withdrawal by Subject|2|||
19601140|NCT01071083|42049830|FG003|Overall Study|Withdrawal by Subject|0|||
19601141|NCT01071083|42049831|FG004|Overall Study|Withdrawal by Subject|3|||
19601142|NCT01071083|42049827|FG000|Overall Study|Physician Decision|1|||
19601143|NCT01071083|42049828|FG001|Overall Study|Physician Decision|0|||
19601144|NCT01071083|42049829|FG002|Overall Study|Physician Decision|0|||
19601145|NCT01071083|42049830|FG003|Overall Study|Physician Decision|1|||
19601146|NCT01071083|42049831|FG004|Overall Study|Physician Decision|1|||
19601147|NCT01071083|42049827|FG000|Overall Study|Early Rescue|1|||
19601148|NCT01071083|42049828|FG001|Overall Study|Early Rescue|0|||
19601149|NCT01071083|42049829|FG002|Overall Study|Early Rescue|0|||
19601150|NCT01071083|42049830|FG003|Overall Study|Early Rescue|0|||
19601151|NCT01071083|42049831|FG004|Overall Study|Early Rescue|1|||
19601152|NCT01071083|42049827|FG000|Overall Study|Subject Moved|0|||
19601153|NCT01071083|42049828|FG001|Overall Study|Subject Moved|1|||
19601154|NCT01071083|42049829|FG002|Overall Study|Subject Moved|0|||
19601155|NCT01071083|42049830|FG003|Overall Study|Subject Moved|0|||
19601156|NCT01071083|42049831|FG004|Overall Study|Subject Moved|0|||
19601157|NCT01071083|42049827|FG000|Overall Study|Images Not Usable (Motion)|0|||
19601158|NCT01071083|42049828|FG001|Overall Study|Images Not Usable (Motion)|1|||
19601159|NCT01071083|42049829|FG002|Overall Study|Images Not Usable (Motion)|0|||
19601160|NCT01071083|42049830|FG003|Overall Study|Images Not Usable (Motion)|0|||
19601161|NCT01071083|42049831|FG004|Overall Study|Images Not Usable (Motion)|0|||
19601162|NCT01071083|42049827|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
19601163|NCT01071083|42049828|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
19601164|NCT01071083|42049829|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
19601165|NCT01071083|42049830|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
19601166|NCT01071083|42049831|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
19601167|NCT01071083|42049827|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
19601168|NCT01071083|42049828|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
19601169|NCT01071083|42049829|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
19601170|NCT01071083|42049830|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
19601171|NCT01071083|42049831|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
19601172|NCT01071083|42049827|FG000|Overall Study|Subject Refused to Continue|1|||
19601173|NCT01071083|42049828|FG001|Overall Study|Subject Refused to Continue|0|||
19601174|NCT01071083|42049829|FG002|Overall Study|Subject Refused to Continue|0|||
19601175|NCT01071083|42049830|FG003|Overall Study|Subject Refused to Continue|0|||
19601176|NCT01071083|42049831|FG004|Overall Study|Subject Refused to Continue|0|||
19601177|NCT01070771|42049843|FG000|Overall Study|Adverse Event|2|||
19601178|NCT01070771|42049843|FG000|Overall Study|Protocol Violation|1|||
19601179|NCT01070381|42049848|FG000|Period 2, 1 Week of Wear|Handling|0|||
19601180|NCT01070381|42049849|FG001|Period 2, 1 Week of Wear|Handling|1|||
19601181|NCT01070381|42049848|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
19650948|NCT03879772|42100448|FG002|Overall Study|Protocol Violation|3|||
19601182|NCT01070381|42049849|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
19601183|NCT01010126|42049870|FG000|Overall Study|Withdrawal by Subject|1|||
19601184|NCT01010126|42049871|FG001|Overall Study|Withdrawal by Subject|0|||
19601185|NCT01010126|42049872|FG002|Overall Study|Withdrawal by Subject|1|||
19650949|NCT03879772|42100449|FG003|Overall Study|Protocol Violation|1|||
19650950|NCT03879772|42100450|FG004|Overall Study|Protocol Violation|2|||
19650951|NCT03879772|42100446|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
19751455|NCT03757715|42200708|FG001|Overall Study|Lost to Follow-up|9|||
19751456|NCT03757715|42200707|FG000|Overall Study|Withdrawal by Subject|1|||
19650952|NCT03879772|42100447|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
19650953|NCT03879772|42100448|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
19650954|NCT03879772|42100449|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
19650955|NCT03879772|42100450|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
19650956|NCT00642954|42100467|FG000|Overall Study|Progressive Disease|3|||
19650957|NCT00642954|42100468|FG001|Overall Study|Progressive Disease|3|||
19650958|NCT00642954|42100469|FG002|Overall Study|Progressive Disease|3|||
19650959|NCT00642954|42100470|FG003|Overall Study|Progressive Disease|3|||
19650960|NCT00642954|42100471|FG004|Overall Study|Progressive Disease|9|||
19650961|NCT00642954|42100467|FG000|Overall Study|Withdrawal by Subject|0|||
19650962|NCT00642954|42100468|FG001|Overall Study|Withdrawal by Subject|0|||
19650963|NCT00642954|42100469|FG002|Overall Study|Withdrawal by Subject|0|||
19650964|NCT00642954|42100470|FG003|Overall Study|Withdrawal by Subject|0|||
19650965|NCT00642954|42100471|FG004|Overall Study|Withdrawal by Subject|1|||
19650966|NCT00642954|42100467|FG000|Overall Study|Adverse Event|1|||
19650967|NCT00642954|42100468|FG001|Overall Study|Adverse Event|1|||
19650968|NCT00642954|42100469|FG002|Overall Study|Adverse Event|0|||
19751457|NCT03757715|42200708|FG001|Overall Study|Withdrawal by Subject|1|||
19751458|NCT03281577|42200718|FG000|Overall Study|Adverse Event|0|||
19751459|NCT03281577|42200719|FG001|Overall Study|Adverse Event|0|||
19751460|NCT03281577|42200720|FG002|Overall Study|Adverse Event|0|||
19751461|NCT03281577|42200721|FG003|Overall Study|Adverse Event|1|||
19751462|NCT03281577|42200718|FG000|Overall Study|Withdrawal by Subject|1|||
19650969|NCT00642954|42100470|FG003|Overall Study|Adverse Event|0|||
19650970|NCT00642954|42100471|FG004|Overall Study|Adverse Event|6|||
19650971|NCT00640146|42100485|FG000|Overall Study|Adverse Event|2|||
19650972|NCT00640146|42100486|FG001|Overall Study|Adverse Event|0|||
19650973|NCT00640146|42100485|FG000|Overall Study|Lost to Follow-up|0|||
19650974|NCT00640146|42100486|FG001|Overall Study|Lost to Follow-up|1|||
19650975|NCT00640146|42100485|FG000|Overall Study|Lack of Efficacy|0|||
19650976|NCT00640146|42100486|FG001|Overall Study|Lack of Efficacy|1|||
19650977|NCT00640146|42100485|FG000|Overall Study|Withdrawal by Subject|1|||
19650978|NCT00640146|42100486|FG001|Overall Study|Withdrawal by Subject|1|||
19650979|NCT00640146|42100485|FG000|Overall Study|Randomized but not treated|1|||
19650980|NCT00640146|42100486|FG001|Overall Study|Randomized but not treated|3|||
19650981|NCT00317473|42100498|FG000|Overall Study|Withdrawal by Subject|2|||
19650982|NCT00317473|42100499|FG001|Overall Study|Withdrawal by Subject|1|||
19650983|NCT00317473|42100500|FG002|Overall Study|Withdrawal by Subject|2|||
19650984|NCT00317473|42100501|FG003|Overall Study|Withdrawal by Subject|1|||
19650985|NCT00317473|42100502|FG004|Overall Study|Withdrawal by Subject|3|||
19650986|NCT00317473|42100503|FG005|Overall Study|Withdrawal by Subject|1|||
19650987|NCT00317473|42100498|FG000|Overall Study|Relocation|1|||
19650988|NCT00317473|42100499|FG001|Overall Study|Relocation|0|||
19650989|NCT00317473|42100500|FG002|Overall Study|Relocation|1|||
19650990|NCT00317473|42100501|FG003|Overall Study|Relocation|1|||
19650991|NCT00317473|42100502|FG004|Overall Study|Relocation|5|||
19751463|NCT03281577|42200719|FG001|Overall Study|Withdrawal by Subject|0|||
19751464|NCT03281577|42200720|FG002|Overall Study|Withdrawal by Subject|0|||
19751465|NCT03281577|42200721|FG003|Overall Study|Withdrawal by Subject|0|||
19751466|NCT04098367|42200737|FG000|Overall Study|Adverse Event|0|||
19751467|NCT04098367|42200738|FG001|Overall Study|Adverse Event|0|||
19751468|NCT04098367|42200739|FG002|Overall Study|Adverse Event|1|||
19751469|NCT04098367|42200737|FG000|Overall Study|Lost to Follow-up|1|||
19751470|NCT04098367|42200738|FG001|Overall Study|Lost to Follow-up|5|||
19751471|NCT04098367|42200739|FG002|Overall Study|Lost to Follow-up|2|||
19751472|NCT04098367|42200737|FG000|Overall Study|Withdrawal by Subject|0|||
19751473|NCT04098367|42200738|FG001|Overall Study|Withdrawal by Subject|0|||
19751474|NCT04098367|42200739|FG002|Overall Study|Withdrawal by Subject|1|||
19751475|NCT04098367|42200737|FG000|Overall Study|Sick . Could not attend visit|1|||
19751476|NCT04098367|42200738|FG001|Overall Study|Sick . Could not attend visit|0|||
19751477|NCT04098367|42200739|FG002|Overall Study|Sick . Could not attend visit|0|||
19751478|NCT03759587|42200754|FG000|Overall Study|Ongoing|19|||
19601186|NCT01010126|42049873|FG003|Overall Study|Withdrawal by Subject|0|||
19601187|NCT01010126|42049874|FG004|Overall Study|Withdrawal by Subject|3|||
19601188|NCT01010126|42049875|FG005|Overall Study|Withdrawal by Subject|0|||
19601189|NCT01043705|42049892|FG000|Overall Study|Death|28|||
19601190|NCT01043705|42049893|FG001|Overall Study|Death|60|||
19601191|NCT01043705|42049894|FG002|Overall Study|Death|26|||
19601192|NCT01043705|42049892|FG000|Overall Study|Lost to Follow-up|27|||
19601193|NCT01043705|42049893|FG001|Overall Study|Lost to Follow-up|12|||
19650992|NCT00317473|42100503|FG005|Overall Study|Relocation|2|||
19650993|NCT00317473|42100498|FG000|Overall Study|Death|1|||
19650994|NCT00317473|42100499|FG001|Overall Study|Death|0|||
19751479|NCT04091659|42200760|FG000|Overall Study|Protocol Violation|3|||
19650995|NCT00317473|42100500|FG002|Overall Study|Death|0|||
19650996|NCT00317473|42100501|FG003|Overall Study|Death|0|||
19650997|NCT00317473|42100502|FG004|Overall Study|Death|0|||
19650998|NCT00317473|42100503|FG005|Overall Study|Death|0|||
19650999|NCT00317473|42100498|FG000|Overall Study|Other|0|||
19651000|NCT00317473|42100499|FG001|Overall Study|Other|2|||
19651001|NCT00317473|42100500|FG002|Overall Study|Other|0|||
19651002|NCT00317473|42100501|FG003|Overall Study|Other|0|||
19651003|NCT00317473|42100502|FG004|Overall Study|Other|0|||
19651004|NCT00317473|42100503|FG005|Overall Study|Other|0|||
19601194|NCT01043705|42049894|FG002|Overall Study|Lost to Follow-up|0|||
19601195|NCT01043705|42049892|FG000|Overall Study|Multiple Reasons|4|||
19601196|NCT01043705|42049893|FG001|Overall Study|Multiple Reasons|7|||
19601197|NCT01043705|42049894|FG002|Overall Study|Multiple Reasons|0|||
19601198|NCT01043705|42049892|FG000|Overall Study|Protocol Violation|2|||
19601199|NCT01043705|42049893|FG001|Overall Study|Protocol Violation|1|||
19601200|NCT01043705|42049894|FG002|Overall Study|Protocol Violation|0|||
19601201|NCT01043705|42049892|FG000|Overall Study|Withdrawal by Subject|8|||
19601202|NCT01043705|42049893|FG001|Overall Study|Withdrawal by Subject|6|||
19601203|NCT01043705|42049894|FG002|Overall Study|Withdrawal by Subject|0|||
19601204|NCT01043705|42049892|FG000|Overall Study|Site Closure|8|||
19601205|NCT01043705|42049893|FG001|Overall Study|Site Closure|0|||
19601206|NCT01043705|42049894|FG002|Overall Study|Site Closure|0|||
19601207|NCT01043705|42049892|FG000|Overall Study|Subsequent Procedure|9|||
19601208|NCT01043705|42049893|FG001|Overall Study|Subsequent Procedure|24|||
19601209|NCT01043705|42049894|FG002|Overall Study|Subsequent Procedure|29|||
19601210|NCT01043705|42049892|FG000|Overall Study|Adverse Event|0|||
19601211|NCT01043705|42049893|FG001|Overall Study|Adverse Event|2|||
19601212|NCT01043705|42049894|FG002|Overall Study|Adverse Event|0|||
19601213|NCT01043705|42049892|FG000|Overall Study|Screen Fail|21|||
19601214|NCT01043705|42049893|FG001|Overall Study|Screen Fail|0|||
19601215|NCT01043705|42049894|FG002|Overall Study|Screen Fail|0|||
19651005|NCT00530218|42100527|FG000|Overall Study|CMV Not Detected|13|||
19651006|NCT00530218|42100527|FG000|Overall Study|Death|12|||
19651007|NCT00761267|42100537|FG000|Overall Study|Death|1|||
19651008|NCT00761267|42100538|FG001|Overall Study|Death|2|||
19651009|NCT00761267|42100539|FG002|Overall Study|Death|5|||
19651010|NCT00761267|42100537|FG000|Overall Study|Lost to Follow-up|0|||
19651011|NCT00761267|42100538|FG001|Overall Study|Lost to Follow-up|0|||
19651012|NCT00761267|42100539|FG002|Overall Study|Lost to Follow-up|1|||
19651013|NCT00761267|42100537|FG000|Overall Study|Randomized but not treated|1|||
19651014|NCT00761267|42100538|FG001|Overall Study|Randomized but not treated|1|||
19651015|NCT00761267|42100539|FG002|Overall Study|Randomized but not treated|0|||
19651016|NCT00761267|42100537|FG000|Overall Study|Withdrawal by Subject|0|||
19651017|NCT00761267|42100538|FG001|Overall Study|Withdrawal by Subject|1|||
19651018|NCT00761267|42100539|FG002|Overall Study|Withdrawal by Subject|0|||
19651019|NCT00303667|42100560|FG000|Overall Study|Death|0|||
19651020|NCT00303667|42100561|FG001|Overall Study|Death|4|||
19651021|NCT00761189|42100567|FG000|Overall Study|Adverse Event|42|||
19388234|NCT02698865|41631621|FG000|Overall Study|Lost to Follow-up|4|||
19601216|NCT01043705|42049892|FG000|Overall Study|Other|0|||
19601217|NCT01043705|42049893|FG001|Overall Study|Other|19|||
19651022|NCT00761189|42100567|FG000|Overall Study|Lack of Efficacy|45|||
19651023|NCT00761189|42100567|FG000|Overall Study|Lost to Follow-up|36|||
19651024|NCT00761189|42100567|FG000|Overall Study|Withdrawal by Subject|49|||
19651025|NCT00761189|42100567|FG000|Overall Study|Other|13|||
19651026|NCT00529516|42100574|FG000|Overall Study|Adverse Event|2|||
19651027|NCT00529516|42100575|FG001|Overall Study|Adverse Event|1|||
19601218|NCT01043705|42049894|FG002|Overall Study|Other|25|||
19601219|NCT03141177|42049905|FG000|Overall Study|Death|62|||
19601220|NCT03141177|42049906|FG001|Overall Study|Death|13|||
19601221|NCT03141177|42049907|FG002|Overall Study|Death|84|||
19601222|NCT03141177|42049905|FG000|Overall Study|Participant withdrew consent|9|||
19651028|NCT00529516|42100576|FG002|Overall Study|Adverse Event|0|||
19651029|NCT00529516|42100574|FG000|Overall Study|Withdrawal by Subject|1|||
19651030|NCT00529516|42100575|FG001|Overall Study|Withdrawal by Subject|1|||
19651031|NCT00529516|42100576|FG002|Overall Study|Withdrawal by Subject|0|||
19651032|NCT00529516|42100574|FG000|Overall Study|Lost to Follow-up|0|||
19651033|NCT00529516|42100575|FG001|Overall Study|Lost to Follow-up|0|||
19651034|NCT00529516|42100576|FG002|Overall Study|Lost to Follow-up|1|||
19651035|NCT00316693|42100586|FG000|Overall Study|Adverse Event|6|||
19651036|NCT00316693|42100587|FG001|Overall Study|Adverse Event|1|||
19651037|NCT00316693|42100586|FG000|Overall Study|Protocol Violation|1|||
19651038|NCT00316693|42100587|FG001|Overall Study|Protocol Violation|0|||
19651039|NCT00316693|42100586|FG000|Overall Study|Withdrawal by Subject|6|||
19651040|NCT00316693|42100587|FG001|Overall Study|Withdrawal by Subject|6|||
19651041|NCT00316693|42100586|FG000|Overall Study|Lost to Follow-up|26|||
19651042|NCT00316693|42100587|FG001|Overall Study|Lost to Follow-up|34|||
19651043|NCT00316693|42100586|FG000|Overall Study|Other|38|||
19651044|NCT00316693|42100587|FG001|Overall Study|Other|44|||
19651045|NCT00316303|42100595|FG000|Overall Study|Lost to Follow-up|11|||
19651046|NCT00316303|42100596|FG001|Overall Study|Lost to Follow-up|16|||
19651047|NCT00760877|42100607|FG000|Overall Study|Protocol Violation|1|||
19651048|NCT00760877|42100608|FG001|Overall Study|Protocol Violation|0|||
19651049|NCT00760877|42100607|FG000|Overall Study|Non-compliance with protocol treatment|2|||
19651050|NCT00760877|42100608|FG001|Overall Study|Non-compliance with protocol treatment|1|||
19651051|NCT00760877|42100607|FG000|Overall Study|Pregnancy|1|||
19651052|NCT00760877|42100608|FG001|Overall Study|Pregnancy|4|||
19651053|NCT00760877|42100607|FG000|Overall Study|Death|2|||
19651054|NCT00760877|42100608|FG001|Overall Study|Death|1|||
19651055|NCT00760877|42100607|FG000|Overall Study|Withdrawal by Subject|7|||
19651056|NCT00760877|42100608|FG001|Overall Study|Withdrawal by Subject|3|||
19651057|NCT00760877|42100607|FG000|Overall Study|Adverse Event|19|||
19651058|NCT00760877|42100608|FG001|Overall Study|Adverse Event|12|||
19651059|NCT00760877|42100607|FG000|Overall Study|Participant diagnosed with AML|0|||
19651060|NCT00760877|42100608|FG001|Overall Study|Participant diagnosed with AML|1|||
19651061|NCT00760877|42100607|FG000|Overall Study|Participant not eligible to cross-over|0|||
19651062|NCT00760877|42100608|FG001|Overall Study|Participant not eligible to cross-over|1|||
19601223|NCT03141177|42049906|FG001|Overall Study|Participant withdrew consent|2|||
19651063|NCT00760877|42100607|FG000|Overall Study|Physician Decision|1|||
19651064|NCT00760877|42100608|FG001|Overall Study|Physician Decision|2|||
19651065|NCT00760877|42100607|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
19601224|NCT03141177|42049907|FG002|Overall Study|Participant withdrew consent|13|||
19601225|NCT03141177|42049905|FG000|Overall Study|Not reported|1|||
19601226|NCT03141177|42049906|FG001|Overall Study|Not reported|0|||
19601227|NCT03141177|42049907|FG002|Overall Study|Not reported|1|||
19601228|NCT03141177|42049905|FG000|Overall Study|Lost to Follow-up|2|||
19651066|NCT00760877|42100608|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
19651067|NCT00760877|42100607|FG000|Overall Study|Treatment failure|1|||
19651068|NCT00760877|42100608|FG001|Overall Study|Treatment failure|0|||
19651069|NCT00302731|42100619|FG000|Overall Study|Lost to Follow-up|1|||
19651070|NCT00302731|42100620|FG001|Overall Study|Lost to Follow-up|2|||
19651071|NCT00302731|42100621|FG002|Overall Study|Lost to Follow-up|0|||
19651072|NCT00302731|42100622|FG003|Overall Study|Lost to Follow-up|0|||
19651073|NCT00302731|42100619|FG000|Overall Study|Adverse Event|0|||
19651074|NCT00302731|42100620|FG001|Overall Study|Adverse Event|2|||
19651075|NCT00302731|42100621|FG002|Overall Study|Adverse Event|2|||
19651076|NCT00302731|42100622|FG003|Overall Study|Adverse Event|0|||
19651077|NCT00302731|42100619|FG000|Overall Study|Withdrawal by Subject|1|||
19651078|NCT00302731|42100620|FG001|Overall Study|Withdrawal by Subject|1|||
19651079|NCT00302731|42100621|FG002|Overall Study|Withdrawal by Subject|0|||
19651080|NCT00302731|42100622|FG003|Overall Study|Withdrawal by Subject|0|||
19651081|NCT00302731|42100619|FG000|Overall Study|Protocol Violation|1|||
19651082|NCT00302731|42100620|FG001|Overall Study|Protocol Violation|0|||
19651083|NCT00302731|42100621|FG002|Overall Study|Protocol Violation|0|||
19651084|NCT00302731|42100622|FG003|Overall Study|Protocol Violation|0|||
19651085|NCT00302731|42100619|FG000|Overall Study|cancer unrelated to study discovered|1|||
19651086|NCT00302731|42100620|FG001|Overall Study|cancer unrelated to study discovered|0|||
19651087|NCT00302731|42100621|FG002|Overall Study|cancer unrelated to study discovered|1|||
19651088|NCT00302731|42100622|FG003|Overall Study|cancer unrelated to study discovered|0|||
19651089|NCT00780143|42100632|FG000|Overall Study|Progressive disease|1|||
19651090|NCT00780143|42100632|FG000|Overall Study|Toxicity|1|||
19651091|NCT00780143|42100632|FG000|Overall Study|Adverse Event|1|||
19651092|NCT00779909|42100640|FG000|Overall Study|Lost to Follow-up|1|||
19651093|NCT00779909|42100641|FG001|Overall Study|Lost to Follow-up|0|||
19651094|NCT00779909|42100642|FG002|Overall Study|Lost to Follow-up|0|||
19651095|NCT00779909|42100643|FG003|Overall Study|Lost to Follow-up|1|||
19651096|NCT00779909|42100640|FG000|Overall Study|Withdrawal by Subject|0|||
19651097|NCT00779909|42100641|FG001|Overall Study|Withdrawal by Subject|1|||
19651098|NCT00779909|42100642|FG002|Overall Study|Withdrawal by Subject|0|||
19651099|NCT00779909|42100643|FG003|Overall Study|Withdrawal by Subject|0|||
19651100|NCT00302107|42100662|FG000|Overall Study|Lost to Follow-up|6|||
19651101|NCT00302107|42100663|FG001|Overall Study|Lost to Follow-up|5|||
19651102|NCT00302107|42100662|FG000|Overall Study|Protocol Violation|1|||
19651103|NCT00302107|42100663|FG001|Overall Study|Protocol Violation|0|||
19651104|NCT00302107|42100662|FG000|Overall Study|Relocation|0|||
19651105|NCT00302107|42100663|FG001|Overall Study|Relocation|1|||
19651106|NCT00302107|42100662|FG000|Overall Study|Withdrawal by Subject|0|||
19651107|NCT00302107|42100663|FG001|Overall Study|Withdrawal by Subject|3|||
19651108|NCT00302107|42100662|FG000|Overall Study|Adverse Event|1|||
19651109|NCT00302107|42100663|FG001|Overall Study|Adverse Event|0|||
19651110|NCT00760487|42100669|FG000|Overall Study|Unilateral implantation|3|||
19651111|NCT00316225|42100673|FG000|Overall Study|Adverse Event|2|||
19651112|NCT00316225|42100673|FG000|Overall Study|Physician Decision|3|||
19651113|NCT00316225|42100673|FG000|Overall Study|Progressive Disease|15|||
19651114|NCT00316225|42100673|FG000|Overall Study|Withdrawal by Subject|3|||
19651115|NCT00316225|42100673|FG000|Overall Study|Death|2|||
19751480|NCT04091659|42200761|FG001|Overall Study|Protocol Violation|0|||
19601229|NCT03141177|42049906|FG001|Overall Study|Lost to Follow-up|1|||
19601230|NCT03141177|42049907|FG002|Overall Study|Lost to Follow-up|1|||
19601231|NCT03141177|42049905|FG000|Overall Study|Other reasons|4|||
19601232|NCT03141177|42049906|FG001|Overall Study|Other reasons|0|||
19601233|NCT03141177|42049907|FG002|Overall Study|Other reasons|11|||
19601234|NCT03141177|42049905|FG000|Overall Study|Participants did not start treatment period|3|||
19601235|NCT03141177|42049906|FG001|Overall Study|Participants did not start treatment period|0|||
19601236|NCT03141177|42049907|FG002|Overall Study|Participants did not start treatment period|8|||
19601237|NCT01070303|42049918|FG000|Overall Study|Adverse Event|39|||
19601238|NCT01070303|42049918|FG000|Overall Study|Withdrawal by Subject|20|||
19601239|NCT01070303|42049918|FG000|Overall Study|Lost to Follow-up|9|||
19601240|NCT01070303|42049918|FG000|Overall Study|Protocol Violation|0|||
19601241|NCT01070303|42049918|FG000|Overall Study|Lack of Efficacy|2|||
19601242|NCT01070303|42049918|FG000|Overall Study|Administrative Reason|1|||
19601243|NCT01070303|42049918|FG000|Overall Study|Other|18|||
19601244|NCT01009814|42049933|FG000|Overall Study|No longer met study criteria|1|||
19601245|NCT01009814|42049934|FG001|Overall Study|No longer met study criteria|1|||
19601246|NCT01009814|42049935|FG002|Overall Study|No longer met study criteria|0|||
19601247|NCT01009814|42049936|FG003|Overall Study|No longer met study criteria|0|||
19601248|NCT01009814|42049937|FG004|Overall Study|No longer met study criteria|0|||
19601249|NCT03824587|42049955|FG000|Run-in Period|Screen Failure|0|||
19601250|NCT03824587|42049956|FG001|Run-in Period|Screen Failure|275|||
19601251|NCT03824587|42049955|FG000|Treatment Period|Adverse Event|4|||
19601252|NCT03824587|42049956|FG001|Treatment Period|Adverse Event|1|||
19601253|NCT03824587|42049955|FG000|Treatment Period|Withdrawal by Subject|0|||
19601254|NCT03824587|42049956|FG001|Treatment Period|Withdrawal by Subject|1|||
19601255|NCT03824587|42049955|FG000|Treatment Period|Kidney Transplant|1|||
19601256|NCT03824587|42049956|FG001|Treatment Period|Kidney Transplant|1|||
19651116|NCT00586703|42100677|FG000|Overall Study|Death|12|||
19651117|NCT00586625|42100683|FG000|Overall Study|Adverse Event|6|||
19651118|NCT00586625|42100684|FG001|Overall Study|Adverse Event|6|||
19651119|NCT00586625|42100683|FG000|Overall Study|Protocol Violation|3|||
19651120|NCT00586625|42100684|FG001|Overall Study|Protocol Violation|0|||
19651121|NCT00586625|42100683|FG000|Overall Study|Withdrawal by Subject|32|||
19651122|NCT00586625|42100684|FG001|Overall Study|Withdrawal by Subject|10|||
19651123|NCT00586625|42100683|FG000|Overall Study|Subject non-compliance|0|||
19651124|NCT00586625|42100684|FG001|Overall Study|Subject non-compliance|1|||
19651125|NCT00586625|42100683|FG000|Overall Study|Subject unable to return for visit|2|||
19651126|NCT00586625|42100684|FG001|Overall Study|Subject unable to return for visit|0|||
19651127|NCT00636168|42100692|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
19651128|NCT00636168|42100693|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
19651129|NCT00636168|42100692|FG000|Randomized to Study Drug|Adverse Event|1|||
19651130|NCT00636168|42100693|FG001|Randomized to Study Drug|Adverse Event|0|||
19651131|NCT00636168|42100692|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
19651132|NCT00636168|42100693|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
19651133|NCT00636168|42100692|FG000|Treated With Study Drug|Recurrence of disease|135|||
19651134|NCT00636168|42100693|FG001|Treated With Study Drug|Recurrence of disease|282|||
19651135|NCT00636168|42100692|FG000|Treated With Study Drug|Adverse Event|250|||
19651136|NCT00636168|42100693|FG001|Treated With Study Drug|Adverse Event|22|||
19651137|NCT00636168|42100692|FG000|Treated With Study Drug|Participant withdrew consent|16|||
19651138|NCT00636168|42100693|FG001|Treated With Study Drug|Participant withdrew consent|21|||
19651139|NCT00636168|42100692|FG000|Treated With Study Drug|Poor/non-compliance|1|||
19651140|NCT00636168|42100693|FG001|Treated With Study Drug|Poor/non-compliance|3|||
19651141|NCT00636168|42100692|FG000|Treated With Study Drug|Death|3|||
19651142|NCT00636168|42100693|FG001|Treated With Study Drug|Death|0|||
19651143|NCT00636168|42100692|FG000|Treated With Study Drug|Pregnancy|1|||
19651144|NCT00636168|42100693|FG001|Treated With Study Drug|Pregnancy|0|||
19651145|NCT00636168|42100692|FG000|Treated With Study Drug|No longer meets study criteria|1|||
19651146|NCT00636168|42100693|FG001|Treated With Study Drug|No longer meets study criteria|0|||
19651147|NCT00636168|42100692|FG000|Treated With Study Drug|Other reason|1|||
19651148|NCT00636168|42100693|FG001|Treated With Study Drug|Other reason|3|||
19651149|NCT00636168|42100692|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
19651150|NCT00636168|42100693|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
19651151|NCT00636168|42100692|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
19651152|NCT00636168|42100693|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
19651153|NCT00636168|42100692|FG000|Long Term Follow-Up|Death|8|||
19651154|NCT00636168|42100693|FG001|Long Term Follow-Up|Death|9|||
19651155|NCT00759941|42100701|FG000|Overall Study|Use of medication|1|||
19651156|NCT00759941|42100702|FG001|Overall Study|Use of medication|0|||
19651157|NCT00759941|42100701|FG000|Overall Study|Adverse Event|1|||
19651158|NCT00759941|42100702|FG001|Overall Study|Adverse Event|0|||
19651159|NCT00759941|42100701|FG000|Overall Study|Exited in error by site|1|||
19651160|NCT00759941|42100702|FG001|Overall Study|Exited in error by site|1|||
19651161|NCT00528424|42100708|FG000|Overall Study|Lost to Follow-up|13|||
19601257|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
19601258|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
19601259|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
19601260|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
19601261|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
19601262|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
19651162|NCT00528424|42100708|FG000|Overall Study|Withdrew consent|2|||
19651163|NCT00528424|42100708|FG000|Overall Study|Administrative reason|2|||
19651164|NCT00528424|42100708|FG000|Overall Study|Other|12|||
19651165|NCT00315445|42100715|FG000|Overall Study|Adverse Event|7|||
19651166|NCT00315445|42100716|FG001|Overall Study|Adverse Event|12|||
19651167|NCT00315445|42100717|FG002|Overall Study|Adverse Event|15|||
19651168|NCT00315445|42100715|FG000|Overall Study|Lack of Efficacy|16|||
19651169|NCT00315445|42100716|FG001|Overall Study|Lack of Efficacy|1|||
19651170|NCT00315445|42100717|FG002|Overall Study|Lack of Efficacy|7|||
19651171|NCT00315445|42100715|FG000|Overall Study|Lost to Follow-up|1|||
19651172|NCT00315445|42100716|FG001|Overall Study|Lost to Follow-up|0|||
19651173|NCT00315445|42100717|FG002|Overall Study|Lost to Follow-up|1|||
19651174|NCT00315445|42100715|FG000|Overall Study|Protocol Violation|2|||
19651175|NCT00315445|42100716|FG001|Overall Study|Protocol Violation|0|||
19651176|NCT00315445|42100717|FG002|Overall Study|Protocol Violation|1|||
19601263|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
19601264|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
19601265|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
19601266|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
19601267|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
19601268|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
19601269|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
19651177|NCT00315445|42100715|FG000|Overall Study|Other|1|||
19651178|NCT00315445|42100716|FG001|Overall Study|Other|3|||
19651179|NCT00315445|42100717|FG002|Overall Study|Other|0|||
19651180|NCT03687736|42100725|FG000|Overall Study|Lost to Follow-up|7|||
19651181|NCT03687736|42100725|FG000|Overall Study|Withdrawal by Subject|3|||
19651182|NCT00779675|42100731|FG000|Treatment Period|Adverse Event|87|||
19651183|NCT00779675|42100731|FG000|Treatment Period|Treatment Failure|80|||
19651184|NCT00779675|42100731|FG000|Treatment Period|Transferred to Another Study|38|||
19651185|NCT00779675|42100731|FG000|Treatment Period|Lost to Follow-up|23|||
19651186|NCT00779675|42100731|FG000|Treatment Period|Withdrawal by Subject|46|||
19651187|NCT00779675|42100731|FG000|Treatment Period|Protocol Violation|54|||
19651188|NCT00779675|42100731|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
19601270|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
19601271|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
19601272|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
19601273|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
19601274|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
19601275|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
19601276|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
19601277|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
19601278|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
19601279|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
19601280|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
19601281|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
19601282|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
19651189|NCT00779675|42100731|FG000|Treatment Period|Administrative|3|||
19651190|NCT00779675|42100731|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
19651191|NCT00779675|42100731|FG000|Extended Treatment Period|Protocol Violation|13|||
19751481|NCT04091659|42200760|FG000|Overall Study|Lost to Follow-up|0|||
19751482|NCT04091659|42200761|FG001|Overall Study|Lost to Follow-up|1|||
19751483|NCT04256785|42200798|FG000|Overall Study|Adverse Event|8|||
19751484|NCT04256785|42200799|FG001|Overall Study|Adverse Event|6|||
19751485|NCT04256785|42200798|FG000|Overall Study|Lack of Efficacy|3|||
19651192|NCT00779675|42100731|FG000|Extended Treatment Period|Adverse Event|6|||
19651193|NCT00779675|42100731|FG000|Extended Treatment Period|Treatment Failure|11|||
19651194|NCT00779675|42100731|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
19651195|NCT00779675|42100731|FG000|Extended Treatment Period|Lost to Follow-up|6|||
19651196|NCT00759863|42100741|FG000|Overall Study|Death, moved, or lost contact|20|||
19651197|NCT00759863|42100742|FG001|Overall Study|Death, moved, or lost contact|18|||
19651198|NCT00759785|42100750|FG000|Overall Study|Participant sample not evaluable|11|||
19651199|NCT00759785|42100751|FG001|Overall Study|Participant sample not evaluable|2|||
19651200|NCT00759785|42100750|FG000|Overall Study|Participant sample lost|0|||
19651201|NCT00759785|42100751|FG001|Overall Study|Participant sample lost|1|||
19651202|NCT00759785|42100750|FG000|Overall Study|Protocol Violation|1|||
19651203|NCT00759785|42100751|FG001|Overall Study|Protocol Violation|0|||
19651204|NCT00759785|42100750|FG000|Overall Study|Physician Decision|0|||
19651205|NCT00759785|42100751|FG001|Overall Study|Physician Decision|1|||
19651206|NCT00759785|42100750|FG000|Overall Study|Withdrawal by Subject|0|||
19651207|NCT00759785|42100751|FG001|Overall Study|Withdrawal by Subject|1|||
19651208|NCT00300781|42100759|FG000|Overall Study|Disease Progression|55|||
19651209|NCT00300781|42100760|FG001|Overall Study|Disease Progression|52|||
19651210|NCT00300781|42100759|FG000|Overall Study|Adverse Event|5|||
19651211|NCT00300781|42100760|FG001|Overall Study|Adverse Event|6|||
19651212|NCT00300781|42100759|FG000|Overall Study|Withdrawal by Subject|1|||
19651213|NCT00300781|42100760|FG001|Overall Study|Withdrawal by Subject|2|||
19651214|NCT00300781|42100759|FG000|Overall Study|Physician Decision|1|||
19651215|NCT00300781|42100760|FG001|Overall Study|Physician Decision|0|||
19651216|NCT00300781|42100759|FG000|Overall Study|Not Recorded|0|||
19651217|NCT00300781|42100760|FG001|Overall Study|Not Recorded|1|||
19651218|NCT00300781|42100759|FG000|Overall Study|Symptomatic Deterioration|1|||
19651219|NCT00300781|42100760|FG001|Overall Study|Symptomatic Deterioration|0|||
19651220|NCT00300781|42100759|FG000|Overall Study|Lost to Follow-up|0|||
19651221|NCT00300781|42100760|FG001|Overall Study|Lost to Follow-up|1|||
19651222|NCT00315055|42100768|FG000|Overall Study|Protocol Violation|2|||
19651223|NCT00315055|42100769|FG001|Overall Study|Protocol Violation|4|||
19651224|NCT00315055|42100768|FG000|Overall Study|Lost to Follow-up|1|||
19651225|NCT00315055|42100769|FG001|Overall Study|Lost to Follow-up|1|||
19651226|NCT00528970|42100781|FG000|Overall Study|Adverse Event|6|||
19651227|NCT00528970|42100782|FG001|Overall Study|Adverse Event|8|||
19651228|NCT00528970|42100783|FG002|Overall Study|Adverse Event|5|||
19651229|NCT00528970|42100781|FG000|Overall Study|Lost to Follow-up|0|||
19651230|NCT00528970|42100782|FG001|Overall Study|Lost to Follow-up|0|||
19651231|NCT00528970|42100783|FG002|Overall Study|Lost to Follow-up|1|||
19651232|NCT00528970|42100781|FG000|Overall Study|Other than specified|2|||
19651233|NCT00528970|42100782|FG001|Overall Study|Other than specified|3|||
19651234|NCT00528970|42100783|FG002|Overall Study|Other than specified|3|||
19651235|NCT00528970|42100781|FG000|Overall Study|Protocol Violation|2|||
19651236|NCT00528970|42100782|FG001|Overall Study|Protocol Violation|1|||
19751486|NCT04256785|42200799|FG001|Overall Study|Lack of Efficacy|4|||
19751487|NCT04256785|42200798|FG000|Overall Study|Lost to Follow-up|7|||
19651237|NCT00528970|42100783|FG002|Overall Study|Protocol Violation|4|||
19651238|NCT00528970|42100781|FG000|Overall Study|Lack of Efficacy|0|||
19651239|NCT00528970|42100782|FG001|Overall Study|Lack of Efficacy|0|||
19651240|NCT00528970|42100783|FG002|Overall Study|Lack of Efficacy|1|||
19651241|NCT00528970|42100781|FG000|Overall Study|Withdrawal by Subject|4|||
19651242|NCT00528970|42100782|FG001|Overall Study|Withdrawal by Subject|3|||
19651243|NCT00528970|42100783|FG002|Overall Study|Withdrawal by Subject|5|||
19651244|NCT00528970|42100781|FG000|Overall Study|Randomized but not treated|0|||
19651245|NCT00528970|42100782|FG001|Overall Study|Randomized but not treated|0|||
19651246|NCT00528970|42100783|FG002|Overall Study|Randomized but not treated|1|||
19651247|NCT00759395|42100793|FG000|Overall Study|Adverse Event|1|||
19651248|NCT00759395|42100794|FG001|Overall Study|Adverse Event|0|||
19651249|NCT00759395|42100793|FG000|Overall Study|Withdrawal by Subject|1|||
19651250|NCT00759395|42100794|FG001|Overall Study|Withdrawal by Subject|0|||
19651251|NCT00759395|42100793|FG000|Overall Study|Lack of Efficacy|0|||
19651252|NCT00759395|42100794|FG001|Overall Study|Lack of Efficacy|2|||
19651253|NCT00293293|42100802|FG000|Overall Study|Withdrawal by Subject|1|||
19651254|NCT00293293|42100803|FG001|Overall Study|Withdrawal by Subject|1|||
19651255|NCT00293293|42100802|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
19651256|NCT00293293|42100803|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
19651257|NCT00293293|42100802|FG000|Overall Study|Patient discontinued chemotherapy|0|||
19751488|NCT04256785|42200799|FG001|Overall Study|Lost to Follow-up|7|||
19751489|NCT04256785|42200798|FG000|Overall Study|Protocol Violation|1|||
19751490|NCT04256785|42200799|FG001|Overall Study|Protocol Violation|0|||
19751491|NCT04256785|42200798|FG000|Overall Study|Withdrawal by Subject|4|||
19751492|NCT04256785|42200799|FG001|Overall Study|Withdrawal by Subject|1|||
19751493|NCT04256785|42200798|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
19751494|NCT04256785|42200799|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
19751495|NCT02959918|42200821|FG000|Overall Study|Adverse Event|1|||
19751496|NCT02959918|42200822|FG001|Overall Study|Adverse Event|1|||
19751497|NCT02959918|42200823|FG002|Overall Study|Adverse Event|2|||
19751498|NCT02959918|42200824|FG003|Overall Study|Adverse Event|0|||
19751499|NCT02959918|42200825|FG004|Overall Study|Adverse Event|0|||
19751500|NCT02959918|42200826|FG005|Overall Study|Adverse Event|2|||
19751501|NCT02959918|42200827|FG006|Overall Study|Adverse Event|2|||
19751502|NCT02959918|42200828|FG007|Overall Study|Adverse Event|1|||
19751503|NCT02959918|42200829|FG008|Overall Study|Adverse Event|2|||
19751504|NCT02959918|42200830|FG009|Overall Study|Adverse Event|1|||
19751505|NCT02959918|42200831|FG010|Overall Study|Adverse Event|1|||
19601283|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
19601284|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
19601285|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
19601286|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
19601287|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
19601288|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
19601289|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
19601290|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
19651258|NCT00293293|42100803|FG001|Overall Study|Patient discontinued chemotherapy|1|||
19651259|NCT04864639|42100810|FG000|Overall Study|Death|1|||
19651260|NCT04864639|42100810|FG000|Overall Study|Lost to Follow-up|1|||
19651261|NCT04439123|42100832|FG000|Overall Study|Adverse Event|11|||
19751506|NCT02959918|42200832|FG011|Overall Study|Adverse Event|3|||
19751507|NCT02959918|42200833|FG012|Overall Study|Adverse Event|2|||
19651262|NCT04439123|42100832|FG000|Overall Study|Death|1|||
19751508|NCT02959918|42200834|FG013|Overall Study|Adverse Event|4|||
19651263|NCT04439123|42100832|FG000|Overall Study|Disease progression|19|||
19751509|NCT02959918|42200821|FG000|Overall Study|Lost to Follow-up|0|||
19751510|NCT02959918|42200822|FG001|Overall Study|Lost to Follow-up|0|||
19751511|NCT02959918|42200823|FG002|Overall Study|Lost to Follow-up|0|||
19751512|NCT02959918|42200824|FG003|Overall Study|Lost to Follow-up|0|||
19651264|NCT04439123|42100832|FG000|Overall Study|Withdrawal by Subject|2|||
19651265|NCT04439123|42100832|FG000|Overall Study|Still on treatment|2|||
19651266|NCT04439110|42100836|FG000|Overall Study|Ineligible|2|||
19651267|NCT04439110|42100836|FG000|Overall Study|Adverse Event|4|||
19651268|NCT04439110|42100836|FG000|Overall Study|Death|2|||
19651269|NCT04439110|42100836|FG000|Overall Study|Disease proression|25|||
19651270|NCT04439110|42100836|FG000|Overall Study|Withdrawal by Subject|1|||
19651271|NCT04439110|42100836|FG000|Overall Study|Alternative therapy|1|||
19651272|NCT04439110|42100836|FG000|Overall Study|Other complicating disease|1|||
19651273|NCT04439110|42100836|FG000|Overall Study|Personal reasons|1|||
19651274|NCT04439110|42100836|FG000|Overall Study|Still on treatment|1|||
19651275|NCT04245449|42100844|FG000|Overall Study|COVID shutdown|7|||
19651276|NCT03887221|42100854|FG000|Overall Study|Protocol Violation|1|||
19651277|NCT03887221|42100855|FG001|Overall Study|Protocol Violation|0|||
19651278|NCT03164616|42100876|FG000|Overall Study|Death|250|||
19651279|NCT03164616|42100877|FG001|Overall Study|Death|264|||
19651280|NCT03164616|42100878|FG002|Overall Study|Death|279|||
19651281|NCT03164616|42100876|FG000|Overall Study|Lost to Follow-up|2|||
19751513|NCT02959918|42200825|FG004|Overall Study|Lost to Follow-up|0|||
19751514|NCT02959918|42200826|FG005|Overall Study|Lost to Follow-up|0|||
19651282|NCT03164616|42100877|FG001|Overall Study|Lost to Follow-up|2|||
19651283|NCT03164616|42100878|FG002|Overall Study|Lost to Follow-up|2|||
19651284|NCT03164616|42100876|FG000|Overall Study|Withdrawal by Subject|6|||
19651285|NCT03164616|42100877|FG001|Overall Study|Withdrawal by Subject|7|||
19651286|NCT03164616|42100878|FG002|Overall Study|Withdrawal by Subject|16|||
19651287|NCT02782741|42100890|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
19651288|NCT02782741|42100891|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
19651289|NCT02782741|42100890|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
19651290|NCT02782741|42100891|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
19651291|NCT02782741|42100890|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
19651292|NCT02782741|42100891|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
19651293|NCT02782741|42100890|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
19651294|NCT02782741|42100891|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
19651295|NCT02782741|42100890|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
19651296|NCT02782741|42100891|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
19651297|NCT02771626|42100907|FG000|Overall Study|Adverse Event|1|||
19751515|NCT02959918|42200827|FG006|Overall Study|Lost to Follow-up|0|||
19751516|NCT02959918|42200828|FG007|Overall Study|Lost to Follow-up|0|||
19601291|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
19601292|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
19601293|NCT00773734|42049966|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
19601294|NCT00773734|42049967|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
19601295|NCT00773734|42049968|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
19601296|NCT00773734|42049969|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
19601297|NCT00773734|42049970|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
19601298|NCT00773734|42049971|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
19601299|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
19601300|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
19601301|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
19601302|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
19601303|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
19601304|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
19601305|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
19601306|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
19601307|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
19601308|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
19601309|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
19601310|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
19651298|NCT02771626|42100908|FG001|Overall Study|Adverse Event|5|||
19651299|NCT02771626|42100909|FG002|Overall Study|Adverse Event|3|||
19651300|NCT02771626|42100910|FG003|Overall Study|Adverse Event|0|||
19651301|NCT02771626|42100911|FG004|Overall Study|Adverse Event|1|||
19651302|NCT02771626|42100912|FG005|Overall Study|Adverse Event|1|||
19651303|NCT02771626|42100907|FG000|Overall Study|Radiologic Disease Progression|6|||
19651304|NCT02771626|42100908|FG001|Overall Study|Radiologic Disease Progression|13|||
19651305|NCT02771626|42100909|FG002|Overall Study|Radiologic Disease Progression|10|||
19651306|NCT02771626|42100910|FG003|Overall Study|Radiologic Disease Progression|7|||
19651307|NCT02771626|42100911|FG004|Overall Study|Radiologic Disease Progression|28|||
19651308|NCT02771626|42100912|FG005|Overall Study|Radiologic Disease Progression|15|||
19651309|NCT02771626|42100907|FG000|Overall Study|Symptomatic Deterioration|0|||
19651310|NCT02771626|42100908|FG001|Overall Study|Symptomatic Deterioration|4|||
19651311|NCT02771626|42100909|FG002|Overall Study|Symptomatic Deterioration|2|||
19651312|NCT02771626|42100910|FG003|Overall Study|Symptomatic Deterioration|0|||
19651313|NCT02771626|42100911|FG004|Overall Study|Symptomatic Deterioration|5|||
19751517|NCT02959918|42200829|FG008|Overall Study|Lost to Follow-up|0|||
19751518|NCT02959918|42200830|FG009|Overall Study|Lost to Follow-up|1|||
19751519|NCT02959918|42200831|FG010|Overall Study|Lost to Follow-up|0|||
19751520|NCT02959918|42200832|FG011|Overall Study|Lost to Follow-up|0|||
19751521|NCT02959918|42200833|FG012|Overall Study|Lost to Follow-up|1|||
19751522|NCT02959918|42200834|FG013|Overall Study|Lost to Follow-up|0|||
19751523|NCT02959918|42200821|FG000|Overall Study|Withdrawal by Subject|0|||
19751524|NCT02959918|42200822|FG001|Overall Study|Withdrawal by Subject|0|||
19751525|NCT02959918|42200823|FG002|Overall Study|Withdrawal by Subject|1|||
19651314|NCT02771626|42100912|FG005|Overall Study|Symptomatic Deterioration|2|||
19651315|NCT02771626|42100907|FG000|Overall Study|Participant Request|0|||
19651316|NCT02771626|42100908|FG001|Overall Study|Participant Request|1|||
19651317|NCT02771626|42100909|FG002|Overall Study|Participant Request|0|||
19651318|NCT02771626|42100910|FG003|Overall Study|Participant Request|2|||
19651319|NCT02771626|42100911|FG004|Overall Study|Participant Request|0|||
19651320|NCT02771626|42100912|FG005|Overall Study|Participant Request|1|||
19651321|NCT02771626|42100907|FG000|Overall Study|Investigator Decision|0|||
19651322|NCT02771626|42100908|FG001|Overall Study|Investigator Decision|1|||
19651323|NCT02771626|42100909|FG002|Overall Study|Investigator Decision|0|||
19651324|NCT02771626|42100910|FG003|Overall Study|Investigator Decision|0|||
19651325|NCT02771626|42100911|FG004|Overall Study|Investigator Decision|1|||
19651326|NCT02771626|42100912|FG005|Overall Study|Investigator Decision|0|||
19651327|NCT02771626|42100907|FG000|Overall Study|Study Termination by Sponsor|0|||
19651328|NCT02771626|42100908|FG001|Overall Study|Study Termination by Sponsor|2|||
19651329|NCT02771626|42100909|FG002|Overall Study|Study Termination by Sponsor|1|||
19651330|NCT02771626|42100910|FG003|Overall Study|Study Termination by Sponsor|0|||
19651331|NCT02771626|42100911|FG004|Overall Study|Study Termination by Sponsor|1|||
19651332|NCT02771626|42100912|FG005|Overall Study|Study Termination by Sponsor|0|||
19651333|NCT02771626|42100907|FG000|Overall Study|Informed Consent Withdrawn|0|||
19651334|NCT02771626|42100908|FG001|Overall Study|Informed Consent Withdrawn|0|||
19651335|NCT02771626|42100909|FG002|Overall Study|Informed Consent Withdrawn|1|||
19651336|NCT02771626|42100910|FG003|Overall Study|Informed Consent Withdrawn|0|||
19651337|NCT02771626|42100911|FG004|Overall Study|Informed Consent Withdrawn|1|||
19651338|NCT02771626|42100912|FG005|Overall Study|Informed Consent Withdrawn|1|||
19651339|NCT02771626|42100907|FG000|Overall Study|Other, Not Specified|1|||
19651340|NCT02771626|42100908|FG001|Overall Study|Other, Not Specified|0|||
19651341|NCT02771626|42100909|FG002|Overall Study|Other, Not Specified|0|||
19651342|NCT02771626|42100910|FG003|Overall Study|Other, Not Specified|0|||
19651343|NCT02771626|42100911|FG004|Overall Study|Other, Not Specified|0|||
19651344|NCT02771626|42100912|FG005|Overall Study|Other, Not Specified|1|||
19651345|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Death|113|||
19651346|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Death|189|||
19651347|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
19651348|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
19651349|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
19651350|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
19651351|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
19651352|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
19651353|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
19651354|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
19651355|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
19651356|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
19651357|NCT02677896|42100928|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
19651358|NCT02677896|42100929|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
19651359|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
19651360|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
19651361|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
19651362|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
19651363|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
19651364|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
19651365|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
19651366|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
19651367|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
19651368|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
19651369|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
19651370|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
19651371|NCT02677896|42100928|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
19651372|NCT02677896|42100929|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
19651373|NCT02272790|42100942|FG000|Overall Study|Physician Decision|0|||
19651374|NCT02272790|42100943|FG001|Overall Study|Physician Decision|1|||
19651375|NCT02272790|42100944|FG002|Overall Study|Physician Decision|0|||
19651376|NCT02272790|42100945|FG003|Overall Study|Physician Decision|0|||
19651377|NCT02272790|42100946|FG004|Overall Study|Physician Decision|0|||
19651378|NCT02272790|42100947|FG005|Overall Study|Physician Decision|0|||
19651379|NCT01566695|42100969|FG000|Overall Study|Lack of Efficacy|18|||
19651380|NCT01566695|42100970|FG001|Overall Study|Lack of Efficacy|45|||
19651381|NCT01566695|42100969|FG000|Overall Study|Adverse Event|28|||
19651382|NCT01566695|42100970|FG001|Overall Study|Adverse Event|27|||
19651383|NCT01566695|42100969|FG000|Overall Study|Death|20|||
19651384|NCT01566695|42100970|FG001|Overall Study|Death|8|||
19651385|NCT01566695|42100969|FG000|Overall Study|Withdrawal by Subject|14|||
19651386|NCT01566695|42100970|FG001|Overall Study|Withdrawal by Subject|7|||
19651387|NCT01566695|42100969|FG000|Overall Study|Progressive Disease|11|||
19651388|NCT01566695|42100970|FG001|Overall Study|Progressive Disease|6|||
19651389|NCT01566695|42100969|FG000|Overall Study|Miscellaneous|4|||
19651390|NCT01566695|42100970|FG001|Overall Study|Miscellaneous|6|||
19651391|NCT01557751|42100976|FG000|Overall Study|Physician Decision|3|||
19651392|NCT01464164|42100987|FG000|Overall Study|Screen failure|0|||
19651393|NCT01464164|42100988|FG001|Overall Study|Screen failure|1|||
19651394|NCT01464164|42100989|FG002|Overall Study|Screen failure|2|||
19651395|NCT01464164|42100990|FG003|Overall Study|Screen failure|0|||
19651396|NCT01464164|42100991|FG004|Overall Study|Screen failure|0|||
19651397|NCT01464164|42100992|FG005|Overall Study|Screen failure|0|||
19651398|NCT01464164|42100993|FG006|Overall Study|Screen failure|0|||
19651399|NCT01464164|42100987|FG000|Overall Study|Physician Decision|0|||
19651400|NCT01464164|42100988|FG001|Overall Study|Physician Decision|1|||
19651401|NCT01464164|42100989|FG002|Overall Study|Physician Decision|0|||
19651402|NCT01464164|42100990|FG003|Overall Study|Physician Decision|0|||
19651403|NCT01464164|42100991|FG004|Overall Study|Physician Decision|0|||
19651404|NCT01464164|42100992|FG005|Overall Study|Physician Decision|0|||
19651405|NCT01464164|42100993|FG006|Overall Study|Physician Decision|2|||
19651406|NCT01377389|42101009|FG000|Overall Study|Withdrawal by Subject|1|||
19651407|NCT01377389|42101009|FG000|Overall Study|Screen failure|2|||
19651408|NCT01194271|42101013|FG000|Overall Study|Withdrawal by Subject|1|||
19651409|NCT01194271|42101013|FG000|Overall Study|Ineligible, Screen Failure|1|||
19651410|NCT01194271|42101013|FG000|Overall Study|Death|1|||
19651411|NCT01119508|42101017|FG000|Overall Study|Adverse Event|56|||
19651412|NCT01119508|42101017|FG000|Overall Study|Withdrawal by Subject|2|||
19651413|NCT01119508|42101017|FG000|Overall Study|Died before tumor response evaluation|1|||
19651414|NCT00769379|42101023|FG000|Overall Study|No follow up data mapped to Other.|3|||
19651415|NCT00769379|42101024|FG001|Overall Study|No follow up data mapped to Other.|13|||
19651416|NCT00568776|42101057|FG000|Overall Study|Adverse Event|8|||
19651417|NCT00568776|42101058|FG001|Overall Study|Adverse Event|8|||
19751526|NCT02959918|42200824|FG003|Overall Study|Withdrawal by Subject|2|||
19751527|NCT02959918|42200825|FG004|Overall Study|Withdrawal by Subject|0|||
19651418|NCT00568776|42101059|FG002|Overall Study|Adverse Event|10|||
19651419|NCT00568776|42101060|FG003|Overall Study|Adverse Event|8|||
19651420|NCT00568776|42101057|FG000|Overall Study|Death|0|||
19651421|NCT00568776|42101058|FG001|Overall Study|Death|1|||
19651422|NCT00568776|42101059|FG002|Overall Study|Death|4|||
19651423|NCT00568776|42101060|FG003|Overall Study|Death|3|||
19651424|NCT00568776|42101057|FG000|Overall Study|Physician Decision|0|||
19651425|NCT00568776|42101058|FG001|Overall Study|Physician Decision|2|||
19651426|NCT00568776|42101059|FG002|Overall Study|Physician Decision|0|||
19651427|NCT00568776|42101060|FG003|Overall Study|Physician Decision|0|||
19651428|NCT00568776|42101057|FG000|Overall Study|Lack of Efficacy|2|||
19651429|NCT00568776|42101058|FG001|Overall Study|Lack of Efficacy|2|||
19651430|NCT00568776|42101059|FG002|Overall Study|Lack of Efficacy|2|||
19651431|NCT00568776|42101060|FG003|Overall Study|Lack of Efficacy|4|||
19651432|NCT00568776|42101057|FG000|Overall Study|Lost to Follow-up|1|||
19651433|NCT00568776|42101058|FG001|Overall Study|Lost to Follow-up|1|||
19651434|NCT00568776|42101059|FG002|Overall Study|Lost to Follow-up|1|||
19651435|NCT00568776|42101060|FG003|Overall Study|Lost to Follow-up|1|||
19651436|NCT00568776|42101057|FG000|Overall Study|Protocol Violation|1|||
19651437|NCT00568776|42101058|FG001|Overall Study|Protocol Violation|0|||
19651438|NCT00568776|42101059|FG002|Overall Study|Protocol Violation|1|||
19751528|NCT02959918|42200826|FG005|Overall Study|Withdrawal by Subject|0|||
19751529|NCT02959918|42200827|FG006|Overall Study|Withdrawal by Subject|1|||
19751530|NCT02959918|42200828|FG007|Overall Study|Withdrawal by Subject|0|||
19751531|NCT02959918|42200829|FG008|Overall Study|Withdrawal by Subject|1|||
19751532|NCT02959918|42200830|FG009|Overall Study|Withdrawal by Subject|1|||
19751533|NCT02959918|42200831|FG010|Overall Study|Withdrawal by Subject|2|||
19651439|NCT00568776|42101060|FG003|Overall Study|Protocol Violation|1|||
19651440|NCT00568776|42101057|FG000|Overall Study|Withdrawal by Subject|13|||
19651441|NCT00568776|42101058|FG001|Overall Study|Withdrawal by Subject|15|||
19651442|NCT00568776|42101059|FG002|Overall Study|Withdrawal by Subject|13|||
19651443|NCT00568776|42101060|FG003|Overall Study|Withdrawal by Subject|7|||
19651444|NCT00568776|42101057|FG000|Overall Study|Loss of Caregiver|0|||
19651445|NCT00568776|42101058|FG001|Overall Study|Loss of Caregiver|2|||
19651446|NCT00568776|42101059|FG002|Overall Study|Loss of Caregiver|1|||
19651447|NCT00568776|42101060|FG003|Overall Study|Loss of Caregiver|2|||
19651448|NCT00568776|42101057|FG000|Overall Study|Sponsor Decision|2|||
19651449|NCT00568776|42101058|FG001|Overall Study|Sponsor Decision|2|||
19651450|NCT00568776|42101059|FG002|Overall Study|Sponsor Decision|41|||
19651451|NCT00568776|42101060|FG003|Overall Study|Sponsor Decision|42|||
19651452|NCT00568776|42101057|FG000|Overall Study|Miscellaeneous|3|||
19651453|NCT00568776|42101058|FG001|Overall Study|Miscellaeneous|3|||
19651454|NCT00568776|42101059|FG002|Overall Study|Miscellaeneous|1|||
19651455|NCT00568776|42101060|FG003|Overall Study|Miscellaeneous|4|||
19651456|NCT00758771|42101072|FG000|Overall Study|Withdrawal by Subject|1|||
19651457|NCT00758771|42101073|FG001|Overall Study|Withdrawal by Subject|1|||
19651458|NCT00758771|42101072|FG000|Overall Study|Did not meet eligibility criteria|2|||
19651459|NCT00758771|42101073|FG001|Overall Study|Did not meet eligibility criteria|4|||
19651460|NCT00635154|42101079|FG000|Overall Study|Alternative Treatment|8|||
19651461|NCT00635154|42101079|FG000|Overall Study|Other|4|||
19651462|NCT00635154|42101079|FG000|Overall Study|Still on treatment|21|||
19651463|NCT00778895|42101088|FG000|Active Phase|Adverse Event|3|||
19751534|NCT02959918|42200832|FG011|Overall Study|Withdrawal by Subject|3|||
19751535|NCT02959918|42200833|FG012|Overall Study|Withdrawal by Subject|1|||
19751536|NCT02959918|42200834|FG013|Overall Study|Withdrawal by Subject|1|||
19751537|NCT02959918|42200821|FG000|Overall Study|Protocol Violation|0|||
19651464|NCT00778895|42101089|FG001|Active Phase|Adverse Event|1|||
19651465|NCT00778895|42101090|FG002|Active Phase|Adverse Event|0|||
19651466|NCT00778895|42101088|FG000|Active Phase|Withdrawal by Subject|1|||
19651467|NCT00778895|42101089|FG001|Active Phase|Withdrawal by Subject|4|||
19651468|NCT00778895|42101090|FG002|Active Phase|Withdrawal by Subject|0|||
19651469|NCT00778895|42101088|FG000|Active Phase|Lost to Follow-up|1|||
19651470|NCT00778895|42101089|FG001|Active Phase|Lost to Follow-up|1|||
19651471|NCT00778895|42101090|FG002|Active Phase|Lost to Follow-up|0|||
19651472|NCT00778895|42101088|FG000|Active Phase|Other|2|||
19651473|NCT00778895|42101089|FG001|Active Phase|Other|0|||
19651474|NCT00778895|42101090|FG002|Active Phase|Other|0|||
19651475|NCT00778895|42101088|FG000|ESFU Phase|Adverse Event|2|||
19651476|NCT00778895|42101089|FG001|ESFU Phase|Adverse Event|1|||
19651477|NCT00778895|42101090|FG002|ESFU Phase|Adverse Event|0|||
19651478|NCT00778895|42101088|FG000|ESFU Phase|Withdrawal by Subject|1|||
19651479|NCT00778895|42101089|FG001|ESFU Phase|Withdrawal by Subject|4|||
19651480|NCT00778895|42101090|FG002|ESFU Phase|Withdrawal by Subject|0|||
19651481|NCT00778895|42101088|FG000|ESFU Phase|Lost to Follow-up|6|||
19651482|NCT00778895|42101089|FG001|ESFU Phase|Lost to Follow-up|7|||
19651483|NCT00778895|42101090|FG002|ESFU Phase|Lost to Follow-up|2|||
19651484|NCT00778895|42101088|FG000|ESFU Phase|Other|2|||
19651485|NCT00778895|42101089|FG001|ESFU Phase|Other|0|||
19651486|NCT00778895|42101090|FG002|ESFU Phase|Other|0|||
19651487|NCT00293215|42101101|FG000|Overall Study|Progressive disease|3|||
19751538|NCT02959918|42200822|FG001|Overall Study|Protocol Violation|0|||
19651488|NCT00293215|42101102|FG001|Overall Study|Progressive disease|1|||
19651489|NCT00293215|42101101|FG000|Overall Study|Adverse Event|2|||
19651490|NCT00293215|42101102|FG001|Overall Study|Adverse Event|2|||
19651491|NCT00778817|42101108|FG000|Overall Study|Adverse Event|2|||
19651492|NCT00778817|42101108|FG000|Overall Study|Withdrawal by Subject|2|||
19651493|NCT00293059|42101114|FG000|Overall Study|Adverse Event|12|||
19651494|NCT00293059|42101115|FG001|Overall Study|Adverse Event|4|||
19651495|NCT00293059|42101114|FG000|Overall Study|Lack of Efficacy|2|||
19651496|NCT00293059|42101115|FG001|Overall Study|Lack of Efficacy|0|||
19651497|NCT00293059|42101114|FG000|Overall Study|Lost to Follow-up|2|||
19651498|NCT00293059|42101115|FG001|Overall Study|Lost to Follow-up|3|||
19651499|NCT00293059|42101114|FG000|Overall Study|Pregnancy|1|||
19651500|NCT00293059|42101115|FG001|Overall Study|Pregnancy|1|||
19651501|NCT00293059|42101114|FG000|Overall Study|Protocol Violation|2|||
19651502|NCT00293059|42101115|FG001|Overall Study|Protocol Violation|0|||
19651503|NCT00293059|42101114|FG000|Overall Study|Withdrawal by Subject|11|||
19651504|NCT00293059|42101115|FG001|Overall Study|Withdrawal by Subject|5|||
19651505|NCT00293059|42101114|FG000|Overall Study|Participant moved out of state|1|||
19651506|NCT00293059|42101115|FG001|Overall Study|Participant moved out of state|0|||
19651507|NCT00293059|42101114|FG000|Overall Study|Participant stopped study drug|1|||
19651508|NCT00293059|42101115|FG001|Overall Study|Participant stopped study drug|0|||
19651509|NCT00293059|42101114|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
19651510|NCT00293059|42101115|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
19651511|NCT00293059|42101114|FG000|Overall Study|missing|3|||
19651512|NCT00293059|42101115|FG001|Overall Study|missing|5|||
19651513|NCT00756275|42101123|FG000|Overall Study|Lost to Follow-up|25|||
19651514|NCT00756275|42101124|FG001|Overall Study|Lost to Follow-up|21|||
19651515|NCT00756275|42101123|FG000|Overall Study|Withdrawal by Subject|4|||
19651516|NCT00756275|42101124|FG001|Overall Study|Withdrawal by Subject|7|||
19651517|NCT00758459|42101132|FG000|Overall Study|Adverse Event|3|||
19651518|NCT00758459|42101133|FG001|Overall Study|Adverse Event|2|||
19651519|NCT00758459|42101132|FG000|Overall Study|Protocol Violation|0|||
19651520|NCT00758459|42101133|FG001|Overall Study|Protocol Violation|1|||
19651521|NCT00758459|42101132|FG000|Overall Study|Withdrawal by Subject|0|||
19651522|NCT00758459|42101133|FG001|Overall Study|Withdrawal by Subject|1|||
19651523|NCT00298831|42101139|FG000|Overall Study|Adverse Event|1|||
19651524|NCT00298831|42101139|FG000|Overall Study|Lost to Follow-up|3|||
19651525|NCT00298831|42101139|FG000|Overall Study|Withdrawal by Subject|1|||
19651526|NCT00298831|42101139|FG000|Overall Study|Participants did not receive treatment|27|||
19651527|NCT00758069|42101146|FG000|Overall Study|Lack of Efficacy|0|||
19651528|NCT00758069|42101147|FG001|Overall Study|Lack of Efficacy|0|||
19651529|NCT00758069|42101148|FG002|Overall Study|Lack of Efficacy|1|||
19751539|NCT02959918|42200823|FG002|Overall Study|Protocol Violation|1|||
19751540|NCT02959918|42200824|FG003|Overall Study|Protocol Violation|0|||
19651530|NCT00758069|42101146|FG000|Overall Study|Incorrect Study Drug|1|||
19651531|NCT00758069|42101147|FG001|Overall Study|Incorrect Study Drug|0|||
19651532|NCT00758069|42101148|FG002|Overall Study|Incorrect Study Drug|0|||
19651533|NCT00311623|42101159|FG000|Overall Study|Physician Decision|0|||
19651534|NCT00311623|42101160|FG001|Overall Study|Physician Decision|0|||
19651535|NCT00311623|42101161|FG002|Overall Study|Physician Decision|2|||
19651536|NCT00528112|42101172|FG000|Treatment up to 3 Years|Adverse Event|313|||
19651537|NCT00528112|42101173|FG001|Treatment up to 3 Years|Adverse Event|278|||
19651538|NCT00528112|42101172|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
19651539|NCT00528112|42101173|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
19651540|NCT00528112|42101172|FG000|Treatment up to 3 Years|Protocol Violation|16|||
19651541|NCT00528112|42101173|FG001|Treatment up to 3 Years|Protocol Violation|16|||
19651542|NCT00528112|42101172|FG000|Treatment up to 3 Years|Death|0|||
19651543|NCT00528112|42101173|FG001|Treatment up to 3 Years|Death|1|||
19651544|NCT00528112|42101172|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
19651545|NCT00528112|42101173|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
19651546|NCT00528112|42101172|FG000|Treatment up to 3 Years|Pregnancy|9|||
19651547|NCT00528112|42101173|FG001|Treatment up to 3 Years|Pregnancy|10|||
19651548|NCT00528112|42101172|FG000|Treatment up to 3 Years|Other reasons|186|||
19651549|NCT00528112|42101173|FG001|Treatment up to 3 Years|Other reasons|186|||
19651550|NCT00528112|42101172|FG000|Extension Phase|Withdrawal by Subject|0|||
19651551|NCT00528112|42101173|FG001|Extension Phase|Withdrawal by Subject|3|||
19651552|NCT00528112|42101172|FG000|Extension Phase|Other reasons|0|||
19651553|NCT00528112|42101173|FG001|Extension Phase|Other reasons|100|||
19651554|NCT00528112|42101172|FG000|Extension Phase|Pregnancy|0|||
19751541|NCT02959918|42200825|FG004|Overall Study|Protocol Violation|0|||
19751542|NCT02959918|42200826|FG005|Overall Study|Protocol Violation|1|||
19751543|NCT02959918|42200827|FG006|Overall Study|Protocol Violation|0|||
19751544|NCT02959918|42200828|FG007|Overall Study|Protocol Violation|0|||
19751545|NCT02959918|42200829|FG008|Overall Study|Protocol Violation|2|||
19751546|NCT02959918|42200830|FG009|Overall Study|Protocol Violation|1|||
19751547|NCT02959918|42200831|FG010|Overall Study|Protocol Violation|0|||
19751548|NCT02959918|42200832|FG011|Overall Study|Protocol Violation|1|||
19751549|NCT02959918|42200833|FG012|Overall Study|Protocol Violation|1|||
19751550|NCT02959918|42200834|FG013|Overall Study|Protocol Violation|0|||
19751551|NCT02959918|42200821|FG000|Overall Study|Stopping Rule Met|1|||
19751552|NCT02959918|42200822|FG001|Overall Study|Stopping Rule Met|0|||
19651555|NCT00528112|42101173|FG001|Extension Phase|Pregnancy|3|||
19651556|NCT00528112|42101172|FG000|Extension Phase|Lost to Follow-up|0|||
19651557|NCT00528112|42101173|FG001|Extension Phase|Lost to Follow-up|12|||
19651558|NCT00528112|42101172|FG000|Extension Phase|Death|0|||
19651559|NCT00528112|42101173|FG001|Extension Phase|Death|1|||
19651560|NCT00528112|42101172|FG000|Extension Phase|Adverse Event|0|||
19651561|NCT00528112|42101173|FG001|Extension Phase|Adverse Event|36|||
19751553|NCT02959918|42200823|FG002|Overall Study|Stopping Rule Met|3|||
19751554|NCT02959918|42200824|FG003|Overall Study|Stopping Rule Met|4|||
19751555|NCT02959918|42200825|FG004|Overall Study|Stopping Rule Met|5|||
19751556|NCT02959918|42200826|FG005|Overall Study|Stopping Rule Met|3|||
19751557|NCT02959918|42200827|FG006|Overall Study|Stopping Rule Met|2|||
19751558|NCT02959918|42200828|FG007|Overall Study|Stopping Rule Met|4|||
19751559|NCT02959918|42200829|FG008|Overall Study|Stopping Rule Met|1|||
19751560|NCT02959918|42200830|FG009|Overall Study|Stopping Rule Met|1|||
19751561|NCT02959918|42200831|FG010|Overall Study|Stopping Rule Met|3|||
19751562|NCT02959918|42200832|FG011|Overall Study|Stopping Rule Met|5|||
19751563|NCT02959918|42200833|FG012|Overall Study|Stopping Rule Met|2|||
19751564|NCT02959918|42200834|FG013|Overall Study|Stopping Rule Met|1|||
19751565|NCT02959918|42200821|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
19751566|NCT02959918|42200822|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
19751567|NCT02959918|42200823|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
19751568|NCT02959918|42200824|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
19751569|NCT02959918|42200825|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751570|NCT02959918|42200826|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751571|NCT02959918|42200827|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751572|NCT02959918|42200828|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751573|NCT02959918|42200829|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751574|NCT02959918|42200830|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751575|NCT02959918|42200831|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751576|NCT02959918|42200832|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751577|NCT02959918|42200833|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751578|NCT02959918|42200834|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
19751579|NCT02959918|42200821|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751580|NCT02959918|42200822|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751581|NCT02959918|42200823|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751582|NCT02959918|42200824|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751583|NCT02959918|42200825|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751584|NCT02959918|42200826|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751585|NCT02959918|42200827|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751586|NCT02959918|42200828|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
19751587|NCT02959918|42200829|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751588|NCT02959918|42200830|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751589|NCT02959918|42200831|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751590|NCT02959918|42200832|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751591|NCT02959918|42200833|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751592|NCT02959918|42200834|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
19751593|NCT02959918|42200821|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751594|NCT02959918|42200822|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751595|NCT02959918|42200823|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751596|NCT02959918|42200824|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751597|NCT02959918|42200825|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751598|NCT02959918|42200826|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19601311|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
19601312|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
19601313|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
19601314|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
19601315|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
19601316|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
19601317|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
19601318|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
19601319|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
19601320|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
19601321|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
19601322|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
19601323|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
19601324|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
19651562|NCT00528112|42101172|FG000|Extension Phase|Protocol Violation|0|||
19651563|NCT00528112|42101173|FG001|Extension Phase|Protocol Violation|2|||
19651564|NCT00633594|42101184|FG000|Overall Study|Adverse Event|0|||
19651565|NCT00633594|42101185|FG001|Overall Study|Adverse Event|4|||
19651566|NCT00633594|42101186|FG002|Overall Study|Adverse Event|7|||
19651567|NCT00633594|42101184|FG000|Overall Study|Death|0|||
19651568|NCT00633594|42101185|FG001|Overall Study|Death|1|||
19651569|NCT00633594|42101186|FG002|Overall Study|Death|2|||
19751599|NCT02959918|42200827|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751600|NCT02959918|42200828|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751601|NCT02959918|42200829|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
19751602|NCT02959918|42200830|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751603|NCT02959918|42200831|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751604|NCT02959918|42200832|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751605|NCT02959918|42200833|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751606|NCT02959918|42200834|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
19751607|NCT02959918|42200821|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751608|NCT02959918|42200822|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751609|NCT02959918|42200823|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751610|NCT02959918|42200824|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19651570|NCT00633594|42101184|FG000|Overall Study|Disease Progression|0|||
19651571|NCT00633594|42101185|FG001|Overall Study|Disease Progression|0|||
19651572|NCT00633594|42101186|FG002|Overall Study|Disease Progression|1|||
19651573|NCT00755807|42101199|FG000|Acute Phase|Adverse Event|16|||
19651574|NCT00755807|42101200|FG001|Acute Phase|Adverse Event|5|||
19651575|NCT00755807|42101199|FG000|Acute Phase|Protocol Violation|1|||
19651576|NCT00755807|42101200|FG001|Acute Phase|Protocol Violation|3|||
19651577|NCT00755807|42101199|FG000|Acute Phase|Withdrawal by Subject|1|||
19651578|NCT00755807|42101200|FG001|Acute Phase|Withdrawal by Subject|2|||
19651579|NCT00755807|42101199|FG000|Acute Phase|Lack of Efficacy|0|||
19388235|NCT02698865|41631622|FG001|Overall Study|Lost to Follow-up|2|||
19388236|NCT02698787|41631630|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
19388237|NCT02698787|41631631|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
19388238|NCT02698475|41631638|FG000|Main Study Period|Lack of Efficacy|1|||
19388239|NCT02698475|41631638|FG000|Main Study Period|Protocol Violation|2|||
19388240|NCT02698475|41631638|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
19388241|NCT02698475|41631638|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
19388242|NCT02698475|41631638|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
19651580|NCT00755807|42101200|FG001|Acute Phase|Lack of Efficacy|1|||
19651581|NCT00755807|42101199|FG000|Acute Phase|Physician Decision|0|||
19651582|NCT00755807|42101200|FG001|Acute Phase|Physician Decision|1|||
19651583|NCT00755807|42101199|FG000|Open-label Extension Phase|Adverse Event|7|||
19651584|NCT00755807|42101200|FG001|Open-label Extension Phase|Adverse Event|7|||
19651585|NCT00755807|42101199|FG000|Open-label Extension Phase|Protocol Violation|5|||
19651586|NCT00755807|42101200|FG001|Open-label Extension Phase|Protocol Violation|2|||
19651587|NCT00755807|42101199|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
19651588|NCT00755807|42101200|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
19651589|NCT00755807|42101199|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
19651590|NCT00755807|42101200|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
19651591|NCT00755807|42101199|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
19651592|NCT00755807|42101200|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
19651593|NCT00755807|42101199|FG000|Open-label Extension Phase|Sponsor Decision|0|||
19651594|NCT00755807|42101200|FG001|Open-label Extension Phase|Sponsor Decision|1|||
19651595|NCT00631410|42101212|FG000|Overall Study|Adverse Event|1|||
19651596|NCT00631410|42101213|FG001|Overall Study|Adverse Event|3|||
19651597|NCT00631410|42101212|FG000|Overall Study|Objective Progression or Relapse|4|||
19651598|NCT00631410|42101213|FG001|Overall Study|Objective Progression or Relapse|3|||
19651599|NCT00631410|42101212|FG000|Overall Study|Surgery|1|||
19651600|NCT00631410|42101213|FG001|Overall Study|Surgery|0|||
19651601|NCT03686176|42101225|FG000|Overall Study|Procedure cancelled|1|||
19651602|NCT03686176|42101226|FG001|Overall Study|Procedure cancelled|0|||
19651603|NCT03686176|42101227|FG002|Overall Study|Procedure cancelled|0|||
19651604|NCT03686176|42101225|FG000|Overall Study|VR Malfunction|1|||
19651605|NCT03686176|42101226|FG001|Overall Study|VR Malfunction|0|||
19651606|NCT03686176|42101227|FG002|Overall Study|VR Malfunction|0|||
19651607|NCT00755417|42101238|FG000|Overall Study|Adverse Event|28|||
19651608|NCT00755417|42101239|FG001|Overall Study|Adverse Event|20|||
19651609|NCT00755417|42101240|FG002|Overall Study|Adverse Event|7|||
19651610|NCT00755417|42101238|FG000|Overall Study|Lack of Efficacy|8|||
19651611|NCT00755417|42101239|FG001|Overall Study|Lack of Efficacy|4|||
19651612|NCT00755417|42101240|FG002|Overall Study|Lack of Efficacy|9|||
19651613|NCT00755417|42101238|FG000|Overall Study|Protocol Violation|2|||
19651614|NCT00755417|42101239|FG001|Overall Study|Protocol Violation|1|||
19651615|NCT00755417|42101240|FG002|Overall Study|Protocol Violation|1|||
19651616|NCT00755417|42101238|FG000|Overall Study|Lost to Follow-up|3|||
19651617|NCT00755417|42101239|FG001|Overall Study|Lost to Follow-up|0|||
19651618|NCT00755417|42101240|FG002|Overall Study|Lost to Follow-up|1|||
19651619|NCT00755417|42101238|FG000|Overall Study|Withdrawal by Subject|12|||
19651620|NCT00755417|42101239|FG001|Overall Study|Withdrawal by Subject|12|||
19651621|NCT00755417|42101240|FG002|Overall Study|Withdrawal by Subject|12|||
19651622|NCT00755417|42101238|FG000|Overall Study|Not specified or missing data|9|||
19651623|NCT00755417|42101239|FG001|Overall Study|Not specified or missing data|18|||
19651624|NCT00755417|42101240|FG002|Overall Study|Not specified or missing data|12|||
19651625|NCT03685708|42101251|FG000|Overall Study|Withdrawal by Subject|0|||
19651626|NCT03685708|42101252|FG001|Overall Study|Withdrawal by Subject|0|||
19651627|NCT03685708|42101253|FG002|Overall Study|Withdrawal by Subject|1|||
19651628|NCT03685708|42101251|FG000|Overall Study|Screen Fail|0|||
19651629|NCT03685708|42101252|FG001|Overall Study|Screen Fail|1|||
19651630|NCT03685708|42101253|FG002|Overall Study|Screen Fail|1|||
19651631|NCT03685708|42101251|FG000|Overall Study|COVID 19 Pandemic|1|||
19751611|NCT02959918|42200825|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751612|NCT02959918|42200826|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751613|NCT02959918|42200827|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751614|NCT02959918|42200828|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751615|NCT02959918|42200829|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751616|NCT02959918|42200830|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
19751617|NCT02959918|42200831|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751618|NCT02959918|42200832|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751619|NCT02959918|42200833|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19651632|NCT03685708|42101252|FG001|Overall Study|COVID 19 Pandemic|1|||
19651633|NCT03685708|42101253|FG002|Overall Study|COVID 19 Pandemic|6|||
19651634|NCT03685708|42101251|FG000|Overall Study|Disease Progression|0|||
19651635|NCT03685708|42101252|FG001|Overall Study|Disease Progression|0|||
19651636|NCT03685708|42101253|FG002|Overall Study|Disease Progression|1|||
19651637|NCT03684928|42101261|FG000|First Intervention|Lost to Follow-up|0|||
19651638|NCT03684928|42101262|FG001|First Intervention|Lost to Follow-up|1|||
19651639|NCT03684928|42101261|FG000|First Intervention|Withdrawal by Subject|0|||
19651640|NCT03684928|42101262|FG001|First Intervention|Withdrawal by Subject|2|||
19651641|NCT03684928|42101261|FG000|Second Intervention|Soft Tissue Injury|1|||
19651642|NCT03684928|42101262|FG001|Second Intervention|Soft Tissue Injury|0|||
19651643|NCT00777803|42101270|FG000|Overall Study|Lost to Follow-up|12|||
19651644|NCT00777803|42101271|FG001|Overall Study|Lost to Follow-up|5|||
19651645|NCT00777803|42101270|FG000|Overall Study|Adverse Event|1|||
19651646|NCT00777803|42101271|FG001|Overall Study|Adverse Event|0|||
19651647|NCT00777803|42101270|FG000|Overall Study|Non-compliance|2|||
19651648|NCT00777803|42101271|FG001|Overall Study|Non-compliance|2|||
19651649|NCT00527488|42101281|FG000|Overall Study|Withdrawn prior to dosing|0|||
19651650|NCT00527488|42101282|FG001|Overall Study|Withdrawn prior to dosing|1|||
19651651|NCT00527488|42101283|FG002|Overall Study|Withdrawn prior to dosing|1|||
19651652|NCT00527488|42101284|FG003|Overall Study|Withdrawn prior to dosing|0|||
19651653|NCT00527332|42101296|FG000|Overall Study|Protocol Violation|4|||
19651654|NCT00527332|42101297|FG001|Overall Study|Protocol Violation|8|||
19651655|NCT00527332|42101296|FG000|Overall Study|Withdrew consent|5|||
19651656|NCT00527332|42101297|FG001|Overall Study|Withdrew consent|1|||
19651657|NCT00752609|42101305|FG000|Overall Study|Adverse Event|2|||
19651658|NCT00752609|42101306|FG001|Overall Study|Adverse Event|2|||
19651659|NCT00752609|42101305|FG000|Overall Study|Withdrawal by Subject|3|||
19651660|NCT00752609|42101306|FG001|Overall Study|Withdrawal by Subject|0|||
19651661|NCT00752609|42101305|FG000|Overall Study|Physician Decision|1|||
19651662|NCT00752609|42101306|FG001|Overall Study|Physician Decision|0|||
19651663|NCT00752609|42101305|FG000|Overall Study|Death|1|||
19651664|NCT00752609|42101306|FG001|Overall Study|Death|0|||
19651665|NCT00752609|42101305|FG000|Overall Study|Met exclusion criteria|1|||
19651666|NCT00752609|42101306|FG001|Overall Study|Met exclusion criteria|0|||
19651667|NCT00752609|42101305|FG000|Overall Study|Received Aranesp in error|1|||
19651668|NCT00752609|42101306|FG001|Overall Study|Received Aranesp in error|0|||
19651669|NCT03684304|42101317|FG000|Overall Study|Lost to Follow-up|19|||
19651670|NCT03684304|42101318|FG001|Overall Study|Lost to Follow-up|17|||
19651671|NCT00629772|42101326|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
19651672|NCT00629772|42101327|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
19651673|NCT00629772|42101326|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
19651674|NCT00629772|42101327|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
19651675|NCT00526630|42101334|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
19651676|NCT00526630|42101335|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
19651677|NCT00526630|42101334|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
19651678|NCT00526630|42101335|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
19651679|NCT00755183|42101345|FG000|Overall Study|Adverse Event|5|||
19651680|NCT00755183|42101346|FG001|Overall Study|Adverse Event|2|||
19651681|NCT00755183|42101345|FG000|Overall Study|Protocol Violation|0|||
19651682|NCT00755183|42101346|FG001|Overall Study|Protocol Violation|1|||
19651683|NCT00755183|42101345|FG000|Overall Study|Withdrawal by Subject|0|||
19651684|NCT00755183|42101346|FG001|Overall Study|Withdrawal by Subject|2|||
19651685|NCT00755183|42101345|FG000|Overall Study|Administrative|2|||
19651686|NCT00755183|42101346|FG001|Overall Study|Administrative|1|||
19651687|NCT00755105|42101357|FG000|Overall Study|Withdrawal by Subject|9|||
19651688|NCT00755105|42101358|FG001|Overall Study|Withdrawal by Subject|11|||
19651689|NCT00755105|42101359|FG002|Overall Study|Withdrawal by Subject|4|||
19651690|NCT00526162|42101367|FG000|Overall Study|Device not implanted|3|||
19651691|NCT03875482|42101377|FG000|Overall Study|Adverse Event|0|||
19651692|NCT03875482|42101378|FG001|Overall Study|Adverse Event|1|||
19651693|NCT03875482|42101377|FG000|Overall Study|Withdrew consent|5|||
19651694|NCT03875482|42101378|FG001|Overall Study|Withdrew consent|6|||
19651695|NCT03875482|42101377|FG000|Overall Study|Lost to Follow-up|8|||
19651696|NCT03875482|42101378|FG001|Overall Study|Lost to Follow-up|2|||
19651697|NCT03875482|42101377|FG000|Overall Study|Lack of Efficacy|0|||
19651698|NCT03875482|42101378|FG001|Overall Study|Lack of Efficacy|11|||
19651699|NCT00754793|42101386|FG000|Overall Study|voluntary withdrawn from study|0|||
19651700|NCT00754793|42101387|FG001|Overall Study|voluntary withdrawn from study|1|||
19651701|NCT00586469|42101395|FG000|Overall Study|Adverse Event|0|||
19651702|NCT00586469|42101396|FG001|Overall Study|Adverse Event|1|||
19651703|NCT00626028|42101404|FG000|Overall Study|Adverse Event|1|||
19651704|NCT00626028|42101405|FG001|Overall Study|Adverse Event|1|||
19651705|NCT00626028|42101404|FG000|Overall Study|Device Failure|0|||
19651706|NCT00626028|42101405|FG001|Overall Study|Device Failure|1|||
19651707|NCT00626028|42101404|FG000|Overall Study|Physician Decision|2|||
19651708|NCT00626028|42101405|FG001|Overall Study|Physician Decision|1|||
19651709|NCT00626028|42101404|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
19651710|NCT00626028|42101405|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
19651711|NCT00777257|42101414|FG000|Overall Study|Adverse Event|3|||
19651712|NCT00777257|42101415|FG001|Overall Study|Adverse Event|1|||
19651713|NCT00777257|42101416|FG002|Overall Study|Adverse Event|0|||
19651714|NCT00777257|42101414|FG000|Overall Study|Lost to Follow-up|3|||
19651715|NCT00777257|42101415|FG001|Overall Study|Lost to Follow-up|3|||
19651716|NCT00777257|42101416|FG002|Overall Study|Lost to Follow-up|2|||
19651717|NCT00777257|42101414|FG000|Overall Study|Protocol Violation|2|||
19651718|NCT00777257|42101415|FG001|Overall Study|Protocol Violation|2|||
19651719|NCT00777257|42101416|FG002|Overall Study|Protocol Violation|2|||
19651720|NCT00777257|42101414|FG000|Overall Study|Withdrawal by Subject|3|||
19651721|NCT00777257|42101415|FG001|Overall Study|Withdrawal by Subject|6|||
19651722|NCT00777257|42101416|FG002|Overall Study|Withdrawal by Subject|5|||
19651723|NCT00628758|42101426|FG000|Overall Study|Adverse Event|2|||
19651724|NCT00628758|42101427|FG001|Overall Study|Adverse Event|3|||
19651725|NCT00628758|42101426|FG000|Overall Study|Withdrawal by Subject|6|||
19651726|NCT00628758|42101427|FG001|Overall Study|Withdrawal by Subject|3|||
19651727|NCT00628758|42101426|FG000|Overall Study|Death|1|||
19651728|NCT00628758|42101427|FG001|Overall Study|Death|0|||
19651729|NCT00628758|42101426|FG000|Overall Study|Protocol Violation|5|||
19651730|NCT00628758|42101427|FG001|Overall Study|Protocol Violation|1|||
19651731|NCT00628758|42101426|FG000|Overall Study|Lost to Follow-up|25|||
19651732|NCT00628758|42101427|FG001|Overall Study|Lost to Follow-up|31|||
19651733|NCT00628758|42101426|FG000|Overall Study|Pregnancy|2|||
19651734|NCT00628758|42101427|FG001|Overall Study|Pregnancy|2|||
19651735|NCT00628758|42101426|FG000|Overall Study|Investigator Moved|3|||
19651736|NCT00628758|42101427|FG001|Overall Study|Investigator Moved|0|||
19651737|NCT00628758|42101426|FG000|Overall Study|Treatment Failure|0|||
19651738|NCT00628758|42101427|FG001|Overall Study|Treatment Failure|2|||
19651739|NCT04491604|42101435|FG000|Overall Study|Withdrawal by Subject|3|||
19651740|NCT00628446|42101440|FG000|Overall Study|Lost to Follow-up|3|||
19651741|NCT00628446|42101440|FG000|Overall Study|Withdrawal by Subject|1|||
19651742|NCT00628446|42101440|FG000|Overall Study|Protocol Violation|3|||
19651743|NCT00754559|42101445|FG000|Overall Study|Adverse Event|15|||
19651744|NCT00754559|42101445|FG000|Overall Study|Protocol Violation|11|||
19651745|NCT00754559|42101445|FG000|Overall Study|Lack of Efficacy|10|||
19651746|NCT00754559|42101445|FG000|Overall Study|Lost to Follow-up|2|||
19651747|NCT00754559|42101445|FG000|Overall Study|Administrative reason|1|||
19651748|NCT00754559|42101445|FG000|Overall Study|Other|5|||
19651749|NCT00754559|42101445|FG000|Overall Study|Withdrawal by Subject|3|||
19651750|NCT00525148|42101456|FG000|Overall Study|Other Adverse Event|3|||
19651751|NCT00525148|42101457|FG001|Overall Study|Other Adverse Event|5|||
19651752|NCT00525148|42101458|FG002|Overall Study|Other Adverse Event|1|||
19651753|NCT00525148|42101459|FG003|Overall Study|Other Adverse Event|8|||
19651754|NCT00525148|42101456|FG000|Overall Study|Progressive disease|18|||
19651755|NCT00525148|42101457|FG001|Overall Study|Progressive disease|30|||
19651756|NCT00525148|42101458|FG002|Overall Study|Progressive disease|6|||
19651757|NCT00525148|42101459|FG003|Overall Study|Progressive disease|49|||
19651758|NCT00525148|42101456|FG000|Overall Study|Refused continuation of study medication|0|||
19651759|NCT00525148|42101457|FG001|Overall Study|Refused continuation of study medication|2|||
19651760|NCT00525148|42101458|FG002|Overall Study|Refused continuation of study medication|0|||
19651761|NCT00525148|42101459|FG003|Overall Study|Refused continuation of study medication|1|||
19651762|NCT00525148|42101456|FG000|Overall Study|Other than stated|2|||
19651763|NCT00525148|42101457|FG001|Overall Study|Other than stated|1|||
19651764|NCT00525148|42101458|FG002|Overall Study|Other than stated|0|||
19651765|NCT00525148|42101459|FG003|Overall Study|Other than stated|3|||
19651766|NCT00754325|42101471|FG000|Initial Treatment|Continuing Active Treatment|4|||
19651767|NCT00754325|42101472|FG001|Initial Treatment|Continuing Active Treatment|5|||
19651768|NCT00754325|42101471|FG000|Initial Treatment|Adverse Event|7|||
19651769|NCT00754325|42101472|FG001|Initial Treatment|Adverse Event|6|||
19651770|NCT00754325|42101471|FG000|Initial Treatment|Withdrawal by Subject|2|||
19651771|NCT00754325|42101472|FG001|Initial Treatment|Withdrawal by Subject|2|||
19651772|NCT00754325|42101471|FG000|Initial Treatment|Physician Decision|2|||
19651773|NCT00754325|42101472|FG001|Initial Treatment|Physician Decision|0|||
19751620|NCT02959918|42200834|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
19751621|NCT03263442|42200869|FG000|Inpatient Phase|Death|1|||
19751622|NCT03263442|42200870|FG001|Inpatient Phase|Death|0|||
19751623|NCT03263442|42200869|FG000|Inpatient Phase|Withdrawal by Subject|1|||
19751624|NCT03263442|42200870|FG001|Inpatient Phase|Withdrawal by Subject|0|||
19751625|NCT03263442|42200869|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
19751626|NCT03263442|42200870|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
19751627|NCT03263442|42200869|FG000|1-month Follow-Up|Lost to Follow-up|1|||
19651774|NCT00754325|42101471|FG000|Initial Treatment|Sponsor Request|0|||
19651775|NCT00754325|42101472|FG001|Initial Treatment|Sponsor Request|1|||
19651776|NCT00754325|42101471|FG000|Initial Treatment|Disease Progression|35|||
19651777|NCT00754325|42101472|FG001|Initial Treatment|Disease Progression|35|||
19751628|NCT03263442|42200870|FG001|1-month Follow-Up|Lost to Follow-up|0|||
19651778|NCT00524680|42101483|FG000|Overall Study|progression|0|||
19651779|NCT00524680|42101484|FG001|Overall Study|progression|0|||
19651780|NCT00524680|42101485|FG002|Overall Study|progression|0|||
19651781|NCT00524680|42101486|FG003|Overall Study|progression|1|||
19651782|NCT00524680|42101483|FG000|Overall Study|Adverse Event|2|||
19651783|NCT00524680|42101484|FG001|Overall Study|Adverse Event|0|||
19651784|NCT00524680|42101485|FG002|Overall Study|Adverse Event|0|||
19651785|NCT00524680|42101486|FG003|Overall Study|Adverse Event|1|||
19651786|NCT00524680|42101483|FG000|Overall Study|Other|0|||
19651787|NCT00524680|42101484|FG001|Overall Study|Other|1|||
19751629|NCT03263442|42200869|FG000|3-month Follow-Up|Lost to Follow-up|1|||
19751630|NCT03263442|42200870|FG001|3-month Follow-Up|Lost to Follow-up|3|||
19751631|NCT03263442|42200869|FG000|6-month Follow-Up|Lost to Follow-up|2|||
19751632|NCT03263442|42200870|FG001|6-month Follow-Up|Lost to Follow-up|2|||
19751633|NCT04245709|42200878|FG000|Overall Study|Adverse Event|13|||
19751634|NCT04245709|42200878|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
19751635|NCT04091581|42200884|FG000|Overall Study|Lost to Follow-up|0|||
19601325|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
19601326|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
19601327|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
19601328|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
19601329|NCT00773734|42049966|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
19601330|NCT00773734|42049967|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
19601331|NCT00773734|42049968|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
19601332|NCT00773734|42049969|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
19601333|NCT00773734|42049970|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
19651788|NCT00524680|42101485|FG002|Overall Study|Other|2|||
19651789|NCT00524680|42101486|FG003|Overall Study|Other|3|||
19651790|NCT00524680|42101483|FG000|Overall Study|Withdrawal by Subject|1|||
19651791|NCT00524680|42101484|FG001|Overall Study|Withdrawal by Subject|0|||
19651792|NCT00524680|42101485|FG002|Overall Study|Withdrawal by Subject|1|||
19651793|NCT00524680|42101486|FG003|Overall Study|Withdrawal by Subject|1|||
19751636|NCT04091581|42200885|FG001|Overall Study|Lost to Follow-up|1|||
19751637|NCT02940522|42200893|FG000|Overall Study|Lost to Follow-up|1|||
19751638|NCT02940522|42200894|FG001|Overall Study|Lost to Follow-up|2|||
19388243|NCT02698475|41631638|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
19388244|NCT02698475|41631638|FG000|Long-Term Extension Period|Other|1|||
19651794|NCT00628212|42101500|FG000|Overall Study|Adverse Event|2|||
19651795|NCT00628212|42101501|FG001|Overall Study|Adverse Event|0|||
19751639|NCT02940522|42200893|FG000|Overall Study|Withdrawal by Subject|1|||
19751640|NCT02940522|42200894|FG001|Overall Study|Withdrawal by Subject|0|||
19651796|NCT00628212|42101502|FG002|Overall Study|Adverse Event|1|||
19651797|NCT00628212|42101503|FG003|Overall Study|Adverse Event|2|||
19651798|NCT00628212|42101500|FG000|Overall Study|Physician Decision|1|||
19651799|NCT00628212|42101501|FG001|Overall Study|Physician Decision|1|||
19651800|NCT00628212|42101502|FG002|Overall Study|Physician Decision|2|||
19651801|NCT00628212|42101503|FG003|Overall Study|Physician Decision|3|||
19651802|NCT00298363|42101516|FG000|Overall Study|Lost to Follow-up|0|||
19651803|NCT00298363|42101517|FG001|Overall Study|Lost to Follow-up|0|||
19651804|NCT00298363|42101518|FG002|Overall Study|Lost to Follow-up|1|||
19651805|NCT00298363|42101516|FG000|Overall Study|Physician Decision|4|||
19651806|NCT00298363|42101517|FG001|Overall Study|Physician Decision|1|||
19751641|NCT03262038|42200902|FG000|Overall Study|Withdrawal by Subject|0|||
19751642|NCT03262038|42200903|FG001|Overall Study|Withdrawal by Subject|1|||
19751643|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
19751644|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
19751645|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|disease progression|58|||
19751646|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|disease progression|47|||
19751647|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Death|3|||
19751648|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Death|6|||
19751649|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
19751650|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
19751651|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
19751652|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
19751653|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
19751654|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
19751655|NCT02472964|42200911|FG000|Part 1 (up to Week 24)|Other|2|||
19751656|NCT02472964|42200912|FG001|Part 1 (up to Week 24)|Other|1|||
19751657|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
19751658|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
19751659|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
19751660|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
19751661|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Death|0|||
19751662|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Death|1|||
19751663|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
19751664|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
19751665|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
19751666|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
19751667|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
19601334|NCT00773734|42049971|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
19601335|NCT00773734|42049966|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
19601336|NCT00773734|42049967|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
19601337|NCT00773734|42049968|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
19601338|NCT00773734|42049969|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
19601339|NCT00773734|42049970|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
19601340|NCT00773734|42049971|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
19601341|NCT00773734|42049966|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
19601342|NCT00773734|42049967|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
19601343|NCT00773734|42049968|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
19601344|NCT00773734|42049969|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
19651807|NCT00298363|42101518|FG002|Overall Study|Physician Decision|0|||
19651808|NCT00298363|42101516|FG000|Overall Study|Protocol Violation|1|||
19651809|NCT00298363|42101517|FG001|Overall Study|Protocol Violation|1|||
19751668|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
19751669|NCT02472964|42200911|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
19751670|NCT02472964|42200912|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
19751671|NCT04223791|42200920|FG000|Overall Study|Lost to Follow-up|0|||
19751672|NCT04223791|42200921|FG001|Overall Study|Lost to Follow-up|4|||
19751673|NCT04223791|42200920|FG000|Overall Study|Physician Decision|5|||
19751674|NCT04223791|42200921|FG001|Overall Study|Physician Decision|1|||
19651810|NCT00298363|42101518|FG002|Overall Study|Protocol Violation|0|||
19751675|NCT04223791|42200920|FG000|Overall Study|Protocol Violation|1|||
19751676|NCT04223791|42200921|FG001|Overall Study|Protocol Violation|1|||
19751677|NCT04223791|42200920|FG000|Overall Study|Withdrawal by Subject|10|||
19751678|NCT04223791|42200921|FG001|Overall Study|Withdrawal by Subject|12|||
19751679|NCT04223791|42200920|FG000|Overall Study|Pregnancy|1|||
19751680|NCT04223791|42200921|FG001|Overall Study|Pregnancy|1|||
19751681|NCT04223791|42200920|FG000|Overall Study|Ongoing in Study|305|||
19751682|NCT04223791|42200921|FG001|Overall Study|Ongoing in Study|302|||
19751683|NCT04079803|42200934|FG000|Overall Study|Withdrawal by Subject|0|||
19751684|NCT04079803|42200935|FG001|Overall Study|Withdrawal by Subject|0|||
19751685|NCT04079803|42200936|FG002|Overall Study|Withdrawal by Subject|1|||
19751686|NCT03278613|42200964|FG000|Overall Study|Lost to Follow-up|3|||
19751687|NCT03278613|42200965|FG001|Overall Study|Lost to Follow-up|1|||
19751688|NCT03761147|42200973|FG000|Overall Study|Withdrawal by Subject|6|||
19751689|NCT03761147|42200974|FG001|Overall Study|Withdrawal by Subject|1|||
19751690|NCT03761147|42200973|FG000|Overall Study|Adverse Event|1|||
19751691|NCT03761147|42200974|FG001|Overall Study|Adverse Event|3|||
19751692|NCT04076917|42200980|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
19751693|NCT04076917|42200980|FG000|Overall Study|Study closure|13|||
19751694|NCT04076917|42200980|FG000|Overall Study|Physician Decision|3|||
19751695|NCT04076917|42200980|FG000|Overall Study|Death|1|||
19751696|NCT04076917|42200980|FG000|Overall Study|Lost to Follow-up|1|||
19751697|NCT04076917|42200980|FG000|Overall Study|Withdrawal by Subject|1|||
19751698|NCT04076917|42200980|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
19751699|NCT04222699|42200984|FG000|Overall Study|Lost to Follow-up|2|||
19751700|NCT02731690|42200997|FG000|Overall Study|Adverse Event|1|||
19751701|NCT02731690|42200997|FG000|Overall Study|Withdrawal by Subject|3|||
19751702|NCT02731690|42200997|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
19751703|NCT04075513|42201003|FG000|Overall Study|Withdrawal by Subject|2|||
19751704|NCT04075513|42201004|FG001|Overall Study|Withdrawal by Subject|2|||
19751705|NCT04075513|42201003|FG000|Overall Study|Lack of Efficacy|1|||
19751706|NCT04075513|42201004|FG001|Overall Study|Lack of Efficacy|0|||
19751707|NCT04075513|42201003|FG000|Overall Study|Lost to Follow-up|4|||
19751708|NCT04075513|42201004|FG001|Overall Study|Lost to Follow-up|2|||
19751709|NCT04075513|42201003|FG000|Overall Study|Switch to insulin pump|1|||
19751710|NCT04075513|42201004|FG001|Overall Study|Switch to insulin pump|0|||
19751711|NCT04073407|42201012|FG000|Part 1|Withdrawal by Subject|1|||
19751712|NCT04073407|42201013|FG001|Part 1|Withdrawal by Subject|0|||
19751713|NCT04073407|42201012|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
19751714|NCT04073407|42201013|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
19751715|NCT04073407|42201012|FG000|Part 2|Withdrawal by Subject|0|||
19751716|NCT04073407|42201013|FG001|Part 2|Withdrawal by Subject|1|||
19751717|NCT02778204|42201023|FG000|Overall Study|Adverse Event|1|||
19751718|NCT02778204|42201024|FG001|Overall Study|Adverse Event|0|||
19751719|NCT02778204|42201025|FG002|Overall Study|Adverse Event|0|||
19751720|NCT02778204|42201026|FG003|Overall Study|Adverse Event|0|||
19751721|NCT02778204|42201023|FG000|Overall Study|Withdrawal by Subject|0|||
19751722|NCT02778204|42201024|FG001|Overall Study|Withdrawal by Subject|0|||
19751723|NCT02778204|42201025|FG002|Overall Study|Withdrawal by Subject|1|||
19751724|NCT02778204|42201026|FG003|Overall Study|Withdrawal by Subject|2|||
19651811|NCT00298363|42101516|FG000|Overall Study|Withdrawal by Subject|5|||
19651812|NCT00298363|42101517|FG001|Overall Study|Withdrawal by Subject|1|||
19651813|NCT00298363|42101518|FG002|Overall Study|Withdrawal by Subject|3|||
19651814|NCT00298363|42101516|FG000|Overall Study|Adverse Event|5|||
19651815|NCT00298363|42101517|FG001|Overall Study|Adverse Event|2|||
19651816|NCT00298363|42101518|FG002|Overall Study|Adverse Event|2|||
19651817|NCT00298363|42101516|FG000|Overall Study|Lack of Efficacy|2|||
19651818|NCT00298363|42101517|FG001|Overall Study|Lack of Efficacy|3|||
19651819|NCT00298363|42101518|FG002|Overall Study|Lack of Efficacy|0|||
19651820|NCT00524368|42101534|FG000|Overall Study|Adverse Event|10|||
19651821|NCT00524368|42101535|FG001|Overall Study|Adverse Event|12|||
19651822|NCT00524368|42101534|FG000|Overall Study|Lost to Follow-up|9|||
19651823|NCT00524368|42101535|FG001|Overall Study|Lost to Follow-up|13|||
19651824|NCT00524368|42101534|FG000|Overall Study|Withdrawal by Subject|4|||
19651825|NCT00524368|42101535|FG001|Overall Study|Withdrawal by Subject|5|||
19651826|NCT00524368|42101534|FG000|Overall Study|Non-compliant|8|||
19651827|NCT00524368|42101535|FG001|Overall Study|Non-compliant|9|||
19651828|NCT00524368|42101534|FG000|Overall Study|Reached a Virologic Endpoint|3|||
19651829|NCT00524368|42101535|FG001|Overall Study|Reached a Virologic Endpoint|2|||
19651830|NCT00524368|42101534|FG000|Overall Study|Sponsor's Decision|2|||
19651831|NCT00524368|42101535|FG001|Overall Study|Sponsor's Decision|0|||
19651832|NCT00524368|42101534|FG000|Overall Study|Ineligible to Continue the study|2|||
19751725|NCT02778204|42201023|FG000|Overall Study|Lost to Follow-up|1|||
19751726|NCT02778204|42201024|FG001|Overall Study|Lost to Follow-up|0|||
19751727|NCT02778204|42201025|FG002|Overall Study|Lost to Follow-up|2|||
19751728|NCT02778204|42201026|FG003|Overall Study|Lost to Follow-up|1|||
19751729|NCT02778204|42201023|FG000|Overall Study|Protocol Violation|0|||
19651833|NCT00524368|42101535|FG001|Overall Study|Ineligible to Continue the study|5|||
19651834|NCT00524368|42101534|FG000|Overall Study|Other|3|||
19751730|NCT02778204|42201024|FG001|Overall Study|Protocol Violation|0|||
19751731|NCT02778204|42201025|FG002|Overall Study|Protocol Violation|1|||
19751732|NCT02778204|42201026|FG003|Overall Study|Protocol Violation|0|||
19751733|NCT02778204|42201023|FG000|Overall Study|Eligibility Violation|0|||
19751734|NCT02778204|42201024|FG001|Overall Study|Eligibility Violation|0|||
19751735|NCT02778204|42201025|FG002|Overall Study|Eligibility Violation|0|||
19751736|NCT02778204|42201026|FG003|Overall Study|Eligibility Violation|1|||
19751737|NCT04072159|42201040|FG000|Overall Study|Lost to Follow-up|6|||
19751738|NCT04072159|42201041|FG001|Overall Study|Lost to Follow-up|6|||
19751739|NCT04072159|42201040|FG000|Overall Study|Withdrawal by Subject|2|||
19751740|NCT04072159|42201041|FG001|Overall Study|Withdrawal by Subject|0|||
19751741|NCT03232281|42201051|FG000|Overall Study|Adverse Event|1|||
19751742|NCT03232281|42201052|FG001|Overall Study|Adverse Event|1|||
19751743|NCT03232281|42201051|FG000|Overall Study|Withdrawal by Subject|5|||
19751744|NCT03232281|42201052|FG001|Overall Study|Withdrawal by Subject|4|||
19751745|NCT03232281|42201051|FG000|Overall Study|Protocol Deviation|1|||
19751746|NCT03232281|42201052|FG001|Overall Study|Protocol Deviation|1|||
19751747|NCT04071301|42201058|FG000|Overall Study|Withdrawal by Subject|6|||
19751748|NCT04071301|42201058|FG000|Overall Study|Death|1|||
19751749|NCT03261336|42201062|FG000|Overall Study|Adverse Event|1|||
19751750|NCT00462748|42201069|FG000|Overall Study|Adverse Event|7|||
19751751|NCT00462748|42201070|FG001|Overall Study|Adverse Event|5|||
19751752|NCT00462748|42201071|FG002|Overall Study|Adverse Event|9|||
19751753|NCT00462748|42201069|FG000|Overall Study|Protocol Violation|0|||
19651835|NCT00524368|42101535|FG001|Overall Study|Other|2|||
19651836|NCT00777101|42101543|FG000|Overall Study|Death|48|||
19651837|NCT00777101|42101544|FG001|Overall Study|Death|43|||
19651838|NCT00777101|42101543|FG000|Overall Study|Withdrawal by Subject|11|||
19651839|NCT00777101|42101544|FG001|Overall Study|Withdrawal by Subject|6|||
19651840|NCT00777101|42101543|FG000|Overall Study|Lost to Follow-up|2|||
19651841|NCT00777101|42101544|FG001|Overall Study|Lost to Follow-up|1|||
19751754|NCT00462748|42201070|FG001|Overall Study|Protocol Violation|2|||
19751755|NCT00462748|42201071|FG002|Overall Study|Protocol Violation|1|||
19751756|NCT00462748|42201069|FG000|Overall Study|Withdrew consent|3|||
19751757|NCT00462748|42201070|FG001|Overall Study|Withdrew consent|3|||
19751758|NCT00462748|42201071|FG002|Overall Study|Withdrew consent|0|||
19751759|NCT00462748|42201069|FG000|Overall Study|Lost to Follow-up|1|||
19751760|NCT00462748|42201070|FG001|Overall Study|Lost to Follow-up|1|||
19751761|NCT00462748|42201071|FG002|Overall Study|Lost to Follow-up|1|||
19751762|NCT00462748|42201069|FG000|Overall Study|Discontinued after 41 days Rx|1|||
19751763|NCT00462748|42201070|FG001|Overall Study|Discontinued after 41 days Rx|0|||
19751764|NCT00462748|42201071|FG002|Overall Study|Discontinued after 41 days Rx|0|||
19751765|NCT04206085|42201082|FG000|Overall Study|Lost to Follow-up|0|||
19751766|NCT04206085|42201083|FG001|Overall Study|Lost to Follow-up|1|||
19651842|NCT00777101|42101543|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
19651843|NCT00777101|42101544|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19651844|NCT00777101|42101543|FG000|Overall Study|Failed to Return|0|||
19651845|NCT00777101|42101544|FG001|Overall Study|Failed to Return|1|||
19651846|NCT00297427|42101553|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
19651847|NCT00297427|42101554|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
19651848|NCT00297427|42101553|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
19751767|NCT04206085|42201084|FG002|Overall Study|Lost to Follow-up|0|||
19751768|NCT04206085|42201082|FG000|Overall Study|Lost to Follow-up|0|||
19751769|NCT04206085|42201083|FG001|Overall Study|Lost to Follow-up|0|||
19751770|NCT04206085|42201084|FG002|Overall Study|Lost to Follow-up|1|||
19651849|NCT00297427|42101554|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
19751771|NCT04202497|42201092|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
19751772|NCT04202497|42201093|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
19751773|NCT04202497|42201094|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
19751774|NCT04202497|42201095|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
19651850|NCT00297427|42101553|FG000|Phase 1: Initial Intervention|Death|0|||
19751775|NCT03297294|42201111|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
19751776|NCT03297294|42201112|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
19751777|NCT03297294|42201113|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19751778|NCT03297294|42201114|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19751779|NCT03297294|42201115|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19751780|NCT03297294|42201111|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
19751781|NCT03297294|42201112|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
19751782|NCT03297294|42201113|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19751783|NCT03297294|42201114|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19751784|NCT03297294|42201115|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19751785|NCT03297294|42201111|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
19751786|NCT03297294|42201112|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
19751787|NCT03297294|42201113|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19751788|NCT03297294|42201114|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19751789|NCT03297294|42201115|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19751790|NCT03297294|42201111|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
19751791|NCT03297294|42201112|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
19751792|NCT03297294|42201113|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19751793|NCT03297294|42201114|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19751794|NCT03297294|42201115|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19751795|NCT03297294|42201111|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
19751796|NCT03297294|42201112|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
19751797|NCT03297294|42201113|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
19751798|NCT03297294|42201114|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
19751799|NCT03297294|42201115|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
19751800|NCT03238911|42201129|FG000|Overall Study|Withdrawal by Subject|1|||
19751801|NCT03238911|42201130|FG001|Overall Study|Withdrawal by Subject|2|||
19751802|NCT03238911|42201129|FG000|Overall Study|Lost to Follow-up|2|||
19751803|NCT03238911|42201130|FG001|Overall Study|Lost to Follow-up|1|||
19751804|NCT00418834|42201139|FG000|Overall Study|Adverse Event|16|||
19751805|NCT00418834|42201140|FG001|Overall Study|Adverse Event|9|||
19751806|NCT00418834|42201139|FG000|Overall Study|Lost to Follow-up|0|||
19751807|NCT00418834|42201140|FG001|Overall Study|Lost to Follow-up|1|||
19751808|NCT00418834|42201139|FG000|Overall Study|Protocol Violation|4|||
19751809|NCT00418834|42201140|FG001|Overall Study|Protocol Violation|3|||
19751810|NCT00418834|42201139|FG000|Overall Study|Withdrawal by Subject|3|||
19751811|NCT00418834|42201140|FG001|Overall Study|Withdrawal by Subject|7|||
19751812|NCT03276975|42201148|FG000|Overall Study|Withdrawal by Subject|1|||
19751813|NCT03276975|42201149|FG001|Overall Study|Withdrawal by Subject|0|||
19751814|NCT03297216|42201157|FG000|Overall Study|Death|0|||
19751815|NCT03297216|42201158|FG001|Overall Study|Death|1|||
19751816|NCT03297216|42201157|FG000|Overall Study|Miscarriage|0|||
19751817|NCT03297216|42201158|FG001|Overall Study|Miscarriage|2|||
19751818|NCT03297216|42201157|FG000|Overall Study|Lost to Follow-up|3|||
19388245|NCT02559687|41631645|FG000|Overall Study|Death|112|||
19388246|NCT02559687|41631645|FG000|Overall Study|Sponsor Decision|5|||
19388247|NCT02559687|41631645|FG000|Overall Study|Withdrawal by Subject|4|||
19388248|NCT04294719|41631659|FG000|Overall Study|Withdrawal by Subject|1|||
19601345|NCT00773734|42049970|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
19601346|NCT00773734|42049971|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
19601347|NCT00773734|42049966|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
19601348|NCT00773734|42049967|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
19601349|NCT00773734|42049968|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
19601350|NCT00773734|42049969|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
19601351|NCT00773734|42049970|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
19601352|NCT00773734|42049971|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
19601353|NCT00773734|42049966|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
19601354|NCT00773734|42049967|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
19601355|NCT00773734|42049968|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
19601356|NCT00773734|42049969|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
19601357|NCT00773734|42049970|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
19601358|NCT00773734|42049971|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
19601359|NCT00773734|42049966|FG000|Extension: Active Treatment Week 24-52|Other|0|||
19601360|NCT00773734|42049967|FG001|Extension: Active Treatment Week 24-52|Other|0|||
19601361|NCT00773734|42049968|FG002|Extension: Active Treatment Week 24-52|Other|1|||
19651851|NCT00297427|42101554|FG001|Phase 1: Initial Intervention|Death|1|||
19651852|NCT00297427|42101553|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
19651853|NCT00297427|42101554|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
19651854|NCT00297427|42101553|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
19651855|NCT00297427|42101554|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
19651856|NCT00297427|42101553|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
19651857|NCT00297427|42101554|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
19651858|NCT00297427|42101553|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
19651859|NCT00297427|42101554|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
19651860|NCT00297427|42101553|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
19651861|NCT00297427|42101554|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
19651862|NCT00524134|42101568|FG000|Overall Study|Withdrawal by Subject|1|||
19651863|NCT00524134|42101568|FG000|Overall Study|Physician Decision|1|||
19651864|NCT00777023|42101575|FG000|Overall Study|Adverse Event|15|||
19651865|NCT00777023|42101576|FG001|Overall Study|Adverse Event|21|||
19651866|NCT00777023|42101577|FG002|Overall Study|Adverse Event|8|||
19651867|NCT00777023|42101575|FG000|Overall Study|Lack of Efficacy|1|||
19651868|NCT00777023|42101576|FG001|Overall Study|Lack of Efficacy|0|||
19651869|NCT00777023|42101577|FG002|Overall Study|Lack of Efficacy|14|||
19651870|NCT00777023|42101575|FG000|Overall Study|Protocol Violation|2|||
19751819|NCT03297216|42201158|FG001|Overall Study|Lost to Follow-up|2|||
19751820|NCT03260868|42201173|FG000|Overall Study|Poor Compliance to Protocol|0|||
19751821|NCT03260868|42201174|FG001|Overall Study|Poor Compliance to Protocol|2|||
19751822|NCT03260868|42201173|FG000|Overall Study|Study Terminated By Sponsor|2|||
19751823|NCT03260868|42201174|FG001|Overall Study|Study Terminated By Sponsor|1|||
19751824|NCT03260868|42201173|FG000|Overall Study|Other than specified above|1|||
19651871|NCT00777023|42101576|FG001|Overall Study|Protocol Violation|1|||
19651872|NCT00777023|42101577|FG002|Overall Study|Protocol Violation|1|||
19651873|NCT00777023|42101575|FG000|Overall Study|Lost to Follow-up|2|||
19651874|NCT00777023|42101576|FG001|Overall Study|Lost to Follow-up|3|||
19651875|NCT00777023|42101577|FG002|Overall Study|Lost to Follow-up|3|||
19651876|NCT00777023|42101575|FG000|Overall Study|Death|0|||
19651877|NCT00777023|42101576|FG001|Overall Study|Death|1|||
19651878|NCT00777023|42101577|FG002|Overall Study|Death|0|||
19651879|NCT00777023|42101575|FG000|Overall Study|Withdrawal by Subject|7|||
19651880|NCT00777023|42101576|FG001|Overall Study|Withdrawal by Subject|7|||
19651881|NCT00777023|42101577|FG002|Overall Study|Withdrawal by Subject|8|||
19651882|NCT00777023|42101575|FG000|Overall Study|Missing data|1|||
19651883|NCT00777023|42101576|FG001|Overall Study|Missing data|1|||
19651884|NCT00777023|42101577|FG002|Overall Study|Missing data|0|||
19651885|NCT00777023|42101575|FG000|Overall Study|Reasons not specified|4|||
19651886|NCT00777023|42101576|FG001|Overall Study|Reasons not specified|4|||
19651887|NCT00777023|42101577|FG002|Overall Study|Reasons not specified|2|||
19651888|NCT00777023|42101575|FG000|Overall Study|Last dose date unknown|3|||
19651889|NCT00777023|42101576|FG001|Overall Study|Last dose date unknown|3|||
19651890|NCT00777023|42101577|FG002|Overall Study|Last dose date unknown|1|||
19651891|NCT00297037|42101587|FG000|Overall Study|Withdrawal by Subject|2|||
19651892|NCT00297037|42101588|FG001|Overall Study|Withdrawal by Subject|0|||
19751825|NCT03260868|42201174|FG001|Overall Study|Other than specified above|0|||
19751826|NCT03293394|42201182|FG000|Follow-up (6 Months)|Adverse Event|4|||
19751827|NCT03293394|42201183|FG001|Follow-up (6 Months)|Adverse Event|2|||
19751828|NCT03259308|42201192|FG000|Overall Study|Adverse Event|5|||
19751829|NCT03259308|42201193|FG001|Overall Study|Adverse Event|4|||
19751830|NCT03259308|42201194|FG002|Overall Study|Adverse Event|1|||
19751831|NCT03259308|42201192|FG000|Overall Study|Withdrawal by Subject|2|||
19751832|NCT03259308|42201193|FG001|Overall Study|Withdrawal by Subject|1|||
19751833|NCT03259308|42201194|FG002|Overall Study|Withdrawal by Subject|3|||
19751834|NCT03259308|42201192|FG000|Overall Study|Lost to Follow-up|0|||
19751835|NCT03259308|42201193|FG001|Overall Study|Lost to Follow-up|0|||
19751836|NCT03259308|42201194|FG002|Overall Study|Lost to Follow-up|1|||
19751837|NCT03259308|42201192|FG000|Overall Study|Pregnancy|0|||
19751838|NCT03259308|42201193|FG001|Overall Study|Pregnancy|0|||
19751839|NCT03259308|42201194|FG002|Overall Study|Pregnancy|1|||
19651893|NCT00292981|42101596|FG000|Overall Study|Adverse Event|1|||
19651894|NCT00292981|42101596|FG000|Overall Study|Lost to Follow-up|13|||
19751840|NCT03259308|42201192|FG000|Overall Study|Protocol Deviation|0|||
19751841|NCT03259308|42201193|FG001|Overall Study|Protocol Deviation|3|||
19651895|NCT00292981|42101596|FG000|Overall Study|Withdrawal by Subject|22|||
19651896|NCT00292981|42101596|FG000|Overall Study|Other|3|||
19651897|NCT00296725|42101600|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
19651898|NCT00296725|42101600|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
19751842|NCT03259308|42201194|FG002|Overall Study|Protocol Deviation|0|||
19651899|NCT00296725|42101600|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
19651900|NCT00625872|42101608|FG000|Overall Study|Withdrawal by Subject|1|||
19751843|NCT03259308|42201192|FG000|Overall Study|Lack of Efficacy|0|||
19751844|NCT03259308|42201193|FG001|Overall Study|Lack of Efficacy|0|||
19651901|NCT00625872|42101609|FG001|Overall Study|Withdrawal by Subject|0|||
19651902|NCT00625872|42101608|FG000|Overall Study|Does not meet inclusion criteria|1|||
19651903|NCT00625872|42101609|FG001|Overall Study|Does not meet inclusion criteria|0|||
19651904|NCT00625872|42101608|FG000|Overall Study|Terminated by sponsor|2|||
19651905|NCT00625872|42101609|FG001|Overall Study|Terminated by sponsor|5|||
19651906|NCT00625872|42101608|FG000|Overall Study|Randomized but not treated|0|||
19651907|NCT00625872|42101609|FG001|Overall Study|Randomized but not treated|1|||
19651908|NCT00523978|42101617|FG000|Overall Study|Withdrawal by Subject|3|||
19651909|NCT00523978|42101618|FG001|Overall Study|Withdrawal by Subject|7|||
19651910|NCT00523978|42101617|FG000|Overall Study|Screen Failures|5|||
19651911|NCT00523978|42101618|FG001|Overall Study|Screen Failures|1|||
19651912|NCT00523978|42101617|FG000|Overall Study|Death|1|||
19651913|NCT00523978|42101618|FG001|Overall Study|Death|0|||
19651914|NCT00296647|42101630|FG000|Overall Study|Death|4|||
19651915|NCT00296647|42101631|FG001|Overall Study|Death|1|||
19651916|NCT00296647|42101632|FG002|Overall Study|Death|2|||
19651917|NCT00296647|42101633|FG003|Overall Study|Death|1|||
19651918|NCT00296647|42101634|FG004|Overall Study|Death|1|||
19651919|NCT00296647|42101630|FG000|Overall Study|Withdrawal by Subject|28|||
19651920|NCT00296647|42101631|FG001|Overall Study|Withdrawal by Subject|27|||
19651921|NCT00296647|42101632|FG002|Overall Study|Withdrawal by Subject|32|||
19651922|NCT00296647|42101633|FG003|Overall Study|Withdrawal by Subject|16|||
19751845|NCT03259308|42201194|FG002|Overall Study|Lack of Efficacy|1|||
19751846|NCT03258762|42201204|FG000|Overall Study|Lost to Follow-up|0|||
19651923|NCT00296647|42101634|FG004|Overall Study|Withdrawal by Subject|19|||
19651924|NCT00754013|42101648|FG000|Overall Study|Lost to Follow-up|1|||
19651925|NCT00754013|42101649|FG001|Overall Study|Lost to Follow-up|1|||
19651926|NCT00754013|42101648|FG000|Overall Study|didn't return after study termed|3|||
19651927|NCT00754013|42101649|FG001|Overall Study|didn't return after study termed|4|||
19651928|NCT00523744|42101655|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
19651929|NCT00523744|42101655|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
19751847|NCT03258762|42201205|FG001|Overall Study|Lost to Follow-up|1|||
19751848|NCT04502589|42201214|FG000|Overall Study|Physician Decision|1|||
19751849|NCT04502589|42201215|FG001|Overall Study|Physician Decision|0|||
19751850|NCT03291288|42201221|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
19751851|NCT03291288|42201222|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
19751852|NCT03291288|42201221|FG000|Drug-drug Interaction Phase|Disease progression|1|||
19751853|NCT03291288|42201222|FG001|Drug-drug Interaction Phase|Disease progression|0|||
19751854|NCT03291288|42201221|FG000|Drug-drug Interaction Phase|Other|3|||
19751855|NCT03291288|42201222|FG001|Drug-drug Interaction Phase|Other|0|||
19751856|NCT03291288|42201221|FG000|Pexidartinib Only|Ongoing|0|||
19751857|NCT03291288|42201222|FG001|Pexidartinib Only|Ongoing|2|||
19751858|NCT04428333|42201238|FG000|Overall Study|Physician Decision|2|||
19751859|NCT04428333|42201239|FG001|Overall Study|Physician Decision|0|||
19751860|NCT04428333|42201238|FG000|Overall Study|Withdrawal by Subject|0|||
19751861|NCT04428333|42201239|FG001|Overall Study|Withdrawal by Subject|1|||
19751862|NCT04428333|42201238|FG000|Overall Study|In Follow-Up|5|||
19751863|NCT04428333|42201239|FG001|Overall Study|In Follow-Up|10|||
19751864|NCT04428333|42201238|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
19751865|NCT04428333|42201239|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
19751866|NCT03257358|42201256|FG000|Overall Study|Adverse Event|25|||
19751867|NCT03257358|42201257|FG001|Overall Study|Adverse Event|12|||
19751868|NCT03257358|42201256|FG000|Overall Study|Lack of Efficacy|1|||
19751869|NCT03257358|42201257|FG001|Overall Study|Lack of Efficacy|1|||
19751870|NCT03257358|42201256|FG000|Overall Study|Lost to Follow-up|12|||
19751871|NCT03257358|42201257|FG001|Overall Study|Lost to Follow-up|4|||
19751872|NCT03257358|42201256|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
19751873|NCT03257358|42201257|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
19751874|NCT03257358|42201256|FG000|Overall Study|Physician Decision|2|||
19751875|NCT03257358|42201257|FG001|Overall Study|Physician Decision|2|||
19751876|NCT03257358|42201256|FG000|Overall Study|Protocol Violation|5|||
19751877|NCT03257358|42201257|FG001|Overall Study|Protocol Violation|3|||
19751878|NCT03257358|42201256|FG000|Overall Study|Technical problems|4|||
19751879|NCT03257358|42201257|FG001|Overall Study|Technical problems|1|||
19751880|NCT03257358|42201256|FG000|Overall Study|Withdrawal by Subject|8|||
19751881|NCT03257358|42201257|FG001|Overall Study|Withdrawal by Subject|3|||
19651930|NCT00523744|42101655|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
19651931|NCT00523744|42101655|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
19651932|NCT00523744|42101655|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
19651933|NCT00523744|42101655|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
19651934|NCT00752219|42101673|FG000|Overall Study|Clinical failure|0|||
19651935|NCT00752219|42101674|FG001|Overall Study|Clinical failure|1|||
19651936|NCT00752219|42101673|FG000|Overall Study|Adverse Event|5|||
19751882|NCT03257358|42201256|FG000|Overall Study|Withdrawal of informed consent|9|||
19751883|NCT03257358|42201257|FG001|Overall Study|Withdrawal of informed consent|5|||
19751884|NCT03257358|42201256|FG000|Overall Study|New therapy for study indication|1|||
19751885|NCT03257358|42201257|FG001|Overall Study|New therapy for study indication|0|||
19751886|NCT03257358|42201256|FG000|Overall Study|No longer requires treatment|0|||
19751887|NCT03257358|42201257|FG001|Overall Study|No longer requires treatment|1|||
19751888|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
19751889|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
19751890|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
19751891|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
19751892|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
19651937|NCT00752219|42101674|FG001|Overall Study|Adverse Event|3|||
19651938|NCT00752219|42101673|FG000|Overall Study|Protocol deviation|1|||
19651939|NCT00752219|42101674|FG001|Overall Study|Protocol deviation|0|||
19651940|NCT00752219|42101673|FG000|Overall Study|Lost to Follow-up|1|||
19651941|NCT00752219|42101674|FG001|Overall Study|Lost to Follow-up|2|||
19651942|NCT00752219|42101673|FG000|Overall Study|Randomized but not treated|1|||
19651943|NCT00752219|42101674|FG001|Overall Study|Randomized but not treated|0|||
19651944|NCT00752219|42101673|FG000|Overall Study|Other|3|||
19651945|NCT00752219|42101674|FG001|Overall Study|Other|0|||
19651946|NCT00622908|42101682|FG000|Overall Study|Protocol Violation|1|||
19651947|NCT00622908|42101683|FG001|Overall Study|Protocol Violation|0|||
19651948|NCT00622908|42101682|FG000|Overall Study|Adverse Event|0|||
19651949|NCT00622908|42101683|FG001|Overall Study|Adverse Event|1|||
19651950|NCT00622908|42101682|FG000|Overall Study|Lack of Efficacy|1|||
19651951|NCT00622908|42101683|FG001|Overall Study|Lack of Efficacy|7|||
19651952|NCT00622908|42101682|FG000|Overall Study|Lost to Follow-up|1|||
19651953|NCT00622908|42101683|FG001|Overall Study|Lost to Follow-up|0|||
19651954|NCT00622908|42101682|FG000|Overall Study|Refusal|0|||
19651955|NCT00622908|42101683|FG001|Overall Study|Refusal|1|||
19651956|NCT00622908|42101682|FG000|Overall Study|Termination by study sponser|0|||
19651957|NCT00622908|42101683|FG001|Overall Study|Termination by study sponser|1|||
19651958|NCT00296491|42101693|FG000|Overall Study|Low Pollen Counts|18|||
19651959|NCT00296491|42101694|FG001|Overall Study|Low Pollen Counts|26|||
19651960|NCT00296491|42101695|FG002|Overall Study|Low Pollen Counts|25|||
19751893|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
19751894|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Death|0|||
19751895|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Death|1|||
19751896|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Adverse Event|11|||
19751897|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Adverse Event|11|||
19751898|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
19751899|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
19751900|NCT02936037|42201265|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19751901|NCT02936037|42201266|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
19751902|NCT02936037|42201265|FG000|Open Label Extension|Adverse Event|0|||
19751903|NCT02936037|42201266|FG001|Open Label Extension|Adverse Event|3|||
19751904|NCT02936037|42201265|FG000|Open Label Extension|Other|0|||
19751905|NCT02936037|42201266|FG001|Open Label Extension|Other|3|||
19751906|NCT02936037|42201265|FG000|Open Label Extension|Withdrawal by Subject|0|||
19751907|NCT02936037|42201266|FG001|Open Label Extension|Withdrawal by Subject|4|||
19751908|NCT03288714|42201274|FG000|Overall Study|Lost to Follow-up|2|||
19751909|NCT03288714|42201275|FG001|Overall Study|Lost to Follow-up|1|||
19751910|NCT03288714|42201274|FG000|Overall Study|Non-compliance with study schedule|2|||
19751911|NCT03288714|42201275|FG001|Overall Study|Non-compliance with study schedule|0|||
19751912|NCT03288714|42201274|FG000|Overall Study|Withdrawal by Subject|3|||
19751913|NCT03288714|42201275|FG001|Overall Study|Withdrawal by Subject|1|||
19751914|NCT03288714|42201274|FG000|Overall Study|Clinical Worsening|2|||
19751915|NCT03288714|42201275|FG001|Overall Study|Clinical Worsening|1|||
19751916|NCT03288714|42201274|FG000|Overall Study|Adverse Event|1|||
19751917|NCT03288714|42201275|FG001|Overall Study|Adverse Event|0|||
19751918|NCT04068181|42201287|FG000|Overall Study|Withdrawal by Subject|2|||
19751919|NCT04068181|42201288|FG001|Overall Study|Withdrawal by Subject|0|||
19751920|NCT04068181|42201289|FG002|Overall Study|Withdrawal by Subject|0|||
19651961|NCT00296491|42101696|FG003|Overall Study|Low Pollen Counts|16|||
19651962|NCT00296491|42101693|FG000|Overall Study|Protocol Violation|4|||
19651963|NCT00296491|42101694|FG001|Overall Study|Protocol Violation|6|||
19651964|NCT00296491|42101695|FG002|Overall Study|Protocol Violation|2|||
19651965|NCT00296491|42101696|FG003|Overall Study|Protocol Violation|3|||
19651966|NCT00296491|42101693|FG000|Overall Study|Adverse Event|1|||
19651967|NCT00296491|42101694|FG001|Overall Study|Adverse Event|3|||
19651968|NCT00296491|42101695|FG002|Overall Study|Adverse Event|1|||
19651969|NCT00296491|42101696|FG003|Overall Study|Adverse Event|4|||
19751921|NCT04068181|42201290|FG003|Overall Study|Withdrawal by Subject|0|||
19751922|NCT04068181|42201287|FG000|Overall Study|Lost to Follow-up|1|||
19751923|NCT04068181|42201288|FG001|Overall Study|Lost to Follow-up|0|||
19651970|NCT00296491|42101693|FG000|Overall Study|Withdrawn due to Asthma|0|||
19651971|NCT00296491|42101694|FG001|Overall Study|Withdrawn due to Asthma|0|||
19651972|NCT00296491|42101695|FG002|Overall Study|Withdrawn due to Asthma|0|||
19651973|NCT00296491|42101696|FG003|Overall Study|Withdrawn due to Asthma|4|||
19651974|NCT00296491|42101693|FG000|Overall Study|Withdrawal by Subject|7|||
19651975|NCT00296491|42101694|FG001|Overall Study|Withdrawal by Subject|3|||
19651976|NCT00296491|42101695|FG002|Overall Study|Withdrawal by Subject|3|||
19651977|NCT00296491|42101696|FG003|Overall Study|Withdrawal by Subject|2|||
19651978|NCT00296491|42101693|FG000|Overall Study|Non-Compliance|12|||
19651979|NCT00296491|42101694|FG001|Overall Study|Non-Compliance|13|||
19651980|NCT00296491|42101695|FG002|Overall Study|Non-Compliance|10|||
19651981|NCT00296491|42101696|FG003|Overall Study|Non-Compliance|14|||
19651982|NCT00296491|42101693|FG000|Overall Study|Lost to Follow-up|0|||
19651983|NCT00296491|42101694|FG001|Overall Study|Lost to Follow-up|2|||
19651984|NCT00296491|42101695|FG002|Overall Study|Lost to Follow-up|2|||
19651985|NCT00296491|42101696|FG003|Overall Study|Lost to Follow-up|0|||
19651986|NCT00747617|42101715|FG000|Overall Study|Lost to Follow-up|3|||
19651987|NCT00747617|42101716|FG001|Overall Study|Lost to Follow-up|1|||
19651988|NCT00296335|42101724|FG000|Overall Study|Recurrence|3|||
19651989|NCT00296335|42101725|FG001|Overall Study|Recurrence|51|||
19651990|NCT00296335|42101724|FG000|Overall Study|Adverse Event|17|||
19651991|NCT00296335|42101725|FG001|Overall Study|Adverse Event|27|||
19651992|NCT00296335|42101724|FG000|Overall Study|Lost to Follow-up|7|||
19651993|NCT00296335|42101725|FG001|Overall Study|Lost to Follow-up|33|||
19651994|NCT00296335|42101724|FG000|Overall Study|Physician Decision|3|||
19651995|NCT00296335|42101725|FG001|Overall Study|Physician Decision|11|||
19651996|NCT00747461|42101733|FG000|Overall Study|study terminated by sponsor|5|||
19651997|NCT03683758|42101740|FG000|Overall Study|Non-study commitment conflict|1|||
19651998|NCT03683758|42101741|FG001|Overall Study|Non-study commitment conflict|3|||
19651999|NCT03683758|42101740|FG000|Overall Study|Illness preventing participation|1|||
19652000|NCT03683758|42101741|FG001|Overall Study|Illness preventing participation|0|||
19652001|NCT03683758|42101740|FG000|Overall Study|Adverse Event|1|||
19751924|NCT04068181|42201289|FG002|Overall Study|Lost to Follow-up|0|||
19751925|NCT04068181|42201290|FG003|Overall Study|Lost to Follow-up|0|||
19751926|NCT04068181|42201287|FG000|Overall Study|Death|8|||
19751927|NCT04068181|42201288|FG001|Overall Study|Death|8|||
19751928|NCT04068181|42201289|FG002|Overall Study|Death|4|||
19751929|NCT04068181|42201290|FG003|Overall Study|Death|2|||
19751930|NCT04068181|42201287|FG000|Overall Study|Continuing Study|16|||
19751931|NCT04068181|42201288|FG001|Overall Study|Continuing Study|7|||
19751932|NCT04068181|42201289|FG002|Overall Study|Continuing Study|11|||
19751933|NCT04068181|42201290|FG003|Overall Study|Continuing Study|13|||
19751934|NCT03256578|42201302|FG000|Overall Study|Excluded Post Randomization|66|||
19751935|NCT03256578|42201303|FG001|Overall Study|Excluded Post Randomization|56|||
19751936|NCT03227445|42201309|FG000|Period 1 (28 Days)|Adverse Event|1|||
19751937|NCT03227445|42201310|FG001|Period 1 (28 Days)|Adverse Event|2|||
19652002|NCT03683758|42101741|FG001|Overall Study|Adverse Event|0|||
19652003|NCT00522418|42101749|FG000|Overall Study|Local IRB Consent Violation|5|||
19652004|NCT00522418|42101750|FG001|Overall Study|Local IRB Consent Violation|5|||
19652005|NCT00522418|42101749|FG000|Overall Study|Early Study Termination|46|||
19652006|NCT00522418|42101750|FG001|Overall Study|Early Study Termination|47|||
19652007|NCT00522418|42101749|FG000|Overall Study|Noncompliance|2|||
19652008|NCT00522418|42101750|FG001|Overall Study|Noncompliance|2|||
19652009|NCT00522418|42101749|FG000|Overall Study|Reason Not Specified|3|||
19652010|NCT00522418|42101750|FG001|Overall Study|Reason Not Specified|1|||
19652011|NCT00522418|42101749|FG000|Overall Study|Consent Withdraw|1|||
19652012|NCT00522418|42101750|FG001|Overall Study|Consent Withdraw|2|||
19652013|NCT00522418|42101749|FG000|Overall Study|Lack of Efficacy|0|||
19652014|NCT00522418|42101750|FG001|Overall Study|Lack of Efficacy|1|||
19652015|NCT00624780|42101764|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
19652016|NCT00624780|42101765|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
19652017|NCT00624780|42101766|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
19652018|NCT00624780|42101767|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
19652019|NCT00624780|42101768|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
19652020|NCT00624780|42101769|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
19652021|NCT00624780|42101764|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
19652022|NCT00624780|42101765|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
19652023|NCT00624780|42101766|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
19652024|NCT00624780|42101767|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
19751938|NCT03227445|42201311|FG002|Period 1 (28 Days)|Adverse Event|0|||
19751939|NCT03227445|42201312|FG003|Period 1 (28 Days)|Adverse Event|1|||
19751940|NCT03227445|42201309|FG000|Period 1 (28 Days)|Protocol Violation|1|||
19652025|NCT00624780|42101768|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
19652026|NCT00624780|42101769|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
19652027|NCT00624780|42101764|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
19751941|NCT03227445|42201310|FG001|Period 1 (28 Days)|Protocol Violation|0|||
19751942|NCT03227445|42201311|FG002|Period 1 (28 Days)|Protocol Violation|0|||
19751943|NCT03227445|42201312|FG003|Period 1 (28 Days)|Protocol Violation|0|||
19751944|NCT03227445|42201309|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
19751945|NCT03227445|42201310|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
19652028|NCT00624780|42101765|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
19751946|NCT03227445|42201311|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
19751947|NCT03227445|42201312|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
19751948|NCT03227445|42201309|FG000|Period 2 (28 Days)|Adverse Event|1|||
19751949|NCT03227445|42201310|FG001|Period 2 (28 Days)|Adverse Event|0|||
19751950|NCT03227445|42201311|FG002|Period 2 (28 Days)|Adverse Event|2|||
19751951|NCT03227445|42201312|FG003|Period 2 (28 Days)|Adverse Event|1|||
19652029|NCT00624780|42101766|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
19652030|NCT00624780|42101767|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
19652031|NCT00624780|42101768|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
19652032|NCT00624780|42101769|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
19652033|NCT00624780|42101764|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
19652034|NCT00624780|42101765|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
19652035|NCT00624780|42101766|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
19652036|NCT00624780|42101767|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
19652037|NCT00624780|42101768|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
19652038|NCT00624780|42101769|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
19652039|NCT00624780|42101764|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
19652040|NCT00624780|42101765|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
19652041|NCT00624780|42101766|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
19652042|NCT00624780|42101767|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
19652043|NCT00624780|42101768|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
19652044|NCT00624780|42101769|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
19652045|NCT00624780|42101764|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
19652046|NCT00624780|42101765|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
19652047|NCT00624780|42101766|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
19652048|NCT00624780|42101767|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
19751952|NCT03227445|42201309|FG000|Period 2 (28 Days)|Protocol Violation|0|||
19751953|NCT03227445|42201310|FG001|Period 2 (28 Days)|Protocol Violation|0|||
19652049|NCT00624780|42101768|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
19652050|NCT00624780|42101769|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
19652051|NCT00624780|42101764|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
19652052|NCT00624780|42101765|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
19652053|NCT00624780|42101766|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
19652054|NCT00624780|42101767|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
19751954|NCT03227445|42201311|FG002|Period 2 (28 Days)|Protocol Violation|0|||
19751955|NCT03227445|42201312|FG003|Period 2 (28 Days)|Protocol Violation|1|||
19601362|NCT00773734|42049969|FG003|Extension: Active Treatment Week 24-52|Other|2|||
19601363|NCT00773734|42049970|FG004|Extension: Active Treatment Week 24-52|Other|0|||
19601364|NCT00773734|42049971|FG005|Extension: Active Treatment Week 24-52|Other|1|||
19601365|NCT00773734|42049966|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
19601366|NCT00773734|42049967|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
19601367|NCT00773734|42049968|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
19601368|NCT00773734|42049969|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
19601369|NCT00773734|42049970|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
19601370|NCT00773734|42049971|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
19601371|NCT00773734|42049966|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
19601372|NCT00773734|42049967|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
19601373|NCT00773734|42049968|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
19601374|NCT00773734|42049969|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
19601375|NCT00773734|42049970|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
19601376|NCT00773734|42049971|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
19601377|NCT00773734|42049966|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
19601378|NCT00773734|42049967|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
19601379|NCT00773734|42049968|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
19601380|NCT00773734|42049969|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
19601381|NCT00773734|42049970|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
19601382|NCT00773734|42049971|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
19601383|NCT00773734|42049966|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
19601384|NCT00773734|42049967|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
19601385|NCT00773734|42049968|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
19601386|NCT00773734|42049969|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
19601387|NCT00773734|42049970|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
19601388|NCT00773734|42049971|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
19652055|NCT00624780|42101768|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
19601389|NCT01009580|42050030|FG000|Overall Study|Adverse Event|4|||
19601390|NCT01009580|42050031|FG001|Overall Study|Adverse Event|4|||
19601391|NCT01009580|42050030|FG000|Overall Study|Lack of Efficacy|0|||
19601392|NCT01009580|42050031|FG001|Overall Study|Lack of Efficacy|1|||
19601393|NCT01009580|42050030|FG000|Overall Study|Protocol Violation|2|||
19601394|NCT01009580|42050031|FG001|Overall Study|Protocol Violation|3|||
19601395|NCT01009580|42050030|FG000|Overall Study|Withdrawal Criteria|4|||
19601396|NCT01009580|42050031|FG001|Overall Study|Withdrawal Criteria|6|||
19601397|NCT01009580|42050030|FG000|Overall Study|Unclassified|17|||
19601398|NCT01009580|42050031|FG001|Overall Study|Unclassified|21|||
19601399|NCT01009346|42050037|FG000|Overall Study|Adverse Event|4|||
19601400|NCT01001702|42050042|FG000|Overall Study|Lost to Follow-up|7|||
19601401|NCT01001702|42050042|FG000|Overall Study|Adverse Event|7|||
19601402|NCT01001702|42050042|FG000|Overall Study|Sponsor Discontinued Study|4|||
19601403|NCT01001702|42050042|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
19601404|NCT01001702|42050042|FG000|Overall Study|Investigator withdrew Subject|10|||
19601405|NCT01001702|42050042|FG000|Overall Study|Withdrawal by Subject|19|||
19601406|NCT01001702|42050042|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
19601407|NCT01070069|42050051|FG000|Overall Study|Death|1|||
19601408|NCT01070069|42050052|FG001|Overall Study|Death|0|||
19652056|NCT00624780|42101769|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
19652057|NCT00624780|42101764|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
19652058|NCT00624780|42101765|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
19601409|NCT01070069|42050053|FG002|Overall Study|Death|2|||
19601410|NCT01070069|42050054|FG003|Overall Study|Death|0|||
19601411|NCT01070069|42050055|FG004|Overall Study|Death|1|||
19601412|NCT01070069|42050051|FG000|Overall Study|Withdrawal by Subject|1|||
19601413|NCT01070069|42050052|FG001|Overall Study|Withdrawal by Subject|1|||
19601414|NCT01070069|42050053|FG002|Overall Study|Withdrawal by Subject|4|||
19652059|NCT00624780|42101766|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
19652060|NCT00624780|42101767|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
19652061|NCT00624780|42101768|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
19652062|NCT00624780|42101769|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
19652063|NCT00624780|42101764|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
19652064|NCT00624780|42101765|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
19652065|NCT00624780|42101766|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
19652066|NCT00624780|42101767|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
19652067|NCT00624780|42101768|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
19652068|NCT00624780|42101769|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
19652069|NCT00624780|42101764|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
19652070|NCT00624780|42101765|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
19652071|NCT00624780|42101766|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
19652072|NCT00624780|42101767|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
19652073|NCT00624780|42101768|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
19652074|NCT00624780|42101769|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
19652075|NCT00624780|42101764|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
19652076|NCT00624780|42101765|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
19652077|NCT00624780|42101766|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
19652078|NCT00624780|42101767|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
19652079|NCT00624780|42101768|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
19652080|NCT00624780|42101769|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
19652081|NCT00624780|42101764|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
19652082|NCT00624780|42101765|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
19652083|NCT00624780|42101766|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
19652084|NCT00624780|42101767|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
19652085|NCT00624780|42101768|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
19652086|NCT00624780|42101769|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
19652087|NCT00624780|42101764|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
19652088|NCT00624780|42101765|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
19652089|NCT00624780|42101766|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
19652090|NCT00624780|42101767|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
19652091|NCT00624780|42101768|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
19751956|NCT03227445|42201309|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
19601415|NCT01070069|42050054|FG003|Overall Study|Withdrawal by Subject|0|||
19601416|NCT01070069|42050055|FG004|Overall Study|Withdrawal by Subject|0|||
19601417|NCT01070069|42050051|FG000|Overall Study|Lost to Follow-up|4|||
19601418|NCT01070069|42050052|FG001|Overall Study|Lost to Follow-up|1|||
19601419|NCT01070069|42050053|FG002|Overall Study|Lost to Follow-up|0|||
19601420|NCT01070069|42050054|FG003|Overall Study|Lost to Follow-up|0|||
19601421|NCT01070069|42050055|FG004|Overall Study|Lost to Follow-up|3|||
19601422|NCT01068665|42050072|FG000|Overall Study|Adverse Event|5|||
19652092|NCT00624780|42101769|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
19652093|NCT00624780|42101764|FG000|Follow-up (Week 26)|Death|0|||
19652094|NCT00624780|42101765|FG001|Follow-up (Week 26)|Death|0|||
19751957|NCT03227445|42201310|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
19751958|NCT03227445|42201311|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
19652095|NCT00624780|42101766|FG002|Follow-up (Week 26)|Death|1|||
19652096|NCT00624780|42101767|FG003|Follow-up (Week 26)|Death|0|||
19652097|NCT00624780|42101768|FG004|Follow-up (Week 26)|Death|0|||
19652098|NCT00624780|42101769|FG005|Follow-up (Week 26)|Death|0|||
19652099|NCT00624780|42101764|FG000|Follow-up (Week 26)|Adverse Event|0|||
19652100|NCT00624780|42101765|FG001|Follow-up (Week 26)|Adverse Event|0|||
19652101|NCT00624780|42101766|FG002|Follow-up (Week 26)|Adverse Event|0|||
19652102|NCT00624780|42101767|FG003|Follow-up (Week 26)|Adverse Event|0|||
19652103|NCT00624780|42101768|FG004|Follow-up (Week 26)|Adverse Event|1|||
19652104|NCT00624780|42101769|FG005|Follow-up (Week 26)|Adverse Event|0|||
19652105|NCT00624780|42101764|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
19652106|NCT00624780|42101765|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
19652107|NCT00624780|42101766|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
19652108|NCT00624780|42101767|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
19652109|NCT00624780|42101768|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
19652110|NCT00624780|42101769|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
19652111|NCT00624780|42101764|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
19652112|NCT00624780|42101765|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
19652113|NCT00624780|42101766|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
19652114|NCT00624780|42101767|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
19652115|NCT00624780|42101768|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
19652116|NCT00624780|42101769|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
19652117|NCT00624780|42101764|FG000|Follow-up (Week 26)|Other|1|||
19652118|NCT00624780|42101765|FG001|Follow-up (Week 26)|Other|1|||
19652119|NCT00624780|42101766|FG002|Follow-up (Week 26)|Other|0|||
19652120|NCT00624780|42101767|FG003|Follow-up (Week 26)|Other|0|||
19652121|NCT00624780|42101768|FG004|Follow-up (Week 26)|Other|0|||
19652122|NCT00624780|42101769|FG005|Follow-up (Week 26)|Other|0|||
19652123|NCT00750893|42101786|FG000|Overall Study|Adverse Event|5|||
19652124|NCT00750893|42101786|FG000|Overall Study|Withdrawal by Subject|10|||
19652125|NCT00750893|42101786|FG000|Overall Study|Lost to Follow-up|510|||
19652126|NCT00750893|42101786|FG000|Overall Study|Other|17|||
19652127|NCT00753623|42101792|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
19652128|NCT00753623|42101793|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
19652129|NCT00753623|42101792|FG000|Phase I (14 Days)|Physician Decision|1|||
19652130|NCT00753623|42101793|FG001|Phase I (14 Days)|Physician Decision|2|||
19652131|NCT00753623|42101792|FG000|Phase I (14 Days)|Adverse Event|0|||
19652132|NCT00753623|42101793|FG001|Phase I (14 Days)|Adverse Event|1|||
19652133|NCT00753623|42101792|FG000|Washout (7 Days)|Physician Decision|1|||
19652134|NCT00753623|42101793|FG001|Washout (7 Days)|Physician Decision|0|||
19652135|NCT00753623|42101792|FG000|Phase II (14 Days)|Physician Decision|0|||
19652136|NCT00753623|42101793|FG001|Phase II (14 Days)|Physician Decision|1|||
19652137|NCT00750737|42101801|FG000|Overall Study|Withdrawal by Subject|3|||
19652138|NCT00750737|42101802|FG001|Overall Study|Withdrawal by Subject|3|||
19652139|NCT00622440|42101810|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
19652140|NCT00622440|42101811|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
19652141|NCT00622440|42101810|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
19652142|NCT00622440|42101811|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
19652143|NCT00622440|42101810|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
19652144|NCT00622440|42101811|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
19652145|NCT00622440|42101810|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
19652146|NCT00622440|42101811|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
19652147|NCT00744653|42101817|FG000|Overall Study|antineoplastic treatment|11|||
19652148|NCT00744653|42101817|FG000|Overall Study|Death|1|||
19652149|NCT00744653|42101817|FG000|Overall Study|Lost to Follow-up|1|||
19652150|NCT00744653|42101817|FG000|Overall Study|Physician Decision|3|||
19652151|NCT00311311|42101824|FG000|Overall Study|Adverse Event|3|||
19652152|NCT00311311|42101825|FG001|Overall Study|Adverse Event|2|||
19652153|NCT00311311|42101824|FG000|Overall Study|Withdrawal by Subject|1|||
19652154|NCT00311311|42101825|FG001|Overall Study|Withdrawal by Subject|1|||
19652155|NCT00311311|42101824|FG000|Overall Study|Noncompliance|0|||
19652156|NCT00311311|42101825|FG001|Overall Study|Noncompliance|1|||
19652157|NCT00311311|42101824|FG000|Overall Study|Study Termination by Sponsor|3|||
19652158|NCT00311311|42101825|FG001|Overall Study|Study Termination by Sponsor|4|||
19652159|NCT00311311|42101824|FG000|Overall Study|Death|1|||
19652160|NCT00311311|42101825|FG001|Overall Study|Death|0|||
19652161|NCT00311311|42101824|FG000|Overall Study|Lack of ancillary assistance|0|||
19652162|NCT00311311|42101825|FG001|Overall Study|Lack of ancillary assistance|1|||
19652163|NCT00521404|42101831|FG000|Overall Study|Adverse Event|13|||
19751959|NCT03227445|42201312|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
19652164|NCT00521404|42101831|FG000|Overall Study|Disease Progression|33|||
19751960|NCT04067401|42201323|FG000|Overall Study|Withdrawal by Subject|7|||
19652165|NCT00521404|42101831|FG000|Overall Study|Investigator decision|5|||
19652166|NCT00521404|42101831|FG000|Overall Study|Withdrawal of consent|3|||
19652167|NCT00521404|42101831|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
19652168|NCT00521404|42101831|FG000|Overall Study|Other|7|||
19652169|NCT00311155|42101835|FG000|Overall Study|Adverse Event|21|||
19652170|NCT00311155|42101835|FG000|Overall Study|Withdrawal by Subject|17|||
19652171|NCT00311155|42101835|FG000|Overall Study|Did not meet entry criteria|55|||
19652172|NCT00292045|42101839|FG000|Core Study (Through Week 13)|Adverse Event|1|||
19652173|NCT00292045|42101839|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
19652174|NCT00274651|42101845|FG000|Overall Study|Adverse Event|6|||
19652175|NCT00274651|42101846|FG001|Overall Study|Adverse Event|3|||
19652176|NCT00274651|42101845|FG000|Overall Study|Lack of Efficacy|13|||
19652177|NCT00274651|42101846|FG001|Overall Study|Lack of Efficacy|6|||
19652178|NCT00274651|42101845|FG000|Overall Study|Death|1|||
19652179|NCT00274651|42101846|FG001|Overall Study|Death|3|||
19652180|NCT00274651|42101845|FG000|Overall Study|Withdrawal by Subject|0|||
19652181|NCT00274651|42101846|FG001|Overall Study|Withdrawal by Subject|1|||
19652182|NCT00274651|42101845|FG000|Overall Study|Physician Decision|8|||
19652183|NCT00274651|42101846|FG001|Overall Study|Physician Decision|7|||
19652184|NCT00274261|42101855|FG000|Overall Study|Adverse Event|19|||
19652185|NCT00274261|42101856|FG001|Overall Study|Adverse Event|11|||
19652186|NCT00274261|42101855|FG000|Overall Study|Pregnancy|114|||
19652187|NCT00274261|42101856|FG001|Overall Study|Pregnancy|83|||
19652188|NCT00274261|42101855|FG000|Overall Study|Withdrawal by Subject|179|||
19652189|NCT00274261|42101856|FG001|Overall Study|Withdrawal by Subject|126|||
19652190|NCT00274261|42101855|FG000|Overall Study|Protocol Violation|71|||
19652191|NCT00274261|42101856|FG001|Overall Study|Protocol Violation|42|||
19652192|NCT00274261|42101855|FG000|Overall Study|Lost to Follow-up|106|||
19652193|NCT00274261|42101856|FG001|Overall Study|Lost to Follow-up|75|||
19652194|NCT00624468|42101866|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
19652195|NCT00624468|42101867|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
19652196|NCT00624468|42101868|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
19652197|NCT00624468|42101869|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
19652198|NCT00624468|42101866|FG000|Double-blind Period|Withdrew Prematurely|1|||
19652199|NCT00624468|42101867|FG001|Double-blind Period|Withdrew Prematurely|1|||
19652200|NCT00624468|42101868|FG002|Double-blind Period|Withdrew Prematurely|0|||
19751961|NCT04067401|42201324|FG001|Overall Study|Withdrawal by Subject|0|||
19751962|NCT04067401|42201323|FG000|Overall Study|no data provided|1|||
19652201|NCT00624468|42101869|FG003|Double-blind Period|Withdrew Prematurely|0|||
19652202|NCT00624468|42101866|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
19652203|NCT00624468|42101867|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
19652204|NCT00624468|42101868|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
19652205|NCT00624468|42101869|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
19652206|NCT00624468|42101866|FG000|Safety Follow-up (SFU) Period|Other|0|||
19652207|NCT00624468|42101867|FG001|Safety Follow-up (SFU) Period|Other|0|||
19652208|NCT00624468|42101868|FG002|Safety Follow-up (SFU) Period|Other|1|||
19652209|NCT00624468|42101869|FG003|Safety Follow-up (SFU) Period|Other|1|||
19652210|NCT02367040|42101879|FG000|Overall Study|Lost to Follow-up|1|||
19652211|NCT02367040|42101880|FG001|Overall Study|Lost to Follow-up|1|||
19652212|NCT02367040|42101879|FG000|Overall Study|Lack of Efficacy|1|||
19652213|NCT02367040|42101880|FG001|Overall Study|Lack of Efficacy|0|||
19652214|NCT02367040|42101879|FG000|Overall Study|Additional primary malignancy|0|||
19652215|NCT02367040|42101880|FG001|Overall Study|Additional primary malignancy|1|||
19652216|NCT02367040|42101879|FG000|Overall Study|AE not associated with clinical disease progression|104|||
19751963|NCT04067401|42201324|FG001|Overall Study|no data provided|0|||
19751964|NCT04194151|42201336|FG000|Overall Study|Physician Decision|1|||
19751965|NCT04194151|42201337|FG001|Overall Study|Physician Decision|1|||
19652217|NCT02367040|42101880|FG001|Overall Study|AE not associated with clinical disease progression|9|||
19652218|NCT02367040|42101879|FG000|Overall Study|AE associated with clinical disease progression|1|||
19652219|NCT02367040|42101880|FG001|Overall Study|AE associated with clinical disease progression|3|||
19652220|NCT02367040|42101879|FG000|Overall Study|Physician Decision|2|||
19652221|NCT02367040|42101880|FG001|Overall Study|Physician Decision|8|||
19652222|NCT02367040|42101879|FG000|Overall Study|Non-compliance with study drug|1|||
19652223|NCT02367040|42101880|FG001|Overall Study|Non-compliance with study drug|0|||
19652224|NCT02367040|42101879|FG000|Overall Study|Failure to meet continuation criteria|1|||
19652225|NCT02367040|42101880|FG001|Overall Study|Failure to meet continuation criteria|0|||
19652226|NCT02367040|42101879|FG000|Overall Study|Switching to other therapy|2|||
19652227|NCT02367040|42101880|FG001|Overall Study|Switching to other therapy|0|||
19652228|NCT02367040|42101879|FG000|Overall Study|Withdrawal by Subject|41|||
19652229|NCT02367040|42101880|FG001|Overall Study|Withdrawal by Subject|14|||
19652230|NCT02367040|42101879|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
19652231|NCT02367040|42101880|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
19652232|NCT02367040|42101879|FG000|Overall Study|Patient decision|35|||
19652233|NCT02367040|42101880|FG001|Overall Study|Patient decision|11|||
19652234|NCT02367040|42101879|FG000|Overall Study|Required procedure failed|1|||
19751966|NCT04194151|42201338|FG002|Overall Study|Physician Decision|1|||
19751967|NCT04194151|42201339|FG003|Overall Study|Physician Decision|1|||
19751968|NCT04194151|42201340|FG004|Overall Study|Physician Decision|0|||
19652235|NCT02367040|42101880|FG001|Overall Study|Required procedure failed|0|||
19652236|NCT02367040|42101879|FG000|Overall Study|Randomized by mistake with study treatment|1|||
19652237|NCT02367040|42101880|FG001|Overall Study|Randomized by mistake with study treatment|0|||
19652238|NCT02367040|42101879|FG000|Overall Study|Protocol Violation|1|||
19652239|NCT02367040|42101880|FG001|Overall Study|Protocol Violation|0|||
19652240|NCT02367040|42101879|FG000|Overall Study|Progressive disease - radiological progression|39|||
19652241|NCT02367040|42101880|FG001|Overall Study|Progressive disease - radiological progression|67|||
19652242|NCT02367040|42101879|FG000|Overall Study|Progressive disease - clinical progression|2|||
19652243|NCT02367040|42101880|FG001|Overall Study|Progressive disease - clinical progression|6|||
19652244|NCT02367040|42101879|FG000|Overall Study|Drug not administered|3|||
19652245|NCT02367040|42101880|FG001|Overall Study|Drug not administered|2|||
19652246|NCT00521014|42101886|FG000|Overall Study|Inevaluable, not treated|1|||
19652247|NCT00560235|42101893|FG000|Phase 1|Discontinued|8|||
19652248|NCT00560235|42101894|FG001|Phase 1|Discontinued|0|||
19652249|NCT00560235|42101895|FG002|Phase 1|Discontinued|0|||
19652250|NCT00560235|42101893|FG000|Phase 1B|Discontinued|0|||
19652251|NCT00560235|42101894|FG001|Phase 1B|Discontinued|19|||
19652252|NCT00560235|42101895|FG002|Phase 1B|Discontinued|0|||
19652253|NCT00560235|42101893|FG000|Phase 2|Discontinued|0|||
19652254|NCT00560235|42101894|FG001|Phase 2|Discontinued|0|||
19652255|NCT00560235|42101895|FG002|Phase 2|Discontinued|96|||
19652256|NCT00560235|42101893|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
19652257|NCT00560235|42101894|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
19652258|NCT00560235|42101895|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
19652259|NCT00291577|42101913|FG000|Overall Study|Adverse Event|1|||
19652260|NCT00291577|42101913|FG000|Overall Study|Other|4|||
19652261|NCT00291577|42101913|FG000|Overall Study|Withdrawal by Subject|2|||
19652262|NCT00291577|42101913|FG000|Overall Study|Lack of Efficacy|14|||
19652263|NCT00520936|42101925|FG000|Overall Study|Physician Decision|0|||
19652264|NCT00520936|42101926|FG001|Overall Study|Physician Decision|2|||
19652265|NCT00520936|42101927|FG002|Overall Study|Physician Decision|1|||
19652266|NCT00520936|42101928|FG003|Overall Study|Physician Decision|0|||
19652267|NCT00520936|42101929|FG004|Overall Study|Physician Decision|0|||
19652268|NCT00520936|42101930|FG005|Overall Study|Physician Decision|0|||
19652269|NCT00520936|42101931|FG006|Overall Study|Physician Decision|0|||
19652270|NCT00520936|42101932|FG007|Overall Study|Physician Decision|0|||
19652271|NCT00520936|42101925|FG000|Overall Study|Withdrawal by Subject|0|||
19652272|NCT00520936|42101926|FG001|Overall Study|Withdrawal by Subject|0|||
19652273|NCT00520936|42101927|FG002|Overall Study|Withdrawal by Subject|0|||
19652274|NCT00520936|42101928|FG003|Overall Study|Withdrawal by Subject|0|||
19652275|NCT00520936|42101929|FG004|Overall Study|Withdrawal by Subject|0|||
19652276|NCT00520936|42101930|FG005|Overall Study|Withdrawal by Subject|0|||
19652277|NCT00520936|42101931|FG006|Overall Study|Withdrawal by Subject|0|||
19652278|NCT00520936|42101932|FG007|Overall Study|Withdrawal by Subject|1|||
19652279|NCT00520936|42101925|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
19652280|NCT00520936|42101926|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
19652281|NCT00520936|42101927|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
19652282|NCT00520936|42101928|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
19652283|NCT00520936|42101929|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
19652284|NCT00520936|42101930|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
19652285|NCT00520936|42101931|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
19652286|NCT00520936|42101932|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
19652287|NCT00520936|42101925|FG000|Overall Study|Death|0|||
19652288|NCT00520936|42101926|FG001|Overall Study|Death|0|||
19751969|NCT04194151|42201341|FG005|Overall Study|Physician Decision|1|||
19751970|NCT04194151|42201336|FG000|Overall Study|Monitorization problem|0|||
19751971|NCT04194151|42201337|FG001|Overall Study|Monitorization problem|1|||
19751972|NCT04194151|42201338|FG002|Overall Study|Monitorization problem|0|||
19751973|NCT04194151|42201339|FG003|Overall Study|Monitorization problem|0|||
19751974|NCT04194151|42201340|FG004|Overall Study|Monitorization problem|0|||
19751975|NCT04194151|42201341|FG005|Overall Study|Monitorization problem|0|||
19751976|NCT03820323|42201357|FG000|Overall Study|Lost to Follow-up|2|||
19373632|NCT02760407|41614833|FG000|Overall Study|Inadequately Enrolled|0|||
19652289|NCT00520936|42101927|FG002|Overall Study|Death|0|||
19652290|NCT00520936|42101928|FG003|Overall Study|Death|0|||
19652291|NCT00520936|42101929|FG004|Overall Study|Death|0|||
19652292|NCT00520936|42101930|FG005|Overall Study|Death|0|||
19652293|NCT00520936|42101931|FG006|Overall Study|Death|1|||
19652294|NCT00520936|42101932|FG007|Overall Study|Death|0|||
19652295|NCT00520936|42101925|FG000|Overall Study|Protocol Violation|0|||
19652296|NCT00520936|42101926|FG001|Overall Study|Protocol Violation|1|||
19652297|NCT00520936|42101927|FG002|Overall Study|Protocol Violation|1|||
19652298|NCT00520936|42101928|FG003|Overall Study|Protocol Violation|0|||
19751977|NCT03820323|42201358|FG001|Overall Study|Lost to Follow-up|1|||
19751978|NCT03820323|42201357|FG000|Overall Study|Missed 12-month visit|22|||
19751979|NCT03820323|42201358|FG001|Overall Study|Missed 12-month visit|14|||
19751980|NCT03820323|42201357|FG000|Overall Study|Death|2|||
19751981|NCT03820323|42201358|FG001|Overall Study|Death|1|||
19751982|NCT03820323|42201357|FG000|Overall Study|Transferred out|13|||
19751983|NCT03820323|42201358|FG001|Overall Study|Transferred out|11|||
19751984|NCT03820323|42201357|FG000|Overall Study|Terminated|0|||
19652299|NCT00520936|42101929|FG004|Overall Study|Protocol Violation|1|||
19652300|NCT00520936|42101930|FG005|Overall Study|Protocol Violation|0|||
19652301|NCT00520936|42101931|FG006|Overall Study|Protocol Violation|1|||
19652302|NCT00520936|42101932|FG007|Overall Study|Protocol Violation|0|||
19652303|NCT03867760|42101945|FG000|Overall Study|Lost to Follow-up|2|||
19652304|NCT03867760|42101946|FG001|Overall Study|Lost to Follow-up|3|||
19652305|NCT03867760|42101945|FG000|Overall Study|Withdrawal by Subject|1|||
19652306|NCT03867760|42101946|FG001|Overall Study|Withdrawal by Subject|2|||
19652307|NCT03867760|42101945|FG000|Overall Study|subject could not meet study logistics|3|||
19652308|NCT03867760|42101946|FG001|Overall Study|subject could not meet study logistics|3|||
19652309|NCT03865732|42101956|FG000|Overall Study|Adverse Event|0|||
19652310|NCT03865732|42101957|FG001|Overall Study|Adverse Event|1|||
19652311|NCT00520546|42101964|FG000|Overall Study|Withdrawal by Subject|1|||
19652312|NCT00520546|42101964|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
19652313|NCT00555009|42101975|FG000|Overall Study|Withdrawal by Subject|0|||
19652314|NCT00555009|42101976|FG001|Overall Study|Withdrawal by Subject|1|||
19652315|NCT00555009|42101975|FG000|Overall Study|Terminated by Sponsor|2|||
19652316|NCT00555009|42101976|FG001|Overall Study|Terminated by Sponsor|5|||
19652317|NCT00623766|42101984|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
19652318|NCT00623766|42101985|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
19652319|NCT00623766|42101984|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
19652320|NCT00623766|42101985|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
19652321|NCT00623766|42101984|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
19652322|NCT00623766|42101985|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
19751985|NCT03820323|42201358|FG001|Overall Study|Terminated|3|||
19751986|NCT03820323|42201357|FG000|Overall Study|Withdrawal by Subject|1|||
19652323|NCT00623766|42101984|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
19652324|NCT00623766|42101985|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
19652325|NCT00623766|42101984|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
19751987|NCT03820323|42201358|FG001|Overall Study|Withdrawal by Subject|6|||
19751988|NCT03287622|42201373|FG000|Overall Study|Withdrawal by Subject|1|||
19751989|NCT03287622|42201374|FG001|Overall Study|Withdrawal by Subject|0|||
19751990|NCT03287622|42201373|FG000|Overall Study|Lost to Follow-up|27|||
19751991|NCT03287622|42201374|FG001|Overall Study|Lost to Follow-up|15|||
19751992|NCT03287622|42201373|FG000|Overall Study|No prescripion after surgery|28|||
19652326|NCT00623766|42101985|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
19652327|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
19652328|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
19652329|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
19652330|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
19652331|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
19652332|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
19652333|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
19652334|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
19652335|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
19751993|NCT03287622|42201374|FG001|Overall Study|No prescripion after surgery|31|||
19751994|NCT03287622|42201373|FG000|Overall Study|prolonged Length of stay|2|||
19751995|NCT03287622|42201374|FG001|Overall Study|prolonged Length of stay|0|||
19751996|NCT03287622|42201373|FG000|Overall Study|surgery related|0|||
19751997|NCT03287622|42201374|FG001|Overall Study|surgery related|2|||
19751998|NCT04063657|42201389|FG000|Overall Study|Lost to Follow-up|1|||
19751999|NCT04063657|42201390|FG001|Overall Study|Lost to Follow-up|0|||
19752000|NCT04058353|42201407|FG000|Overall Study|Adverse Event|2|||
19752001|NCT04058353|42201408|FG001|Overall Study|Adverse Event|1|||
19752002|NCT04058353|42201407|FG000|Overall Study|Physician Decision|1|||
19752003|NCT04058353|42201408|FG001|Overall Study|Physician Decision|0|||
19752004|NCT04058353|42201407|FG000|Overall Study|Other|1|||
19752005|NCT04058353|42201408|FG001|Overall Study|Other|0|||
19752006|NCT03226353|42201415|FG000|Overall Study|Withdrawal by Subject|1|||
19752007|NCT03226353|42201415|FG000|Overall Study|Screen Failure|5|||
19752008|NCT02730598|42201424|FG000|Overall Study|Withdrawal by Subject|3|||
19752009|NCT02730598|42201425|FG001|Overall Study|Withdrawal by Subject|3|||
19752010|NCT02730598|42201424|FG000|Overall Study|Protocol Violation|0|||
19652336|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
19752011|NCT02730598|42201425|FG001|Overall Study|Protocol Violation|1|||
19652337|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
19652338|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
19652339|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
19652340|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
19652341|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
19652342|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
19652343|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
19652344|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
19752012|NCT02730598|42201424|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
19752013|NCT02730598|42201425|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
19652345|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
19752014|NCT03226275|42201435|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
19388249|NCT02703311|41631667|FG000|Overall Study|Death|5|||
19652346|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
19652347|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
19652348|NCT00550407|42101997|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
19652349|NCT00550407|42101998|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
19652350|NCT00550407|42101999|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
19652351|NCT00550407|42101997|FG000|26-Week Randomized Phase|Adverse Event|0|||
19652352|NCT00550407|42101998|FG001|26-Week Randomized Phase|Adverse Event|5|||
19652353|NCT00550407|42101999|FG002|26-Week Randomized Phase|Adverse Event|2|||
19652354|NCT00550407|42101997|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
19652355|NCT00550407|42101998|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
19652356|NCT00550407|42101999|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
19652357|NCT00550407|42101997|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
19652358|NCT00550407|42101998|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
19652359|NCT00550407|42101999|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
19652360|NCT00550407|42101997|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
19652361|NCT00550407|42101998|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
19652362|NCT00550407|42101999|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
19652363|NCT00531934|42102009|FG000|Overall Study|Adverse Event|4|||
19652364|NCT00531934|42102010|FG001|Overall Study|Adverse Event|8|||
19652365|NCT00531934|42102009|FG000|Overall Study|Progression|52|||
19652366|NCT00531934|42102010|FG001|Overall Study|Progression|42|||
19652367|NCT00531934|42102009|FG000|Overall Study|Death|7|||
19652368|NCT00531934|42102010|FG001|Overall Study|Death|10|||
19652369|NCT00531934|42102009|FG000|Overall Study|Withdrawal by Subject|1|||
19652370|NCT00531934|42102010|FG001|Overall Study|Withdrawal by Subject|1|||
19652371|NCT00531934|42102009|FG000|Overall Study|Other|2|||
19652372|NCT00531934|42102010|FG001|Overall Study|Other|2|||
19652373|NCT00549939|42102019|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
19652374|NCT00549939|42102020|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
19652375|NCT00549939|42102021|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
19652376|NCT00549939|42102019|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
19652377|NCT00549939|42102020|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
19652378|NCT00549939|42102021|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
19652379|NCT00549939|42102019|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
19652380|NCT00549939|42102020|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
19652381|NCT00549939|42102021|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
19652382|NCT00549939|42102019|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
19652383|NCT00549939|42102020|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
19652384|NCT00549939|42102021|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
19652385|NCT00549939|42102019|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
19652386|NCT00549939|42102020|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
19652387|NCT00549939|42102021|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
19652388|NCT00549939|42102019|FG000|40-week Open Label Treatment Period|Other|0|||
19652389|NCT00549939|42102020|FG001|40-week Open Label Treatment Period|Other|1|||
19652390|NCT00549939|42102021|FG002|40-week Open Label Treatment Period|Other|4|||
19652391|NCT00272779|42102033|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
19652392|NCT00272779|42102034|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
19652393|NCT00272779|42102033|FG000|Baseline Through Week 48|Death before Week 48|4|||
19652394|NCT00272779|42102034|FG001|Baseline Through Week 48|Death before Week 48|4|||
19652395|NCT00272779|42102033|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
19652396|NCT00272779|42102034|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
19652397|NCT00272779|42102033|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
19652398|NCT00272779|42102034|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
19652399|NCT00272779|42102033|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
19388250|NCT02703311|41631667|FG000|Overall Study|Withdrawal by Subject|3|||
19652400|NCT00272779|42102034|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
19652401|NCT00272779|42102033|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
19652402|NCT00272779|42102034|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
19652403|NCT00272779|42102033|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
19652404|NCT00272779|42102034|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
19652405|NCT00272779|42102033|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
19652406|NCT00272779|42102034|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
19652407|NCT00272779|42102033|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
19652408|NCT00272779|42102034|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
19652409|NCT00272779|42102033|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
19652410|NCT00272779|42102034|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
19652411|NCT00272779|42102033|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
19652412|NCT00272779|42102034|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
19652413|NCT00272779|42102033|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
19652414|NCT00272779|42102034|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
19652415|NCT00272779|42102033|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
19652416|NCT00272779|42102034|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
19652417|NCT00272779|42102033|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
19652418|NCT00272779|42102034|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
19652419|NCT00272779|42102033|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
19652420|NCT00272779|42102034|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
19652421|NCT00272779|42102033|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
19652422|NCT00272779|42102034|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
19652423|NCT00272779|42102033|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
19652424|NCT00272779|42102034|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
19652425|NCT00272779|42102033|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
19652426|NCT00272779|42102034|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
19652427|NCT00272779|42102033|FG000|Baseline Through Week 48|Continuing treatment|385|||
19652428|NCT00272779|42102034|FG001|Baseline Through Week 48|Continuing treatment|368|||
19652429|NCT00272779|42102033|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
19652430|NCT00272779|42102034|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
19652431|NCT00272779|42102033|FG000|Baseline Through Week 48|Never treated|2|||
19652432|NCT00272779|42102034|FG001|Baseline Through Week 48|Never treated|3|||
19652433|NCT00272779|42102033|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
19652434|NCT00272779|42102034|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
19652435|NCT00272779|42102033|FG000|Baseline Through Week 96|Death before Week 96|6|||
19652436|NCT00272779|42102034|FG001|Baseline Through Week 96|Death before Week 96|5|||
19652437|NCT00272779|42102033|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
19652438|NCT00272779|42102034|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
19652439|NCT00272779|42102033|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
19652440|NCT00272779|42102034|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
19652441|NCT00272779|42102033|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
19652442|NCT00272779|42102034|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
19652443|NCT00272779|42102033|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
19388251|NCT02697617|41631671|FG000|Overall Study|Withdrawal by Subject|0|||
19388252|NCT02697617|41631672|FG001|Overall Study|Withdrawal by Subject|2|||
19388253|NCT02697617|41631671|FG000|Overall Study|Pregnancy|1|||
19388254|NCT02697617|41631672|FG001|Overall Study|Pregnancy|0|||
19652444|NCT00272779|42102034|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
19652445|NCT00272779|42102033|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
19652446|NCT00272779|42102034|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
19752015|NCT03226275|42201436|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
19601423|NCT01068665|42050073|FG001|Overall Study|Adverse Event|4|||
19601424|NCT01068665|42050072|FG000|Overall Study|Lack of Efficacy|0|||
19601425|NCT01068665|42050073|FG001|Overall Study|Lack of Efficacy|2|||
19601426|NCT01068665|42050072|FG000|Overall Study|Protocol Violation|5|||
19601427|NCT01068665|42050073|FG001|Overall Study|Protocol Violation|2|||
19601428|NCT01068665|42050072|FG000|Overall Study|Withdrawal Criteria|3|||
19601429|NCT01068665|42050073|FG001|Overall Study|Withdrawal Criteria|9|||
19601430|NCT01068665|42050072|FG000|Overall Study|Other|17|||
19601431|NCT01068665|42050073|FG001|Overall Study|Other|12|||
19601432|NCT01001390|42050079|FG000|Overall Study|Failure to wear AFO device|2|||
19601433|NCT01001390|42050080|FG001|Overall Study|Failure to wear AFO device|0|||
19601434|NCT00772954|42050088|FG000|Overall Study|Adverse Event|0|||
19601435|NCT00772954|42050089|FG001|Overall Study|Adverse Event|0|||
19601436|NCT00772954|42050090|FG002|Overall Study|Adverse Event|1|||
19601437|NCT00781768|42050100|FG000|Overall Study|Not transplanted.|0|||
19752016|NCT03226275|42201437|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
19752017|NCT03226275|42201438|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
19752018|NCT03226275|42201435|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
19752019|NCT03226275|42201436|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
19652447|NCT00272779|42102033|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
19652448|NCT00272779|42102034|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
19652449|NCT00272779|42102033|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
19652450|NCT00272779|42102034|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
19652451|NCT00272779|42102033|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
19652452|NCT00272779|42102034|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
19652453|NCT00272779|42102033|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
19652454|NCT00272779|42102034|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
19652455|NCT00272779|42102033|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
19652456|NCT00272779|42102034|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
19652457|NCT00272779|42102033|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
19652458|NCT00272779|42102034|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
19652459|NCT00272779|42102033|FG000|Baseline Through Week 96|Never treated|2|||
19652460|NCT00272779|42102034|FG001|Baseline Through Week 96|Never treated|3|||
19652461|NCT00272779|42102033|FG000|Baseline Through Week 96|Continuing on treatment|61|||
19652462|NCT00272779|42102034|FG001|Baseline Through Week 96|Continuing on treatment|38|||
19652463|NCT00511810|42102043|FG000|Overall Study|Lost to Follow-up|1|||
19652464|NCT00511810|42102044|FG001|Overall Study|Lost to Follow-up|2|||
19652465|NCT00511810|42102043|FG000|Overall Study|Lack of Efficacy|0|||
19652466|NCT00511810|42102044|FG001|Overall Study|Lack of Efficacy|2|||
19652467|NCT00511810|42102043|FG000|Overall Study|Refused second scn|0|||
19652468|NCT00511810|42102044|FG001|Overall Study|Refused second scn|1|||
19652469|NCT00291499|42102052|FG000|Overall Study|Adverse Event|3|||
19652470|NCT00291499|42102053|FG001|Overall Study|Adverse Event|8|||
19652471|NCT00291499|42102052|FG000|Overall Study|Change to other therapy|2|||
19652472|NCT00291499|42102053|FG001|Overall Study|Change to other therapy|1|||
19652473|NCT00291499|42102052|FG000|Overall Study|Intercurrent illness|1|||
19652474|NCT00291499|42102053|FG001|Overall Study|Intercurrent illness|0|||
19652475|NCT00291499|42102052|FG000|Overall Study|Protocol Violation|2|||
19652476|NCT00291499|42102053|FG001|Overall Study|Protocol Violation|2|||
19652477|NCT00291499|42102052|FG000|Overall Study|Other reasons|1|||
19652478|NCT00291499|42102053|FG001|Overall Study|Other reasons|4|||
19652479|NCT00553605|42102061|FG000|Overall Study|Did not meet entrance criteria|1|||
19652480|NCT00553605|42102062|FG001|Overall Study|Did not meet entrance criteria|3|||
19652481|NCT00553605|42102061|FG000|Overall Study|Did not receive full dose|1|||
19652482|NCT00553605|42102062|FG001|Overall Study|Did not receive full dose|0|||
19652483|NCT00553605|42102061|FG000|Overall Study|Randomized but not treated|2|||
19652484|NCT00553605|42102062|FG001|Overall Study|Randomized but not treated|0|||
19652485|NCT00621582|42102068|FG000|Overall Study|Adverse Event|7|||
19652486|NCT00621582|42102068|FG000|Overall Study|Protocol Violation|57|||
19652487|NCT00621582|42102068|FG000|Overall Study|Lost to Follow-up|24|||
19652488|NCT00621582|42102068|FG000|Overall Study|issues not identified by investigators|18|||
19652489|NCT00744497|42102074|FG000|Overall Study|Withdrawal by Subject|21|||
19652490|NCT00744497|42102075|FG001|Overall Study|Withdrawal by Subject|18|||
19652491|NCT00744497|42102074|FG000|Overall Study|Death|11|||
19652492|NCT00744497|42102075|FG001|Overall Study|Death|9|||
19652493|NCT00744497|42102074|FG000|Overall Study|Lost to Follow-up|4|||
19652494|NCT00744497|42102075|FG001|Overall Study|Lost to Follow-up|2|||
19652495|NCT00744497|42102074|FG000|Overall Study|Poor compliance/noncompliance|9|||
19652496|NCT00744497|42102075|FG001|Overall Study|Poor compliance/noncompliance|5|||
19652497|NCT00744497|42102074|FG000|Overall Study|No longer meets study criteria|7|||
19652498|NCT00744497|42102075|FG001|Overall Study|No longer meets study criteria|3|||
19652499|NCT00744497|42102074|FG000|Overall Study|Administrative Reason By Sponsor|25|||
19652500|NCT00744497|42102075|FG001|Overall Study|Administrative Reason By Sponsor|8|||
19652501|NCT00744497|42102074|FG000|Overall Study|Disease progression|312|||
19752020|NCT03226275|42201437|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
19752021|NCT03226275|42201438|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
19752022|NCT04189081|42201451|FG000|Overall Study|Lost to Follow-up|1|||
19752023|NCT04189081|42201452|FG001|Overall Study|Lost to Follow-up|0|||
19752024|NCT04189081|42201453|FG002|Overall Study|Lost to Follow-up|0|||
19752025|NCT04189081|42201451|FG000|Overall Study|Withdrawal by Subject|0|||
19752026|NCT04189081|42201452|FG001|Overall Study|Withdrawal by Subject|0|||
19652502|NCT00744497|42102075|FG001|Overall Study|Disease progression|219|||
19652503|NCT00744497|42102074|FG000|Overall Study|Study drug toxicity|68|||
19652504|NCT00744497|42102075|FG001|Overall Study|Study drug toxicity|141|||
19652505|NCT00744497|42102074|FG000|Overall Study|Adverse event unrelated to study drug|78|||
19652506|NCT00744497|42102075|FG001|Overall Study|Adverse event unrelated to study drug|122|||
19652507|NCT00744497|42102074|FG000|Overall Study|Patient requested to stop study drug|65|||
19752027|NCT04189081|42201453|FG002|Overall Study|Withdrawal by Subject|1|||
19752028|NCT04187989|42201463|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
19752029|NCT04187989|42201464|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
19752030|NCT04187989|42201463|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
19752031|NCT04187989|42201464|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
19752032|NCT01150890|42201474|FG000|Overall Study|Other|0|||
19752033|NCT01150890|42201475|FG001|Overall Study|Other|1|||
19752034|NCT01150890|42201476|FG002|Overall Study|Other|0|||
19652508|NCT00744497|42102075|FG001|Overall Study|Patient requested to stop study drug|80|||
19652509|NCT00744497|42102074|FG000|Overall Study|Maximum clinical benefit|141|||
19652510|NCT00744497|42102075|FG001|Overall Study|Maximum clinical benefit|142|||
19652511|NCT00744497|42102074|FG000|Overall Study|Not defined|19|||
19652512|NCT00744497|42102075|FG001|Overall Study|Not defined|13|||
19652513|NCT00747227|42102083|FG000|Overall Study|Death|3|||
19652514|NCT00747227|42102084|FG001|Overall Study|Death|1|||
19652515|NCT00747227|42102083|FG000|Overall Study|Withdrawal by Subject|1|||
19652516|NCT00747227|42102084|FG001|Overall Study|Withdrawal by Subject|0|||
19652517|NCT00747227|42102083|FG000|Overall Study|Lost to Follow-up|1|||
19652518|NCT00747227|42102084|FG001|Overall Study|Lost to Follow-up|2|||
19652519|NCT00747227|42102083|FG000|Overall Study|Illness|1|||
19652520|NCT00747227|42102084|FG001|Overall Study|Illness|1|||
19652521|NCT00747149|42102092|FG000|Overall Study|Adverse Event|0|||
19652522|NCT00747149|42102093|FG001|Overall Study|Adverse Event|15|||
19652523|NCT00747149|42102092|FG000|Overall Study|Lost to Follow-up|0|||
19652524|NCT00747149|42102093|FG001|Overall Study|Lost to Follow-up|10|||
19652525|NCT00747149|42102092|FG000|Overall Study|Withdrawal by Subject|0|||
19652526|NCT00747149|42102093|FG001|Overall Study|Withdrawal by Subject|6|||
19652527|NCT00747149|42102092|FG000|Overall Study|Did not receive treatment|0|||
19652528|NCT00747149|42102093|FG001|Overall Study|Did not receive treatment|1|||
19652529|NCT00747149|42102092|FG000|Overall Study|Incorrect enrollment|0|||
19652530|NCT00747149|42102093|FG001|Overall Study|Incorrect enrollment|6|||
19652531|NCT00747149|42102092|FG000|Overall Study|Severe non-compliance to protocol|0|||
19652532|NCT00747149|42102093|FG001|Overall Study|Severe non-compliance to protocol|1|||
19652533|NCT00747149|42102092|FG000|Overall Study|Not reported|1|||
19652534|NCT00747149|42102093|FG001|Overall Study|Not reported|4|||
19652535|NCT00271609|42102107|FG000|Overall Study|Adverse Event|11|||
19652536|NCT00271609|42102108|FG001|Overall Study|Adverse Event|3|||
19652537|NCT00271609|42102107|FG000|Overall Study|Withdrawal by Subject|2|||
19752035|NCT01150890|42201477|FG003|Overall Study|Other|2|||
19752036|NCT01150890|42201474|FG000|Overall Study|Pregnancy|0|||
19752037|NCT01150890|42201475|FG001|Overall Study|Pregnancy|0|||
19752038|NCT01150890|42201476|FG002|Overall Study|Pregnancy|0|||
19752039|NCT01150890|42201477|FG003|Overall Study|Pregnancy|1|||
19752040|NCT01150890|42201474|FG000|Overall Study|Administrative Decision|4|||
19652538|NCT00271609|42102108|FG001|Overall Study|Withdrawal by Subject|0|||
19652539|NCT00548847|42102114|FG000|Overall Study|Disease progression|7|||
19652540|NCT00290407|42102118|FG000|Overall Study|Physician Decision|2|||
19652541|NCT00749411|42102124|FG000|Overall Study|Adverse Event|0|||
19652542|NCT00749411|42102125|FG001|Overall Study|Adverse Event|2|||
19652543|NCT00749411|42102124|FG000|Overall Study|Lack of Efficacy|0|||
19652544|NCT00749411|42102125|FG001|Overall Study|Lack of Efficacy|1|||
19652545|NCT00749411|42102124|FG000|Overall Study|Protocol Violation|1|||
19652546|NCT00749411|42102125|FG001|Overall Study|Protocol Violation|1|||
19652547|NCT00749411|42102124|FG000|Overall Study|Protocol-defined stopping criteria|0|||
19652548|NCT00749411|42102125|FG001|Overall Study|Protocol-defined stopping criteria|1|||
19652549|NCT03958149|42102133|FG000|Overall Study|Withdrawal by Subject|0|||
19652550|NCT03958149|42102134|FG001|Overall Study|Withdrawal by Subject|1|||
19652551|NCT00549549|42102148|FG000|Overall Study|Adverse Event|5|||
19652552|NCT00549549|42102149|FG001|Overall Study|Adverse Event|3|||
19652553|NCT00549549|42102150|FG002|Overall Study|Adverse Event|1|||
19652554|NCT00549549|42102151|FG003|Overall Study|Adverse Event|9|||
19652555|NCT00549549|42102148|FG000|Overall Study|Lack of Efficacy|9|||
19652556|NCT00549549|42102149|FG001|Overall Study|Lack of Efficacy|6|||
19652557|NCT00549549|42102150|FG002|Overall Study|Lack of Efficacy|4|||
19652558|NCT00549549|42102151|FG003|Overall Study|Lack of Efficacy|2|||
19652559|NCT00549549|42102148|FG000|Overall Study|Lost to Follow-up|1|||
19652560|NCT00549549|42102149|FG001|Overall Study|Lost to Follow-up|0|||
19652561|NCT00549549|42102150|FG002|Overall Study|Lost to Follow-up|1|||
19652562|NCT00549549|42102151|FG003|Overall Study|Lost to Follow-up|2|||
19652563|NCT00549549|42102148|FG000|Overall Study|Withdrawal by Subject|0|||
19652564|NCT00549549|42102149|FG001|Overall Study|Withdrawal by Subject|4|||
19652565|NCT00549549|42102150|FG002|Overall Study|Withdrawal by Subject|1|||
19652566|NCT00549549|42102151|FG003|Overall Study|Withdrawal by Subject|0|||
19652567|NCT00549549|42102148|FG000|Overall Study|Other|9|||
19652568|NCT00549549|42102149|FG001|Overall Study|Other|9|||
19652569|NCT00549549|42102150|FG002|Overall Study|Other|9|||
19652570|NCT00549549|42102151|FG003|Overall Study|Other|11|||
19652571|NCT00549549|42102148|FG000|Overall Study|Randomized but not treated|0|||
19652572|NCT00549549|42102149|FG001|Overall Study|Randomized but not treated|0|||
19752041|NCT01150890|42201475|FG001|Overall Study|Administrative Decision|4|||
19752042|NCT01150890|42201476|FG002|Overall Study|Administrative Decision|5|||
19652573|NCT00549549|42102150|FG002|Overall Study|Randomized but not treated|1|||
19652574|NCT00549549|42102151|FG003|Overall Study|Randomized but not treated|1|||
19652575|NCT00270205|42102165|FG000|Overall Study|Lost to Follow-up|1|||
19652576|NCT00270205|42102166|FG001|Overall Study|Lost to Follow-up|0|||
19652577|NCT00270205|42102167|FG002|Overall Study|Lost to Follow-up|0|||
19652578|NCT00270205|42102168|FG003|Overall Study|Lost to Follow-up|1|||
19652579|NCT00622284|42102180|FG000|Overall Study|Lack of Efficacy|45|||
19652580|NCT00622284|42102181|FG001|Overall Study|Lack of Efficacy|15|||
19652581|NCT00622284|42102180|FG000|Overall Study|Adverse Event|61|||
19652582|NCT00622284|42102181|FG001|Overall Study|Adverse Event|90|||
19652583|NCT00622284|42102180|FG000|Overall Study|Protocol Violation|12|||
19652584|NCT00622284|42102181|FG001|Overall Study|Protocol Violation|5|||
19652585|NCT00622284|42102180|FG000|Overall Study|Lost to Follow-up|11|||
19652586|NCT00622284|42102181|FG001|Overall Study|Lost to Follow-up|13|||
19652587|NCT00622284|42102180|FG000|Overall Study|Withdrawal by Subject|27|||
19652588|NCT00622284|42102181|FG001|Overall Study|Withdrawal by Subject|24|||
19652589|NCT00622284|42102180|FG000|Overall Study|Other reason (not specified)|33|||
19652590|NCT00622284|42102181|FG001|Overall Study|Other reason (not specified)|24|||
19652591|NCT00269113|42102189|FG000|Overall Study|Adverse Event|14|||
19652592|NCT00269113|42102190|FG001|Overall Study|Adverse Event|7|||
19652593|NCT00269113|42102189|FG000|Overall Study|Lack of Efficacy|35|||
19652594|NCT00269113|42102190|FG001|Overall Study|Lack of Efficacy|18|||
19652595|NCT00269113|42102189|FG000|Overall Study|Early Improvement|2|||
19652596|NCT00269113|42102190|FG001|Overall Study|Early Improvement|0|||
19652597|NCT00269113|42102189|FG000|Overall Study|Withdrawal by Subject|0|||
19652598|NCT00269113|42102190|FG001|Overall Study|Withdrawal by Subject|2|||
19652599|NCT00269113|42102189|FG000|Overall Study|Death|6|||
19652600|NCT00269113|42102190|FG001|Overall Study|Death|2|||
19652601|NCT00269113|42102189|FG000|Overall Study|Lost to Follow-up|2|||
19652602|NCT00269113|42102190|FG001|Overall Study|Lost to Follow-up|1|||
19652603|NCT00269113|42102189|FG000|Overall Study|Protocol Violation|15|||
19652604|NCT00269113|42102190|FG001|Overall Study|Protocol Violation|5|||
19652605|NCT00269113|42102189|FG000|Overall Study|Other|0|||
19652606|NCT00269113|42102190|FG001|Overall Study|Other|2|||
19652607|NCT00291187|42102200|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
19652608|NCT00291187|42102201|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
19652609|NCT00291187|42102202|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
19652610|NCT00291187|42102203|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
19652611|NCT00546819|42102219|FG000|Overall Study|Adverse Event|2|||
19652612|NCT00546819|42102220|FG001|Overall Study|Adverse Event|3|||
19652613|NCT00546819|42102219|FG000|Overall Study|Lost to Follow-up|2|||
19652614|NCT00546819|42102220|FG001|Overall Study|Lost to Follow-up|1|||
19652615|NCT00546819|42102219|FG000|Overall Study|Withdrawal by Subject|4|||
19652616|NCT00546819|42102220|FG001|Overall Study|Withdrawal by Subject|2|||
19652617|NCT00621504|42102228|FG000|Overall Study|Adverse Event|1|||
19652618|NCT00621504|42102229|FG001|Overall Study|Adverse Event|3|||
19652619|NCT00621504|42102228|FG000|Overall Study|At the request of sponsor/investigator|1|||
19652620|NCT00621504|42102229|FG001|Overall Study|At the request of sponsor/investigator|0|||
19652621|NCT00621504|42102228|FG000|Overall Study|Withdrew consent|9|||
19652622|NCT00621504|42102229|FG001|Overall Study|Withdrew consent|6|||
19652623|NCT00621504|42102228|FG000|Overall Study|Lost to Follow-up|8|||
19652624|NCT00621504|42102229|FG001|Overall Study|Lost to Follow-up|10|||
19652625|NCT00621504|42102228|FG000|Overall Study|Other|1|||
19652626|NCT00621504|42102229|FG001|Overall Study|Other|0|||
19652627|NCT00621504|42102228|FG000|Overall Study|Death|6|||
19652628|NCT00621504|42102229|FG001|Overall Study|Death|6|||
19652629|NCT00548145|42102237|FG000|Overall Study|Death|0|||
19652630|NCT00548145|42102238|FG001|Overall Study|Death|1|||
19652631|NCT00548145|42102237|FG000|Overall Study|Withdrawal by Subject|0|||
19652632|NCT00548145|42102238|FG001|Overall Study|Withdrawal by Subject|2|||
19652633|NCT00548145|42102237|FG000|Overall Study|Physician Decision|1|||
19652634|NCT00548145|42102238|FG001|Overall Study|Physician Decision|1|||
19652635|NCT00547911|42102248|FG000|Overall Study|Adverse Event|0|||
19652636|NCT00547911|42102249|FG001|Overall Study|Adverse Event|0|||
19652637|NCT00547911|42102250|FG002|Overall Study|Adverse Event|0|||
19652638|NCT00547911|42102251|FG003|Overall Study|Adverse Event|1|||
19652639|NCT00547911|42102252|FG004|Overall Study|Adverse Event|0|||
19652640|NCT00547911|42102253|FG005|Overall Study|Adverse Event|0|||
19601438|NCT00781768|42050101|FG001|Overall Study|Not transplanted.|2|||
19601439|NCT01005680|42050109|FG000|Overall Study|Lost to Follow-up|4|||
19601440|NCT01005680|42050110|FG001|Overall Study|Lost to Follow-up|6|||
19601441|NCT01005680|42050109|FG000|Overall Study|Withdrawal by Subject|1|||
19601442|NCT01005680|42050110|FG001|Overall Study|Withdrawal by Subject|4|||
19601443|NCT01005680|42050109|FG000|Overall Study|Physician Decision|1|||
19601444|NCT01005680|42050110|FG001|Overall Study|Physician Decision|1|||
19601445|NCT01005602|42050119|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
19601446|NCT01005602|42050120|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
19652641|NCT00289783|42102268|FG000|Primary Phase|Adverse Event|10|||
19652642|NCT00289783|42102269|FG001|Primary Phase|Adverse Event|1|||
19652643|NCT00289783|42102268|FG000|Primary Phase|Protocol Violation|27|||
19652644|NCT00289783|42102269|FG001|Primary Phase|Protocol Violation|6|||
19652645|NCT00289783|42102268|FG000|Primary Phase|Withdrawal by Subject|93|||
19652646|NCT00289783|42102269|FG001|Primary Phase|Withdrawal by Subject|40|||
19652647|NCT00289783|42102268|FG000|Primary Phase|Lost to Follow-up|60|||
19652648|NCT00289783|42102269|FG001|Primary Phase|Lost to Follow-up|14|||
19652649|NCT00289783|42102268|FG000|Primary Phase|Migration from the study area|26|||
19652650|NCT00289783|42102269|FG001|Primary Phase|Migration from the study area|10|||
19652651|NCT00289783|42102268|FG000|Primary Phase|Other|32|||
19652652|NCT00289783|42102269|FG001|Primary Phase|Other|12|||
19652653|NCT00289783|42102268|FG000|Fourth Dose Phase|Adverse Event|1|||
19652654|NCT00289783|42102269|FG001|Fourth Dose Phase|Adverse Event|0|||
19652655|NCT00289783|42102268|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
19652656|NCT00289783|42102269|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
19652657|NCT00289783|42102268|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
19652658|NCT00289783|42102269|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
19652659|NCT00289783|42102268|FG000|Fourth Dose Phase|Migration from the study area|1|||
19652660|NCT00289783|42102269|FG001|Fourth Dose Phase|Migration from the study area|1|||
19652661|NCT00289783|42102268|FG000|Fourth Dose Phase|Other|22|||
19652662|NCT00289783|42102269|FG001|Fourth Dose Phase|Other|10|||
19652663|NCT00574080|42102285|FG000|Overall Study|Death|10|||
19652664|NCT00574080|42102286|FG001|Overall Study|Death|10|||
19652665|NCT00546351|42102292|FG000|Overall Study|Adverse Event|76|||
19652666|NCT00546351|42102292|FG000|Overall Study|Lack of Efficacy|15|||
19652667|NCT00546351|42102292|FG000|Overall Study|Withdrawal by Subject|109|||
19652668|NCT00546351|42102292|FG000|Overall Study|Lost to Follow-up|9|||
19652669|NCT00546351|42102292|FG000|Overall Study|Protocol Deviation|1|||
19652670|NCT00546351|42102292|FG000|Overall Study|Unsatisfactory compliance|9|||
19652671|NCT00546351|42102292|FG000|Overall Study|Other reasons for premature termination|17|||
19652672|NCT00267865|42102296|FG000|Induction Treatment|Died before completing.|2|||
19652673|NCT00267865|42102296|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
19652674|NCT00546117|42102302|FG000|Overall Study|Withdrawal by Subject|3|||
19652675|NCT00546117|42102303|FG001|Overall Study|Withdrawal by Subject|0|||
19652676|NCT00546117|42102302|FG000|Overall Study|Inability to schedule follow-up visit|1|||
19652677|NCT00546117|42102303|FG001|Overall Study|Inability to schedule follow-up visit|0|||
19652678|NCT00251719|42102314|FG000|Overall Study|Adverse Event|14|||
19652679|NCT00251719|42102315|FG001|Overall Study|Adverse Event|8|||
19652680|NCT00251719|42102316|FG002|Overall Study|Adverse Event|7|||
19652681|NCT00251719|42102314|FG000|Overall Study|Protocol Violation|1|||
19652682|NCT00251719|42102315|FG001|Overall Study|Protocol Violation|1|||
19652683|NCT00251719|42102316|FG002|Overall Study|Protocol Violation|1|||
19652684|NCT00251719|42102314|FG000|Overall Study|Lost to Follow-up|5|||
19652685|NCT00251719|42102315|FG001|Overall Study|Lost to Follow-up|11|||
19752043|NCT01150890|42201477|FG003|Overall Study|Administrative Decision|6|||
19752044|NCT01150890|42201474|FG000|Overall Study|Ineligibility determined|0|||
19752045|NCT01150890|42201475|FG001|Overall Study|Ineligibility determined|1|||
19601447|NCT01068509|42050136|FG000|Overall Study|Death|0|||
19652686|NCT00251719|42102316|FG002|Overall Study|Lost to Follow-up|8|||
19652687|NCT00251719|42102314|FG000|Overall Study|Withdrawal by Subject|14|||
19652688|NCT00251719|42102315|FG001|Overall Study|Withdrawal by Subject|12|||
19652689|NCT00251719|42102316|FG002|Overall Study|Withdrawal by Subject|11|||
19652690|NCT00251719|42102314|FG000|Overall Study|Lack of Efficacy|2|||
19652691|NCT00251719|42102315|FG001|Overall Study|Lack of Efficacy|1|||
19652692|NCT00251719|42102316|FG002|Overall Study|Lack of Efficacy|0|||
19652693|NCT00251719|42102314|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
19652694|NCT00251719|42102315|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
19652695|NCT00251719|42102316|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
19652696|NCT00251719|42102314|FG000|Overall Study|Investigator decision|1|||
19652697|NCT00251719|42102315|FG001|Overall Study|Investigator decision|1|||
19752046|NCT01150890|42201476|FG002|Overall Study|Ineligibility determined|0|||
19601448|NCT01068509|42050137|FG001|Overall Study|Death|0|||
19601449|NCT01068509|42050138|FG002|Overall Study|Death|1|||
19601450|NCT01068509|42050136|FG000|Overall Study|Disease Progression|5|||
19601451|NCT01068509|42050137|FG001|Overall Study|Disease Progression|20|||
19601452|NCT01068509|42050138|FG002|Overall Study|Disease Progression|18|||
19601453|NCT01068509|42050136|FG000|Overall Study|Lost to Follow-up|1|||
19601454|NCT01068509|42050137|FG001|Overall Study|Lost to Follow-up|0|||
19601455|NCT01068509|42050138|FG002|Overall Study|Lost to Follow-up|0|||
19601456|NCT01068509|42050136|FG000|Overall Study|Withdrew Consent|0|||
19601457|NCT01068509|42050137|FG001|Overall Study|Withdrew Consent|1|||
19601458|NCT01068509|42050138|FG002|Overall Study|Withdrew Consent|2|||
19601459|NCT01068509|42050136|FG000|Overall Study|Reason Not Specified|0|||
19601460|NCT01068509|42050137|FG001|Overall Study|Reason Not Specified|1|||
19601461|NCT01068509|42050138|FG002|Overall Study|Reason Not Specified|0|||
19601462|NCT01009034|42050145|FG000|Overall Study|Lost to Follow-up|2|||
19652698|NCT00251719|42102316|FG002|Overall Study|Investigator decision|0|||
19652699|NCT00251719|42102314|FG000|Overall Study|Noncompliance|2|||
19652700|NCT00251719|42102315|FG001|Overall Study|Noncompliance|3|||
19652701|NCT00251719|42102316|FG002|Overall Study|Noncompliance|1|||
19652702|NCT00251719|42102314|FG000|Overall Study|Barrett's esophagus|2|||
19652703|NCT00251719|42102315|FG001|Overall Study|Barrett's esophagus|2|||
19652704|NCT00251719|42102316|FG002|Overall Study|Barrett's esophagus|0|||
19652705|NCT03952143|42102326|FG000|Lead-In Period|Adverse Event|2|||
19652706|NCT03952143|42102327|FG001|Lead-In Period|Adverse Event|0|||
19652707|NCT03952143|42102328|FG002|Lead-In Period|Adverse Event|0|||
19652708|NCT03952143|42102326|FG000|Lead-In Period|Lack of Efficacy|2|||
19652709|NCT03952143|42102327|FG001|Lead-In Period|Lack of Efficacy|0|||
19652710|NCT03952143|42102328|FG002|Lead-In Period|Lack of Efficacy|0|||
19652711|NCT03952143|42102326|FG000|Lead-In Period|Physician Decision|5|||
19652712|NCT03952143|42102327|FG001|Lead-In Period|Physician Decision|0|||
19652713|NCT03952143|42102328|FG002|Lead-In Period|Physician Decision|0|||
19652714|NCT03952143|42102326|FG000|Lead-In Period|Protocol Violation|5|||
19652715|NCT03952143|42102327|FG001|Lead-In Period|Protocol Violation|0|||
19652716|NCT03952143|42102328|FG002|Lead-In Period|Protocol Violation|0|||
19652717|NCT03952143|42102326|FG000|Lead-In Period|Withdrawal by Subject|19|||
19652718|NCT03952143|42102327|FG001|Lead-In Period|Withdrawal by Subject|0|||
19652719|NCT03952143|42102328|FG002|Lead-In Period|Withdrawal by Subject|0|||
19652720|NCT03952143|42102326|FG000|Treatment Period|Adverse Event|0|||
19652721|NCT03952143|42102327|FG001|Treatment Period|Adverse Event|0|||
19652722|NCT03952143|42102328|FG002|Treatment Period|Adverse Event|1|||
19652723|NCT03952143|42102326|FG000|Treatment Period|Lost to Follow-up|0|||
19652724|NCT03952143|42102327|FG001|Treatment Period|Lost to Follow-up|2|||
19652725|NCT03952143|42102328|FG002|Treatment Period|Lost to Follow-up|0|||
19652726|NCT03952143|42102326|FG000|Treatment Period|Physician Decision|0|||
19652727|NCT03952143|42102327|FG001|Treatment Period|Physician Decision|0|||
19652728|NCT03952143|42102328|FG002|Treatment Period|Physician Decision|2|||
19652729|NCT03952143|42102326|FG000|Treatment Period|Protocol Violation|0|||
19652730|NCT03952143|42102327|FG001|Treatment Period|Protocol Violation|0|||
19652731|NCT03952143|42102328|FG002|Treatment Period|Protocol Violation|1|||
19652732|NCT03952143|42102326|FG000|Treatment Period|Withdrawal by Subject|0|||
19652733|NCT03952143|42102327|FG001|Treatment Period|Withdrawal by Subject|5|||
19652734|NCT03952143|42102328|FG002|Treatment Period|Withdrawal by Subject|26|||
19652735|NCT03952143|42102326|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
19652736|NCT03952143|42102327|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
19652737|NCT03952143|42102328|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
19652738|NCT03952143|42102326|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
19652739|NCT03952143|42102327|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
19652740|NCT03952143|42102328|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
19652741|NCT00267007|42102337|FG000|Overall Study|Withdrawal by Subject|6|||
19652742|NCT00267007|42102338|FG001|Overall Study|Withdrawal by Subject|0|||
19652743|NCT00267007|42102337|FG000|Overall Study|Lost to Follow-up|1|||
19652744|NCT00267007|42102338|FG001|Overall Study|Lost to Follow-up|0|||
19652745|NCT00267007|42102337|FG000|Overall Study|Non-compliance|0|||
19652746|NCT00267007|42102338|FG001|Overall Study|Non-compliance|1|||
19652747|NCT00267007|42102337|FG000|Overall Study|Adverse Event|1|||
19652748|NCT00267007|42102338|FG001|Overall Study|Adverse Event|0|||
19652749|NCT03943095|42102346|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
19652750|NCT03943095|42102347|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
19601463|NCT01009034|42050145|FG000|Overall Study|Withdrawal by Subject|2|||
19601464|NCT00768430|42050151|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
19601465|NCT00768430|42050152|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
19601466|NCT01064297|42050161|FG000|Overall Study|Lost to Follow-up|791|||
19601467|NCT01064297|42050162|FG001|Overall Study|Lost to Follow-up|48|||
19601468|NCT01064297|42050163|FG002|Overall Study|Lost to Follow-up|133|||
19601469|NCT00781456|42050180|FG000|Overall Study|Adverse Event|3|||
19601470|NCT00781456|42050181|FG001|Overall Study|Adverse Event|3|||
19601471|NCT00781456|42050180|FG000|Overall Study|Withdrawal by Subject|3|||
19601472|NCT00781456|42050181|FG001|Overall Study|Withdrawal by Subject|5|||
19601473|NCT00781456|42050180|FG000|Overall Study|Protocol Violation|4|||
19601474|NCT00781456|42050181|FG001|Overall Study|Protocol Violation|1|||
19652751|NCT03943095|42102346|FG000|Overall Study|Withdrawal by Subject|1|||
19652752|NCT03943095|42102347|FG001|Overall Study|Withdrawal by Subject|0|||
19652753|NCT00251641|42102356|FG000|Overall Study|Adverse Event|80|||
19652754|NCT00251641|42102357|FG001|Overall Study|Adverse Event|8|||
19652755|NCT00251641|42102356|FG000|Overall Study|Lack of Efficacy|2|||
19652756|NCT00251641|42102357|FG001|Overall Study|Lack of Efficacy|1|||
19652757|NCT00251641|42102356|FG000|Overall Study|Progression of Disease|0|||
19601475|NCT00781456|42050180|FG000|Overall Study|Noncompliance With Protocol|1|||
19652758|NCT00251641|42102357|FG001|Overall Study|Progression of Disease|2|||
19652759|NCT00251641|42102356|FG000|Overall Study|Lost to Follow-up|3|||
19652760|NCT00251641|42102357|FG001|Overall Study|Lost to Follow-up|3|||
19652761|NCT00251641|42102356|FG000|Overall Study|Withdrawal by Subject|6|||
19652762|NCT00251641|42102357|FG001|Overall Study|Withdrawal by Subject|8|||
19652763|NCT00251641|42102356|FG000|Overall Study|Protocol Violation|10|||
19652764|NCT00251641|42102357|FG001|Overall Study|Protocol Violation|2|||
19652765|NCT00251641|42102356|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
19652766|NCT00251641|42102357|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
19652767|NCT00251641|42102356|FG000|Overall Study|Switched Treatment|9|||
19652768|NCT00251641|42102357|FG001|Overall Study|Switched Treatment|63|||
19652769|NCT00250705|42102365|FG000|Overall Study|Lack of Efficacy|2|||
19652770|NCT00266695|42102371|FG000|Overall Study|Adverse Event|1|||
19652771|NCT00266695|42102371|FG000|Overall Study|Death|9|||
19652772|NCT00266695|42102371|FG000|Overall Study|Physician Decision|1|||
19652773|NCT00266695|42102371|FG000|Overall Study|Lost to Follow-up|3|||
19652774|NCT00266695|42102371|FG000|Overall Study|Withdrawal by Subject|15|||
19601476|NCT00781456|42050181|FG001|Overall Study|Noncompliance With Protocol|1|||
19601477|NCT00781456|42050180|FG000|Overall Study|Lost to Follow-up|10|||
19601478|NCT00781456|42050181|FG001|Overall Study|Lost to Follow-up|5|||
19601479|NCT00781456|42050180|FG000|Overall Study|Other Reason, Unknown|0|||
19601480|NCT00781456|42050181|FG001|Overall Study|Other Reason, Unknown|1|||
19601481|NCT00587158|42050189|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
19601482|NCT00587158|42050190|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
19601483|NCT00587158|42050189|FG000|Overall Study|Physician Decision|0|||
19601484|NCT00587158|42050190|FG001|Overall Study|Physician Decision|1|||
19601485|NCT00587158|42050189|FG000|Overall Study|Lost to Follow-up|1|||
19601486|NCT00587158|42050190|FG001|Overall Study|Lost to Follow-up|2|||
19601487|NCT00587158|42050189|FG000|Overall Study|Death|0|||
19601488|NCT00587158|42050190|FG001|Overall Study|Death|1|||
19601489|NCT00587158|42050189|FG000|Overall Study|Subject did not want to take study med|0|||
19601490|NCT00587158|42050190|FG001|Overall Study|Subject did not want to take study med|1|||
19601491|NCT00582907|42050196|FG000|1st Course|Withdrawal by Subject|1|||
19601492|NCT00582907|42050197|FG001|1st Course|Withdrawal by Subject|0|||
19601493|NCT00582907|42050198|FG002|1st Course|Withdrawal by Subject|0|||
19652775|NCT00620022|42102375|FG000|Treatment Period 1|Adverse Event|4|||
19652776|NCT00620022|42102376|FG001|Treatment Period 1|Adverse Event|6|||
19652777|NCT00620022|42102375|FG000|Treatment Period 1|Subject withdrew consent|1|||
19652778|NCT00620022|42102376|FG001|Treatment Period 1|Subject withdrew consent|0|||
19652779|NCT00620022|42102375|FG000|Treatment Period 2|Adverse Event|2|||
19652780|NCT00620022|42102376|FG001|Treatment Period 2|Adverse Event|2|||
19652781|NCT00547521|42102384|FG000|Short Term Study (4 Months)|Adverse Event|1|||
19652782|NCT00547521|42102385|FG001|Short Term Study (4 Months)|Adverse Event|0|||
19652783|NCT00547521|42102384|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
19652784|NCT00547521|42102385|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
19652785|NCT00547521|42102384|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
19652786|NCT00547521|42102385|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
19652787|NCT00547521|42102384|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
19652788|NCT00547521|42102385|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
19652789|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
19652790|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
19652791|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
19652792|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
19652793|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
19652794|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
19652795|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
19652796|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
19652797|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Other|0|||
19652798|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Other|2|||
19652799|NCT00547521|42102384|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
19652800|NCT00547521|42102385|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
19601494|NCT00582907|42050199|FG003|1st Course|Withdrawal by Subject|0|||
19601495|NCT00582907|42050196|FG000|1st Course|Lost to Follow-up|0|||
19652801|NCT00266227|42102400|FG000|Initial Treatment|Adverse Event|0|||
19652802|NCT00266227|42102401|FG001|Initial Treatment|Adverse Event|0|||
19652803|NCT00266227|42102402|FG002|Initial Treatment|Adverse Event|13|||
19652804|NCT00266227|42102400|FG000|Initial Treatment|Lost to Follow-up|0|||
19652805|NCT00266227|42102401|FG001|Initial Treatment|Lost to Follow-up|0|||
19652806|NCT00266227|42102402|FG002|Initial Treatment|Lost to Follow-up|6|||
19601496|NCT00582907|42050197|FG001|1st Course|Lost to Follow-up|0|||
19601497|NCT00582907|42050198|FG002|1st Course|Lost to Follow-up|0|||
19601498|NCT00582907|42050199|FG003|1st Course|Lost to Follow-up|1|||
19601499|NCT00582907|42050196|FG000|2nd Course|Lack of Efficacy|1|||
19601500|NCT00582907|42050197|FG001|2nd Course|Lack of Efficacy|0|||
19601501|NCT00582907|42050198|FG002|2nd Course|Lack of Efficacy|0|||
19601502|NCT00582907|42050199|FG003|2nd Course|Lack of Efficacy|0|||
19601503|NCT01062113|42050208|FG000|Overall Study|Adverse Event|1|||
19601504|NCT01062113|42050209|FG001|Overall Study|Adverse Event|0|||
19601505|NCT01062113|42050210|FG002|Overall Study|Adverse Event|0|||
19652807|NCT00266227|42102400|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
19652808|NCT00266227|42102401|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
19652809|NCT00266227|42102402|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
19652810|NCT00266227|42102400|FG000|Initial Treatment|Physician decision to withdraw|0|||
19652811|NCT00266227|42102401|FG001|Initial Treatment|Physician decision to withdraw|0|||
19652812|NCT00266227|42102402|FG002|Initial Treatment|Physician decision to withdraw|12|||
19652813|NCT00266227|42102400|FG000|Initial Treatment|Pregnancy|0|||
19652814|NCT00266227|42102401|FG001|Initial Treatment|Pregnancy|0|||
19652815|NCT00266227|42102402|FG002|Initial Treatment|Pregnancy|1|||
19652816|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Death|1|||
19652817|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Death|0|||
19652818|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Death|0|||
19652819|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
19652820|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
19652821|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
19652822|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
19652823|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
19652824|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
19652825|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
19652826|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
19652827|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
19652828|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
19652829|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
19652830|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
19652831|NCT00266227|42102400|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
19652832|NCT00266227|42102401|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
19652833|NCT00266227|42102402|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
19652834|NCT00266227|42102400|FG000|Retreatment: Week 48 to Week 72|Death|1|||
19652835|NCT00266227|42102401|FG001|Retreatment: Week 48 to Week 72|Death|1|||
19652836|NCT00266227|42102402|FG002|Retreatment: Week 48 to Week 72|Death|0|||
19652837|NCT00266227|42102400|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
19652838|NCT00266227|42102401|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
19652839|NCT00266227|42102402|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
19652840|NCT00266227|42102400|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
19652841|NCT00266227|42102401|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
19652842|NCT00266227|42102402|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
19652843|NCT00266227|42102400|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
19652844|NCT00266227|42102401|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
19652845|NCT00266227|42102402|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
19652846|NCT00266227|42102400|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
19652847|NCT00266227|42102401|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
19652848|NCT00266227|42102402|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
19652849|NCT00287365|42102411|FG000|Overall Study|sample not acquired|13|||
19652850|NCT00573768|42102419|FG000|Overall Study|Adverse Event|1|||
19652851|NCT00573768|42102420|FG001|Overall Study|Adverse Event|1|||
19652852|NCT00573768|42102421|FG002|Overall Study|Adverse Event|2|||
19652853|NCT00573768|42102419|FG000|Overall Study|Protocol Violation|1|||
19652854|NCT00573768|42102420|FG001|Overall Study|Protocol Violation|0|||
19652855|NCT00573768|42102421|FG002|Overall Study|Protocol Violation|1|||
19652856|NCT00573768|42102419|FG000|Overall Study|Withdrawal by Subject|0|||
19652857|NCT00573768|42102420|FG001|Overall Study|Withdrawal by Subject|1|||
19652858|NCT00573768|42102421|FG002|Overall Study|Withdrawal by Subject|0|||
19652859|NCT00573768|42102419|FG000|Overall Study|Lost to Follow-up|0|||
19652860|NCT00573768|42102420|FG001|Overall Study|Lost to Follow-up|0|||
19652861|NCT00573768|42102421|FG002|Overall Study|Lost to Follow-up|1|||
19652862|NCT00547365|42102429|FG000|Overall Study|Physician Decision|1|||
19601506|NCT01062113|42050208|FG000|Overall Study|Lack of Efficacy|38|||
19652863|NCT00547365|42102429|FG000|Overall Study|Lost to Follow-up|1|||
19652864|NCT00547365|42102429|FG000|Overall Study|Protocol Violation|2|||
19652865|NCT00547365|42102429|FG000|Overall Study|death (not related to study)|4|||
19652866|NCT00619866|42102437|FG000|Weeks 1 - 12|Adverse Event|0|||
19601507|NCT01062113|42050209|FG001|Overall Study|Lack of Efficacy|22|||
19601508|NCT01062113|42050210|FG002|Overall Study|Lack of Efficacy|31|||
19601509|NCT01062113|42050208|FG000|Overall Study|Withdrawal by Subject|1|||
19601510|NCT01062113|42050209|FG001|Overall Study|Withdrawal by Subject|0|||
19601511|NCT01062113|42050210|FG002|Overall Study|Withdrawal by Subject|0|||
19601512|NCT00772330|42050218|FG000|Overall Study|Lost to Follow-up|3|||
19601513|NCT01038869|42050225|FG000|Overall Study|Withdrawal by Subject|1|||
19601514|NCT01038869|42050225|FG000|Overall Study|Lost to Follow-up|6|||
19601515|NCT01038713|42050236|FG000|Overall Study|Patient to hospice|1|||
19652867|NCT00619866|42102438|FG001|Weeks 1 - 12|Adverse Event|1|||
19652868|NCT00619866|42102439|FG002|Weeks 1 - 12|Adverse Event|2|||
19652869|NCT00619866|42102440|FG003|Weeks 1 - 12|Adverse Event|0|||
19652870|NCT00619866|42102441|FG004|Weeks 1 - 12|Adverse Event|0|||
19652871|NCT00619866|42102437|FG000|Weeks 1 - 12|Non-compliance|0|||
19652872|NCT00619866|42102438|FG001|Weeks 1 - 12|Non-compliance|0|||
19652873|NCT00619866|42102439|FG002|Weeks 1 - 12|Non-compliance|1|||
19652874|NCT00619866|42102440|FG003|Weeks 1 - 12|Non-compliance|0|||
19652875|NCT00619866|42102441|FG004|Weeks 1 - 12|Non-compliance|0|||
19652876|NCT00619866|42102437|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
19652877|NCT00619866|42102438|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
19652878|NCT00619866|42102439|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
19652879|NCT00619866|42102440|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
19652880|NCT00619866|42102441|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
19652881|NCT00619866|42102437|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
19752047|NCT01150890|42201477|FG003|Overall Study|Ineligibility determined|0|||
19752048|NCT01150890|42201474|FG000|Overall Study|Adverse Event|0|||
19752049|NCT01150890|42201475|FG001|Overall Study|Adverse Event|0|||
19752050|NCT01150890|42201476|FG002|Overall Study|Adverse Event|2|||
19752051|NCT01150890|42201477|FG003|Overall Study|Adverse Event|0|||
19752052|NCT01150890|42201474|FG000|Overall Study|Withdrawal by Subject|0|||
19752053|NCT01150890|42201475|FG001|Overall Study|Withdrawal by Subject|0|||
19752054|NCT01150890|42201476|FG002|Overall Study|Withdrawal by Subject|2|||
19752055|NCT01150890|42201477|FG003|Overall Study|Withdrawal by Subject|1|||
19652882|NCT00619866|42102438|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
19652883|NCT00619866|42102439|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
19652884|NCT00619866|42102440|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
19652885|NCT00619866|42102441|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
19652886|NCT00619866|42102437|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
19652887|NCT00619866|42102438|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
19652888|NCT00619866|42102439|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
19652889|NCT00619866|42102440|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
19652890|NCT00619866|42102441|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
19752056|NCT01150890|42201474|FG000|Overall Study|Disease progression|0|||
19752057|NCT01150890|42201475|FG001|Overall Study|Disease progression|7|||
19752058|NCT01150890|42201476|FG002|Overall Study|Disease progression|3|||
19752059|NCT01150890|42201477|FG003|Overall Study|Disease progression|7|||
19752060|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Adverse Event|2|||
19752061|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Adverse Event|0|||
19752062|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Adverse Event|0|||
19752063|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Adverse Event|0|||
19752064|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
19752065|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
19752066|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
19752067|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
19752068|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
19752069|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
19752070|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
19752071|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
19752072|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Physician Decision|1|||
19752073|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Physician Decision|0|||
19752074|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Physician Decision|0|||
19752075|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Physician Decision|0|||
19752076|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Pregnancy|1|||
19752077|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Pregnancy|0|||
19752078|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Pregnancy|0|||
19752079|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Pregnancy|0|||
19752080|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
19752081|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
19752082|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
19752083|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
19752084|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
19752085|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
19752086|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
19752087|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
19652891|NCT00619866|42102437|FG000|Weeks 1 - 12|Sponsor Decision|0|||
19652892|NCT00619866|42102438|FG001|Weeks 1 - 12|Sponsor Decision|1|||
19752088|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
19752089|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
19752090|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
19752091|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
19652893|NCT00619866|42102439|FG002|Weeks 1 - 12|Sponsor Decision|0|||
19652894|NCT00619866|42102440|FG003|Weeks 1 - 12|Sponsor Decision|0|||
19752092|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
19752093|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
19652895|NCT00619866|42102441|FG004|Weeks 1 - 12|Sponsor Decision|0|||
19652896|NCT00619866|42102437|FG000|Weeks 13 - 24|Adverse Event|0|||
19652897|NCT00619866|42102438|FG001|Weeks 13 - 24|Adverse Event|0|||
19652898|NCT00619866|42102439|FG002|Weeks 13 - 24|Adverse Event|2|||
19652899|NCT00619866|42102440|FG003|Weeks 13 - 24|Adverse Event|1|||
19652900|NCT00619866|42102441|FG004|Weeks 13 - 24|Adverse Event|0|||
19652901|NCT00619866|42102437|FG000|Weeks 13 - 24|Protocol Deviation|0|||
19652902|NCT00619866|42102438|FG001|Weeks 13 - 24|Protocol Deviation|0|||
19652903|NCT00619866|42102439|FG002|Weeks 13 - 24|Protocol Deviation|0|||
19652904|NCT00619866|42102440|FG003|Weeks 13 - 24|Protocol Deviation|1|||
19652905|NCT00619866|42102441|FG004|Weeks 13 - 24|Protocol Deviation|0|||
19652906|NCT00619866|42102437|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
19652907|NCT00619866|42102438|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
19652908|NCT00619866|42102439|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
19652909|NCT00619866|42102440|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
19652910|NCT00619866|42102441|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
19652911|NCT00619866|42102437|FG000|Weeks 13 - 24|Non-compliance|0|||
19652912|NCT00619866|42102438|FG001|Weeks 13 - 24|Non-compliance|1|||
19652913|NCT00619866|42102439|FG002|Weeks 13 - 24|Non-compliance|1|||
19652914|NCT00619866|42102440|FG003|Weeks 13 - 24|Non-compliance|0|||
19652915|NCT00619866|42102441|FG004|Weeks 13 - 24|Non-compliance|0|||
19652916|NCT00619866|42102437|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
19652917|NCT00619866|42102438|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
19652918|NCT00619866|42102439|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
19652919|NCT00619866|42102440|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
19752094|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
19652920|NCT00619866|42102441|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
19652921|NCT03937479|42102469|FG000|Overall Study|Adverse Event|2|||
19652922|NCT03937479|42102470|FG001|Overall Study|Adverse Event|3|||
19652923|NCT03937479|42102471|FG002|Overall Study|Adverse Event|0|||
19652924|NCT03937479|42102472|FG003|Overall Study|Adverse Event|0|||
19652925|NCT03937479|42102473|FG004|Overall Study|Adverse Event|1|||
19652926|NCT03937479|42102469|FG000|Overall Study|Withdrawal by Subject|3|||
19652927|NCT03937479|42102470|FG001|Overall Study|Withdrawal by Subject|5|||
19652928|NCT03937479|42102471|FG002|Overall Study|Withdrawal by Subject|2|||
19652929|NCT03937479|42102472|FG003|Overall Study|Withdrawal by Subject|2|||
19652930|NCT03937479|42102473|FG004|Overall Study|Withdrawal by Subject|1|||
19652931|NCT03937479|42102469|FG000|Overall Study|Protocol Violation|5|||
19652932|NCT03937479|42102470|FG001|Overall Study|Protocol Violation|6|||
19652933|NCT03937479|42102471|FG002|Overall Study|Protocol Violation|4|||
19652934|NCT03937479|42102472|FG003|Overall Study|Protocol Violation|3|||
19652935|NCT03937479|42102473|FG004|Overall Study|Protocol Violation|2|||
19652936|NCT03937479|42102469|FG000|Overall Study|Lost to Follow-up|0|||
19652937|NCT03937479|42102470|FG001|Overall Study|Lost to Follow-up|1|||
19652938|NCT03937479|42102471|FG002|Overall Study|Lost to Follow-up|0|||
19652939|NCT03937479|42102472|FG003|Overall Study|Lost to Follow-up|1|||
19652940|NCT03937479|42102473|FG004|Overall Study|Lost to Follow-up|0|||
19652941|NCT03937479|42102469|FG000|Overall Study|Physician Decision|0|||
19652942|NCT03937479|42102470|FG001|Overall Study|Physician Decision|0|||
19652943|NCT03937479|42102471|FG002|Overall Study|Physician Decision|1|||
19652944|NCT03937479|42102472|FG003|Overall Study|Physician Decision|0|||
19652945|NCT03937479|42102473|FG004|Overall Study|Physician Decision|1|||
19652946|NCT00619476|42102489|FG000|Overall Study|Adverse Event|12|||
19652947|NCT00619476|42102490|FG001|Overall Study|Adverse Event|6|||
19652948|NCT00619476|42102491|FG002|Overall Study|Adverse Event|12|||
19652949|NCT00619476|42102492|FG003|Overall Study|Adverse Event|16|||
19652950|NCT00619476|42102489|FG000|Overall Study|Lack of Efficacy|6|||
19652951|NCT00619476|42102490|FG001|Overall Study|Lack of Efficacy|1|||
19652952|NCT00619476|42102491|FG002|Overall Study|Lack of Efficacy|1|||
19652953|NCT00619476|42102492|FG003|Overall Study|Lack of Efficacy|4|||
19652954|NCT00619476|42102489|FG000|Overall Study|Protocol Violation|5|||
19652955|NCT00619476|42102490|FG001|Overall Study|Protocol Violation|4|||
19652956|NCT00619476|42102491|FG002|Overall Study|Protocol Violation|4|||
19652957|NCT00619476|42102492|FG003|Overall Study|Protocol Violation|9|||
19652958|NCT00619476|42102489|FG000|Overall Study|Lost to Follow-up|1|||
19652959|NCT00619476|42102490|FG001|Overall Study|Lost to Follow-up|2|||
19652960|NCT00619476|42102491|FG002|Overall Study|Lost to Follow-up|0|||
19652961|NCT00619476|42102492|FG003|Overall Study|Lost to Follow-up|1|||
19652962|NCT00619476|42102489|FG000|Overall Study|Investigator Discretion|2|||
19652963|NCT00619476|42102490|FG001|Overall Study|Investigator Discretion|2|||
19652964|NCT00619476|42102491|FG002|Overall Study|Investigator Discretion|2|||
19652965|NCT00619476|42102492|FG003|Overall Study|Investigator Discretion|0|||
19652966|NCT00619476|42102489|FG000|Overall Study|Withdrawal by Subject|5|||
19652967|NCT00619476|42102490|FG001|Overall Study|Withdrawal by Subject|7|||
19652968|NCT00619476|42102491|FG002|Overall Study|Withdrawal by Subject|5|||
19652969|NCT00619476|42102492|FG003|Overall Study|Withdrawal by Subject|4|||
19652970|NCT00618072|42102505|FG000|Overall Study|Lost to Follow-up|2|||
19652971|NCT00618072|42102506|FG001|Overall Study|Lost to Follow-up|0|||
19652972|NCT00618072|42102507|FG002|Overall Study|Lost to Follow-up|3|||
19652973|NCT00618072|42102505|FG000|Overall Study|Physician Decision|0|||
19652974|NCT00618072|42102506|FG001|Overall Study|Physician Decision|1|||
19652975|NCT00618072|42102507|FG002|Overall Study|Physician Decision|1|||
19652976|NCT00666926|42102515|FG000|Overall Study|Adverse Event|0|||
19652977|NCT00666926|42102516|FG001|Overall Study|Adverse Event|0|||
19652978|NCT00666926|42102517|FG002|Overall Study|Adverse Event|0|||
19652979|NCT00666926|42102518|FG003|Overall Study|Adverse Event|0|||
19652980|NCT00666926|42102519|FG004|Overall Study|Adverse Event|0|||
19652981|NCT00666926|42102520|FG005|Overall Study|Adverse Event|0|||
19652982|NCT00666926|42102521|FG006|Overall Study|Adverse Event|0|||
19652983|NCT00666926|42102522|FG007|Overall Study|Adverse Event|0|||
19652984|NCT00666926|42102523|FG008|Overall Study|Adverse Event|0|||
19652985|NCT00666926|42102524|FG009|Overall Study|Adverse Event|2|||
19652986|NCT00666926|42102525|FG010|Overall Study|Adverse Event|2|||
19652987|NCT00666926|42102526|FG011|Overall Study|Adverse Event|2|||
19652988|NCT00666926|42102527|FG012|Overall Study|Adverse Event|0|||
19652989|NCT00666926|42102528|FG013|Overall Study|Adverse Event|1|||
19652990|NCT00666926|42102529|FG014|Overall Study|Adverse Event|0|||
19652991|NCT00666926|42102530|FG015|Overall Study|Adverse Event|0|||
19652992|NCT00666926|42102515|FG000|Overall Study|Laboratory abnormality|0|||
19652993|NCT00666926|42102516|FG001|Overall Study|Laboratory abnormality|0|||
19652994|NCT00666926|42102517|FG002|Overall Study|Laboratory abnormality|0|||
19652995|NCT00666926|42102518|FG003|Overall Study|Laboratory abnormality|0|||
19652996|NCT00666926|42102519|FG004|Overall Study|Laboratory abnormality|0|||
19652997|NCT00666926|42102520|FG005|Overall Study|Laboratory abnormality|0|||
19652998|NCT00666926|42102521|FG006|Overall Study|Laboratory abnormality|0|||
19652999|NCT00666926|42102522|FG007|Overall Study|Laboratory abnormality|0|||
19653000|NCT00666926|42102523|FG008|Overall Study|Laboratory abnormality|0|||
19653001|NCT00666926|42102524|FG009|Overall Study|Laboratory abnormality|0|||
19653002|NCT00666926|42102525|FG010|Overall Study|Laboratory abnormality|1|||
19653003|NCT00666926|42102526|FG011|Overall Study|Laboratory abnormality|0|||
19653004|NCT00666926|42102527|FG012|Overall Study|Laboratory abnormality|0|||
19653005|NCT00666926|42102528|FG013|Overall Study|Laboratory abnormality|0|||
19653006|NCT00666926|42102529|FG014|Overall Study|Laboratory abnormality|0|||
19653007|NCT00666926|42102530|FG015|Overall Study|Laboratory abnormality|1|||
19653008|NCT00666926|42102515|FG000|Overall Study|Lack of Efficacy|0|||
19653009|NCT00666926|42102516|FG001|Overall Study|Lack of Efficacy|0|||
19653010|NCT00666926|42102517|FG002|Overall Study|Lack of Efficacy|0|||
19653011|NCT00666926|42102518|FG003|Overall Study|Lack of Efficacy|0|||
19752095|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
19752096|NCT04057573|42201492|FG000|24-Week Double-Blind Period|Not Treated|1|||
19752097|NCT04057573|42201493|FG001|24-Week Double-Blind Period|Not Treated|0|||
19752098|NCT04057573|42201494|FG002|24-Week Double-Blind Period|Not Treated|0|||
19601516|NCT01038713|42050237|FG001|Overall Study|Patient to hospice|1|||
19601517|NCT01038713|42050238|FG002|Overall Study|Patient to hospice|1|||
19601518|NCT01038713|42050236|FG000|Overall Study|Lost to Follow-up|3|||
19601519|NCT01038713|42050237|FG001|Overall Study|Lost to Follow-up|0|||
19601520|NCT01038713|42050238|FG002|Overall Study|Lost to Follow-up|0|||
19601521|NCT01038713|42050236|FG000|Overall Study|Neuroendocrine Tumor|0|||
19601522|NCT01038713|42050237|FG001|Overall Study|Neuroendocrine Tumor|1|||
19752099|NCT04057573|42201495|FG003|24-Week Double-Blind Period|Not Treated|0|||
19752100|NCT04057573|42201492|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
19752101|NCT04057573|42201493|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
19752102|NCT04057573|42201494|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
19752103|NCT04057573|42201495|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
19752104|NCT04057573|42201492|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
19752105|NCT04057573|42201493|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
19752106|NCT04057573|42201494|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
19752107|NCT04057573|42201495|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
19752108|NCT04057573|42201492|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
19752109|NCT04057573|42201493|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
19752110|NCT04057573|42201494|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
19601523|NCT01038713|42050238|FG002|Overall Study|Neuroendocrine Tumor|0|||
19601524|NCT01038713|42050236|FG000|Overall Study|died from PEP|0|||
19601525|NCT01038713|42050237|FG001|Overall Study|died from PEP|1|||
19601526|NCT01038713|42050238|FG002|Overall Study|died from PEP|0|||
19752111|NCT04057573|42201495|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
19601527|NCT01038713|42050236|FG000|Overall Study|Autoimmune Pancreatitis|1|||
19601528|NCT01038713|42050237|FG001|Overall Study|Autoimmune Pancreatitis|0|||
19601529|NCT01038713|42050238|FG002|Overall Study|Autoimmune Pancreatitis|0|||
19653012|NCT00666926|42102519|FG004|Overall Study|Lack of Efficacy|0|||
19653013|NCT00666926|42102520|FG005|Overall Study|Lack of Efficacy|1|||
19653014|NCT00666926|42102521|FG006|Overall Study|Lack of Efficacy|0|||
19752112|NCT04057573|42201492|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
19752113|NCT04057573|42201493|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
19752114|NCT04057573|42201494|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
19752115|NCT04057573|42201495|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
19752116|NCT04057573|42201492|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
19752117|NCT04057573|42201493|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
19601530|NCT00768040|42050248|FG000|Overall Study|Adverse Event|3|||
19601531|NCT00768040|42050249|FG001|Overall Study|Adverse Event|2|||
19601532|NCT00768040|42050248|FG000|Overall Study|Abnormal laboratory value|1|||
19601533|NCT00768040|42050249|FG001|Overall Study|Abnormal laboratory value|1|||
19601534|NCT00767806|42050257|FG000|Overall Study|Adverse Event|30|||
19653015|NCT00666926|42102522|FG007|Overall Study|Lack of Efficacy|0|||
19653016|NCT00666926|42102523|FG008|Overall Study|Lack of Efficacy|0|||
19653017|NCT00666926|42102524|FG009|Overall Study|Lack of Efficacy|0|||
19653018|NCT00666926|42102525|FG010|Overall Study|Lack of Efficacy|0|||
19653019|NCT00666926|42102526|FG011|Overall Study|Lack of Efficacy|1|||
19653020|NCT00666926|42102527|FG012|Overall Study|Lack of Efficacy|0|||
19653021|NCT00666926|42102528|FG013|Overall Study|Lack of Efficacy|0|||
19653022|NCT00666926|42102529|FG014|Overall Study|Lack of Efficacy|0|||
19653023|NCT00666926|42102530|FG015|Overall Study|Lack of Efficacy|0|||
19653024|NCT00666926|42102515|FG000|Overall Study|Lost to Follow-up|0|||
19653025|NCT00666926|42102516|FG001|Overall Study|Lost to Follow-up|0|||
19653026|NCT00666926|42102517|FG002|Overall Study|Lost to Follow-up|0|||
19653027|NCT00666926|42102518|FG003|Overall Study|Lost to Follow-up|1|||
19653028|NCT00666926|42102519|FG004|Overall Study|Lost to Follow-up|0|||
19653029|NCT00666926|42102520|FG005|Overall Study|Lost to Follow-up|0|||
19653030|NCT00666926|42102521|FG006|Overall Study|Lost to Follow-up|0|||
19653031|NCT00666926|42102522|FG007|Overall Study|Lost to Follow-up|0|||
19653032|NCT00666926|42102523|FG008|Overall Study|Lost to Follow-up|0|||
19653033|NCT00666926|42102524|FG009|Overall Study|Lost to Follow-up|0|||
19653034|NCT00666926|42102525|FG010|Overall Study|Lost to Follow-up|0|||
19653035|NCT00666926|42102526|FG011|Overall Study|Lost to Follow-up|0|||
19653036|NCT00666926|42102527|FG012|Overall Study|Lost to Follow-up|0|||
19653037|NCT00666926|42102528|FG013|Overall Study|Lost to Follow-up|0|||
19653038|NCT00666926|42102529|FG014|Overall Study|Lost to Follow-up|0|||
19653039|NCT00666926|42102530|FG015|Overall Study|Lost to Follow-up|0|||
19653040|NCT00666926|42102515|FG000|Overall Study|Other|2|||
19653041|NCT00666926|42102516|FG001|Overall Study|Other|4|||
19653042|NCT00666926|42102517|FG002|Overall Study|Other|3|||
19653043|NCT00666926|42102518|FG003|Overall Study|Other|3|||
19653044|NCT00666926|42102519|FG004|Overall Study|Other|3|||
19653045|NCT00666926|42102520|FG005|Overall Study|Other|3|||
19653046|NCT00666926|42102521|FG006|Overall Study|Other|4|||
19653047|NCT00666926|42102522|FG007|Overall Study|Other|0|||
19653048|NCT00666926|42102523|FG008|Overall Study|Other|3|||
19653049|NCT00666926|42102524|FG009|Overall Study|Other|5|||
19653050|NCT00666926|42102525|FG010|Overall Study|Other|3|||
19653051|NCT00666926|42102526|FG011|Overall Study|Other|26|||
19653052|NCT00666926|42102527|FG012|Overall Study|Other|3|||
19653053|NCT00666926|42102528|FG013|Overall Study|Other|2|||
19653054|NCT00666926|42102529|FG014|Overall Study|Other|4|||
19653055|NCT00666926|42102530|FG015|Overall Study|Other|4|||
19653056|NCT00666926|42102515|FG000|Overall Study|Withdrawal by Subject|0|||
19653057|NCT00666926|42102516|FG001|Overall Study|Withdrawal by Subject|0|||
19799379|NCT02873221|42257355|FG000|Safety Follow-up Period|Protocol Violation|0|||
19601535|NCT00767806|42050258|FG001|Overall Study|Adverse Event|11|||
19601536|NCT00767806|42050257|FG000|Overall Study|Withdrawal by Subject|8|||
19601537|NCT00767806|42050258|FG001|Overall Study|Withdrawal by Subject|13|||
19601538|NCT00767806|42050257|FG000|Overall Study|Protocol Violation|6|||
19601539|NCT00767806|42050258|FG001|Overall Study|Protocol Violation|5|||
19601540|NCT00767806|42050257|FG000|Overall Study|Lack of Efficacy|1|||
19601541|NCT00767806|42050258|FG001|Overall Study|Lack of Efficacy|9|||
19601542|NCT00767806|42050257|FG000|Overall Study|Physician Decision|4|||
19601543|NCT00767806|42050258|FG001|Overall Study|Physician Decision|3|||
19601544|NCT00767806|42050257|FG000|Overall Study|Lost to Follow-up|1|||
19601545|NCT00767806|42050258|FG001|Overall Study|Lost to Follow-up|4|||
19653058|NCT00666926|42102517|FG002|Overall Study|Withdrawal by Subject|0|||
19653059|NCT00666926|42102518|FG003|Overall Study|Withdrawal by Subject|0|||
19653060|NCT00666926|42102519|FG004|Overall Study|Withdrawal by Subject|0|||
19653061|NCT00666926|42102520|FG005|Overall Study|Withdrawal by Subject|0|||
19653062|NCT00666926|42102521|FG006|Overall Study|Withdrawal by Subject|0|||
19653063|NCT00666926|42102522|FG007|Overall Study|Withdrawal by Subject|1|||
19653064|NCT00666926|42102523|FG008|Overall Study|Withdrawal by Subject|0|||
19653065|NCT00666926|42102524|FG009|Overall Study|Withdrawal by Subject|3|||
19653066|NCT00666926|42102525|FG010|Overall Study|Withdrawal by Subject|0|||
19653067|NCT00666926|42102526|FG011|Overall Study|Withdrawal by Subject|3|||
19653068|NCT00666926|42102527|FG012|Overall Study|Withdrawal by Subject|0|||
19653069|NCT00666926|42102528|FG013|Overall Study|Withdrawal by Subject|1|||
19653070|NCT00666926|42102529|FG014|Overall Study|Withdrawal by Subject|3|||
19653071|NCT00666926|42102530|FG015|Overall Study|Withdrawal by Subject|3|||
19653072|NCT00666926|42102515|FG000|Overall Study|Death|0|||
19653073|NCT00666926|42102516|FG001|Overall Study|Death|0|||
19653074|NCT00666926|42102517|FG002|Overall Study|Death|0|||
19653075|NCT00666926|42102518|FG003|Overall Study|Death|0|||
19653076|NCT00666926|42102519|FG004|Overall Study|Death|0|||
19653077|NCT00666926|42102520|FG005|Overall Study|Death|0|||
19653078|NCT00666926|42102521|FG006|Overall Study|Death|0|||
19653079|NCT00666926|42102522|FG007|Overall Study|Death|0|||
19653080|NCT00666926|42102523|FG008|Overall Study|Death|0|||
19653081|NCT00666926|42102524|FG009|Overall Study|Death|0|||
19653082|NCT00666926|42102525|FG010|Overall Study|Death|0|||
19653083|NCT00666926|42102526|FG011|Overall Study|Death|1|||
19653084|NCT00666926|42102527|FG012|Overall Study|Death|0|||
19653085|NCT00666926|42102528|FG013|Overall Study|Death|0|||
19653086|NCT00666926|42102529|FG014|Overall Study|Death|0|||
19653087|NCT00666926|42102530|FG015|Overall Study|Death|0|||
19653088|NCT03861052|42102585|FG000|Overall Study|Adverse Event|1|||
19653089|NCT03861052|42102586|FG001|Overall Study|Adverse Event|1|||
19653090|NCT03861052|42102587|FG002|Overall Study|Adverse Event|2|||
19653091|NCT03861052|42102588|FG003|Overall Study|Adverse Event|4|||
19653092|NCT03861052|42102585|FG000|Overall Study|Lost to Follow-up|0|||
19653093|NCT03861052|42102586|FG001|Overall Study|Lost to Follow-up|0|||
19653094|NCT03861052|42102587|FG002|Overall Study|Lost to Follow-up|0|||
19653095|NCT03861052|42102588|FG003|Overall Study|Lost to Follow-up|1|||
19653096|NCT03861052|42102585|FG000|Overall Study|Physician Decision|0|||
19653097|NCT03861052|42102586|FG001|Overall Study|Physician Decision|1|||
19653098|NCT03861052|42102587|FG002|Overall Study|Physician Decision|0|||
19653099|NCT03861052|42102588|FG003|Overall Study|Physician Decision|0|||
19653100|NCT03861052|42102585|FG000|Overall Study|Withdrawal by Subject|2|||
19653101|NCT03861052|42102586|FG001|Overall Study|Withdrawal by Subject|5|||
19653102|NCT03861052|42102587|FG002|Overall Study|Withdrawal by Subject|3|||
19653103|NCT03861052|42102588|FG003|Overall Study|Withdrawal by Subject|0|||
19653104|NCT03861052|42102585|FG000|Overall Study|Relocation to other city|1|||
19653105|NCT03861052|42102586|FG001|Overall Study|Relocation to other city|0|||
19653106|NCT03861052|42102587|FG002|Overall Study|Relocation to other city|0|||
19653107|NCT03861052|42102588|FG003|Overall Study|Relocation to other city|0|||
19653108|NCT00664742|42102603|FG000|Overall Study|Withdrawn due to adverse events|3|||
19653109|NCT00664742|42102603|FG000|Overall Study|Withdrawal by Subject|31|||
19653110|NCT00664742|42102603|FG000|Overall Study|Lost to Follow-up|92|||
19653111|NCT00511342|42102609|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
19653112|NCT00511342|42102610|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
19653113|NCT00511342|42102609|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
19653114|NCT00511342|42102610|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
19653115|NCT00511342|42102609|FG000|Overall Study|Pregnancy|0|||
19653116|NCT00511342|42102610|FG001|Overall Study|Pregnancy|1|||
19653117|NCT00511342|42102609|FG000|Overall Study|Pregnancy wish|0|||
19653118|NCT00511342|42102610|FG001|Overall Study|Pregnancy wish|1|||
19653119|NCT00511342|42102609|FG000|Overall Study|Lost to Follow-up|1|||
19653120|NCT00511342|42102610|FG001|Overall Study|Lost to Follow-up|5|||
19653121|NCT00511342|42102609|FG000|Overall Study|Other Reason|2|||
19653122|NCT00511342|42102610|FG001|Overall Study|Other Reason|2|||
19653123|NCT03931785|42102620|FG000|Overall Study|Lost to Follow-up|4|||
19653124|NCT03931785|42102621|FG001|Overall Study|Lost to Follow-up|1|||
19653125|NCT03931785|42102622|FG002|Overall Study|Lost to Follow-up|4|||
19653126|NCT03931785|42102623|FG003|Overall Study|Lost to Follow-up|3|||
19653127|NCT03931785|42102620|FG000|Overall Study|Adverse Event|1|||
19653128|NCT03931785|42102621|FG001|Overall Study|Adverse Event|0|||
19653129|NCT03931785|42102622|FG002|Overall Study|Adverse Event|3|||
19653130|NCT03931785|42102623|FG003|Overall Study|Adverse Event|4|||
19653131|NCT03931785|42102620|FG000|Overall Study|Protocol Violation|0|||
19653132|NCT03931785|42102621|FG001|Overall Study|Protocol Violation|1|||
19653133|NCT03931785|42102622|FG002|Overall Study|Protocol Violation|0|||
19653134|NCT03931785|42102623|FG003|Overall Study|Protocol Violation|0|||
19653135|NCT03931785|42102620|FG000|Overall Study|Noncompliance With Study drug|0|||
19653136|NCT03931785|42102621|FG001|Overall Study|Noncompliance With Study drug|1|||
19653137|NCT03931785|42102622|FG002|Overall Study|Noncompliance With Study drug|0|||
19752118|NCT04057573|42201494|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
19653138|NCT03931785|42102623|FG003|Overall Study|Noncompliance With Study drug|0|||
19653139|NCT03931785|42102620|FG000|Overall Study|Other Not specified|0|||
19653140|NCT03931785|42102621|FG001|Overall Study|Other Not specified|2|||
19653141|NCT03931785|42102622|FG002|Overall Study|Other Not specified|2|||
19653142|NCT03931785|42102623|FG003|Overall Study|Other Not specified|2|||
19653143|NCT03931785|42102620|FG000|Overall Study|Withdrawal by Subject|0|||
19653144|NCT03931785|42102621|FG001|Overall Study|Withdrawal by Subject|2|||
19653145|NCT03931785|42102622|FG002|Overall Study|Withdrawal by Subject|4|||
19653146|NCT03931785|42102623|FG003|Overall Study|Withdrawal by Subject|1|||
19653147|NCT03931785|42102620|FG000|Overall Study|Pregnancy|0|||
19653148|NCT03931785|42102621|FG001|Overall Study|Pregnancy|0|||
19653149|NCT03931785|42102622|FG002|Overall Study|Pregnancy|0|||
19653150|NCT03931785|42102623|FG003|Overall Study|Pregnancy|1|||
19653151|NCT00666536|42102635|FG000|Overall Study|Adverse Event|9|||
19653152|NCT00666536|42102636|FG001|Overall Study|Adverse Event|19|||
19653153|NCT00666536|42102635|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19653154|NCT00666536|42102636|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19653155|NCT00666536|42102635|FG000|Overall Study|Protocol deviation(s)|8|||
19653156|NCT00666536|42102636|FG001|Overall Study|Protocol deviation(s)|6|||
19653157|NCT00666536|42102635|FG000|Overall Study|Withdrawal by Subject|10|||
19653158|NCT00666536|42102636|FG001|Overall Study|Withdrawal by Subject|9|||
19653159|NCT00666536|42102635|FG000|Overall Study|Lost to Follow-up|4|||
19653160|NCT00666536|42102636|FG001|Overall Study|Lost to Follow-up|3|||
19653161|NCT00519532|42102642|FG000|Overall Study|Adverse Event|11|||
19653162|NCT00519532|42102642|FG000|Overall Study|Withdrawal by Subject|5|||
19653163|NCT00519532|42102642|FG000|Overall Study|Lost to Follow-up|2|||
19653164|NCT00666458|42102648|FG000|Overall Study|Adverse Event|8|||
19653165|NCT00666458|42102649|FG001|Overall Study|Adverse Event|7|||
19653166|NCT00666458|42102648|FG000|Overall Study|Withdrawal by Subject|5|||
19653167|NCT00666458|42102649|FG001|Overall Study|Withdrawal by Subject|4|||
19653168|NCT00666458|42102648|FG000|Overall Study|Lost to Follow-up|0|||
19653169|NCT00666458|42102649|FG001|Overall Study|Lost to Follow-up|3|||
19653170|NCT00666458|42102648|FG000|Overall Study|Administrative reason by sponsor|1|||
19653171|NCT00666458|42102649|FG001|Overall Study|Administrative reason by sponsor|1|||
19653172|NCT00666458|42102648|FG000|Overall Study|Incorrect enrollment|7|||
19653173|NCT00666458|42102649|FG001|Overall Study|Incorrect enrollment|1|||
19653174|NCT00666458|42102648|FG000|Overall Study|Study specific discontinuation criteria|14|||
19653175|NCT00666458|42102649|FG001|Overall Study|Study specific discontinuation criteria|7|||
19653176|NCT00666458|42102648|FG000|Overall Study|Severe non-compliance to the protocol|1|||
19653177|NCT00666458|42102649|FG001|Overall Study|Severe non-compliance to the protocol|1|||
19653178|NCT00666458|42102648|FG000|Overall Study|Safety reasons|1|||
19653179|NCT00666458|42102649|FG001|Overall Study|Safety reasons|0|||
19653180|NCT00666458|42102648|FG000|Overall Study|Medical history of anemia|1|||
19653181|NCT00666458|42102649|FG001|Overall Study|Medical history of anemia|0|||
19653182|NCT00511108|42102659|FG000|Overall Study|Adverse Event|2|||
19653183|NCT00511108|42102660|FG001|Overall Study|Adverse Event|0|||
19653184|NCT00511108|42102661|FG002|Overall Study|Adverse Event|1|||
19752119|NCT04057573|42201495|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
19653185|NCT00511108|42102662|FG003|Overall Study|Adverse Event|2|||
19653186|NCT00511108|42102659|FG000|Overall Study|Lost to Follow-up|0|||
19653187|NCT00511108|42102660|FG001|Overall Study|Lost to Follow-up|2|||
19653188|NCT00511108|42102661|FG002|Overall Study|Lost to Follow-up|1|||
19653189|NCT00511108|42102662|FG003|Overall Study|Lost to Follow-up|0|||
19653190|NCT00511108|42102659|FG000|Overall Study|Physician Decision|0|||
19653191|NCT00511108|42102660|FG001|Overall Study|Physician Decision|0|||
19653192|NCT00511108|42102661|FG002|Overall Study|Physician Decision|0|||
19653193|NCT00511108|42102662|FG003|Overall Study|Physician Decision|1|||
19653194|NCT00511108|42102659|FG000|Overall Study|Withdrawal by Subject|4|||
19653195|NCT00511108|42102660|FG001|Overall Study|Withdrawal by Subject|0|||
19653196|NCT00511108|42102661|FG002|Overall Study|Withdrawal by Subject|3|||
19653197|NCT00511108|42102662|FG003|Overall Study|Withdrawal by Subject|2|||
19653198|NCT00510952|42102674|FG000|Overall Study|Adverse Event|1|||
19653199|NCT00510952|42102675|FG001|Overall Study|Adverse Event|0|||
19653200|NCT00510952|42102674|FG000|Overall Study|Entry Criteria Not Met|3|||
19653201|NCT00510952|42102675|FG001|Overall Study|Entry Criteria Not Met|1|||
19653202|NCT00510952|42102674|FG000|Overall Study|Lost to Follow-up|5|||
19752120|NCT04054765|42201508|FG000|Baseline|Withdrawal by Subject|5|||
19653203|NCT00510952|42102675|FG001|Overall Study|Lost to Follow-up|3|||
19653204|NCT00510952|42102674|FG000|Overall Study|Physician Decision|1|||
19653205|NCT00510952|42102675|FG001|Overall Study|Physician Decision|1|||
19653206|NCT00510952|42102674|FG000|Overall Study|Protocol Violation|7|||
19653207|NCT00510952|42102675|FG001|Overall Study|Protocol Violation|4|||
19653208|NCT00510952|42102674|FG000|Overall Study|Sponsor Decision|1|||
19653209|NCT00510952|42102675|FG001|Overall Study|Sponsor Decision|0|||
19653210|NCT00510952|42102674|FG000|Overall Study|Withdrawal by Subject|6|||
19653211|NCT00510952|42102675|FG001|Overall Study|Withdrawal by Subject|7|||
19653212|NCT00510952|42102674|FG000|Overall Study|Did Not Receive Study Drug|2|||
19653213|NCT00510952|42102675|FG001|Overall Study|Did Not Receive Study Drug|0|||
19653214|NCT00617604|42102683|FG000|Overall Study|Death|2|||
19653215|NCT00617604|42102684|FG001|Overall Study|Death|1|||
19653216|NCT00617604|42102683|FG000|Overall Study|Lost to Follow-up|1|||
19653217|NCT00617604|42102684|FG001|Overall Study|Lost to Follow-up|0|||
19653218|NCT00617604|42102683|FG000|Overall Study|Miscellaneous Reasons|8|||
19653219|NCT00617604|42102684|FG001|Overall Study|Miscellaneous Reasons|10|||
19653220|NCT00617604|42102683|FG000|Overall Study|Withdrawal by Subject|4|||
19653221|NCT00617604|42102684|FG001|Overall Study|Withdrawal by Subject|6|||
19653222|NCT00617604|42102683|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
19653223|NCT00617604|42102684|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
19653224|NCT00661622|42102692|FG000|Overall Study|Protocol Violation|1|||
19653225|NCT00661622|42102693|FG001|Overall Study|Protocol Violation|0|||
19653226|NCT04093752|42102704|FG000|Overall Study|Adverse Event|7|||
19653227|NCT04093752|42102705|FG001|Overall Study|Adverse Event|19|||
19653228|NCT04093752|42102706|FG002|Overall Study|Adverse Event|18|||
19653229|NCT04093752|42102707|FG003|Overall Study|Adverse Event|4|||
19653230|NCT04093752|42102704|FG000|Overall Study|Withdrawal by Subject|6|||
19653231|NCT04093752|42102705|FG001|Overall Study|Withdrawal by Subject|6|||
19653232|NCT04093752|42102706|FG002|Overall Study|Withdrawal by Subject|8|||
19653233|NCT04093752|42102707|FG003|Overall Study|Withdrawal by Subject|20|||
19653234|NCT04093752|42102704|FG000|Overall Study|Lost to Follow-up|2|||
19653235|NCT04093752|42102705|FG001|Overall Study|Lost to Follow-up|1|||
19653236|NCT04093752|42102706|FG002|Overall Study|Lost to Follow-up|1|||
19653237|NCT04093752|42102707|FG003|Overall Study|Lost to Follow-up|1|||
19653238|NCT04093752|42102704|FG000|Overall Study|Death|0|||
19653239|NCT04093752|42102705|FG001|Overall Study|Death|0|||
19653240|NCT04093752|42102706|FG002|Overall Study|Death|1|||
19653241|NCT04093752|42102707|FG003|Overall Study|Death|2|||
19653242|NCT04093752|42102704|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
19653243|NCT04093752|42102705|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
19653244|NCT04093752|42102706|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
19653245|NCT04093752|42102707|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
19653246|NCT04093752|42102704|FG000|Overall Study|Covid 19|0|||
19653247|NCT04093752|42102705|FG001|Overall Study|Covid 19|0|||
19653248|NCT04093752|42102706|FG002|Overall Study|Covid 19|0|||
19653249|NCT04093752|42102707|FG003|Overall Study|Covid 19|1|||
19653250|NCT04093752|42102704|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
19653251|NCT04093752|42102705|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
19653252|NCT04093752|42102706|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
19653253|NCT04093752|42102707|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
19653254|NCT04093752|42102704|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
19653255|NCT04093752|42102705|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
19653256|NCT04093752|42102706|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
19653257|NCT04093752|42102707|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
19653258|NCT04093752|42102704|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
19653259|NCT04093752|42102705|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
19653260|NCT04093752|42102706|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
19653261|NCT04093752|42102707|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
19653262|NCT03928821|42102725|FG000|Overall Study|Death|0|||
19653263|NCT03928821|42102726|FG001|Overall Study|Death|1|||
19653264|NCT03928821|42102727|FG002|Overall Study|Death|0|||
19653265|NCT03928821|42102728|FG003|Overall Study|Death|0|||
19653266|NCT03928821|42102725|FG000|Overall Study|Lost to Follow-up|0|||
19653267|NCT03928821|42102726|FG001|Overall Study|Lost to Follow-up|2|||
19653268|NCT03928821|42102727|FG002|Overall Study|Lost to Follow-up|3|||
19653269|NCT03928821|42102728|FG003|Overall Study|Lost to Follow-up|0|||
19653270|NCT03928821|42102725|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
19653271|NCT03928821|42102726|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
19653272|NCT03928821|42102727|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
19653273|NCT03928821|42102728|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
19653274|NCT00666224|42102740|FG000|Double-Blind|Adverse Event|15|||
19653275|NCT00666224|42102741|FG001|Double-Blind|Adverse Event|5|||
19653276|NCT00666224|42102740|FG000|Double-Blind|Lost to Follow-up|2|||
19653277|NCT00666224|42102741|FG001|Double-Blind|Lost to Follow-up|2|||
19653278|NCT00666224|42102740|FG000|Double-Blind|Withdrawal by Subject|18|||
19653279|NCT00666224|42102741|FG001|Double-Blind|Withdrawal by Subject|14|||
19653280|NCT00666224|42102740|FG000|Double-Blind|Physician Decision|0|||
19653281|NCT00666224|42102741|FG001|Double-Blind|Physician Decision|3|||
19653282|NCT00666224|42102740|FG000|Double-Blind|Sponsor decision|1|||
19653283|NCT00666224|42102741|FG001|Double-Blind|Sponsor decision|0|||
19653284|NCT00666224|42102740|FG000|Double-Blind|Pregnancy|3|||
19653285|NCT00666224|42102741|FG001|Double-Blind|Pregnancy|2|||
19653286|NCT00666224|42102740|FG000|Double-Blind|Noncompliance|1|||
19653287|NCT00666224|42102741|FG001|Double-Blind|Noncompliance|0|||
19653288|NCT00666224|42102740|FG000|Double-Blind|Death|1|||
19653289|NCT00666224|42102741|FG001|Double-Blind|Death|0|||
19653290|NCT00666224|42102740|FG000|Double-Blind|Undefined/Unknown|4|||
19653291|NCT00666224|42102741|FG001|Double-Blind|Undefined/Unknown|1|||
19653292|NCT00666224|42102740|FG000|Open-Label|Adverse Event|8|||
19653293|NCT00666224|42102741|FG001|Open-Label|Adverse Event|43|||
19653294|NCT00666224|42102740|FG000|Open-Label|Lost to Follow-up|4|||
19653295|NCT00666224|42102741|FG001|Open-Label|Lost to Follow-up|5|||
19653296|NCT00666224|42102740|FG000|Open-Label|Withdrawal by Subject|12|||
19653297|NCT00666224|42102741|FG001|Open-Label|Withdrawal by Subject|25|||
19653298|NCT00666224|42102740|FG000|Open-Label|Physician Decision|7|||
19653299|NCT00666224|42102741|FG001|Open-Label|Physician Decision|5|||
19653300|NCT00666224|42102740|FG000|Open-Label|Pregnancy|1|||
19653301|NCT00666224|42102741|FG001|Open-Label|Pregnancy|5|||
19653302|NCT00666224|42102740|FG000|Open-Label|Noncompliance|2|||
19653303|NCT00666224|42102741|FG001|Open-Label|Noncompliance|1|||
19653304|NCT00666224|42102740|FG000|Open-Label|Undefined/Unknown|1|||
19653305|NCT00666224|42102741|FG001|Open-Label|Undefined/Unknown|1|||
19653306|NCT00663962|42102750|FG000|Overall Study|somnolence|1|||
19653307|NCT00663962|42102751|FG001|Overall Study|somnolence|0|||
19653308|NCT00265759|42102763|FG000|Overall Study|Withdrawal by Subject|0|||
19653309|NCT00265759|42102764|FG001|Overall Study|Withdrawal by Subject|1|||
19653310|NCT00265759|42102765|FG002|Overall Study|Withdrawal by Subject|2|||
19653311|NCT00265759|42102766|FG003|Overall Study|Withdrawal by Subject|2|||
19653312|NCT00265759|42102763|FG000|Overall Study|Cancel|0|||
19653313|NCT00265759|42102764|FG001|Overall Study|Cancel|0|||
19653314|NCT00265759|42102765|FG002|Overall Study|Cancel|0|||
19653315|NCT00265759|42102766|FG003|Overall Study|Cancel|3|||
19653316|NCT00265759|42102763|FG000|Overall Study|Ineligible|0|||
19653317|NCT00265759|42102764|FG001|Overall Study|Ineligible|0|||
19653318|NCT00265759|42102765|FG002|Overall Study|Ineligible|0|||
19653319|NCT00265759|42102766|FG003|Overall Study|Ineligible|1|||
19653320|NCT00265759|42102763|FG000|Overall Study|Bilateral disease|0|||
19653321|NCT00265759|42102764|FG001|Overall Study|Bilateral disease|0|||
19653322|NCT00265759|42102765|FG002|Overall Study|Bilateral disease|0|||
19653323|NCT00265759|42102766|FG003|Overall Study|Bilateral disease|2|||
19653324|NCT00265759|42102763|FG000|Overall Study|Discontinued due to intolerability|0|||
19653325|NCT00265759|42102764|FG001|Overall Study|Discontinued due to intolerability|0|||
19653326|NCT00265759|42102765|FG002|Overall Study|Discontinued due to intolerability|0|||
19653327|NCT00265759|42102766|FG003|Overall Study|Discontinued due to intolerability|1|||
19653328|NCT00744263|42102779|FG000|Overall Study|Death|3006|||
19653329|NCT00744263|42102780|FG001|Overall Study|Death|3005|||
19653330|NCT00744263|42102779|FG000|Overall Study|Lost to Follow-up|2038|||
19653331|NCT00744263|42102780|FG001|Overall Study|Lost to Follow-up|2135|||
19653332|NCT00744263|42102779|FG000|Overall Study|Withdrawal by Subject|166|||
19653333|NCT00744263|42102780|FG001|Overall Study|Withdrawal by Subject|150|||
19653334|NCT00744263|42102779|FG000|Overall Study|Physician Decision|20|||
19653335|NCT00744263|42102780|FG001|Overall Study|Physician Decision|23|||
19653336|NCT00744263|42102779|FG000|Overall Study|Protocol Violation|3|||
19653337|NCT00744263|42102780|FG001|Overall Study|Protocol Violation|5|||
19653338|NCT00744263|42102779|FG000|Overall Study|Adverse Event|1|||
19653339|NCT00744263|42102780|FG001|Overall Study|Adverse Event|0|||
19653340|NCT00744263|42102779|FG000|Overall Study|Other|2|||
19653341|NCT00744263|42102780|FG001|Overall Study|Other|2|||
19653342|NCT00618774|42102790|FG000|Overall Study|Adverse Event|5|||
19653343|NCT00618774|42102791|FG001|Overall Study|Adverse Event|3|||
19653344|NCT00618774|42102790|FG000|Overall Study|Withdrawal by Subject|1|||
19653345|NCT00618774|42102791|FG001|Overall Study|Withdrawal by Subject|0|||
19653346|NCT00545571|42102797|FG000|Overall Study|Administrative Reasons|1|||
19653347|NCT00545571|42102797|FG000|Overall Study|Adverse Event|2|||
19653348|NCT00545571|42102797|FG000|Overall Study|Death|5|||
19653349|NCT00545571|42102797|FG000|Overall Study|Lack of Efficacy|1|||
19653350|NCT00545571|42102797|FG000|Overall Study|Protocol Violation|2|||
19653351|NCT00545571|42102797|FG000|Overall Study|Refused Treatment|1|||
19653352|NCT00545571|42102797|FG000|Overall Study|Screen Failure|16|||
19653353|NCT00545571|42102797|FG000|Overall Study|Transfusion|12|||
19653354|NCT00545571|42102797|FG000|Overall Study|Early Termination of Study|24|||
19653355|NCT00545571|42102797|FG000|Overall Study|Kidney Transplantation|3|||
19653356|NCT00748709|42102801|FG000|Overall Study|Progressive disease|15|||
19653357|NCT00748709|42102801|FG000|Overall Study|Drug reducing Toxity|2|||
19653358|NCT00748709|42102801|FG000|Overall Study|Other Adverse Event|1|||
19653359|NCT00748709|42102801|FG000|Overall Study|Withdrawal by Subject|1|||
19653360|NCT00748709|42102801|FG000|Overall Study|Other Reasons|1|||
19653361|NCT00263887|42102807|FG000|Overall Study|Withdrawal by Subject|1|||
19653362|NCT00263887|42102808|FG001|Overall Study|Withdrawal by Subject|1|||
19752121|NCT04054765|42201509|FG001|Baseline|Withdrawal by Subject|3|||
19752122|NCT04054765|42201508|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
19752123|NCT04054765|42201509|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
19752124|NCT04054765|42201508|FG000|3-month Follow up|Withdrawal by Subject|0|||
19752125|NCT04054765|42201509|FG001|3-month Follow up|Withdrawal by Subject|3|||
19752126|NCT04054765|42201508|FG000|6-month Follow up|Lost to Follow-up|32|||
19752127|NCT04054765|42201509|FG001|6-month Follow up|Lost to Follow-up|32|||
19752128|NCT04179721|42201517|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
19752129|NCT04179721|42201518|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
19752130|NCT04179721|42201517|FG000|Overall Study|Lost to Follow-up|0|||
19752131|NCT04179721|42201518|FG001|Overall Study|Lost to Follow-up|1|||
19752132|NCT03286218|42201524|FG000|Qualification Phase Period 1|Adverse Event|1|||
19653363|NCT00263887|42102807|FG000|Overall Study|Lung transplantation|1|||
19653364|NCT00263887|42102808|FG001|Overall Study|Lung transplantation|2|||
19653365|NCT00263887|42102807|FG000|Overall Study|Too ill to attend visit|1|||
19653366|NCT00263887|42102808|FG001|Overall Study|Too ill to attend visit|0|||
19653367|NCT00263887|42102807|FG000|Overall Study|Adverse Event|0|||
19653368|NCT00263887|42102808|FG001|Overall Study|Adverse Event|2|||
19653369|NCT00263887|42102807|FG000|Overall Study|Disease progression|0|||
19653370|NCT00263887|42102808|FG001|Overall Study|Disease progression|1|||
19653371|NCT00263887|42102807|FG000|Overall Study|Lack of Efficacy|0|||
19653372|NCT00263887|42102808|FG001|Overall Study|Lack of Efficacy|1|||
19653373|NCT00748553|42102816|FG000|Overall Study|Adverse Event|0|||
19653374|NCT00748553|42102817|FG001|Overall Study|Adverse Event|1|||
19653375|NCT00748553|42102816|FG000|Overall Study|disease progression|2|||
19653376|NCT00748553|42102817|FG001|Overall Study|disease progression|0|||
19653377|NCT00748553|42102816|FG000|Overall Study|noncompliance|1|||
19653378|NCT00748553|42102817|FG001|Overall Study|noncompliance|0|||
19653379|NCT00661388|42102822|FG000|Overall Study|Adverse Event|14|||
19653380|NCT00661388|42102822|FG000|Overall Study|Protocol Violation|7|||
19653381|NCT00661388|42102822|FG000|Overall Study|Renal transplantation|1|||
19653382|NCT00661388|42102822|FG000|Overall Study|Dialysis initiation|1|||
19653383|NCT00661388|42102822|FG000|Overall Study|Administrative reasons|1|||
19653384|NCT00743483|42102826|FG000|Baseline Period|Physician Decision|1|||
19653385|NCT00743483|42102826|FG000|Treatment Period|Adverse Event|1|||
19653386|NCT00263575|42102830|FG000|Titration Period|Adverse Event|14|||
19653387|NCT00263575|42102830|FG000|Titration Period|Withdrawal by Subject|10|||
19653388|NCT00263575|42102830|FG000|Titration Period|Protocol Violation|9|||
19653389|NCT00263575|42102830|FG000|Titration Period|Sponsor Decision|2|||
19653390|NCT00263575|42102830|FG000|Titration Period|Other|2|||
19653391|NCT00263575|42102830|FG000|Titration Period|Lack of Efficacy|6|||
19653392|NCT00263575|42102830|FG000|Maintence Period|Adverse Event|23|||
19653393|NCT00263575|42102830|FG000|Maintence Period|Withdrawal by Subject|8|||
19653394|NCT00263575|42102830|FG000|Maintence Period|Protocol Violation|4|||
19653395|NCT00263575|42102830|FG000|Maintence Period|Lack of Efficacy|4|||
19653396|NCT00263575|42102830|FG000|Maintence Period|Physician Decision|6|||
19653397|NCT00263575|42102830|FG000|Maintence Period|Lost to Follow-up|1|||
19653398|NCT00263575|42102830|FG000|Maintence Period|Sponsor Decision|24|||
19653399|NCT00263575|42102830|FG000|Maintence Period|Other|7|||
19653400|NCT00748241|42102836|FG000|Overall Study|Implant failure|1|||
19653401|NCT00748241|42102836|FG000|Overall Study|Lost to Follow-up|5|||
19653402|NCT00748241|42102836|FG000|Overall Study|Death|2|||
19653403|NCT00570128|42102842|FG000|Overall Study|Adverse Event|1|||
19653404|NCT00570128|42102843|FG001|Overall Study|Adverse Event|0|||
19653405|NCT00570128|42102842|FG000|Overall Study|Lost to Follow-up|1|||
19653406|NCT00570128|42102843|FG001|Overall Study|Lost to Follow-up|0|||
19653407|NCT00570128|42102842|FG000|Overall Study|Withdrawal by Subject|2|||
19653408|NCT00570128|42102843|FG001|Overall Study|Withdrawal by Subject|0|||
19653409|NCT00743249|42102851|FG000|Overall Study|Adverse Event|0|||
19653410|NCT00743249|42102852|FG001|Overall Study|Adverse Event|4|||
19653411|NCT00743249|42102851|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
19653412|NCT00743249|42102852|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
19653413|NCT00743249|42102851|FG000|Overall Study|Unsuccessful insertion of stent|2|||
19653414|NCT00743249|42102852|FG001|Overall Study|Unsuccessful insertion of stent|1|||
19653415|NCT00262951|42102858|FG000|Overall Study|Progressive disease/relapse|3|||
19653416|NCT00262951|42102858|FG000|Overall Study|Adverse Event|7|||
19653417|NCT00262951|42102858|FG000|Overall Study|Death|1|||
19653418|NCT00262951|42102858|FG000|Overall Study|Withdrawal by Subject|1|||
19653419|NCT00262951|42102858|FG000|Overall Study|Alternative treatment|3|||
19653420|NCT00262951|42102858|FG000|Overall Study|Off treatment for other disease|1|||
19653421|NCT00262873|42102862|FG000|Overall Study|Adverse Event|3|||
19653422|NCT00262873|42102862|FG000|Overall Study|Withdrawal by Subject|5|||
19653423|NCT00573534|42102866|FG000|Overall Study|oppositional behavior|3|||
19653424|NCT00260533|42102873|FG000|Overall Study|Other|3|||
19653425|NCT00260533|42102874|FG001|Overall Study|Other|3|||
19653426|NCT03945981|42102880|FG000|Overall Study|Lost to Follow-up|12|||
19653427|NCT03945981|42102880|FG000|Overall Study|Physician Decision|4|||
19653428|NCT03945981|42102880|FG000|Overall Study|Withdrawal by Subject|6|||
19653429|NCT03945981|42102880|FG000|Overall Study|Protocol Violation|1|||
19653430|NCT00745901|42102907|FG000|Overall Study|Adverse Event|3|||
19653431|NCT00745901|42102908|FG001|Overall Study|Adverse Event|4|||
19653432|NCT00745901|42102907|FG000|Overall Study|Protocol Violation|0|||
19653433|NCT00745901|42102908|FG001|Overall Study|Protocol Violation|1|||
19653434|NCT00745901|42102907|FG000|Overall Study|Withdrawal by Subject|1|||
19653435|NCT00745901|42102908|FG001|Overall Study|Withdrawal by Subject|0|||
19653436|NCT00745901|42102907|FG000|Overall Study|Lost to Follow-up|7|||
19653437|NCT00745901|42102908|FG001|Overall Study|Lost to Follow-up|4|||
19653438|NCT00745901|42102907|FG000|Overall Study|Pregnancy|2|||
19653439|NCT00745901|42102908|FG001|Overall Study|Pregnancy|4|||
19653440|NCT00745901|42102907|FG000|Overall Study|Lack of compliance|2|||
19653441|NCT00745901|42102908|FG001|Overall Study|Lack of compliance|2|||
19653442|NCT00745901|42102907|FG000|Overall Study|Patient's next menses did not start with|1|||
19653443|NCT00745901|42102908|FG001|Overall Study|Patient's next menses did not start with|0|||
19653444|NCT00745901|42102907|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
19653445|NCT00745901|42102908|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
19653446|NCT00745901|42102907|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
19653447|NCT00745901|42102908|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
19653448|NCT00745901|42102907|FG000|Overall Study|Patient didn't take any study medication|7|||
19653449|NCT00745901|42102908|FG001|Overall Study|Patient didn't take any study medication|3|||
19653450|NCT00286429|42102917|FG000|Overall Study|Adverse Event|4|||
19653451|NCT00286429|42102918|FG001|Overall Study|Adverse Event|1|||
19653452|NCT00286429|42102919|FG002|Overall Study|Adverse Event|6|||
19653453|NCT00286429|42102917|FG000|Overall Study|Lack of Efficacy|52|||
19653454|NCT00286429|42102918|FG001|Overall Study|Lack of Efficacy|27|||
19653455|NCT00286429|42102919|FG002|Overall Study|Lack of Efficacy|25|||
19653456|NCT00286429|42102917|FG000|Overall Study|Lost to Follow-up|2|||
19653457|NCT00286429|42102918|FG001|Overall Study|Lost to Follow-up|4|||
19653458|NCT00286429|42102919|FG002|Overall Study|Lost to Follow-up|3|||
19653459|NCT00286429|42102917|FG000|Overall Study|Physician Decision|10|||
19653460|NCT00286429|42102918|FG001|Overall Study|Physician Decision|7|||
19653461|NCT00286429|42102919|FG002|Overall Study|Physician Decision|7|||
19653462|NCT00286429|42102917|FG000|Overall Study|Protocol Violation|3|||
19653463|NCT00286429|42102918|FG001|Overall Study|Protocol Violation|5|||
19653464|NCT00286429|42102919|FG002|Overall Study|Protocol Violation|4|||
19653465|NCT00286429|42102917|FG000|Overall Study|Withdrawal by Subject|3|||
19653466|NCT00286429|42102918|FG001|Overall Study|Withdrawal by Subject|2|||
19653467|NCT00286429|42102919|FG002|Overall Study|Withdrawal by Subject|6|||
19653468|NCT00286429|42102917|FG000|Overall Study|Administrative Error|1|||
19653469|NCT00286429|42102918|FG001|Overall Study|Administrative Error|1|||
19653470|NCT00286429|42102919|FG002|Overall Study|Administrative Error|1|||
19653471|NCT00286429|42102917|FG000|Overall Study|Administrative Decision|0|||
19653472|NCT00286429|42102918|FG001|Overall Study|Administrative Decision|1|||
19653473|NCT00286429|42102919|FG002|Overall Study|Administrative Decision|0|||
19653474|NCT00665444|42102927|FG000|Overall Study|Physician Decision|1|||
19653475|NCT00665444|42102927|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
19653476|NCT03926169|42102934|FG000|Period A|Adverse Event|2|||
19653477|NCT03926169|42102935|FG001|Period A|Adverse Event|2|||
19653478|NCT03926169|42102936|FG002|Period A|Adverse Event|1|||
19653479|NCT03926169|42102934|FG000|Period A|Withdrawal by Subject|2|||
19653480|NCT03926169|42102935|FG001|Period A|Withdrawal by Subject|2|||
19653481|NCT03926169|42102936|FG002|Period A|Withdrawal by Subject|2|||
19653482|NCT03926169|42102934|FG000|Period A|Lost to Follow-up|3|||
19653483|NCT03926169|42102935|FG001|Period A|Lost to Follow-up|1|||
19653484|NCT03926169|42102936|FG002|Period A|Lost to Follow-up|0|||
19653485|NCT03926169|42102934|FG000|Period A|Lack of Efficacy|0|||
19653486|NCT03926169|42102935|FG001|Period A|Lack of Efficacy|2|||
19653487|NCT03926169|42102936|FG002|Period A|Lack of Efficacy|2|||
19653488|NCT03926169|42102934|FG000|Period A|COVID-19 Infection|0|||
19653489|NCT03926169|42102935|FG001|Period A|COVID-19 Infection|1|||
19653490|NCT03926169|42102936|FG002|Period A|COVID-19 Infection|0|||
19653491|NCT03926169|42102934|FG000|Period A|COVID-19 Logistical Restrictions|0|||
19653492|NCT03926169|42102935|FG001|Period A|COVID-19 Logistical Restrictions|2|||
19653493|NCT03926169|42102936|FG002|Period A|COVID-19 Logistical Restrictions|1|||
19653494|NCT03926169|42102934|FG000|Period A|Other, Not Specified|1|||
19653495|NCT03926169|42102935|FG001|Period A|Other, Not Specified|0|||
19653496|NCT03926169|42102936|FG002|Period A|Other, Not Specified|0|||
19653497|NCT03926169|42102934|FG000|Period B|Adverse Event|3|||
19653498|NCT03926169|42102935|FG001|Period B|Adverse Event|1|||
19653499|NCT03926169|42102936|FG002|Period B|Adverse Event|1|||
19653500|NCT03926169|42102934|FG000|Period B|Withdrawal by Subject|1|||
19653501|NCT03926169|42102935|FG001|Period B|Withdrawal by Subject|3|||
19653502|NCT03926169|42102936|FG002|Period B|Withdrawal by Subject|0|||
19653503|NCT03926169|42102934|FG000|Period B|Lack of Efficacy|3|||
19653504|NCT03926169|42102935|FG001|Period B|Lack of Efficacy|1|||
19653505|NCT03926169|42102936|FG002|Period B|Lack of Efficacy|1|||
19653506|NCT03926169|42102934|FG000|Period B|Lost to Follow-up|1|||
19653507|NCT03926169|42102935|FG001|Period B|Lost to Follow-up|1|||
19653508|NCT03926169|42102936|FG002|Period B|Lost to Follow-up|4|||
19653509|NCT03926169|42102934|FG000|Period B|Other, Not Specified|62|||
19653510|NCT03926169|42102935|FG001|Period B|Other, Not Specified|57|||
19653511|NCT03926169|42102936|FG002|Period B|Other, Not Specified|65|||
19752133|NCT03286218|42201525|FG001|Qualification Phase Period 1|Adverse Event|0|||
19752134|NCT03286218|42201526|FG002|Qualification Phase Period 1|Adverse Event|0|||
19752135|NCT03286218|42201527|FG003|Qualification Phase Period 1|Adverse Event|0|||
19752136|NCT03286218|42201528|FG004|Qualification Phase Period 1|Adverse Event|0|||
19752137|NCT03286218|42201529|FG005|Qualification Phase Period 1|Adverse Event|0|||
19752138|NCT03286218|42201530|FG006|Qualification Phase Period 1|Adverse Event|0|||
19653512|NCT00285649|42102950|FG000|Overall Study|Lost to Follow-up|6|||
19653513|NCT00285649|42102951|FG001|Overall Study|Lost to Follow-up|4|||
19653514|NCT00285649|42102952|FG002|Overall Study|Lost to Follow-up|4|||
19653515|NCT00285649|42102950|FG000|Overall Study|Withdrawal by Subject|3|||
19653516|NCT00285649|42102951|FG001|Overall Study|Withdrawal by Subject|2|||
19653517|NCT00285649|42102952|FG002|Overall Study|Withdrawal by Subject|2|||
19653518|NCT00745823|42102962|FG000|Overall Study|Adverse Event|5|||
19653519|NCT00745823|42102963|FG001|Overall Study|Adverse Event|3|||
19653520|NCT00745823|42102962|FG000|Overall Study|Lack of Efficacy|20|||
19653521|NCT00745823|42102963|FG001|Overall Study|Lack of Efficacy|6|||
19653522|NCT00745823|42102962|FG000|Overall Study|Lost to Follow-up|10|||
19653523|NCT00745823|42102963|FG001|Overall Study|Lost to Follow-up|11|||
19653524|NCT00745823|42102962|FG000|Overall Study|Physician Decision|10|||
19653525|NCT00745823|42102963|FG001|Overall Study|Physician Decision|5|||
19653526|NCT00745823|42102962|FG000|Overall Study|Pregnancy|0|||
19653527|NCT00745823|42102963|FG001|Overall Study|Pregnancy|4|||
19653528|NCT00745823|42102962|FG000|Overall Study|Withdrawal by Subject|14|||
19653529|NCT00745823|42102963|FG001|Overall Study|Withdrawal by Subject|8|||
19653530|NCT00745823|42102962|FG000|Overall Study|Study Terminated by Sponsor|326|||
19653531|NCT00745823|42102963|FG001|Overall Study|Study Terminated by Sponsor|349|||
19653532|NCT00663260|42102974|FG000|Overall Study|Lack of Efficacy|2|||
19653533|NCT00663260|42102975|FG001|Overall Study|Lack of Efficacy|0|||
19653534|NCT00663260|42102976|FG002|Overall Study|Lack of Efficacy|0|||
19653535|NCT00663260|42102974|FG000|Overall Study|Adverse Event|12|||
19653536|NCT00663260|42102975|FG001|Overall Study|Adverse Event|7|||
19653537|NCT00663260|42102976|FG002|Overall Study|Adverse Event|6|||
19653538|NCT00663260|42102974|FG000|Overall Study|Withdrawal by Subject|3|||
19653539|NCT00663260|42102975|FG001|Overall Study|Withdrawal by Subject|1|||
19653540|NCT00663260|42102976|FG002|Overall Study|Withdrawal by Subject|6|||
19653541|NCT00663260|42102974|FG000|Overall Study|Death|1|||
19653542|NCT00663260|42102975|FG001|Overall Study|Death|0|||
19653543|NCT00663260|42102976|FG002|Overall Study|Death|1|||
19653544|NCT00663260|42102974|FG000|Overall Study|Lost to Follow-up|0|||
19653545|NCT00663260|42102975|FG001|Overall Study|Lost to Follow-up|1|||
19653546|NCT00663260|42102976|FG002|Overall Study|Lost to Follow-up|0|||
19653547|NCT00663260|42102974|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
19653548|NCT00663260|42102975|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
19653549|NCT00663260|42102976|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
19653550|NCT00740597|42102984|FG000|Overall Study|insurance would not cover treatment|1|||
19653551|NCT00284089|42102992|FG000|Multiple Dose Phase|Adverse Event|1|||
19653552|NCT00284089|42102993|FG001|Multiple Dose Phase|Adverse Event|0|||
19653553|NCT00284089|42102994|FG002|Multiple Dose Phase|Adverse Event|1|||
19653554|NCT00284089|42102995|FG003|Multiple Dose Phase|Adverse Event|1|||
19653555|NCT00284089|42102992|FG000|Multiple Dose Phase|Protocol Violation|0|||
19752139|NCT03286218|42201531|FG007|Qualification Phase Period 1|Adverse Event|0|||
19752140|NCT03286218|42201532|FG008|Qualification Phase Period 1|Adverse Event|0|||
19752141|NCT03286218|42201533|FG009|Qualification Phase Period 1|Adverse Event|0|||
19752142|NCT03286218|42201534|FG010|Qualification Phase Period 1|Adverse Event|0|||
19653556|NCT00284089|42102993|FG001|Multiple Dose Phase|Protocol Violation|0|||
19653557|NCT00284089|42102994|FG002|Multiple Dose Phase|Protocol Violation|1|||
19653558|NCT00284089|42102995|FG003|Multiple Dose Phase|Protocol Violation|0|||
19653559|NCT00284089|42102992|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
19653560|NCT00284089|42102993|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
19653561|NCT00284089|42102994|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
19653562|NCT00284089|42102995|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
19653563|NCT00284089|42102992|FG000|Multiple Dose Phase|Death|0|||
19653564|NCT00284089|42102993|FG001|Multiple Dose Phase|Death|0|||
19653565|NCT00284089|42102994|FG002|Multiple Dose Phase|Death|1|||
19653566|NCT00284089|42102995|FG003|Multiple Dose Phase|Death|1|||
19653567|NCT00284089|42102992|FG000|Extension Phase|Adverse Event|0|||
19653568|NCT00284089|42102993|FG001|Extension Phase|Adverse Event|0|||
19653569|NCT00284089|42102994|FG002|Extension Phase|Adverse Event|2|||
19752143|NCT03286218|42201535|FG011|Qualification Phase Period 1|Adverse Event|0|||
19752144|NCT03286218|42201524|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752145|NCT03286218|42201525|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
19752146|NCT03286218|42201526|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752147|NCT03286218|42201527|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752148|NCT03286218|42201528|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752149|NCT03286218|42201529|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752150|NCT03286218|42201530|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752151|NCT03286218|42201531|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752152|NCT03286218|42201532|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752153|NCT03286218|42201533|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752154|NCT03286218|42201534|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752155|NCT03286218|42201535|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
19752156|NCT03286218|42201524|FG000|Qualification Phase Period 2|Adverse Event|0|||
19653570|NCT00284089|42102995|FG003|Extension Phase|Adverse Event|2|||
19752157|NCT03286218|42201525|FG001|Qualification Phase Period 2|Adverse Event|1|||
19752158|NCT03286218|42201526|FG002|Qualification Phase Period 2|Adverse Event|0|||
19653571|NCT00284089|42102992|FG000|Extension Phase|condition no longer requires study drug|2|||
19653572|NCT00284089|42102993|FG001|Extension Phase|condition no longer requires study drug|0|||
19653573|NCT00284089|42102994|FG002|Extension Phase|condition no longer requires study drug|2|||
19653574|NCT00284089|42102995|FG003|Extension Phase|condition no longer requires study drug|7|||
19653575|NCT00284089|42102992|FG000|Extension Phase|Protocol Violation|0|||
19653576|NCT00284089|42102993|FG001|Extension Phase|Protocol Violation|0|||
19653577|NCT00284089|42102994|FG002|Extension Phase|Protocol Violation|1|||
19653578|NCT00284089|42102995|FG003|Extension Phase|Protocol Violation|0|||
19653579|NCT00284089|42102992|FG000|Extension Phase|Withdrawal by Subject|0|||
19653580|NCT00284089|42102993|FG001|Extension Phase|Withdrawal by Subject|0|||
19653581|NCT00284089|42102994|FG002|Extension Phase|Withdrawal by Subject|1|||
19653582|NCT00284089|42102995|FG003|Extension Phase|Withdrawal by Subject|3|||
19653583|NCT00659984|42103005|FG000|Overall Study|Adverse Event|1|||
19653584|NCT00283387|42103019|FG000|First Intervention|Subject non-compliant|1|||
19653585|NCT00283387|42103020|FG001|First Intervention|Subject non-compliant|1|||
19653586|NCT00283387|42103019|FG000|First Intervention|Withdrawal by Subject|0|||
19653587|NCT00283387|42103020|FG001|First Intervention|Withdrawal by Subject|1|||
19653588|NCT00282919|42103026|FG000|Overall Study|Lack of Efficacy|4|||
19653589|NCT00282919|42103026|FG000|Overall Study|Withdrawal by Subject|1|||
19653590|NCT00282919|42103026|FG000|Overall Study|Asymptomatic Parasitemia|2|||
19653591|NCT00742859|42103034|FG000|Overall Study|Adverse Event|5|||
19653592|NCT00742859|42103035|FG001|Overall Study|Adverse Event|6|||
19653593|NCT00742859|42103036|FG002|Overall Study|Adverse Event|3|||
19653594|NCT00742859|42103037|FG003|Overall Study|Adverse Event|1|||
19653595|NCT00742859|42103034|FG000|Overall Study|Death|1|||
19653596|NCT00742859|42103035|FG001|Overall Study|Death|0|||
19653597|NCT00742859|42103036|FG002|Overall Study|Death|0|||
19653598|NCT00742859|42103037|FG003|Overall Study|Death|1|||
19653599|NCT00742859|42103034|FG000|Overall Study|Physician Decision|1|||
19653600|NCT00742859|42103035|FG001|Overall Study|Physician Decision|2|||
19653601|NCT00742859|42103036|FG002|Overall Study|Physician Decision|0|||
19653602|NCT00742859|42103037|FG003|Overall Study|Physician Decision|0|||
19653603|NCT00742859|42103034|FG000|Overall Study|Withdrawal by Subject|4|||
19653604|NCT00742859|42103035|FG001|Overall Study|Withdrawal by Subject|2|||
19653605|NCT00742859|42103036|FG002|Overall Study|Withdrawal by Subject|4|||
19653606|NCT00742859|42103037|FG003|Overall Study|Withdrawal by Subject|1|||
19653607|NCT00742859|42103034|FG000|Overall Study|Endpoint|0|||
19653608|NCT00742859|42103035|FG001|Overall Study|Endpoint|1|||
19653609|NCT00742859|42103036|FG002|Overall Study|Endpoint|1|||
19653610|NCT00742859|42103037|FG003|Overall Study|Endpoint|2|||
19653611|NCT00742859|42103034|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
19653612|NCT00742859|42103035|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
19653613|NCT00742859|42103036|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
19653614|NCT00742859|42103037|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
19653615|NCT00742859|42103034|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
19653616|NCT00742859|42103035|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
19653617|NCT00742859|42103036|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
19653618|NCT00742859|42103037|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
19653619|NCT00742859|42103034|FG000|Overall Study|Sponsor request patient out of town|0|||
19653620|NCT00742859|42103035|FG001|Overall Study|Sponsor request patient out of town|0|||
19653621|NCT00742859|42103036|FG002|Overall Study|Sponsor request patient out of town|1|||
19653622|NCT00742859|42103037|FG003|Overall Study|Sponsor request patient out of town|1|||
19653623|NCT00742859|42103034|FG000|Overall Study|Site error|0|||
19653624|NCT00742859|42103035|FG001|Overall Study|Site error|0|||
19653625|NCT00742859|42103036|FG002|Overall Study|Site error|1|||
19653626|NCT00742859|42103037|FG003|Overall Study|Site error|1|||
19653627|NCT00282295|42103050|FG000|Overall Study|Adverse Event|0|||
19653628|NCT00282295|42103051|FG001|Overall Study|Adverse Event|1|||
19653629|NCT00282295|42103052|FG002|Overall Study|Adverse Event|0|||
19653630|NCT00282295|42103050|FG000|Overall Study|Serious Adverse Events|0|||
19653631|NCT00282295|42103051|FG001|Overall Study|Serious Adverse Events|0|||
19653632|NCT00282295|42103052|FG002|Overall Study|Serious Adverse Events|1|||
19653633|NCT00282295|42103050|FG000|Overall Study|Protocol Violation|0|||
19653634|NCT00282295|42103051|FG001|Overall Study|Protocol Violation|2|||
19653635|NCT00282295|42103052|FG002|Overall Study|Protocol Violation|1|||
19653636|NCT00282295|42103050|FG000|Overall Study|Withdrawal by Subject|2|||
19653637|NCT00282295|42103051|FG001|Overall Study|Withdrawal by Subject|6|||
19653638|NCT00282295|42103052|FG002|Overall Study|Withdrawal by Subject|4|||
19653639|NCT00282295|42103050|FG000|Overall Study|Lost to Follow-up|1|||
19653640|NCT00282295|42103051|FG001|Overall Study|Lost to Follow-up|7|||
19653641|NCT00282295|42103052|FG002|Overall Study|Lost to Follow-up|2|||
19653642|NCT00282295|42103050|FG000|Overall Study|Other|0|||
19653643|NCT00282295|42103051|FG001|Overall Study|Other|1|||
19653644|NCT00282295|42103052|FG002|Overall Study|Other|0|||
19653645|NCT00742781|42103065|FG000|Overall Study|Withdrawal by Subject|3|||
19653646|NCT00663026|42103073|FG000|Overall Study|Lost to Follow-up|1|||
19653647|NCT00663026|42103074|FG001|Overall Study|Lost to Follow-up|0|||
19653648|NCT00663026|42103075|FG002|Overall Study|Lost to Follow-up|0|||
19653649|NCT00663026|42103073|FG000|Overall Study|Other|1|||
19653650|NCT00663026|42103074|FG001|Overall Study|Other|2|||
19653651|NCT00663026|42103075|FG002|Overall Study|Other|0|||
19653652|NCT00663026|42103073|FG000|Overall Study|Adverse Event|0|||
19653653|NCT00663026|42103074|FG001|Overall Study|Adverse Event|2|||
19653654|NCT00663026|42103075|FG002|Overall Study|Adverse Event|3|||
19653655|NCT00663026|42103073|FG000|Overall Study|Caregiver Request|0|||
19653656|NCT00663026|42103074|FG001|Overall Study|Caregiver Request|2|||
19653657|NCT00663026|42103075|FG002|Overall Study|Caregiver Request|0|||
19653658|NCT00663026|42103073|FG000|Overall Study|Withdrawal by Subject|0|||
19653659|NCT00663026|42103074|FG001|Overall Study|Withdrawal by Subject|0|||
19653660|NCT00663026|42103075|FG002|Overall Study|Withdrawal by Subject|1|||
19653661|NCT00280735|42103085|FG000|Overall Study|Adverse Event|5|||
19653662|NCT00280735|42103085|FG000|Overall Study|Lack of Efficacy|3|||
19653663|NCT00280735|42103085|FG000|Overall Study|Withdrawal by Subject|8|||
19653664|NCT00280735|42103085|FG000|Overall Study|Intercurrent Illness|2|||
19653665|NCT00260065|42103093|FG000|Overall Study|Progressive Disease|22|||
19653666|NCT00260065|42103093|FG000|Overall Study|Adverse Event|17|||
19653667|NCT00260065|42103093|FG000|Overall Study|Death|13|||
19653668|NCT00260065|42103093|FG000|Overall Study|Withdrawal by Subject|13|||
19653669|NCT00260065|42103093|FG000|Overall Study|Physician Decision|19|||
19653670|NCT00260065|42103093|FG000|Overall Study|Not otherwise specified|8|||
19653671|NCT00260065|42103093|FG000|Overall Study|Medication Noncompliance|1|||
19653672|NCT00506350|42103106|FG000|Overall Study|Serious Adverse Event|1|||
19653673|NCT00506350|42103107|FG001|Overall Study|Serious Adverse Event|0|||
19653674|NCT00506350|42103108|FG002|Overall Study|Serious Adverse Event|0|||
19653675|NCT00506350|42103109|FG003|Overall Study|Serious Adverse Event|0|||
19653676|NCT00506350|42103110|FG004|Overall Study|Serious Adverse Event|0|||
19653677|NCT00506350|42103111|FG005|Overall Study|Serious Adverse Event|0|||
19653678|NCT00506350|42103112|FG006|Overall Study|Serious Adverse Event|0|||
19653679|NCT00506350|42103113|FG007|Overall Study|Serious Adverse Event|0|||
19653680|NCT00506350|42103114|FG008|Overall Study|Serious Adverse Event|0|||
19653681|NCT00506350|42103106|FG000|Overall Study|Adverse Event|0|||
19653682|NCT00506350|42103107|FG001|Overall Study|Adverse Event|0|||
19653683|NCT00506350|42103108|FG002|Overall Study|Adverse Event|0|||
19653684|NCT00506350|42103109|FG003|Overall Study|Adverse Event|0|||
19653685|NCT00506350|42103110|FG004|Overall Study|Adverse Event|0|||
19653686|NCT00506350|42103111|FG005|Overall Study|Adverse Event|0|||
19653687|NCT00506350|42103112|FG006|Overall Study|Adverse Event|0|||
19653688|NCT00506350|42103113|FG007|Overall Study|Adverse Event|1|||
19653689|NCT00506350|42103114|FG008|Overall Study|Adverse Event|1|||
19653690|NCT00506350|42103106|FG000|Overall Study|Protocol Violation|0|||
19653691|NCT00506350|42103107|FG001|Overall Study|Protocol Violation|0|||
19653692|NCT00506350|42103108|FG002|Overall Study|Protocol Violation|1|||
19653693|NCT00506350|42103109|FG003|Overall Study|Protocol Violation|0|||
19653694|NCT00506350|42103110|FG004|Overall Study|Protocol Violation|0|||
19653695|NCT00506350|42103111|FG005|Overall Study|Protocol Violation|0|||
19653696|NCT00506350|42103112|FG006|Overall Study|Protocol Violation|1|||
19653697|NCT00506350|42103113|FG007|Overall Study|Protocol Violation|0|||
19653698|NCT00506350|42103114|FG008|Overall Study|Protocol Violation|0|||
19653699|NCT00506350|42103106|FG000|Overall Study|Withdrawal by Subject|0|||
19653700|NCT00506350|42103107|FG001|Overall Study|Withdrawal by Subject|1|||
19653701|NCT00506350|42103108|FG002|Overall Study|Withdrawal by Subject|1|||
19653702|NCT00506350|42103109|FG003|Overall Study|Withdrawal by Subject|1|||
19653703|NCT00506350|42103110|FG004|Overall Study|Withdrawal by Subject|4|||
19653704|NCT00506350|42103111|FG005|Overall Study|Withdrawal by Subject|1|||
19653705|NCT00506350|42103112|FG006|Overall Study|Withdrawal by Subject|1|||
19653706|NCT00506350|42103113|FG007|Overall Study|Withdrawal by Subject|2|||
19653707|NCT00506350|42103114|FG008|Overall Study|Withdrawal by Subject|0|||
19653708|NCT00506350|42103106|FG000|Overall Study|Lost to Follow-up|1|||
19653709|NCT00506350|42103107|FG001|Overall Study|Lost to Follow-up|1|||
19653710|NCT00506350|42103108|FG002|Overall Study|Lost to Follow-up|1|||
19653711|NCT00506350|42103109|FG003|Overall Study|Lost to Follow-up|1|||
19653712|NCT00506350|42103110|FG004|Overall Study|Lost to Follow-up|2|||
19653713|NCT00506350|42103111|FG005|Overall Study|Lost to Follow-up|1|||
19653714|NCT00506350|42103112|FG006|Overall Study|Lost to Follow-up|0|||
19601546|NCT00767806|42050257|FG000|Overall Study|Entry Criteria Not Met|1|||
19601547|NCT00767806|42050258|FG001|Overall Study|Entry Criteria Not Met|1|||
19601548|NCT00767806|42050257|FG000|Overall Study|Sponsor Decision|0|||
19601549|NCT00767806|42050258|FG001|Overall Study|Sponsor Decision|1|||
19601550|NCT00780910|42050264|FG000|Overall Study|Adverse Event|2|||
19601551|NCT00767104|42050270|FG000|Overall Study|Lost to Follow-up|1|||
19601552|NCT00767104|42050271|FG001|Overall Study|Lost to Follow-up|2|||
19601553|NCT00771472|42050279|FG000|Overall Study|Physician Decision|2|||
19601554|NCT00771472|42050280|FG001|Overall Study|Physician Decision|3|||
19601555|NCT00771472|42050279|FG000|Overall Study|Progressive Disease|3|||
19653715|NCT00506350|42103113|FG007|Overall Study|Lost to Follow-up|0|||
19653716|NCT00506350|42103114|FG008|Overall Study|Lost to Follow-up|2|||
19653717|NCT00506350|42103106|FG000|Overall Study|Medical Reason|0|||
19653718|NCT00506350|42103107|FG001|Overall Study|Medical Reason|0|||
19653719|NCT00506350|42103108|FG002|Overall Study|Medical Reason|0|||
19653720|NCT00506350|42103109|FG003|Overall Study|Medical Reason|0|||
19653721|NCT00506350|42103110|FG004|Overall Study|Medical Reason|1|||
19653722|NCT00506350|42103111|FG005|Overall Study|Medical Reason|0|||
19653723|NCT00506350|42103112|FG006|Overall Study|Medical Reason|0|||
19653724|NCT00506350|42103113|FG007|Overall Study|Medical Reason|0|||
19653725|NCT00506350|42103114|FG008|Overall Study|Medical Reason|0|||
19653726|NCT00506350|42103106|FG000|Overall Study|Other|1|||
19653727|NCT00506350|42103107|FG001|Overall Study|Other|1|||
19653728|NCT00506350|42103108|FG002|Overall Study|Other|3|||
19653729|NCT00506350|42103109|FG003|Overall Study|Other|0|||
19653730|NCT00506350|42103110|FG004|Overall Study|Other|3|||
19653731|NCT00506350|42103111|FG005|Overall Study|Other|0|||
19653732|NCT00506350|42103112|FG006|Overall Study|Other|0|||
19653733|NCT00506350|42103113|FG007|Overall Study|Other|2|||
19653734|NCT00506350|42103114|FG008|Overall Study|Other|2|||
19653735|NCT00258895|42103143|FG000|Overall Study|Lost to Follow-up|3|||
19653736|NCT00258895|42103144|FG001|Overall Study|Lost to Follow-up|1|||
19653737|NCT00258895|42103143|FG000|Overall Study|Protocol Violation|6|||
19653738|NCT00258895|42103144|FG001|Overall Study|Protocol Violation|2|||
19653739|NCT00258895|42103143|FG000|Overall Study|Withdrawal by Subject|1|||
19653740|NCT00258895|42103144|FG001|Overall Study|Withdrawal by Subject|0|||
19653741|NCT00742625|42103150|FG000|Remission Induction|Progression|6|||
19653742|NCT00742625|42103150|FG000|Remission Induction|Failed induction|8|||
19653743|NCT00742625|42103150|FG000|Remission Induction|Adverse Event|3|||
19653744|NCT00742625|42103150|FG000|Remission Induction|Death|10|||
19653745|NCT00742625|42103150|FG000|Remission Induction|Refusal|5|||
19653746|NCT00742625|42103150|FG000|Remission Induction|Non protocol treatment|17|||
19653747|NCT00742625|42103150|FG000|Remission Induction|Other, not specified|5|||
19653748|NCT00742625|42103150|FG000|Consolidation|Progression|5|||
19653749|NCT00742625|42103150|FG000|Consolidation|Adverse Event|1|||
19653750|NCT00742625|42103150|FG000|Consolidation|Death|1|||
19653751|NCT00742625|42103150|FG000|Consolidation|Refused|1|||
19653752|NCT00742625|42103150|FG000|Consolidation|Non protocol therapy|13|||
19653753|NCT00618618|42103161|FG000|Overall Study|Patient Request|0|||
19653754|NCT00618618|42103162|FG001|Overall Study|Patient Request|0|||
19653755|NCT00618618|42103163|FG002|Overall Study|Patient Request|2|||
19653756|NCT00618618|42103164|FG003|Overall Study|Patient Request|0|||
19653757|NCT00618618|42103161|FG000|Overall Study|Inability to Complete Study Procedures|0|||
19653758|NCT00618618|42103162|FG001|Overall Study|Inability to Complete Study Procedures|1|||
19653759|NCT00618618|42103163|FG002|Overall Study|Inability to Complete Study Procedures|0|||
19653760|NCT00618618|42103164|FG003|Overall Study|Inability to Complete Study Procedures|0|||
19653761|NCT00618618|42103161|FG000|Overall Study|Lost to Follow-up|3|||
19653762|NCT00618618|42103162|FG001|Overall Study|Lost to Follow-up|0|||
19653763|NCT00618618|42103163|FG002|Overall Study|Lost to Follow-up|0|||
19653764|NCT00618618|42103164|FG003|Overall Study|Lost to Follow-up|1|||
19653765|NCT00618618|42103161|FG000|Overall Study|Non-compliance|1|||
19653766|NCT00618618|42103162|FG001|Overall Study|Non-compliance|1|||
19653767|NCT00618618|42103163|FG002|Overall Study|Non-compliance|0|||
19653768|NCT00618618|42103164|FG003|Overall Study|Non-compliance|0|||
19653769|NCT00618618|42103161|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
19653770|NCT00618618|42103162|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
19653771|NCT00618618|42103163|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
19653772|NCT00618618|42103164|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
19653773|NCT00618618|42103161|FG000|Overall Study|Death|0|||
19653774|NCT00618618|42103162|FG001|Overall Study|Death|1|||
19653775|NCT00618618|42103163|FG002|Overall Study|Death|0|||
19653776|NCT00618618|42103164|FG003|Overall Study|Death|0|||
19653777|NCT00246805|42103177|FG000|Phase 1|Lost to Follow-up|1|||
19653778|NCT00246805|42103178|FG001|Phase 1|Lost to Follow-up|0|||
19653779|NCT00519376|42103184|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653780|NCT00519376|42103185|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653781|NCT00519376|42103186|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653782|NCT00519376|42103187|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653783|NCT00519376|42103188|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653784|NCT00519376|42103189|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653785|NCT00519376|42103190|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653786|NCT00519376|42103191|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653787|NCT00519376|42103192|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653788|NCT00519376|42103193|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653789|NCT00519376|42103194|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653790|NCT00519376|42103195|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653791|NCT00519376|42103196|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
19653792|NCT00519376|42103197|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653793|NCT00519376|42103198|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653794|NCT00519376|42103199|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
19653795|NCT00519376|42103184|FG000|Treatment Period 4|Lost to Follow-up|0|||
19653796|NCT00519376|42103185|FG001|Treatment Period 4|Lost to Follow-up|0|||
19653797|NCT00519376|42103186|FG002|Treatment Period 4|Lost to Follow-up|1|||
19653798|NCT00519376|42103187|FG003|Treatment Period 4|Lost to Follow-up|0|||
19752159|NCT03286218|42201527|FG003|Qualification Phase Period 2|Adverse Event|0|||
19752160|NCT03286218|42201528|FG004|Qualification Phase Period 2|Adverse Event|0|||
19752161|NCT03286218|42201529|FG005|Qualification Phase Period 2|Adverse Event|0|||
19752162|NCT03286218|42201530|FG006|Qualification Phase Period 2|Adverse Event|0|||
19752163|NCT03286218|42201531|FG007|Qualification Phase Period 2|Adverse Event|0|||
19752164|NCT03286218|42201532|FG008|Qualification Phase Period 2|Adverse Event|0|||
19752165|NCT03286218|42201533|FG009|Qualification Phase Period 2|Adverse Event|0|||
19752166|NCT03286218|42201534|FG010|Qualification Phase Period 2|Adverse Event|0|||
19752167|NCT03286218|42201535|FG011|Qualification Phase Period 2|Adverse Event|0|||
19752168|NCT03286218|42201524|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
19752169|NCT03286218|42201525|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
19752170|NCT03286218|42201526|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752171|NCT03286218|42201527|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752172|NCT03286218|42201528|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752173|NCT03286218|42201529|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752174|NCT03286218|42201530|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752175|NCT03286218|42201531|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752176|NCT03286218|42201532|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752177|NCT03286218|42201533|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752178|NCT03286218|42201534|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19653799|NCT00519376|42103188|FG004|Treatment Period 4|Lost to Follow-up|0|||
19653800|NCT00519376|42103189|FG005|Treatment Period 4|Lost to Follow-up|0|||
19752179|NCT03286218|42201535|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
19752180|NCT03286218|42201524|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
19752181|NCT03286218|42201525|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
19752182|NCT03286218|42201526|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
19752183|NCT03286218|42201527|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
19752184|NCT03286218|42201528|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
19752185|NCT03286218|42201529|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
19752186|NCT03286218|42201530|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
19752187|NCT03286218|42201531|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
19752188|NCT03286218|42201532|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
19752189|NCT03286218|42201533|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
19752190|NCT03286218|42201534|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
19752191|NCT03286218|42201535|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
19752192|NCT03286218|42201524|FG000|Qualification Phase Period 2|Protocol Violation|2|||
19752193|NCT03286218|42201525|FG001|Qualification Phase Period 2|Protocol Violation|0|||
19752194|NCT03286218|42201526|FG002|Qualification Phase Period 2|Protocol Violation|0|||
19653801|NCT00519376|42103190|FG006|Treatment Period 4|Lost to Follow-up|0|||
19653802|NCT00519376|42103191|FG007|Treatment Period 4|Lost to Follow-up|0|||
19653803|NCT00519376|42103192|FG008|Treatment Period 4|Lost to Follow-up|0|||
19653804|NCT00519376|42103193|FG009|Treatment Period 4|Lost to Follow-up|0|||
19653805|NCT00519376|42103194|FG010|Treatment Period 4|Lost to Follow-up|0|||
19653806|NCT00519376|42103195|FG011|Treatment Period 4|Lost to Follow-up|0|||
19653807|NCT00519376|42103196|FG012|Treatment Period 4|Lost to Follow-up|0|||
19653808|NCT00519376|42103197|FG013|Treatment Period 4|Lost to Follow-up|0|||
19653809|NCT00519376|42103198|FG014|Treatment Period 4|Lost to Follow-up|0|||
19653810|NCT00519376|42103199|FG015|Treatment Period 4|Lost to Follow-up|0|||
19653811|NCT00745121|42103213|FG000|Overall Study|Death|3|||
19653812|NCT00745121|42103214|FG001|Overall Study|Death|0|||
19752195|NCT03286218|42201527|FG003|Qualification Phase Period 2|Protocol Violation|0|||
19601556|NCT00771472|42050280|FG001|Overall Study|Progressive Disease|1|||
19601557|NCT00771472|42050279|FG000|Overall Study|Protocol Violation|1|||
19601558|NCT00771472|42050280|FG001|Overall Study|Protocol Violation|0|||
19601559|NCT00771316|42050287|FG000|Overall Study|Adverse Event|0|||
19601560|NCT00771316|42050288|FG001|Overall Study|Adverse Event|1|||
19601561|NCT00771316|42050287|FG000|Overall Study|Patient withdrew consent|1|||
19601562|NCT00771316|42050288|FG001|Overall Study|Patient withdrew consent|0|||
19601563|NCT00771316|42050287|FG000|Overall Study|Discontinued due to early termination|1|||
19601564|NCT00771316|42050288|FG001|Overall Study|Discontinued due to early termination|0|||
19601565|NCT00770770|42050296|FG000|Overall Study|Lost to Follow-up|1|||
19601566|NCT00770770|42050297|FG001|Overall Study|Lost to Follow-up|0|||
19653813|NCT00745121|42103213|FG000|Overall Study|Adverse Event|1|||
19653814|NCT00745121|42103214|FG001|Overall Study|Adverse Event|0|||
19653815|NCT00745121|42103213|FG000|Overall Study|Lost to Follow-up|1|||
19653816|NCT00745121|42103214|FG001|Overall Study|Lost to Follow-up|0|||
19653817|NCT00745121|42103213|FG000|Overall Study|Withdrawal by Subject|4|||
19653818|NCT00745121|42103214|FG001|Overall Study|Withdrawal by Subject|2|||
19653819|NCT00740051|42103222|FG000|Overall Study|Lack of Efficacy|2|||
19653820|NCT00740051|42103223|FG001|Overall Study|Lack of Efficacy|5|||
19653821|NCT00740051|42103222|FG000|Overall Study|Adverse Event|1|||
19653822|NCT00740051|42103223|FG001|Overall Study|Adverse Event|4|||
19653823|NCT00740051|42103222|FG000|Overall Study|Protocol Violation|2|||
19653824|NCT00740051|42103223|FG001|Overall Study|Protocol Violation|6|||
19653825|NCT00740051|42103222|FG000|Overall Study|Lost to Follow-up|3|||
19653826|NCT00740051|42103223|FG001|Overall Study|Lost to Follow-up|8|||
19653827|NCT00740051|42103222|FG000|Overall Study|Withdrawal by Subject|6|||
19653828|NCT00740051|42103223|FG001|Overall Study|Withdrawal by Subject|8|||
19752196|NCT03286218|42201528|FG004|Qualification Phase Period 2|Protocol Violation|0|||
19752197|NCT03286218|42201529|FG005|Qualification Phase Period 2|Protocol Violation|0|||
19752198|NCT03286218|42201530|FG006|Qualification Phase Period 2|Protocol Violation|0|||
19752199|NCT03286218|42201531|FG007|Qualification Phase Period 2|Protocol Violation|0|||
19752200|NCT03286218|42201532|FG008|Qualification Phase Period 2|Protocol Violation|0|||
19752201|NCT03286218|42201533|FG009|Qualification Phase Period 2|Protocol Violation|0|||
19752202|NCT03286218|42201534|FG010|Qualification Phase Period 2|Protocol Violation|0|||
19752203|NCT03286218|42201535|FG011|Qualification Phase Period 2|Protocol Violation|0|||
19752204|NCT03286218|42201524|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
19752205|NCT03286218|42201525|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
19752206|NCT03286218|42201526|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752207|NCT03286218|42201527|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752208|NCT03286218|42201528|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752209|NCT03286218|42201529|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752210|NCT03286218|42201530|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752211|NCT03286218|42201531|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752212|NCT03286218|42201532|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752213|NCT03286218|42201533|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752214|NCT03286218|42201534|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
19653829|NCT00740051|42103222|FG000|Overall Study|Other reason (not specified)|4|||
19752215|NCT03286218|42201535|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
19752216|NCT03286218|42201524|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752217|NCT03286218|42201525|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752218|NCT03286218|42201526|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
19752219|NCT03286218|42201527|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
19752220|NCT03286218|42201528|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752221|NCT03286218|42201529|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
19752222|NCT03286218|42201530|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752223|NCT03286218|42201531|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752224|NCT03286218|42201532|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752225|NCT03286218|42201533|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752226|NCT03286218|42201534|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
19752227|NCT03286218|42201535|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
19752228|NCT03286218|42201524|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752229|NCT03286218|42201525|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752230|NCT03286218|42201526|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752231|NCT03286218|42201527|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752232|NCT03286218|42201528|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752233|NCT03286218|42201529|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752234|NCT03286218|42201530|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752235|NCT03286218|42201531|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752236|NCT03286218|42201532|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752237|NCT03286218|42201533|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752238|NCT03286218|42201534|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
19752239|NCT03286218|42201535|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
19752240|NCT03224325|42201569|FG000|Overall Study|Adverse Event|1|||
19752241|NCT03224325|42201570|FG001|Overall Study|Adverse Event|0|||
19752242|NCT03224325|42201571|FG002|Overall Study|Adverse Event|0|||
19752243|NCT03224325|42201572|FG003|Overall Study|Adverse Event|0|||
19752244|NCT03224325|42201573|FG004|Overall Study|Adverse Event|0|||
19752245|NCT03224325|42201574|FG005|Overall Study|Adverse Event|0|||
19752246|NCT03224325|42201575|FG006|Overall Study|Adverse Event|1|||
19752247|NCT03224325|42201569|FG000|Overall Study|Withdrawal by Subject|0|||
19752248|NCT03224325|42201570|FG001|Overall Study|Withdrawal by Subject|0|||
19752249|NCT03224325|42201571|FG002|Overall Study|Withdrawal by Subject|0|||
19752250|NCT03224325|42201572|FG003|Overall Study|Withdrawal by Subject|1|||
19752251|NCT03224325|42201573|FG004|Overall Study|Withdrawal by Subject|0|||
19752252|NCT03224325|42201574|FG005|Overall Study|Withdrawal by Subject|0|||
19752253|NCT03224325|42201575|FG006|Overall Study|Withdrawal by Subject|0|||
19752254|NCT04016779|42201599|FG000|Overall Study|Adverse Event|9|||
19752255|NCT04016779|42201600|FG001|Overall Study|Adverse Event|17|||
19752256|NCT04016779|42201599|FG000|Overall Study|Lack of Efficacy|4|||
19752257|NCT04016779|42201600|FG001|Overall Study|Lack of Efficacy|1|||
19752258|NCT04016779|42201599|FG000|Overall Study|Lost to Follow-up|5|||
19752259|NCT04016779|42201600|FG001|Overall Study|Lost to Follow-up|14|||
19752260|NCT04016779|42201599|FG000|Overall Study|Physician Decision|1|||
19752261|NCT04016779|42201600|FG001|Overall Study|Physician Decision|3|||
19752262|NCT04016779|42201599|FG000|Overall Study|Withdrawal by Subject|6|||
19752263|NCT04016779|42201600|FG001|Overall Study|Withdrawal by Subject|8|||
19752264|NCT04016779|42201599|FG000|Overall Study|Non-compliance with Study Drug|2|||
19752265|NCT04016779|42201600|FG001|Overall Study|Non-compliance with Study Drug|3|||
19752266|NCT04016779|42201599|FG000|Overall Study|Other, Multiple categories|17|||
19752267|NCT04016779|42201600|FG001|Overall Study|Other, Multiple categories|17|||
19752268|NCT02857426|42201610|FG000|Overall Study|Disease progression|34|||
19752269|NCT02857426|42201611|FG001|Overall Study|Disease progression|13|||
19752270|NCT02857426|42201610|FG000|Overall Study|Study drug toxicity|4|||
19752271|NCT02857426|42201611|FG001|Overall Study|Study drug toxicity|1|||
19752272|NCT02857426|42201610|FG000|Overall Study|Death|1|||
19752273|NCT02857426|42201611|FG001|Overall Study|Death|0|||
19752274|NCT02857426|42201610|FG000|Overall Study|Adverse event unrelated to study drug|6|||
19752275|NCT02857426|42201611|FG001|Overall Study|Adverse event unrelated to study drug|2|||
19752276|NCT02857426|42201610|FG000|Overall Study|Participant withdrew consent|1|||
19752277|NCT02857426|42201611|FG001|Overall Study|Participant withdrew consent|1|||
19752278|NCT02857426|42201610|FG000|Overall Study|Maximum clinical benefit|1|||
19752279|NCT02857426|42201611|FG001|Overall Study|Maximum clinical benefit|0|||
19752280|NCT02857426|42201610|FG000|Overall Study|Completed treatment|0|||
19752281|NCT02857426|42201611|FG001|Overall Study|Completed treatment|2|||
19752282|NCT01127256|42201619|FG000|Overall Study|Adverse Event|13|||
19752283|NCT01127256|42201620|FG001|Overall Study|Adverse Event|13|||
19752284|NCT01127256|42201619|FG000|Overall Study|Lack of Efficacy|4|||
19752285|NCT01127256|42201620|FG001|Overall Study|Lack of Efficacy|0|||
19752286|NCT01127256|42201619|FG000|Overall Study|Lost to Follow-up|16|||
19752287|NCT01127256|42201620|FG001|Overall Study|Lost to Follow-up|17|||
19752288|NCT01127256|42201619|FG000|Overall Study|Withdrawal by Subject|5|||
19752289|NCT01127256|42201620|FG001|Overall Study|Withdrawal by Subject|9|||
19752290|NCT01127256|42201619|FG000|Overall Study|Protocol Violation|1|||
19752291|NCT01127256|42201620|FG001|Overall Study|Protocol Violation|0|||
19752292|NCT03668613|42201628|FG000|Overall Study|Adverse Event|0|||
19752293|NCT03668613|42201629|FG001|Overall Study|Adverse Event|2|||
19752294|NCT03668613|42201628|FG000|Overall Study|Lack of Efficacy|0|||
19752295|NCT03668613|42201629|FG001|Overall Study|Lack of Efficacy|1|||
19752296|NCT04016311|42201638|FG000|Overall Study|Withdrawal by Subject|1|||
19752297|NCT04016311|42201639|FG001|Overall Study|Withdrawal by Subject|0|||
19752298|NCT04052425|42201649|FG000|24-Week Double-blind Period|Adverse Event|0|||
19752299|NCT04052425|42201650|FG001|24-Week Double-blind Period|Adverse Event|1|||
19752300|NCT04052425|42201651|FG002|24-Week Double-blind Period|Adverse Event|0|||
19752301|NCT04052425|42201652|FG003|24-Week Double-blind Period|Adverse Event|0|||
19752302|NCT04052425|42201649|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
19752303|NCT04052425|42201650|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
19752304|NCT04052425|42201651|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
19752305|NCT04052425|42201652|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
19752306|NCT04052425|42201649|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
19752307|NCT04052425|42201650|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
19752308|NCT04052425|42201651|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
19752309|NCT04052425|42201652|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
19752310|NCT04052425|42201649|FG000|24-Week Double-blind Period|Physician Decision|1|||
19752311|NCT04052425|42201650|FG001|24-Week Double-blind Period|Physician Decision|0|||
19752312|NCT04052425|42201651|FG002|24-Week Double-blind Period|Physician Decision|0|||
19752313|NCT04052425|42201652|FG003|24-Week Double-blind Period|Physician Decision|0|||
19752314|NCT04052425|42201649|FG000|24-Week Double-blind Period|Protocol Violation|1|||
19752315|NCT04052425|42201650|FG001|24-Week Double-blind Period|Protocol Violation|0|||
19752316|NCT04052425|42201651|FG002|24-Week Double-blind Period|Protocol Violation|0|||
19752317|NCT04052425|42201652|FG003|24-Week Double-blind Period|Protocol Violation|0|||
19752318|NCT04052425|42201649|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
19752319|NCT04052425|42201650|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
19752320|NCT04052425|42201651|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
19752321|NCT04052425|42201652|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
19752322|NCT04052425|42201649|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
19752323|NCT04052425|42201650|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
19752324|NCT04052425|42201651|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
19752325|NCT04052425|42201652|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
19752326|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
19752327|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
19752328|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
19752329|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
19752330|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
19752331|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
19752332|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
19752333|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
19752334|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
19752335|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
19752336|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
19752337|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
19752338|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
19601567|NCT00770770|42050296|FG000|Overall Study|Withdrawal by Subject|1|||
19752339|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
19752340|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
19752341|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
19752342|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
19752343|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
19752344|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
19752345|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
19752346|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
19752347|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
19752348|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
19752349|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
19752350|NCT04052425|42201649|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
19752351|NCT04052425|42201650|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
19752352|NCT04052425|42201651|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
19752353|NCT04052425|42201652|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
19752354|NCT03235089|42201662|FG000|Overall Study|Lost to Follow-up|1|||
19752355|NCT03235089|42201663|FG001|Overall Study|Lost to Follow-up|1|||
19752356|NCT03235089|42201662|FG000|Overall Study|Physician Decision|2|||
19752357|NCT03235089|42201663|FG001|Overall Study|Physician Decision|2|||
19752358|NCT04013191|42201672|FG000|Overall Study|Adverse Event|1|||
19752359|NCT04013191|42201673|FG001|Overall Study|Adverse Event|0|||
19752360|NCT03285594|42201686|FG000|Overall Study|At the Participant's Own Request|10|||
19752361|NCT03285594|42201687|FG001|Overall Study|At the Participant's Own Request|5|||
19752362|NCT03285594|42201688|FG002|Overall Study|At the Participant's Own Request|21|||
19752363|NCT03285594|42201686|FG000|Overall Study|Adverse Event|2|||
19752364|NCT03285594|42201687|FG001|Overall Study|Adverse Event|2|||
19752365|NCT03285594|42201688|FG002|Overall Study|Adverse Event|6|||
19752366|NCT03285594|42201686|FG000|Overall Study|Poor Compliance to Protocol|0|||
19752367|NCT03285594|42201687|FG001|Overall Study|Poor Compliance to Protocol|0|||
19752368|NCT03285594|42201688|FG002|Overall Study|Poor Compliance to Protocol|1|||
19752369|NCT03285594|42201686|FG000|Overall Study|Lost to Follow-up|0|||
19752370|NCT03285594|42201687|FG001|Overall Study|Lost to Follow-up|0|||
19752371|NCT03285594|42201688|FG002|Overall Study|Lost to Follow-up|1|||
19752372|NCT03285594|42201686|FG000|Overall Study|Reason Not Specified|3|||
19752373|NCT03285594|42201687|FG001|Overall Study|Reason Not Specified|4|||
19752374|NCT03285594|42201688|FG002|Overall Study|Reason Not Specified|8|||
19752375|NCT03234465|42201699|FG000|Overall Study|Adverse Event|4|||
19752376|NCT03234465|42201700|FG001|Overall Study|Adverse Event|2|||
19752377|NCT03234465|42201699|FG000|Overall Study|Death|0|||
19752378|NCT03234465|42201700|FG001|Overall Study|Death|1|||
19752379|NCT03234465|42201699|FG000|Overall Study|Lost to Follow-up|1|||
19752380|NCT03234465|42201700|FG001|Overall Study|Lost to Follow-up|1|||
19752381|NCT03234465|42201699|FG000|Overall Study|Withdrawal by Subject|12|||
19752382|NCT03234465|42201700|FG001|Overall Study|Withdrawal by Subject|27|||
19752383|NCT03234465|42201699|FG000|Overall Study|Symptomatic deterioration|0|||
19752384|NCT03234465|42201700|FG001|Overall Study|Symptomatic deterioration|1|||
19752385|NCT03234465|42201699|FG000|Overall Study|Non-compliance|2|||
19752386|NCT03234465|42201700|FG001|Overall Study|Non-compliance|0|||
19752387|NCT03234465|42201699|FG000|Overall Study|Other|14|||
19752388|NCT03234465|42201700|FG001|Overall Study|Other|8|||
19752389|NCT03290131|42201709|FG000|Overall Study|Adverse Event|22|||
19752390|NCT03290131|42201710|FG001|Overall Study|Adverse Event|57|||
19752391|NCT03290131|42201711|FG002|Overall Study|Adverse Event|11|||
19752392|NCT03290131|42201709|FG000|Overall Study|Withdrawal by Subject|18|||
19752393|NCT03290131|42201710|FG001|Overall Study|Withdrawal by Subject|13|||
19752394|NCT03290131|42201711|FG002|Overall Study|Withdrawal by Subject|8|||
19752395|NCT03290131|42201709|FG000|Overall Study|MS Relapse|2|||
19752396|NCT03290131|42201710|FG001|Overall Study|MS Relapse|1|||
19752397|NCT03290131|42201711|FG002|Overall Study|MS Relapse|0|||
19752398|NCT03290131|42201709|FG000|Overall Study|Unknown reason|0|||
19752399|NCT03290131|42201710|FG001|Overall Study|Unknown reason|1|||
19752400|NCT03290131|42201711|FG002|Overall Study|Unknown reason|0|||
19752401|NCT04050865|42201722|FG000|Overall Study|Adverse Event|1|||
19752402|NCT04050865|42201723|FG001|Overall Study|Adverse Event|0|||
19752403|NCT04050865|42201722|FG000|Overall Study|no insert|1|||
19752404|NCT04050865|42201723|FG001|Overall Study|no insert|0|||
19752405|NCT04050865|42201722|FG000|Overall Study|Only 1 insert|2|||
19752406|NCT04050865|42201723|FG001|Overall Study|Only 1 insert|3|||
19752407|NCT04050865|42201722|FG000|Overall Study|Physician Decision|0|||
19752408|NCT04050865|42201723|FG001|Overall Study|Physician Decision|1|||
19752409|NCT04050865|42201722|FG000|Overall Study|Withdrawal by Subject|0|||
19752410|NCT04050865|42201723|FG001|Overall Study|Withdrawal by Subject|1|||
19752411|NCT03283566|42201731|FG000|Overall Study|Lost to Follow-up|1|||
19752412|NCT03283566|42201732|FG001|Overall Study|Lost to Follow-up|2|||
19752413|NCT03210519|42201740|FG000|Overall Study|Adverse Event|2|||
19752414|NCT03210519|42201741|FG001|Overall Study|Adverse Event|0|||
19752415|NCT04048681|42201747|FG000|Overall Study|family emergency|0|||
19752416|NCT04048681|42201748|FG001|Overall Study|family emergency|0|||
19752417|NCT04048681|42201749|FG002|Overall Study|family emergency|0|||
19752418|NCT04048681|42201750|FG003|Overall Study|family emergency|1|||
19752419|NCT04048681|42201751|FG004|Overall Study|family emergency|0|||
19752420|NCT04007107|42201759|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
19752421|NCT04007107|42201760|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
19752422|NCT04007107|42201761|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
19752423|NCT04007107|42201762|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
19752424|NCT04046341|42201767|FG000|Overall Study|Lost to Follow-up|2|||
19752425|NCT04046341|42201767|FG000|Overall Study|Withdrawal by Subject|1|||
19752426|NCT03233529|42201771|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
19752427|NCT03233529|42201771|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
19752428|NCT04006171|42201781|FG000|Overall Study|Withdrawal by Subject|8|||
19752429|NCT04006171|42201782|FG001|Overall Study|Withdrawal by Subject|7|||
19752430|NCT04006171|42201781|FG000|Overall Study|missing serum samples|2|||
19752431|NCT04006171|42201782|FG001|Overall Study|missing serum samples|2|||
19752432|NCT04006171|42201781|FG000|Overall Study|insufficient sample volume|2|||
19752433|NCT04006171|42201782|FG001|Overall Study|insufficient sample volume|3|||
19752434|NCT04043143|42201795|FG000|Overall Study|Lost to Follow-up|5|||
19752435|NCT04043143|42201796|FG001|Overall Study|Lost to Follow-up|5|||
19752436|NCT04043143|42201795|FG000|Overall Study|screen failure|1|||
19752437|NCT04043143|42201796|FG001|Overall Study|screen failure|0|||
19752438|NCT03283098|42201804|FG000|Overall Study|Withdrawal by Subject|0|||
19752439|NCT03283098|42201805|FG001|Overall Study|Withdrawal by Subject|1|||
19752440|NCT03655951|42201813|FG000|Overall Study|Lost to Follow-up|39|||
19752441|NCT03655951|42201814|FG001|Overall Study|Lost to Follow-up|20|||
19752442|NCT03655951|42201813|FG000|Overall Study|Withdrawal by Subject|0|||
19752443|NCT03655951|42201814|FG001|Overall Study|Withdrawal by Subject|1|||
19752444|NCT02527798|42201826|FG000|Overall Study|Physician Decision|1|||
19752445|NCT02527798|42201827|FG001|Overall Study|Physician Decision|0|||
19752446|NCT02527798|42201828|FG002|Overall Study|Physician Decision|1|||
19752447|NCT02527798|42201829|FG003|Overall Study|Physician Decision|1|||
19752448|NCT02527798|42201830|FG004|Overall Study|Physician Decision|0|||
19752449|NCT02527798|42201831|FG005|Overall Study|Physician Decision|0|||
19752450|NCT02527798|42201826|FG000|Overall Study|Death|0|||
19752451|NCT02527798|42201827|FG001|Overall Study|Death|0|||
19752452|NCT02527798|42201828|FG002|Overall Study|Death|1|||
19752453|NCT02527798|42201829|FG003|Overall Study|Death|0|||
19752454|NCT02527798|42201830|FG004|Overall Study|Death|0|||
19752455|NCT02527798|42201831|FG005|Overall Study|Death|0|||
19752456|NCT02527798|42201826|FG000|Overall Study|Withdrawal by Subject|0|||
19752457|NCT02527798|42201827|FG001|Overall Study|Withdrawal by Subject|1|||
19752458|NCT02527798|42201828|FG002|Overall Study|Withdrawal by Subject|2|||
19752459|NCT02527798|42201829|FG003|Overall Study|Withdrawal by Subject|0|||
19752460|NCT02527798|42201830|FG004|Overall Study|Withdrawal by Subject|0|||
19752461|NCT02527798|42201831|FG005|Overall Study|Withdrawal by Subject|0|||
19752462|NCT02527798|42201826|FG000|Overall Study|Reason undisclosed|1|||
19752463|NCT02527798|42201827|FG001|Overall Study|Reason undisclosed|0|||
19752464|NCT02527798|42201828|FG002|Overall Study|Reason undisclosed|1|||
19752465|NCT02527798|42201829|FG003|Overall Study|Reason undisclosed|0|||
19752466|NCT02527798|42201830|FG004|Overall Study|Reason undisclosed|0|||
19752467|NCT02527798|42201831|FG005|Overall Study|Reason undisclosed|0|||
19752468|NCT02527798|42201826|FG000|Overall Study|Did not receive intervention|1|||
19752469|NCT02527798|42201827|FG001|Overall Study|Did not receive intervention|1|||
19752470|NCT02527798|42201828|FG002|Overall Study|Did not receive intervention|0|||
19752471|NCT02527798|42201829|FG003|Overall Study|Did not receive intervention|0|||
19752472|NCT02527798|42201830|FG004|Overall Study|Did not receive intervention|0|||
19752473|NCT02527798|42201831|FG005|Overall Study|Did not receive intervention|0|||
19752474|NCT03188991|42201862|FG000|Overall Study|Withdrawal by Subject|0|||
19752475|NCT03188991|42201863|FG001|Overall Study|Withdrawal by Subject|0|||
19752476|NCT03188991|42201864|FG002|Overall Study|Withdrawal by Subject|0|||
19601568|NCT00770770|42050297|FG001|Overall Study|Withdrawal by Subject|0|||
19601569|NCT00770770|42050296|FG000|Overall Study|Death|0|||
19752477|NCT03188991|42201865|FG003|Overall Study|Withdrawal by Subject|1|||
19752478|NCT03857542|42201877|FG000|Overall Study|Adverse Event|1|||
19752479|NCT03857542|42201878|FG001|Overall Study|Adverse Event|3|||
19752480|NCT03857542|42201877|FG000|Overall Study|Withdrawal by Subject|2|||
19752481|NCT03857542|42201878|FG001|Overall Study|Withdrawal by Subject|1|||
19752482|NCT03857542|42201877|FG000|Overall Study|Lost to Follow-up|2|||
19752483|NCT03857542|42201878|FG001|Overall Study|Lost to Follow-up|1|||
19752484|NCT03857542|42201877|FG000|Overall Study|Reason not Specified|1|||
19752485|NCT03857542|42201878|FG001|Overall Study|Reason not Specified|0|||
19752486|NCT03209973|42201885|FG000|Overall Study|Withdrawal by Subject|7|||
19752487|NCT03209973|42201885|FG000|Overall Study|Lost to Follow-up|2|||
19752488|NCT03209973|42201885|FG000|Overall Study|Death|8|||
19752489|NCT03209973|42201885|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
19752490|NCT03209973|42201885|FG000|Overall Study|Sponsor Decision|18|||
19752491|NCT03209973|42201885|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
19752492|NCT03209973|42201885|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
19752493|NCT03751631|42201891|FG000|Overall Study|Withdrawal by Subject|0|||
19752494|NCT03751631|42201892|FG001|Overall Study|Withdrawal by Subject|0|||
19752495|NCT03751631|42201893|FG002|Overall Study|Withdrawal by Subject|1|||
19752496|NCT03751631|42201894|FG003|Overall Study|Withdrawal by Subject|1|||
19752497|NCT03751631|42201895|FG004|Overall Study|Withdrawal by Subject|0|||
19752498|NCT03751631|42201896|FG005|Overall Study|Withdrawal by Subject|0|||
19752499|NCT03688711|42201909|FG000|Overall Study|Withdrawal by Subject|0|||
19752500|NCT03688711|42201910|FG001|Overall Study|Withdrawal by Subject|1|||
19752501|NCT03188055|42201918|FG000|Overall Study|Unavailable for training|0|||
19752502|NCT03188055|42201919|FG001|Overall Study|Unavailable for training|0|||
19752503|NCT03188055|42201920|FG002|Overall Study|Unavailable for training|19|||
19752504|NCT03188055|42201921|FG003|Overall Study|Unavailable for training|0|||
19752505|NCT03188055|42201922|FG004|Overall Study|Unavailable for training|0|||
19752506|NCT03188055|42201923|FG005|Overall Study|Unavailable for training||||
19752507|NCT03188055|42201918|FG000|Overall Study|Lost to Follow-up|0|||
19752508|NCT03188055|42201919|FG001|Overall Study|Lost to Follow-up|18|||
19752509|NCT03188055|42201920|FG002|Overall Study|Lost to Follow-up|0|||
19752510|NCT03188055|42201921|FG003|Overall Study|Lost to Follow-up|11|||
19752511|NCT03188055|42201922|FG004|Overall Study|Lost to Follow-up|0|||
19752512|NCT03188055|42201923|FG005|Overall Study|Lost to Follow-up||||
19752513|NCT03188055|42201918|FG000|Overall Study|Withdrawal by Subject|0|||
19752514|NCT03188055|42201919|FG001|Overall Study|Withdrawal by Subject|1|||
19752515|NCT03188055|42201920|FG002|Overall Study|Withdrawal by Subject|0|||
19752516|NCT03188055|42201921|FG003|Overall Study|Withdrawal by Subject|1|||
19752517|NCT03188055|42201922|FG004|Overall Study|Withdrawal by Subject|0|||
19752518|NCT03188055|42201923|FG005|Overall Study|Withdrawal by Subject||||
19752519|NCT04035577|42201934|FG000|Overall Study|Lost to Follow-up|1|||
19752520|NCT04035577|42201934|FG000|Overall Study|Withdrawal by Subject|1|||
19752521|NCT03655717|42201962|FG000|Overall Study|Withdrawal by Subject|4|||
19752522|NCT03655717|42201963|FG001|Overall Study|Withdrawal by Subject|8|||
19752523|NCT03655717|42201964|FG002|Overall Study|Withdrawal by Subject|1|||
19752524|NCT03655717|42201965|FG003|Overall Study|Withdrawal by Subject|0|||
19752525|NCT03655717|42201966|FG004|Overall Study|Withdrawal by Subject|0|||
19752526|NCT03655717|42201967|FG005|Overall Study|Withdrawal by Subject|1|||
19752527|NCT03655717|42201968|FG006|Overall Study|Withdrawal by Subject|3|||
19752528|NCT03655717|42201969|FG007|Overall Study|Withdrawal by Subject|1|||
19752529|NCT03655717|42201970|FG008|Overall Study|Withdrawal by Subject|2|||
19752530|NCT03655717|42201971|FG009|Overall Study|Withdrawal by Subject|0|||
19752531|NCT03655717|42201972|FG010|Overall Study|Withdrawal by Subject|0|||
19752532|NCT03655717|42201973|FG011|Overall Study|Withdrawal by Subject|1|||
19752533|NCT03655717|42201974|FG012|Overall Study|Withdrawal by Subject|0|||
19752534|NCT03655717|42201975|FG013|Overall Study|Withdrawal by Subject|3|||
19752535|NCT03655717|42201976|FG014|Overall Study|Withdrawal by Subject|0|||
19752536|NCT03655717|42201977|FG015|Overall Study|Withdrawal by Subject|1|||
19752537|NCT03655717|42201978|FG016|Overall Study|Withdrawal by Subject|0|||
19752538|NCT03655717|42201979|FG017|Overall Study|Withdrawal by Subject|0|||
19752539|NCT03655717|42201980|FG018|Overall Study|Withdrawal by Subject|1|||
19752540|NCT03655717|42201981|FG019|Overall Study|Withdrawal by Subject|0|||
19752541|NCT03655717|42201982|FG020|Overall Study|Withdrawal by Subject|0|||
19752542|NCT03655717|42201983|FG021|Overall Study|Withdrawal by Subject|1|||
19752543|NCT03655717|42201984|FG022|Overall Study|Withdrawal by Subject|2|||
19752544|NCT03655717|42201985|FG023|Overall Study|Withdrawal by Subject|1|||
19752545|NCT03655717|42201986|FG024|Overall Study|Withdrawal by Subject|1|||
19752546|NCT03655717|42201987|FG025|Overall Study|Withdrawal by Subject|0|||
19752547|NCT03655717|42201962|FG000|Overall Study|Physician Decision|3|||
19752548|NCT03655717|42201963|FG001|Overall Study|Physician Decision|3|||
19752549|NCT03655717|42201964|FG002|Overall Study|Physician Decision|0|||
19601570|NCT00770770|42050297|FG001|Overall Study|Death|1|||
19752550|NCT03655717|42201965|FG003|Overall Study|Physician Decision|0|||
19752551|NCT03655717|42201966|FG004|Overall Study|Physician Decision|0|||
19752552|NCT03655717|42201967|FG005|Overall Study|Physician Decision|0|||
19752553|NCT03655717|42201968|FG006|Overall Study|Physician Decision|0|||
19752554|NCT03655717|42201969|FG007|Overall Study|Physician Decision|0|||
19752555|NCT03655717|42201970|FG008|Overall Study|Physician Decision|0|||
19752556|NCT03655717|42201971|FG009|Overall Study|Physician Decision|1|||
19752557|NCT03655717|42201972|FG010|Overall Study|Physician Decision|0|||
19752558|NCT03655717|42201973|FG011|Overall Study|Physician Decision|0|||
19752559|NCT03655717|42201974|FG012|Overall Study|Physician Decision|0|||
19752560|NCT03655717|42201975|FG013|Overall Study|Physician Decision|0|||
19752561|NCT03655717|42201976|FG014|Overall Study|Physician Decision|0|||
19752562|NCT03655717|42201977|FG015|Overall Study|Physician Decision|0|||
19752563|NCT03655717|42201978|FG016|Overall Study|Physician Decision|0|||
19752564|NCT03655717|42201979|FG017|Overall Study|Physician Decision|0|||
19752565|NCT03655717|42201980|FG018|Overall Study|Physician Decision|0|||
19752566|NCT03655717|42201981|FG019|Overall Study|Physician Decision|1|||
19752567|NCT03655717|42201982|FG020|Overall Study|Physician Decision|0|||
19752568|NCT03655717|42201983|FG021|Overall Study|Physician Decision|0|||
19752569|NCT03655717|42201984|FG022|Overall Study|Physician Decision|0|||
19752570|NCT03655717|42201985|FG023|Overall Study|Physician Decision|1|||
19752571|NCT03655717|42201986|FG024|Overall Study|Physician Decision|0|||
19752572|NCT03655717|42201987|FG025|Overall Study|Physician Decision|0|||
19752573|NCT03655717|42201962|FG000|Overall Study|Lost to Follow-up|3|||
19752574|NCT03655717|42201963|FG001|Overall Study|Lost to Follow-up|1|||
19752575|NCT03655717|42201964|FG002|Overall Study|Lost to Follow-up|0|||
19752576|NCT03655717|42201965|FG003|Overall Study|Lost to Follow-up|1|||
19752577|NCT03655717|42201966|FG004|Overall Study|Lost to Follow-up|0|||
19752578|NCT03655717|42201967|FG005|Overall Study|Lost to Follow-up|1|||
19752579|NCT03655717|42201968|FG006|Overall Study|Lost to Follow-up|0|||
19752580|NCT03655717|42201969|FG007|Overall Study|Lost to Follow-up|0|||
19752581|NCT03655717|42201970|FG008|Overall Study|Lost to Follow-up|0|||
19752582|NCT03655717|42201971|FG009|Overall Study|Lost to Follow-up|0|||
19752583|NCT03655717|42201972|FG010|Overall Study|Lost to Follow-up|0|||
19752584|NCT03655717|42201973|FG011|Overall Study|Lost to Follow-up|1|||
19752585|NCT03655717|42201974|FG012|Overall Study|Lost to Follow-up|0|||
19752586|NCT03655717|42201975|FG013|Overall Study|Lost to Follow-up|0|||
19752587|NCT03655717|42201976|FG014|Overall Study|Lost to Follow-up|0|||
19752588|NCT03655717|42201977|FG015|Overall Study|Lost to Follow-up|0|||
19752589|NCT03655717|42201978|FG016|Overall Study|Lost to Follow-up|0|||
19752590|NCT03655717|42201979|FG017|Overall Study|Lost to Follow-up|0|||
19752591|NCT03655717|42201980|FG018|Overall Study|Lost to Follow-up|0|||
19752592|NCT03655717|42201981|FG019|Overall Study|Lost to Follow-up|0|||
19752593|NCT03655717|42201982|FG020|Overall Study|Lost to Follow-up|0|||
19752594|NCT03655717|42201983|FG021|Overall Study|Lost to Follow-up|0|||
19752595|NCT03655717|42201984|FG022|Overall Study|Lost to Follow-up|0|||
19752596|NCT03655717|42201985|FG023|Overall Study|Lost to Follow-up|0|||
19752597|NCT03655717|42201986|FG024|Overall Study|Lost to Follow-up|0|||
19752598|NCT03655717|42201987|FG025|Overall Study|Lost to Follow-up|0|||
19752599|NCT04032613|42202003|FG000|Overall Study|Did not complete post-program assessment|5|||
19752600|NCT04032613|42202004|FG001|Overall Study|Did not complete post-program assessment|2|||
19752601|NCT04000165|42202010|FG000|Overall Study|Physician Decision|1|||
19752602|NCT04000165|42202010|FG000|Overall Study|Withdrawal by Subject|1|||
19752603|NCT03187197|42202017|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
19752604|NCT03187197|42202018|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
19752605|NCT03187197|42202019|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
19752606|NCT03187197|42202017|FG000|Overall Study|Withdrawal by Subject|8|||
19752607|NCT03187197|42202018|FG001|Overall Study|Withdrawal by Subject|63|||
19752608|NCT03187197|42202019|FG002|Overall Study|Withdrawal by Subject|4|||
19752609|NCT03187197|42202017|FG000|Overall Study|Lost to Follow-up|1|||
19752610|NCT03187197|42202018|FG001|Overall Study|Lost to Follow-up|60|||
19752611|NCT03187197|42202019|FG002|Overall Study|Lost to Follow-up|7|||
19752612|NCT03187197|42202017|FG000|Overall Study|Adverse Event|6|||
19752613|NCT03187197|42202018|FG001|Overall Study|Adverse Event|29|||
19752614|NCT03187197|42202019|FG002|Overall Study|Adverse Event|0|||
19752615|NCT03187197|42202017|FG000|Overall Study|Death|0|||
19752616|NCT03187197|42202018|FG001|Overall Study|Death|11|||
19752617|NCT03187197|42202019|FG002|Overall Study|Death|0|||
19752618|NCT03187197|42202017|FG000|Overall Study|Administrative problem|1|||
19752619|NCT03187197|42202018|FG001|Overall Study|Administrative problem|1|||
19752620|NCT03187197|42202019|FG002|Overall Study|Administrative problem|0|||
19752621|NCT03187197|42202017|FG000|Overall Study|Reason not listed|2|||
19752622|NCT03187197|42202018|FG001|Overall Study|Reason not listed|54|||
19601571|NCT00770770|42050296|FG000|Overall Study|Study Terminated|8|||
19752623|NCT03187197|42202019|FG002|Overall Study|Reason not listed|1|||
19752624|NCT03187197|42202017|FG000|Overall Study|Missing|1|||
19752625|NCT03187197|42202018|FG001|Overall Study|Missing|32|||
19752626|NCT03187197|42202019|FG002|Overall Study|Missing|3|||
19752627|NCT03187197|42202017|FG000|Overall Study|Status missing|2|||
19752628|NCT03187197|42202018|FG001|Overall Study|Status missing|33|||
19752629|NCT03187197|42202019|FG002|Overall Study|Status missing|3|||
19752630|NCT03187197|42202017|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
19752631|NCT03187197|42202018|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
19752632|NCT03187197|42202019|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
19752633|NCT04000009|42202027|FG000|Overall Study|Adverse Event|13|||
19752634|NCT04000009|42202027|FG000|Overall Study|Lack of Efficacy|7|||
19752635|NCT04000009|42202027|FG000|Overall Study|Lost to Follow-up|8|||
19752636|NCT04000009|42202027|FG000|Overall Study|Noncompliance with study drug|4|||
19752637|NCT04000009|42202027|FG000|Overall Study|Physician Decision|1|||
19752638|NCT04000009|42202027|FG000|Overall Study|Use of prohibited medication|3|||
19752639|NCT04000009|42202027|FG000|Overall Study|Pregnancy|1|||
19752640|NCT04000009|42202027|FG000|Overall Study|Withdrawal by Subject|22|||
19752641|NCT04000009|42202027|FG000|Overall Study|Study terminated by sponsor|98|||
19752642|NCT04000009|42202027|FG000|Overall Study|Not further specified|8|||
19752643|NCT03282240|42202034|FG000|Overall Study|Adverse Event|2|||
19752644|NCT03282240|42202035|FG001|Overall Study|Adverse Event|2|||
19752645|NCT03282240|42202036|FG002|Overall Study|Adverse Event|0|||
19752646|NCT03282240|42202034|FG000|Overall Study|Lost to Follow-up|3|||
19752647|NCT03282240|42202035|FG001|Overall Study|Lost to Follow-up|0|||
19752648|NCT03282240|42202036|FG002|Overall Study|Lost to Follow-up|0|||
19752649|NCT03282240|42202034|FG000|Overall Study|Protocol Deviation|4|||
19752650|NCT03282240|42202035|FG001|Overall Study|Protocol Deviation|1|||
19752651|NCT03282240|42202036|FG002|Overall Study|Protocol Deviation|2|||
19752652|NCT03282240|42202034|FG000|Overall Study|Withdrawal by Subject|1|||
19752653|NCT03282240|42202035|FG001|Overall Study|Withdrawal by Subject|0|||
19752654|NCT03282240|42202036|FG002|Overall Study|Withdrawal by Subject|1|||
19752655|NCT03185949|42202049|FG000|ITT Analysis|Withdrawal by Subject|4|||
19752656|NCT03185949|42202050|FG001|ITT Analysis|Withdrawal by Subject|3|||
19752657|NCT03185949|42202049|FG000|PP Analysis|Protocol Violation|2|||
19752658|NCT03185949|42202050|FG001|PP Analysis|Protocol Violation|2|||
19752659|NCT03185949|42202049|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
19752660|NCT03185949|42202050|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
19752661|NCT03655405|42202060|FG000|Overall Study|Death after initial data collection|4|||
19752662|NCT03655405|42202061|FG001|Overall Study|Death after initial data collection|2|||
19752663|NCT03655405|42202060|FG000|Overall Study|Died before initial data collection|1|||
19752664|NCT03655405|42202061|FG001|Overall Study|Died before initial data collection|2|||
19752665|NCT03655405|42202060|FG000|Overall Study|Protocol Violation|0|||
19752666|NCT03655405|42202061|FG001|Overall Study|Protocol Violation|1|||
19752667|NCT03510598|42202067|FG000|Overall Study|Withdrawal by Subject|1|||
19752668|NCT03222141|42202071|FG000|Overall Study|Death|15|||
19752669|NCT03222141|42202071|FG000|Overall Study|Lost to Follow-up|3|||
19752670|NCT04029961|42202078|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
19752671|NCT04029961|42202079|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
19752672|NCT04029961|42202078|FG000|Overall Study|Change in Treatment Course|0|||
19752673|NCT04029961|42202079|FG001|Overall Study|Change in Treatment Course|1|||
19752674|NCT03997825|42202085|FG000|Overall Study|Death|3|||
19752675|NCT03997825|42202085|FG000|Overall Study|Lost to Follow-up|10|||
19752676|NCT03997825|42202085|FG000|Overall Study|Withdrawal by Subject|3|||
19752677|NCT03997825|42202085|FG000|Overall Study|Refused participation|1|||
19752678|NCT04024891|42202091|FG000|Overall Study|Pregnancy|0|||
19752679|NCT04024891|42202092|FG001|Overall Study|Pregnancy|1|||
19752680|NCT03250182|42202098|FG000|Overall Study|Withdrawal by Subject|1|||
19752681|NCT03993379|42202106|FG000|Overall Study|The study was terminated early due to business decision.|0|||
19752682|NCT03993379|42202107|FG001|Overall Study|The study was terminated early due to business decision.|2|||
19752683|NCT03993379|42202108|FG002|Overall Study|The study was terminated early due to business decision.|0|||
19752684|NCT03993379|42202109|FG003|Overall Study|The study was terminated early due to business decision.|0|||
19752685|NCT03993379|42202106|FG000|Overall Study|Withdrawal by Subject|0|||
19752686|NCT03993379|42202107|FG001|Overall Study|Withdrawal by Subject|1|||
19752687|NCT03993379|42202108|FG002|Overall Study|Withdrawal by Subject|0|||
19752688|NCT03993379|42202109|FG003|Overall Study|Withdrawal by Subject|0|||
19752689|NCT03370120|42202119|FG000|Overall Study|Adverse event, non-fatal|24|||
19752690|NCT03370120|42202119|FG000|Overall Study|Withdrawal by Subject|6|||
19752691|NCT03370120|42202119|FG000|Overall Study|Lost to Follow-up|1|||
19752692|NCT03370120|42202119|FG000|Overall Study|Lack of Efficacy|37|||
19752693|NCT03370120|42202119|FG000|Overall Study|Per sponsor's instructions|1|||
19752694|NCT03370120|42202119|FG000|Overall Study|Study was terminated by parent company UCB|2|||
19752695|NCT03370120|42202119|FG000|Overall Study|The study was ended by the promoter|3|||
19752696|NCT03370120|42202119|FG000|Overall Study|Discontinuation of drug development|3|||
19752697|NCT03370120|42202119|FG000|Overall Study|End of project|2|||
19752698|NCT03370120|42202119|FG000|Overall Study|Premature study closure|2|||
19752699|NCT03370120|42202119|FG000|Overall Study|Premature program termination|1|||
19752700|NCT03370120|42202119|FG000|Overall Study|Premature study termination|7|||
19752701|NCT03370120|42202119|FG000|Overall Study|Trial terminated by sponsor|2|||
19752702|NCT03370120|42202119|FG000|Overall Study|Trial discontinued by sponsor|2|||
19752703|NCT03370120|42202119|FG000|Overall Study|Study ended|15|||
19752704|NCT03370120|42202119|FG000|Overall Study|Clinical trial has been cancelled|1|||
19752705|NCT03370120|42202119|FG000|Overall Study|End of study per sponsor decision|2|||
19752706|NCT03370120|42202119|FG000|Overall Study|Promoter's decision|2|||
19752707|NCT03370120|42202119|FG000|Overall Study|The trial has been suspended|3|||
19752708|NCT03370120|42202119|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
19752709|NCT03370120|42202119|FG000|Overall Study|Early termination by order of sponsor|2|||
19752710|NCT03370120|42202119|FG000|Overall Study|Discontinuation of the study|5|||
19752711|NCT03370120|42202119|FG000|Overall Study|End of clinical trial discontinuation|1|||
19752712|NCT03370120|42202119|FG000|Overall Study|Because the clinical trial ended halfway|4|||
19752713|NCT03370120|42202119|FG000|Overall Study|Development discontinued|5|||
19752714|NCT03370120|42202119|FG000|Overall Study|Padsenovil program closed|3|||
19752715|NCT03370120|42202119|FG000|Overall Study|End of project|2|||
19752716|NCT03370120|42202119|FG000|Overall Study|Termination of project|1|||
19752717|NCT03370120|42202119|FG000|Overall Study|The study was interrupted by sponsor|4|||
19752718|NCT03370120|42202119|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
19752719|NCT03370120|42202119|FG000|Overall Study|End of sponsor decision|1|||
19752720|NCT03370120|42202119|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
19752721|NCT03370120|42202119|FG000|Overall Study|Early termination of studies|5|||
19752722|NCT03370120|42202119|FG000|Overall Study|This study is ended early|1|||
19752723|NCT03370120|42202119|FG000|Overall Study|End of padsevonil program|2|||
19752724|NCT03370120|42202119|FG000|Overall Study|Decision of sponsor|6|||
19752725|NCT03370120|42202119|FG000|Overall Study|Asked by the sponsor|3|||
19752726|NCT03370120|42202119|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
19752727|NCT03370120|42202119|FG000|Overall Study|PI decision poor compliance from participant|1|||
19752728|NCT03370120|42202119|FG000|Overall Study|Promoter ended the study|3|||
19752729|NCT03370120|42202119|FG000|Overall Study|Premature study close by sponsor's decision|4|||
19752730|NCT03370120|42202119|FG000|Overall Study|Study terminated by sponsor|33|||
19752731|NCT03370120|42202119|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
19752732|NCT03370120|42202119|FG000|Overall Study|Sponsor decision to terminate study|63|||
19752733|NCT03370120|42202119|FG000|Overall Study|Program closure|3|||
19752734|NCT03370120|42202119|FG000|Overall Study|Study ended prematurely|1|||
19752735|NCT03370120|42202119|FG000|Overall Study|Study stopped by sponsor|2|||
19752736|NCT03370120|42202119|FG000|Overall Study|Program termination|55|||
19752737|NCT03370120|42202119|FG000|Overall Study|Sponsor decision|62|||
19752738|NCT03370120|42202119|FG000|Overall Study|Sponsor study closure|10|||
19752739|NCT03247686|42202127|FG000|Overall Study|Withdrawal by Subject|1|||
19752740|NCT03247686|42202128|FG001|Overall Study|Withdrawal by Subject|2|||
19752741|NCT03990649|42202139|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
19752742|NCT03990649|42202140|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
19752743|NCT03990649|42202141|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
19752744|NCT03990649|42202139|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
19752745|NCT03990649|42202140|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
19752746|NCT03990649|42202141|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
19752747|NCT03990649|42202139|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
19752748|NCT03990649|42202140|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
19752749|NCT03990649|42202141|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
19752750|NCT03990649|42202139|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
19752751|NCT03990649|42202140|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
19752752|NCT03990649|42202141|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
19752753|NCT03990649|42202139|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
19752754|NCT03990649|42202140|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
19752755|NCT03990649|42202141|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
19752756|NCT03990649|42202139|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
19752757|NCT03990649|42202140|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
19752758|NCT03990649|42202141|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
19752759|NCT03990649|42202139|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
19752760|NCT03990649|42202140|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
19752761|NCT03990649|42202141|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
19752762|NCT03220737|42202155|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
19752763|NCT03220737|42202156|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
19752764|NCT03220737|42202157|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
19752765|NCT03220737|42202158|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
19752766|NCT03220737|42202159|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
19752767|NCT03220737|42202160|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
19752768|NCT03220737|42202161|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
19752769|NCT03220737|42202155|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
19601572|NCT00770770|42050297|FG001|Overall Study|Study Terminated|0|||
19752770|NCT03220737|42202156|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
19752771|NCT03220737|42202157|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
19752772|NCT03220737|42202158|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
19752773|NCT03220737|42202159|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
19752774|NCT03220737|42202160|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
19752775|NCT03220737|42202161|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
19752776|NCT03220737|42202155|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
19752777|NCT03220737|42202156|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
19752778|NCT03220737|42202157|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
19752779|NCT03220737|42202158|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
19752780|NCT03220737|42202159|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
19752781|NCT03220737|42202160|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
19752782|NCT03220737|42202161|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
19752783|NCT03220737|42202155|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752784|NCT03220737|42202156|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752785|NCT03220737|42202157|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
19752786|NCT03220737|42202158|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752787|NCT03220737|42202159|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752788|NCT03220737|42202160|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752789|NCT03220737|42202161|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
19752790|NCT03220737|42202155|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752791|NCT03220737|42202156|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752792|NCT03220737|42202157|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752793|NCT03220737|42202158|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752794|NCT03220737|42202159|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
19752795|NCT03220737|42202160|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752796|NCT03220737|42202161|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
19752797|NCT03220737|42202155|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
19752798|NCT03220737|42202156|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752799|NCT03220737|42202157|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752800|NCT03220737|42202158|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752801|NCT03220737|42202159|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752802|NCT03220737|42202160|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752803|NCT03220737|42202161|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
19752804|NCT03220737|42202155|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
19752805|NCT03220737|42202156|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752806|NCT03220737|42202157|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752807|NCT03220737|42202158|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752808|NCT03220737|42202159|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752809|NCT03220737|42202160|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752810|NCT03220737|42202161|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
19752811|NCT03220737|42202155|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
19752812|NCT03220737|42202156|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752813|NCT03220737|42202157|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752814|NCT03220737|42202158|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752815|NCT03220737|42202159|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752816|NCT03220737|42202160|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752817|NCT03220737|42202161|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
19752818|NCT03185481|42202183|FG000|Overall Study|Adverse Event|1|||
19752819|NCT03185481|42202183|FG000|Overall Study|Study Terminated by Sponsor|4|||
19752820|NCT03652675|42202189|FG000|Overall Study|Lost to Follow-up|4|||
19752821|NCT03652675|42202190|FG001|Overall Study|Lost to Follow-up|4|||
19752822|NCT03241368|42202196|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
19752823|NCT03241368|42202196|FG000|Overall Study|Lost to Follow-up|1|||
19752824|NCT03241368|42202196|FG000|Overall Study|Physician Decision|6|||
19752825|NCT03241368|42202196|FG000|Overall Study|Withdrawal by Subject|6|||
19752826|NCT03241368|42202196|FG000|Overall Study|Protocol Violation|1|||
19752827|NCT03220581|42202203|FG000|Overall Study|Withdrawal by Subject|0|||
19752828|NCT03220581|42202204|FG001|Overall Study|Withdrawal by Subject|1|||
19752829|NCT03220581|42202203|FG000|Overall Study|Lost to Follow-up|3|||
19752830|NCT03220581|42202204|FG001|Overall Study|Lost to Follow-up|6|||
19752831|NCT02954575|42202212|FG000|Overall Study|Withdrawal by Subject|2|||
19752832|NCT02954575|42202212|FG000|Overall Study|Adverse Event|1|||
19752833|NCT03184701|42202220|FG000|Overall Study|Death|3|||
19752834|NCT03184701|42202220|FG000|Overall Study|Physician Decision|3|||
19752835|NCT03184701|42202220|FG000|Overall Study|Withdrawal by Subject|6|||
19752836|NCT03184701|42202220|FG000|Overall Study|Lost to Follow-up|5|||
19752837|NCT03247530|42202227|FG000|Overall Study|Withdrawal by caregiver|19|||
19752838|NCT03247530|42202228|FG001|Overall Study|Withdrawal by caregiver|8|||
19752839|NCT03247530|42202229|FG002|Overall Study|Withdrawal by caregiver|10|||
19752840|NCT03247530|42202227|FG000|Overall Study|Lost to Follow-up|3|||
19752841|NCT03247530|42202228|FG001|Overall Study|Lost to Follow-up|9|||
19752842|NCT03247530|42202229|FG002|Overall Study|Lost to Follow-up|6|||
19752843|NCT03247530|42202227|FG000|Overall Study|Adverse Event|2|||
19752844|NCT03247530|42202228|FG001|Overall Study|Adverse Event|5|||
19653830|NCT00740051|42103223|FG001|Overall Study|Other reason (not specified)|1|||
19653831|NCT00518986|42103232|FG000|Overall Study|Adverse Event|12|||
19653832|NCT00518986|42103233|FG001|Overall Study|Adverse Event|7|||
19752845|NCT03247530|42202229|FG002|Overall Study|Adverse Event|2|||
19752846|NCT03247530|42202227|FG000|Overall Study|Failure to follow procedure|1|||
19752847|NCT03247530|42202228|FG001|Overall Study|Failure to follow procedure|1|||
19752848|NCT03247530|42202229|FG002|Overall Study|Failure to follow procedure|1|||
19752849|NCT03247530|42202227|FG000|Overall Study|Withdrawal by Subject|1|||
19752850|NCT03247530|42202228|FG001|Overall Study|Withdrawal by Subject|1|||
19752851|NCT03247530|42202229|FG002|Overall Study|Withdrawal by Subject|0|||
19752852|NCT03247530|42202227|FG000|Overall Study|Study medication misuse|0|||
19752853|NCT03247530|42202228|FG001|Overall Study|Study medication misuse|1|||
19752854|NCT03247530|42202229|FG002|Overall Study|Study medication misuse|0|||
19752855|NCT03247530|42202227|FG000|Overall Study|Other, multiple categories|1|||
19752856|NCT03247530|42202228|FG001|Overall Study|Other, multiple categories|3|||
19752857|NCT03247530|42202229|FG002|Overall Study|Other, multiple categories|1|||
19752858|NCT03246672|42202240|FG000|Overall Study|Lost to Follow-up|2|||
19752859|NCT03983317|42202244|FG000|Overall Study|Physician Decision|5|||
19752860|NCT03207243|42202250|FG000|Overall Study|Adverse Event|2|||
19752861|NCT03207243|42202251|FG001|Overall Study|Adverse Event|2|||
19752862|NCT03207243|42202250|FG000|Overall Study|Loss of Asthma Control|47|||
19752863|NCT03207243|42202251|FG001|Overall Study|Loss of Asthma Control|31|||
19752864|NCT03207243|42202250|FG000|Overall Study|Withdrawal by Subject|2|||
19752865|NCT03207243|42202251|FG001|Overall Study|Withdrawal by Subject|4|||
19752866|NCT03207243|42202250|FG000|Overall Study|Physician Decision|1|||
19752867|NCT03207243|42202251|FG001|Overall Study|Physician Decision|1|||
19752868|NCT03207243|42202250|FG000|Overall Study|Lost to Follow-up|0|||
19752869|NCT03207243|42202251|FG001|Overall Study|Lost to Follow-up|1|||
19752870|NCT03207243|42202250|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
19752871|NCT03207243|42202251|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
19752872|NCT03207243|42202250|FG000|Overall Study|Protocol Violation|0|||
19752873|NCT03207243|42202251|FG001|Overall Study|Protocol Violation|3|||
19752874|NCT03982069|42202262|FG000|Overall Study|Lost to Follow-up|5|||
19752875|NCT03982069|42202263|FG001|Overall Study|Lost to Follow-up|5|||
19653833|NCT00518986|42103232|FG000|Overall Study|Lack of Efficacy|0|||
19752876|NCT03982069|42202264|FG002|Overall Study|Lost to Follow-up|3|||
19752877|NCT03982069|42202265|FG003|Overall Study|Lost to Follow-up|5|||
19752878|NCT03982069|42202262|FG000|Overall Study|Physician Decision|0|||
19752879|NCT03982069|42202263|FG001|Overall Study|Physician Decision|1|||
19752880|NCT03982069|42202264|FG002|Overall Study|Physician Decision|0|||
19752881|NCT03982069|42202265|FG003|Overall Study|Physician Decision|0|||
19752882|NCT03982069|42202262|FG000|Overall Study|Withdrawal by Subject|2|||
19752883|NCT03982069|42202263|FG001|Overall Study|Withdrawal by Subject|1|||
19752884|NCT03982069|42202264|FG002|Overall Study|Withdrawal by Subject|5|||
19752885|NCT03982069|42202265|FG003|Overall Study|Withdrawal by Subject|2|||
19653834|NCT00518986|42103233|FG001|Overall Study|Lack of Efficacy|2|||
19752886|NCT03982069|42202262|FG000|Overall Study|Specimen loss|3|||
19653835|NCT00518986|42103232|FG000|Overall Study|Lost to Follow-up|3|||
19653836|NCT00518986|42103233|FG001|Overall Study|Lost to Follow-up|2|||
19653837|NCT00518986|42103232|FG000|Overall Study|Physician Decision|0|||
19653838|NCT00518986|42103233|FG001|Overall Study|Physician Decision|3|||
19752887|NCT03982069|42202263|FG001|Overall Study|Specimen loss|3|||
19752888|NCT03982069|42202264|FG002|Overall Study|Specimen loss|1|||
19752889|NCT03982069|42202265|FG003|Overall Study|Specimen loss|1|||
19752890|NCT02937870|42202273|FG000|Overall Study|Adverse Event|1|||
19752891|NCT02937870|42202273|FG000|Overall Study|Protocol Deviation|2|||
19752892|NCT03629041|42202287|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
19752893|NCT03629041|42202288|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
19752894|NCT03629041|42202289|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
19752895|NCT03629041|42202290|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
19752896|NCT03219723|42202308|FG000|Overall Study|Case Report Forms Uncollected|6|||
19752897|NCT03219723|42202308|FG000|Overall Study|Protocol Deviation|4|||
19752898|NCT03628417|42202312|FG000|Overall Study|Death|1|||
19752899|NCT03628417|42202313|FG001|Overall Study|Death|1|||
19752900|NCT03184077|42202325|FG000|Overall Study|Lost to Follow-up|21|||
19752901|NCT03184077|42202326|FG001|Overall Study|Lost to Follow-up|21|||
19752902|NCT03245736|42202332|FG000|Overall Study|Adverse Event|1|||
19752903|NCT03245736|42202332|FG000|Overall Study|Progressive Disease|4|||
19752904|NCT02954887|42202336|FG000|Overall Study|Withdrawal by Subject|3|||
19752905|NCT02954887|42202336|FG000|Overall Study|Lack of Efficacy|3|||
19752906|NCT02954887|42202336|FG000|Overall Study|Other|1|||
19752907|NCT03183063|42202343|FG000|Overall Study|Withdrawal by Subject|2|||
19752908|NCT03183063|42202344|FG001|Overall Study|Withdrawal by Subject|0|||
19752909|NCT03183063|42202345|FG002|Overall Study|Withdrawal by Subject|0|||
19752910|NCT03183063|42202343|FG000|Overall Study|Physician Decision|3|||
19752911|NCT03183063|42202344|FG001|Overall Study|Physician Decision|4|||
19752912|NCT03183063|42202345|FG002|Overall Study|Physician Decision|4|||
19752913|NCT03182829|42202361|FG000|Overall Study|Protocol Violation|12|||
19752914|NCT03182829|42202362|FG001|Overall Study|Protocol Violation|12|||
19752915|NCT03182829|42202361|FG000|Overall Study|Other|4|||
19752916|NCT03182829|42202362|FG001|Overall Study|Other|3|||
19752917|NCT03278028|42202370|FG000|Overall Study|Lost to Follow-up|1|||
19752918|NCT03278028|42202371|FG001|Overall Study|Lost to Follow-up|0|||
19752919|NCT03278028|42202370|FG000|Overall Study|Withdrawal by Subject|3|||
19752920|NCT03278028|42202371|FG001|Overall Study|Withdrawal by Subject|1|||
19752921|NCT03278028|42202370|FG000|Overall Study|Pregnancy|0|||
19752922|NCT03278028|42202371|FG001|Overall Study|Pregnancy|1|||
19752923|NCT03181503|42202379|FG000|Overall Study|Adverse Event|2|||
19752924|NCT03181503|42202380|FG001|Overall Study|Adverse Event|2|||
19752925|NCT03181503|42202379|FG000|Overall Study|Protocol Violation|1|||
19752926|NCT03181503|42202380|FG001|Overall Study|Protocol Violation|0|||
19752927|NCT03181503|42202379|FG000|Overall Study|Withdrawal by Subject|3|||
19752928|NCT03181503|42202380|FG001|Overall Study|Withdrawal by Subject|0|||
19752929|NCT03181503|42202379|FG000|Overall Study|Lost to Follow-up|1|||
19752930|NCT03181503|42202380|FG001|Overall Study|Lost to Follow-up|1|||
19752931|NCT03277794|42202391|FG000|Overall Study|Lost to Follow-up|2|||
19752932|NCT03277794|42202392|FG001|Overall Study|Lost to Follow-up|4|||
19752933|NCT03277794|42202391|FG000|Overall Study|Withdrew due to high acuity|1|||
19752934|NCT03277794|42202392|FG001|Overall Study|Withdrew due to high acuity|0|||
19752935|NCT03276078|42202399|FG000|Overall Study|Adverse Event|1|||
19752936|NCT03180801|42202406|FG000|Overall Study|Physician Decision|3|||
19752937|NCT03180801|42202407|FG001|Overall Study|Physician Decision|3|||
19752938|NCT03180801|42202408|FG002|Overall Study|Physician Decision|1|||
19752939|NCT03180801|42202406|FG000|Overall Study|Non-compliance|1|||
19752940|NCT03180801|42202407|FG001|Overall Study|Non-compliance|4|||
19752941|NCT03180801|42202408|FG002|Overall Study|Non-compliance|0|||
19752942|NCT03180801|42202406|FG000|Overall Study|Inoculation Target Reached|1|||
19752943|NCT03180801|42202407|FG001|Overall Study|Inoculation Target Reached|1|||
19752944|NCT03180801|42202408|FG002|Overall Study|Inoculation Target Reached|3|||
19752945|NCT03180801|42202406|FG000|Overall Study|Adverse Event|1|||
19752946|NCT03180801|42202407|FG001|Overall Study|Adverse Event|0|||
19752947|NCT03180801|42202408|FG002|Overall Study|Adverse Event|2|||
19752948|NCT03180801|42202406|FG000|Overall Study|Withdrawal by Subject|2|||
19752949|NCT03180801|42202407|FG001|Overall Study|Withdrawal by Subject|2|||
19752950|NCT03180801|42202408|FG002|Overall Study|Withdrawal by Subject|1|||
19752951|NCT03180801|42202406|FG000|Overall Study|Lost to Follow-up|0|||
19752952|NCT03180801|42202407|FG001|Overall Study|Lost to Follow-up|2|||
19752953|NCT03180801|42202408|FG002|Overall Study|Lost to Follow-up|3|||
19752954|NCT03742271|42202419|FG000|Overall Study|Unsatisfactory Visual Response|1|||
19752955|NCT03742271|42202419|FG000|Overall Study|Withdrawal by Subject|3|||
19752956|NCT03742271|42202419|FG000|Overall Study|Lost to Follow-up|4|||
19752957|NCT03742271|42202419|FG000|Overall Study|Failed Insertion & removal|3|||
19752958|NCT03742271|42202419|FG000|Overall Study|Protocol Violation|1|||
19752959|NCT03214224|42202423|FG000|Overall Study|Protocol Violation|1|||
19752960|NCT03214224|42202423|FG000|Overall Study|Withdrawal by Subject|2|||
19752961|NCT03214224|42202423|FG000|Overall Study|Practice controls or therapists|6|||
19752962|NCT03180645|42202430|FG000|Overall Study|Adverse Event|0|||
19752963|NCT03180645|42202431|FG001|Overall Study|Adverse Event|1|||
19752964|NCT03180645|42202432|FG002|Overall Study|Adverse Event|2|||
19752965|NCT03750695|42202444|FG000|Overall Study|Lost to Follow-up|0|||
19752966|NCT03750695|42202445|FG001|Overall Study|Lost to Follow-up|1|||
19752967|NCT03748823|42202458|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
19752968|NCT03748823|42202459|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
19752969|NCT03748823|42202458|FG000|Extension Period|Withdrawal by Subject|1|||
19752970|NCT03748823|42202459|FG001|Extension Period|Withdrawal by Subject|2|||
19752971|NCT03748823|42202458|FG000|Extension Period|Death|0|||
19752972|NCT03748823|42202459|FG001|Extension Period|Death|1|||
19752973|NCT03748823|42202458|FG000|Extension Period|Protocol Violation|1|||
19752974|NCT03748823|42202459|FG001|Extension Period|Protocol Violation|0|||
19752975|NCT03748823|42202458|FG000|Extension Period|Ongoing in the Extension Period|41|||
19752976|NCT03748823|42202459|FG001|Extension Period|Ongoing in the Extension Period|84|||
19752977|NCT03231228|42202468|FG000|Overall Study|Lost to Follow-up|2|||
19752978|NCT03231228|42202469|FG001|Overall Study|Lost to Follow-up|0|||
19752979|NCT03231228|42202468|FG000|Overall Study|Physician Decision|1|||
19752980|NCT03231228|42202469|FG001|Overall Study|Physician Decision|0|||
19752981|NCT03213366|42202477|FG000|Overall Study|Lost to Follow-up|9|||
19752982|NCT03213366|42202478|FG001|Overall Study|Lost to Follow-up|4|||
19752983|NCT03230838|42202486|FG000|Overall Study|Withdrawal by Subject|3|||
19752984|NCT03230838|42202487|FG001|Overall Study|Withdrawal by Subject|0|||
19752985|NCT03230838|42202486|FG000|Overall Study|Temperature excursion|1|||
19752986|NCT03230838|42202487|FG001|Overall Study|Temperature excursion|0|||
19752987|NCT03213210|42202493|FG000|Overall Study|Lost to Follow-up|2|||
19752988|NCT03213210|42202493|FG000|Overall Study|Study termination|3|||
19653839|NCT00518986|42103232|FG000|Overall Study|Protocol Violation|5|||
19653840|NCT00518986|42103233|FG001|Overall Study|Protocol Violation|7|||
19653841|NCT00518986|42103232|FG000|Overall Study|Withdrawal by Subject|4|||
19653842|NCT00518986|42103233|FG001|Overall Study|Withdrawal by Subject|4|||
19653843|NCT00518986|42103232|FG000|Overall Study|Non-Specific|2|||
19653844|NCT00518986|42103233|FG001|Overall Study|Non-Specific|1|||
19653845|NCT00742391|42103241|FG000|Overall Study|Adverse Event|2|||
19653846|NCT00742391|42103242|FG001|Overall Study|Adverse Event|1|||
19653847|NCT00742391|42103241|FG000|Overall Study|Lost to Follow-up|1|||
19653848|NCT00742391|42103242|FG001|Overall Study|Lost to Follow-up|0|||
19653849|NCT00742391|42103241|FG000|Overall Study|Protocol Violation|1|||
19653850|NCT00742391|42103242|FG001|Overall Study|Protocol Violation|0|||
19653851|NCT00742235|42103250|FG000|Overall Study|Lost to Follow-up|0|||
19653852|NCT00742235|42103251|FG001|Overall Study|Lost to Follow-up|31|||
19653853|NCT00742079|42103259|FG000|Overall Study|Lost to Follow-up|0|||
19653854|NCT00742079|42103260|FG001|Overall Study|Lost to Follow-up|1|||
19653855|NCT00662792|42103266|FG000|Period 1|Personal Reasons|0|||
19653856|NCT00662792|42103267|FG001|Period 1|Personal Reasons|0|||
19653857|NCT00662792|42103268|FG002|Period 1|Personal Reasons|1|||
19653858|NCT00662792|42103269|FG003|Period 1|Personal Reasons|0|||
19653859|NCT00662792|42103266|FG000|Period 1|Refused continuing medication|0|||
19653860|NCT00662792|42103267|FG001|Period 1|Refused continuing medication|1|||
19653861|NCT00662792|42103268|FG002|Period 1|Refused continuing medication|1|||
19653862|NCT00662792|42103269|FG003|Period 1|Refused continuing medication|0|||
19653863|NCT00662792|42103266|FG000|Period 1|Lost to Follow-up|1|||
19653864|NCT00662792|42103267|FG001|Period 1|Lost to Follow-up|0|||
19653865|NCT00662792|42103268|FG002|Period 1|Lost to Follow-up|0|||
19653866|NCT00662792|42103269|FG003|Period 1|Lost to Follow-up|0|||
19653867|NCT00662792|42103266|FG000|Period 1|Other adverse event (AE)|0|||
19653868|NCT00662792|42103267|FG001|Period 1|Other adverse event (AE)|2|||
19653869|NCT00662792|42103268|FG002|Period 1|Other adverse event (AE)|0|||
19653870|NCT00662792|42103269|FG003|Period 1|Other adverse event (AE)|0|||
19653871|NCT00662792|42103266|FG000|Period 1|Worsening of disease under study (AE)|1|||
19653872|NCT00662792|42103267|FG001|Period 1|Worsening of disease under study (AE)|3|||
19653873|NCT00662792|42103268|FG002|Period 1|Worsening of disease under study (AE)|2|||
19752989|NCT02932878|42202499|FG000|Overall Study|Due to Lab Results|2|||
19752990|NCT02932878|42202500|FG001|Overall Study|Due to Lab Results|1|||
19752991|NCT03230292|42202506|FG000|Overall Study|Adverse Event|1|||
19653874|NCT00662792|42103269|FG003|Period 1|Worsening of disease under study (AE)|0|||
19653875|NCT00662792|42103266|FG000|Period 1|Not treated|0|||
19752992|NCT03230292|42202506|FG000|Overall Study|Protocol Violation|1|||
19752993|NCT03230292|42202506|FG000|Overall Study|Lost to Follow-up|1|||
19653876|NCT00662792|42103267|FG001|Period 1|Not treated|1|||
19653877|NCT00662792|42103268|FG002|Period 1|Not treated|0|||
19653878|NCT00662792|42103269|FG003|Period 1|Not treated|0|||
19653879|NCT00662792|42103266|FG000|Period 2|Worsening of disease under study|1|||
19653880|NCT00662792|42103267|FG001|Period 2|Worsening of disease under study|0|||
19752994|NCT03230292|42202506|FG000|Overall Study|Withdrawal by Subject|3|||
19653881|NCT00662792|42103268|FG002|Period 2|Worsening of disease under study|0|||
19653882|NCT00662792|42103269|FG003|Period 2|Worsening of disease under study|3|||
19653883|NCT00662792|42103266|FG000|Period 3|Refused continuing medication|1|||
19653884|NCT00662792|42103267|FG001|Period 3|Refused continuing medication|0|||
19653885|NCT00662792|42103268|FG002|Period 3|Refused continuing medication|1|||
19653886|NCT00662792|42103269|FG003|Period 3|Refused continuing medication|0|||
19653887|NCT00662792|42103266|FG000|Period 3|Other adverse event (AE)|0|||
19653888|NCT00662792|42103267|FG001|Period 3|Other adverse event (AE)|0|||
19653889|NCT00662792|42103268|FG002|Period 3|Other adverse event (AE)|1|||
19653890|NCT00662792|42103269|FG003|Period 3|Other adverse event (AE)|1|||
19653891|NCT00662792|42103266|FG000|Period 4|Refused continuing medication|0|||
19752995|NCT03228420|42202518|FG000|Overall Study|Lost to Follow-up|5|||
19752996|NCT03228420|42202519|FG001|Overall Study|Lost to Follow-up|3|||
19752997|NCT03228420|42202518|FG000|Overall Study|Withdrawal by Subject|10|||
19752998|NCT03228420|42202519|FG001|Overall Study|Withdrawal by Subject|0|||
19752999|NCT03228420|42202518|FG000|Overall Study|Adverse Event|5|||
19753000|NCT03228420|42202519|FG001|Overall Study|Adverse Event|2|||
19753001|NCT03117049|42202527|FG000|Overall Study|Continued the follow-up period|109|||
19753002|NCT03117049|42202528|FG001|Overall Study|Continued the follow-up period|129|||
19753003|NCT03117049|42202527|FG000|Overall Study|Died|82|||
19753004|NCT03117049|42202528|FG001|Overall Study|Died|93|||
19753005|NCT03117049|42202527|FG000|Overall Study|Consent withdrawal|7|||
19753006|NCT03117049|42202528|FG001|Overall Study|Consent withdrawal|6|||
19753007|NCT03117049|42202527|FG000|Overall Study|Missing contact|3|||
19753008|NCT03117049|42202528|FG001|Overall Study|Missing contact|3|||
19753009|NCT03746483|42202536|FG000|Overall Study|Adverse Event|0|||
19753010|NCT03746483|42202537|FG001|Overall Study|Adverse Event|1|||
19753011|NCT03746483|42202536|FG000|Overall Study|Lack of Efficacy|3|||
19753012|NCT03746483|42202537|FG001|Overall Study|Lack of Efficacy|2|||
19753013|NCT03746483|42202536|FG000|Overall Study|Lost to Follow-up|1|||
19653892|NCT00662792|42103267|FG001|Period 4|Refused continuing medication|1|||
19653893|NCT00662792|42103268|FG002|Period 4|Refused continuing medication|0|||
19653894|NCT00662792|42103269|FG003|Period 4|Refused continuing medication|0|||
19653895|NCT00662792|42103266|FG000|Period 4|Other adverse event (AE)|1|||
19653896|NCT00662792|42103267|FG001|Period 4|Other adverse event (AE)|0|||
19653897|NCT00662792|42103268|FG002|Period 4|Other adverse event (AE)|0|||
19653898|NCT00662792|42103269|FG003|Period 4|Other adverse event (AE)|0|||
19653899|NCT00662792|42103266|FG000|Period 4|Worsening of disease under study (AE)|0|||
19653900|NCT00662792|42103267|FG001|Period 4|Worsening of disease under study (AE)|0|||
19653901|NCT00662792|42103268|FG002|Period 4|Worsening of disease under study (AE)|0|||
19653902|NCT00662792|42103269|FG003|Period 4|Worsening of disease under study (AE)|1|||
19653903|NCT00742001|42103284|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
19653904|NCT00742001|42103285|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
19653905|NCT00742001|42103286|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
19653906|NCT00616902|42103299|FG000|Overall Study|Termination of study|6|||
19653907|NCT00616902|42103300|FG001|Overall Study|Termination of study|6|||
19653908|NCT00741611|42103309|FG000|Overall Study|Death|0|||
19653909|NCT00741611|42103310|FG001|Overall Study|Death|0|||
19653910|NCT00741611|42103311|FG002|Overall Study|Death|1|||
19653911|NCT00741611|42103309|FG000|Overall Study|Withdrawal by Subject|0|||
19653912|NCT00741611|42103310|FG001|Overall Study|Withdrawal by Subject|2|||
19653913|NCT00741611|42103311|FG002|Overall Study|Withdrawal by Subject|2|||
19653914|NCT00662558|42103322|FG000|Overall Study|Adverse Event|21|||
19653915|NCT00662558|42103323|FG001|Overall Study|Adverse Event|59|||
19653916|NCT00662558|42103322|FG000|Overall Study|Lack of Efficacy|4|||
19653917|NCT00662558|42103323|FG001|Overall Study|Lack of Efficacy|7|||
19653918|NCT00662558|42103322|FG000|Overall Study|Lost to Follow-up|13|||
19653919|NCT00662558|42103323|FG001|Overall Study|Lost to Follow-up|10|||
19653920|NCT00662558|42103322|FG000|Overall Study|Other|9|||
19653921|NCT00662558|42103323|FG001|Overall Study|Other|14|||
19653922|NCT00662558|42103322|FG000|Overall Study|Withdrawal by Subject|7|||
19653923|NCT00662558|42103323|FG001|Overall Study|Withdrawal by Subject|12|||
19653924|NCT00662558|42103322|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
19653925|NCT00662558|42103323|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
19653926|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
19653927|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653928|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19753014|NCT03746483|42202537|FG001|Overall Study|Lost to Follow-up|0|||
19753015|NCT03746483|42202536|FG000|Overall Study|Protocol Violation|2|||
19653929|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653930|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653931|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653932|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653933|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19653934|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
19753016|NCT03746483|42202537|FG001|Overall Study|Protocol Violation|0|||
19753017|NCT03746405|42202547|FG000|Overall Study|Withdrawal by Subject|3|||
19653935|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
19653936|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653937|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653938|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653939|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653940|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653941|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653942|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653943|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
19653944|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
19653945|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653946|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653947|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653948|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653949|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653950|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653951|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653952|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
19653953|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
19653954|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653955|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653956|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653957|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653958|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653959|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653960|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653961|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
19653962|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
19653963|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653964|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653965|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653966|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653967|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653968|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653969|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653970|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
19653971|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
19653972|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653973|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653974|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653975|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653976|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653977|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653978|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653979|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
19653980|NCT00739973|42103338|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
19653981|NCT00739973|42103339|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653982|NCT00739973|42103340|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653983|NCT00739973|42103341|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653984|NCT00739973|42103342|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653985|NCT00739973|42103343|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653986|NCT00739973|42103344|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653987|NCT00739973|42103345|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653988|NCT00739973|42103346|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
19653989|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
19653990|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
19653991|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
19653992|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
19653993|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
19653994|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
19653995|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
19653996|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
19653997|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
19653998|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19653999|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654000|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654001|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654002|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
19654003|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654004|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654005|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
19654006|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
19654007|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
19654008|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
19654009|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654010|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654011|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654012|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654013|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654014|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654015|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
19654016|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
19654017|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
19654018|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
19654019|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
19654020|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
19654021|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
19654022|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
19654023|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
19654024|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
19654025|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654026|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654027|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
19654028|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654029|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654030|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654031|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654032|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654033|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
19654034|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
19654035|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
19654036|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
19654037|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
19654038|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
19654039|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
19654040|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
19654041|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
19654042|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
19654043|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
19654044|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
19654045|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
19654046|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
19654047|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
19654048|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
19654049|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
19654050|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
19654051|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
19654052|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654053|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654054|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654055|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654056|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654057|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654058|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
19654059|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654060|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
19654061|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
19654062|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
19654063|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
19654064|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
19654065|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
19654066|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
19654067|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
19654068|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
19654069|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
19654070|NCT00739973|42103338|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654071|NCT00739973|42103339|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
19698949|NCT00312494|42143767|FG000|Overall Study|Laboratory abnormality|1|||
19698950|NCT00312494|42143768|FG001|Overall Study|Laboratory abnormality|0|||
19698951|NCT00312494|42143769|FG002|Overall Study|Laboratory abnormality|0|||
19698952|NCT00312494|42143767|FG000|Overall Study|Lost to Follow-up|8|||
19698953|NCT00312494|42143768|FG001|Overall Study|Lost to Follow-up|8|||
19698954|NCT00312494|42143769|FG002|Overall Study|Lost to Follow-up|8|||
19698955|NCT00312494|42143767|FG000|Overall Study|Withdrawal by Subject|6|||
19698956|NCT00312494|42143768|FG001|Overall Study|Withdrawal by Subject|9|||
19698957|NCT00312494|42143769|FG002|Overall Study|Withdrawal by Subject|10|||
19753018|NCT03746405|42202548|FG001|Overall Study|Withdrawal by Subject|0|||
19753019|NCT03746405|42202547|FG000|Overall Study|technical difficulties|0|||
19753020|NCT03746405|42202548|FG001|Overall Study|technical difficulties|2|||
19753021|NCT03226392|42202556|FG000|Overall Study|Protocol Deviation|1|||
19753022|NCT03226392|42202557|FG001|Overall Study|Protocol Deviation|0|||
19753023|NCT03226392|42202556|FG000|Overall Study|Physician Decision|1|||
19753024|NCT03226392|42202557|FG001|Overall Study|Physician Decision|0|||
19753025|NCT03226392|42202556|FG000|Overall Study|Lost to Follow-up|1|||
19753026|NCT03226392|42202557|FG001|Overall Study|Lost to Follow-up|0|||
19753027|NCT03226392|42202556|FG000|Overall Study|Adverse Event|1|||
19753028|NCT03226392|42202557|FG001|Overall Study|Adverse Event|0|||
19753029|NCT03226392|42202556|FG000|Overall Study|Technical Problems|0|||
19753030|NCT03226392|42202557|FG001|Overall Study|Technical Problems|2|||
19753031|NCT03226392|42202556|FG000|Overall Study|Subject/Guardian Decision|7|||
19753032|NCT03226392|42202557|FG001|Overall Study|Subject/Guardian Decision|6|||
19753033|NCT03205371|42202575|FG000|Overall Study|Withdrawal by Subject|4|||
19753034|NCT03205371|42202576|FG001|Overall Study|Withdrawal by Subject|1|||
19753035|NCT03205371|42202577|FG002|Overall Study|Withdrawal by Subject|0|||
19753036|NCT03205371|42202578|FG003|Overall Study|Withdrawal by Subject|0|||
19753037|NCT03205371|42202579|FG004|Overall Study|Withdrawal by Subject|0|||
19753038|NCT03205371|42202580|FG005|Overall Study|Withdrawal by Subject|0|||
19753039|NCT03205371|42202581|FG006|Overall Study|Withdrawal by Subject|4|||
19753040|NCT03205371|42202582|FG007|Overall Study|Withdrawal by Subject|0|||
19753041|NCT03205371|42202583|FG008|Overall Study|Withdrawal by Subject|2|||
19753042|NCT03205371|42202584|FG009|Overall Study|Withdrawal by Subject|0|||
19753043|NCT03205371|42202585|FG010|Overall Study|Withdrawal by Subject|0|||
19753044|NCT03205371|42202586|FG011|Overall Study|Withdrawal by Subject|1|||
19753045|NCT03205371|42202575|FG000|Overall Study|Lost to Follow-up|0|||
19753046|NCT03205371|42202576|FG001|Overall Study|Lost to Follow-up|0|||
19753047|NCT03205371|42202577|FG002|Overall Study|Lost to Follow-up|0|||
19753048|NCT03205371|42202578|FG003|Overall Study|Lost to Follow-up|0|||
19753049|NCT03205371|42202579|FG004|Overall Study|Lost to Follow-up|0|||
19753050|NCT03205371|42202580|FG005|Overall Study|Lost to Follow-up|0|||
19753051|NCT03205371|42202581|FG006|Overall Study|Lost to Follow-up|5|||
19753052|NCT03205371|42202582|FG007|Overall Study|Lost to Follow-up|2|||
19753053|NCT03205371|42202583|FG008|Overall Study|Lost to Follow-up|3|||
19654072|NCT00739973|42103340|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654073|NCT00739973|42103341|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654074|NCT00739973|42103342|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654075|NCT00739973|42103343|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654076|NCT00739973|42103344|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
19654077|NCT00739973|42103345|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654078|NCT00739973|42103346|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
19654079|NCT00510874|42103381|FG000|Overall Study|Withdrawal by Subject|1|||
19753054|NCT03205371|42202584|FG009|Overall Study|Lost to Follow-up|0|||
19753055|NCT03205371|42202585|FG010|Overall Study|Lost to Follow-up|0|||
19753056|NCT03205371|42202586|FG011|Overall Study|Lost to Follow-up|0|||
19753057|NCT03205371|42202575|FG000|Overall Study|Protocol Violation|0|||
19753058|NCT03205371|42202576|FG001|Overall Study|Protocol Violation|0|||
19753059|NCT03205371|42202577|FG002|Overall Study|Protocol Violation|0|||
19753060|NCT03205371|42202578|FG003|Overall Study|Protocol Violation|0|||
19753061|NCT03205371|42202579|FG004|Overall Study|Protocol Violation|0|||
19753062|NCT03205371|42202580|FG005|Overall Study|Protocol Violation|0|||
19753063|NCT03205371|42202581|FG006|Overall Study|Protocol Violation|1|||
19753064|NCT03205371|42202582|FG007|Overall Study|Protocol Violation|0|||
19753065|NCT03205371|42202583|FG008|Overall Study|Protocol Violation|0|||
19753066|NCT03205371|42202584|FG009|Overall Study|Protocol Violation|0|||
19753067|NCT03205371|42202585|FG010|Overall Study|Protocol Violation|0|||
19753068|NCT03205371|42202586|FG011|Overall Study|Protocol Violation|0|||
19753069|NCT03205371|42202575|FG000|Overall Study|Adverse Event|0|||
19753070|NCT03205371|42202576|FG001|Overall Study|Adverse Event|0|||
19753071|NCT03205371|42202577|FG002|Overall Study|Adverse Event|0|||
19753072|NCT03205371|42202578|FG003|Overall Study|Adverse Event|0|||
19753073|NCT03205371|42202579|FG004|Overall Study|Adverse Event|0|||
19753074|NCT03205371|42202580|FG005|Overall Study|Adverse Event|0|||
19753075|NCT03205371|42202581|FG006|Overall Study|Adverse Event|0|||
19753076|NCT03205371|42202582|FG007|Overall Study|Adverse Event|1|||
19753077|NCT03205371|42202583|FG008|Overall Study|Adverse Event|0|||
19753078|NCT03205371|42202584|FG009|Overall Study|Adverse Event|0|||
19753079|NCT03205371|42202585|FG010|Overall Study|Adverse Event|0|||
19753080|NCT03205371|42202586|FG011|Overall Study|Adverse Event|0|||
19753081|NCT03682705|42202638|FG000|Overall Study|Adverse Event|1|||
19753082|NCT03682705|42202639|FG001|Overall Study|Adverse Event|1|||
19753083|NCT03682705|42202640|FG002|Overall Study|Adverse Event|1|||
19753084|NCT03682705|42202641|FG003|Overall Study|Adverse Event|0|||
19753085|NCT03682705|42202642|FG004|Overall Study|Adverse Event|1|||
19753086|NCT03682705|42202643|FG005|Overall Study|Adverse Event|1|||
19753087|NCT03682705|42202638|FG000|Overall Study|Withdrawal by Subject|1|||
19753088|NCT03682705|42202639|FG001|Overall Study|Withdrawal by Subject|3|||
19753089|NCT03682705|42202640|FG002|Overall Study|Withdrawal by Subject|2|||
19753090|NCT03682705|42202641|FG003|Overall Study|Withdrawal by Subject|4|||
19753091|NCT03682705|42202642|FG004|Overall Study|Withdrawal by Subject|0|||
19753092|NCT03682705|42202643|FG005|Overall Study|Withdrawal by Subject|1|||
19753093|NCT03682705|42202638|FG000|Overall Study|Other, not specified|0|||
19753094|NCT03682705|42202639|FG001|Overall Study|Other, not specified|0|||
19753095|NCT03682705|42202640|FG002|Overall Study|Other, not specified|0|||
19753096|NCT03682705|42202641|FG003|Overall Study|Other, not specified|1|||
19753097|NCT03682705|42202642|FG004|Overall Study|Other, not specified|2|||
19753098|NCT03682705|42202643|FG005|Overall Study|Other, not specified|0|||
19753099|NCT03682705|42202638|FG000|Overall Study|Lost to Follow-up|0|||
19753100|NCT03682705|42202639|FG001|Overall Study|Lost to Follow-up|0|||
19753101|NCT03682705|42202640|FG002|Overall Study|Lost to Follow-up|0|||
19753102|NCT03682705|42202641|FG003|Overall Study|Lost to Follow-up|0|||
19753103|NCT03682705|42202642|FG004|Overall Study|Lost to Follow-up|3|||
19753104|NCT03682705|42202643|FG005|Overall Study|Lost to Follow-up|0|||
19753105|NCT03179787|42202657|FG000|Overall Study|Lost to Follow-up|15|||
19753106|NCT03179787|42202657|FG000|Overall Study|Case report failures|2|||
19654080|NCT00510874|42103382|FG001|Overall Study|Withdrawal by Subject|1|||
19654081|NCT00510874|42103383|FG002|Overall Study|Withdrawal by Subject|0|||
19654082|NCT00510874|42103384|FG003|Overall Study|Withdrawal by Subject|0|||
19654083|NCT00510874|42103385|FG004|Overall Study|Withdrawal by Subject|3|||
19654084|NCT00510874|42103386|FG005|Overall Study|Withdrawal by Subject|0|||
19654085|NCT00510874|42103387|FG006|Overall Study|Withdrawal by Subject|0|||
19654086|NCT00510874|42103381|FG000|Overall Study|Lost to Follow-up|2|||
19654087|NCT00510874|42103382|FG001|Overall Study|Lost to Follow-up|3|||
19654088|NCT00510874|42103383|FG002|Overall Study|Lost to Follow-up|1|||
19654089|NCT00510874|42103384|FG003|Overall Study|Lost to Follow-up|3|||
19654090|NCT00510874|42103385|FG004|Overall Study|Lost to Follow-up|4|||
19654091|NCT00510874|42103386|FG005|Overall Study|Lost to Follow-up|0|||
19654092|NCT00510874|42103387|FG006|Overall Study|Lost to Follow-up|1|||
19654093|NCT00739661|42103406|FG000|Overall Study|Adverse Event|2|||
19654094|NCT00739661|42103407|FG001|Overall Study|Adverse Event|0|||
19654095|NCT00739661|42103406|FG000|Overall Study|Physician decision to withdraw patient|1|||
19654096|NCT00739661|42103407|FG001|Overall Study|Physician decision to withdraw patient|0|||
19654097|NCT00739661|42103406|FG000|Overall Study|Patient decision to withdraw|9|||
19654098|NCT00739661|42103407|FG001|Overall Study|Patient decision to withdraw|4|||
19654099|NCT00739661|42103406|FG000|Overall Study|Disease progression, radiographic|33|||
19654100|NCT00739661|42103407|FG001|Overall Study|Disease progression, radiographic|37|||
19654101|NCT00739661|42103406|FG000|Overall Study|Reason for discontinuation not available|1|||
19654102|NCT00739661|42103407|FG001|Overall Study|Reason for discontinuation not available|1|||
19654103|NCT00615030|42103413|FG000|Period I|Administrative problem|0|||
19654104|NCT00615030|42103414|FG001|Period I|Administrative problem|0|||
19654105|NCT00615030|42103415|FG002|Period I|Administrative problem|0|||
19654106|NCT00615030|42103416|FG003|Period I|Administrative problem|0|||
19654107|NCT00615030|42103417|FG004|Period I|Administrative problem|1|||
19654108|NCT00615030|42103418|FG005|Period I|Administrative problem|0|||
19654109|NCT00615030|42103419|FG006|Period I|Administrative problem|0|||
19654110|NCT00615030|42103420|FG007|Period I|Administrative problem|0|||
19654111|NCT00615030|42103421|FG008|Period I|Administrative problem|0|||
19654112|NCT00615030|42103422|FG009|Period I|Administrative problem|0|||
19654113|NCT00615030|42103423|FG010|Period I|Administrative problem|0|||
19654114|NCT00615030|42103424|FG011|Period I|Administrative problem|0|||
19654115|NCT00615030|42103413|FG000|Period I|Protocol deviation|1|||
19654116|NCT00615030|42103414|FG001|Period I|Protocol deviation|0|||
19654117|NCT00615030|42103415|FG002|Period I|Protocol deviation|0|||
19654118|NCT00615030|42103416|FG003|Period I|Protocol deviation|0|||
19654119|NCT00615030|42103417|FG004|Period I|Protocol deviation|0|||
19654120|NCT00615030|42103418|FG005|Period I|Protocol deviation|0|||
19654121|NCT00615030|42103419|FG006|Period I|Protocol deviation|0|||
19654122|NCT00615030|42103420|FG007|Period I|Protocol deviation|0|||
19654123|NCT00615030|42103421|FG008|Period I|Protocol deviation|0|||
19654124|NCT00615030|42103422|FG009|Period I|Protocol deviation|0|||
19654125|NCT00615030|42103423|FG010|Period I|Protocol deviation|0|||
19654126|NCT00615030|42103424|FG011|Period I|Protocol deviation|0|||
19654127|NCT00615030|42103413|FG000|Period I|Subject withdrew consent|0|||
19654128|NCT00615030|42103414|FG001|Period I|Subject withdrew consent|0|||
19753107|NCT03179787|42202657|FG000|Overall Study|Treatment not administered|1|||
19753108|NCT03745937|42202665|FG000|Overall Study|Withdrawal by Subject|0|||
19654129|NCT00615030|42103415|FG002|Period I|Subject withdrew consent|0|||
19654130|NCT00615030|42103416|FG003|Period I|Subject withdrew consent|0|||
19654131|NCT00615030|42103417|FG004|Period I|Subject withdrew consent|0|||
19654132|NCT00615030|42103418|FG005|Period I|Subject withdrew consent|0|||
19654133|NCT00615030|42103419|FG006|Period I|Subject withdrew consent|0|||
19753109|NCT03745937|42202666|FG001|Overall Study|Withdrawal by Subject|0|||
19654134|NCT00615030|42103420|FG007|Period I|Subject withdrew consent|0|||
19654135|NCT00615030|42103421|FG008|Period I|Subject withdrew consent|1|||
19654136|NCT00615030|42103422|FG009|Period I|Subject withdrew consent|0|||
19654137|NCT00615030|42103423|FG010|Period I|Subject withdrew consent|1|||
19654138|NCT00615030|42103424|FG011|Period I|Subject withdrew consent|1|||
19654139|NCT00615030|42103413|FG000|Period I|Abnormal laboratory value(s)|0|||
19654140|NCT00615030|42103414|FG001|Period I|Abnormal laboratory value(s)|0|||
19654141|NCT00615030|42103415|FG002|Period I|Abnormal laboratory value(s)|0|||
19654142|NCT00615030|42103416|FG003|Period I|Abnormal laboratory value(s)|0|||
19654143|NCT00615030|42103417|FG004|Period I|Abnormal laboratory value(s)|0|||
19654144|NCT00615030|42103418|FG005|Period I|Abnormal laboratory value(s)|1|||
19654145|NCT00615030|42103419|FG006|Period I|Abnormal laboratory value(s)|0|||
19654146|NCT00615030|42103420|FG007|Period I|Abnormal laboratory value(s)|0|||
19654147|NCT00615030|42103421|FG008|Period I|Abnormal laboratory value(s)|0|||
19654148|NCT00615030|42103422|FG009|Period I|Abnormal laboratory value(s)|0|||
19654149|NCT00615030|42103423|FG010|Period I|Abnormal laboratory value(s)|0|||
19654150|NCT00615030|42103424|FG011|Period I|Abnormal laboratory value(s)|0|||
19654151|NCT00615030|42103413|FG000|Period II|Adverse Event|0|||
19654152|NCT00615030|42103414|FG001|Period II|Adverse Event|0|||
19654153|NCT00615030|42103415|FG002|Period II|Adverse Event|1|||
19654154|NCT00615030|42103416|FG003|Period II|Adverse Event|0|||
19654155|NCT00615030|42103417|FG004|Period II|Adverse Event|0|||
19654156|NCT00615030|42103418|FG005|Period II|Adverse Event|0|||
19654157|NCT00615030|42103419|FG006|Period II|Adverse Event|0|||
19654158|NCT00615030|42103420|FG007|Period II|Adverse Event|0|||
19654159|NCT00615030|42103421|FG008|Period II|Adverse Event|1|||
19654160|NCT00615030|42103422|FG009|Period II|Adverse Event|0|||
19654161|NCT00615030|42103423|FG010|Period II|Adverse Event|0|||
19654162|NCT00615030|42103424|FG011|Period II|Adverse Event|0|||
19654163|NCT00615030|42103413|FG000|Period II|Subject withdrew consent|0|||
19654164|NCT00615030|42103414|FG001|Period II|Subject withdrew consent|0|||
19654165|NCT00615030|42103415|FG002|Period II|Subject withdrew consent|0|||
19654166|NCT00615030|42103416|FG003|Period II|Subject withdrew consent|1|||
19654167|NCT00615030|42103417|FG004|Period II|Subject withdrew consent|0|||
19654168|NCT00615030|42103418|FG005|Period II|Subject withdrew consent|0|||
19654169|NCT00615030|42103419|FG006|Period II|Subject withdrew consent|1|||
19654170|NCT00615030|42103420|FG007|Period II|Subject withdrew consent|0|||
19654171|NCT00615030|42103421|FG008|Period II|Subject withdrew consent|0|||
19654172|NCT00615030|42103422|FG009|Period II|Subject withdrew consent|0|||
19654173|NCT00615030|42103423|FG010|Period II|Subject withdrew consent|0|||
19654174|NCT00615030|42103424|FG011|Period II|Subject withdrew consent|0|||
19654175|NCT00615030|42103413|FG000|Period III|Administrative problems|1|||
19654176|NCT00615030|42103414|FG001|Period III|Administrative problems|0|||
19654177|NCT00615030|42103415|FG002|Period III|Administrative problems|0|||
19654178|NCT00615030|42103416|FG003|Period III|Administrative problems|1|||
19654179|NCT00615030|42103417|FG004|Period III|Administrative problems|0|||
19654180|NCT00615030|42103418|FG005|Period III|Administrative problems|0|||
19654181|NCT00615030|42103419|FG006|Period III|Administrative problems|0|||
19654182|NCT00615030|42103420|FG007|Period III|Administrative problems|0|||
19654183|NCT00615030|42103421|FG008|Period III|Administrative problems|0|||
19654184|NCT00615030|42103422|FG009|Period III|Administrative problems|0|||
19654185|NCT00615030|42103423|FG010|Period III|Administrative problems|0|||
19654186|NCT00615030|42103424|FG011|Period III|Administrative problems|0|||
19654187|NCT00518284|42103442|FG000|Overall Study|Adverse Event|0|||
19654188|NCT00518284|42103443|FG001|Overall Study|Adverse Event|1|||
19654189|NCT00518284|42103444|FG002|Overall Study|Adverse Event|0|||
19654190|NCT00518284|42103445|FG003|Overall Study|Adverse Event|0|||
19654191|NCT00518284|42103442|FG000|Overall Study|Study Termination|0|||
19654192|NCT00518284|42103443|FG001|Overall Study|Study Termination|2|||
19654193|NCT00518284|42103444|FG002|Overall Study|Study Termination|1|||
19654194|NCT00518284|42103445|FG003|Overall Study|Study Termination|2|||
19654195|NCT00614874|42103455|FG000|Overall Study|Protocol Violation|1|||
19654196|NCT00614874|42103455|FG000|Overall Study|Withdrawal by Subject|1|||
19654197|NCT00727415|42103459|FG000|Phase I|Dose Limiting Toxicity|2|||
19654198|NCT00544557|42103463|FG000|Overall Study|Adverse Event|140|||
19654199|NCT00544557|42103463|FG000|Overall Study|Lack of Efficacy|196|||
19654200|NCT00544557|42103463|FG000|Overall Study|Other|98|||
19654201|NCT00727259|42103467|FG000|Overall Study|Not all questionnaires completed|1055|||
19654202|NCT00735371|42103476|FG000|Overall Study|Adverse Event|3|||
19654203|NCT00735371|42103477|FG001|Overall Study|Adverse Event|3|||
19654204|NCT00735371|42103478|FG002|Overall Study|Adverse Event|4|||
19654205|NCT00735371|42103479|FG003|Overall Study|Adverse Event|1|||
19654206|NCT00735371|42103476|FG000|Overall Study|Protocol Violation|2|||
19654207|NCT00735371|42103477|FG001|Overall Study|Protocol Violation|2|||
19654208|NCT00735371|42103478|FG002|Overall Study|Protocol Violation|0|||
19654209|NCT00735371|42103479|FG003|Overall Study|Protocol Violation|3|||
19654210|NCT00735371|42103476|FG000|Overall Study|Withdrawal by Subject|0|||
19654211|NCT00735371|42103477|FG001|Overall Study|Withdrawal by Subject|2|||
19654212|NCT00735371|42103478|FG002|Overall Study|Withdrawal by Subject|2|||
19654213|NCT00735371|42103479|FG003|Overall Study|Withdrawal by Subject|0|||
19654214|NCT00735371|42103476|FG000|Overall Study|Lost to Follow-up|1|||
19654215|NCT00735371|42103477|FG001|Overall Study|Lost to Follow-up|1|||
19654216|NCT00735371|42103478|FG002|Overall Study|Lost to Follow-up|3|||
19654217|NCT00735371|42103479|FG003|Overall Study|Lost to Follow-up|1|||
19654218|NCT00735371|42103476|FG000|Overall Study|Lack of Efficacy|4|||
19654219|NCT00735371|42103477|FG001|Overall Study|Lack of Efficacy|2|||
19654220|NCT00735371|42103478|FG002|Overall Study|Lack of Efficacy|0|||
19654221|NCT00735371|42103479|FG003|Overall Study|Lack of Efficacy|4|||
19654222|NCT00735371|42103476|FG000|Overall Study|Sponsor Decision|3|||
19654223|NCT00735371|42103477|FG001|Overall Study|Sponsor Decision|1|||
19654224|NCT00735371|42103478|FG002|Overall Study|Sponsor Decision|0|||
19654225|NCT00735371|42103479|FG003|Overall Study|Sponsor Decision|1|||
19654226|NCT00735371|42103476|FG000|Overall Study|Protocol Violation|0|||
19654227|NCT00735371|42103477|FG001|Overall Study|Protocol Violation|1|||
19654228|NCT00735371|42103478|FG002|Overall Study|Protocol Violation|2|||
19654229|NCT00735371|42103479|FG003|Overall Study|Protocol Violation|0|||
19654230|NCT00735371|42103476|FG000|Overall Study|Prior Vyvanse Exposure|1|||
19654231|NCT00735371|42103477|FG001|Overall Study|Prior Vyvanse Exposure|1|||
19654232|NCT00735371|42103478|FG002|Overall Study|Prior Vyvanse Exposure|0|||
19654233|NCT00735371|42103479|FG003|Overall Study|Prior Vyvanse Exposure|0|||
19654234|NCT00735371|42103476|FG000|Overall Study|Exclusion criteria|1|||
19654235|NCT00735371|42103477|FG001|Overall Study|Exclusion criteria|0|||
19654236|NCT00735371|42103478|FG002|Overall Study|Exclusion criteria|0|||
19654237|NCT00735371|42103479|FG003|Overall Study|Exclusion criteria|0|||
19654238|NCT00518206|42103491|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
19753110|NCT03745937|42202667|FG002|Overall Study|Withdrawal by Subject|0|||
19654239|NCT00518206|42103492|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
19654240|NCT00518206|42103491|FG000|Overall Study|Withdrawal by Subject|2|||
19654241|NCT00518206|42103492|FG001|Overall Study|Withdrawal by Subject|0|||
19654242|NCT00518206|42103491|FG000|Overall Study|Drug Supply Issue|1|||
19654243|NCT00518206|42103492|FG001|Overall Study|Drug Supply Issue|0|||
19654244|NCT00518206|42103491|FG000|Overall Study|Reason Unknown|1|||
19654245|NCT00518206|42103492|FG001|Overall Study|Reason Unknown|0|||
19654246|NCT00518206|42103491|FG000|Overall Study|Completion Status Unknown|1|||
19654247|NCT00518206|42103492|FG001|Overall Study|Completion Status Unknown|0|||
19654248|NCT00586313|42103498|FG000|Overall Study|Lack of Efficacy|2|||
19654249|NCT00727025|42103502|FG000|Overall Study|Physician Decision|23|||
19654250|NCT00734747|42103510|FG000|SRS Procedure|No staples placed|3|||
19654251|NCT00734747|42103510|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
19654252|NCT00726557|42103514|FG000|Overall Study|Screening failure|4|||
19654253|NCT00726557|42103514|FG000|Overall Study|No end of treatment documentation|37|||
19654254|NCT00726557|42103514|FG000|Overall Study|No follow-up documentation available|55|||
19654255|NCT00726557|42103514|FG000|Overall Study|Treatment less than 3 months|17|||
19373633|NCT02760407|41614834|FG001|Overall Study|Inadequately Enrolled|0|||
19654256|NCT00726557|42103514|FG000|Overall Study|Inclusion criteria not met|15|||
19654257|NCT00738881|42103521|FG000|Overall Study|Withdrawal by Subject|0|||
19654258|NCT00738881|42103522|FG001|Overall Study|Withdrawal by Subject|2|||
19654259|NCT00657020|42103528|FG000|PERIOD 1|Adverse Event|0|||
19654260|NCT00657020|42103529|FG001|PERIOD 1|Adverse Event|1|||
19654261|NCT03921723|42103541|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
19654262|NCT03921723|42103541|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
19654263|NCT00544167|42103549|FG000|Overall Study|Adverse Event|21|||
19654264|NCT00544167|42103549|FG000|Overall Study|Physician Decision|8|||
19654265|NCT00659438|42103555|FG000|Overall Study|Withdrawal by Subject|2|||
19654266|NCT00659438|42103556|FG001|Overall Study|Withdrawal by Subject|2|||
19654267|NCT00659438|42103555|FG000|Overall Study|Death|11|||
19654268|NCT00659438|42103556|FG001|Overall Study|Death|6|||
19654269|NCT00659438|42103555|FG000|Overall Study|Lost to Follow-up|1|||
19654270|NCT00659438|42103556|FG001|Overall Study|Lost to Follow-up|0|||
19654271|NCT00543855|42103566|FG000|Overall Study|Adverse Event|3|||
19654272|NCT00543855|42103567|FG001|Overall Study|Adverse Event|1|||
19654273|NCT00543855|42103568|FG002|Overall Study|Adverse Event|3|||
19654274|NCT00543855|42103569|FG003|Overall Study|Adverse Event|4|||
19654275|NCT00543855|42103566|FG000|Overall Study|Lost to Follow-up|0|||
19654276|NCT00543855|42103567|FG001|Overall Study|Lost to Follow-up|0|||
19654277|NCT00543855|42103568|FG002|Overall Study|Lost to Follow-up|1|||
19654278|NCT00543855|42103569|FG003|Overall Study|Lost to Follow-up|0|||
19654279|NCT00543855|42103566|FG000|Overall Study|Withdrawal by Subject|0|||
19654280|NCT00543855|42103567|FG001|Overall Study|Withdrawal by Subject|1|||
19654281|NCT00543855|42103568|FG002|Overall Study|Withdrawal by Subject|2|||
19654282|NCT00543855|42103569|FG003|Overall Study|Withdrawal by Subject|0|||
19654283|NCT00543855|42103566|FG000|Overall Study|Protocol Violation|1|||
19753111|NCT03745937|42202668|FG003|Overall Study|Withdrawal by Subject|1|||
19654284|NCT00543855|42103567|FG001|Overall Study|Protocol Violation|0|||
19654285|NCT00543855|42103568|FG002|Overall Study|Protocol Violation|0|||
19654286|NCT00543855|42103569|FG003|Overall Study|Protocol Violation|0|||
19654287|NCT00656474|42103579|FG000|Overall Study|Other Reason|1|||
19654288|NCT00656084|42103584|FG000|Overall Study|Adverse Event|4|||
19654289|NCT00656084|42103584|FG000|Overall Study|Withdrawal by Subject|1|||
19654290|NCT00656084|42103584|FG000|Overall Study|Patient Request|1|||
19654291|NCT00656084|42103584|FG000|Overall Study|Investigator Request|1|||
19654292|NCT00613938|42103592|FG000|Overall Study|Withdrawal by Subject|2|||
19654293|NCT00613938|42103593|FG001|Overall Study|Withdrawal by Subject|4|||
19654294|NCT00613938|42103594|FG002|Overall Study|Withdrawal by Subject|9|||
19654295|NCT00613938|42103595|FG003|Overall Study|Withdrawal by Subject|9|||
19654296|NCT00613938|42103592|FG000|Overall Study|Adverse Event|1|||
19654297|NCT00613938|42103593|FG001|Overall Study|Adverse Event|4|||
19654298|NCT00613938|42103594|FG002|Overall Study|Adverse Event|8|||
19654299|NCT00613938|42103595|FG003|Overall Study|Adverse Event|5|||
19654300|NCT00613938|42103592|FG000|Overall Study|Lack of Efficacy|16|||
19654301|NCT00613938|42103593|FG001|Overall Study|Lack of Efficacy|18|||
19654302|NCT00613938|42103594|FG002|Overall Study|Lack of Efficacy|5|||
19654303|NCT00613938|42103595|FG003|Overall Study|Lack of Efficacy|9|||
19654304|NCT00613938|42103592|FG000|Overall Study|Other|1|||
19654305|NCT00613938|42103593|FG001|Overall Study|Other|2|||
19654306|NCT00613938|42103594|FG002|Overall Study|Other|1|||
19654307|NCT00613938|42103595|FG003|Overall Study|Other|3|||
19753112|NCT03745937|42202665|FG000|Overall Study|Not-specifed|0|||
19654308|NCT00655928|42103607|FG000|Overall Study|Withdrawal by Subject|2|||
19654309|NCT00655928|42103608|FG001|Overall Study|Withdrawal by Subject|1|||
19654310|NCT00655928|42103607|FG000|Overall Study|Physician Decision|1|||
19654311|NCT00655928|42103608|FG001|Overall Study|Physician Decision|1|||
19654312|NCT00655850|42103614|FG000|Overall Study|Death|2|||
19654313|NCT00655850|42103614|FG000|Overall Study|Withdrawal by Subject|1|||
19654314|NCT00726323|42103622|FG000|Overall Study|Withdrawal by Subject|3|||
19654315|NCT00726323|42103623|FG001|Overall Study|Withdrawal by Subject|1|||
19654316|NCT00726323|42103622|FG000|Overall Study|Physician Decision|1|||
19654317|NCT00726323|42103623|FG001|Overall Study|Physician Decision|0|||
19654318|NCT00726323|42103622|FG000|Overall Study|Progressive disease|23|||
19654319|NCT00726323|42103623|FG001|Overall Study|Progressive disease|16|||
19654320|NCT00726323|42103622|FG000|Overall Study|Clinical progression|0|||
19654321|NCT00726323|42103623|FG001|Overall Study|Clinical progression|3|||
19654322|NCT00726323|42103622|FG000|Overall Study|Adverse Event|9|||
19654323|NCT00726323|42103623|FG001|Overall Study|Adverse Event|9|||
19654324|NCT00726323|42103622|FG000|Overall Study|Death|1|||
19654325|NCT00726323|42103623|FG001|Overall Study|Death|0|||
19654326|NCT00726323|42103622|FG000|Overall Study|Participant wished to discontinue|0|||
19753113|NCT03745937|42202666|FG001|Overall Study|Not-specifed|1|||
19753114|NCT03745937|42202667|FG002|Overall Study|Not-specifed|0|||
19753115|NCT03745937|42202668|FG003|Overall Study|Not-specifed|1|||
19753116|NCT02956057|42202685|FG000|Overall Study|Discontinued intervention|14|||
19753117|NCT02956057|42202686|FG001|Overall Study|Discontinued intervention|10|||
19753118|NCT02956057|42202687|FG002|Overall Study|Discontinued intervention|7|||
19753119|NCT02956057|42202688|FG003|Overall Study|Discontinued intervention|14|||
19654327|NCT00726323|42103623|FG001|Overall Study|Participant wished to discontinue|1|||
19654328|NCT00726323|42103622|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
19654329|NCT00726323|42103623|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
19654330|NCT00246571|42103631|FG000|Overall Study|Adverse Event|7|||
19654331|NCT00246571|42103632|FG001|Overall Study|Adverse Event|0|||
19654332|NCT00246571|42103631|FG000|Overall Study|Protocol Violation|0|||
19654333|NCT00246571|42103632|FG001|Overall Study|Protocol Violation|1|||
19654334|NCT00246571|42103631|FG000|Overall Study|Withdrawal by Subject|2|||
19654335|NCT00246571|42103632|FG001|Overall Study|Withdrawal by Subject|3|||
19654336|NCT00246571|42103631|FG000|Overall Study|Lack of Efficacy|84|||
19654337|NCT00246571|42103632|FG001|Overall Study|Lack of Efficacy|21|||
19654338|NCT00246571|42103631|FG000|Overall Study|Death|17|||
19654339|NCT00246571|42103632|FG001|Overall Study|Death|3|||
19654340|NCT00246571|42103631|FG000|Overall Study|Sponsor|0|||
19654341|NCT00246571|42103632|FG001|Overall Study|Sponsor|1|||
19654342|NCT00246571|42103631|FG000|Overall Study|Did not meet entrance criteria|2|||
19654343|NCT00246571|42103632|FG001|Overall Study|Did not meet entrance criteria|1|||
19654344|NCT00246571|42103631|FG000|Overall Study|Laboratory abnormalities|1|||
19654345|NCT00246571|42103632|FG001|Overall Study|Laboratory abnormalities|0|||
19654346|NCT00246571|42103631|FG000|Overall Study|Crossover participants|0|||
19654347|NCT00246571|42103632|FG001|Overall Study|Crossover participants|74|||
19654348|NCT00734591|42103640|FG000|Screening for Prospective Period|Site did not participate|1604|||
19654349|NCT00734591|42103641|FG001|Screening for Prospective Period|Site did not participate|1488|||
19654350|NCT00734591|42103640|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
19654351|NCT00734591|42103641|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
19654352|NCT00734591|42103640|FG000|Prospective Period|Withdrawal by Subject|11|||
19654353|NCT00734591|42103641|FG001|Prospective Period|Withdrawal by Subject|9|||
19654354|NCT00734591|42103640|FG000|Prospective Period|Lost to Follow-up|37|||
19753120|NCT02956057|42202689|FG004|Overall Study|Discontinued intervention|4|||
19654355|NCT00734591|42103641|FG001|Prospective Period|Lost to Follow-up|33|||
19753121|NCT02956057|42202690|FG005|Overall Study|Discontinued intervention|17|||
19654356|NCT00734591|42103640|FG000|Prospective Period|Study Terminated|1|||
19654357|NCT00734591|42103641|FG001|Prospective Period|Study Terminated|0|||
19654358|NCT00734591|42103640|FG000|Prospective Period|Other|2|||
19654359|NCT00734591|42103641|FG001|Prospective Period|Other|2|||
19654360|NCT00569270|42103647|FG000|Period: First Intervention|Protocol Violation|0|||
19654361|NCT00569270|42103648|FG001|Period: First Intervention|Protocol Violation|1|||
19654362|NCT00545103|42103667|FG000|Overall Study|Lack of Efficacy|48|||
19654363|NCT00545103|42103668|FG001|Overall Study|Lack of Efficacy|45|||
19654364|NCT00545103|42103669|FG002|Overall Study|Lack of Efficacy|31|||
19654365|NCT00545103|42103670|FG003|Overall Study|Lack of Efficacy|27|||
19654366|NCT00545103|42103667|FG000|Overall Study|Withdrawal by Subject|6|||
19654367|NCT00545103|42103668|FG001|Overall Study|Withdrawal by Subject|10|||
19654368|NCT00545103|42103669|FG002|Overall Study|Withdrawal by Subject|18|||
19654369|NCT00545103|42103670|FG003|Overall Study|Withdrawal by Subject|22|||
19654370|NCT00545103|42103667|FG000|Overall Study|Adverse Event|11|||
19654371|NCT00545103|42103668|FG001|Overall Study|Adverse Event|12|||
19654372|NCT00545103|42103669|FG002|Overall Study|Adverse Event|17|||
19654373|NCT00545103|42103670|FG003|Overall Study|Adverse Event|10|||
19654374|NCT00545103|42103667|FG000|Overall Study|Lost to Follow-up|4|||
19654375|NCT00545103|42103668|FG001|Overall Study|Lost to Follow-up|6|||
19654376|NCT00545103|42103669|FG002|Overall Study|Lost to Follow-up|3|||
19654377|NCT00545103|42103670|FG003|Overall Study|Lost to Follow-up|4|||
19654378|NCT00545103|42103667|FG000|Overall Study|Protocol Violation|1|||
19654379|NCT00545103|42103668|FG001|Overall Study|Protocol Violation|2|||
19654380|NCT00545103|42103669|FG002|Overall Study|Protocol Violation|3|||
19654381|NCT00545103|42103670|FG003|Overall Study|Protocol Violation|0|||
19654382|NCT00545103|42103667|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
19654383|NCT00545103|42103668|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
19654384|NCT00545103|42103669|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
19654385|NCT00545103|42103670|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
19654386|NCT00545103|42103667|FG000|Overall Study|Difficult to open package|0|||
19654387|NCT00545103|42103668|FG001|Overall Study|Difficult to open package|0|||
19654388|NCT00545103|42103669|FG002|Overall Study|Difficult to open package|0|||
19654389|NCT00545103|42103670|FG003|Overall Study|Difficult to open package|1|||
19654390|NCT00545103|42103667|FG000|Overall Study|Investigational product not taken|1|||
19654391|NCT00545103|42103668|FG001|Overall Study|Investigational product not taken|0|||
19654392|NCT00545103|42103669|FG002|Overall Study|Investigational product not taken|0|||
19654393|NCT00545103|42103670|FG003|Overall Study|Investigational product not taken|1|||
19654394|NCT00545103|42103667|FG000|Overall Study|Wish to start a family|0|||
19654395|NCT00545103|42103668|FG001|Overall Study|Wish to start a family|0|||
19654396|NCT00545103|42103669|FG002|Overall Study|Wish to start a family|0|||
19654397|NCT00545103|42103670|FG003|Overall Study|Wish to start a family|1|||
19654398|NCT00545103|42103667|FG000|Overall Study|Diverticulitis crisis|0|||
19654399|NCT00545103|42103668|FG001|Overall Study|Diverticulitis crisis|0|||
19654400|NCT00545103|42103669|FG002|Overall Study|Diverticulitis crisis|0|||
19654401|NCT00545103|42103670|FG003|Overall Study|Diverticulitis crisis|1|||
19654402|NCT00545103|42103667|FG000|Overall Study|Personal reasons|1|||
19654403|NCT00545103|42103668|FG001|Overall Study|Personal reasons|0|||
19654404|NCT00545103|42103669|FG002|Overall Study|Personal reasons|0|||
19654405|NCT00545103|42103670|FG003|Overall Study|Personal reasons|0|||
19654406|NCT00545103|42103667|FG000|Overall Study|Subject's decision|1|||
19654407|NCT00545103|42103668|FG001|Overall Study|Subject's decision|0|||
19654408|NCT00545103|42103669|FG002|Overall Study|Subject's decision|0|||
19654409|NCT00545103|42103670|FG003|Overall Study|Subject's decision|0|||
19654410|NCT00545103|42103667|FG000|Overall Study|Noncompliance|0|||
19654411|NCT00545103|42103668|FG001|Overall Study|Noncompliance|1|||
19654412|NCT00545103|42103669|FG002|Overall Study|Noncompliance|0|||
19654413|NCT00545103|42103670|FG003|Overall Study|Noncompliance|0|||
19654414|NCT00545103|42103667|FG000|Overall Study|Investigator decision|0|||
19654415|NCT00545103|42103668|FG001|Overall Study|Investigator decision|0|||
19654416|NCT00545103|42103669|FG002|Overall Study|Investigator decision|1|||
19654417|NCT00545103|42103670|FG003|Overall Study|Investigator decision|0|||
19654418|NCT00545103|42103667|FG000|Overall Study|Subject moved|0|||
19654419|NCT00545103|42103668|FG001|Overall Study|Subject moved|1|||
19654420|NCT00545103|42103669|FG002|Overall Study|Subject moved|0|||
19654421|NCT00545103|42103670|FG003|Overall Study|Subject moved|0|||
19654422|NCT00545103|42103667|FG000|Overall Study|Use of prohibited medication|0|||
19654423|NCT00545103|42103668|FG001|Overall Study|Use of prohibited medication|0|||
19654424|NCT00545103|42103669|FG002|Overall Study|Use of prohibited medication|1|||
19654425|NCT00545103|42103670|FG003|Overall Study|Use of prohibited medication|0|||
19654426|NCT00545103|42103667|FG000|Overall Study|Does not want to take study drug anymore|1|||
19654427|NCT00545103|42103668|FG001|Overall Study|Does not want to take study drug anymore|0|||
19654428|NCT00545103|42103669|FG002|Overall Study|Does not want to take study drug anymore|1|||
19654429|NCT00545103|42103670|FG003|Overall Study|Does not want to take study drug anymore|0|||
19654430|NCT00545103|42103667|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
19654431|NCT00545103|42103668|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
19654432|NCT00545103|42103669|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
19654433|NCT00545103|42103670|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
19654434|NCT00545103|42103667|FG000|Overall Study|Death|0|||
19654435|NCT00545103|42103668|FG001|Overall Study|Death|1|||
19654436|NCT00545103|42103669|FG002|Overall Study|Death|0|||
19654437|NCT00545103|42103670|FG003|Overall Study|Death|0|||
19654438|NCT00586157|42103680|FG000|First Intervention|Worsening behavior|1|||
19654439|NCT00586157|42103681|FG001|First Intervention|Worsening behavior|0|||
19654440|NCT00586157|42103680|FG000|Second Intervention|Withdrawal by Subject|1|||
19654441|NCT00586157|42103681|FG001|Second Intervention|Withdrawal by Subject|0|||
19654442|NCT00586157|42103680|FG000|Second Intervention|Worsening behavior|1|||
19654443|NCT00586157|42103681|FG001|Second Intervention|Worsening behavior|0|||
19654444|NCT00586157|42103680|FG000|Second Intervention|Adverse Event|0|||
19654445|NCT00586157|42103681|FG001|Second Intervention|Adverse Event|1|||
19654446|NCT00246337|42103696|FG000|Overall Study|Lost to Follow-up|3|||
19654447|NCT00246337|42103697|FG001|Overall Study|Lost to Follow-up|0|||
19654448|NCT00246337|42103698|FG002|Overall Study|Lost to Follow-up|0|||
19654449|NCT00246337|42103699|FG003|Overall Study|Lost to Follow-up|0|||
19654450|NCT00246337|42103700|FG004|Overall Study|Lost to Follow-up|2|||
19654451|NCT00246337|42103701|FG005|Overall Study|Lost to Follow-up|2|||
19654452|NCT00246337|42103702|FG006|Overall Study|Lost to Follow-up|1|||
19654453|NCT00246337|42103703|FG007|Overall Study|Lost to Follow-up|2|||
19654454|NCT00246337|42103704|FG008|Overall Study|Lost to Follow-up|0|||
19654455|NCT00246337|42103696|FG000|Overall Study|Protocol Violation|1|||
19654456|NCT00246337|42103697|FG001|Overall Study|Protocol Violation|0|||
19654457|NCT00246337|42103698|FG002|Overall Study|Protocol Violation|0|||
19654458|NCT00246337|42103699|FG003|Overall Study|Protocol Violation|0|||
19654459|NCT00246337|42103700|FG004|Overall Study|Protocol Violation|1|||
19654460|NCT00246337|42103701|FG005|Overall Study|Protocol Violation|0|||
19654461|NCT00246337|42103702|FG006|Overall Study|Protocol Violation|1|||
19654462|NCT00246337|42103703|FG007|Overall Study|Protocol Violation|1|||
19654463|NCT00246337|42103704|FG008|Overall Study|Protocol Violation|0|||
19654464|NCT00246337|42103696|FG000|Overall Study|Withdrawal by Subject|2|||
19654465|NCT00246337|42103697|FG001|Overall Study|Withdrawal by Subject|0|||
19654466|NCT00246337|42103698|FG002|Overall Study|Withdrawal by Subject|0|||
19654467|NCT00246337|42103699|FG003|Overall Study|Withdrawal by Subject|0|||
19654468|NCT00246337|42103700|FG004|Overall Study|Withdrawal by Subject|0|||
19654469|NCT00246337|42103701|FG005|Overall Study|Withdrawal by Subject|0|||
19654470|NCT00246337|42103702|FG006|Overall Study|Withdrawal by Subject|1|||
19654471|NCT00246337|42103703|FG007|Overall Study|Withdrawal by Subject|1|||
19654472|NCT00246337|42103704|FG008|Overall Study|Withdrawal by Subject|0|||
19654473|NCT00246337|42103696|FG000|Overall Study|Lack of Qualifying Event|8|||
19654474|NCT00246337|42103697|FG001|Overall Study|Lack of Qualifying Event|2|||
19654475|NCT00246337|42103698|FG002|Overall Study|Lack of Qualifying Event|1|||
19654476|NCT00246337|42103699|FG003|Overall Study|Lack of Qualifying Event|1|||
19654477|NCT00246337|42103700|FG004|Overall Study|Lack of Qualifying Event|1|||
19654478|NCT00246337|42103701|FG005|Overall Study|Lack of Qualifying Event|3|||
19654479|NCT00246337|42103702|FG006|Overall Study|Lack of Qualifying Event|3|||
19654480|NCT00246337|42103703|FG007|Overall Study|Lack of Qualifying Event|2|||
19654481|NCT00246337|42103704|FG008|Overall Study|Lack of Qualifying Event|5|||
19654482|NCT00246337|42103696|FG000|Overall Study|Site Terminated|10|||
19654483|NCT00246337|42103697|FG001|Overall Study|Site Terminated|0|||
19654484|NCT00246337|42103698|FG002|Overall Study|Site Terminated|0|||
19654485|NCT00246337|42103699|FG003|Overall Study|Site Terminated|0|||
19654486|NCT00246337|42103700|FG004|Overall Study|Site Terminated|0|||
19753122|NCT02956057|42202685|FG000|Overall Study|Lost to Follow-up|0|||
19753123|NCT02956057|42202686|FG001|Overall Study|Lost to Follow-up|2|||
19753124|NCT02956057|42202687|FG002|Overall Study|Lost to Follow-up|1|||
19753125|NCT02956057|42202688|FG003|Overall Study|Lost to Follow-up|1|||
19753126|NCT02956057|42202689|FG004|Overall Study|Lost to Follow-up|1|||
19753127|NCT02956057|42202690|FG005|Overall Study|Lost to Follow-up|0|||
19753128|NCT03179319|42202706|FG000|Overall Study|Lost to Follow-up|6|||
19753129|NCT03179319|42202707|FG001|Overall Study|Lost to Follow-up|0|||
19753130|NCT03627091|42202716|FG000|Overall Study|Adverse Event|0|||
19654487|NCT00246337|42103701|FG005|Overall Study|Site Terminated|7|||
19654488|NCT00246337|42103702|FG006|Overall Study|Site Terminated|1|||
19654489|NCT00246337|42103703|FG007|Overall Study|Site Terminated|6|||
19654490|NCT00246337|42103704|FG008|Overall Study|Site Terminated|2|||
19654491|NCT00246337|42103696|FG000|Overall Study|Abnormal baseline lab values|7|||
19753131|NCT03627091|42202717|FG001|Overall Study|Adverse Event|0|||
19654492|NCT00246337|42103697|FG001|Overall Study|Abnormal baseline lab values|0|||
19654493|NCT00246337|42103698|FG002|Overall Study|Abnormal baseline lab values|2|||
19753132|NCT03627091|42202718|FG002|Overall Study|Adverse Event|2|||
19753133|NCT03627091|42202716|FG000|Overall Study|Withdrawal by Subject|2|||
19753134|NCT03627091|42202717|FG001|Overall Study|Withdrawal by Subject|0|||
19753135|NCT03627091|42202718|FG002|Overall Study|Withdrawal by Subject|2|||
19753136|NCT03627091|42202716|FG000|Overall Study|Physician Decision|2|||
19753137|NCT03627091|42202717|FG001|Overall Study|Physician Decision|0|||
19753138|NCT03627091|42202718|FG002|Overall Study|Physician Decision|0|||
19753139|NCT03627091|42202716|FG000|Overall Study|Site terminated by sponsor|0|||
19388255|NCT02698241|41631682|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
19388256|NCT02698241|41631682|FG000|Overall Study|Screening not met|7|||
19388257|NCT02698241|41631682|FG000|Overall Study|Withdrawal by Subject|7|||
19388258|NCT02698241|41631682|FG000|Overall Study|Physician Decision|2|||
19388259|NCT02698241|41631682|FG000|Overall Study|Subject underwent system modification|2|||
19388260|NCT02698241|41631682|FG000|Overall Study|Lost to Follow-up|3|||
19388261|NCT02698241|41631682|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
19388262|NCT02698241|41631682|FG000|Overall Study|geographic and licensing issue|1|||
19388263|NCT02698241|41631682|FG000|Overall Study|Death|2|||
19388264|NCT01663233|41631688|FG000|Overall Study|Withdrawal by Subject|3|||
19388265|NCT01663233|41631689|FG001|Overall Study|Withdrawal by Subject|2|||
19388266|NCT01663233|41631688|FG000|Overall Study|Protocol Deviation|1|||
19388267|NCT01663233|41631689|FG001|Overall Study|Protocol Deviation|4|||
19388268|NCT01663233|41631688|FG000|Overall Study|Lost to Follow-up|0|||
19388269|NCT01663233|41631689|FG001|Overall Study|Lost to Follow-up|1|||
19388270|NCT02556255|41631708|FG000|Overall Study|Lost to Follow-up|4|||
19388271|NCT02556801|41631716|FG000|Overall Study|Lost to Follow-up|1|||
19388272|NCT02556801|41631717|FG001|Overall Study|Lost to Follow-up|0|||
19388273|NCT02556801|41631718|FG002|Overall Study|Lost to Follow-up|2|||
19654494|NCT00246337|42103699|FG003|Overall Study|Abnormal baseline lab values|0|||
19654495|NCT00246337|42103700|FG004|Overall Study|Abnormal baseline lab values|0|||
19698958|NCT00312494|42143767|FG000|Overall Study|Other|10|||
19753140|NCT03627091|42202717|FG001|Overall Study|Site terminated by sponsor|1|||
19753141|NCT03627091|42202718|FG002|Overall Study|Site terminated by sponsor|0|||
19654496|NCT00246337|42103701|FG005|Overall Study|Abnormal baseline lab values|2|||
19654497|NCT00246337|42103702|FG006|Overall Study|Abnormal baseline lab values|2|||
19654498|NCT00246337|42103703|FG007|Overall Study|Abnormal baseline lab values|0|||
19654499|NCT00246337|42103704|FG008|Overall Study|Abnormal baseline lab values|4|||
19654500|NCT00246337|42103696|FG000|Overall Study|Overwhelmed|0|||
19654501|NCT00246337|42103697|FG001|Overall Study|Overwhelmed|0|||
19654502|NCT00246337|42103698|FG002|Overall Study|Overwhelmed|0|||
19654503|NCT00246337|42103699|FG003|Overall Study|Overwhelmed|0|||
19654504|NCT00246337|42103700|FG004|Overall Study|Overwhelmed|0|||
19654505|NCT00246337|42103701|FG005|Overall Study|Overwhelmed|1|||
19654506|NCT00246337|42103702|FG006|Overall Study|Overwhelmed|0|||
19654507|NCT00246337|42103703|FG007|Overall Study|Overwhelmed|0|||
19654508|NCT00246337|42103704|FG008|Overall Study|Overwhelmed|0|||
19654509|NCT00246337|42103696|FG000|Overall Study|Protocol Violator|1|||
19654510|NCT00246337|42103697|FG001|Overall Study|Protocol Violator|0|||
19654511|NCT00246337|42103698|FG002|Overall Study|Protocol Violator|0|||
19654512|NCT00246337|42103699|FG003|Overall Study|Protocol Violator|0|||
19654513|NCT00246337|42103700|FG004|Overall Study|Protocol Violator|0|||
19654514|NCT00246337|42103701|FG005|Overall Study|Protocol Violator|0|||
19654515|NCT00246337|42103702|FG006|Overall Study|Protocol Violator|0|||
19654516|NCT00246337|42103703|FG007|Overall Study|Protocol Violator|0|||
19654517|NCT00246337|42103704|FG008|Overall Study|Protocol Violator|0|||
19654518|NCT00246337|42103696|FG000|Overall Study|Reported as completing trial in error|0|||
19654519|NCT00246337|42103697|FG001|Overall Study|Reported as completing trial in error|0|||
19654520|NCT00246337|42103698|FG002|Overall Study|Reported as completing trial in error|0|||
19654521|NCT00246337|42103699|FG003|Overall Study|Reported as completing trial in error|0|||
19654522|NCT00246337|42103700|FG004|Overall Study|Reported as completing trial in error|0|||
19654523|NCT00246337|42103701|FG005|Overall Study|Reported as completing trial in error|0|||
19654524|NCT00246337|42103702|FG006|Overall Study|Reported as completing trial in error|0|||
19654525|NCT00246337|42103703|FG007|Overall Study|Reported as completing trial in error|1|||
19654526|NCT00246337|42103704|FG008|Overall Study|Reported as completing trial in error|0|||
19654527|NCT00243919|42103727|FG000|Overall Study|Death|3|||
19654528|NCT00243919|42103728|FG001|Overall Study|Death|4|||
19654529|NCT00243919|42103729|FG002|Overall Study|Death|6|||
19654530|NCT00243919|42103727|FG000|Overall Study|Withdrawal by Subject|6|||
19654531|NCT00243919|42103728|FG001|Overall Study|Withdrawal by Subject|6|||
19654532|NCT00243919|42103729|FG002|Overall Study|Withdrawal by Subject|2|||
19601573|NCT00766636|42050305|FG000|Overall Study|Withdrawal by Subject|1|||
19601574|NCT00766636|42050306|FG001|Overall Study|Withdrawal by Subject|1|||
19601575|NCT00766636|42050305|FG000|Overall Study|Incomplete Treatment|0|||
19601576|NCT00766636|42050306|FG001|Overall Study|Incomplete Treatment|1|||
19601577|NCT00766636|42050305|FG000|Overall Study|Adverse Event|1|||
19601578|NCT00766636|42050306|FG001|Overall Study|Adverse Event|0|||
19601579|NCT00766636|42050305|FG000|Overall Study|Disease Progression|1|||
19601580|NCT00766636|42050306|FG001|Overall Study|Disease Progression|0|||
19601581|NCT00770692|42050316|FG000|Overall Study|Withdrawal by Subject|7|||
19601582|NCT00770692|42050317|FG001|Overall Study|Withdrawal by Subject|9|||
19601583|NCT00770692|42050318|FG002|Overall Study|Withdrawal by Subject|9|||
19601584|NCT00770692|42050319|FG003|Overall Study|Withdrawal by Subject|6|||
19601585|NCT00770692|42050316|FG000|Overall Study|Adverse Event|3|||
19601586|NCT00770692|42050317|FG001|Overall Study|Adverse Event|0|||
19601587|NCT00770692|42050318|FG002|Overall Study|Adverse Event|4|||
19601588|NCT00770692|42050319|FG003|Overall Study|Adverse Event|4|||
19601589|NCT00770692|42050316|FG000|Overall Study|Investigator judgment|2|||
19601590|NCT00770692|42050317|FG001|Overall Study|Investigator judgment|0|||
19601591|NCT00770692|42050318|FG002|Overall Study|Investigator judgment|1|||
19601592|NCT00770692|42050319|FG003|Overall Study|Investigator judgment|1|||
19601593|NCT03213691|42050329|FG000|Overall Study|Adverse Event|2|||
19601594|NCT03213691|42050329|FG000|Overall Study|Death|3|||
19601595|NCT03213691|42050329|FG000|Overall Study|Physician Decision|1|||
19601596|NCT03213691|42050329|FG000|Overall Study|Progressive Disease|14|||
19601597|NCT03213691|42050329|FG000|Overall Study|Ineligible|1|||
19601598|NCT02743819|42050333|FG000|Overall Study|Lack of Efficacy|5|||
19601599|NCT02743819|42050333|FG000|Overall Study|Death|2|||
19601600|NCT02743819|42050333|FG000|Overall Study|Adverse Event|1|||
19601601|NCT01004822|42050345|FG000|Overall Study|Objective progression or relapse|3|||
19601602|NCT01004822|42050346|FG001|Overall Study|Objective progression or relapse|3|||
19601603|NCT01004822|42050347|FG002|Overall Study|Objective progression or relapse|0|||
19601604|NCT01004822|42050348|FG003|Overall Study|Objective progression or relapse|1|||
19601605|NCT01004822|42050349|FG004|Overall Study|Objective progression or relapse|2|||
19601606|NCT01004822|42050350|FG005|Overall Study|Objective progression or relapse|2|||
19654533|NCT00243919|42103727|FG000|Overall Study|Lost to Follow-up|6|||
19654534|NCT00243919|42103728|FG001|Overall Study|Lost to Follow-up|7|||
19654535|NCT00243919|42103729|FG002|Overall Study|Lost to Follow-up|3|||
19654536|NCT00243919|42103727|FG000|Overall Study|Administrative Error|1|||
19654537|NCT00243919|42103728|FG001|Overall Study|Administrative Error|0|||
19654538|NCT00243919|42103729|FG002|Overall Study|Administrative Error|0|||
19654539|NCT00243919|42103727|FG000|Overall Study|Physician Decision|1|||
19654540|NCT00243919|42103728|FG001|Overall Study|Physician Decision|1|||
19654541|NCT00243919|42103729|FG002|Overall Study|Physician Decision|0|||
19654542|NCT00725621|42103737|FG000|Overall Study|Adverse Event|25|||
19654543|NCT00725621|42103737|FG000|Overall Study|Lack of Efficacy|46|||
19654544|NCT00725621|42103737|FG000|Overall Study|Withdrawal by Subject|57|||
19654545|NCT00725621|42103737|FG000|Overall Study|Physician Decision|19|||
19654546|NCT00725621|42103737|FG000|Overall Study|Lost to Follow-up|52|||
19654547|NCT00725621|42103737|FG000|Overall Study|Non-compliance|8|||
19654548|NCT00725621|42103737|FG000|Overall Study|Continued treatment by other physician|6|||
19654549|NCT00725621|42103737|FG000|Overall Study|Switched to other study|1|||
19654550|NCT00725621|42103737|FG000|Overall Study|Switched to other drug|1|||
19654551|NCT00725621|42103737|FG000|Overall Study|Prepared for elective surgery|1|||
19654552|NCT00725621|42103737|FG000|Overall Study|Reason not specified|55|||
19654553|NCT00613626|42103748|FG000|Overall Study|Ineligible|0|||
19654554|NCT00613626|42103749|FG001|Overall Study|Ineligible|1|||
19654555|NCT00613626|42103750|FG002|Overall Study|Ineligible|0|||
19654556|NCT00725543|42103757|FG000|Overall Study|Adverse Event|10|||
19654557|NCT00725543|42103757|FG000|Overall Study|Lack of Efficacy|3|||
19654558|NCT00725543|42103757|FG000|Overall Study|Withdrawal by Subject|10|||
19654559|NCT00725543|42103757|FG000|Overall Study|Physician Decision|5|||
19654560|NCT00725543|42103757|FG000|Overall Study|Lost to Follow-up|4|||
19654561|NCT00725543|42103757|FG000|Overall Study|Non-compliance|2|||
19654562|NCT00725543|42103757|FG000|Overall Study|Other|119|||
19654563|NCT00239005|42103763|FG000|Overall Study|Adverse Event|6|||
19654564|NCT00239005|42103764|FG001|Overall Study|Adverse Event|6|||
19654565|NCT00239005|42103763|FG000|Overall Study|Withdrawal by Subject|3|||
19654566|NCT00239005|42103764|FG001|Overall Study|Withdrawal by Subject|4|||
19654567|NCT00239005|42103763|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
19654568|NCT00239005|42103764|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
19654569|NCT00239005|42103763|FG000|Overall Study|Protocol Violation|1|||
19654570|NCT00239005|42103764|FG001|Overall Study|Protocol Violation|0|||
19654571|NCT00239005|42103763|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
19654572|NCT00239005|42103764|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
19654573|NCT00239005|42103763|FG000|Overall Study|Lost to Follow-up|0|||
19654574|NCT00239005|42103764|FG001|Overall Study|Lost to Follow-up|1|||
19654575|NCT00616434|42103772|FG000|Overall Study|Adverse Event|5|||
19654576|NCT00616434|42103773|FG001|Overall Study|Adverse Event|2|||
19654577|NCT00616434|42103772|FG000|Overall Study|Physician Decision|0|||
19654578|NCT00616434|42103773|FG001|Overall Study|Physician Decision|4|||
19654579|NCT00616434|42103772|FG000|Overall Study|Withdrawal by Subject|1|||
19654580|NCT00616434|42103773|FG001|Overall Study|Withdrawal by Subject|1|||
19654581|NCT00616434|42103772|FG000|Overall Study|Protocol deviation|0|||
19654582|NCT00616434|42103773|FG001|Overall Study|Protocol deviation|1|||
19654583|NCT00652340|42103781|FG000|Overall Study|Had not progressed.|4|||
19654584|NCT00652340|42103782|FG001|Overall Study|Had not progressed.|3|||
19654585|NCT00613314|42103788|FG000|Overall Study|Adverse Event|5|||
19654586|NCT00613314|42103788|FG000|Overall Study|Protocol Violation|14|||
19654587|NCT00613314|42103788|FG000|Overall Study|Lost to Follow-up|46|||
19654588|NCT00613314|42103788|FG000|Overall Study|Other reason not defined above|90|||
19654589|NCT00257725|42103792|FG000|Overall Study|Adverse Event|3|||
19654590|NCT00544869|42103800|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
19654591|NCT00544869|42103801|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
19654592|NCT00544869|42103802|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
19654593|NCT00544869|42103800|FG000|Overall Study|Adverse Event|6|||
19654594|NCT00544869|42103801|FG001|Overall Study|Adverse Event|1|||
19654595|NCT00544869|42103802|FG002|Overall Study|Adverse Event|0|||
19654596|NCT00544869|42103800|FG000|Overall Study|Lack of Efficacy|1|||
19654597|NCT00544869|42103801|FG001|Overall Study|Lack of Efficacy|1|||
19654598|NCT00544869|42103802|FG002|Overall Study|Lack of Efficacy|0|||
19654599|NCT00544869|42103800|FG000|Overall Study|Physician Decision|2|||
19654600|NCT00544869|42103801|FG001|Overall Study|Physician Decision|0|||
19654601|NCT00544869|42103802|FG002|Overall Study|Physician Decision|0|||
19654602|NCT00725075|42103813|FG000|Overall Study|Use of Excluded Medication|0|||
19654603|NCT00725075|42103814|FG001|Overall Study|Use of Excluded Medication|1|||
19654604|NCT00725075|42103815|FG002|Overall Study|Use of Excluded Medication|0|||
19654605|NCT00725075|42103813|FG000|Overall Study|Protocol Violation|0|||
19654606|NCT00725075|42103814|FG001|Overall Study|Protocol Violation|0|||
19654607|NCT00725075|42103815|FG002|Overall Study|Protocol Violation|1|||
19654608|NCT00725075|42103813|FG000|Overall Study|Lost to Follow-up|1|||
19654609|NCT00725075|42103814|FG001|Overall Study|Lost to Follow-up|0|||
19654610|NCT00725075|42103815|FG002|Overall Study|Lost to Follow-up|0|||
19654611|NCT00725075|42103813|FG000|Overall Study|Withdrawal by Subject|4|||
19654612|NCT00725075|42103814|FG001|Overall Study|Withdrawal by Subject|5|||
19654613|NCT00725075|42103815|FG002|Overall Study|Withdrawal by Subject|4|||
19654614|NCT00725075|42103813|FG000|Overall Study|Adverse Event|2|||
19654615|NCT00725075|42103814|FG001|Overall Study|Adverse Event|1|||
19654616|NCT00725075|42103815|FG002|Overall Study|Adverse Event|1|||
19654617|NCT00725075|42103813|FG000|Overall Study|Worsening of Disease|2|||
19654618|NCT00725075|42103814|FG001|Overall Study|Worsening of Disease|1|||
19654619|NCT00725075|42103815|FG002|Overall Study|Worsening of Disease|2|||
19654620|NCT00725075|42103813|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
19654621|NCT00725075|42103814|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
19654622|NCT00725075|42103815|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
19654623|NCT00725075|42103813|FG000|Overall Study|Other|1|||
19654624|NCT00725075|42103814|FG001|Overall Study|Other|0|||
19654625|NCT00725075|42103815|FG002|Overall Study|Other|0|||
19753142|NCT03627091|42202716|FG000|Overall Study|Disease relapse|7|||
19753143|NCT03627091|42202717|FG001|Overall Study|Disease relapse|5|||
19753144|NCT03627091|42202718|FG002|Overall Study|Disease relapse|1|||
19654626|NCT00733499|42103825|FG000|Pre-operative|Protocol Violation|0|||
19654627|NCT00733499|42103826|FG001|Pre-operative|Protocol Violation|1|||
19654628|NCT00733499|42103825|FG000|3 Months Follow-up|Death|1|||
19654629|NCT00733499|42103826|FG001|3 Months Follow-up|Death|2|||
19654630|NCT00733499|42103825|FG000|6 Months Follow-up|Death|0|||
19654631|NCT00733499|42103826|FG001|6 Months Follow-up|Death|2|||
19654632|NCT00733499|42103825|FG000|6 Months Follow-up|Adverse Event|0|||
19654633|NCT00733499|42103826|FG001|6 Months Follow-up|Adverse Event|1|||
19654634|NCT00733499|42103825|FG000|12 Months Follow-up|Death|2|||
19654635|NCT00733499|42103826|FG001|12 Months Follow-up|Death|1|||
19654636|NCT00733499|42103825|FG000|24 Months Follow-up|Death|0|||
19654637|NCT00733499|42103826|FG001|24 Months Follow-up|Death|1|||
19654638|NCT00733499|42103825|FG000|5 Year Followup|Adverse Event|2|||
19654639|NCT00733499|42103826|FG001|5 Year Followup|Adverse Event|2|||
19654640|NCT00733499|42103825|FG000|5 Year Followup|Non device related AE|0|||
19654641|NCT00733499|42103826|FG001|5 Year Followup|Non device related AE|1|||
19654642|NCT00733499|42103825|FG000|5 Year Followup|Revision of Study Implant|0|||
19654643|NCT00733499|42103826|FG001|5 Year Followup|Revision of Study Implant|1|||
19654644|NCT00733499|42103825|FG000|5 Year Followup|Lost to Follow-up|2|||
19654645|NCT00733499|42103826|FG001|5 Year Followup|Lost to Follow-up|0|||
19654646|NCT00733499|42103825|FG000|5 Year Followup|Death|13|||
19654647|NCT00733499|42103826|FG001|5 Year Followup|Death|19|||
19654648|NCT00733499|42103825|FG000|5 Year Followup|missing, unable to locate|0|||
19654649|NCT00733499|42103826|FG001|5 Year Followup|missing, unable to locate|1|||
19654650|NCT00733499|42103825|FG000|5 Year Followup|Withdrawal by Subject|4|||
19654651|NCT00733499|42103826|FG001|5 Year Followup|Withdrawal by Subject|1|||
19654652|NCT00733499|42103825|FG000|10 Year Followup|Death|9|||
19654653|NCT00733499|42103826|FG001|10 Year Followup|Death|7|||
19654654|NCT00733499|42103825|FG000|10 Year Followup|Adverse Event|3|||
19654655|NCT00733499|42103826|FG001|10 Year Followup|Adverse Event|3|||
19654656|NCT00733499|42103825|FG000|10 Year Followup|Lost to Follow-up|3|||
19654657|NCT00733499|42103826|FG001|10 Year Followup|Lost to Follow-up|2|||
19654658|NCT00733499|42103825|FG000|10 Year Followup|Withdrawal by Subject|5|||
19654659|NCT00733499|42103826|FG001|10 Year Followup|Withdrawal by Subject|5|||
19654660|NCT00733499|42103825|FG000|10 Year Followup|missing, unable to locate|0|||
19654661|NCT00733499|42103826|FG001|10 Year Followup|missing, unable to locate|2|||
19654662|NCT00652028|42103836|FG000|Overall Study|Adverse Event|1|||
19654663|NCT00652028|42103837|FG001|Overall Study|Adverse Event|0|||
19654664|NCT00652028|42103838|FG002|Overall Study|Adverse Event|0|||
19654665|NCT00652028|42103839|FG003|Overall Study|Adverse Event|0|||
19654666|NCT00652028|42103836|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
19654667|NCT00652028|42103837|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
19654668|NCT00652028|42103838|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
19654669|NCT00652028|42103839|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
19654670|NCT00652028|42103836|FG000|Overall Study|Physician Decision|0|||
19654671|NCT00652028|42103837|FG001|Overall Study|Physician Decision|0|||
19654672|NCT00652028|42103838|FG002|Overall Study|Physician Decision|1|||
19654673|NCT00652028|42103839|FG003|Overall Study|Physician Decision|0|||
19654674|NCT00738101|42103849|FG000|Overall Study|Physician Decision|5|||
19654675|NCT00738101|42103849|FG000|Overall Study|Death|1|||
19654676|NCT00738101|42103849|FG000|Overall Study|Repeat enrollment|1|||
19654677|NCT00733421|42103855|FG000|Overall Study|Withdrawal by Subject|1|||
19654678|NCT00733421|42103856|FG001|Overall Study|Withdrawal by Subject|1|||
19654679|NCT00613080|42103862|FG000|Overall Study|Ineligible / no protocol treatment|11|||
19654680|NCT00732875|42103866|FG000|Overall Study|Adverse Event|16|||
19654681|NCT00732875|42103866|FG000|Overall Study|Withdrawal by Subject|6|||
19654682|NCT00732875|42103866|FG000|Overall Study|Lack of Efficacy|13|||
19654683|NCT00615264|42103876|FG000|Overall Study|Withdrawal by Subject|17|||
19654684|NCT00615264|42103877|FG001|Overall Study|Withdrawal by Subject|19|||
19654685|NCT00615264|42103876|FG000|Overall Study|Lost to Follow-up|6|||
19654686|NCT00615264|42103877|FG001|Overall Study|Lost to Follow-up|13|||
19654687|NCT00615264|42103876|FG000|Overall Study|Adverse Event|8|||
19654688|NCT00615264|42103877|FG001|Overall Study|Adverse Event|5|||
19654689|NCT00615264|42103876|FG000|Overall Study|Death|1|||
19654690|NCT00615264|42103877|FG001|Overall Study|Death|1|||
19654691|NCT00615264|42103876|FG000|Overall Study|Protocol Violation|11|||
19654692|NCT00615264|42103877|FG001|Overall Study|Protocol Violation|7|||
19654693|NCT00615264|42103876|FG000|Overall Study|Not defined|7|||
19654694|NCT00615264|42103877|FG001|Overall Study|Not defined|4|||
19654695|NCT00615264|42103876|FG000|Overall Study|Dermal Hypersensitivity|0|||
19654696|NCT00615264|42103877|FG001|Overall Study|Dermal Hypersensitivity|3|||
19654697|NCT00732641|42103885|FG000|Overall Study|Relapse or Progressive Disease|65|||
19654698|NCT00732641|42103886|FG001|Overall Study|Relapse or Progressive Disease|101|||
19654699|NCT00732641|42103885|FG000|Overall Study|Serious Adverse Events|12|||
19388274|NCT02556801|41631719|FG003|Overall Study|Lost to Follow-up|0|||
19654700|NCT00732641|42103886|FG001|Overall Study|Serious Adverse Events|3|||
19654701|NCT00732641|42103885|FG000|Overall Study|Physician Decision|6|||
19654702|NCT00732641|42103886|FG001|Overall Study|Physician Decision|0|||
19654703|NCT00732641|42103885|FG000|Overall Study|Withdrawal by Subject|4|||
19654704|NCT00732641|42103886|FG001|Overall Study|Withdrawal by Subject|2|||
19654705|NCT00732641|42103885|FG000|Overall Study|Unable to Complete|1|||
19654706|NCT00732641|42103886|FG001|Overall Study|Unable to Complete|1|||
19654707|NCT00732641|42103885|FG000|Overall Study|Other|18|||
19654708|NCT00732641|42103886|FG001|Overall Study|Other|5|||
19654709|NCT00737711|42103892|FG000|Overall Study|Adverse Event|2|||
19654710|NCT00737711|42103892|FG000|Overall Study|Death|8|||
19654711|NCT00737711|42103892|FG000|Overall Study|Failure to return|4|||
19654712|NCT00737711|42103892|FG000|Overall Study|Protocol Violation|1|||
19654713|NCT00737711|42103892|FG000|Overall Study|Withdrawal by Subject|5|||
19654714|NCT00737711|42103892|FG000|Overall Study|Blood transfusion|6|||
19654715|NCT00737711|42103892|FG000|Overall Study|Other|5|||
19654716|NCT00615108|42103896|FG000|Overall Study|Adverse Event|122|||
19654717|NCT00615108|42103896|FG000|Overall Study|Other|370|||
19654718|NCT00615108|42103896|FG000|Overall Study|Lost to Follow-up|15|||
19654719|NCT00238303|42103905|FG000|Overall Study|Withdrawal by Subject|11|||
19654720|NCT00238303|42103906|FG001|Overall Study|Withdrawal by Subject|1|||
19654721|NCT00238303|42103907|FG002|Overall Study|Withdrawal by Subject|2|||
19654722|NCT00238303|42103905|FG000|Overall Study|Death|1|||
19654723|NCT00238303|42103906|FG001|Overall Study|Death|0|||
19654724|NCT00238303|42103907|FG002|Overall Study|Death|1|||
19654725|NCT00238303|42103905|FG000|Overall Study|Other Medical Problems|2|||
19654726|NCT00238303|42103906|FG001|Overall Study|Other Medical Problems|0|||
19654727|NCT00238303|42103907|FG002|Overall Study|Other Medical Problems|2|||
19654728|NCT00238303|42103905|FG000|Overall Study|Poor tolerance of study treatment|1|||
19753145|NCT03627091|42202716|FG000|Overall Study|Other|1|||
19753146|NCT03627091|42202717|FG001|Overall Study|Other|0|||
19753147|NCT03627091|42202718|FG002|Overall Study|Other|0|||
19753148|NCT04237584|42202731|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
19753149|NCT04237584|42202732|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
19753150|NCT04237584|42202733|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
19654729|NCT00238303|42103906|FG001|Overall Study|Poor tolerance of study treatment|0|||
19654730|NCT00238303|42103907|FG002|Overall Study|Poor tolerance of study treatment|1|||
19654731|NCT00238303|42103905|FG000|Overall Study|Adverse Event|0|||
19654732|NCT00238303|42103906|FG001|Overall Study|Adverse Event|1|||
19654733|NCT00238303|42103907|FG002|Overall Study|Adverse Event|3|||
19654734|NCT00737633|42103918|FG000|Overall Study|Study terminated by sponsor|44|||
19654735|NCT00737633|42103919|FG001|Overall Study|Study terminated by sponsor|55|||
19654736|NCT00737633|42103918|FG000|Overall Study|Lost to Follow-up|0|||
19654737|NCT00737633|42103919|FG001|Overall Study|Lost to Follow-up|1|||
19654738|NCT00737633|42103918|FG000|Overall Study|protocol non-compliance|0|||
19753151|NCT04237584|42202734|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
19753152|NCT04237584|42202731|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
19753153|NCT04237584|42202732|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
19753154|NCT04237584|42202733|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
19753155|NCT04237584|42202734|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
19654739|NCT00737633|42103919|FG001|Overall Study|protocol non-compliance|1|||
19654740|NCT00732251|42103925|FG000|Overall Study|Lost to Follow-up|3|||
19654741|NCT00732251|42103925|FG000|Overall Study|Withdrawal by Subject|3|||
19654742|NCT00732251|42103925|FG000|Overall Study|Early Term due to Site Closure|1|||
19654743|NCT00737477|42103929|FG000|Overall Study|Adverse Event|9|||
19654744|NCT00737477|42103929|FG000|Overall Study|Death|9|||
19654745|NCT00737477|42103929|FG000|Overall Study|Treatment Refusal|1|||
19654746|NCT00737477|42103929|FG000|Overall Study|Withdrawal by Subject|1|||
19654747|NCT00737477|42103929|FG000|Overall Study|Renal Transplantation|10|||
19654748|NCT00737477|42103929|FG000|Overall Study|Other|4|||
19654749|NCT00256867|42103941|FG000|Overall Study|Adverse Event|0|||
19654750|NCT00256867|42103942|FG001|Overall Study|Adverse Event|1|||
19654751|NCT00256867|42103943|FG002|Overall Study|Adverse Event|1|||
19654752|NCT00256867|42103944|FG003|Overall Study|Adverse Event|1|||
19654753|NCT00256867|42103945|FG004|Overall Study|Adverse Event|2|||
19654754|NCT00256867|42103946|FG005|Overall Study|Adverse Event|2|||
19654755|NCT00256867|42103947|FG006|Overall Study|Adverse Event|1|||
19654756|NCT00256867|42103948|FG007|Overall Study|Adverse Event|4|||
19654757|NCT00256867|42103941|FG000|Overall Study|Lost to Follow-up|2|||
19654758|NCT00256867|42103942|FG001|Overall Study|Lost to Follow-up|2|||
19654759|NCT00256867|42103943|FG002|Overall Study|Lost to Follow-up|2|||
19654760|NCT00256867|42103944|FG003|Overall Study|Lost to Follow-up|3|||
19654761|NCT00256867|42103945|FG004|Overall Study|Lost to Follow-up|2|||
19654762|NCT00256867|42103946|FG005|Overall Study|Lost to Follow-up|0|||
19654763|NCT00256867|42103947|FG006|Overall Study|Lost to Follow-up|1|||
19654764|NCT00256867|42103948|FG007|Overall Study|Lost to Follow-up|2|||
19654765|NCT00256867|42103941|FG000|Overall Study|Protocol Violation|0|||
19654766|NCT00256867|42103942|FG001|Overall Study|Protocol Violation|0|||
19654767|NCT00256867|42103943|FG002|Overall Study|Protocol Violation|0|||
19654768|NCT00256867|42103944|FG003|Overall Study|Protocol Violation|1|||
19654769|NCT00256867|42103945|FG004|Overall Study|Protocol Violation|0|||
19654770|NCT00256867|42103946|FG005|Overall Study|Protocol Violation|1|||
19654771|NCT00256867|42103947|FG006|Overall Study|Protocol Violation|0|||
19654772|NCT00256867|42103948|FG007|Overall Study|Protocol Violation|1|||
19654773|NCT00256867|42103941|FG000|Overall Study|Withdrawal by Subject|0|||
19654774|NCT00256867|42103942|FG001|Overall Study|Withdrawal by Subject|0|||
19654775|NCT00256867|42103943|FG002|Overall Study|Withdrawal by Subject|1|||
19654776|NCT00256867|42103944|FG003|Overall Study|Withdrawal by Subject|1|||
19654777|NCT00256867|42103945|FG004|Overall Study|Withdrawal by Subject|2|||
19654778|NCT00256867|42103946|FG005|Overall Study|Withdrawal by Subject|2|||
19654779|NCT00256867|42103947|FG006|Overall Study|Withdrawal by Subject|3|||
19654780|NCT00256867|42103948|FG007|Overall Study|Withdrawal by Subject|2|||
19654781|NCT00256867|42103941|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654782|NCT00256867|42103942|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
19654783|NCT00256867|42103943|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654784|NCT00256867|42103944|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654785|NCT00256867|42103945|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654786|NCT00256867|42103946|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654787|NCT00256867|42103947|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654788|NCT00256867|42103948|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
19654789|NCT00256867|42103941|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654790|NCT00256867|42103942|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654791|NCT00256867|42103943|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654792|NCT00256867|42103944|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654793|NCT00256867|42103945|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654794|NCT00256867|42103946|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654795|NCT00256867|42103947|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
19654796|NCT00256867|42103948|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
19654797|NCT00256867|42103941|FG000|Overall Study|Investigator's Decision|0|||
19753156|NCT04237584|42202731|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
19753157|NCT04237584|42202732|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
19753158|NCT04237584|42202733|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
19753159|NCT04237584|42202734|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
19753160|NCT04237584|42202731|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
19753161|NCT04237584|42202732|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
19753162|NCT04237584|42202733|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
19753163|NCT04237584|42202734|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
19753164|NCT04237584|42202731|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
19753165|NCT04237584|42202732|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
19753166|NCT04237584|42202733|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
19753167|NCT04237584|42202734|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
19753168|NCT03224598|42202751|FG000|Overall Study|Lost to Follow-up|0|||
19753169|NCT03224598|42202752|FG001|Overall Study|Lost to Follow-up|2|||
19753170|NCT03224598|42202753|FG002|Overall Study|Lost to Follow-up|0|||
19753171|NCT03224598|42202751|FG000|Overall Study|Other|0|||
19753172|NCT03224598|42202752|FG001|Overall Study|Other|1|||
19753173|NCT03224598|42202753|FG002|Overall Study|Other|0|||
19753174|NCT03681691|42202763|FG000|Overall Study|COVID|1|||
19753175|NCT03681691|42202764|FG001|Overall Study|COVID|0|||
19601607|NCT01004822|42050351|FG006|Overall Study|Objective progression or relapse|1|||
19601608|NCT01004822|42050352|FG007|Overall Study|Objective progression or relapse|4|||
19601609|NCT01004822|42050345|FG000|Overall Study|Global deterioration of health status|0|||
19654798|NCT00256867|42103942|FG001|Overall Study|Investigator's Decision|0|||
19654799|NCT00256867|42103943|FG002|Overall Study|Investigator's Decision|0|||
19654800|NCT00256867|42103944|FG003|Overall Study|Investigator's Decision|0|||
19654801|NCT00256867|42103945|FG004|Overall Study|Investigator's Decision|1|||
19654802|NCT00256867|42103946|FG005|Overall Study|Investigator's Decision|0|||
19654803|NCT00256867|42103947|FG006|Overall Study|Investigator's Decision|0|||
19654804|NCT00256867|42103948|FG007|Overall Study|Investigator's Decision|0|||
19601610|NCT01004822|42050346|FG001|Overall Study|Global deterioration of health status|0|||
19601611|NCT01004822|42050347|FG002|Overall Study|Global deterioration of health status|0|||
19601612|NCT01004822|42050348|FG003|Overall Study|Global deterioration of health status|1|||
19601613|NCT01004822|42050349|FG004|Overall Study|Global deterioration of health status|0|||
19601614|NCT01004822|42050350|FG005|Overall Study|Global deterioration of health status|0|||
19601615|NCT01004822|42050351|FG006|Overall Study|Global deterioration of health status|1|||
19601616|NCT01004822|42050352|FG007|Overall Study|Global deterioration of health status|0|||
19601617|NCT01004822|42050345|FG000|Overall Study|No longer willing to continue|0|||
19654805|NCT00256867|42103941|FG000|Overall Study|Non-compliance with study medication|0|||
19654806|NCT00256867|42103942|FG001|Overall Study|Non-compliance with study medication|0|||
19654807|NCT00256867|42103943|FG002|Overall Study|Non-compliance with study medication|0|||
19654808|NCT00256867|42103944|FG003|Overall Study|Non-compliance with study medication|0|||
19654809|NCT00256867|42103945|FG004|Overall Study|Non-compliance with study medication|0|||
19654810|NCT00256867|42103946|FG005|Overall Study|Non-compliance with study medication|0|||
19654811|NCT00256867|42103947|FG006|Overall Study|Non-compliance with study medication|0|||
19654812|NCT00256867|42103948|FG007|Overall Study|Non-compliance with study medication|1|||
19654813|NCT00256867|42103941|FG000|Overall Study|Participant travelled Overseas|0|||
19654814|NCT00256867|42103942|FG001|Overall Study|Participant travelled Overseas|1|||
19654815|NCT00256867|42103943|FG002|Overall Study|Participant travelled Overseas|0|||
19654816|NCT00256867|42103944|FG003|Overall Study|Participant travelled Overseas|0|||
19654817|NCT00256867|42103945|FG004|Overall Study|Participant travelled Overseas|0|||
19654818|NCT00256867|42103946|FG005|Overall Study|Participant travelled Overseas|0|||
19654819|NCT00256867|42103947|FG006|Overall Study|Participant travelled Overseas|0|||
19654820|NCT00256867|42103948|FG007|Overall Study|Participant travelled Overseas|0|||
19654821|NCT00256867|42103941|FG000|Overall Study|Participant out of assessment window|0|||
19654822|NCT00256867|42103942|FG001|Overall Study|Participant out of assessment window|0|||
19654823|NCT00256867|42103943|FG002|Overall Study|Participant out of assessment window|1|||
19654824|NCT00256867|42103944|FG003|Overall Study|Participant out of assessment window|0|||
19654825|NCT00256867|42103945|FG004|Overall Study|Participant out of assessment window|0|||
19654826|NCT00256867|42103946|FG005|Overall Study|Participant out of assessment window|0|||
19654827|NCT00256867|42103947|FG006|Overall Study|Participant out of assessment window|0|||
19654828|NCT00256867|42103948|FG007|Overall Study|Participant out of assessment window|0|||
19654829|NCT00256867|42103941|FG000|Overall Study|Withdrawal by participant|0|||
19654830|NCT00256867|42103942|FG001|Overall Study|Withdrawal by participant|0|||
19654831|NCT00256867|42103943|FG002|Overall Study|Withdrawal by participant|0|||
19601618|NCT01004822|42050346|FG001|Overall Study|No longer willing to continue|0|||
19601619|NCT01004822|42050347|FG002|Overall Study|No longer willing to continue|0|||
19601620|NCT01004822|42050348|FG003|Overall Study|No longer willing to continue|1|||
19601621|NCT01004822|42050349|FG004|Overall Study|No longer willing to continue|2|||
19601622|NCT01004822|42050350|FG005|Overall Study|No longer willing to continue|1|||
19601623|NCT01004822|42050351|FG006|Overall Study|No longer willing to continue|1|||
19601624|NCT01004822|42050352|FG007|Overall Study|No longer willing to continue|0|||
19601625|NCT01004822|42050345|FG000|Overall Study|Adverse Event|0|||
19601626|NCT01004822|42050346|FG001|Overall Study|Adverse Event|0|||
19601627|NCT01004822|42050347|FG002|Overall Study|Adverse Event|0|||
19601628|NCT01004822|42050348|FG003|Overall Study|Adverse Event|0|||
19601629|NCT01004822|42050349|FG004|Overall Study|Adverse Event|0|||
19601630|NCT01004822|42050350|FG005|Overall Study|Adverse Event|0|||
19601631|NCT01004822|42050351|FG006|Overall Study|Adverse Event|1|||
19601632|NCT01004822|42050352|FG007|Overall Study|Adverse Event|1|||
19601633|NCT01004822|42050345|FG000|Overall Study|Other|0|||
19601634|NCT01004822|42050346|FG001|Overall Study|Other|0|||
19601635|NCT01004822|42050347|FG002|Overall Study|Other|4|||
19601636|NCT01004822|42050348|FG003|Overall Study|Other|1|||
19601637|NCT01004822|42050349|FG004|Overall Study|Other|0|||
19601638|NCT01004822|42050350|FG005|Overall Study|Other|1|||
19601639|NCT01004822|42050351|FG006|Overall Study|Other|0|||
19601640|NCT01004822|42050352|FG007|Overall Study|Other|0|||
19601641|NCT01001234|42050377|FG000|Overall Study|Withdrawal by Subject|2|||
19601642|NCT01001234|42050378|FG001|Overall Study|Withdrawal by Subject|0|||
19601643|NCT01001234|42050379|FG002|Overall Study|Withdrawal by Subject|3|||
19601644|NCT01001234|42050380|FG003|Overall Study|Withdrawal by Subject|0|||
19601645|NCT01001234|42050381|FG004|Overall Study|Withdrawal by Subject|0|||
19601646|NCT01001234|42050377|FG000|Overall Study|Protocol Violation|34|||
19601647|NCT01001234|42050378|FG001|Overall Study|Protocol Violation|3|||
19601648|NCT01001234|42050379|FG002|Overall Study|Protocol Violation|19|||
19601649|NCT01001234|42050380|FG003|Overall Study|Protocol Violation|18|||
19601650|NCT01001234|42050381|FG004|Overall Study|Protocol Violation|0|||
19601651|NCT01001234|42050377|FG000|Overall Study|Lost to Follow-up|0|||
19601652|NCT01001234|42050378|FG001|Overall Study|Lost to Follow-up|0|||
19601653|NCT01001234|42050379|FG002|Overall Study|Lost to Follow-up|1|||
19601654|NCT01001234|42050380|FG003|Overall Study|Lost to Follow-up|2|||
19601655|NCT01001234|42050381|FG004|Overall Study|Lost to Follow-up|0|||
19601656|NCT01001234|42050377|FG000|Overall Study|Physician Decision|1|||
19601657|NCT01001234|42050378|FG001|Overall Study|Physician Decision|0|||
19601658|NCT01001234|42050379|FG002|Overall Study|Physician Decision|0|||
19601659|NCT01001234|42050380|FG003|Overall Study|Physician Decision|0|||
19601660|NCT01001234|42050381|FG004|Overall Study|Physician Decision|0|||
19601661|NCT01001234|42050377|FG000|Overall Study|Not Treated: Adverse Event|1|||
19601662|NCT01001234|42050378|FG001|Overall Study|Not Treated: Adverse Event|0|||
19601663|NCT01001234|42050379|FG002|Overall Study|Not Treated: Adverse Event|0|||
19601664|NCT01001234|42050380|FG003|Overall Study|Not Treated: Adverse Event|0|||
19601665|NCT01001234|42050381|FG004|Overall Study|Not Treated: Adverse Event|0|||
19601666|NCT01001234|42050377|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
19601667|NCT01001234|42050378|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
19601668|NCT01001234|42050379|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
19654832|NCT00256867|42103944|FG003|Overall Study|Withdrawal by participant|0|||
19654833|NCT00256867|42103945|FG004|Overall Study|Withdrawal by participant|0|||
19654834|NCT00256867|42103946|FG005|Overall Study|Withdrawal by participant|1|||
19654835|NCT00256867|42103947|FG006|Overall Study|Withdrawal by participant|0|||
19654836|NCT00256867|42103948|FG007|Overall Study|Withdrawal by participant|0|||
19654837|NCT00731939|42103971|FG000|Overall Study|Adverse Event|6|||
19654838|NCT00731939|42103971|FG000|Overall Study|Lost to Follow-up|15|||
19654839|NCT00731939|42103971|FG000|Overall Study|Not implanted with study device|9|||
19654840|NCT00731939|42103971|FG000|Overall Study|Withdrawal by Subject|2|||
19654841|NCT00731939|42103971|FG000|Overall Study|Did not meet enrollment criteria|2|||
19654842|NCT00731783|42103977|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
19654843|NCT00731783|42103978|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
19654844|NCT00731783|42103977|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
19654845|NCT00731783|42103978|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
19654846|NCT00731783|42103977|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
19654847|NCT00731783|42103978|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
19654848|NCT00731783|42103977|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
19654849|NCT00731783|42103978|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
19654850|NCT00724451|42103984|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
19654851|NCT00724451|42103984|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
19654852|NCT00724451|42103984|FG000|Overall Study|Not Eligible for Treatment|431|||
19654853|NCT00724451|42103984|FG000|Overall Study|Participant Refused Treatment|89|||
19654854|NCT00724451|42103984|FG000|Overall Study|Never Started Treatment|89|||
19654855|NCT00724451|42103984|FG000|Overall Study|Unknown; No Data Sources Available|9|||
19654856|NCT00724451|42103984|FG000|Overall Study|Physician Decision|116|||
19654857|NCT00724451|42103984|FG000|Overall Study|Withdrawal by Subject|45|||
19654858|NCT00724451|42103984|FG000|Overall Study|Investigator + Participant Decision|13|||
19654859|NCT00724373|42103988|FG000|Overall Study|Adverse Event|41|||
19654860|NCT00724373|42103988|FG000|Overall Study|Lack of Efficacy|82|||
19654861|NCT00724373|42103988|FG000|Overall Study|Lost to Follow-up|7|||
19601669|NCT01001234|42050380|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
19601670|NCT01001234|42050381|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
19601671|NCT01001234|42050377|FG000|Overall Study|Not Treated: Protocol Violation|3|||
19601672|NCT01001234|42050378|FG001|Overall Study|Not Treated: Protocol Violation|0|||
19601673|NCT01001234|42050379|FG002|Overall Study|Not Treated: Protocol Violation|0|||
19601674|NCT01001234|42050380|FG003|Overall Study|Not Treated: Protocol Violation|0|||
19601675|NCT01001234|42050381|FG004|Overall Study|Not Treated: Protocol Violation|0|||
19601676|NCT01001234|42050377|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
19601677|NCT01001234|42050378|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
19601678|NCT01001234|42050379|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
19601679|NCT01001234|42050380|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
19601680|NCT01001234|42050381|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
19601681|NCT01001234|42050377|FG000|Overall Study|Not Treated: Pregnancy|3|||
19601682|NCT01001234|42050378|FG001|Overall Study|Not Treated: Pregnancy|0|||
19601683|NCT01001234|42050379|FG002|Overall Study|Not Treated: Pregnancy|0|||
19601684|NCT01001234|42050380|FG003|Overall Study|Not Treated: Pregnancy|0|||
19601685|NCT01001234|42050381|FG004|Overall Study|Not Treated: Pregnancy|0|||
19601686|NCT01001234|42050377|FG000|Overall Study|Not Treated: Physician Decision|37|||
19601687|NCT01001234|42050378|FG001|Overall Study|Not Treated: Physician Decision|4|||
19601688|NCT01001234|42050379|FG002|Overall Study|Not Treated: Physician Decision|0|||
19601689|NCT01001234|42050380|FG003|Overall Study|Not Treated: Physician Decision|0|||
19601690|NCT01001234|42050381|FG004|Overall Study|Not Treated: Physician Decision|0|||
19601691|NCT01001234|42050377|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
19601692|NCT01001234|42050378|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
19601693|NCT01001234|42050379|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
19601694|NCT01001234|42050380|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
19601695|NCT01001234|42050381|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
19601696|NCT01004510|42050387|FG000|Overall Study|Adverse Event|1|||
19601697|NCT02609503|42050391|FG000|Overall Study|Adverse Event|1|||
19601698|NCT02609503|42050391|FG000|Overall Study|Death|1|||
19601699|NCT02609503|42050391|FG000|Overall Study|Withdrawal by Subject|1|||
19601700|NCT02609503|42050391|FG000|Overall Study|Disease progression|1|||
19601701|NCT01004432|42050398|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
19601702|NCT01004432|42050399|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
19601703|NCT01004432|42050400|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
19601704|NCT01004432|42050401|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
19601705|NCT01004432|42050402|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
19601706|NCT01004432|42050398|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
19601707|NCT01004432|42050399|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
19654862|NCT00724373|42103988|FG000|Overall Study|Non-compliance|2|||
19654863|NCT00724373|42103988|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
19654864|NCT00724373|42103988|FG000|Overall Study|Participant moved away|1|||
19654865|NCT00724373|42103988|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
19654866|NCT00724373|42103988|FG000|Overall Study|Only to have 24 week regimen|1|||
19654867|NCT00724373|42103988|FG000|Overall Study|Viral Relapse|1|||
19654868|NCT00724373|42103988|FG000|Overall Study|Acute HCV infection|1|||
19654869|NCT00724373|42103988|FG000|Overall Study|Drug Relapse|1|||
19654870|NCT00724373|42103988|FG000|Overall Study|Tolerability|23|||
19654871|NCT00724061|42103992|FG000|Dose Escalation Phase|Adverse Event|2|||
19654872|NCT00724061|42103992|FG000|Dose Escalation Phase|Disease Progression|3|||
19654873|NCT00731549|42103996|FG000|Overall Study|Lost to Follow-up|19|||
19654874|NCT00731549|42103996|FG000|Overall Study|Met withdrawal criteria|24|||
19654875|NCT00731549|42103996|FG000|Overall Study|Physician Decision|16|||
19654876|NCT00731549|42103996|FG000|Overall Study|Withdrawal by Subject|89|||
19654877|NCT00731549|42103996|FG000|Overall Study|Protocol deviation|1|||
19654878|NCT00731549|42103996|FG000|Overall Study|Adverse Event|31|||
19654879|NCT00731549|42103996|FG000|Overall Study|Lack of efficacy with AE|37|||
19654880|NCT00731549|42103996|FG000|Overall Study|Lack of efficacy without AE|6|||
19654881|NCT00730925|42104041|FG000|Overall Study|Progressive Disease|21|||
19654882|NCT00730925|42104041|FG000|Overall Study|Dose reducing Event|2|||
19654883|NCT00730925|42104041|FG000|Overall Study|Other Averse Event|7|||
19654884|NCT00730925|42104041|FG000|Overall Study|Protocol Violation|1|||
19654885|NCT00730925|42104041|FG000|Overall Study|Withdrawal by Subject|1|||
19654886|NCT00730925|42104041|FG000|Overall Study|Switch to combination therapy|8|||
19654887|NCT00730925|42104041|FG000|Overall Study|Other|1|||
19654888|NCT00236899|42104049|FG000|Overall Study|Adverse Event (Study Related)|1|||
19654889|NCT00236899|42104050|FG001|Overall Study|Adverse Event (Study Related)|1|||
19654890|NCT00236899|42104051|FG002|Overall Study|Adverse Event (Study Related)|2|||
19654891|NCT00236899|42104052|FG003|Overall Study|Adverse Event (Study Related)|1|||
19654892|NCT00236899|42104049|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
19654893|NCT00236899|42104050|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
19654894|NCT00236899|42104051|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
19654895|NCT00236899|42104052|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
19654896|NCT00236899|42104049|FG000|Overall Study|Death (Study Disease)|1|||
19654897|NCT00236899|42104050|FG001|Overall Study|Death (Study Disease)|4|||
19654898|NCT00236899|42104051|FG002|Overall Study|Death (Study Disease)|0|||
19654899|NCT00236899|42104052|FG003|Overall Study|Death (Study Disease)|0|||
19654900|NCT00236899|42104049|FG000|Overall Study|Death (Not Study Related)|2|||
19654901|NCT00236899|42104050|FG001|Overall Study|Death (Not Study Related)|0|||
19654902|NCT00236899|42104051|FG002|Overall Study|Death (Not Study Related)|0|||
19654903|NCT00236899|42104052|FG003|Overall Study|Death (Not Study Related)|0|||
19654904|NCT00236899|42104049|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
19654905|NCT00236899|42104050|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
19654906|NCT00236899|42104051|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
19654907|NCT00236899|42104052|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
19654908|NCT00236899|42104049|FG000|Overall Study|Lost to Follow-up|0|||
19654909|NCT00236899|42104050|FG001|Overall Study|Lost to Follow-up|1|||
19654910|NCT00236899|42104051|FG002|Overall Study|Lost to Follow-up|0|||
19388275|NCT02556801|41631716|FG000|Overall Study|Withdrawal by Subject|1|||
19388276|NCT02556801|41631717|FG001|Overall Study|Withdrawal by Subject|1|||
19388277|NCT02556801|41631718|FG002|Overall Study|Withdrawal by Subject|1|||
19601708|NCT01004432|42050400|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
19601709|NCT01004432|42050401|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
19601710|NCT01004432|42050402|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
19601711|NCT01004432|42050398|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
19601712|NCT01004432|42050399|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
19601713|NCT01004432|42050400|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
19601714|NCT01004432|42050401|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
19601715|NCT01004432|42050402|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
19601716|NCT01004432|42050398|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
19601717|NCT01004432|42050399|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
19601718|NCT01004432|42050400|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
19601719|NCT01004432|42050401|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
19601720|NCT01004432|42050402|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
19601721|NCT01004432|42050398|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
19601722|NCT01004432|42050399|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
19601723|NCT01004432|42050400|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
19601724|NCT01004432|42050401|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
19601725|NCT01004432|42050402|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
19601726|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
19654911|NCT00236899|42104052|FG003|Overall Study|Lost to Follow-up|0|||
19388278|NCT02556801|41631719|FG003|Overall Study|Withdrawal by Subject|0|||
19388279|NCT02556801|41631716|FG000|Overall Study|Protocol Violation|0|||
19654912|NCT00236899|42104049|FG000|Overall Study|Entry Criteria Exclusion|0|||
19698959|NCT00312494|42143768|FG001|Overall Study|Other|10|||
19753176|NCT03681691|42202763|FG000|Overall Study|prolonged bleeding|1|||
19753177|NCT03681691|42202764|FG001|Overall Study|prolonged bleeding|0|||
19753178|NCT03681691|42202763|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
19753179|NCT03681691|42202764|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
19753180|NCT02935842|42202776|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
19753181|NCT02935842|42202777|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
19753182|NCT02935842|42202778|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
19753183|NCT02935842|42202779|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
19753184|NCT02935842|42202776|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
19753185|NCT02935842|42202777|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
19753186|NCT02935842|42202778|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
19753187|NCT02935842|42202779|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
19753188|NCT02935842|42202776|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
19753189|NCT02935842|42202777|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
19753190|NCT02935842|42202778|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
19753191|NCT02935842|42202779|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
19753192|NCT02935842|42202776|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
19654913|NCT00236899|42104050|FG001|Overall Study|Entry Criteria Exclusion|1|||
19654914|NCT00236899|42104051|FG002|Overall Study|Entry Criteria Exclusion|1|||
19654915|NCT00236899|42104052|FG003|Overall Study|Entry Criteria Exclusion|0|||
19654916|NCT00236899|42104049|FG000|Overall Study|Protocol Violation|1|||
19654917|NCT00236899|42104050|FG001|Overall Study|Protocol Violation|0|||
19654918|NCT00236899|42104051|FG002|Overall Study|Protocol Violation|0|||
19654919|NCT00236899|42104052|FG003|Overall Study|Protocol Violation|0|||
19654920|NCT00236899|42104049|FG000|Overall Study|Withdrawal by Subject|6|||
19654921|NCT00236899|42104050|FG001|Overall Study|Withdrawal by Subject|4|||
19388280|NCT02556801|41631717|FG001|Overall Study|Protocol Violation|3|||
19388281|NCT02556801|41631718|FG002|Overall Study|Protocol Violation|1|||
19388282|NCT02556801|41631719|FG003|Overall Study|Protocol Violation|1|||
19388283|NCT02556801|41631716|FG000|Overall Study|Adverse Event|0|||
19388284|NCT02556801|41631717|FG001|Overall Study|Adverse Event|2|||
19388285|NCT02556801|41631718|FG002|Overall Study|Adverse Event|0|||
19388286|NCT02556801|41631719|FG003|Overall Study|Adverse Event|3|||
19388287|NCT02556801|41631716|FG000|Overall Study|Pregnancy|0|||
19388288|NCT02556801|41631717|FG001|Overall Study|Pregnancy|1|||
19388289|NCT02556801|41631718|FG002|Overall Study|Pregnancy|0|||
19388290|NCT02556801|41631719|FG003|Overall Study|Pregnancy|0|||
19388291|NCT02556801|41631716|FG000|Overall Study|Personal reasons patient|0|||
19388292|NCT02556801|41631717|FG001|Overall Study|Personal reasons patient|0|||
19601727|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
19601728|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
19601729|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
19601730|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
19601731|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
19601732|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
19601733|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
19601734|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
19601735|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
19601736|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
19601737|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
19654922|NCT00236899|42104051|FG002|Overall Study|Withdrawal by Subject|5|||
19654923|NCT00236899|42104052|FG003|Overall Study|Withdrawal by Subject|2|||
19388293|NCT02556801|41631718|FG002|Overall Study|Personal reasons patient|0|||
19388294|NCT02556801|41631719|FG003|Overall Study|Personal reasons patient|1|||
19388295|NCT02556177|41631731|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
19388296|NCT02556177|41631732|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
19388297|NCT02554929|41631740|FG000|Overall Study|Lost to Follow-up|4|||
19388298|NCT02554929|41631741|FG001|Overall Study|Lost to Follow-up|4|||
19388299|NCT02554929|41631740|FG000|Overall Study|Withdrawal by Subject|2|||
19388300|NCT02554929|41631741|FG001|Overall Study|Withdrawal by Subject|8|||
19388301|NCT03745989|41631759|FG000|Overall Study|Death|3|||
19388302|NCT03745989|41631760|FG001|Overall Study|Death|7|||
19388303|NCT03745989|41631761|FG002|Overall Study|Death|4|||
19654924|NCT00236899|42104049|FG000|Overall Study|Physician Decision|7|||
19654925|NCT00236899|42104050|FG001|Overall Study|Physician Decision|8|||
19654926|NCT00236899|42104051|FG002|Overall Study|Physician Decision|7|||
19654927|NCT00236899|42104052|FG003|Overall Study|Physician Decision|6|||
19654928|NCT00236899|42104049|FG000|Overall Study|Satisfactory Response|2|||
19654929|NCT00236899|42104050|FG001|Overall Study|Satisfactory Response|0|||
19654930|NCT00236899|42104051|FG002|Overall Study|Satisfactory Response|0|||
19654931|NCT00236899|42104052|FG003|Overall Study|Satisfactory Response|1|||
19654932|NCT00236899|42104049|FG000|Overall Study|Lack of Efficacy|18|||
19654933|NCT00236899|42104050|FG001|Overall Study|Lack of Efficacy|18|||
19654934|NCT00236899|42104051|FG002|Overall Study|Lack of Efficacy|25|||
19654935|NCT00236899|42104052|FG003|Overall Study|Lack of Efficacy|23|||
19654936|NCT00611130|42104071|FG000|Overall Study|Lost to Follow-up|25|||
19654937|NCT00611130|42104072|FG001|Overall Study|Lost to Follow-up|29|||
19654938|NCT00611130|42104071|FG000|Overall Study|Protocol noncompliance|7|||
19654939|NCT00611130|42104072|FG001|Overall Study|Protocol noncompliance|6|||
19654940|NCT00611130|42104071|FG000|Overall Study|Withdrawal by Subject|6|||
19654941|NCT00611130|42104072|FG001|Overall Study|Withdrawal by Subject|5|||
19654942|NCT00611130|42104071|FG000|Overall Study|Other|5|||
19654943|NCT00611130|42104072|FG001|Overall Study|Other|4|||
19654944|NCT00611130|42104071|FG000|Overall Study|Incarceration|3|||
19654945|NCT00611130|42104072|FG001|Overall Study|Incarceration|2|||
19654946|NCT00611130|42104071|FG000|Overall Study|Administrative|1|||
19654947|NCT00611130|42104072|FG001|Overall Study|Administrative|1|||
19654948|NCT00611130|42104071|FG000|Overall Study|Adverse Event|1|||
19654949|NCT00611130|42104072|FG001|Overall Study|Adverse Event|0|||
19654950|NCT00611130|42104071|FG000|Overall Study|Death|1|||
19654951|NCT00611130|42104072|FG001|Overall Study|Death|0|||
19654952|NCT00256243|42104079|FG000|Overall Study|Lost to Follow-up|2|||
19654953|NCT00256243|42104079|FG000|Overall Study|Death|7|||
19654954|NCT00256243|42104079|FG000|Overall Study|Not treated|1|||
19654955|NCT00236197|42104086|FG000|Overall Study|Withdrawal by Subject|3|||
19654956|NCT00236197|42104087|FG001|Overall Study|Withdrawal by Subject|2|||
19654957|NCT00236197|42104086|FG000|Overall Study|Lost to Follow-up|1|||
19654958|NCT00236197|42104087|FG001|Overall Study|Lost to Follow-up|5|||
19654959|NCT00236197|42104086|FG000|Overall Study|Protocol Violation|0|||
19654960|NCT00236197|42104087|FG001|Overall Study|Protocol Violation|3|||
19654961|NCT00236197|42104086|FG000|Overall Study|Medication non-compliance|1|||
19654962|NCT00236197|42104087|FG001|Overall Study|Medication non-compliance|2|||
19654963|NCT00236197|42104086|FG000|Overall Study|Other|0|||
19654964|NCT00236197|42104087|FG001|Overall Study|Other|2|||
19654965|NCT00278629|42104093|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
19654966|NCT00612690|42104100|FG000|Overall Study|Lost to Follow-up|72|||
19654967|NCT00612690|42104101|FG001|Overall Study|Lost to Follow-up|98|||
19654968|NCT00612690|42104100|FG000|Overall Study|Withdrawal by Subject|32|||
19654969|NCT00612690|42104101|FG001|Overall Study|Withdrawal by Subject|20|||
19654970|NCT00612690|42104100|FG000|Overall Study|Withdrawal by Site|11|||
19654971|NCT00612690|42104101|FG001|Overall Study|Withdrawal by Site|0|||
19654972|NCT00278473|42104111|FG000|Overall Study|drop out|4|||
19654973|NCT00278473|42104112|FG001|Overall Study|drop out|3|||
19654974|NCT00278395|42104118|FG000|Overall Study|Adverse Event|2|||
19654975|NCT00278395|42104118|FG000|Overall Study|Nonevaluable|1|||
19654976|NCT00612534|42104129|FG000|Overall Study|Adverse Event|0|||
19654977|NCT00612534|42104130|FG001|Overall Study|Adverse Event|4|||
19654978|NCT00612534|42104131|FG002|Overall Study|Adverse Event|2|||
19654979|NCT00612534|42104132|FG003|Overall Study|Adverse Event|1|||
19654980|NCT00612534|42104129|FG000|Overall Study|Lack of Efficacy|13|||
19654981|NCT00612534|42104130|FG001|Overall Study|Lack of Efficacy|12|||
19654982|NCT00612534|42104131|FG002|Overall Study|Lack of Efficacy|5|||
19654983|NCT00612534|42104132|FG003|Overall Study|Lack of Efficacy|16|||
19654984|NCT00612534|42104129|FG000|Overall Study|Other Reason|0|||
19654985|NCT00612534|42104130|FG001|Overall Study|Other Reason|1|||
19388304|NCT03745989|41631759|FG000|Overall Study|Lost to Follow-up|0|||
19388305|NCT03745989|41631760|FG001|Overall Study|Lost to Follow-up|2|||
19388306|NCT03745989|41631761|FG002|Overall Study|Lost to Follow-up|0|||
19654986|NCT00612534|42104131|FG002|Overall Study|Other Reason|0|||
19654987|NCT00612534|42104132|FG003|Overall Study|Other Reason|0|||
19654988|NCT00736853|42104142|FG000|Open-Label Period|Physician Decision|2|||
19654989|NCT00736853|42104143|FG001|Open-Label Period|Physician Decision|0|||
19654990|NCT00736853|42104144|FG002|Open-Label Period|Physician Decision|0|||
19654991|NCT00736853|42104142|FG000|Open-Label Period|Adverse Event|31|||
19654992|NCT00736853|42104143|FG001|Open-Label Period|Adverse Event|0|||
19654993|NCT00736853|42104144|FG002|Open-Label Period|Adverse Event|0|||
19654994|NCT00736853|42104142|FG000|Open-Label Period|Withdrawal by Subject|16|||
19654995|NCT00736853|42104143|FG001|Open-Label Period|Withdrawal by Subject|0|||
19654996|NCT00736853|42104144|FG002|Open-Label Period|Withdrawal by Subject|0|||
19654997|NCT00736853|42104142|FG000|Open-Label Period|Started but not treated|42|||
19654998|NCT00736853|42104143|FG001|Open-Label Period|Started but not treated|0|||
19654999|NCT00736853|42104144|FG002|Open-Label Period|Started but not treated|0|||
19655000|NCT00736853|42104142|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
19655001|NCT00736853|42104143|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
19655002|NCT00736853|42104144|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
19655003|NCT00736853|42104142|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
19655004|NCT00736853|42104143|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
19655005|NCT00736853|42104144|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
19655006|NCT00736853|42104142|FG000|Double-Blind Period|Lack of Efficacy|0|||
19601738|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
19601739|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
19655007|NCT00736853|42104143|FG001|Double-Blind Period|Lack of Efficacy|19|||
19655008|NCT00736853|42104144|FG002|Double-Blind Period|Lack of Efficacy|42|||
19655009|NCT00736853|42104142|FG000|Double-Blind Period|Adverse Event|0|||
19655010|NCT00736853|42104143|FG001|Double-Blind Period|Adverse Event|3|||
19655011|NCT00736853|42104144|FG002|Double-Blind Period|Adverse Event|2|||
19655012|NCT00736853|42104142|FG000|Double-Blind Period|Withdrawal by Subject|0|||
19655013|NCT00736853|42104143|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19655014|NCT00736853|42104144|FG002|Double-Blind Period|Withdrawal by Subject|4|||
19655015|NCT00736853|42104142|FG000|Double-Blind Period|Ineligible to participate the study|0|||
19655016|NCT00736853|42104143|FG001|Double-Blind Period|Ineligible to participate the study|1|||
19655017|NCT00736853|42104144|FG002|Double-Blind Period|Ineligible to participate the study|0|||
19655018|NCT00730847|42104153|FG000|Overall Study|Adverse Event|1|||
19655019|NCT00730847|42104153|FG000|Overall Study|Protocol Violation|2|||
19655020|NCT00730847|42104153|FG000|Overall Study|Withdrawal by Subject|16|||
19655021|NCT00730847|42104153|FG000|Overall Study|Lost to Follow-up|67|||
19655022|NCT00730847|42104153|FG000|Overall Study|Unknown completion status|21|||
19655023|NCT00730847|42104153|FG000|Overall Study|Other|24|||
19655024|NCT00573066|42104157|FG000|Overall Study|Exclusion criteria|18|||
19388307|NCT03745989|41631759|FG000|Overall Study|Sponsor Decision|0|||
19601740|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
19601741|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
19601742|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
19601743|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
19601744|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
19601745|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
19601746|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
19655025|NCT00573066|42104157|FG000|Overall Study|IV malfunction|1|||
19655026|NCT00573066|42104157|FG000|Overall Study|Postoperative bleeding|1|||
19655027|NCT00612456|42104164|FG000|Overall Study|Adverse Event|1|||
19655028|NCT00612456|42104165|FG001|Overall Study|Adverse Event|0|||
19655029|NCT00612456|42104166|FG002|Overall Study|Adverse Event|0|||
19655030|NCT00612456|42104164|FG000|Overall Study|Lack of Efficacy|1|||
19655031|NCT00612456|42104165|FG001|Overall Study|Lack of Efficacy|1|||
19655032|NCT00612456|42104166|FG002|Overall Study|Lack of Efficacy|0|||
19655033|NCT00612456|42104164|FG000|Overall Study|Withdrawal by Subject|0|||
19655034|NCT00612456|42104165|FG001|Overall Study|Withdrawal by Subject|1|||
19655035|NCT00612456|42104166|FG002|Overall Study|Withdrawal by Subject|0|||
19655036|NCT00730691|42104181|FG000|Overall Study|Adverse Event|4|||
19655037|NCT00730691|42104182|FG001|Overall Study|Adverse Event|8|||
19655038|NCT00730691|42104183|FG002|Overall Study|Adverse Event|11|||
19655039|NCT00730691|42104184|FG003|Overall Study|Adverse Event|11|||
19655040|NCT00730691|42104185|FG004|Overall Study|Adverse Event|23|||
19655041|NCT00730691|42104181|FG000|Overall Study|Lack of Efficacy|4|||
19655042|NCT00730691|42104182|FG001|Overall Study|Lack of Efficacy|4|||
19655043|NCT00730691|42104183|FG002|Overall Study|Lack of Efficacy|2|||
19655044|NCT00730691|42104184|FG003|Overall Study|Lack of Efficacy|1|||
19655045|NCT00730691|42104185|FG004|Overall Study|Lack of Efficacy|1|||
19655046|NCT00730691|42104181|FG000|Overall Study|Non-compliance with Study Drug|6|||
19655047|NCT00730691|42104182|FG001|Overall Study|Non-compliance with Study Drug|1|||
19655048|NCT00730691|42104183|FG002|Overall Study|Non-compliance with Study Drug|6|||
19655049|NCT00730691|42104184|FG003|Overall Study|Non-compliance with Study Drug|3|||
19655050|NCT00730691|42104185|FG004|Overall Study|Non-compliance with Study Drug|3|||
19655051|NCT00730691|42104181|FG000|Overall Study|Protocol Deviations|3|||
19655052|NCT00730691|42104182|FG001|Overall Study|Protocol Deviations|5|||
19655053|NCT00730691|42104183|FG002|Overall Study|Protocol Deviations|3|||
19655054|NCT00730691|42104184|FG003|Overall Study|Protocol Deviations|7|||
19655055|NCT00730691|42104185|FG004|Overall Study|Protocol Deviations|5|||
19655056|NCT00730691|42104181|FG000|Overall Study|Withdrawal of Consent|7|||
19655057|NCT00730691|42104182|FG001|Overall Study|Withdrawal of Consent|9|||
19655058|NCT00730691|42104183|FG002|Overall Study|Withdrawal of Consent|3|||
19655059|NCT00730691|42104184|FG003|Overall Study|Withdrawal of Consent|6|||
19655060|NCT00730691|42104185|FG004|Overall Study|Withdrawal of Consent|3|||
19655061|NCT00730691|42104181|FG000|Overall Study|Lost to Follow-up|11|||
19655062|NCT00730691|42104182|FG001|Overall Study|Lost to Follow-up|8|||
19655063|NCT00730691|42104183|FG002|Overall Study|Lost to Follow-up|13|||
19655064|NCT00730691|42104184|FG003|Overall Study|Lost to Follow-up|15|||
19655065|NCT00730691|42104185|FG004|Overall Study|Lost to Follow-up|13|||
19655066|NCT00730691|42104181|FG000|Overall Study|Other|1|||
19655067|NCT00730691|42104182|FG001|Overall Study|Other|1|||
19655068|NCT00730691|42104183|FG002|Overall Study|Other|1|||
19655069|NCT00730691|42104184|FG003|Overall Study|Other|2|||
19655070|NCT00730691|42104185|FG004|Overall Study|Other|2|||
19655071|NCT00235495|42104199|FG000|Overall Study|Death|52|||
19655072|NCT00235495|42104200|FG001|Overall Study|Death|42|||
19655073|NCT00235495|42104199|FG000|Overall Study|Withdrawal by Subject|5|||
19655074|NCT00235495|42104200|FG001|Overall Study|Withdrawal by Subject|3|||
19655075|NCT00235495|42104199|FG000|Overall Study|Lost to Follow-up|11|||
19655076|NCT00235495|42104200|FG001|Overall Study|Lost to Follow-up|13|||
19655077|NCT00235495|42104199|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
19655078|NCT00235495|42104200|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
19655079|NCT00278161|42104206|FG000|Overall Study|Death|11|||
19655080|NCT00255151|42104213|FG000|Overall Study|Adverse Event|10|||
19655081|NCT00255151|42104214|FG001|Overall Study|Adverse Event|6|||
19655082|NCT00255151|42104215|FG002|Overall Study|Adverse Event|9|||
19655083|NCT00255151|42104213|FG000|Overall Study|Lost to Follow-up|4|||
19655084|NCT00255151|42104214|FG001|Overall Study|Lost to Follow-up|3|||
19655085|NCT00255151|42104215|FG002|Overall Study|Lost to Follow-up|4|||
19655086|NCT00255151|42104213|FG000|Overall Study|Withdrawal by Subject|18|||
19655087|NCT00255151|42104214|FG001|Overall Study|Withdrawal by Subject|17|||
19655088|NCT00255151|42104215|FG002|Overall Study|Withdrawal by Subject|8|||
19655089|NCT00255151|42104213|FG000|Overall Study|Noncompliance|0|||
19655090|NCT00255151|42104214|FG001|Overall Study|Noncompliance|1|||
19655091|NCT00255151|42104215|FG002|Overall Study|Noncompliance|2|||
19655092|NCT00255151|42104213|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
19655093|NCT00255151|42104214|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
19655094|NCT00255151|42104215|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
19655095|NCT00255151|42104213|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
19655096|NCT00255151|42104214|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
19655097|NCT00255151|42104215|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
19655098|NCT00255151|42104213|FG000|Overall Study|Possible Barrett's Esophagus|1|||
19655099|NCT00255151|42104214|FG001|Overall Study|Possible Barrett's Esophagus|3|||
19655100|NCT00255151|42104215|FG002|Overall Study|Possible Barrett's Esophagus|8|||
19655101|NCT00255151|42104213|FG000|Overall Study|Esophageal Stricture|0|||
19655102|NCT00255151|42104214|FG001|Overall Study|Esophageal Stricture|0|||
19655103|NCT00255151|42104215|FG002|Overall Study|Esophageal Stricture|1|||
19655104|NCT00255151|42104213|FG000|Overall Study|Therapeutic Failure|11|||
19655105|NCT00255151|42104214|FG001|Overall Study|Therapeutic Failure|2|||
19655106|NCT00255151|42104215|FG002|Overall Study|Therapeutic Failure|3|||
19655107|NCT00658658|42104228|FG000|Overall Study|Withdrawal by Subject|0|||
19698960|NCT00312494|42143769|FG002|Overall Study|Other|1|||
19655108|NCT00658658|42104229|FG001|Overall Study|Withdrawal by Subject|1|||
19655109|NCT00658658|42104230|FG002|Overall Study|Withdrawal by Subject|0|||
19655110|NCT00658658|42104231|FG003|Overall Study|Withdrawal by Subject|0|||
19655111|NCT00658658|42104232|FG004|Overall Study|Withdrawal by Subject|0|||
19655112|NCT00658658|42104228|FG000|Overall Study|Death|4|||
19655113|NCT00658658|42104229|FG001|Overall Study|Death|0|||
19655114|NCT00658658|42104230|FG002|Overall Study|Death|0|||
19655115|NCT00658658|42104231|FG003|Overall Study|Death|1|||
19655116|NCT00658658|42104232|FG004|Overall Study|Death|1|||
19655117|NCT00658658|42104228|FG000|Overall Study|Disease Progression|0|||
19655118|NCT00658658|42104229|FG001|Overall Study|Disease Progression|1|||
19655119|NCT00658658|42104230|FG002|Overall Study|Disease Progression|0|||
19655120|NCT00658658|42104231|FG003|Overall Study|Disease Progression|1|||
19655121|NCT00658658|42104232|FG004|Overall Study|Disease Progression|3|||
19655122|NCT00658658|42104228|FG000|Overall Study|Protocol-specified Criteria|1|||
19655123|NCT00658658|42104229|FG001|Overall Study|Protocol-specified Criteria|0|||
19655124|NCT00658658|42104230|FG002|Overall Study|Protocol-specified Criteria|0|||
19655125|NCT00658658|42104231|FG003|Overall Study|Protocol-specified Criteria|0|||
19655126|NCT00658658|42104232|FG004|Overall Study|Protocol-specified Criteria|0|||
19655127|NCT00658658|42104228|FG000|Overall Study|Other|0|||
19655128|NCT00658658|42104229|FG001|Overall Study|Other|0|||
19655129|NCT00658658|42104230|FG002|Overall Study|Other|0|||
19655130|NCT00658658|42104231|FG003|Overall Study|Other|0|||
19655131|NCT00658658|42104232|FG004|Overall Study|Other|1|||
19655132|NCT00723203|42104244|FG000|Overall Study|Withdrawal by Subject|3|||
19655133|NCT00233389|42104250|FG000|Overall Study|Adverse Event|5|||
19655134|NCT00233389|42104251|FG001|Overall Study|Adverse Event|5|||
19655135|NCT00233389|42104250|FG000|Overall Study|Lack of Efficacy|11|||
19655136|NCT00233389|42104251|FG001|Overall Study|Lack of Efficacy|8|||
19655137|NCT00233389|42104250|FG000|Overall Study|Lost to Follow-up|1|||
19655138|NCT00233389|42104251|FG001|Overall Study|Lost to Follow-up|1|||
19655139|NCT00233389|42104250|FG000|Overall Study|Physician Decision|1|||
19655140|NCT00233389|42104251|FG001|Overall Study|Physician Decision|0|||
19655141|NCT00233389|42104250|FG000|Overall Study|Protocol Violation|0|||
19655142|NCT00233389|42104251|FG001|Overall Study|Protocol Violation|1|||
19655143|NCT00233389|42104250|FG000|Overall Study|Withdrawal by Subject|0|||
19655144|NCT00233389|42104251|FG001|Overall Study|Withdrawal by Subject|1|||
19655145|NCT00543543|42104261|FG000|Base Study|Adverse Event|1|||
19655146|NCT00543543|42104262|FG001|Base Study|Adverse Event|11|||
19655147|NCT00543543|42104263|FG002|Base Study|Adverse Event|0|||
19655148|NCT00543543|42104264|FG003|Base Study|Adverse Event|5|||
19655149|NCT00543543|42104261|FG000|Base Study|Lost to Follow-up|12|||
19655150|NCT00543543|42104262|FG001|Base Study|Lost to Follow-up|749|||
19655151|NCT00543543|42104263|FG002|Base Study|Lost to Follow-up|9|||
19655152|NCT00543543|42104264|FG003|Base Study|Lost to Follow-up|701|||
19655153|NCT00543543|42104261|FG000|Base Study|Physician Decision|0|||
19655154|NCT00543543|42104262|FG001|Base Study|Physician Decision|4|||
19655155|NCT00543543|42104263|FG002|Base Study|Physician Decision|0|||
19655156|NCT00543543|42104264|FG003|Base Study|Physician Decision|7|||
19655157|NCT00543543|42104261|FG000|Base Study|Protocol Violation|0|||
19655158|NCT00543543|42104262|FG001|Base Study|Protocol Violation|6|||
19655159|NCT00543543|42104263|FG002|Base Study|Protocol Violation|0|||
19655160|NCT00543543|42104264|FG003|Base Study|Protocol Violation|6|||
19655161|NCT00543543|42104261|FG000|Base Study|Withdrawal by Subject|7|||
19655162|NCT00543543|42104262|FG001|Base Study|Withdrawal by Subject|482|||
19655163|NCT00543543|42104263|FG002|Base Study|Withdrawal by Subject|5|||
19655164|NCT00543543|42104264|FG003|Base Study|Withdrawal by Subject|503|||
19655165|NCT00543543|42104261|FG000|Extension Study|Adverse Event|0|||
19655166|NCT00543543|42104262|FG001|Extension Study|Adverse Event|0|||
19655167|NCT00543543|42104263|FG002|Extension Study|Adverse Event|0|||
19655168|NCT00543543|42104264|FG003|Extension Study|Adverse Event|5|||
19655169|NCT00543543|42104261|FG000|Extension Study|Lost to Follow-up|0|||
19655170|NCT00543543|42104262|FG001|Extension Study|Lost to Follow-up|0|||
19753193|NCT02935842|42202777|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
19753194|NCT02935842|42202778|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
19753195|NCT02935842|42202779|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
19753196|NCT02935842|42202776|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
19753197|NCT02935842|42202777|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
19655171|NCT00543543|42104263|FG002|Extension Study|Lost to Follow-up|0|||
19655172|NCT00543543|42104264|FG003|Extension Study|Lost to Follow-up|77|||
19655173|NCT00543543|42104261|FG000|Extension Study|Physician Decision|0|||
19655174|NCT00543543|42104262|FG001|Extension Study|Physician Decision|0|||
19655175|NCT00543543|42104263|FG002|Extension Study|Physician Decision|0|||
19655176|NCT00543543|42104264|FG003|Extension Study|Physician Decision|7|||
19655177|NCT00543543|42104261|FG000|Extension Study|Pregnancy|0|||
19655178|NCT00543543|42104262|FG001|Extension Study|Pregnancy|0|||
19655179|NCT00543543|42104263|FG002|Extension Study|Pregnancy|0|||
19655180|NCT00543543|42104264|FG003|Extension Study|Pregnancy|6|||
19655181|NCT00543543|42104261|FG000|Extension Study|Protocol Violation|0|||
19655182|NCT00543543|42104262|FG001|Extension Study|Protocol Violation|0|||
19655183|NCT00543543|42104263|FG002|Extension Study|Protocol Violation|0|||
19655184|NCT00543543|42104264|FG003|Extension Study|Protocol Violation|11|||
19655185|NCT00543543|42104261|FG000|Extension Study|Withdrawal by Subject|0|||
19655186|NCT00543543|42104262|FG001|Extension Study|Withdrawal by Subject|0|||
19655187|NCT00543543|42104263|FG002|Extension Study|Withdrawal by Subject|0|||
19655188|NCT00543543|42104264|FG003|Extension Study|Withdrawal by Subject|120|||
19655189|NCT00649220|42104279|FG000|Overall Study|Adverse Event|2|||
19655190|NCT00649220|42104279|FG000|Overall Study|Withdrawal by Subject|1|||
19655191|NCT00654368|42104286|FG000|Overall Study|Ineligibility determined|6|||
19655192|NCT00654368|42104287|FG001|Overall Study|Ineligibility determined|0|||
19655193|NCT00654368|42104288|FG002|Overall Study|Ineligibility determined|0|||
19655194|NCT00654368|42104286|FG000|Overall Study|Protocol deviation|3|||
19655195|NCT00654368|42104287|FG001|Overall Study|Protocol deviation|2|||
19655196|NCT00654368|42104288|FG002|Overall Study|Protocol deviation|1|||
19655197|NCT00654368|42104286|FG000|Overall Study|Non-compliance|2|||
19655198|NCT00654368|42104287|FG001|Overall Study|Non-compliance|1|||
19655199|NCT00654368|42104288|FG002|Overall Study|Non-compliance|2|||
19655200|NCT00654368|42104286|FG000|Overall Study|Withdrawal by Subject|5|||
19655201|NCT00654368|42104287|FG001|Overall Study|Withdrawal by Subject|2|||
19655202|NCT00654368|42104288|FG002|Overall Study|Withdrawal by Subject|2|||
19655203|NCT00654368|42104286|FG000|Overall Study|Disease progression|21|||
19655204|NCT00654368|42104287|FG001|Overall Study|Disease progression|31|||
19655205|NCT00654368|42104288|FG002|Overall Study|Disease progression|13|||
19655206|NCT00654368|42104286|FG000|Overall Study|Requirement for alternative therapy|1|||
19655207|NCT00654368|42104287|FG001|Overall Study|Requirement for alternative therapy|1|||
19655208|NCT00654368|42104288|FG002|Overall Study|Requirement for alternative therapy|1|||
19655209|NCT00654368|42104286|FG000|Overall Study|Physician Decision|0|||
19655210|NCT00654368|42104287|FG001|Overall Study|Physician Decision|0|||
19655211|NCT00654368|42104288|FG002|Overall Study|Physician Decision|2|||
19655212|NCT00654368|42104286|FG000|Overall Study|Death|1|||
19655213|NCT00654368|42104287|FG001|Overall Study|Death|0|||
19655214|NCT00654368|42104288|FG002|Overall Study|Death|0|||
19655215|NCT00654368|42104286|FG000|Overall Study|Pregnancy|0|||
19655216|NCT00654368|42104287|FG001|Overall Study|Pregnancy|0|||
19655217|NCT00654368|42104288|FG002|Overall Study|Pregnancy|2|||
19655218|NCT00654368|42104286|FG000|Overall Study|Other|0|||
19655219|NCT00654368|42104287|FG001|Overall Study|Other|2|||
19655220|NCT00654368|42104288|FG002|Overall Study|Other|3|||
19655221|NCT00654368|42104286|FG000|Overall Study|Adverse Event|14|||
19655222|NCT00654368|42104287|FG001|Overall Study|Adverse Event|9|||
19655223|NCT00654368|42104288|FG002|Overall Study|Adverse Event|6|||
19655224|NCT00647426|42104295|FG000|Overall Study|Withdrawal by Subject|2|||
19655225|NCT00647348|42104302|FG000|Overall Study|Lost to Follow-up|3|||
19655226|NCT00647348|42104303|FG001|Overall Study|Lost to Follow-up|6|||
19655227|NCT00647270|42104312|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
19655228|NCT00647270|42104313|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
19655229|NCT00647270|42104314|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
19655230|NCT00647270|42104312|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
19655231|NCT00647270|42104313|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
19655232|NCT00647270|42104314|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
19655233|NCT00647270|42104312|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
19655234|NCT00647270|42104313|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
19655235|NCT00647270|42104314|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
19655236|NCT00647270|42104312|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
19655237|NCT00647270|42104313|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
19655238|NCT00647270|42104314|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
19655239|NCT00647270|42104312|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
19655240|NCT00647270|42104313|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
19655241|NCT00647270|42104314|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
19655242|NCT00647270|42104312|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
19655243|NCT00647270|42104313|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
19655244|NCT00647270|42104314|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
19655245|NCT00647270|42104312|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
19655246|NCT00647270|42104313|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
19655247|NCT00647270|42104314|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
19655248|NCT00645944|42104327|FG000|Randomized|Withdrawal by Subject|1|||
19655249|NCT00645944|42104328|FG001|Randomized|Withdrawal by Subject|2|||
19655250|NCT00645944|42104327|FG000|Received Medication|Adverse Event|2|||
19655251|NCT00645944|42104328|FG001|Received Medication|Adverse Event|1|||
19655252|NCT00645944|42104327|FG000|Received Medication|Withdrawal by Subject|1|||
19655253|NCT00645944|42104328|FG001|Received Medication|Withdrawal by Subject|1|||
19655254|NCT00645944|42104327|FG000|Received Medication|Lost to Follow-up|1|||
19655255|NCT00645944|42104328|FG001|Received Medication|Lost to Follow-up|0|||
19655256|NCT00645944|42104327|FG000|Received Medication|Protocol Violation|2|||
19655257|NCT00645944|42104328|FG001|Received Medication|Protocol Violation|1|||
19655258|NCT00646958|42104337|FG000|Overall Study|Lack of Efficacy|1|||
19655259|NCT00646958|42104338|FG001|Overall Study|Lack of Efficacy|0|||
19655260|NCT00646958|42104339|FG002|Overall Study|Lack of Efficacy|0|||
19655261|NCT00646958|42104337|FG000|Overall Study|Adverse Event|4|||
19655262|NCT00646958|42104338|FG001|Overall Study|Adverse Event|0|||
19655263|NCT00646958|42104339|FG002|Overall Study|Adverse Event|0|||
19655264|NCT00646958|42104337|FG000|Overall Study|Lost to Follow-up|1|||
19655265|NCT00646958|42104338|FG001|Overall Study|Lost to Follow-up|5|||
19655266|NCT00646958|42104339|FG002|Overall Study|Lost to Follow-up|7|||
19655267|NCT00646958|42104337|FG000|Overall Study|Protocol Violation|1|||
19655268|NCT00646958|42104338|FG001|Overall Study|Protocol Violation|1|||
19655269|NCT00646958|42104339|FG002|Overall Study|Protocol Violation|0|||
19655270|NCT00646958|42104337|FG000|Overall Study|Abnormal screening lab tests|1|||
19655271|NCT00646958|42104338|FG001|Overall Study|Abnormal screening lab tests|1|||
19655272|NCT00646958|42104339|FG002|Overall Study|Abnormal screening lab tests|0|||
19655273|NCT00646958|42104337|FG000|Overall Study|Withdrawal by Subject|1|||
19655274|NCT00646958|42104338|FG001|Overall Study|Withdrawal by Subject|2|||
19655275|NCT00646958|42104339|FG002|Overall Study|Withdrawal by Subject|0|||
19655276|NCT00646958|42104337|FG000|Overall Study|Did not receive study drug|2|||
19655277|NCT00646958|42104338|FG001|Overall Study|Did not receive study drug|0|||
19655278|NCT00646958|42104339|FG002|Overall Study|Did not receive study drug|2|||
19655279|NCT00642746|42104349|FG000|Overall Study|Patient unevaluable|1|||
19655280|NCT00642746|42104350|FG001|Overall Study|Patient unevaluable|0|||
19655281|NCT00642668|42104356|FG000|Overall Study|Lost to Follow-up|1|||
19655282|NCT00642668|42104356|FG000|Overall Study|Adverse Event|2|||
19655283|NCT00642668|42104356|FG000|Overall Study|Death|2|||
19655284|NCT00642668|42104356|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19655285|NCT00642668|42104356|FG000|Overall Study|Failure to Return|1|||
19655286|NCT00642668|42104356|FG000|Overall Study|Dialysis Initiation|5|||
19655287|NCT00642668|42104356|FG000|Overall Study|Blood Transfusion|2|||
19655288|NCT00729833|42104360|FG000|Overall Study|Death|5|||
19655289|NCT00729833|42104361|FG001|Overall Study|Death|1|||
19655290|NCT00729833|42104362|FG002|Overall Study|Death|3|||
19655291|NCT00729833|42104363|FG003|Overall Study|Death|5|||
19655292|NCT00729833|42104360|FG000|Overall Study|Study Terminated by Sponsor|0|||
19655293|NCT00729833|42104361|FG001|Overall Study|Study Terminated by Sponsor|0|||
19655294|NCT00729833|42104362|FG002|Overall Study|Study Terminated by Sponsor|1|||
19655295|NCT00729833|42104363|FG003|Overall Study|Study Terminated by Sponsor|0|||
19655296|NCT00729833|42104360|FG000|Overall Study|Lost to Follow-up|1|||
19655297|NCT00729833|42104361|FG001|Overall Study|Lost to Follow-up|0|||
19655298|NCT00729833|42104362|FG002|Overall Study|Lost to Follow-up|0|||
19655299|NCT00729833|42104363|FG003|Overall Study|Lost to Follow-up|0|||
19655300|NCT00729833|42104360|FG000|Overall Study|Withdrawal by Subject|3|||
19655301|NCT00729833|42104361|FG001|Overall Study|Withdrawal by Subject|1|||
19655302|NCT00729833|42104362|FG002|Overall Study|Withdrawal by Subject|3|||
19655303|NCT00729833|42104363|FG003|Overall Study|Withdrawal by Subject|0|||
19655304|NCT00729833|42104360|FG000|Overall Study|Unspecified Reasons|11|||
19655305|NCT00729833|42104361|FG001|Overall Study|Unspecified Reasons|5|||
19655306|NCT00729833|42104362|FG002|Overall Study|Unspecified Reasons|5|||
19655307|NCT00729833|42104363|FG003|Overall Study|Unspecified Reasons|1|||
19655308|NCT00645788|42104378|FG000|Overall Study|Did not receive study drug|1|||
19655309|NCT00645788|42104379|FG001|Overall Study|Did not receive study drug|1|||
19655310|NCT00645788|42104380|FG002|Overall Study|Did not receive study drug|0|||
19655311|NCT00645788|42104381|FG003|Overall Study|Did not receive study drug|0|||
19655312|NCT00645788|42104378|FG000|Overall Study|Adverse Event|4|||
19655313|NCT00645788|42104379|FG001|Overall Study|Adverse Event|9|||
19655314|NCT00645788|42104380|FG002|Overall Study|Adverse Event|5|||
19655315|NCT00645788|42104381|FG003|Overall Study|Adverse Event|3|||
19655316|NCT00645788|42104378|FG000|Overall Study|Lost to Follow-up|1|||
19655317|NCT00645788|42104379|FG001|Overall Study|Lost to Follow-up|0|||
19655318|NCT00645788|42104380|FG002|Overall Study|Lost to Follow-up|0|||
19655319|NCT00645788|42104381|FG003|Overall Study|Lost to Follow-up|0|||
19655320|NCT00645788|42104378|FG000|Overall Study|Protocol Violation|1|||
19655321|NCT00645788|42104379|FG001|Overall Study|Protocol Violation|0|||
19655322|NCT00645788|42104380|FG002|Overall Study|Protocol Violation|2|||
19655323|NCT00645788|42104381|FG003|Overall Study|Protocol Violation|0|||
19655324|NCT00645788|42104378|FG000|Overall Study|Withdrawal by Subject|0|||
19601747|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
19601748|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
19601749|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
19601750|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
19388308|NCT03745989|41631760|FG001|Overall Study|Sponsor Decision|2|||
19601751|NCT01004432|42050398|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
19601752|NCT01004432|42050399|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
19601753|NCT01004432|42050400|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
19601754|NCT01004432|42050401|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
19601755|NCT01004432|42050402|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
19601756|NCT01004432|42050398|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
19601757|NCT01004432|42050399|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
19601758|NCT01004432|42050400|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
19601759|NCT01004432|42050401|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
19601760|NCT01004432|42050402|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
19601761|NCT01004432|42050398|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
19601762|NCT01004432|42050399|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
19601763|NCT01004432|42050400|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
19655325|NCT00645788|42104379|FG001|Overall Study|Withdrawal by Subject|1|||
19655326|NCT00645788|42104380|FG002|Overall Study|Withdrawal by Subject|0|||
19655327|NCT00645788|42104381|FG003|Overall Study|Withdrawal by Subject|2|||
19655328|NCT00645788|42104378|FG000|Overall Study|Pulmonary exacerbation|13|||
19655329|NCT00645788|42104379|FG001|Overall Study|Pulmonary exacerbation|16|||
19655330|NCT00645788|42104380|FG002|Overall Study|Pulmonary exacerbation|11|||
19655331|NCT00645788|42104381|FG003|Overall Study|Pulmonary exacerbation|9|||
19655332|NCT00642356|42104393|FG000|Overall Study|Adverse Event|1|||
19655333|NCT00642356|42104394|FG001|Overall Study|Adverse Event|0|||
19655334|NCT00642356|42104393|FG000|Overall Study|Protocol Violation|0|||
19655335|NCT00642356|42104394|FG001|Overall Study|Protocol Violation|3|||
19655336|NCT00642356|42104393|FG000|Overall Study|Lack of Efficacy|1|||
19655337|NCT00642356|42104394|FG001|Overall Study|Lack of Efficacy|0|||
19655338|NCT00642278|42104407|FG000|Overall Study|Adverse Event|2|||
19655339|NCT00642278|42104408|FG001|Overall Study|Adverse Event|1|||
19655340|NCT00642278|42104409|FG002|Overall Study|Adverse Event|3|||
19655341|NCT00642278|42104410|FG003|Overall Study|Adverse Event|1|||
19655342|NCT00642278|42104411|FG004|Overall Study|Adverse Event|2|||
19655343|NCT00642278|42104412|FG005|Overall Study|Adverse Event|2|||
19655344|NCT00642278|42104413|FG006|Overall Study|Adverse Event|0|||
19655345|NCT00642278|42104407|FG000|Overall Study|Lack of Efficacy|0|||
19655346|NCT00642278|42104408|FG001|Overall Study|Lack of Efficacy|1|||
19655347|NCT00642278|42104409|FG002|Overall Study|Lack of Efficacy|0|||
19655348|NCT00642278|42104410|FG003|Overall Study|Lack of Efficacy|0|||
19655349|NCT00642278|42104411|FG004|Overall Study|Lack of Efficacy|0|||
19655350|NCT00642278|42104412|FG005|Overall Study|Lack of Efficacy|0|||
19655351|NCT00642278|42104413|FG006|Overall Study|Lack of Efficacy|0|||
19655352|NCT00642278|42104407|FG000|Overall Study|Lost to Follow-up|5|||
19655353|NCT00642278|42104408|FG001|Overall Study|Lost to Follow-up|1|||
19655354|NCT00642278|42104409|FG002|Overall Study|Lost to Follow-up|0|||
19655355|NCT00642278|42104410|FG003|Overall Study|Lost to Follow-up|1|||
19655356|NCT00642278|42104411|FG004|Overall Study|Lost to Follow-up|0|||
19655357|NCT00642278|42104412|FG005|Overall Study|Lost to Follow-up|1|||
19655358|NCT00642278|42104413|FG006|Overall Study|Lost to Follow-up|1|||
19655359|NCT00642278|42104407|FG000|Overall Study|Physician Decision|0|||
19655360|NCT00642278|42104408|FG001|Overall Study|Physician Decision|0|||
19655361|NCT00642278|42104409|FG002|Overall Study|Physician Decision|0|||
19655362|NCT00642278|42104410|FG003|Overall Study|Physician Decision|1|||
19655363|NCT00642278|42104411|FG004|Overall Study|Physician Decision|0|||
19655364|NCT00642278|42104412|FG005|Overall Study|Physician Decision|0|||
19655365|NCT00642278|42104413|FG006|Overall Study|Physician Decision|0|||
19655366|NCT00642278|42104407|FG000|Overall Study|Protocol Violation|0|||
19655367|NCT00642278|42104408|FG001|Overall Study|Protocol Violation|0|||
19655368|NCT00642278|42104409|FG002|Overall Study|Protocol Violation|1|||
19655369|NCT00642278|42104410|FG003|Overall Study|Protocol Violation|1|||
19655370|NCT00642278|42104411|FG004|Overall Study|Protocol Violation|0|||
19655371|NCT00642278|42104412|FG005|Overall Study|Protocol Violation|1|||
19655372|NCT00642278|42104413|FG006|Overall Study|Protocol Violation|2|||
19655373|NCT00642278|42104407|FG000|Overall Study|Withdrawal by Subject|1|||
19655374|NCT00642278|42104408|FG001|Overall Study|Withdrawal by Subject|1|||
19655375|NCT00642278|42104409|FG002|Overall Study|Withdrawal by Subject|1|||
19655376|NCT00642278|42104410|FG003|Overall Study|Withdrawal by Subject|3|||
19655377|NCT00642278|42104411|FG004|Overall Study|Withdrawal by Subject|6|||
19655378|NCT00642278|42104412|FG005|Overall Study|Withdrawal by Subject|2|||
19655379|NCT00642278|42104413|FG006|Overall Study|Withdrawal by Subject|2|||
19655380|NCT00642278|42104407|FG000|Overall Study|Noncompliance with study drug regimen|0|||
19655381|NCT00642278|42104408|FG001|Overall Study|Noncompliance with study drug regimen|0|||
19655382|NCT00642278|42104409|FG002|Overall Study|Noncompliance with study drug regimen|0|||
19655383|NCT00642278|42104410|FG003|Overall Study|Noncompliance with study drug regimen|1|||
19655384|NCT00642278|42104411|FG004|Overall Study|Noncompliance with study drug regimen|0|||
19655385|NCT00642278|42104412|FG005|Overall Study|Noncompliance with study drug regimen|0|||
19655386|NCT00642278|42104413|FG006|Overall Study|Noncompliance with study drug regimen|0|||
19655387|NCT00642278|42104407|FG000|Overall Study|Other|2|||
19655388|NCT00642278|42104408|FG001|Overall Study|Other|1|||
19655389|NCT00642278|42104409|FG002|Overall Study|Other|0|||
19655390|NCT00642278|42104410|FG003|Overall Study|Other|1|||
19655391|NCT00642278|42104411|FG004|Overall Study|Other|0|||
19655392|NCT00642278|42104412|FG005|Overall Study|Other|1|||
19655393|NCT00642278|42104413|FG006|Overall Study|Other|0|||
19655394|NCT00645164|42104429|FG000|Overall Study|Lost to Follow-up|2|||
19655395|NCT00645164|42104429|FG000|Overall Study|Withdrawal by Subject|4|||
19655396|NCT00645164|42104429|FG000|Overall Study|Protocol Violation|1|||
19655397|NCT00723125|42104435|FG000|Overall Study|Met Dx|1|||
19655398|NCT00723125|42104436|FG001|Overall Study|Met Dx|0|||
19655399|NCT00723125|42104435|FG000|Overall Study|Withdrawal by Subject|15|||
19655400|NCT00723125|42104436|FG001|Overall Study|Withdrawal by Subject|6|||
19655401|NCT00723125|42104435|FG000|Overall Study|Adverse Event|2|||
19655402|NCT00723125|42104436|FG001|Overall Study|Adverse Event|0|||
19655403|NCT00722423|42104450|FG000|Overall Study|Protocol Violation|0|||
19655404|NCT00722423|42104451|FG001|Overall Study|Protocol Violation|1|||
19655405|NCT00640562|42104461|FG000|Overall Study|Adverse Event|8|||
19655406|NCT00640562|42104462|FG001|Overall Study|Adverse Event|5|||
19655407|NCT00640562|42104461|FG000|Overall Study|Lack of Efficacy|1|||
19655408|NCT00640562|42104462|FG001|Overall Study|Lack of Efficacy|4|||
19655409|NCT00640562|42104461|FG000|Overall Study|Protocol Violation|2|||
19655410|NCT00640562|42104462|FG001|Overall Study|Protocol Violation|4|||
19655411|NCT00640562|42104461|FG000|Overall Study|Withdrawal by Subject|6|||
19655412|NCT00640562|42104462|FG001|Overall Study|Withdrawal by Subject|10|||
19655413|NCT00640562|42104461|FG000|Overall Study|Known risperidone intolerance|0|||
19655414|NCT00640562|42104462|FG001|Overall Study|Known risperidone intolerance|1|||
19655415|NCT00640562|42104461|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
19655416|NCT00640562|42104462|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
19655417|NCT00640562|42104461|FG000|Overall Study|Low study drug dose|0|||
19655418|NCT00640562|42104462|FG001|Overall Study|Low study drug dose|1|||
19655419|NCT00640562|42104461|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
19655420|NCT00640562|42104462|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
19655421|NCT00585923|42104470|FG000|Overall Study|Physician decided not to continue|31|||
19655422|NCT00585923|42104471|FG001|Overall Study|Physician decided not to continue|33|||
19655423|NCT00721955|42104480|FG000|Overall Study|Adverse Event|0|||
19655424|NCT00721955|42104481|FG001|Overall Study|Adverse Event|0|||
19655425|NCT00721955|42104482|FG002|Overall Study|Adverse Event|2|||
19655426|NCT00585689|42104490|FG000|Overall Study|Received different ABI-007 schedule|3|||
19655427|NCT00585689|42104490|FG000|Overall Study|Adverse Event|1|||
19655428|NCT00585689|42104490|FG000|Overall Study|Patient Declined Surgery|1|||
19655429|NCT00585689|42104490|FG000|Overall Study|Patient had unresectable disease|1|||
19655430|NCT00585689|42104490|FG000|Overall Study|Death|1|||
19655431|NCT00721799|42104494|FG000|Overall Study|Withdrawal by Subject|7|||
19655432|NCT00721799|42104494|FG000|Overall Study|withdraw by subject after scan 1|1|||
19655433|NCT00653432|42104500|FG000|Overall Study|Adverse Event|4|||
19655434|NCT00653432|42104501|FG001|Overall Study|Adverse Event|1|||
19655435|NCT00653432|42104500|FG000|Overall Study|Withdrawal by Subject|4|||
19655436|NCT00653432|42104501|FG001|Overall Study|Withdrawal by Subject|5|||
19655437|NCT00653432|42104500|FG000|Overall Study|Lost to Follow-up|7|||
19655438|NCT00653432|42104501|FG001|Overall Study|Lost to Follow-up|6|||
19655439|NCT00653432|42104500|FG000|Overall Study|Use/Need of Con Therapy|2|||
19655440|NCT00653432|42104501|FG001|Overall Study|Use/Need of Con Therapy|1|||
19655441|NCT00653432|42104500|FG000|Overall Study|Other - Reason Not Provided|5|||
19655442|NCT00653432|42104501|FG001|Overall Study|Other - Reason Not Provided|3|||
19655443|NCT00729365|42104510|FG000|Overall Study|Physician Decision|33|||
19655444|NCT00729365|42104511|FG001|Overall Study|Physician Decision|6|||
19655445|NCT00729365|42104512|FG002|Overall Study|Physician Decision|7|||
19655446|NCT00254293|42104528|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
19655447|NCT00254293|42104529|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
19655448|NCT00254293|42104530|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
19655449|NCT00254293|42104531|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
19655450|NCT00254293|42104532|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
19655451|NCT00254293|42104533|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
19655452|NCT00254293|42104534|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
19655453|NCT00254293|42104528|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655454|NCT00254293|42104529|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655455|NCT00254293|42104530|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
19655456|NCT00254293|42104531|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655457|NCT00254293|42104532|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655458|NCT00254293|42104533|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655459|NCT00254293|42104534|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
19655460|NCT00254293|42104528|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655461|NCT00254293|42104529|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655462|NCT00254293|42104530|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
19655463|NCT00254293|42104531|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655464|NCT00254293|42104532|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655465|NCT00254293|42104533|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655466|NCT00254293|42104534|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
19655467|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Death|0|||
19655468|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Death|0|||
19655469|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Death|1|||
19655470|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Death|0|||
19655471|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Death|0|||
19655472|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Death|0|||
19655473|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Death|0|||
19655474|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
19655475|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
19655476|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
19655477|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
19655478|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
19655479|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
19655480|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
19655481|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
19655482|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
19655483|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
19655484|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
19655485|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
19655486|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
19655487|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
19655488|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655489|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655490|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
19655491|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655492|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655493|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655494|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
19655495|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655496|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655497|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
19655498|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655499|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655500|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655501|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
19655502|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655503|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655504|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
19655505|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655506|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655507|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655508|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
19655509|NCT00254293|42104528|FG000|LTE Open Label Variable SC Dosing|Other|0|||
19655510|NCT00254293|42104529|FG001|LTE Open Label Variable SC Dosing|Other|0|||
19655511|NCT00254293|42104530|FG002|LTE Open Label Variable SC Dosing|Other|2|||
19655512|NCT00254293|42104531|FG003|LTE Open Label Variable SC Dosing|Other|0|||
19655513|NCT00254293|42104532|FG004|LTE Open Label Variable SC Dosing|Other|0|||
19655514|NCT00254293|42104533|FG005|LTE Open Label Variable SC Dosing|Other|0|||
19655515|NCT00254293|42104534|FG006|LTE Open Label Variable SC Dosing|Other|0|||
19655516|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Death|0|||
19655517|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Death|0|||
19655518|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Death|0|||
19655519|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Death|0|||
19655520|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Death|0|||
19655521|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Death|0|||
19655522|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Death|3|||
19655523|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655524|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655525|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655526|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655527|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655528|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
19655529|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
19655530|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655531|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655532|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655533|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655534|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655535|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
19655536|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
19655537|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655538|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655539|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655540|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655541|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655542|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
19655543|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
19655544|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655545|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655546|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655547|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655548|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655549|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
19655550|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
19655551|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19655552|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19655553|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19655554|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19753198|NCT02935842|42202778|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
19753199|NCT02935842|42202779|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
19753200|NCT01064479|42202798|FG000|Overall Study|Death|10|||
19655555|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19655556|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
19655557|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
19655558|NCT00254293|42104528|FG000|LTE Open Label Fixed Dosing|Other|0|||
19655559|NCT00254293|42104529|FG001|LTE Open Label Fixed Dosing|Other|0|||
19655560|NCT00254293|42104530|FG002|LTE Open Label Fixed Dosing|Other|0|||
19753201|NCT01064479|42202799|FG001|Overall Study|Death|11|||
19753202|NCT01064479|42202798|FG000|Overall Study|Withdrawal by Subject|2|||
19753203|NCT01064479|42202799|FG001|Overall Study|Withdrawal by Subject|2|||
19753204|NCT01064479|42202798|FG000|Overall Study|Disease progression|1|||
19753205|NCT01064479|42202799|FG001|Overall Study|Disease progression|1|||
19753206|NCT01064479|42202798|FG000|Overall Study|Toxicity|1|||
19753207|NCT01064479|42202799|FG001|Overall Study|Toxicity|1|||
19753208|NCT01064479|42202798|FG000|Overall Study|Other|1|||
19753209|NCT01064479|42202799|FG001|Overall Study|Other|2|||
19753210|NCT03680911|42202807|FG000|At Home Treatment|Study Termination|3|||
19753211|NCT03680911|42202808|FG001|At Home Treatment|Study Termination|0|||
19753212|NCT03680911|42202807|FG000|At Home Treatment|Lost to Follow-up|0|||
19753213|NCT03680911|42202808|FG001|At Home Treatment|Lost to Follow-up|1|||
19753214|NCT03680911|42202807|FG000|At Home Treatment|Withdrawal by Subject|0|||
19753215|NCT03680911|42202808|FG001|At Home Treatment|Withdrawal by Subject|2|||
19753216|NCT03680911|42202807|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
19753217|NCT03680911|42202808|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
19753218|NCT03224130|42202816|FG000|Overall Study|consent issue|0|||
19753219|NCT03224130|42202817|FG001|Overall Study|consent issue|1|||
19753220|NCT03680521|42202825|FG000|Overall Study|Ongoing in long-term follow up|7|||
19753221|NCT03680521|42202826|FG001|Overall Study|Ongoing in long-term follow up|11|||
19753222|NCT03679741|42202835|FG000|Period 1|No longer meet eligibility criteria|1|||
19753223|NCT03679741|42202836|FG001|Period 1|No longer meet eligibility criteria|0|||
19753224|NCT03679741|42202835|FG000|Period 1|Lost to Follow-up|0|||
19753225|NCT03679741|42202836|FG001|Period 1|Lost to Follow-up|1|||
19753226|NCT03679741|42202835|FG000|Period 1|Adverse Event|1|||
19753227|NCT03679741|42202836|FG001|Period 1|Adverse Event|1|||
19753228|NCT03679741|42202835|FG000|Period 1|Withdrawal by Subject|0|||
19753229|NCT03679741|42202836|FG001|Period 1|Withdrawal by Subject|1|||
19753230|NCT03679741|42202835|FG000|Period 2|Adverse Event|2|||
19753231|NCT03679741|42202836|FG001|Period 2|Adverse Event|1|||
19753232|NCT03679741|42202835|FG000|Period 2|Withdrawal by Subject|1|||
19753233|NCT03679741|42202836|FG001|Period 2|Withdrawal by Subject|1|||
19753234|NCT03678103|42202842|FG000|Overall Study|Withdrawn prior to completion|4|||
19753235|NCT03649477|42202849|FG000|Overall Study|Adverse Event|2|||
19753236|NCT03649477|42202850|FG001|Overall Study|Adverse Event|0|||
19753237|NCT03649477|42202851|FG002|Overall Study|Adverse Event|0|||
19753238|NCT03677869|42202859|FG000|Overall Study|Withdrawal by Subject|1|||
19753239|NCT03677401|42202865|FG000|Overall Study|Adverse Event|4|||
19753240|NCT03677401|42202866|FG001|Overall Study|Adverse Event|14|||
19753241|NCT03677401|42202865|FG000|Overall Study|Lack of Efficacy|3|||
19753242|NCT03677401|42202866|FG001|Overall Study|Lack of Efficacy|1|||
19753243|NCT03677401|42202865|FG000|Overall Study|Withdrawal by Subject|2|||
19753244|NCT03677401|42202866|FG001|Overall Study|Withdrawal by Subject|2|||
19753245|NCT03677401|42202865|FG000|Overall Study|Sponsor decision|0|||
19753246|NCT03677401|42202866|FG001|Overall Study|Sponsor decision|1|||
19753247|NCT03677401|42202865|FG000|Overall Study|Reason Unspecified|1|||
19753248|NCT03677401|42202866|FG001|Overall Study|Reason Unspecified|0|||
19753249|NCT03218787|42202872|FG000|Overall Study|Lost to Follow-up|12|||
19753250|NCT03218787|42202872|FG000|Overall Study|Withdrawal by Subject|72|||
19753251|NCT03218787|42202872|FG000|Overall Study|Physician Decision|11|||
19753252|NCT03218787|42202872|FG000|Overall Study|Death|111|||
19753253|NCT01348087|42202876|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
19753254|NCT01348087|42202876|FG000|Overall Study|Administrative problems|79|||
19753255|NCT01348087|42202876|FG000|Overall Study|protocol deviation|1|||
19753256|NCT01348087|42202876|FG000|Overall Study|Lost to Follow-up|1|||
19753257|NCT01348087|42202876|FG000|Overall Study|Subject withdrew consent|7|||
19753258|NCT01348087|42202876|FG000|Overall Study|Adverse Event|25|||
19753259|NCT01347931|42202890|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
19753260|NCT03645421|42202900|FG000|Overall Study|Adverse Event|0|||
19753261|NCT03645421|42202901|FG001|Overall Study|Adverse Event|0|||
19753262|NCT03645421|42202902|FG002|Overall Study|Adverse Event|4|||
19753263|NCT03645421|42202903|FG003|Overall Study|Adverse Event|1|||
19753264|NCT03645421|42202900|FG000|Overall Study|Withdrawal by patient|0|||
19753265|NCT03645421|42202901|FG001|Overall Study|Withdrawal by patient|0|||
19753266|NCT03645421|42202902|FG002|Overall Study|Withdrawal by patient|0|||
19753267|NCT03645421|42202903|FG003|Overall Study|Withdrawal by patient|3|||
19753268|NCT03645421|42202900|FG000|Overall Study|Study specific withdrawal criteria|0|||
19753269|NCT03645421|42202901|FG001|Overall Study|Study specific withdrawal criteria|0|||
19753270|NCT03645421|42202902|FG002|Overall Study|Study specific withdrawal criteria|1|||
19753271|NCT03645421|42202903|FG003|Overall Study|Study specific withdrawal criteria|0|||
19753272|NCT03207750|42202918|FG000|Overall Study|Adverse Event|3|||
19753273|NCT03207750|42202919|FG001|Overall Study|Adverse Event|2|||
19753274|NCT03207750|42202918|FG000|Overall Study|Lost to Follow-up|21|||
19753275|NCT03207750|42202919|FG001|Overall Study|Lost to Follow-up|29|||
19753276|NCT03207750|42202918|FG000|Overall Study|Protocol Violation|0|||
19753277|NCT03207750|42202919|FG001|Overall Study|Protocol Violation|1|||
19753278|NCT03207750|42202918|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
19753279|NCT03207750|42202919|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
19753280|NCT03207750|42202918|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
19753281|NCT03207750|42202919|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
19753282|NCT03207750|42202918|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
19753283|NCT03207750|42202919|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
19753284|NCT03207750|42202918|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
19753285|NCT03207750|42202919|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
19753286|NCT03207750|42202918|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
19753287|NCT03207750|42202919|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
19753288|NCT03674281|42202928|FG000|Overall Study|screen failure|2|||
19753289|NCT03674281|42202929|FG001|Overall Study|screen failure|0|||
19753290|NCT03674281|42202930|FG002|Overall Study|screen failure|0|||
19753291|NCT03674281|42202928|FG000|Overall Study|Withdrawal by Subject|1|||
19753292|NCT03674281|42202929|FG001|Overall Study|Withdrawal by Subject|3|||
19753293|NCT03674281|42202930|FG002|Overall Study|Withdrawal by Subject|3|||
19753294|NCT03673345|42202954|FG000|Overall Study|Lost to Follow-up|1|||
19753295|NCT03673345|42202955|FG001|Overall Study|Lost to Follow-up|0|||
19753296|NCT03673345|42202956|FG002|Overall Study|Lost to Follow-up|3|||
19753297|NCT03673345|42202957|FG003|Overall Study|Lost to Follow-up|3|||
19753298|NCT03673345|42202958|FG004|Overall Study|Lost to Follow-up|2|||
19753299|NCT03673345|42202959|FG005|Overall Study|Lost to Follow-up|1|||
19753300|NCT03673345|42202960|FG006|Overall Study|Lost to Follow-up|0|||
19753301|NCT03673345|42202961|FG007|Overall Study|Lost to Follow-up|0|||
19753302|NCT03673345|42202954|FG000|Overall Study|Withdrawal by Subject|1|||
19753303|NCT03673345|42202955|FG001|Overall Study|Withdrawal by Subject|0|||
19753304|NCT03673345|42202956|FG002|Overall Study|Withdrawal by Subject|4|||
19753305|NCT03673345|42202957|FG003|Overall Study|Withdrawal by Subject|2|||
19753306|NCT03673345|42202958|FG004|Overall Study|Withdrawal by Subject|0|||
19753307|NCT03673345|42202959|FG005|Overall Study|Withdrawal by Subject|0|||
19753308|NCT03673345|42202960|FG006|Overall Study|Withdrawal by Subject|0|||
19753309|NCT03673345|42202961|FG007|Overall Study|Withdrawal by Subject|0|||
19753310|NCT03673345|42202954|FG000|Overall Study|Physician Decision|0|||
19753311|NCT03673345|42202955|FG001|Overall Study|Physician Decision|0|||
19753312|NCT03673345|42202956|FG002|Overall Study|Physician Decision|2|||
19753313|NCT03673345|42202957|FG003|Overall Study|Physician Decision|0|||
19753314|NCT03673345|42202958|FG004|Overall Study|Physician Decision|0|||
19753315|NCT03673345|42202959|FG005|Overall Study|Physician Decision|0|||
19753316|NCT03673345|42202960|FG006|Overall Study|Physician Decision|0|||
19753317|NCT03673345|42202961|FG007|Overall Study|Physician Decision|0|||
19753318|NCT03223662|42202979|FG000|Overall Study|Physician Decision|1|||
19753319|NCT03223662|42202979|FG000|Overall Study|Study closure|1|||
19753320|NCT03672097|42202983|FG000|Period 1|Withdrawal by Subject|2|||
19753321|NCT03672097|42202983|FG000|Period 1|Adverse Event|1|||
19753322|NCT03672097|42202983|FG000|Period 1|Did not receive treatment|1|||
19753323|NCT03672097|42202983|FG000|Period 2|Withdrawal by Subject|3|||
19753324|NCT03672097|42202983|FG000|Period 2|Other|1|||
19753325|NCT03847896|42202992|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
19753326|NCT03847896|42202993|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
19753327|NCT03847896|42202994|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
19753328|NCT03847896|42202995|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
19753329|NCT03847896|42202996|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
19753330|NCT03847896|42202992|FG000|Overall Study|Withdrawal by Subject|2|||
19753331|NCT03847896|42202993|FG001|Overall Study|Withdrawal by Subject|10|||
19753332|NCT03847896|42202994|FG002|Overall Study|Withdrawal by Subject|5|||
19753333|NCT03847896|42202995|FG003|Overall Study|Withdrawal by Subject|9|||
19753334|NCT03847896|42202996|FG004|Overall Study|Withdrawal by Subject|8|||
19753335|NCT03847896|42202992|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19753336|NCT03847896|42202993|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19753337|NCT03847896|42202994|FG002|Overall Study|Withdrawal by parent/guardian|1|||
19753338|NCT03847896|42202995|FG003|Overall Study|Withdrawal by parent/guardian|0|||
19753339|NCT03847896|42202996|FG004|Overall Study|Withdrawal by parent/guardian|0|||
19753340|NCT03847896|42202992|FG000|Overall Study|Adverse Event|2|||
19753341|NCT03847896|42202993|FG001|Overall Study|Adverse Event|1|||
19753342|NCT03847896|42202994|FG002|Overall Study|Adverse Event|3|||
19753343|NCT03847896|42202995|FG003|Overall Study|Adverse Event|2|||
19753344|NCT03847896|42202996|FG004|Overall Study|Adverse Event|4|||
19753345|NCT03847896|42202992|FG000|Overall Study|A severe exacerbation event|0|||
19753346|NCT03847896|42202993|FG001|Overall Study|A severe exacerbation event|0|||
19753347|NCT03847896|42202994|FG002|Overall Study|A severe exacerbation event|0|||
19753348|NCT03847896|42202995|FG003|Overall Study|A severe exacerbation event|0|||
19753349|NCT03847896|42202996|FG004|Overall Study|A severe exacerbation event|3|||
19753350|NCT03847896|42202992|FG000|Overall Study|Protocol Violation|0|||
19753351|NCT03847896|42202993|FG001|Overall Study|Protocol Violation|2|||
19753352|NCT03847896|42202994|FG002|Overall Study|Protocol Violation|1|||
19753353|NCT03847896|42202995|FG003|Overall Study|Protocol Violation|0|||
19753354|NCT03847896|42202996|FG004|Overall Study|Protocol Violation|2|||
19753355|NCT03847896|42202992|FG000|Overall Study|Lost to Follow-up|0|||
19753356|NCT03847896|42202993|FG001|Overall Study|Lost to Follow-up|0|||
19753357|NCT03847896|42202994|FG002|Overall Study|Lost to Follow-up|0|||
19753358|NCT03847896|42202995|FG003|Overall Study|Lost to Follow-up|1|||
19753359|NCT03847896|42202996|FG004|Overall Study|Lost to Follow-up|0|||
19753360|NCT03847896|42202992|FG000|Overall Study|Condition under investigation worsened|0|||
19753361|NCT03847896|42202993|FG001|Overall Study|Condition under investigation worsened|0|||
19753362|NCT03847896|42202994|FG002|Overall Study|Condition under investigation worsened|0|||
19753363|NCT03847896|42202995|FG003|Overall Study|Condition under investigation worsened|1|||
19753364|NCT03847896|42202996|FG004|Overall Study|Condition under investigation worsened|1|||
19753365|NCT03847896|42202992|FG000|Overall Study|Lack of Efficacy|0|||
19753366|NCT03847896|42202993|FG001|Overall Study|Lack of Efficacy|0|||
19753367|NCT03847896|42202994|FG002|Overall Study|Lack of Efficacy|0|||
19753368|NCT03847896|42202995|FG003|Overall Study|Lack of Efficacy|2|||
19753369|NCT03847896|42202996|FG004|Overall Study|Lack of Efficacy|2|||
19753370|NCT03847896|42202992|FG000|Overall Study|Other reasons|3|||
19753371|NCT03847896|42202993|FG001|Overall Study|Other reasons|3|||
19753372|NCT03847896|42202994|FG002|Overall Study|Other reasons|1|||
19753373|NCT03847896|42202995|FG003|Overall Study|Other reasons|2|||
19753374|NCT03847896|42202996|FG004|Overall Study|Other reasons|1|||
19753375|NCT03670537|42203008|FG000|Overall Study|Protocol Violation|1|||
19753376|NCT03619837|42203012|FG000|Screening|received organs from HCV-negative donors|47|||
19753377|NCT03619837|42203012|FG000|Screening|died on the wait-list|2|||
19753378|NCT03619837|42203012|FG000|Screening|remained on the wait list|40|||
19753379|NCT03619837|42203012|FG000|Screening|didn't meet eligibility criteria|3|||
19753380|NCT03619837|42203012|FG000|Screening|withdrew consent|2|||
19753381|NCT03619837|42203012|FG000|Screening|never listed for HCV-viremic donor|1|||
19753382|NCT03619837|42203012|FG000|Screening|developed exclusion criteria|2|||
19753383|NCT03619837|42203012|FG000|Screening|excluded by the investigator due to non-compliance|1|||
19753384|NCT03206970|42203016|FG000|Overall Study|Death|21|||
19753385|NCT03206970|42203016|FG000|Overall Study|Withdrawal by Subject|13|||
19753386|NCT03206970|42203016|FG000|Overall Study|Lost to Follow-up|3|||
19753387|NCT03206970|42203016|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
19753388|NCT03644173|42203020|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
19753389|NCT03644173|42203020|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
19753390|NCT03644173|42203020|FG000|Participants at the 1-month Follow up|Death|2|||
19753391|NCT03644173|42203020|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
19753392|NCT03178851|42203028|FG000|Overall Study|Death|48|||
19753393|NCT03178851|42203029|FG001|Overall Study|Death|2|||
19753394|NCT03178851|42203030|FG002|Overall Study|Death|25|||
19753395|NCT03178851|42203028|FG000|Overall Study|Withdrawal by Subject|8|||
19753396|NCT03178851|42203029|FG001|Overall Study|Withdrawal by Subject|0|||
19753397|NCT03178851|42203030|FG002|Overall Study|Withdrawal by Subject|0|||
19753398|NCT03178851|42203028|FG000|Overall Study|Lost to Follow-up|5|||
19753399|NCT03178851|42203029|FG001|Overall Study|Lost to Follow-up|2|||
19753400|NCT03178851|42203030|FG002|Overall Study|Lost to Follow-up|0|||
19753401|NCT03178851|42203028|FG000|Overall Study|Adverse Event|0|||
19753402|NCT03178851|42203029|FG001|Overall Study|Adverse Event|0|||
19753403|NCT03178851|42203030|FG002|Overall Study|Adverse Event|1|||
19753404|NCT03178851|42203028|FG000|Overall Study|Study Termination by Sponsor|31|||
19753405|NCT03178851|42203029|FG001|Overall Study|Study Termination by Sponsor|7|||
19753406|NCT03178851|42203030|FG002|Overall Study|Study Termination by Sponsor|26|||
19753407|NCT03643159|42203041|FG000|Overall Study|Adverse Event|1|||
19753408|NCT03643159|42203041|FG000|Overall Study|Withdrawal by Subject|1|||
19753409|NCT03205566|42203048|FG000|Phase 1|Protocol Violation|1|||
19753410|NCT03205566|42203049|FG001|Phase 1|Protocol Violation|1|||
19753411|NCT02935452|42203061|FG000|Overall Study|work and life commintment|3|||
19753412|NCT02935452|42203062|FG001|Overall Study|work and life commintment|1|||
19753413|NCT03178773|42203070|FG000|Overall Study|Death|0|||
19753414|NCT03178773|42203071|FG001|Overall Study|Death|1|||
19753415|NCT03178773|42203070|FG000|Overall Study|Lost to Follow-up|29|||
19753416|NCT03178773|42203071|FG001|Overall Study|Lost to Follow-up|25|||
19753417|NCT03178773|42203070|FG000|Overall Study|Withdrawal by Subject|10|||
19753418|NCT03178773|42203071|FG001|Overall Study|Withdrawal by Subject|14|||
19753419|NCT03713034|42203080|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
19753420|NCT03713034|42203081|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
19753421|NCT03218397|42203091|FG000|Overall Study|Prior positive blood culture|8|||
19753422|NCT03218397|42203092|FG001|Overall Study|Prior positive blood culture|13|||
19753423|NCT03218397|42203091|FG000|Overall Study|Comfort care|8|||
19753424|NCT03218397|42203092|FG001|Overall Study|Comfort care|5|||
19753425|NCT03218397|42203091|FG000|Overall Study|Comfort care and positive blood culture|1|||
19753426|NCT03218397|42203092|FG001|Overall Study|Comfort care and positive blood culture|0|||
19388309|NCT03745989|41631761|FG002|Overall Study|Sponsor Decision|8|||
19753427|NCT03218397|42203091|FG000|Overall Study|Comfort care and mixed culture|0|||
19753428|NCT03218397|42203092|FG001|Overall Study|Comfort care and mixed culture|1|||
19753429|NCT03218397|42203091|FG000|Overall Study|Mixed culture|2|||
19753430|NCT03218397|42203092|FG001|Overall Study|Mixed culture|2|||
19753431|NCT03218397|42203091|FG000|Overall Study|Inaccessible hospital records|2|||
19753432|NCT03218397|42203092|FG001|Overall Study|Inaccessible hospital records|5|||
19753433|NCT03218397|42203091|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
19753434|NCT03218397|42203092|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
19753435|NCT03218397|42203091|FG000|Overall Study|Randomized during laboratory off hours|2|||
19753436|NCT03218397|42203092|FG001|Overall Study|Randomized during laboratory off hours|1|||
19753437|NCT03618823|42203100|FG000|Overall Study|Lost to Follow-up|63|||
19753438|NCT03618823|42203101|FG001|Overall Study|Lost to Follow-up|61|||
19753439|NCT03640507|42203113|FG000|Overall Study|Withdrawal by Subject|0|||
19753440|NCT03640507|42203114|FG001|Overall Study|Withdrawal by Subject|0|||
19753441|NCT03640507|42203115|FG002|Overall Study|Withdrawal by Subject|1|||
19753442|NCT02937636|42203125|FG000|Overall Study|Other (Not specified)|3|||
19753443|NCT02937636|42203126|FG001|Overall Study|Other (Not specified)|2|||
19753444|NCT03638635|42203135|FG000|Initial Hospitalization|Study terminated prematurely|0|||
19753445|NCT03638635|42203136|FG001|Initial Hospitalization|Study terminated prematurely|1|||
19753446|NCT03638635|42203135|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
19753447|NCT03638635|42203136|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
19753448|NCT03638635|42203135|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
19753449|NCT03638635|42203136|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
19753450|NCT03204981|42203142|FG000|Overall Study|Physician Decision|2|||
19753451|NCT03204981|42203142|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
19753452|NCT03205488|42203151|FG000|Overall Study|Adverse Event|1|||
19753453|NCT03205488|42203152|FG001|Overall Study|Adverse Event|2|||
19753454|NCT03205488|42203153|FG002|Overall Study|Adverse Event|4|||
19753455|NCT03205488|42203151|FG000|Overall Study|Protocol Violation|0|||
19753456|NCT03205488|42203152|FG001|Overall Study|Protocol Violation|0|||
19753457|NCT03205488|42203153|FG002|Overall Study|Protocol Violation|1|||
19753458|NCT03204279|42203167|FG000|Overall Study|Withdrawal by Subject|0|||
19753459|NCT03204279|42203168|FG001|Overall Study|Withdrawal by Subject|1|||
19753460|NCT03173547|42203177|FG000|Overall Study|Adverse Event|2|||
19753461|NCT03173547|42203178|FG001|Overall Study|Adverse Event|0|||
19753462|NCT03173547|42203177|FG000|Overall Study|Withdrawal by Subject|2|||
19753463|NCT03173547|42203178|FG001|Overall Study|Withdrawal by Subject|2|||
19753464|NCT02954653|42203186|FG000|Overall Study|Death|3|||
19753465|NCT02954653|42203187|FG001|Overall Study|Death|1|||
19753466|NCT02954653|42203188|FG002|Overall Study|Death|0|||
19753467|NCT02954653|42203189|FG003|Overall Study|Death|0|||
19753468|NCT02954653|42203190|FG004|Overall Study|Death|0|||
19753469|NCT02954653|42203191|FG005|Overall Study|Death|0|||
19753470|NCT02954653|42203192|FG006|Overall Study|Death|0|||
19753471|NCT02954653|42203193|FG007|Overall Study|Death|0|||
19753472|NCT02954653|42203194|FG008|Overall Study|Death|0|||
19753473|NCT02954653|42203186|FG000|Overall Study|Randomized but did not receive treatment|1|||
19753474|NCT02954653|42203187|FG001|Overall Study|Randomized but did not receive treatment|0|||
19753475|NCT02954653|42203188|FG002|Overall Study|Randomized but did not receive treatment|0|||
19753476|NCT02954653|42203189|FG003|Overall Study|Randomized but did not receive treatment|0|||
19753477|NCT02954653|42203190|FG004|Overall Study|Randomized but did not receive treatment|0|||
19753478|NCT02954653|42203191|FG005|Overall Study|Randomized but did not receive treatment|0|||
19753479|NCT02954653|42203192|FG006|Overall Study|Randomized but did not receive treatment|0|||
19753480|NCT02954653|42203193|FG007|Overall Study|Randomized but did not receive treatment|0|||
19753481|NCT02954653|42203194|FG008|Overall Study|Randomized but did not receive treatment|0|||
19753482|NCT02954653|42203186|FG000|Overall Study|Started another anti-cancer therapy|0|||
19753483|NCT02954653|42203187|FG001|Overall Study|Started another anti-cancer therapy|1|||
19753484|NCT02954653|42203188|FG002|Overall Study|Started another anti-cancer therapy|0|||
19753485|NCT02954653|42203189|FG003|Overall Study|Started another anti-cancer therapy|0|||
19753486|NCT02954653|42203190|FG004|Overall Study|Started another anti-cancer therapy|0|||
19753487|NCT02954653|42203191|FG005|Overall Study|Started another anti-cancer therapy|0|||
19753488|NCT02954653|42203192|FG006|Overall Study|Started another anti-cancer therapy|0|||
19753489|NCT02954653|42203193|FG007|Overall Study|Started another anti-cancer therapy|0|||
19753490|NCT02954653|42203194|FG008|Overall Study|Started another anti-cancer therapy|0|||
19753491|NCT02954653|42203186|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
19753492|NCT02954653|42203187|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
19753493|NCT02954653|42203188|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
19753494|NCT02954653|42203189|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
19753495|NCT02954653|42203190|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
19753496|NCT02954653|42203191|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
19753497|NCT02954653|42203192|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
19753498|NCT02954653|42203193|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
19753499|NCT02954653|42203194|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
19753500|NCT03173313|42203208|FG000|Overall Study|Lost to Follow-up|2|||
19753501|NCT03173313|42203209|FG001|Overall Study|Lost to Follow-up|3|||
19753502|NCT03173313|42203208|FG000|Overall Study|Withdrawal by Subject|0|||
19753503|NCT03173313|42203209|FG001|Overall Study|Withdrawal by Subject|1|||
19753504|NCT03173313|42203208|FG000|Overall Study|Death|5|||
19753505|NCT03173313|42203209|FG001|Overall Study|Death|0|||
19753506|NCT03173313|42203208|FG000|Overall Study|Physician Decision|1|||
19753507|NCT03173313|42203209|FG001|Overall Study|Physician Decision|0|||
19753508|NCT03173313|42203208|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
19753509|NCT03173313|42203209|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
19753510|NCT03173313|42203208|FG000|Overall Study|Bone Fracture|1|||
19753511|NCT03173313|42203209|FG001|Overall Study|Bone Fracture|0|||
19753512|NCT03215667|42203215|FG000|Overall Study|Physician Decision|4|||
19753513|NCT03634579|42203219|FG000|Overall Study|study termination|9|||
19753514|NCT02730208|42203225|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
19753515|NCT02730208|42203226|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
19753516|NCT03170349|42203232|FG000|At 30 Days Follow-up|Death|1|||
19753517|NCT03170349|42203232|FG000|At 6 Months Follow-up|Death|3|||
19753518|NCT03170349|42203232|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
19753519|NCT03170349|42203232|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
19753520|NCT03170349|42203232|FG000|At 1 Year Follow-up|Death|6|||
19753521|NCT03170349|42203232|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
19753522|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
19753523|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
19753524|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
19753525|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
19753526|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
19753527|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
19753528|NCT03201900|42203236|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
19753529|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
19753530|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
19753531|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
19753532|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
19753533|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
19753534|NCT03201900|42203236|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
19753535|NCT03170271|42203251|FG000|Overall Study|Adverse Event|7|||
19753536|NCT03170271|42203252|FG001|Overall Study|Adverse Event|2|||
19753537|NCT03170271|42203251|FG000|Overall Study|Lost to Follow-up|0|||
19753538|NCT03170271|42203252|FG001|Overall Study|Lost to Follow-up|1|||
19753539|NCT03170271|42203251|FG000|Overall Study|Physician Decision|1|||
19753540|NCT03170271|42203252|FG001|Overall Study|Physician Decision|0|||
19753541|NCT03170271|42203251|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
19753542|NCT03170271|42203252|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
19753543|NCT03170271|42203251|FG000|Overall Study|Withdrawal by Subject|17|||
19753544|NCT03170271|42203252|FG001|Overall Study|Withdrawal by Subject|5|||
19753545|NCT03170271|42203251|FG000|Overall Study|Other|2|||
19753546|NCT03170271|42203252|FG001|Overall Study|Other|2|||
19753547|NCT03170271|42203251|FG000|Overall Study|Randomized in error|4|||
19753548|NCT03170271|42203252|FG001|Overall Study|Randomized in error|0|||
19753549|NCT03613129|42203262|FG000|Pre-treatment Assessment|Protocol Violation|2|||
19753550|NCT03613129|42203263|FG001|Pre-treatment Assessment|Protocol Violation|0|||
19753551|NCT03613129|42203264|FG002|Pre-treatment Assessment|Protocol Violation|0|||
19753552|NCT03613129|42203265|FG003|Pre-treatment Assessment|Protocol Violation|0|||
19753553|NCT03613129|42203266|FG004|Pre-treatment Assessment|Protocol Violation|0|||
19753554|NCT03613129|42203262|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
19753555|NCT03613129|42203263|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
19753556|NCT03613129|42203264|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
19753557|NCT03613129|42203265|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
19753558|NCT03613129|42203266|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
19753559|NCT03235284|42203281|FG000|Overall Study|Adverse Event|1|||
19753560|NCT03235284|42203282|FG001|Overall Study|Adverse Event|2|||
19753561|NCT03235284|42203283|FG002|Overall Study|Adverse Event|1|||
19753562|NCT03170193|42203298|FG000|Overall Study|Withdrawal by Subject|0|||
19753563|NCT03170193|42203299|FG001|Overall Study|Withdrawal by Subject|0|||
19753564|NCT03170193|42203300|FG002|Overall Study|Withdrawal by Subject|0|||
19753565|NCT03170193|42203301|FG003|Overall Study|Withdrawal by Subject|1|||
19753566|NCT03170193|42203302|FG004|Overall Study|Withdrawal by Subject|0|||
19753567|NCT03170193|42203303|FG005|Overall Study|Withdrawal by Subject|0|||
19753568|NCT03170193|42203304|FG006|Overall Study|Withdrawal by Subject|0|||
19753569|NCT03170193|42203298|FG000|Overall Study|Lost to Follow-up|1|||
19753570|NCT03170193|42203299|FG001|Overall Study|Lost to Follow-up|1|||
19753571|NCT03170193|42203300|FG002|Overall Study|Lost to Follow-up|0|||
19753572|NCT03170193|42203301|FG003|Overall Study|Lost to Follow-up|0|||
19753573|NCT03170193|42203302|FG004|Overall Study|Lost to Follow-up|0|||
19753574|NCT03170193|42203303|FG005|Overall Study|Lost to Follow-up|0|||
19753575|NCT03170193|42203304|FG006|Overall Study|Lost to Follow-up|0|||
19753576|NCT03633331|42203326|FG000|Overall Study|Withdrawal by Subject|1|||
19753577|NCT03201003|42203332|FG000|Overall Study|Adverse Event|14|||
19753578|NCT03201003|42203333|FG001|Overall Study|Adverse Event|1|||
19753579|NCT03201003|42203332|FG000|Overall Study|Other reasons|5|||
19753580|NCT03201003|42203333|FG001|Overall Study|Other reasons|1|||
19753581|NCT03201003|42203332|FG000|Overall Study|Withdrawal by Subject|4|||
19753582|NCT03201003|42203333|FG001|Overall Study|Withdrawal by Subject|1|||
19753583|NCT03201003|42203332|FG000|Overall Study|Lost to Follow-up|2|||
19753584|NCT03201003|42203333|FG001|Overall Study|Lost to Follow-up|0|||
19753585|NCT03201003|42203332|FG000|Overall Study|Protocol Violation|1|||
19753586|NCT03201003|42203333|FG001|Overall Study|Protocol Violation|0|||
19753587|NCT03166215|42203341|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
19753588|NCT03166215|42203342|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
19753589|NCT03166215|42203343|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
19753590|NCT03166215|42203341|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
19753591|NCT03166215|42203342|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
19753592|NCT03166215|42203343|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
19753593|NCT03168711|42203365|FG000|Overall Study|Adverse Event|2|||
19753594|NCT03168711|42203366|FG001|Overall Study|Adverse Event|0|||
19753595|NCT03168711|42203365|FG000|Overall Study|Withdrawal by Subject|0|||
19753596|NCT03168711|42203366|FG001|Overall Study|Withdrawal by Subject|1|||
19753597|NCT03168711|42203365|FG000|Overall Study|Death|0|||
19753598|NCT03168711|42203366|FG001|Overall Study|Death|1|||
19753599|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
19753600|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
19753601|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
19753602|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
19753603|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
19753604|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19753605|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
19753606|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
19753607|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
19753608|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
19753609|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
19753610|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
19753611|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
19753612|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
19753613|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
19753614|NCT03738215|42203375|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
19753615|NCT03738215|42203376|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
19753616|NCT03738215|42203377|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
19753617|NCT03738215|42203375|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
19753618|NCT03738215|42203376|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
19753619|NCT03738215|42203377|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
19753620|NCT03738215|42203375|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
19753621|NCT03738215|42203376|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
19753622|NCT03738215|42203377|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
19753623|NCT03738215|42203375|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
19753624|NCT03738215|42203376|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
19753625|NCT03738215|42203377|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
19753626|NCT03738215|42203375|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
19753627|NCT03738215|42203376|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
19601764|NCT01004432|42050401|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
19601765|NCT01004432|42050402|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
19601766|NCT01004432|42050398|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
19601767|NCT01004432|42050399|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
19601768|NCT01004432|42050400|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
19601769|NCT01004432|42050401|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
19601770|NCT01004432|42050402|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
19601771|NCT01004432|42050398|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
19601772|NCT01004432|42050399|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
19655561|NCT00254293|42104531|FG003|LTE Open Label Fixed Dosing|Other|0|||
19753628|NCT03738215|42203377|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
19753629|NCT03199911|42203387|FG000|Overall Study|Lost to Follow-up|5|||
19753630|NCT03199911|42203388|FG001|Overall Study|Lost to Follow-up|5|||
19753631|NCT03199911|42203387|FG000|Overall Study|Did not proceed with surgery|2|||
19753632|NCT03199911|42203388|FG001|Overall Study|Did not proceed with surgery|1|||
19388310|NCT03745989|41631759|FG000|Overall Study|Withdrawal by Subject|0|||
19388311|NCT03745989|41631760|FG001|Overall Study|Withdrawal by Subject|1|||
19388312|NCT03745989|41631761|FG002|Overall Study|Withdrawal by Subject|3|||
19388313|NCT02697773|41631772|FG000|Overall Study|Adverse Event|2|||
19601773|NCT01004432|42050400|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
19601774|NCT01004432|42050401|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
19753633|NCT03736967|42203398|FG000|Overall Study|Withdrawal by Subject|26|||
19753634|NCT03736967|42203399|FG001|Overall Study|Withdrawal by Subject|25|||
19753635|NCT03736967|42203400|FG002|Overall Study|Withdrawal by Subject|23|||
19753636|NCT03736967|42203401|FG003|Overall Study|Withdrawal by Subject|26|||
19753637|NCT03736967|42203398|FG000|Overall Study|Lost to Follow-up|3|||
19753638|NCT03736967|42203399|FG001|Overall Study|Lost to Follow-up|2|||
19753639|NCT03736967|42203400|FG002|Overall Study|Lost to Follow-up|1|||
19753640|NCT03736967|42203401|FG003|Overall Study|Lost to Follow-up|1|||
19753641|NCT03736967|42203398|FG000|Overall Study|Physician Decision|1|||
19753642|NCT03736967|42203399|FG001|Overall Study|Physician Decision|0|||
19753643|NCT03736967|42203400|FG002|Overall Study|Physician Decision|0|||
19753644|NCT03736967|42203401|FG003|Overall Study|Physician Decision|1|||
19753645|NCT03736967|42203398|FG000|Overall Study|Adverse Event|0|||
19753646|NCT03736967|42203399|FG001|Overall Study|Adverse Event|1|||
19753647|NCT03736967|42203400|FG002|Overall Study|Adverse Event|0|||
19753648|NCT03736967|42203401|FG003|Overall Study|Adverse Event|1|||
19388314|NCT02697773|41631773|FG001|Overall Study|Adverse Event|1|||
19388315|NCT02697773|41631774|FG002|Overall Study|Adverse Event|2|||
19601775|NCT01004432|42050402|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
19655562|NCT00254293|42104532|FG004|LTE Open Label Fixed Dosing|Other|0|||
19655563|NCT00254293|42104533|FG005|LTE Open Label Fixed Dosing|Other|0|||
19655564|NCT00254293|42104534|FG006|LTE Open Label Fixed Dosing|Other|1|||
19655565|NCT00736385|42104579|FG000|Overall Study|Withdrawal by Subject|2|||
19655566|NCT00736385|42104580|FG001|Overall Study|Withdrawal by Subject|2|||
19655567|NCT00736385|42104579|FG000|Overall Study|Adverse Event|0|||
19655568|NCT00736385|42104580|FG001|Overall Study|Adverse Event|1|||
19655569|NCT00585221|42104586|FG000|Overall Study|Protocol Violation|8|||
19655570|NCT00253747|42104592|FG000|Overall Study|Lost to Follow-up|13|||
19655571|NCT00253747|42104593|FG001|Overall Study|Lost to Follow-up|14|||
19655572|NCT00253747|42104592|FG000|Overall Study|Withdrawal by Subject|10|||
19655573|NCT00253747|42104593|FG001|Overall Study|Withdrawal by Subject|11|||
19655574|NCT00253747|42104592|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
19655575|NCT00253747|42104593|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
19655576|NCT00252733|42104611|FG000|Overall Study|Withdrawal by Subject|73|||
19655577|NCT00252733|42104612|FG001|Overall Study|Withdrawal by Subject|67|||
19655578|NCT00252733|42104611|FG000|Overall Study|Death|7|||
19655579|NCT00252733|42104612|FG001|Overall Study|Death|5|||
19655580|NCT00252733|42104611|FG000|Overall Study|Lost to Follow-up|12|||
19655581|NCT00252733|42104612|FG001|Overall Study|Lost to Follow-up|6|||
19655582|NCT00252733|42104611|FG000|Overall Study|Multiple Reasons|14|||
19655583|NCT00252733|42104612|FG001|Overall Study|Multiple Reasons|14|||
19655584|NCT00275821|42104621|FG000|Overall Study|Adverse Event|4|||
19655585|NCT00275821|42104622|FG001|Overall Study|Adverse Event|12|||
19655586|NCT00275821|42104623|FG002|Overall Study|Adverse Event|5|||
19655587|NCT00275821|42104621|FG000|Overall Study|Administrative problems|3|||
19655588|NCT00275821|42104622|FG001|Overall Study|Administrative problems|4|||
19655589|NCT00275821|42104623|FG002|Overall Study|Administrative problems|4|||
19601776|NCT01000610|42050416|FG000|Overall Study|Adverse Event|1|||
19601777|NCT01000610|42050416|FG000|Overall Study|Lost to Follow-up|4|||
19601778|NCT01000610|42050416|FG000|Overall Study|Treatment failure|1|||
19601779|NCT01877655|42050422|FG000|Overall Study|Death|57|||
19601780|NCT01877655|42050423|FG001|Overall Study|Death|52|||
19601781|NCT01877655|42050422|FG000|Overall Study|Withdrawal by Subject|18|||
19601782|NCT01877655|42050423|FG001|Overall Study|Withdrawal by Subject|26|||
19601783|NCT01877655|42050422|FG000|Overall Study|Physician Decision|11|||
19601784|NCT01877655|42050423|FG001|Overall Study|Physician Decision|10|||
19601785|NCT01877655|42050422|FG000|Overall Study|Miscellaneous|4|||
19601786|NCT01877655|42050423|FG001|Overall Study|Miscellaneous|4|||
19601787|NCT01877655|42050422|FG000|Overall Study|Randomized but Never Received Drug|8|||
19601788|NCT01877655|42050423|FG001|Overall Study|Randomized but Never Received Drug|5|||
19655590|NCT00275821|42104621|FG000|Overall Study|Withdrawal by Subject|0|||
19655591|NCT00275821|42104622|FG001|Overall Study|Withdrawal by Subject|2|||
19655592|NCT00275821|42104623|FG002|Overall Study|Withdrawal by Subject|1|||
19655593|NCT00275821|42104621|FG000|Overall Study|Lost to Follow-up|0|||
19655594|NCT00275821|42104622|FG001|Overall Study|Lost to Follow-up|1|||
19655595|NCT00275821|42104623|FG002|Overall Study|Lost to Follow-up|1|||
19753649|NCT03736967|42203398|FG000|Overall Study|Death|0|||
19753650|NCT03736967|42203399|FG001|Overall Study|Death|0|||
19753651|NCT03736967|42203400|FG002|Overall Study|Death|0|||
19753652|NCT03736967|42203401|FG003|Overall Study|Death|1|||
19753653|NCT03736967|42203398|FG000|Overall Study|Randomized but never treated|1|||
19753654|NCT03736967|42203399|FG001|Overall Study|Randomized but never treated|0|||
19655596|NCT00275821|42104621|FG000|Overall Study|Death|0|||
19655597|NCT00275821|42104622|FG001|Overall Study|Death|2|||
19655598|NCT00275821|42104623|FG002|Overall Study|Death|1|||
19655599|NCT00275821|42104621|FG000|Overall Study|Lack of Efficacy|2|||
19655600|NCT00275821|42104622|FG001|Overall Study|Lack of Efficacy|1|||
19655601|NCT00275821|42104623|FG002|Overall Study|Lack of Efficacy|0|||
19655602|NCT00275821|42104621|FG000|Overall Study|Protocol Violation|5|||
19655603|NCT00275821|42104622|FG001|Overall Study|Protocol Violation|1|||
19655604|NCT00275821|42104623|FG002|Overall Study|Protocol Violation|0|||
19655605|NCT00275509|42104633|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
19655606|NCT00275509|42104634|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
19655607|NCT00252577|42104640|FG000|Overall Study|Lost to Follow-up|20|||
19655608|NCT00252499|42104647|FG000|Overall Study|Lost to Follow-up|1|||
19655609|NCT00252499|42104648|FG001|Overall Study|Lost to Follow-up|0|||
19655610|NCT00252499|42104649|FG002|Overall Study|Lost to Follow-up|0|||
19655611|NCT00252187|42104659|FG000|Overall Study|Adverse Event|3|||
19655612|NCT00252187|42104660|FG001|Overall Study|Adverse Event|1|||
19655613|NCT00252187|42104659|FG000|Overall Study|Withdrawal by Subject|1|||
19655614|NCT00252187|42104660|FG001|Overall Study|Withdrawal by Subject|0|||
19655615|NCT00572910|42104672|FG000|Overall Study|Adverse Event|1|||
19655616|NCT00572910|42104673|FG001|Overall Study|Adverse Event|2|||
19655617|NCT00572910|42104674|FG002|Overall Study|Adverse Event|0|||
19655618|NCT00572910|42104675|FG003|Overall Study|Adverse Event|2|||
19655619|NCT00572910|42104676|FG004|Overall Study|Adverse Event|0|||
19655620|NCT00572910|42104677|FG005|Overall Study|Adverse Event|0|||
19655621|NCT00572910|42104678|FG006|Overall Study|Adverse Event|4|||
19655622|NCT00572910|42104679|FG007|Overall Study|Adverse Event|2|||
19655623|NCT00572910|42104680|FG008|Overall Study|Adverse Event|1|||
19655624|NCT00572910|42104681|FG009|Overall Study|Adverse Event|3|||
19655625|NCT00572910|42104682|FG010|Overall Study|Adverse Event|2|||
19655626|NCT00572910|42104672|FG000|Overall Study|Lost to Follow-up|0|||
19655627|NCT00572910|42104673|FG001|Overall Study|Lost to Follow-up|1|||
19655628|NCT00572910|42104674|FG002|Overall Study|Lost to Follow-up|1|||
19655629|NCT00572910|42104675|FG003|Overall Study|Lost to Follow-up|2|||
19655630|NCT00572910|42104676|FG004|Overall Study|Lost to Follow-up|1|||
19655631|NCT00572910|42104677|FG005|Overall Study|Lost to Follow-up|0|||
19655632|NCT00572910|42104678|FG006|Overall Study|Lost to Follow-up|0|||
19655633|NCT00572910|42104679|FG007|Overall Study|Lost to Follow-up|0|||
19655634|NCT00572910|42104680|FG008|Overall Study|Lost to Follow-up|0|||
19655635|NCT00572910|42104681|FG009|Overall Study|Lost to Follow-up|1|||
19655636|NCT00572910|42104682|FG010|Overall Study|Lost to Follow-up|0|||
19655637|NCT00572910|42104672|FG000|Overall Study|Withdrawal by Subject|3|||
19655638|NCT00572910|42104673|FG001|Overall Study|Withdrawal by Subject|0|||
19655639|NCT00572910|42104674|FG002|Overall Study|Withdrawal by Subject|1|||
19655640|NCT00572910|42104675|FG003|Overall Study|Withdrawal by Subject|0|||
19655641|NCT00572910|42104676|FG004|Overall Study|Withdrawal by Subject|1|||
19655642|NCT00572910|42104677|FG005|Overall Study|Withdrawal by Subject|3|||
19655643|NCT00572910|42104678|FG006|Overall Study|Withdrawal by Subject|0|||
19655644|NCT00572910|42104679|FG007|Overall Study|Withdrawal by Subject|2|||
19655645|NCT00572910|42104680|FG008|Overall Study|Withdrawal by Subject|2|||
19655646|NCT00572910|42104681|FG009|Overall Study|Withdrawal by Subject|2|||
19655647|NCT00572910|42104682|FG010|Overall Study|Withdrawal by Subject|1|||
19655648|NCT00163657|42104720|FG000|Overall Study|Death|12|||
19655649|NCT00163657|42104721|FG001|Overall Study|Death|14|||
19655650|NCT00163657|42104722|FG002|Overall Study|Death|19|||
19655651|NCT00163657|42104720|FG000|Overall Study|graft loss|4|||
19655652|NCT00163657|42104721|FG001|Overall Study|graft loss|1|||
19655653|NCT00163657|42104722|FG002|Overall Study|graft loss|2|||
19655654|NCT00163657|42104720|FG000|Overall Study|Withdrawal by Subject|2|||
19655655|NCT00163657|42104721|FG001|Overall Study|Withdrawal by Subject|3|||
19655656|NCT00163657|42104722|FG002|Overall Study|Withdrawal by Subject|2|||
19655657|NCT00163657|42104720|FG000|Overall Study|Physician Decision|0|||
19655658|NCT00163657|42104721|FG001|Overall Study|Physician Decision|1|||
19655659|NCT00163657|42104722|FG002|Overall Study|Physician Decision|1|||
19655660|NCT00163657|42104720|FG000|Overall Study|Non Compliance|1|||
19655661|NCT00163657|42104721|FG001|Overall Study|Non Compliance|0|||
19655662|NCT00163657|42104722|FG002|Overall Study|Non Compliance|0|||
19655663|NCT00163657|42104720|FG000|Overall Study|Lost to Follow-up|1|||
19655664|NCT00163657|42104721|FG001|Overall Study|Lost to Follow-up|3|||
19655665|NCT00163657|42104722|FG002|Overall Study|Lost to Follow-up|10|||
19655666|NCT00163657|42104720|FG000|Overall Study|Other reason|0|||
19655667|NCT00163657|42104721|FG001|Overall Study|Other reason|1|||
19655668|NCT00163657|42104722|FG002|Overall Study|Other reason|3|||
19655669|NCT00609492|42104733|FG000|Overall Study|Withdrawal by Subject|0|||
19655670|NCT00609492|42104734|FG001|Overall Study|Withdrawal by Subject|2|||
19655671|NCT00609492|42104735|FG002|Overall Study|Withdrawal by Subject|3|||
19655672|NCT00609492|42104733|FG000|Overall Study|Lost to Follow-up|1|||
19655673|NCT00609492|42104734|FG001|Overall Study|Lost to Follow-up|1|||
19655674|NCT00609492|42104735|FG002|Overall Study|Lost to Follow-up|4|||
19655675|NCT00230971|42104747|FG000|Randomization|No study drug administered|3|||
19655676|NCT00230971|42104748|FG001|Randomization|No study drug administered|3|||
19655677|NCT00230971|42104747|FG000|Baseline Participants|Lost to Follow-up|5|||
19655678|NCT00230971|42104748|FG001|Baseline Participants|Lost to Follow-up|12|||
19655679|NCT00230971|42104747|FG000|Baseline Participants|Death|6|||
19655680|NCT00230971|42104748|FG001|Baseline Participants|Death|5|||
19655681|NCT00230971|42104747|FG000|Baseline Participants|Withdrawal by Subject|7|||
19655682|NCT00230971|42104748|FG001|Baseline Participants|Withdrawal by Subject|1|||
19655683|NCT00230971|42104747|FG000|Baseline Participants|Adverse Event|1|||
19655684|NCT00230971|42104748|FG001|Baseline Participants|Adverse Event|0|||
19655685|NCT00230971|42104747|FG000|Baseline Participants|No bacteria observed|1|||
19655686|NCT00230971|42104748|FG001|Baseline Participants|No bacteria observed|0|||
19655687|NCT00230971|42104747|FG000|Baseline Participants|Failure to return|1|||
19655688|NCT00230971|42104748|FG001|Baseline Participants|Failure to return|1|||
19655689|NCT00230971|42104747|FG000|Baseline Participants|Reintervention|1|||
19655690|NCT00230971|42104748|FG001|Baseline Participants|Reintervention|0|||
19655691|NCT00211081|42104754|FG000|Overall Study|Withdrawal by Subject|2|||
19655692|NCT00609336|42104758|FG000|Overall Study|Protocol Violation|3|||
19655693|NCT00609336|42104758|FG000|Overall Study|Death|1|||
19655694|NCT00609336|42104758|FG000|Overall Study|LA or Met at Surgery|9|||
19655695|NCT00612066|42104763|FG000|Overall Study|Adverse Event|1|||
19655696|NCT00573144|42104769|FG000|Overall Study|Withdrawal by Subject|2|||
19655697|NCT00573144|42104770|FG001|Overall Study|Withdrawal by Subject|3|||
19655698|NCT00640328|42104782|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
19655699|NCT00640328|42104783|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
19655700|NCT00640328|42104784|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
19655701|NCT00640328|42104785|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
19655702|NCT00640328|42104786|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
19655703|NCT00640328|42104787|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
19655704|NCT00640328|42104782|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
19655705|NCT00640328|42104783|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
19655706|NCT00640328|42104784|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
19655707|NCT00640328|42104785|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
19655708|NCT00640328|42104786|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
19655709|NCT00640328|42104787|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
19655710|NCT00640328|42104782|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
19655711|NCT00640328|42104783|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
19655712|NCT00640328|42104784|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
19655713|NCT00640328|42104785|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
19655714|NCT00640328|42104786|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
19655715|NCT00640328|42104787|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
19655716|NCT00640328|42104782|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
19655717|NCT00640328|42104783|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
19655718|NCT00640328|42104784|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
19655719|NCT00640328|42104785|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
19655720|NCT00640328|42104786|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
19655721|NCT00640328|42104787|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
19655722|NCT00163189|42104808|FG000|Overall Study|Other|6|||
19655723|NCT00163189|42104808|FG000|Overall Study|Lost to Follow-up|1|||
19655724|NCT00163189|42104808|FG000|Overall Study|Protocol Violation|2|||
19655725|NCT00163189|42104808|FG000|Overall Study|Death|3|||
19655726|NCT00163189|42104808|FG000|Overall Study|Adverse Event|6|||
19655727|NCT00163189|42104808|FG000|Overall Study|Lack of Efficacy|7|||
19655728|NCT00163189|42104808|FG000|Overall Study|Study terminated by sponsor|11|||
19655729|NCT00163189|42104808|FG000|Overall Study|Withdrawal by Subject|11|||
19655730|NCT00163189|42104808|FG000|Overall Study|Did not meet continuation criterion|16|||
19655731|NCT00162097|42104816|FG000|Overall Study|Participant no longer met study criteria|0|||
19655732|NCT00162097|42104817|FG001|Overall Study|Participant no longer met study criteria|0|||
19655733|NCT00162097|42104818|FG002|Overall Study|Participant no longer met study criteria|0|||
19655734|NCT00162097|42104819|FG003|Overall Study|Participant no longer met study criteria|1|||
19655735|NCT00640016|42104839|FG000|Overall Study|Withdrawal by Subject|0|||
19655736|NCT00640016|42104840|FG001|Overall Study|Withdrawal by Subject|1|||
19655737|NCT00640016|42104841|FG002|Overall Study|Withdrawal by Subject|0|||
19655738|NCT00640016|42104842|FG003|Overall Study|Withdrawal by Subject|0|||
19655739|NCT00640016|42104839|FG000|Overall Study|Study termination|2|||
19655740|NCT00640016|42104840|FG001|Overall Study|Study termination|1|||
19655741|NCT00640016|42104841|FG002|Overall Study|Study termination|3|||
19655742|NCT00640016|42104842|FG003|Overall Study|Study termination|2|||
19655743|NCT00640016|42104839|FG000|Overall Study|Adverse Event|0|||
19655744|NCT00640016|42104840|FG001|Overall Study|Adverse Event|0|||
19655745|NCT00640016|42104841|FG002|Overall Study|Adverse Event|0|||
19655746|NCT00640016|42104842|FG003|Overall Study|Adverse Event|1|||
19655747|NCT00608868|42104859|FG000|Overall Study|Withdrawal by Subject|7|||
19655748|NCT00608868|42104859|FG000|Overall Study|Protocol Violation|3|||
19655749|NCT00608868|42104859|FG000|Overall Study|Lost to Follow-up|2|||
19655750|NCT00608868|42104859|FG000|Overall Study|Adverse Event|1|||
19655751|NCT00608868|42104859|FG000|Overall Study|Physician Decision|2|||
19655752|NCT00608322|42104865|FG000|Overall Study|Death|2|||
19655753|NCT00608322|42104866|FG001|Overall Study|Death|1|||
19655754|NCT00606294|42104874|FG000|Overall Study|Withdrawal by Subject|36|||
19655755|NCT00606294|42104875|FG001|Overall Study|Withdrawal by Subject|0|||
19753655|NCT03736967|42203400|FG002|Overall Study|Randomized but never treated|0|||
19753656|NCT03736967|42203401|FG003|Overall Study|Randomized but never treated|0|||
19388316|NCT02697773|41631772|FG000|Overall Study|Death|0|||
19655756|NCT00608244|42104881|FG000|Overall Study|Adverse Event|1|||
19655757|NCT00608244|42104881|FG000|Overall Study|Low trough levels|1|||
19655758|NCT00605280|42104891|FG000|Year 1|Protocol Violation|0|||
19655759|NCT00605280|42104892|FG001|Year 1|Protocol Violation|0|||
19655760|NCT00605280|42104893|FG002|Year 1|Protocol Violation|0|||
19655761|NCT00605280|42104894|FG003|Year 1|Protocol Violation|1|||
19655762|NCT00605280|42104891|FG000|Year 1|Adverse Event|3|||
19655763|NCT00605280|42104892|FG001|Year 1|Adverse Event|1|||
19655764|NCT00605280|42104893|FG002|Year 1|Adverse Event|1|||
19655765|NCT00605280|42104894|FG003|Year 1|Adverse Event|5|||
19655766|NCT00605280|42104891|FG000|Year 1|Physician Decision|7|||
19655767|NCT00605280|42104892|FG001|Year 1|Physician Decision|4|||
19655768|NCT00605280|42104893|FG002|Year 1|Physician Decision|0|||
19655769|NCT00605280|42104894|FG003|Year 1|Physician Decision|6|||
19655770|NCT00605280|42104891|FG000|Year 1|Withdrawal by Subject|2|||
19655771|NCT00605280|42104892|FG001|Year 1|Withdrawal by Subject|4|||
19655772|NCT00605280|42104893|FG002|Year 1|Withdrawal by Subject|0|||
19655773|NCT00605280|42104894|FG003|Year 1|Withdrawal by Subject|4|||
19655774|NCT00605280|42104891|FG000|Year 1|Other|2|||
19655775|NCT00605280|42104892|FG001|Year 1|Other|1|||
19655776|NCT00605280|42104893|FG002|Year 1|Other|0|||
19655777|NCT00605280|42104894|FG003|Year 1|Other|1|||
19655778|NCT00605280|42104891|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
19655779|NCT00605280|42104892|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
19655780|NCT00605280|42104893|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
19655781|NCT00605280|42104894|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
19655782|NCT00605280|42104891|FG000|Year 2|Adverse Event|4|||
19655783|NCT00605280|42104892|FG001|Year 2|Adverse Event|0|||
19655784|NCT00605280|42104893|FG002|Year 2|Adverse Event|2|||
19655785|NCT00605280|42104894|FG003|Year 2|Adverse Event|4|||
19655786|NCT00605280|42104891|FG000|Year 2|Physician Decision|11|||
19655787|NCT00605280|42104892|FG001|Year 2|Physician Decision|6|||
19655788|NCT00605280|42104893|FG002|Year 2|Physician Decision|4|||
19655789|NCT00605280|42104894|FG003|Year 2|Physician Decision|11|||
19655790|NCT00605280|42104891|FG000|Year 2|Withdrawal by Subject|4|||
19655791|NCT00605280|42104892|FG001|Year 2|Withdrawal by Subject|0|||
19655792|NCT00605280|42104893|FG002|Year 2|Withdrawal by Subject|0|||
19655793|NCT00605280|42104894|FG003|Year 2|Withdrawal by Subject|4|||
19655794|NCT00605280|42104891|FG000|Year 2|Other|1|||
19655795|NCT00605280|42104892|FG001|Year 2|Other|0|||
19655796|NCT00605280|42104893|FG002|Year 2|Other|0|||
19655797|NCT00605280|42104894|FG003|Year 2|Other|1|||
19655798|NCT00605280|42104891|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
19655799|NCT00605280|42104892|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
19655800|NCT00605280|42104893|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
19655801|NCT00605280|42104894|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
19655802|NCT00605280|42104891|FG000|Year 3 Extension|Adverse Event|2|||
19655803|NCT00605280|42104892|FG001|Year 3 Extension|Adverse Event|0|||
19655804|NCT00605280|42104893|FG002|Year 3 Extension|Adverse Event|0|||
19655805|NCT00605280|42104894|FG003|Year 3 Extension|Adverse Event|2|||
19655806|NCT00605280|42104891|FG000|Year 3 Extension|Physician Decision|0|||
19655807|NCT00605280|42104892|FG001|Year 3 Extension|Physician Decision|0|||
19655808|NCT00605280|42104893|FG002|Year 3 Extension|Physician Decision|0|||
19655809|NCT00605280|42104894|FG003|Year 3 Extension|Physician Decision|2|||
19655810|NCT00605280|42104891|FG000|Year 3 Extension|Withdrawal by Subject|2|||
19655811|NCT00605280|42104892|FG001|Year 3 Extension|Withdrawal by Subject|0|||
19655812|NCT00605280|42104893|FG002|Year 3 Extension|Withdrawal by Subject|0|||
19655813|NCT00605280|42104894|FG003|Year 3 Extension|Withdrawal by Subject|5|||
19655814|NCT00605280|42104891|FG000|Year 3 Extension|Other|2|||
19655815|NCT00605280|42104892|FG001|Year 3 Extension|Other|0|||
19655816|NCT00605280|42104893|FG002|Year 3 Extension|Other|0|||
19655817|NCT00605280|42104894|FG003|Year 3 Extension|Other|0|||
19655818|NCT00605280|42104891|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
19655819|NCT00605280|42104892|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
19655820|NCT00605280|42104893|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
19655821|NCT00605280|42104894|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
19655822|NCT00607386|42104904|FG000|Overall Study|Physician Decision|1|||
19655823|NCT00638690|42104910|FG000|Overall Study|Death|655|||
19655824|NCT00638690|42104911|FG001|Overall Study|Death|335|||
19655825|NCT00638690|42104910|FG000|Overall Study|Withdrawal by Subject|22|||
19655826|NCT00638690|42104911|FG001|Overall Study|Withdrawal by Subject|5|||
19655827|NCT00638690|42104910|FG000|Overall Study|Lost to Follow-up|4|||
19655828|NCT00638690|42104911|FG001|Overall Study|Lost to Follow-up|2|||
19655829|NCT00543387|42104927|FG000|Panel 1 + Panel 2|Adverse Event|0|||
19655830|NCT00543387|42104928|FG001|Panel 1 + Panel 2|Adverse Event|1|||
19655831|NCT00543387|42104929|FG002|Panel 1 + Panel 2|Adverse Event|0|||
19655832|NCT00543387|42104930|FG003|Panel 1 + Panel 2|Adverse Event|0|||
19655833|NCT00543387|42104931|FG004|Panel 1 + Panel 2|Adverse Event|0|||
19655834|NCT00543387|42104932|FG005|Panel 1 + Panel 2|Adverse Event|0|||
19655835|NCT00543387|42104933|FG006|Panel 1 + Panel 2|Adverse Event|0|||
19655836|NCT00543387|42104934|FG007|Panel 1 + Panel 2|Adverse Event|1|||
19655837|NCT00543387|42104935|FG008|Panel 1 + Panel 2|Adverse Event|1|||
19655838|NCT00543387|42104936|FG009|Panel 1 + Panel 2|Adverse Event|0|||
19655839|NCT00543387|42104937|FG010|Panel 1 + Panel 2|Adverse Event|0|||
19655840|NCT00543387|42104927|FG000|Panel 1 + Panel 2|Physician Decision|0|||
19655841|NCT00543387|42104928|FG001|Panel 1 + Panel 2|Physician Decision|0|||
19655842|NCT00543387|42104929|FG002|Panel 1 + Panel 2|Physician Decision|1|||
19655843|NCT00543387|42104930|FG003|Panel 1 + Panel 2|Physician Decision|0|||
19655844|NCT00543387|42104931|FG004|Panel 1 + Panel 2|Physician Decision|0|||
19655845|NCT00543387|42104932|FG005|Panel 1 + Panel 2|Physician Decision|0|||
19655846|NCT00543387|42104933|FG006|Panel 1 + Panel 2|Physician Decision|0|||
19655847|NCT00543387|42104934|FG007|Panel 1 + Panel 2|Physician Decision|1|||
19655848|NCT00543387|42104935|FG008|Panel 1 + Panel 2|Physician Decision|0|||
19655849|NCT00543387|42104936|FG009|Panel 1 + Panel 2|Physician Decision|0|||
19655850|NCT00543387|42104937|FG010|Panel 1 + Panel 2|Physician Decision|0|||
19388317|NCT02697773|41631773|FG001|Overall Study|Death|0|||
19388318|NCT02697773|41631774|FG002|Overall Study|Death|2|||
19655851|NCT00543387|42104927|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
19655852|NCT00543387|42104928|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
19655853|NCT00543387|42104929|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
19655854|NCT00543387|42104930|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
19655855|NCT00543387|42104931|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
19655856|NCT00543387|42104932|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
19655857|NCT00543387|42104933|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
19655858|NCT00543387|42104934|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
19655859|NCT00543387|42104935|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
19655860|NCT00543387|42104936|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
19655861|NCT00543387|42104937|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
19655862|NCT00543387|42104927|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655863|NCT00543387|42104928|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655864|NCT00543387|42104929|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655865|NCT00543387|42104930|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655866|NCT00543387|42104931|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655867|NCT00543387|42104932|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655868|NCT00543387|42104933|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
19655869|NCT00543387|42104934|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655870|NCT00543387|42104935|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655871|NCT00543387|42104936|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655872|NCT00543387|42104937|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
19655873|NCT00543387|42104927|FG000|Crossover Participants|Progressive Disease|0|||
19655874|NCT00543387|42104928|FG001|Crossover Participants|Progressive Disease|0|||
19655875|NCT00543387|42104929|FG002|Crossover Participants|Progressive Disease|0|||
19655876|NCT00543387|42104930|FG003|Crossover Participants|Progressive Disease|0|||
19655877|NCT00543387|42104931|FG004|Crossover Participants|Progressive Disease|0|||
19655878|NCT00543387|42104932|FG005|Crossover Participants|Progressive Disease|0|||
19655879|NCT00543387|42104933|FG006|Crossover Participants|Progressive Disease|0|||
19655880|NCT00543387|42104934|FG007|Crossover Participants|Progressive Disease|0|||
19655881|NCT00543387|42104935|FG008|Crossover Participants|Progressive Disease|0|||
19655882|NCT00543387|42104936|FG009|Crossover Participants|Progressive Disease|1|||
19655883|NCT00543387|42104937|FG010|Crossover Participants|Progressive Disease|2|||
19655884|NCT00543387|42104927|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
19655885|NCT00543387|42104928|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
19655886|NCT00543387|42104929|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
19655887|NCT00543387|42104930|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
19655888|NCT00543387|42104931|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
19655889|NCT00543387|42104932|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
19655890|NCT00543387|42104933|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
19655891|NCT00543387|42104934|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
19388319|NCT02697773|41631772|FG000|Overall Study|Lack of Efficacy|4|||
19388320|NCT02697773|41631773|FG001|Overall Study|Lack of Efficacy|6|||
19388321|NCT02697773|41631774|FG002|Overall Study|Lack of Efficacy|6|||
19388322|NCT02697773|41631772|FG000|Overall Study|Lost to Follow-up|5|||
19655892|NCT00543387|42104935|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
19655893|NCT00543387|42104936|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
19655894|NCT00543387|42104937|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
19655895|NCT00635570|42104967|FG000|Overall Study|Lost to Follow-up|8|||
19388323|NCT02697773|41631773|FG001|Overall Study|Lost to Follow-up|5|||
19388324|NCT02697773|41631774|FG002|Overall Study|Lost to Follow-up|7|||
19655896|NCT00635570|42104968|FG001|Overall Study|Lost to Follow-up|8|||
19655897|NCT00635570|42104967|FG000|Overall Study|Withdrawal by Subject|1|||
19655898|NCT00635570|42104968|FG001|Overall Study|Withdrawal by Subject|1|||
19655899|NCT00635570|42104967|FG000|Overall Study|Adverse Event|2|||
19655900|NCT00635570|42104968|FG001|Overall Study|Adverse Event|0|||
19655901|NCT00635570|42104967|FG000|Overall Study|Physician Decision|1|||
19655902|NCT00635570|42104968|FG001|Overall Study|Physician Decision|0|||
19655903|NCT00635570|42104967|FG000|Overall Study|Did not complete survey|2|||
19655904|NCT00635570|42104968|FG001|Overall Study|Did not complete survey|1|||
19655905|NCT00635570|42104967|FG000|Overall Study|Early termination(No sexual activity)|1|||
19655906|NCT00635570|42104968|FG001|Overall Study|Early termination(No sexual activity)|1|||
19655907|NCT00635492|42104976|FG000|Overall Study|Death|12|||
19655908|NCT00635492|42104977|FG001|Overall Study|Death|40|||
19655909|NCT00635492|42104976|FG000|Overall Study|Lost to Follow-up|151|||
19655910|NCT00635492|42104977|FG001|Overall Study|Lost to Follow-up|172|||
19655911|NCT00635492|42104976|FG000|Overall Study|Physician Decision|32|||
19655912|NCT00635492|42104977|FG001|Overall Study|Physician Decision|22|||
19655913|NCT00635492|42104976|FG000|Overall Study|Sponsor decision|2|||
19655914|NCT00635492|42104977|FG001|Overall Study|Sponsor decision|3|||
19388325|NCT02697773|41631772|FG000|Overall Study|Other|15|||
19388326|NCT02697773|41631773|FG001|Overall Study|Other|11|||
19388327|NCT02697773|41631774|FG002|Overall Study|Other|10|||
19388328|NCT02697773|41631772|FG000|Overall Study|Protocol Violation|1|||
19388329|NCT02697773|41631773|FG001|Overall Study|Protocol Violation|1|||
19388330|NCT02697773|41631774|FG002|Overall Study|Protocol Violation|0|||
19388331|NCT02697773|41631772|FG000|Overall Study|Withdrawal by Subject|10|||
19388332|NCT02697773|41631773|FG001|Overall Study|Withdrawal by Subject|13|||
19388333|NCT02697773|41631774|FG002|Overall Study|Withdrawal by Subject|13|||
19388334|NCT02697773|41631772|FG000|Overall Study|Randomized but not treated|1|||
19388335|NCT02697773|41631773|FG001|Overall Study|Randomized but not treated|1|||
19388336|NCT02697773|41631774|FG002|Overall Study|Randomized but not treated|0|||
19655915|NCT00635492|42104976|FG000|Overall Study|Withdrawal by Subject|82|||
19655916|NCT00635492|42104977|FG001|Overall Study|Withdrawal by Subject|45|||
19655917|NCT00543309|42104990|FG000|Overall Study|Physician Decision|0|||
19655918|NCT00543309|42104991|FG001|Overall Study|Physician Decision|1|||
19655919|NCT00543309|42104992|FG002|Overall Study|Physician Decision|0|||
19655920|NCT00569582|42105001|FG000|Overall Study|Withdrawal by Subject|5|||
19655921|NCT00569582|42105001|FG000|Overall Study|Death|2|||
19655922|NCT00569582|42105001|FG000|Overall Study|Adverse Event|7|||
19655923|NCT00569582|42105001|FG000|Overall Study|Subject was too ill to travel.|1|||
19655924|NCT00569582|42105001|FG000|Overall Study|Subject was non-compliant.|1|||
19655925|NCT00721409|42105008|FG000|Overall Study|Global deterioration of health status|2|||
19655926|NCT00721409|42105009|FG001|Overall Study|Global deterioration of health status|6|||
19655927|NCT00721409|42105010|FG002|Overall Study|Global deterioration of health status|3|||
19655928|NCT00721409|42105008|FG000|Overall Study|Death|0|||
19655929|NCT00721409|42105009|FG001|Overall Study|Death|1|||
19655930|NCT00721409|42105010|FG002|Overall Study|Death|0|||
19655931|NCT00721409|42105008|FG000|Overall Study|Randomized not Treated|0|||
19655932|NCT00721409|42105009|FG001|Overall Study|Randomized not Treated|1|||
19655933|NCT00721409|42105010|FG002|Overall Study|Randomized not Treated|4|||
19655934|NCT00721409|42105008|FG000|Overall Study|Reason not specified|1|||
19655935|NCT00721409|42105009|FG001|Overall Study|Reason not specified|0|||
19655936|NCT00721409|42105010|FG002|Overall Study|Reason not specified|2|||
19655937|NCT00721409|42105008|FG000|Overall Study|Adverse Event|0|||
19655938|NCT00721409|42105009|FG001|Overall Study|Adverse Event|13|||
19655939|NCT00721409|42105010|FG002|Overall Study|Adverse Event|2|||
19655940|NCT00721409|42105008|FG000|Overall Study|Lost to Follow-up|0|||
19655941|NCT00721409|42105009|FG001|Overall Study|Lost to Follow-up|0|||
19655942|NCT00721409|42105010|FG002|Overall Study|Lost to Follow-up|1|||
19655943|NCT00721409|42105008|FG000|Overall Study|Withdrawal by Subject|1|||
19655944|NCT00721409|42105009|FG001|Overall Study|Withdrawal by Subject|6|||
19655945|NCT00721409|42105010|FG002|Overall Study|Withdrawal by Subject|5|||
19388337|NCT02693171|41631782|FG000|Overall Study|Adverse Event|1|||
19655946|NCT00721409|42105008|FG000|Overall Study|Objective progression or relapse|8|||
19655947|NCT00721409|42105009|FG001|Overall Study|Objective progression or relapse|55|||
19655948|NCT00721409|42105010|FG002|Overall Study|Objective progression or relapse|62|||
19655949|NCT00542997|42105034|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
19655950|NCT00542997|42105034|FG000|Wash in / Wash Out Period|Adverse Event|3|||
19655951|NCT00542997|42105034|FG000|Efficacy Period|Adverse Event|3|||
19655952|NCT00572832|42105043|FG000|Overall Study|Lost to Follow-up|0|||
19655953|NCT00572832|42105044|FG001|Overall Study|Lost to Follow-up|11|||
19655954|NCT00572832|42105043|FG000|Overall Study|Pregnancy|0|||
19388338|NCT02693171|41631782|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
19388339|NCT02692703|41631786|FG000|Overall Study|Lost to Follow-up|1|||
19655955|NCT00572832|42105044|FG001|Overall Study|Pregnancy|1|||
19655956|NCT03917823|42105052|FG000|Overall Study|Lost to Follow-up|1|||
19655957|NCT03917823|42105053|FG001|Overall Study|Lost to Follow-up|1|||
19655958|NCT03917823|42105052|FG000|Overall Study|Withdrawal by Subject|0|||
19655959|NCT03917823|42105053|FG001|Overall Study|Withdrawal by Subject|1|||
19655960|NCT00229723|42105066|FG000|Concomitant Phase|Adverse Event|4|||
19655961|NCT00229723|42105067|FG001|Concomitant Phase|Adverse Event|2|||
19655962|NCT00229723|42105068|FG002|Concomitant Phase|Adverse Event|5|||
19655963|NCT00229723|42105069|FG003|Concomitant Phase|Adverse Event|2|||
19655964|NCT00229723|42105070|FG004|Concomitant Phase|Adverse Event|0|||
19655965|NCT00229723|42105071|FG005|Concomitant Phase|Adverse Event|1|||
19655966|NCT00229723|42105072|FG006|Concomitant Phase|Adverse Event|2|||
19655967|NCT00229723|42105066|FG000|Concomitant Phase|Objective disease progression|0|||
19655968|NCT00229723|42105067|FG001|Concomitant Phase|Objective disease progression|0|||
19655969|NCT00229723|42105068|FG002|Concomitant Phase|Objective disease progression|0|||
19655970|NCT00229723|42105069|FG003|Concomitant Phase|Objective disease progression|0|||
19655971|NCT00229723|42105070|FG004|Concomitant Phase|Objective disease progression|0|||
19655972|NCT00229723|42105071|FG005|Concomitant Phase|Objective disease progression|0|||
19655973|NCT00229723|42105072|FG006|Concomitant Phase|Objective disease progression|0|||
19655974|NCT00229723|42105066|FG000|Concomitant Phase|Clinical progression|0|||
19655975|NCT00229723|42105067|FG001|Concomitant Phase|Clinical progression|0|||
19655976|NCT00229723|42105068|FG002|Concomitant Phase|Clinical progression|0|||
19655977|NCT00229723|42105069|FG003|Concomitant Phase|Clinical progression|0|||
19655978|NCT00229723|42105070|FG004|Concomitant Phase|Clinical progression|0|||
19655979|NCT00229723|42105071|FG005|Concomitant Phase|Clinical progression|0|||
19655980|NCT00229723|42105072|FG006|Concomitant Phase|Clinical progression|1|||
19655981|NCT00229723|42105066|FG000|Concomitant Phase|Lost to Follow-up|0|||
19655982|NCT00229723|42105067|FG001|Concomitant Phase|Lost to Follow-up|0|||
19655983|NCT00229723|42105068|FG002|Concomitant Phase|Lost to Follow-up|0|||
19655984|NCT00229723|42105069|FG003|Concomitant Phase|Lost to Follow-up|0|||
19655985|NCT00229723|42105070|FG004|Concomitant Phase|Lost to Follow-up|1|||
19655986|NCT00229723|42105071|FG005|Concomitant Phase|Lost to Follow-up|0|||
19655987|NCT00229723|42105072|FG006|Concomitant Phase|Lost to Follow-up|0|||
19655988|NCT00229723|42105066|FG000|Concomitant Phase|Informed consent withdrawn|3|||
19655989|NCT00229723|42105067|FG001|Concomitant Phase|Informed consent withdrawn|2|||
19655990|NCT00229723|42105068|FG002|Concomitant Phase|Informed consent withdrawn|0|||
19655991|NCT00229723|42105069|FG003|Concomitant Phase|Informed consent withdrawn|2|||
19655992|NCT00229723|42105070|FG004|Concomitant Phase|Informed consent withdrawn|0|||
19655993|NCT00229723|42105071|FG005|Concomitant Phase|Informed consent withdrawn|0|||
19655994|NCT00229723|42105072|FG006|Concomitant Phase|Informed consent withdrawn|0|||
19655995|NCT00229723|42105066|FG000|Concomitant Phase|Severe non-compliance|0|||
19655996|NCT00229723|42105067|FG001|Concomitant Phase|Severe non-compliance|1|||
19655997|NCT00229723|42105068|FG002|Concomitant Phase|Severe non-compliance|0|||
19655998|NCT00229723|42105069|FG003|Concomitant Phase|Severe non-compliance|0|||
19655999|NCT00229723|42105070|FG004|Concomitant Phase|Severe non-compliance|1|||
19656000|NCT00229723|42105071|FG005|Concomitant Phase|Severe non-compliance|0|||
19656001|NCT00229723|42105072|FG006|Concomitant Phase|Severe non-compliance|0|||
19656002|NCT00229723|42105066|FG000|Concomitant Phase|Other|3|||
19656003|NCT00229723|42105067|FG001|Concomitant Phase|Other|0|||
19656004|NCT00229723|42105068|FG002|Concomitant Phase|Other|1|||
19656005|NCT00229723|42105069|FG003|Concomitant Phase|Other|1|||
19656006|NCT00229723|42105070|FG004|Concomitant Phase|Other|0|||
19656007|NCT00229723|42105071|FG005|Concomitant Phase|Other|2|||
19656008|NCT00229723|42105072|FG006|Concomitant Phase|Other|0|||
19656009|NCT00229723|42105066|FG000|Maintenance Phase|Adverse Event|7|||
19656010|NCT00229723|42105067|FG001|Maintenance Phase|Adverse Event|2|||
19656011|NCT00229723|42105068|FG002|Maintenance Phase|Adverse Event|1|||
19656012|NCT00229723|42105069|FG003|Maintenance Phase|Adverse Event|4|||
19656013|NCT00229723|42105070|FG004|Maintenance Phase|Adverse Event|7|||
19656014|NCT00229723|42105071|FG005|Maintenance Phase|Adverse Event|5|||
19656015|NCT00229723|42105072|FG006|Maintenance Phase|Adverse Event|2|||
19656016|NCT00229723|42105066|FG000|Maintenance Phase|Objective disease progression|5|||
19656017|NCT00229723|42105067|FG001|Maintenance Phase|Objective disease progression|5|||
19656018|NCT00229723|42105068|FG002|Maintenance Phase|Objective disease progression|3|||
19656019|NCT00229723|42105069|FG003|Maintenance Phase|Objective disease progression|6|||
19656020|NCT00229723|42105070|FG004|Maintenance Phase|Objective disease progression|2|||
19656021|NCT00229723|42105071|FG005|Maintenance Phase|Objective disease progression|9|||
19656022|NCT00229723|42105072|FG006|Maintenance Phase|Objective disease progression|5|||
19656023|NCT00229723|42105066|FG000|Maintenance Phase|Clinical progression|4|||
19656024|NCT00229723|42105067|FG001|Maintenance Phase|Clinical progression|1|||
19656025|NCT00229723|42105068|FG002|Maintenance Phase|Clinical progression|2|||
19656026|NCT00229723|42105069|FG003|Maintenance Phase|Clinical progression|2|||
19656027|NCT00229723|42105070|FG004|Maintenance Phase|Clinical progression|1|||
19656028|NCT00229723|42105071|FG005|Maintenance Phase|Clinical progression|1|||
19656029|NCT00229723|42105072|FG006|Maintenance Phase|Clinical progression|1|||
19656030|NCT00229723|42105066|FG000|Maintenance Phase|Lost to Follow-up|0|||
19656031|NCT00229723|42105067|FG001|Maintenance Phase|Lost to Follow-up|1|||
19656032|NCT00229723|42105068|FG002|Maintenance Phase|Lost to Follow-up|2|||
19656033|NCT00229723|42105069|FG003|Maintenance Phase|Lost to Follow-up|2|||
19656034|NCT00229723|42105070|FG004|Maintenance Phase|Lost to Follow-up|0|||
19656035|NCT00229723|42105071|FG005|Maintenance Phase|Lost to Follow-up|0|||
19656036|NCT00229723|42105072|FG006|Maintenance Phase|Lost to Follow-up|1|||
19656037|NCT00229723|42105066|FG000|Maintenance Phase|Informed consent withdrawn|1|||
19656038|NCT00229723|42105067|FG001|Maintenance Phase|Informed consent withdrawn|0|||
19656039|NCT00229723|42105068|FG002|Maintenance Phase|Informed consent withdrawn|0|||
19656040|NCT00229723|42105069|FG003|Maintenance Phase|Informed consent withdrawn|1|||
19656041|NCT00229723|42105070|FG004|Maintenance Phase|Informed consent withdrawn|1|||
19753657|NCT03168555|42203414|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
19753658|NCT03168555|42203414|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
19753659|NCT03168555|42203414|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
19656042|NCT00229723|42105071|FG005|Maintenance Phase|Informed consent withdrawn|1|||
19656043|NCT00229723|42105072|FG006|Maintenance Phase|Informed consent withdrawn|0|||
19656044|NCT00229723|42105066|FG000|Maintenance Phase|Severe non-compliance|3|||
19656045|NCT00229723|42105067|FG001|Maintenance Phase|Severe non-compliance|1|||
19656046|NCT00229723|42105068|FG002|Maintenance Phase|Severe non-compliance|0|||
19656047|NCT00229723|42105069|FG003|Maintenance Phase|Severe non-compliance|0|||
19656048|NCT00229723|42105070|FG004|Maintenance Phase|Severe non-compliance|1|||
19656049|NCT00229723|42105071|FG005|Maintenance Phase|Severe non-compliance|0|||
19656050|NCT00229723|42105072|FG006|Maintenance Phase|Severe non-compliance|0|||
19656051|NCT00229723|42105066|FG000|Maintenance Phase|Other|5|||
19656052|NCT00229723|42105067|FG001|Maintenance Phase|Other|4|||
19656053|NCT00229723|42105068|FG002|Maintenance Phase|Other|1|||
19656054|NCT00229723|42105069|FG003|Maintenance Phase|Other|2|||
19656055|NCT00229723|42105070|FG004|Maintenance Phase|Other|3|||
19656056|NCT00229723|42105071|FG005|Maintenance Phase|Other|3|||
19656057|NCT00229723|42105072|FG006|Maintenance Phase|Other|1|||
19656058|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
19656059|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656060|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656061|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656062|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656063|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656064|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
19656065|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
19656066|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656067|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656068|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656069|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656070|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656071|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
19656072|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
19656073|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656074|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656075|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656076|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656077|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656078|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
19656079|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
19656080|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656081|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656082|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656083|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656084|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656085|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
19656086|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
19656087|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19656088|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19656089|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19698961|NCT00312338|42143779|FG000|Overall Study|Adverse Event|7|||
19656090|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19656091|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19656092|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
19656093|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
19656094|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656095|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656096|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656097|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656098|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656099|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
19656100|NCT00606684|42105094|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
19656101|NCT00606684|42105095|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656102|NCT00606684|42105096|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656103|NCT00606684|42105097|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656104|NCT00606684|42105098|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656105|NCT00606684|42105099|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656106|NCT00606684|42105100|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
19656107|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19656108|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Adverse Event|3|||
19656109|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Adverse Event|2|||
19656110|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Adverse Event|4|||
19656111|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Adverse Event|2|||
19656112|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Adverse Event|0|||
19656113|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Adverse Event|1|||
19656114|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
19656115|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
19656116|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
19656117|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
19656118|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
19656119|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
19656120|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
19656121|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
19656122|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
19656123|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
19656124|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
19656125|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
19656126|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
19656127|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
19656128|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
19656129|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
19656130|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
19656131|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
19656132|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
19656133|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
19656134|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
19656135|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Physician Decision|0|||
19656136|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Physician Decision|5|||
19656137|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Physician Decision|1|||
19656138|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Physician Decision|0|||
19656139|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Physician Decision|3|||
19656140|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Physician Decision|1|||
19656141|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Physician Decision|2|||
19656142|NCT00606684|42105094|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19656143|NCT00606684|42105095|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19656144|NCT00606684|42105096|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19656145|NCT00606684|42105097|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
19656146|NCT00606684|42105098|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19656147|NCT00606684|42105099|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
19656148|NCT00606684|42105100|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19656149|NCT00627926|42105117|FG000|Overall Study|Adverse Event|26|||
19656150|NCT00627926|42105118|FG001|Overall Study|Adverse Event|37|||
19656151|NCT00627926|42105119|FG002|Overall Study|Adverse Event|36|||
19656152|NCT00627926|42105117|FG000|Overall Study|Death|1|||
19656153|NCT00627926|42105118|FG001|Overall Study|Death|0|||
19656154|NCT00627926|42105119|FG002|Overall Study|Death|0|||
19656155|NCT00627926|42105117|FG000|Overall Study|Lost to Follow-up|4|||
19656156|NCT00627926|42105118|FG001|Overall Study|Lost to Follow-up|3|||
19656157|NCT00627926|42105119|FG002|Overall Study|Lost to Follow-up|4|||
19656158|NCT00627926|42105117|FG000|Overall Study|Withdrawal by Subject|2|||
19656159|NCT00627926|42105118|FG001|Overall Study|Withdrawal by Subject|1|||
19656160|NCT00627926|42105119|FG002|Overall Study|Withdrawal by Subject|0|||
19656161|NCT00627926|42105117|FG000|Overall Study|Lack of Efficacy|118|||
19656162|NCT00627926|42105118|FG001|Overall Study|Lack of Efficacy|40|||
19656163|NCT00627926|42105119|FG002|Overall Study|Lack of Efficacy|38|||
19656164|NCT00627926|42105117|FG000|Overall Study|Noncompliance/unspecified|8|||
19656165|NCT00627926|42105118|FG001|Overall Study|Noncompliance/unspecified|23|||
19656166|NCT00627926|42105119|FG002|Overall Study|Noncompliance/unspecified|17|||
19656167|NCT00228553|42105127|FG000|Overall Study|Adverse Event|112|||
19656168|NCT00228553|42105127|FG000|Overall Study|Lack of Efficacy|34|||
19656169|NCT00228553|42105127|FG000|Overall Study|Lost to Follow-up|67|||
19753660|NCT03168555|42203414|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
19753661|NCT03235050|42203426|FG000|Overall Study|Adverse Event|0|||
19753662|NCT03235050|42203427|FG001|Overall Study|Adverse Event|0|||
19656170|NCT00228553|42105127|FG000|Overall Study|Physician Decision|48|||
19656171|NCT00228553|42105127|FG000|Overall Study|Protocol Violation|6|||
19656172|NCT00228553|42105127|FG000|Overall Study|Withdrawal by Subject|115|||
19656173|NCT00228553|42105127|FG000|Overall Study|Pregnancy|2|||
19753663|NCT03235050|42203428|FG002|Overall Study|Adverse Event|1|||
19753664|NCT03235050|42203429|FG003|Overall Study|Adverse Event|4|||
19388340|NCT02692703|41631786|FG000|Overall Study|Other|1|||
19388341|NCT02692235|41631792|FG000|Overall Study|Withdrawal by Subject|2|||
19656174|NCT00228553|42105127|FG000|Overall Study|Miscellaneous|46|||
19656175|NCT00643916|42105137|FG000|Overall Study|Protocol Violation|0|||
19656176|NCT00643916|42105138|FG001|Overall Study|Protocol Violation|1|||
19656177|NCT00643916|42105139|FG002|Overall Study|Protocol Violation|1|||
19656178|NCT00643916|42105140|FG003|Overall Study|Protocol Violation|1|||
19656179|NCT00643916|42105141|FG004|Overall Study|Protocol Violation|0|||
19656180|NCT00643916|42105142|FG005|Overall Study|Protocol Violation|0|||
19656181|NCT00643916|42105137|FG000|Overall Study|Lost to Follow-up|0|||
19656182|NCT00643916|42105138|FG001|Overall Study|Lost to Follow-up|1|||
19656183|NCT00643916|42105139|FG002|Overall Study|Lost to Follow-up|0|||
19656184|NCT00643916|42105140|FG003|Overall Study|Lost to Follow-up|0|||
19656185|NCT00643916|42105141|FG004|Overall Study|Lost to Follow-up|0|||
19656186|NCT00643916|42105142|FG005|Overall Study|Lost to Follow-up|0|||
19656187|NCT00643916|42105137|FG000|Overall Study|Withdrawal by Subject|2|||
19656188|NCT00643916|42105138|FG001|Overall Study|Withdrawal by Subject|2|||
19656189|NCT00643916|42105139|FG002|Overall Study|Withdrawal by Subject|2|||
19656190|NCT00643916|42105140|FG003|Overall Study|Withdrawal by Subject|1|||
19656191|NCT00643916|42105141|FG004|Overall Study|Withdrawal by Subject|0|||
19656192|NCT00643916|42105142|FG005|Overall Study|Withdrawal by Subject|1|||
19656193|NCT00643916|42105137|FG000|Overall Study|Not Vaccinated|2|||
19656194|NCT00643916|42105138|FG001|Overall Study|Not Vaccinated|2|||
19656195|NCT00643916|42105139|FG002|Overall Study|Not Vaccinated|3|||
19656196|NCT00643916|42105140|FG003|Overall Study|Not Vaccinated|0|||
19656197|NCT00643916|42105141|FG004|Overall Study|Not Vaccinated|2|||
19656198|NCT00643916|42105142|FG005|Overall Study|Not Vaccinated|0|||
19656199|NCT00160693|42105156|FG000|Overall Study|Adverse Event|97|||
19656200|NCT00160693|42105156|FG000|Overall Study|Lack of Efficacy|30|||
19656201|NCT00160693|42105156|FG000|Overall Study|Protocol Violation|24|||
19656202|NCT00160693|42105156|FG000|Overall Study|Lost to Follow-up|15|||
19656203|NCT00160693|42105156|FG000|Overall Study|Withdrawal by Subject|54|||
19656204|NCT00160693|42105156|FG000|Overall Study|Study terminated by sponsor|15|||
19656205|NCT00643760|42105165|FG000|Overall Study|Adverse Event|11|||
19656206|NCT00643760|42105166|FG001|Overall Study|Adverse Event|5|||
19656207|NCT00643760|42105167|FG002|Overall Study|Adverse Event|12|||
19388342|NCT02692235|41631793|FG001|Overall Study|Withdrawal by Subject|1|||
19656208|NCT00643760|42105168|FG003|Overall Study|Adverse Event|21|||
19388343|NCT02692235|41631792|FG000|Overall Study|Adverse Event|1|||
19388344|NCT02692235|41631793|FG001|Overall Study|Adverse Event|2|||
19388345|NCT02552121|41631807|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
19388346|NCT02552121|41631808|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388347|NCT02552121|41631809|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388348|NCT02552121|41631810|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388349|NCT02552121|41631811|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388350|NCT02552121|41631812|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388351|NCT02552121|41631813|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19656209|NCT00643760|42105169|FG004|Overall Study|Adverse Event|6|||
19656210|NCT00643760|42105165|FG000|Overall Study|Lack of Efficacy|3|||
19656211|NCT00643760|42105166|FG001|Overall Study|Lack of Efficacy|1|||
19656212|NCT00643760|42105167|FG002|Overall Study|Lack of Efficacy|0|||
19656213|NCT00643760|42105168|FG003|Overall Study|Lack of Efficacy|4|||
19656214|NCT00643760|42105169|FG004|Overall Study|Lack of Efficacy|3|||
19656215|NCT00643760|42105165|FG000|Overall Study|Protocol Violation|7|||
19656216|NCT00643760|42105166|FG001|Overall Study|Protocol Violation|6|||
19656217|NCT00643760|42105167|FG002|Overall Study|Protocol Violation|4|||
19753665|NCT03235050|42203430|FG004|Overall Study|Adverse Event|1|||
19388352|NCT02552121|41631814|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
19388353|NCT02552121|41631807|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
19388354|NCT02552121|41631808|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388355|NCT02552121|41631809|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388356|NCT02552121|41631810|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388357|NCT02552121|41631811|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388358|NCT02552121|41631812|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388359|NCT02552121|41631813|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388360|NCT02552121|41631814|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
19388361|NCT02552121|41631807|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19388362|NCT02552121|41631808|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
19656218|NCT00643760|42105168|FG003|Overall Study|Protocol Violation|4|||
19656219|NCT00643760|42105169|FG004|Overall Study|Protocol Violation|6|||
19656220|NCT00643760|42105165|FG000|Overall Study|Lost to Follow-up|6|||
19656221|NCT00643760|42105166|FG001|Overall Study|Lost to Follow-up|2|||
19656222|NCT00643760|42105167|FG002|Overall Study|Lost to Follow-up|1|||
19656223|NCT00643760|42105168|FG003|Overall Study|Lost to Follow-up|3|||
19656224|NCT00643760|42105169|FG004|Overall Study|Lost to Follow-up|3|||
19656225|NCT00643760|42105165|FG000|Overall Study|Investigator Discretion|0|||
19656226|NCT00643760|42105166|FG001|Overall Study|Investigator Discretion|0|||
19656227|NCT00643760|42105167|FG002|Overall Study|Investigator Discretion|0|||
19656228|NCT00643760|42105168|FG003|Overall Study|Investigator Discretion|2|||
19656229|NCT00643760|42105169|FG004|Overall Study|Investigator Discretion|0|||
19656230|NCT00643760|42105165|FG000|Overall Study|Withdrawal by Subject|3|||
19656231|NCT00643760|42105166|FG001|Overall Study|Withdrawal by Subject|1|||
19656232|NCT00643760|42105167|FG002|Overall Study|Withdrawal by Subject|2|||
19656233|NCT00643760|42105168|FG003|Overall Study|Withdrawal by Subject|4|||
19656234|NCT00643760|42105169|FG004|Overall Study|Withdrawal by Subject|1|||
19656235|NCT00643682|42105183|FG000|Overall Study|did not keep appointment|522|||
19656236|NCT00643682|42105184|FG001|Overall Study|did not keep appointment|509|||
19656237|NCT00643604|42105190|FG000|Overall Study|Death|1|||
19656238|NCT00603798|42105197|FG000|Overall Study|Adverse Event|4|||
19656239|NCT00603798|42105198|FG001|Overall Study|Adverse Event|2|||
19656240|NCT00603798|42105199|FG002|Overall Study|Adverse Event|1|||
19656241|NCT00603798|42105197|FG000|Overall Study|Withdrawal by Subject|4|||
19656242|NCT00603798|42105198|FG001|Overall Study|Withdrawal by Subject|3|||
19656243|NCT00603798|42105199|FG002|Overall Study|Withdrawal by Subject|4|||
19656244|NCT00603798|42105197|FG000|Overall Study|Lost to Follow-up|1|||
19656245|NCT00603798|42105198|FG001|Overall Study|Lost to Follow-up|0|||
19656246|NCT00603798|42105199|FG002|Overall Study|Lost to Follow-up|1|||
19656247|NCT00603798|42105197|FG000|Overall Study|Non-compliance with study procedures|0|||
19656248|NCT00603798|42105198|FG001|Overall Study|Non-compliance with study procedures|1|||
19656249|NCT00603798|42105199|FG002|Overall Study|Non-compliance with study procedures|0|||
19656250|NCT00603798|42105197|FG000|Overall Study|Not due to AE|1|||
19656251|NCT00603798|42105198|FG001|Overall Study|Not due to AE|1|||
19656252|NCT00603798|42105199|FG002|Overall Study|Not due to AE|4|||
19656253|NCT00630812|42105209|FG000|Randomisation to First Dose|Adverse Event|1|||
19656254|NCT00630812|42105210|FG001|Randomisation to First Dose|Adverse Event|1|||
19656255|NCT00630812|42105209|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
19656256|NCT00630812|42105210|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
19656257|NCT00630812|42105209|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
19656258|NCT00630812|42105210|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
19656259|NCT00630812|42105209|FG000|Randomisation to First Dose|Protocol Violation|4|||
19656260|NCT00630812|42105210|FG001|Randomisation to First Dose|Protocol Violation|1|||
19656261|NCT00630812|42105209|FG000|Double Blind Treatment Period|Adverse Event|13|||
19656262|NCT00630812|42105210|FG001|Double Blind Treatment Period|Adverse Event|5|||
19656263|NCT00630812|42105209|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
19656264|NCT00630812|42105210|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
19656265|NCT00630812|42105209|FG000|Double Blind Treatment Period|Physician Decision|2|||
19656266|NCT00630812|42105210|FG001|Double Blind Treatment Period|Physician Decision|1|||
19656267|NCT00630812|42105209|FG000|Double Blind Treatment Period|Protocol Violation|1|||
19656268|NCT00630812|42105210|FG001|Double Blind Treatment Period|Protocol Violation|0|||
19656269|NCT00630812|42105209|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
19656270|NCT00630812|42105210|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
19656271|NCT00630812|42105209|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
19388363|NCT02552121|41631809|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19388364|NCT02552121|41631810|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19656272|NCT00630812|42105210|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
19656273|NCT00630812|42105209|FG000|Double Blind Treatment Period|Non-compliance|0|||
19656274|NCT00630812|42105210|FG001|Double Blind Treatment Period|Non-compliance|1|||
19656275|NCT00629798|42105216|FG000|Overall Study|Not Treated|4|||
19656276|NCT00160615|42105222|FG000|Overall Study|Adverse Event|5|||
19388365|NCT02552121|41631811|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19656277|NCT00160615|42105223|FG001|Overall Study|Adverse Event|12|||
19656278|NCT00160615|42105222|FG000|Overall Study|Withdrawal by Subject|0|||
19656279|NCT00160615|42105223|FG001|Overall Study|Withdrawal by Subject|2|||
19656280|NCT00160615|42105222|FG000|Overall Study|Lack of Efficacy|11|||
19656281|NCT00160615|42105223|FG001|Overall Study|Lack of Efficacy|23|||
19656282|NCT00160615|42105222|FG000|Overall Study|Patient decision|1|||
19656283|NCT00160615|42105223|FG001|Overall Study|Patient decision|2|||
19656284|NCT00160615|42105222|FG000|Overall Study|Investigator decision|1|||
19656285|NCT00160615|42105223|FG001|Overall Study|Investigator decision|1|||
19656286|NCT00160615|42105222|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
19656287|NCT00160615|42105223|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
19753666|NCT03235050|42203426|FG000|Overall Study|Death|0|||
19753667|NCT03235050|42203427|FG001|Overall Study|Death|0|||
19753668|NCT03235050|42203428|FG002|Overall Study|Death|0|||
19753669|NCT03235050|42203429|FG003|Overall Study|Death|2|||
19753670|NCT03235050|42203430|FG004|Overall Study|Death|1|||
19656288|NCT00160615|42105222|FG000|Overall Study|Switch to surgical treatment|0|||
19656289|NCT00160615|42105223|FG001|Overall Study|Switch to surgical treatment|2|||
19656290|NCT00160615|42105222|FG000|Overall Study|Non-compliance was suspected|0|||
19656291|NCT00160615|42105223|FG001|Overall Study|Non-compliance was suspected|1|||
19656292|NCT00160615|42105222|FG000|Overall Study|Poor compliance|0|||
19656293|NCT00160615|42105223|FG001|Overall Study|Poor compliance|1|||
19656294|NCT00643448|42105234|FG000|Overall Study|Lack of Efficacy|2|||
19656295|NCT00643448|42105235|FG001|Overall Study|Lack of Efficacy|0|||
19656296|NCT00643448|42105236|FG002|Overall Study|Lack of Efficacy|4|||
19656297|NCT00643448|42105234|FG000|Overall Study|Adverse Event|2|||
19656298|NCT00643448|42105235|FG001|Overall Study|Adverse Event|2|||
19656299|NCT00643448|42105236|FG002|Overall Study|Adverse Event|2|||
19656300|NCT00643448|42105234|FG000|Overall Study|QTcF>550 ms|0|||
19656301|NCT00643448|42105235|FG001|Overall Study|QTcF>550 ms|3|||
19656302|NCT00643448|42105236|FG002|Overall Study|QTcF>550 ms|0|||
19656303|NCT00604500|42105246|FG000|Overall Study|Adverse Event|2|||
19656304|NCT00604500|42105246|FG000|Overall Study|Protocol Violation|2|||
19656305|NCT00604500|42105246|FG000|Overall Study|Treatment Failure|1|||
19656306|NCT00604500|42105246|FG000|Overall Study|Withdrawal by Subject|4|||
19656307|NCT00604500|42105246|FG000|Overall Study|Administrative|1|||
19656308|NCT00604500|42105246|FG000|Overall Study|Did not meet protocol eligibility|1|||
19656309|NCT00627458|42105253|FG000|Overall Study|Migrated from study area|1|||
19656310|NCT00627458|42105254|FG001|Overall Study|Migrated from study area|0|||
19656311|NCT00627458|42105255|FG002|Overall Study|Migrated from study area|1|||
19656312|NCT00627458|42105253|FG000|Overall Study|Withdrawal by Subject|2|||
19656313|NCT00627458|42105254|FG001|Overall Study|Withdrawal by Subject|6|||
19656314|NCT00627458|42105255|FG002|Overall Study|Withdrawal by Subject|5|||
19656315|NCT00627458|42105253|FG000|Overall Study|Lost to Follow-up|1|||
19656316|NCT00627458|42105254|FG001|Overall Study|Lost to Follow-up|1|||
19656317|NCT00627458|42105255|FG002|Overall Study|Lost to Follow-up|0|||
19656318|NCT00542919|42105267|FG000|Overall Study|Adverse Event|1|||
19656319|NCT00542919|42105268|FG001|Overall Study|Adverse Event|5|||
19656320|NCT00542919|42105269|FG002|Overall Study|Adverse Event|1|||
19656321|NCT00542919|42105267|FG000|Overall Study|Withdrawal by Subject|1|||
19656322|NCT00542919|42105268|FG001|Overall Study|Withdrawal by Subject|0|||
19656323|NCT00542919|42105269|FG002|Overall Study|Withdrawal by Subject|3|||
19656324|NCT00542919|42105267|FG000|Overall Study|Physician Decision|2|||
19656325|NCT00542919|42105268|FG001|Overall Study|Physician Decision|2|||
19656326|NCT00542919|42105269|FG002|Overall Study|Physician Decision|1|||
19656327|NCT00542919|42105267|FG000|Overall Study|Sponsor Decision|1|||
19656328|NCT00542919|42105268|FG001|Overall Study|Sponsor Decision|0|||
19656329|NCT00542919|42105269|FG002|Overall Study|Sponsor Decision|0|||
19656330|NCT00542919|42105267|FG000|Overall Study|Lost to Follow-up|2|||
19656331|NCT00542919|42105268|FG001|Overall Study|Lost to Follow-up|0|||
19656332|NCT00542919|42105269|FG002|Overall Study|Lost to Follow-up|1|||
19656333|NCT00159913|42105296|FG000|Overall Study|Adverse Event|1|||
19656334|NCT00159913|42105297|FG001|Overall Study|Adverse Event|0|||
19656335|NCT00159913|42105298|FG002|Overall Study|Adverse Event|1|||
19656336|NCT00159913|42105299|FG003|Overall Study|Adverse Event|0|||
19656337|NCT00159913|42105296|FG000|Overall Study|Withdrawal by Subject|0|||
19656338|NCT00159913|42105297|FG001|Overall Study|Withdrawal by Subject|0|||
19656339|NCT00159913|42105298|FG002|Overall Study|Withdrawal by Subject|0|||
19753671|NCT03235050|42203426|FG000|Overall Study|Lost to Follow-up|1|||
19753672|NCT03235050|42203427|FG001|Overall Study|Lost to Follow-up|2|||
19656340|NCT00159913|42105299|FG003|Overall Study|Withdrawal by Subject|1|||
19656341|NCT00159913|42105296|FG000|Overall Study|Lost to Follow-up|0|||
19656342|NCT00159913|42105297|FG001|Overall Study|Lost to Follow-up|0|||
19656343|NCT00159913|42105298|FG002|Overall Study|Lost to Follow-up|0|||
19656344|NCT00159913|42105299|FG003|Overall Study|Lost to Follow-up|1|||
19656345|NCT00159913|42105296|FG000|Overall Study|Protocol Violation|1|||
19656346|NCT00159913|42105297|FG001|Overall Study|Protocol Violation|0|||
19656347|NCT00159913|42105298|FG002|Overall Study|Protocol Violation|1|||
19656348|NCT00159913|42105299|FG003|Overall Study|Protocol Violation|0|||
19656349|NCT00604188|42105313|FG000|Overall Study|Adverse Event|1|||
19656350|NCT00604188|42105314|FG001|Overall Study|Adverse Event|4|||
19656351|NCT00604188|42105313|FG000|Overall Study|Lost to Follow-up|17|||
19656352|NCT00604188|42105314|FG001|Overall Study|Lost to Follow-up|15|||
19656353|NCT00604188|42105313|FG000|Overall Study|Withdrawal by Subject|5|||
19656354|NCT00604188|42105314|FG001|Overall Study|Withdrawal by Subject|1|||
19656355|NCT00604188|42105313|FG000|Overall Study|Non-compliance with protocol|4|||
19656356|NCT00604188|42105314|FG001|Overall Study|Non-compliance with protocol|4|||
19656357|NCT00604188|42105313|FG000|Overall Study|Did not receive study drug|0|||
19656358|NCT00604188|42105314|FG001|Overall Study|Did not receive study drug|1|||
19656359|NCT03913377|42105322|FG000|Period 1|Test Article no longer available|0|||
19656360|NCT03913377|42105323|FG001|Period 1|Test Article no longer available|1|||
19656361|NCT03913377|42105324|FG002|Period 1|Test Article no longer available|0|||
19656362|NCT03913377|42105322|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
19656363|NCT03913377|42105323|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
19656364|NCT03913377|42105324|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
19656365|NCT00227539|42105331|FG000|Overall Study|Protocol Violation|1|||
19656366|NCT00227305|42105335|FG000|Overall Study|Adverse Event|40|||
19656367|NCT00227305|42105335|FG000|Overall Study|Withdrawal by Subject|42|||
19656368|NCT00227305|42105335|FG000|Overall Study|Lost to Follow-up|33|||
19656369|NCT00227305|42105335|FG000|Overall Study|Study specific discontinuation|13|||
19656370|NCT00227305|42105335|FG000|Overall Study|MOVED OUT OF AREA|3|||
19656371|NCT00227305|42105335|FG000|Overall Study|Lack of Efficacy|7|||
19656372|NCT00227305|42105335|FG000|Overall Study|Physician Decision|3|||
19656373|NCT00227305|42105335|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
19656374|NCT00227305|42105335|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
19753673|NCT03235050|42203428|FG002|Overall Study|Lost to Follow-up|1|||
19753674|NCT03235050|42203429|FG003|Overall Study|Lost to Follow-up|2|||
19753675|NCT03235050|42203430|FG004|Overall Study|Lost to Follow-up|0|||
19753676|NCT03235050|42203426|FG000|Overall Study|Withdrawal by Subject|3|||
19753677|NCT03235050|42203427|FG001|Overall Study|Withdrawal by Subject|2|||
19753678|NCT03235050|42203428|FG002|Overall Study|Withdrawal by Subject|2|||
19753679|NCT03235050|42203429|FG003|Overall Study|Withdrawal by Subject|5|||
19753680|NCT03235050|42203430|FG004|Overall Study|Withdrawal by Subject|7|||
19753681|NCT03235050|42203426|FG000|Overall Study|Other reasons|0|||
19753682|NCT03235050|42203427|FG001|Overall Study|Other reasons|1|||
19753683|NCT03235050|42203428|FG002|Overall Study|Other reasons|0|||
19753684|NCT03235050|42203429|FG003|Overall Study|Other reasons|1|||
19753685|NCT03235050|42203430|FG004|Overall Study|Other reasons|2|||
19753686|NCT04502212|42203459|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
19753687|NCT04502212|42203459|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
19753688|NCT03167619|42203466|FG000|Overall Study|Death|11|||
19753689|NCT03167619|42203467|FG001|Overall Study|Death|8|||
19753690|NCT03167619|42203466|FG000|Overall Study|Withdrawal by Subject|1|||
19753691|NCT03167619|42203467|FG001|Overall Study|Withdrawal by Subject|2|||
19753692|NCT03167619|42203466|FG000|Overall Study|Physician Decision|0|||
19753693|NCT03167619|42203467|FG001|Overall Study|Physician Decision|1|||
19753694|NCT03578809|42203477|FG000|Overall Study|Death|0|||
19753695|NCT03578809|42203478|FG001|Overall Study|Death|2|||
19753696|NCT03578809|42203479|FG002|Overall Study|Death|0|||
19753697|NCT03578809|42203480|FG003|Overall Study|Death|1|||
19753698|NCT03578809|42203477|FG000|Overall Study|Lost to Follow-up|0|||
19753699|NCT03578809|42203478|FG001|Overall Study|Lost to Follow-up|1|||
19753700|NCT03578809|42203479|FG002|Overall Study|Lost to Follow-up|0|||
19753701|NCT03578809|42203480|FG003|Overall Study|Lost to Follow-up|0|||
19753702|NCT03578809|42203477|FG000|Overall Study|Withdrawal by Subject|3|||
19753703|NCT03578809|42203478|FG001|Overall Study|Withdrawal by Subject|5|||
19656375|NCT00227305|42105335|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
19656376|NCT00720941|42105341|FG000|Overall Study|Death|334|||
19656377|NCT00720941|42105342|FG001|Overall Study|Death|335|||
19656378|NCT00720941|42105341|FG000|Overall Study|Protocol Violation|0|||
19753704|NCT03578809|42203479|FG002|Overall Study|Withdrawal by Subject|2|||
19753705|NCT03578809|42203480|FG003|Overall Study|Withdrawal by Subject|0|||
19753706|NCT03578809|42203477|FG000|Overall Study|Other|3|||
19753707|NCT03578809|42203478|FG001|Overall Study|Other|6|||
19753708|NCT03578809|42203479|FG002|Overall Study|Other|2|||
19753709|NCT03578809|42203480|FG003|Overall Study|Other|8|||
19753710|NCT03198507|42203495|FG000|Overall Study|Withdrawal by Subject|1|||
19753711|NCT03198507|42203496|FG001|Overall Study|Withdrawal by Subject|0|||
19753712|NCT03610165|42203504|FG000|Overall Study|Device didn't work|0|||
19753713|NCT03610165|42203505|FG001|Overall Study|Device didn't work|1|||
19753714|NCT03609619|42203513|FG000|Overall Study|Adverse Event|1|||
19753715|NCT03609619|42203514|FG001|Overall Study|Adverse Event|0|||
19753716|NCT03609619|42203513|FG000|Overall Study|Lack of Efficacy|1|||
19753717|NCT03609619|42203514|FG001|Overall Study|Lack of Efficacy|2|||
19753718|NCT03609619|42203513|FG000|Overall Study|Protocol Violation|5|||
19753719|NCT03609619|42203514|FG001|Overall Study|Protocol Violation|0|||
19753720|NCT03609619|42203513|FG000|Overall Study|Withdrawal by Subject|2|||
19753721|NCT03609619|42203514|FG001|Overall Study|Withdrawal by Subject|3|||
19753722|NCT03609619|42203513|FG000|Overall Study|Lost to Follow-up|1|||
19656379|NCT00720941|42105342|FG001|Overall Study|Protocol Violation|2|||
19656380|NCT00720941|42105341|FG000|Overall Study|Lost to Follow-up|17|||
19656381|NCT00720941|42105342|FG001|Overall Study|Lost to Follow-up|15|||
19656382|NCT00720941|42105341|FG000|Overall Study|Physician Decision|1|||
19656383|NCT00720941|42105342|FG001|Overall Study|Physician Decision|5|||
19656384|NCT00720941|42105341|FG000|Overall Study|Withdrawal by Subject|27|||
19656385|NCT00720941|42105342|FG001|Overall Study|Withdrawal by Subject|35|||
19656386|NCT00720941|42105341|FG000|Overall Study|Ongoing|34|||
19656387|NCT00720941|42105342|FG001|Overall Study|Ongoing|23|||
19656388|NCT00585533|42105348|FG000|Overall Study|objective or symptomatic progression|9|||
19656389|NCT00628862|42105355|FG000|Overall Study|Adverse Event|6|||
19656390|NCT00628862|42105356|FG001|Overall Study|Adverse Event|8|||
19656391|NCT00628862|42105357|FG002|Overall Study|Adverse Event|10|||
19656392|NCT00628862|42105355|FG000|Overall Study|Withdrawal by Subject|4|||
19656393|NCT00628862|42105356|FG001|Overall Study|Withdrawal by Subject|6|||
19656394|NCT00628862|42105357|FG002|Overall Study|Withdrawal by Subject|11|||
19656395|NCT00628862|42105355|FG000|Overall Study|Lost to Follow-up|0|||
19656396|NCT00628862|42105356|FG001|Overall Study|Lost to Follow-up|2|||
19656397|NCT00628862|42105357|FG002|Overall Study|Lost to Follow-up|1|||
19656398|NCT00628862|42105355|FG000|Overall Study|Protocol Violation|1|||
19656399|NCT00628862|42105356|FG001|Overall Study|Protocol Violation|0|||
19656400|NCT00628862|42105357|FG002|Overall Study|Protocol Violation|0|||
19656401|NCT00628862|42105355|FG000|Overall Study|COPD Exacerbation|0|||
19656402|NCT00628862|42105356|FG001|Overall Study|COPD Exacerbation|1|||
19656403|NCT00628862|42105357|FG002|Overall Study|COPD Exacerbation|0|||
19656404|NCT00584987|42105369|FG000|Overall Study|Protocol Violation|1|||
19656405|NCT00584987|42105370|FG001|Overall Study|Protocol Violation|1|||
19656406|NCT00584987|42105371|FG002|Overall Study|Protocol Violation|1|||
19656407|NCT00584987|42105372|FG003|Overall Study|Protocol Violation|0|||
19656408|NCT00584987|42105369|FG000|Overall Study|Adverse Event|0|||
19656409|NCT00584987|42105370|FG001|Overall Study|Adverse Event|0|||
19656410|NCT00584987|42105371|FG002|Overall Study|Adverse Event|0|||
19656411|NCT00584987|42105372|FG003|Overall Study|Adverse Event|1|||
19656412|NCT00727961|42105382|FG000|Overall Study|Lost to Follow-up|1|||
19656413|NCT00727961|42105382|FG000|Overall Study|Adverse Event|4|||
19656414|NCT00727961|42105382|FG000|Overall Study|Patient's refusal|2|||
19656415|NCT00727961|42105382|FG000|Overall Study|Progression|30|||
19656416|NCT00568958|42105388|FG000|Allocation|Withdrawal by Subject|7|||
19656417|NCT00568958|42105389|FG001|Allocation|Withdrawal by Subject|3|||
19656418|NCT00568958|42105388|FG000|Allocation|Physician Decision|2|||
19656419|NCT00568958|42105389|FG001|Allocation|Physician Decision|0|||
19656420|NCT00568958|42105388|FG000|Follow-Up|Withdrawal by Subject|6|||
19656421|NCT00568958|42105389|FG001|Follow-Up|Withdrawal by Subject|6|||
19656422|NCT00568958|42105388|FG000|Follow-Up|Physician Decision|1|||
19656423|NCT00568958|42105389|FG001|Follow-Up|Physician Decision|1|||
19656424|NCT00568958|42105388|FG000|Follow-Up|Family Emergency|1|||
19656425|NCT00568958|42105389|FG001|Follow-Up|Family Emergency|0|||
19656426|NCT00568958|42105388|FG000|Follow-Up|Adverse Event|1|||
19753723|NCT03609619|42203514|FG001|Overall Study|Lost to Follow-up|1|||
19753724|NCT03167151|42203523|FG000|Overall Study|Withdrawal by Subject|1|||
19753725|NCT03167151|42203524|FG001|Overall Study|Withdrawal by Subject|0|||
19388366|NCT02552121|41631812|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19656427|NCT00568958|42105389|FG001|Follow-Up|Adverse Event|0|||
19656428|NCT00727649|42105397|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
19656429|NCT00727649|42105398|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
19656430|NCT00727649|42105397|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
19656431|NCT00727649|42105398|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
19656432|NCT00727649|42105397|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
19656433|NCT00727649|42105398|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
19656434|NCT00727649|42105397|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
19656435|NCT00727649|42105398|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
19656436|NCT00727649|42105397|FG000|Second Intervention (4-weeks)|Death|1|||
19656437|NCT00727649|42105398|FG001|Second Intervention (4-weeks)|Death|0|||
19753726|NCT03167151|42203525|FG002|Overall Study|Withdrawal by Subject|0|||
19753727|NCT03167151|42203523|FG000|Overall Study|No evidence of tumour at surgery|0|||
19753728|NCT03167151|42203524|FG001|Overall Study|No evidence of tumour at surgery|1|||
19753729|NCT03167151|42203525|FG002|Overall Study|No evidence of tumour at surgery|1|||
19656438|NCT00727649|42105397|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
19656439|NCT00727649|42105398|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
19656440|NCT00727649|42105397|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
19656441|NCT00727649|42105398|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
19656442|NCT00568334|42105408|FG000|Overall Study|Withdrawal by Subject|0|||
19656443|NCT00568334|42105409|FG001|Overall Study|Withdrawal by Subject|1|||
19656444|NCT00568334|42105408|FG000|Overall Study|Lost to Follow-up|1|||
19656445|NCT00568334|42105409|FG001|Overall Study|Lost to Follow-up|0|||
19656446|NCT00727571|42105419|FG000|Overall Study|Ineligibility determined|1|||
19656447|NCT00727571|42105420|FG001|Overall Study|Ineligibility determined|1|||
19656448|NCT00727571|42105421|FG002|Overall Study|Ineligibility determined|1|||
19656449|NCT00727571|42105422|FG003|Overall Study|Ineligibility determined|0|||
19656450|NCT00727571|42105419|FG000|Overall Study|Death|0|||
19656451|NCT00727571|42105420|FG001|Overall Study|Death|19|||
19656452|NCT00727571|42105421|FG002|Overall Study|Death|5|||
19656453|NCT00727571|42105422|FG003|Overall Study|Death|1|||
19656454|NCT00727571|42105419|FG000|Overall Study|Physician Decision|0|||
19656455|NCT00727571|42105420|FG001|Overall Study|Physician Decision|5|||
19656456|NCT00727571|42105421|FG002|Overall Study|Physician Decision|0|||
19656457|NCT00727571|42105422|FG003|Overall Study|Physician Decision|0|||
19656458|NCT00727571|42105419|FG000|Overall Study|Withdrawal by Subject|0|||
19656459|NCT00727571|42105420|FG001|Overall Study|Withdrawal by Subject|10|||
19656460|NCT00727571|42105421|FG002|Overall Study|Withdrawal by Subject|11|||
19656461|NCT00727571|42105422|FG003|Overall Study|Withdrawal by Subject|0|||
19656462|NCT00727571|42105419|FG000|Overall Study|Subject Non Compliance|0|||
19656463|NCT00727571|42105420|FG001|Overall Study|Subject Non Compliance|6|||
19656464|NCT00727571|42105421|FG002|Overall Study|Subject Non Compliance|0|||
19656465|NCT00727571|42105422|FG003|Overall Study|Subject Non Compliance|4|||
19656466|NCT00727571|42105419|FG000|Overall Study|Dismissed from nursing home|0|||
19656467|NCT00727571|42105420|FG001|Overall Study|Dismissed from nursing home|9|||
19656468|NCT00727571|42105421|FG002|Overall Study|Dismissed from nursing home|5|||
19656469|NCT00727571|42105422|FG003|Overall Study|Dismissed from nursing home|0|||
19656470|NCT00727571|42105419|FG000|Overall Study|Hospitalization|0|||
19656471|NCT00727571|42105420|FG001|Overall Study|Hospitalization|1|||
19656472|NCT00727571|42105421|FG002|Overall Study|Hospitalization|0|||
19656473|NCT00727571|42105422|FG003|Overall Study|Hospitalization|1|||
19656474|NCT00727571|42105419|FG000|Overall Study|AE not leading to hospitalization|0|||
19656475|NCT00727571|42105420|FG001|Overall Study|AE not leading to hospitalization|0|||
19656476|NCT00727571|42105421|FG002|Overall Study|AE not leading to hospitalization|2|||
19656477|NCT00727571|42105422|FG003|Overall Study|AE not leading to hospitalization|0|||
19656478|NCT00727571|42105419|FG000|Overall Study|Other|0|||
19656479|NCT00727571|42105420|FG001|Overall Study|Other|4|||
19656480|NCT00727571|42105421|FG002|Overall Study|Other|6|||
19656481|NCT00727571|42105422|FG003|Overall Study|Other|0|||
19656482|NCT00225277|42105434|FG000|Overall Study|Adverse Event|30|||
19656483|NCT00225277|42105435|FG001|Overall Study|Adverse Event|34|||
19656484|NCT00225277|42105434|FG000|Overall Study|Lack of Efficacy|4|||
19656485|NCT00225277|42105435|FG001|Overall Study|Lack of Efficacy|1|||
19656486|NCT00225277|42105434|FG000|Overall Study|Lost to Follow-up|4|||
19656487|NCT00225277|42105435|FG001|Overall Study|Lost to Follow-up|6|||
19656488|NCT00225277|42105434|FG000|Overall Study|Physician Decision|6|||
19656489|NCT00225277|42105435|FG001|Overall Study|Physician Decision|8|||
19388367|NCT02552121|41631813|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19388368|NCT02552121|41631814|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
19388369|NCT02552121|41631807|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388370|NCT02552121|41631808|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
19388371|NCT02552121|41631809|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388372|NCT02552121|41631810|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388373|NCT02552121|41631811|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388374|NCT02552121|41631812|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19656490|NCT00225277|42105434|FG000|Overall Study|Protocol Violation|6|||
19656491|NCT00225277|42105435|FG001|Overall Study|Protocol Violation|3|||
19656492|NCT00225277|42105434|FG000|Overall Study|Withdrawal by Subject|40|||
19656493|NCT00225277|42105435|FG001|Overall Study|Withdrawal by Subject|34|||
19388375|NCT02552121|41631813|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388376|NCT02552121|41631814|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
19388377|NCT02552121|41631807|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388378|NCT02552121|41631808|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
19388379|NCT02552121|41631809|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388380|NCT02552121|41631810|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388381|NCT02552121|41631811|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388382|NCT02552121|41631812|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388383|NCT02552121|41631813|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19388384|NCT02552121|41631814|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
19656494|NCT00225277|42105434|FG000|Overall Study|Other|7|||
19656495|NCT00225277|42105435|FG001|Overall Study|Other|9|||
19656496|NCT00567996|42105444|FG000|Overall Study|Adverse Event|18|||
19656497|NCT00567996|42105445|FG001|Overall Study|Adverse Event|16|||
19656498|NCT00567996|42105446|FG002|Overall Study|Adverse Event|13|||
19656499|NCT00567996|42105444|FG000|Overall Study|Protocol Deviation|9|||
19656500|NCT00567996|42105445|FG001|Overall Study|Protocol Deviation|11|||
19656501|NCT00567996|42105446|FG002|Overall Study|Protocol Deviation|13|||
19656502|NCT00567996|42105444|FG000|Overall Study|Withdrawal by Subject|8|||
19656503|NCT00567996|42105445|FG001|Overall Study|Withdrawal by Subject|12|||
19388385|NCT02552121|41631807|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388386|NCT02552121|41631808|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
19388387|NCT02552121|41631809|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388388|NCT02552121|41631810|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388389|NCT02552121|41631811|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388390|NCT02552121|41631812|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388391|NCT02552121|41631813|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388392|NCT02552121|41631814|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
19388393|NCT02552121|41631807|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
19388394|NCT02552121|41631808|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
19388395|NCT02552121|41631809|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
19388396|NCT02552121|41631810|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
19388397|NCT02552121|41631811|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
19388398|NCT02552121|41631812|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
19388399|NCT02552121|41631813|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
19656504|NCT00567996|42105446|FG002|Overall Study|Withdrawal by Subject|22|||
19656505|NCT00567996|42105444|FG000|Overall Study|Abnormal Lab value(s)|2|||
19388400|NCT02552121|41631814|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
19388401|NCT02552121|41631807|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
19388402|NCT02552121|41631808|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
19388403|NCT02552121|41631809|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
19388404|NCT02552121|41631810|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
19388405|NCT02552121|41631811|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
19388406|NCT02552121|41631812|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
19388407|NCT02552121|41631813|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
19388408|NCT02552121|41631814|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
19388409|NCT02552121|41631807|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
19388410|NCT02552121|41631808|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
19388411|NCT02552121|41631809|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
19388412|NCT02552121|41631810|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
19388413|NCT02552121|41631811|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
19388414|NCT02552121|41631812|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
19388415|NCT02552121|41631813|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
19388416|NCT02552121|41631814|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
19388417|NCT02552121|41631807|FG000|Part 2: Cohort Expansion|Death|0|||
19388418|NCT02552121|41631808|FG001|Part 2: Cohort Expansion|Death|0|||
19388419|NCT02552121|41631809|FG002|Part 2: Cohort Expansion|Death|1|||
19388420|NCT02552121|41631810|FG003|Part 2: Cohort Expansion|Death|0|||
19388421|NCT02552121|41631811|FG004|Part 2: Cohort Expansion|Death|0|||
19388422|NCT02552121|41631812|FG005|Part 2: Cohort Expansion|Death|0|||
19388423|NCT02552121|41631813|FG006|Part 2: Cohort Expansion|Death|0|||
19388424|NCT02552121|41631814|FG007|Part 2: Cohort Expansion|Death|0|||
19388425|NCT02552355|41631859|FG000|Overall Study|Adverse Event|0|||
19388426|NCT02552355|41631860|FG001|Overall Study|Adverse Event|2|||
19388427|NCT02552355|41631861|FG002|Overall Study|Adverse Event|2|||
19388428|NCT02552355|41631862|FG003|Overall Study|Adverse Event|0|||
19388429|NCT02552355|41631859|FG000|Overall Study|Withdrawal by Subject|0|||
19388430|NCT02552355|41631860|FG001|Overall Study|Withdrawal by Subject|0|||
19388431|NCT02552355|41631861|FG002|Overall Study|Withdrawal by Subject|0|||
19388432|NCT02552355|41631862|FG003|Overall Study|Withdrawal by Subject|1|||
19388433|NCT02551731|41631872|FG000|Overall Study|Withdrawal by Subject|2|||
19388434|NCT02542605|41631876|FG000|Part B: Challenge Phase|Sponsor decision|1|||
19388435|NCT02542605|41631877|FG001|Part B: Challenge Phase|Sponsor decision|0|||
19388436|NCT02542605|41631878|FG002|Part B: Challenge Phase|Sponsor decision|0|||
19388437|NCT02542605|41631876|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
19388438|NCT02542605|41631877|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
19388439|NCT02542605|41631878|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
19388440|NCT02550873|41631889|FG000|Randomized Double Blind|Adverse Event|3|||
19388441|NCT02550873|41631890|FG001|Randomized Double Blind|Adverse Event|1|||
19388442|NCT02550873|41631891|FG002|Randomized Double Blind|Adverse Event|0|||
19388443|NCT02550873|41631889|FG000|Randomized Double Blind|Disease progression|1|||
19388444|NCT02550873|41631890|FG001|Randomized Double Blind|Disease progression|1|||
19388445|NCT02550873|41631891|FG002|Randomized Double Blind|Disease progression|0|||
19388446|NCT02550873|41631889|FG000|Open Label Extension|Study ongoing|0|||
19388447|NCT02550873|41631890|FG001|Open Label Extension|Study ongoing|0|||
19388448|NCT02550873|41631891|FG002|Open Label Extension|Study ongoing|111|||
19388449|NCT02535741|41631913|FG000|Overall Study|Adverse Event|3|||
19388450|NCT02535741|41631913|FG000|Overall Study|Withdrawal by Subject|9|||
19388451|NCT02535741|41631913|FG000|Overall Study|Lost to Follow-up|10|||
19388452|NCT02535741|41631913|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
19388453|NCT02535741|41631913|FG000|Overall Study|Missing data|6|||
19388454|NCT03299049|41631933|FG000|Overall Study|On-going|486|||
19388455|NCT03299049|41631934|FG001|Overall Study|On-going|481|||
19388456|NCT03299049|41631933|FG000|Overall Study|Withdrawal by Subject|6|||
19388457|NCT03299049|41631934|FG001|Overall Study|Withdrawal by Subject|21|||
19388458|NCT03299049|41631933|FG000|Overall Study|Physician Decision|5|||
19388459|NCT03299049|41631934|FG001|Overall Study|Physician Decision|1|||
19388460|NCT03299049|41631933|FG000|Overall Study|Lost to Follow-up|2|||
19388461|NCT03299049|41631934|FG001|Overall Study|Lost to Follow-up|0|||
19388462|NCT03299049|41631933|FG000|Overall Study|Pregnancy|1|||
19388463|NCT03299049|41631934|FG001|Overall Study|Pregnancy|3|||
19388464|NCT03299049|41631933|FG000|Overall Study|Protocol Violation|1|||
19388465|NCT03299049|41631934|FG001|Overall Study|Protocol Violation|1|||
19388466|NCT03299049|41631933|FG000|Overall Study|Lack of Efficacy|9|||
19388467|NCT03299049|41631934|FG001|Overall Study|Lack of Efficacy|3|||
19388468|NCT03299049|41631933|FG000|Overall Study|Adverse Event|12|||
19388469|NCT03299049|41631934|FG001|Overall Study|Adverse Event|13|||
19388470|NCT02550795|41631950|FG000|Overall Study|Physician Decision|0|||
19388471|NCT02550795|41631951|FG001|Overall Study|Physician Decision|1|||
19388472|NCT02550795|41631952|FG002|Overall Study|Physician Decision|0|||
19388473|NCT02541903|41631960|FG000|Overall Study|Death|1|||
19388474|NCT02541669|41631969|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
19388475|NCT02541669|41631970|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
19388476|NCT02541669|41631971|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
19388477|NCT02541669|41631972|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
19388478|NCT02541669|41631973|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
19388479|NCT02549859|41631984|FG000|Long-term 60 Hz DBS|Study Closed|1|||
19388480|NCT02688647|41631994|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
19388481|NCT02688647|41631995|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
19388482|NCT02688647|41631994|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
19388483|NCT02688647|41631995|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
19388484|NCT02688647|41631994|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
19388485|NCT02688647|41631995|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
19388486|NCT02688647|41631994|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
19388487|NCT02688647|41631995|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
19388488|NCT02688647|41631994|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
19388489|NCT02688647|41631995|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
19388490|NCT02688647|41631994|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
19388491|NCT02688647|41631995|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
19388492|NCT02688647|41631994|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
19388493|NCT02688647|41631995|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
19388494|NCT02687711|41632013|FG000|Overall Study|Adverse Event|89|||
19388495|NCT02687711|41632013|FG000|Overall Study|Lack of Efficacy|70|||
19388496|NCT02687711|41632013|FG000|Overall Study|Lost to Follow-up|20|||
19388497|NCT02687711|41632013|FG000|Overall Study|Consent withdrawn|15|||
19388498|NCT02687711|41632013|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
19388499|NCT02687711|41632013|FG000|Overall Study|Too expensive|4|||
19388500|NCT02687711|41632013|FG000|Overall Study|Participant moved abroad|1|||
19388501|NCT02687711|41632013|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
19388502|NCT02687711|41632013|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
19388503|NCT02687711|41632013|FG000|Overall Study|Disliked taste|1|||
19388504|NCT02687711|41632013|FG000|Overall Study|Low mood|1|||
19388505|NCT02687711|41632013|FG000|Overall Study|Side effects|1|||
19388506|NCT02687711|41632013|FG000|Overall Study|Change of Hospital|1|||
19388507|NCT02687711|41632013|FG000|Overall Study|Liver Encephalopathy|1|||
19388508|NCT02687711|41632013|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
19388509|NCT02687711|41632013|FG000|Overall Study|Withdrawn due to intake interruption|1|||
19388510|NCT02687711|41632013|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
19388511|NCT02687711|41632013|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
19388512|NCT02687711|41632013|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
19698962|NCT00312338|42143780|FG001|Overall Study|Adverse Event|2|||
19388513|NCT01662063|41632019|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
19388514|NCT01662063|41632020|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
19388515|NCT01662063|41632021|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
19388516|NCT01662063|41632019|FG000|Overall Study|Lack of Efficacy|1|||
19388517|NCT01662063|41632020|FG001|Overall Study|Lack of Efficacy|6|||
19388518|NCT01662063|41632021|FG002|Overall Study|Lack of Efficacy|0|||
19388519|NCT01662063|41632019|FG000|Overall Study|Lost to Follow-up|0|||
19388520|NCT01662063|41632020|FG001|Overall Study|Lost to Follow-up|4|||
19388521|NCT01662063|41632021|FG002|Overall Study|Lost to Follow-up|0|||
19388522|NCT01662063|41632019|FG000|Overall Study|Protocol Violation|1|||
19388523|NCT01662063|41632020|FG001|Overall Study|Protocol Violation|0|||
19388524|NCT01662063|41632021|FG002|Overall Study|Protocol Violation|0|||
19388525|NCT01662063|41632019|FG000|Overall Study|Withdrawal by Subject|2|||
19388526|NCT01662063|41632020|FG001|Overall Study|Withdrawal by Subject|4|||
19388527|NCT01662063|41632021|FG002|Overall Study|Withdrawal by Subject|1|||
19388528|NCT01662063|41632019|FG000|Overall Study|Physician Decision|0|||
19388529|NCT01662063|41632020|FG001|Overall Study|Physician Decision|2|||
19388530|NCT01662063|41632021|FG002|Overall Study|Physician Decision|0|||
19388531|NCT01662063|41632019|FG000|Overall Study|Other|0|||
19388532|NCT01662063|41632020|FG001|Overall Study|Other|1|||
19388533|NCT01662063|41632021|FG002|Overall Study|Other|0|||
19388534|NCT02548455|41632029|FG000|Overall Study|Withdrawal by Subject|27|||
19388535|NCT02548455|41632029|FG000|Overall Study|Death|26|||
19388536|NCT02548455|41632029|FG000|Overall Study|Lost to Follow-up|14|||
19388537|NCT02548455|41632029|FG000|Overall Study|Visit not completed|173|||
19388538|NCT02691455|41632035|FG000|Overall Study|Withdrawal by Subject|1|||
19388539|NCT02691455|41632036|FG001|Overall Study|Withdrawal by Subject|2|||
19388540|NCT02691455|41632035|FG000|Overall Study|Lost to Follow-up|15|||
19388541|NCT02691455|41632036|FG001|Overall Study|Lost to Follow-up|15|||
19388542|NCT02534883|41632044|FG000|Overall Study|Early Termination|8|||
19388543|NCT02534883|41632045|FG001|Overall Study|Early Termination|3|||
19388544|NCT02685995|41632053|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
19388545|NCT02685995|41632054|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
19388546|NCT02548143|41632062|FG000|Overall Study|Adverse Event|1|||
19388547|NCT02548143|41632063|FG001|Overall Study|Adverse Event|0|||
19388548|NCT02548143|41632062|FG000|Overall Study|Withdrawal by Subject|0|||
19388549|NCT02548143|41632063|FG001|Overall Study|Withdrawal by Subject|1|||
19388550|NCT02547987|41632069|FG000|Overall Study|Withdrawal by Subject|1|||
19388551|NCT02547987|41632069|FG000|Overall Study|Adverse Event|2|||
19388552|NCT02547441|41632075|FG000|Double-Blind Study Period|Adverse Event|4|||
19656506|NCT00567996|42105445|FG001|Overall Study|Abnormal Lab value(s)|1|||
19388553|NCT02547441|41632076|FG001|Double-Blind Study Period|Adverse Event|9|||
19388554|NCT02547441|41632075|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
19388555|NCT02547441|41632076|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
19388556|NCT02547441|41632075|FG000|Double-Blind Study Period|Physician Decision|1|||
19388557|NCT02547441|41632076|FG001|Double-Blind Study Period|Physician Decision|0|||
19388558|NCT02547441|41632075|FG000|Double-Blind Study Period|Protocol Violation|1|||
19656507|NCT00567996|42105446|FG002|Overall Study|Abnormal Lab value(s)|2|||
19388559|NCT02547441|41632076|FG001|Double-Blind Study Period|Protocol Violation|2|||
19388560|NCT02547441|41632075|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
19388561|NCT02547441|41632076|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
19388562|NCT02547441|41632075|FG000|Double-Blind Study Period|Sponsor Decision|1|||
19388563|NCT02547441|41632076|FG001|Double-Blind Study Period|Sponsor Decision|0|||
19656508|NCT00567996|42105444|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19388564|NCT02547441|41632075|FG000|Open-Label Study Period|Adverse Event|10|||
19388565|NCT02547441|41632076|FG001|Open-Label Study Period|Adverse Event|11|||
19388566|NCT02547441|41632075|FG000|Open-Label Study Period|Lack of Efficacy|3|||
19388567|NCT02547441|41632076|FG001|Open-Label Study Period|Lack of Efficacy|2|||
19388568|NCT02547441|41632075|FG000|Open-Label Study Period|Lost to Follow-up|7|||
19388569|NCT02547441|41632076|FG001|Open-Label Study Period|Lost to Follow-up|8|||
19388570|NCT02547441|41632075|FG000|Open-Label Study Period|Physician Decision|1|||
19388571|NCT02547441|41632076|FG001|Open-Label Study Period|Physician Decision|0|||
19388572|NCT02547441|41632075|FG000|Open-Label Study Period|Protocol Violation|2|||
19388573|NCT02547441|41632076|FG001|Open-Label Study Period|Protocol Violation|0|||
19388574|NCT02547441|41632075|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
19388575|NCT02547441|41632076|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
19388576|NCT02547441|41632075|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
19388577|NCT02547441|41632076|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
19388578|NCT02540265|41632086|FG000|Overall Study|Lost to Follow-up|0|||
19388579|NCT02540265|41632087|FG001|Overall Study|Lost to Follow-up|0|||
19388580|NCT02540265|41632088|FG002|Overall Study|Lost to Follow-up|1|||
19388581|NCT02547363|41632098|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
19388582|NCT02547363|41632099|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
19388583|NCT02547363|41632098|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
19388584|NCT02547363|41632099|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
19388585|NCT02547363|41632098|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
19388586|NCT02547363|41632099|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
19388587|NCT02547363|41632098|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
19388588|NCT02547363|41632099|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
19388589|NCT02547363|41632098|FG000|12-month Follow-up|Withdrawal by Subject|4|||
19388590|NCT02547363|41632099|FG001|12-month Follow-up|Withdrawal by Subject|3|||
19388591|NCT02547363|41632098|FG000|12-month Follow-up|Lost to Follow-up|4|||
19388592|NCT02547363|41632099|FG001|12-month Follow-up|Lost to Follow-up|1|||
19388593|NCT02547363|41632098|FG000|12-month Follow-up|Lack of Efficacy|1|||
19388594|NCT02547363|41632099|FG001|12-month Follow-up|Lack of Efficacy|1|||
19388595|NCT02547363|41632098|FG000|12-month Follow-up|Other|1|||
19388596|NCT02547363|41632099|FG001|12-month Follow-up|Other|0|||
19388597|NCT02539797|41632107|FG000|Overall Study|Lost to Follow-up|0|||
19388598|NCT02539797|41632108|FG001|Overall Study|Lost to Follow-up|1|||
19388599|NCT02539797|41632109|FG002|Overall Study|Lost to Follow-up|0|||
19388600|NCT02684981|41632120|FG000|Overall Study|Permanently discontinued the treatment|157|||
19388601|NCT02684981|41632121|FG001|Overall Study|Permanently discontinued the treatment|161|||
19388602|NCT02684981|41632122|FG002|Overall Study|Permanently discontinued the treatment|110|||
19388603|NCT02684981|41632120|FG000|Overall Study|Other|83|||
19388604|NCT02684981|41632121|FG001|Overall Study|Other|49|||
19388605|NCT02684981|41632122|FG002|Overall Study|Other|17|||
19388606|NCT02684357|41632139|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
19388607|NCT02684357|41632140|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
19388608|NCT02684357|41632141|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
19388609|NCT02684357|41632142|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
19388610|NCT02684357|41632143|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
19388611|NCT02684357|41632144|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
19388612|NCT02684357|41632139|FG000|Part A|Lost to Follow-up|0|||
19388613|NCT02684357|41632140|FG001|Part A|Lost to Follow-up|2|||
19388614|NCT02684357|41632141|FG002|Part A|Lost to Follow-up|2|||
19388615|NCT02684357|41632142|FG003|Part A|Lost to Follow-up|0|||
19388616|NCT02684357|41632143|FG004|Part A|Lost to Follow-up|0|||
19388617|NCT02684357|41632144|FG005|Part A|Lost to Follow-up|0|||
19388618|NCT02684357|41632139|FG000|Part A|Withdrawal by Subject|3|||
19388619|NCT02684357|41632140|FG001|Part A|Withdrawal by Subject|0|||
19388620|NCT02684357|41632141|FG002|Part A|Withdrawal by Subject|0|||
19388621|NCT02684357|41632142|FG003|Part A|Withdrawal by Subject|0|||
19388622|NCT02684357|41632143|FG004|Part A|Withdrawal by Subject|0|||
19388623|NCT02684357|41632144|FG005|Part A|Withdrawal by Subject|0|||
19388624|NCT02684357|41632139|FG000|Part A|Other|0|||
19388625|NCT02684357|41632140|FG001|Part A|Other|1|||
19388626|NCT02684357|41632141|FG002|Part A|Other|0|||
19388627|NCT02684357|41632142|FG003|Part A|Other|0|||
19388628|NCT02684357|41632143|FG004|Part A|Other|0|||
19388629|NCT02684357|41632144|FG005|Part A|Other|0|||
19388630|NCT02684357|41632139|FG000|Part B|Adverse Event (Other)|0|||
19388631|NCT02684357|41632140|FG001|Part B|Adverse Event (Other)|0|||
19388632|NCT02684357|41632141|FG002|Part B|Adverse Event (Other)|0|||
19388633|NCT02684357|41632142|FG003|Part B|Adverse Event (Other)|1|||
19388634|NCT02684357|41632143|FG004|Part B|Adverse Event (Other)|1|||
19388635|NCT02684357|41632144|FG005|Part B|Adverse Event (Other)|1|||
19388636|NCT02684357|41632139|FG000|Part B|Lost to Follow-up|0|||
19388637|NCT02684357|41632140|FG001|Part B|Lost to Follow-up|0|||
19388638|NCT02684357|41632141|FG002|Part B|Lost to Follow-up|0|||
19388639|NCT02684357|41632142|FG003|Part B|Lost to Follow-up|1|||
19388640|NCT02684357|41632143|FG004|Part B|Lost to Follow-up|1|||
19388641|NCT02684357|41632144|FG005|Part B|Lost to Follow-up|7|||
19388642|NCT02684357|41632139|FG000|Part B|Withdrawal by Subject|0|||
19388643|NCT02684357|41632140|FG001|Part B|Withdrawal by Subject|0|||
19388644|NCT02684357|41632141|FG002|Part B|Withdrawal by Subject|0|||
19388645|NCT02684357|41632142|FG003|Part B|Withdrawal by Subject|0|||
19388646|NCT02684357|41632143|FG004|Part B|Withdrawal by Subject|2|||
19388647|NCT02684357|41632144|FG005|Part B|Withdrawal by Subject|4|||
19388648|NCT02684357|41632139|FG000|Part B|Other|0|||
19388649|NCT02684357|41632140|FG001|Part B|Other|0|||
19388650|NCT02684357|41632141|FG002|Part B|Other|0|||
19388651|NCT02684357|41632142|FG003|Part B|Other|1|||
19388652|NCT02684357|41632143|FG004|Part B|Other|0|||
19388653|NCT02684357|41632144|FG005|Part B|Other|1|||
19388654|NCT02684279|41632157|FG000|Overall Study|Adverse Event|87|||
19388655|NCT02684279|41632157|FG000|Overall Study|Lack of Efficacy|4|||
19656509|NCT00567996|42105445|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19388656|NCT02684279|41632157|FG000|Overall Study|Lost to Follow-up|61|||
19388657|NCT02684279|41632157|FG000|Overall Study|Protocol Violation|6|||
19388658|NCT02684279|41632157|FG000|Overall Study|Pregnancy|8|||
19388659|NCT02684279|41632157|FG000|Overall Study|Withdrawal by Subject|92|||
19388660|NCT02684279|41632157|FG000|Overall Study|non-compliance with study drug|9|||
19656510|NCT00567996|42105446|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19388661|NCT02684279|41632157|FG000|Overall Study|non compliance with study visits|2|||
19388662|NCT02684279|41632157|FG000|Overall Study|subject to have surgery|1|||
19388663|NCT02684279|41632157|FG000|Overall Study|family emergency|1|||
19388664|NCT02684279|41632157|FG000|Overall Study|Site closures|7|||
19388665|NCT02684279|41632157|FG000|Overall Study|Physician Decision|1|||
19388666|NCT03206073|41632165|FG000|Overall Study|Participant Noncompliance|0|||
19388667|NCT03206073|41632166|FG001|Overall Study|Participant Noncompliance|1|||
19388668|NCT03206073|41632167|FG002|Overall Study|Participant Noncompliance|0|||
19388669|NCT03206073|41632168|FG003|Overall Study|Participant Noncompliance|0|||
19388670|NCT03206073|41632165|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
19388671|NCT03206073|41632166|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
19388672|NCT03206073|41632167|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
19388673|NCT03206073|41632168|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
19388674|NCT03206073|41632165|FG000|Overall Study|Death|0|||
19388675|NCT03206073|41632166|FG001|Overall Study|Death|0|||
19388676|NCT03206073|41632167|FG002|Overall Study|Death|1|||
19388677|NCT03206073|41632168|FG003|Overall Study|Death|0|||
19388678|NCT03206073|41632165|FG000|Overall Study|Taken off active treatment|0|||
19388679|NCT03206073|41632166|FG001|Overall Study|Taken off active treatment|0|||
19388680|NCT03206073|41632167|FG002|Overall Study|Taken off active treatment|3|||
19388681|NCT03206073|41632168|FG003|Overall Study|Taken off active treatment|0|||
19388682|NCT02534493|41632178|FG000|Overall Study|Lost to Follow-up|1|||
19388683|NCT02534493|41632178|FG000|Overall Study|Withdrawal by Subject|1|||
19388684|NCT02547129|41632186|FG000|Overall Study|Difficulty with ongoing infection|1|||
19388685|NCT02547129|41632187|FG001|Overall Study|Difficulty with ongoing infection|0|||
19388686|NCT02546193|41632195|FG000|Overall Study|Withdrawal by Subject|2|||
19388687|NCT02546193|41632196|FG001|Overall Study|Withdrawal by Subject|0|||
19388688|NCT02546193|41632197|FG002|Overall Study|Withdrawal by Subject|1|||
19388689|NCT02546193|41632198|FG003|Overall Study|Withdrawal by Subject|0|||
19388690|NCT02546193|41632195|FG000|Overall Study|Not eligible at time of induction|4|||
19388691|NCT02546193|41632196|FG001|Overall Study|Not eligible at time of induction|6|||
19388692|NCT02546193|41632197|FG002|Overall Study|Not eligible at time of induction|1|||
19601789|NCT00586924|42050435|FG000|Overall Study|Adverse event/serious adverse event|0|||
19601790|NCT00586924|42050436|FG001|Overall Study|Adverse event/serious adverse event|0|||
19601791|NCT00586924|42050437|FG002|Overall Study|Adverse event/serious adverse event|0|||
19601792|NCT00586924|42050438|FG003|Overall Study|Adverse event/serious adverse event|1|||
19656511|NCT00567996|42105444|FG000|Overall Study|Lost to Follow-up|2|||
19656512|NCT00567996|42105445|FG001|Overall Study|Lost to Follow-up|5|||
19656513|NCT00567996|42105446|FG002|Overall Study|Lost to Follow-up|2|||
19656514|NCT00567996|42105444|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19656515|NCT00567996|42105445|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19656516|NCT00567996|42105446|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
19656517|NCT00567996|42105444|FG000|Overall Study|Administrative problems|1|||
19656518|NCT00567996|42105445|FG001|Overall Study|Administrative problems|1|||
19388693|NCT02546193|41632198|FG003|Overall Study|Not eligible at time of induction|0|||
19388694|NCT02538471|41632204|FG000|Overall Study|Progression of disease|2|||
19601793|NCT00586924|42050439|FG004|Overall Study|Adverse event/serious adverse event|0|||
19601794|NCT00586924|42050440|FG005|Overall Study|Adverse event/serious adverse event|2|||
19601795|NCT00586924|42050435|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
19601796|NCT00586924|42050436|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
19601797|NCT00586924|42050437|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
19601798|NCT00586924|42050438|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
19601799|NCT00586924|42050439|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
19601800|NCT00586924|42050440|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
19601801|NCT00586924|42050435|FG000|Overall Study|Disease progression|0|||
19601802|NCT00586924|42050436|FG001|Overall Study|Disease progression|0|||
19601803|NCT00586924|42050437|FG002|Overall Study|Disease progression|0|||
19601804|NCT00586924|42050438|FG003|Overall Study|Disease progression|1|||
19601805|NCT00586924|42050439|FG004|Overall Study|Disease progression|1|||
19601806|NCT00586924|42050440|FG005|Overall Study|Disease progression|0|||
19601807|NCT00586924|42050435|FG000|Overall Study|Development of neutralizing antibodies|2|||
19601808|NCT00586924|42050436|FG001|Overall Study|Development of neutralizing antibodies|2|||
19601809|NCT00586924|42050437|FG002|Overall Study|Development of neutralizing antibodies|2|||
19601810|NCT00586924|42050438|FG003|Overall Study|Development of neutralizing antibodies|0|||
19601811|NCT00586924|42050439|FG004|Overall Study|Development of neutralizing antibodies|0|||
19601812|NCT00586924|42050440|FG005|Overall Study|Development of neutralizing antibodies|22|||
19601813|NCT00586924|42050435|FG000|Overall Study|Complete response|0|||
19601814|NCT00586924|42050436|FG001|Overall Study|Complete response|1|||
19601815|NCT00586924|42050437|FG002|Overall Study|Complete response|0|||
19601816|NCT00586924|42050438|FG003|Overall Study|Complete response|0|||
19601817|NCT00586924|42050439|FG004|Overall Study|Complete response|2|||
19601818|NCT00586924|42050440|FG005|Overall Study|Complete response|2|||
19601819|NCT00586924|42050435|FG000|Overall Study|Other|1|||
19656519|NCT00567996|42105446|FG002|Overall Study|Administrative problems|0|||
19388695|NCT01661595|41632212|FG000|Phase 1: Week 0-4|Adverse Event|1|||
19656520|NCT00567996|42105444|FG000|Overall Study|Death|1|||
19656521|NCT00567996|42105445|FG001|Overall Study|Death|0|||
19656522|NCT00567996|42105446|FG002|Overall Study|Death|2|||
19656523|NCT00567996|42105444|FG000|Overall Study|Patient's inability to use the device|0|||
19656524|NCT00567996|42105445|FG001|Overall Study|Patient's inability to use the device|1|||
19656525|NCT00567996|42105446|FG002|Overall Study|Patient's inability to use the device|0|||
19656526|NCT00224887|42105460|FG000|Overall Study|Pregnancy|6|||
19656527|NCT00224887|42105461|FG001|Overall Study|Pregnancy|6|||
19656528|NCT00148759|42105469|FG000|Overall Study|Withdrawal by Subject|1|||
19656529|NCT00148759|42105470|FG001|Overall Study|Withdrawal by Subject|1|||
19656530|NCT00148759|42105469|FG000|Overall Study|Lost to Follow-up|1|||
19656531|NCT00148759|42105470|FG001|Overall Study|Lost to Follow-up|0|||
19656532|NCT00717275|42105476|FG000|Overall Study|Premature study termination.|3|||
19656533|NCT00584909|42105480|FG000|Overall Study|Adverse Event|4|||
19656534|NCT00147823|42105486|FG000|Overall Study|Lost to Follow-up|6|||
19656535|NCT00147823|42105487|FG001|Overall Study|Lost to Follow-up|12|||
19656536|NCT00147823|42105486|FG000|Overall Study|Physician Decision|1|||
19656537|NCT00147823|42105487|FG001|Overall Study|Physician Decision|0|||
19656538|NCT00147823|42105486|FG000|Overall Study|Withdrawal by Subject|0|||
19656539|NCT00147823|42105487|FG001|Overall Study|Withdrawal by Subject|1|||
19656540|NCT00147823|42105486|FG000|Overall Study|Did not receive vitoss due to infection|6|||
19656541|NCT00147823|42105487|FG001|Overall Study|Did not receive vitoss due to infection|2|||
19656542|NCT00717197|42105493|FG000|Overall Study|Unable to purchase study drug|5|||
19656543|NCT00717197|42105493|FG000|Overall Study|Tumor Progression|1|||
19656544|NCT00717197|42105493|FG000|Overall Study|Physician Decision|1|||
19656545|NCT00147745|42105500|FG000|Overall Study|Withdrawal by Subject|1|||
19753730|NCT03660943|42203535|FG000|Overall Study|Adverse Event|5|||
19753731|NCT03660943|42203536|FG001|Overall Study|Adverse Event|3|||
19753732|NCT03660943|42203535|FG000|Overall Study|Death|0|||
19656546|NCT00147745|42105501|FG001|Overall Study|Withdrawal by Subject|0|||
19656547|NCT00147745|42105502|FG002|Overall Study|Withdrawal by Subject|0|||
19656548|NCT00642902|42105514|FG000|Overall Study|Adverse Event|0|||
19656549|NCT00642902|42105515|FG001|Overall Study|Adverse Event|1|||
19656550|NCT00642902|42105516|FG002|Overall Study|Adverse Event|3|||
19656551|NCT00642902|42105517|FG003|Overall Study|Adverse Event|1|||
19656552|NCT00642902|42105514|FG000|Overall Study|Lost to Follow-up|1|||
19656553|NCT00642902|42105515|FG001|Overall Study|Lost to Follow-up|1|||
19656554|NCT00642902|42105516|FG002|Overall Study|Lost to Follow-up|0|||
19656555|NCT00642902|42105517|FG003|Overall Study|Lost to Follow-up|0|||
19656556|NCT00642902|42105514|FG000|Overall Study|Lack of Efficacy|0|||
19656557|NCT00642902|42105515|FG001|Overall Study|Lack of Efficacy|3|||
19656558|NCT00642902|42105516|FG002|Overall Study|Lack of Efficacy|3|||
19656559|NCT00642902|42105517|FG003|Overall Study|Lack of Efficacy|0|||
19656560|NCT00642902|42105514|FG000|Overall Study|Death|1|||
19656561|NCT00642902|42105515|FG001|Overall Study|Death|0|||
19656562|NCT00642902|42105516|FG002|Overall Study|Death|0|||
19656563|NCT00642902|42105517|FG003|Overall Study|Death|0|||
19656564|NCT00642902|42105514|FG000|Overall Study|Premature termination of clinical trial|37|||
19656565|NCT00642902|42105515|FG001|Overall Study|Premature termination of clinical trial|32|||
19656566|NCT00642902|42105516|FG002|Overall Study|Premature termination of clinical trial|35|||
19656567|NCT00642902|42105517|FG003|Overall Study|Premature termination of clinical trial|35|||
19656568|NCT00642902|42105514|FG000|Overall Study|Randomized, but not treated|0|||
19656569|NCT00642902|42105515|FG001|Overall Study|Randomized, but not treated|0|||
19656570|NCT00642902|42105516|FG002|Overall Study|Randomized, but not treated|1|||
19656571|NCT00642902|42105517|FG003|Overall Study|Randomized, but not treated|0|||
19656572|NCT00642902|42105514|FG000|Overall Study|Other|1|||
19656573|NCT00642902|42105515|FG001|Overall Study|Other|5|||
19656574|NCT00642902|42105516|FG002|Overall Study|Other|1|||
19656575|NCT00642902|42105517|FG003|Overall Study|Other|4|||
19656576|NCT00224107|42105529|FG000|Overall Study|Adverse Event|20|||
19656577|NCT00224107|42105530|FG001|Overall Study|Adverse Event|6|||
19656578|NCT00224107|42105529|FG000|Overall Study|Protocol Violation|2|||
19753733|NCT03660943|42203536|FG001|Overall Study|Death|2|||
19753734|NCT03660943|42203535|FG000|Overall Study|Lost to Follow-up|7|||
19656579|NCT00224107|42105530|FG001|Overall Study|Protocol Violation|3|||
19656580|NCT00224107|42105529|FG000|Overall Study|Withdrawal by Subject|1|||
19656581|NCT00224107|42105530|FG001|Overall Study|Withdrawal by Subject|4|||
19656582|NCT00224107|42105529|FG000|Overall Study|Lack of Efficacy|2|||
19656583|NCT00224107|42105530|FG001|Overall Study|Lack of Efficacy|0|||
19656584|NCT00224107|42105529|FG000|Overall Study|Lost to Follow-up|4|||
19656585|NCT00224107|42105530|FG001|Overall Study|Lost to Follow-up|0|||
19656586|NCT00224107|42105529|FG000|Overall Study|Physician Decision|1|||
19656587|NCT00224107|42105530|FG001|Overall Study|Physician Decision|0|||
19656588|NCT00224107|42105529|FG000|Overall Study|Other|1|||
19656589|NCT00224107|42105530|FG001|Overall Study|Other|1|||
19656590|NCT00720083|42105538|FG000|Overall Study|Ineligible|1|||
19656591|NCT00720083|42105539|FG001|Overall Study|Ineligible|2|||
19656592|NCT00209131|42105547|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
19753735|NCT03660943|42203536|FG001|Overall Study|Lost to Follow-up|3|||
19656593|NCT00209131|42105548|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
19656594|NCT00224029|42105554|FG000|Overall Study|Lost to Follow-up|1|||
19656595|NCT00224029|42105554|FG000|Overall Study|Withdrawal by Subject|4|||
19656596|NCT00224029|42105554|FG000|Overall Study|Other|1|||
19656597|NCT00223795|42105558|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
19656598|NCT00223795|42105559|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
19656599|NCT00223795|42105558|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
19656600|NCT00223795|42105559|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
19656601|NCT00719849|42105568|FG000|Overall Study|Death|0|||
19656602|NCT00719849|42105569|FG001|Overall Study|Death|1|||
19656603|NCT03907683|42105575|FG000|Overall Study|Pregnancy|1|||
19656604|NCT03907683|42105575|FG000|Overall Study|Withdrawal by Subject|1|||
19656605|NCT00626522|42105585|FG000|Overall Study|Protocol Violation|0|||
19656606|NCT00626522|42105586|FG001|Overall Study|Protocol Violation|0|||
19656607|NCT00626522|42105587|FG002|Overall Study|Protocol Violation|0|||
19656608|NCT00626522|42105588|FG003|Overall Study|Protocol Violation|0|||
19656609|NCT00626522|42105589|FG004|Overall Study|Protocol Violation|1|||
19656610|NCT00626522|42105590|FG005|Overall Study|Protocol Violation|0|||
19656611|NCT00626522|42105585|FG000|Overall Study|Adverse Event|2|||
19656612|NCT00626522|42105586|FG001|Overall Study|Adverse Event|1|||
19656613|NCT00626522|42105587|FG002|Overall Study|Adverse Event|2|||
19656614|NCT00626522|42105588|FG003|Overall Study|Adverse Event|0|||
19656615|NCT00626522|42105589|FG004|Overall Study|Adverse Event|1|||
19656616|NCT00626522|42105590|FG005|Overall Study|Adverse Event|1|||
19656617|NCT00626522|42105585|FG000|Overall Study|Withdrawal by Subject|2|||
19656618|NCT00626522|42105586|FG001|Overall Study|Withdrawal by Subject|5|||
19656619|NCT00626522|42105587|FG002|Overall Study|Withdrawal by Subject|5|||
19656620|NCT00626522|42105588|FG003|Overall Study|Withdrawal by Subject|0|||
19656621|NCT00626522|42105589|FG004|Overall Study|Withdrawal by Subject|4|||
19656622|NCT00626522|42105590|FG005|Overall Study|Withdrawal by Subject|1|||
19656623|NCT00626522|42105585|FG000|Overall Study|COPD exacerbation|0|||
19656624|NCT00626522|42105586|FG001|Overall Study|COPD exacerbation|0|||
19656625|NCT00626522|42105587|FG002|Overall Study|COPD exacerbation|0|||
19753736|NCT03660943|42203535|FG000|Overall Study|Protocol Violation|3|||
19753737|NCT03660943|42203536|FG001|Overall Study|Protocol Violation|5|||
19656626|NCT00626522|42105588|FG003|Overall Study|COPD exacerbation|1|||
19656627|NCT00626522|42105589|FG004|Overall Study|COPD exacerbation|1|||
19656628|NCT00626522|42105590|FG005|Overall Study|COPD exacerbation|0|||
19656629|NCT00626522|42105585|FG000|Overall Study|Lost to Follow-up|0|||
19656630|NCT00626522|42105586|FG001|Overall Study|Lost to Follow-up|1|||
19656631|NCT00626522|42105587|FG002|Overall Study|Lost to Follow-up|0|||
19656632|NCT00626522|42105588|FG003|Overall Study|Lost to Follow-up|0|||
19656633|NCT00626522|42105589|FG004|Overall Study|Lost to Follow-up|0|||
19656634|NCT00626522|42105590|FG005|Overall Study|Lost to Follow-up|0|||
19656635|NCT00626522|42105585|FG000|Overall Study|Inconsistent reason reported|1|||
19656636|NCT00626522|42105586|FG001|Overall Study|Inconsistent reason reported|0|||
19656637|NCT00626522|42105587|FG002|Overall Study|Inconsistent reason reported|0|||
19656638|NCT00626522|42105588|FG003|Overall Study|Inconsistent reason reported|0|||
19656639|NCT00626522|42105589|FG004|Overall Study|Inconsistent reason reported|0|||
19656640|NCT00626522|42105590|FG005|Overall Study|Inconsistent reason reported|0|||
19656641|NCT00626522|42105585|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
19656642|NCT00626522|42105586|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
19656643|NCT00626522|42105587|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
19656644|NCT00626522|42105588|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
19656645|NCT00626522|42105589|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
19656646|NCT00626522|42105590|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
19656647|NCT00540423|42105615|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19656648|NCT00540423|42105616|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19656649|NCT00540423|42105617|FG002|Double-Blind Treatment Period|Adverse Event|0|||
19656650|NCT00540423|42105615|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
19656651|NCT00540423|42105616|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
19656652|NCT00540423|42105617|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
19656653|NCT00566982|42105637|FG000|Overall Study|Adverse Event|6|||
19656654|NCT00566982|42105638|FG001|Overall Study|Adverse Event|48|||
19656655|NCT00566982|42105637|FG000|Overall Study|Withdrawal by Subject|1|||
19656656|NCT00566982|42105638|FG001|Overall Study|Withdrawal by Subject|14|||
19656657|NCT00566982|42105637|FG000|Overall Study|Protocol Violation|1|||
19656658|NCT00566982|42105638|FG001|Overall Study|Protocol Violation|4|||
19656659|NCT00566982|42105637|FG000|Overall Study|Lost to Follow-up|0|||
19656660|NCT00566982|42105638|FG001|Overall Study|Lost to Follow-up|1|||
19656661|NCT00566982|42105637|FG000|Overall Study|Other-family problems & doctor's request|0|||
19656662|NCT00566982|42105638|FG001|Overall Study|Other-family problems & doctor's request|2|||
19656663|NCT00624338|42105650|FG000|Overall Study|Adverse Event|14|||
19656664|NCT00624338|42105651|FG001|Overall Study|Adverse Event|14|||
19656665|NCT00624338|42105652|FG002|Overall Study|Adverse Event|18|||
19656666|NCT00624338|42105650|FG000|Overall Study|Lost to Follow-up|1|||
19656667|NCT00624338|42105651|FG001|Overall Study|Lost to Follow-up|0|||
19656668|NCT00624338|42105652|FG002|Overall Study|Lost to Follow-up|0|||
19656669|NCT00624338|42105650|FG000|Overall Study|Lack of Efficacy|11|||
19656670|NCT00624338|42105651|FG001|Overall Study|Lack of Efficacy|3|||
19753738|NCT03660943|42203535|FG000|Overall Study|Withdrawal by Subject|8|||
19753739|NCT03660943|42203536|FG001|Overall Study|Withdrawal by Subject|15|||
19753740|NCT03660943|42203535|FG000|Overall Study|Lack of Efficacy|9|||
19753741|NCT03660943|42203536|FG001|Overall Study|Lack of Efficacy|12|||
19656671|NCT00624338|42105652|FG002|Overall Study|Lack of Efficacy|14|||
19656672|NCT00624338|42105650|FG000|Overall Study|Protocol Violation|3|||
19656673|NCT00624338|42105651|FG001|Overall Study|Protocol Violation|3|||
19656674|NCT00624338|42105652|FG002|Overall Study|Protocol Violation|2|||
19656675|NCT00624338|42105650|FG000|Overall Study|Death|0|||
19656676|NCT00624338|42105651|FG001|Overall Study|Death|2|||
19753742|NCT03660943|42203535|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
19753743|NCT03660943|42203536|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
19753744|NCT03167073|42203544|FG000|Overall Study|Stillbirth|1|||
19753745|NCT03167073|42203545|FG001|Overall Study|Stillbirth|0|||
19753746|NCT03657277|42203551|FG000|Overall Study|Physician Decision|2|||
19656677|NCT00624338|42105652|FG002|Overall Study|Death|0|||
19656678|NCT00624338|42105650|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
19656679|NCT00624338|42105651|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
19656680|NCT00624338|42105652|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
19656681|NCT00624338|42105650|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
19656682|NCT00624338|42105651|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
19656683|NCT00624338|42105652|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
19656684|NCT00624338|42105650|FG000|Overall Study|Other|15|||
19656685|NCT00624338|42105651|FG001|Overall Study|Other|5|||
19656686|NCT00624338|42105652|FG002|Overall Study|Other|9|||
19656687|NCT00624338|42105650|FG000|Overall Study|Randomized but not treated|2|||
19656688|NCT00624338|42105651|FG001|Overall Study|Randomized but not treated|1|||
19656689|NCT00624338|42105652|FG002|Overall Study|Randomized but not treated|3|||
19656690|NCT03977454|42105662|FG000|Overall Study|immediate postoperative revision|2|||
19656691|NCT03977454|42105663|FG001|Overall Study|immediate postoperative revision|2|||
19656692|NCT00538785|42105671|FG000|Overall Study|Death|9|||
19656693|NCT00538785|42105672|FG001|Overall Study|Death|10|||
19656694|NCT00538785|42105671|FG000|Overall Study|Withdrawal of consent|9|||
19656695|NCT00538785|42105672|FG001|Overall Study|Withdrawal of consent|7|||
19656696|NCT00538785|42105671|FG000|Overall Study|Lost to Follow-up|1|||
19656697|NCT00538785|42105672|FG001|Overall Study|Lost to Follow-up|0|||
19656698|NCT00538629|42105678|FG000|Overall Study|At subject's request|1|||
19656699|NCT00538629|42105678|FG000|Overall Study|Adverse Event|2|||
19656700|NCT00538629|42105678|FG000|Overall Study|Lack of Efficacy|12|||
19656701|NCT00538629|42105678|FG000|Overall Study|Lost to Follow-up|6|||
19656702|NCT00538629|42105678|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
19656703|NCT00622700|42105685|FG000|Core Treatment Period|Randomized but Not Treated|0|||
19656704|NCT00622700|42105686|FG001|Core Treatment Period|Randomized but Not Treated|2|||
19656705|NCT00622700|42105687|FG002|Core Treatment Period|Randomized but Not Treated|2|||
19656706|NCT00622700|42105688|FG003|Core Treatment Period|Randomized but Not Treated|0|||
19656707|NCT00622700|42105689|FG004|Core Treatment Period|Randomized but Not Treated|0|||
19656708|NCT00622700|42105690|FG005|Core Treatment Period|Randomized but Not Treated|0|||
19656709|NCT00622700|42105691|FG006|Core Treatment Period|Randomized but Not Treated|0|||
19656710|NCT00622700|42105685|FG000|Core Treatment Period|Adverse Event|18|||
19656711|NCT00622700|42105686|FG001|Core Treatment Period|Adverse Event|25|||
19656712|NCT00622700|42105687|FG002|Core Treatment Period|Adverse Event|18|||
19656713|NCT00622700|42105688|FG003|Core Treatment Period|Adverse Event|0|||
19656714|NCT00622700|42105689|FG004|Core Treatment Period|Adverse Event|0|||
19656715|NCT00622700|42105690|FG005|Core Treatment Period|Adverse Event|0|||
19656716|NCT00622700|42105691|FG006|Core Treatment Period|Adverse Event|0|||
19656717|NCT00622700|42105685|FG000|Core Treatment Period|Lack of Efficacy|19|||
19656718|NCT00622700|42105686|FG001|Core Treatment Period|Lack of Efficacy|6|||
19656719|NCT00622700|42105687|FG002|Core Treatment Period|Lack of Efficacy|12|||
19656720|NCT00622700|42105688|FG003|Core Treatment Period|Lack of Efficacy|0|||
19656721|NCT00622700|42105689|FG004|Core Treatment Period|Lack of Efficacy|0|||
19656722|NCT00622700|42105690|FG005|Core Treatment Period|Lack of Efficacy|0|||
19656723|NCT00622700|42105691|FG006|Core Treatment Period|Lack of Efficacy|0|||
19656724|NCT00622700|42105685|FG000|Core Treatment Period|Lost to Follow-up|1|||
19656725|NCT00622700|42105686|FG001|Core Treatment Period|Lost to Follow-up|1|||
19753747|NCT03657277|42203551|FG000|Overall Study|Lost to Follow-up|1|||
19656726|NCT00622700|42105687|FG002|Core Treatment Period|Lost to Follow-up|1|||
19656727|NCT00622700|42105688|FG003|Core Treatment Period|Lost to Follow-up|0|||
19656728|NCT00622700|42105689|FG004|Core Treatment Period|Lost to Follow-up|0|||
19753748|NCT03657277|42203551|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
19656729|NCT00622700|42105690|FG005|Core Treatment Period|Lost to Follow-up|0|||
19656730|NCT00622700|42105691|FG006|Core Treatment Period|Lost to Follow-up|0|||
19656731|NCT00622700|42105685|FG000|Core Treatment Period|Death|1|||
19656732|NCT00622700|42105686|FG001|Core Treatment Period|Death|0|||
19656733|NCT00622700|42105687|FG002|Core Treatment Period|Death|0|||
19656734|NCT00622700|42105688|FG003|Core Treatment Period|Death|0|||
19656735|NCT00622700|42105689|FG004|Core Treatment Period|Death|0|||
19656736|NCT00622700|42105690|FG005|Core Treatment Period|Death|0|||
19656737|NCT00622700|42105691|FG006|Core Treatment Period|Death|0|||
19656738|NCT00622700|42105685|FG000|Core Treatment Period|Progressive Disease|3|||
19656739|NCT00622700|42105686|FG001|Core Treatment Period|Progressive Disease|1|||
19656740|NCT00622700|42105687|FG002|Core Treatment Period|Progressive Disease|0|||
19656741|NCT00622700|42105688|FG003|Core Treatment Period|Progressive Disease|0|||
19656742|NCT00622700|42105689|FG004|Core Treatment Period|Progressive Disease|0|||
19656743|NCT00622700|42105690|FG005|Core Treatment Period|Progressive Disease|0|||
19656744|NCT00622700|42105691|FG006|Core Treatment Period|Progressive Disease|0|||
19656745|NCT00622700|42105685|FG000|Core Treatment Period|Withdrawal by Subject|12|||
19656746|NCT00622700|42105686|FG001|Core Treatment Period|Withdrawal by Subject|18|||
19656747|NCT00622700|42105687|FG002|Core Treatment Period|Withdrawal by Subject|15|||
19656748|NCT00622700|42105688|FG003|Core Treatment Period|Withdrawal by Subject|0|||
19656749|NCT00622700|42105689|FG004|Core Treatment Period|Withdrawal by Subject|0|||
19656750|NCT00622700|42105690|FG005|Core Treatment Period|Withdrawal by Subject|0|||
19656751|NCT00622700|42105691|FG006|Core Treatment Period|Withdrawal by Subject|0|||
19656752|NCT00622700|42105685|FG000|Core Treatment Period|Other than specified above|2|||
19656753|NCT00622700|42105686|FG001|Core Treatment Period|Other than specified above|2|||
19656754|NCT00622700|42105687|FG002|Core Treatment Period|Other than specified above|5|||
19656755|NCT00622700|42105688|FG003|Core Treatment Period|Other than specified above|0|||
19656756|NCT00622700|42105689|FG004|Core Treatment Period|Other than specified above|0|||
19656757|NCT00622700|42105690|FG005|Core Treatment Period|Other than specified above|0|||
19656758|NCT00622700|42105691|FG006|Core Treatment Period|Other than specified above|0|||
19656759|NCT00622700|42105685|FG000|Extension Treatment Period|Adverse Event|0|||
19656760|NCT00622700|42105686|FG001|Extension Treatment Period|Adverse Event|0|||
19656761|NCT00622700|42105687|FG002|Extension Treatment Period|Adverse Event|0|||
19656762|NCT00622700|42105688|FG003|Extension Treatment Period|Adverse Event|5|||
19753749|NCT03197883|42203557|FG000|Overall Study|Adverse Event|1|||
19753750|NCT03197883|42203558|FG001|Overall Study|Adverse Event|1|||
19753751|NCT03197883|42203557|FG000|Overall Study|Lost to Follow-up|1|||
19753752|NCT03197883|42203558|FG001|Overall Study|Lost to Follow-up|0|||
19753753|NCT03197883|42203557|FG000|Overall Study|Protocol Violation|1|||
19753754|NCT03197883|42203558|FG001|Overall Study|Protocol Violation|0|||
19753755|NCT03197883|42203557|FG000|Overall Study|Other (Not Specified)|0|||
19753756|NCT03197883|42203558|FG001|Overall Study|Other (Not Specified)|5|||
19753757|NCT03234036|42203567|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
19753758|NCT03234036|42203568|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
19753759|NCT03234036|42203569|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
19753760|NCT03234036|42203570|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
19753761|NCT03606109|42203588|FG000|Overall Study|Lost to Follow-up|2|||
19753762|NCT03606109|42203589|FG001|Overall Study|Lost to Follow-up|1|||
19753763|NCT03768336|42203595|FG000|Overall Study|Lost to Follow-up|3|||
19753764|NCT03768336|42203596|FG001|Overall Study|Lost to Follow-up|2|||
19656763|NCT00622700|42105689|FG004|Extension Treatment Period|Adverse Event|9|||
19656764|NCT00622700|42105690|FG005|Extension Treatment Period|Adverse Event|6|||
19656765|NCT00622700|42105691|FG006|Extension Treatment Period|Adverse Event|8|||
19656766|NCT00622700|42105685|FG000|Extension Treatment Period|Lack of Efficacy|0|||
19656767|NCT00622700|42105686|FG001|Extension Treatment Period|Lack of Efficacy|0|||
19656768|NCT00622700|42105687|FG002|Extension Treatment Period|Lack of Efficacy|0|||
19656769|NCT00622700|42105688|FG003|Extension Treatment Period|Lack of Efficacy|2|||
19753765|NCT03768336|42203595|FG000|Overall Study|Became Ineligible|2|||
19753766|NCT03768336|42203596|FG001|Overall Study|Became Ineligible|0|||
19753767|NCT03768336|42203595|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
19753768|NCT03768336|42203596|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
19753769|NCT03768336|42203595|FG000|Overall Study|Missed final survey (post-treatment|0|||
19656770|NCT00622700|42105689|FG004|Extension Treatment Period|Lack of Efficacy|8|||
19656771|NCT00622700|42105690|FG005|Extension Treatment Period|Lack of Efficacy|1|||
19656772|NCT00622700|42105691|FG006|Extension Treatment Period|Lack of Efficacy|9|||
19656773|NCT00622700|42105685|FG000|Extension Treatment Period|Protocol Violation|0|||
19656774|NCT00622700|42105686|FG001|Extension Treatment Period|Protocol Violation|0|||
19656775|NCT00622700|42105687|FG002|Extension Treatment Period|Protocol Violation|0|||
19656776|NCT00622700|42105688|FG003|Extension Treatment Period|Protocol Violation|0|||
19656777|NCT00622700|42105689|FG004|Extension Treatment Period|Protocol Violation|0|||
19753770|NCT03768336|42203596|FG001|Overall Study|Missed final survey (post-treatment|1|||
19753771|NCT02729896|42203606|FG000|Overall Study|Death|0|||
19753772|NCT02729896|42203607|FG001|Overall Study|Death|2|||
19753773|NCT02729896|42203608|FG002|Overall Study|Death|13|||
19753774|NCT02729896|42203606|FG000|Overall Study|Lost to Follow-up|0|||
19753775|NCT02729896|42203607|FG001|Overall Study|Lost to Follow-up|2|||
19753776|NCT02729896|42203608|FG002|Overall Study|Lost to Follow-up|3|||
19753777|NCT02729896|42203606|FG000|Overall Study|Other|0|||
19753778|NCT02729896|42203607|FG001|Overall Study|Other|2|||
19753779|NCT02729896|42203608|FG002|Overall Study|Other|0|||
19753780|NCT02729896|42203606|FG000|Overall Study|Physician Decision|1|||
19753781|NCT02729896|42203607|FG001|Overall Study|Physician Decision|2|||
19753782|NCT02729896|42203608|FG002|Overall Study|Physician Decision|3|||
19753783|NCT02729896|42203606|FG000|Overall Study|Progressive Disease|0|||
19753784|NCT02729896|42203607|FG001|Overall Study|Progressive Disease|1|||
19753785|NCT02729896|42203608|FG002|Overall Study|Progressive Disease|0|||
19753786|NCT02729896|42203606|FG000|Overall Study|Withdrawal by Subject|1|||
19753787|NCT02729896|42203607|FG001|Overall Study|Withdrawal by Subject|0|||
19753788|NCT02729896|42203608|FG002|Overall Study|Withdrawal by Subject|3|||
19753789|NCT03575065|42203619|FG000|Overall Study|Death|31|||
19753790|NCT03575065|42203620|FG001|Overall Study|Death|12|||
19753791|NCT03575065|42203619|FG000|Overall Study|Sponsor's Decision|28|||
19753792|NCT03575065|42203620|FG001|Overall Study|Sponsor's Decision|13|||
19753793|NCT03575065|42203619|FG000|Overall Study|Withdrawal by Subject|2|||
19753794|NCT03575065|42203620|FG001|Overall Study|Withdrawal by Subject|1|||
19753795|NCT03575065|42203619|FG000|Overall Study|Lost to Follow-up|1|||
19753796|NCT03575065|42203620|FG001|Overall Study|Lost to Follow-up|0|||
19753797|NCT03188718|42203627|FG000|Overall Study|Participant noncompliance|4|||
19656778|NCT00622700|42105690|FG005|Extension Treatment Period|Protocol Violation|2|||
19656779|NCT00622700|42105691|FG006|Extension Treatment Period|Protocol Violation|0|||
19656780|NCT00622700|42105685|FG000|Extension Treatment Period|Lost to Follow-up|0|||
19656781|NCT00622700|42105686|FG001|Extension Treatment Period|Lost to Follow-up|0|||
19656782|NCT00622700|42105687|FG002|Extension Treatment Period|Lost to Follow-up|0|||
19656783|NCT00622700|42105688|FG003|Extension Treatment Period|Lost to Follow-up|0|||
19601820|NCT00586924|42050436|FG001|Overall Study|Other|0|||
19601821|NCT00586924|42050437|FG002|Overall Study|Other|1|||
19601822|NCT00586924|42050438|FG003|Overall Study|Other|1|||
19601823|NCT00586924|42050439|FG004|Overall Study|Other|1|||
19601824|NCT00586924|42050440|FG005|Overall Study|Other|6|||
19601825|NCT01000376|42050456|FG000|Cycle 1 Day 1|Adverse Event|1|||
19601826|NCT01000376|42050457|FG001|Cycle 1 Day 1|Adverse Event|0|||
19656784|NCT00622700|42105689|FG004|Extension Treatment Period|Lost to Follow-up|1|||
19656785|NCT00622700|42105690|FG005|Extension Treatment Period|Lost to Follow-up|0|||
19753798|NCT03188718|42203627|FG000|Overall Study|Withdrawal by Subject|1|||
19753799|NCT03188718|42203627|FG000|Overall Study|Device failure|3|||
19753800|NCT03574753|42203631|FG000|Overall Study|Adverse Event|3|||
19753801|NCT03574753|42203631|FG000|Overall Study|Progression/relapse|19|||
19753802|NCT03574753|42203631|FG000|Overall Study|Death|1|||
19753803|NCT03573505|42203638|FG000|Overall Study|Adverse Event|1|||
19753804|NCT03573505|42203639|FG001|Overall Study|Adverse Event|1|||
19753805|NCT03573505|42203638|FG000|Overall Study|Consent withdrawn|0|||
19753806|NCT03573505|42203639|FG001|Overall Study|Consent withdrawn|1|||
19753807|NCT03573505|42203638|FG000|Overall Study|Disease progression|0|||
19753808|NCT03573505|42203639|FG001|Overall Study|Disease progression|1|||
19753809|NCT03573505|42203638|FG000|Overall Study|Site Terminated by Sponsor|1|||
19753810|NCT03573505|42203639|FG001|Overall Study|Site Terminated by Sponsor|1|||
19753811|NCT03573505|42203638|FG000|Overall Study|Study terminated by sponsor|50|||
19753812|NCT03573505|42203639|FG001|Overall Study|Study terminated by sponsor|45|||
19753813|NCT03573505|42203638|FG000|Overall Study|Reason not specified|0|||
19753814|NCT03573505|42203639|FG001|Overall Study|Reason not specified|1|||
19753815|NCT03573505|42203638|FG000|Overall Study|Death|0|||
19753816|NCT03573505|42203639|FG001|Overall Study|Death|4|||
19601827|NCT01000376|42050456|FG000|Cycle 1 Day 1|Progressive Disease|1|||
19601828|NCT01000376|42050457|FG001|Cycle 1 Day 1|Progressive Disease|0|||
19601829|NCT01038635|42050472|FG000|Overall Study|Disease Progression|2|||
19601830|NCT01038635|42050473|FG001|Overall Study|Disease Progression|0|||
19656786|NCT00622700|42105691|FG006|Extension Treatment Period|Lost to Follow-up|0|||
19656787|NCT00622700|42105685|FG000|Extension Treatment Period|Progressive Disease|0|||
19656788|NCT00622700|42105686|FG001|Extension Treatment Period|Progressive Disease|0|||
19753817|NCT01376908|42203648|FG000|Overall Study|Protocol Violation|1|||
19753818|NCT01376908|42203649|FG001|Overall Study|Protocol Violation|1|||
19753819|NCT01376908|42203648|FG000|Overall Study|Withdrawal by Subject|1|||
19753820|NCT01376908|42203649|FG001|Overall Study|Withdrawal by Subject|2|||
19601831|NCT01038635|42050474|FG002|Overall Study|Disease Progression|0|||
19601832|NCT01038635|42050475|FG003|Overall Study|Disease Progression|0|||
19601833|NCT01038635|42050476|FG004|Overall Study|Disease Progression|0|||
19753821|NCT02668653|42203664|FG000|Overall Study|Refractory disease|41|||
19753822|NCT02668653|42203665|FG001|Overall Study|Refractory disease|70|||
19753823|NCT02668653|42203664|FG000|Overall Study|Relapse|44|||
19753824|NCT02668653|42203665|FG001|Overall Study|Relapse|65|||
19753825|NCT02668653|42203664|FG000|Overall Study|Adverse Event|58|||
19753826|NCT02668653|42203665|FG001|Overall Study|Adverse Event|23|||
19753827|NCT02668653|42203664|FG000|Overall Study|Subject decision to stop study drug|25|||
19753828|NCT02668653|42203665|FG001|Overall Study|Subject decision to stop study drug|23|||
19753829|NCT02668653|42203664|FG000|Overall Study|Other reasons not specified|16|||
19753830|NCT02668653|42203665|FG001|Overall Study|Other reasons not specified|11|||
19753831|NCT02668653|42203664|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
19753832|NCT02668653|42203665|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
19753833|NCT02668653|42203664|FG000|Overall Study|Investigator decision|10|||
19753834|NCT02668653|42203665|FG001|Overall Study|Investigator decision|7|||
19753835|NCT02668653|42203664|FG000|Overall Study|Failure to meet continuation criteria|5|||
19753836|NCT02668653|42203665|FG001|Overall Study|Failure to meet continuation criteria|12|||
19753837|NCT02668653|42203664|FG000|Overall Study|Lost to Follow-up|1|||
19753838|NCT02668653|42203665|FG001|Overall Study|Lost to Follow-up|0|||
19753839|NCT02668653|42203664|FG000|Overall Study|Pregnancy|0|||
19753840|NCT02668653|42203665|FG001|Overall Study|Pregnancy|1|||
19753841|NCT02668653|42203664|FG000|Overall Study|Death|0|||
19753842|NCT02668653|42203665|FG001|Overall Study|Death|1|||
19753843|NCT03736031|42203673|FG000|Overall Study|Death|2|||
19753844|NCT03736031|42203674|FG001|Overall Study|Death|4|||
19753845|NCT03736031|42203673|FG000|Overall Study|Lost to Follow-up|21|||
19753846|NCT03736031|42203674|FG001|Overall Study|Lost to Follow-up|2|||
19753847|NCT03736031|42203673|FG000|Overall Study|Withdrawal by Subject|9|||
19753848|NCT03736031|42203674|FG001|Overall Study|Withdrawal by Subject|0|||
19753849|NCT03555565|42203680|FG000|Overall Study|Case Report Forms Uncollected|2|||
19753850|NCT03555565|42203680|FG000|Overall Study|Protocol Deviation|13|||
19753851|NCT03602053|42203687|FG000|Overall Study|Withdrawal by Subject|7|||
19753852|NCT03602053|42203688|FG001|Overall Study|Withdrawal by Subject|9|||
19753853|NCT03602053|42203689|FG002|Overall Study|Withdrawal by Subject|7|||
19753854|NCT03602053|42203687|FG000|Overall Study|Lost to Follow-up|5|||
19753855|NCT03602053|42203688|FG001|Overall Study|Lost to Follow-up|6|||
19753856|NCT03602053|42203689|FG002|Overall Study|Lost to Follow-up|0|||
19753857|NCT03602053|42203687|FG000|Overall Study|Protocol Violation|3|||
19753858|NCT03602053|42203688|FG001|Overall Study|Protocol Violation|0|||
19753859|NCT03602053|42203689|FG002|Overall Study|Protocol Violation|4|||
19753860|NCT03602053|42203687|FG000|Overall Study|Physician Decision|1|||
19753861|NCT03602053|42203688|FG001|Overall Study|Physician Decision|0|||
19753862|NCT03602053|42203689|FG002|Overall Study|Physician Decision|0|||
19753863|NCT03602053|42203687|FG000|Overall Study|migration|2|||
19753864|NCT03602053|42203688|FG001|Overall Study|migration|3|||
19753865|NCT03602053|42203689|FG002|Overall Study|migration|0|||
19753866|NCT03602053|42203687|FG000|Overall Study|Other|1|||
19753867|NCT03602053|42203688|FG001|Overall Study|Other|0|||
19753868|NCT03602053|42203689|FG002|Overall Study|Other|0|||
19753869|NCT04831515|42203701|FG000|First Intervention|Adverse Event|0|||
19753870|NCT04831515|42203702|FG001|First Intervention|Adverse Event|1|||
19753871|NCT03554629|42203708|FG000|Overall Study|Inadequate data|6|||
19753872|NCT03196791|42203738|FG000|Overall Study|Protocol Violation|7|||
19753873|NCT03196791|42203739|FG001|Overall Study|Protocol Violation|3|||
19753874|NCT03196791|42203738|FG000|Overall Study|Withdrawal by Subject|3|||
19753875|NCT03196791|42203739|FG001|Overall Study|Withdrawal by Subject|2|||
19753876|NCT03196635|42203745|FG000|Overall Study|Withdrawal by Subject|1|||
19753877|NCT03194217|42203767|FG000|Overall Study|Adverse Event|0|||
19753878|NCT03194217|42203768|FG001|Overall Study|Adverse Event|2|||
19753879|NCT03194217|42203769|FG002|Overall Study|Adverse Event|3|||
19753880|NCT03194217|42203770|FG003|Overall Study|Adverse Event|3|||
19753881|NCT03194217|42203767|FG000|Overall Study|Failure to meet randomisation criteria|0|||
19753882|NCT03194217|42203768|FG001|Overall Study|Failure to meet randomisation criteria|0|||
19753883|NCT03194217|42203769|FG002|Overall Study|Failure to meet randomisation criteria|0|||
19753884|NCT03194217|42203770|FG003|Overall Study|Failure to meet randomisation criteria|1|||
19753885|NCT03194217|42203767|FG000|Overall Study|Other|0|||
19753886|NCT03194217|42203768|FG001|Overall Study|Other|1|||
19753887|NCT03194217|42203769|FG002|Overall Study|Other|1|||
19753888|NCT03194217|42203770|FG003|Overall Study|Other|0|||
19656789|NCT00622700|42105687|FG002|Extension Treatment Period|Progressive Disease|0|||
19656790|NCT00622700|42105688|FG003|Extension Treatment Period|Progressive Disease|1|||
19656791|NCT00622700|42105689|FG004|Extension Treatment Period|Progressive Disease|2|||
19656792|NCT00622700|42105690|FG005|Extension Treatment Period|Progressive Disease|0|||
19656793|NCT00622700|42105691|FG006|Extension Treatment Period|Progressive Disease|2|||
19656794|NCT00622700|42105685|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
19753889|NCT00709618|42203780|FG000|Overall Study|Withdrawal by Subject|4|||
19656795|NCT00622700|42105686|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
19656796|NCT00622700|42105687|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
19753890|NCT00709618|42203780|FG000|Overall Study|Lost to Follow-up|1|||
19753891|NCT00709618|42203780|FG000|Overall Study|Study Closed/Terminated|25|||
19753892|NCT03193047|42203786|FG000|Overall Study|Physician Decision|1|||
19753893|NCT03193047|42203787|FG001|Overall Study|Physician Decision|0|||
19753894|NCT03193047|42203786|FG000|Overall Study|Participant Left State|1|||
19753895|NCT03193047|42203787|FG001|Overall Study|Participant Left State|0|||
19753896|NCT02918019|42203799|FG000|Overall Study|Death|0|||
19753897|NCT02918019|42203800|FG001|Overall Study|Death|0|||
19656797|NCT00622700|42105688|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
19656798|NCT00622700|42105689|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
19656799|NCT00622700|42105690|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
19656800|NCT00622700|42105691|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
19656801|NCT00622700|42105685|FG000|Extension Treatment Period|Missing|0|||
19656802|NCT00622700|42105686|FG001|Extension Treatment Period|Missing|0|||
19656803|NCT00622700|42105687|FG002|Extension Treatment Period|Missing|0|||
19656804|NCT00622700|42105688|FG003|Extension Treatment Period|Missing|2|||
19656805|NCT00622700|42105689|FG004|Extension Treatment Period|Missing|3|||
19656806|NCT00622700|42105690|FG005|Extension Treatment Period|Missing|1|||
19656807|NCT00622700|42105691|FG006|Extension Treatment Period|Missing|0|||
19656808|NCT00622700|42105685|FG000|Extension Treatment Period|Other than specified above|0|||
19656809|NCT00622700|42105686|FG001|Extension Treatment Period|Other than specified above|0|||
19656810|NCT00622700|42105687|FG002|Extension Treatment Period|Other than specified above|0|||
19656811|NCT00622700|42105688|FG003|Extension Treatment Period|Other than specified above|0|||
19656812|NCT00622700|42105689|FG004|Extension Treatment Period|Other than specified above|0|||
19656813|NCT00622700|42105690|FG005|Extension Treatment Period|Other than specified above|1|||
19656814|NCT00622700|42105691|FG006|Extension Treatment Period|Other than specified above|1|||
19656815|NCT00538473|42105710|FG000|Overall Study|Adverse Event|1|||
19656816|NCT00538473|42105711|FG001|Overall Study|Adverse Event|0|||
19656817|NCT00622466|42105717|FG000|Overall Study|Death|1|||
19656818|NCT00622466|42105717|FG000|Overall Study|Adverse Event|1|||
19656819|NCT00622466|42105717|FG000|Overall Study|Withdrawal by Subject|2|||
19656820|NCT00537771|42105723|FG000|Overall Study|Withdrawal by Subject|6|||
19656821|NCT00537771|42105724|FG001|Overall Study|Withdrawal by Subject|23|||
19656822|NCT00537771|42105723|FG000|Overall Study|Adverse Event|8|||
19656823|NCT00537771|42105724|FG001|Overall Study|Adverse Event|15|||
19656824|NCT00537771|42105723|FG000|Overall Study|Lost to Follow-up|9|||
19656825|NCT00537771|42105724|FG001|Overall Study|Lost to Follow-up|15|||
19656826|NCT00537771|42105723|FG000|Overall Study|Protocol Violation|2|||
19656827|NCT00537771|42105724|FG001|Overall Study|Protocol Violation|6|||
19656828|NCT00537771|42105723|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
19656829|NCT00537771|42105724|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
19656830|NCT00623480|42105732|FG000|Overall Study|Lost to Follow-up|0|||
19656831|NCT00623480|42105733|FG001|Overall Study|Lost to Follow-up|1|||
19656832|NCT00623480|42105732|FG000|Overall Study|Withdrawal by Subject|2|||
19656833|NCT00623480|42105733|FG001|Overall Study|Withdrawal by Subject|4|||
19656834|NCT00623480|42105732|FG000|Overall Study|Lack of Efficacy|1|||
19656835|NCT00623480|42105733|FG001|Overall Study|Lack of Efficacy|0|||
19656836|NCT00623480|42105732|FG000|Overall Study|Non-compliant with study medication|4|||
19656837|NCT00623480|42105733|FG001|Overall Study|Non-compliant with study medication|0|||
19656838|NCT00623480|42105732|FG000|Overall Study|Protocol Violation|0|||
19656839|NCT00623480|42105733|FG001|Overall Study|Protocol Violation|1|||
19656840|NCT00623480|42105732|FG000|Overall Study|Site closed by sponsor|0|||
19656841|NCT00623480|42105733|FG001|Overall Study|Site closed by sponsor|1|||
19656842|NCT02513667|42105741|FG000|Overall Study|Withdrawal by Subject|0|||
19656843|NCT02513667|42105742|FG001|Overall Study|Withdrawal by Subject|1|||
19656844|NCT00621764|42105752|FG000|Overall Study|Protocol Violation|0|||
19656845|NCT00621764|42105753|FG001|Overall Study|Protocol Violation|0|||
19753898|NCT02918019|42203801|FG002|Overall Study|Death|1|||
19753899|NCT02918019|42203802|FG003|Overall Study|Death|0|||
19753900|NCT02918019|42203799|FG000|Overall Study|Lost to Follow-up|1|||
19601834|NCT01038635|42050477|FG005|Overall Study|Disease Progression|0|||
19601835|NCT01038635|42050478|FG006|Overall Study|Disease Progression|1|||
19601836|NCT01038635|42050479|FG007|Overall Study|Disease Progression|4|||
19601837|NCT01038635|42050480|FG008|Overall Study|Disease Progression|0|||
19601838|NCT01038635|42050472|FG000|Overall Study|Death|0|||
19601839|NCT01038635|42050473|FG001|Overall Study|Death|0|||
19601840|NCT01038635|42050474|FG002|Overall Study|Death|0|||
19601841|NCT01038635|42050475|FG003|Overall Study|Death|0|||
19601842|NCT01038635|42050476|FG004|Overall Study|Death|1|||
19601843|NCT01038635|42050477|FG005|Overall Study|Death|0|||
19656846|NCT00621764|42105754|FG002|Overall Study|Protocol Violation|0|||
19656847|NCT00621764|42105755|FG003|Overall Study|Protocol Violation|1|||
19656848|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
19656849|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
19656850|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
19656851|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
19656852|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
19656853|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
19656854|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
19656855|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
19656856|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
19388696|NCT01661595|41632213|FG001|Phase 1: Week 0-4|Adverse Event|0|||
19601844|NCT01038635|42050478|FG006|Overall Study|Death|1|||
19601845|NCT01038635|42050479|FG007|Overall Study|Death|1|||
19656857|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
19656858|NCT00510718|42105773|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
19656859|NCT00510718|42105774|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
19656860|NCT00537381|42105795|FG000|Overall Study|Adverse Event|13|||
19656861|NCT00537381|42105796|FG001|Overall Study|Adverse Event|9|||
19656862|NCT00537381|42105795|FG000|Overall Study|Death|3|||
19656863|NCT00537381|42105796|FG001|Overall Study|Death|3|||
19656864|NCT00537381|42105795|FG000|Overall Study|Withdrawal by Subject|5|||
19656865|NCT00537381|42105796|FG001|Overall Study|Withdrawal by Subject|14|||
19656866|NCT00537381|42105795|FG000|Overall Study|Physician Decision|7|||
19656867|NCT00537381|42105796|FG001|Overall Study|Physician Decision|6|||
19656868|NCT00537381|42105795|FG000|Overall Study|Disease Progression|9|||
19656869|NCT00537381|42105796|FG001|Overall Study|Disease Progression|18|||
19656870|NCT00537381|42105795|FG000|Overall Study|Sponsor decision|14|||
19656871|NCT00537381|42105796|FG001|Overall Study|Sponsor decision|9|||
19656872|NCT00537381|42105795|FG000|Overall Study|Other|5|||
19656873|NCT00537381|42105796|FG001|Overall Study|Other|3|||
19656874|NCT03791398|42105807|FG000|Overall Study|Progression of Disease Under Study|2|||
19656875|NCT03791398|42105808|FG001|Overall Study|Progression of Disease Under Study|0|||
19656876|NCT03791398|42105809|FG002|Overall Study|Progression of Disease Under Study|0|||
19656877|NCT00517192|42105815|FG000|Overall Study|Adverse Event|1|||
19656878|NCT00517192|42105816|FG001|Overall Study|Adverse Event|1|||
19656879|NCT00517192|42105815|FG000|Overall Study|Lost to Follow-up|1|||
19656880|NCT00517192|42105816|FG001|Overall Study|Lost to Follow-up|1|||
19656881|NCT00517192|42105815|FG000|Overall Study|Withdrawal by Subject|1|||
19656882|NCT00517192|42105816|FG001|Overall Study|Withdrawal by Subject|0|||
19656883|NCT00517192|42105815|FG000|Overall Study|Early termination of the trial|16|||
19656884|NCT00517192|42105816|FG001|Overall Study|Early termination of the trial|18|||
19656885|NCT00625820|42105822|FG000|Overall Study|Withdrawal by Subject|1|||
19656886|NCT00145327|42105830|FG000|Overall Study|Withdrawal by Subject|77|||
19656887|NCT00145327|42105831|FG001|Overall Study|Withdrawal by Subject|72|||
19656888|NCT00145327|42105832|FG002|Overall Study|Withdrawal by Subject|164|||
19656889|NCT00145327|42105830|FG000|Overall Study|Death|26|||
19656890|NCT00145327|42105831|FG001|Overall Study|Death|18|||
19656891|NCT00145327|42105832|FG002|Overall Study|Death|30|||
19656892|NCT00145327|42105830|FG000|Overall Study|Adverse Event|14|||
19753901|NCT02918019|42203800|FG001|Overall Study|Lost to Follow-up|1|||
19753902|NCT02918019|42203801|FG002|Overall Study|Lost to Follow-up|0|||
19753903|NCT02918019|42203802|FG003|Overall Study|Lost to Follow-up|1|||
19753904|NCT02918019|42203799|FG000|Overall Study|Principal investigator request|0|||
19753905|NCT02918019|42203800|FG001|Overall Study|Principal investigator request|0|||
19601846|NCT01038635|42050480|FG008|Overall Study|Death|2|||
19601847|NCT01000064|42050501|FG000|Overall Study|Withdrawal by Subject|1|||
19601848|NCT01000064|42050502|FG001|Overall Study|Withdrawal by Subject|1|||
19601849|NCT00766090|42050513|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601850|NCT00766090|42050514|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601851|NCT00766090|42050515|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601852|NCT00766090|42050516|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601853|NCT00766090|42050517|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601854|NCT00766090|42050518|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19656893|NCT00145327|42105831|FG001|Overall Study|Adverse Event|11|||
19656894|NCT00145327|42105832|FG002|Overall Study|Adverse Event|22|||
19656895|NCT00145327|42105830|FG000|Overall Study|Lost to Follow-up|9|||
19656896|NCT00145327|42105831|FG001|Overall Study|Lost to Follow-up|14|||
19656897|NCT00145327|42105832|FG002|Overall Study|Lost to Follow-up|14|||
19656898|NCT00145327|42105830|FG000|Overall Study|Administrative problems|12|||
19656899|NCT00145327|42105831|FG001|Overall Study|Administrative problems|9|||
19656900|NCT00145327|42105832|FG002|Overall Study|Administrative problems|13|||
19656901|NCT00145327|42105830|FG000|Overall Study|Protocol Violation|2|||
19656902|NCT00145327|42105831|FG001|Overall Study|Protocol Violation|0|||
19656903|NCT00145327|42105832|FG002|Overall Study|Protocol Violation|2|||
19656904|NCT00145327|42105830|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19656905|NCT00145327|42105831|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19656906|NCT00145327|42105832|FG002|Overall Study|Abnormal laboratory value(s)|2|||
19656907|NCT00145327|42105830|FG000|Overall Study|Missing - not stated|1|||
19656908|NCT00145327|42105831|FG001|Overall Study|Missing - not stated|0|||
19656909|NCT00145327|42105832|FG002|Overall Study|Missing - not stated|1|||
19656910|NCT00510484|42105842|FG000|Wash-out Period|Adverse Event|0|||
19656911|NCT00510484|42105843|FG001|Wash-out Period|Adverse Event|1|||
19656912|NCT00622388|42105849|FG000|Overall Study|Disease Progression|47|||
19656913|NCT00622388|42105849|FG000|Overall Study|Adverse Event|6|||
19656914|NCT00622388|42105849|FG000|Overall Study|Protocol Violation|3|||
19656915|NCT00622388|42105849|FG000|Overall Study|Participant Refusal|1|||
19656916|NCT00622388|42105849|FG000|Overall Study|Death|3|||
19656917|NCT00622388|42105849|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
19656918|NCT00622388|42105849|FG000|Overall Study|Took Prohibited Medication|2|||
19656919|NCT00622388|42105849|FG000|Overall Study|Withdrew Consent|1|||
19656920|NCT00622388|42105849|FG000|Overall Study|Insurance Expired|1|||
19656921|NCT01156389|42105856|FG000|Overall Study|Elevated liver enzymes|4|||
19656922|NCT01156389|42105857|FG001|Overall Study|Elevated liver enzymes|0|||
19656923|NCT01156389|42105856|FG000|Overall Study|Vomiting|0|||
19656924|NCT01156389|42105857|FG001|Overall Study|Vomiting|1|||
19656925|NCT01105767|42105866|FG000|Overall Study|Lost to Follow-up|1160|||
19656926|NCT01105767|42105867|FG001|Overall Study|Lost to Follow-up|1614|||
19656927|NCT01105767|42105868|FG002|Overall Study|Lost to Follow-up|1184|||
19656928|NCT03693430|42105878|FG000|Overall Study|Lost to Follow-up|3|||
19656929|NCT03693430|42105879|FG001|Overall Study|Lost to Follow-up|14|||
19656930|NCT03693430|42105878|FG000|Overall Study|Death|1|||
19656931|NCT03693430|42105879|FG001|Overall Study|Death|0|||
19656932|NCT03693430|42105878|FG000|Overall Study|Withdrawal by Subject|0|||
19656933|NCT03693430|42105879|FG001|Overall Study|Withdrawal by Subject|4|||
19656934|NCT00625742|42105885|FG000|Overall Study|Disease Progression|2|||
19656935|NCT00625742|42105885|FG000|Overall Study|Withdrawal by Subject|1|||
19656936|NCT00625742|42105885|FG000|Overall Study|Adverse Event|4|||
19656937|NCT00625742|42105885|FG000|Overall Study|Lost to Follow-up|4|||
19656938|NCT00625742|42105885|FG000|Overall Study|Ineligible|1|||
19656939|NCT00621296|42105898|FG000|Overall Study|Adverse Event|2|||
19656940|NCT00621296|42105898|FG000|Overall Study|Lack of Efficacy|1|||
19656941|NCT00621296|42105898|FG000|Overall Study|Physician Decision|7|||
19656942|NCT00621296|42105898|FG000|Overall Study|Unmatch Criteria|1|||
19656943|NCT00621296|42105898|FG000|Overall Study|Stopping Criteria|3|||
19656944|NCT00537303|42105904|FG000|Overall Study|Adverse Event|1|||
19753906|NCT02918019|42203801|FG002|Overall Study|Principal investigator request|0|||
19656945|NCT00537303|42105905|FG001|Overall Study|Adverse Event|4|||
19656946|NCT00537303|42105904|FG000|Overall Study|Lack of Efficacy|6|||
19656947|NCT00537303|42105905|FG001|Overall Study|Lack of Efficacy|7|||
19656948|NCT00537303|42105904|FG000|Overall Study|Protocol Violation|8|||
19656949|NCT00537303|42105905|FG001|Overall Study|Protocol Violation|4|||
19656950|NCT00537303|42105904|FG000|Overall Study|Withdrawal criteria|3|||
19656951|NCT00537303|42105905|FG001|Overall Study|Withdrawal criteria|3|||
19656952|NCT00537303|42105904|FG000|Overall Study|Unclassified|8|||
19656953|NCT00537303|42105905|FG001|Overall Study|Unclassified|7|||
19656954|NCT00505414|42105913|FG000|Titration Phase|Adverse Event|0|||
19656955|NCT00505414|42105914|FG001|Titration Phase|Adverse Event|0|||
19656956|NCT00505414|42105915|FG002|Titration Phase|Adverse Event|0|||
19656957|NCT00505414|42105916|FG003|Titration Phase|Adverse Event|8|||
19656958|NCT00505414|42105917|FG004|Titration Phase|Adverse Event|3|||
19656959|NCT00505414|42105913|FG000|Titration Phase|Death|0|||
19656960|NCT00505414|42105914|FG001|Titration Phase|Death|0|||
19656961|NCT00505414|42105915|FG002|Titration Phase|Death|0|||
19656962|NCT00505414|42105916|FG003|Titration Phase|Death|2|||
19656963|NCT00505414|42105917|FG004|Titration Phase|Death|0|||
19656964|NCT00505414|42105913|FG000|Titration Phase|Lack of Efficacy|0|||
19656965|NCT00505414|42105914|FG001|Titration Phase|Lack of Efficacy|0|||
19656966|NCT00505414|42105915|FG002|Titration Phase|Lack of Efficacy|0|||
19656967|NCT00505414|42105916|FG003|Titration Phase|Lack of Efficacy|10|||
19656968|NCT00505414|42105917|FG004|Titration Phase|Lack of Efficacy|1|||
19656969|NCT00505414|42105913|FG000|Titration Phase|Protocol Violation|0|||
19656970|NCT00505414|42105914|FG001|Titration Phase|Protocol Violation|0|||
19753907|NCT02918019|42203802|FG003|Overall Study|Principal investigator request|1|||
19656971|NCT00505414|42105915|FG002|Titration Phase|Protocol Violation|0|||
19656972|NCT00505414|42105916|FG003|Titration Phase|Protocol Violation|0|||
19656973|NCT00505414|42105917|FG004|Titration Phase|Protocol Violation|1|||
19656974|NCT00505414|42105913|FG000|Titration Phase|Withdrawal by Subject|0|||
19656975|NCT00505414|42105914|FG001|Titration Phase|Withdrawal by Subject|0|||
19656976|NCT00505414|42105915|FG002|Titration Phase|Withdrawal by Subject|0|||
19656977|NCT00505414|42105916|FG003|Titration Phase|Withdrawal by Subject|3|||
19656978|NCT00505414|42105917|FG004|Titration Phase|Withdrawal by Subject|4|||
19753908|NCT02918019|42203799|FG000|Overall Study|Physician Decision|1|||
19656979|NCT00505414|42105913|FG000|Titration Phase|Underlying disease and therapy required|0|||
19656980|NCT00505414|42105914|FG001|Titration Phase|Underlying disease and therapy required|0|||
19656981|NCT00505414|42105915|FG002|Titration Phase|Underlying disease and therapy required|0|||
19656982|NCT00505414|42105916|FG003|Titration Phase|Underlying disease and therapy required|7|||
19656983|NCT00505414|42105917|FG004|Titration Phase|Underlying disease and therapy required|3|||
19656984|NCT00505414|42105913|FG000|Maintenance Phase|Adverse Event|2|||
19656985|NCT00505414|42105914|FG001|Maintenance Phase|Adverse Event|2|||
19656986|NCT00505414|42105915|FG002|Maintenance Phase|Adverse Event|3|||
19656987|NCT00505414|42105916|FG003|Maintenance Phase|Adverse Event|0|||
19656988|NCT00505414|42105917|FG004|Maintenance Phase|Adverse Event|0|||
19656989|NCT00505414|42105913|FG000|Maintenance Phase|Death|2|||
19656990|NCT00505414|42105914|FG001|Maintenance Phase|Death|0|||
19656991|NCT00505414|42105915|FG002|Maintenance Phase|Death|1|||
19656992|NCT00505414|42105916|FG003|Maintenance Phase|Death|0|||
19656993|NCT00505414|42105917|FG004|Maintenance Phase|Death|0|||
19753909|NCT02918019|42203800|FG001|Overall Study|Physician Decision|3|||
19753910|NCT02918019|42203801|FG002|Overall Study|Physician Decision|2|||
19753911|NCT02918019|42203802|FG003|Overall Study|Physician Decision|0|||
19753912|NCT02918019|42203799|FG000|Overall Study|Protocol deviation|1|||
19656994|NCT00505414|42105913|FG000|Maintenance Phase|Lack of Efficacy|2|||
19656995|NCT00505414|42105914|FG001|Maintenance Phase|Lack of Efficacy|1|||
19656996|NCT00505414|42105915|FG002|Maintenance Phase|Lack of Efficacy|1|||
19656997|NCT00505414|42105916|FG003|Maintenance Phase|Lack of Efficacy|0|||
19656998|NCT00505414|42105917|FG004|Maintenance Phase|Lack of Efficacy|0|||
19656999|NCT00505414|42105913|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19657000|NCT00505414|42105914|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19657001|NCT00505414|42105915|FG002|Maintenance Phase|Withdrawal by Subject|1|||
19753913|NCT02918019|42203800|FG001|Overall Study|Protocol deviation|1|||
19753914|NCT02918019|42203801|FG002|Overall Study|Protocol deviation|0|||
19753915|NCT02918019|42203802|FG003|Overall Study|Protocol deviation|2|||
19753916|NCT02918019|42203799|FG000|Overall Study|Withdrawal by Subject|3|||
19753917|NCT02918019|42203800|FG001|Overall Study|Withdrawal by Subject|4|||
19753918|NCT02918019|42203801|FG002|Overall Study|Withdrawal by Subject|6|||
19753919|NCT02918019|42203802|FG003|Overall Study|Withdrawal by Subject|4|||
19753920|NCT02918019|42203799|FG000|Overall Study|Adverse Event|0|||
19753921|NCT02918019|42203800|FG001|Overall Study|Adverse Event|1|||
19753922|NCT02918019|42203801|FG002|Overall Study|Adverse Event|0|||
19753923|NCT02918019|42203802|FG003|Overall Study|Adverse Event|1|||
19753924|NCT03055988|42203820|FG000|Period 1|Adverse Event|0|||
19753925|NCT03055988|42203821|FG001|Period 1|Adverse Event|1|||
19753926|NCT03055988|42203820|FG000|Period 1|Lost to Follow-up|1|||
19753927|NCT03055988|42203821|FG001|Period 1|Lost to Follow-up|0|||
19657002|NCT00505414|42105916|FG003|Maintenance Phase|Withdrawal by Subject|0|||
19657003|NCT00505414|42105917|FG004|Maintenance Phase|Withdrawal by Subject|0|||
19657004|NCT00505414|42105913|FG000|Maintenance Phase|underlying disease and therapy required|0|||
19657005|NCT00505414|42105914|FG001|Maintenance Phase|underlying disease and therapy required|2|||
19657006|NCT00505414|42105915|FG002|Maintenance Phase|underlying disease and therapy required|2|||
19657007|NCT00505414|42105916|FG003|Maintenance Phase|underlying disease and therapy required|0|||
19657008|NCT00505414|42105917|FG004|Maintenance Phase|underlying disease and therapy required|0|||
19657009|NCT00625586|42105933|FG000|Overall Study|Adverse Event|1|||
19657010|NCT00144781|42105955|FG000|Overall Study|Adverse Event|0|||
19657011|NCT00144781|42105956|FG001|Overall Study|Adverse Event|1|||
19657012|NCT00144781|42105957|FG002|Overall Study|Adverse Event|0|||
19657013|NCT00144781|42105958|FG003|Overall Study|Adverse Event|0|||
19657014|NCT00144781|42105955|FG000|Overall Study|Non-compliant|0|||
19753928|NCT03055988|42203820|FG000|Period 1|Withdrawal by Subject|0|||
19753929|NCT03055988|42203821|FG001|Period 1|Withdrawal by Subject|4|||
19657015|NCT00144781|42105956|FG001|Overall Study|Non-compliant|1|||
19657016|NCT00144781|42105957|FG002|Overall Study|Non-compliant|0|||
19657017|NCT00144781|42105958|FG003|Overall Study|Non-compliant|0|||
19657018|NCT00621140|42105974|FG000|Overall Study|Adverse Event|4|||
19657019|NCT00621140|42105975|FG001|Overall Study|Adverse Event|5|||
19753930|NCT03055988|42203820|FG000|Period 2|Adverse Event|0|||
19753931|NCT03055988|42203821|FG001|Period 2|Adverse Event|1|||
19753932|NCT03055988|42203820|FG000|Period 2|Other than listed|1|||
19657020|NCT00621140|42105974|FG000|Overall Study|Lost to Follow-up|1|||
19657021|NCT00621140|42105975|FG001|Overall Study|Lost to Follow-up|2|||
19657022|NCT00621140|42105974|FG000|Overall Study|Withdrawal by Subject|4|||
19657023|NCT00621140|42105975|FG001|Overall Study|Withdrawal by Subject|6|||
19657024|NCT00621140|42105974|FG000|Overall Study|Other incl. lack of efficacy|6|||
19657025|NCT00621140|42105975|FG001|Overall Study|Other incl. lack of efficacy|5|||
19657026|NCT00207727|42105986|FG000|Overall Study|Withdrawal by Subject|0|||
19657027|NCT00207727|42105987|FG001|Overall Study|Withdrawal by Subject|0|||
19657028|NCT00207727|42105988|FG002|Overall Study|Withdrawal by Subject|0|||
19657029|NCT00207727|42105989|FG003|Overall Study|Withdrawal by Subject|0|||
19753933|NCT03055988|42203821|FG001|Period 2|Other than listed|1|||
19753934|NCT01250912|42203827|FG000|Overall Study|Lost to Follow-up|1|||
19753935|NCT03733301|42203837|FG000|Overall Study|Screen Fail|1|||
19657030|NCT00207727|42105990|FG004|Overall Study|Withdrawal by Subject|1|||
19657031|NCT00207727|42105986|FG000|Overall Study|Lost to Follow-up|0|||
19657032|NCT00207727|42105987|FG001|Overall Study|Lost to Follow-up|1|||
19657033|NCT00207727|42105988|FG002|Overall Study|Lost to Follow-up|0|||
19657034|NCT00207727|42105989|FG003|Overall Study|Lost to Follow-up|0|||
19657035|NCT00207727|42105990|FG004|Overall Study|Lost to Follow-up|0|||
19657036|NCT00207727|42105986|FG000|Overall Study|Other|38|||
19657037|NCT00207727|42105987|FG001|Overall Study|Other|41|||
19657038|NCT00207727|42105988|FG002|Overall Study|Other|41|||
19657039|NCT00207727|42105989|FG003|Overall Study|Other|37|||
19657040|NCT00207727|42105990|FG004|Overall Study|Other|33|||
19657041|NCT00504556|42106007|FG000|Overall Study|Adverse Event|11|||
19657042|NCT00504556|42106008|FG001|Overall Study|Adverse Event|11|||
19657043|NCT00504556|42106009|FG002|Overall Study|Adverse Event|14|||
19657044|NCT00504556|42106010|FG003|Overall Study|Adverse Event|13|||
19657045|NCT00504556|42106011|FG004|Overall Study|Adverse Event|5|||
19657046|NCT00504556|42106007|FG000|Overall Study|Death|3|||
19657047|NCT00504556|42106008|FG001|Overall Study|Death|3|||
19753936|NCT03733301|42203838|FG001|Overall Study|Screen Fail|0|||
19753937|NCT03733301|42203839|FG002|Overall Study|Screen Fail|0|||
19753938|NCT03733301|42203837|FG000|Overall Study|Non-compliance|1|||
19753939|NCT03733301|42203838|FG001|Overall Study|Non-compliance|0|||
19753940|NCT03733301|42203839|FG002|Overall Study|Non-compliance|0|||
19753941|NCT03733301|42203837|FG000|Overall Study|Lack of Efficacy|2|||
19753942|NCT03733301|42203838|FG001|Overall Study|Lack of Efficacy|3|||
19753943|NCT03733301|42203839|FG002|Overall Study|Lack of Efficacy|0|||
19753944|NCT03733301|42203837|FG000|Overall Study|Adverse Event|0|||
19753945|NCT03733301|42203838|FG001|Overall Study|Adverse Event|1|||
19753946|NCT03733301|42203839|FG002|Overall Study|Adverse Event|3|||
19753947|NCT03733301|42203837|FG000|Overall Study|Withdrawal by Subject|3|||
19657048|NCT00504556|42106009|FG002|Overall Study|Death|1|||
19657049|NCT00504556|42106010|FG003|Overall Study|Death|0|||
19657050|NCT00504556|42106011|FG004|Overall Study|Death|2|||
19657051|NCT00504556|42106007|FG000|Overall Study|Protocol Violation|1|||
19657052|NCT00504556|42106008|FG001|Overall Study|Protocol Violation|3|||
19657053|NCT00504556|42106009|FG002|Overall Study|Protocol Violation|2|||
19657054|NCT00504556|42106010|FG003|Overall Study|Protocol Violation|1|||
19657055|NCT00504556|42106011|FG004|Overall Study|Protocol Violation|2|||
19657056|NCT00504556|42106007|FG000|Overall Study|Lost to Follow-up|0|||
19657057|NCT00504556|42106008|FG001|Overall Study|Lost to Follow-up|0|||
19657058|NCT00504556|42106009|FG002|Overall Study|Lost to Follow-up|1|||
19657059|NCT00504556|42106010|FG003|Overall Study|Lost to Follow-up|1|||
19657060|NCT00504556|42106011|FG004|Overall Study|Lost to Follow-up|1|||
19657061|NCT00504556|42106007|FG000|Overall Study|Withdrawal by Subject|16|||
19657062|NCT00504556|42106008|FG001|Overall Study|Withdrawal by Subject|16|||
19657063|NCT00504556|42106009|FG002|Overall Study|Withdrawal by Subject|7|||
19657064|NCT00504556|42106010|FG003|Overall Study|Withdrawal by Subject|8|||
19657065|NCT00504556|42106011|FG004|Overall Study|Withdrawal by Subject|12|||
19657066|NCT00504556|42106007|FG000|Overall Study|administrative reasons|0|||
19657067|NCT00504556|42106008|FG001|Overall Study|administrative reasons|2|||
19657068|NCT00504556|42106009|FG002|Overall Study|administrative reasons|2|||
19657069|NCT00504556|42106010|FG003|Overall Study|administrative reasons|1|||
19657070|NCT00504556|42106011|FG004|Overall Study|administrative reasons|2|||
19657071|NCT00504556|42106007|FG000|Overall Study|did not meet entry criteria|2|||
19657072|NCT00504556|42106008|FG001|Overall Study|did not meet entry criteria|0|||
19657073|NCT00504556|42106009|FG002|Overall Study|did not meet entry criteria|1|||
19657074|NCT00504556|42106010|FG003|Overall Study|did not meet entry criteria|1|||
19657075|NCT00504556|42106011|FG004|Overall Study|did not meet entry criteria|0|||
19657076|NCT00504556|42106007|FG000|Overall Study|data monitor committee decision|0|||
19657077|NCT00504556|42106008|FG001|Overall Study|data monitor committee decision|0|||
19657078|NCT00504556|42106009|FG002|Overall Study|data monitor committee decision|0|||
19657079|NCT00504556|42106010|FG003|Overall Study|data monitor committee decision|100|||
19657080|NCT00504556|42106011|FG004|Overall Study|data monitor committee decision|0|||
19657081|NCT00504556|42106007|FG000|Overall Study|Other|2|||
19657082|NCT00504556|42106008|FG001|Overall Study|Other|2|||
19657083|NCT00504556|42106009|FG002|Overall Study|Other|2|||
19657084|NCT00504556|42106010|FG003|Overall Study|Other|3|||
19657085|NCT00504556|42106011|FG004|Overall Study|Other|0|||
19753948|NCT03733301|42203838|FG001|Overall Study|Withdrawal by Subject|5|||
19753949|NCT03733301|42203839|FG002|Overall Study|Withdrawal by Subject|1|||
19657086|NCT00504556|42106007|FG000|Overall Study|not in safety analysis set|0|||
19753950|NCT02871297|42203848|FG000|Overall Study|Adverse Event|34|||
19753951|NCT02871297|42203848|FG000|Overall Study|Lack of Efficacy|10|||
19657087|NCT00504556|42106008|FG001|Overall Study|not in safety analysis set|1|||
19657088|NCT00504556|42106009|FG002|Overall Study|not in safety analysis set|1|||
19657089|NCT00504556|42106010|FG003|Overall Study|not in safety analysis set|0|||
19657090|NCT00504556|42106011|FG004|Overall Study|not in safety analysis set|1|||
19657091|NCT00206323|42106025|FG000|Overall Study|Lack of Efficacy|4|||
19753952|NCT02871297|42203848|FG000|Overall Study|Non-compliance with study drug|15|||
19753953|NCT02871297|42203848|FG000|Overall Study|Protocol Violation|3|||
19657092|NCT00206323|42106026|FG001|Overall Study|Lack of Efficacy|1|||
19657093|NCT00206323|42106025|FG000|Overall Study|Adverse Event|1|||
19657094|NCT00206323|42106026|FG001|Overall Study|Adverse Event|1|||
19657095|NCT00206323|42106025|FG000|Overall Study|Lost to Follow-up|1|||
19657096|NCT00206323|42106026|FG001|Overall Study|Lost to Follow-up|1|||
19657097|NCT03903159|42106032|FG000|Overall Study|Discharged with Staff Approval|2|||
19657098|NCT03903159|42106032|FG000|Overall Study|Discharged at Staff Request|2|||
19657099|NCT03903159|42106032|FG000|Overall Study|Discharged Against Staff Advice|1|||
19657100|NCT00205855|42106036|FG000|Overall Study|Only received temporary implants|16|||
19657101|NCT00205855|42106036|FG000|Overall Study|Withdrawal by Subject|5|||
19657102|NCT00536991|42106040|FG000|Overall Study|Withdrawal by Subject|10|||
19657103|NCT00536991|42106040|FG000|Overall Study|Physician Decision|1|||
19657104|NCT00536991|42106040|FG000|Overall Study|patient ineligible|2|||
19657105|NCT03902613|42106045|FG000|Overall Study|Physician Decision|1|||
19657106|NCT00504166|42106051|FG000|Overall Study|Adverse Event|1|||
19657107|NCT00504166|42106052|FG001|Overall Study|Adverse Event|4|||
19657108|NCT00504166|42106051|FG000|Overall Study|Withdrawal by Subject|3|||
19657109|NCT00504166|42106052|FG001|Overall Study|Withdrawal by Subject|6|||
19657110|NCT00504166|42106051|FG000|Overall Study|Physician Decision|1|||
19657111|NCT00504166|42106052|FG001|Overall Study|Physician Decision|1|||
19657112|NCT00504166|42106051|FG000|Overall Study|Lost to Follow-up|1|||
19657113|NCT00504166|42106052|FG001|Overall Study|Lost to Follow-up|3|||
19657114|NCT00509236|42106060|FG000|Overall Study|Adverse Event|7|||
19657115|NCT00509236|42106061|FG001|Overall Study|Adverse Event|9|||
19657116|NCT00509236|42106060|FG000|Overall Study|Withdrawal by Subject|5|||
19657117|NCT00509236|42106061|FG001|Overall Study|Withdrawal by Subject|10|||
19657118|NCT00509236|42106060|FG000|Overall Study|Protocol Violation|3|||
19657119|NCT00509236|42106061|FG001|Overall Study|Protocol Violation|0|||
19657120|NCT00509236|42106060|FG000|Overall Study|Excluded Medication|1|||
19657121|NCT00509236|42106061|FG001|Overall Study|Excluded Medication|1|||
19657122|NCT00509236|42106060|FG000|Overall Study|Scheduled Kidney Transplant|1|||
19657123|NCT00509236|42106061|FG001|Overall Study|Scheduled Kidney Transplant|0|||
19657124|NCT03896295|42106069|FG000|Overall Study|Adverse Event|0|||
19657125|NCT03896295|42106070|FG001|Overall Study|Adverse Event|1|||
19657126|NCT03896295|42106069|FG000|Overall Study|COVID-19|7|||
19657127|NCT03896295|42106070|FG001|Overall Study|COVID-19|29|||
19753954|NCT02871297|42203848|FG000|Overall Study|Withdrawal by Subject|20|||
19753955|NCT02871297|42203848|FG000|Overall Study|Lost to Follow-up|13|||
19753956|NCT02871297|42203848|FG000|Overall Study|Rolled over to 13546A|2|||
19657128|NCT00508924|42106085|FG000|Overall Study|Protocol Violation|0|||
19657129|NCT00508924|42106086|FG001|Overall Study|Protocol Violation|0|||
19657130|NCT00508924|42106087|FG002|Overall Study|Protocol Violation|1|||
19657131|NCT00508924|42106088|FG003|Overall Study|Protocol Violation|1|||
19657132|NCT00620750|42106098|FG000|Overall Study|Lost to Follow-up|25|||
19657133|NCT00508144|42106102|FG000|Overall Study|Not eligible|6|||
19657134|NCT00508144|42106102|FG000|Overall Study|Death|5|||
19657135|NCT00621842|42106106|FG000|Overall Study|Adverse Event|6|||
19657136|NCT00621842|42106106|FG000|Overall Study|Withdrawal by Subject|7|||
19657137|NCT00621842|42106106|FG000|Overall Study|Protocol Violation|4|||
19657138|NCT00621842|42106106|FG000|Overall Study|Lack of Efficacy|2|||
19657139|NCT00503776|42106114|FG000|Overall Study|Withdrawal by Subject|1|||
19657140|NCT00503776|42106115|FG001|Overall Study|Withdrawal by Subject|0|||
19657141|NCT00503776|42106116|FG002|Overall Study|Withdrawal by Subject|1|||
19657142|NCT00503776|42106117|FG003|Overall Study|Withdrawal by Subject|1|||
19657143|NCT00503776|42106114|FG000|Overall Study|Physician Decision|0|||
19657144|NCT00503776|42106115|FG001|Overall Study|Physician Decision|0|||
19657145|NCT00503776|42106116|FG002|Overall Study|Physician Decision|1|||
19657146|NCT00503776|42106117|FG003|Overall Study|Physician Decision|1|||
19657147|NCT00619112|42106134|FG000|Overall Study|Adverse Event|1|||
19657148|NCT00619112|42106135|FG001|Overall Study|Adverse Event|2|||
19657149|NCT00619502|42106146|FG000|Overall Study|Lost to Follow-up|8|||
19657150|NCT00619502|42106147|FG001|Overall Study|Lost to Follow-up|10|||
19657151|NCT00618956|42106157|FG000|Overall Study|Adverse Event|10|||
19657152|NCT00618956|42106158|FG001|Overall Study|Adverse Event|34|||
19657153|NCT00618956|42106157|FG000|Overall Study|Lack of Efficacy|2|||
19657154|NCT00618956|42106158|FG001|Overall Study|Lack of Efficacy|1|||
19657155|NCT00618956|42106157|FG000|Overall Study|Withdrawal by Subject|5|||
19657156|NCT00618956|42106158|FG001|Overall Study|Withdrawal by Subject|7|||
19657157|NCT00618956|42106157|FG000|Overall Study|Lost to Follow-up|4|||
19657158|NCT00618956|42106158|FG001|Overall Study|Lost to Follow-up|5|||
19657159|NCT00618956|42106157|FG000|Overall Study|Protocol Violation|2|||
19657160|NCT00618956|42106158|FG001|Overall Study|Protocol Violation|2|||
19657161|NCT00618956|42106157|FG000|Overall Study|did not meet criteria, non-compliance|2|||
19657162|NCT00618956|42106158|FG001|Overall Study|did not meet criteria, non-compliance|1|||
19657163|NCT00716417|42106180|FG000|Overall Study|Adverse Event|0|||
19657164|NCT00716417|42106181|FG001|Overall Study|Adverse Event|0|||
19657165|NCT00716417|42106182|FG002|Overall Study|Adverse Event|2|||
19657166|NCT00716417|42106183|FG003|Overall Study|Adverse Event|1|||
19657167|NCT00716417|42106184|FG004|Overall Study|Adverse Event|0|||
19657168|NCT00716417|42106185|FG005|Overall Study|Adverse Event|0|||
19657169|NCT00716417|42106186|FG006|Overall Study|Adverse Event|3|||
19657170|NCT00716417|42106187|FG007|Overall Study|Adverse Event|1|||
19657171|NCT00716417|42106188|FG008|Overall Study|Adverse Event|0|||
19657172|NCT00716417|42106189|FG009|Overall Study|Adverse Event|3|||
19657173|NCT00716417|42106180|FG000|Overall Study|Withdrawal by Subject|0|||
19657174|NCT00716417|42106181|FG001|Overall Study|Withdrawal by Subject|1|||
19657175|NCT00716417|42106182|FG002|Overall Study|Withdrawal by Subject|0|||
19657176|NCT00716417|42106183|FG003|Overall Study|Withdrawal by Subject|2|||
19657177|NCT00716417|42106184|FG004|Overall Study|Withdrawal by Subject|0|||
19657178|NCT00716417|42106185|FG005|Overall Study|Withdrawal by Subject|0|||
19657179|NCT00716417|42106186|FG006|Overall Study|Withdrawal by Subject|1|||
19657180|NCT00716417|42106187|FG007|Overall Study|Withdrawal by Subject|0|||
19657181|NCT00716417|42106188|FG008|Overall Study|Withdrawal by Subject|0|||
19657182|NCT00716417|42106189|FG009|Overall Study|Withdrawal by Subject|0|||
19657183|NCT00716417|42106180|FG000|Overall Study|Progressive disease|3|||
19657184|NCT00716417|42106181|FG001|Overall Study|Progressive disease|5|||
19657185|NCT00716417|42106182|FG002|Overall Study|Progressive disease|3|||
19753957|NCT02871297|42203848|FG000|Overall Study|Other than specified|39|||
19753958|NCT03554005|42203858|FG000|Overall Study|Not in participant's best interest|0|||
19753959|NCT03554005|42203859|FG001|Overall Study|Not in participant's best interest|0|||
19753960|NCT03554005|42203860|FG002|Overall Study|Not in participant's best interest|0|||
19753961|NCT03554005|42203861|FG003|Overall Study|Not in participant's best interest|0|||
19753962|NCT03554005|42203862|FG004|Overall Study|Not in participant's best interest|0|||
19753963|NCT03554005|42203863|FG005|Overall Study|Not in participant's best interest|1|||
19753964|NCT03554005|42203858|FG000|Overall Study|Disease Progression|1|||
19657186|NCT00716417|42106183|FG003|Overall Study|Progressive disease|8|||
19657187|NCT00716417|42106184|FG004|Overall Study|Progressive disease|0|||
19657188|NCT00716417|42106185|FG005|Overall Study|Progressive disease|3|||
19657189|NCT00716417|42106186|FG006|Overall Study|Progressive disease|3|||
19657190|NCT00716417|42106187|FG007|Overall Study|Progressive disease|1|||
19657191|NCT00716417|42106188|FG008|Overall Study|Progressive disease|5|||
19657192|NCT00716417|42106189|FG009|Overall Study|Progressive disease|0|||
19657193|NCT00716417|42106180|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
19657194|NCT00716417|42106181|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
19657195|NCT00716417|42106182|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
19657196|NCT00716417|42106183|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
19657197|NCT00716417|42106184|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
19657198|NCT00716417|42106185|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
19657199|NCT00716417|42106186|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
19657200|NCT00716417|42106187|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
19657201|NCT00716417|42106188|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
19657202|NCT00716417|42106189|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
19657203|NCT00716417|42106180|FG000|Overall Study|On patient request due to toxicities|0|||
19657204|NCT00716417|42106181|FG001|Overall Study|On patient request due to toxicities|0|||
19657205|NCT00716417|42106182|FG002|Overall Study|On patient request due to toxicities|0|||
19657206|NCT00716417|42106183|FG003|Overall Study|On patient request due to toxicities|0|||
19657207|NCT00716417|42106184|FG004|Overall Study|On patient request due to toxicities|0|||
19657208|NCT00716417|42106185|FG005|Overall Study|On patient request due to toxicities|0|||
19657209|NCT00716417|42106186|FG006|Overall Study|On patient request due to toxicities|0|||
19657210|NCT00716417|42106187|FG007|Overall Study|On patient request due to toxicities|1|||
19657211|NCT00716417|42106188|FG008|Overall Study|On patient request due to toxicities|0|||
19657212|NCT00716417|42106189|FG009|Overall Study|On patient request due to toxicities|0|||
19657213|NCT00719537|42106215|FG000|Overall Study|Withdrawal by Subject|1|||
19657214|NCT00719537|42106216|FG001|Overall Study|Withdrawal by Subject|0|||
19657215|NCT00719537|42106215|FG000|Overall Study|Lost to Follow-up|0|||
19657216|NCT00719537|42106216|FG001|Overall Study|Lost to Follow-up|1|||
19657217|NCT00715949|42106222|FG000|Overall Study|could not finish first test|4|||
19657218|NCT00503698|42106228|FG000|Overall Study|Protocol Violation|5|||
19657219|NCT00503698|42106229|FG001|Overall Study|Protocol Violation|6|||
19657220|NCT00503698|42106228|FG000|Overall Study|Adverse Event|52|||
19753965|NCT03554005|42203859|FG001|Overall Study|Disease Progression|1|||
19753966|NCT03554005|42203860|FG002|Overall Study|Disease Progression|1|||
19657221|NCT00503698|42106229|FG001|Overall Study|Adverse Event|41|||
19657222|NCT00503698|42106228|FG000|Overall Study|Death|1|||
19657223|NCT00503698|42106229|FG001|Overall Study|Death|0|||
19657224|NCT00503698|42106228|FG000|Overall Study|Lack of Efficacy|3|||
19657225|NCT00503698|42106229|FG001|Overall Study|Lack of Efficacy|4|||
19657226|NCT00503698|42106228|FG000|Overall Study|Trial terminated|216|||
19657227|NCT00503698|42106229|FG001|Overall Study|Trial terminated|253|||
19657228|NCT00503698|42106228|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
19657229|NCT00503698|42106229|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
19657230|NCT00503698|42106228|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
19657231|NCT00503698|42106229|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
19657232|NCT00503698|42106228|FG000|Overall Study|Any condition in exclusion criteria|4|||
19657233|NCT00503698|42106229|FG001|Overall Study|Any condition in exclusion criteria|6|||
19657234|NCT00503698|42106228|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
19657235|NCT00503698|42106229|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
19657236|NCT00503698|42106228|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
19657237|NCT00503698|42106229|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
19657238|NCT00503698|42106228|FG000|Overall Study|Critically ill|2|||
19657239|NCT00503698|42106229|FG001|Overall Study|Critically ill|0|||
19657240|NCT00503698|42106228|FG000|Overall Study|Unclassified|48|||
19657241|NCT00503698|42106229|FG001|Overall Study|Unclassified|32|||
19657242|NCT00503698|42106228|FG000|Overall Study|Not exposed to trial drug|11|||
19657243|NCT00503698|42106229|FG001|Overall Study|Not exposed to trial drug|6|||
19657244|NCT00573794|42106244|FG000|Overall Study|Adverse Event|81|||
19657245|NCT00573794|42106244|FG000|Overall Study|Withdrew Consent|90|||
19657246|NCT00573794|42106244|FG000|Overall Study|Lost to Follow-up|13|||
19657247|NCT00573794|42106244|FG000|Overall Study|Protocol Violation|6|||
19657248|NCT00573794|42106244|FG000|Overall Study|Lack of Efficacy|94|||
19657249|NCT00573794|42106244|FG000|Overall Study|Other|46|||
19657250|NCT00715793|42106248|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
19657251|NCT00715793|42106249|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
19657252|NCT00715793|42106248|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
19657253|NCT00715793|42106249|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
19657254|NCT00718523|42106258|FG000|Overall Study|Withdrawal by Subject|5|||
19657255|NCT00718523|42106259|FG001|Overall Study|Withdrawal by Subject|7|||
19657256|NCT00718523|42106258|FG000|Overall Study|Death|13|||
19657257|NCT00718523|42106259|FG001|Overall Study|Death|17|||
19657258|NCT00715559|42106265|FG000|Overall Study|medication not tolerated - nausea|1|||
19657259|NCT00620282|42106281|FG000|Overall Study|Adverse Event|0|||
19657260|NCT00620282|42106282|FG001|Overall Study|Adverse Event|1|||
19657261|NCT00620282|42106283|FG002|Overall Study|Adverse Event|0|||
19657262|NCT00620282|42106281|FG000|Overall Study|Arterial line unable to be placed|0|||
19657263|NCT00620282|42106282|FG001|Overall Study|Arterial line unable to be placed|0|||
19657264|NCT00620282|42106283|FG002|Overall Study|Arterial line unable to be placed|1|||
19657265|NCT00620282|42106281|FG000|Overall Study|Withdrawal by Subject|0|||
19657266|NCT00620282|42106282|FG001|Overall Study|Withdrawal by Subject|1|||
19657267|NCT00620282|42106283|FG002|Overall Study|Withdrawal by Subject|0|||
19657268|NCT00515086|42106295|FG000|Overall Study|Adverse Event|1|||
19657269|NCT00515086|42106296|FG001|Overall Study|Adverse Event|1|||
19657270|NCT00515086|42106297|FG002|Overall Study|Adverse Event|2|||
19657271|NCT00515086|42106298|FG003|Overall Study|Adverse Event|3|||
19657272|NCT00515086|42106295|FG000|Overall Study|Administrative|1|||
19657273|NCT00515086|42106296|FG001|Overall Study|Administrative|1|||
19753967|NCT03554005|42203861|FG003|Overall Study|Disease Progression|1|||
19657274|NCT00515086|42106297|FG002|Overall Study|Administrative|0|||
19657275|NCT00515086|42106298|FG003|Overall Study|Administrative|0|||
19657276|NCT00515086|42106295|FG000|Overall Study|Withdrawal by Subject|1|||
19657277|NCT00515086|42106296|FG001|Overall Study|Withdrawal by Subject|0|||
19657278|NCT00515086|42106297|FG002|Overall Study|Withdrawal by Subject|0|||
19657279|NCT00515086|42106298|FG003|Overall Study|Withdrawal by Subject|1|||
19657280|NCT00515086|42106295|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
19657281|NCT00515086|42106296|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19657282|NCT00515086|42106297|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
19657283|NCT00515086|42106298|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
19657284|NCT00515086|42106295|FG000|Overall Study|Lost to Follow-up|1|||
19657285|NCT00515086|42106296|FG001|Overall Study|Lost to Follow-up|0|||
19657286|NCT00515086|42106297|FG002|Overall Study|Lost to Follow-up|0|||
19657287|NCT00515086|42106298|FG003|Overall Study|Lost to Follow-up|0|||
19657288|NCT00515086|42106295|FG000|Overall Study|Study drug no longer required|0|||
19657289|NCT00515086|42106296|FG001|Overall Study|Study drug no longer required|1|||
19657290|NCT00515086|42106297|FG002|Overall Study|Study drug no longer required|0|||
19657291|NCT00515086|42106298|FG003|Overall Study|Study drug no longer required|0|||
19657292|NCT00515086|42106295|FG000|Overall Study|Death|2|||
19657293|NCT00515086|42106296|FG001|Overall Study|Death|0|||
19657294|NCT00515086|42106297|FG002|Overall Study|Death|0|||
19657295|NCT00515086|42106298|FG003|Overall Study|Death|0|||
19657296|NCT00618410|42106314|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
19657297|NCT00618410|42106315|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
19657298|NCT00618722|42106325|FG000|Overall Study|Refusal of Treatment|0|||
19657299|NCT00618722|42106326|FG001|Overall Study|Refusal of Treatment|0|||
19657300|NCT00618722|42106327|FG002|Overall Study|Refusal of Treatment|1|||
19657301|NCT00618722|42106328|FG003|Overall Study|Refusal of Treatment|0|||
19657302|NCT00618722|42106325|FG000|Overall Study|Patient Request|1|||
19657303|NCT00618722|42106326|FG001|Overall Study|Patient Request|1|||
19657304|NCT00618722|42106327|FG002|Overall Study|Patient Request|1|||
19657305|NCT00618722|42106328|FG003|Overall Study|Patient Request|1|||
19657306|NCT00618722|42106325|FG000|Overall Study|Inability to Complete Study Procedure|0|||
19657307|NCT00618722|42106326|FG001|Overall Study|Inability to Complete Study Procedure|1|||
19657308|NCT00618722|42106327|FG002|Overall Study|Inability to Complete Study Procedure|0|||
19657309|NCT00618722|42106328|FG003|Overall Study|Inability to Complete Study Procedure|0|||
19657310|NCT00618722|42106325|FG000|Overall Study|Lost to Follow-up|2|||
19657311|NCT00618722|42106326|FG001|Overall Study|Lost to Follow-up|0|||
19657312|NCT00618722|42106327|FG002|Overall Study|Lost to Follow-up|0|||
19657313|NCT00618722|42106328|FG003|Overall Study|Lost to Follow-up|2|||
19657314|NCT00618722|42106325|FG000|Overall Study|Miscellaneous Reasons|0|||
19657315|NCT00618722|42106326|FG001|Overall Study|Miscellaneous Reasons|0|||
19657316|NCT00618722|42106327|FG002|Overall Study|Miscellaneous Reasons|1|||
19657317|NCT00618722|42106328|FG003|Overall Study|Miscellaneous Reasons|1|||
19657318|NCT00507442|42106342|FG000|Overall Study|Adverse Event|8|||
19657319|NCT00507442|42106343|FG001|Overall Study|Adverse Event|11|||
19657320|NCT00507442|42106344|FG002|Overall Study|Adverse Event|4|||
19657321|NCT00507442|42106345|FG003|Overall Study|Adverse Event|1|||
19657322|NCT00507442|42106342|FG000|Overall Study|Protocol Violation|0|||
19657323|NCT00507442|42106343|FG001|Overall Study|Protocol Violation|1|||
19657324|NCT00507442|42106344|FG002|Overall Study|Protocol Violation|0|||
19657325|NCT00507442|42106345|FG003|Overall Study|Protocol Violation|0|||
19657326|NCT00507442|42106342|FG000|Overall Study|Lost to Follow-up|0|||
19657327|NCT00507442|42106343|FG001|Overall Study|Lost to Follow-up|0|||
19657328|NCT00507442|42106344|FG002|Overall Study|Lost to Follow-up|1|||
19657329|NCT00507442|42106345|FG003|Overall Study|Lost to Follow-up|0|||
19657330|NCT00507442|42106342|FG000|Overall Study|Physician Decision|0|||
19657331|NCT00507442|42106343|FG001|Overall Study|Physician Decision|2|||
19657332|NCT00507442|42106344|FG002|Overall Study|Physician Decision|4|||
19657333|NCT00507442|42106345|FG003|Overall Study|Physician Decision|1|||
19657334|NCT00507442|42106342|FG000|Overall Study|Progressive Disease|2|||
19657335|NCT00507442|42106343|FG001|Overall Study|Progressive Disease|4|||
19657336|NCT00507442|42106344|FG002|Overall Study|Progressive Disease|2|||
19753968|NCT03554005|42203862|FG004|Overall Study|Disease Progression|5|||
19753969|NCT03554005|42203863|FG005|Overall Study|Disease Progression|6|||
19753970|NCT03554005|42203858|FG000|Overall Study|Adverse Event|0|||
19753971|NCT03554005|42203859|FG001|Overall Study|Adverse Event|0|||
19753972|NCT03554005|42203860|FG002|Overall Study|Adverse Event|0|||
19753973|NCT03554005|42203861|FG003|Overall Study|Adverse Event|0|||
19753974|NCT03554005|42203862|FG004|Overall Study|Adverse Event|0|||
19753975|NCT03554005|42203863|FG005|Overall Study|Adverse Event|3|||
19753976|NCT03554005|42203858|FG000|Overall Study|Physician Decision|0|||
19753977|NCT03554005|42203859|FG001|Overall Study|Physician Decision|0|||
19753978|NCT03554005|42203860|FG002|Overall Study|Physician Decision|0|||
19753979|NCT03554005|42203861|FG003|Overall Study|Physician Decision|0|||
19753980|NCT03554005|42203862|FG004|Overall Study|Physician Decision|1|||
19753981|NCT03554005|42203863|FG005|Overall Study|Physician Decision|0|||
19753982|NCT03554005|42203858|FG000|Overall Study|Other|0|||
19753983|NCT03554005|42203859|FG001|Overall Study|Other|0|||
19753984|NCT03554005|42203860|FG002|Overall Study|Other|0|||
19753985|NCT03554005|42203861|FG003|Overall Study|Other|0|||
19657337|NCT00507442|42106345|FG003|Overall Study|Progressive Disease|0|||
19657338|NCT00507442|42106342|FG000|Overall Study|Withdrawal by Subject|4|||
19657339|NCT00507442|42106343|FG001|Overall Study|Withdrawal by Subject|4|||
19657340|NCT00507442|42106344|FG002|Overall Study|Withdrawal by Subject|2|||
19657341|NCT00507442|42106345|FG003|Overall Study|Withdrawal by Subject|1|||
19657342|NCT00507442|42106342|FG000|Overall Study|Other|2|||
19657343|NCT00507442|42106343|FG001|Overall Study|Other|5|||
19657344|NCT00507442|42106344|FG002|Overall Study|Other|2|||
19657345|NCT00507442|42106345|FG003|Overall Study|Other|2|||
19657346|NCT00619892|42106361|FG000|Overall Study|Adverse Event|3|||
19753986|NCT03554005|42203862|FG004|Overall Study|Other|0|||
19753987|NCT03554005|42203863|FG005|Overall Study|Other|1|||
19753988|NCT00709228|42203877|FG000|Overall Study|Not treated|14|||
19753989|NCT00709228|42203877|FG000|Overall Study|Eligibility criteria not met|281|||
19657347|NCT00619892|42106362|FG001|Overall Study|Adverse Event|0|||
19657348|NCT00619892|42106361|FG000|Overall Study|Lost to Follow-up|0|||
19753990|NCT00709228|42203877|FG000|Overall Study|Adverse events|2|||
19753991|NCT00709228|42203877|FG000|Overall Study|Discontinued treatment|14|||
19753992|NCT00709228|42203877|FG000|Overall Study|Did not enter follow-up|4|||
19753993|NCT00709228|42203877|FG000|Overall Study|Discontinued follow-up|5|||
19753994|NCT00709228|42203877|FG000|Overall Study|Disease progression|1|||
19753995|NCT00709228|42203877|FG000|Overall Study|Lost to Follow-up|6|||
19657349|NCT00619892|42106362|FG001|Overall Study|Lost to Follow-up|1|||
19657350|NCT00619892|42106361|FG000|Overall Study|Intercurrent illness|0|||
19657351|NCT00619892|42106362|FG001|Overall Study|Intercurrent illness|1|||
19657352|NCT00507130|42106374|FG000|Overall Study|Lost to Follow-up|0|||
19753996|NCT00709228|42203877|FG000|Overall Study|Non-compliance|5|||
19753997|NCT03219372|42203900|FG000|Overall Study|Withdrawal by Subject|1|||
19753998|NCT03219372|42203901|FG001|Overall Study|Withdrawal by Subject|0|||
19753999|NCT03056690|42203916|FG000|Overall Study|Adverse Event|3|||
19754000|NCT03056690|42203917|FG001|Overall Study|Adverse Event|2|||
19754001|NCT03056690|42203916|FG000|Overall Study|Lack of Efficacy|1|||
19754002|NCT03056690|42203917|FG001|Overall Study|Lack of Efficacy|2|||
19754003|NCT03056690|42203916|FG000|Overall Study|Lost to Follow-up|3|||
19754004|NCT03056690|42203917|FG001|Overall Study|Lost to Follow-up|2|||
19657353|NCT00507130|42106375|FG001|Overall Study|Lost to Follow-up|0|||
19657354|NCT00507130|42106376|FG002|Overall Study|Lost to Follow-up|1|||
19657355|NCT00507130|42106377|FG003|Overall Study|Lost to Follow-up|1|||
19657356|NCT00507130|42106374|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
19657357|NCT00507130|42106375|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
19657358|NCT00507130|42106376|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
19657359|NCT00507130|42106377|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
19657360|NCT00503308|42106389|FG000|Overall Study|Protocol Violation|2|||
19657361|NCT00503308|42106390|FG001|Overall Study|Protocol Violation|1|||
19657362|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
19657363|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
19657364|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657365|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657366|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
19657367|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657368|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657369|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657370|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
19657371|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657372|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
19657373|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657374|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657375|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657376|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657377|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657378|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657379|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
19657380|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657381|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
19657382|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657383|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
19657384|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657385|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657386|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657387|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657388|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657389|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657390|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
19657391|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657392|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
19657393|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657394|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657395|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657396|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657397|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
19657398|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
19657399|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
19657400|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
19657401|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657402|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
19754005|NCT03056690|42203916|FG000|Overall Study|Protocol Violation|2|||
19754006|NCT03056690|42203917|FG001|Overall Study|Protocol Violation|2|||
19754007|NCT03056690|42203916|FG000|Overall Study|Withdrawal by Subject|3|||
19754008|NCT03056690|42203917|FG001|Overall Study|Withdrawal by Subject|6|||
19754009|NCT03056690|42203916|FG000|Overall Study|Non-compliance with Study Drug|1|||
19657403|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657404|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657405|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657406|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19754010|NCT03056690|42203917|FG001|Overall Study|Non-compliance with Study Drug|0|||
19754011|NCT03056690|42203916|FG000|Overall Study|Miscellaneous|1|||
19657407|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657408|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
19657409|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657410|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657411|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657412|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657413|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657414|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657415|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
19657416|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657417|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657418|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657419|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
19657420|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657421|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657422|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657423|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657424|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657425|NCT03893565|42106401|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19657426|NCT03893565|42106402|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
19657427|NCT03893565|42106403|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
19657428|NCT03893565|42106404|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
19657429|NCT03893565|42106405|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19657430|NCT03893565|42106406|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19657431|NCT03893565|42106407|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19657432|NCT03893565|42106408|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19754012|NCT03056690|42203917|FG001|Overall Study|Miscellaneous|2|||
19754013|NCT03191799|42203923|FG000|Overall Study|Withdrawal by Subject|4|||
19754014|NCT03191799|42203923|FG000|Overall Study|Physician Decision|2|||
19754015|NCT03191799|42203923|FG000|Overall Study|Lost to Follow-up|1|||
19754016|NCT03191799|42203923|FG000|Overall Study|Death|2|||
19754017|NCT00708916|42203927|FG000|Overall Study|Subject Noncompliance|2|||
19754018|NCT00708916|42203927|FG000|Overall Study|Adverse Event|2|||
19754019|NCT02352753|42203932|FG000|6-Month Dosing Period|Decision by sponsor|2|||
19754020|NCT02352753|42203932|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
19754021|NCT02352753|42203932|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
19754022|NCT02352753|42203932|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
19754023|NCT02352753|42203932|FG000|3-Month Dosing Period|Decision by sponsor|14|||
19754024|NCT02352753|42203932|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
19754025|NCT04532294|42203943|FG000|Overall Study|Withdrawal by Subject|0|||
19754026|NCT04532294|42203944|FG001|Overall Study|Withdrawal by Subject|0|||
19754027|NCT04532294|42203945|FG002|Overall Study|Withdrawal by Subject|1|||
19754028|NCT04532294|42203943|FG000|Overall Study|Participants Not Dosed|0|||
19754029|NCT04532294|42203944|FG001|Overall Study|Participants Not Dosed|0|||
19754030|NCT04532294|42203945|FG002|Overall Study|Participants Not Dosed|2|||
19754031|NCT03197766|42203957|FG000|Overall Study|Withdrawal by Subject|2|||
19754032|NCT03197766|42203958|FG001|Overall Study|Withdrawal by Subject|0|||
19754033|NCT03738332|42203964|FG000|Overall Study|Withdrawal by Subject|1|||
19754034|NCT03173456|42203974|FG000|Baseline|Medication dispensing system malfunction'|0|||
19754035|NCT03173456|42203975|FG001|Baseline|Medication dispensing system malfunction'|1|||
19754036|NCT03173456|42203976|FG002|Baseline|Medication dispensing system malfunction'|0|||
19754037|NCT03173456|42203977|FG003|Baseline|Medication dispensing system malfunction'|0|||
19754038|NCT03173456|42203978|FG004|Baseline|Medication dispensing system malfunction'|2|||
19754039|NCT03173456|42203974|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
19754040|NCT03173456|42203975|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
19754041|NCT03173456|42203976|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
19754042|NCT03173456|42203977|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
19754043|NCT03173456|42203978|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
19754044|NCT03197376|42204001|FG000|Primary and Booster Phase|Adverse Event|0|||
19754045|NCT03197376|42204002|FG001|Primary and Booster Phase|Adverse Event|0|||
19754046|NCT03197376|42204003|FG002|Primary and Booster Phase|Adverse Event|0|||
19754047|NCT03197376|42204004|FG003|Primary and Booster Phase|Adverse Event|1|||
19754048|NCT03197376|42204001|FG000|Primary and Booster Phase|Death|1|||
19754049|NCT03197376|42204002|FG001|Primary and Booster Phase|Death|0|||
19754050|NCT03197376|42204003|FG002|Primary and Booster Phase|Death|0|||
19754051|NCT03197376|42204004|FG003|Primary and Booster Phase|Death|2|||
19754052|NCT03197376|42204001|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
19754053|NCT03197376|42204002|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
19754054|NCT03197376|42204003|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
19657433|NCT03893565|42106409|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
19657434|NCT03893565|42106401|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
19754055|NCT03197376|42204004|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
19754056|NCT03197376|42204001|FG000|Primary and Booster Phase|Physician Decision|1|||
19754057|NCT03197376|42204002|FG001|Primary and Booster Phase|Physician Decision|0|||
19754058|NCT03197376|42204003|FG002|Primary and Booster Phase|Physician Decision|1|||
19754059|NCT03197376|42204004|FG003|Primary and Booster Phase|Physician Decision|3|||
19754060|NCT03197376|42204001|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
19754061|NCT03197376|42204002|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
19754062|NCT03197376|42204003|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
19754063|NCT03197376|42204004|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
19754064|NCT03197376|42204001|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
19754065|NCT03197376|42204002|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
19754066|NCT03197376|42204003|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
19657435|NCT03893565|42106402|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
19657436|NCT03893565|42106403|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
19657437|NCT03893565|42106404|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
19657438|NCT03893565|42106405|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
19657439|NCT03893565|42106406|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
19657440|NCT03893565|42106407|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
19657441|NCT03893565|42106408|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
19657442|NCT03893565|42106409|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
19657443|NCT03893565|42106401|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657444|NCT03893565|42106402|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657445|NCT03893565|42106403|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657446|NCT03893565|42106404|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657447|NCT03893565|42106405|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657448|NCT03893565|42106406|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657449|NCT03893565|42106407|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
19657450|NCT03893565|42106408|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657451|NCT03893565|42106409|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
19657452|NCT03893565|42106401|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657453|NCT03893565|42106402|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657454|NCT03893565|42106403|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657455|NCT03893565|42106404|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657456|NCT03893565|42106405|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657457|NCT03893565|42106406|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
19657458|NCT03893565|42106407|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
19657459|NCT03893565|42106408|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657460|NCT03893565|42106409|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
19657461|NCT03893565|42106401|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
19657462|NCT03893565|42106402|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
19657463|NCT03893565|42106403|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
19657464|NCT03893565|42106404|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
19657465|NCT03893565|42106405|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
19657466|NCT03893565|42106406|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
19657467|NCT03893565|42106407|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
19657468|NCT03893565|42106408|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
19657469|NCT03893565|42106409|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
19657470|NCT03893565|42106401|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657471|NCT03893565|42106402|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657472|NCT03893565|42106403|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657473|NCT03893565|42106404|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657474|NCT03893565|42106405|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657475|NCT03893565|42106406|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657476|NCT03893565|42106407|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19754067|NCT03197376|42204004|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
19754068|NCT03197376|42204001|FG000|Primary and Booster Phase|Not vaccine related|1|||
19657477|NCT03893565|42106408|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
19657478|NCT03893565|42106409|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
19657479|NCT03893565|42106401|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19754069|NCT03197376|42204002|FG001|Primary and Booster Phase|Not vaccine related|2|||
19754070|NCT03197376|42204003|FG002|Primary and Booster Phase|Not vaccine related|0|||
19754071|NCT03197376|42204004|FG003|Primary and Booster Phase|Not vaccine related|6|||
19754072|NCT03197376|42204001|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
19754073|NCT03197376|42204002|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
19754074|NCT03197376|42204003|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
19657480|NCT03893565|42106402|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657481|NCT03893565|42106403|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657482|NCT03893565|42106404|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657483|NCT03893565|42106405|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657484|NCT03893565|42106406|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657485|NCT03893565|42106407|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657486|NCT03893565|42106408|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
19657487|NCT03893565|42106409|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
19657488|NCT03893565|42106401|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657489|NCT03893565|42106402|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657490|NCT03893565|42106403|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657491|NCT03893565|42106404|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657492|NCT03893565|42106405|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657493|NCT03893565|42106406|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657494|NCT03893565|42106407|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657495|NCT03893565|42106408|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
19657496|NCT03893565|42106409|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
19657497|NCT03893565|42106401|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657498|NCT03893565|42106402|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657499|NCT03893565|42106403|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657500|NCT03893565|42106404|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657501|NCT03893565|42106405|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657502|NCT03893565|42106406|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657503|NCT03893565|42106407|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19754075|NCT03197376|42204004|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
19754076|NCT03197376|42204001|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
19754077|NCT03197376|42204002|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
19754078|NCT03197376|42204003|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
19754079|NCT03197376|42204004|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
19754080|NCT03197376|42204001|FG000|Immune Persistence Phase|Not vaccine related|1|||
19754081|NCT03197376|42204002|FG001|Immune Persistence Phase|Not vaccine related|0|||
19754082|NCT03197376|42204003|FG002|Immune Persistence Phase|Not vaccine related|1|||
19754083|NCT03197376|42204004|FG003|Immune Persistence Phase|Not vaccine related|1|||
19754084|NCT03600805|42204041|FG000|Overall Study|Adverse Event|2|||
19657504|NCT03893565|42106408|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
19657505|NCT03893565|42106409|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
19657506|NCT00502996|42106428|FG000|Overall Study|Lost to Follow-up|9|||
19657507|NCT00502996|42106428|FG000|Overall Study|Protocol Violation|2|||
19657508|NCT00502996|42106428|FG000|Overall Study|Treatment failure|25|||
19657509|NCT00502996|42106428|FG000|Overall Study|Withdrawal Informed Consent|6|||
19657510|NCT00502996|42106428|FG000|Overall Study|Adverse Event|2|||
19657511|NCT00715403|42106439|FG000|Overall Study|Progressive disease|0|||
19754085|NCT03600805|42204042|FG001|Overall Study|Adverse Event|1|||
19754086|NCT03600805|42204043|FG002|Overall Study|Adverse Event|1|||
19601855|NCT00766090|42050519|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601856|NCT00766090|42050520|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601857|NCT00766090|42050521|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
19601858|NCT00766090|42050522|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601859|NCT00766090|42050523|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601860|NCT00766090|42050524|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
19601861|NCT00766090|42050513|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
19601862|NCT00766090|42050514|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601863|NCT00766090|42050515|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601864|NCT00766090|42050516|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19657512|NCT00715403|42106440|FG001|Overall Study|Progressive disease|1|||
19657513|NCT00715403|42106441|FG002|Overall Study|Progressive disease|3|||
19657514|NCT00715403|42106442|FG003|Overall Study|Progressive disease|9|||
19657515|NCT00715403|42106443|FG004|Overall Study|Progressive disease|5|||
19657516|NCT00715403|42106444|FG005|Overall Study|Progressive disease|14|||
19657517|NCT00715403|42106445|FG006|Overall Study|Progressive disease|1|||
19754087|NCT03600805|42204044|FG003|Overall Study|Adverse Event|7|||
19754088|NCT03600805|42204041|FG000|Overall Study|Lack of Efficacy|2|||
19601865|NCT00766090|42050517|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19754089|NCT03600805|42204042|FG001|Overall Study|Lack of Efficacy|1|||
19754090|NCT03600805|42204043|FG002|Overall Study|Lack of Efficacy|0|||
19754091|NCT03600805|42204044|FG003|Overall Study|Lack of Efficacy|0|||
19754092|NCT03600805|42204041|FG000|Overall Study|Withdrawal by Subject|1|||
19754093|NCT03600805|42204042|FG001|Overall Study|Withdrawal by Subject|0|||
19754094|NCT03600805|42204043|FG002|Overall Study|Withdrawal by Subject|0|||
19754095|NCT03600805|42204044|FG003|Overall Study|Withdrawal by Subject|1|||
19754096|NCT03600805|42204041|FG000|Overall Study|Other unspecified|14|||
19601866|NCT00766090|42050518|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601867|NCT00766090|42050519|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601868|NCT00766090|42050520|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601869|NCT00766090|42050521|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601870|NCT00766090|42050522|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601871|NCT00766090|42050523|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601872|NCT00766090|42050524|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
19601873|NCT00766090|42050513|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
19601874|NCT00766090|42050514|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601875|NCT00766090|42050515|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601876|NCT00766090|42050516|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
19601877|NCT00766090|42050517|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601878|NCT00766090|42050518|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601879|NCT00766090|42050519|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601880|NCT00766090|42050520|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601881|NCT00766090|42050521|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601882|NCT00766090|42050522|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601883|NCT00766090|42050523|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601884|NCT00766090|42050524|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19601885|NCT00766090|42050513|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601886|NCT00766090|42050514|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601887|NCT00766090|42050515|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
19601888|NCT00766090|42050516|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601889|NCT00766090|42050517|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601890|NCT00766090|42050518|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601891|NCT00766090|42050519|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601892|NCT00766090|42050520|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601893|NCT00766090|42050521|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
19657518|NCT00715403|42106439|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
19657519|NCT00715403|42106440|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
19754097|NCT03600805|42204042|FG001|Overall Study|Other unspecified|6|||
19754098|NCT03600805|42204043|FG002|Overall Study|Other unspecified|7|||
19657520|NCT00715403|42106441|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
19657521|NCT00715403|42106442|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
19657522|NCT00715403|42106443|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
19657523|NCT00715403|42106444|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
19657524|NCT00715403|42106445|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
19657525|NCT00715403|42106439|FG000|Overall Study|Other Adverse Event than DLT|1|||
19657526|NCT00715403|42106440|FG001|Overall Study|Other Adverse Event than DLT|0|||
19657527|NCT00715403|42106441|FG002|Overall Study|Other Adverse Event than DLT|0|||
19657528|NCT00715403|42106442|FG003|Overall Study|Other Adverse Event than DLT|0|||
19657529|NCT00715403|42106443|FG004|Overall Study|Other Adverse Event than DLT|0|||
19657530|NCT00715403|42106444|FG005|Overall Study|Other Adverse Event than DLT|2|||
19657531|NCT00715403|42106445|FG006|Overall Study|Other Adverse Event than DLT|0|||
19657532|NCT00715403|42106439|FG000|Overall Study|Protocol Violation|0|||
19657533|NCT00715403|42106440|FG001|Overall Study|Protocol Violation|0|||
19657534|NCT00715403|42106441|FG002|Overall Study|Protocol Violation|0|||
19657535|NCT00715403|42106442|FG003|Overall Study|Protocol Violation|0|||
19657536|NCT00715403|42106443|FG004|Overall Study|Protocol Violation|0|||
19657537|NCT00715403|42106444|FG005|Overall Study|Protocol Violation|1|||
19657538|NCT00715403|42106445|FG006|Overall Study|Protocol Violation|0|||
19657539|NCT00715403|42106439|FG000|Overall Study|Other reason not defined above|0|||
19657540|NCT00715403|42106440|FG001|Overall Study|Other reason not defined above|0|||
19657541|NCT00715403|42106441|FG002|Overall Study|Other reason not defined above|1|||
19657542|NCT00715403|42106442|FG003|Overall Study|Other reason not defined above|0|||
19657543|NCT00715403|42106443|FG004|Overall Study|Other reason not defined above|1|||
19657544|NCT00715403|42106444|FG005|Overall Study|Other reason not defined above|1|||
19657545|NCT00715403|42106445|FG006|Overall Study|Other reason not defined above|0|||
19657546|NCT00502840|42106461|FG000|Overall Study|Adverse Event|5|||
19657547|NCT00502840|42106461|FG000|Overall Study|Additional or changed therapy|48|||
19657548|NCT00502840|42106461|FG000|Overall Study|Lack of Efficacy|11|||
19657549|NCT00502840|42106461|FG000|Overall Study|Protocol Violation|4|||
19657550|NCT00502840|42106461|FG000|Overall Study|Withdrawal by Subject|5|||
19657551|NCT00502840|42106461|FG000|Overall Study|Lost to Follow-up|6|||
19657552|NCT00502840|42106461|FG000|Overall Study|Administrative problems|1|||
19657553|NCT00502840|42106461|FG000|Overall Study|Other|20|||
19657554|NCT00515008|42106468|FG000|Overall Study|Lost to Follow-up|1|||
19657555|NCT00515008|42106469|FG001|Overall Study|Lost to Follow-up|0|||
19657556|NCT00515008|42106468|FG000|Overall Study|Declined|0|||
19657557|NCT00515008|42106469|FG001|Overall Study|Declined|3|||
19657558|NCT00515008|42106468|FG000|Overall Study|Left the Boston Area|1|||
19754099|NCT03600805|42204044|FG003|Overall Study|Other unspecified|11|||
19754100|NCT02729740|42204056|FG000|Overall Study|Early Termination|130|||
19657559|NCT00515008|42106469|FG001|Overall Study|Left the Boston Area|1|||
19657560|NCT00515008|42106468|FG000|Overall Study|Scheduling conflict|1|||
19657561|NCT00515008|42106469|FG001|Overall Study|Scheduling conflict|0|||
19657562|NCT00514540|42106478|FG000|First-Line Chemo|Withdrawal by Subject|1|||
19657563|NCT00514540|42106478|FG000|First-Line Chemo|Protocol Violation|7|||
19657564|NCT00514540|42106478|FG000|Second-Line|Physician/Patient Decision|31|||
19657565|NCT00506662|42106488|FG000|Overall Study|Adverse Event|0|||
19657566|NCT00506662|42106489|FG001|Overall Study|Adverse Event|2|||
19657567|NCT00506662|42106488|FG000|Overall Study|Lack of Efficacy|1|||
19657568|NCT00506662|42106489|FG001|Overall Study|Lack of Efficacy|0|||
19657569|NCT00506662|42106488|FG000|Overall Study|Protocol Violation|2|||
19657570|NCT00506662|42106489|FG001|Overall Study|Protocol Violation|4|||
19657571|NCT00506662|42106488|FG000|Overall Study|Trial terminated|10|||
19657572|NCT00506662|42106489|FG001|Overall Study|Trial terminated|16|||
19657573|NCT00506662|42106488|FG000|Overall Study|Not recorded|4|||
19657574|NCT00506662|42106489|FG001|Overall Study|Not recorded|6|||
19657575|NCT00713609|42106505|FG000|Overall Study|Adverse Event|2|||
19657576|NCT00713609|42106506|FG001|Overall Study|Adverse Event|0|||
19657577|NCT00713609|42106507|FG002|Overall Study|Adverse Event|2|||
19657578|NCT00713609|42106508|FG003|Overall Study|Adverse Event|2|||
19657579|NCT00713609|42106509|FG004|Overall Study|Adverse Event|3|||
19657580|NCT00713609|42106510|FG005|Overall Study|Adverse Event|1|||
19657581|NCT00713609|42106505|FG000|Overall Study|Lost to Follow-up|5|||
19657582|NCT00713609|42106506|FG001|Overall Study|Lost to Follow-up|7|||
19657583|NCT00713609|42106507|FG002|Overall Study|Lost to Follow-up|5|||
19657584|NCT00713609|42106508|FG003|Overall Study|Lost to Follow-up|5|||
19657585|NCT00713609|42106509|FG004|Overall Study|Lost to Follow-up|7|||
19657586|NCT00713609|42106510|FG005|Overall Study|Lost to Follow-up|0|||
19657587|NCT00713609|42106505|FG000|Overall Study|Lack of Efficacy|1|||
19657588|NCT00713609|42106506|FG001|Overall Study|Lack of Efficacy|3|||
19657589|NCT00713609|42106507|FG002|Overall Study|Lack of Efficacy|0|||
19657590|NCT00713609|42106508|FG003|Overall Study|Lack of Efficacy|0|||
19657591|NCT00713609|42106509|FG004|Overall Study|Lack of Efficacy|1|||
19657592|NCT00713609|42106510|FG005|Overall Study|Lack of Efficacy|0|||
19754101|NCT02729740|42204056|FG000|Overall Study|Other|1|||
19657593|NCT00713609|42106505|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
19754102|NCT02297438|42204066|FG000|Overall Study|Death|79|||
19754103|NCT02297438|42204067|FG001|Overall Study|Death|86|||
19754104|NCT02297438|42204066|FG000|Overall Study|Lost to Follow-up|9|||
19754105|NCT02297438|42204067|FG001|Overall Study|Lost to Follow-up|7|||
19754106|NCT02297438|42204066|FG000|Overall Study|Withdrawal by Subject|7|||
19754107|NCT02297438|42204067|FG001|Overall Study|Withdrawal by Subject|0|||
19754108|NCT02297438|42204066|FG000|Overall Study|Other|9|||
19754109|NCT02297438|42204067|FG001|Overall Study|Other|5|||
19754110|NCT02297438|42204066|FG000|Overall Study|Ongoing|65|||
19754111|NCT02297438|42204067|FG001|Overall Study|Ongoing|73|||
19754112|NCT03196284|42204075|FG000|Main Part|Withdrawal by Subject|0|||
19754113|NCT03196284|42204076|FG001|Main Part|Withdrawal by Subject|1|||
19754114|NCT03196284|42204077|FG002|Main Part|Withdrawal by Subject|0|||
19754115|NCT03196284|42204075|FG000|Extension Part|Lack of Efficacy|0|||
19754116|NCT03196284|42204076|FG001|Extension Part|Lack of Efficacy|0|||
19754117|NCT03196284|42204077|FG002|Extension Part|Lack of Efficacy|1|||
19754118|NCT03196284|42204075|FG000|Extension Part|Withdrawal by Subject|0|||
19754119|NCT03196284|42204076|FG001|Extension Part|Withdrawal by Subject|0|||
19754120|NCT03196284|42204077|FG002|Extension Part|Withdrawal by Subject|1|||
19754121|NCT03196284|42204075|FG000|Extension Part|Physician Decision|0|||
19754122|NCT03196284|42204076|FG001|Extension Part|Physician Decision|0|||
19754123|NCT03196284|42204077|FG002|Extension Part|Physician Decision|1|||
19754124|NCT03730961|42204099|FG000|Overall Study|Adverse Event|0|||
19754125|NCT03730961|42204100|FG001|Overall Study|Adverse Event|1|||
19754126|NCT01078454|42204108|FG000|Overall Study|Adverse Event|1|||
19754127|NCT01078454|42204109|FG001|Overall Study|Adverse Event|1|||
19754128|NCT01078454|42204108|FG000|Overall Study|Death|0|||
19754129|NCT01078454|42204109|FG001|Overall Study|Death|1|||
19754130|NCT03345004|42204126|FG000|Overall Study|Physician Decision|1|||
19754131|NCT03345004|42204127|FG001|Overall Study|Physician Decision|0|||
19754132|NCT03345004|42204126|FG000|Overall Study|Withdrawal by Subject|0|||
19754133|NCT03345004|42204127|FG001|Overall Study|Withdrawal by Subject|1|||
19754134|NCT03552757|42204138|FG000|Overall Study|Withdrawal by Subject|10|||
19754135|NCT03552757|42204139|FG001|Overall Study|Withdrawal by Subject|5|||
19754136|NCT03552757|42204140|FG002|Overall Study|Withdrawal by Subject|12|||
19754137|NCT03552757|42204138|FG000|Overall Study|Lost to Follow-up|2|||
19754138|NCT03552757|42204139|FG001|Overall Study|Lost to Follow-up|7|||
19754139|NCT03552757|42204140|FG002|Overall Study|Lost to Follow-up|7|||
19754140|NCT03552757|42204138|FG000|Overall Study|Death|1|||
19754141|NCT03552757|42204139|FG001|Overall Study|Death|1|||
19754142|NCT03552757|42204140|FG002|Overall Study|Death|1|||
19754143|NCT03730103|42204153|FG000|Overall Study|Did not meet inclusion criteria|0|||
19754144|NCT03730103|42204154|FG001|Overall Study|Did not meet inclusion criteria|5|||
19799380|NCT02873221|42257356|FG001|Safety Follow-up Period|Protocol Violation|0|||
19799381|NCT02873221|42257357|FG002|Safety Follow-up Period|Protocol Violation|1|||
19799382|NCT02873221|42257355|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
19799383|NCT02873221|42257356|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
19799384|NCT02873221|42257357|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
19799385|NCT02873221|42257355|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
19799386|NCT02873221|42257356|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
19799387|NCT02873221|42257357|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
19799388|NCT02968979|42257365|FG000|Overall Study|Protocol Violation|7|||
19799389|NCT02968979|42257365|FG000|Overall Study|Withdrawal by Subject|1|||
19799390|NCT02966015|42257417|FG000|Inclusion Visit|did not answer questionnaire|8|||
19799391|NCT02966015|42257418|FG001|Inclusion Visit|did not answer questionnaire|3|||
19799392|NCT02968433|42257424|FG000|Overall Study|Withdrawal by Subject|1|||
19799393|NCT02872285|42257436|FG000|Overall Study|Withdrawal by Subject|2|||
19799394|NCT02872285|42257437|FG001|Overall Study|Withdrawal by Subject|0|||
19799395|NCT02872285|42257436|FG000|Overall Study|Lost to Follow-up|2|||
19799396|NCT02872285|42257437|FG001|Overall Study|Lost to Follow-up|2|||
19799397|NCT02872285|42257436|FG000|Overall Study|Discontinued due to back surgery|1|||
19799398|NCT02872285|42257437|FG001|Overall Study|Discontinued due to back surgery|0|||
19799399|NCT02871739|42257447|FG000|Overall Study|Lost to Follow-up|3|||
19799400|NCT02871739|42257448|FG001|Overall Study|Lost to Follow-up|2|||
19799401|NCT02871739|42257449|FG002|Overall Study|Lost to Follow-up|0|||
19799402|NCT02871739|42257450|FG003|Overall Study|Lost to Follow-up|2|||
19799403|NCT02896361|42257460|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
19799404|NCT02896361|42257461|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
19799405|NCT02896361|42257462|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
19799406|NCT02896361|42257460|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
19799407|NCT02896361|42257461|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
19799408|NCT02896361|42257462|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
19799409|NCT02962739|42257485|FG000|Overall Study|Withdrawal by Subject|0|||
19799410|NCT02962739|42257486|FG001|Overall Study|Withdrawal by Subject|1|||
19799411|NCT02962739|42257487|FG002|Overall Study|Withdrawal by Subject|0|||
19799412|NCT02962739|42257488|FG003|Overall Study|Withdrawal by Subject|0|||
19754145|NCT03727841|42204162|FG000|Overall Study|Physician Decision|3|||
19657594|NCT00713609|42106506|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
19657595|NCT00713609|42106507|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
19657596|NCT00713609|42106508|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
19657597|NCT00713609|42106509|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
19657598|NCT00713609|42106510|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
19657599|NCT00713609|42106505|FG000|Overall Study|Withdrawal by Subject|6|||
19657600|NCT00713609|42106506|FG001|Overall Study|Withdrawal by Subject|1|||
19657601|NCT00713609|42106507|FG002|Overall Study|Withdrawal by Subject|5|||
19657602|NCT00713609|42106508|FG003|Overall Study|Withdrawal by Subject|1|||
19657603|NCT00713609|42106509|FG004|Overall Study|Withdrawal by Subject|5|||
19657604|NCT00713609|42106510|FG005|Overall Study|Withdrawal by Subject|7|||
19657605|NCT00713609|42106505|FG000|Overall Study|Protocol Violation|6|||
19657606|NCT00713609|42106506|FG001|Overall Study|Protocol Violation|3|||
19657607|NCT00713609|42106507|FG002|Overall Study|Protocol Violation|1|||
19657608|NCT00713609|42106508|FG003|Overall Study|Protocol Violation|1|||
19657609|NCT00713609|42106509|FG004|Overall Study|Protocol Violation|2|||
19657610|NCT00713609|42106510|FG005|Overall Study|Protocol Violation|0|||
19657611|NCT00513682|42106524|FG000|Washout Phase|Adverse Event|2|||
19657612|NCT00493012|42106533|FG000|Overall Study|Lost to Follow-up|18|||
19657613|NCT00493012|42106534|FG001|Overall Study|Lost to Follow-up|17|||
19657614|NCT05144477|42106542|FG000|Overall Study|Withdrawal by Subject|1|||
19657615|NCT05144477|42106543|FG001|Overall Study|Withdrawal by Subject|1|||
19657616|NCT00617708|42106559|FG000|Overall Study|Adverse Event|0|||
19657617|NCT00617708|42106560|FG001|Overall Study|Adverse Event|6|||
19657618|NCT00617708|42106561|FG002|Overall Study|Adverse Event|9|||
19657619|NCT00617708|42106559|FG000|Overall Study|Withdrawal by Subject|1|||
19657620|NCT00617708|42106560|FG001|Overall Study|Withdrawal by Subject|1|||
19657621|NCT00617708|42106561|FG002|Overall Study|Withdrawal by Subject|7|||
19657622|NCT00617708|42106559|FG000|Overall Study|Death|0|||
19657623|NCT00617708|42106560|FG001|Overall Study|Death|6|||
19657624|NCT00617708|42106561|FG002|Overall Study|Death|5|||
19657625|NCT00617708|42106559|FG000|Overall Study|Progression/Relapse|7|||
19657626|NCT00617708|42106560|FG001|Overall Study|Progression/Relapse|40|||
19657627|NCT00617708|42106561|FG002|Overall Study|Progression/Relapse|36|||
19657628|NCT00617708|42106559|FG000|Overall Study|Not protocol specified|1|||
19657629|NCT00617708|42106560|FG001|Overall Study|Not protocol specified|4|||
19657630|NCT00617708|42106561|FG002|Overall Study|Not protocol specified|2|||
19657631|NCT00617708|42106559|FG000|Overall Study|Not eligible|1|||
19657632|NCT00617708|42106560|FG001|Overall Study|Not eligible|3|||
19657633|NCT00617708|42106561|FG002|Overall Study|Not eligible|5|||
19657634|NCT03894969|42106576|FG000|Overall Study|Adverse Event|0|||
19657635|NCT03894969|42106577|FG001|Overall Study|Adverse Event|2|||
19657636|NCT03894969|42106578|FG002|Overall Study|Adverse Event|0|||
19657637|NCT03894969|42106579|FG003|Overall Study|Adverse Event|1|||
19657638|NCT03894969|42106580|FG004|Overall Study|Adverse Event|2|||
19657639|NCT03894969|42106576|FG000|Overall Study|Lost to Follow-up|3|||
19657640|NCT03894969|42106577|FG001|Overall Study|Lost to Follow-up|1|||
19657641|NCT03894969|42106578|FG002|Overall Study|Lost to Follow-up|1|||
19657642|NCT03894969|42106579|FG003|Overall Study|Lost to Follow-up|0|||
19657643|NCT03894969|42106580|FG004|Overall Study|Lost to Follow-up|0|||
19657644|NCT03894969|42106576|FG000|Overall Study|Withdrawal by Subject|2|||
19657645|NCT03894969|42106577|FG001|Overall Study|Withdrawal by Subject|1|||
19657646|NCT03894969|42106578|FG002|Overall Study|Withdrawal by Subject|3|||
19657647|NCT03894969|42106579|FG003|Overall Study|Withdrawal by Subject|4|||
19657648|NCT03894969|42106580|FG004|Overall Study|Withdrawal by Subject|8|||
19657649|NCT03894969|42106576|FG000|Overall Study|Other|0|||
19657650|NCT03894969|42106577|FG001|Overall Study|Other|0|||
19657651|NCT03894969|42106578|FG002|Overall Study|Other|0|||
19657652|NCT03894969|42106579|FG003|Overall Study|Other|0|||
19657653|NCT03894969|42106580|FG004|Overall Study|Other|3|||
19657654|NCT03894969|42106576|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
19657655|NCT03894969|42106577|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
19657656|NCT03894969|42106578|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
19657657|NCT03894969|42106579|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
19657658|NCT03894969|42106580|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
19657659|NCT03894969|42106576|FG000|Overall Study|Solicited Adverse Event|0|||
19657660|NCT03894969|42106577|FG001|Overall Study|Solicited Adverse Event|1|||
19388697|NCT01661595|41632214|FG002|Phase 1: Week 0-4|Adverse Event|0|||
19657661|NCT03894969|42106578|FG002|Overall Study|Solicited Adverse Event|0|||
19657662|NCT03894969|42106579|FG003|Overall Study|Solicited Adverse Event|0|||
19657663|NCT03894969|42106580|FG004|Overall Study|Solicited Adverse Event|0|||
19657664|NCT03894813|42106596|FG000|Overall Study|Adverse Event|1|||
19657665|NCT03894813|42106597|FG001|Overall Study|Adverse Event|1|||
19657666|NCT03894813|42106596|FG000|Overall Study|Lack of Efficacy|3|||
19657667|NCT03894813|42106597|FG001|Overall Study|Lack of Efficacy|3|||
19657668|NCT03894813|42106596|FG000|Overall Study|Lost to Follow-up|1|||
19657669|NCT03894813|42106597|FG001|Overall Study|Lost to Follow-up|0|||
19657670|NCT03894813|42106596|FG000|Overall Study|Pregnancy|2|||
19657671|NCT03894813|42106597|FG001|Overall Study|Pregnancy|1|||
19657672|NCT03894813|42106596|FG000|Overall Study|Protocol Violation|3|||
19657673|NCT03894813|42106597|FG001|Overall Study|Protocol Violation|7|||
19657674|NCT03894813|42106596|FG000|Overall Study|Withdrawal by Subject|1|||
19657675|NCT03894813|42106597|FG001|Overall Study|Withdrawal by Subject|3|||
19657676|NCT03894813|42106596|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
19657677|NCT03894813|42106597|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
19657678|NCT00615992|42106603|FG000|Overall Study|Protocol Violation|67|||
19657679|NCT03892707|42106609|FG000|Overall Study|Screen failure|6|||
19657680|NCT03892707|42106610|FG001|Overall Study|Screen failure|0|||
19657681|NCT03892707|42106609|FG000|Overall Study|Pain resolution|0|||
19657682|NCT03892707|42106610|FG001|Overall Study|Pain resolution|4|||
19657683|NCT03892707|42106609|FG000|Overall Study|Withdrawal by Subject|0|||
19657684|NCT03892707|42106610|FG001|Overall Study|Withdrawal by Subject|1|||
19657685|NCT03892707|42106609|FG000|Overall Study|Other (long business trip)|0|||
19657686|NCT03892707|42106610|FG001|Overall Study|Other (long business trip)|1|||
19657687|NCT00615914|42106617|FG000|Overall Study|Adverse Event|274|||
19657688|NCT00615914|42106617|FG000|Overall Study|Death|20|||
19657689|NCT00615914|42106617|FG000|Overall Study|Lack of Efficacy|59|||
19657690|NCT00615914|42106617|FG000|Overall Study|Lost to Follow-up|187|||
19754146|NCT03727841|42204163|FG001|Overall Study|Physician Decision|1|||
19754147|NCT03552523|42204169|FG000|Overall Study|Withdrawal by Subject|1|||
19657691|NCT00615914|42106617|FG000|Overall Study|Withdrawal by Subject|16|||
19657692|NCT00615914|42106617|FG000|Overall Study|Physician Decision|4|||
19657693|NCT00615914|42106617|FG000|Overall Study|No data was collected.|65|||
19657694|NCT00615914|42106617|FG000|Overall Study|No treatment|2|||
19657695|NCT00615914|42106617|FG000|Overall Study|Irregularly enrolled patients|10|||
19657696|NCT00513604|42106627|FG000|Overall Study|Not treated|2|||
19657697|NCT00513604|42106628|FG001|Overall Study|Not treated|0|||
19657698|NCT00513604|42106629|FG002|Overall Study|Not treated|1|||
19657699|NCT00513604|42106630|FG003|Overall Study|Not treated|0|||
19657700|NCT00513604|42106631|FG004|Overall Study|Not treated|0|||
19657701|NCT00513604|42106627|FG000|Overall Study|Death during treatment|0|||
19657702|NCT00513604|42106628|FG001|Overall Study|Death during treatment|3|||
19657703|NCT00513604|42106629|FG002|Overall Study|Death during treatment|2|||
19657704|NCT00513604|42106630|FG003|Overall Study|Death during treatment|0|||
19657705|NCT00513604|42106631|FG004|Overall Study|Death during treatment|0|||
19657706|NCT00534105|42106645|FG000|Overall Study|Lost to Follow-up|23|||
19657707|NCT00534105|42106646|FG001|Overall Study|Lost to Follow-up|39|||
19657708|NCT00573248|42106661|FG000|Overall Study|scheduling conflicts|15|||
19657709|NCT00573248|42106662|FG001|Overall Study|scheduling conflicts|11|||
19754148|NCT03552523|42204170|FG001|Overall Study|Withdrawal by Subject|1|||
19657710|NCT00532935|42106670|FG000|Overall Study|Adverse Event|11|||
19657711|NCT00532935|42106671|FG001|Overall Study|Adverse Event|12|||
19657712|NCT00532935|42106670|FG000|Overall Study|Lack of Efficacy|0|||
19657713|NCT00532935|42106671|FG001|Overall Study|Lack of Efficacy|3|||
19657714|NCT00532935|42106670|FG000|Overall Study|Lost to Follow-up|10|||
19657715|NCT00532935|42106671|FG001|Overall Study|Lost to Follow-up|6|||
19657716|NCT00532935|42106670|FG000|Overall Study|Physician Decision|4|||
19657717|NCT00532935|42106671|FG001|Overall Study|Physician Decision|5|||
19657718|NCT00532935|42106670|FG000|Overall Study|Pregnancy|1|||
19657719|NCT00532935|42106671|FG001|Overall Study|Pregnancy|0|||
19657720|NCT00532935|42106670|FG000|Overall Study|Protocol Violation|4|||
19657721|NCT00532935|42106671|FG001|Overall Study|Protocol Violation|2|||
19657722|NCT00532935|42106670|FG000|Overall Study|Withdrawal by Subject|10|||
19657723|NCT00532935|42106671|FG001|Overall Study|Withdrawal by Subject|9|||
19657724|NCT00532935|42106670|FG000|Overall Study|Protocol Specific Criteria|11|||
19754149|NCT03186378|42204178|FG000|Overall Study|Lost to Follow-up|1|||
19754150|NCT03186378|42204179|FG001|Overall Study|Lost to Follow-up|0|||
19754151|NCT00687596|42204187|FG000|Overall Study|Adverse Event (AE)|10|||
19754152|NCT00687596|42204188|FG001|Overall Study|Adverse Event (AE)|3|||
19754153|NCT00687596|42204187|FG000|Overall Study|Radiological Disease Progression|6|||
19754154|NCT00687596|42204188|FG001|Overall Study|Radiological Disease Progression|2|||
19754155|NCT00687596|42204187|FG000|Overall Study|Clinical Disease Progression|1|||
19754156|NCT00687596|42204188|FG001|Overall Study|Clinical Disease Progression|3|||
19657725|NCT00532935|42106671|FG001|Overall Study|Protocol Specific Criteria|15|||
19657726|NCT03016312|42106679|FG000|Overall Study|Death|194|||
19657727|NCT03016312|42106680|FG001|Overall Study|Death|164|||
19657728|NCT03016312|42106679|FG000|Overall Study|Lost to Follow-up|11|||
19657729|NCT03016312|42106680|FG001|Overall Study|Lost to Follow-up|12|||
19657730|NCT03016312|42106679|FG000|Overall Study|Started new therapy, loss of contact|2|||
19657731|NCT03016312|42106680|FG001|Overall Study|Started new therapy, loss of contact|1|||
19657732|NCT03016312|42106679|FG000|Overall Study|Physician Decision|0|||
19657733|NCT03016312|42106680|FG001|Overall Study|Physician Decision|2|||
19657734|NCT03016312|42106679|FG000|Overall Study|Withdrawal by Subject|34|||
19657735|NCT03016312|42106680|FG001|Overall Study|Withdrawal by Subject|39|||
19657736|NCT00512902|42106686|FG000|Overall Study|Adverse Event|7|||
19657737|NCT00512902|42106686|FG000|Overall Study|Lost to Follow-up|1|||
19657738|NCT00492232|42106692|FG000|Placebo Run-in|Adverse Event|0|||
19657739|NCT00492232|42106693|FG001|Placebo Run-in|Adverse Event|2|||
19657740|NCT00492232|42106692|FG000|Placebo Run-in|Protocol Violation|0|||
19657741|NCT00492232|42106693|FG001|Placebo Run-in|Protocol Violation|3|||
19657742|NCT00492232|42106692|FG000|Placebo Run-in|Lost to Follow-up|0|||
19657743|NCT00492232|42106693|FG001|Placebo Run-in|Lost to Follow-up|3|||
19657744|NCT00492232|42106692|FG000|Placebo Run-in|Withdrawal by Subject|0|||
19657745|NCT00492232|42106693|FG001|Placebo Run-in|Withdrawal by Subject|8|||
19657746|NCT00492232|42106692|FG000|Placebo Run-in|Pregnancy|0|||
19657747|NCT00492232|42106693|FG001|Placebo Run-in|Pregnancy|1|||
19657748|NCT00492232|42106692|FG000|Placebo Run-in|Entrance criteria not met|0|||
19657749|NCT00492232|42106693|FG001|Placebo Run-in|Entrance criteria not met|45|||
19657750|NCT00492232|42106692|FG000|Placebo Run-in|Other|0|||
19657751|NCT00492232|42106693|FG001|Placebo Run-in|Other|6|||
19657752|NCT00492232|42106692|FG000|Placebo Run-in|Missing|0|||
19657753|NCT00492232|42106693|FG001|Placebo Run-in|Missing|2|||
19657754|NCT00492232|42106692|FG000|Double-Blind Treatment|Adverse Event|1|||
19657755|NCT00492232|42106693|FG001|Double-Blind Treatment|Adverse Event|2|||
19657756|NCT00492232|42106692|FG000|Double-Blind Treatment|Protocol Violation|3|||
19657757|NCT00492232|42106693|FG001|Double-Blind Treatment|Protocol Violation|7|||
19657758|NCT00492232|42106692|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
19657759|NCT00492232|42106693|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
19657760|NCT00492232|42106692|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
19657761|NCT00492232|42106693|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
19657762|NCT00492232|42106692|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
19657763|NCT00492232|42106693|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
19657764|NCT00492232|42106692|FG000|Double-Blind Treatment|Other|6|||
19657765|NCT00492232|42106693|FG001|Double-Blind Treatment|Other|5|||
19657766|NCT00492232|42106692|FG000|Double-Blind Treatment|Randomized not treated|1|||
19657767|NCT00492232|42106693|FG001|Double-Blind Treatment|Randomized not treated|0|||
19657768|NCT00492232|42106692|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
19657769|NCT00492232|42106693|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
19657770|NCT00491764|42106705|FG000|Overall Study|Adverse Event|1|||
19657771|NCT00491764|42106706|FG001|Overall Study|Adverse Event|2|||
19657772|NCT00491764|42106707|FG002|Overall Study|Adverse Event|4|||
19754157|NCT00687596|42204187|FG000|Overall Study|Investigator Discretion|3|||
19754158|NCT00687596|42204188|FG001|Overall Study|Investigator Discretion|1|||
19754159|NCT00687596|42204187|FG000|Overall Study|Sponsor Terminated Study|6|||
19754160|NCT00687596|42204188|FG001|Overall Study|Sponsor Terminated Study|17|||
19754161|NCT02892409|42204196|FG000|Overall Study|Adverse Event|1|||
19754162|NCT02892409|42204197|FG001|Overall Study|Adverse Event|0|||
19754163|NCT02892409|42204196|FG000|Overall Study|Withdrawal by Subject|2|||
19754164|NCT02892409|42204197|FG001|Overall Study|Withdrawal by Subject|1|||
19754165|NCT03219216|42204205|FG000|Overall Study|Lost to Follow-up|0|||
19754166|NCT03219216|42204206|FG001|Overall Study|Lost to Follow-up|1|||
19754167|NCT03195660|42204220|FG000|Overall Study|The study was terminated|2|||
19657773|NCT00491764|42106708|FG003|Overall Study|Adverse Event|4|||
19657774|NCT00491764|42106709|FG004|Overall Study|Adverse Event|0|||
19657775|NCT00491764|42106710|FG005|Overall Study|Adverse Event|1|||
19657776|NCT00491764|42106705|FG000|Overall Study|Lost to Follow-up|0|||
19657777|NCT00491764|42106706|FG001|Overall Study|Lost to Follow-up|1|||
19657778|NCT00491764|42106707|FG002|Overall Study|Lost to Follow-up|0|||
19657779|NCT00491764|42106708|FG003|Overall Study|Lost to Follow-up|1|||
19657780|NCT00491764|42106709|FG004|Overall Study|Lost to Follow-up|0|||
19754168|NCT03194490|42204226|FG000|Overall Study|Lost to Follow-up|1|||
19754169|NCT03194490|42204227|FG001|Overall Study|Lost to Follow-up|3|||
19657781|NCT00491764|42106710|FG005|Overall Study|Lost to Follow-up|3|||
19657782|NCT00491764|42106705|FG000|Overall Study|Withdrawal by Subject|2|||
19657783|NCT00491764|42106706|FG001|Overall Study|Withdrawal by Subject|3|||
19657784|NCT00491764|42106707|FG002|Overall Study|Withdrawal by Subject|1|||
19657785|NCT00491764|42106708|FG003|Overall Study|Withdrawal by Subject|2|||
19657786|NCT00491764|42106709|FG004|Overall Study|Withdrawal by Subject|2|||
19657787|NCT00491764|42106710|FG005|Overall Study|Withdrawal by Subject|4|||
19657788|NCT00491764|42106705|FG000|Overall Study|Non Compliance with the Protocol|1|||
19657789|NCT00491764|42106706|FG001|Overall Study|Non Compliance with the Protocol|0|||
19657790|NCT00491764|42106707|FG002|Overall Study|Non Compliance with the Protocol|0|||
19657791|NCT00491764|42106708|FG003|Overall Study|Non Compliance with the Protocol|0|||
19657792|NCT00491764|42106709|FG004|Overall Study|Non Compliance with the Protocol|0|||
19657793|NCT00491764|42106710|FG005|Overall Study|Non Compliance with the Protocol|0|||
19657794|NCT00491764|42106705|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
19657795|NCT00491764|42106706|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
19657796|NCT00491764|42106707|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
19657797|NCT00491764|42106708|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
19657798|NCT00491764|42106709|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
19657799|NCT00491764|42106710|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
19657800|NCT00491764|42106705|FG000|Overall Study|Administrative|1|||
19657801|NCT00491764|42106706|FG001|Overall Study|Administrative|0|||
19657802|NCT00491764|42106707|FG002|Overall Study|Administrative|2|||
19657803|NCT00491764|42106708|FG003|Overall Study|Administrative|1|||
19657804|NCT00491764|42106709|FG004|Overall Study|Administrative|0|||
19657805|NCT00491764|42106710|FG005|Overall Study|Administrative|0|||
19657806|NCT00491608|42106724|FG000|Overall Study|Death|2|||
19657807|NCT00491608|42106724|FG000|Overall Study|Withdrawal by Subject|1|||
19657808|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
19754170|NCT03194490|42204226|FG000|Overall Study|participant developed specific neck pain|1|||
19754171|NCT03194490|42204227|FG001|Overall Study|participant developed specific neck pain|0|||
19754172|NCT03217968|42204234|FG000|Overall Study|Withdrawal by Subject|4|||
19754173|NCT03217968|42204234|FG000|Overall Study|Lost to Follow-up|1|||
19754174|NCT03217968|42204234|FG000|Overall Study|Protocol Violation|6|||
19754175|NCT03192306|42204240|FG000|Overall Study|Did not treat cold sore during study|149|||
19754176|NCT03192306|42204241|FG001|Overall Study|Did not treat cold sore during study|143|||
19754177|NCT03192306|42204240|FG000|Overall Study|Withdrawal by Subject|1|||
19754178|NCT03192306|42204241|FG001|Overall Study|Withdrawal by Subject|1|||
19754179|NCT03192306|42204240|FG000|Overall Study|Lost to Follow-up|1|||
19754180|NCT03192306|42204241|FG001|Overall Study|Lost to Follow-up|0|||
19754181|NCT03192306|42204240|FG000|Overall Study|Protocol Violation|1|||
19754182|NCT03192306|42204241|FG001|Overall Study|Protocol Violation|1|||
19754183|NCT03216954|42204264|FG000|Overall Study|Adverse Event|0|||
19754184|NCT03216954|42204265|FG001|Overall Study|Adverse Event|0|||
19754185|NCT03216954|42204266|FG002|Overall Study|Adverse Event|1|||
19657809|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
19657810|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
19657811|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
19657812|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
19657813|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
19657814|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
19657815|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
19657816|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
19657817|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
19657818|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
19657819|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
19657820|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
19657821|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
19657822|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
19657823|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
19657824|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
19657825|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
19657826|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
19657827|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
19657828|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
19657829|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
19657830|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
19657831|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
19657832|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
19754186|NCT03216954|42204267|FG003|Overall Study|Adverse Event|0|||
19754187|NCT03216954|42204268|FG004|Overall Study|Adverse Event|1|||
19754188|NCT03216954|42204264|FG000|Overall Study|Withdrawal by Subject|2|||
19657833|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
19754189|NCT03216954|42204265|FG001|Overall Study|Withdrawal by Subject|0|||
19754190|NCT03216954|42204266|FG002|Overall Study|Withdrawal by Subject|0|||
19754191|NCT03216954|42204267|FG003|Overall Study|Withdrawal by Subject|0|||
19754192|NCT03216954|42204268|FG004|Overall Study|Withdrawal by Subject|0|||
19754193|NCT03216954|42204264|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
19754194|NCT03216954|42204265|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
19754195|NCT03216954|42204266|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
19754196|NCT03216954|42204267|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
19754197|NCT03216954|42204268|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
19754198|NCT03599089|42204280|FG000|Overall Study|Lost to Follow-up|1|||
19754199|NCT03599089|42204281|FG001|Overall Study|Lost to Follow-up|0|||
19754200|NCT03599089|42204282|FG002|Overall Study|Lost to Follow-up|0|||
19754201|NCT03599089|42204283|FG003|Overall Study|Lost to Follow-up|0|||
19754202|NCT03599089|42204280|FG000|Overall Study|Withdrawal by Subject|2|||
19754203|NCT03599089|42204281|FG001|Overall Study|Withdrawal by Subject|1|||
19754204|NCT03599089|42204282|FG002|Overall Study|Withdrawal by Subject|0|||
19754205|NCT03599089|42204283|FG003|Overall Study|Withdrawal by Subject|0|||
19754206|NCT03599089|42204280|FG000|Overall Study|Lack of Efficacy|0|||
19754207|NCT03599089|42204281|FG001|Overall Study|Lack of Efficacy|0|||
19754208|NCT03599089|42204282|FG002|Overall Study|Lack of Efficacy|1|||
19754209|NCT03599089|42204283|FG003|Overall Study|Lack of Efficacy|2|||
19754210|NCT03192150|42204295|FG000|Overall Study|Adverse Event|14|||
19754211|NCT03192150|42204296|FG001|Overall Study|Adverse Event|12|||
19754212|NCT03192150|42204295|FG000|Overall Study|Lack of Efficacy|23|||
19657834|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
19657835|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
19657836|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
19657837|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
19657838|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Other|10|||
19657839|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Other|7|||
19657840|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Other|8|||
19657841|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Other|8|||
19657842|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Other|0|||
19657843|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
19657844|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
19657845|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
19657846|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
19657847|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
19657848|NCT00615836|42106732|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
19657849|NCT00615836|42106733|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
19657850|NCT00615836|42106734|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
19657851|NCT00615836|42106735|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
19657852|NCT00615836|42106736|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
19657853|NCT00491530|42106755|FG000|Overall Study|Adverse Event|6|||
19657854|NCT00491530|42106756|FG001|Overall Study|Adverse Event|1|||
19657855|NCT00491530|42106757|FG002|Overall Study|Adverse Event|2|||
19657856|NCT00491530|42106755|FG000|Overall Study|Withdrawal by Subject|3|||
19657857|NCT00491530|42106756|FG001|Overall Study|Withdrawal by Subject|0|||
19657858|NCT00491530|42106757|FG002|Overall Study|Withdrawal by Subject|0|||
19657859|NCT00491530|42106755|FG000|Overall Study|Lost to Follow-up|3|||
19657860|NCT00491530|42106756|FG001|Overall Study|Lost to Follow-up|2|||
19657861|NCT00491530|42106757|FG002|Overall Study|Lost to Follow-up|2|||
19657862|NCT00491530|42106755|FG000|Overall Study|Lack of Efficacy|0|||
19657863|NCT00491530|42106756|FG001|Overall Study|Lack of Efficacy|1|||
19657864|NCT00491530|42106757|FG002|Overall Study|Lack of Efficacy|0|||
19657865|NCT00491530|42106755|FG000|Overall Study|Investigator Discretion|0|||
19657866|NCT00491530|42106756|FG001|Overall Study|Investigator Discretion|1|||
19657867|NCT00491530|42106757|FG002|Overall Study|Investigator Discretion|0|||
19657868|NCT00491530|42106755|FG000|Overall Study|Patient Request|0|||
19657869|NCT00491530|42106756|FG001|Overall Study|Patient Request|1|||
19657870|NCT00491530|42106757|FG002|Overall Study|Patient Request|0|||
19657871|NCT00491530|42106755|FG000|Overall Study|Use of Prohibited Medication|0|||
19657872|NCT00491530|42106756|FG001|Overall Study|Use of Prohibited Medication|0|||
19657873|NCT00491530|42106757|FG002|Overall Study|Use of Prohibited Medication|1|||
19657874|NCT00617240|42106767|FG000|Overall Study|Lack of Efficacy|1|||
19657875|NCT00617240|42106768|FG001|Overall Study|Lack of Efficacy|0|||
19657876|NCT00615290|42106774|FG000|Overall Study|Adverse Event|2|||
19657877|NCT00615290|42106774|FG000|Overall Study|Lost to Follow-up|3|||
19657878|NCT00615290|42106774|FG000|Overall Study|Withdrawal by Subject|1|||
19754213|NCT03192150|42204296|FG001|Overall Study|Lack of Efficacy|30|||
19754214|NCT03192150|42204295|FG000|Overall Study|Lost to Follow-up|1|||
19754215|NCT03192150|42204296|FG001|Overall Study|Lost to Follow-up|1|||
19657879|NCT00615290|42106774|FG000|Overall Study|Other|2|||
19657880|NCT00501046|42106780|FG000|Overall Study|Adverse Event|21|||
19657881|NCT00501046|42106781|FG001|Overall Study|Adverse Event|25|||
19657882|NCT00501046|42106780|FG000|Overall Study|Death|23|||
19657883|NCT00501046|42106781|FG001|Overall Study|Death|30|||
19657884|NCT00501046|42106780|FG000|Overall Study|Lost to Follow-up|14|||
19657885|NCT00501046|42106781|FG001|Overall Study|Lost to Follow-up|13|||
19657886|NCT00501046|42106780|FG000|Overall Study|Physician Decision|7|||
19657887|NCT00501046|42106781|FG001|Overall Study|Physician Decision|2|||
19657888|NCT00501046|42106780|FG000|Overall Study|Pregnancy|0|||
19657889|NCT00501046|42106781|FG001|Overall Study|Pregnancy|3|||
19657890|NCT00501046|42106780|FG000|Overall Study|Protocol Violation|2|||
19657891|NCT00501046|42106781|FG001|Overall Study|Protocol Violation|1|||
19657892|NCT00501046|42106780|FG000|Overall Study|Withdrawal by Subject|84|||
19657893|NCT00501046|42106781|FG001|Overall Study|Withdrawal by Subject|83|||
19657894|NCT00501046|42106780|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
19657895|NCT00501046|42106781|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
19657896|NCT00533949|42106791|FG000|Overall Study|Protocol Violation|12|||
19657897|NCT00533949|42106792|FG001|Overall Study|Protocol Violation|12|||
19657898|NCT00533949|42106793|FG002|Overall Study|Protocol Violation|9|||
19657899|NCT00533949|42106794|FG003|Overall Study|Protocol Violation|9|||
19657900|NCT00533949|42106791|FG000|Overall Study|Withdrawal by Subject|3|||
19657901|NCT00533949|42106792|FG001|Overall Study|Withdrawal by Subject|2|||
19657902|NCT00533949|42106793|FG002|Overall Study|Withdrawal by Subject|1|||
19657903|NCT00533949|42106794|FG003|Overall Study|Withdrawal by Subject|1|||
19657904|NCT00485134|42106820|FG000|Overall Study|Lost to Follow-up|1|||
19657905|NCT00485134|42106821|FG001|Overall Study|Lost to Follow-up|0|||
19657906|NCT00485134|42106822|FG002|Overall Study|Lost to Follow-up|0|||
19657907|NCT00485134|42106823|FG003|Overall Study|Lost to Follow-up|0|||
19657908|NCT00485134|42106824|FG004|Overall Study|Lost to Follow-up|0|||
19657909|NCT00485134|42106825|FG005|Overall Study|Lost to Follow-up|0|||
19657910|NCT00485134|42106826|FG006|Overall Study|Lost to Follow-up|0|||
19657911|NCT00485134|42106827|FG007|Overall Study|Lost to Follow-up|0|||
19657912|NCT00485134|42106820|FG000|Overall Study|Withdrawal by Subject|0|||
19657913|NCT00485134|42106821|FG001|Overall Study|Withdrawal by Subject|1|||
19657914|NCT00485134|42106822|FG002|Overall Study|Withdrawal by Subject|0|||
19657915|NCT00485134|42106823|FG003|Overall Study|Withdrawal by Subject|0|||
19657916|NCT00485134|42106824|FG004|Overall Study|Withdrawal by Subject|0|||
19657917|NCT00485134|42106825|FG005|Overall Study|Withdrawal by Subject|0|||
19657918|NCT00485134|42106826|FG006|Overall Study|Withdrawal by Subject|0|||
19657919|NCT00485134|42106827|FG007|Overall Study|Withdrawal by Subject|0|||
19657920|NCT00485134|42106820|FG000|Overall Study|Change in health status|0|||
19657921|NCT00485134|42106821|FG001|Overall Study|Change in health status|1|||
19657922|NCT00485134|42106822|FG002|Overall Study|Change in health status|2|||
19657923|NCT00485134|42106823|FG003|Overall Study|Change in health status|1|||
19657924|NCT00485134|42106824|FG004|Overall Study|Change in health status|0|||
19657925|NCT00485134|42106825|FG005|Overall Study|Change in health status|1|||
19657926|NCT00485134|42106826|FG006|Overall Study|Change in health status|0|||
19657927|NCT00485134|42106827|FG007|Overall Study|Change in health status|0|||
19657928|NCT00485134|42106820|FG000|Overall Study|Withdrew for adverse event|0|||
19657929|NCT00485134|42106821|FG001|Overall Study|Withdrew for adverse event|0|||
19657930|NCT00485134|42106822|FG002|Overall Study|Withdrew for adverse event|1|||
19657931|NCT00485134|42106823|FG003|Overall Study|Withdrew for adverse event|0|||
19657932|NCT00485134|42106824|FG004|Overall Study|Withdrew for adverse event|0|||
19657933|NCT00485134|42106825|FG005|Overall Study|Withdrew for adverse event|0|||
19657934|NCT00485134|42106826|FG006|Overall Study|Withdrew for adverse event|0|||
19657935|NCT00485134|42106827|FG007|Overall Study|Withdrew for adverse event|0|||
19657936|NCT00485134|42106820|FG000|Overall Study|Positive drug test|0|||
19657937|NCT00485134|42106821|FG001|Overall Study|Positive drug test|0|||
19657938|NCT00485134|42106822|FG002|Overall Study|Positive drug test|0|||
19657939|NCT00485134|42106823|FG003|Overall Study|Positive drug test|0|||
19657940|NCT00485134|42106824|FG004|Overall Study|Positive drug test|2|||
19657941|NCT00485134|42106825|FG005|Overall Study|Positive drug test|1|||
19657942|NCT00485134|42106826|FG006|Overall Study|Positive drug test|0|||
19657943|NCT00485134|42106827|FG007|Overall Study|Positive drug test|0|||
19657944|NCT00485134|42106820|FG000|Overall Study|Non-compliance|0|||
19657945|NCT00485134|42106821|FG001|Overall Study|Non-compliance|0|||
19657946|NCT00485134|42106822|FG002|Overall Study|Non-compliance|0|||
19657947|NCT00485134|42106823|FG003|Overall Study|Non-compliance|0|||
19657948|NCT00485134|42106824|FG004|Overall Study|Non-compliance|1|||
19657949|NCT00485134|42106825|FG005|Overall Study|Non-compliance|2|||
19657950|NCT00485134|42106826|FG006|Overall Study|Non-compliance|2|||
19657951|NCT00485134|42106827|FG007|Overall Study|Non-compliance|0|||
19657952|NCT00485134|42106820|FG000|Overall Study|Unable to comply with study schedule|0|||
19657953|NCT00485134|42106821|FG001|Overall Study|Unable to comply with study schedule|0|||
19657954|NCT00485134|42106822|FG002|Overall Study|Unable to comply with study schedule|0|||
19657955|NCT00485134|42106823|FG003|Overall Study|Unable to comply with study schedule|0|||
19657956|NCT00485134|42106824|FG004|Overall Study|Unable to comply with study schedule|0|||
19657957|NCT00485134|42106825|FG005|Overall Study|Unable to comply with study schedule|0|||
19657958|NCT00485134|42106826|FG006|Overall Study|Unable to comply with study schedule|0|||
19657959|NCT00485134|42106827|FG007|Overall Study|Unable to comply with study schedule|1|||
19657960|NCT00485134|42106820|FG000|Overall Study|Pregnancy|0|||
19657961|NCT00485134|42106821|FG001|Overall Study|Pregnancy|0|||
19657962|NCT00485134|42106822|FG002|Overall Study|Pregnancy|0|||
19657963|NCT00485134|42106823|FG003|Overall Study|Pregnancy|0|||
19657964|NCT00485134|42106824|FG004|Overall Study|Pregnancy|0|||
19657965|NCT00485134|42106825|FG005|Overall Study|Pregnancy|0|||
19657966|NCT00485134|42106826|FG006|Overall Study|Pregnancy|1|||
19657967|NCT00485134|42106827|FG007|Overall Study|Pregnancy|0|||
19657968|NCT03890367|42106842|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19657969|NCT03890367|42106843|FG001|Overall Study|Withdrawal by parent/guardian|3|||
19657970|NCT03890367|42106844|FG002|Overall Study|Withdrawal by parent/guardian|0|||
19657971|NCT03890367|42106842|FG000|Overall Study|Protocol deviation|2|||
19657972|NCT03890367|42106843|FG001|Overall Study|Protocol deviation|2|||
19657973|NCT03890367|42106844|FG002|Overall Study|Protocol deviation|1|||
19657974|NCT03890367|42106842|FG000|Overall Study|Lost to Follow-up|1|||
19657975|NCT03890367|42106843|FG001|Overall Study|Lost to Follow-up|1|||
19657976|NCT03890367|42106844|FG002|Overall Study|Lost to Follow-up|0|||
19657977|NCT00583115|42106852|FG000|Overall Study|Death|1|||
19657978|NCT00532779|42106859|FG000|Overall Study|Adverse Event|122|||
19657979|NCT00532779|42106860|FG001|Overall Study|Adverse Event|112|||
19657980|NCT00532779|42106861|FG002|Overall Study|Adverse Event|56|||
19657981|NCT00532779|42106859|FG000|Overall Study|Lost to Follow-up|76|||
19657982|NCT00532779|42106860|FG001|Overall Study|Lost to Follow-up|65|||
19657983|NCT00532779|42106861|FG002|Overall Study|Lost to Follow-up|66|||
19657984|NCT00532779|42106859|FG000|Overall Study|Withdrawal by Subject|63|||
19657985|NCT00532779|42106860|FG001|Overall Study|Withdrawal by Subject|60|||
19657986|NCT00532779|42106861|FG002|Overall Study|Withdrawal by Subject|90|||
19657987|NCT00532779|42106859|FG000|Overall Study|Lack of Efficacy|12|||
19657988|NCT00532779|42106860|FG001|Overall Study|Lack of Efficacy|12|||
19657989|NCT00532779|42106861|FG002|Overall Study|Lack of Efficacy|40|||
19657990|NCT00532779|42106859|FG000|Overall Study|Protocol Violation|5|||
19657991|NCT00532779|42106860|FG001|Overall Study|Protocol Violation|9|||
19657992|NCT00532779|42106861|FG002|Overall Study|Protocol Violation|7|||
19657993|NCT00532779|42106859|FG000|Overall Study|Pregnancy|2|||
19657994|NCT00532779|42106860|FG001|Overall Study|Pregnancy|5|||
19657995|NCT00532779|42106861|FG002|Overall Study|Pregnancy|3|||
19657996|NCT00532779|42106859|FG000|Overall Study|Death|0|||
19657997|NCT00532779|42106860|FG001|Overall Study|Death|1|||
19657998|NCT00532779|42106861|FG002|Overall Study|Death|0|||
19657999|NCT00532779|42106859|FG000|Overall Study|Drug noncompliance, moved, other|14|||
19658000|NCT00532779|42106860|FG001|Overall Study|Drug noncompliance, moved, other|23|||
19658001|NCT00532779|42106861|FG002|Overall Study|Drug noncompliance, moved, other|29|||
19658002|NCT00500266|42106869|FG000|Overall Study|Death|3|||
19601894|NCT00766090|42050522|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601895|NCT00766090|42050523|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601896|NCT00766090|42050524|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
19601897|NCT00766090|42050513|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601898|NCT00766090|42050514|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601899|NCT00766090|42050515|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601900|NCT00766090|42050516|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601901|NCT00766090|42050517|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
19601902|NCT00766090|42050518|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601903|NCT00766090|42050519|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601904|NCT00766090|42050520|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601905|NCT00766090|42050521|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601906|NCT00766090|42050522|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601907|NCT00766090|42050523|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19388698|NCT01661595|41632215|FG003|Phase 1: Week 0-4|Adverse Event|0|||
19601908|NCT00766090|42050524|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
19601909|NCT00766090|42050513|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19658003|NCT00500266|42106869|FG000|Overall Study|Lost to Follow-up|3|||
19658004|NCT00500266|42106869|FG000|Overall Study|Withdrawal by Subject|3|||
19658005|NCT00500266|42106869|FG000|Overall Study|Assigned, not treated|4|||
19658006|NCT00500110|42106874|FG000|Overall Study|Withdrawal by Subject|3|||
19658007|NCT00534495|42106880|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
19658008|NCT00534495|42106881|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
19658009|NCT00534495|42106882|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
19658010|NCT00534495|42106880|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
19658011|NCT00534495|42106881|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
19658012|NCT00534495|42106882|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
19658013|NCT00534495|42106880|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
19658014|NCT00534495|42106881|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
19658015|NCT00534495|42106882|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
19658016|NCT00534495|42106880|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
19658017|NCT00534495|42106881|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
19658018|NCT00534495|42106882|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
19658019|NCT00534495|42106880|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
19658020|NCT00534495|42106881|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
19658021|NCT00534495|42106882|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
19658022|NCT00534495|42106880|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
19658023|NCT00534495|42106881|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
19658024|NCT00534495|42106882|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
19658025|NCT00534495|42106880|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
19658026|NCT00534495|42106881|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
19658027|NCT00534495|42106882|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
19658028|NCT00534495|42106880|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
19658029|NCT00534495|42106881|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
19658030|NCT00534495|42106882|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
19658031|NCT00534495|42106880|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
19658032|NCT00534495|42106881|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
19658033|NCT00534495|42106882|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
19658034|NCT00484198|42106906|FG000|Overall Study|Participant Withdrew Consent|12|||
19658035|NCT00484198|42106907|FG001|Overall Study|Participant Withdrew Consent|21|||
19658036|NCT00484198|42106908|FG002|Overall Study|Participant Withdrew Consent|47|||
19658037|NCT00484198|42106909|FG003|Overall Study|Participant Withdrew Consent|59|||
19658038|NCT00484198|42106906|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
19658039|NCT00484198|42106907|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
19658040|NCT00484198|42106908|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
19658041|NCT00484198|42106909|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
19658042|NCT00484198|42106906|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
19658043|NCT00484198|42106907|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
19658044|NCT00484198|42106908|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
19658045|NCT00484198|42106909|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
19658046|NCT00484198|42106906|FG000|Overall Study|Adverse Event|3|||
19658047|NCT00484198|42106907|FG001|Overall Study|Adverse Event|11|||
19658048|NCT00484198|42106908|FG002|Overall Study|Adverse Event|32|||
19658049|NCT00484198|42106909|FG003|Overall Study|Adverse Event|31|||
19658050|NCT00484198|42106906|FG000|Overall Study|Protocol Violation|0|||
19658051|NCT00484198|42106907|FG001|Overall Study|Protocol Violation|5|||
19658052|NCT00484198|42106908|FG002|Overall Study|Protocol Violation|6|||
19658053|NCT00484198|42106909|FG003|Overall Study|Protocol Violation|8|||
19658054|NCT00484198|42106906|FG000|Overall Study|Other|7|||
19658055|NCT00484198|42106907|FG001|Overall Study|Other|10|||
19658056|NCT00484198|42106908|FG002|Overall Study|Other|31|||
19658057|NCT00484198|42106909|FG003|Overall Study|Other|28|||
19658058|NCT00499486|42106924|FG000|Overall Study|Withdrawal by Subject|16|||
19658059|NCT00499252|42106928|FG000|Overall Study|Adverse Event|3|||
19658060|NCT00499252|42106928|FG000|Overall Study|Refused further treatment|2|||
19658061|NCT00499252|42106928|FG000|Overall Study|Ineligible|4|||
19658062|NCT00499252|42106928|FG000|Overall Study|<no further label>|3|||
19658063|NCT00499174|42106938|FG000|Overall Study|Physician Decision|78|||
19658064|NCT00499174|42106939|FG001|Overall Study|Physician Decision|9|||
19658065|NCT03775421|42106947|FG000|Overall Study|Lost to Follow-up|2|||
19658066|NCT03775421|42106947|FG000|Overall Study|Withdrawal by Subject|10|||
19658067|NCT03775421|42106947|FG000|Overall Study|Physician Decision|3|||
19658068|NCT03775421|42106947|FG000|Overall Study|Death|1|||
19658069|NCT03775421|42106947|FG000|Overall Study|Study Terminated by Sponsor|94|||
19658070|NCT00532155|42106953|FG000|Overall Study|Adverse Event|66|||
19658071|NCT00532155|42106954|FG001|Overall Study|Adverse Event|123|||
19658072|NCT00532155|42106953|FG000|Overall Study|Lack of Efficacy|332|||
19754216|NCT03192150|42204295|FG000|Overall Study|Withdrawal by Subject|4|||
19658073|NCT00532155|42106954|FG001|Overall Study|Lack of Efficacy|255|||
19658074|NCT00532155|42106953|FG000|Overall Study|Protocol Violation|1|||
19658075|NCT00532155|42106954|FG001|Overall Study|Protocol Violation|3|||
19658076|NCT00532155|42106953|FG000|Overall Study|Lost to Follow-up|2|||
19754217|NCT03192150|42204296|FG001|Overall Study|Withdrawal by Subject|2|||
19754218|NCT03192150|42204295|FG000|Overall Study|Protocol Violation|5|||
19754219|NCT03192150|42204296|FG001|Overall Study|Protocol Violation|2|||
19658077|NCT00532155|42106954|FG001|Overall Study|Lost to Follow-up|0|||
19658078|NCT00532155|42106953|FG000|Overall Study|Physician Decision|16|||
19601910|NCT00766090|42050514|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601911|NCT00766090|42050515|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
19601912|NCT00766090|42050516|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601913|NCT00766090|42050517|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601914|NCT00766090|42050518|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601915|NCT00766090|42050519|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601916|NCT00766090|42050520|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601917|NCT00766090|42050521|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601918|NCT00766090|42050522|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601919|NCT00766090|42050523|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601920|NCT00766090|42050524|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
19601921|NCT00766090|42050513|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
19601922|NCT00766090|42050514|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
19601923|NCT00766090|42050515|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
19601924|NCT00766090|42050516|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
19601925|NCT00766090|42050517|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
19601926|NCT00766090|42050518|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
19601927|NCT00766090|42050519|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
19601928|NCT00766090|42050520|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
19601929|NCT00766090|42050521|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
19601930|NCT00766090|42050522|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
19601931|NCT00766090|42050523|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
19601932|NCT00766090|42050524|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
19601933|NCT00766090|42050513|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601934|NCT00766090|42050514|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601935|NCT00766090|42050515|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601936|NCT00766090|42050516|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601937|NCT00766090|42050517|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601938|NCT00766090|42050518|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
19601939|NCT00766090|42050519|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601940|NCT00766090|42050520|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601941|NCT00766090|42050521|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601942|NCT00766090|42050522|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601943|NCT00766090|42050523|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601944|NCT00766090|42050524|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
19601945|NCT00766090|42050513|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601946|NCT00766090|42050514|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
19658079|NCT00532155|42106954|FG001|Overall Study|Physician Decision|15|||
19658080|NCT00532155|42106953|FG000|Overall Study|Withdrawal by Subject|23|||
19658081|NCT00532155|42106954|FG001|Overall Study|Withdrawal by Subject|44|||
19658082|NCT00532155|42106953|FG000|Overall Study|Consent withdrawn|5|||
19658083|NCT00532155|42106954|FG001|Overall Study|Consent withdrawn|7|||
19658084|NCT00532155|42106953|FG000|Overall Study|Moved|1|||
19658085|NCT00532155|42106954|FG001|Overall Study|Moved|0|||
19658086|NCT00532155|42106953|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
19658087|NCT00532155|42106954|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
19658088|NCT00532155|42106953|FG000|Overall Study|Occurence of a second cancer|0|||
19658089|NCT00532155|42106954|FG001|Overall Study|Occurence of a second cancer|1|||
19658090|NCT00532155|42106953|FG000|Overall Study|Occurence of a secondary cancer|0|||
19658091|NCT00532155|42106954|FG001|Overall Study|Occurence of a secondary cancer|1|||
19658092|NCT00532155|42106953|FG000|Overall Study|Promotor ended study|1|||
19658093|NCT00532155|42106954|FG001|Overall Study|Promotor ended study|0|||
19658094|NCT00532155|42106953|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
19658095|NCT00532155|42106954|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
19658096|NCT00532155|42106953|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
19658097|NCT00532155|42106954|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
19658098|NCT00532155|42106953|FG000|Overall Study|Study stopped|1|||
19658099|NCT00532155|42106954|FG001|Overall Study|Study stopped|0|||
19658100|NCT00532155|42106953|FG000|Overall Study|Study terminated by sponsor|1|||
19658101|NCT00532155|42106954|FG001|Overall Study|Study terminated by sponsor|0|||
19658102|NCT00532155|42106953|FG000|Overall Study|Study termination stop further treatment|4|||
19658103|NCT00532155|42106954|FG001|Overall Study|Study termination stop further treatment|0|||
19658104|NCT00532155|42106953|FG000|Overall Study|Did not receive study medication|2|||
19658105|NCT00532155|42106954|FG001|Overall Study|Did not receive study medication|6|||
19658106|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
19658107|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
19658108|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
19658109|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
19658110|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
19658111|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
19658112|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Death|9|||
19658113|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Death|7|||
19658114|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Death|14|||
19658115|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Death|7|||
19658116|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Death|0|||
19658117|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Death|0|||
19658118|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
19658119|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
19658120|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
19658121|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
19658122|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
19658123|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
19658124|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Other Event|49|||
19658125|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Other Event|52|||
19658126|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Other Event|41|||
19754220|NCT03192150|42204295|FG000|Overall Study|Surgery Canceled|6|||
19658127|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Other Event|58|||
19658128|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Other Event|0|||
19658129|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Other Event|0|||
19658130|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
19698963|NCT00312338|42143779|FG000|Overall Study|Lost to Follow-up|9|||
19754221|NCT03192150|42204296|FG001|Overall Study|Surgery Canceled|2|||
19658131|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
19658132|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
19658133|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
19658134|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
19658135|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
19658136|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
19658137|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
19658138|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
19658139|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
19658140|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
19658141|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
19658142|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
19658143|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
19658144|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
19658145|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
19658146|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
19658147|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
19658148|NCT00205777|42106964|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
19658149|NCT00205777|42106965|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
19658150|NCT00205777|42106966|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
19658151|NCT00205777|42106967|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
19658152|NCT00205777|42106968|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
19658153|NCT00205777|42106969|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
19658154|NCT00205777|42106964|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
19658155|NCT00205777|42106965|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
19658156|NCT00205777|42106966|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
19658157|NCT00205777|42106967|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
19658158|NCT00205777|42106968|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
19658159|NCT00205777|42106969|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
19658160|NCT00205777|42106964|FG000|Completed Core Study, Entered SE I|Other Event|52|||
19658161|NCT00205777|42106965|FG001|Completed Core Study, Entered SE I|Other Event|46|||
19658162|NCT00205777|42106966|FG002|Completed Core Study, Entered SE I|Other Event|47|||
19658163|NCT00205777|42106967|FG003|Completed Core Study, Entered SE I|Other Event|50|||
19658164|NCT00205777|42106968|FG004|Completed Core Study, Entered SE I|Other Event|0|||
19658165|NCT00205777|42106969|FG005|Completed Core Study, Entered SE I|Other Event|0|||
19658166|NCT00205777|42106964|FG000|Study Extension I|Adverse Event|57|||
19658167|NCT00205777|42106965|FG001|Study Extension I|Adverse Event|0|||
19658168|NCT00205777|42106966|FG002|Study Extension I|Adverse Event|0|||
19658169|NCT00205777|42106967|FG003|Study Extension I|Adverse Event|61|||
19658170|NCT00205777|42106968|FG004|Study Extension I|Adverse Event|58|||
19658171|NCT00205777|42106969|FG005|Study Extension I|Adverse Event|0|||
19658172|NCT00205777|42106964|FG000|Study Extension I|Death|5|||
19658173|NCT00205777|42106965|FG001|Study Extension I|Death|0|||
19658174|NCT00205777|42106966|FG002|Study Extension I|Death|0|||
19658175|NCT00205777|42106967|FG003|Study Extension I|Death|1|||
19658176|NCT00205777|42106968|FG004|Study Extension I|Death|2|||
19658177|NCT00205777|42106969|FG005|Study Extension I|Death|0|||
19658178|NCT00205777|42106964|FG000|Study Extension I|Withdrawal by Subject|99|||
19658179|NCT00205777|42106965|FG001|Study Extension I|Withdrawal by Subject|0|||
19658180|NCT00205777|42106966|FG002|Study Extension I|Withdrawal by Subject|0|||
19658181|NCT00205777|42106967|FG003|Study Extension I|Withdrawal by Subject|106|||
19658182|NCT00205777|42106968|FG004|Study Extension I|Withdrawal by Subject|89|||
19658183|NCT00205777|42106969|FG005|Study Extension I|Withdrawal by Subject|0|||
19658184|NCT00205777|42106964|FG000|Study Extension I|Protocol Violation|4|||
19658185|NCT00205777|42106965|FG001|Study Extension I|Protocol Violation|0|||
19658186|NCT00205777|42106966|FG002|Study Extension I|Protocol Violation|0|||
19658187|NCT00205777|42106967|FG003|Study Extension I|Protocol Violation|8|||
19658188|NCT00205777|42106968|FG004|Study Extension I|Protocol Violation|8|||
19658189|NCT00205777|42106969|FG005|Study Extension I|Protocol Violation|0|||
19658190|NCT00205777|42106964|FG000|Study Extension I|Lack of Efficacy|0|||
19658191|NCT00205777|42106965|FG001|Study Extension I|Lack of Efficacy|0|||
19658192|NCT00205777|42106966|FG002|Study Extension I|Lack of Efficacy|0|||
19658193|NCT00205777|42106967|FG003|Study Extension I|Lack of Efficacy|1|||
19658194|NCT00205777|42106968|FG004|Study Extension I|Lack of Efficacy|2|||
19658195|NCT00205777|42106969|FG005|Study Extension I|Lack of Efficacy|0|||
19658196|NCT00205777|42106964|FG000|Study Extension I|Failed to return|15|||
19754222|NCT03192150|42204295|FG000|Overall Study|Other-Various Administrative Reasons|2|||
19658197|NCT00205777|42106965|FG001|Study Extension I|Failed to return|0|||
19658198|NCT00205777|42106966|FG002|Study Extension I|Failed to return|0|||
19658199|NCT00205777|42106967|FG003|Study Extension I|Failed to return|17|||
19658200|NCT00205777|42106968|FG004|Study Extension I|Failed to return|13|||
19658201|NCT00205777|42106969|FG005|Study Extension I|Failed to return|0|||
19658202|NCT00205777|42106964|FG000|Study Extension I|Other Event|34|||
19658203|NCT00205777|42106965|FG001|Study Extension I|Other Event|0|||
19658204|NCT00205777|42106966|FG002|Study Extension I|Other Event|0|||
19658205|NCT00205777|42106967|FG003|Study Extension I|Other Event|34|||
19658206|NCT00205777|42106968|FG004|Study Extension I|Other Event|29|||
19658207|NCT00205777|42106969|FG005|Study Extension I|Other Event|0|||
19658208|NCT00205777|42106964|FG000|Study Extension I|Withdrawn as per protocol|0|||
19658209|NCT00205777|42106965|FG001|Study Extension I|Withdrawn as per protocol|0|||
19658210|NCT00205777|42106966|FG002|Study Extension I|Withdrawn as per protocol|1070|||
19658211|NCT00205777|42106967|FG003|Study Extension I|Withdrawn as per protocol|0|||
19658212|NCT00205777|42106968|FG004|Study Extension I|Withdrawn as per protocol|0|||
19658213|NCT00205777|42106969|FG005|Study Extension I|Withdrawn as per protocol|0|||
19658214|NCT00205777|42106964|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
19658215|NCT00205777|42106965|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
19658216|NCT00205777|42106966|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
19658217|NCT00205777|42106967|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
19658218|NCT00205777|42106968|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
19658219|NCT00205777|42106969|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
19658220|NCT00205777|42106964|FG000|Study Extension II|Adverse Event|0|||
19658221|NCT00205777|42106965|FG001|Study Extension II|Adverse Event|0|||
19658222|NCT00205777|42106966|FG002|Study Extension II|Adverse Event|0|||
19658223|NCT00205777|42106967|FG003|Study Extension II|Adverse Event|14|||
19658224|NCT00205777|42106968|FG004|Study Extension II|Adverse Event|0|||
19658225|NCT00205777|42106969|FG005|Study Extension II|Adverse Event|30|||
19658226|NCT00205777|42106964|FG000|Study Extension II|Death|0|||
19658227|NCT00205777|42106965|FG001|Study Extension II|Death|0|||
19658228|NCT00205777|42106966|FG002|Study Extension II|Death|0|||
19658229|NCT00205777|42106967|FG003|Study Extension II|Death|2|||
19658230|NCT00205777|42106968|FG004|Study Extension II|Death|0|||
19658231|NCT00205777|42106969|FG005|Study Extension II|Death|5|||
19658232|NCT00205777|42106964|FG000|Study Extension II|Withdrawal by Subject|0|||
19658233|NCT00205777|42106965|FG001|Study Extension II|Withdrawal by Subject|0|||
19658234|NCT00205777|42106966|FG002|Study Extension II|Withdrawal by Subject|0|||
19658235|NCT00205777|42106967|FG003|Study Extension II|Withdrawal by Subject|35|||
19658236|NCT00205777|42106968|FG004|Study Extension II|Withdrawal by Subject|0|||
19658237|NCT00205777|42106969|FG005|Study Extension II|Withdrawal by Subject|59|||
19658238|NCT00205777|42106964|FG000|Study Extension II|Protocol Violation|0|||
19658239|NCT00205777|42106965|FG001|Study Extension II|Protocol Violation|0|||
19658240|NCT00205777|42106966|FG002|Study Extension II|Protocol Violation|0|||
19658241|NCT00205777|42106967|FG003|Study Extension II|Protocol Violation|1|||
19658242|NCT00205777|42106968|FG004|Study Extension II|Protocol Violation|0|||
19658243|NCT00205777|42106969|FG005|Study Extension II|Protocol Violation|10|||
19658244|NCT00205777|42106964|FG000|Study Extension II|Lack of Efficacy|0|||
19658245|NCT00205777|42106965|FG001|Study Extension II|Lack of Efficacy|0|||
19658246|NCT00205777|42106966|FG002|Study Extension II|Lack of Efficacy|0|||
19658247|NCT00205777|42106967|FG003|Study Extension II|Lack of Efficacy|0|||
19658248|NCT00205777|42106968|FG004|Study Extension II|Lack of Efficacy|0|||
19658249|NCT00205777|42106969|FG005|Study Extension II|Lack of Efficacy|1|||
19658250|NCT00205777|42106964|FG000|Study Extension II|Failed to return|0|||
19658251|NCT00205777|42106965|FG001|Study Extension II|Failed to return|0|||
19658252|NCT00205777|42106966|FG002|Study Extension II|Failed to return|0|||
19658253|NCT00205777|42106967|FG003|Study Extension II|Failed to return|14|||
19658254|NCT00205777|42106968|FG004|Study Extension II|Failed to return|0|||
19658255|NCT00205777|42106969|FG005|Study Extension II|Failed to return|26|||
19658256|NCT00205777|42106964|FG000|Study Extension II|Other Event|0|||
19658257|NCT00205777|42106965|FG001|Study Extension II|Other Event|0|||
19658258|NCT00205777|42106966|FG002|Study Extension II|Other Event|0|||
19658259|NCT00205777|42106967|FG003|Study Extension II|Other Event|12|||
19658260|NCT00205777|42106968|FG004|Study Extension II|Other Event|0|||
19658261|NCT00205777|42106969|FG005|Study Extension II|Other Event|20|||
19658262|NCT00205777|42106964|FG000|Study Extension II|Enrolled but not treated|0|||
19658263|NCT00205777|42106965|FG001|Study Extension II|Enrolled but not treated|0|||
19658264|NCT00205777|42106966|FG002|Study Extension II|Enrolled but not treated|0|||
19658265|NCT00205777|42106967|FG003|Study Extension II|Enrolled but not treated|71|||
19658266|NCT00205777|42106968|FG004|Study Extension II|Enrolled but not treated|0|||
19658267|NCT00205777|42106969|FG005|Study Extension II|Enrolled but not treated|131|||
19658268|NCT00483652|42106986|FG000|Double-blind Treatment Period|Protocol Violation|2|||
19658269|NCT00483652|42106987|FG001|Double-blind Treatment Period|Protocol Violation|1|||
19658270|NCT00483652|42106986|FG000|Double-blind Treatment Period|Adverse Event|3|||
19658271|NCT00483652|42106987|FG001|Double-blind Treatment Period|Adverse Event|4|||
19658272|NCT00483652|42106986|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
19658273|NCT00483652|42106987|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
19658274|NCT00483652|42106986|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
19658275|NCT00483652|42106987|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
19658276|NCT00483574|42106995|FG000|Overall Study|Adverse Event|6|||
19658277|NCT00483574|42106996|FG001|Overall Study|Adverse Event|0|||
19658278|NCT00483574|42106995|FG000|Overall Study|Protocol Violation|28|||
19658279|NCT00483574|42106996|FG001|Overall Study|Protocol Violation|9|||
19658280|NCT00483574|42106995|FG000|Overall Study|Lost to Follow-up|16|||
19658281|NCT00483574|42106996|FG001|Overall Study|Lost to Follow-up|4|||
19658282|NCT00483574|42106995|FG000|Overall Study|Withdrawal by Subject|52|||
19658283|NCT00483574|42106996|FG001|Overall Study|Withdrawal by Subject|0|||
19658284|NCT00483184|42107007|FG000|Overall Study|Withdrawal by Subject|2|||
19658285|NCT00483184|42107008|FG001|Overall Study|Withdrawal by Subject|2|||
19658286|NCT00483184|42107009|FG002|Overall Study|Withdrawal by Subject|0|||
19658287|NCT00483184|42107007|FG000|Overall Study|Lost to Follow-up|1|||
19658288|NCT00483184|42107008|FG001|Overall Study|Lost to Follow-up|0|||
19658289|NCT00483184|42107009|FG002|Overall Study|Lost to Follow-up|0|||
19658290|NCT00483184|42107007|FG000|Overall Study|Adverse Event|1|||
19658291|NCT00483184|42107008|FG001|Overall Study|Adverse Event|2|||
19658292|NCT00483184|42107009|FG002|Overall Study|Adverse Event|2|||
19658293|NCT00483184|42107007|FG000|Overall Study|Protocol Violation|1|||
19658294|NCT00483184|42107008|FG001|Overall Study|Protocol Violation|0|||
19658295|NCT00483184|42107009|FG002|Overall Study|Protocol Violation|1|||
19658296|NCT00482170|42107019|FG000|Overall Study|Adverse Event|5|||
19658297|NCT00482170|42107020|FG001|Overall Study|Adverse Event|14|||
19658298|NCT00482170|42107019|FG000|Overall Study|Withdrawal by Subject|6|||
19658299|NCT00482170|42107020|FG001|Overall Study|Withdrawal by Subject|1|||
19658300|NCT00482170|42107019|FG000|Overall Study|Protocol Violation|2|||
19658301|NCT00482170|42107020|FG001|Overall Study|Protocol Violation|3|||
19658302|NCT00482170|42107019|FG000|Overall Study|Lost to Follow-up|2|||
19658303|NCT00482170|42107020|FG001|Overall Study|Lost to Follow-up|0|||
19658304|NCT00482170|42107019|FG000|Overall Study|Unspecified reason|0|||
19658305|NCT00482170|42107020|FG001|Overall Study|Unspecified reason|2|||
19658306|NCT03883113|42107028|FG000|Overall Study|Physician Decision|4|||
19658307|NCT03883113|42107029|FG001|Overall Study|Physician Decision|2|||
19658308|NCT03883113|42107028|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
19658309|NCT03883113|42107029|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
19658310|NCT03883113|42107028|FG000|Overall Study|Pregnancy|1|||
19658311|NCT03883113|42107029|FG001|Overall Study|Pregnancy|0|||
19658312|NCT03883113|42107028|FG000|Overall Study|Adverse Event|0|||
19658313|NCT03883113|42107029|FG001|Overall Study|Adverse Event|1|||
19658314|NCT03883113|42107028|FG000|Overall Study|Withdrawal by Subject|1|||
19658315|NCT03883113|42107029|FG001|Overall Study|Withdrawal by Subject|2|||
19658316|NCT03883113|42107028|FG000|Overall Study|Lost to Follow-up|1|||
19658317|NCT03883113|42107029|FG001|Overall Study|Lost to Follow-up|0|||
19658318|NCT04218695|42107051|FG000|Overall Study|Adverse Event|1|||
19373634|NCT02760407|41614835|FG002|Overall Study|Inadequately Enrolled|0|||
19658319|NCT04218695|42107052|FG001|Overall Study|Adverse Event|0|||
19658320|NCT00490282|42107058|FG000|Overall Study|Withdrawal by Subject|3|||
19658321|NCT00615056|42107067|FG000|Overall Study|Death|31|||
19658322|NCT00615056|42107068|FG001|Overall Study|Death|31|||
19658323|NCT00615056|42107069|FG002|Overall Study|Death|21|||
19658324|NCT00615056|42107070|FG003|Overall Study|Death|23|||
19658325|NCT00615056|42107067|FG000|Overall Study|Lost to Follow-up|1|||
19658326|NCT00615056|42107068|FG001|Overall Study|Lost to Follow-up|2|||
19658327|NCT00615056|42107069|FG002|Overall Study|Lost to Follow-up|4|||
19658328|NCT00615056|42107070|FG003|Overall Study|Lost to Follow-up|5|||
19658329|NCT00615056|42107067|FG000|Overall Study|Other|13|||
19658330|NCT00615056|42107068|FG001|Overall Study|Other|15|||
19658331|NCT00615056|42107069|FG002|Overall Study|Other|10|||
19658332|NCT00615056|42107070|FG003|Overall Study|Other|7|||
19658333|NCT00615056|42107067|FG000|Overall Study|Objective progression or relapse|0|||
19658334|NCT00615056|42107068|FG001|Overall Study|Objective progression or relapse|2|||
19658335|NCT00615056|42107069|FG002|Overall Study|Objective progression or relapse|0|||
19658336|NCT00615056|42107070|FG003|Overall Study|Objective progression or relapse|0|||
19658337|NCT00615056|42107067|FG000|Overall Study|Withdrawal by Subject|0|||
19658338|NCT00615056|42107068|FG001|Overall Study|Withdrawal by Subject|1|||
19658339|NCT00615056|42107069|FG002|Overall Study|Withdrawal by Subject|1|||
19658340|NCT00615056|42107070|FG003|Overall Study|Withdrawal by Subject|0|||
19601947|NCT00766090|42050515|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19754223|NCT03192150|42204296|FG001|Overall Study|Other-Various Administrative Reasons|5|||
19754224|NCT03597529|42204304|FG000|Overall Study|Lost to Follow-up|10|||
19754225|NCT03597529|42204305|FG001|Overall Study|Lost to Follow-up|12|||
19754226|NCT03597529|42204304|FG000|Overall Study|Physician Decision|3|||
19754227|NCT03597529|42204305|FG001|Overall Study|Physician Decision|1|||
19754228|NCT03597529|42204304|FG000|Overall Study|Withdrawal by Subject|6|||
19754229|NCT03597529|42204305|FG001|Overall Study|Withdrawal by Subject|3|||
19754230|NCT03597529|42204304|FG000|Overall Study|Non-compliant with study activities|1|||
19754231|NCT03597529|42204305|FG001|Overall Study|Non-compliant with study activities|2|||
19754232|NCT03180528|42204311|FG000|Overall Study|Adverse Event|1|||
19754233|NCT03180528|42204311|FG000|Overall Study|Withdrawal by Subject|1|||
19754234|NCT03180528|42204311|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
19754235|NCT03597295|42204315|FG000|Overall Study|Death|70|||
19754236|NCT03597295|42204315|FG000|Overall Study|Lost to Follow-up|7|||
19754237|NCT03180138|42204322|FG000|Overall Study|Mobile-phone could not be verified|2|||
19754238|NCT03180138|42204323|FG001|Overall Study|Mobile-phone could not be verified|13|||
19754239|NCT03180138|42204324|FG002|Overall Study|Mobile-phone could not be verified|15|||
19754240|NCT03180138|42204322|FG000|Overall Study|No prior immunization records|17|||
19754241|NCT03180138|42204323|FG001|Overall Study|No prior immunization records|0|||
19754242|NCT03180138|42204324|FG002|Overall Study|No prior immunization records|6|||
19754243|NCT03180138|42204322|FG000|Overall Study|Found to be >24 mon after randomization|3|||
19754244|NCT03180138|42204323|FG001|Overall Study|Found to be >24 mon after randomization|0|||
19754245|NCT03180138|42204324|FG002|Overall Study|Found to be >24 mon after randomization|3|||
19754246|NCT03597139|42204334|FG000|Overall Study|Adverse Event|3|||
19601948|NCT00766090|42050516|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
19601949|NCT00766090|42050517|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19754247|NCT03597139|42204335|FG001|Overall Study|Adverse Event|0|||
19754248|NCT03597139|42204334|FG000|Overall Study|Protocol Non-compliance|1|||
19754249|NCT03597139|42204335|FG001|Overall Study|Protocol Non-compliance|0|||
19754250|NCT03179202|42204341|FG000|Overall Study|Screen Failure|67|||
19754251|NCT03179202|42204341|FG000|Overall Study|Subject Lost to Follow Up|12|||
19754252|NCT03179202|42204341|FG000|Overall Study|Withdrawal by Subject|7|||
19754253|NCT03179202|42204341|FG000|Overall Study|Adverse Event|3|||
19754254|NCT03179202|42204341|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
19754255|NCT03179202|42204341|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
19754256|NCT03597061|42204349|FG000|Overall Study|Lost to Follow-up|1|||
19754257|NCT03597061|42204350|FG001|Overall Study|Lost to Follow-up|0|||
19754258|NCT03597061|42204349|FG000|Overall Study|Protocol Violation|0|||
19754259|NCT03597061|42204350|FG001|Overall Study|Protocol Violation|1|||
19754260|NCT00708214|42204359|FG000|Overall Study|Other Adverse Event|3|||
19754261|NCT00708214|42204360|FG001|Overall Study|Other Adverse Event|6|||
19601950|NCT00766090|42050518|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601951|NCT00766090|42050519|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601952|NCT00766090|42050520|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601953|NCT00766090|42050521|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601954|NCT00766090|42050522|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19601955|NCT00766090|42050523|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
19754262|NCT00708214|42204361|FG002|Overall Study|Other Adverse Event|2|||
19754263|NCT00708214|42204359|FG000|Overall Study|Other|0|||
19754264|NCT00708214|42204360|FG001|Overall Study|Other|1|||
19754265|NCT00708214|42204361|FG002|Overall Study|Other|1|||
19754266|NCT00708214|42204359|FG000|Overall Study|Progressive Disease|4|||
19754267|NCT00708214|42204360|FG001|Overall Study|Progressive Disease|6|||
19754268|NCT00708214|42204361|FG002|Overall Study|Progressive Disease|5|||
19754269|NCT03570697|42204376|FG000|Overall Study|Lost to Follow-up|0|||
19754270|NCT03570697|42204377|FG001|Overall Study|Lost to Follow-up|1|||
19754271|NCT03570697|42204376|FG000|Overall Study|Death|2|||
19754272|NCT03570697|42204377|FG001|Overall Study|Death|0|||
19754273|NCT03570697|42204376|FG000|Overall Study|Withdrawal by Subject|4|||
19754274|NCT03570697|42204377|FG001|Overall Study|Withdrawal by Subject|2|||
19754275|NCT03569371|42204394|FG000|Overall Study|Lack of Efficacy|1|||
19754276|NCT03569371|42204394|FG000|Overall Study|Lost to Follow-up|1|||
19754277|NCT03569371|42204394|FG000|Overall Study|Adverse Event|1|||
19754278|NCT01318070|42204401|FG000|Overall Study|Adverse Event|1|||
19754279|NCT01318070|42204402|FG001|Overall Study|Adverse Event|1|||
19754280|NCT01318070|42204403|FG002|Overall Study|Adverse Event|5|||
19754281|NCT01318070|42204401|FG000|Overall Study|Withdrawal by Subject|0|||
19754282|NCT01318070|42204402|FG001|Overall Study|Withdrawal by Subject|1|||
19754283|NCT01318070|42204403|FG002|Overall Study|Withdrawal by Subject|1|||
19754284|NCT01318070|42204401|FG000|Overall Study|Lack of Efficacy|0|||
19754285|NCT01318070|42204402|FG001|Overall Study|Lack of Efficacy|0|||
19754286|NCT01318070|42204403|FG002|Overall Study|Lack of Efficacy|1|||
19754287|NCT01318070|42204401|FG000|Overall Study|Principal Investigator Discretion|1|||
19754288|NCT01318070|42204402|FG001|Overall Study|Principal Investigator Discretion|0|||
19754289|NCT01318070|42204403|FG002|Overall Study|Principal Investigator Discretion|0|||
19754290|NCT02895295|42204414|FG000|Overall Study|Survey Non-response|71|||
19754291|NCT02895295|42204415|FG001|Overall Study|Survey Non-response|94|||
19754292|NCT02895295|42204416|FG002|Overall Study|Survey Non-response|92|||
19754293|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
19658341|NCT00615056|42107067|FG000|Overall Study|Discontinued by Sponsor|1|||
19658342|NCT00615056|42107068|FG001|Overall Study|Discontinued by Sponsor|0|||
19754294|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
19754295|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
19754296|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
19754297|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
19754298|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
19754299|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
19754300|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
19658343|NCT00615056|42107069|FG002|Overall Study|Discontinued by Sponsor|0|||
19658344|NCT00615056|42107070|FG003|Overall Study|Discontinued by Sponsor|0|||
19658345|NCT00615056|42107067|FG000|Overall Study|Randomized but not treated|3|||
19658346|NCT00615056|42107068|FG001|Overall Study|Randomized but not treated|0|||
19658347|NCT00615056|42107069|FG002|Overall Study|Randomized but not treated|0|||
19658348|NCT00615056|42107070|FG003|Overall Study|Randomized but not treated|0|||
19658349|NCT00482014|42107084|FG000|Overall Study|Withdrawal by Subject|1|||
19658350|NCT00482014|42107085|FG001|Overall Study|Withdrawal by Subject|2|||
19658351|NCT00482014|42107086|FG002|Overall Study|Withdrawal by Subject|3|||
19658352|NCT00482014|42107087|FG003|Overall Study|Withdrawal by Subject|4|||
19658353|NCT00482014|42107084|FG000|Overall Study|Adverse Event|3|||
19658354|NCT00482014|42107085|FG001|Overall Study|Adverse Event|0|||
19658355|NCT00482014|42107086|FG002|Overall Study|Adverse Event|2|||
19658356|NCT00482014|42107087|FG003|Overall Study|Adverse Event|8|||
19658357|NCT00482014|42107084|FG000|Overall Study|Death|1|||
19658358|NCT00482014|42107085|FG001|Overall Study|Death|2|||
19658359|NCT00482014|42107086|FG002|Overall Study|Death|1|||
19658360|NCT00482014|42107087|FG003|Overall Study|Death|4|||
19658361|NCT00482014|42107084|FG000|Overall Study|Lack of Efficacy|1|||
19658362|NCT00482014|42107085|FG001|Overall Study|Lack of Efficacy|0|||
19658363|NCT00482014|42107086|FG002|Overall Study|Lack of Efficacy|4|||
19658364|NCT00482014|42107087|FG003|Overall Study|Lack of Efficacy|6|||
19658365|NCT00482014|42107084|FG000|Overall Study|Sponsor Decision|1|||
19658366|NCT00482014|42107085|FG001|Overall Study|Sponsor Decision|2|||
19658367|NCT00482014|42107086|FG002|Overall Study|Sponsor Decision|1|||
19658368|NCT00482014|42107087|FG003|Overall Study|Sponsor Decision|1|||
19658369|NCT03595553|42107101|FG000|Overall Study|Withdrawal by Subject|20|||
19658370|NCT03595553|42107102|FG001|Overall Study|Withdrawal by Subject|8|||
19658371|NCT03595553|42107101|FG000|Overall Study|Physician Decision|3|||
19658372|NCT03595553|42107102|FG001|Overall Study|Physician Decision|2|||
19658373|NCT03595553|42107101|FG000|Overall Study|Adverse Event|2|||
19658374|NCT03595553|42107102|FG001|Overall Study|Adverse Event|5|||
19658375|NCT03595553|42107101|FG000|Overall Study|Death|24|||
19658376|NCT03595553|42107102|FG001|Overall Study|Death|22|||
19658377|NCT03595553|42107101|FG000|Overall Study|Lost to Follow-up|6|||
19658378|NCT03595553|42107102|FG001|Overall Study|Lost to Follow-up|7|||
19658379|NCT03595553|42107101|FG000|Overall Study|Other as indicated in CSR|3|||
19754301|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
19754302|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
19658380|NCT03595553|42107102|FG001|Overall Study|Other as indicated in CSR|3|||
19658381|NCT03595553|42107101|FG000|Overall Study|Sponsor Decision|0|||
19754303|NCT00245960|42204426|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
19658382|NCT03595553|42107102|FG001|Overall Study|Sponsor Decision|1|||
19658383|NCT00614822|42107108|FG000|Overall Study|Adverse Event|3|||
19658384|NCT00529659|42107115|FG000|Overall Study|Adverse Event|8|||
19658385|NCT00529659|42107116|FG001|Overall Study|Adverse Event|7|||
19658386|NCT00529659|42107115|FG000|Overall Study|Lost to Follow-up|0|||
19658387|NCT00529659|42107116|FG001|Overall Study|Lost to Follow-up|2|||
19658388|NCT00529659|42107115|FG000|Overall Study|Physician Decision|0|||
19658389|NCT00529659|42107116|FG001|Overall Study|Physician Decision|2|||
19658390|NCT00529659|42107115|FG000|Overall Study|Protocol Violation|2|||
19658391|NCT00529659|42107116|FG001|Overall Study|Protocol Violation|6|||
19658392|NCT00529659|42107115|FG000|Overall Study|Withdrawal by Subject|1|||
19658393|NCT00529659|42107116|FG001|Overall Study|Withdrawal by Subject|6|||
19658394|NCT03569891|42107122|FG000|Lead-in|Ineligible during lead-in|8|||
19658395|NCT03569891|42107122|FG000|Lead-in|Withdrawal by Subject|3|||
19658396|NCT03569891|42107122|FG000|Lead-in|Risks related to COVID-19|2|||
19658397|NCT03569891|42107122|FG000|AMT-061|Adverse Event|1|||
19658398|NCT00143455|42107135|FG000|Cohort 1|Adverse Event|8|||
19658399|NCT00143455|42107136|FG001|Cohort 1|Adverse Event|4|||
19658400|NCT00143455|42107137|FG002|Cohort 1|Adverse Event|0|||
19658401|NCT00143455|42107138|FG003|Cohort 1|Adverse Event|0|||
19658402|NCT00143455|42107135|FG000|Cohort 1|Death|5|||
19658403|NCT00143455|42107136|FG001|Cohort 1|Death|2|||
19658404|NCT00143455|42107137|FG002|Cohort 1|Death|0|||
19658405|NCT00143455|42107138|FG003|Cohort 1|Death|0|||
19658406|NCT00143455|42107135|FG000|Cohort 1|Progressive Disease|0|||
19658407|NCT00143455|42107136|FG001|Cohort 1|Progressive Disease|6|||
19658408|NCT00143455|42107137|FG002|Cohort 1|Progressive Disease|0|||
19658409|NCT00143455|42107138|FG003|Cohort 1|Progressive Disease|0|||
19658410|NCT00143455|42107135|FG000|Cohort 1|Withdrawal by Subject|1|||
19658411|NCT00143455|42107136|FG001|Cohort 1|Withdrawal by Subject|4|||
19658412|NCT00143455|42107137|FG002|Cohort 1|Withdrawal by Subject|0|||
19658413|NCT00143455|42107138|FG003|Cohort 1|Withdrawal by Subject|0|||
19658414|NCT00143455|42107135|FG000|Cohort 1|Randomized But Not Treated|0|||
19658415|NCT00143455|42107136|FG001|Cohort 1|Randomized But Not Treated|1|||
19658416|NCT00143455|42107137|FG002|Cohort 1|Randomized But Not Treated|0|||
19658417|NCT00143455|42107138|FG003|Cohort 1|Randomized But Not Treated|0|||
19658418|NCT00143455|42107135|FG000|Cohort 2|Adverse Event|0|||
19658419|NCT00143455|42107136|FG001|Cohort 2|Adverse Event|0|||
19658420|NCT00143455|42107137|FG002|Cohort 2|Adverse Event|42|||
19658421|NCT00143455|42107138|FG003|Cohort 2|Adverse Event|30|||
19658422|NCT00143455|42107135|FG000|Cohort 2|No Longer Required Study Treatment|0|||
19658423|NCT00143455|42107136|FG001|Cohort 2|No Longer Required Study Treatment|0|||
19658424|NCT00143455|42107137|FG002|Cohort 2|No Longer Required Study Treatment|1|||
19658425|NCT00143455|42107138|FG003|Cohort 2|No Longer Required Study Treatment|0|||
19658426|NCT00143455|42107135|FG000|Cohort 2|Protocol Violation|0|||
19658427|NCT00143455|42107136|FG001|Cohort 2|Protocol Violation|0|||
19658428|NCT00143455|42107137|FG002|Cohort 2|Protocol Violation|1|||
19658429|NCT00143455|42107138|FG003|Cohort 2|Protocol Violation|1|||
19658430|NCT00143455|42107135|FG000|Cohort 2|Lost to Follow-up|0|||
19658431|NCT00143455|42107136|FG001|Cohort 2|Lost to Follow-up|0|||
19658432|NCT00143455|42107137|FG002|Cohort 2|Lost to Follow-up|1|||
19658433|NCT00143455|42107138|FG003|Cohort 2|Lost to Follow-up|4|||
19658434|NCT00143455|42107135|FG000|Cohort 2|Death|0|||
19658435|NCT00143455|42107136|FG001|Cohort 2|Death|0|||
19658436|NCT00143455|42107137|FG002|Cohort 2|Death|20|||
19658437|NCT00143455|42107138|FG003|Cohort 2|Death|12|||
19658438|NCT00143455|42107135|FG000|Cohort 2|Progressive Disease|0|||
19658439|NCT00143455|42107136|FG001|Cohort 2|Progressive Disease|0|||
19658440|NCT00143455|42107137|FG002|Cohort 2|Progressive Disease|20|||
19658441|NCT00143455|42107138|FG003|Cohort 2|Progressive Disease|27|||
19658442|NCT00143455|42107135|FG000|Cohort 2|Withdrawal by Subject|0|||
19658443|NCT00143455|42107136|FG001|Cohort 2|Withdrawal by Subject|0|||
19658444|NCT00143455|42107137|FG002|Cohort 2|Withdrawal by Subject|13|||
19658445|NCT00143455|42107138|FG003|Cohort 2|Withdrawal by Subject|12|||
19658446|NCT00143455|42107135|FG000|Cohort 2|Other|0|||
19658447|NCT00143455|42107136|FG001|Cohort 2|Other|0|||
19658448|NCT00143455|42107137|FG002|Cohort 2|Other|7|||
19658449|NCT00143455|42107138|FG003|Cohort 2|Other|6|||
19658450|NCT00143455|42107135|FG000|Cohort 2|Randomized But Not Treated|0|||
19658451|NCT00143455|42107136|FG001|Cohort 2|Randomized But Not Treated|0|||
19658452|NCT00143455|42107137|FG002|Cohort 2|Randomized But Not Treated|1|||
19658453|NCT00143455|42107138|FG003|Cohort 2|Randomized But Not Treated|1|||
19658454|NCT03529955|42107150|FG000|Overall Study|Adverse Event|1|||
19658455|NCT03529955|42107150|FG000|Overall Study|Lack of Efficacy|1|||
19658456|NCT00142909|42107166|FG000|Randomization|Various Reasons|7|||
19658457|NCT00142909|42107167|FG001|Randomization|Various Reasons|10|||
19658458|NCT00142909|42107166|FG000|Medications Begin|Protocol Violation|2|||
19658459|NCT00142909|42107167|FG001|Medications Begin|Protocol Violation|0|||
19658460|NCT00142909|42107166|FG000|Medications Begin|Withdrawal by Subject|5|||
19658461|NCT00142909|42107167|FG001|Medications Begin|Withdrawal by Subject|3|||
19658462|NCT00142909|42107166|FG000|Medications Begin|Withdrawal by Subject|2|||
19658463|NCT00142909|42107167|FG001|Medications Begin|Withdrawal by Subject|0|||
19658464|NCT00205699|42107176|FG000|Overall Study|Lost to Follow-up|1|||
19658465|NCT00205699|42107177|FG001|Overall Study|Lost to Follow-up|3|||
19658466|NCT00205699|42107178|FG002|Overall Study|Lost to Follow-up|5|||
19658467|NCT00205699|42107176|FG000|Overall Study|Adverse Event|1|||
19658468|NCT00205699|42107177|FG001|Overall Study|Adverse Event|0|||
19658469|NCT00205699|42107178|FG002|Overall Study|Adverse Event|0|||
19658470|NCT00205699|42107176|FG000|Overall Study|Withdrawal by Subject|1|||
19658471|NCT00205699|42107177|FG001|Overall Study|Withdrawal by Subject|2|||
19658472|NCT00205699|42107178|FG002|Overall Study|Withdrawal by Subject|1|||
19658473|NCT00205699|42107176|FG000|Overall Study|Lack of Efficacy|0|||
19658474|NCT00205699|42107177|FG001|Overall Study|Lack of Efficacy|1|||
19658475|NCT00205699|42107178|FG002|Overall Study|Lack of Efficacy|0|||
19658476|NCT03882801|42107191|FG000|Period 1|Adverse Event|0|||
19658477|NCT03882801|42107192|FG001|Period 1|Adverse Event|1|||
19658478|NCT03882801|42107191|FG000|Period 1|Non-compliance with study drug|1|||
19658479|NCT03882801|42107192|FG001|Period 1|Non-compliance with study drug|1|||
19658480|NCT03882801|42107191|FG000|Period 1|Never treated with study drug|1|||
19658481|NCT03882801|42107192|FG001|Period 1|Never treated with study drug|0|||
19658482|NCT03882801|42107191|FG000|Washout Period|Physician Decision|0|||
19658483|NCT03882801|42107192|FG001|Washout Period|Physician Decision|1|||
19658484|NCT03882801|42107191|FG000|Period 2|Non-compliance with study drug|0|||
19658485|NCT03882801|42107192|FG001|Period 2|Non-compliance with study drug|1|||
19658486|NCT03880227|42107202|FG000|First Visit|Withdrawal by Subject|1|||
19658487|NCT03880227|42107203|FG001|First Visit|Withdrawal by Subject|0|||
19658488|NCT03880227|42107204|FG002|First Visit|Withdrawal by Subject|0|||
19658489|NCT03880227|42107205|FG003|First Visit|Withdrawal by Subject|0|||
19658490|NCT03880227|42107202|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
19658491|NCT03880227|42107203|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
19658492|NCT03880227|42107204|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
19658493|NCT03880227|42107205|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
19658494|NCT03880227|42107202|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
19658495|NCT03880227|42107203|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
19658496|NCT03880227|42107204|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
19658497|NCT03880227|42107205|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
19658498|NCT03880227|42107202|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
19658499|NCT03880227|42107203|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
19658500|NCT03880227|42107204|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
19658501|NCT03880227|42107205|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
19658502|NCT00530439|42107238|FG000|Overall Study|GDM|9|||
19658503|NCT00530439|42107239|FG001|Overall Study|GDM|3|||
19658504|NCT00530439|42107238|FG000|Overall Study|Withdraw|18|||
19658505|NCT00530439|42107239|FG001|Overall Study|Withdraw|14|||
19658506|NCT00530439|42107238|FG000|Overall Study|Missed abortion|1|||
19658507|NCT00530439|42107239|FG001|Overall Study|Missed abortion|4|||
19658508|NCT00530439|42107238|FG000|Overall Study|Misclassification|2|||
19658509|NCT00530439|42107239|FG001|Overall Study|Misclassification|0|||
19658510|NCT00530439|42107238|FG000|Overall Study|Twin pregnancy|0|||
19658511|NCT00530439|42107239|FG001|Overall Study|Twin pregnancy|2|||
19658512|NCT00530439|42107238|FG000|Overall Study|Severe malformation/abortion|0|||
19658513|NCT00530439|42107239|FG001|Overall Study|Severe malformation/abortion|3|||
19658514|NCT00497146|42107247|FG000|Treatment Period|Adverse Event|6|||
19658515|NCT00497146|42107248|FG001|Treatment Period|Adverse Event|2|||
19658516|NCT00497146|42107247|FG000|Treatment Period|Withdrawal by Subject|5|||
19658517|NCT00497146|42107248|FG001|Treatment Period|Withdrawal by Subject|9|||
19658518|NCT00497146|42107247|FG000|Treatment Period|Lost to Follow-up|1|||
19658519|NCT00497146|42107248|FG001|Treatment Period|Lost to Follow-up|3|||
19658520|NCT00497146|42107247|FG000|Treatment Period|Required dialysis|4|||
19658521|NCT00497146|42107248|FG001|Treatment Period|Required dialysis|1|||
19658522|NCT00497146|42107247|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
19658523|NCT00497146|42107248|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
19658524|NCT00497146|42107247|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
19658525|NCT00497146|42107248|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
19658526|NCT00497146|42107247|FG000|Treatment Period|Other Reason|2|||
19658527|NCT00497146|42107248|FG001|Treatment Period|Other Reason|3|||
19658528|NCT00497146|42107247|FG000|Long-term Follow-up Period|Adverse Event|2|||
19658529|NCT00497146|42107248|FG001|Long-term Follow-up Period|Adverse Event|2|||
19658530|NCT00497146|42107247|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
19658531|NCT00497146|42107248|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
19658532|NCT00497146|42107247|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
19658533|NCT00497146|42107248|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
19658534|NCT00497146|42107247|FG000|Long-term Follow-up Period|Other|0|||
19658535|NCT00497146|42107248|FG001|Long-term Follow-up Period|Other|1|||
19658536|NCT00489970|42107259|FG000|Persistence Year 9|Lost to Follow-up|2|||
19658537|NCT00489970|42107260|FG001|Persistence Year 9|Lost to Follow-up|2|||
19658538|NCT00489970|42107261|FG002|Persistence Year 9|Lost to Follow-up|3|||
19658539|NCT00489970|42107259|FG000|Persistence Year 9|Other|1|||
19658540|NCT00489970|42107260|FG001|Persistence Year 9|Other|0|||
19658541|NCT00489970|42107261|FG002|Persistence Year 9|Other|2|||
19658542|NCT02798471|42107274|FG000|Overall Study|Adverse Event|7|||
19658543|NCT02798471|42107275|FG001|Overall Study|Adverse Event|2|||
19658544|NCT02798471|42107274|FG000|Overall Study|Physician Decision|3|||
19658545|NCT02798471|42107275|FG001|Overall Study|Physician Decision|7|||
19658546|NCT02798471|42107274|FG000|Overall Study|Death|2|||
19658547|NCT02798471|42107275|FG001|Overall Study|Death|3|||
19658548|NCT02798471|42107274|FG000|Overall Study|Lost to Follow-up|0|||
19658549|NCT02798471|42107275|FG001|Overall Study|Lost to Follow-up|1|||
19658550|NCT02798471|42107274|FG000|Overall Study|Other|5|||
19658551|NCT02798471|42107275|FG001|Overall Study|Other|3|||
19658552|NCT02798471|42107274|FG000|Overall Study|Subject withdrew consent|0|||
19658553|NCT02798471|42107275|FG001|Overall Study|Subject withdrew consent|6|||
19658554|NCT02798471|42107274|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
19658555|NCT02798471|42107275|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
19658556|NCT02798471|42107274|FG000|Overall Study|Randomized, but not treated|0|||
19658557|NCT02798471|42107275|FG001|Overall Study|Randomized, but not treated|2|||
19658558|NCT00489736|42107283|FG000|Overall Study|Lack of Efficacy|53|||
19658559|NCT00489736|42107284|FG001|Overall Study|Lack of Efficacy|14|||
19658560|NCT00489736|42107283|FG000|Overall Study|Adverse Event|32|||
19658561|NCT00489736|42107284|FG001|Overall Study|Adverse Event|45|||
19658562|NCT00489736|42107283|FG000|Overall Study|Poor compliance|6|||
19658563|NCT00489736|42107284|FG001|Overall Study|Poor compliance|2|||
19658564|NCT00489736|42107283|FG000|Overall Study|Not coded/ Not pre-specified|5|||
19658565|NCT00489736|42107284|FG001|Overall Study|Not coded/ Not pre-specified|8|||
19658566|NCT00617084|42107292|FG000|Overall Study|Withdrawal by Subject|5|||
19658567|NCT00617084|42107293|FG001|Overall Study|Withdrawal by Subject|7|||
19658568|NCT00617084|42107292|FG000|Overall Study|Missed 12 Months visit|16|||
19658569|NCT00617084|42107293|FG001|Overall Study|Missed 12 Months visit|19|||
19658570|NCT00489424|42107302|FG000|Overall Study|Adverse Event|3|||
19658571|NCT00489424|42107303|FG001|Overall Study|Adverse Event|3|||
19658572|NCT00489424|42107304|FG002|Overall Study|Adverse Event|4|||
19658573|NCT00489424|42107302|FG000|Overall Study|Lack of Efficacy|1|||
19658574|NCT00489424|42107303|FG001|Overall Study|Lack of Efficacy|0|||
19658575|NCT00489424|42107304|FG002|Overall Study|Lack of Efficacy|0|||
19658576|NCT00489424|42107302|FG000|Overall Study|Administrative problems|0|||
19658577|NCT00489424|42107303|FG001|Overall Study|Administrative problems|2|||
19658578|NCT00489424|42107304|FG002|Overall Study|Administrative problems|1|||
19658579|NCT00614744|42107314|FG000|Overall Study|Lost to Follow-up|5|||
19658580|NCT00614744|42107315|FG001|Overall Study|Lost to Follow-up|4|||
19658581|NCT00614744|42107314|FG000|Overall Study|Incomplete for Behavior Issues|0|||
19658582|NCT00614744|42107315|FG001|Overall Study|Incomplete for Behavior Issues|2|||
19658583|NCT00565812|42107324|FG000|Overall Study|Death|2|||
19658584|NCT00565812|42107325|FG001|Overall Study|Death|1|||
19658585|NCT00565812|42107326|FG002|Overall Study|Death|3|||
19658586|NCT00565812|42107324|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
19658587|NCT00565812|42107325|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
19658588|NCT00565812|42107326|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
19658589|NCT00565812|42107324|FG000|Overall Study|Lost to Follow-up|10|||
19658590|NCT00565812|42107325|FG001|Overall Study|Lost to Follow-up|8|||
19658591|NCT00565812|42107326|FG002|Overall Study|Lost to Follow-up|8|||
19658592|NCT00565812|42107324|FG000|Overall Study|Withdrawal by Subject|58|||
19658593|NCT00565812|42107325|FG001|Overall Study|Withdrawal by Subject|47|||
19658594|NCT00565812|42107326|FG002|Overall Study|Withdrawal by Subject|48|||
19658595|NCT00565812|42107324|FG000|Overall Study|Work Schedule|5|||
19658596|NCT00565812|42107325|FG001|Overall Study|Work Schedule|3|||
19658597|NCT00565812|42107326|FG002|Overall Study|Work Schedule|1|||
19658598|NCT00565812|42107324|FG000|Overall Study|Protocol Violation|2|||
19658599|NCT00565812|42107325|FG001|Overall Study|Protocol Violation|6|||
19658600|NCT00565812|42107326|FG002|Overall Study|Protocol Violation|4|||
19658601|NCT00565812|42107324|FG000|Overall Study|Adverse Event|41|||
19658602|NCT00565812|42107325|FG001|Overall Study|Adverse Event|54|||
19658603|NCT00565812|42107326|FG002|Overall Study|Adverse Event|40|||
19658604|NCT00565812|42107324|FG000|Overall Study|Jury Duty|1|||
19658605|NCT00565812|42107325|FG001|Overall Study|Jury Duty|0|||
19658606|NCT00565812|42107326|FG002|Overall Study|Jury Duty|0|||
19754304|NCT00245960|42204427|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
19754305|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
19658607|NCT00565812|42107324|FG000|Overall Study|Relocated Out of Area|5|||
19658608|NCT00565812|42107325|FG001|Overall Study|Relocated Out of Area|8|||
19658609|NCT00565812|42107326|FG002|Overall Study|Relocated Out of Area|9|||
19658610|NCT00565812|42107324|FG000|Overall Study|Sponsor Decision|1|||
19658611|NCT00565812|42107325|FG001|Overall Study|Sponsor Decision|5|||
19658612|NCT00565812|42107326|FG002|Overall Study|Sponsor Decision|1|||
19658613|NCT00565812|42107324|FG000|Overall Study|Domestic Reasons|7|||
19658614|NCT00565812|42107325|FG001|Overall Study|Domestic Reasons|1|||
19658615|NCT00565812|42107326|FG002|Overall Study|Domestic Reasons|3|||
19658616|NCT00565812|42107324|FG000|Overall Study|Research Site Closure|6|||
19658617|NCT00565812|42107325|FG001|Overall Study|Research Site Closure|1|||
19754306|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
19754307|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
19754308|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
19754309|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
19754310|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
19754311|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
19754312|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
19754313|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
19754314|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
19754315|NCT00245960|42204426|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
19754316|NCT00245960|42204427|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
19754317|NCT02729194|42204433|FG000|Overall Study|Withdrawal by Subject|3|||
19754318|NCT03215706|42204439|FG000|Randomization|Adverse Event unrelated to study drug|1|||
19754319|NCT03215706|42204440|FG001|Randomization|Adverse Event unrelated to study drug|0|||
19754320|NCT03215706|42204439|FG000|Randomization|participant withdrew consent|1|||
19754321|NCT03215706|42204440|FG001|Randomization|participant withdrew consent|3|||
19754322|NCT03215706|42204439|FG000|Randomization|no longer meets study criteria|1|||
19754323|NCT03215706|42204440|FG001|Randomization|no longer meets study criteria|4|||
19754324|NCT03215706|42204439|FG000|Randomization|other reasons|0|||
19754325|NCT03215706|42204440|FG001|Randomization|other reasons|2|||
19754326|NCT03215706|42204439|FG000|Treatment Period|Disease Progression|150|||
19754327|NCT03215706|42204440|FG001|Treatment Period|Disease Progression|142|||
19754328|NCT03215706|42204439|FG000|Treatment Period|Study Drug Toxicity|53|||
19754329|NCT03215706|42204440|FG001|Treatment Period|Study Drug Toxicity|21|||
19754330|NCT03215706|42204439|FG000|Treatment Period|Death|2|||
19754331|NCT03215706|42204440|FG001|Treatment Period|Death|1|||
19754332|NCT03215706|42204439|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
19754333|NCT03215706|42204440|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
19754334|NCT03215706|42204439|FG000|Treatment Period|Request to D/C treatment|1|||
19754335|NCT03215706|42204440|FG001|Treatment Period|Request to D/C treatment|6|||
19754336|NCT03215706|42204439|FG000|Treatment Period|Participant withdrew consent|3|||
19754337|NCT03215706|42204440|FG001|Treatment Period|Participant withdrew consent|4|||
19754338|NCT03215706|42204439|FG000|Treatment Period|Lost to Follow-up|0|||
19754339|NCT03215706|42204440|FG001|Treatment Period|Lost to Follow-up|1|||
19754340|NCT03215706|42204439|FG000|Treatment Period|Other Reasons|4|||
19754341|NCT03215706|42204440|FG001|Treatment Period|Other Reasons|5|||
19754342|NCT03215706|42204439|FG000|Treatment Period|Ongoing in the treatment period|105|||
19754343|NCT03215706|42204440|FG001|Treatment Period|Ongoing in the treatment period|43|||
19754344|NCT03178266|42204448|FG000|Overall Study|Death|0|||
19754345|NCT03178266|42204449|FG001|Overall Study|Death|1|||
19754346|NCT03178266|42204448|FG000|Overall Study|Disont. Early|0|||
19754347|NCT03178266|42204449|FG001|Overall Study|Disont. Early|1|||
19754348|NCT03178266|42204448|FG000|Overall Study|Withdrawal by Subject|0|||
19754349|NCT03178266|42204449|FG001|Overall Study|Withdrawal by Subject|2|||
19754350|NCT03548935|42204457|FG000|Overall Study|Withdrawal by Subject|26|||
19754351|NCT03548935|42204458|FG001|Overall Study|Withdrawal by Subject|17|||
19754352|NCT03548935|42204457|FG000|Overall Study|Lost to Follow-up|39|||
19754353|NCT03548935|42204458|FG001|Overall Study|Lost to Follow-up|28|||
19754354|NCT03548935|42204457|FG000|Overall Study|Death|1|||
19754355|NCT03548935|42204458|FG001|Overall Study|Death|1|||
19754356|NCT03547687|42204464|FG000|Overall Study|Withdrawal by Subject|1|||
19754357|NCT03547687|42204464|FG000|Overall Study|Death|1|||
19754358|NCT03547531|42204470|FG000|Overall Study|not coming in data collection : sick|2|||
19754359|NCT03547531|42204471|FG001|Overall Study|not coming in data collection : sick|2|||
19754360|NCT03547531|42204470|FG000|Overall Study|having family occasion|0|||
19754361|NCT03547531|42204471|FG001|Overall Study|having family occasion|2|||
19754362|NCT03566485|42204479|FG000|Overall Study|Disease progression|5|||
19754363|NCT03566485|42204480|FG001|Overall Study|Disease progression|4|||
19754364|NCT03566485|42204479|FG000|Overall Study|Clinical progression|0|||
19754365|NCT03566485|42204480|FG001|Overall Study|Clinical progression|1|||
19754366|NCT03566485|42204479|FG000|Overall Study|Toxicity|0|||
19754367|NCT03566485|42204480|FG001|Overall Study|Toxicity|2|||
19754368|NCT03176238|42204488|FG000|Overall Study|Unacceptable AEs|15|||
19754369|NCT03176238|42204489|FG001|Overall Study|Unacceptable AEs|8|||
19754370|NCT03176238|42204488|FG000|Overall Study|Abnormal lab value(s)|2|||
19754371|NCT03176238|42204489|FG001|Overall Study|Abnormal lab value(s)|0|||
19754372|NCT03176238|42204488|FG000|Overall Study|Inter-current illness|0|||
19754373|NCT03176238|42204489|FG001|Overall Study|Inter-current illness|1|||
19754374|NCT03176238|42204488|FG000|Overall Study|Consent withdrawal|14|||
19754375|NCT03176238|42204489|FG001|Overall Study|Consent withdrawal|2|||
19754376|NCT03176238|42204488|FG000|Overall Study|Lost to Follow-up|3|||
19754377|NCT03176238|42204489|FG001|Overall Study|Lost to Follow-up|0|||
19754378|NCT03176238|42204488|FG000|Overall Study|Administrative problems|1|||
19754379|NCT03176238|42204489|FG001|Overall Study|Administrative problems|0|||
19754380|NCT03176238|42204488|FG000|Overall Study|Death|3|||
19754381|NCT03176238|42204489|FG001|Overall Study|Death|0|||
19754382|NCT03176238|42204488|FG000|Overall Study|Disease Progression|133|||
19754383|NCT03176238|42204489|FG001|Overall Study|Disease Progression|22|||
19754384|NCT03176238|42204488|FG000|Overall Study|Tx duration completed per EAP|0|||
19754385|NCT03176238|42204489|FG001|Overall Study|Tx duration completed per EAP|1|||
19754386|NCT03176238|42204488|FG000|Overall Study|Patient is switched to commercial drug|16|||
19754387|NCT03176238|42204489|FG001|Overall Study|Patient is switched to commercial drug|1|||
19754388|NCT03176238|42204488|FG000|Overall Study|Protocol Violation|1|||
19754389|NCT03176238|42204489|FG001|Overall Study|Protocol Violation|0|||
19754390|NCT03176238|42204488|FG000|Overall Study|Changes in the patient's condition|2|||
19754391|NCT03176238|42204489|FG001|Overall Study|Changes in the patient's condition|1|||
19658618|NCT00565812|42107326|FG002|Overall Study|Research Site Closure|8|||
19658619|NCT00565812|42107324|FG000|Overall Study|Surgical Intervention|0|||
19658620|NCT00565812|42107325|FG001|Overall Study|Surgical Intervention|1|||
19658621|NCT00565812|42107326|FG002|Overall Study|Surgical Intervention|2|||
19658622|NCT00565812|42107324|FG000|Overall Study|Low Compliance|1|||
19658623|NCT00565812|42107325|FG001|Overall Study|Low Compliance|0|||
19658624|NCT00565812|42107326|FG002|Overall Study|Low Compliance|1|||
19658625|NCT00565812|42107324|FG000|Overall Study|Follow-up Visit Not Completed|2|||
19658626|NCT00565812|42107325|FG001|Overall Study|Follow-up Visit Not Completed|0|||
19658627|NCT00565812|42107326|FG002|Overall Study|Follow-up Visit Not Completed|1|||
19658628|NCT00565812|42107324|FG000|Overall Study|Physician Decision|2|||
19658629|NCT00565812|42107325|FG001|Overall Study|Physician Decision|0|||
19658630|NCT00565812|42107326|FG002|Overall Study|Physician Decision|0|||
19658631|NCT03974334|42107334|FG000|Overall Study|Lost to Follow-up|1|||
19658632|NCT03970824|42107341|FG000|Overall Study|Withdrawal by Subject|1|||
19658633|NCT03970824|42107342|FG001|Overall Study|Withdrawal by Subject|1|||
19658634|NCT03970824|42107343|FG002|Overall Study|Withdrawal by Subject|3|||
19658635|NCT03970824|42107341|FG000|Overall Study|Lost to Follow-up|0|||
19658636|NCT03970824|42107342|FG001|Overall Study|Lost to Follow-up|2|||
19658637|NCT03970824|42107343|FG002|Overall Study|Lost to Follow-up|1|||
19658638|NCT03970824|42107341|FG000|Overall Study|Adverse Event|1|||
19658639|NCT03970824|42107342|FG001|Overall Study|Adverse Event|0|||
19658640|NCT03970824|42107343|FG002|Overall Study|Adverse Event|0|||
19658641|NCT00564486|42107354|FG000|Overall Study|Adverse Event|0|||
19658642|NCT00564486|42107355|FG001|Overall Study|Adverse Event|1|||
19658643|NCT00564486|42107356|FG002|Overall Study|Adverse Event|0|||
19658644|NCT00564486|42107357|FG003|Overall Study|Adverse Event|0|||
19658645|NCT00564486|42107354|FG000|Overall Study|Withdrawal by Subject|4|||
19658646|NCT00564486|42107355|FG001|Overall Study|Withdrawal by Subject|0|||
19658647|NCT00564486|42107356|FG002|Overall Study|Withdrawal by Subject|0|||
19754392|NCT03176238|42204488|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
19754393|NCT03176238|42204489|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
19754394|NCT03565315|42204503|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
19754395|NCT03565315|42204504|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
19754396|NCT03565315|42204505|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
19754397|NCT03565315|42204506|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
19754398|NCT03565237|42204529|FG000|Overall Study|Non-compliance of Investigational Product|1|||
19754399|NCT03565237|42204529|FG000|Overall Study|Physician Decision|1|||
19658648|NCT00564486|42107357|FG003|Overall Study|Withdrawal by Subject|5|||
19658649|NCT00564486|42107354|FG000|Overall Study|Subject refused to have blood drawn|0|||
19658650|NCT00564486|42107355|FG001|Overall Study|Subject refused to have blood drawn|0|||
19658651|NCT00564486|42107356|FG002|Overall Study|Subject refused to have blood drawn|1|||
19658652|NCT00564486|42107357|FG003|Overall Study|Subject refused to have blood drawn|0|||
19658653|NCT00564486|42107354|FG000|Overall Study|Lost to Follow-up|3|||
19658654|NCT00564486|42107355|FG001|Overall Study|Lost to Follow-up|0|||
19658655|NCT00564486|42107356|FG002|Overall Study|Lost to Follow-up|2|||
19658656|NCT00564486|42107357|FG003|Overall Study|Lost to Follow-up|2|||
19658657|NCT00481078|42107373|FG000|Overall Study|Progression of disease|11|||
19754400|NCT01345682|42204535|FG000|Overall Study|Progressive disease per RECIST|226|||
19754401|NCT01345682|42204536|FG001|Overall Study|Progressive disease per RECIST|93|||
19658658|NCT00481078|42107374|FG001|Overall Study|Progression of disease|11|||
19658659|NCT00481078|42107373|FG000|Overall Study|Adverse Event|15|||
19658660|NCT00481078|42107374|FG001|Overall Study|Adverse Event|3|||
19658661|NCT00481078|42107373|FG000|Overall Study|Death|5|||
19658662|NCT00481078|42107374|FG001|Overall Study|Death|3|||
19658663|NCT00481078|42107373|FG000|Overall Study|Intercurrent illness|1|||
19658664|NCT00481078|42107374|FG001|Overall Study|Intercurrent illness|0|||
19658665|NCT00481078|42107373|FG000|Overall Study|Withdrawal by Subject|7|||
19658666|NCT00481078|42107374|FG001|Overall Study|Withdrawal by Subject|1|||
19658667|NCT00481078|42107373|FG000|Overall Study|Information not available|1|||
19658668|NCT00481078|42107374|FG001|Overall Study|Information not available|0|||
19754402|NCT01345682|42204535|FG000|Overall Study|Worsening of underlying cancer disease|23|||
19658669|NCT00481078|42107373|FG000|Overall Study|Received other treatment|2|||
19658670|NCT00481078|42107374|FG001|Overall Study|Received other treatment|1|||
19658671|NCT00481078|42107373|FG000|Overall Study|Brain metastasis|0|||
19658672|NCT00481078|42107374|FG001|Overall Study|Brain metastasis|1|||
19658673|NCT00480532|42107384|FG000|Overall Study|Withdrawal by Subject|2|||
19658674|NCT00480532|42107385|FG001|Overall Study|Withdrawal by Subject|4|||
19658675|NCT00480532|42107386|FG002|Overall Study|Withdrawal by Subject|3|||
19658676|NCT00480532|42107387|FG003|Overall Study|Withdrawal by Subject|1|||
19658677|NCT00480532|42107384|FG000|Overall Study|Protocol Violation|0|||
19658678|NCT00480532|42107385|FG001|Overall Study|Protocol Violation|0|||
19658679|NCT00480532|42107386|FG002|Overall Study|Protocol Violation|1|||
19658680|NCT00480532|42107387|FG003|Overall Study|Protocol Violation|0|||
19658681|NCT00496366|42107397|FG000|Overall Study|Death|1|||
19658682|NCT00488644|42107401|FG000|Overall Study|Not Eligible|1|||
19658683|NCT00488644|42107401|FG000|Overall Study|Not Evaluable|1|||
19658684|NCT00564018|42107408|FG000|Overall Study|Withdrawal by Subject|2|||
19658685|NCT00564018|42107409|FG001|Overall Study|Withdrawal by Subject|3|||
19658686|NCT00564018|42107410|FG002|Overall Study|Withdrawal by Subject|1|||
19658687|NCT03381287|42107422|FG000|Overall Study|Withdrawal by Subject|0|||
19658688|NCT03381287|42107423|FG001|Overall Study|Withdrawal by Subject|1|||
19658689|NCT03381287|42107424|FG002|Overall Study|Withdrawal by Subject|0|||
19658690|NCT03381287|42107425|FG003|Overall Study|Withdrawal by Subject|0|||
19658691|NCT03381287|42107422|FG000|Overall Study|Adverse Event|0|||
19658692|NCT03381287|42107423|FG001|Overall Study|Adverse Event|0|||
19658693|NCT03381287|42107424|FG002|Overall Study|Adverse Event|0|||
19658694|NCT03381287|42107425|FG003|Overall Study|Adverse Event|1|||
19658695|NCT03381287|42107422|FG000|Overall Study|Physician Decision|0|||
19658696|NCT03381287|42107423|FG001|Overall Study|Physician Decision|0|||
19658697|NCT03381287|42107424|FG002|Overall Study|Physician Decision|0|||
19754403|NCT01345682|42204536|FG001|Overall Study|Worsening of underlying cancer disease|12|||
19754404|NCT01345682|42204535|FG000|Overall Study|Adverse Event|51|||
19658698|NCT03381287|42107425|FG003|Overall Study|Physician Decision|1|||
19658699|NCT00616928|42107449|FG000|Overall Study|Adverse Event|6|||
19658700|NCT00616928|42107450|FG001|Overall Study|Adverse Event|3|||
19658701|NCT00616928|42107451|FG002|Overall Study|Adverse Event|2|||
19658702|NCT00616928|42107452|FG003|Overall Study|Adverse Event|2|||
19658703|NCT00616928|42107449|FG000|Overall Study|Other|51|||
19658704|NCT00616928|42107450|FG001|Overall Study|Other|8|||
19658705|NCT00616928|42107451|FG002|Overall Study|Other|15|||
19658706|NCT00616928|42107452|FG003|Overall Study|Other|5|||
19658707|NCT00616928|42107449|FG000|Overall Study|Lost to Follow-up|5|||
19658708|NCT00616928|42107450|FG001|Overall Study|Lost to Follow-up|7|||
19658709|NCT00616928|42107451|FG002|Overall Study|Lost to Follow-up|0|||
19658710|NCT00616928|42107452|FG003|Overall Study|Lost to Follow-up|0|||
19658711|NCT00563784|42107474|FG000|Overall Study|Withdrawal by Subject|2|||
19658712|NCT00563784|42107474|FG000|Overall Study|Screen Failures|20|||
19658713|NCT00203047|42107489|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
19658714|NCT00203047|42107490|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
19658715|NCT00203047|42107489|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
19658716|NCT00203047|42107490|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
19658717|NCT00203047|42107489|FG000|Overall Study|Withdrawal by Subject|13|||
19658718|NCT00203047|42107490|FG001|Overall Study|Withdrawal by Subject|47|||
19658719|NCT00203047|42107489|FG000|Overall Study|Teva requested participant withdrawal|1|||
19658720|NCT00203047|42107490|FG001|Overall Study|Teva requested participant withdrawal|1|||
19658721|NCT00203047|42107489|FG000|Overall Study|Physician Decision|8|||
19658722|NCT00203047|42107490|FG001|Overall Study|Physician Decision|7|||
19658723|NCT00203047|42107489|FG000|Overall Study|Non-compliance|4|||
19658724|NCT00203047|42107490|FG001|Overall Study|Non-compliance|8|||
19658725|NCT00203047|42107489|FG000|Overall Study|Protocol Violation|1|||
19658726|NCT00203047|42107490|FG001|Overall Study|Protocol Violation|0|||
19658727|NCT00203047|42107489|FG000|Overall Study|Lost to Follow-up|11|||
19658728|NCT00203047|42107490|FG001|Overall Study|Lost to Follow-up|5|||
19658729|NCT00203047|42107489|FG000|Overall Study|Adverse Event|8|||
19658730|NCT00203047|42107490|FG001|Overall Study|Adverse Event|18|||
19658731|NCT00203047|42107489|FG000|Overall Study|Death|1|||
19658732|NCT00203047|42107490|FG001|Overall Study|Death|2|||
19658733|NCT00203047|42107489|FG000|Overall Study|Pregnancy|3|||
19658734|NCT00203047|42107490|FG001|Overall Study|Pregnancy|0|||
19754405|NCT01345682|42204536|FG001|Overall Study|Adverse Event|41|||
19754406|NCT01345682|42204535|FG000|Overall Study|Non-compliance with protocol|0|||
19658735|NCT00203047|42107489|FG000|Overall Study|Other|5|||
19658736|NCT00203047|42107490|FG001|Overall Study|Other|5|||
19658737|NCT00142519|42107498|FG000|Overall Study|Not Treated|7|||
19658738|NCT00142519|42107499|FG001|Overall Study|Not Treated|9|||
19658739|NCT00142519|42107498|FG000|Overall Study|Protocol Violation|1|||
19658740|NCT00142519|42107499|FG001|Overall Study|Protocol Violation|0|||
19658741|NCT00142519|42107498|FG000|Overall Study|Withdrawal by Subject|10|||
19754407|NCT01345682|42204536|FG001|Overall Study|Non-compliance with protocol|1|||
19754408|NCT01345682|42204535|FG000|Overall Study|Lost to Follow-up|0|||
19658742|NCT00142519|42107499|FG001|Overall Study|Withdrawal by Subject|7|||
19658743|NCT00141817|42107518|FG000|Overall Study|Protocol Violation|0|||
19658744|NCT00141817|42107519|FG001|Overall Study|Protocol Violation|0|||
19658745|NCT00141817|42107520|FG002|Overall Study|Protocol Violation|1|||
19658746|NCT00141817|42107521|FG003|Overall Study|Protocol Violation|0|||
19658747|NCT00141817|42107518|FG000|Overall Study|Parent request|1|||
19658748|NCT00141817|42107519|FG001|Overall Study|Parent request|0|||
19658749|NCT00141817|42107520|FG002|Overall Study|Parent request|0|||
19658750|NCT00141817|42107521|FG003|Overall Study|Parent request|0|||
19658751|NCT00573170|42107531|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
19658752|NCT00573170|42107532|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
19658753|NCT00573170|42107533|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
19658754|NCT00573170|42107534|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
19658755|NCT00573170|42107535|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
19658756|NCT00573170|42107536|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
19658757|NCT00573170|42107531|FG000|First Washout Period|Adverse Event|1|||
19658758|NCT00573170|42107532|FG001|First Washout Period|Adverse Event|1|||
19658759|NCT00573170|42107533|FG002|First Washout Period|Adverse Event|0|||
19658760|NCT00573170|42107534|FG003|First Washout Period|Adverse Event|0|||
19658761|NCT00573170|42107535|FG004|First Washout Period|Adverse Event|0|||
19754409|NCT01345682|42204536|FG001|Overall Study|Lost to Follow-up|1|||
19754410|NCT01345682|42204535|FG000|Overall Study|Refused to continue trial medication|16|||
19754411|NCT01345682|42204536|FG001|Overall Study|Refused to continue trial medication|9|||
19658762|NCT00573170|42107536|FG005|First Washout Period|Adverse Event|1|||
19658763|NCT00573170|42107531|FG000|First Washout Period|Lack of Efficacy|0|||
19658764|NCT00573170|42107532|FG001|First Washout Period|Lack of Efficacy|0|||
19658765|NCT00573170|42107533|FG002|First Washout Period|Lack of Efficacy|0|||
19658766|NCT00573170|42107534|FG003|First Washout Period|Lack of Efficacy|0|||
19658767|NCT00573170|42107535|FG004|First Washout Period|Lack of Efficacy|0|||
19658768|NCT00573170|42107536|FG005|First Washout Period|Lack of Efficacy|1|||
19658769|NCT00573170|42107531|FG000|First Washout Period|Lost to Follow-up|1|||
19658770|NCT00573170|42107532|FG001|First Washout Period|Lost to Follow-up|1|||
19658771|NCT00573170|42107533|FG002|First Washout Period|Lost to Follow-up|0|||
19658772|NCT00573170|42107534|FG003|First Washout Period|Lost to Follow-up|2|||
19658773|NCT00573170|42107535|FG004|First Washout Period|Lost to Follow-up|0|||
19658774|NCT00573170|42107536|FG005|First Washout Period|Lost to Follow-up|2|||
19658775|NCT00573170|42107531|FG000|First Washout Period|Withdrawal by Subject|2|||
19658776|NCT00573170|42107532|FG001|First Washout Period|Withdrawal by Subject|0|||
19658777|NCT00573170|42107533|FG002|First Washout Period|Withdrawal by Subject|0|||
19658778|NCT00573170|42107534|FG003|First Washout Period|Withdrawal by Subject|2|||
19658779|NCT00573170|42107535|FG004|First Washout Period|Withdrawal by Subject|3|||
19658780|NCT00573170|42107536|FG005|First Washout Period|Withdrawal by Subject|3|||
19658781|NCT00573170|42107531|FG000|First Washout Period|Other|4|||
19658782|NCT00573170|42107532|FG001|First Washout Period|Other|0|||
19658783|NCT00573170|42107533|FG002|First Washout Period|Other|1|||
19658784|NCT00573170|42107534|FG003|First Washout Period|Other|1|||
19658785|NCT00573170|42107535|FG004|First Washout Period|Other|0|||
19658786|NCT00573170|42107536|FG005|First Washout Period|Other|0|||
19658787|NCT00573170|42107531|FG000|Second Washout Period|Adverse Event|1|||
19658788|NCT00573170|42107532|FG001|Second Washout Period|Adverse Event|0|||
19658789|NCT00573170|42107533|FG002|Second Washout Period|Adverse Event|0|||
19658790|NCT00573170|42107534|FG003|Second Washout Period|Adverse Event|0|||
19658791|NCT00573170|42107535|FG004|Second Washout Period|Adverse Event|1|||
19658792|NCT00573170|42107536|FG005|Second Washout Period|Adverse Event|0|||
19658793|NCT00573170|42107531|FG000|Second Washout Period|Protocol Violation|2|||
19658794|NCT00573170|42107532|FG001|Second Washout Period|Protocol Violation|1|||
19658795|NCT00573170|42107533|FG002|Second Washout Period|Protocol Violation|1|||
19658796|NCT00573170|42107534|FG003|Second Washout Period|Protocol Violation|0|||
19658797|NCT00573170|42107535|FG004|Second Washout Period|Protocol Violation|0|||
19658798|NCT00573170|42107536|FG005|Second Washout Period|Protocol Violation|0|||
19658799|NCT00573170|42107531|FG000|Second Washout Period|Withdrawal by Subject|1|||
19658800|NCT00573170|42107532|FG001|Second Washout Period|Withdrawal by Subject|1|||
19658801|NCT00573170|42107533|FG002|Second Washout Period|Withdrawal by Subject|2|||
19658802|NCT00573170|42107534|FG003|Second Washout Period|Withdrawal by Subject|0|||
19658803|NCT00573170|42107535|FG004|Second Washout Period|Withdrawal by Subject|1|||
19658804|NCT00573170|42107536|FG005|Second Washout Period|Withdrawal by Subject|0|||
19658805|NCT00573170|42107531|FG000|Second Washout Period|Lost to Follow-up|0|||
19658806|NCT00573170|42107532|FG001|Second Washout Period|Lost to Follow-up|0|||
19658807|NCT00573170|42107533|FG002|Second Washout Period|Lost to Follow-up|0|||
19658808|NCT00573170|42107534|FG003|Second Washout Period|Lost to Follow-up|1|||
19658809|NCT00573170|42107535|FG004|Second Washout Period|Lost to Follow-up|0|||
19658810|NCT00573170|42107536|FG005|Second Washout Period|Lost to Follow-up|0|||
19658811|NCT00573170|42107531|FG000|Second Washout Period|Other|1|||
19754412|NCT01345682|42204535|FG000|Overall Study|Not treated|2|||
19658812|NCT00573170|42107532|FG001|Second Washout Period|Other|2|||
19658813|NCT00573170|42107533|FG002|Second Washout Period|Other|1|||
19658814|NCT00573170|42107534|FG003|Second Washout Period|Other|4|||
19658815|NCT00573170|42107535|FG004|Second Washout Period|Other|6|||
19658816|NCT00573170|42107536|FG005|Second Washout Period|Other|2|||
19658817|NCT00573170|42107531|FG000|Third Treatment Period|Withdrawal by Subject|1|||
19658818|NCT00573170|42107532|FG001|Third Treatment Period|Withdrawal by Subject|0|||
19658819|NCT00573170|42107533|FG002|Third Treatment Period|Withdrawal by Subject|0|||
19658820|NCT00573170|42107534|FG003|Third Treatment Period|Withdrawal by Subject|0|||
19658821|NCT00573170|42107535|FG004|Third Treatment Period|Withdrawal by Subject|0|||
19658822|NCT00573170|42107536|FG005|Third Treatment Period|Withdrawal by Subject|0|||
19658823|NCT00573170|42107531|FG000|Third Treatment Period|Lost to Follow-up|0|||
19658824|NCT00573170|42107532|FG001|Third Treatment Period|Lost to Follow-up|0|||
19658825|NCT00573170|42107533|FG002|Third Treatment Period|Lost to Follow-up|0|||
19658826|NCT00573170|42107534|FG003|Third Treatment Period|Lost to Follow-up|0|||
19754413|NCT01345682|42204536|FG001|Overall Study|Not treated|1|||
19754414|NCT01345682|42204535|FG000|Overall Study|Reason other than those specified above|4|||
19754415|NCT01345682|42204536|FG001|Overall Study|Reason other than those specified above|3|||
19754416|NCT03562117|42204545|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
19658827|NCT00573170|42107535|FG004|Third Treatment Period|Lost to Follow-up|0|||
19658828|NCT00573170|42107536|FG005|Third Treatment Period|Lost to Follow-up|2|||
19658829|NCT00201643|42107555|FG000|Overall Study|Withdrawal by Subject|5|||
19658830|NCT00201643|42107556|FG001|Overall Study|Withdrawal by Subject|4|||
19754417|NCT03562117|42204546|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
19754418|NCT03562117|42204547|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
19754419|NCT03561883|42204557|FG000|Overall Study|Adverse Event|10|||
19754420|NCT03561883|42204558|FG001|Overall Study|Adverse Event|13|||
19658831|NCT00130039|42107564|FG000|Overall Study|Withdrawal by Subject|15|||
19754421|NCT03561883|42204557|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19754422|NCT03561883|42204558|FG001|Overall Study|Non-Compliance With Study Drug|2|||
19754423|NCT03561883|42204557|FG000|Overall Study|Protocol Violation|2|||
19754424|NCT03561883|42204558|FG001|Overall Study|Protocol Violation|3|||
19754425|NCT03561883|42204557|FG000|Overall Study|Withdrawal by Subject|14|||
19754426|NCT03561883|42204558|FG001|Overall Study|Withdrawal by Subject|6|||
19754427|NCT03561883|42204557|FG000|Overall Study|Lost to Follow-up|2|||
19754428|NCT03561883|42204558|FG001|Overall Study|Lost to Follow-up|6|||
19754429|NCT03561883|42204557|FG000|Overall Study|Study Terminated by Sponsor|12|||
19754430|NCT03561883|42204558|FG001|Overall Study|Study Terminated by Sponsor|11|||
19754431|NCT03561883|42204557|FG000|Overall Study|Physician Decision|1|||
19754432|NCT03561883|42204558|FG001|Overall Study|Physician Decision|0|||
19754433|NCT03561883|42204557|FG000|Overall Study|Randomized by Mistake|1|||
19754434|NCT03561883|42204558|FG001|Overall Study|Randomized by Mistake|0|||
19754435|NCT03561883|42204557|FG000|Overall Study|Other, Not Specified|3|||
19754436|NCT03561883|42204558|FG001|Overall Study|Other, Not Specified|2|||
19754437|NCT03546907|42204566|FG000|Overall Study|Lack of Efficacy|1|||
19658832|NCT00130039|42107565|FG001|Overall Study|Withdrawal by Subject|11|||
19658833|NCT00130039|42107564|FG000|Overall Study|Lost to Follow-up|3|||
19658834|NCT00130039|42107565|FG001|Overall Study|Lost to Follow-up|1|||
19754438|NCT03546907|42204567|FG001|Overall Study|Lack of Efficacy|1|||
19754439|NCT03546907|42204566|FG000|Overall Study|Withdrawal by Subject|8|||
19754440|NCT03546907|42204567|FG001|Overall Study|Withdrawal by Subject|9|||
19754441|NCT03546907|42204566|FG000|Overall Study|Adverse events (AEs)|7|||
19754442|NCT03546907|42204567|FG001|Overall Study|Adverse events (AEs)|10|||
19754443|NCT03546907|42204566|FG000|Overall Study|Other-unspecified|1|||
19658835|NCT00130039|42107564|FG000|Overall Study|Adverse Event|4|||
19658836|NCT00130039|42107565|FG001|Overall Study|Adverse Event|2|||
19658837|NCT00130039|42107564|FG000|Overall Study|Physician Decision|3|||
19658838|NCT00130039|42107565|FG001|Overall Study|Physician Decision|0|||
19658839|NCT00130039|42107564|FG000|Overall Study|clinical events without follow up MRI|5|||
19658840|NCT00130039|42107565|FG001|Overall Study|clinical events without follow up MRI|4|||
19658841|NCT00475852|42107573|FG000|Overall Study|Death|444|||
19658842|NCT00475852|42107574|FG001|Overall Study|Death|456|||
19658843|NCT00475852|42107573|FG000|Overall Study|Withdrawal by Subject|19|||
19658844|NCT00475852|42107574|FG001|Overall Study|Withdrawal by Subject|24|||
19658845|NCT00475852|42107573|FG000|Overall Study|Lost to Follow-up|54|||
19658846|NCT00475852|42107574|FG001|Overall Study|Lost to Follow-up|68|||
19658847|NCT00141271|42107583|FG000|Overall Study|Adverse Event|31|||
19658848|NCT00141271|42107584|FG001|Overall Study|Adverse Event|19|||
19658849|NCT00141271|42107585|FG002|Overall Study|Adverse Event|17|||
19658850|NCT00141271|42107583|FG000|Overall Study|Laboratory Abnormality|2|||
19658851|NCT00141271|42107584|FG001|Overall Study|Laboratory Abnormality|1|||
19658852|NCT00141271|42107585|FG002|Overall Study|Laboratory Abnormality|1|||
19658853|NCT00141271|42107583|FG000|Overall Study|Lack of Efficacy|7|||
19658854|NCT00141271|42107584|FG001|Overall Study|Lack of Efficacy|7|||
19658855|NCT00141271|42107585|FG002|Overall Study|Lack of Efficacy|3|||
19658856|NCT00141271|42107583|FG000|Overall Study|Lost to Follow-up|15|||
19658857|NCT00141271|42107584|FG001|Overall Study|Lost to Follow-up|15|||
19658858|NCT00141271|42107585|FG002|Overall Study|Lost to Follow-up|21|||
19658859|NCT00141271|42107583|FG000|Overall Study|Withdrawal by Subject|14|||
19658860|NCT00141271|42107584|FG001|Overall Study|Withdrawal by Subject|9|||
19658861|NCT00141271|42107585|FG002|Overall Study|Withdrawal by Subject|10|||
19658862|NCT00141271|42107583|FG000|Overall Study|Other|11|||
19658863|NCT00141271|42107584|FG001|Overall Study|Other|12|||
19658864|NCT00141271|42107585|FG002|Overall Study|Other|5|||
19754444|NCT03546907|42204567|FG001|Overall Study|Other-unspecified|1|||
19754445|NCT01318382|42204573|FG000|Overall Study|Physician Decision|2|||
19754446|NCT01318382|42204573|FG000|Overall Study|Device Malfunction|10|||
19754447|NCT01318382|42204573|FG000|Overall Study|Protocol Violation|1|||
19754448|NCT03053180|42204591|FG000|Overall Study|Failure to Return|1|||
19754449|NCT03560869|42204595|FG000|Overall Study|Withdrawal by Subject|3|||
19754450|NCT03560869|42204596|FG001|Overall Study|Withdrawal by Subject|4|||
19754451|NCT03560869|42204595|FG000|Overall Study|Screening failure|4|||
19754452|NCT03560869|42204596|FG001|Overall Study|Screening failure|4|||
19658865|NCT00614120|42107597|FG000|Overall Study|Adverse Event|9|||
19754453|NCT03560869|42204595|FG000|Overall Study|Withdrawal by PI|0|||
19754454|NCT03560869|42204596|FG001|Overall Study|Withdrawal by PI|1|||
19754455|NCT03590743|42204604|FG000|Overall Study|Withdrawal by Subject|0|||
19754456|NCT03590743|42204605|FG001|Overall Study|Withdrawal by Subject|1|||
19658866|NCT00614120|42107598|FG001|Overall Study|Adverse Event|22|||
19658867|NCT00614120|42107599|FG002|Overall Study|Adverse Event|30|||
19658868|NCT00614120|42107600|FG003|Overall Study|Adverse Event|3|||
19658869|NCT00614120|42107597|FG000|Overall Study|Lack of Efficacy|3|||
19658870|NCT00614120|42107598|FG001|Overall Study|Lack of Efficacy|3|||
19754457|NCT03053102|42204611|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
19754458|NCT03053102|42204611|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
19754459|NCT03589885|42204619|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
19754460|NCT03589885|42204620|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
19754461|NCT03589885|42204621|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
19754462|NCT03589885|42204622|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
19754463|NCT03589885|42204623|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
19754464|NCT03589885|42204619|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
19658871|NCT00614120|42107599|FG002|Overall Study|Lack of Efficacy|2|||
19754465|NCT03589885|42204620|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
19754466|NCT03589885|42204621|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
19658872|NCT00614120|42107600|FG003|Overall Study|Lack of Efficacy|2|||
19658873|NCT00614120|42107597|FG000|Overall Study|Protocol Violation|2|||
19658874|NCT00614120|42107598|FG001|Overall Study|Protocol Violation|5|||
19658875|NCT00614120|42107599|FG002|Overall Study|Protocol Violation|3|||
19658876|NCT00614120|42107600|FG003|Overall Study|Protocol Violation|1|||
19658877|NCT00614120|42107597|FG000|Overall Study|Withdrawal criteria|1|||
19658878|NCT00614120|42107598|FG001|Overall Study|Withdrawal criteria|0|||
19658879|NCT00614120|42107599|FG002|Overall Study|Withdrawal criteria|0|||
19658880|NCT00614120|42107600|FG003|Overall Study|Withdrawal criteria|0|||
19658881|NCT00614120|42107597|FG000|Overall Study|Withdrawal by Subject|9|||
19658882|NCT00614120|42107598|FG001|Overall Study|Withdrawal by Subject|10|||
19658883|NCT00614120|42107599|FG002|Overall Study|Withdrawal by Subject|16|||
19658884|NCT00614120|42107600|FG003|Overall Study|Withdrawal by Subject|3|||
19658885|NCT00614120|42107597|FG000|Overall Study|Did not meet trial criteria|0|||
19658886|NCT00614120|42107598|FG001|Overall Study|Did not meet trial criteria|1|||
19658887|NCT00614120|42107599|FG002|Overall Study|Did not meet trial criteria|1|||
19658888|NCT00614120|42107600|FG003|Overall Study|Did not meet trial criteria|1|||
19658889|NCT00614120|42107597|FG000|Overall Study|hCG positive (not pregnant)|0|||
19658890|NCT00614120|42107598|FG001|Overall Study|hCG positive (not pregnant)|0|||
19658891|NCT00614120|42107599|FG002|Overall Study|hCG positive (not pregnant)|1|||
19658892|NCT00614120|42107600|FG003|Overall Study|hCG positive (not pregnant)|0|||
19658893|NCT00614120|42107597|FG000|Overall Study|Hypoglycaemia|0|||
19658894|NCT00614120|42107598|FG001|Overall Study|Hypoglycaemia|0|||
19658895|NCT00614120|42107599|FG002|Overall Study|Hypoglycaemia|0|||
19658896|NCT00614120|42107600|FG003|Overall Study|Hypoglycaemia|1|||
19658897|NCT00614120|42107597|FG000|Overall Study|Lack of trial product|3|||
19658898|NCT00614120|42107598|FG001|Overall Study|Lack of trial product|3|||
19658899|NCT00614120|42107599|FG002|Overall Study|Lack of trial product|2|||
19658900|NCT00614120|42107600|FG003|Overall Study|Lack of trial product|0|||
19658901|NCT00614120|42107597|FG000|Overall Study|Late syphilis, latent|1|||
19658902|NCT00614120|42107598|FG001|Overall Study|Late syphilis, latent|0|||
19658903|NCT00614120|42107599|FG002|Overall Study|Late syphilis, latent|0|||
19658904|NCT00614120|42107600|FG003|Overall Study|Late syphilis, latent|0|||
19658905|NCT00614120|42107597|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
19658906|NCT00614120|42107598|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
19658907|NCT00614120|42107599|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
19658908|NCT00614120|42107600|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
19658909|NCT00614120|42107597|FG000|Overall Study|Lost to Follow-up|1|||
19658910|NCT00614120|42107598|FG001|Overall Study|Lost to Follow-up|2|||
19658911|NCT00614120|42107599|FG002|Overall Study|Lost to Follow-up|3|||
19658912|NCT00614120|42107600|FG003|Overall Study|Lost to Follow-up|4|||
19658913|NCT00496054|42107610|FG000|Overall Study|Adverse Event|1|||
19658914|NCT00496054|42107610|FG000|Overall Study|Lost to Follow-up|7|||
19658915|NCT00495820|42107616|FG000|Overall Study|Adverse Event|1|||
19658916|NCT00495820|42107617|FG001|Overall Study|Adverse Event|1|||
19658917|NCT00495586|42107625|FG000|Overall Study|Withdrawal by Subject|4|||
19658918|NCT00495586|42107626|FG001|Overall Study|Withdrawal by Subject|4|||
19658919|NCT00613730|42107634|FG000|Overall Study|Disease progression|2|||
19658920|NCT00613730|42107634|FG000|Overall Study|Administrative decision|1|||
19658921|NCT00613574|42107638|FG000|Overall Study|Adverse Event|3|||
19658922|NCT00613574|42107638|FG000|Overall Study|Lost to Follow-up|2|||
19658923|NCT00613574|42107638|FG000|Overall Study|Other|1|||
19658924|NCT00613106|42107644|FG000|Overall Study|Adverse Event|3|||
19658925|NCT00613106|42107645|FG001|Overall Study|Adverse Event|1|||
19658926|NCT00613106|42107644|FG000|Overall Study|Withdrawal by Subject|6|||
19754467|NCT03589885|42204622|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
19754468|NCT03589885|42204623|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
19658927|NCT00613106|42107645|FG001|Overall Study|Withdrawal by Subject|3|||
19658928|NCT00613106|42107644|FG000|Overall Study|Lost to Follow-up|7|||
19658929|NCT00613106|42107645|FG001|Overall Study|Lost to Follow-up|2|||
19658930|NCT00613106|42107644|FG000|Overall Study|misc|4|||
19658931|NCT00613106|42107645|FG001|Overall Study|misc|3|||
19658932|NCT00141037|42107653|FG000|Overall Study|Physician Decision|1|||
19658933|NCT00141037|42107654|FG001|Overall Study|Physician Decision|2|||
19658934|NCT00141037|42107653|FG000|Overall Study|Lost to Follow-up|3|||
19658935|NCT00141037|42107654|FG001|Overall Study|Lost to Follow-up|1|||
19658936|NCT00141037|42107653|FG000|Overall Study|Protocol Violation|0|||
19658937|NCT00141037|42107654|FG001|Overall Study|Protocol Violation|2|||
19658938|NCT00141037|42107653|FG000|Overall Study|Withdrawal by Subject|2|||
19658939|NCT00141037|42107654|FG001|Overall Study|Withdrawal by Subject|1|||
19658940|NCT00141037|42107653|FG000|Overall Study|Other|0|||
19658941|NCT00141037|42107654|FG001|Overall Study|Other|1|||
19658942|NCT00141037|42107653|FG000|Overall Study|Moved from area|1|||
19658943|NCT00141037|42107654|FG001|Overall Study|Moved from area|7|||
19658944|NCT00141037|42107653|FG000|Overall Study|Graft Failure|3|||
19658945|NCT00141037|42107654|FG001|Overall Study|Graft Failure|4|||
19658946|NCT00140413|42107663|FG000|Overall Study|Lost to Follow-up|1|||
19658947|NCT00140413|42107664|FG001|Overall Study|Lost to Follow-up|0|||
19658948|NCT00140413|42107663|FG000|Overall Study|Withdrawal by Subject|2|||
19658949|NCT00140413|42107664|FG001|Overall Study|Withdrawal by Subject|0|||
19658950|NCT00563706|42107680|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
19658951|NCT00563706|42107681|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
19658952|NCT00563706|42107682|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
19658953|NCT00563706|42107683|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
19658954|NCT00563706|42107684|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
19658955|NCT00563706|42107685|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
19658956|NCT00563706|42107686|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
19658957|NCT00563706|42107687|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
19658958|NCT00563706|42107688|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
19658959|NCT00563706|42107680|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
19658960|NCT00563706|42107681|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
19658961|NCT00563706|42107682|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
19658962|NCT00563706|42107683|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
19658963|NCT00563706|42107684|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
19658964|NCT00563706|42107685|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
19658965|NCT00563706|42107686|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
19658966|NCT00563706|42107687|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
19658967|NCT00563706|42107688|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
19658968|NCT00563706|42107680|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
19658969|NCT00563706|42107681|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
19658970|NCT00563706|42107682|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
19658971|NCT00563706|42107683|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
19658972|NCT00563706|42107684|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
19658973|NCT00563706|42107685|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
19658974|NCT00563706|42107686|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
19658975|NCT00563706|42107687|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
19658976|NCT00563706|42107688|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
19658977|NCT00563706|42107680|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
19658978|NCT00563706|42107681|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658979|NCT00563706|42107682|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658980|NCT00563706|42107683|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658981|NCT00563706|42107684|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658982|NCT00563706|42107685|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658983|NCT00563706|42107686|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658984|NCT00563706|42107687|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
19658985|NCT00563706|42107688|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
19658986|NCT00563706|42107680|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658987|NCT00563706|42107681|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658988|NCT00563706|42107682|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658989|NCT00563706|42107683|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658990|NCT00563706|42107684|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658991|NCT00563706|42107685|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658992|NCT00563706|42107686|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
19658993|NCT00563706|42107687|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
19754469|NCT03589885|42204619|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
19754470|NCT03589885|42204620|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
19754471|NCT03589885|42204621|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
19754472|NCT03589885|42204622|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
19658994|NCT00563706|42107688|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
19658995|NCT00129961|42107710|FG000|Overall Study|Adverse Event|1|||
19658996|NCT00129961|42107711|FG001|Overall Study|Adverse Event|0|||
19754473|NCT03589885|42204623|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
19754474|NCT03589885|42204619|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
19754475|NCT03589885|42204620|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
19754476|NCT03589885|42204621|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
19754477|NCT03589885|42204622|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
19658997|NCT00129961|42107710|FG000|Overall Study|Death|1|||
19658998|NCT00129961|42107711|FG001|Overall Study|Death|1|||
19754478|NCT03589885|42204623|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
19754479|NCT03589885|42204619|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
19754480|NCT03589885|42204620|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
19754481|NCT03589885|42204621|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
19754482|NCT03589885|42204622|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
19754483|NCT03589885|42204623|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
19754484|NCT03589885|42204619|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
19754485|NCT03589885|42204620|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
19754486|NCT03589885|42204621|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
19754487|NCT03589885|42204622|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
19754488|NCT03589885|42204623|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
19754489|NCT03589885|42204619|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
19658999|NCT00129961|42107710|FG000|Overall Study|Withdrawal by Sponsor|14|||
19659000|NCT00129961|42107711|FG001|Overall Study|Withdrawal by Sponsor|20|||
19659001|NCT00129961|42107710|FG000|Overall Study|Physician Decision|1|||
19659002|NCT00129961|42107711|FG001|Overall Study|Physician Decision|0|||
19659003|NCT00129961|42107710|FG000|Overall Study|Withdrawal by Subject|2|||
19659004|NCT00129961|42107711|FG001|Overall Study|Withdrawal by Subject|1|||
19659005|NCT00129961|42107710|FG000|Overall Study|Missing Record|0|||
19659006|NCT00129961|42107711|FG001|Overall Study|Missing Record|1|||
19659007|NCT00528567|42107719|FG000|Overall Study|Death|4|||
19659008|NCT00528567|42107720|FG001|Overall Study|Death|5|||
19659009|NCT00528567|42107719|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
19659010|NCT00528567|42107720|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
19659011|NCT00528567|42107719|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
19659012|NCT00528567|42107720|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
19659013|NCT00528567|42107719|FG000|Overall Study|Violation Criteria at Entry|3|||
19659014|NCT00528567|42107720|FG001|Overall Study|Violation Criteria at Entry|17|||
19659015|NCT00528567|42107719|FG000|Overall Study|Withdrew Consent|59|||
19659016|NCT00528567|42107720|FG001|Overall Study|Withdrew Consent|55|||
19659017|NCT00528567|42107719|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
19659018|NCT00528567|42107720|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
19659019|NCT00528567|42107719|FG000|Overall Study|Failure to Return|1|||
19659020|NCT00528567|42107720|FG001|Overall Study|Failure to Return|4|||
19659021|NCT00528567|42107719|FG000|Overall Study|Other Protocol Violation|5|||
19659022|NCT00528567|42107720|FG001|Overall Study|Other Protocol Violation|21|||
19659023|NCT00528567|42107719|FG000|Overall Study|Administrative/Other|22|||
19659024|NCT00528567|42107720|FG001|Overall Study|Administrative/Other|75|||
19659025|NCT00138151|42107733|FG000|Overall Study|Withdrawal by Subject|3|||
19659026|NCT00138151|42107733|FG000|Overall Study|Physician Decision|1|||
19659027|NCT00138073|42107737|FG000|Overall Study|lack of resources|55|||
19659028|NCT02581631|42107746|FG000|Overall Study|Disease progression|29|||
19659029|NCT02581631|42107747|FG001|Overall Study|Disease progression|19|||
19659030|NCT02581631|42107748|FG002|Overall Study|Disease progression|13|||
19659031|NCT02581631|42107749|FG003|Overall Study|Disease progression|5|||
19659032|NCT02581631|42107750|FG004|Overall Study|Disease progression|8|||
19659033|NCT02581631|42107746|FG000|Overall Study|Study drug toxicity|4|||
19659034|NCT02581631|42107747|FG001|Overall Study|Study drug toxicity|6|||
19659035|NCT02581631|42107748|FG002|Overall Study|Study drug toxicity|7|||
19659036|NCT02581631|42107749|FG003|Overall Study|Study drug toxicity|0|||
19659037|NCT02581631|42107750|FG004|Overall Study|Study drug toxicity|3|||
19659038|NCT02581631|42107746|FG000|Overall Study|AE unrelated to study drug|3|||
19659039|NCT02581631|42107747|FG001|Overall Study|AE unrelated to study drug|1|||
19659040|NCT02581631|42107748|FG002|Overall Study|AE unrelated to study drug|1|||
19659041|NCT02581631|42107749|FG003|Overall Study|AE unrelated to study drug|0|||
19659042|NCT02581631|42107750|FG004|Overall Study|AE unrelated to study drug|2|||
19659043|NCT02581631|42107746|FG000|Overall Study|Request to discontinue|1|||
19659044|NCT02581631|42107747|FG001|Overall Study|Request to discontinue|0|||
19659045|NCT02581631|42107748|FG002|Overall Study|Request to discontinue|3|||
19659046|NCT02581631|42107749|FG003|Overall Study|Request to discontinue|0|||
19659047|NCT02581631|42107750|FG004|Overall Study|Request to discontinue|1|||
19659048|NCT02581631|42107746|FG000|Overall Study|participant withdrew consent|3|||
19659049|NCT02581631|42107747|FG001|Overall Study|participant withdrew consent|0|||
19659050|NCT02581631|42107748|FG002|Overall Study|participant withdrew consent|1|||
19659051|NCT02581631|42107749|FG003|Overall Study|participant withdrew consent|0|||
19659052|NCT02581631|42107750|FG004|Overall Study|participant withdrew consent|0|||
19659053|NCT02581631|42107746|FG000|Overall Study|Maximum clinical benefit|1|||
19659054|NCT02581631|42107747|FG001|Overall Study|Maximum clinical benefit|7|||
19659055|NCT02581631|42107748|FG002|Overall Study|Maximum clinical benefit|1|||
19659056|NCT02581631|42107749|FG003|Overall Study|Maximum clinical benefit|3|||
19659057|NCT02581631|42107750|FG004|Overall Study|Maximum clinical benefit|13|||
19659058|NCT02581631|42107746|FG000|Overall Study|Other Reasons|1|||
19659059|NCT02581631|42107747|FG001|Overall Study|Other Reasons|0|||
19659060|NCT02581631|42107748|FG002|Overall Study|Other Reasons|2|||
19659061|NCT02581631|42107749|FG003|Overall Study|Other Reasons|2|||
19659062|NCT02581631|42107750|FG004|Overall Study|Other Reasons|3|||
19659063|NCT02581631|42107746|FG000|Overall Study|Poor/Non-Compliance|0|||
19659064|NCT02581631|42107747|FG001|Overall Study|Poor/Non-Compliance|0|||
19659065|NCT02581631|42107748|FG002|Overall Study|Poor/Non-Compliance|1|||
19659066|NCT02581631|42107749|FG003|Overall Study|Poor/Non-Compliance|0|||
19659067|NCT02581631|42107750|FG004|Overall Study|Poor/Non-Compliance|0|||
19659068|NCT00529035|42107762|FG000|Overall Study|Withdrawal by Subject|1|||
19659069|NCT00609674|42107775|FG000|Overall Study|Adverse Event|1|||
19659070|NCT00609674|42107776|FG001|Overall Study|Adverse Event|1|||
19659071|NCT00609674|42107775|FG000|Overall Study|Protocol Violation|3|||
19659072|NCT00609674|42107776|FG001|Overall Study|Protocol Violation|5|||
19659073|NCT00609674|42107775|FG000|Overall Study|Lost to Follow-up|1|||
19659074|NCT00609674|42107776|FG001|Overall Study|Lost to Follow-up|0|||
19659075|NCT00609674|42107775|FG000|Overall Study|Withdrew consent|2|||
19659076|NCT00609674|42107776|FG001|Overall Study|Withdrew consent|1|||
19659077|NCT00137839|42107782|FG000|Overall Study|Adverse Event|7|||
19659078|NCT00137839|42107782|FG000|Overall Study|Physician Decision|7|||
19659079|NCT00137839|42107782|FG000|Overall Study|Death|8|||
19659080|NCT00137839|42107782|FG000|Overall Study|Disease Progression|60|||
19659081|NCT00137839|42107782|FG000|Overall Study|Not Start Treatment|1|||
19659082|NCT00137839|42107782|FG000|Overall Study|Prolonged Treatment Delay|1|||
19659083|NCT00563316|42107789|FG000|Overall Study|Adverse Event|2|||
19659084|NCT00563316|42107789|FG000|Overall Study|Physician Decision|1|||
19754490|NCT03589885|42204620|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
19754491|NCT03589885|42204621|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
19754492|NCT03589885|42204622|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
19754493|NCT03589885|42204623|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
19754494|NCT03589885|42204619|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
19754495|NCT03589885|42204620|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
19659085|NCT00563316|42107789|FG000|Overall Study|Lost to Follow-up|2|||
19659086|NCT00563316|42107789|FG000|Overall Study|Death|1|||
19659087|NCT00563316|42107789|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
19659088|NCT00563316|42107789|FG000|Overall Study|Other|1|||
19659089|NCT03178487|42107799|FG000|Period 1|Adverse Event|1|||
19659090|NCT03178487|42107800|FG001|Period 1|Adverse Event|2|||
19659091|NCT03178487|42107799|FG000|Period 1|Withdrawal by Subject|2|||
19659092|NCT03178487|42107800|FG001|Period 1|Withdrawal by Subject|1|||
19659093|NCT03178487|42107799|FG000|Period 1|Lost to Follow-up|1|||
19659094|NCT03178487|42107800|FG001|Period 1|Lost to Follow-up|0|||
19659095|NCT03178487|42107799|FG000|Period 1|Other|0|||
19659096|NCT03178487|42107800|FG001|Period 1|Other|1|||
19659097|NCT03178487|42107799|FG000|Period 2|Adverse Event|4|||
19659098|NCT03178487|42107800|FG001|Period 2|Adverse Event|4|||
19659099|NCT03178487|42107799|FG000|Period 2|Withdrawal by Subject|6|||
19659100|NCT03178487|42107800|FG001|Period 2|Withdrawal by Subject|6|||
19659101|NCT03178487|42107799|FG000|Period 2|Lost to Follow-up|2|||
19659102|NCT03178487|42107800|FG001|Period 2|Lost to Follow-up|2|||
19659103|NCT03178487|42107799|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
19659104|NCT03178487|42107800|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
19659105|NCT03178487|42107799|FG000|Period 2|Other|8|||
19659106|NCT03178487|42107800|FG001|Period 2|Other|7|||
19659107|NCT00528957|42107809|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
19659108|NCT00528957|42107810|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
19659109|NCT00528957|42107809|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
19659110|NCT00528957|42107810|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
19659111|NCT00528957|42107809|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
19659112|NCT00528957|42107810|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
19659113|NCT00528957|42107809|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
19659114|NCT00528957|42107810|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
19659115|NCT00528957|42107809|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
19659116|NCT00528957|42107810|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
19659117|NCT00528957|42107809|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
19659118|NCT00528957|42107810|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
19659119|NCT00528957|42107809|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
19659120|NCT00528957|42107810|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
19659121|NCT00528957|42107809|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
19659122|NCT00528957|42107810|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
19659123|NCT00528957|42107809|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
19659124|NCT00528957|42107810|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
19659125|NCT00528957|42107809|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
19659126|NCT00528957|42107810|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
19659127|NCT00528957|42107809|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
19659128|NCT00528957|42107810|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
19754496|NCT03589885|42204621|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
19754497|NCT03589885|42204622|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
19754498|NCT03589885|42204623|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
19754499|NCT03545503|42204643|FG000|Overall Study|Protocol Violation|14|||
19754500|NCT03545503|42204644|FG001|Overall Study|Protocol Violation|16|||
19754501|NCT03545113|42204652|FG000|Overall Study|Surgery Cancelled|1|||
19754502|NCT03545113|42204653|FG001|Overall Study|Surgery Cancelled|0|||
19754503|NCT03545113|42204652|FG000|Overall Study|Death|1|||
19754504|NCT03545113|42204653|FG001|Overall Study|Death|0|||
19659129|NCT00528957|42107809|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
19659130|NCT00528957|42107810|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
19659131|NCT00528957|42107809|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
19659132|NCT00528957|42107810|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
19659133|NCT00528957|42107809|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
19659134|NCT00528957|42107810|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
19659135|NCT00528957|42107809|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
19659136|NCT00528957|42107810|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
19659137|NCT00528957|42107809|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
19659138|NCT00528957|42107810|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
19659139|NCT00560508|42107828|FG000|12 Week Double-blind Period|Adverse Event|3|||
19659140|NCT00560508|42107829|FG001|12 Week Double-blind Period|Adverse Event|2|||
19659141|NCT00560508|42107828|FG000|12 Week Double-blind Period|Protocol Violation|1|||
19659142|NCT00560508|42107829|FG001|12 Week Double-blind Period|Protocol Violation|0|||
19659143|NCT00560508|42107828|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
19659144|NCT00560508|42107829|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
19659145|NCT00560508|42107828|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
19659146|NCT00560508|42107829|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
19659147|NCT00560508|42107828|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
19659148|NCT00560508|42107829|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
19659149|NCT00560508|42107828|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
19659150|NCT00560508|42107829|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
19659151|NCT00560508|42107828|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
19659152|NCT00560508|42107829|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
19659153|NCT03962790|42107840|FG000|Period 1|Adverse Event|0|||
19659154|NCT03962790|42107841|FG001|Period 1|Adverse Event|1|||
19659155|NCT03962790|42107840|FG000|Period 1|Failed to meet all eligibility criteria|1|||
19659156|NCT03962790|42107841|FG001|Period 1|Failed to meet all eligibility criteria|1|||
19659157|NCT03962790|42107840|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
19659158|NCT03962790|42107841|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
19659159|NCT03962790|42107840|FG000|Period 1|Withdrawal by Subject|1|||
19659160|NCT03962790|42107841|FG001|Period 1|Withdrawal by Subject|0|||
19659161|NCT00609518|42107849|FG000|Overall Study|Death from Study Disease|32|||
19659162|NCT00609518|42107850|FG001|Overall Study|Death from Study Disease|32|||
19659163|NCT00609518|42107849|FG000|Overall Study|Withdrawal by Subject|5|||
19659164|NCT00609518|42107850|FG001|Overall Study|Withdrawal by Subject|3|||
19659165|NCT00609518|42107849|FG000|Overall Study|Lost to Follow-up|3|||
19659166|NCT00609518|42107850|FG001|Overall Study|Lost to Follow-up|0|||
19659167|NCT00609518|42107849|FG000|Overall Study|Physician Decision|1|||
19659168|NCT00609518|42107850|FG001|Overall Study|Physician Decision|3|||
19659169|NCT00609518|42107849|FG000|Overall Study|Death from Adverse Event|2|||
19659170|NCT00609518|42107850|FG001|Overall Study|Death from Adverse Event|2|||
19659171|NCT00609362|42107858|FG000|Overall Study|Withdrawal by Subject|2|||
19659172|NCT00609362|42107859|FG001|Overall Study|Withdrawal by Subject|1|||
19659173|NCT00609362|42107858|FG000|Overall Study|Adverse Event|1|||
19659174|NCT00609362|42107859|FG001|Overall Study|Adverse Event|0|||
19659175|NCT00611858|42107865|FG000|Overall Study|Adverse Event|2|||
19659176|NCT00611858|42107865|FG000|Overall Study|Withdrawal by Subject|2|||
19659177|NCT00137449|42107873|FG000|Overall Study|Disease Progression|8|||
19659178|NCT00137449|42107874|FG001|Overall Study|Disease Progression|13|||
19659179|NCT00137449|42107873|FG000|Overall Study|Death|4|||
19659180|NCT00137449|42107874|FG001|Overall Study|Death|3|||
19659181|NCT00137449|42107873|FG000|Overall Study|Adverse Event|3|||
19659182|NCT00137449|42107874|FG001|Overall Study|Adverse Event|1|||
19754505|NCT03545113|42204652|FG000|Overall Study|Adverse Event|2|||
19754506|NCT03545113|42204653|FG001|Overall Study|Adverse Event|0|||
19659183|NCT00137449|42107873|FG000|Overall Study|Withdrawal by Subject|1|||
19659184|NCT00137449|42107874|FG001|Overall Study|Withdrawal by Subject|1|||
19659185|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
19659186|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
19659187|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
19659188|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
19659189|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
19659190|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
19659191|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
19659192|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
19659193|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
19659194|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
19388699|NCT01661595|41632212|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
19388700|NCT01661595|41632213|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
19388701|NCT01661595|41632214|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
19601956|NCT00766090|42050524|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
19659195|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
19659196|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
19659197|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
19659198|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
19659199|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
19659200|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
19659201|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
19659202|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
19659203|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
19659204|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
19659205|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
19659206|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
19754507|NCT03545113|42204652|FG000|Overall Study|Received different surgery|1|||
19659207|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
19659208|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
19659209|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
19659210|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
19659211|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
19659212|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
19659213|NCT00528879|42107885|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
19659214|NCT00528879|42107886|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
19659215|NCT00528879|42107887|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
19659216|NCT00528879|42107888|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
19659217|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
19659218|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
19659219|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
19659220|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
19659221|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
19659222|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
19659223|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
19659224|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
19659225|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
19659226|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
19659227|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
19659228|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
19659229|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
19659230|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
19659231|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
19659232|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
19388702|NCT01661595|41632215|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
19601957|NCT00766090|42050513|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601958|NCT00766090|42050514|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601959|NCT00766090|42050515|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601960|NCT00766090|42050516|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601961|NCT00766090|42050517|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
19601962|NCT00766090|42050518|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601963|NCT00766090|42050519|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601964|NCT00766090|42050520|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601965|NCT00766090|42050521|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601966|NCT00766090|42050522|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19659233|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
19659234|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
19659235|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
19659236|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
19659237|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
19659238|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
19659239|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
19659240|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
19659241|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
19659242|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
19659243|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
19659244|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
19659245|NCT00528879|42107885|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
19659246|NCT00528879|42107886|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
19659247|NCT00528879|42107887|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
19659248|NCT00528879|42107888|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
19659249|NCT00608894|42107900|FG000|Overall Study|Withdrawal by Subject|0|||
19659250|NCT00608894|42107901|FG001|Overall Study|Withdrawal by Subject|2|||
19659251|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
19659252|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
19659253|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
19659254|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
19659255|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
19659256|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
19659257|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
19754508|NCT03545113|42204653|FG001|Overall Study|Received different surgery|0|||
19754509|NCT03214380|42204665|FG000|Lead-in|Adverse Event|3|||
19754510|NCT03214380|42204666|FG001|Lead-in|Adverse Event|0|||
19754511|NCT03214380|42204667|FG002|Lead-in|Adverse Event|0|||
19754512|NCT03214380|42204668|FG003|Lead-in|Adverse Event|1|||
19754513|NCT03214380|42204669|FG004|Lead-in|Adverse Event|0|||
19659258|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
19659259|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
19659260|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
19659261|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659262|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
19659263|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659264|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659265|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659266|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659267|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659268|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
19659269|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
19659270|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
19659271|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
19659272|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
19659273|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
19659274|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
19659275|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
19659276|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
19659277|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
19659278|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|Other|0|||
19659279|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|Other|0|||
19659280|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|Other|1|||
19659281|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|Other|1|||
19659282|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|Other|0|||
19659283|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|Other|0|||
19659284|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|Other|0|||
19659285|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|Other|1|||
19659286|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|Other|0|||
19659287|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|Death|0|||
19659288|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|Death|0|||
19659289|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|Death|0|||
19659290|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|Death|0|||
19659291|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|Death|0|||
19659292|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|Death|1|||
19659293|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|Death|0|||
19659294|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|Death|0|||
19754514|NCT03214380|42204670|FG005|Lead-in|Adverse Event|0|||
19754515|NCT03214380|42204665|FG000|Lead-in|Lost to Follow-up|4|||
19659295|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|Death|0|||
19659296|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659297|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659298|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659299|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659300|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659301|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
19659302|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
19659303|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659304|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
19659305|NCT00557856|42107909|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
19659306|NCT00557856|42107910|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659307|NCT00557856|42107911|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659308|NCT00557856|42107912|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659309|NCT00557856|42107913|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659310|NCT00557856|42107914|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659311|NCT00557856|42107915|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659312|NCT00557856|42107916|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659313|NCT00557856|42107917|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
19659314|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659315|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659316|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659317|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659318|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659319|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659320|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659321|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
19659322|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
19659323|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659324|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659325|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659326|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659327|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659328|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659329|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659330|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
19659331|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
19659332|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
19659333|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
19659334|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
19659335|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
19659336|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
19659337|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
19659338|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
19754516|NCT03214380|42204666|FG001|Lead-in|Lost to Follow-up|0|||
19754517|NCT03214380|42204667|FG002|Lead-in|Lost to Follow-up|0|||
19754518|NCT03214380|42204668|FG003|Lead-in|Lost to Follow-up|1|||
19754519|NCT03214380|42204669|FG004|Lead-in|Lost to Follow-up|0|||
19754520|NCT03214380|42204670|FG005|Lead-in|Lost to Follow-up|0|||
19754521|NCT03214380|42204665|FG000|Lead-in|Eligibility Criteria|3|||
19754522|NCT03214380|42204666|FG001|Lead-in|Eligibility Criteria|0|||
19754523|NCT03214380|42204667|FG002|Lead-in|Eligibility Criteria|0|||
19754524|NCT03214380|42204668|FG003|Lead-in|Eligibility Criteria|0|||
19754525|NCT03214380|42204669|FG004|Lead-in|Eligibility Criteria|0|||
19754526|NCT03214380|42204670|FG005|Lead-in|Eligibility Criteria|0|||
19754527|NCT03214380|42204665|FG000|Lead-in|Physician Decision|6|||
19754528|NCT03214380|42204666|FG001|Lead-in|Physician Decision|0|||
19754529|NCT03214380|42204667|FG002|Lead-in|Physician Decision|0|||
19601967|NCT00766090|42050523|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601968|NCT00766090|42050524|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
19601969|NCT00580801|42050541|FG000|Overall Study|Physician Decision|1|||
19601970|NCT00580801|42050542|FG001|Overall Study|Physician Decision|0|||
19601971|NCT00580801|42050543|FG002|Overall Study|Physician Decision|0|||
19601972|NCT00580801|42050541|FG000|Overall Study|Adverse Event|2|||
19601973|NCT00580801|42050542|FG001|Overall Study|Adverse Event|0|||
19601974|NCT00580801|42050543|FG002|Overall Study|Adverse Event|0|||
19601975|NCT00580801|42050541|FG000|Overall Study|Lost to Follow-up|2|||
19601976|NCT00580801|42050542|FG001|Overall Study|Lost to Follow-up|0|||
19601977|NCT00580801|42050543|FG002|Overall Study|Lost to Follow-up|0|||
19601978|NCT00580801|42050541|FG000|Overall Study|Reached a virologic endpoint|0|||
19754530|NCT03214380|42204668|FG003|Lead-in|Physician Decision|0|||
19659339|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
19659340|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
19659341|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|Other|0|||
19659342|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|Other|0|||
19659343|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|Other|0|||
19659344|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|Other|0|||
19659345|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|Other|0|||
19659346|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|Other|0|||
19659347|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|Other|0|||
19659348|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|Other|0|||
19659349|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|Other|1|||
19659350|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|Death|0|||
19659351|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|Death|0|||
19659352|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|Death|0|||
19754531|NCT03214380|42204669|FG004|Lead-in|Physician Decision|0|||
19754532|NCT03214380|42204670|FG005|Lead-in|Physician Decision|0|||
19754533|NCT03214380|42204665|FG000|Lead-in|Protocol Deviation|7|||
19754534|NCT03214380|42204666|FG001|Lead-in|Protocol Deviation|0|||
19659353|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|Death|0|||
19659354|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|Death|0|||
19659355|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|Death|0|||
19659356|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|Death|0|||
19659357|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|Death|0|||
19659358|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|Death|2|||
19659359|NCT00557856|42107909|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659360|NCT00557856|42107910|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
19754535|NCT03214380|42204667|FG002|Lead-in|Protocol Deviation|0|||
19754536|NCT03214380|42204668|FG003|Lead-in|Protocol Deviation|3|||
19754537|NCT03214380|42204669|FG004|Lead-in|Protocol Deviation|0|||
19754538|NCT03214380|42204670|FG005|Lead-in|Protocol Deviation|0|||
19754539|NCT03214380|42204665|FG000|Lead-in|Withdrawal by Subject|41|||
19754540|NCT03214380|42204666|FG001|Lead-in|Withdrawal by Subject|0|||
19754541|NCT03214380|42204667|FG002|Lead-in|Withdrawal by Subject|0|||
19754542|NCT03214380|42204668|FG003|Lead-in|Withdrawal by Subject|14|||
19754543|NCT03214380|42204669|FG004|Lead-in|Withdrawal by Subject|0|||
19754544|NCT03214380|42204670|FG005|Lead-in|Withdrawal by Subject|0|||
19754545|NCT03214380|42204665|FG000|Lead-in|Family Emergency|1|||
19754546|NCT03214380|42204666|FG001|Lead-in|Family Emergency|0|||
19754547|NCT03214380|42204667|FG002|Lead-in|Family Emergency|0|||
19754548|NCT03214380|42204668|FG003|Lead-in|Family Emergency|0|||
19754549|NCT03214380|42204669|FG004|Lead-in|Family Emergency|0|||
19601979|NCT00580801|42050542|FG001|Overall Study|Reached a virologic endpoint|1|||
19659361|NCT00557856|42107911|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659362|NCT00557856|42107912|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659363|NCT00557856|42107913|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659364|NCT00557856|42107914|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659365|NCT00557856|42107915|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
19659366|NCT00557856|42107916|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
19601980|NCT00580801|42050543|FG002|Overall Study|Reached a virologic endpoint|2|||
19601981|NCT00580801|42050541|FG000|Overall Study|Participant non-compliant|0|||
19601982|NCT00580801|42050542|FG001|Overall Study|Participant non-compliant|0|||
19601983|NCT00580801|42050543|FG002|Overall Study|Participant non-compliant|1|||
19601984|NCT00580801|42050541|FG000|Overall Study|Travel|1|||
19601985|NCT00580801|42050542|FG001|Overall Study|Travel|0|||
19601986|NCT00580801|42050543|FG002|Overall Study|Travel|0|||
19601987|NCT01059539|42050551|FG000|Overall Study|Adverse Event|66|||
19601988|NCT01059539|42050551|FG000|Overall Study|Insufficient Therapeutic Response|26|||
19601989|NCT01059539|42050551|FG000|Overall Study|Protocol Violation|55|||
19601990|NCT01059539|42050551|FG000|Overall Study|Withdrawal of Consent|80|||
19601991|NCT01059539|42050551|FG000|Overall Study|Lost to Follow-up|42|||
19601992|NCT01059539|42050551|FG000|Overall Study|Reason Not Specified|2|||
19601993|NCT00999908|42050555|FG000|Treatment Period 1|Subject withdrew consent|2|||
19601994|NCT00999908|42050556|FG001|Treatment Period 1|Subject withdrew consent|0|||
19601995|NCT00999908|42050557|FG002|Treatment Period 1|Subject withdrew consent|0|||
19601996|NCT00999908|42050555|FG000|Treatment Period 2|Protocol Violation|1|||
19601997|NCT00999908|42050556|FG001|Treatment Period 2|Protocol Violation|0|||
19601998|NCT00999908|42050557|FG002|Treatment Period 2|Protocol Violation|0|||
19601999|NCT00580723|42050565|FG000|Overall Study|Did not want to participate in extension|3|||
19602000|NCT00580723|42050565|FG000|Overall Study|Lost to Follow-up|5|||
19659367|NCT00557856|42107917|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
19659368|NCT00191113|42107934|FG000|Core Study|Withdrawal by Subject|25|||
19754550|NCT03214380|42204670|FG005|Lead-in|Family Emergency|0|||
19754551|NCT03214380|42204665|FG000|Lead-in|Natural Disaster|9|||
19754552|NCT03214380|42204666|FG001|Lead-in|Natural Disaster|0|||
19754553|NCT03214380|42204667|FG002|Lead-in|Natural Disaster|0|||
19754554|NCT03214380|42204668|FG003|Lead-in|Natural Disaster|0|||
19659369|NCT00191113|42107935|FG001|Core Study|Withdrawal by Subject|9|||
19659370|NCT00191113|42107934|FG000|Core Study|Protocol Violation|6|||
19659371|NCT00191113|42107935|FG001|Core Study|Protocol Violation|2|||
19659372|NCT00191113|42107934|FG000|Core Study|Lost to Follow-up|3|||
19659373|NCT00191113|42107935|FG001|Core Study|Lost to Follow-up|0|||
19659374|NCT00191113|42107934|FG000|Core Study|Adverse Event|0|||
19659375|NCT00191113|42107935|FG001|Core Study|Adverse Event|2|||
19659376|NCT00191113|42107934|FG000|Core Study|Lack of Efficacy|0|||
19659377|NCT00191113|42107935|FG001|Core Study|Lack of Efficacy|2|||
19659378|NCT00191113|42107934|FG000|Core Study|Death|1|||
19659379|NCT00191113|42107935|FG001|Core Study|Death|0|||
19659380|NCT00608582|42107949|FG000|Overall Study|Lost to Follow-up|2|||
19659381|NCT00608582|42107950|FG001|Overall Study|Lost to Follow-up|0|||
19659382|NCT00608582|42107949|FG000|Overall Study|No Best Response in Phase 1 located|1|||
19659383|NCT00608582|42107950|FG001|Overall Study|No Best Response in Phase 1 located|1|||
19659384|NCT00608582|42107949|FG000|Overall Study|Illicit Drug Use|1|||
19659385|NCT00608582|42107950|FG001|Overall Study|Illicit Drug Use|0|||
19659386|NCT00608582|42107949|FG000|Overall Study|Early stage Design Change|0|||
19659387|NCT00608582|42107950|FG001|Overall Study|Early stage Design Change|3|||
19659388|NCT03965052|42107960|FG000|Overall Study|Protocol Violation|1|||
19659389|NCT03965052|42107961|FG001|Overall Study|Protocol Violation|0|||
19659390|NCT03964974|42107969|FG000|Overall Study|Lost to Follow-up|3|||
19659391|NCT03964974|42107970|FG001|Overall Study|Lost to Follow-up|2|||
19659392|NCT03964974|42107969|FG000|Overall Study|Withdrawal by Subject|0|||
19659393|NCT03964974|42107970|FG001|Overall Study|Withdrawal by Subject|3|||
19659394|NCT00606320|42107976|FG000|Overall Study|Adverse Event|3|||
19659395|NCT00606320|42107976|FG000|Overall Study|Lack of Efficacy|5|||
19659396|NCT00606320|42107976|FG000|Overall Study|Physician Decision|7|||
19659397|NCT00606320|42107976|FG000|Overall Study|Protocol Violation|8|||
19659398|NCT00606320|42107976|FG000|Overall Study|Withdrawal by Subject|10|||
19659399|NCT00606320|42107976|FG000|Overall Study|Progression to depressive phase|4|||
19659400|NCT00528411|42107983|FG000|Overall Study|Adverse Event|4|||
19659401|NCT00528411|42107984|FG001|Overall Study|Adverse Event|0|||
19659402|NCT00528411|42107985|FG002|Overall Study|Adverse Event|1|||
19659403|NCT00528411|42107983|FG000|Overall Study|Incorrect Enrolment|1|||
19659404|NCT00528411|42107984|FG001|Overall Study|Incorrect Enrolment|1|||
19659405|NCT00528411|42107985|FG002|Overall Study|Incorrect Enrolment|0|||
19659406|NCT00528411|42107983|FG000|Overall Study|Severe non-compliance to protocol|0|||
19659407|NCT00528411|42107984|FG001|Overall Study|Severe non-compliance to protocol|1|||
19659408|NCT00528411|42107985|FG002|Overall Study|Severe non-compliance to protocol|0|||
19659409|NCT00528411|42107983|FG000|Overall Study|Prior commitment medication|0|||
19659410|NCT00528411|42107984|FG001|Overall Study|Prior commitment medication|1|||
19659411|NCT00528411|42107985|FG002|Overall Study|Prior commitment medication|0|||
19659412|NCT00136357|42107995|FG000|Overall Study|Withdrawal by Subject|3|||
19659413|NCT00136357|42107996|FG001|Overall Study|Withdrawal by Subject|2|||
19659414|NCT00129649|42108004|FG000|Overall Study|Withdrawal by Subject|76|||
19659415|NCT00129649|42108005|FG001|Overall Study|Withdrawal by Subject|65|||
19659416|NCT00187135|42108017|FG000|Visit One|Withdrawal by Subject|1|||
19659417|NCT00187135|42108018|FG001|Visit One|Withdrawal by Subject|0|||
19659418|NCT00187135|42108019|FG002|Visit One|Withdrawal by Subject|0|||
19659419|NCT00187135|42108020|FG003|Visit One|Withdrawal by Subject|0|||
19602001|NCT00999596|42050569|FG000|Overall Study|Statistical population not required|101|||
19659420|NCT00187135|42108021|FG004|Visit One|Withdrawal by Subject|0|||
19602002|NCT04676867|42050578|FG000|Overall Study|Screen failure|0|||
19602003|NCT04676867|42050579|FG001|Overall Study|Screen failure|0|||
19602004|NCT04676867|42050580|FG002|Overall Study|Screen failure|6|||
19602005|NCT04676867|42050581|FG003|Overall Study|Screen failure|2|||
19602006|NCT04676867|42050578|FG000|Overall Study|Death|0|||
19602007|NCT04676867|42050579|FG001|Overall Study|Death|0|||
19602008|NCT04676867|42050580|FG002|Overall Study|Death|1|||
19602009|NCT04676867|42050581|FG003|Overall Study|Death|0|||
19659421|NCT00187135|42108022|FG005|Visit One|Withdrawal by Subject|1|||
19659422|NCT00187135|42108017|FG000|Visit One|Physician Decision|3|||
19659423|NCT00187135|42108018|FG001|Visit One|Physician Decision|1|||
19659424|NCT00187135|42108019|FG002|Visit One|Physician Decision|0|||
19659425|NCT00187135|42108020|FG003|Visit One|Physician Decision|0|||
19659426|NCT00187135|42108021|FG004|Visit One|Physician Decision|0|||
19659427|NCT00187135|42108022|FG005|Visit One|Physician Decision|1|||
19659428|NCT00187135|42108017|FG000|Visit Two|Death|0|||
19659429|NCT00187135|42108018|FG001|Visit Two|Death|0|||
19659430|NCT00187135|42108019|FG002|Visit Two|Death|0|||
19659431|NCT00187135|42108020|FG003|Visit Two|Death|1|||
19659432|NCT00187135|42108021|FG004|Visit Two|Death|0|||
19659433|NCT00187135|42108022|FG005|Visit Two|Death|1|||
19659434|NCT00187135|42108017|FG000|Visit Two|Physician Decision|1|||
19659435|NCT00187135|42108018|FG001|Visit Two|Physician Decision|0|||
19659436|NCT00187135|42108019|FG002|Visit Two|Physician Decision|0|||
19659437|NCT00187135|42108020|FG003|Visit Two|Physician Decision|0|||
19659438|NCT00187135|42108021|FG004|Visit Two|Physician Decision|0|||
19659439|NCT00187135|42108022|FG005|Visit Two|Physician Decision|0|||
19659440|NCT00187135|42108017|FG000|Visit Two|Withdrawal by Subject|1|||
19659441|NCT00187135|42108018|FG001|Visit Two|Withdrawal by Subject|1|||
19659442|NCT00187135|42108019|FG002|Visit Two|Withdrawal by Subject|1|||
19659443|NCT00187135|42108020|FG003|Visit Two|Withdrawal by Subject|0|||
19659444|NCT00187135|42108021|FG004|Visit Two|Withdrawal by Subject|1|||
19659445|NCT00187135|42108022|FG005|Visit Two|Withdrawal by Subject|1|||
19659446|NCT00187135|42108017|FG000|Visit Two|Study Discontinued|3|||
19659447|NCT00187135|42108018|FG001|Visit Two|Study Discontinued|2|||
19659448|NCT00187135|42108019|FG002|Visit Two|Study Discontinued|1|||
19659449|NCT00187135|42108020|FG003|Visit Two|Study Discontinued|7|||
19659450|NCT00187135|42108021|FG004|Visit Two|Study Discontinued|5|||
19659451|NCT00187135|42108022|FG005|Visit Two|Study Discontinued|6|||
19659452|NCT00187135|42108017|FG000|Visit Three|Death|0|||
19659453|NCT00187135|42108018|FG001|Visit Three|Death|0|||
19659454|NCT00187135|42108019|FG002|Visit Three|Death|1|||
19659455|NCT00187135|42108020|FG003|Visit Three|Death|0|||
19659456|NCT00187135|42108021|FG004|Visit Three|Death|1|||
19659457|NCT00187135|42108022|FG005|Visit Three|Death|0|||
19659458|NCT00187135|42108017|FG000|Visit Three|Withdrawal by Subject|0|||
19659459|NCT00187135|42108018|FG001|Visit Three|Withdrawal by Subject|1|||
19659460|NCT00187135|42108019|FG002|Visit Three|Withdrawal by Subject|1|||
19659461|NCT00187135|42108020|FG003|Visit Three|Withdrawal by Subject|2|||
19659462|NCT00187135|42108021|FG004|Visit Three|Withdrawal by Subject|0|||
19659463|NCT00187135|42108022|FG005|Visit Three|Withdrawal by Subject|0|||
19659464|NCT00187135|42108017|FG000|Visit Three|Study Discontinued|7|||
19659465|NCT00187135|42108018|FG001|Visit Three|Study Discontinued|6|||
19659466|NCT00187135|42108019|FG002|Visit Three|Study Discontinued|7|||
19659467|NCT00187135|42108020|FG003|Visit Three|Study Discontinued|7|||
19659468|NCT00187135|42108021|FG004|Visit Three|Study Discontinued|7|||
19659469|NCT00187135|42108022|FG005|Visit Three|Study Discontinued|6|||
19659470|NCT00528021|42108038|FG000|Overall Study|Lack of Efficacy|17|||
19659471|NCT00528021|42108039|FG001|Overall Study|Lack of Efficacy|13|||
19659472|NCT00528021|42108040|FG002|Overall Study|Lack of Efficacy|7|||
19659473|NCT00528021|42108041|FG003|Overall Study|Lack of Efficacy|9|||
19659474|NCT00560352|42108054|FG000|Overall Study|Adverse event unrelated to study drug|2|||
19659475|NCT00560352|42108055|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19659476|NCT00560352|42108056|FG002|Overall Study|Adverse event unrelated to study drug|1|||
19659477|NCT00560352|42108054|FG000|Overall Study|Study drug toxicity|3|||
19659478|NCT00560352|42108055|FG001|Overall Study|Study drug toxicity|0|||
19659479|NCT00560352|42108056|FG002|Overall Study|Study drug toxicity|1|||
19659480|NCT00560352|42108054|FG000|Overall Study|Disease progression|0|||
19659481|NCT00560352|42108055|FG001|Overall Study|Disease progression|1|||
19659482|NCT00560352|42108056|FG002|Overall Study|Disease progression|1|||
19659483|NCT00560352|42108054|FG000|Overall Study|Withdrawal by Subject|1|||
19659484|NCT00560352|42108055|FG001|Overall Study|Withdrawal by Subject|1|||
19659485|NCT00560352|42108056|FG002|Overall Study|Withdrawal by Subject|1|||
19659486|NCT00560352|42108054|FG000|Overall Study|Maximum clinical benefit|1|||
19659487|NCT00560352|42108055|FG001|Overall Study|Maximum clinical benefit|0|||
19659488|NCT00560352|42108056|FG002|Overall Study|Maximum clinical benefit|0|||
19659489|NCT00527787|42108070|FG000|Overall Study|Adverse Event|14|||
19659490|NCT00527787|42108071|FG001|Overall Study|Adverse Event|24|||
19659491|NCT00527787|42108070|FG000|Overall Study|Withdrawal by Subject|13|||
19659492|NCT00527787|42108071|FG001|Overall Study|Withdrawal by Subject|25|||
19659493|NCT00527787|42108070|FG000|Overall Study|Lost to Follow-up|5|||
19659494|NCT00527787|42108071|FG001|Overall Study|Lost to Follow-up|2|||
19659495|NCT00527787|42108070|FG000|Overall Study|Duodenal Ulcer|1|||
19659496|NCT00527787|42108071|FG001|Overall Study|Duodenal Ulcer|10|||
19659497|NCT00527787|42108070|FG000|Overall Study|misc|5|||
19659498|NCT00527787|42108071|FG001|Overall Study|misc|2|||
19659499|NCT00608426|42108079|FG000|Overall Study|Death|32|||
19659500|NCT00608426|42108080|FG001|Overall Study|Death|36|||
19659501|NCT00608426|42108079|FG000|Overall Study|Lost to Follow-up|485|||
19659502|NCT00608426|42108080|FG001|Overall Study|Lost to Follow-up|521|||
19659503|NCT00608426|42108079|FG000|Overall Study|refused, health issues, wrong address|319|||
19659504|NCT00608426|42108080|FG001|Overall Study|refused, health issues, wrong address|348|||
19659505|NCT00557076|42108088|FG000|Overall Study|Unblinding|0|||
19659506|NCT00557076|42108089|FG001|Overall Study|Unblinding|1|||
19659507|NCT00129259|42108097|FG000|Overall Study|Lost to Follow-up|1|||
19659508|NCT00129259|42108098|FG001|Overall Study|Lost to Follow-up|1|||
19659509|NCT00129259|42108097|FG000|Overall Study|Withdrawal by Subject|2|||
19659510|NCT00129259|42108098|FG001|Overall Study|Withdrawal by Subject|1|||
19659511|NCT00129259|42108097|FG000|Overall Study|Only available minimal phone assessments|0|||
19659512|NCT00129259|42108098|FG001|Overall Study|Only available minimal phone assessments|1|||
19659513|NCT00186901|42108107|FG000|Overall Study|Pregnancy|6|||
19659514|NCT00186901|42108108|FG001|Overall Study|Pregnancy|3|||
19659515|NCT00186901|42108109|FG002|Overall Study|Pregnancy|0|||
19659516|NCT00186901|42108107|FG000|Overall Study|Lost to Follow-up|6|||
19659517|NCT00186901|42108108|FG001|Overall Study|Lost to Follow-up|3|||
19659518|NCT00186901|42108109|FG002|Overall Study|Lost to Follow-up|0|||
19659519|NCT00186901|42108107|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
19659520|NCT00186901|42108108|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
19659521|NCT00186901|42108109|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
19659522|NCT00186901|42108107|FG000|Overall Study|ALL relapse or second malignancy|1|||
19659523|NCT00186901|42108108|FG001|Overall Study|ALL relapse or second malignancy|2|||
19659524|NCT00186901|42108109|FG002|Overall Study|ALL relapse or second malignancy|0|||
19659525|NCT00186901|42108107|FG000|Overall Study|Withdrawal by Subject|4|||
19659526|NCT00186901|42108108|FG001|Overall Study|Withdrawal by Subject|5|||
19659527|NCT00186901|42108109|FG002|Overall Study|Withdrawal by Subject|0|||
19659528|NCT00186901|42108107|FG000|Overall Study|Open label|3|||
19659529|NCT00186901|42108108|FG001|Overall Study|Open label|2|||
19659530|NCT00186901|42108109|FG002|Overall Study|Open label|0|||
19659531|NCT00186901|42108107|FG000|Overall Study|Limited adherence to study requirements|20|||
19659532|NCT00186901|42108108|FG001|Overall Study|Limited adherence to study requirements|23|||
19659533|NCT00186901|42108109|FG002|Overall Study|Limited adherence to study requirements|0|||
19659534|NCT00186901|42108107|FG000|Overall Study|Bone Mineral Density > 0|0|||
19659535|NCT00186901|42108108|FG001|Overall Study|Bone Mineral Density > 0|0|||
19659536|NCT00186901|42108109|FG002|Overall Study|Bone Mineral Density > 0|149|||
19659537|NCT00186121|42108146|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
19659538|NCT00186121|42108146|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
19659539|NCT00186121|42108146|FG000|Overall Study|Not eligible (no treatment)|1|||
19659540|NCT00186043|42108152|FG000|Overall Study|Lack of Efficacy|1|||
19659541|NCT00186043|42108153|FG001|Overall Study|Lack of Efficacy|3|||
19659542|NCT00186043|42108152|FG000|Overall Study|Lost to Follow-up|4|||
19659543|NCT00186043|42108153|FG001|Overall Study|Lost to Follow-up|6|||
19659544|NCT00186043|42108152|FG000|Overall Study|Withdrawal by Subject|1|||
19659545|NCT00186043|42108153|FG001|Overall Study|Withdrawal by Subject|0|||
19659546|NCT00186043|42108152|FG000|Overall Study|Adverse Event|7|||
19659547|NCT00186043|42108153|FG001|Overall Study|Adverse Event|3|||
19659548|NCT00186043|42108152|FG000|Overall Study|Protocol Violation|2|||
19659549|NCT00186043|42108153|FG001|Overall Study|Protocol Violation|1|||
19659550|NCT00185965|42108161|FG000|Overall Study|Adverse Event|0|||
19659551|NCT00185965|42108162|FG001|Overall Study|Adverse Event|1|||
19659552|NCT00607880|42108170|FG000|Overall Study|Unable to place port due to occlusion|1|||
19754555|NCT03214380|42204669|FG004|Lead-in|Natural Disaster|0|||
19754556|NCT03214380|42204670|FG005|Lead-in|Natural Disaster|0|||
19754557|NCT03214380|42204665|FG000|Lead-in|Non Compliance|1|||
19754558|NCT03214380|42204666|FG001|Lead-in|Non Compliance|0|||
19754559|NCT03214380|42204667|FG002|Lead-in|Non Compliance|0|||
19754560|NCT03214380|42204668|FG003|Lead-in|Non Compliance|0|||
19754561|NCT03214380|42204669|FG004|Lead-in|Non Compliance|0|||
19754562|NCT03214380|42204670|FG005|Lead-in|Non Compliance|0|||
19754563|NCT03214380|42204665|FG000|Lead-in|Participant Schedule|2|||
19754564|NCT03214380|42204666|FG001|Lead-in|Participant Schedule|0|||
19754565|NCT03214380|42204667|FG002|Lead-in|Participant Schedule|0|||
19602010|NCT04676867|42050578|FG000|Overall Study|Withdrawal by Subject|2|||
19602011|NCT04676867|42050579|FG001|Overall Study|Withdrawal by Subject|2|||
19602012|NCT04676867|42050580|FG002|Overall Study|Withdrawal by Subject|4|||
19602013|NCT04676867|42050581|FG003|Overall Study|Withdrawal by Subject|4|||
19602014|NCT04676867|42050578|FG000|Overall Study|Lost to Follow-up|1|||
19602015|NCT04676867|42050579|FG001|Overall Study|Lost to Follow-up|0|||
19602016|NCT04676867|42050580|FG002|Overall Study|Lost to Follow-up|0|||
19602017|NCT04676867|42050581|FG003|Overall Study|Lost to Follow-up|0|||
19602018|NCT00770224|42050591|FG000|Step 1: Induction|Adverse Event|3|||
19602019|NCT00770224|42050592|FG001|Step 1: Induction|Adverse Event|0|||
19659553|NCT00607880|42108171|FG001|Overall Study|Unable to place port due to occlusion|0|||
19754566|NCT03214380|42204668|FG003|Lead-in|Participant Schedule|0|||
19754567|NCT03214380|42204669|FG004|Lead-in|Participant Schedule|0|||
19602020|NCT00770224|42050591|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
19602021|NCT00770224|42050592|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
19659554|NCT00127933|42108179|FG000|Overall Study|Randomized but not dosed|1|||
19659555|NCT00127933|42108180|FG001|Overall Study|Randomized but not dosed|0|||
19659556|NCT03875313|42108191|FG000|Overall Study|Withdrawal by Subject|1|||
19659557|NCT03875313|42108192|FG001|Overall Study|Withdrawal by Subject|3|||
19659558|NCT03875313|42108193|FG002|Overall Study|Withdrawal by Subject|0|||
19659559|NCT03875313|42108194|FG003|Overall Study|Withdrawal by Subject|0|||
19754568|NCT03214380|42204670|FG005|Lead-in|Participant Schedule|0|||
19754569|NCT03214380|42204665|FG000|Treatment Period|Adverse Event|0|||
19754570|NCT03214380|42204666|FG001|Treatment Period|Adverse Event|1|||
19754571|NCT03214380|42204667|FG002|Treatment Period|Adverse Event|1|||
19754572|NCT03214380|42204668|FG003|Treatment Period|Adverse Event|0|||
19659560|NCT03875313|42108195|FG004|Overall Study|Withdrawal by Subject|0|||
19659561|NCT03875313|42108191|FG000|Overall Study|Death|0|||
19659562|NCT03875313|42108192|FG001|Overall Study|Death|0|||
19659563|NCT03875313|42108193|FG002|Overall Study|Death|0|||
19659564|NCT03875313|42108194|FG003|Overall Study|Death|0|||
19659565|NCT03875313|42108195|FG004|Overall Study|Death|1|||
19659566|NCT03875313|42108191|FG000|Overall Study|Lost to Follow-up|0|||
19659567|NCT03875313|42108192|FG001|Overall Study|Lost to Follow-up|0|||
19659568|NCT03875313|42108193|FG002|Overall Study|Lost to Follow-up|0|||
19659569|NCT03875313|42108194|FG003|Overall Study|Lost to Follow-up|0|||
19659570|NCT03875313|42108195|FG004|Overall Study|Lost to Follow-up|1|||
19659571|NCT03875313|42108191|FG000|Overall Study|Study Termination by Sponsor|0|||
19659572|NCT03875313|42108192|FG001|Overall Study|Study Termination by Sponsor|1|||
19659573|NCT03875313|42108193|FG002|Overall Study|Study Termination by Sponsor|1|||
19754573|NCT03214380|42204669|FG004|Treatment Period|Adverse Event|1|||
19754574|NCT03214380|42204670|FG005|Treatment Period|Adverse Event|0|||
19659574|NCT03875313|42108194|FG003|Overall Study|Study Termination by Sponsor|0|||
19659575|NCT03875313|42108195|FG004|Overall Study|Study Termination by Sponsor|1|||
19659576|NCT03875313|42108191|FG000|Overall Study|New Anticancer Treatment|0|||
19659577|NCT03875313|42108192|FG001|Overall Study|New Anticancer Treatment|1|||
19659578|NCT03875313|42108193|FG002|Overall Study|New Anticancer Treatment|2|||
19659579|NCT03875313|42108194|FG003|Overall Study|New Anticancer Treatment|1|||
19659580|NCT03875313|42108195|FG004|Overall Study|New Anticancer Treatment|0|||
19659581|NCT03875313|42108191|FG000|Overall Study|Other, Not Specified|2|||
19659582|NCT03875313|42108192|FG001|Overall Study|Other, Not Specified|11|||
19659583|NCT03875313|42108193|FG002|Overall Study|Other, Not Specified|3|||
19659584|NCT03875313|42108194|FG003|Overall Study|Other, Not Specified|3|||
19659585|NCT03875313|42108195|FG004|Overall Study|Other, Not Specified|1|||
19659586|NCT00556998|42108207|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
19659587|NCT00556998|42108207|FG000|Voriconazole Intravenous (IV)|Other|4|||
19659588|NCT00556998|42108207|FG000|Voriconazole Oral|Adverse Event|1|||
19659589|NCT00556998|42108207|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
19659590|NCT00528801|42108217|FG000|Overall Study|Withdrawal by Subject|1|||
19659591|NCT00528801|42108218|FG001|Overall Study|Withdrawal by Subject|1|||
19659592|NCT00528801|42108217|FG000|Overall Study|Protocol Violation|11|||
19659593|NCT00528801|42108218|FG001|Overall Study|Protocol Violation|5|||
19659594|NCT00528801|42108217|FG000|Overall Study|Lost to Follow-up|15|||
19659595|NCT00528801|42108218|FG001|Overall Study|Lost to Follow-up|4|||
19659596|NCT00528801|42108217|FG000|Overall Study|Administrative Reasons|0|||
19659597|NCT00528801|42108218|FG001|Overall Study|Administrative Reasons|1|||
19659598|NCT00527397|42108224|FG000|Overall Study|Adverse Event|3|||
19659599|NCT00527397|42108224|FG000|Overall Study|Lack of Efficacy|1|||
19659600|NCT00527397|42108224|FG000|Overall Study|Protocol Violation|1|||
19659601|NCT00527397|42108224|FG000|Overall Study|Withdrawal by Subject|6|||
19659602|NCT00527397|42108224|FG000|Overall Study|Study terminated by sponsor|13|||
19659603|NCT00527319|42108234|FG000|Overall Study|Withdrawal by Subject|5|||
19659604|NCT00527319|42108235|FG001|Overall Study|Withdrawal by Subject|0|||
19754575|NCT03214380|42204665|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
19754576|NCT03214380|42204666|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
19754577|NCT03214380|42204667|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
19754578|NCT03214380|42204668|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
19754579|NCT03214380|42204669|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
19754580|NCT03214380|42204670|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
19659605|NCT00527319|42108236|FG002|Overall Study|Withdrawal by Subject|1|||
19659606|NCT00527319|42108234|FG000|Overall Study|Lost to Follow-up|1|||
19659607|NCT00527319|42108235|FG001|Overall Study|Lost to Follow-up|0|||
19659608|NCT00527319|42108236|FG002|Overall Study|Lost to Follow-up|0|||
19659609|NCT00527319|42108234|FG000|Overall Study|Death|0|||
19659610|NCT00527319|42108235|FG001|Overall Study|Death|3|||
19659611|NCT00527319|42108236|FG002|Overall Study|Death|1|||
19659612|NCT00527319|42108234|FG000|Overall Study|Intercurrent Medical Illness|0|||
19659613|NCT00527319|42108235|FG001|Overall Study|Intercurrent Medical Illness|1|||
19754581|NCT03214380|42204665|FG000|Treatment Period|Withdrawal by Subject|0|||
19754582|NCT03214380|42204666|FG001|Treatment Period|Withdrawal by Subject|10|||
19754583|NCT03214380|42204667|FG002|Treatment Period|Withdrawal by Subject|8|||
19754584|NCT03214380|42204668|FG003|Treatment Period|Withdrawal by Subject|0|||
19659614|NCT00527319|42108236|FG002|Overall Study|Intercurrent Medical Illness|3|||
19659615|NCT00527319|42108234|FG000|Overall Study|Adverse Event|0|||
19659616|NCT00527319|42108235|FG001|Overall Study|Adverse Event|0|||
19754585|NCT03214380|42204669|FG004|Treatment Period|Withdrawal by Subject|7|||
19754586|NCT03214380|42204670|FG005|Treatment Period|Withdrawal by Subject|11|||
19659617|NCT00527319|42108236|FG002|Overall Study|Adverse Event|1|||
19659618|NCT00562302|42108246|FG000|Overall Study|Lost to Follow-up|3|||
19659619|NCT00562302|42108247|FG001|Overall Study|Lost to Follow-up|3|||
19659620|NCT00562302|42108246|FG000|Overall Study|Adverse Event|0|||
19659621|NCT00562302|42108247|FG001|Overall Study|Adverse Event|6|||
19659622|NCT00562302|42108246|FG000|Overall Study|Non-compliance|1|||
19659623|NCT00562302|42108247|FG001|Overall Study|Non-compliance|2|||
19659624|NCT00562302|42108246|FG000|Overall Study|Withdrawal by Subject|7|||
19659625|NCT00562302|42108247|FG001|Overall Study|Withdrawal by Subject|8|||
19659626|NCT00562302|42108246|FG000|Overall Study|Death|1|||
19659627|NCT00562302|42108247|FG001|Overall Study|Death|2|||
19659628|NCT00562302|42108246|FG000|Overall Study|Lung resection prior to study completion|7|||
19659629|NCT00562302|42108247|FG001|Overall Study|Lung resection prior to study completion|7|||
19659630|NCT00562302|42108246|FG000|Overall Study|Not stated|1|||
19659631|NCT00562302|42108247|FG001|Overall Study|Not stated|4|||
19659632|NCT00134719|42108256|FG000|Primary Vaccination Phase|Adverse Event|4|||
19659633|NCT00134719|42108257|FG001|Primary Vaccination Phase|Adverse Event|0|||
19659634|NCT00134719|42108258|FG002|Primary Vaccination Phase|Adverse Event|0|||
19659635|NCT00134719|42108256|FG000|Primary Vaccination Phase|Protocol Violation|1|||
19659636|NCT00134719|42108257|FG001|Primary Vaccination Phase|Protocol Violation|0|||
19659637|NCT00134719|42108258|FG002|Primary Vaccination Phase|Protocol Violation|0|||
19659638|NCT00134719|42108256|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
19659639|NCT00134719|42108257|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
19659640|NCT00134719|42108258|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
19659641|NCT00134719|42108256|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
19754587|NCT03214380|42204665|FG000|Treatment Period|Death|0|||
19754588|NCT03214380|42204666|FG001|Treatment Period|Death|1|||
19754589|NCT03214380|42204667|FG002|Treatment Period|Death|2|||
19754590|NCT03214380|42204668|FG003|Treatment Period|Death|0|||
19754591|NCT03214380|42204669|FG004|Treatment Period|Death|0|||
19754592|NCT03214380|42204670|FG005|Treatment Period|Death|0|||
19754593|NCT03214380|42204665|FG000|Treatment Period|Lost to Follow-up|0|||
19754594|NCT03214380|42204666|FG001|Treatment Period|Lost to Follow-up|6|||
19754595|NCT03214380|42204667|FG002|Treatment Period|Lost to Follow-up|3|||
19754596|NCT03214380|42204668|FG003|Treatment Period|Lost to Follow-up|0|||
19754597|NCT03214380|42204669|FG004|Treatment Period|Lost to Follow-up|0|||
19754598|NCT03214380|42204670|FG005|Treatment Period|Lost to Follow-up|0|||
19754599|NCT03214380|42204665|FG000|Treatment Period|Participant schedule|0|||
19754600|NCT03214380|42204666|FG001|Treatment Period|Participant schedule|0|||
19754601|NCT03214380|42204667|FG002|Treatment Period|Participant schedule|1|||
19754602|NCT03214380|42204668|FG003|Treatment Period|Participant schedule|0|||
19754603|NCT03214380|42204669|FG004|Treatment Period|Participant schedule|0|||
19754604|NCT03214380|42204670|FG005|Treatment Period|Participant schedule|0|||
19754605|NCT03214380|42204665|FG000|Treatment Period|Treatment Interruption|0|||
19754606|NCT03214380|42204666|FG001|Treatment Period|Treatment Interruption|0|||
19754607|NCT03214380|42204667|FG002|Treatment Period|Treatment Interruption|1|||
19754608|NCT03214380|42204668|FG003|Treatment Period|Treatment Interruption|0|||
19754609|NCT03214380|42204669|FG004|Treatment Period|Treatment Interruption|0|||
19754610|NCT03214380|42204670|FG005|Treatment Period|Treatment Interruption|0|||
19754611|NCT02674464|42204684|FG000|Overall Study|Death|10|||
19754612|NCT02674464|42204685|FG001|Overall Study|Death|21|||
19754613|NCT02674464|42204684|FG000|Overall Study|Withdrawal by Subject|24|||
19754614|NCT02674464|42204685|FG001|Overall Study|Withdrawal by Subject|44|||
19754615|NCT02674464|42204684|FG000|Overall Study|Lost to Follow-up|97|||
19754616|NCT02674464|42204685|FG001|Overall Study|Lost to Follow-up|92|||
19754617|NCT02674464|42204684|FG000|Overall Study|Outside survey window|6|||
19754618|NCT02674464|42204685|FG001|Overall Study|Outside survey window|3|||
19754619|NCT03172026|42204693|FG000|Overall Study|Withdrawal by Subject|1|||
19754620|NCT03172026|42204694|FG001|Overall Study|Withdrawal by Subject|0|||
19754621|NCT03172026|42204693|FG000|Overall Study|COVID restrictions|1|||
19754622|NCT03172026|42204694|FG001|Overall Study|COVID restrictions|0|||
19659642|NCT00134719|42108257|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
19659643|NCT00134719|42108258|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
19659644|NCT00134719|42108256|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
19754623|NCT01343888|42204704|FG000|Overall Study|Adverse Event|12|||
19754624|NCT01343888|42204705|FG001|Overall Study|Adverse Event|22|||
19754625|NCT01343888|42204706|FG002|Overall Study|Adverse Event|5|||
19754626|NCT01343888|42204704|FG000|Overall Study|Lack of Efficacy|9|||
19754627|NCT01343888|42204705|FG001|Overall Study|Lack of Efficacy|9|||
19754628|NCT01343888|42204706|FG002|Overall Study|Lack of Efficacy|13|||
19754629|NCT01343888|42204704|FG000|Overall Study|Lost to Follow-up|0|||
19659645|NCT00134719|42108257|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
19754630|NCT01343888|42204705|FG001|Overall Study|Lost to Follow-up|2|||
19754631|NCT01343888|42204706|FG002|Overall Study|Lost to Follow-up|1|||
19754632|NCT01343888|42204704|FG000|Overall Study|Protocol Violation|0|||
19754633|NCT01343888|42204705|FG001|Overall Study|Protocol Violation|2|||
19754634|NCT01343888|42204706|FG002|Overall Study|Protocol Violation|0|||
19754635|NCT01343888|42204704|FG000|Overall Study|Withdrawal by Subject|4|||
19659646|NCT00134719|42108258|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
19659647|NCT00134719|42108256|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
19659648|NCT00134719|42108257|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
19659649|NCT00134719|42108258|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
19659650|NCT00526071|42108275|FG000|Overall Study|Adverse Event|1|||
19659651|NCT00526071|42108275|FG000|Overall Study|Withdrawal by Subject|1|||
19659652|NCT00526071|42108275|FG000|Overall Study|Lack of Response to Study Drug|4|||
19659653|NCT00525915|42108285|FG000|Overall Study|Non-Compliance|0|||
19659654|NCT00525915|42108286|FG001|Overall Study|Non-Compliance|1|||
19659655|NCT00525915|42108285|FG000|Overall Study|Disease Progression|5|||
19659656|NCT00525915|42108286|FG001|Overall Study|Disease Progression|6|||
19659657|NCT00525915|42108285|FG000|Overall Study|Withdrawal by Subject|1|||
19659658|NCT00525915|42108286|FG001|Overall Study|Withdrawal by Subject|0|||
19659659|NCT00525915|42108285|FG000|Overall Study|Refused Surgery|1|||
19659660|NCT00525915|42108286|FG001|Overall Study|Refused Surgery|2|||
19659661|NCT00525915|42108285|FG000|Overall Study|Unrelated illness|1|||
19659662|NCT00525915|42108286|FG001|Overall Study|Unrelated illness|0|||
19659663|NCT03143153|42108295|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
19659664|NCT03143153|42108296|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
19659665|NCT03143153|42108297|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
19659666|NCT03143153|42108295|FG000|Pre-Treatment|Participant withdrew consent|0|||
19659667|NCT03143153|42108296|FG001|Pre-Treatment|Participant withdrew consent|1|||
19659668|NCT03143153|42108297|FG002|Pre-Treatment|Participant withdrew consent|12|||
19659669|NCT03143153|42108295|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
19659670|NCT03143153|42108296|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
19659671|NCT03143153|42108297|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
19659672|NCT03143153|42108295|FG000|Pre-Treatment|Other Reasons|1|||
19659673|NCT03143153|42108296|FG001|Pre-Treatment|Other Reasons|2|||
19659674|NCT03143153|42108297|FG002|Pre-Treatment|Other Reasons|1|||
19659675|NCT03143153|42108295|FG000|Pre-Treatment|Disease Progression|1|||
19659676|NCT03143153|42108296|FG001|Pre-Treatment|Disease Progression|1|||
19659677|NCT03143153|42108297|FG002|Pre-Treatment|Disease Progression|2|||
19659678|NCT03143153|42108295|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
19659679|NCT03143153|42108296|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
19659680|NCT03143153|42108297|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
19659681|NCT03143153|42108295|FG000|Treatment|Disease progression|174|||
19659682|NCT03143153|42108296|FG001|Treatment|Disease progression|184|||
19659683|NCT03143153|42108297|FG002|Treatment|Disease progression|193|||
19659684|NCT03143153|42108295|FG000|Treatment|Study drug toxicity|59|||
19659685|NCT03143153|42108296|FG001|Treatment|Study drug toxicity|33|||
19659686|NCT03143153|42108297|FG002|Treatment|Study drug toxicity|40|||
19659687|NCT03143153|42108295|FG000|Treatment|Death|5|||
19659688|NCT03143153|42108296|FG001|Treatment|Death|3|||
19659689|NCT03143153|42108297|FG002|Treatment|Death|4|||
19659690|NCT03143153|42108295|FG000|Treatment|Adverse event unrelated to study drug|19|||
19659691|NCT03143153|42108296|FG001|Treatment|Adverse event unrelated to study drug|28|||
19659692|NCT03143153|42108297|FG002|Treatment|Adverse event unrelated to study drug|12|||
19659693|NCT03143153|42108295|FG000|Treatment|Participant request to discontinue study treatment|13|||
19659694|NCT03143153|42108296|FG001|Treatment|Participant request to discontinue study treatment|15|||
19659695|NCT03143153|42108297|FG002|Treatment|Participant request to discontinue study treatment|20|||
19659696|NCT03143153|42108295|FG000|Treatment|Participant withdrew consent|3|||
19659697|NCT03143153|42108296|FG001|Treatment|Participant withdrew consent|4|||
19659698|NCT03143153|42108297|FG002|Treatment|Participant withdrew consent|12|||
19659699|NCT03143153|42108295|FG000|Treatment|Pregnancy|1|||
19659700|NCT03143153|42108296|FG001|Treatment|Pregnancy|0|||
19754636|NCT01343888|42204705|FG001|Overall Study|Withdrawal by Subject|4|||
19754637|NCT01343888|42204706|FG002|Overall Study|Withdrawal by Subject|2|||
19659701|NCT03143153|42108297|FG002|Treatment|Pregnancy|0|||
19659702|NCT03143153|42108295|FG000|Treatment|Maximum clinical benefit|1|||
19659703|NCT03143153|42108296|FG001|Treatment|Maximum clinical benefit|3|||
19659704|NCT03143153|42108297|FG002|Treatment|Maximum clinical benefit|4|||
19659705|NCT03143153|42108295|FG000|Treatment|Completed treatment as per Protocol|13|||
19659706|NCT03143153|42108296|FG001|Treatment|Completed treatment as per Protocol|8|||
19659707|NCT03143153|42108297|FG002|Treatment|Completed treatment as per Protocol|0|||
19659708|NCT03143153|42108295|FG000|Treatment|Other reasons|12|||
19659709|NCT03143153|42108296|FG001|Treatment|Other reasons|7|||
19659710|NCT03143153|42108297|FG002|Treatment|Other reasons|15|||
19659711|NCT03143153|42108295|FG000|Treatment|Not reported|1|||
19659712|NCT03143153|42108296|FG001|Treatment|Not reported|0|||
19659713|NCT03143153|42108297|FG002|Treatment|Not reported|0|||
19659714|NCT00521079|42108307|FG000|Overall Study|Adverse Event|7|||
19659715|NCT00521079|42108308|FG001|Overall Study|Adverse Event|1|||
19659716|NCT00521079|42108307|FG000|Overall Study|Lost to Follow-up|2|||
19659717|NCT00521079|42108308|FG001|Overall Study|Lost to Follow-up|1|||
19659718|NCT00521079|42108307|FG000|Overall Study|Withdrawal by Subject|5|||
19659719|NCT00521079|42108308|FG001|Overall Study|Withdrawal by Subject|3|||
19659720|NCT00521001|42108314|FG000|Overall Study|Ineligible|1|||
19659721|NCT00134563|42108321|FG000|Overall Study|Not treated due to protocol violation|0|||
19659722|NCT00134563|42108322|FG001|Overall Study|Not treated due to protocol violation|1|||
19659723|NCT00134563|42108323|FG002|Overall Study|Not treated due to protocol violation|1|||
19659724|NCT00134563|42108321|FG000|Overall Study|Adverse Event|29|||
19659725|NCT00134563|42108322|FG001|Overall Study|Adverse Event|37|||
19659726|NCT00134563|42108323|FG002|Overall Study|Adverse Event|38|||
19659727|NCT00134563|42108321|FG000|Overall Study|Lack of Efficacy|24|||
19659728|NCT00134563|42108322|FG001|Overall Study|Lack of Efficacy|14|||
19659729|NCT00134563|42108323|FG002|Overall Study|Lack of Efficacy|17|||
19659730|NCT00134563|42108321|FG000|Overall Study|Protocol Violation|3|||
19659731|NCT00134563|42108322|FG001|Overall Study|Protocol Violation|2|||
19659732|NCT00134563|42108323|FG002|Overall Study|Protocol Violation|5|||
19659733|NCT00134563|42108321|FG000|Overall Study|Lost to Follow-up|4|||
19659734|NCT00134563|42108322|FG001|Overall Study|Lost to Follow-up|0|||
19659735|NCT00134563|42108323|FG002|Overall Study|Lost to Follow-up|2|||
19659736|NCT00134563|42108321|FG000|Overall Study|progressive disease|11|||
19659737|NCT00134563|42108322|FG001|Overall Study|progressive disease|4|||
19659738|NCT00134563|42108323|FG002|Overall Study|progressive disease|2|||
19659739|NCT00134563|42108321|FG000|Overall Study|did not wish to continue|33|||
19659740|NCT00134563|42108322|FG001|Overall Study|did not wish to continue|32|||
19659741|NCT00134563|42108323|FG002|Overall Study|did not wish to continue|26|||
19659742|NCT00134563|42108321|FG000|Overall Study|Reason other than above|0|||
19659743|NCT00134563|42108322|FG001|Overall Study|Reason other than above|2|||
19659744|NCT00134563|42108323|FG002|Overall Study|Reason other than above|5|||
19659745|NCT00520845|42108331|FG000|Overall Study|Death|3|||
19659746|NCT00520845|42108331|FG000|Overall Study|Adverse Event|4|||
19659747|NCT00520845|42108331|FG000|Overall Study|Disease Progression, relapse|13|||
19754638|NCT01343888|42204704|FG000|Overall Study|other than stated above|0|||
19754639|NCT01343888|42204705|FG001|Overall Study|other than stated above|0|||
19659748|NCT00520845|42108331|FG000|Overall Study|Withdrawal by Subject|1|||
19659749|NCT00520845|42108331|FG000|Overall Study|Alternative Therapy|1|||
19659750|NCT00185731|42108335|FG000|Overall Study|Withdrawal by Subject|1|||
19659751|NCT00185731|42108335|FG000|Overall Study|Not Eligible|1|||
19659752|NCT00582491|42108343|FG000|Overall Study|Withdrawal by Subject|1|||
19659753|NCT00582491|42108344|FG001|Overall Study|Withdrawal by Subject|0|||
19659754|NCT00520767|42108350|FG000|Overall Study|Death|2|||
19659755|NCT04679051|42108356|FG000|Overall Study|felt tired after restricted time in bed|3|||
19754640|NCT01343888|42204706|FG002|Overall Study|other than stated above|1|||
19754641|NCT03589807|42204720|FG000|Overall Study|Lost to Follow-up|0|||
19754642|NCT03589807|42204721|FG001|Overall Study|Lost to Follow-up|2|||
19659756|NCT04679051|42108357|FG001|Overall Study|felt tired after restricted time in bed|0|||
19659757|NCT04679051|42108356|FG000|Overall Study|discomfort with blood pressure cuff|2|||
19659758|NCT04679051|42108357|FG001|Overall Study|discomfort with blood pressure cuff|0|||
19659759|NCT04679051|42108356|FG000|Overall Study|scheduling conflict|1|||
19754643|NCT03589807|42204722|FG002|Overall Study|Lost to Follow-up|2|||
19659760|NCT04679051|42108357|FG001|Overall Study|scheduling conflict|1|||
19659761|NCT04679051|42108356|FG000|Overall Study|Protocol Violation|0|||
19373615|NCT02760407|41614836|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
19373616|NCT02760407|41614833|FG000|Overall Study|Use of prohibited Medication|0|||
19373617|NCT02760407|41614834|FG001|Overall Study|Use of prohibited Medication|0|||
19373618|NCT02760407|41614835|FG002|Overall Study|Use of prohibited Medication|1|||
19373619|NCT02760407|41614836|FG003|Overall Study|Use of prohibited Medication|0|||
19373620|NCT02760407|41614833|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
19373621|NCT02760407|41614834|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
19373622|NCT02760407|41614835|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
19373623|NCT02760407|41614836|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
19373624|NCT02760407|41614833|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
19373625|NCT02760407|41614834|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
19373626|NCT02760407|41614835|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
19373627|NCT02760407|41614836|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
19659762|NCT04679051|42108357|FG001|Overall Study|Protocol Violation|4|||
19659763|NCT03873987|42108368|FG000|Overall Study|Adverse Event|1|||
19659764|NCT03873987|42108369|FG001|Overall Study|Adverse Event|0|||
19659765|NCT03873987|42108368|FG000|Overall Study|staff was unable to start a new IV line|1|||
19659766|NCT03873987|42108369|FG001|Overall Study|staff was unable to start a new IV line|0|||
19659767|NCT03873987|42108368|FG000|Overall Study|Lost to Follow-up|0|||
19659768|NCT03873987|42108369|FG001|Overall Study|Lost to Follow-up|1|||
19659769|NCT00474760|42108387|FG000|Overall Study|Death|0|||
19659770|NCT00474760|42108388|FG001|Overall Study|Death|0|||
19659771|NCT00474760|42108389|FG002|Overall Study|Death|0|||
19659772|NCT00474760|42108390|FG003|Overall Study|Death|0|||
19659773|NCT00474760|42108391|FG004|Overall Study|Death|2|||
19659774|NCT00474760|42108392|FG005|Overall Study|Death|0|||
19659775|NCT00474760|42108393|FG006|Overall Study|Death|0|||
19659776|NCT00474760|42108387|FG000|Overall Study|Adverse Event|0|||
19659777|NCT00474760|42108388|FG001|Overall Study|Adverse Event|0|||
19659778|NCT00474760|42108389|FG002|Overall Study|Adverse Event|0|||
19659779|NCT00474760|42108390|FG003|Overall Study|Adverse Event|0|||
19659780|NCT00474760|42108391|FG004|Overall Study|Adverse Event|1|||
19659781|NCT00474760|42108392|FG005|Overall Study|Adverse Event|7|||
19659782|NCT00474760|42108393|FG006|Overall Study|Adverse Event|0|||
19659783|NCT00474760|42108387|FG000|Overall Study|Laboratory abnormality|0|||
19659784|NCT00474760|42108388|FG001|Overall Study|Laboratory abnormality|0|||
19659785|NCT00474760|42108389|FG002|Overall Study|Laboratory abnormality|0|||
19659786|NCT00474760|42108390|FG003|Overall Study|Laboratory abnormality|0|||
19754644|NCT03589807|42204723|FG003|Overall Study|Lost to Follow-up|3|||
19754645|NCT03589807|42204724|FG004|Overall Study|Lost to Follow-up|1|||
19754646|NCT03589807|42204725|FG005|Overall Study|Lost to Follow-up|1|||
19754647|NCT03589807|42204720|FG000|Overall Study|Withdrawal by Subject|0|||
19754648|NCT03589807|42204721|FG001|Overall Study|Withdrawal by Subject|5|||
19754649|NCT03589807|42204722|FG002|Overall Study|Withdrawal by Subject|0|||
19754650|NCT03589807|42204723|FG003|Overall Study|Withdrawal by Subject|0|||
19754651|NCT03589807|42204724|FG004|Overall Study|Withdrawal by Subject|0|||
19659787|NCT00474760|42108391|FG004|Overall Study|Laboratory abnormality|0|||
19659788|NCT00474760|42108392|FG005|Overall Study|Laboratory abnormality|1|||
19659789|NCT00474760|42108393|FG006|Overall Study|Laboratory abnormality|0|||
19659790|NCT00474760|42108387|FG000|Overall Study|Withdrawal by Subject|0|||
19659791|NCT00474760|42108388|FG001|Overall Study|Withdrawal by Subject|0|||
19659792|NCT00474760|42108389|FG002|Overall Study|Withdrawal by Subject|0|||
19659793|NCT00474760|42108390|FG003|Overall Study|Withdrawal by Subject|1|||
19659794|NCT00474760|42108391|FG004|Overall Study|Withdrawal by Subject|0|||
19659795|NCT00474760|42108392|FG005|Overall Study|Withdrawal by Subject|1|||
19659796|NCT00474760|42108393|FG006|Overall Study|Withdrawal by Subject|1|||
19754652|NCT03589807|42204725|FG005|Overall Study|Withdrawal by Subject|0|||
19754653|NCT03589807|42204720|FG000|Overall Study|Protocol Violation|0|||
19754654|NCT03589807|42204721|FG001|Overall Study|Protocol Violation|0|||
19659797|NCT00474760|42108387|FG000|Overall Study|Other|0|||
19659798|NCT00474760|42108388|FG001|Overall Study|Other|1|||
19754655|NCT03589807|42204722|FG002|Overall Study|Protocol Violation|0|||
19754656|NCT03589807|42204723|FG003|Overall Study|Protocol Violation|1|||
19754657|NCT03589807|42204724|FG004|Overall Study|Protocol Violation|0|||
19659799|NCT00474760|42108389|FG002|Overall Study|Other|0|||
19659800|NCT00474760|42108390|FG003|Overall Study|Other|0|||
19659801|NCT00474760|42108391|FG004|Overall Study|Other|1|||
19659802|NCT00474760|42108392|FG005|Overall Study|Other|0|||
19659803|NCT00474760|42108393|FG006|Overall Study|Other|0|||
19659804|NCT00474760|42108387|FG000|Overall Study|Progressive disease|3|||
19659805|NCT00474760|42108388|FG001|Overall Study|Progressive disease|2|||
19659806|NCT00474760|42108389|FG002|Overall Study|Progressive disease|3|||
19659807|NCT00474760|42108390|FG003|Overall Study|Progressive disease|2|||
19659808|NCT00474760|42108391|FG004|Overall Study|Progressive disease|8|||
19659809|NCT00474760|42108392|FG005|Overall Study|Progressive disease|20|||
19659810|NCT00474760|42108393|FG006|Overall Study|Progressive disease|7|||
19659811|NCT00474760|42108387|FG000|Overall Study|Terminated by sponsor|0|||
19659812|NCT00474760|42108388|FG001|Overall Study|Terminated by sponsor|0|||
19659813|NCT00474760|42108389|FG002|Overall Study|Terminated by sponsor|0|||
19659814|NCT00474760|42108390|FG003|Overall Study|Terminated by sponsor|0|||
19659815|NCT00474760|42108391|FG004|Overall Study|Terminated by sponsor|0|||
19659816|NCT00474760|42108392|FG005|Overall Study|Terminated by sponsor|0|||
19659817|NCT00474760|42108393|FG006|Overall Study|Terminated by sponsor|2|||
19659818|NCT00528645|42108416|FG000|Overall Study|Adverse Event|3|||
19659819|NCT00524745|42108425|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
19659820|NCT00524745|42108426|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
19659821|NCT00524745|42108427|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
19659822|NCT00524745|42108428|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
19659823|NCT00495040|42108438|FG000|Overall Study|Withdrawal by Subject|3|||
19659824|NCT00494026|42108446|FG000|Overall Study|Sponsor Decision|4|||
19659825|NCT00524589|42108450|FG000|Overall Study|Withdrawal by Subject|2|||
19659826|NCT00524589|42108450|FG000|Overall Study|Disease Progression|16|||
19754658|NCT03589807|42204725|FG005|Overall Study|Protocol Violation|0|||
19754659|NCT03589807|42204720|FG000|Overall Study|Enrolled but treatment not administered|0|||
19754660|NCT03589807|42204721|FG001|Overall Study|Enrolled but treatment not administered|0|||
19754661|NCT03589807|42204722|FG002|Overall Study|Enrolled but treatment not administered|0|||
19659827|NCT00472030|42108456|FG000|Overall Study|Physician Decision|1|||
19659828|NCT00472030|42108457|FG001|Overall Study|Physician Decision|0|||
19659829|NCT00127855|42108472|FG000|Primary Vaccination Course|Adverse Event|0|||
19659830|NCT00127855|42108473|FG001|Primary Vaccination Course|Adverse Event|0|||
19659831|NCT00127855|42108474|FG002|Primary Vaccination Course|Adverse Event|1|||
19659832|NCT00127855|42108475|FG003|Primary Vaccination Course|Adverse Event|0|||
19659833|NCT00127855|42108476|FG004|Primary Vaccination Course|Adverse Event|0|||
19659834|NCT00127855|42108472|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
19659835|NCT00127855|42108473|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
19659836|NCT00127855|42108474|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
19659837|NCT00127855|42108475|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
19659838|NCT00127855|42108476|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
19659839|NCT00127855|42108472|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
19659840|NCT00127855|42108473|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
19659841|NCT00127855|42108474|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
19659842|NCT00127855|42108475|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
19659843|NCT00127855|42108476|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
19659844|NCT00127855|42108472|FG000|Primary Vaccination Course|Other|0|||
19754662|NCT03589807|42204723|FG003|Overall Study|Enrolled but treatment not administered|0|||
19754663|NCT03589807|42204724|FG004|Overall Study|Enrolled but treatment not administered|1|||
19477090|NCT01488071|41755997|FG000|Overall Study|Non-compliance with study drug|2|||
19477091|NCT01488071|41755998|FG001|Overall Study|Non-compliance with study drug|0|||
19477092|NCT01488071|41755997|FG000|Overall Study|Protocol Violation|5|||
19477093|NCT01488071|41755998|FG001|Overall Study|Protocol Violation|7|||
19477094|NCT01488071|41755997|FG000|Overall Study|Withdrawal of Consent|14|||
19477095|NCT01488071|41755998|FG001|Overall Study|Withdrawal of Consent|12|||
19477096|NCT01488071|41755997|FG000|Overall Study|Lost to Follow-up|1|||
19477097|NCT01488071|41755998|FG001|Overall Study|Lost to Follow-up|0|||
19477098|NCT01488071|41755997|FG000|Overall Study|Administrative or Other Reason(s)|5|||
19754664|NCT03589807|42204725|FG005|Overall Study|Enrolled but treatment not administered|0|||
19754665|NCT03544333|42204744|FG000|Overall Study|Withdrawal by Subject|1|||
19754666|NCT03544333|42204745|FG001|Overall Study|Withdrawal by Subject|0|||
19754667|NCT03560245|42204753|FG000|Overall Study|Withdrawal by Subject|3|||
19659845|NCT00127855|42108473|FG001|Primary Vaccination Course|Other|0|||
19659846|NCT00127855|42108474|FG002|Primary Vaccination Course|Other|0|||
19659847|NCT00127855|42108475|FG003|Primary Vaccination Course|Other|0|||
19659848|NCT00127855|42108476|FG004|Primary Vaccination Course|Other|1|||
19659849|NCT00493636|42108490|FG000|Overall Study|Withdrawal by Subject|1|||
19659850|NCT00493636|42108491|FG001|Overall Study|Withdrawal by Subject|0|||
19659851|NCT00493636|42108490|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
19659852|NCT00493636|42108491|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
19659853|NCT00493636|42108490|FG000|Overall Study|Mis-randomization|1|||
19659854|NCT00493636|42108491|FG001|Overall Study|Mis-randomization|1|||
19659855|NCT00524121|42108497|FG000|Overall Study|Disease progression|6|||
19659856|NCT00524121|42108497|FG000|Overall Study|Adverse Event|4|||
19659857|NCT00524121|42108497|FG000|Overall Study|Patient refused|2|||
19659858|NCT00524121|42108497|FG000|Overall Study|Other|1|||
19659859|NCT00524121|42108497|FG000|Overall Study|Death|1|||
19659860|NCT00524121|42108497|FG000|Overall Study|Not treated (became ineligible)|4|||
19659861|NCT00524121|42108497|FG000|Overall Study|Not treated (changed mind)|1|||
19659862|NCT00470626|42108512|FG000|Overall Study|Lost to Follow-up|10|||
19659863|NCT00470626|42108512|FG000|Overall Study|Withdrawal by Subject|7|||
19659864|NCT00133705|42108518|FG000|Overall Study|Withdrawal by Subject|2|||
19659865|NCT00133705|42108519|FG001|Overall Study|Withdrawal by Subject|3|||
19659866|NCT00132769|42108527|FG000|Overall Study|Withdrawal by Subject|1|||
19659867|NCT00132769|42108528|FG001|Overall Study|Withdrawal by Subject|3|||
19659868|NCT00132769|42108527|FG000|Overall Study|Lack of Efficacy|7|||
19659869|NCT00132769|42108528|FG001|Overall Study|Lack of Efficacy|6|||
19659870|NCT00132769|42108527|FG000|Overall Study|Adverse Event|2|||
19659871|NCT00132769|42108528|FG001|Overall Study|Adverse Event|1|||
19659872|NCT00132769|42108527|FG000|Overall Study|Protocol Violation|1|||
19659873|NCT00132769|42108528|FG001|Overall Study|Protocol Violation|1|||
19659874|NCT00520299|42108537|FG000|Overall Study|Withdrawal by Subject|0|||
19659875|NCT00520299|42108538|FG001|Overall Study|Withdrawal by Subject|0|||
19659876|NCT00520299|42108539|FG002|Overall Study|Withdrawal by Subject|2|||
19659877|NCT00520299|42108537|FG000|Overall Study|Progressive disease|0|||
19659878|NCT00520299|42108538|FG001|Overall Study|Progressive disease|3|||
19659879|NCT00520299|42108539|FG002|Overall Study|Progressive disease|4|||
19659880|NCT02478255|42108549|FG000|Overall Study|Physician Decision|6|||
19659881|NCT02478255|42108550|FG001|Overall Study|Physician Decision|0|||
19659882|NCT02478255|42108549|FG000|Overall Study|Withdrawal by Subject|2|||
19659883|NCT02478255|42108550|FG001|Overall Study|Withdrawal by Subject|0|||
19659884|NCT00132691|42108558|FG000|Overall Study|Lost to Follow-up|5|||
19659885|NCT00132691|42108559|FG001|Overall Study|Lost to Follow-up|8|||
19659886|NCT00132691|42108558|FG000|Overall Study|Missed 2-year visit|4|||
19659887|NCT00132691|42108559|FG001|Overall Study|Missed 2-year visit|4|||
19659888|NCT00132691|42108558|FG000|Overall Study|Death|2|||
19659889|NCT00132691|42108559|FG001|Overall Study|Death|0|||
19659890|NCT00125359|42108570|FG000|Overall Study|Death|4|||
19659891|NCT00125359|42108570|FG000|Overall Study|Adverse Event|5|||
19659892|NCT00125359|42108570|FG000|Overall Study|Physician Decision|14|||
19659893|NCT00524043|42108577|FG000|Overall Study|Lack of Efficacy|15|||
19659894|NCT00524043|42108578|FG001|Overall Study|Lack of Efficacy|13|||
19659895|NCT00524043|42108579|FG002|Overall Study|Lack of Efficacy|14|||
19659896|NCT00524043|42108577|FG000|Overall Study|Withdrawal by Subject|5|||
19659897|NCT00524043|42108578|FG001|Overall Study|Withdrawal by Subject|7|||
19659898|NCT00524043|42108579|FG002|Overall Study|Withdrawal by Subject|7|||
19659899|NCT00524043|42108577|FG000|Overall Study|Adverse Event|5|||
19659900|NCT00524043|42108578|FG001|Overall Study|Adverse Event|2|||
19659901|NCT00524043|42108579|FG002|Overall Study|Adverse Event|7|||
19659902|NCT00524043|42108577|FG000|Overall Study|Lost to Follow-up|3|||
19659903|NCT00524043|42108578|FG001|Overall Study|Lost to Follow-up|5|||
19659904|NCT00524043|42108579|FG002|Overall Study|Lost to Follow-up|3|||
19659905|NCT00524043|42108577|FG000|Overall Study|Various (eg, incarceration)|2|||
19659906|NCT00524043|42108578|FG001|Overall Study|Various (eg, incarceration)|1|||
19659907|NCT00524043|42108579|FG002|Overall Study|Various (eg, incarceration)|0|||
19659908|NCT00523419|42108587|FG000|Overall Study|Adverse Event|1|||
19659909|NCT00523419|42108587|FG000|Overall Study|Withdrawal by Subject|1|||
19659910|NCT00523419|42108587|FG000|Overall Study|Physician Decision|2|||
19754668|NCT03560245|42204754|FG001|Overall Study|Withdrawal by Subject|2|||
19754669|NCT03560245|42204753|FG000|Overall Study|Adverse Event|1|||
19754670|NCT03560245|42204754|FG001|Overall Study|Adverse Event|1|||
19754671|NCT03560245|42204753|FG000|Overall Study|Protocol Violation|1|||
19754672|NCT03560245|42204754|FG001|Overall Study|Protocol Violation|0|||
19754673|NCT03560245|42204753|FG000|Overall Study|Death|0|||
19754674|NCT03560245|42204754|FG001|Overall Study|Death|1|||
19754675|NCT03560245|42204753|FG000|Overall Study|Lost to Follow-up|0|||
19754676|NCT03560245|42204754|FG001|Overall Study|Lost to Follow-up|1|||
19754677|NCT03560245|42204753|FG000|Overall Study|Physician Decision|0|||
19754678|NCT03560245|42204754|FG001|Overall Study|Physician Decision|1|||
19754679|NCT03560245|42204753|FG000|Overall Study|Other|0|||
19659911|NCT00523419|42108587|FG000|Overall Study|Progressive Disease|22|||
19659912|NCT00523419|42108587|FG000|Overall Study|Death due to Study Disease|4|||
19659913|NCT00523419|42108587|FG000|Overall Study|Death due to Adverse Event|2|||
19659914|NCT03868059|42108591|FG000|Overall Study|Adverse Event|3|||
19659915|NCT03868059|42108591|FG000|Overall Study|Lost to Follow-up|3|||
19659916|NCT03868059|42108591|FG000|Overall Study|Withdrawal by Subject|6|||
19659917|NCT00522951|42108595|FG000|Period 1|body motion|0|||
19659918|NCT00522951|42108596|FG001|Period 1|body motion|1|||
19659919|NCT00522951|42108595|FG000|Washout Period|Adverse Event|0|||
19659920|NCT00522951|42108596|FG001|Washout Period|Adverse Event|1|||
19659921|NCT00522951|42108595|FG000|Washout Period|Death|0|||
19659922|NCT00522951|42108596|FG001|Washout Period|Death|1|||
19659923|NCT00522951|42108595|FG000|Period 2|Withdrawal by Subject|1|||
19659924|NCT00522951|42108596|FG001|Period 2|Withdrawal by Subject|0|||
19659925|NCT00522951|42108595|FG000|Period 2|residual contrast medium|1|||
19659926|NCT00522951|42108596|FG001|Period 2|residual contrast medium|1|||
19659927|NCT03865953|42108608|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
19659928|NCT03865953|42108609|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
19659929|NCT03865953|42108608|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
19659930|NCT03865953|42108609|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
19659931|NCT03865953|42108608|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
19659932|NCT03865953|42108609|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
19659933|NCT03865407|42108617|FG000|Overall Study|Adverse Event|1|||
19659934|NCT03865407|42108618|FG001|Overall Study|Adverse Event|0|||
19659935|NCT03865407|42108617|FG000|Overall Study|Withdrawal by Subject|1|||
19659936|NCT03865407|42108618|FG001|Overall Study|Withdrawal by Subject|0|||
19659937|NCT03865407|42108617|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
19659938|NCT03865407|42108618|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
19659939|NCT00487942|42108628|FG000|Overall Study|Adverse Event|1|||
19659940|NCT00487942|42108629|FG001|Overall Study|Adverse Event|1|||
19659941|NCT00487942|42108630|FG002|Overall Study|Adverse Event|1|||
19659942|NCT00487942|42108631|FG003|Overall Study|Adverse Event|1|||
19659943|NCT00487942|42108628|FG000|Overall Study|Lost to Follow-up|1|||
19659944|NCT00487942|42108629|FG001|Overall Study|Lost to Follow-up|0|||
19659945|NCT00487942|42108630|FG002|Overall Study|Lost to Follow-up|0|||
19659946|NCT00487942|42108631|FG003|Overall Study|Lost to Follow-up|1|||
19659947|NCT00487942|42108628|FG000|Overall Study|Protocol Violation|1|||
19659948|NCT00487942|42108629|FG001|Overall Study|Protocol Violation|1|||
19659949|NCT00487942|42108630|FG002|Overall Study|Protocol Violation|0|||
19659950|NCT00487942|42108631|FG003|Overall Study|Protocol Violation|0|||
19659951|NCT00487942|42108628|FG000|Overall Study|Withdrawal by Subject|0|||
19659952|NCT00487942|42108629|FG001|Overall Study|Withdrawal by Subject|1|||
19659953|NCT00487942|42108630|FG002|Overall Study|Withdrawal by Subject|2|||
19659954|NCT00487942|42108631|FG003|Overall Study|Withdrawal by Subject|0|||
19659955|NCT00132301|42108643|FG000|Overall Study|Death|7|||
19659956|NCT00132301|42108644|FG001|Overall Study|Death|6|||
19659957|NCT00132301|42108643|FG000|Overall Study|Withdrawal by Subject|5|||
19659958|NCT00132301|42108644|FG001|Overall Study|Withdrawal by Subject|2|||
19659959|NCT00132301|42108643|FG000|Overall Study|Physician Decision|1|||
19659960|NCT00132301|42108644|FG001|Overall Study|Physician Decision|1|||
19659961|NCT00132301|42108643|FG000|Overall Study|Lost to Follow-up|5|||
19659962|NCT00132301|42108644|FG001|Overall Study|Lost to Follow-up|3|||
19659963|NCT00132301|42108643|FG000|Overall Study|Other|1|||
19659964|NCT00132301|42108644|FG001|Overall Study|Other|1|||
19659965|NCT00132301|42108643|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
19659966|NCT00132301|42108644|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
19659967|NCT00522873|42108652|FG000|Overall Study|Adverse Event|41|||
19659968|NCT00522873|42108653|FG001|Overall Study|Adverse Event|26|||
19659969|NCT00522873|42108652|FG000|Overall Study|Withdrawal by Subject|20|||
19659970|NCT00522873|42108653|FG001|Overall Study|Withdrawal by Subject|9|||
19659971|NCT00522873|42108652|FG000|Overall Study|Protocol Violation|14|||
19754680|NCT03560245|42204754|FG001|Overall Study|Other|1|||
19754681|NCT00707434|42204762|FG000|Overall Study|Adverse Event|1|||
19754682|NCT03054428|42204769|FG000|Overall Study|Physician Decision|0|||
19754683|NCT03054428|42204770|FG001|Overall Study|Physician Decision|1|||
19754684|NCT03054428|42204771|FG002|Overall Study|Physician Decision|1|||
19754685|NCT03054428|42204769|FG000|Overall Study|Lack of Efficacy|3|||
19754686|NCT03054428|42204770|FG001|Overall Study|Lack of Efficacy|1|||
19754687|NCT03054428|42204771|FG002|Overall Study|Lack of Efficacy|0|||
19754688|NCT03054428|42204769|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
19754689|NCT03054428|42204770|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
19754690|NCT03054428|42204771|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
19754691|NCT03054428|42204769|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
19754692|NCT03054428|42204770|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
19754693|NCT03054428|42204771|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
19754694|NCT03054428|42204769|FG000|Overall Study|Transitioned to OLE study|76|||
19754695|NCT03054428|42204770|FG001|Overall Study|Transitioned to OLE study|76|||
19754696|NCT03054428|42204771|FG002|Overall Study|Transitioned to OLE study|73|||
19754697|NCT03054428|42204769|FG000|Overall Study|Withdrawal by Subject|3|||
19659972|NCT00522873|42108653|FG001|Overall Study|Protocol Violation|4|||
19659973|NCT00522873|42108652|FG000|Overall Study|Lost to Follow-up|11|||
19659974|NCT00522873|42108653|FG001|Overall Study|Lost to Follow-up|3|||
19659975|NCT00522873|42108652|FG000|Overall Study|Personal Reasons|8|||
19659976|NCT00522873|42108653|FG001|Overall Study|Personal Reasons|1|||
19659977|NCT00522873|42108652|FG000|Overall Study|Medication Errors|1|||
19659978|NCT00522873|42108653|FG001|Overall Study|Medication Errors|1|||
19754698|NCT03054428|42204770|FG001|Overall Study|Withdrawal by Subject|2|||
19754699|NCT03054428|42204771|FG002|Overall Study|Withdrawal by Subject|3|||
19754700|NCT03054428|42204769|FG000|Overall Study|Lost to Follow-up|0|||
19754701|NCT03054428|42204770|FG001|Overall Study|Lost to Follow-up|0|||
19754702|NCT03054428|42204771|FG002|Overall Study|Lost to Follow-up|1|||
19754703|NCT03558997|42204783|FG000|Overall Study|Adverse Event|0|||
19754704|NCT03558997|42204784|FG001|Overall Study|Adverse Event|2|||
19754705|NCT03558997|42204785|FG002|Overall Study|Adverse Event|5|||
19754706|NCT03558997|42204786|FG003|Overall Study|Adverse Event|1|||
19754707|NCT03558997|42204783|FG000|Overall Study|Physician Decision|0|||
19754708|NCT03558997|42204784|FG001|Overall Study|Physician Decision|0|||
19754709|NCT03558997|42204785|FG002|Overall Study|Physician Decision|1|||
19754710|NCT03558997|42204786|FG003|Overall Study|Physician Decision|0|||
19754711|NCT03558997|42204783|FG000|Overall Study|Withdrawal by Subject|1|||
19754712|NCT03558997|42204784|FG001|Overall Study|Withdrawal by Subject|0|||
19754713|NCT03558997|42204785|FG002|Overall Study|Withdrawal by Subject|1|||
19754714|NCT03558997|42204786|FG003|Overall Study|Withdrawal by Subject|1|||
19754715|NCT03558997|42204783|FG000|Overall Study|Lost to Follow-up|0|||
19754716|NCT03558997|42204784|FG001|Overall Study|Lost to Follow-up|0|||
19754717|NCT03558997|42204785|FG002|Overall Study|Lost to Follow-up|1|||
19754718|NCT03558997|42204786|FG003|Overall Study|Lost to Follow-up|0|||
19754719|NCT03052400|42204801|FG000|Overall Study|Lost to Follow-up|1|||
19754720|NCT03052400|42204802|FG001|Overall Study|Lost to Follow-up|0|||
19754721|NCT03052400|42204801|FG000|Overall Study|Withdrawal by Subject|0|||
19754722|NCT03052400|42204802|FG001|Overall Study|Withdrawal by Subject|1|||
19754723|NCT03538951|42204810|FG000|Overall Study|Withdrawal by Subject|1|||
19754724|NCT03538951|42204811|FG001|Overall Study|Withdrawal by Subject|2|||
19754725|NCT03052322|42204819|FG000|Overall Study|Other un-specified|1|||
19754726|NCT03052322|42204820|FG001|Overall Study|Other un-specified|2|||
19754727|NCT03052322|42204819|FG000|Overall Study|Withdrawal by Subject|10|||
19754728|NCT03052322|42204820|FG001|Overall Study|Withdrawal by Subject|9|||
19754729|NCT03052322|42204819|FG000|Overall Study|Death|0|||
19754730|NCT03052322|42204820|FG001|Overall Study|Death|2|||
19659979|NCT00522873|42108652|FG000|Overall Study|Never Received Medication|1|||
19659980|NCT00522873|42108653|FG001|Overall Study|Never Received Medication|0|||
19659981|NCT03684057|42108661|FG000|Overall Study|Withdrawal by Subject|4|||
19659982|NCT03684057|42108662|FG001|Overall Study|Withdrawal by Subject|5|||
19659983|NCT03864627|42108671|FG000|Overall Study|Adverse Event|0|||
19659984|NCT03864627|42108672|FG001|Overall Study|Adverse Event|1|||
19659985|NCT03864627|42108671|FG000|Overall Study|Lack of Efficacy|0|||
19659986|NCT03864627|42108672|FG001|Overall Study|Lack of Efficacy|1|||
19659987|NCT03864627|42108671|FG000|Overall Study|Lost to Follow-up|0|||
19659988|NCT03864627|42108672|FG001|Overall Study|Lost to Follow-up|1|||
19659989|NCT03864627|42108671|FG000|Overall Study|Withdrawal by Subject|4|||
19659990|NCT03864627|42108672|FG001|Overall Study|Withdrawal by Subject|8|||
19659991|NCT03864627|42108671|FG000|Overall Study|Study terminated by sponsor|0|||
19659992|NCT03864627|42108672|FG001|Overall Study|Study terminated by sponsor|1|||
19659993|NCT00519831|42108679|FG000|Overall Study|Adverse Event|3|||
19659994|NCT00131911|42108689|FG000|Overall Study|Withdrawal by Subject|1|||
19659995|NCT00131911|42108690|FG001|Overall Study|Withdrawal by Subject|0|||
19659996|NCT00184093|42108695|FG000|Overall Study|Adverse Event|3|||
19659997|NCT00184093|42108695|FG000|Overall Study|Lost to Follow-up|3|||
19659998|NCT00184093|42108695|FG000|Overall Study|Physician Decision|1|||
19659999|NCT00184093|42108695|FG000|Overall Study|Withdrawal by Subject|2|||
19660000|NCT00183625|42108701|FG000|Overall Study|Withdrawal by Subject|18|||
19660001|NCT00183625|42108702|FG001|Overall Study|Withdrawal by Subject|18|||
19660002|NCT00183625|42108703|FG002|Overall Study|Withdrawal by Subject|19|||
19660003|NCT00183625|42108704|FG003|Overall Study|Withdrawal by Subject|14|||
19660004|NCT00511875|42108714|FG000|Overall Study|Lost to Follow-up|4|||
19660005|NCT00511875|42108715|FG001|Overall Study|Lost to Follow-up|0|||
19660006|NCT00511875|42108714|FG000|Overall Study|Missing variables|1|||
19660007|NCT00511875|42108715|FG001|Overall Study|Missing variables|0|||
19660008|NCT02286089|42108725|FG000|Overall Study|Ongoing in Study|1|||
19660009|NCT02286089|42108726|FG001|Overall Study|Ongoing in Study|1|||
19660010|NCT02286089|42108727|FG002|Overall Study|Ongoing in Study|4|||
19660011|NCT02286089|42108728|FG003|Overall Study|Ongoing in Study|10|||
19660012|NCT02286089|42108725|FG000|Overall Study|Withdrawal by Subject|0|||
19660013|NCT02286089|42108726|FG001|Overall Study|Withdrawal by Subject|0|||
19660014|NCT02286089|42108727|FG002|Overall Study|Withdrawal by Subject|2|||
19660015|NCT02286089|42108728|FG003|Overall Study|Withdrawal by Subject|2|||
19660016|NCT00183391|42108740|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
19660017|NCT00183391|42108741|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
19754731|NCT03052322|42204819|FG000|Overall Study|Lack of Efficacy|1|||
19754732|NCT03052322|42204820|FG001|Overall Study|Lack of Efficacy|2|||
19754733|NCT03052322|42204819|FG000|Overall Study|Protocol Violation|1|||
19754734|NCT03052322|42204820|FG001|Overall Study|Protocol Violation|0|||
19660018|NCT00183391|42108740|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
19660019|NCT00183391|42108741|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
19660020|NCT00493246|42108757|FG000|Overall Study|Withdrawal by Subject|0|||
19754735|NCT03052322|42204819|FG000|Overall Study|Lost to Follow-up|2|||
19754736|NCT03052322|42204820|FG001|Overall Study|Lost to Follow-up|4|||
19660021|NCT00493246|42108758|FG001|Overall Study|Withdrawal by Subject|0|||
19660022|NCT00493246|42108759|FG002|Overall Study|Withdrawal by Subject|0|||
19660023|NCT00493246|42108760|FG003|Overall Study|Withdrawal by Subject|0|||
19660024|NCT00493246|42108761|FG004|Overall Study|Withdrawal by Subject|1|||
19660025|NCT00493246|42108762|FG005|Overall Study|Withdrawal by Subject|0|||
19660026|NCT00493246|42108763|FG006|Overall Study|Withdrawal by Subject|0|||
19660027|NCT00493246|42108764|FG007|Overall Study|Withdrawal by Subject|0|||
19660028|NCT00493246|42108757|FG000|Overall Study|No access to draw blood|0|||
19660029|NCT00493246|42108758|FG001|Overall Study|No access to draw blood|0|||
19660030|NCT00493246|42108759|FG002|Overall Study|No access to draw blood|0|||
19660031|NCT00493246|42108760|FG003|Overall Study|No access to draw blood|0|||
19660032|NCT00493246|42108761|FG004|Overall Study|No access to draw blood|0|||
19660033|NCT00493246|42108762|FG005|Overall Study|No access to draw blood|1|||
19660034|NCT00493246|42108763|FG006|Overall Study|No access to draw blood|0|||
19660035|NCT00493246|42108764|FG007|Overall Study|No access to draw blood|0|||
19660036|NCT00493246|42108757|FG000|Overall Study|Lost to Follow-up|0|||
19660037|NCT00493246|42108758|FG001|Overall Study|Lost to Follow-up|0|||
19660038|NCT00493246|42108759|FG002|Overall Study|Lost to Follow-up|0|||
19660039|NCT00493246|42108760|FG003|Overall Study|Lost to Follow-up|0|||
19660040|NCT00493246|42108761|FG004|Overall Study|Lost to Follow-up|0|||
19660041|NCT00493246|42108762|FG005|Overall Study|Lost to Follow-up|0|||
19660042|NCT00493246|42108763|FG006|Overall Study|Lost to Follow-up|1|||
19660043|NCT00493246|42108764|FG007|Overall Study|Lost to Follow-up|0|||
19660044|NCT02281955|42108782|FG000|Overall Study|Death|1|||
19660045|NCT00511797|42108790|FG000|Overall Study|Adverse Event|1|||
19660046|NCT00511797|42108791|FG001|Overall Study|Adverse Event|2|||
19660047|NCT00511797|42108792|FG002|Overall Study|Adverse Event|2|||
19660048|NCT00511797|42108793|FG003|Overall Study|Adverse Event|2|||
19660049|NCT00511797|42108790|FG000|Overall Study|Lost to Follow-up|1|||
19660050|NCT00511797|42108791|FG001|Overall Study|Lost to Follow-up|0|||
19660051|NCT00511797|42108792|FG002|Overall Study|Lost to Follow-up|0|||
19660052|NCT00511797|42108793|FG003|Overall Study|Lost to Follow-up|1|||
19660053|NCT00511797|42108790|FG000|Overall Study|Pregnancy|0|||
19660054|NCT00511797|42108791|FG001|Overall Study|Pregnancy|0|||
19660055|NCT00511797|42108792|FG002|Overall Study|Pregnancy|0|||
19660056|NCT00511797|42108793|FG003|Overall Study|Pregnancy|1|||
19660057|NCT00511797|42108790|FG000|Overall Study|Protocol Violation|0|||
19660058|NCT00511797|42108791|FG001|Overall Study|Protocol Violation|2|||
19660059|NCT00511797|42108792|FG002|Overall Study|Protocol Violation|2|||
19660060|NCT00511797|42108793|FG003|Overall Study|Protocol Violation|3|||
19660061|NCT00511797|42108790|FG000|Overall Study|Withdrawal by Subject|3|||
19660062|NCT00511797|42108791|FG001|Overall Study|Withdrawal by Subject|3|||
19660063|NCT00511797|42108792|FG002|Overall Study|Withdrawal by Subject|4|||
19660064|NCT00511797|42108793|FG003|Overall Study|Withdrawal by Subject|2|||
19660065|NCT00511797|42108790|FG000|Overall Study|Never dispensed|1|||
19660066|NCT00511797|42108791|FG001|Overall Study|Never dispensed|0|||
19660067|NCT00511797|42108792|FG002|Overall Study|Never dispensed|1|||
19660068|NCT00511797|42108793|FG003|Overall Study|Never dispensed|3|||
19754737|NCT03052322|42204819|FG000|Overall Study|Adverse Event|6|||
19754738|NCT03052322|42204820|FG001|Overall Study|Adverse Event|13|||
19754739|NCT03521791|42204828|FG000|Overall Study|Protocol Violation|7|||
19754740|NCT03521791|42204829|FG001|Overall Study|Protocol Violation|17|||
19754741|NCT03521635|42204837|FG000|Overall Study|Adverse Event|1|||
19754742|NCT03521635|42204838|FG001|Overall Study|Adverse Event|1|||
19754743|NCT03521635|42204837|FG000|Overall Study|Refused to complete study visit|1|||
19754744|NCT03521635|42204838|FG001|Overall Study|Refused to complete study visit|0|||
19754745|NCT03521635|42204837|FG000|Overall Study|Refused to continue trial medication|2|||
19754746|NCT03521635|42204838|FG001|Overall Study|Refused to continue trial medication|2|||
19754747|NCT03521635|42204837|FG000|Overall Study|Lost to Follow-up|0|||
19754748|NCT03521635|42204838|FG001|Overall Study|Lost to Follow-up|1|||
19754749|NCT03521635|42204837|FG000|Overall Study|Meet exclusion criteria|0|||
19754750|NCT03521635|42204838|FG001|Overall Study|Meet exclusion criteria|1|||
19660069|NCT00511797|42108790|FG000|Overall Study|Study drug not taken|0|||
19660070|NCT00511797|42108791|FG001|Overall Study|Study drug not taken|1|||
19660071|NCT00511797|42108792|FG002|Overall Study|Study drug not taken|0|||
19660072|NCT00511797|42108793|FG003|Overall Study|Study drug not taken|1|||
19660073|NCT00511797|42108790|FG000|Overall Study|Partially missing diary|0|||
19660074|NCT00511797|42108791|FG001|Overall Study|Partially missing diary|0|||
19660075|NCT00511797|42108792|FG002|Overall Study|Partially missing diary|1|||
19660076|NCT00511797|42108793|FG003|Overall Study|Partially missing diary|0|||
19660077|NCT00511797|42108790|FG000|Overall Study|Other (moving etc)|1|||
19660078|NCT00511797|42108791|FG001|Overall Study|Other (moving etc)|0|||
19660079|NCT00511797|42108792|FG002|Overall Study|Other (moving etc)|1|||
19660080|NCT00511797|42108793|FG003|Overall Study|Other (moving etc)|2|||
19660081|NCT00487552|42108803|FG000|Overall Study|Unsuccessful magnet placements|3|||
19660082|NCT00487552|42108803|FG000|Overall Study|Death due to progressive malignancy|2|||
19660083|NCT00487552|42108803|FG000|Overall Study|Stent not placed|1|||
19660084|NCT00182689|42108810|FG000|Overall Study|Adverse Event|8|||
19754751|NCT03521635|42204837|FG000|Overall Study|Patient not taken study medicine|0|||
19754752|NCT03521635|42204838|FG001|Overall Study|Patient not taken study medicine|1|||
19754753|NCT03170544|42204856|FG000|Part 1|Lost to Follow-up|1|||
19754754|NCT03170544|42204857|FG001|Part 1|Lost to Follow-up|0|||
19754755|NCT03170544|42204858|FG002|Part 1|Lost to Follow-up|0|||
19754756|NCT03170544|42204859|FG003|Part 1|Lost to Follow-up|0|||
19754757|NCT03170544|42204860|FG004|Part 1|Lost to Follow-up|0|||
19754758|NCT03170544|42204861|FG005|Part 1|Lost to Follow-up|0|||
19754759|NCT03170544|42204862|FG006|Part 1|Lost to Follow-up|0|||
19754760|NCT03170544|42204863|FG007|Part 1|Lost to Follow-up|0|||
19754761|NCT03170544|42204864|FG008|Part 1|Lost to Follow-up|0|||
19754762|NCT03170544|42204865|FG009|Part 1|Lost to Follow-up|0|||
19754763|NCT03170544|42204866|FG010|Part 1|Lost to Follow-up|0|||
19754764|NCT03170544|42204867|FG011|Part 1|Lost to Follow-up|0|||
19754765|NCT03170544|42204856|FG000|Part 1|Not treated|0|||
19754766|NCT03170544|42204857|FG001|Part 1|Not treated|0|||
19754767|NCT03170544|42204858|FG002|Part 1|Not treated|0|||
19754768|NCT03170544|42204859|FG003|Part 1|Not treated|1|||
19754769|NCT03170544|42204860|FG004|Part 1|Not treated|0|||
19754770|NCT03170544|42204861|FG005|Part 1|Not treated|0|||
19754771|NCT03170544|42204862|FG006|Part 1|Not treated|0|||
19754772|NCT03170544|42204863|FG007|Part 1|Not treated|0|||
19754773|NCT03170544|42204864|FG008|Part 1|Not treated|0|||
19754774|NCT03170544|42204865|FG009|Part 1|Not treated|0|||
19754775|NCT03170544|42204866|FG010|Part 1|Not treated|0|||
19754776|NCT03170544|42204867|FG011|Part 1|Not treated|0|||
19754777|NCT03582943|42204952|FG000|Allocated to Groups|Withdrawal by Subject|1|||
19754778|NCT03582943|42204953|FG001|Allocated to Groups|Withdrawal by Subject|1|||
19754779|NCT03582943|42204952|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
19754780|NCT03582943|42204953|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
19754781|NCT03582943|42204952|FG000|Analyzed|Protocol Violation|4|||
19754782|NCT03582943|42204953|FG001|Analyzed|Protocol Violation|1|||
19754783|NCT03532009|42204961|FG000|Overall Study|Other|1|||
19754784|NCT03532009|42204962|FG001|Overall Study|Other|1|||
19754785|NCT03532009|42204961|FG000|Overall Study|Death|1|||
19754786|NCT03532009|42204962|FG001|Overall Study|Death|1|||
19754787|NCT03532009|42204961|FG000|Overall Study|Withdrawal by Patient|0|||
19754788|NCT03532009|42204962|FG001|Overall Study|Withdrawal by Patient|2|||
19754789|NCT03520387|42204973|FG000|Pre-Randomization|Withdrawal by Subject|1|||
19754790|NCT03520387|42204974|FG001|Pre-Randomization|Withdrawal by Subject|0|||
19754791|NCT03520387|42204975|FG002|Pre-Randomization|Withdrawal by Subject|0|||
19754792|NCT03520387|42204976|FG003|Pre-Randomization|Withdrawal by Subject|0|||
19754793|NCT03520387|42204977|FG004|Pre-Randomization|Withdrawal by Subject|0|||
19754794|NCT03520387|42204973|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
19754795|NCT03520387|42204974|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
19754796|NCT03520387|42204975|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
19754797|NCT03520387|42204976|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
19754798|NCT03520387|42204977|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
19754799|NCT03170232|42204990|FG000|Overall Study|Adverse Event|0|||
19754800|NCT03170232|42204991|FG001|Overall Study|Adverse Event|1|||
19754801|NCT03170232|42204990|FG000|Overall Study|Protocol Violation|0|||
19754802|NCT03170232|42204991|FG001|Overall Study|Protocol Violation|1|||
19754803|NCT03170232|42204990|FG000|Overall Study|Lack of Efficacy|0|||
19754804|NCT03170232|42204991|FG001|Overall Study|Lack of Efficacy|1|||
19754805|NCT03170232|42204990|FG000|Overall Study|Study closed/terminated|26|||
19660085|NCT00182689|42108811|FG001|Overall Study|Adverse Event|11|||
19660086|NCT00182689|42108810|FG000|Overall Study|Withdrawal by Subject|2|||
19660087|NCT00182689|42108811|FG001|Overall Study|Withdrawal by Subject|2|||
19660088|NCT00182689|42108810|FG000|Overall Study|Progression|27|||
19660089|NCT00182689|42108811|FG001|Overall Study|Progression|29|||
19660090|NCT00182689|42108810|FG000|Overall Study|Death|1|||
19660091|NCT00182689|42108811|FG001|Overall Study|Death|0|||
19660092|NCT00182689|42108810|FG000|Overall Study|not protocol specified|0|||
19660093|NCT00182689|42108811|FG001|Overall Study|not protocol specified|3|||
19660094|NCT00182689|42108810|FG000|Overall Study|Ineligible|1|||
19754806|NCT03170232|42204991|FG001|Overall Study|Study closed/terminated|23|||
19754807|NCT03170232|42204990|FG000|Overall Study|Lost to Follow-up|1|||
19754808|NCT03170232|42204991|FG001|Overall Study|Lost to Follow-up|0|||
19754809|NCT03170232|42204990|FG000|Overall Study|Withdrawal by Subject|0|||
19754810|NCT03170232|42204991|FG001|Overall Study|Withdrawal by Subject|1|||
19660095|NCT00182689|42108811|FG001|Overall Study|Ineligible|4|||
19660096|NCT00182689|42108810|FG000|Overall Study|Never received treatment|1|||
19660097|NCT00182689|42108811|FG001|Overall Study|Never received treatment|0|||
19754811|NCT03519919|42204997|FG000|Overall Study|Withdrawal by Subject|1|||
19754812|NCT03519919|42204997|FG000|Overall Study|Lack of Efficacy|1|||
19754813|NCT03519919|42204997|FG000|Overall Study|Screen Failure|1|||
19754814|NCT03478969|42205030|FG000|Overall Study|Withdrawal by Subject|4|||
19754815|NCT03478969|42205031|FG001|Overall Study|Withdrawal by Subject|7|||
19754816|NCT03478969|42205032|FG002|Overall Study|Withdrawal by Subject|6|||
19660098|NCT03860259|42108823|FG000|Overall Study|Lost to Follow-up|5|||
19660099|NCT03860259|42108824|FG001|Overall Study|Lost to Follow-up|5|||
19660100|NCT03860259|42108823|FG000|Overall Study|Protocol Violation|1|||
19660101|NCT03860259|42108824|FG001|Overall Study|Protocol Violation|0|||
19660102|NCT00131365|42108830|FG000|Overall Study|Withdrawal by Subject|1|||
19660103|NCT00131365|42108830|FG000|Overall Study|Alternative treatment|3|||
19660104|NCT00487240|42108837|FG000|Overall Study|Withdrawal by Subject|12|||
19660105|NCT00487240|42108838|FG001|Overall Study|Withdrawal by Subject|6|||
19660106|NCT00487240|42108837|FG000|Overall Study|Lost to Follow-up|7|||
19660107|NCT00487240|42108838|FG001|Overall Study|Lost to Follow-up|6|||
19660108|NCT00487240|42108837|FG000|Overall Study|Adverse Event|0|||
19660109|NCT00487240|42108838|FG001|Overall Study|Adverse Event|4|||
19660110|NCT00487240|42108837|FG000|Overall Study|Protocol Violation|5|||
19660111|NCT00487240|42108838|FG001|Overall Study|Protocol Violation|5|||
19660112|NCT00487240|42108837|FG000|Overall Study|Entry Criteria Not Met|3|||
19660113|NCT00487240|42108838|FG001|Overall Study|Entry Criteria Not Met|4|||
19660114|NCT00487240|42108837|FG000|Overall Study|Sponsor Decision|2|||
19660115|NCT00487240|42108838|FG001|Overall Study|Sponsor Decision|1|||
19660116|NCT00487240|42108837|FG000|Overall Study|Physician Decision|2|||
19660117|NCT00487240|42108838|FG001|Overall Study|Physician Decision|0|||
19660118|NCT02224391|42108846|FG000|Overall Study|Lost to Follow-up|26|||
19660119|NCT02224391|42108847|FG001|Overall Study|Lost to Follow-up|19|||
19660120|NCT02224391|42108846|FG000|Overall Study|Withdrawal by Subject|6|||
19660121|NCT02224391|42108847|FG001|Overall Study|Withdrawal by Subject|5|||
19660122|NCT00487162|42108855|FG000|Overall Study|Adverse Event|0|||
19660123|NCT00487162|42108856|FG001|Overall Study|Adverse Event|1|||
19660124|NCT00487162|42108855|FG000|Overall Study|Physician Decision|0|||
19660125|NCT00487162|42108856|FG001|Overall Study|Physician Decision|1|||
19660126|NCT00487162|42108855|FG000|Overall Study|Withdrawal by Subject|2|||
19660127|NCT00487162|42108856|FG001|Overall Study|Withdrawal by Subject|3|||
19660128|NCT00487084|42108865|FG000|Overall Study|Did not receive intervention|4|||
19660129|NCT00487084|42108866|FG001|Overall Study|Did not receive intervention|3|||
19660130|NCT00487084|42108867|FG002|Overall Study|Did not receive intervention|5|||
19660131|NCT00466726|42108875|FG000|Overall Study|Not evaluable for response|14|||
19660132|NCT01721291|42108881|FG000|Overall Study|Withdrawal by Subject|1|||
19660133|NCT01721291|42108882|FG001|Overall Study|Withdrawal by Subject|0|||
19660134|NCT01721291|42108881|FG000|Overall Study|did not like the treatment|1|||
19660135|NCT01721291|42108882|FG001|Overall Study|did not like the treatment|0|||
19660136|NCT00486226|42108908|FG000|Overall Study|Death|3|||
19660137|NCT00486226|42108908|FG000|Overall Study|Adverse Event|1|||
19754817|NCT03478969|42205030|FG000|Overall Study|Adverse Event|2|||
19754818|NCT03478969|42205031|FG001|Overall Study|Adverse Event|0|||
19754819|NCT03478969|42205032|FG002|Overall Study|Adverse Event|1|||
19754820|NCT03478969|42205030|FG000|Overall Study|Pregnancy|1|||
19754821|NCT03478969|42205031|FG001|Overall Study|Pregnancy|0|||
19754822|NCT03478969|42205032|FG002|Overall Study|Pregnancy|0|||
19660138|NCT00486226|42108908|FG000|Overall Study|Withdrawal by Subject|1|||
19660139|NCT00486226|42108908|FG000|Overall Study|Lost to Follow-up|8|||
19660140|NCT00485758|42108917|FG000|Overall Study|Adverse Event|102|||
19660141|NCT00485758|42108918|FG001|Overall Study|Adverse Event|31|||
19660142|NCT00485758|42108917|FG000|Overall Study|Death|0|||
19660143|NCT00485758|42108918|FG001|Overall Study|Death|1|||
19660144|NCT00485758|42108917|FG000|Overall Study|Lost to Follow-up|5|||
19660145|NCT00485758|42108918|FG001|Overall Study|Lost to Follow-up|1|||
19660146|NCT00485758|42108917|FG000|Overall Study|Physician Decision|3|||
19660147|NCT00485758|42108918|FG001|Overall Study|Physician Decision|3|||
19660148|NCT00485758|42108917|FG000|Overall Study|Protocol Violation|11|||
19660149|NCT00485758|42108918|FG001|Overall Study|Protocol Violation|2|||
19660150|NCT00485758|42108917|FG000|Overall Study|Withdrawal by Subject|32|||
19660151|NCT00485758|42108918|FG001|Overall Study|Withdrawal by Subject|27|||
19660152|NCT00485758|42108917|FG000|Overall Study|Study Terminated by Sponsor|3|||
19660153|NCT00485758|42108918|FG001|Overall Study|Study Terminated by Sponsor|0|||
19660154|NCT03850444|42108926|FG000|Overall Study|Adverse Event|12|||
19660155|NCT03850444|42108927|FG001|Overall Study|Adverse Event|9|||
19660156|NCT03850444|42108926|FG000|Overall Study|Death|38|||
19660157|NCT03850444|42108927|FG001|Overall Study|Death|64|||
19660158|NCT03850444|42108926|FG000|Overall Study|Lost to Follow-up|0|||
19660159|NCT03850444|42108927|FG001|Overall Study|Lost to Follow-up|1|||
19660160|NCT03850444|42108926|FG000|Overall Study|Withdrawal by Subject|0|||
19660161|NCT03850444|42108927|FG001|Overall Study|Withdrawal by Subject|1|||
19754823|NCT03478969|42205030|FG000|Overall Study|Personal Reasons|1|||
19660162|NCT03850444|42108926|FG000|Overall Study|Ongoing in Study|78|||
19660163|NCT03850444|42108927|FG001|Overall Study|Ongoing in Study|59|||
19660164|NCT00469612|42108935|FG000|Overall Study|Study terminated before data collected|2|||
19660165|NCT00469612|42108936|FG001|Overall Study|Study terminated before data collected|0|||
19660166|NCT00469456|42108944|FG000|Overall Study|Adverse Event|4|||
19660167|NCT00469456|42108945|FG001|Overall Study|Adverse Event|3|||
19660168|NCT00469456|42108944|FG000|Overall Study|Protocol Violation|1|||
19660169|NCT00469456|42108945|FG001|Overall Study|Protocol Violation|0|||
19660170|NCT00469456|42108944|FG000|Overall Study|Withdrawal by Subject|4|||
19660171|NCT00469456|42108945|FG001|Overall Study|Withdrawal by Subject|1|||
19660172|NCT00581555|42108953|FG000|Overall Study|Adverse Event|4|||
19660173|NCT00581555|42108954|FG001|Overall Study|Adverse Event|3|||
19660174|NCT00581555|42108953|FG000|Overall Study|Physician Decision|3|||
19660175|NCT00581555|42108954|FG001|Overall Study|Physician Decision|2|||
19660176|NCT00581555|42108953|FG000|Overall Study|Withdrawal by Subject|18|||
19660177|NCT00581555|42108954|FG001|Overall Study|Withdrawal by Subject|9|||
19660178|NCT00581555|42108953|FG000|Overall Study|Lost to Follow-up|2|||
19660179|NCT00581555|42108954|FG001|Overall Study|Lost to Follow-up|2|||
19660180|NCT00581555|42108953|FG000|Overall Study|Other reasons|16|||
19660181|NCT00581555|42108954|FG001|Overall Study|Other reasons|4|||
19660182|NCT00469144|42108962|FG000|Overall Study|Death|0|||
19660183|NCT00469144|42108963|FG001|Overall Study|Death|1|||
19660184|NCT00469144|42108962|FG000|Overall Study|No Response|5|||
19660185|NCT00469144|42108963|FG001|Overall Study|No Response|5|||
19660186|NCT00469144|42108962|FG000|Overall Study|Progressive Disease|1|||
19660187|NCT00469144|42108963|FG001|Overall Study|Progressive Disease|0|||
19660188|NCT00468910|42108975|FG000|Overall Study|Lost to Follow-up|2|||
19660189|NCT00468910|42108976|FG001|Overall Study|Lost to Follow-up|1|||
19660190|NCT00468910|42108975|FG000|Overall Study|Withdrawal by Subject|2|||
19660191|NCT00468910|42108976|FG001|Overall Study|Withdrawal by Subject|1|||
19660192|NCT00468910|42108975|FG000|Overall Study|Medical Contraindication|0|||
19660193|NCT00468910|42108976|FG001|Overall Study|Medical Contraindication|1|||
19660194|NCT01412333|42108985|FG000|Overall Study|Death|1|||
19660195|NCT01412333|42108986|FG001|Overall Study|Death|1|||
19660196|NCT01412333|42108985|FG000|Overall Study|Physician Decision|0|||
19660197|NCT01412333|42108986|FG001|Overall Study|Physician Decision|1|||
19660198|NCT01412333|42108985|FG000|Overall Study|Reason not specified|16|||
19660199|NCT01412333|42108986|FG001|Overall Study|Reason not specified|10|||
19660200|NCT01412333|42108985|FG000|Overall Study|Non-compliance with study drug|1|||
19660201|NCT01412333|42108986|FG001|Overall Study|Non-compliance with study drug|1|||
19660202|NCT01412333|42108985|FG000|Overall Study|Protocol Violation|1|||
19660203|NCT01412333|42108986|FG001|Overall Study|Protocol Violation|1|||
19660204|NCT01412333|42108985|FG000|Overall Study|Non-compliance|1|||
19660205|NCT01412333|42108986|FG001|Overall Study|Non-compliance|3|||
19660206|NCT01412333|42108985|FG000|Overall Study|Lack of Efficacy|15|||
19660207|NCT01412333|42108986|FG001|Overall Study|Lack of Efficacy|6|||
19660208|NCT01412333|42108985|FG000|Overall Study|Pregnancy|3|||
19660209|NCT01412333|42108986|FG001|Overall Study|Pregnancy|0|||
19660210|NCT01412333|42108985|FG000|Overall Study|Consent withdrawn by participant|25|||
19660211|NCT01412333|42108986|FG001|Overall Study|Consent withdrawn by participant|12|||
19660212|NCT01412333|42108985|FG000|Overall Study|Adverse Event|25|||
19660213|NCT01412333|42108986|FG001|Overall Study|Adverse Event|16|||
19660214|NCT01412333|42108985|FG000|Overall Study|Lost to Follow-up|10|||
19660215|NCT01412333|42108986|FG001|Overall Study|Lost to Follow-up|6|||
19660216|NCT00519285|42108995|FG000|Overall Study|Adverse Event|127|||
19660217|NCT00519285|42108996|FG001|Overall Study|Adverse Event|266|||
19660218|NCT00519285|42108995|FG000|Overall Study|Disease progression|334|||
19660219|NCT00519285|42108996|FG001|Overall Study|Disease progression|186|||
19660220|NCT00519285|42108995|FG000|Overall Study|Physician Decision|75|||
19660221|NCT00519285|42108996|FG001|Overall Study|Physician Decision|47|||
19660222|NCT00519285|42108995|FG000|Overall Study|Participant's request|53|||
19660223|NCT00519285|42108996|FG001|Overall Study|Participant's request|84|||
19660224|NCT00519285|42108995|FG000|Overall Study|Consent withdrawn|4|||
19660225|NCT00519285|42108996|FG001|Overall Study|Consent withdrawn|5|||
19660226|NCT00519285|42108995|FG000|Overall Study|Poor compliance to protocol|5|||
19660227|NCT00519285|42108996|FG001|Overall Study|Poor compliance to protocol|7|||
19660228|NCT00519285|42108995|FG000|Overall Study|Reason unspecified|5|||
19660229|NCT00519285|42108996|FG001|Overall Study|Reason unspecified|8|||
19660230|NCT00519285|42108995|FG000|Overall Study|Not treated|8|||
19660231|NCT00519285|42108996|FG001|Overall Study|Not treated|7|||
19660232|NCT00519285|42108995|FG000|Overall Study|Treatment ongoing|1|||
19660233|NCT00519285|42108996|FG001|Overall Study|Treatment ongoing|2|||
19660234|NCT00464620|42109002|FG000|Overall Study|Physician Decision|1|||
19660235|NCT00464620|42109003|FG001|Overall Study|Physician Decision|0|||
19660236|NCT00464620|42109004|FG002|Overall Study|Physician Decision|0|||
19660237|NCT00464620|42109002|FG000|Overall Study|Withdrawal by Subject|1|||
19660238|NCT00464620|42109003|FG001|Overall Study|Withdrawal by Subject|0|||
19660239|NCT00464620|42109004|FG002|Overall Study|Withdrawal by Subject|3|||
19660240|NCT00464620|42109002|FG000|Overall Study|Ineligible sarcoma subtype|0|||
19660241|NCT00464620|42109003|FG001|Overall Study|Ineligible sarcoma subtype|2|||
19660242|NCT00464620|42109004|FG002|Overall Study|Ineligible sarcoma subtype|2|||
19660243|NCT00464620|42109002|FG000|Overall Study|Use of prohibited concomitant medication|0|||
19698964|NCT00312338|42143780|FG001|Overall Study|Lost to Follow-up|1|||
19660244|NCT00464620|42109003|FG001|Overall Study|Use of prohibited concomitant medication|0|||
19660245|NCT00464620|42109004|FG002|Overall Study|Use of prohibited concomitant medication|2|||
19660246|NCT00464542|42109017|FG000|Pre-treatment|Withdrawal by Subject|2|||
19660247|NCT00468676|42109023|FG000|Overall Study|Lost to Follow-up|14|||
19660248|NCT00468676|42109024|FG001|Overall Study|Lost to Follow-up|11|||
19660249|NCT00468676|42109023|FG000|Overall Study|Death|2|||
19660250|NCT00468676|42109024|FG001|Overall Study|Death|1|||
19660251|NCT00464308|42109035|FG000|Overall Study|Adverse Event|22|||
19660252|NCT00464308|42109036|FG001|Overall Study|Adverse Event|27|||
19660253|NCT00464308|42109037|FG002|Overall Study|Adverse Event|16|||
19660254|NCT00464308|42109035|FG000|Overall Study|Lost to Follow-up|29|||
19754824|NCT03478969|42205031|FG001|Overall Study|Personal Reasons|0|||
19754825|NCT03478969|42205032|FG002|Overall Study|Personal Reasons|1|||
19754826|NCT03478969|42205030|FG000|Overall Study|Covid-19|1|||
19754827|NCT03478969|42205031|FG001|Overall Study|Covid-19|4|||
19754828|NCT03478969|42205032|FG002|Overall Study|Covid-19|3|||
19754829|NCT03478969|42205030|FG000|Overall Study|Multiple Reasons|0|||
19754830|NCT03478969|42205031|FG001|Overall Study|Multiple Reasons|1|||
19754831|NCT03478969|42205032|FG002|Overall Study|Multiple Reasons|1|||
19754832|NCT03478969|42205030|FG000|Overall Study|Eligibility Criteria|0|||
19754833|NCT03478969|42205031|FG001|Overall Study|Eligibility Criteria|0|||
19754834|NCT03478969|42205032|FG002|Overall Study|Eligibility Criteria|5|||
19754835|NCT03478969|42205030|FG000|Overall Study|Lost to Follow-up|0|||
19754836|NCT03478969|42205031|FG001|Overall Study|Lost to Follow-up|0|||
19754837|NCT03478969|42205032|FG002|Overall Study|Lost to Follow-up|1|||
19754838|NCT02318784|42205042|FG000|Overall Study|Adverse Event|13|||
19754839|NCT02318784|42205042|FG000|Overall Study|Death|2|||
19754840|NCT02318784|42205042|FG000|Overall Study|Progressive Disease|37|||
19754841|NCT02318784|42205042|FG000|Overall Study|Withdrawal by Subject|10|||
19754842|NCT03170154|42205057|FG000|Overall Study|Lost to Follow-up|4|||
19754843|NCT03170154|42205057|FG000|Overall Study|Death|2|||
19754844|NCT03170154|42205057|FG000|Overall Study|Withdrawal by Subject|2|||
19754845|NCT03518125|42205072|FG000|Overall Study|Lost to Follow-up|0|||
19660255|NCT00464308|42109036|FG001|Overall Study|Lost to Follow-up|19|||
19660256|NCT00464308|42109037|FG002|Overall Study|Lost to Follow-up|20|||
19660257|NCT00464308|42109035|FG000|Overall Study|Patient discontinued and other reasons|17|||
19660258|NCT00464308|42109036|FG001|Overall Study|Patient discontinued and other reasons|17|||
19660259|NCT00464308|42109037|FG002|Overall Study|Patient discontinued and other reasons|23|||
19660260|NCT00464308|42109035|FG000|Overall Study|Physician Decision|1|||
19660261|NCT00464308|42109036|FG001|Overall Study|Physician Decision|0|||
19754846|NCT03518125|42205073|FG001|Overall Study|Lost to Follow-up|2|||
19754847|NCT03518125|42205074|FG002|Overall Study|Lost to Follow-up|0|||
19754848|NCT03518125|42205075|FG003|Overall Study|Lost to Follow-up|0|||
19754849|NCT03518125|42205076|FG004|Overall Study|Lost to Follow-up|3|||
19754850|NCT03518125|42205077|FG005|Overall Study|Lost to Follow-up|5|||
19754851|NCT03518125|42205072|FG000|Overall Study|Physician Decision|0|||
19660262|NCT00464308|42109037|FG002|Overall Study|Physician Decision|0|||
19660263|NCT00468286|42109047|FG000|Overall Study|Adverse Event|1|||
19660264|NCT00468286|42109048|FG001|Overall Study|Adverse Event|6|||
19660265|NCT00468286|42109047|FG000|Overall Study|Protocol Violation|2|||
19388703|NCT02213133|41632235|FG000|Overall Study|Participant discontinued study therapy|2|||
19388704|NCT02213133|41632236|FG001|Overall Study|Participant discontinued study therapy|0|||
19388705|NCT02213133|41632237|FG002|Overall Study|Participant discontinued study therapy|0|||
19388706|NCT02213133|41632235|FG000|Overall Study|Participant withdrew informed consent|2|||
19388707|NCT02213133|41632236|FG001|Overall Study|Participant withdrew informed consent|1|||
19388708|NCT02213133|41632237|FG002|Overall Study|Participant withdrew informed consent|2|||
19388709|NCT02213133|41632235|FG000|Overall Study|Disease progression|11|||
19388710|NCT02213133|41632236|FG001|Overall Study|Disease progression|2|||
19388711|NCT02213133|41632237|FG002|Overall Study|Disease progression|0|||
19388712|NCT02213133|41632235|FG000|Overall Study|Adverse Event (AE)|1|||
19388713|NCT02213133|41632236|FG001|Overall Study|Adverse Event (AE)|0|||
19388714|NCT02213133|41632237|FG002|Overall Study|Adverse Event (AE)|0|||
19388715|NCT02213133|41632235|FG000|Overall Study|Death|16|||
19388716|NCT02213133|41632236|FG001|Overall Study|Death|2|||
19388717|NCT02213133|41632237|FG002|Overall Study|Death|1|||
19388718|NCT02213133|41632235|FG000|Overall Study|Other|5|||
19388719|NCT02213133|41632236|FG001|Overall Study|Other|0|||
19388720|NCT02213133|41632237|FG002|Overall Study|Other|0|||
19388721|NCT02146833|41632246|FG000|Overall Study|Death|10|||
19388722|NCT02146833|41632246|FG000|Overall Study|No longer consented to study treatment|1|||
19388723|NCT02690207|41632250|FG000|Overall Study|Lost to Follow-up|48|||
19388724|NCT02690207|41632250|FG000|Overall Study|Withdrawal by Subject|46|||
19388725|NCT02690207|41632250|FG000|Overall Study|Protocol Violation|2|||
19388726|NCT02690207|41632250|FG000|Overall Study|Serious adverse event|110|||
19388727|NCT02690207|41632250|FG000|Overall Study|Non-serious Adverse Event|18|||
19388728|NCT02690207|41632250|FG000|Overall Study|Migrated/moved from study area|5|||
19388729|NCT02690207|41632250|FG000|Overall Study|Suspected HZ Episode|1|||
19388730|NCT02690207|41632250|FG000|Overall Study|Other reasons for withdrawal|23|||
19388731|NCT02689349|41632256|FG000|Overall Study|Not implanted|4|||
19388732|NCT02689349|41632257|FG001|Overall Study|Not implanted|0|||
19388733|NCT02689349|41632256|FG000|Overall Study|Withdrawal by Subject|9|||
19388734|NCT02689349|41632257|FG001|Overall Study|Withdrawal by Subject|0|||
19602022|NCT00770224|42050591|FG000|Step 1: Induction|Other reason not protocol specified|2|||
19602023|NCT00770224|42050592|FG001|Step 1: Induction|Other reason not protocol specified|0|||
19388735|NCT02679287|41632268|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
19388736|NCT02679287|41632269|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
19602024|NCT00770224|42050591|FG000|Step 1: Induction|Ineligible|2|||
19602025|NCT00770224|42050592|FG001|Step 1: Induction|Ineligible|0|||
19602026|NCT00770224|42050591|FG000|Step 1: Induction|No protocol treatment given|1|||
19602027|NCT00770224|42050592|FG001|Step 1: Induction|No protocol treatment given|0|||
19602028|NCT00770224|42050591|FG000|Step 2: Maintenance|Adverse Event|0|||
19602029|NCT00770224|42050592|FG001|Step 2: Maintenance|Adverse Event|10|||
19602030|NCT00770224|42050591|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
19602031|NCT00770224|42050592|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
19602032|NCT00770224|42050591|FG000|Step 2: Maintenance|Progression/relapse|0|||
19388737|NCT02679287|41632268|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
19388738|NCT02679287|41632269|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
19477099|NCT01488071|41755998|FG001|Overall Study|Administrative or Other Reason(s)|4|||
19477100|NCT01487525|41756006|FG000|Overall Study|Withdrawal by Subject|0|||
19754852|NCT03518125|42205073|FG001|Overall Study|Physician Decision|1|||
19660266|NCT00468286|42109048|FG001|Overall Study|Protocol Violation|2|||
19660267|NCT00468286|42109047|FG000|Overall Study|Withdrawal by Subject|4|||
19660268|NCT00468286|42109048|FG001|Overall Study|Withdrawal by Subject|3|||
19660269|NCT00468286|42109047|FG000|Overall Study|Physician Decision|0|||
19660270|NCT00468286|42109048|FG001|Overall Study|Physician Decision|1|||
19660271|NCT00463840|42109054|FG000|Overall Study|Disease progression|7|||
19660272|NCT00463840|42109054|FG000|Overall Study|Withdrawal by Subject|2|||
19660273|NCT00463840|42109054|FG000|Overall Study|Adverse Event|3|||
19660274|NCT00129389|42109060|FG000|Overall Study|Adverse Event|19|||
19660275|NCT00129389|42109061|FG001|Overall Study|Adverse Event|87|||
19660276|NCT00129389|42109060|FG000|Overall Study|Death|0|||
19660277|NCT00129389|42109061|FG001|Overall Study|Death|1|||
19660278|NCT00129389|42109060|FG000|Overall Study|Lost to Follow-up|2|||
19660279|NCT00129389|42109061|FG001|Overall Study|Lost to Follow-up|1|||
19660280|NCT00129389|42109060|FG000|Overall Study|Physician Decision|0|||
19660281|NCT00129389|42109061|FG001|Overall Study|Physician Decision|4|||
19660282|NCT00129389|42109060|FG000|Overall Study|Protocol Violation|0|||
19660283|NCT00129389|42109061|FG001|Overall Study|Protocol Violation|6|||
19660284|NCT00129389|42109060|FG000|Overall Study|Withdrawal by Subject|9|||
19660285|NCT00129389|42109061|FG001|Overall Study|Withdrawal by Subject|23|||
19660286|NCT00129389|42109060|FG000|Overall Study|Relapse|1|||
19660287|NCT00129389|42109061|FG001|Overall Study|Relapse|0|||
19660288|NCT00129389|42109060|FG000|Overall Study|Not eligible|1|||
19660289|NCT00129389|42109061|FG001|Overall Study|Not eligible|2|||
19660290|NCT00129389|42109060|FG000|Overall Study|Crossed to the other arm|1|||
19660291|NCT00129389|42109061|FG001|Overall Study|Crossed to the other arm|16|||
19660292|NCT00468052|42109069|FG000|Overall Study|Protocol Violation|7|||
19660293|NCT00468052|42109070|FG001|Overall Study|Protocol Violation|8|||
19660294|NCT00453310|42109078|FG000|Overall Study|Progression of Disease|10|||
19660295|NCT00124657|42109085|FG000|Overall Study|Toxicity|0|||
19660296|NCT00124657|42109086|FG001|Overall Study|Toxicity|0|||
19660297|NCT00124657|42109087|FG002|Overall Study|Toxicity|1|||
19660298|NCT00124657|42109085|FG000|Overall Study|Non-compliance|1|||
19660299|NCT00124657|42109086|FG001|Overall Study|Non-compliance|0|||
19660300|NCT00124657|42109087|FG002|Overall Study|Non-compliance|4|||
19660301|NCT00124657|42109085|FG000|Overall Study|Progressive disease|14|||
19660302|NCT00124657|42109086|FG001|Overall Study|Progressive disease|5|||
19660303|NCT00124657|42109087|FG002|Overall Study|Progressive disease|27|||
19660304|NCT00124657|42109085|FG000|Overall Study|Intercurrent illness|1|||
19660305|NCT00124657|42109086|FG001|Overall Study|Intercurrent illness|0|||
19660306|NCT00124657|42109087|FG002|Overall Study|Intercurrent illness|0|||
19660307|NCT00581945|42109110|FG000|Overall Study|Adverse Event|4|||
19660308|NCT00581945|42109111|FG001|Overall Study|Adverse Event|4|||
19660309|NCT00581945|42109110|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19660310|NCT00581945|42109111|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19660311|NCT00581945|42109110|FG000|Overall Study|Withdrawal by Subject|2|||
19660312|NCT00581945|42109111|FG001|Overall Study|Withdrawal by Subject|6|||
19660313|NCT00581945|42109110|FG000|Overall Study|Death|1|||
19660314|NCT00581945|42109111|FG001|Overall Study|Death|0|||
19660315|NCT00555906|42109120|FG000|Phase 1|Objective Progression or Relapse|3|||
19660316|NCT00555906|42109121|FG001|Phase 1|Objective Progression or Relapse|5|||
19660317|NCT00555906|42109122|FG002|Phase 1|Objective Progression or Relapse|3|||
19660318|NCT00555906|42109123|FG003|Phase 1|Objective Progression or Relapse|1|||
19660319|NCT00555906|42109124|FG004|Phase 1|Objective Progression or Relapse|0|||
19660320|NCT00555906|42109120|FG000|Phase 1|Global Deterioration of Health Status|0|||
19660321|NCT00555906|42109121|FG001|Phase 1|Global Deterioration of Health Status|1|||
19660322|NCT00555906|42109122|FG002|Phase 1|Global Deterioration of Health Status|1|||
19660323|NCT00555906|42109123|FG003|Phase 1|Global Deterioration of Health Status|1|||
19660324|NCT00555906|42109124|FG004|Phase 1|Global Deterioration of Health Status|0|||
19660325|NCT00555906|42109120|FG000|Phase 1|Adverse Event|0|||
19660326|NCT00555906|42109121|FG001|Phase 1|Adverse Event|0|||
19660327|NCT00555906|42109122|FG002|Phase 1|Adverse Event|3|||
19660328|NCT00555906|42109123|FG003|Phase 1|Adverse Event|2|||
19660329|NCT00555906|42109124|FG004|Phase 1|Adverse Event|0|||
19660330|NCT00555906|42109120|FG000|Phase 1|Withdrawal by Subject|0|||
19660331|NCT00555906|42109121|FG001|Phase 1|Withdrawal by Subject|0|||
19660332|NCT00555906|42109122|FG002|Phase 1|Withdrawal by Subject|0|||
19660333|NCT00555906|42109123|FG003|Phase 1|Withdrawal by Subject|1|||
19660334|NCT00555906|42109124|FG004|Phase 1|Withdrawal by Subject|0|||
19660335|NCT00555906|42109120|FG000|Phase 2|Adverse Event|0|||
19660336|NCT00555906|42109121|FG001|Phase 2|Adverse Event|0|||
19660337|NCT00555906|42109122|FG002|Phase 2|Adverse Event|0|||
19660338|NCT00555906|42109123|FG003|Phase 2|Adverse Event|0|||
19660339|NCT00555906|42109124|FG004|Phase 2|Adverse Event|4|||
19660340|NCT00555906|42109120|FG000|Phase 2|Global Deterioration of Health Status|0|||
19660341|NCT00555906|42109121|FG001|Phase 2|Global Deterioration of Health Status|0|||
19660342|NCT00555906|42109122|FG002|Phase 2|Global Deterioration of Health Status|0|||
19660343|NCT00555906|42109123|FG003|Phase 2|Global Deterioration of Health Status|0|||
19660344|NCT00555906|42109124|FG004|Phase 2|Global Deterioration of Health Status|2|||
19660345|NCT00555906|42109120|FG000|Phase 2|Objective Progression or Relapse|0|||
19660346|NCT00555906|42109121|FG001|Phase 2|Objective Progression or Relapse|0|||
19660347|NCT00555906|42109122|FG002|Phase 2|Objective Progression or Relapse|0|||
19660348|NCT00555906|42109123|FG003|Phase 2|Objective Progression or Relapse|0|||
19660349|NCT00555906|42109124|FG004|Phase 2|Objective Progression or Relapse|16|||
19660350|NCT00555906|42109120|FG000|Phase 2|Withdrawal by Subject|0|||
19660351|NCT00555906|42109121|FG001|Phase 2|Withdrawal by Subject|0|||
19660352|NCT00555906|42109122|FG002|Phase 2|Withdrawal by Subject|0|||
19660353|NCT00555906|42109123|FG003|Phase 2|Withdrawal by Subject|0|||
19660354|NCT00555906|42109124|FG004|Phase 2|Withdrawal by Subject|2|||
19660355|NCT00555906|42109120|FG000|Phase 2|Other|0|||
19660356|NCT00555906|42109121|FG001|Phase 2|Other|0|||
19660357|NCT00555906|42109122|FG002|Phase 2|Other|0|||
19660358|NCT00555906|42109123|FG003|Phase 2|Other|0|||
19660359|NCT00555906|42109124|FG004|Phase 2|Other|6|||
19660360|NCT00555906|42109120|FG000|Phase 2|Randomized but not Treated|0|||
19660361|NCT00555906|42109121|FG001|Phase 2|Randomized but not Treated|0|||
19660362|NCT00555906|42109122|FG002|Phase 2|Randomized but not Treated|0|||
19660363|NCT00555906|42109123|FG003|Phase 2|Randomized but not Treated|0|||
19660364|NCT00555906|42109124|FG004|Phase 2|Randomized but not Treated|2|||
19754853|NCT03518125|42205074|FG002|Overall Study|Physician Decision|0|||
19754854|NCT03518125|42205075|FG003|Overall Study|Physician Decision|0|||
19754855|NCT03518125|42205076|FG004|Overall Study|Physician Decision|0|||
19754856|NCT03518125|42205077|FG005|Overall Study|Physician Decision|0|||
19754857|NCT03518125|42205072|FG000|Overall Study|Withdrawal by Subject|1|||
19754858|NCT03518125|42205073|FG001|Overall Study|Withdrawal by Subject|1|||
19754859|NCT03518125|42205074|FG002|Overall Study|Withdrawal by Subject|0|||
19754860|NCT03518125|42205075|FG003|Overall Study|Withdrawal by Subject|1|||
19754861|NCT03518125|42205076|FG004|Overall Study|Withdrawal by Subject|1|||
19754862|NCT03518125|42205077|FG005|Overall Study|Withdrawal by Subject|3|||
19754863|NCT03518125|42205072|FG000|Overall Study|Missed Day 394 Visit|1|||
19754864|NCT03518125|42205073|FG001|Overall Study|Missed Day 394 Visit|0|||
19754865|NCT03518125|42205074|FG002|Overall Study|Missed Day 394 Visit|0|||
19754866|NCT03518125|42205075|FG003|Overall Study|Missed Day 394 Visit|0|||
19754867|NCT03518125|42205076|FG004|Overall Study|Missed Day 394 Visit|0|||
19754868|NCT03518125|42205077|FG005|Overall Study|Missed Day 394 Visit|0|||
19754869|NCT03169530|42205094|FG000|Overall Study|Study ended by NIH|15|||
19602033|NCT00770224|42050592|FG001|Step 2: Maintenance|Progression/relapse|1|||
19602034|NCT00770224|42050591|FG000|Step 2: Maintenance|Death|0|||
19602035|NCT00770224|42050592|FG001|Step 2: Maintenance|Death|2|||
19602036|NCT00770224|42050591|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
19602037|NCT00770224|42050592|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
19602038|NCT00770224|42050591|FG000|Step 2: Maintenance|Ineligible|0|||
19602039|NCT00770224|42050592|FG001|Step 2: Maintenance|Ineligible|2|||
19602040|NCT02399215|42050599|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
19602041|NCT02399215|42050599|FG000|Overall Study|Withdrawal by Subject|1|||
19602042|NCT01057589|42050603|FG000|Overall Study|Disease Progression|35|||
19602043|NCT01057589|42050603|FG000|Overall Study|Adverse Event|10|||
19602044|NCT01057589|42050603|FG000|Overall Study|Physician Decision|8|||
19602045|NCT01057589|42050603|FG000|Overall Study|Withdrawal by Subject|3|||
19602046|NCT01057589|42050603|FG000|Overall Study|Sponsor Decision|1|||
19602047|NCT01057589|42050603|FG000|Overall Study|Death|8|||
19602048|NCT01057589|42050603|FG000|Overall Study|Lost to Follow-up|1|||
19602049|NCT01716117|42050609|FG000|Overall Study|Death|5|||
19660365|NCT03817879|42109141|FG000|Overall Study|Drop out|5|||
19754870|NCT03169530|42205095|FG001|Overall Study|Study ended by NIH|17|||
19660366|NCT03817879|42109142|FG001|Overall Study|Drop out|12|||
19660367|NCT03817879|42109141|FG000|Overall Study|Withdrawal by Subject|0|||
19660368|NCT03817879|42109142|FG001|Overall Study|Withdrawal by Subject|1|||
19660369|NCT00555672|42109150|FG000|Overall Study|Death|0|||
19660370|NCT00555672|42109151|FG001|Overall Study|Death|2|||
19660371|NCT00555672|42109150|FG000|Overall Study|Adverse Event|8|||
19660372|NCT00555672|42109151|FG001|Overall Study|Adverse Event|2|||
19660373|NCT00555672|42109150|FG000|Overall Study|Objective progression or relapse|11|||
19660374|NCT00555672|42109151|FG001|Overall Study|Objective progression or relapse|5|||
19660375|NCT00555672|42109150|FG000|Overall Study|Other|3|||
19660376|NCT00555672|42109151|FG001|Overall Study|Other|1|||
19660377|NCT00555672|42109150|FG000|Overall Study|Participant refused|2|||
19754871|NCT03478891|42205113|FG000|Overall Study|Enrolled, but product never administered|0|||
19754872|NCT03478891|42205114|FG001|Overall Study|Enrolled, but product never administered|0|||
19754873|NCT03478891|42205115|FG002|Overall Study|Enrolled, but product never administered|1|||
19754874|NCT03478891|42205113|FG000|Overall Study|Moved from area|0|||
19754875|NCT03478891|42205114|FG001|Overall Study|Moved from area|0|||
19754876|NCT03478891|42205115|FG002|Overall Study|Moved from area|1|||
19754877|NCT03478891|42205113|FG000|Overall Study|Lost to Follow-up|1|||
19754878|NCT03478891|42205114|FG001|Overall Study|Lost to Follow-up|0|||
19754879|NCT03478891|42205115|FG002|Overall Study|Lost to Follow-up|1|||
19754880|NCT01585103|42205127|FG000|Overall Study|Unable to swallow Cytosponge|6|||
19754881|NCT03168906|42205133|FG000|Overall Study|Lack of Efficacy|6|||
19754882|NCT03168906|42205134|FG001|Overall Study|Lack of Efficacy|6|||
19754883|NCT00706966|42205141|FG000|Overall Study|Adverse Event|1|||
19754884|NCT03478657|42205175|FG000|Overall Study|Withdrawal by Subject|0|||
19754885|NCT03478657|42205176|FG001|Overall Study|Withdrawal by Subject|1|||
19754886|NCT03515941|42205184|FG000|Overall Study|Adverse Event|1|||
19754887|NCT03515941|42205185|FG001|Overall Study|Adverse Event|0|||
19754888|NCT03011034|42205193|FG000|Overall Study|Adverse Event|1|||
19754889|NCT03011034|42205194|FG001|Overall Study|Adverse Event|0|||
19754890|NCT03515629|42205202|FG000|Overall Study|Death|0|||
19754891|NCT03515629|42205203|FG001|Overall Study|Death|1|||
19754892|NCT03515629|42205204|FG002|Overall Study|Death|1|||
19660378|NCT00555672|42109151|FG001|Overall Study|Participant refused|0|||
19660379|NCT03958656|42109161|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
19660380|NCT03958656|42109162|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
19660381|NCT03958656|42109163|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
19660382|NCT03958656|42109164|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
19660383|NCT03958656|42109161|FG000|Overall Study|No longer meets eligibility criteria|0|||
19660384|NCT03958656|42109162|FG001|Overall Study|No longer meets eligibility criteria|0|||
19660385|NCT03958656|42109163|FG002|Overall Study|No longer meets eligibility criteria|1|||
19660386|NCT03958656|42109164|FG003|Overall Study|No longer meets eligibility criteria|0|||
19660387|NCT03958656|42109161|FG000|Overall Study|Started anti-cancer treatment|0|||
19660388|NCT03958656|42109162|FG001|Overall Study|Started anti-cancer treatment|0|||
19754893|NCT03515629|42205202|FG000|Overall Study|Progressive disease|0|||
19754894|NCT03515629|42205203|FG001|Overall Study|Progressive disease|1|||
19754895|NCT03515629|42205204|FG002|Overall Study|Progressive disease|0|||
19754896|NCT03512353|42205213|FG000|Overall Study|Sponsor Decision|3|||
19602050|NCT01716117|42050610|FG001|Overall Study|Death|2|||
19602051|NCT01716117|42050609|FG000|Overall Study|Withdrawal by Subject|2|||
19602052|NCT01716117|42050610|FG001|Overall Study|Withdrawal by Subject|0|||
19602053|NCT00579553|42050626|FG000|Overall Study|Lost to Follow-up|16|||
19602054|NCT00579553|42050627|FG001|Overall Study|Lost to Follow-up|13|||
19602055|NCT01650831|42050633|FG000|Overall Study|Screen failure|1|||
19602056|NCT00581893|42050641|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
19602057|NCT00581893|42050642|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
19602058|NCT00770146|42050650|FG000|Treatment Period|Withdrawal by Subject|6|||
19602059|NCT00770146|42050651|FG001|Treatment Period|Withdrawal by Subject|13|||
19602060|NCT00770146|42050650|FG000|Treatment Period|Adverse Event|2|||
19602061|NCT00770146|42050651|FG001|Treatment Period|Adverse Event|26|||
19602062|NCT00770146|42050650|FG000|Treatment Period|Other|1|||
19602063|NCT00770146|42050651|FG001|Treatment Period|Other|5|||
19602064|NCT00770146|42050650|FG000|Treatment Period|Protocol non-compliance|0|||
19602065|NCT00770146|42050651|FG001|Treatment Period|Protocol non-compliance|1|||
19602066|NCT00770146|42050650|FG000|Follow-up Period|Withdrawal by Subject|7|||
19602067|NCT00770146|42050651|FG001|Follow-up Period|Withdrawal by Subject|13|||
19602068|NCT00770146|42050650|FG000|Follow-up Period|Adverse Event|0|||
19602069|NCT00770146|42050651|FG001|Follow-up Period|Adverse Event|2|||
19602070|NCT00770146|42050650|FG000|Follow-up Period|Other|4|||
19602071|NCT00770146|42050651|FG001|Follow-up Period|Other|5|||
19602072|NCT01056341|42050662|FG000|Overall Study|Treatment Intolerance|0|||
19660389|NCT03958656|42109163|FG002|Overall Study|Started anti-cancer treatment|1|||
19754897|NCT03512353|42205213|FG000|Overall Study|Death|1|||
19754898|NCT03512275|42205221|FG000|Overall Study|Withdrawal by Subject|1|||
19754899|NCT03512275|42205222|FG001|Overall Study|Withdrawal by Subject|3|||
19754900|NCT03512275|42205221|FG000|Overall Study|Physician Decision|0|||
19660390|NCT03958656|42109164|FG003|Overall Study|Started anti-cancer treatment|0|||
19660391|NCT00561912|42109174|FG000|Overall Study|ineligible|1|||
19660392|NCT00561678|42109180|FG000|Overall Study|Withdrawal by Subject|4|||
19660393|NCT00561678|42109181|FG001|Overall Study|Withdrawal by Subject|3|||
19660394|NCT00561678|42109180|FG000|Overall Study|surgery cancelled|1|||
19660395|NCT00561678|42109181|FG001|Overall Study|surgery cancelled|1|||
19660396|NCT00561678|42109180|FG000|Overall Study|surgery rescheduled to different site|2|||
19754901|NCT03512275|42205222|FG001|Overall Study|Physician Decision|1|||
19754902|NCT03512275|42205221|FG000|Overall Study|Lost to Follow-up|0|||
19754903|NCT03512275|42205222|FG001|Overall Study|Lost to Follow-up|3|||
19660397|NCT00561678|42109181|FG001|Overall Study|surgery rescheduled to different site|2|||
19660398|NCT00561678|42109180|FG000|Overall Study|anesthesia provider refusal|1|||
19660399|NCT00561678|42109181|FG001|Overall Study|anesthesia provider refusal|0|||
19660400|NCT00463684|42109187|FG000|Overall Study|Withdrawal by Subject|1|||
19660401|NCT00463684|42109187|FG000|Overall Study|Lost to Follow-up|3|||
19660402|NCT00463606|42109194|FG000|Overall Study|Adverse Event|21|||
19660403|NCT00463606|42109195|FG001|Overall Study|Adverse Event|18|||
19660404|NCT00463606|42109196|FG002|Overall Study|Adverse Event|11|||
19660405|NCT00463606|42109194|FG000|Overall Study|Withdrawal by Subject|11|||
19660406|NCT00463606|42109195|FG001|Overall Study|Withdrawal by Subject|11|||
19660407|NCT00463606|42109196|FG002|Overall Study|Withdrawal by Subject|5|||
19660408|NCT00463606|42109194|FG000|Overall Study|Lost to Follow-up|2|||
19660409|NCT00463606|42109195|FG001|Overall Study|Lost to Follow-up|2|||
19660410|NCT00463606|42109196|FG002|Overall Study|Lost to Follow-up|3|||
19660411|NCT00463606|42109194|FG000|Overall Study|Subject noncompliance|1|||
19660412|NCT00463606|42109195|FG001|Overall Study|Subject noncompliance|1|||
19660413|NCT00463606|42109196|FG002|Overall Study|Subject noncompliance|0|||
19660414|NCT00463606|42109194|FG000|Overall Study|Subject moved out of town|1|||
19660415|NCT00463606|42109195|FG001|Overall Study|Subject moved out of town|0|||
19660416|NCT00463606|42109196|FG002|Overall Study|Subject moved out of town|0|||
19660417|NCT00463606|42109194|FG000|Overall Study|Physician Decision|0|||
19660418|NCT00463606|42109195|FG001|Overall Study|Physician Decision|1|||
19660419|NCT00463606|42109196|FG002|Overall Study|Physician Decision|0|||
19660420|NCT00463606|42109194|FG000|Overall Study|Sponsor request|0|||
19660421|NCT00463606|42109195|FG001|Overall Study|Sponsor request|1|||
19660422|NCT00463606|42109196|FG002|Overall Study|Sponsor request|0|||
19660423|NCT00463606|42109194|FG000|Overall Study|Exclusion criteria violation|2|||
19660424|NCT00463606|42109195|FG001|Overall Study|Exclusion criteria violation|0|||
19660425|NCT00463606|42109196|FG002|Overall Study|Exclusion criteria violation|0|||
19660426|NCT00463606|42109194|FG000|Overall Study|Coordinator error|1|||
19660427|NCT00463606|42109195|FG001|Overall Study|Coordinator error|0|||
19660428|NCT00463606|42109196|FG002|Overall Study|Coordinator error|0|||
19660429|NCT00463606|42109194|FG000|Overall Study|Patient randomized in error|1|||
19660430|NCT00463606|42109195|FG001|Overall Study|Patient randomized in error|0|||
19660431|NCT00463606|42109196|FG002|Overall Study|Patient randomized in error|0|||
19660432|NCT00463606|42109194|FG000|Overall Study|Participation in another ABT-335 trial|1|||
19660433|NCT00463606|42109195|FG001|Overall Study|Participation in another ABT-335 trial|0|||
19660434|NCT00463606|42109196|FG002|Overall Study|Participation in another ABT-335 trial|0|||
19660435|NCT00463606|42109194|FG000|Overall Study|Protocol Violation|0|||
19660436|NCT00463606|42109195|FG001|Overall Study|Protocol Violation|0|||
19660437|NCT00463606|42109196|FG002|Overall Study|Protocol Violation|1|||
19660438|NCT03961308|42109206|FG000|Overall Study|Withdrawal by Subject|1|||
19660439|NCT03961308|42109207|FG001|Overall Study|Withdrawal by Subject|0|||
19660440|NCT03961308|42109206|FG000|Overall Study|Other|1|||
19660441|NCT03961308|42109207|FG001|Overall Study|Other|0|||
19660442|NCT03961308|42109206|FG000|Overall Study|Lost to Follow-up|0|||
19660443|NCT03961308|42109207|FG001|Overall Study|Lost to Follow-up|1|||
19660444|NCT03961308|42109206|FG000|Overall Study|Adverse Event|0|||
19660445|NCT03961308|42109207|FG001|Overall Study|Adverse Event|1|||
19660446|NCT00174187|42109215|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
19660447|NCT00174187|42109216|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
19660448|NCT00174187|42109217|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
19660449|NCT00174187|42109215|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
19660450|NCT00174187|42109216|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
19660451|NCT00174187|42109217|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
19660452|NCT00174187|42109215|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
19660453|NCT00174187|42109216|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
19660454|NCT00174187|42109217|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
19660455|NCT00174187|42109215|FG000|Period 1 (up to 3 Years)|Other|0|||
19660456|NCT00174187|42109216|FG001|Period 1 (up to 3 Years)|Other|1|||
19754904|NCT03512275|42205221|FG000|Overall Study|Other|1|||
19754905|NCT03512275|42205222|FG001|Overall Study|Other|0|||
19660457|NCT00174187|42109217|FG002|Period 1 (up to 3 Years)|Other|0|||
19660458|NCT00174187|42109215|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
19660459|NCT00174187|42109216|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
19660460|NCT00174187|42109217|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
19660461|NCT00174187|42109215|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
19660462|NCT00174187|42109216|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
19660463|NCT00174187|42109217|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
19660464|NCT00174187|42109215|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
19660465|NCT00174187|42109216|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
19660466|NCT00174187|42109217|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
19754906|NCT03473197|42205228|FG000|Overall Study|Adverse Event|4|||
19754907|NCT03473197|42205228|FG000|Overall Study|Lost to Follow-up|1|||
19754908|NCT03473197|42205228|FG000|Overall Study|Withdrawal by Subject|5|||
19754909|NCT03511105|42205234|FG000|Overall Study|Adverse Event|1|||
19754910|NCT03511105|42205235|FG001|Overall Study|Adverse Event|0|||
19754911|NCT03511105|42205234|FG000|Overall Study|Withdrew consent|1|||
19754912|NCT03511105|42205235|FG001|Overall Study|Withdrew consent|0|||
19754913|NCT03510715|42205255|FG000|Overall Study|Adverse Event|1|||
19754914|NCT03510715|42205256|FG001|Overall Study|Adverse Event|0|||
19754915|NCT03508843|42205263|FG000|Overall Study|Withdrawal by Subject|1|||
19754916|NCT03508843|42205263|FG000|Overall Study|technical difficulties|2|||
19754917|NCT03508609|42205267|FG000|Overall Study|Withdrawal by Subject|1|||
19754918|NCT03054350|42205277|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
19754919|NCT03054350|42205278|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
19754920|NCT03054350|42205279|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
19754921|NCT03054350|42205280|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
19754922|NCT03054350|42205281|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
19754923|NCT03054350|42205282|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
19754924|NCT03054350|42205277|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
19754925|NCT03054350|42205278|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
19754926|NCT03054350|42205279|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
19754927|NCT03054350|42205280|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
19754928|NCT03054350|42205281|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
19754929|NCT03054350|42205282|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
19754930|NCT03054350|42205277|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
19754931|NCT03054350|42205278|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
19754932|NCT03054350|42205279|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
19754933|NCT03054350|42205280|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
19388739|NCT02679287|41632268|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
19602073|NCT01056341|42050663|FG001|Overall Study|Treatment Intolerance|2|||
19660467|NCT00174187|42109215|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
19660468|NCT00174187|42109216|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
19660469|NCT00174187|42109217|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
19660470|NCT00174187|42109215|FG000|Period 2 (After 3 Years)|Other|0|||
19660471|NCT00174187|42109216|FG001|Period 2 (After 3 Years)|Other|0|||
19660472|NCT00174187|42109217|FG002|Period 2 (After 3 Years)|Other|5|||
19660473|NCT01011335|42109229|FG000|Overall Study|Lost to Follow-up|0|||
19660474|NCT01011335|42109230|FG001|Overall Study|Lost to Follow-up|0|||
19660475|NCT01011335|42109231|FG002|Overall Study|Lost to Follow-up|1|||
19660476|NCT01011335|42109232|FG003|Overall Study|Lost to Follow-up|1|||
19660477|NCT01011335|42109233|FG004|Overall Study|Lost to Follow-up|1|||
19660478|NCT01011335|42109234|FG005|Overall Study|Lost to Follow-up|1|||
19660479|NCT01011335|42109235|FG006|Overall Study|Lost to Follow-up|2|||
19660480|NCT01011335|42109236|FG007|Overall Study|Lost to Follow-up|2|||
19660481|NCT01011335|42109237|FG008|Overall Study|Lost to Follow-up|1|||
19660482|NCT01011335|42109238|FG009|Overall Study|Lost to Follow-up|0|||
19660483|NCT01011335|42109239|FG010|Overall Study|Lost to Follow-up|0|||
19660484|NCT01011335|42109240|FG011|Overall Study|Lost to Follow-up|1|||
19660485|NCT01011335|42109241|FG012|Overall Study|Lost to Follow-up|2|||
19660486|NCT01011335|42109229|FG000|Overall Study|Protocol Violation|0|||
19660487|NCT01011335|42109230|FG001|Overall Study|Protocol Violation|1|||
19660488|NCT01011335|42109231|FG002|Overall Study|Protocol Violation|0|||
19660489|NCT01011335|42109232|FG003|Overall Study|Protocol Violation|0|||
19602074|NCT01056341|42050664|FG002|Overall Study|Treatment Intolerance|0|||
19602075|NCT01056341|42050665|FG003|Overall Study|Treatment Intolerance|2|||
19602076|NCT01056341|42050666|FG004|Overall Study|Treatment Intolerance|0|||
19602077|NCT01056341|42050662|FG000|Overall Study|Lack of Efficacy|32|||
19602078|NCT01056341|42050663|FG001|Overall Study|Lack of Efficacy|30|||
19602079|NCT01056341|42050664|FG002|Overall Study|Lack of Efficacy|7|||
19602080|NCT01056341|42050665|FG003|Overall Study|Lack of Efficacy|25|||
19602081|NCT01056341|42050666|FG004|Overall Study|Lack of Efficacy|9|||
19660490|NCT01011335|42109233|FG004|Overall Study|Protocol Violation|0|||
19660491|NCT01011335|42109234|FG005|Overall Study|Protocol Violation|0|||
19660492|NCT01011335|42109235|FG006|Overall Study|Protocol Violation|0|||
19660493|NCT01011335|42109236|FG007|Overall Study|Protocol Violation|0|||
19660494|NCT01011335|42109237|FG008|Overall Study|Protocol Violation|0|||
19660495|NCT01011335|42109238|FG009|Overall Study|Protocol Violation|0|||
19660496|NCT01011335|42109239|FG010|Overall Study|Protocol Violation|0|||
19660497|NCT01011335|42109240|FG011|Overall Study|Protocol Violation|0|||
19660498|NCT01011335|42109241|FG012|Overall Study|Protocol Violation|0|||
19660499|NCT01011335|42109229|FG000|Overall Study|Moved/deployed or no booster|1|||
19660500|NCT01011335|42109230|FG001|Overall Study|Moved/deployed or no booster|0|||
19660501|NCT01011335|42109231|FG002|Overall Study|Moved/deployed or no booster|0|||
19660502|NCT01011335|42109232|FG003|Overall Study|Moved/deployed or no booster|1|||
19660503|NCT01011335|42109233|FG004|Overall Study|Moved/deployed or no booster|0|||
19660504|NCT01011335|42109234|FG005|Overall Study|Moved/deployed or no booster|0|||
19660505|NCT01011335|42109235|FG006|Overall Study|Moved/deployed or no booster|1|||
19660506|NCT01011335|42109236|FG007|Overall Study|Moved/deployed or no booster|0|||
19660507|NCT01011335|42109237|FG008|Overall Study|Moved/deployed or no booster|1|||
19660508|NCT01011335|42109238|FG009|Overall Study|Moved/deployed or no booster|0|||
19660509|NCT01011335|42109239|FG010|Overall Study|Moved/deployed or no booster|2|||
19660510|NCT01011335|42109240|FG011|Overall Study|Moved/deployed or no booster|0|||
19660511|NCT01011335|42109241|FG012|Overall Study|Moved/deployed or no booster|0|||
19660512|NCT01011335|42109229|FG000|Overall Study|Adverse Event|0|||
19660513|NCT01011335|42109230|FG001|Overall Study|Adverse Event|0|||
19660514|NCT01011335|42109231|FG002|Overall Study|Adverse Event|0|||
19660515|NCT01011335|42109232|FG003|Overall Study|Adverse Event|0|||
19660516|NCT01011335|42109233|FG004|Overall Study|Adverse Event|0|||
19660517|NCT01011335|42109234|FG005|Overall Study|Adverse Event|0|||
19660518|NCT01011335|42109235|FG006|Overall Study|Adverse Event|0|||
19660519|NCT01011335|42109236|FG007|Overall Study|Adverse Event|0|||
19660520|NCT01011335|42109237|FG008|Overall Study|Adverse Event|0|||
19660521|NCT01011335|42109238|FG009|Overall Study|Adverse Event|0|||
19660522|NCT01011335|42109239|FG010|Overall Study|Adverse Event|4|||
19660523|NCT01011335|42109240|FG011|Overall Study|Adverse Event|0|||
19660524|NCT01011335|42109241|FG012|Overall Study|Adverse Event|1|||
19660525|NCT00467896|42109278|FG000|Overall Study|Consent Withdrawal|18|||
19660526|NCT00467896|42109278|FG000|Overall Study|Adverse Event|7|||
19660527|NCT00467896|42109278|FG000|Overall Study|Serious Adverse Event|13|||
19660528|NCT00467896|42109278|FG000|Overall Study|Non-compliance|3|||
19660529|NCT00467896|42109278|FG000|Overall Study|Changed therapy|2|||
19660530|NCT00467896|42109278|FG000|Overall Study|Patient received transplant|2|||
19660531|NCT00467896|42109278|FG000|Overall Study|Patient had atrial septostomy|1|||
19660532|NCT00467896|42109278|FG000|Overall Study|Patient weaned off iloprost|1|||
19660533|NCT00467896|42109278|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
19660534|NCT00467896|42109278|FG000|Overall Study|Started intravenous prostacyclin|1|||
19660535|NCT00467896|42109278|FG000|Overall Study|Started inhaled Remodulin|1|||
19660536|NCT00467896|42109278|FG000|Overall Study|Patient had no improvement|1|||
19660537|NCT00579059|42109286|FG000|Overall Study|Study Canceled at 1 Year|21|||
19660538|NCT00579059|42109287|FG001|Overall Study|Study Canceled at 1 Year|10|||
19660539|NCT00467818|42109295|FG000|Overall Study|Adverse Event|1|||
19660540|NCT00467818|42109296|FG001|Overall Study|Adverse Event|0|||
19660541|NCT00467818|42109295|FG000|Overall Study|Lost to Follow-up|2|||
19660542|NCT00467818|42109296|FG001|Overall Study|Lost to Follow-up|2|||
19660543|NCT00467740|42109309|FG000|Overall Study|Adverse Event|0|||
19660544|NCT00467740|42109310|FG001|Overall Study|Adverse Event|0|||
19660545|NCT00467740|42109311|FG002|Overall Study|Adverse Event|1|||
19754934|NCT03054350|42205281|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
19754935|NCT03054350|42205282|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
19754936|NCT03054350|42205277|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
19754937|NCT03054350|42205278|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
19754938|NCT03054350|42205279|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
19660546|NCT00467740|42109312|FG003|Overall Study|Adverse Event|0|||
19660547|NCT00467740|42109313|FG004|Overall Study|Adverse Event|0|||
19660548|NCT00467740|42109309|FG000|Overall Study|Protocol Violation|0|||
19660549|NCT00467740|42109310|FG001|Overall Study|Protocol Violation|0|||
19660550|NCT00467740|42109311|FG002|Overall Study|Protocol Violation|1|||
19660551|NCT00467740|42109312|FG003|Overall Study|Protocol Violation|0|||
19660552|NCT00467740|42109313|FG004|Overall Study|Protocol Violation|0|||
19660553|NCT00467740|42109309|FG000|Overall Study|Lost to Follow-up|0|||
19660554|NCT00467740|42109310|FG001|Overall Study|Lost to Follow-up|1|||
19660555|NCT00467740|42109311|FG002|Overall Study|Lost to Follow-up|0|||
19660556|NCT00467740|42109312|FG003|Overall Study|Lost to Follow-up|0|||
19660557|NCT00467740|42109313|FG004|Overall Study|Lost to Follow-up|0|||
19660558|NCT00467740|42109309|FG000|Overall Study|Withdrawal by Subject|1|||
19660559|NCT00467740|42109310|FG001|Overall Study|Withdrawal by Subject|1|||
19660560|NCT00467740|42109311|FG002|Overall Study|Withdrawal by Subject|0|||
19660561|NCT00467740|42109312|FG003|Overall Study|Withdrawal by Subject|1|||
19660562|NCT00467740|42109313|FG004|Overall Study|Withdrawal by Subject|0|||
19660563|NCT00467740|42109309|FG000|Overall Study|Lack of Efficacy|0|||
19660564|NCT00467740|42109310|FG001|Overall Study|Lack of Efficacy|1|||
19660565|NCT00467740|42109311|FG002|Overall Study|Lack of Efficacy|0|||
19660566|NCT00467740|42109312|FG003|Overall Study|Lack of Efficacy|0|||
19660567|NCT00467740|42109313|FG004|Overall Study|Lack of Efficacy|0|||
19660568|NCT00553254|42109327|FG000|Overall Study|Death|3|||
19660569|NCT00553254|42109328|FG001|Overall Study|Death|6|||
19660570|NCT00553254|42109329|FG002|Overall Study|Death|25|||
19660571|NCT00553254|42109327|FG000|Overall Study|Lost to Follow-up|0|||
19754939|NCT03054350|42205280|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
19754940|NCT03054350|42205281|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
19660572|NCT00553254|42109328|FG001|Overall Study|Lost to Follow-up|0|||
19660573|NCT00553254|42109329|FG002|Overall Study|Lost to Follow-up|2|||
19660574|NCT00553254|42109327|FG000|Overall Study|Withdrawal by Subject|2|||
19660575|NCT00553254|42109328|FG001|Overall Study|Withdrawal by Subject|0|||
19754941|NCT03054350|42205282|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
19754942|NCT03528577|42205313|FG000|Sequence 1|Failed Spirometry|1|||
19754943|NCT03528577|42205313|FG000|Sequence 1|Restricted medication|1|||
19660576|NCT00553254|42109329|FG002|Overall Study|Withdrawal by Subject|2|||
19660577|NCT00553254|42109327|FG000|Overall Study|Study terminated by Sponsor|0|||
19660578|NCT00553254|42109328|FG001|Overall Study|Study terminated by Sponsor|0|||
19660579|NCT00553254|42109329|FG002|Overall Study|Study terminated by Sponsor|1|||
19660580|NCT00553254|42109327|FG000|Overall Study|Other|1|||
19660581|NCT00553254|42109328|FG001|Overall Study|Other|0|||
19660582|NCT00553254|42109329|FG002|Overall Study|Other|13|||
19660583|NCT00168805|42109344|FG000|Overall Study|Adverse Event|7|||
19660584|NCT00168805|42109345|FG001|Overall Study|Adverse Event|11|||
19660585|NCT00168805|42109346|FG002|Overall Study|Adverse Event|16|||
19660586|NCT00168805|42109344|FG000|Overall Study|Protocol Violation|12|||
19660587|NCT00168805|42109345|FG001|Overall Study|Protocol Violation|11|||
19660588|NCT00168805|42109346|FG002|Overall Study|Protocol Violation|8|||
19660589|NCT00168805|42109344|FG000|Overall Study|Lost to Follow-up|12|||
19660590|NCT00168805|42109345|FG001|Overall Study|Lost to Follow-up|17|||
19660591|NCT00168805|42109346|FG002|Overall Study|Lost to Follow-up|11|||
19660592|NCT00168805|42109344|FG000|Overall Study|Withdrawal by Subject|16|||
19660593|NCT00168805|42109345|FG001|Overall Study|Withdrawal by Subject|18|||
19660594|NCT00168805|42109346|FG002|Overall Study|Withdrawal by Subject|21|||
19660595|NCT00168805|42109344|FG000|Overall Study|Other|24|||
19660596|NCT00168805|42109345|FG001|Overall Study|Other|21|||
19660597|NCT00168805|42109346|FG002|Overall Study|Other|22|||
19660598|NCT00168805|42109344|FG000|Treatment|Adverse Event|25|||
19660599|NCT00168805|42109345|FG001|Treatment|Adverse Event|26|||
19660600|NCT00168805|42109346|FG002|Treatment|Adverse Event|32|||
19660601|NCT00168805|42109344|FG000|Treatment|Protocol Violation|3|||
19660602|NCT00168805|42109345|FG001|Treatment|Protocol Violation|5|||
19660603|NCT00168805|42109346|FG002|Treatment|Protocol Violation|5|||
19660604|NCT00168805|42109344|FG000|Treatment|Withdrawal by Subject|3|||
19660605|NCT00168805|42109345|FG001|Treatment|Withdrawal by Subject|7|||
19660606|NCT00168805|42109346|FG002|Treatment|Withdrawal by Subject|8|||
19660607|NCT00168805|42109344|FG000|Treatment|Other|18|||
19660608|NCT00168805|42109345|FG001|Treatment|Other|18|||
19660609|NCT00168805|42109346|FG002|Treatment|Other|17|||
19660610|NCT00467584|42109357|FG000|Overall Study|Withdrawal by Subject|4|||
19660611|NCT00467584|42109358|FG001|Overall Study|Withdrawal by Subject|5|||
19660612|NCT00467584|42109359|FG002|Overall Study|Withdrawal by Subject|1|||
19660613|NCT03839212|42109367|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
19660614|NCT00168103|42109374|FG000|Overall Study|Withdrawal by Subject|1|||
19660615|NCT00168103|42109375|FG001|Overall Study|Withdrawal by Subject|2|||
19660616|NCT00168103|42109376|FG002|Overall Study|Withdrawal by Subject|1|||
19660617|NCT00168103|42109377|FG003|Overall Study|Withdrawal by Subject|0|||
19660618|NCT00168103|42109374|FG000|Overall Study|Lost to Follow-up|1|||
19660619|NCT00168103|42109375|FG001|Overall Study|Lost to Follow-up|3|||
19660620|NCT00168103|42109376|FG002|Overall Study|Lost to Follow-up|0|||
19660621|NCT00168103|42109377|FG003|Overall Study|Lost to Follow-up|0|||
19660622|NCT00463060|42109387|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
19660623|NCT00463060|42109387|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
19660624|NCT00462982|42109396|FG000|Overall Study|Adverse Event|1|||
19660625|NCT00462982|42109396|FG000|Overall Study|Patient Not Treated|2|||
19660626|NCT00462904|42109417|FG000|Overall Study|Lost to Follow-up|1|||
19660627|NCT00467272|42109421|FG000|Overall Study|Pneumonia|2|||
19660628|NCT00467272|42109421|FG000|Overall Study|Thrombophlebitis|1|||
19660629|NCT00462826|42109425|FG000|Overall Study|Ineligible - second primary|1|||
19660630|NCT00462826|42109425|FG000|Overall Study|Ineligible - wrong cell type|1|||
19660631|NCT00462826|42109425|FG000|Overall Study|Ineligible - wrong primary|2|||
19660632|NCT00462826|42109425|FG000|Overall Study|Never treated|1|||
19660633|NCT00551616|42109437|FG000|Overall Study|Lost to Follow-up|48|||
19660634|NCT00551616|42109438|FG001|Overall Study|Lost to Follow-up|40|||
19660635|NCT00452530|42109446|FG000|Overall Study|Death|1|||
19660636|NCT00452530|42109447|FG001|Overall Study|Death|0|||
19660637|NCT00452530|42109446|FG000|Overall Study|Adverse Event|40|||
19660638|NCT00452530|42109447|FG001|Overall Study|Adverse Event|44|||
19660639|NCT00452530|42109446|FG000|Overall Study|Withdrawal by Subject|68|||
19660640|NCT00452530|42109447|FG001|Overall Study|Withdrawal by Subject|57|||
19660641|NCT00452530|42109446|FG000|Overall Study|Lost to Follow-up|1|||
19660642|NCT00452530|42109447|FG001|Overall Study|Lost to Follow-up|0|||
19660643|NCT00452530|42109446|FG000|Overall Study|Poor compliance/noncompliance|1|||
19660644|NCT00452530|42109447|FG001|Overall Study|Poor compliance/noncompliance|2|||
19660645|NCT00452530|42109446|FG000|Overall Study|No longer met study criteria|18|||
19660646|NCT00452530|42109447|FG001|Overall Study|No longer met study criteria|22|||
19660647|NCT00452530|42109446|FG000|Overall Study|Other|7|||
19660648|NCT00452530|42109447|FG001|Overall Study|Other|11|||
19660649|NCT00549198|42109459|FG000|Overall Study|Adverse Event|28|||
19660650|NCT00549198|42109460|FG001|Overall Study|Adverse Event|26|||
19660651|NCT00549198|42109459|FG000|Overall Study|Insufficient Viral Load Response|4|||
19660652|NCT00549198|42109460|FG001|Overall Study|Insufficient Viral Load Response|2|||
19660653|NCT00549198|42109459|FG000|Overall Study|Protocol-defined Virological Failure|7|||
19660654|NCT00549198|42109460|FG001|Overall Study|Protocol-defined Virological Failure|0|||
19660655|NCT00549198|42109459|FG000|Overall Study|Non-compliance|2|||
19660656|NCT00549198|42109460|FG001|Overall Study|Non-compliance|4|||
19660657|NCT00549198|42109459|FG000|Overall Study|Lost to Follow-up|7|||
19660658|NCT00549198|42109460|FG001|Overall Study|Lost to Follow-up|8|||
19660659|NCT00549198|42109459|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
19660660|NCT00549198|42109460|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19660661|NCT00549198|42109459|FG000|Overall Study|Protocol Violation|7|||
19660662|NCT00549198|42109460|FG001|Overall Study|Protocol Violation|2|||
19660663|NCT00549198|42109459|FG000|Overall Study|Investigator Decision|4|||
19660664|NCT00549198|42109460|FG001|Overall Study|Investigator Decision|3|||
19660665|NCT00549198|42109459|FG000|Overall Study|Withdrawal by Subject|7|||
19660666|NCT00549198|42109460|FG001|Overall Study|Withdrawal by Subject|7|||
19660667|NCT00549198|42109459|FG000|Overall Study|Disease Progression|1|||
19660668|NCT00549198|42109460|FG001|Overall Study|Disease Progression|0|||
19660669|NCT00549198|42109459|FG000|Overall Study|Participant Moved|2|||
19660670|NCT00549198|42109460|FG001|Overall Study|Participant Moved|0|||
19660671|NCT00549198|42109459|FG000|Overall Study|Participant not able to perform Week 96|1|||
19660672|NCT00549198|42109460|FG001|Overall Study|Participant not able to perform Week 96|0|||
19660673|NCT00549198|42109459|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
19660674|NCT00549198|42109460|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
19660675|NCT00549198|42109459|FG000|Overall Study|Prohibited Medication|1|||
19660676|NCT00549198|42109460|FG001|Overall Study|Prohibited Medication|2|||
19660677|NCT00549198|42109459|FG000|Overall Study|Participant planning pregnancy|1|||
19660678|NCT00549198|42109460|FG001|Overall Study|Participant planning pregnancy|0|||
19660679|NCT00549198|42109459|FG000|Overall Study|Participant overweight, no scan possible|1|||
19660680|NCT00549198|42109460|FG001|Overall Study|Participant overweight, no scan possible|0|||
19660681|NCT00549198|42109459|FG000|Overall Study|No scan facilities|0|||
19660682|NCT00549198|42109460|FG001|Overall Study|No scan facilities|2|||
19660683|NCT00549198|42109459|FG000|Overall Study|Pregnancy|0|||
19660684|NCT00549198|42109460|FG001|Overall Study|Pregnancy|3|||
19660685|NCT00549198|42109459|FG000|Overall Study|Not Exposed to Study Drug|3|||
19660686|NCT00549198|42109460|FG001|Overall Study|Not Exposed to Study Drug|4|||
19660687|NCT00607724|42109473|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
19660688|NCT00607724|42109474|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
19660689|NCT00607724|42109475|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
19660690|NCT00607724|42109476|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
19660691|NCT00607724|42109477|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
19660692|NCT00607724|42109478|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
19660693|NCT00607724|42109479|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
19660694|NCT00607724|42109473|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
19660695|NCT00607724|42109474|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
19660696|NCT00607724|42109475|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
19660697|NCT00607724|42109476|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
19660698|NCT00607724|42109477|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
19660699|NCT00607724|42109478|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
19660700|NCT00607724|42109479|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
19660701|NCT00607724|42109473|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
19660702|NCT00607724|42109474|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
19660703|NCT00607724|42109475|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
19754944|NCT03528577|42205313|FG000|Sequence 2|Adverse Event|1|||
19754945|NCT03528577|42205313|FG000|Sequence 2|Withdrawal by Subject|1|||
19754946|NCT03528577|42205313|FG000|Sequence 2|Failed Spirometry|1|||
19754947|NCT03528577|42205313|FG000|Sequence 3|Failed Spirometry|1|||
19754948|NCT03528577|42205313|FG000|Sequence 4|Failed Spirometry|2|||
19754949|NCT03528577|42205313|FG000|Sequence 4|Adverse Event|1|||
19754950|NCT00706654|42205323|FG000|Conversion Phase|Lost to Follow-up|4|||
19754951|NCT00706654|42205324|FG001|Conversion Phase|Lost to Follow-up|0|||
19754952|NCT00706654|42205325|FG002|Conversion Phase|Lost to Follow-up|0|||
19754953|NCT00706654|42205326|FG003|Conversion Phase|Lost to Follow-up|0|||
19754954|NCT00706654|42205323|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
19754955|NCT00706654|42205324|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
19754956|NCT00706654|42205325|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
19754957|NCT00706654|42205326|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
19754958|NCT00706654|42205323|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
19660704|NCT00607724|42109476|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
19660705|NCT00607724|42109477|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
19660706|NCT00607724|42109478|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
19660707|NCT00607724|42109479|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
19660708|NCT00607724|42109473|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
19660709|NCT00607724|42109474|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
19660710|NCT00607724|42109475|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
19660711|NCT00607724|42109476|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
19660712|NCT00607724|42109477|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
19660713|NCT00607724|42109478|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
19660714|NCT00607724|42109479|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
19660715|NCT00607724|42109473|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660716|NCT00607724|42109474|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660717|NCT00607724|42109475|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660718|NCT00607724|42109476|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
19660719|NCT00607724|42109477|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660720|NCT00607724|42109478|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660721|NCT00607724|42109479|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
19660722|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
19660723|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19660724|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19660725|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19660726|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
19660727|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
19660728|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
19660729|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
19660730|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
19660731|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
19660732|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
19660733|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
19660734|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
19660735|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660736|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660737|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660738|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
19660739|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19660740|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19660741|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19754959|NCT00706654|42205324|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
19754960|NCT00706654|42205325|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
19754961|NCT00706654|42205326|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
19754962|NCT00706654|42205323|FG000|Conversion Phase|Withdrawn by Investigator|14|||
19754963|NCT00706654|42205324|FG001|Conversion Phase|Withdrawn by Investigator|0|||
19660742|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
19660743|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660744|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660745|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660746|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
19660747|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
19660748|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
19660749|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
19660750|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
19660751|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
19660752|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
19660753|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
19660754|NCT00506415|42109503|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
19660755|NCT00506415|42109504|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19754964|NCT00706654|42205325|FG002|Conversion Phase|Withdrawn by Investigator|0|||
19754965|NCT00706654|42205326|FG003|Conversion Phase|Withdrawn by Investigator|0|||
19754966|NCT00706654|42205323|FG000|Conversion Phase|Withdrew Consent|38|||
19754967|NCT00706654|42205324|FG001|Conversion Phase|Withdrew Consent|0|||
19754968|NCT00706654|42205325|FG002|Conversion Phase|Withdrew Consent|0|||
19754969|NCT00706654|42205326|FG003|Conversion Phase|Withdrew Consent|0|||
19754970|NCT00706654|42205323|FG000|Conversion Phase|Adverse Event|18|||
19754971|NCT00706654|42205324|FG001|Conversion Phase|Adverse Event|0|||
19754972|NCT00706654|42205325|FG002|Conversion Phase|Adverse Event|0|||
19754973|NCT00706654|42205326|FG003|Conversion Phase|Adverse Event|0|||
19754974|NCT00706654|42205323|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
19754975|NCT00706654|42205324|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
19754976|NCT00706654|42205325|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
19754977|NCT00706654|42205326|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
19602082|NCT01056341|42050662|FG000|Overall Study|Other reasons|4|||
19602083|NCT01056341|42050663|FG001|Overall Study|Other reasons|4|||
19602084|NCT01056341|42050664|FG002|Overall Study|Other reasons|8|||
19602085|NCT01056341|42050665|FG003|Overall Study|Other reasons|9|||
19602086|NCT01056341|42050666|FG004|Overall Study|Other reasons|5|||
19602087|NCT00999518|42050689|FG000|Overall Study|Adverse Event|1|||
19602088|NCT00999518|42050690|FG001|Overall Study|Adverse Event|6|||
19602089|NCT00999518|42050691|FG002|Overall Study|Adverse Event|3|||
19602090|NCT00999518|42050692|FG003|Overall Study|Adverse Event|1|||
19602091|NCT00999518|42050693|FG004|Overall Study|Adverse Event|2|||
19602092|NCT00999518|42050689|FG000|Overall Study|Lack of Efficacy|2|||
19602093|NCT00999518|42050690|FG001|Overall Study|Lack of Efficacy|0|||
19602094|NCT00999518|42050691|FG002|Overall Study|Lack of Efficacy|0|||
19602095|NCT00999518|42050692|FG003|Overall Study|Lack of Efficacy|2|||
19602096|NCT00999518|42050693|FG004|Overall Study|Lack of Efficacy|2|||
19602097|NCT00999518|42050689|FG000|Overall Study|Lost to Follow-up|0|||
19602098|NCT00999518|42050690|FG001|Overall Study|Lost to Follow-up|0|||
19602099|NCT00999518|42050691|FG002|Overall Study|Lost to Follow-up|0|||
19602100|NCT00999518|42050692|FG003|Overall Study|Lost to Follow-up|4|||
19602101|NCT00999518|42050693|FG004|Overall Study|Lost to Follow-up|1|||
19602102|NCT00999518|42050689|FG000|Overall Study|Did not meet entrance criteria|0|||
19602103|NCT00999518|42050690|FG001|Overall Study|Did not meet entrance criteria|0|||
19602104|NCT00999518|42050691|FG002|Overall Study|Did not meet entrance criteria|0|||
19602105|NCT00999518|42050692|FG003|Overall Study|Did not meet entrance criteria|0|||
19602106|NCT00999518|42050693|FG004|Overall Study|Did not meet entrance criteria|1|||
19602107|NCT00999518|42050689|FG000|Overall Study|Study terminated by sponsor|10|||
19602108|NCT00999518|42050690|FG001|Overall Study|Study terminated by sponsor|6|||
19660756|NCT00506415|42109505|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19660757|NCT00506415|42109506|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19660758|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
19660759|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
19660760|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
19660761|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
19660762|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
19660763|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
19660764|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
19660765|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
19660766|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
19660767|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
19660768|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
19660769|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
19660770|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
19660771|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
19660772|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
19660773|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
19660774|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
19660775|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
19660776|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
19660777|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
19660778|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
19660779|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
19660780|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
19660781|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
19660782|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
19660783|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
19660784|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
19660785|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
19660786|NCT00506415|42109503|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
19660787|NCT00506415|42109504|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
19660788|NCT00506415|42109505|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
19660789|NCT00506415|42109506|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
19660790|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
19660791|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
19660792|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
19660793|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
19660794|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19660795|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19660796|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
19602109|NCT00999518|42050691|FG002|Overall Study|Study terminated by sponsor|5|||
19602110|NCT00999518|42050692|FG003|Overall Study|Study terminated by sponsor|5|||
19602111|NCT00999518|42050693|FG004|Overall Study|Study terminated by sponsor|9|||
19602112|NCT00999518|42050689|FG000|Overall Study|Pregnancy|0|||
19602113|NCT00999518|42050690|FG001|Overall Study|Pregnancy|0|||
19602114|NCT00999518|42050691|FG002|Overall Study|Pregnancy|1|||
19602115|NCT00999518|42050692|FG003|Overall Study|Pregnancy|0|||
19602116|NCT00999518|42050693|FG004|Overall Study|Pregnancy|0|||
19602117|NCT00999518|42050689|FG000|Overall Study|Protocol Violation|0|||
19602118|NCT00999518|42050690|FG001|Overall Study|Protocol Violation|1|||
19602119|NCT00999518|42050691|FG002|Overall Study|Protocol Violation|0|||
19602120|NCT00999518|42050692|FG003|Overall Study|Protocol Violation|0|||
19602121|NCT00999518|42050693|FG004|Overall Study|Protocol Violation|2|||
19602122|NCT00999518|42050689|FG000|Overall Study|Withdrawal by Subject|5|||
19602123|NCT00999518|42050690|FG001|Overall Study|Withdrawal by Subject|4|||
19602124|NCT00999518|42050691|FG002|Overall Study|Withdrawal by Subject|10|||
19602125|NCT00999518|42050692|FG003|Overall Study|Withdrawal by Subject|6|||
19602126|NCT00999518|42050693|FG004|Overall Study|Withdrawal by Subject|1|||
19602127|NCT00999518|42050689|FG000|Overall Study|Other|5|||
19602128|NCT00999518|42050690|FG001|Overall Study|Other|7|||
19602129|NCT00999518|42050691|FG002|Overall Study|Other|1|||
19602130|NCT00999518|42050692|FG003|Overall Study|Other|4|||
19602131|NCT00999518|42050693|FG004|Overall Study|Other|5|||
19602132|NCT00999518|42050689|FG000|Overall Study|Randomized but not Treated|1|||
19602133|NCT00999518|42050690|FG001|Overall Study|Randomized but not Treated|1|||
19602134|NCT00999518|42050691|FG002|Overall Study|Randomized but not Treated|2|||
19602135|NCT00999518|42050692|FG003|Overall Study|Randomized but not Treated|0|||
19602136|NCT00999518|42050693|FG004|Overall Study|Randomized but not Treated|1|||
19602137|NCT01056263|42050709|FG000|Overall Study|Adverse Event|12|||
19754978|NCT00706654|42205323|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
19754979|NCT00706654|42205324|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
19754980|NCT00706654|42205325|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
19754981|NCT00706654|42205326|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
19754982|NCT00706654|42205323|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
19754983|NCT00706654|42205324|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
19754984|NCT00706654|42205325|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
19754985|NCT00706654|42205326|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
19754986|NCT00706654|42205323|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
19754987|NCT00706654|42205324|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
19754988|NCT00706654|42205325|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
19754989|NCT00706654|42205326|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
19754990|NCT00706654|42205323|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
19754991|NCT00706654|42205324|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
19754992|NCT00706654|42205325|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
19660797|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
19660798|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660799|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660800|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
19660801|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
19660802|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19660803|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19660804|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
19660805|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
19660806|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19660807|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19660808|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
19660809|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
19660810|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660811|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660812|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
19660813|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
19660814|NCT00506415|42109503|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
19660815|NCT00506415|42109504|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
19660816|NCT00506415|42109505|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
19660817|NCT00506415|42109506|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
19754993|NCT00706654|42205326|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
19754994|NCT00706654|42205323|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
19754995|NCT00706654|42205324|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
19754996|NCT00706654|42205325|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
19754997|NCT00706654|42205326|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
19754998|NCT00706654|42205323|FG000|Oral Stabilization Phase|Withdrew consent|55|||
19754999|NCT00706654|42205324|FG001|Oral Stabilization Phase|Withdrew consent|0|||
19755000|NCT00706654|42205325|FG002|Oral Stabilization Phase|Withdrew consent|0|||
19755001|NCT00706654|42205326|FG003|Oral Stabilization Phase|Withdrew consent|0|||
19755002|NCT00706654|42205323|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
19755003|NCT00706654|42205324|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
19755004|NCT00706654|42205325|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
19755005|NCT00706654|42205326|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
19755006|NCT00706654|42205323|FG000|Oral Stabilization Phase|Adverse Event|21|||
19755007|NCT00706654|42205324|FG001|Oral Stabilization Phase|Adverse Event|0|||
19755008|NCT00706654|42205325|FG002|Oral Stabilization Phase|Adverse Event|0|||
19755009|NCT00706654|42205326|FG003|Oral Stabilization Phase|Adverse Event|0|||
19660818|NCT00452452|42109522|FG000|Overall Study|Protocol Violation|0|||
19660819|NCT00452452|42109523|FG001|Overall Study|Protocol Violation|0|||
19660820|NCT00452452|42109524|FG002|Overall Study|Protocol Violation|1|||
19660821|NCT00452452|42109522|FG000|Overall Study|Withdrawal by Subject|1|||
19660822|NCT00452452|42109523|FG001|Overall Study|Withdrawal by Subject|0|||
19660823|NCT00452452|42109524|FG002|Overall Study|Withdrawal by Subject|0|||
19660824|NCT00452452|42109522|FG000|Overall Study|Lost to Follow-up|1|||
19660825|NCT00452452|42109523|FG001|Overall Study|Lost to Follow-up|0|||
19660826|NCT00452452|42109524|FG002|Overall Study|Lost to Follow-up|0|||
19660827|NCT00510783|42109540|FG000|Overall Study|Lost to Follow-up|29|||
19660828|NCT00510783|42109541|FG001|Overall Study|Lost to Follow-up|25|||
19660829|NCT00510783|42109540|FG000|Overall Study|Withdrawal by Subject|2|||
19660830|NCT00510783|42109541|FG001|Overall Study|Withdrawal by Subject|3|||
19660831|NCT00510783|42109540|FG000|Overall Study|Protocol Violation|0|||
19660832|NCT00510783|42109541|FG001|Overall Study|Protocol Violation|1|||
19660833|NCT00518973|42109549|FG000|Overall Study|Withdrawal by Subject|3|||
19660834|NCT00518973|42109550|FG001|Overall Study|Withdrawal by Subject|2|||
19660835|NCT00462670|42109558|FG000|Overall Study|Adverse Event|3|||
19660836|NCT00462670|42109559|FG001|Overall Study|Adverse Event|5|||
19755010|NCT00706654|42205323|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
19755011|NCT00706654|42205324|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19755012|NCT00706654|42205325|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19755013|NCT00706654|42205326|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19755014|NCT00706654|42205323|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
19755015|NCT00706654|42205324|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19755016|NCT00706654|42205325|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19755017|NCT00706654|42205326|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19755018|NCT00706654|42205323|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
19755019|NCT00706654|42205324|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
19755020|NCT00706654|42205325|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
19755021|NCT00706654|42205326|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
19755022|NCT00706654|42205323|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
19755023|NCT00706654|42205324|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
19755024|NCT00706654|42205325|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
19660837|NCT00462670|42109558|FG000|Overall Study|Lack of Efficacy|1|||
19660838|NCT00462670|42109559|FG001|Overall Study|Lack of Efficacy|0|||
19660839|NCT00462670|42109558|FG000|Overall Study|Protocol Violation|1|||
19660840|NCT00462670|42109559|FG001|Overall Study|Protocol Violation|0|||
19660841|NCT00462670|42109558|FG000|Overall Study|Resolution of signs and symptoms|0|||
19660842|NCT00462670|42109559|FG001|Overall Study|Resolution of signs and symptoms|2|||
19660843|NCT00606086|42109567|FG000|Overall Study|Adverse Event|1|||
19660844|NCT00606086|42109568|FG001|Overall Study|Adverse Event|1|||
19660845|NCT00606086|42109567|FG000|Overall Study|Lost to Follow-up|4|||
19660846|NCT00606086|42109568|FG001|Overall Study|Lost to Follow-up|8|||
19660847|NCT00606086|42109567|FG000|Overall Study|Protocol Violation|1|||
19660848|NCT00606086|42109568|FG001|Overall Study|Protocol Violation|0|||
19660849|NCT00606086|42109567|FG000|Overall Study|Withdrawal by Subject|5|||
19660850|NCT00606086|42109568|FG001|Overall Study|Withdrawal by Subject|3|||
19660851|NCT00606086|42109567|FG000|Overall Study|Non-compliance|0|||
19660852|NCT00606086|42109568|FG001|Overall Study|Non-compliance|1|||
19660853|NCT00606086|42109567|FG000|Overall Study|Randomized, not treated|1|||
19660854|NCT00606086|42109568|FG001|Overall Study|Randomized, not treated|2|||
19660855|NCT00609986|42109576|FG000|Overall Study|Did not receive transplant or treatment|8|||
19660856|NCT00609986|42109577|FG001|Overall Study|Did not receive transplant or treatment|3|||
19660857|NCT00451906|42109583|FG000|Overall Study|Adverse Event|515|||
19660858|NCT00451906|42109583|FG000|Overall Study|Lost to Follow-up|31|||
19660859|NCT00451906|42109583|FG000|Overall Study|Withdrawal by Subject|111|||
19660860|NCT00451906|42109583|FG000|Overall Study|Protocol Violation|21|||
19660861|NCT00451906|42109583|FG000|Overall Study|Progressive disease|1328|||
19660862|NCT00451906|42109583|FG000|Overall Study|Termination of the study|108|||
19660863|NCT00451906|42109583|FG000|Overall Study|Other Reasons|121|||
19660864|NCT00451906|42109583|FG000|Overall Study|Did not complete final visit|4|||
19660865|NCT00451282|42109589|FG000|Overall Study|Lost to Follow-up|6|||
19660866|NCT00451282|42109590|FG001|Overall Study|Lost to Follow-up|5|||
19660867|NCT03838198|42109598|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
19660868|NCT03838198|42109599|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
19660869|NCT03838198|42109600|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
19660870|NCT03838198|42109601|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
19660871|NCT03838198|42109598|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
19660872|NCT03838198|42109599|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
19660873|NCT03838198|42109600|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
19660874|NCT03838198|42109601|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
19660875|NCT00115765|42109616|FG000|Overall Study|Withdrawal by Subject|22|||
19660876|NCT00115765|42109617|FG001|Overall Study|Withdrawal by Subject|53|||
19660877|NCT00115765|42109618|FG002|Overall Study|Withdrawal by Subject|76|||
19660878|NCT00115765|42109619|FG003|Overall Study|Withdrawal by Subject|15|||
19660879|NCT00115765|42109616|FG000|Overall Study|Physician Decision|4|||
19660880|NCT00115765|42109617|FG001|Overall Study|Physician Decision|15|||
19660881|NCT00115765|42109618|FG002|Overall Study|Physician Decision|18|||
19660882|NCT00115765|42109619|FG003|Overall Study|Physician Decision|13|||
19660883|NCT00115765|42109616|FG000|Overall Study|Lost to Follow-up|3|||
19660884|NCT00115765|42109617|FG001|Overall Study|Lost to Follow-up|20|||
19660885|NCT00115765|42109618|FG002|Overall Study|Lost to Follow-up|18|||
19660886|NCT00115765|42109619|FG003|Overall Study|Lost to Follow-up|1|||
19660887|NCT00115765|42109616|FG000|Overall Study|Other|6|||
19660888|NCT00115765|42109617|FG001|Overall Study|Other|12|||
19660889|NCT00115765|42109618|FG002|Overall Study|Other|9|||
19660890|NCT00115765|42109619|FG003|Overall Study|Other|2|||
19660891|NCT00606008|42109627|FG000|Overall Study|Adverse Event|1|||
19660892|NCT00606008|42109627|FG000|Overall Study|Withdrawal by Subject|4|||
19660893|NCT00461812|42109639|FG000|Overall Study|study terminated|10|||
19660894|NCT00123955|42109646|FG000|Overall Study|Adverse Event|1|||
19660895|NCT00123955|42109647|FG001|Overall Study|Adverse Event|0|||
19660896|NCT00123955|42109646|FG000|Overall Study|Withdrawal by Subject|4|||
19660897|NCT00123955|42109647|FG001|Overall Study|Withdrawal by Subject|3|||
19660898|NCT00123955|42109646|FG000|Overall Study|Death|0|||
19660899|NCT00123955|42109647|FG001|Overall Study|Death|1|||
19660900|NCT03837028|42109657|FG000|Overall Study|Lost to Follow-up|4|||
19660901|NCT03837028|42109658|FG001|Overall Study|Lost to Follow-up|0|||
19660902|NCT03837028|42109659|FG002|Overall Study|Lost to Follow-up|2|||
19660903|NCT03837028|42109660|FG003|Overall Study|Lost to Follow-up|0|||
19660904|NCT03837028|42109657|FG000|Overall Study|Withdrawal by Subject|12|||
19660905|NCT03837028|42109658|FG001|Overall Study|Withdrawal by Subject|11|||
19660906|NCT03837028|42109659|FG002|Overall Study|Withdrawal by Subject|11|||
19660907|NCT03837028|42109660|FG003|Overall Study|Withdrawal by Subject|7|||
19660908|NCT00115063|42109672|FG000|Overall Study|Lost to Follow-up|98|||
19660909|NCT00115063|42109673|FG001|Overall Study|Lost to Follow-up|104|||
19660910|NCT00115063|42109672|FG000|Overall Study|Death|1|||
19660911|NCT00115063|42109673|FG001|Overall Study|Death|0|||
19660912|NCT00461500|42109681|FG000|Overall Study|Adverse Event|1|||
19660913|NCT00461500|42109682|FG001|Overall Study|Adverse Event|0|||
19660914|NCT00461500|42109681|FG000|Overall Study|Lack of Efficacy|0|||
19660915|NCT00461500|42109682|FG001|Overall Study|Lack of Efficacy|1|||
19660916|NCT00461500|42109681|FG000|Overall Study|Expired Drug Treatment|1|||
19660917|NCT00461500|42109682|FG001|Overall Study|Expired Drug Treatment|1|||
19660918|NCT00461500|42109681|FG000|Overall Study|Study Stopped|1|||
19660919|NCT00461500|42109682|FG001|Overall Study|Study Stopped|2|||
19660920|NCT00461500|42109681|FG000|Overall Study|Drug Treatment Misuse|1|||
19660921|NCT00461500|42109682|FG001|Overall Study|Drug Treatment Misuse|0|||
19660922|NCT00461500|42109681|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
19755025|NCT00706654|42205326|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
19755026|NCT00706654|42205323|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
19755027|NCT00706654|42205324|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
19755028|NCT00706654|42205325|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
19755029|NCT00706654|42205326|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
19755030|NCT00706654|42205323|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
19755031|NCT00706654|42205324|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
19755032|NCT00706654|42205325|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
19755033|NCT00706654|42205326|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
19755034|NCT00706654|42205323|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
19755035|NCT00706654|42205324|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
19755036|NCT00706654|42205325|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
19755037|NCT00706654|42205326|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
19755038|NCT00706654|42205323|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
19755039|NCT00706654|42205324|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
19660923|NCT00461500|42109682|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
19660924|NCT00461500|42109681|FG000|Overall Study|Lost to Follow-up|2|||
19660925|NCT00461500|42109682|FG001|Overall Study|Lost to Follow-up|2|||
19660926|NCT00167245|42109690|FG000|Overall Study|Lost to Follow-up|20|||
19755040|NCT00706654|42205325|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
19755041|NCT00706654|42205326|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
19755042|NCT00706654|42205323|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
19755043|NCT00706654|42205324|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
19755044|NCT00706654|42205325|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
19755045|NCT00706654|42205326|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
19755046|NCT00706654|42205323|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
19755047|NCT00706654|42205324|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
19755048|NCT00706654|42205325|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
19755049|NCT00706654|42205326|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
19755050|NCT03471871|42205338|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
19755051|NCT03471871|42205339|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
19660927|NCT00167245|42109691|FG001|Overall Study|Lost to Follow-up|31|||
19660928|NCT00167245|42109690|FG000|Overall Study|Withdrawal by Subject|5|||
19660929|NCT00167245|42109691|FG001|Overall Study|Withdrawal by Subject|8|||
19660930|NCT00167245|42109690|FG000|Overall Study|Incarcerated|3|||
19660931|NCT00167245|42109691|FG001|Overall Study|Incarcerated|2|||
19660932|NCT00167245|42109690|FG000|Overall Study|Drowsy|1|||
19660933|NCT00167245|42109691|FG001|Overall Study|Drowsy|0|||
19660934|NCT00443560|42109702|FG000|Overall Study|No intrathecal dose|58|||
19660935|NCT00443560|42109703|FG001|Overall Study|No intrathecal dose|26|||
19660936|NCT00443560|42109702|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
19660937|NCT00443560|42109703|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
19660938|NCT00451204|42109711|FG000|Overall Study|Adverse Event|4|||
19660939|NCT00451204|42109712|FG001|Overall Study|Adverse Event|6|||
19660940|NCT00451204|42109711|FG000|Overall Study|Lack of Efficacy|4|||
19660941|NCT00451204|42109712|FG001|Overall Study|Lack of Efficacy|4|||
19660942|NCT00451204|42109711|FG000|Overall Study|Lost to Follow-up|4|||
19660943|NCT00451204|42109712|FG001|Overall Study|Lost to Follow-up|4|||
19660944|NCT00451204|42109711|FG000|Overall Study|Protocol Violation|1|||
19660945|NCT00451204|42109712|FG001|Overall Study|Protocol Violation|0|||
19660946|NCT00451204|42109711|FG000|Overall Study|Patient refusal|8|||
19660947|NCT00451204|42109712|FG001|Overall Study|Patient refusal|4|||
19755052|NCT03471871|42205340|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
19755053|NCT03471871|42205341|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
19755054|NCT03471871|42205342|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
19602138|NCT01056263|42050709|FG000|Overall Study|Death|1|||
19602139|NCT01056263|42050709|FG000|Overall Study|Withdrawal by Subject|1|||
19602140|NCT01056263|42050709|FG000|Overall Study|Lack of Efficacy|29|||
19602141|NCT01056263|42050709|FG000|Overall Study|Progressive disease|2|||
19602142|NCT01056263|42050709|FG000|Overall Study|Neoplasm progression|1|||
19602143|NCT01056263|42050709|FG000|Overall Study|Objective progression or relapse|1|||
19602144|NCT01056263|42050709|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
19602145|NCT01056107|42050717|FG000|Overall Study|Withdrawal by Subject|0|||
19602146|NCT01056107|42050718|FG001|Overall Study|Withdrawal by Subject|1|||
19602147|NCT01056107|42050719|FG002|Overall Study|Withdrawal by Subject|3|||
19602148|NCT01056107|42050720|FG003|Overall Study|Withdrawal by Subject|0|||
19602149|NCT01003886|42050730|FG000|Overall Study|Lack of Efficacy|5|||
19602150|NCT01003886|42050730|FG000|Overall Study|Lost to Follow-up|169|||
19602151|NCT01003886|42050730|FG000|Overall Study|Withdrawal by Subject|39|||
19660948|NCT00451204|42109711|FG000|Overall Study|Other|1|||
19660949|NCT00451204|42109712|FG001|Overall Study|Other|2|||
19660950|NCT00605540|42109721|FG000|Overall Study|Death|15|||
19660951|NCT00605540|42109721|FG000|Overall Study|Lost to Follow-up|23|||
19660952|NCT00605306|42109727|FG000|Overall Study|Adverse Event|0|||
19660953|NCT00605306|42109728|FG001|Overall Study|Adverse Event|1|||
19755055|NCT03471871|42205338|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
19755056|NCT03471871|42205339|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
19755057|NCT03471871|42205340|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
19755058|NCT03471871|42205341|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
19755059|NCT03471871|42205342|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
19755060|NCT03471871|42205338|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
19755061|NCT03471871|42205339|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
19755062|NCT03471871|42205340|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
19755063|NCT03471871|42205341|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
19755064|NCT03471871|42205342|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
19755065|NCT03471871|42205338|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
19755066|NCT03471871|42205339|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
19755067|NCT03471871|42205340|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
19602152|NCT01003886|42050730|FG000|Overall Study|Other|14|||
19602153|NCT01003886|42050730|FG000|Overall Study|Adverse Event|3|||
19660954|NCT00607022|42109737|FG000|Overall Study|Withdrawal by Subject|1|||
19660955|NCT00607022|42109738|FG001|Overall Study|Withdrawal by Subject|0|||
19660956|NCT00607022|42109739|FG002|Overall Study|Withdrawal by Subject|0|||
19660957|NCT00606632|42109747|FG000|Overall Study|Withdrawal by Subject|13|||
19660958|NCT00606632|42109747|FG000|Overall Study|Miscellaneous reasons|9|||
19660959|NCT00450814|42109766|FG000|Overall Study|Failed to complete the initial therapy|0|||
19660960|NCT00450814|42109767|FG001|Overall Study|Failed to complete the initial therapy|0|||
19660961|NCT00450814|42109768|FG002|Overall Study|Failed to complete the initial therapy|0|||
19660962|NCT00450814|42109769|FG003|Overall Study|Failed to complete the initial therapy|1|||
19660963|NCT00450814|42109770|FG004|Overall Study|Failed to complete the initial therapy|1|||
19660964|NCT00450814|42109771|FG005|Overall Study|Failed to complete the initial therapy|1|||
19660965|NCT00450814|42109772|FG006|Overall Study|Failed to complete the initial therapy|0|||
19660966|NCT00450814|42109773|FG007|Overall Study|Failed to complete the initial therapy|0|||
19602154|NCT01003184|42050736|FG000|Overall Study|Adverse Event|12|||
19602155|NCT01003184|42050737|FG001|Overall Study|Adverse Event|5|||
19660967|NCT00450814|42109774|FG008|Overall Study|Failed to complete the initial therapy|0|||
19602156|NCT01003184|42050736|FG000|Overall Study|Lost to Follow-up|1|||
19602157|NCT01003184|42050737|FG001|Overall Study|Lost to Follow-up|0|||
19660968|NCT00450814|42109775|FG009|Overall Study|Failed to complete the initial therapy|0|||
19660969|NCT00450814|42109776|FG010|Overall Study|Failed to complete the initial therapy|0|||
19660970|NCT00450814|42109766|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
19660971|NCT00450814|42109767|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
19660972|NCT00450814|42109768|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
19660973|NCT00450814|42109769|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
19660974|NCT00450814|42109770|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
19660975|NCT00450814|42109771|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
19660976|NCT00450814|42109772|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
19660977|NCT00450814|42109773|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
19660978|NCT00450814|42109774|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
19660979|NCT00450814|42109775|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
19660980|NCT00450814|42109776|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
19660981|NCT00518115|42109811|FG000|Overall Study|Adverse Event|6|||
19660982|NCT00518115|42109812|FG001|Overall Study|Adverse Event|1|||
19660983|NCT00518115|42109813|FG002|Overall Study|Adverse Event|5|||
19660984|NCT00518115|42109814|FG003|Overall Study|Adverse Event|6|||
19660985|NCT00518115|42109815|FG004|Overall Study|Adverse Event|5|||
19660986|NCT00518115|42109816|FG005|Overall Study|Adverse Event|5|||
19660987|NCT00518115|42109817|FG006|Overall Study|Adverse Event|5|||
19660988|NCT00518115|42109818|FG007|Overall Study|Adverse Event|10|||
19660989|NCT00518115|42109819|FG008|Overall Study|Adverse Event|2|||
19660990|NCT00518115|42109820|FG009|Overall Study|Adverse Event|9|||
19660991|NCT00518115|42109811|FG000|Overall Study|Lost to Follow-up|0|||
19660992|NCT00518115|42109812|FG001|Overall Study|Lost to Follow-up|0|||
19660993|NCT00518115|42109813|FG002|Overall Study|Lost to Follow-up|2|||
19660994|NCT00518115|42109814|FG003|Overall Study|Lost to Follow-up|3|||
19660995|NCT00518115|42109815|FG004|Overall Study|Lost to Follow-up|1|||
19660996|NCT00518115|42109816|FG005|Overall Study|Lost to Follow-up|3|||
19660997|NCT00518115|42109817|FG006|Overall Study|Lost to Follow-up|0|||
19660998|NCT00518115|42109818|FG007|Overall Study|Lost to Follow-up|1|||
19660999|NCT00518115|42109819|FG008|Overall Study|Lost to Follow-up|1|||
19661000|NCT00518115|42109820|FG009|Overall Study|Lost to Follow-up|1|||
19661001|NCT00518115|42109811|FG000|Overall Study|Protocol Violation|1|||
19661002|NCT00518115|42109812|FG001|Overall Study|Protocol Violation|3|||
19661003|NCT00518115|42109813|FG002|Overall Study|Protocol Violation|1|||
19661004|NCT00518115|42109814|FG003|Overall Study|Protocol Violation|0|||
19661005|NCT00518115|42109815|FG004|Overall Study|Protocol Violation|0|||
19661006|NCT00518115|42109816|FG005|Overall Study|Protocol Violation|0|||
19661007|NCT00518115|42109817|FG006|Overall Study|Protocol Violation|0|||
19661008|NCT00518115|42109818|FG007|Overall Study|Protocol Violation|0|||
19661009|NCT00518115|42109819|FG008|Overall Study|Protocol Violation|0|||
19661010|NCT00518115|42109820|FG009|Overall Study|Protocol Violation|0|||
19661011|NCT00518115|42109811|FG000|Overall Study|Withdrawal by Subject|1|||
19661012|NCT00518115|42109812|FG001|Overall Study|Withdrawal by Subject|1|||
19661013|NCT00518115|42109813|FG002|Overall Study|Withdrawal by Subject|5|||
19661014|NCT00518115|42109814|FG003|Overall Study|Withdrawal by Subject|0|||
19661015|NCT00518115|42109815|FG004|Overall Study|Withdrawal by Subject|2|||
19661016|NCT00518115|42109816|FG005|Overall Study|Withdrawal by Subject|1|||
19661017|NCT00518115|42109817|FG006|Overall Study|Withdrawal by Subject|0|||
19661018|NCT00518115|42109818|FG007|Overall Study|Withdrawal by Subject|2|||
19661019|NCT00518115|42109819|FG008|Overall Study|Withdrawal by Subject|1|||
19661020|NCT00518115|42109820|FG009|Overall Study|Withdrawal by Subject|3|||
19661021|NCT00518115|42109811|FG000|Overall Study|Lack of Efficacy|1|||
19661022|NCT00518115|42109812|FG001|Overall Study|Lack of Efficacy|0|||
19661023|NCT00518115|42109813|FG002|Overall Study|Lack of Efficacy|1|||
19661024|NCT00518115|42109814|FG003|Overall Study|Lack of Efficacy|1|||
19661025|NCT00518115|42109815|FG004|Overall Study|Lack of Efficacy|0|||
19661026|NCT00518115|42109816|FG005|Overall Study|Lack of Efficacy|0|||
19661027|NCT00518115|42109817|FG006|Overall Study|Lack of Efficacy|0|||
19661028|NCT00518115|42109818|FG007|Overall Study|Lack of Efficacy|1|||
19661029|NCT00518115|42109819|FG008|Overall Study|Lack of Efficacy|0|||
19661030|NCT00518115|42109820|FG009|Overall Study|Lack of Efficacy|0|||
19661031|NCT00518115|42109811|FG000|Overall Study|Non-Compliance|1|||
19602158|NCT01003184|42050736|FG000|Overall Study|Loss of glucose control|1|||
19602159|NCT01003184|42050737|FG001|Overall Study|Loss of glucose control|1|||
19602160|NCT01003184|42050736|FG000|Overall Study|Protocol Violation|3|||
19602161|NCT01003184|42050737|FG001|Overall Study|Protocol Violation|0|||
19602162|NCT01003184|42050736|FG000|Overall Study|Withdrawal by Subject|1|||
19602163|NCT01003184|42050737|FG001|Overall Study|Withdrawal by Subject|6|||
19602164|NCT01003184|42050736|FG000|Overall Study|Physician Decision|1|||
19602165|NCT01003184|42050737|FG001|Overall Study|Physician Decision|0|||
19602166|NCT01029353|42050747|FG000|Overall Study|Lost to Follow-up|4|||
19602167|NCT01029353|42050748|FG001|Overall Study|Lost to Follow-up|5|||
19602168|NCT01029353|42050749|FG002|Overall Study|Lost to Follow-up|5|||
19602169|NCT01029353|42050750|FG003|Overall Study|Lost to Follow-up|4|||
19602170|NCT01029353|42050747|FG000|Overall Study|Consent Withdrawn|2|||
19602171|NCT01029353|42050748|FG001|Overall Study|Consent Withdrawn|0|||
19602172|NCT01029353|42050749|FG002|Overall Study|Consent Withdrawn|0|||
19602173|NCT01029353|42050750|FG003|Overall Study|Consent Withdrawn|0|||
19602174|NCT01029353|42050747|FG000|Overall Study|Primary Outcome Indeterminate|1|||
19602175|NCT01029353|42050748|FG001|Overall Study|Primary Outcome Indeterminate|3|||
19602176|NCT01029353|42050749|FG002|Overall Study|Primary Outcome Indeterminate|2|||
19661032|NCT00518115|42109812|FG001|Overall Study|Non-Compliance|0|||
19661033|NCT00518115|42109813|FG002|Overall Study|Non-Compliance|1|||
19661034|NCT00518115|42109814|FG003|Overall Study|Non-Compliance|0|||
19661035|NCT00518115|42109815|FG004|Overall Study|Non-Compliance|1|||
19661036|NCT00518115|42109816|FG005|Overall Study|Non-Compliance|1|||
19661037|NCT00518115|42109817|FG006|Overall Study|Non-Compliance|1|||
19661038|NCT00518115|42109818|FG007|Overall Study|Non-Compliance|1|||
19661039|NCT00518115|42109819|FG008|Overall Study|Non-Compliance|0|||
19661040|NCT00518115|42109820|FG009|Overall Study|Non-Compliance|1|||
19661041|NCT00518115|42109811|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
19661042|NCT00518115|42109812|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
19661043|NCT00518115|42109813|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661044|NCT00518115|42109814|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661045|NCT00518115|42109815|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661046|NCT00518115|42109816|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
19661047|NCT00518115|42109817|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661048|NCT00518115|42109818|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661049|NCT00518115|42109819|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661050|NCT00518115|42109820|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
19661051|NCT00518115|42109811|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
19661052|NCT00518115|42109812|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661053|NCT00518115|42109813|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661054|NCT00518115|42109814|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661055|NCT00518115|42109815|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661056|NCT00518115|42109816|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661057|NCT00518115|42109817|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661058|NCT00518115|42109818|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661059|NCT00518115|42109819|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661060|NCT00518115|42109820|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
19661061|NCT00518115|42109811|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661062|NCT00518115|42109812|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661063|NCT00518115|42109813|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
19661064|NCT00518115|42109814|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661065|NCT00518115|42109815|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661066|NCT00518115|42109816|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661067|NCT00518115|42109817|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661068|NCT00518115|42109818|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661069|NCT00518115|42109819|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
19661070|NCT00518115|42109820|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
19661071|NCT00518115|42109811|FG000|Overall Study|Wrong Monotherapy Administered|0|||
19661072|NCT00518115|42109812|FG001|Overall Study|Wrong Monotherapy Administered|0|||
19661073|NCT00518115|42109813|FG002|Overall Study|Wrong Monotherapy Administered|1|||
19661074|NCT00518115|42109814|FG003|Overall Study|Wrong Monotherapy Administered|0|||
19661075|NCT00518115|42109815|FG004|Overall Study|Wrong Monotherapy Administered|0|||
19602177|NCT01029353|42050750|FG003|Overall Study|Primary Outcome Indeterminate|0|||
19661076|NCT00518115|42109816|FG005|Overall Study|Wrong Monotherapy Administered|0|||
19661077|NCT00518115|42109817|FG006|Overall Study|Wrong Monotherapy Administered|1|||
19661078|NCT00518115|42109818|FG007|Overall Study|Wrong Monotherapy Administered|0|||
19661079|NCT00518115|42109819|FG008|Overall Study|Wrong Monotherapy Administered|0|||
19661080|NCT00518115|42109820|FG009|Overall Study|Wrong Monotherapy Administered|0|||
19661081|NCT00518115|42109811|FG000|Overall Study|Violation of Exclusion Criteria|0|||
19661082|NCT00518115|42109812|FG001|Overall Study|Violation of Exclusion Criteria|0|||
19661083|NCT00518115|42109813|FG002|Overall Study|Violation of Exclusion Criteria|0|||
19661084|NCT00518115|42109814|FG003|Overall Study|Violation of Exclusion Criteria|1|||
19661085|NCT00518115|42109815|FG004|Overall Study|Violation of Exclusion Criteria|0|||
19661086|NCT00518115|42109816|FG005|Overall Study|Violation of Exclusion Criteria|0|||
19661087|NCT00518115|42109817|FG006|Overall Study|Violation of Exclusion Criteria|1|||
19661088|NCT00518115|42109818|FG007|Overall Study|Violation of Exclusion Criteria|0|||
19661089|NCT00518115|42109819|FG008|Overall Study|Violation of Exclusion Criteria|0|||
19661090|NCT00518115|42109820|FG009|Overall Study|Violation of Exclusion Criteria|0|||
19661091|NCT00518115|42109811|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
19661092|NCT00518115|42109812|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
19661093|NCT00518115|42109813|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
19661094|NCT00518115|42109814|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
19661095|NCT00518115|42109815|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
19661096|NCT00518115|42109816|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
19661097|NCT00518115|42109817|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
19661098|NCT00518115|42109818|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
19661099|NCT00518115|42109819|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
19661100|NCT00518115|42109820|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
19661101|NCT00518115|42109811|FG000|Overall Study|Withdrew Consent|0|||
19661102|NCT00518115|42109812|FG001|Overall Study|Withdrew Consent|0|||
19661103|NCT00518115|42109813|FG002|Overall Study|Withdrew Consent|0|||
19661104|NCT00518115|42109814|FG003|Overall Study|Withdrew Consent|0|||
19661105|NCT00518115|42109815|FG004|Overall Study|Withdrew Consent|0|||
19661106|NCT00518115|42109816|FG005|Overall Study|Withdrew Consent|1|||
19661107|NCT00518115|42109817|FG006|Overall Study|Withdrew Consent|0|||
19661108|NCT00518115|42109818|FG007|Overall Study|Withdrew Consent|0|||
19661109|NCT00518115|42109819|FG008|Overall Study|Withdrew Consent|0|||
19661110|NCT00518115|42109820|FG009|Overall Study|Withdrew Consent|0|||
19661111|NCT00518115|42109811|FG000|Overall Study|Moved Out of State|0|||
19661112|NCT00518115|42109812|FG001|Overall Study|Moved Out of State|0|||
19661113|NCT00518115|42109813|FG002|Overall Study|Moved Out of State|0|||
19661114|NCT00518115|42109814|FG003|Overall Study|Moved Out of State|0|||
19661115|NCT00518115|42109815|FG004|Overall Study|Moved Out of State|0|||
19661116|NCT00518115|42109816|FG005|Overall Study|Moved Out of State|0|||
19661117|NCT00518115|42109817|FG006|Overall Study|Moved Out of State|0|||
19661118|NCT00518115|42109818|FG007|Overall Study|Moved Out of State|0|||
19661119|NCT00518115|42109819|FG008|Overall Study|Moved Out of State|0|||
19661120|NCT00518115|42109820|FG009|Overall Study|Moved Out of State|1|||
19661121|NCT00450658|42109845|FG000|Overall Study|Adverse Event|24|||
19661122|NCT00450658|42109846|FG001|Overall Study|Adverse Event|15|||
19661123|NCT00450658|42109845|FG000|Overall Study|Withdrawal by Subject|43|||
19661124|NCT00450658|42109846|FG001|Overall Study|Withdrawal by Subject|26|||
19661125|NCT00450658|42109845|FG000|Overall Study|Lost to Follow-up|22|||
19661126|NCT00450658|42109846|FG001|Overall Study|Lost to Follow-up|5|||
19661127|NCT00450658|42109845|FG000|Overall Study|UGI ulcer|33|||
19661128|NCT00450658|42109846|FG001|Overall Study|UGI ulcer|34|||
19661129|NCT00450658|42109845|FG000|Overall Study|misc|21|||
19661130|NCT00450658|42109846|FG001|Overall Study|misc|10|||
19661131|NCT00517881|42109852|FG000|Overall Study|Protocol Violation|2|||
19661132|NCT00517881|42109852|FG000|Overall Study|Adverse Event|1|||
19661133|NCT00517881|42109852|FG000|Overall Study|Renal transplantation|2|||
19661134|NCT00517413|42109873|FG000|Overall Study|Adverse Event|7|||
19661135|NCT00517413|42109873|FG000|Overall Study|Death|13|||
19661136|NCT00517413|42109873|FG000|Overall Study|Protocol Violation|15|||
19661137|NCT00517413|42109873|FG000|Overall Study|Withdrawal by Subject|2|||
19661138|NCT00517413|42109873|FG000|Overall Study|Failure to return|1|||
19661139|NCT00517413|42109873|FG000|Overall Study|Other-Reasons|23|||
19661140|NCT00604214|42109887|FG000|Baseline to Day 28|Death|223|||
19661141|NCT00604214|42109888|FG001|Baseline to Day 28|Death|202|||
19661142|NCT00604214|42109887|FG000|Baseline to Day 28|Lost to Follow-up|2|||
19661143|NCT00604214|42109888|FG001|Baseline to Day 28|Lost to Follow-up|4|||
19661144|NCT00604214|42109887|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
19661145|NCT00604214|42109888|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
19661146|NCT00604214|42109887|FG000|Day 29 to Day 90|Death|64|||
19661147|NCT00604214|42109888|FG001|Day 29 to Day 90|Death|67|||
19661148|NCT00604214|42109887|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
19661149|NCT00604214|42109888|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
19661150|NCT00604214|42109887|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
19661151|NCT00604214|42109888|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
19661152|NCT00604214|42109887|FG000|Day 91 to Day 180|Death|19|||
19661153|NCT00604214|42109888|FG001|Day 91 to Day 180|Death|23|||
19661154|NCT00604214|42109887|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
19661155|NCT00604214|42109888|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
19661156|NCT00604214|42109887|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
19661157|NCT00604214|42109888|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
19661158|NCT00450580|42109896|FG000|Overall Study|Adverse Event|5|||
19661159|NCT00450580|42109897|FG001|Overall Study|Adverse Event|7|||
19661160|NCT00450580|42109896|FG000|Overall Study|Lost to Follow-up|4|||
19755068|NCT03471871|42205341|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
19755069|NCT03471871|42205342|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
19755070|NCT03471871|42205338|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
19755071|NCT03471871|42205339|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
19755072|NCT03471871|42205340|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
19755073|NCT03471871|42205341|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
19755074|NCT03471871|42205342|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
19755075|NCT01957176|42205360|FG000|Overall Study|Adverse Event|2|||
19755076|NCT01957176|42205361|FG001|Overall Study|Adverse Event|0|||
19661161|NCT00450580|42109897|FG001|Overall Study|Lost to Follow-up|5|||
19661162|NCT00450580|42109896|FG000|Overall Study|Withdrawal by Subject|2|||
19755077|NCT01957176|42205360|FG000|Overall Study|Physician Decision|2|||
19755078|NCT01957176|42205361|FG001|Overall Study|Physician Decision|1|||
19755079|NCT01957176|42205360|FG000|Overall Study|Withdrawal by Subject|1|||
19755080|NCT01957176|42205361|FG001|Overall Study|Withdrawal by Subject|0|||
19755081|NCT03527173|42205370|FG000|Overall Study|Lost to Follow-up|4|||
19755082|NCT03527173|42205371|FG001|Overall Study|Lost to Follow-up|2|||
19755083|NCT03527173|42205370|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
19755084|NCT03527173|42205371|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
19755085|NCT03527173|42205370|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
19755086|NCT03527173|42205371|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
19755087|NCT03527173|42205370|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
19755088|NCT03527173|42205371|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19755089|NCT00707980|42205377|FG000|Overall Study|Adverse Event|49|||
19755090|NCT00707980|42205377|FG000|Overall Study|Lack of Efficacy|35|||
19661163|NCT00450580|42109897|FG001|Overall Study|Withdrawal by Subject|2|||
19661164|NCT00450580|42109896|FG000|Overall Study|Protocol Violation|1|||
19661165|NCT00450580|42109897|FG001|Overall Study|Protocol Violation|1|||
19661166|NCT00450580|42109896|FG000|Overall Study|Protocol-defined virologic failure|1|||
19661167|NCT00450580|42109897|FG001|Overall Study|Protocol-defined virologic failure|0|||
19661168|NCT00450580|42109896|FG000|Overall Study|Could not comply with scheduled visits|1|||
19661169|NCT00450580|42109897|FG001|Overall Study|Could not comply with scheduled visits|0|||
19661170|NCT00450580|42109896|FG000|Overall Study|Patient went to Brazil|1|||
19661171|NCT00450580|42109897|FG001|Overall Study|Patient went to Brazil|0|||
19661172|NCT00450580|42109896|FG000|Overall Study|Patient could not swallow Norvir|1|||
19661173|NCT00450580|42109897|FG001|Overall Study|Patient could not swallow Norvir|0|||
19661174|NCT00450580|42109896|FG000|Overall Study|Withdrawal due to pregnancy|0|||
19661175|NCT00450580|42109897|FG001|Overall Study|Withdrawal due to pregnancy|1|||
19661176|NCT00123487|42109905|FG000|Randomized|Death prior to starting treatment|0|||
19661177|NCT00123487|42109906|FG001|Randomized|Death prior to starting treatment|1|||
19661178|NCT00123487|42109905|FG000|Randomized|SAE prior to starting treatment|1|||
19661179|NCT00123487|42109906|FG001|Randomized|SAE prior to starting treatment|0|||
19661180|NCT00123487|42109905|FG000|Treated With Study Drug|Adverse Event|23|||
19661181|NCT00123487|42109906|FG001|Treated With Study Drug|Adverse Event|22|||
19661182|NCT00123487|42109905|FG000|Treated With Study Drug|Disease Progression|141|||
19661183|NCT00123487|42109906|FG001|Treated With Study Drug|Disease Progression|122|||
19661184|NCT00123487|42109905|FG000|Treated With Study Drug|Physician Decision|8|||
19661185|NCT00123487|42109906|FG001|Treated With Study Drug|Physician Decision|9|||
19661186|NCT00123487|42109905|FG000|Treated With Study Drug|Other|59|||
19661187|NCT00123487|42109906|FG001|Treated With Study Drug|Other|58|||
19661188|NCT00123487|42109905|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
19661189|NCT00123487|42109906|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
19661190|NCT00123487|42109905|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
19661191|NCT00123487|42109906|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
19661192|NCT00123487|42109905|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
19755091|NCT00707980|42205377|FG000|Overall Study|Non-Compliance with Study Drug|28|||
19755092|NCT00707980|42205377|FG000|Overall Study|Protocol Deviations|19|||
19661193|NCT00123487|42109906|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
19661194|NCT00509925|42109913|FG000|Overall Study|Personal reasons|0|||
19661195|NCT00509925|42109914|FG001|Overall Study|Personal reasons|1|||
19661196|NCT00504777|42109922|FG000|Overall Study|Adverse Event|1|||
19661197|NCT00509769|42109926|FG000|Overall Study|Progressive disease|77|||
19661198|NCT00509769|42109926|FG000|Overall Study|Adverse Event|4|||
19661199|NCT00509769|42109926|FG000|Overall Study|Patient's decision|1|||
19661200|NCT00509769|42109926|FG000|Overall Study|Physician Decision|8|||
19661201|NCT00509769|42109926|FG000|Overall Study|Use of prohibited therapies during study|1|||
19661202|NCT00114127|42109932|FG000|Overall Study|Adverse Event|2|||
19661203|NCT00114127|42109933|FG001|Overall Study|Adverse Event|1|||
19661204|NCT00114127|42109932|FG000|Overall Study|Lost to Follow-up|1|||
19661205|NCT00114127|42109933|FG001|Overall Study|Lost to Follow-up|0|||
19661206|NCT00114127|42109932|FG000|Overall Study|Withdrawal by Subject|1|||
19755093|NCT00707980|42205377|FG000|Overall Study|Withdrawal of Consent|81|||
19755094|NCT00707980|42205377|FG000|Overall Study|Lost to Follow-up|59|||
19661207|NCT00114127|42109933|FG001|Overall Study|Withdrawal by Subject|3|||
19661208|NCT00572624|42109941|FG000|Overall Study|Lost to Follow-up|10|||
19661209|NCT00572624|42109942|FG001|Overall Study|Lost to Follow-up|4|||
19661210|NCT00572624|42109941|FG000|Overall Study|Wanted to do a different diet program|1|||
19661211|NCT00572624|42109942|FG001|Overall Study|Wanted to do a different diet program|0|||
19661212|NCT00572624|42109941|FG000|Overall Study|Medication change|1|||
19661213|NCT00572624|42109942|FG001|Overall Study|Medication change|0|||
19661214|NCT00572624|42109941|FG000|Overall Study|Started a new job-- no time for study|1|||
19661215|NCT00572624|42109942|FG001|Overall Study|Started a new job-- no time for study|0|||
19661216|NCT00572624|42109941|FG000|Overall Study|Admitted to being a smoker|1|||
19661217|NCT00572624|42109942|FG001|Overall Study|Admitted to being a smoker|0|||
19661218|NCT00572624|42109941|FG000|Overall Study|Refused to do the stress test|1|||
19661219|NCT00572624|42109942|FG001|Overall Study|Refused to do the stress test|0|||
19661220|NCT00572624|42109941|FG000|Overall Study|Problem with vascular access|1|||
19661221|NCT00572624|42109942|FG001|Overall Study|Problem with vascular access|0|||
19661222|NCT00572624|42109941|FG000|Overall Study|Health issues unrelated to the study|1|||
19602178|NCT01008410|42050762|FG000|Overall Study|Adverse Event|13|||
19602179|NCT01008410|42050763|FG001|Overall Study|Adverse Event|7|||
19602180|NCT01008410|42050762|FG000|Overall Study|Withdrawal by Subject|6|||
19661223|NCT00572624|42109942|FG001|Overall Study|Health issues unrelated to the study|0|||
19661224|NCT00122317|42109948|FG000|Overall Study|Death|3|||
19661225|NCT00122317|42109948|FG000|Overall Study|Adverse Event|4|||
19661226|NCT00122317|42109948|FG000|Overall Study|Physician Decision|2|||
19661227|NCT00122317|42109948|FG000|Overall Study|patient non-compliance|1|||
19661228|NCT00122317|42109948|FG000|Overall Study|Withdrawal by Subject|1|||
19661229|NCT03870555|42109955|FG000|Period 3 (2 Days)|Adverse Event|1|||
19661230|NCT03870555|42109956|FG001|Period 3 (2 Days)|Adverse Event|0|||
19661231|NCT03870555|42109957|FG002|Period 3 (2 Days)|Adverse Event|0|||
19661232|NCT03870477|42109968|FG000|Overall Study|Early Study Termination|1|||
19661233|NCT00165841|42109974|FG000|Overall Study|Adverse Event|2|||
19661234|NCT00165841|42109975|FG001|Overall Study|Adverse Event|3|||
19661235|NCT00165841|42109974|FG000|Overall Study|Lack of Efficacy|6|||
19661236|NCT00165841|42109975|FG001|Overall Study|Lack of Efficacy|33|||
19661237|NCT00165841|42109974|FG000|Overall Study|Lost to Follow-up|4|||
19661238|NCT00165841|42109975|FG001|Overall Study|Lost to Follow-up|4|||
19661239|NCT00165841|42109974|FG000|Overall Study|Withdrawal by Subject|7|||
19661240|NCT00165841|42109975|FG001|Overall Study|Withdrawal by Subject|8|||
19661241|NCT00165841|42109974|FG000|Overall Study|Physician Decision|1|||
19661242|NCT00165841|42109975|FG001|Overall Study|Physician Decision|0|||
19661243|NCT00165841|42109974|FG000|Overall Study|Protocol Violation|6|||
19602181|NCT01008410|42050763|FG001|Overall Study|Withdrawal by Subject|2|||
19602182|NCT01008410|42050762|FG000|Overall Study|Lost to Follow-up|1|||
19602183|NCT01008410|42050763|FG001|Overall Study|Lost to Follow-up|0|||
19602184|NCT01008410|42050762|FG000|Overall Study|Noncompliance|1|||
19602185|NCT01008410|42050763|FG001|Overall Study|Noncompliance|0|||
19602186|NCT01008410|42050762|FG000|Overall Study|Low Cortisol|2|||
19602187|NCT01008410|42050763|FG001|Overall Study|Low Cortisol|0|||
19602188|NCT01008410|42050762|FG000|Overall Study|Lack of Efficacy|2|||
19661244|NCT00165841|42109975|FG001|Overall Study|Protocol Violation|8|||
19661245|NCT00165841|42109974|FG000|Overall Study|Other|3|||
19661246|NCT00165841|42109975|FG001|Overall Study|Other|5|||
19661247|NCT00165841|42109974|FG000|Overall Study|Medication Noncompliance|1|||
19661248|NCT00165841|42109975|FG001|Overall Study|Medication Noncompliance|1|||
19661249|NCT00509223|42109983|FG000|Overall Study|Lost to Follow-up|1|||
19661250|NCT00509223|42109984|FG001|Overall Study|Lost to Follow-up|1|||
19661251|NCT00509223|42109983|FG000|Overall Study|Adverse Event|1|||
19661252|NCT00509223|42109984|FG001|Overall Study|Adverse Event|1|||
19661253|NCT00509223|42109983|FG000|Overall Study|Withdrawal by Subject|25|||
19661254|NCT00509223|42109984|FG001|Overall Study|Withdrawal by Subject|6|||
19661255|NCT00509223|42109983|FG000|Overall Study|Including: subject change of address|5|||
19661256|NCT00509223|42109984|FG001|Overall Study|Including: subject change of address|2|||
19755095|NCT00707980|42205377|FG000|Overall Study|Other|39|||
19755096|NCT03506425|42205384|FG000|Overall Study|Adverse Event|1|||
19755097|NCT03506425|42205385|FG001|Overall Study|Adverse Event|3|||
19755098|NCT03506425|42205386|FG002|Overall Study|Adverse Event|0|||
19755099|NCT03506425|42205384|FG000|Overall Study|Death|1|||
19755100|NCT03506425|42205385|FG001|Overall Study|Death|0|||
19755101|NCT03506425|42205386|FG002|Overall Study|Death|0|||
19755102|NCT03506425|42205384|FG000|Overall Study|Withdrawal by Subject|0|||
19755103|NCT03506425|42205385|FG001|Overall Study|Withdrawal by Subject|0|||
19755104|NCT03506425|42205386|FG002|Overall Study|Withdrawal by Subject|1|||
19755105|NCT03051620|42205395|FG000|Overall Study|Lost to Follow-up|6|||
19388740|NCT02679287|41632269|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
19602189|NCT01008410|42050763|FG001|Overall Study|Lack of Efficacy|6|||
19602190|NCT01008410|42050762|FG000|Overall Study|Met Exclusion Criterion|0|||
19602191|NCT01008410|42050763|FG001|Overall Study|Met Exclusion Criterion|1|||
19602192|NCT01023269|42050769|FG000|Overall Study|early termination of the study|2|||
19602193|NCT01023269|42050770|FG001|Overall Study|early termination of the study|0|||
19602194|NCT01007942|42050802|FG000|Overall Study|Adverse Event|29|||
19602195|NCT01007942|42050803|FG001|Overall Study|Adverse Event|14|||
19602196|NCT01007942|42050802|FG000|Overall Study|Abnormal test procedure|0|||
19602197|NCT01007942|42050803|FG001|Overall Study|Abnormal test procedure|1|||
19602198|NCT01007942|42050802|FG000|Overall Study|Disease progression|217|||
19602199|NCT01007942|42050803|FG001|Overall Study|Disease progression|242|||
19602200|NCT01007942|42050802|FG000|Overall Study|New cancer therapy|5|||
19602201|NCT01007942|42050803|FG001|Overall Study|New cancer therapy|1|||
19602202|NCT01007942|42050802|FG000|Overall Study|Protocol Violation|1|||
19602203|NCT01007942|42050803|FG001|Overall Study|Protocol Violation|1|||
19602204|NCT01007942|42050802|FG000|Overall Study|Withdrawal by Subject|19|||
19602205|NCT01007942|42050803|FG001|Overall Study|Withdrawal by Subject|14|||
19602206|NCT01007942|42050802|FG000|Overall Study|Lost to Follow-up|1|||
19602207|NCT01007942|42050803|FG001|Overall Study|Lost to Follow-up|0|||
19602208|NCT01007942|42050802|FG000|Overall Study|Administrative problems|2|||
19602209|NCT01007942|42050803|FG001|Overall Study|Administrative problems|0|||
19602210|NCT01007942|42050802|FG000|Overall Study|Death|3|||
19602211|NCT01007942|42050803|FG001|Overall Study|Death|2|||
19602212|NCT01007942|42050802|FG000|Overall Study|Patients untreated|4|||
19602213|NCT01007942|42050803|FG001|Overall Study|Patients untreated|3|||
19602214|NCT01023035|42050816|FG000|Treatment Period|Adverse Event|27|||
19602215|NCT01023035|42050817|FG001|Treatment Period|Adverse Event|32|||
19602216|NCT01023035|42050818|FG002|Treatment Period|Adverse Event|50|||
19602217|NCT01023035|42050816|FG000|Treatment Period|Non-Medical Reasons|19|||
19602218|NCT01023035|42050817|FG001|Treatment Period|Non-Medical Reasons|22|||
19602219|NCT01023035|42050818|FG002|Treatment Period|Non-Medical Reasons|44|||
19602220|NCT01023035|42050816|FG000|Treatment Period|Treatment Failure|26|||
19602221|NCT01023035|42050817|FG001|Treatment Period|Treatment Failure|31|||
19602222|NCT01023035|42050818|FG002|Treatment Period|Treatment Failure|24|||
19602223|NCT01023035|42050816|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
19602224|NCT01023035|42050817|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
19602225|NCT01023035|42050818|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
19602226|NCT01023035|42050816|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
19602227|NCT01023035|42050817|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
19602228|NCT01023035|42050818|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
19602229|NCT01028651|42050828|FG000|Overall Study|Death|2|||
19602230|NCT01028651|42050828|FG000|Overall Study|Adverse Event|1|||
19602231|NCT01028027|42050836|FG000|Overall Study|Lost to Follow-up|4|||
19602232|NCT01028027|42050837|FG001|Overall Study|Lost to Follow-up|1|||
19602233|NCT01028027|42050836|FG000|Overall Study|Withdrawal by Subject|5|||
19602234|NCT01028027|42050837|FG001|Overall Study|Withdrawal by Subject|3|||
19602235|NCT01028027|42050836|FG000|Overall Study|Adverse Event|4|||
19602236|NCT01028027|42050837|FG001|Overall Study|Adverse Event|7|||
19602237|NCT01028027|42050836|FG000|Overall Study|Protocol Violation|3|||
19602238|NCT01028027|42050837|FG001|Overall Study|Protocol Violation|1|||
19602239|NCT01028027|42050836|FG000|Overall Study|Lack of Efficacy|0|||
19602240|NCT01028027|42050837|FG001|Overall Study|Lack of Efficacy|1|||
19602241|NCT01007552|42050843|FG000|Overall Study|Withdrawal by Subject|1|||
19602242|NCT01007396|42050847|FG000|Overall Study|Lost to Follow-up|47|||
19661257|NCT00509223|42109983|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
19755106|NCT03051620|42205395|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
19661258|NCT00509223|42109984|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
19602243|NCT00998738|42050851|FG000|Overall Study|Uknown|1|||
19602244|NCT00997334|42050855|FG000|Overall Study|still on therapy|12|||
19602245|NCT00997334|42050855|FG000|Overall Study|Adverse Event|3|||
19602246|NCT00997334|42050855|FG000|Overall Study|Patient non-compliance|1|||
19602247|NCT00997334|42050855|FG000|Overall Study|Withdrawal by Subject|3|||
19602248|NCT00997334|42050855|FG000|Overall Study|Death|2|||
19661259|NCT00460798|42109990|FG000|Overall Study|Death|59|||
19661260|NCT00460798|42109990|FG000|Overall Study|Adverse Event|27|||
19661261|NCT00460798|42109990|FG000|Overall Study|Lost to Follow-up|19|||
19661262|NCT00460798|42109990|FG000|Overall Study|Progressive Disease|99|||
19661263|NCT00460798|42109990|FG000|Overall Study|Other|27|||
19661264|NCT00460798|42109990|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
19661265|NCT00460798|42109990|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
19661266|NCT00603980|42109994|FG000|Study Qualification|Protocol Violation|3|||
19661267|NCT00603980|42109994|FG000|Study Qualification|Inconsistent data reporting|13|||
19661268|NCT00603980|42109994|FG000|Main Study|14th subject completed trial|1|||
19661269|NCT00450190|42110014|FG000|Overall Study|Withdrawal by Subject|2|||
19661270|NCT00450112|42110020|FG000|Overall Study|Other Treatment Required|5|||
19661271|NCT00450112|42110021|FG001|Overall Study|Other Treatment Required|1|||
19661272|NCT00450112|42110020|FG000|Overall Study|Withdrawal by Subject|4|||
19661273|NCT00450112|42110021|FG001|Overall Study|Withdrawal by Subject|1|||
19661274|NCT00450112|42110020|FG000|Overall Study|Lost to Follow-up|2|||
19661275|NCT00450112|42110021|FG001|Overall Study|Lost to Follow-up|1|||
19661276|NCT00450112|42110020|FG000|Overall Study|Others|2|||
19661277|NCT00450112|42110021|FG001|Overall Study|Others|3|||
19661278|NCT00449956|42110030|FG000|Overall Study|Adverse Event|7|||
19661279|NCT00449956|42110031|FG001|Overall Study|Adverse Event|1|||
19661280|NCT00449956|42110032|FG002|Overall Study|Adverse Event|6|||
19661281|NCT00449956|42110030|FG000|Overall Study|Lack of Efficacy|0|||
19661282|NCT00449956|42110031|FG001|Overall Study|Lack of Efficacy|0|||
19661283|NCT00449956|42110032|FG002|Overall Study|Lack of Efficacy|1|||
19661284|NCT00449956|42110030|FG000|Overall Study|Protocol Violation|1|||
19661285|NCT00449956|42110031|FG001|Overall Study|Protocol Violation|1|||
19661286|NCT00449956|42110032|FG002|Overall Study|Protocol Violation|1|||
19661287|NCT00449956|42110030|FG000|Overall Study|Withdrawal by Subject|0|||
19661288|NCT00449956|42110031|FG001|Overall Study|Withdrawal by Subject|1|||
19661289|NCT00449956|42110032|FG002|Overall Study|Withdrawal by Subject|0|||
19661290|NCT00449956|42110030|FG000|Overall Study|Physician Decision|2|||
19661291|NCT00449956|42110031|FG001|Overall Study|Physician Decision|1|||
19661292|NCT00449956|42110032|FG002|Overall Study|Physician Decision|1|||
19661293|NCT00509145|42110042|FG000|Overall Study|Death|0|||
19602249|NCT00997334|42050855|FG000|Overall Study|Urgent Palliative Care|2|||
19661294|NCT00509145|42110043|FG001|Overall Study|Death|2|||
19661295|NCT00509145|42110042|FG000|Overall Study|Adverse Event|42|||
19661296|NCT00509145|42110043|FG001|Overall Study|Adverse Event|28|||
19661297|NCT00509145|42110042|FG000|Overall Study|Withdrawal by Subject|32|||
19661298|NCT00509145|42110043|FG001|Overall Study|Withdrawal by Subject|38|||
19661299|NCT00509145|42110042|FG000|Overall Study|Physician Decision|11|||
19661300|NCT00509145|42110043|FG001|Overall Study|Physician Decision|14|||
19661301|NCT00509145|42110042|FG000|Overall Study|Protocol Violation|1|||
19661302|NCT00509145|42110043|FG001|Overall Study|Protocol Violation|6|||
19661303|NCT00509145|42110042|FG000|Overall Study|Pregnancy|3|||
19661304|NCT00509145|42110043|FG001|Overall Study|Pregnancy|8|||
19661305|NCT00509145|42110042|FG000|Overall Study|Lost to Follow-up|6|||
19661306|NCT00509145|42110043|FG001|Overall Study|Lost to Follow-up|5|||
19661307|NCT00509145|42110042|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
19661308|NCT00509145|42110043|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
19661309|NCT00509145|42110042|FG000|Overall Study|Other|6|||
19661310|NCT00509145|42110043|FG001|Overall Study|Other|6|||
19602250|NCT00997334|42050855|FG000|Overall Study|No lesion amenable|1|||
19602251|NCT00997334|42050855|FG000|Overall Study|Ineligible|1|||
19602252|NCT00996944|42050861|FG000|Double-blind Treatment Period|Adverse Event|2|||
19602253|NCT00996944|42050862|FG001|Double-blind Treatment Period|Adverse Event|1|||
19602254|NCT00996944|42050861|FG000|Double-blind Treatment Period|Protocol Violation|1|||
19602255|NCT00996944|42050862|FG001|Double-blind Treatment Period|Protocol Violation|0|||
19602256|NCT00996944|42050861|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
19602257|NCT00996944|42050862|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
19602258|NCT00996944|42050861|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
19602259|NCT00996944|42050862|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
19602260|NCT00996944|42050861|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
19602261|NCT00996944|42050862|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
19602262|NCT01002482|42050872|FG000|Overall Study|Withdrawal by Subject|14|||
19602263|NCT01002482|42050873|FG001|Overall Study|Withdrawal by Subject|21|||
19661311|NCT00509067|42110051|FG000|Overall Study|Lost to Follow-up|1|||
19661312|NCT00509067|42110052|FG001|Overall Study|Lost to Follow-up|1|||
19661313|NCT00509067|42110051|FG000|Overall Study|Adverse Event|3|||
19661314|NCT00509067|42110052|FG001|Overall Study|Adverse Event|1|||
19661315|NCT00509067|42110051|FG000|Overall Study|Protocol Violation|0|||
19661316|NCT00509067|42110052|FG001|Overall Study|Protocol Violation|3|||
19661317|NCT00504309|42110068|FG000|Overall Study|Death|0|||
19661318|NCT00504309|42110069|FG001|Overall Study|Death|0|||
19661319|NCT00504309|42110070|FG002|Overall Study|Death|0|||
19661320|NCT00504309|42110071|FG003|Overall Study|Death|0|||
19661321|NCT00504309|42110072|FG004|Overall Study|Death|1|||
19661322|NCT00504309|42110073|FG005|Overall Study|Death|0|||
19661323|NCT00504309|42110068|FG000|Overall Study|Withdrawal by Subject|0|||
19661324|NCT00504309|42110069|FG001|Overall Study|Withdrawal by Subject|0|||
19661325|NCT00504309|42110070|FG002|Overall Study|Withdrawal by Subject|1|||
19661326|NCT00504309|42110071|FG003|Overall Study|Withdrawal by Subject|0|||
19661327|NCT00504309|42110072|FG004|Overall Study|Withdrawal by Subject|0|||
19661328|NCT00504309|42110073|FG005|Overall Study|Withdrawal by Subject|0|||
19661329|NCT00508755|42110085|FG000|Overall Study|Withdrawal by Subject|1|||
19661330|NCT00504231|42110095|FG000|Overall Study|Discrepant chart documentation re route|0|||
19661331|NCT00504231|42110096|FG001|Overall Study|Discrepant chart documentation re route|0|||
19661332|NCT00504231|42110097|FG002|Overall Study|Discrepant chart documentation re route|1|||
19661333|NCT00504231|42110098|FG003|Overall Study|Discrepant chart documentation re route|0|||
19661334|NCT00568178|42110150|FG000|Double Blind Base Study|Adverse Event|0|||
19661335|NCT00568178|42110151|FG001|Double Blind Base Study|Adverse Event|2|||
19661336|NCT00568178|42110152|FG002|Double Blind Base Study|Adverse Event|1|||
19661337|NCT00568178|42110153|FG003|Double Blind Base Study|Adverse Event|2|||
19661338|NCT00568178|42110154|FG004|Double Blind Base Study|Adverse Event|0|||
19602264|NCT01002482|42050872|FG000|Overall Study|Included twice|1|||
19661339|NCT00568178|42110155|FG005|Double Blind Base Study|Adverse Event|0|||
19661340|NCT00568178|42110150|FG000|Double Blind Base Study|Lost to Follow-up|1|||
19661341|NCT00568178|42110151|FG001|Double Blind Base Study|Lost to Follow-up|0|||
19661342|NCT00568178|42110152|FG002|Double Blind Base Study|Lost to Follow-up|0|||
19661343|NCT00568178|42110153|FG003|Double Blind Base Study|Lost to Follow-up|1|||
19661344|NCT00568178|42110154|FG004|Double Blind Base Study|Lost to Follow-up|0|||
19661345|NCT00568178|42110155|FG005|Double Blind Base Study|Lost to Follow-up|0|||
19661346|NCT00568178|42110150|FG000|Double Blind Base Study|Physician Decision|1|||
19661347|NCT00568178|42110151|FG001|Double Blind Base Study|Physician Decision|1|||
19661348|NCT00568178|42110152|FG002|Double Blind Base Study|Physician Decision|0|||
19661349|NCT00568178|42110153|FG003|Double Blind Base Study|Physician Decision|1|||
19661350|NCT00568178|42110154|FG004|Double Blind Base Study|Physician Decision|0|||
19661351|NCT00568178|42110155|FG005|Double Blind Base Study|Physician Decision|0|||
19661352|NCT00568178|42110150|FG000|Double Blind Base Study|Protocol Violation|3|||
19755107|NCT03053492|42205401|FG000|Overall Study|Adverse Event|1|||
19755108|NCT03053492|42205402|FG001|Overall Study|Adverse Event|1|||
19602265|NCT01002482|42050873|FG001|Overall Study|Included twice|0|||
19602266|NCT01027949|42050879|FG000|Overall Study|Death|174|||
19602267|NCT01027949|42050879|FG000|Overall Study|Progressive Disease|163|||
19602268|NCT01027949|42050879|FG000|Overall Study|Adverse Event|172|||
19602269|NCT01027949|42050879|FG000|Overall Study|Withdrawal by Subject|113|||
19602270|NCT01027949|42050879|FG000|Overall Study|Lost to Follow-up|17|||
19602271|NCT01027949|42050879|FG000|Overall Study|Protocol Violation|13|||
19602272|NCT01027949|42050879|FG000|Overall Study|PI Decision|8|||
19602273|NCT01027949|42050879|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
19602274|NCT01027949|42050879|FG000|Overall Study|Non-compliance with Study Procedures|7|||
19602275|NCT01027949|42050879|FG000|Overall Study|Lung Transplant|5|||
19602276|NCT01027949|42050879|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
19602277|NCT01027949|42050879|FG000|Overall Study|Use of Excluded Medication|2|||
19602278|NCT01027949|42050879|FG000|Overall Study|Patient Self-discontinuation|1|||
19602279|NCT01027949|42050879|FG000|Overall Study|Pregnancy|1|||
19602280|NCT01027949|42050879|FG000|Overall Study|Surgery|1|||
19661353|NCT00568178|42110151|FG001|Double Blind Base Study|Protocol Violation|2|||
19661354|NCT00568178|42110152|FG002|Double Blind Base Study|Protocol Violation|0|||
19661355|NCT00568178|42110153|FG003|Double Blind Base Study|Protocol Violation|0|||
19661356|NCT00568178|42110154|FG004|Double Blind Base Study|Protocol Violation|0|||
19661357|NCT00568178|42110155|FG005|Double Blind Base Study|Protocol Violation|0|||
19661358|NCT00568178|42110150|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
19661359|NCT00568178|42110151|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
19661360|NCT00568178|42110152|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
19661361|NCT00568178|42110153|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
19661362|NCT00568178|42110154|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
19661363|NCT00568178|42110155|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
19661364|NCT00568178|42110150|FG000|Double Blind Base Study|Progressive Disease|0|||
19661365|NCT00568178|42110151|FG001|Double Blind Base Study|Progressive Disease|0|||
19661366|NCT00568178|42110152|FG002|Double Blind Base Study|Progressive Disease|0|||
19661367|NCT00568178|42110153|FG003|Double Blind Base Study|Progressive Disease|1|||
19661368|NCT00568178|42110154|FG004|Double Blind Base Study|Progressive Disease|0|||
19661369|NCT00568178|42110155|FG005|Double Blind Base Study|Progressive Disease|0|||
19661370|NCT00568178|42110150|FG000|Open Label Extension|Adverse Event|0|||
19661371|NCT00568178|42110151|FG001|Open Label Extension|Adverse Event|0|||
19661372|NCT00568178|42110152|FG002|Open Label Extension|Adverse Event|0|||
19661373|NCT00568178|42110153|FG003|Open Label Extension|Adverse Event|0|||
19661374|NCT00568178|42110154|FG004|Open Label Extension|Adverse Event|11|||
19661375|NCT00568178|42110155|FG005|Open Label Extension|Adverse Event|8|||
19755109|NCT03053492|42205401|FG000|Overall Study|Withdrawal by Subject|7|||
19755110|NCT03053492|42205402|FG001|Overall Study|Withdrawal by Subject|5|||
19755111|NCT04239872|42205408|FG000|Overall Study|Lost to Follow-up|0|||
19755112|NCT04239872|42205409|FG001|Overall Study|Lost to Follow-up|1|||
19755113|NCT03164772|42205417|FG000|Overall Study|Death|4|||
19755114|NCT03164772|42205418|FG001|Overall Study|Death|2|||
19755115|NCT03164772|42205417|FG000|Overall Study|Adverse Event|1|||
19755116|NCT03164772|42205418|FG001|Overall Study|Adverse Event|4|||
19755117|NCT03164772|42205417|FG000|Overall Study|Progressive Disease|11|||
19755118|NCT03164772|42205418|FG001|Overall Study|Progressive Disease|21|||
19661376|NCT00568178|42110150|FG000|Open Label Extension|Protocol Violation|0|||
19661377|NCT00568178|42110151|FG001|Open Label Extension|Protocol Violation|0|||
19661378|NCT00568178|42110152|FG002|Open Label Extension|Protocol Violation|0|||
19661379|NCT00568178|42110153|FG003|Open Label Extension|Protocol Violation|0|||
19661380|NCT00568178|42110154|FG004|Open Label Extension|Protocol Violation|1|||
19661381|NCT00568178|42110155|FG005|Open Label Extension|Protocol Violation|0|||
19661382|NCT00568178|42110150|FG000|Open Label Extension|Lost to Follow-up|0|||
19661383|NCT00568178|42110151|FG001|Open Label Extension|Lost to Follow-up|0|||
19661384|NCT00568178|42110152|FG002|Open Label Extension|Lost to Follow-up|0|||
19661385|NCT00568178|42110153|FG003|Open Label Extension|Lost to Follow-up|0|||
19661386|NCT00568178|42110154|FG004|Open Label Extension|Lost to Follow-up|6|||
19661387|NCT00568178|42110155|FG005|Open Label Extension|Lost to Follow-up|11|||
19661388|NCT00568178|42110150|FG000|Open Label Extension|Physician Decision|0|||
19661389|NCT00568178|42110151|FG001|Open Label Extension|Physician Decision|0|||
19661390|NCT00568178|42110152|FG002|Open Label Extension|Physician Decision|0|||
19661391|NCT00568178|42110153|FG003|Open Label Extension|Physician Decision|0|||
19661392|NCT00568178|42110154|FG004|Open Label Extension|Physician Decision|9|||
19661393|NCT00568178|42110155|FG005|Open Label Extension|Physician Decision|8|||
19661394|NCT00568178|42110150|FG000|Open Label Extension|Pregnancy|0|||
19661395|NCT00568178|42110151|FG001|Open Label Extension|Pregnancy|0|||
19661396|NCT00568178|42110152|FG002|Open Label Extension|Pregnancy|0|||
19661397|NCT00568178|42110153|FG003|Open Label Extension|Pregnancy|0|||
19661398|NCT00568178|42110154|FG004|Open Label Extension|Pregnancy|0|||
19661399|NCT00568178|42110155|FG005|Open Label Extension|Pregnancy|1|||
19661400|NCT00568178|42110150|FG000|Open Label Extension|Progressive Disease|0|||
19661401|NCT00568178|42110151|FG001|Open Label Extension|Progressive Disease|0|||
19661402|NCT00568178|42110152|FG002|Open Label Extension|Progressive Disease|0|||
19661403|NCT00568178|42110153|FG003|Open Label Extension|Progressive Disease|0|||
19661404|NCT00568178|42110154|FG004|Open Label Extension|Progressive Disease|3|||
19661405|NCT00568178|42110155|FG005|Open Label Extension|Progressive Disease|1|||
19661406|NCT00568178|42110150|FG000|Open Label Extension|Termination of Trial|0|||
19661407|NCT00568178|42110151|FG001|Open Label Extension|Termination of Trial|0|||
19755119|NCT03164772|42205417|FG000|Overall Study|Physician Decision|2|||
19755120|NCT03164772|42205418|FG001|Overall Study|Physician Decision|0|||
19755121|NCT03164772|42205417|FG000|Overall Study|Withdrawal by Subject|0|||
19755122|NCT03164772|42205418|FG001|Overall Study|Withdrawal by Subject|4|||
19755123|NCT03050450|42205441|FG000|Overall Study|Physician Decision|1|||
19755124|NCT03050450|42205442|FG001|Overall Study|Physician Decision|0|||
19755125|NCT03050450|42205443|FG002|Overall Study|Physician Decision|0|||
19755126|NCT03050450|42205444|FG003|Overall Study|Physician Decision|0|||
19755127|NCT03050450|42205445|FG004|Overall Study|Physician Decision|0|||
19661408|NCT00568178|42110152|FG002|Open Label Extension|Termination of Trial|0|||
19661409|NCT00568178|42110153|FG003|Open Label Extension|Termination of Trial|0|||
19755128|NCT03505021|42205459|FG000|Overall Study|Protocol Violation|1|||
19755129|NCT03505021|42205460|FG001|Overall Study|Protocol Violation|0|||
19755130|NCT03505021|42205459|FG000|Overall Study|Death|9|||
19661410|NCT00568178|42110154|FG004|Open Label Extension|Termination of Trial|45|||
19661411|NCT00568178|42110155|FG005|Open Label Extension|Termination of Trial|47|||
19661412|NCT00568178|42110150|FG000|Open Label Extension|Withdrawal by Subject|0|||
19661413|NCT00568178|42110151|FG001|Open Label Extension|Withdrawal by Subject|0|||
19661414|NCT00568178|42110152|FG002|Open Label Extension|Withdrawal by Subject|0|||
19755131|NCT03505021|42205460|FG001|Overall Study|Death|8|||
19661415|NCT00568178|42110153|FG003|Open Label Extension|Withdrawal by Subject|0|||
19661416|NCT00568178|42110154|FG004|Open Label Extension|Withdrawal by Subject|4|||
19661417|NCT00568178|42110155|FG005|Open Label Extension|Withdrawal by Subject|4|||
19661418|NCT00577889|42110172|FG000|Overall Study|Withdrawal by Subject|1|||
19661419|NCT00577889|42110173|FG001|Overall Study|Withdrawal by Subject|0|||
19661420|NCT00577889|42110174|FG002|Overall Study|Withdrawal by Subject|0|||
19661421|NCT00460564|42110186|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
19661422|NCT00460564|42110187|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
19661423|NCT00460564|42110188|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19661424|NCT00460564|42110189|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19661425|NCT00460564|42110190|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19661426|NCT00460564|42110191|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19755132|NCT03505021|42205459|FG000|Overall Study|Consent withdrawn by subject|6|||
19755133|NCT03505021|42205460|FG001|Overall Study|Consent withdrawn by subject|1|||
19755134|NCT03505021|42205459|FG000|Overall Study|Lost to Follow-up|5|||
19755135|NCT03505021|42205460|FG001|Overall Study|Lost to Follow-up|3|||
19388741|NCT02679287|41632268|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
19602281|NCT01038323|42050886|FG000|Overall Study|Withdrawal by Subject|3|||
19661427|NCT00460564|42110192|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19661428|NCT00460564|42110193|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19661429|NCT00460564|42110186|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
19661430|NCT00460564|42110187|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661431|NCT00460564|42110188|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661432|NCT00460564|42110189|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661433|NCT00460564|42110190|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661434|NCT00460564|42110191|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661435|NCT00460564|42110192|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661436|NCT00460564|42110193|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19661437|NCT00460564|42110186|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19661438|NCT00460564|42110187|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19661439|NCT00460564|42110188|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19661440|NCT00460564|42110189|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19661441|NCT00460564|42110190|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
19661442|NCT00460564|42110191|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
19661443|NCT00460564|42110192|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
19661444|NCT00460564|42110193|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19661445|NCT00460564|42110186|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661446|NCT00460564|42110187|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661447|NCT00460564|42110188|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661448|NCT00460564|42110189|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661449|NCT00460564|42110190|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
19661450|NCT00460564|42110191|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
19661451|NCT00460564|42110192|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661452|NCT00460564|42110193|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19661453|NCT00460564|42110186|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661454|NCT00460564|42110187|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661455|NCT00460564|42110188|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661456|NCT00460564|42110189|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661457|NCT00460564|42110190|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
19661458|NCT00460564|42110191|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661459|NCT00460564|42110192|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19602282|NCT01038323|42050887|FG001|Overall Study|Withdrawal by Subject|2|||
19602283|NCT01038323|42050888|FG002|Overall Study|Withdrawal by Subject|4|||
19602284|NCT01027871|42050899|FG000|Overall Study|Physician Decision|1|||
19602285|NCT01027871|42050900|FG001|Overall Study|Physician Decision|5|||
19602286|NCT01027871|42050901|FG002|Overall Study|Physician Decision|0|||
19602287|NCT01027871|42050899|FG000|Overall Study|Protocol Violation|0|||
19602288|NCT01027871|42050900|FG001|Overall Study|Protocol Violation|2|||
19602289|NCT01027871|42050901|FG002|Overall Study|Protocol Violation|2|||
19602290|NCT01027871|42050899|FG000|Overall Study|Withdrawal by Subject|1|||
19602291|NCT01027871|42050900|FG001|Overall Study|Withdrawal by Subject|2|||
19602292|NCT01027871|42050901|FG002|Overall Study|Withdrawal by Subject|2|||
19602293|NCT01027871|42050899|FG000|Overall Study|Adverse Event|0|||
19602294|NCT01027871|42050900|FG001|Overall Study|Adverse Event|2|||
19602295|NCT01027871|42050901|FG002|Overall Study|Adverse Event|2|||
19602296|NCT01027871|42050899|FG000|Overall Study|Sponsor Decision|0|||
19661460|NCT00460564|42110193|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
19661461|NCT00567476|42110215|FG000|Overall Study|Adverse Event|2|||
19755136|NCT03505021|42205459|FG000|Overall Study|Adverse Event|26|||
19602297|NCT01027871|42050900|FG001|Overall Study|Sponsor Decision|2|||
19602298|NCT01027871|42050901|FG002|Overall Study|Sponsor Decision|0|||
19661462|NCT00567476|42110216|FG001|Overall Study|Adverse Event|0|||
19661463|NCT00567476|42110215|FG000|Overall Study|Pregnancy|1|||
19661464|NCT00567476|42110216|FG001|Overall Study|Pregnancy|0|||
19661465|NCT00567476|42110215|FG000|Overall Study|Protocol Violation|4|||
19661466|NCT00567476|42110216|FG001|Overall Study|Protocol Violation|1|||
19661467|NCT00567476|42110215|FG000|Overall Study|Lost to Follow-up|0|||
19661468|NCT00567476|42110216|FG001|Overall Study|Lost to Follow-up|1|||
19661469|NCT00567476|42110215|FG000|Overall Study|Administrative issues|1|||
19661470|NCT00567476|42110216|FG001|Overall Study|Administrative issues|0|||
19661471|NCT00567476|42110215|FG000|Overall Study|Medical Decision|0|||
19661472|NCT00567476|42110216|FG001|Overall Study|Medical Decision|1|||
19661473|NCT00567476|42110215|FG000|Overall Study|Non-adherence to protocol|0|||
19661474|NCT00567476|42110216|FG001|Overall Study|Non-adherence to protocol|1|||
19661475|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
19661476|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
19661477|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
19661478|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
19661479|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
19661480|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
19661481|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
19661482|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
19661483|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
19661484|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
19661485|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
19661486|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
19661487|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
19661488|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
19661489|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
19661490|NCT00516321|42110224|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
19661491|NCT00516321|42110225|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
19661492|NCT00516321|42110226|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
19661493|NCT00516321|42110224|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
19661494|NCT00516321|42110225|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
19661495|NCT00516321|42110226|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
19388742|NCT02679287|41632269|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
19388743|NCT02679287|41632268|FG000|Period 2|Work/Scheduling Conflict|1|||
19388744|NCT02679287|41632269|FG001|Period 2|Work/Scheduling Conflict|0|||
19661496|NCT00516321|42110224|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
19661497|NCT00516321|42110225|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
19661498|NCT00516321|42110226|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
19661499|NCT00516321|42110224|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
19661500|NCT00516321|42110225|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
19661501|NCT00516321|42110226|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
19661502|NCT00516321|42110224|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
19661503|NCT00516321|42110225|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
19661504|NCT00516321|42110226|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
19661505|NCT00516321|42110224|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
19661506|NCT00516321|42110225|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
19661507|NCT00516321|42110226|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
19755137|NCT03505021|42205460|FG001|Overall Study|Adverse Event|9|||
19388745|NCT02679287|41632268|FG000|Period 2|Disliked Mobile System|2|||
19661508|NCT00460408|42110238|FG000|Overall Study|Adverse Event|1|||
19661509|NCT00460408|42110239|FG001|Overall Study|Adverse Event|0|||
19661510|NCT00460408|42110240|FG002|Overall Study|Adverse Event|0|||
19661511|NCT00460408|42110241|FG003|Overall Study|Adverse Event|0|||
19661512|NCT00460408|42110238|FG000|Overall Study|Death|7|||
19661513|NCT00460408|42110239|FG001|Overall Study|Death|0|||
19661514|NCT00460408|42110240|FG002|Overall Study|Death|0|||
19661515|NCT00460408|42110241|FG003|Overall Study|Death|0|||
19661516|NCT00460408|42110238|FG000|Overall Study|Lost to Follow-up|11|||
19661517|NCT00460408|42110239|FG001|Overall Study|Lost to Follow-up|0|||
19661518|NCT00460408|42110240|FG002|Overall Study|Lost to Follow-up|1|||
19661519|NCT00460408|42110241|FG003|Overall Study|Lost to Follow-up|0|||
19661520|NCT00460408|42110238|FG000|Overall Study|Withdrawal by Subject|31|||
19661521|NCT00460408|42110239|FG001|Overall Study|Withdrawal by Subject|0|||
19661522|NCT00460408|42110240|FG002|Overall Study|Withdrawal by Subject|0|||
19661523|NCT00460408|42110241|FG003|Overall Study|Withdrawal by Subject|0|||
19661524|NCT00460408|42110238|FG000|Overall Study|Insufficient clinical response|5|||
19755138|NCT03505021|42205459|FG000|Overall Study|Disease progression|33|||
19661525|NCT00460408|42110239|FG001|Overall Study|Insufficient clinical response|1|||
19661526|NCT00460408|42110240|FG002|Overall Study|Insufficient clinical response|5|||
19661527|NCT00460408|42110241|FG003|Overall Study|Insufficient clinical response|0|||
19661528|NCT00460408|42110238|FG000|Overall Study|Other|12|||
19661529|NCT00460408|42110239|FG001|Overall Study|Other|2|||
19661530|NCT00460408|42110240|FG002|Overall Study|Other|0|||
19661531|NCT00460408|42110241|FG003|Overall Study|Other|0|||
19661532|NCT00507819|42110251|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
19661533|NCT00507819|42110252|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
19661534|NCT00442936|42110282|FG000|Overall Study|Protocol Violation|1|||
19661535|NCT00442936|42110283|FG001|Overall Study|Protocol Violation|0|||
19755139|NCT03505021|42205460|FG001|Overall Study|Disease progression|17|||
19755140|NCT03505021|42205459|FG000|Overall Study|Other|11|||
19755141|NCT03505021|42205460|FG001|Overall Study|Other|5|||
19755142|NCT03505021|42205459|FG000|Overall Study|Personal reason|21|||
19755143|NCT03505021|42205460|FG001|Overall Study|Personal reason|12|||
19755144|NCT03050372|42205466|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
19755145|NCT03050372|42205467|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
19755146|NCT03050372|42205466|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
19755147|NCT03050372|42205467|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
19755148|NCT03470545|42205474|FG000|Overall Study|Death|0|||
19755149|NCT03470545|42205475|FG001|Overall Study|Death|1|||
19755150|NCT03470545|42205474|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
19755151|NCT03470545|42205475|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
19755152|NCT03470545|42205474|FG000|Overall Study|Adverse Event|2|||
19755153|NCT03470545|42205475|FG001|Overall Study|Adverse Event|0|||
19755154|NCT03470545|42205474|FG000|Overall Study|Withdrawal by Subject|1|||
19755155|NCT03470545|42205475|FG001|Overall Study|Withdrawal by Subject|1|||
19755156|NCT03470545|42205474|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
19755157|NCT03470545|42205475|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
19755158|NCT03163446|42205484|FG000|Overall Study|Unable to return for Day 180 visit|2|||
19661536|NCT00442936|42110284|FG002|Overall Study|Protocol Violation|1|||
19661537|NCT00442936|42110285|FG003|Overall Study|Protocol Violation|1|||
19661538|NCT00577655|42110297|FG000|Overall Study|Patient Request|0|||
19661539|NCT00577655|42110298|FG001|Overall Study|Patient Request|2|||
19661540|NCT00577655|42110297|FG000|Overall Study|Protocol Violation|0|||
19661541|NCT00577655|42110298|FG001|Overall Study|Protocol Violation|1|||
19661542|NCT00577655|42110297|FG000|Overall Study|Lost to Follow-up|1|||
19661543|NCT00577655|42110298|FG001|Overall Study|Lost to Follow-up|1|||
19661544|NCT00113269|42110309|FG000|Overall Study|Not transplanted, donor issues|4|||
19661545|NCT00113269|42110310|FG001|Overall Study|Not transplanted, donor issues|0|||
19661546|NCT00113269|42110311|FG002|Overall Study|Not transplanted, donor issues|2|||
19661547|NCT00113269|42110312|FG003|Overall Study|Not transplanted, donor issues|2|||
19661548|NCT00113269|42110309|FG000|Overall Study|Not transplanted, recipient issues|2|||
19661549|NCT00113269|42110310|FG001|Overall Study|Not transplanted, recipient issues|1|||
19661550|NCT00113269|42110311|FG002|Overall Study|Not transplanted, recipient issues|7|||
19661551|NCT00113269|42110312|FG003|Overall Study|Not transplanted, recipient issues|4|||
19661552|NCT00113269|42110309|FG000|Overall Study|Early graft loss, technical|0|||
19661553|NCT00113269|42110310|FG001|Overall Study|Early graft loss, technical|0|||
19661554|NCT00113269|42110311|FG002|Overall Study|Early graft loss, technical|2|||
19661555|NCT00113269|42110312|FG003|Overall Study|Early graft loss, technical|0|||
19661556|NCT00113269|42110309|FG000|Overall Study|Death in operating room|0|||
19661557|NCT00113269|42110310|FG001|Overall Study|Death in operating room|0|||
19661558|NCT00113269|42110311|FG002|Overall Study|Death in operating room|0|||
19661559|NCT00113269|42110312|FG003|Overall Study|Death in operating room|1|||
19661560|NCT00113269|42110309|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
19661561|NCT00113269|42110310|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
19661562|NCT00113269|42110311|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
19661563|NCT00113269|42110312|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
19661564|NCT00113269|42110309|FG000|Overall Study|Adverse Event|2|||
19661565|NCT00113269|42110310|FG001|Overall Study|Adverse Event|7|||
19661566|NCT00113269|42110311|FG002|Overall Study|Adverse Event|11|||
19661567|NCT00113269|42110312|FG003|Overall Study|Adverse Event|7|||
19661568|NCT00113269|42110309|FG000|Overall Study|Withdrawal by Subject|4|||
19661569|NCT00113269|42110310|FG001|Overall Study|Withdrawal by Subject|3|||
19661570|NCT00113269|42110311|FG002|Overall Study|Withdrawal by Subject|4|||
19661571|NCT00113269|42110312|FG003|Overall Study|Withdrawal by Subject|2|||
19661572|NCT00113269|42110309|FG000|Overall Study|Graft loss|6|||
19661573|NCT00113269|42110310|FG001|Overall Study|Graft loss|6|||
19661574|NCT00113269|42110311|FG002|Overall Study|Graft loss|4|||
19661575|NCT00113269|42110312|FG003|Overall Study|Graft loss|9|||
19755159|NCT03163446|42205485|FG001|Overall Study|Unable to return for Day 180 visit|0|||
19755160|NCT03163446|42205484|FG000|Overall Study|Withdrawal by Subject|2|||
19755161|NCT03163446|42205485|FG001|Overall Study|Withdrawal by Subject|6|||
19755162|NCT03163446|42205484|FG000|Overall Study|Death|16|||
19755163|NCT03163446|42205485|FG001|Overall Study|Death|5|||
19755164|NCT03163446|42205484|FG000|Overall Study|Lost to Follow-up|6|||
19755165|NCT03163446|42205485|FG001|Overall Study|Lost to Follow-up|5|||
19755166|NCT03163446|42205484|FG000|Overall Study|Physician Decision|1|||
19755167|NCT03163446|42205485|FG001|Overall Study|Physician Decision|1|||
19755168|NCT03163446|42205484|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
19755169|NCT03163446|42205485|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
19755170|NCT03043664|42205515|FG000|Overall Study|Lost to Follow-up|1|||
19755171|NCT03043664|42205515|FG000|Overall Study|In Observation for Overall Survival|6|||
19755172|NCT03047720|42205525|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
19755173|NCT03047720|42205526|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
19755174|NCT03626168|42205551|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
19755175|NCT03626168|42205552|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
19755176|NCT03626168|42205551|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
19755177|NCT03626168|42205552|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
19755178|NCT03626168|42205551|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
19755179|NCT03626168|42205552|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
19755180|NCT02966873|42205560|FG000|Overall Study|Lost to Follow-up|16|||
19755181|NCT02966873|42205561|FG001|Overall Study|Lost to Follow-up|15|||
19755182|NCT01389024|42205569|FG000|Overall Study|Withdrawal by Subject|0|||
19755183|NCT01389024|42205570|FG001|Overall Study|Withdrawal by Subject|1|||
19755184|NCT01389024|42205569|FG000|Overall Study|Lost to Follow-up|1|||
19755185|NCT01389024|42205570|FG001|Overall Study|Lost to Follow-up|0|||
19755186|NCT03050060|42205580|FG000|Overall Study|Adverse Event|7|||
19755187|NCT03050060|42205580|FG000|Overall Study|Withdrawal by Subject|1|||
19755188|NCT03050060|42205580|FG000|Overall Study|Progression|7|||
19755189|NCT00706342|42205593|FG000|Overall Study|Adverse Event|3|||
19755190|NCT00706342|42205593|FG000|Overall Study|Not responding to treatment|2|||
19755191|NCT00706342|42205593|FG000|Overall Study|Withdrawn due to failure to respond|1|||
19755192|NCT00706342|42205593|FG000|Overall Study|Death|1|||
19755193|NCT00706342|42205593|FG000|Overall Study|Withdrew from the study on his own.|1|||
19755194|NCT00706342|42205593|FG000|Overall Study|Investigator discretion|2|||
19755195|NCT00706342|42205593|FG000|Overall Study|Non-responder Week 12|1|||
19755196|NCT00706342|42205593|FG000|Overall Study|Ongoing|6|||
19755197|NCT00706342|42205593|FG000|Overall Study|WIthdrawal of consent|1|||
19755198|NCT03049748|42205599|FG000|Overall Study|Lost to Follow-up|1|||
19755199|NCT03049748|42205600|FG001|Overall Study|Lost to Follow-up|0|||
19755200|NCT03049748|42205599|FG000|Overall Study|Death|3|||
19755201|NCT03049748|42205600|FG001|Overall Study|Death|0|||
19755202|NCT03049748|42205599|FG000|Overall Study|Withdrawal by Subject|0|||
19661576|NCT00113269|42110309|FG000|Overall Study|Protocol Violation|1|||
19661577|NCT00113269|42110310|FG001|Overall Study|Protocol Violation|0|||
19661578|NCT00113269|42110311|FG002|Overall Study|Protocol Violation|4|||
19661579|NCT00113269|42110312|FG003|Overall Study|Protocol Violation|2|||
19661580|NCT00113269|42110309|FG000|Overall Study|Lost to Follow-up|2|||
19661581|NCT00113269|42110310|FG001|Overall Study|Lost to Follow-up|3|||
19661582|NCT00113269|42110311|FG002|Overall Study|Lost to Follow-up|6|||
19661583|NCT00113269|42110312|FG003|Overall Study|Lost to Follow-up|3|||
19661584|NCT00113269|42110309|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
19661585|NCT00113269|42110310|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
19661586|NCT00113269|42110311|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
19661587|NCT00113269|42110312|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
19661588|NCT00113269|42110309|FG000|Overall Study|Discontinued due to rejection|0|||
19661589|NCT00113269|42110310|FG001|Overall Study|Discontinued due to rejection|0|||
19661590|NCT00113269|42110311|FG002|Overall Study|Discontinued due to rejection|1|||
19661591|NCT00113269|42110312|FG003|Overall Study|Discontinued due to rejection|0|||
19755203|NCT03049748|42205600|FG001|Overall Study|Withdrawal by Subject|3|||
19755204|NCT03049748|42205599|FG000|Overall Study|Protocol Violation|0|||
19755205|NCT03049748|42205600|FG001|Overall Study|Protocol Violation|2|||
19755206|NCT03049748|42205599|FG000|Overall Study|Moved out of state (relocation)|0|||
19755207|NCT03049748|42205600|FG001|Overall Study|Moved out of state (relocation)|1|||
19755208|NCT03526861|42205613|FG000|Initial Treatment Period|Not dosed|1|||
19755209|NCT03526861|42205614|FG001|Initial Treatment Period|Not dosed|1|||
19755210|NCT03526861|42205615|FG002|Initial Treatment Period|Not dosed|1|||
19755211|NCT03526861|42205616|FG003|Initial Treatment Period|Not dosed|0|||
19755212|NCT03526861|42205617|FG004|Initial Treatment Period|Not dosed|0|||
19755213|NCT03526861|42205618|FG005|Initial Treatment Period|Not dosed|0|||
19755214|NCT03526861|42205619|FG006|Initial Treatment Period|Not dosed|0|||
19755215|NCT03526861|42205620|FG007|Initial Treatment Period|Not dosed|0|||
19755216|NCT03526861|42205621|FG008|Initial Treatment Period|Not dosed|0|||
19755217|NCT03526861|42205613|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
19755218|NCT03526861|42205614|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
19755219|NCT03526861|42205615|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
19755220|NCT03526861|42205616|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755221|NCT03526861|42205617|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755222|NCT03526861|42205618|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755223|NCT03526861|42205619|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755224|NCT03526861|42205620|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755225|NCT03526861|42205621|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755226|NCT03526861|42205613|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
19755227|NCT03526861|42205614|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
19755228|NCT03526861|42205615|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
19755229|NCT03526861|42205616|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755230|NCT03526861|42205617|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755231|NCT03526861|42205618|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755232|NCT03526861|42205619|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755233|NCT03526861|42205620|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755234|NCT03526861|42205621|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
19755235|NCT03526861|42205613|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755236|NCT03526861|42205614|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755237|NCT03526861|42205615|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755238|NCT03526861|42205616|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
19755239|NCT03526861|42205617|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
19755240|NCT03526861|42205618|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755241|NCT03526861|42205619|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
19755242|NCT03526861|42205620|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755243|NCT03526861|42205621|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19661592|NCT00113269|42110309|FG000|Overall Study|Moved|0|||
19661593|NCT00113269|42110310|FG001|Overall Study|Moved|1|||
19661594|NCT00113269|42110311|FG002|Overall Study|Moved|0|||
19661595|NCT00113269|42110312|FG003|Overall Study|Moved|3|||
19661596|NCT00113269|42110309|FG000|Overall Study|Received pancreas transplant|0|||
19661597|NCT00113269|42110310|FG001|Overall Study|Received pancreas transplant|0|||
19661598|NCT00113269|42110311|FG002|Overall Study|Received pancreas transplant|0|||
19661599|NCT00113269|42110312|FG003|Overall Study|Received pancreas transplant|2|||
19661600|NCT00113269|42110309|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
19661601|NCT00113269|42110310|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
19661602|NCT00113269|42110311|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
19661603|NCT00113269|42110312|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
19661604|NCT00113269|42110309|FG000|Overall Study|Did not meet eligibility criteria|1|||
19661605|NCT00113269|42110310|FG001|Overall Study|Did not meet eligibility criteria|0|||
19661606|NCT00113269|42110311|FG002|Overall Study|Did not meet eligibility criteria|0|||
19661607|NCT00113269|42110312|FG003|Overall Study|Did not meet eligibility criteria|1|||
19661608|NCT00113269|42110309|FG000|Overall Study|Unable to return for follow up|2|||
19661609|NCT00113269|42110310|FG001|Overall Study|Unable to return for follow up|1|||
19661610|NCT00113269|42110311|FG002|Overall Study|Unable to return for follow up|0|||
19661611|NCT00113269|42110312|FG003|Overall Study|Unable to return for follow up|0|||
19661612|NCT00515619|42110322|FG000|Overall Study|Adverse Event|34|||
19661613|NCT00515619|42110322|FG000|Overall Study|Lack of Efficacy|92|||
19661614|NCT00515619|42110322|FG000|Overall Study|Withdrawal by Subject|66|||
19661615|NCT00515619|42110322|FG000|Overall Study|Protocol Violation|3|||
19661616|NCT00515619|42110322|FG000|Overall Study|Lost to Follow-up|4|||
19661617|NCT00515619|42110322|FG000|Overall Study|Unsatisfactory compliance|6|||
19661618|NCT00515619|42110322|FG000|Overall Study|Other: Site discontinuing trials|2|||
19661619|NCT00515619|42110322|FG000|Overall Study|Other: Subject cannot attend visits|2|||
19661620|NCT00515619|42110322|FG000|Overall Study|Other: Subject required surgery|1|||
19661621|NCT00515619|42110322|FG000|Overall Study|Other: Subject moved to another country|1|||
19661622|NCT00515619|42110322|FG000|Overall Study|Other: Investigator decision|1|||
19661623|NCT00515619|42110322|FG000|Overall Study|Other: Subject became pregnant|1|||
19661624|NCT00515619|42110322|FG000|Overall Study|Other: Request from sponsor|1|||
19661625|NCT00515619|42110322|FG000|Overall Study|Other: Drug available on license|1|||
19661626|NCT00515619|42110322|FG000|Overall Study|Other: Subject interested in other AED|1|||
19661627|NCT00449644|42110330|FG000|Overall Study|Adverse Event|0|||
19661628|NCT00449644|42110331|FG001|Overall Study|Adverse Event|0|||
19661629|NCT00449644|42110332|FG002|Overall Study|Adverse Event|3|||
19661630|NCT00449644|42110333|FG003|Overall Study|Adverse Event|5|||
19661631|NCT00449644|42110330|FG000|Overall Study|Death|1|||
19661632|NCT00449644|42110331|FG001|Overall Study|Death|0|||
19661633|NCT00449644|42110332|FG002|Overall Study|Death|6|||
19661634|NCT00449644|42110333|FG003|Overall Study|Death|1|||
19661635|NCT00449644|42110330|FG000|Overall Study|Lost to Follow-up|1|||
19661636|NCT00449644|42110331|FG001|Overall Study|Lost to Follow-up|1|||
19661637|NCT00449644|42110332|FG002|Overall Study|Lost to Follow-up|5|||
19661638|NCT00449644|42110333|FG003|Overall Study|Lost to Follow-up|3|||
19661639|NCT00449644|42110330|FG000|Overall Study|Pregnancy|0|||
19661640|NCT00449644|42110331|FG001|Overall Study|Pregnancy|0|||
19661641|NCT00449644|42110332|FG002|Overall Study|Pregnancy|3|||
19661642|NCT00449644|42110333|FG003|Overall Study|Pregnancy|2|||
19661643|NCT00449644|42110330|FG000|Overall Study|Protocol Violation|4|||
19661644|NCT00449644|42110331|FG001|Overall Study|Protocol Violation|4|||
19661645|NCT00449644|42110332|FG002|Overall Study|Protocol Violation|3|||
19661646|NCT00449644|42110333|FG003|Overall Study|Protocol Violation|7|||
19661647|NCT00449644|42110330|FG000|Overall Study|Withdrawal by Subject|3|||
19661648|NCT00449644|42110331|FG001|Overall Study|Withdrawal by Subject|4|||
19661649|NCT00449644|42110332|FG002|Overall Study|Withdrawal by Subject|6|||
19661650|NCT00449644|42110333|FG003|Overall Study|Withdrawal by Subject|7|||
19661651|NCT00449644|42110330|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
19661652|NCT00449644|42110331|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
19661653|NCT00449644|42110332|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
19661654|NCT00449644|42110333|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
19661655|NCT00449644|42110330|FG000|Overall Study|Other|1|||
19661656|NCT00449644|42110331|FG001|Overall Study|Other|4|||
19661657|NCT00449644|42110332|FG002|Overall Study|Other|1|||
19661658|NCT00449644|42110333|FG003|Overall Study|Other|0|||
19388746|NCT02679287|41632269|FG001|Period 2|Disliked Mobile System|0|||
19388747|NCT02679287|41632268|FG000|Period 3|Work/Scheduling Conflict|0|||
19388748|NCT02679287|41632269|FG001|Period 3|Work/Scheduling Conflict|1|||
19602299|NCT01027871|42050899|FG000|Overall Study|Discontinued Prior to Treatment|0|||
19602300|NCT01027871|42050900|FG001|Overall Study|Discontinued Prior to Treatment|0|||
19602301|NCT01027871|42050901|FG002|Overall Study|Discontinued Prior to Treatment|1|||
19602302|NCT01021553|42050917|FG000|Overall Study|Adverse Event|1|||
19602303|NCT01021553|42050918|FG001|Overall Study|Adverse Event|0|||
19602304|NCT01021553|42050919|FG002|Overall Study|Adverse Event|0|||
19602305|NCT01021553|42050917|FG000|Overall Study|Lack of Efficacy|2|||
19602306|NCT01021553|42050918|FG001|Overall Study|Lack of Efficacy|2|||
19602307|NCT01021553|42050919|FG002|Overall Study|Lack of Efficacy|0|||
19602308|NCT01021553|42050917|FG000|Overall Study|Protocol Violation|0|||
19602309|NCT01021553|42050918|FG001|Overall Study|Protocol Violation|2|||
19602310|NCT01021553|42050919|FG002|Overall Study|Protocol Violation|2|||
19602311|NCT01021553|42050917|FG000|Overall Study|Lost to Follow-up|0|||
19602312|NCT01021553|42050918|FG001|Overall Study|Lost to Follow-up|0|||
19602313|NCT01021553|42050919|FG002|Overall Study|Lost to Follow-up|1|||
19602314|NCT01021553|42050917|FG000|Overall Study|Withdrawal by Subject|1|||
19602315|NCT01021553|42050918|FG001|Overall Study|Withdrawal by Subject|1|||
19602316|NCT01021553|42050919|FG002|Overall Study|Withdrawal by Subject|0|||
19602317|NCT01026389|42050934|FG000|Overall Study|Withdrawal by Subject|1|||
19602318|NCT01026389|42050935|FG001|Overall Study|Withdrawal by Subject|3|||
19602319|NCT01026389|42050934|FG000|Overall Study|change of treatment, patient moved|4|||
19602320|NCT01026389|42050935|FG001|Overall Study|change of treatment, patient moved|2|||
19602321|NCT01006616|42050945|FG000|Period 1 (6 Months)|Adverse Event|10|||
19602322|NCT01006616|42050946|FG001|Period 1 (6 Months)|Adverse Event|31|||
19602323|NCT01006616|42050947|FG002|Period 1 (6 Months)|Adverse Event|37|||
19602324|NCT01006616|42050948|FG003|Period 1 (6 Months)|Adverse Event|9|||
19602325|NCT01006616|42050945|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
19602326|NCT01006616|42050946|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
19602327|NCT01006616|42050947|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
19602328|NCT01006616|42050948|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
19602329|NCT01006616|42050945|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
19661659|NCT00449644|42110330|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
19661660|NCT00449644|42110331|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
19661661|NCT00449644|42110332|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
19661662|NCT00449644|42110333|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
19661663|NCT00515541|42110350|FG000|Overall Study|Physician Decision|0|||
19661664|NCT00515541|42110351|FG001|Overall Study|Physician Decision|2|||
19661665|NCT00515541|42110352|FG002|Overall Study|Physician Decision|0|||
19661666|NCT00515541|42110353|FG003|Overall Study|Physician Decision|1|||
19661667|NCT00515541|42110350|FG000|Overall Study|No show for appointments|0|||
19661668|NCT00515541|42110351|FG001|Overall Study|No show for appointments|1|||
19661669|NCT00515541|42110352|FG002|Overall Study|No show for appointments|0|||
19661670|NCT00515541|42110353|FG003|Overall Study|No show for appointments|2|||
19661671|NCT00515541|42110350|FG000|Overall Study|Withdrawal by Subject|0|||
19661672|NCT00515541|42110351|FG001|Overall Study|Withdrawal by Subject|2|||
19661673|NCT00515541|42110352|FG002|Overall Study|Withdrawal by Subject|0|||
19661674|NCT00515541|42110353|FG003|Overall Study|Withdrawal by Subject|2|||
19661675|NCT00112489|42110363|FG000|Overall Study|Refused further treatment|8|||
19661676|NCT00112489|42110363|FG000|Overall Study|Adverse Event|12|||
19661677|NCT00112489|42110363|FG000|Overall Study|Death|2|||
19661678|NCT00112489|42110363|FG000|Overall Study|Other, Not Specified|9|||
19661679|NCT00112489|42110363|FG000|Overall Study|Patient never treated|2|||
19661680|NCT00112489|42110363|FG000|Overall Study|Ineligible|7|||
19661681|NCT00711971|42110376|FG000|Overall Study|Lost to Follow-up|3|||
19661682|NCT00711971|42110377|FG001|Overall Study|Lost to Follow-up|4|||
19755244|NCT03526861|42205613|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
19755245|NCT03526861|42205614|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
19388749|NCT02544633|41632285|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
19661683|NCT00711971|42110378|FG002|Overall Study|Lost to Follow-up|1|||
19661684|NCT00515463|42110392|FG000|Overall Study|Physician Decision|4|||
19661685|NCT00515463|42110393|FG001|Overall Study|Physician Decision|2|||
19661686|NCT00515463|42110392|FG000|Overall Study|Adverse Event|1|||
19661687|NCT00515463|42110393|FG001|Overall Study|Adverse Event|2|||
19661688|NCT00515463|42110392|FG000|Overall Study|Withdrawal by Subject|3|||
19661689|NCT00515463|42110393|FG001|Overall Study|Withdrawal by Subject|4|||
19661690|NCT00515463|42110392|FG000|Overall Study|Lost to Follow-up|6|||
19661691|NCT00515463|42110393|FG001|Overall Study|Lost to Follow-up|5|||
19661692|NCT00515463|42110392|FG000|Overall Study|Other|0|||
19661693|NCT00515463|42110393|FG001|Overall Study|Other|1|||
19661694|NCT00507507|42110402|FG000|Treatment Period|Lost to Follow-up|0|||
19661695|NCT00507507|42110403|FG001|Treatment Period|Lost to Follow-up|2|||
19661696|NCT00507507|42110402|FG000|Treatment Period|Physician Decision|4|||
19661697|NCT00507507|42110403|FG001|Treatment Period|Physician Decision|1|||
19661698|NCT00507507|42110402|FG000|Treatment Period|Protocol Violation|1|||
19661699|NCT00507507|42110403|FG001|Treatment Period|Protocol Violation|2|||
19661700|NCT00507507|42110402|FG000|Treatment Period|Adverse Event|1|||
19661701|NCT00507507|42110403|FG001|Treatment Period|Adverse Event|1|||
19661702|NCT00507507|42110402|FG000|Treatment Period|Withdrawal by Subject|46|||
19661703|NCT00507507|42110403|FG001|Treatment Period|Withdrawal by Subject|47|||
19661704|NCT00507507|42110402|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
19661705|NCT00507507|42110403|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
19661706|NCT00507507|42110402|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
19661707|NCT00507507|42110403|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
19661708|NCT00507507|42110402|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
19661709|NCT00507507|42110403|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
19661710|NCT00459706|42110413|FG000|Overall Study|Adverse Event|19|||
19661711|NCT00459706|42110414|FG001|Overall Study|Adverse Event|13|||
19661712|NCT00459706|42110413|FG000|Overall Study|Withdrawal by Subject|1|||
19661713|NCT00459706|42110414|FG001|Overall Study|Withdrawal by Subject|6|||
19661714|NCT00459706|42110413|FG000|Overall Study|Physician Decision|2|||
19661715|NCT00459706|42110414|FG001|Overall Study|Physician Decision|0|||
19661716|NCT00459706|42110413|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
19661717|NCT00459706|42110414|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19661718|NCT00459706|42110413|FG000|Overall Study|Protocol Violation|2|||
19661719|NCT00459706|42110414|FG001|Overall Study|Protocol Violation|1|||
19661720|NCT00459706|42110413|FG000|Overall Study|Failed to Return|1|||
19661721|NCT00459706|42110414|FG001|Overall Study|Failed to Return|0|||
19661722|NCT00459706|42110413|FG000|Overall Study|Other|0|||
19661723|NCT00459706|42110414|FG001|Overall Study|Other|1|||
19661724|NCT00507429|42110422|FG000|Treatment Phase|Disease Progression|12|||
19661725|NCT00507429|42110423|FG001|Treatment Phase|Disease Progression|5|||
19661726|NCT00507429|42110422|FG000|Treatment Phase|Adverse Event|12|||
19661727|NCT00507429|42110423|FG001|Treatment Phase|Adverse Event|5|||
19661728|NCT00507429|42110422|FG000|Treatment Phase|Withdrawal by Subject|3|||
19661729|NCT00507429|42110423|FG001|Treatment Phase|Withdrawal by Subject|3|||
19477101|NCT01487525|41756007|FG001|Overall Study|Withdrawal by Subject|1|||
19661730|NCT00507429|42110422|FG000|Treatment Phase|Physician Decision|4|||
19661731|NCT00507429|42110423|FG001|Treatment Phase|Physician Decision|2|||
19661732|NCT00507429|42110422|FG000|Treatment Phase|Other|6|||
19661733|NCT00507429|42110423|FG001|Treatment Phase|Other|3|||
19661734|NCT00507429|42110422|FG000|Maintenance Phase|Progressive Disease|14|||
19661735|NCT00507429|42110423|FG001|Maintenance Phase|Progressive Disease|0|||
19661736|NCT00449176|42110434|FG000|Overall Study|Withdrawal by Subject|39|||
19661737|NCT00449176|42110435|FG001|Overall Study|Withdrawal by Subject|43|||
19661738|NCT00449176|42110436|FG002|Overall Study|Withdrawal by Subject|59|||
19661739|NCT00449176|42110434|FG000|Overall Study|Lost to Follow-up|13|||
19661740|NCT00449176|42110435|FG001|Overall Study|Lost to Follow-up|8|||
19661741|NCT00449176|42110436|FG002|Overall Study|Lost to Follow-up|12|||
19661742|NCT00449176|42110434|FG000|Overall Study|Adverse Event|51|||
19661743|NCT00449176|42110435|FG001|Overall Study|Adverse Event|107|||
19661744|NCT00449176|42110436|FG002|Overall Study|Adverse Event|15|||
19661745|NCT00449176|42110434|FG000|Overall Study|Lack of Efficacy|13|||
19661746|NCT00449176|42110435|FG001|Overall Study|Lack of Efficacy|7|||
19661747|NCT00449176|42110436|FG002|Overall Study|Lack of Efficacy|50|||
19661748|NCT00449176|42110434|FG000|Overall Study|Study drug non-compliant|14|||
19755246|NCT03526861|42205615|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
19755247|NCT03526861|42205616|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
19755248|NCT03526861|42205617|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
19602330|NCT01006616|42050946|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
19602331|NCT01006616|42050947|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
19602332|NCT01006616|42050948|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
19602333|NCT01006616|42050945|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
19602334|NCT01006616|42050946|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
19602335|NCT01006616|42050947|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
19602336|NCT01006616|42050948|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
19602337|NCT01006616|42050945|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
19602338|NCT01006616|42050946|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
19602339|NCT01006616|42050947|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
19602340|NCT01006616|42050948|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
19602341|NCT01006616|42050945|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
19602342|NCT01006616|42050946|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
19602343|NCT01006616|42050947|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
19602344|NCT01006616|42050948|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
19602345|NCT01006616|42050945|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
19602346|NCT01006616|42050946|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
19602347|NCT01006616|42050947|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
19602348|NCT01006616|42050948|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
19602349|NCT01006616|42050945|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
19602350|NCT01006616|42050946|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
19602351|NCT01006616|42050947|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
19602352|NCT01006616|42050948|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
19602353|NCT01006616|42050945|FG000|Period 1 (6 Months)|Not Treated|0|||
19602354|NCT01006616|42050946|FG001|Period 1 (6 Months)|Not Treated|0|||
19602355|NCT01006616|42050947|FG002|Period 1 (6 Months)|Not Treated|1|||
19602356|NCT01006616|42050948|FG003|Period 1 (6 Months)|Not Treated|1|||
19602357|NCT01006616|42050945|FG000|Period 2 (18 Months)|Adverse Event|6|||
19602358|NCT01006616|42050946|FG001|Period 2 (18 Months)|Adverse Event|6|||
19602359|NCT01006616|42050947|FG002|Period 2 (18 Months)|Adverse Event|6|||
19602360|NCT01006616|42050948|FG003|Period 2 (18 Months)|Adverse Event|4|||
19602361|NCT01006616|42050945|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
19602362|NCT01006616|42050946|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
19602363|NCT01006616|42050947|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
19602364|NCT01006616|42050948|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
19602365|NCT01006616|42050945|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
19602366|NCT01006616|42050946|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
19602367|NCT01006616|42050947|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
19602368|NCT01006616|42050948|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
19602369|NCT01006616|42050945|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
19602370|NCT01006616|42050946|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
19602371|NCT01006616|42050947|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
19602372|NCT01006616|42050948|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
19602373|NCT01006616|42050945|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
19602374|NCT01006616|42050946|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
19661749|NCT00449176|42110435|FG001|Overall Study|Study drug non-compliant|11|||
19602375|NCT01006616|42050947|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
19661750|NCT00449176|42110436|FG002|Overall Study|Study drug non-compliant|11|||
19661751|NCT00449176|42110434|FG000|Overall Study|all other|22|||
19661752|NCT00449176|42110435|FG001|Overall Study|all other|19|||
19661753|NCT00449176|42110436|FG002|Overall Study|all other|20|||
19661754|NCT00515073|42110444|FG000|Overall Study|Withdrawal by Subject|1|||
19661755|NCT00515073|42110444|FG000|Overall Study|Physician Decision|1|||
19661756|NCT00710021|42110451|FG000|Overall Study|Lost to Follow-up|1|||
19661757|NCT00710021|42110452|FG001|Overall Study|Lost to Follow-up|0|||
19661758|NCT00710021|42110453|FG002|Overall Study|Lost to Follow-up|0|||
19661759|NCT00710021|42110451|FG000|Overall Study|Subject's Decision|0|||
19661760|NCT00710021|42110452|FG001|Overall Study|Subject's Decision|1|||
19661761|NCT00710021|42110453|FG002|Overall Study|Subject's Decision|0|||
19661762|NCT00710021|42110451|FG000|Overall Study|Subject misrandomized|0|||
19661763|NCT00710021|42110452|FG001|Overall Study|Subject misrandomized|1|||
19661764|NCT00710021|42110453|FG002|Overall Study|Subject misrandomized|1|||
19661765|NCT00710021|42110451|FG000|Overall Study|Physician Decision|0|||
19661766|NCT00710021|42110452|FG001|Overall Study|Physician Decision|1|||
19661767|NCT00710021|42110453|FG002|Overall Study|Physician Decision|0|||
19661768|NCT00504153|42110462|FG000|Overall Study|Withdrawal by Subject|1|||
19661769|NCT00504153|42110462|FG000|Overall Study|Adverse Event|4|||
19661770|NCT00504153|42110462|FG000|Overall Study|Death|1|||
19661771|NCT00442702|42110468|FG000|Titration Period|Adverse Event|2|||
19661772|NCT00442702|42110469|FG001|Titration Period|Adverse Event|0|||
19661773|NCT00442702|42110468|FG000|Titration Period|Death|3|||
19755249|NCT03526861|42205618|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
19661774|NCT00442702|42110469|FG001|Titration Period|Death|2|||
19661775|NCT00442702|42110468|FG000|Titration Period|Insufficient Therapeutic Response|1|||
19661776|NCT00442702|42110469|FG001|Titration Period|Insufficient Therapeutic Response|0|||
19661777|NCT00442702|42110468|FG000|Titration Period|Refused Treatment|4|||
19661778|NCT00442702|42110469|FG001|Titration Period|Refused Treatment|1|||
19661779|NCT00442702|42110468|FG000|Titration Period|Failure to return|1|||
19661780|NCT00442702|42110469|FG001|Titration Period|Failure to return|0|||
19661781|NCT00442702|42110468|FG000|Titration Period|Hospitalized in another hospital|1|||
19661782|NCT00442702|42110469|FG001|Titration Period|Hospitalized in another hospital|0|||
19661783|NCT00442702|42110468|FG000|Evaluation Period|Adverse Event|1|||
19661784|NCT00442702|42110469|FG001|Evaluation Period|Adverse Event|0|||
19661785|NCT00442702|42110468|FG000|Evaluation Period|Death|1|||
19661786|NCT00442702|42110469|FG001|Evaluation Period|Death|1|||
19661787|NCT00442702|42110468|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
19661788|NCT00442702|42110469|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
19661789|NCT00442702|42110468|FG000|Evaluation Period|Refused treatment|1|||
19661790|NCT00442702|42110469|FG001|Evaluation Period|Refused treatment|1|||
19661791|NCT00442702|42110468|FG000|Evaluation Period|Renal transplant|0|||
19661792|NCT00442702|42110469|FG001|Evaluation Period|Renal transplant|1|||
19661793|NCT00442702|42110468|FG000|Evaluation Period|Failure to return|1|||
19661794|NCT00442702|42110469|FG001|Evaluation Period|Failure to return|0|||
19661795|NCT00442702|42110468|FG000|Evaluation Period|Site closure|0|||
19661796|NCT00442702|42110469|FG001|Evaluation Period|Site closure|1|||
19661797|NCT00514917|42110477|FG000|Overall Study|Death|4|||
19661798|NCT00514917|42110478|FG001|Overall Study|Death|10|||
19661799|NCT00514917|42110477|FG000|Overall Study|Protocol Violation|1|||
19661800|NCT00514917|42110478|FG001|Overall Study|Protocol Violation|0|||
19661801|NCT00514917|42110477|FG000|Overall Study|Lost to Follow-up|4|||
19661802|NCT00514917|42110478|FG001|Overall Study|Lost to Follow-up|3|||
19661803|NCT00514917|42110477|FG000|Overall Study|Withdrawal by Subject|18|||
19661804|NCT00514917|42110478|FG001|Overall Study|Withdrawal by Subject|16|||
19661805|NCT00514917|42110477|FG000|Overall Study|Discontinued due to study closure|88|||
19661806|NCT00514917|42110478|FG001|Overall Study|Discontinued due to study closure|81|||
19661807|NCT00514917|42110477|FG000|Overall Study|Undefined|11|||
19661808|NCT00514917|42110478|FG001|Overall Study|Undefined|5|||
19661809|NCT00711425|42110486|FG000|Overall Study|Protocol Violation|1|||
19661810|NCT00711425|42110486|FG000|Overall Study|Death|2|||
19661811|NCT00711425|42110486|FG000|Overall Study|Lost to Follow-up|1|||
19661812|NCT00504075|42110490|FG000|Overall Study|Adverse Event|1|||
19661813|NCT00504075|42110490|FG000|Overall Study|Lost to Follow-up|5|||
19661814|NCT00504075|42110490|FG000|Overall Study|Withdrawal by Subject|1|||
19661815|NCT00504075|42110490|FG000|Overall Study|Required other therapeutic intervention|1|||
19661816|NCT00503997|42110495|FG000|Overall Study|disease progression|1|||
19661817|NCT00503997|42110495|FG000|Overall Study|Adverse Event|5|||
19661818|NCT00503997|42110495|FG000|Overall Study|Death|1|||
19661819|NCT00503997|42110495|FG000|Overall Study|Withdrawal by Subject|1|||
19661820|NCT00096265|42110502|FG000|Overall Study|Ineligible|1|||
19661821|NCT00096265|42110503|FG001|Overall Study|Ineligible|0|||
19661822|NCT00096265|42110504|FG002|Overall Study|Ineligible|0|||
19661823|NCT00711191|42110516|FG000|Overall Study|Adverse Event|1|||
19661824|NCT00711191|42110517|FG001|Overall Study|Adverse Event|1|||
19661825|NCT00711191|42110518|FG002|Overall Study|Adverse Event|2|||
19661826|NCT00711191|42110516|FG000|Overall Study|Objective progression or relapse|2|||
19661827|NCT00711191|42110517|FG001|Overall Study|Objective progression or relapse|3|||
19661828|NCT00711191|42110518|FG002|Overall Study|Objective progression or relapse|7|||
19661829|NCT00711191|42110516|FG000|Overall Study|Withdrawal by Subject|0|||
19661830|NCT00711191|42110517|FG001|Overall Study|Withdrawal by Subject|1|||
19661831|NCT00711191|42110518|FG002|Overall Study|Withdrawal by Subject|3|||
19661832|NCT00706511|42110533|FG000|Overall Study|Withdrawal by Subject|1|||
19661833|NCT00706511|42110534|FG001|Overall Study|Withdrawal by Subject|0|||
19661834|NCT00706511|42110535|FG002|Overall Study|Withdrawal by Subject|0|||
19661835|NCT00706511|42110536|FG003|Overall Study|Withdrawal by Subject|0|||
19661836|NCT00448864|42110547|FG000|Overall Study|Death|1|||
19661837|NCT00448864|42110548|FG001|Overall Study|Death|0|||
19661838|NCT00448864|42110549|FG002|Overall Study|Death|0|||
19661839|NCT00448864|42110547|FG000|Overall Study|Lost to Follow-up|3|||
19661840|NCT00448864|42110548|FG001|Overall Study|Lost to Follow-up|1|||
19661841|NCT00448864|42110549|FG002|Overall Study|Lost to Follow-up|0|||
19661842|NCT00448864|42110547|FG000|Overall Study|Physician Decision|1|||
19661843|NCT00448864|42110548|FG001|Overall Study|Physician Decision|0|||
19661844|NCT00448864|42110549|FG002|Overall Study|Physician Decision|1|||
19661845|NCT00448864|42110547|FG000|Overall Study|Withdrawal by Subject|0|||
19661846|NCT00448864|42110548|FG001|Overall Study|Withdrawal by Subject|2|||
19661847|NCT00448864|42110549|FG002|Overall Study|Withdrawal by Subject|0|||
19661848|NCT00448864|42110547|FG000|Overall Study|Protocol Violation|0|||
19661849|NCT00448864|42110548|FG001|Overall Study|Protocol Violation|2|||
19661850|NCT00448864|42110549|FG002|Overall Study|Protocol Violation|0|||
19661851|NCT00567398|42110561|FG000|Overall Study|Adverse Event|6|||
19661852|NCT00567398|42110562|FG001|Overall Study|Adverse Event|14|||
19661853|NCT00567398|42110561|FG000|Overall Study|Physician Decision|0|||
19661854|NCT00567398|42110562|FG001|Overall Study|Physician Decision|4|||
19661855|NCT00567398|42110561|FG000|Overall Study|Withdrawal by Subject|0|||
19661856|NCT00567398|42110562|FG001|Overall Study|Withdrawal by Subject|2|||
19661857|NCT00567398|42110561|FG000|Overall Study|Renal Transplantation|0|||
19661858|NCT00567398|42110562|FG001|Overall Study|Renal Transplantation|3|||
19661859|NCT00567398|42110561|FG000|Overall Study|Other|1|||
19661860|NCT00567398|42110562|FG001|Overall Study|Other|0|||
19661861|NCT00448708|42110570|FG000|Overall Study|Death|21|||
19661862|NCT00448708|42110571|FG001|Overall Study|Death|17|||
19661863|NCT00448708|42110570|FG000|Overall Study|Withdrawal by Subject|8|||
19661864|NCT00448708|42110571|FG001|Overall Study|Withdrawal by Subject|4|||
19661865|NCT00448708|42110570|FG000|Overall Study|Lost to Follow-up|6|||
19661866|NCT00448708|42110571|FG001|Overall Study|Lost to Follow-up|8|||
19661867|NCT00448708|42110570|FG000|Overall Study|not listed|0|||
19661868|NCT00448708|42110571|FG001|Overall Study|not listed|2|||
19661869|NCT00706355|42110581|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
19661870|NCT00706355|42110582|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
19661871|NCT00706355|42110583|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
19661872|NCT00706355|42110584|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
19661873|NCT00706355|42110581|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
19661874|NCT00706355|42110582|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
19755250|NCT03526861|42205619|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
19661875|NCT00706355|42110583|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
19661876|NCT00706355|42110584|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
19661877|NCT00706355|42110581|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
19661878|NCT00706355|42110582|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
19661879|NCT00706355|42110583|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
19661880|NCT00706355|42110584|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
19661881|NCT00706355|42110581|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
19661882|NCT00706355|42110582|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
19661883|NCT00706355|42110583|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
19661884|NCT00706355|42110584|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
19661885|NCT00706355|42110581|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
19661886|NCT00706355|42110582|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
19661887|NCT00706355|42110583|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
19661888|NCT00706355|42110584|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
19661889|NCT00706355|42110581|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
19661890|NCT00706355|42110582|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
19661891|NCT00706355|42110583|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
19661892|NCT00706355|42110584|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
19661893|NCT00706355|42110581|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
19661894|NCT00706355|42110582|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
19661895|NCT00706355|42110583|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
19661896|NCT00706355|42110584|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
19661897|NCT00706355|42110581|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
19661898|NCT00706355|42110582|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
19661899|NCT00706355|42110583|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
19661900|NCT00706355|42110584|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
19661901|NCT00706355|42110581|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
19661902|NCT00706355|42110582|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
19661903|NCT00706355|42110583|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
19661904|NCT00706355|42110584|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
19661905|NCT00711113|42110596|FG000|Overall Study|Lost to Follow-up|9|||
19661906|NCT00711113|42110596|FG000|Overall Study|Implant lost|2|||
19661907|NCT00710879|42110606|FG000|Overall Study|Lost to Follow-up|2|||
19661908|NCT00710879|42110607|FG001|Overall Study|Lost to Follow-up|1|||
19661909|NCT00710879|42110606|FG000|Overall Study|Protocol Violation|0|||
19661910|NCT00710879|42110607|FG001|Overall Study|Protocol Violation|3|||
19661911|NCT03979274|42110613|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19661912|NCT03979274|42110614|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19661913|NCT00459316|42110624|FG000|Steps 1 & 2|Other eligibility failure|1|||
19661914|NCT00459316|42110625|FG001|Steps 1 & 2|Other eligibility failure|1|||
19661915|NCT00459316|42110626|FG002|Steps 1 & 2|Other eligibility failure|0|||
19661916|NCT00459316|42110624|FG000|Steps 1 & 2|Death|1|||
19661917|NCT00459316|42110625|FG001|Steps 1 & 2|Death|1|||
19755251|NCT03526861|42205620|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
19755252|NCT03526861|42205621|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
19755253|NCT03526861|42205613|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755254|NCT03526861|42205614|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755255|NCT03526861|42205615|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755256|NCT03526861|42205616|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
19755257|NCT03526861|42205617|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755258|NCT03526861|42205618|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755259|NCT03526861|42205619|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755260|NCT03526861|42205620|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755261|NCT03526861|42205621|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755262|NCT03526861|42205613|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19661918|NCT00459316|42110626|FG002|Steps 1 & 2|Death|0|||
19661919|NCT00459316|42110624|FG000|Steps 1 & 2|Not able to get to clinic|7|||
19661920|NCT00459316|42110625|FG001|Steps 1 & 2|Not able to get to clinic|4|||
19661921|NCT00459316|42110626|FG002|Steps 1 & 2|Not able to get to clinic|0|||
19661922|NCT00459316|42110624|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
19661923|NCT00459316|42110625|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
19755263|NCT03526861|42205614|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755264|NCT03526861|42205615|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755265|NCT03526861|42205616|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755266|NCT03526861|42205617|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755267|NCT03526861|42205618|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755268|NCT03526861|42205619|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755269|NCT03526861|42205620|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
19755270|NCT03526861|42205621|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
19755271|NCT03526861|42205613|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755272|NCT03526861|42205614|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755273|NCT03526861|42205615|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755274|NCT03526861|42205616|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19661924|NCT00459316|42110626|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
19661925|NCT00459316|42110624|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
19661926|NCT00459316|42110625|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
19661927|NCT00459316|42110626|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
19661928|NCT00459316|42110624|FG000|Steps 1 & 2|Lost to Follow-up|5|||
19661929|NCT00459316|42110625|FG001|Steps 1 & 2|Lost to Follow-up|0|||
19661930|NCT00459316|42110626|FG002|Steps 1 & 2|Lost to Follow-up|2|||
19661931|NCT00459316|42110624|FG000|Step 3|Withdrawal by Subject|3|||
19661932|NCT00459316|42110625|FG001|Step 3|Withdrawal by Subject|0|||
19661933|NCT00459316|42110626|FG002|Step 3|Withdrawal by Subject|1|||
19602376|NCT01006616|42050948|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
19602377|NCT01006616|42050945|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
19661934|NCT00567164|42110652|FG000|Overall Study|Withdrawal by Subject|171|||
19661935|NCT00567164|42110653|FG001|Overall Study|Withdrawal by Subject|21|||
19661936|NCT00567164|42110654|FG002|Overall Study|Withdrawal by Subject|17|||
19661937|NCT00567164|42110652|FG000|Overall Study|Protocol Violation|23|||
19661938|NCT00567164|42110653|FG001|Overall Study|Protocol Violation|4|||
19661939|NCT00567164|42110654|FG002|Overall Study|Protocol Violation|2|||
19661940|NCT00567164|42110652|FG000|Overall Study|Adverse Event|92|||
19661941|NCT00567164|42110653|FG001|Overall Study|Adverse Event|13|||
19661942|NCT00567164|42110654|FG002|Overall Study|Adverse Event|9|||
19661943|NCT00567164|42110652|FG000|Overall Study|Death|0|||
19661944|NCT00567164|42110653|FG001|Overall Study|Death|0|||
19661945|NCT00567164|42110654|FG002|Overall Study|Death|1|||
19661946|NCT00567164|42110652|FG000|Overall Study|Lost to Follow-up|202|||
19661947|NCT00567164|42110653|FG001|Overall Study|Lost to Follow-up|23|||
19661948|NCT00567164|42110654|FG002|Overall Study|Lost to Follow-up|21|||
19661949|NCT00567164|42110652|FG000|Overall Study|Pregnancy|20|||
19661950|NCT00567164|42110653|FG001|Overall Study|Pregnancy|4|||
19661951|NCT00567164|42110654|FG002|Overall Study|Pregnancy|6|||
19661952|NCT00567164|42110652|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
19602378|NCT01006616|42050946|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
19602379|NCT01006616|42050947|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
19602380|NCT01006616|42050948|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
19602381|NCT01006616|42050945|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
19602382|NCT01006616|42050946|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
19602383|NCT01006616|42050947|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
19602384|NCT01006616|42050948|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
19602385|NCT01006616|42050945|FG000|Period 2 (18 Months)|Study Terminated|63|||
19602386|NCT01006616|42050946|FG001|Period 2 (18 Months)|Study Terminated|46|||
19602387|NCT01006616|42050947|FG002|Period 2 (18 Months)|Study Terminated|44|||
19602388|NCT01006616|42050948|FG003|Period 2 (18 Months)|Study Terminated|70|||
19602389|NCT00996632|42050960|FG000|Overall Study|Physician Decision|0|||
19602390|NCT00996632|42050961|FG001|Overall Study|Physician Decision|0|||
19602391|NCT01025843|42050977|FG000|Washout 4|Withdrawal by Subject|0|||
19602392|NCT01025843|42050978|FG001|Washout 4|Withdrawal by Subject|0|||
19602393|NCT01025843|42050979|FG002|Washout 4|Withdrawal by Subject|1|||
19602394|NCT01025843|42050980|FG003|Washout 4|Withdrawal by Subject|1|||
19602395|NCT01025843|42050981|FG004|Washout 4|Withdrawal by Subject|0|||
19602396|NCT01025843|42050982|FG005|Washout 4|Withdrawal by Subject|0|||
19602397|NCT01025843|42050983|FG006|Washout 4|Withdrawal by Subject|0|||
19602398|NCT01025843|42050984|FG007|Washout 4|Withdrawal by Subject|0|||
19602399|NCT01025843|42050985|FG008|Washout 4|Withdrawal by Subject|0|||
19602400|NCT01025843|42050986|FG009|Washout 4|Withdrawal by Subject|0|||
19661953|NCT00567164|42110653|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
19661954|NCT00567164|42110654|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
19661955|NCT00567164|42110652|FG000|Overall Study|Missing|1|||
19661956|NCT00567164|42110653|FG001|Overall Study|Missing|0|||
19661957|NCT00567164|42110654|FG002|Overall Study|Missing|0|||
19661958|NCT00713219|42110666|FG000|Overall Study|Death|1|||
19661959|NCT00713219|42110666|FG000|Overall Study|Protocol Violation|1|||
19661960|NCT00712985|42110670|FG000|Overall Study|1 withdrew prior to start of drug|1|||
19661961|NCT00712985|42110670|FG000|Overall Study|1 patient moved out of state|1|||
19661962|NCT00712985|42110670|FG000|Overall Study|Lack of Efficacy|3|||
19661963|NCT00700115|42110676|FG000|Overall Study|Withdrawal by Subject|1|||
19661964|NCT00700115|42110677|FG001|Overall Study|Withdrawal by Subject|0|||
19661965|NCT00700115|42110676|FG000|Overall Study|Lost to Follow-up|0|||
19661966|NCT00700115|42110677|FG001|Overall Study|Lost to Follow-up|1|||
19661967|NCT00566852|42110685|FG000|Overall Study|Protocol Violation|22|||
19661968|NCT00566852|42110686|FG001|Overall Study|Protocol Violation|24|||
19602401|NCT01036763|42051014|FG000|Overall Study|Adverse Event|25|||
19602402|NCT01036763|42051014|FG000|Overall Study|Lost to Follow-up|28|||
19602403|NCT01036763|42051014|FG000|Overall Study|Other reason (not specified)|40|||
19602404|NCT01021007|42051020|FG000|Overall Study|Lost to Follow-up|1|||
19602405|NCT01021007|42051021|FG001|Overall Study|Lost to Follow-up|1|||
19602406|NCT01021007|42051020|FG000|Overall Study|Adverse Event|1|||
19602407|NCT01021007|42051021|FG001|Overall Study|Adverse Event|3|||
19602408|NCT01020773|42051029|FG000|Overall Study|Withdrawal by Subject|4|||
19602409|NCT01020773|42051030|FG001|Overall Study|Withdrawal by Subject|3|||
19602410|NCT01020305|42051036|FG000|Overall Study|Adverse Event|2|||
19602411|NCT01036529|42051042|FG000|Overall Study|Adverse Event|0|||
19602412|NCT01036529|42051043|FG001|Overall Study|Adverse Event|1|||
19602413|NCT01036529|42051042|FG000|Overall Study|Lost to Follow-up|0|||
19602414|NCT01036529|42051043|FG001|Overall Study|Lost to Follow-up|1|||
19602415|NCT01036529|42051042|FG000|Overall Study|Physician Decision|1|||
19602416|NCT01036529|42051043|FG001|Overall Study|Physician Decision|0|||
19602417|NCT01036529|42051042|FG000|Overall Study|Withdrawal by Subject|1|||
19602418|NCT01036529|42051043|FG001|Overall Study|Withdrawal by Subject|1|||
19602419|NCT01036529|42051042|FG000|Overall Study|Sponsor study termination|11|||
19602420|NCT01036529|42051043|FG001|Overall Study|Sponsor study termination|12|||
19602421|NCT01024751|42051051|FG000|Enrolled Participants|Ineligible at baseline|3|||
19602422|NCT01024751|42051052|FG001|Enrolled Participants|Ineligible at baseline|4|||
19602423|NCT01024751|42051051|FG000|Eligible Participants|Withdrawal by Subject|0|||
19602424|NCT01024751|42051052|FG001|Eligible Participants|Withdrawal by Subject|1|||
19602425|NCT01024751|42051051|FG000|Eligible Participants|Lost to Follow-up|0|||
19602426|NCT01024751|42051052|FG001|Eligible Participants|Lost to Follow-up|1|||
19602427|NCT01024751|42051051|FG000|Eligible Participants|Ineligible|0|||
19602428|NCT01024751|42051052|FG001|Eligible Participants|Ineligible|1|||
19602429|NCT01019369|42051060|FG000|Overall Study|Lost to Follow-up|10|||
19661969|NCT00566852|42110685|FG000|Overall Study|Death|95|||
19661970|NCT00566852|42110686|FG001|Overall Study|Death|78|||
19661971|NCT00566852|42110685|FG000|Overall Study|Withdrawal by Subject|30|||
19661972|NCT00566852|42110686|FG001|Overall Study|Withdrawal by Subject|25|||
19602430|NCT01019369|42051061|FG001|Overall Study|Lost to Follow-up|6|||
19602431|NCT01019369|42051060|FG000|Overall Study|Withdrawal by Subject|0|||
19602432|NCT01019369|42051061|FG001|Overall Study|Withdrawal by Subject|1|||
19602433|NCT01019135|42051071|FG000|Overall Study|Did not receive allocated intervention|12|||
19602434|NCT01019135|42051072|FG001|Overall Study|Did not receive allocated intervention|6|||
19602435|NCT01019135|42051073|FG002|Overall Study|Did not receive allocated intervention|25|||
19602436|NCT01019135|42051071|FG000|Overall Study|Did not attend CR|8|||
19602437|NCT01019135|42051072|FG001|Overall Study|Did not attend CR|13|||
19602438|NCT01019135|42051073|FG002|Overall Study|Did not attend CR|6|||
19602439|NCT01018979|42051083|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
19602440|NCT01018979|42051084|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
19602441|NCT01018979|42051083|FG000|Overall Study|Not received at least one dose|0|||
19602442|NCT01018979|42051084|FG001|Overall Study|Not received at least one dose|1|||
19602443|NCT01572493|42051102|FG000|Overall Study|Physician Decision|1|||
19602444|NCT01572493|42051103|FG001|Overall Study|Physician Decision|0|||
19602445|NCT01572493|42051104|FG002|Overall Study|Physician Decision|0|||
19602446|NCT01572493|42051105|FG003|Overall Study|Physician Decision|0|||
19661973|NCT00566852|42110685|FG000|Overall Study|Patient refusal|37|||
19661974|NCT00566852|42110686|FG001|Overall Study|Patient refusal|37|||
19661975|NCT00566852|42110685|FG000|Overall Study|Not tested due to disability|6|||
19661976|NCT00566852|42110686|FG001|Overall Study|Not tested due to disability|12|||
19661977|NCT00566852|42110685|FG000|Overall Study|Missing reason not specified|1|||
19661978|NCT00566852|42110686|FG001|Overall Study|Missing reason not specified|2|||
19661979|NCT00566852|42110685|FG000|Overall Study|Missing reason not reported|16|||
19661980|NCT00566852|42110686|FG001|Overall Study|Missing reason not reported|20|||
19661981|NCT00442546|42110695|FG000|Overall Study|Adverse Event|11|||
19661982|NCT00442546|42110696|FG001|Overall Study|Adverse Event|17|||
19661983|NCT00442546|42110697|FG002|Overall Study|Adverse Event|13|||
19661984|NCT00442546|42110695|FG000|Overall Study|Lost to Follow-up|1|||
19661985|NCT00442546|42110696|FG001|Overall Study|Lost to Follow-up|2|||
19661986|NCT00442546|42110697|FG002|Overall Study|Lost to Follow-up|1|||
19661987|NCT00442546|42110695|FG000|Overall Study|Other|4|||
19661988|NCT00442546|42110696|FG001|Overall Study|Other|9|||
19661989|NCT00442546|42110697|FG002|Overall Study|Other|6|||
19661990|NCT00442546|42110695|FG000|Overall Study|Withdrawal by Subject|5|||
19661991|NCT00442546|42110696|FG001|Overall Study|Withdrawal by Subject|5|||
19661992|NCT00442546|42110697|FG002|Overall Study|Withdrawal by Subject|7|||
19661993|NCT00442546|42110695|FG000|Overall Study|Randomized But Not Treated|5|||
19661994|NCT00442546|42110696|FG001|Overall Study|Randomized But Not Treated|4|||
19661995|NCT00442546|42110697|FG002|Overall Study|Randomized But Not Treated|6|||
19661996|NCT00514683|42110712|FG000|Overall Study|Not treated|2|||
19661997|NCT00514683|42110713|FG001|Overall Study|Not treated|1|||
19661998|NCT00514683|42110714|FG002|Overall Study|Not treated|0|||
19661999|NCT00514683|42110715|FG003|Overall Study|Not treated|0|||
19662000|NCT00514683|42110716|FG004|Overall Study|Not treated|1|||
19662001|NCT00514683|42110712|FG000|Overall Study|Adverse Event|21|||
19662002|NCT00514683|42110713|FG001|Overall Study|Adverse Event|20|||
19662003|NCT00514683|42110714|FG002|Overall Study|Adverse Event|15|||
19662004|NCT00514683|42110715|FG003|Overall Study|Adverse Event|13|||
19662005|NCT00514683|42110716|FG004|Overall Study|Adverse Event|27|||
19662006|NCT00514683|42110712|FG000|Overall Study|Protocol Violation|1|||
19662007|NCT00514683|42110713|FG001|Overall Study|Protocol Violation|1|||
19662008|NCT00514683|42110714|FG002|Overall Study|Protocol Violation|0|||
19662009|NCT00514683|42110715|FG003|Overall Study|Protocol Violation|1|||
19662010|NCT00514683|42110716|FG004|Overall Study|Protocol Violation|0|||
19662011|NCT00514683|42110712|FG000|Overall Study|Withdrawal by Subject|2|||
19662012|NCT00514683|42110713|FG001|Overall Study|Withdrawal by Subject|2|||
19662013|NCT00514683|42110714|FG002|Overall Study|Withdrawal by Subject|1|||
19662014|NCT00514683|42110715|FG003|Overall Study|Withdrawal by Subject|0|||
19662015|NCT00514683|42110716|FG004|Overall Study|Withdrawal by Subject|4|||
19662016|NCT00514683|42110712|FG000|Overall Study|Reason other than listed above|0|||
19662017|NCT00514683|42110713|FG001|Overall Study|Reason other than listed above|1|||
19662018|NCT00514683|42110714|FG002|Overall Study|Reason other than listed above|2|||
19662019|NCT00514683|42110715|FG003|Overall Study|Reason other than listed above|0|||
19662020|NCT00514683|42110716|FG004|Overall Study|Reason other than listed above|1|||
19662021|NCT00566696|42110732|FG000|Overall Study|Met Exclusion Criteria|2|||
19662022|NCT00566696|42110732|FG000|Overall Study|Muromonab not available|1|||
19755275|NCT03526861|42205617|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755276|NCT03526861|42205618|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755277|NCT03526861|42205619|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755278|NCT03526861|42205620|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
19755279|NCT03526861|42205621|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
19755280|NCT03526861|42205613|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755281|NCT03526861|42205614|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755282|NCT03526861|42205615|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755283|NCT03526861|42205616|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755284|NCT03526861|42205617|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19662023|NCT00566696|42110732|FG000|Overall Study|Health Status Change|1|||
19662024|NCT00566696|42110732|FG000|Overall Study|Physician Decision|1|||
19662025|NCT00566696|42110732|FG000|Overall Study|Non-Patient Donors|37|||
19662026|NCT00503841|42110736|FG000|Overall Study|All screen failures|44|||
19662027|NCT00442468|42110742|FG000|Overall Study|Adverse Event|4|||
19662028|NCT00442468|42110742|FG000|Overall Study|Withdrawal by Subject|91|||
19755285|NCT03526861|42205618|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755286|NCT03526861|42205619|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755287|NCT03526861|42205620|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
19755288|NCT03526861|42205621|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
19755289|NCT03501277|42205645|FG000|Intervention Period 1 (4 Days)|Other|0|||
19755290|NCT03501277|42205646|FG001|Intervention Period 1 (4 Days)|Other|0|||
19755291|NCT03501277|42205647|FG002|Intervention Period 1 (4 Days)|Other|1|||
19755292|NCT03501277|42205648|FG003|Intervention Period 1 (4 Days)|Other|0|||
19755293|NCT03501277|42205645|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
19755294|NCT03501277|42205646|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
19755295|NCT03501277|42205647|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
19755296|NCT03501277|42205648|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
19755297|NCT03501277|42205645|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
19755298|NCT03501277|42205646|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
19755299|NCT03501277|42205647|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
19755300|NCT03501277|42205648|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
19755301|NCT03501277|42205645|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
19755302|NCT03501277|42205646|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
19755303|NCT03501277|42205647|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
19755304|NCT03501277|42205648|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
19755305|NCT03500419|42205660|FG000|Overall Study|Withdrawal by Subject|2|||
19662029|NCT00442468|42110742|FG000|Overall Study|Did not complete all study procedures|88|||
19662030|NCT00506883|42110749|FG000|Overall Study|Lost to Follow-up|1|||
19662031|NCT00506883|42110750|FG001|Overall Study|Lost to Follow-up|1|||
19662032|NCT00506883|42110751|FG002|Overall Study|Lost to Follow-up|1|||
19662033|NCT00506883|42110749|FG000|Overall Study|Withdrawal by Subject|1|||
19662034|NCT00506883|42110750|FG001|Overall Study|Withdrawal by Subject|0|||
19662035|NCT00506883|42110751|FG002|Overall Study|Withdrawal by Subject|1|||
19662036|NCT00506883|42110749|FG000|Overall Study|Lack of Efficacy|0|||
19662037|NCT00506883|42110750|FG001|Overall Study|Lack of Efficacy|1|||
19662038|NCT00506883|42110751|FG002|Overall Study|Lack of Efficacy|1|||
19662039|NCT00506883|42110749|FG000|Overall Study|Other|5|||
19662040|NCT00506883|42110750|FG001|Overall Study|Other|1|||
19662041|NCT00506883|42110751|FG002|Overall Study|Other|1|||
19662042|NCT00503685|42110762|FG000|Overall Study|Adverse Event|0|||
19662043|NCT00503685|42110763|FG001|Overall Study|Adverse Event|0|||
19662044|NCT00503685|42110764|FG002|Overall Study|Adverse Event|2|||
19662045|NCT00503685|42110762|FG000|Overall Study|Withdrawal by Subject|0|||
19662046|NCT00503685|42110763|FG001|Overall Study|Withdrawal by Subject|1|||
19662047|NCT00503685|42110764|FG002|Overall Study|Withdrawal by Subject|0|||
19662048|NCT00503685|42110762|FG000|Overall Study|Protocol Violation|0|||
19662049|NCT00503685|42110763|FG001|Overall Study|Protocol Violation|1|||
19662050|NCT00503685|42110764|FG002|Overall Study|Protocol Violation|0|||
19662051|NCT00503685|42110762|FG000|Overall Study|Eligibility Criteria Not Met|0|||
19662052|NCT00503685|42110763|FG001|Overall Study|Eligibility Criteria Not Met|1|||
19662053|NCT00503685|42110764|FG002|Overall Study|Eligibility Criteria Not Met|0|||
19662054|NCT00712673|42110776|FG000|Overall Study|Adverse Event|3|||
19662055|NCT00712673|42110777|FG001|Overall Study|Adverse Event|3|||
19662056|NCT00712673|42110778|FG002|Overall Study|Adverse Event|21|||
19662057|NCT00712673|42110779|FG003|Overall Study|Adverse Event|26|||
19662058|NCT00712673|42110776|FG000|Overall Study|Lack of Efficacy|2|||
19662059|NCT00712673|42110777|FG001|Overall Study|Lack of Efficacy|8|||
19662060|NCT00712673|42110778|FG002|Overall Study|Lack of Efficacy|8|||
19662061|NCT00712673|42110779|FG003|Overall Study|Lack of Efficacy|6|||
19662062|NCT00712673|42110776|FG000|Overall Study|Poor Compliance to Protocol|3|||
19662063|NCT00712673|42110777|FG001|Overall Study|Poor Compliance to Protocol|3|||
19662064|NCT00712673|42110778|FG002|Overall Study|Poor Compliance to Protocol|4|||
19662065|NCT00712673|42110779|FG003|Overall Study|Poor Compliance to Protocol|16|||
19662066|NCT00712673|42110776|FG000|Overall Study|Lost to Follow-up|1|||
19662067|NCT00712673|42110777|FG001|Overall Study|Lost to Follow-up|0|||
19662068|NCT00712673|42110778|FG002|Overall Study|Lost to Follow-up|2|||
19662069|NCT00712673|42110779|FG003|Overall Study|Lost to Follow-up|0|||
19662070|NCT00712673|42110776|FG000|Overall Study|Withdrawal by Subject|6|||
19662071|NCT00712673|42110777|FG001|Overall Study|Withdrawal by Subject|7|||
19662072|NCT00712673|42110778|FG002|Overall Study|Withdrawal by Subject|15|||
19662073|NCT00712673|42110779|FG003|Overall Study|Withdrawal by Subject|20|||
19662074|NCT00712673|42110776|FG000|Overall Study|Familial and Personal Reasons|5|||
19662075|NCT00712673|42110777|FG001|Overall Study|Familial and Personal Reasons|0|||
19662076|NCT00712673|42110778|FG002|Overall Study|Familial and Personal Reasons|5|||
19662077|NCT00712673|42110779|FG003|Overall Study|Familial and Personal Reasons|2|||
19662078|NCT00712673|42110776|FG000|Overall Study|Investigator's Decision|1|||
19662079|NCT00712673|42110777|FG001|Overall Study|Investigator's Decision|0|||
19755306|NCT03500419|42205661|FG001|Overall Study|Withdrawal by Subject|25|||
19755307|NCT03500341|42205667|FG000|Overall Study|Withdrawn prior to Completion|2|||
19662080|NCT00712673|42110778|FG002|Overall Study|Investigator's Decision|0|||
19662081|NCT00712673|42110779|FG003|Overall Study|Investigator's Decision|0|||
19662082|NCT00712673|42110776|FG000|Overall Study|Protocol Violation|0|||
19662083|NCT00712673|42110777|FG001|Overall Study|Protocol Violation|0|||
19662084|NCT00712673|42110778|FG002|Overall Study|Protocol Violation|2|||
19662085|NCT00712673|42110779|FG003|Overall Study|Protocol Violation|0|||
19662086|NCT03976466|42110800|FG000|Overall Study|Lost to Follow-up|1|||
19662087|NCT03976466|42110801|FG001|Overall Study|Lost to Follow-up|3|||
19662088|NCT02536755|42110809|FG000|Overall Study|Adverse Event|4|||
19662089|NCT03303105|42110818|FG000|Overall Study|Adverse Event|0|||
19662090|NCT03303105|42110819|FG001|Overall Study|Adverse Event|2|||
19662091|NCT03303105|42110818|FG000|Overall Study|Lack of Efficacy|1|||
19662092|NCT03303105|42110819|FG001|Overall Study|Lack of Efficacy|0|||
19662093|NCT03303105|42110818|FG000|Overall Study|Protocol Violation|1|||
19662094|NCT03303105|42110819|FG001|Overall Study|Protocol Violation|0|||
19662095|NCT03303105|42110818|FG000|Overall Study|Withdrawal by Subject|0|||
19662096|NCT03303105|42110819|FG001|Overall Study|Withdrawal by Subject|2|||
19662097|NCT00447694|42110825|FG000|Overall Study|Adverse Event|2|||
19662098|NCT00447694|42110825|FG000|Overall Study|Abnormal laboratory value|1|||
19662099|NCT00447694|42110825|FG000|Overall Study|Abnormal test procedure result|1|||
19662100|NCT00447694|42110825|FG000|Overall Study|Withdrawal by Subject|2|||
19662101|NCT00564278|42110831|FG000|Overall Study|Lost to Follow-up|35|||
19662102|NCT00564278|42110832|FG001|Overall Study|Lost to Follow-up|33|||
19662103|NCT00564278|42110831|FG000|Overall Study|Physician Decision|1|||
19662104|NCT00564278|42110832|FG001|Overall Study|Physician Decision|2|||
19662105|NCT00564278|42110831|FG000|Overall Study|Withdrawal by Subject|11|||
19662106|NCT00564278|42110832|FG001|Overall Study|Withdrawal by Subject|7|||
19662107|NCT00565604|42110838|FG000|Overall Study|Failure to treat|2|||
19662108|NCT00565604|42110838|FG000|Overall Study|Lost to Follow-up|2|||
19662109|NCT00447382|42110844|FG000|Overall Study|Adverse Event|1|||
19662110|NCT00447382|42110845|FG001|Overall Study|Adverse Event|1|||
19662111|NCT00447382|42110844|FG000|Overall Study|Lack of Efficacy|1|||
19662112|NCT00447382|42110845|FG001|Overall Study|Lack of Efficacy|0|||
19662113|NCT00447382|42110844|FG000|Overall Study|Protocol Violation|2|||
19662114|NCT00447382|42110845|FG001|Overall Study|Protocol Violation|0|||
19662115|NCT00447382|42110844|FG000|Overall Study|Unclassified|2|||
19662116|NCT00447382|42110845|FG001|Overall Study|Unclassified|5|||
19662117|NCT00447226|42110851|FG000|12-Week Open-label Phase|Adverse Event|0|||
19662118|NCT00447226|42110852|FG001|12-Week Open-label Phase|Adverse Event|3|||
19662119|NCT00447226|42110851|FG000|12-Week Open-label Phase|Protocol Violation|0|||
19662120|NCT00447226|42110852|FG001|12-Week Open-label Phase|Protocol Violation|1|||
19662121|NCT00447226|42110851|FG000|12-Week Open-label Phase|Disease Progression|0|||
19662122|NCT00447226|42110852|FG001|12-Week Open-label Phase|Disease Progression|20|||
19662123|NCT00447226|42110851|FG000|12-Week Open-label Phase|Physician Decision|0|||
19755308|NCT01316900|42205688|FG000|Overall Study|Adverse Event|10|||
19755309|NCT01316900|42205689|FG001|Overall Study|Adverse Event|10|||
19755310|NCT01316900|42205690|FG002|Overall Study|Adverse Event|15|||
19755311|NCT01316900|42205691|FG003|Overall Study|Adverse Event|9|||
19755312|NCT01316900|42205688|FG000|Overall Study|Lack of Efficacy|17|||
19755313|NCT01316900|42205689|FG001|Overall Study|Lack of Efficacy|9|||
19755314|NCT01316900|42205690|FG002|Overall Study|Lack of Efficacy|5|||
19755315|NCT01316900|42205691|FG003|Overall Study|Lack of Efficacy|7|||
19755316|NCT01316900|42205688|FG000|Overall Study|Protocol Violation|7|||
19755317|NCT01316900|42205689|FG001|Overall Study|Protocol Violation|1|||
19755318|NCT01316900|42205690|FG002|Overall Study|Protocol Violation|4|||
19662124|NCT00447226|42110852|FG001|12-Week Open-label Phase|Physician Decision|1|||
19662125|NCT00447226|42110851|FG000|Double-blind Phase|Disease Progression|4|||
19662126|NCT00447226|42110852|FG001|Double-blind Phase|Disease Progression|3|||
19662127|NCT00446992|42110867|FG000|Overall Study|Adverse Event|11|||
19662128|NCT00446992|42110867|FG000|Overall Study|Lost to Follow-up|5|||
19662129|NCT00503139|42110871|FG000|Overall Study|Case Report Forms were not collected|4|||
19662130|NCT00503139|42110871|FG000|Overall Study|Protocol Violation|4|||
19662131|NCT00577031|42110875|FG000|Overall Study|Adverse Event|52|||
19755319|NCT01316900|42205691|FG003|Overall Study|Protocol Violation|0|||
19755320|NCT01316900|42205688|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
19755321|NCT01316900|42205689|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
19755322|NCT01316900|42205690|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
19662132|NCT00577031|42110875|FG000|Overall Study|Progression of disease|93|||
19662133|NCT00577031|42110875|FG000|Overall Study|Protocol Violation|5|||
19755323|NCT01316900|42205691|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
19662134|NCT00577031|42110875|FG000|Overall Study|Participant withdrew consent|13|||
19662135|NCT00577031|42110875|FG000|Overall Study|Participant non-compliance|5|||
19662136|NCT00577031|42110875|FG000|Overall Study|Need for surgery|17|||
19662137|NCT00577031|42110875|FG000|Overall Study|Medical decision|14|||
19662138|NCT00577031|42110875|FG000|Overall Study|Death|6|||
19662139|NCT00565448|42110884|FG000|Overall Study|Adverse Event|1|||
19662140|NCT00565448|42110885|FG001|Overall Study|Adverse Event|2|||
19662141|NCT00565448|42110884|FG000|Overall Study|Disease progression|1|||
19662142|NCT00565448|42110885|FG001|Overall Study|Disease progression|0|||
19662143|NCT00565448|42110884|FG000|Overall Study|Withdrawal by Subject|1|||
19662144|NCT00565448|42110885|FG001|Overall Study|Withdrawal by Subject|0|||
19662145|NCT00446446|42110894|FG000|Overall Study|Death|10|||
19662146|NCT00446446|42110894|FG000|Overall Study|Withdrawal by Subject|6|||
19662147|NCT00446446|42110894|FG000|Overall Study|Other|4|||
19662148|NCT00446446|42110894|FG000|Overall Study|Disease Progession|2|||
19662149|NCT00446446|42110894|FG000|Overall Study|Adverse Event|1|||
19662150|NCT00446446|42110894|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
19662151|NCT00506493|42110898|FG000|Overall Study|Death|6|||
19662152|NCT00506493|42110898|FG000|Overall Study|Withdrawal by Subject|5|||
19662153|NCT00514449|42110906|FG000|Overall Study|Withdrawal by Subject|1|||
19662154|NCT00514449|42110907|FG001|Overall Study|Withdrawal by Subject|2|||
19662155|NCT00514449|42110906|FG000|Overall Study|Protocol Violation|1|||
19662156|NCT00514449|42110907|FG001|Overall Study|Protocol Violation|2|||
19662157|NCT00514449|42110906|FG000|Overall Study|Lost to Follow-up|1|||
19662158|NCT00514449|42110907|FG001|Overall Study|Lost to Follow-up|0|||
19662159|NCT00565136|42110916|FG000|Overall Study|Lost to Follow-up|1|||
19662160|NCT00565136|42110916|FG000|Overall Study|Withdrawal by Subject|1|||
19662161|NCT00565136|42110916|FG000|Overall Study|Protocol Violation|1|||
19662162|NCT00492921|42110920|FG000|Overall Study|Death|1|||
19662163|NCT00492921|42110921|FG001|Overall Study|Death|0|||
19662164|NCT00492921|42110922|FG002|Overall Study|Death|1|||
19662165|NCT00502671|42110930|FG000|Overall Study|Disease Progression|13|||
19662166|NCT00502671|42110930|FG000|Overall Study|Personal Reasons|22|||
19662167|NCT00502671|42110930|FG000|Overall Study|Lost to Follow-up|7|||
19662168|NCT00502671|42110930|FG000|Overall Study|Protocol Violation|16|||
19662169|NCT00502671|42110930|FG000|Overall Study|Adverse Event|19|||
19662170|NCT00697463|42110934|FG000|Overall Study|Withdrawal by Subject|1|||
19662171|NCT00492531|42110940|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
19662172|NCT00492531|42110941|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
19662173|NCT00111475|42110957|FG000|Overall Study|Lost to Follow-up|0|||
19662174|NCT00111475|42110958|FG001|Overall Study|Lost to Follow-up|0|||
19662175|NCT00111475|42110959|FG002|Overall Study|Lost to Follow-up|0|||
19662176|NCT00111475|42110960|FG003|Overall Study|Lost to Follow-up|0|||
19662177|NCT00111475|42110961|FG004|Overall Study|Lost to Follow-up|0|||
19662178|NCT00111475|42110962|FG005|Overall Study|Lost to Follow-up|1|||
19662179|NCT00111475|42110963|FG006|Overall Study|Lost to Follow-up|0|||
19662180|NCT00111475|42110964|FG007|Overall Study|Lost to Follow-up|0|||
19662181|NCT00111475|42110965|FG008|Overall Study|Lost to Follow-up|0|||
19662182|NCT00111475|42110966|FG009|Overall Study|Lost to Follow-up|0|||
19662183|NCT00111241|42110995|FG000|Overall Study|Lost to Follow-up|1|||
19662184|NCT00111241|42110996|FG001|Overall Study|Lost to Follow-up|0|||
19662185|NCT00111241|42110995|FG000|Overall Study|Withdrawal by Subject|4|||
19662186|NCT00111241|42110996|FG001|Overall Study|Withdrawal by Subject|0|||
19662187|NCT00111241|42110995|FG000|Overall Study|Protocol Violation|9|||
19662188|NCT00111241|42110996|FG001|Overall Study|Protocol Violation|8|||
19662189|NCT00111241|42110995|FG000|Overall Study|Adverse Event|1|||
19662190|NCT00111241|42110996|FG001|Overall Study|Adverse Event|0|||
19662191|NCT00492297|42111004|FG000|Treatment|Death|2|||
19662192|NCT00492297|42111004|FG000|Treatment|Study terminated by sponsor|3|||
19662193|NCT00492297|42111004|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
19662194|NCT00492297|42111004|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
19662195|NCT00492297|42111004|FG000|Survival Only Follow-up|Death|46|||
19662196|NCT00492297|42111004|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
19662197|NCT00492297|42111004|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
19662198|NCT00697073|42111008|FG000|Overall Study|Withdrawal by Subject|2|||
19662199|NCT00697073|42111008|FG000|Overall Study|Pregnancy|1|||
19662200|NCT00697073|42111008|FG000|Overall Study|non compliance and other|6|||
19662201|NCT00565058|42111014|FG000|Overall Study|Adverse Event|1|||
19662202|NCT00565058|42111015|FG001|Overall Study|Adverse Event|0|||
19662203|NCT00564902|42111024|FG000|Overall Study|Withdrawal by Subject|0|||
19662204|NCT00564902|42111025|FG001|Overall Study|Withdrawal by Subject|3|||
19662205|NCT00564902|42111026|FG002|Overall Study|Withdrawal by Subject|4|||
19755324|NCT01316900|42205688|FG000|Overall Study|Lost to Follow-up|1|||
19662206|NCT00564902|42111024|FG000|Overall Study|Death|1|||
19662207|NCT00564902|42111025|FG001|Overall Study|Death|1|||
19662208|NCT00564902|42111026|FG002|Overall Study|Death|0|||
19662209|NCT00446134|42111038|FG000|Overall Study|Adverse Event|7|||
19662210|NCT00446134|42111039|FG001|Overall Study|Adverse Event|17|||
19662211|NCT00446134|42111040|FG002|Overall Study|Adverse Event|13|||
19755325|NCT01316900|42205689|FG001|Overall Study|Lost to Follow-up|0|||
19755326|NCT01316900|42205690|FG002|Overall Study|Lost to Follow-up|1|||
19755327|NCT01316900|42205691|FG003|Overall Study|Lost to Follow-up|1|||
19755328|NCT01316900|42205688|FG000|Overall Study|Withdrawal by Subject|7|||
19755329|NCT01316900|42205689|FG001|Overall Study|Withdrawal by Subject|8|||
19755330|NCT01316900|42205690|FG002|Overall Study|Withdrawal by Subject|6|||
19755331|NCT01316900|42205691|FG003|Overall Study|Withdrawal by Subject|9|||
19755332|NCT03714815|42205701|FG000|Overall Study|Physician Decision|2|||
19755333|NCT03714815|42205701|FG000|Overall Study|Withdrawal by Subject|2|||
19755334|NCT03714815|42205701|FG000|Overall Study|Death|11|||
19755335|NCT00936390|42205707|FG000|Overall Study|Protocol Violation|21|||
19755336|NCT00936390|42205708|FG001|Overall Study|Protocol Violation|25|||
19755337|NCT03499873|42205719|FG000|Overall Study|Withdrawal by Subject|4|||
19662212|NCT00446134|42111041|FG003|Overall Study|Adverse Event|18|||
19662213|NCT00446134|42111038|FG000|Overall Study|Lack of Efficacy|19|||
19662214|NCT00446134|42111039|FG001|Overall Study|Lack of Efficacy|19|||
19662215|NCT00446134|42111040|FG002|Overall Study|Lack of Efficacy|24|||
19662216|NCT00446134|42111041|FG003|Overall Study|Lack of Efficacy|19|||
19662217|NCT00446134|42111038|FG000|Overall Study|Protocol Violation|0|||
19662218|NCT00446134|42111039|FG001|Overall Study|Protocol Violation|2|||
19662219|NCT00446134|42111040|FG002|Overall Study|Protocol Violation|1|||
19755338|NCT03499873|42205720|FG001|Overall Study|Withdrawal by Subject|6|||
19662220|NCT00446134|42111041|FG003|Overall Study|Protocol Violation|0|||
19662221|NCT00446134|42111038|FG000|Overall Study|Lost to Follow-up|1|||
19662222|NCT00446134|42111039|FG001|Overall Study|Lost to Follow-up|3|||
19662223|NCT00446134|42111040|FG002|Overall Study|Lost to Follow-up|1|||
19662224|NCT00446134|42111041|FG003|Overall Study|Lost to Follow-up|1|||
19662225|NCT00446134|42111038|FG000|Overall Study|Withdrawal by Subject|3|||
19662226|NCT00446134|42111039|FG001|Overall Study|Withdrawal by Subject|3|||
19662227|NCT00446134|42111040|FG002|Overall Study|Withdrawal by Subject|1|||
19662228|NCT00446134|42111041|FG003|Overall Study|Withdrawal by Subject|3|||
19662229|NCT00446134|42111038|FG000|Overall Study|Physician Decision|0|||
19662230|NCT00446134|42111039|FG001|Overall Study|Physician Decision|0|||
19662231|NCT00446134|42111040|FG002|Overall Study|Physician Decision|0|||
19662232|NCT00446134|42111041|FG003|Overall Study|Physician Decision|2|||
19662233|NCT00446134|42111038|FG000|Overall Study|Adverse Event-Diarrhea|1|||
19662234|NCT00446134|42111039|FG001|Overall Study|Adverse Event-Diarrhea|1|||
19662235|NCT00446134|42111040|FG002|Overall Study|Adverse Event-Diarrhea|2|||
19662236|NCT00446134|42111041|FG003|Overall Study|Adverse Event-Diarrhea|0|||
19662237|NCT00446134|42111038|FG000|Overall Study|Reason Not Completed|3|||
19662238|NCT00446134|42111039|FG001|Overall Study|Reason Not Completed|0|||
19662239|NCT00446134|42111040|FG002|Overall Study|Reason Not Completed|1|||
19662240|NCT00446134|42111041|FG003|Overall Study|Reason Not Completed|2|||
19662241|NCT00563186|42111053|FG000|Overall Study|LOS<48 hours|97|||
19662242|NCT00563186|42111054|FG001|Overall Study|LOS<48 hours|74|||
19755339|NCT03499873|42205721|FG002|Overall Study|Withdrawal by Subject|1|||
19477102|NCT01486199|41756015|FG000|Two Year Period Between Study Days|Physician Decision|1|||
19477103|NCT01486199|41756016|FG001|Two Year Period Between Study Days|Physician Decision|0|||
19602447|NCT01572493|42051106|FG004|Overall Study|Physician Decision|0|||
19602448|NCT01572493|42051107|FG005|Overall Study|Physician Decision|0|||
19602449|NCT01572493|42051108|FG006|Overall Study|Physician Decision|0|||
19602450|NCT01572493|42051109|FG007|Overall Study|Physician Decision|0|||
19602451|NCT01572493|42051110|FG008|Overall Study|Physician Decision|0|||
19602452|NCT01572493|42051102|FG000|Overall Study|Switched to alternative treatment|0|||
19602453|NCT01572493|42051103|FG001|Overall Study|Switched to alternative treatment|1|||
19602454|NCT01572493|42051104|FG002|Overall Study|Switched to alternative treatment|2|||
19602455|NCT01572493|42051105|FG003|Overall Study|Switched to alternative treatment|1|||
19602456|NCT01572493|42051106|FG004|Overall Study|Switched to alternative treatment|2|||
19602457|NCT01572493|42051107|FG005|Overall Study|Switched to alternative treatment|0|||
19602458|NCT01572493|42051108|FG006|Overall Study|Switched to alternative treatment|2|||
19602459|NCT01572493|42051109|FG007|Overall Study|Switched to alternative treatment|0|||
19602460|NCT01572493|42051110|FG008|Overall Study|Switched to alternative treatment|2|||
19602461|NCT01572493|42051102|FG000|Overall Study|Death|0|||
19602462|NCT01572493|42051103|FG001|Overall Study|Death|0|||
19602463|NCT01572493|42051104|FG002|Overall Study|Death|0|||
19602464|NCT01572493|42051105|FG003|Overall Study|Death|1|||
19602465|NCT01572493|42051106|FG004|Overall Study|Death|0|||
19602466|NCT01572493|42051107|FG005|Overall Study|Death|1|||
19602467|NCT01572493|42051108|FG006|Overall Study|Death|0|||
19602468|NCT01572493|42051109|FG007|Overall Study|Death|0|||
19602469|NCT01572493|42051110|FG008|Overall Study|Death|0|||
19602470|NCT01572493|42051102|FG000|Overall Study|Adverse Event|0|||
19602471|NCT01572493|42051103|FG001|Overall Study|Adverse Event|0|||
19602472|NCT01572493|42051104|FG002|Overall Study|Adverse Event|0|||
19602473|NCT01572493|42051105|FG003|Overall Study|Adverse Event|0|||
19602474|NCT01572493|42051106|FG004|Overall Study|Adverse Event|0|||
19477104|NCT01485887|41756022|FG000|Overall Study|Withdrawal by Subject|2|||
19477105|NCT01485887|41756022|FG000|Overall Study|Adverse Event|8|||
19477106|NCT01485887|41756022|FG000|Overall Study|Deterioration of primary disease|1|||
19477107|NCT01485887|41756022|FG000|Overall Study|Primary disease markedly improved|1|||
19477108|NCT01546519|41756030|FG000|Overall Study|Adverse Event|0|||
19477109|NCT01546519|41756031|FG001|Overall Study|Adverse Event|0|||
19477110|NCT01546519|41756032|FG002|Overall Study|Adverse Event|1|||
19477111|NCT01546519|41756033|FG003|Overall Study|Adverse Event|1|||
19477112|NCT01546519|41756030|FG000|Overall Study|Death|0|||
19477113|NCT01546519|41756031|FG001|Overall Study|Death|1|||
19477114|NCT01546519|41756032|FG002|Overall Study|Death|3|||
19477115|NCT01546519|41756033|FG003|Overall Study|Death|1|||
19477116|NCT01546519|41756030|FG000|Overall Study|related to disease progression|2|||
19477117|NCT01546519|41756031|FG001|Overall Study|related to disease progression|2|||
19477118|NCT01546519|41756032|FG002|Overall Study|related to disease progression|2|||
19477119|NCT01546519|41756033|FG003|Overall Study|related to disease progression|1|||
19477120|NCT01546519|41756030|FG000|Overall Study|Physician Decision|6|||
19477121|NCT01546519|41756031|FG001|Overall Study|Physician Decision|5|||
19602475|NCT01572493|42051107|FG005|Overall Study|Adverse Event|0|||
19602476|NCT01572493|42051108|FG006|Overall Study|Adverse Event|1|||
19755340|NCT03499873|42205719|FG000|Overall Study|Subjects condition worsened|0|||
19755341|NCT03499873|42205720|FG001|Overall Study|Subjects condition worsened|3|||
19755342|NCT03499873|42205721|FG002|Overall Study|Subjects condition worsened|11|||
19602477|NCT01572493|42051109|FG007|Overall Study|Adverse Event|0|||
19662243|NCT00563186|42111053|FG000|Overall Study|Incomplete data|1|||
19662244|NCT00563186|42111054|FG001|Overall Study|Incomplete data|1|||
19662245|NCT00699413|42111065|FG000|Overall Study|Withdrawal by Subject|0|||
19662246|NCT00699413|42111066|FG001|Overall Study|Withdrawal by Subject|2|||
19662247|NCT00699413|42111065|FG000|Overall Study|Study terminated by sponsor|4|||
19662248|NCT00699413|42111066|FG001|Overall Study|Study terminated by sponsor|2|||
19662249|NCT04808609|42111074|FG000|Overall Study|Lost to Follow-up|0|||
19662250|NCT04808609|42111075|FG001|Overall Study|Lost to Follow-up|2|||
19662251|NCT04808609|42111074|FG000|Overall Study|Administrative Withdrawal|0|||
19662252|NCT04808609|42111075|FG001|Overall Study|Administrative Withdrawal|1|||
19662253|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
19602478|NCT01572493|42051110|FG008|Overall Study|Adverse Event|0|||
19602479|NCT01018511|42051137|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
19602480|NCT01018511|42051138|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
19602481|NCT01018511|42051139|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
19602482|NCT01018511|42051140|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
19602483|NCT01018511|42051137|FG000|Overall Study|Adverse Event|5|||
19602484|NCT01018511|42051138|FG001|Overall Study|Adverse Event|9|||
19602485|NCT01018511|42051139|FG002|Overall Study|Adverse Event|13|||
19602486|NCT01018511|42051140|FG003|Overall Study|Adverse Event|10|||
19602487|NCT01018511|42051137|FG000|Overall Study|Lack of Efficacy|4|||
19602488|NCT01018511|42051138|FG001|Overall Study|Lack of Efficacy|1|||
19602489|NCT01018511|42051139|FG002|Overall Study|Lack of Efficacy|1|||
19602490|NCT01018511|42051140|FG003|Overall Study|Lack of Efficacy|2|||
19602491|NCT01018511|42051137|FG000|Overall Study|Withdrawal by Subject|6|||
19602492|NCT01018511|42051138|FG001|Overall Study|Withdrawal by Subject|5|||
19602493|NCT01018511|42051139|FG002|Overall Study|Withdrawal by Subject|11|||
19602494|NCT01018511|42051140|FG003|Overall Study|Withdrawal by Subject|9|||
19602495|NCT01018511|42051137|FG000|Overall Study|Lost to Follow-up|0|||
19602496|NCT01018511|42051138|FG001|Overall Study|Lost to Follow-up|0|||
19602497|NCT01018511|42051139|FG002|Overall Study|Lost to Follow-up|1|||
19602498|NCT01018511|42051140|FG003|Overall Study|Lost to Follow-up|0|||
19602499|NCT01018511|42051137|FG000|Overall Study|Protocol Violation|5|||
19602500|NCT01018511|42051138|FG001|Overall Study|Protocol Violation|8|||
19602501|NCT01018511|42051139|FG002|Overall Study|Protocol Violation|7|||
19602502|NCT01018511|42051140|FG003|Overall Study|Protocol Violation|9|||
19602503|NCT01018511|42051137|FG000|Overall Study|Miscellaneous|0|||
19602504|NCT01018511|42051138|FG001|Overall Study|Miscellaneous|2|||
19602505|NCT01018511|42051139|FG002|Overall Study|Miscellaneous|0|||
19602506|NCT01018511|42051140|FG003|Overall Study|Miscellaneous|0|||
19602507|NCT00996476|42051161|FG000|Overall Study|Withdrawal by Subject|1|||
19602508|NCT00996476|42051162|FG001|Overall Study|Withdrawal by Subject|2|||
19602509|NCT00996476|42051163|FG002|Overall Study|Withdrawal by Subject|1|||
19602510|NCT00996476|42051164|FG003|Overall Study|Withdrawal by Subject|0|||
19602511|NCT00996476|42051165|FG004|Overall Study|Withdrawal by Subject|1|||
19602512|NCT00996476|42051161|FG000|Overall Study|Adverse Event|0|||
19602513|NCT00996476|42051162|FG001|Overall Study|Adverse Event|1|||
19602514|NCT00996476|42051163|FG002|Overall Study|Adverse Event|0|||
19602515|NCT00996476|42051164|FG003|Overall Study|Adverse Event|0|||
19602516|NCT00996476|42051165|FG004|Overall Study|Adverse Event|1|||
19602517|NCT02269267|42051182|FG000|Overall Study|Death|5|||
19602518|NCT01017731|42051186|FG000|Overall Study|Lost to Follow-up|2|||
19477122|NCT01546519|41756032|FG002|Overall Study|Physician Decision|2|||
19477123|NCT01546519|41756033|FG003|Overall Study|Physician Decision|3|||
19662254|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
19662255|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Death|5|||
19662256|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Death|2|||
19662257|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
19662258|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
19662259|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
19662260|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
19662261|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
19662262|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
19662263|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Relapse|1|||
19662264|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Relapse|0|||
19662265|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
19662266|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
19662267|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
19662268|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
19662269|NCT00111007|42111083|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
19662270|NCT00111007|42111084|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
19662271|NCT00111007|42111083|FG000|Active Follow-up|Adverse Event|1|||
19662272|NCT00111007|42111084|FG001|Active Follow-up|Adverse Event|0|||
19662273|NCT00111007|42111083|FG000|Active Follow-up|Death|2|||
19662274|NCT00111007|42111084|FG001|Active Follow-up|Death|0|||
19662275|NCT00111007|42111083|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
19662276|NCT00111007|42111084|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
19662277|NCT00111007|42111083|FG000|Long Term Follow-up|Death|34|||
19662278|NCT00111007|42111084|FG001|Long Term Follow-up|Death|39|||
19662279|NCT00111007|42111083|FG000|Long Term Follow-up|Lost to Follow-up|1|||
19662280|NCT00111007|42111084|FG001|Long Term Follow-up|Lost to Follow-up|1|||
19662281|NCT00111007|42111083|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
19662282|NCT00111007|42111084|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
19662283|NCT00111007|42111083|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
19662284|NCT00111007|42111084|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
19662285|NCT00111007|42111083|FG000|Long Term Follow-up|Missing|10|||
19662286|NCT00111007|42111084|FG001|Long Term Follow-up|Missing|3|||
19662287|NCT03975920|42111092|FG000|Overall Study|Lost to Follow-up|1|||
19662288|NCT03975920|42111093|FG001|Overall Study|Lost to Follow-up|2|||
19662289|NCT03975920|42111092|FG000|Overall Study|Protocol Violation|1|||
19662290|NCT03975920|42111093|FG001|Overall Study|Protocol Violation|1|||
19662291|NCT03975920|42111092|FG000|Overall Study|Did not complete survey|2|||
19662292|NCT03975920|42111093|FG001|Overall Study|Did not complete survey|1|||
19662293|NCT00699335|42111099|FG000|Overall Study|Combination of multiple reasons|176|||
19662294|NCT00699335|42111099|FG000|Overall Study|Missing data|52|||
19388750|NCT02544633|41632286|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
19388751|NCT02544633|41632287|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
19662295|NCT00445978|42111106|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
19662296|NCT00445978|42111106|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
19662297|NCT00445978|42111106|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
19662298|NCT00445978|42111106|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
19662299|NCT00445978|42111106|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
19662300|NCT00445978|42111106|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
19662301|NCT00445978|42111106|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
19662302|NCT00445978|42111106|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
19755343|NCT03499873|42205719|FG000|Overall Study|Adverse Event|8|||
19755344|NCT03499873|42205720|FG001|Overall Study|Adverse Event|3|||
19755345|NCT03499873|42205721|FG002|Overall Study|Adverse Event|6|||
19755346|NCT03499873|42205719|FG000|Overall Study|Physician Decision|1|||
19755347|NCT03499873|42205720|FG001|Overall Study|Physician Decision|0|||
19755348|NCT03499873|42205721|FG002|Overall Study|Physician Decision|0|||
19755349|NCT03499873|42205719|FG000|Overall Study|Administrative reasons|0|||
19755350|NCT03499873|42205720|FG001|Overall Study|Administrative reasons|1|||
19755351|NCT03499873|42205721|FG002|Overall Study|Administrative reasons|0|||
19755352|NCT03499873|42205719|FG000|Overall Study|Concomitant therapy|5|||
19662303|NCT00445978|42111106|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
19662304|NCT00566228|42111119|FG000|Overall Study|Withdrawal by Subject|1|||
19662305|NCT00566228|42111120|FG001|Overall Study|Withdrawal by Subject|0|||
19662306|NCT00566228|42111119|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
19662307|NCT00566228|42111120|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
19662308|NCT00566228|42111119|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
19662309|NCT00566228|42111120|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
19662310|NCT00566228|42111119|FG000|Overall Study|progressed before infusion could occur|0|||
19662311|NCT00566228|42111120|FG001|Overall Study|progressed before infusion could occur|1|||
19662312|NCT00698009|42111126|FG000|Overall Study|Withdrawal by Subject|1|||
19662313|NCT03968978|42111132|FG000|Overall Study|Adverse Event|1|||
19662314|NCT03968978|42111133|FG001|Overall Study|Adverse Event|0|||
19662315|NCT00562718|42111139|FG000|Overall Study|Death|1|||
19662316|NCT00562718|42111139|FG000|Overall Study|Withdrawal by Subject|3|||
19662317|NCT00562718|42111139|FG000|Overall Study|Adverse Event|4|||
19662318|NCT00562718|42111139|FG000|Overall Study|Lack of Efficacy|2|||
19662319|NCT00562718|42111139|FG000|Overall Study|not stated|1|||
19662320|NCT00697619|42111145|FG000|Overall Study|Lack of Efficacy|2|||
19662321|NCT00697619|42111146|FG001|Overall Study|Lack of Efficacy|2|||
19662322|NCT00697619|42111145|FG000|Overall Study|Adverse Event|4|||
19662323|NCT00697619|42111146|FG001|Overall Study|Adverse Event|6|||
19662324|NCT00445432|42111155|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
19662325|NCT00445432|42111156|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
19662326|NCT00445432|42111157|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
19662327|NCT00445432|42111158|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
19662328|NCT00445432|42111155|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
19662329|NCT00445432|42111156|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
19662330|NCT00445432|42111157|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
19662331|NCT00445432|42111158|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
19662332|NCT00445432|42111155|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
19662333|NCT00445432|42111156|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
19662334|NCT00445432|42111157|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
19662335|NCT00445432|42111158|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
19662336|NCT00445432|42111155|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
19662337|NCT00445432|42111156|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
19662338|NCT00445432|42111157|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
19662339|NCT00445432|42111158|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
19662340|NCT00445432|42111155|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
19662341|NCT00445432|42111156|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
19662342|NCT00445432|42111157|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
19662343|NCT00445432|42111158|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
19662344|NCT00445432|42111155|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
19662345|NCT00445432|42111156|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
19662346|NCT00445432|42111157|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
19662347|NCT00445432|42111158|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
19662348|NCT00445432|42111155|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
19662349|NCT00445432|42111156|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
19662350|NCT00445432|42111157|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
19662351|NCT00445432|42111158|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
19755353|NCT03499873|42205720|FG001|Overall Study|Concomitant therapy|4|||
19755354|NCT03499873|42205721|FG002|Overall Study|Concomitant therapy|7|||
19755355|NCT03499873|42205719|FG000|Overall Study|Miscellaneous|1|||
19755356|NCT03499873|42205720|FG001|Overall Study|Miscellaneous|2|||
19755357|NCT03499873|42205721|FG002|Overall Study|Miscellaneous|2|||
19662352|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
19662353|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
19662354|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
19662355|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
19662356|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
19662357|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
19662358|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Death|1|||
19662359|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Death|1|||
19662360|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Death|1|||
19662361|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Death|0|||
19662362|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Death|0|||
19662363|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Death|0|||
19662364|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
19662365|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
19662366|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
19662367|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
19755358|NCT03499873|42205719|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
19662368|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
19662369|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
19662370|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
19662371|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
19662372|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
19662373|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
19662374|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
19662375|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
19662376|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
19662377|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
19662378|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
19662379|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
19662380|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
19662381|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
19662382|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
19662383|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
19662384|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
19662385|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
19662386|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
19662387|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
19662388|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
19662389|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
19662390|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
19662391|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
19662392|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
19662393|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
19662394|NCT03370133|42111172|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
19662395|NCT03370133|42111173|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
19662396|NCT03370133|42111174|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
19662397|NCT03370133|42111175|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
19662398|NCT03370133|42111176|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
19662399|NCT03370133|42111177|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
19662400|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
19662401|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
19662402|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
19662403|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
19755359|NCT03499873|42205720|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
19755360|NCT03499873|42205721|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
19755361|NCT03467971|42205731|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19755362|NCT03467971|42205732|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19755363|NCT03049280|42205748|FG000|Overall Study|Physician Decision|1|||
19755364|NCT03048500|42205754|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
19755365|NCT03048500|42205754|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
19755366|NCT03048500|42205754|FG000|Reached 1st Response/Continued Treatment|Death|1|||
19662404|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
19662405|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
19662406|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
19662407|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
19755367|NCT03048500|42205754|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
19755368|NCT03048500|42205754|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
19755369|NCT03048500|42205754|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
19755370|NCT03048500|42205754|FG000|Follow up for 3 Years|Death|12|||
19755371|NCT00908076|42205760|FG000|Overall Study|Lack of Efficacy|1|||
19755372|NCT00908076|42205761|FG001|Overall Study|Lack of Efficacy|1|||
19755373|NCT03467425|42205769|FG000|Overall Study|Adverse Event|9|||
19755374|NCT03467425|42205770|FG001|Overall Study|Adverse Event|9|||
19755375|NCT03467425|42205769|FG000|Overall Study|Lack of Efficacy|3|||
19755376|NCT03467425|42205770|FG001|Overall Study|Lack of Efficacy|1|||
19755377|NCT03467425|42205769|FG000|Overall Study|Protocol Violation|0|||
19755378|NCT03467425|42205770|FG001|Overall Study|Protocol Violation|1|||
19755379|NCT03467425|42205769|FG000|Overall Study|Lost to Follow-up|18|||
19755380|NCT03467425|42205770|FG001|Overall Study|Lost to Follow-up|25|||
19755381|NCT03467425|42205769|FG000|Overall Study|Physician Decision|2|||
19755382|NCT03467425|42205770|FG001|Overall Study|Physician Decision|1|||
19755383|NCT03467425|42205769|FG000|Overall Study|Withdrawal by Subject|15|||
19755384|NCT03467425|42205770|FG001|Overall Study|Withdrawal by Subject|17|||
19755385|NCT02886702|42205779|FG000|Overall Study|Other|4|||
19755386|NCT02886702|42205780|FG001|Overall Study|Other|3|||
19755387|NCT02886702|42205781|FG002|Overall Study|Other|9|||
19662408|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
19662409|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
19662410|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
19662411|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
19662412|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
19662413|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
19662414|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
19662415|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
19662416|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
19662417|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
19662418|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
19662419|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
19662420|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
19662421|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
19662422|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
19662423|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
19662424|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
19662425|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
19662426|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
19662427|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
19662428|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
19662429|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
19662430|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
19662431|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
19662432|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
19662433|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
19755388|NCT02886702|42205779|FG000|Overall Study|Withdrawal by Subject|24|||
19755389|NCT02886702|42205780|FG001|Overall Study|Withdrawal by Subject|18|||
19755390|NCT02886702|42205781|FG002|Overall Study|Withdrawal by Subject|22|||
19755391|NCT02886702|42205779|FG000|Overall Study|Significant Worsening of Condition|0|||
19755392|NCT02886702|42205780|FG001|Overall Study|Significant Worsening of Condition|1|||
19755393|NCT02886702|42205781|FG002|Overall Study|Significant Worsening of Condition|0|||
19755394|NCT02886702|42205779|FG000|Overall Study|Protocol Violation|2|||
19755395|NCT02886702|42205780|FG001|Overall Study|Protocol Violation|2|||
19755396|NCT02886702|42205781|FG002|Overall Study|Protocol Violation|1|||
19755397|NCT02886702|42205779|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19755398|NCT02886702|42205780|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19755399|NCT02886702|42205781|FG002|Overall Study|Non-Compliance With Study Drug|4|||
19755400|NCT02886702|42205779|FG000|Overall Study|Lost to Follow-up|11|||
19755401|NCT02886702|42205780|FG001|Overall Study|Lost to Follow-up|13|||
19755402|NCT02886702|42205781|FG002|Overall Study|Lost to Follow-up|8|||
19755403|NCT02886702|42205779|FG000|Overall Study|Lack of Efficacy|3|||
19755404|NCT02886702|42205780|FG001|Overall Study|Lack of Efficacy|4|||
19755405|NCT02886702|42205781|FG002|Overall Study|Lack of Efficacy|5|||
19755406|NCT02886702|42205779|FG000|Overall Study|Adverse Event|4|||
19755407|NCT02886702|42205780|FG001|Overall Study|Adverse Event|9|||
19755408|NCT02886702|42205781|FG002|Overall Study|Adverse Event|3|||
19755409|NCT02886702|42205779|FG000|Overall Study|Administrative Reasons|0|||
19755410|NCT02886702|42205780|FG001|Overall Study|Administrative Reasons|0|||
19662434|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
19755411|NCT02886702|42205781|FG002|Overall Study|Administrative Reasons|1|||
19755412|NCT03498313|42205795|FG000|Experimental Period 1|Adverse Event|1|||
19755413|NCT03498313|42205796|FG001|Experimental Period 1|Adverse Event|0|||
19755414|NCT03498313|42205797|FG002|Experimental Period 1|Adverse Event|0|||
19755415|NCT03498313|42205798|FG003|Experimental Period 1|Adverse Event|1|||
19755416|NCT03498313|42205799|FG004|Experimental Period 1|Adverse Event|0|||
19755417|NCT03498313|42205800|FG005|Experimental Period 1|Adverse Event|0|||
19755418|NCT03498313|42205795|FG000|Experimental Period 1|Withdrawal by Subject|0|||
19755419|NCT03498313|42205796|FG001|Experimental Period 1|Withdrawal by Subject|1|||
19755420|NCT03498313|42205797|FG002|Experimental Period 1|Withdrawal by Subject|0|||
19755421|NCT03498313|42205798|FG003|Experimental Period 1|Withdrawal by Subject|0|||
19755422|NCT03498313|42205799|FG004|Experimental Period 1|Withdrawal by Subject|0|||
19755423|NCT03498313|42205800|FG005|Experimental Period 1|Withdrawal by Subject|0|||
19755424|NCT03498313|42205795|FG000|Washout Period 1|Anovulation|1|||
19755425|NCT03498313|42205796|FG001|Washout Period 1|Anovulation|0|||
19755426|NCT03498313|42205797|FG002|Washout Period 1|Anovulation|0|||
19755427|NCT03498313|42205798|FG003|Washout Period 1|Anovulation|0|||
19755428|NCT03498313|42205799|FG004|Washout Period 1|Anovulation|0|||
19755429|NCT03498313|42205800|FG005|Washout Period 1|Anovulation|0|||
19755430|NCT03498313|42205795|FG000|Washout Period 1|Withdrawal by Subject|0|||
19755431|NCT03498313|42205796|FG001|Washout Period 1|Withdrawal by Subject|3|||
19662435|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
19662436|NCT03370133|42111172|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
19662437|NCT03370133|42111173|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
19662438|NCT03370133|42111174|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
19662439|NCT03370133|42111175|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
19662440|NCT03370133|42111176|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
19662441|NCT03370133|42111177|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
19662442|NCT00696137|42111195|FG000|Overall Study|Withdrawal by Subject|2|||
19662443|NCT00441142|42111203|FG000|Overall Study|Adverse Event|2|||
19662444|NCT00441142|42111204|FG001|Overall Study|Adverse Event|3|||
19662445|NCT00441142|42111205|FG002|Overall Study|Adverse Event|3|||
19662446|NCT00441142|42111206|FG003|Overall Study|Adverse Event|22|||
19662447|NCT00441142|42111203|FG000|Overall Study|Lack of Efficacy|3|||
19662448|NCT00441142|42111204|FG001|Overall Study|Lack of Efficacy|3|||
19662449|NCT00441142|42111205|FG002|Overall Study|Lack of Efficacy|17|||
19662450|NCT00441142|42111206|FG003|Overall Study|Lack of Efficacy|32|||
19662451|NCT00441142|42111203|FG000|Overall Study|Withdrawal by Subject|0|||
19662452|NCT00441142|42111204|FG001|Overall Study|Withdrawal by Subject|0|||
19662453|NCT00441142|42111205|FG002|Overall Study|Withdrawal by Subject|2|||
19662454|NCT00441142|42111206|FG003|Overall Study|Withdrawal by Subject|10|||
19662455|NCT00441142|42111203|FG000|Overall Study|Patient still receiving active study tx|1|||
19662456|NCT00441142|42111204|FG001|Overall Study|Patient still receiving active study tx|0|||
19662457|NCT00441142|42111205|FG002|Overall Study|Patient still receiving active study tx|0|||
19662458|NCT00441142|42111206|FG003|Overall Study|Patient still receiving active study tx|2|||
19662459|NCT00441142|42111203|FG000|Overall Study|Physician Decision|0|||
19662460|NCT00441142|42111204|FG001|Overall Study|Physician Decision|1|||
19662461|NCT00441142|42111205|FG002|Overall Study|Physician Decision|0|||
19662462|NCT00441142|42111206|FG003|Overall Study|Physician Decision|1|||
19662463|NCT00441142|42111203|FG000|Overall Study|Death|0|||
19662464|NCT00441142|42111204|FG001|Overall Study|Death|0|||
19662465|NCT00441142|42111205|FG002|Overall Study|Death|0|||
19662466|NCT00441142|42111206|FG003|Overall Study|Death|1|||
19662467|NCT04025021|42111220|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
19662468|NCT04025021|42111221|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
19662469|NCT03848416|42111231|FG000|Overall Study|Withdrawal by Subject|1|||
19662470|NCT03848416|42111232|FG001|Overall Study|Withdrawal by Subject|0|||
19662471|NCT03848416|42111233|FG002|Overall Study|Withdrawal by Subject|0|||
19662472|NCT03848416|42111231|FG000|Overall Study|Death|0|||
19662473|NCT03848416|42111232|FG001|Overall Study|Death|0|||
19662474|NCT03848416|42111233|FG002|Overall Study|Death|1|||
19662475|NCT00458302|42111243|FG000|Overall Study|Adverse Event|4|||
19662476|NCT00458302|42111244|FG001|Overall Study|Adverse Event|14|||
19662477|NCT00458302|42111243|FG000|Overall Study|Pregnancy|2|||
19662478|NCT00458302|42111244|FG001|Overall Study|Pregnancy|1|||
19662479|NCT00458302|42111243|FG000|Overall Study|Protocol Violation|0|||
19662480|NCT00458302|42111244|FG001|Overall Study|Protocol Violation|2|||
19662481|NCT00458302|42111243|FG000|Overall Study|Withdrawal by Subject|6|||
19662482|NCT00458302|42111244|FG001|Overall Study|Withdrawal by Subject|4|||
19755432|NCT03498313|42205797|FG002|Washout Period 1|Withdrawal by Subject|0|||
19662483|NCT00458302|42111243|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
19662484|NCT00458302|42111244|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
19662485|NCT00458302|42111243|FG000|Overall Study|Study Termination By Sponsor|1|||
19662486|NCT00458302|42111244|FG001|Overall Study|Study Termination By Sponsor|0|||
19662487|NCT00458302|42111243|FG000|Overall Study|Lost to Follow-up|2|||
19662488|NCT00458302|42111244|FG001|Overall Study|Lost to Follow-up|0|||
19662489|NCT00458302|42111243|FG000|Overall Study|Other|4|||
19662490|NCT00458302|42111244|FG001|Overall Study|Other|2|||
19662491|NCT00444106|42111254|FG000|Overall Study|Lost to Follow-up|2|||
19662492|NCT00444106|42111255|FG001|Overall Study|Lost to Follow-up|1|||
19755433|NCT03498313|42205798|FG003|Washout Period 1|Withdrawal by Subject|1|||
19755434|NCT03498313|42205799|FG004|Washout Period 1|Withdrawal by Subject|0|||
19755435|NCT03498313|42205800|FG005|Washout Period 1|Withdrawal by Subject|1|||
19755436|NCT03498313|42205795|FG000|Experimental Period 2|Adverse Event|0|||
19755437|NCT03498313|42205796|FG001|Experimental Period 2|Adverse Event|0|||
19755438|NCT03498313|42205797|FG002|Experimental Period 2|Adverse Event|0|||
19662493|NCT00444106|42111256|FG002|Overall Study|Lost to Follow-up|0|||
19662494|NCT00444106|42111254|FG000|Overall Study|Abnormal Test Procedure Results|0|||
19662495|NCT00444106|42111255|FG001|Overall Study|Abnormal Test Procedure Results|0|||
19662496|NCT00444106|42111256|FG002|Overall Study|Abnormal Test Procedure Results|1|||
19662497|NCT00561470|42111269|FG000|Overall Study|Adverse Event|74|||
19662498|NCT00561470|42111270|FG001|Overall Study|Adverse Event|163|||
19755439|NCT03498313|42205798|FG003|Experimental Period 2|Adverse Event|0|||
19755440|NCT03498313|42205799|FG004|Experimental Period 2|Adverse Event|1|||
19662499|NCT00561470|42111269|FG000|Overall Study|Disease progression|437|||
19662500|NCT00561470|42111270|FG001|Overall Study|Disease progression|305|||
19662501|NCT00561470|42111269|FG000|Overall Study|poor compliance to protocol|4|||
19662502|NCT00561470|42111270|FG001|Overall Study|poor compliance to protocol|4|||
19662503|NCT00561470|42111269|FG000|Overall Study|Lost to Follow-up|2|||
19662504|NCT00561470|42111270|FG001|Overall Study|Lost to Follow-up|0|||
19662505|NCT00561470|42111269|FG000|Overall Study|Physician Decision|21|||
19662506|NCT00561470|42111270|FG001|Overall Study|Physician Decision|20|||
19662507|NCT00561470|42111269|FG000|Overall Study|Consent Withdrawn|2|||
19662508|NCT00561470|42111270|FG001|Overall Study|Consent Withdrawn|6|||
19662509|NCT00561470|42111269|FG000|Overall Study|Subject request|43|||
19662510|NCT00561470|42111270|FG001|Overall Study|Subject request|77|||
19662511|NCT00561470|42111269|FG000|Overall Study|Metastatic surgery|10|||
19662512|NCT00561470|42111270|FG001|Overall Study|Metastatic surgery|12|||
19662513|NCT00561470|42111269|FG000|Overall Study|Unauthorized procedure|3|||
19662514|NCT00561470|42111270|FG001|Overall Study|Unauthorized procedure|1|||
19662515|NCT00561470|42111269|FG000|Overall Study|Randomized but not treated|5|||
19662516|NCT00561470|42111270|FG001|Overall Study|Randomized but not treated|5|||
19662517|NCT00561470|42111269|FG000|Overall Study|Missed visit window|1|||
19662518|NCT00561470|42111270|FG001|Overall Study|Missed visit window|4|||
19662519|NCT00561470|42111269|FG000|Overall Study|Planning surgery|1|||
19662520|NCT00561470|42111270|FG001|Overall Study|Planning surgery|1|||
19662521|NCT00561470|42111269|FG000|Overall Study|Ongoing Treatment|11|||
19662522|NCT00561470|42111270|FG001|Overall Study|Ongoing Treatment|14|||
19662523|NCT00443872|42111278|FG000|Overall Study|Protocol Violation|7|||
19662524|NCT00443872|42111278|FG000|Overall Study|Lost to Follow-up|2|||
19662525|NCT00443872|42111278|FG000|Overall Study|Adverse Event|8|||
19662526|NCT00441064|42111293|FG000|Overall Study|Adverse Event|1|||
19662527|NCT00441064|42111294|FG001|Overall Study|Adverse Event|0|||
19662528|NCT00441064|42111293|FG000|Overall Study|Abnormal laboratory values|0|||
19662529|NCT00441064|42111294|FG001|Overall Study|Abnormal laboratory values|2|||
19662530|NCT00441064|42111293|FG000|Overall Study|Abnormal test procedure results|0|||
19662531|NCT00441064|42111294|FG001|Overall Study|Abnormal test procedure results|1|||
19662532|NCT00441064|42111293|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19662533|NCT00441064|42111294|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19662534|NCT00441064|42111293|FG000|Overall Study|Protocol Deviation|3|||
19662535|NCT00441064|42111294|FG001|Overall Study|Protocol Deviation|2|||
19662536|NCT00441064|42111293|FG000|Overall Study|Patient withdrew consent|5|||
19662537|NCT00441064|42111294|FG001|Overall Study|Patient withdrew consent|2|||
19662538|NCT03962738|42111304|FG000|Overall Study|Protocol Deviation|3|||
19662539|NCT03962738|42111305|FG001|Overall Study|Protocol Deviation|0|||
19662540|NCT03962738|42111306|FG002|Overall Study|Protocol Deviation|1|||
19662541|NCT03962738|42111307|FG003|Overall Study|Protocol Deviation|1|||
19662542|NCT03962738|42111304|FG000|Overall Study|Withdrawal by Subject|4|||
19662543|NCT03962738|42111305|FG001|Overall Study|Withdrawal by Subject|0|||
19662544|NCT03962738|42111306|FG002|Overall Study|Withdrawal by Subject|0|||
19662545|NCT03962738|42111307|FG003|Overall Study|Withdrawal by Subject|0|||
19662546|NCT03962738|42111304|FG000|Overall Study|Lost to Follow-up|0|||
19662547|NCT03962738|42111305|FG001|Overall Study|Lost to Follow-up|0|||
19662548|NCT03962738|42111306|FG002|Overall Study|Lost to Follow-up|1|||
19662549|NCT03962738|42111307|FG003|Overall Study|Lost to Follow-up|0|||
19662550|NCT00561392|42111325|FG000|Overall Study|Adverse Event|38|||
19662551|NCT00561392|42111325|FG000|Overall Study|Lack of Efficacy|2|||
19662552|NCT00561392|42111325|FG000|Overall Study|Protocol Violation|1|||
19662553|NCT00561392|42111325|FG000|Overall Study|Withdrawal by Subject|8|||
19662554|NCT00561392|42111325|FG000|Overall Study|Administrative problems|4|||
19755441|NCT03498313|42205800|FG005|Experimental Period 2|Adverse Event|2|||
19755442|NCT03498313|42205795|FG000|Washout Period 2|Physician Decision|1|||
19755443|NCT03498313|42205796|FG001|Washout Period 2|Physician Decision|0|||
19662555|NCT00694109|42111329|FG000|Overall Study|Physician Decision|3|||
19662556|NCT00694109|42111329|FG000|Overall Study|Adverse Event|74|||
19662557|NCT00694109|42111329|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
19662558|NCT00694109|42111329|FG000|Overall Study|Lack of Efficacy|2|||
19662559|NCT00694109|42111329|FG000|Overall Study|Withdrawal by Subject|13|||
19662560|NCT00694109|42111329|FG000|Overall Study|Pregnancy|1|||
19662561|NCT00694109|42111329|FG000|Overall Study|Enrolled but not treated|1|||
19662562|NCT00694109|42111329|FG000|Overall Study|Other|2|||
19662563|NCT00694109|42111329|FG000|Overall Study|Consented but no additional treatment|3|||
19662564|NCT00562484|42111340|FG000|Overall Study|Adverse Event|6|||
19662565|NCT00562484|42111341|FG001|Overall Study|Adverse Event|1|||
19662566|NCT00562484|42111340|FG000|Overall Study|Protocol Violation|11|||
19662567|NCT00562484|42111341|FG001|Overall Study|Protocol Violation|2|||
19662568|NCT00562484|42111340|FG000|Overall Study|Withdrawal by Subject|12|||
19662569|NCT00562484|42111341|FG001|Overall Study|Withdrawal by Subject|9|||
19662570|NCT00562484|42111340|FG000|Overall Study|Moved away from the study area|20|||
19662571|NCT00562484|42111341|FG001|Overall Study|Moved away from the study area|9|||
19662572|NCT00562484|42111340|FG000|Overall Study|Lost to Follow-up|132|||
19662573|NCT00562484|42111341|FG001|Overall Study|Lost to Follow-up|71|||
19662574|NCT00562484|42111340|FG000|Overall Study|Reason not provided or not specified|25|||
19662575|NCT00562484|42111341|FG001|Overall Study|Reason not provided or not specified|12|||
19662576|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
19662577|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
19662578|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
19662579|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
19662580|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
19662581|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
19662582|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
19662583|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
19662584|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
19662585|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
19662586|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
19662587|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
19662588|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
19662589|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
19662590|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
19662591|NCT00561080|42111350|FG000|Vaccination Period (up to Month 4)|Other|0|||
19662592|NCT00561080|42111351|FG001|Vaccination Period (up to Month 4)|Other|2|||
19755444|NCT03498313|42205797|FG002|Washout Period 2|Physician Decision|0|||
19755445|NCT03498313|42205798|FG003|Washout Period 2|Physician Decision|1|||
19755446|NCT03498313|42205799|FG004|Washout Period 2|Physician Decision|0|||
19755447|NCT03498313|42205800|FG005|Washout Period 2|Physician Decision|1|||
19755448|NCT03498313|42205795|FG000|Washout Period 2|Withdrawal by Subject|3|||
19755449|NCT03498313|42205796|FG001|Washout Period 2|Withdrawal by Subject|2|||
19755450|NCT03498313|42205797|FG002|Washout Period 2|Withdrawal by Subject|0|||
19755451|NCT03498313|42205798|FG003|Washout Period 2|Withdrawal by Subject|0|||
19755452|NCT03498313|42205799|FG004|Washout Period 2|Withdrawal by Subject|2|||
19755453|NCT03498313|42205800|FG005|Washout Period 2|Withdrawal by Subject|0|||
19755454|NCT03498313|42205795|FG000|Washout Period 2|Anovulation|0|||
19388752|NCT02544633|41632288|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
19662593|NCT00561080|42111352|FG002|Vaccination Period (up to Month 4)|Other|1|||
19662594|NCT00561080|42111350|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
19662595|NCT00561080|42111351|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
19388753|NCT02544633|41632285|FG000|Treatment Period|Adverse Event|7|||
19755455|NCT03498313|42205796|FG001|Washout Period 2|Anovulation|0|||
19755456|NCT03498313|42205797|FG002|Washout Period 2|Anovulation|0|||
19755457|NCT03498313|42205798|FG003|Washout Period 2|Anovulation|0|||
19755458|NCT03498313|42205799|FG004|Washout Period 2|Anovulation|0|||
19755459|NCT03498313|42205800|FG005|Washout Period 2|Anovulation|1|||
19755460|NCT02601014|42205810|FG000|Overall Study|Adverse Event|3|||
19755461|NCT02601014|42205811|FG001|Overall Study|Adverse Event|3|||
19755462|NCT02601014|42205810|FG000|Overall Study|Death|3|||
19755463|NCT02601014|42205811|FG001|Overall Study|Death|1|||
19755464|NCT02601014|42205810|FG000|Overall Study|Disease progression|4|||
19755465|NCT02601014|42205811|FG001|Overall Study|Disease progression|8|||
19755466|NCT01307046|42205819|FG000|Overall Study|Adverse Event|3|||
19755467|NCT01307046|42205820|FG001|Overall Study|Adverse Event|3|||
19755468|NCT01307046|42205819|FG000|Overall Study|Lack of Efficacy|0|||
19662596|NCT00561080|42111352|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
19662597|NCT00561080|42111350|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
19662598|NCT00561080|42111351|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
19662599|NCT00561080|42111352|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
19662600|NCT00561080|42111350|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
19662601|NCT00561080|42111351|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
19662602|NCT00561080|42111352|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
19662603|NCT00561080|42111350|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
19662604|NCT00561080|42111351|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
19662605|NCT00561080|42111352|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
19662606|NCT00562094|42111362|FG000|Overall Study|Lost to Follow-up|62|||
19662607|NCT03817853|42111370|FG000|Induction Phase|Adverse Event|5|||
19662608|NCT03817853|42111371|FG001|Induction Phase|Adverse Event|0|||
19662609|NCT03817853|42111372|FG002|Induction Phase|Adverse Event|0|||
19662610|NCT03817853|42111370|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
19662611|NCT03817853|42111371|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
19662612|NCT03817853|42111372|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
19662613|NCT03817853|42111370|FG000|Induction Phase|Physician Decision|2|||
19662614|NCT03817853|42111371|FG001|Induction Phase|Physician Decision|0|||
19662615|NCT03817853|42111372|FG002|Induction Phase|Physician Decision|0|||
19662616|NCT03817853|42111370|FG000|Induction Phase|Progressive Disease|4|||
19662617|NCT03817853|42111371|FG001|Induction Phase|Progressive Disease|0|||
19662618|NCT03817853|42111372|FG002|Induction Phase|Progressive Disease|0|||
19662619|NCT03817853|42111370|FG000|Induction Phase|Withdrawal by Subject|3|||
19662620|NCT03817853|42111371|FG001|Induction Phase|Withdrawal by Subject|0|||
19662621|NCT03817853|42111372|FG002|Induction Phase|Withdrawal by Subject|0|||
19662622|NCT03817853|42111370|FG000|Induction Phase|Continuing on Study|34|||
19662623|NCT03817853|42111371|FG001|Induction Phase|Continuing on Study|0|||
19662624|NCT03817853|42111372|FG002|Induction Phase|Continuing on Study|0|||
19662625|NCT03817853|42111370|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
19662626|NCT03817853|42111371|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
19662627|NCT03817853|42111372|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
19662628|NCT03817853|42111370|FG000|Maintenance/ Follow-up Phase|Death|0|||
19662629|NCT03817853|42111371|FG001|Maintenance/ Follow-up Phase|Death|1|||
19662630|NCT03817853|42111372|FG002|Maintenance/ Follow-up Phase|Death|1|||
19662631|NCT03817853|42111370|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
19662632|NCT03817853|42111371|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
19662633|NCT03817853|42111372|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
19662634|NCT03817853|42111370|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
19662635|NCT03817853|42111371|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
19662636|NCT03817853|42111372|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
19662637|NCT03817853|42111370|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
19662638|NCT03817853|42111371|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
19662639|NCT03817853|42111372|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
19662640|NCT00439270|42111385|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
19662641|NCT00439270|42111386|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
19662642|NCT00439270|42111387|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
19662643|NCT00439270|42111388|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
19662644|NCT00439270|42111389|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
19662645|NCT00439270|42111385|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
19755469|NCT01307046|42205820|FG001|Overall Study|Lack of Efficacy|2|||
19755470|NCT01307046|42205819|FG000|Overall Study|Physician Decision|2|||
19755471|NCT01307046|42205820|FG001|Overall Study|Physician Decision|0|||
19662646|NCT00439270|42111386|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
19662647|NCT00439270|42111387|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
19662648|NCT00439270|42111388|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
19755472|NCT01307046|42205819|FG000|Overall Study|Withdrawal by Subject|1|||
19755473|NCT01307046|42205820|FG001|Overall Study|Withdrawal by Subject|1|||
19662649|NCT00439270|42111389|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
19662650|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
19662651|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
19662652|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
19662653|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
19662654|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
19662655|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
19662656|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
19662657|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
19662658|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
19662659|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
19662660|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
19662661|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
19662662|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
19662663|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
19662664|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
19662665|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
19662666|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
19662667|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
19662668|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
19662669|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
19662670|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
19662671|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
19662672|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
19662673|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
19662674|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
19662675|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
19662676|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
19662677|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
19662678|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
19662679|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
19662680|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
19662681|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
19662682|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
19662683|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
19662684|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
19662685|NCT00439270|42111385|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
19662686|NCT00439270|42111386|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
19662687|NCT00439270|42111387|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
19662688|NCT00439270|42111388|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
19662689|NCT00439270|42111389|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
19662690|NCT00553280|42111408|FG000|Overall Study|Adverse Event|19|||
19662691|NCT00553280|42111408|FG000|Overall Study|Lack of Efficacy|3|||
19662692|NCT00553280|42111408|FG000|Overall Study|Withdrawal by Subject|3|||
19662693|NCT00553280|42111408|FG000|Overall Study|Physician Decision|1|||
19662694|NCT00440518|42111415|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
19662695|NCT00440518|42111416|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
19662696|NCT00440518|42111417|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
19662697|NCT00440518|42111415|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
19662698|NCT00440518|42111416|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
19662699|NCT00440518|42111417|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
19662700|NCT00440518|42111415|FG000|Randomized /Titration Period|Protocol Deviation|1|||
19662701|NCT00440518|42111416|FG001|Randomized /Titration Period|Protocol Deviation|0|||
19662702|NCT00440518|42111417|FG002|Randomized /Titration Period|Protocol Deviation|0|||
19662703|NCT00440518|42111415|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
19662704|NCT00440518|42111416|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
19662705|NCT00440518|42111417|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
19662706|NCT00440518|42111415|FG000|Randomized /Titration Period|Other|1|||
19662707|NCT00440518|42111416|FG001|Randomized /Titration Period|Other|0|||
19662708|NCT00440518|42111417|FG002|Randomized /Titration Period|Other|0|||
19662709|NCT00440518|42111415|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
19662710|NCT00440518|42111416|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
19662711|NCT00440518|42111417|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
19662712|NCT00440518|42111415|FG000|Randomized /Titration Period|Adverse Event|2|||
19662713|NCT00440518|42111416|FG001|Randomized /Titration Period|Adverse Event|3|||
19662714|NCT00440518|42111417|FG002|Randomized /Titration Period|Adverse Event|0|||
19662715|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
19662716|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
19662717|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
19662718|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
19662719|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
19662720|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
19662721|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
19662722|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
19662723|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
19662724|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
19662725|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
19662726|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
19755474|NCT01307046|42205819|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
19755475|NCT01307046|42205820|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
19755476|NCT01307046|42205819|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
19755477|NCT01307046|42205820|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
19755478|NCT03495817|42205826|FG000|26 Week Open Label|Adverse Event|3|||
19755479|NCT03495817|42205826|FG000|26 Week Open Label|Withdrawal by Subject|4|||
19755480|NCT03495817|42205826|FG000|26 Week Open Label|Lost to Follow-up|1|||
19755481|NCT03495817|42205826|FG000|26 Week Extension|Lost to Follow-up|2|||
19755482|NCT02886624|42205830|FG000|12-week Post Treatment Follow-up|Death|1|||
19755483|NCT02886624|42205830|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
19388754|NCT02544633|41632286|FG001|Treatment Period|Adverse Event|4|||
19662727|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
19662728|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
19662729|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
19662730|NCT00440518|42111415|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
19662731|NCT00440518|42111416|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
19662732|NCT00440518|42111417|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
19662733|NCT00438256|42111425|FG000|Overall Study|Ineligible for Resection|2|||
19662734|NCT00438256|42111426|FG001|Overall Study|Ineligible for Resection|1|||
19662735|NCT00438256|42111427|FG002|Overall Study|Ineligible for Resection|1|||
19662736|NCT00438256|42111428|FG003|Overall Study|Ineligible for Resection|7|||
19662737|NCT00438256|42111425|FG000|Overall Study|Excluded final Diagnosis|0|||
19662738|NCT00438256|42111426|FG001|Overall Study|Excluded final Diagnosis|0|||
19662739|NCT00438256|42111427|FG002|Overall Study|Excluded final Diagnosis|0|||
19662740|NCT00438256|42111428|FG003|Overall Study|Excluded final Diagnosis|2|||
19662741|NCT00436852|42111447|FG000|Overall Study|Death|23|||
19602519|NCT01017731|42051186|FG000|Overall Study|Withdrawal by Subject|3|||
19662742|NCT00436852|42111448|FG001|Overall Study|Death|34|||
19662743|NCT00436852|42111447|FG000|Overall Study|Lack of Efficacy|9|||
19755484|NCT02963766|42205837|FG000|Double-Blind Period|Adverse Event|1|||
19755485|NCT02963766|42205838|FG001|Double-Blind Period|Adverse Event|0|||
19755486|NCT02963766|42205839|FG002|Double-Blind Period|Adverse Event|1|||
19755487|NCT02963766|42205837|FG000|Double-Blind Period|Physician Decision|1|||
19755488|NCT02963766|42205838|FG001|Double-Blind Period|Physician Decision|0|||
19755489|NCT02963766|42205839|FG002|Double-Blind Period|Physician Decision|0|||
19662744|NCT00436852|42111448|FG001|Overall Study|Lack of Efficacy|7|||
19662745|NCT00436852|42111447|FG000|Overall Study|Withdrawal by Subject|2|||
19662746|NCT00436852|42111448|FG001|Overall Study|Withdrawal by Subject|4|||
19662747|NCT00436852|42111447|FG000|Overall Study|Ineligible|1|||
19662748|NCT00436852|42111448|FG001|Overall Study|Ineligible|0|||
19755490|NCT02963766|42205837|FG000|Double-Blind Period|Withdrawal by Subject|1|||
19755491|NCT02963766|42205838|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19755492|NCT02963766|42205839|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19755493|NCT02963766|42205837|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
19755494|NCT02963766|42205838|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
19755495|NCT02963766|42205839|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
19755496|NCT02963766|42205837|FG000|Double-Blind Period|Protocol Violation|1|||
19755497|NCT02963766|42205838|FG001|Double-Blind Period|Protocol Violation|0|||
19755498|NCT02963766|42205839|FG002|Double-Blind Period|Protocol Violation|0|||
19662749|NCT00120289|42111459|FG000|Overall Study|Death|96|||
19662750|NCT00120289|42111460|FG001|Overall Study|Death|82|||
19662751|NCT00120289|42111459|FG000|Overall Study|Lost to Follow-up|11|||
19662752|NCT00120289|42111460|FG001|Overall Study|Lost to Follow-up|14|||
19662753|NCT00120289|42111459|FG000|Overall Study|Withdrawal by Subject|14|||
19662754|NCT00120289|42111460|FG001|Overall Study|Withdrawal by Subject|13|||
19662755|NCT00550446|42111473|FG000|Up To Week 12|Adverse Event|2|||
19602520|NCT01017731|42051186|FG000|Overall Study|Physician Decision|2|||
19602521|NCT01017731|42051186|FG000|Overall Study|Adverse Event|1|||
19602522|NCT01035905|42051193|FG000|Overall Study|Lack of Efficacy|1|||
19602523|NCT01035905|42051194|FG001|Overall Study|Lack of Efficacy|1|||
19602524|NCT00779584|42051218|FG000|Overall Study|Protocol Violation|0|||
19602525|NCT00779584|42051219|FG001|Overall Study|Protocol Violation|0|||
19602526|NCT00779584|42051220|FG002|Overall Study|Protocol Violation|0|||
19602527|NCT00779584|42051221|FG003|Overall Study|Protocol Violation|0|||
19602528|NCT00779584|42051222|FG004|Overall Study|Protocol Violation|0|||
19602529|NCT00779584|42051223|FG005|Overall Study|Protocol Violation|1|||
19602530|NCT00779584|42051224|FG006|Overall Study|Protocol Violation|0|||
19602531|NCT00779584|42051225|FG007|Overall Study|Protocol Violation|0|||
19602532|NCT00779584|42051226|FG008|Overall Study|Protocol Violation|0|||
19602533|NCT00779584|42051218|FG000|Overall Study|Withdrawal by Subject|1|||
19602534|NCT00779584|42051219|FG001|Overall Study|Withdrawal by Subject|1|||
19602535|NCT00779584|42051220|FG002|Overall Study|Withdrawal by Subject|2|||
19602536|NCT00779584|42051221|FG003|Overall Study|Withdrawal by Subject|0|||
19602537|NCT00779584|42051222|FG004|Overall Study|Withdrawal by Subject|0|||
19602538|NCT00779584|42051223|FG005|Overall Study|Withdrawal by Subject|2|||
19662756|NCT00550446|42111474|FG001|Up To Week 12|Adverse Event|2|||
19662757|NCT00550446|42111475|FG002|Up To Week 12|Adverse Event|0|||
19662758|NCT00550446|42111476|FG003|Up To Week 12|Adverse Event|0|||
19388755|NCT02544633|41632287|FG002|Treatment Period|Adverse Event|0|||
19662759|NCT00550446|42111477|FG004|Up To Week 12|Adverse Event|2|||
19662760|NCT00550446|42111478|FG005|Up To Week 12|Adverse Event|2|||
19662761|NCT00550446|42111479|FG006|Up To Week 12|Adverse Event|1|||
19662762|NCT00550446|42111480|FG007|Up To Week 12|Adverse Event|0|||
19662763|NCT00550446|42111481|FG008|Up To Week 12|Adverse Event|0|||
19662764|NCT00550446|42111482|FG009|Up To Week 12|Adverse Event|0|||
19662765|NCT00550446|42111483|FG010|Up To Week 12|Adverse Event|0|||
19662766|NCT00550446|42111473|FG000|Up To Week 12|Lack of Efficacy|3|||
19662767|NCT00550446|42111474|FG001|Up To Week 12|Lack of Efficacy|1|||
19662768|NCT00550446|42111475|FG002|Up To Week 12|Lack of Efficacy|0|||
19662769|NCT00550446|42111476|FG003|Up To Week 12|Lack of Efficacy|1|||
19662770|NCT00550446|42111477|FG004|Up To Week 12|Lack of Efficacy|0|||
19662771|NCT00550446|42111478|FG005|Up To Week 12|Lack of Efficacy|3|||
19662772|NCT00550446|42111479|FG006|Up To Week 12|Lack of Efficacy|3|||
19662773|NCT00550446|42111480|FG007|Up To Week 12|Lack of Efficacy|0|||
19662774|NCT00550446|42111481|FG008|Up To Week 12|Lack of Efficacy|0|||
19662775|NCT00550446|42111482|FG009|Up To Week 12|Lack of Efficacy|0|||
19662776|NCT00550446|42111483|FG010|Up To Week 12|Lack of Efficacy|0|||
19662777|NCT00550446|42111473|FG000|Up To Week 12|Lost to Follow-up|0|||
19662778|NCT00550446|42111474|FG001|Up To Week 12|Lost to Follow-up|1|||
19662779|NCT00550446|42111475|FG002|Up To Week 12|Lost to Follow-up|0|||
19662780|NCT00550446|42111476|FG003|Up To Week 12|Lost to Follow-up|0|||
19662781|NCT00550446|42111477|FG004|Up To Week 12|Lost to Follow-up|1|||
19662782|NCT00550446|42111478|FG005|Up To Week 12|Lost to Follow-up|1|||
19662783|NCT00550446|42111479|FG006|Up To Week 12|Lost to Follow-up|2|||
19662784|NCT00550446|42111480|FG007|Up To Week 12|Lost to Follow-up|0|||
19662785|NCT00550446|42111481|FG008|Up To Week 12|Lost to Follow-up|0|||
19662786|NCT00550446|42111482|FG009|Up To Week 12|Lost to Follow-up|0|||
19662787|NCT00550446|42111483|FG010|Up To Week 12|Lost to Follow-up|0|||
19662788|NCT00550446|42111473|FG000|Up To Week 12|Withdrawal by Subject|2|||
19662789|NCT00550446|42111474|FG001|Up To Week 12|Withdrawal by Subject|0|||
19662790|NCT00550446|42111475|FG002|Up To Week 12|Withdrawal by Subject|3|||
19662791|NCT00550446|42111476|FG003|Up To Week 12|Withdrawal by Subject|2|||
19662792|NCT00550446|42111477|FG004|Up To Week 12|Withdrawal by Subject|0|||
19662793|NCT00550446|42111478|FG005|Up To Week 12|Withdrawal by Subject|1|||
19662794|NCT00550446|42111479|FG006|Up To Week 12|Withdrawal by Subject|3|||
19662795|NCT00550446|42111480|FG007|Up To Week 12|Withdrawal by Subject|0|||
19662796|NCT00550446|42111481|FG008|Up To Week 12|Withdrawal by Subject|0|||
19662797|NCT00550446|42111482|FG009|Up To Week 12|Withdrawal by Subject|0|||
19662798|NCT00550446|42111483|FG010|Up To Week 12|Withdrawal by Subject|0|||
19662799|NCT00550446|42111473|FG000|Up To Week 12|Other|3|||
19662800|NCT00550446|42111474|FG001|Up To Week 12|Other|0|||
19662801|NCT00550446|42111475|FG002|Up To Week 12|Other|0|||
19662802|NCT00550446|42111476|FG003|Up To Week 12|Other|0|||
19662803|NCT00550446|42111477|FG004|Up To Week 12|Other|0|||
19662804|NCT00550446|42111478|FG005|Up To Week 12|Other|1|||
19662805|NCT00550446|42111479|FG006|Up To Week 12|Other|4|||
19662806|NCT00550446|42111480|FG007|Up To Week 12|Other|0|||
19662807|NCT00550446|42111481|FG008|Up To Week 12|Other|0|||
19662808|NCT00550446|42111482|FG009|Up To Week 12|Other|0|||
19662809|NCT00550446|42111483|FG010|Up To Week 12|Other|0|||
19662810|NCT00550446|42111473|FG000|Up To Week 12|Randomized not treated|0|||
19662811|NCT00550446|42111474|FG001|Up To Week 12|Randomized not treated|1|||
19662812|NCT00550446|42111475|FG002|Up To Week 12|Randomized not treated|1|||
19662813|NCT00550446|42111476|FG003|Up To Week 12|Randomized not treated|0|||
19662814|NCT00550446|42111477|FG004|Up To Week 12|Randomized not treated|0|||
19662815|NCT00550446|42111478|FG005|Up To Week 12|Randomized not treated|0|||
19662816|NCT00550446|42111479|FG006|Up To Week 12|Randomized not treated|0|||
19662817|NCT00550446|42111480|FG007|Up To Week 12|Randomized not treated|0|||
19662818|NCT00550446|42111481|FG008|Up To Week 12|Randomized not treated|0|||
19662819|NCT00550446|42111482|FG009|Up To Week 12|Randomized not treated|0|||
19662820|NCT00550446|42111483|FG010|Up To Week 12|Randomized not treated|0|||
19662821|NCT00550446|42111473|FG000|Post Week 12|Adverse Event|2|||
19662822|NCT00550446|42111474|FG001|Post Week 12|Adverse Event|1|||
19662823|NCT00550446|42111475|FG002|Post Week 12|Adverse Event|1|||
19662824|NCT00550446|42111476|FG003|Post Week 12|Adverse Event|1|||
19662825|NCT00550446|42111477|FG004|Post Week 12|Adverse Event|1|||
19662826|NCT00550446|42111478|FG005|Post Week 12|Adverse Event|1|||
19662827|NCT00550446|42111479|FG006|Post Week 12|Adverse Event|0|||
19662828|NCT00550446|42111480|FG007|Post Week 12|Adverse Event|0|||
19662829|NCT00550446|42111481|FG008|Post Week 12|Adverse Event|0|||
19662830|NCT00550446|42111482|FG009|Post Week 12|Adverse Event|4|||
19662831|NCT00550446|42111483|FG010|Post Week 12|Adverse Event|0|||
19662832|NCT00550446|42111473|FG000|Post Week 12|Lack of Efficacy|0|||
19662833|NCT00550446|42111474|FG001|Post Week 12|Lack of Efficacy|0|||
19662834|NCT00550446|42111475|FG002|Post Week 12|Lack of Efficacy|1|||
19662835|NCT00550446|42111476|FG003|Post Week 12|Lack of Efficacy|0|||
19662836|NCT00550446|42111477|FG004|Post Week 12|Lack of Efficacy|0|||
19662837|NCT00550446|42111478|FG005|Post Week 12|Lack of Efficacy|0|||
19662838|NCT00550446|42111479|FG006|Post Week 12|Lack of Efficacy|0|||
19662839|NCT00550446|42111480|FG007|Post Week 12|Lack of Efficacy|1|||
19662840|NCT00550446|42111481|FG008|Post Week 12|Lack of Efficacy|1|||
19662841|NCT00550446|42111482|FG009|Post Week 12|Lack of Efficacy|2|||
19662842|NCT00550446|42111483|FG010|Post Week 12|Lack of Efficacy|1|||
19662843|NCT00550446|42111473|FG000|Post Week 12|Lost to Follow-up|0|||
19662844|NCT00550446|42111474|FG001|Post Week 12|Lost to Follow-up|0|||
19662845|NCT00550446|42111475|FG002|Post Week 12|Lost to Follow-up|1|||
19662846|NCT00550446|42111476|FG003|Post Week 12|Lost to Follow-up|1|||
19662847|NCT00550446|42111477|FG004|Post Week 12|Lost to Follow-up|0|||
19662848|NCT00550446|42111478|FG005|Post Week 12|Lost to Follow-up|0|||
19662849|NCT00550446|42111479|FG006|Post Week 12|Lost to Follow-up|1|||
19662850|NCT00550446|42111480|FG007|Post Week 12|Lost to Follow-up|0|||
19662851|NCT00550446|42111481|FG008|Post Week 12|Lost to Follow-up|0|||
19662852|NCT00550446|42111482|FG009|Post Week 12|Lost to Follow-up|0|||
19662853|NCT00550446|42111483|FG010|Post Week 12|Lost to Follow-up|0|||
19662854|NCT00550446|42111473|FG000|Post Week 12|Withdrawal by Subject|0|||
19662855|NCT00550446|42111474|FG001|Post Week 12|Withdrawal by Subject|0|||
19662856|NCT00550446|42111475|FG002|Post Week 12|Withdrawal by Subject|0|||
19662857|NCT00550446|42111476|FG003|Post Week 12|Withdrawal by Subject|0|||
19662858|NCT00550446|42111477|FG004|Post Week 12|Withdrawal by Subject|1|||
19662859|NCT00550446|42111478|FG005|Post Week 12|Withdrawal by Subject|0|||
19755499|NCT02963766|42205837|FG000|Double-Blind Period|Lost to Follow-up|0|||
19755500|NCT02963766|42205838|FG001|Double-Blind Period|Lost to Follow-up|1|||
19662860|NCT00550446|42111479|FG006|Post Week 12|Withdrawal by Subject|0|||
19662861|NCT00550446|42111480|FG007|Post Week 12|Withdrawal by Subject|0|||
19662862|NCT00550446|42111481|FG008|Post Week 12|Withdrawal by Subject|0|||
19662863|NCT00550446|42111482|FG009|Post Week 12|Withdrawal by Subject|0|||
19755501|NCT02963766|42205839|FG002|Double-Blind Period|Lost to Follow-up|0|||
19755502|NCT02963766|42205837|FG000|Open Label Extension (OLE)|Physician Decision|1|||
19755503|NCT02963766|42205838|FG001|Open Label Extension (OLE)|Physician Decision|2|||
19755504|NCT02963766|42205839|FG002|Open Label Extension (OLE)|Physician Decision|2|||
19755505|NCT02963766|42205837|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
19755506|NCT02963766|42205838|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
19755507|NCT02963766|42205839|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
19755508|NCT04839965|42205859|FG000|Overall Study|Death|6|||
19755509|NCT04839965|42205860|FG001|Overall Study|Death|6|||
19755510|NCT04839965|42205859|FG000|Overall Study|Lost to Follow-up|1|||
19755511|NCT04839965|42205860|FG001|Overall Study|Lost to Follow-up|0|||
19755512|NCT03466099|42205869|FG000|Overall Study|Adverse Event|1|||
19755513|NCT03466099|42205870|FG001|Overall Study|Adverse Event|1|||
19755514|NCT03466099|42205871|FG002|Overall Study|Adverse Event|1|||
19755515|NCT03466099|42205869|FG000|Overall Study|Withdrawal by Subject|2|||
19662864|NCT00550446|42111483|FG010|Post Week 12|Withdrawal by Subject|0|||
19662865|NCT00550446|42111473|FG000|Post Week 12|Other|1|||
19662866|NCT00550446|42111474|FG001|Post Week 12|Other|1|||
19662867|NCT00550446|42111475|FG002|Post Week 12|Other|0|||
19662868|NCT00550446|42111476|FG003|Post Week 12|Other|1|||
19662869|NCT00550446|42111477|FG004|Post Week 12|Other|0|||
19662870|NCT00550446|42111478|FG005|Post Week 12|Other|0|||
19662871|NCT00550446|42111479|FG006|Post Week 12|Other|1|||
19662872|NCT00550446|42111480|FG007|Post Week 12|Other|0|||
19662873|NCT00550446|42111481|FG008|Post Week 12|Other|1|||
19662874|NCT00550446|42111482|FG009|Post Week 12|Other|1|||
19662875|NCT00550446|42111483|FG010|Post Week 12|Other|0|||
19662876|NCT00436618|42111524|FG000|Overall Study|Withdrawal by Subject|5|||
19662877|NCT00436618|42111525|FG001|Overall Study|Withdrawal by Subject|8|||
19662878|NCT00436618|42111526|FG002|Overall Study|Withdrawal by Subject|11|||
19662879|NCT00436618|42111524|FG000|Overall Study|Adverse Event|8|||
19662880|NCT00436618|42111525|FG001|Overall Study|Adverse Event|8|||
19662881|NCT00436618|42111526|FG002|Overall Study|Adverse Event|9|||
19662882|NCT00436618|42111524|FG000|Overall Study|Alternate Treatment|3|||
19662883|NCT00436618|42111525|FG001|Overall Study|Alternate Treatment|4|||
19662884|NCT00436618|42111526|FG002|Overall Study|Alternate Treatment|12|||
19662885|NCT00436618|42111524|FG000|Overall Study|Other Medical Problems|3|||
19662886|NCT00436618|42111525|FG001|Overall Study|Other Medical Problems|1|||
19755516|NCT03466099|42205870|FG001|Overall Study|Withdrawal by Subject|3|||
19755517|NCT03466099|42205871|FG002|Overall Study|Withdrawal by Subject|1|||
19755518|NCT03466099|42205869|FG000|Overall Study|Use of rescue medication|8|||
19755519|NCT03466099|42205870|FG001|Overall Study|Use of rescue medication|9|||
19755520|NCT03466099|42205871|FG002|Overall Study|Use of rescue medication|13|||
19662887|NCT00436618|42111526|FG002|Overall Study|Other Medical Problems|7|||
19662888|NCT00436618|42111524|FG000|Overall Study|Death|4|||
19662889|NCT00436618|42111525|FG001|Overall Study|Death|2|||
19662890|NCT00436618|42111526|FG002|Overall Study|Death|3|||
19662891|NCT00436618|42111524|FG000|Overall Study|New Primary or Other Reasons|6|||
19662892|NCT00436618|42111525|FG001|Overall Study|New Primary or Other Reasons|2|||
19662893|NCT00436618|42111526|FG002|Overall Study|New Primary or Other Reasons|12|||
19662894|NCT00436618|42111524|FG000|Overall Study|Still on treatment|1|||
19662895|NCT00436618|42111525|FG001|Overall Study|Still on treatment|2|||
19662896|NCT00436618|42111526|FG002|Overall Study|Still on treatment|7|||
19662897|NCT00548808|42111563|FG000|Overall Study|Lost to Follow-up|9|||
19662898|NCT00548808|42111564|FG001|Overall Study|Lost to Follow-up|3|||
19755521|NCT03466099|42205869|FG000|Overall Study|Rescued without meeting criteria|4|||
19662899|NCT00548808|42111563|FG000|Overall Study|Protocol Violation|8|||
19662900|NCT00548808|42111564|FG001|Overall Study|Protocol Violation|8|||
19662901|NCT00548808|42111563|FG000|Overall Study|Withdrawal by Subject|8|||
19662902|NCT00548808|42111564|FG001|Overall Study|Withdrawal by Subject|4|||
19662903|NCT00548808|42111563|FG000|Overall Study|Physician Decision|6|||
19662904|NCT00548808|42111564|FG001|Overall Study|Physician Decision|3|||
19662905|NCT00548808|42111563|FG000|Overall Study|Adverse Event|4|||
19662906|NCT00548808|42111564|FG001|Overall Study|Adverse Event|5|||
19662907|NCT00548808|42111563|FG000|Overall Study|Death|2|||
19662908|NCT00548808|42111564|FG001|Overall Study|Death|0|||
19662909|NCT00548808|42111563|FG000|Overall Study|Entry Criteria Not Met|2|||
19662910|NCT00548808|42111564|FG001|Overall Study|Entry Criteria Not Met|2|||
19662911|NCT00548808|42111563|FG000|Overall Study|Lack of Efficacy|2|||
19662912|NCT00548808|42111564|FG001|Overall Study|Lack of Efficacy|0|||
19662913|NCT00548808|42111563|FG000|Overall Study|Sponsor Decision|1|||
19662914|NCT00548808|42111564|FG001|Overall Study|Sponsor Decision|1|||
19662915|NCT00110617|42111572|FG000|Overall Study|Adverse Event|2|||
19662916|NCT00110617|42111573|FG001|Overall Study|Adverse Event|4|||
19662917|NCT00110617|42111572|FG000|Overall Study|Abnormal Laboratory Value|4|||
19662918|NCT00110617|42111573|FG001|Overall Study|Abnormal Laboratory Value|2|||
19662919|NCT00110617|42111572|FG000|Overall Study|Lack of Efficacy|1|||
19662920|NCT00110617|42111573|FG001|Overall Study|Lack of Efficacy|0|||
19662921|NCT00110617|42111572|FG000|Overall Study|Patient no longer requires study drug|1|||
19662922|NCT00110617|42111573|FG001|Overall Study|Patient no longer requires study drug|0|||
19662923|NCT00110617|42111572|FG000|Overall Study|Protocol Violation|5|||
19662924|NCT00110617|42111573|FG001|Overall Study|Protocol Violation|0|||
19662925|NCT00110617|42111572|FG000|Overall Study|Withdrawal by Subject|10|||
19755522|NCT03466099|42205870|FG001|Overall Study|Rescued without meeting criteria|1|||
19755523|NCT03466099|42205871|FG002|Overall Study|Rescued without meeting criteria|1|||
19662926|NCT00110617|42111573|FG001|Overall Study|Withdrawal by Subject|4|||
19662927|NCT00110617|42111572|FG000|Overall Study|Lost to Follow-up|9|||
19662928|NCT00110617|42111573|FG001|Overall Study|Lost to Follow-up|1|||
19662929|NCT00110617|42111572|FG000|Overall Study|Administrative problems|6|||
19662930|NCT00110617|42111573|FG001|Overall Study|Administrative problems|5|||
19662931|NCT00110617|42111572|FG000|Overall Study|Death|1|||
19662932|NCT00110617|42111573|FG001|Overall Study|Death|1|||
19662933|NCT00110617|42111572|FG000|Overall Study|Did not receive study drug|0|||
19662934|NCT00110617|42111573|FG001|Overall Study|Did not receive study drug|12|||
19755524|NCT03466099|42205869|FG000|Overall Study|Subject compliance|2|||
19755525|NCT03466099|42205870|FG001|Overall Study|Subject compliance|0|||
19755526|NCT03466099|42205871|FG002|Overall Study|Subject compliance|0|||
19755527|NCT03466099|42205869|FG000|Overall Study|Worsening disease|0|||
19755528|NCT03466099|42205870|FG001|Overall Study|Worsening disease|0|||
19755529|NCT03466099|42205871|FG002|Overall Study|Worsening disease|1|||
19755530|NCT00739674|42205881|FG000|Overall Study|Screening failures|19|||
19755531|NCT00739674|42205882|FG001|Overall Study|Screening failures|17|||
19755532|NCT00739674|42205881|FG000|Overall Study|Site 212 removal|19|||
19755533|NCT00739674|42205882|FG001|Overall Study|Site 212 removal|13|||
19755534|NCT00739674|42205881|FG000|Overall Study|No follow-up data|33|||
19755535|NCT00739674|42205882|FG001|Overall Study|No follow-up data|18|||
19755536|NCT00739674|42205881|FG000|Overall Study|Dietician consultation >30 days|1|||
19755537|NCT00739674|42205882|FG001|Overall Study|Dietician consultation >30 days|9|||
19755538|NCT00739674|42205881|FG000|Overall Study|Adverse Event|22|||
19755539|NCT00739674|42205882|FG001|Overall Study|Adverse Event|13|||
19755540|NCT00739674|42205881|FG000|Overall Study|Death|1|||
19755541|NCT00739674|42205882|FG001|Overall Study|Death|0|||
19755542|NCT00739674|42205881|FG000|Overall Study|Lack of Efficacy|1|||
19755543|NCT00739674|42205882|FG001|Overall Study|Lack of Efficacy|0|||
19755544|NCT00739674|42205881|FG000|Overall Study|Lost to Follow-up|52|||
19755545|NCT00739674|42205882|FG001|Overall Study|Lost to Follow-up|30|||
19755546|NCT00739674|42205881|FG000|Overall Study|Protocol Violation|5|||
19755547|NCT00739674|42205882|FG001|Overall Study|Protocol Violation|5|||
19755548|NCT00739674|42205881|FG000|Overall Study|Withdrawal by Subject|9|||
19755549|NCT00739674|42205882|FG001|Overall Study|Withdrawal by Subject|9|||
19755550|NCT00739674|42205881|FG000|Overall Study|Reason missing|2|||
19755551|NCT00739674|42205882|FG001|Overall Study|Reason missing|0|||
19755552|NCT00739674|42205881|FG000|Overall Study|Clinic closed|6|||
19755553|NCT00739674|42205882|FG001|Overall Study|Clinic closed|4|||
19755554|NCT00739674|42205881|FG000|Overall Study|Patient moved|3|||
19662935|NCT03956862|42111583|FG000|Overall Study|Lost to Follow-up|1|||
19662936|NCT03956862|42111584|FG001|Overall Study|Lost to Follow-up|1|||
19662937|NCT03956862|42111583|FG000|Overall Study|Withdrawal by Subject|1|||
19755555|NCT00739674|42205882|FG001|Overall Study|Patient moved|2|||
19755556|NCT00739674|42205881|FG000|Overall Study|Non compliant|4|||
19755557|NCT00739674|42205882|FG001|Overall Study|Non compliant|0|||
19662938|NCT03956862|42111584|FG001|Overall Study|Withdrawal by Subject|1|||
19662939|NCT00550238|42111590|FG000|Overall Study|Adverse Event|88|||
19662940|NCT00550238|42111590|FG000|Overall Study|Death|34|||
19662941|NCT00550238|42111590|FG000|Overall Study|Disease progression|46|||
19662942|NCT00550238|42111590|FG000|Overall Study|Withdrawal by Subject|167|||
19662943|NCT00550238|42111590|FG000|Overall Study|Physician Decision|31|||
19662944|NCT00550238|42111590|FG000|Overall Study|Patient noncompliance|25|||
19662945|NCT00550238|42111590|FG000|Overall Study|Lost to Follow-up|13|||
19662946|NCT00550238|42111590|FG000|Overall Study|Sponsor decision|55|||
19662947|NCT03956550|42111597|FG000|Overall Study|Sponsor decision|65|||
19662948|NCT03956550|42111598|FG001|Overall Study|Sponsor decision|66|||
19662949|NCT03956550|42111599|FG002|Overall Study|Sponsor decision|64|||
19662950|NCT03956550|42111597|FG000|Overall Study|Adverse Event|0|||
19662951|NCT03956550|42111598|FG001|Overall Study|Adverse Event|1|||
19662952|NCT03956550|42111599|FG002|Overall Study|Adverse Event|0|||
19662953|NCT03956550|42111597|FG000|Overall Study|Withdrawal by Subject|5|||
19755558|NCT00739674|42205881|FG000|Overall Study|Unable to attend visit|3|||
19755559|NCT00739674|42205882|FG001|Overall Study|Unable to attend visit|1|||
19755560|NCT00739674|42205881|FG000|Overall Study|Home monitoring off meds|1|||
19755561|NCT00739674|42205882|FG001|Overall Study|Home monitoring off meds|0|||
19755562|NCT00739674|42205881|FG000|Overall Study|Erectile dysfunction|0|||
19755563|NCT00739674|42205882|FG001|Overall Study|Erectile dysfunction|1|||
19755564|NCT03494725|42205890|FG000|Overall Study|Withdrawal by Subject|0|||
19755565|NCT03494725|42205891|FG001|Overall Study|Withdrawal by Subject|2|||
19755566|NCT03494725|42205890|FG000|Overall Study|Antibiotic use|1|||
19755567|NCT03494725|42205891|FG001|Overall Study|Antibiotic use|0|||
19755568|NCT00705718|42205905|FG000|Overall Study|Death|6|||
19755569|NCT00705718|42205906|FG001|Overall Study|Death|6|||
19755570|NCT00705718|42205905|FG000|Overall Study|Not due for Visit|0|||
19662954|NCT03956550|42111598|FG001|Overall Study|Withdrawal by Subject|5|||
19662955|NCT03956550|42111599|FG002|Overall Study|Withdrawal by Subject|6|||
19662956|NCT00110305|42111611|FG000|Overall Study|Adverse Event|46|||
19662957|NCT00110305|42111612|FG001|Overall Study|Adverse Event|13|||
19662958|NCT00110305|42111611|FG000|Overall Study|Sponsors Decision|1|||
19662959|NCT00110305|42111612|FG001|Overall Study|Sponsors Decision|0|||
19662960|NCT00110305|42111611|FG000|Overall Study|Subject Non-Compliant|9|||
19662961|NCT00110305|42111612|FG001|Overall Study|Subject Non-Compliant|2|||
19662962|NCT00110305|42111611|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
19662963|NCT00110305|42111612|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
19662964|NCT00110305|42111611|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
19662965|NCT00110305|42111612|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
19662966|NCT00110305|42111611|FG000|Overall Study|Protocol Violation|0|||
19662967|NCT00110305|42111612|FG001|Overall Study|Protocol Violation|1|||
19662968|NCT00110305|42111611|FG000|Overall Study|Withdrawal by Subject|7|||
19662969|NCT00110305|42111612|FG001|Overall Study|Withdrawal by Subject|7|||
19662970|NCT00110305|42111611|FG000|Overall Study|Lost to Follow-up|20|||
19662971|NCT00110305|42111612|FG001|Overall Study|Lost to Follow-up|3|||
19662972|NCT00110305|42111611|FG000|Overall Study|Other|8|||
19662973|NCT00110305|42111612|FG001|Overall Study|Other|2|||
19662974|NCT00428116|42111631|FG000|Overall Study|Death|1|||
19662975|NCT00428116|42111632|FG001|Overall Study|Death|0|||
19662976|NCT00428116|42111631|FG000|Overall Study|Withdrawal by Subject|1|||
19662977|NCT00428116|42111632|FG001|Overall Study|Withdrawal by Subject|0|||
19662978|NCT00428116|42111631|FG000|Overall Study|Lost to Follow-up|1|||
19662979|NCT00428116|42111632|FG001|Overall Study|Lost to Follow-up|0|||
19662980|NCT00560066|42111641|FG000|Overall Study|Death|2|||
19662981|NCT00560066|42111642|FG001|Overall Study|Death|1|||
19662982|NCT00560066|42111641|FG000|Overall Study|Withdrawal by Subject|0|||
19662983|NCT00560066|42111642|FG001|Overall Study|Withdrawal by Subject|3|||
19662984|NCT00560066|42111641|FG000|Overall Study|Lost to Follow-up|4|||
19662985|NCT00560066|42111642|FG001|Overall Study|Lost to Follow-up|10|||
19662986|NCT00560066|42111641|FG000|Overall Study|Protocol Violation|0|||
19662987|NCT00560066|42111642|FG001|Overall Study|Protocol Violation|1|||
19662988|NCT00560066|42111641|FG000|Overall Study|Administrative reason|0|||
19662989|NCT00560066|42111642|FG001|Overall Study|Administrative reason|5|||
19662990|NCT00560066|42111641|FG000|Overall Study|Missing primary reason|0|||
19662991|NCT00560066|42111642|FG001|Overall Study|Missing primary reason|2|||
19662992|NCT00549900|42111653|FG000|Overall Study|Adverse Event|1|||
19662993|NCT00435994|42111660|FG000|Overall Study|Lost to Follow-up|7|||
19662994|NCT00435994|42111661|FG001|Overall Study|Lost to Follow-up|0|||
19662995|NCT00435994|42111662|FG002|Overall Study|Lost to Follow-up|0|||
19662996|NCT00435370|42111673|FG000|Overall Study|Adverse Event|8|||
19662997|NCT00435370|42111674|FG001|Overall Study|Adverse Event|8|||
19662998|NCT00435370|42111673|FG000|Overall Study|Withdrawal by Subject|10|||
19662999|NCT00435370|42111674|FG001|Overall Study|Withdrawal by Subject|10|||
19663000|NCT00435370|42111673|FG000|Overall Study|Antipsychotic medication changed|4|||
19755571|NCT00705718|42205906|FG001|Overall Study|Not due for Visit|12|||
19663001|NCT00435370|42111674|FG001|Overall Study|Antipsychotic medication changed|2|||
19663002|NCT00096031|42111680|FG000|Overall Study|Adverse Event|3|||
19663003|NCT00096031|42111680|FG000|Overall Study|Lack of Efficacy|42|||
19663004|NCT00096031|42111680|FG000|Overall Study|Death|4|||
19663005|NCT00096031|42111680|FG000|Overall Study|Withdrawal by Subject|1|||
19663006|NCT00096031|42111680|FG000|Overall Study|Ineligible|8|||
19663007|NCT00096031|42111680|FG000|Overall Study|Not protocol specified|5|||
19663008|NCT00118417|42111684|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
19663009|NCT00118417|42111685|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
19663010|NCT00118417|42111684|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
19663011|NCT00118417|42111685|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
19663012|NCT00118417|42111684|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
19663013|NCT00118417|42111685|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
19663014|NCT00118417|42111684|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
19663015|NCT00118417|42111685|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
19663016|NCT00118417|42111684|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
19663017|NCT00118417|42111685|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
19663018|NCT00549848|42111698|FG000|Overall Study|Death|1|||
19663019|NCT00549848|42111699|FG001|Overall Study|Death|4|||
19663020|NCT00549848|42111700|FG002|Overall Study|Death|13|||
19663021|NCT00549848|42111698|FG000|Overall Study|Physician Decision|0|||
19663022|NCT00549848|42111699|FG001|Overall Study|Physician Decision|0|||
19663023|NCT00549848|42111700|FG002|Overall Study|Physician Decision|4|||
19663024|NCT00549848|42111698|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
19663025|NCT00549848|42111699|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
19663026|NCT00549848|42111700|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
19663027|NCT00549848|42111698|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
19663028|NCT00549848|42111699|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
19663029|NCT00549848|42111700|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
19663030|NCT00549848|42111698|FG000|Overall Study|Participant/Family Withdraw|2|||
19663031|NCT00549848|42111699|FG001|Overall Study|Participant/Family Withdraw|3|||
19663032|NCT00549848|42111700|FG002|Overall Study|Participant/Family Withdraw|5|||
19663033|NCT00549848|42111698|FG000|Overall Study|Second Malignancy|1|||
19663034|NCT00549848|42111699|FG001|Overall Study|Second Malignancy|0|||
19663035|NCT00549848|42111700|FG002|Overall Study|Second Malignancy|0|||
19663036|NCT00549848|42111698|FG000|Overall Study|Transplant|3|||
19663037|NCT00549848|42111699|FG001|Overall Study|Transplant|3|||
19755572|NCT00705718|42205905|FG000|Overall Study|Follow up not done|1|||
19755573|NCT00705718|42205906|FG001|Overall Study|Follow up not done|4|||
19755574|NCT03435211|42205921|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
19663038|NCT00549848|42111700|FG002|Overall Study|Transplant|18|||
19663039|NCT00549848|42111698|FG000|Overall Study|Unacceptable Toxicity|1|||
19755575|NCT03465709|42205934|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
19755576|NCT03465709|42205934|FG000|Overall Study|Withdrawal by Subject|3|||
19663040|NCT00549848|42111699|FG001|Overall Study|Unacceptable Toxicity|6|||
19663041|NCT00549848|42111700|FG002|Overall Study|Unacceptable Toxicity|6|||
19663042|NCT00549770|42111724|FG000|Overall Study|Protocol deviation|1|||
19663043|NCT00549770|42111725|FG001|Overall Study|Protocol deviation|1|||
19663044|NCT00549770|42111726|FG002|Overall Study|Protocol deviation|1|||
19663045|NCT00549770|42111727|FG003|Overall Study|Protocol deviation|2|||
19663046|NCT00549770|42111728|FG004|Overall Study|Protocol deviation|2|||
19663047|NCT00549770|42111729|FG005|Overall Study|Protocol deviation|2|||
19663048|NCT00549770|42111730|FG006|Overall Study|Protocol deviation|1|||
19663049|NCT00549770|42111731|FG007|Overall Study|Protocol deviation|2|||
19663050|NCT00549770|42111724|FG000|Overall Study|Administrative problems|0|||
19663051|NCT00549770|42111725|FG001|Overall Study|Administrative problems|1|||
19755577|NCT03435055|42205940|FG000|Screening|Physician Decision|2|||
19755578|NCT03435055|42205940|FG000|Received Intervention|Did not complete nitrous administration|3|||
19755579|NCT03434977|42205953|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
19755580|NCT03434977|42205954|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
19755581|NCT03434119|42205962|FG000|Overall Study|Randomized but not treated|1|||
19755582|NCT03434119|42205963|FG001|Overall Study|Randomized but not treated|0|||
19755583|NCT03434119|42205962|FG000|Overall Study|Adverse Event|1|||
19755584|NCT03434119|42205963|FG001|Overall Study|Adverse Event|0|||
19755585|NCT03434119|42205962|FG000|Overall Study|Poor Compliance to Protocol|0|||
19755586|NCT03434119|42205963|FG001|Overall Study|Poor Compliance to Protocol|1|||
19755587|NCT03434119|42205962|FG000|Overall Study|Study Terminated by Sponsor|91|||
19663052|NCT00549770|42111726|FG002|Overall Study|Administrative problems|0|||
19663053|NCT00549770|42111727|FG003|Overall Study|Administrative problems|0|||
19663054|NCT00549770|42111728|FG004|Overall Study|Administrative problems|0|||
19663055|NCT00549770|42111729|FG005|Overall Study|Administrative problems|0|||
19663056|NCT00549770|42111730|FG006|Overall Study|Administrative problems|0|||
19663057|NCT00549770|42111731|FG007|Overall Study|Administrative problems|1|||
19663058|NCT00549770|42111724|FG000|Overall Study|Lost to Follow-up|0|||
19663059|NCT00549770|42111725|FG001|Overall Study|Lost to Follow-up|0|||
19663060|NCT00549770|42111726|FG002|Overall Study|Lost to Follow-up|2|||
19663061|NCT00549770|42111727|FG003|Overall Study|Lost to Follow-up|2|||
19663062|NCT00549770|42111728|FG004|Overall Study|Lost to Follow-up|3|||
19663063|NCT00549770|42111729|FG005|Overall Study|Lost to Follow-up|2|||
19663064|NCT00549770|42111730|FG006|Overall Study|Lost to Follow-up|0|||
19663065|NCT00549770|42111731|FG007|Overall Study|Lost to Follow-up|0|||
19663066|NCT00549770|42111724|FG000|Overall Study|Withdrawal by Subject|4|||
19663067|NCT00549770|42111725|FG001|Overall Study|Withdrawal by Subject|6|||
19663068|NCT00549770|42111726|FG002|Overall Study|Withdrawal by Subject|4|||
19663069|NCT00549770|42111727|FG003|Overall Study|Withdrawal by Subject|5|||
19663070|NCT00549770|42111728|FG004|Overall Study|Withdrawal by Subject|6|||
19663071|NCT00549770|42111729|FG005|Overall Study|Withdrawal by Subject|6|||
19663072|NCT00549770|42111730|FG006|Overall Study|Withdrawal by Subject|4|||
19663073|NCT00549770|42111731|FG007|Overall Study|Withdrawal by Subject|9|||
19663074|NCT00549770|42111724|FG000|Overall Study|Lack of Efficacy|1|||
19663075|NCT00549770|42111725|FG001|Overall Study|Lack of Efficacy|0|||
19663076|NCT00549770|42111726|FG002|Overall Study|Lack of Efficacy|2|||
19663077|NCT00549770|42111727|FG003|Overall Study|Lack of Efficacy|3|||
19663078|NCT00549770|42111728|FG004|Overall Study|Lack of Efficacy|5|||
19663079|NCT00549770|42111729|FG005|Overall Study|Lack of Efficacy|1|||
19663080|NCT00549770|42111730|FG006|Overall Study|Lack of Efficacy|3|||
19663081|NCT00549770|42111731|FG007|Overall Study|Lack of Efficacy|8|||
19663082|NCT00549770|42111724|FG000|Overall Study|Abnormal test procedure results|0|||
19663083|NCT00549770|42111725|FG001|Overall Study|Abnormal test procedure results|0|||
19663084|NCT00549770|42111726|FG002|Overall Study|Abnormal test procedure results|0|||
19663085|NCT00549770|42111727|FG003|Overall Study|Abnormal test procedure results|2|||
19663086|NCT00549770|42111728|FG004|Overall Study|Abnormal test procedure results|0|||
19663087|NCT00549770|42111729|FG005|Overall Study|Abnormal test procedure results|1|||
19663088|NCT00549770|42111730|FG006|Overall Study|Abnormal test procedure results|1|||
19663089|NCT00549770|42111731|FG007|Overall Study|Abnormal test procedure results|1|||
19663090|NCT00549770|42111724|FG000|Overall Study|Abnormal laboratory values|0|||
19663091|NCT00549770|42111725|FG001|Overall Study|Abnormal laboratory values|0|||
19663092|NCT00549770|42111726|FG002|Overall Study|Abnormal laboratory values|0|||
19663093|NCT00549770|42111727|FG003|Overall Study|Abnormal laboratory values|0|||
19663094|NCT00549770|42111728|FG004|Overall Study|Abnormal laboratory values|0|||
19663095|NCT00549770|42111729|FG005|Overall Study|Abnormal laboratory values|1|||
19663096|NCT00549770|42111730|FG006|Overall Study|Abnormal laboratory values|0|||
19755588|NCT03434119|42205963|FG001|Overall Study|Study Terminated by Sponsor|102|||
19755589|NCT03434119|42205962|FG000|Overall Study|Withdrawal by Subject|7|||
19755590|NCT03434119|42205963|FG001|Overall Study|Withdrawal by Subject|5|||
19755591|NCT03434119|42205962|FG000|Overall Study|Other than specified|7|||
19755592|NCT03434119|42205963|FG001|Overall Study|Other than specified|5|||
19755593|NCT00378378|42205972|FG000|Overall Study|Withdrawal by Subject|0|||
19755594|NCT00378378|42205973|FG001|Overall Study|Withdrawal by Subject|1|||
19755595|NCT00378378|42205974|FG002|Overall Study|Withdrawal by Subject|0|||
19755596|NCT00378378|42205972|FG000|Overall Study|Treatment Failure|0|||
19755597|NCT00378378|42205973|FG001|Overall Study|Treatment Failure|0|||
19755598|NCT00378378|42205974|FG002|Overall Study|Treatment Failure|1|||
19755599|NCT00378378|42205972|FG000|Overall Study|Non-compliance with protocol|0|||
19755600|NCT00378378|42205973|FG001|Overall Study|Non-compliance with protocol|0|||
19755601|NCT00378378|42205974|FG002|Overall Study|Non-compliance with protocol|1|||
19755602|NCT03490981|42205984|FG000|Overall Study|Lost to Follow-up|1|||
19755603|NCT03490981|42205985|FG001|Overall Study|Lost to Follow-up|2|||
19755604|NCT03160716|42205991|FG000|Overall Study|Lost to Follow-up|1|||
19755605|NCT03713021|42205995|FG000|Overall Study|Did not have CT sim scan available|6|||
19755606|NCT03713021|42205995|FG000|Overall Study|Not eligible|4|||
19755607|NCT03713021|42205995|FG000|Overall Study|Issues with TraceIT markers|5|||
19755608|NCT03160560|42206003|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
19755609|NCT03160560|42206004|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19755610|NCT03160560|42206005|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19755611|NCT03160560|42206006|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
19755612|NCT03160560|42206003|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
19755613|NCT03160560|42206004|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
19602539|NCT00779584|42051224|FG006|Overall Study|Withdrawal by Subject|1|||
19602540|NCT00779584|42051225|FG007|Overall Study|Withdrawal by Subject|0|||
19602541|NCT00779584|42051226|FG008|Overall Study|Withdrawal by Subject|0|||
19602542|NCT00779584|42051218|FG000|Overall Study|Lost to Follow-up|0|||
19602543|NCT00779584|42051219|FG001|Overall Study|Lost to Follow-up|0|||
19602544|NCT00779584|42051220|FG002|Overall Study|Lost to Follow-up|0|||
19602545|NCT00779584|42051221|FG003|Overall Study|Lost to Follow-up|0|||
19602546|NCT00779584|42051222|FG004|Overall Study|Lost to Follow-up|1|||
19602547|NCT00779584|42051223|FG005|Overall Study|Lost to Follow-up|0|||
19602548|NCT00779584|42051224|FG006|Overall Study|Lost to Follow-up|0|||
19602549|NCT00779584|42051225|FG007|Overall Study|Lost to Follow-up|0|||
19602550|NCT00779584|42051226|FG008|Overall Study|Lost to Follow-up|0|||
19602551|NCT00779584|42051218|FG000|Overall Study|Progression of Disease|0|||
19602552|NCT00779584|42051219|FG001|Overall Study|Progression of Disease|1|||
19602553|NCT00779584|42051220|FG002|Overall Study|Progression of Disease|2|||
19602554|NCT00779584|42051221|FG003|Overall Study|Progression of Disease|6|||
19663097|NCT00549770|42111731|FG007|Overall Study|Abnormal laboratory values|0|||
19663098|NCT00549770|42111724|FG000|Overall Study|Adverse Event|1|||
19663099|NCT00549770|42111725|FG001|Overall Study|Adverse Event|3|||
19663100|NCT00549770|42111726|FG002|Overall Study|Adverse Event|1|||
19663101|NCT00549770|42111727|FG003|Overall Study|Adverse Event|2|||
19663102|NCT00549770|42111728|FG004|Overall Study|Adverse Event|1|||
19663103|NCT00549770|42111729|FG005|Overall Study|Adverse Event|0|||
19663104|NCT00549770|42111730|FG006|Overall Study|Adverse Event|5|||
19663105|NCT00549770|42111731|FG007|Overall Study|Adverse Event|4|||
19663106|NCT00548184|42111749|FG000|Overall Study|Adverse Event|3|||
19663107|NCT00548184|42111749|FG000|Overall Study|took other drug|1|||
19663108|NCT00548184|42111749|FG000|Overall Study|Found Her2 negative|1|||
19663109|NCT00454636|42111757|FG000|Overall Study|Adverse Event|10|||
19663110|NCT00454636|42111758|FG001|Overall Study|Adverse Event|6|||
19663111|NCT00454636|42111759|FG002|Overall Study|Adverse Event|9|||
19663112|NCT00454636|42111760|FG003|Overall Study|Adverse Event|15|||
19663113|NCT00454636|42111757|FG000|Overall Study|Disease Progression|11|||
19663114|NCT00454636|42111758|FG001|Overall Study|Disease Progression|12|||
19663115|NCT00454636|42111759|FG002|Overall Study|Disease Progression|4|||
19663116|NCT00454636|42111760|FG003|Overall Study|Disease Progression|11|||
19663117|NCT00454636|42111757|FG000|Overall Study|Protocol Violation|3|||
19663118|NCT00454636|42111758|FG001|Overall Study|Protocol Violation|2|||
19663119|NCT00454636|42111759|FG002|Overall Study|Protocol Violation|3|||
19663120|NCT00454636|42111760|FG003|Overall Study|Protocol Violation|3|||
19663121|NCT00454636|42111757|FG000|Overall Study|Death|6|||
19663122|NCT00454636|42111758|FG001|Overall Study|Death|1|||
19663123|NCT00454636|42111759|FG002|Overall Study|Death|1|||
19663124|NCT00454636|42111760|FG003|Overall Study|Death|1|||
19663125|NCT00454636|42111757|FG000|Overall Study|Patient refusal|1|||
19663126|NCT00454636|42111758|FG001|Overall Study|Patient refusal|1|||
19663127|NCT00454636|42111759|FG002|Overall Study|Patient refusal|3|||
19663128|NCT00454636|42111760|FG003|Overall Study|Patient refusal|2|||
19663129|NCT00454636|42111757|FG000|Overall Study|Lost to Follow-up|0|||
19663130|NCT00454636|42111758|FG001|Overall Study|Lost to Follow-up|1|||
19663131|NCT00454636|42111759|FG002|Overall Study|Lost to Follow-up|0|||
19663132|NCT00454636|42111760|FG003|Overall Study|Lost to Follow-up|0|||
19663133|NCT00427960|42111772|FG000|Overall Study|Adverse Event|2|||
19663134|NCT00427960|42111773|FG001|Overall Study|Adverse Event|0|||
19663135|NCT00427960|42111772|FG000|Overall Study|Withdrawal by Subject|0|||
19663136|NCT00427960|42111773|FG001|Overall Study|Withdrawal by Subject|3|||
19663137|NCT00427960|42111772|FG000|Overall Study|Other|0|||
19663138|NCT00427960|42111773|FG001|Overall Study|Other|1|||
19388756|NCT02544633|41632288|FG003|Treatment Period|Adverse Event|5|||
19602555|NCT00779584|42051222|FG004|Overall Study|Progression of Disease|5|||
19602556|NCT00779584|42051223|FG005|Overall Study|Progression of Disease|1|||
19602557|NCT00779584|42051224|FG006|Overall Study|Progression of Disease|4|||
19602558|NCT00779584|42051225|FG007|Overall Study|Progression of Disease|2|||
19602559|NCT00779584|42051226|FG008|Overall Study|Progression of Disease|1|||
19602560|NCT00779584|42051218|FG000|Overall Study|Adverse Event|1|||
19602561|NCT00779584|42051219|FG001|Overall Study|Adverse Event|0|||
19602562|NCT00779584|42051220|FG002|Overall Study|Adverse Event|2|||
19602563|NCT00779584|42051221|FG003|Overall Study|Adverse Event|0|||
19602564|NCT00779584|42051222|FG004|Overall Study|Adverse Event|0|||
19602565|NCT00779584|42051223|FG005|Overall Study|Adverse Event|0|||
19602566|NCT00779584|42051224|FG006|Overall Study|Adverse Event|2|||
19602567|NCT00779584|42051225|FG007|Overall Study|Adverse Event|1|||
19602568|NCT00779584|42051226|FG008|Overall Study|Adverse Event|1|||
19663139|NCT00548340|42111782|FG000|Overall Study|Protocol Violation|2|||
19602569|NCT00779584|42051218|FG000|Overall Study|Symptomatic Deterioration|1|||
19602570|NCT00779584|42051219|FG001|Overall Study|Symptomatic Deterioration|1|||
19602571|NCT00779584|42051220|FG002|Overall Study|Symptomatic Deterioration|1|||
19602572|NCT00779584|42051221|FG003|Overall Study|Symptomatic Deterioration|0|||
19602573|NCT00779584|42051222|FG004|Overall Study|Symptomatic Deterioration|0|||
19663140|NCT00548340|42111783|FG001|Overall Study|Protocol Violation|3|||
19663141|NCT00548340|42111784|FG002|Overall Study|Protocol Violation|3|||
19663142|NCT00548340|42111782|FG000|Overall Study|Adverse Event|2|||
19663143|NCT00548340|42111783|FG001|Overall Study|Adverse Event|2|||
19663144|NCT00548340|42111784|FG002|Overall Study|Adverse Event|2|||
19663145|NCT00548340|42111782|FG000|Overall Study|Lost to Follow-up|1|||
19663146|NCT00548340|42111783|FG001|Overall Study|Lost to Follow-up|1|||
19663147|NCT00548340|42111784|FG002|Overall Study|Lost to Follow-up|0|||
19755614|NCT03160560|42206005|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
19755615|NCT03160560|42206006|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
19755616|NCT03489343|42206023|FG000|Overall Study|Documented progressive disease|1|||
19755617|NCT03489343|42206024|FG001|Overall Study|Documented progressive disease|0|||
19755618|NCT03489343|42206025|FG002|Overall Study|Documented progressive disease|3|||
19755619|NCT03489343|42206026|FG003|Overall Study|Documented progressive disease|1|||
19755620|NCT03489343|42206027|FG004|Overall Study|Documented progressive disease|3|||
19755621|NCT03489343|42206028|FG005|Overall Study|Documented progressive disease|5|||
19755622|NCT03489343|42206029|FG006|Overall Study|Documented progressive disease|4|||
19755623|NCT03489343|42206023|FG000|Overall Study|Adverse Event|0|||
19755624|NCT03489343|42206024|FG001|Overall Study|Adverse Event|1|||
19755625|NCT03489343|42206025|FG002|Overall Study|Adverse Event|0|||
19755626|NCT03489343|42206026|FG003|Overall Study|Adverse Event|0|||
19755627|NCT03489343|42206027|FG004|Overall Study|Adverse Event|0|||
19755628|NCT03489343|42206028|FG005|Overall Study|Adverse Event|1|||
19755629|NCT03489343|42206029|FG006|Overall Study|Adverse Event|0|||
19755630|NCT03489343|42206023|FG000|Overall Study|Withdrawal by Subject|0|||
19755631|NCT03489343|42206024|FG001|Overall Study|Withdrawal by Subject|0|||
19755632|NCT03489343|42206025|FG002|Overall Study|Withdrawal by Subject|0|||
19755633|NCT03489343|42206026|FG003|Overall Study|Withdrawal by Subject|1|||
19755634|NCT03489343|42206027|FG004|Overall Study|Withdrawal by Subject|0|||
19755635|NCT03489343|42206028|FG005|Overall Study|Withdrawal by Subject|1|||
19755636|NCT03489343|42206029|FG006|Overall Study|Withdrawal by Subject|1|||
19755637|NCT03489343|42206023|FG000|Overall Study|Clinical progression|0|||
19755638|NCT03489343|42206024|FG001|Overall Study|Clinical progression|0|||
19755639|NCT03489343|42206025|FG002|Overall Study|Clinical progression|0|||
19755640|NCT03489343|42206026|FG003|Overall Study|Clinical progression|1|||
19755641|NCT03489343|42206027|FG004|Overall Study|Clinical progression|0|||
19755642|NCT03489343|42206028|FG005|Overall Study|Clinical progression|0|||
19755643|NCT03489343|42206029|FG006|Overall Study|Clinical progression|1|||
19755644|NCT03489109|42206047|FG000|Overall Study|Lost to Follow-up|1|||
19755645|NCT03489109|42206048|FG001|Overall Study|Lost to Follow-up|2|||
19755646|NCT03709823|42206060|FG000|Overall Study|Adverse Event|0|||
19755647|NCT03709823|42206061|FG001|Overall Study|Adverse Event|0|||
19755648|NCT03709823|42206062|FG002|Overall Study|Adverse Event|1|||
19755649|NCT03709823|42206063|FG003|Overall Study|Adverse Event|0|||
19755650|NCT03709823|42206064|FG004|Overall Study|Adverse Event|0|||
19755651|NCT03709823|42206065|FG005|Overall Study|Adverse Event|0|||
19755652|NCT03709823|42206060|FG000|Overall Study|Lost to Follow-up|2|||
19755653|NCT03709823|42206061|FG001|Overall Study|Lost to Follow-up|2|||
19755654|NCT03709823|42206062|FG002|Overall Study|Lost to Follow-up|2|||
19755655|NCT03709823|42206063|FG003|Overall Study|Lost to Follow-up|1|||
19755656|NCT03709823|42206064|FG004|Overall Study|Lost to Follow-up|1|||
19755657|NCT03709823|42206065|FG005|Overall Study|Lost to Follow-up|0|||
19755658|NCT03709823|42206060|FG000|Overall Study|Withdrawal by Subject|1|||
19755659|NCT03709823|42206061|FG001|Overall Study|Withdrawal by Subject|3|||
19755660|NCT03709823|42206062|FG002|Overall Study|Withdrawal by Subject|0|||
19755661|NCT03709823|42206063|FG003|Overall Study|Withdrawal by Subject|0|||
19755662|NCT03709823|42206064|FG004|Overall Study|Withdrawal by Subject|0|||
19755663|NCT03709823|42206065|FG005|Overall Study|Withdrawal by Subject|0|||
19755664|NCT03709823|42206060|FG000|Overall Study|Other, Not Specified|0|||
19755665|NCT03709823|42206061|FG001|Overall Study|Other, Not Specified|0|||
19755666|NCT03709823|42206062|FG002|Overall Study|Other, Not Specified|0|||
19755667|NCT03709823|42206063|FG003|Overall Study|Other, Not Specified|1|||
19755668|NCT03709823|42206064|FG004|Overall Study|Other, Not Specified|0|||
19755669|NCT03709823|42206065|FG005|Overall Study|Other, Not Specified|0|||
19755670|NCT03488563|42206085|FG000|Overall Study|Lost to Follow-up|7|||
19755671|NCT03488563|42206086|FG001|Overall Study|Lost to Follow-up|6|||
19755672|NCT03488563|42206087|FG002|Overall Study|Lost to Follow-up|7|||
19755673|NCT03488563|42206085|FG000|Overall Study|Withdrawal by Subject|8|||
19388757|NCT02544633|41632285|FG000|Treatment Period|Lack of Efficacy|17|||
19755674|NCT03488563|42206086|FG001|Overall Study|Withdrawal by Subject|7|||
19755675|NCT03488563|42206087|FG002|Overall Study|Withdrawal by Subject|7|||
19755676|NCT03488563|42206085|FG000|Overall Study|Physician Decision|0|||
19755677|NCT03488563|42206086|FG001|Overall Study|Physician Decision|0|||
19755678|NCT03488563|42206087|FG002|Overall Study|Physician Decision|1|||
19755679|NCT03488563|42206085|FG000|Overall Study|Protocol Violation|3|||
19755680|NCT03488563|42206086|FG001|Overall Study|Protocol Violation|2|||
19755681|NCT03488563|42206087|FG002|Overall Study|Protocol Violation|6|||
19755682|NCT03488563|42206085|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
19755683|NCT03488563|42206086|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
19755684|NCT03488563|42206087|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
19755685|NCT03488563|42206085|FG000|Overall Study|Use of prohibited medication|2|||
19755686|NCT03488563|42206086|FG001|Overall Study|Use of prohibited medication|0|||
19755687|NCT03488563|42206087|FG002|Overall Study|Use of prohibited medication|0|||
19755688|NCT03488563|42206085|FG000|Overall Study|Adverse Event|1|||
19755689|NCT03488563|42206086|FG001|Overall Study|Adverse Event|0|||
19755690|NCT03488563|42206087|FG002|Overall Study|Adverse Event|1|||
19755691|NCT03488563|42206085|FG000|Overall Study|Subject returned for ET visit|0|||
19755692|NCT03488563|42206086|FG001|Overall Study|Subject returned for ET visit|1|||
19755693|NCT03488563|42206087|FG002|Overall Study|Subject returned for ET visit|0|||
19663148|NCT00548340|42111782|FG000|Overall Study|Withdrawal by Subject|2|||
19663149|NCT00548340|42111783|FG001|Overall Study|Withdrawal by Subject|4|||
19663150|NCT00548340|42111784|FG002|Overall Study|Withdrawal by Subject|3|||
19663151|NCT00548340|42111782|FG000|Overall Study|Other|1|||
19663152|NCT00548340|42111783|FG001|Overall Study|Other|1|||
19663153|NCT00548340|42111784|FG002|Overall Study|Other|1|||
19663154|NCT00454246|42111795|FG000|Overall Study|Adverse Event|2|||
19663155|NCT00454246|42111796|FG001|Overall Study|Adverse Event|2|||
19663156|NCT00454246|42111797|FG002|Overall Study|Adverse Event|0|||
19663157|NCT00454246|42111795|FG000|Overall Study|Violation of selection criteria at entry|6|||
19663158|NCT00454246|42111796|FG001|Overall Study|Violation of selection criteria at entry|0|||
19663159|NCT00454246|42111797|FG002|Overall Study|Violation of selection criteria at entry|0|||
19663160|NCT00454246|42111795|FG000|Overall Study|Protocol Violation|1|||
19663161|NCT00454246|42111796|FG001|Overall Study|Protocol Violation|0|||
19663162|NCT00454246|42111797|FG002|Overall Study|Protocol Violation|0|||
19663163|NCT00454246|42111795|FG000|Overall Study|Refused Treatment|1|||
19663164|NCT00454246|42111796|FG001|Overall Study|Refused Treatment|1|||
19663165|NCT00454246|42111797|FG002|Overall Study|Refused Treatment|0|||
19663166|NCT00454246|42111795|FG000|Overall Study|Failure to return|1|||
19663167|NCT00454246|42111796|FG001|Overall Study|Failure to return|0|||
19663168|NCT00454246|42111797|FG002|Overall Study|Failure to return|0|||
19663169|NCT00454246|42111795|FG000|Overall Study|Early termination of study|62|||
19663170|NCT00454246|42111796|FG001|Overall Study|Early termination of study|26|||
19663171|NCT00454246|42111797|FG002|Overall Study|Early termination of study|9|||
19663172|NCT00434590|42111807|FG000|Overall Study|Administrative problems|5|||
19663173|NCT00434590|42111808|FG001|Overall Study|Administrative problems|5|||
19663174|NCT02891837|42111816|FG000|Overall Study|Lost to Follow-up|2|||
19663175|NCT02891837|42111817|FG001|Overall Study|Lost to Follow-up|0|||
19663176|NCT02891837|42111816|FG000|Overall Study|Withdrawal by Subject|1|||
19663177|NCT02891837|42111817|FG001|Overall Study|Withdrawal by Subject|0|||
19663178|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
19663179|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
19663180|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
19663181|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
19663182|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
19663183|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
19663184|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
19663185|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
19663186|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
19663187|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
19663188|NCT00695903|42111841|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
19663189|NCT00695903|42111842|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
19663190|NCT00695903|42111841|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
19663191|NCT00695903|42111842|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
19663192|NCT00695903|42111841|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
19663193|NCT00695903|42111842|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
19663194|NCT00695903|42111841|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
19663195|NCT00695903|42111842|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
19663196|NCT02759861|42111848|FG000|Overall Study|Death|1|||
19755694|NCT03488563|42206085|FG000|Overall Study|Sponsor's decision|0|||
19663197|NCT00548262|42111853|FG000|Overall Study|Death|21|||
19663198|NCT00548262|42111853|FG000|Overall Study|Adverse Event|2|||
19663199|NCT00548262|42111853|FG000|Overall Study|Lack of Efficacy|4|||
19663200|NCT00548262|42111853|FG000|Overall Study|Lost to Follow-up|1|||
19663201|NCT00548262|42111853|FG000|Overall Study|Other|3|||
19663202|NCT00548262|42111853|FG000|Overall Study|Withdrawal by Subject|1|||
19663203|NCT00095173|42111857|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
19663204|NCT00095173|42111858|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
19663205|NCT00095173|42111859|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
19663206|NCT00095173|42111860|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
19663207|NCT00095173|42111861|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
19663208|NCT00095173|42111862|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
19663209|NCT00095173|42111857|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
19663210|NCT00095173|42111858|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
19663211|NCT00095173|42111859|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
19663212|NCT00095173|42111860|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
19663213|NCT00095173|42111861|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
19663214|NCT00095173|42111862|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
19663215|NCT00095173|42111857|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
19663216|NCT00095173|42111858|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
19663217|NCT00095173|42111859|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
19663218|NCT00095173|42111860|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
19663219|NCT00095173|42111861|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
19663220|NCT00095173|42111862|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
19663221|NCT00095173|42111857|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
19663222|NCT00095173|42111858|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
19663223|NCT00095173|42111859|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
19663224|NCT00095173|42111860|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
19663225|NCT00095173|42111861|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
19663226|NCT00095173|42111862|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
19663227|NCT00095173|42111857|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
19663228|NCT00095173|42111858|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
19663229|NCT00095173|42111859|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
19663230|NCT00095173|42111860|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
19663231|NCT00095173|42111861|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
19663232|NCT00095173|42111862|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
19663233|NCT00095173|42111857|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
19663234|NCT00095173|42111858|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
19663235|NCT00095173|42111859|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
19663236|NCT00095173|42111860|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
19663237|NCT00095173|42111861|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
19663238|NCT00095173|42111862|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
19663239|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Death|0|||
19663240|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Death|0|||
19663241|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Death|0|||
19755695|NCT03488563|42206086|FG001|Overall Study|Sponsor's decision|0|||
19755696|NCT03488563|42206087|FG002|Overall Study|Sponsor's decision|1|||
19755697|NCT00706030|42206101|FG000|Overall Study|Disease Progression|4|||
19755698|NCT00706030|42206102|FG001|Overall Study|Disease Progression|6|||
19755699|NCT00706030|42206103|FG002|Overall Study|Disease Progression|46|||
19755700|NCT00706030|42206104|FG003|Overall Study|Disease Progression|12|||
19755701|NCT00706030|42206101|FG000|Overall Study|Adverse Event|1|||
19755702|NCT00706030|42206102|FG001|Overall Study|Adverse Event|0|||
19755703|NCT00706030|42206103|FG002|Overall Study|Adverse Event|4|||
19755704|NCT00706030|42206104|FG003|Overall Study|Adverse Event|2|||
19755705|NCT00706030|42206101|FG000|Overall Study|Withdrawal by Subject|1|||
19755706|NCT00706030|42206102|FG001|Overall Study|Withdrawal by Subject|0|||
19755707|NCT00706030|42206103|FG002|Overall Study|Withdrawal by Subject|2|||
19755708|NCT00706030|42206104|FG003|Overall Study|Withdrawal by Subject|0|||
19755709|NCT00706030|42206101|FG000|Overall Study|Physician Decision|0|||
19755710|NCT00706030|42206102|FG001|Overall Study|Physician Decision|0|||
19755711|NCT00706030|42206103|FG002|Overall Study|Physician Decision|2|||
19755712|NCT00706030|42206104|FG003|Overall Study|Physician Decision|0|||
19755713|NCT00706030|42206101|FG000|Overall Study|Not recorded|0|||
19755714|NCT00706030|42206102|FG001|Overall Study|Not recorded|0|||
19755715|NCT00706030|42206103|FG002|Overall Study|Not recorded|2|||
19663242|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Death|0|||
19663243|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Death|0|||
19663244|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Death|1|||
19663245|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
19755716|NCT00706030|42206104|FG003|Overall Study|Not recorded|0|||
19755717|NCT00706030|42206101|FG000|Overall Study|Protocol Violation|0|||
19755718|NCT00706030|42206102|FG001|Overall Study|Protocol Violation|0|||
19755719|NCT00706030|42206103|FG002|Overall Study|Protocol Violation|1|||
19755720|NCT00706030|42206104|FG003|Overall Study|Protocol Violation|1|||
19755721|NCT00706030|42206101|FG000|Overall Study|Failed to return|0|||
19755722|NCT00706030|42206102|FG001|Overall Study|Failed to return|0|||
19663246|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
19663247|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
19663248|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
19663249|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
19663250|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
19663251|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
19663252|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
19663253|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
19663254|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
19663255|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
19663256|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
19663257|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
19663258|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
19663259|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
19663260|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
19663261|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
19663262|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
19663263|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
19663264|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
19663265|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
19663266|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
19663267|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
19663268|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
19663269|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
19663270|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
19663271|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
19663272|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
19663273|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
19663274|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
19663275|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
19663276|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
19663277|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
19663278|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
19663279|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
19663280|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
19663281|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
19663282|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
19663283|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
19663284|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
19663285|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
19663286|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
19663287|NCT00095173|42111857|FG000|Open-Label Extension Phase (Period C)|Other|0|||
19663288|NCT00095173|42111858|FG001|Open-Label Extension Phase (Period C)|Other|0|||
19663289|NCT00095173|42111859|FG002|Open-Label Extension Phase (Period C)|Other|0|||
19663290|NCT00095173|42111860|FG003|Open-Label Extension Phase (Period C)|Other|4|||
19755723|NCT00706030|42206103|FG002|Overall Study|Failed to return|1|||
19755724|NCT00706030|42206104|FG003|Overall Study|Failed to return|0|||
19755725|NCT00706030|42206101|FG000|Overall Study|Symptomatic Deterioration|0|||
19602574|NCT00779584|42051223|FG005|Overall Study|Symptomatic Deterioration|1|||
19602575|NCT00779584|42051224|FG006|Overall Study|Symptomatic Deterioration|1|||
19602576|NCT00779584|42051225|FG007|Overall Study|Symptomatic Deterioration|0|||
19602577|NCT00779584|42051226|FG008|Overall Study|Symptomatic Deterioration|0|||
19602578|NCT00779584|42051218|FG000|Overall Study|Ongoing in Study|0|||
19602579|NCT00779584|42051219|FG001|Overall Study|Ongoing in Study|0|||
19602580|NCT00779584|42051220|FG002|Overall Study|Ongoing in Study|0|||
19602581|NCT00779584|42051221|FG003|Overall Study|Ongoing in Study|0|||
19602582|NCT00779584|42051222|FG004|Overall Study|Ongoing in Study|1|||
19602583|NCT00779584|42051223|FG005|Overall Study|Ongoing in Study|1|||
19602584|NCT00779584|42051224|FG006|Overall Study|Ongoing in Study|0|||
19602585|NCT00779584|42051225|FG007|Overall Study|Ongoing in Study|0|||
19602586|NCT00779584|42051226|FG008|Overall Study|Ongoing in Study|0|||
19602587|NCT00995930|42051248|FG000|Overall Study|Protocol deviation|2|||
19663291|NCT00095173|42111861|FG004|Open-Label Extension Phase (Period C)|Other|6|||
19663292|NCT00095173|42111862|FG005|Open-Label Extension Phase (Period C)|Other|8|||
19663293|NCT00690443|42111878|FG000|Overall Study|Adverse Event|1|||
19663294|NCT00690443|42111879|FG001|Overall Study|Adverse Event|2|||
19663295|NCT03954834|42111889|FG000|Overall Study|Adverse Event|1|||
19663296|NCT03954834|42111890|FG001|Overall Study|Adverse Event|3|||
19663297|NCT03954834|42111891|FG002|Overall Study|Adverse Event|1|||
19663298|NCT03954834|42111892|FG003|Overall Study|Adverse Event|1|||
19663299|NCT03954834|42111889|FG000|Overall Study|Death|0|||
19663300|NCT03954834|42111890|FG001|Overall Study|Death|0|||
19663301|NCT03954834|42111891|FG002|Overall Study|Death|0|||
19663302|NCT03954834|42111892|FG003|Overall Study|Death|1|||
19663303|NCT03954834|42111889|FG000|Overall Study|Physician Decision|0|||
19663304|NCT03954834|42111890|FG001|Overall Study|Physician Decision|1|||
19663305|NCT03954834|42111891|FG002|Overall Study|Physician Decision|0|||
19663306|NCT03954834|42111892|FG003|Overall Study|Physician Decision|2|||
19663307|NCT03954834|42111889|FG000|Overall Study|Protocol Violation|1|||
19663308|NCT03954834|42111890|FG001|Overall Study|Protocol Violation|0|||
19663309|NCT03954834|42111891|FG002|Overall Study|Protocol Violation|0|||
19663310|NCT03954834|42111892|FG003|Overall Study|Protocol Violation|1|||
19663311|NCT03954834|42111889|FG000|Overall Study|Withdrawal by Subject|2|||
19663312|NCT03954834|42111890|FG001|Overall Study|Withdrawal by Subject|3|||
19755726|NCT00706030|42206102|FG001|Overall Study|Symptomatic Deterioration|0|||
19755727|NCT00706030|42206103|FG002|Overall Study|Symptomatic Deterioration|1|||
19663313|NCT03954834|42111891|FG002|Overall Study|Withdrawal by Subject|13|||
19663314|NCT03954834|42111892|FG003|Overall Study|Withdrawal by Subject|6|||
19663315|NCT03954834|42111889|FG000|Overall Study|Participant left the country|0|||
19663316|NCT03954834|42111890|FG001|Overall Study|Participant left the country|0|||
19663317|NCT03954834|42111891|FG002|Overall Study|Participant left the country|1|||
19663318|NCT03954834|42111892|FG003|Overall Study|Participant left the country|0|||
19663319|NCT03954834|42111889|FG000|Overall Study|Lost to Follow-up|3|||
19663320|NCT03954834|42111890|FG001|Overall Study|Lost to Follow-up|2|||
19663321|NCT03954834|42111891|FG002|Overall Study|Lost to Follow-up|3|||
19663322|NCT03954834|42111892|FG003|Overall Study|Lost to Follow-up|5|||
19663323|NCT00693017|42111904|FG000|Overall Study|Sponsor Decision|2|||
19663324|NCT00693017|42111905|FG001|Overall Study|Sponsor Decision|1|||
19663325|NCT00693017|42111904|FG000|Overall Study|Death|0|||
19663326|NCT00693017|42111905|FG001|Overall Study|Death|1|||
19663327|NCT00692237|42111913|FG000|Overall Study|Withdrawal by Subject|1|||
19663328|NCT00692237|42111914|FG001|Overall Study|Withdrawal by Subject|3|||
19663329|NCT00692237|42111913|FG000|Overall Study|Adverse Event|0|||
19663330|NCT00692237|42111914|FG001|Overall Study|Adverse Event|1|||
19663331|NCT00110149|42111920|FG000|Overall Study|Physician Decision|3|||
19663332|NCT03954444|42111928|FG000|Overall Study|Withdrawal by Subject|5|||
19663333|NCT03954444|42111929|FG001|Overall Study|Withdrawal by Subject|5|||
19663334|NCT03954444|42111930|FG002|Overall Study|Withdrawal by Subject|5|||
19663335|NCT03954444|42111928|FG000|Overall Study|Adverse Event|1|||
19663336|NCT03954444|42111929|FG001|Overall Study|Adverse Event|3|||
19663337|NCT03954444|42111930|FG002|Overall Study|Adverse Event|2|||
19663338|NCT03954444|42111928|FG000|Overall Study|Protocol Violation|0|||
19663339|NCT03954444|42111929|FG001|Overall Study|Protocol Violation|3|||
19663340|NCT03954444|42111930|FG002|Overall Study|Protocol Violation|5|||
19663341|NCT03954444|42111928|FG000|Overall Study|Use of prohibited therapy|1|||
19663342|NCT03954444|42111929|FG001|Overall Study|Use of prohibited therapy|1|||
19663343|NCT03954444|42111930|FG002|Overall Study|Use of prohibited therapy|2|||
19663344|NCT03954444|42111928|FG000|Overall Study|Lost to Follow-up|1|||
19663345|NCT03954444|42111929|FG001|Overall Study|Lost to Follow-up|0|||
19663346|NCT03954444|42111930|FG002|Overall Study|Lost to Follow-up|1|||
19663347|NCT03954444|42111928|FG000|Overall Study|Non-compliant with study drug application|2|||
19663348|NCT03954444|42111929|FG001|Overall Study|Non-compliant with study drug application|2|||
19663349|NCT03954444|42111930|FG002|Overall Study|Non-compliant with study drug application|0|||
19663350|NCT03954444|42111928|FG000|Overall Study|Administrative reasons|0|||
19663351|NCT03954444|42111929|FG001|Overall Study|Administrative reasons|0|||
19663352|NCT03954444|42111930|FG002|Overall Study|Administrative reasons|1|||
19663353|NCT03954444|42111928|FG000|Overall Study|Miscellaneous|3|||
19663354|NCT03954444|42111929|FG001|Overall Study|Miscellaneous|2|||
19663355|NCT03954444|42111930|FG002|Overall Study|Miscellaneous|1|||
19663356|NCT03953820|42111938|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
19663357|NCT03953820|42111939|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
19663358|NCT03953820|42111940|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
19663359|NCT03953820|42111938|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
19663360|NCT03953820|42111939|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
19663361|NCT03953820|42111940|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
19663362|NCT00117949|42111957|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
19663363|NCT00117949|42111958|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
19602588|NCT00995930|42051249|FG001|Overall Study|Protocol deviation|5|||
19602589|NCT00995930|42051248|FG000|Overall Study|Death|0|||
19602590|NCT00995930|42051249|FG001|Overall Study|Death|1|||
19602591|NCT00995930|42051248|FG000|Overall Study|Administrative problems|4|||
19602592|NCT00995930|42051249|FG001|Overall Study|Administrative problems|2|||
19602593|NCT00995930|42051248|FG000|Overall Study|Lost to Follow-up|1|||
19602594|NCT00995930|42051249|FG001|Overall Study|Lost to Follow-up|2|||
19602595|NCT00995930|42051248|FG000|Overall Study|Withdrawal by Subject|3|||
19602596|NCT00995930|42051249|FG001|Overall Study|Withdrawal by Subject|4|||
19602597|NCT00995930|42051248|FG000|Overall Study|Adverse Event|11|||
19602598|NCT00995930|42051249|FG001|Overall Study|Adverse Event|14|||
19602599|NCT00779506|42051256|FG000|Overall Study|Screening Failed|2|||
19602600|NCT00779506|42051256|FG000|Overall Study|Adverse Event|4|||
19602601|NCT00779506|42051256|FG000|Overall Study|Lack of Efficacy|11|||
19663364|NCT00117949|42111959|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
19663365|NCT00117949|42111960|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
19663366|NCT00117949|42111957|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
19663367|NCT00117949|42111958|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
19663368|NCT00117949|42111959|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
19663369|NCT00117949|42111960|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
19663370|NCT00117949|42111957|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
19663371|NCT00117949|42111958|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
19663372|NCT00117949|42111959|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
19663373|NCT00117949|42111960|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
19663374|NCT00117949|42111957|FG000|Overall Study|PSA increase >=10ng/mL|0|||
19663375|NCT00117949|42111958|FG001|Overall Study|PSA increase >=10ng/mL|1|||
19663376|NCT00117949|42111959|FG002|Overall Study|PSA increase >=10ng/mL|1|||
19663377|NCT00117949|42111960|FG003|Overall Study|PSA increase >=10ng/mL|0|||
19663378|NCT00117949|42111957|FG000|Overall Study|PSA reduction <=50%|0|||
19663379|NCT00117949|42111958|FG001|Overall Study|PSA reduction <=50%|2|||
19663380|NCT00117949|42111959|FG002|Overall Study|PSA reduction <=50%|2|||
19663381|NCT00117949|42111960|FG003|Overall Study|PSA reduction <=50%|4|||
19663382|NCT00117949|42111957|FG000|Overall Study|Hepatic abnormalities|0|||
19663383|NCT00117949|42111958|FG001|Overall Study|Hepatic abnormalities|1|||
19663384|NCT00117949|42111959|FG002|Overall Study|Hepatic abnormalities|0|||
19663385|NCT00117949|42111960|FG003|Overall Study|Hepatic abnormalities|1|||
19663386|NCT02611037|42111970|FG000|Overall Study|Withdrawal prior to treatment|2|||
19663387|NCT02611037|42111971|FG001|Overall Study|Withdrawal prior to treatment|0|||
19663388|NCT00117793|42111976|FG000|Overall Study|Withdrawal by Subject|12|||
19663389|NCT00695669|42111985|FG000|Overall Study|Adverse Event|0|||
19663390|NCT00695669|42111986|FG001|Overall Study|Adverse Event|0|||
19663391|NCT00695669|42111987|FG002|Overall Study|Adverse Event|2|||
19755728|NCT00706030|42206104|FG003|Overall Study|Symptomatic Deterioration|0|||
19602602|NCT00779506|42051256|FG000|Overall Study|Protocol Violation|5|||
19663392|NCT00695669|42111988|FG003|Overall Study|Adverse Event|0|||
19663393|NCT00695669|42111985|FG000|Overall Study|Lost to Follow-up|4|||
19663394|NCT00695669|42111986|FG001|Overall Study|Lost to Follow-up|4|||
19663395|NCT00695669|42111987|FG002|Overall Study|Lost to Follow-up|1|||
19663396|NCT00695669|42111988|FG003|Overall Study|Lost to Follow-up|4|||
19663397|NCT03671369|42112001|FG000|Overall Study|Other|1|||
19663398|NCT03671369|42112001|FG000|Overall Study|Withdrawal by Subject|289|||
19663399|NCT03671369|42112001|FG000|Overall Study|Not willing to be vaccinated|1|||
19663400|NCT00692003|42112007|FG000|Overall Study|Sponsor Decision|5|||
19663401|NCT00692003|42112008|FG001|Overall Study|Sponsor Decision|1|||
19663402|NCT00434512|42112020|FG000|Overall Study|Migrated/moved from study area|0|||
19663403|NCT00434512|42112021|FG001|Overall Study|Migrated/moved from study area|0|||
19663404|NCT00434512|42112022|FG002|Overall Study|Migrated/moved from study area|0|||
19663405|NCT00434512|42112023|FG003|Overall Study|Migrated/moved from study area|1|||
19663406|NCT00434512|42112024|FG004|Overall Study|Migrated/moved from study area|1|||
19663407|NCT00434512|42112025|FG005|Overall Study|Migrated/moved from study area|1|||
19663408|NCT00434512|42112020|FG000|Overall Study|Other|0|||
19663409|NCT00434512|42112021|FG001|Overall Study|Other|1|||
19663410|NCT00434512|42112022|FG002|Overall Study|Other|0|||
19663411|NCT00434512|42112023|FG003|Overall Study|Other|0|||
19663412|NCT00434512|42112024|FG004|Overall Study|Other|0|||
19602603|NCT00779506|42051256|FG000|Overall Study|Withdrawal by Subject|6|||
19663413|NCT00434512|42112025|FG005|Overall Study|Other|0|||
19663414|NCT00427648|42112045|FG000|Overall Study|Protocol Violation|1|||
19663415|NCT00427648|42112046|FG001|Overall Study|Protocol Violation|2|||
19663416|NCT00427648|42112045|FG000|Overall Study|Adverse Event|0|||
19663417|NCT00427648|42112046|FG001|Overall Study|Adverse Event|1|||
19602604|NCT00779506|42051256|FG000|Overall Study|Lost to Follow-up|1|||
19755729|NCT00706030|42206101|FG000|Overall Study|No treatment received|0|||
19663418|NCT00416884|42112054|FG000|Overall Study|Study terminated due to low accrual|1|||
19663419|NCT00434122|42112060|FG000|Overall Study|Non-compliance with protocol|0|||
19663420|NCT00434122|42112061|FG001|Overall Study|Non-compliance with protocol|1|||
19663421|NCT00434122|42112060|FG000|Overall Study|loss of subject contact|1|||
19663422|NCT00434122|42112061|FG001|Overall Study|loss of subject contact|1|||
19663423|NCT00434122|42112060|FG000|Overall Study|Personal reasons|1|||
19663424|NCT00434122|42112061|FG001|Overall Study|Personal reasons|1|||
19663425|NCT00434122|42112060|FG000|Overall Study|Large follicle size|2|||
19663426|NCT00434122|42112061|FG001|Overall Study|Large follicle size|2|||
19663427|NCT00434122|42112060|FG000|Overall Study|Low follicular response.|1|||
19663428|NCT00434122|42112061|FG001|Overall Study|Low follicular response.|2|||
19663429|NCT00434122|42112060|FG000|Overall Study|Travelling of subject.|1|||
19663430|NCT00434122|42112061|FG001|Overall Study|Travelling of subject.|0|||
19663431|NCT00555620|42112075|FG000|Overall Study|Death|0|||
19663432|NCT00555620|42112076|FG001|Overall Study|Death|1|||
19663433|NCT00555620|42112077|FG002|Overall Study|Death|0|||
19663434|NCT00555620|42112078|FG003|Overall Study|Death|0|||
19663435|NCT00555620|42112079|FG004|Overall Study|Death|0|||
19663436|NCT00555620|42112080|FG005|Overall Study|Death|1|||
19663437|NCT00555620|42112075|FG000|Overall Study|Study terminated by sponsor|0|||
19663438|NCT00555620|42112076|FG001|Overall Study|Study terminated by sponsor|0|||
19663439|NCT00555620|42112077|FG002|Overall Study|Study terminated by sponsor|1|||
19663440|NCT00555620|42112078|FG003|Overall Study|Study terminated by sponsor|0|||
19663441|NCT00555620|42112079|FG004|Overall Study|Study terminated by sponsor|0|||
19663442|NCT00555620|42112080|FG005|Overall Study|Study terminated by sponsor|0|||
19663443|NCT00555620|42112075|FG000|Overall Study|Adverse Event|0|||
19663444|NCT00555620|42112076|FG001|Overall Study|Adverse Event|0|||
19663445|NCT00555620|42112077|FG002|Overall Study|Adverse Event|1|||
19663446|NCT00555620|42112078|FG003|Overall Study|Adverse Event|5|||
19663447|NCT00555620|42112079|FG004|Overall Study|Adverse Event|0|||
19663448|NCT00555620|42112080|FG005|Overall Study|Adverse Event|1|||
19663449|NCT00555620|42112075|FG000|Overall Study|Objective progression or relapse|6|||
19663450|NCT00555620|42112076|FG001|Overall Study|Objective progression or relapse|5|||
19663451|NCT00555620|42112077|FG002|Overall Study|Objective progression or relapse|12|||
19663452|NCT00555620|42112078|FG003|Overall Study|Objective progression or relapse|17|||
19663453|NCT00555620|42112079|FG004|Overall Study|Objective progression or relapse|3|||
19663454|NCT00555620|42112080|FG005|Overall Study|Objective progression or relapse|16|||
19663455|NCT00555620|42112075|FG000|Overall Study|Participant refused treatment|0|||
19663456|NCT00555620|42112076|FG001|Overall Study|Participant refused treatment|1|||
19663457|NCT00555620|42112077|FG002|Overall Study|Participant refused treatment|1|||
19663458|NCT00555620|42112078|FG003|Overall Study|Participant refused treatment|0|||
19663459|NCT00555620|42112079|FG004|Overall Study|Participant refused treatment|0|||
19663460|NCT00555620|42112080|FG005|Overall Study|Participant refused treatment|1|||
19663461|NCT00555620|42112075|FG000|Overall Study|Other|0|||
19663462|NCT00555620|42112076|FG001|Overall Study|Other|0|||
19663463|NCT00555620|42112077|FG002|Overall Study|Other|0|||
19663464|NCT00555620|42112078|FG003|Overall Study|Other|1|||
19663465|NCT00555620|42112079|FG004|Overall Study|Other|0|||
19663466|NCT00555620|42112080|FG005|Overall Study|Other|3|||
19663467|NCT00433966|42112100|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
19663468|NCT00433966|42112101|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
19663469|NCT00433966|42112102|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
19663470|NCT00433966|42112103|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
19663471|NCT00433966|42112100|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
19663472|NCT00433966|42112101|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
19663473|NCT00433966|42112102|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
19663474|NCT00433966|42112103|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
19663475|NCT00433966|42112100|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
19663476|NCT00433966|42112101|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
19663477|NCT00433966|42112102|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
19663478|NCT00433966|42112103|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
19663479|NCT00433966|42112100|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
19663480|NCT00433966|42112101|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
19663481|NCT00433966|42112102|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
19663482|NCT00433966|42112103|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
19663483|NCT00433966|42112100|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
19663484|NCT00433966|42112101|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
19663485|NCT00433966|42112102|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
19663486|NCT00433966|42112103|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
19663487|NCT03952650|42112120|FG000|Overall Study|TRAVEL|0|||
19663488|NCT03952650|42112121|FG001|Overall Study|TRAVEL|4|||
19663489|NCT03952650|42112122|FG002|Overall Study|TRAVEL|0|||
19663490|NCT03952650|42112123|FG003|Overall Study|TRAVEL|4|||
19663491|NCT03952650|42112124|FG004|Overall Study|TRAVEL|0|||
19663492|NCT03952650|42112125|FG005|Overall Study|TRAVEL|3|||
19663493|NCT03952650|42112126|FG006|Overall Study|TRAVEL|2|||
19663494|NCT03952650|42112120|FG000|Overall Study|Withdrawal by Subject|0|||
19663495|NCT03952650|42112121|FG001|Overall Study|Withdrawal by Subject|2|||
19663496|NCT03952650|42112122|FG002|Overall Study|Withdrawal by Subject|0|||
19663497|NCT03952650|42112123|FG003|Overall Study|Withdrawal by Subject|3|||
19663498|NCT03952650|42112124|FG004|Overall Study|Withdrawal by Subject|0|||
19663499|NCT03952650|42112125|FG005|Overall Study|Withdrawal by Subject|1|||
19663500|NCT03952650|42112126|FG006|Overall Study|Withdrawal by Subject|1|||
19663501|NCT03952650|42112120|FG000|Overall Study|Lost to Follow-up|0|||
19663502|NCT03952650|42112121|FG001|Overall Study|Lost to Follow-up|1|||
19663503|NCT03952650|42112122|FG002|Overall Study|Lost to Follow-up|0|||
19663504|NCT03952650|42112123|FG003|Overall Study|Lost to Follow-up|0|||
19663505|NCT03952650|42112124|FG004|Overall Study|Lost to Follow-up|0|||
19663506|NCT03952650|42112125|FG005|Overall Study|Lost to Follow-up|1|||
19663507|NCT03952650|42112126|FG006|Overall Study|Lost to Follow-up|1|||
19663508|NCT03952650|42112120|FG000|Overall Study|Received wrong vaccine and travelled|0|||
19663509|NCT03952650|42112121|FG001|Overall Study|Received wrong vaccine and travelled|0|||
19663510|NCT03952650|42112122|FG002|Overall Study|Received wrong vaccine and travelled|0|||
19663511|NCT03952650|42112123|FG003|Overall Study|Received wrong vaccine and travelled|0|||
19663512|NCT03952650|42112124|FG004|Overall Study|Received wrong vaccine and travelled|0|||
19663513|NCT03952650|42112125|FG005|Overall Study|Received wrong vaccine and travelled|1|||
19663514|NCT03952650|42112126|FG006|Overall Study|Received wrong vaccine and travelled|0|||
19663515|NCT03952650|42112120|FG000|Overall Study|Unable to make study visit|0|||
19663516|NCT03952650|42112121|FG001|Overall Study|Unable to make study visit|0|||
19663517|NCT03952650|42112122|FG002|Overall Study|Unable to make study visit|0|||
19663518|NCT03952650|42112123|FG003|Overall Study|Unable to make study visit|0|||
19663519|NCT03952650|42112124|FG004|Overall Study|Unable to make study visit|0|||
19663520|NCT03952650|42112125|FG005|Overall Study|Unable to make study visit|1|||
19663521|NCT03952650|42112126|FG006|Overall Study|Unable to make study visit|0|||
19663522|NCT00691301|42112142|FG000|Overall Study|Adverse Event|10|||
19663523|NCT00691301|42112142|FG000|Overall Study|Death|2|||
19663524|NCT00691301|42112142|FG000|Overall Study|Lack of Efficacy|32|||
19663525|NCT00691301|42112142|FG000|Overall Study|Withdrawal by Subject|4|||
19663526|NCT00691301|42112142|FG000|Overall Study|Concurrent illness|2|||
19663527|NCT00691301|42112142|FG000|Overall Study|other reason|3|||
19663528|NCT00691301|42112142|FG000|Overall Study|Did not initiate study treatment|1|||
19663529|NCT00927563|42112152|FG000|Overall Study|Lost to Follow-up|1|||
19663530|NCT00927563|42112152|FG000|Overall Study|Withdrawal by Subject|1|||
19663531|NCT00653159|42112167|FG000|Overall Study|Adverse Event|4|||
19663532|NCT00653159|42112168|FG001|Overall Study|Adverse Event|1|||
19663533|NCT00653159|42112167|FG000|Overall Study|Lost to Follow-up|1|||
19663534|NCT00653159|42112168|FG001|Overall Study|Lost to Follow-up|2|||
19663535|NCT00117637|42112176|FG000|First Intervention (Period 1)|Adverse Event|11|||
19663536|NCT00117637|42112177|FG001|First Intervention (Period 1)|Adverse Event|16|||
19663537|NCT00117637|42112176|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
19663538|NCT00117637|42112177|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
19663539|NCT00117637|42112176|FG000|First Intervention (Period 1)|Protocol Violation|1|||
19663540|NCT00117637|42112177|FG001|First Intervention (Period 1)|Protocol Violation|0|||
19663541|NCT00117637|42112176|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
19663542|NCT00117637|42112177|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
19663543|NCT00117637|42112176|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
19663544|NCT00117637|42112177|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
19663545|NCT00117637|42112176|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
19663546|NCT00117637|42112177|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
19663547|NCT00117637|42112176|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
19663548|NCT00117637|42112177|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
19663549|NCT00117637|42112176|FG000|First Intervention (Period 1)|reason not reported|0|||
19663550|NCT00117637|42112177|FG001|First Intervention (Period 1)|reason not reported|1|||
19663551|NCT00117637|42112176|FG000|Second Intervention (Period 2)|Adverse Event|0|||
19663552|NCT00117637|42112177|FG001|Second Intervention (Period 2)|Adverse Event|9|||
19663553|NCT00117637|42112176|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
19663554|NCT00117637|42112177|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
19663555|NCT00117637|42112176|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
19663556|NCT00117637|42112177|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
19663557|NCT00117637|42112176|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
19663558|NCT00117637|42112177|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
19755730|NCT00706030|42206102|FG001|Overall Study|No treatment received|0|||
19755731|NCT00706030|42206103|FG002|Overall Study|No treatment received|0|||
19755732|NCT00706030|42206104|FG003|Overall Study|No treatment received|1|||
19663559|NCT00117637|42112176|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
19755733|NCT00706030|42206101|FG000|Overall Study|Death|0|||
19755734|NCT00706030|42206102|FG001|Overall Study|Death|0|||
19663560|NCT00117637|42112177|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
19663561|NCT00117637|42112176|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
19663562|NCT00117637|42112177|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
19663563|NCT00117637|42112176|FG000|Second Intervention (Period 2)|reason not reported|1|||
19663564|NCT00117637|42112177|FG001|Second Intervention (Period 2)|reason not reported|0|||
19663565|NCT00690755|42112197|FG000|Overall Study|Physician Decision|2|||
19663566|NCT00690755|42112198|FG001|Overall Study|Physician Decision|0|||
19663567|NCT00690755|42112199|FG002|Overall Study|Physician Decision|46|||
19663568|NCT00690755|42112200|FG003|Overall Study|Physician Decision|5|||
19663569|NCT00690755|42112201|FG004|Overall Study|Physician Decision|0|||
19663570|NCT00690755|42112202|FG005|Overall Study|Physician Decision|4|||
19663571|NCT00690755|42112203|FG006|Overall Study|Physician Decision|0|||
19663572|NCT00549302|42112221|FG000|Double-Blind|Death|2|||
19663573|NCT00549302|42112222|FG001|Double-Blind|Death|9|||
19663574|NCT00549302|42112223|FG002|Double-Blind|Death|0|||
19663575|NCT00549302|42112221|FG000|Double-Blind|Adverse Event|3|||
19663576|NCT00549302|42112222|FG001|Double-Blind|Adverse Event|16|||
19663577|NCT00549302|42112223|FG002|Double-Blind|Adverse Event|0|||
19663578|NCT00549302|42112221|FG000|Double-Blind|Withdrawal by Subject|3|||
19663579|NCT00549302|42112222|FG001|Double-Blind|Withdrawal by Subject|8|||
19663580|NCT00549302|42112223|FG002|Double-Blind|Withdrawal by Subject|0|||
19663581|NCT00549302|42112221|FG000|Double-Blind|Investigator Decision|1|||
19663582|NCT00549302|42112222|FG001|Double-Blind|Investigator Decision|5|||
19755735|NCT00706030|42206103|FG002|Overall Study|Death|1|||
19755736|NCT00706030|42206104|FG003|Overall Study|Death|0|||
19755737|NCT03488251|42206119|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
19755738|NCT03488251|42206120|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
19755739|NCT03488251|42206121|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
19663583|NCT00549302|42112223|FG002|Double-Blind|Investigator Decision|0|||
19663584|NCT00549302|42112221|FG000|Double-Blind|Sponsor Decision|0|||
19663585|NCT00549302|42112222|FG001|Double-Blind|Sponsor Decision|1|||
19663586|NCT00549302|42112223|FG002|Double-Blind|Sponsor Decision|0|||
19663587|NCT00549302|42112221|FG000|Double-Blind|Lost to Follow-up|1|||
19663588|NCT00549302|42112222|FG001|Double-Blind|Lost to Follow-up|2|||
19663589|NCT00549302|42112223|FG002|Double-Blind|Lost to Follow-up|0|||
19663590|NCT00549302|42112221|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
19663591|NCT00549302|42112222|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
19663592|NCT00549302|42112223|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
19663593|NCT00549302|42112221|FG000|Double-Blind|New condition or starts new therapy|0|||
19663594|NCT00549302|42112222|FG001|Double-Blind|New condition or starts new therapy|2|||
19663595|NCT00549302|42112223|FG002|Double-Blind|New condition or starts new therapy|0|||
19663596|NCT00549302|42112221|FG000|Open-Label|Adverse Event|0|||
19663597|NCT00549302|42112222|FG001|Open-Label|Adverse Event|0|||
19663598|NCT00549302|42112223|FG002|Open-Label|Adverse Event|11|||
19663599|NCT00549302|42112221|FG000|Open-Label|Death|0|||
19663600|NCT00549302|42112222|FG001|Open-Label|Death|0|||
19663601|NCT00549302|42112223|FG002|Open-Label|Death|40|||
19663602|NCT00549302|42112221|FG000|Open-Label|Investigator Decision|0|||
19663603|NCT00549302|42112222|FG001|Open-Label|Investigator Decision|0|||
19663604|NCT00549302|42112223|FG002|Open-Label|Investigator Decision|5|||
19663605|NCT00549302|42112221|FG000|Open-Label|Lost to Follow-up|0|||
19663606|NCT00549302|42112222|FG001|Open-Label|Lost to Follow-up|0|||
19663607|NCT00549302|42112223|FG002|Open-Label|Lost to Follow-up|2|||
19663608|NCT00549302|42112221|FG000|Open-Label|Other|0|||
19663609|NCT00549302|42112222|FG001|Open-Label|Other|0|||
19663610|NCT00549302|42112223|FG002|Open-Label|Other|3|||
19663611|NCT00549302|42112221|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
19663612|NCT00549302|42112222|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
19663613|NCT00549302|42112223|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
19755740|NCT03488251|42206122|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
19755741|NCT03488251|42206119|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
19663614|NCT00549302|42112221|FG000|Open-Label|Withdrawal by Subject|0|||
19663615|NCT00549302|42112222|FG001|Open-Label|Withdrawal by Subject|0|||
19663616|NCT00549302|42112223|FG002|Open-Label|Withdrawal by Subject|6|||
19663617|NCT00117325|42112233|FG000|Overall Study|Adverse Event|3|||
19663618|NCT00117325|42112234|FG001|Overall Study|Adverse Event|3|||
19663619|NCT00117325|42112233|FG000|Overall Study|Lost to Follow-up|1|||
19663620|NCT00117325|42112234|FG001|Overall Study|Lost to Follow-up|1|||
19663621|NCT00117325|42112233|FG000|Overall Study|Protocol Violation|2|||
19663622|NCT00117325|42112234|FG001|Overall Study|Protocol Violation|3|||
19663623|NCT00117325|42112233|FG000|Overall Study|Withdrawal by Subject|3|||
19663624|NCT00117325|42112234|FG001|Overall Study|Withdrawal by Subject|2|||
19755742|NCT03488251|42206120|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
19663625|NCT00117325|42112233|FG000|Overall Study|Lack of Efficacy|1|||
19663626|NCT00117325|42112234|FG001|Overall Study|Lack of Efficacy|0|||
19663627|NCT00117325|42112233|FG000|Overall Study|Use of prohibited medicine|1|||
19663628|NCT00117325|42112234|FG001|Overall Study|Use of prohibited medicine|2|||
19663629|NCT00117325|42112233|FG000|Overall Study|Early termination|1|||
19663630|NCT00117325|42112234|FG001|Overall Study|Early termination|1|||
19663631|NCT00117325|42112233|FG000|Overall Study|Admisnitrative|1|||
19663632|NCT00117325|42112234|FG001|Overall Study|Admisnitrative|0|||
19663633|NCT00108433|42112243|FG000|Overall Study|Lack of Efficacy|1|||
19663634|NCT00108433|42112244|FG001|Overall Study|Lack of Efficacy|2|||
19663635|NCT00108433|42112243|FG000|Overall Study|Death|3|||
19663636|NCT00108433|42112244|FG001|Overall Study|Death|0|||
19663637|NCT00108433|42112243|FG000|Overall Study|Adverse Event|3|||
19663638|NCT00108433|42112244|FG001|Overall Study|Adverse Event|1|||
19663639|NCT00108433|42112243|FG000|Overall Study|Other|14|||
19663640|NCT00108433|42112244|FG001|Overall Study|Other|14|||
19663641|NCT00116779|42112252|FG000|Overall Study|Adverse Event|4|||
19663642|NCT00116779|42112253|FG001|Overall Study|Adverse Event|2|||
19663643|NCT00116779|42112252|FG000|Overall Study|Protocol Violation|1|||
19663644|NCT00116779|42112253|FG001|Overall Study|Protocol Violation|4|||
19663645|NCT00116779|42112252|FG000|Overall Study|Withdrawal by Subject|4|||
19663646|NCT00116779|42112253|FG001|Overall Study|Withdrawal by Subject|1|||
19663647|NCT00116779|42112252|FG000|Overall Study|Inadequate testosterone suppression|7|||
19663648|NCT00116779|42112253|FG001|Overall Study|Inadequate testosterone suppression|9|||
19663649|NCT00116779|42112252|FG000|Overall Study|Physician Decision|3|||
19663650|NCT00116779|42112253|FG001|Overall Study|Physician Decision|1|||
19663651|NCT00116779|42112252|FG000|Overall Study|Elevated PSA levels|2|||
19663652|NCT00116779|42112253|FG001|Overall Study|Elevated PSA levels|2|||
19663653|NCT03943290|42112268|FG000|Overall Study|Sponsor Terminated Study|6|||
19755743|NCT03488251|42206121|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
19755744|NCT03488251|42206122|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
19755745|NCT03488251|42206119|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
19663654|NCT03943290|42112269|FG001|Overall Study|Sponsor Terminated Study|1|||
19663655|NCT03943290|42112270|FG002|Overall Study|Sponsor Terminated Study|11|||
19663656|NCT03943290|42112271|FG003|Overall Study|Sponsor Terminated Study|6|||
19663657|NCT03943290|42112272|FG004|Overall Study|Sponsor Terminated Study|7|||
19663658|NCT03943290|42112273|FG005|Overall Study|Sponsor Terminated Study|6|||
19663659|NCT03943290|42112274|FG006|Overall Study|Sponsor Terminated Study|6|||
19663660|NCT03943290|42112275|FG007|Overall Study|Sponsor Terminated Study|7|||
19663661|NCT03943290|42112276|FG008|Overall Study|Sponsor Terminated Study|8|||
19663662|NCT03943290|42112268|FG000|Overall Study|Lost to Follow-up|1|||
19663663|NCT03943290|42112269|FG001|Overall Study|Lost to Follow-up|0|||
19663664|NCT03943290|42112270|FG002|Overall Study|Lost to Follow-up|1|||
19663665|NCT03943290|42112271|FG003|Overall Study|Lost to Follow-up|0|||
19663666|NCT03943290|42112272|FG004|Overall Study|Lost to Follow-up|0|||
19663667|NCT03943290|42112273|FG005|Overall Study|Lost to Follow-up|0|||
19663668|NCT03943290|42112274|FG006|Overall Study|Lost to Follow-up|0|||
19663669|NCT03943290|42112275|FG007|Overall Study|Lost to Follow-up|1|||
19663670|NCT03943290|42112276|FG008|Overall Study|Lost to Follow-up|0|||
19663671|NCT03943290|42112268|FG000|Overall Study|Withdrawal by Subject|0|||
19663672|NCT03943290|42112269|FG001|Overall Study|Withdrawal by Subject|0|||
19663673|NCT03943290|42112270|FG002|Overall Study|Withdrawal by Subject|1|||
19663674|NCT03943290|42112271|FG003|Overall Study|Withdrawal by Subject|0|||
19663675|NCT03943290|42112272|FG004|Overall Study|Withdrawal by Subject|0|||
19663676|NCT03943290|42112273|FG005|Overall Study|Withdrawal by Subject|0|||
19663677|NCT03943290|42112274|FG006|Overall Study|Withdrawal by Subject|0|||
19663678|NCT03943290|42112275|FG007|Overall Study|Withdrawal by Subject|0|||
19663679|NCT03943290|42112276|FG008|Overall Study|Withdrawal by Subject|0|||
19663680|NCT00108355|42112311|FG000|Overall Study|Peritonitis at index paracentesis|1|||
19663681|NCT00108355|42112312|FG001|Overall Study|Peritonitis at index paracentesis|1|||
19663682|NCT00108355|42112311|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
19663683|NCT00108355|42112312|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
19663684|NCT00094861|42112333|FG000|Overall Study|Adverse Event|5|||
19663685|NCT00094861|42112334|FG001|Overall Study|Adverse Event|2|||
19663686|NCT00094861|42112333|FG000|Overall Study|Withdrawal by Subject|5|||
19755746|NCT03488251|42206120|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
19755747|NCT03488251|42206121|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
19755748|NCT03488251|42206122|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
19755749|NCT03488251|42206119|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
19755750|NCT03488251|42206120|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
19755751|NCT03488251|42206121|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
19663687|NCT00094861|42112334|FG001|Overall Study|Withdrawal by Subject|3|||
19663688|NCT00094861|42112333|FG000|Overall Study|Physician Decision|1|||
19663689|NCT00094861|42112334|FG001|Overall Study|Physician Decision|1|||
19663690|NCT00094861|42112333|FG000|Overall Study|Lost to Follow-up|0|||
19663691|NCT00094861|42112334|FG001|Overall Study|Lost to Follow-up|1|||
19663692|NCT00094861|42112333|FG000|Overall Study|Death|4|||
19663693|NCT00094861|42112334|FG001|Overall Study|Death|2|||
19663694|NCT00094861|42112333|FG000|Overall Study|Other|3|||
19663695|NCT00094861|42112334|FG001|Overall Study|Other|0|||
19663696|NCT00426556|42112344|FG000|Phase I - Core Phase|Disease Progression|0|||
19663697|NCT00426556|42112345|FG001|Phase I - Core Phase|Disease Progression|6|||
19663698|NCT00426556|42112346|FG002|Phase I - Core Phase|Disease Progression|2|||
19663699|NCT00426556|42112347|FG003|Phase I - Core Phase|Disease Progression|0|||
19663700|NCT00426556|42112344|FG000|Phase I - Core Phase|Adverse Event|1|||
19663701|NCT00426556|42112345|FG001|Phase I - Core Phase|Adverse Event|3|||
19663702|NCT00426556|42112346|FG002|Phase I - Core Phase|Adverse Event|1|||
19663703|NCT00426556|42112347|FG003|Phase I - Core Phase|Adverse Event|0|||
19663704|NCT00426556|42112344|FG000|Phase I - Core Phase|Death|0|||
19663705|NCT00426556|42112345|FG001|Phase I - Core Phase|Death|1|||
19663706|NCT00426556|42112346|FG002|Phase I - Core Phase|Death|0|||
19663707|NCT00426556|42112347|FG003|Phase I - Core Phase|Death|0|||
19663708|NCT00426556|42112344|FG000|Phase I - Extension Phase|Adverse Event|0|||
19663709|NCT00426556|42112345|FG001|Phase I - Extension Phase|Adverse Event|1|||
19663710|NCT00426556|42112346|FG002|Phase I - Extension Phase|Adverse Event|1|||
19663711|NCT00426556|42112347|FG003|Phase I - Extension Phase|Adverse Event|0|||
19663712|NCT00426556|42112344|FG000|Phase I - Extension Phase|Disease Progression|5|||
19663713|NCT00426556|42112345|FG001|Phase I - Extension Phase|Disease Progression|5|||
19663714|NCT00426556|42112346|FG002|Phase I - Extension Phase|Disease Progression|6|||
19663715|NCT00426556|42112347|FG003|Phase I - Extension Phase|Disease Progression|0|||
19663716|NCT00426556|42112344|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
19663717|NCT00426556|42112345|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
19663718|NCT00426556|42112346|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
19663719|NCT00426556|42112347|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
19663720|NCT00426556|42112344|FG000|Phase II - Core Phase|Disease Progression|0|||
19663721|NCT00426556|42112345|FG001|Phase II - Core Phase|Disease Progression|0|||
19663722|NCT00426556|42112346|FG002|Phase II - Core Phase|Disease Progression|0|||
19663723|NCT00426556|42112347|FG003|Phase II - Core Phase|Disease Progression|16|||
19663724|NCT00426556|42112344|FG000|Phase II - Core Phase|Adverse Event|0|||
19663725|NCT00426556|42112345|FG001|Phase II - Core Phase|Adverse Event|0|||
19663726|NCT00426556|42112346|FG002|Phase II - Core Phase|Adverse Event|0|||
19663727|NCT00426556|42112347|FG003|Phase II - Core Phase|Adverse Event|8|||
19755752|NCT03488251|42206122|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
19755753|NCT03488251|42206119|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
19755754|NCT03488251|42206120|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
19388758|NCT02544633|41632286|FG001|Treatment Period|Lack of Efficacy|11|||
19663728|NCT00426556|42112344|FG000|Phase II - Extension Phase|Disease Progression|0|||
19663729|NCT00426556|42112345|FG001|Phase II - Extension Phase|Disease Progression|0|||
19663730|NCT00426556|42112346|FG002|Phase II - Extension Phase|Disease Progression|0|||
19663731|NCT00426556|42112347|FG003|Phase II - Extension Phase|Disease Progression|21|||
19663732|NCT00426556|42112344|FG000|Phase II - Extension Phase|Adverse Event|0|||
19663733|NCT00426556|42112345|FG001|Phase II - Extension Phase|Adverse Event|0|||
19663734|NCT00426556|42112346|FG002|Phase II - Extension Phase|Adverse Event|0|||
19663735|NCT00426556|42112347|FG003|Phase II - Extension Phase|Adverse Event|2|||
19663736|NCT00107653|42112359|FG000|Overall Study|Adverse Event|24|||
19663737|NCT00107653|42112360|FG001|Overall Study|Adverse Event|43|||
19663738|NCT00107653|42112359|FG000|Overall Study|Insufficient Therapeutic Response|25|||
19663739|NCT00107653|42112360|FG001|Overall Study|Insufficient Therapeutic Response|11|||
19663740|NCT00107653|42112359|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
19663741|NCT00107653|42112360|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19663742|NCT00107653|42112359|FG000|Overall Study|Protocol Violation|1|||
19663743|NCT00107653|42112360|FG001|Overall Study|Protocol Violation|0|||
19755755|NCT03488251|42206121|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
19755756|NCT03488251|42206122|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
19755757|NCT03158688|42206135|FG000|Overall Study|Continuing in study|107|||
19755758|NCT03158688|42206136|FG001|Overall Study|Continuing in study|233|||
19755759|NCT03158688|42206135|FG000|Overall Study|Death|36|||
19755760|NCT03158688|42206136|FG001|Overall Study|Death|59|||
19755761|NCT03158688|42206135|FG000|Overall Study|Withdrawal by Subject|9|||
19755762|NCT03158688|42206136|FG001|Overall Study|Withdrawal by Subject|14|||
19755763|NCT03158688|42206135|FG000|Overall Study|Decision by sponsor|2|||
19755764|NCT03158688|42206136|FG001|Overall Study|Decision by sponsor|3|||
19755765|NCT03158688|42206135|FG000|Overall Study|Lost to Follow-up|0|||
19755766|NCT03158688|42206136|FG001|Overall Study|Lost to Follow-up|3|||
19755767|NCT02727322|42206144|FG000|Overall Study|Withdrawal by Subject|1|||
19755768|NCT02727322|42206145|FG001|Overall Study|Withdrawal by Subject|1|||
19755769|NCT02727322|42206144|FG000|Overall Study|Protocol Violation|1|||
19755770|NCT02727322|42206145|FG001|Overall Study|Protocol Violation|0|||
19755771|NCT03431857|42206155|FG000|Overall Study|Death|6|||
19755772|NCT03431857|42206155|FG000|Overall Study|Lost to Follow-up|41|||
19755773|NCT03431857|42206155|FG000|Overall Study|Adverse Event|6|||
19755774|NCT03431857|42206155|FG000|Overall Study|Withdrawal by Subject|1|||
19755775|NCT03487549|42206161|FG000|Overall Study|Protocol Violation|0|||
19755776|NCT03487549|42206162|FG001|Overall Study|Protocol Violation|1|||
19755777|NCT03487549|42206161|FG000|Overall Study|Lost to Follow-up|2|||
19755778|NCT03487549|42206162|FG001|Overall Study|Lost to Follow-up|1|||
19755779|NCT03487549|42206161|FG000|Overall Study|Withdrawal by Subject|2|||
19755780|NCT03487549|42206162|FG001|Overall Study|Withdrawal by Subject|0|||
19755781|NCT03464383|42206171|FG000|Overall Study|Lost to Follow-up|1|||
19755782|NCT03464383|42206172|FG001|Overall Study|Lost to Follow-up|0|||
19755783|NCT03464383|42206173|FG002|Overall Study|Lost to Follow-up|0|||
19755784|NCT03464383|42206171|FG000|Overall Study|Withdrawal by Subject|0|||
19755785|NCT03464383|42206172|FG001|Overall Study|Withdrawal by Subject|1|||
19755786|NCT03464383|42206173|FG002|Overall Study|Withdrawal by Subject|0|||
19755787|NCT01444092|42206182|FG000|Overall Study|Adverse Event|8|||
19755788|NCT01444092|42206182|FG000|Overall Study|Protocol Violation|1|||
19755789|NCT01444092|42206182|FG000|Overall Study|Withdrawal by Subject|1|||
19755790|NCT01444092|42206182|FG000|Overall Study|Other Eligibility criteria|7|||
19755791|NCT01265784|42206189|FG000|Overall Study|Lost to Follow-up|5|||
19755792|NCT01265784|42206190|FG001|Overall Study|Lost to Follow-up|3|||
19755793|NCT01265784|42206191|FG002|Overall Study|Lost to Follow-up|2|||
19755794|NCT01265784|42206189|FG000|Overall Study|Withdrawal by Subject|0|||
19755795|NCT01265784|42206190|FG001|Overall Study|Withdrawal by Subject|5|||
19755796|NCT01265784|42206191|FG002|Overall Study|Withdrawal by Subject|0|||
19755797|NCT01265784|42206189|FG000|Overall Study|Physician Decision|1|||
19755798|NCT01265784|42206190|FG001|Overall Study|Physician Decision|0|||
19755799|NCT01265784|42206191|FG002|Overall Study|Physician Decision|1|||
19755800|NCT01265784|42206189|FG000|Overall Study|Adverse Event|1|||
19755801|NCT01265784|42206190|FG001|Overall Study|Adverse Event|0|||
19755802|NCT01265784|42206191|FG002|Overall Study|Adverse Event|0|||
19755803|NCT01265784|42206189|FG000|Overall Study|Death|3|||
19755804|NCT01265784|42206190|FG001|Overall Study|Death|0|||
19755805|NCT01265784|42206191|FG002|Overall Study|Death|0|||
19755806|NCT01265784|42206189|FG000|Overall Study|Protocol Violation|2|||
19755807|NCT01265784|42206190|FG001|Overall Study|Protocol Violation|0|||
19755808|NCT01265784|42206191|FG002|Overall Study|Protocol Violation|0|||
19755809|NCT01265784|42206189|FG000|Overall Study|Incorrectly Randomized|0|||
19755810|NCT01265784|42206190|FG001|Overall Study|Incorrectly Randomized|0|||
19755811|NCT01265784|42206191|FG002|Overall Study|Incorrectly Randomized|1|||
19755812|NCT03156504|42206199|FG000|Overall Study|Withdrawal by Subject|1|||
19755813|NCT03159468|42206209|FG000|Overall Study|Withdrawal by Subject|0|||
19755814|NCT03159468|42206210|FG001|Overall Study|Withdrawal by Subject|0|||
19755815|NCT03159468|42206211|FG002|Overall Study|Withdrawal by Subject|3|||
19755816|NCT03159468|42206212|FG003|Overall Study|Withdrawal by Subject|0|||
19755817|NCT03159468|42206213|FG004|Overall Study|Withdrawal by Subject|0|||
19755818|NCT03159468|42206214|FG005|Overall Study|Withdrawal by Subject|0|||
19755819|NCT03430063|42206231|FG000|Overall Study|Adverse Event|0|||
19755820|NCT03430063|42206232|FG001|Overall Study|Adverse Event|1|||
19755821|NCT03430063|42206233|FG002|Overall Study|Adverse Event|0|||
19755822|NCT03430063|42206231|FG000|Overall Study|Death|3|||
19755823|NCT03430063|42206232|FG001|Overall Study|Death|2|||
19755824|NCT03430063|42206233|FG002|Overall Study|Death|3|||
19755825|NCT03430063|42206231|FG000|Overall Study|Lost to Follow-up|0|||
19755826|NCT03430063|42206232|FG001|Overall Study|Lost to Follow-up|1|||
19755827|NCT03430063|42206233|FG002|Overall Study|Lost to Follow-up|0|||
19755828|NCT03430063|42206231|FG000|Overall Study|Withdrawal by Subject|0|||
19755829|NCT03430063|42206232|FG001|Overall Study|Withdrawal by Subject|0|||
19755830|NCT03430063|42206233|FG002|Overall Study|Withdrawal by Subject|1|||
19755831|NCT03430063|42206231|FG000|Overall Study|Withdrawal of consent|3|||
19755832|NCT03430063|42206232|FG001|Overall Study|Withdrawal of consent|1|||
19755833|NCT03430063|42206233|FG002|Overall Study|Withdrawal of consent|2|||
19755834|NCT03430063|42206231|FG000|Overall Study|Progressive disease|1|||
19755835|NCT03430063|42206232|FG001|Overall Study|Progressive disease|2|||
19755836|NCT03430063|42206233|FG002|Overall Study|Progressive disease|1|||
19755837|NCT03430063|42206231|FG000|Overall Study|Other un-specified|1|||
19755838|NCT03430063|42206232|FG001|Overall Study|Other un-specified|1|||
19755839|NCT03430063|42206233|FG002|Overall Study|Other un-specified|0|||
19755840|NCT03430063|42206231|FG000|Overall Study|Randomized, but never treated|0|||
19755841|NCT03430063|42206232|FG001|Overall Study|Randomized, but never treated|0|||
19755842|NCT03430063|42206233|FG002|Overall Study|Randomized, but never treated|1|||
19755843|NCT03158220|42206244|FG000|Overall Study|Screen Failure|0|||
19755844|NCT03158220|42206245|FG001|Overall Study|Screen Failure|1|||
19755845|NCT03158220|42206244|FG000|Overall Study|Withdrawal by Subject|8|||
19755846|NCT03158220|42206245|FG001|Overall Study|Withdrawal by Subject|9|||
19755847|NCT03158220|42206244|FG000|Overall Study|Status unknown|0|||
19755848|NCT03158220|42206245|FG001|Overall Study|Status unknown|1|||
19755849|NCT03158220|42206244|FG000|Overall Study|Lost to Follow-up|8|||
19755850|NCT03158220|42206245|FG001|Overall Study|Lost to Follow-up|5|||
19755851|NCT03158220|42206244|FG000|Overall Study|Physician Decision|1|||
19755852|NCT03158220|42206245|FG001|Overall Study|Physician Decision|0|||
19755853|NCT03156270|42206251|FG000|Overall Study|Failed pre-treatment screening|1|||
19755854|NCT03156270|42206251|FG000|Overall Study|Lost to Follow-up|1|||
19755855|NCT03429049|42206259|FG000|Overall Study|Adverse Event|2|||
19755856|NCT03429049|42206260|FG001|Overall Study|Adverse Event|3|||
19755857|NCT03429049|42206259|FG000|Overall Study|Death|0|||
19755858|NCT03429049|42206260|FG001|Overall Study|Death|1|||
19755859|NCT03429049|42206259|FG000|Overall Study|Lack of Efficacy|4|||
19755860|NCT03429049|42206260|FG001|Overall Study|Lack of Efficacy|2|||
19755861|NCT03429049|42206259|FG000|Overall Study|Lost to Follow-up|9|||
19755862|NCT03429049|42206260|FG001|Overall Study|Lost to Follow-up|8|||
19755863|NCT03429049|42206259|FG000|Overall Study|Physician Decision|1|||
19755864|NCT03429049|42206260|FG001|Overall Study|Physician Decision|0|||
19755865|NCT03429049|42206259|FG000|Overall Study|Protocol Violation|3|||
19755866|NCT03429049|42206260|FG001|Overall Study|Protocol Violation|0|||
19755867|NCT03429049|42206259|FG000|Overall Study|Sponsor Decision|2|||
19755868|NCT03429049|42206260|FG001|Overall Study|Sponsor Decision|0|||
19755869|NCT03429049|42206259|FG000|Overall Study|Withdrawal by Subject|4|||
19755870|NCT03429049|42206260|FG001|Overall Study|Withdrawal by Subject|20|||
19755871|NCT03429049|42206259|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
19755872|NCT03429049|42206260|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
19755873|NCT03428815|42206268|FG000|Overall Study|Lost to Follow-up|2|||
19755874|NCT03428815|42206269|FG001|Overall Study|Lost to Follow-up|2|||
19755875|NCT03428815|42206268|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
19755876|NCT03428815|42206269|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
19755877|NCT03428815|42206268|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
19755878|NCT03428815|42206269|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
19755879|NCT03155724|42206275|FG000|Overall Study|Death|3|||
19755880|NCT03155724|42206275|FG000|Overall Study|Physician Decision|1|||
19755881|NCT03155724|42206275|FG000|Overall Study|Study closure|7|||
19755882|NCT03426787|42206279|FG000|Overall Study|Withdrawal by Subject|6|||
19755883|NCT03426787|42206279|FG000|Overall Study|Lost to Follow-up|7|||
19755884|NCT03426787|42206279|FG000|Overall Study|Unrelated to intervention death|1|||
19755885|NCT03426631|42206289|FG000|Overall Study|Lost to Follow-up|0|||
19755886|NCT03426631|42206290|FG001|Overall Study|Lost to Follow-up|1|||
19755887|NCT03484429|42206298|FG000|Overall Study|Withdrawal by Subject|1|||
19755888|NCT03484429|42206299|FG001|Overall Study|Withdrawal by Subject|0|||
19755889|NCT03484429|42206298|FG000|Overall Study|Adverse Event|2|||
19755890|NCT03484429|42206299|FG001|Overall Study|Adverse Event|0|||
19755891|NCT03484273|42206305|FG000|Overall Study|Equipment Malfunction|1|||
19755892|NCT03484273|42206305|FG000|Overall Study|Data excluded from analysis|1|||
19755893|NCT02724592|42206319|FG000|Overall Study|Lost to Follow-up|4|||
19755894|NCT02724592|42206320|FG001|Overall Study|Lost to Follow-up|1|||
19755895|NCT03154476|42206328|FG000|Overall Study|Lost to Follow-up|4|||
19755896|NCT03154476|42206329|FG001|Overall Study|Lost to Follow-up|4|||
19755897|NCT02726074|42206335|FG000|Overall Study|Withdrawal by Subject|4|||
19755898|NCT02726074|42206335|FG000|Overall Study|Adverse Event|14|||
19755899|NCT02726074|42206335|FG000|Overall Study|Protocol Violation|3|||
19755900|NCT02726074|42206335|FG000|Overall Study|Lost to Follow-up|2|||
19755901|NCT02726074|42206335|FG000|Overall Study|Others|3|||
19755902|NCT03483961|42206349|FG000|Overall Study|Lost to Follow-up|7|||
19755903|NCT03483961|42206350|FG001|Overall Study|Lost to Follow-up|6|||
19755904|NCT03483961|42206351|FG002|Overall Study|Lost to Follow-up|6|||
19602605|NCT00995774|42051262|FG000|Training Period 2|Withdrawal by Subject|2|||
19602606|NCT00995774|42051263|FG001|Training Period 2|Withdrawal by Subject|0|||
19755905|NCT03483961|42206352|FG003|Overall Study|Lost to Follow-up|6|||
19755906|NCT03483961|42206353|FG004|Overall Study|Lost to Follow-up|6|||
19755907|NCT03483961|42206354|FG005|Overall Study|Lost to Follow-up|4|||
19755908|NCT03483961|42206355|FG006|Overall Study|Lost to Follow-up|4|||
19755909|NCT03483961|42206356|FG007|Overall Study|Lost to Follow-up|11|||
19755910|NCT03483961|42206357|FG008|Overall Study|Lost to Follow-up|1|||
19755911|NCT03483961|42206358|FG009|Overall Study|Lost to Follow-up|0|||
19755912|NCT03483961|42206349|FG000|Overall Study|Withdrawal by Subject|3|||
19755913|NCT03483961|42206350|FG001|Overall Study|Withdrawal by Subject|4|||
19755914|NCT03483961|42206351|FG002|Overall Study|Withdrawal by Subject|5|||
19755915|NCT03483961|42206352|FG003|Overall Study|Withdrawal by Subject|3|||
19755916|NCT03483961|42206353|FG004|Overall Study|Withdrawal by Subject|4|||
19755917|NCT03483961|42206354|FG005|Overall Study|Withdrawal by Subject|2|||
19755918|NCT03483961|42206355|FG006|Overall Study|Withdrawal by Subject|1|||
19755919|NCT03483961|42206356|FG007|Overall Study|Withdrawal by Subject|2|||
19755920|NCT03483961|42206357|FG008|Overall Study|Withdrawal by Subject|1|||
19755921|NCT03483961|42206358|FG009|Overall Study|Withdrawal by Subject|0|||
19755922|NCT03483961|42206349|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
19755923|NCT03483961|42206350|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755924|NCT03483961|42206351|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755925|NCT03483961|42206352|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755926|NCT03483961|42206353|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755927|NCT03483961|42206354|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755928|NCT03483961|42206355|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755929|NCT03483961|42206356|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755930|NCT03483961|42206357|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755931|NCT03483961|42206358|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
19755932|NCT03483961|42206349|FG000|Overall Study|Adverse Event|0|||
19755933|NCT03483961|42206350|FG001|Overall Study|Adverse Event|0|||
19755934|NCT03483961|42206351|FG002|Overall Study|Adverse Event|1|||
19755935|NCT03483961|42206352|FG003|Overall Study|Adverse Event|0|||
19755936|NCT03483961|42206353|FG004|Overall Study|Adverse Event|0|||
19755937|NCT03483961|42206354|FG005|Overall Study|Adverse Event|0|||
19755938|NCT03483961|42206355|FG006|Overall Study|Adverse Event|0|||
19755939|NCT03483961|42206356|FG007|Overall Study|Adverse Event|0|||
19755940|NCT03483961|42206357|FG008|Overall Study|Adverse Event|0|||
19755941|NCT03483961|42206358|FG009|Overall Study|Adverse Event|0|||
19755942|NCT03482635|42206383|FG000|Overall Study|Lack of Efficacy|0|||
19755943|NCT03482635|42206384|FG001|Overall Study|Lack of Efficacy|0|||
19755944|NCT03482635|42206385|FG002|Overall Study|Lack of Efficacy|1|||
19755945|NCT03482635|42206386|FG003|Overall Study|Lack of Efficacy|3|||
19755946|NCT03482635|42206383|FG000|Overall Study|Adverse Event|2|||
19755947|NCT03482635|42206384|FG001|Overall Study|Adverse Event|2|||
19755948|NCT03482635|42206385|FG002|Overall Study|Adverse Event|0|||
19755949|NCT03482635|42206386|FG003|Overall Study|Adverse Event|3|||
19755950|NCT03482635|42206383|FG000|Overall Study|Withdrawal by Subject|2|||
19755951|NCT03482635|42206384|FG001|Overall Study|Withdrawal by Subject|1|||
19755952|NCT03482635|42206385|FG002|Overall Study|Withdrawal by Subject|0|||
19755953|NCT03482635|42206386|FG003|Overall Study|Withdrawal by Subject|1|||
19755954|NCT03482635|42206383|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
19755955|NCT03482635|42206384|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
19755956|NCT03482635|42206385|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
19755957|NCT03482635|42206386|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
19755958|NCT03482635|42206383|FG000|Overall Study|Not treated|0|||
19755959|NCT03482635|42206384|FG001|Overall Study|Not treated|0|||
19755960|NCT03482635|42206385|FG002|Overall Study|Not treated|0|||
19755961|NCT03482635|42206386|FG003|Overall Study|Not treated|1|||
19755962|NCT03712787|42206400|FG000|Overall Study|Adverse Event|2|||
19755963|NCT03712787|42206401|FG001|Overall Study|Adverse Event|3|||
19755964|NCT03712787|42206402|FG002|Overall Study|Adverse Event|0|||
19755965|NCT03712787|42206403|FG003|Overall Study|Adverse Event|4|||
19755966|NCT03712787|42206400|FG000|Overall Study|Withdrawal by Subject|4|||
19755967|NCT03712787|42206401|FG001|Overall Study|Withdrawal by Subject|14|||
19755968|NCT03712787|42206402|FG002|Overall Study|Withdrawal by Subject|12|||
19755969|NCT03712787|42206403|FG003|Overall Study|Withdrawal by Subject|8|||
19755970|NCT03712787|42206400|FG000|Overall Study|Lost to Follow-up|1|||
19755971|NCT03712787|42206401|FG001|Overall Study|Lost to Follow-up|1|||
19755972|NCT03712787|42206402|FG002|Overall Study|Lost to Follow-up|2|||
19755973|NCT03712787|42206403|FG003|Overall Study|Lost to Follow-up|1|||
19755974|NCT03712787|42206400|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
19755975|NCT03712787|42206401|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
19755976|NCT03712787|42206402|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
19755977|NCT03712787|42206403|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
19755978|NCT03712787|42206400|FG000|Overall Study|COVID-19 Infection|0|||
19755979|NCT03712787|42206401|FG001|Overall Study|COVID-19 Infection|1|||
19755980|NCT03712787|42206402|FG002|Overall Study|COVID-19 Infection|0|||
19755981|NCT03712787|42206403|FG003|Overall Study|COVID-19 Infection|0|||
19755982|NCT03712787|42206400|FG000|Overall Study|Other, Not Specified|79|||
19755983|NCT03712787|42206401|FG001|Overall Study|Other, Not Specified|77|||
19755984|NCT03712787|42206402|FG002|Overall Study|Other, Not Specified|74|||
19755985|NCT03712787|42206403|FG003|Overall Study|Other, Not Specified|78|||
19755986|NCT03048422|42206435|FG000|Overall Study|Death|1|||
19755987|NCT03048422|42206436|FG001|Overall Study|Death|0|||
19755988|NCT03048422|42206437|FG002|Overall Study|Death|0|||
19755989|NCT03048422|42206435|FG000|Overall Study|Lost to Follow-up|5|||
19755990|NCT03048422|42206436|FG001|Overall Study|Lost to Follow-up|0|||
19755991|NCT03048422|42206437|FG002|Overall Study|Lost to Follow-up|1|||
19755992|NCT03048422|42206435|FG000|Overall Study|Withdrawal by Subject|5|||
19755993|NCT03048422|42206436|FG001|Overall Study|Withdrawal by Subject|7|||
19755994|NCT03048422|42206437|FG002|Overall Study|Withdrawal by Subject|4|||
19755995|NCT03048422|42206435|FG000|Overall Study|Moved|3|||
19755996|NCT03048422|42206436|FG001|Overall Study|Moved|2|||
19755997|NCT03048422|42206437|FG002|Overall Study|Moved|2|||
19755998|NCT03048422|42206435|FG000|Overall Study|Noncompliant with Study Requirements|2|||
19755999|NCT03048422|42206436|FG001|Overall Study|Noncompliant with Study Requirements|1|||
19756000|NCT03048422|42206437|FG002|Overall Study|Noncompliant with Study Requirements|2|||
19756001|NCT03048422|42206435|FG000|Overall Study|Not Able to Get to Clinic|1|||
19756002|NCT03048422|42206436|FG001|Overall Study|Not Able to Get to Clinic|0|||
19756003|NCT03048422|42206437|FG002|Overall Study|Not Able to Get to Clinic|0|||
19756004|NCT04664855|42206457|FG000|Overall Study|Withdrawal by Subject|0|||
19756005|NCT04664855|42206458|FG001|Overall Study|Withdrawal by Subject|2|||
19756006|NCT04664153|42206468|FG000|Overall Study|Lack of Efficacy|0|||
19756007|NCT04664153|42206469|FG001|Overall Study|Lack of Efficacy|0|||
19756008|NCT04664153|42206470|FG002|Overall Study|Lack of Efficacy|1|||
19756009|NCT04664153|42206471|FG003|Overall Study|Lack of Efficacy|0|||
19756010|NCT04664153|42206468|FG000|Overall Study|Physician Decision|0|||
19756011|NCT04664153|42206469|FG001|Overall Study|Physician Decision|0|||
19756012|NCT04664153|42206470|FG002|Overall Study|Physician Decision|1|||
19756013|NCT04664153|42206471|FG003|Overall Study|Physician Decision|0|||
19756014|NCT04664153|42206468|FG000|Overall Study|Withdrawal by Subject|3|||
19756015|NCT04664153|42206469|FG001|Overall Study|Withdrawal by Subject|2|||
19756016|NCT04664153|42206470|FG002|Overall Study|Withdrawal by Subject|1|||
19756017|NCT04664153|42206471|FG003|Overall Study|Withdrawal by Subject|2|||
19756018|NCT04664153|42206468|FG000|Overall Study|Other|0|||
19756019|NCT04664153|42206469|FG001|Overall Study|Other|1|||
19756020|NCT04664153|42206470|FG002|Overall Study|Other|0|||
19756021|NCT04664153|42206471|FG003|Overall Study|Other|0|||
19756022|NCT04664153|42206468|FG000|Overall Study|Adverse Event|4|||
19756023|NCT04664153|42206469|FG001|Overall Study|Adverse Event|0|||
19756024|NCT04664153|42206470|FG002|Overall Study|Adverse Event|1|||
19756025|NCT04664153|42206471|FG003|Overall Study|Adverse Event|0|||
19756026|NCT04663295|42206483|FG000|Run-in Period|Withdrawal by Subject|3|||
19756027|NCT04663295|42206483|FG000|Overall Study Period|Pregnancy|1|||
19756028|NCT04663295|42206483|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
19756029|NCT04228445|42206494|FG000|Overall Study|Lost to Follow-up|1|||
19756030|NCT04228445|42206495|FG001|Overall Study|Lost to Follow-up|1|||
19756031|NCT04228445|42206494|FG000|Overall Study|Physician Decision|1|||
19756032|NCT04228445|42206495|FG001|Overall Study|Physician Decision|2|||
19756033|NCT04228445|42206494|FG000|Overall Study|Withdrawal by Subject|0|||
19756034|NCT04228445|42206495|FG001|Overall Study|Withdrawal by Subject|1|||
19756035|NCT04228445|42206494|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
19756036|NCT04228445|42206495|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
19756037|NCT04641299|42206507|FG000|Overall Study|Adverse Event|0|||
19756038|NCT04641299|42206508|FG001|Overall Study|Adverse Event|0|||
19756039|NCT04641299|42206509|FG002|Overall Study|Adverse Event|2|||
19756040|NCT04641299|42206510|FG003|Overall Study|Adverse Event|0|||
19756041|NCT04641299|42206507|FG000|Overall Study|Lost to Follow-up|0|||
19663744|NCT00107653|42112359|FG000|Overall Study|Withdrawal by Subject|12|||
19756042|NCT04641299|42206508|FG001|Overall Study|Lost to Follow-up|1|||
19756043|NCT04641299|42206509|FG002|Overall Study|Lost to Follow-up|0|||
19756044|NCT04641299|42206510|FG003|Overall Study|Lost to Follow-up|0|||
19756045|NCT04641299|42206507|FG000|Overall Study|Withdrawal by Subject|1|||
19756046|NCT04641299|42206508|FG001|Overall Study|Withdrawal by Subject|0|||
19756047|NCT04641299|42206509|FG002|Overall Study|Withdrawal by Subject|0|||
19756048|NCT04641299|42206510|FG003|Overall Study|Withdrawal by Subject|0|||
19756049|NCT04641299|42206507|FG000|Overall Study|Reason not given|1|||
19756050|NCT04641299|42206508|FG001|Overall Study|Reason not given|0|||
19756051|NCT04641299|42206509|FG002|Overall Study|Reason not given|0|||
19756052|NCT04641299|42206510|FG003|Overall Study|Reason not given|0|||
19756053|NCT03703817|42206526|FG000|Overall Study|Not meeting eligibility criteria|7|||
19756054|NCT03703817|42206527|FG001|Overall Study|Not meeting eligibility criteria|4|||
19756055|NCT03698591|42206535|FG000|Overall Study|Withdrawal by Subject|2|||
19756056|NCT03698591|42206536|FG001|Overall Study|Withdrawal by Subject|2|||
19756057|NCT03698591|42206535|FG000|Overall Study|Failed drug screen|1|||
19756058|NCT03698591|42206536|FG001|Overall Study|Failed drug screen|1|||
19756059|NCT03698591|42206535|FG000|Overall Study|Failed health screen|0|||
19756060|NCT03698591|42206536|FG001|Overall Study|Failed health screen|1|||
19756061|NCT03698591|42206535|FG000|Overall Study|Ineligible for financial compensation|1|||
19756062|NCT03698591|42206536|FG001|Overall Study|Ineligible for financial compensation|0|||
19756063|NCT03698591|42206535|FG000|Overall Study|Equipment Error|1|||
19756064|NCT03698591|42206536|FG001|Overall Study|Equipment Error|0|||
19756065|NCT03698591|42206535|FG000|Overall Study|Could not establish TMS dosage|0|||
19756066|NCT03698591|42206536|FG001|Overall Study|Could not establish TMS dosage|1|||
19756067|NCT04606199|42206542|FG000|Overall Study|Withdrawal by Subject|2|||
19756068|NCT05085665|42206548|FG000|Overall Study|Physician Decision|2|||
19756069|NCT05017493|42206554|FG000|Overall Study|Withdrawal by Subject|26|||
19756070|NCT05017493|42206555|FG001|Overall Study|Withdrawal by Subject|0|||
19756071|NCT05017493|42206554|FG000|Overall Study|Physician Decision|15|||
19756072|NCT05017493|42206555|FG001|Overall Study|Physician Decision|0|||
19756073|NCT05017493|42206554|FG000|Overall Study|Protocol Violation|81|||
19756074|NCT05017493|42206555|FG001|Overall Study|Protocol Violation|0|||
19756075|NCT04599803|42206561|FG000|Overall Study|Withdrawal by Subject|5|||
19756076|NCT04599803|42206561|FG000|Overall Study|Lost to Follow-up|26|||
19756077|NCT05002985|42206565|FG000|Overall Study|Withdrawal by Subject|1|||
19756078|NCT04580303|42206571|FG000|Overall Study|Adverse Event|0|||
19756079|NCT04580303|42206572|FG001|Overall Study|Adverse Event|1|||
19756080|NCT04580303|42206573|FG002|Overall Study|Adverse Event|0|||
19756081|NCT04580303|42206574|FG003|Overall Study|Adverse Event|0|||
19756082|NCT04580303|42206571|FG000|Overall Study|Withdrawal by Subject|0|||
19756083|NCT04580303|42206572|FG001|Overall Study|Withdrawal by Subject|0|||
19756084|NCT04580303|42206573|FG002|Overall Study|Withdrawal by Subject|1|||
19756085|NCT04580303|42206574|FG003|Overall Study|Withdrawal by Subject|0|||
19756086|NCT04577183|42206584|FG000|Overall Study|Death|1|||
19756087|NCT04577183|42206584|FG000|Overall Study|Withdrawal by Subject|3|||
19756088|NCT04577183|42206584|FG000|Overall Study|Early termination|2|||
19756089|NCT03704051|42206588|FG000|Overall Study|Withdrawal by Subject|4|||
19756090|NCT03704051|42206589|FG001|Overall Study|Withdrawal by Subject|0|||
19756091|NCT04574999|42206599|FG000|Overall Study|Adverse Event|1|||
19756092|NCT04574999|42206600|FG001|Overall Study|Adverse Event|0|||
19756093|NCT04574999|42206599|FG000|Overall Study|Lack of Efficacy|2|||
19756094|NCT04574999|42206600|FG001|Overall Study|Lack of Efficacy|3|||
19756095|NCT04574999|42206599|FG000|Overall Study|Protocol Violation|1|||
19756096|NCT04574999|42206600|FG001|Overall Study|Protocol Violation|0|||
19756097|NCT04574999|42206599|FG000|Overall Study|Withdrawal by Subject|2|||
19756098|NCT04574999|42206600|FG001|Overall Study|Withdrawal by Subject|2|||
19756099|NCT04574999|42206599|FG000|Overall Study|Lost to Follow-up|1|||
19756100|NCT04574999|42206600|FG001|Overall Study|Lost to Follow-up|0|||
19756101|NCT04574999|42206599|FG000|Overall Study|Personal problems|1|||
19756102|NCT04574999|42206600|FG001|Overall Study|Personal problems|0|||
19756103|NCT04574999|42206599|FG000|Overall Study|Previous planned surgery|1|||
19756104|NCT04574999|42206600|FG001|Overall Study|Previous planned surgery|0|||
19756105|NCT04565249|42206610|FG000|Overall Study|Death|0|||
19756106|NCT04565249|42206611|FG001|Overall Study|Death|0|||
19756107|NCT04565249|42206612|FG002|Overall Study|Death|0|||
19756108|NCT04565249|42206613|FG003|Overall Study|Death|1|||
19756109|NCT04942925|42206625|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
19756110|NCT04942925|42206626|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
19756111|NCT04942925|42206625|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
19756112|NCT04942925|42206626|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
19663745|NCT00107653|42112360|FG001|Overall Study|Withdrawal by Subject|13|||
19663746|NCT00107653|42112359|FG000|Overall Study|Lost to Follow-up|13|||
19663747|NCT00107653|42112360|FG001|Overall Study|Lost to Follow-up|5|||
19663748|NCT00107653|42112359|FG000|Overall Study|Administrative Reasons|3|||
19663749|NCT00107653|42112360|FG001|Overall Study|Administrative Reasons|3|||
19663750|NCT03950856|42112370|FG000|Overall Study|Death|1|||
19663751|NCT03950856|42112371|FG001|Overall Study|Death|2|||
19663752|NCT03950856|42112372|FG002|Overall Study|Death|0|||
19663753|NCT03950856|42112373|FG003|Overall Study|Death|0|||
19663754|NCT03950856|42112370|FG000|Overall Study|Lost to Follow-up|5|||
19663755|NCT03950856|42112371|FG001|Overall Study|Lost to Follow-up|6|||
19663756|NCT03950856|42112372|FG002|Overall Study|Lost to Follow-up|8|||
19663757|NCT03950856|42112373|FG003|Overall Study|Lost to Follow-up|2|||
19756113|NCT04854707|42206638|FG000|Overall Study|Lack of Efficacy|78|||
19756114|NCT04854707|42206639|FG001|Overall Study|Lack of Efficacy|59|||
19756115|NCT04854707|42206640|FG002|Overall Study|Lack of Efficacy|30|||
19756116|NCT04557371|42206655|FG000|Overall Study|Covid-19-related|0|||
19756117|NCT04557371|42206656|FG001|Overall Study|Covid-19-related|1|||
19663758|NCT03950856|42112370|FG000|Overall Study|Protocol Violation|2|||
19663759|NCT03950856|42112371|FG001|Overall Study|Protocol Violation|0|||
19663760|NCT03950856|42112372|FG002|Overall Study|Protocol Violation|0|||
19663761|NCT03950856|42112373|FG003|Overall Study|Protocol Violation|1|||
19663762|NCT03950856|42112370|FG000|Overall Study|Withdrawal by Subject|4|||
19663763|NCT03950856|42112371|FG001|Overall Study|Withdrawal by Subject|1|||
19663764|NCT03950856|42112372|FG002|Overall Study|Withdrawal by Subject|3|||
19663765|NCT03950856|42112373|FG003|Overall Study|Withdrawal by Subject|1|||
19663766|NCT03950856|42112370|FG000|Overall Study|Unable to phone|7|||
19663767|NCT03950856|42112371|FG001|Overall Study|Unable to phone|6|||
19663768|NCT03950856|42112372|FG002|Overall Study|Unable to phone|7|||
19663769|NCT03950856|42112373|FG003|Overall Study|Unable to phone|2|||
19663770|NCT00433654|42112387|FG000|Overall Study|Death|4|||
19663771|NCT00433654|42112388|FG001|Overall Study|Death|0|||
19663772|NCT00433654|42112387|FG000|Overall Study|Missed visit|6|||
19663773|NCT00433654|42112388|FG001|Overall Study|Missed visit|3|||
19663774|NCT00433654|42112387|FG000|Overall Study|Subject not yet due for visit|4|||
19663775|NCT00433654|42112388|FG001|Overall Study|Subject not yet due for visit|0|||
19663776|NCT00433654|42112387|FG000|Overall Study|Withdrawal by Subject|1|||
19602607|NCT00765388|42051269|FG000|Period 1|Lack of Efficacy|1|||
19602608|NCT00765388|42051270|FG001|Period 1|Lack of Efficacy|2|||
19602609|NCT00765388|42051269|FG000|Period 1|Lost to Follow-up|0|||
19602610|NCT00765388|42051270|FG001|Period 1|Lost to Follow-up|1|||
19663777|NCT00433654|42112388|FG001|Overall Study|Withdrawal by Subject|2|||
19663778|NCT00689351|42112402|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
19663779|NCT00689351|42112403|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
19663780|NCT00689351|42112402|FG000|Infant Series of Dosing|Adverse Event|1|||
19663781|NCT00689351|42112403|FG001|Infant Series of Dosing|Adverse Event|0|||
19663782|NCT00689351|42112402|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
19663783|NCT00689351|42112403|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
19663784|NCT00689351|42112402|FG000|After Infant Series|Parent/legal guardian request|1|||
19663785|NCT00689351|42112403|FG001|After Infant Series|Parent/legal guardian request|0|||
19663786|NCT03950622|42112415|FG000|Overall Study|Withdrawal by Subject|1|||
19663787|NCT03950622|42112416|FG001|Overall Study|Withdrawal by Subject|0|||
19663788|NCT03950622|42112415|FG000|Overall Study|Protocol Deviation|0|||
19663789|NCT03950622|42112416|FG001|Overall Study|Protocol Deviation|1|||
19663790|NCT03950622|42112415|FG000|Overall Study|Physician Decision|1|||
19663791|NCT03950622|42112416|FG001|Overall Study|Physician Decision|0|||
19663792|NCT03950622|42112415|FG000|Overall Study|Lost to Follow-up|5|||
19663793|NCT03950622|42112416|FG001|Overall Study|Lost to Follow-up|5|||
19663794|NCT03950622|42112415|FG000|Overall Study|Death|1|||
19663795|NCT03950622|42112416|FG001|Overall Study|Death|1|||
19663796|NCT03937908|42112422|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
19663797|NCT03937908|42112423|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
19663798|NCT00689273|42112431|FG000|Overall Study|Adverse Event|3|||
19663799|NCT00689273|42112432|FG001|Overall Study|Adverse Event|1|||
19663800|NCT00689273|42112431|FG000|Overall Study|Lack of Efficacy|3|||
19663801|NCT00689273|42112432|FG001|Overall Study|Lack of Efficacy|0|||
19663802|NCT00689273|42112431|FG000|Overall Study|Lost to Follow-up|0|||
19663803|NCT00689273|42112432|FG001|Overall Study|Lost to Follow-up|2|||
19663804|NCT00689273|42112431|FG000|Overall Study|Other|6|||
19663805|NCT00689273|42112432|FG001|Overall Study|Other|2|||
19663806|NCT00689273|42112431|FG000|Overall Study|Randomized but not Treated|1|||
19663807|NCT00689273|42112432|FG001|Overall Study|Randomized but not Treated|0|||
19663808|NCT00553358|42112441|FG000|Overall Study|Randomized but did not receive treatment|3|||
19663809|NCT00553358|42112442|FG001|Overall Study|Randomized but did not receive treatment|3|||
19663810|NCT00553358|42112443|FG002|Overall Study|Randomized but did not receive treatment|1|||
19663811|NCT00553358|42112441|FG000|Overall Study|Lost to Follow-up|22|||
19663812|NCT00553358|42112442|FG001|Overall Study|Lost to Follow-up|26|||
19663813|NCT00553358|42112443|FG002|Overall Study|Lost to Follow-up|18|||
19663814|NCT00553358|42112441|FG000|Overall Study|Withdrew completely|23|||
19663815|NCT00553358|42112442|FG001|Overall Study|Withdrew completely|33|||
19602611|NCT00765388|42051269|FG000|Period 1|Herpes Zoster|0|||
19602612|NCT00765388|42051270|FG001|Period 1|Herpes Zoster|1|||
19602613|NCT00765388|42051269|FG000|Period 1|Hip operation|0|||
19602614|NCT00765388|42051270|FG001|Period 1|Hip operation|1|||
19602615|NCT00769132|42051285|FG000|Period 1|Adverse Event|1|||
19602616|NCT00769132|42051286|FG001|Period 1|Adverse Event|0|||
19663816|NCT00553358|42112443|FG002|Overall Study|Withdrew completely|34|||
19663817|NCT00553358|42112441|FG000|Overall Study|Died during clinical follow-up|25|||
19663818|NCT00553358|42112442|FG001|Overall Study|Died during clinical follow-up|29|||
19663819|NCT00553358|42112443|FG002|Overall Study|Died during clinical follow-up|32|||
19663820|NCT00553358|42112441|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
19663821|NCT00553358|42112442|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
19663822|NCT00553358|42112443|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
19663823|NCT00553358|42112441|FG000|Overall Study|Died after clinical follow-up ended|1|||
19663824|NCT00553358|42112442|FG001|Overall Study|Died after clinical follow-up ended|2|||
19602617|NCT00769132|42051287|FG002|Period 1|Adverse Event|0|||
19663825|NCT00553358|42112443|FG002|Overall Study|Died after clinical follow-up ended|0|||
19663826|NCT00553358|42112441|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
19663827|NCT00553358|42112442|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
19663828|NCT00553358|42112443|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
19663829|NCT00688259|42112459|FG000|Overall Study|Lost to Follow-up|2|||
19756118|NCT04557371|42206657|FG002|Overall Study|Covid-19-related|0|||
19663830|NCT00688259|42112460|FG001|Overall Study|Lost to Follow-up|4|||
19663831|NCT00688259|42112459|FG000|Overall Study|Physician Decision|1|||
19663832|NCT00688259|42112460|FG001|Overall Study|Physician Decision|0|||
19663833|NCT00688259|42112459|FG000|Overall Study|Withdrawal by Subject|2|||
19663834|NCT00688259|42112460|FG001|Overall Study|Withdrawal by Subject|0|||
19663835|NCT00688259|42112459|FG000|Overall Study|Declined Interview|2|||
19663836|NCT00688259|42112460|FG001|Overall Study|Declined Interview|3|||
19756119|NCT04557371|42206655|FG000|Overall Study|Withdrawal by Subject|0|||
19756120|NCT04557371|42206656|FG001|Overall Study|Withdrawal by Subject|1|||
19756121|NCT04557371|42206657|FG002|Overall Study|Withdrawal by Subject|0|||
19756122|NCT04557371|42206655|FG000|Overall Study|Adverse Event|1|||
19663837|NCT00688259|42112459|FG000|Overall Study|Hospitalized at Follow-up|0|||
19663838|NCT00688259|42112460|FG001|Overall Study|Hospitalized at Follow-up|1|||
19663839|NCT00688181|42112466|FG000|Overall Study|Lost to Follow-up|17|||
19663840|NCT00688181|42112466|FG000|Overall Study|Unknown Reason|4|||
19663841|NCT00688181|42112466|FG000|Overall Study|Non-clinical Reason|2|||
19663842|NCT00689117|42112485|FG000|Overall Study|Adverse Event|6|||
19663843|NCT00689117|42112486|FG001|Overall Study|Adverse Event|0|||
19663844|NCT00689117|42112487|FG002|Overall Study|Adverse Event|5|||
19663845|NCT00689117|42112488|FG003|Overall Study|Adverse Event|0|||
19663846|NCT00689117|42112485|FG000|Overall Study|Lost to Follow-up|26|||
19756123|NCT04557371|42206656|FG001|Overall Study|Adverse Event|0|||
19663847|NCT00689117|42112486|FG001|Overall Study|Lost to Follow-up|19|||
19663848|NCT00689117|42112487|FG002|Overall Study|Lost to Follow-up|17|||
19663849|NCT00689117|42112488|FG003|Overall Study|Lost to Follow-up|11|||
19663850|NCT00689117|42112485|FG000|Overall Study|Lack of Efficacy|1|||
19663851|NCT00689117|42112486|FG001|Overall Study|Lack of Efficacy|2|||
19663852|NCT00689117|42112487|FG002|Overall Study|Lack of Efficacy|2|||
19663853|NCT00689117|42112488|FG003|Overall Study|Lack of Efficacy|2|||
19663854|NCT00689117|42112485|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
19663855|NCT00689117|42112486|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
19663856|NCT00689117|42112487|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
19663857|NCT00689117|42112488|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
19663858|NCT00689117|42112485|FG000|Overall Study|Withdrawal by Subject|19|||
19663859|NCT00689117|42112486|FG001|Overall Study|Withdrawal by Subject|18|||
19663860|NCT00689117|42112487|FG002|Overall Study|Withdrawal by Subject|26|||
19663861|NCT00689117|42112488|FG003|Overall Study|Withdrawal by Subject|13|||
19663862|NCT00689117|42112485|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
19663863|NCT00689117|42112486|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
19663864|NCT00689117|42112487|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
19663865|NCT00689117|42112488|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
19663866|NCT00689117|42112485|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19663867|NCT00689117|42112486|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
19663868|NCT00689117|42112487|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19663869|NCT00689117|42112488|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19663870|NCT00689117|42112485|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
19663871|NCT00689117|42112486|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
19663872|NCT00689117|42112487|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
19663873|NCT00689117|42112488|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
19663874|NCT00689117|42112485|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
19663875|NCT00689117|42112486|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
19663876|NCT00689117|42112487|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
19663877|NCT00689117|42112488|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
19663878|NCT00689117|42112485|FG000|Overall Study|Use of Prohibitive Medication|2|||
19663879|NCT00689117|42112486|FG001|Overall Study|Use of Prohibitive Medication|1|||
19663880|NCT00689117|42112487|FG002|Overall Study|Use of Prohibitive Medication|3|||
19663881|NCT00689117|42112488|FG003|Overall Study|Use of Prohibitive Medication|0|||
19663882|NCT00689117|42112485|FG000|Overall Study|Pregnancy|0|||
19663883|NCT00689117|42112486|FG001|Overall Study|Pregnancy|2|||
19663884|NCT00689117|42112487|FG002|Overall Study|Pregnancy|0|||
19663885|NCT00689117|42112488|FG003|Overall Study|Pregnancy|2|||
19663886|NCT00689117|42112485|FG000|Overall Study|Incarceration|2|||
19663887|NCT00689117|42112486|FG001|Overall Study|Incarceration|0|||
19388759|NCT02544633|41632287|FG002|Treatment Period|Lack of Efficacy|5|||
19663888|NCT00689117|42112487|FG002|Overall Study|Incarceration|0|||
19663889|NCT00689117|42112488|FG003|Overall Study|Incarceration|0|||
19756124|NCT04557371|42206657|FG002|Overall Study|Adverse Event|0|||
19388760|NCT02544633|41632288|FG003|Treatment Period|Lack of Efficacy|5|||
19663890|NCT00689117|42112485|FG000|Overall Study|Fear of Birth Defects|0|||
19663891|NCT00689117|42112486|FG001|Overall Study|Fear of Birth Defects|0|||
19663892|NCT00689117|42112487|FG002|Overall Study|Fear of Birth Defects|1|||
19663893|NCT00689117|42112488|FG003|Overall Study|Fear of Birth Defects|0|||
19756125|NCT04821245|42206665|FG000|Overall Study|Withdrawal by Subject|3|||
19756126|NCT04821245|42206665|FG000|Overall Study|Physician Decision|1|||
19756127|NCT04821245|42206665|FG000|Overall Study|Protocol Violation|5|||
19756128|NCT04539275|42206673|FG000|Overall Study|Death|2|||
19756129|NCT04539275|42206674|FG001|Overall Study|Death|4|||
19756130|NCT04539275|42206673|FG000|Overall Study|Lost to Follow-up|1|||
19756131|NCT04539275|42206674|FG001|Overall Study|Lost to Follow-up|1|||
19756132|NCT04539275|42206673|FG000|Overall Study|Withdrawal by Subject|3|||
19756133|NCT04539275|42206674|FG001|Overall Study|Withdrawal by Subject|0|||
19756134|NCT04784897|42206683|FG000|Overall Study|Death|4|||
19756135|NCT04784897|42206684|FG001|Overall Study|Death|2|||
19756136|NCT04784897|42206685|FG002|Overall Study|Death|1|||
19756137|NCT04784897|42206683|FG000|Overall Study|Withdrawal by Subject|0|||
19756138|NCT04784897|42206684|FG001|Overall Study|Withdrawal by Subject|0|||
19756139|NCT04784897|42206685|FG002|Overall Study|Withdrawal by Subject|1|||
19756140|NCT02780804|42206699|FG000|Overall Study|Death|1|||
19756141|NCT02780804|42206700|FG001|Overall Study|Death|0|||
19756142|NCT02780804|42206701|FG002|Overall Study|Death|0|||
19756143|NCT02780804|42206699|FG000|Overall Study|Lack of Efficacy|5|||
19756144|NCT02780804|42206700|FG001|Overall Study|Lack of Efficacy|8|||
19756145|NCT02780804|42206701|FG002|Overall Study|Lack of Efficacy|4|||
19756146|NCT02780804|42206699|FG000|Overall Study|Physician Decision|0|||
19756147|NCT02780804|42206700|FG001|Overall Study|Physician Decision|0|||
19756148|NCT02780804|42206701|FG002|Overall Study|Physician Decision|2|||
19756149|NCT02780804|42206699|FG000|Overall Study|Withdrawal by Subject|0|||
19756150|NCT02780804|42206700|FG001|Overall Study|Withdrawal by Subject|1|||
19756151|NCT02780804|42206701|FG002|Overall Study|Withdrawal by Subject|0|||
19756152|NCT04537949|42206718|FG000|Overall Study|personal reasons not related to the IMP|1|||
19756153|NCT04537949|42206719|FG001|Overall Study|personal reasons not related to the IMP|0|||
19756154|NCT04537949|42206720|FG002|Overall Study|personal reasons not related to the IMP|0|||
19756155|NCT04537949|42206721|FG003|Overall Study|personal reasons not related to the IMP|0|||
19756156|NCT04537949|42206722|FG004|Overall Study|personal reasons not related to the IMP|0|||
19756157|NCT04537949|42206723|FG005|Overall Study|personal reasons not related to the IMP|0|||
19756158|NCT04537949|42206724|FG006|Overall Study|personal reasons not related to the IMP|0|||
19756159|NCT04537949|42206725|FG007|Overall Study|personal reasons not related to the IMP|0|||
19756160|NCT04532099|42206746|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
19756161|NCT04532099|42206747|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
19756162|NCT04532099|42206748|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
19756163|NCT03041792|42206762|FG000|Overall Study|Adverse Event|4|||
19756164|NCT03041792|42206763|FG001|Overall Study|Adverse Event|0|||
19756165|NCT03041792|42206762|FG000|Overall Study|Death in the family|0|||
19756166|NCT03041792|42206763|FG001|Overall Study|Death in the family|2|||
19756167|NCT03041792|42206762|FG000|Overall Study|Randomized but not treated|0|||
19756168|NCT03041792|42206763|FG001|Overall Study|Randomized but not treated|1|||
19756169|NCT04507763|42206769|FG000|Overall Study|Participants did not meet entrance criteria|201|||
19756170|NCT03045302|42206776|FG000|Overall Study|Pre-treatment adverse event|1|||
19756171|NCT00705484|42206782|FG000|Overall Study|Adverse Event|28|||
19756172|NCT00705484|42206783|FG001|Overall Study|Adverse Event|27|||
19756173|NCT00705484|42206782|FG000|Overall Study|Lost to Follow-up|169|||
19756174|NCT00705484|42206783|FG001|Overall Study|Lost to Follow-up|250|||
19756175|NCT00705484|42206782|FG000|Overall Study|Withdrawal by Subject|96|||
19756176|NCT00705484|42206783|FG001|Overall Study|Withdrawal by Subject|72|||
19756177|NCT00705484|42206782|FG000|Overall Study|Administrative|89|||
19756178|NCT00705484|42206783|FG001|Overall Study|Administrative|59|||
19756179|NCT04523831|42206793|FG000|Overall Study|Lost to Follow-up|15|||
19756180|NCT04523831|42206794|FG001|Overall Study|Lost to Follow-up|17|||
19756181|NCT04523831|42206793|FG000|Overall Study|Death|0|||
19756182|NCT04523831|42206794|FG001|Overall Study|Death|3|||
19756183|NCT04523831|42206793|FG000|Overall Study|Adverse Event|2|||
19663894|NCT00689117|42112485|FG000|Overall Study|Transportation|1|||
19663895|NCT00689117|42112486|FG001|Overall Study|Transportation|0|||
19663896|NCT00689117|42112487|FG002|Overall Study|Transportation|0|||
19756184|NCT04523831|42206794|FG001|Overall Study|Adverse Event|0|||
19756185|NCT04707664|42206805|FG000|Overall Study|Adverse Event|2|||
19756186|NCT04707664|42206806|FG001|Overall Study|Adverse Event|0|||
19756187|NCT04707664|42206805|FG000|Overall Study|Death|1|||
19756188|NCT04707664|42206806|FG001|Overall Study|Death|2|||
19756189|NCT04707664|42206805|FG000|Overall Study|Withdrawal by Subject|13|||
19756190|NCT04707664|42206806|FG001|Overall Study|Withdrawal by Subject|21|||
19756191|NCT04707664|42206805|FG000|Overall Study|Lost to Follow-up|11|||
19756192|NCT04707664|42206806|FG001|Overall Study|Lost to Follow-up|13|||
19756193|NCT04707664|42206805|FG000|Overall Study|Not treated|2|||
19756194|NCT04707664|42206806|FG001|Overall Study|Not treated|0|||
19756195|NCT01316276|42206812|FG000|Overall Study|Death|1|||
19663897|NCT00689117|42112488|FG003|Overall Study|Transportation|0|||
19663898|NCT00689117|42112485|FG000|Overall Study|Patient Withdrew from Study|0|||
19663899|NCT00689117|42112486|FG001|Overall Study|Patient Withdrew from Study|0|||
19663900|NCT00689117|42112487|FG002|Overall Study|Patient Withdrew from Study|0|||
19663901|NCT00689117|42112488|FG003|Overall Study|Patient Withdrew from Study|1|||
19663902|NCT00689117|42112485|FG000|Overall Study|Personal Reason|0|||
19663903|NCT00689117|42112486|FG001|Overall Study|Personal Reason|1|||
19663904|NCT00689117|42112487|FG002|Overall Study|Personal Reason|0|||
19663905|NCT00689117|42112488|FG003|Overall Study|Personal Reason|0|||
19663906|NCT00689117|42112485|FG000|Overall Study|Dispensing Error|0|||
19663907|NCT00689117|42112486|FG001|Overall Study|Dispensing Error|1|||
19663908|NCT00689117|42112487|FG002|Overall Study|Dispensing Error|0|||
19663909|NCT00689117|42112488|FG003|Overall Study|Dispensing Error|0|||
19663910|NCT00547248|42112502|FG000|Overall Study|Protocol Violation|0|||
19663911|NCT00547248|42112503|FG001|Overall Study|Protocol Violation|0|||
19663912|NCT00547248|42112504|FG002|Overall Study|Protocol Violation|1|||
19663913|NCT00547248|42112505|FG003|Overall Study|Protocol Violation|1|||
19663914|NCT00547248|42112502|FG000|Overall Study|Migrated/moved from study area|0|||
19663915|NCT00547248|42112503|FG001|Overall Study|Migrated/moved from study area|0|||
19663916|NCT00547248|42112504|FG002|Overall Study|Migrated/moved from study area|2|||
19663917|NCT00547248|42112505|FG003|Overall Study|Migrated/moved from study area|0|||
19663918|NCT00547248|42112502|FG000|Overall Study|Withdrawal by Subject|0|||
19663919|NCT00547248|42112503|FG001|Overall Study|Withdrawal by Subject|0|||
19663920|NCT00547248|42112504|FG002|Overall Study|Withdrawal by Subject|7|||
19663921|NCT00547248|42112505|FG003|Overall Study|Withdrawal by Subject|1|||
19663922|NCT00688103|42112520|FG000|Overall Study|Adverse Event|4|||
19663923|NCT00688103|42112521|FG001|Overall Study|Adverse Event|1|||
19663924|NCT00688103|42112520|FG000|Overall Study|Lack of Efficacy|11|||
19663925|NCT00688103|42112521|FG001|Overall Study|Lack of Efficacy|1|||
19663926|NCT00688103|42112520|FG000|Overall Study|Withdrawal by Subject|4|||
19663927|NCT00688103|42112521|FG001|Overall Study|Withdrawal by Subject|2|||
19663928|NCT00688103|42112520|FG000|Overall Study|complex reasons|11|||
19663929|NCT00688103|42112521|FG001|Overall Study|complex reasons|9|||
19663930|NCT00686855|42112531|FG000|Overall Study|Lost to Follow-up|1|||
19663931|NCT00686855|42112532|FG001|Overall Study|Lost to Follow-up|0|||
19663932|NCT00686855|42112531|FG000|Overall Study|Progressive GVHD|0|||
19663933|NCT00686855|42112532|FG001|Overall Study|Progressive GVHD|1|||
19663934|NCT00686777|42112538|FG000|Overall Study|Adverse Event|2|||
19663935|NCT00686777|42112538|FG000|Overall Study|Pregnancy|1|||
19663936|NCT00686777|42112538|FG000|Overall Study|Withdrawal by Subject|2|||
19663937|NCT00686777|42112538|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
19663938|NCT00686777|42112538|FG000|Overall Study|No Visit|1|||
19663939|NCT00686699|42112544|FG000|Treatment Period 1|Adverse Event|0|||
19663940|NCT00686699|42112545|FG001|Treatment Period 1|Adverse Event|2|||
19663941|NCT00106639|42112554|FG000|Overall Study|Adverse Event|3|||
19663942|NCT00106639|42112555|FG001|Overall Study|Adverse Event|4|||
19663943|NCT00106639|42112556|FG002|Overall Study|Adverse Event|1|||
19663944|NCT00106639|42112554|FG000|Overall Study|Protocol Violation|0|||
19663945|NCT00106639|42112555|FG001|Overall Study|Protocol Violation|1|||
19663946|NCT00106639|42112556|FG002|Overall Study|Protocol Violation|0|||
19663947|NCT00106639|42112554|FG000|Overall Study|Withdrawal by Subject|0|||
19663948|NCT00106639|42112555|FG001|Overall Study|Withdrawal by Subject|1|||
19663949|NCT00106639|42112556|FG002|Overall Study|Withdrawal by Subject|0|||
19663950|NCT00106639|42112554|FG000|Overall Study|Participant defaulted|0|||
19663951|NCT00106639|42112555|FG001|Overall Study|Participant defaulted|1|||
19663952|NCT00106639|42112556|FG002|Overall Study|Participant defaulted|1|||
19663953|NCT00106249|42112567|FG000|Overall Study|Lost to Follow-up|3|||
19663954|NCT00106249|42112568|FG001|Overall Study|Lost to Follow-up|2|||
19663955|NCT00105469|42112576|FG000|Overall Study|Adverse Event|9|||
19663956|NCT00105469|42112577|FG001|Overall Study|Adverse Event|8|||
19663957|NCT00105469|42112576|FG000|Overall Study|Protocol Violation|4|||
19663958|NCT00105469|42112577|FG001|Overall Study|Protocol Violation|0|||
19663959|NCT00105469|42112576|FG000|Overall Study|Withdrawal by Subject|2|||
19663960|NCT00105469|42112577|FG001|Overall Study|Withdrawal by Subject|3|||
19663961|NCT00105469|42112576|FG000|Overall Study|Lost to Follow-up|1|||
19663962|NCT00105469|42112577|FG001|Overall Study|Lost to Follow-up|0|||
19663963|NCT00105469|42112576|FG000|Overall Study|Lack of Efficacy|2|||
19663964|NCT00105469|42112577|FG001|Overall Study|Lack of Efficacy|0|||
19663965|NCT00105469|42112576|FG000|Overall Study|Other Reason|4|||
19663966|NCT00105469|42112577|FG001|Overall Study|Other Reason|0|||
19663967|NCT00105235|42112583|FG000|Overall Study|Death|4|||
19663968|NCT00105235|42112583|FG000|Overall Study|Physician Decision|1|||
19663969|NCT00105235|42112583|FG000|Overall Study|Withdrawal by Subject|2|||
19663970|NCT00547118|42112593|FG000|Overall Study|Did not qualify prior to starting drug|1|||
19663971|NCT00547118|42112594|FG001|Overall Study|Did not qualify prior to starting drug|1|||
19663972|NCT00547118|42112593|FG000|Overall Study|Study suspended|7|||
19663973|NCT00547118|42112594|FG001|Overall Study|Study suspended|8|||
19663974|NCT00502593|42112614|FG000|Overall Study|Withdrawn unspecified reason|1|||
19663975|NCT00502593|42112615|FG001|Overall Study|Withdrawn unspecified reason|1|||
19663976|NCT00502593|42112616|FG002|Overall Study|Withdrawn unspecified reason|3|||
19663977|NCT00502593|42112617|FG003|Overall Study|Withdrawn unspecified reason|1|||
19663978|NCT00502593|42112618|FG004|Overall Study|Withdrawn unspecified reason|2|||
19663979|NCT00502593|42112619|FG005|Overall Study|Withdrawn unspecified reason|0|||
19663980|NCT00502593|42112620|FG006|Overall Study|Withdrawn unspecified reason|2|||
19663981|NCT00502593|42112621|FG007|Overall Study|Withdrawn unspecified reason|0|||
19663982|NCT00502593|42112622|FG008|Overall Study|Withdrawn unspecified reason|0|||
19663983|NCT00502593|42112623|FG009|Overall Study|Withdrawn unspecified reason|0|||
19663984|NCT00502593|42112624|FG010|Overall Study|Withdrawn unspecified reason|0|||
19663985|NCT00502593|42112625|FG011|Overall Study|Withdrawn unspecified reason|0|||
19663986|NCT00502593|42112614|FG000|Overall Study|Withdrawal by Subject|0|||
19663987|NCT00502593|42112615|FG001|Overall Study|Withdrawal by Subject|0|||
19663988|NCT00502593|42112616|FG002|Overall Study|Withdrawal by Subject|6|||
19663989|NCT00502593|42112617|FG003|Overall Study|Withdrawal by Subject|2|||
19663990|NCT00502593|42112618|FG004|Overall Study|Withdrawal by Subject|2|||
19663991|NCT00502593|42112619|FG005|Overall Study|Withdrawal by Subject|0|||
19663992|NCT00502593|42112620|FG006|Overall Study|Withdrawal by Subject|3|||
19663993|NCT00502593|42112621|FG007|Overall Study|Withdrawal by Subject|0|||
19663994|NCT00502593|42112622|FG008|Overall Study|Withdrawal by Subject|3|||
19663995|NCT00502593|42112623|FG009|Overall Study|Withdrawal by Subject|0|||
19663996|NCT00502593|42112624|FG010|Overall Study|Withdrawal by Subject|1|||
19663997|NCT00502593|42112625|FG011|Overall Study|Withdrawal by Subject|0|||
19663998|NCT00502593|42112614|FG000|Overall Study|Lost to Follow-up|2|||
19663999|NCT00502593|42112615|FG001|Overall Study|Lost to Follow-up|1|||
19664000|NCT00502593|42112616|FG002|Overall Study|Lost to Follow-up|1|||
19664001|NCT00502593|42112617|FG003|Overall Study|Lost to Follow-up|1|||
19664002|NCT00502593|42112618|FG004|Overall Study|Lost to Follow-up|0|||
19664003|NCT00502593|42112619|FG005|Overall Study|Lost to Follow-up|0|||
19664004|NCT00502593|42112620|FG006|Overall Study|Lost to Follow-up|0|||
19664005|NCT00502593|42112621|FG007|Overall Study|Lost to Follow-up|0|||
19664006|NCT00502593|42112622|FG008|Overall Study|Lost to Follow-up|3|||
19664007|NCT00502593|42112623|FG009|Overall Study|Lost to Follow-up|0|||
19664008|NCT00502593|42112624|FG010|Overall Study|Lost to Follow-up|1|||
19664009|NCT00502593|42112625|FG011|Overall Study|Lost to Follow-up|0|||
19664010|NCT03946124|42112674|FG000|Overall Study|Withdrawal by Subject|19|||
19664011|NCT00686543|42112682|FG000|Overall Study|Adverse Event|9|||
19664012|NCT00686543|42112683|FG001|Overall Study|Adverse Event|1|||
19664013|NCT00686543|42112684|FG002|Overall Study|Adverse Event|3|||
19664014|NCT00686543|42112685|FG003|Overall Study|Adverse Event|2|||
19664015|NCT00686543|42112682|FG000|Overall Study|Withdrawal by Subject|2|||
19664016|NCT00686543|42112683|FG001|Overall Study|Withdrawal by Subject|0|||
19664017|NCT00686543|42112684|FG002|Overall Study|Withdrawal by Subject|0|||
19664018|NCT00686543|42112685|FG003|Overall Study|Withdrawal by Subject|0|||
19664019|NCT00686543|42112682|FG000|Overall Study|Protocol Violation|3|||
19664020|NCT00686543|42112683|FG001|Overall Study|Protocol Violation|0|||
19664021|NCT00686543|42112684|FG002|Overall Study|Protocol Violation|2|||
19664022|NCT00686543|42112685|FG003|Overall Study|Protocol Violation|1|||
19664023|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
19664024|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
19664025|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
19664026|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
19664027|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
19664028|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
19664029|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
19664030|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
19664031|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
19664032|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
19664033|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
19664034|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
19664035|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Death|0|||
19664036|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Death|1|||
19664037|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Death|0|||
19664038|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Death|0|||
19664039|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
19664040|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
19664041|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
19664042|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
19664043|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
19664044|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
19664045|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
19664046|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
19664047|NCT00545688|42112699|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
19664048|NCT00545688|42112700|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
19664049|NCT00545688|42112701|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
19664050|NCT00545688|42112702|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
19664051|NCT00545688|42112699|FG000|Adjuvant Treatment Period|Disease Progression|3|||
19664052|NCT00545688|42112700|FG001|Adjuvant Treatment Period|Disease Progression|3|||
19664053|NCT00545688|42112701|FG002|Adjuvant Treatment Period|Disease Progression|0|||
19664054|NCT00545688|42112702|FG003|Adjuvant Treatment Period|Disease Progression|7|||
19664055|NCT00545688|42112699|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
19664056|NCT00545688|42112700|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
19664057|NCT00545688|42112701|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
19664058|NCT00545688|42112702|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
19664059|NCT00545688|42112699|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
19664060|NCT00545688|42112700|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
19664061|NCT00545688|42112701|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
19664062|NCT00545688|42112702|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
19664063|NCT00545688|42112699|FG000|Adjuvant Treatment Period|Adverse Event|0|||
19664064|NCT00545688|42112700|FG001|Adjuvant Treatment Period|Adverse Event|3|||
19664065|NCT00545688|42112701|FG002|Adjuvant Treatment Period|Adverse Event|2|||
19664066|NCT00545688|42112702|FG003|Adjuvant Treatment Period|Adverse Event|2|||
19664067|NCT00545688|42112699|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
19664068|NCT00545688|42112700|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
19664069|NCT00545688|42112701|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
19664070|NCT00545688|42112702|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
19664071|NCT00545688|42112699|FG000|Follow-Up Period|Death|4|||
19664072|NCT00545688|42112700|FG001|Follow-Up Period|Death|2|||
19664073|NCT00545688|42112701|FG002|Follow-Up Period|Death|2|||
19664074|NCT00545688|42112702|FG003|Follow-Up Period|Death|6|||
19664075|NCT00545688|42112699|FG000|Follow-Up Period|Disease Progression|6|||
19664076|NCT00545688|42112700|FG001|Follow-Up Period|Disease Progression|5|||
19664077|NCT00545688|42112701|FG002|Follow-Up Period|Disease Progression|9|||
19664078|NCT00545688|42112702|FG003|Follow-Up Period|Disease Progression|9|||
19664079|NCT00545688|42112699|FG000|Follow-Up Period|Refused Treatment|6|||
19664080|NCT00545688|42112700|FG001|Follow-Up Period|Refused Treatment|2|||
19664081|NCT00545688|42112701|FG002|Follow-Up Period|Refused Treatment|0|||
19664082|NCT00545688|42112702|FG003|Follow-Up Period|Refused Treatment|2|||
19664083|NCT00545688|42112699|FG000|Follow-Up Period|Lost to Follow-up|3|||
19664084|NCT00545688|42112700|FG001|Follow-Up Period|Lost to Follow-up|3|||
19664085|NCT00545688|42112701|FG002|Follow-Up Period|Lost to Follow-up|3|||
19664086|NCT00545688|42112702|FG003|Follow-Up Period|Lost to Follow-up|1|||
19664087|NCT00545688|42112699|FG000|Follow-Up Period|Unspecified Reason|2|||
19664088|NCT00545688|42112700|FG001|Follow-Up Period|Unspecified Reason|5|||
19664089|NCT00545688|42112701|FG002|Follow-Up Period|Unspecified Reason|6|||
19664090|NCT00545688|42112702|FG003|Follow-Up Period|Unspecified Reason|8|||
19664091|NCT00545688|42112699|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
19664092|NCT00545688|42112700|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
19756196|NCT01316276|42206812|FG000|Overall Study|Adverse Event|19|||
19756197|NCT01316276|42206812|FG000|Overall Study|Withdrawal of consent|24|||
19756198|NCT01316276|42206812|FG000|Overall Study|Lost to Follow-up|1|||
19756199|NCT01316276|42206812|FG000|Overall Study|Other|22|||
19756200|NCT04668989|42206817|FG000|First Intervention|Covid-19 related self-isolation|0|||
19756201|NCT04668989|42206818|FG001|First Intervention|Covid-19 related self-isolation|1|||
19756202|NCT04668989|42206817|FG000|Second Intervention|Adverse Event|0|||
19756203|NCT04668989|42206818|FG001|Second Intervention|Adverse Event|1|||
19756204|NCT03700385|42206824|FG000|Overall Study|Lost to Follow-up|1|||
19756205|NCT04498403|42206830|FG000|Overall Study|Adverse Event|1|||
19756206|NCT04498403|42206831|FG001|Overall Study|Adverse Event|0|||
19756207|NCT04498403|42206830|FG000|Overall Study|Study Terminated By Sponsor|29|||
19756208|NCT04498403|42206831|FG001|Overall Study|Study Terminated By Sponsor|10|||
19756209|NCT04362137|42206839|FG000|Overall Study|Death|9|||
19756210|NCT04362137|42206840|FG001|Overall Study|Death|3|||
19756211|NCT04362137|42206839|FG000|Overall Study|Patient decision|6|||
19756212|NCT04362137|42206840|FG001|Overall Study|Patient decision|3|||
19756213|NCT04362137|42206839|FG000|Overall Study|Adverse Event|1|||
19756214|NCT04362137|42206840|FG001|Overall Study|Adverse Event|0|||
19756215|NCT04362137|42206839|FG000|Overall Study|Lost to Follow-up|1|||
19756216|NCT04362137|42206840|FG001|Overall Study|Lost to Follow-up|0|||
19756217|NCT04362137|42206839|FG000|Overall Study|Protocol deviation|1|||
19756218|NCT04362137|42206840|FG001|Overall Study|Protocol deviation|0|||
19756219|NCT05099380|42206848|FG000|Overall Study|Subject enrolled in error|1|||
19664093|NCT00545688|42112701|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
19756220|NCT05099380|42206849|FG001|Overall Study|Subject enrolled in error|0|||
19756221|NCT05099380|42206848|FG000|Overall Study|Study Procedure|1|||
19756222|NCT05099380|42206849|FG001|Overall Study|Study Procedure|0|||
19756223|NCT05099380|42206848|FG000|Overall Study|Protocol Violation|1|||
19756224|NCT05099380|42206849|FG001|Overall Study|Protocol Violation|0|||
19756225|NCT05099380|42206848|FG000|Overall Study|Adverse Event|1|||
19756226|NCT05099380|42206849|FG001|Overall Study|Adverse Event|1|||
19756227|NCT05099380|42206848|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
19756228|NCT05099380|42206849|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
19756229|NCT03614728|42206859|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
19756230|NCT03614728|42206860|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
19756231|NCT03614728|42206861|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
19756232|NCT03614728|42206862|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
19756233|NCT03614728|42206859|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
19756234|NCT03614728|42206860|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
19756235|NCT03614728|42206861|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
19756236|NCT03614728|42206862|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
19756237|NCT03154086|42206885|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756238|NCT03154086|42206886|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756239|NCT03154086|42206887|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756240|NCT03154086|42206888|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
19756241|NCT03154086|42206889|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756242|NCT03154086|42206890|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756243|NCT03154086|42206891|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756244|NCT03154086|42206892|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756245|NCT03154086|42206893|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756246|NCT03154086|42206894|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756247|NCT03154086|42206895|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19664094|NCT00545688|42112702|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
19664095|NCT00502203|42112715|FG000|Overall Study|Inevaluable|1|||
19664096|NCT00546078|42112721|FG000|Overall Study|Lost to Follow-up|1|||
19664097|NCT00546078|42112722|FG001|Overall Study|Lost to Follow-up|3|||
19664098|NCT00546078|42112721|FG000|Overall Study|Withdrawal by Subject|2|||
19664099|NCT00546078|42112722|FG001|Overall Study|Withdrawal by Subject|3|||
19664100|NCT00546078|42112721|FG000|Overall Study|Other reason|1|||
19664101|NCT00546078|42112722|FG001|Overall Study|Other reason|1|||
19664102|NCT00546000|42112728|FG000|Overall Study|Adverse Event|1|||
19664103|NCT00546000|42112728|FG000|Overall Study|Lost to Follow-up|1|||
19664104|NCT00546000|42112728|FG000|Overall Study|Baseline HPA Axis Supression|2|||
19664105|NCT00501969|42112732|FG000|Overall Study|Major Protocol Violation|4|||
19664106|NCT00501969|42112732|FG000|Overall Study|Lack of Efficacy|29|||
19664107|NCT00501969|42112732|FG000|Overall Study|Adverse Event|76|||
19664108|NCT00501969|42112732|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
19664109|NCT00501969|42112732|FG000|Overall Study|Subject withdrew consent|51|||
19664110|NCT00501969|42112732|FG000|Overall Study|Lost to Follow-up|4|||
19664111|NCT00501969|42112732|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
19664112|NCT00501969|42112732|FG000|Overall Study|Other: Sponsors Request|10|||
19664113|NCT00501969|42112732|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
19664114|NCT00501969|42112732|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
19664115|NCT00501969|42112732|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
19664116|NCT00501969|42112732|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
19664117|NCT00501969|42112732|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
19664118|NCT00501969|42112732|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
19664119|NCT00501969|42112732|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
19664120|NCT00501969|42112732|FG000|Overall Study|Other: As Required by Local EC|2|||
19664121|NCT00501969|42112732|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
19664122|NCT00501969|42112732|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
19664123|NCT03942042|42112738|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
19664124|NCT03942042|42112739|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
19664125|NCT03942042|42112738|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
19664126|NCT03942042|42112739|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
19664127|NCT00104299|42112751|FG000|Overall Study|Adverse Event|3|||
19664128|NCT00104299|42112752|FG001|Overall Study|Adverse Event|1|||
19664129|NCT00104299|42112751|FG000|Overall Study|Death|2|||
19664130|NCT00104299|42112752|FG001|Overall Study|Death|2|||
19664131|NCT00104299|42112751|FG000|Overall Study|Withdrawal by Subject|2|||
19664132|NCT00104299|42112752|FG001|Overall Study|Withdrawal by Subject|6|||
19664133|NCT00104299|42112751|FG000|Overall Study|Physician Decision|1|||
19664134|NCT00104299|42112752|FG001|Overall Study|Physician Decision|1|||
19664135|NCT00104299|42112751|FG000|Overall Study|To have renal transplant|1|||
19664136|NCT00104299|42112752|FG001|Overall Study|To have renal transplant|0|||
19664137|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
19664138|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
19664139|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
19664140|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
19664141|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
19664142|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
19664143|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
19664144|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
19664145|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
19664146|NCT03939312|42112758|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
19664147|NCT03939312|42112758|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
19664148|NCT03939312|42112758|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
19664149|NCT00082381|42112766|FG000|Overall Study|Adverse Event|27|||
19664150|NCT00082381|42112767|FG001|Overall Study|Adverse Event|2|||
19664151|NCT00082381|42112766|FG000|Overall Study|Lost to Follow-up|5|||
19664152|NCT00082381|42112767|FG001|Overall Study|Lost to Follow-up|7|||
19664153|NCT00082381|42112766|FG000|Overall Study|Patient Decision|8|||
19664154|NCT00082381|42112767|FG001|Overall Study|Patient Decision|4|||
19664155|NCT00082381|42112766|FG000|Overall Study|Physician Decision|1|||
19664156|NCT00082381|42112767|FG001|Overall Study|Physician Decision|2|||
19664157|NCT00082381|42112766|FG000|Overall Study|Protocol Violation|10|||
19664158|NCT00082381|42112767|FG001|Overall Study|Protocol Violation|11|||
19664159|NCT00082381|42112766|FG000|Overall Study|Loss of Glucose Control|4|||
19664160|NCT00082381|42112767|FG001|Overall Study|Loss of Glucose Control|0|||
19664161|NCT00545844|42112773|FG000|Overall Study|Lost to Follow-up|9|||
19664162|NCT00545844|42112773|FG000|Overall Study|Protocol Violation|1|||
19664163|NCT00545844|42112773|FG000|Overall Study|Withdrawal by Subject|2|||
19664164|NCT00492063|42112783|FG000|Overall Study|Death|0|||
19664165|NCT00492063|42112784|FG001|Overall Study|Death|0|||
19664166|NCT00492063|42112785|FG002|Overall Study|Death|1|||
19664167|NCT00492063|42112786|FG003|Overall Study|Death|2|||
19664168|NCT00492063|42112783|FG000|Overall Study|Withdrawal by Subject|4|||
19664169|NCT00492063|42112784|FG001|Overall Study|Withdrawal by Subject|3|||
19664170|NCT00492063|42112785|FG002|Overall Study|Withdrawal by Subject|5|||
19664171|NCT00492063|42112786|FG003|Overall Study|Withdrawal by Subject|4|||
19664172|NCT00492063|42112783|FG000|Overall Study|Lost to Follow-up|6|||
19664173|NCT00492063|42112784|FG001|Overall Study|Lost to Follow-up|11|||
19664174|NCT00492063|42112785|FG002|Overall Study|Lost to Follow-up|5|||
19664175|NCT00492063|42112786|FG003|Overall Study|Lost to Follow-up|3|||
19664176|NCT00492063|42112783|FG000|Overall Study|Protocol Violation|0|||
19664177|NCT00492063|42112784|FG001|Overall Study|Protocol Violation|0|||
19664178|NCT00492063|42112785|FG002|Overall Study|Protocol Violation|0|||
19664179|NCT00492063|42112786|FG003|Overall Study|Protocol Violation|1|||
19664180|NCT00093145|42112796|FG000|Overall Study|Unacceptable Toxicity Only|2|||
19664181|NCT00093145|42112796|FG000|Overall Study|Physician Decision|5|||
19664182|NCT00093145|42112796|FG000|Overall Study|Withdrawal by Subject|9|||
19664183|NCT00093145|42112796|FG000|Overall Study|Other|1|||
19664184|NCT00513357|42112802|FG000|Overall Study|did not receive allocated placebo|2|||
19664185|NCT00513357|42112803|FG001|Overall Study|did not receive allocated placebo|3|||
19664186|NCT00513357|42112802|FG000|Overall Study|Adverse Event|4|||
19664187|NCT00513357|42112803|FG001|Overall Study|Adverse Event|2|||
19664188|NCT00513357|42112802|FG000|Overall Study|Death|2|||
19664189|NCT00513357|42112803|FG001|Overall Study|Death|0|||
19664190|NCT00513357|42112802|FG000|Overall Study|Withdrawal by Subject|5|||
19664191|NCT00513357|42112803|FG001|Overall Study|Withdrawal by Subject|4|||
19664192|NCT00513357|42112802|FG000|Overall Study|Disease Progression|2|||
19664193|NCT00513357|42112803|FG001|Overall Study|Disease Progression|1|||
19664194|NCT03933462|42112809|FG000|Overall Study|Adverse Event|2|||
19664195|NCT03933462|42112810|FG001|Overall Study|Adverse Event|0|||
19664196|NCT03929562|42112818|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
19664197|NCT03929562|42112819|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
19664198|NCT03929562|42112818|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
19664199|NCT03929562|42112819|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
19664200|NCT03929562|42112818|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
19664201|NCT03929562|42112819|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
19664202|NCT00415636|42112833|FG000|Overall Study|Symptomatic deterioration|1|||
19664203|NCT00415636|42112834|FG001|Overall Study|Symptomatic deterioration|0|||
19664204|NCT00415636|42112835|FG002|Overall Study|Symptomatic deterioration|1|||
19664205|NCT00415636|42112836|FG003|Overall Study|Symptomatic deterioration|2|||
19664206|NCT00415636|42112837|FG004|Overall Study|Symptomatic deterioration|0|||
19664207|NCT00415636|42112838|FG005|Overall Study|Symptomatic deterioration|1|||
19664208|NCT00415636|42112833|FG000|Overall Study|Adverse Event|0|||
19388761|NCT02544633|41632285|FG000|Treatment Period|Global Deterioration of Health|3|||
19664209|NCT00415636|42112834|FG001|Overall Study|Adverse Event|0|||
19664210|NCT00415636|42112835|FG002|Overall Study|Adverse Event|0|||
19664211|NCT00415636|42112836|FG003|Overall Study|Adverse Event|1|||
19664212|NCT00415636|42112837|FG004|Overall Study|Adverse Event|1|||
19664213|NCT00415636|42112838|FG005|Overall Study|Adverse Event|0|||
19664214|NCT00415636|42112833|FG000|Overall Study|Withdrawal by Subject|0|||
19664215|NCT00415636|42112834|FG001|Overall Study|Withdrawal by Subject|0|||
19664216|NCT00415636|42112835|FG002|Overall Study|Withdrawal by Subject|0|||
19664217|NCT00415636|42112836|FG003|Overall Study|Withdrawal by Subject|0|||
19664218|NCT00415636|42112837|FG004|Overall Study|Withdrawal by Subject|1|||
19664219|NCT00415636|42112838|FG005|Overall Study|Withdrawal by Subject|0|||
19664220|NCT00415636|42112833|FG000|Overall Study|Disease progression|0|||
19664221|NCT00415636|42112834|FG001|Overall Study|Disease progression|0|||
19664222|NCT00415636|42112835|FG002|Overall Study|Disease progression|0|||
19664223|NCT00415636|42112836|FG003|Overall Study|Disease progression|3|||
19664224|NCT00415636|42112837|FG004|Overall Study|Disease progression|0|||
19664225|NCT00415636|42112838|FG005|Overall Study|Disease progression|1|||
19664226|NCT00425854|42112862|FG000|Overall Study|Progressive Disease|19|||
19664227|NCT00425854|42112863|FG001|Overall Study|Progressive Disease|12|||
19664228|NCT00425854|42112862|FG000|Overall Study|Dose reduction toxicity AE|8|||
19664229|NCT00425854|42112863|FG001|Overall Study|Dose reduction toxicity AE|7|||
19664230|NCT00425854|42112862|FG000|Overall Study|Other Adverse Event|2|||
19664231|NCT00425854|42112863|FG001|Overall Study|Other Adverse Event|2|||
19664232|NCT00425698|42112872|FG000|Overall Study|Adverse Event|3|||
19664233|NCT00425698|42112873|FG001|Overall Study|Adverse Event|1|||
19664234|NCT00425698|42112872|FG000|Overall Study|Withdrawal by Subject|0|||
19664235|NCT00425698|42112873|FG001|Overall Study|Withdrawal by Subject|1|||
19664236|NCT00425308|42112881|FG000|Overall Study|Adverse Event|2|||
19664237|NCT00425308|42112882|FG001|Overall Study|Adverse Event|1|||
19664238|NCT00425308|42112881|FG000|Overall Study|Withdrawal by Subject|1|||
19664239|NCT00425308|42112882|FG001|Overall Study|Withdrawal by Subject|0|||
19664240|NCT00425308|42112881|FG000|Overall Study|Death|1|||
19664241|NCT00425308|42112882|FG001|Overall Study|Death|0|||
19664242|NCT00545064|42112888|FG000|Overall Study|Lost to Follow-up|3|||
19664243|NCT00545064|42112888|FG000|Overall Study|Withdrawal by Subject|2|||
19664244|NCT00545064|42112888|FG000|Overall Study|did not complete course of treatment|1|||
19664245|NCT00545064|42112888|FG000|Overall Study|cancel all appointments, no rebooking|1|||
19664246|NCT00545064|42112888|FG000|Overall Study|inclement weather|1|||
19664247|NCT00432562|42112896|FG000|Overall Study|Death|3|||
19664248|NCT00432562|42112897|FG001|Overall Study|Death|0|||
19664249|NCT00432172|42112907|FG000|Overall Study|Physician Decision|0|||
19664250|NCT00432172|42112908|FG001|Overall Study|Physician Decision|0|||
19664251|NCT00432172|42112909|FG002|Overall Study|Physician Decision|2|||
19664252|NCT00432172|42112910|FG003|Overall Study|Physician Decision|0|||
19664253|NCT00432172|42112907|FG000|Overall Study|Adverse Event|4|||
19664254|NCT00432172|42112908|FG001|Overall Study|Adverse Event|2|||
19664255|NCT00432172|42112909|FG002|Overall Study|Adverse Event|4|||
19664256|NCT00432172|42112910|FG003|Overall Study|Adverse Event|3|||
19664257|NCT00432172|42112907|FG000|Overall Study|Disease progression|0|||
19664258|NCT00432172|42112908|FG001|Overall Study|Disease progression|2|||
19664259|NCT00432172|42112909|FG002|Overall Study|Disease progression|5|||
19664260|NCT00432172|42112910|FG003|Overall Study|Disease progression|1|||
19664261|NCT00432172|42112907|FG000|Overall Study|Withdrawal by Subject|0|||
19664262|NCT00432172|42112908|FG001|Overall Study|Withdrawal by Subject|1|||
19664263|NCT00432172|42112909|FG002|Overall Study|Withdrawal by Subject|0|||
19664264|NCT00432172|42112910|FG003|Overall Study|Withdrawal by Subject|2|||
19664265|NCT00432172|42112907|FG000|Overall Study|No treatment received|2|||
19664266|NCT00432172|42112908|FG001|Overall Study|No treatment received|2|||
19664267|NCT00432172|42112909|FG002|Overall Study|No treatment received|0|||
19664268|NCT00432172|42112910|FG003|Overall Study|No treatment received|1|||
19664269|NCT00415168|42112922|FG000|Overall Study|Death|26|||
19664270|NCT00415168|42112922|FG000|Overall Study|Lost to Follow-up|3|||
19664271|NCT00415168|42112922|FG000|Overall Study|Physician Decision|13|||
19664272|NCT00415168|42112922|FG000|Overall Study|Sponsor Decision|4|||
19664273|NCT00415168|42112922|FG000|Overall Study|Withdrawal by Subject|6|||
19664274|NCT00424762|42112928|FG000|Overall Study|Withdrawal by Subject|18|||
19664275|NCT00424762|42112929|FG001|Overall Study|Withdrawal by Subject|19|||
19664276|NCT00424762|42112928|FG000|Overall Study|Lost to Follow-up|2|||
19664277|NCT00424762|42112929|FG001|Overall Study|Lost to Follow-up|3|||
19664278|NCT00424528|42112938|FG000|Overall Study|Adverse Event|2|||
19664279|NCT00424528|42112939|FG001|Overall Study|Adverse Event|1|||
19664280|NCT00424528|42112940|FG002|Overall Study|Adverse Event|2|||
19664281|NCT00424528|42112938|FG000|Overall Study|Protocol Violation|1|||
19664282|NCT00424528|42112939|FG001|Overall Study|Protocol Violation|1|||
19664283|NCT00424528|42112940|FG002|Overall Study|Protocol Violation|0|||
19664284|NCT00424528|42112938|FG000|Overall Study|Lost to Follow-up|0|||
19664285|NCT00424528|42112939|FG001|Overall Study|Lost to Follow-up|1|||
19664286|NCT00424528|42112940|FG002|Overall Study|Lost to Follow-up|0|||
19664287|NCT00424528|42112938|FG000|Overall Study|noncompliance with study requirements|2|||
19664288|NCT00424528|42112939|FG001|Overall Study|noncompliance with study requirements|1|||
19664289|NCT00424528|42112940|FG002|Overall Study|noncompliance with study requirements|2|||
19664290|NCT00414544|42112948|FG000|Overall Study|Lost to Follow-up|14|||
19664291|NCT00414466|42112958|FG000|Overall Study|Adverse Event|0|||
19664292|NCT00414466|42112959|FG001|Overall Study|Adverse Event|0|||
19664293|NCT00414466|42112960|FG002|Overall Study|Adverse Event|1|||
19664294|NCT00414466|42112961|FG003|Overall Study|Adverse Event|1|||
19664295|NCT00414466|42112958|FG000|Overall Study|Lack of Efficacy|1|||
19664296|NCT00414466|42112959|FG001|Overall Study|Lack of Efficacy|0|||
19664297|NCT00414466|42112960|FG002|Overall Study|Lack of Efficacy|0|||
19664298|NCT00414466|42112961|FG003|Overall Study|Lack of Efficacy|0|||
19664299|NCT00414466|42112958|FG000|Overall Study|Withdrawn by Sponsor|1|||
19664300|NCT00414466|42112959|FG001|Overall Study|Withdrawn by Sponsor|0|||
19664301|NCT00414466|42112960|FG002|Overall Study|Withdrawn by Sponsor|0|||
19664302|NCT00414466|42112961|FG003|Overall Study|Withdrawn by Sponsor|0|||
19664303|NCT00545532|42112976|FG000|Overall Study|Withdrawal by Subject|1|||
19664304|NCT00545532|42112977|FG001|Overall Study|Withdrawal by Subject|3|||
19664305|NCT00545532|42112976|FG000|Overall Study|Lost to Follow-up|5|||
19664306|NCT00545532|42112977|FG001|Overall Study|Lost to Follow-up|6|||
19664307|NCT00545532|42112976|FG000|Overall Study|Death|0|||
19664308|NCT00545532|42112977|FG001|Overall Study|Death|1|||
19664309|NCT00544440|42112985|FG000|Overall Study|Other|1|||
19664310|NCT00544440|42112985|FG000|Overall Study|Adverse Event|1|||
19664311|NCT00544440|42112985|FG000|Overall Study|Withdrawal by Subject|2|||
19664312|NCT00544440|42112985|FG000|Overall Study|Subject Non-compliance|1|||
19664313|NCT00544440|42112985|FG000|Overall Study|Progressive Disease|47|||
19664314|NCT00544440|42112985|FG000|Overall Study|Other|5|||
19664315|NCT03920670|42112991|FG000|Overall Study|Protocol Violation|2|||
19664316|NCT03920670|42112992|FG001|Overall Study|Protocol Violation|2|||
19664317|NCT03920670|42112991|FG000|Overall Study|Adverse Event|1|||
19664318|NCT03920670|42112992|FG001|Overall Study|Adverse Event|0|||
19664319|NCT00430300|42113002|FG000|Overall Study|Adverse Event|0|||
19664320|NCT00430300|42113003|FG001|Overall Study|Adverse Event|2|||
19664321|NCT00430300|42113004|FG002|Overall Study|Adverse Event|1|||
19664322|NCT00430300|42113005|FG003|Overall Study|Adverse Event|1|||
19664323|NCT00430300|42113002|FG000|Overall Study|Withdrawal by Subject|1|||
19664324|NCT00430300|42113003|FG001|Overall Study|Withdrawal by Subject|0|||
19664325|NCT00430300|42113004|FG002|Overall Study|Withdrawal by Subject|5|||
19756248|NCT03154086|42206896|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756249|NCT03154086|42206897|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756250|NCT03154086|42206898|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756251|NCT03154086|42206899|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
19756252|NCT03154086|42206885|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756253|NCT03154086|42206886|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
19756254|NCT03154086|42206887|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756255|NCT03154086|42206888|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756256|NCT03154086|42206889|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756257|NCT03154086|42206890|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756258|NCT03154086|42206891|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756259|NCT03154086|42206892|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756260|NCT03154086|42206893|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756261|NCT03154086|42206894|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19664326|NCT00430300|42113005|FG003|Overall Study|Withdrawal by Subject|0|||
19664327|NCT00430300|42113002|FG000|Overall Study|Laboratory abnormality|1|||
19664328|NCT00430300|42113003|FG001|Overall Study|Laboratory abnormality|0|||
19664329|NCT00430300|42113004|FG002|Overall Study|Laboratory abnormality|0|||
19664330|NCT00430300|42113005|FG003|Overall Study|Laboratory abnormality|0|||
19664331|NCT00430300|42113002|FG000|Overall Study|Other|0|||
19664332|NCT00430300|42113003|FG001|Overall Study|Other|0|||
19664333|NCT00430300|42113004|FG002|Overall Study|Other|0|||
19664334|NCT00430300|42113005|FG003|Overall Study|Other|1|||
19664335|NCT03927846|42113017|FG000|Overall Study|Lost to Follow-up|10|||
19664336|NCT03927846|42113018|FG001|Overall Study|Lost to Follow-up|11|||
19664337|NCT03927144|42113026|FG000|Overall Study|Adverse Event|9|||
19664338|NCT03927144|42113027|FG001|Overall Study|Adverse Event|5|||
19664339|NCT03927144|42113026|FG000|Overall Study|Lost to Follow-up|3|||
19664340|NCT03927144|42113027|FG001|Overall Study|Lost to Follow-up|2|||
19664341|NCT03927144|42113026|FG000|Overall Study|New Therapy for Study Indication|0|||
19664342|NCT03927144|42113027|FG001|Overall Study|New Therapy for Study Indication|1|||
19664343|NCT03927144|42113026|FG000|Overall Study|No Longer Clinically Benefiting|4|||
19756262|NCT03154086|42206895|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756263|NCT03154086|42206896|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756264|NCT03154086|42206897|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756265|NCT03154086|42206898|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756266|NCT03154086|42206899|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
19756267|NCT03154086|42206885|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756268|NCT03154086|42206886|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19664344|NCT03927144|42113027|FG001|Overall Study|No Longer Clinically Benefiting|4|||
19664345|NCT03927144|42113026|FG000|Overall Study|Physician Decision|2|||
19664346|NCT03927144|42113027|FG001|Overall Study|Physician Decision|8|||
19664347|NCT03927144|42113026|FG000|Overall Study|Protocol Violation|2|||
19664348|NCT03927144|42113027|FG001|Overall Study|Protocol Violation|2|||
19664349|NCT03927144|42113026|FG000|Overall Study|Withdrawal by Subject|16|||
19664350|NCT03927144|42113027|FG001|Overall Study|Withdrawal by Subject|40|||
19664351|NCT00545298|42113036|FG000|Overall Study|Issues with Standard of Care|2|||
19664352|NCT00545298|42113037|FG001|Overall Study|Issues with Standard of Care|0|||
19664353|NCT00545298|42113038|FG002|Overall Study|Issues with Standard of Care|1|||
19756269|NCT03154086|42206887|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
19756270|NCT03154086|42206888|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756271|NCT03154086|42206889|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756272|NCT03154086|42206890|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756273|NCT03154086|42206891|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756274|NCT03154086|42206892|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756275|NCT03154086|42206893|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756276|NCT03154086|42206894|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756277|NCT03154086|42206895|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756278|NCT03154086|42206896|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19664354|NCT00429364|42113051|FG000|Overall Study|Withdrawal by Subject|11|||
19664355|NCT00429364|42113052|FG001|Overall Study|Withdrawal by Subject|5|||
19664356|NCT00429364|42113051|FG000|Overall Study|Physician Decision|4|||
19664357|NCT00429364|42113052|FG001|Overall Study|Physician Decision|2|||
19664358|NCT00429364|42113051|FG000|Overall Study|Lost to Follow-up|7|||
19664359|NCT00429364|42113052|FG001|Overall Study|Lost to Follow-up|6|||
19664360|NCT00429364|42113051|FG000|Overall Study|Death|0|||
19664361|NCT00429364|42113052|FG001|Overall Study|Death|1|||
19664362|NCT00429364|42113051|FG000|Overall Study|Underwent aortic root surgery|10|||
19664363|NCT00429364|42113052|FG001|Overall Study|Underwent aortic root surgery|18|||
19664364|NCT00429364|42113051|FG000|Overall Study|Pregnancy|0|||
19664365|NCT00429364|42113052|FG001|Overall Study|Pregnancy|1|||
19664366|NCT00414388|42113058|FG000|Overall Study|Adverse Event|1|||
19664367|NCT03920280|42113065|FG000|Overall Study|Adverse Event|2|||
19664368|NCT03920280|42113066|FG001|Overall Study|Adverse Event|3|||
19664369|NCT03920280|42113065|FG000|Overall Study|Lost to Follow-up|0|||
19756279|NCT03154086|42206897|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19664370|NCT03920280|42113066|FG001|Overall Study|Lost to Follow-up|1|||
19664371|NCT03920280|42113065|FG000|Overall Study|Withdrawal by Subject|1|||
19664372|NCT03920280|42113066|FG001|Overall Study|Withdrawal by Subject|1|||
19664373|NCT03920280|42113065|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
19664374|NCT03920280|42113066|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
19664375|NCT00424372|42113075|FG000|Overall Study|Death|1|||
19664376|NCT00424372|42113075|FG000|Overall Study|Adverse Event|18|||
19664377|NCT00424372|42113075|FG000|Overall Study|Lack of Efficacy|6|||
19664378|NCT00424372|42113075|FG000|Overall Study|Withdrawal by Subject|4|||
19664379|NCT00424372|42113075|FG000|Overall Study|Protocol Violation|1|||
19664380|NCT00424372|42113075|FG000|Overall Study|Health deterioration|1|||
19664381|NCT00414310|42113081|FG000|Overall Study|Not treated|1|||
19664382|NCT00414310|42113082|FG001|Overall Study|Not treated|0|||
19664383|NCT00542880|42113092|FG000|Period 1|Eligibility criteria not fulfilled|2|||
19664384|NCT00542880|42113093|FG001|Period 1|Eligibility criteria not fulfilled|6|||
19664385|NCT00542880|42113092|FG000|Period 1|Adverse Event|2|||
19664386|NCT00542880|42113093|FG001|Period 1|Adverse Event|2|||
19664387|NCT00542880|42113092|FG000|Period 1|Development of study-specific criteria|1|||
19664388|NCT00542880|42113093|FG001|Period 1|Development of study-specific criteria|2|||
19664389|NCT00542880|42113092|FG000|Period 1|Withdrawal by Subject|1|||
19664390|NCT00542880|42113093|FG001|Period 1|Withdrawal by Subject|1|||
19664391|NCT00542880|42113092|FG000|Period 1|Protocol Violation|0|||
19664392|NCT00542880|42113093|FG001|Period 1|Protocol Violation|1|||
19756280|NCT03154086|42206898|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756281|NCT03154086|42206899|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
19756282|NCT03154086|42206885|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
19756283|NCT03154086|42206886|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756284|NCT03154086|42206887|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756285|NCT03154086|42206888|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756286|NCT03154086|42206889|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756287|NCT03154086|42206890|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756288|NCT03154086|42206891|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756289|NCT03154086|42206892|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756290|NCT03154086|42206893|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756291|NCT03154086|42206894|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756292|NCT03154086|42206895|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756293|NCT03154086|42206896|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756294|NCT03154086|42206897|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756295|NCT03154086|42206898|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19664393|NCT00542880|42113092|FG000|Period 2|Adverse Event|5|||
19664394|NCT00542880|42113093|FG001|Period 2|Adverse Event|7|||
19664395|NCT00542880|42113092|FG000|Period 2|Eligibility not fulfilled|0|||
19664396|NCT00542880|42113093|FG001|Period 2|Eligibility not fulfilled|1|||
19664397|NCT00542880|42113092|FG000|Period 2|Discontinuation criteria|2|||
19756296|NCT03154086|42206899|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
19756297|NCT03154086|42206885|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756298|NCT03154086|42206886|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756299|NCT03154086|42206887|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756300|NCT03154086|42206888|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756301|NCT03154086|42206889|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756302|NCT03154086|42206890|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756303|NCT03154086|42206891|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756304|NCT03154086|42206892|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19388762|NCT02544633|41632286|FG001|Treatment Period|Global Deterioration of Health|3|||
19664398|NCT00542880|42113093|FG001|Period 2|Discontinuation criteria|0|||
19664399|NCT00542880|42113092|FG000|Period 2|Severe non-compliance|0|||
19664400|NCT00542880|42113093|FG001|Period 2|Severe non-compliance|1|||
19664401|NCT00542880|42113092|FG000|Period 2|Other|0|||
19664402|NCT00542880|42113093|FG001|Period 2|Other|1|||
19664403|NCT00542880|42113092|FG000|Period 3|Adverse Event|0|||
19664404|NCT00542880|42113093|FG001|Period 3|Adverse Event|2|||
19664405|NCT00414076|42113102|FG000|Overall Study|Progression|1|||
19664406|NCT00414076|42113103|FG001|Overall Study|Progression|2|||
19664407|NCT00414076|42113102|FG000|Overall Study|Withdrawal by Subject|1|||
19664408|NCT00414076|42113103|FG001|Overall Study|Withdrawal by Subject|3|||
19664409|NCT00414076|42113102|FG000|Overall Study|Adverse Event|1|||
19664410|NCT00414076|42113103|FG001|Overall Study|Adverse Event|0|||
19664411|NCT00092677|42113111|FG000|Overall Study|Lost to Follow-up|0|||
19664412|NCT00092677|42113112|FG001|Overall Study|Lost to Follow-up|2|||
19664413|NCT00092677|42113111|FG000|Overall Study|Adminstrative|5|||
19664414|NCT00092677|42113112|FG001|Overall Study|Adminstrative|9|||
19664415|NCT00542178|42113124|FG000|Overall Study|did not complete year 4 follow-up|75|||
19664416|NCT00542178|42113125|FG001|Overall Study|did not complete year 4 follow-up|80|||
19664417|NCT00542178|42113126|FG002|Overall Study|did not complete year 4 follow-up|74|||
19664418|NCT00542178|42113127|FG003|Overall Study|did not complete year 4 follow-up|62|||
19664419|NCT00542178|42113128|FG004|Overall Study|did not complete year 4 follow-up|64|||
19664420|NCT00542178|42113129|FG005|Overall Study|did not complete year 4 follow-up|89|||
19664421|NCT00542178|42113130|FG006|Overall Study|did not complete year 4 follow-up|87|||
19664422|NCT00542178|42113131|FG007|Overall Study|did not complete year 4 follow-up|85|||
19664423|NCT00424294|42113147|FG000|Overall Study|Adverse Event|4|||
19664424|NCT00424294|42113148|FG001|Overall Study|Adverse Event|10|||
19664425|NCT00424294|42113147|FG000|Overall Study|Lack of Efficacy|2|||
19664426|NCT00424294|42113148|FG001|Overall Study|Lack of Efficacy|1|||
19664427|NCT00424294|42113147|FG000|Overall Study|Withdrawal by Subject|1|||
19664428|NCT00424294|42113148|FG001|Overall Study|Withdrawal by Subject|2|||
19664429|NCT00424294|42113147|FG000|Overall Study|Other|0|||
19664430|NCT00424294|42113148|FG001|Overall Study|Other|2|||
19664431|NCT00424294|42113147|FG000|Overall Study|Randomized but not Treated|1|||
19664432|NCT00424294|42113148|FG001|Overall Study|Randomized but not Treated|0|||
19664433|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
19664434|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
19664435|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
19664436|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
19664437|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
19664438|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
19664439|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
19664440|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
19664441|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
19664442|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
19664443|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
19664444|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
19664445|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
19664446|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
19664447|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
19664448|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
19664449|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
19664450|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
19664451|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
19664452|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
19664453|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
19664454|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
19664455|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
19664456|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
19664457|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
19664458|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
19664459|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
19664460|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
19664461|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
19664462|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
19664463|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
19664464|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
19664465|NCT00092521|42113157|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
19664466|NCT00092521|42113158|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
19664467|NCT00092521|42113159|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
19664468|NCT00092521|42113160|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
19664469|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
19664470|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
19664471|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
19664472|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
19664473|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
19664474|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
19664475|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
19664476|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
19664477|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
19664478|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
19664479|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
19664480|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
19664481|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Death|2|||
19664482|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Death|0|||
19664483|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Death|1|||
19664484|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Death|0|||
19664485|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
19664486|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
19664487|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
19664488|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
19664489|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
19664490|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
19664491|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
19664492|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
19664493|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
19664494|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
19756305|NCT03154086|42206893|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
19756306|NCT03154086|42206894|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756307|NCT03154086|42206895|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756308|NCT03154086|42206896|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756309|NCT03154086|42206897|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756310|NCT03154086|42206898|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756311|NCT03154086|42206899|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
19756312|NCT03154086|42206885|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756313|NCT03154086|42206886|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756314|NCT03154086|42206887|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756315|NCT03154086|42206888|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756316|NCT03154086|42206889|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756317|NCT03154086|42206890|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19664495|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
19664496|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
19664497|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Moved|32|||
19664498|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Moved|2|||
19664499|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Moved|28|||
19664500|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Moved|0|||
19664501|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
19664502|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
19664503|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
19664504|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
19664505|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Travel|2|||
19664506|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Travel|0|||
19664507|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Travel|0|||
19664508|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Travel|0|||
19664509|NCT00092521|42113157|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
19664510|NCT00092521|42113158|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
19664511|NCT00092521|42113159|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
19664512|NCT00092521|42113160|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
19664513|NCT00092521|42113157|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
19664514|NCT00092521|42113158|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
19664515|NCT00092521|42113159|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
19664516|NCT00092521|42113160|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
19664517|NCT00092521|42113157|FG000|Extension Study (Group 4)|Adverse Event|0|||
19664518|NCT00092521|42113158|FG001|Extension Study (Group 4)|Adverse Event|0|||
19664519|NCT00092521|42113159|FG002|Extension Study (Group 4)|Adverse Event|0|||
19664520|NCT00092521|42113160|FG003|Extension Study (Group 4)|Adverse Event|2|||
19664521|NCT00092521|42113157|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
19664522|NCT00092521|42113158|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
19664523|NCT00092521|42113159|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
19664524|NCT00092521|42113160|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
19664525|NCT00092521|42113157|FG000|Extension Study (Group 4)|Pregnancy|0|||
19664526|NCT00092521|42113158|FG001|Extension Study (Group 4)|Pregnancy|0|||
19664527|NCT00092521|42113159|FG002|Extension Study (Group 4)|Pregnancy|0|||
19664528|NCT00092521|42113160|FG003|Extension Study (Group 4)|Pregnancy|4|||
19664529|NCT00092521|42113157|FG000|Extension Study (Group 4)|Protocol Violation|0|||
19664530|NCT00092521|42113158|FG001|Extension Study (Group 4)|Protocol Violation|0|||
19664531|NCT00092521|42113159|FG002|Extension Study (Group 4)|Protocol Violation|0|||
19664532|NCT00092521|42113160|FG003|Extension Study (Group 4)|Protocol Violation|2|||
19664533|NCT00092521|42113157|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
19756318|NCT03154086|42206891|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756319|NCT03154086|42206892|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
19756320|NCT03154086|42206893|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756321|NCT03154086|42206894|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756322|NCT03154086|42206895|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756323|NCT03154086|42206896|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19664534|NCT00092521|42113158|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
19756324|NCT03154086|42206897|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756325|NCT03154086|42206898|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756326|NCT03154086|42206899|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
19756327|NCT03154086|42206885|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
19664535|NCT00092521|42113159|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
19664536|NCT00092521|42113160|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
19664537|NCT00092521|42113157|FG000|Extension Study (Group 4)|Moved|0|||
19664538|NCT00092521|42113158|FG001|Extension Study (Group 4)|Moved|0|||
19664539|NCT00092521|42113159|FG002|Extension Study (Group 4)|Moved|0|||
19664540|NCT00092521|42113160|FG003|Extension Study (Group 4)|Moved|16|||
19756328|NCT03154086|42206886|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
19756329|NCT03154086|42206887|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
19756330|NCT03154086|42206888|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
19756331|NCT03154086|42206889|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
19756332|NCT03154086|42206890|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
19756333|NCT03154086|42206891|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
19756334|NCT03154086|42206892|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
19756335|NCT03154086|42206893|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
19756336|NCT03154086|42206894|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
19756337|NCT03154086|42206895|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
19664541|NCT00092521|42113157|FG000|Extension Study (Group 4)|Site Terminated|0|||
19664542|NCT00092521|42113158|FG001|Extension Study (Group 4)|Site Terminated|0|||
19664543|NCT00092521|42113159|FG002|Extension Study (Group 4)|Site Terminated|0|||
19664544|NCT00092521|42113160|FG003|Extension Study (Group 4)|Site Terminated|4|||
19664545|NCT00092521|42113157|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
19388763|NCT02544633|41632287|FG002|Treatment Period|Global Deterioration of Health|0|||
19388764|NCT02544633|41632288|FG003|Treatment Period|Global Deterioration of Health|1|||
19388765|NCT02544633|41632285|FG000|Treatment Period|Withdrawal by Subject|1|||
19388766|NCT02544633|41632286|FG001|Treatment Period|Withdrawal by Subject|0|||
19388767|NCT02544633|41632287|FG002|Treatment Period|Withdrawal by Subject|0|||
19388768|NCT02544633|41632288|FG003|Treatment Period|Withdrawal by Subject|0|||
19388769|NCT02544633|41632285|FG000|Treatment Period|Lost to Follow-up|0|||
19388770|NCT02544633|41632286|FG001|Treatment Period|Lost to Follow-up|1|||
19388771|NCT02544633|41632287|FG002|Treatment Period|Lost to Follow-up|0|||
19388772|NCT02544633|41632288|FG003|Treatment Period|Lost to Follow-up|0|||
19388773|NCT02544633|41632285|FG000|Treatment Period|Death|0|||
19664546|NCT00092521|42113158|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
19664547|NCT00092521|42113159|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
19664548|NCT00092521|42113160|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
19664549|NCT03908970|42113170|FG000|Overall Study|Adverse Event|7|||
19664550|NCT03908970|42113171|FG001|Overall Study|Adverse Event|21|||
19664551|NCT03908970|42113170|FG000|Overall Study|Physician Decision|1|||
19664552|NCT03908970|42113171|FG001|Overall Study|Physician Decision|4|||
19664553|NCT03908970|42113170|FG000|Overall Study|Withdrawal by Subject|9|||
19664554|NCT03908970|42113171|FG001|Overall Study|Withdrawal by Subject|22|||
19664555|NCT00092443|42113179|FG000|Overall Study|Adverse Event|9|||
19664556|NCT00092443|42113180|FG001|Overall Study|Adverse Event|13|||
19664557|NCT00092443|42113179|FG000|Overall Study|Lost to Follow-up|7|||
19664558|NCT00092443|42113180|FG001|Overall Study|Lost to Follow-up|3|||
19756338|NCT03154086|42206896|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
19756339|NCT03154086|42206897|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
19664559|NCT00092443|42113179|FG000|Overall Study|Protocol Violation|11|||
19664560|NCT00092443|42113180|FG001|Overall Study|Protocol Violation|9|||
19664561|NCT00092443|42113179|FG000|Overall Study|Withdrawal by Subject|9|||
19664562|NCT00092443|42113180|FG001|Overall Study|Withdrawal by Subject|11|||
19664563|NCT00092443|42113179|FG000|Overall Study|Moved|5|||
19664564|NCT00092443|42113180|FG001|Overall Study|Moved|5|||
19664565|NCT00092443|42113179|FG000|Overall Study|Other|17|||
19664566|NCT00092443|42113180|FG001|Overall Study|Other|13|||
19664567|NCT00413920|42113198|FG000|Overall Study|Adverse Event|9|||
19664568|NCT00413920|42113199|FG001|Overall Study|Adverse Event|11|||
19664569|NCT00413920|42113198|FG000|Overall Study|Lack of Efficacy|11|||
19664570|NCT00413920|42113199|FG001|Overall Study|Lack of Efficacy|9|||
19664571|NCT00413920|42113198|FG000|Overall Study|Death|3|||
19664572|NCT00413920|42113199|FG001|Overall Study|Death|5|||
19664573|NCT00413920|42113198|FG000|Overall Study|Graft Loss|5|||
19756340|NCT03154086|42206898|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
19756341|NCT03154086|42206899|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
19756342|NCT02723344|42206962|FG000|Overall Study|Lost to Follow-up|0|||
19756343|NCT02723344|42206963|FG001|Overall Study|Lost to Follow-up|4|||
19756344|NCT02723188|42206972|FG000|Overall Study|Withdrawal by Subject|1|||
19756345|NCT02723188|42206973|FG001|Overall Study|Withdrawal by Subject|0|||
19756346|NCT02723188|42206974|FG002|Overall Study|Withdrawal by Subject|0|||
19756347|NCT00705406|42206984|FG000|Overall Study|Lost to Follow-up|3|||
19756348|NCT00705406|42206985|FG001|Overall Study|Lost to Follow-up|3|||
19756349|NCT00705406|42206984|FG000|Overall Study|Did not receive study drug|1|||
19756350|NCT00705406|42206985|FG001|Overall Study|Did not receive study drug|2|||
19756351|NCT03155178|42206996|FG000|Overall Study|Did not meet treatment day baseline|7|||
19756352|NCT03155178|42206997|FG001|Overall Study|Did not meet treatment day baseline|7|||
19664574|NCT00413920|42113199|FG001|Overall Study|Graft Loss|3|||
19664575|NCT00091819|42113207|FG000|Overall Study|Adverse Event|1|||
19664576|NCT00091819|42113208|FG001|Overall Study|Adverse Event|1|||
19664577|NCT00091819|42113207|FG000|Overall Study|Death|4|||
19664578|NCT00091819|42113208|FG001|Overall Study|Death|5|||
19664579|NCT00091819|42113207|FG000|Overall Study|Lost to Follow-up|26|||
19664580|NCT00091819|42113208|FG001|Overall Study|Lost to Follow-up|23|||
19664581|NCT00091819|42113207|FG000|Overall Study|Withdrawal by Subject|5|||
19664582|NCT00091819|42113208|FG001|Overall Study|Withdrawal by Subject|8|||
19664583|NCT00091819|42113207|FG000|Overall Study|Protocol Violation|1|||
19664584|NCT00091819|42113208|FG001|Overall Study|Protocol Violation|2|||
19664585|NCT00091819|42113207|FG000|Overall Study|Other|2|||
19664586|NCT00091819|42113208|FG001|Overall Study|Other|3|||
19664587|NCT00091819|42113207|FG000|Overall Study|Never received study treatment|3|||
19664588|NCT00091819|42113208|FG001|Overall Study|Never received study treatment|4|||
19664589|NCT00540228|42113219|FG000|Overall Study|Adverse Event|2|||
19664590|NCT00540228|42113220|FG001|Overall Study|Adverse Event|0|||
19664591|NCT00540228|42113221|FG002|Overall Study|Adverse Event|0|||
19664592|NCT00540228|42113222|FG003|Overall Study|Adverse Event|0|||
19664593|NCT00540228|42113223|FG004|Overall Study|Adverse Event|0|||
19664594|NCT00540228|42113219|FG000|Overall Study|Lost to Follow-up|1|||
19664595|NCT00540228|42113220|FG001|Overall Study|Lost to Follow-up|1|||
19664596|NCT00540228|42113221|FG002|Overall Study|Lost to Follow-up|0|||
19664597|NCT00540228|42113222|FG003|Overall Study|Lost to Follow-up|0|||
19664598|NCT00540228|42113223|FG004|Overall Study|Lost to Follow-up|0|||
19664599|NCT00539994|42113238|FG000|Overall Study|Lost to Follow-up|2|||
19664600|NCT00539994|42113239|FG001|Overall Study|Lost to Follow-up|1|||
19664601|NCT00539994|42113240|FG002|Overall Study|Lost to Follow-up|0|||
19664602|NCT00539994|42113238|FG000|Overall Study|Withdrawal by Subject|1|||
19664603|NCT00539994|42113239|FG001|Overall Study|Withdrawal by Subject|0|||
19664604|NCT00539994|42113240|FG002|Overall Study|Withdrawal by Subject|1|||
19664605|NCT00539994|42113238|FG000|Overall Study|Physician Decision|0|||
19664606|NCT00539994|42113239|FG001|Overall Study|Physician Decision|0|||
19664607|NCT00539994|42113240|FG002|Overall Study|Physician Decision|1|||
19664608|NCT00098839|42113257|FG000|Overall Study|Adverse Event|5|||
19664609|NCT00098839|42113258|FG001|Overall Study|Adverse Event|2|||
19664610|NCT00098839|42113257|FG000|Overall Study|Death|1|||
19664611|NCT00098839|42113258|FG001|Overall Study|Death|2|||
19664612|NCT00098839|42113257|FG000|Overall Study|Physician Decision|4|||
19664613|NCT00098839|42113258|FG001|Overall Study|Physician Decision|14|||
19664614|NCT00098839|42113257|FG000|Overall Study|Withdrawal by Subject|1|||
19388774|NCT02544633|41632286|FG001|Treatment Period|Death|0|||
19664615|NCT00098839|42113258|FG001|Overall Study|Withdrawal by Subject|0|||
19664616|NCT00098839|42113257|FG000|Overall Study|Refusal of further protocol therapy|3|||
19664617|NCT00098839|42113258|FG001|Overall Study|Refusal of further protocol therapy|1|||
19664618|NCT00098839|42113257|FG000|Overall Study|Relapse|6|||
19756353|NCT03155178|42206998|FG002|Overall Study|Did not meet treatment day baseline|7|||
19664619|NCT00098839|42113258|FG001|Overall Study|Relapse|3|||
19664620|NCT00098839|42113257|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
19664621|NCT00098839|42113258|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
19664622|NCT00098839|42113257|FG000|Overall Study|Ineligible|2|||
19664623|NCT00098839|42113258|FG001|Overall Study|Ineligible|0|||
19664624|NCT03811093|42113267|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
19664625|NCT03811093|42113268|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
19664626|NCT03811093|42113267|FG000|Overall Study|Unable to measure body fat percentage|2|||
19664627|NCT03811093|42113268|FG001|Overall Study|Unable to measure body fat percentage|0|||
19664628|NCT00485589|42113280|FG000|Overall Study|Death|2|||
19664629|NCT00485589|42113281|FG001|Overall Study|Death|2|||
19664630|NCT00485589|42113282|FG002|Overall Study|Death|0|||
19664631|NCT00485589|42113280|FG000|Overall Study|Failure to return|6|||
19664632|NCT00485589|42113281|FG001|Overall Study|Failure to return|5|||
19664633|NCT00485589|42113282|FG002|Overall Study|Failure to return|1|||
19664634|NCT00485589|42113280|FG000|Overall Study|Protocol Violation|1|||
19664635|NCT00485589|42113281|FG001|Overall Study|Protocol Violation|0|||
19664636|NCT00485589|42113282|FG002|Overall Study|Protocol Violation|0|||
19664637|NCT00485589|42113280|FG000|Overall Study|Violation of selection criteria at entry|0|||
19756354|NCT03155178|42206999|FG003|Overall Study|Did not meet treatment day baseline|7|||
19756355|NCT00705250|42207023|FG000|Overall Study|Withdrawal by Subject|1|||
19756356|NCT00705250|42207023|FG000|Overall Study|Patient died in car accident|1|||
19756357|NCT03078192|42207029|FG000|Overall Study|Withdrawal by Subject|2|||
19756358|NCT03078192|42207030|FG001|Overall Study|Withdrawal by Subject|1|||
19756359|NCT03078192|42207029|FG000|Overall Study|screen failure|0|||
19756360|NCT03078192|42207030|FG001|Overall Study|screen failure|3|||
19756361|NCT00703846|42207036|FG000|Overall Study|Adverse Event|8|||
19664638|NCT00485589|42113281|FG001|Overall Study|Violation of selection criteria at entry|3|||
19664639|NCT00485589|42113282|FG002|Overall Study|Violation of selection criteria at entry|1|||
19664640|NCT00485589|42113280|FG000|Overall Study|Administrative/Other|1|||
19664641|NCT00485589|42113281|FG001|Overall Study|Administrative/Other|2|||
19664642|NCT00485589|42113282|FG002|Overall Study|Administrative/Other|1|||
19664643|NCT00485589|42113280|FG000|Overall Study|Insufficient therapeutic response|10|||
19664644|NCT00485589|42113281|FG001|Overall Study|Insufficient therapeutic response|3|||
19664645|NCT00485589|42113282|FG002|Overall Study|Insufficient therapeutic response|1|||
19664646|NCT00485589|42113280|FG000|Overall Study|Refused treatment/did not cooperate|1|||
19664647|NCT00485589|42113281|FG001|Overall Study|Refused treatment/did not cooperate|0|||
19664648|NCT00485589|42113282|FG002|Overall Study|Refused treatment/did not cooperate|2|||
19664649|NCT00485589|42113280|FG000|Overall Study|Withdrawal by Subject|3|||
19664650|NCT00485589|42113281|FG001|Overall Study|Withdrawal by Subject|2|||
19664651|NCT00485589|42113282|FG002|Overall Study|Withdrawal by Subject|2|||
19664652|NCT00485589|42113280|FG000|Overall Study|Adverse Event|3|||
19664653|NCT00485589|42113281|FG001|Overall Study|Adverse Event|3|||
19664654|NCT00485589|42113282|FG002|Overall Study|Adverse Event|10|||
19664655|NCT00490971|42113301|FG000|Acute/Continuation|Adverse Event|62|||
19664656|NCT00490971|42113302|FG001|Acute/Continuation|Adverse Event|13|||
19664657|NCT00490971|42113303|FG002|Acute/Continuation|Adverse Event|0|||
19664658|NCT00490971|42113304|FG003|Acute/Continuation|Adverse Event|0|||
19664659|NCT00490971|42113305|FG004|Acute/Continuation|Adverse Event|0|||
19664660|NCT00490971|42113301|FG000|Acute/Continuation|Death|2|||
19664661|NCT00490971|42113302|FG001|Acute/Continuation|Death|0|||
19664662|NCT00490971|42113303|FG002|Acute/Continuation|Death|0|||
19756362|NCT00703846|42207036|FG000|Overall Study|Lost to Follow-up|55|||
19756363|NCT00703846|42207036|FG000|Overall Study|Lack of Efficacy|15|||
19756364|NCT00703846|42207036|FG000|Overall Study|Noncompliance with Study Treatment|2|||
19756365|NCT00703846|42207036|FG000|Overall Study|Withdrawal by Subject|40|||
19756366|NCT00703846|42207036|FG000|Overall Study|Death|1|||
19756367|NCT00703846|42207036|FG000|Overall Study|Other|14|||
19756368|NCT00703846|42207036|FG000|Overall Study|Did Not Receive Study Drug|2|||
19756369|NCT01314872|42207051|FG000|Treatment Period 1|Protocol Violation|2|||
19756370|NCT01314872|42207052|FG001|Treatment Period 1|Protocol Violation|1|||
19664663|NCT00490971|42113304|FG003|Acute/Continuation|Death|0|||
19664664|NCT00490971|42113305|FG004|Acute/Continuation|Death|0|||
19664665|NCT00490971|42113301|FG000|Acute/Continuation|Lack of Efficacy|106|||
19664666|NCT00490971|42113302|FG001|Acute/Continuation|Lack of Efficacy|12|||
19664667|NCT00490971|42113303|FG002|Acute/Continuation|Lack of Efficacy|0|||
19664668|NCT00490971|42113304|FG003|Acute/Continuation|Lack of Efficacy|0|||
19664669|NCT00490971|42113305|FG004|Acute/Continuation|Lack of Efficacy|0|||
19664670|NCT00490971|42113301|FG000|Acute/Continuation|Lost to Follow-up|23|||
19664671|NCT00490971|42113302|FG001|Acute/Continuation|Lost to Follow-up|7|||
19664672|NCT00490971|42113303|FG002|Acute/Continuation|Lost to Follow-up|0|||
19664673|NCT00490971|42113304|FG003|Acute/Continuation|Lost to Follow-up|0|||
19664674|NCT00490971|42113305|FG004|Acute/Continuation|Lost to Follow-up|0|||
19756371|NCT01314872|42207053|FG002|Treatment Period 1|Protocol Violation|1|||
19756372|NCT01314872|42207054|FG003|Treatment Period 1|Protocol Violation|0|||
19664675|NCT00490971|42113301|FG000|Acute/Continuation|Protocol Violation|10|||
19664676|NCT00490971|42113302|FG001|Acute/Continuation|Protocol Violation|2|||
19664677|NCT00490971|42113303|FG002|Acute/Continuation|Protocol Violation|0|||
19664678|NCT00490971|42113304|FG003|Acute/Continuation|Protocol Violation|0|||
19664679|NCT00490971|42113305|FG004|Acute/Continuation|Protocol Violation|0|||
19664680|NCT00490971|42113301|FG000|Acute/Continuation|Withdrawal by Subject|92|||
19664681|NCT00490971|42113302|FG001|Acute/Continuation|Withdrawal by Subject|24|||
19664682|NCT00490971|42113303|FG002|Acute/Continuation|Withdrawal by Subject|0|||
19664683|NCT00490971|42113304|FG003|Acute/Continuation|Withdrawal by Subject|0|||
19664684|NCT00490971|42113305|FG004|Acute/Continuation|Withdrawal by Subject|0|||
19664685|NCT00490971|42113301|FG000|Acute/Continuation|Other|11|||
19664686|NCT00490971|42113302|FG001|Acute/Continuation|Other|4|||
19664687|NCT00490971|42113303|FG002|Acute/Continuation|Other|0|||
19664688|NCT00490971|42113304|FG003|Acute/Continuation|Other|0|||
19664689|NCT00490971|42113305|FG004|Acute/Continuation|Other|0|||
19664690|NCT00490971|42113301|FG000|Maintenance|Adverse Event|0|||
19756373|NCT01314872|42207055|FG004|Treatment Period 1|Protocol Violation|1|||
19756374|NCT01314872|42207056|FG005|Treatment Period 1|Protocol Violation|0|||
19756375|NCT01314872|42207057|FG006|Treatment Period 1|Protocol Violation|0|||
19756376|NCT01314872|42207058|FG007|Treatment Period 1|Protocol Violation|0|||
19756377|NCT01314872|42207059|FG008|Treatment Period 1|Protocol Violation|0|||
19756378|NCT01314872|42207060|FG009|Treatment Period 1|Protocol Violation|1|||
19756379|NCT01314872|42207061|FG010|Treatment Period 1|Protocol Violation|1|||
19756380|NCT01314872|42207062|FG011|Treatment Period 1|Protocol Violation|0|||
19664691|NCT00490971|42113302|FG001|Maintenance|Adverse Event|0|||
19664692|NCT00490971|42113303|FG002|Maintenance|Adverse Event|4|||
19664693|NCT00490971|42113304|FG003|Maintenance|Adverse Event|5|||
19664694|NCT00490971|42113305|FG004|Maintenance|Adverse Event|7|||
19664695|NCT00490971|42113301|FG000|Maintenance|Death|0|||
19664696|NCT00490971|42113302|FG001|Maintenance|Death|0|||
19664697|NCT00490971|42113303|FG002|Maintenance|Death|0|||
19664698|NCT00490971|42113304|FG003|Maintenance|Death|2|||
19664699|NCT00490971|42113305|FG004|Maintenance|Death|0|||
19664700|NCT00490971|42113301|FG000|Maintenance|Lost to Follow-up|0|||
19664701|NCT00490971|42113302|FG001|Maintenance|Lost to Follow-up|0|||
19664702|NCT00490971|42113303|FG002|Maintenance|Lost to Follow-up|5|||
19664703|NCT00490971|42113304|FG003|Maintenance|Lost to Follow-up|8|||
19664704|NCT00490971|42113305|FG004|Maintenance|Lost to Follow-up|10|||
19664705|NCT00490971|42113301|FG000|Maintenance|Pregnancy|0|||
19664706|NCT00490971|42113302|FG001|Maintenance|Pregnancy|0|||
19664707|NCT00490971|42113303|FG002|Maintenance|Pregnancy|1|||
19664708|NCT00490971|42113304|FG003|Maintenance|Pregnancy|0|||
19664709|NCT00490971|42113305|FG004|Maintenance|Pregnancy|0|||
19664710|NCT00490971|42113301|FG000|Maintenance|Protocol Violation|0|||
19664711|NCT00490971|42113302|FG001|Maintenance|Protocol Violation|0|||
19664712|NCT00490971|42113303|FG002|Maintenance|Protocol Violation|4|||
19664713|NCT00490971|42113304|FG003|Maintenance|Protocol Violation|1|||
19664714|NCT00490971|42113305|FG004|Maintenance|Protocol Violation|1|||
19664715|NCT00490971|42113301|FG000|Maintenance|Withdrawal by Subject|0|||
19664716|NCT00490971|42113302|FG001|Maintenance|Withdrawal by Subject|0|||
19664717|NCT00490971|42113303|FG002|Maintenance|Withdrawal by Subject|26|||
19664718|NCT00490971|42113304|FG003|Maintenance|Withdrawal by Subject|28|||
19664719|NCT00490971|42113305|FG004|Maintenance|Withdrawal by Subject|18|||
19664720|NCT00490971|42113301|FG000|Maintenance|Other|0|||
19664721|NCT00490971|42113302|FG001|Maintenance|Other|0|||
19664722|NCT00490971|42113303|FG002|Maintenance|Other|11|||
19664723|NCT00490971|42113304|FG003|Maintenance|Other|9|||
19664724|NCT00490971|42113305|FG004|Maintenance|Other|3|||
19664725|NCT00686075|42113327|FG000|Overall Study|Withdrawal by Subject|4|||
19664726|NCT00686075|42113328|FG001|Overall Study|Withdrawal by Subject|3|||
19664727|NCT00686075|42113329|FG002|Overall Study|Withdrawal by Subject|3|||
19664728|NCT00686075|42113330|FG003|Overall Study|Withdrawal by Subject|7|||
19664729|NCT00686075|42113331|FG004|Overall Study|Withdrawal by Subject|1|||
19756381|NCT01314872|42207063|FG012|Treatment Period 1|Protocol Violation|0|||
19664730|NCT00686075|42113332|FG005|Overall Study|Withdrawal by Subject|0|||
19664731|NCT00686075|42113333|FG006|Overall Study|Withdrawal by Subject|0|||
19664732|NCT00686075|42113334|FG007|Overall Study|Withdrawal by Subject|2|||
19664733|NCT00686075|42113335|FG008|Overall Study|Withdrawal by Subject|4|||
19664734|NCT00686075|42113336|FG009|Overall Study|Withdrawal by Subject|6|||
19664735|NCT00686075|42113327|FG000|Overall Study|Lost to Follow-up|3|||
19664736|NCT00686075|42113328|FG001|Overall Study|Lost to Follow-up|6|||
19664737|NCT00686075|42113329|FG002|Overall Study|Lost to Follow-up|3|||
19664738|NCT00686075|42113330|FG003|Overall Study|Lost to Follow-up|2|||
19664739|NCT00686075|42113331|FG004|Overall Study|Lost to Follow-up|3|||
19664740|NCT00686075|42113332|FG005|Overall Study|Lost to Follow-up|3|||
19664741|NCT00686075|42113333|FG006|Overall Study|Lost to Follow-up|0|||
19664742|NCT00686075|42113334|FG007|Overall Study|Lost to Follow-up|0|||
19664743|NCT00686075|42113335|FG008|Overall Study|Lost to Follow-up|2|||
19664744|NCT00686075|42113336|FG009|Overall Study|Lost to Follow-up|3|||
19664745|NCT00686075|42113327|FG000|Overall Study|Other|1|||
19664746|NCT00686075|42113328|FG001|Overall Study|Other|1|||
19664747|NCT00686075|42113329|FG002|Overall Study|Other|0|||
19664748|NCT00686075|42113330|FG003|Overall Study|Other|0|||
19664749|NCT00686075|42113331|FG004|Overall Study|Other|0|||
19664750|NCT00686075|42113332|FG005|Overall Study|Other|0|||
19664751|NCT00686075|42113333|FG006|Overall Study|Other|0|||
19664752|NCT00686075|42113334|FG007|Overall Study|Other|0|||
19664753|NCT00686075|42113335|FG008|Overall Study|Other|0|||
19664754|NCT00686075|42113336|FG009|Overall Study|Other|1|||
19664755|NCT00685763|42113358|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
19664756|NCT00685763|42113358|FG000|Overall Study|Protocol Violation|1|||
19664757|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Adverse Event|14|||
19664758|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Adverse Event|27|||
19664759|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Adverse Event|60|||
19664760|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Adverse Event|0|||
19664761|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Adverse Event|0|||
19664762|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Pregnancy|0|||
19664763|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Pregnancy|7|||
19664764|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Pregnancy|9|||
19664765|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Pregnancy|0|||
19664766|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Pregnancy|0|||
19664767|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
19664768|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
19664769|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
19664770|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
19664771|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
19664772|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
19664773|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
19664774|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
19664775|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
19664776|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
19756382|NCT01314872|42207064|FG013|Treatment Period 1|Protocol Violation|0|||
19756383|NCT01314872|42207065|FG014|Treatment Period 1|Protocol Violation|0|||
19756384|NCT01314872|42207051|FG000|Treatment Period 1|Physician Decision|0|||
19664777|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Death|1|||
19756385|NCT01314872|42207052|FG001|Treatment Period 1|Physician Decision|1|||
19756386|NCT01314872|42207053|FG002|Treatment Period 1|Physician Decision|0|||
19756387|NCT01314872|42207054|FG003|Treatment Period 1|Physician Decision|1|||
19664778|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Death|2|||
19664779|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Death|2|||
19664780|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Death|0|||
19664781|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Death|0|||
19664782|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
19664783|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
19664784|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
19664785|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
19664786|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
19664787|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
19664788|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
19664789|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
19664790|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
19664791|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
19664792|NCT00098293|42113365|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
19664793|NCT00098293|42113366|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
19664794|NCT00098293|42113367|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
19664795|NCT00098293|42113368|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
19664796|NCT00098293|42113369|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
19664797|NCT00098293|42113365|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
19664798|NCT00098293|42113366|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
19664799|NCT00098293|42113367|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
19664800|NCT00098293|42113368|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
19664801|NCT00098293|42113369|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
19664802|NCT00098293|42113365|FG000|Open-label (OL) Phase|Adverse Event|0|||
19664803|NCT00098293|42113366|FG001|Open-label (OL) Phase|Adverse Event|3|||
19664804|NCT00098293|42113367|FG002|Open-label (OL) Phase|Adverse Event|7|||
19664805|NCT00098293|42113368|FG003|Open-label (OL) Phase|Adverse Event|6|||
19664806|NCT00098293|42113369|FG004|Open-label (OL) Phase|Adverse Event|0|||
19664807|NCT00098293|42113365|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
19664808|NCT00098293|42113366|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
19664809|NCT00098293|42113367|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
19664810|NCT00098293|42113368|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
19664811|NCT00098293|42113369|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
19664812|NCT00098293|42113365|FG000|Open-label (OL) Phase|Pregnancy|0|||
19664813|NCT00098293|42113366|FG001|Open-label (OL) Phase|Pregnancy|1|||
19664814|NCT00098293|42113367|FG002|Open-label (OL) Phase|Pregnancy|0|||
19664815|NCT00098293|42113368|FG003|Open-label (OL) Phase|Pregnancy|3|||
19664816|NCT00098293|42113369|FG004|Open-label (OL) Phase|Pregnancy|0|||
19664817|NCT00098293|42113365|FG000|Open-label (OL) Phase|Protocol Violation|0|||
19664818|NCT00098293|42113366|FG001|Open-label (OL) Phase|Protocol Violation|6|||
19664819|NCT00098293|42113367|FG002|Open-label (OL) Phase|Protocol Violation|13|||
19664820|NCT00098293|42113368|FG003|Open-label (OL) Phase|Protocol Violation|16|||
19664821|NCT00098293|42113369|FG004|Open-label (OL) Phase|Protocol Violation|0|||
19664822|NCT00098293|42113365|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
19664823|NCT00098293|42113366|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
19664824|NCT00098293|42113367|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
19664825|NCT00098293|42113368|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
19664826|NCT00098293|42113369|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
19664827|NCT00098293|42113365|FG000|Open-label (OL) Phase|Death|0|||
19664828|NCT00098293|42113366|FG001|Open-label (OL) Phase|Death|2|||
19664829|NCT00098293|42113367|FG002|Open-label (OL) Phase|Death|3|||
19664830|NCT00098293|42113368|FG003|Open-label (OL) Phase|Death|0|||
19664831|NCT00098293|42113369|FG004|Open-label (OL) Phase|Death|0|||
19664832|NCT00098293|42113365|FG000|Supplemental Phase (SP)|Death|0|||
19664833|NCT00098293|42113366|FG001|Supplemental Phase (SP)|Death|0|||
19664834|NCT00098293|42113367|FG002|Supplemental Phase (SP)|Death|0|||
19756388|NCT01314872|42207055|FG004|Treatment Period 1|Physician Decision|0|||
19756389|NCT01314872|42207056|FG005|Treatment Period 1|Physician Decision|0|||
19664835|NCT00098293|42113368|FG003|Supplemental Phase (SP)|Death|0|||
19664836|NCT00098293|42113369|FG004|Supplemental Phase (SP)|Death|1|||
19664837|NCT00098293|42113365|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
19664838|NCT00098293|42113366|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
19664839|NCT00098293|42113367|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
19664840|NCT00098293|42113368|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
19664841|NCT00098293|42113369|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
19664842|NCT00098293|42113365|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
19756390|NCT01314872|42207057|FG006|Treatment Period 1|Physician Decision|0|||
19756391|NCT01314872|42207058|FG007|Treatment Period 1|Physician Decision|0|||
19756392|NCT01314872|42207059|FG008|Treatment Period 1|Physician Decision|0|||
19756393|NCT01314872|42207060|FG009|Treatment Period 1|Physician Decision|1|||
19756394|NCT01314872|42207061|FG010|Treatment Period 1|Physician Decision|0|||
19756395|NCT01314872|42207062|FG011|Treatment Period 1|Physician Decision|0|||
19756396|NCT01314872|42207063|FG012|Treatment Period 1|Physician Decision|0|||
19756397|NCT01314872|42207064|FG013|Treatment Period 1|Physician Decision|0|||
19756398|NCT01314872|42207065|FG014|Treatment Period 1|Physician Decision|0|||
19756399|NCT01314872|42207051|FG000|Treatment Period 1|Lack of Efficacy|1|||
19756400|NCT01314872|42207052|FG001|Treatment Period 1|Lack of Efficacy|0|||
19756401|NCT01314872|42207053|FG002|Treatment Period 1|Lack of Efficacy|0|||
19756402|NCT01314872|42207054|FG003|Treatment Period 1|Lack of Efficacy|0|||
19756403|NCT01314872|42207055|FG004|Treatment Period 1|Lack of Efficacy|0|||
19756404|NCT01314872|42207056|FG005|Treatment Period 1|Lack of Efficacy|1|||
19756405|NCT01314872|42207057|FG006|Treatment Period 1|Lack of Efficacy|0|||
19756406|NCT01314872|42207058|FG007|Treatment Period 1|Lack of Efficacy|2|||
19664843|NCT00098293|42113366|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
19664844|NCT00098293|42113367|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
19664845|NCT00098293|42113368|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
19664846|NCT00098293|42113369|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
19664847|NCT00098293|42113365|FG000|Supplemental Phase (SP)|Other|0|||
19664848|NCT00098293|42113366|FG001|Supplemental Phase (SP)|Other|0|||
19664849|NCT00098293|42113367|FG002|Supplemental Phase (SP)|Other|0|||
19664850|NCT00098293|42113368|FG003|Supplemental Phase (SP)|Other|0|||
19664851|NCT00098293|42113369|FG004|Supplemental Phase (SP)|Other|22|||
19664852|NCT00685685|42113380|FG000|Washout Period of 7 Days|Adverse Event|2|||
19664853|NCT00685685|42113381|FG001|Washout Period of 7 Days|Adverse Event|0|||
19664854|NCT00685685|42113380|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19756407|NCT01314872|42207059|FG008|Treatment Period 1|Lack of Efficacy|0|||
19664855|NCT00685685|42113381|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19664856|NCT00684671|42113390|FG000|Overall Study|Adverse Event|1|||
19664857|NCT00684671|42113391|FG001|Overall Study|Adverse Event|0|||
19756408|NCT01314872|42207060|FG009|Treatment Period 1|Lack of Efficacy|0|||
19664858|NCT00684671|42113392|FG002|Overall Study|Adverse Event|0|||
19664859|NCT00684671|42113390|FG000|Overall Study|Lost to Follow-up|1|||
19664860|NCT00684671|42113391|FG001|Overall Study|Lost to Follow-up|0|||
19664861|NCT00684671|42113392|FG002|Overall Study|Lost to Follow-up|0|||
19664862|NCT00684671|42113390|FG000|Overall Study|Alcoholic dependance|1|||
19664863|NCT00684671|42113391|FG001|Overall Study|Alcoholic dependance|0|||
19664864|NCT00684671|42113392|FG002|Overall Study|Alcoholic dependance|0|||
19756409|NCT01314872|42207061|FG010|Treatment Period 1|Lack of Efficacy|0|||
19756410|NCT01314872|42207062|FG011|Treatment Period 1|Lack of Efficacy|0|||
19756411|NCT01314872|42207063|FG012|Treatment Period 1|Lack of Efficacy|0|||
19756412|NCT01314872|42207064|FG013|Treatment Period 1|Lack of Efficacy|0|||
19756413|NCT01314872|42207065|FG014|Treatment Period 1|Lack of Efficacy|0|||
19756414|NCT01314872|42207051|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
19756415|NCT01314872|42207052|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
19756416|NCT01314872|42207053|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
19756417|NCT01314872|42207054|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
19756418|NCT01314872|42207055|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
19756419|NCT01314872|42207056|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
19756420|NCT01314872|42207057|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
19756421|NCT01314872|42207058|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
19756422|NCT01314872|42207059|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
19756423|NCT01314872|42207060|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
19756424|NCT01314872|42207061|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
19756425|NCT01314872|42207062|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
19756426|NCT01314872|42207063|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
19756427|NCT01314872|42207064|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
19756428|NCT01314872|42207065|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
19756429|NCT01314872|42207051|FG000|Treatment Period 1|Withdrawal by Subject|3|||
19756430|NCT01314872|42207052|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19756431|NCT01314872|42207053|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19756432|NCT01314872|42207054|FG003|Treatment Period 1|Withdrawal by Subject|2|||
19756433|NCT01314872|42207055|FG004|Treatment Period 1|Withdrawal by Subject|3|||
19756434|NCT01314872|42207056|FG005|Treatment Period 1|Withdrawal by Subject|1|||
19756435|NCT01314872|42207057|FG006|Treatment Period 1|Withdrawal by Subject|3|||
19756436|NCT01314872|42207058|FG007|Treatment Period 1|Withdrawal by Subject|2|||
19756437|NCT01314872|42207059|FG008|Treatment Period 1|Withdrawal by Subject|2|||
19756438|NCT01314872|42207060|FG009|Treatment Period 1|Withdrawal by Subject|2|||
19756439|NCT01314872|42207061|FG010|Treatment Period 1|Withdrawal by Subject|1|||
19756440|NCT01314872|42207062|FG011|Treatment Period 1|Withdrawal by Subject|0|||
19756441|NCT01314872|42207063|FG012|Treatment Period 1|Withdrawal by Subject|0|||
19756442|NCT01314872|42207064|FG013|Treatment Period 1|Withdrawal by Subject|0|||
19756443|NCT01314872|42207065|FG014|Treatment Period 1|Withdrawal by Subject|0|||
19756444|NCT01314872|42207051|FG000|Treatment Period 1|Lost to Follow-up|0|||
19756445|NCT01314872|42207052|FG001|Treatment Period 1|Lost to Follow-up|1|||
19756446|NCT01314872|42207053|FG002|Treatment Period 1|Lost to Follow-up|2|||
19756447|NCT01314872|42207054|FG003|Treatment Period 1|Lost to Follow-up|2|||
19756448|NCT01314872|42207055|FG004|Treatment Period 1|Lost to Follow-up|1|||
19756449|NCT01314872|42207056|FG005|Treatment Period 1|Lost to Follow-up|1|||
19756450|NCT01314872|42207057|FG006|Treatment Period 1|Lost to Follow-up|1|||
19664865|NCT03859323|42113413|FG000|Overall Study|Lost to Follow-up|0|||
19664866|NCT03859323|42113414|FG001|Overall Study|Lost to Follow-up|0|||
19664867|NCT03859323|42113415|FG002|Overall Study|Lost to Follow-up|0|||
19664868|NCT03859323|42113416|FG003|Overall Study|Lost to Follow-up|0|||
19664869|NCT03859323|42113417|FG004|Overall Study|Lost to Follow-up|0|||
19664870|NCT03859323|42113418|FG005|Overall Study|Lost to Follow-up|0|||
19664871|NCT03859323|42113419|FG006|Overall Study|Lost to Follow-up|1|||
19756451|NCT01314872|42207058|FG007|Treatment Period 1|Lost to Follow-up|1|||
19756452|NCT01314872|42207059|FG008|Treatment Period 1|Lost to Follow-up|1|||
19664872|NCT03859323|42113420|FG007|Overall Study|Lost to Follow-up|0|||
19664873|NCT03859323|42113421|FG008|Overall Study|Lost to Follow-up|0|||
19664874|NCT03859323|42113422|FG009|Overall Study|Lost to Follow-up|0|||
19664875|NCT03859323|42113423|FG010|Overall Study|Lost to Follow-up|0|||
19664876|NCT03859323|42113424|FG011|Overall Study|Lost to Follow-up|0|||
19664877|NCT03859323|42113425|FG012|Overall Study|Lost to Follow-up|0|||
19664878|NCT03859323|42113413|FG000|Overall Study|Withdrawal by Subject|0|||
19664879|NCT03859323|42113414|FG001|Overall Study|Withdrawal by Subject|0|||
19664880|NCT03859323|42113415|FG002|Overall Study|Withdrawal by Subject|1|||
19664881|NCT03859323|42113416|FG003|Overall Study|Withdrawal by Subject|0|||
19664882|NCT03859323|42113417|FG004|Overall Study|Withdrawal by Subject|0|||
19664883|NCT03859323|42113418|FG005|Overall Study|Withdrawal by Subject|1|||
19664884|NCT03859323|42113419|FG006|Overall Study|Withdrawal by Subject|0|||
19664885|NCT03859323|42113420|FG007|Overall Study|Withdrawal by Subject|0|||
19664886|NCT03859323|42113421|FG008|Overall Study|Withdrawal by Subject|0|||
19664887|NCT03859323|42113422|FG009|Overall Study|Withdrawal by Subject|1|||
19664888|NCT03859323|42113423|FG010|Overall Study|Withdrawal by Subject|1|||
19664889|NCT03859323|42113424|FG011|Overall Study|Withdrawal by Subject|2|||
19664890|NCT03859323|42113425|FG012|Overall Study|Withdrawal by Subject|1|||
19664891|NCT03859323|42113413|FG000|Overall Study|Pregnancy|0|||
19664892|NCT03859323|42113414|FG001|Overall Study|Pregnancy|0|||
19664893|NCT03859323|42113415|FG002|Overall Study|Pregnancy|0|||
19664894|NCT03859323|42113416|FG003|Overall Study|Pregnancy|0|||
19664895|NCT03859323|42113417|FG004|Overall Study|Pregnancy|0|||
19664896|NCT03859323|42113418|FG005|Overall Study|Pregnancy|0|||
19664897|NCT03859323|42113419|FG006|Overall Study|Pregnancy|0|||
19664898|NCT03859323|42113420|FG007|Overall Study|Pregnancy|0|||
19664899|NCT03859323|42113421|FG008|Overall Study|Pregnancy|0|||
19664900|NCT03859323|42113422|FG009|Overall Study|Pregnancy|1|||
19664901|NCT03859323|42113423|FG010|Overall Study|Pregnancy|0|||
19664902|NCT03859323|42113424|FG011|Overall Study|Pregnancy|0|||
19664903|NCT03859323|42113425|FG012|Overall Study|Pregnancy|0|||
19664904|NCT03857841|42113468|FG000|Overall Study|Death|1|||
19664905|NCT03857841|42113469|FG001|Overall Study|Death|0|||
19664906|NCT03857841|42113470|FG002|Overall Study|Death|0|||
19664907|NCT03857841|42113471|FG003|Overall Study|Death|0|||
19664908|NCT03857841|42113468|FG000|Overall Study|Study Terminated by Sponsor|1|||
19664909|NCT03857841|42113469|FG001|Overall Study|Study Terminated by Sponsor|0|||
19664910|NCT03857841|42113470|FG002|Overall Study|Study Terminated by Sponsor|0|||
19664911|NCT03857841|42113471|FG003|Overall Study|Study Terminated by Sponsor|0|||
19664912|NCT00500331|42113488|FG000|Overall Study|Adverse Event|0|||
19664913|NCT00500331|42113489|FG001|Overall Study|Adverse Event|2|||
19664914|NCT00500331|42113490|FG002|Overall Study|Adverse Event|0|||
19664915|NCT00500331|42113491|FG003|Overall Study|Adverse Event|1|||
19664916|NCT00500331|42113492|FG004|Overall Study|Adverse Event|2|||
19664917|NCT00500331|42113493|FG005|Overall Study|Adverse Event|2|||
19664918|NCT00500331|42113494|FG006|Overall Study|Adverse Event|0|||
19664919|NCT00500331|42113488|FG000|Overall Study|Lost to Follow-up|1|||
19664920|NCT00500331|42113489|FG001|Overall Study|Lost to Follow-up|1|||
19664921|NCT00500331|42113490|FG002|Overall Study|Lost to Follow-up|1|||
19664922|NCT00500331|42113491|FG003|Overall Study|Lost to Follow-up|2|||
19664923|NCT00500331|42113492|FG004|Overall Study|Lost to Follow-up|1|||
19664924|NCT00500331|42113493|FG005|Overall Study|Lost to Follow-up|0|||
19664925|NCT00500331|42113494|FG006|Overall Study|Lost to Follow-up|0|||
19664926|NCT00500331|42113488|FG000|Overall Study|Protocol Violation|3|||
19664927|NCT00500331|42113489|FG001|Overall Study|Protocol Violation|1|||
19664928|NCT00500331|42113490|FG002|Overall Study|Protocol Violation|1|||
19664929|NCT00500331|42113491|FG003|Overall Study|Protocol Violation|0|||
19664930|NCT00500331|42113492|FG004|Overall Study|Protocol Violation|1|||
19664931|NCT00500331|42113493|FG005|Overall Study|Protocol Violation|1|||
19664932|NCT00500331|42113494|FG006|Overall Study|Protocol Violation|1|||
19664933|NCT00500331|42113488|FG000|Overall Study|Withdrawal by Subject|4|||
19664934|NCT00500331|42113489|FG001|Overall Study|Withdrawal by Subject|0|||
19664935|NCT00500331|42113490|FG002|Overall Study|Withdrawal by Subject|1|||
19664936|NCT00500331|42113491|FG003|Overall Study|Withdrawal by Subject|5|||
19664937|NCT00500331|42113492|FG004|Overall Study|Withdrawal by Subject|0|||
19664938|NCT00500331|42113493|FG005|Overall Study|Withdrawal by Subject|1|||
19664939|NCT00500331|42113494|FG006|Overall Study|Withdrawal by Subject|1|||
19664940|NCT00500331|42113488|FG000|Overall Study|Lack of Efficacy|3|||
19664941|NCT00500331|42113489|FG001|Overall Study|Lack of Efficacy|1|||
19664942|NCT00500331|42113490|FG002|Overall Study|Lack of Efficacy|0|||
19664943|NCT00500331|42113491|FG003|Overall Study|Lack of Efficacy|0|||
19664944|NCT00500331|42113492|FG004|Overall Study|Lack of Efficacy|0|||
19664945|NCT00500331|42113493|FG005|Overall Study|Lack of Efficacy|0|||
19664946|NCT00500331|42113494|FG006|Overall Study|Lack of Efficacy|0|||
19664947|NCT00500331|42113488|FG000|Overall Study|Liver function test abnormality|0|||
19664948|NCT00500331|42113489|FG001|Overall Study|Liver function test abnormality|0|||
19664949|NCT00500331|42113490|FG002|Overall Study|Liver function test abnormality|1|||
19664950|NCT00500331|42113491|FG003|Overall Study|Liver function test abnormality|0|||
19664951|NCT00500331|42113492|FG004|Overall Study|Liver function test abnormality|0|||
19664952|NCT00500331|42113493|FG005|Overall Study|Liver function test abnormality|0|||
19664953|NCT00500331|42113494|FG006|Overall Study|Liver function test abnormality|0|||
19664954|NCT00500331|42113488|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
19664955|NCT00500331|42113489|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
19664956|NCT00500331|42113490|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
19664957|NCT00500331|42113491|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
19664958|NCT00500331|42113492|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
19664959|NCT00500331|42113493|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
19664960|NCT00500331|42113494|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
19388775|NCT02544633|41632287|FG002|Treatment Period|Death|1|||
19602618|NCT00769132|42051288|FG003|Period 1|Adverse Event|1|||
19602619|NCT00769132|42051285|FG000|Period 2|Withdrawal by Subject|0|||
19602620|NCT00769132|42051286|FG001|Period 2|Withdrawal by Subject|0|||
19602621|NCT00769132|42051287|FG002|Period 2|Withdrawal by Subject|0|||
19602622|NCT00769132|42051288|FG003|Period 2|Withdrawal by Subject|1|||
19602623|NCT00769132|42051285|FG000|Period 3|Withdrawal by Subject|1|||
19602624|NCT00769132|42051286|FG001|Period 3|Withdrawal by Subject|0|||
19602625|NCT00769132|42051287|FG002|Period 3|Withdrawal by Subject|0|||
19602626|NCT00769132|42051288|FG003|Period 3|Withdrawal by Subject|0|||
19602627|NCT00769132|42051285|FG000|Period 4|Withdrawal by Subject|0|||
19602628|NCT00769132|42051286|FG001|Period 4|Withdrawal by Subject|1|||
19602629|NCT00769132|42051287|FG002|Period 4|Withdrawal by Subject|0|||
19602630|NCT00769132|42051288|FG003|Period 4|Withdrawal by Subject|0|||
19602631|NCT00991952|42051300|FG000|Overall Study|Adverse Event|0|||
19602632|NCT00991952|42051301|FG001|Overall Study|Adverse Event|1|||
19602633|NCT00779038|42051307|FG000|Overall Study|Study Prematurely Terminated|13|||
19602634|NCT00765076|42051314|FG000|Overall Study|Adverse Event|1|||
19602635|NCT00765076|42051315|FG001|Overall Study|Adverse Event|0|||
19602636|NCT00765076|42051316|FG002|Overall Study|Adverse Event|0|||
19602637|NCT00765076|42051314|FG000|Overall Study|Withdrawal by Subject|0|||
19602638|NCT00765076|42051315|FG001|Overall Study|Withdrawal by Subject|0|||
19664961|NCT00500331|42113488|FG000|Overall Study|Didn't return for continuation of study|1|||
19664962|NCT00500331|42113489|FG001|Overall Study|Didn't return for continuation of study|0|||
19664963|NCT00500331|42113490|FG002|Overall Study|Didn't return for continuation of study|0|||
19664964|NCT00500331|42113491|FG003|Overall Study|Didn't return for continuation of study|0|||
19756453|NCT01314872|42207060|FG009|Treatment Period 1|Lost to Follow-up|0|||
19664965|NCT00500331|42113492|FG004|Overall Study|Didn't return for continuation of study|0|||
19664966|NCT00500331|42113493|FG005|Overall Study|Didn't return for continuation of study|0|||
19664967|NCT00500331|42113494|FG006|Overall Study|Didn't return for continuation of study|0|||
19664968|NCT00500331|42113488|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
19664969|NCT00500331|42113489|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664970|NCT00500331|42113490|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664971|NCT00500331|42113491|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664972|NCT00500331|42113492|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664973|NCT00500331|42113493|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664974|NCT00500331|42113494|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
19664975|NCT00500331|42113488|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
19664976|NCT00500331|42113489|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
19664977|NCT00500331|42113490|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
19664978|NCT00500331|42113491|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
19664979|NCT00500331|42113492|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
19664980|NCT00500331|42113493|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
19664981|NCT00500331|42113494|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
19664982|NCT00500331|42113488|FG000|Overall Study|Participant was randomized by mistake|1|||
19664983|NCT00500331|42113489|FG001|Overall Study|Participant was randomized by mistake|0|||
19664984|NCT00500331|42113490|FG002|Overall Study|Participant was randomized by mistake|0|||
19664985|NCT00500331|42113491|FG003|Overall Study|Participant was randomized by mistake|0|||
19664986|NCT00500331|42113492|FG004|Overall Study|Participant was randomized by mistake|0|||
19664987|NCT00500331|42113493|FG005|Overall Study|Participant was randomized by mistake|0|||
19664988|NCT00500331|42113494|FG006|Overall Study|Participant was randomized by mistake|0|||
19664989|NCT00500331|42113488|FG000|Overall Study|Diabetologist nurse in the study|0|||
19664990|NCT00500331|42113489|FG001|Overall Study|Diabetologist nurse in the study|0|||
19664991|NCT00500331|42113490|FG002|Overall Study|Diabetologist nurse in the study|1|||
19664992|NCT00500331|42113491|FG003|Overall Study|Diabetologist nurse in the study|0|||
19664993|NCT00500331|42113492|FG004|Overall Study|Diabetologist nurse in the study|0|||
19664994|NCT00500331|42113493|FG005|Overall Study|Diabetologist nurse in the study|0|||
19664995|NCT00500331|42113494|FG006|Overall Study|Diabetologist nurse in the study|0|||
19664996|NCT00500331|42113488|FG000|Overall Study|State ban of biological samples export|0|||
19664997|NCT00500331|42113489|FG001|Overall Study|State ban of biological samples export|0|||
19664998|NCT00500331|42113490|FG002|Overall Study|State ban of biological samples export|0|||
19664999|NCT00500331|42113491|FG003|Overall Study|State ban of biological samples export|1|||
19665000|NCT00500331|42113492|FG004|Overall Study|State ban of biological samples export|0|||
19665001|NCT00500331|42113493|FG005|Overall Study|State ban of biological samples export|0|||
19665002|NCT00500331|42113494|FG006|Overall Study|State ban of biological samples export|0|||
19665003|NCT00500331|42113488|FG000|Overall Study|Protocol violated|0|||
19665004|NCT00500331|42113489|FG001|Overall Study|Protocol violated|0|||
19665005|NCT00500331|42113490|FG002|Overall Study|Protocol violated|0|||
19665006|NCT00500331|42113491|FG003|Overall Study|Protocol violated|1|||
19665007|NCT00500331|42113492|FG004|Overall Study|Protocol violated|0|||
19665008|NCT00500331|42113493|FG005|Overall Study|Protocol violated|0|||
19665009|NCT00500331|42113494|FG006|Overall Study|Protocol violated|0|||
19665010|NCT00499863|42113513|FG000|Overall Study|Lack of Efficacy|21|||
19665011|NCT00499863|42113514|FG001|Overall Study|Lack of Efficacy|27|||
19665012|NCT00499863|42113513|FG000|Overall Study|Protocol Violation|12|||
19665013|NCT00499863|42113514|FG001|Overall Study|Protocol Violation|7|||
19665014|NCT00499863|42113513|FG000|Overall Study|Withdrawal by Subject|6|||
19665015|NCT00499863|42113514|FG001|Overall Study|Withdrawal by Subject|4|||
19665016|NCT00499863|42113513|FG000|Overall Study|Adverse Event|8|||
19665017|NCT00499863|42113514|FG001|Overall Study|Adverse Event|2|||
19665018|NCT00499863|42113513|FG000|Overall Study|Sponsor decision|2|||
19665019|NCT00499863|42113514|FG001|Overall Study|Sponsor decision|2|||
19665020|NCT00499863|42113513|FG000|Overall Study|Lost to Follow-up|1|||
19665021|NCT00499863|42113514|FG001|Overall Study|Lost to Follow-up|1|||
19665022|NCT00484185|42113520|FG000|Overall Study|Lost to Follow-up|44|||
19665023|NCT00484185|42113520|FG000|Overall Study|Other|20|||
19665024|NCT00484185|42113520|FG000|Overall Study|Randomized but not treated|5|||
19665025|NCT00484185|42113520|FG000|Overall Study|Death|2|||
19665026|NCT00097981|42113526|FG000|Overall Study|Adverse Event|31|||
19665027|NCT00097981|42113527|FG001|Overall Study|Adverse Event|44|||
19665028|NCT00097981|42113526|FG000|Overall Study|Withdrawal by Subject|10|||
19665029|NCT00097981|42113527|FG001|Overall Study|Withdrawal by Subject|8|||
19665030|NCT00097981|42113526|FG000|Overall Study|Protocol Violation|1|||
19665031|NCT00097981|42113527|FG001|Overall Study|Protocol Violation|1|||
19665032|NCT00097981|42113526|FG000|Overall Study|Death|2|||
19665033|NCT00097981|42113527|FG001|Overall Study|Death|4|||
19665034|NCT00097981|42113526|FG000|Overall Study|Physician Decision|7|||
19665035|NCT00097981|42113527|FG001|Overall Study|Physician Decision|1|||
19665036|NCT00097981|42113526|FG000|Overall Study|Disease Progression|8|||
19665037|NCT00097981|42113527|FG001|Overall Study|Disease Progression|2|||
19665038|NCT00097981|42113526|FG000|Overall Study|Transplant planned|28|||
19665039|NCT00097981|42113527|FG001|Overall Study|Transplant planned|27|||
19665040|NCT00097981|42113526|FG000|Overall Study|Other|19|||
19665041|NCT00097981|42113527|FG001|Overall Study|Other|13|||
19665042|NCT00499083|42113533|FG000|Overall Study|Not evaluable|3|||
19665043|NCT00572195|42113537|FG000|Overall Study|Withdrawal by Subject|50|||
19665044|NCT00572195|42113537|FG000|Overall Study|Death|9|||
19665045|NCT00572195|42113537|FG000|Overall Study|Adverse Event|4|||
19665046|NCT00572195|42113537|FG000|Overall Study|Lost to Follow-up|5|||
19665047|NCT00572039|42113543|FG000|Overall Study|Withdrawal by Subject|9|||
19665048|NCT00572039|42113544|FG001|Overall Study|Withdrawal by Subject|6|||
19665049|NCT00572039|42113543|FG000|Overall Study|Death|2|||
19665050|NCT00572039|42113544|FG001|Overall Study|Death|3|||
19665051|NCT00572039|42113543|FG000|Overall Study|Ill|5|||
19665052|NCT00572039|42113544|FG001|Overall Study|Ill|1|||
19665053|NCT00684593|42113554|FG000|Overall Study|Adverse Event|0|||
19665054|NCT00684593|42113555|FG001|Overall Study|Adverse Event|2|||
19665055|NCT00685373|42113561|FG000|Overall Study|Adverse Event|3|||
19665056|NCT00685373|42113561|FG000|Overall Study|Withdrawal by Subject|5|||
19665057|NCT00685373|42113561|FG000|Overall Study|Lack of Efficacy|3|||
19665058|NCT00685373|42113561|FG000|Overall Study|Condition no longer requires study drug|1|||
19756454|NCT01314872|42207061|FG010|Treatment Period 1|Lost to Follow-up|0|||
19756455|NCT01314872|42207062|FG011|Treatment Period 1|Lost to Follow-up|0|||
19756456|NCT01314872|42207063|FG012|Treatment Period 1|Lost to Follow-up|0|||
19756457|NCT01314872|42207064|FG013|Treatment Period 1|Lost to Follow-up|0|||
19756458|NCT01314872|42207065|FG014|Treatment Period 1|Lost to Follow-up|0|||
19756459|NCT01314872|42207051|FG000|Period 2|Protocol Violation|0|||
19756460|NCT01314872|42207052|FG001|Period 2|Protocol Violation|0|||
19756461|NCT01314872|42207053|FG002|Period 2|Protocol Violation|0|||
19756462|NCT01314872|42207054|FG003|Period 2|Protocol Violation|0|||
19756463|NCT01314872|42207055|FG004|Period 2|Protocol Violation|0|||
19756464|NCT01314872|42207056|FG005|Period 2|Protocol Violation|0|||
19756465|NCT01314872|42207057|FG006|Period 2|Protocol Violation|0|||
19756466|NCT01314872|42207058|FG007|Period 2|Protocol Violation|0|||
19756467|NCT01314872|42207059|FG008|Period 2|Protocol Violation|0|||
19756468|NCT01314872|42207060|FG009|Period 2|Protocol Violation|0|||
19756469|NCT01314872|42207061|FG010|Period 2|Protocol Violation|0|||
19756470|NCT01314872|42207062|FG011|Period 2|Protocol Violation|3|||
19756471|NCT01314872|42207063|FG012|Period 2|Protocol Violation|3|||
19756472|NCT01314872|42207064|FG013|Period 2|Protocol Violation|2|||
19665059|NCT00685373|42113561|FG000|Overall Study|Lost to Follow-up|2|||
19665060|NCT00685373|42113561|FG000|Overall Study|Protocol Violation|1|||
19665061|NCT00684515|42113568|FG000|Overall Study|Adverse Event|3|||
19665062|NCT00684515|42113569|FG001|Overall Study|Adverse Event|3|||
19665063|NCT00684515|42113570|FG002|Overall Study|Adverse Event|1|||
19665064|NCT00684515|42113568|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
19665065|NCT00684515|42113569|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
19665066|NCT00684515|42113570|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
19665067|NCT00490815|42113580|FG000|Overall Study|Adverse Event|2|||
19665068|NCT00490815|42113581|FG001|Overall Study|Adverse Event|3|||
19665069|NCT00490815|42113580|FG000|Overall Study|Withdrawal by Subject|4|||
19665070|NCT00490815|42113581|FG001|Overall Study|Withdrawal by Subject|0|||
19665071|NCT00490815|42113580|FG000|Overall Study|Lost to Follow-up|1|||
19665072|NCT00490815|42113581|FG001|Overall Study|Lost to Follow-up|3|||
19665073|NCT00490815|42113580|FG000|Overall Study|Death|1|||
19665074|NCT00490815|42113581|FG001|Overall Study|Death|3|||
19665075|NCT03855189|42113590|FG000|Overall Study|Adverse Event|5|||
19665076|NCT03855189|42113591|FG001|Overall Study|Adverse Event|2|||
19665077|NCT03855189|42113592|FG002|Overall Study|Adverse Event|4|||
19665078|NCT03855189|42113590|FG000|Overall Study|Treatment Failure|1|||
19665079|NCT03855189|42113591|FG001|Overall Study|Treatment Failure|1|||
19665080|NCT03855189|42113592|FG002|Overall Study|Treatment Failure|2|||
19665081|NCT03855189|42113590|FG000|Overall Study|Noncompliance with Protocol|0|||
19665082|NCT03855189|42113591|FG001|Overall Study|Noncompliance with Protocol|1|||
19665083|NCT03855189|42113592|FG002|Overall Study|Noncompliance with Protocol|0|||
19665084|NCT03855189|42113590|FG000|Overall Study|Did Not Return|4|||
19665085|NCT03855189|42113591|FG001|Overall Study|Did Not Return|3|||
19665086|NCT03855189|42113592|FG002|Overall Study|Did Not Return|0|||
19665087|NCT03853551|42113600|FG000|Overall Study|Death|2|||
19665088|NCT03853551|42113600|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
19665089|NCT00423670|42113611|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
19665090|NCT00423670|42113612|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665091|NCT00423670|42113613|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
19756473|NCT01314872|42207065|FG014|Period 2|Protocol Violation|0|||
19756474|NCT01314872|42207051|FG000|Period 2|Non-compliance with study drug|0|||
19756475|NCT01314872|42207052|FG001|Period 2|Non-compliance with study drug|0|||
19756476|NCT01314872|42207053|FG002|Period 2|Non-compliance with study drug|0|||
19665092|NCT00423670|42113614|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665093|NCT00423670|42113615|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665094|NCT00423670|42113616|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665095|NCT00423670|42113617|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665096|NCT00423670|42113618|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
19665097|NCT00423670|42113611|FG000|Treatment Period|Adverse Event|8|||
19665098|NCT00423670|42113612|FG001|Treatment Period|Adverse Event|12|||
19665099|NCT00423670|42113613|FG002|Treatment Period|Adverse Event|15|||
19665100|NCT00423670|42113614|FG003|Treatment Period|Adverse Event|20|||
19665101|NCT00423670|42113615|FG004|Treatment Period|Adverse Event|9|||
19665102|NCT00423670|42113616|FG005|Treatment Period|Adverse Event|4|||
19665103|NCT00423670|42113617|FG006|Treatment Period|Adverse Event|7|||
19665104|NCT00423670|42113618|FG007|Treatment Period|Adverse Event|2|||
19665105|NCT00423670|42113611|FG000|Treatment Period|Protocol-defined clinical event|0|||
19665106|NCT00423670|42113612|FG001|Treatment Period|Protocol-defined clinical event|7|||
19665107|NCT00423670|42113613|FG002|Treatment Period|Protocol-defined clinical event|4|||
19665108|NCT00423670|42113614|FG003|Treatment Period|Protocol-defined clinical event|12|||
19665109|NCT00423670|42113615|FG004|Treatment Period|Protocol-defined clinical event|5|||
19665110|NCT00423670|42113616|FG005|Treatment Period|Protocol-defined clinical event|4|||
19665111|NCT00423670|42113617|FG006|Treatment Period|Protocol-defined clinical event|16|||
19665112|NCT00423670|42113618|FG007|Treatment Period|Protocol-defined clinical event|15|||
19665113|NCT00423670|42113611|FG000|Treatment Period|Lost to Follow-up|2|||
19665114|NCT00423670|42113612|FG001|Treatment Period|Lost to Follow-up|1|||
19665115|NCT00423670|42113613|FG002|Treatment Period|Lost to Follow-up|3|||
19665116|NCT00423670|42113614|FG003|Treatment Period|Lost to Follow-up|1|||
19665117|NCT00423670|42113615|FG004|Treatment Period|Lost to Follow-up|6|||
19665118|NCT00423670|42113616|FG005|Treatment Period|Lost to Follow-up|0|||
19665119|NCT00423670|42113617|FG006|Treatment Period|Lost to Follow-up|3|||
19665120|NCT00423670|42113618|FG007|Treatment Period|Lost to Follow-up|1|||
19665121|NCT00423670|42113611|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
19665122|NCT00423670|42113612|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
19665123|NCT00423670|42113613|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
19665124|NCT00423670|42113614|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
19665125|NCT00423670|42113615|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
19665126|NCT00423670|42113616|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
19665127|NCT00423670|42113617|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
19665128|NCT00423670|42113618|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
19665129|NCT00423670|42113611|FG000|Treatment Period|Investigator decision|0|||
19665130|NCT00423670|42113612|FG001|Treatment Period|Investigator decision|0|||
19665131|NCT00423670|42113613|FG002|Treatment Period|Investigator decision|0|||
19665132|NCT00423670|42113614|FG003|Treatment Period|Investigator decision|0|||
19665133|NCT00423670|42113615|FG004|Treatment Period|Investigator decision|0|||
19665134|NCT00423670|42113616|FG005|Treatment Period|Investigator decision|0|||
19756477|NCT01314872|42207054|FG003|Period 2|Non-compliance with study drug|0|||
19756478|NCT01314872|42207055|FG004|Period 2|Non-compliance with study drug|0|||
19756479|NCT01314872|42207056|FG005|Period 2|Non-compliance with study drug|0|||
19756480|NCT01314872|42207057|FG006|Period 2|Non-compliance with study drug|0|||
19756481|NCT01314872|42207058|FG007|Period 2|Non-compliance with study drug|0|||
19756482|NCT01314872|42207059|FG008|Period 2|Non-compliance with study drug|0|||
19756483|NCT01314872|42207060|FG009|Period 2|Non-compliance with study drug|0|||
19756484|NCT01314872|42207061|FG010|Period 2|Non-compliance with study drug|0|||
19756485|NCT01314872|42207062|FG011|Period 2|Non-compliance with study drug|3|||
19477124|NCT01546519|41756030|FG000|Overall Study|Withdrawal by Subject|1|||
19602639|NCT00765076|42051316|FG002|Overall Study|Withdrawal by Subject|1|||
19602640|NCT00994682|42051326|FG000|Double Bilnd|Withdrawal by Subject|5|||
19602641|NCT00994682|42051327|FG001|Double Bilnd|Withdrawal by Subject|6|||
19602642|NCT00994682|42051326|FG000|Double Bilnd|Lost to Follow-up|3|||
19602643|NCT00994682|42051327|FG001|Double Bilnd|Lost to Follow-up|3|||
19602644|NCT00994682|42051326|FG000|Double Bilnd|Adverse Event|1|||
19602645|NCT00994682|42051327|FG001|Double Bilnd|Adverse Event|0|||
19602646|NCT00994682|42051326|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
19602647|NCT00994682|42051327|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
19602648|NCT00994682|42051326|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
19602649|NCT00994682|42051327|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
19602650|NCT00994682|42051326|FG000|Pioglitazone Open Label|Physician Decision|6|||
19602651|NCT00994682|42051327|FG001|Pioglitazone Open Label|Physician Decision|1|||
19602652|NCT00768898|42051337|FG000|Overall Study|Unrelated injury|1|||
19602653|NCT00768898|42051337|FG000|Overall Study|Headache|1|||
19602654|NCT00994448|42051348|FG000|Overall Study|Adverse Event|1|||
19602655|NCT00994448|42051349|FG001|Overall Study|Adverse Event|0|||
19602656|NCT00994448|42051348|FG000|Overall Study|Lost to Follow-up|5|||
19602657|NCT00994448|42051349|FG001|Overall Study|Lost to Follow-up|1|||
19602658|NCT00994448|42051348|FG000|Overall Study|Withdrawal by Subject|1|||
19602659|NCT00994448|42051349|FG001|Overall Study|Withdrawal by Subject|1|||
19665135|NCT00423670|42113617|FG006|Treatment Period|Investigator decision|0|||
19665136|NCT00423670|42113618|FG007|Treatment Period|Investigator decision|1|||
19665137|NCT00423670|42113611|FG000|Treatment Period|Non-compliance with protocol|3|||
19665138|NCT00423670|42113612|FG001|Treatment Period|Non-compliance with protocol|1|||
19756486|NCT01314872|42207063|FG012|Period 2|Non-compliance with study drug|3|||
19756487|NCT01314872|42207064|FG013|Period 2|Non-compliance with study drug|1|||
19665139|NCT00423670|42113613|FG002|Treatment Period|Non-compliance with protocol|1|||
19665140|NCT00423670|42113614|FG003|Treatment Period|Non-compliance with protocol|3|||
19665141|NCT00423670|42113615|FG004|Treatment Period|Non-compliance with protocol|2|||
19665142|NCT00423670|42113616|FG005|Treatment Period|Non-compliance with protocol|0|||
19665143|NCT00423670|42113617|FG006|Treatment Period|Non-compliance with protocol|2|||
19665144|NCT00423670|42113618|FG007|Treatment Period|Non-compliance with protocol|2|||
19665145|NCT00423670|42113611|FG000|Follow-up Period|Lost to Follow-up|0|||
19665146|NCT00423670|42113612|FG001|Follow-up Period|Lost to Follow-up|12|||
19665147|NCT00423670|42113613|FG002|Follow-up Period|Lost to Follow-up|8|||
19665148|NCT00423670|42113614|FG003|Follow-up Period|Lost to Follow-up|3|||
19665149|NCT00423670|42113615|FG004|Follow-up Period|Lost to Follow-up|1|||
19665150|NCT00423670|42113616|FG005|Follow-up Period|Lost to Follow-up|0|||
19665151|NCT00423670|42113617|FG006|Follow-up Period|Lost to Follow-up|5|||
19665152|NCT00423670|42113618|FG007|Follow-up Period|Lost to Follow-up|0|||
19665153|NCT00423670|42113611|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
19665154|NCT00423670|42113612|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
19665155|NCT00423670|42113613|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
19665156|NCT00423670|42113614|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
19665157|NCT00423670|42113615|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
19665158|NCT00423670|42113616|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
19665159|NCT00423670|42113617|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
19665160|NCT00423670|42113618|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
19665161|NCT00423670|42113611|FG000|Follow-up Period|Non-compliance with protocol|2|||
19665162|NCT00423670|42113612|FG001|Follow-up Period|Non-compliance with protocol|0|||
19665163|NCT00423670|42113613|FG002|Follow-up Period|Non-compliance with protocol|1|||
19665164|NCT00423670|42113614|FG003|Follow-up Period|Non-compliance with protocol|1|||
19665165|NCT00423670|42113615|FG004|Follow-up Period|Non-compliance with protocol|0|||
19665166|NCT00423670|42113616|FG005|Follow-up Period|Non-compliance with protocol|0|||
19665167|NCT00423670|42113617|FG006|Follow-up Period|Non-compliance with protocol|3|||
19665168|NCT00423670|42113618|FG007|Follow-up Period|Non-compliance with protocol|2|||
19665169|NCT00483717|42113641|FG000|Overall Study|Protocol Violation|5|||
19665170|NCT00483717|42113642|FG001|Overall Study|Protocol Violation|7|||
19665171|NCT00483717|42113641|FG000|Overall Study|Time of dosing missing|1|||
19665172|NCT00483717|42113642|FG001|Overall Study|Time of dosing missing|1|||
19665173|NCT00483717|42113641|FG000|Overall Study|No treatment for migraine|16|||
19665174|NCT00483717|42113642|FG001|Overall Study|No treatment for migraine|13|||
19665175|NCT00483717|42113641|FG000|Overall Study|Lost to Follow-up|1|||
19665176|NCT00483717|42113642|FG001|Overall Study|Lost to Follow-up|0|||
19756488|NCT01314872|42207065|FG014|Period 2|Non-compliance with study drug|2|||
19756489|NCT01314872|42207051|FG000|Period 2|Lack of Efficacy|0|||
19756490|NCT01314872|42207052|FG001|Period 2|Lack of Efficacy|0|||
19756491|NCT01314872|42207053|FG002|Period 2|Lack of Efficacy|0|||
19756492|NCT01314872|42207054|FG003|Period 2|Lack of Efficacy|0|||
19756493|NCT01314872|42207055|FG004|Period 2|Lack of Efficacy|0|||
19756494|NCT01314872|42207056|FG005|Period 2|Lack of Efficacy|0|||
19756495|NCT01314872|42207057|FG006|Period 2|Lack of Efficacy|0|||
19756496|NCT01314872|42207058|FG007|Period 2|Lack of Efficacy|0|||
19756497|NCT01314872|42207059|FG008|Period 2|Lack of Efficacy|0|||
19756498|NCT01314872|42207060|FG009|Period 2|Lack of Efficacy|0|||
19756499|NCT01314872|42207061|FG010|Period 2|Lack of Efficacy|0|||
19756500|NCT01314872|42207062|FG011|Period 2|Lack of Efficacy|7|||
19756501|NCT01314872|42207063|FG012|Period 2|Lack of Efficacy|12|||
19756502|NCT01314872|42207064|FG013|Period 2|Lack of Efficacy|9|||
19756503|NCT01314872|42207065|FG014|Period 2|Lack of Efficacy|2|||
19756504|NCT01314872|42207051|FG000|Period 2|Pregnancy|0|||
19756505|NCT01314872|42207052|FG001|Period 2|Pregnancy|0|||
19388776|NCT02544633|41632288|FG003|Treatment Period|Death|0|||
19665177|NCT00483717|42113641|FG000|Overall Study|Withdrawal by Subject|1|||
19665178|NCT00483717|42113642|FG001|Overall Study|Withdrawal by Subject|0|||
19665179|NCT00406354|42113651|FG000|All Randomized Patients|Protocol Violation|0|||
19665180|NCT00406354|42113652|FG001|All Randomized Patients|Protocol Violation|0|||
19756506|NCT01314872|42207053|FG002|Period 2|Pregnancy|0|||
19756507|NCT01314872|42207054|FG003|Period 2|Pregnancy|0|||
19756508|NCT01314872|42207055|FG004|Period 2|Pregnancy|0|||
19665181|NCT00406354|42113653|FG002|All Randomized Patients|Protocol Violation|1|||
19665182|NCT00406354|42113651|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
19756509|NCT01314872|42207056|FG005|Period 2|Pregnancy|0|||
19756510|NCT01314872|42207057|FG006|Period 2|Pregnancy|0|||
19756511|NCT01314872|42207058|FG007|Period 2|Pregnancy|0|||
19756512|NCT01314872|42207059|FG008|Period 2|Pregnancy|0|||
19756513|NCT01314872|42207060|FG009|Period 2|Pregnancy|0|||
19665183|NCT00406354|42113652|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
19665184|NCT00406354|42113653|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
19665185|NCT00406354|42113651|FG000|All Randomized and Treated Patients|Adverse Event|6|||
19665186|NCT00406354|42113652|FG001|All Randomized and Treated Patients|Adverse Event|2|||
19665187|NCT00406354|42113653|FG002|All Randomized and Treated Patients|Adverse Event|1|||
19665188|NCT00406354|42113651|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
19665189|NCT00406354|42113652|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
19665190|NCT00406354|42113653|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
19665191|NCT00406354|42113651|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
19665192|NCT00406354|42113652|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
19665193|NCT00406354|42113653|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
19665194|NCT00406354|42113651|FG000|All Randomized and Treated Patients|Physician Decision|0|||
19665195|NCT00406354|42113652|FG001|All Randomized and Treated Patients|Physician Decision|0|||
19665196|NCT00406354|42113653|FG002|All Randomized and Treated Patients|Physician Decision|1|||
19665197|NCT00483405|42113661|FG000|Overall Study|Adverse Event|8|||
19665198|NCT00483405|42113661|FG000|Overall Study|Lack of Efficacy|14|||
19665199|NCT00483405|42113661|FG000|Overall Study|Death|3|||
19665200|NCT00483405|42113661|FG000|Overall Study|Withdrawal by Subject|2|||
19665201|NCT00483405|42113661|FG000|Overall Study|Other complicating disease|1|||
19665202|NCT00483327|42113669|FG000|Overall Study|Adverse Event|1|||
19665203|NCT00483327|42113669|FG000|Overall Study|Withdrawal by Subject|3|||
19665204|NCT00483327|42113669|FG000|Overall Study|Lost to Follow-up|4|||
19665205|NCT00483327|42113669|FG000|Overall Study|Patient Non Compliance|2|||
19665206|NCT00684203|42113681|FG000|Overall Study|Adverse Event|6|||
19665207|NCT00684203|42113682|FG001|Overall Study|Adverse Event|4|||
19665208|NCT00684203|42113683|FG002|Overall Study|Adverse Event|8|||
19665209|NCT00684203|42113684|FG003|Overall Study|Adverse Event|0|||
19665210|NCT00684203|42113685|FG004|Overall Study|Adverse Event|0|||
19665211|NCT00684203|42113686|FG005|Overall Study|Adverse Event|0|||
19665212|NCT00684203|42113681|FG000|Overall Study|Protocol-defined clinical event|3|||
19665213|NCT00684203|42113682|FG001|Overall Study|Protocol-defined clinical event|1|||
19665214|NCT00684203|42113683|FG002|Overall Study|Protocol-defined clinical event|0|||
19665215|NCT00684203|42113684|FG003|Overall Study|Protocol-defined clinical event|0|||
19665216|NCT00684203|42113685|FG004|Overall Study|Protocol-defined clinical event|0|||
19665217|NCT00684203|42113686|FG005|Overall Study|Protocol-defined clinical event|0|||
19665218|NCT00684203|42113681|FG000|Overall Study|Withdrawal by Subject|0|||
19665219|NCT00684203|42113682|FG001|Overall Study|Withdrawal by Subject|2|||
19665220|NCT00684203|42113683|FG002|Overall Study|Withdrawal by Subject|1|||
19665221|NCT00684203|42113684|FG003|Overall Study|Withdrawal by Subject|0|||
19665222|NCT00684203|42113685|FG004|Overall Study|Withdrawal by Subject|0|||
19665223|NCT00684203|42113686|FG005|Overall Study|Withdrawal by Subject|0|||
19665224|NCT00684203|42113681|FG000|Overall Study|Did not meet protocol eligibility|0|||
19665225|NCT00684203|42113682|FG001|Overall Study|Did not meet protocol eligibility|1|||
19665226|NCT00684203|42113683|FG002|Overall Study|Did not meet protocol eligibility|0|||
19665227|NCT00684203|42113684|FG003|Overall Study|Did not meet protocol eligibility|0|||
19665228|NCT00684203|42113685|FG004|Overall Study|Did not meet protocol eligibility|0|||
19602660|NCT00994448|42051348|FG000|Overall Study|Physician Decision|1|||
19602661|NCT00994448|42051349|FG001|Overall Study|Physician Decision|0|||
19602662|NCT00991406|42051355|FG000|Overall Study|One participant did not respond to FES.|1|||
19602663|NCT01017575|42051364|FG000|Overall Study|Lack of Efficacy|0|||
19602664|NCT01017575|42051365|FG001|Overall Study|Lack of Efficacy|1|||
19602665|NCT01017575|42051366|FG002|Overall Study|Lack of Efficacy|0|||
19602666|NCT01017575|42051367|FG003|Overall Study|Lack of Efficacy|1|||
19602667|NCT01017575|42051368|FG004|Overall Study|Lack of Efficacy|1|||
19602668|NCT01017575|42051364|FG000|Overall Study|Adverse Event|0|||
19602669|NCT01017575|42051365|FG001|Overall Study|Adverse Event|1|||
19602670|NCT01017575|42051366|FG002|Overall Study|Adverse Event|0|||
19602671|NCT01017575|42051367|FG003|Overall Study|Adverse Event|0|||
19602672|NCT01017575|42051368|FG004|Overall Study|Adverse Event|2|||
19602673|NCT01017575|42051364|FG000|Overall Study|Withdrawal by Subject|1|||
19602674|NCT01017575|42051365|FG001|Overall Study|Withdrawal by Subject|0|||
19602675|NCT01017575|42051366|FG002|Overall Study|Withdrawal by Subject|0|||
19602676|NCT01017575|42051367|FG003|Overall Study|Withdrawal by Subject|0|||
19602677|NCT01017575|42051368|FG004|Overall Study|Withdrawal by Subject|0|||
19665229|NCT00684203|42113686|FG005|Overall Study|Did not meet protocol eligibility|0|||
19602678|NCT01017263|42051380|FG000|Overall Study|not eligible|12|||
19665230|NCT00423592|42113707|FG000|Overall Study|Adverse Event (through Week 12)|2|||
19665231|NCT00423592|42113707|FG000|Overall Study|Adverse Event (post Week 12)|5|||
19665232|NCT00683657|42113713|FG000|Overall Study|Adverse Event|0|||
19665233|NCT00683657|42113714|FG001|Overall Study|Adverse Event|1|||
19665234|NCT00683657|42113713|FG000|Overall Study|Subject Withdrew Consent|1|||
19665235|NCT00683657|42113714|FG001|Overall Study|Subject Withdrew Consent|0|||
19602679|NCT00768664|42051384|FG000|Overall Study|Death|57|||
19602680|NCT00768664|42051384|FG000|Overall Study|Lost to Follow-up|2|||
19665236|NCT00680771|42113722|FG000|Overall Study|Withdrawal by Subject|1|||
19665237|NCT00680771|42113723|FG001|Overall Study|Withdrawal by Subject|0|||
19665238|NCT00680771|42113722|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
19665239|NCT00680771|42113723|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
19665240|NCT00680771|42113722|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
19665241|NCT00680771|42113723|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
19665242|NCT00482703|42113731|FG000|Overall Study|Poor compliance|1|||
19665243|NCT00482703|42113732|FG001|Overall Study|Poor compliance|0|||
19665244|NCT00482391|42113745|FG000|Overall Study|Withdrawal by Subject|1|||
19665245|NCT00482391|42113745|FG000|Overall Study|Adverse Event|1|||
19665246|NCT00482391|42113745|FG000|Overall Study|Death|1|||
19665247|NCT00423046|42113752|FG000|Overall Study|Other|340|||
19665248|NCT00423046|42113753|FG001|Overall Study|Other|345|||
19665249|NCT00496587|42113761|FG000|Overall Study|Adverse Event|2|||
19665250|NCT00496587|42113761|FG000|Overall Study|Progressive Disease|24|||
19665251|NCT00496587|42113761|FG000|Overall Study|Withdrawal by Subject|2|||
19665252|NCT00496587|42113761|FG000|Overall Study|Death|1|||
19665253|NCT00496587|42113761|FG000|Overall Study|Complications unrelated|2|||
19665254|NCT00405652|42113765|FG000|Overall Study|Adverse Event|4|||
19665255|NCT00422734|42113771|FG000|Overall Study|Physician Decision|1|||
19665256|NCT00422734|42113772|FG001|Overall Study|Physician Decision|1|||
19665257|NCT00422734|42113771|FG000|Overall Study|Protocol Violation|1|||
19665258|NCT00422734|42113772|FG001|Overall Study|Protocol Violation|6|||
19665259|NCT00422734|42113771|FG000|Overall Study|Withdrawal by Subject|12|||
19665260|NCT00422734|42113772|FG001|Overall Study|Withdrawal by Subject|8|||
19665261|NCT00422734|42113771|FG000|Overall Study|Adverse Event|0|||
19665262|NCT00422734|42113772|FG001|Overall Study|Adverse Event|3|||
19665263|NCT00422734|42113771|FG000|Overall Study|Partner Decision|0|||
19665264|NCT00422734|42113772|FG001|Overall Study|Partner Decision|3|||
19665265|NCT00422422|42113778|FG000|Overall Study|Lack of Efficacy|1|||
19756514|NCT01314872|42207061|FG010|Period 2|Pregnancy|0|||
19756515|NCT01314872|42207062|FG011|Period 2|Pregnancy|0|||
19756516|NCT01314872|42207063|FG012|Period 2|Pregnancy|0|||
19756517|NCT01314872|42207064|FG013|Period 2|Pregnancy|0|||
19756518|NCT01314872|42207065|FG014|Period 2|Pregnancy|1|||
19756519|NCT01314872|42207051|FG000|Period 2|Study terminated by Sponsor|0|||
19756520|NCT01314872|42207052|FG001|Period 2|Study terminated by Sponsor|0|||
19665266|NCT00422422|42113778|FG000|Overall Study|Protocol Violation|1|||
19665267|NCT00422422|42113778|FG000|Overall Study|Withdrawal by Subject|2|||
19665268|NCT00422422|42113778|FG000|Overall Study|SAE, non-fatal|1|||
19665269|NCT00422422|42113778|FG000|Overall Study|AE, non-serious non-fatal|5|||
19665270|NCT00413374|42113786|FG000|Overall Study|Ineligible due to screening criteria.|3|||
19665271|NCT00413374|42113787|FG001|Overall Study|Ineligible due to screening criteria.|0|||
19665272|NCT00413374|42113786|FG000|Overall Study|Adverse Event|1|||
19665273|NCT00413374|42113787|FG001|Overall Study|Adverse Event|0|||
19665274|NCT00413374|42113786|FG000|Overall Study|Lost to Follow-up|1|||
19665275|NCT00413374|42113787|FG001|Overall Study|Lost to Follow-up|0|||
19665276|NCT00413374|42113786|FG000|Overall Study|Surgery|1|||
19665277|NCT00413374|42113787|FG001|Overall Study|Surgery|0|||
19665278|NCT00682643|42113798|FG000|Overall Study|Adverse Event|12|||
19665279|NCT00682643|42113799|FG001|Overall Study|Adverse Event|23|||
19665280|NCT00682643|42113798|FG000|Overall Study|Lack of Efficacy|2|||
19665281|NCT00682643|42113799|FG001|Overall Study|Lack of Efficacy|0|||
19665282|NCT00682643|42113798|FG000|Overall Study|Protocol Violation|38|||
19665283|NCT00682643|42113799|FG001|Overall Study|Protocol Violation|76|||
19665284|NCT00682643|42113798|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
19665285|NCT00682643|42113799|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
19665286|NCT00682643|42113798|FG000|Overall Study|Lost to Follow-up|1|||
19665287|NCT00682643|42113799|FG001|Overall Study|Lost to Follow-up|6|||
19756521|NCT01314872|42207053|FG002|Period 2|Study terminated by Sponsor|0|||
19602681|NCT00768664|42051384|FG000|Overall Study|Other|9|||
19602682|NCT00768664|42051384|FG000|Overall Study|Participant refused|1|||
19602683|NCT00778336|42051392|FG000|Index Procedure-Discharge|Death|6|||
19602684|NCT00778336|42051393|FG001|Index Procedure-Discharge|Death|3|||
19602685|NCT00778336|42051394|FG002|Index Procedure-Discharge|Death|2|||
19602686|NCT00778336|42051395|FG003|Index Procedure-Discharge|Death|0|||
19602687|NCT00778336|42051392|FG000|3 Month Follow Up|Lost to Follow-up|15|||
19602688|NCT00778336|42051393|FG001|3 Month Follow Up|Lost to Follow-up|20|||
19602689|NCT00778336|42051394|FG002|3 Month Follow Up|Lost to Follow-up|3|||
19388777|NCT02544633|41632285|FG000|Treatment Period|Non-compliance|0|||
19602690|NCT00778336|42051395|FG003|3 Month Follow Up|Lost to Follow-up|0|||
19665288|NCT00682643|42113798|FG000|Overall Study|Physician Decision|2|||
19665289|NCT00682643|42113799|FG001|Overall Study|Physician Decision|6|||
19665290|NCT00682643|42113798|FG000|Overall Study|Withdrawal by Subject|19|||
19665291|NCT00682643|42113799|FG001|Overall Study|Withdrawal by Subject|53|||
19756522|NCT01314872|42207054|FG003|Period 2|Study terminated by Sponsor|0|||
19602691|NCT00778336|42051392|FG000|3 Month Follow Up|Death|8|||
19665292|NCT00682643|42113798|FG000|Overall Study|Did Not Receive Study Drug|1|||
19756523|NCT01314872|42207055|FG004|Period 2|Study terminated by Sponsor|0|||
19756524|NCT01314872|42207056|FG005|Period 2|Study terminated by Sponsor|0|||
19665293|NCT00682643|42113799|FG001|Overall Study|Did Not Receive Study Drug|1|||
19665294|NCT00421408|42113808|FG000|Overall Study|Lost to Follow-up|30|||
19665295|NCT00421408|42113809|FG001|Overall Study|Lost to Follow-up|20|||
19665296|NCT00421408|42113808|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
19665297|NCT00421408|42113809|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
19665298|NCT00679913|42113817|FG000|Overall Study|Protocol Violation|18|||
19665299|NCT00679913|42113818|FG001|Overall Study|Protocol Violation|13|||
19665300|NCT00482001|42113835|FG000|Overall Study|Protocol Violation|1|||
19665301|NCT00482001|42113836|FG001|Overall Study|Protocol Violation|1|||
19665302|NCT00490035|42113848|FG000|Overall Study|AE, non-serious non-fatal|3|||
19665303|NCT00490035|42113849|FG001|Overall Study|AE, non-serious non-fatal|4|||
19665304|NCT00490035|42113850|FG002|Overall Study|AE, non-serious non-fatal|4|||
19665305|NCT00490035|42113851|FG003|Overall Study|AE, non-serious non-fatal|5|||
19665306|NCT00490035|42113848|FG000|Overall Study|Lost to Follow-up|2|||
19665307|NCT00490035|42113849|FG001|Overall Study|Lost to Follow-up|0|||
19665308|NCT00490035|42113850|FG002|Overall Study|Lost to Follow-up|1|||
19665309|NCT00490035|42113851|FG003|Overall Study|Lost to Follow-up|0|||
19665310|NCT00490035|42113848|FG000|Overall Study|Withdrawal by Subject|2|||
19665311|NCT00490035|42113849|FG001|Overall Study|Withdrawal by Subject|1|||
19665312|NCT00490035|42113850|FG002|Overall Study|Withdrawal by Subject|1|||
19665313|NCT00490035|42113851|FG003|Overall Study|Withdrawal by Subject|0|||
19665314|NCT00490035|42113848|FG000|Overall Study|Other reason|0|||
19665315|NCT00490035|42113849|FG001|Overall Study|Other reason|1|||
19665316|NCT00490035|42113850|FG002|Overall Study|Other reason|3|||
19665317|NCT00490035|42113851|FG003|Overall Study|Other reason|1|||
19665318|NCT00490035|42113848|FG000|Overall Study|AE, serious fatal|1|||
19665319|NCT00490035|42113849|FG001|Overall Study|AE, serious fatal|0|||
19665320|NCT00490035|42113850|FG002|Overall Study|AE, serious fatal|0|||
19665321|NCT00490035|42113851|FG003|Overall Study|AE, serious fatal|0|||
19665322|NCT00490035|42113848|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
19756525|NCT01314872|42207057|FG006|Period 2|Study terminated by Sponsor|0|||
19756526|NCT01314872|42207058|FG007|Period 2|Study terminated by Sponsor|0|||
19756527|NCT01314872|42207059|FG008|Period 2|Study terminated by Sponsor|0|||
19756528|NCT01314872|42207060|FG009|Period 2|Study terminated by Sponsor|0|||
19756529|NCT01314872|42207061|FG010|Period 2|Study terminated by Sponsor|0|||
19756530|NCT01314872|42207062|FG011|Period 2|Study terminated by Sponsor|2|||
19756531|NCT01314872|42207063|FG012|Period 2|Study terminated by Sponsor|2|||
19756532|NCT01314872|42207064|FG013|Period 2|Study terminated by Sponsor|3|||
19756533|NCT01314872|42207065|FG014|Period 2|Study terminated by Sponsor|0|||
19756534|NCT01314872|42207051|FG000|Period 2|Adverse event, non-fatal|0|||
19756535|NCT01314872|42207052|FG001|Period 2|Adverse event, non-fatal|0|||
19756536|NCT01314872|42207053|FG002|Period 2|Adverse event, non-fatal|0|||
19756537|NCT01314872|42207054|FG003|Period 2|Adverse event, non-fatal|0|||
19756538|NCT01314872|42207055|FG004|Period 2|Adverse event, non-fatal|0|||
19756539|NCT01314872|42207056|FG005|Period 2|Adverse event, non-fatal|0|||
19756540|NCT01314872|42207057|FG006|Period 2|Adverse event, non-fatal|0|||
19756541|NCT01314872|42207058|FG007|Period 2|Adverse event, non-fatal|0|||
19756542|NCT01314872|42207059|FG008|Period 2|Adverse event, non-fatal|0|||
19756543|NCT01314872|42207060|FG009|Period 2|Adverse event, non-fatal|0|||
19756544|NCT01314872|42207061|FG010|Period 2|Adverse event, non-fatal|0|||
19756545|NCT01314872|42207062|FG011|Period 2|Adverse event, non-fatal|13|||
19756546|NCT01314872|42207063|FG012|Period 2|Adverse event, non-fatal|16|||
19756547|NCT01314872|42207064|FG013|Period 2|Adverse event, non-fatal|24|||
19756548|NCT01314872|42207065|FG014|Period 2|Adverse event, non-fatal|9|||
19756549|NCT01314872|42207051|FG000|Period 2|Withdrawal by Subject|0|||
19756550|NCT01314872|42207052|FG001|Period 2|Withdrawal by Subject|0|||
19756551|NCT01314872|42207053|FG002|Period 2|Withdrawal by Subject|0|||
19665323|NCT00490035|42113849|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
19665324|NCT00490035|42113850|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
19665325|NCT00490035|42113851|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
19665326|NCT00490035|42113848|FG000|Overall Study|AE of unknown type|0|||
19665327|NCT00490035|42113849|FG001|Overall Study|AE of unknown type|0|||
19665328|NCT00490035|42113850|FG002|Overall Study|AE of unknown type|2|||
19756552|NCT01314872|42207054|FG003|Period 2|Withdrawal by Subject|0|||
19756553|NCT01314872|42207055|FG004|Period 2|Withdrawal by Subject|0|||
19756554|NCT01314872|42207056|FG005|Period 2|Withdrawal by Subject|0|||
19756555|NCT01314872|42207057|FG006|Period 2|Withdrawal by Subject|0|||
19756556|NCT01314872|42207058|FG007|Period 2|Withdrawal by Subject|0|||
19756557|NCT01314872|42207059|FG008|Period 2|Withdrawal by Subject|0|||
19756558|NCT01314872|42207060|FG009|Period 2|Withdrawal by Subject|0|||
19665329|NCT00490035|42113851|FG003|Overall Study|AE of unknown type|0|||
19665330|NCT00404248|42113864|FG000|Overall Study|pts declining status|0|||
19665331|NCT00404248|42113865|FG001|Overall Study|pts declining status|1|||
19665332|NCT00404248|42113866|FG002|Overall Study|pts declining status|0|||
19756559|NCT01314872|42207061|FG010|Period 2|Withdrawal by Subject|0|||
19756560|NCT01314872|42207062|FG011|Period 2|Withdrawal by Subject|14|||
19665333|NCT00404248|42113867|FG003|Overall Study|pts declining status|0|||
19665334|NCT00404248|42113868|FG004|Overall Study|pts declining status|0|||
19665335|NCT00404248|42113869|FG005|Overall Study|pts declining status|0|||
19665336|NCT00404248|42113870|FG006|Overall Study|pts declining status|0|||
19665337|NCT00404248|42113871|FG007|Overall Study|pts declining status|0|||
19665338|NCT00404248|42113872|FG008|Overall Study|pts declining status|0|||
19665339|NCT00421174|42113900|FG000|Overall Study|Withdrawal by Subject|0|||
19665340|NCT00421174|42113901|FG001|Overall Study|Withdrawal by Subject|1|||
19665341|NCT00421174|42113900|FG000|Overall Study|Ineligible due to infection|2|||
19665342|NCT00421174|42113901|FG001|Overall Study|Ineligible due to infection|0|||
19665343|NCT00496197|42113907|FG000|Overall Study|Discontinued study due to death|43|||
19665344|NCT00496197|42113907|FG000|Overall Study|Adverse Event|13|||
19665345|NCT00496197|42113907|FG000|Overall Study|Does not meet entrance criteria|5|||
19665346|NCT00496197|42113907|FG000|Overall Study|Insufficient clinical response|3|||
19665347|NCT00496197|42113907|FG000|Overall Study|Insufficient bacteriological response|10|||
19665348|NCT00496197|42113907|FG000|Overall Study|Lost to Follow-up|11|||
19665349|NCT00496197|42113907|FG000|Overall Study|Withdrawal by Subject|11|||
19665350|NCT00496197|42113907|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
19665351|NCT00496197|42113907|FG000|Overall Study|Other|14|||
19665352|NCT00496197|42113907|FG000|Overall Study|Protocol Violation|8|||
19665353|NCT00495495|42113911|FG000|Overall Study|Protocol Violation|99|||
19665354|NCT00404092|42113920|FG000|Overall Study|Death|1|||
19665355|NCT00404092|42113921|FG001|Overall Study|Death|0|||
19665356|NCT00404092|42113922|FG002|Overall Study|Death|0|||
19665357|NCT00404092|42113923|FG003|Overall Study|Death|0|||
19665358|NCT00404092|42113920|FG000|Overall Study|Adverse Event|0|||
19665359|NCT00404092|42113921|FG001|Overall Study|Adverse Event|0|||
19665360|NCT00404092|42113922|FG002|Overall Study|Adverse Event|1|||
19665361|NCT00404092|42113923|FG003|Overall Study|Adverse Event|0|||
19665362|NCT00481767|42113935|FG000|Overall Study|Withdrawal by Subject|16|||
19665363|NCT00481767|42113936|FG001|Overall Study|Withdrawal by Subject|11|||
19665364|NCT00481767|42113935|FG000|Overall Study|Lost to Follow-up|16|||
19665365|NCT00481767|42113936|FG001|Overall Study|Lost to Follow-up|10|||
19665366|NCT00489489|42113945|FG000|Overall Study|Not treated due to protocol violation|0|||
19665367|NCT00489489|42113946|FG001|Overall Study|Not treated due to protocol violation|1|||
19665368|NCT00489489|42113947|FG002|Overall Study|Not treated due to protocol violation|1|||
19665369|NCT00489489|42113945|FG000|Overall Study|Adverse Event|1|||
19665370|NCT00489489|42113946|FG001|Overall Study|Adverse Event|1|||
19665371|NCT00489489|42113947|FG002|Overall Study|Adverse Event|1|||
19602692|NCT00778336|42051393|FG001|3 Month Follow Up|Death|3|||
19602693|NCT00778336|42051394|FG002|3 Month Follow Up|Death|2|||
19602694|NCT00778336|42051395|FG003|3 Month Follow Up|Death|0|||
19602695|NCT01253161|42051405|FG000|Overall Study|Adverse Event|1|||
19602696|NCT00581113|42051411|FG000|Overall Study|Withdrawal by Subject|0|||
19602697|NCT00581113|42051412|FG001|Overall Study|Withdrawal by Subject|1|||
19602698|NCT01017029|42051420|FG000|Overall Study|Lost to Follow-up|1|||
19602699|NCT01017029|42051421|FG001|Overall Study|Lost to Follow-up|0|||
19602700|NCT01017029|42051420|FG000|Overall Study|Administrative problem|0|||
19602701|NCT01017029|42051421|FG001|Overall Study|Administrative problem|1|||
19602702|NCT01017029|42051420|FG000|Overall Study|Death|3|||
19665372|NCT00489489|42113945|FG000|Overall Study|Protocol Violation|1|||
19665373|NCT00489489|42113946|FG001|Overall Study|Protocol Violation|0|||
19665374|NCT00489489|42113947|FG002|Overall Study|Protocol Violation|1|||
19665375|NCT00489489|42113945|FG000|Overall Study|Progressive disease|0|||
19665376|NCT00489489|42113946|FG001|Overall Study|Progressive disease|1|||
19665377|NCT00489489|42113947|FG002|Overall Study|Progressive disease|0|||
19665378|NCT00489489|42113945|FG000|Overall Study|Participant did not wish to continue|1|||
19665379|NCT00489489|42113946|FG001|Overall Study|Participant did not wish to continue|1|||
19665380|NCT00489489|42113947|FG002|Overall Study|Participant did not wish to continue|0|||
19602703|NCT01017029|42051421|FG001|Overall Study|Death|1|||
19602704|NCT01016015|42051427|FG000|Overall Study|Not Treated|3|||
19665381|NCT00489489|42113945|FG000|Overall Study|Other than above|0|||
19665382|NCT00489489|42113946|FG001|Overall Study|Other than above|1|||
19665383|NCT00489489|42113947|FG002|Overall Study|Other than above|0|||
19665384|NCT00489411|42113959|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
19665385|NCT00489411|42113960|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
19665386|NCT00489411|42113959|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
19665387|NCT00489411|42113960|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
19665388|NCT00489411|42113959|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
19665389|NCT00489411|42113960|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
19665390|NCT00489411|42113959|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
19602705|NCT01016015|42051427|FG000|Overall Study|Withdrawal by Subject|1|||
19602706|NCT01016015|42051427|FG000|Overall Study|Adverse Event|15|||
19602707|NCT01015703|42051436|FG000|Overall Study|Withdrawal by Subject|0|||
19602708|NCT01015703|42051437|FG001|Overall Study|Withdrawal by Subject|1|||
19665391|NCT00489411|42113960|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
19665392|NCT00489411|42113959|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
19665393|NCT00489411|42113960|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
19665394|NCT00420784|42113970|FG000|Overall Study|Adverse Event|11|||
19665395|NCT00420784|42113971|FG001|Overall Study|Adverse Event|29|||
19665396|NCT00420784|42113972|FG002|Overall Study|Adverse Event|10|||
19665397|NCT00420784|42113973|FG003|Overall Study|Adverse Event|5|||
19665398|NCT00420784|42113970|FG000|Overall Study|Withdrawal by Subject|0|||
19665399|NCT00420784|42113971|FG001|Overall Study|Withdrawal by Subject|1|||
19665400|NCT00420784|42113972|FG002|Overall Study|Withdrawal by Subject|0|||
19756561|NCT01314872|42207063|FG012|Period 2|Withdrawal by Subject|17|||
19756562|NCT01314872|42207064|FG013|Period 2|Withdrawal by Subject|12|||
19756563|NCT01314872|42207065|FG014|Period 2|Withdrawal by Subject|4|||
19665401|NCT00420784|42113973|FG003|Overall Study|Withdrawal by Subject|0|||
19665402|NCT00420784|42113970|FG000|Overall Study|Lost to Follow-up|0|||
19665403|NCT00420784|42113971|FG001|Overall Study|Lost to Follow-up|0|||
19665404|NCT00420784|42113972|FG002|Overall Study|Lost to Follow-up|2|||
19665405|NCT00420784|42113973|FG003|Overall Study|Lost to Follow-up|1|||
19665406|NCT00420784|42113970|FG000|Overall Study|Virologic Stopping Rule|17|||
19665407|NCT00420784|42113971|FG001|Overall Study|Virologic Stopping Rule|26|||
19665408|NCT00420784|42113972|FG002|Overall Study|Virologic Stopping Rule|41|||
19665409|NCT00420784|42113973|FG003|Overall Study|Virologic Stopping Rule|67|||
19665410|NCT00420784|42113970|FG000|Overall Study|Other|1|||
19665411|NCT00420784|42113971|FG001|Overall Study|Other|2|||
19665412|NCT00420784|42113972|FG002|Overall Study|Other|0|||
19665413|NCT00420784|42113973|FG003|Overall Study|Other|5|||
19665414|NCT00420628|42113986|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
19665415|NCT00420628|42113987|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
19665416|NCT00420628|42113986|FG000|Overall Study|Lost to Follow-up|3|||
19665417|NCT00420628|42113987|FG001|Overall Study|Lost to Follow-up|2|||
19665418|NCT00420628|42113986|FG000|Overall Study|Adverse Event|1|||
19665419|NCT00420628|42113987|FG001|Overall Study|Adverse Event|0|||
19665420|NCT00489255|42113995|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
19665421|NCT00489255|42113996|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
19665422|NCT00489255|42113995|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
19665423|NCT00489255|42113996|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
19665424|NCT00489255|42113995|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
19665425|NCT00489255|42113996|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
19665426|NCT00489255|42113995|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
19665427|NCT00489255|42113996|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
19665428|NCT00489255|42113995|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
19665429|NCT00489255|42113996|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
19665430|NCT00489255|42113995|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
19665431|NCT00489255|42113996|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
19665432|NCT00489255|42113995|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
19665433|NCT00489255|42113996|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
19665434|NCT00489255|42113995|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
19665435|NCT00489255|42113996|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
19665436|NCT00489255|42113995|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
19665437|NCT00489255|42113996|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
19665438|NCT00489255|42113995|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
19665439|NCT00489255|42113996|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
19665440|NCT00413218|42114004|FG000|Overall Study|Randomized but didn't receive study drug|2|||
19665441|NCT00413218|42114005|FG001|Overall Study|Randomized but didn't receive study drug|8|||
19665442|NCT00413218|42114004|FG000|Overall Study|Death|57|||
19665443|NCT00413218|42114005|FG001|Overall Study|Death|56|||
19665444|NCT00413218|42114004|FG000|Overall Study|Lost to Follow-up|14|||
19665445|NCT00413218|42114005|FG001|Overall Study|Lost to Follow-up|17|||
19665446|NCT00413218|42114004|FG000|Overall Study|Admin|20|||
19665447|NCT00413218|42114005|FG001|Overall Study|Admin|14|||
19665448|NCT00413218|42114004|FG000|Overall Study|Missing|1|||
19665449|NCT00413218|42114005|FG001|Overall Study|Missing|0|||
19665450|NCT00413218|42114004|FG000|Overall Study|Withdrawal by Subject|9|||
19665451|NCT00413218|42114005|FG001|Overall Study|Withdrawal by Subject|1|||
19665452|NCT00420316|42114014|FG000|Overall Study|Withdrawal by Subject|0|||
19665453|NCT00420316|42114015|FG001|Overall Study|Withdrawal by Subject|1|||
19665454|NCT00420316|42114014|FG000|Overall Study|Lost to Follow-up|12|||
19665455|NCT00420316|42114015|FG001|Overall Study|Lost to Follow-up|8|||
19665456|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
19665457|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
19665458|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
19665459|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
19665460|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Death|8|||
19756564|NCT01314872|42207051|FG000|Period 2|Lost to Follow-up|0|||
19756565|NCT01314872|42207052|FG001|Period 2|Lost to Follow-up|0|||
19388778|NCT02544633|41632286|FG001|Treatment Period|Non-compliance|0|||
19665461|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Death|3|||
19665462|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
19665463|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
19665464|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
19665465|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
19665466|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
19665467|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
19665468|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
19665469|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
19665470|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
19665471|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
19665472|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
19665473|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
19756566|NCT01314872|42207053|FG002|Period 2|Lost to Follow-up|0|||
19756567|NCT01314872|42207054|FG003|Period 2|Lost to Follow-up|0|||
19665474|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
19665475|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
19665476|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
19665477|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
19665478|NCT00494871|42114023|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
19665479|NCT00494871|42114024|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
19665480|NCT00494871|42114023|FG000|Follow-up (FU) Period|Adverse Event|1|||
19665481|NCT00494871|42114024|FG001|Follow-up (FU) Period|Adverse Event|1|||
19665482|NCT00494871|42114023|FG000|Follow-up (FU) Period|Death|13|||
19665483|NCT00494871|42114024|FG001|Follow-up (FU) Period|Death|12|||
19665484|NCT00494871|42114023|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
19665485|NCT00494871|42114024|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
19665486|NCT00494871|42114023|FG000|Follow-up (FU) Period|Physician Decision|0|||
19665487|NCT00494871|42114024|FG001|Follow-up (FU) Period|Physician Decision|1|||
19665488|NCT00494871|42114023|FG000|Follow-up (FU) Period|Protocol Violation|1|||
19665489|NCT00494871|42114024|FG001|Follow-up (FU) Period|Protocol Violation|0|||
19665490|NCT00494871|42114023|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
19665491|NCT00494871|42114024|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
19665492|NCT00494871|42114023|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
19665493|NCT00494871|42114024|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
19665494|NCT00420238|42114034|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
19665495|NCT00420238|42114035|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
19665496|NCT00420238|42114034|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
19665497|NCT00420238|42114035|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
19665498|NCT00420238|42114034|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
19665499|NCT00420238|42114035|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
19665500|NCT00420238|42114034|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
19665501|NCT00420238|42114035|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
19665502|NCT00420238|42114034|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
19665503|NCT00420238|42114035|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
19665504|NCT00420238|42114034|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
19665505|NCT00420238|42114035|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
19665506|NCT00420004|42114050|FG000|Overall Study|Adverse Event|4|||
19665507|NCT00420004|42114051|FG001|Overall Study|Adverse Event|1|||
19665508|NCT00420004|42114052|FG002|Overall Study|Adverse Event|1|||
19665509|NCT00420004|42114050|FG000|Overall Study|Lack of Efficacy|5|||
19665510|NCT00420004|42114051|FG001|Overall Study|Lack of Efficacy|4|||
19665511|NCT00420004|42114052|FG002|Overall Study|Lack of Efficacy|1|||
19665512|NCT00420004|42114050|FG000|Overall Study|Lost to Follow-up|31|||
19665513|NCT00420004|42114051|FG001|Overall Study|Lost to Follow-up|12|||
19665514|NCT00420004|42114052|FG002|Overall Study|Lost to Follow-up|10|||
19665515|NCT00420004|42114050|FG000|Overall Study|Entry Criteria Not Met|0|||
19665516|NCT00420004|42114051|FG001|Overall Study|Entry Criteria Not Met|1|||
19665517|NCT00420004|42114052|FG002|Overall Study|Entry Criteria Not Met|0|||
19665518|NCT00420004|42114050|FG000|Overall Study|Physician Decision|14|||
19665519|NCT00420004|42114051|FG001|Overall Study|Physician Decision|4|||
19665520|NCT00420004|42114052|FG002|Overall Study|Physician Decision|2|||
19665521|NCT00420004|42114050|FG000|Overall Study|Protocol Violation|5|||
19665522|NCT00420004|42114051|FG001|Overall Study|Protocol Violation|4|||
19665523|NCT00420004|42114052|FG002|Overall Study|Protocol Violation|3|||
19665524|NCT00420004|42114050|FG000|Overall Study|Withdrawal by Subject|67|||
19665525|NCT00420004|42114051|FG001|Overall Study|Withdrawal by Subject|42|||
19665526|NCT00420004|42114052|FG002|Overall Study|Withdrawal by Subject|14|||
19665527|NCT00420004|42114050|FG000|Overall Study|Sponsor Decision|3|||
19665528|NCT00420004|42114051|FG001|Overall Study|Sponsor Decision|3|||
19665529|NCT00420004|42114052|FG002|Overall Study|Sponsor Decision|1|||
19665530|NCT00494481|42114066|FG000|Overall Study|Condition under investigation worsened|11|||
19665531|NCT00494481|42114067|FG001|Overall Study|Condition under investigation worsened|13|||
19665532|NCT00494481|42114066|FG000|Overall Study|Adverse Event|15|||
19665533|NCT00494481|42114067|FG001|Overall Study|Adverse Event|11|||
19665534|NCT00494481|42114066|FG000|Overall Study|Other|1|||
19665535|NCT00494481|42114067|FG001|Overall Study|Other|0|||
19665536|NCT00494481|42114066|FG000|Overall Study|Never received IP|2|||
19665537|NCT00494481|42114067|FG001|Overall Study|Never received IP|0|||
19665538|NCT00097591|42114075|FG000|Overall Study|Withdrawal of consent|342|||
19665539|NCT00097591|42114076|FG001|Overall Study|Withdrawal of consent|323|||
19665540|NCT00097591|42114075|FG000|Overall Study|Less than 6 months on study drug|9|||
19665541|NCT00097591|42114076|FG001|Overall Study|Less than 6 months on study drug|7|||
19665542|NCT00097591|42114075|FG000|Overall Study|Unable to attend termination visit|53|||
19665543|NCT00097591|42114076|FG001|Overall Study|Unable to attend termination visit|51|||
19665544|NCT00097591|42114075|FG000|Overall Study|Lost to follow up|6|||
19665545|NCT00097591|42114076|FG001|Overall Study|Lost to follow up|10|||
19665546|NCT00097591|42114075|FG000|Overall Study|Other|0|||
19665547|NCT00097591|42114076|FG001|Overall Study|Other|3|||
19665548|NCT00419926|42114084|FG000|Overall Study|Withdrawal by Subject|7|||
19665549|NCT00419926|42114085|FG001|Overall Study|Withdrawal by Subject|3|||
19665550|NCT00419926|42114084|FG000|Overall Study|Administrative Problem|4|||
19665551|NCT00419926|42114085|FG001|Overall Study|Administrative Problem|4|||
19665552|NCT00419926|42114084|FG000|Overall Study|Lost to Follow-up|1|||
19665553|NCT00419926|42114085|FG001|Overall Study|Lost to Follow-up|2|||
19665554|NCT00419926|42114084|FG000|Overall Study|Death|2|||
19665555|NCT00419926|42114085|FG001|Overall Study|Death|1|||
19665556|NCT00419770|42114093|FG000|Overall Study|Withdrawal by Subject|5|||
19665557|NCT00419770|42114094|FG001|Overall Study|Withdrawal by Subject|1|||
19665558|NCT00080119|42114104|FG000|Overall Study|Discontinued because of study closure|0|||
19665559|NCT00080119|42114105|FG001|Overall Study|Discontinued because of study closure|0|||
19665560|NCT00080119|42114106|FG002|Overall Study|Discontinued because of study closure|130|||
19665561|NCT00080119|42114107|FG003|Overall Study|Discontinued because of study closure|141|||
19665562|NCT00080119|42114104|FG000|Overall Study|Unable to get to clinic|24|||
19665563|NCT00080119|42114105|FG001|Overall Study|Unable to get to clinic|24|||
19665564|NCT00080119|42114106|FG002|Overall Study|Unable to get to clinic|7|||
19665565|NCT00080119|42114107|FG003|Overall Study|Unable to get to clinic|1|||
19665566|NCT00080119|42114104|FG000|Overall Study|Consent withdrawn|13|||
19665567|NCT00080119|42114105|FG001|Overall Study|Consent withdrawn|17|||
19665568|NCT00080119|42114106|FG002|Overall Study|Consent withdrawn|4|||
19665569|NCT00080119|42114107|FG003|Overall Study|Consent withdrawn|6|||
19665570|NCT00080119|42114104|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
19665571|NCT00080119|42114105|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
19665572|NCT00080119|42114106|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
19665573|NCT00080119|42114107|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
19665574|NCT00080119|42114104|FG000|Overall Study|Lost to Follow-up|16|||
19665575|NCT00080119|42114105|FG001|Overall Study|Lost to Follow-up|19|||
19665576|NCT00080119|42114106|FG002|Overall Study|Lost to Follow-up|19|||
19665577|NCT00080119|42114107|FG003|Overall Study|Lost to Follow-up|14|||
19665578|NCT00419380|42114121|FG000|Overall Study|Lack of Efficacy|1|||
19665579|NCT00419380|42114122|FG001|Overall Study|Lack of Efficacy|7|||
19665580|NCT00419380|42114121|FG000|Overall Study|Physician Decision|0|||
19665581|NCT00419380|42114122|FG001|Overall Study|Physician Decision|1|||
19665582|NCT00419380|42114121|FG000|Overall Study|Lost to Follow-up|0|||
19665583|NCT00419380|42114122|FG001|Overall Study|Lost to Follow-up|1|||
19665584|NCT00419380|42114121|FG000|Overall Study|Withdrawal by Subject|0|||
19665585|NCT00419380|42114122|FG001|Overall Study|Withdrawal by Subject|1|||
19665586|NCT00413062|42114130|FG000|Overall Study|Adverse event/serious adverse event|289|||
19665587|NCT00413062|42114131|FG001|Overall Study|Adverse event/serious adverse event|56|||
19665588|NCT00413062|42114130|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
19665589|NCT00413062|42114131|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
19665590|NCT00413062|42114130|FG000|Overall Study|Withdrawal of informed consent|111|||
19665591|NCT00413062|42114131|FG001|Overall Study|Withdrawal of informed consent|36|||
19665592|NCT00413062|42114130|FG000|Overall Study|Pregnancy|15|||
19665593|NCT00413062|42114131|FG001|Overall Study|Pregnancy|5|||
19665594|NCT00413062|42114130|FG000|Overall Study|Pregnancy wish|17|||
19665595|NCT00413062|42114131|FG001|Overall Study|Pregnancy wish|6|||
19665596|NCT00413062|42114130|FG000|Overall Study|Lost to Follow-up|175|||
19665597|NCT00413062|42114131|FG001|Overall Study|Lost to Follow-up|73|||
19665598|NCT00413062|42114130|FG000|Overall Study|Other reason|70|||
19665599|NCT00413062|42114131|FG001|Overall Study|Other reason|34|||
19665600|NCT00494091|42114141|FG000|Overall Study|Death|5|||
19665601|NCT00494091|42114142|FG001|Overall Study|Death|54|||
19665602|NCT00494091|42114141|FG000|Overall Study|Lost to Follow-up|0|||
19665603|NCT00494091|42114142|FG001|Overall Study|Lost to Follow-up|4|||
19665604|NCT00494091|42114141|FG000|Overall Study|Other|1|||
19665605|NCT00494091|42114142|FG001|Overall Study|Other|11|||
19665606|NCT00494091|42114141|FG000|Overall Study|Withdrawal by Subject|0|||
19756568|NCT01314872|42207055|FG004|Period 2|Lost to Follow-up|0|||
19756569|NCT01314872|42207056|FG005|Period 2|Lost to Follow-up|0|||
19665607|NCT00494091|42114142|FG001|Overall Study|Withdrawal by Subject|7|||
19665608|NCT00494013|42114151|FG000|Overall Study|Adverse Event|0|||
19665609|NCT00494013|42114152|FG001|Overall Study|Adverse Event|1|||
19665610|NCT00494013|42114151|FG000|Overall Study|Entry Criteria Not Met|1|||
19665611|NCT00494013|42114152|FG001|Overall Study|Entry Criteria Not Met|4|||
19665612|NCT00494013|42114151|FG000|Overall Study|Lost to Follow-up|5|||
19665613|NCT00494013|42114152|FG001|Overall Study|Lost to Follow-up|6|||
19665614|NCT00494013|42114151|FG000|Overall Study|Physician Decision|3|||
19665615|NCT00494013|42114152|FG001|Overall Study|Physician Decision|5|||
19665616|NCT00494013|42114151|FG000|Overall Study|Protocol Violation|8|||
19665617|NCT00494013|42114152|FG001|Overall Study|Protocol Violation|5|||
19665618|NCT00494013|42114151|FG000|Overall Study|Withdrawal by Subject|13|||
19665619|NCT00494013|42114152|FG001|Overall Study|Withdrawal by Subject|14|||
19665620|NCT00494013|42114151|FG000|Overall Study|Sponsor Decision|0|||
19665621|NCT00494013|42114152|FG001|Overall Study|Sponsor Decision|1|||
19665622|NCT00079339|42114161|FG000|Overall Study|Adverse Event|1|||
19665623|NCT00079339|42114162|FG001|Overall Study|Adverse Event|7|||
19665624|NCT00079339|42114163|FG002|Overall Study|Adverse Event|2|||
19665625|NCT00079339|42114161|FG000|Overall Study|Death|1|||
19665626|NCT00079339|42114162|FG001|Overall Study|Death|0|||
19665627|NCT00079339|42114163|FG002|Overall Study|Death|0|||
19665628|NCT00079339|42114161|FG000|Overall Study|Non-compliance|0|||
19665629|NCT00079339|42114162|FG001|Overall Study|Non-compliance|0|||
19665630|NCT00079339|42114163|FG002|Overall Study|Non-compliance|1|||
19665631|NCT00079339|42114161|FG000|Overall Study|Withdrawal by Subject|0|||
19665632|NCT00079339|42114162|FG001|Overall Study|Withdrawal by Subject|4|||
19665633|NCT00079339|42114163|FG002|Overall Study|Withdrawal by Subject|1|||
19665634|NCT00079339|42114161|FG000|Overall Study|Disease progression|3|||
19665635|NCT00079339|42114162|FG001|Overall Study|Disease progression|28|||
19665636|NCT00079339|42114163|FG002|Overall Study|Disease progression|2|||
19665637|NCT00493779|42114176|FG000|Overall Study|Logistical issue at site|1|||
19665638|NCT00541866|42114186|FG000|Overall Study|Adverse Event|3|||
19665639|NCT00541866|42114187|FG001|Overall Study|Adverse Event|0|||
19665640|NCT00541866|42114188|FG002|Overall Study|Adverse Event|0|||
19665641|NCT00541866|42114189|FG003|Overall Study|Adverse Event|0|||
19665642|NCT00541866|42114190|FG004|Overall Study|Adverse Event|0|||
19665643|NCT00541866|42114186|FG000|Overall Study|Death|1|||
19665644|NCT00541866|42114187|FG001|Overall Study|Death|0|||
19665645|NCT00541866|42114188|FG002|Overall Study|Death|0|||
19665646|NCT00541866|42114189|FG003|Overall Study|Death|0|||
19665647|NCT00541866|42114190|FG004|Overall Study|Death|0|||
19665648|NCT00541866|42114186|FG000|Overall Study|Lack of Efficacy|19|||
19665649|NCT00541866|42114187|FG001|Overall Study|Lack of Efficacy|15|||
19665650|NCT00541866|42114188|FG002|Overall Study|Lack of Efficacy|10|||
19665651|NCT00541866|42114189|FG003|Overall Study|Lack of Efficacy|12|||
19665652|NCT00541866|42114190|FG004|Overall Study|Lack of Efficacy|14|||
19665653|NCT00541866|42114186|FG000|Overall Study|Not Reported or Other|11|||
19665654|NCT00541866|42114187|FG001|Overall Study|Not Reported or Other|3|||
19665655|NCT00541866|42114188|FG002|Overall Study|Not Reported or Other|3|||
19665656|NCT00541866|42114189|FG003|Overall Study|Not Reported or Other|3|||
19665657|NCT00541866|42114190|FG004|Overall Study|Not Reported or Other|1|||
19665658|NCT00541866|42114186|FG000|Overall Study|Physician Decision|0|||
19665659|NCT00541866|42114187|FG001|Overall Study|Physician Decision|0|||
19665660|NCT00541866|42114188|FG002|Overall Study|Physician Decision|2|||
19665661|NCT00541866|42114189|FG003|Overall Study|Physician Decision|1|||
19665662|NCT00541866|42114190|FG004|Overall Study|Physician Decision|0|||
19665663|NCT00493467|42114218|FG000|Overall Study|Death|1|||
19665664|NCT00090493|42114222|FG000|Overall Study|Physician Decision|2|||
19665665|NCT04329702|42114229|FG000|Overall Study|illness|3|||
19665666|NCT04329702|42114230|FG001|Overall Study|illness|4|||
19665667|NCT04329702|42114231|FG002|Overall Study|illness|0|||
19665668|NCT04329702|42114229|FG000|Overall Study|Lost to Follow-up|0|||
19665669|NCT04329702|42114230|FG001|Overall Study|Lost to Follow-up|0|||
19665670|NCT04329702|42114231|FG002|Overall Study|Lost to Follow-up|2|||
19756570|NCT01314872|42207057|FG006|Period 2|Lost to Follow-up|0|||
19665671|NCT04329702|42114229|FG000|Overall Study|Death|0|||
19665672|NCT04329702|42114230|FG001|Overall Study|Death|2|||
19665673|NCT04329702|42114231|FG002|Overall Study|Death|0|||
19665674|NCT00481065|42114252|FG000|Overall Study|Adverse event or death|1|||
19665675|NCT00481065|42114253|FG001|Overall Study|Adverse event or death|1|||
19665676|NCT00481065|42114254|FG002|Overall Study|Adverse event or death|3|||
19665677|NCT00481065|42114255|FG003|Overall Study|Adverse event or death|0|||
19756571|NCT01314872|42207058|FG007|Period 2|Lost to Follow-up|0|||
19665678|NCT00481065|42114256|FG004|Overall Study|Adverse event or death|2|||
19665679|NCT00481065|42114257|FG005|Overall Study|Adverse event or death|0|||
19756572|NCT01314872|42207059|FG008|Period 2|Lost to Follow-up|0|||
19756573|NCT01314872|42207060|FG009|Period 2|Lost to Follow-up|0|||
19756574|NCT01314872|42207061|FG010|Period 2|Lost to Follow-up|0|||
19756575|NCT01314872|42207062|FG011|Period 2|Lost to Follow-up|6|||
19756576|NCT01314872|42207063|FG012|Period 2|Lost to Follow-up|7|||
19756577|NCT01314872|42207064|FG013|Period 2|Lost to Follow-up|2|||
19756578|NCT01314872|42207065|FG014|Period 2|Lost to Follow-up|6|||
19756579|NCT00703924|42207099|FG000|Overall Study|Withdrawal by Subject|1|||
19756580|NCT00703924|42207100|FG001|Overall Study|Withdrawal by Subject|1|||
19756581|NCT03152526|42207112|FG000|Overall Study|Withdrawal by Subject|0|||
19756582|NCT03152526|42207113|FG001|Overall Study|Withdrawal by Subject|1|||
19756583|NCT03149328|42207121|FG000|Overall Study|Withdrawal by Subject|30|||
19756584|NCT03149328|42207122|FG001|Overall Study|Withdrawal by Subject|26|||
19756585|NCT03149328|42207121|FG000|Overall Study|Changed Dialysis Modality|18|||
19756586|NCT03149328|42207122|FG001|Overall Study|Changed Dialysis Modality|1|||
19756587|NCT03149328|42207121|FG000|Overall Study|Transplant|9|||
19756588|NCT03149328|42207122|FG001|Overall Study|Transplant|1|||
19756589|NCT03149328|42207121|FG000|Overall Study|Lost to Follow-up|25|||
19756590|NCT03149328|42207122|FG001|Overall Study|Lost to Follow-up|16|||
19756591|NCT03149328|42207121|FG000|Overall Study|Left Study Site|1|||
19756592|NCT03149328|42207122|FG001|Overall Study|Left Study Site|2|||
19756593|NCT03149328|42207121|FG000|Overall Study|Language Barrier|1|||
19756594|NCT03149328|42207122|FG001|Overall Study|Language Barrier|0|||
19756595|NCT04296942|42207171|FG000|Overall Study|Study closure by sponsor|1|||
19756596|NCT04296942|42207172|FG001|Overall Study|Study closure by sponsor|0|||
19756597|NCT04296942|42207173|FG002|Overall Study|Study closure by sponsor|0|||
19756598|NCT01522976|42207211|FG000|Overall Study|Ineligible|4|||
19756599|NCT01522976|42207212|FG001|Overall Study|Ineligible|0|||
19756600|NCT01522976|42207213|FG002|Overall Study|Ineligible|1|||
19756601|NCT01522976|42207211|FG000|Overall Study|Death|7|||
19602709|NCT01015703|42051438|FG002|Overall Study|Withdrawal by Subject|0|||
19602710|NCT01015703|42051439|FG003|Overall Study|Withdrawal by Subject|0|||
19602711|NCT01015703|42051440|FG004|Overall Study|Withdrawal by Subject|0|||
19602712|NCT01015703|42051436|FG000|Overall Study|Adverse Event|1|||
19665680|NCT00481065|42114258|FG006|Overall Study|Adverse event or death|1|||
19665681|NCT00481065|42114259|FG007|Overall Study|Adverse event or death|1|||
19665682|NCT00481065|42114252|FG000|Overall Study|Withdrawal by Subject|11|||
19665683|NCT00481065|42114253|FG001|Overall Study|Withdrawal by Subject|12|||
19665684|NCT00481065|42114254|FG002|Overall Study|Withdrawal by Subject|7|||
19665685|NCT00481065|42114255|FG003|Overall Study|Withdrawal by Subject|11|||
19665686|NCT00481065|42114256|FG004|Overall Study|Withdrawal by Subject|13|||
19665687|NCT00481065|42114257|FG005|Overall Study|Withdrawal by Subject|12|||
19665688|NCT00481065|42114258|FG006|Overall Study|Withdrawal by Subject|9|||
19665689|NCT00481065|42114259|FG007|Overall Study|Withdrawal by Subject|10|||
19665690|NCT00481065|42114252|FG000|Overall Study|Lost to Follow-up|4|||
19665691|NCT00481065|42114253|FG001|Overall Study|Lost to Follow-up|2|||
19665692|NCT00481065|42114254|FG002|Overall Study|Lost to Follow-up|4|||
19665693|NCT00481065|42114255|FG003|Overall Study|Lost to Follow-up|3|||
19665694|NCT00481065|42114256|FG004|Overall Study|Lost to Follow-up|3|||
19602713|NCT01015703|42051437|FG001|Overall Study|Adverse Event|0|||
19602714|NCT01015703|42051438|FG002|Overall Study|Adverse Event|0|||
19602715|NCT01015703|42051439|FG003|Overall Study|Adverse Event|0|||
19602716|NCT01015703|42051440|FG004|Overall Study|Adverse Event|0|||
19602717|NCT01015703|42051436|FG000|Overall Study|Protocol Violation|1|||
19602718|NCT01015703|42051437|FG001|Overall Study|Protocol Violation|0|||
19602719|NCT01015703|42051438|FG002|Overall Study|Protocol Violation|0|||
19602720|NCT01015703|42051439|FG003|Overall Study|Protocol Violation|0|||
19756602|NCT01522976|42207212|FG001|Overall Study|Death|6|||
19756603|NCT01522976|42207213|FG002|Overall Study|Death|2|||
19756604|NCT01522976|42207211|FG000|Overall Study|Still on treatment|9|||
19756605|NCT01522976|42207212|FG001|Overall Study|Still on treatment|9|||
19756606|NCT01522976|42207213|FG002|Overall Study|Still on treatment|6|||
19756607|NCT01522976|42207211|FG000|Overall Study|Disease progression|28|||
19756608|NCT01522976|42207212|FG001|Overall Study|Disease progression|30|||
19756609|NCT01522976|42207213|FG002|Overall Study|Disease progression|25|||
19756610|NCT01522976|42207211|FG000|Overall Study|Adverse Event|17|||
19756611|NCT01522976|42207212|FG001|Overall Study|Adverse Event|7|||
19756612|NCT01522976|42207213|FG002|Overall Study|Adverse Event|18|||
19602721|NCT01015703|42051440|FG004|Overall Study|Protocol Violation|0|||
19665695|NCT00481065|42114257|FG005|Overall Study|Lost to Follow-up|3|||
19756613|NCT01522976|42207211|FG000|Overall Study|Refusal unrelated to adverse event|10|||
19665696|NCT00481065|42114258|FG006|Overall Study|Lost to Follow-up|2|||
19665697|NCT00481065|42114259|FG007|Overall Study|Lost to Follow-up|5|||
19665698|NCT00481065|42114252|FG000|Overall Study|Inappropriate enrollment|4|||
19665699|NCT00481065|42114253|FG001|Overall Study|Inappropriate enrollment|0|||
19665700|NCT00481065|42114254|FG002|Overall Study|Inappropriate enrollment|2|||
19665701|NCT00481065|42114255|FG003|Overall Study|Inappropriate enrollment|0|||
19665702|NCT00481065|42114256|FG004|Overall Study|Inappropriate enrollment|2|||
19665703|NCT00481065|42114257|FG005|Overall Study|Inappropriate enrollment|1|||
19665704|NCT00481065|42114258|FG006|Overall Study|Inappropriate enrollment|0|||
19665705|NCT00481065|42114259|FG007|Overall Study|Inappropriate enrollment|1|||
19665706|NCT00481065|42114252|FG000|Overall Study|Administrative reason|0|||
19665707|NCT00481065|42114253|FG001|Overall Study|Administrative reason|0|||
19665708|NCT00481065|42114254|FG002|Overall Study|Administrative reason|0|||
19665709|NCT00481065|42114255|FG003|Overall Study|Administrative reason|0|||
19665710|NCT00481065|42114256|FG004|Overall Study|Administrative reason|0|||
19665711|NCT00481065|42114257|FG005|Overall Study|Administrative reason|2|||
19665712|NCT00481065|42114258|FG006|Overall Study|Administrative reason|1|||
19665713|NCT00481065|42114259|FG007|Overall Study|Administrative reason|0|||
19665714|NCT00481065|42114252|FG000|Overall Study|Protocol Violation|2|||
19665715|NCT00481065|42114253|FG001|Overall Study|Protocol Violation|1|||
19665716|NCT00481065|42114254|FG002|Overall Study|Protocol Violation|1|||
19756614|NCT01522976|42207212|FG001|Overall Study|Refusal unrelated to adverse event|13|||
19756615|NCT01522976|42207213|FG002|Overall Study|Refusal unrelated to adverse event|14|||
19756616|NCT01522976|42207211|FG000|Overall Study|Not protocol specified|22|||
19756617|NCT01522976|42207212|FG001|Overall Study|Not protocol specified|27|||
19665717|NCT00481065|42114255|FG003|Overall Study|Protocol Violation|1|||
19665718|NCT00481065|42114256|FG004|Overall Study|Protocol Violation|2|||
19665719|NCT00481065|42114257|FG005|Overall Study|Protocol Violation|6|||
19665720|NCT00481065|42114258|FG006|Overall Study|Protocol Violation|3|||
19665721|NCT00481065|42114259|FG007|Overall Study|Protocol Violation|2|||
19665722|NCT00481065|42114252|FG000|Overall Study|Unable to classify|0|||
19665723|NCT00481065|42114253|FG001|Overall Study|Unable to classify|1|||
19665724|NCT00481065|42114254|FG002|Overall Study|Unable to classify|2|||
19665725|NCT00481065|42114255|FG003|Overall Study|Unable to classify|0|||
19665726|NCT00481065|42114256|FG004|Overall Study|Unable to classify|1|||
19665727|NCT00481065|42114257|FG005|Overall Study|Unable to classify|0|||
19665728|NCT00481065|42114258|FG006|Overall Study|Unable to classify|0|||
19665729|NCT00481065|42114259|FG007|Overall Study|Unable to classify|0|||
19665730|NCT00493311|42114281|FG000|Overall Study|Need for rescue medication|2|||
19665731|NCT00493311|42114282|FG001|Overall Study|Need for rescue medication|2|||
19665732|NCT00571649|42114290|FG000|Treatment Period|Adverse Event|438|||
19665733|NCT00571649|42114291|FG001|Treatment Period|Adverse Event|385|||
19665734|NCT00571649|42114290|FG000|Treatment Period|Clinical endpoint reached|50|||
19665735|NCT00571649|42114291|FG001|Treatment Period|Clinical endpoint reached|56|||
19665736|NCT00571649|42114290|FG000|Treatment Period|Withdrawal by Subject|285|||
19665737|NCT00571649|42114291|FG001|Treatment Period|Withdrawal by Subject|255|||
19665738|NCT00571649|42114290|FG000|Treatment Period|Death|76|||
19665739|NCT00571649|42114291|FG001|Treatment Period|Death|59|||
19665740|NCT00571649|42114290|FG000|Treatment Period|Physician Decision|8|||
19665741|NCT00571649|42114291|FG001|Treatment Period|Physician Decision|9|||
19665742|NCT00571649|42114290|FG000|Treatment Period|Lost to Follow-up|43|||
19665743|NCT00571649|42114291|FG001|Treatment Period|Lost to Follow-up|41|||
19665744|NCT00571649|42114290|FG000|Treatment Period|Non-compliant with study medication|88|||
19665745|NCT00571649|42114291|FG001|Treatment Period|Non-compliant with study medication|89|||
19665746|NCT00571649|42114290|FG000|Treatment Period|Patient convenience|11|||
19665747|NCT00571649|42114291|FG001|Treatment Period|Patient convenience|13|||
19665748|NCT00571649|42114290|FG000|Treatment Period|Protocol Violation|90|||
19665749|NCT00571649|42114291|FG001|Treatment Period|Protocol Violation|92|||
19665750|NCT00571649|42114290|FG000|Treatment Period|Technical problems|3|||
19665751|NCT00571649|42114291|FG001|Treatment Period|Technical problems|5|||
19665752|NCT00571649|42114290|FG000|Follow-up Period|Adverse Event|46|||
19665753|NCT00571649|42114291|FG001|Follow-up Period|Adverse Event|40|||
19665754|NCT00571649|42114290|FG000|Follow-up Period|Clinical endpoint reached|5|||
19665755|NCT00571649|42114291|FG001|Follow-up Period|Clinical endpoint reached|2|||
19665756|NCT00571649|42114290|FG000|Follow-up Period|Withdrawal by Subject|119|||
19665757|NCT00571649|42114291|FG001|Follow-up Period|Withdrawal by Subject|115|||
19665758|NCT00571649|42114290|FG000|Follow-up Period|Death|132|||
19665759|NCT00571649|42114291|FG001|Follow-up Period|Death|133|||
19665760|NCT00571649|42114290|FG000|Follow-up Period|Physician Decision|7|||
19756618|NCT01522976|42207213|FG002|Overall Study|Not protocol specified|27|||
19665761|NCT00571649|42114291|FG001|Follow-up Period|Physician Decision|13|||
19665762|NCT00571649|42114290|FG000|Follow-up Period|Lost to Follow-up|95|||
19665763|NCT00571649|42114291|FG001|Follow-up Period|Lost to Follow-up|92|||
19665764|NCT00571649|42114290|FG000|Follow-up Period|Patient convenience|136|||
19665765|NCT00571649|42114291|FG001|Follow-up Period|Patient convenience|121|||
19665766|NCT00571649|42114290|FG000|Follow-up Period|Protocol Violation|5|||
19665767|NCT00571649|42114291|FG001|Follow-up Period|Protocol Violation|12|||
19665768|NCT00546572|42114299|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
19665769|NCT00546572|42114300|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
19665770|NCT00546572|42114299|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
19665771|NCT00546572|42114300|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
19665772|NCT00546572|42114299|FG000|Vax 1 / Year 0|Protocol Violation|3|||
19665773|NCT00546572|42114300|FG001|Vax 1 / Year 0|Protocol Violation|4|||
19665774|NCT00546572|42114299|FG000|Vax 1 / Year 0|Death|2|||
19665775|NCT00546572|42114300|FG001|Vax 1 / Year 0|Death|2|||
19665776|NCT00546572|42114299|FG000|Vax 1 / Year 0|Adverse Event|0|||
19665777|NCT00546572|42114300|FG001|Vax 1 / Year 0|Adverse Event|1|||
19665778|NCT00546572|42114299|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
19665779|NCT00546572|42114300|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
19665780|NCT00546572|42114299|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
19665781|NCT00546572|42114300|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
19665782|NCT00546572|42114299|FG000|Vax 2 / Year 1|Other|1|||
19665783|NCT00546572|42114300|FG001|Vax 2 / Year 1|Other|1|||
19665784|NCT00546572|42114299|FG000|Vax 2 / Year 1|Adverse Event|1|||
19665785|NCT00546572|42114300|FG001|Vax 2 / Year 1|Adverse Event|0|||
19665786|NCT00546572|42114299|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
19665787|NCT00546572|42114300|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
19665788|NCT03917472|42114319|FG000|Overall Study|Physician Decision|4|||
19665789|NCT03917472|42114320|FG001|Overall Study|Physician Decision|0|||
19665790|NCT03917472|42114319|FG000|Overall Study|Adverse Event|3|||
19665791|NCT03917472|42114320|FG001|Overall Study|Adverse Event|1|||
19665792|NCT03917472|42114319|FG000|Overall Study|Death|7|||
19665793|NCT03917472|42114320|FG001|Overall Study|Death|5|||
19665794|NCT03917472|42114319|FG000|Overall Study|Withdrawal by Subject|11|||
19665795|NCT03917472|42114320|FG001|Overall Study|Withdrawal by Subject|4|||
19665796|NCT03917472|42114319|FG000|Overall Study|Lost to Follow-up|10|||
19665797|NCT03917472|42114320|FG001|Overall Study|Lost to Follow-up|5|||
19665798|NCT00681863|42114327|FG000|Overall Study|Adverse Event|1|||
19665799|NCT00681863|42114327|FG000|Overall Study|Lost to Follow-up|2|||
19665800|NCT00681863|42114327|FG000|Overall Study|Lack of Efficacy|2|||
19665801|NCT00681863|42114327|FG000|Overall Study|Other|18|||
19665802|NCT00681629|42114333|FG000|Overall Study|Study termination|4|||
19665803|NCT00681629|42114334|FG001|Overall Study|Study termination|2|||
19665804|NCT00681629|42114333|FG000|Overall Study|Adverse Event|1|||
19665805|NCT00681629|42114334|FG001|Overall Study|Adverse Event|0|||
19665806|NCT00546260|42114342|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
19665807|NCT00546260|42114343|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
19665808|NCT00679367|42114349|FG000|Overall Study|Adverse Event|7|||
19665809|NCT00679367|42114349|FG000|Overall Study|inability to swallow oral drugs|1|||
19665810|NCT00679367|42114349|FG000|Overall Study|Lack of Efficacy|3|||
19665811|NCT00679367|42114349|FG000|Overall Study|Withdrawal by Subject|1|||
19665812|NCT03937778|42114354|FG000|Overall Study|Withdrawal by Subject|1|||
19665813|NCT03937778|42114354|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
19665814|NCT03935126|42114358|FG000|Overall Study|Study termination by sponsor|3|||
19665815|NCT00545714|42114362|FG000|Induction Phase (6 Months)|Physician Decision|3|||
19665816|NCT00545714|42114362|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
19665817|NCT00545714|42114362|FG000|Induction Phase (6 Months)|Disease Progression|1|||
19665818|NCT00545714|42114362|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
19665819|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
19665820|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
19665821|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
19665822|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
19665823|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
19665824|NCT00545714|42114362|FG000|Maintenance Phase (36 Months)|Death|2|||
19665825|NCT00539838|42114369|FG000|Overall Study|Fail to return|2|||
19665826|NCT00539838|42114370|FG001|Overall Study|Fail to return|0|||
19665827|NCT00539838|42114371|FG002|Overall Study|Fail to return|0|||
19665828|NCT00539838|42114369|FG000|Overall Study|Withdrawal by Subject|0|||
19665829|NCT00539838|42114370|FG001|Overall Study|Withdrawal by Subject|4|||
19665830|NCT00539838|42114371|FG002|Overall Study|Withdrawal by Subject|0|||
19665831|NCT00539838|42114369|FG000|Overall Study|Death|0|||
19665832|NCT00539838|42114370|FG001|Overall Study|Death|2|||
19665833|NCT00539838|42114371|FG002|Overall Study|Death|0|||
19665834|NCT00539838|42114369|FG000|Overall Study|Did not cooperate|1|||
19665835|NCT00539838|42114370|FG001|Overall Study|Did not cooperate|0|||
19665836|NCT00539838|42114371|FG002|Overall Study|Did not cooperate|1|||
19665837|NCT00539838|42114369|FG000|Overall Study|Administrative|4|||
19665838|NCT00539838|42114370|FG001|Overall Study|Administrative|0|||
19665839|NCT00539838|42114371|FG002|Overall Study|Administrative|8|||
19665840|NCT00679289|42114384|FG000|Overall Study|Progressive disease|4|||
19665841|NCT00679289|42114385|FG001|Overall Study|Progressive disease|5|||
19665842|NCT00679289|42114386|FG002|Overall Study|Progressive disease|18|||
19665843|NCT00679289|42114384|FG000|Overall Study|Withdrawal by Subject|0|||
19665844|NCT00679289|42114385|FG001|Overall Study|Withdrawal by Subject|1|||
19665845|NCT00679289|42114386|FG002|Overall Study|Withdrawal by Subject|1|||
19665846|NCT00679289|42114384|FG000|Overall Study|Adverse Event|0|||
19665847|NCT00679289|42114385|FG001|Overall Study|Adverse Event|0|||
19665848|NCT00679289|42114386|FG002|Overall Study|Adverse Event|3|||
19665849|NCT00679289|42114384|FG000|Overall Study|Physician Decision|1|||
19665850|NCT00679289|42114385|FG001|Overall Study|Physician Decision|0|||
19665851|NCT00679289|42114386|FG002|Overall Study|Physician Decision|1|||
19665852|NCT00679211|42114396|FG000|Overall Study|Progressive disease|82|||
19665853|NCT00679211|42114396|FG000|Overall Study|Adverse Event|7|||
19665854|NCT00679211|42114396|FG000|Overall Study|Withdrawal by Subject|2|||
19665855|NCT00679211|42114396|FG000|Overall Study|Physician Decision|5|||
19665856|NCT00679211|42114396|FG000|Overall Study|Refused to undergo protocol procedures|1|||
19665857|NCT00679211|42114396|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
19665858|NCT00679211|42114396|FG000|Overall Study|Other|1|||
19665859|NCT00545948|42114405|FG000|Overall Study|Not Treated|1|||
19665860|NCT00545948|42114406|FG001|Overall Study|Not Treated|1|||
19665861|NCT00545948|42114407|FG002|Overall Study|Not Treated|7|||
19665862|NCT00679055|42114418|FG000|Overall Study|Adverse Event|0|||
19665863|NCT00679055|42114419|FG001|Overall Study|Adverse Event|1|||
19665864|NCT00679055|42114418|FG000|Overall Study|Other|0|||
19665865|NCT00679055|42114419|FG001|Overall Study|Other|3|||
19665866|NCT00679055|42114418|FG000|Overall Study|Study Terminated|2|||
19665867|NCT00679055|42114419|FG001|Overall Study|Study Terminated|1|||
19698965|NCT00312338|42143779|FG000|Overall Study|Withdrawal by Subject|4|||
19698966|NCT00312338|42143780|FG001|Overall Study|Withdrawal by Subject|0|||
19698967|NCT00312338|42143779|FG000|Overall Study|Subsequent infection|2|||
19698968|NCT00312338|42143780|FG001|Overall Study|Subsequent infection|0|||
19698969|NCT00290498|42143788|FG000|Overall Study|Death|2|||
19698970|NCT00290498|42143789|FG001|Overall Study|Death|0|||
19698971|NCT00290498|42143788|FG000|Overall Study|Physician Decision|1|||
19698972|NCT00290498|42143789|FG001|Overall Study|Physician Decision|0|||
19698973|NCT00290498|42143788|FG000|Overall Study|Withdrawal by Subject|1|||
19698974|NCT00290498|42143789|FG001|Overall Study|Withdrawal by Subject|0|||
19698975|NCT00290498|42143788|FG000|Overall Study|Ineligible|3|||
19698976|NCT00290498|42143789|FG001|Overall Study|Ineligible|0|||
19698977|NCT00290498|42143788|FG000|Overall Study|Non-Compliance|1|||
19698978|NCT00290498|42143789|FG001|Overall Study|Non-Compliance|0|||
19698979|NCT00451451|42143800|FG000|Overall Study|Adverse Event|11|||
19698980|NCT00451451|42143801|FG001|Overall Study|Adverse Event|21|||
19698981|NCT00451451|42143802|FG002|Overall Study|Adverse Event|26|||
19698982|NCT00451451|42143803|FG003|Overall Study|Adverse Event|10|||
19698983|NCT00451451|42143800|FG000|Overall Study|Lost to Follow-up|11|||
19698984|NCT00451451|42143801|FG001|Overall Study|Lost to Follow-up|9|||
19698985|NCT00451451|42143802|FG002|Overall Study|Lost to Follow-up|8|||
19698986|NCT00451451|42143803|FG003|Overall Study|Lost to Follow-up|11|||
19698987|NCT00451451|42143800|FG000|Overall Study|Consent Withdrawn|14|||
19698988|NCT00451451|42143801|FG001|Overall Study|Consent Withdrawn|9|||
19698989|NCT00451451|42143802|FG002|Overall Study|Consent Withdrawn|17|||
19698990|NCT00451451|42143803|FG003|Overall Study|Consent Withdrawn|17|||
19698991|NCT00451451|42143800|FG000|Overall Study|Investigator Decision|6|||
19698992|NCT00451451|42143801|FG001|Overall Study|Investigator Decision|2|||
19698993|NCT00451451|42143802|FG002|Overall Study|Investigator Decision|1|||
19698994|NCT00451451|42143803|FG003|Overall Study|Investigator Decision|2|||
19698995|NCT00451451|42143800|FG000|Overall Study|Subject Non-Compliance|8|||
19698996|NCT00451451|42143801|FG001|Overall Study|Subject Non-Compliance|4|||
19698997|NCT00451451|42143802|FG002|Overall Study|Subject Non-Compliance|3|||
19698998|NCT00451451|42143803|FG003|Overall Study|Subject Non-Compliance|3|||
19698999|NCT00451451|42143800|FG000|Overall Study|Death|1|||
19699000|NCT00451451|42143801|FG001|Overall Study|Death|0|||
19699001|NCT00451451|42143802|FG002|Overall Study|Death|0|||
19699002|NCT00451451|42143803|FG003|Overall Study|Death|1|||
19699003|NCT00451451|42143800|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
19699004|NCT00451451|42143801|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
19699005|NCT00451451|42143802|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
19699006|NCT00451451|42143803|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
19699007|NCT03824912|42143818|FG000|Overall Study|Lost to Follow-up|18|||
19699008|NCT03824912|42143819|FG001|Overall Study|Lost to Follow-up|15|||
19699009|NCT03824912|42143820|FG002|Overall Study|Lost to Follow-up|8|||
19699010|NCT03824912|42143818|FG000|Overall Study|Negative Baseline Culture Result|118|||
19699011|NCT03824912|42143819|FG001|Overall Study|Negative Baseline Culture Result|112|||
19699012|NCT03824912|42143820|FG002|Overall Study|Negative Baseline Culture Result|57|||
19699013|NCT03824912|42143818|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19699014|NCT03824912|42143819|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19665868|NCT03927950|42114425|FG000|Overall Study|Adverse Event|9|||
19665869|NCT00678899|42114430|FG000|Overall Study|Adverse Event|1|||
19665870|NCT00678587|42114437|FG000|Overall Study|Adverse Event|3|||
19665871|NCT00678587|42114438|FG001|Overall Study|Adverse Event|3|||
19665872|NCT00678587|42114437|FG000|Overall Study|Lack of Efficacy|1|||
19665873|NCT00678587|42114438|FG001|Overall Study|Lack of Efficacy|0|||
19665874|NCT00678587|42114437|FG000|Overall Study|Protocol Violation|2|||
19665875|NCT00678587|42114438|FG001|Overall Study|Protocol Violation|1|||
19665876|NCT00678587|42114437|FG000|Overall Study|Study Closed/Terminated|1|||
19665877|NCT00678587|42114438|FG001|Overall Study|Study Closed/Terminated|0|||
19665878|NCT00678587|42114437|FG000|Overall Study|Lost to Follow-up|3|||
19665879|NCT00678587|42114438|FG001|Overall Study|Lost to Follow-up|5|||
19665880|NCT00678587|42114437|FG000|Overall Study|Investigator Discretion|2|||
19665881|NCT00678587|42114438|FG001|Overall Study|Investigator Discretion|6|||
19665882|NCT00678587|42114437|FG000|Overall Study|Withdrew Consent|8|||
19665883|NCT00678587|42114438|FG001|Overall Study|Withdrew Consent|3|||
19665884|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Adverse Event|2|||
19665885|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Adverse Event|2|||
19665886|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Adverse Event|4|||
19665887|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Adverse Event|0|||
19665888|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Adverse Event|0|||
19665889|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Progressive disease|0|||
19665890|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Progressive disease|0|||
19665891|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Progressive disease|1|||
19665892|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Progressive disease|0|||
19665893|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Progressive disease|0|||
19665894|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
19665895|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
19665896|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
19665897|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
19665898|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
19665899|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
19665900|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
19665901|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
19665902|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
19665903|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
19665904|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
19665905|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
19665906|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
19756619|NCT03144804|42207224|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
19756620|NCT01315028|42207260|FG000|Overall Study|Lost to Follow-up|1|||
19756621|NCT01315028|42207261|FG001|Overall Study|Lost to Follow-up|0|||
19756622|NCT01315028|42207260|FG000|Overall Study|Death|0|||
19756623|NCT01315028|42207261|FG001|Overall Study|Death|1|||
19756624|NCT02720536|42207267|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
19665907|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
19665908|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
19665909|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
19665910|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
19665911|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
19665912|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
19665913|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
19665914|NCT03523728|42114450|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
19665915|NCT03523728|42114451|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
19665916|NCT03523728|42114452|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
19665917|NCT03523728|42114453|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
19665918|NCT03523728|42114454|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
19665919|NCT03523728|42114450|FG000|Stage 2 (24 Months)|Adverse Event|0|||
19665920|NCT03523728|42114451|FG001|Stage 2 (24 Months)|Adverse Event|0|||
19665921|NCT03523728|42114452|FG002|Stage 2 (24 Months)|Adverse Event|0|||
19665922|NCT03523728|42114453|FG003|Stage 2 (24 Months)|Adverse Event|1|||
19665923|NCT03523728|42114454|FG004|Stage 2 (24 Months)|Adverse Event|2|||
19665924|NCT03523728|42114450|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
19665925|NCT03523728|42114451|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
19665926|NCT03523728|42114452|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
19665927|NCT03523728|42114453|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
19756625|NCT02720536|42207267|FG000|Overall Study|PR - pregnancy|2|||
19756626|NCT02720536|42207267|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
19756627|NCT02720536|42207267|FG000|Overall Study|PR - death|1|||
19665928|NCT03523728|42114454|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
19665929|NCT03523728|42114450|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
19388779|NCT02544633|41632287|FG002|Treatment Period|Non-compliance|1|||
19665930|NCT03523728|42114451|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
19665931|NCT03523728|42114452|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
19665932|NCT03523728|42114453|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
19756628|NCT02720536|42207267|FG000|Overall Study|PR - adverse event|1|||
19756629|NCT02720536|42207267|FG000|Overall Study|PR - abnormal lab value(s)|1|||
19756630|NCT02720536|42207267|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
19756631|NCT03168438|42207279|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
19756632|NCT03168438|42207280|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
19756633|NCT03137784|42207287|FG000|Overall Study|Adverse Event|1|||
19756634|NCT03137784|42207288|FG001|Overall Study|Adverse Event|1|||
19756635|NCT03137784|42207289|FG002|Overall Study|Adverse Event|0|||
19665933|NCT03523728|42114454|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
19665934|NCT03523728|42114450|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
19665935|NCT03523728|42114451|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
19665936|NCT03523728|42114452|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
19665937|NCT03523728|42114453|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
19665938|NCT03523728|42114454|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
19665939|NCT03523728|42114450|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
19665940|NCT03523728|42114451|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
19665941|NCT03523728|42114452|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
19665942|NCT03523728|42114453|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
19665943|NCT03523728|42114454|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
19665944|NCT00538590|42114473|FG000|Overall Study|Death|1|||
19665945|NCT00538590|42114474|FG001|Overall Study|Death|0|||
19665946|NCT00466947|42114482|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
19665947|NCT00466947|42114483|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
19665948|NCT00466947|42114482|FG000|Study End Analysis Period|Adverse Event|35|||
19665949|NCT00466947|42114483|FG001|Study End Analysis Period|Adverse Event|43|||
19665950|NCT00466947|42114482|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
19665951|NCT00466947|42114483|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
19665952|NCT00466947|42114482|FG000|Study End Analysis Period|Physician Decision|29|||
19665953|NCT00466947|42114483|FG001|Study End Analysis Period|Physician Decision|29|||
19665954|NCT00466947|42114482|FG000|Study End Analysis Period|Protocol Violation|9|||
19665955|NCT00466947|42114483|FG001|Study End Analysis Period|Protocol Violation|17|||
19665956|NCT00466947|42114482|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
19665957|NCT00466947|42114483|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
19665958|NCT00466947|42114482|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
19665959|NCT00466947|42114483|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
19665960|NCT00466947|42114482|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
19665961|NCT00466947|42114483|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
19665962|NCT00466947|42114482|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
19665963|NCT00466947|42114483|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
19665964|NCT00537810|42114494|FG000|Overall Study|Withdrawal by Subject|4|||
19665965|NCT00537810|42114495|FG001|Overall Study|Withdrawal by Subject|11|||
19665966|NCT00537810|42114496|FG002|Overall Study|Withdrawal by Subject|4|||
19665967|NCT00537810|42114497|FG003|Overall Study|Withdrawal by Subject|3|||
19665968|NCT00537810|42114494|FG000|Overall Study|Medically withdrawn|2|||
19665969|NCT00537810|42114495|FG001|Overall Study|Medically withdrawn|2|||
19665970|NCT00537810|42114496|FG002|Overall Study|Medically withdrawn|0|||
19665971|NCT00537810|42114497|FG003|Overall Study|Medically withdrawn|1|||
19665972|NCT01287936|42114510|FG000|Overall Study|Lost to Follow-up|0|||
19665973|NCT01287936|42114511|FG001|Overall Study|Lost to Follow-up|1|||
19665974|NCT01287936|42114512|FG002|Overall Study|Lost to Follow-up|1|||
19665975|NCT00090259|42114522|FG000|Overall Study|Lost to Follow-up|30|||
19665976|NCT00090259|42114523|FG001|Overall Study|Lost to Follow-up|26|||
19665977|NCT00090259|42114522|FG000|Overall Study|Withdrawal by Subject|21|||
19665978|NCT00090259|42114523|FG001|Overall Study|Withdrawal by Subject|15|||
19665979|NCT00090259|42114522|FG000|Overall Study|Investigator site closed|11|||
19665980|NCT00090259|42114523|FG001|Overall Study|Investigator site closed|7|||
19665981|NCT00079183|42114529|FG000|Overall Study|Withdrawal by Subject|4|||
19665982|NCT00079183|42114529|FG000|Overall Study|Study medication non-compliance|2|||
19665983|NCT00079183|42114529|FG000|Overall Study|Specimen collection non-compliance|1|||
19665984|NCT00676403|42114540|FG000|Overall Study|Adverse Event|1|||
19665985|NCT00676403|42114541|FG001|Overall Study|Adverse Event|2|||
19665986|NCT00676403|42114542|FG002|Overall Study|Adverse Event|0|||
19665987|NCT00676403|42114543|FG003|Overall Study|Adverse Event|5|||
19665988|NCT00676403|42114544|FG004|Overall Study|Adverse Event|1|||
19665989|NCT00676403|42114545|FG005|Overall Study|Adverse Event|2|||
19665990|NCT00676403|42114540|FG000|Overall Study|Lost to Follow-up|0|||
19756636|NCT03137784|42207290|FG003|Overall Study|Adverse Event|0|||
19665991|NCT00676403|42114541|FG001|Overall Study|Lost to Follow-up|0|||
19665992|NCT00676403|42114542|FG002|Overall Study|Lost to Follow-up|0|||
19665993|NCT00676403|42114543|FG003|Overall Study|Lost to Follow-up|0|||
19665994|NCT00676403|42114544|FG004|Overall Study|Lost to Follow-up|0|||
19665995|NCT00676403|42114545|FG005|Overall Study|Lost to Follow-up|1|||
19665996|NCT00676403|42114540|FG000|Overall Study|Reason Unspecified|1|||
19665997|NCT00676403|42114541|FG001|Overall Study|Reason Unspecified|0|||
19665998|NCT00676403|42114542|FG002|Overall Study|Reason Unspecified|1|||
19665999|NCT00676403|42114543|FG003|Overall Study|Reason Unspecified|0|||
19666000|NCT00676403|42114544|FG004|Overall Study|Reason Unspecified|0|||
19666001|NCT00676403|42114545|FG005|Overall Study|Reason Unspecified|1|||
19666002|NCT00676403|42114540|FG000|Overall Study|Withdrawal by Subject|0|||
19666003|NCT00676403|42114541|FG001|Overall Study|Withdrawal by Subject|0|||
19666004|NCT00676403|42114542|FG002|Overall Study|Withdrawal by Subject|0|||
19666005|NCT00676403|42114543|FG003|Overall Study|Withdrawal by Subject|0|||
19666006|NCT00676403|42114544|FG004|Overall Study|Withdrawal by Subject|0|||
19666007|NCT00676403|42114545|FG005|Overall Study|Withdrawal by Subject|1|||
19666008|NCT00078949|42114569|FG000|Overall Study|No treated|4|||
19666009|NCT00078949|42114570|FG001|Overall Study|No treated|5|||
19666010|NCT00078949|42114571|FG002|Overall Study|No treated|3|||
19666011|NCT00078949|42114572|FG003|Overall Study|No treated|3|||
19666012|NCT00078325|42114587|FG000|Overall Study|Adverse Event|15|||
19666013|NCT00078325|42114588|FG001|Overall Study|Adverse Event|10|||
19666014|NCT00078325|42114589|FG002|Overall Study|Adverse Event|5|||
19666015|NCT00078325|42114587|FG000|Overall Study|Protocol Violation|2|||
19666016|NCT00078325|42114588|FG001|Overall Study|Protocol Violation|2|||
19666017|NCT00078325|42114589|FG002|Overall Study|Protocol Violation|0|||
19666018|NCT00078325|42114587|FG000|Overall Study|Withdrawal by Subject|1|||
19666019|NCT00078325|42114588|FG001|Overall Study|Withdrawal by Subject|5|||
19666020|NCT00078325|42114589|FG002|Overall Study|Withdrawal by Subject|3|||
19666021|NCT00078325|42114587|FG000|Overall Study|Lost to Follow-up|0|||
19666022|NCT00078325|42114588|FG001|Overall Study|Lost to Follow-up|1|||
19666023|NCT00078325|42114589|FG002|Overall Study|Lost to Follow-up|1|||
19666024|NCT00078325|42114587|FG000|Overall Study|Physician Decision|2|||
19666025|NCT00078325|42114588|FG001|Overall Study|Physician Decision|0|||
19666026|NCT00078325|42114589|FG002|Overall Study|Physician Decision|1|||
19666027|NCT00078325|42114587|FG000|Overall Study|Miscellaneous|1|||
19666028|NCT00078325|42114588|FG001|Overall Study|Miscellaneous|1|||
19666029|NCT00078325|42114589|FG002|Overall Study|Miscellaneous|1|||
19666030|NCT00077857|42114599|FG000|Overall Study|Adverse Event|30|||
19666031|NCT00077857|42114600|FG001|Overall Study|Adverse Event|32|||
19666032|NCT00077857|42114599|FG000|Overall Study|Death|7|||
19666033|NCT00077857|42114600|FG001|Overall Study|Death|3|||
19666034|NCT00077857|42114599|FG000|Overall Study|Insufficient therapeutic response|112|||
19666035|NCT00077857|42114600|FG001|Overall Study|Insufficient therapeutic response|128|||
19666036|NCT00077857|42114599|FG000|Overall Study|Violation of selection criteria at entry|3|||
19666037|NCT00077857|42114600|FG001|Overall Study|Violation of selection criteria at entry|1|||
19666038|NCT00077857|42114599|FG000|Overall Study|Other protocol violation|0|||
19666039|NCT00077857|42114600|FG001|Overall Study|Other protocol violation|1|||
19666040|NCT00077857|42114599|FG000|Overall Study|Refused treatment|29|||
19666041|NCT00077857|42114600|FG001|Overall Study|Refused treatment|21|||
19666042|NCT00077857|42114599|FG000|Overall Study|Failure to return|5|||
19666043|NCT00077857|42114600|FG001|Overall Study|Failure to return|5|||
19666044|NCT00077857|42114599|FG000|Overall Study|Other|15|||
19666045|NCT00077857|42114600|FG001|Overall Study|Other|13|||
19666046|NCT00545402|42114608|FG000|Overall Study|Discontinuation of treatment|17|||
19666047|NCT00545402|42114609|FG001|Overall Study|Discontinuation of treatment|9|||
19666048|NCT00545402|42114608|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
19666049|NCT00545402|42114609|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
19666050|NCT00545402|42114608|FG000|Overall Study|Death|5|||
19666051|NCT00545402|42114609|FG001|Overall Study|Death|7|||
19666052|NCT00545402|42114608|FG000|Overall Study|Graft loss|2|||
19756637|NCT03137784|42207291|FG004|Overall Study|Adverse Event|0|||
19756638|NCT03137784|42207292|FG005|Overall Study|Adverse Event|0|||
19756639|NCT03137784|42207287|FG000|Overall Study|Subject/guardian decision|1|||
19756640|NCT03137784|42207288|FG001|Overall Study|Subject/guardian decision|0|||
19756641|NCT03137784|42207289|FG002|Overall Study|Subject/guardian decision|0|||
19756642|NCT03137784|42207290|FG003|Overall Study|Subject/guardian decision|0|||
19756643|NCT03137784|42207291|FG004|Overall Study|Subject/guardian decision|0|||
19756644|NCT03137784|42207292|FG005|Overall Study|Subject/guardian decision|0|||
19756645|NCT03137784|42207287|FG000|Overall Study|Non-compliance with study treatment|0|||
19666053|NCT00545402|42114609|FG001|Overall Study|Graft loss|4|||
19666054|NCT00545402|42114608|FG000|Overall Study|Withdrawal by Subject|0|||
19666055|NCT00545402|42114609|FG001|Overall Study|Withdrawal by Subject|1|||
19666056|NCT00545402|42114608|FG000|Overall Study|Protocol Violation|1|||
19666057|NCT00545402|42114609|FG001|Overall Study|Protocol Violation|0|||
19666058|NCT00545402|42114608|FG000|Overall Study|Reason not specified|1|||
19666059|NCT00545402|42114609|FG001|Overall Study|Reason not specified|1|||
19666060|NCT00545792|42114615|FG000|Overall Study|Withdrawal by Subject|1|||
19666061|NCT00545168|42114622|FG000|Overall Study|Lost to Follow-up|5|||
19666062|NCT00545168|42114623|FG001|Overall Study|Lost to Follow-up|5|||
19666063|NCT00545168|42114624|FG002|Overall Study|Lost to Follow-up|5|||
19666064|NCT00545168|42114622|FG000|Overall Study|Withdrawal by Subject|9|||
19666065|NCT00545168|42114623|FG001|Overall Study|Withdrawal by Subject|0|||
19666066|NCT00545168|42114624|FG002|Overall Study|Withdrawal by Subject|13|||
19666067|NCT00545168|42114622|FG000|Overall Study|Protocol Violation|1|||
19666068|NCT00545168|42114623|FG001|Overall Study|Protocol Violation|0|||
19666069|NCT00545168|42114624|FG002|Overall Study|Protocol Violation|1|||
19666070|NCT00545168|42114622|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
19666071|NCT00545168|42114623|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
19666072|NCT00545168|42114624|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
19666073|NCT00544544|42114633|FG000|Overall Study|Withdrawal by Subject|1|||
19666074|NCT00544544|42114633|FG000|Overall Study|Adverse Event|1|||
19666075|NCT00544544|42114633|FG000|Overall Study|Lost to Follow-up|1|||
19666076|NCT00541346|42114637|FG000|Follow-up|Adverse Event|1|||
19666077|NCT00077623|42114644|FG000|Overall Study|Adverse Event|1|||
19666078|NCT00077623|42114645|FG001|Overall Study|Adverse Event|0|||
19666079|NCT00077623|42114646|FG002|Overall Study|Adverse Event|1|||
19666080|NCT00077623|42114644|FG000|Overall Study|Withdrawal by Subject|2|||
19666081|NCT00077623|42114645|FG001|Overall Study|Withdrawal by Subject|10|||
19666082|NCT00077623|42114646|FG002|Overall Study|Withdrawal by Subject|1|||
19666083|NCT00077623|42114644|FG000|Overall Study|Other-Non safety reason|18|||
19666084|NCT00077623|42114645|FG001|Overall Study|Other-Non safety reason|15|||
19666085|NCT00077623|42114646|FG002|Overall Study|Other-Non safety reason|19|||
19666086|NCT00077623|42114644|FG000|Overall Study|Insufficient therapeutic response|2|||
19666087|NCT00077623|42114645|FG001|Overall Study|Insufficient therapeutic response|0|||
19666088|NCT00077623|42114646|FG002|Overall Study|Insufficient therapeutic response|0|||
19666089|NCT00077623|42114644|FG000|Overall Study|Death|12|||
19666090|NCT00077623|42114645|FG001|Overall Study|Death|18|||
19666091|NCT00077623|42114646|FG002|Overall Study|Death|11|||
19666092|NCT00077623|42114644|FG000|Overall Study|Failure to return|1|||
19666093|NCT00077623|42114645|FG001|Overall Study|Failure to return|0|||
19666094|NCT00077623|42114646|FG002|Overall Study|Failure to return|0|||
19666095|NCT00541034|42114654|FG000|Overall Study|Non-Compliance|3|||
19666096|NCT00540644|42114660|FG000|Overall Study|Adverse Event|3|||
19666097|NCT00540644|42114661|FG001|Overall Study|Adverse Event|1|||
19666098|NCT00540644|42114660|FG000|Overall Study|Disease Progression|3|||
19666099|NCT00540644|42114661|FG001|Overall Study|Disease Progression|1|||
19666100|NCT00540644|42114660|FG000|Overall Study|Physician Decision|0|||
19666101|NCT00540644|42114661|FG001|Overall Study|Physician Decision|5|||
19666102|NCT00540644|42114660|FG000|Overall Study|Withdrawal by Subject|2|||
19666103|NCT00540644|42114661|FG001|Overall Study|Withdrawal by Subject|2|||
19666104|NCT00540644|42114660|FG000|Overall Study|Noncomplilance|1|||
19666105|NCT00540644|42114661|FG001|Overall Study|Noncomplilance|0|||
19666106|NCT00543296|42114667|FG000|Overall Study|Physician Decision|7|||
19666107|NCT00543140|42114671|FG000|Overall Study|Lost to Follow-up|33|||
19666108|NCT00543140|42114671|FG000|Overall Study|Withdrawal by Subject|13|||
19666109|NCT00543140|42114671|FG000|Overall Study|Protocol Violation|10|||
19666110|NCT00543140|42114671|FG000|Overall Study|Insufficient weight loss|10|||
19666111|NCT00543140|42114671|FG000|Overall Study|SAE leading to explant of SAGB|3|||
19666112|NCT00543140|42114671|FG000|Overall Study|Death|1|||
19666113|NCT00543140|42114671|FG000|Overall Study|Subject moved|1|||
19666114|NCT00543140|42114671|FG000|Overall Study|Conversion to different procedure|1|||
19666115|NCT00543062|42114675|FG000|Overall Study|Withdrawal by Subject|1|||
19666116|NCT00543062|42114676|FG001|Overall Study|Withdrawal by Subject|0|||
19666117|NCT00543062|42114677|FG002|Overall Study|Withdrawal by Subject|2|||
19666118|NCT00543062|42114678|FG003|Overall Study|Withdrawal by Subject|0|||
19666119|NCT00543062|42114675|FG000|Overall Study|Adverse Event|0|||
19666120|NCT00543062|42114676|FG001|Overall Study|Adverse Event|1|||
19666121|NCT00543062|42114677|FG002|Overall Study|Adverse Event|1|||
19666122|NCT00543062|42114678|FG003|Overall Study|Adverse Event|1|||
19666123|NCT00543062|42114675|FG000|Overall Study|Protocol Violation|1|||
19666124|NCT00543062|42114676|FG001|Overall Study|Protocol Violation|0|||
19666125|NCT00543062|42114677|FG002|Overall Study|Protocol Violation|0|||
19666126|NCT00543062|42114678|FG003|Overall Study|Protocol Violation|0|||
19666127|NCT03911960|42114698|FG000|Overall Study|Lost to Follow-up|5|||
19666128|NCT03911960|42114699|FG001|Overall Study|Lost to Follow-up|3|||
19666129|NCT00676091|42114708|FG000|Infant Series|Parent or legal guardian request|10|||
19666130|NCT00676091|42114709|FG001|Infant Series|Parent or legal guardian request|8|||
19666131|NCT00676091|42114708|FG000|Infant Series|Protocol Violation|6|||
19666132|NCT00676091|42114709|FG001|Infant Series|Protocol Violation|3|||
19666133|NCT00676091|42114708|FG000|Infant Series|Adverse Event|2|||
19666134|NCT00676091|42114709|FG001|Infant Series|Adverse Event|3|||
19666135|NCT00676091|42114708|FG000|Infant Series|Failed to return|1|||
19666136|NCT00676091|42114709|FG001|Infant Series|Failed to return|3|||
19666137|NCT00676091|42114708|FG000|Infant Series|Lost to Follow-up|1|||
19666138|NCT00676091|42114709|FG001|Infant Series|Lost to Follow-up|0|||
19666139|NCT00676091|42114708|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
19666140|NCT00676091|42114709|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
19666141|NCT00676091|42114708|FG000|After Infant Series|Adverse Event|0|||
19666142|NCT00676091|42114709|FG001|After Infant Series|Adverse Event|1|||
19666143|NCT00676091|42114708|FG000|After Infant Series|Protocol Violation|0|||
19666144|NCT00676091|42114709|FG001|After Infant Series|Protocol Violation|1|||
19666145|NCT00676091|42114708|FG000|After Infant Series|Failed to return|1|||
19666146|NCT00676091|42114709|FG001|After Infant Series|Failed to return|1|||
19666147|NCT00676091|42114708|FG000|Toddler Dose|Failed to return|2|||
19666148|NCT00676091|42114709|FG001|Toddler Dose|Failed to return|0|||
19666149|NCT00676091|42114708|FG000|Toddler Dose|Parent or legal guardian request|1|||
19666150|NCT00676091|42114709|FG001|Toddler Dose|Parent or legal guardian request|0|||
19666151|NCT00678041|42114721|FG000|Overall Study|Physician Decision|5|||
19666152|NCT00678041|42114722|FG001|Overall Study|Physician Decision|5|||
19756646|NCT03137784|42207288|FG001|Overall Study|Non-compliance with study treatment|0|||
19756647|NCT03137784|42207289|FG002|Overall Study|Non-compliance with study treatment|0|||
19756648|NCT03137784|42207290|FG003|Overall Study|Non-compliance with study treatment|0|||
19756649|NCT03137784|42207291|FG004|Overall Study|Non-compliance with study treatment|1|||
19756650|NCT03137784|42207292|FG005|Overall Study|Non-compliance with study treatment|0|||
19756651|NCT01314716|42207302|FG000|Double-Blind Phase|Randomized but not treated|1|||
19756652|NCT01314716|42207303|FG001|Double-Blind Phase|Randomized but not treated|1|||
19756653|NCT01314716|42207302|FG000|Double-Blind Phase|Adverse Event|10|||
19756654|NCT01314716|42207303|FG001|Double-Blind Phase|Adverse Event|4|||
19756655|NCT01314716|42207302|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
19756656|NCT01314716|42207303|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
19756657|NCT01314716|42207302|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19756658|NCT01314716|42207303|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19756659|NCT01314716|42207302|FG000|Double-Blind Phase|Sponsor request|1|||
19756660|NCT01314716|42207303|FG001|Double-Blind Phase|Sponsor request|2|||
19756661|NCT01314716|42207302|FG000|Double-Blind Phase|Physician Decision|0|||
19756662|NCT01314716|42207303|FG001|Double-Blind Phase|Physician Decision|1|||
19756663|NCT01314716|42207302|FG000|Open-Label Phase|Adverse Event|4|||
19756664|NCT01314716|42207303|FG001|Open-Label Phase|Adverse Event|6|||
19756665|NCT01314716|42207302|FG000|Open-Label Phase|Withdrawal by Subject|1|||
19756666|NCT01314716|42207303|FG001|Open-Label Phase|Withdrawal by Subject|2|||
19756667|NCT01314716|42207302|FG000|Open-Label Phase|Physician Decision|5|||
19756668|NCT01314716|42207303|FG001|Open-Label Phase|Physician Decision|4|||
19666153|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
19666154|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
19666155|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
19666156|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
19666157|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
19756669|NCT03144180|42207313|FG000|Overall Study|STAT Delivery|1|||
19602722|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
19602723|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
19666158|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
19666159|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
19666160|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
19666161|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666162|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666163|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666164|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666165|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
19666166|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
19666167|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666168|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
19666169|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19602724|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
19602725|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
19602726|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
19602727|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
19602728|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
19602729|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
19602730|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
19756670|NCT03144180|42207314|FG001|Overall Study|STAT Delivery|1|||
19756671|NCT03144180|42207313|FG000|Overall Study|Provider forgot to fill out forms|1|||
19756672|NCT03144180|42207314|FG001|Overall Study|Provider forgot to fill out forms|3|||
19756673|NCT03144180|42207313|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
19756674|NCT03144180|42207314|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
19756675|NCT03144180|42207313|FG000|Overall Study|Scrub tech removed tube cap|0|||
19756676|NCT03144180|42207314|FG001|Overall Study|Scrub tech removed tube cap|1|||
19756677|NCT01465334|42207324|FG000|Overall Study|Disease Progression|1|||
19756678|NCT01465334|42207325|FG001|Overall Study|Disease Progression|0|||
19756679|NCT01465334|42207324|FG000|Overall Study|Adverse Event|1|||
19666170|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19388780|NCT02544633|41632288|FG003|Treatment Period|Non-compliance|0|||
19666171|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19666172|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19666173|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19666174|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
19666175|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
19666176|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
19666177|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666178|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
19666179|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666180|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666181|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666182|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666183|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666184|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
19666185|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666186|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666187|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666188|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
19666189|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
19666190|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666191|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666192|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
19666193|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666194|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666195|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666196|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
19666197|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666198|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666199|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666200|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
19666201|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
19666202|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
19666203|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
19666204|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
19666205|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
19666206|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
19666207|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
19666208|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
19666209|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
19666210|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19666211|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19666212|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19756680|NCT01465334|42207325|FG001|Overall Study|Adverse Event|0|||
19756681|NCT01465334|42207324|FG000|Overall Study|Richter's transformation|0|||
19756682|NCT01465334|42207325|FG001|Overall Study|Richter's transformation|3|||
19666213|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19666214|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
19666215|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19666216|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
19666217|NCT03903822|42114737|FG000|Treatment Phase (6 Weeks)|Other|2|||
19666218|NCT03903822|42114738|FG001|Treatment Phase (6 Weeks)|Other|1|||
19666219|NCT03903822|42114739|FG002|Treatment Phase (6 Weeks)|Other|0|||
19666220|NCT03903822|42114740|FG003|Treatment Phase (6 Weeks)|Other|0|||
19756683|NCT01465334|42207324|FG000|Overall Study|Refractory Disease|0|||
19756684|NCT01465334|42207325|FG001|Overall Study|Refractory Disease|3|||
19756685|NCT00702208|42207331|FG000|Overall Study|Lost to Follow-up|28|||
19756686|NCT00702208|42207331|FG000|Overall Study|Did not self-lavage|1|||
19756687|NCT00702208|42207331|FG000|Overall Study|Unsatisfactory colposcopy|2|||
19756688|NCT02718898|42207348|FG000|Blinded Treatment Period|Adverse Event|5|||
19756689|NCT02718898|42207349|FG001|Blinded Treatment Period|Adverse Event|1|||
19756690|NCT02718898|42207350|FG002|Blinded Treatment Period|Adverse Event|0|||
19756691|NCT02718898|42207351|FG003|Blinded Treatment Period|Adverse Event|0|||
19756692|NCT02718898|42207352|FG004|Blinded Treatment Period|Adverse Event|0|||
19756693|NCT02718898|42207353|FG005|Blinded Treatment Period|Adverse Event|0|||
19756694|NCT02718898|42207354|FG006|Blinded Treatment Period|Adverse Event|0|||
19756695|NCT02718898|42207348|FG000|Blinded Treatment Period|Physician Decision|1|||
19756696|NCT02718898|42207349|FG001|Blinded Treatment Period|Physician Decision|0|||
19666221|NCT03903822|42114741|FG004|Treatment Phase (6 Weeks)|Other|1|||
19666222|NCT03903822|42114742|FG005|Treatment Phase (6 Weeks)|Other|1|||
19666223|NCT03903822|42114743|FG006|Treatment Phase (6 Weeks)|Other|0|||
19666224|NCT03903822|42114744|FG007|Treatment Phase (6 Weeks)|Other|0|||
19666225|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
19666226|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
19666227|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
19666228|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
19666229|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
19666230|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
19666231|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
19666232|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
19666233|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666234|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666235|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666236|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666237|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
19666238|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666239|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666240|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
19666241|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
19666242|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
19666243|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
19666244|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
19666245|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
19666246|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
19666247|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
19666248|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
19666249|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666250|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666251|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666252|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
19666253|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
19666254|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666255|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666256|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
19666257|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
19666258|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
19666259|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
19602731|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
19666260|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
19666261|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
19666262|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
19666263|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
19666264|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
19666265|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666266|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19756697|NCT02718898|42207350|FG002|Blinded Treatment Period|Physician Decision|0|||
19756698|NCT02718898|42207351|FG003|Blinded Treatment Period|Physician Decision|0|||
19756699|NCT02718898|42207352|FG004|Blinded Treatment Period|Physician Decision|0|||
19602732|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
19602733|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
19602734|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
19602735|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
19602736|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
19666267|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666268|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666269|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666270|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
19666271|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666272|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
19666273|NCT03903822|42114737|FG000|Follow up Phase (4 Weeks)|Other|1|||
19666274|NCT03903822|42114738|FG001|Follow up Phase (4 Weeks)|Other|1|||
19666275|NCT03903822|42114739|FG002|Follow up Phase (4 Weeks)|Other|0|||
19666276|NCT03903822|42114740|FG003|Follow up Phase (4 Weeks)|Other|0|||
19666277|NCT03903822|42114741|FG004|Follow up Phase (4 Weeks)|Other|0|||
19756700|NCT02718898|42207353|FG005|Blinded Treatment Period|Physician Decision|0|||
19756701|NCT02718898|42207354|FG006|Blinded Treatment Period|Physician Decision|0|||
19602737|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
19602738|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
19666278|NCT03903822|42114742|FG005|Follow up Phase (4 Weeks)|Other|0|||
19666279|NCT03903822|42114743|FG006|Follow up Phase (4 Weeks)|Other|0|||
19666280|NCT03903822|42114744|FG007|Follow up Phase (4 Weeks)|Other|0|||
19666281|NCT00677807|42114765|FG000|Overall Study|Adverse Event|4|||
19666282|NCT00677807|42114766|FG001|Overall Study|Adverse Event|1|||
19666283|NCT00677807|42114767|FG002|Overall Study|Adverse Event|6|||
19666284|NCT00677807|42114765|FG000|Overall Study|Lack of Efficacy|0|||
19666285|NCT00677807|42114766|FG001|Overall Study|Lack of Efficacy|0|||
19666286|NCT00677807|42114767|FG002|Overall Study|Lack of Efficacy|2|||
19666287|NCT00677807|42114765|FG000|Overall Study|Participant no longer needs study drug|0|||
19666288|NCT00677807|42114766|FG001|Overall Study|Participant no longer needs study drug|0|||
19666289|NCT00677807|42114767|FG002|Overall Study|Participant no longer needs study drug|1|||
19666290|NCT00677807|42114765|FG000|Overall Study|Withdrawal by Subject|10|||
19666291|NCT00677807|42114766|FG001|Overall Study|Withdrawal by Subject|3|||
19666292|NCT00677807|42114767|FG002|Overall Study|Withdrawal by Subject|6|||
19666293|NCT00677807|42114765|FG000|Overall Study|Lost to Follow-up|2|||
19666294|NCT00677807|42114766|FG001|Overall Study|Lost to Follow-up|2|||
19666295|NCT00677807|42114767|FG002|Overall Study|Lost to Follow-up|2|||
19666296|NCT00677807|42114765|FG000|Overall Study|Administrative problems|1|||
19666297|NCT00677807|42114766|FG001|Overall Study|Administrative problems|1|||
19666298|NCT00677807|42114767|FG002|Overall Study|Administrative problems|2|||
19666299|NCT00677807|42114765|FG000|Overall Study|Death|0|||
19666300|NCT00677807|42114766|FG001|Overall Study|Death|1|||
19666301|NCT00677807|42114767|FG002|Overall Study|Death|1|||
19666302|NCT00677807|42114765|FG000|Overall Study|Protocol Deviation|1|||
19666303|NCT00677807|42114766|FG001|Overall Study|Protocol Deviation|3|||
19666304|NCT00677807|42114767|FG002|Overall Study|Protocol Deviation|0|||
19666305|NCT00687401|42114775|FG000|Overall Study|Protocol Violation|7|||
19666306|NCT00687401|42114775|FG000|Overall Study|Adverse Event|6|||
19666307|NCT00687401|42114775|FG000|Overall Study|Lack of Efficacy|6|||
19666308|NCT00687401|42114775|FG000|Overall Study|Withdrawal by Subject|4|||
19666309|NCT00687401|42114775|FG000|Overall Study|Did not return for visit|3|||
19666310|NCT00687401|42114775|FG000|Overall Study|For reasons different from those above|4|||
19666311|NCT00538902|42114795|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
19666312|NCT00538902|42114796|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
19666313|NCT00538902|42114797|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
19666314|NCT00538902|42114795|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
19666315|NCT00538902|42114796|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
19666316|NCT00538902|42114797|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
19666317|NCT00538902|42114795|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
19666318|NCT00538902|42114796|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
19666319|NCT00538902|42114797|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
19666320|NCT00538902|42114795|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
19666321|NCT00538902|42114796|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
19666322|NCT00538902|42114797|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
19666323|NCT00538902|42114795|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
19666324|NCT00538902|42114796|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
19666325|NCT00538902|42114797|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
19666326|NCT00538902|42114795|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
19666327|NCT00538902|42114796|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
19666328|NCT00538902|42114797|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
19666329|NCT00538902|42114795|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
19666330|NCT00538902|42114796|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
19756702|NCT02718898|42207348|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
19756703|NCT02718898|42207349|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
19756704|NCT02718898|42207350|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
19756705|NCT02718898|42207351|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
19756706|NCT02718898|42207352|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
19756707|NCT02718898|42207353|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
19756708|NCT02718898|42207354|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
19756709|NCT02718898|42207348|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
19756710|NCT02718898|42207349|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
19756711|NCT02718898|42207350|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
19756712|NCT02718898|42207351|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
19756713|NCT02718898|42207352|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
19756714|NCT02718898|42207353|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
19756715|NCT02718898|42207354|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
19756716|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
19756717|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
19756718|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
19756719|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
19756720|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
19756721|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
19756722|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
19756723|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756724|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756725|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756726|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
19756727|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756728|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756729|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
19756730|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19756731|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19666331|NCT00538902|42114797|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
19666332|NCT00538902|42114795|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
19666333|NCT00538902|42114796|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
19666334|NCT00538902|42114797|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
19666335|NCT00541970|42114811|FG000|Month 7|Protocol Violation|9|||
19666336|NCT00541970|42114812|FG001|Month 7|Protocol Violation|13|||
19666337|NCT00541970|42114813|FG002|Month 7|Protocol Violation|11|||
19666338|NCT00541970|42114814|FG003|Month 7|Protocol Violation|5|||
19666339|NCT00541970|42114811|FG000|Month 12|Adverse Event|0|||
19666340|NCT00541970|42114812|FG001|Month 12|Adverse Event|1|||
19666341|NCT00541970|42114813|FG002|Month 12|Adverse Event|1|||
19666342|NCT00541970|42114814|FG003|Month 12|Adverse Event|1|||
19666343|NCT00541970|42114811|FG000|Month 12|Protocol Violation|12|||
19666344|NCT00541970|42114812|FG001|Month 12|Protocol Violation|21|||
19666345|NCT00541970|42114813|FG002|Month 12|Protocol Violation|20|||
19666346|NCT00541970|42114814|FG003|Month 12|Protocol Violation|15|||
19666347|NCT00541970|42114811|FG000|Month 18|Adverse Event|0|||
19756732|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
19756733|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
19756734|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19756735|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19756736|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19756737|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
19756738|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
19756739|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
19756740|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
19666348|NCT00541970|42114812|FG001|Month 18|Adverse Event|1|||
19756741|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
19756742|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
19756743|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
19756744|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756745|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756746|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756747|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
19756748|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756749|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756750|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
19756751|NCT02718898|42207348|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19756752|NCT02718898|42207349|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19756753|NCT02718898|42207350|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19756754|NCT02718898|42207351|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
19756755|NCT02718898|42207352|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19756756|NCT02718898|42207353|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19799413|NCT02962739|42257489|FG004|Overall Study|Withdrawal by Subject|0|||
19666349|NCT00541970|42114813|FG002|Month 18|Adverse Event|1|||
19666350|NCT00541970|42114814|FG003|Month 18|Adverse Event|1|||
19666351|NCT00541970|42114811|FG000|Month 18|Protocol Violation|14|||
19666352|NCT00541970|42114812|FG001|Month 18|Protocol Violation|23|||
19666353|NCT00541970|42114813|FG002|Month 18|Protocol Violation|24|||
19666354|NCT00541970|42114814|FG003|Month 18|Protocol Violation|16|||
19666355|NCT00541970|42114811|FG000|Month 24|Adverse Event|0|||
19666356|NCT00541970|42114812|FG001|Month 24|Adverse Event|1|||
19666357|NCT00541970|42114813|FG002|Month 24|Adverse Event|1|||
19666358|NCT00541970|42114814|FG003|Month 24|Adverse Event|1|||
19666359|NCT00541970|42114811|FG000|Month 24|Protocol Violation|29|||
19666360|NCT00541970|42114812|FG001|Month 24|Protocol Violation|31|||
19666361|NCT00541970|42114813|FG002|Month 24|Protocol Violation|31|||
19666362|NCT00541970|42114814|FG003|Month 24|Protocol Violation|21|||
19666363|NCT00541970|42114811|FG000|Month 36|Protocol Violation|61|||
19666364|NCT00541970|42114812|FG001|Month 36|Protocol Violation|66|||
19666365|NCT00541970|42114813|FG002|Month 36|Protocol Violation|66|||
19666366|NCT00541970|42114814|FG003|Month 36|Protocol Violation|60|||
19666367|NCT00541970|42114811|FG000|Month 48|Withdrawal by Subject|2|||
19666368|NCT00541970|42114812|FG001|Month 48|Withdrawal by Subject|4|||
19666369|NCT00541970|42114813|FG002|Month 48|Withdrawal by Subject|4|||
19666370|NCT00541970|42114814|FG003|Month 48|Withdrawal by Subject|2|||
19666371|NCT00541970|42114811|FG000|Month 48|Other|3|||
19666372|NCT00541970|42114812|FG001|Month 48|Other|1|||
19666373|NCT00541970|42114813|FG002|Month 48|Other|1|||
19666374|NCT00541970|42114814|FG003|Month 48|Other|0|||
19666375|NCT00541970|42114811|FG000|Month 48|Lost to Follow-up|66|||
19666376|NCT00541970|42114812|FG001|Month 48|Lost to Follow-up|68|||
19666377|NCT00541970|42114813|FG002|Month 48|Lost to Follow-up|68|||
19666378|NCT00541970|42114814|FG003|Month 48|Lost to Follow-up|73|||
19666379|NCT00541970|42114811|FG000|Month 60|Protocol Violation|78|||
19666380|NCT00541970|42114812|FG001|Month 60|Protocol Violation|77|||
19666381|NCT00541970|42114813|FG002|Month 60|Protocol Violation|82|||
19666382|NCT00541970|42114814|FG003|Month 60|Protocol Violation|72|||
19666383|NCT00687323|42114824|FG000|Overall Study|Death|25|||
19666384|NCT00687323|42114824|FG000|Overall Study|Withdrawal by Subject|1|||
19666385|NCT00687323|42114824|FG000|Overall Study|Excluded from efficacy evaluations|6|||
19666386|NCT00687323|42114824|FG000|Overall Study|Screen failure|148|||
19666387|NCT03899064|42114841|FG000|Overall Study|Lost to Follow-up|1|||
19666388|NCT03899064|42114841|FG000|Overall Study|Protocol Violation|2|||
19666389|NCT03899064|42114841|FG000|Overall Study|Withdrawal by Subject|2|||
19666390|NCT03899064|42114841|FG000|Overall Study|Other|2|||
19666391|NCT03902574|42114848|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
19666392|NCT03902574|42114849|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
19666393|NCT03902574|42114850|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
19666394|NCT00542828|42114862|FG000|Overall Study|Physician Decision|1|||
19666395|NCT00542828|42114862|FG000|Overall Study|Need for Prohibited Treatment|3|||
19666396|NCT00542828|42114862|FG000|Overall Study|Study Prematurely Discontinued|7|||
19666397|NCT00542828|42114862|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
19666398|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
19666399|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
19666400|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
19666401|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
19666402|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
19666403|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
19666404|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
19666405|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
19666406|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
19666407|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
19666408|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
19666409|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
19666410|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
19666411|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
19666412|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
19666413|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
19666414|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
19666415|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
19666416|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
19666417|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
19666418|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
19666419|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
19666420|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
19666421|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
19666422|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
19666423|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
19666424|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
19666425|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
19666426|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
19666427|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
19666428|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
19666429|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
19666430|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
19666431|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
19666432|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
19666433|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
19666434|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
19666435|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
19666436|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
19666437|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
19666438|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
19666439|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
19666440|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
19666441|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
19666442|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
19666443|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
19666444|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
19666445|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
19666446|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
19666447|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
19666448|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
19666449|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
19666450|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
19666451|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
19666452|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
19666453|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
19666454|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
19666455|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
19666456|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
19666457|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
19666458|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
19666459|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
19666460|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
19666461|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
19666462|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
19666463|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
19666464|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
19666465|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
19666466|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
19666467|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
19666468|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
19666469|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
19666470|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
19666471|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
19666472|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
19666473|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
19666474|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
19666475|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
19666476|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
19666477|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
19666478|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
19666479|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
19666480|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
19666481|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
19666482|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
19666483|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
19666484|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
19666485|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
19666486|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
19666487|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
19666488|NCT00090103|42114869|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
19666489|NCT00090103|42114870|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
19666490|NCT00090103|42114871|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
19666491|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
19666492|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
19666493|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
19666494|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
19666495|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
19666496|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
19666497|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
19666498|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
19666499|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
19666500|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
19666501|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
19666502|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
19602739|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
19602740|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
19602741|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
19602742|NCT00994214|42051456|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
19602743|NCT00994214|42051457|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
19602744|NCT00994214|42051458|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
19602745|NCT00994214|42051459|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
19602746|NCT01034657|42051487|FG000|Core Phase|Withdrawal by Subject|1|||
19602747|NCT01034657|42051488|FG001|Core Phase|Withdrawal by Subject|0|||
19602748|NCT01034657|42051489|FG002|Core Phase|Withdrawal by Subject|0|||
19602749|NCT01034657|42051487|FG000|Core Phase|Lack of Efficacy|2|||
19602750|NCT01034657|42051488|FG001|Core Phase|Lack of Efficacy|0|||
19602751|NCT01034657|42051489|FG002|Core Phase|Lack of Efficacy|0|||
19602752|NCT01034657|42051487|FG000|Core Phase|Abnormal laboratory value|1|||
19602753|NCT01034657|42051488|FG001|Core Phase|Abnormal laboratory value|0|||
19602754|NCT01034657|42051489|FG002|Core Phase|Abnormal laboratory value|0|||
19602755|NCT01034657|42051487|FG000|Core Phase|Adverse Event|8|||
19602756|NCT01034657|42051488|FG001|Core Phase|Adverse Event|0|||
19602757|NCT01034657|42051489|FG002|Core Phase|Adverse Event|0|||
19602758|NCT01034657|42051487|FG000|Core Phase|Protocol Violation|2|||
19602759|NCT01034657|42051488|FG001|Core Phase|Protocol Violation|0|||
19602760|NCT01034657|42051489|FG002|Core Phase|Protocol Violation|0|||
19602761|NCT01034657|42051487|FG000|Randomized Phase|Withdrawal by Subject|0|||
19602762|NCT01034657|42051488|FG001|Randomized Phase|Withdrawal by Subject|2|||
19602763|NCT01034657|42051489|FG002|Randomized Phase|Withdrawal by Subject|0|||
19602764|NCT01034657|42051487|FG000|Randomized Phase|Lack of Efficacy|5|||
19602765|NCT01034657|42051488|FG001|Randomized Phase|Lack of Efficacy|1|||
19602766|NCT01034657|42051489|FG002|Randomized Phase|Lack of Efficacy|0|||
19602767|NCT01034657|42051487|FG000|Randomized Phase|Abnormal laboratory value|0|||
19602768|NCT01034657|42051488|FG001|Randomized Phase|Abnormal laboratory value|1|||
19666503|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
19666504|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
19666505|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
19666506|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
19666507|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
19666508|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
19666509|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
19666510|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
19666511|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
19666512|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
19666513|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
19666514|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
19666515|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
19666516|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
19666517|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
19666518|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
19666519|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
19666520|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
19666521|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
19666522|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
19666523|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
19666524|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
19666525|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
19666526|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
19666527|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
19666528|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
19666529|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
19666530|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
19666531|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
19666532|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
19666533|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
19666534|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
19666535|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
19666536|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
19666537|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
19666538|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
19666539|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Death|1|||
19666540|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Death|0|||
19666541|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Death|1|||
19666542|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
19666543|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
19666544|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
19666545|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
19666546|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
19666547|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
19666548|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
19666549|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
19666550|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
19666551|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
19666552|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
19666553|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
19666554|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
19666555|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
19666556|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
19666557|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
19666558|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
19666559|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
19666560|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
19666561|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
19666562|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
19666563|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Depression|0|||
19666564|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Depression|1|||
19666565|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Depression|0|||
19666566|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
19666567|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
19666568|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
19666569|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Jailed|0|||
19666570|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Jailed|1|||
19666571|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Jailed|0|||
19666572|NCT00090103|42114869|FG000|16-Week Safety Follow-up Period|Other|0|||
19666573|NCT00090103|42114870|FG001|16-Week Safety Follow-up Period|Other|1|||
19666574|NCT00090103|42114871|FG002|16-Week Safety Follow-up Period|Other|0|||
19666575|NCT00087607|42114881|FG000|Overall Study|Adverse Event|14|||
19666576|NCT00087607|42114882|FG001|Overall Study|Adverse Event|24|||
19666577|NCT00087607|42114881|FG000|Overall Study|Death|0|||
19666578|NCT00087607|42114882|FG001|Overall Study|Death|1|||
19666579|NCT00087607|42114881|FG000|Overall Study|Insufficient Therapeutic Response|53|||
19666580|NCT00087607|42114882|FG001|Overall Study|Insufficient Therapeutic Response|42|||
19666581|NCT00087607|42114881|FG000|Overall Study|Failure to return|21|||
19666582|NCT00087607|42114882|FG001|Overall Study|Failure to return|17|||
19666583|NCT00087607|42114881|FG000|Overall Study|Withdrew Consent|12|||
19666584|NCT00087607|42114882|FG001|Overall Study|Withdrew Consent|16|||
19666585|NCT00087607|42114881|FG000|Overall Study|Administrative|12|||
19666586|NCT00087607|42114882|FG001|Overall Study|Administrative|12|||
19666587|NCT00087607|42114881|FG000|Overall Study|Refused Treatment|5|||
19756757|NCT02718898|42207354|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
19756758|NCT02718898|42207348|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
19756759|NCT02718898|42207349|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
19756760|NCT02718898|42207350|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
19756761|NCT02718898|42207351|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
19756762|NCT02718898|42207352|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
19666588|NCT00087607|42114882|FG001|Overall Study|Refused Treatment|7|||
19666589|NCT00087607|42114881|FG000|Overall Study|Other Protocol Violation|5|||
19666590|NCT00087607|42114882|FG001|Overall Study|Other Protocol Violation|2|||
19666591|NCT00087607|42114881|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
19666592|NCT00087607|42114882|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19666593|NCT00069823|42114894|FG000|Overall Study|Did not have follow-up diary cards|6|||
19666594|NCT00069823|42114895|FG001|Overall Study|Did not have follow-up diary cards|3|||
19666595|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
19666596|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
19666597|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
19666598|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
19666599|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
19666600|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
19666601|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
19666602|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
19666603|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
19666604|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
19666605|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
19666606|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
19666607|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
19666608|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
19666609|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
19666610|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
19666611|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
19666612|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
19666613|NCT00086515|42114907|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
19666614|NCT00086515|42114908|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
19666615|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
19666616|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
19666617|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
19666618|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
19666619|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
19666620|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
19666621|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
19666622|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
19666623|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
19666624|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
19666625|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
19666626|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
19666627|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
19666628|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
19666629|NCT00086515|42114907|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
19666630|NCT00086515|42114908|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
19666631|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
19666632|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
19666633|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
19666634|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
19666635|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
19666636|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
19666637|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
19666638|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
19666639|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
19666640|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
19666641|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
19666642|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
19666643|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
19666644|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
19666645|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
19666646|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
19666647|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
19666648|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
19666649|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
19666650|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
19666651|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
19666652|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
19666653|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
19666654|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
19666655|NCT00086515|42114907|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
19666656|NCT00086515|42114908|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
19666657|NCT00541658|42114917|FG000|Overall Study|Adverse Event|28|||
19666658|NCT00541658|42114918|FG001|Overall Study|Adverse Event|37|||
19666659|NCT00541658|42114919|FG002|Overall Study|Adverse Event|25|||
19666660|NCT00541658|42114917|FG000|Overall Study|Physician Decision|0|||
19666661|NCT00541658|42114918|FG001|Overall Study|Physician Decision|0|||
19666662|NCT00541658|42114919|FG002|Overall Study|Physician Decision|4|||
19666663|NCT00541658|42114917|FG000|Overall Study|Lost to Follow-up|3|||
19666664|NCT00541658|42114918|FG001|Overall Study|Lost to Follow-up|3|||
19666665|NCT00541658|42114919|FG002|Overall Study|Lost to Follow-up|6|||
19666666|NCT00541658|42114917|FG000|Overall Study|Protocol Violation|0|||
19666667|NCT00541658|42114918|FG001|Overall Study|Protocol Violation|1|||
19666668|NCT00541658|42114919|FG002|Overall Study|Protocol Violation|1|||
19666669|NCT00541658|42114917|FG000|Overall Study|Withdrawal by Subject|28|||
19666670|NCT00541658|42114918|FG001|Overall Study|Withdrawal by Subject|32|||
19666671|NCT00541658|42114919|FG002|Overall Study|Withdrawal by Subject|32|||
19666672|NCT00541658|42114917|FG000|Overall Study|Took No Study Drug|1|||
19666673|NCT00541658|42114918|FG001|Overall Study|Took No Study Drug|0|||
19666674|NCT00541658|42114919|FG002|Overall Study|Took No Study Drug|0|||
19666675|NCT03907280|42114943|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
19666676|NCT03907280|42114944|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
19666677|NCT03907280|42114945|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
19666678|NCT04120376|42114957|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
19666679|NCT04120376|42114958|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
19666680|NCT03905642|42114965|FG000|Overall Study|Withdrawal by Subject|3|||
19666681|NCT03905642|42114965|FG000|Overall Study|Pregnancy|1|||
19666682|NCT03905642|42114965|FG000|Overall Study|Adverse Event|1|||
19666683|NCT03905642|42114965|FG000|Overall Study|Lack of Efficacy|1|||
19666684|NCT03905642|42114965|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
19666685|NCT00412984|42115005|FG000|Overall Study|Death|331|||
19666686|NCT00412984|42115006|FG001|Overall Study|Death|349|||
19666687|NCT00412984|42115005|FG000|Overall Study|Adverse Event|679|||
19666688|NCT00412984|42115006|FG001|Overall Study|Adverse Event|738|||
19666689|NCT00412984|42115005|FG000|Overall Study|Withdrawal by Subject|921|||
19666690|NCT00412984|42115006|FG001|Overall Study|Withdrawal by Subject|989|||
19666691|NCT00412984|42115005|FG000|Overall Study|Lost to Follow-up|51|||
19666692|NCT00412984|42115006|FG001|Overall Study|Lost to Follow-up|39|||
19666693|NCT00412984|42115005|FG000|Overall Study|Poor/Noncompliance|57|||
19666694|NCT00412984|42115006|FG001|Overall Study|Poor/Noncompliance|77|||
19666695|NCT00412984|42115005|FG000|Overall Study|Pregnancy|1|||
19666696|NCT00412984|42115006|FG001|Overall Study|Pregnancy|0|||
19666697|NCT00412984|42115005|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
19666698|NCT00412984|42115006|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
19666699|NCT00412984|42115005|FG000|Overall Study|Administrative Reason by Sponsor|11|||
19666700|NCT00412984|42115006|FG001|Overall Study|Administrative Reason by Sponsor|8|||
19666701|NCT00412984|42115005|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
19666702|NCT00412984|42115006|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
19666703|NCT00412984|42115005|FG000|Overall Study|Other Reason|80|||
19666704|NCT00412984|42115006|FG001|Overall Study|Other Reason|92|||
19666705|NCT00412984|42115005|FG000|Overall Study|Not Reported|11|||
19666706|NCT00412984|42115006|FG001|Overall Study|Not Reported|12|||
19666707|NCT00539864|42115014|FG000|Overall Study|Lost to Follow-up|0|||
19666708|NCT00539864|42115015|FG001|Overall Study|Lost to Follow-up|1|||
19666709|NCT00539864|42115014|FG000|Overall Study|Withdrawal by Subject|1|||
19666710|NCT00539864|42115015|FG001|Overall Study|Withdrawal by Subject|1|||
19666711|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
19666712|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
19666713|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
19666714|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
19666715|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Death|235|||
19666716|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Death|167|||
19666717|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Death|1|||
19666718|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Death|0|||
19666719|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
19666720|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
19666721|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
19666722|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
19666723|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
19666724|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
19666725|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
19666726|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
19666727|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Other|1|||
19756763|NCT02718898|42207353|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
19756764|NCT02718898|42207354|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
19756765|NCT02718898|42207348|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
19756766|NCT02718898|42207349|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
19756767|NCT02718898|42207350|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
19756768|NCT02718898|42207351|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
19756769|NCT02718898|42207352|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
19756770|NCT02718898|42207353|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
19666728|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Other|2|||
19666729|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Other|0|||
19666730|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Other|0|||
19666731|NCT00673049|42115023|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
19666732|NCT00673049|42115024|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
19666733|NCT00673049|42115025|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
19666734|NCT00673049|42115026|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
19666735|NCT00673049|42115023|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
19666736|NCT00673049|42115024|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
19666737|NCT00673049|42115025|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
19666738|NCT00673049|42115026|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
19666739|NCT00673049|42115023|FG000|After Progression on Erlotinib|Death|0|||
19756771|NCT02718898|42207354|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
19756772|NCT02718898|42207348|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19756773|NCT02718898|42207349|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19756774|NCT02718898|42207350|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19756775|NCT02718898|42207351|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19756776|NCT02718898|42207352|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19756777|NCT02718898|42207353|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
19756778|NCT02718898|42207354|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
19756779|NCT03143166|42207371|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
19756780|NCT02879994|42207377|FG000|Overall Study|off treatment early|7|||
19756781|NCT02879994|42207377|FG000|Overall Study|Adverse Event|2|||
19756782|NCT02879994|42207377|FG000|Overall Study|Death|2|||
19756783|NCT03142932|42207383|FG000|Overall Study|Lost to Follow-up|2|||
19756784|NCT03142932|42207384|FG001|Overall Study|Lost to Follow-up|11|||
19756785|NCT00702052|42207390|FG000|Overall Study|Adverse Event|23|||
19756786|NCT00702052|42207390|FG000|Overall Study|Disease Progression|30|||
19756787|NCT00702052|42207390|FG000|Overall Study|Withdrawal by Subject|5|||
19666740|NCT00673049|42115024|FG001|After Progression on Erlotinib|Death|0|||
19666741|NCT00673049|42115025|FG002|After Progression on Erlotinib|Death|0|||
19666742|NCT00673049|42115026|FG003|After Progression on Erlotinib|Death|71|||
19666743|NCT00673049|42115023|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
19666744|NCT00673049|42115024|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
19666745|NCT00673049|42115025|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
19666746|NCT00673049|42115026|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
19666747|NCT00673049|42115023|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
19666748|NCT00673049|42115024|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
19666749|NCT00673049|42115025|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
19666750|NCT00673049|42115026|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
19666751|NCT00673049|42115023|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
19666752|NCT00673049|42115024|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
19666753|NCT00673049|42115025|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
19666754|NCT00673049|42115026|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
19666755|NCT00412750|42115037|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19666756|NCT00412750|42115038|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19666757|NCT00412750|42115039|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19666758|NCT00412750|42115037|FG000|Overall Study|Administrative problems|21|||
19666759|NCT00412750|42115038|FG001|Overall Study|Administrative problems|17|||
19666760|NCT00412750|42115039|FG002|Overall Study|Administrative problems|14|||
19666761|NCT00412750|42115037|FG000|Overall Study|Adverse Event|8|||
19666762|NCT00412750|42115038|FG001|Overall Study|Adverse Event|3|||
19666763|NCT00412750|42115039|FG002|Overall Study|Adverse Event|3|||
19666764|NCT00412750|42115037|FG000|Overall Study|Lost to Follow-up|1|||
19666765|NCT00412750|42115038|FG001|Overall Study|Lost to Follow-up|0|||
19666766|NCT00412750|42115039|FG002|Overall Study|Lost to Follow-up|1|||
19666767|NCT00412750|42115037|FG000|Overall Study|Withdrawal by Subject|0|||
19666768|NCT00412750|42115038|FG001|Overall Study|Withdrawal by Subject|1|||
19666769|NCT00412750|42115039|FG002|Overall Study|Withdrawal by Subject|2|||
19666770|NCT00412750|42115037|FG000|Overall Study|Lack of Efficacy|0|||
19666771|NCT00412750|42115038|FG001|Overall Study|Lack of Efficacy|0|||
19666772|NCT00412750|42115039|FG002|Overall Study|Lack of Efficacy|3|||
19666773|NCT00076999|42115053|FG000|Overall Study|Adverse Event|2|||
19666774|NCT00076999|42115054|FG001|Overall Study|Adverse Event|8|||
19666775|NCT00076999|42115055|FG002|Overall Study|Adverse Event|6|||
19666776|NCT00076999|42115056|FG003|Overall Study|Adverse Event|0|||
19666777|NCT00076999|42115057|FG004|Overall Study|Adverse Event|2|||
19666778|NCT00076999|42115053|FG000|Overall Study|Protocol Violation|0|||
19666779|NCT00076999|42115054|FG001|Overall Study|Protocol Violation|3|||
19666780|NCT00076999|42115055|FG002|Overall Study|Protocol Violation|4|||
19666781|NCT00076999|42115056|FG003|Overall Study|Protocol Violation|0|||
19666782|NCT00076999|42115057|FG004|Overall Study|Protocol Violation|9|||
19666783|NCT00076999|42115053|FG000|Overall Study|Lost to Follow-up|2|||
19666784|NCT00076999|42115054|FG001|Overall Study|Lost to Follow-up|1|||
19666785|NCT00076999|42115055|FG002|Overall Study|Lost to Follow-up|0|||
19666786|NCT00076999|42115056|FG003|Overall Study|Lost to Follow-up|0|||
19666787|NCT00076999|42115057|FG004|Overall Study|Lost to Follow-up|0|||
19666788|NCT00076999|42115053|FG000|Overall Study|Withdrawal by Subject|0|||
19666789|NCT00076999|42115054|FG001|Overall Study|Withdrawal by Subject|4|||
19666790|NCT00076999|42115055|FG002|Overall Study|Withdrawal by Subject|3|||
19666791|NCT00076999|42115056|FG003|Overall Study|Withdrawal by Subject|0|||
19666792|NCT00076999|42115057|FG004|Overall Study|Withdrawal by Subject|1|||
19666793|NCT00076999|42115053|FG000|Overall Study|Other reason (not specified)|8|||
19666794|NCT00076999|42115054|FG001|Overall Study|Other reason (not specified)|8|||
19666795|NCT00076999|42115055|FG002|Overall Study|Other reason (not specified)|4|||
19666796|NCT00076999|42115056|FG003|Overall Study|Other reason (not specified)|1|||
19666797|NCT00076999|42115057|FG004|Overall Study|Other reason (not specified)|13|||
19666798|NCT03905096|42115072|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
19666799|NCT03905096|42115073|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
19666800|NCT00412360|42115088|FG000|Overall Study|Lost to Follow-up|0|||
19666801|NCT00412360|42115089|FG001|Overall Study|Lost to Follow-up|1|||
19666802|NCT00412360|42115088|FG000|Overall Study|Not Transplanted|1|||
19666803|NCT00412360|42115089|FG001|Overall Study|Not Transplanted|2|||
19666804|NCT00571103|42115095|FG000|Overall Study|Withdrawal by Subject|1|||
19666805|NCT00571103|42115095|FG000|Overall Study|Lost to Follow-up|1|||
19666806|NCT00084799|42115101|FG000|Overall Study|Disease Progression|1|||
19666807|NCT00084799|42115102|FG001|Overall Study|Disease Progression|0|||
19666808|NCT00069277|42115108|FG000|Overall Study|Adverse Event|3|||
19666809|NCT00069277|42115108|FG000|Overall Study|Withdrawal by Subject|1|||
19666810|NCT00069277|42115108|FG000|Overall Study|Progressive Disease|15|||
19666811|NCT00069277|42115108|FG000|Overall Study|Physician Decision|2|||
19666812|NCT00418522|42115114|FG000|Overall Study|Adverse Event|7|||
19666813|NCT00418522|42115115|FG001|Overall Study|Adverse Event|1|||
19666814|NCT00418522|42115114|FG000|Overall Study|Lack of Efficacy|1|||
19666815|NCT00418522|42115115|FG001|Overall Study|Lack of Efficacy|3|||
19666816|NCT00418522|42115114|FG000|Overall Study|Lost to Follow-up|10|||
19666817|NCT00418522|42115115|FG001|Overall Study|Lost to Follow-up|4|||
19666818|NCT00418522|42115114|FG000|Overall Study|Withdrawal by Subject|31|||
19666819|NCT00418522|42115115|FG001|Overall Study|Withdrawal by Subject|7|||
19666820|NCT00418522|42115114|FG000|Overall Study|Other|27|||
19666821|NCT00418522|42115115|FG001|Overall Study|Other|23|||
19666822|NCT00418522|42115114|FG000|Overall Study|Randomized but did not receive treatment|7|||
19666823|NCT00418522|42115115|FG001|Overall Study|Randomized but did not receive treatment|4|||
19666824|NCT00403546|42115123|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
19666825|NCT00403546|42115124|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
19666826|NCT00403546|42115125|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
19666827|NCT00403546|42115123|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
19666828|NCT00403546|42115124|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
19666829|NCT00403546|42115125|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
19666830|NCT00403546|42115123|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
19666831|NCT00403546|42115124|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
19666832|NCT00403546|42115125|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
19666833|NCT00403546|42115123|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
19666834|NCT00403546|42115124|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
19666835|NCT00403546|42115125|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
19666836|NCT00403546|42115123|FG000|Screening Phase|Screening Failure|22|||
19666837|NCT00403546|42115124|FG001|Screening Phase|Screening Failure|0|||
19666838|NCT00403546|42115125|FG002|Screening Phase|Screening Failure|0|||
19666839|NCT00403546|42115123|FG000|Screening Phase|Adverse Event|1|||
19666840|NCT00403546|42115124|FG001|Screening Phase|Adverse Event|0|||
19666841|NCT00403546|42115125|FG002|Screening Phase|Adverse Event|0|||
19666842|NCT00403546|42115123|FG000|Screening Phase|Terminated Prior to Randomization|5|||
19666843|NCT00403546|42115124|FG001|Screening Phase|Terminated Prior to Randomization|0|||
19666844|NCT00403546|42115125|FG002|Screening Phase|Terminated Prior to Randomization|0|||
19666845|NCT00403546|42115123|FG000|Randomized Trial|Early Terminations|0|||
19666846|NCT00403546|42115124|FG001|Randomized Trial|Early Terminations|17|||
19666847|NCT00403546|42115125|FG002|Randomized Trial|Early Terminations|16|||
19666848|NCT00403390|42115136|FG000|Overall Study|Withdrawal by Subject|1|||
19666849|NCT00403390|42115137|FG001|Overall Study|Withdrawal by Subject|0|||
19666850|NCT00403390|42115136|FG000|Overall Study|samples lost|1|||
19666851|NCT00403390|42115137|FG001|Overall Study|samples lost|0|||
19666852|NCT00403390|42115136|FG000|Overall Study|non-compliant|1|||
19666853|NCT00403390|42115137|FG001|Overall Study|non-compliant|0|||
19666854|NCT00403234|42115147|FG000|Overall Study|Withdrawal by Subject|0|||
19666855|NCT00403234|42115148|FG001|Overall Study|Withdrawal by Subject|1|||
19666856|NCT00403234|42115149|FG002|Overall Study|Withdrawal by Subject|0|||
19666857|NCT00403234|42115150|FG003|Overall Study|Withdrawal by Subject|0|||
19666858|NCT00403234|42115147|FG000|Overall Study|Adverse Event|1|||
19666859|NCT00403234|42115148|FG001|Overall Study|Adverse Event|0|||
19666860|NCT00403234|42115149|FG002|Overall Study|Adverse Event|1|||
19666861|NCT00403234|42115150|FG003|Overall Study|Adverse Event|0|||
19666862|NCT00402688|42115163|FG000|Overall Study|Adverse Event|12|||
19666863|NCT00402688|42115164|FG001|Overall Study|Adverse Event|9|||
19666864|NCT00402688|42115165|FG002|Overall Study|Adverse Event|3|||
19666865|NCT00402688|42115163|FG000|Overall Study|Withdrawal by Subject|3|||
19666866|NCT00402688|42115164|FG001|Overall Study|Withdrawal by Subject|1|||
19666867|NCT00402688|42115165|FG002|Overall Study|Withdrawal by Subject|1|||
19666868|NCT00402688|42115163|FG000|Overall Study|Physician Decision|0|||
19666869|NCT00402688|42115164|FG001|Overall Study|Physician Decision|0|||
19666870|NCT00402688|42115165|FG002|Overall Study|Physician Decision|1|||
19666871|NCT00402688|42115163|FG000|Overall Study|Lack of Efficacy|4|||
19666872|NCT00402688|42115164|FG001|Overall Study|Lack of Efficacy|4|||
19666873|NCT00402688|42115165|FG002|Overall Study|Lack of Efficacy|5|||
19666874|NCT00402688|42115163|FG000|Overall Study|Protocol Violation|1|||
19666875|NCT00402688|42115164|FG001|Overall Study|Protocol Violation|1|||
19666876|NCT00402688|42115165|FG002|Overall Study|Protocol Violation|1|||
19666877|NCT00402688|42115163|FG000|Overall Study|Lost to Follow-up|1|||
19666878|NCT00402688|42115164|FG001|Overall Study|Lost to Follow-up|0|||
19666879|NCT00402688|42115165|FG002|Overall Study|Lost to Follow-up|2|||
19666880|NCT00402688|42115163|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
19666881|NCT00402688|42115164|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
19666882|NCT00402688|42115165|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
19666883|NCT00402688|42115163|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
19666884|NCT00402688|42115164|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
19666885|NCT00402688|42115165|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
19756788|NCT03140280|42207394|FG000|Overall Study|Physician Decision|5|||
19756789|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
19756790|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
19756791|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
19666886|NCT00402688|42115163|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
19666887|NCT00402688|42115164|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
19666888|NCT00402688|42115165|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
19666889|NCT00671879|42115176|FG000|Overall Study|Withdrawal by Subject|0|||
19666890|NCT00671879|42115177|FG001|Overall Study|Withdrawal by Subject|4|||
19666891|NCT00671879|42115178|FG002|Overall Study|Withdrawal by Subject|6|||
19666892|NCT00402298|42115189|FG000|Overall Study|Withdrawal by Subject|1|||
19666893|NCT00402298|42115190|FG001|Overall Study|Withdrawal by Subject|0|||
19666894|NCT00401830|42115198|FG000|Overall Study|Adverse Event|10|||
19666895|NCT00401830|42115199|FG001|Overall Study|Adverse Event|18|||
19666896|NCT00401830|42115198|FG000|Overall Study|Lack of Efficacy|11|||
19666897|NCT00401830|42115199|FG001|Overall Study|Lack of Efficacy|5|||
19666898|NCT00401830|42115198|FG000|Overall Study|Withdrawal by Subject|4|||
19666899|NCT00401830|42115199|FG001|Overall Study|Withdrawal by Subject|3|||
19666900|NCT00401830|42115198|FG000|Overall Study|Protocol Violation|3|||
19666901|NCT00401830|42115199|FG001|Overall Study|Protocol Violation|3|||
19666902|NCT00401830|42115198|FG000|Overall Study|Non-compliance with drug study|1|||
19666903|NCT00401830|42115199|FG001|Overall Study|Non-compliance with drug study|0|||
19666904|NCT00401830|42115198|FG000|Overall Study|Lost to Follow-up|1|||
19666905|NCT00401830|42115199|FG001|Overall Study|Lost to Follow-up|3|||
19666906|NCT00401830|42115198|FG000|Overall Study|Other: Personal / Family problems|1|||
19666907|NCT00401830|42115199|FG001|Overall Study|Other: Personal / Family problems|0|||
19666908|NCT02471144|42115209|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
19666909|NCT02471144|42115210|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
19666910|NCT02471144|42115211|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
19756792|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
19666911|NCT02471144|42115212|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
19666912|NCT02471144|42115213|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
19666913|NCT02471144|42115214|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
19666914|NCT02471144|42115215|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
19666915|NCT02471144|42115216|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
19666916|NCT02471144|42115217|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
19666917|NCT02471144|42115218|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
19666918|NCT02471144|42115219|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
19666919|NCT02471144|42115209|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666920|NCT02471144|42115210|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666921|NCT02471144|42115211|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666922|NCT02471144|42115212|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
19666923|NCT02471144|42115213|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666924|NCT02471144|42115214|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666925|NCT02471144|42115215|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666926|NCT02471144|42115216|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19756793|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
19756794|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
19756795|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Death|1|||
19756796|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Death|4|||
19756797|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
19756798|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
19756799|NCT00658814|42207400|FG000|Remission Induction Chemotherapy|Not eligible|1|||
19756800|NCT00658814|42207401|FG001|Remission Induction Chemotherapy|Not eligible|2|||
19756801|NCT00658814|42207400|FG000|Consolidation Therapy|Not protocol specified|0|||
19756802|NCT00658814|42207401|FG001|Consolidation Therapy|Not protocol specified|1|||
19756803|NCT00658814|42207400|FG000|Consolidation Therapy|Not eligible|2|||
19756804|NCT00658814|42207401|FG001|Consolidation Therapy|Not eligible|2|||
19756805|NCT00658814|42207400|FG000|Maintenance Therapy|Adverse Event|1|||
19756806|NCT00658814|42207401|FG001|Maintenance Therapy|Adverse Event|1|||
19756807|NCT00658814|42207400|FG000|Maintenance Therapy|Not protocol specified|1|||
19756808|NCT00658814|42207401|FG001|Maintenance Therapy|Not protocol specified|0|||
19666927|NCT02471144|42115217|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666928|NCT02471144|42115218|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666929|NCT02471144|42115219|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
19666930|NCT02471144|42115209|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666931|NCT02471144|42115210|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666932|NCT02471144|42115211|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
19666933|NCT02471144|42115212|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666934|NCT02471144|42115213|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666935|NCT02471144|42115214|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666936|NCT02471144|42115215|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666937|NCT02471144|42115216|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666938|NCT02471144|42115217|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666939|NCT02471144|42115218|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666940|NCT02471144|42115219|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
19666941|NCT02471144|42115209|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
19666942|NCT02471144|42115210|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
19666943|NCT02471144|42115211|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666944|NCT02471144|42115212|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666945|NCT02471144|42115213|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666946|NCT02471144|42115214|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666947|NCT02471144|42115215|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666948|NCT02471144|42115216|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666949|NCT02471144|42115217|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666950|NCT02471144|42115218|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666951|NCT02471144|42115219|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
19666952|NCT02471144|42115209|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666953|NCT02471144|42115210|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666954|NCT02471144|42115211|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666955|NCT02471144|42115212|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666956|NCT02471144|42115213|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
19666957|NCT02471144|42115214|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666958|NCT02471144|42115215|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
19666959|NCT02471144|42115216|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666960|NCT02471144|42115217|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
19666961|NCT02471144|42115218|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666962|NCT02471144|42115219|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
19666963|NCT02471144|42115209|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666964|NCT02471144|42115210|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666965|NCT02471144|42115211|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666966|NCT02471144|42115212|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666967|NCT02471144|42115213|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666968|NCT02471144|42115214|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
19666969|NCT02471144|42115215|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666970|NCT02471144|42115216|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666971|NCT02471144|42115217|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
19666972|NCT02471144|42115218|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666973|NCT02471144|42115219|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
19666974|NCT02471144|42115209|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666975|NCT02471144|42115210|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666976|NCT02471144|42115211|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666977|NCT02471144|42115212|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666978|NCT02471144|42115213|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666979|NCT02471144|42115214|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666980|NCT02471144|42115215|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666981|NCT02471144|42115216|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666982|NCT02471144|42115217|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
19666983|NCT02471144|42115218|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666984|NCT02471144|42115219|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
19666985|NCT02471144|42115209|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666986|NCT02471144|42115210|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666987|NCT02471144|42115211|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666988|NCT02471144|42115212|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666989|NCT02471144|42115213|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666990|NCT02471144|42115214|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666991|NCT02471144|42115215|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666992|NCT02471144|42115216|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
19666993|NCT02471144|42115217|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
19666994|NCT02471144|42115218|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666995|NCT02471144|42115219|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
19666996|NCT02471144|42115209|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19666997|NCT02471144|42115210|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19666998|NCT02471144|42115211|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19666999|NCT02471144|42115212|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667000|NCT02471144|42115213|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667001|NCT02471144|42115214|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667002|NCT02471144|42115215|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667003|NCT02471144|42115216|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667004|NCT02471144|42115217|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
19667005|NCT02471144|42115218|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
19667006|NCT02471144|42115219|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
19667007|NCT02471144|42115209|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667008|NCT02471144|42115210|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667009|NCT02471144|42115211|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667010|NCT02471144|42115212|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667011|NCT02471144|42115213|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667012|NCT02471144|42115214|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667013|NCT02471144|42115215|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667014|NCT02471144|42115216|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667015|NCT02471144|42115217|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667016|NCT02471144|42115218|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
19667017|NCT02471144|42115219|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
19667018|NCT02471144|42115209|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667019|NCT02471144|42115210|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667020|NCT02471144|42115211|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667021|NCT02471144|42115212|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667022|NCT02471144|42115213|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667023|NCT02471144|42115214|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667024|NCT02471144|42115215|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667025|NCT02471144|42115216|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667026|NCT02471144|42115217|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667027|NCT02471144|42115218|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
19667028|NCT02471144|42115219|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
19667029|NCT00401752|42115237|FG000|Overall Study|Adverse Event|2|||
19667030|NCT00401752|42115238|FG001|Overall Study|Adverse Event|5|||
19667031|NCT00401752|42115237|FG000|Overall Study|Withdrawal by Subject|2|||
19667032|NCT00401752|42115238|FG001|Overall Study|Withdrawal by Subject|6|||
19667033|NCT00401752|42115237|FG000|Overall Study|Lost to Follow-up|1|||
19667034|NCT00401752|42115238|FG001|Overall Study|Lost to Follow-up|4|||
19667035|NCT00401752|42115237|FG000|Overall Study|Development of any exclusion criteria|4|||
19756809|NCT00658814|42207400|FG000|Maintenance Therapy|Not eligible|1|||
19756810|NCT00658814|42207401|FG001|Maintenance Therapy|Not eligible|0|||
19756811|NCT03136380|42207413|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19756812|NCT03136380|42207414|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
19756813|NCT03136380|42207415|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19756814|NCT03136380|42207416|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19756815|NCT03136380|42207417|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
19477125|NCT01546519|41756031|FG001|Overall Study|Withdrawal by Subject|0|||
19667036|NCT00401752|42115238|FG001|Overall Study|Development of any exclusion criteria|2|||
19667037|NCT00401752|42115237|FG000|Overall Study|Physician Decision|1|||
19667038|NCT00401752|42115238|FG001|Overall Study|Physician Decision|1|||
19667039|NCT00539240|42115247|FG000|Overall Study|Withdrawal by Subject|0|||
19667040|NCT00539240|42115248|FG001|Overall Study|Withdrawal by Subject|2|||
19667041|NCT00539240|42115249|FG002|Overall Study|Withdrawal by Subject|0|||
19667042|NCT00539240|42115247|FG000|Overall Study|Protocol Violation|1|||
19667043|NCT00539240|42115248|FG001|Overall Study|Protocol Violation|1|||
19667044|NCT00539240|42115249|FG002|Overall Study|Protocol Violation|4|||
19667045|NCT00539240|42115247|FG000|Overall Study|Lost to Follow-up|2|||
19667046|NCT00539240|42115248|FG001|Overall Study|Lost to Follow-up|3|||
19667047|NCT00539240|42115249|FG002|Overall Study|Lost to Follow-up|1|||
19667048|NCT00539240|42115247|FG000|Overall Study|Adverse Event|3|||
19667049|NCT00539240|42115248|FG001|Overall Study|Adverse Event|1|||
19667050|NCT00539240|42115249|FG002|Overall Study|Adverse Event|10|||
19667051|NCT00417976|42115257|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
19667052|NCT00417976|42115257|FG000|Overall Study|Treatment -related toxicity|2|||
19667053|NCT00673673|42115262|FG000|Overall Study|Progressive disease|27|||
19667054|NCT00673673|42115262|FG000|Overall Study|Adverse Event|4|||
19667055|NCT00673673|42115262|FG000|Overall Study|Withdrawal by Subject|3|||
19667056|NCT00673673|42115262|FG000|Overall Study|Investigators' discretion|2|||
19667057|NCT00069121|42115268|FG000|Overall Study|Death|286|||
19667058|NCT00069121|42115269|FG001|Overall Study|Death|242|||
19667059|NCT00069121|42115268|FG000|Overall Study|Withdrawal by Subject|18|||
19756816|NCT03136068|42207437|FG000|Overall Study|Lost to Follow-up|1|||
19667060|NCT00069121|42115269|FG001|Overall Study|Withdrawal by Subject|20|||
19667061|NCT00069121|42115268|FG000|Overall Study|Lost to Follow-up|63|||
19667062|NCT00069121|42115269|FG001|Overall Study|Lost to Follow-up|63|||
19667063|NCT00399802|42115281|FG000|Overall Study|Adverse Event|0|||
19667064|NCT00399802|42115282|FG001|Overall Study|Adverse Event|2|||
19667065|NCT00399802|42115281|FG000|Overall Study|Participant discontinued by mistake|0|||
19667066|NCT00399802|42115282|FG001|Overall Study|Participant discontinued by mistake|1|||
19667067|NCT03900728|42115291|FG000|Overall Study|No text responses|0|||
19667068|NCT03900728|42115292|FG001|Overall Study|No text responses|0|||
19667069|NCT03900728|42115293|FG002|Overall Study|No text responses|4|||
19667070|NCT00399568|42115303|FG000|Overall Study|Adverse Event|1|||
19667071|NCT00399568|42115304|FG001|Overall Study|Adverse Event|2|||
19667072|NCT00399568|42115303|FG000|Overall Study|Withdrawal by Subject|7|||
19667073|NCT00399568|42115304|FG001|Overall Study|Withdrawal by Subject|3|||
19667074|NCT00399568|42115303|FG000|Overall Study|Protocol non-compliance|2|||
19667075|NCT00399568|42115304|FG001|Overall Study|Protocol non-compliance|2|||
19667076|NCT00399568|42115303|FG000|Overall Study|Lost to Follow-up|2|||
19667077|NCT00399568|42115304|FG001|Overall Study|Lost to Follow-up|2|||
19667078|NCT00068419|42115312|FG000|Overall Study|Adverse Event|3|||
19667079|NCT00068419|42115312|FG000|Overall Study|Lack of Efficacy|24|||
19667080|NCT00068419|42115312|FG000|Overall Study|Lost to Follow-up|1|||
19667081|NCT00068419|42115312|FG000|Overall Study|Physician Decision|7|||
19667082|NCT00068419|42115312|FG000|Overall Study|Withdrawal by Subject|14|||
19667083|NCT00068419|42115312|FG000|Overall Study|Ineligible|11|||
19667084|NCT00068107|42115316|FG000|Overall Study|end-stage renal disease|6|||
19667085|NCT00068107|42115316|FG000|Overall Study|Death|2|||
19667086|NCT00068107|42115316|FG000|Overall Study|Withdrawal by Subject|1|||
19667087|NCT00394654|42115325|FG000|Overall Study|Lost to Follow-up|1|||
19667088|NCT00394654|42115326|FG001|Overall Study|Lost to Follow-up|0|||
19667089|NCT00394654|42115325|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
19667090|NCT00394654|42115326|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
19667091|NCT03900416|42115334|FG000|Six Week Follow-up|Lost to Follow-up|1|||
19667092|NCT03900416|42115335|FG001|Six Week Follow-up|Lost to Follow-up|0|||
19667093|NCT03900416|42115334|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
19667094|NCT03900416|42115335|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
19667095|NCT03900416|42115334|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
19667096|NCT03900416|42115335|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
19667097|NCT03900416|42115334|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
19667098|NCT03900416|42115335|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
19667099|NCT03900416|42115334|FG000|Twelve Week Follow-up|Adverse Event|1|||
19667100|NCT03900416|42115335|FG001|Twelve Week Follow-up|Adverse Event|1|||
19756817|NCT03136068|42207438|FG001|Overall Study|Lost to Follow-up|1|||
19756818|NCT03136068|42207437|FG000|Overall Study|Protocol Violation|1|||
19756819|NCT03136068|42207438|FG001|Overall Study|Protocol Violation|0|||
19756820|NCT02585232|42207446|FG000|Overall Study|Lost to Follow-up|8|||
19756821|NCT02585232|42207447|FG001|Overall Study|Lost to Follow-up|8|||
19756822|NCT02585232|42207446|FG000|Overall Study|Withdrawal by Subject|4|||
19756823|NCT02585232|42207447|FG001|Overall Study|Withdrawal by Subject|8|||
19756824|NCT03377790|42207476|FG000|Overall Study|Withdrawal by Subject|1|||
19756825|NCT03377790|42207477|FG001|Overall Study|Withdrawal by Subject|0|||
19756826|NCT03377790|42207476|FG000|Overall Study|Adverse Event|1|||
19667101|NCT03900416|42115334|FG000|Six Month Follow-up|Lost to Follow-up|4|||
19667102|NCT03900416|42115335|FG001|Six Month Follow-up|Lost to Follow-up|3|||
19756827|NCT03377790|42207477|FG001|Overall Study|Adverse Event|0|||
19756828|NCT03377790|42207476|FG000|Overall Study|Lost to Follow-up|0|||
19756829|NCT03377790|42207477|FG001|Overall Study|Lost to Follow-up|2|||
19756830|NCT03377790|42207476|FG000|Overall Study|Randomized but not treated|1|||
19756831|NCT03377790|42207477|FG001|Overall Study|Randomized but not treated|0|||
19756832|NCT03377790|42207476|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
19756833|NCT03377790|42207477|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
19756834|NCT02717494|42207486|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
19756835|NCT02717494|42207487|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
19756836|NCT02717494|42207488|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
19756837|NCT02717494|42207486|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
19756838|NCT02717494|42207487|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
19756839|NCT02717494|42207488|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
19756840|NCT02717494|42207486|FG000|First Intervention (Step 1)|Death|0|||
19756841|NCT02717494|42207487|FG001|First Intervention (Step 1)|Death|0|||
19756842|NCT02717494|42207488|FG002|First Intervention (Step 1)|Death|1|||
19756843|NCT02717494|42207486|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
19756844|NCT02717494|42207487|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
19756845|NCT02717494|42207488|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
19756846|NCT00644228|42207516|FG000|Randomization & Eligibility|Ineligible|31|||
19756847|NCT00644228|42207517|FG001|Randomization & Eligibility|Ineligible|21|||
19756848|NCT00644228|42207516|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
19756849|NCT00644228|42207517|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
19756850|NCT00644228|42207516|FG000|Randomization & Eligibility|Invalid Consent|0|||
19667103|NCT03900416|42115334|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
19667104|NCT03900416|42115335|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
19667105|NCT00399490|42115341|FG000|Overall Study|Adverse Event|19|||
19667106|NCT00399490|42115341|FG000|Overall Study|Lack of Efficacy|31|||
19667107|NCT00399490|42115341|FG000|Overall Study|Lost to Follow-up|5|||
19667108|NCT00399490|42115341|FG000|Overall Study|Withdrawal by Subject|18|||
19667109|NCT00399490|42115341|FG000|Overall Study|Other|25|||
19667110|NCT00398866|42115350|FG000|Overall Study|Adverse Event|1|||
19667111|NCT00398866|42115351|FG001|Overall Study|Adverse Event|0|||
19667112|NCT00398866|42115352|FG002|Overall Study|Adverse Event|0|||
19667113|NCT00398866|42115350|FG000|Overall Study|Lack of Efficacy|0|||
19667114|NCT00398866|42115351|FG001|Overall Study|Lack of Efficacy|0|||
19667115|NCT00398866|42115352|FG002|Overall Study|Lack of Efficacy|1|||
19667116|NCT00398866|42115350|FG000|Overall Study|Lost to Follow-up|7|||
19756851|NCT00644228|42207517|FG001|Randomization & Eligibility|Invalid Consent|1|||
19756852|NCT00644228|42207516|FG000|Induction Therapy|Adverse Event|22|||
19756853|NCT00644228|42207517|FG001|Induction Therapy|Adverse Event|55|||
19756854|NCT00644228|42207516|FG000|Induction Therapy|Withdrawal by Subject|10|||
19756855|NCT00644228|42207517|FG001|Induction Therapy|Withdrawal by Subject|3|||
19667117|NCT00398866|42115351|FG001|Overall Study|Lost to Follow-up|6|||
19667118|NCT00398866|42115352|FG002|Overall Study|Lost to Follow-up|4|||
19667119|NCT00398866|42115350|FG000|Overall Study|Withdrawal by Subject|5|||
19667120|NCT00398866|42115351|FG001|Overall Study|Withdrawal by Subject|1|||
19667121|NCT00398866|42115352|FG002|Overall Study|Withdrawal by Subject|2|||
19667122|NCT00398866|42115350|FG000|Overall Study|Unable to complete requirements of study|1|||
19667123|NCT00398866|42115351|FG001|Overall Study|Unable to complete requirements of study|1|||
19667124|NCT00398866|42115352|FG002|Overall Study|Unable to complete requirements of study|1|||
19667125|NCT00398632|42115361|FG000|Overall Study|Withdrawal by Subject|1|||
19667126|NCT00398632|42115361|FG000|Overall Study|Lack of Efficacy|1|||
19667127|NCT00673361|42115366|FG000|Overall Study|Screen Failure|2|||
19667128|NCT00393718|42115372|FG000|Overall Study|Adverse Event|20|||
19667129|NCT00393718|42115373|FG001|Overall Study|Adverse Event|8|||
19667130|NCT00393718|42115372|FG000|Overall Study|Protocol Violation|1|||
19667131|NCT00393718|42115373|FG001|Overall Study|Protocol Violation|2|||
19667132|NCT00393718|42115372|FG000|Overall Study|Lack of Efficacy|10|||
19667133|NCT00393718|42115373|FG001|Overall Study|Lack of Efficacy|9|||
19667134|NCT00393718|42115372|FG000|Overall Study|Hypoglycaemia|3|||
19667135|NCT00393718|42115373|FG001|Overall Study|Hypoglycaemia|2|||
19667136|NCT00393718|42115372|FG000|Overall Study|Subject decision|5|||
19667137|NCT00393718|42115373|FG001|Overall Study|Subject decision|0|||
19667138|NCT00393718|42115372|FG000|Overall Study|Withdrawal of consent|2|||
19667139|NCT00393718|42115373|FG001|Overall Study|Withdrawal of consent|1|||
19667140|NCT00393718|42115372|FG000|Overall Study|Missed measurement|1|||
19667141|NCT00393718|42115373|FG001|Overall Study|Missed measurement|0|||
19667142|NCT00393718|42115372|FG000|Overall Study|Move|1|||
19667143|NCT00393718|42115373|FG001|Overall Study|Move|0|||
19667144|NCT00669071|42115379|FG000|Overall Study|Lost to Follow-up|3|||
19667145|NCT00669071|42115379|FG000|Overall Study|Final visit 40 days out of window|1|||
19667146|NCT00398320|42115385|FG000|Overall Study|Death|1|||
19667147|NCT00398320|42115385|FG000|Overall Study|Adverse Event|4|||
19667148|NCT00398320|42115385|FG000|Overall Study|Physician Decision|1|||
19667149|NCT00670007|42115389|FG000|Overall Study|Drug abuse|1|||
19667150|NCT00670007|42115389|FG000|Overall Study|Lung transplant|1|||
19667151|NCT00670007|42115389|FG000|Overall Study|Travel/Vacation|1|||
19667152|NCT00670007|42115389|FG000|Overall Study|Adverse event, serious fatal|1|||
19667153|NCT00670007|42115389|FG000|Overall Study|Adverse Event|1|||
19667154|NCT00670007|42115389|FG000|Overall Study|Withdrawal by Subject|4|||
19667155|NCT00535496|42115396|FG000|Overall Study|Lost to Follow-up|0|||
19667156|NCT00535496|42115397|FG001|Overall Study|Lost to Follow-up|1|||
19667157|NCT00535496|42115398|FG002|Overall Study|Lost to Follow-up|0|||
19756856|NCT00644228|42207516|FG000|Induction Therapy|Progression/Relapse|24|||
19667158|NCT00535496|42115399|FG003|Overall Study|Lost to Follow-up|0|||
19667159|NCT00535496|42115396|FG000|Overall Study|Not treated with sugammadex|0|||
19667160|NCT00535496|42115397|FG001|Overall Study|Not treated with sugammadex|1|||
19667161|NCT00535496|42115398|FG002|Overall Study|Not treated with sugammadex|0|||
19667162|NCT00535496|42115399|FG003|Overall Study|Not treated with sugammadex|0|||
19667163|NCT00539006|42115410|FG000|Pre-treatment|Other|0|||
19667164|NCT00539006|42115411|FG001|Pre-treatment|Other|1|||
19667165|NCT00539006|42115412|FG002|Pre-treatment|Other|0|||
19667166|NCT00539006|42115413|FG003|Pre-treatment|Other|0|||
19756857|NCT00644228|42207517|FG001|Induction Therapy|Progression/Relapse|12|||
19756858|NCT00644228|42207516|FG000|Induction Therapy|Death|3|||
19756859|NCT00644228|42207517|FG001|Induction Therapy|Death|7|||
19756860|NCT00644228|42207516|FG000|Induction Therapy|Not Protocol-Specified|24|||
19667167|NCT00539006|42115410|FG000|Treatment Period 1|Lost to Follow-up|0|||
19667168|NCT00539006|42115411|FG001|Treatment Period 1|Lost to Follow-up|0|||
19667169|NCT00539006|42115412|FG002|Treatment Period 1|Lost to Follow-up|1|||
19667170|NCT00539006|42115413|FG003|Treatment Period 1|Lost to Follow-up|0|||
19667171|NCT00539006|42115410|FG000|Treatment Period 1|Protocol Violation|0|||
19667172|NCT00539006|42115411|FG001|Treatment Period 1|Protocol Violation|0|||
19667173|NCT00539006|42115412|FG002|Treatment Period 1|Protocol Violation|1|||
19667174|NCT00539006|42115413|FG003|Treatment Period 1|Protocol Violation|0|||
19667175|NCT00539006|42115410|FG000|Treatment Period 1|Lack of Efficacy|0|||
19667176|NCT00539006|42115411|FG001|Treatment Period 1|Lack of Efficacy|0|||
19667177|NCT00539006|42115412|FG002|Treatment Period 1|Lack of Efficacy|0|||
19667178|NCT00539006|42115413|FG003|Treatment Period 1|Lack of Efficacy|1|||
19667179|NCT00539006|42115410|FG000|Washout|Adverse Event|2|||
19667180|NCT00539006|42115411|FG001|Washout|Adverse Event|1|||
19667181|NCT00539006|42115412|FG002|Washout|Adverse Event|0|||
19667182|NCT00539006|42115413|FG003|Washout|Adverse Event|0|||
19667183|NCT00539006|42115410|FG000|Washout|Protocol Violation|1|||
19602769|NCT01034657|42051489|FG002|Randomized Phase|Abnormal laboratory value|0|||
19602770|NCT01034657|42051487|FG000|Randomized Phase|Adverse Event|0|||
19602771|NCT01034657|42051488|FG001|Randomized Phase|Adverse Event|2|||
19602772|NCT01034657|42051489|FG002|Randomized Phase|Adverse Event|1|||
19602773|NCT01014767|42051503|FG000|Overall Study|PI left institution, data unavailable|12|||
19602774|NCT01014767|42051504|FG001|Overall Study|PI left institution, data unavailable|1|||
19602775|NCT01014767|42051505|FG002|Overall Study|PI left institution, data unavailable|4|||
19602776|NCT01014767|42051506|FG003|Overall Study|PI left institution, data unavailable|1|||
19667184|NCT00539006|42115411|FG001|Washout|Protocol Violation|1|||
19667185|NCT00539006|42115412|FG002|Washout|Protocol Violation|0|||
19667186|NCT00539006|42115413|FG003|Washout|Protocol Violation|0|||
19667187|NCT00539006|42115410|FG000|Washout|Withdrawal by Subject|0|||
19667188|NCT00539006|42115411|FG001|Washout|Withdrawal by Subject|2|||
19667189|NCT00539006|42115412|FG002|Washout|Withdrawal by Subject|0|||
19667190|NCT00539006|42115413|FG003|Washout|Withdrawal by Subject|0|||
19602777|NCT02016781|42051518|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
19602778|NCT02016781|42051519|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
19602779|NCT02016781|42051518|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
19667191|NCT00539006|42115410|FG000|Washout|Failed to meet continuation criteria|16|||
19667192|NCT00539006|42115411|FG001|Washout|Failed to meet continuation criteria|5|||
19667193|NCT00539006|42115412|FG002|Washout|Failed to meet continuation criteria|14|||
19756861|NCT00644228|42207517|FG001|Induction Therapy|Not Protocol-Specified|28|||
19756862|NCT00644228|42207516|FG000|Maintenance|Adverse Event|27|||
19756863|NCT00644228|42207517|FG001|Maintenance|Adverse Event|31|||
19756864|NCT00644228|42207516|FG000|Maintenance|Withdrawal by Subject|6|||
19756865|NCT00644228|42207517|FG001|Maintenance|Withdrawal by Subject|4|||
19756866|NCT00644228|42207516|FG000|Maintenance|Progression/Relapse|67|||
19756867|NCT00644228|42207517|FG001|Maintenance|Progression/Relapse|42|||
19756868|NCT00644228|42207516|FG000|Maintenance|Death|3|||
19667194|NCT00539006|42115413|FG003|Washout|Failed to meet continuation criteria|6|||
19756869|NCT00644228|42207517|FG001|Maintenance|Death|3|||
19667195|NCT00539006|42115410|FG000|Washout|Other|1|||
19667196|NCT00539006|42115411|FG001|Washout|Other|1|||
19667197|NCT00539006|42115412|FG002|Washout|Other|2|||
19667198|NCT00539006|42115413|FG003|Washout|Other|3|||
19667199|NCT00539006|42115410|FG000|Treatment Period 2|Protocol Violation|1|||
19667200|NCT00539006|42115411|FG001|Treatment Period 2|Protocol Violation|0|||
19667201|NCT00539006|42115412|FG002|Treatment Period 2|Protocol Violation|0|||
19667202|NCT00539006|42115413|FG003|Treatment Period 2|Protocol Violation|0|||
19667203|NCT00539006|42115410|FG000|Treatment Period 2|Other|0|||
19667204|NCT00539006|42115411|FG001|Treatment Period 2|Other|1|||
19667205|NCT00539006|42115412|FG002|Treatment Period 2|Other|0|||
19667206|NCT00539006|42115413|FG003|Treatment Period 2|Other|0|||
19667207|NCT00537056|42115429|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
19667208|NCT00535262|42115435|FG000|Overall Study|No funding|3|||
19667209|NCT00074581|42115441|FG000|Overall Study|Death|15|||
19667210|NCT00074581|42115442|FG001|Overall Study|Death|16|||
19667211|NCT00074581|42115441|FG000|Overall Study|Withdrawal by Subject|50|||
19667212|NCT00074581|42115442|FG001|Overall Study|Withdrawal by Subject|49|||
19667213|NCT00074581|42115441|FG000|Overall Study|Unable to adhere to visit schedule|13|||
19667214|NCT00074581|42115442|FG001|Overall Study|Unable to adhere to visit schedule|14|||
19667215|NCT00074581|42115441|FG000|Overall Study|Relocated|14|||
19667216|NCT00074581|42115442|FG001|Overall Study|Relocated|9|||
19667217|NCT00074581|42115441|FG000|Overall Study|Were withdrawn by investigator|5|||
19667218|NCT00074581|42115442|FG001|Overall Study|Were withdrawn by investigator|2|||
19667219|NCT00074581|42115441|FG000|Overall Study|Lost to Follow-up|16|||
19667220|NCT00074581|42115442|FG001|Overall Study|Lost to Follow-up|11|||
19667221|NCT00074581|42115441|FG000|Overall Study|Ended relationship w. index participant|117|||
19667222|NCT00074581|42115442|FG001|Overall Study|Ended relationship w. index participant|106|||
19667223|NCT00074581|42115441|FG000|Overall Study|Other|14|||
19756870|NCT00644228|42207516|FG000|Maintenance|Not Protocol-Specified|14|||
19756871|NCT00644228|42207517|FG001|Maintenance|Not Protocol-Specified|15|||
19756872|NCT00644228|42207516|FG000|Maintenance|On Treatment|26|||
19756873|NCT00644228|42207517|FG001|Maintenance|On Treatment|40|||
19756874|NCT01844856|42207525|FG000|Overall Study|Lost to Follow-up|15|||
19756875|NCT01844856|42207526|FG001|Overall Study|Lost to Follow-up|3|||
19756876|NCT01844856|42207525|FG000|Overall Study|Adverse Event|3|||
19756877|NCT01844856|42207526|FG001|Overall Study|Adverse Event|6|||
19667224|NCT00074581|42115442|FG001|Overall Study|Other|19|||
19667225|NCT03895034|42115448|FG000|Overall Study|Lost to Follow-up|2|||
19667226|NCT00536978|42115452|FG000|Overall Study|Not eligible for Adback Infusion|22|||
19667227|NCT03809611|42115458|FG000|Overall Study|Withdrawal by Subject|1|||
19667228|NCT03809611|42115459|FG001|Overall Study|Withdrawal by Subject|1|||
19667229|NCT03807739|42115470|FG000|Overall Study|Adverse Event|1|||
19667230|NCT03807739|42115471|FG001|Overall Study|Adverse Event|0|||
19667231|NCT03807739|42115472|FG002|Overall Study|Adverse Event|0|||
19667232|NCT03807739|42115473|FG003|Overall Study|Adverse Event|0|||
19667233|NCT03807739|42115470|FG000|Overall Study|Withdrawal by Subject|1|||
19667234|NCT03807739|42115471|FG001|Overall Study|Withdrawal by Subject|0|||
19667235|NCT03807739|42115472|FG002|Overall Study|Withdrawal by Subject|0|||
19756878|NCT01844856|42207525|FG000|Overall Study|Withdrawal by Subject|3|||
19667236|NCT03807739|42115473|FG003|Overall Study|Withdrawal by Subject|0|||
19667237|NCT00536744|42115485|FG000|Overall Study|Adverse Event|13|||
19667238|NCT00536744|42115486|FG001|Overall Study|Adverse Event|10|||
19667239|NCT00536744|42115485|FG000|Overall Study|Death|2|||
19756879|NCT01844856|42207526|FG001|Overall Study|Withdrawal by Subject|2|||
19756880|NCT01844856|42207525|FG000|Overall Study|Noncompliance|2|||
19756881|NCT01844856|42207526|FG001|Overall Study|Noncompliance|3|||
19756882|NCT01844856|42207525|FG000|Overall Study|Enterococcus Resistant|0|||
19756883|NCT01844856|42207526|FG001|Overall Study|Enterococcus Resistant|1|||
19756884|NCT01844856|42207525|FG000|Overall Study|Inadvertently Not Scheduled|1|||
19756885|NCT01844856|42207526|FG001|Overall Study|Inadvertently Not Scheduled|0|||
19756886|NCT01844856|42207525|FG000|Overall Study|Randomized but was a Screen Failure|0|||
19756887|NCT01844856|42207526|FG001|Overall Study|Randomized but was a Screen Failure|1|||
19756888|NCT03135210|42207562|FG000|Overall Study|Death|0|||
19756889|NCT03135210|42207563|FG001|Overall Study|Death|1|||
19756890|NCT00588770|42207571|FG000|Overall Study|Disease progression|85|||
19756891|NCT00588770|42207572|FG001|Overall Study|Disease progression|68|||
19756892|NCT00588770|42207571|FG000|Overall Study|Adverse Event|29|||
19756893|NCT00588770|42207572|FG001|Overall Study|Adverse Event|58|||
19756894|NCT00588770|42207571|FG000|Overall Study|Death|13|||
19756895|NCT00588770|42207572|FG001|Overall Study|Death|22|||
19756896|NCT00588770|42207571|FG000|Overall Study|Withdrawal by Subject|15|||
19756897|NCT00588770|42207572|FG001|Overall Study|Withdrawal by Subject|25|||
19756898|NCT00588770|42207571|FG000|Overall Study|Alternative therapy|2|||
19756899|NCT00588770|42207572|FG001|Overall Study|Alternative therapy|4|||
19756900|NCT00588770|42207571|FG000|Overall Study|Other complicating disease|3|||
19667240|NCT00536744|42115486|FG001|Overall Study|Death|1|||
19667241|NCT00536744|42115485|FG000|Overall Study|Physician Decision|3|||
19667242|NCT00536744|42115486|FG001|Overall Study|Physician Decision|1|||
19667243|NCT00536744|42115485|FG000|Overall Study|Lost to Follow-up|3|||
19667244|NCT00536744|42115486|FG001|Overall Study|Lost to Follow-up|5|||
19667245|NCT00536744|42115485|FG000|Overall Study|Withdrawal by Subject|7|||
19667246|NCT00536744|42115486|FG001|Overall Study|Withdrawal by Subject|8|||
19667247|NCT00536744|42115485|FG000|Overall Study|PI tried alternative treatment|1|||
19667248|NCT00536744|42115486|FG001|Overall Study|PI tried alternative treatment|3|||
19667249|NCT00536510|42115503|FG000|Overall Study|Adverse Event|27|||
19667250|NCT00536510|42115504|FG001|Overall Study|Adverse Event|4|||
19667251|NCT00536510|42115503|FG000|Overall Study|Lost to Follow-up|11|||
19667252|NCT00536510|42115504|FG001|Overall Study|Lost to Follow-up|8|||
19667253|NCT00536510|42115503|FG000|Overall Study|Protocol Violation|4|||
19667254|NCT00536510|42115504|FG001|Overall Study|Protocol Violation|5|||
19667255|NCT00536510|42115503|FG000|Overall Study|Withdrawal by Subject|16|||
19667256|NCT00536510|42115504|FG001|Overall Study|Withdrawal by Subject|9|||
19667257|NCT00536510|42115503|FG000|Overall Study|Flushing with Product|20|||
19667258|NCT00536510|42115504|FG001|Overall Study|Flushing with Product|0|||
19667259|NCT00536510|42115503|FG000|Overall Study|Laboratory Adverse Event|2|||
19667260|NCT00536510|42115504|FG001|Overall Study|Laboratory Adverse Event|1|||
19667261|NCT00536510|42115503|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
19756901|NCT00588770|42207572|FG001|Overall Study|Other complicating disease|2|||
19756902|NCT00588770|42207571|FG000|Overall Study|Not start protocol therapy|0|||
19667262|NCT00536510|42115504|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
19667263|NCT00398086|42115513|FG000|Overall Study|Unacceptable Toxicity|2|||
19756903|NCT00588770|42207572|FG001|Overall Study|Not start protocol therapy|9|||
19756904|NCT00588770|42207571|FG000|Overall Study|Lack of Efficacy|8|||
19756905|NCT00588770|42207572|FG001|Overall Study|Lack of Efficacy|10|||
19756906|NCT00588770|42207571|FG000|Overall Study|Physician discretion|2|||
19756907|NCT00588770|42207572|FG001|Overall Study|Physician discretion|0|||
19756908|NCT00588770|42207571|FG000|Overall Study|Patient non-compliance|2|||
19756909|NCT00588770|42207572|FG001|Overall Study|Patient non-compliance|2|||
19756910|NCT02147184|42207580|FG000|Overall Study|Lost to Follow-up|28|||
19756911|NCT02147184|42207581|FG001|Overall Study|Lost to Follow-up|15|||
19756912|NCT02147184|42207580|FG000|Overall Study|Study Burden|11|||
19756913|NCT02147184|42207581|FG001|Overall Study|Study Burden|7|||
19756914|NCT02147184|42207580|FG000|Overall Study|Pregnancy|6|||
19756915|NCT02147184|42207581|FG001|Overall Study|Pregnancy|0|||
19756916|NCT02147184|42207580|FG000|Overall Study|Moved out of state|3|||
19756917|NCT02147184|42207581|FG001|Overall Study|Moved out of state|3|||
19756918|NCT02147184|42207580|FG000|Overall Study|Physician Decision|0|||
19756919|NCT02147184|42207581|FG001|Overall Study|Physician Decision|2|||
19756920|NCT02147184|42207580|FG000|Overall Study|Other|1|||
19756921|NCT02147184|42207581|FG001|Overall Study|Other|0|||
19756922|NCT00701662|42207587|FG000|Overall Study|Lack of Efficacy|1|||
19756923|NCT02878590|42207591|FG000|Overall Study|Withdrawal by Subject|2|||
19756924|NCT04634409|42207622|FG000|Overall Study|Death|0|||
19756925|NCT04634409|42207623|FG001|Overall Study|Death|0|||
19756926|NCT04634409|42207624|FG002|Overall Study|Death|0|||
19756927|NCT04634409|42207625|FG003|Overall Study|Death|0|||
19756928|NCT04634409|42207626|FG004|Overall Study|Death|0|||
19756929|NCT04634409|42207627|FG005|Overall Study|Death|0|||
19756930|NCT04634409|42207628|FG006|Overall Study|Death|0|||
19756931|NCT04634409|42207629|FG007|Overall Study|Death|0|||
19756932|NCT04634409|42207630|FG008|Overall Study|Death|0|||
19756933|NCT04634409|42207631|FG009|Overall Study|Death|0|||
19756934|NCT04634409|42207632|FG010|Overall Study|Death|1|||
19756935|NCT04634409|42207633|FG011|Overall Study|Death|0|||
19756936|NCT04634409|42207634|FG012|Overall Study|Death|1|||
19756937|NCT04634409|42207635|FG013|Overall Study|Death|0|||
19667264|NCT00398086|42115514|FG001|Overall Study|Unacceptable Toxicity|8|||
19667265|NCT00398086|42115515|FG002|Overall Study|Unacceptable Toxicity|2|||
19667266|NCT00398086|42115513|FG000|Overall Study|Adverse Event|1|||
19667267|NCT00398086|42115514|FG001|Overall Study|Adverse Event|4|||
19667268|NCT00398086|42115515|FG002|Overall Study|Adverse Event|0|||
19667269|NCT00398086|42115513|FG000|Overall Study|Physician Decision|1|||
19667270|NCT00398086|42115514|FG001|Overall Study|Physician Decision|4|||
19667271|NCT00398086|42115515|FG002|Overall Study|Physician Decision|0|||
19667272|NCT00398086|42115513|FG000|Overall Study|Withdrawal by Subject|5|||
19667273|NCT00398086|42115514|FG001|Overall Study|Withdrawal by Subject|7|||
19667274|NCT00398086|42115515|FG002|Overall Study|Withdrawal by Subject|0|||
19667275|NCT00536198|42115525|FG000|Overall Study|Lost to Follow-up|15|||
19667276|NCT00536198|42115526|FG001|Overall Study|Lost to Follow-up|14|||
19667277|NCT00536198|42115525|FG000|Overall Study|Withdrawal by Subject|16|||
19667278|NCT00536198|42115526|FG001|Overall Study|Withdrawal by Subject|12|||
19667279|NCT00536198|42115525|FG000|Overall Study|Adverse Event|2|||
19667280|NCT00536198|42115526|FG001|Overall Study|Adverse Event|2|||
19667281|NCT00536198|42115525|FG000|Overall Study|Rescue|3|||
19667282|NCT00536198|42115526|FG001|Overall Study|Rescue|9|||
19667283|NCT00536198|42115525|FG000|Overall Study|Pregnancy|1|||
19667284|NCT00536198|42115526|FG001|Overall Study|Pregnancy|1|||
19667285|NCT00536198|42115525|FG000|Overall Study|Protocol Violation|0|||
19667286|NCT00536198|42115526|FG001|Overall Study|Protocol Violation|1|||
19667287|NCT00393484|42115536|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
19667288|NCT00393484|42115537|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
19667289|NCT00393484|42115536|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
19667290|NCT00393484|42115537|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
19667291|NCT00393484|42115536|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
19667292|NCT00393484|42115537|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
19756938|NCT04634409|42207636|FG014|Overall Study|Death|0|||
19756939|NCT04634409|42207637|FG015|Overall Study|Death|0|||
19756940|NCT04634409|42207638|FG016|Overall Study|Death|0|||
19756941|NCT04634409|42207639|FG017|Overall Study|Death|0|||
19756942|NCT04634409|42207640|FG018|Overall Study|Death|0|||
19756943|NCT04634409|42207641|FG019|Overall Study|Death|0|||
19756944|NCT04634409|42207642|FG020|Overall Study|Death|0|||
19756945|NCT04634409|42207643|FG021|Overall Study|Death|0|||
19756946|NCT04634409|42207644|FG022|Overall Study|Death|0|||
19756947|NCT04634409|42207645|FG023|Overall Study|Death|0|||
19667293|NCT00393484|42115536|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
19667294|NCT00393484|42115537|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
19667295|NCT00393484|42115536|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
19667296|NCT00393484|42115537|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
19667297|NCT00393484|42115536|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
19667298|NCT00393484|42115537|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
19667299|NCT00393484|42115536|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
19667300|NCT00393484|42115537|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
19667301|NCT00393484|42115536|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
19667302|NCT00393484|42115537|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
19667303|NCT00393484|42115536|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
19667304|NCT00393484|42115537|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
19667305|NCT00393484|42115536|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
19667306|NCT00393484|42115537|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
19667307|NCT00667823|42115545|FG000|Overall Study|Lost to Follow-up|5|||
19667308|NCT00667823|42115545|FG000|Overall Study|Adverse Event|7|||
19667309|NCT00667823|42115545|FG000|Overall Study|Death|182|||
19667310|NCT00667823|42115545|FG000|Overall Study|Withdrawal by Subject|12|||
19667311|NCT00667823|42115545|FG000|Overall Study|Other|8|||
19667312|NCT00667823|42115545|FG000|Overall Study|Missing (completion page missing)|2|||
19667313|NCT00397930|42115551|FG000|Overall Study|Personal reasons|14|||
19667314|NCT00397930|42115552|FG001|Overall Study|Personal reasons|8|||
19667315|NCT00397930|42115551|FG000|Overall Study|Other medical|9|||
19667316|NCT00397930|42115552|FG001|Overall Study|Other medical|4|||
19667317|NCT00397930|42115551|FG000|Overall Study|Unknown reasons|9|||
19667318|NCT00397930|42115552|FG001|Overall Study|Unknown reasons|14|||
19667319|NCT00397930|42115551|FG000|Overall Study|Noncompliant|3|||
19667320|NCT00397930|42115552|FG001|Overall Study|Noncompliant|2|||
19667321|NCT00397930|42115551|FG000|Overall Study|Too time-consuming|2|||
19667322|NCT00397930|42115552|FG001|Overall Study|Too time-consuming|9|||
19667323|NCT00397930|42115551|FG000|Overall Study|Started own yoga program|1|||
19667324|NCT00397930|42115552|FG001|Overall Study|Started own yoga program|1|||
19667325|NCT00397930|42115551|FG000|Overall Study|Did not want to be in control group|0|||
19667326|NCT00397930|42115552|FG001|Overall Study|Did not want to be in control group|1|||
19667327|NCT00397930|42115551|FG000|Overall Study|Withdrawal by Subject|0|||
19667328|NCT00397930|42115552|FG001|Overall Study|Withdrawal by Subject|8|||
19667329|NCT00397930|42115551|FG000|Overall Study|Missing data|0|||
19756948|NCT04634409|42207646|FG024|Overall Study|Death|0|||
19756949|NCT04634409|42207647|FG025|Overall Study|Death|0|||
19667330|NCT00397930|42115552|FG001|Overall Study|Missing data|4|||
19667331|NCT00397540|42115560|FG000|Overall Study|short follow-up duration < 12 months|1|||
19667332|NCT00397540|42115561|FG001|Overall Study|short follow-up duration < 12 months|0|||
19667333|NCT00536120|42115570|FG000|Overall Study|Lost to Follow-up|1|||
19667334|NCT00536120|42115571|FG001|Overall Study|Lost to Follow-up|0|||
19602780|NCT02016781|42051519|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
19667335|NCT00536120|42115570|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
19667336|NCT00536120|42115571|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
19667337|NCT00536120|42115570|FG000|Overall Study|Non-compliance|1|||
19667338|NCT00536120|42115571|FG001|Overall Study|Non-compliance|0|||
19667339|NCT00536120|42115570|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
19667340|NCT00536120|42115571|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
19667341|NCT00536120|42115570|FG000|Overall Study|Steroid Use|0|||
19667342|NCT00536120|42115571|FG001|Overall Study|Steroid Use|2|||
19667343|NCT00536120|42115570|FG000|Overall Study|Missed Study Visit|0|||
19667344|NCT00536120|42115571|FG001|Overall Study|Missed Study Visit|1|||
19667345|NCT00057811|42115579|FG000|Overall Study|Lack of Efficacy|1|||
19667346|NCT00057811|42115580|FG001|Overall Study|Lack of Efficacy|4|||
19667347|NCT00057811|42115579|FG000|Overall Study|Physician Decision|1|||
19667348|NCT00057811|42115580|FG001|Overall Study|Physician Decision|0|||
19667349|NCT00057811|42115579|FG000|Overall Study|Withdrawal by Subject|3|||
19756950|NCT04634409|42207648|FG026|Overall Study|Death|0|||
19756951|NCT04634409|42207622|FG000|Overall Study|Adverse Event|0|||
19602781|NCT02016781|42051518|FG000|Final Database Lock|Withdrawal by Subject|2|||
19602782|NCT02016781|42051519|FG001|Final Database Lock|Withdrawal by Subject|1|||
19602783|NCT02016781|42051518|FG000|Final Database Lock|Lost to Follow-up|11|||
19602784|NCT02016781|42051519|FG001|Final Database Lock|Lost to Follow-up|4|||
19602785|NCT02016781|42051518|FG000|Final Database Lock|Missing data|0|||
19602786|NCT02016781|42051519|FG001|Final Database Lock|Missing data|3|||
19602787|NCT01014689|42051527|FG000|Overall Study|Lack of Efficacy|0|||
19602788|NCT01014689|42051528|FG001|Overall Study|Lack of Efficacy|1|||
19602789|NCT01014689|42051527|FG000|Overall Study|Adverse Event|3|||
19602790|NCT01014689|42051528|FG001|Overall Study|Adverse Event|0|||
19667350|NCT00057811|42115580|FG001|Overall Study|Withdrawal by Subject|4|||
19667351|NCT00057811|42115579|FG000|Overall Study|Ineligible|4|||
19667352|NCT00057811|42115580|FG001|Overall Study|Ineligible|2|||
19667353|NCT00057811|42115579|FG000|Overall Study|Inevaluable|1|||
19667354|NCT00057811|42115580|FG001|Overall Study|Inevaluable|2|||
19667355|NCT02866682|42115593|FG000|Overall Study|Death|0|||
19667356|NCT02866682|42115594|FG001|Overall Study|Death|1|||
19667357|NCT02866682|42115593|FG000|Overall Study|Lost to Follow-up|0|||
19667358|NCT02866682|42115594|FG001|Overall Study|Lost to Follow-up|4|||
19667359|NCT02866682|42115593|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
19667360|NCT02866682|42115594|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
19667361|NCT02866682|42115593|FG000|Overall Study|Other|0|||
19667362|NCT02866682|42115594|FG001|Overall Study|Other|1|||
19756952|NCT04634409|42207623|FG001|Overall Study|Adverse Event|0|||
19756953|NCT04634409|42207624|FG002|Overall Study|Adverse Event|1|||
19667363|NCT00570713|42115611|FG000|Overall Study|Adverse Event|16|||
19667364|NCT00570713|42115612|FG001|Overall Study|Adverse Event|9|||
19667365|NCT00570713|42115611|FG000|Overall Study|Death|7|||
19667366|NCT00570713|42115612|FG001|Overall Study|Death|7|||
19667367|NCT00570713|42115611|FG000|Overall Study|Lack of Efficacy|40|||
19667368|NCT00570713|42115612|FG001|Overall Study|Lack of Efficacy|49|||
19667369|NCT00570713|42115611|FG000|Overall Study|Physician Decision|2|||
19667370|NCT00570713|42115612|FG001|Overall Study|Physician Decision|2|||
19667371|NCT00570713|42115611|FG000|Overall Study|Withdrawal by Subject|3|||
19667372|NCT00570713|42115612|FG001|Overall Study|Withdrawal by Subject|3|||
19667373|NCT00570713|42115611|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
19667374|NCT00570713|42115612|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
19667375|NCT00669617|42115622|FG000|Period 1|Withdrawal by Subject|0|||
19667376|NCT00669617|42115623|FG001|Period 1|Withdrawal by Subject|0|||
19667377|NCT00669617|42115624|FG002|Period 1|Withdrawal by Subject|1|||
19667378|NCT00669617|42115625|FG003|Period 1|Withdrawal by Subject|0|||
19667379|NCT00669617|42115626|FG004|Period 1|Withdrawal by Subject|0|||
19667380|NCT00669617|42115622|FG000|Period 1|Protocol Deviation|0|||
19667381|NCT00669617|42115623|FG001|Period 1|Protocol Deviation|0|||
19667382|NCT00669617|42115624|FG002|Period 1|Protocol Deviation|0|||
19667383|NCT00669617|42115625|FG003|Period 1|Protocol Deviation|0|||
19667384|NCT00669617|42115626|FG004|Period 1|Protocol Deviation|1|||
19667385|NCT00669617|42115622|FG000|Period 3|Lost to Follow-up|1|||
19667386|NCT00669617|42115623|FG001|Period 3|Lost to Follow-up|0|||
19667387|NCT00669617|42115624|FG002|Period 3|Lost to Follow-up|0|||
19667388|NCT00669617|42115625|FG003|Period 3|Lost to Follow-up|0|||
19667389|NCT00669617|42115626|FG004|Period 3|Lost to Follow-up|0|||
19667390|NCT00535730|42115640|FG000|Overall Study|Adverse Event|1|||
19667391|NCT00535730|42115641|FG001|Overall Study|Adverse Event|1|||
19667392|NCT00535730|42115640|FG000|Overall Study|Lost to Follow-up|0|||
19667393|NCT00535730|42115641|FG001|Overall Study|Lost to Follow-up|1|||
19667394|NCT00535730|42115640|FG000|Overall Study|Physician Decision|0|||
19667395|NCT00535730|42115641|FG001|Overall Study|Physician Decision|1|||
19667396|NCT00535730|42115640|FG000|Overall Study|Protocol Violation|1|||
19667397|NCT00535730|42115641|FG001|Overall Study|Protocol Violation|0|||
19667398|NCT00535730|42115640|FG000|Overall Study|Withdrawal by Subject|0|||
19667399|NCT00535730|42115641|FG001|Overall Study|Withdrawal by Subject|4|||
19667400|NCT00666965|42115652|FG000|Overall Study|Adverse Event|0|||
19667401|NCT00666965|42115653|FG001|Overall Study|Adverse Event|2|||
19667402|NCT00666965|42115654|FG002|Overall Study|Adverse Event|1|||
19667403|NCT00666965|42115655|FG003|Overall Study|Adverse Event|9|||
19667404|NCT00666965|42115652|FG000|Overall Study|Lack of Efficacy|1|||
19667405|NCT00666965|42115653|FG001|Overall Study|Lack of Efficacy|1|||
19667406|NCT00666965|42115654|FG002|Overall Study|Lack of Efficacy|0|||
19667407|NCT00666965|42115655|FG003|Overall Study|Lack of Efficacy|0|||
19667408|NCT00666965|42115652|FG000|Overall Study|Protocol Violation|0|||
19667409|NCT00666965|42115653|FG001|Overall Study|Protocol Violation|0|||
19667410|NCT00666965|42115654|FG002|Overall Study|Protocol Violation|0|||
19667411|NCT00666965|42115655|FG003|Overall Study|Protocol Violation|2|||
19667412|NCT00666965|42115652|FG000|Overall Study|Discontinuation criteria|2|||
19667413|NCT00666965|42115653|FG001|Overall Study|Discontinuation criteria|1|||
19667414|NCT00666965|42115654|FG002|Overall Study|Discontinuation criteria|1|||
19667415|NCT00666965|42115655|FG003|Overall Study|Discontinuation criteria|2|||
19667416|NCT00666965|42115652|FG000|Overall Study|Withdrawal by Subject|0|||
19667417|NCT00666965|42115653|FG001|Overall Study|Withdrawal by Subject|0|||
19667418|NCT00666965|42115654|FG002|Overall Study|Withdrawal by Subject|0|||
19667419|NCT00666965|42115655|FG003|Overall Study|Withdrawal by Subject|2|||
19667420|NCT03889886|42115669|FG000|Overall Study|Other|0|||
19667421|NCT03889886|42115670|FG001|Overall Study|Other|1|||
19667422|NCT03889886|42115671|FG002|Overall Study|Other|0|||
19667423|NCT03889886|42115672|FG003|Overall Study|Other|1|||
19667424|NCT03889886|42115669|FG000|Overall Study|Withdrawal by Subject|0|||
19667425|NCT03889886|42115670|FG001|Overall Study|Withdrawal by Subject|0|||
19667426|NCT03889886|42115671|FG002|Overall Study|Withdrawal by Subject|1|||
19667427|NCT03889886|42115672|FG003|Overall Study|Withdrawal by Subject|0|||
19667428|NCT03889886|42115669|FG000|Overall Study|Adverse Event|0|||
19667429|NCT03889886|42115670|FG001|Overall Study|Adverse Event|0|||
19667430|NCT03889886|42115671|FG002|Overall Study|Adverse Event|0|||
19667431|NCT03889886|42115672|FG003|Overall Study|Adverse Event|6|||
19667432|NCT03888482|42115684|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
19667433|NCT03888482|42115685|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
19667434|NCT03888482|42115684|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
19667435|NCT03888482|42115685|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
19667436|NCT00667355|42115693|FG000|Overall Study|Adverse Event|5|||
19667437|NCT00667355|42115693|FG000|Overall Study|Lost to Follow-up|1|||
19667438|NCT00667355|42115693|FG000|Overall Study|Other reason was not specified|5|||
19667439|NCT00532844|42115699|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
19667440|NCT00532844|42115700|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
19667441|NCT00532844|42115699|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
19667442|NCT00532844|42115700|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
19667443|NCT00532844|42115699|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
19667444|NCT00532844|42115700|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
19667445|NCT00532844|42115699|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
19667446|NCT00532844|42115700|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
19667447|NCT00532844|42115699|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
19667448|NCT00532844|42115700|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
19667449|NCT00666263|42115728|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
19667450|NCT00666263|42115729|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
19667451|NCT00666263|42115728|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
19667452|NCT00666263|42115729|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
19667453|NCT00666263|42115728|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
19667454|NCT00666263|42115729|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
19667455|NCT00667277|42115774|FG000|Overall Study|Withdrawal by Subject|2|||
19667456|NCT00534638|42115780|FG000|Overall Study|Withdrawal by Subject|3|||
19667457|NCT00534638|42115781|FG001|Overall Study|Withdrawal by Subject|4|||
19667458|NCT00534638|42115780|FG000|Overall Study|Migrated/moved from study area|13|||
19667459|NCT00534638|42115781|FG001|Overall Study|Migrated/moved from study area|11|||
19667460|NCT00534638|42115780|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
19667461|NCT00534638|42115781|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
19667462|NCT00534638|42115780|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
19667463|NCT00534638|42115781|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
19667464|NCT00534638|42115780|FG000|Overall Study|Other|1685|||
19667465|NCT00534638|42115781|FG001|Overall Study|Other|902|||
19667466|NCT00662129|42115792|FG000|Overall Study|Protocol Violation|1|||
19667467|NCT00662129|42115792|FG000|Overall Study|Cancel prior to beginning treatment|1|||
19667468|NCT00662129|42115792|FG000|Overall Study|Ineligible|1|||
19667469|NCT00664859|42115799|FG000|Overall Study|Adverse Event|2|||
19667470|NCT00664859|42115800|FG001|Overall Study|Adverse Event|1|||
19667471|NCT00664859|42115801|FG002|Overall Study|Adverse Event|3|||
19667472|NCT00664859|42115799|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
19667473|NCT00664859|42115800|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
19667474|NCT00664859|42115801|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
19667475|NCT00664859|42115799|FG000|Overall Study|Noncompliance with protocol|1|||
19667476|NCT00664859|42115800|FG001|Overall Study|Noncompliance with protocol|0|||
19667477|NCT00664859|42115801|FG002|Overall Study|Noncompliance with protocol|4|||
19667478|NCT00664859|42115799|FG000|Overall Study|Laboratory abnormality|2|||
19667479|NCT00664859|42115800|FG001|Overall Study|Laboratory abnormality|1|||
19667480|NCT00664859|42115801|FG002|Overall Study|Laboratory abnormality|4|||
19667481|NCT00664859|42115799|FG000|Overall Study|Withdrawal by Subject|4|||
19667482|NCT00664859|42115800|FG001|Overall Study|Withdrawal by Subject|1|||
19667483|NCT00664859|42115801|FG002|Overall Study|Withdrawal by Subject|3|||
19667484|NCT00664859|42115799|FG000|Overall Study|Lost to Follow-up|2|||
19667485|NCT00664859|42115800|FG001|Overall Study|Lost to Follow-up|2|||
19667486|NCT00664859|42115801|FG002|Overall Study|Lost to Follow-up|1|||
19667487|NCT00664859|42115799|FG000|Overall Study|Other|0|||
19667488|NCT00664859|42115800|FG001|Overall Study|Other|1|||
19667489|NCT00664859|42115801|FG002|Overall Study|Other|2|||
19667490|NCT00570401|42115809|FG000|Overall Study|Adverse Event|2|||
19667491|NCT00532298|42115819|FG000|Overall Study|Adverse Event|1|||
19667492|NCT00532298|42115820|FG001|Overall Study|Adverse Event|0|||
19667493|NCT00532298|42115821|FG002|Overall Study|Adverse Event|0|||
19667494|NCT00532298|42115822|FG003|Overall Study|Adverse Event|0|||
19667495|NCT00532298|42115823|FG004|Overall Study|Adverse Event|1|||
19667496|NCT00532298|42115824|FG005|Overall Study|Adverse Event|1|||
19667497|NCT00532298|42115819|FG000|Overall Study|Lost to Follow-up|1|||
19667498|NCT00532298|42115820|FG001|Overall Study|Lost to Follow-up|1|||
19667499|NCT00532298|42115821|FG002|Overall Study|Lost to Follow-up|1|||
19667500|NCT00532298|42115822|FG003|Overall Study|Lost to Follow-up|0|||
19667501|NCT00532298|42115823|FG004|Overall Study|Lost to Follow-up|0|||
19667502|NCT00532298|42115824|FG005|Overall Study|Lost to Follow-up|1|||
19667503|NCT00410410|42115844|FG000|Induction Period (IP)|Death|1|||
19667504|NCT00410410|42115845|FG001|Induction Period (IP)|Death|0|||
19667505|NCT00410410|42115846|FG002|Induction Period (IP)|Death|0|||
19667506|NCT00410410|42115847|FG003|Induction Period (IP)|Death|0|||
19667507|NCT00410410|42115848|FG004|Induction Period (IP)|Death|0|||
19667508|NCT00410410|42115849|FG005|Induction Period (IP)|Death|0|||
19667509|NCT00410410|42115850|FG006|Induction Period (IP)|Death|0|||
19667510|NCT00410410|42115851|FG007|Induction Period (IP)|Death|0|||
19667511|NCT00410410|42115852|FG008|Induction Period (IP)|Death|0|||
19667512|NCT00410410|42115844|FG000|Induction Period (IP)|Adverse Event|3|||
19667513|NCT00410410|42115845|FG001|Induction Period (IP)|Adverse Event|4|||
19667514|NCT00410410|42115846|FG002|Induction Period (IP)|Adverse Event|2|||
19667515|NCT00410410|42115847|FG003|Induction Period (IP)|Adverse Event|4|||
19667516|NCT00410410|42115848|FG004|Induction Period (IP)|Adverse Event|1|||
19667517|NCT00410410|42115849|FG005|Induction Period (IP)|Adverse Event|0|||
19667518|NCT00410410|42115850|FG006|Induction Period (IP)|Adverse Event|0|||
19667519|NCT00410410|42115851|FG007|Induction Period (IP)|Adverse Event|0|||
19667520|NCT00410410|42115852|FG008|Induction Period (IP)|Adverse Event|0|||
19667521|NCT00410410|42115844|FG000|Induction Period (IP)|Lack of Efficacy|26|||
19667522|NCT00410410|42115845|FG001|Induction Period (IP)|Lack of Efficacy|24|||
19667523|NCT00410410|42115846|FG002|Induction Period (IP)|Lack of Efficacy|8|||
19667524|NCT00410410|42115847|FG003|Induction Period (IP)|Lack of Efficacy|8|||
19667525|NCT00410410|42115848|FG004|Induction Period (IP)|Lack of Efficacy|7|||
19667526|NCT00410410|42115849|FG005|Induction Period (IP)|Lack of Efficacy|7|||
19667527|NCT00410410|42115850|FG006|Induction Period (IP)|Lack of Efficacy|0|||
19667528|NCT00410410|42115851|FG007|Induction Period (IP)|Lack of Efficacy|0|||
19667529|NCT00410410|42115852|FG008|Induction Period (IP)|Lack of Efficacy|0|||
19667530|NCT00410410|42115844|FG000|Induction Period (IP)|Lost to Follow-up|2|||
19667531|NCT00410410|42115845|FG001|Induction Period (IP)|Lost to Follow-up|2|||
19667532|NCT00410410|42115846|FG002|Induction Period (IP)|Lost to Follow-up|2|||
19667533|NCT00410410|42115847|FG003|Induction Period (IP)|Lost to Follow-up|3|||
19667534|NCT00410410|42115848|FG004|Induction Period (IP)|Lost to Follow-up|0|||
19667535|NCT00410410|42115849|FG005|Induction Period (IP)|Lost to Follow-up|1|||
19667536|NCT00410410|42115850|FG006|Induction Period (IP)|Lost to Follow-up|0|||
19667537|NCT00410410|42115851|FG007|Induction Period (IP)|Lost to Follow-up|0|||
19667538|NCT00410410|42115852|FG008|Induction Period (IP)|Lost to Follow-up|0|||
19667539|NCT00410410|42115844|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
19667540|NCT00410410|42115845|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
19667541|NCT00410410|42115846|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
19667542|NCT00410410|42115847|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
19667543|NCT00410410|42115848|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
19667544|NCT00410410|42115849|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
19667545|NCT00410410|42115850|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
19667546|NCT00410410|42115851|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
19667547|NCT00410410|42115852|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
19667548|NCT00410410|42115844|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667549|NCT00410410|42115845|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667550|NCT00410410|42115846|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
19667551|NCT00410410|42115847|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667552|NCT00410410|42115848|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667553|NCT00410410|42115849|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667554|NCT00410410|42115850|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667555|NCT00410410|42115851|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667556|NCT00410410|42115852|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
19667557|NCT00410410|42115844|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667558|NCT00410410|42115845|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667559|NCT00410410|42115846|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667560|NCT00410410|42115847|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667561|NCT00410410|42115848|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
19667562|NCT00410410|42115849|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
19667563|NCT00410410|42115850|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667564|NCT00410410|42115851|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667565|NCT00410410|42115852|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
19667566|NCT00410410|42115844|FG000|Induction Period (IP)|Other|0|||
19667567|NCT00410410|42115845|FG001|Induction Period (IP)|Other|0|||
19667568|NCT00410410|42115846|FG002|Induction Period (IP)|Other|1|||
19667569|NCT00410410|42115847|FG003|Induction Period (IP)|Other|0|||
19667570|NCT00410410|42115848|FG004|Induction Period (IP)|Other|0|||
19667571|NCT00410410|42115849|FG005|Induction Period (IP)|Other|0|||
19667572|NCT00410410|42115850|FG006|Induction Period (IP)|Other|0|||
19667573|NCT00410410|42115851|FG007|Induction Period (IP)|Other|0|||
19667574|NCT00410410|42115852|FG008|Induction Period (IP)|Other|0|||
19667575|NCT00410410|42115844|FG000|Maintenance Period (MP)|Death|0|||
19667576|NCT00410410|42115845|FG001|Maintenance Period (MP)|Death|0|||
19667577|NCT00410410|42115846|FG002|Maintenance Period (MP)|Death|0|||
19667578|NCT00410410|42115847|FG003|Maintenance Period (MP)|Death|0|||
19667579|NCT00410410|42115848|FG004|Maintenance Period (MP)|Death|0|||
19667580|NCT00410410|42115849|FG005|Maintenance Period (MP)|Death|0|||
19667581|NCT00410410|42115850|FG006|Maintenance Period (MP)|Death|1|||
19667582|NCT00410410|42115851|FG007|Maintenance Period (MP)|Death|0|||
19667583|NCT00410410|42115852|FG008|Maintenance Period (MP)|Death|0|||
19667584|NCT00410410|42115844|FG000|Maintenance Period (MP)|Adverse Event|0|||
19667585|NCT00410410|42115845|FG001|Maintenance Period (MP)|Adverse Event|0|||
19667586|NCT00410410|42115846|FG002|Maintenance Period (MP)|Adverse Event|0|||
19667587|NCT00410410|42115847|FG003|Maintenance Period (MP)|Adverse Event|0|||
19667588|NCT00410410|42115848|FG004|Maintenance Period (MP)|Adverse Event|0|||
19667589|NCT00410410|42115849|FG005|Maintenance Period (MP)|Adverse Event|0|||
19667590|NCT00410410|42115850|FG006|Maintenance Period (MP)|Adverse Event|1|||
19667591|NCT00410410|42115851|FG007|Maintenance Period (MP)|Adverse Event|3|||
19667592|NCT00410410|42115852|FG008|Maintenance Period (MP)|Adverse Event|0|||
19667593|NCT00410410|42115844|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
19667594|NCT00410410|42115845|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
19667595|NCT00410410|42115846|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
19667596|NCT00410410|42115847|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
19667597|NCT00410410|42115848|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
19667598|NCT00410410|42115849|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
19667599|NCT00410410|42115850|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
19667600|NCT00410410|42115851|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
19667601|NCT00410410|42115852|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
19667602|NCT00410410|42115844|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
19667603|NCT00410410|42115845|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
19667604|NCT00410410|42115846|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
19667605|NCT00410410|42115847|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
19667606|NCT00410410|42115848|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
19667607|NCT00410410|42115849|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
19667608|NCT00410410|42115850|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
19667609|NCT00410410|42115851|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
19667610|NCT00410410|42115852|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
19388781|NCT02544633|41632285|FG000|Treatment Period|Clinical Disease Progression|0|||
19667611|NCT00410410|42115844|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667612|NCT00410410|42115845|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667613|NCT00410410|42115846|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667614|NCT00410410|42115847|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667615|NCT00410410|42115848|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667616|NCT00410410|42115849|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667617|NCT00410410|42115850|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
19667618|NCT00410410|42115851|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
19667619|NCT00410410|42115852|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
19667620|NCT00410410|42115844|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667621|NCT00410410|42115845|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667622|NCT00410410|42115846|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667623|NCT00410410|42115847|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667624|NCT00410410|42115848|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667625|NCT00410410|42115849|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667626|NCT00410410|42115850|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
19667627|NCT00410410|42115851|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
19667628|NCT00410410|42115852|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
19667629|NCT00410410|42115844|FG000|Open-Label Period (OL)|Death|0|||
19667630|NCT00410410|42115845|FG001|Open-Label Period (OL)|Death|0|||
19667631|NCT00410410|42115846|FG002|Open-Label Period (OL)|Death|0|||
19667632|NCT00410410|42115847|FG003|Open-Label Period (OL)|Death|0|||
19667633|NCT00410410|42115848|FG004|Open-Label Period (OL)|Death|0|||
19667634|NCT00410410|42115849|FG005|Open-Label Period (OL)|Death|0|||
19667635|NCT00410410|42115850|FG006|Open-Label Period (OL)|Death|0|||
19667636|NCT00410410|42115851|FG007|Open-Label Period (OL)|Death|0|||
19667637|NCT00410410|42115852|FG008|Open-Label Period (OL)|Death|1|||
19667638|NCT00410410|42115844|FG000|Open-Label Period (OL)|Adverse Event|0|||
19667639|NCT00410410|42115845|FG001|Open-Label Period (OL)|Adverse Event|0|||
19667640|NCT00410410|42115846|FG002|Open-Label Period (OL)|Adverse Event|0|||
19667641|NCT00410410|42115847|FG003|Open-Label Period (OL)|Adverse Event|0|||
19667642|NCT00410410|42115848|FG004|Open-Label Period (OL)|Adverse Event|0|||
19667643|NCT00410410|42115849|FG005|Open-Label Period (OL)|Adverse Event|0|||
19667644|NCT00410410|42115850|FG006|Open-Label Period (OL)|Adverse Event|0|||
19667645|NCT00410410|42115851|FG007|Open-Label Period (OL)|Adverse Event|0|||
19667646|NCT00410410|42115852|FG008|Open-Label Period (OL)|Adverse Event|10|||
19667647|NCT00410410|42115844|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
19667648|NCT00410410|42115845|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
19667649|NCT00410410|42115846|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
19667650|NCT00410410|42115847|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
19667651|NCT00410410|42115848|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
19667652|NCT00410410|42115849|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
19667653|NCT00410410|42115850|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
19667654|NCT00410410|42115851|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
19667655|NCT00410410|42115852|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
19667656|NCT00410410|42115844|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
19667657|NCT00410410|42115845|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
19667658|NCT00410410|42115846|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
19667659|NCT00410410|42115847|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
19667660|NCT00410410|42115848|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
19667661|NCT00410410|42115849|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
19667662|NCT00410410|42115850|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
19667663|NCT00410410|42115851|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
19667664|NCT00410410|42115852|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
19667665|NCT00410410|42115844|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667666|NCT00410410|42115845|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667667|NCT00410410|42115846|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667668|NCT00410410|42115847|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667669|NCT00410410|42115848|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667670|NCT00410410|42115849|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667671|NCT00410410|42115850|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667672|NCT00410410|42115851|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
19667673|NCT00410410|42115852|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
19667674|NCT00410410|42115844|FG000|Open-Label Period (OL)|Pregnancy|0|||
19667675|NCT00410410|42115845|FG001|Open-Label Period (OL)|Pregnancy|0|||
19667676|NCT00410410|42115846|FG002|Open-Label Period (OL)|Pregnancy|0|||
19667677|NCT00410410|42115847|FG003|Open-Label Period (OL)|Pregnancy|0|||
19667678|NCT00410410|42115848|FG004|Open-Label Period (OL)|Pregnancy|0|||
19667679|NCT00410410|42115849|FG005|Open-Label Period (OL)|Pregnancy|0|||
19667680|NCT00410410|42115850|FG006|Open-Label Period (OL)|Pregnancy|0|||
19667681|NCT00410410|42115851|FG007|Open-Label Period (OL)|Pregnancy|0|||
19667682|NCT00410410|42115852|FG008|Open-Label Period (OL)|Pregnancy|1|||
19667683|NCT00410410|42115844|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667684|NCT00410410|42115845|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667685|NCT00410410|42115846|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667686|NCT00410410|42115847|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667687|NCT00410410|42115848|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667688|NCT00410410|42115849|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667689|NCT00410410|42115850|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667690|NCT00410410|42115851|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
19667691|NCT00410410|42115852|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
19667692|NCT00410410|42115844|FG000|Open-Label Period (OL)|Other|0|||
19667693|NCT00410410|42115845|FG001|Open-Label Period (OL)|Other|0|||
19667694|NCT00410410|42115846|FG002|Open-Label Period (OL)|Other|0|||
19667695|NCT00410410|42115847|FG003|Open-Label Period (OL)|Other|0|||
19667696|NCT00410410|42115848|FG004|Open-Label Period (OL)|Other|0|||
19667697|NCT00410410|42115849|FG005|Open-Label Period (OL)|Other|0|||
19667698|NCT00410410|42115850|FG006|Open-Label Period (OL)|Other|0|||
19667699|NCT00410410|42115851|FG007|Open-Label Period (OL)|Other|0|||
19667700|NCT00410410|42115852|FG008|Open-Label Period (OL)|Other|7|||
19667701|NCT00534404|42115890|FG000|Overall Study|Death|0|||
19667702|NCT00534404|42115891|FG001|Overall Study|Death|0|||
19667703|NCT00534404|42115892|FG002|Overall Study|Death|2|||
19667704|NCT00534404|42115890|FG000|Overall Study|Withdrawal by Subject|8|||
19667705|NCT00534404|42115891|FG001|Overall Study|Withdrawal by Subject|2|||
19667706|NCT00534404|42115892|FG002|Overall Study|Withdrawal by Subject|38|||
19667707|NCT00534404|42115890|FG000|Overall Study|Removed by study staff|2|||
19667708|NCT00534404|42115891|FG001|Overall Study|Removed by study staff|3|||
19667709|NCT00534404|42115892|FG002|Overall Study|Removed by study staff|1|||
19667710|NCT00534404|42115890|FG000|Overall Study|Lost to Follow-up|170|||
19667711|NCT00534404|42115891|FG001|Overall Study|Lost to Follow-up|138|||
19667712|NCT00534404|42115892|FG002|Overall Study|Lost to Follow-up|201|||
19667713|NCT00393094|42115900|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
19667714|NCT00393094|42115900|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
19667715|NCT00409786|42115906|FG000|Overall Study|Withdrawal by Subject|3|||
19667716|NCT00409708|42115912|FG000|Treatment|Abnormal test procedure result(s)|1|||
19667717|NCT00409708|42115913|FG001|Treatment|Abnormal test procedure result(s)|0|||
19667718|NCT00409708|42115912|FG000|Treatment|Lack of Efficacy|0|||
19667719|NCT00409708|42115913|FG001|Treatment|Lack of Efficacy|1|||
19667720|NCT00409708|42115912|FG000|Treatment|Protocol Violation|6|||
19667721|NCT00409708|42115913|FG001|Treatment|Protocol Violation|2|||
19667722|NCT00409708|42115912|FG000|Treatment|Withdrawal by Subject|3|||
19667723|NCT00409708|42115913|FG001|Treatment|Withdrawal by Subject|8|||
19667724|NCT00409708|42115912|FG000|Treatment|Lost to Follow-up|0|||
19667725|NCT00409708|42115913|FG001|Treatment|Lost to Follow-up|6|||
19667726|NCT00409708|42115912|FG000|Treatment|Administrative problems|5|||
19667727|NCT00409708|42115913|FG001|Treatment|Administrative problems|0|||
19667728|NCT00409708|42115912|FG000|Washout|Lack of Efficacy|9|||
19667729|NCT00409708|42115913|FG001|Washout|Lack of Efficacy|1|||
19667730|NCT00409708|42115912|FG000|Washout|Protocol Violation|0|||
19667731|NCT00409708|42115913|FG001|Washout|Protocol Violation|1|||
19667732|NCT00409708|42115912|FG000|Washout|Withdrawal by Subject|11|||
19667733|NCT00409708|42115913|FG001|Washout|Withdrawal by Subject|5|||
19667734|NCT00409708|42115912|FG000|Washout|Lost to Follow-up|1|||
19667735|NCT00409708|42115913|FG001|Washout|Lost to Follow-up|3|||
19667736|NCT00391846|42115930|FG000|Overall Study|Adverse Event|4|||
19667737|NCT00391846|42115931|FG001|Overall Study|Adverse Event|1|||
19667738|NCT00391846|42115930|FG000|Overall Study|Did not meet the required elig. crit|2|||
19667739|NCT00391846|42115931|FG001|Overall Study|Did not meet the required elig. crit|2|||
19667740|NCT00391846|42115930|FG000|Overall Study|Withdrawal by Subject|2|||
19667741|NCT00391846|42115931|FG001|Overall Study|Withdrawal by Subject|3|||
19667742|NCT00391846|42115930|FG000|Overall Study|Developed study specific DC criteria|0|||
19602791|NCT01014689|42051527|FG000|Overall Study|Withdrawal by Subject|5|||
19602792|NCT01014689|42051528|FG001|Overall Study|Withdrawal by Subject|4|||
19602793|NCT01014689|42051527|FG000|Overall Study|Protocol Violation|1|||
19602794|NCT01014689|42051528|FG001|Overall Study|Protocol Violation|1|||
19602795|NCT01014689|42051527|FG000|Overall Study|Lost to Follow-up|3|||
19602796|NCT01014689|42051528|FG001|Overall Study|Lost to Follow-up|7|||
19602797|NCT01014689|42051527|FG000|Overall Study|Pregnancy|1|||
19602798|NCT01014689|42051528|FG001|Overall Study|Pregnancy|0|||
19602799|NCT01014533|42051536|FG000|Overall Study|Protocol Violation|3|||
19602800|NCT01014533|42051537|FG001|Overall Study|Protocol Violation|2|||
19602801|NCT01014533|42051536|FG000|Overall Study|Withdrawal by Subject|2|||
19602802|NCT01014533|42051537|FG001|Overall Study|Withdrawal by Subject|0|||
19602803|NCT01014533|42051536|FG000|Overall Study|unable to come to appointment|0|||
19602804|NCT01014533|42051537|FG001|Overall Study|unable to come to appointment|3|||
19602805|NCT01014143|42051560|FG000|Second Intervention|Lost to Follow-up|2|||
19602806|NCT01014143|42051561|FG001|Second Intervention|Lost to Follow-up|0|||
19602807|NCT01014143|42051562|FG002|Second Intervention|Lost to Follow-up|0|||
19602808|NCT01013753|42051570|FG000|Overall Study|Adverse Event|8|||
19602809|NCT01013753|42051570|FG000|Overall Study|Protocol Violation|3|||
19602810|NCT01013753|42051570|FG000|Overall Study|Lost to Follow-up|1|||
19602811|NCT01013753|42051570|FG000|Overall Study|Withdrawal by Subject|2|||
19602812|NCT01013753|42051570|FG000|Overall Study|Other|2|||
19602813|NCT00757042|42051595|FG000|Overall Study|Lost to Follow-up|0|||
19602814|NCT00757042|42051596|FG001|Overall Study|Lost to Follow-up|0|||
19602815|NCT00757042|42051597|FG002|Overall Study|Lost to Follow-up|0|||
19602816|NCT00757042|42051598|FG003|Overall Study|Lost to Follow-up|0|||
19602817|NCT00757042|42051599|FG004|Overall Study|Lost to Follow-up|0|||
19602818|NCT00757042|42051600|FG005|Overall Study|Lost to Follow-up|0|||
19602819|NCT00757042|42051601|FG006|Overall Study|Lost to Follow-up|0|||
19602820|NCT00757042|42051602|FG007|Overall Study|Lost to Follow-up|0|||
19667743|NCT00391846|42115931|FG001|Overall Study|Developed study specific DC criteria|1|||
19667744|NCT00534248|42115956|FG000|Overall Study|Adverse Event|19|||
19667745|NCT00534248|42115957|FG001|Overall Study|Adverse Event|29|||
19667746|NCT00534248|42115956|FG000|Overall Study|Lost to Follow-up|353|||
19602821|NCT00757042|42051603|FG008|Overall Study|Lost to Follow-up|1|||
19667747|NCT00534248|42115957|FG001|Overall Study|Lost to Follow-up|375|||
19667748|NCT00534248|42115956|FG000|Overall Study|Other protocol specified criteria|13|||
19667749|NCT00534248|42115957|FG001|Overall Study|Other protocol specified criteria|3|||
19667750|NCT00534248|42115956|FG000|Overall Study|Physician Decision|10|||
19667751|NCT00534248|42115957|FG001|Overall Study|Physician Decision|7|||
19667752|NCT00534248|42115956|FG000|Overall Study|Protocol Violation|3|||
19667753|NCT00534248|42115957|FG001|Overall Study|Protocol Violation|4|||
19667754|NCT00534248|42115956|FG000|Overall Study|Withdrawal by Subject|263|||
19667755|NCT00534248|42115957|FG001|Overall Study|Withdrawal by Subject|255|||
19667756|NCT00391768|42115970|FG000|Overall Study|Withdrawal by Subject|0|||
19667757|NCT00391768|42115971|FG001|Overall Study|Withdrawal by Subject|0|||
19667758|NCT00391768|42115972|FG002|Overall Study|Withdrawal by Subject|1|||
19602822|NCT00757042|42051604|FG009|Overall Study|Lost to Follow-up|0|||
19602823|NCT00757042|42051605|FG010|Overall Study|Lost to Follow-up|0|||
19602824|NCT00757042|42051595|FG000|Overall Study|Ineligibility Determined|0|||
19602825|NCT00757042|42051596|FG001|Overall Study|Ineligibility Determined|0|||
19602826|NCT00757042|42051597|FG002|Overall Study|Ineligibility Determined|0|||
19667759|NCT00391768|42115973|FG003|Overall Study|Withdrawal by Subject|0|||
19667760|NCT00391768|42115974|FG004|Overall Study|Withdrawal by Subject|0|||
19667761|NCT00391768|42115975|FG005|Overall Study|Withdrawal by Subject|1|||
19667762|NCT00391768|42115976|FG006|Overall Study|Withdrawal by Subject|1|||
19667763|NCT00391768|42115970|FG000|Overall Study|Lost to Follow-up|0|||
19667764|NCT00391768|42115971|FG001|Overall Study|Lost to Follow-up|0|||
19667765|NCT00391768|42115972|FG002|Overall Study|Lost to Follow-up|0|||
19667766|NCT00391768|42115973|FG003|Overall Study|Lost to Follow-up|1|||
19667767|NCT00391768|42115974|FG004|Overall Study|Lost to Follow-up|2|||
19667768|NCT00391768|42115975|FG005|Overall Study|Lost to Follow-up|2|||
19667769|NCT00391768|42115976|FG006|Overall Study|Lost to Follow-up|3|||
19667770|NCT00391222|42116013|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
19667771|NCT00391222|42116014|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
19667772|NCT00391222|42116015|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
19667773|NCT00391222|42116016|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
19667774|NCT00391222|42116013|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
19667775|NCT00391222|42116014|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
19667776|NCT00391222|42116015|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
19667777|NCT00391222|42116016|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
19667778|NCT00391222|42116013|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
19667779|NCT00391222|42116014|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
19667780|NCT00391222|42116015|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
19667781|NCT00391222|42116016|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
19667782|NCT00391222|42116013|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
19667783|NCT00391222|42116014|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
19667784|NCT00391222|42116015|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
19667785|NCT00391222|42116016|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
19667786|NCT00391222|42116013|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
19667787|NCT00391222|42116014|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
19667788|NCT00391222|42116015|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
19667789|NCT00391222|42116016|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
19667790|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
19667791|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
19667792|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
19667793|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
19667794|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
19667795|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
19667796|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
19667797|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
19667798|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
19667799|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
19667800|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
19667801|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
19667802|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
19667803|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
19667804|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
19667805|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
19667806|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
19667807|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
19667808|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
19667809|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
19667810|NCT00391222|42116013|FG000|Period III (Double-Blind Treatment)|Other|6|||
19667811|NCT00391222|42116014|FG001|Period III (Double-Blind Treatment)|Other|1|||
19667812|NCT00391222|42116015|FG002|Period III (Double-Blind Treatment)|Other|6|||
19667813|NCT00391222|42116016|FG003|Period III (Double-Blind Treatment)|Other|0|||
19667814|NCT00409006|42116028|FG000|Overall Study|Death|15|||
19667815|NCT00409006|42116029|FG001|Overall Study|Death|6|||
19667816|NCT00409006|42116028|FG000|Overall Study|Lost to Follow-up|1|||
19667817|NCT00409006|42116029|FG001|Overall Study|Lost to Follow-up|2|||
19667818|NCT00409006|42116028|FG000|Overall Study|Withdrawal by Subject|3|||
19667819|NCT00409006|42116029|FG001|Overall Study|Withdrawal by Subject|2|||
19667820|NCT00409006|42116028|FG000|Overall Study|Physician Decision|1|||
19667821|NCT00409006|42116029|FG001|Overall Study|Physician Decision|2|||
19667822|NCT00534092|42116037|FG000|Overall Study|Lost to Follow-up|1|||
19667823|NCT00534092|42116038|FG001|Overall Study|Lost to Follow-up|0|||
19667824|NCT00534092|42116037|FG000|Overall Study|personal reasons/family concerns|1|||
19667825|NCT00534092|42116038|FG001|Overall Study|personal reasons/family concerns|0|||
19667826|NCT00408928|42116046|FG000|Overall Study|Withdrawal by Subject|1|||
19667827|NCT00408928|42116046|FG000|Overall Study|Death|1|||
19667828|NCT00408928|42116046|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
19667829|NCT00390910|42116053|FG000|Overall Study|Adverse Event|1|||
19667830|NCT00390910|42116054|FG001|Overall Study|Adverse Event|0|||
19667831|NCT00390910|42116055|FG002|Overall Study|Adverse Event|0|||
19667832|NCT00390910|42116053|FG000|Overall Study|Lost to Follow-up|0|||
19667833|NCT00390910|42116054|FG001|Overall Study|Lost to Follow-up|1|||
19667834|NCT00390910|42116055|FG002|Overall Study|Lost to Follow-up|5|||
19667835|NCT00390910|42116053|FG000|Overall Study|Withdrawal by Subject|1|||
19667836|NCT00390910|42116054|FG001|Overall Study|Withdrawal by Subject|3|||
19667837|NCT00390910|42116055|FG002|Overall Study|Withdrawal by Subject|2|||
19667838|NCT00390910|42116053|FG000|Overall Study|Migrated/moved from study area|0|||
19667839|NCT00390910|42116054|FG001|Overall Study|Migrated/moved from study area|0|||
19667840|NCT00390910|42116055|FG002|Overall Study|Migrated/moved from study area|3|||
19667841|NCT00533702|42116067|FG000|Overall Study|Withdrawal by Subject|3|||
19667842|NCT00533702|42116068|FG001|Overall Study|Withdrawal by Subject|1|||
19667843|NCT00533702|42116067|FG000|Overall Study|Found ineligible after randomization|2|||
19667844|NCT00533702|42116068|FG001|Overall Study|Found ineligible after randomization|1|||
19667845|NCT00408694|42116074|FG000|Overall Study|Ineligible|1|||
19667846|NCT00408694|42116074|FG000|Overall Study|No protocol treatment|1|||
19667847|NCT00396136|42116078|FG000|Overall Study|Death|43|||
19667848|NCT00396136|42116078|FG000|Overall Study|Withdrawal by Subject|59|||
19667849|NCT00396136|42116078|FG000|Overall Study|Lost to Follow-up|15|||
19667850|NCT00396136|42116078|FG000|Overall Study|Study device explanted|8|||
19667851|NCT00530894|42116086|FG000|Overall Study|Death|84|||
19667852|NCT00530894|42116087|FG001|Overall Study|Death|89|||
19667853|NCT00530894|42116088|FG002|Overall Study|Death|55|||
19667854|NCT00530894|42116089|FG003|Overall Study|Death|89|||
19667855|NCT00530894|42116086|FG000|Overall Study|Lost to Follow-up|1|||
19667856|NCT00530894|42116087|FG001|Overall Study|Lost to Follow-up|3|||
19667857|NCT00530894|42116088|FG002|Overall Study|Lost to Follow-up|0|||
19667858|NCT00530894|42116089|FG003|Overall Study|Lost to Follow-up|0|||
19667859|NCT00530894|42116086|FG000|Overall Study|Withdrawal by Subject|1|||
19667860|NCT00530894|42116087|FG001|Overall Study|Withdrawal by Subject|23|||
19667861|NCT00530894|42116088|FG002|Overall Study|Withdrawal by Subject|0|||
19667862|NCT00530894|42116089|FG003|Overall Study|Withdrawal by Subject|5|||
19667863|NCT00530894|42116086|FG000|Overall Study|Alive and censored prior to 1 year|2|||
19667864|NCT00530894|42116087|FG001|Overall Study|Alive and censored prior to 1 year|0|||
19667865|NCT00530894|42116088|FG002|Overall Study|Alive and censored prior to 1 year|0|||
19667866|NCT00530894|42116089|FG003|Overall Study|Alive and censored prior to 1 year|0|||
19667867|NCT00056407|42116103|FG000|Overall Study|Adverse Event|282|||
19667868|NCT00056407|42116104|FG001|Overall Study|Adverse Event|364|||
19667869|NCT00056407|42116103|FG000|Overall Study|Withdrawal by Subject|377|||
19667870|NCT00056407|42116104|FG001|Overall Study|Withdrawal by Subject|361|||
19667871|NCT00056407|42116103|FG000|Overall Study|Lost to Follow-up|123|||
19667872|NCT00056407|42116104|FG001|Overall Study|Lost to Follow-up|113|||
19667873|NCT00056407|42116103|FG000|Overall Study|Protocol Violation|104|||
19667874|NCT00056407|42116104|FG001|Overall Study|Protocol Violation|95|||
19667875|NCT00056407|42116103|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
19667876|NCT00056407|42116104|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
19667877|NCT00056407|42116103|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
19667878|NCT00056407|42116104|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
19667879|NCT00056407|42116103|FG000|Overall Study|Missing|25|||
19667880|NCT00056407|42116104|FG001|Overall Study|Missing|34|||
19667881|NCT00388726|42116112|FG000|Overall Study|Adverse Event|50|||
19667882|NCT00388726|42116113|FG001|Overall Study|Adverse Event|24|||
19667883|NCT00388726|42116112|FG000|Overall Study|Progressive Disease|336|||
19667884|NCT00388726|42116113|FG001|Overall Study|Progressive Disease|153|||
19667885|NCT00388726|42116112|FG000|Overall Study|Clinical Progression|61|||
19667886|NCT00388726|42116113|FG001|Overall Study|Clinical Progression|36|||
19667887|NCT00388726|42116112|FG000|Overall Study|Withdrawal by Subject|10|||
19667888|NCT00388726|42116113|FG001|Overall Study|Withdrawal by Subject|7|||
19667889|NCT00388726|42116112|FG000|Overall Study|Administrative|6|||
19667890|NCT00388726|42116113|FG001|Overall Study|Administrative|9|||
19667891|NCT00388726|42116112|FG000|Overall Study|Physician Decision|18|||
19667892|NCT00388726|42116113|FG001|Overall Study|Physician Decision|13|||
19667893|NCT00388726|42116112|FG000|Overall Study|Death|3|||
19667894|NCT00388726|42116113|FG001|Overall Study|Death|2|||
19667895|NCT00387790|42116119|FG000|Overall Study|Adverse Event|5|||
19667896|NCT00387790|42116119|FG000|Overall Study|Lack of Efficacy|2|||
19667897|NCT00387790|42116119|FG000|Overall Study|Physician Decision|2|||
19667898|NCT00387790|42116119|FG000|Overall Study|Withdrawal by Subject|3|||
19667899|NCT00387790|42116119|FG000|Overall Study|Ineligible for study|2|||
19667900|NCT00073021|42116125|FG000|Overall Study|Protocol Violation|2|||
19667901|NCT00073021|42116126|FG001|Overall Study|Protocol Violation|1|||
19667902|NCT00073021|42116125|FG000|Overall Study|Adverse Event|4|||
19667903|NCT00073021|42116126|FG001|Overall Study|Adverse Event|4|||
19667904|NCT00073021|42116125|FG000|Overall Study|Withdrawal by Subject|6|||
19667905|NCT00073021|42116126|FG001|Overall Study|Withdrawal by Subject|5|||
19667906|NCT00073021|42116125|FG000|Overall Study|Physician Decision|3|||
19667907|NCT00073021|42116126|FG001|Overall Study|Physician Decision|1|||
19667908|NCT00073021|42116125|FG000|Overall Study|Lack of Efficacy|11|||
19667909|NCT00073021|42116126|FG001|Overall Study|Lack of Efficacy|5|||
19756954|NCT04634409|42207625|FG003|Overall Study|Adverse Event|0|||
19756955|NCT04634409|42207626|FG004|Overall Study|Adverse Event|0|||
19756956|NCT04634409|42207627|FG005|Overall Study|Adverse Event|1|||
19756957|NCT04634409|42207628|FG006|Overall Study|Adverse Event|0|||
19756958|NCT04634409|42207629|FG007|Overall Study|Adverse Event|0|||
19756959|NCT04634409|42207630|FG008|Overall Study|Adverse Event|0|||
19756960|NCT04634409|42207631|FG009|Overall Study|Adverse Event|0|||
19756961|NCT04634409|42207632|FG010|Overall Study|Adverse Event|0|||
19756962|NCT04634409|42207633|FG011|Overall Study|Adverse Event|0|||
19756963|NCT04634409|42207634|FG012|Overall Study|Adverse Event|0|||
19756964|NCT04634409|42207635|FG013|Overall Study|Adverse Event|0|||
19756965|NCT04634409|42207636|FG014|Overall Study|Adverse Event|0|||
19756966|NCT04634409|42207637|FG015|Overall Study|Adverse Event|0|||
19756967|NCT04634409|42207638|FG016|Overall Study|Adverse Event|0|||
19756968|NCT04634409|42207639|FG017|Overall Study|Adverse Event|0|||
19756969|NCT04634409|42207640|FG018|Overall Study|Adverse Event|0|||
19756970|NCT04634409|42207641|FG019|Overall Study|Adverse Event|0|||
19756971|NCT04634409|42207642|FG020|Overall Study|Adverse Event|0|||
19756972|NCT04634409|42207643|FG021|Overall Study|Adverse Event|0|||
19756973|NCT04634409|42207644|FG022|Overall Study|Adverse Event|0|||
19756974|NCT04634409|42207645|FG023|Overall Study|Adverse Event|0|||
19756975|NCT04634409|42207646|FG024|Overall Study|Adverse Event|0|||
19602827|NCT00757042|42051598|FG003|Overall Study|Ineligibility Determined|0|||
19602828|NCT00757042|42051599|FG004|Overall Study|Ineligibility Determined|0|||
19667910|NCT00407758|42116132|FG000|Overall Study|ineligible -improper prior treatment|1|||
19602829|NCT00757042|42051600|FG005|Overall Study|Ineligibility Determined|0|||
19667911|NCT00531752|42116140|FG000|First Double-blind Intervention Period|Adverse Event|2|||
19667912|NCT00531752|42116141|FG001|First Double-blind Intervention Period|Adverse Event|0|||
19667913|NCT00531752|42116142|FG002|First Double-blind Intervention Period|Adverse Event|1|||
19602830|NCT00757042|42051601|FG006|Overall Study|Ineligibility Determined|0|||
19602831|NCT00757042|42051602|FG007|Overall Study|Ineligibility Determined|0|||
19602832|NCT00757042|42051603|FG008|Overall Study|Ineligibility Determined|0|||
19602833|NCT00757042|42051604|FG009|Overall Study|Ineligibility Determined|0|||
19602834|NCT00757042|42051605|FG010|Overall Study|Ineligibility Determined|1|||
19602835|NCT00757042|42051595|FG000|Overall Study|Withdrawal by Subject|0|||
19602836|NCT00757042|42051596|FG001|Overall Study|Withdrawal by Subject|0|||
19602837|NCT00757042|42051597|FG002|Overall Study|Withdrawal by Subject|0|||
19602838|NCT00757042|42051598|FG003|Overall Study|Withdrawal by Subject|0|||
19602839|NCT00757042|42051599|FG004|Overall Study|Withdrawal by Subject|0|||
19602840|NCT00757042|42051600|FG005|Overall Study|Withdrawal by Subject|0|||
19602841|NCT00757042|42051601|FG006|Overall Study|Withdrawal by Subject|0|||
19602842|NCT00757042|42051602|FG007|Overall Study|Withdrawal by Subject|0|||
19602843|NCT00757042|42051603|FG008|Overall Study|Withdrawal by Subject|0|||
19602844|NCT00757042|42051604|FG009|Overall Study|Withdrawal by Subject|1|||
19602845|NCT00757042|42051605|FG010|Overall Study|Withdrawal by Subject|0|||
19602846|NCT01013597|42051636|FG000|Overall Study|Withdrawal by Subject|1|||
19602847|NCT01013285|42051655|FG000|Overall Study|Death|48|||
19602848|NCT01013285|42051656|FG001|Overall Study|Death|89|||
19602849|NCT01033643|42051666|FG000|Overall Study|Withdrew Consent|0|||
19602850|NCT01033643|42051667|FG001|Overall Study|Withdrew Consent|3|||
19602851|NCT01033643|42051668|FG002|Overall Study|Withdrew Consent|0|||
19602852|NCT01033643|42051669|FG003|Overall Study|Withdrew Consent|0|||
19602853|NCT01033643|42051670|FG004|Overall Study|Withdrew Consent|0|||
19602854|NCT01033643|42051671|FG005|Overall Study|Withdrew Consent|1|||
19602855|NCT01013207|42051685|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
19602856|NCT01033487|42051689|FG000|Fourth Intervention Period|Adverse Event|0|||
19602857|NCT01033487|42051690|FG001|Fourth Intervention Period|Adverse Event|0|||
19602858|NCT01033487|42051691|FG002|Fourth Intervention Period|Adverse Event|0|||
19602859|NCT01033487|42051692|FG003|Fourth Intervention Period|Adverse Event|0|||
19602860|NCT01033487|42051693|FG004|Fourth Intervention Period|Adverse Event|0|||
19602861|NCT01033487|42051694|FG005|Fourth Intervention Period|Adverse Event|0|||
19602862|NCT01033487|42051695|FG006|Fourth Intervention Period|Adverse Event|0|||
19667914|NCT00531752|42116143|FG003|First Double-blind Intervention Period|Adverse Event|1|||
19667915|NCT00531752|42116140|FG000|First Double-blind Intervention Period|Other|1|||
19602863|NCT01033487|42051696|FG007|Fourth Intervention Period|Adverse Event|0|||
19756976|NCT04634409|42207647|FG025|Overall Study|Adverse Event|0|||
19756977|NCT04634409|42207648|FG026|Overall Study|Adverse Event|0|||
19756978|NCT04634409|42207622|FG000|Overall Study|Lost to Follow-up|3|||
19667916|NCT00531752|42116141|FG001|First Double-blind Intervention Period|Other|4|||
19756979|NCT04634409|42207623|FG001|Overall Study|Lost to Follow-up|1|||
19667917|NCT00531752|42116142|FG002|First Double-blind Intervention Period|Other|4|||
19667918|NCT00531752|42116143|FG003|First Double-blind Intervention Period|Other|0|||
19667919|NCT00531752|42116140|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
19756980|NCT04634409|42207624|FG002|Overall Study|Lost to Follow-up|1|||
19667920|NCT00531752|42116141|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
19667921|NCT00531752|42116142|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
19667922|NCT00531752|42116143|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
19667923|NCT00531752|42116140|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
19667924|NCT00531752|42116141|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
19667925|NCT00531752|42116142|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
19667926|NCT00531752|42116143|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
19667927|NCT00531752|42116140|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
19667928|NCT00531752|42116141|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
19667929|NCT00531752|42116142|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
19756981|NCT04634409|42207625|FG003|Overall Study|Lost to Follow-up|3|||
19756982|NCT04634409|42207626|FG004|Overall Study|Lost to Follow-up|1|||
19756983|NCT04634409|42207627|FG005|Overall Study|Lost to Follow-up|1|||
19756984|NCT04634409|42207628|FG006|Overall Study|Lost to Follow-up|1|||
19756985|NCT04634409|42207629|FG007|Overall Study|Lost to Follow-up|3|||
19667930|NCT00531752|42116143|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
19667931|NCT00531752|42116140|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
19667932|NCT00531752|42116141|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
19667933|NCT00531752|42116142|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
19667934|NCT00531752|42116143|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
19667935|NCT00531752|42116140|FG000|Second Double-blind Intervention Period|Other|1|||
19756986|NCT04634409|42207630|FG008|Overall Study|Lost to Follow-up|3|||
19756987|NCT04634409|42207631|FG009|Overall Study|Lost to Follow-up|11|||
19756988|NCT04634409|42207632|FG010|Overall Study|Lost to Follow-up|8|||
19756989|NCT04634409|42207633|FG011|Overall Study|Lost to Follow-up|15|||
19756990|NCT04634409|42207634|FG012|Overall Study|Lost to Follow-up|3|||
19756991|NCT04634409|42207635|FG013|Overall Study|Lost to Follow-up|2|||
19756992|NCT04634409|42207636|FG014|Overall Study|Lost to Follow-up|7|||
19756993|NCT04634409|42207637|FG015|Overall Study|Lost to Follow-up|0|||
19756994|NCT04634409|42207638|FG016|Overall Study|Lost to Follow-up|0|||
19756995|NCT04634409|42207639|FG017|Overall Study|Lost to Follow-up|0|||
19667936|NCT00531752|42116141|FG001|Second Double-blind Intervention Period|Other|1|||
19667937|NCT00531752|42116142|FG002|Second Double-blind Intervention Period|Other|0|||
19667938|NCT00531752|42116143|FG003|Second Double-blind Intervention Period|Other|0|||
19667939|NCT00531752|42116140|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
19667940|NCT00531752|42116141|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
19667941|NCT00531752|42116142|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
19667942|NCT00531752|42116143|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
19667943|NCT00531752|42116140|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
19667944|NCT00531752|42116141|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
19667945|NCT00531752|42116142|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
19667946|NCT00531752|42116143|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
19667947|NCT00395746|42116154|FG000|Overall Study|Adverse Event|5|||
19667948|NCT00395746|42116155|FG001|Overall Study|Adverse Event|2|||
19667949|NCT00395746|42116156|FG002|Overall Study|Adverse Event|2|||
19667950|NCT00395746|42116154|FG000|Overall Study|Protocol Violation|0|||
19667951|NCT00395746|42116155|FG001|Overall Study|Protocol Violation|1|||
19667952|NCT00395746|42116156|FG002|Overall Study|Protocol Violation|0|||
19667953|NCT00395746|42116154|FG000|Overall Study|Lack of Efficacy|2|||
19667954|NCT00395746|42116155|FG001|Overall Study|Lack of Efficacy|0|||
19667955|NCT00395746|42116156|FG002|Overall Study|Lack of Efficacy|17|||
19756996|NCT04634409|42207640|FG018|Overall Study|Lost to Follow-up|0|||
19667956|NCT00395746|42116154|FG000|Overall Study|Hypoglycaemia|2|||
19667957|NCT00395746|42116155|FG001|Overall Study|Hypoglycaemia|1|||
19667958|NCT00395746|42116156|FG002|Overall Study|Hypoglycaemia|0|||
19667959|NCT00395746|42116154|FG000|Overall Study|Subject decision|0|||
19667960|NCT00395746|42116155|FG001|Overall Study|Subject decision|0|||
19667961|NCT00395746|42116156|FG002|Overall Study|Subject decision|1|||
19667962|NCT00395746|42116154|FG000|Overall Study|Withdrawal of consent|0|||
19667963|NCT00395746|42116155|FG001|Overall Study|Withdrawal of consent|0|||
19667964|NCT00395746|42116156|FG002|Overall Study|Withdrawal of consent|1|||
19667965|NCT00395746|42116154|FG000|Overall Study|Difficultulty in use of device|0|||
19667966|NCT00395746|42116155|FG001|Overall Study|Difficultulty in use of device|0|||
19756997|NCT04634409|42207641|FG019|Overall Study|Lost to Follow-up|0|||
19756998|NCT04634409|42207642|FG020|Overall Study|Lost to Follow-up|0|||
19756999|NCT04634409|42207643|FG021|Overall Study|Lost to Follow-up|0|||
19757000|NCT04634409|42207644|FG022|Overall Study|Lost to Follow-up|0|||
19757001|NCT04634409|42207645|FG023|Overall Study|Lost to Follow-up|0|||
19757002|NCT04634409|42207646|FG024|Overall Study|Lost to Follow-up|0|||
19667967|NCT00395746|42116156|FG002|Overall Study|Difficultulty in use of device|1|||
19667968|NCT00395746|42116154|FG000|Overall Study|Unable to visit site on schedule|1|||
19667969|NCT00395746|42116155|FG001|Overall Study|Unable to visit site on schedule|0|||
19667970|NCT00395746|42116156|FG002|Overall Study|Unable to visit site on schedule|0|||
19667971|NCT00055471|42116167|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
19667972|NCT00055471|42116168|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
19667973|NCT00055471|42116169|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
19667974|NCT00055471|42116167|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
19667975|NCT00055471|42116168|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
19667976|NCT00055471|42116169|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
19667977|NCT00055471|42116167|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
19667978|NCT00055471|42116168|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
19667979|NCT00055471|42116169|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
19667980|NCT00395512|42116181|FG000|Overall Study|Adverse Event|3|||
19667981|NCT00395512|42116182|FG001|Overall Study|Adverse Event|8|||
19667982|NCT00395512|42116183|FG002|Overall Study|Adverse Event|6|||
19667983|NCT00395512|42116184|FG003|Overall Study|Adverse Event|6|||
19667984|NCT00395512|42116181|FG000|Overall Study|Protocol Violation|2|||
19667985|NCT00395512|42116182|FG001|Overall Study|Protocol Violation|3|||
19667986|NCT00395512|42116183|FG002|Overall Study|Protocol Violation|6|||
19667987|NCT00395512|42116184|FG003|Overall Study|Protocol Violation|7|||
19667988|NCT00395512|42116181|FG000|Overall Study|Lost to Follow-up|2|||
19667989|NCT00395512|42116182|FG001|Overall Study|Lost to Follow-up|6|||
19667990|NCT00395512|42116183|FG002|Overall Study|Lost to Follow-up|5|||
19667991|NCT00395512|42116184|FG003|Overall Study|Lost to Follow-up|5|||
19667992|NCT00395512|42116181|FG000|Overall Study|Withdrawal by Subject|6|||
19667993|NCT00395512|42116182|FG001|Overall Study|Withdrawal by Subject|5|||
19667994|NCT00395512|42116183|FG002|Overall Study|Withdrawal by Subject|5|||
19667995|NCT00395512|42116184|FG003|Overall Study|Withdrawal by Subject|12|||
19667996|NCT00395512|42116181|FG000|Overall Study|Physician Decision|6|||
19667997|NCT00395512|42116182|FG001|Overall Study|Physician Decision|4|||
19667998|NCT00395512|42116183|FG002|Overall Study|Physician Decision|2|||
19667999|NCT00395512|42116184|FG003|Overall Study|Physician Decision|2|||
19668000|NCT00395512|42116181|FG000|Overall Study|Other|1|||
19668001|NCT00395512|42116182|FG001|Overall Study|Other|1|||
19668002|NCT00395512|42116183|FG002|Overall Study|Other|0|||
19668003|NCT00395512|42116184|FG003|Overall Study|Other|0|||
19668004|NCT00395512|42116181|FG000|Overall Study|Hyperglycemic Rescue|18|||
19668005|NCT00395512|42116182|FG001|Overall Study|Hyperglycemic Rescue|10|||
19668006|NCT00395512|42116183|FG002|Overall Study|Hyperglycemic Rescue|4|||
19668007|NCT00395512|42116184|FG003|Overall Study|Hyperglycemic Rescue|6|||
19668008|NCT00054691|42116194|FG000|Overall Study|Unmeasurable Disease|2|||
19668009|NCT00054691|42116194|FG000|Overall Study|Noncompliant|1|||
19668010|NCT00387712|42116200|FG000|Overall Study|Physician Decision|6|||
19668011|NCT00387712|42116201|FG001|Overall Study|Physician Decision|4|||
19668012|NCT00387712|42116200|FG000|Overall Study|Lost to Follow-up|17|||
19668013|NCT00387712|42116201|FG001|Overall Study|Lost to Follow-up|20|||
19668014|NCT00387712|42116200|FG000|Overall Study|Withdrawal by Subject|6|||
19668015|NCT00387712|42116201|FG001|Overall Study|Withdrawal by Subject|12|||
19668016|NCT00066703|42116209|FG000|Overall Study|Adverse Event|80|||
19668017|NCT00066703|42116210|FG001|Overall Study|Adverse Event|111|||
19668018|NCT00066703|42116209|FG000|Overall Study|Death|3|||
19668019|NCT00066703|42116210|FG001|Overall Study|Death|0|||
19668020|NCT00066703|42116209|FG000|Overall Study|Lack of Efficacy|114|||
19668021|NCT00066703|42116210|FG001|Overall Study|Lack of Efficacy|69|||
19668022|NCT00066703|42116209|FG000|Overall Study|Lost to Follow-up|31|||
19668023|NCT00066703|42116210|FG001|Overall Study|Lost to Follow-up|28|||
19668024|NCT00066703|42116209|FG000|Overall Study|Withdrawal by Subject|38|||
19668025|NCT00066703|42116210|FG001|Overall Study|Withdrawal by Subject|63|||
19668026|NCT00066703|42116209|FG000|Overall Study|Treatment ongoing|346|||
19668027|NCT00066703|42116210|FG001|Overall Study|Treatment ongoing|311|||
19668028|NCT00072475|42116216|FG000|Overall Study|Adverse Event|44|||
19668029|NCT00072475|42116216|FG000|Overall Study|Death|3|||
19668030|NCT00072475|42116216|FG000|Overall Study|Withdrawal by Subject|46|||
19668031|NCT00072475|42116216|FG000|Overall Study|Patient/Investigator Decision|4|||
19668032|NCT00066469|42116220|FG000|Overall Study|Death|3|||
19668033|NCT00066469|42116220|FG000|Overall Study|Lack of Efficacy|9|||
19668034|NCT00066469|42116220|FG000|Overall Study|Lost to Follow-up|1|||
19668035|NCT00066469|42116220|FG000|Overall Study|Physician Decision|1|||
19668036|NCT00066469|42116220|FG000|Overall Study|Withdrawal by Subject|1|||
19668037|NCT00066469|42116220|FG000|Overall Study|ineligible|1|||
19757003|NCT04634409|42207647|FG025|Overall Study|Lost to Follow-up|0|||
19668038|NCT00387088|42116226|FG000|Overall Study|Adverse Event|143|||
19668039|NCT00387088|42116227|FG001|Overall Study|Adverse Event|156|||
19668040|NCT00387088|42116226|FG000|Overall Study|Protocol Violation|47|||
19668041|NCT00387088|42116227|FG001|Overall Study|Protocol Violation|35|||
19668042|NCT00387088|42116226|FG000|Overall Study|Withdrawal by Subject|20|||
19668043|NCT00387088|42116227|FG001|Overall Study|Withdrawal by Subject|35|||
19668044|NCT00387088|42116226|FG000|Overall Study|Lack of Efficacy|28|||
19668045|NCT00387088|42116227|FG001|Overall Study|Lack of Efficacy|67|||
19668046|NCT00387088|42116226|FG000|Overall Study|Lost to Follow-up|22|||
19668047|NCT00387088|42116227|FG001|Overall Study|Lost to Follow-up|28|||
19668048|NCT00387088|42116226|FG000|Overall Study|Other|58|||
19668049|NCT00387088|42116227|FG001|Overall Study|Other|52|||
19668050|NCT00070291|42116233|FG000|Step 1|Withdrawal by Subject|1|||
19668051|NCT00070291|42116233|FG000|Step 1|Adverse Event|1|||
19668052|NCT00070291|42116233|FG000|Step 2|Adverse Event|1|||
19668053|NCT00053365|42116237|FG000|Overall Study|Incorrect cell type|1|||
19668054|NCT00053365|42116237|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
19668055|NCT00053365|42116237|FG000|Overall Study|Never treated|4|||
19668056|NCT00387010|42116243|FG000|Dose Titration Period|Adverse Event|12|||
19668057|NCT00387010|42116243|FG000|Dose Titration Period|Lack of Efficacy|5|||
19668058|NCT00387010|42116243|FG000|Dose Titration Period|Withdrawal by Subject|3|||
19668059|NCT00387010|42116243|FG000|Dose Titration Period|Protocol Violation|1|||
19668060|NCT00387010|42116243|FG000|Dose Titration Period|Lost to Follow-up|2|||
19668061|NCT00387010|42116243|FG000|Dose Titration Period|Noncompliance with study medication|8|||
19668062|NCT00387010|42116243|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
19668063|NCT00387010|42116243|FG000|Treatment Period|Adverse Event|4|||
19757004|NCT04634409|42207648|FG026|Overall Study|Lost to Follow-up|0|||
19668064|NCT00387010|42116243|FG000|Treatment Period|Withdrawal by Subject|1|||
19668065|NCT00387010|42116243|FG000|Treatment Period|Noncompliance with study medication|2|||
19668066|NCT00387010|42116243|FG000|Treatment Period|Noncompliance with study procedures|3|||
19668067|NCT00387010|42116243|FG000|Treatment Period|Participant reported study drug stolen|1|||
19757005|NCT04634409|42207622|FG000|Overall Study|Withdrawal by Subject|3|||
19757006|NCT04634409|42207623|FG001|Overall Study|Withdrawal by Subject|1|||
19757007|NCT04634409|42207624|FG002|Overall Study|Withdrawal by Subject|6|||
19757008|NCT04634409|42207625|FG003|Overall Study|Withdrawal by Subject|4|||
19757009|NCT04634409|42207626|FG004|Overall Study|Withdrawal by Subject|2|||
19757010|NCT04634409|42207627|FG005|Overall Study|Withdrawal by Subject|0|||
19757011|NCT04634409|42207628|FG006|Overall Study|Withdrawal by Subject|0|||
19757012|NCT04634409|42207629|FG007|Overall Study|Withdrawal by Subject|2|||
19757013|NCT04634409|42207630|FG008|Overall Study|Withdrawal by Subject|3|||
19757014|NCT04634409|42207631|FG009|Overall Study|Withdrawal by Subject|2|||
19757015|NCT04634409|42207632|FG010|Overall Study|Withdrawal by Subject|3|||
19757016|NCT04634409|42207633|FG011|Overall Study|Withdrawal by Subject|2|||
19757017|NCT04634409|42207634|FG012|Overall Study|Withdrawal by Subject|2|||
19757018|NCT04634409|42207635|FG013|Overall Study|Withdrawal by Subject|1|||
19757019|NCT04634409|42207636|FG014|Overall Study|Withdrawal by Subject|5|||
19757020|NCT04634409|42207637|FG015|Overall Study|Withdrawal by Subject|0|||
19757021|NCT04634409|42207638|FG016|Overall Study|Withdrawal by Subject|0|||
19668068|NCT00386776|42116247|FG000|Overall Study|Withdrawal by Subject|8|||
19668069|NCT00065065|42116255|FG000|Overall Study|Adverse Event|3|||
19668070|NCT00065065|42116256|FG001|Overall Study|Adverse Event|2|||
19668071|NCT00065065|42116255|FG000|Overall Study|Withdrawal by Subject|1|||
19668072|NCT00065065|42116256|FG001|Overall Study|Withdrawal by Subject|5|||
19668073|NCT00065065|42116255|FG000|Overall Study|Lack of Efficacy|4|||
19668074|NCT00065065|42116256|FG001|Overall Study|Lack of Efficacy|11|||
19668075|NCT00065065|42116255|FG000|Overall Study|Other|2|||
19668076|NCT00065065|42116256|FG001|Overall Study|Other|2|||
19668077|NCT00386308|42116266|FG000|Overall Study|Adverse Event|3|||
19668078|NCT00386308|42116267|FG001|Overall Study|Adverse Event|3|||
19668079|NCT00386308|42116266|FG000|Overall Study|Protocol Violation|2|||
19668080|NCT00386308|42116267|FG001|Overall Study|Protocol Violation|5|||
19668081|NCT00386308|42116266|FG000|Overall Study|Lack of Efficacy|0|||
19668082|NCT00386308|42116267|FG001|Overall Study|Lack of Efficacy|2|||
19668083|NCT00386308|42116266|FG000|Overall Study|Lost to Follow-up|10|||
19668084|NCT00386308|42116267|FG001|Overall Study|Lost to Follow-up|6|||
19668085|NCT00386308|42116266|FG000|Overall Study|Withdrawal by Subject|6|||
19668086|NCT00386308|42116267|FG001|Overall Study|Withdrawal by Subject|2|||
19668087|NCT00386308|42116266|FG000|Overall Study|Other Event|8|||
19668088|NCT00386308|42116267|FG001|Overall Study|Other Event|1|||
19668089|NCT00064987|42116275|FG000|Overall Study|Physician Decision|3|||
19668090|NCT00064987|42116276|FG001|Overall Study|Physician Decision|0|||
19668091|NCT00374452|42116284|FG000|Overall Study|Left clinic before intervention started|4|||
19668092|NCT00374452|42116285|FG001|Overall Study|Left clinic before intervention started|1|||
19668093|NCT00374452|42116284|FG000|Overall Study|Change in job role before intervention|0|||
19668094|NCT00374452|42116285|FG001|Overall Study|Change in job role before intervention|1|||
19668095|NCT00374452|42116284|FG000|Overall Study|Left clinic after intervention started|1|||
19668096|NCT00374452|42116285|FG001|Overall Study|Left clinic after intervention started|1|||
19668097|NCT00374452|42116284|FG000|Overall Study|Withdrawal by Subject|0|||
19757022|NCT04634409|42207639|FG017|Overall Study|Withdrawal by Subject|1|||
19757023|NCT04634409|42207640|FG018|Overall Study|Withdrawal by Subject|0|||
19757024|NCT04634409|42207641|FG019|Overall Study|Withdrawal by Subject|0|||
19668098|NCT00374452|42116285|FG001|Overall Study|Withdrawal by Subject|2|||
19668099|NCT00064753|42116293|FG000|Overall Study|Death|251|||
19668100|NCT00064753|42116294|FG001|Overall Study|Death|242|||
19668101|NCT00064753|42116293|FG000|Overall Study|Withdrawal by Subject|198|||
19668102|NCT00064753|42116294|FG001|Overall Study|Withdrawal by Subject|171|||
19668103|NCT00064753|42116293|FG000|Overall Study|Lost to Follow-up|225|||
19668104|NCT00064753|42116294|FG001|Overall Study|Lost to Follow-up|235|||
19668105|NCT00374140|42116300|FG000|Overall Study|Lost to Follow-up|1|||
19668106|NCT00374140|42116300|FG000|Overall Study|Protocol Violation|1|||
19668107|NCT00665561|42116306|FG000|Overall Study|Death recorded on subject summary pages|75|||
19668108|NCT00665561|42116307|FG001|Overall Study|Death recorded on subject summary pages|75|||
19668109|NCT00665561|42116306|FG000|Overall Study|Does not meet entrance criteria|19|||
19668110|NCT00665561|42116307|FG001|Overall Study|Does not meet entrance criteria|21|||
19668111|NCT00665561|42116306|FG000|Overall Study|Lost to Follow-up|203|||
19668112|NCT00665561|42116307|FG001|Overall Study|Lost to Follow-up|264|||
19668113|NCT00665561|42116306|FG000|Overall Study|Withdrawal by Subject|74|||
19668114|NCT00665561|42116307|FG001|Overall Study|Withdrawal by Subject|65|||
19668115|NCT00665561|42116306|FG000|Overall Study|Other|123|||
19668116|NCT00665561|42116307|FG001|Overall Study|Other|108|||
19668117|NCT00665561|42116306|FG000|Overall Study|Site closed|8|||
19668118|NCT00665561|42116307|FG001|Overall Study|Site closed|0|||
19668119|NCT00665561|42116306|FG000|Overall Study|Withdrawn due to pregnancy|0|||
19668120|NCT00665561|42116307|FG001|Overall Study|Withdrawn due to pregnancy|1|||
19668121|NCT00663923|42116313|FG000|Overall Study|Lost to Follow-up|2|||
19668122|NCT00386152|42116322|FG000|Overall Study|Adverse Event|6|||
19668123|NCT00386152|42116323|FG001|Overall Study|Adverse Event|5|||
19668124|NCT00386152|42116324|FG002|Overall Study|Adverse Event|4|||
19668125|NCT00386152|42116322|FG000|Overall Study|Chang from original chemo stratification|4|||
19668126|NCT00386152|42116323|FG001|Overall Study|Chang from original chemo stratification|5|||
19668127|NCT00386152|42116324|FG002|Overall Study|Chang from original chemo stratification|6|||
19668128|NCT00386152|42116322|FG000|Overall Study|Death|3|||
19668129|NCT00386152|42116323|FG001|Overall Study|Death|0|||
19668130|NCT00386152|42116324|FG002|Overall Study|Death|1|||
19668131|NCT00386152|42116322|FG000|Overall Study|Disease progression|7|||
19668132|NCT00386152|42116323|FG001|Overall Study|Disease progression|4|||
19668133|NCT00386152|42116324|FG002|Overall Study|Disease progression|5|||
19668134|NCT00386152|42116322|FG000|Overall Study|Physician Decision|13|||
19668135|NCT00386152|42116323|FG001|Overall Study|Physician Decision|10|||
19668136|NCT00386152|42116324|FG002|Overall Study|Physician Decision|4|||
19668137|NCT00386152|42116322|FG000|Overall Study|Lost to Follow-up|1|||
19668138|NCT00386152|42116323|FG001|Overall Study|Lost to Follow-up|0|||
19668139|NCT00386152|42116324|FG002|Overall Study|Lost to Follow-up|0|||
19668140|NCT00386152|42116322|FG000|Overall Study|Completed chemotherapy|4|||
19668141|NCT00386152|42116323|FG001|Overall Study|Completed chemotherapy|5|||
19668142|NCT00386152|42116324|FG002|Overall Study|Completed chemotherapy|1|||
19668143|NCT00386152|42116322|FG000|Overall Study|Protocol Violation|3|||
19668144|NCT00386152|42116323|FG001|Overall Study|Protocol Violation|5|||
19668145|NCT00386152|42116324|FG002|Overall Study|Protocol Violation|2|||
19668146|NCT00386152|42116322|FG000|Overall Study|Withdrawal by Subject|3|||
19668147|NCT00386152|42116323|FG001|Overall Study|Withdrawal by Subject|6|||
19668148|NCT00386152|42116324|FG002|Overall Study|Withdrawal by Subject|10|||
19668149|NCT00385918|42116334|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
19668150|NCT00385918|42116335|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
19668151|NCT00385918|42116336|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
19668152|NCT00385918|42116334|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
19668153|NCT00385918|42116335|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
19668154|NCT00385918|42116336|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
19668155|NCT00385918|42116334|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
19668156|NCT00385918|42116335|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
19668157|NCT00385918|42116336|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
19668158|NCT00385918|42116334|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
19668159|NCT00385918|42116335|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
19668160|NCT00385918|42116336|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
19668161|NCT00385918|42116334|FG000|Intervention Phase After Randomization|Physician Decision|1|||
19668162|NCT00385918|42116335|FG001|Intervention Phase After Randomization|Physician Decision|0|||
19668163|NCT00385918|42116336|FG002|Intervention Phase After Randomization|Physician Decision|0|||
19668164|NCT00385918|42116334|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
19668165|NCT00385918|42116335|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
19668166|NCT00385918|42116336|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
19668167|NCT00385840|42116345|FG000|Overall Study|Adverse Event|1|||
19668168|NCT00385840|42116346|FG001|Overall Study|Adverse Event|1|||
19668169|NCT00385840|42116345|FG000|Overall Study|Lost to Follow-up|3|||
19668170|NCT00385840|42116346|FG001|Overall Study|Lost to Follow-up|13|||
19668171|NCT00385762|42116352|FG000|Overall Study|Adverse Event|1|||
19668172|NCT00385762|42116352|FG000|Overall Study|Lost to Follow-up|1|||
19668173|NCT00385684|42116356|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
19668174|NCT00385684|42116357|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
19668175|NCT00385684|42116356|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
19668176|NCT00385684|42116357|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
19668177|NCT00385684|42116356|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
19668178|NCT00385684|42116357|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
19668179|NCT00661661|42116365|FG000|Overall Study|Adverse Event|99|||
19668180|NCT00661661|42116366|FG001|Overall Study|Adverse Event|24|||
19668181|NCT00661661|42116365|FG000|Overall Study|Lack of Efficacy|3|||
19668182|NCT00661661|42116366|FG001|Overall Study|Lack of Efficacy|2|||
19668183|NCT00661661|42116365|FG000|Overall Study|Lost to Follow-up|0|||
19668184|NCT00661661|42116366|FG001|Overall Study|Lost to Follow-up|1|||
19668185|NCT00661661|42116365|FG000|Overall Study|Withdrawal by Subject|15|||
19668186|NCT00661661|42116366|FG001|Overall Study|Withdrawal by Subject|5|||
19668187|NCT00661661|42116365|FG000|Overall Study|Other|22|||
19668188|NCT00661661|42116366|FG001|Overall Study|Other|7|||
19668189|NCT00661661|42116365|FG000|Overall Study|Not assigned treatment|1|||
19668190|NCT00661661|42116366|FG001|Overall Study|Not assigned treatment|0|||
19668191|NCT00038467|42116376|FG000|Overall Study|Adverse Event|170|||
19668192|NCT00038467|42116377|FG001|Overall Study|Adverse Event|145|||
19668193|NCT00038467|42116376|FG000|Overall Study|Withdrawal by Subject|150|||
19668194|NCT00038467|42116377|FG001|Overall Study|Withdrawal by Subject|107|||
19668195|NCT00038467|42116376|FG000|Overall Study|Protocol Violation|19|||
19668196|NCT00038467|42116377|FG001|Overall Study|Protocol Violation|22|||
19668197|NCT00038467|42116376|FG000|Overall Study|Death|22|||
19668198|NCT00038467|42116377|FG001|Overall Study|Death|16|||
19668199|NCT00038467|42116376|FG000|Overall Study|Lost to Follow-up|15|||
19668200|NCT00038467|42116377|FG001|Overall Study|Lost to Follow-up|10|||
19668201|NCT00038467|42116376|FG000|Overall Study|Recurrence|109|||
19668202|NCT00038467|42116377|FG001|Overall Study|Recurrence|179|||
19668203|NCT00038467|42116376|FG000|Overall Study|Randomized, but not treated|31|||
19668204|NCT00038467|42116377|FG001|Overall Study|Randomized, but not treated|35|||
19668205|NCT00038467|42116376|FG000|Overall Study|Other|26|||
19668206|NCT00038467|42116377|FG001|Overall Study|Other|28|||
19668207|NCT00051025|42116385|FG000|Overall Study|Progressive Disease|1|||
19668208|NCT00051025|42116386|FG001|Overall Study|Progressive Disease|1|||
19668209|NCT00051025|42116385|FG000|Overall Study|Adverse Event|1|||
19668210|NCT00051025|42116386|FG001|Overall Study|Adverse Event|1|||
19668211|NCT00051025|42116385|FG000|Overall Study|Withdrawal by Subject|0|||
19668212|NCT00051025|42116386|FG001|Overall Study|Withdrawal by Subject|1|||
19668213|NCT00051025|42116385|FG000|Overall Study|Death|0|||
19668214|NCT00051025|42116386|FG001|Overall Study|Death|1|||
19668215|NCT00660179|42116395|FG000|Overall Study|Death|44|||
19668216|NCT00660179|42116396|FG001|Overall Study|Death|47|||
19668217|NCT00660179|42116397|FG002|Overall Study|Death|34|||
19668218|NCT00660179|42116395|FG000|Overall Study|Withdrawal of consent|4|||
19668219|NCT00660179|42116396|FG001|Overall Study|Withdrawal of consent|6|||
19668220|NCT00660179|42116397|FG002|Overall Study|Withdrawal of consent|4|||
19668221|NCT00660179|42116395|FG000|Overall Study|Lost to Follow-up|7|||
19668222|NCT00660179|42116396|FG001|Overall Study|Lost to Follow-up|5|||
19668223|NCT00660179|42116397|FG002|Overall Study|Lost to Follow-up|2|||
19668224|NCT00660179|42116395|FG000|Overall Study|Administrative reason|0|||
19668225|NCT00660179|42116396|FG001|Overall Study|Administrative reason|0|||
19668226|NCT00660179|42116397|FG002|Overall Study|Administrative reason|1|||
19668227|NCT00660179|42116395|FG000|Overall Study|Incorrect randomization|1|||
19668228|NCT00660179|42116396|FG001|Overall Study|Incorrect randomization|0|||
19668229|NCT00660179|42116397|FG002|Overall Study|Incorrect randomization|0|||
19668230|NCT00050167|42116407|FG000|Overall Study|not eligible not invasive|1|||
19668231|NCT00050167|42116408|FG001|Overall Study|not eligible not invasive|1|||
19668232|NCT00660023|42116414|FG000|Overall Study|Adverse Event|2|||
19668233|NCT00660023|42116414|FG000|Overall Study|Death|8|||
19668234|NCT00660023|42116414|FG000|Overall Study|Blood Transfusion|5|||
19668235|NCT00660023|42116414|FG000|Overall Study|Renal Transplantation|3|||
19668236|NCT00660023|42116414|FG000|Overall Study|Withdrawal by Subject|1|||
19668237|NCT00660023|42116414|FG000|Overall Study|Missed Pregnancy Test|1|||
19388782|NCT02544633|41632286|FG001|Treatment Period|Clinical Disease Progression|0|||
19668238|NCT00660023|42116414|FG000|Overall Study|Other Screening Failure|9|||
19668239|NCT00062647|42116420|FG000|Overall Study|Death|2|||
19668240|NCT00062647|42116421|FG001|Overall Study|Death|2|||
19668241|NCT00062647|42116420|FG000|Overall Study|Adverse Event|1|||
19668242|NCT00062647|42116421|FG001|Overall Study|Adverse Event|1|||
19668243|NCT00062647|42116420|FG000|Overall Study|Withdrawal by Subject|2|||
19668244|NCT00062647|42116421|FG001|Overall Study|Withdrawal by Subject|1|||
19668245|NCT00062647|42116420|FG000|Overall Study|Protocol Violation|1|||
19668246|NCT00062647|42116421|FG001|Overall Study|Protocol Violation|0|||
19668247|NCT00062647|42116420|FG000|Overall Study|Lost to Follow-up|1|||
19668248|NCT00062647|42116421|FG001|Overall Study|Lost to Follow-up|2|||
19668249|NCT00062647|42116420|FG000|Overall Study|Failed continuation criteria|4|||
19668250|NCT00062647|42116421|FG001|Overall Study|Failed continuation criteria|2|||
19668251|NCT00062647|42116420|FG000|Overall Study|Other|4|||
19757025|NCT04634409|42207642|FG020|Overall Study|Withdrawal by Subject|0|||
19757026|NCT04634409|42207643|FG021|Overall Study|Withdrawal by Subject|0|||
19757027|NCT04634409|42207644|FG022|Overall Study|Withdrawal by Subject|0|||
19668252|NCT00062647|42116421|FG001|Overall Study|Other|4|||
19668253|NCT00062647|42116420|FG000|Overall Study|Never received study treatment|1|||
19668254|NCT00062647|42116421|FG001|Overall Study|Never received study treatment|1|||
19668255|NCT00570323|42116429|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
19668256|NCT00570323|42116430|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
19668257|NCT00570323|42116429|FG000|Started Treatment After Randomization|Protocol Violation|1|||
19668258|NCT00570323|42116430|FG001|Started Treatment After Randomization|Protocol Violation|0|||
19668259|NCT00570323|42116429|FG000|Started Treatment After Randomization|Physician Decision|1|||
19668260|NCT00570323|42116430|FG001|Started Treatment After Randomization|Physician Decision|0|||
19668261|NCT00570323|42116429|FG000|Complete Study After Start|Lost to Follow-up|0|||
19668262|NCT00570323|42116430|FG001|Complete Study After Start|Lost to Follow-up|1|||
19668263|NCT00570323|42116429|FG000|Complete Study After Start|Withdrawal by Subject|2|||
19668264|NCT00570323|42116430|FG001|Complete Study After Start|Withdrawal by Subject|0|||
19668265|NCT00570323|42116429|FG000|Complete Study After Start|Physician Decision|1|||
19668266|NCT00570323|42116430|FG001|Complete Study After Start|Physician Decision|0|||
19668267|NCT00661505|42116438|FG000|Overall Study|Adverse Event|3|||
19668268|NCT00661505|42116438|FG000|Overall Study|Protocol Violation|14|||
19668269|NCT00661505|42116438|FG000|Overall Study|Withdrawal by Subject|8|||
19668270|NCT00661505|42116438|FG000|Overall Study|Lost to Follow-up|3|||
19668271|NCT00661505|42116438|FG000|Overall Study|Other|2|||
19668272|NCT00662909|42116446|FG000|Overall Study|Adverse Event|17|||
19668273|NCT00662909|42116447|FG001|Overall Study|Adverse Event|18|||
19668274|NCT00662909|42116448|FG002|Overall Study|Adverse Event|19|||
19668275|NCT00662909|42116446|FG000|Overall Study|Lack of Efficacy|9|||
19668276|NCT00662909|42116447|FG001|Overall Study|Lack of Efficacy|1|||
19668277|NCT00662909|42116448|FG002|Overall Study|Lack of Efficacy|5|||
19668278|NCT00662909|42116446|FG000|Overall Study|Withdrawal by Subject|29|||
19668279|NCT00662909|42116447|FG001|Overall Study|Withdrawal by Subject|22|||
19668280|NCT00662909|42116448|FG002|Overall Study|Withdrawal by Subject|16|||
19668281|NCT00662909|42116446|FG000|Overall Study|Lost to Follow-up|2|||
19668282|NCT00662909|42116447|FG001|Overall Study|Lost to Follow-up|9|||
19668283|NCT00662909|42116448|FG002|Overall Study|Lost to Follow-up|3|||
19668284|NCT00662909|42116446|FG000|Overall Study|Protocol Violation|7|||
19668285|NCT00662909|42116447|FG001|Overall Study|Protocol Violation|4|||
19668286|NCT00662909|42116448|FG002|Overall Study|Protocol Violation|5|||
19668287|NCT00662909|42116446|FG000|Overall Study|Randomized- never received study drug|1|||
19668288|NCT00662909|42116447|FG001|Overall Study|Randomized- never received study drug|0|||
19668289|NCT00662909|42116448|FG002|Overall Study|Randomized- never received study drug|0|||
19668290|NCT00662909|42116446|FG000|Overall Study|Non-compliance with study procedures|3|||
19668291|NCT00662909|42116447|FG001|Overall Study|Non-compliance with study procedures|3|||
19668292|NCT00662909|42116448|FG002|Overall Study|Non-compliance with study procedures|2|||
19668293|NCT00662909|42116446|FG000|Overall Study|Physician Decision|1|||
19668294|NCT00662909|42116447|FG001|Overall Study|Physician Decision|1|||
19668295|NCT00662909|42116448|FG002|Overall Study|Physician Decision|2|||
19668296|NCT00662909|42116446|FG000|Overall Study|Eligibility criterion not met|0|||
19668297|NCT00662909|42116447|FG001|Overall Study|Eligibility criterion not met|1|||
19668298|NCT00662909|42116448|FG002|Overall Study|Eligibility criterion not met|1|||
19668299|NCT00050011|42116458|FG000|Overall Study|Adverse Event|41|||
19668300|NCT00050011|42116459|FG001|Overall Study|Adverse Event|46|||
19668301|NCT00050011|42116458|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19668302|NCT00050011|42116459|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19668303|NCT00050011|42116458|FG000|Overall Study|Abnormal test procedure results|0|||
19668304|NCT00050011|42116459|FG001|Overall Study|Abnormal test procedure results|1|||
19668305|NCT00050011|42116458|FG000|Overall Study|Lack of Efficacy|16|||
19668306|NCT00050011|42116459|FG001|Overall Study|Lack of Efficacy|21|||
19668307|NCT00050011|42116458|FG000|Overall Study|Participant condition no longer required|1|||
19668308|NCT00050011|42116459|FG001|Overall Study|Participant condition no longer required|0|||
19668309|NCT00050011|42116458|FG000|Overall Study|Protocol Violation|4|||
19668310|NCT00050011|42116459|FG001|Overall Study|Protocol Violation|10|||
19668311|NCT00050011|42116458|FG000|Overall Study|Withdrawal by Subject|34|||
19668312|NCT00050011|42116459|FG001|Overall Study|Withdrawal by Subject|26|||
19668313|NCT00050011|42116458|FG000|Overall Study|Lost to Follow-up|7|||
19668314|NCT00050011|42116459|FG001|Overall Study|Lost to Follow-up|9|||
19668315|NCT00050011|42116458|FG000|Overall Study|Administrative problems|10|||
19668316|NCT00050011|42116459|FG001|Overall Study|Administrative problems|6|||
19757028|NCT04634409|42207645|FG023|Overall Study|Withdrawal by Subject|1|||
19668317|NCT00050011|42116458|FG000|Overall Study|Death|7|||
19668318|NCT00050011|42116459|FG001|Overall Study|Death|4|||
19668319|NCT00050011|42116458|FG000|Overall Study|Unknown - Reason is missing|0|||
19668320|NCT00050011|42116459|FG001|Overall Study|Unknown - Reason is missing|2|||
19668321|NCT00661427|42116468|FG000|Overall Study|Adverse Event|5|||
19668322|NCT00661427|42116469|FG001|Overall Study|Adverse Event|5|||
19668323|NCT00661427|42116468|FG000|Overall Study|Patient not treated|0|||
19668324|NCT00661427|42116469|FG001|Overall Study|Patient not treated|2|||
19668325|NCT00049543|42116477|FG000|Overall Study|still on treatment|2|||
19668326|NCT00049543|42116478|FG001|Overall Study|still on treatment|9|||
19668327|NCT00048997|42116486|FG000|Overall Study|Protocol Violation|7|||
19668328|NCT00048997|42116487|FG001|Overall Study|Protocol Violation|2|||
19668329|NCT00048997|42116486|FG000|Overall Study|Withdrawal by Subject|6|||
19668330|NCT00048997|42116487|FG001|Overall Study|Withdrawal by Subject|1|||
19668331|NCT00035815|42116494|FG000|Overall Study|Withdrawal by Subject|17|||
19668332|NCT00035815|42116495|FG001|Overall Study|Withdrawal by Subject|11|||
19668333|NCT00662831|42116503|FG000|Overall Study|Death|4|||
19668334|NCT00662831|42116504|FG001|Overall Study|Death|1|||
19668335|NCT00662831|42116503|FG000|Overall Study|Lack of Efficacy|6|||
19668336|NCT00662831|42116504|FG001|Overall Study|Lack of Efficacy|6|||
19668337|NCT00662831|42116503|FG000|Overall Study|Lost to Follow-up|1|||
19668338|NCT00662831|42116504|FG001|Overall Study|Lost to Follow-up|0|||
19668339|NCT00662831|42116503|FG000|Overall Study|Withdrawal by Subject|2|||
19668340|NCT00662831|42116504|FG001|Overall Study|Withdrawal by Subject|1|||
19668341|NCT00662831|42116503|FG000|Overall Study|Other|62|||
19668342|NCT00662831|42116504|FG001|Overall Study|Other|31|||
19668343|NCT00662831|42116503|FG000|Overall Study|Protocol Violation|8|||
19668344|NCT00662831|42116504|FG001|Overall Study|Protocol Violation|4|||
19668345|NCT00662831|42116503|FG000|Overall Study|Adverse Event|23|||
19668346|NCT00662831|42116504|FG001|Overall Study|Adverse Event|16|||
19668347|NCT00662363|42116512|FG000|Overall Study|Withdrawal by Subject|6|||
19668348|NCT00662363|42116513|FG001|Overall Study|Withdrawal by Subject|5|||
19668349|NCT00662363|42116512|FG000|Overall Study|Adverse Event|0|||
19668350|NCT00662363|42116513|FG001|Overall Study|Adverse Event|3|||
19668351|NCT00662363|42116512|FG000|Overall Study|Discharged early from rehab|4|||
19668352|NCT00662363|42116513|FG001|Overall Study|Discharged early from rehab|1|||
19668353|NCT00662363|42116512|FG000|Overall Study|Protocol Violation|1|||
19668354|NCT00662363|42116513|FG001|Overall Study|Protocol Violation|1|||
19668355|NCT00661271|42116523|FG000|Overall Study|Lost to Follow-up|28|||
19668356|NCT00661271|42116524|FG001|Overall Study|Lost to Follow-up|25|||
19668357|NCT00661193|42116532|FG000|Overall Study|Adverse Event|2|||
19668358|NCT00661193|42116533|FG001|Overall Study|Adverse Event|1|||
19668359|NCT00661193|42116532|FG000|Overall Study|Withdrawal by Subject|3|||
19668360|NCT00661193|42116533|FG001|Overall Study|Withdrawal by Subject|1|||
19668361|NCT00661193|42116532|FG000|Overall Study|Progression|27|||
19668362|NCT00661193|42116533|FG001|Overall Study|Progression|24|||
19668363|NCT00661193|42116532|FG000|Overall Study|Not protocol specified|1|||
19668364|NCT00661193|42116533|FG001|Overall Study|Not protocol specified|0|||
19668365|NCT00658541|42116539|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
19668366|NCT00658541|42116540|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19668367|NCT00658541|42116539|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
19668368|NCT00658541|42116540|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
19668369|NCT00048061|42116550|FG000|Overall Study|Adverse Event|41|||
19668370|NCT00048061|42116551|FG001|Overall Study|Adverse Event|32|||
19668371|NCT00048061|42116552|FG002|Overall Study|Adverse Event|44|||
19668372|NCT00048061|42116553|FG003|Overall Study|Adverse Event|37|||
19668373|NCT00048061|42116550|FG000|Overall Study|Lost to Follow-up|3|||
19668374|NCT00048061|42116551|FG001|Overall Study|Lost to Follow-up|2|||
19668375|NCT00048061|42116552|FG002|Overall Study|Lost to Follow-up|4|||
19668376|NCT00048061|42116553|FG003|Overall Study|Lost to Follow-up|5|||
19668377|NCT00048061|42116550|FG000|Overall Study|Withdrawal by Subject|20|||
19668378|NCT00048061|42116551|FG001|Overall Study|Withdrawal by Subject|29|||
19602864|NCT01033487|42051697|FG008|Fourth Intervention Period|Adverse Event|1|||
19602865|NCT01033487|42051698|FG009|Fourth Intervention Period|Adverse Event|0|||
19602866|NCT01033019|42051714|FG000|Overall Study|Withdrawal by Subject|1|||
19602867|NCT01033019|42051715|FG001|Overall Study|Withdrawal by Subject|0|||
19602868|NCT00603447|42051729|FG000|Overall Study|Adverse Event|0|||
19602869|NCT00603447|42051730|FG001|Overall Study|Adverse Event|1|||
19602870|NCT00603447|42051731|FG002|Overall Study|Adverse Event|1|||
19602871|NCT00603447|42051732|FG003|Overall Study|Adverse Event|2|||
19602872|NCT00603447|42051733|FG004|Overall Study|Adverse Event|1|||
19668379|NCT00048061|42116552|FG002|Overall Study|Withdrawal by Subject|29|||
19602873|NCT00603447|42051734|FG005|Overall Study|Adverse Event|2|||
19668380|NCT00048061|42116553|FG003|Overall Study|Withdrawal by Subject|32|||
19668381|NCT00048061|42116550|FG000|Overall Study|Did not follow-up|5|||
19668382|NCT00048061|42116551|FG001|Overall Study|Did not follow-up|5|||
19602874|NCT00603447|42051735|FG006|Overall Study|Adverse Event|10|||
19668383|NCT00048061|42116552|FG002|Overall Study|Did not follow-up|4|||
19668384|NCT00048061|42116553|FG003|Overall Study|Did not follow-up|5|||
19668385|NCT00048061|42116550|FG000|Overall Study|Early improvement|6|||
19668386|NCT00048061|42116551|FG001|Overall Study|Early improvement|5|||
19668387|NCT00048061|42116552|FG002|Overall Study|Early improvement|3|||
19668388|NCT00048061|42116553|FG003|Overall Study|Early improvement|0|||
19668389|NCT00656669|42116563|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
19668390|NCT00656669|42116563|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
19668391|NCT00656669|42116563|FG000|AC (Cycles 6-9)|Adverse Event|1|||
19668392|NCT00656669|42116563|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
19668393|NCT00656513|42116575|FG000|Overall Study|Protocol Violation|1|||
19668394|NCT00656513|42116576|FG001|Overall Study|Protocol Violation|0|||
19668395|NCT00656513|42116577|FG002|Overall Study|Protocol Violation|2|||
19668396|NCT00656513|42116575|FG000|Overall Study|Withdrawal by Subject|0|||
19668397|NCT00656513|42116576|FG001|Overall Study|Withdrawal by Subject|11|||
19668398|NCT00656513|42116577|FG002|Overall Study|Withdrawal by Subject|4|||
19668399|NCT00656513|42116575|FG000|Overall Study|Death|0|||
19668400|NCT00656513|42116576|FG001|Overall Study|Death|0|||
19668401|NCT00656513|42116577|FG002|Overall Study|Death|1|||
19668402|NCT00656513|42116575|FG000|Overall Study|Missing data|0|||
19668403|NCT00656513|42116576|FG001|Overall Study|Missing data|11|||
19668404|NCT00656513|42116577|FG002|Overall Study|Missing data|9|||
19668405|NCT00656513|42116575|FG000|Overall Study|Incomplete treatment|3|||
19668406|NCT00656513|42116576|FG001|Overall Study|Incomplete treatment|0|||
19668407|NCT00656513|42116577|FG002|Overall Study|Incomplete treatment|0|||
19668408|NCT00656513|42116575|FG000|Overall Study|Treatment completed outside of timeframe|0|||
19668409|NCT00656513|42116576|FG001|Overall Study|Treatment completed outside of timeframe|3|||
19668410|NCT00656513|42116577|FG002|Overall Study|Treatment completed outside of timeframe|1|||
19668411|NCT00656513|42116575|FG000|Overall Study|Missing baseline form|0|||
19668412|NCT00656513|42116576|FG001|Overall Study|Missing baseline form|5|||
19602875|NCT00603447|42051729|FG000|Overall Study|Other|0|||
19602876|NCT00603447|42051730|FG001|Overall Study|Other|0|||
19602877|NCT00603447|42051731|FG002|Overall Study|Other|1|||
19602878|NCT00603447|42051732|FG003|Overall Study|Other|0|||
19602879|NCT00603447|42051733|FG004|Overall Study|Other|3|||
19602880|NCT00603447|42051734|FG005|Overall Study|Other|0|||
19602881|NCT00603447|42051735|FG006|Overall Study|Other|13|||
19602882|NCT00603447|42051729|FG000|Overall Study|Withdrew Consent|0|||
19602883|NCT00603447|42051730|FG001|Overall Study|Withdrew Consent|2|||
19602884|NCT00603447|42051731|FG002|Overall Study|Withdrew Consent|0|||
19602885|NCT00603447|42051732|FG003|Overall Study|Withdrew Consent|0|||
19602886|NCT00603447|42051733|FG004|Overall Study|Withdrew Consent|1|||
19668413|NCT00656513|42116577|FG002|Overall Study|Missing baseline form|5|||
19668414|NCT00655889|42116585|FG000|Overall Study|Inadequate cell growth|1|||
19668415|NCT00655889|42116585|FG000|Overall Study|Protocol Violation|1|||
19668416|NCT00655733|42116591|FG000|Overall Study|Lost to Follow-up|2|||
19602887|NCT00603447|42051734|FG005|Overall Study|Withdrew Consent|0|||
19668417|NCT00655733|42116592|FG001|Overall Study|Lost to Follow-up|2|||
19668418|NCT00655733|42116591|FG000|Overall Study|Adverse Event|2|||
19668419|NCT00655733|42116592|FG001|Overall Study|Adverse Event|2|||
19668420|NCT00655733|42116591|FG000|Overall Study|Withdrawal by Subject|3|||
19668421|NCT00655733|42116592|FG001|Overall Study|Withdrawal by Subject|3|||
19668422|NCT00655733|42116591|FG000|Overall Study|Physician Decision|0|||
19668423|NCT00655733|42116592|FG001|Overall Study|Physician Decision|1|||
19668424|NCT00657371|42116600|FG000|Overall Study|Poor bowel preparation|15|||
19668425|NCT00657371|42116600|FG000|Overall Study|Unable to intubate the cecum|5|||
19668426|NCT00657371|42116600|FG000|Overall Study|Protocol Violation|2|||
19668427|NCT00657371|42116600|FG000|Overall Study|Device- related reasons|13|||
19668428|NCT00657371|42116600|FG000|Overall Study|Pre-existing medical condition|4|||
19668429|NCT00658775|42116606|FG000|Overall Study|Adverse Event|4|||
19668430|NCT00658775|42116607|FG001|Overall Study|Adverse Event|6|||
19668431|NCT00658775|42116606|FG000|Overall Study|Lost to Follow-up|17|||
19668432|NCT00658775|42116607|FG001|Overall Study|Lost to Follow-up|18|||
19668433|NCT00658775|42116606|FG000|Overall Study|Withdrawal by Subject|6|||
19668434|NCT00658775|42116607|FG001|Overall Study|Withdrawal by Subject|4|||
19668435|NCT00658775|42116606|FG000|Overall Study|Withdrawal of consent|8|||
19668436|NCT00658775|42116607|FG001|Overall Study|Withdrawal of consent|7|||
19668437|NCT00658775|42116606|FG000|Overall Study|Other|7|||
19668438|NCT00658775|42116607|FG001|Overall Study|Other|8|||
19668439|NCT00488631|42116619|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
19668440|NCT00488631|42116620|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
19668441|NCT00488631|42116621|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
19668442|NCT00488631|42116622|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
19668443|NCT00488631|42116623|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
19668444|NCT00488631|42116624|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
19668445|NCT00488631|42116625|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
19668446|NCT00488631|42116626|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
19668447|NCT00488631|42116627|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
19668448|NCT00488631|42116628|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
19668449|NCT00488631|42116619|FG000|Double Blind Period (Week 0-54)|Death|0|||
19668450|NCT00488631|42116620|FG001|Double Blind Period (Week 0-54)|Death|0|||
19668451|NCT00488631|42116621|FG002|Double Blind Period (Week 0-54)|Death|0|||
19668452|NCT00488631|42116622|FG003|Double Blind Period (Week 0-54)|Death|0|||
19668453|NCT00488631|42116623|FG004|Double Blind Period (Week 0-54)|Death|0|||
19668454|NCT00488631|42116624|FG005|Double Blind Period (Week 0-54)|Death|1|||
19668455|NCT00488631|42116625|FG006|Double Blind Period (Week 0-54)|Death|0|||
19668456|NCT00488631|42116626|FG007|Double Blind Period (Week 0-54)|Death|0|||
19668457|NCT00488631|42116627|FG008|Double Blind Period (Week 0-54)|Death|0|||
19668458|NCT00488631|42116628|FG009|Double Blind Period (Week 0-54)|Death|0|||
19668459|NCT00488631|42116619|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
19668460|NCT00488631|42116620|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
19668461|NCT00488631|42116621|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
19668462|NCT00488631|42116622|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
19668463|NCT00488631|42116623|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
19668464|NCT00488631|42116624|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
19668465|NCT00488631|42116625|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
19668466|NCT00488631|42116626|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
19602888|NCT00603447|42051735|FG006|Overall Study|Withdrew Consent|1|||
19602889|NCT00778258|42051760|FG000|Overall Study|Adverse Event|1|||
19668467|NCT00488631|42116627|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
19668468|NCT00488631|42116628|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
19668469|NCT00488631|42116619|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
19668470|NCT00488631|42116620|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
19668471|NCT00488631|42116621|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
19668472|NCT00488631|42116622|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
19668473|NCT00488631|42116623|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
19602890|NCT00778258|42051761|FG001|Overall Study|Adverse Event|0|||
19602891|NCT00778258|42051762|FG002|Overall Study|Adverse Event|0|||
19602892|NCT00778258|42051763|FG003|Overall Study|Adverse Event|0|||
19602893|NCT00778258|42051764|FG004|Overall Study|Adverse Event|0|||
19602894|NCT00778258|42051765|FG005|Overall Study|Adverse Event|1|||
19602895|NCT00778258|42051766|FG006|Overall Study|Adverse Event|0|||
19602896|NCT00778258|42051767|FG007|Overall Study|Adverse Event|0|||
19602897|NCT00778258|42051768|FG008|Overall Study|Adverse Event|0|||
19602898|NCT00778258|42051760|FG000|Overall Study|Lost to Follow-up|0|||
19602899|NCT00778258|42051761|FG001|Overall Study|Lost to Follow-up|0|||
19602900|NCT00778258|42051762|FG002|Overall Study|Lost to Follow-up|2|||
19602901|NCT00778258|42051763|FG003|Overall Study|Lost to Follow-up|0|||
19602902|NCT00778258|42051764|FG004|Overall Study|Lost to Follow-up|0|||
19668474|NCT00488631|42116624|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
19668475|NCT00488631|42116625|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
19602903|NCT00778258|42051765|FG005|Overall Study|Lost to Follow-up|3|||
19668476|NCT00488631|42116626|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
19668477|NCT00488631|42116627|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
19668478|NCT00488631|42116628|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
19668479|NCT00488631|42116619|FG000|Double Blind Period (Week 0-54)|Other|6|||
19668480|NCT00488631|42116620|FG001|Double Blind Period (Week 0-54)|Other|12|||
19668481|NCT00488631|42116621|FG002|Double Blind Period (Week 0-54)|Other|10|||
19668482|NCT00488631|42116622|FG003|Double Blind Period (Week 0-54)|Other|11|||
19668483|NCT00488631|42116623|FG004|Double Blind Period (Week 0-54)|Other|14|||
19668484|NCT00488631|42116624|FG005|Double Blind Period (Week 0-54)|Other|34|||
19668485|NCT00488631|42116625|FG006|Double Blind Period (Week 0-54)|Other|0|||
19668486|NCT00488631|42116626|FG007|Double Blind Period (Week 0-54)|Other|0|||
19668487|NCT00488631|42116627|FG008|Double Blind Period (Week 0-54)|Other|0|||
19668488|NCT00488631|42116628|FG009|Double Blind Period (Week 0-54)|Other|0|||
19668489|NCT00488631|42116619|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668490|NCT00488631|42116620|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19757029|NCT04634409|42207646|FG024|Overall Study|Withdrawal by Subject|0|||
19757030|NCT04634409|42207647|FG025|Overall Study|Withdrawal by Subject|0|||
19757031|NCT04634409|42207648|FG026|Overall Study|Withdrawal by Subject|0|||
19757032|NCT04634409|42207622|FG000|Overall Study|Other - As reported by Investigator|1|||
19757033|NCT04634409|42207623|FG001|Overall Study|Other - As reported by Investigator|0|||
19757034|NCT04634409|42207624|FG002|Overall Study|Other - As reported by Investigator|0|||
19757035|NCT04634409|42207625|FG003|Overall Study|Other - As reported by Investigator|0|||
19668491|NCT00488631|42116621|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668492|NCT00488631|42116622|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668493|NCT00488631|42116623|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668494|NCT00488631|42116624|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668495|NCT00488631|42116625|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
19668496|NCT00488631|42116626|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
19668497|NCT00488631|42116627|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
19668498|NCT00488631|42116628|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
19668499|NCT00488631|42116619|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
19668500|NCT00488631|42116620|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
19668501|NCT00488631|42116621|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
19668502|NCT00488631|42116622|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
19668503|NCT00488631|42116623|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
19668504|NCT00488631|42116624|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
19668505|NCT00488631|42116625|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
19668506|NCT00488631|42116626|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
19668507|NCT00488631|42116627|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
19668508|NCT00488631|42116628|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
19668509|NCT00488631|42116619|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668510|NCT00488631|42116620|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668511|NCT00488631|42116621|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668512|NCT00488631|42116622|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668513|NCT00488631|42116623|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668514|NCT00488631|42116624|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
19668515|NCT00488631|42116625|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
19668516|NCT00488631|42116626|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
19668517|NCT00488631|42116627|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
19668518|NCT00488631|42116628|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
19668519|NCT00488631|42116619|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668520|NCT00488631|42116620|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668521|NCT00488631|42116621|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668522|NCT00488631|42116622|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668523|NCT00488631|42116623|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668524|NCT00488631|42116624|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668525|NCT00488631|42116625|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
19668526|NCT00488631|42116626|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19602904|NCT00778258|42051766|FG006|Overall Study|Lost to Follow-up|2|||
19602905|NCT00778258|42051767|FG007|Overall Study|Lost to Follow-up|2|||
19602906|NCT00778258|42051768|FG008|Overall Study|Lost to Follow-up|0|||
19602907|NCT00778258|42051760|FG000|Overall Study|Withdrawal by Subject|6|||
19602908|NCT00778258|42051761|FG001|Overall Study|Withdrawal by Subject|2|||
19602909|NCT00778258|42051762|FG002|Overall Study|Withdrawal by Subject|8|||
19602910|NCT00778258|42051763|FG003|Overall Study|Withdrawal by Subject|2|||
19602911|NCT00778258|42051764|FG004|Overall Study|Withdrawal by Subject|0|||
19668527|NCT00488631|42116627|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
19668528|NCT00488631|42116628|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
19668529|NCT00488631|42116619|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668530|NCT00488631|42116620|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668531|NCT00488631|42116621|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668532|NCT00488631|42116622|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668533|NCT00488631|42116623|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668534|NCT00488631|42116624|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668535|NCT00488631|42116625|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
19668536|NCT00488631|42116626|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
19668537|NCT00488631|42116627|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
19668538|NCT00488631|42116628|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
19668539|NCT00655499|42116651|FG000|Overall Study|not eligible|4|||
19668540|NCT00654875|42116658|FG000|Overall Study|Adverse Event|5|||
19668541|NCT00654875|42116659|FG001|Overall Study|Adverse Event|5|||
19668542|NCT00654875|42116658|FG000|Overall Study|Withdrawal by Subject|4|||
19668543|NCT00654875|42116659|FG001|Overall Study|Withdrawal by Subject|4|||
19668544|NCT00654875|42116658|FG000|Overall Study|Protocol Violation|3|||
19757036|NCT04634409|42207626|FG004|Overall Study|Other - As reported by Investigator|0|||
19757037|NCT04634409|42207627|FG005|Overall Study|Other - As reported by Investigator|0|||
19757038|NCT04634409|42207628|FG006|Overall Study|Other - As reported by Investigator|0|||
19757039|NCT04634409|42207629|FG007|Overall Study|Other - As reported by Investigator|6|||
19757040|NCT04634409|42207630|FG008|Overall Study|Other - As reported by Investigator|4|||
19757041|NCT04634409|42207631|FG009|Overall Study|Other - As reported by Investigator|0|||
19757042|NCT04634409|42207632|FG010|Overall Study|Other - As reported by Investigator|1|||
19757043|NCT04634409|42207633|FG011|Overall Study|Other - As reported by Investigator|2|||
19757044|NCT04634409|42207634|FG012|Overall Study|Other - As reported by Investigator|2|||
19757045|NCT04634409|42207635|FG013|Overall Study|Other - As reported by Investigator|1|||
19757046|NCT04634409|42207636|FG014|Overall Study|Other - As reported by Investigator|0|||
19757047|NCT04634409|42207637|FG015|Overall Study|Other - As reported by Investigator|0|||
19757048|NCT04634409|42207638|FG016|Overall Study|Other - As reported by Investigator|0|||
19757049|NCT04634409|42207639|FG017|Overall Study|Other - As reported by Investigator|0|||
19757050|NCT04634409|42207640|FG018|Overall Study|Other - As reported by Investigator|0|||
19757051|NCT04634409|42207641|FG019|Overall Study|Other - As reported by Investigator|0|||
19757052|NCT04634409|42207642|FG020|Overall Study|Other - As reported by Investigator|0|||
19757053|NCT04634409|42207643|FG021|Overall Study|Other - As reported by Investigator|0|||
19757054|NCT04634409|42207644|FG022|Overall Study|Other - As reported by Investigator|0|||
19757055|NCT04634409|42207645|FG023|Overall Study|Other - As reported by Investigator|0|||
19757056|NCT04634409|42207646|FG024|Overall Study|Other - As reported by Investigator|0|||
19757057|NCT04634409|42207647|FG025|Overall Study|Other - As reported by Investigator|0|||
19757058|NCT04634409|42207648|FG026|Overall Study|Other - As reported by Investigator|0|||
19757059|NCT00005780|42207726|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
19668545|NCT00654875|42116659|FG001|Overall Study|Protocol Violation|3|||
19668546|NCT00654875|42116658|FG000|Overall Study|Lack of Efficacy|2|||
19668547|NCT00654875|42116659|FG001|Overall Study|Lack of Efficacy|2|||
19668548|NCT00654875|42116658|FG000|Overall Study|Lost to Follow-up|1|||
19668549|NCT00654875|42116659|FG001|Overall Study|Lost to Follow-up|3|||
19668550|NCT00654875|42116658|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
19668551|NCT00654875|42116659|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
19668552|NCT00654875|42116658|FG000|Overall Study|Administrative Problems|1|||
19668553|NCT00654875|42116659|FG001|Overall Study|Administrative Problems|0|||
19668554|NCT00651755|42116665|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
19668555|NCT00651755|42116666|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
19668556|NCT00651755|42116665|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
19668557|NCT00651755|42116666|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
19668558|NCT00654641|42116675|FG000|Overall Study|Lost to Follow-up|2|||
19668559|NCT00654641|42116676|FG001|Overall Study|Lost to Follow-up|3|||
19668560|NCT00569777|42116684|FG000|Overall Study|Withdrawal by Subject|4|||
19668561|NCT00569777|42116685|FG001|Overall Study|Withdrawal by Subject|0|||
19668562|NCT00569777|42116684|FG000|Overall Study|Adverse Event|3|||
19668563|NCT00569777|42116685|FG001|Overall Study|Adverse Event|0|||
19668564|NCT00569777|42116684|FG000|Overall Study|Lost to Follow-up|1|||
19668565|NCT00569777|42116685|FG001|Overall Study|Lost to Follow-up|0|||
19668566|NCT00569777|42116684|FG000|Overall Study|scheduled eye surgery|0|||
19668567|NCT00569777|42116685|FG001|Overall Study|scheduled eye surgery|1|||
19668568|NCT00569777|42116684|FG000|Overall Study|did not meet exclusion criteria|1|||
19668569|NCT00569777|42116685|FG001|Overall Study|did not meet exclusion criteria|2|||
19668570|NCT00569777|42116684|FG000|Overall Study|pregnant|1|||
19668571|NCT00569777|42116685|FG001|Overall Study|pregnant|0|||
19668572|NCT00569231|42116691|FG000|Overall Study|Study unrelated surgery|1|||
19602912|NCT00778258|42051765|FG005|Overall Study|Withdrawal by Subject|6|||
19602913|NCT00778258|42051766|FG006|Overall Study|Withdrawal by Subject|12|||
19602914|NCT00778258|42051767|FG007|Overall Study|Withdrawal by Subject|12|||
19602915|NCT00778258|42051768|FG008|Overall Study|Withdrawal by Subject|4|||
19602916|NCT00778258|42051760|FG000|Overall Study|New Contraindication|0|||
19668573|NCT00569231|42116691|FG000|Overall Study|Airfare expense|2|||
19668574|NCT00569231|42116691|FG000|Overall Study|Withdrawal by Subject|1|||
19668575|NCT00569231|42116691|FG000|Overall Study|Car accident injury|1|||
19668576|NCT00569231|42116691|FG000|Overall Study|Non-compliance|2|||
19668577|NCT00654095|42116695|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
19668578|NCT00654095|42116695|FG000|Overall Study|Elevated triglyceride level (2)|1|||
19668579|NCT00654095|42116695|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
19668580|NCT00654095|42116695|FG000|Overall Study|Adverse Event|11|||
19668581|NCT00654095|42116695|FG000|Overall Study|Withdrawal by Subject|5|||
19668582|NCT00654095|42116695|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
19668583|NCT00654095|42116695|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
19668584|NCT00654095|42116695|FG000|Overall Study|Did not meet inclusion criteria|1|||
19668585|NCT00650585|42116701|FG000|Overall Study|Lost to Follow-up|505|||
19668586|NCT00650585|42116702|FG001|Overall Study|Lost to Follow-up|482|||
19668587|NCT00650585|42116701|FG000|Overall Study|No parental consent|935|||
19668588|NCT00650585|42116702|FG001|Overall Study|No parental consent|866|||
19668589|NCT00650585|42116701|FG000|Overall Study|Excluded/ruled ineligible|357|||
19668590|NCT00650585|42116702|FG001|Overall Study|Excluded/ruled ineligible|129|||
19668591|NCT00653939|42116710|FG000|Overall Study|Adverse Event|1|||
19668592|NCT00653939|42116711|FG001|Overall Study|Adverse Event|3|||
19668593|NCT00653939|42116710|FG000|Overall Study|Withdrawal by Subject|3|||
19668594|NCT00653939|42116711|FG001|Overall Study|Withdrawal by Subject|3|||
19668595|NCT00653939|42116710|FG000|Overall Study|Physician Decision|4|||
19668596|NCT00653939|42116711|FG001|Overall Study|Physician Decision|0|||
19668597|NCT00653939|42116710|FG000|Overall Study|Disease Progression|2|||
19668598|NCT00653939|42116711|FG001|Overall Study|Disease Progression|3|||
19668599|NCT00653939|42116710|FG000|Overall Study|Other|2|||
19668600|NCT00653939|42116711|FG001|Overall Study|Other|6|||
19668601|NCT00646451|42116719|FG000|Overall Study|Adverse Event|3|||
19668602|NCT00646451|42116720|FG001|Overall Study|Adverse Event|0|||
19668603|NCT00646451|42116719|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
19668604|NCT00646451|42116720|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
19668605|NCT00642707|42116732|FG000|Overall Study|Adverse Event|0|||
19668606|NCT00642707|42116733|FG001|Overall Study|Adverse Event|0|||
19668607|NCT00642707|42116734|FG002|Overall Study|Adverse Event|0|||
19668608|NCT00642707|42116735|FG003|Overall Study|Adverse Event|2|||
19602917|NCT00778258|42051761|FG001|Overall Study|New Contraindication|0|||
19602918|NCT00778258|42051762|FG002|Overall Study|New Contraindication|0|||
19602919|NCT00778258|42051763|FG003|Overall Study|New Contraindication|0|||
19602920|NCT00778258|42051764|FG004|Overall Study|New Contraindication|0|||
19602921|NCT00778258|42051765|FG005|Overall Study|New Contraindication|0|||
19602922|NCT00778258|42051766|FG006|Overall Study|New Contraindication|0|||
19602923|NCT00778258|42051767|FG007|Overall Study|New Contraindication|1|||
19602924|NCT00778258|42051768|FG008|Overall Study|New Contraindication|0|||
19602925|NCT00778258|42051760|FG000|Overall Study|Non-compliance|0|||
19602926|NCT00778258|42051761|FG001|Overall Study|Non-compliance|0|||
19602927|NCT00778258|42051762|FG002|Overall Study|Non-compliance|0|||
19602928|NCT00778258|42051763|FG003|Overall Study|Non-compliance|1|||
19602929|NCT00778258|42051764|FG004|Overall Study|Non-compliance|0|||
19602930|NCT00778258|42051765|FG005|Overall Study|Non-compliance|0|||
19602931|NCT00778258|42051766|FG006|Overall Study|Non-compliance|0|||
19602932|NCT00778258|42051767|FG007|Overall Study|Non-compliance|0|||
19668609|NCT00642707|42116732|FG000|Overall Study|Withdrawal by Subject|1|||
19668610|NCT00642707|42116733|FG001|Overall Study|Withdrawal by Subject|0|||
19668611|NCT00642707|42116734|FG002|Overall Study|Withdrawal by Subject|0|||
19668612|NCT00642707|42116735|FG003|Overall Study|Withdrawal by Subject|0|||
19602933|NCT00778258|42051768|FG008|Overall Study|Non-compliance|0|||
19602934|NCT00778258|42051760|FG000|Overall Study|Other|0|||
19602935|NCT00778258|42051761|FG001|Overall Study|Other|0|||
19602936|NCT00778258|42051762|FG002|Overall Study|Other|0|||
19668613|NCT00568685|42116748|FG000|Overall Study|Adverse Event|2|||
19668614|NCT00568685|42116749|FG001|Overall Study|Adverse Event|3|||
19668615|NCT00568685|42116750|FG002|Overall Study|Adverse Event|3|||
19668616|NCT00568685|42116748|FG000|Overall Study|Withdrawal by Subject|7|||
19668617|NCT00568685|42116749|FG001|Overall Study|Withdrawal by Subject|2|||
19668618|NCT00568685|42116750|FG002|Overall Study|Withdrawal by Subject|2|||
19668619|NCT00568685|42116748|FG000|Overall Study|Protocol Violation|1|||
19668620|NCT00568685|42116749|FG001|Overall Study|Protocol Violation|0|||
19668621|NCT00568685|42116750|FG002|Overall Study|Protocol Violation|0|||
19668622|NCT00061945|42116764|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
19668623|NCT00061945|42116765|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
19668624|NCT00061945|42116764|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
19668625|NCT00061945|42116765|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
19602937|NCT00778258|42051763|FG003|Overall Study|Other|0|||
19602938|NCT00778258|42051764|FG004|Overall Study|Other|0|||
19602939|NCT00778258|42051765|FG005|Overall Study|Other|0|||
19602940|NCT00778258|42051766|FG006|Overall Study|Other|1|||
19602941|NCT00778258|42051767|FG007|Overall Study|Other|0|||
19602942|NCT00778258|42051768|FG008|Overall Study|Other|0|||
19602943|NCT00988208|42051796|FG000|Overall Study|Adverse Event|71|||
19602944|NCT00988208|42051797|FG001|Overall Study|Adverse Event|122|||
19602945|NCT00988208|42051796|FG000|Overall Study|Disease Progression|103|||
19602946|NCT00988208|42051797|FG001|Overall Study|Disease Progression|89|||
19602947|NCT00988208|42051796|FG000|Overall Study|Withdrawal by Subject|50|||
19602948|NCT00988208|42051797|FG001|Overall Study|Withdrawal by Subject|57|||
19602949|NCT00988208|42051796|FG000|Overall Study|Death|9|||
19602950|NCT00988208|42051797|FG001|Overall Study|Death|15|||
19602951|NCT00988208|42051796|FG000|Overall Study|Lost to Follow-up|2|||
19602952|NCT00988208|42051797|FG001|Overall Study|Lost to Follow-up|3|||
19602953|NCT00988208|42051796|FG000|Overall Study|Protocol Violation|9|||
19602954|NCT00988208|42051797|FG001|Overall Study|Protocol Violation|2|||
19602955|NCT00988208|42051796|FG000|Overall Study|Sponsor Decision|102|||
19602956|NCT00988208|42051797|FG001|Overall Study|Sponsor Decision|78|||
19602957|NCT00988208|42051796|FG000|Overall Study|Clinical Progression|17|||
19602958|NCT00988208|42051797|FG001|Overall Study|Clinical Progression|16|||
19602959|NCT00988208|42051796|FG000|Overall Study|Biochemical Progression|21|||
19602960|NCT00988208|42051797|FG001|Overall Study|Biochemical Progression|7|||
19602961|NCT00988208|42051796|FG000|Overall Study|Clinical Deterioration|7|||
19602962|NCT00988208|42051797|FG001|Overall Study|Clinical Deterioration|14|||
19602963|NCT00988208|42051796|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
19602964|NCT00988208|42051797|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
19602965|NCT00988208|42051796|FG000|Overall Study|Other|8|||
19602966|NCT00988208|42051797|FG001|Overall Study|Other|3|||
19602967|NCT00990704|42051805|FG000|Overall Study|Adverse Event|1|||
19602968|NCT00990704|42051806|FG001|Overall Study|Adverse Event|1|||
19602969|NCT00990704|42051805|FG000|Overall Study|Physician Decision|0|||
19602970|NCT00990704|42051806|FG001|Overall Study|Physician Decision|1|||
19602971|NCT04089553|42051814|FG000|Overall Study|Death|12|||
19602972|NCT04089553|42051815|FG001|Overall Study|Death|11|||
19602973|NCT04089553|42051814|FG000|Overall Study|Lost to Follow-up|2|||
19602974|NCT04089553|42051815|FG001|Overall Study|Lost to Follow-up|2|||
19602975|NCT04089553|42051814|FG000|Overall Study|Progressive disease|0|||
19668626|NCT00061945|42116764|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
19668627|NCT00061945|42116765|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
19602976|NCT04089553|42051815|FG001|Overall Study|Progressive disease|1|||
19602977|NCT04089553|42051814|FG000|Overall Study|Withdrawal by Subject|5|||
19602978|NCT04089553|42051815|FG001|Overall Study|Withdrawal by Subject|2|||
19668628|NCT00061945|42116764|FG000|Course IV: Alemtuzumab|Early exits|6|||
19668629|NCT00061945|42116765|FG001|Course IV: Alemtuzumab|Early exits|15|||
19668630|NCT00642473|42116776|FG000|Overall Study|Withdrawal by Subject|0|||
19668631|NCT00642473|42116777|FG001|Overall Study|Withdrawal by Subject|5|||
19757060|NCT01978938|42207735|FG000|Overall Study|Lost to Follow-up|12|||
19757061|NCT01978938|42207736|FG001|Overall Study|Lost to Follow-up|6|||
19757062|NCT01978938|42207735|FG000|Overall Study|Withdrawal by Subject|8|||
19757063|NCT01978938|42207736|FG001|Overall Study|Withdrawal by Subject|4|||
19757064|NCT01978938|42207735|FG000|Overall Study|Adverse Event, non-fatal|2|||
19757065|NCT01978938|42207736|FG001|Overall Study|Adverse Event, non-fatal|1|||
19757066|NCT01978938|42207735|FG000|Overall Study|Participant noncompliance|1|||
19757067|NCT01978938|42207736|FG001|Overall Study|Participant noncompliance|1|||
19757068|NCT01978938|42207735|FG000|Overall Study|Did not meet inclusion criteria|0|||
19757069|NCT01978938|42207736|FG001|Overall Study|Did not meet inclusion criteria|1|||
19757070|NCT01978938|42207735|FG000|Overall Study|Previously scheduled procedure|0|||
19757071|NCT01978938|42207736|FG001|Overall Study|Previously scheduled procedure|1|||
19757072|NCT03041090|42207744|FG000|Overall Study|technical error|0|||
19757073|NCT03041090|42207745|FG001|Overall Study|technical error|3|||
19757074|NCT00116142|42207753|FG000|Overall Study|Adverse Event|8|||
19668632|NCT00642473|42116776|FG000|Overall Study|Progression or death|2|||
19668633|NCT00642473|42116777|FG001|Overall Study|Progression or death|4|||
19668634|NCT00642473|42116776|FG000|Overall Study|Other|2|||
19668635|NCT00642473|42116777|FG001|Overall Study|Other|2|||
19668636|NCT00645671|42116788|FG000|Overall Study|Protocol Violation|1|||
19668637|NCT00645671|42116789|FG001|Overall Study|Protocol Violation|0|||
19668638|NCT00645671|42116788|FG000|Overall Study|Withdrawal by Subject|0|||
19668639|NCT00645671|42116789|FG001|Overall Study|Withdrawal by Subject|4|||
19668640|NCT00645671|42116788|FG000|Overall Study|Adverse Event|0|||
19668641|NCT00645671|42116789|FG001|Overall Study|Adverse Event|1|||
19668642|NCT00645671|42116788|FG000|Overall Study|Physician Decision|0|||
19668643|NCT00645671|42116789|FG001|Overall Study|Physician Decision|1|||
19668644|NCT00366340|42116797|FG000|Infant Series|Protocol Violation|3|||
19668645|NCT00366340|42116798|FG001|Infant Series|Protocol Violation|4|||
19668646|NCT00366340|42116797|FG000|Infant Series|Withdrawal by Subject|3|||
19668647|NCT00366340|42116798|FG001|Infant Series|Withdrawal by Subject|3|||
19668648|NCT00366340|42116797|FG000|Infant Series|Adverse Event|0|||
19668649|NCT00366340|42116798|FG001|Infant Series|Adverse Event|2|||
19668650|NCT00366340|42116797|FG000|Infant Series|Lost to Follow-up|1|||
19668651|NCT00366340|42116798|FG001|Infant Series|Lost to Follow-up|1|||
19668652|NCT00366340|42116797|FG000|Infant Series|Failure to return|1|||
19668653|NCT00366340|42116798|FG001|Infant Series|Failure to return|0|||
19668654|NCT00366340|42116797|FG000|After the Infant Series|Parent/legal guardian request|1|||
19668655|NCT00366340|42116798|FG001|After the Infant Series|Parent/legal guardian request|1|||
19668656|NCT00366340|42116797|FG000|After the Infant Series|Failed to return|0|||
19668657|NCT00366340|42116798|FG001|After the Infant Series|Failed to return|1|||
19668658|NCT00366340|42116797|FG000|After the Infant Series|Protocol Violation|2|||
19668659|NCT00366340|42116798|FG001|After the Infant Series|Protocol Violation|2|||
19668660|NCT00366340|42116797|FG000|After the Infant Series|Adverse Event|0|||
19668661|NCT00366340|42116798|FG001|After the Infant Series|Adverse Event|1|||
19668662|NCT00366340|42116797|FG000|After the Infant Series|Lost to Follow-up|0|||
19668663|NCT00366340|42116798|FG001|After the Infant Series|Lost to Follow-up|1|||
19668664|NCT00366340|42116797|FG000|Toddler Dose|Failed to return|1|||
19668665|NCT00366340|42116798|FG001|Toddler Dose|Failed to return|0|||
19668666|NCT00366340|42116797|FG000|Toddler Dose|Parent/legal guardian request|0|||
19668667|NCT00366340|42116798|FG001|Toddler Dose|Parent/legal guardian request|1|||
19668668|NCT00061633|42116830|FG000|Overall Study|Adverse Event|1|||
19668669|NCT00061633|42116831|FG001|Overall Study|Adverse Event|2|||
19668670|NCT00061633|42116830|FG000|Overall Study|Withdrawal by Subject|2|||
19668671|NCT00061633|42116831|FG001|Overall Study|Withdrawal by Subject|2|||
19668672|NCT00061633|42116830|FG000|Overall Study|Lost to Follow-up|1|||
19668673|NCT00061633|42116831|FG001|Overall Study|Lost to Follow-up|4|||
19668674|NCT00061633|42116830|FG000|Overall Study|Other|1|||
19668675|NCT00061633|42116831|FG001|Overall Study|Other|1|||
19668676|NCT00061633|42116830|FG000|Overall Study|Never received study treatment|0|||
19668677|NCT00061633|42116831|FG001|Overall Study|Never received study treatment|2|||
19668678|NCT00645593|42116839|FG000|Overall Study|Later found to be ineligible|1|||
19668679|NCT00645593|42116840|FG001|Overall Study|Later found to be ineligible|0|||
19668680|NCT03832738|42116849|FG000|Overall Study|Withdrawal by Subject|6|||
19668681|NCT03832738|42116850|FG001|Overall Study|Withdrawal by Subject|7|||
19668682|NCT03832738|42116851|FG002|Overall Study|Withdrawal by Subject|16|||
19668683|NCT03832738|42116849|FG000|Overall Study|Physician Decision|0|||
19668684|NCT03832738|42116850|FG001|Overall Study|Physician Decision|1|||
19757075|NCT00116142|42207754|FG001|Overall Study|Adverse Event|7|||
19668685|NCT03832738|42116851|FG002|Overall Study|Physician Decision|2|||
19668686|NCT03832738|42116849|FG000|Overall Study|Adverse Event|2|||
19668687|NCT03832738|42116850|FG001|Overall Study|Adverse Event|3|||
19668688|NCT03832738|42116851|FG002|Overall Study|Adverse Event|1|||
19668689|NCT03832738|42116849|FG000|Overall Study|Pregnancy|0|||
19668690|NCT03832738|42116850|FG001|Overall Study|Pregnancy|1|||
19668691|NCT03832738|42116851|FG002|Overall Study|Pregnancy|0|||
19668692|NCT00046891|42116861|FG000|Overall Study|Cancels|5|||
19668693|NCT00046891|42116862|FG001|Overall Study|Cancels|9|||
19668694|NCT00046891|42116861|FG000|Overall Study|Ineligible|1|||
19668695|NCT00046891|42116862|FG001|Overall Study|Ineligible|1|||
19668696|NCT00046891|42116861|FG000|Overall Study|Withdrawal by Subject|18|||
19668697|NCT00046891|42116862|FG001|Overall Study|Withdrawal by Subject|15|||
19668698|NCT00046891|42116861|FG000|Overall Study|Adverse Event|5|||
19668699|NCT00046891|42116862|FG001|Overall Study|Adverse Event|5|||
19668700|NCT00365794|42116876|FG000|Overall Study|Withdrawal by Subject|2|||
19668701|NCT00383500|42116884|FG000|Overall Study|Withdrawal by Subject|8|||
19668702|NCT00383500|42116885|FG001|Overall Study|Withdrawal by Subject|3|||
19668703|NCT00383500|42116886|FG002|Overall Study|Withdrawal by Subject|0|||
19668704|NCT00383500|42116884|FG000|Overall Study|Lost to Follow-up|0|||
19668705|NCT00383500|42116885|FG001|Overall Study|Lost to Follow-up|0|||
19668706|NCT00383500|42116886|FG002|Overall Study|Lost to Follow-up|2|||
19668707|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
19668708|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
19668709|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19668710|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19668711|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19668712|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19668713|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19668714|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
19668715|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
19668716|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
19668717|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
19668718|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
19668719|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
19668720|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
19668721|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
19668722|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
19668723|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
19668724|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
19668725|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
19668726|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
19668727|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
19668728|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Other|0|||
19668729|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Other|1|||
19668730|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Other|0|||
19668731|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Other|0|||
19668732|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Other|0|||
19668733|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Other|0|||
19388783|NCT02544633|41632287|FG002|Treatment Period|Clinical Disease Progression|0|||
19668734|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Other|0|||
19668735|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
19757076|NCT00116142|42207753|FG000|Overall Study|Protocol Violation|2|||
19757077|NCT00116142|42207754|FG001|Overall Study|Protocol Violation|1|||
19668736|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
19668737|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
19668738|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
19668739|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
19668740|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
19668741|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
19668742|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
19668743|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
19668744|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
19668745|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
19668746|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
19668747|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
19602979|NCT04089553|42051814|FG000|Overall Study|Other|6|||
19602980|NCT04089553|42051815|FG001|Overall Study|Other|2|||
19602981|NCT00993668|42051824|FG000|Single-Blind Period|Adverse Event|1|||
19602982|NCT00993668|42051825|FG001|Single-Blind Period|Adverse Event|1|||
19668748|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
19668749|NCT00365716|42116900|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
19668750|NCT00365716|42116901|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
19668751|NCT00365716|42116902|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
19668752|NCT00365716|42116903|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
19668753|NCT00365716|42116904|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
19668754|NCT00365716|42116905|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
19668755|NCT00365716|42116906|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
19668756|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
19668757|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
19668758|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
19757078|NCT00116142|42207753|FG000|Overall Study|Withdrawal by Subject|5|||
19757079|NCT00116142|42207754|FG001|Overall Study|Withdrawal by Subject|5|||
19602983|NCT00993668|42051824|FG000|Single-Blind Period|Lack of Efficacy|0|||
19668759|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
19668760|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
19668761|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
19668762|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
19668763|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
19668764|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
19668765|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
19668766|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
19668767|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
19668768|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
19668769|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
19668770|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
19602984|NCT00993668|42051825|FG001|Single-Blind Period|Lack of Efficacy|1|||
19668771|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
19668772|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
19668773|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
19668774|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
19668775|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
19668776|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
19668777|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
19668778|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
19602985|NCT00993668|42051824|FG000|Single-Blind Period|Lost to Follow-up|3|||
19602986|NCT00993668|42051825|FG001|Single-Blind Period|Lost to Follow-up|1|||
19602987|NCT00993668|42051824|FG000|Open-Label Period|Adverse Event|9|||
19602988|NCT00993668|42051825|FG001|Open-Label Period|Adverse Event|8|||
19602989|NCT00993668|42051824|FG000|Open-Label Period|Lack of Efficacy|4|||
19668779|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
19668780|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
19668781|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
19668782|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
19757080|NCT00116142|42207753|FG000|Overall Study|Physician Decision|3|||
19668783|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
19668784|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
19668785|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
19668786|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
19668787|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
19668788|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
19668789|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
19668790|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
19668791|NCT00365716|42116900|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
19668792|NCT00365716|42116901|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
19668793|NCT00365716|42116902|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
19668794|NCT00365716|42116903|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
19668795|NCT00365716|42116904|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
19668796|NCT00365716|42116905|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
19668797|NCT00365716|42116906|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
19668798|NCT00365716|42116900|FG000|Extension 1|Lost to Follow-up|0|||
19668799|NCT00365716|42116901|FG001|Extension 1|Lost to Follow-up|0|||
19602990|NCT00993668|42051825|FG001|Open-Label Period|Lack of Efficacy|3|||
19602991|NCT00993668|42051824|FG000|Open-Label Period|Withdrawal by Subject|4|||
19602992|NCT00993668|42051825|FG001|Open-Label Period|Withdrawal by Subject|3|||
19602993|NCT00993668|42051824|FG000|Open-Label Period|Lost to Follow-up|6|||
19602994|NCT00993668|42051825|FG001|Open-Label Period|Lost to Follow-up|1|||
19602995|NCT00778102|42051834|FG000|Overall Study|Adverse Event|8|||
19602996|NCT00778102|42051835|FG001|Overall Study|Adverse Event|5|||
19602997|NCT00778102|42051834|FG000|Overall Study|Death|1|||
19602998|NCT00778102|42051835|FG001|Overall Study|Death|1|||
19602999|NCT00778102|42051834|FG000|Overall Study|Lost to Follow-up|1|||
19603000|NCT00778102|42051835|FG001|Overall Study|Lost to Follow-up|0|||
19603001|NCT00778102|42051834|FG000|Overall Study|Violation of Selection Criteria|1|||
19603002|NCT00778102|42051835|FG001|Overall Study|Violation of Selection Criteria|1|||
19603003|NCT00778102|42051834|FG000|Overall Study|Protocol Violation|0|||
19603004|NCT00778102|42051835|FG001|Overall Study|Protocol Violation|1|||
19603005|NCT00778102|42051834|FG000|Overall Study|Refused Treatment|2|||
19603006|NCT00778102|42051835|FG001|Overall Study|Refused Treatment|3|||
19603007|NCT00778102|42051834|FG000|Overall Study|Withdrawal by Subject|1|||
19603008|NCT00778102|42051835|FG001|Overall Study|Withdrawal by Subject|1|||
19603009|NCT00778102|42051834|FG000|Overall Study|Administrative Reason|7|||
19603010|NCT00778102|42051835|FG001|Overall Study|Administrative Reason|10|||
19603011|NCT00756886|42051843|FG000|Overall Study|Lost to Follow-up|1|||
19603012|NCT00756886|42051844|FG001|Overall Study|Lost to Follow-up|0|||
19603013|NCT00756886|42051843|FG000|Overall Study|Adverse Event|0|||
19603014|NCT00756886|42051844|FG001|Overall Study|Adverse Event|3|||
19603015|NCT00756886|42051843|FG000|Overall Study|Lack of Efficacy|1|||
19603016|NCT00756886|42051844|FG001|Overall Study|Lack of Efficacy|0|||
19603017|NCT00756886|42051843|FG000|Overall Study|Ineligible|9|||
19603018|NCT00756886|42051844|FG001|Overall Study|Ineligible|4|||
19603019|NCT00756730|42051852|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
19603020|NCT00756730|42051853|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
19603021|NCT00756730|42051852|FG000|Overall Study|persistent low-level viremmia|0|||
19603022|NCT00756730|42051853|FG001|Overall Study|persistent low-level viremmia|1|||
19603023|NCT00984620|42051861|FG000|Overall Study|Adverse Event|5|||
19603024|NCT00984620|42051862|FG001|Overall Study|Adverse Event|5|||
19603025|NCT00984620|42051861|FG000|Overall Study|Lost to Follow-up|1|||
19603026|NCT00984620|42051862|FG001|Overall Study|Lost to Follow-up|1|||
19603027|NCT00984620|42051861|FG000|Overall Study|Withdrawal by Subject|0|||
19603028|NCT00984620|42051862|FG001|Overall Study|Withdrawal by Subject|2|||
19603029|NCT00984620|42051861|FG000|Overall Study|reason other than listed above|0|||
19603030|NCT00984620|42051862|FG001|Overall Study|reason other than listed above|4|||
19603031|NCT00777946|42051873|FG000|Overall Study|Adverse Event|11|||
19603032|NCT00777946|42051874|FG001|Overall Study|Adverse Event|1|||
19603033|NCT00777946|42051875|FG002|Overall Study|Adverse Event|3|||
19603034|NCT00777946|42051873|FG000|Overall Study|Lack of Efficacy|0|||
19603035|NCT00777946|42051874|FG001|Overall Study|Lack of Efficacy|0|||
19603036|NCT00777946|42051875|FG002|Overall Study|Lack of Efficacy|9|||
19603037|NCT00777946|42051873|FG000|Overall Study|Condition no longer required study drug|1|||
19603038|NCT00777946|42051874|FG001|Overall Study|Condition no longer required study drug|0|||
19603039|NCT00777946|42051875|FG002|Overall Study|Condition no longer required study drug|0|||
19603040|NCT00777946|42051873|FG000|Overall Study|Patient withdrew consent|3|||
19603041|NCT00777946|42051874|FG001|Overall Study|Patient withdrew consent|2|||
19603042|NCT00777946|42051875|FG002|Overall Study|Patient withdrew consent|3|||
19603043|NCT00777946|42051873|FG000|Overall Study|Lost to Follow-up|3|||
19603044|NCT00777946|42051874|FG001|Overall Study|Lost to Follow-up|1|||
19603045|NCT00777946|42051875|FG002|Overall Study|Lost to Follow-up|0|||
19668800|NCT00365716|42116902|FG002|Extension 1|Lost to Follow-up|0|||
19668801|NCT00365716|42116903|FG003|Extension 1|Lost to Follow-up|0|||
19668802|NCT00365716|42116904|FG004|Extension 1|Lost to Follow-up|0|||
19668803|NCT00365716|42116905|FG005|Extension 1|Lost to Follow-up|1|||
19668804|NCT00365716|42116906|FG006|Extension 1|Lost to Follow-up|0|||
19668805|NCT00365716|42116900|FG000|Extension 1|Other|0|||
19668806|NCT00365716|42116901|FG001|Extension 1|Other|0|||
19668807|NCT00365716|42116902|FG002|Extension 1|Other|0|||
19668808|NCT00365716|42116903|FG003|Extension 1|Other|0|||
19668809|NCT00365716|42116904|FG004|Extension 1|Other|0|||
19668810|NCT00365716|42116905|FG005|Extension 1|Other|9|||
19668811|NCT00365716|42116906|FG006|Extension 1|Other|0|||
19668812|NCT00365716|42116900|FG000|Extension 1|Moved|0|||
19668813|NCT00365716|42116901|FG001|Extension 1|Moved|0|||
19668814|NCT00365716|42116902|FG002|Extension 1|Moved|0|||
19668815|NCT00365716|42116903|FG003|Extension 1|Moved|0|||
19668816|NCT00365716|42116904|FG004|Extension 1|Moved|0|||
19668817|NCT00365716|42116905|FG005|Extension 1|Moved|4|||
19668818|NCT00365716|42116906|FG006|Extension 1|Moved|0|||
19668819|NCT00365716|42116900|FG000|Extension 1|Withdrawal by Subject|0|||
19668820|NCT00365716|42116901|FG001|Extension 1|Withdrawal by Subject|0|||
19668821|NCT00365716|42116902|FG002|Extension 1|Withdrawal by Subject|0|||
19668822|NCT00365716|42116903|FG003|Extension 1|Withdrawal by Subject|0|||
19668823|NCT00365716|42116904|FG004|Extension 1|Withdrawal by Subject|0|||
19668824|NCT00365716|42116905|FG005|Extension 1|Withdrawal by Subject|3|||
19668825|NCT00365716|42116906|FG006|Extension 1|Withdrawal by Subject|0|||
19668826|NCT00365716|42116900|FG000|Extension 1|Pregnancy|0|||
19668827|NCT00365716|42116901|FG001|Extension 1|Pregnancy|0|||
19668828|NCT00365716|42116902|FG002|Extension 1|Pregnancy|0|||
19668829|NCT00365716|42116903|FG003|Extension 1|Pregnancy|0|||
19668830|NCT00365716|42116904|FG004|Extension 1|Pregnancy|0|||
19668831|NCT00365716|42116905|FG005|Extension 1|Pregnancy|4|||
19668832|NCT00365716|42116906|FG006|Extension 1|Pregnancy|0|||
19668833|NCT00365716|42116900|FG000|Extension 1|Protocol Violation|0|||
19668834|NCT00365716|42116901|FG001|Extension 1|Protocol Violation|0|||
19668835|NCT00365716|42116902|FG002|Extension 1|Protocol Violation|0|||
19668836|NCT00365716|42116903|FG003|Extension 1|Protocol Violation|0|||
19668837|NCT00365716|42116904|FG004|Extension 1|Protocol Violation|0|||
19668838|NCT00365716|42116905|FG005|Extension 1|Protocol Violation|1|||
19668839|NCT00365716|42116906|FG006|Extension 1|Protocol Violation|0|||
19668840|NCT00365716|42116900|FG000|Extension 2|Lost to Follow-up|0|||
19668841|NCT00365716|42116901|FG001|Extension 2|Lost to Follow-up|0|||
19668842|NCT00365716|42116902|FG002|Extension 2|Lost to Follow-up|0|||
19388784|NCT02544633|41632288|FG003|Treatment Period|Clinical Disease Progression|1|||
19668843|NCT00365716|42116903|FG003|Extension 2|Lost to Follow-up|0|||
19668844|NCT00365716|42116904|FG004|Extension 2|Lost to Follow-up|0|||
19668845|NCT00365716|42116905|FG005|Extension 2|Lost to Follow-up|0|||
19668846|NCT00365716|42116906|FG006|Extension 2|Lost to Follow-up|2|||
19668847|NCT00365716|42116900|FG000|Extension 2|Other|0|||
19668848|NCT00365716|42116901|FG001|Extension 2|Other|0|||
19668849|NCT00365716|42116902|FG002|Extension 2|Other|0|||
19668850|NCT00365716|42116903|FG003|Extension 2|Other|0|||
19668851|NCT00365716|42116904|FG004|Extension 2|Other|0|||
19668852|NCT00365716|42116905|FG005|Extension 2|Other|0|||
19668853|NCT00365716|42116906|FG006|Extension 2|Other|3|||
19668854|NCT00365716|42116900|FG000|Extension 2|Withdrawal by Subject|0|||
19668855|NCT00365716|42116901|FG001|Extension 2|Withdrawal by Subject|0|||
19668856|NCT00365716|42116902|FG002|Extension 2|Withdrawal by Subject|0|||
19668857|NCT00365716|42116903|FG003|Extension 2|Withdrawal by Subject|0|||
19668858|NCT00365716|42116904|FG004|Extension 2|Withdrawal by Subject|0|||
19668859|NCT00365716|42116905|FG005|Extension 2|Withdrawal by Subject|0|||
19668860|NCT00365716|42116906|FG006|Extension 2|Withdrawal by Subject|5|||
19668861|NCT00059839|42116922|FG000|Overall Study|Death|1|||
19668862|NCT00059839|42116923|FG001|Overall Study|Death|1|||
19668863|NCT00059839|42116922|FG000|Overall Study|Lack of Efficacy|6|||
19668864|NCT00059839|42116923|FG001|Overall Study|Lack of Efficacy|5|||
19668865|NCT00059839|42116922|FG000|Overall Study|Lost to Follow-up|2|||
19668866|NCT00059839|42116923|FG001|Overall Study|Lost to Follow-up|0|||
19668867|NCT00059839|42116922|FG000|Overall Study|Physician Decision|1|||
19668868|NCT00059839|42116923|FG001|Overall Study|Physician Decision|2|||
19668869|NCT00059839|42116922|FG000|Overall Study|Withdrawal by Subject|1|||
19757081|NCT00116142|42207754|FG001|Overall Study|Physician Decision|1|||
19757082|NCT00116142|42207753|FG000|Overall Study|Delayed Radiation Therapy|1|||
19668870|NCT00059839|42116923|FG001|Overall Study|Withdrawal by Subject|6|||
19668871|NCT00059839|42116922|FG000|Overall Study|Ineligible|1|||
19668872|NCT00059839|42116923|FG001|Overall Study|Ineligible|3|||
19668873|NCT00059215|42116933|FG000|Overall Study|Adverse Event|5|||
19668874|NCT00059215|42116934|FG001|Overall Study|Adverse Event|5|||
19668875|NCT00059215|42116935|FG002|Overall Study|Adverse Event|9|||
19668876|NCT00059215|42116936|FG003|Overall Study|Adverse Event|9|||
19668877|NCT00059215|42116933|FG000|Overall Study|Death|0|||
19668878|NCT00059215|42116934|FG001|Overall Study|Death|0|||
19668879|NCT00059215|42116935|FG002|Overall Study|Death|3|||
19668880|NCT00059215|42116936|FG003|Overall Study|Death|0|||
19388785|NCT02544633|41632285|FG000|Survival Follow-up Period|Death|12|||
19668881|NCT00059215|42116933|FG000|Overall Study|Lost to Follow-up|1|||
19668882|NCT00059215|42116934|FG001|Overall Study|Lost to Follow-up|2|||
19668883|NCT00059215|42116935|FG002|Overall Study|Lost to Follow-up|0|||
19668884|NCT00059215|42116936|FG003|Overall Study|Lost to Follow-up|0|||
19668885|NCT00059215|42116933|FG000|Overall Study|Withdrawal by Subject|4|||
19668886|NCT00059215|42116934|FG001|Overall Study|Withdrawal by Subject|4|||
19668887|NCT00059215|42116935|FG002|Overall Study|Withdrawal by Subject|1|||
19668888|NCT00059215|42116936|FG003|Overall Study|Withdrawal by Subject|3|||
19388786|NCT02544633|41632286|FG001|Survival Follow-up Period|Death|14|||
19388787|NCT02544633|41632287|FG002|Survival Follow-up Period|Death|3|||
19388788|NCT02544633|41632288|FG003|Survival Follow-up Period|Death|9|||
19388789|NCT02544633|41632285|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
19388790|NCT02544633|41632286|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
19388791|NCT02544633|41632287|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
19388792|NCT02544633|41632288|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
19388793|NCT02544633|41632285|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
19388794|NCT02544633|41632286|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
19388795|NCT02544633|41632287|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
19388796|NCT02544633|41632288|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
19388797|NCT02544633|41632285|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
19388798|NCT02544633|41632286|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
19388799|NCT02544633|41632287|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
19388800|NCT02544633|41632288|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
19388801|NCT02678351|41632310|FG000|Overall Study|Withdrawal by Subject|1|||
19603046|NCT00777946|42051873|FG000|Overall Study|Protocol deviation|2|||
19603047|NCT00777946|42051874|FG001|Overall Study|Protocol deviation|1|||
19603048|NCT00777946|42051875|FG002|Overall Study|Protocol deviation|1|||
19603049|NCT00777946|42051873|FG000|Overall Study|Randomized in error|1|||
19603050|NCT00777946|42051874|FG001|Overall Study|Randomized in error|1|||
19603051|NCT00777946|42051875|FG002|Overall Study|Randomized in error|0|||
19603052|NCT00990314|42051883|FG000|Overall Study|Death|2|||
19603053|NCT00990314|42051883|FG000|Overall Study|Adverse Event|2|||
19603054|NCT00990314|42051883|FG000|Overall Study|Withdrawal by Subject|3|||
19603055|NCT00990314|42051883|FG000|Overall Study|Non-Compliance|1|||
19603056|NCT00990314|42051883|FG000|Overall Study|Physician Decision|3|||
19603057|NCT00990314|42051883|FG000|Overall Study|Lack of Efficacy|1|||
19603058|NCT00756652|42051889|FG000|Original Phase|Withdrawal by Subject|864|||
19603059|NCT00756652|42051890|FG001|Original Phase|Withdrawal by Subject|23|||
19603060|NCT00756652|42051889|FG000|Original Phase|Lost to Follow-up|601|||
19603061|NCT00756652|42051890|FG001|Original Phase|Lost to Follow-up|0|||
19603062|NCT00756652|42051889|FG000|Original Phase|Other Discontinuation|797|||
19603063|NCT00756652|42051890|FG001|Original Phase|Other Discontinuation|5|||
19603064|NCT00756652|42051889|FG000|Original Phase|Participant Noncompliance|18622|||
19603065|NCT00756652|42051890|FG001|Original Phase|Participant Noncompliance|424|||
19603066|NCT00756652|42051889|FG000|Original Phase|Unknown Discontinuation Reason|2|||
19603067|NCT00756652|42051890|FG001|Original Phase|Unknown Discontinuation Reason|0|||
19603068|NCT00756652|42051889|FG000|Original Phase|Participants without data|3259|||
19603069|NCT00756652|42051890|FG001|Original Phase|Participants without data|466|||
19603070|NCT00756652|42051889|FG000|Original Phase|Death|168|||
19603071|NCT00756652|42051890|FG001|Original Phase|Death|1|||
19603072|NCT00756652|42051889|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
19603073|NCT00756652|42051890|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
19603074|NCT00756652|42051889|FG000|Re-Op Phase|Withdrawal by Subject|62|||
19603075|NCT00756652|42051890|FG001|Re-Op Phase|Withdrawal by Subject|0|||
19603076|NCT00756652|42051889|FG000|Re-Op Phase|Death|6|||
19603077|NCT00756652|42051890|FG001|Re-Op Phase|Death|0|||
19603078|NCT00756652|42051889|FG000|Re-Op Phase|Lost to Follow-up|340|||
19603079|NCT00756652|42051890|FG001|Re-Op Phase|Lost to Follow-up|0|||
19603080|NCT00756652|42051889|FG000|Re-Op Phase|Site Closed|2454|||
19603081|NCT00756652|42051890|FG001|Re-Op Phase|Site Closed|0|||
19603082|NCT00756652|42051889|FG000|Re-Op Phase|Withdrawn after explant|14|||
19603083|NCT00756652|42051890|FG001|Re-Op Phase|Withdrawn after explant|0|||
19603084|NCT00777556|42051894|FG000|Overall Study|Inappropriate self-selection|34|||
19603085|NCT00777556|42051894|FG000|Overall Study|Dispensed but did not use product|12|||
19603086|NCT00777556|42051894|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
19603087|NCT00602979|42051903|FG000|Overall Study|Lost to Follow-up|3|||
19603088|NCT00602979|42051904|FG001|Overall Study|Lost to Follow-up|2|||
19603089|NCT00602979|42051905|FG002|Overall Study|Lost to Follow-up|3|||
19603090|NCT00602979|42051906|FG003|Overall Study|Lost to Follow-up|2|||
19603091|NCT00602979|42051907|FG004|Overall Study|Lost to Follow-up|3|||
19603092|NCT00602979|42051903|FG000|Overall Study|Failed Intubation|0|||
19603093|NCT00602979|42051904|FG001|Overall Study|Failed Intubation|1|||
19603094|NCT00602979|42051905|FG002|Overall Study|Failed Intubation|0|||
19603095|NCT00602979|42051906|FG003|Overall Study|Failed Intubation|1|||
19603096|NCT00602979|42051907|FG004|Overall Study|Failed Intubation|0|||
19603097|NCT04081363|42051921|FG000|Overall Study|Withdrawal by Subject|1|||
19603098|NCT04081363|42051922|FG001|Overall Study|Withdrawal by Subject|0|||
19603099|NCT00993044|42051928|FG000|Irinotecan 50 mg|Physician Decision|1|||
19603100|NCT00777088|42051942|FG000|Overall Study|PED Treatment not attempted|1|||
19603101|NCT00763282|42051958|FG000|Overall Study|Withdrawal by Subject|6|||
19603102|NCT00763282|42051959|FG001|Overall Study|Withdrawal by Subject|5|||
19603103|NCT00763282|42051958|FG000|Overall Study|Death|4|||
19603104|NCT00763282|42051959|FG001|Overall Study|Death|3|||
19603105|NCT00763282|42051958|FG000|Overall Study|Lost to Follow-up|22|||
19668889|NCT00059215|42116933|FG000|Overall Study|Protocol Violation|1|||
19668890|NCT00059215|42116934|FG001|Overall Study|Protocol Violation|0|||
19668891|NCT00059215|42116935|FG002|Overall Study|Protocol Violation|1|||
19668892|NCT00059215|42116936|FG003|Overall Study|Protocol Violation|0|||
19668893|NCT00059215|42116933|FG000|Overall Study|Protocol entry criteria not met|1|||
19668894|NCT00059215|42116934|FG001|Overall Study|Protocol entry criteria not met|1|||
19668895|NCT00059215|42116935|FG002|Overall Study|Protocol entry criteria not met|0|||
19668896|NCT00059215|42116936|FG003|Overall Study|Protocol entry criteria not met|2|||
19668897|NCT00059215|42116933|FG000|Overall Study|Physician Decision|1|||
19668898|NCT00059215|42116934|FG001|Overall Study|Physician Decision|2|||
19757083|NCT00116142|42207754|FG001|Overall Study|Delayed Radiation Therapy|0|||
19757084|NCT00116142|42207753|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
19757085|NCT00116142|42207754|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
19757086|NCT00116142|42207753|FG000|Overall Study|Patient stopped due to depression|0|||
19757087|NCT00116142|42207754|FG001|Overall Study|Patient stopped due to depression|1|||
19757088|NCT00116142|42207753|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
19757089|NCT00116142|42207754|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
19757090|NCT00116142|42207753|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
19757091|NCT00116142|42207754|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
19757092|NCT00116142|42207753|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
19603106|NCT00763282|42051959|FG001|Overall Study|Lost to Follow-up|26|||
19603107|NCT00988598|42051969|FG000|Overall Study|Withdrawal by Subject|2|||
19603108|NCT00988598|42051970|FG001|Overall Study|Withdrawal by Subject|0|||
19603109|NCT00979628|42051979|FG000|Overall Study|received regimen < 24 hours|7|||
19603110|NCT00979628|42051980|FG001|Overall Study|received regimen < 24 hours|6|||
19757093|NCT00116142|42207754|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
19757094|NCT03135522|42207765|FG000|Overall Study|Adverse Event|1|||
19757095|NCT03135522|42207766|FG001|Overall Study|Adverse Event|0|||
19757096|NCT02875080|42207789|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
19757097|NCT02875080|42207790|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
19757098|NCT02875080|42207791|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
19757099|NCT03129360|42207802|FG000|Overall Study|Did not meet entry criteria|0|||
19757100|NCT03129360|42207803|FG001|Overall Study|Did not meet entry criteria|2|||
19757101|NCT03129360|42207804|FG002|Overall Study|Did not meet entry criteria|1|||
19757102|NCT03129360|42207802|FG000|Overall Study|Excluded due to motion in scanner|1|||
19757103|NCT03129360|42207803|FG001|Overall Study|Excluded due to motion in scanner|0|||
19757104|NCT03129360|42207804|FG002|Overall Study|Excluded due to motion in scanner|0|||
19757105|NCT03165045|42207812|FG000|Visit 1|No registration after visit 1|9|||
19757106|NCT03165045|42207812|FG000|Visit 1|No treatment documented|10|||
19603111|NCT00979628|42051981|FG002|Overall Study|received regimen < 24 hours|5|||
19603112|NCT00979628|42051979|FG000|Overall Study|received steroids|1|||
19603113|NCT00979628|42051980|FG001|Overall Study|received steroids|1|||
19757107|NCT03165045|42207812|FG000|Visit 1|No visit 1|10|||
19757108|NCT03165045|42207812|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
19757109|NCT03165045|42207812|FG000|Visit 2|No available total CCQ score at all|29|||
19757110|NCT03165045|42207812|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
19757111|NCT01928199|42207820|FG000|Overall Study|Lost to Follow-up|2|||
19757112|NCT01928199|42207821|FG001|Overall Study|Lost to Follow-up|1|||
19757113|NCT01928199|42207820|FG000|Overall Study|Withdrawal by Subject|3|||
19757114|NCT01928199|42207821|FG001|Overall Study|Withdrawal by Subject|5|||
19757115|NCT03128892|42207827|FG000|Overall Study|Withdrawal by Subject|2|||
19757116|NCT03128892|42207827|FG000|Overall Study|Physician Decision|1|||
19757117|NCT03039686|42207843|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
19757118|NCT03039686|42207844|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
19757119|NCT03039686|42207845|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
19757120|NCT03039686|42207843|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
19757121|NCT03039686|42207844|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
19757122|NCT03039686|42207845|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
19757123|NCT03039686|42207843|FG000|Double-blind Period|Withdrawal by Subject|2|||
19757124|NCT03039686|42207844|FG001|Double-blind Period|Withdrawal by Subject|2|||
19757125|NCT03039686|42207845|FG002|Double-blind Period|Withdrawal by Subject|1|||
19757126|NCT03039686|42207843|FG000|Double-blind Period|Death|0|||
19757127|NCT03039686|42207844|FG001|Double-blind Period|Death|0|||
19757128|NCT03039686|42207845|FG002|Double-blind Period|Death|1|||
19757129|NCT03039686|42207843|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
19757130|NCT03039686|42207844|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
19603114|NCT00979628|42051981|FG002|Overall Study|received steroids|0|||
19757131|NCT03039686|42207845|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
19757132|NCT03039686|42207843|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
19757133|NCT03039686|42207844|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
19757134|NCT03039686|42207845|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
19757135|NCT03039686|42207843|FG000|Open Label Period|Withdrawal by Subject|0|||
19757136|NCT03039686|42207844|FG001|Open Label Period|Withdrawal by Subject|3|||
19757137|NCT03039686|42207845|FG002|Open Label Period|Withdrawal by Subject|1|||
19757138|NCT01822275|42207863|FG000|Overall Study|Withdrawal by Subject|3|||
19757139|NCT01822275|42207863|FG000|Overall Study|Adverse Event|3|||
19757140|NCT01822275|42207863|FG000|Overall Study|Progression|14|||
19757141|NCT01822275|42207863|FG000|Overall Study|Physician Decision|2|||
19757142|NCT01656434|42207875|FG000|Overall Study|Adverse Event|199|||
19757143|NCT01656434|42207876|FG001|Overall Study|Adverse Event|63|||
19757144|NCT01656434|42207875|FG000|Overall Study|Enrollment terminated at trial site|2|||
19757145|NCT01656434|42207876|FG001|Overall Study|Enrollment terminated at trial site|0|||
19757146|NCT01656434|42207875|FG000|Overall Study|Lost to Follow-up|309|||
19757147|NCT01656434|42207876|FG001|Overall Study|Lost to Follow-up|76|||
19757148|NCT01656434|42207875|FG000|Overall Study|Site discontinued study participation|24|||
19757149|NCT01656434|42207876|FG001|Overall Study|Site discontinued study participation|9|||
19757150|NCT01656434|42207875|FG000|Overall Study|Screen failure|2|||
19757151|NCT01656434|42207876|FG001|Overall Study|Screen failure|0|||
19757152|NCT01656434|42207875|FG000|Overall Study|Protocol Violation|7|||
19757153|NCT01656434|42207876|FG001|Overall Study|Protocol Violation|0|||
19757154|NCT01656434|42207875|FG000|Overall Study|Pregnancy wish|18|||
19757155|NCT01656434|42207876|FG001|Overall Study|Pregnancy wish|6|||
19757156|NCT01656434|42207875|FG000|Overall Study|Pregnancy|45|||
19757157|NCT01656434|42207876|FG001|Overall Study|Pregnancy|10|||
19757158|NCT01656434|42207875|FG000|Overall Study|Physician Decision|7|||
19757159|NCT01656434|42207876|FG001|Overall Study|Physician Decision|2|||
19757160|NCT01656434|42207875|FG000|Overall Study|Non-compliance with study drug|48|||
19757161|NCT01656434|42207876|FG001|Overall Study|Non-compliance with study drug|9|||
19757162|NCT01656434|42207875|FG000|Overall Study|Study terminated by sponsor|1501|||
19757163|NCT01656434|42207876|FG001|Overall Study|Study terminated by sponsor|348|||
19757164|NCT01656434|42207875|FG000|Overall Study|Participant discontinued; drug related|13|||
19757165|NCT01656434|42207876|FG001|Overall Study|Participant discontinued; drug related|4|||
19757166|NCT01656434|42207875|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
19757167|NCT01656434|42207876|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
19757168|NCT01656434|42207875|FG000|Overall Study|Non-compliance with protocol|39|||
19757169|NCT01656434|42207876|FG001|Overall Study|Non-compliance with protocol|15|||
19757170|NCT01656434|42207875|FG000|Overall Study|Participant moved|40|||
19757171|NCT01656434|42207876|FG001|Overall Study|Participant moved|12|||
19757172|NCT01656434|42207875|FG000|Overall Study|Participant withdrew consent|28|||
19757173|NCT01656434|42207876|FG001|Overall Study|Participant withdrew consent|9|||
19757174|NCT01656434|42207875|FG000|Overall Study|Withdrawal by Subject|64|||
19757175|NCT01656434|42207876|FG001|Overall Study|Withdrawal by Subject|7|||
19757176|NCT02931396|42207884|FG000|Overall Study|Lost to Follow-up|3|||
19757177|NCT02931396|42207885|FG001|Overall Study|Lost to Follow-up|0|||
19757178|NCT02931396|42207884|FG000|Overall Study|Withdrawal by Subject|2|||
19757179|NCT02931396|42207885|FG001|Overall Study|Withdrawal by Subject|0|||
19757180|NCT03037580|42207893|FG000|Overall Study|Withdrawal by Subject|3|||
19757181|NCT03037580|42207894|FG001|Overall Study|Withdrawal by Subject|0|||
19757182|NCT03037580|42207893|FG000|Overall Study|Adverse Event|1|||
19757183|NCT03037580|42207894|FG001|Overall Study|Adverse Event|0|||
19757184|NCT03037580|42207893|FG000|Overall Study|Study Terminated by Sponsor|12|||
19757185|NCT03037580|42207894|FG001|Overall Study|Study Terminated by Sponsor|15|||
19757186|NCT03037580|42207893|FG000|Overall Study|Death|0|||
19757187|NCT03037580|42207894|FG001|Overall Study|Death|1|||
19757188|NCT01755195|42207900|FG000|Overall Study|Participant noncompliance|2|||
19757189|NCT01755195|42207900|FG000|Overall Study|Switched to alternative treatment|4|||
19757190|NCT01755195|42207900|FG000|Overall Study|Withdrawal by Subject|1|||
19757191|NCT01755195|42207900|FG000|Overall Study|Participant refused to start treatment|1|||
19757192|NCT01755195|42207900|FG000|Overall Study|Participant has been consented for another trial|1|||
19757193|NCT01755195|42207900|FG000|Overall Study|Refused further treatment|3|||
19757194|NCT01755195|42207900|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
19757195|NCT00897104|42207907|FG000|Overall Study|Lost to Follow-up|12|||
19757196|NCT00897104|42207908|FG001|Overall Study|Lost to Follow-up|17|||
19757197|NCT00897104|42207909|FG002|Overall Study|Lost to Follow-up|2|||
19757198|NCT00897104|42207907|FG000|Overall Study|Pregnancy|0|||
19757199|NCT00897104|42207908|FG001|Overall Study|Pregnancy|1|||
19757200|NCT00897104|42207909|FG002|Overall Study|Pregnancy|0|||
19757201|NCT00897104|42207907|FG000|Overall Study|Protocol Violation|0|||
19757202|NCT00897104|42207908|FG001|Overall Study|Protocol Violation|1|||
19757203|NCT00897104|42207909|FG002|Overall Study|Protocol Violation|0|||
19757204|NCT00897104|42207907|FG000|Overall Study|Withdrawal by Subject|23|||
19757205|NCT00897104|42207908|FG001|Overall Study|Withdrawal by Subject|27|||
19757206|NCT00897104|42207909|FG002|Overall Study|Withdrawal by Subject|3|||
19757207|NCT00897104|42207907|FG000|Overall Study|Abnormal Prestudy Labs|2|||
19757208|NCT00897104|42207908|FG001|Overall Study|Abnormal Prestudy Labs|0|||
19757209|NCT00897104|42207909|FG002|Overall Study|Abnormal Prestudy Labs|0|||
19757210|NCT00897104|42207907|FG000|Overall Study|Abnormal Baseline ECG|2|||
19757211|NCT00897104|42207908|FG001|Overall Study|Abnormal Baseline ECG|2|||
19757212|NCT00897104|42207909|FG002|Overall Study|Abnormal Baseline ECG|0|||
19757213|NCT00897104|42207907|FG000|Overall Study|Need for Concom. Med.|0|||
19757214|NCT00897104|42207908|FG001|Overall Study|Need for Concom. Med.|1|||
19757215|NCT00897104|42207909|FG002|Overall Study|Need for Concom. Med.|1|||
19388802|NCT02683187|41632314|FG000|Overall Study|Failed IV access|3|||
19388803|NCT02683187|41632314|FG000|Overall Study|Withdrawal by Subject|5|||
19388804|NCT02683109|41632324|FG000|Overall Study|Adverse Event|1|||
19388805|NCT02683109|41632325|FG001|Overall Study|Adverse Event|0|||
19388806|NCT02544321|41632334|FG000|Overall Study|Withdrawal by Subject|1|||
19388807|NCT02544321|41632335|FG001|Overall Study|Withdrawal by Subject|2|||
19388808|NCT02544321|41632334|FG000|Overall Study|Adverse Event|1|||
19388809|NCT02544321|41632335|FG001|Overall Study|Adverse Event|1|||
19388810|NCT02544321|41632334|FG000|Overall Study|Protocol Violation|0|||
19388811|NCT02544321|41632335|FG001|Overall Study|Protocol Violation|1|||
19388812|NCT02533401|41632350|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
19388813|NCT02533401|41632350|FG000|Overall Study|Death|5|||
19388814|NCT02533401|41632350|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
19388815|NCT02533401|41632350|FG000|Overall Study|Lost to Follow-up|1|||
19388816|NCT02533401|41632350|FG000|Overall Study|Violation of Selection Criteria|1|||
19388817|NCT02536833|41632358|FG000|Overall Study|Discontinued Before Treatment|0|||
19388818|NCT02536833|41632359|FG001|Overall Study|Discontinued Before Treatment|0|||
19388819|NCT02536833|41632360|FG002|Overall Study|Discontinued Before Treatment|1|||
19388820|NCT02536833|41632361|FG003|Overall Study|Discontinued Before Treatment|2|||
19388821|NCT02536833|41632358|FG000|Overall Study|Adverse Event|1|||
19388822|NCT02536833|41632359|FG001|Overall Study|Adverse Event|3|||
19388823|NCT02536833|41632360|FG002|Overall Study|Adverse Event|4|||
19388824|NCT02536833|41632361|FG003|Overall Study|Adverse Event|1|||
19388825|NCT02536833|41632358|FG000|Overall Study|Lost to Follow-up|2|||
19388826|NCT02536833|41632359|FG001|Overall Study|Lost to Follow-up|1|||
19388827|NCT02536833|41632360|FG002|Overall Study|Lost to Follow-up|2|||
19388828|NCT02536833|41632361|FG003|Overall Study|Lost to Follow-up|2|||
19388829|NCT02536833|41632358|FG000|Overall Study|Physician Decision|0|||
19388830|NCT02536833|41632359|FG001|Overall Study|Physician Decision|0|||
19388831|NCT02536833|41632360|FG002|Overall Study|Physician Decision|0|||
19388832|NCT02536833|41632361|FG003|Overall Study|Physician Decision|1|||
19388833|NCT02536833|41632358|FG000|Overall Study|Site Terminated by Sponsor|2|||
19388834|NCT02536833|41632359|FG001|Overall Study|Site Terminated by Sponsor|2|||
19388835|NCT02536833|41632360|FG002|Overall Study|Site Terminated by Sponsor|2|||
19388836|NCT02536833|41632361|FG003|Overall Study|Site Terminated by Sponsor|2|||
19388837|NCT02536833|41632358|FG000|Overall Study|Subject Non-Compliance|0|||
19388838|NCT02536833|41632359|FG001|Overall Study|Subject Non-Compliance|1|||
19388839|NCT02536833|41632360|FG002|Overall Study|Subject Non-Compliance|1|||
19388840|NCT02536833|41632361|FG003|Overall Study|Subject Non-Compliance|0|||
19388841|NCT02536833|41632358|FG000|Overall Study|Withdrawal by Subject|4|||
19388842|NCT02536833|41632359|FG001|Overall Study|Withdrawal by Subject|3|||
19388843|NCT02536833|41632360|FG002|Overall Study|Withdrawal by Subject|5|||
19388844|NCT02536833|41632361|FG003|Overall Study|Withdrawal by Subject|11|||
19388845|NCT02680847|41632375|FG000|Overall Study|Other|2|||
19388846|NCT02680847|41632376|FG001|Overall Study|Other|0|||
19388847|NCT02680847|41632377|FG002|Overall Study|Other|0|||
19388848|NCT02680847|41632375|FG000|Overall Study|No longer met eligibility criteria|2|||
19388849|NCT02680847|41632376|FG001|Overall Study|No longer met eligibility criteria|2|||
19388850|NCT02680847|41632377|FG002|Overall Study|No longer met eligibility criteria|0|||
19388851|NCT02680847|41632375|FG000|Overall Study|Unwilling to participate in study|1|||
19388852|NCT02680847|41632376|FG001|Overall Study|Unwilling to participate in study|1|||
19388853|NCT02680847|41632377|FG002|Overall Study|Unwilling to participate in study|0|||
19388854|NCT02680847|41632375|FG000|Overall Study|Lack of Efficacy|0|||
19388855|NCT02680847|41632376|FG001|Overall Study|Lack of Efficacy|0|||
19388856|NCT02680847|41632377|FG002|Overall Study|Lack of Efficacy|2|||
19388857|NCT02680847|41632375|FG000|Overall Study|Adverse Event|0|||
19388858|NCT02680847|41632376|FG001|Overall Study|Adverse Event|0|||
19388859|NCT02680847|41632377|FG002|Overall Study|Adverse Event|1|||
19388860|NCT02532855|41632387|FG000|Overall Study|Lost to Follow-up|4|||
19757216|NCT00897104|42207907|FG000|Overall Study|Lack of Migraine Attack|20|||
19388861|NCT02532855|41632388|FG001|Overall Study|Lost to Follow-up|3|||
19388862|NCT02532855|41632387|FG000|Overall Study|Withdrawal by Subject|4|||
19388863|NCT02532855|41632388|FG001|Overall Study|Withdrawal by Subject|8|||
19388864|NCT02530125|41632394|FG000|Completed Treatment|Early termination of study|1|||
19388865|NCT02530125|41632394|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
19388866|NCT01661205|41632398|FG000|Overall Study|Physician Decision|2|||
19388867|NCT02055820|41632412|FG000|Phase I: Dose-Finding|Death|1|||
19388868|NCT02055820|41632413|FG001|Phase I: Dose-Finding|Death|0|||
19388869|NCT02055820|41632414|FG002|Phase I: Dose-Finding|Death|1|||
19388870|NCT02055820|41632415|FG003|Phase I: Dose-Finding|Death|2|||
19388871|NCT02055820|41632416|FG004|Phase I: Dose-Finding|Death|0|||
19388872|NCT02055820|41632417|FG005|Phase I: Dose-Finding|Death|1|||
19388873|NCT02055820|41632418|FG006|Phase I: Dose-Finding|Death|1|||
19388874|NCT02055820|41632419|FG007|Phase I: Dose-Finding|Death|0|||
19388875|NCT02055820|41632420|FG008|Phase I: Dose-Finding|Death|0|||
19388876|NCT02055820|41632421|FG009|Phase I: Dose-Finding|Death|0|||
19388877|NCT02055820|41632412|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388878|NCT02055820|41632413|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388879|NCT02055820|41632414|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388880|NCT02055820|41632415|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388881|NCT02055820|41632416|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388882|NCT02055820|41632417|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
19388883|NCT02055820|41632418|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388884|NCT02055820|41632419|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388885|NCT02055820|41632420|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388886|NCT02055820|41632421|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
19388887|NCT02055820|41632412|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388888|NCT02055820|41632413|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388889|NCT02055820|41632414|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388890|NCT02055820|41632415|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
19388891|NCT02055820|41632416|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388892|NCT02055820|41632417|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388893|NCT02055820|41632418|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
19388894|NCT02055820|41632419|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388895|NCT02055820|41632420|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388896|NCT02055820|41632421|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
19388897|NCT02055820|41632412|FG000|Phase II: Expansion|Death|0|||
19388898|NCT02055820|41632413|FG001|Phase II: Expansion|Death|0|||
19388899|NCT02055820|41632414|FG002|Phase II: Expansion|Death|0|||
19388900|NCT02055820|41632415|FG003|Phase II: Expansion|Death|0|||
19388901|NCT02055820|41632416|FG004|Phase II: Expansion|Death|33|||
19388902|NCT02055820|41632417|FG005|Phase II: Expansion|Death|0|||
19388903|NCT02055820|41632418|FG006|Phase II: Expansion|Death|0|||
19388904|NCT02055820|41632419|FG007|Phase II: Expansion|Death|0|||
19388905|NCT02055820|41632420|FG008|Phase II: Expansion|Death|0|||
19388906|NCT02055820|41632421|FG009|Phase II: Expansion|Death|0|||
19388907|NCT02055820|41632412|FG000|Phase II: Expansion|Lost to Follow-up|0|||
19388908|NCT02055820|41632413|FG001|Phase II: Expansion|Lost to Follow-up|0|||
19388909|NCT02055820|41632414|FG002|Phase II: Expansion|Lost to Follow-up|0|||
19388910|NCT02055820|41632415|FG003|Phase II: Expansion|Lost to Follow-up|0|||
19388911|NCT02055820|41632416|FG004|Phase II: Expansion|Lost to Follow-up|4|||
19388912|NCT02055820|41632417|FG005|Phase II: Expansion|Lost to Follow-up|0|||
19388913|NCT02055820|41632418|FG006|Phase II: Expansion|Lost to Follow-up|0|||
19388914|NCT02055820|41632419|FG007|Phase II: Expansion|Lost to Follow-up|0|||
19388915|NCT02055820|41632420|FG008|Phase II: Expansion|Lost to Follow-up|0|||
19388916|NCT02055820|41632421|FG009|Phase II: Expansion|Lost to Follow-up|0|||
19388917|NCT02055820|41632412|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
19388918|NCT02055820|41632413|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
19388919|NCT02055820|41632414|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
19388920|NCT02055820|41632415|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
19388921|NCT02055820|41632416|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
19388922|NCT02055820|41632417|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
19388923|NCT02055820|41632418|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
19388924|NCT02055820|41632419|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
19388925|NCT02055820|41632420|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
19388926|NCT02055820|41632421|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
19388927|NCT02055352|41632465|FG000|Overall Study|Adverse Event|0|||
19388928|NCT02055352|41632466|FG001|Overall Study|Adverse Event|1|||
19388929|NCT02055352|41632465|FG000|Overall Study|Non-eligible|0|||
19388930|NCT02055352|41632466|FG001|Overall Study|Non-eligible|1|||
19388931|NCT02055352|41632465|FG000|Overall Study|Poor compliance|1|||
19388932|NCT02055352|41632466|FG001|Overall Study|Poor compliance|1|||
19388933|NCT02055352|41632465|FG000|Overall Study|Death|1|||
19388934|NCT02055352|41632466|FG001|Overall Study|Death|2|||
19388935|NCT02055352|41632465|FG000|Overall Study|Patient decision|1|||
19388936|NCT02055352|41632466|FG001|Overall Study|Patient decision|1|||
19388937|NCT02055352|41632465|FG000|Overall Study|Use of prohibited treatment|0|||
19388938|NCT02055352|41632466|FG001|Overall Study|Use of prohibited treatment|3|||
19388939|NCT02055352|41632465|FG000|Overall Study|AE, study drug would be detrimental|1|||
19388940|NCT02055352|41632466|FG001|Overall Study|AE, study drug would be detrimental|3|||
19388941|NCT02055352|41632465|FG000|Overall Study|Withdrawal of informed consent|1|||
19388942|NCT02055352|41632466|FG001|Overall Study|Withdrawal of informed consent|0|||
19388943|NCT02055352|41632465|FG000|Overall Study|Reason unknown|1|||
19388944|NCT02055352|41632466|FG001|Overall Study|Reason unknown|5|||
19388945|NCT02034916|41632474|FG000|Overall Study|Death|39|||
19388946|NCT02034916|41632475|FG001|Overall Study|Death|28|||
19388947|NCT02034916|41632474|FG000|Overall Study|Withdrawal by Subject|2|||
19388948|NCT02034916|41632475|FG001|Overall Study|Withdrawal by Subject|1|||
19388949|NCT02034916|41632474|FG000|Overall Study|Lost to Follow-up|4|||
19388950|NCT02034916|41632475|FG001|Overall Study|Lost to Follow-up|1|||
19388951|NCT02034916|41632474|FG000|Overall Study|Study terminated by sponsor|4|||
19388952|NCT02034916|41632475|FG001|Overall Study|Study terminated by sponsor|5|||
19388953|NCT01374425|41632484|FG000|Overall Study|Radiographic Disease Progression|86|||
19388954|NCT01374425|41632485|FG001|Overall Study|Radiographic Disease Progression|81|||
19388955|NCT01374425|41632484|FG000|Overall Study|Clinical Disease Progression|9|||
19388956|NCT01374425|41632485|FG001|Overall Study|Clinical Disease Progression|6|||
19388957|NCT01374425|41632484|FG000|Overall Study|Adverse Event|29|||
19668899|NCT00059215|42116935|FG002|Overall Study|Physician Decision|1|||
19668900|NCT00059215|42116936|FG003|Overall Study|Physician Decision|1|||
19668901|NCT00058825|42116947|FG000|Overall Study|Relapse|9|||
19668902|NCT00058825|42116947|FG000|Overall Study|Progressive Disease|5|||
19668903|NCT00058825|42116947|FG000|Overall Study|Graft Failure|5|||
19668904|NCT00058825|42116947|FG000|Overall Study|Death|3|||
19668905|NCT00364858|42116955|FG000|Overall Study|Adverse Event|1|||
19668906|NCT00364858|42116956|FG001|Overall Study|Adverse Event|5|||
19668907|NCT00364858|42116955|FG000|Overall Study|Withdrawal by Subject|1|||
19668908|NCT00364858|42116956|FG001|Overall Study|Withdrawal by Subject|1|||
19668909|NCT00364858|42116955|FG000|Overall Study|Pregnancy|1|||
19668910|NCT00364858|42116956|FG001|Overall Study|Pregnancy|1|||
19668911|NCT00364858|42116955|FG000|Overall Study|Clinical failure|2|||
19668912|NCT00364858|42116956|FG001|Overall Study|Clinical failure|13|||
19668913|NCT00364858|42116955|FG000|Overall Study|Discontinuation at baseline|1|||
19668914|NCT00364858|42116956|FG001|Overall Study|Discontinuation at baseline|0|||
19668915|NCT00364858|42116955|FG000|Overall Study|Non-compliant|1|||
19668916|NCT00364858|42116956|FG001|Overall Study|Non-compliant|0|||
19668917|NCT00364858|42116955|FG000|Overall Study|Return to Q2 regimen|0|||
19668918|NCT00364858|42116956|FG001|Overall Study|Return to Q2 regimen|1|||
19668919|NCT00364858|42116955|FG000|Overall Study|Clinical baseline issue|0|||
19668920|NCT00364858|42116956|FG001|Overall Study|Clinical baseline issue|1|||
19668921|NCT03803059|42116963|FG000|Overall Study|Protocol Violation|2|||
19668922|NCT03803059|42116963|FG000|Overall Study|Lost to Follow-up|1|||
19668923|NCT00372424|42116968|FG000|Overall Study|Adverse Event|2|||
19668924|NCT00372424|42116968|FG000|Overall Study|Withdrawal by Subject|1|||
19668925|NCT00372424|42116968|FG000|Overall Study|Death|1|||
19668926|NCT00372424|42116968|FG000|Overall Study|Objective Progression or Relapse|14|||
19668927|NCT00372424|42116968|FG000|Overall Study|Other|7|||
19668928|NCT00372424|42116968|FG000|Overall Study|Enrolled, Not Treated|1|||
19668929|NCT00372190|42116974|FG000|Overall Study|Lost to Follow-up|3|||
19668930|NCT00372190|42116975|FG001|Overall Study|Lost to Follow-up|1|||
19668931|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
19668932|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
19668933|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
19668934|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
19668935|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
19668936|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
19388958|NCT01374425|41632485|FG001|Overall Study|Adverse Event|18|||
19388959|NCT01374425|41632484|FG000|Overall Study|Death (Progression of Disease)|1|||
19388960|NCT01374425|41632485|FG001|Overall Study|Death (Progression of Disease)|0|||
19388961|NCT01374425|41632484|FG000|Overall Study|Death (Adverse Event)|2|||
19388962|NCT01374425|41632485|FG001|Overall Study|Death (Adverse Event)|4|||
19388963|NCT01374425|41632484|FG000|Overall Study|Withdrawal by Subject|6|||
19388964|NCT01374425|41632485|FG001|Overall Study|Withdrawal by Subject|7|||
19388965|NCT01374425|41632484|FG000|Overall Study|Refused Treatment|10|||
19668937|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
19668938|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
19668939|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
19757217|NCT00897104|42207908|FG001|Overall Study|Lack of Migraine Attack|22|||
19757218|NCT00897104|42207909|FG002|Overall Study|Lack of Migraine Attack|1|||
19388966|NCT01374425|41632485|FG001|Overall Study|Refused Treatment|24|||
19388967|NCT01374425|41632484|FG000|Overall Study|Protocol Violation|2|||
19388968|NCT01374425|41632485|FG001|Overall Study|Protocol Violation|3|||
19388969|NCT01374425|41632484|FG000|Overall Study|Sponsor Decision|0|||
19388970|NCT01374425|41632485|FG001|Overall Study|Sponsor Decision|1|||
19388971|NCT01374425|41632484|FG000|Overall Study|Lost to Follow-up|2|||
19388972|NCT01374425|41632485|FG001|Overall Study|Lost to Follow-up|1|||
19388973|NCT01374425|41632484|FG000|Overall Study|Other|41|||
19388974|NCT01374425|41632485|FG001|Overall Study|Other|43|||
19388975|NCT02085460|41632515|FG000|Overall Study|Adverse Event|2|||
19388976|NCT02085460|41632516|FG001|Overall Study|Adverse Event|2|||
19388977|NCT02085460|41632517|FG002|Overall Study|Adverse Event|1|||
19388978|NCT02085460|41632515|FG000|Overall Study|Physician Decision|1|||
19388979|NCT02085460|41632516|FG001|Overall Study|Physician Decision|1|||
19388980|NCT02085460|41632517|FG002|Overall Study|Physician Decision|2|||
19388981|NCT02085460|41632515|FG000|Overall Study|Withdrawal by Subject|11|||
19388982|NCT02085460|41632516|FG001|Overall Study|Withdrawal by Subject|5|||
19757219|NCT00897104|42207907|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
19757220|NCT00897104|42207908|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19757221|NCT00897104|42207909|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19757222|NCT00897104|42207907|FG000|Overall Study|Other|3|||
19757223|NCT00897104|42207908|FG001|Overall Study|Other|0|||
19757224|NCT00897104|42207909|FG002|Overall Study|Other|0|||
19757225|NCT00897104|42207907|FG000|Overall Study|Protocol Violation|1|||
19757226|NCT00897104|42207908|FG001|Overall Study|Protocol Violation|0|||
19757227|NCT00897104|42207909|FG002|Overall Study|Protocol Violation|0|||
19757228|NCT00897104|42207907|FG000|Overall Study|Withdrawal by Subject|0|||
19757229|NCT00897104|42207908|FG001|Overall Study|Withdrawal by Subject|0|||
19757230|NCT00897104|42207909|FG002|Overall Study|Withdrawal by Subject|1|||
19757231|NCT01339689|42207919|FG000|Overall Study|Adverse Event|1|||
19757232|NCT01339689|42207920|FG001|Overall Study|Adverse Event|2|||
19757233|NCT01339689|42207919|FG000|Overall Study|Lost to Follow-up|9|||
19388983|NCT02085460|41632517|FG002|Overall Study|Withdrawal by Subject|7|||
19668940|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
19668941|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
19757234|NCT01339689|42207920|FG001|Overall Study|Lost to Follow-up|3|||
19757235|NCT01339689|42207919|FG000|Overall Study|Withdrawal by Subject|3|||
19388984|NCT02084134|41632527|FG000|Overall Study|Protocol Violation|4|||
19668942|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
19757236|NCT01339689|42207920|FG001|Overall Study|Withdrawal by Subject|0|||
19757237|NCT01339689|42207919|FG000|Overall Study|Noncompliance|1|||
19757238|NCT01339689|42207920|FG001|Overall Study|Noncompliance|0|||
19757239|NCT01339689|42207919|FG000|Overall Study|Relocated out of area|0|||
19757240|NCT01339689|42207920|FG001|Overall Study|Relocated out of area|1|||
19757241|NCT01339689|42207919|FG000|Overall Study|Other|2|||
19668943|NCT00044083|42116985|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
19668944|NCT00044083|42116986|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
19668945|NCT00044083|42116985|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
19668946|NCT00044083|42116986|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
19668947|NCT00044083|42116985|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
19668948|NCT00044083|42116986|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
19668949|NCT00044083|42116985|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
19668950|NCT00044083|42116986|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
19668951|NCT00058123|42117019|FG000|Overall Study|Wrong histology|9|||
19668952|NCT00058123|42117019|FG000|Overall Study|Received >3 prior treatments|1|||
19668953|NCT00022633|42117026|FG000|Overall Study|Adverse Event|11|||
19668954|NCT00022633|42117027|FG001|Overall Study|Adverse Event|1|||
19668955|NCT00022633|42117026|FG000|Overall Study|Refusal unrelated to adverse event|1|||
19668956|NCT00022633|42117027|FG001|Overall Study|Refusal unrelated to adverse event|0|||
19668957|NCT00022633|42117026|FG000|Overall Study|Progression/relapse|9|||
19668958|NCT00022633|42117027|FG001|Overall Study|Progression/relapse|2|||
19757242|NCT01339689|42207920|FG001|Overall Study|Other|2|||
19757243|NCT01339689|42207919|FG000|Overall Study|multiple reasons|1|||
19757244|NCT01339689|42207920|FG001|Overall Study|multiple reasons|1|||
19668959|NCT00022633|42117026|FG000|Overall Study|Death|4|||
19668960|NCT00022633|42117027|FG001|Overall Study|Death|0|||
19668961|NCT00022633|42117026|FG000|Overall Study|Other - not protocol specified|3|||
19668962|NCT00022633|42117027|FG001|Overall Study|Other - not protocol specified|2|||
19668963|NCT00022633|42117026|FG000|Overall Study|Ineligible|4|||
19668964|NCT00022633|42117027|FG001|Overall Study|Ineligible|0|||
19668965|NCT00021541|42117034|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
19668966|NCT00021541|42117035|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
19668967|NCT00021541|42117034|FG000|Period 1-First Treatment|Adverse Event|2|||
19668968|NCT00021541|42117035|FG001|Period 1-First Treatment|Adverse Event|1|||
19668969|NCT00021541|42117034|FG000|Period 1-First Treatment|non-adherence|3|||
19668970|NCT00021541|42117035|FG001|Period 1-First Treatment|non-adherence|0|||
19668971|NCT00021541|42117034|FG000|Period 1-First Treatment|Death|1|||
19668972|NCT00021541|42117035|FG001|Period 1-First Treatment|Death|0|||
19668973|NCT00021541|42117034|FG000|Period 1-First Treatment|Pts that did not progress|2|||
19668974|NCT00021541|42117035|FG001|Period 1-First Treatment|Pts that did not progress|2|||
19668975|NCT00021541|42117034|FG000|Period 1-First Treatment|Ineligible|0|||
19668976|NCT00021541|42117035|FG001|Period 1-First Treatment|Ineligible|2|||
19668977|NCT00021541|42117034|FG000|Period 2-crossover|refused phase B|2|||
19668978|NCT00021541|42117035|FG001|Period 2-crossover|refused phase B|2|||
19668979|NCT00021541|42117034|FG000|Period 2-crossover|Withdrawal by Subject|3|||
19668980|NCT00021541|42117035|FG001|Period 2-crossover|Withdrawal by Subject|4|||
19668981|NCT00021541|42117034|FG000|Period 2-crossover|Adverse Event|2|||
19668982|NCT00021541|42117035|FG001|Period 2-crossover|Adverse Event|2|||
19668983|NCT00021541|42117034|FG000|Period 2-crossover|non-adherence|1|||
19668984|NCT00021541|42117035|FG001|Period 2-crossover|non-adherence|0|||
19668985|NCT00021541|42117034|FG000|Period 2-crossover|Pts that did not progress|2|||
19668986|NCT00021541|42117035|FG001|Period 2-crossover|Pts that did not progress|3|||
19668987|NCT00021229|42117046|FG000|Overall Study|Adverse Event|10|||
19668988|NCT00021229|42117047|FG001|Overall Study|Adverse Event|5|||
19668989|NCT00021229|42117048|FG002|Overall Study|Adverse Event|2|||
19668990|NCT00021229|42117046|FG000|Overall Study|Death|0|||
19668991|NCT00021229|42117047|FG001|Overall Study|Death|1|||
19668992|NCT00021229|42117048|FG002|Overall Study|Death|0|||
19668993|NCT00021229|42117046|FG000|Overall Study|Withdrawal by Subject|7|||
19668994|NCT00021229|42117047|FG001|Overall Study|Withdrawal by Subject|7|||
19668995|NCT00021229|42117048|FG002|Overall Study|Withdrawal by Subject|1|||
19668996|NCT00021229|42117046|FG000|Overall Study|Progressive Disease|15|||
19668997|NCT00021229|42117047|FG001|Overall Study|Progressive Disease|19|||
19668998|NCT00021229|42117048|FG002|Overall Study|Progressive Disease|12|||
19668999|NCT00021229|42117046|FG000|Overall Study|Protocol Violation|1|||
19669000|NCT00021229|42117047|FG001|Overall Study|Protocol Violation|1|||
19669001|NCT00021229|42117048|FG002|Overall Study|Protocol Violation|0|||
19669002|NCT00021229|42117046|FG000|Overall Study|Physician Decision|0|||
19669003|NCT00021229|42117047|FG001|Overall Study|Physician Decision|0|||
19669004|NCT00021229|42117048|FG002|Overall Study|Physician Decision|1|||
19669005|NCT00021229|42117046|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
19669006|NCT00021229|42117047|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
19669007|NCT00021229|42117048|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
19669008|NCT00372112|42117062|FG000|Overall Study|Adverse Event|0|||
19757245|NCT03038126|42207928|FG000|Overall Study|Death|1|||
19669009|NCT00372112|42117063|FG001|Overall Study|Adverse Event|1|||
19669010|NCT00372112|42117064|FG002|Overall Study|Adverse Event|1|||
19757246|NCT03038126|42207929|FG001|Overall Study|Death|1|||
19757247|NCT03038126|42207928|FG000|Overall Study|Withdrawal by Subject|5|||
19669011|NCT00372112|42117065|FG003|Overall Study|Adverse Event|1|||
19669012|NCT00372112|42117062|FG000|Overall Study|Withdrawal by Subject|0|||
19669013|NCT00372112|42117063|FG001|Overall Study|Withdrawal by Subject|0|||
19669014|NCT00372112|42117064|FG002|Overall Study|Withdrawal by Subject|2|||
19757248|NCT03038126|42207929|FG001|Overall Study|Withdrawal by Subject|0|||
19757249|NCT03038126|42207928|FG000|Overall Study|Lost to Follow-up|0|||
19757250|NCT03038126|42207929|FG001|Overall Study|Lost to Follow-up|1|||
19757251|NCT03038126|42207928|FG000|Overall Study|Long Term Hospitalization|2|||
19757252|NCT03038126|42207929|FG001|Overall Study|Long Term Hospitalization|0|||
19603115|NCT00979628|42051979|FG000|Overall Study|transferred to ICU|1|||
19669015|NCT00372112|42117065|FG003|Overall Study|Withdrawal by Subject|1|||
19669016|NCT00372112|42117062|FG000|Overall Study|Exacerbation|0|||
19603116|NCT00979628|42051980|FG001|Overall Study|transferred to ICU|2|||
19603117|NCT00979628|42051981|FG002|Overall Study|transferred to ICU|1|||
19603118|NCT00762970|42051995|FG000|Overall Study|Withdrawal by Subject|7|||
19603119|NCT00762970|42051996|FG001|Overall Study|Withdrawal by Subject|4|||
19603120|NCT00762970|42051997|FG002|Overall Study|Withdrawal by Subject|0|||
19603121|NCT00762970|42051995|FG000|Overall Study|Protocol Violation|3|||
19603122|NCT00762970|42051996|FG001|Overall Study|Protocol Violation|1|||
19603123|NCT00762970|42051997|FG002|Overall Study|Protocol Violation|1|||
19603124|NCT00762970|42051995|FG000|Overall Study|Lost to Follow-up|1|||
19603125|NCT00762970|42051996|FG001|Overall Study|Lost to Follow-up|2|||
19603126|NCT00762970|42051997|FG002|Overall Study|Lost to Follow-up|0|||
19603127|NCT00762970|42051995|FG000|Overall Study|Difficulty of handling lens|1|||
19603128|NCT00762970|42051996|FG001|Overall Study|Difficulty of handling lens|2|||
19603129|NCT00762970|42051997|FG002|Overall Study|Difficulty of handling lens|0|||
19603130|NCT00988442|42052007|FG000|Overall Study|Death|1|||
19603131|NCT00988442|42052008|FG001|Overall Study|Death|2|||
19603132|NCT00988442|42052007|FG000|Overall Study|Lost to Follow-up|0|||
19603133|NCT00988442|42052008|FG001|Overall Study|Lost to Follow-up|1|||
19603134|NCT00988442|42052007|FG000|Overall Study|Early Study Closure|29|||
19603135|NCT00988442|42052008|FG001|Overall Study|Early Study Closure|25|||
19603136|NCT03258723|42052017|FG000|Overall Study|COVID Interruption of study|54|||
19603137|NCT03258723|42052017|FG000|Overall Study|Lost to Follow-up|8|||
19603138|NCT00992186|42052021|FG000|Overall Study|Withdrawal by Subject|2|||
19669017|NCT00372112|42117063|FG001|Overall Study|Exacerbation|0|||
19669018|NCT00372112|42117064|FG002|Overall Study|Exacerbation|0|||
19669019|NCT00372112|42117065|FG003|Overall Study|Exacerbation|1|||
19669020|NCT00372112|42117062|FG000|Overall Study|PR >240 at Visit 3|0|||
19669021|NCT00372112|42117063|FG001|Overall Study|PR >240 at Visit 3|0|||
19669022|NCT00372112|42117064|FG002|Overall Study|PR >240 at Visit 3|0|||
19669023|NCT00372112|42117065|FG003|Overall Study|PR >240 at Visit 3|1|||
19669024|NCT00372112|42117062|FG000|Overall Study|Hepatitis B|1|||
19669025|NCT00372112|42117063|FG001|Overall Study|Hepatitis B|0|||
19669026|NCT00372112|42117064|FG002|Overall Study|Hepatitis B|0|||
19669027|NCT00372112|42117065|FG003|Overall Study|Hepatitis B|0|||
19669028|NCT00372112|42117062|FG000|Overall Study|Other-protocol violation|0|||
19669029|NCT00372112|42117063|FG001|Overall Study|Other-protocol violation|0|||
19669030|NCT00372112|42117064|FG002|Overall Study|Other-protocol violation|1|||
19669031|NCT00372112|42117065|FG003|Overall Study|Other-protocol violation|0|||
19669032|NCT00488475|42117078|FG000|Overall Study|Other|1754|||
19669033|NCT00042991|42117089|FG000|Overall Study|Adverse Event|1|||
19669034|NCT00042991|42117090|FG001|Overall Study|Adverse Event|4|||
19669035|NCT00042991|42117091|FG002|Overall Study|Adverse Event|2|||
19669036|NCT00042991|42117092|FG003|Overall Study|Adverse Event|0|||
19669037|NCT00042991|42117093|FG004|Overall Study|Adverse Event|0|||
19669038|NCT00042991|42117094|FG005|Overall Study|Adverse Event|1|||
19669039|NCT00042991|42117095|FG006|Overall Study|Adverse Event|0|||
19669040|NCT00042991|42117089|FG000|Overall Study|Withdrawal by Subject|0|||
19669041|NCT00042991|42117090|FG001|Overall Study|Withdrawal by Subject|7|||
19669042|NCT00042991|42117091|FG002|Overall Study|Withdrawal by Subject|2|||
19669043|NCT00042991|42117092|FG003|Overall Study|Withdrawal by Subject|0|||
19757253|NCT03038126|42207928|FG000|Overall Study|Too Ill to Participate|1|||
19757254|NCT03038126|42207929|FG001|Overall Study|Too Ill to Participate|2|||
19669044|NCT00042991|42117093|FG004|Overall Study|Withdrawal by Subject|1|||
19669045|NCT00042991|42117094|FG005|Overall Study|Withdrawal by Subject|0|||
19757255|NCT02550652|42207949|FG000|Overall Study|Death|1|||
19669046|NCT00042991|42117095|FG006|Overall Study|Withdrawal by Subject|0|||
19669047|NCT00042991|42117089|FG000|Overall Study|Disease Progression|5|||
19669048|NCT00042991|42117090|FG001|Overall Study|Disease Progression|29|||
19603139|NCT00992186|42052021|FG000|Overall Study|Protocol Violation|1|||
19603140|NCT00992186|42052021|FG000|Overall Study|Physician Decision|1|||
19603141|NCT00992186|42052021|FG000|Overall Study|Adverse Event|9|||
19603142|NCT00992186|42052021|FG000|Overall Study|Progressive Disease|30|||
19603143|NCT00992186|42052021|FG000|Overall Study|Refusal To Receive Study Agent|3|||
19669049|NCT00042991|42117091|FG002|Overall Study|Disease Progression|2|||
19669050|NCT00042991|42117092|FG003|Overall Study|Disease Progression|2|||
19669051|NCT00042991|42117093|FG004|Overall Study|Disease Progression|1|||
19669052|NCT00042991|42117094|FG005|Overall Study|Disease Progression|4|||
19669053|NCT00042991|42117095|FG006|Overall Study|Disease Progression|2|||
19669054|NCT00042991|42117089|FG000|Overall Study|Alternative Therapy|0|||
19669055|NCT00042991|42117090|FG001|Overall Study|Alternative Therapy|0|||
19669056|NCT00042991|42117091|FG002|Overall Study|Alternative Therapy|0|||
19669057|NCT00042991|42117092|FG003|Overall Study|Alternative Therapy|0|||
19669058|NCT00042991|42117093|FG004|Overall Study|Alternative Therapy|1|||
19669059|NCT00042991|42117094|FG005|Overall Study|Alternative Therapy|0|||
19669060|NCT00042991|42117095|FG006|Overall Study|Alternative Therapy|0|||
19669061|NCT00466167|42117116|FG000|Overall Study|Adverse Event|8|||
19669062|NCT00466167|42117117|FG001|Overall Study|Adverse Event|8|||
19669063|NCT00466167|42117118|FG002|Overall Study|Adverse Event|7|||
19669064|NCT00466167|42117116|FG000|Overall Study|Lack of Efficacy|2|||
19669065|NCT00466167|42117117|FG001|Overall Study|Lack of Efficacy|0|||
19669066|NCT00466167|42117118|FG002|Overall Study|Lack of Efficacy|3|||
19669067|NCT00466167|42117116|FG000|Overall Study|Protocol Violation|1|||
19669068|NCT00466167|42117117|FG001|Overall Study|Protocol Violation|1|||
19388985|NCT02084134|41632528|FG001|Overall Study|Protocol Violation|2|||
19388986|NCT02084134|41632527|FG000|Overall Study|Death|0|||
19388987|NCT02084134|41632528|FG001|Overall Study|Death|1|||
19388988|NCT02034058|41632534|FG000|Overall Study|Death|3|||
19388989|NCT01374269|41632540|FG000|Overall Study|Withdrawal by Subject|4|||
19388990|NCT01374269|41632541|FG001|Overall Study|Withdrawal by Subject|0|||
19388991|NCT01374269|41632540|FG000|Overall Study|Lost to Follow-up|1|||
19388992|NCT01374269|41632541|FG001|Overall Study|Lost to Follow-up|3|||
19388993|NCT01374269|41632540|FG000|Overall Study|closed research|1|||
19603144|NCT00992108|42052028|FG000|Overall Study|Lost to Follow-up|0|||
19603145|NCT00992108|42052029|FG001|Overall Study|Lost to Follow-up|1|||
19603146|NCT00752986|42052038|FG000|Overall Study|Withdrawal by Subject|2|||
19603147|NCT00752986|42052039|FG001|Overall Study|Withdrawal by Subject|1|||
19603148|NCT00752986|42052040|FG002|Overall Study|Withdrawal by Subject|2|||
19603149|NCT00752986|42052038|FG000|Overall Study|Protocol Violation|3|||
19603150|NCT00752986|42052039|FG001|Overall Study|Protocol Violation|0|||
19603151|NCT00752986|42052040|FG002|Overall Study|Protocol Violation|0|||
19603152|NCT03483103|42052048|FG000|Pre-Treatment Phase|Other reasons|1|||
19603153|NCT03483103|42052048|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
19603154|NCT03483103|42052048|FG000|Pre-Treatment Phase|Disease-related complications|1|||
19603155|NCT03483103|42052048|FG000|Pre-Treatment Phase|Death|5|||
19603156|NCT03483103|42052048|FG000|Treatment Phase|Withdrawal by Subject|6|||
19603157|NCT03483103|42052048|FG000|Treatment Phase|Other reasons|2|||
19603158|NCT03483103|42052048|FG000|Treatment Phase|Death|20|||
19603159|NCT03483103|42052048|FG000|Treatment Phase|Ongoing in study|26|||
19603160|NCT03483103|42052048|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
19603161|NCT03483103|42052048|FG000|Treatment Phase|Received nonconforming product|1|||
19603162|NCT00762892|42052054|FG000|Overall Study|Lost to Follow-up|2|||
19603163|NCT00762892|42052055|FG001|Overall Study|Lost to Follow-up|5|||
19603164|NCT00762892|42052054|FG000|Overall Study|Withdrawal by Subject|0|||
19603165|NCT00762892|42052055|FG001|Overall Study|Withdrawal by Subject|1|||
19603166|NCT00762892|42052054|FG000|Overall Study|Death|1|||
19603167|NCT00762892|42052055|FG001|Overall Study|Death|0|||
19603168|NCT00762892|42052054|FG000|Overall Study|Pregnancy|1|||
19603169|NCT00762892|42052055|FG001|Overall Study|Pregnancy|0|||
19603170|NCT00762892|42052054|FG000|Overall Study|Incarceration|1|||
19603171|NCT00762892|42052055|FG001|Overall Study|Incarceration|0|||
19603172|NCT00755716|42052064|FG000|Overall Study|Adverse Event|1|||
19603173|NCT00755716|42052065|FG001|Overall Study|Adverse Event|4|||
19603174|NCT00755716|42052066|FG002|Overall Study|Adverse Event|1|||
19603175|NCT00755716|42052064|FG000|Overall Study|Lack of Efficacy|2|||
19603176|NCT00755716|42052065|FG001|Overall Study|Lack of Efficacy|0|||
19669069|NCT00466167|42117118|FG002|Overall Study|Protocol Violation|2|||
19388994|NCT01374269|41632541|FG001|Overall Study|closed research|2|||
19603177|NCT00755716|42052066|FG002|Overall Study|Lack of Efficacy|0|||
19603178|NCT00755716|42052064|FG000|Overall Study|Lost to Follow-up|5|||
19603179|NCT00755716|42052065|FG001|Overall Study|Lost to Follow-up|3|||
19603180|NCT00755716|42052066|FG002|Overall Study|Lost to Follow-up|1|||
19669070|NCT00466167|42117116|FG000|Overall Study|Lost to Follow-up|3|||
19603181|NCT00755716|42052064|FG000|Overall Study|work schedule issues|0|||
19603182|NCT00755716|42052065|FG001|Overall Study|work schedule issues|1|||
19669071|NCT00466167|42117117|FG001|Overall Study|Lost to Follow-up|2|||
19669072|NCT00466167|42117118|FG002|Overall Study|Lost to Follow-up|2|||
19669073|NCT00466167|42117116|FG000|Overall Study|Withdrawal by Subject|4|||
19669074|NCT00466167|42117117|FG001|Overall Study|Withdrawal by Subject|1|||
19669075|NCT00466167|42117118|FG002|Overall Study|Withdrawal by Subject|6|||
19669076|NCT00466167|42117116|FG000|Overall Study|patient did not meet inclusion criteria|1|||
19669077|NCT00466167|42117117|FG001|Overall Study|patient did not meet inclusion criteria|0|||
19669078|NCT00466167|42117118|FG002|Overall Study|patient did not meet inclusion criteria|1|||
19669079|NCT00466167|42117116|FG000|Overall Study|Not treated|1|||
19669080|NCT00466167|42117117|FG001|Overall Study|Not treated|0|||
19669081|NCT00466167|42117118|FG002|Overall Study|Not treated|0|||
19757256|NCT02550652|42207950|FG001|Overall Study|Death|4|||
19757257|NCT02550652|42207949|FG000|Overall Study|Lack of Efficacy|1|||
19757258|NCT02550652|42207950|FG001|Overall Study|Lack of Efficacy|0|||
19757259|NCT02550652|42207949|FG000|Overall Study|Withdrawal by Subject|3|||
19757260|NCT02550652|42207950|FG001|Overall Study|Withdrawal by Subject|7|||
19757261|NCT02550652|42207949|FG000|Overall Study|Post Trial Access|1|||
19757262|NCT02550652|42207950|FG001|Overall Study|Post Trial Access|0|||
19757263|NCT02550652|42207949|FG000|Overall Study|Lost to Follow-up|1|||
19757264|NCT02550652|42207950|FG001|Overall Study|Lost to Follow-up|3|||
19757265|NCT02550652|42207949|FG000|Overall Study|Physician Decision|0|||
19757266|NCT02550652|42207950|FG001|Overall Study|Physician Decision|2|||
19669082|NCT00480441|42117128|FG000|Screening|Not Eligible|37|||
19669083|NCT00480441|42117129|FG001|Screening|Not Eligible|0|||
19669084|NCT00480441|42117130|FG002|Screening|Not Eligible|0|||
19669085|NCT00480441|42117128|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
19669086|NCT00480441|42117129|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
19669087|NCT00480441|42117130|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
19669088|NCT00480441|42117128|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
19669089|NCT00480441|42117129|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
19669090|NCT00480441|42117130|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
19669091|NCT00480441|42117128|FG000|Baseline Functional MRI|physical contraindication|4|||
19669092|NCT00480441|42117129|FG001|Baseline Functional MRI|physical contraindication|0|||
19669093|NCT00480441|42117130|FG002|Baseline Functional MRI|physical contraindication|0|||
19669094|NCT00480441|42117128|FG000|Randomization|Lost to Follow-up|0|||
19669095|NCT00480441|42117129|FG001|Randomization|Lost to Follow-up|7|||
19669096|NCT00480441|42117130|FG002|Randomization|Lost to Follow-up|2|||
19669097|NCT00488319|42117140|FG000|Overall Study|Adverse Event|1|||
19669098|NCT00488319|42117141|FG001|Overall Study|Adverse Event|2|||
19669099|NCT00488319|42117142|FG002|Overall Study|Adverse Event|23|||
19669100|NCT00488319|42117140|FG000|Overall Study|Lack of Efficacy|6|||
19669101|NCT00488319|42117141|FG001|Overall Study|Lack of Efficacy|12|||
19669102|NCT00488319|42117142|FG002|Overall Study|Lack of Efficacy|27|||
19669103|NCT00488319|42117140|FG000|Overall Study|Lost to Follow-up|3|||
19669104|NCT00488319|42117141|FG001|Overall Study|Lost to Follow-up|5|||
19669105|NCT00488319|42117142|FG002|Overall Study|Lost to Follow-up|16|||
19669106|NCT00488319|42117140|FG000|Overall Study|Withdrawal by Subject|5|||
19669107|NCT00488319|42117141|FG001|Overall Study|Withdrawal by Subject|20|||
19669108|NCT00488319|42117142|FG002|Overall Study|Withdrawal by Subject|44|||
19669109|NCT00488319|42117140|FG000|Overall Study|Other reasons for withdrawal|0|||
19669110|NCT00488319|42117141|FG001|Overall Study|Other reasons for withdrawal|4|||
19669111|NCT00488319|42117142|FG002|Overall Study|Other reasons for withdrawal|12|||
19669112|NCT00463047|42117151|FG000|Titration Period 1|Adverse Event|10|||
19669113|NCT00463047|42117152|FG001|Titration Period 1|Adverse Event|8|||
19669114|NCT00463047|42117151|FG000|Titration Period 1|Lack of Efficacy|10|||
19669115|NCT00463047|42117152|FG001|Titration Period 1|Lack of Efficacy|4|||
19757267|NCT02550652|42207949|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
19757268|NCT02550652|42207950|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
19757269|NCT00696878|42207956|FG000|Overall Study|Adverse Event|8|||
19757270|NCT00696878|42207956|FG000|Overall Study|Withdrawal by Subject|87|||
19669116|NCT00463047|42117151|FG000|Titration Period 1|Lost to Follow-up|2|||
19669117|NCT00463047|42117152|FG001|Titration Period 1|Lost to Follow-up|0|||
19669118|NCT00463047|42117151|FG000|Titration Period 1|Non-compliance with study medication|3|||
19669119|NCT00463047|42117152|FG001|Titration Period 1|Non-compliance with study medication|5|||
19669120|NCT00463047|42117151|FG000|Titration Period 1|Protocol Violation|5|||
19669121|NCT00463047|42117152|FG001|Titration Period 1|Protocol Violation|5|||
19669122|NCT00463047|42117151|FG000|Titration Period 1|Withdrawal by Subject|3|||
19477126|NCT01546519|41756032|FG002|Overall Study|Withdrawal by Subject|0|||
19669123|NCT00463047|42117152|FG001|Titration Period 1|Withdrawal by Subject|5|||
19669124|NCT00463047|42117151|FG000|Titration Period 1|Non-compliance procedures|4|||
19669125|NCT00463047|42117152|FG001|Titration Period 1|Non-compliance procedures|10|||
19669126|NCT00463047|42117151|FG000|Titration Period 1|Other|0|||
19669127|NCT00463047|42117152|FG001|Titration Period 1|Other|2|||
19669128|NCT00463047|42117151|FG000|Titration Period 2|Adverse Event|9|||
19669129|NCT00463047|42117152|FG001|Titration Period 2|Adverse Event|9|||
19669130|NCT00463047|42117151|FG000|Titration Period 2|Lack of Efficacy|6|||
19669131|NCT00463047|42117152|FG001|Titration Period 2|Lack of Efficacy|4|||
19669132|NCT00463047|42117151|FG000|Titration Period 2|Withdrawal by Subject|1|||
19669133|NCT00463047|42117152|FG001|Titration Period 2|Withdrawal by Subject|0|||
19669134|NCT00463047|42117151|FG000|Titration Period 2|Protocol Violation|2|||
19669135|NCT00463047|42117152|FG001|Titration Period 2|Protocol Violation|3|||
19669136|NCT00463047|42117151|FG000|Titration Period 2|Lost to Follow-up|1|||
19669137|NCT00463047|42117152|FG001|Titration Period 2|Lost to Follow-up|2|||
19669138|NCT00463047|42117151|FG000|Titration Period 2|Non-compliance study medication|4|||
19669139|NCT00463047|42117152|FG001|Titration Period 2|Non-compliance study medication|2|||
19669140|NCT00463047|42117151|FG000|Titration Period 2|Non-compliance procedures|4|||
19669141|NCT00463047|42117152|FG001|Titration Period 2|Non-compliance procedures|1|||
19669142|NCT00463047|42117151|FG000|Titration Period 2|Other|3|||
19669143|NCT00463047|42117152|FG001|Titration Period 2|Other|2|||
19669144|NCT00463047|42117151|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
19669145|NCT00463047|42117152|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
19669146|NCT00463047|42117151|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
19669147|NCT00463047|42117152|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
19669148|NCT00463047|42117151|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
19669149|NCT00463047|42117152|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
19669150|NCT00463047|42117151|FG000|Double-Blind Treatment Period 1|Other|1|||
19669151|NCT00463047|42117152|FG001|Double-Blind Treatment Period 1|Other|0|||
19669152|NCT00463047|42117151|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
19669153|NCT00463047|42117152|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
19669154|NCT00463047|42117151|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
19669155|NCT00463047|42117152|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
19669156|NCT00463047|42117151|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
19669157|NCT00463047|42117152|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
19669158|NCT00487695|42117159|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
19669159|NCT00487695|42117160|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
19669160|NCT00487695|42117159|FG000|First Procedure|active wheezing (did not have procedure)|1|||
19669161|NCT00487695|42117160|FG001|First Procedure|active wheezing (did not have procedure)|0|||
19669162|NCT00487695|42117159|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
19669163|NCT00487695|42117160|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
19669164|NCT00487695|42117159|FG000|Second Procedure|active wheezing|0|||
19669165|NCT00487695|42117160|FG001|Second Procedure|active wheezing|1|||
19669166|NCT00487695|42117159|FG000|Second Procedure|Withdrawal by Subject|1|||
19669167|NCT00487695|42117160|FG001|Second Procedure|Withdrawal by Subject|2|||
19669168|NCT00487539|42117170|FG000|Overall Study|Adverse Event|3|||
19669169|NCT00487539|42117171|FG001|Overall Study|Adverse Event|2|||
19669170|NCT00487539|42117172|FG002|Overall Study|Adverse Event|1|||
19669171|NCT00487539|42117173|FG003|Overall Study|Adverse Event|1|||
19669172|NCT00487539|42117170|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19669173|NCT00487539|42117171|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19669174|NCT00487539|42117172|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19669175|NCT00487539|42117173|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
19669176|NCT00487539|42117170|FG000|Overall Study|Other|3|||
19669177|NCT00487539|42117171|FG001|Overall Study|Other|1|||
19669178|NCT00487539|42117172|FG002|Overall Study|Other|2|||
19669179|NCT00487539|42117173|FG003|Overall Study|Other|2|||
19669180|NCT00486837|42117184|FG000|Overall Study|Withdrawal by Subject|1|||
19669181|NCT00486837|42117185|FG001|Overall Study|Withdrawal by Subject|0|||
19669182|NCT00486837|42117184|FG000|Overall Study|Adverse Event|1|||
19669183|NCT00486837|42117185|FG001|Overall Study|Adverse Event|1|||
19669184|NCT00486837|42117184|FG000|Overall Study|Protocol Violation|4|||
19669185|NCT00486837|42117185|FG001|Overall Study|Protocol Violation|2|||
19757271|NCT00696878|42207956|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
19757272|NCT00696878|42207956|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
19757273|NCT00696878|42207956|FG000|Overall Study|Trial stopped|32|||
19757274|NCT00696878|42207956|FG000|Overall Study|Other reason (not specified)|55|||
19757275|NCT00696800|42207962|FG000|Overall Study|Adverse Event|16|||
19757276|NCT00696800|42207963|FG001|Overall Study|Adverse Event|3|||
19757277|NCT00696800|42207962|FG000|Overall Study|Insufficient compliance with medication|2|||
19757278|NCT00696800|42207963|FG001|Overall Study|Insufficient compliance with medication|1|||
19757279|NCT00696800|42207962|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
19757280|NCT00696800|42207963|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
19757281|NCT00696800|42207962|FG000|Overall Study|Insufficient ovarian response|4|||
19757282|NCT00696800|42207963|FG001|Overall Study|Insufficient ovarian response|1|||
19669186|NCT00486837|42117184|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
19669187|NCT00486837|42117185|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
19669188|NCT00486759|42117195|FG000|Treatment|Adverse event/intercurrent illness|86|||
19669189|NCT00486759|42117196|FG001|Treatment|Adverse event/intercurrent illness|39|||
19669190|NCT00486759|42117195|FG000|Treatment|Insufficient therapeutic response|37|||
19669191|NCT00486759|42117196|FG001|Treatment|Insufficient therapeutic response|39|||
19669192|NCT00486759|42117195|FG000|Treatment|Death|17|||
19669193|NCT00486759|42117196|FG001|Treatment|Death|10|||
19669194|NCT00486759|42117195|FG000|Treatment|Withdrew consent|15|||
19669195|NCT00486759|42117196|FG001|Treatment|Withdrew consent|12|||
19669196|NCT00486759|42117195|FG000|Treatment|Administrative/reason not specified|17|||
19669197|NCT00486759|42117196|FG001|Treatment|Administrative/reason not specified|21|||
19669198|NCT00486759|42117195|FG000|Treatment|Refused treatment|10|||
19669199|NCT00486759|42117196|FG001|Treatment|Refused treatment|7|||
19669200|NCT00486759|42117195|FG000|Treatment|Violation of selection criteria at entry|3|||
19669201|NCT00486759|42117196|FG001|Treatment|Violation of selection criteria at entry|3|||
19603183|NCT00755716|42052066|FG002|Overall Study|work schedule issues|1|||
19603184|NCT00755326|42052076|FG000|Overall Study|Lost to Follow-up|2|||
19669202|NCT00486759|42117195|FG000|Treatment|Other protocol violation|1|||
19669203|NCT00486759|42117196|FG001|Treatment|Other protocol violation|5|||
19669204|NCT00486759|42117195|FG000|Treatment|Failure to return|1|||
19669205|NCT00486759|42117196|FG001|Treatment|Failure to return|1|||
19669206|NCT00486759|42117195|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
19669207|NCT00486759|42117196|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
19669208|NCT00486759|42117195|FG000|Safety Follow-up|Death|40|||
19603185|NCT00755326|42052077|FG001|Overall Study|Lost to Follow-up|3|||
19603186|NCT03084471|42052084|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
19603187|NCT03084471|42052084|FG000|Overall Study|Condition under investigation worsened|84|||
19603188|NCT03084471|42052084|FG000|Overall Study|Lack of therapeutic response|2|||
19603189|NCT03084471|42052084|FG000|Overall Study|Protocol Violation|1|||
19603190|NCT03084471|42052084|FG000|Overall Study|Adverse Event|73|||
19603191|NCT03084471|42052084|FG000|Overall Study|Withdrawal by Subject|12|||
19603192|NCT03084471|42052084|FG000|Overall Study|Disease relapse|181|||
19603193|NCT03084471|42052084|FG000|Overall Study|Subjective disease progression|359|||
19603194|NCT03084471|42052084|FG000|Overall Study|Other (as recorded)|33|||
19603195|NCT03084471|42052084|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
19603196|NCT00754936|42052091|FG000|Overall Study|Lost to Follow-up|3|||
19603197|NCT00754936|42052091|FG000|Overall Study|Physician Decision|1|||
19603198|NCT00754936|42052091|FG000|Overall Study|Withdrawal by Subject|2|||
19603199|NCT00754936|42052091|FG000|Overall Study|Side Effects|3|||
19603200|NCT00754936|42052091|FG000|Overall Study|Inter-current medical events|3|||
19603201|NCT00762502|42052098|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
19603202|NCT00762502|42052099|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
19603203|NCT00762502|42052100|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
19603204|NCT00762502|42052098|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
19603205|NCT00762502|42052099|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
19603206|NCT00762502|42052100|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
19603207|NCT00762502|42052098|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
19603208|NCT00762502|42052099|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
19603209|NCT00762502|42052100|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
19603210|NCT00762268|42052108|FG000|Overall Study|Withdrawal by Subject|3|||
19603211|NCT00762268|42052109|FG001|Overall Study|Withdrawal by Subject|3|||
19388995|NCT02679755|41632549|FG000|Overall Study|Death|0|||
19603212|NCT00975884|42052117|FG000|Overall Study|Adverse Event|1|||
19603213|NCT00975884|42052118|FG001|Overall Study|Adverse Event|0|||
19603214|NCT00975884|42052117|FG000|Overall Study|Lost to Follow-up|5|||
19603215|NCT00975884|42052118|FG001|Overall Study|Lost to Follow-up|3|||
19603216|NCT00975884|42052117|FG000|Overall Study|Withdrawal by Subject|9|||
19603217|NCT00975884|42052118|FG001|Overall Study|Withdrawal by Subject|9|||
19603218|NCT00975884|42052117|FG000|Overall Study|Other|1|||
19603219|NCT00975884|42052118|FG001|Overall Study|Other|3|||
19603220|NCT00578227|42052137|FG000|Overall Study|Lost to Follow-up|0|||
19603221|NCT00578227|42052138|FG001|Overall Study|Lost to Follow-up|1|||
19603222|NCT00578227|42052139|FG002|Overall Study|Lost to Follow-up|1|||
19603223|NCT00578227|42052137|FG000|Overall Study|Withdrawal by Subject|5|||
19603224|NCT00578227|42052138|FG001|Overall Study|Withdrawal by Subject|1|||
19603225|NCT00578227|42052139|FG002|Overall Study|Withdrawal by Subject|3|||
19603226|NCT00978380|42052149|FG000|Overall Study|Protocol Violation|2|||
19603227|NCT00978380|42052149|FG000|Overall Study|Withdrawal criteria|9|||
19603228|NCT00978380|42052149|FG000|Overall Study|Unclassified|8|||
19603229|NCT00577993|42052157|FG000|Overall Study|Adverse Event|1|||
19603230|NCT00577993|42052158|FG001|Overall Study|Adverse Event|0|||
19603231|NCT00577993|42052159|FG002|Overall Study|Adverse Event|0|||
19603232|NCT00577993|42052157|FG000|Overall Study|Death|0|||
19603233|NCT00577993|42052158|FG001|Overall Study|Death|1|||
19603234|NCT00577993|42052159|FG002|Overall Study|Death|1|||
19603235|NCT00577993|42052157|FG000|Overall Study|Lack of Efficacy|0|||
19603236|NCT00577993|42052158|FG001|Overall Study|Lack of Efficacy|1|||
19603237|NCT00577993|42052159|FG002|Overall Study|Lack of Efficacy|0|||
19603238|NCT00577993|42052157|FG000|Overall Study|Protocol Violation|2|||
19603239|NCT00577993|42052158|FG001|Overall Study|Protocol Violation|3|||
19603240|NCT00577993|42052159|FG002|Overall Study|Protocol Violation|0|||
19603241|NCT00577993|42052157|FG000|Overall Study|Withdrawal by Subject|1|||
19603242|NCT00577993|42052158|FG001|Overall Study|Withdrawal by Subject|0|||
19603243|NCT00577993|42052159|FG002|Overall Study|Withdrawal by Subject|2|||
19388996|NCT02679755|41632550|FG001|Overall Study|Death|3|||
19603244|NCT00577993|42052157|FG000|Overall Study|Conversion|2|||
19603245|NCT00577993|42052158|FG001|Overall Study|Conversion|5|||
19603246|NCT00577993|42052159|FG002|Overall Study|Conversion|0|||
19603247|NCT00577993|42052157|FG000|Overall Study|Uninsured|1|||
19669209|NCT00486759|42117196|FG001|Safety Follow-up|Death|29|||
19669210|NCT00486759|42117195|FG000|Safety Follow-up|Withdrew consent|32|||
19669211|NCT00486759|42117196|FG001|Safety Follow-up|Withdrew consent|23|||
19669212|NCT00486759|42117195|FG000|Safety Follow-up|Failure to return|9|||
19669213|NCT00486759|42117196|FG001|Safety Follow-up|Failure to return|6|||
19669214|NCT00486759|42117195|FG000|Safety Follow-up|Administrative/not specified|8|||
19669215|NCT00486759|42117196|FG001|Safety Follow-up|Administrative/not specified|6|||
19669216|NCT00486759|42117195|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
19669217|NCT00486759|42117196|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
19669218|NCT00486759|42117195|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
19669219|NCT00486759|42117196|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
19669220|NCT00486603|42117204|FG000|Overall Study|Withdrawal by Subject|1|||
19669221|NCT00486603|42117205|FG001|Overall Study|Withdrawal by Subject|0|||
19669222|NCT00486603|42117206|FG002|Overall Study|Withdrawal by Subject|0|||
19669223|NCT00486603|42117207|FG003|Overall Study|Withdrawal by Subject|0|||
19669224|NCT00486603|42117208|FG004|Overall Study|Withdrawal by Subject|0|||
19669225|NCT00486603|42117204|FG000|Overall Study|Physician Decision|0|||
19669226|NCT00486603|42117205|FG001|Overall Study|Physician Decision|1|||
19669227|NCT00486603|42117206|FG002|Overall Study|Physician Decision|0|||
19669228|NCT00486603|42117207|FG003|Overall Study|Physician Decision|0|||
19669229|NCT00486603|42117208|FG004|Overall Study|Physician Decision|0|||
19757283|NCT00696800|42207962|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
19477127|NCT01546519|41756033|FG003|Overall Study|Withdrawal by Subject|0|||
19477128|NCT01484951|41756047|FG000|Overall Study|Adverse Event|3|||
19477129|NCT01484951|41756047|FG000|Overall Study|Personal Reasons|1|||
19477130|NCT01484951|41756047|FG000|Overall Study|Non-Compliance|1|||
19477131|NCT01484873|41756051|FG000|Overall Study|Withdrawal by Subject|2|||
19477132|NCT01486927|41756056|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
19388997|NCT02679755|41632549|FG000|Overall Study|Global deterioration of health status|1|||
19477133|NCT01486927|41756056|FG000|Overall Study|Physician Decision|1|||
19477134|NCT01486927|41756056|FG000|Overall Study|50 Exposure days not reached|2|||
19477135|NCT01486927|41756056|FG000|Overall Study|Withdrawal by Subject|8|||
19477136|NCT01486927|41756056|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
19477137|NCT01513759|41756089|FG000|Overall Study|Protocol Violation|4|||
19477138|NCT01513759|41756089|FG000|Overall Study|Death during catheter placement|1|||
19477139|NCT01484561|41756095|FG000|Overall Study|Lack of Efficacy|3|||
19477140|NCT01484561|41756096|FG001|Overall Study|Lack of Efficacy|1|||
19477141|NCT01484561|41756095|FG000|Overall Study|Lost to Follow-up|1|||
19477142|NCT01484561|41756096|FG001|Overall Study|Lost to Follow-up|0|||
19477143|NCT01484561|41756095|FG000|Overall Study|Withdrawal by Subject|3|||
19477144|NCT01484561|41756096|FG001|Overall Study|Withdrawal by Subject|0|||
19477145|NCT01484561|41756095|FG000|Overall Study|Other|1|||
19477146|NCT01484561|41756096|FG001|Overall Study|Other|1|||
19757284|NCT00696800|42207963|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
19757285|NCT00696800|42207962|FG000|Overall Study|Too high ovarian response|6|||
19757286|NCT00696800|42207963|FG001|Overall Study|Too high ovarian response|1|||
19757287|NCT00696800|42207962|FG000|Overall Study|No/too few/bad quality oocytes|4|||
19757288|NCT00696800|42207963|FG001|Overall Study|No/too few/bad quality oocytes|3|||
19477147|NCT01484561|41756095|FG000|Overall Study|Adverse Event|1|||
19477148|NCT01484561|41756096|FG001|Overall Study|Adverse Event|4|||
19669230|NCT00486291|42117225|FG000|Overall Study|Adverse Event|3|||
19669231|NCT00486291|42117226|FG001|Overall Study|Adverse Event|4|||
19477149|NCT01546207|41756102|FG000|Overall Study|Death|1|||
19477150|NCT01513291|41756108|FG000|Treatment Period|Adverse Event|8|||
19477151|NCT01513291|41756109|FG001|Treatment Period|Adverse Event|4|||
19477152|NCT01513291|41756110|FG002|Treatment Period|Adverse Event|0|||
19477153|NCT01513291|41756111|FG003|Treatment Period|Adverse Event|0|||
19477154|NCT01513291|41756112|FG004|Treatment Period|Adverse Event|0|||
19477155|NCT01513291|41756108|FG000|Treatment Period|Lack of Efficacy|3|||
19477156|NCT01513291|41756109|FG001|Treatment Period|Lack of Efficacy|0|||
19477157|NCT01513291|41756110|FG002|Treatment Period|Lack of Efficacy|0|||
19477158|NCT01513291|41756111|FG003|Treatment Period|Lack of Efficacy|0|||
19669232|NCT00486291|42117225|FG000|Overall Study|Lost to Follow-up|3|||
19669233|NCT00486291|42117226|FG001|Overall Study|Lost to Follow-up|7|||
19669234|NCT00486291|42117225|FG000|Overall Study|protocol non-compliance|10|||
19669235|NCT00486291|42117226|FG001|Overall Study|protocol non-compliance|15|||
19669236|NCT00486291|42117225|FG000|Overall Study|requirement for restricted medication|0|||
19757289|NCT00696800|42207962|FG000|Overall Study|No/abnormal fertilization|11|||
19757290|NCT00696800|42207963|FG001|Overall Study|No/abnormal fertilization|13|||
19669237|NCT00486291|42117226|FG001|Overall Study|requirement for restricted medication|3|||
19669238|NCT00474045|42117234|FG000|Overall Study|Adverse Event|18|||
19669239|NCT00474045|42117235|FG001|Overall Study|Adverse Event|8|||
19669240|NCT00474045|42117234|FG000|Overall Study|Unclassified|1|||
19669241|NCT00474045|42117235|FG001|Overall Study|Unclassified|3|||
19669242|NCT00474045|42117234|FG000|Overall Study|Lack of Efficacy|0|||
19669243|NCT00474045|42117235|FG001|Overall Study|Lack of Efficacy|9|||
19669244|NCT00474045|42117234|FG000|Overall Study|Lost to Follow-up|1|||
19669245|NCT00474045|42117235|FG001|Overall Study|Lost to Follow-up|1|||
19669246|NCT00474045|42117234|FG000|Overall Study|Protocol Violation|10|||
19669247|NCT00474045|42117235|FG001|Overall Study|Protocol Violation|12|||
19669248|NCT00474045|42117234|FG000|Overall Study|Withdrawal by Subject|16|||
19669249|NCT00474045|42117235|FG001|Overall Study|Withdrawal by Subject|18|||
19669250|NCT00474045|42117234|FG000|Overall Study|Withdrawal criteria|60|||
19669251|NCT00474045|42117235|FG001|Overall Study|Withdrawal criteria|50|||
19669252|NCT00462501|42117241|FG000|Overall Study|Not treated|3|||
19669253|NCT00462501|42117241|FG000|Overall Study|Adverse Event|2|||
19669254|NCT00383188|42117250|FG000|Overall Study|Adverse Event|4|||
19669255|NCT00383188|42117251|FG001|Overall Study|Adverse Event|7|||
19669256|NCT00383188|42117252|FG002|Overall Study|Adverse Event|9|||
19669257|NCT00383188|42117253|FG003|Overall Study|Adverse Event|8|||
19669258|NCT00383188|42117254|FG004|Overall Study|Adverse Event|8|||
19669259|NCT00383188|42117250|FG000|Overall Study|Lack of Efficacy|9|||
19669260|NCT00383188|42117251|FG001|Overall Study|Lack of Efficacy|3|||
19669261|NCT00383188|42117252|FG002|Overall Study|Lack of Efficacy|3|||
19669262|NCT00383188|42117253|FG003|Overall Study|Lack of Efficacy|2|||
19669263|NCT00383188|42117254|FG004|Overall Study|Lack of Efficacy|6|||
19669264|NCT00383188|42117250|FG000|Overall Study|Other|3|||
19669265|NCT00383188|42117251|FG001|Overall Study|Other|1|||
19669266|NCT00383188|42117252|FG002|Overall Study|Other|0|||
19669267|NCT00383188|42117253|FG003|Overall Study|Other|2|||
19669268|NCT00383188|42117254|FG004|Overall Study|Other|6|||
19669269|NCT00383188|42117250|FG000|Overall Study|No longer willing to participate|1|||
19669270|NCT00383188|42117251|FG001|Overall Study|No longer willing to participate|0|||
19669271|NCT00383188|42117252|FG002|Overall Study|No longer willing to participate|1|||
19669272|NCT00383188|42117253|FG003|Overall Study|No longer willing to participate|0|||
19477159|NCT01513291|41756112|FG004|Treatment Period|Lack of Efficacy|0|||
19669273|NCT00383188|42117254|FG004|Overall Study|No longer willing to participate|2|||
19669274|NCT00383188|42117250|FG000|Overall Study|Lost to Follow-up|0|||
19669275|NCT00383188|42117251|FG001|Overall Study|Lost to Follow-up|0|||
19669276|NCT00383188|42117252|FG002|Overall Study|Lost to Follow-up|0|||
19669277|NCT00383188|42117253|FG003|Overall Study|Lost to Follow-up|0|||
19669278|NCT00383188|42117254|FG004|Overall Study|Lost to Follow-up|1|||
19669279|NCT00462345|42117268|FG000|Overall Study|Withdrawal by Subject|2|||
19669280|NCT00462345|42117268|FG000|Overall Study|Did not complete second course|1|||
19669281|NCT00453999|42117275|FG000|Overall Study|Adverse Event|1|||
19669282|NCT00453999|42117276|FG001|Overall Study|Adverse Event|2|||
19669283|NCT00453999|42117277|FG002|Overall Study|Adverse Event|1|||
19669284|NCT00453999|42117275|FG000|Overall Study|Lost to Follow-up|0|||
19669285|NCT00453999|42117276|FG001|Overall Study|Lost to Follow-up|1|||
19669286|NCT00453999|42117277|FG002|Overall Study|Lost to Follow-up|1|||
19757291|NCT00696800|42207962|FG000|Overall Study|No/too few/bad quality embryos|24|||
19757292|NCT00696800|42207963|FG001|Overall Study|No/too few/bad quality embryos|18|||
19757293|NCT00696800|42207962|FG000|Overall Study|Other Reasons|5|||
19757294|NCT00696800|42207963|FG001|Overall Study|Other Reasons|3|||
19757295|NCT00696800|42207962|FG000|Overall Study|Not treated|1|||
19757296|NCT00696800|42207963|FG001|Overall Study|Not treated|2|||
19757297|NCT00289874|42207971|FG000|Overall Study|Adverse Event|1|||
19757298|NCT00289874|42207972|FG001|Overall Study|Adverse Event|5|||
19757299|NCT00289874|42207971|FG000|Overall Study|Lost to Follow-up|1|||
19757300|NCT00289874|42207972|FG001|Overall Study|Lost to Follow-up|1|||
19757301|NCT00289874|42207971|FG000|Overall Study|Protocol Violation|3|||
19669287|NCT00453999|42117275|FG000|Overall Study|Withdrawal by Subject|2|||
19669288|NCT00453999|42117276|FG001|Overall Study|Withdrawal by Subject|1|||
19669289|NCT00453999|42117277|FG002|Overall Study|Withdrawal by Subject|1|||
19669290|NCT00453999|42117275|FG000|Overall Study|Subject Request|2|||
19669291|NCT00453999|42117276|FG001|Overall Study|Subject Request|1|||
19669292|NCT00453999|42117277|FG002|Overall Study|Subject Request|0|||
19669293|NCT00453921|42117290|FG000|Overall Study|Withdrawal by Subject|1|||
19669294|NCT00453921|42117291|FG001|Overall Study|Withdrawal by Subject|1|||
19669295|NCT00453921|42117292|FG002|Overall Study|Withdrawal by Subject|1|||
19669296|NCT00453921|42117293|FG003|Overall Study|Withdrawal by Subject|1|||
19669297|NCT00453921|42117290|FG000|Overall Study|Lost to Follow-up|0|||
19669298|NCT00453921|42117291|FG001|Overall Study|Lost to Follow-up|0|||
19669299|NCT00453921|42117292|FG002|Overall Study|Lost to Follow-up|1|||
19669300|NCT00453921|42117293|FG003|Overall Study|Lost to Follow-up|0|||
19669301|NCT00382720|42117310|FG000|Overall Study|Adverse Event|21|||
19669302|NCT00382720|42117311|FG001|Overall Study|Adverse Event|23|||
19757302|NCT00289874|42207972|FG001|Overall Study|Protocol Violation|2|||
19757303|NCT00289874|42207971|FG000|Overall Study|Did not meet eligibility|1|||
19669303|NCT00382720|42117312|FG002|Overall Study|Adverse Event|15|||
19669304|NCT00382720|42117310|FG000|Overall Study|Protocol Violation|2|||
19669305|NCT00382720|42117311|FG001|Overall Study|Protocol Violation|5|||
19669306|NCT00382720|42117312|FG002|Overall Study|Protocol Violation|1|||
19669307|NCT00382720|42117310|FG000|Overall Study|Death|0|||
19669308|NCT00382720|42117311|FG001|Overall Study|Death|1|||
19669309|NCT00382720|42117312|FG002|Overall Study|Death|2|||
19669310|NCT00382720|42117310|FG000|Overall Study|Progressive disease|37|||
19669311|NCT00382720|42117311|FG001|Overall Study|Progressive disease|28|||
19669312|NCT00382720|42117312|FG002|Overall Study|Progressive disease|38|||
19669313|NCT00382720|42117310|FG000|Overall Study|Withdrew consent|1|||
19669314|NCT00382720|42117311|FG001|Overall Study|Withdrew consent|1|||
19669315|NCT00382720|42117312|FG002|Overall Study|Withdrew consent|2|||
19669316|NCT00382720|42117310|FG000|Overall Study|Withdrawal by Subject|11|||
19669317|NCT00382720|42117311|FG001|Overall Study|Withdrawal by Subject|20|||
19669318|NCT00382720|42117312|FG002|Overall Study|Withdrawal by Subject|12|||
19669319|NCT00382720|42117310|FG000|Overall Study|Surgery|1|||
19669320|NCT00382720|42117311|FG001|Overall Study|Surgery|1|||
19669321|NCT00382720|42117312|FG002|Overall Study|Surgery|4|||
19669322|NCT00382720|42117310|FG000|Overall Study|Patient did not receive study medication|1|||
19669323|NCT00382720|42117311|FG001|Overall Study|Patient did not receive study medication|1|||
19669324|NCT00382720|42117312|FG002|Overall Study|Patient did not receive study medication|4|||
19669325|NCT00382720|42117310|FG000|Overall Study|Clinically progressive disease|0|||
19669326|NCT00382720|42117311|FG001|Overall Study|Clinically progressive disease|1|||
19669327|NCT00382720|42117312|FG002|Overall Study|Clinically progressive disease|0|||
19669328|NCT00382720|42117310|FG000|Overall Study|Good prognosis|0|||
19757304|NCT00289874|42207972|FG001|Overall Study|Did not meet eligibility|0|||
19757305|NCT00245570|42207978|FG000|Washout Between Periods III and IV|Adverse Event|0|||
19757306|NCT00245570|42207979|FG001|Washout Between Periods III and IV|Adverse Event|1|||
19757307|NCT00245570|42207980|FG002|Washout Between Periods III and IV|Adverse Event|0|||
19757308|NCT00245570|42207981|FG003|Washout Between Periods III and IV|Adverse Event|0|||
19757309|NCT00245570|42207982|FG004|Washout Between Periods III and IV|Adverse Event|0|||
19757310|NCT00245570|42207983|FG005|Washout Between Periods III and IV|Adverse Event|0|||
19757311|NCT00840177|42208010|FG000|Overall Study|Adverse Event|5|||
19757312|NCT00840177|42208011|FG001|Overall Study|Adverse Event|1|||
19757313|NCT00840177|42208012|FG002|Overall Study|Adverse Event|1|||
19669329|NCT00382720|42117311|FG001|Overall Study|Good prognosis|1|||
19757314|NCT00840177|42208010|FG000|Overall Study|Refusal unrelated to adverse events|1|||
19757315|NCT00840177|42208011|FG001|Overall Study|Refusal unrelated to adverse events|0|||
19757316|NCT00840177|42208012|FG002|Overall Study|Refusal unrelated to adverse events|1|||
19757317|NCT00840177|42208010|FG000|Overall Study|Progression/relapse|2|||
19669330|NCT00382720|42117312|FG002|Overall Study|Good prognosis|0|||
19669331|NCT00382720|42117310|FG000|Overall Study|Investigator/Clinical decision|5|||
19669332|NCT00382720|42117311|FG001|Overall Study|Investigator/Clinical decision|6|||
19669333|NCT00382720|42117312|FG002|Overall Study|Investigator/Clinical decision|6|||
19669334|NCT00382720|42117310|FG000|Overall Study|Discontinued at end of study|0|||
19669335|NCT00382720|42117311|FG001|Overall Study|Discontinued at end of study|1|||
19669336|NCT00382720|42117312|FG002|Overall Study|Discontinued at end of study|2|||
19669337|NCT00453063|42117322|FG000|Overall Study|Adverse Event|1|||
19669338|NCT00453063|42117323|FG001|Overall Study|Adverse Event|2|||
19669339|NCT00453063|42117322|FG000|Overall Study|Withdrawal by Subject|1|||
19669340|NCT00453063|42117323|FG001|Overall Study|Withdrawal by Subject|1|||
19669341|NCT00453063|42117322|FG000|Overall Study|Protocol Violation|1|||
19669342|NCT00453063|42117323|FG001|Overall Study|Protocol Violation|0|||
19669343|NCT00371566|42117331|FG000|Treatment Phase|Withdrawal by Subject|0|||
19669344|NCT00371566|42117332|FG001|Treatment Phase|Withdrawal by Subject|1|||
19669345|NCT00371566|42117331|FG000|Treatment Phase|Adverse Event|0|||
19669346|NCT00371566|42117332|FG001|Treatment Phase|Adverse Event|1|||
19669347|NCT00371566|42117331|FG000|Treatment Phase|Protocol Violation|0|||
19669348|NCT00371566|42117332|FG001|Treatment Phase|Protocol Violation|1|||
19669349|NCT00371566|42117331|FG000|Chemoradiation Phase|Physician Decision|2|||
19669350|NCT00371566|42117332|FG001|Chemoradiation Phase|Physician Decision|0|||
19669351|NCT00371566|42117331|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
19669352|NCT00371566|42117332|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
19669353|NCT00371566|42117331|FG000|Chemoradiation Phase|Non compliant|0|||
19669354|NCT00371566|42117332|FG001|Chemoradiation Phase|Non compliant|1|||
19669355|NCT00371566|42117331|FG000|Chemoradiation Phase|Progressive Disease|1|||
19669356|NCT00371566|42117332|FG001|Chemoradiation Phase|Progressive Disease|1|||
19669357|NCT00371566|42117331|FG000|Chemoradiation Phase|Death|2|||
19669358|NCT00371566|42117332|FG001|Chemoradiation Phase|Death|0|||
19669359|NCT00371566|42117331|FG000|Follow Up Phase|Death|0|||
19669360|NCT00371566|42117332|FG001|Follow Up Phase|Death|5|||
19669361|NCT00371566|42117331|FG000|Follow Up Phase|Disease progression|1|||
19669362|NCT00371566|42117332|FG001|Follow Up Phase|Disease progression|0|||
19669363|NCT00371566|42117331|FG000|Follow Up Phase|Withdrawal by Subject|0|||
19669364|NCT00371566|42117332|FG001|Follow Up Phase|Withdrawal by Subject|1|||
19669365|NCT00371566|42117331|FG000|Follow Up Phase|Physician Decision|1|||
19669366|NCT00371566|42117332|FG001|Follow Up Phase|Physician Decision|1|||
19669367|NCT00371566|42117331|FG000|Follow Up Phase|Lost to Follow-up|1|||
19669368|NCT00371566|42117332|FG001|Follow Up Phase|Lost to Follow-up|0|||
19669369|NCT00382408|42117340|FG000|Overall Study|Did not meet protocol requirement|3|||
19669370|NCT00382408|42117341|FG001|Overall Study|Did not meet protocol requirement|3|||
19669371|NCT00382408|42117340|FG000|Overall Study|Protocol Violation|2|||
19669372|NCT00382408|42117341|FG001|Overall Study|Protocol Violation|2|||
19669373|NCT00382408|42117340|FG000|Overall Study|Physician Decision|1|||
19669374|NCT00382408|42117341|FG001|Overall Study|Physician Decision|0|||
19669375|NCT00382408|42117340|FG000|Overall Study|Withdrawal by Subject|17|||
19669376|NCT00382408|42117341|FG001|Overall Study|Withdrawal by Subject|6|||
19669377|NCT00382408|42117340|FG000|Overall Study|Pregnancy|2|||
19669378|NCT00382408|42117341|FG001|Overall Study|Pregnancy|0|||
19669379|NCT00382408|42117340|FG000|Overall Study|Lost to Follow-up|19|||
19669380|NCT00382408|42117341|FG001|Overall Study|Lost to Follow-up|8|||
19669381|NCT00382408|42117340|FG000|Overall Study|Other|100|||
19669382|NCT00382408|42117341|FG001|Overall Study|Other|35|||
19669383|NCT00371254|42117349|FG000|Overall Study|Disease progression|13|||
19669384|NCT00371254|42117350|FG001|Overall Study|Disease progression|13|||
19669385|NCT00371254|42117349|FG000|Overall Study|Study drug toxicity|3|||
19669386|NCT00371254|42117350|FG001|Overall Study|Study drug toxicity|5|||
19669387|NCT00371254|42117349|FG000|Overall Study|Subject request|5|||
19669388|NCT00371254|42117350|FG001|Overall Study|Subject request|0|||
19669389|NCT00371254|42117349|FG000|Overall Study|Investigator Decision|2|||
19669390|NCT00371254|42117350|FG001|Overall Study|Investigator Decision|0|||
19669391|NCT00371254|42117349|FG000|Overall Study|Adverse event unrelated to study drug|0|||
19669392|NCT00371254|42117350|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19669393|NCT00371254|42117349|FG000|Overall Study|Lost to Follow-up|0|||
19669394|NCT00371254|42117350|FG001|Overall Study|Lost to Follow-up|1|||
19669395|NCT00371254|42117349|FG000|Overall Study|Withdrawal by Subject|0|||
19669396|NCT00371254|42117350|FG001|Overall Study|Withdrawal by Subject|1|||
19669397|NCT00452673|42117360|FG000|Dose Escalation Period|Disease Progression|6|||
19669398|NCT00452673|42117361|FG001|Dose Escalation Period|Disease Progression|6|||
19669399|NCT00452673|42117362|FG002|Dose Escalation Period|Disease Progression|2|||
19669400|NCT00452673|42117363|FG003|Dose Escalation Period|Disease Progression|6|||
19669401|NCT00452673|42117364|FG004|Dose Escalation Period|Disease Progression|0|||
19669402|NCT00452673|42117360|FG000|Dose Escalation Period|study drug toxicity|1|||
19669403|NCT00452673|42117361|FG001|Dose Escalation Period|study drug toxicity|3|||
19669404|NCT00452673|42117362|FG002|Dose Escalation Period|study drug toxicity|3|||
19669405|NCT00452673|42117363|FG003|Dose Escalation Period|study drug toxicity|1|||
19669406|NCT00452673|42117364|FG004|Dose Escalation Period|study drug toxicity|0|||
19669407|NCT00452673|42117360|FG000|Dose Escalation Period|Other|0|||
19669408|NCT00452673|42117361|FG001|Dose Escalation Period|Other|0|||
19669409|NCT00452673|42117362|FG002|Dose Escalation Period|Other|1|||
19669410|NCT00452673|42117363|FG003|Dose Escalation Period|Other|0|||
19669411|NCT00452673|42117364|FG004|Dose Escalation Period|Other|0|||
19669412|NCT00452673|42117360|FG000|Dose Escalation Period|Adverse Event|0|||
19669413|NCT00452673|42117361|FG001|Dose Escalation Period|Adverse Event|0|||
19669414|NCT00452673|42117362|FG002|Dose Escalation Period|Adverse Event|0|||
19669415|NCT00452673|42117363|FG003|Dose Escalation Period|Adverse Event|1|||
19669416|NCT00452673|42117364|FG004|Dose Escalation Period|Adverse Event|0|||
19669417|NCT00452673|42117360|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
19669418|NCT00452673|42117361|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
19669419|NCT00452673|42117362|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
19669420|NCT00452673|42117363|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
19669421|NCT00452673|42117364|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
19669422|NCT00452673|42117360|FG000|Dose Expansion Period|Disease Progression|0|||
19669423|NCT00452673|42117361|FG001|Dose Expansion Period|Disease Progression|0|||
19669424|NCT00452673|42117362|FG002|Dose Expansion Period|Disease Progression|0|||
19669425|NCT00452673|42117363|FG003|Dose Expansion Period|Disease Progression|0|||
19669426|NCT00452673|42117364|FG004|Dose Expansion Period|Disease Progression|19|||
19757318|NCT00840177|42208011|FG001|Overall Study|Progression/relapse|0|||
19757319|NCT00840177|42208012|FG002|Overall Study|Progression/relapse|0|||
19757320|NCT00840177|42208010|FG000|Overall Study|Death|4|||
19669427|NCT00452673|42117360|FG000|Dose Expansion Period|Other|0|||
19669428|NCT00452673|42117361|FG001|Dose Expansion Period|Other|0|||
19669429|NCT00452673|42117362|FG002|Dose Expansion Period|Other|0|||
19669430|NCT00452673|42117363|FG003|Dose Expansion Period|Other|0|||
19669431|NCT00452673|42117364|FG004|Dose Expansion Period|Other|2|||
19669432|NCT00461253|42117377|FG000|Overall Study|Death|985|||
19669433|NCT00461253|42117378|FG001|Overall Study|Death|0|||
19669434|NCT00461253|42117377|FG000|Overall Study|Protocol Violation|613|||
19669435|NCT00461253|42117378|FG001|Overall Study|Protocol Violation|236|||
19669436|NCT00461253|42117377|FG000|Overall Study|no response|2609|||
19669437|NCT00461253|42117378|FG001|Overall Study|no response|11789|||
19669438|NCT00461253|42117377|FG000|Overall Study|administrative|773|||
19757321|NCT00840177|42208011|FG001|Overall Study|Death|5|||
19603248|NCT00577993|42052158|FG001|Overall Study|Uninsured|0|||
19669439|NCT00461253|42117378|FG001|Overall Study|administrative|7773|||
19669440|NCT00469833|42117384|FG000|Overall Study|No IV access|2|||
19669441|NCT00382174|42117396|FG000|Overall Study|Lost to Follow-up|1|||
19669442|NCT00382174|42117397|FG001|Overall Study|Lost to Follow-up|4|||
19669443|NCT00382174|42117398|FG002|Overall Study|Lost to Follow-up|5|||
19669444|NCT00382174|42117396|FG000|Overall Study|Adverse Event|1|||
19669445|NCT00382174|42117397|FG001|Overall Study|Adverse Event|4|||
19669446|NCT00382174|42117398|FG002|Overall Study|Adverse Event|5|||
19669447|NCT00382174|42117396|FG000|Overall Study|Withdrawal by Subject|1|||
19757322|NCT00840177|42208012|FG002|Overall Study|Death|5|||
19603249|NCT00577993|42052159|FG002|Overall Study|Uninsured|0|||
19603250|NCT00975806|42052168|FG000|Overall Study|Adverse Event|2|||
19603251|NCT00975806|42052169|FG001|Overall Study|Adverse Event|1|||
19603252|NCT00975806|42052170|FG002|Overall Study|Adverse Event|2|||
19603253|NCT00975806|42052168|FG000|Overall Study|Disease Progression|1|||
19603254|NCT00975806|42052169|FG001|Overall Study|Disease Progression|5|||
19603255|NCT00975806|42052170|FG002|Overall Study|Disease Progression|1|||
19603256|NCT00975806|42052168|FG000|Overall Study|Withdrawal by Subject|1|||
19603257|NCT00975806|42052169|FG001|Overall Study|Withdrawal by Subject|0|||
19603258|NCT00975806|42052170|FG002|Overall Study|Withdrawal by Subject|0|||
19603259|NCT00975806|42052168|FG000|Overall Study|Death|0|||
19603260|NCT00975806|42052169|FG001|Overall Study|Death|1|||
19603261|NCT00975806|42052170|FG002|Overall Study|Death|0|||
19603262|NCT00975806|42052168|FG000|Overall Study|Physician decision and disease related|1|||
19603263|NCT00975806|42052169|FG001|Overall Study|Physician decision and disease related|0|||
19603264|NCT00975806|42052170|FG002|Overall Study|Physician decision and disease related|1|||
19603265|NCT00978068|42052182|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
19669448|NCT00382174|42117397|FG001|Overall Study|Withdrawal by Subject|4|||
19603266|NCT00978068|42052183|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
19603267|NCT00978068|42052182|FG000|Overall Study|Death|1|||
19603268|NCT00978068|42052183|FG001|Overall Study|Death|2|||
19603269|NCT00978068|42052182|FG000|Overall Study|Lost to Follow-up|1|||
19603270|NCT00978068|42052183|FG001|Overall Study|Lost to Follow-up|2|||
19603271|NCT00978068|42052182|FG000|Overall Study|Physician Decision|0|||
19669449|NCT00382174|42117398|FG002|Overall Study|Withdrawal by Subject|5|||
19669450|NCT00382174|42117396|FG000|Overall Study|Non compliance|1|||
19669451|NCT00382174|42117397|FG001|Overall Study|Non compliance|0|||
19669452|NCT00382174|42117398|FG002|Overall Study|Non compliance|1|||
19669453|NCT00382174|42117396|FG000|Overall Study|Physician Decision|0|||
19669454|NCT00382174|42117397|FG001|Overall Study|Physician Decision|2|||
19669455|NCT00382174|42117398|FG002|Overall Study|Physician Decision|2|||
19669456|NCT00382174|42117396|FG000|Overall Study|Failed to meet criteria|0|||
19669457|NCT00382174|42117397|FG001|Overall Study|Failed to meet criteria|1|||
19669458|NCT00382174|42117398|FG002|Overall Study|Failed to meet criteria|1|||
19669459|NCT00382174|42117396|FG000|Overall Study|Wounds merged|0|||
19669460|NCT00382174|42117397|FG001|Overall Study|Wounds merged|2|||
19669461|NCT00382174|42117398|FG002|Overall Study|Wounds merged|2|||
19669462|NCT00641537|42117411|FG000|96-week Period|Adverse Event|0|||
19669463|NCT00641537|42117412|FG001|96-week Period|Adverse Event|1|||
19669464|NCT00641537|42117413|FG002|96-week Period|Adverse Event|3|||
19669465|NCT00641537|42117414|FG003|96-week Period|Adverse Event|0|||
19669466|NCT00641537|42117415|FG004|96-week Period|Adverse Event|2|||
19669467|NCT00641537|42117416|FG005|96-week Period|Adverse Event|0|||
19669468|NCT00641537|42117417|FG006|96-week Period|Adverse Event|0|||
19669469|NCT00641537|42117418|FG007|96-week Period|Adverse Event|0|||
19669470|NCT00641537|42117411|FG000|96-week Period|Lost to Follow-up|3|||
19669471|NCT00641537|42117412|FG001|96-week Period|Lost to Follow-up|1|||
19669472|NCT00641537|42117413|FG002|96-week Period|Lost to Follow-up|2|||
19669473|NCT00641537|42117414|FG003|96-week Period|Lost to Follow-up|2|||
19669474|NCT00641537|42117415|FG004|96-week Period|Lost to Follow-up|4|||
19669475|NCT00641537|42117416|FG005|96-week Period|Lost to Follow-up|0|||
19669476|NCT00641537|42117417|FG006|96-week Period|Lost to Follow-up|1|||
19669477|NCT00641537|42117418|FG007|96-week Period|Lost to Follow-up|0|||
19669478|NCT00641537|42117411|FG000|96-week Period|Protocol Violation|0|||
19669479|NCT00641537|42117412|FG001|96-week Period|Protocol Violation|1|||
19669480|NCT00641537|42117413|FG002|96-week Period|Protocol Violation|0|||
19669481|NCT00641537|42117414|FG003|96-week Period|Protocol Violation|1|||
19669482|NCT00641537|42117415|FG004|96-week Period|Protocol Violation|0|||
19669483|NCT00641537|42117416|FG005|96-week Period|Protocol Violation|1|||
19373628|NCT02760407|41614833|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
19669484|NCT00641537|42117417|FG006|96-week Period|Protocol Violation|0|||
19669485|NCT00641537|42117418|FG007|96-week Period|Protocol Violation|0|||
19669486|NCT00641537|42117411|FG000|96-week Period|Death|2|||
19669487|NCT00641537|42117412|FG001|96-week Period|Death|0|||
19669488|NCT00641537|42117413|FG002|96-week Period|Death|1|||
19669489|NCT00641537|42117414|FG003|96-week Period|Death|0|||
19669490|NCT00641537|42117415|FG004|96-week Period|Death|0|||
19669491|NCT00641537|42117416|FG005|96-week Period|Death|0|||
19669492|NCT00641537|42117417|FG006|96-week Period|Death|0|||
19669493|NCT00641537|42117418|FG007|96-week Period|Death|0|||
19669494|NCT00641537|42117411|FG000|96-week Period|Other|4|||
19669495|NCT00641537|42117412|FG001|96-week Period|Other|7|||
19669496|NCT00641537|42117413|FG002|96-week Period|Other|14|||
19669497|NCT00641537|42117414|FG003|96-week Period|Other|9|||
19669498|NCT00641537|42117415|FG004|96-week Period|Other|11|||
19669499|NCT00641537|42117416|FG005|96-week Period|Other|6|||
19669500|NCT00641537|42117417|FG006|96-week Period|Other|4|||
19669501|NCT00641537|42117418|FG007|96-week Period|Other|6|||
19669502|NCT00641537|42117411|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
19669503|NCT00641537|42117412|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
19669504|NCT00641537|42117413|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
19669505|NCT00641537|42117414|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
19669506|NCT00641537|42117415|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
19669507|NCT00641537|42117416|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
19669508|NCT00641537|42117417|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
19757323|NCT00840177|42208010|FG000|Overall Study|not protocol specified|6|||
19757324|NCT00840177|42208011|FG001|Overall Study|not protocol specified|3|||
19669509|NCT00641537|42117418|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
19669510|NCT00641537|42117411|FG000|24-Week Supplemental Follow-up Period|Other|0|||
19669511|NCT00641537|42117412|FG001|24-Week Supplemental Follow-up Period|Other|2|||
19669512|NCT00641537|42117413|FG002|24-Week Supplemental Follow-up Period|Other|2|||
19669513|NCT00641537|42117414|FG003|24-Week Supplemental Follow-up Period|Other|1|||
19669514|NCT00641537|42117415|FG004|24-Week Supplemental Follow-up Period|Other|3|||
19669515|NCT00641537|42117416|FG005|24-Week Supplemental Follow-up Period|Other|0|||
19669516|NCT00641537|42117417|FG006|24-Week Supplemental Follow-up Period|Other|1|||
19669517|NCT00641537|42117418|FG007|24-Week Supplemental Follow-up Period|Other|1|||
19669518|NCT03840135|42117438|FG000|Overall Study|Protocol Violation|6|||
19669519|NCT03840135|42117439|FG001|Overall Study|Protocol Violation|1|||
19669520|NCT03840135|42117438|FG000|Overall Study|Withdrawal by Subject|1|||
19669521|NCT03840135|42117439|FG001|Overall Study|Withdrawal by Subject|0|||
19669522|NCT00461175|42117451|FG000|Overall Study|Protocol Violation|522|||
19669523|NCT00461175|42117452|FG001|Overall Study|Protocol Violation|365|||
19669524|NCT00641147|42117460|FG000|Completed 4 Months.|Physician Decision|1|||
19669525|NCT00641147|42117461|FG001|Completed 4 Months.|Physician Decision|0|||
19669526|NCT00641147|42117460|FG000|Completed 4 Months.|Adverse Event|1|||
19669527|NCT00641147|42117461|FG001|Completed 4 Months.|Adverse Event|0|||
19757325|NCT00840177|42208012|FG002|Overall Study|not protocol specified|0|||
19757326|NCT00840177|42208010|FG000|Overall Study|Ineligible|0|||
19757327|NCT00840177|42208011|FG001|Overall Study|Ineligible|0|||
19757328|NCT00840177|42208012|FG002|Overall Study|Ineligible|3|||
19757329|NCT00840177|42208010|FG000|Overall Study|Did not start treatment|0|||
19757330|NCT00840177|42208011|FG001|Overall Study|Did not start treatment|0|||
19757331|NCT00840177|42208012|FG002|Overall Study|Did not start treatment|1|||
19757332|NCT03512210|42208024|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
19757333|NCT03512210|42208024|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
19757334|NCT03512210|42208024|FG000|Step 2:Post-MINMON|Death|2|||
19757335|NCT03512210|42208024|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
19757336|NCT03512210|42208024|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
19669528|NCT00641147|42117460|FG000|Completed 8 Months.|Physician Decision|2|||
19669529|NCT00641147|42117461|FG001|Completed 8 Months.|Physician Decision|1|||
19669530|NCT00641147|42117460|FG000|Completed 8 Months.|non compliance|1|||
19757337|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
19757338|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
19757339|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
19757340|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
19757341|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
19757342|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
19757343|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
19757344|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
19757345|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
19757346|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
19757347|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
19757348|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
19757349|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
19757350|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
19757351|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
19757352|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
19757353|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
19757354|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
19757355|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
19757356|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
19757357|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
19757358|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
19757359|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
19757360|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
19757361|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
19757362|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
19757363|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
19757364|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
19757365|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
19757366|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
19757367|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
19757368|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
19757369|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
19757370|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
19757371|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
19757372|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
19757373|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
19757374|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
19757375|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
19757376|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
19757377|NCT00383721|42208033|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
19757378|NCT00383721|42208034|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
19757379|NCT00383721|42208035|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
19757380|NCT00383721|42208036|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
19757381|NCT00383721|42208037|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
19757382|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
19757383|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
19757384|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
19757385|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
19757386|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
19757387|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
19757388|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
19757389|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
19757390|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
19757391|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
19757392|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
19757393|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
19757394|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
19757395|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
19757396|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
19757397|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
19757398|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
19757399|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
19757400|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
19757401|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
19757402|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19757403|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19757404|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19757405|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19757406|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
19757407|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
19757408|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
19757409|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
19757410|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
19757411|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
19757412|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
19757413|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
19757414|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
19757415|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
19757416|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
19757417|NCT00383721|42208033|FG000|26-Week Treatment Safety Extension|Administrative|1|||
19757418|NCT00383721|42208034|FG001|26-Week Treatment Safety Extension|Administrative|2|||
19757419|NCT00383721|42208035|FG002|26-Week Treatment Safety Extension|Administrative|3|||
19757420|NCT00383721|42208036|FG003|26-Week Treatment Safety Extension|Administrative|1|||
19757421|NCT00383721|42208037|FG004|26-Week Treatment Safety Extension|Administrative|0|||
19757422|NCT03035942|42208065|FG000|Overall Study|Adverse Event|8|||
19757423|NCT03035942|42208066|FG001|Overall Study|Adverse Event|4|||
19757424|NCT03035942|42208067|FG002|Overall Study|Adverse Event|5|||
19757425|NCT02616146|42208079|FG000|Overall Study|Adverse Event|64|||
19757426|NCT02616146|42208080|FG001|Overall Study|Adverse Event|24|||
19757427|NCT02616146|42208079|FG000|Overall Study|Lost to Follow-up|23|||
19757428|NCT02616146|42208080|FG001|Overall Study|Lost to Follow-up|13|||
19757429|NCT02616146|42208079|FG000|Overall Study|Non-compliance with study protocol|2|||
19757430|NCT02616146|42208080|FG001|Overall Study|Non-compliance with study protocol|0|||
19757431|NCT02616146|42208079|FG000|Overall Study|Non-compliance with study drug|4|||
19757432|NCT02616146|42208080|FG001|Overall Study|Non-compliance with study drug|2|||
19757433|NCT02616146|42208079|FG000|Overall Study|Pregnancy|2|||
19757434|NCT02616146|42208080|FG001|Overall Study|Pregnancy|2|||
19757435|NCT02616146|42208079|FG000|Overall Study|Pregnancy wish|3|||
19603272|NCT00978068|42052183|FG001|Overall Study|Physician Decision|1|||
19603273|NCT00978068|42052182|FG000|Overall Study|Unable to Comply with Study|0|||
19603274|NCT00978068|42052183|FG001|Overall Study|Unable to Comply with Study|2|||
19603275|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
19603276|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
19603277|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
19603278|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
19603279|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
19603280|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
19603281|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
19603282|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
19603283|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
19603284|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
19603285|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
19603286|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19603287|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
19603288|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
19603289|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19603290|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
19603291|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
19603292|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
19603293|NCT00603525|42052195|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
19603294|NCT00603525|42052196|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
19603295|NCT00603525|42052197|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
19603296|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
19603297|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
19603298|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
19603299|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
19603300|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
19669531|NCT00641147|42117461|FG001|Completed 8 Months.|non compliance|0|||
19669532|NCT00641147|42117460|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
19669533|NCT00641147|42117461|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
19669534|NCT00641147|42117460|FG000|Completed 12 Months.|Physician Decision|1|||
19669535|NCT00641147|42117461|FG001|Completed 12 Months.|Physician Decision|1|||
19669536|NCT00641147|42117460|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
19669537|NCT00641147|42117461|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
19669538|NCT00641147|42117460|FG000|Completed 16 Months.|Physician Decision|1|||
19669539|NCT00641147|42117461|FG001|Completed 16 Months.|Physician Decision|0|||
19669540|NCT00641147|42117460|FG000|Completed 16 Months.|Lost to Follow-up|1|||
19669541|NCT00641147|42117461|FG001|Completed 16 Months.|Lost to Follow-up|0|||
19669542|NCT00460239|42117471|FG000|Overall Study|Physician Decision|0|||
19669543|NCT00460239|42117472|FG001|Overall Study|Physician Decision|1|||
19669544|NCT00460239|42117473|FG002|Overall Study|Physician Decision|0|||
19669545|NCT00460239|42117474|FG003|Overall Study|Physician Decision|0|||
19669546|NCT00460239|42117475|FG004|Overall Study|Physician Decision|0|||
19669547|NCT00460239|42117476|FG005|Overall Study|Physician Decision|2|||
19669548|NCT00460239|42117477|FG006|Overall Study|Physician Decision|0|||
19669549|NCT00460239|42117478|FG007|Overall Study|Physician Decision|0|||
19669550|NCT00460239|42117479|FG008|Overall Study|Physician Decision|0|||
19669551|NCT00460239|42117471|FG000|Overall Study|Withdrawal by Subject|0|||
19669552|NCT00460239|42117472|FG001|Overall Study|Withdrawal by Subject|0|||
19669553|NCT00460239|42117473|FG002|Overall Study|Withdrawal by Subject|0|||
19669554|NCT00460239|42117474|FG003|Overall Study|Withdrawal by Subject|0|||
19669555|NCT00460239|42117475|FG004|Overall Study|Withdrawal by Subject|0|||
19669556|NCT00460239|42117476|FG005|Overall Study|Withdrawal by Subject|1|||
19669557|NCT00460239|42117477|FG006|Overall Study|Withdrawal by Subject|0|||
19669558|NCT00460239|42117478|FG007|Overall Study|Withdrawal by Subject|0|||
19669559|NCT00460239|42117479|FG008|Overall Study|Withdrawal by Subject|0|||
19669560|NCT00640835|42117494|FG000|Overall Study|Adverse Event|5|||
19669561|NCT00640835|42117495|FG001|Overall Study|Adverse Event|3|||
19669562|NCT00640835|42117494|FG000|Overall Study|Withdrawal by Subject|12|||
19669563|NCT00640835|42117495|FG001|Overall Study|Withdrawal by Subject|14|||
19669564|NCT00640835|42117494|FG000|Overall Study|Physician Decision|10|||
19669565|NCT00640835|42117495|FG001|Overall Study|Physician Decision|14|||
19669566|NCT00640835|42117494|FG000|Overall Study|Sponsor's Decision|11|||
19757436|NCT02616146|42208080|FG001|Overall Study|Pregnancy wish|0|||
19757437|NCT02616146|42208079|FG000|Overall Study|Protocol Violation|6|||
19757438|NCT02616146|42208080|FG001|Overall Study|Protocol Violation|3|||
19757439|NCT02616146|42208079|FG000|Overall Study|Study terminated by sponsor|1372|||
19757440|NCT02616146|42208080|FG001|Overall Study|Study terminated by sponsor|432|||
19669567|NCT00640835|42117495|FG001|Overall Study|Sponsor's Decision|7|||
19669568|NCT00640835|42117494|FG000|Overall Study|Protocol Violation|2|||
19669569|NCT00640835|42117495|FG001|Overall Study|Protocol Violation|2|||
19669570|NCT00640835|42117494|FG000|Overall Study|Lost to Follow-up|17|||
19669571|NCT00640835|42117495|FG001|Overall Study|Lost to Follow-up|13|||
19669572|NCT00640835|42117494|FG000|Overall Study|Other Reason|19|||
19669573|NCT00640835|42117495|FG001|Overall Study|Other Reason|4|||
19669574|NCT03839355|42117503|FG000|Overall Study|Withdrawal by Subject|1|||
19669575|NCT03839355|42117504|FG001|Overall Study|Withdrawal by Subject|0|||
19669576|NCT00382018|42117514|FG000|Overall Study|Progression|0|||
19669577|NCT00382018|42117515|FG001|Overall Study|Progression|136|||
19669578|NCT00382018|42117516|FG002|Overall Study|Progression|51|||
19669579|NCT00382018|42117517|FG003|Overall Study|Progression|43|||
19669580|NCT00382018|42117514|FG000|Overall Study|Death|0|||
19669581|NCT00382018|42117515|FG001|Overall Study|Death|9|||
19669582|NCT00382018|42117516|FG002|Overall Study|Death|7|||
19669583|NCT00382018|42117517|FG003|Overall Study|Death|11|||
19669584|NCT00382018|42117514|FG000|Overall Study|Withdrawal by Subject|0|||
19669585|NCT00382018|42117515|FG001|Overall Study|Withdrawal by Subject|4|||
19669586|NCT00382018|42117516|FG002|Overall Study|Withdrawal by Subject|3|||
19669587|NCT00382018|42117517|FG003|Overall Study|Withdrawal by Subject|4|||
19669588|NCT00382018|42117514|FG000|Overall Study|Other, not protocol specified|0|||
19669589|NCT00382018|42117515|FG001|Overall Study|Other, not protocol specified|16|||
19669590|NCT00382018|42117516|FG002|Overall Study|Other, not protocol specified|3|||
19669591|NCT00382018|42117517|FG003|Overall Study|Other, not protocol specified|1|||
19669592|NCT00640601|42117530|FG000|Overall Study|Adverse Event|43|||
19669593|NCT00640601|42117530|FG000|Overall Study|Withdrawal by Subject|20|||
19669594|NCT00640601|42117530|FG000|Overall Study|Protocol Violation|6|||
19669595|NCT00640601|42117530|FG000|Overall Study|Lack of Efficacy|16|||
19669596|NCT00640601|42117530|FG000|Overall Study|Lost to Follow-up|9|||
19757441|NCT02616146|42208079|FG000|Overall Study|Participant moved|4|||
19669597|NCT00640601|42117530|FG000|Overall Study|Physician Decision|8|||
19669598|NCT00640601|42117530|FG000|Overall Study|treatment naive, combination therapy|10|||
19669599|NCT03838731|42117536|FG000|Overall Study|Pregnancy|0|||
19669600|NCT03838731|42117537|FG001|Overall Study|Pregnancy|1|||
19669601|NCT03838731|42117536|FG000|Overall Study|Withdrawal of consent|1|||
19669602|NCT03838731|42117537|FG001|Overall Study|Withdrawal of consent|0|||
19669603|NCT00452439|42117545|FG000|Overall Study|Lost to Follow-up|1|||
19669604|NCT00452439|42117546|FG001|Overall Study|Lost to Follow-up|1|||
19669605|NCT00452439|42117545|FG000|Overall Study|Refused Treatment|4|||
19669606|NCT00452439|42117546|FG001|Overall Study|Refused Treatment|3|||
19669607|NCT00452439|42117545|FG000|Overall Study|Death|3|||
19669608|NCT00452439|42117546|FG001|Overall Study|Death|1|||
19669609|NCT00452439|42117545|FG000|Overall Study|Bone Marrow Transplant|0|||
19669610|NCT00452439|42117546|FG001|Overall Study|Bone Marrow Transplant|1|||
19669611|NCT00452439|42117545|FG000|Overall Study|Too Ill to Continue|0|||
19669612|NCT00452439|42117546|FG001|Overall Study|Too Ill to Continue|1|||
19669613|NCT00452439|42117545|FG000|Overall Study|Failed to achieve complete response|2|||
19669614|NCT00452439|42117546|FG001|Overall Study|Failed to achieve complete response|0|||
19669615|NCT00452439|42117545|FG000|Overall Study|Relapse|3|||
19669616|NCT00452439|42117546|FG001|Overall Study|Relapse|0|||
19669617|NCT00452439|42117545|FG000|Overall Study|Fracture|1|||
19669618|NCT00452439|42117546|FG001|Overall Study|Fracture|0|||
19669619|NCT00381940|42117552|FG000|Overall Study|Lack of Efficacy|3|||
19669620|NCT00381940|42117552|FG000|Overall Study|Protocol Violation|1|||
19669621|NCT00381940|42117552|FG000|Overall Study|Ineligible|1|||
19669622|NCT00364156|42117558|FG000|Overall Study|Withdrawal by Subject|73|||
19669623|NCT00364156|42117559|FG001|Overall Study|Withdrawal by Subject|80|||
19669624|NCT00364156|42117558|FG000|Overall Study|Protocol Violation|6|||
19669625|NCT00364156|42117559|FG001|Overall Study|Protocol Violation|1|||
19669626|NCT00452361|42117567|FG000|Overall Study|Adverse Event|8|||
19669627|NCT00452361|42117568|FG001|Overall Study|Adverse Event|0|||
19757442|NCT02616146|42208080|FG001|Overall Study|Participant moved|3|||
19757443|NCT02616146|42208079|FG000|Overall Study|Withdrawal by Subject|30|||
19757444|NCT02616146|42208080|FG001|Overall Study|Withdrawal by Subject|24|||
19757445|NCT02616146|42208079|FG000|Overall Study|Physician Decision|2|||
19757446|NCT02616146|42208080|FG001|Overall Study|Physician Decision|1|||
19757447|NCT03035864|42208088|FG000|Treatment Period|Adverse Event|1|||
19757448|NCT03035864|42208089|FG001|Treatment Period|Adverse Event|0|||
19757449|NCT03035864|42208088|FG000|Treatment Period|Other|3|||
19757450|NCT03035864|42208089|FG001|Treatment Period|Other|1|||
19757451|NCT03035864|42208088|FG000|Follow-up Period|Adverse Event|1|||
19757452|NCT03035864|42208089|FG001|Follow-up Period|Adverse Event|0|||
19757453|NCT03035864|42208088|FG000|Follow-up Period|Lost to Follow-up|6|||
19757454|NCT03035864|42208089|FG001|Follow-up Period|Lost to Follow-up|2|||
19757455|NCT03035864|42208088|FG000|Follow-up Period|Physician Decision|1|||
19757456|NCT03035864|42208089|FG001|Follow-up Period|Physician Decision|0|||
19669628|NCT00452361|42117567|FG000|Overall Study|Withdrawal by Subject|0|||
19669629|NCT00452361|42117568|FG001|Overall Study|Withdrawal by Subject|1|||
19669630|NCT00452361|42117567|FG000|Overall Study|Premature termination|13|||
19669631|NCT00452361|42117568|FG001|Overall Study|Premature termination|9|||
19669632|NCT00640289|42117574|FG000|Overall Study|Death|3|||
19669633|NCT00640289|42117574|FG000|Overall Study|Withdrawal by Subject|1|||
19669634|NCT00640289|42117574|FG000|Overall Study|Lost to Follow-up|1|||
19669635|NCT00640289|42117574|FG000|Overall Study|Data collected under different amendment|2|||
19669636|NCT00640289|42117574|FG000|Overall Study|Transferred to another center|1|||
19669637|NCT00640289|42117574|FG000|Overall Study|Missing status|5|||
19669638|NCT00568451|42117582|FG000|Overall Study|Disease Progression|0|||
19669639|NCT00568451|42117583|FG001|Overall Study|Disease Progression|0|||
19669640|NCT00568451|42117584|FG002|Overall Study|Disease Progression|2|||
19669641|NCT00568451|42117585|FG003|Overall Study|Disease Progression|7|||
19757457|NCT03035864|42208088|FG000|Follow-up Period|Other|3|||
19757458|NCT03035864|42208089|FG001|Follow-up Period|Other|2|||
19757459|NCT02885181|42208107|FG000|Overall Study|Investigator's Discretion|0|||
19757460|NCT02885181|42208108|FG001|Overall Study|Investigator's Discretion|1|||
19669642|NCT00459537|42117598|FG000|Overall Study|Adverse Event|1|||
19669643|NCT00459537|42117599|FG001|Overall Study|Adverse Event|6|||
19669644|NCT00459537|42117598|FG000|Overall Study|Lack of Efficacy|10|||
19669645|NCT00459537|42117599|FG001|Overall Study|Lack of Efficacy|11|||
19669646|NCT00459537|42117598|FG000|Overall Study|Withdrawal by Subject|20|||
19669647|NCT00459537|42117599|FG001|Overall Study|Withdrawal by Subject|26|||
19669648|NCT00459537|42117598|FG000|Overall Study|Lost to Follow-up|27|||
19669649|NCT00459537|42117599|FG001|Overall Study|Lost to Follow-up|30|||
19669650|NCT00459537|42117598|FG000|Overall Study|Administrative problems|3|||
19669651|NCT00459537|42117599|FG001|Overall Study|Administrative problems|0|||
19669652|NCT00459537|42117598|FG000|Overall Study|Protocol Violation|4|||
19669653|NCT00459537|42117599|FG001|Overall Study|Protocol Violation|3|||
19669654|NCT00459537|42117598|FG000|Overall Study|Missing|1|||
19669655|NCT00459537|42117599|FG001|Overall Study|Missing|0|||
19669656|NCT03850509|42117607|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
19757461|NCT02885181|42208109|FG002|Overall Study|Investigator's Discretion|0|||
19757462|NCT02885181|42208110|FG003|Overall Study|Investigator's Discretion|1|||
19669657|NCT03850509|42117608|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
19669658|NCT00635999|42117617|FG000|Overall Study|Withdrawal by Subject|4|||
19669659|NCT00635999|42117618|FG001|Overall Study|Withdrawal by Subject|2|||
19757463|NCT02885181|42208107|FG000|Overall Study|Adverse Event|0|||
19669660|NCT00635999|42117619|FG002|Overall Study|Withdrawal by Subject|1|||
19669661|NCT00469209|42117630|FG000|Overall Study|Adverse Event|1|||
19669662|NCT00469209|42117631|FG001|Overall Study|Adverse Event|0|||
19669663|NCT00469209|42117632|FG002|Overall Study|Adverse Event|1|||
19669664|NCT00635219|42117645|FG000|Overall Study|Adverse Event|12|||
19669665|NCT00635219|42117646|FG001|Overall Study|Adverse Event|10|||
19669666|NCT00635219|42117647|FG002|Overall Study|Adverse Event|18|||
19669667|NCT00635219|42117648|FG003|Overall Study|Adverse Event|15|||
19669668|NCT00635219|42117649|FG004|Overall Study|Adverse Event|19|||
19669669|NCT00635219|42117645|FG000|Overall Study|Lack of Efficacy|5|||
19669670|NCT00635219|42117646|FG001|Overall Study|Lack of Efficacy|6|||
19669671|NCT00635219|42117647|FG002|Overall Study|Lack of Efficacy|3|||
19669672|NCT00635219|42117648|FG003|Overall Study|Lack of Efficacy|4|||
19669673|NCT00635219|42117649|FG004|Overall Study|Lack of Efficacy|6|||
19669674|NCT00635219|42117645|FG000|Overall Study|Non-compliance With Study Product|0|||
19669675|NCT00635219|42117646|FG001|Overall Study|Non-compliance With Study Product|0|||
19669676|NCT00635219|42117647|FG002|Overall Study|Non-compliance With Study Product|0|||
19669677|NCT00635219|42117648|FG003|Overall Study|Non-compliance With Study Product|2|||
19669678|NCT00635219|42117649|FG004|Overall Study|Non-compliance With Study Product|1|||
19603301|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
19603302|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
19603303|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
19603304|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
19603305|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
19603306|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
19603307|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
19669679|NCT00635219|42117645|FG000|Overall Study|Protocol Violation|0|||
19669680|NCT00635219|42117646|FG001|Overall Study|Protocol Violation|2|||
19669681|NCT00635219|42117647|FG002|Overall Study|Protocol Violation|3|||
19669682|NCT00635219|42117648|FG003|Overall Study|Protocol Violation|2|||
19669683|NCT00635219|42117649|FG004|Overall Study|Protocol Violation|4|||
19669684|NCT00635219|42117645|FG000|Overall Study|Withdrawal of Consent|8|||
19669685|NCT00635219|42117646|FG001|Overall Study|Withdrawal of Consent|6|||
19669686|NCT00635219|42117647|FG002|Overall Study|Withdrawal of Consent|8|||
19669687|NCT00635219|42117648|FG003|Overall Study|Withdrawal of Consent|11|||
19669688|NCT00635219|42117649|FG004|Overall Study|Withdrawal of Consent|8|||
19669689|NCT00635219|42117645|FG000|Overall Study|Lost to Follow-up|0|||
19669690|NCT00635219|42117646|FG001|Overall Study|Lost to Follow-up|0|||
19669691|NCT00635219|42117647|FG002|Overall Study|Lost to Follow-up|2|||
19669692|NCT00635219|42117648|FG003|Overall Study|Lost to Follow-up|0|||
19669693|NCT00635219|42117649|FG004|Overall Study|Lost to Follow-up|3|||
19669694|NCT00635219|42117645|FG000|Overall Study|Administrative or Other Reasons|0|||
19669695|NCT00635219|42117646|FG001|Overall Study|Administrative or Other Reasons|1|||
19669696|NCT00635219|42117647|FG002|Overall Study|Administrative or Other Reasons|1|||
19669697|NCT00635219|42117648|FG003|Overall Study|Administrative or Other Reasons|0|||
19669698|NCT00635219|42117649|FG004|Overall Study|Administrative or Other Reasons|1|||
19669699|NCT00363766|42117663|FG000|Overall Study|Progressive Disease|15|||
19669700|NCT00363766|42117664|FG001|Overall Study|Progressive Disease|9|||
19669701|NCT00363766|42117663|FG000|Overall Study|Adverse Event|10|||
19669702|NCT00363766|42117664|FG001|Overall Study|Adverse Event|2|||
19669703|NCT00363766|42117663|FG000|Overall Study|Disease Related Death|1|||
19669704|NCT00363766|42117664|FG001|Overall Study|Disease Related Death|3|||
19669705|NCT00363766|42117663|FG000|Overall Study|Not Disease Related Death|3|||
19669706|NCT00363766|42117664|FG001|Overall Study|Not Disease Related Death|4|||
19669707|NCT00363766|42117663|FG000|Overall Study|Withdrawal by Subject|2|||
19669708|NCT00363766|42117664|FG001|Overall Study|Withdrawal by Subject|0|||
19669709|NCT00363766|42117663|FG000|Overall Study|Physician Decision|1|||
19669710|NCT00363766|42117664|FG001|Overall Study|Physician Decision|2|||
19669711|NCT00468819|42117674|FG000|Overall Study|Withdrawal by Subject|4|||
19669712|NCT00468819|42117675|FG001|Overall Study|Withdrawal by Subject|0|||
19669713|NCT00468819|42117676|FG002|Overall Study|Withdrawal by Subject|1|||
19669714|NCT00468819|42117674|FG000|Overall Study|Lost to Follow-up|0|||
19669715|NCT00468819|42117675|FG001|Overall Study|Lost to Follow-up|0|||
19669716|NCT00468819|42117676|FG002|Overall Study|Lost to Follow-up|1|||
19669717|NCT00468819|42117674|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
19757464|NCT02885181|42208108|FG001|Overall Study|Adverse Event|0|||
19669718|NCT00468819|42117675|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
19669719|NCT00468819|42117676|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
19669720|NCT00451191|42117688|FG000|Overall Study|withdrawal or received alternate tx|15|||
19669721|NCT00451191|42117689|FG001|Overall Study|withdrawal or received alternate tx|11|||
19669722|NCT00451035|42117695|FG000|Overall Study|Disease progression|11|||
19669723|NCT00451035|42117695|FG000|Overall Study|Death|3|||
19669724|NCT00451035|42117695|FG000|Overall Study|New anti-neoplastic therapy|3|||
19669725|NCT00468585|42117704|FG000|Overall Study|Patient not treated|1|||
19669726|NCT00468585|42117705|FG001|Overall Study|Patient not treated|0|||
19669727|NCT00468585|42117706|FG002|Overall Study|Patient not treated|1|||
19669728|NCT00468585|42117707|FG003|Overall Study|Patient not treated|0|||
19669729|NCT00468585|42117704|FG000|Overall Study|Patient found to be ineligible|0|||
19669730|NCT00468585|42117705|FG001|Overall Study|Patient found to be ineligible|0|||
19669731|NCT00468585|42117706|FG002|Overall Study|Patient found to be ineligible|1|||
19669732|NCT00468585|42117707|FG003|Overall Study|Patient found to be ineligible|0|||
19669733|NCT00468585|42117704|FG000|Overall Study|Adverse Event|0|||
19669734|NCT00468585|42117705|FG001|Overall Study|Adverse Event|0|||
19669735|NCT00468585|42117706|FG002|Overall Study|Adverse Event|1|||
19669736|NCT00468585|42117707|FG003|Overall Study|Adverse Event|0|||
19669737|NCT00468585|42117704|FG000|Overall Study|Withdrawal by Subject|0|||
19669738|NCT00468585|42117705|FG001|Overall Study|Withdrawal by Subject|0|||
19669739|NCT00468585|42117706|FG002|Overall Study|Withdrawal by Subject|2|||
19669740|NCT00468585|42117707|FG003|Overall Study|Withdrawal by Subject|1|||
19669741|NCT00450801|42117717|FG000|Overall Study|Death|1|||
19669742|NCT00458211|42117726|FG000|Overall Study|Lack of Efficacy|12|||
19669743|NCT00458211|42117726|FG000|Overall Study|Withdrawal by Subject|2|||
19669744|NCT00458211|42117726|FG000|Overall Study|Protocol Violation|2|||
19669745|NCT00450723|42117734|FG000|Overall Study|Physician Decision|5|||
19669746|NCT00467961|42117739|FG000|Overall Study|Technical Failures|5|||
19669747|NCT00467961|42117739|FG000|Overall Study|Disease Progression|2|||
19669748|NCT00457821|42117751|FG000|Part 2|Withdrawal by Subject|0|||
19669749|NCT00457821|42117752|FG001|Part 2|Withdrawal by Subject|0|||
19669750|NCT00457821|42117753|FG002|Part 2|Withdrawal by Subject|0|||
19669751|NCT00457821|42117754|FG003|Part 2|Withdrawal by Subject|0|||
19669752|NCT00457821|42117755|FG004|Part 2|Withdrawal by Subject|0|||
19669753|NCT00457821|42117756|FG005|Part 2|Withdrawal by Subject|0|||
19669754|NCT00457821|42117757|FG006|Part 2|Withdrawal by Subject|0|||
19669755|NCT00457821|42117758|FG007|Part 2|Withdrawal by Subject|1|||
19669756|NCT00633893|42117778|FG000|Overall Study|Death|1|||
19669757|NCT00633893|42117779|FG001|Overall Study|Death|3|||
19669758|NCT00633893|42117780|FG002|Overall Study|Death|9|||
19669759|NCT00633893|42117778|FG000|Overall Study|Adverse Event|65|||
19669760|NCT00633893|42117779|FG001|Overall Study|Adverse Event|58|||
19669761|NCT00633893|42117780|FG002|Overall Study|Adverse Event|126|||
19669762|NCT00633893|42117778|FG000|Overall Study|Withdrawal by Subject|7|||
19669763|NCT00633893|42117779|FG001|Overall Study|Withdrawal by Subject|12|||
19669764|NCT00633893|42117780|FG002|Overall Study|Withdrawal by Subject|6|||
19669765|NCT00633893|42117778|FG000|Overall Study|Lost to Follow-up|2|||
19669766|NCT00633893|42117779|FG001|Overall Study|Lost to Follow-up|4|||
19669767|NCT00633893|42117780|FG002|Overall Study|Lost to Follow-up|8|||
19669768|NCT00633893|42117778|FG000|Overall Study|Poor/non-compliance|5|||
19669769|NCT00633893|42117779|FG001|Overall Study|Poor/non-compliance|12|||
19669770|NCT00633893|42117780|FG002|Overall Study|Poor/non-compliance|3|||
19669771|NCT00633893|42117778|FG000|Overall Study|Pregnancy|2|||
19669772|NCT00633893|42117779|FG001|Overall Study|Pregnancy|1|||
19669773|NCT00633893|42117780|FG002|Overall Study|Pregnancy|1|||
19669774|NCT00633893|42117778|FG000|Overall Study|Not meet/no longer meets criteria|4|||
19669775|NCT00633893|42117779|FG001|Overall Study|Not meet/no longer meets criteria|6|||
19757465|NCT02885181|42208109|FG002|Overall Study|Adverse Event|0|||
19757466|NCT02885181|42208110|FG003|Overall Study|Adverse Event|1|||
19757467|NCT02885181|42208107|FG000|Overall Study|Withdrawal by Subject|0|||
19757468|NCT02885181|42208108|FG001|Overall Study|Withdrawal by Subject|0|||
19757469|NCT02885181|42208109|FG002|Overall Study|Withdrawal by Subject|0|||
19757470|NCT02885181|42208110|FG003|Overall Study|Withdrawal by Subject|1|||
19757471|NCT02884089|42208124|FG000|Period 1|Dosing error|2|||
19757472|NCT02884089|42208125|FG001|Period 1|Dosing error|2|||
19757473|NCT02884089|42208126|FG002|Period 1|Dosing error|0|||
19757474|NCT02884089|42208127|FG003|Period 1|Dosing error|0|||
19757475|NCT02884089|42208124|FG000|Washout Period 1|Lost to Follow-up|0|||
19669776|NCT00633893|42117780|FG002|Overall Study|Not meet/no longer meets criteria|4|||
19669777|NCT00633893|42117778|FG000|Overall Study|Other|28|||
19757476|NCT02884089|42208125|FG001|Washout Period 1|Lost to Follow-up|1|||
19669778|NCT00633893|42117779|FG001|Overall Study|Other|33|||
19669779|NCT00633893|42117780|FG002|Overall Study|Other|31|||
19669780|NCT00457743|42117791|FG000|Overall Study|Adverse Event|0|||
19669781|NCT00457743|42117792|FG001|Overall Study|Adverse Event|4|||
19669782|NCT00457743|42117793|FG002|Overall Study|Adverse Event|0|||
19757477|NCT02884089|42208126|FG002|Washout Period 1|Lost to Follow-up|0|||
19669783|NCT00457743|42117791|FG000|Overall Study|Lack of Efficacy|3|||
19669784|NCT00457743|42117792|FG001|Overall Study|Lack of Efficacy|23|||
19669785|NCT00457743|42117793|FG002|Overall Study|Lack of Efficacy|3|||
19669786|NCT00450411|42117802|FG000|Overall Study|Protocol Violation|6|||
19669787|NCT00450411|42117802|FG000|Overall Study|No protocol treatment|2|||
19669788|NCT00644969|42117808|FG000|Treatment Phase|Randomized, not treated|1|||
19669789|NCT00644969|42117809|FG001|Treatment Phase|Randomized, not treated|0|||
19669790|NCT00644969|42117808|FG000|Treatment Phase|Adverse Event|3|||
19669791|NCT00644969|42117809|FG001|Treatment Phase|Adverse Event|0|||
19669792|NCT00644969|42117808|FG000|Treatment Phase|Withdrawal by Subject|4|||
19669793|NCT00644969|42117809|FG001|Treatment Phase|Withdrawal by Subject|0|||
19669794|NCT00644969|42117808|FG000|Treatment Phase|Lost to Follow-up|2|||
19669795|NCT00644969|42117809|FG001|Treatment Phase|Lost to Follow-up|2|||
19669796|NCT00644969|42117808|FG000|Treatment Phase|Other|4|||
19669797|NCT00644969|42117809|FG001|Treatment Phase|Other|1|||
19669798|NCT00644969|42117808|FG000|Post Treatment Phase|Death|1|||
19669799|NCT00644969|42117809|FG001|Post Treatment Phase|Death|0|||
19669800|NCT00644969|42117808|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
19669801|NCT00644969|42117809|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
19669802|NCT00644969|42117808|FG000|Post Treatment Phase|Lost to Follow-up|4|||
19669803|NCT00644969|42117809|FG001|Post Treatment Phase|Lost to Follow-up|1|||
19669804|NCT00644969|42117808|FG000|Post Treatment Phase|Other|1|||
19669805|NCT00644969|42117809|FG001|Post Treatment Phase|Other|0|||
19669806|NCT00644423|42117817|FG000|Overall Study|Lost to Follow-up|1|||
19757478|NCT02884089|42208127|FG003|Washout Period 1|Lost to Follow-up|1|||
19757479|NCT02884089|42208124|FG000|Washout Period 1|Withdrawal by Subject|0|||
19757480|NCT02884089|42208125|FG001|Washout Period 1|Withdrawal by Subject|1|||
19669807|NCT00644423|42117818|FG001|Overall Study|Lost to Follow-up|1|||
19757481|NCT02884089|42208126|FG002|Washout Period 1|Withdrawal by Subject|0|||
19757482|NCT02884089|42208127|FG003|Washout Period 1|Withdrawal by Subject|0|||
19757483|NCT02884089|42208124|FG000|Period 2|Adverse Event|1|||
19757484|NCT02884089|42208125|FG001|Period 2|Adverse Event|0|||
19757485|NCT02884089|42208126|FG002|Period 2|Adverse Event|0|||
19757486|NCT02884089|42208127|FG003|Period 2|Adverse Event|0|||
19757487|NCT02884089|42208124|FG000|Period 3|Withdrawal by Subject|0|||
19757488|NCT02884089|42208125|FG001|Period 3|Withdrawal by Subject|0|||
19757489|NCT02884089|42208126|FG002|Period 3|Withdrawal by Subject|1|||
19757490|NCT02884089|42208127|FG003|Period 3|Withdrawal by Subject|0|||
19757491|NCT02884089|42208124|FG000|Washout Period 3|Withdrawal by Subject|0|||
19757492|NCT02884089|42208125|FG001|Washout Period 3|Withdrawal by Subject|0|||
19757493|NCT02884089|42208126|FG002|Washout Period 3|Withdrawal by Subject|1|||
19757494|NCT02884089|42208127|FG003|Washout Period 3|Withdrawal by Subject|0|||
19757495|NCT02884089|42208124|FG000|Washout Period 3|Lost to Follow-up|0|||
19757496|NCT02884089|42208125|FG001|Washout Period 3|Lost to Follow-up|0|||
19757497|NCT02884089|42208126|FG002|Washout Period 3|Lost to Follow-up|0|||
19669808|NCT00628355|42117826|FG000|Overall Study|Withdrawal by Subject|1|||
19669809|NCT00628355|42117827|FG001|Overall Study|Withdrawal by Subject|1|||
19669810|NCT00627497|42117838|FG000|Overall Study|Lost to Follow-up|1|||
19669811|NCT00627497|42117839|FG001|Overall Study|Lost to Follow-up|1|||
19669812|NCT00627497|42117840|FG002|Overall Study|Lost to Follow-up|0|||
19669813|NCT00627497|42117841|FG003|Overall Study|Lost to Follow-up|0|||
19669814|NCT00648167|42117851|FG000|Overall Study|Adverse Event|6|||
19669815|NCT00648167|42117851|FG000|Overall Study|unable to swallow tablets|1|||
19669816|NCT00647699|42117885|FG000|Overall Study|Lost to Follow-up|5|||
19669817|NCT00647699|42117886|FG001|Overall Study|Lost to Follow-up|4|||
19669818|NCT00647699|42117885|FG000|Overall Study|Withdrawal by Subject|3|||
19669819|NCT00647699|42117886|FG001|Overall Study|Withdrawal by Subject|8|||
19757498|NCT02884089|42208127|FG003|Washout Period 3|Lost to Follow-up|1|||
19669820|NCT00467649|42117894|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
19669821|NCT00467649|42117895|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
19669822|NCT00467649|42117896|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
19669823|NCT00467649|42117897|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
19757499|NCT02884089|42208124|FG000|Period 4|Withdrawal by Subject|0|||
19757500|NCT02884089|42208125|FG001|Period 4|Withdrawal by Subject|1|||
19757501|NCT02884089|42208126|FG002|Period 4|Withdrawal by Subject|0|||
19757502|NCT02884089|42208127|FG003|Period 4|Withdrawal by Subject|0|||
19757503|NCT02884089|42208124|FG000|Period 4|Lost to Follow-up|1|||
19757504|NCT02884089|42208125|FG001|Period 4|Lost to Follow-up|0|||
19757505|NCT02884089|42208126|FG002|Period 4|Lost to Follow-up|0|||
19757506|NCT02884089|42208127|FG003|Period 4|Lost to Follow-up|0|||
19757507|NCT02884089|42208124|FG000|Follow-up Visit|Withdrawal by Subject|1|||
19757508|NCT02884089|42208125|FG001|Follow-up Visit|Withdrawal by Subject|0|||
19757509|NCT02884089|42208126|FG002|Follow-up Visit|Withdrawal by Subject|0|||
19757510|NCT02884089|42208127|FG003|Follow-up Visit|Withdrawal by Subject|1|||
19757511|NCT02809677|42208137|FG000|Overall Study|Withdrawal by Subject|8|||
19757512|NCT02881047|42208142|FG000|Overall Study|Adverse Event|1|||
19757513|NCT02881047|42208142|FG000|Overall Study|Withdrawal by Subject|1|||
19669824|NCT00467649|42117898|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
19669825|NCT00467649|42117899|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
19669826|NCT00467649|42117894|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
19669827|NCT00467649|42117895|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
19669828|NCT00467649|42117896|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
19669829|NCT00467649|42117897|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
19669830|NCT00467649|42117898|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
19669831|NCT00467649|42117899|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
19669832|NCT00467649|42117894|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
19669833|NCT00467649|42117895|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
19669834|NCT00467649|42117896|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
19669835|NCT00467649|42117897|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
19669836|NCT00467649|42117898|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
19669837|NCT00467649|42117899|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
19669838|NCT00467649|42117894|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
19757514|NCT03157089|42208148|FG000|Overall Study|Treated only with pembrolizumab|1|||
19757515|NCT03157089|42208149|FG001|Overall Study|Treated only with pembrolizumab|0|||
19757516|NCT03157089|42208148|FG000|Overall Study|Adverse Event|5|||
19757517|NCT03157089|42208149|FG001|Overall Study|Adverse Event|4|||
19757518|NCT03157089|42208148|FG000|Overall Study|Progressive disease|6|||
19757519|NCT03157089|42208149|FG001|Overall Study|Progressive disease|8|||
19757520|NCT03158727|42208158|FG000|Overall Study|Withdrawal by Subject|2|||
19757521|NCT03158727|42208159|FG001|Overall Study|Withdrawal by Subject|6|||
19757522|NCT03158727|42208158|FG000|Overall Study|Death|11|||
19757523|NCT03158727|42208159|FG001|Overall Study|Death|12|||
19757524|NCT03158727|42208158|FG000|Overall Study|Lost to Follow-up|1|||
19757525|NCT03158727|42208159|FG001|Overall Study|Lost to Follow-up|0|||
19757526|NCT03158727|42208158|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
19757527|NCT03158727|42208159|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
19757528|NCT03158727|42208158|FG000|Overall Study|Visit 11 not done by mistake|0|||
19669839|NCT00467649|42117895|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
19669840|NCT00467649|42117896|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
19669841|NCT00467649|42117897|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
19669842|NCT00467649|42117898|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
19669843|NCT00467649|42117899|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
19669844|NCT00467649|42117894|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
19669845|NCT00467649|42117895|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
19669846|NCT00467649|42117896|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
19669847|NCT00467649|42117897|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
19669848|NCT00467649|42117898|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
19669849|NCT00467649|42117899|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
19669850|NCT00467649|42117894|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
19669851|NCT00467649|42117895|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
19669852|NCT00467649|42117896|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
19757529|NCT03158727|42208159|FG001|Overall Study|Visit 11 not done by mistake|1|||
19757530|NCT03158727|42208158|FG000|Overall Study|Enrolled, not treated|1|||
19669853|NCT00467649|42117897|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
19669854|NCT00467649|42117898|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
19669855|NCT00467649|42117899|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
19669856|NCT00467649|42117894|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
19669857|NCT00467649|42117895|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
19669858|NCT00467649|42117896|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
19669859|NCT00467649|42117897|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
19669860|NCT00467649|42117898|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
19603308|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
19603309|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
19603310|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
19603311|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
19603312|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
19603313|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
19603314|NCT00603525|42052195|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
19603315|NCT00603525|42052196|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
19603316|NCT00603525|42052197|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
19603317|NCT00603525|42052195|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
19603318|NCT00603525|42052196|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
19603319|NCT00603525|42052197|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
19603320|NCT00762034|42052210|FG000|Induction Period|Protocol Violation|1|||
19603321|NCT00762034|42052211|FG001|Induction Period|Protocol Violation|2|||
19603322|NCT00762034|42052210|FG000|Induction Period|Entry Criterion Not Met|12|||
19603323|NCT00762034|42052211|FG001|Induction Period|Entry Criterion Not Met|11|||
19603324|NCT00762034|42052210|FG000|Induction Period|Adverse Event|27|||
19603325|NCT00762034|42052211|FG001|Induction Period|Adverse Event|38|||
19603326|NCT00762034|42052210|FG000|Induction Period|Lost to Follow-up|1|||
19603327|NCT00762034|42052211|FG001|Induction Period|Lost to Follow-up|1|||
19603328|NCT00762034|42052210|FG000|Induction Period|Progressive Disease|73|||
19603329|NCT00762034|42052211|FG001|Induction Period|Progressive Disease|55|||
19603330|NCT00762034|42052210|FG000|Induction Period|Physician Decision|21|||
19603331|NCT00762034|42052211|FG001|Induction Period|Physician Decision|20|||
19603332|NCT00762034|42052210|FG000|Induction Period|Withdrawal by Subject|15|||
19603333|NCT00762034|42052211|FG001|Induction Period|Withdrawal by Subject|19|||
19603334|NCT00762034|42052210|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
19388998|NCT02679755|41632550|FG001|Overall Study|Global deterioration of health status|8|||
19603335|NCT00762034|42052211|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
19603336|NCT00762034|42052210|FG000|Induction Period|Deaths Due to Study Disease|9|||
19603337|NCT00762034|42052211|FG001|Induction Period|Deaths Due to Study Disease|9|||
19603338|NCT00762034|42052210|FG000|Maintenance Period|Protocol Violation|1|||
19603339|NCT00762034|42052211|FG001|Maintenance Period|Protocol Violation|3|||
19603340|NCT00762034|42052210|FG000|Maintenance Period|Entry Criterion Not Met|0|||
19603341|NCT00762034|42052211|FG001|Maintenance Period|Entry Criterion Not Met|2|||
19603342|NCT00762034|42052210|FG000|Maintenance Period|Adverse Event|42|||
19603343|NCT00762034|42052211|FG001|Maintenance Period|Adverse Event|26|||
19603344|NCT00762034|42052210|FG000|Maintenance Period|Progressive Disease|186|||
19603345|NCT00762034|42052211|FG001|Maintenance Period|Progressive Disease|224|||
19603346|NCT00762034|42052210|FG000|Maintenance Period|Physician Decision|25|||
19603347|NCT00762034|42052211|FG001|Maintenance Period|Physician Decision|20|||
19603348|NCT00762034|42052210|FG000|Maintenance Period|Withdrawal by Subject|34|||
19603349|NCT00762034|42052211|FG001|Maintenance Period|Withdrawal by Subject|14|||
19603350|NCT00762034|42052210|FG000|Maintenance Period|Death not due to study disease|2|||
19603351|NCT00762034|42052211|FG001|Maintenance Period|Death not due to study disease|5|||
19603352|NCT00762034|42052210|FG000|Maintenance Period|Death due to study disease|3|||
19603353|NCT00762034|42052211|FG001|Maintenance Period|Death due to study disease|3|||
19669861|NCT00467649|42117899|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
19669862|NCT00450333|42117921|FG000|Overall Study|Study terminated|47|||
19669863|NCT00450333|42117922|FG001|Overall Study|Study terminated|54|||
19669864|NCT00450333|42117923|FG002|Overall Study|Study terminated|16|||
19669865|NCT00450333|42117924|FG003|Overall Study|Study terminated|21|||
19669866|NCT00450333|42117921|FG000|Overall Study|Adverse Event|1|||
19669867|NCT00450333|42117922|FG001|Overall Study|Adverse Event|7|||
19669868|NCT00450333|42117923|FG002|Overall Study|Adverse Event|2|||
19669869|NCT00450333|42117924|FG003|Overall Study|Adverse Event|2|||
19669870|NCT00450333|42117921|FG000|Overall Study|Protocol Violation|1|||
19669871|NCT00450333|42117922|FG001|Overall Study|Protocol Violation|0|||
19669872|NCT00450333|42117923|FG002|Overall Study|Protocol Violation|1|||
19669873|NCT00450333|42117924|FG003|Overall Study|Protocol Violation|0|||
19669874|NCT00450333|42117921|FG000|Overall Study|Withdrawal by Subject|1|||
19669875|NCT00450333|42117922|FG001|Overall Study|Withdrawal by Subject|0|||
19669876|NCT00450333|42117923|FG002|Overall Study|Withdrawal by Subject|3|||
19669877|NCT00450333|42117924|FG003|Overall Study|Withdrawal by Subject|0|||
19669878|NCT00450333|42117921|FG000|Overall Study|Kidney transplant|1|||
19669879|NCT00450333|42117922|FG001|Overall Study|Kidney transplant|0|||
19669880|NCT00450333|42117923|FG002|Overall Study|Kidney transplant|1|||
19669881|NCT00450333|42117924|FG003|Overall Study|Kidney transplant|3|||
19669882|NCT00450333|42117921|FG000|Overall Study|Death|3|||
19669883|NCT00450333|42117922|FG001|Overall Study|Death|2|||
19669884|NCT00450333|42117923|FG002|Overall Study|Death|2|||
19603354|NCT00762034|42052210|FG000|Maintenance Period|Other|1|||
19603355|NCT00762034|42052211|FG001|Maintenance Period|Other|1|||
19669885|NCT00450333|42117924|FG003|Overall Study|Death|2|||
19669886|NCT00643565|42117936|FG000|Overall Study|Death|12|||
19669887|NCT00643565|42117937|FG001|Overall Study|Death|11|||
19669888|NCT00643565|42117936|FG000|Overall Study|Withdrawal by Subject|4|||
19388999|NCT02679755|41632549|FG000|Overall Study|Lost to Follow-up|1|||
19603356|NCT00761956|42052243|FG000|Overall Study|Lost to Follow-up|6|||
19669889|NCT00643565|42117937|FG001|Overall Study|Withdrawal by Subject|1|||
19669890|NCT00643565|42117936|FG000|Overall Study|Lost to Follow-up|0|||
19669891|NCT00643565|42117937|FG001|Overall Study|Lost to Follow-up|6|||
19669892|NCT00643565|42117936|FG000|Overall Study|Other|7|||
19669893|NCT00643565|42117937|FG001|Overall Study|Other|8|||
19669894|NCT00643565|42117936|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
19669895|NCT00643565|42117937|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
19669896|NCT00643565|42117936|FG000|Overall Study|Recurrence of Disease|2|||
19669897|NCT00643565|42117937|FG001|Overall Study|Recurrence of Disease|1|||
19669898|NCT00643565|42117936|FG000|Overall Study|Progression of Disease|18|||
19669899|NCT00643565|42117937|FG001|Overall Study|Progression of Disease|14|||
19669900|NCT00643565|42117936|FG000|Overall Study|Protocol Violation|3|||
19757531|NCT03158727|42208159|FG001|Overall Study|Enrolled, not treated|0|||
19757532|NCT00089895|42208167|FG000|Overall Study|Consent Withdrawn|11|||
19757533|NCT00089895|42208168|FG001|Overall Study|Consent Withdrawn|14|||
19757534|NCT00089895|42208167|FG000|Overall Study|Technical reason|7|||
19757535|NCT00089895|42208168|FG001|Overall Study|Technical reason|2|||
19757536|NCT00089895|42208167|FG000|Overall Study|Surgery|0|||
19757537|NCT00089895|42208168|FG001|Overall Study|Surgery|1|||
19757538|NCT00089895|42208167|FG000|Overall Study|Bleeding|0|||
19757539|NCT00089895|42208168|FG001|Overall Study|Bleeding|2|||
19757540|NCT00089895|42208167|FG000|Overall Study|Physician Decision|3|||
19757541|NCT00089895|42208168|FG001|Overall Study|Physician Decision|7|||
19757542|NCT00089895|42208167|FG000|Overall Study|Exclusion criteria met|6|||
19669901|NCT00643565|42117937|FG001|Overall Study|Protocol Violation|0|||
19669902|NCT00643565|42117936|FG000|Overall Study|Did Not Cooperate|0|||
19669903|NCT00643565|42117937|FG001|Overall Study|Did Not Cooperate|1|||
19669904|NCT00643565|42117936|FG000|Overall Study|Administrative|22|||
19669905|NCT00643565|42117937|FG001|Overall Study|Administrative|16|||
19669906|NCT00643565|42117936|FG000|Overall Study|Adverse Event|5|||
19669907|NCT00643565|42117937|FG001|Overall Study|Adverse Event|8|||
19669908|NCT00643487|42117944|FG000|Overall Study|Technical difficulty|3|||
19757543|NCT00089895|42208168|FG001|Overall Study|Exclusion criteria met|6|||
19757544|NCT00089895|42208167|FG000|Overall Study|Not otherwise specified|4|||
19757545|NCT00089895|42208168|FG001|Overall Study|Not otherwise specified|8|||
19757546|NCT00089895|42208167|FG000|Overall Study|Missing|4|||
19757547|NCT00089895|42208168|FG001|Overall Study|Missing|2|||
19757548|NCT02714218|42208177|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19757549|NCT02714218|42208178|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19757550|NCT02714218|42208179|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19757551|NCT02714218|42208177|FG000|Pre-Treatment Period|Other reasons|0|||
19757552|NCT02714218|42208178|FG001|Pre-Treatment Period|Other reasons|1|||
19757553|NCT02714218|42208179|FG002|Pre-Treatment Period|Other reasons|0|||
19757554|NCT02714218|42208177|FG000|Treatment Period|Disease Progression|55|||
19757555|NCT02714218|42208178|FG001|Treatment Period|Disease Progression|52|||
19669909|NCT00450255|42117948|FG000|Overall Study|Prior RFA ablation of liver|1|||
19669910|NCT00450177|42117955|FG000|Overall Study|Adverse Event|7|||
19669911|NCT00450177|42117956|FG001|Overall Study|Adverse Event|4|||
19669912|NCT00450177|42117955|FG000|Overall Study|Withdrawal by Subject|1|||
19669913|NCT00450177|42117956|FG001|Overall Study|Withdrawal by Subject|6|||
19669914|NCT00450177|42117955|FG000|Overall Study|Withdrawal by Primary Team|1|||
19669915|NCT00450177|42117956|FG001|Overall Study|Withdrawal by Primary Team|1|||
19669916|NCT03848949|42117964|FG000|Overall Study|Lost to Follow-up|5|||
19669917|NCT03848949|42117965|FG001|Overall Study|Lost to Follow-up|7|||
19669918|NCT00467259|42117973|FG000|Overall Study|Adverse Event|24|||
19669919|NCT00467259|42117974|FG001|Overall Study|Adverse Event|90|||
19669920|NCT00467259|42117973|FG000|Overall Study|Protocol Violation|1|||
19669921|NCT00467259|42117974|FG001|Overall Study|Protocol Violation|7|||
19669922|NCT00467259|42117973|FG000|Overall Study|Withdrawal by Subject|34|||
19669923|NCT00467259|42117974|FG001|Overall Study|Withdrawal by Subject|108|||
19669924|NCT00467259|42117973|FG000|Overall Study|Physician Decision|0|||
19669925|NCT00467259|42117974|FG001|Overall Study|Physician Decision|2|||
19669926|NCT00467259|42117973|FG000|Overall Study|Lost to Follow-up|14|||
19669927|NCT00467259|42117974|FG001|Overall Study|Lost to Follow-up|34|||
19669928|NCT00467259|42117973|FG000|Overall Study|Site Closed|2|||
19669929|NCT00467259|42117974|FG001|Overall Study|Site Closed|1|||
19669930|NCT00449865|42117982|FG000|Overall Study|Withdrawal by Subject|110|||
19669931|NCT00449865|42117983|FG001|Overall Study|Withdrawal by Subject|110|||
19669932|NCT00449865|42117982|FG000|Overall Study|Lost to Follow-up|36|||
19669933|NCT00449865|42117983|FG001|Overall Study|Lost to Follow-up|37|||
19669934|NCT00449865|42117982|FG000|Overall Study|Physician Decision|13|||
19669935|NCT00449865|42117983|FG001|Overall Study|Physician Decision|12|||
19669936|NCT00449865|42117982|FG000|Overall Study|Death|31|||
19669937|NCT00449865|42117983|FG001|Overall Study|Death|40|||
19669938|NCT00449865|42117982|FG000|Overall Study|Protocol Violation|8|||
19669939|NCT00449865|42117983|FG001|Overall Study|Protocol Violation|7|||
19757556|NCT02714218|42208179|FG002|Treatment Period|Disease Progression|14|||
19757557|NCT02714218|42208177|FG000|Treatment Period|Study drug toxicity|46|||
19757558|NCT02714218|42208178|FG001|Treatment Period|Study drug toxicity|70|||
19669940|NCT00449865|42117982|FG000|Overall Study|Study was stopped|324|||
19757559|NCT02714218|42208179|FG002|Treatment Period|Study drug toxicity|6|||
19669941|NCT00449865|42117983|FG001|Overall Study|Study was stopped|328|||
19669942|NCT00449787|42117991|FG000|Overall Study|Lost to Follow-up|10|||
19669943|NCT00449787|42117992|FG001|Overall Study|Lost to Follow-up|8|||
19669944|NCT00449787|42117991|FG000|Overall Study|Did not require medication|95|||
19669945|NCT00449787|42117992|FG001|Overall Study|Did not require medication|92|||
19669946|NCT00449163|42118000|FG000|Overall Study|Physician Decision|3|||
19669947|NCT00448539|42118006|FG000|Overall Study|Medication non-compliance|4|||
19757560|NCT02714218|42208177|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
19757561|NCT02714218|42208178|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
19757562|NCT02714218|42208179|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
19757563|NCT02714218|42208177|FG000|Treatment Period|Request to discontinue treatment|1|||
19669948|NCT00448539|42118007|FG001|Overall Study|Medication non-compliance|1|||
19669949|NCT00448539|42118006|FG000|Overall Study|Protocol Violation|1|||
19669950|NCT00448539|42118007|FG001|Overall Study|Protocol Violation|0|||
19669951|NCT00448539|42118006|FG000|Overall Study|Request of the investigator or sponsor|67|||
19669952|NCT00448539|42118007|FG001|Overall Study|Request of the investigator or sponsor|54|||
19669953|NCT00448539|42118006|FG000|Overall Study|Withdrawal by Subject|20|||
19669954|NCT00448539|42118007|FG001|Overall Study|Withdrawal by Subject|24|||
19669955|NCT00448539|42118006|FG000|Overall Study|Diary non-compliance|1|||
19669956|NCT00448539|42118007|FG001|Overall Study|Diary non-compliance|0|||
19669957|NCT00448539|42118006|FG000|Overall Study|Adverse Event|9|||
19669958|NCT00448539|42118007|FG001|Overall Study|Adverse Event|26|||
19669959|NCT00448539|42118006|FG000|Overall Study|Lack of Efficacy|27|||
19669960|NCT00448539|42118007|FG001|Overall Study|Lack of Efficacy|40|||
19669961|NCT00448539|42118006|FG000|Overall Study|Miscellaneous|2|||
19669962|NCT00448539|42118007|FG001|Overall Study|Miscellaneous|1|||
19669963|NCT00448539|42118006|FG000|Overall Study|Change of meds|2|||
19669964|NCT00448539|42118007|FG001|Overall Study|Change of meds|3|||
19669965|NCT00448539|42118006|FG000|Overall Study|Lost to Follow-up|1|||
19669966|NCT00448539|42118007|FG001|Overall Study|Lost to Follow-up|3|||
19669967|NCT00457665|42118015|FG000|12 Months|Drug allergy|1|||
19669968|NCT00457665|42118016|FG001|12 Months|Drug allergy|1|||
19669969|NCT00457665|42118015|FG000|12 Months|High HIV viral load|5|||
19669970|NCT00457665|42118016|FG001|12 Months|High HIV viral load|1|||
19669971|NCT00457665|42118015|FG000|12 Months|Lipodystrophy|2|||
19669972|NCT00457665|42118016|FG001|12 Months|Lipodystrophy|0|||
19669973|NCT00457665|42118015|FG000|12 Months|Withdrawal by Subject|0|||
19669974|NCT00457665|42118016|FG001|12 Months|Withdrawal by Subject|2|||
19669975|NCT00457665|42118015|FG000|12 Months|Abnormal Liver function tests|0|||
19669976|NCT00457665|42118016|FG001|12 Months|Abnormal Liver function tests|5|||
19669977|NCT00457665|42118015|FG000|24 Months|Withdrawal by Subject|3|||
19669978|NCT00457665|42118016|FG001|24 Months|Withdrawal by Subject|2|||
19669979|NCT00457665|42118015|FG000|24 Months|Lipodystrophy|1|||
19669980|NCT00457665|42118016|FG001|24 Months|Lipodystrophy|1|||
19669981|NCT00457665|42118015|FG000|24 Months|Abnormal liver function tests|1|||
19669982|NCT00457665|42118016|FG001|24 Months|Abnormal liver function tests|5|||
19669983|NCT00447603|42118022|FG000|Screening|Withdrawal by Subject|1|||
19669984|NCT00447603|42118023|FG001|Screening|Withdrawal by Subject|0|||
19669985|NCT00447603|42118024|FG002|Screening|Withdrawal by Subject|0|||
19669986|NCT00447603|42118022|FG000|Screening|Protocol Violation|1|||
19669987|NCT00447603|42118023|FG001|Screening|Protocol Violation|0|||
19669988|NCT00447603|42118024|FG002|Screening|Protocol Violation|0|||
19669989|NCT00447603|42118022|FG000|Screening|Screen Failure|4|||
19757564|NCT02714218|42208178|FG001|Treatment Period|Request to discontinue treatment|4|||
19603357|NCT00761956|42052244|FG001|Overall Study|Lost to Follow-up|11|||
19603358|NCT00761956|42052243|FG000|Overall Study|Withdrawal by Subject|3|||
19603359|NCT00761956|42052244|FG001|Overall Study|Withdrawal by Subject|8|||
19603360|NCT00761956|42052243|FG000|Overall Study|Death|0|||
19603361|NCT00761956|42052244|FG001|Overall Study|Death|1|||
19603362|NCT00761956|42052243|FG000|Overall Study|Adverse Event|26|||
19603363|NCT00761956|42052244|FG001|Overall Study|Adverse Event|34|||
19603364|NCT00754624|42052250|FG000|Overall Study|Adverse Event|16|||
19603365|NCT00754624|42052250|FG000|Overall Study|Death|1|||
19603366|NCT00754624|42052250|FG000|Overall Study|Physician Decision|8|||
19603367|NCT00754624|42052250|FG000|Overall Study|Protocol Violation|1|||
19603368|NCT00754624|42052250|FG000|Overall Study|Withdrawal by Subject|28|||
19603369|NCT00754624|42052250|FG000|Overall Study|Various|12|||
19669990|NCT00447603|42118023|FG001|Screening|Screen Failure|0|||
19669991|NCT00447603|42118024|FG002|Screening|Screen Failure|0|||
19669992|NCT00447603|42118022|FG000|Screening|Study Terminated by Sponsor|15|||
19669993|NCT00447603|42118023|FG001|Screening|Study Terminated by Sponsor|0|||
19669994|NCT00447603|42118024|FG002|Screening|Study Terminated by Sponsor|0|||
19477160|NCT01513291|41756108|FG000|Treatment Period|Lost to Follow-up|2|||
19603370|NCT00754624|42052250|FG000|Overall Study|Lost to Follow-up|3|||
19603371|NCT00586846|42052263|FG000|Overall Study|Physician Decision|1|||
19669995|NCT00447603|42118022|FG000|Filter Period|Adverse Event|0|||
19669996|NCT00447603|42118023|FG001|Filter Period|Adverse Event|0|||
19669997|NCT00447603|42118024|FG002|Filter Period|Adverse Event|1|||
19603372|NCT00586846|42052263|FG000|Overall Study|Death|1|||
19669998|NCT00447603|42118022|FG000|Filter Period|Screen Failure|0|||
19669999|NCT00447603|42118023|FG001|Filter Period|Screen Failure|3|||
19757565|NCT02714218|42208179|FG002|Treatment Period|Request to discontinue treatment|1|||
19757566|NCT02714218|42208177|FG000|Treatment Period|Participant withdrew consent|2|||
19757567|NCT02714218|42208178|FG001|Treatment Period|Participant withdrew consent|2|||
19757568|NCT02714218|42208179|FG002|Treatment Period|Participant withdrew consent|0|||
19757569|NCT02714218|42208177|FG000|Treatment Period|Maximum clinical benefit|4|||
19757570|NCT02714218|42208178|FG001|Treatment Period|Maximum clinical benefit|2|||
19757571|NCT02714218|42208179|FG002|Treatment Period|Maximum clinical benefit|0|||
19757572|NCT02714218|42208177|FG000|Treatment Period|Administrative reason by sponsor|2|||
19757573|NCT02714218|42208178|FG001|Treatment Period|Administrative reason by sponsor|1|||
19757574|NCT02714218|42208179|FG002|Treatment Period|Administrative reason by sponsor|0|||
19757575|NCT02714218|42208177|FG000|Treatment Period|Other reasons|6|||
19757576|NCT02714218|42208178|FG001|Treatment Period|Other reasons|6|||
19757577|NCT02714218|42208179|FG002|Treatment Period|Other reasons|0|||
19757578|NCT02714218|42208177|FG000|Treatment Period|Completed treatment as per protocol|36|||
19757579|NCT02714218|42208178|FG001|Treatment Period|Completed treatment as per protocol|27|||
19757580|NCT02714218|42208179|FG002|Treatment Period|Completed treatment as per protocol|3|||
19757581|NCT02714218|42208177|FG000|Treatment Period|Not reported|9|||
19757582|NCT02714218|42208178|FG001|Treatment Period|Not reported|6|||
19757583|NCT02714218|42208179|FG002|Treatment Period|Not reported|0|||
19757584|NCT03154047|42208186|FG000|Overall Study|Death|1|||
19670000|NCT00447603|42118024|FG002|Filter Period|Screen Failure|4|||
19670001|NCT00447603|42118022|FG000|Filter Period|Study terminated by Sponsor|0|||
19670002|NCT00447603|42118023|FG001|Filter Period|Study terminated by Sponsor|1|||
19670003|NCT00447603|42118024|FG002|Filter Period|Study terminated by Sponsor|10|||
19670004|NCT00447057|42118036|FG000|Overall Study|Adverse Event|4|||
19670005|NCT00447057|42118037|FG001|Overall Study|Adverse Event|10|||
19670006|NCT00447057|42118038|FG002|Overall Study|Adverse Event|0|||
19670007|NCT00447057|42118039|FG003|Overall Study|Adverse Event|3|||
19670008|NCT00447057|42118036|FG000|Overall Study|Death due to study disease|6|||
19670009|NCT00447057|42118037|FG001|Overall Study|Death due to study disease|4|||
19670010|NCT00447057|42118038|FG002|Overall Study|Death due to study disease|1|||
19670011|NCT00447057|42118039|FG003|Overall Study|Death due to study disease|1|||
19670012|NCT00447057|42118036|FG000|Overall Study|Lost to Follow-up|0|||
19670013|NCT00447057|42118037|FG001|Overall Study|Lost to Follow-up|1|||
19670014|NCT00447057|42118038|FG002|Overall Study|Lost to Follow-up|0|||
19757585|NCT03154047|42208186|FG000|Overall Study|Study terminated by sponsor|76|||
19757586|NCT03154047|42208186|FG000|Overall Study|Withdrawal by Subject|3|||
19757587|NCT03156621|42208192|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
19757588|NCT03156621|42208193|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
19757589|NCT03156621|42208192|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19757590|NCT03156621|42208193|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
19757591|NCT03156543|42208204|FG000|Overall Study|Withdrawal by Subject|1|||
19757592|NCT03156543|42208205|FG001|Overall Study|Withdrawal by Subject|0|||
19757593|NCT02713594|42208213|FG000|Overall Study|Withdrawal by Subject|32|||
19757594|NCT02713594|42208214|FG001|Overall Study|Withdrawal by Subject|22|||
19757595|NCT02713594|42208213|FG000|Overall Study|Lost to Follow-up|358|||
19757596|NCT02713594|42208214|FG001|Overall Study|Lost to Follow-up|374|||
19757597|NCT03152019|42208224|FG000|Overall Study|Adverse Event|0|||
19757598|NCT03152019|42208225|FG001|Overall Study|Adverse Event|1|||
19757599|NCT02714062|42208238|FG000|Overall Study|Adverse Event|0|||
19757600|NCT02714062|42208239|FG001|Overall Study|Adverse Event|0|||
19757601|NCT02714062|42208240|FG002|Overall Study|Adverse Event|2|||
19389000|NCT02679755|41632550|FG001|Overall Study|Lost to Follow-up|0|||
19670015|NCT00447057|42118039|FG003|Overall Study|Lost to Follow-up|0|||
19670016|NCT00447057|42118036|FG000|Overall Study|Entry criteria not met|1|||
19757602|NCT02714062|42208238|FG000|Overall Study|Withdrawal by Subject|1|||
19757603|NCT02714062|42208239|FG001|Overall Study|Withdrawal by Subject|0|||
19757604|NCT02714062|42208240|FG002|Overall Study|Withdrawal by Subject|1|||
19757605|NCT02714062|42208238|FG000|Overall Study|Protocol Violation|0|||
19757606|NCT02714062|42208239|FG001|Overall Study|Protocol Violation|1|||
19757607|NCT02714062|42208240|FG002|Overall Study|Protocol Violation|0|||
19757608|NCT03151395|42208250|FG000|Overall Study|Adverse Event|2|||
19757609|NCT03151395|42208250|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
19670017|NCT00447057|42118037|FG001|Overall Study|Entry criteria not met|1|||
19670018|NCT00447057|42118038|FG002|Overall Study|Entry criteria not met|0|||
19670019|NCT00447057|42118039|FG003|Overall Study|Entry criteria not met|0|||
19757610|NCT03151395|42208250|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
19757611|NCT03151395|42208250|FG000|Overall Study|Unspecified reason|4|||
19757612|NCT02713828|42208256|FG000|Overall Study|Death|2|||
19757613|NCT02713828|42208257|FG001|Overall Study|Death|0|||
19757614|NCT02713828|42208256|FG000|Overall Study|Withdrawal by Subject|1|||
19757615|NCT02713828|42208257|FG001|Overall Study|Withdrawal by Subject|0|||
19757616|NCT02713828|42208256|FG000|Overall Study|study terminated but patient allowed to|2|||
19757617|NCT02713828|42208257|FG001|Overall Study|study terminated but patient allowed to|0|||
19757618|NCT02876328|42208286|FG000|Overall Study|Death|2|||
19757619|NCT02876328|42208287|FG001|Overall Study|Death|1|||
19757620|NCT02876328|42208288|FG002|Overall Study|Death|3|||
19757621|NCT02876328|42208289|FG003|Overall Study|Death|0|||
19757622|NCT02876328|42208290|FG004|Overall Study|Death|0|||
19757623|NCT02876328|42208291|FG005|Overall Study|Death|0|||
19757624|NCT02876328|42208292|FG006|Overall Study|Death|1|||
19757625|NCT02876328|42208293|FG007|Overall Study|Death|3|||
19757626|NCT02876328|42208294|FG008|Overall Study|Death|0|||
19757627|NCT02876328|42208295|FG009|Overall Study|Death|1|||
19757628|NCT02876328|42208296|FG010|Overall Study|Death|1|||
19757629|NCT02876328|42208297|FG011|Overall Study|Death|0|||
19757630|NCT02876328|42208298|FG012|Overall Study|Death|0|||
19757631|NCT02876328|42208299|FG013|Overall Study|Death|0|||
19757632|NCT02876328|42208300|FG014|Overall Study|Death|0|||
19757633|NCT02876328|42208301|FG015|Overall Study|Death|0|||
19757634|NCT02876328|42208302|FG016|Overall Study|Death|1|||
19757635|NCT02876328|42208303|FG017|Overall Study|Death|1|||
19757636|NCT02876328|42208304|FG018|Overall Study|Death|0|||
19757637|NCT02876328|42208305|FG019|Overall Study|Death|0|||
19757638|NCT02876328|42208306|FG020|Overall Study|Death|0|||
19757639|NCT02876328|42208307|FG021|Overall Study|Death|1|||
19757640|NCT02876328|42208308|FG022|Overall Study|Death|0|||
19757641|NCT02876328|42208309|FG023|Overall Study|Death|0|||
19757642|NCT02876328|42208286|FG000|Overall Study|Withdrawal by Subject|0|||
19757643|NCT02876328|42208287|FG001|Overall Study|Withdrawal by Subject|2|||
19757644|NCT02876328|42208288|FG002|Overall Study|Withdrawal by Subject|3|||
19757645|NCT02876328|42208289|FG003|Overall Study|Withdrawal by Subject|3|||
19757646|NCT02876328|42208290|FG004|Overall Study|Withdrawal by Subject|0|||
19757647|NCT02876328|42208291|FG005|Overall Study|Withdrawal by Subject|1|||
19757648|NCT02876328|42208292|FG006|Overall Study|Withdrawal by Subject|0|||
19757649|NCT02876328|42208293|FG007|Overall Study|Withdrawal by Subject|1|||
19757650|NCT02876328|42208294|FG008|Overall Study|Withdrawal by Subject|1|||
19757651|NCT02876328|42208295|FG009|Overall Study|Withdrawal by Subject|2|||
19757652|NCT02876328|42208296|FG010|Overall Study|Withdrawal by Subject|0|||
19757653|NCT02876328|42208297|FG011|Overall Study|Withdrawal by Subject|0|||
19757654|NCT02876328|42208298|FG012|Overall Study|Withdrawal by Subject|0|||
19757655|NCT02876328|42208299|FG013|Overall Study|Withdrawal by Subject|0|||
19757656|NCT02876328|42208300|FG014|Overall Study|Withdrawal by Subject|0|||
19757657|NCT02876328|42208301|FG015|Overall Study|Withdrawal by Subject|0|||
19757658|NCT02876328|42208302|FG016|Overall Study|Withdrawal by Subject|1|||
19757659|NCT02876328|42208303|FG017|Overall Study|Withdrawal by Subject|3|||
19757660|NCT02876328|42208304|FG018|Overall Study|Withdrawal by Subject|0|||
19757661|NCT02876328|42208305|FG019|Overall Study|Withdrawal by Subject|0|||
19757662|NCT02876328|42208306|FG020|Overall Study|Withdrawal by Subject|1|||
19757663|NCT02876328|42208307|FG021|Overall Study|Withdrawal by Subject|0|||
19757664|NCT02876328|42208308|FG022|Overall Study|Withdrawal by Subject|0|||
19757665|NCT02876328|42208309|FG023|Overall Study|Withdrawal by Subject|0|||
19757666|NCT02876328|42208286|FG000|Overall Study|Missed 12 Month Visit|15|||
19757667|NCT02876328|42208287|FG001|Overall Study|Missed 12 Month Visit|10|||
19757668|NCT02876328|42208288|FG002|Overall Study|Missed 12 Month Visit|11|||
19757669|NCT02876328|42208289|FG003|Overall Study|Missed 12 Month Visit|6|||
19757670|NCT02876328|42208290|FG004|Overall Study|Missed 12 Month Visit|10|||
19670020|NCT00447057|42118036|FG000|Overall Study|Protocol Violation|0|||
19670021|NCT00447057|42118037|FG001|Overall Study|Protocol Violation|1|||
19670022|NCT00447057|42118038|FG002|Overall Study|Protocol Violation|0|||
19670023|NCT00447057|42118039|FG003|Overall Study|Protocol Violation|0|||
19670024|NCT00447057|42118036|FG000|Overall Study|Withdrawal by Subject|4|||
19757671|NCT02876328|42208291|FG005|Overall Study|Missed 12 Month Visit|14|||
19757672|NCT02876328|42208292|FG006|Overall Study|Missed 12 Month Visit|3|||
19757673|NCT02876328|42208293|FG007|Overall Study|Missed 12 Month Visit|8|||
19757674|NCT02876328|42208294|FG008|Overall Study|Missed 12 Month Visit|9|||
19757675|NCT02876328|42208295|FG009|Overall Study|Missed 12 Month Visit|5|||
19757676|NCT02876328|42208296|FG010|Overall Study|Missed 12 Month Visit|4|||
19757677|NCT02876328|42208297|FG011|Overall Study|Missed 12 Month Visit|1|||
19757678|NCT02876328|42208298|FG012|Overall Study|Missed 12 Month Visit|5|||
19757679|NCT02876328|42208299|FG013|Overall Study|Missed 12 Month Visit|4|||
19670025|NCT00447057|42118037|FG001|Overall Study|Withdrawal by Subject|5|||
19670026|NCT00447057|42118038|FG002|Overall Study|Withdrawal by Subject|1|||
19670027|NCT00447057|42118039|FG003|Overall Study|Withdrawal by Subject|1|||
19670028|NCT00447057|42118036|FG000|Overall Study|Physician Decision|9|||
19670029|NCT00447057|42118037|FG001|Overall Study|Physician Decision|6|||
19670030|NCT00447057|42118038|FG002|Overall Study|Physician Decision|3|||
19670031|NCT00447057|42118039|FG003|Overall Study|Physician Decision|1|||
19670032|NCT00447057|42118036|FG000|Overall Study|Sponsor decision|1|||
19670033|NCT00447057|42118037|FG001|Overall Study|Sponsor decision|1|||
19670034|NCT00447057|42118038|FG002|Overall Study|Sponsor decision|0|||
19670035|NCT00447057|42118039|FG003|Overall Study|Sponsor decision|0|||
19670036|NCT00447057|42118036|FG000|Overall Study|Progressive disease|58|||
19670037|NCT00447057|42118037|FG001|Overall Study|Progressive disease|43|||
19670038|NCT00447057|42118038|FG002|Overall Study|Progressive disease|13|||
19670039|NCT00447057|42118039|FG003|Overall Study|Progressive disease|18|||
19670040|NCT00447057|42118036|FG000|Overall Study|Death due to adverse event|0|||
19670041|NCT00447057|42118037|FG001|Overall Study|Death due to adverse event|0|||
19670042|NCT00447057|42118038|FG002|Overall Study|Death due to adverse event|1|||
19670043|NCT00447057|42118039|FG003|Overall Study|Death due to adverse event|2|||
19670044|NCT00447057|42118036|FG000|Overall Study|Death, study drug related|0|||
19670045|NCT00447057|42118037|FG001|Overall Study|Death, study drug related|1|||
19670046|NCT00447057|42118038|FG002|Overall Study|Death, study drug related|0|||
19670047|NCT00447057|42118039|FG003|Overall Study|Death, study drug related|0|||
19670048|NCT00446511|42118051|FG000|Overall Study|Adverse Event|7|||
19670049|NCT00446511|42118052|FG001|Overall Study|Adverse Event|2|||
19670050|NCT00446511|42118053|FG002|Overall Study|Adverse Event|3|||
19670051|NCT00446511|42118054|FG003|Overall Study|Adverse Event|1|||
19670052|NCT00446511|42118051|FG000|Overall Study|Protocol Violation|0|||
19670053|NCT00446511|42118052|FG001|Overall Study|Protocol Violation|0|||
19670054|NCT00446511|42118053|FG002|Overall Study|Protocol Violation|0|||
19670055|NCT00446511|42118054|FG003|Overall Study|Protocol Violation|1|||
19670056|NCT00446511|42118051|FG000|Overall Study|Withdrawal by Subject|0|||
19670057|NCT00446511|42118052|FG001|Overall Study|Withdrawal by Subject|0|||
19670058|NCT00446511|42118053|FG002|Overall Study|Withdrawal by Subject|0|||
19670059|NCT00446511|42118054|FG003|Overall Study|Withdrawal by Subject|3|||
19670060|NCT00446511|42118051|FG000|Overall Study|Administrative Problems|3|||
19670061|NCT00446511|42118052|FG001|Overall Study|Administrative Problems|0|||
19670062|NCT00446511|42118053|FG002|Overall Study|Administrative Problems|4|||
19670063|NCT00446511|42118054|FG003|Overall Study|Administrative Problems|1|||
19670064|NCT00446199|42118070|FG000|Overall Study|Adverse Event|7|||
19670065|NCT00446199|42118071|FG001|Overall Study|Adverse Event|4|||
19670066|NCT00446199|42118072|FG002|Overall Study|Adverse Event|6|||
19757680|NCT02876328|42208300|FG014|Overall Study|Missed 12 Month Visit|4|||
19757681|NCT02876328|42208301|FG015|Overall Study|Missed 12 Month Visit|4|||
19757682|NCT02876328|42208302|FG016|Overall Study|Missed 12 Month Visit|3|||
19757683|NCT02876328|42208303|FG017|Overall Study|Missed 12 Month Visit|6|||
19757684|NCT02876328|42208304|FG018|Overall Study|Missed 12 Month Visit|2|||
19757685|NCT02876328|42208305|FG019|Overall Study|Missed 12 Month Visit|2|||
19757686|NCT02876328|42208306|FG020|Overall Study|Missed 12 Month Visit|11|||
19757687|NCT02876328|42208307|FG021|Overall Study|Missed 12 Month Visit|7|||
19757688|NCT02876328|42208308|FG022|Overall Study|Missed 12 Month Visit|1|||
19670067|NCT00446199|42118073|FG003|Overall Study|Adverse Event|4|||
19670068|NCT00446199|42118070|FG000|Overall Study|Lost to Follow-up|4|||
19670069|NCT00446199|42118071|FG001|Overall Study|Lost to Follow-up|5|||
19670070|NCT00446199|42118072|FG002|Overall Study|Lost to Follow-up|2|||
19670071|NCT00446199|42118073|FG003|Overall Study|Lost to Follow-up|6|||
19670072|NCT00446199|42118070|FG000|Overall Study|Protocol Violation|1|||
19670073|NCT00446199|42118071|FG001|Overall Study|Protocol Violation|2|||
19670074|NCT00446199|42118072|FG002|Overall Study|Protocol Violation|1|||
19670075|NCT00446199|42118073|FG003|Overall Study|Protocol Violation|3|||
19757689|NCT02876328|42208309|FG023|Overall Study|Missed 12 Month Visit|0|||
19757690|NCT02875860|42208337|FG000|Overall Study|Withdrawal by Subject|0|||
19757691|NCT02875860|42208338|FG001|Overall Study|Withdrawal by Subject|1|||
19757692|NCT02875392|42208346|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
19757693|NCT02875392|42208347|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
19670076|NCT00446199|42118070|FG000|Overall Study|Withdrawal by Subject|2|||
19670077|NCT00446199|42118071|FG001|Overall Study|Withdrawal by Subject|5|||
19670078|NCT00446199|42118072|FG002|Overall Study|Withdrawal by Subject|9|||
19670079|NCT00446199|42118073|FG003|Overall Study|Withdrawal by Subject|10|||
19670080|NCT00446199|42118070|FG000|Overall Study|Site termination|2|||
19670081|NCT00446199|42118071|FG001|Overall Study|Site termination|0|||
19670082|NCT00446199|42118072|FG002|Overall Study|Site termination|0|||
19670083|NCT00446199|42118073|FG003|Overall Study|Site termination|1|||
19670084|NCT00446199|42118070|FG000|Overall Study|Randomization in Error|2|||
19670085|NCT00446199|42118071|FG001|Overall Study|Randomization in Error|0|||
19670086|NCT00446199|42118072|FG002|Overall Study|Randomization in Error|1|||
19670087|NCT00446199|42118073|FG003|Overall Study|Randomization in Error|1|||
19670088|NCT00446199|42118070|FG000|Overall Study|Lack of Efficacy|1|||
19670089|NCT00446199|42118071|FG001|Overall Study|Lack of Efficacy|0|||
19670090|NCT00446199|42118072|FG002|Overall Study|Lack of Efficacy|0|||
19670091|NCT00446199|42118073|FG003|Overall Study|Lack of Efficacy|1|||
19603373|NCT00586846|42052263|FG000|Overall Study|Evaluable for Toxicity Only|4|||
19603374|NCT00973700|42052272|FG000|Overall Study|Withdrawal by Subject|2|||
19603375|NCT00973700|42052273|FG001|Overall Study|Withdrawal by Subject|2|||
19603376|NCT00973700|42052274|FG002|Overall Study|Withdrawal by Subject|8|||
19603377|NCT00973700|42052275|FG003|Overall Study|Withdrawal by Subject|4|||
19603378|NCT00973700|42052276|FG004|Overall Study|Withdrawal by Subject|4|||
19670092|NCT00446199|42118070|FG000|Overall Study|Non-compliant with study drug|1|||
19670093|NCT00446199|42118071|FG001|Overall Study|Non-compliant with study drug|0|||
19670094|NCT00446199|42118072|FG002|Overall Study|Non-compliant with study drug|5|||
19670095|NCT00446199|42118073|FG003|Overall Study|Non-compliant with study drug|0|||
19670096|NCT00446199|42118070|FG000|Overall Study|Non-compliant with visit schedule|1|||
19670097|NCT00446199|42118071|FG001|Overall Study|Non-compliant with visit schedule|1|||
19670098|NCT00446199|42118072|FG002|Overall Study|Non-compliant with visit schedule|1|||
19670099|NCT00446199|42118073|FG003|Overall Study|Non-compliant with visit schedule|2|||
19603379|NCT00973700|42052272|FG000|Overall Study|Lost to Follow-up|5|||
19603380|NCT00973700|42052273|FG001|Overall Study|Lost to Follow-up|0|||
19603381|NCT00973700|42052274|FG002|Overall Study|Lost to Follow-up|1|||
19603382|NCT00973700|42052275|FG003|Overall Study|Lost to Follow-up|8|||
19603383|NCT00973700|42052276|FG004|Overall Study|Lost to Follow-up|5|||
19603384|NCT00973700|42052272|FG000|Overall Study|Inappropriate enrolment|0|||
19670100|NCT00446199|42118070|FG000|Overall Study|Hormone fear|0|||
19670101|NCT00446199|42118071|FG001|Overall Study|Hormone fear|0|||
19670102|NCT00446199|42118072|FG002|Overall Study|Hormone fear|0|||
19757694|NCT03127644|42208356|FG000|Overall Study|Study-specific withdrawal criteria|0|||
19757695|NCT03127644|42208357|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19757696|NCT03127644|42208358|FG002|Overall Study|Study-specific withdrawal criteria|2|||
19757697|NCT03965962|42208372|FG000|Overall Study|Adverse Event|1|||
19757698|NCT03965962|42208373|FG001|Overall Study|Adverse Event|0|||
19757699|NCT03965962|42208374|FG002|Overall Study|Adverse Event|0|||
19757700|NCT03965962|42208375|FG003|Overall Study|Adverse Event|0|||
19757701|NCT03965962|42208372|FG000|Overall Study|Protocol Violation|21|||
19757702|NCT03965962|42208373|FG001|Overall Study|Protocol Violation|4|||
19757703|NCT03965962|42208374|FG002|Overall Study|Protocol Violation|10|||
19757704|NCT03965962|42208375|FG003|Overall Study|Protocol Violation|5|||
19757705|NCT03965962|42208372|FG000|Overall Study|Lost to Follow-up|0|||
19757706|NCT03965962|42208373|FG001|Overall Study|Lost to Follow-up|1|||
19757707|NCT03965962|42208374|FG002|Overall Study|Lost to Follow-up|0|||
19757708|NCT03965962|42208375|FG003|Overall Study|Lost to Follow-up|0|||
19757709|NCT03965962|42208372|FG000|Overall Study|Withdrawal by Subject|3|||
19757710|NCT03965962|42208373|FG001|Overall Study|Withdrawal by Subject|0|||
19757711|NCT03965962|42208374|FG002|Overall Study|Withdrawal by Subject|0|||
19757712|NCT03965962|42208375|FG003|Overall Study|Withdrawal by Subject|1|||
19757713|NCT03151551|42208387|FG000|Open-Label Treatment Period|Adverse Event|0|||
19670103|NCT00446199|42118073|FG003|Overall Study|Hormone fear|1|||
19670104|NCT00446199|42118070|FG000|Overall Study|Lost interest in study participation|0|||
19670105|NCT00446199|42118071|FG001|Overall Study|Lost interest in study participation|1|||
19670106|NCT00446199|42118072|FG002|Overall Study|Lost interest in study participation|0|||
19670107|NCT00446199|42118073|FG003|Overall Study|Lost interest in study participation|0|||
19670108|NCT00446199|42118070|FG000|Overall Study|In-/Exclusion criterion violated|2|||
19670109|NCT00446199|42118071|FG001|Overall Study|In-/Exclusion criterion violated|1|||
19670110|NCT00446199|42118072|FG002|Overall Study|In-/Exclusion criterion violated|2|||
19670111|NCT00446199|42118073|FG003|Overall Study|In-/Exclusion criterion violated|1|||
19670112|NCT00446199|42118070|FG000|Overall Study|Move|0|||
19670113|NCT00446199|42118071|FG001|Overall Study|Move|1|||
19670114|NCT00446199|42118072|FG002|Overall Study|Move|0|||
19670115|NCT00446199|42118073|FG003|Overall Study|Move|0|||
19670116|NCT00456495|42118083|FG000|Overall Study|Physician Decision|2|||
19670117|NCT00445341|42118088|FG000|Overall Study|refused further treatment|1|||
19670118|NCT00445341|42118088|FG000|Overall Study|taken off treatment too early|1|||
19670119|NCT03846453|42118094|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
19670120|NCT03846453|42118095|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
19670121|NCT03846453|42118096|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
19670122|NCT03846453|42118094|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
19670123|NCT03846453|42118095|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
19670124|NCT03846453|42118096|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
19670125|NCT03846453|42118094|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
19670126|NCT03846453|42118095|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
19670127|NCT03846453|42118096|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
19670128|NCT03846453|42118094|FG000|Placebo Run-in (14 Days)|Other|2|||
19670129|NCT03846453|42118095|FG001|Placebo Run-in (14 Days)|Other|0|||
19670130|NCT03846453|42118096|FG002|Placebo Run-in (14 Days)|Other|0|||
19670131|NCT03846453|42118094|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
19670132|NCT03846453|42118095|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
19670133|NCT03846453|42118096|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
19670134|NCT03846453|42118094|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
19670135|NCT03846453|42118095|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
19670136|NCT03846453|42118096|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
19670137|NCT03846453|42118094|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
19670138|NCT03846453|42118095|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
19670139|NCT03846453|42118096|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
19670140|NCT03846453|42118094|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
19670141|NCT03846453|42118095|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
19670142|NCT03846453|42118096|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
19757714|NCT03151551|42208388|FG001|Open-Label Treatment Period|Adverse Event|2|||
19757715|NCT03151551|42208387|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
19757716|NCT03151551|42208388|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
19670143|NCT03846453|42118094|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
19670144|NCT03846453|42118095|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
19670145|NCT03846453|42118096|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
19670146|NCT00444951|42118107|FG000|Overall Study|Lost to Follow-up|1|||
19670147|NCT00444951|42118108|FG001|Overall Study|Lost to Follow-up|1|||
19670148|NCT00444951|42118109|FG002|Overall Study|Lost to Follow-up|0|||
19670149|NCT00444951|42118107|FG000|Overall Study|Withdrawal by Subject|4|||
19670150|NCT00444951|42118108|FG001|Overall Study|Withdrawal by Subject|5|||
19670151|NCT00444951|42118109|FG002|Overall Study|Withdrawal by Subject|3|||
19670152|NCT00444795|42118117|FG000|Overall Study|Not Treated|1|||
19670153|NCT00444795|42118117|FG000|Overall Study|Treated Prior to the Contract Date|2|||
19670154|NCT03846219|42118124|FG000|Overall Study|Withdrawal by Subject|3|||
19670155|NCT03846219|42118125|FG001|Overall Study|Withdrawal by Subject|2|||
19670156|NCT03846219|42118126|FG002|Overall Study|Withdrawal by Subject|2|||
19670157|NCT03846219|42118124|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
19670158|NCT03846219|42118125|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
19670159|NCT03846219|42118126|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
19670160|NCT03846219|42118124|FG000|Overall Study|Physician Decision|0|||
19670161|NCT03846219|42118125|FG001|Overall Study|Physician Decision|0|||
19670162|NCT03846219|42118126|FG002|Overall Study|Physician Decision|2|||
19670163|NCT00455325|42118142|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
19670164|NCT00455325|42118143|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
19670165|NCT00455325|42118144|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
19670166|NCT00455325|42118145|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
19670167|NCT00455325|42118142|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
19670168|NCT00455325|42118143|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
19670169|NCT00455325|42118144|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
19757717|NCT03151551|42208387|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
19757718|NCT03151551|42208388|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
19757719|NCT03151551|42208387|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
19757720|NCT03151551|42208388|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
19757721|NCT03151551|42208387|FG000|Open-Label Treatment Period|Physician Decision|3|||
19757722|NCT03151551|42208388|FG001|Open-Label Treatment Period|Physician Decision|0|||
19757723|NCT03151551|42208387|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
19757724|NCT03151551|42208388|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
19757725|NCT03151551|42208387|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
19757726|NCT03151551|42208388|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
19757727|NCT03151551|42208387|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
19757728|NCT03151551|42208388|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
19757729|NCT03151551|42208387|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
19757730|NCT03151551|42208388|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
19757731|NCT03151551|42208387|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
19757732|NCT03151551|42208388|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
19757733|NCT03147495|42208398|FG000|Overall Study|Physician Decision|0|||
19757734|NCT03147495|42208399|FG001|Overall Study|Physician Decision|6|||
19670170|NCT00455325|42118145|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
19670171|NCT00455325|42118142|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
19670172|NCT00455325|42118143|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
19670173|NCT00455325|42118144|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
19757735|NCT03126786|42208407|FG000|Overall Study|Adverse Event|3|||
19670174|NCT00455325|42118145|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
19670175|NCT00455325|42118142|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
19670176|NCT00455325|42118143|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
19670177|NCT00455325|42118144|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
19757736|NCT03126786|42208408|FG001|Overall Study|Adverse Event|0|||
19757737|NCT03126786|42208407|FG000|Overall Study|Lost to Follow-up|0|||
19757738|NCT03126786|42208408|FG001|Overall Study|Lost to Follow-up|1|||
19757739|NCT03126786|42208407|FG000|Overall Study|Withdrawal by Subject|3|||
19757740|NCT03126786|42208408|FG001|Overall Study|Withdrawal by Subject|1|||
19670178|NCT00455325|42118145|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
19670179|NCT00455325|42118142|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
19670180|NCT00455325|42118143|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
19670181|NCT00455325|42118144|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
19670182|NCT00455325|42118145|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
19670183|NCT00455325|42118142|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
19670184|NCT00455325|42118143|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
19670185|NCT00455325|42118144|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
19670186|NCT00455325|42118145|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
19670187|NCT00455325|42118142|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
19670188|NCT00455325|42118143|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
19670189|NCT00455325|42118144|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
19670190|NCT00455325|42118145|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
19670191|NCT00443781|42118156|FG000|Overall Study|Lost to Follow-up|10|||
19670192|NCT00443781|42118156|FG000|Overall Study|Physician Decision|2|||
19670193|NCT00443781|42118156|FG000|Overall Study|Protocol Violation|1|||
19670194|NCT00443781|42118156|FG000|Overall Study|Withdrawal by Subject|6|||
19670195|NCT00443781|42118156|FG000|Overall Study|Unable to comply with study follow up|2|||
19670196|NCT00443781|42118156|FG000|Overall Study|Investigator terminated participation|1|||
19670197|NCT00443781|42118156|FG000|Overall Study|Insurance not covered|2|||
19670198|NCT00443781|42118156|FG000|Overall Study|PD/FAD not done|1|||
19670199|NCT00443703|42118162|FG000|Overall Study|Never Treated|3|||
19670200|NCT00443703|42118163|FG001|Overall Study|Never Treated|1|||
19670201|NCT00443703|42118162|FG000|Overall Study|Adverse Event|7|||
19670202|NCT00443703|42118163|FG001|Overall Study|Adverse Event|3|||
19670203|NCT00443703|42118162|FG000|Overall Study|Lack of Efficacy|3|||
19670204|NCT00443703|42118163|FG001|Overall Study|Lack of Efficacy|1|||
19670205|NCT00443703|42118162|FG000|Overall Study|Lost to Follow-up|0|||
19670206|NCT00443703|42118163|FG001|Overall Study|Lost to Follow-up|4|||
19670207|NCT00443703|42118162|FG000|Overall Study|Physician Decision|4|||
19670208|NCT00443703|42118163|FG001|Overall Study|Physician Decision|2|||
19670209|NCT00443703|42118162|FG000|Overall Study|Protocol Violation|1|||
19670210|NCT00443703|42118163|FG001|Overall Study|Protocol Violation|1|||
19670211|NCT00443703|42118162|FG000|Overall Study|Withdrawal by Subject|9|||
19670212|NCT00443703|42118163|FG001|Overall Study|Withdrawal by Subject|6|||
19670213|NCT00443703|42118162|FG000|Overall Study|Progressive Disease|1|||
19670214|NCT00443703|42118163|FG001|Overall Study|Progressive Disease|0|||
19670215|NCT00381706|42118175|FG000|Overall Study|Never treated|7|||
19670216|NCT00381706|42118176|FG001|Overall Study|Never treated|2|||
19670217|NCT00381706|42118177|FG002|Overall Study|Never treated|1|||
19670218|NCT00535236|42118201|FG000|Overall Study|Adverse Event|1|||
19670219|NCT00535236|42118202|FG001|Overall Study|Adverse Event|0|||
19670220|NCT00535236|42118203|FG002|Overall Study|Adverse Event|9|||
19670221|NCT00535236|42118204|FG003|Overall Study|Adverse Event|3|||
19670222|NCT00535236|42118205|FG004|Overall Study|Adverse Event|3|||
19670223|NCT00535236|42118206|FG005|Overall Study|Adverse Event|0|||
19670224|NCT00535236|42118207|FG006|Overall Study|Adverse Event|5|||
19670225|NCT00535236|42118208|FG007|Overall Study|Adverse Event|1|||
19757741|NCT03146403|42208416|FG000|Overall Study|Withdrawal by Subject|0|||
19670226|NCT00535236|42118209|FG008|Overall Study|Adverse Event|2|||
19670227|NCT00535236|42118210|FG009|Overall Study|Adverse Event|1|||
19670228|NCT00535236|42118201|FG000|Overall Study|Lost to Follow-up|1|||
19670229|NCT00535236|42118202|FG001|Overall Study|Lost to Follow-up|2|||
19670230|NCT00535236|42118203|FG002|Overall Study|Lost to Follow-up|0|||
19670231|NCT00535236|42118204|FG003|Overall Study|Lost to Follow-up|0|||
19670232|NCT00535236|42118205|FG004|Overall Study|Lost to Follow-up|2|||
19670233|NCT00535236|42118206|FG005|Overall Study|Lost to Follow-up|0|||
19670234|NCT00535236|42118207|FG006|Overall Study|Lost to Follow-up|0|||
19670235|NCT00535236|42118208|FG007|Overall Study|Lost to Follow-up|0|||
19603385|NCT00973700|42052273|FG001|Overall Study|Inappropriate enrolment|0|||
19603386|NCT00973700|42052274|FG002|Overall Study|Inappropriate enrolment|0|||
19603387|NCT00973700|42052275|FG003|Overall Study|Inappropriate enrolment|4|||
19603388|NCT00973700|42052276|FG004|Overall Study|Inappropriate enrolment|0|||
19603389|NCT00973700|42052272|FG000|Overall Study|Unable to Classify|0|||
19603390|NCT00973700|42052273|FG001|Overall Study|Unable to Classify|0|||
19603391|NCT00973700|42052274|FG002|Overall Study|Unable to Classify|1|||
19603392|NCT00973700|42052275|FG003|Overall Study|Unable to Classify|2|||
19603393|NCT00973700|42052276|FG004|Overall Study|Unable to Classify|1|||
19603394|NCT00754390|42052303|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
19603395|NCT00754390|42052303|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
19603396|NCT00754390|42052303|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
19603397|NCT00754390|42052303|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
19603398|NCT00754234|42052310|FG000|Overall Study|Withdrawal by Subject|3|||
19603399|NCT00753922|42052318|FG000|Overall Study|Lost to Follow-up|155|||
19603400|NCT00753922|42052319|FG001|Overall Study|Lost to Follow-up|24|||
19603401|NCT00753922|42052320|FG002|Overall Study|Lost to Follow-up|28|||
19603402|NCT00753922|42052321|FG003|Overall Study|Lost to Follow-up|5|||
19603403|NCT00753922|42052318|FG000|Overall Study|Withdrawal by Subject|9|||
19603404|NCT00753922|42052319|FG001|Overall Study|Withdrawal by Subject|11|||
19603405|NCT00753922|42052320|FG002|Overall Study|Withdrawal by Subject|4|||
19603406|NCT00753922|42052321|FG003|Overall Study|Withdrawal by Subject|2|||
19603407|NCT00753922|42052318|FG000|Overall Study|Patient Non-compliance|55|||
19603408|NCT00753922|42052319|FG001|Overall Study|Patient Non-compliance|22|||
19603409|NCT00753922|42052320|FG002|Overall Study|Patient Non-compliance|14|||
19603410|NCT00753922|42052321|FG003|Overall Study|Patient Non-compliance|11|||
19603411|NCT00753922|42052318|FG000|Overall Study|Patients Not Completing Visit|11|||
19603412|NCT00753922|42052319|FG001|Overall Study|Patients Not Completing Visit|0|||
19603413|NCT00753922|42052320|FG002|Overall Study|Patients Not Completing Visit|1|||
19603414|NCT00753922|42052321|FG003|Overall Study|Patients Not Completing Visit|0|||
19603415|NCT00753922|42052318|FG000|Overall Study|Death|2|||
19603416|NCT00753922|42052319|FG001|Overall Study|Death|23|||
19603417|NCT00753922|42052320|FG002|Overall Study|Death|2|||
19603418|NCT00753922|42052321|FG003|Overall Study|Death|1|||
19603419|NCT00753922|42052318|FG000|Overall Study|Discontinuation Due to Explantation|14|||
19603420|NCT00753922|42052319|FG001|Overall Study|Discontinuation Due to Explantation|14|||
19603421|NCT00753922|42052320|FG002|Overall Study|Discontinuation Due to Explantation|14|||
19603422|NCT00753922|42052321|FG003|Overall Study|Discontinuation Due to Explantation|4|||
19603423|NCT00761176|42052333|FG000|Overall Study|Death|1|||
19603424|NCT00761176|42052334|FG001|Overall Study|Death|0|||
19603425|NCT00761176|42052333|FG000|Overall Study|Withdrawal by Subject|1|||
19603426|NCT00761176|42052334|FG001|Overall Study|Withdrawal by Subject|1|||
19603427|NCT00760552|42052342|FG000|Overall Study|Death|2|||
19603428|NCT00760552|42052343|FG001|Overall Study|Death|0|||
19603429|NCT00760552|42052342|FG000|Overall Study|Lost to Follow-up|11|||
19603430|NCT00760552|42052343|FG001|Overall Study|Lost to Follow-up|10|||
19603431|NCT00753766|42052351|FG000|Overall Study|Physician Decision|1|||
19603432|NCT00753766|42052352|FG001|Overall Study|Physician Decision|0|||
19603433|NCT00976898|42052359|FG000|Overall Study|Protocol Violation|1|||
19603434|NCT00976898|42052359|FG000|Overall Study|Adverse Event|1|||
19603435|NCT00976898|42052359|FG000|Overall Study|Physician Decision|1|||
19603436|NCT00976898|42052359|FG000|Overall Study|Liver Transplant|1|||
19603437|NCT00976898|42052359|FG000|Overall Study|Progressive Disease|1|||
19603438|NCT02620579|42052371|FG000|Overall Study|Physician Decision|0|||
19603439|NCT02620579|42052372|FG001|Overall Study|Physician Decision|0|||
19603440|NCT02620579|42052373|FG002|Overall Study|Physician Decision|0|||
19603441|NCT02620579|42052374|FG003|Overall Study|Physician Decision|1|||
19603442|NCT02620579|42052371|FG000|Overall Study|Withdrawal by Subject|0|||
19603443|NCT02620579|42052372|FG001|Overall Study|Withdrawal by Subject|1|||
19757742|NCT03146403|42208417|FG001|Overall Study|Withdrawal by Subject|3|||
19757743|NCT03146403|42208416|FG000|Overall Study|Lost to Follow-up|2|||
19757744|NCT03146403|42208417|FG001|Overall Study|Lost to Follow-up|0|||
19603444|NCT02620579|42052373|FG002|Overall Study|Withdrawal by Subject|1|||
19603445|NCT02620579|42052374|FG003|Overall Study|Withdrawal by Subject|0|||
19670236|NCT00535236|42118209|FG008|Overall Study|Lost to Follow-up|6|||
19670237|NCT00535236|42118210|FG009|Overall Study|Lost to Follow-up|1|||
19603446|NCT00753688|42052390|FG000|Overall Study|Death|102|||
19603447|NCT00753688|42052391|FG001|Overall Study|Death|203|||
19603448|NCT00753688|42052390|FG000|Overall Study|Missing|4|||
19603449|NCT00753688|42052391|FG001|Overall Study|Missing|9|||
19670238|NCT00535236|42118201|FG000|Overall Study|Physician Decision|0|||
19670239|NCT00535236|42118202|FG001|Overall Study|Physician Decision|0|||
19670240|NCT00535236|42118203|FG002|Overall Study|Physician Decision|0|||
19670241|NCT00535236|42118204|FG003|Overall Study|Physician Decision|0|||
19670242|NCT00535236|42118205|FG004|Overall Study|Physician Decision|1|||
19670243|NCT00535236|42118206|FG005|Overall Study|Physician Decision|0|||
19670244|NCT00535236|42118207|FG006|Overall Study|Physician Decision|1|||
19670245|NCT00535236|42118208|FG007|Overall Study|Physician Decision|0|||
19670246|NCT00535236|42118209|FG008|Overall Study|Physician Decision|0|||
19670247|NCT00535236|42118210|FG009|Overall Study|Physician Decision|0|||
19670248|NCT00535236|42118201|FG000|Overall Study|Protocol Violation|2|||
19757745|NCT03132636|42208425|FG000|Overall Study|Adverse Event|1|||
19757746|NCT03132636|42208426|FG001|Overall Study|Adverse Event|2|||
19757747|NCT03132636|42208425|FG000|Overall Study|Death|4|||
19757748|NCT03132636|42208426|FG001|Overall Study|Death|7|||
19757749|NCT03132636|42208425|FG000|Overall Study|Lost to Follow-up|2|||
19757750|NCT03132636|42208426|FG001|Overall Study|Lost to Follow-up|2|||
19757751|NCT03132636|42208425|FG000|Overall Study|Protocol Violation|1|||
19757752|NCT03132636|42208426|FG001|Overall Study|Protocol Violation|1|||
19757753|NCT03132636|42208425|FG000|Overall Study|Participant Decision|1|||
19757754|NCT03132636|42208426|FG001|Overall Study|Participant Decision|9|||
19757755|NCT03132636|42208425|FG000|Overall Study|Sponsor Decision|0|||
19670249|NCT00535236|42118202|FG001|Overall Study|Protocol Violation|0|||
19670250|NCT00535236|42118203|FG002|Overall Study|Protocol Violation|1|||
19670251|NCT00535236|42118204|FG003|Overall Study|Protocol Violation|0|||
19670252|NCT00535236|42118205|FG004|Overall Study|Protocol Violation|0|||
19670253|NCT00535236|42118206|FG005|Overall Study|Protocol Violation|0|||
19670254|NCT00535236|42118207|FG006|Overall Study|Protocol Violation|0|||
19670255|NCT00535236|42118208|FG007|Overall Study|Protocol Violation|0|||
19670256|NCT00535236|42118209|FG008|Overall Study|Protocol Violation|1|||
19670257|NCT00535236|42118210|FG009|Overall Study|Protocol Violation|0|||
19670258|NCT00535236|42118201|FG000|Overall Study|Withdrawal by Subject|3|||
19670259|NCT00535236|42118202|FG001|Overall Study|Withdrawal by Subject|0|||
19757756|NCT03132636|42208426|FG001|Overall Study|Sponsor Decision|1|||
19757757|NCT03132636|42208425|FG000|Overall Study|Progressive disease|32|||
19757758|NCT03132636|42208426|FG001|Overall Study|Progressive disease|36|||
19757759|NCT03132636|42208425|FG000|Overall Study|Withdrawal of consent|2|||
19670260|NCT00535236|42118203|FG002|Overall Study|Withdrawal by Subject|2|||
19670261|NCT00535236|42118204|FG003|Overall Study|Withdrawal by Subject|1|||
19670262|NCT00535236|42118205|FG004|Overall Study|Withdrawal by Subject|6|||
19757760|NCT03132636|42208426|FG001|Overall Study|Withdrawal of consent|5|||
19670263|NCT00535236|42118206|FG005|Overall Study|Withdrawal by Subject|1|||
19670264|NCT00535236|42118207|FG006|Overall Study|Withdrawal by Subject|5|||
19670265|NCT00535236|42118208|FG007|Overall Study|Withdrawal by Subject|0|||
19670266|NCT00535236|42118209|FG008|Overall Study|Withdrawal by Subject|4|||
19670267|NCT00535236|42118210|FG009|Overall Study|Withdrawal by Subject|2|||
19670268|NCT00370552|42118238|FG000|Overall Study|Adverse Event|2|||
19670269|NCT00370552|42118239|FG001|Overall Study|Adverse Event|2|||
19670270|NCT00370552|42118240|FG002|Overall Study|Adverse Event|2|||
19670271|NCT00370552|42118238|FG000|Overall Study|Disease progression|23|||
19670272|NCT00370552|42118239|FG001|Overall Study|Disease progression|23|||
19670273|NCT00370552|42118240|FG002|Overall Study|Disease progression|15|||
19670274|NCT00370552|42118238|FG000|Overall Study|Maximum clinical benefit|3|||
19670275|NCT00370552|42118239|FG001|Overall Study|Maximum clinical benefit|5|||
19757761|NCT03132636|42208425|FG000|Overall Study|Study ongoing|9|||
19757762|NCT03132636|42208426|FG001|Overall Study|Study ongoing|10|||
19757763|NCT03132636|42208425|FG000|Overall Study|Other|1|||
19757764|NCT03132636|42208426|FG001|Overall Study|Other|2|||
19757765|NCT02713204|42208435|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
19757766|NCT02713204|42208436|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757767|NCT02713204|42208437|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
19757768|NCT02713204|42208438|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757769|NCT02713204|42208439|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757770|NCT02713204|42208440|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757771|NCT02713204|42208441|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757772|NCT02713204|42208442|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
19757773|NCT02713204|42208435|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757774|NCT02713204|42208436|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757775|NCT02713204|42208437|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
19757776|NCT02713204|42208438|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757777|NCT02713204|42208439|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757778|NCT02713204|42208440|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757779|NCT02713204|42208441|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757780|NCT02713204|42208442|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19757781|NCT02713204|42208435|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757782|NCT02713204|42208436|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
19757783|NCT02713204|42208437|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757784|NCT02713204|42208438|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757785|NCT02713204|42208439|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757786|NCT02713204|42208440|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757787|NCT02713204|42208441|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757788|NCT02713204|42208442|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19757789|NCT02713204|42208435|FG000|From Week 12 up to Week 36|Adverse Event|1|||
19757790|NCT02713204|42208436|FG001|From Week 12 up to Week 36|Adverse Event|0|||
19757791|NCT02713204|42208437|FG002|From Week 12 up to Week 36|Adverse Event|0|||
19757792|NCT02713204|42208438|FG003|From Week 12 up to Week 36|Adverse Event|1|||
19757793|NCT02713204|42208439|FG004|From Week 12 up to Week 36|Adverse Event|1|||
19757794|NCT02713204|42208440|FG005|From Week 12 up to Week 36|Adverse Event|0|||
19757795|NCT02713204|42208441|FG006|From Week 12 up to Week 36|Adverse Event|2|||
19757796|NCT02713204|42208442|FG007|From Week 12 up to Week 36|Adverse Event|1|||
19757797|NCT02713204|42208435|FG000|From Week 12 up to Week 36|Death|0|||
19757798|NCT02713204|42208436|FG001|From Week 12 up to Week 36|Death|0|||
19757799|NCT02713204|42208437|FG002|From Week 12 up to Week 36|Death|0|||
19757800|NCT02713204|42208438|FG003|From Week 12 up to Week 36|Death|1|||
19757801|NCT02713204|42208439|FG004|From Week 12 up to Week 36|Death|0|||
19757802|NCT02713204|42208440|FG005|From Week 12 up to Week 36|Death|1|||
19757803|NCT02713204|42208441|FG006|From Week 12 up to Week 36|Death|0|||
19757804|NCT02713204|42208442|FG007|From Week 12 up to Week 36|Death|3|||
19757805|NCT02713204|42208435|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757806|NCT02713204|42208436|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757807|NCT02713204|42208437|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757808|NCT02713204|42208438|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
19757809|NCT02713204|42208439|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757810|NCT02713204|42208440|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757811|NCT02713204|42208441|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757812|NCT02713204|42208442|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
19757813|NCT02713204|42208435|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
19757814|NCT02713204|42208436|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
19670276|NCT00370552|42118240|FG002|Overall Study|Maximum clinical benefit|5|||
19670277|NCT00370552|42118238|FG000|Overall Study|Poor or noncompliance|0|||
19757815|NCT02713204|42208437|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
19757816|NCT02713204|42208438|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
19757817|NCT02713204|42208439|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
19757818|NCT02713204|42208440|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
19670278|NCT00370552|42118239|FG001|Overall Study|Poor or noncompliance|0|||
19670279|NCT00370552|42118240|FG002|Overall Study|Poor or noncompliance|1|||
19670280|NCT00370552|42118238|FG000|Overall Study|Study drug toxicity|11|||
19670281|NCT00370552|42118239|FG001|Overall Study|Study drug toxicity|8|||
19670282|NCT00370552|42118240|FG002|Overall Study|Study drug toxicity|6|||
19670283|NCT00370552|42118238|FG000|Overall Study|Withdrawal by Subject|2|||
19670284|NCT00370552|42118239|FG001|Overall Study|Withdrawal by Subject|0|||
19670285|NCT00370552|42118240|FG002|Overall Study|Withdrawal by Subject|1|||
19670286|NCT00370552|42118238|FG000|Overall Study|Still on treatment|1|||
19670287|NCT00370552|42118239|FG001|Overall Study|Still on treatment|3|||
19670288|NCT00370552|42118240|FG002|Overall Study|Still on treatment|2|||
19670289|NCT00370552|42118238|FG000|Overall Study|Never treated|1|||
19670290|NCT00370552|42118239|FG001|Overall Study|Never treated|0|||
19670291|NCT00370552|42118240|FG002|Overall Study|Never treated|0|||
19670292|NCT00370552|42118238|FG000|Overall Study|Physician Decision|1|||
19670293|NCT00370552|42118239|FG001|Overall Study|Physician Decision|1|||
19670294|NCT00370552|42118240|FG002|Overall Study|Physician Decision|0|||
19670295|NCT00370552|42118238|FG000|Overall Study|Investigator decision|2|||
19670296|NCT00370552|42118239|FG001|Overall Study|Investigator decision|1|||
19670297|NCT00370552|42118240|FG002|Overall Study|Investigator decision|0|||
19670298|NCT00370552|42118238|FG000|Overall Study|High risk of allergic reaction|0|||
19670299|NCT00370552|42118239|FG001|Overall Study|High risk of allergic reaction|1|||
19670300|NCT00370552|42118240|FG002|Overall Study|High risk of allergic reaction|0|||
19670301|NCT00370552|42118238|FG000|Overall Study|Planned radiation for palliation|0|||
19670302|NCT00370552|42118239|FG001|Overall Study|Planned radiation for palliation|1|||
19670303|NCT00370552|42118240|FG002|Overall Study|Planned radiation for palliation|0|||
19670304|NCT00537030|42118248|FG000|Overall Study|Physician Decision|2|||
19670305|NCT00537030|42118248|FG000|Overall Study|Withdrawal by Subject|2|||
19670306|NCT00537030|42118248|FG000|Overall Study|≥ Grade 2 allergy|7|||
19670307|NCT00537030|42118248|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
19670308|NCT00537030|42118248|FG000|Overall Study|Ineligible|2|||
19670309|NCT00537030|42118248|FG000|Overall Study|Inevaluable|2|||
19757819|NCT02713204|42208441|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
19757820|NCT02713204|42208442|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
19757821|NCT03695172|42208462|FG000|Overall Study|Withdrawal by Subject|1|||
19670310|NCT00381238|42118252|FG000|Overall Study|Adverse Event|3|||
19670311|NCT00381238|42118252|FG000|Overall Study|Protocol Violation|1|||
19670312|NCT00381238|42118252|FG000|Overall Study|Withdrawal by Subject|4|||
19670313|NCT00381238|42118252|FG000|Overall Study|Lack of Efficacy|2|||
19670314|NCT00381238|42118252|FG000|Overall Study|Withdrew by physician|1|||
19670315|NCT00381238|42118252|FG000|Overall Study|Disease progression|1|||
19670316|NCT03896022|42118259|FG000|Overall Study|Withdrawal by Subject|1|||
19670317|NCT03896022|42118260|FG001|Overall Study|Withdrawal by Subject|0|||
19670318|NCT03896022|42118261|FG002|Overall Study|Withdrawal by Subject|0|||
19670319|NCT03896022|42118259|FG000|Overall Study|Did not have procedure|3|||
19670320|NCT03896022|42118260|FG001|Overall Study|Did not have procedure|0|||
19670321|NCT03896022|42118261|FG002|Overall Study|Did not have procedure|0|||
19670322|NCT03831880|42118273|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
19670323|NCT03831880|42118274|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
19670324|NCT03831880|42118273|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
19670325|NCT03831880|42118274|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
19670326|NCT00380692|42118297|FG000|Study Period II - Double Blind|Adverse Event|1|||
19670327|NCT00380692|42118298|FG001|Study Period II - Double Blind|Adverse Event|0|||
19670328|NCT00380692|42118297|FG000|Study Period II - Double Blind|Protocol Violation|2|||
19670329|NCT00380692|42118298|FG001|Study Period II - Double Blind|Protocol Violation|2|||
19670330|NCT00380692|42118297|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
19670331|NCT00380692|42118298|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
19670332|NCT00380692|42118297|FG000|Study Period II - Double Blind|Physician Decision|0|||
19670333|NCT00380692|42118298|FG001|Study Period II - Double Blind|Physician Decision|1|||
19670334|NCT00380692|42118297|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
19670335|NCT00380692|42118298|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
19670336|NCT00380692|42118297|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
19670337|NCT00380692|42118298|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
19670338|NCT00380692|42118297|FG000|Study Period III - Open Label|Adverse Event|5|||
19670339|NCT00380692|42118298|FG001|Study Period III - Open Label|Adverse Event|3|||
19670340|NCT00380692|42118297|FG000|Study Period III - Open Label|Protocol Violation|0|||
19670341|NCT00380692|42118298|FG001|Study Period III - Open Label|Protocol Violation|0|||
19670342|NCT00380692|42118297|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
19670343|NCT00380692|42118298|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
19670344|NCT00380692|42118297|FG000|Study Period III - Open Label|Physician Decision|0|||
19670345|NCT00380692|42118298|FG001|Study Period III - Open Label|Physician Decision|3|||
19670346|NCT00380692|42118297|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
19757822|NCT03695172|42208463|FG001|Overall Study|Withdrawal by Subject|1|||
19757823|NCT03695172|42208464|FG002|Overall Study|Withdrawal by Subject|0|||
19670347|NCT00380692|42118298|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
19670348|NCT00380692|42118297|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
19670349|NCT00380692|42118298|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
19670350|NCT00536874|42118304|FG000|Overall Study|Adverse Event|1|||
19670351|NCT00536874|42118304|FG000|Overall Study|Death|2|||
19670352|NCT00536874|42118304|FG000|Overall Study|Withdrawal by Subject|1|||
19670353|NCT00380068|42118308|FG000|Overall Study|Adverse Event|40|||
19670354|NCT00380068|42118308|FG000|Overall Study|Withdrawal by Subject|10|||
19670355|NCT00380068|42118308|FG000|Overall Study|Not compliant|6|||
19670356|NCT00380068|42118308|FG000|Overall Study|Lost to Follow-up|1|||
19670357|NCT00380068|42118308|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
19670358|NCT00380068|42118308|FG000|Overall Study|Lung transplant|3|||
19670359|NCT00380068|42118308|FG000|Overall Study|Physician Decision|2|||
19670360|NCT00380068|42118308|FG000|Overall Study|Partipant moved away|1|||
19670361|NCT00380068|42118308|FG000|Overall Study|Lack of Efficacy|5|||
19670362|NCT00536484|42118314|FG000|Overall Study|Adverse Event|21|||
19670363|NCT00536484|42118315|FG001|Overall Study|Adverse Event|34|||
19670364|NCT00536484|42118314|FG000|Overall Study|Withdrawal by Subject|11|||
19670365|NCT00536484|42118315|FG001|Overall Study|Withdrawal by Subject|11|||
19670366|NCT00536484|42118314|FG000|Overall Study|Lost to Follow-up|8|||
19757824|NCT03721107|42208476|FG000|Overall Study|Adverse Event|1|||
19670367|NCT00536484|42118315|FG001|Overall Study|Lost to Follow-up|6|||
19670368|NCT00536484|42118314|FG000|Overall Study|Lack of Efficacy|16|||
19670369|NCT00536484|42118315|FG001|Overall Study|Lack of Efficacy|5|||
19757825|NCT03721107|42208477|FG001|Overall Study|Adverse Event|1|||
19670370|NCT00536484|42118314|FG000|Overall Study|Other|4|||
19670371|NCT00536484|42118315|FG001|Overall Study|Other|0|||
19757826|NCT03721107|42208478|FG002|Overall Study|Adverse Event|6|||
19757827|NCT03721107|42208479|FG003|Overall Study|Adverse Event|5|||
19757828|NCT03721107|42208476|FG000|Overall Study|Lost to Follow-up|2|||
19757829|NCT03721107|42208477|FG001|Overall Study|Lost to Follow-up|0|||
19757830|NCT03721107|42208478|FG002|Overall Study|Lost to Follow-up|3|||
19757831|NCT03721107|42208479|FG003|Overall Study|Lost to Follow-up|0|||
19757832|NCT03721107|42208476|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
19757833|NCT03721107|42208477|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
19757834|NCT03721107|42208478|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
19757835|NCT03721107|42208479|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
19757836|NCT03721107|42208476|FG000|Overall Study|Physician Decision|0|||
19757837|NCT03721107|42208477|FG001|Overall Study|Physician Decision|1|||
19757838|NCT03721107|42208478|FG002|Overall Study|Physician Decision|0|||
19757839|NCT03721107|42208479|FG003|Overall Study|Physician Decision|0|||
19757840|NCT03721107|42208476|FG000|Overall Study|Pregnancy|0|||
19603450|NCT00753688|42052390|FG000|Overall Study|Participant Withdrew Consent|2|||
19603451|NCT00753688|42052391|FG001|Overall Study|Participant Withdrew Consent|2|||
19603452|NCT00753688|42052390|FG000|Overall Study|Ongoing - in Follow-up|15|||
19603453|NCT00753688|42052391|FG001|Overall Study|Ongoing - in Follow-up|31|||
19603454|NCT00753688|42052390|FG000|Overall Study|Adverse Event|0|||
19603455|NCT00753688|42052391|FG001|Overall Study|Adverse Event|1|||
19603456|NCT00586612|42052399|FG000|Primary Phase|Protocol Violation|1|||
19603457|NCT00586612|42052400|FG001|Primary Phase|Protocol Violation|0|||
19603458|NCT00586612|42052399|FG000|Primary Phase|Lost to Follow-up|0|||
19603459|NCT00586612|42052400|FG001|Primary Phase|Lost to Follow-up|1|||
19603460|NCT00586612|42052399|FG000|Primary Phase|Withdrawal by Subject|0|||
19603461|NCT00586612|42052400|FG001|Primary Phase|Withdrawal by Subject|2|||
19603462|NCT00586612|42052399|FG000|Booster Phase|Lost to Follow-up|3|||
19603463|NCT00586612|42052400|FG001|Booster Phase|Lost to Follow-up|1|||
19603464|NCT00586690|42052408|FG000|Overall Study|Death|2|||
19603465|NCT00586690|42052409|FG001|Overall Study|Death|0|||
19670372|NCT00370396|42118324|FG000|Overall Study|Withdrawal by Subject|0|||
19670373|NCT00370396|42118325|FG001|Overall Study|Withdrawal by Subject|0|||
19603466|NCT00586690|42052408|FG000|Overall Study|Disease Progression|10|||
19670374|NCT00370396|42118326|FG002|Overall Study|Withdrawal by Subject|1|||
19670375|NCT00370396|42118324|FG000|Overall Study|Lost to Follow-up|11|||
19670376|NCT00370396|42118325|FG001|Overall Study|Lost to Follow-up|1|||
19757841|NCT03721107|42208477|FG001|Overall Study|Pregnancy|0|||
19757842|NCT03721107|42208478|FG002|Overall Study|Pregnancy|1|||
19757843|NCT03721107|42208479|FG003|Overall Study|Pregnancy|0|||
19757844|NCT03721107|42208476|FG000|Overall Study|Withdrawal by Subject|1|||
19757845|NCT03721107|42208477|FG001|Overall Study|Withdrawal by Subject|1|||
19757846|NCT03721107|42208478|FG002|Overall Study|Withdrawal by Subject|5|||
19757847|NCT03721107|42208479|FG003|Overall Study|Withdrawal by Subject|5|||
19757848|NCT03721107|42208476|FG000|Overall Study|Other|1|||
19757849|NCT03721107|42208477|FG001|Overall Study|Other|0|||
19757850|NCT03721107|42208478|FG002|Overall Study|Other|0|||
19757851|NCT03721107|42208479|FG003|Overall Study|Other|1|||
19757852|NCT03052920|42208498|FG000|Overall Study|Withdrawal by Subject|1|||
19757853|NCT02930226|42208508|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
19757854|NCT02930226|42208509|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
19757855|NCT02930226|42208510|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
19757856|NCT02930226|42208511|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
19757857|NCT02930226|42208512|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
19757858|NCT02930226|42208513|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
19757859|NCT02722434|42208550|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
19757860|NCT02722434|42208551|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
19757861|NCT02722434|42208550|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
19757862|NCT02722434|42208551|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
19670377|NCT00370396|42118326|FG002|Overall Study|Lost to Follow-up|0|||
19670378|NCT00455013|42118337|FG000|Short Term Period|Adverse Event|2|||
19670379|NCT00455013|42118338|FG001|Short Term Period|Adverse Event|5|||
19670380|NCT00455013|42118339|FG002|Short Term Period|Adverse Event|0|||
19670381|NCT00455013|42118337|FG000|Short Term Period|Withdrawal by Subject|0|||
19670382|NCT00455013|42118338|FG001|Short Term Period|Withdrawal by Subject|0|||
19670383|NCT00455013|42118339|FG002|Short Term Period|Withdrawal by Subject|1|||
19670384|NCT00455013|42118337|FG000|Short Term Period|Lack of Efficacy|4|||
19670385|NCT00455013|42118338|FG001|Short Term Period|Lack of Efficacy|0|||
19603467|NCT00586690|42052409|FG001|Overall Study|Disease Progression|0|||
19603468|NCT00586690|42052408|FG000|Overall Study|Adverse Event|1|||
19603469|NCT00586690|42052409|FG001|Overall Study|Adverse Event|0|||
19603470|NCT00586690|42052408|FG000|Overall Study|Lack of Efficacy|2|||
19603471|NCT00586690|42052409|FG001|Overall Study|Lack of Efficacy|0|||
19603472|NCT00586690|42052408|FG000|Overall Study|Lab can't accommodate|1|||
19603473|NCT00586690|42052409|FG001|Overall Study|Lab can't accommodate|0|||
19757863|NCT03539601|42208561|FG000|Overall Study|Withdraw by parent/guardian|1|||
19603474|NCT00976820|42052418|FG000|Overall Study|Lost to Follow-up|5|||
19603475|NCT00976820|42052419|FG001|Overall Study|Lost to Follow-up|16|||
19670386|NCT00455013|42118339|FG002|Short Term Period|Lack of Efficacy|0|||
19603476|NCT00976820|42052420|FG002|Overall Study|Lost to Follow-up|2|||
19603477|NCT00976820|42052421|FG003|Overall Study|Lost to Follow-up|3|||
19603478|NCT00976820|42052418|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
19603479|NCT00976820|42052419|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
19603480|NCT00976820|42052420|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
19603481|NCT00976820|42052421|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
19603482|NCT00976820|42052418|FG000|Overall Study|Withdrawal by Subject|2|||
19603483|NCT00976820|42052419|FG001|Overall Study|Withdrawal by Subject|4|||
19603484|NCT00976820|42052420|FG002|Overall Study|Withdrawal by Subject|1|||
19603485|NCT00976820|42052421|FG003|Overall Study|Withdrawal by Subject|4|||
19603486|NCT00760474|42052472|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
19603487|NCT00760474|42052473|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
19603488|NCT00760474|42052472|FG000|Placebo Washout Period|Other|0|||
19603489|NCT00760474|42052473|FG001|Placebo Washout Period|Other|1|||
19603490|NCT00760474|42052472|FG000|Period 2 (P2)|Lost to Follow-up|1|||
19603491|NCT00760474|42052473|FG001|Period 2 (P2)|Lost to Follow-up|0|||
19603492|NCT00760474|42052472|FG000|Period 2 (P2)|Adverse Event|0|||
19603493|NCT00760474|42052473|FG001|Period 2 (P2)|Adverse Event|1|||
19603494|NCT00975416|42052482|FG000|Overall Study|early discharge from tx|3|||
19603495|NCT00975416|42052483|FG001|Overall Study|early discharge from tx|5|||
19603496|NCT00760084|42052490|FG000|Overall Study|Physician Decision|5|||
19603497|NCT00760084|42052490|FG000|Overall Study|Withdrawal by Subject|2|||
19603498|NCT00760084|42052490|FG000|Overall Study|Progressive Disease|3|||
19603499|NCT00752206|42052496|FG000|Overall Study|Disease progression|8|||
19603500|NCT00752206|42052497|FG001|Overall Study|Disease progression|11|||
19603501|NCT00752206|42052496|FG000|Overall Study|Pregnancy|1|||
19603502|NCT00752206|42052497|FG001|Overall Study|Pregnancy|0|||
19603503|NCT00752128|42052503|FG000|Overall Study|Withdrawal by Subject|4|||
19603504|NCT00976508|42052510|FG000|Overall Study|Death|7|||
19603505|NCT00976508|42052511|FG001|Overall Study|Death|1|||
19757864|NCT03539601|42208562|FG001|Overall Study|Withdraw by parent/guardian|0|||
19757865|NCT03539601|42208563|FG002|Overall Study|Withdraw by parent/guardian|1|||
19757866|NCT03539601|42208564|FG003|Overall Study|Withdraw by parent/guardian|0|||
19757867|NCT03539601|42208561|FG000|Overall Study|Adverse Event|0|||
19757868|NCT03539601|42208562|FG001|Overall Study|Adverse Event|2|||
19757869|NCT03539601|42208563|FG002|Overall Study|Adverse Event|0|||
19757870|NCT03539601|42208564|FG003|Overall Study|Adverse Event|0|||
19757871|NCT03539601|42208561|FG000|Overall Study|Lost to Follow-up|2|||
19757872|NCT03539601|42208562|FG001|Overall Study|Lost to Follow-up|4|||
19757873|NCT03539601|42208563|FG002|Overall Study|Lost to Follow-up|5|||
19757874|NCT03539601|42208564|FG003|Overall Study|Lost to Follow-up|0|||
19757875|NCT03539601|42208561|FG000|Overall Study|Withdrawal by Subject|2|||
19757876|NCT03539601|42208562|FG001|Overall Study|Withdrawal by Subject|0|||
19757877|NCT03539601|42208563|FG002|Overall Study|Withdrawal by Subject|0|||
19757878|NCT03539601|42208564|FG003|Overall Study|Withdrawal by Subject|1|||
19757879|NCT03539601|42208561|FG000|Overall Study|Randomized but not treated|1|||
19757880|NCT03539601|42208562|FG001|Overall Study|Randomized but not treated|1|||
19603506|NCT00976508|42052510|FG000|Overall Study|Lost to Follow-up|1|||
19603507|NCT00976508|42052511|FG001|Overall Study|Lost to Follow-up|0|||
19757881|NCT03539601|42208563|FG002|Overall Study|Randomized but not treated|0|||
19757882|NCT03539601|42208564|FG003|Overall Study|Randomized but not treated|0|||
19757883|NCT00700804|42208584|FG000|Overall Study|Withdrawal by Subject|1|||
19757884|NCT00700804|42208585|FG001|Overall Study|Withdrawal by Subject|2|||
19757885|NCT00700804|42208584|FG000|Overall Study|Protocol Violation|1|||
19757886|NCT00700804|42208585|FG001|Overall Study|Protocol Violation|1|||
19757887|NCT00700804|42208584|FG000|Overall Study|Loose Stools|1|||
19757888|NCT00700804|42208585|FG001|Overall Study|Loose Stools|1|||
19757889|NCT02903823|42208591|FG000|Overall Study|Physician Decision|5|||
19757890|NCT02903823|42208591|FG000|Overall Study|Could not advance catheter|1|||
19757891|NCT02903823|42208591|FG000|Overall Study|Catheter dislodgement|1|||
19757892|NCT00832455|42208620|FG000|Overall Study|Adverse Event|13|||
19757893|NCT00832455|42208620|FG000|Overall Study|Lost to Follow-up|26|||
19757894|NCT00832455|42208620|FG000|Overall Study|Protocol Violation|4|||
19757895|NCT00832455|42208620|FG000|Overall Study|Withdrawal by Subject|17|||
19757896|NCT00832455|42208620|FG000|Overall Study|Screening Failure|2|||
19757897|NCT00832455|42208620|FG000|Overall Study|Stopped Medication|4|||
19757898|NCT00832455|42208620|FG000|Overall Study|Parent misunderstood study|1|||
19757899|NCT00832455|42208620|FG000|Overall Study|Parent dissatisfied|1|||
19757900|NCT00832455|42208620|FG000|Overall Study|No improvement|3|||
19757901|NCT00832455|42208620|FG000|Overall Study|Patient moved|1|||
19757902|NCT00687531|42208633|FG000|Overall Study|Did not meet protocol eligibility|104|||
19757903|NCT00687531|42208633|FG000|Overall Study|Adverse Event|5|||
19757904|NCT00687531|42208633|FG000|Overall Study|Lost to Follow-up|26|||
19757905|NCT00423579|42208639|FG000|Overall Study|Lost to Follow-up|3|||
19757906|NCT00423579|42208640|FG001|Overall Study|Lost to Follow-up|0|||
19757907|NCT00423579|42208639|FG000|Overall Study|Protocol Violation|1|||
19757908|NCT00423579|42208640|FG001|Overall Study|Protocol Violation|3|||
19757909|NCT00423579|42208639|FG000|Overall Study|Diagnosis of diabetes|0|||
19757910|NCT00423579|42208640|FG001|Overall Study|Diagnosis of diabetes|1|||
19757911|NCT03268005|42208648|FG000|Overall Study|Death|2|||
19757912|NCT03268005|42208649|FG001|Overall Study|Death|1|||
19757913|NCT03268005|42208648|FG000|Overall Study|Lost to Follow-up|2|||
19757914|NCT03268005|42208649|FG001|Overall Study|Lost to Follow-up|2|||
19670387|NCT00455013|42118337|FG000|Short Term Period|Other|0|||
19670388|NCT00455013|42118338|FG001|Short Term Period|Other|0|||
19670389|NCT00455013|42118339|FG002|Short Term Period|Other|1|||
19670390|NCT00455013|42118337|FG000|Long Term Extension (LTE)|Adverse Event|0|||
19670391|NCT00455013|42118338|FG001|Long Term Extension (LTE)|Adverse Event|1|||
19670392|NCT00455013|42118339|FG002|Long Term Extension (LTE)|Adverse Event|1|||
19670393|NCT00455013|42118337|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
19670394|NCT00455013|42118338|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
19670395|NCT00455013|42118339|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
19670396|NCT00455013|42118337|FG000|Long Term Extension (LTE)|Death|1|||
19670397|NCT00455013|42118338|FG001|Long Term Extension (LTE)|Death|1|||
19670398|NCT00455013|42118339|FG002|Long Term Extension (LTE)|Death|0|||
19670399|NCT00455013|42118337|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
19670400|NCT00455013|42118338|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
19670401|NCT00455013|42118339|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
19670402|NCT00455013|42118337|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
19670403|NCT00455013|42118338|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
19670404|NCT00455013|42118339|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
19670405|NCT00455013|42118337|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
19670406|NCT00455013|42118338|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
19670407|NCT00455013|42118339|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
19670408|NCT00455013|42118337|FG000|Long Term Extension (LTE)|non-specified|0|||
19670409|NCT00455013|42118338|FG001|Long Term Extension (LTE)|non-specified|0|||
19670410|NCT00455013|42118339|FG002|Long Term Extension (LTE)|non-specified|1|||
19670411|NCT00363298|42118349|FG000|First Study Week|Lack of Efficacy|6|||
19670412|NCT00363298|42118350|FG001|First Study Week|Lack of Efficacy|5|||
19670413|NCT00363298|42118349|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
19670414|NCT00363298|42118350|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
19670415|NCT00363142|42118359|FG000|Overall Study|Adverse Event|2|||
19670416|NCT00363142|42118360|FG001|Overall Study|Adverse Event|0|||
19670417|NCT00363142|42118359|FG000|Overall Study|Lack of Efficacy|0|||
19670418|NCT00363142|42118360|FG001|Overall Study|Lack of Efficacy|1|||
19670419|NCT00363142|42118359|FG000|Overall Study|Lost to Follow-up|1|||
19670420|NCT00363142|42118360|FG001|Overall Study|Lost to Follow-up|0|||
19670421|NCT00363142|42118359|FG000|Overall Study|Non-compliance|1|||
19670422|NCT00363142|42118360|FG001|Overall Study|Non-compliance|1|||
19670423|NCT00363142|42118359|FG000|Overall Study|Withdrawal by Subject|3|||
19670424|NCT00363142|42118360|FG001|Overall Study|Withdrawal by Subject|1|||
19670425|NCT00454857|42118369|FG000|Overall Study|Withdrawal by Subject|15|||
19670426|NCT00454857|42118369|FG000|Overall Study|Lost to Follow-up|16|||
19757915|NCT03268005|42208648|FG000|Overall Study|Withdrawal by Subject|11|||
19757916|NCT03268005|42208649|FG001|Overall Study|Withdrawal by Subject|11|||
19757917|NCT03149055|42208655|FG000|Overall Study|Not treated|4|||
19757918|NCT03137121|42208670|FG000|Overall Study|Withdrawal by Subject|0|||
19670427|NCT00454857|42118369|FG000|Overall Study|Noncompliance|6|||
19670428|NCT00454857|42118369|FG000|Overall Study|Death|5|||
19670429|NCT00454857|42118369|FG000|Overall Study|Other|11|||
19670430|NCT00454857|42118369|FG000|Overall Study|Reason unknown|1|||
19670431|NCT00379912|42118375|FG000|Overall Study|Lack of Efficacy|1|||
19670432|NCT00379912|42118376|FG001|Overall Study|Lack of Efficacy|0|||
19670433|NCT00379834|42118388|FG000|Overall Study|Time constraints|2|||
19670434|NCT00379210|42118394|FG000|Overall Study|Withdrawal by Subject|10|||
19670435|NCT00379210|42118395|FG001|Overall Study|Withdrawal by Subject|7|||
19670436|NCT00378898|42118403|FG000|Overall Study|Withdrawal by Subject|10|||
19670437|NCT00378898|42118404|FG001|Overall Study|Withdrawal by Subject|5|||
19670438|NCT00378898|42118403|FG000|Overall Study|Protocol Violation|1|||
19670439|NCT00378898|42118404|FG001|Overall Study|Protocol Violation|1|||
19670440|NCT00378508|42118414|FG000|Overall Study|Withdrawal by Subject|1|||
19670441|NCT00378508|42118415|FG001|Overall Study|Withdrawal by Subject|3|||
19670442|NCT00378508|42118414|FG000|Overall Study|Lost to Follow-up|1|||
19670443|NCT00378508|42118415|FG001|Overall Study|Lost to Follow-up|0|||
19670444|NCT00454779|42118424|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
19670445|NCT00454779|42118425|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
19670446|NCT00454779|42118424|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
19670447|NCT00454779|42118425|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
19670448|NCT00454779|42118424|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
19670449|NCT00454779|42118425|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
19670450|NCT00454779|42118424|FG000|First-line Treatment Phase|Protocol Violation|0|||
19670451|NCT00454779|42118425|FG001|First-line Treatment Phase|Protocol Violation|1|||
19757919|NCT03137121|42208671|FG001|Overall Study|Withdrawal by Subject|1|||
19757920|NCT00700570|42208714|FG000|Overall Study|Adverse Event|2|||
19757921|NCT00700570|42208715|FG001|Overall Study|Adverse Event|6|||
19757922|NCT00700570|42208714|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
19757923|NCT00700570|42208715|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
19757924|NCT00700570|42208714|FG000|Overall Study|Disease Progression|8|||
19757925|NCT00700570|42208715|FG001|Overall Study|Disease Progression|11|||
19757926|NCT00700570|42208714|FG000|Overall Study|Withdrawal by Subject|1|||
19670452|NCT00454779|42118424|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
19670453|NCT00454779|42118425|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
19670454|NCT00454779|42118424|FG000|First-line Treatment Phase|Ongoing|1|||
19670455|NCT00454779|42118425|FG001|First-line Treatment Phase|Ongoing|0|||
19670456|NCT00454779|42118424|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
19603508|NCT00976508|42052510|FG000|Overall Study|Withdrawal by Subject|1|||
19603509|NCT00976508|42052511|FG001|Overall Study|Withdrawal by Subject|0|||
19603510|NCT00976508|42052510|FG000|Overall Study|Disease Progression|4|||
19603511|NCT00976508|42052511|FG001|Overall Study|Disease Progression|4|||
19603512|NCT00976508|42052510|FG000|Overall Study|Subject Enrolled in Hospice|1|||
19603513|NCT00976508|42052511|FG001|Overall Study|Subject Enrolled in Hospice|0|||
19603514|NCT00976508|42052510|FG000|Overall Study|Terminated by the Sponsor|0|||
19603515|NCT00976508|42052511|FG001|Overall Study|Terminated by the Sponsor|1|||
19603516|NCT00973622|42052522|FG000|Overall Study|did not attend MRI|14|||
19603517|NCT00973622|42052523|FG001|Overall Study|did not attend MRI|3|||
19603518|NCT00973622|42052522|FG000|Overall Study|did not pass MRI screen|6|||
19603519|NCT00973622|42052523|FG001|Overall Study|did not pass MRI screen|0|||
19603520|NCT00973622|42052522|FG000|Overall Study|did not complete rTMS sessions|11|||
19603521|NCT00973622|42052523|FG001|Overall Study|did not complete rTMS sessions|2|||
19603522|NCT04044716|42052531|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
19603523|NCT04044716|42052532|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
19603524|NCT04044716|42052533|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
19603525|NCT04044716|42052531|FG000|Overall Study|Lost to Follow-up|2|||
19603526|NCT04044716|42052532|FG001|Overall Study|Lost to Follow-up|3|||
19603527|NCT04044716|42052533|FG002|Overall Study|Lost to Follow-up|0|||
19603528|NCT00753454|42052540|FG000|Overall Study|Adverse Event|4|||
19603529|NCT00753454|42052540|FG000|Overall Study|Lack of Efficacy|1|||
19603530|NCT00753454|42052540|FG000|Overall Study|Lost to Follow-up|3|||
19603531|NCT00753454|42052540|FG000|Overall Study|Withdrawal by Subject|5|||
19603532|NCT00753454|42052540|FG000|Overall Study|Investigator Decision|1|||
19603533|NCT00976274|42052546|FG000|Overall Study|Lost to Follow-up|5|||
19670457|NCT00454779|42118425|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
19670458|NCT00454779|42118424|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
19757927|NCT00700570|42208715|FG001|Overall Study|Withdrawal by Subject|6|||
19670459|NCT00454779|42118425|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
19670460|NCT00454779|42118424|FG000|Second-line Treatment Phase|Ongoing|0|||
19670461|NCT00454779|42118425|FG001|Second-line Treatment Phase|Ongoing|1|||
19389001|NCT02679755|41632549|FG000|Overall Study|Objective progression or relapse|24|||
19389002|NCT02679755|41632550|FG001|Overall Study|Objective progression or relapse|83|||
19389003|NCT02679755|41632549|FG000|Overall Study|Not defined|0|||
19389004|NCT02679755|41632550|FG001|Overall Study|Not defined|2|||
19670462|NCT00439569|42118431|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
19389005|NCT02679755|41632549|FG000|Overall Study|Withdrawal by participant|6|||
19670463|NCT00439569|42118431|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
19670464|NCT00439569|42118431|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
19389006|NCT02679755|41632550|FG001|Overall Study|Withdrawal by participant|3|||
19389007|NCT02679755|41632549|FG000|Overall Study|Adverse Event|1|||
19389008|NCT02679755|41632550|FG001|Overall Study|Adverse Event|4|||
19389009|NCT02679755|41632549|FG000|Overall Study|Adverse events not related to study drug|1|||
19389010|NCT02679755|41632550|FG001|Overall Study|Adverse events not related to study drug|2|||
19389011|NCT02675231|41632562|FG000|Overall Study|Withdrawal by Subject|1|||
19389012|NCT02675231|41632563|FG001|Overall Study|Withdrawal by Subject|3|||
19389013|NCT02675231|41632564|FG002|Overall Study|Withdrawal by Subject|1|||
19670465|NCT00443079|42118437|FG000|Overall Study|Lost to Follow-up|0|||
19670466|NCT00443079|42118438|FG001|Overall Study|Lost to Follow-up|1|||
19670467|NCT00427635|42118474|FG000|Treatment Phase|Withdrawal by Subject|1|||
19670468|NCT00427635|42118475|FG001|Treatment Phase|Withdrawal by Subject|0|||
19670469|NCT00427635|42118474|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
19670470|NCT00427635|42118475|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
19670471|NCT00427011|42118481|FG000|Overall Study|Adverse Event|10|||
19670472|NCT00427011|42118481|FG000|Overall Study|Withdrawal by Subject|1|||
19670473|NCT00427011|42118481|FG000|Overall Study|Lack of Efficacy|2|||
19670474|NCT00427011|42118481|FG000|Overall Study|Other|12|||
19670475|NCT03891264|42118486|FG000|Overall Study|Adverse Event|1|||
19670476|NCT03891264|42118486|FG000|Overall Study|Withdrawal by Subject|2|||
19670477|NCT03891264|42118486|FG000|Overall Study|Physician Decision|2|||
19670478|NCT00439179|42118494|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
19757928|NCT04427501|42208740|FG000|Overall Study|Death|0|||
19757929|NCT04427501|42208741|FG001|Overall Study|Death|0|||
19757930|NCT04427501|42208742|FG002|Overall Study|Death|0|||
19757931|NCT04427501|42208743|FG003|Overall Study|Death|0|||
19757932|NCT04427501|42208744|FG004|Overall Study|Death|0|||
19757933|NCT04427501|42208745|FG005|Overall Study|Death|15|||
19757934|NCT04427501|42208746|FG006|Overall Study|Death|0|||
19757935|NCT04427501|42208747|FG007|Overall Study|Death|0|||
19757936|NCT04427501|42208748|FG008|Overall Study|Death|0|||
19757937|NCT04427501|42208749|FG009|Overall Study|Death|0|||
19757938|NCT04427501|42208740|FG000|Overall Study|Lost to Follow-up|5|||
19757939|NCT04427501|42208741|FG001|Overall Study|Lost to Follow-up|1|||
19757940|NCT04427501|42208742|FG002|Overall Study|Lost to Follow-up|2|||
19670479|NCT00439179|42118495|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
19670480|NCT00439179|42118496|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
19670481|NCT00439179|42118497|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
19670482|NCT00438633|42118512|FG000|Overall Study|Withdrawal by Subject|1|||
19670483|NCT00438633|42118513|FG001|Overall Study|Withdrawal by Subject|0|||
19670484|NCT00438633|42118512|FG000|Overall Study|Lost to Follow-up|15|||
19670485|NCT00438633|42118513|FG001|Overall Study|Lost to Follow-up|17|||
19670486|NCT00438399|42118522|FG000|Overall Study|Lost to Follow-up|2|||
19670487|NCT00438399|42118523|FG001|Overall Study|Lost to Follow-up|2|||
19670488|NCT00438399|42118524|FG002|Overall Study|Lost to Follow-up|1|||
19670489|NCT00438399|42118525|FG003|Overall Study|Lost to Follow-up|1|||
19670490|NCT00438399|42118526|FG004|Overall Study|Lost to Follow-up|1|||
19670491|NCT00438399|42118527|FG005|Overall Study|Lost to Follow-up|1|||
19670492|NCT00438399|42118522|FG000|Overall Study|Adverse Event|0|||
19670493|NCT00438399|42118523|FG001|Overall Study|Adverse Event|0|||
19670494|NCT00438399|42118524|FG002|Overall Study|Adverse Event|1|||
19670495|NCT00438399|42118525|FG003|Overall Study|Adverse Event|1|||
19670496|NCT00438399|42118526|FG004|Overall Study|Adverse Event|0|||
19670497|NCT00438399|42118527|FG005|Overall Study|Adverse Event|1|||
19670498|NCT00438399|42118522|FG000|Overall Study|Withdrawal by Subject|5|||
19670499|NCT00438399|42118523|FG001|Overall Study|Withdrawal by Subject|6|||
19670500|NCT00438399|42118524|FG002|Overall Study|Withdrawal by Subject|3|||
19670501|NCT00438399|42118525|FG003|Overall Study|Withdrawal by Subject|2|||
19670502|NCT00438399|42118526|FG004|Overall Study|Withdrawal by Subject|2|||
19670503|NCT00438399|42118527|FG005|Overall Study|Withdrawal by Subject|2|||
19670504|NCT00438399|42118522|FG000|Overall Study|Protocol Violation|0|||
19670505|NCT00438399|42118523|FG001|Overall Study|Protocol Violation|0|||
19670506|NCT00438399|42118524|FG002|Overall Study|Protocol Violation|1|||
19670507|NCT00438399|42118525|FG003|Overall Study|Protocol Violation|0|||
19670508|NCT00438399|42118526|FG004|Overall Study|Protocol Violation|0|||
19670509|NCT00438399|42118527|FG005|Overall Study|Protocol Violation|1|||
19670510|NCT00438399|42118522|FG000|Overall Study|Subje stopped study|0|||
19670511|NCT00438399|42118523|FG001|Overall Study|Subje stopped study|0|||
19670512|NCT00438399|42118524|FG002|Overall Study|Subje stopped study|1|||
19757941|NCT04427501|42208743|FG003|Overall Study|Lost to Follow-up|0|||
19670513|NCT00438399|42118525|FG003|Overall Study|Subje stopped study|0|||
19670514|NCT00438399|42118526|FG004|Overall Study|Subje stopped study|0|||
19670515|NCT00438399|42118527|FG005|Overall Study|Subje stopped study|0|||
19670516|NCT00438399|42118522|FG000|Overall Study|Pregnancy|0|||
19670517|NCT00438399|42118523|FG001|Overall Study|Pregnancy|0|||
19670518|NCT00438399|42118524|FG002|Overall Study|Pregnancy|0|||
19757942|NCT04427501|42208744|FG004|Overall Study|Lost to Follow-up|2|||
19757943|NCT04427501|42208745|FG005|Overall Study|Lost to Follow-up|11|||
19670519|NCT00438399|42118525|FG003|Overall Study|Pregnancy|0|||
19670520|NCT00438399|42118526|FG004|Overall Study|Pregnancy|0|||
19670521|NCT00438399|42118527|FG005|Overall Study|Pregnancy|1|||
19670522|NCT00438399|42118522|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
19670523|NCT00438399|42118523|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
19670524|NCT00438399|42118524|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
19757944|NCT04427501|42208746|FG006|Overall Study|Lost to Follow-up|10|||
19757945|NCT04427501|42208747|FG007|Overall Study|Lost to Follow-up|10|||
19757946|NCT04427501|42208748|FG008|Overall Study|Lost to Follow-up|2|||
19757947|NCT04427501|42208749|FG009|Overall Study|Lost to Follow-up|5|||
19757948|NCT04427501|42208740|FG000|Overall Study|Physician Decision|0|||
19757949|NCT04427501|42208741|FG001|Overall Study|Physician Decision|3|||
19757950|NCT04427501|42208742|FG002|Overall Study|Physician Decision|0|||
19757951|NCT04427501|42208743|FG003|Overall Study|Physician Decision|0|||
19757952|NCT04427501|42208744|FG004|Overall Study|Physician Decision|0|||
19757953|NCT04427501|42208745|FG005|Overall Study|Physician Decision|0|||
19757954|NCT04427501|42208746|FG006|Overall Study|Physician Decision|2|||
19757955|NCT04427501|42208747|FG007|Overall Study|Physician Decision|0|||
19757956|NCT04427501|42208748|FG008|Overall Study|Physician Decision|0|||
19757957|NCT04427501|42208749|FG009|Overall Study|Physician Decision|0|||
19757958|NCT04427501|42208740|FG000|Overall Study|Withdrawal by Subject|9|||
19757959|NCT04427501|42208741|FG001|Overall Study|Withdrawal by Subject|2|||
19757960|NCT04427501|42208742|FG002|Overall Study|Withdrawal by Subject|2|||
19757961|NCT04427501|42208743|FG003|Overall Study|Withdrawal by Subject|3|||
19757962|NCT04427501|42208744|FG004|Overall Study|Withdrawal by Subject|7|||
19757963|NCT04427501|42208745|FG005|Overall Study|Withdrawal by Subject|25|||
19757964|NCT04427501|42208746|FG006|Overall Study|Withdrawal by Subject|15|||
19757965|NCT04427501|42208747|FG007|Overall Study|Withdrawal by Subject|7|||
19757966|NCT04427501|42208748|FG008|Overall Study|Withdrawal by Subject|4|||
19757967|NCT04427501|42208749|FG009|Overall Study|Withdrawal by Subject|1|||
19757968|NCT04427501|42208740|FG000|Overall Study|Other - as reported by the investigator|1|||
19757969|NCT04427501|42208741|FG001|Overall Study|Other - as reported by the investigator|0|||
19757970|NCT04427501|42208742|FG002|Overall Study|Other - as reported by the investigator|0|||
19757971|NCT04427501|42208743|FG003|Overall Study|Other - as reported by the investigator|0|||
19757972|NCT04427501|42208744|FG004|Overall Study|Other - as reported by the investigator|0|||
19757973|NCT04427501|42208745|FG005|Overall Study|Other - as reported by the investigator|6|||
19757974|NCT04427501|42208746|FG006|Overall Study|Other - as reported by the investigator|6|||
19757975|NCT04427501|42208747|FG007|Overall Study|Other - as reported by the investigator|0|||
19757976|NCT04427501|42208748|FG008|Overall Study|Other - as reported by the investigator|0|||
19670525|NCT00438399|42118525|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
19670526|NCT00438399|42118526|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
19670527|NCT00438399|42118527|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
19670528|NCT00426231|42118538|FG000|Overall Study|Withdrawal by Subject|9|||
19670529|NCT00426231|42118539|FG001|Overall Study|Withdrawal by Subject|12|||
19670530|NCT00425607|42118545|FG000|Overall Study|Death|1|||
19670531|NCT00425607|42118545|FG000|Overall Study|Withdrawal by Subject|1|||
19670532|NCT00437073|42118551|FG000|Overall Study|Sponsor Terminated Study|1|||
19670533|NCT00437073|42118552|FG001|Overall Study|Sponsor Terminated Study|0|||
19670534|NCT00437073|42118551|FG000|Overall Study|Physician Decision|0|||
19670535|NCT00437073|42118552|FG001|Overall Study|Physician Decision|1|||
19670536|NCT00425373|42118567|FG000|Overall Study|Adverse Event|2|||
19670537|NCT00425373|42118568|FG001|Overall Study|Adverse Event|2|||
19670538|NCT00425373|42118569|FG002|Overall Study|Adverse Event|0|||
19670539|NCT00425373|42118570|FG003|Overall Study|Adverse Event|1|||
19670540|NCT00425373|42118571|FG004|Overall Study|Adverse Event|4|||
19670541|NCT00425373|42118572|FG005|Overall Study|Adverse Event|6|||
19670542|NCT00425373|42118573|FG006|Overall Study|Adverse Event|2|||
19670543|NCT00425373|42118574|FG007|Overall Study|Adverse Event|3|||
19670544|NCT00425373|42118575|FG008|Overall Study|Adverse Event|8|||
19670545|NCT00425373|42118567|FG000|Overall Study|Lost to Follow-up|0|||
19757977|NCT04427501|42208749|FG009|Overall Study|Other - as reported by the investigator|0|||
19670546|NCT00425373|42118568|FG001|Overall Study|Lost to Follow-up|1|||
19670547|NCT00425373|42118569|FG002|Overall Study|Lost to Follow-up|0|||
19670548|NCT00425373|42118570|FG003|Overall Study|Lost to Follow-up|0|||
19670549|NCT00425373|42118571|FG004|Overall Study|Lost to Follow-up|1|||
19670550|NCT00425373|42118572|FG005|Overall Study|Lost to Follow-up|0|||
19670551|NCT00425373|42118573|FG006|Overall Study|Lost to Follow-up|0|||
19670552|NCT00425373|42118574|FG007|Overall Study|Lost to Follow-up|0|||
19670553|NCT00425373|42118575|FG008|Overall Study|Lost to Follow-up|0|||
19670554|NCT00425373|42118567|FG000|Overall Study|Protocol Violation|1|||
19670555|NCT00425373|42118568|FG001|Overall Study|Protocol Violation|0|||
19670556|NCT00425373|42118569|FG002|Overall Study|Protocol Violation|1|||
19670557|NCT00425373|42118570|FG003|Overall Study|Protocol Violation|0|||
19670558|NCT00425373|42118571|FG004|Overall Study|Protocol Violation|0|||
19670559|NCT00425373|42118572|FG005|Overall Study|Protocol Violation|0|||
19670560|NCT00425373|42118573|FG006|Overall Study|Protocol Violation|0|||
19670561|NCT00425373|42118574|FG007|Overall Study|Protocol Violation|5|||
19670562|NCT00425373|42118575|FG008|Overall Study|Protocol Violation|3|||
19670563|NCT00425373|42118567|FG000|Overall Study|Withdrawal by Subject|2|||
19670564|NCT00425373|42118568|FG001|Overall Study|Withdrawal by Subject|0|||
19670565|NCT00425373|42118569|FG002|Overall Study|Withdrawal by Subject|2|||
19670566|NCT00425373|42118570|FG003|Overall Study|Withdrawal by Subject|1|||
19670567|NCT00425373|42118571|FG004|Overall Study|Withdrawal by Subject|4|||
19670568|NCT00425373|42118572|FG005|Overall Study|Withdrawal by Subject|0|||
19670569|NCT00425373|42118573|FG006|Overall Study|Withdrawal by Subject|2|||
19670570|NCT00425373|42118574|FG007|Overall Study|Withdrawal by Subject|2|||
19670571|NCT00425373|42118575|FG008|Overall Study|Withdrawal by Subject|2|||
19670572|NCT00425373|42118567|FG000|Overall Study|Lack of Efficacy|0|||
19670573|NCT00425373|42118568|FG001|Overall Study|Lack of Efficacy|0|||
19670574|NCT00425373|42118569|FG002|Overall Study|Lack of Efficacy|0|||
19670575|NCT00425373|42118570|FG003|Overall Study|Lack of Efficacy|0|||
19670576|NCT00425373|42118571|FG004|Overall Study|Lack of Efficacy|1|||
19670577|NCT00425373|42118572|FG005|Overall Study|Lack of Efficacy|3|||
19670578|NCT00425373|42118573|FG006|Overall Study|Lack of Efficacy|3|||
19670579|NCT00425373|42118574|FG007|Overall Study|Lack of Efficacy|0|||
19670580|NCT00425373|42118575|FG008|Overall Study|Lack of Efficacy|5|||
19670581|NCT03894540|42118601|FG000|Overall Study|Adverse Event|0|||
19670582|NCT03894540|42118602|FG001|Overall Study|Adverse Event|0|||
19670583|NCT03894540|42118603|FG002|Overall Study|Adverse Event|0|||
19670584|NCT03894540|42118604|FG003|Overall Study|Adverse Event|0|||
19670585|NCT03894540|42118605|FG004|Overall Study|Adverse Event|1|||
19670586|NCT03894540|42118606|FG005|Overall Study|Adverse Event|0|||
19670587|NCT03894540|42118601|FG000|Overall Study|Withdrawal by Subject|0|||
19670588|NCT03894540|42118602|FG001|Overall Study|Withdrawal by Subject|0|||
19670589|NCT03894540|42118603|FG002|Overall Study|Withdrawal by Subject|0|||
19670590|NCT03894540|42118604|FG003|Overall Study|Withdrawal by Subject|0|||
19670591|NCT03894540|42118605|FG004|Overall Study|Withdrawal by Subject|1|||
19670592|NCT03894540|42118606|FG005|Overall Study|Withdrawal by Subject|0|||
19670593|NCT03894540|42118601|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
19670594|NCT03894540|42118602|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
19670595|NCT03894540|42118603|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
19670596|NCT03894540|42118604|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
19670597|NCT03894540|42118605|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
19670598|NCT03894540|42118606|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
19670599|NCT03894540|42118601|FG000|Overall Study|Progressive Disease Clinical|1|||
19670600|NCT03894540|42118602|FG001|Overall Study|Progressive Disease Clinical|1|||
19670601|NCT03894540|42118603|FG002|Overall Study|Progressive Disease Clinical|0|||
19670602|NCT03894540|42118604|FG003|Overall Study|Progressive Disease Clinical|1|||
19670603|NCT03894540|42118605|FG004|Overall Study|Progressive Disease Clinical|5|||
19670604|NCT03894540|42118606|FG005|Overall Study|Progressive Disease Clinical|1|||
19670605|NCT03894540|42118601|FG000|Overall Study|Study termination by sponsor|0|||
19670606|NCT03894540|42118602|FG001|Overall Study|Study termination by sponsor|0|||
19670607|NCT03894540|42118603|FG002|Overall Study|Study termination by sponsor|0|||
19670608|NCT03894540|42118604|FG003|Overall Study|Study termination by sponsor|0|||
19670609|NCT03894540|42118605|FG004|Overall Study|Study termination by sponsor|2|||
19670610|NCT03894540|42118606|FG005|Overall Study|Study termination by sponsor|0|||
19670611|NCT00535626|42118624|FG000|Overall Study|Death|15|||
19670612|NCT00535626|42118624|FG000|Overall Study|Lost to Follow-up|29|||
19670613|NCT00535626|42118624|FG000|Overall Study|Withdrawal by Subject|20|||
19670614|NCT00535626|42118624|FG000|Overall Study|Removal/revision of study component|8|||
19670615|NCT00535626|42118624|FG000|Overall Study|Subject terminated|31|||
19757978|NCT02874924|42208785|FG000|Overall Study|Adverse Event|2|||
19757979|NCT02874924|42208786|FG001|Overall Study|Adverse Event|0|||
19670616|NCT00535626|42118624|FG000|Overall Study|Unable to return|2|||
19670617|NCT03889704|42118647|FG000|Overall Study|Study terminated due to pandemic|1|||
19670618|NCT03887442|42118653|FG000|Overall Study|Adverse Event|1|||
19670619|NCT03887442|42118654|FG001|Overall Study|Adverse Event|0|||
19670620|NCT00425061|42118669|FG000|Overall Study|Adverse Event|1|||
19670621|NCT00425061|42118670|FG001|Overall Study|Adverse Event|0|||
19670622|NCT00425061|42118671|FG002|Overall Study|Adverse Event|0|||
19670623|NCT00425061|42118672|FG003|Overall Study|Adverse Event|2|||
19670624|NCT00425061|42118673|FG004|Overall Study|Adverse Event|2|||
19670625|NCT00425061|42118674|FG005|Overall Study|Adverse Event|0|||
19670626|NCT00425061|42118675|FG006|Overall Study|Adverse Event|0|||
19670627|NCT00425061|42118669|FG000|Overall Study|Lost to Follow-up|0|||
19670628|NCT00425061|42118670|FG001|Overall Study|Lost to Follow-up|1|||
19670629|NCT00425061|42118671|FG002|Overall Study|Lost to Follow-up|0|||
19670630|NCT00425061|42118672|FG003|Overall Study|Lost to Follow-up|0|||
19670631|NCT00425061|42118673|FG004|Overall Study|Lost to Follow-up|0|||
19670632|NCT00425061|42118674|FG005|Overall Study|Lost to Follow-up|0|||
19670633|NCT00425061|42118675|FG006|Overall Study|Lost to Follow-up|0|||
19670634|NCT00425061|42118669|FG000|Overall Study|Protocol Violation|1|||
19670635|NCT00425061|42118670|FG001|Overall Study|Protocol Violation|0|||
19670636|NCT00425061|42118671|FG002|Overall Study|Protocol Violation|0|||
19670637|NCT00425061|42118672|FG003|Overall Study|Protocol Violation|0|||
19670638|NCT00425061|42118673|FG004|Overall Study|Protocol Violation|0|||
19670639|NCT00425061|42118674|FG005|Overall Study|Protocol Violation|0|||
19670640|NCT00425061|42118675|FG006|Overall Study|Protocol Violation|0|||
19670641|NCT00425061|42118669|FG000|Overall Study|Withdrawal by Subject|0|||
19670642|NCT00425061|42118670|FG001|Overall Study|Withdrawal by Subject|1|||
19670643|NCT00425061|42118671|FG002|Overall Study|Withdrawal by Subject|0|||
19670644|NCT00425061|42118672|FG003|Overall Study|Withdrawal by Subject|0|||
19670645|NCT00425061|42118673|FG004|Overall Study|Withdrawal by Subject|1|||
19670646|NCT00425061|42118674|FG005|Overall Study|Withdrawal by Subject|0|||
19670647|NCT00425061|42118675|FG006|Overall Study|Withdrawal by Subject|3|||
19670648|NCT00425061|42118669|FG000|Overall Study|Sponsor's request|0|||
19670649|NCT00425061|42118670|FG001|Overall Study|Sponsor's request|0|||
19670650|NCT00425061|42118671|FG002|Overall Study|Sponsor's request|0|||
19670651|NCT00425061|42118672|FG003|Overall Study|Sponsor's request|0|||
19670652|NCT00425061|42118673|FG004|Overall Study|Sponsor's request|19|||
19670653|NCT00425061|42118674|FG005|Overall Study|Sponsor's request|4|||
19670654|NCT00425061|42118675|FG006|Overall Study|Sponsor's request|15|||
19670655|NCT00425061|42118669|FG000|Overall Study|Physician Decision|0|||
19670656|NCT00425061|42118670|FG001|Overall Study|Physician Decision|0|||
19670657|NCT00425061|42118671|FG002|Overall Study|Physician Decision|0|||
19670658|NCT00425061|42118672|FG003|Overall Study|Physician Decision|0|||
19670659|NCT00425061|42118673|FG004|Overall Study|Physician Decision|1|||
19670660|NCT00425061|42118674|FG005|Overall Study|Physician Decision|0|||
19670661|NCT00425061|42118675|FG006|Overall Study|Physician Decision|0|||
19670662|NCT00425061|42118669|FG000|Overall Study|Other|0|||
19670663|NCT00425061|42118670|FG001|Overall Study|Other|0|||
19670664|NCT00425061|42118671|FG002|Overall Study|Other|0|||
19670665|NCT00425061|42118672|FG003|Overall Study|Other|0|||
19670666|NCT00425061|42118673|FG004|Overall Study|Other|3|||
19670667|NCT00425061|42118674|FG005|Overall Study|Other|0|||
19670668|NCT00425061|42118675|FG006|Overall Study|Other|1|||
19670669|NCT00424827|42118693|FG000|Overall Study|Adverse Event|1|||
19670670|NCT03885726|42118698|FG000|Overall Study|Staffing issues/lost interest|1|||
19670671|NCT03885726|42118698|FG000|Overall Study|Early discharge from hospital|3|||
19670672|NCT00377962|42118708|FG000|Core Study: 0-12 Months|Adverse Event|18|||
19757980|NCT02874924|42208787|FG002|Overall Study|Adverse Event|0|||
19757981|NCT02874924|42208785|FG000|Overall Study|Withdrawal by Subject|1|||
19670673|NCT00377962|42118709|FG001|Core Study: 0-12 Months|Adverse Event|2|||
19670674|NCT00377962|42118708|FG000|Core Study: 0-12 Months|Death|3|||
19670675|NCT00377962|42118709|FG001|Core Study: 0-12 Months|Death|0|||
19670676|NCT00377962|42118708|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
19670677|NCT00377962|42118709|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
19670678|NCT00377962|42118708|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
19670679|NCT00377962|42118709|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
19670680|NCT00377962|42118708|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
19670681|NCT00377962|42118709|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
19670682|NCT00377962|42118708|FG000|Extension Study: 12-24 Months|Death|1|||
19670683|NCT00377962|42118709|FG001|Extension Study: 12-24 Months|Death|1|||
19670684|NCT00377962|42118708|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
19670685|NCT00377962|42118709|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
19670686|NCT00377962|42118708|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
19670687|NCT00377962|42118709|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
19670688|NCT00377962|42118708|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
19757982|NCT02874924|42208786|FG001|Overall Study|Withdrawal by Subject|0|||
19670689|NCT00377962|42118709|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
19670690|NCT00424749|42118721|FG000|Overall Study|Withdrawal by Subject|1|||
19670691|NCT00424593|42118727|FG000|Acute Double-Blind Period|Adverse Event|16|||
19670692|NCT00424593|42118728|FG001|Acute Double-Blind Period|Adverse Event|7|||
19670693|NCT00424593|42118727|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
19757983|NCT02874924|42208787|FG002|Overall Study|Withdrawal by Subject|0|||
19670694|NCT00424593|42118728|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
19670695|NCT00424593|42118727|FG000|Acute Double-Blind Period|Protocol Violation|2|||
19670696|NCT00424593|42118728|FG001|Acute Double-Blind Period|Protocol Violation|2|||
19670697|NCT00424593|42118727|FG000|Acute Double-Blind Period|Physician Decision|1|||
19670698|NCT00424593|42118728|FG001|Acute Double-Blind Period|Physician Decision|2|||
19670699|NCT00424593|42118727|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
19670700|NCT00424593|42118728|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
19670701|NCT00424593|42118727|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
19670702|NCT00424593|42118728|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
19670703|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
19670704|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
19670705|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Adverse Event|18|||
19670706|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Adverse Event|0|||
19670707|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
19670708|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
19670709|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
19670710|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
19670711|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
19670712|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
19670713|NCT00424593|42118727|FG000|Dose-Blind Extension Period|Physician Decision|3|||
19670714|NCT00424593|42118728|FG001|Dose-Blind Extension Period|Physician Decision|0|||
19670715|NCT00369382|42118736|FG000|Overall Study|Death|0|||
19670716|NCT00369382|42118737|FG001|Overall Study|Death|2|||
19670717|NCT00369382|42118736|FG000|Overall Study|Physician Decision|2|||
19670718|NCT00369382|42118737|FG001|Overall Study|Physician Decision|1|||
19670719|NCT00369382|42118736|FG000|Overall Study|Withdrawal by Subject|5|||
19670720|NCT00369382|42118737|FG001|Overall Study|Withdrawal by Subject|0|||
19670721|NCT00369382|42118736|FG000|Overall Study|Randomized, not treated|2|||
19670722|NCT00369382|42118737|FG001|Overall Study|Randomized, not treated|0|||
19670723|NCT00369382|42118736|FG000|Overall Study|Other|1|||
19670724|NCT00369382|42118737|FG001|Overall Study|Other|0|||
19757984|NCT04425863|42208798|FG000|Overall Study|Death|0|||
19757985|NCT04425863|42208799|FG001|Overall Study|Death|0|||
19757986|NCT04425863|42208800|FG002|Overall Study|Death|1|||
19757987|NCT04360187|42208822|FG000|Double-Blind Treatment|Adverse Event|9|||
19757988|NCT04360187|42208823|FG001|Double-Blind Treatment|Adverse Event|11|||
19757989|NCT04360187|42208822|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
19757990|NCT04360187|42208823|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
19757991|NCT04360187|42208822|FG000|Double-Blind Treatment|Physician Decision|1|||
19757992|NCT04360187|42208823|FG001|Double-Blind Treatment|Physician Decision|0|||
19757993|NCT04360187|42208822|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
19757994|NCT04360187|42208823|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
19757995|NCT04360187|42208822|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
19757996|NCT04360187|42208823|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
19757997|NCT04360187|42208822|FG000|Follow-Up|Lost to Follow-up|1|||
19757998|NCT04360187|42208823|FG001|Follow-Up|Lost to Follow-up|0|||
19757999|NCT04498169|42208831|FG000|Study Completion|Adverse Event|1|||
19758000|NCT04498169|42208832|FG001|Study Completion|Adverse Event|1|||
19758001|NCT03695393|42208840|FG000|Overall Study|Death|3|||
19758002|NCT03695393|42208841|FG001|Overall Study|Death|1|||
19758003|NCT03695393|42208840|FG000|Overall Study|Lost to Follow-up|0|||
19758004|NCT03695393|42208841|FG001|Overall Study|Lost to Follow-up|1|||
19603534|NCT00976274|42052547|FG001|Overall Study|Lost to Follow-up|5|||
19603535|NCT00976274|42052546|FG000|Overall Study|Withdrawal by Subject|1|||
19603536|NCT00976274|42052547|FG001|Overall Study|Withdrawal by Subject|1|||
19603537|NCT00976274|42052546|FG000|Overall Study|Physician Decision|1|||
19603538|NCT00976274|42052547|FG001|Overall Study|Physician Decision|2|||
19603539|NCT00759148|42052555|FG000|Overall Study|Adverse Event|1|||
19603540|NCT00759148|42052556|FG001|Overall Study|Adverse Event|6|||
19670725|NCT00424515|42118746|FG000|Overall Study|Progressive Disease|10|||
19670726|NCT00424515|42118747|FG001|Overall Study|Progressive Disease|11|||
19758005|NCT01164228|42208849|FG000|Overall Study|Progression|24|||
19603541|NCT00759148|42052555|FG000|Overall Study|Withdrawal by Subject|3|||
19603542|NCT00759148|42052556|FG001|Overall Study|Withdrawal by Subject|7|||
19603543|NCT00759148|42052555|FG000|Overall Study|Lost to Follow-up|3|||
19603544|NCT00759148|42052556|FG001|Overall Study|Lost to Follow-up|9|||
19603545|NCT00759148|42052555|FG000|Overall Study|Treatment Failure|6|||
19603546|NCT00759148|42052556|FG001|Overall Study|Treatment Failure|10|||
19670727|NCT00424515|42118746|FG000|Overall Study|Adverse Event|0|||
19670728|NCT00424515|42118747|FG001|Overall Study|Adverse Event|1|||
19670729|NCT00424515|42118746|FG000|Overall Study|Intercurrent Illness|0|||
19670730|NCT00424515|42118747|FG001|Overall Study|Intercurrent Illness|1|||
19670731|NCT00424515|42118746|FG000|Overall Study|Withdrawal by Subject|1|||
19670732|NCT00424515|42118747|FG001|Overall Study|Withdrawal by Subject|0|||
19670733|NCT00377260|42118755|FG000|Overall Study|Lost to Follow-up|0|||
19670734|NCT00377260|42118756|FG001|Overall Study|Lost to Follow-up|1|||
19670735|NCT00377260|42118755|FG000|Overall Study|Withdrawal by Subject|2|||
19670736|NCT00377260|42118756|FG001|Overall Study|Withdrawal by Subject|4|||
19670737|NCT00441441|42118764|FG000|Overall Study|Adverse Event|2|||
19670738|NCT00441441|42118765|FG001|Overall Study|Adverse Event|1|||
19670739|NCT00441441|42118764|FG000|Overall Study|Protocol Violation|4|||
19670740|NCT00441441|42118765|FG001|Overall Study|Protocol Violation|6|||
19670741|NCT00441441|42118764|FG000|Overall Study|Exacerbation of asthma|1|||
19670742|NCT00441441|42118765|FG001|Overall Study|Exacerbation of asthma|2|||
19603547|NCT00759148|42052555|FG000|Overall Study|Reason not given|1|||
19603548|NCT00759148|42052556|FG001|Overall Study|Reason not given|0|||
19603549|NCT02794285|42052566|FG000|Overall Study|Adverse Event|11|||
19603550|NCT02794285|42052567|FG001|Overall Study|Adverse Event|4|||
19603551|NCT02794285|42052568|FG002|Overall Study|Adverse Event|5|||
19603552|NCT02794285|42052569|FG003|Overall Study|Adverse Event|8|||
19603553|NCT02794285|42052566|FG000|Overall Study|Condition Under Investigation Improved|1|||
19603554|NCT02794285|42052567|FG001|Overall Study|Condition Under Investigation Improved|0|||
19603555|NCT02794285|42052568|FG002|Overall Study|Condition Under Investigation Improved|0|||
19603556|NCT02794285|42052569|FG003|Overall Study|Condition Under Investigation Improved|0|||
19603557|NCT02794285|42052566|FG000|Overall Study|Condition Under Investigation Worsened|0|||
19603558|NCT02794285|42052567|FG001|Overall Study|Condition Under Investigation Worsened|2|||
19603559|NCT02794285|42052568|FG002|Overall Study|Condition Under Investigation Worsened|1|||
19603560|NCT02794285|42052569|FG003|Overall Study|Condition Under Investigation Worsened|0|||
19603561|NCT02794285|42052566|FG000|Overall Study|Death|2|||
19603562|NCT02794285|42052567|FG001|Overall Study|Death|1|||
19603563|NCT02794285|42052568|FG002|Overall Study|Death|2|||
19603564|NCT02794285|42052569|FG003|Overall Study|Death|0|||
19603565|NCT02794285|42052566|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
19603566|NCT02794285|42052567|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
19603567|NCT02794285|42052568|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
19603568|NCT02794285|42052569|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
19603569|NCT02794285|42052566|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
19603570|NCT02794285|42052567|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
19603571|NCT02794285|42052568|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
19603572|NCT02794285|42052569|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
19603573|NCT02794285|42052566|FG000|Overall Study|Lack of Efficacy|10|||
19603574|NCT02794285|42052567|FG001|Overall Study|Lack of Efficacy|6|||
19603575|NCT02794285|42052568|FG002|Overall Study|Lack of Efficacy|3|||
19603576|NCT02794285|42052569|FG003|Overall Study|Lack of Efficacy|3|||
19603577|NCT02794285|42052566|FG000|Overall Study|Lost to Follow-up|5|||
19603578|NCT02794285|42052567|FG001|Overall Study|Lost to Follow-up|6|||
19603579|NCT02794285|42052568|FG002|Overall Study|Lost to Follow-up|3|||
19670743|NCT00441441|42118764|FG000|Overall Study|Withdrawal by Subject|1|||
19670744|NCT00441441|42118765|FG001|Overall Study|Withdrawal by Subject|2|||
19603580|NCT02794285|42052569|FG003|Overall Study|Lost to Follow-up|1|||
19603581|NCT02794285|42052566|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
19670745|NCT00441441|42118764|FG000|Overall Study|Other|3|||
19670746|NCT00441441|42118765|FG001|Overall Study|Other|3|||
19670747|NCT00436917|42118785|FG000|Overall Study|Withdrawal by Subject|13|||
19670748|NCT00436917|42118785|FG000|Overall Study|Adverse Event|2|||
19670749|NCT00436917|42118785|FG000|Overall Study|Physician Decision|1|||
19670750|NCT00436917|42118785|FG000|Overall Study|Death|1|||
19670751|NCT00436917|42118785|FG000|Overall Study|Lost to Follow-up|1|||
19670752|NCT00436917|42118785|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
19670753|NCT00436917|42118785|FG000|Overall Study|Increased creatinine|1|||
19670754|NCT00436917|42118785|FG000|Overall Study|Personal conflicts of patient|1|||
19670755|NCT00436605|42118789|FG000|Overall Study|Protocol Violation|3|||
19670756|NCT00368992|42118793|FG000|Overall Study|Ineligible|5|||
19670757|NCT00368992|42118793|FG000|Overall Study|Refused treatment|3|||
19670758|NCT00368992|42118793|FG000|Overall Study|Lack of Efficacy|63|||
19670759|NCT00368992|42118793|FG000|Overall Study|Adverse Event|26|||
19670760|NCT00368992|42118793|FG000|Overall Study|Death|4|||
19670761|NCT00368992|42118793|FG000|Overall Study|Other|9|||
19670762|NCT00376246|42118798|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
19670763|NCT00376246|42118799|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
19670764|NCT00376246|42118798|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
19670765|NCT00376246|42118799|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
19670766|NCT00376246|42118798|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
19758006|NCT01164228|42208850|FG001|Overall Study|Progression|25|||
19670767|NCT00376246|42118799|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19670768|NCT00368836|42118809|FG000|Phase II|Screen Failure|1|||
19670769|NCT00368836|42118809|FG000|Phase II|Withdrawal by Subject|1|||
19670770|NCT00368836|42118809|FG000|Phase II|unable to collect blood and/or breath|17|||
19670771|NCT00368836|42118809|FG000|Phase II|Protocol Violation|2|||
19670772|NCT00376168|42118818|FG000|Overall Study|Adverse Event|1|||
19670773|NCT00376168|42118819|FG001|Overall Study|Adverse Event|1|||
19670774|NCT00376168|42118818|FG000|Overall Study|Pregnancy|1|||
19670775|NCT00376168|42118819|FG001|Overall Study|Pregnancy|0|||
19670776|NCT00375934|42118827|FG000|Overall Study|Adverse Event|1|||
19670777|NCT00375934|42118828|FG001|Overall Study|Adverse Event|1|||
19670778|NCT00375934|42118827|FG000|Overall Study|Withdrawal by Subject|2|||
19670779|NCT00375934|42118828|FG001|Overall Study|Withdrawal by Subject|2|||
19670780|NCT00375934|42118827|FG000|Overall Study|Lack of Efficacy|0|||
19670781|NCT00375934|42118828|FG001|Overall Study|Lack of Efficacy|2|||
19670782|NCT00375934|42118827|FG000|Overall Study|Physician Decision|0|||
19670783|NCT00375934|42118828|FG001|Overall Study|Physician Decision|1|||
19670784|NCT00642941|42118846|FG000|Overall Study|Physician Decision|3|||
19670785|NCT00642941|42118847|FG001|Overall Study|Physician Decision|1|||
19670786|NCT00642941|42118848|FG002|Overall Study|Physician Decision|0|||
19670787|NCT00642941|42118849|FG003|Overall Study|Physician Decision|0|||
19670788|NCT00642941|42118850|FG004|Overall Study|Physician Decision|0|||
19670789|NCT00642941|42118851|FG005|Overall Study|Physician Decision|0|||
19670790|NCT00642941|42118852|FG006|Overall Study|Physician Decision|1|||
19670791|NCT00642941|42118853|FG007|Overall Study|Physician Decision|0|||
19670792|NCT00642941|42118854|FG008|Overall Study|Physician Decision|0|||
19670793|NCT00642941|42118855|FG009|Overall Study|Physician Decision|1|||
19670794|NCT00642941|42118856|FG010|Overall Study|Physician Decision|0|||
19670795|NCT00642941|42118857|FG011|Overall Study|Physician Decision|1|||
19670796|NCT00642941|42118846|FG000|Overall Study|Death|4|||
19670797|NCT00642941|42118847|FG001|Overall Study|Death|0|||
19670798|NCT00642941|42118848|FG002|Overall Study|Death|1|||
19670799|NCT00642941|42118849|FG003|Overall Study|Death|1|||
19758007|NCT01164228|42208849|FG000|Overall Study|Adverse Event|13|||
19758008|NCT01164228|42208850|FG001|Overall Study|Adverse Event|7|||
19758009|NCT01164228|42208849|FG000|Overall Study|Death|1|||
19758010|NCT01164228|42208850|FG001|Overall Study|Death|1|||
19758011|NCT01164228|42208849|FG000|Overall Study|Withdrawal by Subject|2|||
19758012|NCT01164228|42208850|FG001|Overall Study|Withdrawal by Subject|0|||
19758013|NCT01164228|42208849|FG000|Overall Study|Physician Decision|1|||
19758014|NCT01164228|42208850|FG001|Overall Study|Physician Decision|2|||
19758015|NCT01164228|42208849|FG000|Overall Study|Symptomatic deterioration|1|||
19758016|NCT01164228|42208850|FG001|Overall Study|Symptomatic deterioration|0|||
19758017|NCT01164228|42208849|FG000|Overall Study|Never started treatment|1|||
19758018|NCT01164228|42208850|FG001|Overall Study|Never started treatment|3|||
19758019|NCT01164228|42208849|FG000|Overall Study|Ineligible|1|||
19758020|NCT01164228|42208850|FG001|Overall Study|Ineligible|0|||
19758021|NCT03694925|42208859|FG000|Overall Study|Inadequate laboratory testing|0|||
19758022|NCT03694925|42208860|FG001|Overall Study|Inadequate laboratory testing|3|||
19758023|NCT03694925|42208861|FG002|Overall Study|Inadequate laboratory testing|0|||
19758024|NCT04495829|42208871|FG000|Overall Study|Lost to Follow-up|2|||
19670800|NCT00642941|42118850|FG004|Overall Study|Death|2|||
19670801|NCT00642941|42118851|FG005|Overall Study|Death|1|||
19758025|NCT04495829|42208871|FG000|Overall Study|Inclusion criterion not met|3|||
19758026|NCT04258020|42208877|FG000|Overall Study|Withdrawal by Subject|1|||
19670802|NCT00642941|42118852|FG006|Overall Study|Death|0|||
19670803|NCT00642941|42118853|FG007|Overall Study|Death|0|||
19670804|NCT00642941|42118854|FG008|Overall Study|Death|0|||
19670805|NCT00642941|42118855|FG009|Overall Study|Death|0|||
19670806|NCT00642941|42118856|FG010|Overall Study|Death|0|||
19670807|NCT00642941|42118857|FG011|Overall Study|Death|1|||
19670808|NCT00642941|42118846|FG000|Overall Study|Study closed by Sponsor|0|||
19670809|NCT00642941|42118847|FG001|Overall Study|Study closed by Sponsor|1|||
19670810|NCT00642941|42118848|FG002|Overall Study|Study closed by Sponsor|0|||
19670811|NCT00642941|42118849|FG003|Overall Study|Study closed by Sponsor|0|||
19670812|NCT00642941|42118850|FG004|Overall Study|Study closed by Sponsor|0|||
19670813|NCT00642941|42118851|FG005|Overall Study|Study closed by Sponsor|0|||
19670814|NCT00642941|42118852|FG006|Overall Study|Study closed by Sponsor|0|||
19670815|NCT00642941|42118853|FG007|Overall Study|Study closed by Sponsor|0|||
19670816|NCT00642941|42118854|FG008|Overall Study|Study closed by Sponsor|0|||
19670817|NCT00642941|42118855|FG009|Overall Study|Study closed by Sponsor|0|||
19670818|NCT00642941|42118856|FG010|Overall Study|Study closed by Sponsor|0|||
19670819|NCT00642941|42118857|FG011|Overall Study|Study closed by Sponsor|0|||
19603582|NCT02794285|42052567|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
19603583|NCT02794285|42052568|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
19603584|NCT02794285|42052569|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
19603585|NCT02794285|42052566|FG000|Overall Study|Withdrawal by Subject|38|||
19603586|NCT02794285|42052567|FG001|Overall Study|Withdrawal by Subject|29|||
19603587|NCT02794285|42052568|FG002|Overall Study|Withdrawal by Subject|20|||
19603588|NCT02794285|42052569|FG003|Overall Study|Withdrawal by Subject|12|||
19603589|NCT02794285|42052566|FG000|Overall Study|Missing|1|||
19603590|NCT02794285|42052567|FG001|Overall Study|Missing|0|||
19603591|NCT02794285|42052568|FG002|Overall Study|Missing|0|||
19670820|NCT00642941|42118846|FG000|Overall Study|Withdrawal by Subject|1|||
19670821|NCT00642941|42118847|FG001|Overall Study|Withdrawal by Subject|0|||
19670822|NCT00642941|42118848|FG002|Overall Study|Withdrawal by Subject|0|||
19670823|NCT00642941|42118849|FG003|Overall Study|Withdrawal by Subject|2|||
19670824|NCT00642941|42118850|FG004|Overall Study|Withdrawal by Subject|0|||
19670825|NCT00642941|42118851|FG005|Overall Study|Withdrawal by Subject|0|||
19670826|NCT00642941|42118852|FG006|Overall Study|Withdrawal by Subject|2|||
19758027|NCT04258020|42208878|FG001|Overall Study|Withdrawal by Subject|0|||
19758028|NCT04495283|42208887|FG000|Overall Study|Physician Decision|0|||
19758029|NCT04495283|42208888|FG001|Overall Study|Physician Decision|0|||
19603592|NCT02794285|42052569|FG003|Overall Study|Missing|0|||
19670827|NCT00642941|42118853|FG007|Overall Study|Withdrawal by Subject|0|||
19670828|NCT00642941|42118854|FG008|Overall Study|Withdrawal by Subject|1|||
19670829|NCT00642941|42118855|FG009|Overall Study|Withdrawal by Subject|0|||
19670830|NCT00642941|42118856|FG010|Overall Study|Withdrawal by Subject|0|||
19670831|NCT00642941|42118857|FG011|Overall Study|Withdrawal by Subject|1|||
19670832|NCT00642941|42118846|FG000|Overall Study|Protocol Violation|0|||
19670833|NCT00642941|42118847|FG001|Overall Study|Protocol Violation|0|||
19670834|NCT00642941|42118848|FG002|Overall Study|Protocol Violation|0|||
19670835|NCT00642941|42118849|FG003|Overall Study|Protocol Violation|0|||
19670836|NCT00642941|42118850|FG004|Overall Study|Protocol Violation|0|||
19670837|NCT00642941|42118851|FG005|Overall Study|Protocol Violation|0|||
19670838|NCT00642941|42118852|FG006|Overall Study|Protocol Violation|1|||
19670839|NCT00642941|42118853|FG007|Overall Study|Protocol Violation|0|||
19670840|NCT00642941|42118854|FG008|Overall Study|Protocol Violation|0|||
19670841|NCT00642941|42118855|FG009|Overall Study|Protocol Violation|0|||
19670842|NCT00642941|42118856|FG010|Overall Study|Protocol Violation|0|||
19670843|NCT00642941|42118857|FG011|Overall Study|Protocol Violation|0|||
19670844|NCT00642941|42118846|FG000|Overall Study|Adverse Event|1|||
19670845|NCT00642941|42118847|FG001|Overall Study|Adverse Event|1|||
19670846|NCT00642941|42118848|FG002|Overall Study|Adverse Event|0|||
19670847|NCT00642941|42118849|FG003|Overall Study|Adverse Event|0|||
19670848|NCT00642941|42118850|FG004|Overall Study|Adverse Event|0|||
19670849|NCT00642941|42118851|FG005|Overall Study|Adverse Event|0|||
19670850|NCT00642941|42118852|FG006|Overall Study|Adverse Event|1|||
19670851|NCT00642941|42118853|FG007|Overall Study|Adverse Event|1|||
19670852|NCT00642941|42118854|FG008|Overall Study|Adverse Event|0|||
19670853|NCT00642941|42118855|FG009|Overall Study|Adverse Event|1|||
19670854|NCT00642941|42118856|FG010|Overall Study|Adverse Event|0|||
19670855|NCT00642941|42118857|FG011|Overall Study|Adverse Event|0|||
19670856|NCT00642941|42118846|FG000|Overall Study|Other|1|||
19670857|NCT00642941|42118847|FG001|Overall Study|Other|1|||
19670858|NCT00642941|42118848|FG002|Overall Study|Other|1|||
19670859|NCT00642941|42118849|FG003|Overall Study|Other|1|||
19670860|NCT00642941|42118850|FG004|Overall Study|Other|0|||
19670861|NCT00642941|42118851|FG005|Overall Study|Other|1|||
19670862|NCT00642941|42118852|FG006|Overall Study|Other|0|||
19670863|NCT00642941|42118853|FG007|Overall Study|Other|1|||
19670864|NCT00642941|42118854|FG008|Overall Study|Other|0|||
19670865|NCT00642941|42118855|FG009|Overall Study|Other|0|||
19670866|NCT00642941|42118856|FG010|Overall Study|Other|0|||
19670867|NCT00642941|42118857|FG011|Overall Study|Other|1|||
19670868|NCT00642941|42118846|FG000|Overall Study|Disease progression|60|||
19670869|NCT00642941|42118847|FG001|Overall Study|Disease progression|50|||
19670870|NCT00642941|42118848|FG002|Overall Study|Disease progression|5|||
19670871|NCT00642941|42118849|FG003|Overall Study|Disease progression|36|||
19670872|NCT00642941|42118850|FG004|Overall Study|Disease progression|23|||
19670873|NCT00642941|42118851|FG005|Overall Study|Disease progression|39|||
19670874|NCT00642941|42118852|FG006|Overall Study|Disease progression|18|||
19670875|NCT00642941|42118853|FG007|Overall Study|Disease progression|12|||
19670876|NCT00642941|42118854|FG008|Overall Study|Disease progression|10|||
19670877|NCT00642941|42118855|FG009|Overall Study|Disease progression|7|||
19670878|NCT00642941|42118856|FG010|Overall Study|Disease progression|12|||
19670879|NCT00642941|42118857|FG011|Overall Study|Disease progression|7|||
19670880|NCT00531960|42118906|FG000|Overall Study|Adverse Event|5|||
19670881|NCT00531960|42118907|FG001|Overall Study|Adverse Event|4|||
19670882|NCT00531960|42118906|FG000|Overall Study|Death|3|||
19670883|NCT00531960|42118907|FG001|Overall Study|Death|2|||
19670884|NCT00531960|42118906|FG000|Overall Study|Lack of Efficacy|42|||
19670885|NCT00531960|42118907|FG001|Overall Study|Lack of Efficacy|41|||
19670886|NCT00531960|42118906|FG000|Overall Study|Violation of Selection Criteria|2|||
19670887|NCT00531960|42118907|FG001|Overall Study|Violation of Selection Criteria|0|||
19670888|NCT00531960|42118906|FG000|Overall Study|Refused Treatment|5|||
19670889|NCT00531960|42118907|FG001|Overall Study|Refused Treatment|6|||
19670890|NCT00531960|42118906|FG000|Overall Study|Other|4|||
19670891|NCT00531960|42118907|FG001|Overall Study|Other|10|||
19670892|NCT00361504|42118915|FG000|Overall Study|Withdrawal by Subject|94|||
19670893|NCT00361504|42118916|FG001|Overall Study|Withdrawal by Subject|31|||
19670894|NCT00361504|42118915|FG000|Overall Study|Lost to Follow-up|40|||
19670895|NCT00361504|42118916|FG001|Overall Study|Lost to Follow-up|7|||
19670896|NCT00361504|42118915|FG000|Overall Study|Adverse Event|203|||
19670897|NCT00361504|42118916|FG001|Overall Study|Adverse Event|82|||
19670898|NCT00361504|42118915|FG000|Overall Study|Lack of Efficacy|72|||
19670899|NCT00361504|42118916|FG001|Overall Study|Lack of Efficacy|7|||
19670900|NCT00361504|42118915|FG000|Overall Study|Resolution of Pain|2|||
19670901|NCT00361504|42118916|FG001|Overall Study|Resolution of Pain|0|||
19670902|NCT00361504|42118915|FG000|Overall Study|Study medication non compliant|42|||
19670903|NCT00361504|42118916|FG001|Overall Study|Study medication non compliant|15|||
19670904|NCT00361504|42118915|FG000|Overall Study|All other|28|||
19670905|NCT00361504|42118916|FG001|Overall Study|All other|3|||
19670906|NCT00361270|42118926|FG000|Overall Study|Death|0|||
19670907|NCT00361270|42118927|FG001|Overall Study|Death|0|||
19670908|NCT00361270|42118928|FG002|Overall Study|Death|0|||
19670909|NCT00361270|42118929|FG003|Overall Study|Death|2|||
19670910|NCT00361270|42118926|FG000|Overall Study|Lost to Follow-up|4|||
19670911|NCT00361270|42118927|FG001|Overall Study|Lost to Follow-up|1|||
19670912|NCT00361270|42118928|FG002|Overall Study|Lost to Follow-up|0|||
19670913|NCT00361270|42118929|FG003|Overall Study|Lost to Follow-up|0|||
19670914|NCT00361270|42118926|FG000|Overall Study|Physician Decision|0|||
19670915|NCT00361270|42118927|FG001|Overall Study|Physician Decision|0|||
19670916|NCT00361270|42118928|FG002|Overall Study|Physician Decision|1|||
19670917|NCT00361270|42118929|FG003|Overall Study|Physician Decision|0|||
19670918|NCT00361270|42118926|FG000|Overall Study|Protocol Violation|9|||
19670919|NCT00361270|42118927|FG001|Overall Study|Protocol Violation|4|||
19670920|NCT00361270|42118928|FG002|Overall Study|Protocol Violation|5|||
19670921|NCT00361270|42118929|FG003|Overall Study|Protocol Violation|4|||
19670922|NCT00361270|42118926|FG000|Overall Study|Withdrawal by Subject|6|||
19670923|NCT00361270|42118927|FG001|Overall Study|Withdrawal by Subject|6|||
19670924|NCT00361270|42118928|FG002|Overall Study|Withdrawal by Subject|3|||
19670925|NCT00361270|42118929|FG003|Overall Study|Withdrawal by Subject|7|||
19670926|NCT00361270|42118926|FG000|Overall Study|Afraid of Hypnosis|1|||
19670927|NCT00361270|42118927|FG001|Overall Study|Afraid of Hypnosis|2|||
19670928|NCT00361270|42118928|FG002|Overall Study|Afraid of Hypnosis|0|||
19670929|NCT00361270|42118929|FG003|Overall Study|Afraid of Hypnosis|0|||
19670930|NCT00361270|42118926|FG000|Overall Study|Problems with Transportation|4|||
19670931|NCT00361270|42118927|FG001|Overall Study|Problems with Transportation|0|||
19670932|NCT00361270|42118928|FG002|Overall Study|Problems with Transportation|0|||
19670933|NCT00361270|42118929|FG003|Overall Study|Problems with Transportation|0|||
19670934|NCT00361270|42118926|FG000|Overall Study|Adverse Event|0|||
19670935|NCT00361270|42118927|FG001|Overall Study|Adverse Event|1|||
19670936|NCT00361270|42118928|FG002|Overall Study|Adverse Event|1|||
19670937|NCT00361270|42118929|FG003|Overall Study|Adverse Event|0|||
19670938|NCT00367744|42118948|FG000|Overall Study|Lost to Follow-up|4|||
19670939|NCT00367744|42118949|FG001|Overall Study|Lost to Follow-up|5|||
19670940|NCT03883386|42118958|FG000|First Assignment|Lost to Follow-up|1|||
19670941|NCT03883386|42118959|FG001|First Assignment|Lost to Follow-up|0|||
19670942|NCT03883386|42118958|FG000|First Assignment|Withdrawal by Subject|1|||
19670943|NCT03883386|42118959|FG001|First Assignment|Withdrawal by Subject|1|||
19670944|NCT00530946|42118969|FG000|Overall Study|Adverse Event|1|||
19670945|NCT00530946|42118970|FG001|Overall Study|Adverse Event|2|||
19670946|NCT00530946|42118971|FG002|Overall Study|Adverse Event|1|||
19670947|NCT00530946|42118972|FG003|Overall Study|Adverse Event|1|||
19670948|NCT00530946|42118969|FG000|Overall Study|Protocol Violation|0|||
19670949|NCT00530946|42118970|FG001|Overall Study|Protocol Violation|0|||
19670950|NCT00530946|42118971|FG002|Overall Study|Protocol Violation|0|||
19670951|NCT00530946|42118972|FG003|Overall Study|Protocol Violation|1|||
19670952|NCT00530946|42118969|FG000|Overall Study|Noncompliance|1|||
19670953|NCT00530946|42118970|FG001|Overall Study|Noncompliance|0|||
19670954|NCT00530946|42118971|FG002|Overall Study|Noncompliance|0|||
19670955|NCT00530946|42118972|FG003|Overall Study|Noncompliance|0|||
19670956|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
19670957|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
19670958|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
19670959|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
19670960|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
19670961|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
19670962|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
19670963|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
19670964|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
19670965|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
19670966|NCT00424047|42118984|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
19758030|NCT04495283|42208889|FG002|Overall Study|Physician Decision|1|||
19758031|NCT04495283|42208887|FG000|Overall Study|Withdrawal by Subject|0|||
19758032|NCT04495283|42208888|FG001|Overall Study|Withdrawal by Subject|1|||
19758033|NCT04495283|42208889|FG002|Overall Study|Withdrawal by Subject|1|||
19758034|NCT04495283|42208887|FG000|Overall Study|Other|1|||
19758035|NCT04495283|42208888|FG001|Overall Study|Other|0|||
19670967|NCT00424047|42118985|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
19670968|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Adverse Event|22|||
19670969|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Adverse Event|12|||
19670970|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Progression of disease|92|||
19758036|NCT04495283|42208889|FG002|Overall Study|Other|1|||
19670971|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Progression of disease|128|||
19670972|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
19670973|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
19670974|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
19758037|NCT03117738|42208902|FG000|Overall Study|Withdrawal by Subject|3|||
19758038|NCT03117738|42208903|FG001|Overall Study|Withdrawal by Subject|1|||
19758039|NCT03117738|42208902|FG000|Overall Study|Lost to Follow-up|1|||
19758040|NCT03117738|42208903|FG001|Overall Study|Lost to Follow-up|4|||
19758041|NCT04234464|42208911|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
19758042|NCT04234464|42208912|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
19758043|NCT03123588|42208920|FG000|Overall Study|Study Terminated by Sponsor|2|||
19758044|NCT03123588|42208921|FG001|Overall Study|Study Terminated by Sponsor|5|||
19758045|NCT03123588|42208920|FG000|Overall Study|Withdrawal by Subject|1|||
19758046|NCT03123588|42208921|FG001|Overall Study|Withdrawal by Subject|0|||
19758047|NCT03123588|42208920|FG000|Overall Study|Adverse Event|1|||
19758048|NCT03123588|42208921|FG001|Overall Study|Adverse Event|0|||
19758049|NCT03123588|42208920|FG000|Overall Study|Physician Decision|2|||
19670975|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
19670976|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Death|11|||
19670977|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Death|11|||
19670978|NCT00424047|42118984|FG000|On Study at Time of Unblinding|Other|5|||
19670979|NCT00424047|42118985|FG001|On Study at Time of Unblinding|Other|4|||
19670980|NCT00424047|42118984|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
19670981|NCT00424047|42118985|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
19670982|NCT00424047|42118984|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
19670983|NCT00424047|42118985|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
19670984|NCT00424047|42118984|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
19670985|NCT00424047|42118985|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
19670986|NCT00424047|42118984|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
19670987|NCT00424047|42118985|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
19670988|NCT00424047|42118984|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
19670989|NCT00424047|42118985|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
19670990|NCT00530790|42118996|FG000|Overall Study|Adverse Event|2|||
19670991|NCT00530790|42118996|FG000|Overall Study|Withdrawal by Subject|2|||
19670992|NCT00530790|42118996|FG000|Overall Study|Physician Decision|1|||
19670993|NCT00530088|42119000|FG000|Overall Study|Disease Progression|4|||
19670994|NCT00530088|42119000|FG000|Overall Study|Physician Decision|4|||
19670995|NCT00530088|42119000|FG000|Overall Study|Other Not Specified|2|||
19670996|NCT00360568|42119006|FG000|Overall Study|Adverse Event|1|||
19670997|NCT00360568|42119007|FG001|Overall Study|Adverse Event|2|||
19670998|NCT00360568|42119006|FG000|Overall Study|Lack of Efficacy|1|||
19670999|NCT00360568|42119007|FG001|Overall Study|Lack of Efficacy|0|||
19671000|NCT00360568|42119006|FG000|Overall Study|Withdrawal by Subject|0|||
19671001|NCT00360568|42119007|FG001|Overall Study|Withdrawal by Subject|3|||
19671002|NCT00436215|42119015|FG000|Overall Study|Refused further treatment|3|||
19671003|NCT00436215|42119015|FG000|Overall Study|Small bowel obstruction|1|||
19671004|NCT00441363|42119021|FG000|Overall Study|Adverse Event|4|||
19671005|NCT00441363|42119022|FG001|Overall Study|Adverse Event|2|||
19671006|NCT00441363|42119021|FG000|Overall Study|Withdrawal by Subject|3|||
19671007|NCT00441363|42119022|FG001|Overall Study|Withdrawal by Subject|4|||
19671008|NCT00441363|42119021|FG000|Overall Study|Physician Decision|6|||
19671009|NCT00441363|42119022|FG001|Overall Study|Physician Decision|7|||
19671010|NCT00441363|42119021|FG000|Overall Study|Lost to Follow-up|2|||
19671011|NCT00441363|42119022|FG001|Overall Study|Lost to Follow-up|2|||
19671012|NCT00441363|42119021|FG000|Overall Study|Other|2|||
19671013|NCT00441363|42119022|FG001|Overall Study|Other|0|||
19671014|NCT00530712|42119028|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
19671015|NCT00530712|42119028|FG000|30 Day Follow-up Visit|Missed Visit|5|||
19671016|NCT00530712|42119028|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
19671017|NCT00530712|42119028|FG000|6 Month Follow-up Visit|Missed Visit|3|||
19671018|NCT00530712|42119028|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
19671019|NCT00530712|42119028|FG000|6 Month Follow-up Visit|Death|2|||
19671020|NCT00530712|42119028|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
19671021|NCT00530712|42119028|FG000|12 Month Follow-up Visit|Missed Visit|3|||
19671022|NCT00530712|42119028|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
19671023|NCT00530712|42119028|FG000|12 Month Follow-up Visit|Death|9|||
19671024|NCT00626795|42119036|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
19671025|NCT00626795|42119037|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
19671026|NCT00626795|42119038|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
19671027|NCT00626795|42119036|FG000|Blinded Treatment|Lack of Efficacy|2|||
19671028|NCT00626795|42119037|FG001|Blinded Treatment|Lack of Efficacy|0|||
19671029|NCT00626795|42119038|FG002|Blinded Treatment|Lack of Efficacy|0|||
19758050|NCT03123588|42208921|FG001|Overall Study|Physician Decision|1|||
19671030|NCT00626795|42119036|FG000|Blinded Treatment|Unacceptable adverse event|0|||
19671031|NCT00626795|42119037|FG001|Blinded Treatment|Unacceptable adverse event|0|||
19671032|NCT00626795|42119038|FG002|Blinded Treatment|Unacceptable adverse event|1|||
19758051|NCT03123354|42208928|FG000|Overall Study|Physician Decision|6|||
19758052|NCT04421027|42208934|FG000|Treatment Period|Adverse Event|5|||
19758053|NCT04421027|42208935|FG001|Treatment Period|Adverse Event|3|||
19758054|NCT04421027|42208936|FG002|Treatment Period|Adverse Event|0|||
19758055|NCT04421027|42208937|FG003|Treatment Period|Adverse Event|0|||
19758056|NCT04421027|42208934|FG000|Treatment Period|Death|98|||
19758057|NCT04421027|42208935|FG001|Treatment Period|Death|61|||
19758058|NCT04421027|42208936|FG002|Treatment Period|Death|0|||
19758059|NCT04421027|42208937|FG003|Treatment Period|Death|0|||
19758060|NCT04421027|42208934|FG000|Treatment Period|Lost to Follow-up|22|||
19758061|NCT04421027|42208935|FG001|Treatment Period|Lost to Follow-up|20|||
19758062|NCT04421027|42208936|FG002|Treatment Period|Lost to Follow-up|0|||
19758063|NCT04421027|42208937|FG003|Treatment Period|Lost to Follow-up|0|||
19758064|NCT04421027|42208934|FG000|Treatment Period|Other-Unknown|15|||
19758065|NCT04421027|42208935|FG001|Treatment Period|Other-Unknown|9|||
19758066|NCT04421027|42208936|FG002|Treatment Period|Other-Unknown|0|||
19758067|NCT04421027|42208937|FG003|Treatment Period|Other-Unknown|0|||
19758068|NCT04421027|42208934|FG000|Treatment Period|Physician Decision|1|||
19758069|NCT04421027|42208935|FG001|Treatment Period|Physician Decision|1|||
19758070|NCT04421027|42208936|FG002|Treatment Period|Physician Decision|0|||
19758071|NCT04421027|42208937|FG003|Treatment Period|Physician Decision|0|||
19758072|NCT04421027|42208934|FG000|Treatment Period|Withdrawal by Subject|7|||
19758073|NCT04421027|42208935|FG001|Treatment Period|Withdrawal by Subject|12|||
19758074|NCT04421027|42208936|FG002|Treatment Period|Withdrawal by Subject|0|||
19758075|NCT04421027|42208937|FG003|Treatment Period|Withdrawal by Subject|0|||
19758076|NCT04421027|42208934|FG000|Treatment Period|Randomized Not Dosed|9|||
19758077|NCT04421027|42208935|FG001|Treatment Period|Randomized Not Dosed|14|||
19758078|NCT04421027|42208936|FG002|Treatment Period|Randomized Not Dosed|0|||
19758079|NCT04421027|42208937|FG003|Treatment Period|Randomized Not Dosed|0|||
19758080|NCT04421027|42208934|FG000|Follow-Up Period|Adverse Event|0|||
19758081|NCT04421027|42208935|FG001|Follow-Up Period|Adverse Event|0|||
19758082|NCT04421027|42208936|FG002|Follow-Up Period|Adverse Event|0|||
19758083|NCT04421027|42208937|FG003|Follow-Up Period|Adverse Event|3|||
19758084|NCT04421027|42208934|FG000|Follow-Up Period|Death|0|||
19758085|NCT04421027|42208935|FG001|Follow-Up Period|Death|0|||
19758086|NCT04421027|42208936|FG002|Follow-Up Period|Death|16|||
19758087|NCT04421027|42208937|FG003|Follow-Up Period|Death|17|||
19758088|NCT04421027|42208934|FG000|Follow-Up Period|Lost to Follow-up|0|||
19758089|NCT04421027|42208935|FG001|Follow-Up Period|Lost to Follow-up|0|||
19758090|NCT04421027|42208936|FG002|Follow-Up Period|Lost to Follow-up|7|||
19758091|NCT04421027|42208937|FG003|Follow-Up Period|Lost to Follow-up|7|||
19758092|NCT04421027|42208934|FG000|Follow-Up Period|Protocol Deviation|0|||
19758093|NCT04421027|42208935|FG001|Follow-Up Period|Protocol Deviation|0|||
19758094|NCT04421027|42208936|FG002|Follow-Up Period|Protocol Deviation|1|||
19758095|NCT04421027|42208937|FG003|Follow-Up Period|Protocol Deviation|0|||
19758096|NCT04421027|42208934|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
19758097|NCT04421027|42208935|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
19758098|NCT04421027|42208936|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
19758099|NCT04421027|42208937|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
19758100|NCT04421027|42208934|FG000|Follow-Up Period|Left message, participant did not call back|0|||
19758101|NCT04421027|42208935|FG001|Follow-Up Period|Left message, participant did not call back|0|||
19758102|NCT04421027|42208936|FG002|Follow-Up Period|Left message, participant did not call back|0|||
19758103|NCT04421027|42208937|FG003|Follow-Up Period|Left message, participant did not call back|1|||
19758104|NCT04421027|42208934|FG000|Follow-Up Period|Participant died|0|||
19758105|NCT04421027|42208935|FG001|Follow-Up Period|Participant died|0|||
19758106|NCT04421027|42208936|FG002|Follow-Up Period|Participant died|0|||
19671033|NCT00626795|42119036|FG000|Blinded Treatment|Protocol Violation|0|||
19671034|NCT00626795|42119037|FG001|Blinded Treatment|Protocol Violation|1|||
19671035|NCT00626795|42119038|FG002|Blinded Treatment|Protocol Violation|1|||
19671036|NCT00626795|42119036|FG000|Blinded Treatment|Withdrawal by Subject|1|||
19671037|NCT00626795|42119037|FG001|Blinded Treatment|Withdrawal by Subject|1|||
19671038|NCT00626795|42119038|FG002|Blinded Treatment|Withdrawal by Subject|0|||
19758107|NCT04421027|42208937|FG003|Follow-Up Period|Participant died|1|||
19758108|NCT04421027|42208934|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
19758109|NCT04421027|42208935|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
19758110|NCT04421027|42208936|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
19758111|NCT04421027|42208937|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
19671039|NCT00626795|42119036|FG000|Blinded Treatment|Other reasons|2|||
19671040|NCT00626795|42119037|FG001|Blinded Treatment|Other reasons|0|||
19671041|NCT00626795|42119038|FG002|Blinded Treatment|Other reasons|2|||
19671042|NCT00626795|42119036|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
19671043|NCT00626795|42119037|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
19671044|NCT00626795|42119038|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
19671045|NCT00626639|42119052|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
19671046|NCT00626639|42119053|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
19671047|NCT00626561|42119061|FG000|Overall Study|Withdrawal by Subject|2|||
19671048|NCT00626561|42119061|FG000|Overall Study|Disease Progression|2|||
19671049|NCT03880266|42119073|FG000|Overall Study|Withdrawal by Subject|0|||
19671050|NCT03880266|42119074|FG001|Overall Study|Withdrawal by Subject|1|||
19671051|NCT03880266|42119075|FG002|Overall Study|Withdrawal by Subject|1|||
19671052|NCT03880266|42119076|FG003|Overall Study|Withdrawal by Subject|0|||
19671053|NCT03880266|42119077|FG004|Overall Study|Withdrawal by Subject|0|||
19671054|NCT03880266|42119078|FG005|Overall Study|Withdrawal by Subject|0|||
19671055|NCT03880266|42119079|FG006|Overall Study|Withdrawal by Subject|0|||
19671056|NCT03880266|42119080|FG007|Overall Study|Withdrawal by Subject|0|||
19671057|NCT00423891|42119101|FG000|Enrolled|Withdrawal by Subject|0|||
19671058|NCT00423891|42119102|FG001|Enrolled|Withdrawal by Subject|0|||
19671059|NCT00423891|42119103|FG002|Enrolled|Withdrawal by Subject|1|||
19671060|NCT00423891|42119101|FG000|Enrolled|Lost to Follow-up|0|||
19671061|NCT00423891|42119102|FG001|Enrolled|Lost to Follow-up|0|||
19671062|NCT00423891|42119103|FG002|Enrolled|Lost to Follow-up|1|||
19671063|NCT00423891|42119101|FG000|Enrolled|No longer met criteria|11|||
19671064|NCT00423891|42119102|FG001|Enrolled|No longer met criteria|2|||
19671065|NCT00423891|42119103|FG002|Enrolled|No longer met criteria|1|||
19671066|NCT00423891|42119101|FG000|Treatment|Withdrawal by Subject|1|||
19671067|NCT00423891|42119102|FG001|Treatment|Withdrawal by Subject|0|||
19671068|NCT00423891|42119103|FG002|Treatment|Withdrawal by Subject|0|||
19671069|NCT00423891|42119101|FG000|Treatment|Lost to Follow-up|1|||
19671070|NCT00423891|42119102|FG001|Treatment|Lost to Follow-up|0|||
19671071|NCT00423891|42119103|FG002|Treatment|Lost to Follow-up|0|||
19671072|NCT00423891|42119101|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
19671073|NCT00423891|42119102|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
19671074|NCT00423891|42119103|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
19671075|NCT00423891|42119101|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
19671076|NCT00423891|42119102|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
19671077|NCT00423891|42119103|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
19671078|NCT00423813|42119116|FG000|Overall Study|Adverse Event|11|||
19671079|NCT00423813|42119117|FG001|Overall Study|Adverse Event|30|||
19671080|NCT00423813|42119118|FG002|Overall Study|Adverse Event|40|||
19671081|NCT00423813|42119116|FG000|Overall Study|Withdrawal by Subject|6|||
19671082|NCT00423813|42119117|FG001|Overall Study|Withdrawal by Subject|8|||
19671083|NCT00423813|42119118|FG002|Overall Study|Withdrawal by Subject|5|||
19671084|NCT00423813|42119116|FG000|Overall Study|Lost to Follow-up|5|||
19671085|NCT00423813|42119117|FG001|Overall Study|Lost to Follow-up|4|||
19671086|NCT00423813|42119118|FG002|Overall Study|Lost to Follow-up|4|||
19671087|NCT00423813|42119116|FG000|Overall Study|Lack of Efficacy|23|||
19671088|NCT00423813|42119117|FG001|Overall Study|Lack of Efficacy|18|||
19671089|NCT00423813|42119118|FG002|Overall Study|Lack of Efficacy|19|||
19671090|NCT00423813|42119116|FG000|Overall Study|Physician Decision|2|||
19671091|NCT00423813|42119117|FG001|Overall Study|Physician Decision|0|||
19671092|NCT00423813|42119118|FG002|Overall Study|Physician Decision|0|||
19671093|NCT00423813|42119116|FG000|Overall Study|Sponsor Decision|0|||
19671094|NCT00423813|42119117|FG001|Overall Study|Sponsor Decision|1|||
19671095|NCT00423813|42119118|FG002|Overall Study|Sponsor Decision|0|||
19671096|NCT00423813|42119116|FG000|Overall Study|Protocol Violation|9|||
19671097|NCT00423813|42119117|FG001|Overall Study|Protocol Violation|4|||
19671098|NCT00423813|42119118|FG002|Overall Study|Protocol Violation|4|||
19671099|NCT00423813|42119116|FG000|Overall Study|Pregnancy|0|||
19671100|NCT00423813|42119117|FG001|Overall Study|Pregnancy|0|||
19671101|NCT00423813|42119118|FG002|Overall Study|Pregnancy|1|||
19671102|NCT00423813|42119116|FG000|Overall Study|Subject started night shift work|1|||
19671103|NCT00423813|42119117|FG001|Overall Study|Subject started night shift work|0|||
19671104|NCT00423813|42119118|FG002|Overall Study|Subject started night shift work|0|||
19671105|NCT00423813|42119116|FG000|Overall Study|Will start exclusionary medications|0|||
19671106|NCT00423813|42119117|FG001|Overall Study|Will start exclusionary medications|1|||
19671107|NCT00423813|42119118|FG002|Overall Study|Will start exclusionary medications|0|||
19671108|NCT00423813|42119116|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
19671109|NCT00423813|42119117|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
19671110|NCT00423813|42119118|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
19671111|NCT03687372|42119128|FG000|Overall Study|Lost to Follow-up|12|||
19671112|NCT03687372|42119129|FG001|Overall Study|Lost to Follow-up|21|||
19671113|NCT03687372|42119128|FG000|Overall Study|Withdrawal by Subject|4|||
19671114|NCT03687372|42119129|FG001|Overall Study|Withdrawal by Subject|17|||
19671115|NCT03687372|42119128|FG000|Overall Study|Investigator Decision|1|||
19671116|NCT03687372|42119129|FG001|Overall Study|Investigator Decision|1|||
19671117|NCT00626405|42119139|FG000|Overall Study|Deemed Ineligible|1|||
19671118|NCT00626405|42119140|FG001|Overall Study|Deemed Ineligible|0|||
19671119|NCT00626405|42119139|FG000|Overall Study|Withdrawal by Subject|0|||
19671120|NCT00626405|42119140|FG001|Overall Study|Withdrawal by Subject|1|||
19671121|NCT00358150|42119146|FG000|Overall Study|Adverse Event|3|||
19671122|NCT00358150|42119146|FG000|Overall Study|Withdrawal by Subject|1|||
19671123|NCT00358150|42119146|FG000|Overall Study|Undefined|3|||
19671124|NCT00423735|42119156|FG000|Overall Study|Ineligible / No protocol treatment|8|||
19671125|NCT00423735|42119157|FG001|Overall Study|Ineligible / No protocol treatment|6|||
19671126|NCT00423735|42119158|FG002|Overall Study|Ineligible / No protocol treatment|0|||
19671127|NCT00626327|42119171|FG000|Overall Study|Withdrawal by Subject|21|||
19671128|NCT00626327|42119172|FG001|Overall Study|Withdrawal by Subject|29|||
19671129|NCT00626327|42119173|FG002|Overall Study|Withdrawal by Subject|30|||
19671130|NCT00626327|42119171|FG000|Overall Study|Adverse Event|1|||
19671131|NCT00626327|42119172|FG001|Overall Study|Adverse Event|0|||
19671132|NCT00626327|42119173|FG002|Overall Study|Adverse Event|0|||
19671133|NCT00626327|42119171|FG000|Overall Study|Lost to Follow-up|24|||
19671134|NCT00626327|42119172|FG001|Overall Study|Lost to Follow-up|21|||
19671135|NCT00626327|42119173|FG002|Overall Study|Lost to Follow-up|23|||
19671136|NCT00626327|42119171|FG000|Overall Study|Inappropriate enrollment|4|||
19671137|NCT00626327|42119172|FG001|Overall Study|Inappropriate enrollment|5|||
19671138|NCT00626327|42119173|FG002|Overall Study|Inappropriate enrollment|3|||
19671139|NCT00626327|42119171|FG000|Overall Study|Administrative Reason|2|||
19671140|NCT00626327|42119172|FG001|Overall Study|Administrative Reason|0|||
19671141|NCT00626327|42119173|FG002|Overall Study|Administrative Reason|6|||
19671142|NCT00626327|42119171|FG000|Overall Study|Protocol Violation|26|||
19671143|NCT00626327|42119172|FG001|Overall Study|Protocol Violation|4|||
19671144|NCT00626327|42119173|FG002|Overall Study|Protocol Violation|26|||
19671145|NCT00357994|42119191|FG000|Overall Study|Adverse Event|1|||
19671146|NCT00357994|42119192|FG001|Overall Study|Adverse Event|2|||
19671147|NCT00357994|42119191|FG000|Overall Study|Lack of Efficacy|0|||
19671148|NCT00357994|42119192|FG001|Overall Study|Lack of Efficacy|1|||
19671149|NCT00357994|42119191|FG000|Overall Study|Protocol Violation|1|||
19671150|NCT00357994|42119192|FG001|Overall Study|Protocol Violation|0|||
19671151|NCT00423657|42119200|FG000|Overall Study|Withdrew consent|10|||
19671152|NCT00423657|42119201|FG001|Overall Study|Withdrew consent|8|||
19671153|NCT00423657|42119200|FG000|Overall Study|Non-compliance|0|||
19671154|NCT00423657|42119201|FG001|Overall Study|Non-compliance|1|||
19671155|NCT00423657|42119200|FG000|Overall Study|Other|15|||
19671156|NCT00423657|42119201|FG001|Overall Study|Other|16|||
19671157|NCT00423657|42119200|FG000|Overall Study|Request of sponsor/investigator|1|||
19671158|NCT00423657|42119201|FG001|Overall Study|Request of sponsor/investigator|0|||
19671159|NCT00367432|42119207|FG000|First Period (16 Weeks)|Adverse Event|6|||
19671160|NCT00367432|42119208|FG001|First Period (16 Weeks)|Adverse Event|0|||
19671161|NCT00367432|42119207|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
19671162|NCT00367432|42119208|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
19671163|NCT00367432|42119207|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
19671164|NCT00367432|42119208|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
19671165|NCT00367432|42119207|FG000|First Period (16 Weeks)|Other Reason|2|||
19671166|NCT00367432|42119208|FG001|First Period (16 Weeks)|Other Reason|0|||
19671167|NCT00367432|42119207|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
19671168|NCT00367432|42119208|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
19671169|NCT00367432|42119207|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
19671170|NCT00367432|42119208|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
19671171|NCT00367432|42119207|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
19671172|NCT00367432|42119208|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
19671173|NCT00367432|42119207|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
19671174|NCT00367432|42119208|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
19671175|NCT00367432|42119207|FG000|Second Period (up to 54 Months)|Other Reason|6|||
19671176|NCT00367432|42119208|FG001|Second Period (up to 54 Months)|Other Reason|2|||
19671177|NCT00623363|42119214|FG000|Overall Study|Adverse Event|2|||
19671178|NCT00623363|42119215|FG001|Overall Study|Adverse Event|2|||
19671179|NCT00423267|42119224|FG000|Period A|Withdrawal by Subject|0|||
19671180|NCT00423267|42119225|FG001|Period A|Withdrawal by Subject|1|||
19758112|NCT04419311|42208947|FG000|Overall Study|Lost to Follow-up|1|||
19758113|NCT04419311|42208948|FG001|Overall Study|Lost to Follow-up|0|||
19758114|NCT04411667|42208958|FG000|Overall Study|Physician Decision|1|||
19758115|NCT04411667|42208959|FG001|Overall Study|Physician Decision|0|||
19758116|NCT04358549|42208967|FG000|Overall Study|Adverse Event|0|||
19758117|NCT04358549|42208968|FG001|Overall Study|Adverse Event|1|||
19758118|NCT04358549|42208967|FG000|Overall Study|Death|1|||
19758119|NCT04358549|42208968|FG001|Overall Study|Death|0|||
19758120|NCT04358549|42208967|FG000|Overall Study|Lost to Follow-up|2|||
19758121|NCT04358549|42208968|FG001|Overall Study|Lost to Follow-up|1|||
19758122|NCT04358549|42208967|FG000|Overall Study|Withdrawal by Subject|6|||
19758123|NCT04358549|42208968|FG001|Overall Study|Withdrawal by Subject|6|||
19758124|NCT04358549|42208967|FG000|Overall Study|Start remdesivir|1|||
19758125|NCT04358549|42208968|FG001|Overall Study|Start remdesivir|0|||
19758126|NCT00700180|42208976|FG000|Overall Study|Death|99|||
19758127|NCT00700180|42208977|FG001|Overall Study|Death|114|||
19671181|NCT00423267|42119224|FG000|Period A|Non-compliance with protocol|1|||
19671182|NCT00423267|42119225|FG001|Period A|Non-compliance with protocol|0|||
19671183|NCT00423267|42119224|FG000|Period A|Administrative|1|||
19671184|NCT00423267|42119225|FG001|Period A|Administrative|0|||
19671185|NCT00626093|42119233|FG000|Overall Study|Lost to Follow-up|5|||
19671186|NCT00626093|42119233|FG000|Overall Study|Death|1|||
19389014|NCT02675231|41632562|FG000|Overall Study|Lost to Follow-up|2|||
19671187|NCT00626093|42119233|FG000|Overall Study|Physician Decision|4|||
19671188|NCT00626093|42119233|FG000|Overall Study|Withdrawal by Subject|6|||
19671189|NCT00626093|42119233|FG000|Overall Study|Protocol Violation|1|||
19671190|NCT00626093|42119233|FG000|Overall Study|One of the required devices not implante|6|||
19758128|NCT00700180|42208976|FG000|Overall Study|Alive on treatment|5|||
19758129|NCT00700180|42208977|FG001|Overall Study|Alive on treatment|3|||
19758130|NCT00700180|42208976|FG000|Overall Study|Alive in follow-up|46|||
19758131|NCT00700180|42208977|FG001|Overall Study|Alive in follow-up|27|||
19671191|NCT00357760|42119239|FG000|Overall Study|Disease progression|44|||
19671192|NCT00357760|42119240|FG001|Overall Study|Disease progression|17|||
19758132|NCT00700180|42208976|FG000|Overall Study|Lost to Follow-up|4|||
19758133|NCT00700180|42208977|FG001|Overall Study|Lost to Follow-up|5|||
19758134|NCT00238420|42208985|FG000|Overall Study|Protocol Violation|1|||
19758135|NCT00238420|42208986|FG001|Overall Study|Protocol Violation|1|||
19758136|NCT04492475|42208994|FG000|Overall Study|Enrolled but not treated|8|||
19603593|NCT02794285|42052566|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
19603594|NCT02794285|42052567|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
19603595|NCT02794285|42052568|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
19603596|NCT02794285|42052569|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
19671193|NCT00357760|42119239|FG000|Overall Study|Adverse Event|10|||
19671194|NCT00357760|42119240|FG001|Overall Study|Adverse Event|7|||
19671195|NCT00357760|42119239|FG000|Overall Study|Death|0|||
19671196|NCT00357760|42119240|FG001|Overall Study|Death|3|||
19603597|NCT02794285|42052566|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
19671197|NCT00357760|42119239|FG000|Overall Study|Alternative therapy|1|||
19603598|NCT02794285|42052567|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
19603599|NCT02794285|42052568|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
19603600|NCT02794285|42052569|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
19671198|NCT00357760|42119240|FG001|Overall Study|Alternative therapy|0|||
19671199|NCT00357760|42119239|FG000|Overall Study|Withdrawal by Subject|0|||
19758137|NCT04492475|42208995|FG001|Overall Study|Enrolled but not treated|8|||
19758138|NCT04492475|42208994|FG000|Overall Study|Withdrawal by Subject|4|||
19758139|NCT04492475|42208995|FG001|Overall Study|Withdrawal by Subject|0|||
19758140|NCT04492475|42208994|FG000|Overall Study|Became ineligible after enrollment|2|||
19389015|NCT02675231|41632563|FG001|Overall Study|Lost to Follow-up|2|||
19603601|NCT00970268|42052581|FG000|Overall Study|Withdrawal by Subject|12|||
19603602|NCT00970268|42052582|FG001|Overall Study|Withdrawal by Subject|19|||
19603603|NCT00970268|42052581|FG000|Overall Study|Adverse Event|15|||
19603604|NCT00970268|42052582|FG001|Overall Study|Adverse Event|12|||
19603605|NCT00970268|42052581|FG000|Overall Study|Lack of Efficacy|3|||
19603606|NCT00970268|42052582|FG001|Overall Study|Lack of Efficacy|6|||
19603607|NCT00970268|42052581|FG000|Overall Study|Protocol Violation|4|||
19603608|NCT00970268|42052582|FG001|Overall Study|Protocol Violation|7|||
19603609|NCT00970268|42052581|FG000|Overall Study|Other Reason|3|||
19603610|NCT00970268|42052582|FG001|Overall Study|Other Reason|1|||
19603611|NCT00970268|42052581|FG000|Overall Study|COPD Exacerbation|4|||
19603612|NCT00970268|42052582|FG001|Overall Study|COPD Exacerbation|2|||
19603613|NCT00970268|42052581|FG000|Overall Study|Lost to Follow-up|1|||
19603614|NCT00970268|42052582|FG001|Overall Study|Lost to Follow-up|2|||
19603615|NCT00970268|42052581|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
19603616|NCT00970268|42052582|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
19603617|NCT00969332|42052594|FG000|Overall Study|Physician Decision|8|||
19603618|NCT00969332|42052594|FG000|Overall Study|Withdrawal by Subject|3|||
19603619|NCT00968864|42052599|FG000|Overall Study|Protocol exception/ not evaluable|1|||
19603620|NCT00758680|42052617|FG000|Overall Study|Adverse Event|0|||
19603621|NCT00758680|42052618|FG001|Overall Study|Adverse Event|0|||
19603622|NCT00758680|42052619|FG002|Overall Study|Adverse Event|0|||
19603623|NCT00758680|42052620|FG003|Overall Study|Adverse Event|0|||
19603624|NCT00758680|42052621|FG004|Overall Study|Adverse Event|0|||
19603625|NCT00758680|42052622|FG005|Overall Study|Adverse Event|0|||
19603626|NCT00758680|42052623|FG006|Overall Study|Adverse Event|0|||
19603627|NCT00758680|42052624|FG007|Overall Study|Adverse Event|1|||
19603628|NCT00758680|42052625|FG008|Overall Study|Adverse Event|0|||
19603629|NCT00758680|42052626|FG009|Overall Study|Adverse Event|1|||
19603630|NCT00758680|42052617|FG000|Overall Study|Laboratory Adverse Event|0|||
19603631|NCT00758680|42052618|FG001|Overall Study|Laboratory Adverse Event|0|||
19603632|NCT00758680|42052619|FG002|Overall Study|Laboratory Adverse Event|0|||
19603633|NCT00758680|42052620|FG003|Overall Study|Laboratory Adverse Event|0|||
19603634|NCT00758680|42052621|FG004|Overall Study|Laboratory Adverse Event|0|||
19603635|NCT00758680|42052622|FG005|Overall Study|Laboratory Adverse Event|0|||
19603636|NCT00758680|42052623|FG006|Overall Study|Laboratory Adverse Event|0|||
19603637|NCT00758680|42052624|FG007|Overall Study|Laboratory Adverse Event|0|||
19603638|NCT00758680|42052625|FG008|Overall Study|Laboratory Adverse Event|1|||
19603639|NCT00758680|42052626|FG009|Overall Study|Laboratory Adverse Event|0|||
19603640|NCT00758680|42052617|FG000|Overall Study|Withdrawal by Subject|0|||
19603641|NCT00758680|42052618|FG001|Overall Study|Withdrawal by Subject|0|||
19603642|NCT00758680|42052619|FG002|Overall Study|Withdrawal by Subject|0|||
19603643|NCT00758680|42052620|FG003|Overall Study|Withdrawal by Subject|0|||
19603644|NCT00758680|42052621|FG004|Overall Study|Withdrawal by Subject|0|||
19671200|NCT00357760|42119240|FG001|Overall Study|Withdrawal by Subject|2|||
19671201|NCT00357760|42119239|FG000|Overall Study|Never started treatment|2|||
19671202|NCT00357760|42119240|FG001|Overall Study|Never started treatment|1|||
19671203|NCT00357760|42119239|FG000|Overall Study|Ineligible|0|||
19671204|NCT00357760|42119240|FG001|Overall Study|Ineligible|2|||
19671205|NCT00357760|42119239|FG000|Overall Study|Physician Decision|2|||
19671206|NCT00357760|42119240|FG001|Overall Study|Physician Decision|1|||
19671207|NCT00357760|42119239|FG000|Overall Study|Protocol Violation|0|||
19671208|NCT00357760|42119240|FG001|Overall Study|Protocol Violation|1|||
19671209|NCT00357760|42119239|FG000|Overall Study|To receive hospice care|0|||
19671210|NCT00357760|42119240|FG001|Overall Study|To receive hospice care|1|||
19671211|NCT00622739|42119248|FG000|Overall Study|Physician Decision|1|||
19671212|NCT00622739|42119249|FG001|Overall Study|Physician Decision|0|||
19671213|NCT00622739|42119248|FG000|Overall Study|Adverse Event|1|||
19671214|NCT00622739|42119249|FG001|Overall Study|Adverse Event|2|||
19671215|NCT00622739|42119248|FG000|Overall Study|Lack of Efficacy|0|||
19671216|NCT00622739|42119249|FG001|Overall Study|Lack of Efficacy|2|||
19671217|NCT00622739|42119248|FG000|Overall Study|Withdrawal by Subject|0|||
19671218|NCT00622739|42119249|FG001|Overall Study|Withdrawal by Subject|1|||
19671219|NCT00622739|42119248|FG000|Overall Study|Lost to Follow-up|0|||
19671220|NCT00622739|42119249|FG001|Overall Study|Lost to Follow-up|1|||
19671221|NCT00435825|42119261|FG000|Overall Study|Abnormality of Laboratory Test|0|||
19671222|NCT00435825|42119262|FG001|Overall Study|Abnormality of Laboratory Test|1|||
19671223|NCT00435825|42119263|FG002|Overall Study|Abnormality of Laboratory Test|0|||
19671224|NCT00435825|42119264|FG003|Overall Study|Abnormality of Laboratory Test|0|||
19671225|NCT00435825|42119261|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19671226|NCT00435825|42119262|FG001|Overall Study|Insufficient Therapeutic Response|1|||
19671227|NCT00435825|42119263|FG002|Overall Study|Insufficient Therapeutic Response|0|||
19671228|NCT00435825|42119264|FG003|Overall Study|Insufficient Therapeutic Response|3|||
19671229|NCT00435825|42119261|FG000|Overall Study|Other Protocol Violation|1|||
19671230|NCT00435825|42119262|FG001|Overall Study|Other Protocol Violation|0|||
19671231|NCT00435825|42119263|FG002|Overall Study|Other Protocol Violation|0|||
19671232|NCT00435825|42119264|FG003|Overall Study|Other Protocol Violation|0|||
19671233|NCT00435825|42119261|FG000|Overall Study|Refused treatment|2|||
19671234|NCT00435825|42119262|FG001|Overall Study|Refused treatment|0|||
19671235|NCT00435825|42119263|FG002|Overall Study|Refused treatment|0|||
19671236|NCT00435825|42119264|FG003|Overall Study|Refused treatment|5|||
19671237|NCT00435825|42119261|FG000|Overall Study|Failure to return|5|||
19671238|NCT00435825|42119262|FG001|Overall Study|Failure to return|0|||
19671239|NCT00435825|42119263|FG002|Overall Study|Failure to return|4|||
19671240|NCT00435825|42119264|FG003|Overall Study|Failure to return|0|||
19671241|NCT00435825|42119261|FG000|Overall Study|Did not receive study drug|1|||
19671242|NCT00435825|42119262|FG001|Overall Study|Did not receive study drug|0|||
19671243|NCT00435825|42119263|FG002|Overall Study|Did not receive study drug|2|||
19671244|NCT00435825|42119264|FG003|Overall Study|Did not receive study drug|0|||
19671245|NCT00435825|42119261|FG000|Overall Study|Did not enter follow-up|0|||
19671246|NCT00435825|42119262|FG001|Overall Study|Did not enter follow-up|4|||
19671247|NCT00435825|42119263|FG002|Overall Study|Did not enter follow-up|1|||
19671248|NCT00435825|42119264|FG003|Overall Study|Did not enter follow-up|3|||
19671249|NCT00435825|42119261|FG000|Overall Study|Did not complete full follow-up period|6|||
19758141|NCT04492475|42208995|FG001|Overall Study|Became ineligible after enrollment|0|||
19758142|NCT04486235|42209010|FG000|Overall Study|Pregnancy|1|||
19671250|NCT00435825|42119262|FG001|Overall Study|Did not complete full follow-up period|6|||
19671251|NCT00435825|42119263|FG002|Overall Study|Did not complete full follow-up period|4|||
19671252|NCT00435825|42119264|FG003|Overall Study|Did not complete full follow-up period|5|||
19671253|NCT00574145|42119276|FG000|Overall Study|Withdrawal by Subject|2|||
19671254|NCT00574145|42119277|FG001|Overall Study|Withdrawal by Subject|1|||
19671255|NCT00423189|42119286|FG000|Overall Study|Death|0|||
19671256|NCT00423189|42119287|FG001|Overall Study|Death|1|||
19671257|NCT00423189|42119288|FG002|Overall Study|Death|0|||
19671258|NCT00422799|42119301|FG000|Overall Study|Withdrawal by Subject|6|||
19671259|NCT00422799|42119301|FG000|Overall Study|Adverse Event|7|||
19671260|NCT00435045|42119307|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
19671261|NCT00435045|42119308|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
19671262|NCT00435045|42119307|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
19671263|NCT00435045|42119308|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
19671264|NCT00435045|42119307|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
19671265|NCT00435045|42119308|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
19671266|NCT00435045|42119307|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
19671267|NCT00435045|42119308|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
19671268|NCT00435045|42119307|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
19671269|NCT00435045|42119308|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
19671270|NCT00435045|42119307|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
19671271|NCT00435045|42119308|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
19671272|NCT00435045|42119307|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
19758143|NCT04486235|42209011|FG001|Overall Study|Pregnancy|0|||
19671273|NCT00435045|42119308|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
19671274|NCT00435045|42119307|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
19671275|NCT00435045|42119308|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
19671276|NCT00435045|42119307|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
19671277|NCT00435045|42119308|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
19671278|NCT00435045|42119307|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
19671279|NCT00435045|42119308|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
19671280|NCT00435045|42119307|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
19671281|NCT00435045|42119308|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
19758144|NCT04486235|42209010|FG000|Overall Study|Lost to Follow-up|1|||
19758145|NCT04486235|42209011|FG001|Overall Study|Lost to Follow-up|0|||
19671282|NCT00441129|42119316|FG000|Overall Study|Withdrawal by Subject|6|||
19671283|NCT00441129|42119317|FG001|Overall Study|Withdrawal by Subject|14|||
19671284|NCT00622505|42119325|FG000|Overall Study|Adverse Event|9|||
19671285|NCT00622505|42119326|FG001|Overall Study|Adverse Event|7|||
19758146|NCT04358081|42209021|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
19758147|NCT04358081|42209022|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
19758148|NCT04358081|42209023|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
19758149|NCT04358081|42209021|FG000|Treatment Phase of Study|Adverse Event|1|||
19603645|NCT00758680|42052622|FG005|Overall Study|Withdrawal by Subject|0|||
19603646|NCT00758680|42052623|FG006|Overall Study|Withdrawal by Subject|1|||
19603647|NCT00758680|42052624|FG007|Overall Study|Withdrawal by Subject|0|||
19603648|NCT00758680|42052625|FG008|Overall Study|Withdrawal by Subject|1|||
19603649|NCT00758680|42052626|FG009|Overall Study|Withdrawal by Subject|0|||
19603650|NCT00758602|42052651|FG000|Overall Study|Adverse Event|11|||
19603651|NCT00758602|42052652|FG001|Overall Study|Adverse Event|10|||
19603652|NCT00758602|42052651|FG000|Overall Study|Lost to Follow-up|4|||
19603653|NCT00758602|42052652|FG001|Overall Study|Lost to Follow-up|3|||
19603654|NCT00758602|42052651|FG000|Overall Study|Withdrawal by Subject|1|||
19603655|NCT00758602|42052652|FG001|Overall Study|Withdrawal by Subject|3|||
19603656|NCT00758602|42052651|FG000|Overall Study|Protocol Violation|0|||
19603657|NCT00758602|42052652|FG001|Overall Study|Protocol Violation|2|||
19603658|NCT00758602|42052651|FG000|Overall Study|Death|0|||
19603659|NCT00758602|42052652|FG001|Overall Study|Death|1|||
19603660|NCT00758602|42052651|FG000|Overall Study|Reason not specified|3|||
19603661|NCT00758602|42052652|FG001|Overall Study|Reason not specified|3|||
19603662|NCT00713323|42052659|FG000|Overall Study|Adverse Event|75|||
19603663|NCT00713323|42052659|FG000|Overall Study|Withdrawal by Subject|15|||
19603664|NCT00713323|42052659|FG000|Overall Study|Lost to Follow-up|11|||
19603665|NCT00713323|42052659|FG000|Overall Study|Lack of Efficacy|36|||
19603666|NCT00713323|42052659|FG000|Overall Study|Low creatine clearance at screening|1|||
19603667|NCT00713323|42052659|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
19603668|NCT00713323|42052659|FG000|Overall Study|Surgery cured allodynic pain|1|||
19603669|NCT00713323|42052659|FG000|Overall Study|Pain free|1|||
19603670|NCT00713323|42052659|FG000|Overall Study|Non-compliance|1|||
19603671|NCT00713323|42052659|FG000|Overall Study|Pain resolved|1|||
19603672|NCT00713323|42052659|FG000|Overall Study|Subject travelling to USA|1|||
19603673|NCT00713323|42052659|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
19603674|NCT00713323|42052659|FG000|Overall Study|Treatment that may interact with Sativex|1|||
19603675|NCT00711529|42052665|FG000|Overall Study|Protocol Violation|2|||
19603676|NCT00711529|42052666|FG001|Overall Study|Protocol Violation|0|||
19603677|NCT00711529|42052665|FG000|Overall Study|Withdrawal by Subject|2|||
19603678|NCT00711529|42052666|FG001|Overall Study|Withdrawal by Subject|6|||
19603679|NCT00601419|42052672|FG000|Overall Study|Lost to Follow-up|3|||
19603680|NCT00601419|42052672|FG000|Overall Study|Missed Visits|1|||
19603681|NCT00712933|42052692|FG000|Overall Study|Adverse Event|69|||
19603682|NCT00712933|42052692|FG000|Overall Study|Lack of Efficacy|6|||
19603683|NCT00712933|42052692|FG000|Overall Study|Lost to Follow-up|22|||
19603684|NCT00712933|42052692|FG000|Overall Study|Non-compliance with study drug|13|||
19603685|NCT00712933|42052692|FG000|Overall Study|Other Pregnancy|37|||
19603686|NCT00712933|42052692|FG000|Overall Study|Sponsor decision|14|||
19603687|NCT00712933|42052692|FG000|Overall Study|Withdrew consent|4|||
19603688|NCT00712933|42052692|FG000|Overall Study|Hip replacement surgery|1|||
19603689|NCT00712933|42052692|FG000|Overall Study|Involved in Clinical research|3|||
19603690|NCT00712933|42052692|FG000|Overall Study|Participant hospitalized|1|||
19603691|NCT00712933|42052692|FG000|Overall Study|Participant travelled overseas|2|||
19603692|NCT00712933|42052692|FG000|Overall Study|Death of patient|1|||
19603693|NCT00712933|42052692|FG000|Overall Study|Other Physician decision|1|||
19603694|NCT00712933|42052692|FG000|Overall Study|Not committed to contraception|1|||
19603695|NCT00712933|42052692|FG000|Overall Study|Participant received medication|1|||
19603696|NCT00712933|42052692|FG000|Overall Study|Physician Decision|36|||
19603697|NCT00712933|42052692|FG000|Overall Study|Protocol Violation|4|||
19603698|NCT00712933|42052692|FG000|Overall Study|Withdrawal by Subject|151|||
19603699|NCT00712543|42052702|FG000|Day 8-14|Lost to Follow-up|0|||
19603700|NCT00712543|42052703|FG001|Day 8-14|Lost to Follow-up|2|||
19477161|NCT01513291|41756109|FG001|Treatment Period|Lost to Follow-up|3|||
19603701|NCT00709111|42052709|FG000|Overall Study|Withdrawal by Subject|1|||
19603702|NCT00709111|42052709|FG000|Overall Study|Unable to attend clinic visits|1|||
19603703|NCT00710749|42052713|FG000|First Intervention|Withdrawal by Subject|1|||
19603704|NCT00710749|42052714|FG001|First Intervention|Withdrawal by Subject|0|||
19603705|NCT00699907|42052734|FG000|Overall Study|Withdrawal by Subject|2|||
19603706|NCT00699907|42052735|FG001|Overall Study|Withdrawal by Subject|1|||
19603707|NCT00699907|42052736|FG002|Overall Study|Withdrawal by Subject|0|||
19603708|NCT00699907|42052734|FG000|Overall Study|No usable sample|0|||
19603709|NCT00699907|42052735|FG001|Overall Study|No usable sample|9|||
19603710|NCT00699907|42052736|FG002|Overall Study|No usable sample|8|||
19603711|NCT00710593|42052746|FG000|Overall Study|Incarceration|1|||
19603712|NCT00710593|42052747|FG001|Overall Study|Incarceration|0|||
19603713|NCT00710593|42052746|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
19603714|NCT00710593|42052747|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
19603715|NCT00710593|42052746|FG000|Overall Study|Lost to Follow-up|3|||
19603716|NCT00710593|42052747|FG001|Overall Study|Lost to Follow-up|1|||
19603717|NCT00710593|42052746|FG000|Overall Study|Moved out of area|1|||
19603718|NCT00710593|42052747|FG001|Overall Study|Moved out of area|0|||
19603719|NCT00710593|42052746|FG000|Overall Study|Failure to adhere or complete study eval|1|||
19603720|NCT00710593|42052747|FG001|Overall Study|Failure to adhere or complete study eval|1|||
19603721|NCT00710593|42052746|FG000|Overall Study|Protocol Violation|1|||
19603722|NCT00710593|42052747|FG001|Overall Study|Protocol Violation|1|||
19671286|NCT00622505|42119325|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
19671287|NCT00622505|42119326|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
19671288|NCT00622505|42119325|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
19671289|NCT00622505|42119326|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
19758150|NCT04358081|42209022|FG001|Treatment Phase of Study|Adverse Event|0|||
19758151|NCT04358081|42209023|FG002|Treatment Phase of Study|Adverse Event|1|||
19758152|NCT04358081|42209021|FG000|Treatment Phase of Study|Physician Decision|2|||
19758153|NCT04358081|42209022|FG001|Treatment Phase of Study|Physician Decision|0|||
19758154|NCT04358081|42209023|FG002|Treatment Phase of Study|Physician Decision|1|||
19671290|NCT00622505|42119325|FG000|Overall Study|Withdrawal by Subject|12|||
19671291|NCT00622505|42119326|FG001|Overall Study|Withdrawal by Subject|5|||
19671292|NCT00622505|42119325|FG000|Overall Study|Administrative Problems|2|||
19671293|NCT00622505|42119326|FG001|Overall Study|Administrative Problems|4|||
19671294|NCT00622505|42119325|FG000|Overall Study|Death|2|||
19671295|NCT00622505|42119326|FG001|Overall Study|Death|2|||
19671296|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Adverse Event|1|||
19671297|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Adverse Event|0|||
19477162|NCT01513291|41756110|FG002|Treatment Period|Lost to Follow-up|0|||
19477163|NCT01513291|41756111|FG003|Treatment Period|Lost to Follow-up|0|||
19671298|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Death|1|||
19671299|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Death|0|||
19671300|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2|||
19671301|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0|||
19671302|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3|||
19671303|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0|||
19671304|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Physician Decision|2|||
19671305|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Physician Decision|1|||
19671306|NCT00350272|42119334|FG000|Blinded 12 Week Treatment|Sponsor decision|0|||
19671307|NCT00350272|42119335|FG001|Blinded 12 Week Treatment|Sponsor decision|1|||
19671308|NCT00350272|42119334|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
19671309|NCT00350272|42119335|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
19671310|NCT00350272|42119334|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
19671311|NCT00350272|42119335|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
19671312|NCT00350272|42119334|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
19671313|NCT00350272|42119335|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
19671314|NCT00350272|42119334|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
19671315|NCT00350272|42119335|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
19671316|NCT00350272|42119334|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
19671317|NCT00350272|42119335|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
19671318|NCT00357370|42119346|FG000|Cohort 2|Lack of Efficacy|0|||
19671319|NCT00357370|42119347|FG001|Cohort 2|Lack of Efficacy|2|||
19671320|NCT00357370|42119348|FG002|Cohort 2|Lack of Efficacy|1|||
19758155|NCT04358081|42209021|FG000|Treatment Phase of Study|Protocol Violation|1|||
19477164|NCT01513291|41756112|FG004|Treatment Period|Lost to Follow-up|0|||
19671321|NCT00357370|42119346|FG000|Cohort 2|Adverse Event|1|||
19671322|NCT00357370|42119347|FG001|Cohort 2|Adverse Event|1|||
19671323|NCT00357370|42119348|FG002|Cohort 2|Adverse Event|1|||
19671324|NCT00357370|42119346|FG000|Cohort 2|Lost to Follow-up|0|||
19671325|NCT00357370|42119347|FG001|Cohort 2|Lost to Follow-up|1|||
19671326|NCT00357370|42119348|FG002|Cohort 2|Lost to Follow-up|0|||
19671327|NCT00357370|42119346|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
19671328|NCT00357370|42119347|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
19671329|NCT00357370|42119348|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
19671330|NCT00357370|42119346|FG000|Cohort 2|Withdrawal by Subject|0|||
19671331|NCT00357370|42119347|FG001|Cohort 2|Withdrawal by Subject|2|||
19671332|NCT00357370|42119348|FG002|Cohort 2|Withdrawal by Subject|0|||
19671333|NCT00574847|42119358|FG000|Overall Study|Adverse Event|2|||
19671334|NCT00574847|42119359|FG001|Overall Study|Adverse Event|0|||
19671335|NCT00574847|42119358|FG000|Overall Study|Death|1|||
19671336|NCT00574847|42119359|FG001|Overall Study|Death|0|||
19671337|NCT00574847|42119358|FG000|Overall Study|Withdrawal by Subject|2|||
19671338|NCT00574847|42119359|FG001|Overall Study|Withdrawal by Subject|2|||
19671339|NCT00574847|42119358|FG000|Overall Study|Physician Decision|1|||
19671340|NCT00574847|42119359|FG001|Overall Study|Physician Decision|0|||
19671341|NCT00574847|42119358|FG000|Overall Study|Did not receive medication (declined)|2|||
19758156|NCT04358081|42209022|FG001|Treatment Phase of Study|Protocol Violation|0|||
19758157|NCT04358081|42209023|FG002|Treatment Phase of Study|Protocol Violation|0|||
19758158|NCT04358081|42209021|FG000|Study Completion Phase|Death|0|||
19758159|NCT04358081|42209022|FG001|Study Completion Phase|Death|0|||
19671342|NCT00574847|42119359|FG001|Overall Study|Did not receive medication (declined)|5|||
19671343|NCT00348790|42119365|FG000|Completed Treatment|Withdrawal by Subject|4|||
19671344|NCT00348790|42119365|FG000|Completed Treatment|Disease progression|14|||
19671345|NCT00348790|42119365|FG000|Completed Treatment|Adverse Event|4|||
19671346|NCT00348790|42119365|FG000|Completed Treatment|Required surgery|2|||
19671347|NCT00348790|42119365|FG000|Completed Treatment|Unable to travel to study site|1|||
19671348|NCT00360490|42119372|FG000|Overall Study|Adverse Event|4|||
19671349|NCT00360490|42119373|FG001|Overall Study|Adverse Event|2|||
19671350|NCT00360490|42119372|FG000|Overall Study|Lost to Follow-up|2|||
19671351|NCT00360490|42119373|FG001|Overall Study|Lost to Follow-up|1|||
19671352|NCT00360490|42119372|FG000|Overall Study|Physician Decision|2|||
19671353|NCT00360490|42119373|FG001|Overall Study|Physician Decision|1|||
19671354|NCT00360490|42119372|FG000|Overall Study|Protocol Violation|0|||
19671355|NCT00360490|42119373|FG001|Overall Study|Protocol Violation|4|||
19671356|NCT00360490|42119372|FG000|Overall Study|Withdrawal by Subject|1|||
19671357|NCT00360490|42119373|FG001|Overall Study|Withdrawal by Subject|3|||
19671358|NCT00624377|42119379|FG000|Overall Study|Lost to Follow-up|355|||
19671359|NCT00624377|42119379|FG000|Overall Study|Withdrawal by Subject|100|||
19671360|NCT00624377|42119379|FG000|Overall Study|Adverse Event|14|||
19671361|NCT00624377|42119379|FG000|Overall Study|Other|91|||
19671362|NCT00624377|42119379|FG000|Overall Study|Non-evaluable population|84|||
19671363|NCT00624065|42119385|FG000|Overall Study|Adverse Event|5|||
19671364|NCT00624065|42119386|FG001|Overall Study|Adverse Event|6|||
19671365|NCT00624065|42119385|FG000|Overall Study|Lost to Follow-up|4|||
19671366|NCT00624065|42119386|FG001|Overall Study|Lost to Follow-up|1|||
19671367|NCT00624065|42119385|FG000|Overall Study|Consent withdrawn|6|||
19671368|NCT00624065|42119386|FG001|Overall Study|Consent withdrawn|5|||
19671369|NCT00624065|42119385|FG000|Overall Study|Lack of Efficacy|0|||
19671370|NCT00624065|42119386|FG001|Overall Study|Lack of Efficacy|3|||
19671371|NCT00624065|42119385|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
19671372|NCT00624065|42119386|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
19671373|NCT00360412|42119394|FG000|Overall Study|Adverse Event|37|||
19671374|NCT00360412|42119395|FG001|Overall Study|Adverse Event|65|||
19758160|NCT04358081|42209023|FG002|Study Completion Phase|Death|1|||
19758161|NCT04358081|42209021|FG000|Study Completion Phase|Lost to Follow-up|1|||
19758162|NCT04358081|42209022|FG001|Study Completion Phase|Lost to Follow-up|0|||
19671375|NCT00360412|42119394|FG000|Overall Study|Protocol Violation|2|||
19671376|NCT00360412|42119395|FG001|Overall Study|Protocol Violation|5|||
19671377|NCT00360412|42119394|FG000|Overall Study|Patient withdrew consent|27|||
19671378|NCT00360412|42119395|FG001|Overall Study|Patient withdrew consent|52|||
19671379|NCT00360412|42119394|FG000|Overall Study|Lack of therapeutic efficacy|46|||
19671380|NCT00360412|42119395|FG001|Overall Study|Lack of therapeutic efficacy|61|||
19671381|NCT00360412|42119394|FG000|Overall Study|Physician Decision|2|||
19671382|NCT00360412|42119395|FG001|Overall Study|Physician Decision|4|||
19671383|NCT00360412|42119394|FG000|Overall Study|Other|5|||
19671384|NCT00360412|42119395|FG001|Overall Study|Other|6|||
19671385|NCT00360412|42119394|FG000|Overall Study|Study termination by Sponsor|214|||
19671386|NCT00360412|42119395|FG001|Overall Study|Study termination by Sponsor|469|||
19671387|NCT00623831|42119403|FG000|Overall Study|Withdrawal by Subject|1|||
19671388|NCT00623831|42119404|FG001|Overall Study|Withdrawal by Subject|0|||
19671389|NCT00623831|42119403|FG000|Overall Study|Progressive Disease|0|||
19671390|NCT00623831|42119404|FG001|Overall Study|Progressive Disease|1|||
19758163|NCT04358081|42209023|FG002|Study Completion Phase|Lost to Follow-up|1|||
19671391|NCT00360334|42119415|FG000|Overall Study|Adverse Event|7|||
19671392|NCT00360334|42119416|FG001|Overall Study|Adverse Event|4|||
19671393|NCT00360334|42119415|FG000|Overall Study|Protocol Violation|1|||
19671394|NCT00360334|42119416|FG001|Overall Study|Protocol Violation|1|||
19671395|NCT00360334|42119415|FG000|Overall Study|Physician Decision|2|||
19671396|NCT00360334|42119416|FG001|Overall Study|Physician Decision|3|||
19671397|NCT00360334|42119415|FG000|Overall Study|Lack of Efficacy|0|||
19671398|NCT00360334|42119416|FG001|Overall Study|Lack of Efficacy|1|||
19671399|NCT00360334|42119415|FG000|Overall Study|Entry criterion not met|1|||
19671400|NCT00360334|42119416|FG001|Overall Study|Entry criterion not met|2|||
19671401|NCT00360334|42119415|FG000|Overall Study|Subject decision|8|||
19671402|NCT00360334|42119416|FG001|Overall Study|Subject decision|2|||
19671403|NCT00422097|42119428|FG000|Dose Level 2|Still on treatment|0|||
19671404|NCT00422097|42119429|FG001|Dose Level 2|Still on treatment|1|||
19671405|NCT00422097|42119430|FG002|Dose Level 2|Still on treatment|0|||
19671406|NCT00422097|42119431|FG003|Dose Level 2|Still on treatment|0|||
19671407|NCT00422097|42119432|FG004|Dose Level 2|Still on treatment|0|||
19671408|NCT00422097|42119433|FG005|Dose Level 2|Still on treatment|0|||
19671409|NCT00422097|42119434|FG006|Dose Level 2|Still on treatment|0|||
19671410|NCT00422097|42119435|FG007|Dose Level 2|Still on treatment|0|||
19671411|NCT00348556|42119459|FG000|Overall Study|Adverse Event|1|||
19671412|NCT00434967|42119467|FG000|Overall Study|Adverse Event|2|||
19671413|NCT00434967|42119468|FG001|Overall Study|Adverse Event|4|||
19671414|NCT00434967|42119469|FG002|Overall Study|Adverse Event|3|||
19671415|NCT00434967|42119470|FG003|Overall Study|Adverse Event|3|||
19671416|NCT00434967|42119467|FG000|Overall Study|Lost to Follow-up|0|||
19671417|NCT00434967|42119468|FG001|Overall Study|Lost to Follow-up|0|||
19671418|NCT00434967|42119469|FG002|Overall Study|Lost to Follow-up|1|||
19671419|NCT00434967|42119470|FG003|Overall Study|Lost to Follow-up|0|||
19671420|NCT00434967|42119467|FG000|Overall Study|Withdrawal by Subject|2|||
19671421|NCT00434967|42119468|FG001|Overall Study|Withdrawal by Subject|2|||
19671422|NCT00434967|42119469|FG002|Overall Study|Withdrawal by Subject|4|||
19671423|NCT00434967|42119470|FG003|Overall Study|Withdrawal by Subject|6|||
19671424|NCT00434967|42119467|FG000|Overall Study|Randomized in error|0|||
19671425|NCT00434967|42119468|FG001|Overall Study|Randomized in error|0|||
19671426|NCT00434967|42119469|FG002|Overall Study|Randomized in error|0|||
19671427|NCT00434967|42119470|FG003|Overall Study|Randomized in error|1|||
19671428|NCT00434967|42119467|FG000|Overall Study|Protocol Violation|0|||
19671429|NCT00434967|42119468|FG001|Overall Study|Protocol Violation|1|||
19671430|NCT00434967|42119469|FG002|Overall Study|Protocol Violation|0|||
19758164|NCT04355663|42209036|FG000|Overall Study|Physician Decision|2|||
19758165|NCT04355663|42209037|FG001|Overall Study|Physician Decision|7|||
19758166|NCT04355663|42209038|FG002|Overall Study|Physician Decision|0|||
19758167|NCT04355663|42209036|FG000|Overall Study|Adverse Event|0|||
19758168|NCT04355663|42209037|FG001|Overall Study|Adverse Event|0|||
19758169|NCT04355663|42209038|FG002|Overall Study|Adverse Event|1|||
19758170|NCT04355663|42209036|FG000|Overall Study|Withdrawal by Subject|0|||
19758171|NCT04355663|42209037|FG001|Overall Study|Withdrawal by Subject|8|||
19758172|NCT04355663|42209038|FG002|Overall Study|Withdrawal by Subject|3|||
19758173|NCT04345367|42209048|FG000|Overall Study|Other|3|||
19671431|NCT00434967|42119470|FG003|Overall Study|Protocol Violation|1|||
19671432|NCT00434967|42119467|FG000|Overall Study|Physician Decision|1|||
19671433|NCT00434967|42119468|FG001|Overall Study|Physician Decision|1|||
19671434|NCT00434967|42119469|FG002|Overall Study|Physician Decision|1|||
19671435|NCT00434967|42119470|FG003|Overall Study|Physician Decision|0|||
19671436|NCT00434967|42119467|FG000|Overall Study|Patient Disposition Challenges|2|||
19671437|NCT00434967|42119468|FG001|Overall Study|Patient Disposition Challenges|0|||
19671438|NCT00434967|42119469|FG002|Overall Study|Patient Disposition Challenges|0|||
19671439|NCT00434967|42119470|FG003|Overall Study|Patient Disposition Challenges|3|||
19671440|NCT00356590|42119480|FG000|Overall Study|Adverse Event|54|||
19671441|NCT00356590|42119480|FG000|Overall Study|Death|10|||
19671442|NCT00356590|42119480|FG000|Overall Study|Lost to Follow-up|35|||
19671443|NCT00356590|42119480|FG000|Overall Study|Physician Decision|46|||
19671444|NCT00356590|42119480|FG000|Overall Study|Withdrawal by Subject|41|||
19671445|NCT00356590|42119480|FG000|Overall Study|Completed month 12 only|2|||
19671446|NCT00356590|42119480|FG000|Overall Study|Protocol issues|6|||
19671447|NCT00356590|42119480|FG000|Overall Study|Response status|28|||
19671448|NCT00356590|42119480|FG000|Overall Study|Other|52|||
19671449|NCT00356278|42119487|FG000|Overall Study|Withdrawal by Subject|25|||
19671450|NCT00356278|42119488|FG001|Overall Study|Withdrawal by Subject|15|||
19671451|NCT00356278|42119489|FG002|Overall Study|Withdrawal by Subject|19|||
19671452|NCT00356200|42119499|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
19671453|NCT00356200|42119500|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
19671454|NCT00356200|42119499|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
19671455|NCT00356200|42119500|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
19671456|NCT00356122|42119512|FG000|TREATMENT|Lack of Efficacy|26|||
19758174|NCT04345367|42209049|FG001|Overall Study|Other|4|||
19671457|NCT00356122|42119512|FG000|TREATMENT|Adverse Event|10|||
19671458|NCT00356122|42119512|FG000|TREATMENT|Subject's request|4|||
19671459|NCT00356122|42119512|FG000|TREATMENT|Other|4|||
19671460|NCT00356122|42119512|FG000|TREATMENT|Did not receive study medication|1|||
19671461|NCT00356122|42119512|FG000|FOLLOW-UP|Death|37|||
19671462|NCT00356122|42119512|FG000|FOLLOW-UP|Lost to Follow-up|2|||
19671463|NCT00356122|42119512|FG000|FOLLOW-UP|Other|2|||
19671464|NCT00347932|42119518|FG000|Overall Study|Adverse Event|4|||
19671465|NCT00347932|42119519|FG001|Overall Study|Adverse Event|5|||
19671466|NCT00347932|42119518|FG000|Overall Study|Lack of Efficacy|3|||
19671467|NCT00347932|42119519|FG001|Overall Study|Lack of Efficacy|14|||
19671468|NCT00347932|42119518|FG000|Overall Study|Lost to Follow-up|10|||
19671469|NCT00347932|42119519|FG001|Overall Study|Lost to Follow-up|9|||
19671470|NCT00347932|42119518|FG000|Overall Study|Withdrawal by Subject|10|||
19671471|NCT00347932|42119519|FG001|Overall Study|Withdrawal by Subject|16|||
19671472|NCT00347932|42119518|FG000|Overall Study|Did not meet inclusion criteria|4|||
19671473|NCT00347932|42119519|FG001|Overall Study|Did not meet inclusion criteria|8|||
19671474|NCT00528996|42119530|FG000|Overall Study|Other reasons than listing|6|||
19671475|NCT00528996|42119531|FG001|Overall Study|Other reasons than listing|7|||
19671476|NCT00528996|42119532|FG002|Overall Study|Other reasons than listing|14|||
19671477|NCT00528996|42119533|FG003|Overall Study|Other reasons than listing|11|||
19671478|NCT00528996|42119534|FG004|Overall Study|Other reasons than listing|5|||
19671479|NCT00528996|42119530|FG000|Overall Study|Refused continue medication|16|||
19671480|NCT00528996|42119531|FG001|Overall Study|Refused continue medication|0|||
19671481|NCT00528996|42119532|FG002|Overall Study|Refused continue medication|3|||
19671482|NCT00528996|42119533|FG003|Overall Study|Refused continue medication|3|||
19671483|NCT00528996|42119534|FG004|Overall Study|Refused continue medication|6|||
19671484|NCT00528996|42119530|FG000|Overall Study|Lost to Follow-up|2|||
19671485|NCT00528996|42119531|FG001|Overall Study|Lost to Follow-up|0|||
19671486|NCT00528996|42119532|FG002|Overall Study|Lost to Follow-up|4|||
19671487|NCT00528996|42119533|FG003|Overall Study|Lost to Follow-up|1|||
19671488|NCT00528996|42119534|FG004|Overall Study|Lost to Follow-up|3|||
19671489|NCT00528996|42119530|FG000|Overall Study|Protocol Violation|1|||
19671490|NCT00528996|42119531|FG001|Overall Study|Protocol Violation|2|||
19671491|NCT00528996|42119532|FG002|Overall Study|Protocol Violation|3|||
19671492|NCT00528996|42119533|FG003|Overall Study|Protocol Violation|3|||
19671493|NCT00528996|42119534|FG004|Overall Study|Protocol Violation|2|||
19671494|NCT00528996|42119530|FG000|Overall Study|Lack of Efficacy|7|||
19671495|NCT00528996|42119531|FG001|Overall Study|Lack of Efficacy|2|||
19671496|NCT00528996|42119532|FG002|Overall Study|Lack of Efficacy|1|||
19671497|NCT00528996|42119533|FG003|Overall Study|Lack of Efficacy|3|||
19671498|NCT00528996|42119534|FG004|Overall Study|Lack of Efficacy|3|||
19671499|NCT00528996|42119530|FG000|Overall Study|Adverse Event|32|||
19671500|NCT00528996|42119531|FG001|Overall Study|Adverse Event|13|||
19671501|NCT00528996|42119532|FG002|Overall Study|Adverse Event|18|||
19671502|NCT00528996|42119533|FG003|Overall Study|Adverse Event|29|||
19671503|NCT00528996|42119534|FG004|Overall Study|Adverse Event|18|||
19671504|NCT00359788|42119551|FG000|Overall Study|Adverse Event|11|||
19671505|NCT00359788|42119552|FG001|Overall Study|Adverse Event|10|||
19671506|NCT00359788|42119551|FG000|Overall Study|Lack of Efficacy|1|||
19758175|NCT04345367|42209048|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
19758176|NCT04345367|42209049|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
19671507|NCT00359788|42119552|FG001|Overall Study|Lack of Efficacy|2|||
19671508|NCT00359788|42119551|FG000|Overall Study|Lost to Follow-up|3|||
19671509|NCT00359788|42119552|FG001|Overall Study|Lost to Follow-up|2|||
19671510|NCT00359788|42119551|FG000|Overall Study|Withdrawal by Subject|4|||
19671511|NCT00359788|42119552|FG001|Overall Study|Withdrawal by Subject|1|||
19671512|NCT00359788|42119551|FG000|Overall Study|Protocol Violation|4|||
19671513|NCT00359788|42119552|FG001|Overall Study|Protocol Violation|2|||
19671514|NCT03878160|42119561|FG000|Overall Study|Lost to Follow-up|1|||
19671515|NCT03878160|42119562|FG001|Overall Study|Lost to Follow-up|1|||
19671516|NCT03878160|42119563|FG002|Overall Study|Lost to Follow-up|1|||
19671517|NCT03878160|42119561|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
19671518|NCT03878160|42119562|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
19671519|NCT03878160|42119563|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
19671520|NCT00623597|42119573|FG000|Overall Study|Failed to return|1|||
19671521|NCT00623597|42119574|FG001|Overall Study|Failed to return|0|||
19671522|NCT00347776|42119585|FG000|1.5 Month Follow-up|Death|2|||
19671523|NCT00347776|42119586|FG001|1.5 Month Follow-up|Death|0|||
19671524|NCT00347776|42119587|FG002|1.5 Month Follow-up|Death|0|||
19671525|NCT00347776|42119585|FG000|1.5 Month Follow-up|reached the endpoint|12|||
19671526|NCT00347776|42119586|FG001|1.5 Month Follow-up|reached the endpoint|8|||
19671527|NCT00347776|42119587|FG002|1.5 Month Follow-up|reached the endpoint|12|||
19671528|NCT00347776|42119585|FG000|6 Month Follow-up|Death|2|||
19758177|NCT04345367|42209048|FG000|Overall Study|Withdrawal by Subject|11|||
19671529|NCT00347776|42119586|FG001|6 Month Follow-up|Death|1|||
19671530|NCT00347776|42119587|FG002|6 Month Follow-up|Death|3|||
19671531|NCT00347776|42119585|FG000|6 Month Follow-up|reached endpont|20|||
19671532|NCT00347776|42119586|FG001|6 Month Follow-up|reached endpont|12|||
19671533|NCT00347776|42119587|FG002|6 Month Follow-up|reached endpont|15|||
19671534|NCT00347776|42119585|FG000|12 Month Follow-up|Lost to Follow-up|7|||
19671535|NCT00347776|42119586|FG001|12 Month Follow-up|Lost to Follow-up|6|||
19671536|NCT00347776|42119587|FG002|12 Month Follow-up|Lost to Follow-up|6|||
19671537|NCT00347776|42119585|FG000|12 Month Follow-up|Death|3|||
19671538|NCT00347776|42119586|FG001|12 Month Follow-up|Death|4|||
19671539|NCT00347776|42119587|FG002|12 Month Follow-up|Death|4|||
19671540|NCT00347776|42119585|FG000|12 Month Follow-up|Reached endpoint|13|||
19671541|NCT00347776|42119586|FG001|12 Month Follow-up|Reached endpoint|6|||
19671542|NCT00347776|42119587|FG002|12 Month Follow-up|Reached endpoint|9|||
19671543|NCT03829228|42119595|FG000|Overall Study|Protocol Violation|1|||
19671544|NCT00529542|42119601|FG000|Overall Study|Withdrawal by Subject|1|||
19671545|NCT00529542|42119602|FG001|Overall Study|Withdrawal by Subject|0|||
19671546|NCT00529542|42119601|FG000|Overall Study|Lost to Follow-up|0|||
19671547|NCT00529542|42119602|FG001|Overall Study|Lost to Follow-up|1|||
19671548|NCT00621959|42119610|FG000|Overall Study|Adverse Event|4|||
19671549|NCT00621959|42119611|FG001|Overall Study|Adverse Event|2|||
19671550|NCT00621959|42119610|FG000|Overall Study|Lack of Efficacy|1|||
19671551|NCT00621959|42119611|FG001|Overall Study|Lack of Efficacy|1|||
19671552|NCT00621959|42119610|FG000|Overall Study|Lost to Follow-up|0|||
19671553|NCT00621959|42119611|FG001|Overall Study|Lost to Follow-up|2|||
19671554|NCT00621959|42119610|FG000|Overall Study|Withdrawal by Subject|1|||
19671555|NCT00621959|42119611|FG001|Overall Study|Withdrawal by Subject|1|||
19671556|NCT00621959|42119610|FG000|Overall Study|Other|1|||
19671557|NCT00621959|42119611|FG001|Overall Study|Other|3|||
19671558|NCT03877224|42119619|FG000|Overall Study|Death|3|||
19671559|NCT03877224|42119620|FG001|Overall Study|Death|2|||
19671560|NCT03877224|42119619|FG000|Overall Study|Withdrawal by Subject|1|||
19671561|NCT03877224|42119620|FG001|Overall Study|Withdrawal by Subject|6|||
19671562|NCT03877224|42119619|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
19671563|NCT03877224|42119620|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
19671564|NCT00528606|42119628|FG000|Overall Study|Withdrew consent|4|||
19671565|NCT00528606|42119629|FG001|Overall Study|Withdrew consent|3|||
19671566|NCT00528606|42119628|FG000|Overall Study|Lost to Follow-up|4|||
19671567|NCT00528606|42119629|FG001|Overall Study|Lost to Follow-up|1|||
19671568|NCT00528606|42119628|FG000|Overall Study|Adverse Event|3|||
19671569|NCT00528606|42119629|FG001|Overall Study|Adverse Event|0|||
19671570|NCT00528606|42119628|FG000|Overall Study|Other|2|||
19671571|NCT00528606|42119629|FG001|Overall Study|Other|0|||
19671572|NCT00621257|42119640|FG000|Overall Study|Lost to Follow-up|4|||
19671573|NCT00621257|42119641|FG001|Overall Study|Lost to Follow-up|0|||
19671574|NCT00621257|42119642|FG002|Overall Study|Lost to Follow-up|2|||
19671575|NCT00621257|42119643|FG003|Overall Study|Lost to Follow-up|4|||
19671576|NCT00621257|42119644|FG004|Overall Study|Lost to Follow-up|7|||
19671577|NCT00621257|42119640|FG000|Overall Study|Adverse Event|0|||
19671578|NCT00621257|42119641|FG001|Overall Study|Adverse Event|1|||
19671579|NCT00621257|42119642|FG002|Overall Study|Adverse Event|1|||
19671580|NCT00621257|42119643|FG003|Overall Study|Adverse Event|0|||
19671581|NCT00621257|42119644|FG004|Overall Study|Adverse Event|0|||
19671582|NCT00621257|42119640|FG000|Overall Study|Physician Decision|0|||
19671583|NCT00621257|42119641|FG001|Overall Study|Physician Decision|2|||
19671584|NCT00621257|42119642|FG002|Overall Study|Physician Decision|0|||
19671585|NCT00621257|42119643|FG003|Overall Study|Physician Decision|1|||
19671586|NCT00621257|42119644|FG004|Overall Study|Physician Decision|1|||
19671587|NCT00621257|42119640|FG000|Overall Study|Withdrawal by Subject|0|||
19671588|NCT00621257|42119641|FG001|Overall Study|Withdrawal by Subject|0|||
19671589|NCT00621257|42119642|FG002|Overall Study|Withdrawal by Subject|0|||
19671590|NCT00621257|42119643|FG003|Overall Study|Withdrawal by Subject|1|||
19671591|NCT00621257|42119644|FG004|Overall Study|Withdrawal by Subject|1|||
19671592|NCT00528840|42119656|FG000|Overall Study|Lost to Follow-up|10|||
19671593|NCT00528840|42119656|FG000|Overall Study|Adverse Event|1|||
19671594|NCT00528840|42119656|FG000|Overall Study|Withdrawal by Subject|17|||
19671595|NCT00528840|42119656|FG000|Overall Study|Death|2|||
19671596|NCT00528840|42119656|FG000|Overall Study|Administrative Reasons|1|||
19671597|NCT00528840|42119656|FG000|Overall Study|Other|2|||
19671598|NCT00528528|42119664|FG000|Overall Study|Lost to Follow-up|0|||
19671599|NCT00528528|42119665|FG001|Overall Study|Lost to Follow-up|0|||
19671600|NCT00528528|42119666|FG002|Overall Study|Lost to Follow-up|1|||
19671601|NCT00528528|42119667|FG003|Overall Study|Lost to Follow-up|1|||
19671602|NCT00528528|42119664|FG000|Overall Study|Ineligible to continue the trial|0|||
19671603|NCT00528528|42119665|FG001|Overall Study|Ineligible to continue the trial|0|||
19671604|NCT00528528|42119666|FG002|Overall Study|Ineligible to continue the trial|0|||
19671605|NCT00528528|42119667|FG003|Overall Study|Ineligible to continue the trial|1|||
19671606|NCT00528528|42119664|FG000|Overall Study|Other|0|||
19671607|NCT00528528|42119665|FG001|Overall Study|Other|1|||
19671608|NCT00528528|42119666|FG002|Overall Study|Other|0|||
19671609|NCT00528528|42119667|FG003|Overall Study|Other|0|||
19671610|NCT00528528|42119664|FG000|Overall Study|Withdrawal by Subject|3|||
19671611|NCT00528528|42119665|FG001|Overall Study|Withdrawal by Subject|2|||
19671612|NCT00528528|42119666|FG002|Overall Study|Withdrawal by Subject|1|||
19671613|NCT00528528|42119667|FG003|Overall Study|Withdrawal by Subject|1|||
19671614|NCT00528528|42119664|FG000|Overall Study|Ongoing participant|0|||
19671615|NCT00528528|42119665|FG001|Overall Study|Ongoing participant|0|||
19671616|NCT00528528|42119666|FG002|Overall Study|Ongoing participant|1|||
19671617|NCT00528528|42119667|FG003|Overall Study|Ongoing participant|0|||
19671618|NCT00620555|42119679|FG000|Overall Study|Adverse Event|4|||
19671619|NCT00620555|42119679|FG000|Overall Study|Protocol Violation|2|||
19671620|NCT00620555|42119679|FG000|Overall Study|Lack of Efficacy|12|||
19671621|NCT00620555|42119679|FG000|Overall Study|Withdrawal by Subject|1|||
19671622|NCT00620555|42119679|FG000|Overall Study|Choice of other treatment|1|||
19671623|NCT00620555|42119679|FG000|Overall Study|Visit failure against planned|1|||
19671624|NCT00529386|42119683|FG000|Overall Study|Lost to Follow-up|1|||
19671625|NCT03875118|42119689|FG000|Overall Study|Withdrawal by Subject|4|||
19671626|NCT03875118|42119690|FG001|Overall Study|Withdrawal by Subject|4|||
19758178|NCT04345367|42209049|FG001|Overall Study|Withdrawal by Subject|11|||
19758179|NCT04345367|42209048|FG000|Overall Study|Protocol Violation|4|||
19671627|NCT00529308|42119698|FG000|Overall Study|Withdrawal by Subject|1|||
19671628|NCT00529308|42119699|FG001|Overall Study|Withdrawal by Subject|1|||
19671629|NCT03875508|42119705|FG000|Overall Study|Adverse Event|1|||
19671630|NCT03875508|42119705|FG000|Overall Study|Lost to Follow-up|8|||
19671631|NCT03875508|42119705|FG000|Overall Study|Lack of Efficacy|1|||
19671632|NCT03875508|42119705|FG000|Overall Study|Other, not specified|2|||
19671633|NCT00620321|42119711|FG000|Overall Study|Adverse Event|1|||
19671634|NCT00620321|42119712|FG001|Overall Study|Adverse Event|1|||
19671635|NCT00620321|42119711|FG000|Overall Study|Death|1|||
19671636|NCT00620321|42119712|FG001|Overall Study|Death|1|||
19671637|NCT00620321|42119711|FG000|Overall Study|Physician Decision|0|||
19671638|NCT00620321|42119712|FG001|Overall Study|Physician Decision|7|||
19671639|NCT00620321|42119711|FG000|Overall Study|Progressive Disease|5|||
19671640|NCT00620321|42119712|FG001|Overall Study|Progressive Disease|5|||
19671641|NCT00620321|42119711|FG000|Overall Study|Sponsor Decision|0|||
19671642|NCT00620321|42119712|FG001|Overall Study|Sponsor Decision|1|||
19671643|NCT00620321|42119711|FG000|Overall Study|Withdrawal by Subject|1|||
19671644|NCT00620321|42119712|FG001|Overall Study|Withdrawal by Subject|1|||
19671645|NCT00621023|42119718|FG000|Overall Study|Death|5|||
19671646|NCT00621023|42119718|FG000|Overall Study|Follow up discontinued|1|||
19758180|NCT04345367|42209049|FG001|Overall Study|Protocol Violation|3|||
19758181|NCT04345367|42209048|FG000|Overall Study|Lost to Follow-up|2|||
19758182|NCT04345367|42209049|FG001|Overall Study|Lost to Follow-up|4|||
19758183|NCT04345367|42209048|FG000|Overall Study|Lack of Efficacy|2|||
19758184|NCT04345367|42209049|FG001|Overall Study|Lack of Efficacy|0|||
19758185|NCT04345367|42209048|FG000|Overall Study|Death|2|||
19758186|NCT04345367|42209049|FG001|Overall Study|Death|0|||
19758187|NCT04345367|42209048|FG000|Overall Study|Adverse Event|10|||
19758188|NCT04345367|42209049|FG001|Overall Study|Adverse Event|9|||
19389016|NCT02675231|41632564|FG002|Overall Study|Lost to Follow-up|2|||
19671647|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
19671648|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671649|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671650|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671651|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671652|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671653|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671654|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19758189|NCT04404725|42209055|FG000|First Intervention|Withdrawal by Subject|0|||
19758190|NCT04404725|42209056|FG001|First Intervention|Withdrawal by Subject|2|||
19671655|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
19671656|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
19671657|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
19671658|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
19671659|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
19671660|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
19671661|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
19671662|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
19671663|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
19671664|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
19671665|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
19671666|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
19671667|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
19671668|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
19671669|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
19671670|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
19671671|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
19671672|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
19671673|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
19671674|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
19758191|NCT04404725|42209055|FG000|Second Intervention|Adverse Event|1|||
19758192|NCT04404725|42209056|FG001|Second Intervention|Adverse Event|1|||
19758193|NCT04404725|42209055|FG000|Second Intervention|Withdrawal by Subject|0|||
19758194|NCT04404725|42209056|FG001|Second Intervention|Withdrawal by Subject|1|||
19758195|NCT04343261|42209062|FG000|Overall Study|Adverse Event|1|||
19758196|NCT04343261|42209062|FG000|Overall Study|received inadequate amount of antibodies|7|||
19671675|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
19671676|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
19671677|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
19671678|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
19671679|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
19671680|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
19671681|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
19671682|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
19671683|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671684|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671685|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671686|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
19671687|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19758197|NCT04336475|42209068|FG000|Overall Study|pain|1|||
19671688|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
19671689|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671690|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671691|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
19671692|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
19671693|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19671694|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
19671695|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19671696|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19671697|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
19671698|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19671699|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19758198|NCT04336475|42209069|FG001|Overall Study|pain|0|||
19671700|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
19671701|NCT00528372|42119731|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
19671702|NCT00528372|42119732|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671703|NCT00528372|42119733|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671704|NCT00528372|42119734|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
19671705|NCT00528372|42119735|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671706|NCT00528372|42119736|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671707|NCT00528372|42119737|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671708|NCT00528372|42119738|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
19671709|NCT00528372|42119739|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
19671710|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
19671711|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
19671712|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
19671713|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
19671714|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
19671715|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
19758199|NCT04336475|42209068|FG000|Overall Study|upper respiratory infection|1|||
19671716|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
19758200|NCT04336475|42209069|FG001|Overall Study|upper respiratory infection|0|||
19671717|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
19671718|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
19671719|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
19671720|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
19671721|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
19671722|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
19671723|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
19671724|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
19671725|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
19671726|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
19671727|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
19671728|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
19671729|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
19671730|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
19671731|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
19671732|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
19671733|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
19758201|NCT04336475|42209068|FG000|Overall Study|Lost to Follow-up|0|||
19389017|NCT02675231|41632562|FG000|Overall Study|On study treatment/follow up|23|||
19758202|NCT04336475|42209069|FG001|Overall Study|Lost to Follow-up|2|||
19671734|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
19671735|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
19671736|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
19671737|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
19671738|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
19671739|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
19671740|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
19603723|NCT00710593|42052746|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
19671741|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
19671742|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
19671743|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
19671744|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
19671745|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
19671746|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
19671747|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
19671748|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
19671749|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
19671750|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
19671751|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
19603724|NCT00710593|42052747|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
19603725|NCT00599313|42052769|FG000|Overall Study|Adverse Event|19|||
19603726|NCT00599313|42052769|FG000|Overall Study|Disease Progression|12|||
19603727|NCT00599313|42052769|FG000|Overall Study|Patient Request|4|||
19603728|NCT00599313|42052769|FG000|Overall Study|Ineligible|1|||
19603729|NCT00708175|42052775|FG000|Overall Study|Adverse Event|4|||
19603730|NCT00708175|42052776|FG001|Overall Study|Adverse Event|5|||
19603731|NCT00708175|42052775|FG000|Overall Study|Protocol Violation|2|||
19603732|NCT00708175|42052776|FG001|Overall Study|Protocol Violation|3|||
19603733|NCT00708175|42052775|FG000|Overall Study|Lost to Follow-up|5|||
19603734|NCT00708175|42052776|FG001|Overall Study|Lost to Follow-up|3|||
19603735|NCT00708175|42052775|FG000|Overall Study|Withdrawal by Subject|5|||
19603736|NCT00708175|42052776|FG001|Overall Study|Withdrawal by Subject|7|||
19603737|NCT00708175|42052775|FG000|Overall Study|BMD loss >7%|2|||
19603738|NCT00708175|42052776|FG001|Overall Study|BMD loss >7%|3|||
19603739|NCT00707239|42052785|FG000|Overall Study|Adverse Event|5|||
19603740|NCT00707239|42052786|FG001|Overall Study|Adverse Event|3|||
19603741|NCT00707239|42052787|FG002|Overall Study|Adverse Event|2|||
19603742|NCT00707239|42052785|FG000|Overall Study|Death|3|||
19603743|NCT00707239|42052786|FG001|Overall Study|Death|1|||
19603744|NCT00707239|42052787|FG002|Overall Study|Death|3|||
19603745|NCT00707239|42052785|FG000|Overall Study|Physician Decision|1|||
19603746|NCT00707239|42052786|FG001|Overall Study|Physician Decision|1|||
19603747|NCT00707239|42052787|FG002|Overall Study|Physician Decision|2|||
19603748|NCT00707239|42052785|FG000|Overall Study|Protocol Violation|0|||
19603749|NCT00707239|42052786|FG001|Overall Study|Protocol Violation|0|||
19603750|NCT00707239|42052787|FG002|Overall Study|Protocol Violation|1|||
19603751|NCT00707239|42052785|FG000|Overall Study|Lack of Efficacy|1|||
19603752|NCT00707239|42052786|FG001|Overall Study|Lack of Efficacy|2|||
19603753|NCT00707239|42052787|FG002|Overall Study|Lack of Efficacy|0|||
19603754|NCT00707239|42052785|FG000|Overall Study|Randomized, but not treated|1|||
19603755|NCT00707239|42052786|FG001|Overall Study|Randomized, but not treated|1|||
19603756|NCT00707239|42052787|FG002|Overall Study|Randomized, but not treated|1|||
19603757|NCT00707239|42052785|FG000|Overall Study|Other|8|||
19603758|NCT00707239|42052786|FG001|Overall Study|Other|3|||
19603759|NCT00707239|42052787|FG002|Overall Study|Other|5|||
19603760|NCT00968708|42052800|FG000|Overall Study|Adverse Event|169|||
19603761|NCT00968708|42052801|FG001|Overall Study|Adverse Event|150|||
19603762|NCT00968708|42052800|FG000|Overall Study|Major Protocol Deviation|0|||
19758203|NCT04335929|42209075|FG000|Overall Study|Lost to Follow-up|10|||
19758204|NCT04333199|42209082|FG000|Evaluated Patients|Lost to Follow-up|0|||
19671752|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
19671753|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
19671754|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
19671755|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671756|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671757|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671758|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671759|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
19671760|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
19671761|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19758205|NCT04333199|42209083|FG001|Evaluated Patients|Lost to Follow-up|1|||
19671762|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671763|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
19671764|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671765|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
19671766|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671767|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671768|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671769|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671770|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
19671771|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
19671772|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
19671773|NCT00528372|42119731|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
19758206|NCT04333199|42209084|FG002|Evaluated Patients|Lost to Follow-up|2|||
19758207|NCT04332419|42209093|FG000|Overall Study|Withdrawal by Subject|1|||
19758208|NCT04330157|42209097|FG000|Overall Study|Protocol Violation|4|||
19758209|NCT04330157|42209097|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
19758210|NCT04329923|42209112|FG000|Overall Study|Withdrawal by Subject|1|||
19758211|NCT04329923|42209113|FG001|Overall Study|Withdrawal by Subject|4|||
19671774|NCT00528372|42119732|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
19671775|NCT00528372|42119733|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
19671776|NCT00528372|42119734|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
19671777|NCT00528372|42119735|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
19671778|NCT00528372|42119736|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
19671779|NCT00528372|42119737|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
19671780|NCT00528372|42119738|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
19671781|NCT00528372|42119739|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
19671782|NCT00527982|42119787|FG000|Overall Study|Physician Decision|1|||
19671783|NCT00527982|42119788|FG001|Overall Study|Physician Decision|0|||
19671784|NCT00527904|42119794|FG000|Overall Study|Adverse Event|45|||
19671785|NCT00527904|42119794|FG000|Overall Study|Withdrawal by Subject|21|||
19671786|NCT00527904|42119794|FG000|Overall Study|Lost to Follow-up|8|||
19671787|NCT00527904|42119794|FG000|Overall Study|misc|22|||
19671788|NCT00619619|42119806|FG000|Overall Study|Physician Decision|0|||
19671789|NCT00619619|42119807|FG001|Overall Study|Physician Decision|0|||
19671790|NCT00619619|42119808|FG002|Overall Study|Physician Decision|1|||
19671791|NCT00619619|42119809|FG003|Overall Study|Physician Decision|0|||
19671792|NCT00619619|42119810|FG004|Overall Study|Physician Decision|0|||
19671793|NCT00619619|42119811|FG005|Overall Study|Physician Decision|0|||
19671794|NCT00619619|42119812|FG006|Overall Study|Physician Decision|0|||
19671795|NCT00619619|42119813|FG007|Overall Study|Physician Decision|0|||
19671796|NCT00619619|42119806|FG000|Overall Study|Protocol Violation|0|||
19671797|NCT00619619|42119807|FG001|Overall Study|Protocol Violation|0|||
19671798|NCT00619619|42119808|FG002|Overall Study|Protocol Violation|0|||
19671799|NCT00619619|42119809|FG003|Overall Study|Protocol Violation|1|||
19671800|NCT00619619|42119810|FG004|Overall Study|Protocol Violation|0|||
19671801|NCT00619619|42119811|FG005|Overall Study|Protocol Violation|0|||
19671802|NCT00619619|42119812|FG006|Overall Study|Protocol Violation|1|||
19671803|NCT00619619|42119813|FG007|Overall Study|Protocol Violation|1|||
19671804|NCT00619619|42119806|FG000|Overall Study|Adverse Event|0|||
19671805|NCT00619619|42119807|FG001|Overall Study|Adverse Event|0|||
19671806|NCT00619619|42119808|FG002|Overall Study|Adverse Event|0|||
19671807|NCT00619619|42119809|FG003|Overall Study|Adverse Event|0|||
19671808|NCT00619619|42119810|FG004|Overall Study|Adverse Event|2|||
19671809|NCT00619619|42119811|FG005|Overall Study|Adverse Event|0|||
19671810|NCT00619619|42119812|FG006|Overall Study|Adverse Event|0|||
19671811|NCT00619619|42119813|FG007|Overall Study|Adverse Event|2|||
19671812|NCT00527826|42119836|FG000|Overall Study|Adverse Event|10|||
19671813|NCT00527826|42119837|FG001|Overall Study|Adverse Event|10|||
19671814|NCT00527826|42119836|FG000|Overall Study|Lost to Follow-up|3|||
19671815|NCT00527826|42119837|FG001|Overall Study|Lost to Follow-up|2|||
19671816|NCT00527826|42119836|FG000|Overall Study|Withdrawal by Subject|5|||
19671817|NCT00527826|42119837|FG001|Overall Study|Withdrawal by Subject|8|||
19671818|NCT00527826|42119836|FG000|Overall Study|Inclusion Criteria Not Met|3|||
19671819|NCT00527826|42119837|FG001|Overall Study|Inclusion Criteria Not Met|3|||
19671820|NCT00527826|42119836|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
19671821|NCT00527826|42119837|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
19671822|NCT00527826|42119836|FG000|Overall Study|Additional Intake of Viani forte|0|||
19671823|NCT00527826|42119837|FG001|Overall Study|Additional Intake of Viani forte|1|||
19758212|NCT04329923|42209114|FG002|Overall Study|Withdrawal by Subject|1|||
19758213|NCT04329923|42209115|FG003|Overall Study|Withdrawal by Subject|1|||
19758214|NCT04329923|42209116|FG004|Overall Study|Withdrawal by Subject|1|||
19758215|NCT04329923|42209117|FG005|Overall Study|Withdrawal by Subject|1|||
19758216|NCT04329923|42209112|FG000|Overall Study|early termination of study|0|||
19758217|NCT04329923|42209113|FG001|Overall Study|early termination of study|0|||
19758218|NCT04329923|42209114|FG002|Overall Study|early termination of study|0|||
19758219|NCT04329923|42209115|FG003|Overall Study|early termination of study|0|||
19758220|NCT04329923|42209116|FG004|Overall Study|early termination of study|1|||
19758221|NCT04329923|42209117|FG005|Overall Study|early termination of study|2|||
19758222|NCT04329923|42209112|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
19758223|NCT04329923|42209113|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
19758224|NCT04329923|42209114|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
19758225|NCT04329923|42209115|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
19758226|NCT04329923|42209116|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
19758227|NCT04329923|42209117|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
19758228|NCT04403399|42209133|FG000|Period 2|Physician Decision|0|||
19758229|NCT04403399|42209134|FG001|Period 2|Physician Decision|1|||
19758230|NCT04401293|42209142|FG000|Overall Study|Withdrawal by Subject|1|||
19758231|NCT04401293|42209143|FG001|Overall Study|Withdrawal by Subject|3|||
19758232|NCT04319159|42209151|FG000|Overall Study|Screening failure|13|||
19758233|NCT04319159|42209151|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
19758234|NCT04319159|42209151|FG000|Overall Study|Withdrawal by Subject|1|||
19758235|NCT04318535|42209157|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
19758236|NCT04318535|42209158|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
19758237|NCT04318535|42209159|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
19758238|NCT04454567|42209170|FG000|Overall Study|Study Terminated by Sponsor|1|||
19758239|NCT04454567|42209171|FG001|Overall Study|Study Terminated by Sponsor|1|||
19758240|NCT04449341|42209179|FG000|Overall Study|Protocol Violation|1|||
19758241|NCT04449341|42209180|FG001|Overall Study|Protocol Violation|0|||
19758242|NCT04448561|42209188|FG000|Overall Study|Noncompliance|1|||
19758243|NCT04448561|42209189|FG001|Overall Study|Noncompliance|0|||
19758244|NCT04308239|42209205|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
19758245|NCT04308239|42209206|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
19758246|NCT04308239|42209205|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
19758247|NCT04308239|42209206|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
19758248|NCT04308239|42209205|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
19758249|NCT04308239|42209206|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
19758250|NCT04308239|42209205|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
19758251|NCT04308239|42209206|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
19758252|NCT04302545|42209218|FG000|Overall Study|Lost to Follow-up|3|||
19758253|NCT04302545|42209219|FG001|Overall Study|Lost to Follow-up|4|||
19758254|NCT04297241|42209236|FG000|Overall Study|Withdrawal by Subject|1|||
19758255|NCT04297241|42209236|FG000|Overall Study|Adverse Event|1|||
19758256|NCT04297241|42209236|FG000|Overall Study|Physician Decision|3|||
19758257|NCT04292171|42209252|FG000|Overall Study|Pharmacy error|2|||
19758258|NCT04292171|42209253|FG001|Overall Study|Pharmacy error|0|||
19758259|NCT04292171|42209252|FG000|Overall Study|Delivered prior to procedure|0|||
19603763|NCT00968708|42052801|FG001|Overall Study|Major Protocol Deviation|1|||
19603764|NCT00968708|42052800|FG000|Overall Study|Lost to Follow-up|19|||
19603765|NCT00968708|42052801|FG001|Overall Study|Lost to Follow-up|11|||
19603766|NCT00968708|42052800|FG000|Overall Study|Voluntary Withdrawal|104|||
19603767|NCT00968708|42052801|FG001|Overall Study|Voluntary Withdrawal|101|||
19603768|NCT00968708|42052800|FG000|Overall Study|Investigator Discretion|0|||
19603769|NCT00968708|42052801|FG001|Overall Study|Investigator Discretion|1|||
19603770|NCT00968708|42052800|FG000|Overall Study|Other|26|||
19758260|NCT04292171|42209253|FG001|Overall Study|Delivered prior to procedure|1|||
19758261|NCT04393493|42209261|FG000|First 4 Days of Intervention|Early improvement|5|||
19758262|NCT04393493|42209262|FG001|First 4 Days of Intervention|Early improvement|7|||
19603771|NCT00968708|42052801|FG001|Overall Study|Other|34|||
19758263|NCT04280705|42209272|FG000|Overall Study|Enrolled but not treated|4|||
19603772|NCT00967694|42052807|FG000|Overall Study|Withdrawal by Subject|6|||
19603773|NCT00967616|42052813|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
19603774|NCT00967616|42052814|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
19758264|NCT04280705|42209273|FG001|Overall Study|Enrolled but not treated|10|||
19758265|NCT04280705|42209272|FG000|Overall Study|Physician Decision|1|||
19758266|NCT04280705|42209273|FG001|Overall Study|Physician Decision|0|||
19758267|NCT04280705|42209272|FG000|Overall Study|Withdrawal by Subject|7|||
19758268|NCT04280705|42209273|FG001|Overall Study|Withdrawal by Subject|9|||
19758269|NCT04280705|42209272|FG000|Overall Study|Adverse Event|0|||
19758270|NCT04280705|42209273|FG001|Overall Study|Adverse Event|4|||
19758271|NCT04280705|42209272|FG000|Overall Study|Transferred to another hospital|1|||
19758272|NCT04280705|42209273|FG001|Overall Study|Transferred to another hospital|1|||
19758273|NCT02077166|42209286|FG000|Overall Study|Death|6|||
19671824|NCT00527826|42119836|FG000|Overall Study|Participant moved away|0|||
19671825|NCT00527826|42119837|FG001|Overall Study|Participant moved away|1|||
19671826|NCT00527748|42119855|FG000|Overall Study|Other|3|||
19671827|NCT00619385|42119862|FG000|Overall Study|Adverse Event|0|||
19671828|NCT00619385|42119863|FG001|Overall Study|Adverse Event|0|||
19671829|NCT00619385|42119864|FG002|Overall Study|Adverse Event|3|||
19671830|NCT00619385|42119862|FG000|Overall Study|Other|1|||
19671831|NCT00619385|42119863|FG001|Overall Study|Other|2|||
19671832|NCT00619385|42119864|FG002|Overall Study|Other|1|||
19671833|NCT00619307|42119877|FG000|Overall Study|Adverse Event|0|||
19671834|NCT00619307|42119878|FG001|Overall Study|Adverse Event|1|||
19671835|NCT00619307|42119877|FG000|Overall Study|Lost to Follow-up|0|||
19671836|NCT00619307|42119878|FG001|Overall Study|Lost to Follow-up|1|||
19671837|NCT00619307|42119877|FG000|Overall Study|Protocol Violation|3|||
19671838|NCT00619307|42119878|FG001|Overall Study|Protocol Violation|0|||
19671839|NCT00619307|42119877|FG000|Overall Study|Withdrew consent|1|||
19671840|NCT00619307|42119878|FG001|Overall Study|Withdrew consent|0|||
19671841|NCT00619307|42119877|FG000|Overall Study|Severe migraine|0|||
19758274|NCT02077166|42209287|FG001|Overall Study|Death|7|||
19758275|NCT02077166|42209288|FG002|Overall Study|Death|5|||
19758276|NCT02077166|42209289|FG003|Overall Study|Death|6|||
19671842|NCT00619307|42119878|FG001|Overall Study|Severe migraine|1|||
19671843|NCT00619307|42119877|FG000|Overall Study|MS attack plus steroids|0|||
19603775|NCT00967616|42052813|FG000|Overall Study|Death|0|||
19603776|NCT00967616|42052814|FG001|Overall Study|Death|3|||
19603777|NCT00967616|42052813|FG000|Overall Study|Withdrawal by Subject|8|||
19603778|NCT00967616|42052814|FG001|Overall Study|Withdrawal by Subject|4|||
19603779|NCT00967616|42052813|FG000|Overall Study|Progressive Disease|31|||
19603780|NCT00967616|42052814|FG001|Overall Study|Progressive Disease|18|||
19603781|NCT00967616|42052813|FG000|Overall Study|Other|8|||
19603782|NCT00967616|42052814|FG001|Overall Study|Other|8|||
19603783|NCT00967616|42052813|FG000|Overall Study|Protocol Violation|1|||
19603784|NCT00967616|42052814|FG001|Overall Study|Protocol Violation|0|||
19603785|NCT00971204|42052824|FG000|Overall Study|Did not meet all criteria-not treated|14|||
19671844|NCT00619307|42119878|FG001|Overall Study|MS attack plus steroids|1|||
19671845|NCT00619229|42119886|FG000|Overall Study|Withdrawal by Subject|1|||
19603786|NCT00971204|42052824|FG000|Overall Study|Lost to Follow-up|10|||
19671846|NCT00619229|42119887|FG001|Overall Study|Withdrawal by Subject|1|||
19671847|NCT00619229|42119886|FG000|Overall Study|Lost to Follow-up|1|||
19671848|NCT00619229|42119887|FG001|Overall Study|Lost to Follow-up|0|||
19758277|NCT02077166|42209290|FG004|Overall Study|Death|4|||
19758278|NCT02077166|42209291|FG005|Overall Study|Death|32|||
19758279|NCT02077166|42209292|FG006|Overall Study|Death|22|||
19758280|NCT02077166|42209286|FG000|Overall Study|Study Closure by Sponsor|3|||
19671849|NCT00619229|42119886|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
19671850|NCT00619229|42119887|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
19671851|NCT00619229|42119886|FG000|Overall Study|Investigator planned Cataract Operation|1|||
19671852|NCT00619229|42119887|FG001|Overall Study|Investigator planned Cataract Operation|0|||
19671853|NCT00619151|42119895|FG000|Overall Study|Study terminated prior to followup|1|||
19671854|NCT00619151|42119896|FG001|Overall Study|Study terminated prior to followup|0|||
19671855|NCT00618995|42119902|FG000|Period 1|Adverse Event|0|||
19671856|NCT00618995|42119903|FG001|Period 1|Adverse Event|0|||
19671857|NCT00618995|42119904|FG002|Period 1|Adverse Event|1|||
19671858|NCT00618995|42119905|FG003|Period 1|Adverse Event|0|||
19671859|NCT00618995|42119902|FG000|Period 1|Protocol Violation|0|||
19671860|NCT00618995|42119903|FG001|Period 1|Protocol Violation|1|||
19671861|NCT00618995|42119904|FG002|Period 1|Protocol Violation|1|||
19671862|NCT00618995|42119905|FG003|Period 1|Protocol Violation|0|||
19671863|NCT00618995|42119902|FG000|Period 2|Protocol Violation|0|||
19671864|NCT00618995|42119903|FG001|Period 2|Protocol Violation|0|||
19671865|NCT00618995|42119904|FG002|Period 2|Protocol Violation|1|||
19671866|NCT00618995|42119905|FG003|Period 2|Protocol Violation|0|||
19671867|NCT00618995|42119902|FG000|Period 4|Adverse Event|1|||
19671868|NCT00618995|42119903|FG001|Period 4|Adverse Event|0|||
19671869|NCT00618995|42119904|FG002|Period 4|Adverse Event|0|||
19671870|NCT00618995|42119905|FG003|Period 4|Adverse Event|0|||
19671871|NCT03685344|42119919|FG000|Overall Study|Withdrawal by Subject|1|||
19671872|NCT03685344|42119920|FG001|Overall Study|Withdrawal by Subject|1|||
19671873|NCT03685344|42119921|FG002|Overall Study|Withdrawal by Subject|2|||
19671874|NCT03685344|42119922|FG003|Overall Study|Withdrawal by Subject|0|||
19671875|NCT03685344|42119919|FG000|Overall Study|Physician Decision|1|||
19671876|NCT03685344|42119920|FG001|Overall Study|Physician Decision|1|||
19671877|NCT03685344|42119921|FG002|Overall Study|Physician Decision|5|||
19671878|NCT03685344|42119922|FG003|Overall Study|Physician Decision|0|||
19671879|NCT03685344|42119919|FG000|Overall Study|Death|1|||
19671880|NCT03685344|42119920|FG001|Overall Study|Death|1|||
19671881|NCT03685344|42119921|FG002|Overall Study|Death|0|||
19671882|NCT03685344|42119922|FG003|Overall Study|Death|0|||
19671883|NCT00520572|42119938|FG000|Overall Study|Adverse Event|9|||
19671884|NCT00520572|42119939|FG001|Overall Study|Adverse Event|3|||
19671885|NCT00520572|42119940|FG002|Overall Study|Adverse Event|6|||
19477165|NCT01513291|41756108|FG000|Treatment Period|Physician Decision|1|||
19477166|NCT01513291|41756109|FG001|Treatment Period|Physician Decision|0|||
19671886|NCT00520572|42119941|FG003|Overall Study|Adverse Event|9|||
19671887|NCT00520572|42119942|FG004|Overall Study|Adverse Event|7|||
19671888|NCT00520572|42119943|FG005|Overall Study|Adverse Event|2|||
19671889|NCT00520572|42119938|FG000|Overall Study|Withdrawal by Subject|0|||
19671890|NCT00520572|42119939|FG001|Overall Study|Withdrawal by Subject|9|||
19603787|NCT03107793|42052828|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
19671891|NCT00520572|42119940|FG002|Overall Study|Withdrawal by Subject|5|||
19671892|NCT00520572|42119941|FG003|Overall Study|Withdrawal by Subject|2|||
19671893|NCT00520572|42119942|FG004|Overall Study|Withdrawal by Subject|2|||
19671894|NCT00520572|42119943|FG005|Overall Study|Withdrawal by Subject|0|||
19671895|NCT00520572|42119938|FG000|Overall Study|Protocol Violation|0|||
19671896|NCT00520572|42119939|FG001|Overall Study|Protocol Violation|0|||
19671897|NCT00520572|42119940|FG002|Overall Study|Protocol Violation|1|||
19671898|NCT00520572|42119941|FG003|Overall Study|Protocol Violation|0|||
19671899|NCT00520572|42119942|FG004|Overall Study|Protocol Violation|0|||
19671900|NCT00520572|42119943|FG005|Overall Study|Protocol Violation|0|||
19671901|NCT00520572|42119938|FG000|Overall Study|Lack of Efficacy|1|||
19758281|NCT02077166|42209287|FG001|Overall Study|Study Closure by Sponsor|0|||
19758282|NCT02077166|42209288|FG002|Overall Study|Study Closure by Sponsor|2|||
19671902|NCT00520572|42119939|FG001|Overall Study|Lack of Efficacy|1|||
19671903|NCT00520572|42119940|FG002|Overall Study|Lack of Efficacy|1|||
19671904|NCT00520572|42119941|FG003|Overall Study|Lack of Efficacy|2|||
19671905|NCT00520572|42119942|FG004|Overall Study|Lack of Efficacy|1|||
19671906|NCT00520572|42119943|FG005|Overall Study|Lack of Efficacy|0|||
19671907|NCT00520572|42119938|FG000|Overall Study|Lost to Follow-up|0|||
19671908|NCT00520572|42119939|FG001|Overall Study|Lost to Follow-up|0|||
19671909|NCT00520572|42119940|FG002|Overall Study|Lost to Follow-up|0|||
19671910|NCT00520572|42119941|FG003|Overall Study|Lost to Follow-up|0|||
19671911|NCT00520572|42119942|FG004|Overall Study|Lost to Follow-up|1|||
19671912|NCT00520572|42119943|FG005|Overall Study|Lost to Follow-up|0|||
19671913|NCT00520572|42119938|FG000|Overall Study|Incorrect enrollment|1|||
19671914|NCT00520572|42119939|FG001|Overall Study|Incorrect enrollment|0|||
19671915|NCT00520572|42119940|FG002|Overall Study|Incorrect enrollment|1|||
19671916|NCT00520572|42119941|FG003|Overall Study|Incorrect enrollment|0|||
19671917|NCT00520572|42119942|FG004|Overall Study|Incorrect enrollment|1|||
19671918|NCT00520572|42119943|FG005|Overall Study|Incorrect enrollment|0|||
19671919|NCT00520572|42119938|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
19671920|NCT00520572|42119939|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
19671921|NCT00520572|42119940|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
19671922|NCT00520572|42119941|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
19671923|NCT00520572|42119942|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
19671924|NCT00520572|42119943|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
19671925|NCT00520572|42119938|FG000|Overall Study|Long break in taking Medication|0|||
19671926|NCT00520572|42119939|FG001|Overall Study|Long break in taking Medication|0|||
19671927|NCT00520572|42119940|FG002|Overall Study|Long break in taking Medication|0|||
19671928|NCT00520572|42119941|FG003|Overall Study|Long break in taking Medication|1|||
19671929|NCT00520572|42119942|FG004|Overall Study|Long break in taking Medication|0|||
19671930|NCT00520572|42119943|FG005|Overall Study|Long break in taking Medication|0|||
19671931|NCT00520572|42119938|FG000|Overall Study|Did not receive Treatment|1|||
19671932|NCT00520572|42119939|FG001|Overall Study|Did not receive Treatment|0|||
19671933|NCT00520572|42119940|FG002|Overall Study|Did not receive Treatment|1|||
19671934|NCT00520572|42119941|FG003|Overall Study|Did not receive Treatment|0|||
19671935|NCT00520572|42119942|FG004|Overall Study|Did not receive Treatment|0|||
19671936|NCT00520572|42119943|FG005|Overall Study|Did not receive Treatment|0|||
19671937|NCT00573833|42119957|FG000|Overall Study|Not Treated|2|||
19758283|NCT02077166|42209289|FG003|Overall Study|Study Closure by Sponsor|2|||
19603788|NCT03107793|42052829|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
19603789|NCT03107793|42052830|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
19603790|NCT03107793|42052831|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
19603791|NCT03107793|42052832|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
19603792|NCT03107793|42052828|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
19603793|NCT03107793|42052829|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
19603794|NCT03107793|42052830|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
19603795|NCT03107793|42052831|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
19603796|NCT03107793|42052832|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
19603797|NCT03107793|42052828|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
19603798|NCT03107793|42052829|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
19603799|NCT03107793|42052830|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
19603800|NCT03107793|42052831|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
19603801|NCT03107793|42052832|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
19603802|NCT03107793|42052828|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
19603803|NCT03107793|42052829|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19603804|NCT03107793|42052830|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19671938|NCT00520494|42119961|FG000|Overall Study|Withdrawal by Subject|1|||
19671939|NCT00527514|42119965|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
19671940|NCT00527514|42119965|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
19671941|NCT00527514|42119965|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
19671942|NCT00527514|42119965|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
19671943|NCT00527514|42119965|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
19671944|NCT00527514|42119965|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
19758284|NCT02077166|42209290|FG004|Overall Study|Study Closure by Sponsor|2|||
19758285|NCT02077166|42209291|FG005|Overall Study|Study Closure by Sponsor|12|||
19758286|NCT02077166|42209292|FG006|Overall Study|Study Closure by Sponsor|4|||
19758287|NCT02077166|42209286|FG000|Overall Study|Lost to Follow-up|0|||
19758288|NCT02077166|42209287|FG001|Overall Study|Lost to Follow-up|0|||
19758289|NCT02077166|42209288|FG002|Overall Study|Lost to Follow-up|0|||
19758290|NCT02077166|42209289|FG003|Overall Study|Lost to Follow-up|0|||
19758291|NCT02077166|42209290|FG004|Overall Study|Lost to Follow-up|0|||
19758292|NCT02077166|42209291|FG005|Overall Study|Lost to Follow-up|1|||
19758293|NCT02077166|42209292|FG006|Overall Study|Lost to Follow-up|0|||
19758294|NCT02077166|42209286|FG000|Overall Study|Withdrawal by Subject|3|||
19758295|NCT02077166|42209287|FG001|Overall Study|Withdrawal by Subject|0|||
19758296|NCT02077166|42209288|FG002|Overall Study|Withdrawal by Subject|1|||
19758297|NCT02077166|42209289|FG003|Overall Study|Withdrawal by Subject|1|||
19758298|NCT02077166|42209290|FG004|Overall Study|Withdrawal by Subject|1|||
19758299|NCT02077166|42209291|FG005|Overall Study|Withdrawal by Subject|3|||
19758300|NCT02077166|42209292|FG006|Overall Study|Withdrawal by Subject|0|||
19758301|NCT02077166|42209286|FG000|Overall Study|Other, Not Specified|0|||
19758302|NCT02077166|42209287|FG001|Overall Study|Other, Not Specified|0|||
19758303|NCT02077166|42209288|FG002|Overall Study|Other, Not Specified|1|||
19758304|NCT02077166|42209289|FG003|Overall Study|Other, Not Specified|0|||
19671945|NCT00527514|42119965|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
19671946|NCT00618449|42119978|FG000|Overall Study|Lost to Follow-up|98|||
19671947|NCT00618449|42119979|FG001|Overall Study|Lost to Follow-up|110|||
19671948|NCT03684642|42119988|FG000|Overall Study|Adverse Event|6|||
19671949|NCT03684642|42119989|FG001|Overall Study|Adverse Event|15|||
19671950|NCT03684642|42119990|FG002|Overall Study|Adverse Event|11|||
19671951|NCT03684642|42119988|FG000|Overall Study|Withdrawal by Subject|35|||
19671952|NCT03684642|42119989|FG001|Overall Study|Withdrawal by Subject|53|||
19671953|NCT03684642|42119990|FG002|Overall Study|Withdrawal by Subject|23|||
19671954|NCT03684642|42119988|FG000|Overall Study|Lack of Efficacy|0|||
19671955|NCT03684642|42119989|FG001|Overall Study|Lack of Efficacy|0|||
19671956|NCT03684642|42119990|FG002|Overall Study|Lack of Efficacy|1|||
19671957|NCT03684642|42119988|FG000|Overall Study|Poor compliance to protocol|0|||
19671958|NCT03684642|42119989|FG001|Overall Study|Poor compliance to protocol|4|||
19671959|NCT03684642|42119990|FG002|Overall Study|Poor compliance to protocol|1|||
19671960|NCT03684642|42119988|FG000|Overall Study|Other than specified|62|||
19671961|NCT03684642|42119989|FG001|Overall Study|Other than specified|60|||
19671962|NCT03684642|42119990|FG002|Overall Study|Other than specified|67|||
19671963|NCT03684642|42119988|FG000|Overall Study|Randomized and not treated|0|||
19671964|NCT03684642|42119989|FG001|Overall Study|Randomized and not treated|0|||
19671965|NCT03684642|42119990|FG002|Overall Study|Randomized and not treated|1|||
19671966|NCT03684642|42119988|FG000|Overall Study|Missing completion status but alive at last contact|0|||
19671967|NCT03684642|42119989|FG001|Overall Study|Missing completion status but alive at last contact|1|||
19758305|NCT02077166|42209290|FG004|Overall Study|Other, Not Specified|1|||
19758306|NCT02077166|42209291|FG005|Overall Study|Other, Not Specified|7|||
19758307|NCT02077166|42209292|FG006|Overall Study|Other, Not Specified|8|||
19758308|NCT04273217|42209319|FG000|Overall Study|Lost to Follow-up|0|||
19671968|NCT03684642|42119990|FG002|Overall Study|Missing completion status but alive at last contact|2|||
19671969|NCT00519636|42120002|FG000|Treatment Period 1|Adverse Event|1|||
19671970|NCT00519636|42120003|FG001|Treatment Period 1|Adverse Event|0|||
19671971|NCT00519636|42120004|FG002|Treatment Period 1|Adverse Event|1|||
19671972|NCT00519636|42120005|FG003|Treatment Period 1|Adverse Event|0|||
19671973|NCT00519636|42120002|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
19671974|NCT00519636|42120003|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
19671975|NCT00519636|42120004|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
19671976|NCT00519636|42120005|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
19671977|NCT00519636|42120002|FG000|Washout Period|Adverse Event|2|||
19671978|NCT00519636|42120003|FG001|Washout Period|Adverse Event|1|||
19671979|NCT00519636|42120004|FG002|Washout Period|Adverse Event|1|||
19671980|NCT00519636|42120005|FG003|Washout Period|Adverse Event|0|||
19671981|NCT00519636|42120002|FG000|Washout Period|Lost to Follow-up|1|||
19671982|NCT00519636|42120003|FG001|Washout Period|Lost to Follow-up|0|||
19671983|NCT00519636|42120004|FG002|Washout Period|Lost to Follow-up|0|||
19671984|NCT00519636|42120005|FG003|Washout Period|Lost to Follow-up|0|||
19671985|NCT00519636|42120002|FG000|Washout Period|Protocol Violation|0|||
19671986|NCT00519636|42120003|FG001|Washout Period|Protocol Violation|0|||
19671987|NCT00519636|42120004|FG002|Washout Period|Protocol Violation|1|||
19671988|NCT00519636|42120005|FG003|Washout Period|Protocol Violation|2|||
19671989|NCT00519636|42120002|FG000|Washout Period|Withdrawal by Subject|1|||
19671990|NCT00519636|42120003|FG001|Washout Period|Withdrawal by Subject|0|||
19671991|NCT00519636|42120004|FG002|Washout Period|Withdrawal by Subject|1|||
19671992|NCT00519636|42120005|FG003|Washout Period|Withdrawal by Subject|0|||
19671993|NCT00519636|42120002|FG000|Washout Period|Failed to meet continuation criteria|14|||
19671994|NCT00519636|42120003|FG001|Washout Period|Failed to meet continuation criteria|11|||
19671995|NCT00519636|42120004|FG002|Washout Period|Failed to meet continuation criteria|9|||
19671996|NCT00519636|42120005|FG003|Washout Period|Failed to meet continuation criteria|3|||
19671997|NCT00519636|42120002|FG000|Washout Period|Out of pollen area > 48 hours|1|||
19671998|NCT00519636|42120003|FG001|Washout Period|Out of pollen area > 48 hours|0|||
19671999|NCT00519636|42120004|FG002|Washout Period|Out of pollen area > 48 hours|0|||
19672000|NCT00519636|42120005|FG003|Washout Period|Out of pollen area > 48 hours|0|||
19672001|NCT00519636|42120002|FG000|Washout Period|Participating in study at another site|1|||
19758309|NCT04273217|42209320|FG001|Overall Study|Lost to Follow-up|0|||
19758310|NCT04273217|42209321|FG002|Overall Study|Lost to Follow-up|0|||
19758311|NCT04273217|42209322|FG003|Overall Study|Lost to Follow-up|0|||
19758312|NCT04273217|42209323|FG004|Overall Study|Lost to Follow-up|0|||
19758313|NCT04273217|42209324|FG005|Overall Study|Lost to Follow-up|1|||
19758314|NCT04273217|42209319|FG000|Overall Study|Participant non-compliance|0|||
19758315|NCT04273217|42209320|FG001|Overall Study|Participant non-compliance|0|||
19758316|NCT04273217|42209321|FG002|Overall Study|Participant non-compliance|0|||
19758317|NCT04273217|42209322|FG003|Overall Study|Participant non-compliance|0|||
19758318|NCT04273217|42209323|FG004|Overall Study|Participant non-compliance|1|||
19758319|NCT04273217|42209324|FG005|Overall Study|Participant non-compliance|0|||
19758320|NCT04273217|42209319|FG000|Overall Study|Positive urine drug screen|1|||
19758321|NCT04273217|42209320|FG001|Overall Study|Positive urine drug screen|0|||
19758322|NCT04273217|42209321|FG002|Overall Study|Positive urine drug screen|1|||
19758323|NCT04273217|42209322|FG003|Overall Study|Positive urine drug screen|0|||
19758324|NCT04273217|42209323|FG004|Overall Study|Positive urine drug screen|0|||
19758325|NCT04273217|42209324|FG005|Overall Study|Positive urine drug screen|1|||
19758326|NCT04384523|42209344|FG000|Overall Study|Lost to Follow-up|0|||
19603805|NCT03107793|42052831|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19603806|NCT03107793|42052832|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19603807|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
19603808|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
19603809|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
19603810|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
19603811|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
19672002|NCT00519636|42120003|FG001|Washout Period|Participating in study at another site|0|||
19672003|NCT00519636|42120004|FG002|Washout Period|Participating in study at another site|0|||
19672004|NCT00519636|42120005|FG003|Washout Period|Participating in study at another site|0|||
19672005|NCT00519636|42120002|FG000|Washout Period|Non-compliant|0|||
19758327|NCT04384523|42209345|FG001|Overall Study|Lost to Follow-up|0|||
19758328|NCT04384523|42209346|FG002|Overall Study|Lost to Follow-up|0|||
19758329|NCT04384523|42209347|FG003|Overall Study|Lost to Follow-up|0|||
19758330|NCT04384523|42209348|FG004|Overall Study|Lost to Follow-up|0|||
19758331|NCT04384523|42209349|FG005|Overall Study|Lost to Follow-up|1|||
19672006|NCT00519636|42120003|FG001|Washout Period|Non-compliant|1|||
19758332|NCT04384523|42209344|FG000|Overall Study|Protocol Violation|0|||
19758333|NCT04384523|42209345|FG001|Overall Study|Protocol Violation|1|||
19758334|NCT04384523|42209346|FG002|Overall Study|Protocol Violation|0|||
19758335|NCT04384523|42209347|FG003|Overall Study|Protocol Violation|0|||
19758336|NCT04384523|42209348|FG004|Overall Study|Protocol Violation|0|||
19758337|NCT04384523|42209349|FG005|Overall Study|Protocol Violation|0|||
19758338|NCT04384523|42209344|FG000|Overall Study|Withdrawal by Subject|1|||
19758339|NCT04384523|42209345|FG001|Overall Study|Withdrawal by Subject|0|||
19758340|NCT04384523|42209346|FG002|Overall Study|Withdrawal by Subject|0|||
19758341|NCT04384523|42209347|FG003|Overall Study|Withdrawal by Subject|0|||
19758342|NCT04384523|42209348|FG004|Overall Study|Withdrawal by Subject|0|||
19758343|NCT04384523|42209349|FG005|Overall Study|Withdrawal by Subject|0|||
19758344|NCT04382651|42209384|FG000|Overall Study|Death|26|||
19758345|NCT04382651|42209385|FG001|Overall Study|Death|23|||
19672007|NCT00519636|42120004|FG002|Washout Period|Non-compliant|0|||
19672008|NCT00519636|42120005|FG003|Washout Period|Non-compliant|0|||
19672009|NCT00519636|42120002|FG000|Washout Period|Per doctors request|0|||
19672010|NCT00519636|42120003|FG001|Washout Period|Per doctors request|1|||
19672011|NCT00519636|42120004|FG002|Washout Period|Per doctors request|0|||
19672012|NCT00519636|42120005|FG003|Washout Period|Per doctors request|0|||
19758346|NCT04382651|42209384|FG000|Overall Study|Lost to Follow-up|3|||
19758347|NCT04382651|42209385|FG001|Overall Study|Lost to Follow-up|4|||
19758348|NCT04382651|42209384|FG000|Overall Study|Withdrawal by Subject|2|||
19758349|NCT04382651|42209385|FG001|Overall Study|Withdrawal by Subject|0|||
19758350|NCT04382651|42209384|FG000|Overall Study|Physician Decision|0|||
19758351|NCT04382651|42209385|FG001|Overall Study|Physician Decision|1|||
19758352|NCT04238663|42209400|FG000|Overall Study|Lost to Follow-up|0|||
19758353|NCT04238663|42209401|FG001|Overall Study|Lost to Follow-up|1|||
19758354|NCT04238663|42209402|FG002|Overall Study|Lost to Follow-up|0|||
19758355|NCT03442088|42209410|FG000|Overall Study|Adverse Event|1|||
19758356|NCT03442088|42209410|FG000|Overall Study|Lack of Efficacy|2|||
19758357|NCT03442088|42209410|FG000|Overall Study|Lost to Follow-up|2|||
19758358|NCT04223687|42209416|FG000|Overall Study|Missing primary outcome|1|||
19758359|NCT04223687|42209417|FG001|Overall Study|Missing primary outcome|0|||
19758360|NCT03722576|42209423|FG000|Overall Study|Withdrawal by Subject|3|||
19758361|NCT03722576|42209423|FG000|Overall Study|Adverse Event|2|||
19758362|NCT03722576|42209423|FG000|Overall Study|Physician Decision|1|||
19758363|NCT03722576|42209423|FG000|Overall Study|Lost to Follow-up|1|||
19758364|NCT03693989|42209429|FG000|Overall Study|Protocol Violation|3|||
19758365|NCT03693989|42209430|FG001|Overall Study|Protocol Violation|4|||
19758366|NCT04206293|42209436|FG000|Overall Study|Consent withdrawal|1|||
19758367|NCT02727998|42209443|FG000|Overall Study|Lost to Follow-up|3|||
19758368|NCT02727998|42209444|FG001|Overall Study|Lost to Follow-up|3|||
19758369|NCT02727998|42209443|FG000|Overall Study|Withdrawal by Subject|0|||
19758370|NCT02727998|42209444|FG001|Overall Study|Withdrawal by Subject|1|||
19758371|NCT04366349|42209456|FG000|Overall Study|Withdrawal by Subject|1|||
19758372|NCT04366349|42209457|FG001|Overall Study|Withdrawal by Subject|0|||
19758373|NCT04366349|42209458|FG002|Overall Study|Withdrawal by Subject|0|||
19758374|NCT04366349|42209459|FG003|Overall Study|Withdrawal by Subject|0|||
19758375|NCT04366349|42209460|FG004|Overall Study|Withdrawal by Subject|0|||
19758376|NCT04366349|42209461|FG005|Overall Study|Withdrawal by Subject|0|||
19758377|NCT04179461|42209479|FG000|Overall Study|Lost to Follow-up|4|||
19758378|NCT04017611|42209483|FG000|Overall Study|Withdrawn prior to completion|1|||
19758379|NCT04172831|42209498|FG000|Overall Study|Adverse Event|21|||
19758380|NCT04172831|42209499|FG001|Overall Study|Adverse Event|9|||
19758381|NCT04172831|42209498|FG000|Overall Study|Lack of Efficacy|2|||
19758382|NCT04172831|42209499|FG001|Overall Study|Lack of Efficacy|8|||
19758383|NCT04172831|42209498|FG000|Overall Study|Physician Decision|0|||
19758384|NCT04172831|42209499|FG001|Overall Study|Physician Decision|1|||
19758385|NCT04172831|42209498|FG000|Overall Study|Withdrawal by Subject|12|||
19758386|NCT04172831|42209499|FG001|Overall Study|Withdrawal by Subject|11|||
19758387|NCT04172831|42209498|FG000|Overall Study|Lost to Follow-up|4|||
19758388|NCT04172831|42209499|FG001|Overall Study|Lost to Follow-up|9|||
19758389|NCT04172831|42209498|FG000|Overall Study|COVID-19 related crisis|3|||
19672013|NCT00519636|42120002|FG000|Washout Period|Subject randomized in error|0|||
19758390|NCT04172831|42209499|FG001|Overall Study|COVID-19 related crisis|3|||
19672014|NCT00519636|42120003|FG001|Washout Period|Subject randomized in error|0|||
19758391|NCT04172831|42209498|FG000|Overall Study|Subject non-compliance|1|||
19758392|NCT04172831|42209499|FG001|Overall Study|Subject non-compliance|1|||
19758393|NCT04172831|42209498|FG000|Overall Study|Family emergency|1|||
19758394|NCT04172831|42209499|FG001|Overall Study|Family emergency|0|||
19672015|NCT00519636|42120004|FG002|Washout Period|Subject randomized in error|1|||
19672016|NCT00519636|42120005|FG003|Washout Period|Subject randomized in error|0|||
19672017|NCT00519636|42120002|FG000|Washout Period|Prohibited medications|0|||
19672018|NCT00519636|42120003|FG001|Washout Period|Prohibited medications|0|||
19672019|NCT00519636|42120004|FG002|Washout Period|Prohibited medications|1|||
19672020|NCT00519636|42120005|FG003|Washout Period|Prohibited medications|0|||
19672021|NCT00519636|42120002|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
19672022|NCT00519636|42120003|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
19758395|NCT04165031|42209516|FG000|Overall Study|Adverse Event|1|||
19672023|NCT00519636|42120004|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
19672024|NCT00519636|42120005|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
19672025|NCT00519636|42120002|FG000|Treatment Period 2|Subject randomized in error|0|||
19672026|NCT00519636|42120003|FG001|Treatment Period 2|Subject randomized in error|1|||
19758396|NCT04165031|42209517|FG001|Overall Study|Adverse Event|1|||
19758397|NCT04165031|42209518|FG002|Overall Study|Adverse Event|0|||
19758398|NCT04165031|42209519|FG003|Overall Study|Adverse Event|0|||
19758399|NCT04165031|42209520|FG004|Overall Study|Adverse Event|0|||
19758400|NCT04165031|42209521|FG005|Overall Study|Adverse Event|0|||
19758401|NCT04165031|42209516|FG000|Overall Study|Withdrawal by Subject|0|||
19758402|NCT04165031|42209517|FG001|Overall Study|Withdrawal by Subject|0|||
19758403|NCT04165031|42209518|FG002|Overall Study|Withdrawal by Subject|1|||
19672027|NCT00519636|42120004|FG002|Treatment Period 2|Subject randomized in error|0|||
19672028|NCT00519636|42120005|FG003|Treatment Period 2|Subject randomized in error|0|||
19672029|NCT00519636|42120002|FG000|Treatment Period 2|Per doctors request|0|||
19672030|NCT00519636|42120003|FG001|Treatment Period 2|Per doctors request|0|||
19672031|NCT00519636|42120004|FG002|Treatment Period 2|Per doctors request|1|||
19672032|NCT00519636|42120005|FG003|Treatment Period 2|Per doctors request|0|||
19672033|NCT00519636|42120002|FG000|Treatment Period 2|Subject misrandomized|0|||
19672034|NCT00519636|42120003|FG001|Treatment Period 2|Subject misrandomized|0|||
19672035|NCT00519636|42120004|FG002|Treatment Period 2|Subject misrandomized|0|||
19672036|NCT00519636|42120005|FG003|Treatment Period 2|Subject misrandomized|1|||
19758404|NCT04165031|42209519|FG003|Overall Study|Withdrawal by Subject|0|||
19758405|NCT04165031|42209520|FG004|Overall Study|Withdrawal by Subject|0|||
19672037|NCT00519636|42120002|FG000|Post Study Period|Subject randomized in error|0|||
19672038|NCT00519636|42120003|FG001|Post Study Period|Subject randomized in error|0|||
19672039|NCT00519636|42120004|FG002|Post Study Period|Subject randomized in error|0|||
19672040|NCT00519636|42120005|FG003|Post Study Period|Subject randomized in error|1|||
19672041|NCT00618371|42120019|FG000|Overall Study|Withdrawal by Subject|2|||
19672042|NCT00526890|42120024|FG000|Overall Study|Adverse Event|2|||
19672043|NCT03864900|42120030|FG000|Overall Study|Withdrawal by Subject|1|||
19672044|NCT03864900|42120031|FG001|Overall Study|Withdrawal by Subject|1|||
19672045|NCT03864900|42120030|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
19672046|NCT03864900|42120031|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
19672047|NCT00526656|42120037|FG000|Overall Study|Death|1|||
19672048|NCT00526656|42120037|FG000|Overall Study|Refused surgery|1|||
19672049|NCT00617903|42120044|FG000|Overall Study|Withdrawal by Subject|2|||
19672050|NCT00617903|42120045|FG001|Overall Study|Withdrawal by Subject|3|||
19672051|NCT00617903|42120044|FG000|Overall Study|Lost to Follow-up|1|||
19672052|NCT00617903|42120045|FG001|Overall Study|Lost to Follow-up|1|||
19672053|NCT00617903|42120044|FG000|Overall Study|Lack of Efficacy|0|||
19672054|NCT00617903|42120045|FG001|Overall Study|Lack of Efficacy|1|||
19672055|NCT00617903|42120044|FG000|Overall Study|Adverse Event|0|||
19672056|NCT00617903|42120045|FG001|Overall Study|Adverse Event|1|||
19672057|NCT00617903|42120044|FG000|Overall Study|noncompliance|0|||
19672058|NCT00617903|42120045|FG001|Overall Study|noncompliance|1|||
19758406|NCT04165031|42209521|FG005|Overall Study|Withdrawal by Subject|0|||
19758407|NCT02712424|42209538|FG000|Overall Study|Lost to Follow-up|34|||
19758408|NCT02712424|42209539|FG001|Overall Study|Lost to Follow-up|32|||
19758409|NCT02968004|42209547|FG000|Overall Study|Adverse Event|1|||
19758410|NCT02968004|42209548|FG001|Overall Study|Adverse Event|0|||
19758411|NCT02968004|42209547|FG000|Overall Study|Withdrawal by Subject|0|||
19758412|NCT02968004|42209548|FG001|Overall Study|Withdrawal by Subject|1|||
19672059|NCT00526110|42120053|FG000|Overall Study|Adverse Event|2|||
19758413|NCT03034772|42209556|FG000|Overall Study|Adverse Event|0|||
19758414|NCT03034772|42209557|FG001|Overall Study|Adverse Event|1|||
19758415|NCT03034772|42209556|FG000|Overall Study|Withdrawal by Subject|0|||
19758416|NCT03034772|42209557|FG001|Overall Study|Withdrawal by Subject|1|||
19758417|NCT03032198|42209563|FG000|Overall Study|Screen Fail|1|||
19758418|NCT02431364|42209572|FG000|Overall Study|Adverse Event|0|||
19758419|NCT02431364|42209573|FG001|Overall Study|Adverse Event|1|||
19758420|NCT02431364|42209574|FG002|Overall Study|Adverse Event|0|||
19758421|NCT02431364|42209575|FG003|Overall Study|Adverse Event|0|||
19758422|NCT02431364|42209576|FG004|Overall Study|Adverse Event|0|||
19672060|NCT00526110|42120054|FG001|Overall Study|Adverse Event|9|||
19672061|NCT00526110|42120053|FG000|Overall Study|Disease Progression|0|||
19672062|NCT00526110|42120054|FG001|Overall Study|Disease Progression|19|||
19672063|NCT00526110|42120053|FG000|Overall Study|Maximal Response|0|||
19672064|NCT00526110|42120054|FG001|Overall Study|Maximal Response|6|||
19672065|NCT00526110|42120053|FG000|Overall Study|Withdrawal by Subject|0|||
19672066|NCT00526110|42120054|FG001|Overall Study|Withdrawal by Subject|2|||
19672067|NCT00526110|42120053|FG000|Overall Study|Poor Tolerance|0|||
19672068|NCT00526110|42120054|FG001|Overall Study|Poor Tolerance|5|||
19672069|NCT00512148|42120060|FG000|Primay Study Period|Withdrawal by Subject|1|||
19672070|NCT00511836|42120068|FG000|Double-blind Period|Lost to Follow-up|1|||
19672071|NCT00511836|42120069|FG001|Double-blind Period|Lost to Follow-up|0|||
19672072|NCT00573755|42120078|FG000|Overall Study|Still receiving treatment|1|||
19672073|NCT00573755|42120079|FG001|Overall Study|Still receiving treatment|0|||
19672074|NCT00524316|42120085|FG000|Overall Study|Withdrawal by Subject|2|||
19758423|NCT02431364|42209572|FG000|Overall Study|Randomized but never treated|0|||
19758424|NCT02431364|42209573|FG001|Overall Study|Randomized but never treated|0|||
19758425|NCT02431364|42209574|FG002|Overall Study|Randomized but never treated|0|||
19758426|NCT02431364|42209575|FG003|Overall Study|Randomized but never treated|1|||
19758427|NCT02431364|42209576|FG004|Overall Study|Randomized but never treated|0|||
19758428|NCT03034460|42209594|FG000|Overall Study|Adverse Event|0|||
19758429|NCT03034460|42209595|FG001|Overall Study|Adverse Event|1|||
19758430|NCT03034460|42209594|FG000|Overall Study|Withdrawal by Subject|2|||
19758431|NCT03034460|42209595|FG001|Overall Study|Withdrawal by Subject|2|||
19758432|NCT03034460|42209594|FG000|Overall Study|Personal Reasons|1|||
19758433|NCT03034460|42209595|FG001|Overall Study|Personal Reasons|0|||
19758434|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
19758435|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
19758436|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
19758437|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
19758438|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
19758439|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
19758440|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
19758441|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
19758442|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
19758443|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
19758444|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
19758445|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
19758446|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
19758447|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
19758448|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
19758449|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
19758450|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
19758451|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
19758452|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
19758453|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
19758454|NCT04162769|42209608|FG000|Double-blind Treatment (12-Week)|Other|0|||
19758455|NCT04162769|42209609|FG001|Double-blind Treatment (12-Week)|Other|1|||
19758456|NCT04162769|42209610|FG002|Double-blind Treatment (12-Week)|Other|1|||
19758457|NCT04162769|42209611|FG003|Double-blind Treatment (12-Week)|Other|0|||
19758458|NCT04162769|42209608|FG000|OLE Period (52-Week)|Adverse Event|0|||
19758459|NCT04162769|42209609|FG001|OLE Period (52-Week)|Adverse Event|0|||
19758460|NCT04162769|42209610|FG002|OLE Period (52-Week)|Adverse Event|0|||
19758461|NCT04162769|42209611|FG003|OLE Period (52-Week)|Adverse Event|5|||
19758462|NCT04162769|42209608|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
19758463|NCT04162769|42209609|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
19758464|NCT04162769|42209610|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
19758465|NCT04162769|42209611|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
19758466|NCT04162769|42209608|FG000|OLE Period (52-Week)|Physician Decision|0|||
19672075|NCT00524316|42120085|FG000|Overall Study|Adverse Event|7|||
19672076|NCT00524316|42120085|FG000|Overall Study|Disease Progression|7|||
19672077|NCT03861936|42120102|FG000|Overall Study|Withdrawal by Subject|4|||
19672078|NCT03861936|42120103|FG001|Overall Study|Withdrawal by Subject|1|||
19758467|NCT04162769|42209609|FG001|OLE Period (52-Week)|Physician Decision|0|||
19758468|NCT04162769|42209610|FG002|OLE Period (52-Week)|Physician Decision|0|||
19758469|NCT04162769|42209611|FG003|OLE Period (52-Week)|Physician Decision|1|||
19758470|NCT04162769|42209608|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
19758471|NCT04162769|42209609|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
19758472|NCT04162769|42209610|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
19758473|NCT04162769|42209611|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
19758474|NCT04162769|42209608|FG000|OLE Period (52-Week)|Protocol deviation|0|||
19758475|NCT04162769|42209609|FG001|OLE Period (52-Week)|Protocol deviation|0|||
19758476|NCT04162769|42209610|FG002|OLE Period (52-Week)|Protocol deviation|0|||
19758477|NCT04162769|42209611|FG003|OLE Period (52-Week)|Protocol deviation|2|||
19758478|NCT04161131|42209622|FG000|Overall Study|Ineligible|2|||
19758479|NCT04161131|42209622|FG000|Overall Study|Lost to Follow-up|4|||
19758480|NCT04155047|42209628|FG000|Overall Study|Adverse Event|1|||
19758481|NCT04155047|42209629|FG001|Overall Study|Adverse Event|0|||
19758482|NCT04155047|42209628|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
19758483|NCT04155047|42209629|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
19758484|NCT04152083|42209637|FG000|Overall Study|Lost to Follow-up|2|||
19758485|NCT04152083|42209638|FG001|Overall Study|Lost to Follow-up|1|||
19758486|NCT04152083|42209637|FG000|Overall Study|Adverse Event|1|||
19758487|NCT04152083|42209638|FG001|Overall Study|Adverse Event|0|||
19672079|NCT03861936|42120104|FG002|Overall Study|Withdrawal by Subject|3|||
19672080|NCT03861936|42120102|FG000|Overall Study|Lost to Follow-up|5|||
19672081|NCT03861936|42120103|FG001|Overall Study|Lost to Follow-up|3|||
19672082|NCT03861936|42120104|FG002|Overall Study|Lost to Follow-up|3|||
19672083|NCT03861936|42120102|FG000|Overall Study|Physician Decision|0|||
19672084|NCT03861936|42120103|FG001|Overall Study|Physician Decision|1|||
19672085|NCT03861936|42120104|FG002|Overall Study|Physician Decision|0|||
19672086|NCT03861936|42120102|FG000|Overall Study|Protocol Deviation|0|||
19672087|NCT03861936|42120103|FG001|Overall Study|Protocol Deviation|0|||
19758488|NCT04152083|42209637|FG000|Overall Study|Randomized but not treated|3|||
19758489|NCT04152083|42209638|FG001|Overall Study|Randomized but not treated|2|||
19758490|NCT02711956|42209659|FG000|Overall Study|Adverse Event|0|||
19758491|NCT02711956|42209660|FG001|Overall Study|Adverse Event|0|||
19758492|NCT02711956|42209661|FG002|Overall Study|Adverse Event|0|||
19758493|NCT02711956|42209662|FG003|Overall Study|Adverse Event|1|||
19758494|NCT02711956|42209663|FG004|Overall Study|Adverse Event|2|||
19758495|NCT02711956|42209664|FG005|Overall Study|Adverse Event|0|||
19758496|NCT02711956|42209665|FG006|Overall Study|Adverse Event|0|||
19758497|NCT02711956|42209666|FG007|Overall Study|Adverse Event|1|||
19758498|NCT02711956|42209667|FG008|Overall Study|Adverse Event|1|||
19758499|NCT02711956|42209668|FG009|Overall Study|Adverse Event|1|||
19758500|NCT02711956|42209669|FG010|Overall Study|Adverse Event|1|||
19758501|NCT02711956|42209670|FG011|Overall Study|Adverse Event|0|||
19758502|NCT02711956|42209671|FG012|Overall Study|Adverse Event|0|||
19758503|NCT02711956|42209672|FG013|Overall Study|Adverse Event|0|||
19758504|NCT02711956|42209673|FG014|Overall Study|Adverse Event|2|||
19758505|NCT02711956|42209659|FG000|Overall Study|Physician Decision|0|||
19758506|NCT02711956|42209660|FG001|Overall Study|Physician Decision|0|||
19758507|NCT02711956|42209661|FG002|Overall Study|Physician Decision|0|||
19672088|NCT03861936|42120104|FG002|Overall Study|Protocol Deviation|1|||
19672089|NCT03861936|42120102|FG000|Overall Study|Reason not Specified|5|||
19758508|NCT02711956|42209662|FG003|Overall Study|Physician Decision|2|||
19758509|NCT02711956|42209663|FG004|Overall Study|Physician Decision|0|||
19758510|NCT02711956|42209664|FG005|Overall Study|Physician Decision|0|||
19758511|NCT02711956|42209665|FG006|Overall Study|Physician Decision|0|||
19758512|NCT02711956|42209666|FG007|Overall Study|Physician Decision|0|||
19758513|NCT02711956|42209667|FG008|Overall Study|Physician Decision|0|||
19758514|NCT02711956|42209668|FG009|Overall Study|Physician Decision|0|||
19758515|NCT02711956|42209669|FG010|Overall Study|Physician Decision|0|||
19758516|NCT02711956|42209670|FG011|Overall Study|Physician Decision|0|||
19758517|NCT02711956|42209671|FG012|Overall Study|Physician Decision|0|||
19672090|NCT03861936|42120103|FG001|Overall Study|Reason not Specified|5|||
19672091|NCT03861936|42120104|FG002|Overall Study|Reason not Specified|3|||
19672092|NCT00434577|42120117|FG000|Months 0-3|Serious Adverse Event|0|||
19672093|NCT00434577|42120118|FG001|Months 0-3|Serious Adverse Event|0|||
19672094|NCT00434577|42120119|FG002|Months 0-3|Serious Adverse Event|1|||
19672095|NCT00434577|42120120|FG003|Months 0-3|Serious Adverse Event|0|||
19672096|NCT00434577|42120121|FG004|Months 0-3|Serious Adverse Event|0|||
19672097|NCT00434577|42120117|FG000|Months 0-3|Adverse Event|0|||
19672098|NCT00434577|42120118|FG001|Months 0-3|Adverse Event|1|||
19672099|NCT00434577|42120119|FG002|Months 0-3|Adverse Event|1|||
19672100|NCT00434577|42120120|FG003|Months 0-3|Adverse Event|0|||
19672101|NCT00434577|42120121|FG004|Months 0-3|Adverse Event|0|||
19672102|NCT00434577|42120117|FG000|Months 0-3|Lost to Follow-up|0|||
19672103|NCT00434577|42120118|FG001|Months 0-3|Lost to Follow-up|0|||
19672104|NCT00434577|42120119|FG002|Months 0-3|Lost to Follow-up|0|||
19672105|NCT00434577|42120120|FG003|Months 0-3|Lost to Follow-up|0|||
19672106|NCT00434577|42120121|FG004|Months 0-3|Lost to Follow-up|2|||
19672107|NCT00434577|42120117|FG000|Months 0-3|Protocol Violation|1|||
19672108|NCT00434577|42120118|FG001|Months 0-3|Protocol Violation|0|||
19672109|NCT00434577|42120119|FG002|Months 0-3|Protocol Violation|1|||
19672110|NCT00434577|42120120|FG003|Months 0-3|Protocol Violation|0|||
19672111|NCT00434577|42120121|FG004|Months 0-3|Protocol Violation|0|||
19672112|NCT00434577|42120117|FG000|Months 0-3|Withdrawal by Subject|2|||
19672113|NCT00434577|42120118|FG001|Months 0-3|Withdrawal by Subject|1|||
19672114|NCT00434577|42120119|FG002|Months 0-3|Withdrawal by Subject|1|||
19672115|NCT00434577|42120120|FG003|Months 0-3|Withdrawal by Subject|1|||
19672116|NCT00434577|42120121|FG004|Months 0-3|Withdrawal by Subject|1|||
19672117|NCT00434421|42120133|FG000|Overall Study|Withdrawal by Subject|1|||
19672118|NCT00434421|42120133|FG000|Overall Study|Non-compliance with study treatment|1|||
19672119|NCT00421707|42120139|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
19672120|NCT00421707|42120140|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
19672121|NCT00421707|42120139|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
19672122|NCT00421707|42120140|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
19672123|NCT00421707|42120139|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
19672124|NCT00421707|42120140|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
19672125|NCT00421707|42120139|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
19672126|NCT00421707|42120140|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
19672127|NCT00421707|42120139|FG000|Period 2: Washout|Adverse Event|1|||
19672128|NCT00421707|42120140|FG001|Period 2: Washout|Adverse Event|1|||
19672129|NCT00421707|42120139|FG000|Period 2: Washout|Withdrawal by Subject|0|||
19672130|NCT00421707|42120140|FG001|Period 2: Washout|Withdrawal by Subject|1|||
19672131|NCT00421707|42120139|FG000|Period 2: Washout|Lost to Follow-up|0|||
19672132|NCT00421707|42120140|FG001|Period 2: Washout|Lost to Follow-up|1|||
19672133|NCT00421707|42120139|FG000|Period 2: Washout|Other: Pregnancy|0|||
19672134|NCT00421707|42120140|FG001|Period 2: Washout|Other: Pregnancy|1|||
19672135|NCT00421707|42120139|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
19672136|NCT00421707|42120140|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
19672137|NCT00421707|42120139|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
19672138|NCT00421707|42120140|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
19672139|NCT00421707|42120139|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
19672140|NCT00421707|42120140|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
19672141|NCT00518622|42120166|FG000|Overall Study|Lost to Follow-up|0|||
19672142|NCT00518622|42120167|FG001|Overall Study|Lost to Follow-up|0|||
19672143|NCT00518622|42120168|FG002|Overall Study|Lost to Follow-up|1|||
19672144|NCT00518622|42120169|FG003|Overall Study|Lost to Follow-up|0|||
19672145|NCT00518622|42120170|FG004|Overall Study|Lost to Follow-up|0|||
19672146|NCT00518622|42120171|FG005|Overall Study|Lost to Follow-up|0|||
19672147|NCT00518622|42120172|FG006|Overall Study|Lost to Follow-up|0|||
19672148|NCT00518622|42120173|FG007|Overall Study|Lost to Follow-up|0|||
19672149|NCT00518622|42120166|FG000|Overall Study|Study medication taken incorrectly|0|||
19672150|NCT00518622|42120167|FG001|Overall Study|Study medication taken incorrectly|1|||
19672151|NCT00518622|42120168|FG002|Overall Study|Study medication taken incorrectly|0|||
19672152|NCT00518622|42120169|FG003|Overall Study|Study medication taken incorrectly|0|||
19672153|NCT00518622|42120170|FG004|Overall Study|Study medication taken incorrectly|0|||
19672154|NCT00518622|42120171|FG005|Overall Study|Study medication taken incorrectly|0|||
19672155|NCT00518622|42120172|FG006|Overall Study|Study medication taken incorrectly|0|||
19758518|NCT02711956|42209672|FG013|Overall Study|Physician Decision|0|||
19672156|NCT00518622|42120173|FG007|Overall Study|Study medication taken incorrectly|0|||
19758519|NCT02711956|42209673|FG014|Overall Study|Physician Decision|0|||
19672157|NCT03783078|42120191|FG000|Overall Study|Participants Ongoing|29|||
19672158|NCT03783078|42120191|FG000|Overall Study|Death|26|||
19672159|NCT00517296|42120197|FG000|Overall Study|Withdrawal by Subject|1|||
19672160|NCT00517296|42120198|FG001|Overall Study|Withdrawal by Subject|0|||
19672161|NCT00516906|42120206|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
19672162|NCT00516906|42120207|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
19672163|NCT00523848|42120213|FG000|Overall Study|Adverse Event|11|||
19672164|NCT00523848|42120213|FG000|Overall Study|Withdrawal by Subject|2|||
19672165|NCT00523848|42120213|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
19672166|NCT00523848|42120213|FG000|Overall Study|Disease Progression|5|||
19672167|NCT00523848|42120213|FG000|Overall Study|Other, unspecified|4|||
19672168|NCT00617669|42120219|FG000|Overall Study|Withdrawal by Subject|71|||
19758520|NCT02711956|42209659|FG000|Overall Study|Withdrawal by Subject|0|||
19758521|NCT02711956|42209660|FG001|Overall Study|Withdrawal by Subject|0|||
19758522|NCT02711956|42209661|FG002|Overall Study|Withdrawal by Subject|0|||
19758523|NCT02711956|42209662|FG003|Overall Study|Withdrawal by Subject|0|||
19758524|NCT02711956|42209663|FG004|Overall Study|Withdrawal by Subject|0|||
19758525|NCT02711956|42209664|FG005|Overall Study|Withdrawal by Subject|0|||
19758526|NCT02711956|42209665|FG006|Overall Study|Withdrawal by Subject|1|||
19758527|NCT02711956|42209666|FG007|Overall Study|Withdrawal by Subject|0|||
19758528|NCT02711956|42209667|FG008|Overall Study|Withdrawal by Subject|0|||
19758529|NCT02711956|42209668|FG009|Overall Study|Withdrawal by Subject|0|||
19758530|NCT02711956|42209669|FG010|Overall Study|Withdrawal by Subject|0|||
19758531|NCT02711956|42209670|FG011|Overall Study|Withdrawal by Subject|1|||
19758532|NCT02711956|42209671|FG012|Overall Study|Withdrawal by Subject|6|||
19758533|NCT02711956|42209672|FG013|Overall Study|Withdrawal by Subject|0|||
19758534|NCT02711956|42209673|FG014|Overall Study|Withdrawal by Subject|1|||
19758535|NCT02711956|42209659|FG000|Overall Study|Clinical progression|1|||
19758536|NCT02711956|42209660|FG001|Overall Study|Clinical progression|0|||
19758537|NCT02711956|42209661|FG002|Overall Study|Clinical progression|0|||
19758538|NCT02711956|42209662|FG003|Overall Study|Clinical progression|0|||
19758539|NCT02711956|42209663|FG004|Overall Study|Clinical progression|0|||
19758540|NCT02711956|42209664|FG005|Overall Study|Clinical progression|0|||
19758541|NCT02711956|42209665|FG006|Overall Study|Clinical progression|1|||
19758542|NCT02711956|42209666|FG007|Overall Study|Clinical progression|0|||
19758543|NCT02711956|42209667|FG008|Overall Study|Clinical progression|1|||
19758544|NCT02711956|42209668|FG009|Overall Study|Clinical progression|0|||
19758545|NCT02711956|42209669|FG010|Overall Study|Clinical progression|0|||
19758546|NCT02711956|42209670|FG011|Overall Study|Clinical progression|2|||
19758547|NCT02711956|42209671|FG012|Overall Study|Clinical progression|4|||
19758548|NCT02711956|42209672|FG013|Overall Study|Clinical progression|1|||
19758549|NCT02711956|42209673|FG014|Overall Study|Clinical progression|1|||
19758550|NCT02711956|42209659|FG000|Overall Study|Radiographic progression|1|||
19758551|NCT02711956|42209660|FG001|Overall Study|Radiographic progression|1|||
19758552|NCT02711956|42209661|FG002|Overall Study|Radiographic progression|2|||
19758553|NCT02711956|42209662|FG003|Overall Study|Radiographic progression|0|||
19758554|NCT02711956|42209663|FG004|Overall Study|Radiographic progression|1|||
19758555|NCT02711956|42209664|FG005|Overall Study|Radiographic progression|0|||
19758556|NCT02711956|42209665|FG006|Overall Study|Radiographic progression|0|||
19758557|NCT02711956|42209666|FG007|Overall Study|Radiographic progression|0|||
19758558|NCT02711956|42209667|FG008|Overall Study|Radiographic progression|2|||
19758559|NCT02711956|42209668|FG009|Overall Study|Radiographic progression|1|||
19758560|NCT02711956|42209669|FG010|Overall Study|Radiographic progression|0|||
19758561|NCT02711956|42209670|FG011|Overall Study|Radiographic progression|5|||
19758562|NCT02711956|42209671|FG012|Overall Study|Radiographic progression|3|||
19758563|NCT02711956|42209672|FG013|Overall Study|Radiographic progression|0|||
19758564|NCT02711956|42209673|FG014|Overall Study|Radiographic progression|1|||
19672169|NCT00617669|42120220|FG001|Overall Study|Withdrawal by Subject|77|||
19758565|NCT02711956|42209659|FG000|Overall Study|PSA progression with clinical progression|0|||
19758566|NCT02711956|42209660|FG001|Overall Study|PSA progression with clinical progression|0|||
19758567|NCT02711956|42209661|FG002|Overall Study|PSA progression with clinical progression|0|||
19758568|NCT02711956|42209662|FG003|Overall Study|PSA progression with clinical progression|0|||
19758569|NCT02711956|42209663|FG004|Overall Study|PSA progression with clinical progression|1|||
19758570|NCT02711956|42209664|FG005|Overall Study|PSA progression with clinical progression|0|||
19758571|NCT02711956|42209665|FG006|Overall Study|PSA progression with clinical progression|0|||
19758572|NCT02711956|42209666|FG007|Overall Study|PSA progression with clinical progression|0|||
19758573|NCT02711956|42209667|FG008|Overall Study|PSA progression with clinical progression|0|||
19758574|NCT02711956|42209668|FG009|Overall Study|PSA progression with clinical progression|0|||
19758575|NCT02711956|42209669|FG010|Overall Study|PSA progression with clinical progression|0|||
19758576|NCT02711956|42209670|FG011|Overall Study|PSA progression with clinical progression|0|||
19758577|NCT02711956|42209671|FG012|Overall Study|PSA progression with clinical progression|1|||
19672170|NCT00617669|42120219|FG000|Overall Study|Lost to Follow-up|3|||
19672171|NCT00617669|42120220|FG001|Overall Study|Lost to Follow-up|2|||
19672172|NCT00617669|42120219|FG000|Overall Study|Adverse Event|87|||
19672173|NCT00617669|42120220|FG001|Overall Study|Adverse Event|76|||
19672174|NCT00617669|42120219|FG000|Overall Study|Protocol Violation|2|||
19672175|NCT00617669|42120220|FG001|Overall Study|Protocol Violation|3|||
19672176|NCT00617669|42120219|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
19672177|NCT00617669|42120220|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
19672178|NCT00617669|42120219|FG000|Overall Study|Patients randomized but not treated|2|||
19672179|NCT00617669|42120220|FG001|Overall Study|Patients randomized but not treated|3|||
19672180|NCT03682848|42120226|FG000|Overall Study|Withdrawal by Subject|2|||
19672181|NCT03682848|42120226|FG000|Overall Study|Site closed|5|||
19672182|NCT03682848|42120226|FG000|Overall Study|Protocol Deviation|1|||
19672183|NCT03682848|42120226|FG000|Overall Study|Adverse Event|1|||
19672184|NCT00510510|42120233|FG000|Overall Study|Adverse Event|4|||
19672185|NCT00510510|42120234|FG001|Overall Study|Adverse Event|3|||
19672186|NCT00510510|42120235|FG002|Overall Study|Adverse Event|6|||
19672187|NCT00510510|42120233|FG000|Overall Study|Lack of Efficacy|0|||
19672188|NCT00510510|42120234|FG001|Overall Study|Lack of Efficacy|1|||
19672189|NCT00510510|42120235|FG002|Overall Study|Lack of Efficacy|1|||
19672190|NCT00510510|42120233|FG000|Overall Study|Subjects no longer requires study drug|0|||
19672191|NCT00510510|42120234|FG001|Overall Study|Subjects no longer requires study drug|0|||
19672192|NCT00510510|42120235|FG002|Overall Study|Subjects no longer requires study drug|2|||
19758578|NCT02711956|42209672|FG013|Overall Study|PSA progression with clinical progression|1|||
19758579|NCT02711956|42209673|FG014|Overall Study|PSA progression with clinical progression|0|||
19758580|NCT02711956|42209659|FG000|Overall Study|PSA progression with radiographic progression|0|||
19758581|NCT02711956|42209660|FG001|Overall Study|PSA progression with radiographic progression|1|||
19758582|NCT02711956|42209661|FG002|Overall Study|PSA progression with radiographic progression|0|||
19758583|NCT02711956|42209662|FG003|Overall Study|PSA progression with radiographic progression|0|||
19758584|NCT02711956|42209663|FG004|Overall Study|PSA progression with radiographic progression|0|||
19758585|NCT02711956|42209664|FG005|Overall Study|PSA progression with radiographic progression|2|||
19758586|NCT02711956|42209665|FG006|Overall Study|PSA progression with radiographic progression|2|||
19758587|NCT02711956|42209666|FG007|Overall Study|PSA progression with radiographic progression|1|||
19758588|NCT02711956|42209667|FG008|Overall Study|PSA progression with radiographic progression|0|||
19672193|NCT00510510|42120233|FG000|Overall Study|Withdrawal by Subject|1|||
19758589|NCT02711956|42209668|FG009|Overall Study|PSA progression with radiographic progression|1|||
19758590|NCT02711956|42209669|FG010|Overall Study|PSA progression with radiographic progression|0|||
19758591|NCT02711956|42209670|FG011|Overall Study|PSA progression with radiographic progression|1|||
19758592|NCT02711956|42209671|FG012|Overall Study|PSA progression with radiographic progression|2|||
19758593|NCT02711956|42209672|FG013|Overall Study|PSA progression with radiographic progression|3|||
19758594|NCT02711956|42209673|FG014|Overall Study|PSA progression with radiographic progression|3|||
19758595|NCT04149353|42209714|FG000|Overall Study|Study terminated|1|||
19758596|NCT02711800|42209719|FG000|Overall Study|Lost to Follow-up|1|||
19672194|NCT00510510|42120234|FG001|Overall Study|Withdrawal by Subject|2|||
19672195|NCT00510510|42120235|FG002|Overall Study|Withdrawal by Subject|3|||
19672196|NCT00510510|42120233|FG000|Overall Study|Lost to Follow-up|0|||
19672197|NCT00510510|42120234|FG001|Overall Study|Lost to Follow-up|0|||
19672198|NCT00510510|42120235|FG002|Overall Study|Lost to Follow-up|1|||
19672199|NCT00510510|42120233|FG000|Overall Study|Protocol Violation|0|||
19672200|NCT00510510|42120234|FG001|Overall Study|Protocol Violation|3|||
19672201|NCT00510510|42120235|FG002|Overall Study|Protocol Violation|4|||
19672202|NCT00617591|42120243|FG000|Overall Study|Withdrew consent during Induction|4|||
19672203|NCT00617591|42120243|FG000|Overall Study|Withdrew consent during Maintenance|6|||
19672204|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Adverse Event|21|||
19672205|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Adverse Event|6|||
19672206|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
19672207|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
19672208|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
19672209|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
19758597|NCT02711800|42209719|FG000|Overall Study|Withdrawal by Subject|1|||
19758598|NCT03031496|42209723|FG000|Period 1|Adverse Event|2|||
19672210|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
19672211|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
19672212|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Physician Decision|0|||
19672213|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Physician Decision|3|||
19672214|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
19672215|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
19758599|NCT03031496|42209724|FG001|Period 1|Adverse Event|0|||
19758600|NCT03031496|42209723|FG000|Period 1|Withdrawal by Subject|0|||
19758601|NCT03031496|42209724|FG001|Period 1|Withdrawal by Subject|2|||
19758602|NCT02659020|42209737|FG000|Overall Study|Adverse Event|0|||
19758603|NCT02659020|42209738|FG001|Overall Study|Adverse Event|0|||
19758604|NCT02659020|42209739|FG002|Overall Study|Adverse Event|0|||
19758605|NCT02659020|42209740|FG003|Overall Study|Adverse Event|2|||
19758606|NCT02659020|42209741|FG004|Overall Study|Adverse Event|0|||
19758607|NCT02659020|42209742|FG005|Overall Study|Adverse Event|0|||
19758608|NCT02659020|42209743|FG006|Overall Study|Adverse Event|2|||
19758609|NCT02659020|42209737|FG000|Overall Study|Lost to Follow-up|1|||
19672216|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
19672217|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
19672218|NCT00510276|42120250|FG000|Acute Double-Blind Phase|Subject Decision|26|||
19672219|NCT00510276|42120251|FG001|Acute Double-Blind Phase|Subject Decision|28|||
19672220|NCT00510276|42120250|FG000|Extension Open-Label Phase|Adverse Event|9|||
19672221|NCT00510276|42120251|FG001|Extension Open-Label Phase|Adverse Event|18|||
19672222|NCT00510276|42120250|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
19672223|NCT00510276|42120251|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
19672224|NCT00510276|42120250|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
19672225|NCT00510276|42120251|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
19672226|NCT00510276|42120250|FG000|Extension Open-Label Phase|Physician Decision|2|||
19672227|NCT00510276|42120251|FG001|Extension Open-Label Phase|Physician Decision|3|||
19672228|NCT00510276|42120250|FG000|Extension Open-Label Phase|Protocol Violation|0|||
19672229|NCT00510276|42120251|FG001|Extension Open-Label Phase|Protocol Violation|1|||
19672230|NCT00510276|42120250|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
19672231|NCT00510276|42120251|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
19672232|NCT00510276|42120250|FG000|Extension Open-Label Phase|Subject Decision|7|||
19672233|NCT00510276|42120251|FG001|Extension Open-Label Phase|Subject Decision|9|||
19672234|NCT00616655|42120267|FG000|Overall Study|Adverse Event|10|||
19672235|NCT00616655|42120268|FG001|Overall Study|Adverse Event|7|||
19672236|NCT00616655|42120269|FG002|Overall Study|Adverse Event|12|||
19672237|NCT00616655|42120267|FG000|Overall Study|Lack of Efficacy|5|||
19672238|NCT00616655|42120268|FG001|Overall Study|Lack of Efficacy|5|||
19672239|NCT00616655|42120269|FG002|Overall Study|Lack of Efficacy|5|||
19672240|NCT00616655|42120267|FG000|Overall Study|Lost to Follow-up|3|||
19672241|NCT00616655|42120268|FG001|Overall Study|Lost to Follow-up|12|||
19758610|NCT02659020|42209738|FG001|Overall Study|Lost to Follow-up|2|||
19672242|NCT00616655|42120269|FG002|Overall Study|Lost to Follow-up|10|||
19672243|NCT00616655|42120267|FG000|Overall Study|Protocol Violation|2|||
19672244|NCT00616655|42120268|FG001|Overall Study|Protocol Violation|4|||
19672245|NCT00616655|42120269|FG002|Overall Study|Protocol Violation|3|||
19672246|NCT00616655|42120267|FG000|Overall Study|Withdrawal by Subject|9|||
19758611|NCT02659020|42209739|FG002|Overall Study|Lost to Follow-up|1|||
19758612|NCT02659020|42209740|FG003|Overall Study|Lost to Follow-up|6|||
19672247|NCT00616655|42120268|FG001|Overall Study|Withdrawal by Subject|7|||
19672248|NCT00616655|42120269|FG002|Overall Study|Withdrawal by Subject|11|||
19758613|NCT02659020|42209741|FG004|Overall Study|Lost to Follow-up|1|||
19758614|NCT02659020|42209742|FG005|Overall Study|Lost to Follow-up|5|||
19758615|NCT02659020|42209743|FG006|Overall Study|Lost to Follow-up|0|||
19758616|NCT02659020|42209737|FG000|Overall Study|Physician Decision|0|||
19672249|NCT00616655|42120267|FG000|Overall Study|Does not meet in/ex criteria|0|||
19672250|NCT00616655|42120268|FG001|Overall Study|Does not meet in/ex criteria|0|||
19672251|NCT00616655|42120269|FG002|Overall Study|Does not meet in/ex criteria|2|||
19672252|NCT00616655|42120267|FG000|Overall Study|Other|6|||
19672253|NCT00616655|42120268|FG001|Overall Study|Other|6|||
19672254|NCT00616655|42120269|FG002|Overall Study|Other|5|||
19672255|NCT00510198|42120279|FG000|Overall Study|Withdrawal by Subject|5|||
19672256|NCT00510198|42120280|FG001|Overall Study|Withdrawal by Subject|4|||
19672257|NCT00516048|42120290|FG000|Overall Study|Death|0|||
19672258|NCT00516048|42120291|FG001|Overall Study|Death|0|||
19672259|NCT00516048|42120292|FG002|Overall Study|Death|1|||
19672260|NCT00516048|42120290|FG000|Overall Study|Subject Decision|0|||
19672261|NCT00516048|42120291|FG001|Overall Study|Subject Decision|2|||
19672262|NCT00516048|42120292|FG002|Overall Study|Subject Decision|0|||
19672263|NCT00617357|42120300|FG000|Overall Study|Lost to Follow-up|7|||
19672264|NCT00617357|42120300|FG000|Overall Study|Death|5|||
19672265|NCT00617357|42120300|FG000|Overall Study|insurance concerns|2|||
19672266|NCT00617357|42120300|FG000|Overall Study|Withdrawal by Subject|1|||
19672267|NCT00617357|42120300|FG000|Overall Study|Physician Decision|1|||
19672268|NCT00420927|42120312|FG000|Period 1|Adverse Event|19|||
19672269|NCT00420927|42120313|FG001|Period 1|Adverse Event|15|||
19672270|NCT00420927|42120314|FG002|Period 1|Adverse Event|0|||
19672271|NCT00420927|42120315|FG003|Period 1|Adverse Event|0|||
19672272|NCT00420927|42120316|FG004|Period 1|Adverse Event|0|||
19672273|NCT00420927|42120317|FG005|Period 1|Adverse Event|0|||
19672274|NCT00420927|42120318|FG006|Period 1|Adverse Event|0|||
19672275|NCT00420927|42120312|FG000|Period 1|Withdrawal by Subject|7|||
19672276|NCT00420927|42120313|FG001|Period 1|Withdrawal by Subject|12|||
19672277|NCT00420927|42120314|FG002|Period 1|Withdrawal by Subject|0|||
19672278|NCT00420927|42120315|FG003|Period 1|Withdrawal by Subject|0|||
19672279|NCT00420927|42120316|FG004|Period 1|Withdrawal by Subject|0|||
19672280|NCT00420927|42120317|FG005|Period 1|Withdrawal by Subject|0|||
19672281|NCT00420927|42120318|FG006|Period 1|Withdrawal by Subject|0|||
19672282|NCT00420927|42120312|FG000|Period 1|Lost to Follow-up|8|||
19672283|NCT00420927|42120313|FG001|Period 1|Lost to Follow-up|6|||
19672284|NCT00420927|42120314|FG002|Period 1|Lost to Follow-up|0|||
19758617|NCT02659020|42209738|FG001|Overall Study|Physician Decision|0|||
19758618|NCT02659020|42209739|FG002|Overall Study|Physician Decision|0|||
19758619|NCT02659020|42209740|FG003|Overall Study|Physician Decision|1|||
19758620|NCT02659020|42209741|FG004|Overall Study|Physician Decision|1|||
19758621|NCT02659020|42209742|FG005|Overall Study|Physician Decision|0|||
19758622|NCT02659020|42209743|FG006|Overall Study|Physician Decision|1|||
19758623|NCT02659020|42209737|FG000|Overall Study|Withdrawal by Subject|2|||
19758624|NCT02659020|42209738|FG001|Overall Study|Withdrawal by Subject|1|||
19758625|NCT02659020|42209739|FG002|Overall Study|Withdrawal by Subject|0|||
19758626|NCT02659020|42209740|FG003|Overall Study|Withdrawal by Subject|3|||
19758627|NCT02659020|42209741|FG004|Overall Study|Withdrawal by Subject|3|||
19758628|NCT02659020|42209742|FG005|Overall Study|Withdrawal by Subject|6|||
19758629|NCT02659020|42209743|FG006|Overall Study|Withdrawal by Subject|3|||
19758630|NCT02659020|42209737|FG000|Overall Study|Progressive Disease|0|||
19758631|NCT02659020|42209738|FG001|Overall Study|Progressive Disease|0|||
19758632|NCT02659020|42209739|FG002|Overall Study|Progressive Disease|0|||
19672285|NCT00420927|42120315|FG003|Period 1|Lost to Follow-up|0|||
19672286|NCT00420927|42120316|FG004|Period 1|Lost to Follow-up|0|||
19672287|NCT00420927|42120317|FG005|Period 1|Lost to Follow-up|0|||
19672288|NCT00420927|42120318|FG006|Period 1|Lost to Follow-up|0|||
19672289|NCT00420927|42120312|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
19672290|NCT00420927|42120313|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
19672291|NCT00420927|42120314|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
19672292|NCT00420927|42120315|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
19672293|NCT00420927|42120316|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
19672294|NCT00420927|42120317|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
19758633|NCT02659020|42209740|FG003|Overall Study|Progressive Disease|4|||
19758634|NCT02659020|42209741|FG004|Overall Study|Progressive Disease|1|||
19758635|NCT02659020|42209742|FG005|Overall Study|Progressive Disease|0|||
19758636|NCT02659020|42209743|FG006|Overall Study|Progressive Disease|2|||
19758637|NCT03482011|42209768|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
19758638|NCT03482011|42209769|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
19758639|NCT03482011|42209770|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
19758640|NCT03482011|42209771|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
19758641|NCT03482011|42209772|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
19758642|NCT03482011|42209773|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
19758643|NCT03482011|42209774|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
19758644|NCT03482011|42209775|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
19758645|NCT03482011|42209768|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
19758646|NCT03482011|42209769|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
19758647|NCT03482011|42209770|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758648|NCT03482011|42209771|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758649|NCT03482011|42209772|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758650|NCT03482011|42209773|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758651|NCT03482011|42209774|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758652|NCT03482011|42209775|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19758653|NCT03482011|42209768|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758654|NCT03482011|42209769|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
19758655|NCT03482011|42209770|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758656|NCT03482011|42209771|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758657|NCT03482011|42209772|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758658|NCT03482011|42209773|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758659|NCT03482011|42209774|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758660|NCT03482011|42209775|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
19758661|NCT03482011|42209768|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
19758662|NCT03482011|42209769|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
19758663|NCT03482011|42209770|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
19758664|NCT03482011|42209771|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
19758665|NCT03482011|42209772|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
19758666|NCT03482011|42209773|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
19758667|NCT03482011|42209774|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
19758668|NCT03482011|42209775|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
19758669|NCT03482011|42209768|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
19758670|NCT03482011|42209769|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
19758671|NCT03482011|42209770|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758672|NCT03482011|42209771|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758673|NCT03482011|42209772|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758674|NCT03482011|42209773|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758675|NCT03482011|42209774|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758676|NCT03482011|42209775|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19758677|NCT03482011|42209768|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
19758678|NCT03482011|42209769|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
19758679|NCT03482011|42209770|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
19758680|NCT03482011|42209771|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
19758681|NCT03482011|42209772|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
19758682|NCT03482011|42209773|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
19758683|NCT03482011|42209774|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
19758684|NCT03482011|42209775|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
19758685|NCT03482011|42209768|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
19758686|NCT03482011|42209769|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
19758687|NCT03482011|42209770|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
19758688|NCT03482011|42209771|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
19758689|NCT03482011|42209772|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
19758690|NCT03482011|42209773|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
19758691|NCT03482011|42209774|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
19758692|NCT03482011|42209775|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
19758693|NCT03482011|42209768|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19758694|NCT03482011|42209769|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19758695|NCT03482011|42209770|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19672295|NCT00420927|42120318|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
19672296|NCT00420927|42120312|FG000|Period 1|Death|2|||
19672297|NCT00420927|42120313|FG001|Period 1|Death|0|||
19672298|NCT00420927|42120314|FG002|Period 1|Death|0|||
19672299|NCT00420927|42120315|FG003|Period 1|Death|0|||
19672300|NCT00420927|42120316|FG004|Period 1|Death|0|||
19672301|NCT00420927|42120317|FG005|Period 1|Death|0|||
19672302|NCT00420927|42120318|FG006|Period 1|Death|0|||
19672303|NCT00420927|42120312|FG000|Period 1|Subject moved/relocated|0|||
19672304|NCT00420927|42120313|FG001|Period 1|Subject moved/relocated|2|||
19758696|NCT03482011|42209771|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19758697|NCT03482011|42209772|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
19758698|NCT03482011|42209773|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19672305|NCT00420927|42120314|FG002|Period 1|Subject moved/relocated|0|||
19672306|NCT00420927|42120315|FG003|Period 1|Subject moved/relocated|0|||
19672307|NCT00420927|42120316|FG004|Period 1|Subject moved/relocated|0|||
19758699|NCT03482011|42209774|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19758700|NCT03482011|42209775|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
19758701|NCT03482011|42209768|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
19758702|NCT03482011|42209769|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
19758703|NCT03482011|42209770|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
19758704|NCT03482011|42209771|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
19758705|NCT03482011|42209772|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
19758706|NCT03482011|42209773|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
19758707|NCT03482011|42209774|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
19758708|NCT03482011|42209775|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
19758709|NCT03482011|42209768|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19758710|NCT03482011|42209769|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19758711|NCT03482011|42209770|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19758712|NCT03482011|42209771|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
19758713|NCT03482011|42209772|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
19758714|NCT03482011|42209773|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
19758715|NCT03482011|42209774|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
19758716|NCT03482011|42209775|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
19758717|NCT03482011|42209768|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19758718|NCT03482011|42209769|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19758719|NCT03482011|42209770|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19758720|NCT03482011|42209771|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
19758721|NCT03482011|42209772|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
19758722|NCT03482011|42209773|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
19758723|NCT03482011|42209774|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
19758724|NCT03482011|42209775|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
19758725|NCT03482011|42209768|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758726|NCT03482011|42209769|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758727|NCT03482011|42209770|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758728|NCT03482011|42209771|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758729|NCT03482011|42209772|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758730|NCT03482011|42209773|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
19758731|NCT03482011|42209774|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
19758732|NCT03482011|42209775|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
19758733|NCT03482011|42209768|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
19758734|NCT03482011|42209769|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
19758735|NCT03482011|42209770|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
19672308|NCT00420927|42120317|FG005|Period 1|Subject moved/relocated|0|||
19672309|NCT00420927|42120318|FG006|Period 1|Subject moved/relocated|0|||
19672310|NCT00420927|42120312|FG000|Period 1|Noncompliant with study drug|1|||
19672311|NCT00420927|42120313|FG001|Period 1|Noncompliant with study drug|1|||
19672312|NCT00420927|42120314|FG002|Period 1|Noncompliant with study drug|0|||
19672313|NCT00420927|42120315|FG003|Period 1|Noncompliant with study drug|0|||
19672314|NCT00420927|42120316|FG004|Period 1|Noncompliant with study drug|0|||
19672315|NCT00420927|42120317|FG005|Period 1|Noncompliant with study drug|0|||
19672316|NCT00420927|42120318|FG006|Period 1|Noncompliant with study drug|0|||
19672317|NCT00420927|42120312|FG000|Period 1|Randomization error|1|||
19672318|NCT00420927|42120313|FG001|Period 1|Randomization error|0|||
19672319|NCT00420927|42120314|FG002|Period 1|Randomization error|0|||
19672320|NCT00420927|42120315|FG003|Period 1|Randomization error|0|||
19672321|NCT00420927|42120316|FG004|Period 1|Randomization error|0|||
19672322|NCT00420927|42120317|FG005|Period 1|Randomization error|0|||
19672323|NCT00420927|42120318|FG006|Period 1|Randomization error|0|||
19672324|NCT00420927|42120312|FG000|Period 1|Suspected tuberculosis/positive test|1|||
19672325|NCT00420927|42120313|FG001|Period 1|Suspected tuberculosis/positive test|1|||
19672326|NCT00420927|42120314|FG002|Period 1|Suspected tuberculosis/positive test|0|||
19672327|NCT00420927|42120315|FG003|Period 1|Suspected tuberculosis/positive test|0|||
19672328|NCT00420927|42120316|FG004|Period 1|Suspected tuberculosis/positive test|0|||
19672329|NCT00420927|42120317|FG005|Period 1|Suspected tuberculosis/positive test|0|||
19672330|NCT00420927|42120318|FG006|Period 1|Suspected tuberculosis/positive test|0|||
19672331|NCT00420927|42120312|FG000|Period 1|Study site closure|0|||
19672332|NCT00420927|42120313|FG001|Period 1|Study site closure|1|||
19672333|NCT00420927|42120314|FG002|Period 1|Study site closure|0|||
19672334|NCT00420927|42120315|FG003|Period 1|Study site closure|0|||
19672335|NCT00420927|42120316|FG004|Period 1|Study site closure|0|||
19672336|NCT00420927|42120317|FG005|Period 1|Study site closure|0|||
19672337|NCT00420927|42120318|FG006|Period 1|Study site closure|0|||
19672338|NCT00420927|42120312|FG000|Period 1|Subject received new diagnosis|0|||
19672339|NCT00420927|42120313|FG001|Period 1|Subject received new diagnosis|2|||
19672340|NCT00420927|42120314|FG002|Period 1|Subject received new diagnosis|0|||
19758736|NCT03482011|42209771|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
19672341|NCT00420927|42120315|FG003|Period 1|Subject received new diagnosis|0|||
19672342|NCT00420927|42120316|FG004|Period 1|Subject received new diagnosis|0|||
19672343|NCT00420927|42120317|FG005|Period 1|Subject received new diagnosis|0|||
19672344|NCT00420927|42120318|FG006|Period 1|Subject received new diagnosis|0|||
19672345|NCT00420927|42120312|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
19672346|NCT00420927|42120313|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
19672347|NCT00420927|42120314|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
19672348|NCT00420927|42120315|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
19672349|NCT00420927|42120316|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
19672350|NCT00420927|42120317|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
19672351|NCT00420927|42120318|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
19672352|NCT00420927|42120312|FG000|Period 1|Failed to meet entry criteria|8|||
19672353|NCT00420927|42120313|FG001|Period 1|Failed to meet entry criteria|7|||
19672354|NCT00420927|42120314|FG002|Period 1|Failed to meet entry criteria|0|||
19672355|NCT00420927|42120315|FG003|Period 1|Failed to meet entry criteria|0|||
19672356|NCT00420927|42120316|FG004|Period 1|Failed to meet entry criteria|0|||
19672357|NCT00420927|42120317|FG005|Period 1|Failed to meet entry criteria|0|||
19672358|NCT00420927|42120318|FG006|Period 1|Failed to meet entry criteria|0|||
19672359|NCT00420927|42120312|FG000|Period 1|Took prohibited medication|1|||
19672360|NCT00420927|42120313|FG001|Period 1|Took prohibited medication|3|||
19672361|NCT00420927|42120314|FG002|Period 1|Took prohibited medication|0|||
19672362|NCT00420927|42120315|FG003|Period 1|Took prohibited medication|0|||
19672363|NCT00420927|42120316|FG004|Period 1|Took prohibited medication|0|||
19672364|NCT00420927|42120317|FG005|Period 1|Took prohibited medication|0|||
19672365|NCT00420927|42120318|FG006|Period 1|Took prohibited medication|0|||
19672366|NCT00420927|42120312|FG000|Period 2|Adverse Event|0|||
19672367|NCT00420927|42120313|FG001|Period 2|Adverse Event|0|||
19672368|NCT00420927|42120314|FG002|Period 2|Adverse Event|7|||
19672369|NCT00420927|42120315|FG003|Period 2|Adverse Event|3|||
19672370|NCT00420927|42120316|FG004|Period 2|Adverse Event|17|||
19672371|NCT00420927|42120317|FG005|Period 2|Adverse Event|6|||
19672372|NCT00420927|42120318|FG006|Period 2|Adverse Event|20|||
19672373|NCT00420927|42120312|FG000|Period 2|Withdrawal by Subject|0|||
19672374|NCT00420927|42120313|FG001|Period 2|Withdrawal by Subject|0|||
19672375|NCT00420927|42120314|FG002|Period 2|Withdrawal by Subject|1|||
19672376|NCT00420927|42120315|FG003|Period 2|Withdrawal by Subject|3|||
19672377|NCT00420927|42120316|FG004|Period 2|Withdrawal by Subject|11|||
19672378|NCT00420927|42120317|FG005|Period 2|Withdrawal by Subject|2|||
19672379|NCT00420927|42120318|FG006|Period 2|Withdrawal by Subject|12|||
19672380|NCT00420927|42120312|FG000|Period 2|Lost to Follow-up|0|||
19672381|NCT00420927|42120313|FG001|Period 2|Lost to Follow-up|0|||
19672382|NCT00420927|42120314|FG002|Period 2|Lost to Follow-up|2|||
19672383|NCT00420927|42120315|FG003|Period 2|Lost to Follow-up|2|||
19672384|NCT00420927|42120316|FG004|Period 2|Lost to Follow-up|6|||
19672385|NCT00420927|42120317|FG005|Period 2|Lost to Follow-up|3|||
19672386|NCT00420927|42120318|FG006|Period 2|Lost to Follow-up|9|||
19672387|NCT00420927|42120312|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
19672388|NCT00420927|42120313|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
19672389|NCT00420927|42120314|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
19672390|NCT00420927|42120315|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
19672391|NCT00420927|42120316|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
19672392|NCT00420927|42120317|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
19672393|NCT00420927|42120318|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
19672394|NCT00420927|42120312|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
19758737|NCT03482011|42209772|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
19758738|NCT03482011|42209773|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
19758739|NCT03482011|42209774|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
19758740|NCT03482011|42209775|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
19758741|NCT03482011|42209768|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758742|NCT03482011|42209769|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758743|NCT03482011|42209770|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758744|NCT03482011|42209771|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758745|NCT03482011|42209772|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758746|NCT03482011|42209773|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758747|NCT03482011|42209774|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
19758748|NCT03482011|42209775|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
19758749|NCT03482011|42209768|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758750|NCT03482011|42209769|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758751|NCT03482011|42209770|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758752|NCT03482011|42209771|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19672395|NCT00420927|42120313|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
19672396|NCT00420927|42120314|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
19672397|NCT00420927|42120315|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
19672398|NCT00420927|42120316|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
19672399|NCT00420927|42120317|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
19758753|NCT03482011|42209772|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758754|NCT03482011|42209773|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758755|NCT03482011|42209774|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19758756|NCT03482011|42209775|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
19758757|NCT03481309|42209806|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
19758758|NCT03481309|42209807|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
19758759|NCT03481309|42209808|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
19758760|NCT03481309|42209809|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
19672400|NCT00420927|42120318|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
19672401|NCT00420927|42120312|FG000|Period 2|Subject unable to find transportation|0|||
19672402|NCT00420927|42120313|FG001|Period 2|Subject unable to find transportation|0|||
19672403|NCT00420927|42120314|FG002|Period 2|Subject unable to find transportation|0|||
19672404|NCT00420927|42120315|FG003|Period 2|Subject unable to find transportation|0|||
19672405|NCT00420927|42120316|FG004|Period 2|Subject unable to find transportation|0|||
19672406|NCT00420927|42120317|FG005|Period 2|Subject unable to find transportation|0|||
19672407|NCT00420927|42120318|FG006|Period 2|Subject unable to find transportation|1|||
19672408|NCT00420927|42120312|FG000|Period 2|Physician Decision|0|||
19672409|NCT00420927|42120313|FG001|Period 2|Physician Decision|0|||
19758761|NCT03481309|42209810|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
19758762|NCT03481309|42209811|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
19758763|NCT03480841|42209819|FG000|Overall Study|Lost to Follow-up|2|||
19758764|NCT02709538|42209826|FG000|Overall Study|Adverse Event|13|||
19758765|NCT02709538|42209827|FG001|Overall Study|Adverse Event|2|||
19758766|NCT02709538|42209828|FG002|Overall Study|Adverse Event|3|||
19758767|NCT02709538|42209826|FG000|Overall Study|Lack of Efficacy|1|||
19758768|NCT02709538|42209827|FG001|Overall Study|Lack of Efficacy|0|||
19758769|NCT02709538|42209828|FG002|Overall Study|Lack of Efficacy|0|||
19758770|NCT02709538|42209826|FG000|Overall Study|Lost to Follow-up|24|||
19758771|NCT02709538|42209827|FG001|Overall Study|Lost to Follow-up|8|||
19758772|NCT02709538|42209828|FG002|Overall Study|Lost to Follow-up|4|||
19758773|NCT02709538|42209826|FG000|Overall Study|Physician Decision|1|||
19758774|NCT02709538|42209827|FG001|Overall Study|Physician Decision|0|||
19672410|NCT00420927|42120314|FG002|Period 2|Physician Decision|0|||
19672411|NCT00420927|42120315|FG003|Period 2|Physician Decision|0|||
19672412|NCT00420927|42120316|FG004|Period 2|Physician Decision|1|||
19672413|NCT00420927|42120317|FG005|Period 2|Physician Decision|1|||
19672414|NCT00420927|42120318|FG006|Period 2|Physician Decision|0|||
19672415|NCT00420927|42120312|FG000|Period 2|Sponsor decision|0|||
19672416|NCT00420927|42120313|FG001|Period 2|Sponsor decision|0|||
19672417|NCT00420927|42120314|FG002|Period 2|Sponsor decision|1|||
19672418|NCT00420927|42120315|FG003|Period 2|Sponsor decision|0|||
19672419|NCT00420927|42120316|FG004|Period 2|Sponsor decision|0|||
19672420|NCT00420927|42120317|FG005|Period 2|Sponsor decision|0|||
19672421|NCT00420927|42120318|FG006|Period 2|Sponsor decision|1|||
19672422|NCT00420927|42120312|FG000|Period 2|Randomization error|0|||
19672423|NCT00420927|42120313|FG001|Period 2|Randomization error|0|||
19672424|NCT00420927|42120314|FG002|Period 2|Randomization error|0|||
19672425|NCT00420927|42120315|FG003|Period 2|Randomization error|0|||
19758775|NCT02709538|42209828|FG002|Overall Study|Physician Decision|0|||
19758776|NCT02709538|42209826|FG000|Overall Study|Withdrawal by Subject|40|||
19758777|NCT02709538|42209827|FG001|Overall Study|Withdrawal by Subject|7|||
19758778|NCT02709538|42209828|FG002|Overall Study|Withdrawal by Subject|4|||
19758779|NCT02709538|42209826|FG000|Overall Study|Non-compliance with study procedures|5|||
19672426|NCT00420927|42120316|FG004|Period 2|Randomization error|1|||
19672427|NCT00420927|42120317|FG005|Period 2|Randomization error|1|||
19672428|NCT00420927|42120318|FG006|Period 2|Randomization error|0|||
19672429|NCT00420927|42120312|FG000|Period 2|Noncompliant with study drug|0|||
19672430|NCT00420927|42120313|FG001|Period 2|Noncompliant with study drug|0|||
19672431|NCT00420927|42120314|FG002|Period 2|Noncompliant with study drug|0|||
19672432|NCT00420927|42120315|FG003|Period 2|Noncompliant with study drug|1|||
19672433|NCT00420927|42120316|FG004|Period 2|Noncompliant with study drug|0|||
19672434|NCT00420927|42120317|FG005|Period 2|Noncompliant with study drug|0|||
19672435|NCT00420927|42120318|FG006|Period 2|Noncompliant with study drug|2|||
19672436|NCT00420927|42120312|FG000|Period 2|Methotrexate intolerance|0|||
19672437|NCT00420927|42120313|FG001|Period 2|Methotrexate intolerance|0|||
19672438|NCT00420927|42120314|FG002|Period 2|Methotrexate intolerance|0|||
19672439|NCT00420927|42120315|FG003|Period 2|Methotrexate intolerance|0|||
19758780|NCT02709538|42209827|FG001|Overall Study|Non-compliance with study procedures|0|||
19758781|NCT02709538|42209828|FG002|Overall Study|Non-compliance with study procedures|0|||
19672440|NCT00420927|42120316|FG004|Period 2|Methotrexate intolerance|0|||
19672441|NCT00420927|42120317|FG005|Period 2|Methotrexate intolerance|0|||
19672442|NCT00420927|42120318|FG006|Period 2|Methotrexate intolerance|1|||
19672443|NCT00420927|42120312|FG000|Period 2|Took prohibited medication|0|||
19672444|NCT00420927|42120313|FG001|Period 2|Took prohibited medication|0|||
19672445|NCT00420927|42120314|FG002|Period 2|Took prohibited medication|0|||
19672446|NCT00420927|42120315|FG003|Period 2|Took prohibited medication|0|||
19672447|NCT00420927|42120316|FG004|Period 2|Took prohibited medication|1|||
19672448|NCT00420927|42120317|FG005|Period 2|Took prohibited medication|0|||
19672449|NCT00420927|42120318|FG006|Period 2|Took prohibited medication|0|||
19672450|NCT00573443|42120335|FG000|Double-Blind Phase|Lost to Follow-up|1|||
19672451|NCT00573443|42120336|FG001|Double-Blind Phase|Lost to Follow-up|3|||
19672452|NCT00573443|42120337|FG002|Double-Blind Phase|Lost to Follow-up|2|||
19672453|NCT00573443|42120335|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
19672454|NCT00573443|42120336|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
19672455|NCT00573443|42120337|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
19672456|NCT00573443|42120335|FG000|Double-Blind Phase|Adverse Event|1|||
19672457|NCT00573443|42120336|FG001|Double-Blind Phase|Adverse Event|5|||
19672458|NCT00573443|42120337|FG002|Double-Blind Phase|Adverse Event|0|||
19672459|NCT00573443|42120335|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
19672460|NCT00573443|42120336|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
19672461|NCT00573443|42120337|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
19672462|NCT00573443|42120335|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
19672463|NCT00573443|42120336|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
19672464|NCT00573443|42120337|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
19672465|NCT00573443|42120335|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
19672466|NCT00573443|42120336|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
19672467|NCT00573443|42120337|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
19672468|NCT00573443|42120335|FG000|Double-Blind Phase|Protocol Violation|0|||
19672469|NCT00573443|42120336|FG001|Double-Blind Phase|Protocol Violation|2|||
19672470|NCT00573443|42120337|FG002|Double-Blind Phase|Protocol Violation|1|||
19758782|NCT02709538|42209826|FG000|Overall Study|Non-compliance with study drug|2|||
19758783|NCT02709538|42209827|FG001|Overall Study|Non-compliance with study drug|0|||
19758784|NCT02709538|42209828|FG002|Overall Study|Non-compliance with study drug|0|||
19758785|NCT02709538|42209826|FG000|Overall Study|Protocol deviation|10|||
19758786|NCT02709538|42209827|FG001|Overall Study|Protocol deviation|4|||
19758787|NCT02709538|42209828|FG002|Overall Study|Protocol deviation|4|||
19758788|NCT02709538|42209826|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
19758789|NCT02709538|42209827|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
19758790|NCT02709538|42209828|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
19758791|NCT02709538|42209826|FG000|Overall Study|Other|16|||
19758792|NCT02709538|42209827|FG001|Overall Study|Other|7|||
19758793|NCT02709538|42209828|FG002|Overall Study|Other|5|||
19758794|NCT03789318|42209841|FG000|Overall Study|Adverse Event|0|||
19672471|NCT00573443|42120335|FG000|Double-Blind Phase|Other|0|||
19672472|NCT00573443|42120336|FG001|Double-Blind Phase|Other|2|||
19672473|NCT00573443|42120337|FG002|Double-Blind Phase|Other|3|||
19672474|NCT00573443|42120335|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
19672475|NCT00573443|42120336|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
19672476|NCT00573443|42120337|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
19672477|NCT00573443|42120335|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
19672478|NCT00573443|42120336|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
19672479|NCT00573443|42120337|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
19672480|NCT00573443|42120335|FG000|Open-Label Extension Phase|Adverse Event|3|||
19672481|NCT00573443|42120336|FG001|Open-Label Extension Phase|Adverse Event|0|||
19672482|NCT00573443|42120337|FG002|Open-Label Extension Phase|Adverse Event|0|||
19672483|NCT00573443|42120335|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
19672484|NCT00573443|42120336|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
19672485|NCT00573443|42120337|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
19672486|NCT00573443|42120335|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
19672487|NCT00573443|42120336|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
19672488|NCT00573443|42120337|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
19672489|NCT00573443|42120335|FG000|Open-Label Extension Phase|Protocol Violation|2|||
19672490|NCT00573443|42120336|FG001|Open-Label Extension Phase|Protocol Violation|0|||
19672491|NCT00573443|42120337|FG002|Open-Label Extension Phase|Protocol Violation|0|||
19672492|NCT00573443|42120335|FG000|Open-Label Extension Phase|Other|2|||
19672493|NCT00573443|42120336|FG001|Open-Label Extension Phase|Other|0|||
19672494|NCT00573443|42120337|FG002|Open-Label Extension Phase|Other|0|||
19672495|NCT00420849|42120359|FG000|Overall Study|Lack of Efficacy|154|||
19672496|NCT00420849|42120359|FG000|Overall Study|Adverse Event|107|||
19672497|NCT00420849|42120359|FG000|Overall Study|Withdrawal by Subject|28|||
19672498|NCT00420849|42120359|FG000|Overall Study|Death|18|||
19672499|NCT00420849|42120359|FG000|Overall Study|Other|14|||
19672500|NCT00420849|42120359|FG000|Overall Study|Transplant|8|||
19672501|NCT00420849|42120359|FG000|Overall Study|Protocol Violation|1|||
19672502|NCT00420849|42120359|FG000|Overall Study|Lost to Follow-up|1|||
19672503|NCT00617279|42120368|FG000|Overall Study|Study terminated by Sponsor|10|||
19672504|NCT00617279|42120369|FG001|Overall Study|Study terminated by Sponsor|15|||
19672505|NCT00617279|42120368|FG000|Overall Study|Graft abandonment|2|||
19672506|NCT00617279|42120369|FG001|Overall Study|Graft abandonment|0|||
19672507|NCT00617279|42120368|FG000|Overall Study|Lost to Follow-up|1|||
19672508|NCT00617279|42120369|FG001|Overall Study|Lost to Follow-up|0|||
19758795|NCT03789318|42209842|FG001|Overall Study|Adverse Event|0|||
19672509|NCT00617279|42120368|FG000|Overall Study|Death|1|||
19672510|NCT00617279|42120369|FG001|Overall Study|Death|2|||
19672511|NCT00420381|42120375|FG000|Overall Study|Protocol Violation|1|||
19672512|NCT00617201|42120381|FG000|Overall Study|Lost to Follow-up|9|||
19672513|NCT00617201|42120382|FG001|Overall Study|Lost to Follow-up|13|||
19672514|NCT00420303|42120392|FG000|Overall Study|Serious Adverse Event|1|||
19672515|NCT00420303|42120393|FG001|Overall Study|Serious Adverse Event|0|||
19672516|NCT00420303|42120392|FG000|Overall Study|Lack of Efficacy|0|||
19672517|NCT00420303|42120393|FG001|Overall Study|Lack of Efficacy|3|||
19672518|NCT00420303|42120392|FG000|Overall Study|Physician Decision|0|||
19672519|NCT00420303|42120393|FG001|Overall Study|Physician Decision|1|||
19672520|NCT00617123|42120401|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
19672521|NCT00617123|42120402|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
19672522|NCT00617123|42120401|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
19672523|NCT00617123|42120402|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
19672524|NCT00617123|42120401|FG000|Referral Screening Period|Adverse Event|0|||
19672525|NCT00617123|42120402|FG001|Referral Screening Period|Adverse Event|1|||
19672526|NCT00617123|42120401|FG000|Study Treatment Period|Withdrawal by Subject|8|||
19672527|NCT00617123|42120402|FG001|Study Treatment Period|Withdrawal by Subject|12|||
19672528|NCT00617123|42120401|FG000|Study Treatment Period|Adverse Event|7|||
19672529|NCT00617123|42120402|FG001|Study Treatment Period|Adverse Event|3|||
19672530|NCT00617123|42120401|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
19672531|NCT00617123|42120402|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
19672532|NCT00617123|42120401|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
19672533|NCT00617123|42120402|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
19672534|NCT00419757|42120410|FG000|Overall Study|Adverse Event|1|||
19672535|NCT00419757|42120411|FG001|Overall Study|Adverse Event|4|||
19672536|NCT00419757|42120410|FG000|Overall Study|Lost to Follow-up|1|||
19672537|NCT00419757|42120411|FG001|Overall Study|Lost to Follow-up|4|||
19672538|NCT00419757|42120410|FG000|Overall Study|Withdrawal by Subject|7|||
19672539|NCT00419757|42120411|FG001|Overall Study|Withdrawal by Subject|1|||
19672540|NCT00419757|42120410|FG000|Overall Study|Protocol Violation|2|||
19672541|NCT00419757|42120411|FG001|Overall Study|Protocol Violation|3|||
19672542|NCT00419757|42120410|FG000|Overall Study|Study specific discontinuation criteria|4|||
19672543|NCT00419757|42120411|FG001|Overall Study|Study specific discontinuation criteria|8|||
19672544|NCT00419757|42120410|FG000|Overall Study|Multiple reasons|3|||
19672545|NCT00419757|42120411|FG001|Overall Study|Multiple reasons|1|||
19672546|NCT00434109|42120419|FG000|Overall Study|Physician Decision|9|||
19672547|NCT00434109|42120419|FG000|Overall Study|Adverse Event|5|||
19672548|NCT00434109|42120419|FG000|Overall Study|Protocol Violation|1|||
19672549|NCT00434109|42120419|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
19672550|NCT00433329|42120423|FG000|Overall Study|Adverse Event|9|||
19672551|NCT00433329|42120423|FG000|Overall Study|Death|4|||
19672552|NCT00433329|42120423|FG000|Overall Study|Withdrew consent|3|||
19672553|NCT00433329|42120423|FG000|Overall Study|Discontinued sildenafil|2|||
19672554|NCT00433329|42120423|FG000|Overall Study|Moved out of state|1|||
19672555|NCT00433329|42120423|FG000|Overall Study|Lost to Follow-up|1|||
19672556|NCT00433329|42120423|FG000|Overall Study|Physician Decision|1|||
19672557|NCT00616421|42120430|FG000|Overall Study|Withdrawal by Subject|9|||
19672558|NCT00616421|42120431|FG001|Overall Study|Withdrawal by Subject|11|||
19672559|NCT00616421|42120432|FG002|Overall Study|Withdrawal by Subject|8|||
19672560|NCT00616421|42120430|FG000|Overall Study|Lost to Follow-up|12|||
19672561|NCT00616421|42120431|FG001|Overall Study|Lost to Follow-up|26|||
19672562|NCT00616421|42120432|FG002|Overall Study|Lost to Follow-up|30|||
19672563|NCT00616421|42120430|FG000|Overall Study|Inappropriate enrollment|3|||
19672564|NCT00616421|42120431|FG001|Overall Study|Inappropriate enrollment|0|||
19672565|NCT00616421|42120432|FG002|Overall Study|Inappropriate enrollment|1|||
19672566|NCT00616421|42120430|FG000|Overall Study|Administrative reason|1|||
19672567|NCT00616421|42120431|FG001|Overall Study|Administrative reason|0|||
19672568|NCT00616421|42120432|FG002|Overall Study|Administrative reason|0|||
19672569|NCT00616421|42120430|FG000|Overall Study|Protocol Violation|0|||
19672570|NCT00616421|42120431|FG001|Overall Study|Protocol Violation|1|||
19758796|NCT03789318|42209843|FG002|Overall Study|Adverse Event|1|||
19672571|NCT00616421|42120432|FG002|Overall Study|Protocol Violation|2|||
19672572|NCT00616421|42120430|FG000|Overall Study|Unable to classify|1|||
19672573|NCT00616421|42120431|FG001|Overall Study|Unable to classify|0|||
19672574|NCT00616421|42120432|FG002|Overall Study|Unable to classify|0|||
19672575|NCT00433017|42120456|FG000|Overall Study|Adverse Event|5|||
19672576|NCT00433017|42120457|FG001|Overall Study|Adverse Event|3|||
19672577|NCT00433017|42120456|FG000|Overall Study|Withdrawal by Subject|4|||
19672578|NCT00433017|42120457|FG001|Overall Study|Withdrawal by Subject|5|||
19672579|NCT00433017|42120456|FG000|Overall Study|Lost to Follow-up|3|||
19672580|NCT00433017|42120457|FG001|Overall Study|Lost to Follow-up|4|||
19672581|NCT00433017|42120456|FG000|Overall Study|Administrative problems|80|||
19672582|NCT00433017|42120457|FG001|Overall Study|Administrative problems|86|||
19672583|NCT00433017|42120456|FG000|Overall Study|Protocol Violation|1|||
19672584|NCT00433017|42120457|FG001|Overall Study|Protocol Violation|0|||
19672585|NCT00433017|42120456|FG000|Overall Study|Death|2|||
19672586|NCT00433017|42120457|FG001|Overall Study|Death|2|||
19672587|NCT00433017|42120456|FG000|Overall Study|Subject no longer requires study drug|1|||
19672588|NCT00433017|42120457|FG001|Overall Study|Subject no longer requires study drug|1|||
19672589|NCT00615719|42120489|FG000|Overall Study|Physician Decision|5|||
19672590|NCT00418665|42120496|FG000|Treatment Period|Ineligibility determined|1|||
19672591|NCT00418665|42120497|FG001|Treatment Period|Ineligibility determined|1|||
19672592|NCT00418665|42120498|FG002|Treatment Period|Ineligibility determined|0|||
19672593|NCT00418665|42120496|FG000|Treatment Period|Adverse Event|2|||
19672594|NCT00418665|42120497|FG001|Treatment Period|Adverse Event|2|||
19672595|NCT00418665|42120498|FG002|Treatment Period|Adverse Event|0|||
19672596|NCT00418665|42120496|FG000|Treatment Period|Withdrawal by Subject|0|||
19672597|NCT00418665|42120497|FG001|Treatment Period|Withdrawal by Subject|3|||
19672598|NCT00418665|42120498|FG002|Treatment Period|Withdrawal by Subject|1|||
19672599|NCT00418665|42120496|FG000|Treatment Period|Requirement for alternative therapy|1|||
19672600|NCT00418665|42120497|FG001|Treatment Period|Requirement for alternative therapy|0|||
19672601|NCT00418665|42120498|FG002|Treatment Period|Requirement for alternative therapy|0|||
19672602|NCT00418665|42120496|FG000|Treatment Period|Physician Decision|1|||
19672603|NCT00418665|42120497|FG001|Treatment Period|Physician Decision|0|||
19672604|NCT00418665|42120498|FG002|Treatment Period|Physician Decision|3|||
19672605|NCT00418665|42120496|FG000|Treatment Extension|Adverse Event|1|||
19672606|NCT00418665|42120497|FG001|Treatment Extension|Adverse Event|0|||
19672607|NCT00418665|42120498|FG002|Treatment Extension|Adverse Event|0|||
19672608|NCT00418665|42120496|FG000|Treatment Extension|Withdrawal by Subject|1|||
19672609|NCT00418665|42120497|FG001|Treatment Extension|Withdrawal by Subject|0|||
19672610|NCT00418665|42120498|FG002|Treatment Extension|Withdrawal by Subject|0|||
19672611|NCT00418665|42120496|FG000|Treatment Extension|Requirement for alternative therapy|2|||
19672612|NCT00418665|42120497|FG001|Treatment Extension|Requirement for alternative therapy|2|||
19672613|NCT00418665|42120498|FG002|Treatment Extension|Requirement for alternative therapy|0|||
19672614|NCT00418665|42120496|FG000|Treatment Extension|Physician Decision|2|||
19672615|NCT00418665|42120497|FG001|Treatment Extension|Physician Decision|2|||
19672616|NCT00418665|42120498|FG002|Treatment Extension|Physician Decision|1|||
19672617|NCT00418665|42120496|FG000|Treatment Extension|Death|0|||
19672618|NCT00418665|42120497|FG001|Treatment Extension|Death|0|||
19672619|NCT00418665|42120498|FG002|Treatment Extension|Death|1|||
19672620|NCT00432237|42120510|FG000|Overall Study|Adverse Event|0|||
19672621|NCT00432237|42120511|FG001|Overall Study|Adverse Event|0|||
19672622|NCT00432237|42120512|FG002|Overall Study|Adverse Event|0|||
19672623|NCT00432237|42120513|FG003|Overall Study|Adverse Event|1|||
19672624|NCT00432237|42120510|FG000|Overall Study|Lack of Efficacy|0|||
19672625|NCT00432237|42120511|FG001|Overall Study|Lack of Efficacy|0|||
19672626|NCT00432237|42120512|FG002|Overall Study|Lack of Efficacy|0|||
19672627|NCT00432237|42120513|FG003|Overall Study|Lack of Efficacy|1|||
19672628|NCT00432237|42120510|FG000|Overall Study|Lost to Follow-up|10|||
19672629|NCT00432237|42120511|FG001|Overall Study|Lost to Follow-up|10|||
19672630|NCT00432237|42120512|FG002|Overall Study|Lost to Follow-up|18|||
19672631|NCT00432237|42120513|FG003|Overall Study|Lost to Follow-up|18|||
19672632|NCT00432237|42120510|FG000|Overall Study|Physician Decision|1|||
19672633|NCT00432237|42120511|FG001|Overall Study|Physician Decision|3|||
19672634|NCT00432237|42120512|FG002|Overall Study|Physician Decision|2|||
19672635|NCT00432237|42120513|FG003|Overall Study|Physician Decision|1|||
19672636|NCT00432237|42120510|FG000|Overall Study|Pregnancy|0|||
19672637|NCT00432237|42120511|FG001|Overall Study|Pregnancy|1|||
19672638|NCT00432237|42120512|FG002|Overall Study|Pregnancy|0|||
19672639|NCT00432237|42120513|FG003|Overall Study|Pregnancy|0|||
19672640|NCT00432237|42120510|FG000|Overall Study|Protocol Violation|13|||
19672641|NCT00432237|42120511|FG001|Overall Study|Protocol Violation|10|||
19672642|NCT00432237|42120512|FG002|Overall Study|Protocol Violation|11|||
19672643|NCT00432237|42120513|FG003|Overall Study|Protocol Violation|8|||
19672644|NCT00432237|42120510|FG000|Overall Study|Withdrawal by Subject|5|||
19672645|NCT00432237|42120511|FG001|Overall Study|Withdrawal by Subject|6|||
19672646|NCT00432237|42120512|FG002|Overall Study|Withdrawal by Subject|9|||
19672647|NCT00432237|42120513|FG003|Overall Study|Withdrawal by Subject|11|||
19672648|NCT00432237|42120510|FG000|Overall Study|Lack of Qualifying Event|38|||
19477167|NCT01513291|41756110|FG002|Treatment Period|Physician Decision|0|||
19672649|NCT00432237|42120511|FG001|Overall Study|Lack of Qualifying Event|71|||
19672650|NCT00432237|42120512|FG002|Overall Study|Lack of Qualifying Event|69|||
19672651|NCT00432237|42120513|FG003|Overall Study|Lack of Qualifying Event|84|||
19672652|NCT00531284|42120540|FG000|Overall Study|Progressive Disease|1|||
19672653|NCT00531284|42120541|FG001|Overall Study|Progressive Disease|3|||
19672654|NCT00531284|42120542|FG002|Overall Study|Progressive Disease|5|||
19672655|NCT00531284|42120543|FG003|Overall Study|Progressive Disease|42|||
19672656|NCT00531284|42120544|FG004|Overall Study|Progressive Disease|4|||
19672657|NCT00531284|42120545|FG005|Overall Study|Progressive Disease|4|||
19672658|NCT00531284|42120546|FG006|Overall Study|Progressive Disease|3|||
19672659|NCT00531284|42120547|FG007|Overall Study|Progressive Disease|8|||
19672660|NCT00531284|42120548|FG008|Overall Study|Progressive Disease|6|||
19672661|NCT00531284|42120549|FG009|Overall Study|Progressive Disease|3|||
19672662|NCT00531284|42120550|FG010|Overall Study|Progressive Disease|3|||
19672663|NCT00531284|42120551|FG011|Overall Study|Progressive Disease|14|||
19672664|NCT00531284|42120552|FG012|Overall Study|Progressive Disease|2|||
19672665|NCT00531284|42120553|FG013|Overall Study|Progressive Disease|1|||
19672666|NCT00531284|42120554|FG014|Overall Study|Progressive Disease|2|||
19672667|NCT00531284|42120555|FG015|Overall Study|Progressive Disease|11|||
19672668|NCT00531284|42120556|FG016|Overall Study|Progressive Disease|5|||
19672669|NCT00531284|42120540|FG000|Overall Study|Adverse Event|0|||
19672670|NCT00531284|42120541|FG001|Overall Study|Adverse Event|1|||
19672671|NCT00531284|42120542|FG002|Overall Study|Adverse Event|1|||
19672672|NCT00531284|42120543|FG003|Overall Study|Adverse Event|7|||
19672673|NCT00531284|42120544|FG004|Overall Study|Adverse Event|0|||
19672674|NCT00531284|42120545|FG005|Overall Study|Adverse Event|2|||
19672675|NCT00531284|42120546|FG006|Overall Study|Adverse Event|3|||
19672676|NCT00531284|42120547|FG007|Overall Study|Adverse Event|2|||
19672677|NCT00531284|42120548|FG008|Overall Study|Adverse Event|3|||
19672678|NCT00531284|42120549|FG009|Overall Study|Adverse Event|0|||
19672679|NCT00531284|42120550|FG010|Overall Study|Adverse Event|0|||
19672680|NCT00531284|42120551|FG011|Overall Study|Adverse Event|5|||
19672681|NCT00531284|42120552|FG012|Overall Study|Adverse Event|0|||
19672682|NCT00531284|42120553|FG013|Overall Study|Adverse Event|1|||
19672683|NCT00531284|42120554|FG014|Overall Study|Adverse Event|1|||
19672684|NCT00531284|42120555|FG015|Overall Study|Adverse Event|0|||
19672685|NCT00531284|42120556|FG016|Overall Study|Adverse Event|2|||
19672686|NCT00531284|42120540|FG000|Overall Study|Withdrawal by Subject|1|||
19672687|NCT00531284|42120541|FG001|Overall Study|Withdrawal by Subject|0|||
19672688|NCT00531284|42120542|FG002|Overall Study|Withdrawal by Subject|0|||
19672689|NCT00531284|42120543|FG003|Overall Study|Withdrawal by Subject|4|||
19672690|NCT00531284|42120544|FG004|Overall Study|Withdrawal by Subject|0|||
19672691|NCT00531284|42120545|FG005|Overall Study|Withdrawal by Subject|0|||
19672692|NCT00531284|42120546|FG006|Overall Study|Withdrawal by Subject|0|||
19672693|NCT00531284|42120547|FG007|Overall Study|Withdrawal by Subject|0|||
19672694|NCT00531284|42120548|FG008|Overall Study|Withdrawal by Subject|0|||
19672695|NCT00531284|42120549|FG009|Overall Study|Withdrawal by Subject|0|||
19672696|NCT00531284|42120550|FG010|Overall Study|Withdrawal by Subject|0|||
19672697|NCT00531284|42120551|FG011|Overall Study|Withdrawal by Subject|3|||
19672698|NCT00531284|42120552|FG012|Overall Study|Withdrawal by Subject|0|||
19672699|NCT00531284|42120553|FG013|Overall Study|Withdrawal by Subject|1|||
19672700|NCT00531284|42120554|FG014|Overall Study|Withdrawal by Subject|0|||
19672701|NCT00531284|42120555|FG015|Overall Study|Withdrawal by Subject|1|||
19672702|NCT00531284|42120556|FG016|Overall Study|Withdrawal by Subject|1|||
19672703|NCT00531284|42120540|FG000|Overall Study|Other|1|||
19672704|NCT00531284|42120541|FG001|Overall Study|Other|0|||
19672705|NCT00531284|42120542|FG002|Overall Study|Other|0|||
19758797|NCT03789318|42209844|FG003|Overall Study|Adverse Event|1|||
19758798|NCT03789318|42209845|FG004|Overall Study|Adverse Event|0|||
19758799|NCT03789318|42209841|FG000|Overall Study|Lost to Follow-up|0|||
19758800|NCT03789318|42209842|FG001|Overall Study|Lost to Follow-up|0|||
19758801|NCT03789318|42209843|FG002|Overall Study|Lost to Follow-up|1|||
19758802|NCT03789318|42209844|FG003|Overall Study|Lost to Follow-up|0|||
19758803|NCT03789318|42209845|FG004|Overall Study|Lost to Follow-up|0|||
19672706|NCT00531284|42120543|FG003|Overall Study|Other|10|||
19672707|NCT00531284|42120544|FG004|Overall Study|Other|2|||
19672708|NCT00531284|42120545|FG005|Overall Study|Other|1|||
19672709|NCT00531284|42120546|FG006|Overall Study|Other|0|||
19758804|NCT03789318|42209841|FG000|Overall Study|Withdrawal by Subject|0|||
19672710|NCT00531284|42120547|FG007|Overall Study|Other|0|||
19672711|NCT00531284|42120548|FG008|Overall Study|Other|2|||
19672712|NCT00531284|42120549|FG009|Overall Study|Other|1|||
19672713|NCT00531284|42120550|FG010|Overall Study|Other|0|||
19672714|NCT00531284|42120551|FG011|Overall Study|Other|2|||
19672715|NCT00531284|42120552|FG012|Overall Study|Other|0|||
19672716|NCT00531284|42120553|FG013|Overall Study|Other|0|||
19672717|NCT00531284|42120554|FG014|Overall Study|Other|1|||
19672718|NCT00531284|42120555|FG015|Overall Study|Other|0|||
19672719|NCT00531284|42120556|FG016|Overall Study|Other|0|||
19672720|NCT00531206|42120612|FG000|Overall Study|Adverse Event related|5|||
19672721|NCT00531206|42120612|FG000|Overall Study|Lack of Efficacy|2|||
19672722|NCT00531206|42120612|FG000|Overall Study|Lost to Follow-up|5|||
19758805|NCT03789318|42209842|FG001|Overall Study|Withdrawal by Subject|0|||
19758806|NCT03789318|42209843|FG002|Overall Study|Withdrawal by Subject|1|||
19672723|NCT00531206|42120612|FG000|Overall Study|including non-related adverse events|8|||
19672724|NCT00530816|42120619|FG000|Overall Study|Progressive Disease|16|||
19672725|NCT00530816|42120620|FG001|Overall Study|Progressive Disease|24|||
19672726|NCT00530816|42120621|FG002|Overall Study|Progressive Disease|24|||
19672727|NCT00530816|42120619|FG000|Overall Study|Adverse Event|6|||
19672728|NCT00530816|42120620|FG001|Overall Study|Adverse Event|13|||
19672729|NCT00530816|42120621|FG002|Overall Study|Adverse Event|7|||
19672730|NCT00530816|42120619|FG000|Overall Study|Other|3|||
19672731|NCT00530816|42120620|FG001|Overall Study|Other|3|||
19672732|NCT00530816|42120621|FG002|Overall Study|Other|4|||
19672733|NCT00530816|42120619|FG000|Overall Study|Withdrawal by Subject|1|||
19672734|NCT00530816|42120620|FG001|Overall Study|Withdrawal by Subject|2|||
19672735|NCT00530816|42120621|FG002|Overall Study|Withdrawal by Subject|6|||
19672736|NCT00615017|42120635|FG000|Overall Study|Adverse Event|0|||
19672737|NCT00615017|42120636|FG001|Overall Study|Adverse Event|1|||
19672738|NCT00615017|42120637|FG002|Overall Study|Adverse Event|2|||
19672739|NCT00615017|42120638|FG003|Overall Study|Adverse Event|0|||
19672740|NCT00615017|42120639|FG004|Overall Study|Adverse Event|0|||
19672741|NCT00615017|42120640|FG005|Overall Study|Adverse Event|1|||
19758807|NCT03789318|42209844|FG003|Overall Study|Withdrawal by Subject|0|||
19758808|NCT03789318|42209845|FG004|Overall Study|Withdrawal by Subject|0|||
19758809|NCT00511134|42209863|FG000|Overall Study|Withdrawal by Subject|0|||
19672742|NCT00615017|42120635|FG000|Overall Study|Death|0|||
19672743|NCT00615017|42120636|FG001|Overall Study|Death|0|||
19672744|NCT00615017|42120637|FG002|Overall Study|Death|2|||
19672745|NCT00615017|42120638|FG003|Overall Study|Death|0|||
19672746|NCT00615017|42120639|FG004|Overall Study|Death|1|||
19672747|NCT00615017|42120640|FG005|Overall Study|Death|1|||
19672748|NCT00615017|42120635|FG000|Overall Study|Sepsis resolved|0|||
19672749|NCT00615017|42120636|FG001|Overall Study|Sepsis resolved|0|||
19672750|NCT00615017|42120637|FG002|Overall Study|Sepsis resolved|1|||
19672751|NCT00615017|42120638|FG003|Overall Study|Sepsis resolved|0|||
19672752|NCT00615017|42120639|FG004|Overall Study|Sepsis resolved|0|||
19672753|NCT00615017|42120640|FG005|Overall Study|Sepsis resolved|0|||
19672754|NCT00615017|42120635|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
19758810|NCT00511134|42209864|FG001|Overall Study|Withdrawal by Subject|2|||
19672755|NCT00615017|42120636|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
19672756|NCT00615017|42120637|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
19672757|NCT00615017|42120638|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
19672758|NCT00615017|42120639|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
19672759|NCT00615017|42120640|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
19672760|NCT00615017|42120635|FG000|Overall Study|Physician discontinued drug|0|||
19672761|NCT00615017|42120636|FG001|Overall Study|Physician discontinued drug|0|||
19672762|NCT00615017|42120637|FG002|Overall Study|Physician discontinued drug|0|||
19758811|NCT01372384|42209870|FG000|Overall Study|Progression of disease|3|||
19758812|NCT03115476|42209877|FG000|LP0084-1369|Death|1|||
19758813|NCT03115476|42209878|FG001|LP0084-1369|Death|0|||
19758814|NCT03115476|42209879|FG002|LP0084-1369|Death|2|||
19758815|NCT03115476|42209877|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
19758816|NCT03115476|42209878|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
19758817|NCT03115476|42209879|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
19758818|NCT03480763|42209889|FG000|Overall Study|Withdrawal by Subject|18|||
19758819|NCT03480763|42209890|FG001|Overall Study|Withdrawal by Subject|10|||
19758820|NCT03480763|42209889|FG000|Overall Study|Lost to Follow-up|4|||
19758821|NCT03480763|42209890|FG001|Overall Study|Lost to Follow-up|7|||
19758822|NCT03480763|42209889|FG000|Overall Study|non-study pneumococcal vaccine|1|||
19758823|NCT03480763|42209890|FG001|Overall Study|non-study pneumococcal vaccine|0|||
19758824|NCT03480763|42209889|FG000|Overall Study|oncological treatment|0|||
19758825|NCT03480763|42209890|FG001|Overall Study|oncological treatment|2|||
19758826|NCT03480763|42209889|FG000|Overall Study|pain with vaccination|1|||
19672763|NCT00615017|42120638|FG003|Overall Study|Physician discontinued drug|0|||
19672764|NCT00615017|42120639|FG004|Overall Study|Physician discontinued drug|0|||
19672765|NCT00615017|42120640|FG005|Overall Study|Physician discontinued drug|1|||
19672766|NCT00614939|42120656|FG000|Overall Study|Withdrawal by Subject|10|||
19758827|NCT03480763|42209890|FG001|Overall Study|pain with vaccination|0|||
19758828|NCT03123120|42209904|FG000|Overall Study|Lost to Follow-up|0|||
19758829|NCT03123120|42209905|FG001|Overall Study|Lost to Follow-up|1|||
19758830|NCT03123120|42209904|FG000|Overall Study|Withdrawal by Subject|0|||
19758831|NCT03123120|42209905|FG001|Overall Study|Withdrawal by Subject|1|||
19758832|NCT01319994|42209915|FG000|Overall Study|Protocol Violation|7|||
19758833|NCT01319994|42209916|FG001|Overall Study|Protocol Violation|6|||
19758834|NCT03453151|42209926|FG000|Overall Study|Withdrawal by Subject|1|||
19758835|NCT03453151|42209926|FG000|Overall Study|Physician Decision|3|||
19758836|NCT02887248|42209930|FG000|Overall Study|Withdrawal by Subject|1|||
19758837|NCT02887248|42209930|FG000|Overall Study|Adverse Event|1|||
19758838|NCT02887248|42209930|FG000|Overall Study|Progressive Disease|1|||
19758839|NCT03452527|42209936|FG000|Overall Study|Withdrawal by Subject|1|||
19758840|NCT03452527|42209937|FG001|Overall Study|Withdrawal by Subject|1|||
19758841|NCT03452527|42209936|FG000|Overall Study|Study Terminated|2|||
19758842|NCT03452527|42209937|FG001|Overall Study|Study Terminated|3|||
19758843|NCT03028142|42209943|FG000|Overall Study|Adverse Event|1|||
19758844|NCT03028142|42209944|FG001|Overall Study|Adverse Event|1|||
19758845|NCT03028142|42209945|FG002|Overall Study|Adverse Event|0|||
19758846|NCT03028142|42209946|FG003|Overall Study|Adverse Event|0|||
19758847|NCT03028142|42209947|FG004|Overall Study|Adverse Event|0|||
19758848|NCT03028142|42209948|FG005|Overall Study|Adverse Event|1|||
19758849|NCT03028142|42209943|FG000|Overall Study|Withdrawal by Subject|0|||
19758850|NCT03028142|42209944|FG001|Overall Study|Withdrawal by Subject|0|||
19758851|NCT03028142|42209945|FG002|Overall Study|Withdrawal by Subject|0|||
19758852|NCT03028142|42209946|FG003|Overall Study|Withdrawal by Subject|0|||
19758853|NCT03028142|42209947|FG004|Overall Study|Withdrawal by Subject|1|||
19758854|NCT03028142|42209948|FG005|Overall Study|Withdrawal by Subject|0|||
19758855|NCT03122886|42209959|FG000|Overall Study|Withdrawal by Subject|1|||
19758856|NCT03122886|42209960|FG001|Overall Study|Withdrawal by Subject|2|||
19758857|NCT02708524|42209970|FG000|Overall Study|Adverse Event|0|||
19758858|NCT02708524|42209971|FG001|Overall Study|Adverse Event|1|||
19758859|NCT02708524|42209972|FG002|Overall Study|Adverse Event|0|||
19758860|NCT02708524|42209973|FG003|Overall Study|Adverse Event|0|||
19758861|NCT02708524|42209970|FG000|Overall Study|Lens Discomfort|1|||
19758862|NCT02708524|42209971|FG001|Overall Study|Lens Discomfort|0|||
19758863|NCT02708524|42209972|FG002|Overall Study|Lens Discomfort|1|||
19758864|NCT02708524|42209973|FG003|Overall Study|Lens Discomfort|0|||
19758865|NCT02708524|42209970|FG000|Overall Study|Lost to Follow-up|1|||
19758866|NCT02708524|42209971|FG001|Overall Study|Lost to Follow-up|1|||
19672767|NCT00614939|42120657|FG001|Overall Study|Withdrawal by Subject|17|||
19672768|NCT00614939|42120656|FG000|Overall Study|Study specific discontinuation criteris|13|||
19672769|NCT00614939|42120657|FG001|Overall Study|Study specific discontinuation criteris|16|||
19672770|NCT00614939|42120656|FG000|Overall Study|Adverse Event|2|||
19672771|NCT00614939|42120657|FG001|Overall Study|Adverse Event|5|||
19672772|NCT00614939|42120656|FG000|Overall Study|Incorrect enrollment|1|||
19672773|NCT00614939|42120657|FG001|Overall Study|Incorrect enrollment|2|||
19672774|NCT00614939|42120656|FG000|Overall Study|Death|4|||
19672775|NCT00614939|42120657|FG001|Overall Study|Death|3|||
19672776|NCT00614939|42120656|FG000|Overall Study|Poor/non-compliance|4|||
19672777|NCT00614939|42120657|FG001|Overall Study|Poor/non-compliance|0|||
19672778|NCT00614939|42120656|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
19672779|NCT00614939|42120657|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
19672780|NCT00530504|42120663|FG000|Overall Study|Death|54|||
19672781|NCT00530504|42120663|FG000|Overall Study|Lost to Follow-up|26|||
19672782|NCT00530504|42120663|FG000|Overall Study|Withdrawal by Subject|39|||
19672783|NCT00530504|42120663|FG000|Overall Study|Exited study due to other reasons|33|||
19672784|NCT00531050|42120673|FG000|Part 1: Period 1|Adverse Event|0|||
19672785|NCT00531050|42120674|FG001|Part 1: Period 1|Adverse Event|1|||
19672786|NCT00531050|42120675|FG002|Part 1: Period 1|Adverse Event|0|||
19672787|NCT00531050|42120676|FG003|Part 1: Period 1|Adverse Event|0|||
19758867|NCT02708524|42209972|FG002|Overall Study|Lost to Follow-up|1|||
19758868|NCT02708524|42209973|FG003|Overall Study|Lost to Follow-up|0|||
19758869|NCT02708524|42209970|FG000|Overall Study|Protocol Violation|0|||
19758870|NCT02708524|42209971|FG001|Overall Study|Protocol Violation|1|||
19758871|NCT02708524|42209972|FG002|Overall Study|Protocol Violation|0|||
19758872|NCT02708524|42209973|FG003|Overall Study|Protocol Violation|0|||
19758873|NCT02708524|42209970|FG000|Overall Study|Withdrawal by Subject|1|||
19758874|NCT02708524|42209971|FG001|Overall Study|Withdrawal by Subject|1|||
19758875|NCT02708524|42209972|FG002|Overall Study|Withdrawal by Subject|0|||
19758876|NCT02708524|42209973|FG003|Overall Study|Withdrawal by Subject|0|||
19758877|NCT02708524|42209970|FG000|Overall Study|Dispensed incorrect study lens|0|||
19758878|NCT02708524|42209971|FG001|Overall Study|Dispensed incorrect study lens|1|||
19758879|NCT02708524|42209972|FG002|Overall Study|Dispensed incorrect study lens|1|||
19758880|NCT02708524|42209973|FG003|Overall Study|Dispensed incorrect study lens|0|||
19758881|NCT02708524|42209970|FG000|Overall Study|Did not wear lens at final visit|0|||
19758882|NCT02708524|42209971|FG001|Overall Study|Did not wear lens at final visit|1|||
19758883|NCT02708524|42209972|FG002|Overall Study|Did not wear lens at final visit|0|||
19758884|NCT02708524|42209973|FG003|Overall Study|Did not wear lens at final visit|0|||
19758885|NCT02708524|42209970|FG000|Overall Study|Subject lost study lens|1|||
19672788|NCT00531050|42120677|FG004|Part 1: Period 1|Adverse Event|0|||
19672789|NCT00531050|42120678|FG005|Part 1: Period 1|Adverse Event|0|||
19672790|NCT00531050|42120673|FG000|Part 1: Period 1|Protocol Deviation|0|||
19672791|NCT00531050|42120674|FG001|Part 1: Period 1|Protocol Deviation|0|||
19672792|NCT00531050|42120675|FG002|Part 1: Period 1|Protocol Deviation|0|||
19672793|NCT00531050|42120676|FG003|Part 1: Period 1|Protocol Deviation|1|||
19672794|NCT00531050|42120677|FG004|Part 1: Period 1|Protocol Deviation|0|||
19672795|NCT00531050|42120678|FG005|Part 1: Period 1|Protocol Deviation|0|||
19672796|NCT00531050|42120673|FG000|Part 1: Period 3|Adverse Event|1|||
19672797|NCT00531050|42120674|FG001|Part 1: Period 3|Adverse Event|0|||
19672798|NCT00531050|42120675|FG002|Part 1: Period 3|Adverse Event|0|||
19672799|NCT00531050|42120676|FG003|Part 1: Period 3|Adverse Event|0|||
19672800|NCT00531050|42120677|FG004|Part 1: Period 3|Adverse Event|0|||
19672801|NCT00531050|42120678|FG005|Part 1: Period 3|Adverse Event|0|||
19672802|NCT00531050|42120673|FG000|Part 2: Period 1|Adverse Event|0|||
19672803|NCT00531050|42120674|FG001|Part 2: Period 1|Adverse Event|0|||
19672804|NCT00531050|42120675|FG002|Part 2: Period 1|Adverse Event|0|||
19672805|NCT00531050|42120676|FG003|Part 2: Period 1|Adverse Event|0|||
19672806|NCT00531050|42120677|FG004|Part 2: Period 1|Adverse Event|0|||
19672807|NCT00531050|42120678|FG005|Part 2: Period 1|Adverse Event|1|||
19672808|NCT00531050|42120673|FG000|Part 2: Period 3|Abnormal test procedure|1|||
19672809|NCT00531050|42120674|FG001|Part 2: Period 3|Abnormal test procedure|0|||
19672810|NCT00531050|42120675|FG002|Part 2: Period 3|Abnormal test procedure|0|||
19672811|NCT00531050|42120676|FG003|Part 2: Period 3|Abnormal test procedure|0|||
19672812|NCT00531050|42120677|FG004|Part 2: Period 3|Abnormal test procedure|0|||
19672813|NCT00531050|42120678|FG005|Part 2: Period 3|Abnormal test procedure|1|||
19672814|NCT00530348|42120697|FG000|Overall Study|Adverse Event|5|||
19758886|NCT02708524|42209971|FG001|Overall Study|Subject lost study lens|0|||
19758887|NCT02708524|42209972|FG002|Overall Study|Subject lost study lens|0|||
19758888|NCT02708524|42209973|FG003|Overall Study|Subject lost study lens|0|||
19758889|NCT03418675|42209985|FG000|Overall Study|Lost to Follow-up|13|||
19672815|NCT00530348|42120698|FG001|Overall Study|Adverse Event|1|||
19672816|NCT00530348|42120697|FG000|Overall Study|Death|0|||
19672817|NCT00530348|42120698|FG001|Overall Study|Death|1|||
19672818|NCT00530348|42120697|FG000|Overall Study|Lack of Efficacy|2|||
19672819|NCT00530348|42120698|FG001|Overall Study|Lack of Efficacy|0|||
19672820|NCT00530348|42120697|FG000|Overall Study|Lost to Follow-up|0|||
19672821|NCT00530348|42120698|FG001|Overall Study|Lost to Follow-up|2|||
19672822|NCT00530348|42120697|FG000|Overall Study|Physician Decision|1|||
19672823|NCT00530348|42120698|FG001|Overall Study|Physician Decision|2|||
19672824|NCT00530348|42120697|FG000|Overall Study|Pregnancy|1|||
19672825|NCT00530348|42120698|FG001|Overall Study|Pregnancy|0|||
19672826|NCT00530348|42120697|FG000|Overall Study|Withdrawal by Subject|12|||
19672827|NCT00530348|42120698|FG001|Overall Study|Withdrawal by Subject|12|||
19672828|NCT00530348|42120697|FG000|Overall Study|Randomised in error|1|||
19672829|NCT00530348|42120698|FG001|Overall Study|Randomised in error|0|||
19672830|NCT00530348|42120697|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
19672831|NCT00530348|42120698|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
19672832|NCT03886220|42120706|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
19672833|NCT03886220|42120707|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
19672834|NCT03886220|42120706|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
19672835|NCT03886220|42120707|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19672836|NCT03886220|42120706|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
19672837|NCT03886220|42120707|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
19672838|NCT00530270|42120715|FG000|Overall Study|Protocol Violation|1|||
19672839|NCT00530270|42120716|FG001|Overall Study|Protocol Violation|0|||
19672840|NCT03885596|42120726|FG000|Overall Study|Withdrawal by Subject|2|||
19672841|NCT03885596|42120727|FG001|Overall Study|Withdrawal by Subject|1|||
19672842|NCT03885596|42120728|FG002|Overall Study|Withdrawal by Subject|0|||
19672843|NCT03885596|42120729|FG003|Overall Study|Withdrawal by Subject|0|||
19672844|NCT00529100|42120745|FG000|Overall Study|Adverse Event|0|||
19672845|NCT00529100|42120746|FG001|Overall Study|Adverse Event|5|||
19672846|NCT00529100|42120745|FG000|Overall Study|Protocol Violation|0|||
19672847|NCT00529100|42120746|FG001|Overall Study|Protocol Violation|1|||
19672848|NCT00529100|42120745|FG000|Overall Study|Progressive Disease|0|||
19672849|NCT00529100|42120746|FG001|Overall Study|Progressive Disease|1|||
19672850|NCT00529100|42120745|FG000|Overall Study|Withdrawal by Subject|0|||
19672851|NCT00529100|42120746|FG001|Overall Study|Withdrawal by Subject|1|||
19672852|NCT00529100|42120745|FG000|Overall Study|Participant Ineligibility|0|||
19672853|NCT00529100|42120746|FG001|Overall Study|Participant Ineligibility|1|||
19672854|NCT03878108|42120758|FG000|Overall Study|Adverse Event|1|||
19672855|NCT03878108|42120759|FG001|Overall Study|Adverse Event|0|||
19672856|NCT00529958|42120768|FG000|2-Year Follow-up|Lost to Follow-up|1|||
19672857|NCT00529958|42120769|FG001|2-Year Follow-up|Lost to Follow-up|2|||
19672858|NCT00529958|42120770|FG002|2-Year Follow-up|Lost to Follow-up|2|||
19672859|NCT00529958|42120768|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
19672860|NCT00529958|42120769|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
19672861|NCT00529958|42120770|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
19672862|NCT00529958|42120768|FG000|5-Year Follow-up|Lost to Follow-up|2|||
19672863|NCT00529958|42120769|FG001|5-Year Follow-up|Lost to Follow-up|3|||
19672864|NCT00529958|42120770|FG002|5-Year Follow-up|Lost to Follow-up|1|||
19672865|NCT00529958|42120768|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
19672866|NCT00529958|42120769|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
19672867|NCT00529958|42120770|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
19672868|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
19672869|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
19672870|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
19672871|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Death|1|||
19672872|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
19672873|NCT00529802|42120778|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
19672874|NCT00529802|42120778|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
19672875|NCT00528866|42120784|FG000|Overall Study|Protocol Violation|6|||
19672876|NCT00614393|42120794|FG000|Overall Study|Adverse Event|20|||
19672877|NCT00614393|42120795|FG001|Overall Study|Adverse Event|2|||
19672878|NCT00614393|42120796|FG002|Overall Study|Adverse Event|3|||
19672879|NCT00614393|42120797|FG003|Overall Study|Adverse Event|13|||
19672880|NCT00614393|42120798|FG004|Overall Study|Adverse Event|21|||
19672881|NCT00614393|42120794|FG000|Overall Study|Lost to Follow-up|0|||
19672882|NCT00614393|42120795|FG001|Overall Study|Lost to Follow-up|0|||
19672883|NCT00614393|42120796|FG002|Overall Study|Lost to Follow-up|0|||
19758890|NCT03418675|42209986|FG001|Overall Study|Lost to Follow-up|10|||
19672884|NCT00614393|42120797|FG003|Overall Study|Lost to Follow-up|1|||
19672885|NCT00614393|42120798|FG004|Overall Study|Lost to Follow-up|2|||
19672886|NCT00614393|42120794|FG000|Overall Study|Physician Decision|17|||
19672887|NCT00614393|42120795|FG001|Overall Study|Physician Decision|0|||
19758891|NCT03418675|42209985|FG000|Overall Study|Adverse Event|2|||
19672888|NCT00614393|42120796|FG002|Overall Study|Physician Decision|1|||
19672889|NCT00614393|42120797|FG003|Overall Study|Physician Decision|8|||
19672890|NCT00614393|42120798|FG004|Overall Study|Physician Decision|9|||
19672891|NCT00614393|42120794|FG000|Overall Study|Progressive Disease|118|||
19672892|NCT00614393|42120795|FG001|Overall Study|Progressive Disease|5|||
19672893|NCT00614393|42120796|FG002|Overall Study|Progressive Disease|5|||
19672894|NCT00614393|42120797|FG003|Overall Study|Progressive Disease|138|||
19672895|NCT00614393|42120798|FG004|Overall Study|Progressive Disease|130|||
19672896|NCT00614393|42120794|FG000|Overall Study|Protocol Violation|1|||
19672897|NCT00614393|42120795|FG001|Overall Study|Protocol Violation|0|||
19672898|NCT00614393|42120796|FG002|Overall Study|Protocol Violation|0|||
19672899|NCT00614393|42120797|FG003|Overall Study|Protocol Violation|0|||
19672900|NCT00614393|42120798|FG004|Overall Study|Protocol Violation|0|||
19672901|NCT00614393|42120794|FG000|Overall Study|Terminated by Sponsor|0|||
19672902|NCT00614393|42120795|FG001|Overall Study|Terminated by Sponsor|0|||
19672903|NCT00614393|42120796|FG002|Overall Study|Terminated by Sponsor|0|||
19672904|NCT00614393|42120797|FG003|Overall Study|Terminated by Sponsor|0|||
19672905|NCT00614393|42120798|FG004|Overall Study|Terminated by Sponsor|1|||
19672906|NCT00614393|42120794|FG000|Overall Study|Withdrawal by Subject|20|||
19672907|NCT00614393|42120795|FG001|Overall Study|Withdrawal by Subject|1|||
19672908|NCT00614393|42120796|FG002|Overall Study|Withdrawal by Subject|1|||
19672909|NCT00614393|42120797|FG003|Overall Study|Withdrawal by Subject|16|||
19672910|NCT00614393|42120798|FG004|Overall Study|Withdrawal by Subject|13|||
19672911|NCT00614393|42120794|FG000|Overall Study|Other|4|||
19672912|NCT00614393|42120795|FG001|Overall Study|Other|0|||
19672913|NCT00614393|42120796|FG002|Overall Study|Other|0|||
19672914|NCT00614393|42120797|FG003|Overall Study|Other|4|||
19672915|NCT00614393|42120798|FG004|Overall Study|Other|2|||
19672916|NCT00614393|42120794|FG000|Overall Study|Not Treated|0|||
19672917|NCT00614393|42120795|FG001|Overall Study|Not Treated|0|||
19672918|NCT00614393|42120796|FG002|Overall Study|Not Treated|0|||
19672919|NCT00614393|42120797|FG003|Overall Study|Not Treated|0|||
19672920|NCT00614393|42120798|FG004|Overall Study|Not Treated|2|||
19672921|NCT00612677|42120810|FG000|Overall Study|study closed before treatment started|1|||
19672922|NCT00613925|42120816|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
19672923|NCT00613925|42120817|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
19672924|NCT00613301|42120823|FG000|Overall Study|Adverse Event|49|||
19672925|NCT00613301|42120823|FG000|Overall Study|Lost to Follow-up|88|||
19672926|NCT00613301|42120823|FG000|Overall Study|Withdrawal by Subject|5|||
19672927|NCT00613301|42120823|FG000|Overall Study|Death|6|||
19672928|NCT00613301|42120823|FG000|Overall Study|Lack of Efficacy|13|||
19672929|NCT00613301|42120823|FG000|Overall Study|Physician Decision|2|||
19672930|NCT00613301|42120823|FG000|Overall Study|No data was collected|53|||
19672931|NCT00613301|42120823|FG000|Overall Study|Irregularly enrolled patients|12|||
19672932|NCT00609947|42120828|FG000|Overall Study|Death|1|||
19672933|NCT00609869|42120833|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
19672934|NCT00609869|42120833|FG000|Overall Study|Severe hematologic toxicity|1|||
19672935|NCT00609869|42120833|FG000|Overall Study|Withdrawal by Subject|1|||
19672936|NCT00609869|42120833|FG000|Overall Study|Seizures|1|||
19672937|NCT00609869|42120833|FG000|Overall Study|Severe tumor flare reaction|1|||
19672938|NCT00609869|42120833|FG000|Overall Study|Hepatitis B infection|1|||
19672939|NCT00609869|42120833|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
19672940|NCT00609869|42120833|FG000|Overall Study|Mantle cell: not evaluable|4|||
19672941|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
19672942|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
19672943|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
19672944|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
19672945|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
19672946|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
19672947|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
19672948|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
19672949|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
19672950|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
19672951|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
19672952|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
19672953|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
19672954|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
19672955|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
19672956|NCT00529568|42120839|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
19672957|NCT00529568|42120840|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
19672958|NCT00529568|42120841|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
19672959|NCT00529568|42120839|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
19672960|NCT00529568|42120840|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
19672961|NCT00529568|42120841|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
19672962|NCT00529568|42120839|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
19672963|NCT00529568|42120840|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
19672964|NCT00529568|42120841|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
19672965|NCT00529568|42120839|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
19672966|NCT00529568|42120840|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
19672967|NCT00529568|42120841|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
19672968|NCT00529568|42120839|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
19672969|NCT00529568|42120840|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
19672970|NCT00529568|42120841|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
19672971|NCT00529568|42120839|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
19672972|NCT00529568|42120840|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
19672973|NCT00529568|42120841|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
19672974|NCT00611975|42120852|FG000|Overall Study|Withdrawal by Subject|3|||
19672975|NCT00611975|42120853|FG001|Overall Study|Withdrawal by Subject|7|||
19758892|NCT03418675|42209986|FG001|Overall Study|Adverse Event|0|||
19672976|NCT00611975|42120852|FG000|Overall Study|Pregnancy|2|||
19672977|NCT00611975|42120853|FG001|Overall Study|Pregnancy|1|||
19672978|NCT00573131|42120861|FG000|Overall Study|Withdrawal by Subject|10|||
19672979|NCT00573131|42120862|FG001|Overall Study|Withdrawal by Subject|8|||
19672980|NCT00521144|42120873|FG000|Overall Study|Not Treated|0|||
19672981|NCT00521144|42120874|FG001|Overall Study|Not Treated|0|||
19672982|NCT00521144|42120875|FG002|Overall Study|Not Treated|0|||
19672983|NCT00521144|42120876|FG003|Overall Study|Not Treated|1|||
19672984|NCT00521144|42120877|FG004|Overall Study|Not Treated|0|||
19672985|NCT00521144|42120873|FG000|Overall Study|Adverse Event|0|||
19672986|NCT00521144|42120874|FG001|Overall Study|Adverse Event|1|||
19672987|NCT00521144|42120875|FG002|Overall Study|Adverse Event|0|||
19672988|NCT00521144|42120876|FG003|Overall Study|Adverse Event|0|||
19672989|NCT00521144|42120877|FG004|Overall Study|Adverse Event|1|||
19672990|NCT00521144|42120873|FG000|Overall Study|Progressive Disease|4|||
19672991|NCT00521144|42120874|FG001|Overall Study|Progressive Disease|2|||
19672992|NCT00521144|42120875|FG002|Overall Study|Progressive Disease|2|||
19672993|NCT00521144|42120876|FG003|Overall Study|Progressive Disease|0|||
19672994|NCT00521144|42120877|FG004|Overall Study|Progressive Disease|6|||
19672995|NCT00520676|42120891|FG000|Overall Study|Death|84|||
19672996|NCT00520676|42120892|FG001|Overall Study|Death|81|||
19672997|NCT00520676|42120891|FG000|Overall Study|Lost to Follow-up|6|||
19672998|NCT00520676|42120892|FG001|Overall Study|Lost to Follow-up|10|||
19672999|NCT00520676|42120891|FG000|Overall Study|Physician Decision|4|||
19673000|NCT00520676|42120892|FG001|Overall Study|Physician Decision|1|||
19673001|NCT00520676|42120891|FG000|Overall Study|Withdrawal by Subject|7|||
19673002|NCT00520676|42120892|FG001|Overall Study|Withdrawal by Subject|11|||
19673003|NCT00610649|42120909|FG000|Overall Study|Adverse Event|1|||
19673004|NCT00610649|42120910|FG001|Overall Study|Adverse Event|0|||
19389018|NCT02675231|41632563|FG001|Overall Study|On study treatment/follow up|31|||
19673005|NCT00610649|42120911|FG002|Overall Study|Adverse Event|0|||
19673006|NCT00610649|42120912|FG003|Overall Study|Adverse Event|0|||
19673007|NCT00610649|42120913|FG004|Overall Study|Adverse Event|0|||
19673008|NCT00610649|42120914|FG005|Overall Study|Adverse Event|0|||
19673009|NCT00610649|42120915|FG006|Overall Study|Adverse Event|0|||
19673010|NCT00610649|42120916|FG007|Overall Study|Adverse Event|0|||
19673011|NCT00610649|42120917|FG008|Overall Study|Adverse Event|0|||
19673012|NCT00610649|42120918|FG009|Overall Study|Adverse Event|0|||
19673013|NCT00610649|42120919|FG010|Overall Study|Adverse Event|1|||
19673014|NCT00610649|42120909|FG000|Overall Study|Family Emergency|0|||
19673015|NCT00610649|42120910|FG001|Overall Study|Family Emergency|1|||
19673016|NCT00610649|42120911|FG002|Overall Study|Family Emergency|0|||
19673017|NCT00610649|42120912|FG003|Overall Study|Family Emergency|0|||
19673018|NCT00610649|42120913|FG004|Overall Study|Family Emergency|0|||
19673019|NCT00610649|42120914|FG005|Overall Study|Family Emergency|0|||
19673020|NCT00610649|42120915|FG006|Overall Study|Family Emergency|0|||
19673021|NCT00610649|42120916|FG007|Overall Study|Family Emergency|0|||
19673022|NCT00610649|42120917|FG008|Overall Study|Family Emergency|0|||
19758893|NCT03417505|42209992|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
19758894|NCT03417505|42209993|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
19758895|NCT02953639|42210002|FG000|Overall Study|Adverse Event|2|||
19758896|NCT02953639|42210003|FG001|Overall Study|Adverse Event|0|||
19758897|NCT02953639|42210004|FG002|Overall Study|Adverse Event|1|||
19758898|NCT02953639|42210002|FG000|Overall Study|Lost to Follow-up|8|||
19758899|NCT02953639|42210003|FG001|Overall Study|Lost to Follow-up|4|||
19758900|NCT02953639|42210004|FG002|Overall Study|Lost to Follow-up|3|||
19758901|NCT02953639|42210002|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19758902|NCT02953639|42210003|FG001|Overall Study|Non-Compliance With Study Drug|2|||
19758903|NCT02953639|42210004|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19758904|NCT02953639|42210002|FG000|Overall Study|Multiple Reasons|1|||
19673023|NCT00610649|42120918|FG009|Overall Study|Family Emergency|0|||
19673024|NCT00610649|42120919|FG010|Overall Study|Family Emergency|0|||
19673025|NCT00610649|42120909|FG000|Overall Study|Withdrawal by Subject|0|||
19673026|NCT00610649|42120910|FG001|Overall Study|Withdrawal by Subject|0|||
19673027|NCT00610649|42120911|FG002|Overall Study|Withdrawal by Subject|0|||
19673028|NCT00610649|42120912|FG003|Overall Study|Withdrawal by Subject|0|||
19673029|NCT00610649|42120913|FG004|Overall Study|Withdrawal by Subject|0|||
19673030|NCT00610649|42120914|FG005|Overall Study|Withdrawal by Subject|0|||
19673031|NCT00610649|42120915|FG006|Overall Study|Withdrawal by Subject|0|||
19673032|NCT00610649|42120916|FG007|Overall Study|Withdrawal by Subject|0|||
19673033|NCT00610649|42120917|FG008|Overall Study|Withdrawal by Subject|0|||
19673034|NCT00610649|42120918|FG009|Overall Study|Withdrawal by Subject|1|||
19673035|NCT00610649|42120919|FG010|Overall Study|Withdrawal by Subject|0|||
19673036|NCT00608543|42120943|FG000|Overall Study|Adverse Event|4|||
19673037|NCT00520130|42120950|FG000|Overall Study|Disease progression on study|4|||
19673038|NCT00520130|42120951|FG001|Overall Study|Disease progression on study|0|||
19673039|NCT00520130|42120950|FG000|Overall Study|Physician Decision|1|||
19673040|NCT00520130|42120951|FG001|Overall Study|Physician Decision|1|||
19673041|NCT00519896|42120961|FG000|Overall Study|Protocol Violation|1|||
19673042|NCT00519896|42120961|FG000|Overall Study|Adverse Event|1|||
19673043|NCT00527618|42120974|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
19673044|NCT00527618|42120975|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
19673045|NCT00527618|42120974|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
19673046|NCT00527618|42120975|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
19673047|NCT00527618|42120974|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
19673048|NCT00527618|42120975|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
19673049|NCT00527618|42120974|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
19673050|NCT00527618|42120975|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
19673051|NCT00527618|42120974|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
19673052|NCT00527618|42120975|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
19673053|NCT00527618|42120974|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
19673054|NCT00527618|42120975|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
19673055|NCT00527072|42120982|FG000|Overall Study|Adverse Event|13|||
19673056|NCT00527072|42120982|FG000|Overall Study|Lack of Efficacy|11|||
19673057|NCT00527072|42120982|FG000|Overall Study|Lost to Follow-up|3|||
19673058|NCT00527072|42120982|FG000|Overall Study|Protocol Violation|2|||
19673059|NCT00527072|42120982|FG000|Overall Study|Withdrawal by Subject|7|||
19673060|NCT00526994|42120990|FG000|Overall Study|Lost to Follow-up|98|||
19673061|NCT00526994|42120991|FG001|Overall Study|Lost to Follow-up|108|||
19673062|NCT00526994|42120992|FG002|Overall Study|Lost to Follow-up|96|||
19673063|NCT00526994|42120990|FG000|Overall Study|Death|4|||
19673064|NCT00526994|42120991|FG001|Overall Study|Death|3|||
19673065|NCT00526994|42120992|FG002|Overall Study|Death|3|||
19673066|NCT00526994|42120990|FG000|Overall Study|Withdrawal by Subject|2|||
19673067|NCT00526994|42120991|FG001|Overall Study|Withdrawal by Subject|7|||
19673068|NCT00526994|42120992|FG002|Overall Study|Withdrawal by Subject|5|||
19673069|NCT00526994|42120990|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
19673070|NCT00526994|42120991|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
19673071|NCT00526994|42120992|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
19673072|NCT00519428|42121003|FG000|Overall Study|Adverse Event|5|||
19673073|NCT00519428|42121004|FG001|Overall Study|Adverse Event|2|||
19673074|NCT00519428|42121005|FG002|Overall Study|Adverse Event|10|||
19673075|NCT00519428|42121003|FG000|Overall Study|Lost to Follow-up|7|||
19673076|NCT00519428|42121004|FG001|Overall Study|Lost to Follow-up|7|||
19673077|NCT00519428|42121005|FG002|Overall Study|Lost to Follow-up|6|||
19673078|NCT00519428|42121003|FG000|Overall Study|Withdrawal by Subject|8|||
19673079|NCT00519428|42121004|FG001|Overall Study|Withdrawal by Subject|3|||
19673080|NCT00519428|42121005|FG002|Overall Study|Withdrawal by Subject|7|||
19673081|NCT00519428|42121003|FG000|Overall Study|unstated|1|||
19673082|NCT00519428|42121004|FG001|Overall Study|unstated|3|||
19758905|NCT02953639|42210003|FG001|Overall Study|Multiple Reasons|0|||
19758906|NCT02953639|42210004|FG002|Overall Study|Multiple Reasons|1|||
19758907|NCT02953639|42210002|FG000|Overall Study|Physician Decision|1|||
19758908|NCT02953639|42210003|FG001|Overall Study|Physician Decision|0|||
19673083|NCT00519428|42121005|FG002|Overall Study|unstated|2|||
19673084|NCT00432159|42121021|FG000|Overall Study|Death|0|||
19673085|NCT00432159|42121022|FG001|Overall Study|Death|1|||
19673086|NCT00432159|42121023|FG002|Overall Study|Death|0|||
19673087|NCT00432159|42121024|FG003|Overall Study|Death|0|||
19673088|NCT00432159|42121025|FG004|Overall Study|Death|0|||
19673089|NCT00432159|42121021|FG000|Overall Study|Failure|9|||
19673090|NCT00432159|42121022|FG001|Overall Study|Failure|5|||
19673091|NCT00432159|42121023|FG002|Overall Study|Failure|3|||
19673092|NCT00432159|42121024|FG003|Overall Study|Failure|2|||
19673093|NCT00432159|42121025|FG004|Overall Study|Failure|3|||
19673094|NCT00432159|42121021|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
19673095|NCT00432159|42121022|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
19673096|NCT00432159|42121023|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
19673097|NCT00432159|42121024|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
19673098|NCT00432159|42121025|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
19673099|NCT00519194|42121037|FG000|Overall Study|Withdrawal by Subject|9|||
19673100|NCT00519194|42121037|FG000|Overall Study|Death|9|||
19673101|NCT00519194|42121037|FG000|Overall Study|Lost to Follow-up|3|||
19673102|NCT00431847|42121045|FG000|Overall Study|completion of less than two study visits|6|||
19673103|NCT00431847|42121046|FG001|Overall Study|completion of less than two study visits|3|||
19673104|NCT00431847|42121047|FG002|Overall Study|completion of less than two study visits|4|||
19673105|NCT00431847|42121048|FG003|Overall Study|completion of less than two study visits|14|||
19673106|NCT00431847|42121049|FG004|Overall Study|completion of less than two study visits|0|||
19673107|NCT00431847|42121045|FG000|Overall Study|Protocol Violation|0|||
19673108|NCT00431847|42121046|FG001|Overall Study|Protocol Violation|0|||
19673109|NCT00431847|42121047|FG002|Overall Study|Protocol Violation|0|||
19673110|NCT00431847|42121048|FG003|Overall Study|Protocol Violation|0|||
19673111|NCT00431847|42121049|FG004|Overall Study|Protocol Violation|1|||
19673112|NCT00431067|42121059|FG000|Overall Study|Other Adverse Event|9|||
19673113|NCT00431067|42121059|FG000|Overall Study|Progressive disease|30|||
19673114|NCT00431067|42121059|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
19673115|NCT00430989|42121065|FG000|Overall Study|Lost to Follow-up|2|||
19673116|NCT00430989|42121066|FG001|Overall Study|Lost to Follow-up|3|||
19673117|NCT00430989|42121065|FG000|Overall Study|Withdrawal by Subject|15|||
19673118|NCT00430989|42121066|FG001|Overall Study|Withdrawal by Subject|14|||
19673119|NCT00430989|42121065|FG000|Overall Study|Protocol Violation|30|||
19673120|NCT00430989|42121066|FG001|Overall Study|Protocol Violation|37|||
19673121|NCT00430989|42121065|FG000|Overall Study|Not eligible|13|||
19673122|NCT00430989|42121066|FG001|Overall Study|Not eligible|6|||
19673123|NCT00430755|42121074|FG000|Overall Study|Withdrawal by Subject|53|||
19673124|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
19673125|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
19673126|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
19673127|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
19673128|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
19673129|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
19673130|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
19673131|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
19673132|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
19673133|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
19673134|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Subject decision|1|||
19673135|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Subject decision|1|||
19673136|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
19673137|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
19673138|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
19673139|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
19673140|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
19673141|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
19673142|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
19673143|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
19673144|NCT00518882|42121080|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
19673145|NCT00518882|42121081|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
19673146|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
19673147|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
19673148|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
19673149|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
19673150|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
19673151|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
19673152|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
19673153|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
19673154|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
19673155|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
19673156|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
19758909|NCT02953639|42210004|FG002|Overall Study|Physician Decision|0|||
19673157|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
19673158|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
19673159|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
19673160|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
19673161|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
19673162|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
19673163|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
19673164|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
19673165|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
19673166|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
19673167|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
19673168|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
19673169|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
19673170|NCT00518882|42121080|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
19673171|NCT00518882|42121081|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
19673172|NCT00518336|42121089|FG000|Year 7|Lost to Follow-up|2|||
19673173|NCT00518336|42121090|FG001|Year 7|Lost to Follow-up|0|||
19673174|NCT00518336|42121089|FG000|Year 7|Could not attend in time|0|||
19673175|NCT00518336|42121090|FG001|Year 7|Could not attend in time|3|||
19673176|NCT00518336|42121089|FG000|Year 8|Lost to Follow-up|1|||
19673177|NCT00518336|42121090|FG001|Year 8|Lost to Follow-up|1|||
19673178|NCT00518336|42121089|FG000|Year 8|Could not attend in time|0|||
19673179|NCT00518336|42121090|FG001|Year 8|Could not attend in time|1|||
19673180|NCT00518336|42121089|FG000|Year 9|Migrated/moved from study area|1|||
19673181|NCT00518336|42121090|FG001|Year 9|Migrated/moved from study area|1|||
19673182|NCT00518336|42121089|FG000|Year 9|Lost to Follow-up|3|||
19673183|NCT00518336|42121090|FG001|Year 9|Lost to Follow-up|0|||
19673184|NCT00518336|42121089|FG000|Year 9|Personal reasons|1|||
19673185|NCT00518336|42121090|FG001|Year 9|Personal reasons|0|||
19673186|NCT00518180|42121099|FG000|Overall Study|Withdrawal by Subject|29|||
19673187|NCT00518180|42121100|FG001|Overall Study|Withdrawal by Subject|30|||
19673188|NCT00518180|42121101|FG002|Overall Study|Withdrawal by Subject|42|||
19673189|NCT00518180|42121099|FG000|Overall Study|Lost to Follow-up|30|||
19673190|NCT00518180|42121100|FG001|Overall Study|Lost to Follow-up|28|||
19673191|NCT00518180|42121101|FG002|Overall Study|Lost to Follow-up|34|||
19673192|NCT00518180|42121099|FG000|Overall Study|Administrative reason|0|||
19673193|NCT00518180|42121100|FG001|Overall Study|Administrative reason|2|||
19673194|NCT00518180|42121101|FG002|Overall Study|Administrative reason|2|||
19673195|NCT00518180|42121099|FG000|Overall Study|Protocol Violation|5|||
19673196|NCT00518180|42121100|FG001|Overall Study|Protocol Violation|7|||
19673197|NCT00518180|42121101|FG002|Overall Study|Protocol Violation|4|||
19673198|NCT00518180|42121099|FG000|Overall Study|Unable to classify|0|||
19673199|NCT00518180|42121100|FG001|Overall Study|Unable to classify|2|||
19673200|NCT00518180|42121101|FG002|Overall Study|Unable to classify|0|||
19673201|NCT00518180|42121099|FG000|Overall Study|Adverse Event|1|||
19673202|NCT00518180|42121100|FG001|Overall Study|Adverse Event|0|||
19673203|NCT00518180|42121101|FG002|Overall Study|Adverse Event|0|||
19673204|NCT00525902|42121118|FG000|Overall Study|Lack of Efficacy|1|||
19673205|NCT00525824|42121126|FG000|Overall Study|Adverse Event|7|||
19673206|NCT00525824|42121127|FG001|Overall Study|Adverse Event|11|||
19673207|NCT00525824|42121128|FG002|Overall Study|Adverse Event|6|||
19673208|NCT00525824|42121129|FG003|Overall Study|Adverse Event|7|||
19673209|NCT00525824|42121126|FG000|Overall Study|Withdrawal by Subject|5|||
19673210|NCT00525824|42121127|FG001|Overall Study|Withdrawal by Subject|9|||
19673211|NCT00525824|42121128|FG002|Overall Study|Withdrawal by Subject|3|||
19673212|NCT00525824|42121129|FG003|Overall Study|Withdrawal by Subject|4|||
19673213|NCT00525824|42121126|FG000|Overall Study|Lost to Follow-up|4|||
19758910|NCT02953639|42210002|FG000|Overall Study|Withdrawal by Subject|7|||
19758911|NCT02953639|42210003|FG001|Overall Study|Withdrawal by Subject|8|||
19758912|NCT02953639|42210004|FG002|Overall Study|Withdrawal by Subject|10|||
19758913|NCT02953639|42210002|FG000|Overall Study|Completed or Discontinued information is missing|1|||
19758914|NCT02953639|42210003|FG001|Overall Study|Completed or Discontinued information is missing|0|||
19673214|NCT00525824|42121127|FG001|Overall Study|Lost to Follow-up|2|||
19673215|NCT00525824|42121128|FG002|Overall Study|Lost to Follow-up|4|||
19673216|NCT00525824|42121129|FG003|Overall Study|Lost to Follow-up|0|||
19673217|NCT00525824|42121126|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
19673218|NCT00525824|42121127|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
19673219|NCT00525824|42121128|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
19673220|NCT00525824|42121129|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
19673221|NCT00525824|42121126|FG000|Overall Study|Severe non-compliance|0|||
19673222|NCT00525824|42121127|FG001|Overall Study|Severe non-compliance|1|||
19673223|NCT00525824|42121128|FG002|Overall Study|Severe non-compliance|1|||
19673224|NCT00525824|42121129|FG003|Overall Study|Severe non-compliance|1|||
19673225|NCT00525824|42121126|FG000|Overall Study|Safety reasons|1|||
19673226|NCT00525824|42121127|FG001|Overall Study|Safety reasons|0|||
19673227|NCT00525824|42121128|FG002|Overall Study|Safety reasons|1|||
19673228|NCT00525824|42121129|FG003|Overall Study|Safety reasons|0|||
19673229|NCT00525824|42121126|FG000|Overall Study|Other|1|||
19673230|NCT00525824|42121127|FG001|Overall Study|Other|3|||
19673231|NCT00525824|42121128|FG002|Overall Study|Other|3|||
19673232|NCT00525824|42121129|FG003|Overall Study|Other|1|||
19673233|NCT00525590|42121143|FG000|Overall Study|Adverse Event|3|||
19673234|NCT00525590|42121143|FG000|Overall Study|Physician Decision|3|||
19673235|NCT00525590|42121143|FG000|Overall Study|Withdrawal by Subject|16|||
19673236|NCT00525590|42121143|FG000|Overall Study|Lost to Follow-up|1|||
19673237|NCT00525590|42121143|FG000|Overall Study|Death|9|||
19673238|NCT00525590|42121143|FG000|Overall Study|Other|13|||
19673239|NCT00430677|42121150|FG000|Short-term Period|Death|1|||
19673240|NCT00430677|42121151|FG001|Short-term Period|Death|1|||
19673241|NCT00430677|42121152|FG002|Short-term Period|Death|5|||
19673242|NCT00430677|42121150|FG000|Short-term Period|Adverse Event|15|||
19673243|NCT00430677|42121151|FG001|Short-term Period|Adverse Event|13|||
19673244|NCT00430677|42121152|FG002|Short-term Period|Adverse Event|9|||
19673245|NCT00430677|42121150|FG000|Short-term Period|Lack of Efficacy|5|||
19673246|NCT00430677|42121151|FG001|Short-term Period|Lack of Efficacy|6|||
19673247|NCT00430677|42121152|FG002|Short-term Period|Lack of Efficacy|4|||
19673248|NCT00430677|42121150|FG000|Short-term Period|Withdrawal by Subject|1|||
19673249|NCT00430677|42121151|FG001|Short-term Period|Withdrawal by Subject|1|||
19673250|NCT00430677|42121152|FG002|Short-term Period|Withdrawal by Subject|2|||
19673251|NCT00430677|42121150|FG000|Short-term Period|Participant no longer met study criteria|1|||
19673252|NCT00430677|42121151|FG001|Short-term Period|Participant no longer met study criteria|1|||
19673253|NCT00430677|42121152|FG002|Short-term Period|Participant no longer met study criteria|2|||
19673254|NCT00430677|42121150|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
19673255|NCT00430677|42121151|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
19673256|NCT00430677|42121152|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
19673257|NCT00430677|42121150|FG000|Short-term Period|Pregnancy|0|||
19673258|NCT00430677|42121151|FG001|Short-term Period|Pregnancy|2|||
19673259|NCT00430677|42121152|FG002|Short-term Period|Pregnancy|0|||
19673260|NCT00430677|42121150|FG000|Long-term Extension Period|Death|1|||
19673261|NCT00430677|42121151|FG001|Long-term Extension Period|Death|0|||
19673262|NCT00430677|42121152|FG002|Long-term Extension Period|Death|0|||
19673263|NCT00430677|42121150|FG000|Long-term Extension Period|Adverse Event|3|||
19758915|NCT02953639|42210004|FG002|Overall Study|Completed or Discontinued information is missing|0|||
19758916|NCT04147715|42210026|FG000|Overall Study|Adverse Event|0|||
19758917|NCT04147715|42210027|FG001|Overall Study|Adverse Event|0|||
19673264|NCT00430677|42121151|FG001|Long-term Extension Period|Adverse Event|2|||
19673265|NCT00430677|42121152|FG002|Long-term Extension Period|Adverse Event|5|||
19673266|NCT00430677|42121150|FG000|Long-term Extension Period|Lack of Efficacy|5|||
19673267|NCT00430677|42121151|FG001|Long-term Extension Period|Lack of Efficacy|3|||
19673268|NCT00430677|42121152|FG002|Long-term Extension Period|Lack of Efficacy|8|||
19673269|NCT00430677|42121150|FG000|Long-term Extension Period|Lost to Follow-up|1|||
19673270|NCT00430677|42121151|FG001|Long-term Extension Period|Lost to Follow-up|1|||
19673271|NCT00430677|42121152|FG002|Long-term Extension Period|Lost to Follow-up|1|||
19758918|NCT04147715|42210028|FG002|Overall Study|Adverse Event|0|||
19758919|NCT04147715|42210029|FG003|Overall Study|Adverse Event|0|||
19758920|NCT04147715|42210030|FG004|Overall Study|Adverse Event|0|||
19758921|NCT04147715|42210031|FG005|Overall Study|Adverse Event|0|||
19758922|NCT04147715|42210032|FG006|Overall Study|Adverse Event|0|||
19758923|NCT04147715|42210033|FG007|Overall Study|Adverse Event|2|||
19673272|NCT00430677|42121150|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
19673273|NCT00430677|42121151|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
19673274|NCT00430677|42121152|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
19673275|NCT00430677|42121150|FG000|Long-term Extension Period|Pregnancy|1|||
19673276|NCT00430677|42121151|FG001|Long-term Extension Period|Pregnancy|1|||
19673277|NCT00430677|42121152|FG002|Long-term Extension Period|Pregnancy|0|||
19673278|NCT00430677|42121150|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
19673279|NCT00430677|42121151|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
19673280|NCT00430677|42121152|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
19673281|NCT00430677|42121150|FG000|Long-term Extension Period|Other|2|||
19673282|NCT00430677|42121151|FG001|Long-term Extension Period|Other|1|||
19673283|NCT00430677|42121152|FG002|Long-term Extension Period|Other|1|||
19673284|NCT00430677|42121150|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
19673285|NCT00430677|42121151|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
19673286|NCT00430677|42121152|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
19673287|NCT00525512|42121180|FG000|Double-Blind Phase|Adverse Event|48|||
19673288|NCT00525512|42121181|FG001|Double-Blind Phase|Adverse Event|28|||
19673289|NCT00525512|42121182|FG002|Double-Blind Phase|Adverse Event|0|||
19758924|NCT04147715|42210034|FG008|Overall Study|Adverse Event|1|||
19758925|NCT04147715|42210035|FG009|Overall Study|Adverse Event|0|||
19758926|NCT04147715|42210036|FG010|Overall Study|Adverse Event|0|||
19673290|NCT00525512|42121183|FG003|Double-Blind Phase|Adverse Event|0|||
19673291|NCT00525512|42121180|FG000|Double-Blind Phase|Protocol Violation|3|||
19673292|NCT00525512|42121181|FG001|Double-Blind Phase|Protocol Violation|1|||
19673293|NCT00525512|42121182|FG002|Double-Blind Phase|Protocol Violation|0|||
19673294|NCT00525512|42121183|FG003|Double-Blind Phase|Protocol Violation|0|||
19673295|NCT00525512|42121180|FG000|Double-Blind Phase|Lost to Follow-up|3|||
19673296|NCT00525512|42121181|FG001|Double-Blind Phase|Lost to Follow-up|7|||
19673297|NCT00525512|42121182|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19673298|NCT00525512|42121183|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19673299|NCT00525512|42121180|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
19673300|NCT00525512|42121181|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
19673301|NCT00525512|42121182|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19673302|NCT00525512|42121183|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19673303|NCT00525512|42121180|FG000|Double-Blind Phase|Lack of Efficacy|13|||
19673304|NCT00525512|42121181|FG001|Double-Blind Phase|Lack of Efficacy|5|||
19673305|NCT00525512|42121182|FG002|Double-Blind Phase|Lack of Efficacy|0|||
19673306|NCT00525512|42121183|FG003|Double-Blind Phase|Lack of Efficacy|0|||
19673307|NCT00525512|42121180|FG000|Double-Blind Phase|Other reason (not specified)|12|||
19673308|NCT00525512|42121181|FG001|Double-Blind Phase|Other reason (not specified)|13|||
19673309|NCT00525512|42121182|FG002|Double-Blind Phase|Other reason (not specified)|0|||
19673310|NCT00525512|42121183|FG003|Double-Blind Phase|Other reason (not specified)|0|||
19673311|NCT00525512|42121180|FG000|Open-Label Phase|Adverse Event|0|||
19673312|NCT00525512|42121181|FG001|Open-Label Phase|Adverse Event|0|||
19673313|NCT00525512|42121182|FG002|Open-Label Phase|Adverse Event|1|||
19673314|NCT00525512|42121183|FG003|Open-Label Phase|Adverse Event|0|||
19673315|NCT00525512|42121180|FG000|Open-Label Phase|Lost to Follow-up|0|||
19673316|NCT00525512|42121181|FG001|Open-Label Phase|Lost to Follow-up|0|||
19673317|NCT00525512|42121182|FG002|Open-Label Phase|Lost to Follow-up|1|||
19673318|NCT00525512|42121183|FG003|Open-Label Phase|Lost to Follow-up|0|||
19673319|NCT00525512|42121180|FG000|Open-Label Phase|Other reason (not specified)|0|||
19673320|NCT00525512|42121181|FG001|Open-Label Phase|Other reason (not specified)|0|||
19673321|NCT00525512|42121182|FG002|Open-Label Phase|Other reason (not specified)|4|||
19673322|NCT00525512|42121183|FG003|Open-Label Phase|Other reason (not specified)|5|||
19673323|NCT00517634|42121195|FG000|Second Treatment Period|Withdrawal by Subject|0|||
19673324|NCT00517634|42121196|FG001|Second Treatment Period|Withdrawal by Subject|0|||
19673325|NCT00517634|42121197|FG002|Second Treatment Period|Withdrawal by Subject|0|||
19673326|NCT00517634|42121198|FG003|Second Treatment Period|Withdrawal by Subject|0|||
19673327|NCT00517634|42121199|FG004|Second Treatment Period|Withdrawal by Subject|1|||
19758927|NCT04147715|42210037|FG011|Overall Study|Adverse Event|0|||
19758928|NCT02452554|42210124|FG000|Overall Study|Death|2|||
19758929|NCT02452554|42210125|FG001|Overall Study|Death|1|||
19673328|NCT00517634|42121200|FG005|Second Treatment Period|Withdrawal by Subject|0|||
19673329|NCT03683576|42121212|FG000|Overall Study|Withdrawal by Subject|2|||
19673330|NCT03683576|42121213|FG001|Overall Study|Withdrawal by Subject|0|||
19673331|NCT03683576|42121214|FG002|Overall Study|Withdrawal by Subject|8|||
19673332|NCT03683576|42121215|FG003|Overall Study|Withdrawal by Subject|3|||
19673333|NCT03683576|42121212|FG000|Overall Study|Adverse Event|3|||
19673334|NCT03683576|42121213|FG001|Overall Study|Adverse Event|0|||
19673335|NCT03683576|42121214|FG002|Overall Study|Adverse Event|0|||
19673336|NCT03683576|42121215|FG003|Overall Study|Adverse Event|4|||
19673337|NCT03683576|42121212|FG000|Overall Study|Lack of Efficacy|1|||
19673338|NCT03683576|42121213|FG001|Overall Study|Lack of Efficacy|0|||
19673339|NCT03683576|42121214|FG002|Overall Study|Lack of Efficacy|1|||
19673340|NCT03683576|42121215|FG003|Overall Study|Lack of Efficacy|1|||
19673341|NCT03683576|42121212|FG000|Overall Study|Lost to Follow-up|0|||
19673342|NCT03683576|42121213|FG001|Overall Study|Lost to Follow-up|1|||
19673343|NCT03683576|42121214|FG002|Overall Study|Lost to Follow-up|2|||
19673344|NCT03683576|42121215|FG003|Overall Study|Lost to Follow-up|0|||
19673345|NCT03683576|42121212|FG000|Overall Study|Other, Not Specified|0|||
19673346|NCT03683576|42121213|FG001|Overall Study|Other, Not Specified|2|||
19673347|NCT03683576|42121214|FG002|Overall Study|Other, Not Specified|0|||
19673348|NCT03683576|42121215|FG003|Overall Study|Other, Not Specified|0|||
19673349|NCT03683576|42121212|FG000|Overall Study|Protocol Violation|0|||
19673350|NCT03683576|42121213|FG001|Overall Study|Protocol Violation|1|||
19673351|NCT03683576|42121214|FG002|Overall Study|Protocol Violation|1|||
19673352|NCT03683576|42121215|FG003|Overall Study|Protocol Violation|0|||
19673353|NCT03863834|42121225|FG000|Overall Study|Lost to Follow-up|3|||
19673354|NCT00430521|42121237|FG000|Overall Study|Adverse Event|0|||
19673355|NCT00430521|42121238|FG001|Overall Study|Adverse Event|0|||
19673356|NCT00430521|42121239|FG002|Overall Study|Adverse Event|0|||
19673357|NCT00430521|42121240|FG003|Overall Study|Adverse Event|0|||
19673358|NCT00430521|42121241|FG004|Overall Study|Adverse Event|0|||
19673359|NCT00430521|42121242|FG005|Overall Study|Adverse Event|2|||
19673360|NCT00430521|42121243|FG006|Overall Study|Adverse Event|1|||
19673361|NCT00430521|42121244|FG007|Overall Study|Adverse Event|0|||
19673362|NCT00430521|42121237|FG000|Overall Study|Lost to Follow-up|7|||
19758930|NCT02452554|42210126|FG002|Overall Study|Death|0|||
19673363|NCT00430521|42121238|FG001|Overall Study|Lost to Follow-up|8|||
19673364|NCT00430521|42121239|FG002|Overall Study|Lost to Follow-up|3|||
19673365|NCT00430521|42121240|FG003|Overall Study|Lost to Follow-up|5|||
19673366|NCT00430521|42121241|FG004|Overall Study|Lost to Follow-up|5|||
19673367|NCT00430521|42121242|FG005|Overall Study|Lost to Follow-up|2|||
19673368|NCT00430521|42121243|FG006|Overall Study|Lost to Follow-up|8|||
19673369|NCT00430521|42121244|FG007|Overall Study|Lost to Follow-up|10|||
19673370|NCT00430521|42121237|FG000|Overall Study|Pregnancy|0|||
19673371|NCT00430521|42121238|FG001|Overall Study|Pregnancy|0|||
19673372|NCT00430521|42121239|FG002|Overall Study|Pregnancy|0|||
19673373|NCT00430521|42121240|FG003|Overall Study|Pregnancy|0|||
19673374|NCT00430521|42121241|FG004|Overall Study|Pregnancy|0|||
19673375|NCT00430521|42121242|FG005|Overall Study|Pregnancy|0|||
19673376|NCT00430521|42121243|FG006|Overall Study|Pregnancy|1|||
19673377|NCT00430521|42121244|FG007|Overall Study|Pregnancy|0|||
19673378|NCT00430521|42121237|FG000|Overall Study|Vaccine Expired|0|||
19673379|NCT00430521|42121238|FG001|Overall Study|Vaccine Expired|0|||
19673380|NCT00430521|42121239|FG002|Overall Study|Vaccine Expired|0|||
19673381|NCT00430521|42121240|FG003|Overall Study|Vaccine Expired|0|||
19673382|NCT00430521|42121241|FG004|Overall Study|Vaccine Expired|0|||
19673383|NCT00430521|42121242|FG005|Overall Study|Vaccine Expired|1|||
19673384|NCT00430521|42121243|FG006|Overall Study|Vaccine Expired|0|||
19673385|NCT00430521|42121244|FG007|Overall Study|Vaccine Expired|0|||
19673386|NCT00430521|42121237|FG000|Overall Study|Protocol Violation|1|||
19673387|NCT00430521|42121238|FG001|Overall Study|Protocol Violation|0|||
19673388|NCT00430521|42121239|FG002|Overall Study|Protocol Violation|0|||
19673389|NCT00430521|42121240|FG003|Overall Study|Protocol Violation|0|||
19673390|NCT00430521|42121241|FG004|Overall Study|Protocol Violation|0|||
19673391|NCT00430521|42121242|FG005|Overall Study|Protocol Violation|0|||
19673392|NCT00430521|42121243|FG006|Overall Study|Protocol Violation|0|||
19673393|NCT00430521|42121244|FG007|Overall Study|Protocol Violation|0|||
19673394|NCT00430521|42121237|FG000|Overall Study|Withdrawal by Subject|3|||
19673395|NCT00430521|42121238|FG001|Overall Study|Withdrawal by Subject|1|||
19673396|NCT00430521|42121239|FG002|Overall Study|Withdrawal by Subject|0|||
19673397|NCT00430521|42121240|FG003|Overall Study|Withdrawal by Subject|3|||
19673398|NCT00430521|42121241|FG004|Overall Study|Withdrawal by Subject|0|||
19673399|NCT00430521|42121242|FG005|Overall Study|Withdrawal by Subject|0|||
19673400|NCT00430521|42121243|FG006|Overall Study|Withdrawal by Subject|0|||
19673401|NCT00430521|42121244|FG007|Overall Study|Withdrawal by Subject|2|||
19673402|NCT00429663|42121277|FG000|Overall Study|Lost to Follow-up|24|||
19673403|NCT00429663|42121278|FG001|Overall Study|Lost to Follow-up|31|||
19673404|NCT00429663|42121277|FG000|Overall Study|Physician Decision|6|||
19673405|NCT00429663|42121278|FG001|Overall Study|Physician Decision|3|||
19673406|NCT00429663|42121277|FG000|Overall Study|Withdrawal by Subject|2|||
19673407|NCT00429663|42121278|FG001|Overall Study|Withdrawal by Subject|5|||
19673408|NCT00429663|42121277|FG000|Overall Study|Death|4|||
19673409|NCT00429663|42121278|FG001|Overall Study|Death|0|||
19673410|NCT00429585|42121286|FG000|Overall Study|Death|1|||
19673411|NCT00429585|42121287|FG001|Overall Study|Death|0|||
19673412|NCT00429585|42121286|FG000|Overall Study|Lost to Follow-up|27|||
19673413|NCT00429585|42121287|FG001|Overall Study|Lost to Follow-up|20|||
19673414|NCT00429585|42121286|FG000|Overall Study|Physician Decision|2|||
19673415|NCT00429585|42121287|FG001|Overall Study|Physician Decision|0|||
19673416|NCT00440271|42121295|FG000|Overall Study|Protocol Violation|1|||
19673417|NCT00440271|42121296|FG001|Overall Study|Protocol Violation|1|||
19673418|NCT00440271|42121295|FG000|Overall Study|Adverse Event|0|||
19673419|NCT00440271|42121296|FG001|Overall Study|Adverse Event|1|||
19673420|NCT00440271|42121295|FG000|Overall Study|Lost to Follow-up|1|||
19673421|NCT00440271|42121296|FG001|Overall Study|Lost to Follow-up|0|||
19673422|NCT00440271|42121295|FG000|Overall Study|Withdrawal by Subject|0|||
19673423|NCT00440271|42121296|FG001|Overall Study|Withdrawal by Subject|2|||
19673424|NCT00440271|42121295|FG000|Overall Study|Lack of Efficacy|0|||
19673425|NCT00440271|42121296|FG001|Overall Study|Lack of Efficacy|1|||
19673426|NCT00440271|42121295|FG000|Overall Study|Due to closure of trial|8|||
19673427|NCT00440271|42121296|FG001|Overall Study|Due to closure of trial|10|||
19673428|NCT00440271|42121295|FG000|Overall Study|Other|2|||
19673429|NCT00440271|42121296|FG001|Overall Study|Other|0|||
19758931|NCT02452554|42210127|FG003|Overall Study|Death|0|||
19758932|NCT02452554|42210128|FG004|Overall Study|Death|0|||
19758933|NCT02452554|42210129|FG005|Overall Study|Death|0|||
19673430|NCT00346216|42121305|FG000|Overall Study|Other|181|||
19673431|NCT00346216|42121306|FG001|Overall Study|Other|231|||
19673432|NCT00346216|42121307|FG002|Overall Study|Other|205|||
19673433|NCT00346216|42121305|FG000|Overall Study|No longer willing to participate|600|||
19673434|NCT00346216|42121306|FG001|Overall Study|No longer willing to participate|606|||
19673435|NCT00346216|42121307|FG002|Overall Study|No longer willing to participate|585|||
19673436|NCT00346216|42121305|FG000|Overall Study|Withdrawal by Subject|661|||
19673437|NCT00346216|42121306|FG001|Overall Study|Withdrawal by Subject|692|||
19673438|NCT00346216|42121307|FG002|Overall Study|Withdrawal by Subject|651|||
19673439|NCT00346216|42121305|FG000|Overall Study|Lost to Follow-up|611|||
19758934|NCT02452554|42210124|FG000|Overall Study|Lack of Efficacy|13|||
19673440|NCT00346216|42121306|FG001|Overall Study|Lost to Follow-up|588|||
19673441|NCT00346216|42121307|FG002|Overall Study|Lost to Follow-up|542|||
19673442|NCT00346216|42121305|FG000|Overall Study|Physician Decision|80|||
19673443|NCT00346216|42121306|FG001|Overall Study|Physician Decision|76|||
19673444|NCT00346216|42121307|FG002|Overall Study|Physician Decision|59|||
19673445|NCT00346216|42121305|FG000|Overall Study|Does not meet entrance criteria|13|||
19758935|NCT02452554|42210125|FG001|Overall Study|Lack of Efficacy|14|||
19673446|NCT00346216|42121306|FG001|Overall Study|Does not meet entrance criteria|10|||
19673447|NCT00346216|42121307|FG002|Overall Study|Does not meet entrance criteria|8|||
19673448|NCT00346216|42121305|FG000|Overall Study|Death|189|||
19673449|NCT00346216|42121306|FG001|Overall Study|Death|192|||
19673450|NCT00346216|42121307|FG002|Overall Study|Death|228|||
19758936|NCT02452554|42210126|FG002|Overall Study|Lack of Efficacy|9|||
19673451|NCT00346216|42121305|FG000|Overall Study|Study terminated by sponsor|11|||
19673452|NCT00346216|42121306|FG001|Overall Study|Study terminated by sponsor|4|||
19673453|NCT00346216|42121307|FG002|Overall Study|Study terminated by sponsor|8|||
19673454|NCT00346216|42121305|FG000|Overall Study|Missing Subject Summary Status|62|||
19673455|NCT00346216|42121306|FG001|Overall Study|Missing Subject Summary Status|61|||
19673456|NCT00346216|42121307|FG002|Overall Study|Missing Subject Summary Status|62|||
19673457|NCT00417963|42121315|FG000|Overall Study|Lost to Follow-up|3|||
19673458|NCT00417963|42121315|FG000|Overall Study|Withdrawal by Subject|18|||
19673459|NCT00417963|42121315|FG000|Overall Study|Death|17|||
19673460|NCT00417963|42121315|FG000|Overall Study|Study device could not be deployed|3|||
19673461|NCT00429273|42121327|FG000|Overall Study|Lost to Follow-up|1|||
19673462|NCT00429273|42121328|FG001|Overall Study|Lost to Follow-up|2|||
19673463|NCT00429273|42121329|FG002|Overall Study|Lost to Follow-up|2|||
19673464|NCT00429273|42121327|FG000|Overall Study|Physician Decision|6|||
19673465|NCT00429273|42121328|FG001|Overall Study|Physician Decision|5|||
19673466|NCT00429273|42121329|FG002|Overall Study|Physician Decision|5|||
19673467|NCT00429273|42121327|FG000|Overall Study|Adverse Event|1|||
19673468|NCT00429273|42121328|FG001|Overall Study|Adverse Event|1|||
19673469|NCT00429273|42121329|FG002|Overall Study|Adverse Event|2|||
19673470|NCT00359632|42121339|FG000|Overall Study|Death|2|||
19673471|NCT00359632|42121340|FG001|Overall Study|Death|0|||
19673472|NCT00359632|42121339|FG000|Overall Study|Adverse Event|1|||
19673473|NCT00359632|42121340|FG001|Overall Study|Adverse Event|0|||
19673474|NCT00359632|42121339|FG000|Overall Study|Non-compliance with visit schedule|1|||
19673475|NCT00359632|42121340|FG001|Overall Study|Non-compliance with visit schedule|0|||
19673476|NCT00417885|42121346|FG000|Overall Study|Adverse Event|1|||
19673477|NCT00417885|42121346|FG000|Overall Study|Objective Progression or Relapse|3|||
19673478|NCT00417885|42121346|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
19673479|NCT04488770|42121363|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673480|NCT04488770|42121364|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673481|NCT04488770|42121365|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673482|NCT04488770|42121366|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
19673483|NCT04488770|42121367|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673484|NCT04488770|42121368|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673485|NCT04488770|42121369|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673486|NCT04488770|42121370|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673487|NCT04488770|42121371|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673488|NCT04488770|42121372|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673489|NCT04488770|42121373|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673490|NCT04488770|42121374|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673491|NCT04488770|42121375|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
19673492|NCT04488770|42121363|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
19673493|NCT04488770|42121364|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673494|NCT04488770|42121365|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673495|NCT04488770|42121366|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673496|NCT04488770|42121367|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673497|NCT04488770|42121368|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673498|NCT04488770|42121369|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673499|NCT04488770|42121370|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673500|NCT04488770|42121371|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673501|NCT04488770|42121372|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673502|NCT04488770|42121373|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673503|NCT04488770|42121374|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673504|NCT04488770|42121375|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
19673505|NCT04488770|42121363|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673506|NCT04488770|42121364|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673507|NCT04488770|42121365|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19758937|NCT02452554|42210127|FG003|Overall Study|Lack of Efficacy|1|||
19673508|NCT04488770|42121366|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673509|NCT04488770|42121367|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673510|NCT04488770|42121368|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
19673511|NCT04488770|42121369|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
19673512|NCT04488770|42121370|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673513|NCT04488770|42121371|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673514|NCT04488770|42121372|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673515|NCT04488770|42121373|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673516|NCT04488770|42121374|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673517|NCT04488770|42121375|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19673518|NCT04488770|42121363|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673519|NCT04488770|42121364|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673520|NCT04488770|42121365|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673521|NCT04488770|42121366|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673522|NCT04488770|42121367|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
19673523|NCT04488770|42121368|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673524|NCT04488770|42121369|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673525|NCT04488770|42121370|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673526|NCT04488770|42121371|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673527|NCT04488770|42121372|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673528|NCT04488770|42121373|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673529|NCT04488770|42121374|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673530|NCT04488770|42121375|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
19673531|NCT00525044|42121421|FG000|Overall Study|Lost to Follow-up|0|||
19673532|NCT00525044|42121422|FG001|Overall Study|Lost to Follow-up|1|||
19673533|NCT00355342|42121430|FG000|Overall Study|Adverse Event|13|||
19673534|NCT00355342|42121431|FG001|Overall Study|Adverse Event|15|||
19673535|NCT00355342|42121430|FG000|Overall Study|Lost to Follow-up|4|||
19673536|NCT00355342|42121431|FG001|Overall Study|Lost to Follow-up|2|||
19673537|NCT00355342|42121430|FG000|Overall Study|Withdrawal by Subject|14|||
19673538|NCT00355342|42121431|FG001|Overall Study|Withdrawal by Subject|11|||
19673539|NCT00355342|42121430|FG000|Overall Study|Sponsor terminated study|2|||
19673540|NCT00355342|42121431|FG001|Overall Study|Sponsor terminated study|2|||
19673541|NCT00355342|42121430|FG000|Overall Study|Overcompliant-PI discretion|1|||
19673542|NCT00355342|42121431|FG001|Overall Study|Overcompliant-PI discretion|0|||
19673543|NCT00355342|42121430|FG000|Overall Study|Use of prohibited medication|1|||
19673544|NCT00355342|42121431|FG001|Overall Study|Use of prohibited medication|0|||
19673545|NCT00355342|42121430|FG000|Overall Study|COPD exacerbation|1|||
19673546|NCT00355342|42121431|FG001|Overall Study|COPD exacerbation|1|||
19673547|NCT00355342|42121430|FG000|Overall Study|Dispensed wrong study drug kit|1|||
19673548|NCT00355342|42121431|FG001|Overall Study|Dispensed wrong study drug kit|0|||
19673549|NCT00355342|42121430|FG000|Overall Study|Non-compliance with Dexa scans|1|||
19673550|NCT00355342|42121431|FG001|Overall Study|Non-compliance with Dexa scans|0|||
19673551|NCT00355342|42121430|FG000|Overall Study|Withdrawal by participant and physician|1|||
19673552|NCT00355342|42121431|FG001|Overall Study|Withdrawal by participant and physician|0|||
19673553|NCT00355342|42121430|FG000|Overall Study|Participant relocated|0|||
19673554|NCT00355342|42121431|FG001|Overall Study|Participant relocated|1|||
19673555|NCT00355342|42121430|FG000|Overall Study|Participant discontinued study drug|0|||
19673556|NCT00355342|42121431|FG001|Overall Study|Participant discontinued study drug|1|||
19673557|NCT00355342|42121430|FG000|Overall Study|Study management|0|||
19673558|NCT00355342|42121431|FG001|Overall Study|Study management|1|||
19673559|NCT00355342|42121430|FG000|Overall Study|Protocol Violation|0|||
19673560|NCT00355342|42121431|FG001|Overall Study|Protocol Violation|1|||
19673561|NCT00355342|42121430|FG000|Overall Study|Use of protocol excluded medication|0|||
19673562|NCT00355342|42121431|FG001|Overall Study|Use of protocol excluded medication|1|||
19673563|NCT01573754|42121439|FG000|Overall Study|Noncompliance or remission not achieved|3|||
19758938|NCT02452554|42210128|FG004|Overall Study|Lack of Efficacy|5|||
19758939|NCT02452554|42210129|FG005|Overall Study|Lack of Efficacy|8|||
19673564|NCT01573754|42121440|FG001|Overall Study|Noncompliance or remission not achieved|15|||
19673565|NCT00355264|42121446|FG000|Extension (Variable Duration)|Adverse Event|1|||
19673566|NCT00355264|42121446|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
19673567|NCT00355030|42121457|FG000|Study Period 1 Treatment|Adverse Event|1|||
19673568|NCT00355030|42121458|FG001|Study Period 1 Treatment|Adverse Event|1|||
19758940|NCT02452554|42210124|FG000|Overall Study|Physician Decision|0|||
19673569|NCT00355030|42121457|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
19673570|NCT00355030|42121458|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
19673571|NCT00355030|42121457|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
19673572|NCT00355030|42121458|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
19673573|NCT00355030|42121457|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
19673574|NCT00355030|42121458|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
19673575|NCT00355030|42121457|FG000|Study Period 1 Treatment|Physician Decision|0|||
19673576|NCT00355030|42121458|FG001|Study Period 1 Treatment|Physician Decision|1|||
19673577|NCT00355030|42121457|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
19673578|NCT00355030|42121458|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
19673579|NCT00355030|42121457|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
19673580|NCT00355030|42121458|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
19673581|NCT00355030|42121457|FG000|Study Period 1 Treatment|Other|2|||
19673582|NCT00355030|42121458|FG001|Study Period 1 Treatment|Other|6|||
19673583|NCT00355030|42121457|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
19673584|NCT00355030|42121458|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
19673585|NCT00355030|42121457|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
19673586|NCT00355030|42121458|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
19673587|NCT00354172|42121464|FG000|Overall Study|Did not receive transplant|1|||
19673588|NCT00345592|42121470|FG000|Overall Study|Death|14|||
19673589|NCT00345592|42121471|FG001|Overall Study|Death|16|||
19673590|NCT00345592|42121470|FG000|Overall Study|Withdrawal by Subject|11|||
19673591|NCT00345592|42121471|FG001|Overall Study|Withdrawal by Subject|8|||
19673592|NCT00353704|42121479|FG000|Overall Study|Protocol Violation|3|||
19673593|NCT00353704|42121480|FG001|Overall Study|Protocol Violation|1|||
19673594|NCT00512252|42121489|FG000|Overall Study|Lost to Follow-up|0|||
19673595|NCT00512252|42121490|FG001|Overall Study|Lost to Follow-up|0|||
19673596|NCT00512252|42121491|FG002|Overall Study|Lost to Follow-up|1|||
19673597|NCT00512252|42121489|FG000|Overall Study|Protocol Violation|0|||
19673598|NCT00512252|42121490|FG001|Overall Study|Protocol Violation|0|||
19673599|NCT00512252|42121491|FG002|Overall Study|Protocol Violation|1|||
19673600|NCT00512252|42121489|FG000|Overall Study|Death|0|||
19673601|NCT00512252|42121490|FG001|Overall Study|Death|0|||
19673602|NCT00512252|42121491|FG002|Overall Study|Death|1|||
19673603|NCT00516386|42121506|FG000|Overall Study|not interested in the study|4|||
19673604|NCT00516386|42121506|FG000|Overall Study|Lost to Follow-up|2|||
19673605|NCT00524420|42121512|FG000|Overall Study|Lack of Efficacy|1|||
19673606|NCT00524420|42121513|FG001|Overall Study|Lack of Efficacy|0|||
19673607|NCT00512096|42121521|FG000|Overall Study|Adverse Event|2|||
19673608|NCT00512096|42121521|FG000|Overall Study|Withdrawal by Subject|2|||
19673609|NCT00512096|42121521|FG000|Overall Study|Lack of Efficacy|3|||
19673610|NCT00524030|42121527|FG000|Overall Study|Lack of Efficacy|10|||
19673611|NCT00524030|42121528|FG001|Overall Study|Lack of Efficacy|24|||
19673612|NCT00524030|42121527|FG000|Overall Study|Lost to Follow-up|0|||
19673613|NCT00524030|42121528|FG001|Overall Study|Lost to Follow-up|2|||
19673614|NCT00524030|42121527|FG000|Overall Study|Withdrawal by Subject|3|||
19673615|NCT00524030|42121528|FG001|Overall Study|Withdrawal by Subject|8|||
19673616|NCT00524030|42121527|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
19673617|NCT00524030|42121528|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
19673618|NCT00524030|42121527|FG000|Overall Study|Protocol Violation|0|||
19673619|NCT00524030|42121528|FG001|Overall Study|Protocol Violation|1|||
19673620|NCT00524030|42121527|FG000|Overall Study|Pregnancy|1|||
19673621|NCT00524030|42121528|FG001|Overall Study|Pregnancy|0|||
19673622|NCT00524030|42121527|FG000|Overall Study|Adverse Event|3|||
19673623|NCT00524030|42121528|FG001|Overall Study|Adverse Event|21|||
19673624|NCT00524030|42121527|FG000|Overall Study|Death|0|||
19673625|NCT00524030|42121528|FG001|Overall Study|Death|1|||
19673626|NCT00523718|42121537|FG000|Overall Study|Withdrawal by Subject|1|||
19673627|NCT00523718|42121538|FG001|Overall Study|Withdrawal by Subject|0|||
19673628|NCT00523718|42121537|FG000|Overall Study|Protocol Violation|2|||
19673629|NCT00523718|42121538|FG001|Overall Study|Protocol Violation|0|||
19673630|NCT00523640|42121544|FG000|Overall Study|Death|1|||
19673631|NCT00345358|42121552|FG000|Primary Vaccination Phase|Other|0|||
19673632|NCT00345358|42121553|FG001|Primary Vaccination Phase|Other|1|||
19673633|NCT00345358|42121554|FG002|Primary Vaccination Phase|Other|1|||
19673634|NCT00345358|42121555|FG003|Primary Vaccination Phase|Other|0|||
19673635|NCT00345358|42121552|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
19673636|NCT00345358|42121553|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
19673637|NCT00345358|42121554|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
19673638|NCT00345358|42121555|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
19758941|NCT02452554|42210125|FG001|Overall Study|Physician Decision|1|||
19673639|NCT00345358|42121552|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
19673640|NCT00345358|42121553|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
19673641|NCT00345358|42121554|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
19673642|NCT00345358|42121555|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
19673643|NCT00345358|42121552|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
19673644|NCT00345358|42121553|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
19673645|NCT00345358|42121554|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
19673646|NCT00345358|42121555|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
19673647|NCT00345358|42121552|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
19673648|NCT00345358|42121553|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
19673649|NCT00345358|42121554|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
19673650|NCT00345358|42121555|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
19673651|NCT00345358|42121552|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
19673652|NCT00345358|42121553|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
19673653|NCT00345358|42121554|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
19673654|NCT00345358|42121555|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
19673655|NCT03869684|42121568|FG000|Overall Study|Adverse Event|0|||
19673656|NCT03869684|42121569|FG001|Overall Study|Adverse Event|3|||
19673657|NCT03869684|42121570|FG002|Overall Study|Adverse Event|1|||
19673658|NCT03869684|42121568|FG000|Overall Study|Withdrawal by Subject|1|||
19673659|NCT03869684|42121569|FG001|Overall Study|Withdrawal by Subject|0|||
19673660|NCT03869684|42121570|FG002|Overall Study|Withdrawal by Subject|0|||
19673661|NCT03869684|42121568|FG000|Overall Study|Lost to Follow-up|1|||
19673662|NCT03869684|42121569|FG001|Overall Study|Lost to Follow-up|0|||
19673663|NCT03869684|42121570|FG002|Overall Study|Lost to Follow-up|0|||
19673664|NCT03869684|42121568|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
19673665|NCT03869684|42121569|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
19673666|NCT03869684|42121570|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
19673667|NCT00516074|42121580|FG000|Overall Study|Adverse Event|0|||
19673668|NCT00516074|42121581|FG001|Overall Study|Adverse Event|1|||
19673669|NCT00516074|42121580|FG000|Overall Study|Subject Decision|4|||
19673670|NCT00516074|42121581|FG001|Overall Study|Subject Decision|2|||
19673671|NCT00516074|42121580|FG000|Overall Study|Loss of Glucose Control|2|||
19673672|NCT00516074|42121581|FG001|Overall Study|Loss of Glucose Control|0|||
19673673|NCT00515294|42121591|FG000|Overall Study|Lost to Follow-up|3|||
19673674|NCT00515294|42121592|FG001|Overall Study|Lost to Follow-up|2|||
19673675|NCT00515294|42121593|FG002|Overall Study|Lost to Follow-up|3|||
19673676|NCT00515294|42121594|FG003|Overall Study|Lost to Follow-up|1|||
19673677|NCT00515294|42121591|FG000|Overall Study|Driver simulator problems|1|||
19673678|NCT00515294|42121592|FG001|Overall Study|Driver simulator problems|1|||
19673679|NCT00515294|42121593|FG002|Overall Study|Driver simulator problems|1|||
19673680|NCT00515294|42121594|FG003|Overall Study|Driver simulator problems|3|||
19673681|NCT00515294|42121591|FG000|Overall Study|Caffeine amount inaccurate|5|||
19673682|NCT00515294|42121592|FG001|Overall Study|Caffeine amount inaccurate|0|||
19673683|NCT00515294|42121593|FG002|Overall Study|Caffeine amount inaccurate|7|||
19673684|NCT00515294|42121594|FG003|Overall Study|Caffeine amount inaccurate|0|||
19673685|NCT00345046|42121607|FG000|Overall Study|Protocol Violation|1|||
19673686|NCT00345046|42121608|FG001|Overall Study|Protocol Violation|1|||
19673687|NCT00345046|42121609|FG002|Overall Study|Protocol Violation|2|||
19673688|NCT00515216|42121617|FG000|Overall Study|Withdrawal by Subject|1|||
19673689|NCT01004978|42121624|FG000|Overall Study|Disease progression|31|||
19673690|NCT01004978|42121625|FG001|Overall Study|Disease progression|48|||
19673691|NCT01004978|42121624|FG000|Overall Study|Adverse Event|42|||
19673692|NCT01004978|42121625|FG001|Overall Study|Adverse Event|22|||
19673693|NCT01004978|42121624|FG000|Overall Study|Death|3|||
19673694|NCT01004978|42121625|FG001|Overall Study|Death|2|||
19673695|NCT01004978|42121624|FG000|Overall Study|Withdrawal by Subject|16|||
19673696|NCT01004978|42121625|FG001|Overall Study|Withdrawal by Subject|16|||
19673697|NCT01004978|42121624|FG000|Overall Study|Alternative therapy|4|||
19673698|NCT01004978|42121625|FG001|Overall Study|Alternative therapy|8|||
19673699|NCT01004978|42121624|FG000|Overall Study|Physician Decision|6|||
19673700|NCT01004978|42121625|FG001|Overall Study|Physician Decision|3|||
19673701|NCT01004978|42121624|FG000|Overall Study|Other complicating disease|2|||
19673702|NCT01004978|42121625|FG001|Overall Study|Other complicating disease|2|||
19673703|NCT01004978|42121624|FG000|Overall Study|Protocol Violation|2|||
19673704|NCT01004978|42121625|FG001|Overall Study|Protocol Violation|3|||
19673705|NCT01004978|42121624|FG000|Overall Study|Non-compliance|3|||
19673706|NCT01004978|42121625|FG001|Overall Study|Non-compliance|2|||
19673707|NCT01004978|42121624|FG000|Overall Study|Ineligible|1|||
19673708|NCT01004978|42121625|FG001|Overall Study|Ineligible|0|||
19673709|NCT01004978|42121624|FG000|Overall Study|Unblinded|0|||
19673710|NCT01004978|42121625|FG001|Overall Study|Unblinded|1|||
19673711|NCT01004978|42121624|FG000|Overall Study|Performance status worsening|0|||
19673712|NCT01004978|42121625|FG001|Overall Study|Performance status worsening|1|||
19673713|NCT01004978|42121624|FG000|Overall Study|Never started treatment|8|||
19673714|NCT01004978|42121625|FG001|Overall Study|Never started treatment|9|||
19673715|NCT00522626|42121631|FG000|Overall Study|Lost to Follow-up|7|||
19673716|NCT00440193|42121637|FG000|Treatment Period|Adverse Event|74|||
19673717|NCT00440193|42121638|FG001|Treatment Period|Adverse Event|67|||
19673718|NCT00440193|42121637|FG000|Treatment Period|Death|19|||
19673719|NCT00440193|42121638|FG001|Treatment Period|Death|22|||
19673720|NCT00440193|42121637|FG000|Treatment Period|Lack of Efficacy|0|||
19673721|NCT00440193|42121638|FG001|Treatment Period|Lack of Efficacy|1|||
19673722|NCT00440193|42121637|FG000|Treatment Period|Lost to Follow-up|12|||
19673723|NCT00440193|42121638|FG001|Treatment Period|Lost to Follow-up|18|||
19673724|NCT00440193|42121637|FG000|Treatment Period|Physician Decision|3|||
19673725|NCT00440193|42121638|FG001|Treatment Period|Physician Decision|6|||
19673726|NCT00440193|42121637|FG000|Treatment Period|Protocol Violation|16|||
19673727|NCT00440193|42121638|FG001|Treatment Period|Protocol Violation|19|||
19673728|NCT00440193|42121637|FG000|Treatment Period|Withdrawal by Subject|36|||
19673729|NCT00440193|42121638|FG001|Treatment Period|Withdrawal by Subject|77|||
19673730|NCT00440193|42121637|FG000|Treatment Period|Clinical endpoint reached|28|||
19673731|NCT00440193|42121638|FG001|Treatment Period|Clinical endpoint reached|25|||
19673732|NCT00440193|42121637|FG000|Treatment Period|Study terminated by sponsor|102|||
19673733|NCT00440193|42121638|FG001|Treatment Period|Study terminated by sponsor|94|||
19673734|NCT00440193|42121637|FG000|Treatment Period|Protocol driven decision point|2|||
19673735|NCT00440193|42121638|FG001|Treatment Period|Protocol driven decision point|2|||
19673736|NCT00440193|42121637|FG000|Treatment Period|Switch to commercial drug|0|||
19673737|NCT00440193|42121638|FG001|Treatment Period|Switch to commercial drug|2|||
19673738|NCT00440193|42121637|FG000|Treatment Period|Technical problems|1|||
19673739|NCT00440193|42121638|FG001|Treatment Period|Technical problems|1|||
19673740|NCT00440193|42121637|FG000|Treatment Period|Participant convenience|5|||
19673741|NCT00440193|42121638|FG001|Treatment Period|Participant convenience|2|||
19673742|NCT00440193|42121637|FG000|Treatment Period|Participant did not receive treatment|7|||
19673743|NCT00440193|42121638|FG001|Treatment Period|Participant did not receive treatment|13|||
19673744|NCT00440193|42121637|FG000|Treatment Period|Site closed by investigator|0|||
19673745|NCT00440193|42121638|FG001|Treatment Period|Site closed by investigator|2|||
19673746|NCT00440193|42121637|FG000|Observational Period|Adverse Event|2|||
19673747|NCT00440193|42121638|FG001|Observational Period|Adverse Event|2|||
19673748|NCT00440193|42121637|FG000|Observational Period|Death|15|||
19673749|NCT00440193|42121638|FG001|Observational Period|Death|20|||
19673750|NCT00440193|42121637|FG000|Observational Period|Lost to Follow-up|12|||
19673751|NCT00440193|42121638|FG001|Observational Period|Lost to Follow-up|8|||
19673752|NCT00440193|42121637|FG000|Observational Period|Protocol Violation|1|||
19673753|NCT00440193|42121638|FG001|Observational Period|Protocol Violation|0|||
19673754|NCT00440193|42121637|FG000|Observational Period|Withdrawal by Subject|11|||
19673755|NCT00440193|42121638|FG001|Observational Period|Withdrawal by Subject|8|||
19673756|NCT00440193|42121637|FG000|Observational Period|Physician Decision|1|||
19673757|NCT00440193|42121638|FG001|Observational Period|Physician Decision|0|||
19673758|NCT00440193|42121637|FG000|Observational Period|Clinical endpoint reached|1|||
19673759|NCT00440193|42121638|FG001|Observational Period|Clinical endpoint reached|0|||
19673760|NCT00440193|42121637|FG000|Observational Period|Participant convenience|2|||
19673761|NCT00440193|42121638|FG001|Observational Period|Participant convenience|0|||
19673762|NCT00511472|42121646|FG000|Overall Study|Clinical Adverse Event|1|||
19673763|NCT00511472|42121647|FG001|Overall Study|Clinical Adverse Event|2|||
19673764|NCT00511472|42121646|FG000|Overall Study|Laboratory Adverse Event|0|||
19673765|NCT00511472|42121647|FG001|Overall Study|Laboratory Adverse Event|2|||
19673766|NCT00511472|42121646|FG000|Overall Study|Not reported|2|||
19673767|NCT00511472|42121647|FG001|Overall Study|Not reported|2|||
19673768|NCT00514904|42121664|FG000|Overall Study|Withdrawal by Subject|3|||
19673769|NCT00514904|42121665|FG001|Overall Study|Withdrawal by Subject|2|||
19673770|NCT00514904|42121664|FG000|Overall Study|Lost to Follow-up|21|||
19673771|NCT00514904|42121665|FG001|Overall Study|Lost to Follow-up|3|||
19673772|NCT00440115|42121674|FG000|Overall Study|Death|7|||
19673773|NCT00440115|42121675|FG001|Overall Study|Death|9|||
19673774|NCT00440115|42121676|FG002|Overall Study|Death|5|||
19673775|NCT00440115|42121674|FG000|Overall Study|Incarceration|0|||
19673776|NCT00440115|42121675|FG001|Overall Study|Incarceration|2|||
19673777|NCT00440115|42121676|FG002|Overall Study|Incarceration|1|||
19673778|NCT00440037|42121684|FG000|Overall Study|Withdrawal by Subject|6|||
19673779|NCT00440037|42121684|FG000|Overall Study|Administrative decision|3|||
19673780|NCT00417027|42121691|FG000|Overall Study|Protocol Violation|0|||
19673781|NCT00417027|42121692|FG001|Overall Study|Protocol Violation|5|||
19673782|NCT00417027|42121693|FG002|Overall Study|Protocol Violation|5|||
19673783|NCT00416949|42121701|FG000|Overall Study|Patients refused to participate|5|||
19673784|NCT00416715|42121705|FG000|Overall Study|Not evaluable for joint aches|7|||
19673785|NCT00416715|42121705|FG000|Overall Study|Vitamin D levels not evaluable|8|||
19673786|NCT00406029|42121717|FG000|Overall Study|Adverse Event|12|||
19673787|NCT00406029|42121718|FG001|Overall Study|Adverse Event|2|||
19673788|NCT00406029|42121719|FG002|Overall Study|Adverse Event|5|||
19673789|NCT00406029|42121720|FG003|Overall Study|Adverse Event|10|||
19673790|NCT00406029|42121721|FG004|Overall Study|Adverse Event|7|||
19673791|NCT00406029|42121717|FG000|Overall Study|Withdrawal by Subject|3|||
19673792|NCT00406029|42121718|FG001|Overall Study|Withdrawal by Subject|4|||
19673793|NCT00406029|42121719|FG002|Overall Study|Withdrawal by Subject|2|||
19673794|NCT00406029|42121720|FG003|Overall Study|Withdrawal by Subject|2|||
19673795|NCT00406029|42121721|FG004|Overall Study|Withdrawal by Subject|0|||
19673796|NCT00406029|42121717|FG000|Overall Study|Protocol Violation|1|||
19673797|NCT00406029|42121718|FG001|Overall Study|Protocol Violation|2|||
19673798|NCT00406029|42121719|FG002|Overall Study|Protocol Violation|0|||
19673799|NCT00406029|42121720|FG003|Overall Study|Protocol Violation|2|||
19673800|NCT00406029|42121721|FG004|Overall Study|Protocol Violation|0|||
19673801|NCT00406029|42121717|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
19673802|NCT00406029|42121718|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
19673803|NCT00406029|42121719|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
19673804|NCT00406029|42121720|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
19673805|NCT00406029|42121721|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
19673806|NCT00406029|42121717|FG000|Overall Study|Randomized in Error|0|||
19673807|NCT00406029|42121718|FG001|Overall Study|Randomized in Error|0|||
19673808|NCT00406029|42121719|FG002|Overall Study|Randomized in Error|2|||
19673809|NCT00406029|42121720|FG003|Overall Study|Randomized in Error|3|||
19673810|NCT00406029|42121721|FG004|Overall Study|Randomized in Error|1|||
19673811|NCT00514514|42121736|FG000|Pre-phase|Death|10|||
19673812|NCT00514514|42121737|FG001|Pre-phase|Death|0|||
19673813|NCT00514514|42121738|FG002|Pre-phase|Death|0|||
19673814|NCT00514514|42121736|FG000|Pre-phase|administrative problems|2|||
19673815|NCT00514514|42121737|FG001|Pre-phase|administrative problems|0|||
19673816|NCT00514514|42121738|FG002|Pre-phase|administrative problems|0|||
19673817|NCT00514514|42121736|FG000|Pre-phase|Protocol Violation|6|||
19673818|NCT00514514|42121737|FG001|Pre-phase|Protocol Violation|0|||
19673819|NCT00514514|42121738|FG002|Pre-phase|Protocol Violation|0|||
19673820|NCT00514514|42121736|FG000|Pre-phase|condition no longer requires study drug|7|||
19673821|NCT00514514|42121737|FG001|Pre-phase|condition no longer requires study drug|0|||
19673822|NCT00514514|42121738|FG002|Pre-phase|condition no longer requires study drug|0|||
19673823|NCT00514514|42121736|FG000|Pre-phase|abnormal test procedure results|15|||
19673824|NCT00514514|42121737|FG001|Pre-phase|abnormal test procedure results|0|||
19673825|NCT00514514|42121738|FG002|Pre-phase|abnormal test procedure results|0|||
19673826|NCT00514514|42121736|FG000|Pre-phase|Lost to Follow-up|2|||
19673827|NCT00514514|42121737|FG001|Pre-phase|Lost to Follow-up|0|||
19673828|NCT00514514|42121738|FG002|Pre-phase|Lost to Follow-up|0|||
19673829|NCT00514514|42121736|FG000|Pre-phase|abnormal lab values|23|||
19673830|NCT00514514|42121737|FG001|Pre-phase|abnormal lab values|0|||
19673831|NCT00514514|42121738|FG002|Pre-phase|abnormal lab values|0|||
19673832|NCT00514514|42121736|FG000|Pre-phase|Lack of Efficacy|35|||
19673833|NCT00514514|42121737|FG001|Pre-phase|Lack of Efficacy|0|||
19673834|NCT00514514|42121738|FG002|Pre-phase|Lack of Efficacy|0|||
19673835|NCT00514514|42121736|FG000|Pre-phase|Adverse Event|137|||
19673836|NCT00514514|42121737|FG001|Pre-phase|Adverse Event|0|||
19673837|NCT00514514|42121738|FG002|Pre-phase|Adverse Event|0|||
19673838|NCT00514514|42121736|FG000|Pre-phase|Withdrawal by Subject|66|||
19673839|NCT00514514|42121737|FG001|Pre-phase|Withdrawal by Subject|0|||
19673840|NCT00514514|42121738|FG002|Pre-phase|Withdrawal by Subject|0|||
19673841|NCT00514514|42121736|FG000|Randomized - 9 Month|Death|3|||
19673842|NCT00514514|42121737|FG001|Randomized - 9 Month|Death|2|||
19673843|NCT00514514|42121738|FG002|Randomized - 9 Month|Death|2|||
19673844|NCT00514514|42121736|FG000|Randomized - 9 Month|Administrative problems|1|||
19673845|NCT00514514|42121737|FG001|Randomized - 9 Month|Administrative problems|1|||
19673846|NCT00514514|42121738|FG002|Randomized - 9 Month|Administrative problems|2|||
19673847|NCT00514514|42121736|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
19673848|NCT00514514|42121737|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
19673849|NCT00514514|42121738|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
19673850|NCT00514514|42121736|FG000|Randomized - 9 Month|Protocol Violation|1|||
19673851|NCT00514514|42121737|FG001|Randomized - 9 Month|Protocol Violation|1|||
19673852|NCT00514514|42121738|FG002|Randomized - 9 Month|Protocol Violation|0|||
19673853|NCT00514514|42121736|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
19673854|NCT00514514|42121737|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
19673855|NCT00514514|42121738|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
19673856|NCT00514514|42121736|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
19673857|NCT00514514|42121737|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
19673858|NCT00514514|42121738|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
19673859|NCT00514514|42121736|FG000|Randomized - 9 Month|Adverse Event|25|||
19673860|NCT00514514|42121737|FG001|Randomized - 9 Month|Adverse Event|44|||
19673861|NCT00514514|42121738|FG002|Randomized - 9 Month|Adverse Event|27|||
19673862|NCT00514514|42121736|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
19673863|NCT00514514|42121737|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
19673864|NCT00514514|42121738|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
19758942|NCT02452554|42210126|FG002|Overall Study|Physician Decision|0|||
19673865|NCT00514514|42121736|FG000|Extension - 4 Years|Lost to Follow-up|12|||
19758943|NCT02452554|42210127|FG003|Overall Study|Physician Decision|0|||
19758944|NCT02452554|42210128|FG004|Overall Study|Physician Decision|0|||
19758945|NCT02452554|42210129|FG005|Overall Study|Physician Decision|0|||
19758946|NCT02452554|42210124|FG000|Overall Study|Withdrawal by Subject|1|||
19758947|NCT02452554|42210125|FG001|Overall Study|Withdrawal by Subject|0|||
19758948|NCT02452554|42210126|FG002|Overall Study|Withdrawal by Subject|2|||
19673866|NCT00514514|42121737|FG001|Extension - 4 Years|Lost to Follow-up|10|||
19673867|NCT00514514|42121738|FG002|Extension - 4 Years|Lost to Follow-up|9|||
19673868|NCT00514514|42121736|FG000|Extension - 4 Years|Administrative problems|3|||
19673869|NCT00514514|42121737|FG001|Extension - 4 Years|Administrative problems|1|||
19673870|NCT00514514|42121738|FG002|Extension - 4 Years|Administrative problems|1|||
19673871|NCT00514514|42121736|FG000|Extension - 4 Years|Death|8|||
19673872|NCT00514514|42121737|FG001|Extension - 4 Years|Death|3|||
19673873|NCT00514514|42121738|FG002|Extension - 4 Years|Death|6|||
19673874|NCT00514514|42121736|FG000|Extension - 4 Years|Adverse Event|9|||
19673875|NCT00514514|42121737|FG001|Extension - 4 Years|Adverse Event|6|||
19673876|NCT00514514|42121738|FG002|Extension - 4 Years|Adverse Event|3|||
19673877|NCT00405639|42121748|FG000|Overall Study|Withdrawal by Subject|1|||
19673878|NCT00405639|42121749|FG001|Overall Study|Withdrawal by Subject|0|||
19673879|NCT00405639|42121748|FG000|Overall Study|Adverse Event|1|||
19673880|NCT00405639|42121749|FG001|Overall Study|Adverse Event|0|||
19673881|NCT00405639|42121748|FG000|Overall Study|Seizure prior to receiving BNP|1|||
19673882|NCT00405639|42121749|FG001|Overall Study|Seizure prior to receiving BNP|0|||
19673883|NCT00439725|42121757|FG000|Treatment Period|Withdrawal by Subject|22|||
19673884|NCT00439725|42121758|FG001|Treatment Period|Withdrawal by Subject|19|||
19673885|NCT00439725|42121757|FG000|Treatment Period|Study terminated by sponsor|156|||
19673886|NCT00439725|42121758|FG001|Treatment Period|Study terminated by sponsor|148|||
19673887|NCT00439725|42121757|FG000|Treatment Period|Site closed by investigator|1|||
19673888|NCT00439725|42121758|FG001|Treatment Period|Site closed by investigator|2|||
19673889|NCT00439725|42121757|FG000|Treatment Period|Adverse Event|39|||
19673890|NCT00439725|42121758|FG001|Treatment Period|Adverse Event|18|||
19673891|NCT00439725|42121757|FG000|Treatment Period|Physician Decision|1|||
19673892|NCT00439725|42121758|FG001|Treatment Period|Physician Decision|1|||
19673893|NCT00439725|42121757|FG000|Treatment Period|Protocol Violation|2|||
19673894|NCT00439725|42121758|FG001|Treatment Period|Protocol Violation|1|||
19673895|NCT00439725|42121757|FG000|Treatment Period|Clinical endpoint reached|6|||
19673896|NCT00439725|42121758|FG001|Treatment Period|Clinical endpoint reached|50|||
19673897|NCT00439725|42121757|FG000|Treatment Period|Technical problems|1|||
19673898|NCT00439725|42121758|FG001|Treatment Period|Technical problems|0|||
19673899|NCT00439725|42121757|FG000|Treatment Period|Lost to Follow-up|1|||
19673900|NCT00439725|42121758|FG001|Treatment Period|Lost to Follow-up|1|||
19673901|NCT00439725|42121757|FG000|Treatment Period|Participant convenience|1|||
19673902|NCT00439725|42121758|FG001|Treatment Period|Participant convenience|0|||
19673903|NCT00439725|42121757|FG000|Treatment Period|Protocol driven decision point|1|||
19673904|NCT00439725|42121758|FG001|Treatment Period|Protocol driven decision point|1|||
19673905|NCT00439725|42121757|FG000|Treatment Period|Death|1|||
19673906|NCT00439725|42121758|FG001|Treatment Period|Death|1|||
19758949|NCT02452554|42210127|FG003|Overall Study|Withdrawal by Subject|0|||
19673907|NCT00439725|42121757|FG000|Treatment Period|Participant did not receive treatment|4|||
19673908|NCT00439725|42121758|FG001|Treatment Period|Participant did not receive treatment|4|||
19673909|NCT00439725|42121757|FG000|Observational Period|Withdrawal by Subject|2|||
19673910|NCT00439725|42121758|FG001|Observational Period|Withdrawal by Subject|2|||
19673911|NCT00439725|42121757|FG000|Observational Period|Lost to Follow-up|0|||
19673912|NCT00439725|42121758|FG001|Observational Period|Lost to Follow-up|1|||
19673913|NCT00439725|42121757|FG000|Observational Period|Death|0|||
19673914|NCT00439725|42121758|FG001|Observational Period|Death|2|||
19673915|NCT00439725|42121757|FG000|Observational Period|Study termination by sponsor|1|||
19673916|NCT00439725|42121758|FG001|Observational Period|Study termination by sponsor|1|||
19673917|NCT00439725|42121757|FG000|Observational Period|Clinical endpoint reached|3|||
19673918|NCT00439725|42121758|FG001|Observational Period|Clinical endpoint reached|1|||
19673919|NCT00439725|42121757|FG000|Observational Period|Technical problems|1|||
19673920|NCT00439725|42121758|FG001|Observational Period|Technical problems|0|||
19673921|NCT00439725|42121757|FG000|Observational Period|Participant convenience|1|||
19673922|NCT00439725|42121758|FG001|Observational Period|Participant convenience|0|||
19673923|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Subject request|8|||
19673924|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Subject request|11|||
19673925|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
19673926|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
19673927|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
19673928|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
19673929|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
19673930|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
19673931|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
19673932|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
19673933|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
19673934|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
19673935|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Death|1|||
19673936|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Death|0|||
19758950|NCT02452554|42210128|FG004|Overall Study|Withdrawal by Subject|0|||
19673937|NCT00521586|42121766|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
19673938|NCT00521586|42121767|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
19673939|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
19673940|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
19673941|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
19673942|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
19673943|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
19673944|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
19673945|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
19673946|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
19673947|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
19673948|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
19673949|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
19673950|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
19673951|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
19673952|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
19673953|NCT00521586|42121766|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
19673954|NCT00521586|42121767|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
19673955|NCT00521586|42121766|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
19673956|NCT00521586|42121767|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
19673957|NCT00521586|42121766|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
19673958|NCT00521586|42121767|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
19673959|NCT00521586|42121766|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
19673960|NCT00521586|42121767|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
19389019|NCT02675231|41632564|FG002|Overall Study|On study treatment/follow up|23|||
19389020|NCT02675075|41632575|FG000|Overall Study|Lost to Follow-up|3|||
19389021|NCT02675075|41632576|FG001|Overall Study|Lost to Follow-up|0|||
19673961|NCT00515502|42121785|FG000|Treatment Period 1|Adverse Event|0|||
19389023|NCT02673515|41632590|FG000|Overall Study|Lack of motivation|2|||
19389024|NCT02673515|41632591|FG001|Overall Study|Lack of motivation|1|||
19389025|NCT02667275|41632599|FG000|Overall Study|Protocol Violation|11|||
19389026|NCT02667275|41632600|FG001|Overall Study|Protocol Violation|7|||
19673962|NCT00515502|42121786|FG001|Treatment Period 1|Adverse Event|0|||
19673963|NCT00515502|42121787|FG002|Treatment Period 1|Adverse Event|0|||
19673964|NCT00515502|42121788|FG003|Treatment Period 1|Adverse Event|0|||
19673965|NCT00515502|42121789|FG004|Treatment Period 1|Adverse Event|0|||
19673966|NCT00515502|42121790|FG005|Treatment Period 1|Adverse Event|0|||
19673967|NCT00515502|42121791|FG006|Treatment Period 1|Adverse Event|1|||
19673968|NCT00515502|42121792|FG007|Treatment Period 1|Adverse Event|0|||
19673969|NCT00515502|42121793|FG008|Treatment Period 1|Adverse Event|1|||
19673970|NCT00515502|42121794|FG009|Treatment Period 1|Adverse Event|0|||
19673971|NCT00515502|42121795|FG010|Treatment Period 1|Adverse Event|0|||
19673972|NCT00515502|42121796|FG011|Treatment Period 1|Adverse Event|1|||
19673973|NCT00515502|42121785|FG000|Treatment Period 2|Adverse Event|0|||
19673974|NCT00515502|42121786|FG001|Treatment Period 2|Adverse Event|1|||
19673975|NCT00515502|42121787|FG002|Treatment Period 2|Adverse Event|0|||
19673976|NCT00515502|42121788|FG003|Treatment Period 2|Adverse Event|0|||
19673977|NCT00515502|42121789|FG004|Treatment Period 2|Adverse Event|0|||
19673978|NCT00515502|42121790|FG005|Treatment Period 2|Adverse Event|0|||
19673979|NCT00515502|42121791|FG006|Treatment Period 2|Adverse Event|0|||
19673980|NCT00515502|42121792|FG007|Treatment Period 2|Adverse Event|0|||
19673981|NCT00515502|42121793|FG008|Treatment Period 2|Adverse Event|0|||
19673982|NCT00515502|42121794|FG009|Treatment Period 2|Adverse Event|0|||
19673983|NCT00515502|42121795|FG010|Treatment Period 2|Adverse Event|0|||
19673984|NCT00515502|42121796|FG011|Treatment Period 2|Adverse Event|0|||
19673985|NCT00439647|42121815|FG000|Overall Study|Withdrawal by Subject|25|||
19673986|NCT00439647|42121816|FG001|Overall Study|Withdrawal by Subject|22|||
19673987|NCT00439647|42121815|FG000|Overall Study|Death|15|||
19673988|NCT00439647|42121816|FG001|Overall Study|Death|18|||
19673989|NCT00439647|42121815|FG000|Overall Study|Adverse Event|11|||
19673990|NCT00439647|42121816|FG001|Overall Study|Adverse Event|11|||
19673991|NCT00439647|42121815|FG000|Overall Study|Lost to Follow-up|4|||
19673992|NCT00439647|42121816|FG001|Overall Study|Lost to Follow-up|12|||
19673993|NCT00439647|42121815|FG000|Overall Study|Protocol Violation|3|||
19673994|NCT00439647|42121816|FG001|Overall Study|Protocol Violation|4|||
19673995|NCT00439647|42121815|FG000|Overall Study|Lack of Efficacy|0|||
19673996|NCT00439647|42121816|FG001|Overall Study|Lack of Efficacy|4|||
19673997|NCT00515112|42121824|FG000|Overall Study|Death|0|||
19673998|NCT00515112|42121825|FG001|Overall Study|Death|1|||
19673999|NCT00515112|42121824|FG000|Overall Study|The study was terminated|3|||
19674000|NCT00515112|42121825|FG001|Overall Study|The study was terminated|2|||
19674001|NCT00404547|42121833|FG000|Overall Study|Adverse Event|39|||
19674002|NCT00404547|42121834|FG001|Overall Study|Adverse Event|6|||
19674003|NCT00404547|42121833|FG000|Overall Study|Withdrawal by Subject|19|||
19389027|NCT02667275|41632599|FG000|Overall Study|Lost to Follow-up|0|||
19389028|NCT02667275|41632600|FG001|Overall Study|Lost to Follow-up|2|||
19389029|NCT02667275|41632599|FG000|Overall Study|Withdrawal by Subject|0|||
19389030|NCT02667275|41632600|FG001|Overall Study|Withdrawal by Subject|5|||
19389031|NCT02667275|41632599|FG000|Overall Study|Discontinued early without completing|0|||
19389032|NCT02667275|41632600|FG001|Overall Study|Discontinued early without completing|1|||
19389033|NCT02672423|41632609|FG000|Period 1|Adverse Event|0|||
19389034|NCT02672423|41632610|FG001|Period 1|Adverse Event|0|||
19389035|NCT02672423|41632611|FG002|Period 1|Adverse Event|0|||
19674004|NCT00404547|42121834|FG001|Overall Study|Withdrawal by Subject|2|||
19674005|NCT00404547|42121833|FG000|Overall Study|Protocol Violation|0|||
19674006|NCT00404547|42121834|FG001|Overall Study|Protocol Violation|1|||
19674007|NCT00404547|42121833|FG000|Overall Study|Lost to Follow-up|20|||
19674008|NCT00404547|42121834|FG001|Overall Study|Lost to Follow-up|9|||
19674009|NCT00404547|42121833|FG000|Overall Study|Lack of compliance|5|||
19674010|NCT00404547|42121834|FG001|Overall Study|Lack of compliance|1|||
19674011|NCT00404547|42121833|FG000|Overall Study|Other|4|||
19674012|NCT00404547|42121834|FG001|Overall Study|Other|0|||
19674013|NCT00404547|42121833|FG000|Overall Study|Reason not stated|3|||
19674014|NCT00404547|42121834|FG001|Overall Study|Reason not stated|6|||
19674015|NCT00515034|42121844|FG000|Overall Study|Adverse Event|2|||
19674016|NCT00515034|42121845|FG001|Overall Study|Adverse Event|0|||
19674017|NCT00515034|42121846|FG002|Overall Study|Adverse Event|1|||
19674018|NCT00515034|42121847|FG003|Overall Study|Adverse Event|0|||
19674019|NCT00515034|42121844|FG000|Overall Study|Death|4|||
19758951|NCT02452554|42210129|FG005|Overall Study|Withdrawal by Subject|1|||
19758952|NCT02452554|42210124|FG000|Overall Study|Ineligible|0|||
19758953|NCT02452554|42210125|FG001|Overall Study|Ineligible|1|||
19674020|NCT00515034|42121845|FG001|Overall Study|Death|2|||
19674021|NCT00515034|42121846|FG002|Overall Study|Death|1|||
19674022|NCT00515034|42121847|FG003|Overall Study|Death|3|||
19758954|NCT02452554|42210126|FG002|Overall Study|Ineligible|0|||
19603812|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
19603813|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
19674023|NCT00515034|42121844|FG000|Overall Study|Withdrawal by Subject|1|||
19674024|NCT00515034|42121845|FG001|Overall Study|Withdrawal by Subject|0|||
19674025|NCT00515034|42121846|FG002|Overall Study|Withdrawal by Subject|3|||
19674026|NCT00515034|42121847|FG003|Overall Study|Withdrawal by Subject|0|||
19674027|NCT00515034|42121844|FG000|Overall Study|Physician Decision|0|||
19674028|NCT00515034|42121845|FG001|Overall Study|Physician Decision|0|||
19603814|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
19603815|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
19603816|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
19603817|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
19603818|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
19603819|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
19603820|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
19603821|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
19603822|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
19603823|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
19603824|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
19603825|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
19603826|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
19603827|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
19603828|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
19603829|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
19603830|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
19603831|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
19674029|NCT00515034|42121846|FG002|Overall Study|Physician Decision|1|||
19674030|NCT00515034|42121847|FG003|Overall Study|Physician Decision|1|||
19758955|NCT02452554|42210127|FG003|Overall Study|Ineligible|0|||
19758956|NCT02452554|42210128|FG004|Overall Study|Ineligible|0|||
19758957|NCT02452554|42210129|FG005|Overall Study|Ineligible|0|||
19758958|NCT02452554|42210124|FG000|Overall Study|Never Received Treatment|1|||
19758959|NCT02452554|42210125|FG001|Overall Study|Never Received Treatment|0|||
19674031|NCT00515034|42121844|FG000|Overall Study|Other|1|||
19674032|NCT00515034|42121845|FG001|Overall Study|Other|0|||
19674033|NCT00515034|42121846|FG002|Overall Study|Other|2|||
19674034|NCT00515034|42121847|FG003|Overall Study|Other|1|||
19758960|NCT02452554|42210126|FG002|Overall Study|Never Received Treatment|0|||
19674035|NCT00404235|42121859|FG000|Overall Study|Withdrawal by Subject|1|||
19674036|NCT00404235|42121860|FG001|Overall Study|Withdrawal by Subject|2|||
19674037|NCT00404079|42121868|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
19674038|NCT00404079|42121869|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
19674039|NCT00403845|42121875|FG000|Treatment Period 1|Subject withdrew consent|1|||
19674040|NCT00403845|42121876|FG001|Treatment Period 1|Subject withdrew consent|0|||
19674041|NCT00403845|42121877|FG002|Treatment Period 1|Subject withdrew consent|0|||
19674042|NCT00403845|42121878|FG003|Treatment Period 1|Subject withdrew consent|0|||
19674043|NCT00403845|42121875|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
19674044|NCT00403845|42121876|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
19758961|NCT02452554|42210127|FG003|Overall Study|Never Received Treatment|0|||
19758962|NCT02452554|42210128|FG004|Overall Study|Never Received Treatment|0|||
19758963|NCT02452554|42210129|FG005|Overall Study|Never Received Treatment|0|||
19758964|NCT04009577|42210148|FG000|Core Study|Adverse Event|1|||
19758965|NCT04009577|42210149|FG001|Core Study|Adverse Event|0|||
19758966|NCT04009577|42210150|FG002|Core Study|Adverse Event|2|||
19758967|NCT04009577|42210151|FG003|Core Study|Adverse Event|4|||
19758968|NCT04009577|42210148|FG000|Core Study|Withdrawal by Subject|0|||
19758969|NCT04009577|42210149|FG001|Core Study|Withdrawal by Subject|0|||
19758970|NCT04009577|42210150|FG002|Core Study|Withdrawal by Subject|2|||
19758971|NCT04009577|42210151|FG003|Core Study|Withdrawal by Subject|0|||
19758972|NCT04009577|42210148|FG000|Core Study|Other|0|||
19758973|NCT04009577|42210149|FG001|Core Study|Other|0|||
19758974|NCT04009577|42210150|FG002|Core Study|Other|0|||
19674045|NCT00403845|42121877|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
19674046|NCT00403845|42121878|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
19674047|NCT00403845|42121875|FG000|Treatment Period 2|Subject withdrew consent|1|||
19758975|NCT04009577|42210151|FG003|Core Study|Other|1|||
19758976|NCT04009577|42210148|FG000|Extension Phase|Adverse Event|0|||
19758977|NCT04009577|42210149|FG001|Extension Phase|Adverse Event|0|||
19758978|NCT04009577|42210150|FG002|Extension Phase|Adverse Event|0|||
19758979|NCT04009577|42210151|FG003|Extension Phase|Adverse Event|1|||
19758980|NCT04009577|42210148|FG000|Extension Phase|Inadequate therapeutic effect|0|||
19758981|NCT04009577|42210149|FG001|Extension Phase|Inadequate therapeutic effect|0|||
19758982|NCT04009577|42210150|FG002|Extension Phase|Inadequate therapeutic effect|1|||
19758983|NCT04009577|42210151|FG003|Extension Phase|Inadequate therapeutic effect|0|||
19758984|NCT04009577|42210148|FG000|Extension Phase|Withdrawal by Subject|0|||
19758985|NCT04009577|42210149|FG001|Extension Phase|Withdrawal by Subject|0|||
19758986|NCT04009577|42210150|FG002|Extension Phase|Withdrawal by Subject|1|||
19758987|NCT04009577|42210151|FG003|Extension Phase|Withdrawal by Subject|0|||
19758988|NCT04009577|42210148|FG000|Extension Phase|Not Treated|0|||
19674048|NCT00403845|42121876|FG001|Treatment Period 2|Subject withdrew consent|0|||
19674049|NCT00403845|42121877|FG002|Treatment Period 2|Subject withdrew consent|0|||
19674050|NCT00403845|42121878|FG003|Treatment Period 2|Subject withdrew consent|0|||
19674051|NCT00403845|42121875|FG000|Treatment Period 3|Subject withdrew consent|0|||
19674052|NCT00403845|42121876|FG001|Treatment Period 3|Subject withdrew consent|0|||
19674053|NCT00403845|42121877|FG002|Treatment Period 3|Subject withdrew consent|0|||
19674054|NCT00403845|42121878|FG003|Treatment Period 3|Subject withdrew consent|1|||
19674055|NCT00403845|42121875|FG000|Treatment Period 3|Adverse Event|0|||
19674056|NCT00403845|42121876|FG001|Treatment Period 3|Adverse Event|0|||
19674057|NCT00403845|42121877|FG002|Treatment Period 3|Adverse Event|0|||
19674058|NCT00403845|42121878|FG003|Treatment Period 3|Adverse Event|1|||
19674059|NCT00509262|42121890|FG000|Overall Study|Adverse Event|16|||
19674060|NCT00509262|42121891|FG001|Overall Study|Adverse Event|18|||
19674061|NCT00509262|42121890|FG000|Overall Study|Other|2|||
19674062|NCT00509262|42121891|FG001|Overall Study|Other|2|||
19674063|NCT00509262|42121890|FG000|Overall Study|Lack of Efficacy|1|||
19674064|NCT00509262|42121891|FG001|Overall Study|Lack of Efficacy|0|||
19674065|NCT00509262|42121890|FG000|Overall Study|Lost to Follow-up|1|||
19674066|NCT00509262|42121891|FG001|Overall Study|Lost to Follow-up|6|||
19674067|NCT00509262|42121890|FG000|Overall Study|Physician Decision|1|||
19674068|NCT00509262|42121891|FG001|Overall Study|Physician Decision|3|||
19674069|NCT00509262|42121890|FG000|Overall Study|Protocol Violation|2|||
19674070|NCT00509262|42121891|FG001|Overall Study|Protocol Violation|2|||
19674071|NCT00509262|42121890|FG000|Overall Study|Withdrawal by Subject|24|||
19674072|NCT00509262|42121891|FG001|Overall Study|Withdrawal by Subject|11|||
19674073|NCT00607997|42121901|FG000|Overall Study|Lack of Efficacy|6|||
19674074|NCT00607997|42121902|FG001|Overall Study|Lack of Efficacy|20|||
19674075|NCT00607997|42121903|FG002|Overall Study|Lack of Efficacy|14|||
19674076|NCT00607997|42121904|FG003|Overall Study|Lack of Efficacy|10|||
19674077|NCT00607997|42121901|FG000|Overall Study|Death|8|||
19603832|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
19603833|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
19603834|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
19603835|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
19603836|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
19603837|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
19603838|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
19603839|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
19603840|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
19603841|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
19603842|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
19603843|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
19603844|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
19603845|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
19674078|NCT00607997|42121902|FG001|Overall Study|Death|5|||
19674079|NCT00607997|42121903|FG002|Overall Study|Death|2|||
19674080|NCT00607997|42121904|FG003|Overall Study|Death|5|||
19674081|NCT00607997|42121901|FG000|Overall Study|Adverse Event|3|||
19674082|NCT00607997|42121902|FG001|Overall Study|Adverse Event|1|||
19674083|NCT00607997|42121903|FG002|Overall Study|Adverse Event|2|||
19674084|NCT00607997|42121904|FG003|Overall Study|Adverse Event|0|||
19674085|NCT00607997|42121901|FG000|Overall Study|Physician Decision|4|||
19758989|NCT04009577|42210149|FG001|Extension Phase|Not Treated|0|||
19758990|NCT04009577|42210150|FG002|Extension Phase|Not Treated|2|||
19603846|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
19603847|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
19603848|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
19603849|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
19603850|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
19603851|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
19603852|NCT03107793|42052828|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
19603853|NCT03107793|42052829|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
19603854|NCT03107793|42052830|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
19603855|NCT03107793|42052831|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
19603856|NCT03107793|42052832|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
19603857|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
19603858|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
19674086|NCT00607997|42121902|FG001|Overall Study|Physician Decision|1|||
19674087|NCT00607997|42121903|FG002|Overall Study|Physician Decision|0|||
19674088|NCT00607997|42121904|FG003|Overall Study|Physician Decision|0|||
19674089|NCT00607997|42121901|FG000|Overall Study|Relapse, recurrent illness|4|||
19674090|NCT00607997|42121902|FG001|Overall Study|Relapse, recurrent illness|0|||
19674091|NCT00607997|42121903|FG002|Overall Study|Relapse, recurrent illness|2|||
19674092|NCT00607997|42121904|FG003|Overall Study|Relapse, recurrent illness|0|||
19674093|NCT00607997|42121901|FG000|Overall Study|Other without explanation|2|||
19674094|NCT00607997|42121902|FG001|Overall Study|Other without explanation|0|||
19674095|NCT00607997|42121903|FG002|Overall Study|Other without explanation|4|||
19674096|NCT00607997|42121904|FG003|Overall Study|Other without explanation|1|||
19674097|NCT00509106|42121921|FG000|Overall Study|Adverse Event|3|||
19674098|NCT00509106|42121922|FG001|Overall Study|Adverse Event|2|||
19674099|NCT00509106|42121921|FG000|Overall Study|Noncompliance|0|||
19674100|NCT00509106|42121922|FG001|Overall Study|Noncompliance|1|||
19674101|NCT00509106|42121921|FG000|Overall Study|At the request of sponsor/investigator|1|||
19674102|NCT00509106|42121922|FG001|Overall Study|At the request of sponsor/investigator|2|||
19674103|NCT00509106|42121921|FG000|Overall Study|Withdrew consent|4|||
19674104|NCT00509106|42121922|FG001|Overall Study|Withdrew consent|8|||
19674105|NCT00509106|42121921|FG000|Overall Study|Lost to Follow-up|16|||
19674106|NCT00509106|42121922|FG001|Overall Study|Lost to Follow-up|10|||
19674107|NCT00509106|42121921|FG000|Overall Study|Other|1|||
19674108|NCT00509106|42121922|FG001|Overall Study|Other|0|||
19674109|NCT00509106|42121921|FG000|Overall Study|Death|6|||
19674110|NCT00509106|42121922|FG001|Overall Study|Death|6|||
19674111|NCT00607919|42121930|FG000|Acute Phase|Adverse Event|9|||
19674112|NCT00607919|42121931|FG001|Acute Phase|Adverse Event|2|||
19674113|NCT00607919|42121930|FG000|Acute Phase|Entry Criteria Not Met|1|||
19674114|NCT00607919|42121931|FG001|Acute Phase|Entry Criteria Not Met|1|||
19674115|NCT00607919|42121930|FG000|Acute Phase|Lack of Efficacy|1|||
19674116|NCT00607919|42121931|FG001|Acute Phase|Lack of Efficacy|2|||
19674117|NCT00607919|42121930|FG000|Acute Phase|Lost to Follow-up|9|||
19674118|NCT00607919|42121931|FG001|Acute Phase|Lost to Follow-up|3|||
19758991|NCT04009577|42210151|FG003|Extension Phase|Not Treated|0|||
19758992|NCT04146467|42210179|FG000|Overall Study|Adverse Event|0|||
19758993|NCT04146467|42210180|FG001|Overall Study|Adverse Event|1|||
19758994|NCT04146467|42210179|FG000|Overall Study|Lost to Follow-up|0|||
19758995|NCT04146467|42210180|FG001|Overall Study|Lost to Follow-up|2|||
19758996|NCT02705716|42210191|FG000|Overall Study|Adverse Event|0|||
19758997|NCT02705716|42210192|FG001|Overall Study|Adverse Event|1|||
19758998|NCT02705716|42210191|FG000|Overall Study|Protocol Violation|3|||
19758999|NCT02705716|42210192|FG001|Overall Study|Protocol Violation|0|||
19759000|NCT02705716|42210191|FG000|Overall Study|Withdrawal of Consent|1|||
19759001|NCT02705716|42210192|FG001|Overall Study|Withdrawal of Consent|1|||
19759002|NCT04138043|42210200|FG000|Overall Study|Withdrawal by Subject|0|||
19759003|NCT04138043|42210201|FG001|Overall Study|Withdrawal by Subject|1|||
19759004|NCT04135937|42210217|FG000|Overall Study|Lost to Follow-up|2|||
19759005|NCT04135937|42210217|FG000|Overall Study|Withdrawal by Subject|1|||
19759006|NCT03443713|42210224|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
19759007|NCT03443713|42210225|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
19759008|NCT03443713|42210226|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
19674119|NCT00607919|42121930|FG000|Acute Phase|Parent/Caregiver Decision|6|||
19674120|NCT00607919|42121931|FG001|Acute Phase|Parent/Caregiver Decision|4|||
19759009|NCT04133519|42210240|FG000|Overall Study|Withdrawal by Subject|5|||
19759010|NCT04133519|42210241|FG001|Overall Study|Withdrawal by Subject|4|||
19759011|NCT04133519|42210240|FG000|Overall Study|Protocol Violation|0|||
19759012|NCT04133519|42210241|FG001|Overall Study|Protocol Violation|1|||
19759013|NCT04133519|42210240|FG000|Overall Study|Never started treatment|1|||
19759014|NCT04133519|42210241|FG001|Overall Study|Never started treatment|1|||
19759015|NCT04007159|42210247|FG000|Induction Phase|(missed study visits)|16|||
19759016|NCT04007159|42210247|FG000|Induction Phase|Withdrawal by Subject|4|||
19759017|NCT04007159|42210247|FG000|Induction Phase|Adverse Event|2|||
19759018|NCT04007159|42210247|FG000|Challenge Phase|missed study visits|3|||
19759019|NCT03119688|42210258|FG000|Overall Study|Adverse Event|4|||
19759020|NCT03389893|42210277|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
19759021|NCT03389893|42210278|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
19759022|NCT03389893|42210279|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
19759023|NCT03389893|42210280|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
19759024|NCT03389893|42210277|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
19759025|NCT03389893|42210278|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
19759026|NCT03389893|42210279|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
19759027|NCT03389893|42210280|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
19759028|NCT03389893|42210277|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
19759029|NCT03389893|42210278|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
19759030|NCT03389893|42210279|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
19759031|NCT03389893|42210280|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
19759032|NCT03389893|42210277|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
19759033|NCT03389893|42210278|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
19759034|NCT03389893|42210279|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
19759035|NCT03389893|42210280|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
19674121|NCT00607919|42121930|FG000|Acute Phase|Protocol Violation|5|||
19674122|NCT00607919|42121931|FG001|Acute Phase|Protocol Violation|1|||
19674123|NCT00607919|42121930|FG000|Acute Phase|Withdrawal by Subject|3|||
19674124|NCT00607919|42121931|FG001|Acute Phase|Withdrawal by Subject|3|||
19674125|NCT00607919|42121930|FG000|Open-Label Phase|Adverse Event|1|||
19674126|NCT00607919|42121931|FG001|Open-Label Phase|Adverse Event|5|||
19674127|NCT00607919|42121930|FG000|Open-Label Phase|Lost to Follow-up|4|||
19674128|NCT00607919|42121931|FG001|Open-Label Phase|Lost to Follow-up|1|||
19674129|NCT00607919|42121930|FG000|Open-Label Phase|Protocol Violation|2|||
19674130|NCT00607919|42121931|FG001|Open-Label Phase|Protocol Violation|2|||
19674131|NCT00607919|42121930|FG000|Open-Label Phase|Withdrawal by Subject|2|||
19759036|NCT04128293|42210290|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
19759037|NCT04128293|42210291|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
19674132|NCT00607919|42121931|FG001|Open-Label Phase|Withdrawal by Subject|2|||
19674133|NCT00607919|42121930|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
19674134|NCT00607919|42121931|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
19674135|NCT00344968|42121942|FG000|Overall Study|Adverse Event|5|||
19674136|NCT00344968|42121943|FG001|Overall Study|Adverse Event|4|||
19674137|NCT00344968|42121944|FG002|Overall Study|Adverse Event|15|||
19674138|NCT00344968|42121942|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19759038|NCT04128293|42210292|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
19759039|NCT04128293|42210293|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
19759040|NCT00787176|42210312|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
19759041|NCT00787176|42210313|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
19759042|NCT00787176|42210314|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
19759043|NCT00787176|42210315|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
19759044|NCT03691571|42210328|FG000|Overall Study|Withdrawal by Subject|9|||
19759045|NCT03691571|42210329|FG001|Overall Study|Withdrawal by Subject|2|||
19759046|NCT03113916|42210338|FG000|Overall Study|Withdrawal by Subject|9|||
19759047|NCT03113916|42210339|FG001|Overall Study|Withdrawal by Subject|7|||
19759048|NCT03113916|42210338|FG000|Overall Study|Pregnancy|1|||
19759049|NCT03113916|42210339|FG001|Overall Study|Pregnancy|3|||
19759050|NCT03113916|42210338|FG000|Overall Study|Lost to Follow-up|1|||
19759051|NCT03113916|42210339|FG001|Overall Study|Lost to Follow-up|2|||
19674139|NCT00344968|42121943|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19759052|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
19759053|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
19759054|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
19759055|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
19759056|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
19674140|NCT00344968|42121944|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
19674141|NCT00344968|42121942|FG000|Overall Study|Protocol Violation|2|||
19674142|NCT00344968|42121943|FG001|Overall Study|Protocol Violation|2|||
19674143|NCT00344968|42121944|FG002|Overall Study|Protocol Violation|5|||
19674144|NCT00344968|42121942|FG000|Overall Study|Withdrawal by Subject|14|||
19674145|NCT00344968|42121943|FG001|Overall Study|Withdrawal by Subject|31|||
19674146|NCT00344968|42121944|FG002|Overall Study|Withdrawal by Subject|27|||
19674147|NCT00344968|42121942|FG000|Overall Study|Lost to Follow-up|24|||
19674148|NCT00344968|42121943|FG001|Overall Study|Lost to Follow-up|37|||
19674149|NCT00344968|42121944|FG002|Overall Study|Lost to Follow-up|37|||
19674150|NCT00344968|42121942|FG000|Overall Study|Death|11|||
19674151|NCT00344968|42121943|FG001|Overall Study|Death|27|||
19759057|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
19674152|NCT00344968|42121944|FG002|Overall Study|Death|31|||
19759058|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
19674153|NCT00344968|42121942|FG000|Overall Study|Other|0|||
19674154|NCT00344968|42121943|FG001|Overall Study|Other|1|||
19674155|NCT00344968|42121944|FG002|Overall Study|Other|0|||
19674156|NCT00509028|42121955|FG000|Overall Study|Adverse Event|2|||
19674157|NCT00509028|42121956|FG001|Overall Study|Adverse Event|0|||
19674158|NCT00509028|42121955|FG000|Overall Study|Withdrawal by Subject|4|||
19674159|NCT00509028|42121956|FG001|Overall Study|Withdrawal by Subject|3|||
19674160|NCT00509028|42121955|FG000|Overall Study|Lost to Follow-up|0|||
19674161|NCT00509028|42121956|FG001|Overall Study|Lost to Follow-up|1|||
19674162|NCT00509028|42121955|FG000|Overall Study|Protocol Violation|4|||
19674163|NCT00509028|42121956|FG001|Overall Study|Protocol Violation|2|||
19674164|NCT00509028|42121955|FG000|Overall Study|Non-compliance|2|||
19674165|NCT00509028|42121956|FG001|Overall Study|Non-compliance|1|||
19674166|NCT00352846|42121964|FG000|Overall Study|Disease progression|0|||
19674167|NCT00352846|42121965|FG001|Overall Study|Disease progression|2|||
19674168|NCT00352846|42121964|FG000|Overall Study|Withdrawal by Subject|3|||
19674169|NCT00352846|42121965|FG001|Overall Study|Withdrawal by Subject|8|||
19674170|NCT00352846|42121964|FG000|Overall Study|Ineligible|3|||
19674171|NCT00352846|42121965|FG001|Overall Study|Ineligible|2|||
19674172|NCT00352846|42121964|FG000|Overall Study|Non-compliance|2|||
19674173|NCT00352846|42121965|FG001|Overall Study|Non-compliance|0|||
19674174|NCT00352846|42121964|FG000|Overall Study|Death|0|||
19674175|NCT00352846|42121965|FG001|Overall Study|Death|1|||
19674176|NCT00508872|42121971|FG000|Overall Study|Lost to Follow-up|1|||
19674177|NCT00508872|42121971|FG000|Overall Study|Physician Decision|1|||
19674178|NCT00508482|42121978|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
19674179|NCT00508482|42121979|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
19674180|NCT00508482|42121980|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
19674181|NCT00508482|42121978|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
19674182|NCT00508482|42121979|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
19674183|NCT00508482|42121980|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
19674184|NCT00508482|42121978|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
19674185|NCT00508482|42121979|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
19674186|NCT00508482|42121980|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
19674187|NCT00344500|42121991|FG000|Overall Study|Adverse Event|6|||
19674188|NCT00344500|42121992|FG001|Overall Study|Adverse Event|2|||
19674189|NCT00344500|42121993|FG002|Overall Study|Adverse Event|0|||
19674190|NCT00344500|42121991|FG000|Overall Study|Lost to Follow-up|5|||
19674191|NCT00344500|42121992|FG001|Overall Study|Lost to Follow-up|13|||
19674192|NCT00344500|42121993|FG002|Overall Study|Lost to Follow-up|1|||
19674193|NCT00344500|42121991|FG000|Overall Study|Withdrawal by Subject|7|||
19674194|NCT00344500|42121992|FG001|Overall Study|Withdrawal by Subject|10|||
19674195|NCT00344500|42121993|FG002|Overall Study|Withdrawal by Subject|0|||
19674196|NCT00344500|42121991|FG000|Overall Study|Protocol Violation|4|||
19674197|NCT00344500|42121992|FG001|Overall Study|Protocol Violation|7|||
19674198|NCT00344500|42121993|FG002|Overall Study|Protocol Violation|1|||
19674199|NCT00344500|42121991|FG000|Overall Study|Not Noted|1|||
19674200|NCT00344500|42121992|FG001|Overall Study|Not Noted|3|||
19674201|NCT00344500|42121993|FG002|Overall Study|Not Noted|0|||
19674202|NCT00344032|42122002|FG000|Overall Study|Adverse Event|0|||
19674203|NCT00344032|42122003|FG001|Overall Study|Adverse Event|1|||
19674204|NCT00344032|42122002|FG000|Overall Study|Withdrawal by Subject|6|||
19674205|NCT00344032|42122003|FG001|Overall Study|Withdrawal by Subject|2|||
19674206|NCT00344032|42122002|FG000|Overall Study|Lost to Follow-up|4|||
19674207|NCT00344032|42122003|FG001|Overall Study|Lost to Follow-up|6|||
19674208|NCT00344032|42122002|FG000|Overall Study|Physician Decision|4|||
19674209|NCT00344032|42122003|FG001|Overall Study|Physician Decision|1|||
19674210|NCT00607373|42122011|FG000|Treatment Period|Adverse Event|0|||
19674211|NCT00607373|42122012|FG001|Treatment Period|Adverse Event|4|||
19674212|NCT00607373|42122011|FG000|Treatment Period|Physician Decision|0|||
19674213|NCT00607373|42122012|FG001|Treatment Period|Physician Decision|1|||
19674214|NCT00607373|42122011|FG000|Treatment Period|Withdrawal by Subject|0|||
19674215|NCT00607373|42122012|FG001|Treatment Period|Withdrawal by Subject|1|||
19674216|NCT00607373|42122011|FG000|Follow-up Period|Other|0|||
19674217|NCT00607373|42122012|FG001|Follow-up Period|Other|1|||
19674218|NCT00607373|42122011|FG000|Follow-up Period|Protocol Violation|0|||
19674219|NCT00607373|42122012|FG001|Follow-up Period|Protocol Violation|1|||
19674220|NCT00607373|42122011|FG000|Follow-up Period|Withdrawal by Subject|1|||
19674221|NCT00607373|42122012|FG001|Follow-up Period|Withdrawal by Subject|3|||
19674222|NCT00508404|42122018|FG000|Overall Study|Ongoing at Data Cut-off|12|||
19674223|NCT00508404|42122018|FG000|Overall Study|Adverse Event|2|||
19674224|NCT00508404|42122018|FG000|Overall Study|Death|16|||
19674225|NCT00508404|42122018|FG000|Overall Study|Physician Decision|2|||
19674226|NCT00508404|42122018|FG000|Overall Study|Withdrawal by Subject|3|||
19674227|NCT00508404|42122018|FG000|Overall Study|Protocol-specified Criteria|2|||
19674228|NCT00508404|42122018|FG000|Overall Study|Lost to Follow-up|2|||
19674229|NCT00508404|42122018|FG000|Overall Study|Other - Not Specified|3|||
19674230|NCT00352690|42122025|FG000|Overall Study|Determined to be ineligible|2|||
19674231|NCT00352690|42122026|FG001|Overall Study|Determined to be ineligible|0|||
19674232|NCT00609245|42122032|FG000|Overall Study|Adverse Event|1|||
19674233|NCT00343642|42122041|FG000|Overall Study|Lost to Follow-up|0|||
19674234|NCT00343642|42122042|FG001|Overall Study|Lost to Follow-up|1|||
19674235|NCT00343642|42122043|FG002|Overall Study|Lost to Follow-up|0|||
19674236|NCT00343642|42122041|FG000|Overall Study|Pregnancy|1|||
19674237|NCT00343642|42122042|FG001|Overall Study|Pregnancy|0|||
19674238|NCT00343642|42122043|FG002|Overall Study|Pregnancy|2|||
19674239|NCT00343642|42122041|FG000|Overall Study|Withdrawal by Subject|2|||
19674240|NCT00343642|42122042|FG001|Overall Study|Withdrawal by Subject|3|||
19674241|NCT00343642|42122043|FG002|Overall Study|Withdrawal by Subject|4|||
19674242|NCT00343642|42122041|FG000|Overall Study|Adverse Event|0|||
19674243|NCT00343642|42122042|FG001|Overall Study|Adverse Event|0|||
19674244|NCT00343642|42122043|FG002|Overall Study|Adverse Event|1|||
19674245|NCT00343642|42122041|FG000|Overall Study|Flare up|6|||
19674246|NCT00343642|42122042|FG001|Overall Study|Flare up|4|||
19674247|NCT00343642|42122043|FG002|Overall Study|Flare up|0|||
19674248|NCT00609167|42122056|FG000|Overall Study|Withdrawal by Subject|1|||
19603859|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
19603860|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
19674249|NCT00609167|42122057|FG001|Overall Study|Withdrawal by Subject|0|||
19603861|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
19603862|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
19603863|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
19603864|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
19603865|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
19603866|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
19603867|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
19603868|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
19603869|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
19603870|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
19603871|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
19603872|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Death|0|||
19603873|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Death|0|||
19603874|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Death|0|||
19603875|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Death|0|||
19603876|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Death|1|||
19603877|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
19603878|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
19603879|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
19603880|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
19603881|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
19603882|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
19603883|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
19603884|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
19603885|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
19603886|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
19603887|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
19603888|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
19603889|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
19603890|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
19603891|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
19603892|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
19603893|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
19603894|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
19603895|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
19603896|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
19603897|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
19603898|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
19603899|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
19603900|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
19603901|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
19603902|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Other|0|||
19603903|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Other|0|||
19603904|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Other|0|||
19603905|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Other|1|||
19603906|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Other|3|||
19603907|NCT03107793|42052828|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
19603908|NCT03107793|42052829|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
19603909|NCT03107793|42052830|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
19603910|NCT03107793|42052831|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
19603911|NCT03107793|42052832|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
19603912|NCT00974090|42052843|FG000|Period 1: Double Blind Period|Adverse Event|2|||
19674250|NCT00609167|42122056|FG000|Overall Study|Lack of Efficacy|1|||
19674251|NCT00609167|42122057|FG001|Overall Study|Lack of Efficacy|0|||
19674252|NCT00609167|42122056|FG000|Overall Study|Adverse Event|5|||
19674253|NCT00609167|42122057|FG001|Overall Study|Adverse Event|1|||
19674254|NCT00609167|42122056|FG000|Overall Study|Disease Progression|1|||
19674255|NCT00609167|42122057|FG001|Overall Study|Disease Progression|0|||
19674256|NCT00609167|42122056|FG000|Overall Study|Stem Cell Transplant|0|||
19674257|NCT00609167|42122057|FG001|Overall Study|Stem Cell Transplant|6|||
19674258|NCT00606281|42122065|FG000|Overall Study|Adverse Event|11|||
19674259|NCT00606281|42122066|FG001|Overall Study|Adverse Event|12|||
19674260|NCT00606281|42122065|FG000|Overall Study|Death|1|||
19674261|NCT00606281|42122066|FG001|Overall Study|Death|0|||
19674262|NCT00606281|42122065|FG000|Overall Study|Lack of Efficacy|28|||
19674263|NCT00606281|42122066|FG001|Overall Study|Lack of Efficacy|35|||
19674264|NCT00606281|42122065|FG000|Overall Study|Physician Decision|0|||
19674265|NCT00606281|42122066|FG001|Overall Study|Physician Decision|1|||
19674266|NCT00606281|42122065|FG000|Overall Study|Protocol Violation|3|||
19674267|NCT00606281|42122066|FG001|Overall Study|Protocol Violation|3|||
19674268|NCT00606281|42122065|FG000|Overall Study|Withdrawal by Subject|11|||
19674269|NCT00606281|42122066|FG001|Overall Study|Withdrawal by Subject|13|||
19674270|NCT00606281|42122065|FG000|Overall Study|Progression to depressive phase|1|||
19674271|NCT00606281|42122066|FG001|Overall Study|Progression to depressive phase|1|||
19674272|NCT00606281|42122065|FG000|Overall Study|Change of residence or other commitments|1|||
19674273|NCT00606281|42122066|FG001|Overall Study|Change of residence or other commitments|1|||
19674274|NCT00506142|42122074|FG000|Overall Study|Adverse Event|8|||
19674275|NCT00506142|42122075|FG001|Overall Study|Adverse Event|7|||
19674276|NCT00506142|42122074|FG000|Overall Study|Lack of Efficacy|21|||
19674277|NCT00506142|42122075|FG001|Overall Study|Lack of Efficacy|7|||
19674278|NCT00506142|42122074|FG000|Overall Study|Withdrawal by Subject|4|||
19674279|NCT00506142|42122075|FG001|Overall Study|Withdrawal by Subject|5|||
19674280|NCT00506142|42122074|FG000|Overall Study|Physician Decision|1|||
19674281|NCT00506142|42122075|FG001|Overall Study|Physician Decision|0|||
19674282|NCT00506142|42122074|FG000|Overall Study|New health condition|1|||
19674283|NCT00506142|42122075|FG001|Overall Study|New health condition|0|||
19674284|NCT00514020|42122081|FG000|Overall Study|Adverse Event|6|||
19674285|NCT00514020|42122081|FG000|Overall Study|Withdrawal by Subject|3|||
19674286|NCT00514020|42122081|FG000|Overall Study|Physician Decision|1|||
19674287|NCT00514020|42122081|FG000|Overall Study|disease progression|9|||
19674288|NCT00514020|42122081|FG000|Overall Study|other complicating disease|2|||
19674289|NCT00514020|42122081|FG000|Overall Study|patient went to radiation treatment|1|||
19674290|NCT00514020|42122081|FG000|Overall Study|"patients moved to the no tx group"|6|||
19674291|NCT00513708|42122088|FG000|Overall Study|Lost to Follow-up|4|||
19674292|NCT00513708|42122089|FG001|Overall Study|Lost to Follow-up|4|||
19674293|NCT00513708|42122090|FG002|Overall Study|Lost to Follow-up|4|||
19674294|NCT00513474|42122100|FG000|Overall Study|Death|6|||
19674295|NCT00513474|42122101|FG001|Overall Study|Death|9|||
19674296|NCT00513474|42122100|FG000|Overall Study|Participant Withdrew Consent|1|||
19674297|NCT00513474|42122101|FG001|Overall Study|Participant Withdrew Consent|0|||
19674298|NCT00505752|42122111|FG000|Overall Study|Adverse Event|1|||
19674299|NCT00505752|42122112|FG001|Overall Study|Adverse Event|0|||
19674300|NCT00505752|42122113|FG002|Overall Study|Adverse Event|1|||
19674301|NCT00505752|42122114|FG003|Overall Study|Adverse Event|0|||
19674302|NCT00505752|42122111|FG000|Overall Study|Lost to Follow-up|1|||
19674303|NCT00505752|42122112|FG001|Overall Study|Lost to Follow-up|0|||
19674304|NCT00505752|42122113|FG002|Overall Study|Lost to Follow-up|0|||
19674305|NCT00505752|42122114|FG003|Overall Study|Lost to Follow-up|0|||
19674306|NCT00505752|42122111|FG000|Overall Study|Lack of ovarian response|1|||
19674307|NCT00505752|42122112|FG001|Overall Study|Lack of ovarian response|3|||
19674308|NCT00505752|42122113|FG002|Overall Study|Lack of ovarian response|0|||
19674309|NCT00505752|42122114|FG003|Overall Study|Lack of ovarian response|0|||
19674310|NCT00505752|42122111|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
19674311|NCT00505752|42122112|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
19674312|NCT00505752|42122113|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
19674313|NCT00505752|42122114|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
19674314|NCT00505752|42122111|FG000|Overall Study|No oocytes retrieved|0|||
19674315|NCT00505752|42122112|FG001|Overall Study|No oocytes retrieved|2|||
19674316|NCT00505752|42122113|FG002|Overall Study|No oocytes retrieved|0|||
19674317|NCT00505752|42122114|FG003|Overall Study|No oocytes retrieved|1|||
19674318|NCT00505752|42122111|FG000|Overall Study|No Fertilization|1|||
19674319|NCT00505752|42122112|FG001|Overall Study|No Fertilization|1|||
19674320|NCT00505752|42122113|FG002|Overall Study|No Fertilization|2|||
19674321|NCT00505752|42122114|FG003|Overall Study|No Fertilization|1|||
19674322|NCT00505752|42122111|FG000|Overall Study|All embryos/blastocysts discarded|0|||
19674323|NCT00505752|42122112|FG001|Overall Study|All embryos/blastocysts discarded|0|||
19674324|NCT00505752|42122113|FG002|Overall Study|All embryos/blastocysts discarded|1|||
19674325|NCT00505752|42122114|FG003|Overall Study|All embryos/blastocysts discarded|1|||
19674326|NCT00505752|42122111|FG000|Overall Study|Other|1|||
19674327|NCT00505752|42122112|FG001|Overall Study|Other|2|||
19674328|NCT00505752|42122113|FG002|Overall Study|Other|1|||
19674329|NCT00505752|42122114|FG003|Overall Study|Other|2|||
19674330|NCT03601637|42122126|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
19674331|NCT03601637|42122127|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
19674332|NCT03601637|42122126|FG000|Overall Study|Adverse Event|1|||
19389036|NCT02672423|41632612|FG003|Period 1|Adverse Event|0|||
19389037|NCT02672423|41632613|FG004|Period 1|Adverse Event|1|||
19389038|NCT02672423|41632614|FG005|Period 1|Adverse Event|0|||
19389039|NCT02672423|41632615|FG006|Period 1|Adverse Event|0|||
19674333|NCT03601637|42122127|FG001|Overall Study|Adverse Event|1|||
19674334|NCT03601637|42122126|FG000|Overall Study|Other|0|||
19674335|NCT03601637|42122127|FG001|Overall Study|Other|1|||
19674336|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
19674337|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
19674338|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Death|0|||
19674339|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Death|2|||
19674340|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
19674341|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
19674342|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
19674343|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
19674344|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
19674345|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
19674346|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
19674347|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
19674348|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
19674349|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
19674350|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
19674351|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
19674352|NCT00343252|42122142|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
19674353|NCT00343252|42122143|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
19674354|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
19674355|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
19674356|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Death|3|||
19674357|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Death|3|||
19674358|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
19389040|NCT02672423|41632616|FG007|Period 1|Adverse Event|0|||
19389041|NCT02672423|41632617|FG008|Period 1|Adverse Event|0|||
19674359|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
19674360|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
19674361|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
19674362|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
19674363|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
19674364|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
19674365|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
19674366|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
19674367|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
19674368|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
19674369|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
19674370|NCT00343252|42122142|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
19674371|NCT00343252|42122143|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
19674372|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
19674373|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
19674374|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Death|4|||
19674375|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Death|5|||
19674376|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
19674377|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
19674378|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
19674379|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
19674380|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
19674381|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
19674382|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
19674383|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
19674384|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
19674385|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
19674386|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
19674387|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
19674388|NCT00343252|42122142|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
19674389|NCT00343252|42122143|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
19674390|NCT00342628|42122152|FG000|Overall Study|Withdrawal by Subject|19|||
19674391|NCT00342628|42122153|FG001|Overall Study|Withdrawal by Subject|19|||
19674392|NCT00342628|42122154|FG002|Overall Study|Withdrawal by Subject|18|||
19674393|NCT00342628|42122152|FG000|Overall Study|Death|1|||
19674394|NCT00342628|42122153|FG001|Overall Study|Death|1|||
19674395|NCT00342628|42122154|FG002|Overall Study|Death|0|||
19674396|NCT00342628|42122152|FG000|Overall Study|moved residence|0|||
19674397|NCT00342628|42122153|FG001|Overall Study|moved residence|1|||
19759059|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
19759060|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Other|1|||
19759061|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Other|4|||
19759062|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Other|3|||
19759063|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Other|6|||
19759064|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
19759065|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
19759066|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
19759067|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
19759068|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
19759069|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
19759070|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
19759071|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
19759072|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
19759073|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
19759074|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
19759075|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
19759076|NCT02925494|42210354|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
19759077|NCT02925494|42210355|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
19759078|NCT02925494|42210356|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
19759079|NCT02925494|42210357|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
19759080|NCT04006145|42210370|FG000|Overall Study|Lost to Follow-up|0|||
19759081|NCT04006145|42210371|FG001|Overall Study|Lost to Follow-up|1|||
19759082|NCT04006145|42210370|FG000|Overall Study|Other|1|||
19674398|NCT00342628|42122154|FG002|Overall Study|moved residence|1|||
19674399|NCT00505284|42122167|FG000|Overall Study|Adverse Event|3|||
19674400|NCT00505284|42122168|FG001|Overall Study|Adverse Event|7|||
19674401|NCT00505284|42122169|FG002|Overall Study|Adverse Event|9|||
19674402|NCT00505284|42122170|FG003|Overall Study|Adverse Event|14|||
19389042|NCT02672423|41632618|FG009|Period 1|Adverse Event|0|||
19759083|NCT04006145|42210371|FG001|Overall Study|Other|2|||
19759084|NCT03386773|42210379|FG000|Overall Study|Lost to Follow-up|24|||
19759085|NCT03386773|42210380|FG001|Overall Study|Lost to Follow-up|33|||
19759086|NCT03386773|42210379|FG000|Overall Study|Withdrawal by Subject|3|||
19674403|NCT00505284|42122171|FG004|Overall Study|Adverse Event|22|||
19674404|NCT00505284|42122167|FG000|Overall Study|Protocol Violation|0|||
19674405|NCT00505284|42122168|FG001|Overall Study|Protocol Violation|1|||
19674406|NCT00505284|42122169|FG002|Overall Study|Protocol Violation|1|||
19674407|NCT00505284|42122170|FG003|Overall Study|Protocol Violation|0|||
19674408|NCT00505284|42122171|FG004|Overall Study|Protocol Violation|0|||
19674409|NCT00505284|42122167|FG000|Overall Study|Withdrawal by Subject|2|||
19674410|NCT00505284|42122168|FG001|Overall Study|Withdrawal by Subject|6|||
19674411|NCT00505284|42122169|FG002|Overall Study|Withdrawal by Subject|1|||
19674412|NCT00505284|42122170|FG003|Overall Study|Withdrawal by Subject|0|||
19674413|NCT00505284|42122171|FG004|Overall Study|Withdrawal by Subject|6|||
19674414|NCT00505284|42122167|FG000|Overall Study|Lack of Efficacy|0|||
19674415|NCT00505284|42122168|FG001|Overall Study|Lack of Efficacy|1|||
19674416|NCT00505284|42122169|FG002|Overall Study|Lack of Efficacy|1|||
19759087|NCT03386773|42210380|FG001|Overall Study|Withdrawal by Subject|2|||
19759088|NCT04126343|42210392|FG000|Overall Study|Adverse Event|0|||
19759089|NCT04126343|42210393|FG001|Overall Study|Adverse Event|0|||
19759090|NCT04126343|42210394|FG002|Overall Study|Adverse Event|0|||
19759091|NCT04126343|42210395|FG003|Overall Study|Adverse Event|0|||
19759092|NCT04126343|42210396|FG004|Overall Study|Adverse Event|0|||
19759093|NCT04126343|42210397|FG005|Overall Study|Adverse Event|1|||
19759094|NCT04126343|42210392|FG000|Overall Study|Withdrawal by Subject|0|||
19759095|NCT04126343|42210393|FG001|Overall Study|Withdrawal by Subject|0|||
19759096|NCT04126343|42210394|FG002|Overall Study|Withdrawal by Subject|0|||
19759097|NCT04126343|42210395|FG003|Overall Study|Withdrawal by Subject|1|||
19674417|NCT00505284|42122170|FG003|Overall Study|Lack of Efficacy|1|||
19674418|NCT00505284|42122171|FG004|Overall Study|Lack of Efficacy|1|||
19674419|NCT00505284|42122167|FG000|Overall Study|Physician Decision|0|||
19674420|NCT00505284|42122168|FG001|Overall Study|Physician Decision|1|||
19674421|NCT00505284|42122169|FG002|Overall Study|Physician Decision|0|||
19674422|NCT00505284|42122170|FG003|Overall Study|Physician Decision|0|||
19674423|NCT00505284|42122171|FG004|Overall Study|Physician Decision|0|||
19674424|NCT00505284|42122167|FG000|Overall Study|Other|5|||
19674425|NCT00505284|42122168|FG001|Overall Study|Other|0|||
19674426|NCT00505284|42122169|FG002|Overall Study|Other|0|||
19674427|NCT00505284|42122170|FG003|Overall Study|Other|4|||
19674428|NCT00505284|42122171|FG004|Overall Study|Other|4|||
19674429|NCT00337168|42122183|FG000|Overall Study|Death|5|||
19674430|NCT00337168|42122183|FG000|Overall Study|Not protocol specified|2|||
19674431|NCT00337168|42122183|FG000|Overall Study|Did not start therapy|1|||
19674432|NCT00606905|42122190|FG000|Overall Study|No Pregnancy|9|||
19674433|NCT00606905|42122191|FG001|Overall Study|No Pregnancy|6|||
19759098|NCT04126343|42210396|FG004|Overall Study|Withdrawal by Subject|0|||
19759099|NCT04126343|42210397|FG005|Overall Study|Withdrawal by Subject|0|||
19674434|NCT00606905|42122190|FG000|Overall Study|Non-Index Pregnancy|1|||
19674435|NCT00606905|42122191|FG001|Overall Study|Non-Index Pregnancy|4|||
19674436|NCT00606905|42122190|FG000|Overall Study|Withdrew|5|||
19674437|NCT00606905|42122191|FG001|Overall Study|Withdrew|5|||
19674438|NCT00606593|42122197|FG000|Overall Study|Adverse Event|0|||
19674439|NCT00606593|42122198|FG001|Overall Study|Adverse Event|0|||
19674440|NCT00606593|42122199|FG002|Overall Study|Adverse Event|0|||
19674441|NCT00606593|42122200|FG003|Overall Study|Adverse Event|1|||
19674442|NCT00606593|42122201|FG004|Overall Study|Adverse Event|1|||
19674443|NCT00606593|42122202|FG005|Overall Study|Adverse Event|0|||
19674444|NCT00606593|42122203|FG006|Overall Study|Adverse Event|1|||
19674445|NCT00606593|42122204|FG007|Overall Study|Adverse Event|2|||
19674446|NCT00606593|42122205|FG008|Overall Study|Adverse Event|1|||
19759100|NCT04126343|42210392|FG000|Overall Study|Related to COVID-19 pandemic|3|||
19759101|NCT04126343|42210393|FG001|Overall Study|Related to COVID-19 pandemic|4|||
19674447|NCT00606593|42122206|FG009|Overall Study|Adverse Event|0|||
19674448|NCT00606593|42122197|FG000|Overall Study|Withdrawal of consent|1|||
19674449|NCT00606593|42122198|FG001|Overall Study|Withdrawal of consent|0|||
19674450|NCT00606593|42122199|FG002|Overall Study|Withdrawal of consent|1|||
19674451|NCT00606593|42122200|FG003|Overall Study|Withdrawal of consent|0|||
19674452|NCT00606593|42122201|FG004|Overall Study|Withdrawal of consent|0|||
19674453|NCT00606593|42122202|FG005|Overall Study|Withdrawal of consent|0|||
19674454|NCT00606593|42122203|FG006|Overall Study|Withdrawal of consent|0|||
19674455|NCT00606593|42122204|FG007|Overall Study|Withdrawal of consent|0|||
19759102|NCT04126343|42210394|FG002|Overall Study|Related to COVID-19 pandemic|3|||
19759103|NCT04126343|42210395|FG003|Overall Study|Related to COVID-19 pandemic|3|||
19759104|NCT04126343|42210396|FG004|Overall Study|Related to COVID-19 pandemic|3|||
19759105|NCT04126343|42210397|FG005|Overall Study|Related to COVID-19 pandemic|3|||
19759106|NCT02952313|42210412|FG000|Primary Endpoint|Lost to Follow-up|4|||
19759107|NCT02952313|42210412|FG000|Primary Endpoint|Withdrawal by Subject|1|||
19759108|NCT02952313|42210412|FG000|Primary Endpoint|Lack of Efficacy|1|||
19759109|NCT02952313|42210412|FG000|Primary Endpoint|Missed visit|1|||
19603913|NCT00974090|42052844|FG001|Period 1: Double Blind Period|Adverse Event|1|||
19603914|NCT00974090|42052843|FG000|Period 1: Double Blind Period|Physician Decision|1|||
19603915|NCT00974090|42052844|FG001|Period 1: Double Blind Period|Physician Decision|0|||
19603916|NCT00974090|42052843|FG000|Period 2: Open-label Period|Adverse Event|4|||
19603917|NCT00974090|42052844|FG001|Period 2: Open-label Period|Adverse Event|6|||
19603918|NCT00974090|42052843|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
19603919|NCT00974090|42052844|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
19603920|NCT00974090|42052843|FG000|Period 2: Open-label Period|Physician Decision|0|||
19603921|NCT00974090|42052844|FG001|Period 2: Open-label Period|Physician Decision|3|||
19603922|NCT00974090|42052843|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
19603923|NCT00974090|42052844|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
19603924|NCT00971048|42052856|FG000|Overall Study|Protocol Violation|1|||
19603925|NCT00971048|42052857|FG001|Overall Study|Protocol Violation|2|||
19603926|NCT00971048|42052858|FG002|Overall Study|Protocol Violation|0|||
19603927|NCT00971048|42052859|FG003|Overall Study|Protocol Violation|1|||
19603928|NCT00971048|42052856|FG000|Overall Study|Adverse Event|0|||
19603929|NCT00971048|42052857|FG001|Overall Study|Adverse Event|0|||
19603930|NCT00971048|42052858|FG002|Overall Study|Adverse Event|1|||
19603931|NCT00971048|42052859|FG003|Overall Study|Adverse Event|0|||
19603932|NCT00971048|42052856|FG000|Overall Study|Physician Decision|0|||
19603933|NCT00971048|42052857|FG001|Overall Study|Physician Decision|0|||
19603934|NCT00971048|42052858|FG002|Overall Study|Physician Decision|0|||
19603935|NCT00971048|42052859|FG003|Overall Study|Physician Decision|1|||
19603936|NCT00699751|42052873|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
19603937|NCT00699751|42052874|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
19603938|NCT00699751|42052873|FG000|Period 1: Without/Before Drug Switch|Death|28|||
19603939|NCT00699751|42052874|FG001|Period 1: Without/Before Drug Switch|Death|29|||
19603940|NCT00699751|42052873|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
19759110|NCT02952313|42210412|FG000|Long-term Follow-up|Lost to Follow-up|12|||
19603941|NCT00699751|42052874|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
19674456|NCT00606593|42122205|FG008|Overall Study|Withdrawal of consent|0|||
19674457|NCT00606593|42122206|FG009|Overall Study|Withdrawal of consent|0|||
19674458|NCT00606593|42122197|FG000|Overall Study|Administrative/Other|0|||
19674459|NCT00606593|42122198|FG001|Overall Study|Administrative/Other|0|||
19674460|NCT00606593|42122199|FG002|Overall Study|Administrative/Other|1|||
19674461|NCT00606593|42122200|FG003|Overall Study|Administrative/Other|0|||
19674462|NCT00606593|42122201|FG004|Overall Study|Administrative/Other|0|||
19674463|NCT00606593|42122202|FG005|Overall Study|Administrative/Other|0|||
19674464|NCT00606593|42122203|FG006|Overall Study|Administrative/Other|0|||
19674465|NCT00606593|42122204|FG007|Overall Study|Administrative/Other|0|||
19674466|NCT00606593|42122205|FG008|Overall Study|Administrative/Other|0|||
19759111|NCT02952313|42210412|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
19759112|NCT02952313|42210412|FG000|Long-term Follow-up|Lack of Efficacy|6|||
19759113|NCT02952313|42210412|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
19674467|NCT00606593|42122206|FG009|Overall Study|Administrative/Other|0|||
19674468|NCT00605267|42122221|FG000|Overall Study|Adverse Event|0|||
19674469|NCT00605267|42122222|FG001|Overall Study|Adverse Event|1|||
19674470|NCT00605267|42122221|FG000|Overall Study|Lack of Efficacy|1|||
19674471|NCT00605267|42122222|FG001|Overall Study|Lack of Efficacy|5|||
19674472|NCT00605267|42122221|FG000|Overall Study|Withdrawal by Subject|2|||
19674473|NCT00605267|42122222|FG001|Overall Study|Withdrawal by Subject|3|||
19674474|NCT00605813|42122228|FG000|Overall Study|Protocol Violation|25|||
19674475|NCT00604721|42122241|FG000|Overall Study|Physician Decision|1|||
19674476|NCT00604721|42122241|FG000|Overall Study|Withdrawal by Subject|1|||
19674477|NCT00605657|42122246|FG000|Overall Study|Adverse Event|1|||
19674478|NCT00605657|42122246|FG000|Overall Study|Protocol Violation|1|||
19674479|NCT00604565|42122252|FG000|Overall Study|Study terminated|0|||
19674480|NCT00604565|42122253|FG001|Overall Study|Study terminated|3|||
19674481|NCT00605345|42122261|FG000|Overall Study|Withdrawal by Subject|1|||
19674482|NCT00605345|42122262|FG001|Overall Study|Withdrawal by Subject|0|||
19759114|NCT02952313|42210412|FG000|Long-term Follow-up|Physician Decision|1|||
19674483|NCT00605345|42122261|FG000|Overall Study|Adverse Event|0|||
19674484|NCT00605345|42122262|FG001|Overall Study|Adverse Event|1|||
19759115|NCT02952313|42210412|FG000|Long-term Follow-up|Death|1|||
19674485|NCT00605345|42122261|FG000|Overall Study|Protocol Violation|0|||
19674486|NCT00605345|42122262|FG001|Overall Study|Protocol Violation|2|||
19674487|NCT00604175|42122271|FG000|Entry Through Week 28|Death|2|||
19674488|NCT00604175|42122272|FG001|Entry Through Week 28|Death|0|||
19674489|NCT00604175|42122273|FG002|Entry Through Week 28|Death|0|||
19674490|NCT00604175|42122271|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
19674491|NCT00604175|42122272|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
19674492|NCT00604175|42122273|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
19674493|NCT00604175|42122271|FG000|Entry Through Week 28|Lost to Follow-up|4|||
19674494|NCT00604175|42122272|FG001|Entry Through Week 28|Lost to Follow-up|3|||
19674495|NCT00604175|42122273|FG002|Entry Through Week 28|Lost to Follow-up|0|||
19674496|NCT00604175|42122271|FG000|Entry Through Week 28|Ineligible|1|||
19674497|NCT00604175|42122272|FG001|Entry Through Week 28|Ineligible|0|||
19674498|NCT00604175|42122273|FG002|Entry Through Week 28|Ineligible|0|||
19674499|NCT00604175|42122271|FG000|Entry Through Week 28|Did not start intervention|2|||
19674500|NCT00604175|42122272|FG001|Entry Through Week 28|Did not start intervention|0|||
19674501|NCT00604175|42122273|FG002|Entry Through Week 28|Did not start intervention|1|||
19674502|NCT00604175|42122271|FG000|Week 29 Through Week 72|Death|0|||
19674503|NCT00604175|42122272|FG001|Week 29 Through Week 72|Death|0|||
19674504|NCT00604175|42122273|FG002|Week 29 Through Week 72|Death|1|||
19759116|NCT03119610|42210419|FG000|Overall Study|Adverse Event|1|||
19759117|NCT03119610|42210420|FG001|Overall Study|Adverse Event|0|||
19759118|NCT03119610|42210419|FG000|Overall Study|Lost to Follow-up|0|||
19759119|NCT03119610|42210420|FG001|Overall Study|Lost to Follow-up|1|||
19759120|NCT04005755|42210426|FG000|Overall Study|Adverse Event|6|||
19759121|NCT04005755|42210426|FG000|Overall Study|Physician Decision|3|||
19759122|NCT04005755|42210426|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
19759123|NCT04005755|42210426|FG000|Overall Study|Withdrawal by Subject|3|||
19759124|NCT04005755|42210426|FG000|Overall Study|Lost to Follow-up|1|||
19759125|NCT03442777|42210433|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
19759126|NCT03442777|42210434|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
19759127|NCT03442777|42210435|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
19759128|NCT03401749|42210444|FG000|Overall Study|Lost to Follow-up|20|||
19759129|NCT03401749|42210445|FG001|Overall Study|Lost to Follow-up|16|||
19759130|NCT03401749|42210446|FG002|Overall Study|Lost to Follow-up|26|||
19389043|NCT02672423|41632609|FG000|Period 2|Withdrawal by Subject|0|||
19389044|NCT02672423|41632610|FG001|Period 2|Withdrawal by Subject|0|||
19603942|NCT00699751|42052873|FG000|Period 1: Without/Before Drug Switch|Other|30|||
19603943|NCT00699751|42052874|FG001|Period 1: Without/Before Drug Switch|Other|20|||
19603944|NCT00699751|42052873|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
19603945|NCT00699751|42052874|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
19603946|NCT00699751|42052873|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
19603947|NCT00699751|42052874|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
19603948|NCT00699751|42052873|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
19603949|NCT00699751|42052874|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
19603950|NCT00699751|42052873|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
19603951|NCT00699751|42052874|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
19603952|NCT00970502|42052881|FG000|Overall Study|Withdrawal by Subject|1|||
19603953|NCT00967226|42052891|FG000|Overall Study|Adverse Event|0|||
19603954|NCT00967226|42052892|FG001|Overall Study|Adverse Event|5|||
19603955|NCT00967226|42052891|FG000|Overall Study|Protocol Violation|2|||
19674505|NCT00604175|42122271|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
19674506|NCT00604175|42122272|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
19674507|NCT00604175|42122273|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
19759131|NCT03029624|42210454|FG000|Overall Study|Adverse Event|1|||
19759132|NCT03029624|42210454|FG000|Overall Study|Withdrawal by Subject|1|||
19603956|NCT00967226|42052892|FG001|Overall Study|Protocol Violation|0|||
19603957|NCT00967226|42052891|FG000|Overall Study|Physician Decision|0|||
19603958|NCT00967226|42052892|FG001|Overall Study|Physician Decision|1|||
19603959|NCT00706381|42052926|FG000|Overall Study|Lost to Follow-up|0|||
19603960|NCT00706381|42052927|FG001|Overall Study|Lost to Follow-up|1|||
19603961|NCT00706381|42052928|FG002|Overall Study|Lost to Follow-up|1|||
19603962|NCT00706381|42052929|FG003|Overall Study|Lost to Follow-up|0|||
19603963|NCT00964886|42052946|FG000|Overall Study|Lost to Follow-up|2|||
19603964|NCT00964886|42052947|FG001|Overall Study|Lost to Follow-up|2|||
19603965|NCT00964886|42052948|FG002|Overall Study|Lost to Follow-up|6|||
19603966|NCT00964886|42052949|FG003|Overall Study|Lost to Follow-up|4|||
19603967|NCT00964886|42052946|FG000|Overall Study|Withdrawal by Subject|6|||
19603968|NCT00964886|42052947|FG001|Overall Study|Withdrawal by Subject|2|||
19603969|NCT00964886|42052948|FG002|Overall Study|Withdrawal by Subject|5|||
19603970|NCT00964886|42052949|FG003|Overall Study|Withdrawal by Subject|3|||
19603971|NCT00964886|42052946|FG000|Overall Study|Adverse Event|3|||
19603972|NCT00964886|42052947|FG001|Overall Study|Adverse Event|1|||
19603973|NCT00964886|42052948|FG002|Overall Study|Adverse Event|5|||
19603974|NCT00964886|42052949|FG003|Overall Study|Adverse Event|2|||
19603975|NCT00964886|42052946|FG000|Overall Study|Protocol Violation|0|||
19603976|NCT00964886|42052947|FG001|Overall Study|Protocol Violation|2|||
19603977|NCT00964886|42052948|FG002|Overall Study|Protocol Violation|0|||
19603978|NCT00964886|42052949|FG003|Overall Study|Protocol Violation|0|||
19603979|NCT00705757|42052966|FG000|Overall Study|Lack of Efficacy|5|||
19603980|NCT00705757|42052967|FG001|Overall Study|Lack of Efficacy|1|||
19603981|NCT00705757|42052968|FG002|Overall Study|Lack of Efficacy|3|||
19603982|NCT00705757|42052966|FG000|Overall Study|Lost to Follow-up|7|||
19603983|NCT00705757|42052967|FG001|Overall Study|Lost to Follow-up|6|||
19603984|NCT00705757|42052968|FG002|Overall Study|Lost to Follow-up|6|||
19603985|NCT00705757|42052966|FG000|Overall Study|Withdrawal by Subject|1|||
19603986|NCT00705757|42052967|FG001|Overall Study|Withdrawal by Subject|1|||
19603987|NCT00705757|42052968|FG002|Overall Study|Withdrawal by Subject|2|||
19603988|NCT00960752|42052996|FG000|Overall Study|Adverse Event|0|||
19603989|NCT00960752|42052997|FG001|Overall Study|Adverse Event|0|||
19603990|NCT00960752|42052998|FG002|Overall Study|Adverse Event|1|||
19603991|NCT00960752|42052996|FG000|Overall Study|Progression|0|||
19603992|NCT00960752|42052997|FG001|Overall Study|Progression|0|||
19603993|NCT00960752|42052998|FG002|Overall Study|Progression|1|||
19603994|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
19603995|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
19603996|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
19603997|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19603998|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
19759133|NCT03029624|42210454|FG000|Overall Study|Lack of Efficacy|1|||
19759134|NCT03029624|42210454|FG000|Overall Study|MRI need|2|||
19603999|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
19674508|NCT00604175|42122271|FG000|Week 29 Through Week 72|Site closure|0|||
19674509|NCT00604175|42122272|FG001|Week 29 Through Week 72|Site closure|1|||
19674510|NCT00604175|42122273|FG002|Week 29 Through Week 72|Site closure|0|||
19674511|NCT00604175|42122271|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
19604000|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604001|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604002|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604003|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604004|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604005|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604006|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19674512|NCT00604175|42122272|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
19674513|NCT00604175|42122273|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
19604007|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604008|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604009|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19674514|NCT00605189|42122308|FG000|Overall Study|Adverse Event|1|||
19674515|NCT00605189|42122309|FG001|Overall Study|Adverse Event|0|||
19674516|NCT00605189|42122310|FG002|Overall Study|Adverse Event|0|||
19674517|NCT00605189|42122308|FG000|Overall Study|Other|2|||
19674518|NCT00605189|42122309|FG001|Overall Study|Other|2|||
19674519|NCT00605189|42122310|FG002|Overall Study|Other|0|||
19674520|NCT00340834|42122323|FG000|Core Phase of Study|Adverse Event|26|||
19759135|NCT02952001|42210462|FG000|Overall Study|Adverse Event|3|||
19759136|NCT02952001|42210463|FG001|Overall Study|Adverse Event|0|||
19759137|NCT02952001|42210462|FG000|Overall Study|Prohibited therapy|10|||
19759138|NCT02952001|42210463|FG001|Overall Study|Prohibited therapy|3|||
19759139|NCT02952001|42210462|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
19759140|NCT02952001|42210463|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
19759141|NCT04123067|42210472|FG000|Overall Study|Lost to Follow-up|0|||
19759142|NCT04123067|42210473|FG001|Overall Study|Lost to Follow-up|1|||
19759143|NCT04117607|42210482|FG000|Overall Study|Early Termination|0|||
19759144|NCT04117607|42210483|FG001|Overall Study|Early Termination|1|||
19759145|NCT04117607|42210484|FG002|Overall Study|Early Termination|0|||
19674521|NCT00340834|42122324|FG001|Core Phase of Study|Adverse Event|9|||
19674522|NCT00340834|42122325|FG002|Core Phase of Study|Adverse Event|9|||
19674523|NCT00340834|42122326|FG003|Core Phase of Study|Adverse Event|0|||
19604010|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
19604011|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
19604012|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604013|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
19604014|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
19604015|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
19604016|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
19604017|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604018|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604019|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604020|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604021|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604022|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604023|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19674524|NCT00340834|42122327|FG004|Core Phase of Study|Adverse Event|0|||
19674525|NCT00340834|42122323|FG000|Core Phase of Study|Withdrawal by Subject|11|||
19759146|NCT04117607|42210485|FG003|Overall Study|Early Termination|0|||
19674526|NCT00340834|42122324|FG001|Core Phase of Study|Withdrawal by Subject|9|||
19759147|NCT04117607|42210486|FG004|Overall Study|Early Termination|0|||
19759148|NCT04117607|42210487|FG005|Overall Study|Early Termination|0|||
19759149|NCT04117607|42210488|FG006|Overall Study|Early Termination|1|||
19759150|NCT04117607|42210489|FG007|Overall Study|Early Termination|0|||
19759151|NCT04117607|42210490|FG008|Overall Study|Early Termination|0|||
19674527|NCT00340834|42122325|FG002|Core Phase of Study|Withdrawal by Subject|16|||
19674528|NCT00340834|42122326|FG003|Core Phase of Study|Withdrawal by Subject|0|||
19674529|NCT00340834|42122327|FG004|Core Phase of Study|Withdrawal by Subject|0|||
19759152|NCT04117607|42210491|FG009|Overall Study|Early Termination|0|||
19604024|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604025|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604026|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604027|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
19604028|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
19604029|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
19604030|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
19604031|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
19604032|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
19604033|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
19759153|NCT04117607|42210492|FG010|Overall Study|Early Termination|0|||
19604034|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19759154|NCT04117607|42210493|FG011|Overall Study|Early Termination|0|||
19759155|NCT04117607|42210494|FG012|Overall Study|Early Termination|0|||
19759156|NCT04117607|42210495|FG013|Overall Study|Early Termination|0|||
19759157|NCT04112303|42210511|FG000|Overall Study|Death|1|||
19759158|NCT03998189|42210517|FG000|Overall Study|Lack of Efficacy|0|||
19759159|NCT03998189|42210518|FG001|Overall Study|Lack of Efficacy|1|||
19759160|NCT04099277|42210524|FG000|Overall Study|Physician Decision|1|||
19759161|NCT04099277|42210524|FG000|Overall Study|Withdrawal by Subject|1|||
19759162|NCT03990389|42210530|FG000|Overall Study|Lost to Follow-up|3|||
19759163|NCT03990389|42210531|FG001|Overall Study|Lost to Follow-up|0|||
19759164|NCT03988907|42210539|FG000|Overall Study|Unable to complete visit|0|||
19759165|NCT03988907|42210540|FG001|Overall Study|Unable to complete visit|1|||
19759166|NCT03987191|42210554|FG000|Overall Study|COVID-19 related research disruption|0|||
19759167|NCT03987191|42210555|FG001|Overall Study|COVID-19 related research disruption|2|||
19759168|NCT04098809|42210563|FG000|Overall Study|Withdrawal by Subject|1|||
19759169|NCT04098809|42210564|FG001|Overall Study|Withdrawal by Subject|3|||
19759170|NCT04098809|42210563|FG000|Overall Study|Physician Decision|2|||
19759171|NCT04098809|42210564|FG001|Overall Study|Physician Decision|1|||
19759172|NCT03122184|42210572|FG000|Overall Study|Lost to Follow-up|4|||
19759173|NCT03122184|42210573|FG001|Overall Study|Lost to Follow-up|6|||
19759174|NCT03122184|42210572|FG000|Overall Study|Withdrawal by Subject|3|||
19759175|NCT03122184|42210573|FG001|Overall Study|Withdrawal by Subject|0|||
19759176|NCT03122184|42210572|FG000|Overall Study|Terminated due to cognitive problem|1|||
19759177|NCT03122184|42210573|FG001|Overall Study|Terminated due to cognitive problem|0|||
19759178|NCT04091087|42210598|FG000|Overall Study|Not treated|1|||
19759179|NCT04091087|42210599|FG001|Overall Study|Not treated|0|||
19759180|NCT04091087|42210598|FG000|Overall Study|Adverse Event|4|||
19674530|NCT00340834|42122323|FG000|Core Phase of Study|Administrative Problems|6|||
19674531|NCT00340834|42122324|FG001|Core Phase of Study|Administrative Problems|2|||
19674532|NCT00340834|42122325|FG002|Core Phase of Study|Administrative Problems|7|||
19674533|NCT00340834|42122326|FG003|Core Phase of Study|Administrative Problems|0|||
19674534|NCT00340834|42122327|FG004|Core Phase of Study|Administrative Problems|0|||
19674535|NCT00340834|42122323|FG000|Core Phase of Study|Lack of Efficacy|3|||
19674536|NCT00340834|42122324|FG001|Core Phase of Study|Lack of Efficacy|3|||
19674537|NCT00340834|42122325|FG002|Core Phase of Study|Lack of Efficacy|7|||
19674538|NCT00340834|42122326|FG003|Core Phase of Study|Lack of Efficacy|0|||
19674539|NCT00340834|42122327|FG004|Core Phase of Study|Lack of Efficacy|0|||
19674540|NCT00340834|42122323|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
19674541|NCT00340834|42122324|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
19674542|NCT00340834|42122325|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
19674543|NCT00340834|42122326|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
19674544|NCT00340834|42122327|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
19674545|NCT00340834|42122323|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
19674546|NCT00340834|42122324|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
19674547|NCT00340834|42122325|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
19674548|NCT00340834|42122326|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
19674549|NCT00340834|42122327|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
19674550|NCT00340834|42122323|FG000|Core Phase of Study|Lost to Follow-up|1|||
19674551|NCT00340834|42122324|FG001|Core Phase of Study|Lost to Follow-up|1|||
19674552|NCT00340834|42122325|FG002|Core Phase of Study|Lost to Follow-up|4|||
19674553|NCT00340834|42122326|FG003|Core Phase of Study|Lost to Follow-up|0|||
19674554|NCT00340834|42122327|FG004|Core Phase of Study|Lost to Follow-up|0|||
19674555|NCT00340834|42122323|FG000|Core Phase of Study|Death|2|||
19759181|NCT04091087|42210599|FG001|Overall Study|Adverse Event|4|||
19759182|NCT04091087|42210598|FG000|Overall Study|Protocol Violation|0|||
19759183|NCT04091087|42210599|FG001|Overall Study|Protocol Violation|1|||
19759184|NCT04091087|42210598|FG000|Overall Study|Withdrawal by Subject|5|||
19674556|NCT00340834|42122324|FG001|Core Phase of Study|Death|0|||
19674557|NCT00340834|42122325|FG002|Core Phase of Study|Death|0|||
19674558|NCT00340834|42122326|FG003|Core Phase of Study|Death|0|||
19674559|NCT00340834|42122327|FG004|Core Phase of Study|Death|0|||
19759185|NCT04091087|42210599|FG001|Overall Study|Withdrawal by Subject|2|||
19759186|NCT03400033|42210617|FG000|Overall Study|Withdrawal by Subject|1|||
19759187|NCT03400033|42210618|FG001|Overall Study|Withdrawal by Subject|2|||
19604035|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604036|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604037|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604038|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604039|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604040|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19759188|NCT04089761|42210633|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
19759189|NCT04089761|42210633|FG000|"Run In Phase"|Lost to Follow-up|1|||
19759190|NCT04089761|42210633|FG000|"Treatment Phase"|No evaluable data|5|||
19759191|NCT04089761|42210633|FG000|"Treatment Phase"|Lost to Follow-up|1|||
19759192|NCT03118518|42210639|FG000|Overall Study|Early Exit after treatment|2|||
19759193|NCT03118518|42210640|FG001|Overall Study|Early Exit after treatment|8|||
19759194|NCT03118518|42210639|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
19759195|NCT03118518|42210640|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
19759196|NCT03984305|42210648|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
19759197|NCT03984305|42210649|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
19759198|NCT03984305|42210648|FG000|Overall Study|Withdrawal by Subject|3|||
19759199|NCT03984305|42210649|FG001|Overall Study|Withdrawal by Subject|3|||
19759200|NCT03984305|42210648|FG000|Overall Study|Lost to Follow-up|1|||
19759201|NCT03984305|42210649|FG001|Overall Study|Lost to Follow-up|0|||
19759202|NCT03397771|42210657|FG000|Overall Study|2 erroneously randomized, never treated|3|||
19759203|NCT03397771|42210658|FG001|Overall Study|2 erroneously randomized, never treated|1|||
19759204|NCT03397771|42210657|FG000|Overall Study|Withdrawal by Subject|1|||
19759205|NCT03397771|42210658|FG001|Overall Study|Withdrawal by Subject|3|||
19759206|NCT03397771|42210657|FG000|Overall Study|Protocol Violation|2|||
19759207|NCT03397771|42210658|FG001|Overall Study|Protocol Violation|2|||
19759208|NCT03397771|42210657|FG000|Overall Study|Adverse Event|2|||
19759209|NCT03397771|42210658|FG001|Overall Study|Adverse Event|1|||
19759210|NCT02876835|42210666|FG000|Treatment Period (51.1 Month)|Other|1|||
19759211|NCT02876835|42210667|FG001|Treatment Period (51.1 Month)|Other|0|||
19759212|NCT02876835|42210666|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
19759213|NCT02876835|42210667|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
19759214|NCT02876835|42210666|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
19759215|NCT02876835|42210667|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
19759216|NCT02876835|42210666|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
19759217|NCT02876835|42210667|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
19759218|NCT04086641|42210676|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
19759219|NCT04086641|42210677|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
19759220|NCT03503318|42210686|FG000|Overall Study|Death|1|||
19759221|NCT03503318|42210687|FG001|Overall Study|Death|0|||
19759222|NCT03503318|42210688|FG002|Overall Study|Death|4|||
19759223|NCT03503318|42210686|FG000|Overall Study|Adverse Event|3|||
19604041|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19674560|NCT00340834|42122323|FG000|Core Phase of Study|Protocol Violation|0|||
19674561|NCT00340834|42122324|FG001|Core Phase of Study|Protocol Violation|0|||
19674562|NCT00340834|42122325|FG002|Core Phase of Study|Protocol Violation|2|||
19674563|NCT00340834|42122326|FG003|Core Phase of Study|Protocol Violation|0|||
19674564|NCT00340834|42122327|FG004|Core Phase of Study|Protocol Violation|0|||
19674565|NCT00340834|42122323|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
19674566|NCT00340834|42122324|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
19674567|NCT00340834|42122325|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
19674568|NCT00340834|42122326|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
19674569|NCT00340834|42122327|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
19674570|NCT00340834|42122323|FG000|Extension Phase of Study|Subject withdrew consent|26|||
19674571|NCT00340834|42122324|FG001|Extension Phase of Study|Subject withdrew consent|31|||
19674572|NCT00340834|42122325|FG002|Extension Phase of Study|Subject withdrew consent|0|||
19674573|NCT00340834|42122326|FG003|Extension Phase of Study|Subject withdrew consent|12|||
19759224|NCT03503318|42210687|FG001|Overall Study|Adverse Event|4|||
19759225|NCT03503318|42210688|FG002|Overall Study|Adverse Event|2|||
19759226|NCT03503318|42210686|FG000|Overall Study|Withdrawal by Subject|12|||
19759227|NCT03503318|42210687|FG001|Overall Study|Withdrawal by Subject|17|||
19759228|NCT03503318|42210688|FG002|Overall Study|Withdrawal by Subject|16|||
19674574|NCT00340834|42122327|FG004|Extension Phase of Study|Subject withdrew consent|15|||
19674575|NCT00340834|42122323|FG000|Extension Phase of Study|Adverse Event|21|||
19674576|NCT00340834|42122324|FG001|Extension Phase of Study|Adverse Event|22|||
19674577|NCT00340834|42122325|FG002|Extension Phase of Study|Adverse Event|0|||
19674578|NCT00340834|42122326|FG003|Extension Phase of Study|Adverse Event|19|||
19674579|NCT00340834|42122327|FG004|Extension Phase of Study|Adverse Event|7|||
19674580|NCT00340834|42122323|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
19674581|NCT00340834|42122324|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
19674582|NCT00340834|42122325|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
19674583|NCT00340834|42122326|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
19674584|NCT00340834|42122327|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
19674585|NCT00340834|42122323|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
19674586|NCT00340834|42122324|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
19674587|NCT00340834|42122325|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
19674588|NCT00340834|42122326|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
19674589|NCT00340834|42122327|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
19674590|NCT00340834|42122323|FG000|Extension Phase of Study|Lost to Follow-up|1|||
19674591|NCT00340834|42122324|FG001|Extension Phase of Study|Lost to Follow-up|1|||
19674592|NCT00340834|42122325|FG002|Extension Phase of Study|Lost to Follow-up|0|||
19674593|NCT00340834|42122326|FG003|Extension Phase of Study|Lost to Follow-up|2|||
19759229|NCT03503318|42210686|FG000|Overall Study|Protocol Violation|5|||
19759230|NCT03503318|42210687|FG001|Overall Study|Protocol Violation|0|||
19759231|NCT03503318|42210688|FG002|Overall Study|Protocol Violation|3|||
19759232|NCT03503318|42210686|FG000|Overall Study|Lost to Follow-up|17|||
19759233|NCT03503318|42210687|FG001|Overall Study|Lost to Follow-up|15|||
19759234|NCT03503318|42210688|FG002|Overall Study|Lost to Follow-up|12|||
19759235|NCT03503318|42210686|FG000|Overall Study|Other than specified|1|||
19759236|NCT03503318|42210687|FG001|Overall Study|Other than specified|3|||
19604042|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604043|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604044|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
19604045|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604046|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
19604047|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
19604048|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604049|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
19604050|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
19604051|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604052|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604053|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604054|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19674594|NCT00340834|42122327|FG004|Extension Phase of Study|Lost to Follow-up|3|||
19759237|NCT03503318|42210688|FG002|Overall Study|Other than specified|3|||
19759238|NCT03396913|42210698|FG000|Overall Study|Lost to Follow-up|0|||
19759239|NCT03396913|42210699|FG001|Overall Study|Lost to Follow-up|6|||
19759240|NCT03982433|42210705|FG000|Overall Study|Lost to Follow-up|1|||
19674595|NCT00340834|42122323|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
19674596|NCT00340834|42122324|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
19674597|NCT00340834|42122325|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
19674598|NCT00340834|42122326|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
19674599|NCT00340834|42122327|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
19674600|NCT00340834|42122323|FG000|Extension Phase of Study|Administrative problems|3|||
19674601|NCT00340834|42122324|FG001|Extension Phase of Study|Administrative problems|0|||
19674602|NCT00340834|42122325|FG002|Extension Phase of Study|Administrative problems|0|||
19674603|NCT00340834|42122326|FG003|Extension Phase of Study|Administrative problems|1|||
19674604|NCT00340834|42122327|FG004|Extension Phase of Study|Administrative problems|1|||
19674605|NCT00340834|42122323|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
19674606|NCT00340834|42122324|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
19674607|NCT00340834|42122325|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
19674608|NCT00340834|42122326|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
19674609|NCT00340834|42122327|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
19759241|NCT03396835|42210709|FG000|Overall Study|Withdrawn prior to completion|1|||
19759242|NCT03396835|42210709|FG000|Overall Study|Did not meet criteria for data analysis|1|||
19674610|NCT00340834|42122323|FG000|Extension Phase of Study|Protocol Violation|3|||
19674611|NCT00340834|42122324|FG001|Extension Phase of Study|Protocol Violation|0|||
19674612|NCT00340834|42122325|FG002|Extension Phase of Study|Protocol Violation|0|||
19674613|NCT00340834|42122326|FG003|Extension Phase of Study|Protocol Violation|0|||
19674614|NCT00340834|42122327|FG004|Extension Phase of Study|Protocol Violation|0|||
19674615|NCT00340834|42122323|FG000|Extension Phase of Study|Death|0|||
19674616|NCT00340834|42122324|FG001|Extension Phase of Study|Death|0|||
19674617|NCT00340834|42122325|FG002|Extension Phase of Study|Death|0|||
19674618|NCT00340834|42122326|FG003|Extension Phase of Study|Death|0|||
19674619|NCT00340834|42122327|FG004|Extension Phase of Study|Death|1|||
19674620|NCT00603941|42122340|FG000|Overall Study|Disease progression|6|||
19674621|NCT00603941|42122341|FG001|Overall Study|Disease progression|7|||
19674622|NCT00603941|42122342|FG002|Overall Study|Disease progression|1|||
19674623|NCT00603941|42122340|FG000|Overall Study|Adverse Event|1|||
19674624|NCT00603941|42122341|FG001|Overall Study|Adverse Event|0|||
19674625|NCT00603941|42122342|FG002|Overall Study|Adverse Event|1|||
19674626|NCT00603941|42122340|FG000|Overall Study|Physician Decision|0|||
19674627|NCT00603941|42122341|FG001|Overall Study|Physician Decision|1|||
19674628|NCT00603941|42122342|FG002|Overall Study|Physician Decision|0|||
19674629|NCT00603941|42122340|FG000|Overall Study|Withdrawal by Subject|0|||
19674630|NCT00603941|42122341|FG001|Overall Study|Withdrawal by Subject|2|||
19759243|NCT03122106|42210713|FG000|Overall Study|Not enough tissue|1|||
19759244|NCT03122106|42210713|FG000|Overall Study|Disease progression during screening|2|||
19759245|NCT03122106|42210713|FG000|Overall Study|Poor RNA quality for vaccine|1|||
19759246|NCT04084769|42210721|FG000|Overall Study|Protocol Violation|1|||
19759247|NCT04084769|42210722|FG001|Overall Study|Protocol Violation|3|||
19759248|NCT04084769|42210723|FG002|Overall Study|Protocol Violation|0|||
19759249|NCT04084769|42210724|FG003|Overall Study|Protocol Violation|1|||
19604055|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604056|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604057|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604058|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604059|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604060|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604061|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
19604062|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604063|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604064|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
19604065|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
19674631|NCT00603941|42122342|FG002|Overall Study|Withdrawal by Subject|0|||
19674632|NCT00340678|42122355|FG000|Overall Study|Lost to Follow-up|1|||
19674633|NCT00340678|42122356|FG001|Overall Study|Lost to Follow-up|0|||
19674634|NCT00340678|42122357|FG002|Overall Study|Lost to Follow-up|0|||
19674635|NCT00340678|42122358|FG003|Overall Study|Lost to Follow-up|0|||
19674636|NCT00336856|42122366|FG000|Overall Study|Withdrawal by Subject|3|||
19674637|NCT00336856|42122366|FG000|Overall Study|Found ineligible at time of analysis|1|||
19759250|NCT04084769|42210721|FG000|Overall Study|Withdrawal by Subject|0|||
19759251|NCT04084769|42210722|FG001|Overall Study|Withdrawal by Subject|1|||
19759252|NCT04084769|42210723|FG002|Overall Study|Withdrawal by Subject|0|||
19759253|NCT04084769|42210724|FG003|Overall Study|Withdrawal by Subject|0|||
19759254|NCT04084769|42210721|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19759255|NCT04084769|42210722|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19759256|NCT04084769|42210723|FG002|Overall Study|Withdrawal by parent/guardian|0|||
19759257|NCT04084769|42210724|FG003|Overall Study|Withdrawal by parent/guardian|1|||
19759258|NCT04084769|42210721|FG000|Overall Study|Lost to Follow-up|2|||
19759259|NCT04084769|42210722|FG001|Overall Study|Lost to Follow-up|0|||
19759260|NCT04084769|42210723|FG002|Overall Study|Lost to Follow-up|0|||
19759261|NCT04084769|42210724|FG003|Overall Study|Lost to Follow-up|0|||
19759262|NCT03121950|42210741|FG000|Overall Study|Withdrawal by Subject|11|||
19759263|NCT03121950|42210742|FG001|Overall Study|Withdrawal by Subject|2|||
19759264|NCT03395353|42210750|FG000|Overall Study|Adverse Event|20|||
19759265|NCT03395353|42210750|FG000|Overall Study|Protocol Violation|1|||
19674638|NCT00336544|42122372|FG000|Overall Study|Lack of Efficacy|8|||
19674639|NCT00336544|42122373|FG001|Overall Study|Lack of Efficacy|5|||
19604066|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604067|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604068|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604069|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604070|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604071|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604072|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604073|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604074|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604075|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604076|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19674640|NCT00336544|42122372|FG000|Overall Study|Adverse Event|4|||
19674641|NCT00336544|42122373|FG001|Overall Study|Adverse Event|9|||
19674642|NCT00336544|42122372|FG000|Overall Study|Withdrawal by Subject|4|||
19674643|NCT00336544|42122373|FG001|Overall Study|Withdrawal by Subject|3|||
19674644|NCT00336544|42122372|FG000|Overall Study|Other|3|||
19674645|NCT00336544|42122373|FG001|Overall Study|Other|5|||
19674646|NCT00605033|42122381|FG000|Overall Study|Adverse Event|2|||
19674647|NCT00605033|42122382|FG001|Overall Study|Adverse Event|2|||
19674648|NCT00605033|42122381|FG000|Overall Study|Lost to Follow-up|1|||
19674649|NCT00605033|42122382|FG001|Overall Study|Lost to Follow-up|1|||
19674650|NCT00605033|42122381|FG000|Overall Study|Withdrawal by Subject|3|||
19674651|NCT00605033|42122382|FG001|Overall Study|Withdrawal by Subject|4|||
19674652|NCT00605033|42122381|FG000|Overall Study|Protocol Violation|1|||
19674653|NCT00605033|42122382|FG001|Overall Study|Protocol Violation|1|||
19674654|NCT00339040|42122390|FG000|Stage I|Not able to attend clinic|1|||
19674655|NCT00339040|42122391|FG001|Stage I|Not able to attend clinic|0|||
19674656|NCT00339040|42122390|FG000|Stage I|Protocol Violation|1|||
19674657|NCT00339040|42122391|FG001|Stage I|Protocol Violation|1|||
19674658|NCT00339040|42122390|FG000|Stage II|Lost to Follow-up|3|||
19674659|NCT00339040|42122391|FG001|Stage II|Lost to Follow-up|0|||
19674660|NCT00339040|42122390|FG000|Stage II|Withdrawal by Subject|1|||
19674661|NCT00339040|42122391|FG001|Stage II|Withdrawal by Subject|2|||
19674662|NCT00339040|42122390|FG000|Stage II|Protocol Violation|3|||
19674663|NCT00339040|42122391|FG001|Stage II|Protocol Violation|0|||
19674664|NCT00339040|42122390|FG000|Stage II|Not able to attend clinic|1|||
19674665|NCT00339040|42122391|FG001|Stage II|Not able to attend clinic|0|||
19674666|NCT00339040|42122390|FG000|Stage II|Site closing|2|||
19674667|NCT00339040|42122391|FG001|Stage II|Site closing|0|||
19674668|NCT00338962|42122401|FG000|Overall Study|Lost to Follow-up|3|||
19674669|NCT00338962|42122402|FG001|Overall Study|Lost to Follow-up|3|||
19674670|NCT00338962|42122403|FG002|Overall Study|Lost to Follow-up|2|||
19674671|NCT00338962|42122404|FG003|Overall Study|Lost to Follow-up|3|||
19674672|NCT00338962|42122401|FG000|Overall Study|Withdrawal by Subject|1|||
19674673|NCT00338962|42122402|FG001|Overall Study|Withdrawal by Subject|0|||
19674674|NCT00338962|42122403|FG002|Overall Study|Withdrawal by Subject|0|||
19674675|NCT00338962|42122404|FG003|Overall Study|Withdrawal by Subject|0|||
19674676|NCT00338962|42122401|FG000|Overall Study|No Transportation|2|||
19674677|NCT00338962|42122402|FG001|Overall Study|No Transportation|0|||
19674678|NCT00338962|42122403|FG002|Overall Study|No Transportation|0|||
19674679|NCT00338962|42122404|FG003|Overall Study|No Transportation|0|||
19674680|NCT00338962|42122401|FG000|Overall Study|Time Constraint|2|||
19674681|NCT00338962|42122402|FG001|Overall Study|Time Constraint|0|||
19674682|NCT00338962|42122403|FG002|Overall Study|Time Constraint|0|||
19674683|NCT00338962|42122404|FG003|Overall Study|Time Constraint|0|||
19674684|NCT00338962|42122401|FG000|Overall Study|Moved|0|||
19674685|NCT00338962|42122402|FG001|Overall Study|Moved|1|||
19674686|NCT00338962|42122403|FG002|Overall Study|Moved|0|||
19674687|NCT00338962|42122404|FG003|Overall Study|Moved|0|||
19674688|NCT00338962|42122401|FG000|Overall Study|Adverse Event|0|||
19759266|NCT03395353|42210750|FG000|Overall Study|Lack of Efficacy|3|||
19674689|NCT00338962|42122402|FG001|Overall Study|Adverse Event|0|||
19674690|NCT00338962|42122403|FG002|Overall Study|Adverse Event|2|||
19674691|NCT00338962|42122404|FG003|Overall Study|Adverse Event|0|||
19674692|NCT00338962|42122401|FG000|Overall Study|Poor Compliance|0|||
19674693|NCT00338962|42122402|FG001|Overall Study|Poor Compliance|0|||
19674694|NCT00338962|42122403|FG002|Overall Study|Poor Compliance|2|||
19674695|NCT00338962|42122404|FG003|Overall Study|Poor Compliance|0|||
19759267|NCT03395353|42210750|FG000|Overall Study|Withdrawal by Subject|24|||
19759268|NCT03395353|42210750|FG000|Overall Study|Discontinued visit|1|||
19759269|NCT03395353|42210750|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
19759270|NCT03395353|42210750|FG000|Overall Study|Physician Decision|4|||
19674696|NCT00568061|42122416|FG000|Overall Study|Inclusion / exclusion criteria|5|||
19674697|NCT00568061|42122417|FG001|Overall Study|Inclusion / exclusion criteria|1|||
19674698|NCT00568061|42122416|FG000|Overall Study|Adverse Event|0|||
19674699|NCT00568061|42122417|FG001|Overall Study|Adverse Event|1|||
19674700|NCT00338884|42122424|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
19674701|NCT00338884|42122424|FG000|Overall Study|Adverse Event|14|||
19674702|NCT00338884|42122424|FG000|Overall Study|Death|8|||
19674703|NCT00338884|42122424|FG000|Overall Study|Other|4|||
19674704|NCT00338884|42122424|FG000|Overall Study|Global Deterioration of Health Status|3|||
19674705|NCT00338884|42122424|FG000|Overall Study|Withdrawal by Subject|3|||
19674706|NCT00338884|42122424|FG000|Overall Study|Lost to Follow-up|1|||
19674707|NCT00338884|42122424|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
19674708|NCT00338806|42122430|FG000|Acute Phase|Withdrawal by Subject|0|||
19674709|NCT00338806|42122431|FG001|Acute Phase|Withdrawal by Subject|1|||
19674710|NCT00338806|42122430|FG000|Follow-up|Lost to Follow-up|1|||
19674711|NCT00338806|42122431|FG001|Follow-up|Lost to Follow-up|3|||
19674712|NCT03038100|42122441|FG000|Overall Study|Death|289|||
19674713|NCT03038100|42122442|FG001|Overall Study|Death|272|||
19674714|NCT03038100|42122441|FG000|Overall Study|Lost to Follow-up|9|||
19674715|NCT03038100|42122442|FG001|Overall Study|Lost to Follow-up|10|||
19674716|NCT03038100|42122441|FG000|Overall Study|Protocol Deviation|1|||
19674717|NCT03038100|42122442|FG001|Overall Study|Protocol Deviation|4|||
19674718|NCT03038100|42122441|FG000|Overall Study|Withdrawal by Subject|45|||
19674719|NCT03038100|42122442|FG001|Overall Study|Withdrawal by Subject|51|||
19674720|NCT03038100|42122441|FG000|Overall Study|Study Terminated By Sponsor|305|||
19674721|NCT03038100|42122442|FG001|Overall Study|Study Terminated By Sponsor|311|||
19674722|NCT03038100|42122441|FG000|Overall Study|Physician Decision|1|||
19674723|NCT03038100|42122442|FG001|Overall Study|Physician Decision|3|||
19674724|NCT00338728|42122449|FG000|Overall Study|Screen Failure|14|||
19674725|NCT00566501|42122455|FG000|Overall Study|Adverse Event|68|||
19674726|NCT00566501|42122456|FG001|Overall Study|Adverse Event|59|||
19674727|NCT00566501|42122455|FG000|Overall Study|Medication Non-compliance|5|||
19674728|NCT00566501|42122456|FG001|Overall Study|Medication Non-compliance|0|||
19674729|NCT00566501|42122455|FG000|Overall Study|Protocol Violation|2|||
19674730|NCT00566501|42122456|FG001|Overall Study|Protocol Violation|2|||
19674731|NCT00566501|42122455|FG000|Overall Study|Request of Investigator or Sponsor|6|||
19674732|NCT00566501|42122456|FG001|Overall Study|Request of Investigator or Sponsor|7|||
19674733|NCT00566501|42122455|FG000|Overall Study|Withdrawal by Subject|33|||
19674734|NCT00566501|42122456|FG001|Overall Study|Withdrawal by Subject|30|||
19674735|NCT00566501|42122455|FG000|Overall Study|Lack of Efficacy|8|||
19674736|NCT00566501|42122456|FG001|Overall Study|Lack of Efficacy|3|||
19674737|NCT00566501|42122455|FG000|Overall Study|Other|25|||
19674738|NCT00566501|42122456|FG001|Overall Study|Other|21|||
19674739|NCT00504894|42122465|FG000|Overall Study|fMRI technical problems|1|||
19759271|NCT03395353|42210750|FG000|Overall Study|Early termination of overall study|33|||
19759272|NCT04082663|42210758|FG000|Overall Study|Adverse Event|6|||
19759273|NCT04082663|42210758|FG000|Overall Study|Lost to Follow-up|1|||
19759274|NCT03682367|42210764|FG000|Overall Study|Protocol Violation|2|||
19759275|NCT03682367|42210765|FG001|Overall Study|Protocol Violation|1|||
19674740|NCT00504894|42122466|FG001|Overall Study|fMRI technical problems|1|||
19674741|NCT00504894|42122467|FG002|Overall Study|fMRI technical problems|0|||
19674742|NCT00504894|42122465|FG000|Overall Study|Withdrawal by Subject|0|||
19674743|NCT00504894|42122466|FG001|Overall Study|Withdrawal by Subject|1|||
19674744|NCT00504894|42122467|FG002|Overall Study|Withdrawal by Subject|0|||
19674745|NCT00504894|42122465|FG000|Overall Study|Infusion technical problems|0|||
19674746|NCT00504894|42122466|FG001|Overall Study|Infusion technical problems|1|||
19674747|NCT00504894|42122467|FG002|Overall Study|Infusion technical problems|0|||
19674748|NCT00504894|42122465|FG000|Overall Study|poor subject data|2|||
19674749|NCT00504894|42122466|FG001|Overall Study|poor subject data|0|||
19674750|NCT00504894|42122467|FG002|Overall Study|poor subject data|0|||
19674751|NCT00504582|42122478|FG000|Overall Study|Lost to Follow-up|1|||
19759276|NCT03682367|42210764|FG000|Overall Study|Closed Study Early|0|||
19674752|NCT00504582|42122479|FG001|Overall Study|Lost to Follow-up|0|||
19674753|NCT00504582|42122480|FG002|Overall Study|Lost to Follow-up|0|||
19674754|NCT00513240|42122490|FG000|Overall Study|Did not have intended surgery|3|||
19759277|NCT03682367|42210765|FG001|Overall Study|Closed Study Early|3|||
19759278|NCT03681353|42210771|FG000|Overall Study|Lost to Follow-up|2|||
19759279|NCT03681353|42210771|FG000|Overall Study|Withdrawal by Subject|3|||
19759280|NCT03681353|42210771|FG000|Overall Study|withdrawn by PI|2|||
19674755|NCT00513240|42122491|FG001|Overall Study|Did not have intended surgery|0|||
19674756|NCT00513240|42122490|FG000|Overall Study|Death|3|||
19674757|NCT00513240|42122491|FG001|Overall Study|Death|3|||
19674758|NCT00513240|42122490|FG000|Overall Study|Withdrawal by Subject|7|||
19674759|NCT00513240|42122491|FG001|Overall Study|Withdrawal by Subject|4|||
19674760|NCT00504426|42122504|FG000|Overall Study|Adverse Event|0|||
19674761|NCT00504426|42122505|FG001|Overall Study|Adverse Event|0|||
19674762|NCT00504426|42122506|FG002|Overall Study|Adverse Event|2|||
19674763|NCT00504426|42122507|FG003|Overall Study|Adverse Event|0|||
19674764|NCT00504426|42122504|FG000|Overall Study|Protocol Violation|1|||
19674765|NCT00504426|42122505|FG001|Overall Study|Protocol Violation|1|||
19674766|NCT00504426|42122506|FG002|Overall Study|Protocol Violation|2|||
19674767|NCT00504426|42122507|FG003|Overall Study|Protocol Violation|0|||
19674768|NCT00504426|42122504|FG000|Overall Study|Withdrawal by Subject|2|||
19674769|NCT00504426|42122505|FG001|Overall Study|Withdrawal by Subject|0|||
19674770|NCT00504426|42122506|FG002|Overall Study|Withdrawal by Subject|0|||
19674771|NCT00504426|42122507|FG003|Overall Study|Withdrawal by Subject|0|||
19759281|NCT03394885|42210775|FG000|Overall Study|Adverse Event|4|||
19759282|NCT03394885|42210775|FG000|Overall Study|Lack of Efficacy|1|||
19759283|NCT03394885|42210775|FG000|Overall Study|Physician Decision|1|||
19759284|NCT03394885|42210775|FG000|Overall Study|Withdrawal by Subject|8|||
19759285|NCT03394885|42210775|FG000|Overall Study|Alternative Therapy|1|||
19759286|NCT02877927|42210781|FG000|Overall Study|Adverse Event|1|||
19759287|NCT02877927|42210782|FG001|Overall Study|Adverse Event|0|||
19759288|NCT02877927|42210781|FG000|Overall Study|Lost to Follow-up|37|||
19674772|NCT00504348|42122520|FG000|Overall Study|Adverse Event|3|||
19674773|NCT00504348|42122520|FG000|Overall Study|Lack of Efficacy|4|||
19674774|NCT00504348|42122520|FG000|Overall Study|Physician Decision|1|||
19674775|NCT00507546|42122526|FG000|Overall Study|Withdrawal by Subject|1|||
19674776|NCT00507546|42122527|FG001|Overall Study|Withdrawal by Subject|0|||
19674777|NCT00507546|42122526|FG000|Overall Study|Protocol Violation|1|||
19674778|NCT00507546|42122527|FG001|Overall Study|Protocol Violation|0|||
19674779|NCT00507546|42122526|FG000|Overall Study|Physician Decision|0|||
19674780|NCT00507546|42122527|FG001|Overall Study|Physician Decision|1|||
19674781|NCT00567593|42122535|FG000|Overall Study|Adverse Event|1|||
19674782|NCT00567593|42122535|FG000|Overall Study|Physician Decision|1|||
19674783|NCT00335764|42122544|FG000|Overall Study|wrong histology|1|||
19674784|NCT00335764|42122545|FG001|Overall Study|wrong histology|0|||
19674785|NCT00335764|42122546|FG002|Overall Study|wrong histology|0|||
19674786|NCT00335764|42122547|FG003|Overall Study|wrong histology|0|||
19674787|NCT00335764|42122548|FG004|Overall Study|wrong histology|1|||
19759289|NCT02877927|42210782|FG001|Overall Study|Lost to Follow-up|38|||
19759290|NCT02877927|42210781|FG000|Overall Study|Withdrawal by Subject|11|||
19759291|NCT02877927|42210782|FG001|Overall Study|Withdrawal by Subject|12|||
19759292|NCT02877927|42210781|FG000|Overall Study|Physician Decision|0|||
19759293|NCT02877927|42210782|FG001|Overall Study|Physician Decision|1|||
19759294|NCT02877927|42210781|FG000|Overall Study|Missed EOT/PTE Visit|5|||
19759295|NCT02877927|42210782|FG001|Overall Study|Missed EOT/PTE Visit|6|||
19674788|NCT00567359|42122584|FG000|Overall Study|Withdrawal by Subject|1|||
19674789|NCT00492726|42122590|FG000|Overall Study|Adverse Event|10|||
19674790|NCT00492726|42122591|FG001|Overall Study|Adverse Event|6|||
19674791|NCT00492726|42122590|FG000|Overall Study|Death|7|||
19674792|NCT00492726|42122591|FG001|Overall Study|Death|2|||
19674793|NCT00492726|42122590|FG000|Overall Study|Lack of Efficacy|0|||
19674794|NCT00492726|42122591|FG001|Overall Study|Lack of Efficacy|2|||
19674795|NCT00492726|42122590|FG000|Overall Study|Lost to Follow-up|27|||
19674796|NCT00492726|42122591|FG001|Overall Study|Lost to Follow-up|19|||
19674797|NCT00492726|42122590|FG000|Overall Study|Physician Decision|0|||
19674798|NCT00492726|42122591|FG001|Overall Study|Physician Decision|1|||
19674799|NCT00492726|42122590|FG000|Overall Study|Withdrawal by Subject|6|||
19674800|NCT00492726|42122591|FG001|Overall Study|Withdrawal by Subject|3|||
19674801|NCT00492726|42122590|FG000|Overall Study|Non compliant with study medication|0|||
19674802|NCT00492726|42122591|FG001|Overall Study|Non compliant with study medication|3|||
19674803|NCT00309946|42122597|FG000|Overall Study|Withdrawal by Subject|1|||
19674804|NCT00492648|42122603|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
19674805|NCT00492648|42122604|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
19674806|NCT00506922|42122615|FG000|Overall Study|Physician Decision|0|||
19674807|NCT00506922|42122616|FG001|Overall Study|Physician Decision|0|||
19674808|NCT00506922|42122617|FG002|Overall Study|Physician Decision|0|||
19674809|NCT00506922|42122618|FG003|Overall Study|Physician Decision|2|||
19674810|NCT00506922|42122619|FG004|Overall Study|Physician Decision|0|||
19759296|NCT02706886|42210797|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
19674811|NCT00506922|42122615|FG000|Overall Study|Withdrawal by Subject|0|||
19674812|NCT00506922|42122616|FG001|Overall Study|Withdrawal by Subject|0|||
19759297|NCT02706886|42210798|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
19759298|NCT02706886|42210799|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
19759299|NCT02706886|42210800|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
19759300|NCT02706886|42210801|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
19674813|NCT00506922|42122617|FG002|Overall Study|Withdrawal by Subject|0|||
19674814|NCT00506922|42122618|FG003|Overall Study|Withdrawal by Subject|0|||
19674815|NCT00506922|42122619|FG004|Overall Study|Withdrawal by Subject|1|||
19674816|NCT00492024|42122629|FG000|Treatment|Adverse Event|3|||
19674817|NCT00492024|42122630|FG001|Treatment|Adverse Event|1|||
19674818|NCT00492024|42122629|FG000|Treatment|Lack of Efficacy|21|||
19674819|NCT00492024|42122630|FG001|Treatment|Lack of Efficacy|20|||
19674820|NCT00492024|42122629|FG000|Treatment|Lost to Follow-up|3|||
19674821|NCT00492024|42122630|FG001|Treatment|Lost to Follow-up|1|||
19674822|NCT00492024|42122629|FG000|Treatment|Withdrawal by Subject|2|||
19674823|NCT00492024|42122630|FG001|Treatment|Withdrawal by Subject|0|||
19674824|NCT00492024|42122629|FG000|Follow up|Lack of Efficacy|0|||
19674825|NCT00492024|42122630|FG001|Follow up|Lack of Efficacy|1|||
19674826|NCT00492024|42122629|FG000|Follow up|Lost to Follow-up|1|||
19674827|NCT00492024|42122630|FG001|Follow up|Lost to Follow-up|1|||
19674828|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
19674829|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
19674830|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
19674831|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
19674832|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
19674833|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
19674834|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
19674835|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
19674836|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
19674837|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
19674838|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
19674839|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
19674840|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
19674841|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
19674842|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
19674843|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
19674844|NCT00491556|42122638|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
19674845|NCT00491556|42122639|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
19759301|NCT02706886|42210802|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
19759302|NCT02706886|42210803|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
19759303|NCT02706886|42210804|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
19759304|NCT02706886|42210805|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
19674846|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
19674847|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
19674848|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
19674849|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
19674850|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
19674851|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
19674852|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
19674853|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
19674854|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
19674855|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
19759305|NCT04074161|42210860|FG000|Overall Study|Withdrawal by Subject|2|||
19759306|NCT04074161|42210861|FG001|Overall Study|Withdrawal by Subject|4|||
19759307|NCT04074161|42210862|FG002|Overall Study|Withdrawal by Subject|1|||
19759308|NCT04074161|42210860|FG000|Overall Study|Lost to Follow-up|4|||
19759309|NCT04074161|42210861|FG001|Overall Study|Lost to Follow-up|5|||
19759310|NCT04074161|42210862|FG002|Overall Study|Lost to Follow-up|3|||
19604077|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604078|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
19604079|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604080|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604081|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604082|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604083|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
19604084|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604085|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604086|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604087|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604088|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604089|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19674856|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
19674857|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
19674858|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
19674859|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
19674860|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
19674861|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
19674862|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
19674863|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
19674864|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
19674865|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
19674866|NCT00491556|42122638|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
19674867|NCT00491556|42122639|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
19674868|NCT00506454|42122655|FG000|Overall Study|Withdrawal by Subject|1|||
19674869|NCT00506454|42122656|FG001|Overall Study|Withdrawal by Subject|1|||
19674870|NCT00485472|42122664|FG000|Overall Study|Adverse Event|8|||
19674871|NCT00485472|42122665|FG001|Overall Study|Adverse Event|5|||
19674872|NCT00485472|42122664|FG000|Overall Study|Lack of Efficacy|5|||
19674873|NCT00485472|42122665|FG001|Overall Study|Lack of Efficacy|4|||
19674874|NCT00485472|42122664|FG000|Overall Study|Withdrawal by Subject|1|||
19674875|NCT00485472|42122665|FG001|Overall Study|Withdrawal by Subject|0|||
19674876|NCT00485472|42122664|FG000|Overall Study|Protocol Violation|0|||
19674877|NCT00485472|42122665|FG001|Overall Study|Protocol Violation|1|||
19674878|NCT00485472|42122664|FG000|Overall Study|Other|2|||
19674879|NCT00485472|42122665|FG001|Overall Study|Other|1|||
19674880|NCT00485472|42122664|FG000|Overall Study|Lost to Follow-up|0|||
19674881|NCT00485472|42122665|FG001|Overall Study|Lost to Follow-up|1|||
19674882|NCT00491400|42122673|FG000|Overall Study|Withdrawal by Subject|5|||
19674883|NCT00491400|42122674|FG001|Overall Study|Withdrawal by Subject|4|||
19674884|NCT00491322|42122684|FG000|Overall Study|Protocol Violation|1|||
19674885|NCT00491322|42122685|FG001|Overall Study|Protocol Violation|0|||
19674886|NCT00491322|42122684|FG000|Overall Study|Pregnancy|0|||
19674887|NCT00491322|42122685|FG001|Overall Study|Pregnancy|1|||
19674888|NCT00502320|42122693|FG000|Overall Study|Lost to Follow-up|1|||
19674889|NCT00502320|42122694|FG001|Overall Study|Lost to Follow-up|1|||
19674890|NCT00502320|42122693|FG000|Overall Study|Withdrew Consent|1|||
19674891|NCT00502320|42122694|FG001|Overall Study|Withdrew Consent|0|||
19674892|NCT00502320|42122693|FG000|Overall Study|No longer met criteria|1|||
19674893|NCT00502320|42122694|FG001|Overall Study|No longer met criteria|0|||
19674894|NCT00502320|42122693|FG000|Overall Study|Screen Failure|0|||
19674895|NCT00502320|42122694|FG001|Overall Study|Screen Failure|1|||
19674896|NCT00502320|42122693|FG000|Overall Study|Adverse Event|3|||
19674897|NCT00502320|42122694|FG001|Overall Study|Adverse Event|5|||
19674898|NCT02567825|42122702|FG000|Overall Study|No follow-up post-randomization|5|||
19674899|NCT02567825|42122703|FG001|Overall Study|No follow-up post-randomization|1|||
19674900|NCT02567825|42122702|FG000|Overall Study|Follow-up less than 23 months|16|||
19674901|NCT02567825|42122703|FG001|Overall Study|Follow-up less than 23 months|20|||
19674902|NCT00490776|42122709|FG000|Overall Study|Withdrawal by Subject|1|||
19674903|NCT00490776|42122709|FG000|Overall Study|Administrative Problems|1|||
19674904|NCT00490776|42122709|FG000|Overall Study|Death|1|||
19674905|NCT00490776|42122709|FG000|Overall Study|New Cancer Therapy|1|||
19674906|NCT00490776|42122709|FG000|Overall Study|Disease Progression|5|||
19674907|NCT00566735|42122715|FG000|Overall Study|Withdrawal by Subject|0|||
19674908|NCT00566735|42122716|FG001|Overall Study|Withdrawal by Subject|1|||
19674909|NCT00566735|42122715|FG000|Overall Study|Refused neuropsychological testing|2|||
19674910|NCT00566735|42122716|FG001|Overall Study|Refused neuropsychological testing|5|||
19674911|NCT00566735|42122715|FG000|Overall Study|Switched into a manic episode|0|||
19674912|NCT00566735|42122716|FG001|Overall Study|Switched into a manic episode|1|||
19674913|NCT00566111|42122724|FG000|Overall Study|Adverse Event|0|||
19674914|NCT00566111|42122725|FG001|Overall Study|Adverse Event|2|||
19674915|NCT00514046|42122740|FG000|Overall Study|transferred to another protocol|2|||
19674916|NCT00514046|42122741|FG001|Overall Study|transferred to another protocol|1|||
19674917|NCT00514046|42122742|FG002|Overall Study|transferred to another protocol|3|||
19674918|NCT00514046|42122743|FG003|Overall Study|transferred to another protocol|0|||
19674919|NCT00514046|42122744|FG004|Overall Study|transferred to another protocol|1|||
19674920|NCT00514046|42122745|FG005|Overall Study|transferred to another protocol|0|||
19674921|NCT00514046|42122746|FG006|Overall Study|transferred to another protocol|0|||
19674922|NCT00514046|42122747|FG007|Overall Study|transferred to another protocol|0|||
19674923|NCT00514046|42122748|FG008|Overall Study|transferred to another protocol|0|||
19674924|NCT00514046|42122740|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
19674925|NCT00514046|42122741|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
19674926|NCT00514046|42122742|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
19674927|NCT00514046|42122743|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
19674928|NCT00514046|42122744|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
19674929|NCT00514046|42122745|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
19674930|NCT00514046|42122746|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
19759311|NCT04069715|42210872|FG000|Overall Study|Lost to Follow-up|1|||
19759312|NCT04069715|42210873|FG001|Overall Study|Lost to Follow-up|1|||
19759313|NCT04069715|42210872|FG000|Overall Study|Physician Decision|1|||
19759314|NCT04069715|42210873|FG001|Overall Study|Physician Decision|1|||
19759315|NCT04069715|42210872|FG000|Overall Study|Withdrawal by Subject|3|||
19759316|NCT04069715|42210873|FG001|Overall Study|Withdrawal by Subject|3|||
19759317|NCT03681119|42210881|FG000|Overall Study|No specific reason|4|||
19759318|NCT03681119|42210882|FG001|Overall Study|No specific reason|0|||
19674931|NCT00514046|42122747|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
19674932|NCT00514046|42122748|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
19674933|NCT00514046|42122740|FG000|Overall Study|Disease progression on study|0|||
19674934|NCT00514046|42122741|FG001|Overall Study|Disease progression on study|0|||
19674935|NCT00514046|42122742|FG002|Overall Study|Disease progression on study|2|||
19674936|NCT00514046|42122743|FG003|Overall Study|Disease progression on study|0|||
19674937|NCT00514046|42122744|FG004|Overall Study|Disease progression on study|0|||
19674938|NCT00514046|42122745|FG005|Overall Study|Disease progression on study|1|||
19674939|NCT00514046|42122746|FG006|Overall Study|Disease progression on study|0|||
19674940|NCT00514046|42122747|FG007|Overall Study|Disease progression on study|0|||
19674941|NCT00514046|42122748|FG008|Overall Study|Disease progression on study|0|||
19674942|NCT00564629|42122772|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
19674943|NCT00564629|42122773|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
19674944|NCT00564395|42122779|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
19674945|NCT00564395|42122780|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
19674946|NCT00564395|42122779|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
19674947|NCT00564395|42122780|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
19674948|NCT00502242|42122788|FG000|Overall Study|Lack of Efficacy|1|||
19674949|NCT00502242|42122789|FG001|Overall Study|Lack of Efficacy|11|||
19674950|NCT00502242|42122788|FG000|Overall Study|Adverse Event|31|||
19674951|NCT00502242|42122789|FG001|Overall Study|Adverse Event|20|||
19759319|NCT03681119|42210881|FG000|Overall Study|Sickness|2|||
19759320|NCT03681119|42210882|FG001|Overall Study|Sickness|0|||
19674952|NCT00502242|42122788|FG000|Overall Study|Physician Decision|2|||
19674953|NCT00502242|42122789|FG001|Overall Study|Physician Decision|3|||
19674954|NCT00502242|42122788|FG000|Overall Study|Other - Unspecified|8|||
19674955|NCT00502242|42122789|FG001|Overall Study|Other - Unspecified|14|||
19674956|NCT00502242|42122788|FG000|Overall Study|Protocol Violation|3|||
19759321|NCT03111108|42210888|FG000|Overall Study|Death|0|||
19759322|NCT03111108|42210889|FG001|Overall Study|Death|1|||
19759323|NCT03111108|42210888|FG000|Overall Study|Withdrawal by Subject|1|||
19759324|NCT03111108|42210889|FG001|Overall Study|Withdrawal by Subject|0|||
19759325|NCT03677375|42210895|FG000|Overall Study|Incomplete procedure|8|||
19759326|NCT03677375|42210895|FG000|Overall Study|Adverse Event|3|||
19759327|NCT03677375|42210895|FG000|Overall Study|Physician Decision|1|||
19759328|NCT00702520|42210901|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
19759329|NCT00702520|42210902|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
19389045|NCT02672423|41632611|FG002|Period 2|Withdrawal by Subject|1|||
19389046|NCT02672423|41632612|FG003|Period 2|Withdrawal by Subject|0|||
19674957|NCT00502242|42122789|FG001|Overall Study|Protocol Violation|1|||
19674958|NCT00502242|42122788|FG000|Overall Study|Withdrawal by Subject|6|||
19674959|NCT00502242|42122789|FG001|Overall Study|Withdrawal by Subject|7|||
19674960|NCT03972137|42122799|FG000|Overall Study|Lost to Follow-up|2|||
19674961|NCT03972137|42122799|FG000|Overall Study|Withdrawal by Subject|4|||
19674962|NCT00490698|42122815|FG000|Overall Study|Withdrawal by Subject|1|||
19674963|NCT00490698|42122815|FG000|Overall Study|Disease Progression|7|||
19674964|NCT00490698|42122815|FG000|Overall Study|Physician Decision|2|||
19674965|NCT03855228|42122823|FG000|Overall Study|Adverse Event|2|||
19674966|NCT03855228|42122824|FG001|Overall Study|Adverse Event|4|||
19674967|NCT03855228|42122825|FG002|Overall Study|Adverse Event|4|||
19674968|NCT03855228|42122826|FG003|Overall Study|Adverse Event|8|||
19674969|NCT03855228|42122823|FG000|Overall Study|Treatment Failure|1|||
19674970|NCT03855228|42122824|FG001|Overall Study|Treatment Failure|2|||
19674971|NCT03855228|42122825|FG002|Overall Study|Treatment Failure|1|||
19674972|NCT03855228|42122826|FG003|Overall Study|Treatment Failure|8|||
19674973|NCT03855228|42122823|FG000|Overall Study|Lost to Follow-up|0|||
19759330|NCT00702520|42210903|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
19674974|NCT03855228|42122824|FG001|Overall Study|Lost to Follow-up|0|||
19674975|NCT03855228|42122825|FG002|Overall Study|Lost to Follow-up|0|||
19674976|NCT03855228|42122826|FG003|Overall Study|Lost to Follow-up|1|||
19674977|NCT03855228|42122823|FG000|Overall Study|Protocol Violation|0|||
19674978|NCT03855228|42122824|FG001|Overall Study|Protocol Violation|1|||
19674979|NCT03855228|42122825|FG002|Overall Study|Protocol Violation|2|||
19674980|NCT03855228|42122826|FG003|Overall Study|Protocol Violation|1|||
19674981|NCT03855228|42122823|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
19674982|NCT03855228|42122824|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
19674983|NCT03855228|42122825|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
19674984|NCT03855228|42122826|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
19674985|NCT00511238|42122838|FG000|Overall Study|Adverse Event|13|||
19674986|NCT00511238|42122839|FG001|Overall Study|Adverse Event|33|||
19674987|NCT00511238|42122838|FG000|Overall Study|Withdrawal by Subject|2|||
19674988|NCT00511238|42122839|FG001|Overall Study|Withdrawal by Subject|22|||
19674989|NCT00511238|42122838|FG000|Overall Study|Progressive Disease|23|||
19674990|NCT00511238|42122839|FG001|Overall Study|Progressive Disease|157|||
19674991|NCT00511238|42122838|FG000|Overall Study|various reasons|4|||
19674992|NCT00511238|42122839|FG001|Overall Study|various reasons|14|||
19674993|NCT00513500|42122857|FG000|Overall Study|Lost to Follow-up|35|||
19674994|NCT00513500|42122858|FG001|Overall Study|Lost to Follow-up|39|||
19674995|NCT00513500|42122857|FG000|Overall Study|Death|2|||
19674996|NCT00513500|42122858|FG001|Overall Study|Death|1|||
19674997|NCT00513500|42122857|FG000|Overall Study|Hospitalized|4|||
19674998|NCT00513500|42122858|FG001|Overall Study|Hospitalized|14|||
19674999|NCT03969719|42122867|FG000|Overall Study|Other reasons not specified|1|||
19675000|NCT03969719|42122868|FG001|Overall Study|Other reasons not specified|1|||
19675001|NCT03969719|42122869|FG002|Overall Study|Other reasons not specified|3|||
19675002|NCT03969719|42122867|FG000|Overall Study|Withdrawal by Subject|2|||
19675003|NCT03969719|42122868|FG001|Overall Study|Withdrawal by Subject|3|||
19675004|NCT03969719|42122869|FG002|Overall Study|Withdrawal by Subject|2|||
19675005|NCT03969719|42122867|FG000|Overall Study|Protocol Violation|1|||
19675006|NCT03969719|42122868|FG001|Overall Study|Protocol Violation|2|||
19675007|NCT03969719|42122869|FG002|Overall Study|Protocol Violation|0|||
19675008|NCT03969719|42122867|FG000|Overall Study|Adverse Event|0|||
19675009|NCT03969719|42122868|FG001|Overall Study|Adverse Event|2|||
19675010|NCT03969719|42122869|FG002|Overall Study|Adverse Event|0|||
19675011|NCT03969719|42122867|FG000|Overall Study|Lost to Follow-up|0|||
19675012|NCT03969719|42122868|FG001|Overall Study|Lost to Follow-up|1|||
19675013|NCT03969719|42122869|FG002|Overall Study|Lost to Follow-up|0|||
19675014|NCT00511004|42122880|FG000|Overall Study|Lost to Follow-up|0|||
19675015|NCT00511004|42122881|FG001|Overall Study|Lost to Follow-up|0|||
19675016|NCT00511004|42122882|FG002|Overall Study|Lost to Follow-up|4|||
19675017|NCT02877134|42122909|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675018|NCT02877134|42122910|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
19675019|NCT02877134|42122911|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675020|NCT02877134|42122912|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675021|NCT02877134|42122913|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675022|NCT02877134|42122914|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
19675023|NCT02877134|42122915|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675024|NCT02877134|42122916|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675025|NCT02877134|42122917|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675026|NCT02877134|42122918|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675027|NCT02877134|42122919|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675028|NCT02877134|42122920|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
19675029|NCT02877134|42122909|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675030|NCT02877134|42122910|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
19675031|NCT02877134|42122911|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675032|NCT02877134|42122912|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
19675033|NCT02877134|42122913|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675034|NCT02877134|42122914|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675035|NCT02877134|42122915|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
19675036|NCT02877134|42122916|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675037|NCT02877134|42122917|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675038|NCT02877134|42122918|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675039|NCT02877134|42122919|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675040|NCT02877134|42122920|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
19675041|NCT02877134|42122909|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
19675042|NCT02877134|42122910|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
19675043|NCT02877134|42122911|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
19675044|NCT02877134|42122912|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
19675045|NCT02877134|42122913|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
19675046|NCT02877134|42122914|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
19675047|NCT02877134|42122915|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
19675048|NCT02877134|42122916|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
19675049|NCT02877134|42122917|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
19675050|NCT02877134|42122918|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
19675051|NCT02877134|42122919|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
19675052|NCT02877134|42122920|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
19675053|NCT02877134|42122909|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
19675054|NCT02877134|42122910|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
19675055|NCT02877134|42122911|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
19675056|NCT02877134|42122912|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
19675057|NCT02877134|42122913|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
19675058|NCT02877134|42122914|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
19675059|NCT02877134|42122915|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
19675060|NCT02877134|42122916|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
19675061|NCT02877134|42122917|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
19675062|NCT02877134|42122918|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
19675063|NCT02877134|42122919|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
19675064|NCT02877134|42122920|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
19675065|NCT02877134|42122909|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675066|NCT02877134|42122910|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675067|NCT02877134|42122911|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675068|NCT02877134|42122912|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675069|NCT02877134|42122913|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675070|NCT02877134|42122914|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675071|NCT02877134|42122915|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675072|NCT02877134|42122916|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675073|NCT02877134|42122917|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
19675074|NCT02877134|42122918|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675075|NCT02877134|42122919|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675076|NCT02877134|42122920|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
19675077|NCT02877134|42122909|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675078|NCT02877134|42122910|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675079|NCT02877134|42122911|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675080|NCT02877134|42122912|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675081|NCT02877134|42122913|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675082|NCT02877134|42122914|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675083|NCT02877134|42122915|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
19675084|NCT02877134|42122916|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
19675085|NCT02877134|42122917|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
19675086|NCT02877134|42122918|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
19675087|NCT02877134|42122919|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
19675088|NCT02877134|42122920|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
19675089|NCT02877134|42122909|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675090|NCT02877134|42122910|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675091|NCT02877134|42122911|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675092|NCT02877134|42122912|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675093|NCT02877134|42122913|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675094|NCT02877134|42122914|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675095|NCT02877134|42122915|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675096|NCT02877134|42122916|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
19675097|NCT02877134|42122917|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
19759331|NCT00702520|42210904|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
19759332|NCT00702520|42210901|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
19759333|NCT00702520|42210902|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
19759334|NCT00702520|42210903|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
19759335|NCT00702520|42210904|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
19759336|NCT00702520|42210901|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
19759337|NCT00702520|42210902|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
19759338|NCT00702520|42210903|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
19759339|NCT00702520|42210904|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
19759340|NCT04067141|42210914|FG000|First Intervention|Withdrawal by Subject|0|||
19759341|NCT04067141|42210915|FG001|First Intervention|Withdrawal by Subject|1|||
19759342|NCT04067141|42210914|FG000|Second Intervention|Adverse Event|0|||
19759343|NCT04067141|42210915|FG001|Second Intervention|Adverse Event|2|||
19759344|NCT02876601|42210925|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
19759345|NCT02876601|42210926|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
19759346|NCT02876601|42210927|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
19759347|NCT02876601|42210928|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
19759348|NCT04054193|42210973|FG000|Cycle 1|Physician Decision|1|||
19759349|NCT04054193|42210973|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
19759350|NCT04054193|42210973|FG000|Cycle 1|Allocated but not treated|3|||
19759351|NCT04054193|42210973|FG000|Cycles 2-3|Physician Decision|2|||
19759352|NCT04054193|42210973|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
19759353|NCT04054193|42210973|FG000|Cycles 2-3|Various reasons|17|||
19759354|NCT03394027|42210981|FG000|Overall Study|Ineligible|3|||
19759355|NCT03394027|42210982|FG001|Overall Study|Ineligible|1|||
19759356|NCT03394027|42210983|FG002|Overall Study|Ineligible|3|||
19759357|NCT03394027|42210981|FG000|Overall Study|Participant declined to participate before treatment started|0|||
19759358|NCT03394027|42210982|FG001|Overall Study|Participant declined to participate before treatment started|0|||
19759359|NCT03394027|42210983|FG002|Overall Study|Participant declined to participate before treatment started|1|||
19759360|NCT03136107|42211009|FG000|Overall Study|Other (Not specified)|1|||
19759361|NCT02916056|42211017|FG000|Overall Study|Adverse Event|6|||
19759362|NCT02916056|42211017|FG000|Overall Study|Lost to Follow-up|1|||
19759363|NCT02916056|42211017|FG000|Overall Study|Other|12|||
19759364|NCT02916056|42211017|FG000|Overall Study|Protocol Violation|1|||
19759365|NCT02916056|42211017|FG000|Overall Study|Withdrawal by Subject|8|||
19759366|NCT02916056|42211017|FG000|Overall Study|Study Terminated by Sponsor|269|||
19759367|NCT04854642|42211021|FG000|Overall Study|Adverse Event|1|||
19759368|NCT04854642|42211022|FG001|Overall Study|Adverse Event|2|||
19759369|NCT04854642|42211021|FG000|Overall Study|Withdrawal by Subject|0|||
19759370|NCT04854642|42211022|FG001|Overall Study|Withdrawal by Subject|1|||
19759371|NCT03689712|42211032|FG000|Overall Study|Adverse Event|1|||
19759372|NCT03689712|42211033|FG001|Overall Study|Adverse Event|0|||
19759373|NCT03689712|42211032|FG000|Overall Study|Death|20|||
19759374|NCT03689712|42211033|FG001|Overall Study|Death|10|||
19759375|NCT03689712|42211032|FG000|Overall Study|Lost to Follow-up|6|||
19759376|NCT03689712|42211033|FG001|Overall Study|Lost to Follow-up|6|||
19759377|NCT03689712|42211032|FG000|Overall Study|Other|1|||
19759378|NCT03689712|42211033|FG001|Overall Study|Other|0|||
19759379|NCT03689712|42211032|FG000|Overall Study|Patient Non-Compliance|0|||
19759380|NCT03689712|42211033|FG001|Overall Study|Patient Non-Compliance|1|||
19759381|NCT03689712|42211032|FG000|Overall Study|Withdrawal by Subject|20|||
19759382|NCT03689712|42211033|FG001|Overall Study|Withdrawal by Subject|4|||
19759383|NCT03689712|42211032|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
19759384|NCT03689712|42211033|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
19759385|NCT03689712|42211032|FG000|Overall Study|Randomized but not Treated|13|||
19759386|NCT03689712|42211033|FG001|Overall Study|Randomized but not Treated|7|||
19759387|NCT03689712|42211032|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
19759388|NCT03689712|42211033|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
19759389|NCT03384745|42211045|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
19759390|NCT03384745|42211046|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
19759391|NCT03384745|42211047|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
19759392|NCT03384745|42211048|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
19759393|NCT03384745|42211049|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
19759394|NCT03384745|42211050|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
19759395|NCT03384745|42211045|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
19759396|NCT03384745|42211046|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
19759397|NCT03384745|42211047|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
19759398|NCT03384745|42211048|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
19759399|NCT03384745|42211049|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
19604090|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604091|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19759400|NCT03384745|42211050|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
19759401|NCT03384745|42211045|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
19759402|NCT03384745|42211046|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
19759403|NCT03384745|42211047|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
19759404|NCT03384745|42211048|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
19759405|NCT03384745|42211049|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
19759406|NCT03384745|42211050|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
19759407|NCT03384745|42211045|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
19675098|NCT02877134|42122918|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
19675099|NCT02877134|42122919|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675100|NCT02877134|42122920|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
19675101|NCT02877134|42122909|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
19675102|NCT02877134|42122910|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
19675103|NCT02877134|42122911|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
19675104|NCT02877134|42122912|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
19675105|NCT02877134|42122913|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
19675106|NCT02877134|42122914|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
19675107|NCT02877134|42122915|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
19675108|NCT02877134|42122916|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
19675109|NCT02877134|42122917|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
19675110|NCT02877134|42122918|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
19675111|NCT02877134|42122919|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
19675112|NCT02877134|42122920|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
19675113|NCT00563381|42122946|FG000|Overall Study|Adverse Event|264|||
19675114|NCT00563381|42122947|FG001|Overall Study|Adverse Event|292|||
19675115|NCT00563381|42122946|FG000|Overall Study|Protocol Violation|66|||
19675116|NCT00563381|42122947|FG001|Overall Study|Protocol Violation|74|||
19675117|NCT00563381|42122946|FG000|Overall Study|Lost to Follow-up|7|||
19675118|NCT00563381|42122947|FG001|Overall Study|Lost to Follow-up|15|||
19675119|NCT00563381|42122946|FG000|Overall Study|Withdrawal by Subject|192|||
19675120|NCT00563381|42122947|FG001|Overall Study|Withdrawal by Subject|209|||
19675121|NCT00563381|42122946|FG000|Overall Study|Lack of Efficacy|32|||
19675122|NCT00563381|42122947|FG001|Overall Study|Lack of Efficacy|24|||
19675123|NCT00563381|42122946|FG000|Overall Study|Individual different reasons|24|||
19675124|NCT00563381|42122947|FG001|Overall Study|Individual different reasons|34|||
19675125|NCT00512798|42122955|FG000|Overall Study|Death|0|||
19675126|NCT00512798|42122956|FG001|Overall Study|Death|3|||
19675127|NCT00512798|42122955|FG000|Overall Study|Adverse Event|2|||
19675128|NCT00512798|42122956|FG001|Overall Study|Adverse Event|4|||
19675129|NCT00512798|42122955|FG000|Overall Study|Progression of disease|14|||
19675130|NCT00512798|42122956|FG001|Overall Study|Progression of disease|20|||
19675131|NCT00512798|42122955|FG000|Overall Study|Withdrawal by Subject|3|||
19675132|NCT00512798|42122956|FG001|Overall Study|Withdrawal by Subject|0|||
19675133|NCT00565721|42122963|FG000|Overall Study|Screen Failure|2|||
19675134|NCT00565721|42122963|FG000|Overall Study|Lost to Follow-up|6|||
19675135|NCT00565721|42122963|FG000|Overall Study|Technical Problems|1|||
19675136|NCT00565721|42122963|FG000|Overall Study|Physician Decision|2|||
19675137|NCT00565721|42122963|FG000|Overall Study|Other reasons|6|||
19675138|NCT00561977|42122985|FG000|Overall Study|Withdrawal by Subject|0|||
19675139|NCT00561977|42122986|FG001|Overall Study|Withdrawal by Subject|2|||
19675140|NCT00561977|42122987|FG002|Overall Study|Withdrawal by Subject|1|||
19675141|NCT00561977|42122985|FG000|Overall Study|Pregnancy|0|||
19675142|NCT00561977|42122986|FG001|Overall Study|Pregnancy|1|||
19604092|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604093|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604094|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604095|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
19604096|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604097|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
19604098|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604099|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19675143|NCT00561977|42122987|FG002|Overall Study|Pregnancy|1|||
19675144|NCT00561821|42122999|FG000|Overall Study|Not treated|0|||
19675145|NCT00561821|42123000|FG001|Overall Study|Not treated|0|||
19675146|NCT00561821|42123001|FG002|Overall Study|Not treated|1|||
19675147|NCT00561821|42123002|FG003|Overall Study|Not treated|0|||
19675148|NCT00561821|42122999|FG000|Overall Study|Withdrawal by Subject|0|||
19675149|NCT00561821|42123000|FG001|Overall Study|Withdrawal by Subject|1|||
19675150|NCT00561821|42123001|FG002|Overall Study|Withdrawal by Subject|0|||
19675151|NCT00561821|42123002|FG003|Overall Study|Withdrawal by Subject|2|||
19675152|NCT00561821|42122999|FG000|Overall Study|Reasons not related to trial|2|||
19675153|NCT00561821|42123000|FG001|Overall Study|Reasons not related to trial|1|||
19675154|NCT00561821|42123001|FG002|Overall Study|Reasons not related to trial|0|||
19675155|NCT00561821|42123002|FG003|Overall Study|Reasons not related to trial|0|||
19675156|NCT00561821|42122999|FG000|Overall Study|Other (reason not specified)|1|||
19675157|NCT00561821|42123000|FG001|Overall Study|Other (reason not specified)|1|||
19675158|NCT00561821|42123001|FG002|Overall Study|Other (reason not specified)|0|||
19675159|NCT00561821|42123002|FG003|Overall Study|Other (reason not specified)|0|||
19675160|NCT00561821|42122999|FG000|Overall Study|Adverse Event|2|||
19675161|NCT00561821|42123000|FG001|Overall Study|Adverse Event|3|||
19675162|NCT00561821|42123001|FG002|Overall Study|Adverse Event|1|||
19675163|NCT00561821|42123002|FG003|Overall Study|Adverse Event|1|||
19675164|NCT00558701|42123014|FG000|Overall Study|Protocol Deviations|1|||
19675165|NCT00558701|42123015|FG001|Overall Study|Protocol Deviations|4|||
19675166|NCT03684044|42123023|FG000|Overall Study|Adverse Event|3|||
19675167|NCT03684044|42123024|FG001|Overall Study|Adverse Event|0|||
19675168|NCT03684044|42123023|FG000|Overall Study|Death|4|||
19675169|NCT03684044|42123024|FG001|Overall Study|Death|7|||
19675170|NCT03684044|42123023|FG000|Overall Study|Lost to Follow-up|3|||
19675171|NCT03684044|42123024|FG001|Overall Study|Lost to Follow-up|2|||
19675172|NCT03684044|42123023|FG000|Overall Study|Patient Not Available|0|||
19675173|NCT03684044|42123024|FG001|Overall Study|Patient Not Available|2|||
19675174|NCT03684044|42123023|FG000|Overall Study|Physician Decision|1|||
19675175|NCT03684044|42123024|FG001|Overall Study|Physician Decision|0|||
19675176|NCT03684044|42123023|FG000|Overall Study|Withdrawal by Subject|11|||
19675177|NCT03684044|42123024|FG001|Overall Study|Withdrawal by Subject|9|||
19675178|NCT00510692|42123032|FG000|Overall Study|Adverse Event|1|||
19675179|NCT00510692|42123033|FG001|Overall Study|Adverse Event|3|||
19675180|NCT00510692|42123032|FG000|Overall Study|Withdrawal by Subject|1|||
19675181|NCT00510692|42123033|FG001|Overall Study|Withdrawal by Subject|0|||
19675182|NCT00335452|42123045|FG000|Overall Study|Death|156|||
19675183|NCT00335452|42123046|FG001|Overall Study|Death|144|||
19675184|NCT00335452|42123047|FG002|Overall Study|Death|158|||
19675185|NCT00335452|42123048|FG003|Overall Study|Death|129|||
19675186|NCT00335452|42123045|FG000|Overall Study|Lost to Follow-up|2|||
19675187|NCT00335452|42123046|FG001|Overall Study|Lost to Follow-up|3|||
19675188|NCT00335452|42123047|FG002|Overall Study|Lost to Follow-up|1|||
19675189|NCT00335452|42123048|FG003|Overall Study|Lost to Follow-up|2|||
19675190|NCT00522548|42123065|FG000|Overall Study|Adverse Event|2|||
19675191|NCT00522548|42123066|FG001|Overall Study|Adverse Event|2|||
19675192|NCT00522548|42123065|FG000|Overall Study|Withdrawal by Subject|0|||
19675193|NCT00522548|42123066|FG001|Overall Study|Withdrawal by Subject|2|||
19675194|NCT00522392|42123074|FG000|Overall Study|Disease progression|0|||
19675195|NCT00522392|42123075|FG001|Overall Study|Disease progression|3|||
19675196|NCT00522392|42123074|FG000|Overall Study|Adverse Event|7|||
19675197|NCT00522392|42123075|FG001|Overall Study|Adverse Event|7|||
19675198|NCT00522392|42123074|FG000|Overall Study|Withdrawal by Subject|1|||
19675199|NCT00522392|42123075|FG001|Overall Study|Withdrawal by Subject|1|||
19675200|NCT00522392|42123074|FG000|Overall Study|Physician Decision|0|||
19675201|NCT00522392|42123075|FG001|Overall Study|Physician Decision|1|||
19675202|NCT00522392|42123074|FG000|Overall Study|Non-compliance|0|||
19675203|NCT00522392|42123075|FG001|Overall Study|Non-compliance|1|||
19675204|NCT00335140|42123081|FG000|Overall Study|Ineligible|1|||
19675205|NCT00309244|42123087|FG000|Overall Study|Adverse Event|29|||
19675206|NCT00309244|42123088|FG001|Overall Study|Adverse Event|12|||
19675207|NCT00309244|42123087|FG000|Overall Study|Lost to Follow-up|6|||
19675208|NCT00309244|42123088|FG001|Overall Study|Lost to Follow-up|22|||
19675209|NCT00309244|42123087|FG000|Overall Study|Physician Decision|5|||
19675210|NCT00309244|42123088|FG001|Overall Study|Physician Decision|8|||
19675211|NCT00309244|42123087|FG000|Overall Study|Protocol Violation|6|||
19759408|NCT03384745|42211046|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
19759409|NCT03384745|42211047|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
19675212|NCT00309244|42123088|FG001|Overall Study|Protocol Violation|3|||
19675213|NCT00309244|42123087|FG000|Overall Study|Withdrawal by Subject|50|||
19675214|NCT00309244|42123088|FG001|Overall Study|Withdrawal by Subject|32|||
19675215|NCT00309244|42123087|FG000|Overall Study|Various|7|||
19675216|NCT00309244|42123088|FG001|Overall Study|Various|7|||
19675217|NCT00309244|42123087|FG000|Overall Study|Randomized but not dosed|11|||
19675218|NCT00309244|42123088|FG001|Overall Study|Randomized but not dosed|12|||
19675219|NCT00309244|42123087|FG000|Overall Study|Death|4|||
19759410|NCT03384745|42211048|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
19759411|NCT03384745|42211049|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
19759412|NCT03384745|42211050|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
19759413|NCT03384745|42211045|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
19759414|NCT03384745|42211046|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
19759415|NCT03384745|42211047|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
19759416|NCT03384745|42211048|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
19759417|NCT03384745|42211049|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
19759418|NCT03384745|42211050|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
19759419|NCT03384745|42211045|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
19759420|NCT03384745|42211046|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
19759421|NCT03384745|42211047|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
19759422|NCT03384745|42211048|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
19675220|NCT00309244|42123088|FG001|Overall Study|Death|1|||
19675221|NCT00483756|42123097|FG000|Overall Study|Death|2|||
19675222|NCT00483756|42123098|FG001|Overall Study|Death|0|||
19675223|NCT00483756|42123099|FG002|Overall Study|Death|1|||
19675224|NCT00483756|42123097|FG000|Overall Study|Adverse Event|19|||
19675225|NCT00483756|42123098|FG001|Overall Study|Adverse Event|38|||
19675226|NCT00483756|42123099|FG002|Overall Study|Adverse Event|40|||
19675227|NCT00483756|42123097|FG000|Overall Study|Lack of Efficacy|1|||
19675228|NCT00483756|42123098|FG001|Overall Study|Lack of Efficacy|0|||
19675229|NCT00483756|42123099|FG002|Overall Study|Lack of Efficacy|0|||
19675230|NCT00483756|42123097|FG000|Overall Study|Lost to Follow-up|3|||
19675231|NCT00483756|42123098|FG001|Overall Study|Lost to Follow-up|1|||
19675232|NCT00483756|42123099|FG002|Overall Study|Lost to Follow-up|0|||
19675233|NCT00483756|42123097|FG000|Overall Study|Withdrawal by Subject|5|||
19675234|NCT00483756|42123098|FG001|Overall Study|Withdrawal by Subject|3|||
19675235|NCT00483756|42123099|FG002|Overall Study|Withdrawal by Subject|4|||
19675236|NCT00483756|42123097|FG000|Overall Study|Other|2|||
19675237|NCT00483756|42123098|FG001|Overall Study|Other|4|||
19675238|NCT00483756|42123099|FG002|Overall Study|Other|3|||
19675239|NCT00483756|42123097|FG000|Overall Study|Randomized, Not Treated|1|||
19675240|NCT00483756|42123098|FG001|Overall Study|Randomized, Not Treated|4|||
19675241|NCT00483756|42123099|FG002|Overall Study|Randomized, Not Treated|4|||
19675242|NCT00309166|42123109|FG000|Overall Study|Adverse event, non-fatal|1|||
19675243|NCT00309166|42123110|FG001|Overall Study|Adverse event, non-fatal|0|||
19675244|NCT00309166|42123109|FG000|Overall Study|Withdrawal by Subject|4|||
19675245|NCT00309166|42123110|FG001|Overall Study|Withdrawal by Subject|3|||
19675246|NCT00501852|42123116|FG000|Overall Study|Adverse Event|3|||
19675247|NCT00501852|42123116|FG000|Overall Study|Withdrawal by Subject|2|||
19675248|NCT00482274|42123130|FG000|Overall Study|Adverse Event|1|||
19675249|NCT00490542|42123136|FG000|Overall Study|Lost to Follow-up|3|||
19675250|NCT00490542|42123137|FG001|Overall Study|Lost to Follow-up|0|||
19675251|NCT00490542|42123136|FG000|Overall Study|Adverse Event|3|||
19675252|NCT00490542|42123137|FG001|Overall Study|Adverse Event|3|||
19675253|NCT00490542|42123136|FG000|Overall Study|Lack of Efficacy|1|||
19675254|NCT00490542|42123137|FG001|Overall Study|Lack of Efficacy|1|||
19675255|NCT00501540|42123143|FG000|Overall Study|Death|5|||
19675256|NCT00322348|42123149|FG000|Overall Study|Adverse Event|0|||
19759423|NCT03384745|42211049|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
19675257|NCT00322348|42123150|FG001|Overall Study|Adverse Event|1|||
19675258|NCT00322348|42123149|FG000|Overall Study|Withdrawal by Subject|1|||
19675259|NCT00322348|42123150|FG001|Overall Study|Withdrawal by Subject|4|||
19675260|NCT00322348|42123149|FG000|Overall Study|Lost to Follow-up|1|||
19675261|NCT00322348|42123150|FG001|Overall Study|Lost to Follow-up|0|||
19675262|NCT00322348|42123149|FG000|Overall Study|Death|0|||
19675263|NCT00322348|42123150|FG001|Overall Study|Death|2|||
19675264|NCT00322348|42123149|FG000|Overall Study|Disease Progression|30|||
19675265|NCT00322348|42123150|FG001|Overall Study|Disease Progression|25|||
19675266|NCT00322348|42123149|FG000|Overall Study|Reasons not specified|5|||
19675267|NCT00322348|42123150|FG001|Overall Study|Reasons not specified|1|||
19675268|NCT00501228|42123156|FG000|Overall Study|Withdrawal by Subject|1|||
19675269|NCT00308620|42123163|FG000|Overall Study|Death|1|||
19675270|NCT00308620|42123164|FG001|Overall Study|Death|1|||
19675271|NCT00308620|42123165|FG002|Overall Study|Death|0|||
19675272|NCT00308620|42123163|FG000|Overall Study|Lost to Follow-up|0|||
19675273|NCT00308620|42123164|FG001|Overall Study|Lost to Follow-up|0|||
19675274|NCT00308620|42123165|FG002|Overall Study|Lost to Follow-up|1|||
19675275|NCT00492752|42123175|FG000|Double Blind Treatment|Death|13|||
19675276|NCT00492752|42123176|FG001|Double Blind Treatment|Death|0|||
19675277|NCT00492752|42123177|FG002|Double Blind Treatment|Death|2|||
19675278|NCT00492752|42123178|FG003|Double Blind Treatment|Death|0|||
19675279|NCT00492752|42123175|FG000|Double Blind Treatment|Adverse Event|1|||
19675280|NCT00492752|42123176|FG001|Double Blind Treatment|Adverse Event|0|||
19675281|NCT00492752|42123177|FG002|Double Blind Treatment|Adverse Event|0|||
19675282|NCT00492752|42123178|FG003|Double Blind Treatment|Adverse Event|0|||
19675283|NCT00492752|42123175|FG000|Double Blind Treatment|Protocol Violation|0|||
19675284|NCT00492752|42123176|FG001|Double Blind Treatment|Protocol Violation|0|||
19675285|NCT00492752|42123177|FG002|Double Blind Treatment|Protocol Violation|1|||
19675286|NCT00492752|42123178|FG003|Double Blind Treatment|Protocol Violation|0|||
19675287|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
19675288|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
19675289|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
19675290|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
19759424|NCT03384745|42211050|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
19759425|NCT03384745|42211045|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
19759426|NCT03384745|42211046|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
19759427|NCT03384745|42211047|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
19759428|NCT03384745|42211048|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
19759429|NCT03384745|42211049|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
19759430|NCT03384745|42211050|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
19759431|NCT03384745|42211045|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
19759432|NCT03384745|42211046|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
19759433|NCT03384745|42211047|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
19759434|NCT03384745|42211048|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
19759435|NCT03384745|42211049|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
19759436|NCT03384745|42211050|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
19759437|NCT03384745|42211045|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
19759438|NCT03384745|42211046|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
19759439|NCT03384745|42211047|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
19759440|NCT03384745|42211048|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
19759441|NCT03384745|42211049|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
19675291|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
19675292|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
19675293|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
19675294|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
19675295|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
19675296|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
19759442|NCT03384745|42211050|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
19759443|NCT03384745|42211045|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
19759444|NCT03384745|42211046|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
19759445|NCT03384745|42211047|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
19759446|NCT03384745|42211048|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
19759447|NCT03384745|42211049|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
19759448|NCT03384745|42211050|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
19759449|NCT03384745|42211045|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
19759450|NCT03384745|42211046|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
19759451|NCT03384745|42211047|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
19759452|NCT03384745|42211048|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
19759453|NCT03384745|42211049|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
19759454|NCT03384745|42211050|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
19759455|NCT03383887|42211070|FG000|Overall Study|Lost to Follow-up|0|||
19759456|NCT03383887|42211071|FG001|Overall Study|Lost to Follow-up|1|||
19759457|NCT03379753|42211079|FG000|Overall Study|Withdrawal by Subject|2|||
19759458|NCT03379753|42211080|FG001|Overall Study|Withdrawal by Subject|1|||
19759459|NCT03379753|42211079|FG000|Overall Study|not having correct procedure|1|||
19759460|NCT03379753|42211080|FG001|Overall Study|not having correct procedure|2|||
19759461|NCT03379753|42211079|FG000|Overall Study|No primary outcome|12|||
19759462|NCT03379753|42211080|FG001|Overall Study|No primary outcome|22|||
19759463|NCT03548064|42211094|FG000|Overall Study|Withdrawal by Subject|0|||
19759464|NCT03548064|42211095|FG001|Overall Study|Withdrawal by Subject|0|||
19759465|NCT03548064|42211096|FG002|Overall Study|Withdrawal by Subject|0|||
19759466|NCT03548064|42211097|FG003|Overall Study|Withdrawal by Subject|1|||
19759467|NCT03548064|42211098|FG004|Overall Study|Withdrawal by Subject|0|||
19759468|NCT03548064|42211099|FG005|Overall Study|Withdrawal by Subject|0|||
19759469|NCT03548064|42211100|FG006|Overall Study|Withdrawal by Subject|0|||
19759470|NCT03548064|42211101|FG007|Overall Study|Withdrawal by Subject|0|||
19759471|NCT03548064|42211094|FG000|Overall Study|Lost to Follow-up|0|||
19675297|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
19675298|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
19675299|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
19675300|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
19675301|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
19675302|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
19675303|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
19675304|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
19675305|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
19675306|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
19675307|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
19675308|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
19675309|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
19675310|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
19675311|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
19675312|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
19675313|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
19675314|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
19675315|NCT00492752|42123175|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
19675316|NCT00492752|42123176|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
19675317|NCT00492752|42123177|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
19675318|NCT00492752|42123178|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
19675319|NCT00308308|42123187|FG000|Overall Study|Adverse Event|17|||
19675320|NCT00308308|42123188|FG001|Overall Study|Adverse Event|2|||
19675321|NCT00308308|42123187|FG000|Overall Study|Lost to Follow-up|5|||
19675322|NCT00308308|42123188|FG001|Overall Study|Lost to Follow-up|5|||
19675323|NCT00308308|42123187|FG000|Overall Study|Physician Decision|15|||
19675324|NCT00308308|42123188|FG001|Overall Study|Physician Decision|7|||
19675325|NCT00308308|42123187|FG000|Overall Study|Protocol Violation|3|||
19675326|NCT00308308|42123188|FG001|Overall Study|Protocol Violation|14|||
19675327|NCT00308308|42123187|FG000|Overall Study|Withdrawal by Subject|47|||
19675328|NCT00308308|42123188|FG001|Overall Study|Withdrawal by Subject|19|||
19675329|NCT00308308|42123187|FG000|Overall Study|Various|7|||
19675330|NCT00308308|42123188|FG001|Overall Study|Various|5|||
19675331|NCT00308308|42123187|FG000|Overall Study|Randomized but not dosed|8|||
19759472|NCT03548064|42211095|FG001|Overall Study|Lost to Follow-up|0|||
19759473|NCT03548064|42211096|FG002|Overall Study|Lost to Follow-up|0|||
19675332|NCT00308308|42123188|FG001|Overall Study|Randomized but not dosed|16|||
19759474|NCT03548064|42211097|FG003|Overall Study|Lost to Follow-up|0|||
19759475|NCT03548064|42211098|FG004|Overall Study|Lost to Follow-up|2|||
19675333|NCT00308308|42123187|FG000|Overall Study|Other|1|||
19675334|NCT00308308|42123188|FG001|Overall Study|Other|0|||
19675335|NCT00505934|42123194|FG000|Overall Study|Adverse Event|1|||
19675336|NCT00505934|42123194|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
19675337|NCT00505934|42123194|FG000|Overall Study|Other: IV dose needed to be changed|1|||
19675338|NCT00505778|42123200|FG000|Overall Study|Adverse Event|2|||
19675339|NCT00505778|42123201|FG001|Overall Study|Adverse Event|7|||
19675340|NCT00505778|42123200|FG000|Overall Study|Physician Decision|8|||
19675341|NCT00505778|42123201|FG001|Overall Study|Physician Decision|14|||
19675342|NCT00505778|42123200|FG000|Overall Study|Lost to Follow-up|17|||
19675343|NCT00505778|42123201|FG001|Overall Study|Lost to Follow-up|23|||
19675344|NCT00505778|42123200|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
19675345|NCT00505778|42123201|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
19675346|NCT00505778|42123200|FG000|Overall Study|Protocol Violation|7|||
19675347|NCT00505778|42123201|FG001|Overall Study|Protocol Violation|9|||
19675348|NCT00505778|42123200|FG000|Overall Study|Withdrawal by Subject|29|||
19675349|NCT00505778|42123201|FG001|Overall Study|Withdrawal by Subject|14|||
19675350|NCT00505778|42123200|FG000|Overall Study|Relapse|65|||
19675351|NCT00505778|42123201|FG001|Overall Study|Relapse|65|||
19675352|NCT00505778|42123200|FG000|Overall Study|Took No Study Drug|2|||
19675353|NCT00505778|42123201|FG001|Overall Study|Took No Study Drug|2|||
19675354|NCT00308074|42123207|FG000|Overall Study|Withdrawal by Subject|1|||
19759476|NCT03548064|42211099|FG005|Overall Study|Lost to Follow-up|0|||
19759477|NCT03548064|42211100|FG006|Overall Study|Lost to Follow-up|0|||
19759478|NCT03548064|42211101|FG007|Overall Study|Lost to Follow-up|0|||
19759479|NCT03548064|42211094|FG000|Overall Study|Covid-19 Pandemic|0|||
19759480|NCT03548064|42211095|FG001|Overall Study|Covid-19 Pandemic|0|||
19675355|NCT00500760|42123213|FG000|Overall Study|Death|32|||
19675356|NCT00500760|42123214|FG001|Overall Study|Death|15|||
19675357|NCT00500760|42123213|FG000|Overall Study|Withdrawal by Subject|5|||
19675358|NCT00500760|42123214|FG001|Overall Study|Withdrawal by Subject|7|||
19675359|NCT00500760|42123213|FG000|Overall Study|Administrative decision|2|||
19675360|NCT00500760|42123214|FG001|Overall Study|Administrative decision|0|||
19675361|NCT00500760|42123213|FG000|Overall Study|Lost to Follow-up|3|||
19675362|NCT00500760|42123214|FG001|Overall Study|Lost to Follow-up|0|||
19675363|NCT00500760|42123213|FG000|Overall Study|Other|1|||
19675364|NCT00500760|42123214|FG001|Overall Study|Other|2|||
19675365|NCT00505622|42123223|FG000|Overall Study|Adverse Event|5|||
19675366|NCT00505622|42123224|FG001|Overall Study|Adverse Event|6|||
19675367|NCT00505622|42123225|FG002|Overall Study|Adverse Event|4|||
19675368|NCT00505622|42123223|FG000|Overall Study|Protocol Violation|1|||
19675369|NCT00505622|42123224|FG001|Overall Study|Protocol Violation|1|||
19675370|NCT00505622|42123225|FG002|Overall Study|Protocol Violation|0|||
19675371|NCT00505622|42123223|FG000|Overall Study|Withdrawal by Subject|0|||
19675372|NCT00505622|42123224|FG001|Overall Study|Withdrawal by Subject|3|||
19675373|NCT00505622|42123225|FG002|Overall Study|Withdrawal by Subject|2|||
19675374|NCT00505622|42123223|FG000|Overall Study|Study termination by sponsor|115|||
19675375|NCT00505622|42123224|FG001|Overall Study|Study termination by sponsor|98|||
19675376|NCT00505622|42123225|FG002|Overall Study|Study termination by sponsor|90|||
19675377|NCT03851094|42123235|FG000|Overall Study|Withdrawal by Subject|0|||
19759481|NCT03548064|42211096|FG002|Overall Study|Covid-19 Pandemic|0|||
19759482|NCT03548064|42211097|FG003|Overall Study|Covid-19 Pandemic|0|||
19759483|NCT03548064|42211098|FG004|Overall Study|Covid-19 Pandemic|10|||
19759484|NCT03548064|42211099|FG005|Overall Study|Covid-19 Pandemic|3|||
19759485|NCT03548064|42211100|FG006|Overall Study|Covid-19 Pandemic|0|||
19759486|NCT03548064|42211101|FG007|Overall Study|Covid-19 Pandemic|0|||
19759487|NCT03379675|42211128|FG000|Overall Study|Lost to Follow-up|0|||
19759488|NCT03379675|42211129|FG001|Overall Study|Lost to Follow-up|1|||
19759489|NCT03379675|42211130|FG002|Overall Study|Lost to Follow-up|0|||
19759490|NCT03379675|42211128|FG000|Overall Study|Adverse Event|2|||
19759491|NCT03379675|42211129|FG001|Overall Study|Adverse Event|0|||
19759492|NCT03379675|42211130|FG002|Overall Study|Adverse Event|0|||
19759493|NCT03379675|42211128|FG000|Overall Study|Withdrawal by Subject|2|||
19759494|NCT03379675|42211129|FG001|Overall Study|Withdrawal by Subject|1|||
19759495|NCT03379675|42211130|FG002|Overall Study|Withdrawal by Subject|2|||
19675378|NCT03851094|42123236|FG001|Overall Study|Withdrawal by Subject|1|||
19675379|NCT03851094|42123235|FG000|Overall Study|Participant lost device|0|||
19675380|NCT03851094|42123236|FG001|Overall Study|Participant lost device|1|||
19675381|NCT03851094|42123235|FG000|Overall Study|Participant returned device|0|||
19675382|NCT03851094|42123236|FG001|Overall Study|Participant returned device|2|||
19675383|NCT00505076|42123247|FG000|Overall Study|Adverse Event|1|||
19675384|NCT00505076|42123248|FG001|Overall Study|Adverse Event|0|||
19675385|NCT00505076|42123249|FG002|Overall Study|Adverse Event|1|||
19675386|NCT00505076|42123247|FG000|Overall Study|Protocol Violation|2|||
19675387|NCT00505076|42123248|FG001|Overall Study|Protocol Violation|1|||
19675388|NCT00505076|42123249|FG002|Overall Study|Protocol Violation|2|||
19675389|NCT00505076|42123247|FG000|Overall Study|Withdrawal by Subject|0|||
19675390|NCT00505076|42123248|FG001|Overall Study|Withdrawal by Subject|1|||
19675391|NCT00505076|42123249|FG002|Overall Study|Withdrawal by Subject|2|||
19675392|NCT00307684|42123257|FG000|Open Label Phase|Lack of Efficacy|0|||
19675393|NCT00307684|42123258|FG001|Open Label Phase|Lack of Efficacy|0|||
19675394|NCT00307684|42123259|FG002|Open Label Phase|Lack of Efficacy|3|||
19675395|NCT00307684|42123257|FG000|Open Label Phase|Adverse Event|0|||
19675396|NCT00307684|42123258|FG001|Open Label Phase|Adverse Event|0|||
19675397|NCT00307684|42123259|FG002|Open Label Phase|Adverse Event|16|||
19675398|NCT00307684|42123257|FG000|Open Label Phase|Withdrawal by Subject|0|||
19675399|NCT00307684|42123258|FG001|Open Label Phase|Withdrawal by Subject|0|||
19675400|NCT00307684|42123259|FG002|Open Label Phase|Withdrawal by Subject|15|||
19759496|NCT02930889|42211138|FG000|Overall Study|Lost to Follow-up|2|||
19759497|NCT02930889|42211138|FG000|Overall Study|Withdrawal by Subject|6|||
19675401|NCT00307684|42123257|FG000|Open Label Phase|Lost to Follow-up|0|||
19759498|NCT02930889|42211138|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
19759499|NCT02875977|42211144|FG000|Overall Study|Lost to Follow-up|42|||
19759500|NCT02875977|42211145|FG001|Overall Study|Lost to Follow-up|29|||
19759501|NCT02703532|42211164|FG000|Overall Study|Withdrawal by Subject|0|||
19759502|NCT02703532|42211165|FG001|Overall Study|Withdrawal by Subject|1|||
19759503|NCT02703532|42211166|FG002|Overall Study|Withdrawal by Subject|0|||
19759504|NCT02703532|42211167|FG003|Overall Study|Withdrawal by Subject|1|||
19759505|NCT02703532|42211164|FG000|Overall Study|Lost to Follow-up|2|||
19759506|NCT02703532|42211165|FG001|Overall Study|Lost to Follow-up|0|||
19759507|NCT02703532|42211166|FG002|Overall Study|Lost to Follow-up|2|||
19759508|NCT02703532|42211167|FG003|Overall Study|Lost to Follow-up|0|||
19759509|NCT02930343|42211200|FG000|Overall Study|Lost to Follow-up|9|||
19759510|NCT02930343|42211201|FG001|Overall Study|Lost to Follow-up|7|||
19759511|NCT02703454|42211209|FG000|Overall Study|Not treated|1|||
19759512|NCT02703454|42211210|FG001|Overall Study|Not treated|3|||
19759513|NCT02703454|42211209|FG000|Overall Study|Withdrawal by Subject|4|||
19759514|NCT02703454|42211210|FG001|Overall Study|Withdrawal by Subject|3|||
19759515|NCT02703454|42211209|FG000|Overall Study|Lost to Follow-up|1|||
19759516|NCT02703454|42211210|FG001|Overall Study|Lost to Follow-up|2|||
19759517|NCT02703454|42211209|FG000|Overall Study|Study discontinuation|5|||
19759518|NCT02703454|42211210|FG001|Overall Study|Study discontinuation|8|||
19759519|NCT03103542|42211216|FG000|Overall Study|Physician Decision|2|||
19759520|NCT03103542|42211216|FG000|Overall Study|Adverse Event|2|||
19759521|NCT03103542|42211216|FG000|Overall Study|Other|2|||
19759522|NCT03103542|42211216|FG000|Overall Study|Withdrawal by Subject|1|||
19759523|NCT03376321|42211243|FG000|Overall Study|Other|5|||
19759524|NCT03376321|42211244|FG001|Overall Study|Other|1|||
19759525|NCT03376321|42211243|FG000|Overall Study|Withdrawal by Subject|8|||
19759526|NCT03376321|42211244|FG001|Overall Study|Withdrawal by Subject|14|||
19759527|NCT03376321|42211243|FG000|Overall Study|Lost to Follow-up|1|||
19759528|NCT03376321|42211244|FG001|Overall Study|Lost to Follow-up|7|||
19759529|NCT03376321|42211243|FG000|Overall Study|Death|4|||
19759530|NCT03376321|42211244|FG001|Overall Study|Death|0|||
19759531|NCT03376321|42211243|FG000|Overall Study|Randomized, not treated|5|||
19759532|NCT03376321|42211244|FG001|Overall Study|Randomized, not treated|3|||
19759533|NCT03374995|42211252|FG000|Overall Study|Withdrawal by Subject|0|||
19759534|NCT03374995|42211253|FG001|Overall Study|Withdrawal by Subject|1|||
19759535|NCT02828982|42211259|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19759536|NCT02828982|42211260|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19759537|NCT03133767|42211270|FG000|Overall Study|Lost to Follow-up|38|||
19759538|NCT03133767|42211271|FG001|Overall Study|Lost to Follow-up|24|||
19759539|NCT03133767|42211270|FG000|Overall Study|Protocol Violation|0|||
19759540|NCT03133767|42211271|FG001|Overall Study|Protocol Violation|1|||
19759541|NCT03391765|42211281|FG000|Overall Study|Adverse Event|2|||
19759542|NCT03391765|42211282|FG001|Overall Study|Adverse Event|0|||
19759543|NCT03391765|42211283|FG002|Overall Study|Adverse Event|0|||
19759544|NCT03391765|42211284|FG003|Overall Study|Adverse Event|2|||
19759545|NCT03391765|42211281|FG000|Overall Study|Withdrew consent|5|||
19759546|NCT03391765|42211282|FG001|Overall Study|Withdrew consent|7|||
19759547|NCT03391765|42211283|FG002|Overall Study|Withdrew consent|2|||
19759548|NCT03391765|42211284|FG003|Overall Study|Withdrew consent|5|||
19759549|NCT03391765|42211281|FG000|Overall Study|Other, not specified|44|||
19759550|NCT03391765|42211282|FG001|Overall Study|Other, not specified|38|||
19759551|NCT03391765|42211283|FG002|Overall Study|Other, not specified|21|||
19759552|NCT03391765|42211284|FG003|Overall Study|Other, not specified|16|||
19759553|NCT02802228|42211296|FG000|Overall Study|Withdrawal by Subject|2|||
19759554|NCT02802228|42211297|FG001|Overall Study|Withdrawal by Subject|0|||
19759555|NCT02802228|42211296|FG000|Overall Study|Lost to Follow-up|1|||
19759556|NCT02802228|42211297|FG001|Overall Study|Lost to Follow-up|0|||
19759557|NCT02802228|42211296|FG000|Overall Study|Adverse Event|1|||
19759558|NCT02802228|42211297|FG001|Overall Study|Adverse Event|0|||
19759559|NCT02802228|42211296|FG000|Overall Study|Physician Decision|1|||
19759560|NCT02802228|42211297|FG001|Overall Study|Physician Decision|0|||
19759561|NCT03130257|42211306|FG000|Overall Study|Withdrawal by Subject|1|||
19759562|NCT03130257|42211307|FG001|Overall Study|Withdrawal by Subject|0|||
19759563|NCT03130257|42211308|FG002|Overall Study|Withdrawal by Subject|2|||
19759564|NCT03674177|42211320|FG000|Overall Study|Lost to Follow-up|2|||
19759565|NCT03674177|42211321|FG001|Overall Study|Lost to Follow-up|1|||
19759566|NCT03674177|42211322|FG002|Overall Study|Lost to Follow-up|0|||
19759567|NCT03674177|42211323|FG003|Overall Study|Lost to Follow-up|2|||
19759568|NCT03354637|42211349|FG000|Double-blind Period|Protocol Violation|2|||
19759569|NCT03354637|42211350|FG001|Double-blind Period|Protocol Violation|0|||
19759570|NCT03354637|42211351|FG002|Double-blind Period|Protocol Violation|0|||
19759571|NCT03354637|42211349|FG000|Double-blind Period|Adverse Event|1|||
19759572|NCT03354637|42211350|FG001|Double-blind Period|Adverse Event|2|||
19759573|NCT03354637|42211351|FG002|Double-blind Period|Adverse Event|0|||
19759574|NCT03354637|42211349|FG000|Double-blind Period|Lost to Follow-up|3|||
19759575|NCT03354637|42211350|FG001|Double-blind Period|Lost to Follow-up|4|||
19759576|NCT03354637|42211351|FG002|Double-blind Period|Lost to Follow-up|3|||
19759577|NCT03354637|42211349|FG000|Double-blind Period|Withdrawal by Subject|10|||
19759578|NCT03354637|42211350|FG001|Double-blind Period|Withdrawal by Subject|6|||
19675402|NCT00307684|42123258|FG001|Open Label Phase|Lost to Follow-up|0|||
19759579|NCT03354637|42211351|FG002|Double-blind Period|Withdrawal by Subject|4|||
19759580|NCT03354637|42211349|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
19759581|NCT03354637|42211350|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
19759582|NCT03354637|42211351|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
19759583|NCT03354637|42211349|FG000|Open Label Extension|Adverse Event|0|||
19759584|NCT03354637|42211350|FG001|Open Label Extension|Adverse Event|0|||
19759585|NCT03354637|42211351|FG002|Open Label Extension|Adverse Event|1|||
19759586|NCT03354637|42211349|FG000|Open Label Extension|Lost to Follow-up|0|||
19759587|NCT03354637|42211350|FG001|Open Label Extension|Lost to Follow-up|0|||
19759588|NCT03354637|42211351|FG002|Open Label Extension|Lost to Follow-up|2|||
19759589|NCT03354637|42211349|FG000|Open Label Extension|Withdrawal by Subject|0|||
19759590|NCT03354637|42211350|FG001|Open Label Extension|Withdrawal by Subject|0|||
19675403|NCT00307684|42123259|FG002|Open Label Phase|Lost to Follow-up|11|||
19675404|NCT00307684|42123257|FG000|Open Label Phase|non compliance|0|||
19675405|NCT00307684|42123258|FG001|Open Label Phase|non compliance|0|||
19675406|NCT00307684|42123259|FG002|Open Label Phase|non compliance|5|||
19675407|NCT00307684|42123257|FG000|Open Label Phase|other|0|||
19675408|NCT00307684|42123258|FG001|Open Label Phase|other|0|||
19675409|NCT00307684|42123259|FG002|Open Label Phase|other|6|||
19675410|NCT00307684|42123257|FG000|Double Blind Phase|Lack of Efficacy|2|||
19675411|NCT00307684|42123258|FG001|Double Blind Phase|Lack of Efficacy|5|||
19675412|NCT00307684|42123259|FG002|Double Blind Phase|Lack of Efficacy|0|||
19675413|NCT00489918|42123272|FG000|Overall Study|Withdrawal by Subject|2|||
19675414|NCT00489918|42123273|FG001|Overall Study|Withdrawal by Subject|1|||
19675415|NCT00489918|42123274|FG002|Overall Study|Withdrawal by Subject|1|||
19675416|NCT00489918|42123275|FG003|Overall Study|Withdrawal by Subject|0|||
19675417|NCT00489918|42123276|FG004|Overall Study|Withdrawal by Subject|1|||
19675418|NCT00489918|42123272|FG000|Overall Study|Adverse Event|0|||
19675419|NCT00489918|42123273|FG001|Overall Study|Adverse Event|1|||
19675420|NCT00489918|42123274|FG002|Overall Study|Adverse Event|1|||
19675421|NCT00489918|42123275|FG003|Overall Study|Adverse Event|0|||
19675422|NCT00489918|42123276|FG004|Overall Study|Adverse Event|0|||
19675423|NCT00489918|42123272|FG000|Overall Study|Lost to Follow-up|0|||
19675424|NCT00489918|42123273|FG001|Overall Study|Lost to Follow-up|0|||
19675425|NCT00489918|42123274|FG002|Overall Study|Lost to Follow-up|1|||
19675426|NCT00489918|42123275|FG003|Overall Study|Lost to Follow-up|1|||
19675427|NCT00489918|42123276|FG004|Overall Study|Lost to Follow-up|0|||
19675428|NCT00489918|42123272|FG000|Overall Study|Physician Decision|0|||
19675429|NCT00489918|42123273|FG001|Overall Study|Physician Decision|0|||
19675430|NCT00489918|42123274|FG002|Overall Study|Physician Decision|1|||
19675431|NCT00489918|42123275|FG003|Overall Study|Physician Decision|0|||
19675432|NCT00489918|42123276|FG004|Overall Study|Physician Decision|0|||
19675433|NCT00307294|42123288|FG000|Overall Study|Withdrawal by Subject|1|||
19759591|NCT03354637|42211351|FG002|Open Label Extension|Withdrawal by Subject|5|||
19759592|NCT03354637|42211349|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
19759593|NCT03354637|42211350|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
19675434|NCT03963401|42123299|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
19675435|NCT03963401|42123300|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
19675436|NCT03963401|42123301|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
19675437|NCT03963401|42123302|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
19675438|NCT03963401|42123303|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
19675439|NCT03963401|42123304|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
19675440|NCT03963401|42123299|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
19675441|NCT03963401|42123300|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
19675442|NCT03963401|42123301|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
19675443|NCT03963401|42123302|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
19675444|NCT03963401|42123303|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
19675445|NCT03963401|42123304|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
19675446|NCT03963401|42123299|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
19675447|NCT03963401|42123300|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
19675448|NCT03963401|42123301|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
19675449|NCT03963401|42123302|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
19675450|NCT03963401|42123303|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
19675451|NCT03963401|42123304|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
19675452|NCT03963401|42123299|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
19675453|NCT03963401|42123300|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
19675454|NCT03963401|42123301|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
19675455|NCT03963401|42123302|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
19675456|NCT03963401|42123303|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
19675457|NCT03963401|42123304|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
19675458|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
19675459|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
19675460|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
19675461|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
19675462|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
19675463|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
19675464|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
19675465|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
19675466|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
19675467|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
19675468|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
19675469|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
19675470|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
19675471|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
19675472|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
19675473|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
19759594|NCT03354637|42211351|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
19759595|NCT03354637|42211349|FG000|Open Label Extension|Subject Noncompliance|0|||
19759596|NCT03354637|42211350|FG001|Open Label Extension|Subject Noncompliance|0|||
19759597|NCT03354637|42211351|FG002|Open Label Extension|Subject Noncompliance|1|||
19759598|NCT03354637|42211349|FG000|Open Label Extension|Lack of Efficacy|0|||
19759599|NCT03354637|42211350|FG001|Open Label Extension|Lack of Efficacy|0|||
19759600|NCT03354637|42211351|FG002|Open Label Extension|Lack of Efficacy|1|||
19759601|NCT03354637|42211349|FG000|Open Label Extension|Physician Decision|0|||
19759602|NCT03354637|42211350|FG001|Open Label Extension|Physician Decision|0|||
19759603|NCT03354637|42211351|FG002|Open Label Extension|Physician Decision|1|||
19759604|NCT04053023|42211362|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
19759605|NCT04053023|42211363|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
19759606|NCT03352453|42211375|FG000|Overall Study|Miscellaneous Reasons|1|||
19759607|NCT03352453|42211376|FG001|Overall Study|Miscellaneous Reasons|2|||
19759608|NCT03352453|42211375|FG000|Overall Study|Lack of Efficacy|1|||
19759609|NCT03352453|42211376|FG001|Overall Study|Lack of Efficacy|0|||
19759610|NCT03352453|42211375|FG000|Overall Study|Withdrawal by Subject|8|||
19759611|NCT03352453|42211376|FG001|Overall Study|Withdrawal by Subject|14|||
19759612|NCT03352453|42211375|FG000|Overall Study|Study Terminated by Sponsor|2|||
19759613|NCT03352453|42211376|FG001|Overall Study|Study Terminated by Sponsor|1|||
19389047|NCT02672423|41632613|FG004|Period 2|Withdrawal by Subject|0|||
19389048|NCT02672423|41632614|FG005|Period 2|Withdrawal by Subject|0|||
19675474|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
19759614|NCT03352453|42211375|FG000|Overall Study|Protocol Deviation|1|||
19759615|NCT03352453|42211376|FG001|Overall Study|Protocol Deviation|0|||
19759616|NCT03352453|42211375|FG000|Overall Study|Lost to Follow-up|7|||
19759617|NCT03352453|42211376|FG001|Overall Study|Lost to Follow-up|6|||
19759618|NCT03352453|42211375|FG000|Overall Study|Adverse Event|2|||
19759619|NCT03352453|42211376|FG001|Overall Study|Adverse Event|9|||
19675475|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
19675476|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
19675477|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
19675478|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
19675479|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
19675480|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
19675481|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
19675482|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
19759620|NCT03128931|42211382|FG000|Overall Study|Physician Decision|1|||
19759621|NCT03128931|42211382|FG000|Overall Study|Equipment Issues|3|||
19675483|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
19675484|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
19675485|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
19675486|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
19675487|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
19675488|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
19675489|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
19675490|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
19675491|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
19675492|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
19759622|NCT03107052|42211389|FG000|Overall Study|Adverse Event|6|||
19759623|NCT03107052|42211390|FG001|Overall Study|Adverse Event|1|||
19759624|NCT03107052|42211391|FG002|Overall Study|Adverse Event|2|||
19759625|NCT03107052|42211389|FG000|Overall Study|Withdrawal by Subject|9|||
19675493|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
19675494|NCT03963401|42123299|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
19675495|NCT03963401|42123300|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
19675496|NCT03963401|42123301|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
19675497|NCT03963401|42123302|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
19675498|NCT03963401|42123303|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
19675499|NCT03963401|42123304|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
19675500|NCT00334282|42123324|FG000|Overall Study|Lost to Follow-up|11|||
19675501|NCT00334282|42123325|FG001|Overall Study|Lost to Follow-up|5|||
19675502|NCT00334282|42123324|FG000|Overall Study|Withdrawal by Subject|17|||
19675503|NCT00334282|42123325|FG001|Overall Study|Withdrawal by Subject|3|||
19675504|NCT00334282|42123324|FG000|Overall Study|Death|194|||
19675505|NCT00334282|42123325|FG001|Overall Study|Death|100|||
19675506|NCT00306670|42123337|FG000|Overall Study|patients recruited; Genentech, the st|0|||
19675507|NCT00306670|42123338|FG001|Overall Study|patients recruited; Genentech, the st|2|||
19675508|NCT00306592|42123344|FG000|Overall Study|Adverse Event|8|||
19675509|NCT00306592|42123345|FG001|Overall Study|Adverse Event|15|||
19675510|NCT00306592|42123344|FG000|Overall Study|Lost to Follow-up|1|||
19675511|NCT00306592|42123345|FG001|Overall Study|Lost to Follow-up|0|||
19675512|NCT00306592|42123344|FG000|Overall Study|Noncompliance|0|||
19675513|NCT00306592|42123345|FG001|Overall Study|Noncompliance|2|||
19759626|NCT03107052|42211390|FG001|Overall Study|Withdrawal by Subject|5|||
19759627|NCT03107052|42211391|FG002|Overall Study|Withdrawal by Subject|8|||
19759628|NCT03107052|42211389|FG000|Overall Study|Protocol Violation|6|||
19759629|NCT03107052|42211390|FG001|Overall Study|Protocol Violation|0|||
19759630|NCT03107052|42211391|FG002|Overall Study|Protocol Violation|3|||
19759631|NCT03107052|42211389|FG000|Overall Study|Lost to Follow-up|4|||
19759632|NCT03107052|42211390|FG001|Overall Study|Lost to Follow-up|0|||
19759633|NCT03107052|42211391|FG002|Overall Study|Lost to Follow-up|1|||
19759634|NCT03107052|42211389|FG000|Overall Study|Lack of Efficacy|23|||
19759635|NCT03107052|42211390|FG001|Overall Study|Lack of Efficacy|7|||
19759636|NCT03107052|42211391|FG002|Overall Study|Lack of Efficacy|4|||
19759637|NCT03107052|42211389|FG000|Overall Study|Other than specified|4|||
19675514|NCT00306592|42123344|FG000|Overall Study|Persistent Antibodies|6|||
19759638|NCT03107052|42211390|FG001|Overall Study|Other than specified|2|||
19759639|NCT03107052|42211391|FG002|Overall Study|Other than specified|0|||
19759640|NCT03107052|42211389|FG000|Overall Study|Study terminated due to futility|67|||
19759641|NCT03107052|42211390|FG001|Overall Study|Study terminated due to futility|31|||
19675515|NCT00306592|42123345|FG001|Overall Study|Persistent Antibodies|3|||
19675516|NCT00306592|42123344|FG000|Overall Study|Voluntary|10|||
19675517|NCT00306592|42123345|FG001|Overall Study|Voluntary|6|||
19675518|NCT00306592|42123344|FG000|Overall Study|Other|5|||
19675519|NCT00306592|42123345|FG001|Overall Study|Other|10|||
19675520|NCT00306592|42123344|FG000|Overall Study|Other|1|||
19675521|NCT00306592|42123345|FG001|Overall Study|Other|2|||
19675522|NCT00306592|42123344|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
19675523|NCT00306592|42123345|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
19675524|NCT00321646|42123349|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
19675525|NCT00321646|42123349|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
19675526|NCT00321646|42123349|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
19675527|NCT00403767|42123355|FG000|Overall Study|Adverse Event|993|||
19675528|NCT00403767|42123356|FG001|Overall Study|Adverse Event|919|||
19675529|NCT00403767|42123355|FG000|Overall Study|Non-compliant with study medication|134|||
19675530|NCT00403767|42123356|FG001|Overall Study|Non-compliant with study medication|164|||
19675531|NCT00403767|42123355|FG000|Overall Study|Consent withdrawn|671|||
19675532|NCT00403767|42123356|FG001|Overall Study|Consent withdrawn|673|||
19675533|NCT00403767|42123355|FG000|Overall Study|Investigator dec./not protocol-related|191|||
19675534|NCT00403767|42123356|FG001|Overall Study|Investigator dec./not protocol-related|178|||
19675535|NCT00403767|42123355|FG000|Overall Study|Lost to Follow-up|6|||
19675536|NCT00403767|42123356|FG001|Overall Study|Lost to Follow-up|8|||
19675537|NCT00403767|42123355|FG000|Overall Study|Protocol Violation|142|||
19675538|NCT00403767|42123356|FG001|Overall Study|Protocol Violation|124|||
19759642|NCT03107052|42211391|FG002|Overall Study|Study terminated due to futility|23|||
19759643|NCT04050371|42211401|FG000|Overall Study|Withdrawal by Subject|1|||
19675539|NCT00403767|42123355|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
19675540|NCT00403767|42123356|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
19675541|NCT00403767|42123355|FG000|Overall Study|Study terminated by sponsor|82|||
19675542|NCT00403767|42123356|FG001|Overall Study|Study terminated by sponsor|69|||
19675543|NCT00403767|42123355|FG000|Overall Study|Missing/incomplete data|1|||
19675544|NCT00403767|42123356|FG001|Overall Study|Missing/incomplete data|1|||
19675545|NCT00492284|42123366|FG000|Overall Study|Adverse Event|0|||
19675546|NCT00492284|42123367|FG001|Overall Study|Adverse Event|1|||
19675547|NCT00492284|42123368|FG002|Overall Study|Adverse Event|1|||
19675548|NCT00492284|42123369|FG003|Overall Study|Adverse Event|2|||
19675549|NCT00492284|42123366|FG000|Overall Study|Lost to Follow-up|0|||
19675550|NCT00492284|42123367|FG001|Overall Study|Lost to Follow-up|0|||
19759644|NCT04050371|42211402|FG001|Overall Study|Withdrawal by Subject|0|||
19389049|NCT02672423|41632615|FG006|Period 2|Withdrawal by Subject|0|||
19675551|NCT00492284|42123368|FG002|Overall Study|Lost to Follow-up|3|||
19675552|NCT00492284|42123369|FG003|Overall Study|Lost to Follow-up|1|||
19675553|NCT00492284|42123366|FG000|Overall Study|Death|0|||
19675554|NCT00492284|42123367|FG001|Overall Study|Death|3|||
19675555|NCT00492284|42123368|FG002|Overall Study|Death|2|||
19675556|NCT00492284|42123369|FG003|Overall Study|Death|5|||
19675557|NCT00492284|42123366|FG000|Overall Study|Withdrawal by Subject|1|||
19759645|NCT04447287|42211411|FG000|Period 1: Run-in Period|Adverse Event|3|||
19675558|NCT00492284|42123367|FG001|Overall Study|Withdrawal by Subject|0|||
19675559|NCT00492284|42123368|FG002|Overall Study|Withdrawal by Subject|0|||
19675560|NCT00492284|42123369|FG003|Overall Study|Withdrawal by Subject|2|||
19675561|NCT00510458|42123379|FG000|Overall Study|5 year not evaluable/missed|21|||
19675562|NCT00510458|42123379|FG000|Overall Study|Death|1|||
19675563|NCT00510458|42123379|FG000|Overall Study|Terminated|14|||
19675564|NCT00510458|42123379|FG000|Overall Study|Lost to Follow-up|6|||
19675565|NCT00510458|42123379|FG000|Overall Study|Withdrawal by Subject|3|||
19675566|NCT00510458|42123379|FG000|Overall Study|Revision|2|||
19675567|NCT00414765|42123386|FG000|Overall Study|Adverse Event|5|||
19675568|NCT00414765|42123387|FG001|Overall Study|Adverse Event|9|||
19675569|NCT00414765|42123386|FG000|Overall Study|Withdrawal by Subject|1|||
19675570|NCT00414765|42123387|FG001|Overall Study|Withdrawal by Subject|1|||
19675571|NCT00414765|42123386|FG000|Overall Study|Disease Progression|0|||
19675572|NCT00414765|42123387|FG001|Overall Study|Disease Progression|1|||
19675573|NCT00500682|42123395|FG000|Overall Study|Adverse Event|37|||
19675574|NCT00500682|42123396|FG001|Overall Study|Adverse Event|29|||
19675575|NCT00500682|42123395|FG000|Overall Study|Death|25|||
19675576|NCT00500682|42123396|FG001|Overall Study|Death|16|||
19675577|NCT00500682|42123395|FG000|Overall Study|Lost to Follow-up|11|||
19675578|NCT00500682|42123396|FG001|Overall Study|Lost to Follow-up|11|||
19675579|NCT00500682|42123395|FG000|Overall Study|Physician Decision|6|||
19675580|NCT00500682|42123396|FG001|Overall Study|Physician Decision|10|||
19675581|NCT00500682|42123395|FG000|Overall Study|Pregnancy|2|||
19675582|NCT00500682|42123396|FG001|Overall Study|Pregnancy|0|||
19675583|NCT00500682|42123395|FG000|Overall Study|Protocol Violation|1|||
19675584|NCT00500682|42123396|FG001|Overall Study|Protocol Violation|3|||
19675585|NCT00500682|42123395|FG000|Overall Study|Withdrawal by Subject|80|||
19675586|NCT00500682|42123396|FG001|Overall Study|Withdrawal by Subject|74|||
19675587|NCT00500682|42123395|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
19675588|NCT00500682|42123396|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
19675589|NCT00500370|42123404|FG000|Overall Study|Adverse Event|9|||
19675590|NCT00500370|42123405|FG001|Overall Study|Adverse Event|3|||
19675591|NCT00500370|42123404|FG000|Overall Study|Lost to Follow-up|10|||
19675592|NCT00500370|42123405|FG001|Overall Study|Lost to Follow-up|10|||
19675593|NCT00500370|42123404|FG000|Overall Study|Protocol Violation|2|||
19675594|NCT00500370|42123405|FG001|Overall Study|Protocol Violation|4|||
19675595|NCT00500370|42123404|FG000|Overall Study|Sponsor Decision|2|||
19675596|NCT00500370|42123405|FG001|Overall Study|Sponsor Decision|0|||
19675597|NCT00500370|42123404|FG000|Overall Study|Subject Decision|10|||
19675598|NCT00500370|42123405|FG001|Overall Study|Subject Decision|17|||
19675599|NCT00320788|42123416|FG000|Overall Study|Adverse Event|0|||
19675600|NCT00320788|42123417|FG001|Overall Study|Adverse Event|0|||
19675601|NCT00320788|42123418|FG002|Overall Study|Adverse Event|0|||
19675602|NCT00320788|42123419|FG003|Overall Study|Adverse Event|1|||
19675603|NCT00320788|42123420|FG004|Overall Study|Adverse Event|0|||
19675604|NCT00320788|42123416|FG000|Overall Study|Death|0|||
19675605|NCT00320788|42123417|FG001|Overall Study|Death|0|||
19675606|NCT00320788|42123418|FG002|Overall Study|Death|1|||
19675607|NCT00320788|42123419|FG003|Overall Study|Death|0|||
19675608|NCT00320788|42123420|FG004|Overall Study|Death|1|||
19675609|NCT00320788|42123416|FG000|Overall Study|Lost to Follow-up|0|||
19675610|NCT00320788|42123417|FG001|Overall Study|Lost to Follow-up|2|||
19675611|NCT00320788|42123418|FG002|Overall Study|Lost to Follow-up|1|||
19675612|NCT00320788|42123419|FG003|Overall Study|Lost to Follow-up|0|||
19675613|NCT00320788|42123420|FG004|Overall Study|Lost to Follow-up|0|||
19675614|NCT00320788|42123416|FG000|Overall Study|Decision by the Sponsor|1|||
19675615|NCT00320788|42123417|FG001|Overall Study|Decision by the Sponsor|1|||
19675616|NCT00320788|42123418|FG002|Overall Study|Decision by the Sponsor|0|||
19675617|NCT00320788|42123419|FG003|Overall Study|Decision by the Sponsor|0|||
19675618|NCT00320788|42123420|FG004|Overall Study|Decision by the Sponsor|1|||
19675619|NCT00320788|42123416|FG000|Overall Study|Other|1|||
19675620|NCT00320788|42123417|FG001|Overall Study|Other|2|||
19675621|NCT00320788|42123418|FG002|Overall Study|Other|1|||
19389050|NCT02672423|41632616|FG007|Period 2|Withdrawal by Subject|0|||
19675622|NCT00320788|42123419|FG003|Overall Study|Other|1|||
19675623|NCT00320788|42123420|FG004|Overall Study|Other|1|||
19675624|NCT00320788|42123416|FG000|Overall Study|Physician Decision|1|||
19675625|NCT00320788|42123417|FG001|Overall Study|Physician Decision|1|||
19675626|NCT00320788|42123418|FG002|Overall Study|Physician Decision|0|||
19675627|NCT00320788|42123419|FG003|Overall Study|Physician Decision|0|||
19675628|NCT00320788|42123420|FG004|Overall Study|Physician Decision|0|||
19675629|NCT00320788|42123416|FG000|Overall Study|Protocol Violation|0|||
19675630|NCT00320788|42123417|FG001|Overall Study|Protocol Violation|0|||
19675631|NCT00320788|42123418|FG002|Overall Study|Protocol Violation|0|||
19675632|NCT00320788|42123419|FG003|Overall Study|Protocol Violation|0|||
19675633|NCT00320788|42123420|FG004|Overall Study|Protocol Violation|1|||
19675634|NCT00320788|42123416|FG000|Overall Study|Withdrawal by Subject|3|||
19675635|NCT00320788|42123417|FG001|Overall Study|Withdrawal by Subject|0|||
19675636|NCT00320788|42123418|FG002|Overall Study|Withdrawal by Subject|0|||
19675637|NCT00320788|42123419|FG003|Overall Study|Withdrawal by Subject|3|||
19675638|NCT00320788|42123420|FG004|Overall Study|Withdrawal by Subject|1|||
19675639|NCT00503984|42123440|FG000|Overall Study|Protocol Violation|0|||
19675640|NCT00503984|42123441|FG001|Overall Study|Protocol Violation|1|||
19675641|NCT00503984|42123442|FG002|Overall Study|Protocol Violation|0|||
19675642|NCT00503984|42123443|FG003|Overall Study|Protocol Violation|0|||
19675643|NCT00503984|42123444|FG004|Overall Study|Protocol Violation|0|||
19675644|NCT00503984|42123445|FG005|Overall Study|Protocol Violation|0|||
19675645|NCT00503984|42123440|FG000|Overall Study|Adverse Event|0|||
19675646|NCT00503984|42123441|FG001|Overall Study|Adverse Event|1|||
19675647|NCT00503984|42123442|FG002|Overall Study|Adverse Event|0|||
19675648|NCT00503984|42123443|FG003|Overall Study|Adverse Event|0|||
19675649|NCT00503984|42123444|FG004|Overall Study|Adverse Event|0|||
19675650|NCT00503984|42123445|FG005|Overall Study|Adverse Event|0|||
19675651|NCT00503984|42123440|FG000|Overall Study|Death|0|||
19675652|NCT00503984|42123441|FG001|Overall Study|Death|0|||
19675653|NCT00503984|42123442|FG002|Overall Study|Death|0|||
19675654|NCT00503984|42123443|FG003|Overall Study|Death|0|||
19675655|NCT00503984|42123444|FG004|Overall Study|Death|1|||
19675656|NCT00503984|42123445|FG005|Overall Study|Death|0|||
19675657|NCT00565409|42123469|FG000|Period 1 Open Label|Adverse Event|17|||
19675658|NCT00565409|42123470|FG001|Period 1 Open Label|Adverse Event|0|||
19675659|NCT00565409|42123471|FG002|Period 1 Open Label|Adverse Event|0|||
19675660|NCT00565409|42123472|FG003|Period 1 Open Label|Adverse Event|0|||
19675661|NCT00565409|42123469|FG000|Period 1 Open Label|Death|2|||
19675662|NCT00565409|42123470|FG001|Period 1 Open Label|Death|0|||
19675663|NCT00565409|42123471|FG002|Period 1 Open Label|Death|0|||
19675664|NCT00565409|42123472|FG003|Period 1 Open Label|Death|0|||
19675665|NCT00565409|42123469|FG000|Period 1 Open Label|Lost to Follow-up|1|||
19675666|NCT00565409|42123470|FG001|Period 1 Open Label|Lost to Follow-up|0|||
19675667|NCT00565409|42123471|FG002|Period 1 Open Label|Lost to Follow-up|0|||
19675668|NCT00565409|42123472|FG003|Period 1 Open Label|Lost to Follow-up|0|||
19675669|NCT00565409|42123469|FG000|Period 1 Open Label|Other|21|||
19675670|NCT00565409|42123470|FG001|Period 1 Open Label|Other|0|||
19675671|NCT00565409|42123471|FG002|Period 1 Open Label|Other|0|||
19675672|NCT00565409|42123472|FG003|Period 1 Open Label|Other|0|||
19675673|NCT00565409|42123469|FG000|Period 1 Open Label|Protocol Violation|14|||
19675674|NCT00565409|42123470|FG001|Period 1 Open Label|Protocol Violation|0|||
19675675|NCT00565409|42123471|FG002|Period 1 Open Label|Protocol Violation|0|||
19675676|NCT00565409|42123472|FG003|Period 1 Open Label|Protocol Violation|0|||
19675677|NCT00565409|42123469|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
19675678|NCT00565409|42123470|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
19675679|NCT00565409|42123471|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
19675680|NCT00565409|42123472|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
19675681|NCT00565409|42123469|FG000|Period 1 Open Label|no conclusion of participation record|1|||
19675682|NCT00565409|42123470|FG001|Period 1 Open Label|no conclusion of participation record|0|||
19675683|NCT00565409|42123471|FG002|Period 1 Open Label|no conclusion of participation record|0|||
19675684|NCT00565409|42123472|FG003|Period 1 Open Label|no conclusion of participation record|0|||
19675685|NCT00565409|42123469|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
19675686|NCT00565409|42123470|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
19675687|NCT00565409|42123471|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
19675688|NCT00565409|42123472|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
19675689|NCT00565409|42123469|FG000|Period 2 Double-Blind|Adverse Event|0|||
19675690|NCT00565409|42123470|FG001|Period 2 Double-Blind|Adverse Event|7|||
19675691|NCT00565409|42123471|FG002|Period 2 Double-Blind|Adverse Event|4|||
19675692|NCT00565409|42123472|FG003|Period 2 Double-Blind|Adverse Event|5|||
19675693|NCT00565409|42123469|FG000|Period 2 Double-Blind|Death|0|||
19675694|NCT00565409|42123470|FG001|Period 2 Double-Blind|Death|2|||
19675695|NCT00565409|42123471|FG002|Period 2 Double-Blind|Death|0|||
19675696|NCT00565409|42123472|FG003|Period 2 Double-Blind|Death|0|||
19675697|NCT00565409|42123469|FG000|Period 2 Double-Blind|Protocol Violation|0|||
19675698|NCT00565409|42123470|FG001|Period 2 Double-Blind|Protocol Violation|4|||
19675699|NCT00565409|42123471|FG002|Period 2 Double-Blind|Protocol Violation|6|||
19675700|NCT00565409|42123472|FG003|Period 2 Double-Blind|Protocol Violation|2|||
19675701|NCT00565409|42123469|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
19675702|NCT00565409|42123470|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
19675703|NCT00565409|42123471|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
19675704|NCT00565409|42123472|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
19675705|NCT00565409|42123469|FG000|Period 2 Double-Blind|Other|0|||
19675706|NCT00565409|42123470|FG001|Period 2 Double-Blind|Other|4|||
19389051|NCT02672423|41632617|FG008|Period 2|Withdrawal by Subject|0|||
19675707|NCT00565409|42123471|FG002|Period 2 Double-Blind|Other|5|||
19675708|NCT00565409|42123472|FG003|Period 2 Double-Blind|Other|9|||
19675709|NCT00565409|42123469|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
19675710|NCT00565409|42123470|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
19675711|NCT00565409|42123471|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
19675712|NCT00565409|42123472|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
19675713|NCT00394251|42123484|FG000|Overall Study|Adverse Event|7|||
19675714|NCT00394251|42123485|FG001|Overall Study|Adverse Event|5|||
19675715|NCT00394251|42123484|FG000|Overall Study|Unacceptable Toxicity|20|||
19675716|NCT00394251|42123485|FG001|Overall Study|Unacceptable Toxicity|18|||
19675717|NCT00394251|42123484|FG000|Overall Study|Physician Decision|1|||
19675718|NCT00394251|42123485|FG001|Overall Study|Physician Decision|1|||
19675719|NCT00394251|42123484|FG000|Overall Study|Protocol Violation|0|||
19675720|NCT00394251|42123485|FG001|Overall Study|Protocol Violation|1|||
19675721|NCT00394251|42123484|FG000|Overall Study|Withdrawal by Subject|7|||
19675722|NCT00394251|42123485|FG001|Overall Study|Withdrawal by Subject|11|||
19675723|NCT00394251|42123484|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
19675724|NCT00394251|42123485|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
19675725|NCT00394095|42123497|FG000|Overall Study|Adverse Event|1|||
19675726|NCT00394095|42123498|FG001|Overall Study|Adverse Event|0|||
19675727|NCT00503906|42123505|FG000|Overall Study|Withdrawal by Subject|1|||
19675728|NCT00305110|42123510|FG000|Overall Study|Missing data|29|||
19675729|NCT00491894|42123514|FG000|Overall Study|Adverse Event|14|||
19675730|NCT00491894|42123514|FG000|Overall Study|Withdrawal by Subject|5|||
19675731|NCT00491894|42123514|FG000|Overall Study|Death|3|||
19675732|NCT00491894|42123514|FG000|Overall Study|Lost to Follow-up|3|||
19675733|NCT00491894|42123514|FG000|Overall Study|Lack of Efficacy|2|||
19675734|NCT00491894|42123514|FG000|Overall Study|Other-Failed to meet any criteria|2|||
19675735|NCT00491894|42123514|FG000|Overall Study|Physician Decision|2|||
19675736|NCT00491894|42123514|FG000|Overall Study|Protocol Violation|2|||
19675737|NCT00491894|42123514|FG000|Overall Study|Other-Intake of prohibited medication|1|||
19675738|NCT00491504|42123522|FG000|Overall Study|Adverse Event|0|||
19759646|NCT04447287|42211412|FG001|Period 1: Run-in Period|Adverse Event|0|||
19759647|NCT04447287|42211413|FG002|Period 1: Run-in Period|Adverse Event|0|||
19759648|NCT04447287|42211411|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
19759649|NCT04447287|42211412|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
19759650|NCT04447287|42211413|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
19759651|NCT04447287|42211411|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
19675739|NCT00491504|42123523|FG001|Overall Study|Adverse Event|1|||
19675740|NCT00491504|42123524|FG002|Overall Study|Adverse Event|0|||
19759652|NCT04447287|42211412|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
19759653|NCT04447287|42211413|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
19759654|NCT01879319|42211434|FG000|Overall Study|Withdrawal by Subject|1|||
19759655|NCT01879319|42211435|FG001|Overall Study|Withdrawal by Subject|0|||
19759656|NCT01879319|42211434|FG000|Overall Study|Lost to Follow-up|1|||
19759657|NCT01879319|42211435|FG001|Overall Study|Lost to Follow-up|5|||
19759658|NCT03102918|42211443|FG000|Overall Study|Protocol Violation|1|||
19759659|NCT03102918|42211444|FG001|Overall Study|Protocol Violation|0|||
19759660|NCT03128307|42211450|FG000|Overall Study|Lost to Follow-up|29|||
19759661|NCT03128307|42211450|FG000|Overall Study|Withdrawal by Subject|5|||
19759662|NCT03102762|42211456|FG000|Overall Study|Lost to Follow-up|1|||
19759663|NCT03102762|42211457|FG001|Overall Study|Lost to Follow-up|0|||
19759664|NCT01346475|42211470|FG000|First Intervention|Lost to Follow-up|4|||
19759665|NCT01346475|42211471|FG001|First Intervention|Lost to Follow-up|3|||
19759666|NCT01338636|42211477|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
19759667|NCT00322218|42211483|FG000|Overall Study|Death|3|||
19759668|NCT00322218|42211484|FG001|Overall Study|Death|6|||
19759669|NCT02873754|42211490|FG000|Overall Study|Lost to Follow-up|5|||
19759670|NCT02873754|42211490|FG000|Overall Study|Couldn't complete study procedures|1|||
19759671|NCT03287414|42211496|FG000|Treatment Epoch|Adverse Event|0|||
19759672|NCT03287414|42211497|FG001|Treatment Epoch|Adverse Event|1|||
19759673|NCT03287414|42211496|FG000|Treatment Epoch|Study terminated by sponsor|2|||
19759674|NCT03287414|42211497|FG001|Treatment Epoch|Study terminated by sponsor|2|||
19759675|NCT03287414|42211496|FG000|Treatment Epoch|Subject/Guardian decision|4|||
19759676|NCT03287414|42211497|FG001|Treatment Epoch|Subject/Guardian decision|0|||
19675741|NCT00491504|42123525|FG003|Overall Study|Adverse Event|0|||
19675742|NCT00491504|42123522|FG000|Overall Study|Withdrawal by Subject|0|||
19675743|NCT00491504|42123523|FG001|Overall Study|Withdrawal by Subject|0|||
19675744|NCT00491504|42123524|FG002|Overall Study|Withdrawal by Subject|1|||
19675745|NCT00491504|42123525|FG003|Overall Study|Withdrawal by Subject|2|||
19675746|NCT00491504|42123522|FG000|Overall Study|Protocol Violation|0|||
19675747|NCT00491504|42123523|FG001|Overall Study|Protocol Violation|0|||
19675748|NCT00491504|42123524|FG002|Overall Study|Protocol Violation|3|||
19675749|NCT00491504|42123525|FG003|Overall Study|Protocol Violation|2|||
19675750|NCT00500292|42123536|FG000|Overall Study|Adverse Event|3|||
19675751|NCT00500292|42123537|FG001|Overall Study|Adverse Event|6|||
19759677|NCT03287414|42211496|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
19759678|NCT03287414|42211497|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
19759679|NCT03287414|42211496|FG000|Treatment Epoch|Withdrawal by Subject|1|||
19675752|NCT00500292|42123538|FG002|Overall Study|Adverse Event|4|||
19675753|NCT00500292|42123536|FG000|Overall Study|Condition under investigation worsened|21|||
19675754|NCT00500292|42123537|FG001|Overall Study|Condition under investigation worsened|23|||
19675755|NCT00500292|42123538|FG002|Overall Study|Condition under investigation worsened|19|||
19675756|NCT00500292|42123536|FG000|Overall Study|Withdrawal by Subject|0|||
19675757|NCT00500292|42123537|FG001|Overall Study|Withdrawal by Subject|1|||
19675758|NCT00500292|42123538|FG002|Overall Study|Withdrawal by Subject|0|||
19675759|NCT00500292|42123536|FG000|Overall Study|Other|1|||
19675760|NCT00500292|42123537|FG001|Overall Study|Other|1|||
19675761|NCT00500292|42123538|FG002|Overall Study|Other|4|||
19675762|NCT00499746|42123546|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
19675763|NCT00499746|42123546|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
19675764|NCT00499746|42123546|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
19675765|NCT00499746|42123546|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
19675766|NCT00489216|42123560|FG000|Overall Study|Adverse Event|1|||
19675767|NCT00499590|42123567|FG000|Overall Study|Study Terminated|112|||
19675768|NCT00499590|42123568|FG001|Overall Study|Study Terminated|112|||
19675769|NCT00499590|42123569|FG002|Overall Study|Study Terminated|112|||
19675770|NCT00499590|42123567|FG000|Overall Study|Not treated|1|||
19675771|NCT00499590|42123568|FG001|Overall Study|Not treated|0|||
19675772|NCT00499590|42123569|FG002|Overall Study|Not treated|1|||
19675773|NCT00510146|42123580|FG000|Double-Blind Treatment|Adverse Event|30|||
19675774|NCT00510146|42123581|FG001|Double-Blind Treatment|Adverse Event|13|||
19675775|NCT00510146|42123580|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
19675776|NCT00510146|42123581|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
19675777|NCT00510146|42123580|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
19675778|NCT00510146|42123581|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
19675779|NCT00510146|42123580|FG000|Double-Blind Treatment|Physician Decision|6|||
19675780|NCT00510146|42123581|FG001|Double-Blind Treatment|Physician Decision|0|||
19675781|NCT00510146|42123580|FG000|Double-Blind Treatment|Protocol Violation|1|||
19675782|NCT00510146|42123581|FG001|Double-Blind Treatment|Protocol Violation|2|||
19675783|NCT00510146|42123580|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
19675784|NCT00510146|42123581|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
19675785|NCT00510146|42123580|FG000|Double-Blind Treatment|Clinical Relapse|0|||
19675786|NCT00510146|42123581|FG001|Double-Blind Treatment|Clinical Relapse|1|||
19675787|NCT00510146|42123580|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
19675788|NCT00510146|42123581|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
19675789|NCT00510146|42123580|FG000|Open-Label Treatment|Adverse Event|22|||
19675790|NCT00510146|42123581|FG001|Open-Label Treatment|Adverse Event|8|||
19675791|NCT00510146|42123580|FG000|Open-Label Treatment|Death|1|||
19675792|NCT00510146|42123581|FG001|Open-Label Treatment|Death|1|||
19675793|NCT00510146|42123580|FG000|Open-Label Treatment|Lack of Efficacy|4|||
19675794|NCT00510146|42123581|FG001|Open-Label Treatment|Lack of Efficacy|0|||
19675795|NCT00510146|42123580|FG000|Open-Label Treatment|Lost to Follow-up|10|||
19675796|NCT00510146|42123581|FG001|Open-Label Treatment|Lost to Follow-up|1|||
19675797|NCT00510146|42123580|FG000|Open-Label Treatment|Physician Decision|3|||
19675798|NCT00510146|42123581|FG001|Open-Label Treatment|Physician Decision|1|||
19675799|NCT00510146|42123580|FG000|Open-Label Treatment|Protocol Violation|4|||
19675800|NCT00510146|42123581|FG001|Open-Label Treatment|Protocol Violation|2|||
19675801|NCT00510146|42123580|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
19759680|NCT03287414|42211497|FG001|Treatment Epoch|Withdrawal by Subject|0|||
19759681|NCT03287414|42211496|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
19759682|NCT03287414|42211497|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
19759683|NCT03287414|42211496|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
19759684|NCT03287414|42211497|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
19759685|NCT03101592|42211527|FG000|Overall Study|participant files could not be located|111|||
19759686|NCT03101592|42211528|FG001|Overall Study|participant files could not be located|170|||
19759687|NCT03101592|42211529|FG002|Overall Study|participant files could not be located|118|||
19759688|NCT04046939|42211547|FG000|Primary Assessment Period|Adverse Event|1|||
19675802|NCT00510146|42123581|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
19675803|NCT00510146|42123580|FG000|Open-Label Treatment|Clinical Relapse|1|||
19675804|NCT00510146|42123581|FG001|Open-Label Treatment|Clinical Relapse|1|||
19675805|NCT00510146|42123580|FG000|Open-Label Treatment|Sponsor Decision|2|||
19675806|NCT00510146|42123581|FG001|Open-Label Treatment|Sponsor Decision|0|||
19759689|NCT04046939|42211548|FG001|Primary Assessment Period|Adverse Event|0|||
19759690|NCT04046939|42211549|FG002|Primary Assessment Period|Adverse Event|0|||
19759691|NCT04046939|42211550|FG003|Primary Assessment Period|Adverse Event|0|||
19759692|NCT04046939|42211547|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
19675807|NCT00480636|42123589|FG000|Overall Study|Death|12|||
19675808|NCT00480636|42123589|FG000|Overall Study|Lost to Follow-up|4|||
19675809|NCT00480636|42123589|FG000|Overall Study|Other|2|||
19675810|NCT00480636|42123589|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
19759693|NCT04046939|42211548|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
19759694|NCT04046939|42211549|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
19759695|NCT04046939|42211550|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
19759696|NCT04046939|42211547|FG000|Primary Assessment Period|Physician Decision|0|||
19759697|NCT04046939|42211548|FG001|Primary Assessment Period|Physician Decision|0|||
19759698|NCT04046939|42211549|FG002|Primary Assessment Period|Physician Decision|1|||
19759699|NCT04046939|42211550|FG003|Primary Assessment Period|Physician Decision|0|||
19759700|NCT04046939|42211547|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
19759701|NCT04046939|42211548|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
19759702|NCT04046939|42211549|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
19759703|NCT04046939|42211550|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
19759704|NCT04042103|42211566|FG000|Overall Study|Lost to Follow-up|1|||
19759705|NCT04042103|42211566|FG000|Overall Study|Withdrawal by Subject|1|||
19759706|NCT02955797|42211574|FG000|Overall Study|Protocol Violation|1|||
19759707|NCT02955797|42211575|FG001|Overall Study|Protocol Violation|0|||
19759708|NCT02955797|42211576|FG002|Overall Study|Protocol Violation|0|||
19759709|NCT02955797|42211577|FG003|Overall Study|Protocol Violation|1|||
19759710|NCT02955797|42211574|FG000|Overall Study|Withdrawal by Subject|2|||
19759711|NCT02955797|42211575|FG001|Overall Study|Withdrawal by Subject|2|||
19759712|NCT02955797|42211576|FG002|Overall Study|Withdrawal by Subject|0|||
19759713|NCT02955797|42211577|FG003|Overall Study|Withdrawal by Subject|1|||
19759714|NCT02955797|42211574|FG000|Overall Study|Lost to Follow-up|0|||
19675811|NCT00499122|42123593|FG000|Overall Study|Withdrawal by Subject|2|||
19759715|NCT02955797|42211575|FG001|Overall Study|Lost to Follow-up|1|||
19759716|NCT02955797|42211576|FG002|Overall Study|Lost to Follow-up|0|||
19675812|NCT00393939|42123600|FG000|Overall Study|Protocol Violation|1|||
19675813|NCT00393939|42123601|FG001|Overall Study|Protocol Violation|1|||
19675814|NCT00393939|42123600|FG000|Overall Study|Lost to Follow-up|2|||
19675815|NCT00393939|42123601|FG001|Overall Study|Lost to Follow-up|4|||
19675816|NCT00393939|42123600|FG000|Overall Study|Death|10|||
19675817|NCT00393939|42123601|FG001|Overall Study|Death|4|||
19675818|NCT00393939|42123600|FG000|Overall Study|Sponsor|5|||
19675819|NCT00393939|42123601|FG001|Overall Study|Sponsor|13|||
19675820|NCT00393939|42123600|FG000|Overall Study|Objective progression or relapse|239|||
19675821|NCT00393939|42123601|FG001|Overall Study|Objective progression or relapse|223|||
19675822|NCT00393939|42123600|FG000|Overall Study|Withdrawal by Subject|2|||
19675823|NCT00393939|42123601|FG001|Overall Study|Withdrawal by Subject|7|||
19675824|NCT00393939|42123600|FG000|Overall Study|Other|37|||
19675825|NCT00393939|42123601|FG001|Overall Study|Other|45|||
19675826|NCT00488982|42123607|FG000|Course 1|Physician Decision|0|||
19675827|NCT00488982|42123608|FG001|Course 1|Physician Decision|2|||
19675828|NCT00488982|42123609|FG002|Course 1|Physician Decision|4|||
19675829|NCT00488982|42123607|FG000|Course 1|Withdrawal by Subject|0|||
19675830|NCT00488982|42123608|FG001|Course 1|Withdrawal by Subject|8|||
19675831|NCT00488982|42123609|FG002|Course 1|Withdrawal by Subject|2|||
19675832|NCT00488982|42123607|FG000|Course 1|nonprotocol therapy|0|||
19675833|NCT00488982|42123608|FG001|Course 1|nonprotocol therapy|2|||
19675834|NCT00488982|42123609|FG002|Course 1|nonprotocol therapy|2|||
19675835|NCT00488982|42123607|FG000|Course 1|Adverse Event|0|||
19675836|NCT00488982|42123608|FG001|Course 1|Adverse Event|0|||
19675837|NCT00488982|42123609|FG002|Course 1|Adverse Event|6|||
19675838|NCT00488826|42123626|FG000|Overall Study|Withdrawal by Subject|40|||
19675839|NCT00488826|42123627|FG001|Overall Study|Withdrawal by Subject|35|||
19675840|NCT00488826|42123628|FG002|Overall Study|Withdrawal by Subject|19|||
19675841|NCT00488826|42123626|FG000|Overall Study|Protocol Violation|0|||
19675842|NCT00488826|42123627|FG001|Overall Study|Protocol Violation|0|||
19675843|NCT00488826|42123628|FG002|Overall Study|Protocol Violation|2|||
19675844|NCT00488826|42123626|FG000|Overall Study|Adverse Event|9|||
19675845|NCT00488826|42123627|FG001|Overall Study|Adverse Event|15|||
19675846|NCT00488826|42123628|FG002|Overall Study|Adverse Event|4|||
19675847|NCT00488826|42123626|FG000|Overall Study|Lost to Follow-up|5|||
19675848|NCT00488826|42123627|FG001|Overall Study|Lost to Follow-up|1|||
19675849|NCT00488826|42123628|FG002|Overall Study|Lost to Follow-up|0|||
19675850|NCT00488826|42123626|FG000|Overall Study|Protocol Deviations|2|||
19675851|NCT00488826|42123627|FG001|Overall Study|Protocol Deviations|1|||
19675852|NCT00488826|42123628|FG002|Overall Study|Protocol Deviations|1|||
19675853|NCT00393861|42123636|FG000|Overall Study|Adverse Event|2|||
19675854|NCT00393861|42123636|FG000|Overall Study|Disease Progression|24|||
19675855|NCT00480324|42123642|FG000|Overall Study|Adverse Event|1|||
19675856|NCT00480324|42123643|FG001|Overall Study|Adverse Event|1|||
19675857|NCT00480324|42123642|FG000|Overall Study|Protocol Violation|0|||
19675858|NCT00480324|42123643|FG001|Overall Study|Protocol Violation|1|||
19675859|NCT00480324|42123642|FG000|Overall Study|Withdrawal by Subject|14|||
19675860|NCT00480324|42123643|FG001|Overall Study|Withdrawal by Subject|5|||
19675861|NCT00480324|42123642|FG000|Overall Study|Lost to Follow-up|17|||
19675862|NCT00480324|42123643|FG001|Overall Study|Lost to Follow-up|8|||
19675863|NCT00480324|42123642|FG000|Overall Study|Subject's mother pregnant|0|||
19675864|NCT00480324|42123643|FG001|Overall Study|Subject's mother pregnant|1|||
19675865|NCT00488592|42123649|FG000|Overall Study|Withdrawal by Subject|1|||
19675866|NCT00488592|42123649|FG000|Overall Study|Disease progression|1|||
19675867|NCT00488592|42123649|FG000|Overall Study|Enrolled but not treated|1|||
19675868|NCT00488514|42123653|FG000|Overall Study|Adverse Event|41|||
19675869|NCT00488514|42123653|FG000|Overall Study|Lost to Follow-up|44|||
19675870|NCT00488514|42123653|FG000|Overall Study|Protocol Violation|32|||
19675871|NCT00488514|42123653|FG000|Overall Study|Withdrawal by Subject|106|||
19675872|NCT00488514|42123653|FG000|Overall Study|Lack of Efficacy|28|||
19675873|NCT00488514|42123653|FG000|Overall Study|Did not meet criteria for treatment|30|||
19675874|NCT00488514|42123653|FG000|Overall Study|Postive drug screen|1|||
19675875|NCT00488514|42123653|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
19675876|NCT00488514|42123653|FG000|Overall Study|Investigator decision|1|||
19675877|NCT00488514|42123653|FG000|Overall Study|Participant had too few migraines|5|||
19675878|NCT00488514|42123653|FG000|Overall Study|Increase in number of migraines|2|||
19675879|NCT00488514|42123653|FG000|Overall Study|Increased use of concomitant medication|1|||
19675880|NCT00320710|42123677|FG000|Overall Study|Disease progression|24|||
19675881|NCT00320710|42123678|FG001|Overall Study|Disease progression|19|||
19675882|NCT00320710|42123679|FG002|Overall Study|Disease progression|2|||
19675883|NCT00320710|42123677|FG000|Overall Study|Death|10|||
19675884|NCT00320710|42123678|FG001|Overall Study|Death|7|||
19675885|NCT00320710|42123679|FG002|Overall Study|Death|1|||
19675886|NCT00320710|42123677|FG000|Overall Study|Administrative problems|1|||
19675887|NCT00320710|42123678|FG001|Overall Study|Administrative problems|2|||
19675888|NCT00320710|42123679|FG002|Overall Study|Administrative problems|0|||
19675889|NCT00320710|42123677|FG000|Overall Study|Withdrawal by Subject|20|||
19675890|NCT00320710|42123678|FG001|Overall Study|Withdrawal by Subject|26|||
19675891|NCT00320710|42123679|FG002|Overall Study|Withdrawal by Subject|1|||
19675892|NCT00320710|42123677|FG000|Overall Study|Protocol Violation|6|||
19675893|NCT00320710|42123678|FG001|Overall Study|Protocol Violation|5|||
19675894|NCT00320710|42123679|FG002|Overall Study|Protocol Violation|0|||
19675895|NCT00320710|42123677|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19675896|NCT00320710|42123678|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19675897|NCT00320710|42123679|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19675898|NCT00320710|42123677|FG000|Overall Study|Abnormal laboratory value(s)|12|||
19675899|NCT00320710|42123678|FG001|Overall Study|Abnormal laboratory value(s)|3|||
19675900|NCT00320710|42123679|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19675901|NCT00320710|42123677|FG000|Overall Study|Adverse Event|18|||
19675902|NCT00320710|42123678|FG001|Overall Study|Adverse Event|14|||
19675903|NCT00320710|42123679|FG002|Overall Study|Adverse Event|1|||
19675904|NCT00320710|42123677|FG000|Overall Study|Lost to Follow-up|1|||
19675905|NCT00320710|42123678|FG001|Overall Study|Lost to Follow-up|0|||
19675906|NCT00320710|42123679|FG002|Overall Study|Lost to Follow-up|0|||
19675907|NCT00320398|42123688|FG000|Overall Study|Adverse Event|1|||
19675908|NCT00320398|42123689|FG001|Overall Study|Adverse Event|4|||
19675909|NCT00320398|42123688|FG000|Overall Study|Other|1|||
19675910|NCT00320398|42123689|FG001|Overall Study|Other|0|||
19675911|NCT00498186|42123696|FG000|Overall Study|Protocol Violation|10|||
19675912|NCT00498186|42123696|FG000|Overall Study|Lack of Efficacy|31|||
19675913|NCT00498186|42123696|FG000|Overall Study|Adverse Event|89|||
19675914|NCT00498186|42123696|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
19675915|NCT00498186|42123696|FG000|Overall Study|Withdrawal by Subject|18|||
19675916|NCT00498186|42123696|FG000|Overall Study|Lost to Follow-up|3|||
19675917|NCT00498186|42123696|FG000|Overall Study|Other|10|||
19675918|NCT00333970|42123702|FG000|Overall Study|Withdrawal by Subject|13|||
19675919|NCT00333970|42123703|FG001|Overall Study|Withdrawal by Subject|7|||
19675920|NCT00477594|42123711|FG000|Year 1 and Year 2|Adverse Event|4|||
19675921|NCT00477594|42123712|FG001|Year 1 and Year 2|Adverse Event|2|||
19675922|NCT00477594|42123711|FG000|Year 1 and Year 2|Physician Decision|2|||
19675923|NCT00477594|42123712|FG001|Year 1 and Year 2|Physician Decision|1|||
19675924|NCT00477594|42123711|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
19675925|NCT00477594|42123712|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
19675926|NCT00477594|42123711|FG000|Year 1 and Year 2|Other|1|||
19675927|NCT00477594|42123712|FG001|Year 1 and Year 2|Other|0|||
19759717|NCT02955797|42211577|FG003|Overall Study|Lost to Follow-up|0|||
19759718|NCT03101514|42211590|FG000|Overall Study|Withdrawal by Subject|4|||
19759719|NCT03101514|42211590|FG000|Overall Study|Protocol Violation|2|||
19759720|NCT03101514|42211590|FG000|Overall Study|patient's information was incomplete|1|||
19759721|NCT04040933|42211594|FG000|Overall Study|Protocol Violation|1|||
19675928|NCT00477594|42123711|FG000|Year 3|Adverse Event|1|||
19675929|NCT00477594|42123712|FG001|Year 3|Adverse Event|0|||
19675930|NCT00477594|42123711|FG000|Year 3|Withdrawal by Subject|1|||
19675931|NCT00477594|42123712|FG001|Year 3|Withdrawal by Subject|0|||
19675932|NCT00477594|42123711|FG000|Follow-up Period|Withdrawal by Subject|2|||
19675933|NCT00477594|42123712|FG001|Follow-up Period|Withdrawal by Subject|1|||
19675934|NCT00477594|42123711|FG000|Follow-up Period|Other|1|||
19675935|NCT00477594|42123712|FG001|Follow-up Period|Other|0|||
19675936|NCT00475722|42123720|FG000|Overall Study|Withdrawal by Subject|12|||
19675937|NCT00475722|42123721|FG001|Overall Study|Withdrawal by Subject|12|||
19675938|NCT00475722|42123720|FG000|Overall Study|Protocol Violation|3|||
19675939|NCT00475722|42123721|FG001|Overall Study|Protocol Violation|0|||
19675940|NCT00304954|42123731|FG000|Overall Study|Withdrawal by Subject|0|||
19675941|NCT00304954|42123732|FG001|Overall Study|Withdrawal by Subject|0|||
19675942|NCT00304954|42123733|FG002|Overall Study|Withdrawal by Subject|1|||
19675943|NCT00304954|42123734|FG003|Overall Study|Withdrawal by Subject|0|||
19675944|NCT00304954|42123731|FG000|Overall Study|Adverse Event|1|||
19675945|NCT00304954|42123732|FG001|Overall Study|Adverse Event|0|||
19675946|NCT00304954|42123733|FG002|Overall Study|Adverse Event|0|||
19675947|NCT00304954|42123734|FG003|Overall Study|Adverse Event|0|||
19675948|NCT00475176|42123752|FG000|Overall Study|Adverse Event|2|||
19675949|NCT00475176|42123752|FG000|Overall Study|Withdrawal by Subject|1|||
19675950|NCT00475176|42123752|FG000|Overall Study|Protocol Violation|1|||
19675951|NCT00414609|42123758|FG000|Core Study|Adverse Event|9|||
19675952|NCT00414609|42123759|FG001|Core Study|Adverse Event|11|||
19675953|NCT00414609|42123760|FG002|Core Study|Adverse Event|0|||
19675954|NCT00414609|42123758|FG000|Core Study|Abnormal laboratory values|0|||
19675955|NCT00414609|42123759|FG001|Core Study|Abnormal laboratory values|1|||
19675956|NCT00414609|42123760|FG002|Core Study|Abnormal laboratory values|0|||
19675957|NCT00414609|42123758|FG000|Core Study|Abnormal test procedure results|1|||
19675958|NCT00414609|42123759|FG001|Core Study|Abnormal test procedure results|1|||
19675959|NCT00414609|42123760|FG002|Core Study|Abnormal test procedure results|0|||
19675960|NCT00414609|42123758|FG000|Core Study|Protocol deviation|0|||
19675961|NCT00414609|42123759|FG001|Core Study|Protocol deviation|1|||
19675962|NCT00414609|42123760|FG002|Core Study|Protocol deviation|0|||
19675963|NCT00414609|42123758|FG000|Core Study|Patient withdrew consent|10|||
19675964|NCT00414609|42123759|FG001|Core Study|Patient withdrew consent|11|||
19675965|NCT00414609|42123760|FG002|Core Study|Patient withdrew consent|0|||
19675966|NCT00414609|42123758|FG000|Core Study|Lost to Follow-up|7|||
19675967|NCT00414609|42123759|FG001|Core Study|Lost to Follow-up|4|||
19675968|NCT00414609|42123760|FG002|Core Study|Lost to Follow-up|0|||
19675969|NCT00414609|42123758|FG000|Core Study|Administrative problems|0|||
19675970|NCT00414609|42123759|FG001|Core Study|Administrative problems|2|||
19675971|NCT00414609|42123760|FG002|Core Study|Administrative problems|0|||
19675972|NCT00414609|42123758|FG000|Core Study|Death|7|||
19675973|NCT00414609|42123759|FG001|Core Study|Death|14|||
19675974|NCT00414609|42123760|FG002|Core Study|Death|0|||
19675975|NCT00414609|42123758|FG000|Extension Study|Adverse Event|0|||
19675976|NCT00414609|42123759|FG001|Extension Study|Adverse Event|0|||
19675977|NCT00414609|42123760|FG002|Extension Study|Adverse Event|14|||
19675978|NCT00414609|42123758|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
19675979|NCT00414609|42123759|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
19675980|NCT00414609|42123760|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
19675981|NCT00414609|42123758|FG000|Extension Study|Withdrawal by Subject|0|||
19675982|NCT00414609|42123759|FG001|Extension Study|Withdrawal by Subject|0|||
19675983|NCT00414609|42123760|FG002|Extension Study|Withdrawal by Subject|13|||
19675984|NCT00414609|42123758|FG000|Extension Study|Lost to Follow-up|0|||
19675985|NCT00414609|42123759|FG001|Extension Study|Lost to Follow-up|0|||
19675986|NCT00414609|42123760|FG002|Extension Study|Lost to Follow-up|10|||
19675987|NCT00414609|42123758|FG000|Extension Study|Administrative problems|0|||
19675988|NCT00414609|42123759|FG001|Extension Study|Administrative problems|0|||
19675989|NCT00414609|42123760|FG002|Extension Study|Administrative problems|1|||
19675990|NCT00414609|42123758|FG000|Extension Study|Death|0|||
19675991|NCT00414609|42123759|FG001|Extension Study|Death|0|||
19675992|NCT00414609|42123760|FG002|Extension Study|Death|17|||
19675993|NCT00393705|42123771|FG000|Overall Study|Adverse Event|0|||
19675994|NCT00393705|42123772|FG001|Overall Study|Adverse Event|2|||
19675995|NCT00393705|42123771|FG000|Overall Study|Death|0|||
19675996|NCT00393705|42123772|FG001|Overall Study|Death|1|||
19675997|NCT00393705|42123771|FG000|Overall Study|Lost to Follow-up|2|||
19675998|NCT00393705|42123772|FG001|Overall Study|Lost to Follow-up|2|||
19675999|NCT00393705|42123771|FG000|Overall Study|Entry Criteria Not Met|10|||
19676000|NCT00393705|42123772|FG001|Overall Study|Entry Criteria Not Met|10|||
19676001|NCT00393705|42123771|FG000|Overall Study|Protocol Violation|4|||
19676002|NCT00393705|42123772|FG001|Overall Study|Protocol Violation|3|||
19676003|NCT00393705|42123771|FG000|Overall Study|Withdrawal by Subject|5|||
19676004|NCT00393705|42123772|FG001|Overall Study|Withdrawal by Subject|3|||
19676005|NCT00393705|42123771|FG000|Overall Study|Physician Decision|2|||
19676006|NCT00393705|42123772|FG001|Overall Study|Physician Decision|2|||
19676007|NCT00303628|42123780|FG000|Overall Study|Disease progression|0|||
19676008|NCT00303628|42123781|FG001|Overall Study|Disease progression|1|||
19676009|NCT00303628|42123780|FG000|Overall Study|Adverse Event|26|||
19676010|NCT00303628|42123781|FG001|Overall Study|Adverse Event|36|||
19676011|NCT00303628|42123780|FG000|Overall Study|Death|0|||
19676012|NCT00303628|42123781|FG001|Overall Study|Death|1|||
19676013|NCT00303628|42123780|FG000|Overall Study|Withdrawal by Subject|11|||
19676014|NCT00303628|42123781|FG001|Overall Study|Withdrawal by Subject|20|||
19676015|NCT00303628|42123780|FG000|Overall Study|Alternative therapy|2|||
19676016|NCT00303628|42123781|FG001|Overall Study|Alternative therapy|0|||
19676017|NCT00303628|42123780|FG000|Overall Study|Other complicating disease|0|||
19676018|NCT00303628|42123781|FG001|Overall Study|Other complicating disease|1|||
19676019|NCT00303628|42123780|FG000|Overall Study|Not start protocol therapy|3|||
19676020|NCT00303628|42123781|FG001|Overall Study|Not start protocol therapy|5|||
19676021|NCT00303628|42123780|FG000|Overall Study|Other|8|||
19676022|NCT00303628|42123781|FG001|Overall Study|Other|9|||
19759722|NCT04040933|42211594|FG000|Overall Study|Withdrawal by Subject|2|||
19759723|NCT02702518|42211607|FG000|Overall Study|Lost to Follow-up|3|||
19759724|NCT02702518|42211608|FG001|Overall Study|Lost to Follow-up|4|||
19759725|NCT04039503|42211618|FG000|Overall Study|Adverse Event|3|||
19759726|NCT04039503|42211619|FG001|Overall Study|Adverse Event|0|||
19759727|NCT04039503|42211620|FG002|Overall Study|Adverse Event|2|||
19759728|NCT04039503|42211621|FG003|Overall Study|Adverse Event|0|||
19759729|NCT04039503|42211618|FG000|Overall Study|Lost to Follow-up|0|||
19759730|NCT04039503|42211619|FG001|Overall Study|Lost to Follow-up|0|||
19759731|NCT04039503|42211620|FG002|Overall Study|Lost to Follow-up|1|||
19676023|NCT00414453|42123787|FG000|Overall Study|Abnormal lab work|16|||
19676024|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
19676025|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
19676026|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
19676027|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
19676028|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
19676029|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
19676030|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
19676031|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
19676032|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
19676033|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
19676034|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
19676035|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
19676036|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
19676037|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
19676038|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
19676039|NCT00332488|42123800|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
19676040|NCT00332488|42123801|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
19676041|NCT00332488|42123802|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
19676042|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
19676043|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
19676044|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
19676045|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
19676046|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
19676047|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
19676048|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
19676049|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
19676050|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
19676051|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
19676052|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
19676053|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
19676054|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
19676055|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
19676056|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
19676057|NCT00332488|42123800|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
19676058|NCT00332488|42123801|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
19676059|NCT00332488|42123802|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
19676060|NCT00332332|42123812|FG000|Overall Study|Adverse Event|13|||
19676061|NCT00332332|42123812|FG000|Overall Study|Death|1|||
19676062|NCT00332332|42123812|FG000|Overall Study|Withdrawal by Subject|8|||
19676063|NCT00332332|42123812|FG000|Overall Study|Physician Decision|1|||
19676064|NCT00332332|42123812|FG000|Overall Study|Lost to Follow-up|3|||
19676065|NCT00332332|42123812|FG000|Overall Study|Protocol deviation|4|||
19676066|NCT00332332|42123812|FG000|Overall Study|Noncompliance|2|||
19676067|NCT00332332|42123812|FG000|Overall Study|Disease progression|2|||
19676068|NCT00332332|42123812|FG000|Overall Study|Other|18|||
19676069|NCT00332332|42123812|FG000|Overall Study|Did not receive study treatment|16|||
19676070|NCT00392925|42123820|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
19676071|NCT00392925|42123821|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
19759732|NCT04039503|42211621|FG003|Overall Study|Lost to Follow-up|0|||
19676072|NCT00392925|42123822|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
19676073|NCT00392925|42123823|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
19676074|NCT00392925|42123820|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
19759733|NCT04039503|42211618|FG000|Overall Study|Protocol Violation|0|||
19759734|NCT04039503|42211619|FG001|Overall Study|Protocol Violation|1|||
19676075|NCT00392925|42123821|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
19676076|NCT00392925|42123822|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
19676077|NCT00392925|42123823|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
19676078|NCT00392925|42123820|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
19676079|NCT00392925|42123821|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
19676080|NCT00392925|42123822|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
19676081|NCT00392925|42123823|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
19676082|NCT00392925|42123820|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
19676083|NCT00392925|42123821|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
19676084|NCT00392925|42123822|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
19676085|NCT00392925|42123823|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
19676086|NCT00392925|42123820|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
19676087|NCT00392925|42123821|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
19676088|NCT00392925|42123822|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
19676089|NCT00392925|42123823|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
19676090|NCT00392925|42123820|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
19676091|NCT00392925|42123821|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
19759735|NCT04039503|42211620|FG002|Overall Study|Protocol Violation|2|||
19759736|NCT04039503|42211621|FG003|Overall Study|Protocol Violation|1|||
19676092|NCT00392925|42123822|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
19676093|NCT00392925|42123823|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
19676094|NCT00392925|42123820|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
19676095|NCT00392925|42123821|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
19676096|NCT00392925|42123822|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
19676097|NCT00392925|42123823|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
19676098|NCT00392925|42123820|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
19676099|NCT00392925|42123821|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
19676100|NCT00392925|42123822|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
19676101|NCT00392925|42123823|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
19676102|NCT00392925|42123820|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
19676103|NCT00392925|42123821|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
19676104|NCT00392925|42123822|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
19676105|NCT00392925|42123823|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
19676106|NCT00474786|42123841|FG000|Overall Study|Not Meeting Study Criteria|0|||
19676107|NCT00474786|42123842|FG001|Overall Study|Not Meeting Study Criteria|1|||
19676108|NCT00474786|42123841|FG000|Overall Study|Investigator Request|2|||
19676109|NCT00474786|42123842|FG001|Overall Study|Investigator Request|1|||
19676110|NCT00474786|42123841|FG000|Overall Study|Death|189|||
19676111|NCT00474786|42123842|FG001|Overall Study|Death|170|||
19676112|NCT00474786|42123841|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
19676113|NCT00474786|42123842|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
19676114|NCT00474786|42123841|FG000|Overall Study|Lost to Follow-up|4|||
19676115|NCT00474786|42123842|FG001|Overall Study|Lost to Follow-up|7|||
19676116|NCT00474786|42123841|FG000|Overall Study|Protocol Violation|2|||
19676117|NCT00474786|42123842|FG001|Overall Study|Protocol Violation|0|||
19676118|NCT00474786|42123841|FG000|Overall Study|Withdrawal by Subject|15|||
19676119|NCT00474786|42123842|FG001|Overall Study|Withdrawal by Subject|15|||
19676120|NCT00474786|42123841|FG000|Overall Study|Other|5|||
19676121|NCT00474786|42123842|FG001|Overall Study|Other|0|||
19676122|NCT00392769|42123848|FG000|Overall Study|Clinical Deterioration|9|||
19676123|NCT00392769|42123848|FG000|Overall Study|Adverse Event|1|||
19676124|NCT00319696|42123852|FG000|Overall Study|Adverse Event|36|||
19676125|NCT00319696|42123852|FG000|Overall Study|withdrawal of consent|14|||
19676126|NCT00319696|42123852|FG000|Overall Study|administrative|7|||
19676127|NCT00319696|42123852|FG000|Overall Study|Lost to Follow-up|3|||
19676128|NCT00474630|42123864|FG000|Overall Study|Adverse Event|98|||
19676129|NCT00474630|42123865|FG001|Overall Study|Adverse Event|26|||
19676130|NCT00474630|42123864|FG000|Overall Study|Lost to Follow-up|22|||
19676131|NCT00474630|42123865|FG001|Overall Study|Lost to Follow-up|15|||
19676132|NCT00474630|42123864|FG000|Overall Study|Withdrawal by Subject|21|||
19676133|NCT00474630|42123865|FG001|Overall Study|Withdrawal by Subject|15|||
19676134|NCT00474630|42123864|FG000|Overall Study|Protocol Violation|3|||
19676135|NCT00474630|42123865|FG001|Overall Study|Protocol Violation|4|||
19676136|NCT00474630|42123864|FG000|Overall Study|Lack of Efficacy|5|||
19676137|NCT00474630|42123865|FG001|Overall Study|Lack of Efficacy|6|||
19676138|NCT00474630|42123864|FG000|Overall Study|Drug noncompliance, other|11|||
19676139|NCT00474630|42123865|FG001|Overall Study|Drug noncompliance, other|4|||
19676140|NCT00392379|42123874|FG000|Overall Study|Withdrawal by Subject|17|||
19676141|NCT00392379|42123875|FG001|Overall Study|Withdrawal by Subject|28|||
19676142|NCT00392379|42123874|FG000|Overall Study|Lost to Follow-up|4|||
19676143|NCT00392379|42123875|FG001|Overall Study|Lost to Follow-up|9|||
19676144|NCT00392379|42123874|FG000|Overall Study|Adverse Event|1|||
19676145|NCT00392379|42123875|FG001|Overall Study|Adverse Event|1|||
19676146|NCT00497874|42123883|FG000|Overall Study|Withdrawal by Subject|48|||
19676147|NCT00497874|42123884|FG001|Overall Study|Withdrawal by Subject|17|||
19676148|NCT00497874|42123883|FG000|Overall Study|Illness|8|||
19676149|NCT00497874|42123884|FG001|Overall Study|Illness|4|||
19676150|NCT00497874|42123883|FG000|Overall Study|Death|2|||
19676151|NCT00497874|42123884|FG001|Overall Study|Death|4|||
19676152|NCT00497874|42123883|FG000|Overall Study|Unable to contact|52|||
19676153|NCT00497874|42123884|FG001|Overall Study|Unable to contact|67|||
19676154|NCT00497874|42123883|FG000|Overall Study|Unable to schedule|37|||
19676155|NCT00497874|42123884|FG001|Overall Study|Unable to schedule|24|||
19676156|NCT00403455|42123892|FG000|Overall Study|Withdrawal by Subject|1|||
19676157|NCT00318370|42123896|FG000|Period 1|Lack of Efficacy|5|||
19676158|NCT00318370|42123897|FG001|Period 1|Lack of Efficacy|0|||
19676159|NCT00318370|42123898|FG002|Period 1|Lack of Efficacy|0|||
19676160|NCT00318370|42123896|FG000|Period 1|Physician Decision|1|||
19604100|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604101|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19676161|NCT00318370|42123897|FG001|Period 1|Physician Decision|0|||
19676162|NCT00318370|42123898|FG002|Period 1|Physician Decision|0|||
19676163|NCT00318370|42123896|FG000|Period 1|Withdrawal by Subject|1|||
19676164|NCT00318370|42123897|FG001|Period 1|Withdrawal by Subject|0|||
19676165|NCT00318370|42123898|FG002|Period 1|Withdrawal by Subject|0|||
19676166|NCT00318370|42123896|FG000|Period 2|Adverse Event|0|||
19676167|NCT00318370|42123897|FG001|Period 2|Adverse Event|3|||
19676168|NCT00318370|42123898|FG002|Period 2|Adverse Event|0|||
19676169|NCT00318370|42123896|FG000|Period 2|Lack of Efficacy|0|||
19604102|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604103|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604104|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604105|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604106|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604107|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604108|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604109|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604110|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19676170|NCT00318370|42123897|FG001|Period 2|Lack of Efficacy|5|||
19676171|NCT00318370|42123898|FG002|Period 2|Lack of Efficacy|0|||
19676172|NCT00318370|42123896|FG000|Period 2|Physician Decision|0|||
19676173|NCT00318370|42123897|FG001|Period 2|Physician Decision|1|||
19676174|NCT00318370|42123898|FG002|Period 2|Physician Decision|0|||
19676175|NCT00318370|42123896|FG000|Period 2|Withdrawal by Subject|0|||
19676176|NCT00318370|42123897|FG001|Period 2|Withdrawal by Subject|1|||
19676177|NCT00318370|42123898|FG002|Period 2|Withdrawal by Subject|0|||
19604111|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19604112|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
19676178|NCT00318370|42123896|FG000|Period 2|Other|0|||
19604113|NCT00758524|42053012|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604114|NCT00758524|42053013|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
19604115|NCT00758524|42053014|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604116|NCT00758524|42053015|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604117|NCT00758524|42053016|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604118|NCT00758524|42053017|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19676179|NCT00318370|42123897|FG001|Period 2|Other|1|||
19604119|NCT00758524|42053018|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604120|NCT00758524|42053019|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604121|NCT00758524|42053020|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604122|NCT00758524|42053021|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604123|NCT00758524|42053022|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604124|NCT00758524|42053023|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604125|NCT00758524|42053024|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604126|NCT00758524|42053025|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604127|NCT00758524|42053026|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604128|NCT00758524|42053027|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19676180|NCT00318370|42123898|FG002|Period 2|Other|0|||
19676181|NCT00318370|42123896|FG000|Period 3|Adverse Event|0|||
19676182|NCT00318370|42123897|FG001|Period 3|Adverse Event|0|||
19676183|NCT00318370|42123898|FG002|Period 3|Adverse Event|1|||
19676184|NCT00318370|42123896|FG000|Period 3|Lack of Efficacy|0|||
19676185|NCT00318370|42123897|FG001|Period 3|Lack of Efficacy|0|||
19676186|NCT00318370|42123898|FG002|Period 3|Lack of Efficacy|24|||
19676187|NCT00318370|42123896|FG000|Period 3|Death|0|||
19676188|NCT00318370|42123897|FG001|Period 3|Death|0|||
19676189|NCT00318370|42123898|FG002|Period 3|Death|1|||
19676190|NCT00318370|42123896|FG000|Period 3|Physician Decision|0|||
19676191|NCT00318370|42123897|FG001|Period 3|Physician Decision|0|||
19676192|NCT00318370|42123898|FG002|Period 3|Physician Decision|1|||
19676193|NCT00318370|42123896|FG000|Period 3|Withdrawal by Subject|0|||
19676194|NCT00318370|42123897|FG001|Period 3|Withdrawal by Subject|0|||
19676195|NCT00318370|42123898|FG002|Period 3|Withdrawal by Subject|3|||
19676196|NCT00318370|42123896|FG000|Period 3|Other|0|||
19676197|NCT00318370|42123897|FG001|Period 3|Other|0|||
19676198|NCT00318370|42123898|FG002|Period 3|Other|3|||
19676199|NCT00510068|42123906|FG000|Double-blind Period|Disease progression|98|||
19676200|NCT00510068|42123907|FG001|Double-blind Period|Disease progression|169|||
19676201|NCT00510068|42123906|FG000|Double-blind Period|Final primary analysis|52|||
19676202|NCT00510068|42123907|FG001|Double-blind Period|Final primary analysis|18|||
19676203|NCT00510068|42123906|FG000|Double-blind Period|Adverse Event|37|||
19676204|NCT00510068|42123907|FG001|Double-blind Period|Adverse Event|7|||
19676205|NCT00510068|42123906|FG000|Double-blind Period|Withdrawal by Subject|8|||
19676206|NCT00510068|42123907|FG001|Double-blind Period|Withdrawal by Subject|6|||
19676207|NCT00510068|42123906|FG000|Double-blind Period|Death|4|||
19676208|NCT00510068|42123907|FG001|Double-blind Period|Death|3|||
19676209|NCT00510068|42123906|FG000|Double-blind Period|Abnormal test result (s)|1|||
19676210|NCT00510068|42123907|FG001|Double-blind Period|Abnormal test result (s)|0|||
19676211|NCT00510068|42123906|FG000|Double-blind Period|Lost to Follow-up|1|||
19676212|NCT00510068|42123907|FG001|Double-blind Period|Lost to Follow-up|0|||
19676213|NCT00510068|42123906|FG000|Double-blind Period|Protocol Violation|6|||
19676214|NCT00510068|42123907|FG001|Double-blind Period|Protocol Violation|0|||
19676215|NCT00510068|42123906|FG000|Open-label Period|Disease Progression|124|||
19676216|NCT00510068|42123907|FG001|Open-label Period|Disease Progression|0|||
19676217|NCT00510068|42123906|FG000|Open-label Period|Adverse Event|46|||
19676218|NCT00510068|42123907|FG001|Open-label Period|Adverse Event|0|||
19676219|NCT00510068|42123906|FG000|Open-label Period|Withdrawal by Subject|21|||
19676220|NCT00510068|42123907|FG001|Open-label Period|Withdrawal by Subject|0|||
19676221|NCT00510068|42123906|FG000|Open-label Period|Administrative problems|17|||
19676222|NCT00510068|42123907|FG001|Open-label Period|Administrative problems|0|||
19676223|NCT00510068|42123906|FG000|Open-label Period|Death|7|||
19604129|NCT00758524|42053028|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
19604130|NCT00758524|42053012|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604131|NCT00758524|42053013|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19676224|NCT00510068|42123907|FG001|Open-label Period|Death|0|||
19676225|NCT00510068|42123906|FG000|Open-label Period|New cancer therapy|7|||
19676226|NCT00510068|42123907|FG001|Open-label Period|New cancer therapy|0|||
19676227|NCT00510068|42123906|FG000|Open-label Period|Protocol Violation|2|||
19676228|NCT00510068|42123907|FG001|Open-label Period|Protocol Violation|0|||
19604132|NCT00758524|42053014|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604133|NCT00758524|42053015|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604134|NCT00758524|42053016|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604135|NCT00758524|42053017|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604136|NCT00758524|42053018|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604137|NCT00758524|42053019|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604138|NCT00758524|42053020|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
19604139|NCT00758524|42053021|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604140|NCT00758524|42053022|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604141|NCT00758524|42053023|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604142|NCT00758524|42053024|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604143|NCT00758524|42053025|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19676229|NCT00510068|42123906|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
19676230|NCT00510068|42123907|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
19676231|NCT00509600|42123915|FG000|Overall Study|Adverse Event|1|||
19676232|NCT00402987|42123923|FG000|Overall Study|Lack of Efficacy|0|||
19676233|NCT00402987|42123924|FG001|Overall Study|Lack of Efficacy|0|||
19676234|NCT00402987|42123925|FG002|Overall Study|Lack of Efficacy|1|||
19676235|NCT00402987|42123926|FG003|Overall Study|Lack of Efficacy|0|||
19676236|NCT00501644|42123950|FG000|Overall Study|Adverse Event|4|||
19676237|NCT00501644|42123950|FG000|Overall Study|Withdrawal by Subject|1|||
19676238|NCT00497796|42123956|FG000|Overall Study|Adverse event (not related)|9|||
19676239|NCT00497796|42123957|FG001|Overall Study|Adverse event (not related)|9|||
19676240|NCT00497796|42123956|FG000|Overall Study|Adverse event (related)|5|||
19676241|NCT00497796|42123957|FG001|Overall Study|Adverse event (related)|4|||
19676242|NCT00497796|42123956|FG000|Overall Study|CMV infection or disease treatment|30|||
19676243|NCT00497796|42123957|FG001|Overall Study|CMV infection or disease treatment|4|||
19676244|NCT00497796|42123956|FG000|Overall Study|Consent withdrawn|10|||
19676245|NCT00497796|42123957|FG001|Overall Study|Consent withdrawn|3|||
19676246|NCT00497796|42123956|FG000|Overall Study|Investigator/sponsor discretion|31|||
19676247|NCT00497796|42123957|FG001|Overall Study|Investigator/sponsor discretion|34|||
19676248|NCT00497796|42123956|FG000|Overall Study|Lost to Follow-up|0|||
19676249|NCT00497796|42123957|FG001|Overall Study|Lost to Follow-up|1|||
19676250|NCT00497796|42123956|FG000|Overall Study|Not applicable (randomized not treated)|0|||
19676251|NCT00497796|42123957|FG001|Overall Study|Not applicable (randomized not treated)|4|||
19676252|NCT00496782|42123965|FG000|Overall Study|Protocol Violation|1|||
19676253|NCT00496782|42123966|FG001|Overall Study|Protocol Violation|2|||
19676254|NCT00402831|42123974|FG000|Overall Study|Lost to Follow-up|1|||
19676255|NCT00402831|42123975|FG001|Overall Study|Lost to Follow-up|2|||
19676256|NCT00402831|42123974|FG000|Overall Study|Non-compliance with protocol|0|||
19389052|NCT02672423|41632618|FG009|Period 2|Withdrawal by Subject|0|||
19389053|NCT02672423|41632609|FG000|Period 3|Withdrawal by Subject|0|||
19389054|NCT02672423|41632610|FG001|Period 3|Withdrawal by Subject|0|||
19389055|NCT02672423|41632611|FG002|Period 3|Withdrawal by Subject|0|||
19389056|NCT02672423|41632612|FG003|Period 3|Withdrawal by Subject|0|||
19389057|NCT02672423|41632613|FG004|Period 3|Withdrawal by Subject|0|||
19389058|NCT02672423|41632614|FG005|Period 3|Withdrawal by Subject|0|||
19604144|NCT00758524|42053026|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604145|NCT00758524|42053027|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19676257|NCT00402831|42123975|FG001|Overall Study|Non-compliance with protocol|1|||
19604146|NCT00758524|42053028|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
19604147|NCT00758524|42053012|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604148|NCT00758524|42053013|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604149|NCT00758524|42053014|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604150|NCT00758524|42053015|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604151|NCT00758524|42053016|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604152|NCT00758524|42053017|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604153|NCT00758524|42053018|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
19604154|NCT00758524|42053019|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604155|NCT00758524|42053020|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604156|NCT00758524|42053021|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19676258|NCT00496626|42123985|FG000|Overall Study|Lost to Follow-up|0|||
19676259|NCT00496626|42123986|FG001|Overall Study|Lost to Follow-up|1|||
19676260|NCT00496626|42123985|FG000|Overall Study|Protocol Violation|1|||
19676261|NCT00496626|42123986|FG001|Overall Study|Protocol Violation|0|||
19759737|NCT04039503|42211618|FG000|Overall Study|Withdrawal by Subject|4|||
19759738|NCT04039503|42211619|FG001|Overall Study|Withdrawal by Subject|3|||
19759739|NCT04039503|42211620|FG002|Overall Study|Withdrawal by Subject|5|||
19676262|NCT00496626|42123985|FG000|Overall Study|Withdrawal by Subject|5|||
19676263|NCT00496626|42123986|FG001|Overall Study|Withdrawal by Subject|4|||
19759740|NCT04039503|42211621|FG003|Overall Study|Withdrawal by Subject|2|||
19676264|NCT00496626|42123985|FG000|Overall Study|Relocated|0|||
19676265|NCT00496626|42123986|FG001|Overall Study|Relocated|1|||
19676266|NCT00471822|42123996|FG000|Overall Study|Protocol Violation|2|||
19676267|NCT00471276|42124000|FG000|Overall Study|Death|2|||
19676268|NCT00471276|42124000|FG000|Overall Study|Adverse Event|16|||
19676269|NCT00471276|42124000|FG000|Overall Study|Protocol Violation|1|||
19676270|NCT00471276|42124000|FG000|Overall Study|Objective progression or relapse|54|||
19759741|NCT03131895|42211658|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
19389059|NCT02672423|41632615|FG006|Period 3|Withdrawal by Subject|0|||
19676271|NCT00471276|42124000|FG000|Overall Study|Global deterioration of health status|1|||
19676272|NCT00471276|42124000|FG000|Overall Study|Other|3|||
19676273|NCT00471276|42124000|FG000|Overall Study|Refused treatment|6|||
19676274|NCT00470262|42124006|FG000|Overall Study|Withdrawal by Subject|2|||
19676275|NCT00470262|42124007|FG001|Overall Study|Withdrawal by Subject|0|||
19676276|NCT00496470|42124016|FG000|Overall Study|Adverse Event|8|||
19676277|NCT00496470|42124017|FG001|Overall Study|Adverse Event|10|||
19676278|NCT00496470|42124016|FG000|Overall Study|Withdrawal by Subject|5|||
19676279|NCT00496470|42124017|FG001|Overall Study|Withdrawal by Subject|12|||
19676280|NCT00496470|42124016|FG000|Overall Study|Incorrectly enrolled|13|||
19676281|NCT00496470|42124017|FG001|Overall Study|Incorrectly enrolled|5|||
19676282|NCT00496470|42124016|FG000|Overall Study|Other reason|0|||
19676283|NCT00496470|42124017|FG001|Overall Study|Other reason|2|||
19676284|NCT00496080|42124023|FG000|Overall Study|Lost to Follow-up|9|||
19676285|NCT00496080|42124023|FG000|Overall Study|Surgical re-intervention|7|||
19676286|NCT00496080|42124023|FG000|Overall Study|Withdrawal by Subject|5|||
19389060|NCT02672423|41632616|FG007|Period 3|Withdrawal by Subject|1|||
19676287|NCT00496080|42124023|FG000|Overall Study|Physician Decision|6|||
19676288|NCT00487578|42124030|FG000|Overall Study|Adverse Event|1|||
19676289|NCT00487578|42124031|FG001|Overall Study|Adverse Event|2|||
19676290|NCT00487578|42124030|FG000|Overall Study|Lack of Efficacy|0|||
19389061|NCT02672423|41632617|FG008|Period 3|Withdrawal by Subject|0|||
19389062|NCT02672423|41632618|FG009|Period 3|Withdrawal by Subject|0|||
19389063|NCT02672423|41632609|FG000|Period 3|Physician Decision|0|||
19676291|NCT00487578|42124031|FG001|Overall Study|Lack of Efficacy|1|||
19676292|NCT00487578|42124030|FG000|Overall Study|Lost to Follow-up|0|||
19676293|NCT00487578|42124031|FG001|Overall Study|Lost to Follow-up|1|||
19676294|NCT00495612|42124039|FG000|Overall Study|Lost to Follow-up|1|||
19676295|NCT00495612|42124040|FG001|Overall Study|Lost to Follow-up|0|||
19676296|NCT00495612|42124039|FG000|Overall Study|Subject's Decision to Withdraw|3|||
19676297|NCT00495612|42124040|FG001|Overall Study|Subject's Decision to Withdraw|0|||
19676298|NCT00487188|42124048|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
19676299|NCT00487188|42124049|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
19676300|NCT00487188|42124050|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
19389064|NCT02672423|41632610|FG001|Period 3|Physician Decision|0|||
19389065|NCT02672423|41632611|FG002|Period 3|Physician Decision|0|||
19389066|NCT02672423|41632612|FG003|Period 3|Physician Decision|0|||
19389067|NCT02672423|41632613|FG004|Period 3|Physician Decision|0|||
19389068|NCT02672423|41632614|FG005|Period 3|Physician Decision|1|||
19676301|NCT00487188|42124048|FG000|Induction Phase|Adverse Event|5|||
19676302|NCT00487188|42124049|FG001|Induction Phase|Adverse Event|0|||
19676303|NCT00487188|42124050|FG002|Induction Phase|Adverse Event|0|||
19676304|NCT00487188|42124048|FG000|Induction Phase|Lack of Efficacy|0|||
19676305|NCT00487188|42124049|FG001|Induction Phase|Lack of Efficacy|1|||
19676306|NCT00487188|42124050|FG002|Induction Phase|Lack of Efficacy|0|||
19676307|NCT00487188|42124048|FG000|Induction Phase|Protocol Violation|1|||
19676308|NCT00487188|42124049|FG001|Induction Phase|Protocol Violation|0|||
19676309|NCT00487188|42124050|FG002|Induction Phase|Protocol Violation|0|||
19676310|NCT00487188|42124048|FG000|Induction Phase|Refused Treatment|1|||
19676311|NCT00487188|42124049|FG001|Induction Phase|Refused Treatment|2|||
19676312|NCT00487188|42124050|FG002|Induction Phase|Refused Treatment|0|||
19676313|NCT00487188|42124048|FG000|Induction Phase|Lost to Follow-up|2|||
19676314|NCT00487188|42124049|FG001|Induction Phase|Lost to Follow-up|2|||
19676315|NCT00487188|42124050|FG002|Induction Phase|Lost to Follow-up|0|||
19676316|NCT00487188|42124048|FG000|Induction Phase|Administrative|0|||
19676317|NCT00487188|42124049|FG001|Induction Phase|Administrative|1|||
19676318|NCT00487188|42124050|FG002|Induction Phase|Administrative|0|||
19676319|NCT00487188|42124048|FG000|Maintenance Phase|Adverse Event|1|||
19676320|NCT00487188|42124049|FG001|Maintenance Phase|Adverse Event|0|||
19676321|NCT00487188|42124050|FG002|Maintenance Phase|Adverse Event|0|||
19676322|NCT00487188|42124048|FG000|Maintenance Phase|Death|1|||
19676323|NCT00487188|42124049|FG001|Maintenance Phase|Death|0|||
19676324|NCT00487188|42124050|FG002|Maintenance Phase|Death|0|||
19759742|NCT03131895|42211659|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
19389069|NCT02672423|41632615|FG006|Period 3|Physician Decision|0|||
19389070|NCT02672423|41632616|FG007|Period 3|Physician Decision|0|||
19389071|NCT02672423|41632617|FG008|Period 3|Physician Decision|0|||
19676325|NCT00487188|42124048|FG000|Maintenance Phase|Lost to Follow-up|1|||
19676326|NCT00487188|42124049|FG001|Maintenance Phase|Lost to Follow-up|0|||
19676327|NCT00487188|42124050|FG002|Maintenance Phase|Lost to Follow-up|0|||
19676328|NCT00487188|42124048|FG000|Maintenance Phase|Administrative|0|||
19676329|NCT00487188|42124049|FG001|Maintenance Phase|Administrative|0|||
19676330|NCT00487188|42124050|FG002|Maintenance Phase|Administrative|1|||
19676331|NCT00509366|42124071|FG000|Overall Study|Not Treated (Screen Failure)|1|||
19676332|NCT00509366|42124072|FG001|Overall Study|Not Treated (Screen Failure)|1|||
19676333|NCT00509366|42124073|FG002|Overall Study|Not Treated (Screen Failure)|1|||
19676334|NCT00509366|42124074|FG003|Overall Study|Not Treated (Screen Failure)|0|||
19676335|NCT00509366|42124075|FG004|Overall Study|Not Treated (Screen Failure)|0|||
19759743|NCT03131895|42211660|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
19759744|NCT03131895|42211661|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
19676336|NCT00500318|42124087|FG000|Overall Study|Adverse Event|3|||
19676337|NCT00500318|42124088|FG001|Overall Study|Adverse Event|8|||
19676338|NCT00500318|42124087|FG000|Overall Study|Protocol Violation|1|||
19676339|NCT00500318|42124088|FG001|Overall Study|Protocol Violation|3|||
19676340|NCT00500318|42124087|FG000|Overall Study|Withdrawal by Subject|1|||
19676341|NCT00500318|42124088|FG001|Overall Study|Withdrawal by Subject|2|||
19676342|NCT00500318|42124087|FG000|Overall Study|Lack of Efficacy|0|||
19676343|NCT00500318|42124088|FG001|Overall Study|Lack of Efficacy|3|||
19676344|NCT00500318|42124087|FG000|Overall Study|Other Reason|0|||
19676345|NCT00500318|42124088|FG001|Overall Study|Other Reason|1|||
19676346|NCT00508820|42124096|FG000|Overall Study|Adverse Event|6|||
19676347|NCT00508820|42124097|FG001|Overall Study|Adverse Event|10|||
19676348|NCT00508820|42124096|FG000|Overall Study|Death|6|||
19676349|NCT00508820|42124097|FG001|Overall Study|Death|8|||
19676350|NCT00508820|42124096|FG000|Overall Study|Lost to Follow-up|1|||
19676351|NCT00508820|42124097|FG001|Overall Study|Lost to Follow-up|1|||
19676352|NCT00508820|42124096|FG000|Overall Study|Physician Decision|8|||
19676353|NCT00508820|42124097|FG001|Overall Study|Physician Decision|2|||
19676354|NCT00508820|42124096|FG000|Overall Study|Pregnancy|0|||
19676355|NCT00508820|42124097|FG001|Overall Study|Pregnancy|2|||
19676356|NCT00508820|42124096|FG000|Overall Study|Protocol Violation|2|||
19676357|NCT00508820|42124097|FG001|Overall Study|Protocol Violation|0|||
19676358|NCT00508820|42124096|FG000|Overall Study|Withdrawal by Subject|10|||
19676359|NCT00508820|42124097|FG001|Overall Study|Withdrawal by Subject|12|||
19676360|NCT00508820|42124096|FG000|Overall Study|Other|11|||
19676361|NCT00508820|42124097|FG001|Overall Study|Other|2|||
19676362|NCT00508820|42124096|FG000|Overall Study|Noncompliance|1|||
19676363|NCT00508820|42124097|FG001|Overall Study|Noncompliance|0|||
19676364|NCT00508820|42124096|FG000|Overall Study|Requirement for alternative therapy|7|||
19676365|NCT00508820|42124097|FG001|Overall Study|Requirement for alternative therapy|15|||
19676366|NCT00508820|42124096|FG000|Overall Study|Protocol-specified Criteria|3|||
19676367|NCT00508820|42124097|FG001|Overall Study|Protocol-specified Criteria|12|||
19676368|NCT00499694|42124103|FG000|Overall Study|Patient never received treatment.|1|||
19676369|NCT00486954|42124112|FG000|Pilot Part|Adverse Event|4|||
19676370|NCT00486954|42124113|FG001|Pilot Part|Adverse Event|0|||
19676371|NCT00486954|42124114|FG002|Pilot Part|Adverse Event|5|||
19676372|NCT00486954|42124115|FG003|Pilot Part|Adverse Event|0|||
19676373|NCT00486954|42124116|FG004|Pilot Part|Adverse Event|0|||
19676374|NCT00486954|42124112|FG000|Pilot Part|Disease Progression|2|||
19676375|NCT00486954|42124113|FG001|Pilot Part|Disease Progression|0|||
19676376|NCT00486954|42124114|FG002|Pilot Part|Disease Progression|1|||
19676377|NCT00486954|42124115|FG003|Pilot Part|Disease Progression|0|||
19676378|NCT00486954|42124116|FG004|Pilot Part|Disease Progression|0|||
19676379|NCT00486954|42124112|FG000|Randomized Part|Lost to Follow-up|0|||
19676380|NCT00486954|42124113|FG001|Randomized Part|Lost to Follow-up|0|||
19676381|NCT00486954|42124114|FG002|Randomized Part|Lost to Follow-up|0|||
19759745|NCT03131895|42211658|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
19676382|NCT00486954|42124115|FG003|Randomized Part|Lost to Follow-up|0|||
19676383|NCT00486954|42124116|FG004|Randomized Part|Lost to Follow-up|1|||
19676384|NCT00486954|42124112|FG000|Randomized Part|Withdrawal by Subject|0|||
19676385|NCT00486954|42124113|FG001|Randomized Part|Withdrawal by Subject|0|||
19676386|NCT00486954|42124114|FG002|Randomized Part|Withdrawal by Subject|0|||
19676387|NCT00486954|42124115|FG003|Randomized Part|Withdrawal by Subject|1|||
19676388|NCT00486954|42124116|FG004|Randomized Part|Withdrawal by Subject|0|||
19676389|NCT00486954|42124112|FG000|Randomized Part|Sponsor Terminated Study|0|||
19676390|NCT00486954|42124113|FG001|Randomized Part|Sponsor Terminated Study|0|||
19676391|NCT00486954|42124114|FG002|Randomized Part|Sponsor Terminated Study|0|||
19676392|NCT00486954|42124115|FG003|Randomized Part|Sponsor Terminated Study|19|||
19676393|NCT00486954|42124116|FG004|Randomized Part|Sponsor Terminated Study|13|||
19676394|NCT00494676|42124126|FG000|Allocation|Withdrawal by Subject|2|||
19676395|NCT00494676|42124127|FG001|Allocation|Withdrawal by Subject|4|||
19676396|NCT00494676|42124126|FG000|First Intervention|Withdrawal by Subject|1|||
19676397|NCT00494676|42124127|FG001|First Intervention|Withdrawal by Subject|3|||
19676398|NCT00494676|42124126|FG000|Second Intervention|Withdrawal by Subject|1|||
19676399|NCT00494676|42124127|FG001|Second Intervention|Withdrawal by Subject|1|||
19676400|NCT00486720|42124135|FG000|Overall Study|Adverse Event|1|||
19676401|NCT00486720|42124136|FG001|Overall Study|Adverse Event|2|||
19676402|NCT00486720|42124135|FG000|Overall Study|Lack of Efficacy|4|||
19676403|NCT00486720|42124136|FG001|Overall Study|Lack of Efficacy|6|||
19676404|NCT00486720|42124135|FG000|Overall Study|Physician Decision|1|||
19676405|NCT00486720|42124136|FG001|Overall Study|Physician Decision|2|||
19676406|NCT00486720|42124135|FG000|Overall Study|Protocol Violation|1|||
19676407|NCT00486720|42124136|FG001|Overall Study|Protocol Violation|0|||
19676408|NCT00486720|42124135|FG000|Overall Study|Withdrawal by Subject|3|||
19676409|NCT00486720|42124136|FG001|Overall Study|Withdrawal by Subject|1|||
19676410|NCT00486720|42124135|FG000|Overall Study|Progressive Disease|0|||
19676411|NCT00486720|42124136|FG001|Overall Study|Progressive Disease|1|||
19676412|NCT00486330|42124142|FG000|Overall Study|Adverse Event|2|||
19676413|NCT00486252|42124146|FG000|Overall Study|Adverse Event|7|||
19676414|NCT00486252|42124146|FG000|Overall Study|Lack of Efficacy|9|||
19676415|NCT00486252|42124146|FG000|Overall Study|Lost to Follow-up|24|||
19676416|NCT00486252|42124146|FG000|Overall Study|Other|18|||
19676417|NCT00494442|42124154|FG000|Overall Study|Death|1|||
19676418|NCT00494442|42124155|FG001|Overall Study|Death|1|||
19676419|NCT00494442|42124154|FG000|Overall Study|Lack of Efficacy|16|||
19676420|NCT00494442|42124155|FG001|Overall Study|Lack of Efficacy|10|||
19676421|NCT00494442|42124154|FG000|Overall Study|Adverse Event|0|||
19676422|NCT00494442|42124155|FG001|Overall Study|Adverse Event|2|||
19676423|NCT00494442|42124154|FG000|Overall Study|Physician Decision|0|||
19676424|NCT00494442|42124155|FG001|Overall Study|Physician Decision|1|||
19676425|NCT00494442|42124154|FG000|Overall Study|Non-compliance|0|||
19676426|NCT00494442|42124155|FG001|Overall Study|Non-compliance|1|||
19676427|NCT00494442|42124154|FG000|Overall Study|Intercurrent illness|0|||
19676428|NCT00494442|42124155|FG001|Overall Study|Intercurrent illness|1|||
19676429|NCT03851016|42124163|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19676430|NCT03851016|42124164|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
19676431|NCT00493974|42124172|FG000|Overall Study|Death|1|||
19676432|NCT00493974|42124173|FG001|Overall Study|Death|2|||
19676433|NCT00493974|42124172|FG000|Overall Study|Withdrawal by Subject|8|||
19676434|NCT00493974|42124173|FG001|Overall Study|Withdrawal by Subject|6|||
19676435|NCT00493974|42124172|FG000|Overall Study|Lost to Follow-up|4|||
19676436|NCT00493974|42124173|FG001|Overall Study|Lost to Follow-up|6|||
19676437|NCT00469092|42124181|FG000|Overall Study|Adverse Event|5|||
19676438|NCT00469092|42124182|FG001|Overall Study|Adverse Event|4|||
19676439|NCT00469092|42124181|FG000|Overall Study|Lack of Efficacy|1|||
19676440|NCT00469092|42124182|FG001|Overall Study|Lack of Efficacy|0|||
19759746|NCT03131895|42211659|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
19759747|NCT03131895|42211660|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
19759748|NCT03131895|42211661|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
19759749|NCT03131895|42211658|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19759750|NCT03131895|42211659|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
19676441|NCT00469092|42124181|FG000|Overall Study|Lost to Follow-up|1|||
19676442|NCT00469092|42124182|FG001|Overall Study|Lost to Follow-up|2|||
19676443|NCT00469092|42124181|FG000|Overall Study|Protocol Violation|3|||
19676444|NCT00469092|42124182|FG001|Overall Study|Protocol Violation|3|||
19676445|NCT00469092|42124181|FG000|Overall Study|Withdrawal by Subject|4|||
19676446|NCT00469092|42124182|FG001|Overall Study|Withdrawal by Subject|4|||
19676447|NCT00469092|42124181|FG000|Overall Study|Withdrawal Criteria|3|||
19676448|NCT00469092|42124182|FG001|Overall Study|Withdrawal Criteria|4|||
19676449|NCT00469092|42124181|FG000|Overall Study|Incorrectly Randomised|4|||
19676450|NCT00469092|42124182|FG001|Overall Study|Incorrectly Randomised|3|||
19676451|NCT00469092|42124181|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
19676452|NCT00469092|42124182|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
19676453|NCT00469092|42124181|FG000|Overall Study|Use of lipid lowering drug|1|||
19676454|NCT00469092|42124182|FG001|Overall Study|Use of lipid lowering drug|0|||
19676455|NCT00469092|42124181|FG000|Overall Study|Hypoglycaemic Episodes|1|||
19676456|NCT00469092|42124182|FG001|Overall Study|Hypoglycaemic Episodes|1|||
19676457|NCT00469092|42124181|FG000|Overall Study|Abnormal lab value|1|||
19676458|NCT00469092|42124182|FG001|Overall Study|Abnormal lab value|0|||
19676459|NCT00469092|42124181|FG000|Overall Study|Use of Corticosteroid|1|||
19676460|NCT00469092|42124182|FG001|Overall Study|Use of Corticosteroid|0|||
19676461|NCT00499616|42124192|FG000|Overall Study|Death|1|||
19676462|NCT00499616|42124193|FG001|Overall Study|Death|5|||
19676463|NCT00499616|42124194|FG002|Overall Study|Death|3|||
19676464|NCT00499616|42124195|FG003|Overall Study|Death|1|||
19676465|NCT00499616|42124192|FG000|Overall Study|Lack of Efficacy|5|||
19676466|NCT00499616|42124193|FG001|Overall Study|Lack of Efficacy|0|||
19676467|NCT00499616|42124194|FG002|Overall Study|Lack of Efficacy|19|||
19676468|NCT00499616|42124195|FG003|Overall Study|Lack of Efficacy|0|||
19676469|NCT00499616|42124192|FG000|Overall Study|Lost to Follow-up|0|||
19676470|NCT00499616|42124193|FG001|Overall Study|Lost to Follow-up|0|||
19676471|NCT00499616|42124194|FG002|Overall Study|Lost to Follow-up|1|||
19676472|NCT00499616|42124195|FG003|Overall Study|Lost to Follow-up|0|||
19676473|NCT00499616|42124192|FG000|Overall Study|Physician Decision|6|||
19676474|NCT00499616|42124193|FG001|Overall Study|Physician Decision|16|||
19676475|NCT00499616|42124194|FG002|Overall Study|Physician Decision|9|||
19676476|NCT00499616|42124195|FG003|Overall Study|Physician Decision|0|||
19676477|NCT00499616|42124192|FG000|Overall Study|Withdrawal by Subject|1|||
19676478|NCT00499616|42124193|FG001|Overall Study|Withdrawal by Subject|0|||
19676479|NCT00499616|42124194|FG002|Overall Study|Withdrawal by Subject|1|||
19676480|NCT00499616|42124195|FG003|Overall Study|Withdrawal by Subject|0|||
19676481|NCT00499616|42124192|FG000|Overall Study|Ineligible|1|||
19676482|NCT00499616|42124193|FG001|Overall Study|Ineligible|2|||
19676483|NCT00499616|42124194|FG002|Overall Study|Ineligible|0|||
19676484|NCT00499616|42124195|FG003|Overall Study|Ineligible|15|||
19676485|NCT00499616|42124192|FG000|Overall Study|Not evaluable|0|||
19676486|NCT00499616|42124193|FG001|Overall Study|Not evaluable|0|||
19676487|NCT00499616|42124194|FG002|Overall Study|Not evaluable|0|||
19676488|NCT00499616|42124195|FG003|Overall Study|Not evaluable|41|||
19676489|NCT00499616|42124192|FG000|Overall Study|Patient/Parent Refusal|1|||
19676490|NCT00499616|42124193|FG001|Overall Study|Patient/Parent Refusal|5|||
19676491|NCT00499616|42124194|FG002|Overall Study|Patient/Parent Refusal|3|||
19676492|NCT00499616|42124195|FG003|Overall Study|Patient/Parent Refusal|0|||
19676493|NCT00402597|42124213|FG000|Overall Study|Death|15|||
19676494|NCT00402597|42124214|FG001|Overall Study|Death|7|||
19676495|NCT00402597|42124215|FG002|Overall Study|Death|6|||
19676496|NCT00402597|42124216|FG003|Overall Study|Death|4|||
19676497|NCT00402597|42124217|FG004|Overall Study|Death|6|||
19676498|NCT00402597|42124213|FG000|Overall Study|Adverse Event|81|||
19676499|NCT00402597|42124214|FG001|Overall Study|Adverse Event|18|||
19676500|NCT00402597|42124215|FG002|Overall Study|Adverse Event|106|||
19676501|NCT00402597|42124216|FG003|Overall Study|Adverse Event|39|||
19676502|NCT00402597|42124217|FG004|Overall Study|Adverse Event|71|||
19676503|NCT00402597|42124213|FG000|Overall Study|Lost to Follow-up|8|||
19676504|NCT00402597|42124214|FG001|Overall Study|Lost to Follow-up|1|||
19676505|NCT00402597|42124215|FG002|Overall Study|Lost to Follow-up|8|||
19676506|NCT00402597|42124216|FG003|Overall Study|Lost to Follow-up|2|||
19676507|NCT00402597|42124217|FG004|Overall Study|Lost to Follow-up|3|||
19676508|NCT00402597|42124213|FG000|Overall Study|Withdrawal by Subject|57|||
19676509|NCT00402597|42124214|FG001|Overall Study|Withdrawal by Subject|16|||
19676510|NCT00402597|42124215|FG002|Overall Study|Withdrawal by Subject|65|||
19676511|NCT00402597|42124216|FG003|Overall Study|Withdrawal by Subject|15|||
19676512|NCT00402597|42124217|FG004|Overall Study|Withdrawal by Subject|24|||
19676513|NCT00402597|42124213|FG000|Overall Study|reason not specified|30|||
19676514|NCT00402597|42124214|FG001|Overall Study|reason not specified|4|||
19676515|NCT00402597|42124215|FG002|Overall Study|reason not specified|27|||
19676516|NCT00402597|42124216|FG003|Overall Study|reason not specified|14|||
19676517|NCT00402597|42124217|FG004|Overall Study|reason not specified|20|||
19676518|NCT00402363|42124233|FG000|Overall Study|Adverse Event|9|||
19676519|NCT00402363|42124234|FG001|Overall Study|Adverse Event|14|||
19676520|NCT00402363|42124235|FG002|Overall Study|Adverse Event|2|||
19676521|NCT00402363|42124236|FG003|Overall Study|Adverse Event|2|||
19676522|NCT00402363|42124233|FG000|Overall Study|Withdrew Consent|10|||
19676523|NCT00402363|42124234|FG001|Overall Study|Withdrew Consent|5|||
19676524|NCT00402363|42124235|FG002|Overall Study|Withdrew Consent|2|||
19676525|NCT00402363|42124236|FG003|Overall Study|Withdrew Consent|1|||
19676526|NCT00402363|42124233|FG000|Overall Study|Protocol Violation|3|||
19676527|NCT00402363|42124234|FG001|Overall Study|Protocol Violation|5|||
19676528|NCT00402363|42124235|FG002|Overall Study|Protocol Violation|0|||
19676529|NCT00402363|42124236|FG003|Overall Study|Protocol Violation|3|||
19676530|NCT00402363|42124233|FG000|Overall Study|Lost to Follow-up|5|||
19676531|NCT00402363|42124234|FG001|Overall Study|Lost to Follow-up|4|||
19676532|NCT00402363|42124235|FG002|Overall Study|Lost to Follow-up|0|||
19676533|NCT00402363|42124236|FG003|Overall Study|Lost to Follow-up|2|||
19676534|NCT00402363|42124233|FG000|Overall Study|"Captured as Other"|6|||
19676535|NCT00402363|42124234|FG001|Overall Study|"Captured as Other"|2|||
19676536|NCT00402363|42124235|FG002|Overall Study|"Captured as Other"|2|||
19676537|NCT00402363|42124236|FG003|Overall Study|"Captured as Other"|2|||
19676538|NCT00469014|42124256|FG000|Initial Phase Randomization|Disease Progression|0|||
19676539|NCT00469014|42124257|FG001|Initial Phase Randomization|Disease Progression|1|||
19676540|NCT00469014|42124258|FG002|Initial Phase Randomization|Disease Progression|1|||
19676541|NCT00469014|42124259|FG003|Initial Phase Randomization|Disease Progression|0|||
19676542|NCT00469014|42124256|FG000|Initial Phase Randomization|No Response|1|||
19676543|NCT00469014|42124257|FG001|Initial Phase Randomization|No Response|0|||
19676544|NCT00469014|42124258|FG002|Initial Phase Randomization|No Response|0|||
19676545|NCT00469014|42124259|FG003|Initial Phase Randomization|No Response|1|||
19676546|NCT00469014|42124256|FG000|Adaptive Randomization|Not Evaluable|1|||
19676547|NCT00469014|42124257|FG001|Adaptive Randomization|Not Evaluable|0|||
19676548|NCT00469014|42124258|FG002|Adaptive Randomization|Not Evaluable|0|||
19676549|NCT00469014|42124259|FG003|Adaptive Randomization|Not Evaluable|1|||
19676550|NCT00469014|42124256|FG000|Adaptive Randomization|No Response|0|||
19676551|NCT00469014|42124257|FG001|Adaptive Randomization|No Response|1|||
19676552|NCT00469014|42124258|FG002|Adaptive Randomization|No Response|0|||
19676553|NCT00469014|42124259|FG003|Adaptive Randomization|No Response|0|||
19676554|NCT00469014|42124256|FG000|Adaptive Randomization|Death|0|||
19676555|NCT00469014|42124257|FG001|Adaptive Randomization|Death|0|||
19676556|NCT00469014|42124258|FG002|Adaptive Randomization|Death|1|||
19759751|NCT03131895|42211660|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19759752|NCT03131895|42211661|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
19759753|NCT03131895|42211658|FG000|Washout Period (at Least 5 Days)|Other|0|||
19759754|NCT03131895|42211659|FG001|Washout Period (at Least 5 Days)|Other|0|||
19759755|NCT03131895|42211660|FG002|Washout Period (at Least 5 Days)|Other|2|||
19759756|NCT03131895|42211661|FG003|Washout Period (at Least 5 Days)|Other|0|||
19759757|NCT03131895|42211658|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
19759758|NCT03131895|42211659|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
19676557|NCT00469014|42124259|FG003|Adaptive Randomization|Death|0|||
19676558|NCT00493038|42124271|FG000|Treatment|Adverse Event|8|||
19676559|NCT00493038|42124272|FG001|Treatment|Adverse Event|4|||
19676560|NCT00493038|42124271|FG000|Treatment|Lost to Follow-up|5|||
19676561|NCT00493038|42124272|FG001|Treatment|Lost to Follow-up|3|||
19676562|NCT00493038|42124271|FG000|Treatment|Withdrawal by Subject|11|||
19676563|NCT00493038|42124272|FG001|Treatment|Withdrawal by Subject|12|||
19676564|NCT00493038|42124271|FG000|Treatment|Other|0|||
19676565|NCT00493038|42124272|FG001|Treatment|Other|1|||
19676566|NCT00493038|42124271|FG000|Follow-up|Lost to Follow-up|1|||
19676567|NCT00493038|42124272|FG001|Follow-up|Lost to Follow-up|0|||
19676568|NCT00392223|42124280|FG000|Overall Study|Adverse Event|5|||
19676569|NCT00392223|42124281|FG001|Overall Study|Adverse Event|4|||
19676570|NCT00392223|42124280|FG000|Overall Study|Lost to Follow-up|1|||
19676571|NCT00392223|42124281|FG001|Overall Study|Lost to Follow-up|4|||
19676572|NCT00392223|42124280|FG000|Overall Study|Protocol Violation|0|||
19676573|NCT00392223|42124281|FG001|Overall Study|Protocol Violation|3|||
19676574|NCT00392223|42124280|FG000|Overall Study|Withdrawal by Subject|3|||
19759759|NCT03131895|42211660|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
19759760|NCT03131895|42211661|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
19759761|NCT03131895|42211658|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
19759762|NCT03131895|42211659|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
19759763|NCT03131895|42211660|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
19759764|NCT03131895|42211661|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
19759765|NCT04039919|42211676|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19759766|NCT04039919|42211677|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19759767|NCT04039919|42211678|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19759768|NCT04039919|42211679|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19676575|NCT00392223|42124281|FG001|Overall Study|Withdrawal by Subject|2|||
19676576|NCT00402285|42124290|FG000|Overall Study|insufficient RNA quality|7|||
19676577|NCT00402285|42124291|FG001|Overall Study|insufficient RNA quality|6|||
19676578|NCT00402285|42124292|FG002|Overall Study|insufficient RNA quality|2|||
19759769|NCT04039919|42211680|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19759770|NCT04039919|42211676|FG000|Treatment Period 1|Sponsor's decision|0|||
19759771|NCT04039919|42211677|FG001|Treatment Period 1|Sponsor's decision|0|||
19759772|NCT04039919|42211678|FG002|Treatment Period 1|Sponsor's decision|0|||
19759773|NCT04039919|42211679|FG003|Treatment Period 1|Sponsor's decision|0|||
19759774|NCT04039919|42211680|FG004|Treatment Period 1|Sponsor's decision|16|||
19759775|NCT04039919|42211676|FG000|Treatment Period 5|Withdrawal by Subject|1|||
19676579|NCT00413283|42124302|FG000|Overall Study|Withdrawal by Subject|1|||
19676580|NCT00413283|42124303|FG001|Overall Study|Withdrawal by Subject|0|||
19759776|NCT04039919|42211677|FG001|Treatment Period 5|Withdrawal by Subject|0|||
19676581|NCT00413283|42124304|FG002|Overall Study|Withdrawal by Subject|0|||
19676582|NCT00413283|42124305|FG003|Overall Study|Withdrawal by Subject|1|||
19676583|NCT00413283|42124302|FG000|Overall Study|Death|0|||
19676584|NCT00413283|42124303|FG001|Overall Study|Death|0|||
19676585|NCT00413283|42124304|FG002|Overall Study|Death|1|||
19676586|NCT00413283|42124305|FG003|Overall Study|Death|1|||
19676587|NCT00413283|42124302|FG000|Overall Study|Adverse Event|0|||
19676588|NCT00413283|42124303|FG001|Overall Study|Adverse Event|0|||
19676589|NCT00413283|42124304|FG002|Overall Study|Adverse Event|0|||
19676590|NCT00413283|42124305|FG003|Overall Study|Adverse Event|1|||
19676591|NCT00413283|42124302|FG000|Overall Study|Ineligibility determined|0|||
19676592|NCT00413283|42124303|FG001|Overall Study|Ineligibility determined|0|||
19676593|NCT00413283|42124304|FG002|Overall Study|Ineligibility determined|0|||
19676594|NCT00413283|42124305|FG003|Overall Study|Ineligibility determined|1|||
19676595|NCT00413283|42124302|FG000|Overall Study|Protocol deviation|0|||
19676596|NCT00413283|42124303|FG001|Overall Study|Protocol deviation|1|||
19676597|NCT00413283|42124304|FG002|Overall Study|Protocol deviation|0|||
19676598|NCT00413283|42124305|FG003|Overall Study|Protocol deviation|0|||
19676599|NCT00413283|42124302|FG000|Overall Study|Requirement for alternative therapy|0|||
19676600|NCT00413283|42124303|FG001|Overall Study|Requirement for alternative therapy|2|||
19676601|NCT00413283|42124304|FG002|Overall Study|Requirement for alternative therapy|0|||
19676602|NCT00413283|42124305|FG003|Overall Study|Requirement for alternative therapy|0|||
19676603|NCT00413283|42124302|FG000|Overall Study|Other|0|||
19676604|NCT00413283|42124303|FG001|Overall Study|Other|0|||
19676605|NCT00413283|42124304|FG002|Overall Study|Other|1|||
19676606|NCT00413283|42124305|FG003|Overall Study|Other|0|||
19676607|NCT00402051|42124317|FG000|Overall Study|Progressive Disease|13|||
19676608|NCT00402051|42124318|FG001|Overall Study|Progressive Disease|20|||
19676609|NCT00402051|42124317|FG000|Overall Study|Adverse Event|11|||
19676610|NCT00402051|42124318|FG001|Overall Study|Adverse Event|4|||
19676611|NCT00402051|42124317|FG000|Overall Study|Physician Decision|7|||
19676612|NCT00402051|42124318|FG001|Overall Study|Physician Decision|3|||
19676613|NCT00402051|42124317|FG000|Overall Study|Withdrawal by Subject|3|||
19676614|NCT00402051|42124318|FG001|Overall Study|Withdrawal by Subject|3|||
19676615|NCT00402051|42124317|FG000|Overall Study|Death - Related to Study Drug|1|||
19676616|NCT00402051|42124318|FG001|Overall Study|Death - Related to Study Drug|2|||
19676617|NCT00402051|42124317|FG000|Overall Study|Death Due to Study Disease|2|||
19676618|NCT00402051|42124318|FG001|Overall Study|Death Due to Study Disease|1|||
19676619|NCT00402051|42124317|FG000|Overall Study|Death Due to Adverse Event|0|||
19676620|NCT00402051|42124318|FG001|Overall Study|Death Due to Adverse Event|2|||
19676621|NCT00402051|42124317|FG000|Overall Study|Lost to Follow-up|1|||
19676622|NCT00402051|42124318|FG001|Overall Study|Lost to Follow-up|0|||
19676623|NCT00468858|42124327|FG000|Overall Study|Adverse Event|0|||
19676624|NCT00468858|42124328|FG001|Overall Study|Adverse Event|1|||
19676625|NCT00468858|42124329|FG002|Overall Study|Adverse Event|0|||
19676626|NCT00468858|42124327|FG000|Overall Study|Withdrawal by Subject|7|||
19676627|NCT00468858|42124328|FG001|Overall Study|Withdrawal by Subject|4|||
19676628|NCT00468858|42124329|FG002|Overall Study|Withdrawal by Subject|5|||
19676629|NCT00468858|42124327|FG000|Overall Study|Relocation|1|||
19676630|NCT00468858|42124328|FG001|Overall Study|Relocation|3|||
19676631|NCT00468858|42124329|FG002|Overall Study|Relocation|3|||
19676632|NCT00468858|42124327|FG000|Overall Study|Lost to Follow-up|1|||
19676633|NCT00468858|42124328|FG001|Overall Study|Lost to Follow-up|2|||
19676634|NCT00468858|42124329|FG002|Overall Study|Lost to Follow-up|5|||
19676635|NCT00468858|42124327|FG000|Overall Study|Other|0|||
19676636|NCT00468858|42124328|FG001|Overall Study|Other|0|||
19676637|NCT00468858|42124329|FG002|Overall Study|Other|1|||
19676638|NCT00401973|42124394|FG000|Overall Study|Adverse Event|2|||
19676639|NCT00401973|42124395|FG001|Overall Study|Adverse Event|8|||
19676640|NCT00401973|42124396|FG002|Overall Study|Adverse Event|4|||
19676641|NCT00401973|42124394|FG000|Overall Study|Clinical Relapse|0|||
19676642|NCT00401973|42124395|FG001|Overall Study|Clinical Relapse|1|||
19676643|NCT00401973|42124396|FG002|Overall Study|Clinical Relapse|1|||
19676644|NCT00401973|42124394|FG000|Overall Study|Lack of Efficacy|0|||
19676645|NCT00401973|42124395|FG001|Overall Study|Lack of Efficacy|0|||
19676646|NCT00401973|42124396|FG002|Overall Study|Lack of Efficacy|3|||
19676647|NCT00401973|42124394|FG000|Overall Study|Lost to Follow-up|2|||
19676648|NCT00401973|42124395|FG001|Overall Study|Lost to Follow-up|2|||
19676649|NCT00401973|42124396|FG002|Overall Study|Lost to Follow-up|2|||
19676650|NCT00401973|42124394|FG000|Overall Study|Physician Decision|2|||
19676651|NCT00401973|42124395|FG001|Overall Study|Physician Decision|0|||
19676652|NCT00401973|42124396|FG002|Overall Study|Physician Decision|1|||
19676653|NCT00401973|42124394|FG000|Overall Study|Protocol Violation|1|||
19676654|NCT00401973|42124395|FG001|Overall Study|Protocol Violation|2|||
19676655|NCT00401973|42124396|FG002|Overall Study|Protocol Violation|3|||
19676656|NCT00401973|42124394|FG000|Overall Study|Sponsor Decision|0|||
19676657|NCT00401973|42124395|FG001|Overall Study|Sponsor Decision|1|||
19676658|NCT00401973|42124396|FG002|Overall Study|Sponsor Decision|0|||
19676659|NCT00401973|42124394|FG000|Overall Study|Withdrawal by Subject|4|||
19676660|NCT00401973|42124395|FG001|Overall Study|Withdrawal by Subject|12|||
19676661|NCT00401973|42124396|FG002|Overall Study|Withdrawal by Subject|9|||
19676662|NCT00401193|42124409|FG000|Overall Study|Adverse Event|1|||
19676663|NCT00401193|42124410|FG001|Overall Study|Adverse Event|3|||
19676664|NCT00401193|42124411|FG002|Overall Study|Adverse Event|1|||
19676665|NCT00401193|42124409|FG000|Overall Study|Protocol Violation|3|||
19676666|NCT00401193|42124410|FG001|Overall Study|Protocol Violation|1|||
19676667|NCT00401193|42124411|FG002|Overall Study|Protocol Violation|1|||
19676668|NCT00401193|42124409|FG000|Overall Study|Lost to Follow-up|6|||
19676669|NCT00401193|42124410|FG001|Overall Study|Lost to Follow-up|5|||
19676670|NCT00401193|42124411|FG002|Overall Study|Lost to Follow-up|1|||
19676671|NCT00401193|42124409|FG000|Overall Study|Withdrawal by Subject|2|||
19676672|NCT00401193|42124410|FG001|Overall Study|Withdrawal by Subject|0|||
19676673|NCT00401193|42124411|FG002|Overall Study|Withdrawal by Subject|1|||
19676674|NCT00401193|42124409|FG000|Overall Study|Other Event|3|||
19676675|NCT00401193|42124410|FG001|Overall Study|Other Event|2|||
19676676|NCT00401193|42124411|FG002|Overall Study|Other Event|2|||
19676677|NCT00400569|42124420|FG000|Overall Study|Death|1|||
19676678|NCT00413049|42124429|FG000|Overall Study|Adverse Event|10|||
19676679|NCT00413049|42124430|FG001|Overall Study|Adverse Event|8|||
19676680|NCT00413049|42124429|FG000|Overall Study|Withdrawal by Subject|7|||
19676681|NCT00413049|42124430|FG001|Overall Study|Withdrawal by Subject|5|||
19676682|NCT00413049|42124429|FG000|Overall Study|Lost to Follow-up|2|||
19676683|NCT00413049|42124430|FG001|Overall Study|Lost to Follow-up|3|||
19676684|NCT00413049|42124429|FG000|Overall Study|Protocol Violation|3|||
19676685|NCT00413049|42124430|FG001|Overall Study|Protocol Violation|1|||
19676686|NCT00413049|42124429|FG000|Overall Study|Subject no longer requires study drug|0|||
19676687|NCT00413049|42124430|FG001|Overall Study|Subject no longer requires study drug|1|||
19676688|NCT00413049|42124429|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19604157|NCT00758524|42053022|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604158|NCT00758524|42053023|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604159|NCT00758524|42053024|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604160|NCT00758524|42053025|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604161|NCT00758524|42053026|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604162|NCT00758524|42053027|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604163|NCT00758524|42053028|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
19604164|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
19604165|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
19604166|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
19604167|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
19604168|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
19604169|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
19604170|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
19604171|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
19604172|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
19604173|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
19676689|NCT00413049|42124430|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19676690|NCT00413049|42124429|FG000|Overall Study|Lack of Efficacy|1|||
19676691|NCT00413049|42124430|FG001|Overall Study|Lack of Efficacy|0|||
19676692|NCT00454194|42124438|FG000|Overall Study|Adverse Event|7|||
19676693|NCT00454194|42124439|FG001|Overall Study|Adverse Event|2|||
19676694|NCT00454194|42124438|FG000|Overall Study|Withdrawal by Subject|12|||
19676695|NCT00454194|42124439|FG001|Overall Study|Withdrawal by Subject|8|||
19676696|NCT00454194|42124438|FG000|Overall Study|Other Medical Problems|1|||
19676697|NCT00454194|42124439|FG001|Overall Study|Other Medical Problems|2|||
19676698|NCT00454194|42124438|FG000|Overall Study|Other Unspecified Reason|2|||
19676699|NCT00454194|42124439|FG001|Overall Study|Other Unspecified Reason|2|||
19676700|NCT00412971|42124447|FG000|Overall Study|Lost to Follow-up|17|||
19676701|NCT00412971|42124448|FG001|Overall Study|Lost to Follow-up|9|||
19676702|NCT00412971|42124447|FG000|Overall Study|Protocol Violation|13|||
19676703|NCT00412971|42124448|FG001|Overall Study|Protocol Violation|1|||
19604174|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
19676704|NCT00303472|42124461|FG000|Treatment Period|Adverse Event|0|||
19676705|NCT00303472|42124462|FG001|Treatment Period|Adverse Event|0|||
19676706|NCT00303472|42124463|FG002|Treatment Period|Adverse Event|0|||
19676707|NCT00303472|42124464|FG003|Treatment Period|Adverse Event|0|||
19676708|NCT00303472|42124465|FG004|Treatment Period|Adverse Event|1|||
19676709|NCT00303472|42124466|FG005|Treatment Period|Adverse Event|0|||
19676710|NCT00303472|42124467|FG006|Treatment Period|Adverse Event|0|||
19676711|NCT00303472|42124461|FG000|Treatment Period|Death|0|||
19676712|NCT00303472|42124462|FG001|Treatment Period|Death|0|||
19676713|NCT00303472|42124463|FG002|Treatment Period|Death|0|||
19676714|NCT00303472|42124464|FG003|Treatment Period|Death|1|||
19676715|NCT00303472|42124465|FG004|Treatment Period|Death|0|||
19676716|NCT00303472|42124466|FG005|Treatment Period|Death|0|||
19676717|NCT00303472|42124467|FG006|Treatment Period|Death|1|||
19676718|NCT00303472|42124461|FG000|Treatment Period|Withdrawal by Subject|0|||
19676719|NCT00303472|42124462|FG001|Treatment Period|Withdrawal by Subject|0|||
19676720|NCT00303472|42124463|FG002|Treatment Period|Withdrawal by Subject|0|||
19676721|NCT00303472|42124464|FG003|Treatment Period|Withdrawal by Subject|1|||
19676722|NCT00303472|42124465|FG004|Treatment Period|Withdrawal by Subject|0|||
19676723|NCT00303472|42124466|FG005|Treatment Period|Withdrawal by Subject|1|||
19676724|NCT00303472|42124467|FG006|Treatment Period|Withdrawal by Subject|0|||
19676725|NCT00303472|42124461|FG000|Treatment Period|Other|0|||
19676726|NCT00303472|42124462|FG001|Treatment Period|Other|0|||
19676727|NCT00303472|42124463|FG002|Treatment Period|Other|0|||
19676728|NCT00303472|42124464|FG003|Treatment Period|Other|0|||
19676729|NCT00303472|42124465|FG004|Treatment Period|Other|1|||
19676730|NCT00303472|42124466|FG005|Treatment Period|Other|0|||
19676731|NCT00303472|42124467|FG006|Treatment Period|Other|1|||
19676732|NCT00303472|42124461|FG000|Treatment Period|Disease Progression (to AML)|0|||
19676733|NCT00303472|42124462|FG001|Treatment Period|Disease Progression (to AML)|0|||
19676734|NCT00303472|42124463|FG002|Treatment Period|Disease Progression (to AML)|0|||
19676735|NCT00303472|42124464|FG003|Treatment Period|Disease Progression (to AML)|0|||
19676736|NCT00303472|42124465|FG004|Treatment Period|Disease Progression (to AML)|1|||
19676737|NCT00303472|42124466|FG005|Treatment Period|Disease Progression (to AML)|0|||
19676738|NCT00303472|42124467|FG006|Treatment Period|Disease Progression (to AML)|0|||
19676739|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Adverse Event|1|||
19676740|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Adverse Event|0|||
19676741|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Adverse Event|1|||
19676742|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Adverse Event|0|||
19676743|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Adverse Event|0|||
19676744|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Adverse Event|0|||
19676745|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Adverse Event|0|||
19676746|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Death|2|||
19676747|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Death|0|||
19676748|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Death|1|||
19604175|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
19604176|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
19604177|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
19604178|NCT00757588|42053068|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
19604179|NCT00757588|42053069|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
19604180|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
19604181|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
19604182|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
19604183|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
19604184|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
19604185|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
19604186|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
19604187|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
19676749|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Death|0|||
19676750|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Death|0|||
19676751|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Death|0|||
19676752|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Death|0|||
19676753|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676754|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676755|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676756|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
19676757|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676758|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676759|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
19676760|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Physician Decision|0|||
19676761|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Physician Decision|4|||
19676762|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Physician Decision|2|||
19676763|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Physician Decision|3|||
19676764|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Physician Decision|2|||
19676765|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Physician Decision|0|||
19676766|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Physician Decision|0|||
19676767|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
19676768|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
19676769|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
19676770|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
19676771|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
19676772|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
19676773|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
19676774|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Other|0|||
19676775|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Other|2|||
19676776|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Other|4|||
19759777|NCT04039919|42211678|FG002|Treatment Period 5|Withdrawal by Subject|0|||
19759778|NCT04039919|42211679|FG003|Treatment Period 5|Withdrawal by Subject|0|||
19759779|NCT04039919|42211680|FG004|Treatment Period 5|Withdrawal by Subject|0|||
19759780|NCT04035473|42211716|FG000|Screening/Baseline|Death|0|||
19759781|NCT04035473|42211717|FG001|Screening/Baseline|Death|1|||
19759782|NCT04035473|42211716|FG000|Screening/Baseline|Adverse Event|0|||
19759783|NCT04035473|42211717|FG001|Screening/Baseline|Adverse Event|1|||
19759784|NCT04035473|42211716|FG000|Follow-up Period|Adverse Event|2|||
19759785|NCT04035473|42211717|FG001|Follow-up Period|Adverse Event|0|||
19759786|NCT04032977|42211725|FG000|Overall Study|Withdrawal by Subject|6|||
19759787|NCT04032977|42211726|FG001|Overall Study|Withdrawal by Subject|1|||
19759788|NCT04032977|42211725|FG000|Overall Study|Lost to Follow-up|2|||
19759789|NCT04032977|42211726|FG001|Overall Study|Lost to Follow-up|7|||
19759790|NCT04032977|42211725|FG000|Overall Study|Pregnancy|1|||
19759791|NCT04032977|42211726|FG001|Overall Study|Pregnancy|0|||
19759792|NCT04030247|42211732|FG000|Overall Study|Withdrawal by Subject|4|||
19759793|NCT04030247|42211732|FG000|Overall Study|Lost to Follow-up|13|||
19676777|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Other|2|||
19676778|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Other|1|||
19759794|NCT02915978|42211739|FG000|Overall Study|Adverse Event|2|||
19759795|NCT02915978|42211740|FG001|Overall Study|Adverse Event|1|||
19759796|NCT02915978|42211741|FG002|Overall Study|Adverse Event|0|||
19759797|NCT02701192|42211749|FG000|Overall Study|Protocol Violation|2|||
19759798|NCT02701192|42211749|FG000|Overall Study|Lost to Follow-up|4|||
19759799|NCT03101358|42211757|FG000|Overall Study|Non-compliance with study schedule|1|||
19759800|NCT03101358|42211758|FG001|Overall Study|Non-compliance with study schedule|0|||
19759801|NCT03101358|42211759|FG002|Overall Study|Non-compliance with study schedule|0|||
19759802|NCT03101358|42211760|FG003|Overall Study|Non-compliance with study schedule|1|||
19759803|NCT03101358|42211757|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
19759804|NCT03101358|42211758|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
19759805|NCT03101358|42211759|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
19759806|NCT03101358|42211760|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
19759807|NCT03101358|42211757|FG000|Overall Study|Physician Decision|1|||
19759808|NCT03101358|42211758|FG001|Overall Study|Physician Decision|0|||
19759809|NCT03101358|42211759|FG002|Overall Study|Physician Decision|0|||
19759810|NCT03101358|42211760|FG003|Overall Study|Physician Decision|3|||
19759811|NCT03101358|42211757|FG000|Overall Study|Adverse Event|0|||
19676779|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Other|0|||
19759812|NCT03101358|42211758|FG001|Overall Study|Adverse Event|0|||
19759813|NCT03101358|42211759|FG002|Overall Study|Adverse Event|1|||
19759814|NCT03101358|42211760|FG003|Overall Study|Adverse Event|0|||
19759815|NCT03101358|42211757|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
19759816|NCT03101358|42211758|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
19799414|NCT02962739|42257490|FG005|Overall Study|Withdrawal by Subject|0|||
19676780|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Other|0|||
19676781|NCT00303472|42124461|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
19759817|NCT03101358|42211759|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
19759818|NCT03101358|42211760|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
19759819|NCT03101358|42211757|FG000|Overall Study|Lost to Follow-up|1|||
19759820|NCT03101358|42211758|FG001|Overall Study|Lost to Follow-up|0|||
19676782|NCT00303472|42124462|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
19676783|NCT00303472|42124463|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
19676784|NCT00303472|42124464|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
19676785|NCT00303472|42124465|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
19676786|NCT00303472|42124466|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
19676787|NCT00303472|42124467|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
19676788|NCT00468546|42124485|FG000|Week 24 Analysis|Lack of Efficacy|83|||
19676789|NCT00468546|42124486|FG001|Week 24 Analysis|Lack of Efficacy|37|||
19759821|NCT03101358|42211759|FG002|Overall Study|Lost to Follow-up|0|||
19759822|NCT03101358|42211760|FG003|Overall Study|Lost to Follow-up|1|||
19676790|NCT00468546|42124485|FG000|Week 24 Analysis|Refused treatment|5|||
19676791|NCT00468546|42124486|FG001|Week 24 Analysis|Refused treatment|5|||
19389072|NCT02672423|41632618|FG009|Period 3|Physician Decision|0|||
19604188|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
19604189|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
19604190|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
19604191|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
19604192|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
19604193|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
19604194|NCT00757588|42053068|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
19604195|NCT00757588|42053069|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
19604196|NCT00744796|42053075|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
19604197|NCT00705679|42053084|FG000|Overall Study|Adverse Event|1|||
19676792|NCT00468546|42124485|FG000|Week 24 Analysis|Adverse Event|1|||
19676793|NCT00468546|42124486|FG001|Week 24 Analysis|Adverse Event|8|||
19676794|NCT00468546|42124485|FG000|Week 24 Analysis|Failure to return|3|||
19676795|NCT00468546|42124486|FG001|Week 24 Analysis|Failure to return|4|||
19676796|NCT00468546|42124485|FG000|Week 24 Analysis|Rescue therapy|2|||
19676797|NCT00468546|42124486|FG001|Week 24 Analysis|Rescue therapy|0|||
19676798|NCT00468546|42124485|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
19676799|NCT00468546|42124486|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
19676800|NCT00468546|42124485|FG000|Week 24 Analysis|Due to clinical hold|1|||
19676801|NCT00468546|42124486|FG001|Week 24 Analysis|Due to clinical hold|0|||
19676802|NCT00468546|42124485|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
19676803|NCT00468546|42124486|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
19676804|NCT00468546|42124485|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
19676805|NCT00468546|42124486|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
19676806|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
19676807|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
19676808|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Death|1|||
19676809|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Death|0|||
19676810|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
19676811|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
19676812|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
19676813|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
19676814|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
19676815|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
19676816|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
19676817|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
19676818|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
19676819|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
19676820|NCT00468546|42124485|FG000|Week 24 to Week 104 Analysis|Other|17|||
19676821|NCT00468546|42124486|FG001|Week 24 to Week 104 Analysis|Other|14|||
19676822|NCT00303316|42124494|FG000|Overall Study|Protocol Violation|1|||
19676823|NCT00303316|42124495|FG001|Overall Study|Protocol Violation|0|||
19759823|NCT03657095|42211773|FG000|Overall Study|Withdrawal by Subject|1|||
19759824|NCT03657095|42211774|FG001|Overall Study|Withdrawal by Subject|1|||
19759825|NCT03657095|42211773|FG000|Overall Study|Adverse Event|0|||
19759826|NCT03657095|42211774|FG001|Overall Study|Adverse Event|3|||
19759827|NCT03657095|42211773|FG000|Overall Study|Study Terminated by Sponsor|58|||
19759828|NCT03657095|42211774|FG001|Overall Study|Study Terminated by Sponsor|49|||
19676824|NCT00303316|42124494|FG000|Overall Study|Lost to Follow-up|0|||
19676825|NCT00303316|42124495|FG001|Overall Study|Lost to Follow-up|1|||
19676826|NCT00303316|42124494|FG000|Overall Study|Withdrawal by Subject|1|||
19676827|NCT00303316|42124495|FG001|Overall Study|Withdrawal by Subject|2|||
19676828|NCT00468312|42124503|FG000|Overall Study|Adverse Event|2|||
19676829|NCT00468312|42124504|FG001|Overall Study|Adverse Event|1|||
19676830|NCT00468312|42124503|FG000|Overall Study|Lack of Efficacy|0|||
19676831|NCT00468312|42124504|FG001|Overall Study|Lack of Efficacy|1|||
19676832|NCT00468312|42124503|FG000|Overall Study|Withdrawal by Subject|0|||
19676833|NCT00468312|42124504|FG001|Overall Study|Withdrawal by Subject|1|||
19676834|NCT00468312|42124503|FG000|Overall Study|Protocol Violation|2|||
19676835|NCT00468312|42124504|FG001|Overall Study|Protocol Violation|1|||
19676836|NCT00468312|42124503|FG000|Overall Study|Did not meet protocol eligibility|0|||
19676837|NCT00468312|42124504|FG001|Overall Study|Did not meet protocol eligibility|1|||
19676838|NCT00331864|42124512|FG000|Overall Study|Adverse Event|30|||
19676839|NCT00331864|42124513|FG001|Overall Study|Adverse Event|1|||
19676840|NCT00331864|42124512|FG000|Overall Study|Lack of Efficacy|4|||
19676841|NCT00331864|42124513|FG001|Overall Study|Lack of Efficacy|0|||
19676842|NCT00331864|42124512|FG000|Overall Study|Protocol Violation|3|||
19676843|NCT00331864|42124513|FG001|Overall Study|Protocol Violation|0|||
19676844|NCT00331864|42124512|FG000|Overall Study|Withdrawal by Subject|10|||
19676845|NCT00331864|42124513|FG001|Overall Study|Withdrawal by Subject|0|||
19676846|NCT00331864|42124512|FG000|Overall Study|Lost to Follow-up|4|||
19676847|NCT00331864|42124513|FG001|Overall Study|Lost to Follow-up|3|||
19676848|NCT00331864|42124512|FG000|Overall Study|Administrative Problems|1|||
19676849|NCT00331864|42124513|FG001|Overall Study|Administrative Problems|0|||
19676850|NCT00331864|42124512|FG000|Overall Study|Death|6|||
19676851|NCT00331864|42124513|FG001|Overall Study|Death|0|||
19676852|NCT00331630|42124519|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
19676853|NCT00331630|42124519|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
19676854|NCT00331630|42124519|FG000|Follow up for 5 Years|Death|5|||
19676855|NCT00331630|42124519|FG000|Follow up for 5 Years|Data collection was stopped|24|||
19676856|NCT00331552|42124525|FG000|Period 3: Phase II|Neurological Symptoms|1|||
19676857|NCT00331552|42124526|FG001|Period 3: Phase II|Neurological Symptoms|0|||
19676858|NCT00331552|42124525|FG000|Period 3: Phase II|Severe Nausea|1|||
19676859|NCT00331552|42124526|FG001|Period 3: Phase II|Severe Nausea|0|||
19759829|NCT03100344|42211784|FG000|Overall Study|Adverse Event|0|||
19759830|NCT03100344|42211785|FG001|Overall Study|Adverse Event|3|||
19676860|NCT00317356|42124541|FG000|Overall Study|Adverse Event|0|||
19676861|NCT00317356|42124542|FG001|Overall Study|Adverse Event|0|||
19676862|NCT00317356|42124543|FG002|Overall Study|Adverse Event|1|||
19676863|NCT00317356|42124544|FG003|Overall Study|Adverse Event|0|||
19676864|NCT00317356|42124541|FG000|Overall Study|Lack of Efficacy|1|||
19676865|NCT00317356|42124542|FG001|Overall Study|Lack of Efficacy|1|||
19676866|NCT00317356|42124543|FG002|Overall Study|Lack of Efficacy|0|||
19676867|NCT00317356|42124544|FG003|Overall Study|Lack of Efficacy|3|||
19676868|NCT00317356|42124541|FG000|Overall Study|Physician Decision|0|||
19676869|NCT00317356|42124542|FG001|Overall Study|Physician Decision|1|||
19676870|NCT00317356|42124543|FG002|Overall Study|Physician Decision|0|||
19676871|NCT00317356|42124544|FG003|Overall Study|Physician Decision|0|||
19676872|NCT00331006|42124554|FG000|Screening Phase|Withdrawal by Subject|1|||
19676873|NCT00331006|42124554|FG000|Screening Phase|enrollment halted|1|||
19676874|NCT00331006|42124554|FG000|Screening Phase|Lost to Follow-up|1|||
19676875|NCT00331006|42124554|FG000|Screening Phase|Ineligible for treatment phase|4|||
19676876|NCT00331006|42124554|FG000|Treatment Phase|Withdrawal by Subject|1|||
19676877|NCT00331006|42124554|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
19676878|NCT00331006|42124554|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
19676879|NCT00302458|42124558|FG000|Overall Study|Lost to Follow-up|1|||
19676880|NCT00302458|42124558|FG000|Overall Study|Ineligible after screening|1|||
19676881|NCT00302458|42124558|FG000|Overall Study|Withdrawal by Subject|1|||
19676882|NCT00391053|42124570|FG000|Overall Study|Serious Adverse Events|1|||
19676883|NCT00391053|42124571|FG001|Overall Study|Serious Adverse Events|0|||
19676884|NCT00391053|42124572|FG002|Overall Study|Serious Adverse Events|1|||
19676885|NCT00391053|42124573|FG003|Overall Study|Serious Adverse Events|4|||
19676886|NCT00391053|42124570|FG000|Overall Study|Protocol Violation|2|||
19676887|NCT00391053|42124571|FG001|Overall Study|Protocol Violation|0|||
19676888|NCT00391053|42124572|FG002|Overall Study|Protocol Violation|0|||
19676889|NCT00391053|42124573|FG003|Overall Study|Protocol Violation|0|||
19676890|NCT00391053|42124570|FG000|Overall Study|Lost to Follow-up|1|||
19676891|NCT00391053|42124571|FG001|Overall Study|Lost to Follow-up|0|||
19676892|NCT00391053|42124572|FG002|Overall Study|Lost to Follow-up|0|||
19676893|NCT00391053|42124573|FG003|Overall Study|Lost to Follow-up|5|||
19676894|NCT00391053|42124570|FG000|Overall Study|Withdrawal by Subject|5|||
19676895|NCT00391053|42124571|FG001|Overall Study|Withdrawal by Subject|1|||
19676896|NCT00391053|42124572|FG002|Overall Study|Withdrawal by Subject|1|||
19676897|NCT00391053|42124573|FG003|Overall Study|Withdrawal by Subject|1|||
19759831|NCT03100344|42211786|FG002|Overall Study|Adverse Event|2|||
19676898|NCT00317044|42124586|FG000|Overall Study|Protocol Violation|28|||
19676899|NCT00317044|42124587|FG001|Overall Study|Protocol Violation|22|||
19676900|NCT00317044|42124588|FG002|Overall Study|Protocol Violation|20|||
19676901|NCT00317044|42124586|FG000|Overall Study|Adverse Event|4|||
19676902|NCT00317044|42124587|FG001|Overall Study|Adverse Event|7|||
19676903|NCT00317044|42124588|FG002|Overall Study|Adverse Event|4|||
19676904|NCT00317044|42124586|FG000|Overall Study|Withdrawal by Subject|10|||
19676905|NCT00317044|42124587|FG001|Overall Study|Withdrawal by Subject|7|||
19676906|NCT00317044|42124588|FG002|Overall Study|Withdrawal by Subject|12|||
19676907|NCT00317044|42124586|FG000|Overall Study|Lost to Follow-up|0|||
19676908|NCT00317044|42124587|FG001|Overall Study|Lost to Follow-up|2|||
19676909|NCT00317044|42124588|FG002|Overall Study|Lost to Follow-up|3|||
19676910|NCT00317044|42124586|FG000|Overall Study|Multiple Reasons|6|||
19676911|NCT00317044|42124587|FG001|Overall Study|Multiple Reasons|2|||
19676912|NCT00317044|42124588|FG002|Overall Study|Multiple Reasons|6|||
19676913|NCT00301834|42124596|FG000|Overall Study|Death|1|||
19676914|NCT00301366|42124603|FG000|Overall Study|Adverse Event|1|||
19676915|NCT00330928|42124607|FG000|Overall Study|Lost to Follow-up|6|||
19676916|NCT00330928|42124607|FG000|Overall Study|Physician Decision|9|||
19676917|NCT00330928|42124607|FG000|Overall Study|Death|1|||
19676918|NCT00330928|42124607|FG000|Overall Study|IVUS could not be performed.|1|||
19676919|NCT00330616|42124611|FG000|Overall Study|Adverse Event|13|||
19676920|NCT00330616|42124611|FG000|Overall Study|Lack of Efficacy|1|||
19676921|NCT00330616|42124611|FG000|Overall Study|Lost to Follow-up|2|||
19676922|NCT00330616|42124611|FG000|Overall Study|Withdrawal by Subject|4|||
19676923|NCT00330616|42124611|FG000|Overall Study|Other|1|||
19676924|NCT00466440|42124618|FG000|Overall Study|Adverse Event|0|||
19676925|NCT00466440|42124619|FG001|Overall Study|Adverse Event|3|||
19676926|NCT00466440|42124620|FG002|Overall Study|Adverse Event|1|||
19676927|NCT00466440|42124618|FG000|Overall Study|Death|1|||
19676928|NCT00466440|42124619|FG001|Overall Study|Death|1|||
19676929|NCT00466440|42124620|FG002|Overall Study|Death|0|||
19676930|NCT00466440|42124618|FG000|Overall Study|Progressive disease|13|||
19676931|NCT00466440|42124619|FG001|Overall Study|Progressive disease|5|||
19676932|NCT00466440|42124620|FG002|Overall Study|Progressive disease|4|||
19676933|NCT00466440|42124618|FG000|Overall Study|Lost to Follow-up|0|||
19676934|NCT00466440|42124619|FG001|Overall Study|Lost to Follow-up|1|||
19676935|NCT00466440|42124620|FG002|Overall Study|Lost to Follow-up|0|||
19676936|NCT00466440|42124618|FG000|Overall Study|Physician Decision|0|||
19676937|NCT00466440|42124619|FG001|Overall Study|Physician Decision|1|||
19676938|NCT00466440|42124620|FG002|Overall Study|Physician Decision|2|||
19676939|NCT00466440|42124618|FG000|Overall Study|Protocol entry criteria not met|0|||
19676940|NCT00466440|42124619|FG001|Overall Study|Protocol entry criteria not met|0|||
19676941|NCT00466440|42124620|FG002|Overall Study|Protocol entry criteria not met|4|||
19676942|NCT00466440|42124618|FG000|Overall Study|Withdrawal by Subject|0|||
19676943|NCT00466440|42124619|FG001|Overall Study|Withdrawal by Subject|1|||
19676944|NCT00466440|42124620|FG002|Overall Study|Withdrawal by Subject|0|||
19676945|NCT00466440|42124618|FG000|Overall Study|Sponsor decision|0|||
19676946|NCT00466440|42124619|FG001|Overall Study|Sponsor decision|0|||
19676947|NCT00466440|42124620|FG002|Overall Study|Sponsor decision|1|||
19676948|NCT00465972|42124639|FG000|Overall Study|Withdrawal by Subject|2|||
19676949|NCT00465972|42124640|FG001|Overall Study|Withdrawal by Subject|1|||
19676950|NCT00465894|42124650|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
19676951|NCT00465894|42124651|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
19676952|NCT00465894|42124650|FG000|Treatment For 12 Weeks|Family Issues|1|||
19676953|NCT00465894|42124651|FG001|Treatment For 12 Weeks|Family Issues|1|||
19676954|NCT00465894|42124650|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
19676955|NCT00465894|42124651|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
19676956|NCT00330460|42124675|FG000|Overall Study|Physician Decision|1|||
19676957|NCT00330460|42124676|FG001|Overall Study|Physician Decision|0|||
19676958|NCT00330460|42124675|FG000|Overall Study|Adverse Event|10|||
19676959|NCT00330460|42124676|FG001|Overall Study|Adverse Event|8|||
19676960|NCT00330460|42124675|FG000|Overall Study|Withdrawal by Subject|18|||
19676961|NCT00330460|42124676|FG001|Overall Study|Withdrawal by Subject|17|||
19676962|NCT00330460|42124675|FG000|Overall Study|Death|1|||
19676963|NCT00330460|42124676|FG001|Overall Study|Death|1|||
19676964|NCT00330460|42124675|FG000|Overall Study|Ineligibility determined|1|||
19676965|NCT00330460|42124676|FG001|Overall Study|Ineligibility determined|3|||
19676966|NCT00330460|42124675|FG000|Overall Study|Lost to Follow-up|8|||
19676967|NCT00330460|42124676|FG001|Overall Study|Lost to Follow-up|3|||
19676968|NCT00330460|42124675|FG000|Overall Study|Noncompliance|2|||
19676969|NCT00330460|42124676|FG001|Overall Study|Noncompliance|1|||
19676970|NCT00330460|42124675|FG000|Overall Study|Other|1|||
19676971|NCT00330460|42124676|FG001|Overall Study|Other|0|||
19676972|NCT00454116|42124685|FG000|Overall Study|Adverse Event|5|||
19676973|NCT00454116|42124686|FG001|Overall Study|Adverse Event|11|||
19676974|NCT00454116|42124687|FG002|Overall Study|Adverse Event|9|||
19676975|NCT00454116|42124685|FG000|Overall Study|Condition under investigation worsened|17|||
19759832|NCT03100344|42211787|FG003|Overall Study|Adverse Event|3|||
19676976|NCT00454116|42124686|FG001|Overall Study|Condition under investigation worsened|13|||
19676977|NCT00454116|42124687|FG002|Overall Study|Condition under investigation worsened|18|||
19676978|NCT00454116|42124685|FG000|Overall Study|Withdrawal by Subject|3|||
19676979|NCT00454116|42124686|FG001|Overall Study|Withdrawal by Subject|3|||
19676980|NCT00454116|42124687|FG002|Overall Study|Withdrawal by Subject|1|||
19676981|NCT00454116|42124685|FG000|Overall Study|Other|2|||
19676982|NCT00454116|42124686|FG001|Overall Study|Other|2|||
19676983|NCT00454116|42124687|FG002|Overall Study|Other|0|||
19676984|NCT00465816|42124698|FG000|Overall Study|Lost to Follow-up|0|||
19676985|NCT00465816|42124699|FG001|Overall Study|Lost to Follow-up|0|||
19676986|NCT00465816|42124700|FG002|Overall Study|Lost to Follow-up|2|||
19676987|NCT00465738|42124711|FG000|Overall Study|Lost to Follow-up|2|||
19676988|NCT00465738|42124712|FG001|Overall Study|Lost to Follow-up|0|||
19676989|NCT00465738|42124711|FG000|Overall Study|Adverse Event|0|||
19676990|NCT00465738|42124712|FG001|Overall Study|Adverse Event|1|||
19676991|NCT00465738|42124711|FG000|Overall Study|Withdrawal by Subject|2|||
19676992|NCT00465738|42124712|FG001|Overall Study|Withdrawal by Subject|0|||
19676993|NCT00465738|42124711|FG000|Overall Study|Other|2|||
19676994|NCT00465738|42124712|FG001|Overall Study|Other|5|||
19676995|NCT00400179|42124720|FG000|Overall Study|Adverse Event|2|||
19676996|NCT00400179|42124721|FG001|Overall Study|Adverse Event|2|||
19759833|NCT03100344|42211784|FG000|Overall Study|Lack of Efficacy|2|||
19759834|NCT03100344|42211785|FG001|Overall Study|Lack of Efficacy|0|||
19759835|NCT03100344|42211786|FG002|Overall Study|Lack of Efficacy|0|||
19759836|NCT03100344|42211787|FG003|Overall Study|Lack of Efficacy|0|||
19759837|NCT03100344|42211784|FG000|Overall Study|Protocol Violation|1|||
19759838|NCT03100344|42211785|FG001|Overall Study|Protocol Violation|0|||
19759839|NCT03100344|42211786|FG002|Overall Study|Protocol Violation|0|||
19759840|NCT03100344|42211787|FG003|Overall Study|Protocol Violation|0|||
19759841|NCT03100344|42211784|FG000|Overall Study|Withdrawal by Subject|10|||
19759842|NCT03100344|42211785|FG001|Overall Study|Withdrawal by Subject|7|||
19759843|NCT03100344|42211786|FG002|Overall Study|Withdrawal by Subject|4|||
19759844|NCT03100344|42211787|FG003|Overall Study|Withdrawal by Subject|8|||
19759845|NCT03100344|42211784|FG000|Overall Study|Lost to Follow-up|1|||
19759846|NCT03100344|42211785|FG001|Overall Study|Lost to Follow-up|1|||
19759847|NCT03100344|42211786|FG002|Overall Study|Lost to Follow-up|1|||
19759848|NCT03100344|42211787|FG003|Overall Study|Lost to Follow-up|1|||
19759849|NCT02951533|42211800|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
19759850|NCT02951533|42211801|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
19759851|NCT02951533|42211802|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
19759852|NCT02951533|42211800|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
19759853|NCT02951533|42211801|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
19759854|NCT02951533|42211802|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
19759855|NCT02951533|42211800|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
19759856|NCT02951533|42211801|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
19676997|NCT00400179|42124720|FG000|Overall Study|Death|1|||
19676998|NCT00400179|42124721|FG001|Overall Study|Death|2|||
19676999|NCT00400179|42124720|FG000|Overall Study|Withdrew Consent|1|||
19677000|NCT00400179|42124721|FG001|Overall Study|Withdrew Consent|5|||
19677001|NCT00400179|42124720|FG000|Overall Study|Disease progression|1|||
19677002|NCT00400179|42124721|FG001|Overall Study|Disease progression|1|||
19677003|NCT00400179|42124720|FG000|Overall Study|Intercurrent illness|0|||
19677004|NCT00400179|42124721|FG001|Overall Study|Intercurrent illness|1|||
19677005|NCT00400179|42124720|FG000|Overall Study|Investigator judgment|0|||
19677006|NCT00400179|42124721|FG001|Overall Study|Investigator judgment|1|||
19677007|NCT00400179|42124720|FG000|Overall Study|Randomization error/patient ineligible|1|||
19677008|NCT00400179|42124721|FG001|Overall Study|Randomization error/patient ineligible|6|||
19677009|NCT00465270|42124729|FG000|Overall Study|Death|7|||
19677010|NCT00465270|42124730|FG001|Overall Study|Death|11|||
19677011|NCT00465270|42124729|FG000|Overall Study|Withdrawal by Subject|34|||
19759857|NCT02951533|42211802|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
19677012|NCT00465270|42124730|FG001|Overall Study|Withdrawal by Subject|78|||
19759858|NCT02951533|42211800|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
19759859|NCT02951533|42211801|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
19389073|NCT02670551|41632642|FG000|Overall Study|Adverse Event|4|||
19677013|NCT00465270|42124729|FG000|Overall Study|Lost to Follow-up|60|||
19677014|NCT00465270|42124730|FG001|Overall Study|Lost to Follow-up|67|||
19677015|NCT00465270|42124729|FG000|Overall Study|Investigator request|3|||
19677016|NCT00465270|42124730|FG001|Overall Study|Investigator request|4|||
19677017|NCT00464568|42124736|FG000|Overall Study|Adverse Event|2|||
19759860|NCT02951533|42211802|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
19677018|NCT00464490|42124755|FG000|Overall Study|Physician Decision|11|||
19759861|NCT02951533|42211800|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
19759862|NCT02951533|42211801|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
19759863|NCT02951533|42211802|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
19759864|NCT02951533|42211800|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
19389074|NCT02670551|41632643|FG001|Overall Study|Adverse Event|7|||
19604198|NCT00705679|42053085|FG001|Overall Study|Adverse Event|1|||
19604199|NCT00705679|42053086|FG002|Overall Study|Adverse Event|0|||
19604200|NCT00705679|42053087|FG003|Overall Study|Adverse Event|0|||
19759865|NCT02951533|42211801|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
19759866|NCT02951533|42211802|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
19759867|NCT02951533|42211800|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
19759868|NCT02951533|42211801|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
19759869|NCT02951533|42211802|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
19759870|NCT02951533|42211800|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
19759871|NCT02951533|42211801|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
19759872|NCT02951533|42211802|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
19759873|NCT02951533|42211800|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
19759874|NCT02951533|42211801|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
19759875|NCT02951533|42211802|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
19759876|NCT02951533|42211800|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
19759877|NCT02951533|42211801|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
19759878|NCT02951533|42211802|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
19759879|NCT02951533|42211800|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
19759880|NCT02951533|42211801|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
19799415|NCT02962739|42257485|FG000|Overall Study|Protocol Violation|0|||
19604201|NCT00705679|42053088|FG004|Overall Study|Adverse Event|0|||
19677019|NCT00464490|42124756|FG001|Overall Study|Physician Decision|11|||
19677020|NCT03849300|42124766|FG000|Overall Study|move out to different area|1|||
19677021|NCT03849300|42124767|FG001|Overall Study|move out to different area|3|||
19677022|NCT03849300|42124768|FG002|Overall Study|move out to different area|1|||
19677023|NCT03849300|42124769|FG003|Overall Study|move out to different area|4|||
19677024|NCT03849300|42124766|FG000|Overall Study|scheduling/transportation conflict|4|||
19604202|NCT00705679|42053084|FG000|Overall Study|Death|0|||
19604203|NCT00705679|42053085|FG001|Overall Study|Death|0|||
19604204|NCT00705679|42053086|FG002|Overall Study|Death|3|||
19604205|NCT00705679|42053087|FG003|Overall Study|Death|2|||
19604206|NCT00705679|42053088|FG004|Overall Study|Death|1|||
19604207|NCT00705679|42053084|FG000|Overall Study|Lost to Follow-up|32|||
19604208|NCT00705679|42053085|FG001|Overall Study|Lost to Follow-up|60|||
19604209|NCT00705679|42053086|FG002|Overall Study|Lost to Follow-up|44|||
19604210|NCT00705679|42053087|FG003|Overall Study|Lost to Follow-up|30|||
19604211|NCT00705679|42053088|FG004|Overall Study|Lost to Follow-up|35|||
19604212|NCT00705679|42053084|FG000|Overall Study|Physician Decision|0|||
19604213|NCT00705679|42053085|FG001|Overall Study|Physician Decision|1|||
19604214|NCT00705679|42053086|FG002|Overall Study|Physician Decision|0|||
19604215|NCT00705679|42053087|FG003|Overall Study|Physician Decision|1|||
19604216|NCT00705679|42053088|FG004|Overall Study|Physician Decision|0|||
19604217|NCT00705679|42053084|FG000|Overall Study|Withdrawal by Subject|32|||
19604218|NCT00705679|42053085|FG001|Overall Study|Withdrawal by Subject|77|||
19604219|NCT00705679|42053086|FG002|Overall Study|Withdrawal by Subject|68|||
19604220|NCT00705679|42053087|FG003|Overall Study|Withdrawal by Subject|47|||
19604221|NCT00705679|42053088|FG004|Overall Study|Withdrawal by Subject|33|||
19604222|NCT00751348|42053111|FG000|Overall Study|Withdrawal by Subject|5|||
19604223|NCT00751348|42053112|FG001|Overall Study|Withdrawal by Subject|2|||
19604224|NCT00751348|42053111|FG000|Overall Study|Migration from study area|1|||
19604225|NCT00751348|42053112|FG001|Overall Study|Migration from study area|0|||
19677025|NCT03849300|42124767|FG001|Overall Study|scheduling/transportation conflict|4|||
19604226|NCT00751114|42053120|FG000|Overall Study|Adverse Event|2|||
19604227|NCT00751114|42053121|FG001|Overall Study|Adverse Event|4|||
19604228|NCT00751114|42053120|FG000|Overall Study|Protocol Violation|8|||
19604229|NCT00751114|42053121|FG001|Overall Study|Protocol Violation|9|||
19604230|NCT00751114|42053120|FG000|Overall Study|Withdrawal by Subject|9|||
19604231|NCT00751114|42053121|FG001|Overall Study|Withdrawal by Subject|4|||
19677026|NCT03849300|42124768|FG002|Overall Study|scheduling/transportation conflict|3|||
19677027|NCT03849300|42124769|FG003|Overall Study|scheduling/transportation conflict|2|||
19677028|NCT00412893|42124783|FG000|Overall Study|Adverse Event|31|||
19677029|NCT00412893|42124784|FG001|Overall Study|Adverse Event|53|||
19677030|NCT00412893|42124783|FG000|Overall Study|Death|17|||
19677031|NCT00412893|42124784|FG001|Overall Study|Death|21|||
19677032|NCT00412893|42124783|FG000|Overall Study|Insufficient Therapeutic Response|39|||
19677033|NCT00412893|42124784|FG001|Overall Study|Insufficient Therapeutic Response|23|||
19677034|NCT00412893|42124783|FG000|Overall Study|Lost to Follow-up|2|||
19677035|NCT00412893|42124784|FG001|Overall Study|Lost to Follow-up|1|||
19677036|NCT00412893|42124783|FG000|Overall Study|Violation of Selection at Entry|17|||
19677037|NCT00412893|42124784|FG001|Overall Study|Violation of Selection at Entry|10|||
19677038|NCT00412893|42124783|FG000|Overall Study|Other Protocol Violation|10|||
19677039|NCT00412893|42124784|FG001|Overall Study|Other Protocol Violation|6|||
19677040|NCT00412893|42124783|FG000|Overall Study|Did Not Cooperate|12|||
19677041|NCT00412893|42124784|FG001|Overall Study|Did Not Cooperate|9|||
19677042|NCT00412893|42124783|FG000|Overall Study|Administrative Reason|12|||
19677043|NCT00412893|42124784|FG001|Overall Study|Administrative Reason|15|||
19677044|NCT00412893|42124783|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
19677045|NCT00412893|42124784|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
19677046|NCT00412737|42124792|FG000|Overall Study|Death|1|||
19677047|NCT00412737|42124793|FG001|Overall Study|Death|0|||
19759881|NCT02951533|42211802|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
19759882|NCT02700412|42211819|FG000|Overall Study|Adverse Event|6|||
19759883|NCT02700412|42211819|FG000|Overall Study|Death|1|||
19759884|NCT02700412|42211819|FG000|Overall Study|Lack of Efficacy|19|||
19677048|NCT00412737|42124792|FG000|Overall Study|Adverse Event|3|||
19677049|NCT00412737|42124793|FG001|Overall Study|Adverse Event|2|||
19759885|NCT02700412|42211819|FG000|Overall Study|Protocol Violation|5|||
19759886|NCT02700412|42211819|FG000|Overall Study|Withdrawal by Subject|2|||
19759887|NCT03665441|42211825|FG000|Overall Study|survival follow up ongoing|23|||
19759888|NCT03665441|42211826|FG001|Overall Study|survival follow up ongoing|0|||
19759889|NCT03665441|42211825|FG000|Overall Study|Patients ongoing on treatment|9|||
19759890|NCT03665441|42211826|FG001|Overall Study|Patients ongoing on treatment|6|||
19759891|NCT03665441|42211825|FG000|Overall Study|Randomized but not treated|7|||
19759892|NCT03665441|42211826|FG001|Overall Study|Randomized but not treated|11|||
19759893|NCT02699866|42211832|FG000|Overall Study|Withdrawal by Subject|3|||
19759894|NCT02699866|42211832|FG000|Overall Study|Physician Decision|2|||
19759895|NCT02699866|42211832|FG000|Overall Study|Adverse Event|3|||
19759896|NCT03663569|42211836|FG000|Overall Study|Discontinuation of study|11|||
19759897|NCT03663569|42211836|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
19759898|NCT03663569|42211836|FG000|Overall Study|Deceased patient|6|||
19759899|NCT03663569|42211836|FG000|Overall Study|Lost to Follow-up|18|||
19759900|NCT03663569|42211836|FG000|Overall Study|Withdrawal of consent|5|||
19759901|NCT03663569|42211836|FG000|Overall Study|Patient's request|11|||
19759902|NCT03663569|42211836|FG000|Overall Study|Adverse Event|4|||
19759903|NCT03663569|42211836|FG000|Overall Study|Not come to second visit|3|||
19759904|NCT03663569|42211836|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
19759905|NCT03663569|42211836|FG000|Overall Study|Serious adverse event|1|||
19759906|NCT03596762|42211845|FG000|Overall Study|Protocol Violation|0|||
19759907|NCT03596762|42211846|FG001|Overall Study|Protocol Violation|0|||
19759908|NCT03596762|42211847|FG002|Overall Study|Protocol Violation|0|||
19759909|NCT03596762|42211848|FG003|Overall Study|Protocol Violation|0|||
19759910|NCT03596762|42211849|FG004|Overall Study|Protocol Violation|1|||
19759911|NCT03596762|42211845|FG000|Overall Study|Adverse Event|2|||
19759912|NCT03596762|42211846|FG001|Overall Study|Adverse Event|0|||
19759913|NCT03596762|42211847|FG002|Overall Study|Adverse Event|1|||
19677050|NCT00412737|42124792|FG000|Overall Study|Refused Treatment|6|||
19677051|NCT00412737|42124793|FG001|Overall Study|Refused Treatment|2|||
19759914|NCT03596762|42211848|FG003|Overall Study|Adverse Event|0|||
19759915|NCT03596762|42211849|FG004|Overall Study|Adverse Event|5|||
19759916|NCT03596762|42211845|FG000|Overall Study|Withdrawal by Subject|2|||
19759917|NCT03596762|42211846|FG001|Overall Study|Withdrawal by Subject|1|||
19759918|NCT03596762|42211847|FG002|Overall Study|Withdrawal by Subject|0|||
19759919|NCT03596762|42211848|FG003|Overall Study|Withdrawal by Subject|1|||
19677052|NCT00412737|42124792|FG000|Overall Study|Failure to Return|6|||
19677053|NCT00412737|42124793|FG001|Overall Study|Failure to Return|2|||
19677054|NCT00508742|42124801|FG000|Period 1: Infant Series|Adverse Event|5|||
19677055|NCT00508742|42124802|FG001|Period 1: Infant Series|Adverse Event|4|||
19677056|NCT00508742|42124801|FG000|Period 1: Infant Series|Protocol Violation|1|||
19677057|NCT00508742|42124802|FG001|Period 1: Infant Series|Protocol Violation|0|||
19677058|NCT00508742|42124801|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
19677059|NCT00508742|42124802|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
19677060|NCT00508742|42124801|FG000|Period 1: Infant Series|Physician Decision|1|||
19677061|NCT00508742|42124802|FG001|Period 1: Infant Series|Physician Decision|0|||
19677062|NCT00508742|42124801|FG000|Period 1: Infant Series|Other|4|||
19677063|NCT00508742|42124802|FG001|Period 1: Infant Series|Other|1|||
19677064|NCT00508742|42124801|FG000|Period 2: After Infant Series|Adverse Event|2|||
19677065|NCT00508742|42124802|FG001|Period 2: After Infant Series|Adverse Event|6|||
19677066|NCT00508742|42124801|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
19677067|NCT00508742|42124802|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
19677068|NCT00508742|42124801|FG000|Period 2: After Infant Series|Protocol Violation|1|||
19677069|NCT00508742|42124802|FG001|Period 2: After Infant Series|Protocol Violation|0|||
19677070|NCT00508742|42124801|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
19677071|NCT00508742|42124802|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
19677072|NCT00508742|42124801|FG000|Period 2: After Infant Series|Failed to Return|1|||
19677073|NCT00508742|42124802|FG001|Period 2: After Infant Series|Failed to Return|0|||
19677074|NCT00508742|42124801|FG000|Period 2: After Infant Series|Other|2|||
19677075|NCT00508742|42124802|FG001|Period 2: After Infant Series|Other|1|||
19677076|NCT00508742|42124801|FG000|Period 3: Toddler Dose|Adverse Event|1|||
19677077|NCT00508742|42124802|FG001|Period 3: Toddler Dose|Adverse Event|0|||
19677078|NCT00508742|42124801|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
19677079|NCT00508742|42124802|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
19677080|NCT00508742|42124801|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
19677081|NCT00508742|42124802|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
19677082|NCT00508742|42124801|FG000|Period 3: Toddler Dose|Other|5|||
19677083|NCT00508742|42124802|FG001|Period 3: Toddler Dose|Other|4|||
19677084|NCT00508274|42124823|FG000|Overall Study|Adverse Event|5|||
19677085|NCT00508274|42124823|FG000|Overall Study|Death|7|||
19677086|NCT00508274|42124823|FG000|Overall Study|Disease progression|32|||
19677087|NCT00508274|42124823|FG000|Overall Study|Withdrawal by Subject|1|||
19677088|NCT00508274|42124823|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
19677089|NCT00508274|42124823|FG000|Overall Study|Missing|3|||
19677090|NCT00499460|42124829|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
19677091|NCT00499460|42124830|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
19677092|NCT00499460|42124829|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
19677093|NCT00499460|42124830|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
19677094|NCT00499460|42124829|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
19677095|NCT00499460|42124830|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
19677096|NCT00412113|42124848|FG000|Overall Study|Adverse Event|11|||
19677097|NCT00412113|42124849|FG001|Overall Study|Adverse Event|15|||
19677098|NCT00412113|42124848|FG000|Overall Study|did not receive treatment|1|||
19677099|NCT00412113|42124849|FG001|Overall Study|did not receive treatment|0|||
19677100|NCT00411645|42124857|FG000|Overall Study|Consent Withdrawn|13|||
19677101|NCT00411645|42124858|FG001|Overall Study|Consent Withdrawn|22|||
19677102|NCT00411645|42124857|FG000|Overall Study|Death|56|||
19677103|NCT00411645|42124858|FG001|Overall Study|Death|135|||
19677104|NCT00411645|42124857|FG000|Overall Study|Investigator/Sponsor Decision|10|||
19677105|NCT00411645|42124858|FG001|Overall Study|Investigator/Sponsor Decision|7|||
19677106|NCT00411645|42124857|FG000|Overall Study|Lost to Follow-up|2|||
19677107|NCT00411645|42124858|FG001|Overall Study|Lost to Follow-up|0|||
19677108|NCT00490724|42124868|FG000|Period I|Physician Decision|0|||
19677109|NCT00490724|42124869|FG001|Period I|Physician Decision|0|||
19677110|NCT00490724|42124870|FG002|Period I|Physician Decision|1|||
19677111|NCT00490724|42124868|FG000|Period II|Treatment Discontinuation|3|||
19677112|NCT00490724|42124869|FG001|Period II|Treatment Discontinuation|1|||
19677113|NCT00490724|42124870|FG002|Period II|Treatment Discontinuation|3|||
19677114|NCT03835221|42124878|FG000|Methafilcon A|Withdrawal by Subject|1|||
19677115|NCT00398073|42124886|FG000|Overall Study|Withdrawal by Subject|1|||
19759920|NCT03596762|42211849|FG004|Overall Study|Withdrawal by Subject|1|||
19759921|NCT03663179|42211867|FG000|Overall Study|Withdrawal by Subject|2|||
19759922|NCT03663179|42211868|FG001|Overall Study|Withdrawal by Subject|0|||
19759923|NCT03663179|42211867|FG000|Overall Study|Lost to Follow-up|1|||
19759924|NCT03663179|42211868|FG001|Overall Study|Lost to Follow-up|1|||
19677116|NCT00398073|42124887|FG001|Overall Study|Withdrawal by Subject|0|||
19677117|NCT00490646|42124895|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
19677118|NCT00490646|42124896|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
19677119|NCT00490646|42124895|FG000|Overall Study|Never Treated (had an adverse event)|1|||
19677120|NCT00490646|42124896|FG001|Overall Study|Never Treated (had an adverse event)|0|||
19677121|NCT00490646|42124895|FG000|Overall Study|Never Treated (withdrew consent)|0|||
19677122|NCT00490646|42124896|FG001|Overall Study|Never Treated (withdrew consent)|1|||
19677123|NCT00388947|42124902|FG000|Overall Study|Protocol Violation|47|||
19799416|NCT02962739|42257486|FG001|Overall Study|Protocol Violation|0|||
19759925|NCT03663179|42211867|FG000|Overall Study|Revealed exclusionary condition|1|||
19759926|NCT03663179|42211868|FG001|Overall Study|Revealed exclusionary condition|0|||
19759927|NCT03662789|42211876|FG000|Overall Study|Lost to Follow-up|1|||
19759928|NCT03662789|42211877|FG001|Overall Study|Lost to Follow-up|2|||
19759929|NCT03662789|42211876|FG000|Overall Study|Could not perform treadmill test|4|||
19759930|NCT03662789|42211877|FG001|Overall Study|Could not perform treadmill test|4|||
19759931|NCT03662789|42211876|FG000|Overall Study|Death|0|||
19759932|NCT03662789|42211877|FG001|Overall Study|Death|1|||
19759933|NCT03658889|42211885|FG000|Overall Study|Protocol Violation|2|||
19759934|NCT03658889|42211886|FG001|Overall Study|Protocol Violation|0|||
19759935|NCT03655691|42211894|FG000|Overall Study|Adverse Event|0|||
19759936|NCT03655691|42211895|FG001|Overall Study|Adverse Event|0|||
19759937|NCT03655691|42211896|FG002|Overall Study|Adverse Event|1|||
19759938|NCT03655691|42211894|FG000|Overall Study|Lost to Follow-up|1|||
19759939|NCT03655691|42211895|FG001|Overall Study|Lost to Follow-up|1|||
19759940|NCT03655691|42211896|FG002|Overall Study|Lost to Follow-up|2|||
19759941|NCT03655691|42211894|FG000|Overall Study|Protocol Violation|0|||
19759942|NCT03655691|42211895|FG001|Overall Study|Protocol Violation|1|||
19759943|NCT03655691|42211896|FG002|Overall Study|Protocol Violation|0|||
19759944|NCT03655691|42211894|FG000|Overall Study|Withdrawal by Subject|1|||
19759945|NCT03655691|42211895|FG001|Overall Study|Withdrawal by Subject|1|||
19759946|NCT03655691|42211896|FG002|Overall Study|Withdrawal by Subject|0|||
19759947|NCT03658811|42211904|FG000|Overall Study|Lost to Follow-up|3|||
19759948|NCT03631355|42211914|FG000|Overall Study|Lost to Follow-up|1|||
19759949|NCT03631355|42211915|FG001|Overall Study|Lost to Follow-up|2|||
19759950|NCT03629249|42211924|FG000|Overall Study|Study terminated by sponsor|197|||
19759951|NCT03629249|42211925|FG001|Overall Study|Study terminated by sponsor|197|||
19759952|NCT03629249|42211926|FG002|Overall Study|Study terminated by sponsor|194|||
19759953|NCT03629249|42211924|FG000|Overall Study|Protocol deviation|0|||
19759954|NCT03629249|42211925|FG001|Overall Study|Protocol deviation|2|||
19759955|NCT03629249|42211926|FG002|Overall Study|Protocol deviation|5|||
19759956|NCT03629249|42211924|FG000|Overall Study|Subject decision|1|||
19759957|NCT03629249|42211925|FG001|Overall Study|Subject decision|1|||
19759958|NCT03629249|42211926|FG002|Overall Study|Subject decision|3|||
19759959|NCT03629249|42211924|FG000|Overall Study|Adverse Event|1|||
19759960|NCT03629249|42211925|FG001|Overall Study|Adverse Event|1|||
19759961|NCT03629249|42211926|FG002|Overall Study|Adverse Event|0|||
19759962|NCT03629249|42211924|FG000|Overall Study|Death|1|||
19759963|NCT03629249|42211925|FG001|Overall Study|Death|0|||
19759964|NCT03629249|42211926|FG002|Overall Study|Death|0|||
19759965|NCT03629249|42211924|FG000|Overall Study|Physician Decision|1|||
19759966|NCT03629249|42211925|FG001|Overall Study|Physician Decision|0|||
19759967|NCT03629249|42211926|FG002|Overall Study|Physician Decision|0|||
19759968|NCT03628781|42211936|FG000|Overall Study|Lost to Follow-up|16|||
19759969|NCT03628781|42211937|FG001|Overall Study|Lost to Follow-up|8|||
19759970|NCT03628781|42211936|FG000|Overall Study|Withdrawal by Subject|16|||
19759971|NCT03628781|42211937|FG001|Overall Study|Withdrawal by Subject|1|||
19759972|NCT03371251|42211949|FG000|Overall Study|Withdrawal by Subject|1|||
19759973|NCT03371251|42211950|FG001|Overall Study|Withdrawal by Subject|0|||
19759974|NCT03371251|42211951|FG002|Overall Study|Withdrawal by Subject|1|||
19759975|NCT03371251|42211952|FG003|Overall Study|Withdrawal by Subject|0|||
19759976|NCT03371251|42211953|FG004|Overall Study|Withdrawal by Subject|2|||
19759977|NCT03371251|42211954|FG005|Overall Study|Withdrawal by Subject|2|||
19759978|NCT03371251|42211949|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
19759979|NCT03371251|42211950|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
19677124|NCT00490568|42124906|FG000|Overall Study|Adverse Event|116|||
19677125|NCT00490568|42124906|FG000|Overall Study|Lost to Follow-up|13|||
19677126|NCT00490568|42124906|FG000|Overall Study|Protocol Violation|45|||
19677127|NCT00490568|42124906|FG000|Overall Study|Withdrawal by Subject|135|||
19677128|NCT00490568|42124906|FG000|Overall Study|Still in the study at termination|974|||
19677129|NCT00490568|42124906|FG000|Overall Study|Other|1|||
19677130|NCT00490568|42124906|FG000|Overall Study|Exclusion criteria met|1|||
19677131|NCT00490568|42124906|FG000|Overall Study|Caregiver related|20|||
19677132|NCT00490568|42124906|FG000|Overall Study|Abnormal ECG|25|||
19677133|NCT00490568|42124906|FG000|Overall Study|Participant refused follow-up|9|||
19677134|NCT00490568|42124906|FG000|Overall Study|Legal representative withdrew consent|1|||
19677135|NCT00490568|42124906|FG000|Overall Study|Disease progression|4|||
19677136|NCT00490568|42124906|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
19677137|NCT00490568|42124906|FG000|Overall Study|Investigator decision|3|||
19677138|NCT00490568|42124906|FG000|Overall Study|Non-Compliance|7|||
19677139|NCT00490568|42124906|FG000|Overall Study|Efficacy related|3|||
19677140|NCT00490568|42124906|FG000|Overall Study|Participant died|1|||
19759980|NCT03371251|42211951|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
19759981|NCT03371251|42211952|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
19759982|NCT03371251|42211953|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
19677141|NCT00490568|42124906|FG000|Overall Study|Participant withdrawal due to surgery|1|||
19677142|NCT00561353|42124921|FG000|Overall Study|Subject reached a virologic endpoint|2|||
19677143|NCT00561353|42124922|FG001|Overall Study|Subject reached a virologic endpoint|1|||
19677144|NCT00561353|42124923|FG002|Overall Study|Subject reached a virologic endpoint|1|||
19677145|NCT00561353|42124924|FG003|Overall Study|Subject reached a virologic endpoint|4|||
19677146|NCT00561353|42124925|FG004|Overall Study|Subject reached a virologic endpoint|1|||
19677147|NCT00561353|42124926|FG005|Overall Study|Subject reached a virologic endpoint|3|||
19677148|NCT00561353|42124927|FG006|Overall Study|Subject reached a virologic endpoint|4|||
19677149|NCT00561353|42124928|FG007|Overall Study|Subject reached a virologic endpoint|4|||
19677150|NCT00561353|42124929|FG008|Overall Study|Subject reached a virologic endpoint|5|||
19677151|NCT00561353|42124930|FG009|Overall Study|Subject reached a virologic endpoint|0|||
19677152|NCT00561353|42124921|FG000|Overall Study|Subject ineligible to continue the trial|0|||
19677153|NCT00561353|42124922|FG001|Overall Study|Subject ineligible to continue the trial|0|||
19677154|NCT00561353|42124923|FG002|Overall Study|Subject ineligible to continue the trial|0|||
19677155|NCT00561353|42124924|FG003|Overall Study|Subject ineligible to continue the trial|0|||
19677156|NCT00561353|42124925|FG004|Overall Study|Subject ineligible to continue the trial|0|||
19677157|NCT00561353|42124926|FG005|Overall Study|Subject ineligible to continue the trial|1|||
19677158|NCT00561353|42124927|FG006|Overall Study|Subject ineligible to continue the trial|1|||
19677159|NCT00561353|42124928|FG007|Overall Study|Subject ineligible to continue the trial|0|||
19677160|NCT00561353|42124929|FG008|Overall Study|Subject ineligible to continue the trial|2|||
19677161|NCT00561353|42124930|FG009|Overall Study|Subject ineligible to continue the trial|1|||
19677162|NCT00561353|42124921|FG000|Overall Study|Other|1|||
19677163|NCT00561353|42124922|FG001|Overall Study|Other|0|||
19677164|NCT00561353|42124923|FG002|Overall Study|Other|1|||
19677165|NCT00561353|42124924|FG003|Overall Study|Other|0|||
19677166|NCT00561353|42124925|FG004|Overall Study|Other|0|||
19677167|NCT00561353|42124926|FG005|Overall Study|Other|2|||
19677168|NCT00561353|42124927|FG006|Overall Study|Other|0|||
19677169|NCT00561353|42124928|FG007|Overall Study|Other|0|||
19677170|NCT00561353|42124929|FG008|Overall Study|Other|0|||
19677171|NCT00561353|42124930|FG009|Overall Study|Other|0|||
19677172|NCT00561353|42124921|FG000|Overall Study|Adverse Event|0|||
19677173|NCT00561353|42124922|FG001|Overall Study|Adverse Event|0|||
19677174|NCT00561353|42124923|FG002|Overall Study|Adverse Event|0|||
19677175|NCT00561353|42124924|FG003|Overall Study|Adverse Event|2|||
19677176|NCT00561353|42124925|FG004|Overall Study|Adverse Event|0|||
19677177|NCT00561353|42124926|FG005|Overall Study|Adverse Event|0|||
19677178|NCT00561353|42124927|FG006|Overall Study|Adverse Event|1|||
19677179|NCT00561353|42124928|FG007|Overall Study|Adverse Event|0|||
19677180|NCT00561353|42124929|FG008|Overall Study|Adverse Event|0|||
19677181|NCT00561353|42124930|FG009|Overall Study|Adverse Event|1|||
19677182|NCT00561353|42124921|FG000|Overall Study|Lost to Follow-up|2|||
19677183|NCT00561353|42124922|FG001|Overall Study|Lost to Follow-up|0|||
19677184|NCT00561353|42124923|FG002|Overall Study|Lost to Follow-up|1|||
19677185|NCT00561353|42124924|FG003|Overall Study|Lost to Follow-up|0|||
19677186|NCT00561353|42124925|FG004|Overall Study|Lost to Follow-up|0|||
19677187|NCT00561353|42124926|FG005|Overall Study|Lost to Follow-up|0|||
19677188|NCT00561353|42124927|FG006|Overall Study|Lost to Follow-up|0|||
19677189|NCT00561353|42124928|FG007|Overall Study|Lost to Follow-up|0|||
19677190|NCT00561353|42124929|FG008|Overall Study|Lost to Follow-up|0|||
19677191|NCT00561353|42124930|FG009|Overall Study|Lost to Follow-up|0|||
19677192|NCT00561353|42124921|FG000|Overall Study|Withdrawal by Subject|0|||
19677193|NCT00561353|42124922|FG001|Overall Study|Withdrawal by Subject|2|||
19677194|NCT00561353|42124923|FG002|Overall Study|Withdrawal by Subject|0|||
19677195|NCT00561353|42124924|FG003|Overall Study|Withdrawal by Subject|0|||
19677196|NCT00561353|42124925|FG004|Overall Study|Withdrawal by Subject|0|||
19677197|NCT00561353|42124926|FG005|Overall Study|Withdrawal by Subject|0|||
19677198|NCT00561353|42124927|FG006|Overall Study|Withdrawal by Subject|0|||
19677199|NCT00561353|42124928|FG007|Overall Study|Withdrawal by Subject|0|||
19677200|NCT00561353|42124929|FG008|Overall Study|Withdrawal by Subject|0|||
19677201|NCT00561353|42124930|FG009|Overall Study|Withdrawal by Subject|0|||
19677202|NCT00560885|42124997|FG000|Overall Study|Death|7|||
19677203|NCT00560885|42124997|FG000|Overall Study|Withdrawal by Subject|1|||
19677204|NCT00397215|42125005|FG000|Month 0 (Day 0)|Adverse Event|0|||
19677205|NCT00397215|42125006|FG001|Month 0 (Day 0)|Adverse Event|1|||
19677206|NCT00397215|42125007|FG002|Month 0 (Day 0)|Adverse Event|0|||
19677207|NCT00397215|42125008|FG003|Month 0 (Day 0)|Adverse Event|0|||
19677208|NCT00397215|42125005|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
19677209|NCT00397215|42125006|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
19677210|NCT00397215|42125007|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
19677211|NCT00397215|42125008|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
19677212|NCT00397215|42125005|FG000|Month 0 (Day 0)|Other|4|||
19677213|NCT00397215|42125006|FG001|Month 0 (Day 0)|Other|1|||
19677214|NCT00397215|42125007|FG002|Month 0 (Day 0)|Other|3|||
19677215|NCT00397215|42125008|FG003|Month 0 (Day 0)|Other|3|||
19677216|NCT00397215|42125005|FG000|Month 6 (Day 180)|Adverse Event|0|||
19677217|NCT00397215|42125006|FG001|Month 6 (Day 180)|Adverse Event|3|||
19677218|NCT00397215|42125007|FG002|Month 6 (Day 180)|Adverse Event|2|||
19677219|NCT00397215|42125008|FG003|Month 6 (Day 180)|Adverse Event|0|||
19677220|NCT00397215|42125005|FG000|Month 6 (Day 180)|Other|2|||
19677221|NCT00397215|42125006|FG001|Month 6 (Day 180)|Other|0|||
19677222|NCT00397215|42125007|FG002|Month 6 (Day 180)|Other|3|||
19677223|NCT00397215|42125008|FG003|Month 6 (Day 180)|Other|0|||
19677224|NCT00556439|42125025|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
19677225|NCT00556439|42125026|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
19677226|NCT00556439|42125027|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
19677227|NCT00556439|42125028|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
19677228|NCT00556439|42125025|FG000|Study Entry to Week 12|Physician Decision|1|||
19677229|NCT00556439|42125026|FG001|Study Entry to Week 12|Physician Decision|0|||
19677230|NCT00556439|42125027|FG002|Study Entry to Week 12|Physician Decision|0|||
19677231|NCT00556439|42125028|FG003|Study Entry to Week 12|Physician Decision|0|||
19677232|NCT00556439|42125025|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
19677233|NCT00556439|42125026|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
19677234|NCT00556439|42125027|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
19677235|NCT00556439|42125028|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
19677236|NCT00556439|42125025|FG000|Study Entry to Week 12|Recurrent infection|1|||
19677237|NCT00556439|42125026|FG001|Study Entry to Week 12|Recurrent infection|0|||
19677238|NCT00556439|42125027|FG002|Study Entry to Week 12|Recurrent infection|0|||
19677239|NCT00556439|42125028|FG003|Study Entry to Week 12|Recurrent infection|0|||
19677240|NCT00556439|42125025|FG000|Study Entry to Week 12|Malignancy|0|||
19677241|NCT00556439|42125026|FG001|Study Entry to Week 12|Malignancy|0|||
19677242|NCT00556439|42125027|FG002|Study Entry to Week 12|Malignancy|1|||
19677243|NCT00556439|42125028|FG003|Study Entry to Week 12|Malignancy|0|||
19677244|NCT00556439|42125025|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
19677245|NCT00556439|42125026|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
19677246|NCT00556439|42125027|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
19677247|NCT00556439|42125028|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
19677248|NCT00556439|42125025|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
19677249|NCT00556439|42125026|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
19677250|NCT00556439|42125027|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
19677251|NCT00556439|42125028|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
19677252|NCT00556439|42125025|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
19677253|NCT00556439|42125026|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
19677254|NCT00556439|42125027|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
19677255|NCT00556439|42125028|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
19677256|NCT00556439|42125025|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
19677257|NCT00556439|42125026|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
19677258|NCT00556439|42125027|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
19677259|NCT00556439|42125028|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
19677260|NCT00387465|42125041|FG000|Overall Study|Withdrawal by Subject|0|||
19677261|NCT00387465|42125042|FG001|Overall Study|Withdrawal by Subject|1|||
19677262|NCT00387465|42125043|FG002|Overall Study|Withdrawal by Subject|0|||
19677263|NCT00387153|42125060|FG000|Overall Study|Adverse Event|1|||
19677264|NCT00387153|42125060|FG000|Overall Study|Disease Progression|3|||
19677265|NCT00387153|42125060|FG000|Overall Study|Lack of Response|4|||
19677266|NCT00386607|42125064|FG000|Core|Adverse Event|40|||
19677267|NCT00386607|42125065|FG001|Core|Adverse Event|0|||
19677268|NCT00386607|42125064|FG000|Core|Abnormal laboratory value(s)|3|||
19677269|NCT00386607|42125065|FG001|Core|Abnormal laboratory value(s)|0|||
19677270|NCT00386607|42125064|FG000|Core|Unsatisfactory therapeutic effect|23|||
19677271|NCT00386607|42125065|FG001|Core|Unsatisfactory therapeutic effect|0|||
19677272|NCT00386607|42125064|FG000|Core|Condition no longer requires study drug|4|||
19677273|NCT00386607|42125065|FG001|Core|Condition no longer requires study drug|0|||
19677274|NCT00386607|42125064|FG000|Core|Patient withdrew consent|15|||
19677275|NCT00386607|42125065|FG001|Core|Patient withdrew consent|0|||
19677276|NCT00386607|42125064|FG000|Core|Lost to Follow-up|23|||
19677277|NCT00386607|42125065|FG001|Core|Lost to Follow-up|0|||
19677278|NCT00386607|42125064|FG000|Core|Administrative problems|1|||
19677279|NCT00386607|42125065|FG001|Core|Administrative problems|0|||
19677280|NCT00386607|42125064|FG000|Core|Protocol Deviation|6|||
19677281|NCT00386607|42125065|FG001|Core|Protocol Deviation|0|||
19677282|NCT00386607|42125064|FG000|Extension|Adverse Event|0|||
19677283|NCT00386607|42125065|FG001|Extension|Adverse Event|6|||
19677284|NCT00386607|42125064|FG000|Extension|Abnormal laboratory value(s)|0|||
19677285|NCT00386607|42125065|FG001|Extension|Abnormal laboratory value(s)|1|||
19677286|NCT00386607|42125064|FG000|Extension|Administrative problems|0|||
19677287|NCT00386607|42125065|FG001|Extension|Administrative problems|1|||
19677288|NCT00386607|42125064|FG000|Extension|Lost to Follow-up|0|||
19677289|NCT00386607|42125065|FG001|Extension|Lost to Follow-up|3|||
19677290|NCT00386607|42125064|FG000|Extension|Patient withdrew consent|0|||
19677291|NCT00386607|42125065|FG001|Extension|Patient withdrew consent|5|||
19677292|NCT00386607|42125064|FG000|Extension|Unsatisfactory therapeutic effect|0|||
19677293|NCT00386607|42125065|FG001|Extension|Unsatisfactory therapeutic effect|1|||
19677294|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
19677295|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
19677296|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
19677297|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
19677298|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
19677299|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
19677300|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
19677301|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
19677302|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
19677303|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
19677304|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
19677305|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
19677306|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
19677307|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
19677308|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
19677309|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
19677310|NCT00410163|42125079|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
19677311|NCT00410163|42125080|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
19677312|NCT00410163|42125079|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
19677313|NCT00410163|42125080|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
19677314|NCT00410163|42125079|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
19677315|NCT00410163|42125080|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
19677316|NCT00410163|42125079|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
19677317|NCT00410163|42125080|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
19677318|NCT00410163|42125079|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
19677319|NCT00410163|42125080|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
19677320|NCT00410163|42125079|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
19677321|NCT00410163|42125080|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
19677322|NCT00409617|42125116|FG000|Overall Study|Adverse Event|57|||
19677323|NCT00409617|42125116|FG000|Overall Study|Lack of Efficacy|54|||
19677324|NCT00409617|42125116|FG000|Overall Study|Lost to Follow-up|2|||
19759983|NCT03371251|42211954|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
19759984|NCT03371251|42211949|FG000|Overall Study|Adverse Event|0|||
19759985|NCT03371251|42211950|FG001|Overall Study|Adverse Event|0|||
19677325|NCT00409617|42125116|FG000|Overall Study|Protocol Violation|24|||
19677326|NCT00409617|42125116|FG000|Overall Study|Withdrawal by Subject|8|||
19677327|NCT00409617|42125116|FG000|Overall Study|Administrative reasons|1|||
19677328|NCT00409617|42125116|FG000|Overall Study|Not described|14|||
19677329|NCT00300274|42125123|FG000|Overall Study|Withdrawal by Subject|12|||
19677330|NCT00300274|42125124|FG001|Overall Study|Withdrawal by Subject|3|||
19677331|NCT00300274|42125125|FG002|Overall Study|Withdrawal by Subject|14|||
19677332|NCT00300274|42125123|FG000|Overall Study|Lost to Follow-up|3|||
19677333|NCT00300274|42125124|FG001|Overall Study|Lost to Follow-up|4|||
19677334|NCT00300274|42125125|FG002|Overall Study|Lost to Follow-up|5|||
19677335|NCT00300274|42125123|FG000|Overall Study|Death|31|||
19677336|NCT00300274|42125124|FG001|Overall Study|Death|20|||
19677337|NCT00300274|42125125|FG002|Overall Study|Death|25|||
19677338|NCT00300274|42125123|FG000|Overall Study|Re-transplant|0|||
19677339|NCT00300274|42125124|FG001|Overall Study|Re-transplant|0|||
19677340|NCT00300274|42125125|FG002|Overall Study|Re-transplant|1|||
19677341|NCT00299728|42125135|FG000|Overall Study|Lost to Follow-up|0|||
19677342|NCT00299728|42125136|FG001|Overall Study|Lost to Follow-up|1|||
19677343|NCT00299728|42125135|FG000|Overall Study|Withdrawal by Subject|0|||
19677344|NCT00299728|42125136|FG001|Overall Study|Withdrawal by Subject|1|||
19677345|NCT00299728|42125135|FG000|Overall Study|Progressive disease|0|||
19677346|NCT00299728|42125136|FG001|Overall Study|Progressive disease|1|||
19677347|NCT00396591|42125142|FG000|Overall Study|Disease Progression|13|||
19677348|NCT00396591|42125142|FG000|Overall Study|Adverse Event|2|||
19677349|NCT00396591|42125142|FG000|Overall Study|Participant request|1|||
19677350|NCT00316264|42125149|FG000|Overall Study|Lost to Follow-up|0|||
19759986|NCT03371251|42211951|FG002|Overall Study|Adverse Event|0|||
19759987|NCT03371251|42211952|FG003|Overall Study|Adverse Event|0|||
19677351|NCT00316264|42125150|FG001|Overall Study|Lost to Follow-up|1|||
19677352|NCT00316264|42125151|FG002|Overall Study|Lost to Follow-up|0|||
19677353|NCT00316264|42125149|FG000|Overall Study|Withdrawal of Consent|3|||
19677354|NCT00316264|42125150|FG001|Overall Study|Withdrawal of Consent|5|||
19677355|NCT00316264|42125151|FG002|Overall Study|Withdrawal of Consent|6|||
19677356|NCT00316264|42125149|FG000|Overall Study|Death|2|||
19677357|NCT00316264|42125150|FG001|Overall Study|Death|0|||
19677358|NCT00316264|42125151|FG002|Overall Study|Death|0|||
19677359|NCT00316264|42125149|FG000|Overall Study|Other|1|||
19677360|NCT00316264|42125150|FG001|Overall Study|Other|1|||
19677361|NCT00316264|42125151|FG002|Overall Study|Other|0|||
19677362|NCT00385827|42125162|FG000|Part 1|Adverse Event|1|||
19677363|NCT00385827|42125163|FG001|Part 1|Adverse Event|0|||
19677364|NCT00385827|42125164|FG002|Part 1|Adverse Event|0|||
19677365|NCT00385827|42125162|FG000|Part 1|Death|2|||
19677366|NCT00385827|42125163|FG001|Part 1|Death|0|||
19677367|NCT00385827|42125164|FG002|Part 1|Death|0|||
19677368|NCT00385827|42125162|FG000|Part 1|Lack of Efficacy|5|||
19677369|NCT00385827|42125163|FG001|Part 1|Lack of Efficacy|0|||
19677370|NCT00385827|42125164|FG002|Part 1|Lack of Efficacy|0|||
19677371|NCT00385827|42125162|FG000|Part 1|Other|1|||
19677372|NCT00385827|42125163|FG001|Part 1|Other|0|||
19677373|NCT00385827|42125164|FG002|Part 1|Other|0|||
19677374|NCT00385827|42125162|FG000|Part 2|Adverse Event|0|||
19677375|NCT00385827|42125163|FG001|Part 2|Adverse Event|6|||
19677376|NCT00385827|42125164|FG002|Part 2|Adverse Event|10|||
19677377|NCT00385827|42125162|FG000|Part 2|Death|0|||
19677378|NCT00385827|42125163|FG001|Part 2|Death|0|||
19677379|NCT00385827|42125164|FG002|Part 2|Death|2|||
19677380|NCT00385827|42125162|FG000|Part 2|Lack of Efficacy|0|||
19677381|NCT00385827|42125163|FG001|Part 2|Lack of Efficacy|14|||
19677382|NCT00385827|42125164|FG002|Part 2|Lack of Efficacy|13|||
19677383|NCT00385827|42125162|FG000|Part 2|Randomized but not treated|0|||
19677384|NCT00385827|42125163|FG001|Part 2|Randomized but not treated|2|||
19677385|NCT00385827|42125164|FG002|Part 2|Randomized but not treated|2|||
19677386|NCT00385827|42125162|FG000|Part 2|Other|0|||
19677387|NCT00385827|42125163|FG001|Part 2|Other|11|||
19677388|NCT00385827|42125164|FG002|Part 2|Other|21|||
19677389|NCT00498602|42125181|FG000|Overall Study|Death|0|||
19677390|NCT00498602|42125182|FG001|Overall Study|Death|0|||
19677391|NCT00498602|42125183|FG002|Overall Study|Death|0|||
19677392|NCT00498602|42125184|FG003|Overall Study|Death|0|||
19677393|NCT00498602|42125185|FG004|Overall Study|Death|0|||
19677394|NCT00498602|42125186|FG005|Overall Study|Death|1|||
19677395|NCT00498602|42125187|FG006|Overall Study|Death|0|||
19677396|NCT00498602|42125181|FG000|Overall Study|Lack of Efficacy|1|||
19677397|NCT00498602|42125182|FG001|Overall Study|Lack of Efficacy|0|||
19677398|NCT00498602|42125183|FG002|Overall Study|Lack of Efficacy|0|||
19677399|NCT00498602|42125184|FG003|Overall Study|Lack of Efficacy|0|||
19677400|NCT00498602|42125185|FG004|Overall Study|Lack of Efficacy|0|||
19677401|NCT00498602|42125186|FG005|Overall Study|Lack of Efficacy|0|||
19677402|NCT00498602|42125187|FG006|Overall Study|Lack of Efficacy|0|||
19677403|NCT00498602|42125181|FG000|Overall Study|Lost to Follow-up|0|||
19677404|NCT00498602|42125182|FG001|Overall Study|Lost to Follow-up|2|||
19677405|NCT00498602|42125183|FG002|Overall Study|Lost to Follow-up|0|||
19677406|NCT00498602|42125184|FG003|Overall Study|Lost to Follow-up|2|||
19677407|NCT00498602|42125185|FG004|Overall Study|Lost to Follow-up|0|||
19677408|NCT00498602|42125186|FG005|Overall Study|Lost to Follow-up|0|||
19677409|NCT00498602|42125187|FG006|Overall Study|Lost to Follow-up|0|||
19677410|NCT00498602|42125181|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
19677411|NCT00498602|42125182|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19677412|NCT00498602|42125183|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
19677413|NCT00498602|42125184|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
19677414|NCT00498602|42125185|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19677415|NCT00498602|42125186|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
19677416|NCT00498602|42125187|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19677417|NCT00498602|42125181|FG000|Overall Study|AE not related to Study Drug|1|||
19677418|NCT00498602|42125182|FG001|Overall Study|AE not related to Study Drug|3|||
19677419|NCT00498602|42125183|FG002|Overall Study|AE not related to Study Drug|0|||
19677420|NCT00498602|42125184|FG003|Overall Study|AE not related to Study Drug|0|||
19477168|NCT01513291|41756111|FG003|Treatment Period|Physician Decision|0|||
19677421|NCT00498602|42125185|FG004|Overall Study|AE not related to Study Drug|2|||
19677422|NCT00498602|42125186|FG005|Overall Study|AE not related to Study Drug|2|||
19677423|NCT00498602|42125187|FG006|Overall Study|AE not related to Study Drug|1|||
19677424|NCT00498602|42125181|FG000|Overall Study|Caregiver Request|2|||
19677425|NCT00498602|42125182|FG001|Overall Study|Caregiver Request|2|||
19677426|NCT00498602|42125183|FG002|Overall Study|Caregiver Request|2|||
19677427|NCT00498602|42125184|FG003|Overall Study|Caregiver Request|0|||
19677428|NCT00498602|42125185|FG004|Overall Study|Caregiver Request|1|||
19477169|NCT01513291|41756112|FG004|Treatment Period|Physician Decision|0|||
19677429|NCT00498602|42125186|FG005|Overall Study|Caregiver Request|2|||
19677430|NCT00498602|42125187|FG006|Overall Study|Caregiver Request|0|||
19677431|NCT00498602|42125181|FG000|Overall Study|Investigator Request|0|||
19677432|NCT00498602|42125182|FG001|Overall Study|Investigator Request|0|||
19677433|NCT00498602|42125183|FG002|Overall Study|Investigator Request|1|||
19677434|NCT00498602|42125184|FG003|Overall Study|Investigator Request|0|||
19677435|NCT00498602|42125185|FG004|Overall Study|Investigator Request|0|||
19677436|NCT00498602|42125186|FG005|Overall Study|Investigator Request|0|||
19677437|NCT00498602|42125187|FG006|Overall Study|Investigator Request|0|||
19677438|NCT00498602|42125181|FG000|Overall Study|Subject Request|3|||
19677439|NCT00498602|42125182|FG001|Overall Study|Subject Request|0|||
19677440|NCT00498602|42125183|FG002|Overall Study|Subject Request|1|||
19677441|NCT00498602|42125184|FG003|Overall Study|Subject Request|1|||
19677442|NCT00498602|42125185|FG004|Overall Study|Subject Request|1|||
19677443|NCT00498602|42125186|FG005|Overall Study|Subject Request|4|||
19677444|NCT00498602|42125187|FG006|Overall Study|Subject Request|1|||
19677445|NCT00498602|42125181|FG000|Overall Study|Other|2|||
19677446|NCT00498602|42125182|FG001|Overall Study|Other|3|||
19677447|NCT00498602|42125183|FG002|Overall Study|Other|1|||
19677448|NCT00498602|42125184|FG003|Overall Study|Other|0|||
19677449|NCT00498602|42125185|FG004|Overall Study|Other|0|||
19677450|NCT00498602|42125186|FG005|Overall Study|Other|3|||
19677451|NCT00498602|42125187|FG006|Overall Study|Other|0|||
19677452|NCT00507728|42125206|FG000|Randomization to Month 3|Lost to Follow-up|15|||
19677453|NCT00507728|42125207|FG001|Randomization to Month 3|Lost to Follow-up|14|||
19677454|NCT00507728|42125208|FG002|Randomization to Month 3|Lost to Follow-up|20|||
19677455|NCT00507728|42125206|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
19677456|NCT00507728|42125207|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
19677457|NCT00507728|42125208|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
19677458|NCT00498368|42125224|FG000|Overall Study|Withdrawal by Subject|3|||
19677459|NCT00498368|42125225|FG001|Overall Study|Withdrawal by Subject|2|||
19677460|NCT00385671|42125234|FG000|Overall Study|Adverse Event|14|||
19677461|NCT00385671|42125235|FG001|Overall Study|Adverse Event|27|||
19677462|NCT00385671|42125236|FG002|Overall Study|Adverse Event|18|||
19677463|NCT00385671|42125234|FG000|Overall Study|Lack of Efficacy|5|||
19677464|NCT00385671|42125235|FG001|Overall Study|Lack of Efficacy|9|||
19677465|NCT00385671|42125236|FG002|Overall Study|Lack of Efficacy|5|||
19677466|NCT00385671|42125234|FG000|Overall Study|Lost to Follow-up|6|||
19677467|NCT00385671|42125235|FG001|Overall Study|Lost to Follow-up|6|||
19677468|NCT00385671|42125236|FG002|Overall Study|Lost to Follow-up|5|||
19677469|NCT00385671|42125234|FG000|Overall Study|Physician Decision|2|||
19677470|NCT00385671|42125235|FG001|Overall Study|Physician Decision|1|||
19677471|NCT00385671|42125236|FG002|Overall Study|Physician Decision|2|||
19677472|NCT00385671|42125234|FG000|Overall Study|Protocol Violation|5|||
19677473|NCT00385671|42125235|FG001|Overall Study|Protocol Violation|2|||
19677474|NCT00385671|42125236|FG002|Overall Study|Protocol Violation|1|||
19677475|NCT00385671|42125234|FG000|Overall Study|Sponsor Decision|2|||
19677476|NCT00385671|42125235|FG001|Overall Study|Sponsor Decision|2|||
19677477|NCT00385671|42125236|FG002|Overall Study|Sponsor Decision|1|||
19677478|NCT00385671|42125234|FG000|Overall Study|Withdrawal by Subject|4|||
19677479|NCT00385671|42125235|FG001|Overall Study|Withdrawal by Subject|4|||
19677480|NCT00385671|42125236|FG002|Overall Study|Withdrawal by Subject|4|||
19677481|NCT00497198|42125248|FG000|Overall Study|Adverse Event|4|||
19677482|NCT00497198|42125249|FG001|Overall Study|Adverse Event|2|||
19677483|NCT00497198|42125248|FG000|Overall Study|Physician Decision|1|||
19677484|NCT00497198|42125249|FG001|Overall Study|Physician Decision|2|||
19677485|NCT00497198|42125248|FG000|Overall Study|Withdrawal by Subject|0|||
19677486|NCT00497198|42125249|FG001|Overall Study|Withdrawal by Subject|1|||
19677487|NCT00496964|42125257|FG000|Overall Study|Withdrawal by Subject|0|||
19677488|NCT00496964|42125258|FG001|Overall Study|Withdrawal by Subject|1|||
19677489|NCT00490490|42125266|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
19677490|NCT00490490|42125266|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
19677491|NCT00385593|42125272|FG000|Overall Study|Adverse Event|3|||
19677492|NCT00385593|42125273|FG001|Overall Study|Adverse Event|2|||
19677493|NCT00385593|42125272|FG000|Overall Study|Withdrawal by Subject|17|||
19677494|NCT00385593|42125273|FG001|Overall Study|Withdrawal by Subject|7|||
19677495|NCT00385593|42125272|FG000|Overall Study|Lost to Follow-up|12|||
19677496|NCT00385593|42125273|FG001|Overall Study|Lost to Follow-up|8|||
19677497|NCT00385593|42125272|FG000|Overall Study|Protocol Violation|7|||
19677498|NCT00385593|42125273|FG001|Overall Study|Protocol Violation|4|||
19677499|NCT00385593|42125272|FG000|Overall Study|Several reasons|17|||
19677500|NCT00385593|42125273|FG001|Overall Study|Several reasons|15|||
19677501|NCT00385593|42125272|FG000|Overall Study|Incorrect inclusion|2|||
19604232|NCT00751114|42053120|FG000|Overall Study|Lost to Follow-up|4|||
19604233|NCT00751114|42053121|FG001|Overall Study|Lost to Follow-up|7|||
19604234|NCT00751114|42053120|FG000|Overall Study|Lack of Efficacy|0|||
19604235|NCT00751114|42053121|FG001|Overall Study|Lack of Efficacy|7|||
19604236|NCT00751114|42053120|FG000|Overall Study|Not Treated|13|||
19604237|NCT00751114|42053121|FG001|Overall Study|Not Treated|1|||
19604238|NCT00751114|42053120|FG000|Overall Study|Out of country for 2 months|1|||
19604239|NCT00751114|42053121|FG001|Overall Study|Out of country for 2 months|0|||
19604240|NCT00751114|42053120|FG000|Overall Study|Move to another city|1|||
19604241|NCT00751114|42053121|FG001|Overall Study|Move to another city|0|||
19677502|NCT00385593|42125273|FG001|Overall Study|Incorrect inclusion|0|||
19677503|NCT00385593|42125272|FG000|Overall Study|Incorrect randomization|0|||
19677504|NCT00385593|42125273|FG001|Overall Study|Incorrect randomization|1|||
19677505|NCT00495794|42125281|FG000|Overall Study|Pharmacist did not activate patient|522|||
19604242|NCT00960440|42053131|FG000|Overall Study|Death|0|||
19604243|NCT00960440|42053132|FG001|Overall Study|Death|0|||
19604244|NCT00960440|42053133|FG002|Overall Study|Death|0|||
19604245|NCT00960440|42053134|FG003|Overall Study|Death|1|||
19604246|NCT00960440|42053131|FG000|Overall Study|Adverse Event|12|||
19604247|NCT00960440|42053132|FG001|Overall Study|Adverse Event|12|||
19604248|NCT00960440|42053133|FG002|Overall Study|Adverse Event|4|||
19604249|NCT00960440|42053134|FG003|Overall Study|Adverse Event|4|||
19604250|NCT00960440|42053131|FG000|Overall Study|Lack of Efficacy|2|||
19677506|NCT00495794|42125282|FG001|Overall Study|Pharmacist did not activate patient|0|||
19677507|NCT00495170|42125288|FG000|Overall Study|Lost to Follow-up|9|||
19677508|NCT00495170|42125288|FG000|Overall Study|Withdrawal by Subject|3|||
19677509|NCT00495170|42125288|FG000|Overall Study|Inappropriate staging|8|||
19677510|NCT03853148|42125296|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
19677511|NCT03853148|42125297|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
19759988|NCT03371251|42211953|FG004|Overall Study|Adverse Event|1|||
19759989|NCT03371251|42211954|FG005|Overall Study|Adverse Event|0|||
19677512|NCT03853148|42125298|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
19677513|NCT03853148|42125299|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
19677514|NCT00385203|42125311|FG000|Overall Study|Adverse Event|5|||
19677515|NCT00385203|42125312|FG001|Overall Study|Adverse Event|4|||
19677516|NCT00385203|42125311|FG000|Overall Study|Death|1|||
19677517|NCT00385203|42125312|FG001|Overall Study|Death|0|||
19677518|NCT00385203|42125311|FG000|Overall Study|Condition under investigation worsened|18|||
19677519|NCT00385203|42125312|FG001|Overall Study|Condition under investigation worsened|3|||
19677520|NCT00385203|42125311|FG000|Overall Study|Incorrect enrollment|2|||
19677521|NCT00385203|42125312|FG001|Overall Study|Incorrect enrollment|0|||
19677522|NCT00408993|42125321|FG000|Overall Study|Adverse Event|15|||
19677523|NCT00408993|42125322|FG001|Overall Study|Adverse Event|4|||
19677524|NCT00408993|42125321|FG000|Overall Study|Protocol Violation|1|||
19677525|NCT00408993|42125322|FG001|Overall Study|Protocol Violation|6|||
19677526|NCT00408993|42125321|FG000|Overall Study|Lack of Efficacy|1|||
19677527|NCT00408993|42125322|FG001|Overall Study|Lack of Efficacy|4|||
19677528|NCT00408993|42125321|FG000|Overall Study|Withdrawal by Subject|2|||
19677529|NCT00408993|42125322|FG001|Overall Study|Withdrawal by Subject|3|||
19677530|NCT00395967|42125332|FG000|Treatment Period|Failed Mobilization|1|||
19677531|NCT00395967|42125332|FG000|Follow-up Period|Death|1|||
19759990|NCT03371251|42211949|FG000|Overall Study|Decision by Sponsor|0|||
19759991|NCT03371251|42211950|FG001|Overall Study|Decision by Sponsor|0|||
19759992|NCT03371251|42211951|FG002|Overall Study|Decision by Sponsor|0|||
19759993|NCT03371251|42211952|FG003|Overall Study|Decision by Sponsor|0|||
19759994|NCT03371251|42211953|FG004|Overall Study|Decision by Sponsor|2|||
19759995|NCT03371251|42211954|FG005|Overall Study|Decision by Sponsor|0|||
19759996|NCT03370471|42211973|FG000|Overall Study|Withdrawal by Subject|6|||
19759997|NCT03370471|42211974|FG001|Overall Study|Withdrawal by Subject|1|||
19759998|NCT03370471|42211973|FG000|Overall Study|Unable to access veins for blood draw|0|||
19759999|NCT03370471|42211974|FG001|Overall Study|Unable to access veins for blood draw|1|||
19760000|NCT03370471|42211973|FG000|Overall Study|Screen fail|1|||
19760001|NCT03370471|42211974|FG001|Overall Study|Screen fail|0|||
19760002|NCT03349645|42211982|FG000|Overall Study|Sponsor Terminated Study|75|||
19760003|NCT03349645|42211982|FG000|Overall Study|Withdrawal by Subject|4|||
19760004|NCT03349645|42211982|FG000|Overall Study|Protocol Violation|1|||
19760005|NCT03349645|42211982|FG000|Overall Study|Other|2|||
19760006|NCT03349333|42211986|FG000|Overall Study|Progression of Disease|36|||
19760007|NCT03349333|42211986|FG000|Overall Study|Adverse Event|11|||
19760008|NCT03349333|42211986|FG000|Overall Study|Other|6|||
19760009|NCT03349333|42211986|FG000|Overall Study|Withdrawal by Subject|5|||
19760010|NCT03349333|42211986|FG000|Overall Study|Conditions interfere with participation|2|||
19760011|NCT03349333|42211986|FG000|Overall Study|Physician Decision|2|||
19760012|NCT03349333|42211986|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
19760013|NCT03349333|42211986|FG000|Overall Study|Patients in treatment less than 24 month|8|||
19760014|NCT03349099|42211992|FG000|Overall Study|Physician Decision|3|||
19760015|NCT03349099|42211993|FG001|Overall Study|Physician Decision|4|||
19760016|NCT03349099|42211992|FG000|Overall Study|Stone migrated from the kidney|1|||
19760017|NCT03349099|42211993|FG001|Overall Study|Stone migrated from the kidney|0|||
19760018|NCT03348163|42212001|FG000|Overall Study|Withdrawal by Subject|2|||
19760019|NCT03348163|42212002|FG001|Overall Study|Withdrawal by Subject|0|||
19760020|NCT03347695|42212010|FG000|Overall Study|Death|0|||
19677532|NCT00395967|42125332|FG000|Follow-up Period|Lost to Follow-up|1|||
19760021|NCT03347695|42212011|FG001|Overall Study|Death|4|||
19760022|NCT03347695|42212010|FG000|Overall Study|Lost to Follow-up|0|||
19760023|NCT03347695|42212011|FG001|Overall Study|Lost to Follow-up|1|||
19677533|NCT00395733|42125338|FG000|Period 2|Withdrawal by Subject|1|||
19760024|NCT02892019|42212021|FG000|Overall Study|randomized but not treated|0|||
19604251|NCT00960440|42053132|FG001|Overall Study|Lack of Efficacy|5|||
19760025|NCT02892019|42212022|FG001|Overall Study|randomized but not treated|1|||
19760026|NCT02892019|42212021|FG000|Overall Study|Withdrawal by Subject|0|||
19760027|NCT02892019|42212022|FG001|Overall Study|Withdrawal by Subject|1|||
19760028|NCT02892019|42212021|FG000|Overall Study|Adverse Event|1|||
19760029|NCT02892019|42212022|FG001|Overall Study|Adverse Event|1|||
19760030|NCT03365791|42212028|FG000|Overall Study|Adverse Event|5|||
19760031|NCT03365791|42212028|FG000|Overall Study|Death|1|||
19760032|NCT03365791|42212028|FG000|Overall Study|Lost to Follow-up|1|||
19760033|NCT03365791|42212028|FG000|Overall Study|Physician Decision|9|||
19760034|NCT03365791|42212028|FG000|Overall Study|Progressive disease|51|||
19760035|NCT03365791|42212028|FG000|Overall Study|Subject/guardian decision|5|||
19760036|NCT03365011|42212035|FG000|Overall Study|Withdrawal by Subject|1|||
19760037|NCT03365011|42212036|FG001|Overall Study|Withdrawal by Subject|2|||
19760038|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
19760039|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
19760040|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
19760041|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
19677534|NCT00395733|42125339|FG001|Period 2|Withdrawal by Subject|2|||
19677535|NCT00395733|42125338|FG000|Period 2|Protocol Violation|0|||
19677536|NCT00395733|42125339|FG001|Period 2|Protocol Violation|1|||
19677537|NCT00395733|42125338|FG000|Period 2|Adverse Event|0|||
19677538|NCT00395733|42125339|FG001|Period 2|Adverse Event|2|||
19677539|NCT00395733|42125338|FG000|Period 2|Technical problems|1|||
19677540|NCT00395733|42125339|FG001|Period 2|Technical problems|0|||
19677541|NCT00395343|42125347|FG000|Overall Study|Adverse Event|13|||
19677542|NCT00395343|42125348|FG001|Overall Study|Adverse Event|5|||
19677543|NCT00395343|42125347|FG000|Overall Study|Lack of Efficacy|0|||
19677544|NCT00395343|42125348|FG001|Overall Study|Lack of Efficacy|1|||
19677545|NCT00395343|42125347|FG000|Overall Study|Lost to Follow-up|4|||
19677546|NCT00395343|42125348|FG001|Overall Study|Lost to Follow-up|4|||
19677547|NCT00395343|42125347|FG000|Overall Study|Physician Decision|2|||
19677548|NCT00395343|42125348|FG001|Overall Study|Physician Decision|4|||
19677549|NCT00395343|42125347|FG000|Overall Study|Protocol Violation|6|||
19677550|NCT00395343|42125348|FG001|Overall Study|Protocol Violation|8|||
19677551|NCT00395343|42125347|FG000|Overall Study|Withdrawal by Subject|11|||
19677552|NCT00395343|42125348|FG001|Overall Study|Withdrawal by Subject|12|||
19677553|NCT00395343|42125347|FG000|Overall Study|Other|5|||
19677554|NCT00395343|42125348|FG001|Overall Study|Other|2|||
19677555|NCT00560573|42125354|FG000|Overall Study|Death|4|||
19677556|NCT00560573|42125355|FG001|Overall Study|Death|1|||
19677557|NCT00560573|42125356|FG002|Overall Study|Death|4|||
19677558|NCT00560573|42125357|FG003|Overall Study|Death|5|||
19677559|NCT00560573|42125358|FG004|Overall Study|Death|1|||
19677560|NCT00560573|42125359|FG005|Overall Study|Death|10|||
19677561|NCT00560573|42125354|FG000|Overall Study|Lost to Follow-up|0|||
19677562|NCT00560573|42125355|FG001|Overall Study|Lost to Follow-up|0|||
19677563|NCT00560573|42125356|FG002|Overall Study|Lost to Follow-up|0|||
19677564|NCT00560573|42125357|FG003|Overall Study|Lost to Follow-up|1|||
19677565|NCT00560573|42125358|FG004|Overall Study|Lost to Follow-up|1|||
19677566|NCT00560573|42125359|FG005|Overall Study|Lost to Follow-up|0|||
19677567|NCT00560573|42125354|FG000|Overall Study|Withdrawal by Subject|0|||
19677568|NCT00560573|42125355|FG001|Overall Study|Withdrawal by Subject|0|||
19677569|NCT00560573|42125356|FG002|Overall Study|Withdrawal by Subject|0|||
19677570|NCT00560573|42125357|FG003|Overall Study|Withdrawal by Subject|1|||
19677571|NCT00560573|42125358|FG004|Overall Study|Withdrawal by Subject|1|||
19677572|NCT00560573|42125359|FG005|Overall Study|Withdrawal by Subject|0|||
19677573|NCT00560573|42125354|FG000|Overall Study|Other|2|||
19677574|NCT00560573|42125355|FG001|Overall Study|Other|2|||
19677575|NCT00560573|42125356|FG002|Overall Study|Other|2|||
19677576|NCT00560573|42125357|FG003|Overall Study|Other|3|||
19677577|NCT00560573|42125358|FG004|Overall Study|Other|3|||
19677578|NCT00560573|42125359|FG005|Overall Study|Other|3|||
19677579|NCT00560573|42125354|FG000|Overall Study|Enrolled, not treated|0|||
19677580|NCT00560573|42125355|FG001|Overall Study|Enrolled, not treated|0|||
19760042|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
19760043|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
19760044|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
19760045|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
19389075|NCT02670551|41632644|FG002|Overall Study|Adverse Event|9|||
19677581|NCT00560573|42125356|FG002|Overall Study|Enrolled, not treated|0|||
19677582|NCT00560573|42125357|FG003|Overall Study|Enrolled, not treated|0|||
19760046|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
19760047|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
19677583|NCT00560573|42125358|FG004|Overall Study|Enrolled, not treated|1|||
19677584|NCT00560573|42125359|FG005|Overall Study|Enrolled, not treated|0|||
19677585|NCT03961529|42125392|FG000|Overall Study|Adverse Event|13|||
19677586|NCT03961529|42125393|FG001|Overall Study|Adverse Event|5|||
19677587|NCT03961529|42125394|FG002|Overall Study|Adverse Event|2|||
19677588|NCT03961529|42125392|FG000|Overall Study|Withdrawal by Subject|17|||
19760048|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
19760049|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
19760050|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
19760051|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
19760052|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
19760053|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
19760054|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
19760055|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
19760056|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
19760057|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
19760058|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
19760059|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
19760060|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
19760061|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
19760062|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
19760063|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
19760064|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
19760065|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
19760066|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
19760067|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
19760068|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
19760069|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
19760070|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
19760071|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
19760072|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
19760073|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
19760074|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
19760075|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
19760076|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
19677589|NCT03961529|42125393|FG001|Overall Study|Withdrawal by Subject|2|||
19677590|NCT03961529|42125394|FG002|Overall Study|Withdrawal by Subject|1|||
19677591|NCT03961529|42125392|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19677592|NCT03961529|42125393|FG001|Overall Study|Withdrawal by parent/guardian|7|||
19760077|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
19760078|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
19760079|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
19760080|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
19760081|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
19760082|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
19760083|NCT03627767|42212045|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
19760084|NCT03627767|42212046|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
19760085|NCT03627767|42212047|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
19760086|NCT03627767|42212048|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
19760087|NCT03627767|42212049|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
19760088|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
19760089|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
19760090|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
19760091|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
19760092|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
19760093|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19760094|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19760095|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
19760096|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
19760097|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
19760098|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
19760099|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
19677593|NCT03961529|42125394|FG002|Overall Study|Withdrawal by parent/guardian|0|||
19677594|NCT03961529|42125392|FG000|Overall Study|Physician Decision|2|||
19677595|NCT03961529|42125393|FG001|Overall Study|Physician Decision|1|||
19677596|NCT03961529|42125394|FG002|Overall Study|Physician Decision|1|||
19677597|NCT03961529|42125392|FG000|Overall Study|Lost to Follow-up|2|||
19677598|NCT03961529|42125393|FG001|Overall Study|Lost to Follow-up|1|||
19677599|NCT03961529|42125394|FG002|Overall Study|Lost to Follow-up|0|||
19677600|NCT03961529|42125392|FG000|Overall Study|Lack of Efficacy|2|||
19677601|NCT03961529|42125393|FG001|Overall Study|Lack of Efficacy|0|||
19677602|NCT03961529|42125394|FG002|Overall Study|Lack of Efficacy|1|||
19677603|NCT03961529|42125392|FG000|Overall Study|Other|6|||
19677604|NCT03961529|42125393|FG001|Overall Study|Other|1|||
19677605|NCT03961529|42125394|FG002|Overall Study|Other|0|||
19677606|NCT00494780|42125404|FG000|Overall Study|Adverse Event|1|||
19677607|NCT00494780|42125405|FG001|Overall Study|Adverse Event|0|||
19677608|NCT00494780|42125404|FG000|Overall Study|Withdrew before Dosed|0|||
19677609|NCT00494780|42125405|FG001|Overall Study|Withdrew before Dosed|1|||
19677610|NCT00494780|42125404|FG000|Overall Study|Progression of Study Disease|7|||
19677611|NCT00494780|42125405|FG001|Overall Study|Progression of Study Disease|8|||
19677612|NCT00494780|42125404|FG000|Overall Study|New Treatment|2|||
19677613|NCT00494780|42125405|FG001|Overall Study|New Treatment|2|||
19677614|NCT00494780|42125404|FG000|Overall Study|Non-compliance|1|||
19677615|NCT00494780|42125405|FG001|Overall Study|Non-compliance|0|||
19677616|NCT00494780|42125404|FG000|Overall Study|Residual Tumour Mass|0|||
19677617|NCT00494780|42125405|FG001|Overall Study|Residual Tumour Mass|1|||
19677618|NCT00494780|42125404|FG000|Overall Study|Insurance Issues|0|||
19677619|NCT00494780|42125405|FG001|Overall Study|Insurance Issues|1|||
19677620|NCT00490022|42125415|FG000|Overall Study|Adverse Event|0|||
19677621|NCT00490022|42125416|FG001|Overall Study|Adverse Event|2|||
19677622|NCT00490022|42125415|FG000|Overall Study|Withdrawal by Subject|1|||
19677623|NCT00490022|42125416|FG001|Overall Study|Withdrawal by Subject|0|||
19677624|NCT00490022|42125415|FG000|Overall Study|Subject failed to disclose concommitant|0|||
19677625|NCT00490022|42125416|FG001|Overall Study|Subject failed to disclose concommitant|1|||
19677626|NCT00493454|42125422|FG000|Overall Study|Withdrawal by Subject|1|||
19677627|NCT00493220|42125432|FG000|Third Intervention|Withdrawal by Subject|1|||
19760100|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
19760101|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
19760102|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
19760103|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
19760104|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
19760105|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
19677628|NCT00493220|42125433|FG001|Third Intervention|Withdrawal by Subject|0|||
19677629|NCT00493220|42125434|FG002|Third Intervention|Withdrawal by Subject|0|||
19760106|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
19760107|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
19760108|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
19760109|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
19760110|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
19760111|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
19760112|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
19677630|NCT00493220|42125435|FG003|Third Intervention|Withdrawal by Subject|0|||
19677631|NCT00493220|42125436|FG004|Third Intervention|Withdrawal by Subject|0|||
19677632|NCT00493220|42125437|FG005|Third Intervention|Withdrawal by Subject|0|||
19677633|NCT00394953|42125449|FG000|First Treatment Period|Adverse Event|1|||
19677634|NCT00394953|42125450|FG001|First Treatment Period|Adverse Event|2|||
19677635|NCT00394953|42125449|FG000|First Treatment Period|Death|6|||
19677636|NCT00394953|42125450|FG001|First Treatment Period|Death|7|||
19677637|NCT00394953|42125449|FG000|First Treatment Period|Lack of Efficacy|1|||
19677638|NCT00394953|42125450|FG001|First Treatment Period|Lack of Efficacy|1|||
19677639|NCT00394953|42125449|FG000|First Treatment Period|Withdrawal by Subject|6|||
19677640|NCT00394953|42125450|FG001|First Treatment Period|Withdrawal by Subject|3|||
19677641|NCT00394953|42125449|FG000|First Treatment Period|Lost to Follow-up|0|||
19677642|NCT00394953|42125450|FG001|First Treatment Period|Lost to Follow-up|1|||
19677643|NCT00394953|42125449|FG000|First Treatment Period|Renal transplant|11|||
19677644|NCT00394953|42125450|FG001|First Treatment Period|Renal transplant|7|||
19677645|NCT00394953|42125449|FG000|First Treatment Period|Not defined|4|||
19677646|NCT00394953|42125450|FG001|First Treatment Period|Not defined|1|||
19677647|NCT00394953|42125449|FG000|Second Treatment Period|Adverse Event|2|||
19677648|NCT00394953|42125450|FG001|Second Treatment Period|Adverse Event|5|||
19677649|NCT00394953|42125449|FG000|Second Treatment Period|Death|8|||
19677650|NCT00394953|42125450|FG001|Second Treatment Period|Death|4|||
19677651|NCT00394953|42125449|FG000|Second Treatment Period|Lack of Efficacy|9|||
19677652|NCT00394953|42125450|FG001|Second Treatment Period|Lack of Efficacy|47|||
19677653|NCT00394953|42125449|FG000|Second Treatment Period|Withdrawal by Subject|3|||
19677654|NCT00394953|42125450|FG001|Second Treatment Period|Withdrawal by Subject|3|||
19677655|NCT00394953|42125449|FG000|Second Treatment Period|Lost to Follow-up|0|||
19677656|NCT00394953|42125450|FG001|Second Treatment Period|Lost to Follow-up|1|||
19677657|NCT00394953|42125449|FG000|Second Treatment Period|Renal transplant|4|||
19677658|NCT00394953|42125450|FG001|Second Treatment Period|Renal transplant|6|||
19677659|NCT00394953|42125449|FG000|Second Treatment Period|Not defined|3|||
19677660|NCT00394953|42125450|FG001|Second Treatment Period|Not defined|8|||
19677661|NCT00485732|42125458|FG000|Overall Study|Protocol Violation|1|||
19677662|NCT00485732|42125459|FG001|Overall Study|Protocol Violation|3|||
19677663|NCT00485732|42125458|FG000|Overall Study|Withdrawal by Subject|5|||
19677664|NCT00485732|42125459|FG001|Overall Study|Withdrawal by Subject|4|||
19677665|NCT00485732|42125458|FG000|Overall Study|Lost to Follow-up|2|||
19677666|NCT00485732|42125459|FG001|Overall Study|Lost to Follow-up|2|||
19677667|NCT00489554|42125465|FG000|Overall Study|Adverse Event|2|||
19677668|NCT00489554|42125465|FG000|Overall Study|Withdrawal by Subject|1|||
19677669|NCT00489554|42125465|FG000|Overall Study|Lost to Follow-up|1|||
19677670|NCT00408681|42125469|FG000|Overall Study|Lack of Efficacy|2|||
19677671|NCT00408681|42125469|FG000|Overall Study|Adverse Event|7|||
19677672|NCT00560417|42125476|FG000|Overall Study|Adverse Event|3|||
19677673|NCT00560417|42125477|FG001|Overall Study|Adverse Event|2|||
19677674|NCT00560417|42125476|FG000|Overall Study|Entry Criteria Not Met|1|||
19677675|NCT00560417|42125477|FG001|Overall Study|Entry Criteria Not Met|0|||
19677676|NCT00560417|42125476|FG000|Overall Study|Lost to Follow-up|0|||
19677677|NCT00560417|42125477|FG001|Overall Study|Lost to Follow-up|1|||
19677678|NCT00560417|42125476|FG000|Overall Study|Physician Decision|2|||
19677679|NCT00560417|42125477|FG001|Overall Study|Physician Decision|6|||
19677680|NCT00560417|42125476|FG000|Overall Study|Protocol Violation|6|||
19677681|NCT00560417|42125477|FG001|Overall Study|Protocol Violation|5|||
19677682|NCT00560417|42125476|FG000|Overall Study|Sponsor Decision|2|||
19677683|NCT00560417|42125477|FG001|Overall Study|Sponsor Decision|0|||
19677684|NCT00560417|42125476|FG000|Overall Study|Withdrawal by Subject|3|||
19677685|NCT00560417|42125477|FG001|Overall Study|Withdrawal by Subject|3|||
19677686|NCT03968159|42125490|FG000|Overall Study|Adverse Event|4|||
19677687|NCT03968159|42125491|FG001|Overall Study|Adverse Event|4|||
19677688|NCT03968159|42125490|FG000|Overall Study|Lost to Follow-up|1|||
19677689|NCT03968159|42125491|FG001|Overall Study|Lost to Follow-up|1|||
19677690|NCT03968159|42125490|FG000|Overall Study|Use of prohibited medication|0|||
19677691|NCT03968159|42125491|FG001|Overall Study|Use of prohibited medication|1|||
19677692|NCT03968159|42125490|FG000|Overall Study|Protocol Violation|2|||
19677693|NCT03968159|42125491|FG001|Overall Study|Protocol Violation|2|||
19677694|NCT03968159|42125490|FG000|Overall Study|Withdrawal by Subject|4|||
19677695|NCT03968159|42125491|FG001|Overall Study|Withdrawal by Subject|6|||
19677696|NCT03968159|42125490|FG000|Overall Study|Lack of Efficacy|0|||
19677697|NCT03968159|42125491|FG001|Overall Study|Lack of Efficacy|1|||
19677698|NCT03968159|42125490|FG000|Overall Study|Not further specified|2|||
19677699|NCT03968159|42125491|FG001|Overall Study|Not further specified|0|||
19677700|NCT03966911|42125499|FG000|Overall Study|Adverse Event|1|||
19677701|NCT03966911|42125500|FG001|Overall Study|Adverse Event|1|||
19677702|NCT03966911|42125499|FG000|Overall Study|Withdrawal by Subject|8|||
19677703|NCT03966911|42125500|FG001|Overall Study|Withdrawal by Subject|2|||
19677704|NCT03966911|42125499|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
19677705|NCT03966911|42125500|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
19677706|NCT03966365|42125510|FG000|Overall Study|Protocol Violation|1|||
19677707|NCT03966365|42125511|FG001|Overall Study|Protocol Violation|0|||
19677708|NCT00375219|42125520|FG000|Overall Study|Failure to achieve a response|16|||
19677709|NCT00375219|42125521|FG001|Overall Study|Failure to achieve a response|2|||
19677710|NCT00375219|42125522|FG002|Overall Study|Failure to achieve a response|0|||
19677711|NCT00375219|42125520|FG000|Overall Study|Adverse Event|8|||
19677712|NCT00375219|42125521|FG001|Overall Study|Adverse Event|2|||
19677713|NCT00375219|42125522|FG002|Overall Study|Adverse Event|1|||
19677714|NCT00375219|42125520|FG000|Overall Study|Protocol Violation|1|||
19677715|NCT00375219|42125521|FG001|Overall Study|Protocol Violation|0|||
19677716|NCT00375219|42125522|FG002|Overall Study|Protocol Violation|1|||
19677717|NCT00375219|42125520|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
19677718|NCT00375219|42125521|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
19677719|NCT00375219|42125522|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
19677720|NCT00375219|42125520|FG000|Overall Study|Lost to Follow-up|1|||
19677721|NCT00375219|42125521|FG001|Overall Study|Lost to Follow-up|1|||
19677722|NCT00375219|42125522|FG002|Overall Study|Lost to Follow-up|0|||
19677723|NCT00375219|42125520|FG000|Overall Study|Disease progression|18|||
19677724|NCT00375219|42125521|FG001|Overall Study|Disease progression|9|||
19677725|NCT00375219|42125522|FG002|Overall Study|Disease progression|12|||
19677726|NCT00375219|42125520|FG000|Overall Study|Death|4|||
19677727|NCT00375219|42125521|FG001|Overall Study|Death|3|||
19677728|NCT00375219|42125522|FG002|Overall Study|Death|7|||
19677729|NCT00375219|42125520|FG000|Overall Study|Hematologic resistance|1|||
19677730|NCT00375219|42125521|FG001|Overall Study|Hematologic resistance|0|||
19677731|NCT00375219|42125522|FG002|Overall Study|Hematologic resistance|0|||
19677732|NCT00375219|42125520|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
19677733|NCT00375219|42125521|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
19677734|NCT00375219|42125522|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
19677735|NCT00375219|42125520|FG000|Overall Study|Allograft|2|||
19677736|NCT00375219|42125521|FG001|Overall Study|Allograft|0|||
19677737|NCT00375219|42125522|FG002|Overall Study|Allograft|0|||
19677738|NCT00375219|42125520|FG000|Overall Study|Cord blood transplantation|1|||
19677739|NCT00375219|42125521|FG001|Overall Study|Cord blood transplantation|0|||
19677740|NCT00375219|42125522|FG002|Overall Study|Cord blood transplantation|0|||
19677741|NCT00375219|42125520|FG000|Overall Study|Withdrawal by Subject|1|||
19677742|NCT00375219|42125521|FG001|Overall Study|Withdrawal by Subject|0|||
19677743|NCT00375219|42125522|FG002|Overall Study|Withdrawal by Subject|0|||
19677744|NCT03965351|42125531|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
19677745|NCT03965351|42125532|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
19677746|NCT03965351|42125531|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
19677747|NCT03965351|42125532|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
19677748|NCT00554801|42125540|FG000|Overall Study|left area before completion|5|||
19677749|NCT00554801|42125541|FG001|Overall Study|left area before completion|0|||
19677750|NCT00554801|42125540|FG000|Overall Study|Withdrawal by Subject|14|||
19677751|NCT00554801|42125541|FG001|Overall Study|Withdrawal by Subject|0|||
19677752|NCT00374907|42125551|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
19677753|NCT00374907|42125552|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
19677754|NCT00374907|42125551|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
19677755|NCT00374907|42125552|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
19760113|NCT03627767|42212045|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
19760114|NCT03627767|42212046|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
19760115|NCT03627767|42212047|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
19760116|NCT03627767|42212048|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
19677756|NCT00374907|42125551|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
19677757|NCT00374907|42125552|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
19677758|NCT00374907|42125551|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
19677759|NCT00374907|42125552|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
19677760|NCT00374907|42125551|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
19677761|NCT00374907|42125552|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
19677762|NCT00374127|42125560|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
19677763|NCT00374127|42125560|FG000|Overall Study|Blood could not be drawn.|2|||
19760117|NCT03627767|42212049|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
19760118|NCT03627767|42212045|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
19760119|NCT03627767|42212046|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
19760120|NCT03627767|42212047|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
19760121|NCT03627767|42212048|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
19760122|NCT03627767|42212049|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
19760123|NCT03627767|42212045|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
19760124|NCT03627767|42212046|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
19760125|NCT03627767|42212047|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
19760126|NCT03627767|42212048|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
19760127|NCT03627767|42212049|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
19760128|NCT03627767|42212045|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
19760129|NCT03627767|42212046|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
19760130|NCT03627767|42212047|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
19760131|NCT03627767|42212048|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
19760132|NCT03627767|42212049|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
19760133|NCT03627767|42212045|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
19760134|NCT03627767|42212046|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
19760135|NCT03627767|42212047|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
19760136|NCT03627767|42212048|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
19760137|NCT03627767|42212049|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
19760138|NCT03627065|42212060|FG000|Overall Study|Study Terminated by sponsor|1|||
19760139|NCT03627065|42212060|FG000|Overall Study|Withdrawal by Subject|2|||
19760140|NCT03624881|42212066|FG000|Overall Study|Screen Failure|14|||
19760141|NCT03624881|42212067|FG001|Overall Study|Screen Failure|0|||
19760142|NCT03624881|42212066|FG000|Overall Study|No Catheter Inserted|6|||
19760143|NCT03624881|42212067|FG001|Overall Study|No Catheter Inserted|1|||
19760144|NCT03624881|42212066|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
19760145|NCT03624881|42212067|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
19760146|NCT03624881|42212066|FG000|Overall Study|Death|2|||
19760147|NCT03624881|42212067|FG001|Overall Study|Death|0|||
19760148|NCT03624881|42212066|FG000|Overall Study|Lost to Follow-up|10|||
19760149|NCT03624881|42212067|FG001|Overall Study|Lost to Follow-up|4|||
19760150|NCT03624881|42212066|FG000|Overall Study|Withdrawal by Subject|12|||
19760151|NCT03624881|42212067|FG001|Overall Study|Withdrawal by Subject|1|||
19677764|NCT00374127|42125560|FG000|Overall Study|Protocol Violation|5|||
19677765|NCT00374127|42125560|FG000|Overall Study|Pregnancy|1|||
19677766|NCT00553787|42125573|FG000|Overall Study|Adverse Event|34|||
19677767|NCT00553787|42125574|FG001|Overall Study|Adverse Event|21|||
19760152|NCT02142738|42212075|FG000|Overall Study|Adverse Event|13|||
19760153|NCT02142738|42212076|FG001|Overall Study|Adverse Event|9|||
19760154|NCT02142738|42212075|FG000|Overall Study|Death|92|||
19760155|NCT02142738|42212076|FG001|Overall Study|Death|112|||
19760156|NCT02142738|42212075|FG000|Overall Study|Lost to Follow-up|0|||
19760157|NCT02142738|42212076|FG001|Overall Study|Lost to Follow-up|3|||
19760158|NCT02142738|42212075|FG000|Overall Study|Withdrawal by Subject|6|||
19760159|NCT02142738|42212076|FG001|Overall Study|Withdrawal by Subject|7|||
19760160|NCT02142738|42212075|FG000|Overall Study|Follow up ended by sponsor|43|||
19760161|NCT02142738|42212076|FG001|Overall Study|Follow up ended by sponsor|20|||
19760162|NCT03617861|42212087|FG000|Second Intervention (1 Day)|Adverse Event|0|||
19760163|NCT03617861|42212088|FG001|Second Intervention (1 Day)|Adverse Event|0|||
19760164|NCT03617861|42212089|FG002|Second Intervention (1 Day)|Adverse Event|1|||
19760165|NCT03617861|42212090|FG003|Second Intervention (1 Day)|Adverse Event|0|||
19760166|NCT03099096|42212100|FG000|Overall Study|Adverse Event|1|||
19760167|NCT03099096|42212100|FG000|Overall Study|Physician Decision|1|||
19760168|NCT03614975|42212106|FG000|Overall Study|Physician Decision|7|||
19760169|NCT03614975|42212107|FG001|Overall Study|Physician Decision|5|||
19760170|NCT03614975|42212106|FG000|Overall Study|Withdrawal by Subject|2|||
19760171|NCT03614975|42212107|FG001|Overall Study|Withdrawal by Subject|2|||
19760172|NCT03614975|42212106|FG000|Overall Study|Specimens not in lab batch shipment|1|||
19760173|NCT03614975|42212107|FG001|Overall Study|Specimens not in lab batch shipment|1|||
19760174|NCT03613649|42212125|FG000|Second Treatment|Lost to Follow-up|0|||
19760175|NCT03613649|42212126|FG001|Second Treatment|Lost to Follow-up|0|||
19760176|NCT03613649|42212127|FG002|Second Treatment|Lost to Follow-up|1|||
19760177|NCT03613649|42212128|FG003|Second Treatment|Lost to Follow-up|0|||
19760178|NCT03613649|42212129|FG004|Second Treatment|Lost to Follow-up|0|||
19760179|NCT03613649|42212130|FG005|Second Treatment|Lost to Follow-up|0|||
19677768|NCT00553787|42125575|FG002|Overall Study|Adverse Event|67|||
19677769|NCT00553787|42125573|FG000|Overall Study|Lost to Follow-up|132|||
19677770|NCT00553787|42125574|FG001|Overall Study|Lost to Follow-up|44|||
19677771|NCT00553787|42125575|FG002|Overall Study|Lost to Follow-up|78|||
19677772|NCT00553787|42125573|FG000|Overall Study|Withdrawal by Subject|151|||
19677773|NCT00553787|42125574|FG001|Overall Study|Withdrawal by Subject|40|||
19677774|NCT00553787|42125575|FG002|Overall Study|Withdrawal by Subject|83|||
19677775|NCT00553787|42125573|FG000|Overall Study|Lack of Efficacy|31|||
19677776|NCT00553787|42125574|FG001|Overall Study|Lack of Efficacy|1|||
19677777|NCT00553787|42125575|FG002|Overall Study|Lack of Efficacy|3|||
19677778|NCT00553787|42125573|FG000|Overall Study|Pregnancy|0|||
19677779|NCT00553787|42125574|FG001|Overall Study|Pregnancy|1|||
19677780|NCT00553787|42125575|FG002|Overall Study|Pregnancy|2|||
19677781|NCT00553787|42125573|FG000|Overall Study|non compliance|4|||
19677782|NCT00553787|42125574|FG001|Overall Study|non compliance|0|||
19677783|NCT00553787|42125575|FG002|Overall Study|non compliance|11|||
19677784|NCT00553787|42125573|FG000|Overall Study|Requirement for restricted medication|8|||
19677785|NCT00553787|42125574|FG001|Overall Study|Requirement for restricted medication|7|||
19677786|NCT00553787|42125575|FG002|Overall Study|Requirement for restricted medication|5|||
19677787|NCT00553787|42125573|FG000|Overall Study|Other|18|||
19677788|NCT00553787|42125574|FG001|Overall Study|Other|10|||
19677789|NCT00553787|42125575|FG002|Overall Study|Other|13|||
19677790|NCT00407745|42125585|FG000|Overall Study|Lack of Efficacy|1|||
19677791|NCT00407745|42125586|FG001|Overall Study|Lack of Efficacy|2|||
19760180|NCT03613649|42212131|FG006|Second Treatment|Lost to Follow-up|0|||
19760181|NCT03613649|42212132|FG007|Second Treatment|Lost to Follow-up|0|||
19760182|NCT03613649|42212133|FG008|Second Treatment|Lost to Follow-up|0|||
19677792|NCT00407745|42125585|FG000|Overall Study|Withdrawal by Subject|3|||
19677793|NCT00407745|42125586|FG001|Overall Study|Withdrawal by Subject|3|||
19677794|NCT00407745|42125585|FG000|Overall Study|Protocol Violation|5|||
19677795|NCT00407745|42125586|FG001|Overall Study|Protocol Violation|3|||
19677796|NCT00407745|42125585|FG000|Overall Study|Adverse Event|8|||
19677797|NCT00407745|42125586|FG001|Overall Study|Adverse Event|8|||
19677798|NCT00407745|42125585|FG000|Overall Study|Other|2|||
19677799|NCT00407745|42125586|FG001|Overall Study|Other|0|||
19760183|NCT03613649|42212134|FG009|Second Treatment|Lost to Follow-up|0|||
19677800|NCT00407745|42125585|FG000|Overall Study|Randomized, unknown if treated|0|||
19677801|NCT00407745|42125586|FG001|Overall Study|Randomized, unknown if treated|1|||
19677802|NCT03958955|42125592|FG000|Overall Study|Adverse Event|1|||
19677803|NCT00464334|42125609|FG000|Overall Study|Adverse Event|0|||
19677804|NCT00464334|42125610|FG001|Overall Study|Adverse Event|0|||
19677805|NCT00464334|42125611|FG002|Overall Study|Adverse Event|0|||
19677806|NCT00464334|42125612|FG003|Overall Study|Adverse Event|1|||
19677807|NCT00464334|42125613|FG004|Overall Study|Adverse Event|1|||
19677808|NCT00464334|42125614|FG005|Overall Study|Adverse Event|1|||
19677809|NCT00464334|42125615|FG006|Overall Study|Adverse Event|0|||
19677810|NCT00464334|42125616|FG007|Overall Study|Adverse Event|0|||
19677811|NCT00464334|42125617|FG008|Overall Study|Adverse Event|2|||
19677812|NCT00464334|42125618|FG009|Overall Study|Adverse Event|1|||
19760184|NCT03613649|42212135|FG010|Second Treatment|Lost to Follow-up|0|||
19799417|NCT02962739|42257487|FG002|Overall Study|Protocol Violation|1|||
19677813|NCT00464334|42125619|FG010|Overall Study|Adverse Event|2|||
19677814|NCT00464334|42125609|FG000|Overall Study|Lack of Efficacy|0|||
19677815|NCT00464334|42125610|FG001|Overall Study|Lack of Efficacy|1|||
19677816|NCT00464334|42125611|FG002|Overall Study|Lack of Efficacy|0|||
19677817|NCT00464334|42125612|FG003|Overall Study|Lack of Efficacy|0|||
19677818|NCT00464334|42125613|FG004|Overall Study|Lack of Efficacy|0|||
19677819|NCT00464334|42125614|FG005|Overall Study|Lack of Efficacy|0|||
19677820|NCT00464334|42125615|FG006|Overall Study|Lack of Efficacy|0|||
19677821|NCT00464334|42125616|FG007|Overall Study|Lack of Efficacy|0|||
19677822|NCT00464334|42125617|FG008|Overall Study|Lack of Efficacy|0|||
19677823|NCT00464334|42125618|FG009|Overall Study|Lack of Efficacy|0|||
19677824|NCT00464334|42125619|FG010|Overall Study|Lack of Efficacy|0|||
19677825|NCT00464334|42125609|FG000|Overall Study|Lost to Follow-up|0|||
19677826|NCT00464334|42125610|FG001|Overall Study|Lost to Follow-up|0|||
19677827|NCT00464334|42125611|FG002|Overall Study|Lost to Follow-up|1|||
19677828|NCT00464334|42125612|FG003|Overall Study|Lost to Follow-up|0|||
19677829|NCT00464334|42125613|FG004|Overall Study|Lost to Follow-up|1|||
19677830|NCT00464334|42125614|FG005|Overall Study|Lost to Follow-up|0|||
19677831|NCT00464334|42125615|FG006|Overall Study|Lost to Follow-up|1|||
19677832|NCT00464334|42125616|FG007|Overall Study|Lost to Follow-up|0|||
19677833|NCT00464334|42125617|FG008|Overall Study|Lost to Follow-up|0|||
19677834|NCT00464334|42125618|FG009|Overall Study|Lost to Follow-up|0|||
19677835|NCT00464334|42125619|FG010|Overall Study|Lost to Follow-up|2|||
19677836|NCT00464334|42125609|FG000|Overall Study|Progressive Disease|0|||
19677837|NCT00464334|42125610|FG001|Overall Study|Progressive Disease|0|||
19677838|NCT00464334|42125611|FG002|Overall Study|Progressive Disease|0|||
19677839|NCT00464334|42125612|FG003|Overall Study|Progressive Disease|0|||
19677840|NCT00464334|42125613|FG004|Overall Study|Progressive Disease|0|||
19677841|NCT00464334|42125614|FG005|Overall Study|Progressive Disease|1|||
19677842|NCT00464334|42125615|FG006|Overall Study|Progressive Disease|0|||
19677843|NCT00464334|42125616|FG007|Overall Study|Progressive Disease|0|||
19677844|NCT00464334|42125617|FG008|Overall Study|Progressive Disease|1|||
19677845|NCT00464334|42125618|FG009|Overall Study|Progressive Disease|0|||
19677846|NCT00464334|42125619|FG010|Overall Study|Progressive Disease|0|||
19677847|NCT00464334|42125609|FG000|Overall Study|Study Terminated by Sponsor|0|||
19677848|NCT00464334|42125610|FG001|Overall Study|Study Terminated by Sponsor|0|||
19677849|NCT00464334|42125611|FG002|Overall Study|Study Terminated by Sponsor|0|||
19677850|NCT00464334|42125612|FG003|Overall Study|Study Terminated by Sponsor|1|||
19677851|NCT00464334|42125613|FG004|Overall Study|Study Terminated by Sponsor|0|||
19677852|NCT00464334|42125614|FG005|Overall Study|Study Terminated by Sponsor|0|||
19677853|NCT00464334|42125615|FG006|Overall Study|Study Terminated by Sponsor|0|||
19677854|NCT00464334|42125616|FG007|Overall Study|Study Terminated by Sponsor|0|||
19677855|NCT00464334|42125617|FG008|Overall Study|Study Terminated by Sponsor|0|||
19677856|NCT00464334|42125618|FG009|Overall Study|Study Terminated by Sponsor|0|||
19677857|NCT00464334|42125619|FG010|Overall Study|Study Terminated by Sponsor|0|||
19677858|NCT00464334|42125609|FG000|Overall Study|Withdrawal by Subject|1|||
19677859|NCT00464334|42125610|FG001|Overall Study|Withdrawal by Subject|7|||
19677860|NCT00464334|42125611|FG002|Overall Study|Withdrawal by Subject|4|||
19677861|NCT00464334|42125612|FG003|Overall Study|Withdrawal by Subject|2|||
19677862|NCT00464334|42125613|FG004|Overall Study|Withdrawal by Subject|2|||
19677863|NCT00464334|42125614|FG005|Overall Study|Withdrawal by Subject|2|||
19677864|NCT00464334|42125615|FG006|Overall Study|Withdrawal by Subject|2|||
19677865|NCT00464334|42125616|FG007|Overall Study|Withdrawal by Subject|1|||
19677866|NCT00464334|42125617|FG008|Overall Study|Withdrawal by Subject|3|||
19677867|NCT00464334|42125618|FG009|Overall Study|Withdrawal by Subject|0|||
19677868|NCT00464334|42125619|FG010|Overall Study|Withdrawal by Subject|0|||
19677869|NCT00299494|42125660|FG000|Overall Study|Withdrawal by Subject|0|||
19677870|NCT00299494|42125661|FG001|Overall Study|Withdrawal by Subject|0|||
19677871|NCT00299494|42125662|FG002|Overall Study|Withdrawal by Subject|0|||
19677872|NCT00299494|42125663|FG003|Overall Study|Withdrawal by Subject|3|||
19677873|NCT00299494|42125664|FG004|Overall Study|Withdrawal by Subject|1|||
19677874|NCT00299494|42125665|FG005|Overall Study|Withdrawal by Subject|4|||
19677875|NCT00299494|42125660|FG000|Overall Study|Physician Decision|0|||
19677876|NCT00299494|42125661|FG001|Overall Study|Physician Decision|0|||
19677877|NCT00299494|42125662|FG002|Overall Study|Physician Decision|0|||
19677878|NCT00299494|42125663|FG003|Overall Study|Physician Decision|0|||
19677879|NCT00299494|42125664|FG004|Overall Study|Physician Decision|1|||
19677880|NCT00299494|42125665|FG005|Overall Study|Physician Decision|0|||
19677881|NCT00299494|42125660|FG000|Overall Study|Death|3|||
19677882|NCT00299494|42125661|FG001|Overall Study|Death|1|||
19677883|NCT00299494|42125662|FG002|Overall Study|Death|4|||
19677884|NCT00299494|42125663|FG003|Overall Study|Death|6|||
19677885|NCT00299494|42125664|FG004|Overall Study|Death|18|||
19677886|NCT00299494|42125665|FG005|Overall Study|Death|19|||
19677887|NCT00299494|42125660|FG000|Overall Study|Lost to Follow-up|0|||
19677888|NCT00299494|42125661|FG001|Overall Study|Lost to Follow-up|0|||
19677889|NCT00299494|42125662|FG002|Overall Study|Lost to Follow-up|0|||
19677890|NCT00299494|42125663|FG003|Overall Study|Lost to Follow-up|0|||
19677891|NCT00299494|42125664|FG004|Overall Study|Lost to Follow-up|3|||
19677892|NCT00299494|42125665|FG005|Overall Study|Lost to Follow-up|1|||
19677893|NCT00299494|42125660|FG000|Overall Study|Other - Unspecified|0|||
19677894|NCT00299494|42125661|FG001|Overall Study|Other - Unspecified|0|||
19677895|NCT00299494|42125662|FG002|Overall Study|Other - Unspecified|0|||
19677896|NCT00299494|42125663|FG003|Overall Study|Other - Unspecified|0|||
19677897|NCT00299494|42125664|FG004|Overall Study|Other - Unspecified|3|||
19677898|NCT00299494|42125665|FG005|Overall Study|Other - Unspecified|1|||
19677899|NCT00299494|42125660|FG000|Overall Study|Other - site closure|0|||
19677900|NCT00299494|42125661|FG001|Overall Study|Other - site closure|0|||
19760185|NCT03613649|42212136|FG011|Second Treatment|Lost to Follow-up|0|||
19760186|NCT03613649|42212125|FG000|Second Treatment|Withdrawal by Subject|0|||
19760187|NCT03613649|42212126|FG001|Second Treatment|Withdrawal by Subject|0|||
19677901|NCT00299494|42125662|FG002|Overall Study|Other - site closure|0|||
19677902|NCT00299494|42125663|FG003|Overall Study|Other - site closure|1|||
19677903|NCT00299494|42125664|FG004|Overall Study|Other - site closure|1|||
19677904|NCT00299494|42125665|FG005|Overall Study|Other - site closure|1|||
19677905|NCT00453180|42125692|FG000|Overall Study|Lost to Follow-up|2|||
19677906|NCT00453180|42125693|FG001|Overall Study|Lost to Follow-up|1|||
19677907|NCT00453180|42125692|FG000|Overall Study|Adverse Event|1|||
19677908|NCT00453180|42125693|FG001|Overall Study|Adverse Event|2|||
19677909|NCT00464178|42125699|FG000|Overall Study|Protocol Violation|1|||
19677910|NCT00464178|42125699|FG000|Overall Study|Withdrawal by Subject|1|||
19677911|NCT00560105|42125706|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
19677912|NCT00560105|42125707|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
19677913|NCT00467610|42125713|FG000|Overall Study|Withdrawal by Subject|1|||
19677914|NCT00316186|42125717|FG000|Overall Study|Adverse Event|6|||
19677915|NCT00316186|42125717|FG000|Overall Study|Disease Progression|4|||
19677916|NCT00316186|42125717|FG000|Overall Study|Lost to Follow-up|1|||
19677917|NCT00316186|42125717|FG000|Overall Study|Other|1|||
19677918|NCT00453102|42125721|FG000|Overall Study|Withdrawal by Subject|2|||
19677919|NCT00299182|42125732|FG000|Overall Study|Withdrawal by Subject|0|||
19677920|NCT00299182|42125733|FG001|Overall Study|Withdrawal by Subject|0|||
19677921|NCT00299182|42125734|FG002|Overall Study|Withdrawal by Subject|1|||
19677922|NCT00299182|42125735|FG003|Overall Study|Withdrawal by Subject|0|||
19677923|NCT00299182|42125736|FG004|Overall Study|Withdrawal by Subject|1|||
19677924|NCT00299182|42125737|FG005|Overall Study|Withdrawal by Subject|2|||
19760188|NCT03613649|42212127|FG002|Second Treatment|Withdrawal by Subject|0|||
19760189|NCT03613649|42212128|FG003|Second Treatment|Withdrawal by Subject|0|||
19677925|NCT00299182|42125738|FG006|Overall Study|Withdrawal by Subject|0|||
19677926|NCT00299182|42125732|FG000|Overall Study|Chemotherapy Changed|0|||
19677927|NCT00299182|42125733|FG001|Overall Study|Chemotherapy Changed|0|||
19677928|NCT00299182|42125734|FG002|Overall Study|Chemotherapy Changed|1|||
19677929|NCT00299182|42125735|FG003|Overall Study|Chemotherapy Changed|0|||
19677930|NCT00299182|42125736|FG004|Overall Study|Chemotherapy Changed|1|||
19677931|NCT00299182|42125737|FG005|Overall Study|Chemotherapy Changed|0|||
19677932|NCT00299182|42125738|FG006|Overall Study|Chemotherapy Changed|1|||
19677933|NCT00299182|42125732|FG000|Overall Study|Adverse Event|0|||
19677934|NCT00299182|42125733|FG001|Overall Study|Adverse Event|0|||
19760190|NCT03613649|42212129|FG004|Second Treatment|Withdrawal by Subject|1|||
19760191|NCT03613649|42212130|FG005|Second Treatment|Withdrawal by Subject|0|||
19760192|NCT03613649|42212131|FG006|Second Treatment|Withdrawal by Subject|0|||
19760193|NCT03613649|42212132|FG007|Second Treatment|Withdrawal by Subject|0|||
19760194|NCT03613649|42212133|FG008|Second Treatment|Withdrawal by Subject|0|||
19760195|NCT03613649|42212134|FG009|Second Treatment|Withdrawal by Subject|0|||
19760196|NCT03613649|42212135|FG010|Second Treatment|Withdrawal by Subject|0|||
19760197|NCT03613649|42212136|FG011|Second Treatment|Withdrawal by Subject|0|||
19760198|NCT03613649|42212125|FG000|Third Treatment|Lost to Follow-up|0|||
19760199|NCT03613649|42212126|FG001|Third Treatment|Lost to Follow-up|0|||
19760200|NCT03613649|42212127|FG002|Third Treatment|Lost to Follow-up|0|||
19760201|NCT03613649|42212128|FG003|Third Treatment|Lost to Follow-up|0|||
19477170|NCT01513291|41756108|FG000|Treatment Period|Protocol Violation|1|||
19677935|NCT00299182|42125734|FG002|Overall Study|Adverse Event|0|||
19677936|NCT00299182|42125735|FG003|Overall Study|Adverse Event|0|||
19677937|NCT00299182|42125736|FG004|Overall Study|Adverse Event|0|||
19760202|NCT03613649|42212129|FG004|Third Treatment|Lost to Follow-up|1|||
19760203|NCT03613649|42212130|FG005|Third Treatment|Lost to Follow-up|0|||
19760204|NCT03613649|42212131|FG006|Third Treatment|Lost to Follow-up|0|||
19760205|NCT03613649|42212132|FG007|Third Treatment|Lost to Follow-up|0|||
19760206|NCT03613649|42212133|FG008|Third Treatment|Lost to Follow-up|0|||
19760207|NCT03613649|42212134|FG009|Third Treatment|Lost to Follow-up|0|||
19760208|NCT03613649|42212135|FG010|Third Treatment|Lost to Follow-up|0|||
19760209|NCT03613649|42212136|FG011|Third Treatment|Lost to Follow-up|1|||
19677938|NCT00299182|42125737|FG005|Overall Study|Adverse Event|1|||
19677939|NCT00299182|42125738|FG006|Overall Study|Adverse Event|0|||
19677940|NCT00299182|42125732|FG000|Overall Study|Not Eligible|0|||
19677941|NCT00299182|42125733|FG001|Overall Study|Not Eligible|0|||
19677942|NCT00299182|42125734|FG002|Overall Study|Not Eligible|0|||
19760210|NCT03613649|42212125|FG000|Third Treatment|Protocol Violation|0|||
19760211|NCT03613649|42212126|FG001|Third Treatment|Protocol Violation|0|||
19760212|NCT03613649|42212127|FG002|Third Treatment|Protocol Violation|0|||
19760213|NCT03613649|42212128|FG003|Third Treatment|Protocol Violation|0|||
19760214|NCT03613649|42212129|FG004|Third Treatment|Protocol Violation|0|||
19760215|NCT03613649|42212130|FG005|Third Treatment|Protocol Violation|0|||
19760216|NCT03613649|42212131|FG006|Third Treatment|Protocol Violation|1|||
19760217|NCT03613649|42212132|FG007|Third Treatment|Protocol Violation|0|||
19760218|NCT03613649|42212133|FG008|Third Treatment|Protocol Violation|0|||
19760219|NCT03613649|42212134|FG009|Third Treatment|Protocol Violation|0|||
19760220|NCT03613649|42212135|FG010|Third Treatment|Protocol Violation|0|||
19760221|NCT03613649|42212136|FG011|Third Treatment|Protocol Violation|1|||
19760222|NCT03613649|42212125|FG000|Fourth Treatment|Protocol Violation|1|||
19760223|NCT03613649|42212126|FG001|Fourth Treatment|Protocol Violation|0|||
19760224|NCT03613649|42212127|FG002|Fourth Treatment|Protocol Violation|0|||
19760225|NCT03613649|42212128|FG003|Fourth Treatment|Protocol Violation|0|||
19760226|NCT03613649|42212129|FG004|Fourth Treatment|Protocol Violation|1|||
19677943|NCT00299182|42125735|FG003|Overall Study|Not Eligible|0|||
19677944|NCT00299182|42125736|FG004|Overall Study|Not Eligible|1|||
19677945|NCT00299182|42125737|FG005|Overall Study|Not Eligible|0|||
19677946|NCT00299182|42125738|FG006|Overall Study|Not Eligible|0|||
19677947|NCT00467142|42125756|FG000|Overall Study|Withdrawal by Subject|1|||
19677948|NCT00467142|42125756|FG000|Overall Study|Adverse Event|1|||
19677949|NCT00467142|42125756|FG000|Overall Study|Protocol Violation|1|||
19677950|NCT00553475|42125763|FG000|Overall Study|Adverse Event|7|||
19677951|NCT00553475|42125764|FG001|Overall Study|Adverse Event|17|||
19677952|NCT00553475|42125765|FG002|Overall Study|Adverse Event|13|||
19677953|NCT00553475|42125763|FG000|Overall Study|Lack of Efficacy|7|||
19677954|NCT00553475|42125764|FG001|Overall Study|Lack of Efficacy|1|||
19677955|NCT00553475|42125765|FG002|Overall Study|Lack of Efficacy|0|||
19677956|NCT00553475|42125763|FG000|Overall Study|Withdrawal by Subject|1|||
19677957|NCT00553475|42125764|FG001|Overall Study|Withdrawal by Subject|1|||
19677958|NCT00553475|42125765|FG002|Overall Study|Withdrawal by Subject|0|||
19760227|NCT03613649|42212130|FG005|Fourth Treatment|Protocol Violation|0|||
19760228|NCT03613649|42212131|FG006|Fourth Treatment|Protocol Violation|0|||
19760229|NCT03613649|42212132|FG007|Fourth Treatment|Protocol Violation|0|||
19760230|NCT03613649|42212133|FG008|Fourth Treatment|Protocol Violation|0|||
19760231|NCT03613649|42212134|FG009|Fourth Treatment|Protocol Violation|0|||
19677959|NCT00553475|42125763|FG000|Overall Study|Physician Decision|1|||
19677960|NCT00553475|42125764|FG001|Overall Study|Physician Decision|0|||
19677961|NCT00553475|42125765|FG002|Overall Study|Physician Decision|0|||
19677962|NCT00553475|42125763|FG000|Overall Study|Due to moving|0|||
19677963|NCT00553475|42125764|FG001|Overall Study|Due to moving|1|||
19677964|NCT00553475|42125765|FG002|Overall Study|Due to moving|0|||
19677965|NCT00329602|42125777|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
19677966|NCT00329602|42125778|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
19677967|NCT00329602|42125779|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
19677968|NCT00329602|42125777|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
19677969|NCT00329602|42125778|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
19677970|NCT00329602|42125779|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
19677971|NCT00329602|42125777|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
19677972|NCT00329602|42125778|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
19677973|NCT00329602|42125779|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
19677974|NCT00329602|42125777|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
19677975|NCT00329602|42125778|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
19677976|NCT00329602|42125779|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
19677977|NCT00329602|42125777|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
19677978|NCT00329602|42125778|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
19677979|NCT00329602|42125779|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
19677980|NCT00329602|42125777|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
19677981|NCT00329602|42125778|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
19677982|NCT00329602|42125779|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
19677983|NCT00463866|42125797|FG000|Overall Study|Adverse Event|70|||
19677984|NCT00463866|42125798|FG001|Overall Study|Adverse Event|93|||
19677985|NCT00463866|42125797|FG000|Overall Study|Withdrawal by Subject|81|||
19677986|NCT00463866|42125798|FG001|Overall Study|Withdrawal by Subject|79|||
19677987|NCT00463866|42125797|FG000|Overall Study|Lost to Follow-up|46|||
19677988|NCT00463866|42125798|FG001|Overall Study|Lost to Follow-up|55|||
19760232|NCT03613649|42212135|FG010|Fourth Treatment|Protocol Violation|0|||
19760233|NCT03613649|42212136|FG011|Fourth Treatment|Protocol Violation|0|||
19760234|NCT03613649|42212125|FG000|Fourth Treatment|Physician Decision|0|||
19760235|NCT03613649|42212126|FG001|Fourth Treatment|Physician Decision|0|||
19760236|NCT03613649|42212127|FG002|Fourth Treatment|Physician Decision|0|||
19760237|NCT03613649|42212128|FG003|Fourth Treatment|Physician Decision|0|||
19760238|NCT03613649|42212129|FG004|Fourth Treatment|Physician Decision|0|||
19677989|NCT00463866|42125797|FG000|Overall Study|Incorrect Enrolment|64|||
19677990|NCT00463866|42125798|FG001|Overall Study|Incorrect Enrolment|66|||
19677991|NCT00463866|42125797|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
19677992|NCT00463866|42125798|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
19677993|NCT00463866|42125797|FG000|Overall Study|Safety Reason|1|||
19677994|NCT00463866|42125798|FG001|Overall Study|Safety Reason|3|||
19760239|NCT03613649|42212130|FG005|Fourth Treatment|Physician Decision|0|||
19760240|NCT03613649|42212131|FG006|Fourth Treatment|Physician Decision|1|||
19760241|NCT03613649|42212132|FG007|Fourth Treatment|Physician Decision|0|||
19760242|NCT03613649|42212133|FG008|Fourth Treatment|Physician Decision|0|||
19760243|NCT03613649|42212134|FG009|Fourth Treatment|Physician Decision|0|||
19760244|NCT03613649|42212135|FG010|Fourth Treatment|Physician Decision|0|||
19760245|NCT03613649|42212136|FG011|Fourth Treatment|Physician Decision|0|||
19760246|NCT03096288|42212158|FG000|Overall Study|Withdrawal by Subject|0|||
19677995|NCT00463866|42125797|FG000|Overall Study|Mis-Randomization of subject|0|||
19677996|NCT00463866|42125798|FG001|Overall Study|Mis-Randomization of subject|1|||
19677997|NCT00463866|42125797|FG000|Overall Study|Other|22|||
19677998|NCT00463866|42125798|FG001|Overall Study|Other|22|||
19677999|NCT00313846|42125806|FG000|Overall Study|Withdrawal by Subject|2|||
19678000|NCT00313846|42125807|FG001|Overall Study|Withdrawal by Subject|0|||
19678001|NCT00313846|42125806|FG000|Overall Study|Adverse Event|1|||
19678002|NCT00313846|42125807|FG001|Overall Study|Adverse Event|8|||
19678003|NCT00313846|42125806|FG000|Overall Study|Administrative|2|||
19678004|NCT00313846|42125807|FG001|Overall Study|Administrative|3|||
19678005|NCT00551135|42125818|FG000|Overall Study|Adverse Event|1|||
19678006|NCT00551135|42125819|FG001|Overall Study|Adverse Event|0|||
19678007|NCT00551135|42125820|FG002|Overall Study|Adverse Event|1|||
19678008|NCT00551135|42125821|FG003|Overall Study|Adverse Event|1|||
19678009|NCT00551135|42125818|FG000|Overall Study|Lost to Follow-up|0|||
19678010|NCT00551135|42125819|FG001|Overall Study|Lost to Follow-up|0|||
19678011|NCT00551135|42125820|FG002|Overall Study|Lost to Follow-up|0|||
19678012|NCT00551135|42125821|FG003|Overall Study|Lost to Follow-up|1|||
19678013|NCT00551135|42125818|FG000|Overall Study|Other|3|||
19678014|NCT00551135|42125819|FG001|Overall Study|Other|2|||
19678015|NCT00551135|42125820|FG002|Overall Study|Other|1|||
19678016|NCT00551135|42125821|FG003|Overall Study|Other|2|||
19678017|NCT00551135|42125818|FG000|Overall Study|Withdrawal by Subject|1|||
19678018|NCT00551135|42125819|FG001|Overall Study|Withdrawal by Subject|0|||
19678019|NCT00551135|42125820|FG002|Overall Study|Withdrawal by Subject|3|||
19678020|NCT00551135|42125821|FG003|Overall Study|Withdrawal by Subject|1|||
19678021|NCT00299104|42125834|FG000|Treatment Period|Adverse Event|14|||
19678022|NCT00299104|42125835|FG001|Treatment Period|Adverse Event|9|||
19678023|NCT00299104|42125836|FG002|Treatment Period|Adverse Event|7|||
19678024|NCT00299104|42125834|FG000|Treatment Period|Death|1|||
19678025|NCT00299104|42125835|FG001|Treatment Period|Death|1|||
19678026|NCT00299104|42125836|FG002|Treatment Period|Death|1|||
19678027|NCT00299104|42125834|FG000|Treatment Period|Insufficient therapeutic response|34|||
19678028|NCT00299104|42125835|FG001|Treatment Period|Insufficient therapeutic response|13|||
19678029|NCT00299104|42125836|FG002|Treatment Period|Insufficient therapeutic response|8|||
19678030|NCT00299104|42125834|FG000|Treatment Period|Failure to return|9|||
19678031|NCT00299104|42125835|FG001|Treatment Period|Failure to return|8|||
19678032|NCT00299104|42125836|FG002|Treatment Period|Failure to return|8|||
19678033|NCT00299104|42125834|FG000|Treatment Period|Violation of selection criteria|1|||
19678034|NCT00299104|42125835|FG001|Treatment Period|Violation of selection criteria|2|||
19678035|NCT00299104|42125836|FG002|Treatment Period|Violation of selection criteria|0|||
19678036|NCT00299104|42125834|FG000|Treatment Period|Protocol Violation|1|||
19678037|NCT00299104|42125835|FG001|Treatment Period|Protocol Violation|1|||
19678038|NCT00299104|42125836|FG002|Treatment Period|Protocol Violation|0|||
19678039|NCT00299104|42125834|FG000|Treatment Period|Refused treatment|9|||
19678040|NCT00299104|42125835|FG001|Treatment Period|Refused treatment|2|||
19678041|NCT00299104|42125836|FG002|Treatment Period|Refused treatment|2|||
19678042|NCT00299104|42125834|FG000|Treatment Period|Withdrew consent|14|||
19678043|NCT00299104|42125835|FG001|Treatment Period|Withdrew consent|19|||
19678044|NCT00299104|42125836|FG002|Treatment Period|Withdrew consent|9|||
19678045|NCT00299104|42125834|FG000|Treatment Period|Administrative reasons|106|||
19678046|NCT00299104|42125835|FG001|Treatment Period|Administrative reasons|120|||
19678047|NCT00299104|42125836|FG002|Treatment Period|Administrative reasons|137|||
19678048|NCT00299104|42125834|FG000|Safety Follow-Up (SFU) Period|Death|3|||
19678049|NCT00299104|42125835|FG001|Safety Follow-Up (SFU) Period|Death|2|||
19678050|NCT00299104|42125836|FG002|Safety Follow-Up (SFU) Period|Death|1|||
19760247|NCT03096288|42212159|FG001|Overall Study|Withdrawal by Subject|1|||
19760248|NCT03096288|42212160|FG002|Overall Study|Withdrawal by Subject|0|||
19760249|NCT03096288|42212161|FG003|Overall Study|Withdrawal by Subject|1|||
19760250|NCT03611075|42212180|FG000|Overall Study|Physician Decision|0|||
19760251|NCT03611075|42212181|FG001|Overall Study|Physician Decision|1|||
19678051|NCT00299104|42125834|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
19678052|NCT00299104|42125835|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
19678053|NCT00299104|42125836|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
19678054|NCT00299104|42125834|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
19678055|NCT00299104|42125835|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
19678056|NCT00299104|42125836|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
19678057|NCT00299104|42125834|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
19678058|NCT00299104|42125835|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
19678059|NCT00299104|42125836|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
19678060|NCT00299104|42125834|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
19678061|NCT00299104|42125835|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
19678062|NCT00299104|42125836|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
19678063|NCT00299104|42125834|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
19678064|NCT00299104|42125835|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
19678065|NCT00299104|42125836|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
19678066|NCT00299104|42125834|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
19678067|NCT00299104|42125835|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
19678068|NCT00299104|42125836|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
19678069|NCT00299104|42125834|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
19678070|NCT00299104|42125835|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
19678071|NCT00299104|42125836|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
19678072|NCT00313612|42125846|FG000|Overall Study|Patient never received treatment|0|||
19678073|NCT00313612|42125847|FG001|Overall Study|Patient never received treatment|1|||
19678074|NCT00507416|42125856|FG000|Overall Study|Adverse Event|58|||
19678075|NCT00507416|42125857|FG001|Overall Study|Adverse Event|67|||
19678076|NCT00507416|42125858|FG002|Overall Study|Adverse Event|65|||
19678077|NCT00507416|42125856|FG000|Overall Study|Protocol Violation|1|||
19678078|NCT00507416|42125857|FG001|Overall Study|Protocol Violation|2|||
19678079|NCT00507416|42125858|FG002|Overall Study|Protocol Violation|0|||
19678080|NCT00507416|42125856|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
19678081|NCT00507416|42125857|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
19678082|NCT00507416|42125858|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
19678083|NCT00507416|42125856|FG000|Overall Study|Progressive Disease|20|||
19678084|NCT00507416|42125857|FG001|Overall Study|Progressive Disease|10|||
19678085|NCT00507416|42125858|FG002|Overall Study|Progressive Disease|13|||
19678086|NCT00507416|42125856|FG000|Overall Study|Patient declined further treatment|18|||
19678087|NCT00507416|42125857|FG001|Overall Study|Patient declined further treatment|14|||
19678088|NCT00507416|42125858|FG002|Overall Study|Patient declined further treatment|11|||
19678089|NCT00507416|42125856|FG000|Overall Study|Other|11|||
19678090|NCT00507416|42125857|FG001|Overall Study|Other|16|||
19678091|NCT00507416|42125858|FG002|Overall Study|Other|13|||
19678092|NCT00507416|42125856|FG000|Overall Study|Did not Receive Study Treatment|3|||
19678093|NCT00507416|42125857|FG001|Overall Study|Did not Receive Study Treatment|9|||
19678094|NCT00507416|42125858|FG002|Overall Study|Did not Receive Study Treatment|4|||
19678095|NCT00489476|42125870|FG000|Overall Study|Lost to Follow-up|0|||
19678096|NCT00489476|42125871|FG001|Overall Study|Lost to Follow-up|1|||
19678097|NCT00489476|42125872|FG002|Overall Study|Lost to Follow-up|0|||
19678098|NCT00489476|42125873|FG003|Overall Study|Lost to Follow-up|0|||
19678099|NCT00550745|42125885|FG000|Overall Study|Death|20|||
19678100|NCT00550745|42125886|FG001|Overall Study|Death|16|||
19678101|NCT00550745|42125885|FG000|Overall Study|Lost to Follow-up|45|||
19678102|NCT00550745|42125886|FG001|Overall Study|Lost to Follow-up|30|||
19678103|NCT00550745|42125885|FG000|Overall Study|Physician Decision|0|||
19678104|NCT00550745|42125886|FG001|Overall Study|Physician Decision|2|||
19678105|NCT00550745|42125885|FG000|Overall Study|Protocol Violation|4|||
19678106|NCT00550745|42125886|FG001|Overall Study|Protocol Violation|2|||
19678107|NCT00550745|42125885|FG000|Overall Study|Withdrawal by Subject|17|||
19678108|NCT00550745|42125886|FG001|Overall Study|Withdrawal by Subject|10|||
19678109|NCT00550745|42125885|FG000|Overall Study|Screen failure|1|||
19678110|NCT00550745|42125886|FG001|Overall Study|Screen failure|0|||
19678111|NCT00452790|42125894|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
19678112|NCT00452790|42125895|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
19678113|NCT00452790|42125894|FG000|Infant Series|Parent/legal guardian request|8|||
19604252|NCT00960440|42053133|FG002|Overall Study|Lack of Efficacy|3|||
19604253|NCT00960440|42053134|FG003|Overall Study|Lack of Efficacy|8|||
19604254|NCT00960440|42053131|FG000|Overall Study|Protocol Violation|2|||
19604255|NCT00960440|42053132|FG001|Overall Study|Protocol Violation|8|||
19604256|NCT00960440|42053133|FG002|Overall Study|Protocol Violation|3|||
19604257|NCT00960440|42053134|FG003|Overall Study|Protocol Violation|4|||
19604258|NCT00960440|42053131|FG000|Overall Study|Withdrawal by Subject|9|||
19604259|NCT00960440|42053132|FG001|Overall Study|Withdrawal by Subject|5|||
19604260|NCT00960440|42053133|FG002|Overall Study|Withdrawal by Subject|2|||
19678114|NCT00452790|42125895|FG001|Infant Series|Parent/legal guardian request|6|||
19678115|NCT00452790|42125894|FG000|Infant Series|Failed to return|4|||
19604261|NCT00960440|42053134|FG003|Overall Study|Withdrawal by Subject|1|||
19604262|NCT00960440|42053131|FG000|Overall Study|Other|1|||
19678116|NCT00452790|42125895|FG001|Infant Series|Failed to return|1|||
19678117|NCT00452790|42125894|FG000|Infant Series|Protocol Violation|1|||
19678118|NCT00452790|42125895|FG001|Infant Series|Protocol Violation|3|||
19678119|NCT00452790|42125894|FG000|Infant Series|Lost to Follow-up|2|||
19678120|NCT00452790|42125895|FG001|Infant Series|Lost to Follow-up|2|||
19678121|NCT00452790|42125894|FG000|Infant Series|Adverse Event|1|||
19678122|NCT00452790|42125895|FG001|Infant Series|Adverse Event|2|||
19678123|NCT00452790|42125894|FG000|Infant Series|Other reasons|1|||
19678124|NCT00452790|42125895|FG001|Infant Series|Other reasons|2|||
19678125|NCT00452790|42125894|FG000|Infant Series|Investigator request|0|||
19678126|NCT00452790|42125895|FG001|Infant Series|Investigator request|1|||
19678127|NCT00452790|42125894|FG000|Infant Series|Death|0|||
19678128|NCT00452790|42125895|FG001|Infant Series|Death|1|||
19678129|NCT00452790|42125894|FG000|After Infant Series|Investigator request|10|||
19678130|NCT00452790|42125895|FG001|After Infant Series|Investigator request|10|||
19678131|NCT00452790|42125894|FG000|After Infant Series|Adverse Event|4|||
19678132|NCT00452790|42125895|FG001|After Infant Series|Adverse Event|1|||
19678133|NCT00452790|42125894|FG000|After Infant Series|Parent/legal guardian request|1|||
19678134|NCT00452790|42125895|FG001|After Infant Series|Parent/legal guardian request|3|||
19678135|NCT00452790|42125894|FG000|After Infant Series|Lost to Follow-up|4|||
19678136|NCT00452790|42125895|FG001|After Infant Series|Lost to Follow-up|0|||
19678137|NCT00452790|42125894|FG000|After Infant Series|Failed to return|1|||
19678138|NCT00452790|42125895|FG001|After Infant Series|Failed to return|0|||
19678139|NCT00452790|42125894|FG000|After Infant Series|Other reasons|1|||
19678140|NCT00452790|42125895|FG001|After Infant Series|Other reasons|0|||
19678141|NCT00452790|42125894|FG000|Toddler Dose|Failed to return|0|||
19678142|NCT00452790|42125895|FG001|Toddler Dose|Failed to return|1|||
19678143|NCT00452790|42125894|FG000|Toddler Dose|Parent/legal guardian request|0|||
19678144|NCT00452790|42125895|FG001|Toddler Dose|Parent/legal guardian request|1|||
19678145|NCT00463788|42125907|FG000|Overall Study|Progressive Disease|86|||
19678146|NCT00463788|42125908|FG001|Overall Study|Progressive Disease|42|||
19678147|NCT00463788|42125907|FG000|Overall Study|Adverse Event|6|||
19678148|NCT00463788|42125908|FG001|Overall Study|Adverse Event|2|||
19678149|NCT00463788|42125907|FG000|Overall Study|Withdrawal by Subject|6|||
19678150|NCT00463788|42125908|FG001|Overall Study|Withdrawal by Subject|2|||
19678151|NCT00463788|42125907|FG000|Overall Study|Death|4|||
19678152|NCT00463788|42125908|FG001|Overall Study|Death|3|||
19678153|NCT00463788|42125907|FG000|Overall Study|Symptomatic Deterioration|2|||
19678154|NCT00463788|42125908|FG001|Overall Study|Symptomatic Deterioration|3|||
19678155|NCT00463788|42125907|FG000|Overall Study|Lost to Follow-up|1|||
19678156|NCT00463788|42125908|FG001|Overall Study|Lost to Follow-up|0|||
19678157|NCT00463788|42125907|FG000|Overall Study|Protocol Violation|0|||
19678158|NCT00463788|42125908|FG001|Overall Study|Protocol Violation|1|||
19678159|NCT00463788|42125907|FG000|Overall Study|Other|3|||
19678160|NCT00463788|42125908|FG001|Overall Study|Other|0|||
19678161|NCT00463788|42125907|FG000|Overall Study|Randomized but not treated|1|||
19678162|NCT00463788|42125908|FG001|Overall Study|Randomized but not treated|1|||
19678163|NCT00548249|42125920|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
19678164|NCT00548249|42125921|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
19678165|NCT00548249|42125922|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
19678166|NCT00548249|42125923|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
19678167|NCT00548249|42125924|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
19678168|NCT00548249|42125920|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
19678169|NCT00548249|42125921|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
19678170|NCT00548249|42125922|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
19678171|NCT00548249|42125923|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
19678172|NCT00548249|42125924|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
19678173|NCT00548249|42125920|FG000|Overall Study|Protocol Violation|1|||
19678174|NCT00548249|42125921|FG001|Overall Study|Protocol Violation|1|||
19678175|NCT00548249|42125922|FG002|Overall Study|Protocol Violation|4|||
19678176|NCT00548249|42125923|FG003|Overall Study|Protocol Violation|0|||
19678177|NCT00548249|42125924|FG004|Overall Study|Protocol Violation|3|||
19678178|NCT00548249|42125920|FG000|Overall Study|Miscellaneous|2|||
19678179|NCT00548249|42125921|FG001|Overall Study|Miscellaneous|3|||
19678180|NCT00548249|42125922|FG002|Overall Study|Miscellaneous|2|||
19678181|NCT00548249|42125923|FG003|Overall Study|Miscellaneous|0|||
19678182|NCT00548249|42125924|FG004|Overall Study|Miscellaneous|2|||
19678183|NCT00548249|42125920|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
19678184|NCT00548249|42125921|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
19678185|NCT00548249|42125922|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
19678186|NCT00548249|42125923|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
19678187|NCT00548249|42125924|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
19678188|NCT00548249|42125920|FG000|Overall Study|Adverse Event|2|||
19678189|NCT00548249|42125921|FG001|Overall Study|Adverse Event|2|||
19678190|NCT00548249|42125922|FG002|Overall Study|Adverse Event|0|||
19678191|NCT00548249|42125923|FG003|Overall Study|Adverse Event|1|||
19678192|NCT00548249|42125924|FG004|Overall Study|Adverse Event|1|||
19678193|NCT00548249|42125920|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
19678194|NCT00548249|42125921|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
19678195|NCT00548249|42125922|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
19678196|NCT00548249|42125923|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
19678197|NCT00548249|42125924|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
19678198|NCT00548249|42125920|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
19678199|NCT00548249|42125921|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
19678200|NCT00548249|42125922|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
19760252|NCT03611075|42212182|FG002|Overall Study|Physician Decision|1|||
19760253|NCT03611075|42212183|FG003|Overall Study|Physician Decision|0|||
19760254|NCT03611075|42212184|FG004|Overall Study|Physician Decision|0|||
19760255|NCT03611075|42212185|FG005|Overall Study|Physician Decision|0|||
19760256|NCT03611075|42212186|FG006|Overall Study|Physician Decision|0|||
19760257|NCT03611075|42212187|FG007|Overall Study|Physician Decision|0|||
19760258|NCT03611075|42212188|FG008|Overall Study|Physician Decision|0|||
19760259|NCT03611075|42212180|FG000|Overall Study|Lost to Follow-up|1|||
19760260|NCT03611075|42212181|FG001|Overall Study|Lost to Follow-up|0|||
19760261|NCT03611075|42212182|FG002|Overall Study|Lost to Follow-up|0|||
19760262|NCT03611075|42212183|FG003|Overall Study|Lost to Follow-up|2|||
19760263|NCT03611075|42212184|FG004|Overall Study|Lost to Follow-up|0|||
19760264|NCT03611075|42212185|FG005|Overall Study|Lost to Follow-up|0|||
19760265|NCT03611075|42212186|FG006|Overall Study|Lost to Follow-up|0|||
19760266|NCT03611075|42212187|FG007|Overall Study|Lost to Follow-up|0|||
19760267|NCT03611075|42212188|FG008|Overall Study|Lost to Follow-up|0|||
19760268|NCT03611075|42212180|FG000|Overall Study|Withdrawal by Subject|0|||
19760269|NCT03611075|42212181|FG001|Overall Study|Withdrawal by Subject|1|||
19760270|NCT03611075|42212182|FG002|Overall Study|Withdrawal by Subject|1|||
19760271|NCT03611075|42212183|FG003|Overall Study|Withdrawal by Subject|1|||
19760272|NCT03611075|42212184|FG004|Overall Study|Withdrawal by Subject|0|||
19760273|NCT03611075|42212185|FG005|Overall Study|Withdrawal by Subject|0|||
19760274|NCT03611075|42212186|FG006|Overall Study|Withdrawal by Subject|1|||
19760275|NCT03611075|42212187|FG007|Overall Study|Withdrawal by Subject|0|||
19760276|NCT03611075|42212188|FG008|Overall Study|Withdrawal by Subject|0|||
19760277|NCT03611075|42212180|FG000|Overall Study|Reason unknown|0|||
19760278|NCT03611075|42212181|FG001|Overall Study|Reason unknown|0|||
19678201|NCT00548249|42125923|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
19678202|NCT00548249|42125924|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
19678203|NCT00548249|42125920|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
19678204|NCT00548249|42125921|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
19678205|NCT00548249|42125922|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
19678206|NCT00548249|42125923|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
19678207|NCT00548249|42125924|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
19678208|NCT00548249|42125920|FG000|Overall Study|Prolonged hospitalization|0|||
19678209|NCT00548249|42125921|FG001|Overall Study|Prolonged hospitalization|0|||
19678210|NCT00548249|42125922|FG002|Overall Study|Prolonged hospitalization|2|||
19678211|NCT00548249|42125923|FG003|Overall Study|Prolonged hospitalization|1|||
19678212|NCT00548249|42125924|FG004|Overall Study|Prolonged hospitalization|0|||
19678213|NCT00548249|42125920|FG000|Overall Study|Withdrawal by Subject|2|||
19678214|NCT00548249|42125921|FG001|Overall Study|Withdrawal by Subject|0|||
19678215|NCT00548249|42125922|FG002|Overall Study|Withdrawal by Subject|0|||
19678216|NCT00548249|42125923|FG003|Overall Study|Withdrawal by Subject|0|||
19678217|NCT00548249|42125924|FG004|Overall Study|Withdrawal by Subject|0|||
19678218|NCT00548249|42125920|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
19678219|NCT00548249|42125921|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
19678220|NCT00548249|42125922|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
19678221|NCT00548249|42125923|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
19760279|NCT03611075|42212182|FG002|Overall Study|Reason unknown|0|||
19760280|NCT03611075|42212183|FG003|Overall Study|Reason unknown|1|||
19760281|NCT03611075|42212184|FG004|Overall Study|Reason unknown|0|||
19760282|NCT03611075|42212185|FG005|Overall Study|Reason unknown|0|||
19760283|NCT03611075|42212186|FG006|Overall Study|Reason unknown|1|||
19760284|NCT03611075|42212187|FG007|Overall Study|Reason unknown|0|||
19760285|NCT03611075|42212188|FG008|Overall Study|Reason unknown|0|||
19760286|NCT03095508|42212233|FG000|Overall Study|Adverse Event|0|||
19760287|NCT03095508|42212234|FG001|Overall Study|Adverse Event|1|||
19760288|NCT03607487|42212244|FG000|Overall Study|Withdrawal by Subject|2|||
19760289|NCT03607487|42212245|FG001|Overall Study|Withdrawal by Subject|0|||
19760290|NCT03607487|42212246|FG002|Overall Study|Withdrawal by Subject|0|||
19760291|NCT03607487|42212247|FG003|Overall Study|Withdrawal by Subject|1|||
19760292|NCT03605693|42212261|FG000|Overall Study|Lost to Follow-up|4|||
19760293|NCT03605693|42212262|FG001|Overall Study|Lost to Follow-up|0|||
19760294|NCT03605693|42212261|FG000|Overall Study|Physician Decision|1|||
19760295|NCT03605693|42212262|FG001|Overall Study|Physician Decision|0|||
19760296|NCT03605303|42212268|FG000|Period 1|Study Terminated|2|||
19760297|NCT03605303|42212269|FG001|Period 1|Study Terminated|1|||
19760298|NCT03604523|42212277|FG000|Overall Study|Physician Decision|1|||
19760299|NCT03604523|42212278|FG001|Overall Study|Physician Decision|0|||
19760300|NCT03602339|42212284|FG000|Overall Study|Withdrawal by Subject|9|||
19760301|NCT03602339|42212284|FG000|Overall Study|Physician Decision|2|||
19760302|NCT03602339|42212284|FG000|Overall Study|Other reason|4|||
19760303|NCT03653429|42212293|FG000|Overall Study|Physician Decision|4|||
19760304|NCT03653429|42212294|FG001|Overall Study|Physician Decision|10|||
19760305|NCT03601715|42212303|FG000|Second Intervention|Lost to Follow-up|1|||
19760306|NCT03601715|42212304|FG001|Second Intervention|Lost to Follow-up|1|||
19760307|NCT03601715|42212305|FG002|Second Intervention|Lost to Follow-up|0|||
19760308|NCT03594227|42212317|FG000|Overall Study|Adverse Event|2|||
19760309|NCT03594227|42212318|FG001|Overall Study|Adverse Event|1|||
19760310|NCT03594227|42212319|FG002|Overall Study|Adverse Event|0|||
19760311|NCT03594227|42212320|FG003|Overall Study|Adverse Event|2|||
19760312|NCT03594227|42212317|FG000|Overall Study|Lost to Follow-up|1|||
19678222|NCT00548249|42125924|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
19678223|NCT00548249|42125920|FG000|Overall Study|Sponsor's request|0|||
19678224|NCT00548249|42125921|FG001|Overall Study|Sponsor's request|0|||
19678225|NCT00548249|42125922|FG002|Overall Study|Sponsor's request|0|||
19678226|NCT00548249|42125923|FG003|Overall Study|Sponsor's request|1|||
19678227|NCT00548249|42125924|FG004|Overall Study|Sponsor's request|0|||
19678228|NCT00463476|42125938|FG000|Overall Study|Withdrawal by Subject|1|||
19678229|NCT00463476|42125939|FG001|Overall Study|Withdrawal by Subject|2|||
19678230|NCT00463476|42125938|FG000|Overall Study|Lost to Follow-up|1|||
19678231|NCT00463476|42125939|FG001|Overall Study|Lost to Follow-up|1|||
19678232|NCT03840174|42125949|FG000|Overall Study|Withdrawal by Subject|1|||
19678233|NCT03840174|42125950|FG001|Overall Study|Withdrawal by Subject|0|||
19678234|NCT03840174|42125951|FG002|Overall Study|Withdrawal by Subject|0|||
19678235|NCT03840174|42125952|FG003|Overall Study|Withdrawal by Subject|0|||
19678236|NCT03839940|42125965|FG000|Overall Study|Withdrawal by Subject|3|||
19678237|NCT03839940|42125966|FG001|Overall Study|Withdrawal by Subject|0|||
19678238|NCT03839940|42125965|FG000|Overall Study|Protocol Violation|0|||
19678239|NCT03839940|42125966|FG001|Overall Study|Protocol Violation|1|||
19678240|NCT03839940|42125965|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
19678241|NCT03839940|42125966|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
19678242|NCT03839628|42125974|FG000|Overall Study|Withdrawal by Subject|1|||
19678243|NCT00462462|42125980|FG000|Overall Study|Physician Decision|0|||
19678244|NCT00462462|42125981|FG001|Overall Study|Physician Decision|1|||
19678245|NCT00462384|42125989|FG000|Overall Study|Adverse Event|2|||
19678246|NCT00462384|42125989|FG000|Overall Study|Death|2|||
19678247|NCT00462384|42125989|FG000|Overall Study|Withdrawal by Subject|1|||
19678248|NCT00462384|42125989|FG000|Overall Study|Other|4|||
19678249|NCT00452400|42125998|FG000|Overall Study|Adverse Event|1|||
19678250|NCT00452400|42125999|FG001|Overall Study|Adverse Event|1|||
19678251|NCT00452400|42126000|FG002|Overall Study|Adverse Event|5|||
19678252|NCT00452400|42126001|FG003|Overall Study|Adverse Event|0|||
19678253|NCT00452400|42126002|FG004|Overall Study|Adverse Event|2|||
19678254|NCT00452400|42125998|FG000|Overall Study|Protocol Violation|0|||
19678255|NCT00452400|42125999|FG001|Overall Study|Protocol Violation|0|||
19678256|NCT00452400|42126000|FG002|Overall Study|Protocol Violation|1|||
19678257|NCT00452400|42126001|FG003|Overall Study|Protocol Violation|0|||
19678258|NCT00452400|42126002|FG004|Overall Study|Protocol Violation|0|||
19678259|NCT00452400|42125998|FG000|Overall Study|Lost to Follow-up|1|||
19678260|NCT00452400|42125999|FG001|Overall Study|Lost to Follow-up|0|||
19678261|NCT00452400|42126000|FG002|Overall Study|Lost to Follow-up|0|||
19678262|NCT00452400|42126001|FG003|Overall Study|Lost to Follow-up|0|||
19678263|NCT00452400|42126002|FG004|Overall Study|Lost to Follow-up|0|||
19678264|NCT00452400|42125998|FG000|Overall Study|Withdrawal by Subject|1|||
19678265|NCT00452400|42125999|FG001|Overall Study|Withdrawal by Subject|0|||
19678266|NCT00452400|42126000|FG002|Overall Study|Withdrawal by Subject|1|||
19678267|NCT00452400|42126001|FG003|Overall Study|Withdrawal by Subject|0|||
19678268|NCT00452400|42126002|FG004|Overall Study|Withdrawal by Subject|0|||
19678269|NCT00452400|42125998|FG000|Overall Study|Lack of Efficacy|2|||
19678270|NCT00452400|42125999|FG001|Overall Study|Lack of Efficacy|0|||
19678271|NCT00452400|42126000|FG002|Overall Study|Lack of Efficacy|0|||
19678272|NCT00452400|42126001|FG003|Overall Study|Lack of Efficacy|0|||
19678273|NCT00452400|42126002|FG004|Overall Study|Lack of Efficacy|0|||
19678274|NCT00452400|42125998|FG000|Overall Study|Other reasons not listed above|0|||
19678275|NCT00452400|42125999|FG001|Overall Study|Other reasons not listed above|0|||
19678276|NCT00452400|42126000|FG002|Overall Study|Other reasons not listed above|0|||
19678277|NCT00452400|42126001|FG003|Overall Study|Other reasons not listed above|1|||
19678278|NCT00452400|42126002|FG004|Overall Study|Other reasons not listed above|1|||
19678279|NCT00462306|42126016|FG000|Overall Study|insufficient data|0|||
19678280|NCT00462306|42126017|FG001|Overall Study|insufficient data|13|||
19678281|NCT00461682|42126025|FG000|Overall Study|Protocol Violation|1|||
19678282|NCT00443430|42126033|FG000|Overall Study|Lack of Efficacy|3|||
19678283|NCT00443430|42126034|FG001|Overall Study|Lack of Efficacy|3|||
19678284|NCT00443430|42126033|FG000|Overall Study|Adverse Event|1|||
19678285|NCT00443430|42126034|FG001|Overall Study|Adverse Event|1|||
19678286|NCT00460746|42126040|FG000|Overall Study|Adverse Event|1|||
19678287|NCT00460746|42126040|FG000|Overall Study|Lost to Follow-up|1|||
19678288|NCT00443118|42126047|FG000|Overall Study|unknown primary outcome|3|||
19678289|NCT00443118|42126048|FG001|Overall Study|unknown primary outcome|1|||
19678290|NCT00443118|42126049|FG002|Overall Study|unknown primary outcome|0|||
19678291|NCT00443118|42126047|FG000|Overall Study|Withdrawal by Subject|1|||
19678292|NCT00443118|42126048|FG001|Overall Study|Withdrawal by Subject|0|||
19678293|NCT00443118|42126049|FG002|Overall Study|Withdrawal by Subject|0|||
19678294|NCT00460434|42126077|FG000|Overall Study|Lost to Follow-up|3|||
19678295|NCT00460434|42126078|FG001|Overall Study|Lost to Follow-up|7|||
19678296|NCT00373425|42126089|FG000|Overall Study|Relapse of NSCLC|116|||
19678297|NCT00373425|42126090|FG001|Overall Study|Relapse of NSCLC|104|||
19678298|NCT00373425|42126091|FG002|Overall Study|Relapse of NSCLC|19|||
19678299|NCT00373425|42126092|FG003|Overall Study|Relapse of NSCLC|2|||
19678300|NCT00373425|42126093|FG004|Overall Study|Relapse of NSCLC|26|||
19678301|NCT00373425|42126089|FG000|Overall Study|Adverse Event|191|||
19678302|NCT00373425|42126090|FG001|Overall Study|Adverse Event|22|||
19678303|NCT00373425|42126091|FG002|Overall Study|Adverse Event|59|||
19678304|NCT00373425|42126092|FG003|Overall Study|Adverse Event|0|||
19678305|NCT00373425|42126093|FG004|Overall Study|Adverse Event|34|||
19678306|NCT00373425|42126089|FG000|Overall Study|Patient request|35|||
19678307|NCT00373425|42126090|FG001|Overall Study|Patient request|18|||
19678308|NCT00373425|42126091|FG002|Overall Study|Patient request|43|||
19678309|NCT00373425|42126092|FG003|Overall Study|Patient request|6|||
19678310|NCT00373425|42126093|FG004|Overall Study|Patient request|7|||
19678311|NCT00373425|42126089|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
19678312|NCT00373425|42126090|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
19678313|NCT00373425|42126091|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
19678314|NCT00373425|42126092|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
19678315|NCT00373425|42126093|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
19678316|NCT00373425|42126089|FG000|Overall Study|Death|7|||
19678317|NCT00373425|42126090|FG001|Overall Study|Death|0|||
19678318|NCT00373425|42126091|FG002|Overall Study|Death|3|||
19678319|NCT00373425|42126092|FG003|Overall Study|Death|1|||
19678320|NCT00373425|42126093|FG004|Overall Study|Death|0|||
19678321|NCT00459342|42126102|FG000|Overall Study|Not eligible|1|||
19678322|NCT00443040|42126109|FG000|Overall Study|Withdrawal by Subject|1|||
19678323|NCT00443040|42126110|FG001|Overall Study|Withdrawal by Subject|0|||
19678324|NCT00443040|42126111|FG002|Overall Study|Withdrawal by Subject|0|||
19678325|NCT00443040|42126109|FG000|Overall Study|Converted to an open laparotomy|3|||
19678326|NCT00443040|42126110|FG001|Overall Study|Converted to an open laparotomy|0|||
19678327|NCT00443040|42126111|FG002|Overall Study|Converted to an open laparotomy|1|||
19678328|NCT00442962|42126119|FG000|Overall Study|Pregnancy|1|||
19678329|NCT00442962|42126119|FG000|Overall Study|Lost to Follow-up|7|||
19678330|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
19678331|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
19678332|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
19678333|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
19678334|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
19678335|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
19678336|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
19678337|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
19678338|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
19678339|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
19678340|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
19678341|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
19678342|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
19678343|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
19678344|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
19678345|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
19678346|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
19678347|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
19678348|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
19678349|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
19678350|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
19678351|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
19678352|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
19678353|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
19678354|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
19678355|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
19678356|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
19678357|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
19678358|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
19678359|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
19678360|NCT00313300|42126128|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
19678361|NCT00313300|42126129|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
19678362|NCT00313300|42126130|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
19678363|NCT00313300|42126131|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
19678364|NCT00313300|42126132|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
19678365|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
19678366|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
19678367|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
19678368|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
19678369|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
19678370|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
19678371|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
19678372|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
19678373|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
19678374|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
19678375|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
19678376|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
19678377|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
19678378|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
19678379|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
19678380|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
19678381|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
19678382|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
19678383|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
19678384|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
19678385|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
19678386|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
19678387|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
19678388|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
19678389|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
19678390|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
19678391|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
19678392|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
19678393|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
19678394|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
19678395|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
19678396|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
19678397|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
19678398|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
19678399|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
19678400|NCT00313300|42126128|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
19678401|NCT00313300|42126129|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
19678402|NCT00313300|42126130|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
19678403|NCT00313300|42126131|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
19678404|NCT00313300|42126132|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
19678405|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
19678406|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
19678407|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
19678408|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
19678409|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
19678410|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
19678411|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
19678412|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
19678413|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
19678414|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
19678415|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
19678416|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
19678417|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
19678418|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
19678419|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
19678420|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
19678421|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
19678422|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
19678423|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
19678424|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
19678425|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
19678426|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
19678427|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
19678428|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
19678429|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
19678430|NCT00313300|42126128|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
19678431|NCT00313300|42126129|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
19678432|NCT00313300|42126130|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
19678433|NCT00313300|42126131|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
19678434|NCT00313300|42126132|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
19678435|NCT00459186|42126150|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
19678436|NCT00459186|42126150|FG000|PET Imaging and Assessment|Adverse Event|3|||
19678437|NCT00328510|42126156|FG000|Overall Study|Gag disorder, could not use frame|4|||
19678438|NCT00328510|42126157|FG001|Overall Study|Gag disorder, could not use frame|0|||
19678439|NCT00328510|42126156|FG000|Overall Study|Dentition problems, could not use frame|1|||
19678440|NCT00328510|42126157|FG001|Overall Study|Dentition problems, could not use frame|0|||
19678441|NCT00328510|42126156|FG000|Overall Study|Withdrawal by Subject|4|||
19678442|NCT00328510|42126157|FG001|Overall Study|Withdrawal by Subject|2|||
19678443|NCT00328510|42126156|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
19678444|NCT00328510|42126157|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
19678445|NCT00328510|42126156|FG000|Overall Study|Treatment changed to a single fraction|1|||
19678446|NCT00328510|42126157|FG001|Overall Study|Treatment changed to a single fraction|1|||
19678447|NCT00313144|42126163|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
19678448|NCT00313144|42126163|FG000|Overall Study|Death|7|||
19678449|NCT00313144|42126163|FG000|Overall Study|Lost to Follow-up|5|||
19678450|NCT00313144|42126163|FG000|Overall Study|Withdrawal by Subject|4|||
19678451|NCT00313144|42126163|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
19678452|NCT00313144|42126163|FG000|Overall Study|Physician Decision|4|||
19678453|NCT00313144|42126163|FG000|Overall Study|Adverse event - transient|5|||
19678454|NCT00313144|42126163|FG000|Overall Study|Liver transplant|1|||
19678455|NCT00313144|42126163|FG000|Overall Study|Insurance (homecare provider) change|1|||
19678456|NCT00313144|42126163|FG000|Overall Study|Change to different product|1|||
19678457|NCT00313144|42126163|FG000|Overall Study|Due to termination of the study|66|||
19678458|NCT00459108|42126176|FG000|Overall Study|Withdrawal by Subject|5|||
19678459|NCT00459108|42126176|FG000|Overall Study|Adverse Event|3|||
19678460|NCT00459108|42126176|FG000|Overall Study|Death|2|||
19678461|NCT00459108|42126176|FG000|Overall Study|Progression|1|||
19678462|NCT00458484|42126188|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
19678463|NCT00458484|42126189|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
19678464|NCT00458484|42126190|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
19678465|NCT00458484|42126191|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
19678466|NCT00458484|42126192|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
19678467|NCT00458484|42126193|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
19678468|NCT00458484|42126194|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
19678469|NCT00328198|42126219|FG000|Treatment|Adverse Event|21|||
19678470|NCT00328198|42126219|FG000|Treatment|Death|1|||
19678471|NCT00328198|42126219|FG000|Treatment|Physician Decision|5|||
19678472|NCT00328198|42126219|FG000|Treatment|Withdrawal by Subject|5|||
19678473|NCT00328198|42126219|FG000|Treatment|Evidence of disease progression|2|||
19678474|NCT00328198|42126219|FG000|Treatment|Non-compliance|1|||
19678475|NCT00328198|42126219|FG000|Treatment|Confirmed complete response, MRD -|3|||
19678476|NCT00328198|42126219|FG000|Follow-up|Lost to Follow-up|4|||
19678477|NCT00328198|42126219|FG000|Follow-up|Death|31|||
19678478|NCT00450450|42126225|FG000|Overall Study|Death|1|||
19678479|NCT00450450|42126226|FG001|Overall Study|Death|3|||
19678480|NCT00450450|42126225|FG000|Overall Study|Relapse|2|||
19678481|NCT00450450|42126226|FG001|Overall Study|Relapse|0|||
19678482|NCT00450450|42126225|FG000|Overall Study|Missing Data|2|||
19678483|NCT00450450|42126226|FG001|Overall Study|Missing Data|0|||
19678484|NCT00442572|42126234|FG000|Overall Study|Relapse|8|||
19678485|NCT00442572|42126235|FG001|Overall Study|Relapse|1|||
19678486|NCT00442572|42126234|FG000|Overall Study|Lost to Follow-up|0|||
19678487|NCT00442572|42126235|FG001|Overall Study|Lost to Follow-up|1|||
19678488|NCT00442572|42126234|FG000|Overall Study|Withdrawal by Subject|0|||
19678489|NCT00442572|42126235|FG001|Overall Study|Withdrawal by Subject|1|||
19678490|NCT00442416|42126244|FG000|Overall Study|Adverse Event|4|||
19760313|NCT03594227|42212318|FG001|Overall Study|Lost to Follow-up|1|||
19678491|NCT00442416|42126245|FG001|Overall Study|Adverse Event|1|||
19678492|NCT00442416|42126244|FG000|Overall Study|Death|1|||
19678493|NCT00442416|42126245|FG001|Overall Study|Death|0|||
19678494|NCT00442416|42126244|FG000|Overall Study|Lack of Efficacy|2|||
19678495|NCT00442416|42126245|FG001|Overall Study|Lack of Efficacy|0|||
19678496|NCT00442416|42126244|FG000|Overall Study|Protocol Violation|2|||
19678497|NCT00442416|42126245|FG001|Overall Study|Protocol Violation|3|||
19678498|NCT00442416|42126244|FG000|Overall Study|Withdrew consent|1|||
19678499|NCT00442416|42126245|FG001|Overall Study|Withdrew consent|2|||
19678500|NCT00442416|42126244|FG000|Overall Study|Administrative/Other|27|||
19678501|NCT00442416|42126245|FG001|Overall Study|Administrative/Other|33|||
19678502|NCT00441792|42126253|FG000|Overall Study|Lost to Follow-up|0|||
19678503|NCT00441792|42126254|FG001|Overall Study|Lost to Follow-up|2|||
19678504|NCT00312208|42126262|FG000|Overall Study|Adverse Event|97|||
19678505|NCT00312208|42126263|FG001|Overall Study|Adverse Event|61|||
19678506|NCT00312208|42126262|FG000|Overall Study|Protocol Violation|5|||
19678507|NCT00312208|42126263|FG001|Overall Study|Protocol Violation|3|||
19678508|NCT00312208|42126262|FG000|Overall Study|Death|2|||
19678509|NCT00312208|42126263|FG001|Overall Study|Death|1|||
19678510|NCT00312208|42126262|FG000|Overall Study|Lack of Efficacy|7|||
19678511|NCT00312208|42126263|FG001|Overall Study|Lack of Efficacy|4|||
19678512|NCT00312208|42126262|FG000|Overall Study|Lost to Follow-up|3|||
19678513|NCT00312208|42126263|FG001|Overall Study|Lost to Follow-up|5|||
19678514|NCT00312208|42126262|FG000|Overall Study|Withdrawal by Subject|53|||
19678515|NCT00312208|42126263|FG001|Overall Study|Withdrawal by Subject|42|||
19678516|NCT00312208|42126262|FG000|Overall Study|Other|5|||
19678517|NCT00312208|42126263|FG001|Overall Study|Other|7|||
19678518|NCT00297778|42126271|FG000|Overall Study|Adverse Event|16|||
19678519|NCT00297778|42126272|FG001|Overall Study|Adverse Event|10|||
19678520|NCT00297778|42126271|FG000|Overall Study|Withdrawal by Subject|1|||
19678521|NCT00297778|42126272|FG001|Overall Study|Withdrawal by Subject|5|||
19678522|NCT00297778|42126271|FG000|Overall Study|Lack of Efficacy|2|||
19678523|NCT00297778|42126272|FG001|Overall Study|Lack of Efficacy|1|||
19678524|NCT00297778|42126271|FG000|Overall Study|Non-compliant with trial protocol|0|||
19678525|NCT00297778|42126272|FG001|Overall Study|Non-compliant with trial protocol|3|||
19678526|NCT00297778|42126271|FG000|Overall Study|Other|0|||
19678527|NCT00297778|42126272|FG001|Overall Study|Other|1|||
19678528|NCT03848832|42126281|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
19678529|NCT03848832|42126282|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
19678530|NCT03848832|42126283|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
19678531|NCT03848832|42126281|FG000|Overall Study|Withdrawal by Subject|0|||
19678532|NCT03848832|42126282|FG001|Overall Study|Withdrawal by Subject|0|||
19678533|NCT03848832|42126283|FG002|Overall Study|Withdrawal by Subject|1|||
19678534|NCT03848832|42126281|FG000|Overall Study|Withdrawal (Covid-19)|0|||
19678535|NCT03848832|42126282|FG001|Overall Study|Withdrawal (Covid-19)|2|||
19678536|NCT03848832|42126283|FG002|Overall Study|Withdrawal (Covid-19)|0|||
19678537|NCT03848832|42126281|FG000|Overall Study|Physician Decision|2|||
19678538|NCT03848832|42126282|FG001|Overall Study|Physician Decision|1|||
19678539|NCT03848832|42126283|FG002|Overall Study|Physician Decision|3|||
19678540|NCT03848832|42126281|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
19678541|NCT03848832|42126282|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
19678542|NCT03848832|42126283|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
19678543|NCT03848832|42126281|FG000|Overall Study|Adverse Event|1|||
19678544|NCT03848832|42126282|FG001|Overall Study|Adverse Event|0|||
19678545|NCT03848832|42126283|FG002|Overall Study|Adverse Event|0|||
19678546|NCT00450372|42126293|FG000|Overall Study|Physician Decision|1|||
19678547|NCT00327340|42126302|FG000|Overall Study|Withdrawal by Subject|1|||
19678548|NCT00327340|42126303|FG001|Overall Study|Withdrawal by Subject|5|||
19678549|NCT00327340|42126302|FG000|Overall Study|Physician Decision|1|||
19678550|NCT00327340|42126303|FG001|Overall Study|Physician Decision|1|||
19678551|NCT00327340|42126302|FG000|Overall Study|Disease Progression|10|||
19678552|NCT00327340|42126303|FG001|Overall Study|Disease Progression|19|||
19678553|NCT00327340|42126302|FG000|Overall Study|Symptomatic Disease|0|||
19678554|NCT00327340|42126303|FG001|Overall Study|Symptomatic Disease|2|||
19678555|NCT00327340|42126302|FG000|Overall Study|Adverse Event|3|||
19678556|NCT00327340|42126303|FG001|Overall Study|Adverse Event|3|||
19678557|NCT00548093|42126313|FG000|Overall Study|Death|33|||
19678558|NCT00548093|42126314|FG001|Overall Study|Death|13|||
19678559|NCT00548093|42126313|FG000|Overall Study|Lost to Follow-up|3|||
19678560|NCT00548093|42126314|FG001|Overall Study|Lost to Follow-up|1|||
19678561|NCT00548093|42126313|FG000|Overall Study|Objective progression or relapse|1|||
19678562|NCT00548093|42126314|FG001|Overall Study|Objective progression or relapse|1|||
19678563|NCT00548093|42126313|FG000|Overall Study|Other|11|||
19678564|NCT00548093|42126314|FG001|Overall Study|Other|1|||
19678565|NCT00548093|42126313|FG000|Overall Study|Withdrawal by Subject|1|||
19678566|NCT00548093|42126314|FG001|Overall Study|Withdrawal by Subject|0|||
19678567|NCT00548093|42126313|FG000|Overall Study|Completed post-treatment follow-up|1|||
19678568|NCT00548093|42126314|FG001|Overall Study|Completed post-treatment follow-up|0|||
19678569|NCT03824704|42126323|FG000|Overall Study|Study Terminated by Sponsor|1|||
19678570|NCT00450216|42126329|FG000|Overall Study|Adverse Event|38|||
19678571|NCT00450216|42126330|FG001|Overall Study|Adverse Event|23|||
19678572|NCT00450216|42126329|FG000|Overall Study|Withdrawal by Subject|48|||
19678573|NCT00450216|42126330|FG001|Overall Study|Withdrawal by Subject|26|||
19678574|NCT00450216|42126329|FG000|Overall Study|Lost to Follow-up|16|||
19678575|NCT00450216|42126330|FG001|Overall Study|Lost to Follow-up|9|||
19678576|NCT00450216|42126329|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
19678577|NCT00450216|42126330|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
19678578|NCT00450216|42126329|FG000|Overall Study|misc|21|||
19678579|NCT00450216|42126330|FG001|Overall Study|misc|20|||
19678580|NCT00441480|42126338|FG000|Overall Study|Protocol Violation|1|||
19678581|NCT00441480|42126339|FG001|Overall Study|Protocol Violation|1|||
19760314|NCT03594227|42212319|FG002|Overall Study|Lost to Follow-up|1|||
19760315|NCT03594227|42212320|FG003|Overall Study|Lost to Follow-up|0|||
19760316|NCT03594227|42212317|FG000|Overall Study|Withdrawal by Subject|1|||
19760317|NCT03594227|42212318|FG001|Overall Study|Withdrawal by Subject|1|||
19760318|NCT03594227|42212319|FG002|Overall Study|Withdrawal by Subject|1|||
19760319|NCT03594227|42212320|FG003|Overall Study|Withdrawal by Subject|1|||
19760320|NCT03594227|42212317|FG000|Overall Study|Pregnancy|0|||
19760321|NCT03594227|42212318|FG001|Overall Study|Pregnancy|1|||
19760322|NCT03594227|42212319|FG002|Overall Study|Pregnancy|0|||
19760323|NCT03594227|42212320|FG003|Overall Study|Pregnancy|0|||
19760324|NCT03594227|42212317|FG000|Overall Study|Sponsor Decision|0|||
19760325|NCT03594227|42212318|FG001|Overall Study|Sponsor Decision|0|||
19760326|NCT03594227|42212319|FG002|Overall Study|Sponsor Decision|0|||
19760327|NCT03594227|42212320|FG003|Overall Study|Sponsor Decision|1|||
19760328|NCT03594227|42212317|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
19760329|NCT03594227|42212318|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
19760330|NCT03594227|42212319|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
19760331|NCT03594227|42212320|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
19760332|NCT03098550|42212344|FG000|Overall Study|Disease Progression|30|||
19760333|NCT03098550|42212345|FG001|Overall Study|Disease Progression|19|||
19760334|NCT03098550|42212346|FG002|Overall Study|Disease Progression|41|||
19760335|NCT03098550|42212344|FG000|Overall Study|Study Drug Toxicity|2|||
19760336|NCT03098550|42212345|FG001|Overall Study|Study Drug Toxicity|1|||
19760337|NCT03098550|42212346|FG002|Overall Study|Study Drug Toxicity|0|||
19760338|NCT03098550|42212344|FG000|Overall Study|Death|1|||
19760339|NCT03098550|42212345|FG001|Overall Study|Death|0|||
19760340|NCT03098550|42212346|FG002|Overall Study|Death|0|||
19760341|NCT03098550|42212344|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
19760342|NCT03098550|42212345|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
19760343|NCT03098550|42212346|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
19760344|NCT03098550|42212344|FG000|Overall Study|Administrative reason by sponsor|0|||
19678582|NCT00441480|42126338|FG000|Overall Study|Withdrawal by Subject|2|||
19678583|NCT00441480|42126339|FG001|Overall Study|Withdrawal by Subject|3|||
19678584|NCT00547703|42126347|FG000|Overall Study|Lost to Follow-up|1|||
19678585|NCT00547703|42126348|FG001|Overall Study|Lost to Follow-up|0|||
19678586|NCT00297232|42126354|FG000|Overall Study|Lack of Efficacy|7|||
19678587|NCT00297232|42126354|FG000|Overall Study|Lost to Follow-up|10|||
19678588|NCT00297232|42126354|FG000|Overall Study|Adverse Event|63|||
19678589|NCT00297232|42126354|FG000|Overall Study|Voluntary Withdrawal|120|||
19678590|NCT00297232|42126354|FG000|Overall Study|Subject was Noncompliant|9|||
19678591|NCT00297232|42126354|FG000|Overall Study|Death|9|||
19678592|NCT00297232|42126354|FG000|Overall Study|Anti-natalizumab Positive|8|||
19678593|NCT00297232|42126354|FG000|Overall Study|Switched to Commercial Tysabri|22|||
19678594|NCT00297232|42126354|FG000|Overall Study|Disease Progression|8|||
19678595|NCT00297232|42126354|FG000|Overall Study|Fear of PML|10|||
19678596|NCT00297232|42126354|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
19678597|NCT00297232|42126354|FG000|Overall Study|Miscellaneous|5|||
19678598|NCT00297232|42126354|FG000|Overall Study|Sponsor Decision|34|||
19678599|NCT00297232|42126354|FG000|Overall Study|Subject Relocated|7|||
19760345|NCT03098550|42212345|FG001|Overall Study|Administrative reason by sponsor|0|||
19760346|NCT03098550|42212346|FG002|Overall Study|Administrative reason by sponsor|1|||
19760347|NCT03098550|42212344|FG000|Overall Study|Other reasons|2|||
19760348|NCT03098550|42212345|FG001|Overall Study|Other reasons|0|||
19760349|NCT03098550|42212346|FG002|Overall Study|Other reasons|0|||
19760350|NCT03095118|42212358|FG000|Overall Study|Adverse Event|1|||
19760351|NCT03095118|42212358|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
19760352|NCT03594071|42212362|FG000|Overall Study|Re-operation|3|||
19760353|NCT03594071|42212362|FG000|Overall Study|Missed visit|2|||
19760354|NCT02696902|42212369|FG000|Overall Study|Lost to Follow-up|0|||
19760355|NCT02696902|42212370|FG001|Overall Study|Lost to Follow-up|1|||
19760356|NCT02696902|42212371|FG002|Overall Study|Lost to Follow-up|1|||
19760357|NCT02696902|42212369|FG000|Overall Study|Withdrawal by Subject|0|||
19760358|NCT02696902|42212370|FG001|Overall Study|Withdrawal by Subject|0|||
19760359|NCT02696902|42212371|FG002|Overall Study|Withdrawal by Subject|1|||
19760360|NCT02696902|42212369|FG000|Overall Study|Death|19|||
19678600|NCT00297232|42126354|FG000|Overall Study|Subject Withdrew Consent|37|||
19678601|NCT00297232|42126354|FG000|Overall Study|Persistently Positive Antibodies|11|||
19760361|NCT02696902|42212370|FG001|Overall Study|Death|3|||
19760362|NCT02696902|42212371|FG002|Overall Study|Death|24|||
19760363|NCT02696902|42212369|FG000|Overall Study|Participant not fit post-randomization|0|||
19678602|NCT00297232|42126354|FG000|Overall Study|Investigator Withdrew From Program|19|||
19678603|NCT00297232|42126354|FG000|Overall Study|Did Not Enroll to Week 264|34|||
19678604|NCT00297232|42126354|FG000|Overall Study|Did Not Enroll to Week 480|17|||
19678605|NCT00297232|42126354|FG000|Overall Study|No data available after Week 264|161|||
19678606|NCT00297232|42126354|FG000|Overall Study|Other|1|||
19678607|NCT00449670|42126370|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
19678608|NCT00449670|42126371|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
19678609|NCT00449670|42126370|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
19678610|NCT00449670|42126371|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
19678611|NCT00449670|42126370|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
19678612|NCT00449670|42126371|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
19678613|NCT00449670|42126370|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
19678614|NCT00449670|42126371|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
19678615|NCT00449670|42126370|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
19760364|NCT02696902|42212370|FG001|Overall Study|Participant not fit post-randomization|0|||
19760365|NCT02696902|42212371|FG002|Overall Study|Participant not fit post-randomization|1|||
19760366|NCT02696902|42212369|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
19760367|NCT02696902|42212370|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
19760368|NCT02696902|42212371|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
19760369|NCT02696902|42212369|FG000|Overall Study|Principal investigator's decision|1|||
19760370|NCT02696902|42212370|FG001|Overall Study|Principal investigator's decision|0|||
19760371|NCT02696902|42212371|FG002|Overall Study|Principal investigator's decision|0|||
19760372|NCT02696902|42212369|FG000|Overall Study|Sponsor's decision|1|||
19760373|NCT02696902|42212370|FG001|Overall Study|Sponsor's decision|0|||
19760374|NCT02696902|42212371|FG002|Overall Study|Sponsor's decision|0|||
19760375|NCT02696902|42212369|FG000|Overall Study|Transferred to other hospital|1|||
19760376|NCT02696902|42212370|FG001|Overall Study|Transferred to other hospital|0|||
19760377|NCT02696902|42212371|FG002|Overall Study|Transferred to other hospital|0|||
19760378|NCT02694562|42212381|FG000|Overall Study|Death|8|||
19760379|NCT02694562|42212381|FG000|Overall Study|Protocol Violation|4|||
19760380|NCT02694562|42212381|FG000|Overall Study|Lost to Follow-up|3|||
19760381|NCT02694562|42212381|FG000|Overall Study|Screen Failure|2|||
19760382|NCT02694562|42212381|FG000|Overall Study|Physician Decision|1|||
19760383|NCT02874534|42212387|FG000|Overall Study|Withdrawal by Subject|5|||
19760384|NCT02874534|42212388|FG001|Overall Study|Withdrawal by Subject|8|||
19760385|NCT02874534|42212387|FG000|Overall Study|Lost to Follow-up|2|||
19678616|NCT00449670|42126371|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
19678617|NCT00449670|42126370|FG000|Booster Phase (Study no.109873)|Other|0|||
19678618|NCT00449670|42126371|FG001|Booster Phase (Study no.109873)|Other|2|||
19678619|NCT00296374|42126387|FG000|Overall Study|Adverse Event|14|||
19678620|NCT00296374|42126388|FG001|Overall Study|Adverse Event|10|||
19678621|NCT00296374|42126389|FG002|Overall Study|Adverse Event|7|||
19678622|NCT00296374|42126387|FG000|Overall Study|Withdrawal by Subject|3|||
19678623|NCT00296374|42126388|FG001|Overall Study|Withdrawal by Subject|5|||
19678624|NCT00296374|42126389|FG002|Overall Study|Withdrawal by Subject|11|||
19678625|NCT00296374|42126387|FG000|Overall Study|Incorrect enrollment|3|||
19678626|NCT00296374|42126388|FG001|Overall Study|Incorrect enrollment|3|||
19678627|NCT00296374|42126389|FG002|Overall Study|Incorrect enrollment|4|||
19678628|NCT00296374|42126387|FG000|Overall Study|Protocol Violation|1|||
19678629|NCT00296374|42126388|FG001|Overall Study|Protocol Violation|2|||
19678630|NCT00296374|42126389|FG002|Overall Study|Protocol Violation|3|||
19678631|NCT00296374|42126387|FG000|Overall Study|Lost to Follow-up|3|||
19678632|NCT00296374|42126388|FG001|Overall Study|Lost to Follow-up|1|||
19678633|NCT00296374|42126389|FG002|Overall Study|Lost to Follow-up|1|||
19678634|NCT00296374|42126387|FG000|Overall Study|Relocated to another state|1|||
19760386|NCT02874534|42212388|FG001|Overall Study|Lost to Follow-up|2|||
19760387|NCT02874534|42212387|FG000|Overall Study|Ongoing in study|1|||
19760388|NCT02874534|42212388|FG001|Overall Study|Ongoing in study|1|||
19760389|NCT03097614|42212394|FG000|Overall Study|Adverse Event|3|||
19760390|NCT03364309|42212401|FG000|Induction Period|Adverse Event|4|||
19389076|NCT02670551|41632642|FG000|Overall Study|Lack of Efficacy|2|||
19389077|NCT02670551|41632643|FG001|Overall Study|Lack of Efficacy|0|||
19389078|NCT02670551|41632644|FG002|Overall Study|Lack of Efficacy|3|||
19760391|NCT03364309|42212402|FG001|Induction Period|Adverse Event|0|||
19760392|NCT03364309|42212403|FG002|Induction Period|Adverse Event|1|||
19760393|NCT03364309|42212404|FG003|Induction Period|Adverse Event|0|||
19760394|NCT03364309|42212405|FG004|Induction Period|Adverse Event|0|||
19760395|NCT03364309|42212406|FG005|Induction Period|Adverse Event|0|||
19678635|NCT00296374|42126388|FG001|Overall Study|Relocated to another state|0|||
19678636|NCT00296374|42126389|FG002|Overall Study|Relocated to another state|0|||
19678637|NCT00296374|42126387|FG000|Overall Study|Stopped drug before end of study visit|0|||
19760396|NCT03364309|42212407|FG006|Induction Period|Adverse Event|0|||
19760397|NCT03364309|42212408|FG007|Induction Period|Adverse Event|0|||
19760398|NCT03364309|42212409|FG008|Induction Period|Adverse Event|0|||
19760399|NCT03364309|42212410|FG009|Induction Period|Adverse Event|0|||
19760400|NCT03364309|42212411|FG010|Induction Period|Adverse Event|0|||
19760401|NCT03364309|42212412|FG011|Induction Period|Adverse Event|0|||
19760402|NCT03364309|42212413|FG012|Induction Period|Adverse Event|0|||
19760403|NCT03364309|42212414|FG013|Induction Period|Adverse Event|0|||
19760404|NCT03364309|42212415|FG014|Induction Period|Adverse Event|0|||
19760405|NCT03364309|42212416|FG015|Induction Period|Adverse Event|0|||
19760406|NCT03364309|42212417|FG016|Induction Period|Adverse Event|0|||
19760407|NCT03364309|42212418|FG017|Induction Period|Adverse Event|0|||
19678638|NCT00296374|42126388|FG001|Overall Study|Stopped drug before end of study visit|1|||
19678639|NCT00296374|42126389|FG002|Overall Study|Stopped drug before end of study visit|0|||
19678640|NCT00296374|42126387|FG000|Overall Study|Nephrologist introduced ACE|0|||
19678641|NCT00296374|42126388|FG001|Overall Study|Nephrologist introduced ACE|1|||
19760408|NCT03364309|42212419|FG018|Induction Period|Adverse Event|0|||
19760409|NCT03364309|42212401|FG000|Induction Period|Withdrawal by Subject|1|||
19760410|NCT03364309|42212402|FG001|Induction Period|Withdrawal by Subject|3|||
19760411|NCT03364309|42212403|FG002|Induction Period|Withdrawal by Subject|0|||
19760412|NCT03364309|42212404|FG003|Induction Period|Withdrawal by Subject|0|||
19760413|NCT03364309|42212405|FG004|Induction Period|Withdrawal by Subject|0|||
19760414|NCT03364309|42212406|FG005|Induction Period|Withdrawal by Subject|0|||
19760415|NCT03364309|42212407|FG006|Induction Period|Withdrawal by Subject|0|||
19760416|NCT03364309|42212408|FG007|Induction Period|Withdrawal by Subject|0|||
19760417|NCT03364309|42212409|FG008|Induction Period|Withdrawal by Subject|0|||
19760418|NCT03364309|42212410|FG009|Induction Period|Withdrawal by Subject|0|||
19760419|NCT03364309|42212411|FG010|Induction Period|Withdrawal by Subject|0|||
19760420|NCT03364309|42212412|FG011|Induction Period|Withdrawal by Subject|0|||
19760421|NCT03364309|42212413|FG012|Induction Period|Withdrawal by Subject|0|||
19760422|NCT03364309|42212414|FG013|Induction Period|Withdrawal by Subject|0|||
19760423|NCT03364309|42212415|FG014|Induction Period|Withdrawal by Subject|0|||
19760424|NCT03364309|42212416|FG015|Induction Period|Withdrawal by Subject|0|||
19760425|NCT03364309|42212417|FG016|Induction Period|Withdrawal by Subject|0|||
19760426|NCT03364309|42212418|FG017|Induction Period|Withdrawal by Subject|0|||
19760427|NCT03364309|42212419|FG018|Induction Period|Withdrawal by Subject|0|||
19760428|NCT03364309|42212401|FG000|Induction Period|Lost to Follow-up|1|||
19678642|NCT00296374|42126389|FG002|Overall Study|Nephrologist introduced ACE|0|||
19678643|NCT00296374|42126387|FG000|Overall Study|Pregnancy|0|||
19678644|NCT00296374|42126388|FG001|Overall Study|Pregnancy|0|||
19678645|NCT00296374|42126389|FG002|Overall Study|Pregnancy|2|||
19678646|NCT00296374|42126387|FG000|Overall Study|Other|0|||
19678647|NCT00296374|42126388|FG001|Overall Study|Other|0|||
19678648|NCT00296374|42126389|FG002|Overall Study|Other|1|||
19678649|NCT00326950|42126412|FG000|Overall Study|Progressive Disease|1|||
19678650|NCT00548717|42126418|FG000|Overall Study|Death|5|||
19678651|NCT00548717|42126419|FG001|Overall Study|Death|2|||
19678652|NCT00548717|42126418|FG000|Overall Study|Relapse|3|||
19678653|NCT00548717|42126419|FG001|Overall Study|Relapse|0|||
19678654|NCT00548717|42126418|FG000|Overall Study|Alternative treatment for GVHD|1|||
19678655|NCT00548717|42126419|FG001|Overall Study|Alternative treatment for GVHD|0|||
19678656|NCT00441168|42126430|FG000|Treatment Period|Death|3|||
19678657|NCT00441168|42126431|FG001|Treatment Period|Death|0|||
19678658|NCT00441168|42126430|FG000|Treatment Period|Adverse Event|1|||
19678659|NCT00441168|42126431|FG001|Treatment Period|Adverse Event|2|||
19678660|NCT00441168|42126430|FG000|Treatment Period|Progressive Disease|0|||
19678661|NCT00441168|42126431|FG001|Treatment Period|Progressive Disease|2|||
19678662|NCT00441168|42126430|FG000|Treatment Period|Protocol Violation|0|||
19678663|NCT00441168|42126431|FG001|Treatment Period|Protocol Violation|1|||
19678664|NCT00441168|42126430|FG000|Treatment Period|Lost to Follow-up|0|||
19678665|NCT00441168|42126431|FG001|Treatment Period|Lost to Follow-up|1|||
19678666|NCT00441168|42126430|FG000|Treatment Period|Withdrawal by Subject|3|||
19678667|NCT00441168|42126431|FG001|Treatment Period|Withdrawal by Subject|0|||
19678668|NCT00441168|42126430|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
19678669|NCT00441168|42126431|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
19678670|NCT00441168|42126430|FG000|Treatment Period|refractory disease|1|||
19678671|NCT00441168|42126431|FG001|Treatment Period|refractory disease|0|||
19678672|NCT00441168|42126430|FG000|Follow-up Period|Death|3|||
19678673|NCT00441168|42126431|FG001|Follow-up Period|Death|0|||
19678674|NCT00441168|42126430|FG000|Follow-up Period|Lost to Follow-up|5|||
19678675|NCT00441168|42126431|FG001|Follow-up Period|Lost to Follow-up|6|||
19678676|NCT00441168|42126430|FG000|Follow-up Period|Withdrawal by Subject|3|||
19678677|NCT00441168|42126431|FG001|Follow-up Period|Withdrawal by Subject|0|||
19678678|NCT00441168|42126430|FG000|Follow-up Period|Other|1|||
19678679|NCT00441168|42126431|FG001|Follow-up Period|Other|3|||
19678680|NCT00296140|42126439|FG000|Overall Study|Lost to Follow-up|1|||
19678681|NCT00296140|42126440|FG001|Overall Study|Lost to Follow-up|0|||
19760429|NCT03364309|42212402|FG001|Induction Period|Lost to Follow-up|0|||
19760430|NCT03364309|42212403|FG002|Induction Period|Lost to Follow-up|0|||
19760431|NCT03364309|42212404|FG003|Induction Period|Lost to Follow-up|0|||
19760432|NCT03364309|42212405|FG004|Induction Period|Lost to Follow-up|0|||
19760433|NCT03364309|42212406|FG005|Induction Period|Lost to Follow-up|0|||
19760434|NCT03364309|42212407|FG006|Induction Period|Lost to Follow-up|0|||
19760435|NCT03364309|42212408|FG007|Induction Period|Lost to Follow-up|0|||
19760436|NCT03364309|42212409|FG008|Induction Period|Lost to Follow-up|0|||
19760437|NCT03364309|42212410|FG009|Induction Period|Lost to Follow-up|0|||
19760438|NCT03364309|42212411|FG010|Induction Period|Lost to Follow-up|0|||
19760439|NCT03364309|42212412|FG011|Induction Period|Lost to Follow-up|0|||
19760440|NCT03364309|42212413|FG012|Induction Period|Lost to Follow-up|0|||
19760441|NCT03364309|42212414|FG013|Induction Period|Lost to Follow-up|0|||
19678682|NCT00296140|42126439|FG000|Overall Study|Withdrawal by Subject|1|||
19760442|NCT03364309|42212415|FG014|Induction Period|Lost to Follow-up|0|||
19760443|NCT03364309|42212416|FG015|Induction Period|Lost to Follow-up|0|||
19760444|NCT03364309|42212417|FG016|Induction Period|Lost to Follow-up|0|||
19678683|NCT00296140|42126440|FG001|Overall Study|Withdrawal by Subject|0|||
19678684|NCT00296140|42126439|FG000|Overall Study|Discharge to Nursing Home|1|||
19678685|NCT00296140|42126440|FG001|Overall Study|Discharge to Nursing Home|0|||
19678686|NCT03958331|42126449|FG000|Overall Study|Withdrawal by Subject|3|||
19678687|NCT03958331|42126450|FG001|Overall Study|Withdrawal by Subject|1|||
19678688|NCT03958331|42126451|FG002|Overall Study|Withdrawal by Subject|5|||
19678689|NCT03958331|42126449|FG000|Overall Study|Weaned from medicine|2|||
19678690|NCT03958331|42126450|FG001|Overall Study|Weaned from medicine|0|||
19678691|NCT03958331|42126451|FG002|Overall Study|Weaned from medicine|0|||
19678692|NCT03958331|42126449|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
19678693|NCT03958331|42126450|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
19678694|NCT03958331|42126451|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
19678695|NCT03956615|42126457|FG000|Overall Study|No multiple myeloma confirmed|2|||
19678696|NCT03956615|42126457|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
19678697|NCT03956615|42126457|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
19678698|NCT03956615|42126457|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
19678699|NCT03956225|42126463|FG000|Overall Study|Lack of Efficacy|1|||
19678700|NCT03956225|42126464|FG001|Overall Study|Lack of Efficacy|1|||
19678701|NCT03956225|42126463|FG000|Overall Study|Lost to Follow-up|0|||
19678702|NCT03956225|42126464|FG001|Overall Study|Lost to Follow-up|1|||
19678703|NCT03956225|42126463|FG000|Overall Study|Withdrawal by Subject|2|||
19678704|NCT03956225|42126464|FG001|Overall Study|Withdrawal by Subject|1|||
19678705|NCT03956225|42126463|FG000|Overall Study|Other Reasons|2|||
19678706|NCT03956225|42126464|FG001|Overall Study|Other Reasons|1|||
19678707|NCT00457626|42126473|FG000|Overall Study|Adverse Event|3|||
19678708|NCT00457626|42126473|FG000|Overall Study|Administrative Problems|2|||
19678709|NCT00457626|42126473|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
19678710|NCT00373113|42126479|FG000|Overall Study|Death|1|||
19678711|NCT00373113|42126480|FG001|Overall Study|Death|7|||
19678712|NCT00373113|42126479|FG000|Overall Study|Adverse Event|38|||
19678713|NCT00373113|42126480|FG001|Overall Study|Adverse Event|24|||
19678714|NCT00373113|42126479|FG000|Overall Study|Study terminated by sponsor|9|||
19678715|NCT00373113|42126480|FG001|Overall Study|Study terminated by sponsor|1|||
19678716|NCT00373113|42126479|FG000|Overall Study|Global deterioration of health status|10|||
19678717|NCT00373113|42126480|FG001|Overall Study|Global deterioration of health status|7|||
19678718|NCT00373113|42126479|FG000|Overall Study|Lost to Follow-up|1|||
19678719|NCT00373113|42126480|FG001|Overall Study|Lost to Follow-up|3|||
19678720|NCT00373113|42126479|FG000|Overall Study|Objective progression or relapse|150|||
19678721|NCT00373113|42126480|FG001|Overall Study|Objective progression or relapse|169|||
19678722|NCT00373113|42126479|FG000|Overall Study|Other|14|||
19678723|NCT00373113|42126480|FG001|Overall Study|Other|17|||
19678724|NCT00373113|42126479|FG000|Overall Study|Protocol Violation|5|||
19678725|NCT00373113|42126480|FG001|Overall Study|Protocol Violation|1|||
19678726|NCT00373113|42126479|FG000|Overall Study|Withdrawal by Subject|10|||
19678727|NCT00373113|42126480|FG001|Overall Study|Withdrawal by Subject|15|||
19678728|NCT00407511|42126486|FG000|Overall Study|Adverse Event|9|||
19678729|NCT00407511|42126486|FG000|Overall Study|Lost to Follow-up|4|||
19760445|NCT03364309|42212418|FG017|Induction Period|Lost to Follow-up|0|||
19760446|NCT03364309|42212419|FG018|Induction Period|Lost to Follow-up|0|||
19760447|NCT03364309|42212401|FG000|Induction Period|Physician Decision|0|||
19760448|NCT03364309|42212402|FG001|Induction Period|Physician Decision|1|||
19760449|NCT03364309|42212403|FG002|Induction Period|Physician Decision|0|||
19760450|NCT03364309|42212404|FG003|Induction Period|Physician Decision|0|||
19760451|NCT03364309|42212405|FG004|Induction Period|Physician Decision|0|||
19678730|NCT00407511|42126486|FG000|Overall Study|Other|5|||
19678731|NCT00407511|42126486|FG000|Overall Study|Withdrawal by Subject|4|||
19678732|NCT00384189|42126494|FG000|Overall Study|Reason Not Specified|50|||
19678733|NCT00384189|42126495|FG001|Overall Study|Reason Not Specified|57|||
19678734|NCT00384189|42126496|FG002|Overall Study|Reason Not Specified|58|||
19678735|NCT00384189|42126497|FG003|Overall Study|Reason Not Specified|40|||
19678736|NCT00326716|42126509|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
19799418|NCT02962739|42257488|FG003|Overall Study|Protocol Violation|0|||
19678737|NCT00326716|42126510|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
19678738|NCT00326716|42126511|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
19678739|NCT00326716|42126512|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
19678740|NCT00548405|42126545|FG000|Overall Study|Adverse Event|6|||
19678741|NCT00548405|42126546|FG001|Overall Study|Adverse Event|2|||
19678742|NCT00548405|42126547|FG002|Overall Study|Adverse Event|0|||
19678743|NCT00548405|42126545|FG000|Overall Study|Lack of Efficacy|6|||
19678744|NCT00548405|42126546|FG001|Overall Study|Lack of Efficacy|0|||
19678745|NCT00548405|42126547|FG002|Overall Study|Lack of Efficacy|0|||
19678746|NCT00548405|42126545|FG000|Overall Study|Physician Decision|3|||
19678747|NCT00548405|42126546|FG001|Overall Study|Physician Decision|4|||
19678748|NCT00548405|42126547|FG002|Overall Study|Physician Decision|1|||
19678749|NCT00548405|42126545|FG000|Overall Study|Pregnancy|1|||
19678750|NCT00548405|42126546|FG001|Overall Study|Pregnancy|0|||
19678751|NCT00548405|42126547|FG002|Overall Study|Pregnancy|0|||
19678752|NCT00548405|42126545|FG000|Overall Study|Protocol Violation|1|||
19678753|NCT00548405|42126546|FG001|Overall Study|Protocol Violation|0|||
19678754|NCT00548405|42126547|FG002|Overall Study|Protocol Violation|0|||
19678755|NCT00548405|42126545|FG000|Overall Study|Withdrawal by Subject|36|||
19678756|NCT00548405|42126546|FG001|Overall Study|Withdrawal by Subject|12|||
19678757|NCT00548405|42126547|FG002|Overall Study|Withdrawal by Subject|5|||
19678758|NCT00548405|42126545|FG000|Overall Study|Lost to Follow-up|1|||
19678759|NCT00548405|42126546|FG001|Overall Study|Lost to Follow-up|1|||
19678760|NCT00548405|42126547|FG002|Overall Study|Lost to Follow-up|2|||
19678761|NCT00548405|42126545|FG000|Overall Study|Death|0|||
19678762|NCT00548405|42126546|FG001|Overall Study|Death|1|||
19678763|NCT00548405|42126547|FG002|Overall Study|Death|1|||
19678764|NCT00548405|42126545|FG000|Overall Study|Sponsor decision|1|||
19678765|NCT00548405|42126546|FG001|Overall Study|Sponsor decision|0|||
19678766|NCT00548405|42126547|FG002|Overall Study|Sponsor decision|0|||
19678767|NCT00548405|42126545|FG000|Overall Study|Randomized but not treated|1|||
19678768|NCT00548405|42126546|FG001|Overall Study|Randomized but not treated|0|||
19678769|NCT00548405|42126547|FG002|Overall Study|Randomized but not treated|0|||
19678770|NCT00295750|42126559|FG000|Overall Study|Adverse Event|19|||
19678771|NCT00295750|42126560|FG001|Overall Study|Adverse Event|15|||
19678772|NCT00295750|42126561|FG002|Overall Study|Adverse Event|12|||
19678773|NCT00295750|42126559|FG000|Overall Study|Lack of Efficacy|1|||
19678774|NCT00295750|42126560|FG001|Overall Study|Lack of Efficacy|1|||
19678775|NCT00295750|42126561|FG002|Overall Study|Lack of Efficacy|0|||
19678776|NCT00295750|42126559|FG000|Overall Study|Lost to Follow-up|1|||
19678777|NCT00295750|42126560|FG001|Overall Study|Lost to Follow-up|4|||
19678778|NCT00295750|42126561|FG002|Overall Study|Lost to Follow-up|1|||
19678779|NCT00295750|42126559|FG000|Overall Study|Taking prohibited therapy|2|||
19678780|NCT00295750|42126560|FG001|Overall Study|Taking prohibited therapy|3|||
19678781|NCT00295750|42126561|FG002|Overall Study|Taking prohibited therapy|2|||
19678782|NCT00295750|42126559|FG000|Overall Study|Administrative errors|2|||
19678783|NCT00295750|42126560|FG001|Overall Study|Administrative errors|4|||
19678784|NCT00295750|42126561|FG002|Overall Study|Administrative errors|5|||
19678785|NCT00295750|42126559|FG000|Overall Study|Trial drug errors|1|||
19678786|NCT00295750|42126560|FG001|Overall Study|Trial drug errors|1|||
19678787|NCT00295750|42126561|FG002|Overall Study|Trial drug errors|0|||
19678788|NCT00295750|42126559|FG000|Overall Study|Disease progression|2|||
19678789|NCT00295750|42126560|FG001|Overall Study|Disease progression|1|||
19678790|NCT00295750|42126561|FG002|Overall Study|Disease progression|0|||
19678791|NCT00295750|42126559|FG000|Overall Study|Personal reasons|0|||
19678792|NCT00295750|42126560|FG001|Overall Study|Personal reasons|1|||
19678793|NCT00295750|42126561|FG002|Overall Study|Personal reasons|0|||
19678794|NCT00295750|42126559|FG000|Overall Study|Randomized but never received trial drug|4|||
19678795|NCT00295750|42126560|FG001|Overall Study|Randomized but never received trial drug|3|||
19678796|NCT00295750|42126561|FG002|Overall Study|Randomized but never received trial drug|3|||
19678797|NCT00295750|42126559|FG000|Overall Study|Withdrawal by Subject|9|||
19678798|NCT00295750|42126560|FG001|Overall Study|Withdrawal by Subject|4|||
19678799|NCT00295750|42126561|FG002|Overall Study|Withdrawal by Subject|7|||
19678800|NCT00295750|42126559|FG000|Overall Study|Protocol Violation|2|||
19678801|NCT00295750|42126560|FG001|Overall Study|Protocol Violation|4|||
19678802|NCT00295750|42126561|FG002|Overall Study|Protocol Violation|2|||
19678803|NCT03948581|42126571|FG000|Overall Study|Lost to Follow-up|0|||
19678804|NCT03948581|42126572|FG001|Overall Study|Lost to Follow-up|1|||
19678805|NCT00548327|42126580|FG000|Overall Study|Adverse Event|0|||
19678806|NCT00548327|42126581|FG001|Overall Study|Adverse Event|1|||
19678807|NCT03953183|42126603|FG000|Overall Study|Physician Decision|0|||
19760452|NCT03364309|42212406|FG005|Induction Period|Physician Decision|0|||
19678808|NCT03953183|42126604|FG001|Overall Study|Physician Decision|1|||
19678809|NCT03953183|42126603|FG000|Overall Study|Withdrawal by Subject|0|||
19678810|NCT03953183|42126604|FG001|Overall Study|Withdrawal by Subject|1|||
19678811|NCT00406653|42126614|FG000|Induction Period|Adverse Event|1|||
19678812|NCT00406653|42126615|FG001|Induction Period|Adverse Event|10|||
19760453|NCT03364309|42212407|FG006|Induction Period|Physician Decision|0|||
19678813|NCT00406653|42126616|FG002|Induction Period|Adverse Event|4|||
19678814|NCT00406653|42126617|FG003|Induction Period|Adverse Event|11|||
19678815|NCT00406653|42126618|FG004|Induction Period|Adverse Event|0|||
19678816|NCT00406653|42126619|FG005|Induction Period|Adverse Event|0|||
19678817|NCT00406653|42126620|FG006|Induction Period|Adverse Event|0|||
19678818|NCT00406653|42126614|FG000|Induction Period|Lack of Efficacy|11|||
19678819|NCT00406653|42126615|FG001|Induction Period|Lack of Efficacy|14|||
19678820|NCT00406653|42126616|FG002|Induction Period|Lack of Efficacy|8|||
19678821|NCT00406653|42126617|FG003|Induction Period|Lack of Efficacy|10|||
19678822|NCT00406653|42126618|FG004|Induction Period|Lack of Efficacy|0|||
19678823|NCT00406653|42126619|FG005|Induction Period|Lack of Efficacy|0|||
19678824|NCT00406653|42126620|FG006|Induction Period|Lack of Efficacy|0|||
19678825|NCT00406653|42126614|FG000|Induction Period|Lost to Follow-up|0|||
19678826|NCT00406653|42126615|FG001|Induction Period|Lost to Follow-up|2|||
19678827|NCT00406653|42126616|FG002|Induction Period|Lost to Follow-up|0|||
19678828|NCT00406653|42126617|FG003|Induction Period|Lost to Follow-up|0|||
19678829|NCT00406653|42126618|FG004|Induction Period|Lost to Follow-up|0|||
19678830|NCT00406653|42126619|FG005|Induction Period|Lost to Follow-up|0|||
19678831|NCT00406653|42126620|FG006|Induction Period|Lost to Follow-up|0|||
19678832|NCT00406653|42126614|FG000|Induction Period|Withdrawal of Consent|2|||
19678833|NCT00406653|42126615|FG001|Induction Period|Withdrawal of Consent|5|||
19678834|NCT00406653|42126616|FG002|Induction Period|Withdrawal of Consent|1|||
19678835|NCT00406653|42126617|FG003|Induction Period|Withdrawal of Consent|2|||
19678836|NCT00406653|42126618|FG004|Induction Period|Withdrawal of Consent|0|||
19678837|NCT00406653|42126619|FG005|Induction Period|Withdrawal of Consent|0|||
19678838|NCT00406653|42126620|FG006|Induction Period|Withdrawal of Consent|0|||
19678839|NCT00406653|42126614|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678840|NCT00406653|42126615|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678841|NCT00406653|42126616|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678842|NCT00406653|42126617|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
19678843|NCT00406653|42126618|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678844|NCT00406653|42126619|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678845|NCT00406653|42126620|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
19678846|NCT00406653|42126614|FG000|Induction Period|Pregnancy|1|||
19678847|NCT00406653|42126615|FG001|Induction Period|Pregnancy|0|||
19678848|NCT00406653|42126616|FG002|Induction Period|Pregnancy|0|||
19678849|NCT00406653|42126617|FG003|Induction Period|Pregnancy|0|||
19678850|NCT00406653|42126618|FG004|Induction Period|Pregnancy|0|||
19678851|NCT00406653|42126619|FG005|Induction Period|Pregnancy|0|||
19678852|NCT00406653|42126620|FG006|Induction Period|Pregnancy|0|||
19678853|NCT00406653|42126614|FG000|Induction Period|Declined participation but followup done|0|||
19678854|NCT00406653|42126615|FG001|Induction Period|Declined participation but followup done|2|||
19678855|NCT00406653|42126616|FG002|Induction Period|Declined participation but followup done|1|||
19678856|NCT00406653|42126617|FG003|Induction Period|Declined participation but followup done|1|||
19678857|NCT00406653|42126618|FG004|Induction Period|Declined participation but followup done|0|||
19678858|NCT00406653|42126619|FG005|Induction Period|Declined participation but followup done|0|||
19678859|NCT00406653|42126620|FG006|Induction Period|Declined participation but followup done|0|||
19678860|NCT00406653|42126614|FG000|Induction Period|Given prohibited drug|0|||
19678861|NCT00406653|42126615|FG001|Induction Period|Given prohibited drug|1|||
19678862|NCT00406653|42126616|FG002|Induction Period|Given prohibited drug|2|||
19678863|NCT00406653|42126617|FG003|Induction Period|Given prohibited drug|0|||
19678864|NCT00406653|42126618|FG004|Induction Period|Given prohibited drug|0|||
19678865|NCT00406653|42126619|FG005|Induction Period|Given prohibited drug|0|||
19678866|NCT00406653|42126620|FG006|Induction Period|Given prohibited drug|0|||
19678867|NCT00406653|42126614|FG000|Induction Period|Incarcerated|0|||
19678868|NCT00406653|42126615|FG001|Induction Period|Incarcerated|0|||
19678869|NCT00406653|42126616|FG002|Induction Period|Incarcerated|1|||
19678870|NCT00406653|42126617|FG003|Induction Period|Incarcerated|0|||
19678871|NCT00406653|42126618|FG004|Induction Period|Incarcerated|0|||
19678872|NCT00406653|42126619|FG005|Induction Period|Incarcerated|0|||
19678873|NCT00406653|42126620|FG006|Induction Period|Incarcerated|0|||
19678874|NCT00406653|42126614|FG000|Induction Period|Patient relocated|0|||
19678875|NCT00406653|42126615|FG001|Induction Period|Patient relocated|0|||
19678876|NCT00406653|42126616|FG002|Induction Period|Patient relocated|1|||
19678877|NCT00406653|42126617|FG003|Induction Period|Patient relocated|0|||
19678878|NCT00406653|42126618|FG004|Induction Period|Patient relocated|0|||
19678879|NCT00406653|42126619|FG005|Induction Period|Patient relocated|0|||
19678880|NCT00406653|42126620|FG006|Induction Period|Patient relocated|0|||
19678881|NCT00406653|42126614|FG000|Maintenance Period|Adverse Event|0|||
19678882|NCT00406653|42126615|FG001|Maintenance Period|Adverse Event|0|||
19678883|NCT00406653|42126616|FG002|Maintenance Period|Adverse Event|0|||
19678884|NCT00406653|42126617|FG003|Maintenance Period|Adverse Event|0|||
19678885|NCT00406653|42126618|FG004|Maintenance Period|Adverse Event|1|||
19678886|NCT00406653|42126619|FG005|Maintenance Period|Adverse Event|1|||
19678887|NCT00406653|42126620|FG006|Maintenance Period|Adverse Event|0|||
19678888|NCT00406653|42126614|FG000|Maintenance Period|Lack of Efficacy|0|||
19799419|NCT02962739|42257489|FG004|Overall Study|Protocol Violation|1|||
19678889|NCT00406653|42126615|FG001|Maintenance Period|Lack of Efficacy|0|||
19678890|NCT00406653|42126616|FG002|Maintenance Period|Lack of Efficacy|0|||
19678891|NCT00406653|42126617|FG003|Maintenance Period|Lack of Efficacy|0|||
19678892|NCT00406653|42126618|FG004|Maintenance Period|Lack of Efficacy|20|||
19678893|NCT00406653|42126619|FG005|Maintenance Period|Lack of Efficacy|26|||
19678894|NCT00406653|42126620|FG006|Maintenance Period|Lack of Efficacy|0|||
19678895|NCT00406653|42126614|FG000|Maintenance Period|Lost to Follow-up|0|||
19678896|NCT00406653|42126615|FG001|Maintenance Period|Lost to Follow-up|0|||
19678897|NCT00406653|42126616|FG002|Maintenance Period|Lost to Follow-up|0|||
19678898|NCT00406653|42126617|FG003|Maintenance Period|Lost to Follow-up|0|||
19678899|NCT00406653|42126618|FG004|Maintenance Period|Lost to Follow-up|2|||
19678900|NCT00406653|42126619|FG005|Maintenance Period|Lost to Follow-up|1|||
19678901|NCT00406653|42126620|FG006|Maintenance Period|Lost to Follow-up|0|||
19678902|NCT00406653|42126614|FG000|Maintenance Period|Withdrawal of Consent|0|||
19678903|NCT00406653|42126615|FG001|Maintenance Period|Withdrawal of Consent|0|||
19678904|NCT00406653|42126616|FG002|Maintenance Period|Withdrawal of Consent|0|||
19678905|NCT00406653|42126617|FG003|Maintenance Period|Withdrawal of Consent|0|||
19678906|NCT00406653|42126618|FG004|Maintenance Period|Withdrawal of Consent|2|||
19678907|NCT00406653|42126619|FG005|Maintenance Period|Withdrawal of Consent|0|||
19678908|NCT00406653|42126620|FG006|Maintenance Period|Withdrawal of Consent|0|||
19678909|NCT00406653|42126614|FG000|Maintenance Period|Pregnancy|0|||
19678910|NCT00406653|42126615|FG001|Maintenance Period|Pregnancy|0|||
19678911|NCT00406653|42126616|FG002|Maintenance Period|Pregnancy|0|||
19678912|NCT00406653|42126617|FG003|Maintenance Period|Pregnancy|0|||
19678913|NCT00406653|42126618|FG004|Maintenance Period|Pregnancy|0|||
19678914|NCT00406653|42126619|FG005|Maintenance Period|Pregnancy|1|||
19678915|NCT00406653|42126620|FG006|Maintenance Period|Pregnancy|0|||
19678916|NCT00406653|42126614|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
19678917|NCT00406653|42126615|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
19678918|NCT00406653|42126616|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
19678919|NCT00406653|42126617|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
19678920|NCT00406653|42126618|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
19678921|NCT00406653|42126619|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
19678922|NCT00406653|42126620|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
19678923|NCT00406653|42126614|FG000|Maintenance Period|Error in disease score evaluation|0|||
19678924|NCT00406653|42126615|FG001|Maintenance Period|Error in disease score evaluation|0|||
19678925|NCT00406653|42126616|FG002|Maintenance Period|Error in disease score evaluation|0|||
19678926|NCT00406653|42126617|FG003|Maintenance Period|Error in disease score evaluation|0|||
19678927|NCT00406653|42126618|FG004|Maintenance Period|Error in disease score evaluation|1|||
19678928|NCT00406653|42126619|FG005|Maintenance Period|Error in disease score evaluation|0|||
19678929|NCT00406653|42126620|FG006|Maintenance Period|Error in disease score evaluation|0|||
19678930|NCT00406653|42126614|FG000|Open-Label Period|Death|0|||
19678931|NCT00406653|42126615|FG001|Open-Label Period|Death|0|||
19678932|NCT00406653|42126616|FG002|Open-Label Period|Death|0|||
19760454|NCT03364309|42212408|FG007|Induction Period|Physician Decision|0|||
19760455|NCT03364309|42212409|FG008|Induction Period|Physician Decision|0|||
19678933|NCT00406653|42126617|FG003|Open-Label Period|Death|0|||
19678934|NCT00406653|42126618|FG004|Open-Label Period|Death|0|||
19678935|NCT00406653|42126619|FG005|Open-Label Period|Death|0|||
19678936|NCT00406653|42126620|FG006|Open-Label Period|Death|1|||
19678937|NCT00406653|42126614|FG000|Open-Label Period|Adverse Event|0|||
19678938|NCT00406653|42126615|FG001|Open-Label Period|Adverse Event|0|||
19760456|NCT03364309|42212410|FG009|Induction Period|Physician Decision|0|||
19760457|NCT03364309|42212411|FG010|Induction Period|Physician Decision|0|||
19760458|NCT03364309|42212412|FG011|Induction Period|Physician Decision|0|||
19760459|NCT03364309|42212413|FG012|Induction Period|Physician Decision|0|||
19760460|NCT03364309|42212414|FG013|Induction Period|Physician Decision|0|||
19760461|NCT03364309|42212415|FG014|Induction Period|Physician Decision|0|||
19760462|NCT03364309|42212416|FG015|Induction Period|Physician Decision|0|||
19760463|NCT03364309|42212417|FG016|Induction Period|Physician Decision|0|||
19760464|NCT03364309|42212418|FG017|Induction Period|Physician Decision|0|||
19760465|NCT03364309|42212419|FG018|Induction Period|Physician Decision|0|||
19760466|NCT03364309|42212401|FG000|Maintenance Period|Withdrawal by Subject|0|||
19760467|NCT03364309|42212402|FG001|Maintenance Period|Withdrawal by Subject|0|||
19760468|NCT03364309|42212403|FG002|Maintenance Period|Withdrawal by Subject|0|||
19760469|NCT03364309|42212404|FG003|Maintenance Period|Withdrawal by Subject|1|||
19760470|NCT03364309|42212405|FG004|Maintenance Period|Withdrawal by Subject|3|||
19760471|NCT03364309|42212406|FG005|Maintenance Period|Withdrawal by Subject|1|||
19678939|NCT00406653|42126616|FG002|Open-Label Period|Adverse Event|0|||
19678940|NCT00406653|42126617|FG003|Open-Label Period|Adverse Event|0|||
19678941|NCT00406653|42126618|FG004|Open-Label Period|Adverse Event|0|||
19678942|NCT00406653|42126619|FG005|Open-Label Period|Adverse Event|0|||
19678943|NCT00406653|42126620|FG006|Open-Label Period|Adverse Event|18|||
19678944|NCT00406653|42126614|FG000|Open-Label Period|Lack of Efficacy|0|||
19678945|NCT00406653|42126615|FG001|Open-Label Period|Lack of Efficacy|0|||
19760472|NCT03364309|42212407|FG006|Maintenance Period|Withdrawal by Subject|3|||
19760473|NCT03364309|42212408|FG007|Maintenance Period|Withdrawal by Subject|0|||
19760474|NCT03364309|42212409|FG008|Maintenance Period|Withdrawal by Subject|1|||
19760475|NCT03364309|42212410|FG009|Maintenance Period|Withdrawal by Subject|1|||
19760476|NCT03364309|42212411|FG010|Maintenance Period|Withdrawal by Subject|2|||
19760477|NCT03364309|42212412|FG011|Maintenance Period|Withdrawal by Subject|0|||
19760478|NCT03364309|42212413|FG012|Maintenance Period|Withdrawal by Subject|0|||
19760479|NCT03364309|42212414|FG013|Maintenance Period|Withdrawal by Subject|0|||
19760480|NCT03364309|42212415|FG014|Maintenance Period|Withdrawal by Subject|0|||
19760481|NCT03364309|42212416|FG015|Maintenance Period|Withdrawal by Subject|0|||
19760482|NCT03364309|42212417|FG016|Maintenance Period|Withdrawal by Subject|0|||
19760483|NCT03364309|42212418|FG017|Maintenance Period|Withdrawal by Subject|0|||
19760484|NCT03364309|42212419|FG018|Maintenance Period|Withdrawal by Subject|0|||
19760485|NCT03364309|42212401|FG000|Maintenance Period|Adverse Event|0|||
19760486|NCT03364309|42212402|FG001|Maintenance Period|Adverse Event|0|||
19760487|NCT03364309|42212403|FG002|Maintenance Period|Adverse Event|0|||
19760488|NCT03364309|42212404|FG003|Maintenance Period|Adverse Event|0|||
19760489|NCT03364309|42212405|FG004|Maintenance Period|Adverse Event|2|||
19760490|NCT03364309|42212406|FG005|Maintenance Period|Adverse Event|0|||
19760491|NCT03364309|42212407|FG006|Maintenance Period|Adverse Event|3|||
19760492|NCT03364309|42212408|FG007|Maintenance Period|Adverse Event|0|||
19760493|NCT03364309|42212409|FG008|Maintenance Period|Adverse Event|1|||
19760494|NCT03364309|42212410|FG009|Maintenance Period|Adverse Event|0|||
19760495|NCT03364309|42212411|FG010|Maintenance Period|Adverse Event|2|||
19760496|NCT03364309|42212412|FG011|Maintenance Period|Adverse Event|0|||
19760497|NCT03364309|42212413|FG012|Maintenance Period|Adverse Event|0|||
19760498|NCT03364309|42212414|FG013|Maintenance Period|Adverse Event|0|||
19760499|NCT03364309|42212415|FG014|Maintenance Period|Adverse Event|0|||
19760500|NCT03364309|42212416|FG015|Maintenance Period|Adverse Event|0|||
19760501|NCT03364309|42212417|FG016|Maintenance Period|Adverse Event|0|||
19760502|NCT03364309|42212418|FG017|Maintenance Period|Adverse Event|0|||
19760503|NCT03364309|42212419|FG018|Maintenance Period|Adverse Event|0|||
19760504|NCT03364309|42212401|FG000|Maintenance Period|Relapsed|0|||
19760505|NCT03364309|42212402|FG001|Maintenance Period|Relapsed|0|||
19760506|NCT03364309|42212403|FG002|Maintenance Period|Relapsed|0|||
19760507|NCT03364309|42212404|FG003|Maintenance Period|Relapsed|43|||
19760508|NCT03364309|42212405|FG004|Maintenance Period|Relapsed|7|||
19760509|NCT03364309|42212406|FG005|Maintenance Period|Relapsed|45|||
19760510|NCT03364309|42212407|FG006|Maintenance Period|Relapsed|10|||
19760511|NCT03364309|42212408|FG007|Maintenance Period|Relapsed|2|||
19760512|NCT03364309|42212409|FG008|Maintenance Period|Relapsed|0|||
19760513|NCT03364309|42212410|FG009|Maintenance Period|Relapsed|0|||
19760514|NCT03364309|42212411|FG010|Maintenance Period|Relapsed|0|||
19760515|NCT03364309|42212412|FG011|Maintenance Period|Relapsed|0|||
19760516|NCT03364309|42212413|FG012|Maintenance Period|Relapsed|0|||
19760517|NCT03364309|42212414|FG013|Maintenance Period|Relapsed|0|||
19760518|NCT03364309|42212415|FG014|Maintenance Period|Relapsed|0|||
19760519|NCT03364309|42212416|FG015|Maintenance Period|Relapsed|0|||
19760520|NCT03364309|42212417|FG016|Maintenance Period|Relapsed|0|||
19760521|NCT03364309|42212418|FG017|Maintenance Period|Relapsed|0|||
19760522|NCT03364309|42212419|FG018|Maintenance Period|Relapsed|0|||
19760523|NCT03364309|42212401|FG000|Maintenance Period|Lack of Efficacy|0|||
19760524|NCT03364309|42212402|FG001|Maintenance Period|Lack of Efficacy|0|||
19760525|NCT03364309|42212403|FG002|Maintenance Period|Lack of Efficacy|0|||
19760526|NCT03364309|42212404|FG003|Maintenance Period|Lack of Efficacy|0|||
19760527|NCT03364309|42212405|FG004|Maintenance Period|Lack of Efficacy|0|||
19760528|NCT03364309|42212406|FG005|Maintenance Period|Lack of Efficacy|0|||
19760529|NCT03364309|42212407|FG006|Maintenance Period|Lack of Efficacy|0|||
19760530|NCT03364309|42212408|FG007|Maintenance Period|Lack of Efficacy|0|||
19760531|NCT03364309|42212409|FG008|Maintenance Period|Lack of Efficacy|1|||
19760532|NCT03364309|42212410|FG009|Maintenance Period|Lack of Efficacy|3|||
19760533|NCT03364309|42212411|FG010|Maintenance Period|Lack of Efficacy|2|||
19760534|NCT03364309|42212412|FG011|Maintenance Period|Lack of Efficacy|0|||
19760535|NCT03364309|42212413|FG012|Maintenance Period|Lack of Efficacy|0|||
19760536|NCT03364309|42212414|FG013|Maintenance Period|Lack of Efficacy|0|||
19760537|NCT03364309|42212415|FG014|Maintenance Period|Lack of Efficacy|0|||
19760538|NCT03364309|42212416|FG015|Maintenance Period|Lack of Efficacy|0|||
19760539|NCT03364309|42212417|FG016|Maintenance Period|Lack of Efficacy|0|||
19760540|NCT03364309|42212418|FG017|Maintenance Period|Lack of Efficacy|0|||
19760541|NCT03364309|42212419|FG018|Maintenance Period|Lack of Efficacy|0|||
19760542|NCT03364309|42212401|FG000|Maintenance Period|Death|0|||
19760543|NCT03364309|42212402|FG001|Maintenance Period|Death|0|||
19760544|NCT03364309|42212403|FG002|Maintenance Period|Death|0|||
19760545|NCT03364309|42212404|FG003|Maintenance Period|Death|0|||
19760546|NCT03364309|42212405|FG004|Maintenance Period|Death|0|||
19760547|NCT03364309|42212406|FG005|Maintenance Period|Death|0|||
19477171|NCT01513291|41756109|FG001|Treatment Period|Protocol Violation|2|||
19760548|NCT03364309|42212407|FG006|Maintenance Period|Death|0|||
19760549|NCT03364309|42212408|FG007|Maintenance Period|Death|0|||
19760550|NCT03364309|42212409|FG008|Maintenance Period|Death|1|||
19760551|NCT03364309|42212410|FG009|Maintenance Period|Death|0|||
19760552|NCT03364309|42212411|FG010|Maintenance Period|Death|0|||
19760553|NCT03364309|42212412|FG011|Maintenance Period|Death|0|||
19760554|NCT03364309|42212413|FG012|Maintenance Period|Death|0|||
19760555|NCT03364309|42212414|FG013|Maintenance Period|Death|0|||
19760556|NCT03364309|42212415|FG014|Maintenance Period|Death|0|||
19760557|NCT03364309|42212416|FG015|Maintenance Period|Death|0|||
19760558|NCT03364309|42212417|FG016|Maintenance Period|Death|0|||
19760559|NCT03364309|42212418|FG017|Maintenance Period|Death|0|||
19760560|NCT03364309|42212419|FG018|Maintenance Period|Death|0|||
19760561|NCT03364309|42212401|FG000|Maintenance Period|Lost to Follow-up|0|||
19760562|NCT03364309|42212402|FG001|Maintenance Period|Lost to Follow-up|0|||
19760563|NCT03364309|42212403|FG002|Maintenance Period|Lost to Follow-up|0|||
19760564|NCT03364309|42212404|FG003|Maintenance Period|Lost to Follow-up|0|||
19760565|NCT03364309|42212405|FG004|Maintenance Period|Lost to Follow-up|0|||
19760566|NCT03364309|42212406|FG005|Maintenance Period|Lost to Follow-up|0|||
19760567|NCT03364309|42212407|FG006|Maintenance Period|Lost to Follow-up|0|||
19760568|NCT03364309|42212408|FG007|Maintenance Period|Lost to Follow-up|0|||
19760569|NCT03364309|42212409|FG008|Maintenance Period|Lost to Follow-up|1|||
19760570|NCT03364309|42212410|FG009|Maintenance Period|Lost to Follow-up|0|||
19760571|NCT03364309|42212411|FG010|Maintenance Period|Lost to Follow-up|0|||
19760572|NCT03364309|42212412|FG011|Maintenance Period|Lost to Follow-up|0|||
19760573|NCT03364309|42212413|FG012|Maintenance Period|Lost to Follow-up|0|||
19760574|NCT03364309|42212414|FG013|Maintenance Period|Lost to Follow-up|0|||
19760575|NCT03364309|42212415|FG014|Maintenance Period|Lost to Follow-up|0|||
19760576|NCT03364309|42212416|FG015|Maintenance Period|Lost to Follow-up|0|||
19760577|NCT03364309|42212417|FG016|Maintenance Period|Lost to Follow-up|0|||
19760578|NCT03364309|42212418|FG017|Maintenance Period|Lost to Follow-up|0|||
19760579|NCT03364309|42212419|FG018|Maintenance Period|Lost to Follow-up|0|||
19760580|NCT03364309|42212401|FG000|Maintenance Period|Miscellaneous|0|||
19760581|NCT03364309|42212402|FG001|Maintenance Period|Miscellaneous|0|||
19760582|NCT03364309|42212403|FG002|Maintenance Period|Miscellaneous|0|||
19760583|NCT03364309|42212404|FG003|Maintenance Period|Miscellaneous|0|||
19760584|NCT03364309|42212405|FG004|Maintenance Period|Miscellaneous|0|||
19760585|NCT03364309|42212406|FG005|Maintenance Period|Miscellaneous|0|||
19760586|NCT03364309|42212407|FG006|Maintenance Period|Miscellaneous|0|||
19760587|NCT03364309|42212408|FG007|Maintenance Period|Miscellaneous|0|||
19760588|NCT03364309|42212409|FG008|Maintenance Period|Miscellaneous|1|||
19760589|NCT03364309|42212410|FG009|Maintenance Period|Miscellaneous|0|||
19760590|NCT03364309|42212411|FG010|Maintenance Period|Miscellaneous|0|||
19760591|NCT03364309|42212412|FG011|Maintenance Period|Miscellaneous|0|||
19760592|NCT03364309|42212413|FG012|Maintenance Period|Miscellaneous|0|||
19760593|NCT03364309|42212414|FG013|Maintenance Period|Miscellaneous|0|||
19760594|NCT03364309|42212415|FG014|Maintenance Period|Miscellaneous|0|||
19760595|NCT03364309|42212416|FG015|Maintenance Period|Miscellaneous|0|||
19760596|NCT03364309|42212417|FG016|Maintenance Period|Miscellaneous|0|||
19760597|NCT03364309|42212418|FG017|Maintenance Period|Miscellaneous|0|||
19760598|NCT03364309|42212419|FG018|Maintenance Period|Miscellaneous|0|||
19760599|NCT03364309|42212401|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760600|NCT03364309|42212402|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760601|NCT03364309|42212403|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760602|NCT03364309|42212404|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760603|NCT03364309|42212405|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760604|NCT03364309|42212406|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760605|NCT03364309|42212407|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760606|NCT03364309|42212408|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760607|NCT03364309|42212409|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760608|NCT03364309|42212410|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760609|NCT03364309|42212411|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760610|NCT03364309|42212412|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760611|NCT03364309|42212413|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760612|NCT03364309|42212414|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
19760613|NCT03364309|42212415|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
19760614|NCT03364309|42212416|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
19760615|NCT03364309|42212417|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760616|NCT03364309|42212418|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760617|NCT03364309|42212419|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
19760618|NCT03364309|42212401|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760619|NCT03364309|42212402|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760620|NCT03364309|42212403|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760621|NCT03364309|42212404|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760622|NCT03364309|42212405|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760623|NCT03364309|42212406|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760624|NCT03364309|42212407|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760625|NCT03364309|42212408|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760626|NCT03364309|42212409|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760627|NCT03364309|42212410|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760628|NCT03364309|42212411|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760629|NCT03364309|42212412|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760630|NCT03364309|42212413|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760631|NCT03364309|42212414|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760632|NCT03364309|42212415|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
19760633|NCT03364309|42212416|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760634|NCT03364309|42212417|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760635|NCT03364309|42212418|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760636|NCT03364309|42212419|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
19760637|NCT03364309|42212401|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
19760638|NCT03364309|42212402|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
19760639|NCT03364309|42212403|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
19760640|NCT03364309|42212404|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
19760641|NCT03364309|42212405|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
19760642|NCT03364309|42212406|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
19760643|NCT03364309|42212407|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
19760644|NCT03364309|42212408|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
19760645|NCT03364309|42212409|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
19678946|NCT00406653|42126616|FG002|Open-Label Period|Lack of Efficacy|0|||
19678947|NCT00406653|42126617|FG003|Open-Label Period|Lack of Efficacy|0|||
19678948|NCT00406653|42126618|FG004|Open-Label Period|Lack of Efficacy|0|||
19678949|NCT00406653|42126619|FG005|Open-Label Period|Lack of Efficacy|0|||
19678950|NCT00406653|42126620|FG006|Open-Label Period|Lack of Efficacy|160|||
19678951|NCT00406653|42126614|FG000|Open-Label Period|Lost to Follow-up|0|||
19678952|NCT00406653|42126615|FG001|Open-Label Period|Lost to Follow-up|0|||
19678953|NCT00406653|42126616|FG002|Open-Label Period|Lost to Follow-up|0|||
19678954|NCT00406653|42126617|FG003|Open-Label Period|Lost to Follow-up|0|||
19678955|NCT00406653|42126618|FG004|Open-Label Period|Lost to Follow-up|0|||
19678956|NCT00406653|42126619|FG005|Open-Label Period|Lost to Follow-up|0|||
19678957|NCT00406653|42126620|FG006|Open-Label Period|Lost to Follow-up|6|||
19678958|NCT00406653|42126614|FG000|Open-Label Period|Withdrawal of Consent|0|||
19678959|NCT00406653|42126615|FG001|Open-Label Period|Withdrawal of Consent|0|||
19678960|NCT00406653|42126616|FG002|Open-Label Period|Withdrawal of Consent|0|||
19678961|NCT00406653|42126617|FG003|Open-Label Period|Withdrawal of Consent|0|||
19678962|NCT00406653|42126618|FG004|Open-Label Period|Withdrawal of Consent|0|||
19678963|NCT00406653|42126619|FG005|Open-Label Period|Withdrawal of Consent|0|||
19678964|NCT00406653|42126620|FG006|Open-Label Period|Withdrawal of Consent|11|||
19678965|NCT00406653|42126614|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19678966|NCT00406653|42126615|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19760646|NCT03364309|42212410|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
19760647|NCT03364309|42212411|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
19760648|NCT03364309|42212412|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
19760649|NCT03364309|42212413|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
19678967|NCT00406653|42126616|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19678968|NCT00406653|42126617|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19678969|NCT00406653|42126618|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19678970|NCT00406653|42126619|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
19678971|NCT00406653|42126620|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
19678972|NCT00406653|42126614|FG000|Open-Label Period|Pregnancy|0|||
19678973|NCT00406653|42126615|FG001|Open-Label Period|Pregnancy|0|||
19678974|NCT00406653|42126616|FG002|Open-Label Period|Pregnancy|0|||
19678975|NCT00406653|42126617|FG003|Open-Label Period|Pregnancy|0|||
19760650|NCT03364309|42212414|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
19760651|NCT03364309|42212415|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
19760652|NCT03364309|42212416|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
19678976|NCT00406653|42126618|FG004|Open-Label Period|Pregnancy|0|||
19678977|NCT00406653|42126619|FG005|Open-Label Period|Pregnancy|0|||
19678978|NCT00406653|42126620|FG006|Open-Label Period|Pregnancy|2|||
19678979|NCT00406653|42126614|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
19678980|NCT00406653|42126615|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
19678981|NCT00406653|42126616|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
19678982|NCT00406653|42126617|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
19678983|NCT00406653|42126618|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
19678984|NCT00406653|42126619|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
19760653|NCT03364309|42212417|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
19760654|NCT03364309|42212418|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
19760655|NCT03364309|42212419|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
19760656|NCT03364309|42212401|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19799420|NCT02962739|42257490|FG005|Overall Study|Protocol Violation|0|||
19760657|NCT03364309|42212402|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19678985|NCT00406653|42126620|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
19678986|NCT00406653|42126614|FG000|Open-Label Period|Declined participation but followup done|0|||
19678987|NCT00406653|42126615|FG001|Open-Label Period|Declined participation but followup done|0|||
19678988|NCT00406653|42126616|FG002|Open-Label Period|Declined participation but followup done|0|||
19678989|NCT00406653|42126617|FG003|Open-Label Period|Declined participation but followup done|0|||
19678990|NCT00406653|42126618|FG004|Open-Label Period|Declined participation but followup done|0|||
19678991|NCT00406653|42126619|FG005|Open-Label Period|Declined participation but followup done|0|||
19678992|NCT00406653|42126620|FG006|Open-Label Period|Declined participation but followup done|8|||
19678993|NCT00406653|42126614|FG000|Open-Label Period|Discontinued by Sponsor|0|||
19678994|NCT00406653|42126615|FG001|Open-Label Period|Discontinued by Sponsor|0|||
19678995|NCT00406653|42126616|FG002|Open-Label Period|Discontinued by Sponsor|0|||
19678996|NCT00406653|42126617|FG003|Open-Label Period|Discontinued by Sponsor|0|||
19678997|NCT00406653|42126618|FG004|Open-Label Period|Discontinued by Sponsor|0|||
19678998|NCT00406653|42126619|FG005|Open-Label Period|Discontinued by Sponsor|0|||
19678999|NCT00406653|42126620|FG006|Open-Label Period|Discontinued by Sponsor|1|||
19679000|NCT00406653|42126614|FG000|Open-Label Period|Refused followup|0|||
19679001|NCT00406653|42126615|FG001|Open-Label Period|Refused followup|0|||
19679002|NCT00406653|42126616|FG002|Open-Label Period|Refused followup|0|||
19679003|NCT00406653|42126617|FG003|Open-Label Period|Refused followup|0|||
19679004|NCT00406653|42126618|FG004|Open-Label Period|Refused followup|0|||
19679005|NCT00406653|42126619|FG005|Open-Label Period|Refused followup|0|||
19679006|NCT00406653|42126620|FG006|Open-Label Period|Refused followup|1|||
19679007|NCT00547157|42126642|FG000|Overall Study|Other|1|||
19679008|NCT00547157|42126643|FG001|Overall Study|Other|0|||
19679009|NCT00547157|42126642|FG000|Overall Study|Death|38|||
19679010|NCT00547157|42126643|FG001|Overall Study|Death|18|||
19679011|NCT00547157|42126642|FG000|Overall Study|Withdrawal by Subject|3|||
19679012|NCT00547157|42126643|FG001|Overall Study|Withdrawal by Subject|1|||
19679013|NCT00547157|42126642|FG000|Overall Study|Administrative decision|3|||
19679014|NCT00547157|42126643|FG001|Overall Study|Administrative decision|2|||
19679015|NCT00547157|42126642|FG000|Overall Study|Lost to Follow-up|4|||
19679016|NCT00547157|42126643|FG001|Overall Study|Lost to Follow-up|2|||
19679017|NCT00384033|42126653|FG000|Overall Study|Adverse Event|10|||
19679018|NCT00384033|42126654|FG001|Overall Study|Adverse Event|8|||
19679019|NCT00384033|42126655|FG002|Overall Study|Adverse Event|11|||
19679020|NCT00384033|42126656|FG003|Overall Study|Adverse Event|20|||
19679021|NCT00384033|42126653|FG000|Overall Study|Failed to return|1|||
19679022|NCT00384033|42126654|FG001|Overall Study|Failed to return|3|||
19679023|NCT00384033|42126655|FG002|Overall Study|Failed to return|2|||
19679024|NCT00384033|42126656|FG003|Overall Study|Failed to return|2|||
19679025|NCT00384033|42126653|FG000|Overall Study|Physician Decision|1|||
19679026|NCT00384033|42126654|FG001|Overall Study|Physician Decision|0|||
19679027|NCT00384033|42126655|FG002|Overall Study|Physician Decision|0|||
19679028|NCT00384033|42126656|FG003|Overall Study|Physician Decision|0|||
19679029|NCT00384033|42126653|FG000|Overall Study|Lost to Follow-up|6|||
19679030|NCT00384033|42126654|FG001|Overall Study|Lost to Follow-up|12|||
19679031|NCT00384033|42126655|FG002|Overall Study|Lost to Follow-up|7|||
19679032|NCT00384033|42126656|FG003|Overall Study|Lost to Follow-up|7|||
19679033|NCT00384033|42126653|FG000|Overall Study|Other|2|||
19679034|NCT00384033|42126654|FG001|Overall Study|Other|0|||
19679035|NCT00384033|42126655|FG002|Overall Study|Other|0|||
19679036|NCT00384033|42126656|FG003|Overall Study|Other|0|||
19679037|NCT00384033|42126653|FG000|Overall Study|Protocol Violation|5|||
19679038|NCT00384033|42126654|FG001|Overall Study|Protocol Violation|0|||
19679039|NCT00384033|42126655|FG002|Overall Study|Protocol Violation|5|||
19679040|NCT00384033|42126656|FG003|Overall Study|Protocol Violation|6|||
19679041|NCT00384033|42126653|FG000|Overall Study|Withdrawal by Subject|6|||
19679042|NCT00384033|42126654|FG001|Overall Study|Withdrawal by Subject|2|||
19679043|NCT00384033|42126655|FG002|Overall Study|Withdrawal by Subject|5|||
19679044|NCT00384033|42126656|FG003|Overall Study|Withdrawal by Subject|2|||
19679045|NCT00384033|42126653|FG000|Overall Study|Lack of Efficacy|7|||
19679046|NCT00384033|42126654|FG001|Overall Study|Lack of Efficacy|3|||
19679047|NCT00384033|42126655|FG002|Overall Study|Lack of Efficacy|3|||
19679048|NCT00384033|42126656|FG003|Overall Study|Lack of Efficacy|1|||
19679049|NCT00384033|42126653|FG000|Overall Study|Randomized but not treated|3|||
19679050|NCT00384033|42126654|FG001|Overall Study|Randomized but not treated|7|||
19679051|NCT00384033|42126655|FG002|Overall Study|Randomized but not treated|10|||
19679052|NCT00384033|42126656|FG003|Overall Study|Randomized but not treated|2|||
19679053|NCT00546377|42126666|FG000|Overall Study|Deemed ineligible|1|||
19679054|NCT00546377|42126666|FG000|Overall Study|Adverse Event|6|||
19679055|NCT00545753|42126673|FG000|Overall Study|Withdrawal by Subject|0|||
19679056|NCT00545753|42126674|FG001|Overall Study|Withdrawal by Subject|1|||
19679057|NCT00545753|42126675|FG002|Overall Study|Withdrawal by Subject|10|||
19679058|NCT00545753|42126673|FG000|Overall Study|Lost to Follow-up|13|||
19679059|NCT00545753|42126674|FG001|Overall Study|Lost to Follow-up|3|||
19679060|NCT00545753|42126675|FG002|Overall Study|Lost to Follow-up|12|||
19679061|NCT00545753|42126673|FG000|Overall Study|Protocol Violation|3|||
19477172|NCT01513291|41756110|FG002|Treatment Period|Protocol Violation|0|||
19477173|NCT01513291|41756111|FG003|Treatment Period|Protocol Violation|0|||
19477174|NCT01513291|41756112|FG004|Treatment Period|Protocol Violation|0|||
19477175|NCT01513291|41756108|FG000|Treatment Period|Withdrawal by Subject|8|||
19477176|NCT01513291|41756109|FG001|Treatment Period|Withdrawal by Subject|5|||
19477177|NCT01513291|41756110|FG002|Treatment Period|Withdrawal by Subject|0|||
19477178|NCT01513291|41756111|FG003|Treatment Period|Withdrawal by Subject|0|||
19477179|NCT01513291|41756112|FG004|Treatment Period|Withdrawal by Subject|0|||
19477180|NCT01513291|41756108|FG000|Treatment Period|Randomized not treated|0|||
19477181|NCT01513291|41756109|FG001|Treatment Period|Randomized not treated|2|||
19477182|NCT01513291|41756110|FG002|Treatment Period|Randomized not treated|0|||
19679062|NCT00545753|42126674|FG001|Overall Study|Protocol Violation|1|||
19679063|NCT00545753|42126675|FG002|Overall Study|Protocol Violation|4|||
19679064|NCT00406419|42126687|FG000|Overall Study|Death|3|||
19679065|NCT00406419|42126688|FG001|Overall Study|Death|1|||
19679066|NCT00406419|42126689|FG002|Overall Study|Death|4|||
19679067|NCT00406419|42126687|FG000|Overall Study|Protocol Violation|6|||
19679068|NCT00406419|42126688|FG001|Overall Study|Protocol Violation|2|||
19679069|NCT00406419|42126689|FG002|Overall Study|Protocol Violation|5|||
19679070|NCT00406419|42126687|FG000|Overall Study|Study Terminated by Sponsor|260|||
19679071|NCT00406419|42126688|FG001|Overall Study|Study Terminated by Sponsor|288|||
19679072|NCT00406419|42126689|FG002|Overall Study|Study Terminated by Sponsor|282|||
19679073|NCT00406419|42126687|FG000|Overall Study|Withdrawal by Subject|17|||
19679074|NCT00406419|42126688|FG001|Overall Study|Withdrawal by Subject|24|||
19679075|NCT00406419|42126689|FG002|Overall Study|Withdrawal by Subject|26|||
19679076|NCT00406419|42126687|FG000|Overall Study|Lack of Efficacy|12|||
19679077|NCT00406419|42126688|FG001|Overall Study|Lack of Efficacy|1|||
19679078|NCT00406419|42126689|FG002|Overall Study|Lack of Efficacy|6|||
19679079|NCT00406419|42126687|FG000|Overall Study|Non-Compliance with Study Drug|5|||
19679080|NCT00406419|42126688|FG001|Overall Study|Non-Compliance with Study Drug|6|||
19679081|NCT00406419|42126689|FG002|Overall Study|Non-Compliance with Study Drug|3|||
19679082|NCT00406419|42126687|FG000|Overall Study|Adverse Event|10|||
19679083|NCT00406419|42126688|FG001|Overall Study|Adverse Event|12|||
19679084|NCT00406419|42126689|FG002|Overall Study|Adverse Event|16|||
19679085|NCT00406419|42126687|FG000|Overall Study|Lost to Follow-up|11|||
19679086|NCT00406419|42126688|FG001|Overall Study|Lost to Follow-up|10|||
19679087|NCT00406419|42126689|FG002|Overall Study|Lost to Follow-up|5|||
19679088|NCT00325468|42126702|FG000|Overall Study|Adverse Event|1|||
19679089|NCT00325468|42126703|FG001|Overall Study|Adverse Event|1|||
19679090|NCT00325468|42126704|FG002|Overall Study|Adverse Event|0|||
19679091|NCT00325468|42126705|FG003|Overall Study|Adverse Event|5|||
19679092|NCT00325468|42126706|FG004|Overall Study|Adverse Event|1|||
19679093|NCT00325468|42126702|FG000|Overall Study|Death|2|||
19679094|NCT00325468|42126703|FG001|Overall Study|Death|0|||
19679095|NCT00325468|42126704|FG002|Overall Study|Death|2|||
19679096|NCT00325468|42126705|FG003|Overall Study|Death|4|||
19679097|NCT00325468|42126706|FG004|Overall Study|Death|0|||
19679098|NCT00325468|42126702|FG000|Overall Study|Lost to Follow-up|0|||
19679099|NCT00325468|42126703|FG001|Overall Study|Lost to Follow-up|0|||
19679100|NCT00325468|42126704|FG002|Overall Study|Lost to Follow-up|1|||
19679101|NCT00325468|42126705|FG003|Overall Study|Lost to Follow-up|2|||
19679102|NCT00325468|42126706|FG004|Overall Study|Lost to Follow-up|2|||
19679103|NCT00325468|42126702|FG000|Overall Study|Physician Decision|1|||
19679104|NCT00325468|42126703|FG001|Overall Study|Physician Decision|1|||
19679105|NCT00325468|42126704|FG002|Overall Study|Physician Decision|0|||
19679106|NCT00325468|42126705|FG003|Overall Study|Physician Decision|1|||
19679107|NCT00325468|42126706|FG004|Overall Study|Physician Decision|0|||
19679108|NCT00325468|42126702|FG000|Overall Study|Withdrawal by Subject|3|||
19679109|NCT00325468|42126703|FG001|Overall Study|Withdrawal by Subject|1|||
19679110|NCT00325468|42126704|FG002|Overall Study|Withdrawal by Subject|0|||
19679111|NCT00325468|42126705|FG003|Overall Study|Withdrawal by Subject|14|||
19679112|NCT00325468|42126706|FG004|Overall Study|Withdrawal by Subject|4|||
19679113|NCT00325468|42126702|FG000|Overall Study|site closure etc|4|||
19760658|NCT03364309|42212403|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760659|NCT03364309|42212404|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19604263|NCT00960440|42053132|FG001|Overall Study|Other|1|||
19604264|NCT00960440|42053133|FG002|Overall Study|Other|1|||
19604265|NCT00960440|42053134|FG003|Overall Study|Other|0|||
19604266|NCT00964028|42053148|FG000|Overall Study|Withdrawal by Subject|0|||
19604267|NCT00964028|42053149|FG001|Overall Study|Withdrawal by Subject|1|||
19604268|NCT00960206|42053158|FG000|Overall Study|Death|7|||
19604269|NCT00960206|42053159|FG001|Overall Study|Death|4|||
19604270|NCT00960206|42053160|FG002|Overall Study|Death|1|||
19679114|NCT00325468|42126703|FG001|Overall Study|site closure etc|2|||
19679115|NCT00325468|42126704|FG002|Overall Study|site closure etc|1|||
19679116|NCT00325468|42126705|FG003|Overall Study|site closure etc|8|||
19679117|NCT00325468|42126706|FG004|Overall Study|site closure etc|1|||
19679118|NCT03833661|42126719|FG000|Overall Study|Treatment ongoing|9|||
19679119|NCT00311584|42126725|FG000|Overall Study|Death|1|||
19679120|NCT00311584|42126726|FG001|Overall Study|Death|0|||
19679121|NCT00311584|42126725|FG000|Overall Study|Lack of Efficacy|12|||
19679122|NCT00311584|42126726|FG001|Overall Study|Lack of Efficacy|15|||
19679123|NCT00311584|42126725|FG000|Overall Study|Physician Decision|4|||
19679124|NCT00311584|42126726|FG001|Overall Study|Physician Decision|5|||
19679125|NCT00311584|42126725|FG000|Overall Study|Withdrawal by Subject|1|||
19679126|NCT00311584|42126726|FG001|Overall Study|Withdrawal by Subject|1|||
19679127|NCT00311584|42126725|FG000|Overall Study|ineligible|2|||
19679128|NCT00311584|42126726|FG001|Overall Study|ineligible|2|||
19679129|NCT00383331|42126734|FG000|Overall Study|Protocol Violation|0|||
19679130|NCT00383331|42126735|FG001|Overall Study|Protocol Violation|1|||
19679131|NCT03934541|42126745|FG000|Overall Study|Study Terminated by Sponsor|0|||
19679132|NCT03934541|42126746|FG001|Overall Study|Study Terminated by Sponsor|1|||
19679133|NCT03934541|42126747|FG002|Overall Study|Study Terminated by Sponsor|0|||
19679134|NCT03934541|42126748|FG003|Overall Study|Study Terminated by Sponsor|0|||
19679135|NCT00325234|42126760|FG000|Overall Study|Adverse Event|10|||
19679136|NCT00325234|42126761|FG001|Overall Study|Adverse Event|7|||
19679137|NCT00325234|42126760|FG000|Overall Study|Death due to Study Disease|1|||
19679138|NCT00325234|42126761|FG001|Overall Study|Death due to Study Disease|0|||
19679139|NCT00325234|42126760|FG000|Overall Study|Entry Criteria Not Met|1|||
19679140|NCT00325234|42126761|FG001|Overall Study|Entry Criteria Not Met|2|||
19679141|NCT00325234|42126760|FG000|Overall Study|Subject Decision|6|||
19679142|NCT00325234|42126761|FG001|Overall Study|Subject Decision|8|||
19679143|NCT00325234|42126760|FG000|Overall Study|Physician Decision|17|||
19679144|NCT00325234|42126761|FG001|Overall Study|Physician Decision|12|||
19679145|NCT00325234|42126760|FG000|Overall Study|Progressive Disease|34|||
19679146|NCT00325234|42126761|FG001|Overall Study|Progressive Disease|37|||
19679147|NCT00366249|42126771|FG000|Overall Study|Adverse Event|53|||
19679148|NCT00366249|42126772|FG001|Overall Study|Adverse Event|28|||
19679149|NCT00366249|42126771|FG000|Overall Study|Death|0|||
19679150|NCT00366249|42126772|FG001|Overall Study|Death|1|||
19679151|NCT00366249|42126771|FG000|Overall Study|Physician Decision|5|||
19679152|NCT00366249|42126772|FG001|Overall Study|Physician Decision|2|||
19679153|NCT00366249|42126771|FG000|Overall Study|Lost to Follow-up|2|||
19679154|NCT00366249|42126772|FG001|Overall Study|Lost to Follow-up|0|||
19679155|NCT00366249|42126771|FG000|Overall Study|Protocol Violation|1|||
19679156|NCT00366249|42126772|FG001|Overall Study|Protocol Violation|2|||
19679157|NCT00366249|42126771|FG000|Overall Study|Withdrawal by Subject|18|||
19679158|NCT00366249|42126772|FG001|Overall Study|Withdrawal by Subject|4|||
19679159|NCT00366249|42126771|FG000|Overall Study|Lack of Efficacy|21|||
19679160|NCT00366249|42126772|FG001|Overall Study|Lack of Efficacy|21|||
19679161|NCT00366249|42126771|FG000|Overall Study|Most due to osteomylitis status|31|||
19679162|NCT00366249|42126772|FG001|Overall Study|Most due to osteomylitis status|20|||
19679163|NCT00325156|42126778|FG000|Overall Study|Protocol Violation|8|||
19679164|NCT00325156|42126778|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
19679165|NCT00325156|42126778|FG000|Overall Study|Migrated/moved from study area|12|||
19679166|NCT00325156|42126778|FG000|Overall Study|Adverse event, non-fatal|3|||
19679167|NCT00325156|42126778|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
19679168|NCT00325156|42126778|FG000|Overall Study|Other|1|||
19679169|NCT00325156|42126778|FG000|Overall Study|Withdrawal by Subject|31|||
19679170|NCT03927911|42126788|FG000|Overall Study|problems with eDiary|0|||
19679171|NCT03927911|42126789|FG001|Overall Study|problems with eDiary|1|||
19679172|NCT03927911|42126790|FG002|Overall Study|problems with eDiary|0|||
19679173|NCT03927911|42126791|FG003|Overall Study|problems with eDiary|1|||
19679174|NCT03927911|42126792|FG004|Overall Study|problems with eDiary|0|||
19679175|NCT03927911|42126793|FG005|Overall Study|problems with eDiary|4|||
19679176|NCT03927911|42126788|FG000|Overall Study|Adverse Event|0|||
19679177|NCT03927911|42126789|FG001|Overall Study|Adverse Event|0|||
19679178|NCT03927911|42126790|FG002|Overall Study|Adverse Event|0|||
19679179|NCT03927911|42126791|FG003|Overall Study|Adverse Event|0|||
19679180|NCT03927911|42126792|FG004|Overall Study|Adverse Event|0|||
19679181|NCT03927911|42126793|FG005|Overall Study|Adverse Event|1|||
19679182|NCT03927911|42126788|FG000|Overall Study|not treated -study terminated by sponsor|0|||
19679183|NCT03927911|42126789|FG001|Overall Study|not treated -study terminated by sponsor|1|||
19679184|NCT03927911|42126790|FG002|Overall Study|not treated -study terminated by sponsor|0|||
19679185|NCT03927911|42126791|FG003|Overall Study|not treated -study terminated by sponsor|0|||
19679186|NCT03927911|42126792|FG004|Overall Study|not treated -study terminated by sponsor|0|||
19679187|NCT03927911|42126793|FG005|Overall Study|not treated -study terminated by sponsor|0|||
19679188|NCT03927911|42126788|FG000|Overall Study|Surgery cancelled|0|||
19679189|NCT03927911|42126789|FG001|Overall Study|Surgery cancelled|0|||
19679190|NCT03927911|42126790|FG002|Overall Study|Surgery cancelled|0|||
19679191|NCT03927911|42126791|FG003|Overall Study|Surgery cancelled|1|||
19679192|NCT03927911|42126792|FG004|Overall Study|Surgery cancelled|0|||
19679193|NCT03927911|42126793|FG005|Overall Study|Surgery cancelled|1|||
19679194|NCT03927911|42126788|FG000|Overall Study|Protocol Violation|0|||
19679195|NCT03927911|42126789|FG001|Overall Study|Protocol Violation|0|||
19679196|NCT03927911|42126790|FG002|Overall Study|Protocol Violation|0|||
19679197|NCT03927911|42126791|FG003|Overall Study|Protocol Violation|0|||
19679198|NCT03927911|42126792|FG004|Overall Study|Protocol Violation|0|||
19679199|NCT03927911|42126793|FG005|Overall Study|Protocol Violation|1|||
19679200|NCT00383019|42126809|FG000|Overall Study|Adverse Event|5|||
19679201|NCT00383019|42126810|FG001|Overall Study|Adverse Event|1|||
19679202|NCT00383019|42126809|FG000|Overall Study|Withdrawal by Subject|0|||
19679203|NCT00383019|42126810|FG001|Overall Study|Withdrawal by Subject|1|||
19679204|NCT00310804|42126818|FG000|Overall Study|Lost to Follow-up|2|||
19679205|NCT00310804|42126819|FG001|Overall Study|Lost to Follow-up|0|||
19679206|NCT00310804|42126818|FG000|Overall Study|Withdrawal by Subject|3|||
19679207|NCT00310804|42126819|FG001|Overall Study|Withdrawal by Subject|0|||
19679208|NCT03826186|42126841|FG000|Overall Study|Protocol Violation|2|||
19679209|NCT03826186|42126842|FG001|Overall Study|Protocol Violation|0|||
19679210|NCT03826186|42126841|FG000|Overall Study|Withdrawal by Subject|1|||
19679211|NCT03826186|42126842|FG001|Overall Study|Withdrawal by Subject|0|||
19679212|NCT00382863|42126850|FG000|Overall Study|Death|9|||
19679213|NCT00382863|42126851|FG001|Overall Study|Death|9|||
19679214|NCT00382863|42126850|FG000|Overall Study|Lost to Follow-up|1|||
19679215|NCT00382863|42126851|FG001|Overall Study|Lost to Follow-up|2|||
19679216|NCT00382863|42126850|FG000|Overall Study|Withdrawal by Subject|5|||
19679217|NCT00382863|42126851|FG001|Overall Study|Withdrawal by Subject|25|||
19679218|NCT03933449|42126859|FG000|Overall Study|Adverse Event|6|||
19679219|NCT03933449|42126860|FG001|Overall Study|Adverse Event|4|||
19679220|NCT03933449|42126859|FG000|Overall Study|Death|55|||
19679221|NCT03933449|42126860|FG001|Overall Study|Death|57|||
19679222|NCT03933449|42126859|FG000|Overall Study|Sponsor Decision|1|||
19679223|NCT03933449|42126860|FG001|Overall Study|Sponsor Decision|0|||
19679224|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
19679225|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
19679226|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
19679227|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
19679228|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
19679229|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
19679230|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
19679231|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
19679232|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
19679233|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
19679234|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
19679235|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
19679236|NCT00290758|42126883|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
19679237|NCT00290758|42126884|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
19679238|NCT00290758|42126883|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
19679239|NCT00290758|42126884|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
19679240|NCT00372567|42126897|FG000|Phase 3 Study|Adverse Event|5|||
19679241|NCT00372567|42126898|FG001|Phase 3 Study|Adverse Event|1|||
19679242|NCT00372567|42126899|FG002|Phase 3 Study|Adverse Event|1|||
19679243|NCT00372567|42126897|FG000|Phase 3 Study|Death|1|||
19679244|NCT00372567|42126898|FG001|Phase 3 Study|Death|1|||
19679245|NCT00372567|42126899|FG002|Phase 3 Study|Death|0|||
19679246|NCT00372567|42126897|FG000|Phase 3 Study|Protocol Violation|0|||
19679247|NCT00372567|42126898|FG001|Phase 3 Study|Protocol Violation|0|||
19679248|NCT00372567|42126899|FG002|Phase 3 Study|Protocol Violation|1|||
19679249|NCT00372567|42126897|FG000|Phase 3 Study|Objective progression or relapse|10|||
19604271|NCT00960206|42053158|FG000|Overall Study|Unwilling/Unable to return|1|||
19604272|NCT00960206|42053159|FG001|Overall Study|Unwilling/Unable to return|2|||
19604273|NCT00960206|42053160|FG002|Overall Study|Unwilling/Unable to return|0|||
19604274|NCT00960206|42053158|FG000|Overall Study|Lost to Follow-up|8|||
19604275|NCT00960206|42053159|FG001|Overall Study|Lost to Follow-up|14|||
19604276|NCT00960206|42053160|FG002|Overall Study|Lost to Follow-up|8|||
19604277|NCT00960206|42053158|FG000|Overall Study|Withdrawal by Subject|2|||
19604278|NCT00960206|42053159|FG001|Overall Study|Withdrawal by Subject|4|||
19604279|NCT00960206|42053160|FG002|Overall Study|Withdrawal by Subject|0|||
19604280|NCT00960206|42053158|FG000|Overall Study|Revision of study component|2|||
19604281|NCT00960206|42053159|FG001|Overall Study|Revision of study component|2|||
19604282|NCT00960206|42053160|FG002|Overall Study|Revision of study component|2|||
19604283|NCT00960206|42053158|FG000|Overall Study|Missing 10 year data|20|||
19604284|NCT00960206|42053159|FG001|Overall Study|Missing 10 year data|1|||
19604285|NCT00960206|42053160|FG002|Overall Study|Missing 10 year data|1|||
19604286|NCT00751036|42053171|FG000|Overall Study|Disease Progression|28|||
19679250|NCT00372567|42126898|FG001|Phase 3 Study|Objective progression or relapse|13|||
19679251|NCT00372567|42126899|FG002|Phase 3 Study|Objective progression or relapse|4|||
19679252|NCT00372567|42126897|FG000|Phase 3 Study|Global deterioration of health status|0|||
19679253|NCT00372567|42126898|FG001|Phase 3 Study|Global deterioration of health status|1|||
19679254|NCT00372567|42126899|FG002|Phase 3 Study|Global deterioration of health status|0|||
19679255|NCT00372567|42126897|FG000|Phase 3 Study|Other|2|||
19679256|NCT00372567|42126898|FG001|Phase 3 Study|Other|2|||
19679257|NCT00372567|42126899|FG002|Phase 3 Study|Other|1|||
19679258|NCT00372567|42126897|FG000|Phase 3 Study|study terminated by sponsor|13|||
19679259|NCT00372567|42126898|FG001|Phase 3 Study|study terminated by sponsor|8|||
19679260|NCT00372567|42126899|FG002|Phase 3 Study|study terminated by sponsor|5|||
19679261|NCT00365547|42126907|FG000|Overall Study|Insurance did not cover Avastin|1|||
19679262|NCT00365547|42126907|FG000|Overall Study|Screen failure|1|||
19679263|NCT00365547|42126907|FG000|Overall Study|Withdrawal by Subject|1|||
19679264|NCT00545441|42126916|FG000|Overall Study|Fistula draining at 6 months|2|||
19679265|NCT00545441|42126917|FG001|Overall Study|Fistula draining at 6 months|4|||
19679266|NCT00545441|42126916|FG000|Overall Study|Lost to Follow-up|9|||
19679267|NCT00545441|42126917|FG001|Overall Study|Lost to Follow-up|5|||
19679268|NCT00545441|42126916|FG000|Overall Study|Technical failure|0|||
19679269|NCT00545441|42126917|FG001|Overall Study|Technical failure|1|||
19679270|NCT00545441|42126916|FG000|Overall Study|Withdrawal by Subject|1|||
19679271|NCT00545441|42126917|FG001|Overall Study|Withdrawal by Subject|1|||
19679272|NCT00545441|42126916|FG000|Overall Study|Persistence or recurrence of fistula|5|||
19679273|NCT00545441|42126917|FG001|Overall Study|Persistence or recurrence of fistula|2|||
19679274|NCT00545441|42126916|FG000|Overall Study|Patients were not treated|1|||
19679275|NCT00545441|42126917|FG001|Overall Study|Patients were not treated|3|||
19679276|NCT00294658|42126925|FG000|Overall Study|Death|0|||
19679277|NCT00294658|42126926|FG001|Overall Study|Death|1|||
19679278|NCT00294658|42126925|FG000|Overall Study|Lost to Follow-up|4|||
19679279|NCT00294658|42126926|FG001|Overall Study|Lost to Follow-up|0|||
19679280|NCT00294658|42126925|FG000|Overall Study|Physician Decision|1|||
19679281|NCT00294658|42126926|FG001|Overall Study|Physician Decision|2|||
19679282|NCT00294658|42126925|FG000|Overall Study|Pregnancy|0|||
19679283|NCT00294658|42126926|FG001|Overall Study|Pregnancy|1|||
19679284|NCT00294658|42126925|FG000|Overall Study|Withdrawal by Subject|0|||
19679285|NCT00294658|42126926|FG001|Overall Study|Withdrawal by Subject|4|||
19679286|NCT00294658|42126925|FG000|Overall Study|Found to have invasive thymoma|1|||
19679287|NCT00294658|42126926|FG001|Overall Study|Found to have invasive thymoma|0|||
19679288|NCT00294658|42126925|FG000|Overall Study|Patient and family were not satisfied|0|||
19679289|NCT00294658|42126926|FG001|Overall Study|Patient and family were not satisfied|1|||
19679290|NCT03923933|42126934|FG000|Overall Study|Lost to Follow-up|1|||
19679291|NCT03923933|42126935|FG001|Overall Study|Lost to Follow-up|0|||
19679292|NCT03923933|42126934|FG000|Overall Study|Withdrawal by Subject|0|||
19679293|NCT03923933|42126935|FG001|Overall Study|Withdrawal by Subject|1|||
19679294|NCT00372489|42126941|FG000|Overall Study|Adverse Event|18|||
19679295|NCT00372489|42126941|FG000|Overall Study|Lack of Efficacy|1|||
19679296|NCT00372489|42126941|FG000|Overall Study|Lost to Follow-up|3|||
19679297|NCT00372489|42126941|FG000|Overall Study|Physician Decision|3|||
19679298|NCT00372489|42126941|FG000|Overall Study|Withdrawal by Subject|5|||
19679299|NCT00372489|42126941|FG000|Overall Study|Patient Relocation|2|||
19679300|NCT00372489|42126941|FG000|Overall Study|Renal transplant|6|||
19679301|NCT00372489|42126941|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
19679302|NCT00372411|42126948|FG000|Overall Study|Withdrawal by Subject|3|||
19679303|NCT00372411|42126949|FG001|Overall Study|Withdrawal by Subject|4|||
19679304|NCT00372411|42126950|FG002|Overall Study|Withdrawal by Subject|1|||
19679305|NCT00372411|42126948|FG000|Overall Study|Death|0|||
19679306|NCT00372411|42126949|FG001|Overall Study|Death|2|||
19679307|NCT00372411|42126950|FG002|Overall Study|Death|1|||
19679308|NCT00372411|42126948|FG000|Overall Study|Lost to Follow-up|1|||
19679309|NCT00372411|42126949|FG001|Overall Study|Lost to Follow-up|1|||
19679310|NCT00372411|42126950|FG002|Overall Study|Lost to Follow-up|1|||
19679311|NCT00372411|42126948|FG000|Overall Study|Adverse Event|1|||
19679312|NCT00372411|42126949|FG001|Overall Study|Adverse Event|1|||
19679313|NCT00372411|42126950|FG002|Overall Study|Adverse Event|0|||
19679314|NCT00372255|42126960|FG000|Overall Study|Withdrawn for other reasons|2|||
19679315|NCT00372255|42126961|FG001|Overall Study|Withdrawn for other reasons|1|||
19679316|NCT00274456|42126972|FG000|Overall Study|Still on treatment|2|||
19679317|NCT00274456|42126973|FG001|Overall Study|Still on treatment|3|||
19679318|NCT00274456|42126974|FG002|Overall Study|Still on treatment|5|||
19679319|NCT00274456|42126975|FG003|Overall Study|Still on treatment|1|||
19679320|NCT00274456|42126972|FG000|Overall Study|Unacceptable toxicity|10|||
19679321|NCT00274456|42126973|FG001|Overall Study|Unacceptable toxicity|5|||
19679322|NCT00274456|42126974|FG002|Overall Study|Unacceptable toxicity|12|||
19679323|NCT00274456|42126975|FG003|Overall Study|Unacceptable toxicity|16|||
19679324|NCT00274456|42126972|FG000|Overall Study|Adverse Event|0|||
19679325|NCT00274456|42126973|FG001|Overall Study|Adverse Event|1|||
19679326|NCT00274456|42126974|FG002|Overall Study|Adverse Event|2|||
19679327|NCT00274456|42126975|FG003|Overall Study|Adverse Event|2|||
19679328|NCT00274456|42126972|FG000|Overall Study|Physician Decision|7|||
19679329|NCT00274456|42126973|FG001|Overall Study|Physician Decision|5|||
19760660|NCT03364309|42212405|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760661|NCT03364309|42212406|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760662|NCT03364309|42212407|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760663|NCT03364309|42212408|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760664|NCT03364309|42212409|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760665|NCT03364309|42212410|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760666|NCT03364309|42212411|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760667|NCT03364309|42212412|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760668|NCT03364309|42212413|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760669|NCT03364309|42212414|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760670|NCT03364309|42212415|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760671|NCT03364309|42212416|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
19760672|NCT03364309|42212417|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
19760673|NCT03364309|42212418|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
19760674|NCT03364309|42212419|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
19760675|NCT03364309|42212401|FG000|Post-Treatment Followup Period|Adverse Event|0|||
19760676|NCT03364309|42212402|FG001|Post-Treatment Followup Period|Adverse Event|0|||
19760677|NCT03364309|42212403|FG002|Post-Treatment Followup Period|Adverse Event|0|||
19760678|NCT03364309|42212404|FG003|Post-Treatment Followup Period|Adverse Event|0|||
19760679|NCT03364309|42212405|FG004|Post-Treatment Followup Period|Adverse Event|0|||
19760680|NCT03364309|42212406|FG005|Post-Treatment Followup Period|Adverse Event|0|||
19760681|NCT03364309|42212407|FG006|Post-Treatment Followup Period|Adverse Event|0|||
19760682|NCT03364309|42212408|FG007|Post-Treatment Followup Period|Adverse Event|0|||
19760683|NCT03364309|42212409|FG008|Post-Treatment Followup Period|Adverse Event|0|||
19760684|NCT03364309|42212410|FG009|Post-Treatment Followup Period|Adverse Event|0|||
19760685|NCT03364309|42212411|FG010|Post-Treatment Followup Period|Adverse Event|0|||
19760686|NCT03364309|42212412|FG011|Post-Treatment Followup Period|Adverse Event|0|||
19760687|NCT03364309|42212413|FG012|Post-Treatment Followup Period|Adverse Event|0|||
19760688|NCT03364309|42212414|FG013|Post-Treatment Followup Period|Adverse Event|0|||
19760689|NCT03364309|42212415|FG014|Post-Treatment Followup Period|Adverse Event|0|||
19760690|NCT03364309|42212416|FG015|Post-Treatment Followup Period|Adverse Event|0|||
19760691|NCT03364309|42212417|FG016|Post-Treatment Followup Period|Adverse Event|2|||
19760692|NCT03364309|42212418|FG017|Post-Treatment Followup Period|Adverse Event|6|||
19760693|NCT03364309|42212419|FG018|Post-Treatment Followup Period|Adverse Event|1|||
19760694|NCT03364309|42212401|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760695|NCT03364309|42212402|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760696|NCT03364309|42212403|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760697|NCT03364309|42212404|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760698|NCT03364309|42212405|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
19679330|NCT00274456|42126974|FG002|Overall Study|Physician Decision|6|||
19679331|NCT00274456|42126975|FG003|Overall Study|Physician Decision|13|||
19679332|NCT00274456|42126972|FG000|Overall Study|Lost to Follow-up|0|||
19679333|NCT00274456|42126973|FG001|Overall Study|Lost to Follow-up|0|||
19679334|NCT00274456|42126974|FG002|Overall Study|Lost to Follow-up|1|||
19679335|NCT00274456|42126975|FG003|Overall Study|Lost to Follow-up|0|||
19679336|NCT00274456|42126972|FG000|Overall Study|Withdrawal by Subject|18|||
19679337|NCT00274456|42126973|FG001|Overall Study|Withdrawal by Subject|13|||
19760699|NCT03364309|42212406|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760700|NCT03364309|42212407|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760701|NCT03364309|42212408|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760702|NCT03364309|42212409|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760703|NCT03364309|42212410|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760704|NCT03364309|42212411|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760705|NCT03364309|42212412|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760706|NCT03364309|42212413|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
19679338|NCT00274456|42126974|FG002|Overall Study|Withdrawal by Subject|9|||
19679339|NCT00274456|42126975|FG003|Overall Study|Withdrawal by Subject|13|||
19679340|NCT00364923|42126985|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
19679341|NCT00364923|42126985|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
19679342|NCT00381849|42126991|FG000|Wash Out|Withdrawal by Subject|0|||
19679343|NCT00381849|42126992|FG001|Wash Out|Withdrawal by Subject|1|||
19679344|NCT00273052|42127000|FG000|Overall Study|Withdrawal by Subject|16|||
19679345|NCT00273052|42127001|FG001|Overall Study|Withdrawal by Subject|19|||
19679346|NCT00273052|42127000|FG000|Overall Study|Adverse Event|21|||
19679347|NCT00273052|42127001|FG001|Overall Study|Adverse Event|19|||
19679348|NCT00273052|42127000|FG000|Overall Study|Protocol Violation|14|||
19679349|NCT00273052|42127001|FG001|Overall Study|Protocol Violation|18|||
19679350|NCT00273052|42127000|FG000|Overall Study|Lost to Follow-up|7|||
19679351|NCT00273052|42127001|FG001|Overall Study|Lost to Follow-up|25|||
19679352|NCT00273052|42127000|FG000|Overall Study|Lack of Efficacy|6|||
19679353|NCT00273052|42127001|FG001|Overall Study|Lack of Efficacy|4|||
19679354|NCT00273052|42127000|FG000|Overall Study|Non-Compliance|3|||
19679355|NCT00273052|42127001|FG001|Overall Study|Non-Compliance|1|||
19679356|NCT00273052|42127000|FG000|Overall Study|Other|2|||
19679357|NCT00273052|42127001|FG001|Overall Study|Other|0|||
19679358|NCT00273052|42127000|FG000|Overall Study|Worsening serum lipid levels|0|||
19679359|NCT00273052|42127001|FG001|Overall Study|Worsening serum lipid levels|2|||
19679360|NCT00290290|42127009|FG000|Overall Study|Death|3|||
19679361|NCT00290290|42127010|FG001|Overall Study|Death|4|||
19679362|NCT00290290|42127009|FG000|Overall Study|Withdrawal by Subject|2|||
19679363|NCT00290290|42127010|FG001|Overall Study|Withdrawal by Subject|2|||
19679364|NCT00290290|42127009|FG000|Overall Study|Underwent clean surgical procedure|13|||
19679365|NCT00290290|42127010|FG001|Overall Study|Underwent clean surgical procedure|12|||
19679366|NCT00272038|42127016|FG000|Overall Study|withdrew before they received 2 cycles|7|||
19679367|NCT00271024|42127025|FG000|Overall Study|Lost Interest|3|||
19679368|NCT00271024|42127026|FG001|Overall Study|Lost Interest|4|||
19679369|NCT00271024|42127027|FG002|Overall Study|Lost Interest|2|||
19679370|NCT00271024|42127028|FG003|Overall Study|Lost Interest|3|||
19679371|NCT00271024|42127025|FG000|Overall Study|Unknown/Unspecified|11|||
19679372|NCT00271024|42127026|FG001|Overall Study|Unknown/Unspecified|11|||
19679373|NCT00271024|42127027|FG002|Overall Study|Unknown/Unspecified|8|||
19679374|NCT00271024|42127028|FG003|Overall Study|Unknown/Unspecified|4|||
19679375|NCT00271024|42127025|FG000|Overall Study|Protocol Violation|1|||
19679376|NCT00271024|42127026|FG001|Overall Study|Protocol Violation|6|||
19679377|NCT00271024|42127027|FG002|Overall Study|Protocol Violation|5|||
19679378|NCT00271024|42127028|FG003|Overall Study|Protocol Violation|11|||
19679379|NCT00271024|42127025|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
19679380|NCT00271024|42127026|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
19760707|NCT03364309|42212414|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760708|NCT03364309|42212415|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760709|NCT03364309|42212416|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760710|NCT03364309|42212417|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760711|NCT03364309|42212418|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
19760712|NCT03364309|42212419|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
19760713|NCT03364309|42212401|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
19760714|NCT03364309|42212402|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
19760715|NCT03364309|42212403|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
19760716|NCT03364309|42212404|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
19760717|NCT03364309|42212405|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
19760718|NCT03364309|42212406|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
19760719|NCT03364309|42212407|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
19760720|NCT03364309|42212408|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
19760721|NCT03364309|42212409|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
19760722|NCT03364309|42212410|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
19760723|NCT03364309|42212411|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
19760724|NCT03364309|42212412|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
19760725|NCT03364309|42212413|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
19760726|NCT03364309|42212414|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
19760727|NCT03364309|42212415|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
19760728|NCT03364309|42212416|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
19760729|NCT03364309|42212417|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
19760730|NCT03364309|42212418|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
19760731|NCT03364309|42212419|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
19760732|NCT03334903|42212445|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
19760733|NCT03334903|42212446|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
19760734|NCT03334903|42212445|FG000|Overall Study|Protocol Violation|1|||
19760735|NCT03334903|42212446|FG001|Overall Study|Protocol Violation|3|||
19760736|NCT03334903|42212445|FG000|Overall Study|Surgery postponed|1|||
19760737|NCT03334903|42212446|FG001|Overall Study|Surgery postponed|0|||
19760738|NCT03334903|42212445|FG000|Overall Study|Adverse Event|1|||
19760739|NCT03334903|42212446|FG001|Overall Study|Adverse Event|1|||
19760740|NCT03334903|42212445|FG000|Overall Study|Withdrawal by Subject|0|||
19760741|NCT03334903|42212446|FG001|Overall Study|Withdrawal by Subject|1|||
19760742|NCT01353664|42212452|FG000|Overall Study|Other|3|||
19760743|NCT01353664|42212452|FG000|Overall Study|Disease Progression|16|||
19760744|NCT02694328|42212458|FG000|Overall Study|Adverse Event|27|||
19679381|NCT00271024|42127027|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
19679382|NCT00271024|42127028|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
19679383|NCT00271024|42127025|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
19679384|NCT00271024|42127026|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
19679385|NCT00271024|42127027|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
19679386|NCT00271024|42127028|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
19679387|NCT00381693|42127038|FG000|Overall Study|Death|1|||
19679388|NCT00381693|42127038|FG000|Overall Study|Adverse Event|4|||
19679389|NCT00381693|42127038|FG000|Overall Study|Patient Choice|1|||
19679390|NCT00381693|42127038|FG000|Overall Study|Progression|2|||
19679391|NCT00545363|42127044|FG000|Overall Study|Adverse Event|6|||
19679392|NCT00545363|42127045|FG001|Overall Study|Adverse Event|7|||
19679393|NCT00545363|42127044|FG000|Overall Study|Withdrawal by Subject|6|||
19679394|NCT00545363|42127045|FG001|Overall Study|Withdrawal by Subject|5|||
19679395|NCT00545363|42127044|FG000|Overall Study|Non-compliance|3|||
19679396|NCT00545363|42127045|FG001|Overall Study|Non-compliance|1|||
19679397|NCT00545363|42127044|FG000|Overall Study|Did not meet entry criteria|1|||
19679398|NCT00545363|42127045|FG001|Overall Study|Did not meet entry criteria|1|||
19679399|NCT00545363|42127044|FG000|Overall Study|Lost to Follow-up|2|||
19679400|NCT00545363|42127045|FG001|Overall Study|Lost to Follow-up|0|||
19679401|NCT00545363|42127044|FG000|Overall Study|Other|1|||
19679402|NCT00545363|42127045|FG001|Overall Study|Other|1|||
19679403|NCT00457392|42127053|FG000|Overall Study|Objective Progression or Relapse|229|||
19679404|NCT00457392|42127054|FG001|Overall Study|Objective Progression or Relapse|296|||
19760745|NCT02694328|42212459|FG001|Overall Study|Adverse Event|33|||
19760746|NCT02694328|42212458|FG000|Overall Study|Withdrawal by Subject|27|||
19760747|NCT02694328|42212459|FG001|Overall Study|Withdrawal by Subject|23|||
19760748|NCT02694328|42212458|FG000|Overall Study|Lost to Follow-up|26|||
19760749|NCT02694328|42212459|FG001|Overall Study|Lost to Follow-up|22|||
19760750|NCT02694328|42212458|FG000|Overall Study|Noncompliant with study drug|11|||
19760751|NCT02694328|42212459|FG001|Overall Study|Noncompliant with study drug|8|||
19760752|NCT02694328|42212458|FG000|Overall Study|Incarceration|1|||
19760753|NCT02694328|42212459|FG001|Overall Study|Incarceration|1|||
19760754|NCT02694328|42212458|FG000|Overall Study|Lack of Efficacy|1|||
19760755|NCT02694328|42212459|FG001|Overall Study|Lack of Efficacy|2|||
19760756|NCT02694328|42212458|FG000|Overall Study|Pregnancy|1|||
19760757|NCT02694328|42212459|FG001|Overall Study|Pregnancy|1|||
19760758|NCT02694328|42212458|FG000|Overall Study|Protocol Violation|6|||
19760759|NCT02694328|42212459|FG001|Overall Study|Protocol Violation|5|||
19760760|NCT02694328|42212458|FG000|Overall Study|Abnormal Laboratory Value|0|||
19760761|NCT02694328|42212459|FG001|Overall Study|Abnormal Laboratory Value|3|||
19760762|NCT03334747|42212474|FG000|Treatment Phase|Technical problems|0|||
19760763|NCT03334747|42212475|FG001|Treatment Phase|Technical problems|0|||
19760764|NCT03334747|42212476|FG002|Treatment Phase|Technical problems|0|||
19760765|NCT03334747|42212477|FG003|Treatment Phase|Technical problems|0|||
19760766|NCT03334747|42212478|FG004|Treatment Phase|Technical problems|1|||
19760767|NCT03334747|42212479|FG005|Treatment Phase|Technical problems|0|||
19760768|NCT03334747|42212480|FG006|Treatment Phase|Technical problems|0|||
19679405|NCT00457392|42127053|FG000|Overall Study|Death|106|||
19679406|NCT00457392|42127054|FG001|Overall Study|Death|106|||
19679407|NCT00457392|42127053|FG000|Overall Study|Adverse Event|84|||
19679408|NCT00457392|42127054|FG001|Overall Study|Adverse Event|41|||
19679409|NCT00457392|42127053|FG000|Overall Study|Global Deterioration of Health Status|22|||
19679410|NCT00457392|42127054|FG001|Overall Study|Global Deterioration of Health Status|8|||
19679411|NCT00457392|42127053|FG000|Overall Study|Withdrawal by Subject|14|||
19760769|NCT03334747|42212481|FG007|Treatment Phase|Technical problems|0|||
19760770|NCT03334747|42212482|FG008|Treatment Phase|Technical problems|0|||
19760771|NCT03334747|42212474|FG000|Treatment Phase|Subject/guardian decision|1|||
19760772|NCT03334747|42212475|FG001|Treatment Phase|Subject/guardian decision|0|||
19604287|NCT00751036|42053172|FG001|Overall Study|Disease Progression|29|||
19604288|NCT00751036|42053171|FG000|Overall Study|Adverse Event|6|||
19604289|NCT00751036|42053172|FG001|Overall Study|Adverse Event|4|||
19604290|NCT00751036|42053171|FG000|Overall Study|Administrative Problems|3|||
19604291|NCT00751036|42053172|FG001|Overall Study|Administrative Problems|4|||
19604292|NCT00751036|42053171|FG000|Overall Study|Withdrawal by Subject|5|||
19604293|NCT00751036|42053172|FG001|Overall Study|Withdrawal by Subject|2|||
19604294|NCT00751036|42053171|FG000|Overall Study|Death|3|||
19604295|NCT00751036|42053172|FG001|Overall Study|Death|3|||
19604296|NCT00751036|42053171|FG000|Overall Study|Lost to Follow-up|0|||
19604297|NCT00751036|42053172|FG001|Overall Study|Lost to Follow-up|1|||
19604298|NCT00751036|42053171|FG000|Overall Study|Protocol Violation|1|||
19604299|NCT00751036|42053172|FG001|Overall Study|Protocol Violation|0|||
19604300|NCT00751036|42053171|FG000|Overall Study|Missing end of Treatment Page|2|||
19604301|NCT00751036|42053172|FG001|Overall Study|Missing end of Treatment Page|3|||
19604302|NCT00961298|42053178|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
19604303|NCT00961298|42053178|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
19604304|NCT00961298|42053178|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
19604305|NCT00744328|42053185|FG000|Overall Study|Lost to Follow-up|2|||
19604306|NCT00744328|42053186|FG001|Overall Study|Lost to Follow-up|5|||
19679412|NCT00457392|42127054|FG001|Overall Study|Withdrawal by Subject|8|||
19679413|NCT00457392|42127053|FG000|Overall Study|Lost to Follow-up|6|||
19679414|NCT00457392|42127054|FG001|Overall Study|Lost to Follow-up|7|||
19760773|NCT03334747|42212476|FG002|Treatment Phase|Subject/guardian decision|0|||
19679415|NCT00457392|42127053|FG000|Overall Study|Protocol Violation|4|||
19679416|NCT00457392|42127054|FG001|Overall Study|Protocol Violation|3|||
19679417|NCT00457392|42127053|FG000|Overall Study|Other|7|||
19679418|NCT00457392|42127054|FG001|Overall Study|Other|4|||
19679419|NCT00457392|42127053|FG000|Overall Study|Study Terminated by Sponsor|1|||
19760774|NCT03334747|42212477|FG003|Treatment Phase|Subject/guardian decision|0|||
19760775|NCT03334747|42212478|FG004|Treatment Phase|Subject/guardian decision|0|||
19760776|NCT03334747|42212479|FG005|Treatment Phase|Subject/guardian decision|1|||
19760777|NCT03334747|42212480|FG006|Treatment Phase|Subject/guardian decision|0|||
19760778|NCT03334747|42212481|FG007|Treatment Phase|Subject/guardian decision|0|||
19760779|NCT03334747|42212482|FG008|Treatment Phase|Subject/guardian decision|0|||
19760780|NCT03334747|42212474|FG000|Follow-Up Phase|Subject/guardian decision|0|||
19604307|NCT00744328|42053187|FG002|Overall Study|Lost to Follow-up|3|||
19604308|NCT00744328|42053185|FG000|Overall Study|Withdrawal by Subject|5|||
19604309|NCT00744328|42053186|FG001|Overall Study|Withdrawal by Subject|3|||
19604310|NCT00744328|42053187|FG002|Overall Study|Withdrawal by Subject|4|||
19604311|NCT00744328|42053185|FG000|Overall Study|Found ineligible after randomization|0|||
19604312|NCT00744328|42053186|FG001|Overall Study|Found ineligible after randomization|0|||
19604313|NCT00744328|42053187|FG002|Overall Study|Found ineligible after randomization|1|||
19604314|NCT03245840|42053197|FG000|Overall Study|Adverse Event|6|||
19604315|NCT03245840|42053198|FG001|Overall Study|Adverse Event|0|||
19604316|NCT03245840|42053197|FG000|Overall Study|Death|2|||
19604317|NCT03245840|42053198|FG001|Overall Study|Death|0|||
19679420|NCT00457392|42127054|FG001|Overall Study|Study Terminated by Sponsor|4|||
19679421|NCT00457392|42127053|FG000|Overall Study|Randomized, Not Treated|7|||
19679422|NCT00457392|42127054|FG001|Overall Study|Randomized, Not Treated|3|||
19679423|NCT00545051|42127062|FG000|Overall Study|Adverse Event|7|||
19679424|NCT00545051|42127063|FG001|Overall Study|Adverse Event|3|||
19679425|NCT00545051|42127062|FG000|Overall Study|Death|1|||
19679426|NCT00545051|42127063|FG001|Overall Study|Death|0|||
19679427|NCT00545051|42127062|FG000|Overall Study|Violation of inclusion/exclusion|0|||
19679428|NCT00545051|42127063|FG001|Overall Study|Violation of inclusion/exclusion|2|||
19679429|NCT00545051|42127062|FG000|Overall Study|Protocol Violation|1|||
19679430|NCT00545051|42127063|FG001|Overall Study|Protocol Violation|0|||
19679431|NCT00545051|42127062|FG000|Overall Study|Withdrawal by Subject|0|||
19679432|NCT00545051|42127063|FG001|Overall Study|Withdrawal by Subject|1|||
19679433|NCT00545051|42127062|FG000|Overall Study|Administrative reasons|0|||
19679434|NCT00545051|42127063|FG001|Overall Study|Administrative reasons|1|||
19679435|NCT00381615|42127073|FG000|Overall Study|Withdrawal by Subject|1|||
19679436|NCT00381615|42127074|FG001|Overall Study|Withdrawal by Subject|3|||
19679437|NCT00381615|42127075|FG002|Overall Study|Withdrawal by Subject|0|||
19679438|NCT00381615|42127076|FG003|Overall Study|Withdrawal by Subject|1|||
19679439|NCT00381615|42127073|FG000|Overall Study|Lost to Follow-up|3|||
19679440|NCT00381615|42127074|FG001|Overall Study|Lost to Follow-up|2|||
19679441|NCT00381615|42127075|FG002|Overall Study|Lost to Follow-up|0|||
19679442|NCT00381615|42127076|FG003|Overall Study|Lost to Follow-up|1|||
19679443|NCT00381615|42127073|FG000|Overall Study|Protocol Violation|0|||
19679444|NCT00381615|42127074|FG001|Overall Study|Protocol Violation|0|||
19679445|NCT00381615|42127075|FG002|Overall Study|Protocol Violation|1|||
19679446|NCT00381615|42127076|FG003|Overall Study|Protocol Violation|0|||
19679447|NCT00371865|42127090|FG000|Overall Study|Lack of Efficacy|0|||
19679448|NCT00371865|42127091|FG001|Overall Study|Lack of Efficacy|2|||
19679449|NCT00371865|42127090|FG000|Overall Study|Protocol Violation|3|||
19679450|NCT00371865|42127091|FG001|Overall Study|Protocol Violation|2|||
19679451|NCT00371865|42127090|FG000|Overall Study|Withdrawal by Subject|12|||
19679452|NCT00371865|42127091|FG001|Overall Study|Withdrawal by Subject|10|||
19679453|NCT00364845|42127099|FG000|Overall Study|Adverse Event|1|||
19679454|NCT00364845|42127100|FG001|Overall Study|Adverse Event|0|||
19679455|NCT00364845|42127099|FG000|Overall Study|Withdrawal by Subject|2|||
19679456|NCT00364845|42127100|FG001|Overall Study|Withdrawal by Subject|1|||
19679457|NCT00364845|42127099|FG000|Overall Study|Physician Decision|8|||
19679458|NCT00364845|42127100|FG001|Overall Study|Physician Decision|8|||
19679459|NCT00364845|42127099|FG000|Overall Study|Lost to Follow-up|0|||
19679460|NCT00364845|42127100|FG001|Overall Study|Lost to Follow-up|1|||
19679461|NCT00364845|42127099|FG000|Overall Study|Death|0|||
19679462|NCT00364845|42127100|FG001|Overall Study|Death|1|||
19679463|NCT00293722|42127106|FG000|Overall Study|Other|427|||
19679464|NCT00381303|42127112|FG000|Overall Study|Lost to Follow-up|25|||
19679465|NCT00381303|42127113|FG001|Overall Study|Lost to Follow-up|9|||
19679466|NCT00381303|42127112|FG000|Overall Study|AE/HIV-related event|22|||
19679467|NCT00381303|42127113|FG001|Overall Study|AE/HIV-related event|6|||
19679468|NCT00381303|42127112|FG000|Overall Study|Non-Adherence|13|||
19679469|NCT00381303|42127113|FG001|Overall Study|Non-Adherence|6|||
19679470|NCT00381303|42127112|FG000|Overall Study|Withdrawal by Subject|13|||
19679471|NCT00381303|42127113|FG001|Overall Study|Withdrawal by Subject|6|||
19604318|NCT03245840|42053197|FG000|Overall Study|Withdrawal by Subject|31|||
19679472|NCT00381303|42127112|FG000|Overall Study|Virologic failure|6|||
19679473|NCT00381303|42127113|FG001|Overall Study|Virologic failure|4|||
19679474|NCT00381303|42127112|FG000|Overall Study|Ineligible to continue the trial|2|||
19679475|NCT00381303|42127113|FG001|Overall Study|Ineligible to continue the trial|1|||
19679476|NCT00381303|42127112|FG000|Overall Study|Pregnancy|2|||
19679477|NCT00381303|42127113|FG001|Overall Study|Pregnancy|0|||
19679478|NCT00381303|42127112|FG000|Overall Study|Physician Decision|1|||
19679479|NCT00381303|42127113|FG001|Overall Study|Physician Decision|0|||
19679480|NCT00381303|42127112|FG000|Overall Study|Physician's decision to close the site|3|||
19679481|NCT00381303|42127113|FG001|Overall Study|Physician's decision to close the site|1|||
19679482|NCT00381303|42127112|FG000|Overall Study|Subject moved out of state|2|||
19679483|NCT00381303|42127113|FG001|Overall Study|Subject moved out of state|0|||
19679484|NCT00381303|42127112|FG000|Overall Study|Subject taking too many different meds|1|||
19679485|NCT00381303|42127113|FG001|Overall Study|Subject taking too many different meds|0|||
19679486|NCT00381303|42127112|FG000|Overall Study|No virologic response by week 12|1|||
19679487|NCT00381303|42127113|FG001|Overall Study|No virologic response by week 12|0|||
19679488|NCT00381303|42127112|FG000|Overall Study|Subject was too busy for appointments|1|||
19679489|NCT00381303|42127113|FG001|Overall Study|Subject was too busy for appointments|0|||
19679490|NCT00381303|42127112|FG000|Overall Study|Subject did not continue visits|1|||
19679491|NCT00381303|42127113|FG001|Overall Study|Subject did not continue visits|0|||
19679492|NCT00381303|42127112|FG000|Overall Study|Subject primary physician's decision|1|||
19679493|NCT00381303|42127113|FG001|Overall Study|Subject primary physician's decision|0|||
19679494|NCT00448812|42127133|FG000|Year 2|Missed visit but remained in study|4|||
19679495|NCT00448812|42127134|FG001|Year 2|Missed visit but remained in study|1|||
19679496|NCT00448812|42127133|FG000|Year 3|Withdrawal by Subject|1|||
19679497|NCT00448812|42127134|FG001|Year 3|Withdrawal by Subject|3|||
19679498|NCT00448812|42127133|FG000|Year 3|Lost to Follow-up|1|||
19679499|NCT00448812|42127134|FG001|Year 3|Lost to Follow-up|0|||
19679500|NCT00448812|42127133|FG000|Year 3|Missed visit but remained in study|2|||
19679501|NCT00448812|42127134|FG001|Year 3|Missed visit but remained in study|0|||
19679502|NCT00448812|42127133|FG000|Year 5|Missed visit but remained in study|1|||
19679503|NCT00448812|42127134|FG001|Year 5|Missed visit but remained in study|0|||
19679504|NCT00364689|42127155|FG000|Overall Study|Lost to Follow-up|1|||
19679505|NCT00545129|42127163|FG000|Overall Study|Lack of Efficacy|2|||
19679506|NCT00545129|42127164|FG001|Overall Study|Lack of Efficacy|5|||
19679507|NCT00545129|42127163|FG000|Overall Study|Death|2|||
19679508|NCT00545129|42127164|FG001|Overall Study|Death|1|||
19760781|NCT03334747|42212475|FG001|Follow-Up Phase|Subject/guardian decision|0|||
19760782|NCT03334747|42212476|FG002|Follow-Up Phase|Subject/guardian decision|0|||
19760783|NCT03334747|42212477|FG003|Follow-Up Phase|Subject/guardian decision|0|||
19389079|NCT02670551|41632642|FG000|Overall Study|Withdrawal of Consent|6|||
19389080|NCT02670551|41632643|FG001|Overall Study|Withdrawal of Consent|3|||
19679509|NCT00545129|42127163|FG000|Overall Study|Adverse Event|1|||
19679510|NCT00545129|42127164|FG001|Overall Study|Adverse Event|1|||
19679511|NCT00545129|42127163|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
19679512|NCT00545129|42127164|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
19679513|NCT00545129|42127163|FG000|Overall Study|Other|3|||
19760784|NCT03334747|42212478|FG004|Follow-Up Phase|Subject/guardian decision|0|||
19760785|NCT03334747|42212479|FG005|Follow-Up Phase|Subject/guardian decision|0|||
19760786|NCT03334747|42212480|FG006|Follow-Up Phase|Subject/guardian decision|1|||
19760787|NCT03334747|42212481|FG007|Follow-Up Phase|Subject/guardian decision|0|||
19760788|NCT03334747|42212482|FG008|Follow-Up Phase|Subject/guardian decision|1|||
19760789|NCT03346759|42212504|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
19679514|NCT00545129|42127164|FG001|Overall Study|Other|3|||
19679515|NCT00364611|42127172|FG000|Overall Study|Did not receive study medication|0|||
19679516|NCT00364611|42127173|FG001|Overall Study|Did not receive study medication|1|||
19679517|NCT00364611|42127172|FG000|Overall Study|Adverse Event|7|||
19679518|NCT00364611|42127173|FG001|Overall Study|Adverse Event|4|||
19679519|NCT00364611|42127172|FG000|Overall Study|Participant's Request|3|||
19679520|NCT00364611|42127173|FG001|Overall Study|Participant's Request|4|||
19679521|NCT00364611|42127172|FG000|Overall Study|Disease Progression|38|||
19679522|NCT00364611|42127173|FG001|Overall Study|Disease Progression|8|||
19679523|NCT00364611|42127172|FG000|Overall Study|Investigator decision|2|||
19679524|NCT00364611|42127173|FG001|Overall Study|Investigator decision|2|||
19679525|NCT00364611|42127172|FG000|Overall Study|Found Ineligible|1|||
19679526|NCT00364611|42127173|FG001|Overall Study|Found Ineligible|0|||
19679527|NCT00364611|42127172|FG000|Overall Study|Presumed CR on Study|0|||
19679528|NCT00364611|42127173|FG001|Overall Study|Presumed CR on Study|1|||
19679529|NCT00364611|42127172|FG000|Overall Study|Receiving Liver Ablation|0|||
19679530|NCT00364611|42127173|FG001|Overall Study|Receiving Liver Ablation|1|||
19679531|NCT00364533|42127184|FG000|Overall Study|Adverse Event|8|||
19679532|NCT00364533|42127185|FG001|Overall Study|Adverse Event|7|||
19679533|NCT00364533|42127186|FG002|Overall Study|Adverse Event|15|||
19679534|NCT00364533|42127187|FG003|Overall Study|Adverse Event|5|||
19679535|NCT00364533|42127188|FG004|Overall Study|Adverse Event|2|||
19679536|NCT00364533|42127184|FG000|Overall Study|Withdrawal by Subject|4|||
19679537|NCT00364533|42127185|FG001|Overall Study|Withdrawal by Subject|8|||
19679538|NCT00364533|42127186|FG002|Overall Study|Withdrawal by Subject|6|||
19679539|NCT00364533|42127187|FG003|Overall Study|Withdrawal by Subject|6|||
19679540|NCT00364533|42127188|FG004|Overall Study|Withdrawal by Subject|6|||
19679541|NCT00364533|42127184|FG000|Overall Study|Lack of Efficacy|22|||
19679542|NCT00364533|42127185|FG001|Overall Study|Lack of Efficacy|22|||
19679543|NCT00364533|42127186|FG002|Overall Study|Lack of Efficacy|21|||
19679544|NCT00364533|42127187|FG003|Overall Study|Lack of Efficacy|17|||
19679545|NCT00364533|42127188|FG004|Overall Study|Lack of Efficacy|42|||
19679546|NCT00364533|42127184|FG000|Overall Study|Subject discharged from hospital|4|||
19679547|NCT00364533|42127185|FG001|Overall Study|Subject discharged from hospital|1|||
19679548|NCT00364533|42127186|FG002|Overall Study|Subject discharged from hospital|2|||
19679549|NCT00364533|42127187|FG003|Overall Study|Subject discharged from hospital|3|||
19679550|NCT00364533|42127188|FG004|Overall Study|Subject discharged from hospital|1|||
19679551|NCT00364533|42127184|FG000|Overall Study|Variations in drug compliance|2|||
19679552|NCT00364533|42127185|FG001|Overall Study|Variations in drug compliance|1|||
19679553|NCT00364533|42127186|FG002|Overall Study|Variations in drug compliance|1|||
19679554|NCT00364533|42127187|FG003|Overall Study|Variations in drug compliance|0|||
19679555|NCT00364533|42127188|FG004|Overall Study|Variations in drug compliance|0|||
19679556|NCT00364533|42127184|FG000|Overall Study|Non-compliance|1|||
19679557|NCT00364533|42127185|FG001|Overall Study|Non-compliance|0|||
19679558|NCT00364533|42127186|FG002|Overall Study|Non-compliance|0|||
19679559|NCT00364533|42127187|FG003|Overall Study|Non-compliance|0|||
19679560|NCT00364533|42127188|FG004|Overall Study|Non-compliance|0|||
19679561|NCT00364533|42127184|FG000|Overall Study|Protocol Violation|1|||
19679562|NCT00364533|42127185|FG001|Overall Study|Protocol Violation|1|||
19679563|NCT00364533|42127186|FG002|Overall Study|Protocol Violation|0|||
19679564|NCT00364533|42127187|FG003|Overall Study|Protocol Violation|0|||
19679565|NCT00364533|42127188|FG004|Overall Study|Protocol Violation|0|||
19679566|NCT04006847|42127200|FG000|Overall Study|Product issue|1|||
19679567|NCT00380367|42127204|FG000|Overall Study|Lost to Follow-up|1|||
19679568|NCT00380367|42127204|FG000|Overall Study|Withdrawal by Subject|1|||
19679569|NCT00544817|42127208|FG000|Combined Modality|Lack of Efficacy|2|||
19679570|NCT00544817|42127208|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
19679571|NCT00544817|42127208|FG000|Combined Modality|Adverse Event|2|||
19679572|NCT00544817|42127208|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
19679573|NCT00544817|42127208|FG000|No Treatment Interval|Lack of Efficacy|8|||
19679574|NCT00544817|42127208|FG000|No Treatment Interval|Physician Decision|3|||
19760790|NCT03346759|42212505|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
19760791|NCT03346759|42212504|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
19760792|NCT03346759|42212505|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
19679575|NCT00544817|42127208|FG000|No Treatment Interval|Adverse Event|1|||
19679576|NCT00544817|42127208|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
19679577|NCT00544817|42127208|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
19679578|NCT00544817|42127208|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
19760793|NCT03346759|42212504|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
19760794|NCT03346759|42212505|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
19760795|NCT03361423|42212514|FG000|Overall Study|Withdrawal by Subject|4|||
19760796|NCT03361423|42212515|FG001|Overall Study|Withdrawal by Subject|3|||
19760797|NCT03361423|42212514|FG000|Overall Study|Did not treat|19|||
19760798|NCT03361423|42212515|FG001|Overall Study|Did not treat|18|||
19760799|NCT03361423|42212514|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
19760800|NCT03361423|42212515|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
19760801|NCT03361423|42212514|FG000|Overall Study|Missing data|4|||
19760802|NCT03361423|42212515|FG001|Overall Study|Missing data|1|||
19760803|NCT02693002|42212523|FG000|Overall Study|Withdrawal by Subject|1|||
19760804|NCT02693002|42212524|FG001|Overall Study|Withdrawal by Subject|0|||
19760805|NCT03093870|42212533|FG000|Overall Study|Withdrawal by Subject|2|||
19760806|NCT03093870|42212534|FG001|Overall Study|Withdrawal by Subject|6|||
19760807|NCT03093870|42212535|FG002|Overall Study|Withdrawal by Subject|5|||
19760808|NCT03093870|42212533|FG000|Overall Study|Death|1|||
19679579|NCT00289978|42127215|FG000|Overall Study|Withdrawal by Subject|31|||
19679580|NCT00289978|42127216|FG001|Overall Study|Withdrawal by Subject|17|||
19679581|NCT00289978|42127217|FG002|Overall Study|Withdrawal by Subject|28|||
19679582|NCT00289978|42127215|FG000|Overall Study|Adverse Event|22|||
19679583|NCT00289978|42127216|FG001|Overall Study|Adverse Event|13|||
19679584|NCT00289978|42127217|FG002|Overall Study|Adverse Event|18|||
19679585|NCT00289978|42127215|FG000|Overall Study|Lack of Efficacy|13|||
19679586|NCT00289978|42127216|FG001|Overall Study|Lack of Efficacy|6|||
19679587|NCT00289978|42127217|FG002|Overall Study|Lack of Efficacy|25|||
19679588|NCT00289978|42127215|FG000|Overall Study|Abnormal laboratory value(s)|20|||
19679589|NCT00289978|42127216|FG001|Overall Study|Abnormal laboratory value(s)|9|||
19679590|NCT00289978|42127217|FG002|Overall Study|Abnormal laboratory value(s)|1|||
19679591|NCT00289978|42127215|FG000|Overall Study|Lost to Follow-up|3|||
19679592|NCT00289978|42127216|FG001|Overall Study|Lost to Follow-up|5|||
19679593|NCT00289978|42127217|FG002|Overall Study|Lost to Follow-up|7|||
19679594|NCT00289978|42127215|FG000|Overall Study|Protocol Violation|5|||
19679595|NCT00289978|42127216|FG001|Overall Study|Protocol Violation|5|||
19679596|NCT00289978|42127217|FG002|Overall Study|Protocol Violation|4|||
19679597|NCT00289978|42127215|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19679598|NCT00289978|42127216|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19679599|NCT00289978|42127217|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19679600|NCT00289978|42127215|FG000|Overall Study|Death|1|||
19679601|NCT00289978|42127216|FG001|Overall Study|Death|0|||
19679602|NCT00289978|42127217|FG002|Overall Study|Death|2|||
19679603|NCT00543803|42127225|FG000|Overall Study|Adverse Event|14|||
19679604|NCT00543803|42127225|FG000|Overall Study|Lack of Efficacy|22|||
19760809|NCT03093870|42212534|FG001|Overall Study|Death|35|||
19760810|NCT03093870|42212535|FG002|Overall Study|Death|35|||
19760811|NCT03093870|42212533|FG000|Overall Study|Radiographic disease progression|10|||
19760812|NCT03093870|42212534|FG001|Overall Study|Radiographic disease progression|0|||
19760813|NCT03093870|42212535|FG002|Overall Study|Radiographic disease progression|0|||
19760814|NCT03093870|42212533|FG000|Overall Study|Clinical disease progression|1|||
19760815|NCT03093870|42212534|FG001|Overall Study|Clinical disease progression|0|||
19760816|NCT03093870|42212535|FG002|Overall Study|Clinical disease progression|0|||
19760817|NCT03093870|42212533|FG000|Overall Study|Physician Decision|2|||
19760818|NCT03093870|42212534|FG001|Overall Study|Physician Decision|0|||
19760819|NCT03093870|42212535|FG002|Overall Study|Physician Decision|0|||
19760820|NCT03093870|42212533|FG000|Overall Study|Adverse Event|7|||
19760821|NCT03093870|42212534|FG001|Overall Study|Adverse Event|0|||
19760822|NCT03093870|42212535|FG002|Overall Study|Adverse Event|0|||
19760823|NCT03093870|42212533|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
19760824|NCT03093870|42212534|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
19760825|NCT03093870|42212535|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
19760826|NCT03093870|42212533|FG000|Overall Study|Lost to Follow-up|0|||
19760827|NCT03093870|42212534|FG001|Overall Study|Lost to Follow-up|0|||
19760828|NCT03093870|42212535|FG002|Overall Study|Lost to Follow-up|1|||
19679605|NCT00543803|42127225|FG000|Overall Study|Lost to Follow-up|20|||
19679606|NCT00543803|42127225|FG000|Overall Study|Other|86|||
19679607|NCT00542321|42127233|FG000|Overall Study|Death|0|||
19679608|NCT00542321|42127234|FG001|Overall Study|Death|1|||
19679609|NCT00289900|42127246|FG000|Overall Study|Adverse Event|28|||
19679610|NCT00289900|42127247|FG001|Overall Study|Adverse Event|40|||
19679611|NCT00289900|42127248|FG002|Overall Study|Adverse Event|13|||
19679612|NCT00289900|42127249|FG003|Overall Study|Adverse Event|19|||
19679613|NCT00289900|42127250|FG004|Overall Study|Adverse Event|20|||
19760829|NCT03346057|42212558|FG000|Overall Study|Death|1|||
19760830|NCT03346057|42212559|FG001|Overall Study|Death|2|||
19760831|NCT03346057|42212560|FG002|Overall Study|Death|0|||
19760832|NCT03346057|42212561|FG003|Overall Study|Death|0|||
19760833|NCT03346057|42212558|FG000|Overall Study|Lost to Follow-up|0|||
19760834|NCT03346057|42212559|FG001|Overall Study|Lost to Follow-up|2|||
19679614|NCT00289900|42127251|FG005|Overall Study|Adverse Event|33|||
19679615|NCT00289900|42127246|FG000|Overall Study|Lost to Follow-up|7|||
19679616|NCT00289900|42127247|FG001|Overall Study|Lost to Follow-up|7|||
19679617|NCT00289900|42127248|FG002|Overall Study|Lost to Follow-up|8|||
19679618|NCT00289900|42127249|FG003|Overall Study|Lost to Follow-up|8|||
19760835|NCT03346057|42212560|FG002|Overall Study|Lost to Follow-up|1|||
19760836|NCT03346057|42212561|FG003|Overall Study|Lost to Follow-up|0|||
19760837|NCT03346057|42212558|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
19760838|NCT03346057|42212559|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
19679619|NCT00289900|42127250|FG004|Overall Study|Lost to Follow-up|4|||
19679620|NCT00289900|42127251|FG005|Overall Study|Lost to Follow-up|8|||
19679621|NCT00289900|42127246|FG000|Overall Study|Participant had flushing|18|||
19679622|NCT00289900|42127247|FG001|Overall Study|Participant had flushing|42|||
19679623|NCT00289900|42127248|FG002|Overall Study|Participant had flushing|1|||
19679624|NCT00289900|42127249|FG003|Overall Study|Participant had flushing|2|||
19679625|NCT00289900|42127250|FG004|Overall Study|Participant had flushing|0|||
19679626|NCT00289900|42127251|FG005|Overall Study|Participant had flushing|4|||
19679627|NCT00289900|42127246|FG000|Overall Study|Other|0|||
19679628|NCT00289900|42127247|FG001|Overall Study|Other|0|||
19679629|NCT00289900|42127248|FG002|Overall Study|Other|0|||
19679630|NCT00289900|42127249|FG003|Overall Study|Other|5|||
19679631|NCT00289900|42127250|FG004|Overall Study|Other|1|||
19679632|NCT00289900|42127251|FG005|Overall Study|Other|0|||
19679633|NCT00289900|42127246|FG000|Overall Study|Participant moved|1|||
19679634|NCT00289900|42127247|FG001|Overall Study|Participant moved|0|||
19679635|NCT00289900|42127248|FG002|Overall Study|Participant moved|0|||
19679636|NCT00289900|42127249|FG003|Overall Study|Participant moved|1|||
19679637|NCT00289900|42127250|FG004|Overall Study|Participant moved|1|||
19679638|NCT00289900|42127251|FG005|Overall Study|Participant moved|1|||
19679639|NCT00289900|42127246|FG000|Overall Study|Withdrawal by Subject|10|||
19679640|NCT00289900|42127247|FG001|Overall Study|Withdrawal by Subject|21|||
19679641|NCT00289900|42127248|FG002|Overall Study|Withdrawal by Subject|8|||
19679642|NCT00289900|42127249|FG003|Overall Study|Withdrawal by Subject|18|||
19679643|NCT00289900|42127250|FG004|Overall Study|Withdrawal by Subject|12|||
19760839|NCT03346057|42212560|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
19760840|NCT03346057|42212561|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
19760841|NCT03346057|42212558|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
19760842|NCT03346057|42212559|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
19760843|NCT03346057|42212560|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
19760844|NCT03346057|42212561|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
19760845|NCT03346057|42212558|FG000|Overall Study|Physician Decision|3|||
19760846|NCT03346057|42212559|FG001|Overall Study|Physician Decision|2|||
19760847|NCT03346057|42212560|FG002|Overall Study|Physician Decision|0|||
19760848|NCT03346057|42212561|FG003|Overall Study|Physician Decision|2|||
19760849|NCT03346057|42212558|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
19760850|NCT03346057|42212559|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
19760851|NCT03346057|42212560|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
19760852|NCT03346057|42212561|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
19760853|NCT03346057|42212558|FG000|Overall Study|Withdrawal by Subject|1|||
19760854|NCT03346057|42212559|FG001|Overall Study|Withdrawal by Subject|0|||
19760855|NCT03346057|42212560|FG002|Overall Study|Withdrawal by Subject|0|||
19760856|NCT03346057|42212561|FG003|Overall Study|Withdrawal by Subject|0|||
19760857|NCT03345979|42212573|FG000|Overall Study|Withdrawal by Subject|20|||
19760858|NCT03345979|42212574|FG001|Overall Study|Withdrawal by Subject|31|||
19760859|NCT03345979|42212573|FG000|Overall Study|Adverse Event|10|||
19760860|NCT03345979|42212574|FG001|Overall Study|Adverse Event|11|||
19760861|NCT03345979|42212573|FG000|Overall Study|Lost to Follow-up|8|||
19760862|NCT03345979|42212574|FG001|Overall Study|Lost to Follow-up|9|||
19760863|NCT03345979|42212573|FG000|Overall Study|Lack of Efficacy|4|||
19760864|NCT03345979|42212574|FG001|Overall Study|Lack of Efficacy|2|||
19760865|NCT03345979|42212573|FG000|Overall Study|Protocol Violation|1|||
19760866|NCT03345979|42212574|FG001|Overall Study|Protocol Violation|3|||
19760867|NCT03345979|42212573|FG000|Overall Study|Physician Decision|0|||
19760868|NCT03345979|42212574|FG001|Overall Study|Physician Decision|2|||
19760869|NCT02696434|42212582|FG000|Overall Study|Adverse Event|3|||
19760870|NCT02696434|42212583|FG001|Overall Study|Adverse Event|1|||
19760871|NCT02696434|42212582|FG000|Overall Study|Lost to Follow-up|5|||
19760872|NCT02696434|42212583|FG001|Overall Study|Lost to Follow-up|4|||
19760873|NCT02696434|42212582|FG000|Overall Study|Withdrawal by Subject|14|||
19679644|NCT00289900|42127251|FG005|Overall Study|Withdrawal by Subject|11|||
19760874|NCT02696434|42212583|FG001|Overall Study|Withdrawal by Subject|12|||
19760875|NCT02696434|42212582|FG000|Overall Study|Physician Decision|0|||
19760876|NCT02696434|42212583|FG001|Overall Study|Physician Decision|1|||
19760877|NCT03345901|42212589|FG000|Overall Study|The study was terminated|18|||
19679645|NCT00289900|42127246|FG000|Overall Study|Protocol Violation|3|||
19679646|NCT00289900|42127247|FG001|Overall Study|Protocol Violation|9|||
19760878|NCT02950831|42212594|FG000|Overall Study|Lost to Follow-up|1|||
19760879|NCT02950831|42212594|FG000|Overall Study|Withdrawal by Subject|3|||
19760880|NCT02950831|42212594|FG000|Overall Study|stimulation trail failure|5|||
19760881|NCT03593915|42212604|FG000|Overall Study|Adverse Event|0|||
19760882|NCT03593915|42212605|FG001|Overall Study|Adverse Event|0|||
19760883|NCT03593915|42212606|FG002|Overall Study|Adverse Event|0|||
19760884|NCT03593915|42212607|FG003|Overall Study|Adverse Event|1|||
19760885|NCT03593915|42212608|FG004|Overall Study|Adverse Event|0|||
19760886|NCT03593915|42212609|FG005|Overall Study|Adverse Event|0|||
19679647|NCT00289900|42127248|FG002|Overall Study|Protocol Violation|2|||
19679648|NCT00289900|42127249|FG003|Overall Study|Protocol Violation|6|||
19679649|NCT00289900|42127250|FG004|Overall Study|Protocol Violation|7|||
19679650|NCT00289900|42127251|FG005|Overall Study|Protocol Violation|4|||
19679651|NCT00289900|42127246|FG000|Overall Study|site terminated|1|||
19679652|NCT00289900|42127247|FG001|Overall Study|site terminated|0|||
19679653|NCT00289900|42127248|FG002|Overall Study|site terminated|1|||
19679654|NCT00289900|42127249|FG003|Overall Study|site terminated|0|||
19679655|NCT00289900|42127250|FG004|Overall Study|site terminated|0|||
19679656|NCT00289900|42127251|FG005|Overall Study|site terminated|0|||
19679657|NCT00289900|42127246|FG000|Overall Study|Not treated|0|||
19679658|NCT00289900|42127247|FG001|Overall Study|Not treated|1|||
19679659|NCT00289900|42127248|FG002|Overall Study|Not treated|0|||
19679660|NCT00289900|42127249|FG003|Overall Study|Not treated|0|||
19679661|NCT00289900|42127250|FG004|Overall Study|Not treated|0|||
19679662|NCT00289900|42127251|FG005|Overall Study|Not treated|0|||
19679663|NCT00543725|42127270|FG000|Overall Study|Adverse Event|18|||
19679664|NCT00543725|42127271|FG001|Overall Study|Adverse Event|27|||
19679665|NCT00543725|42127270|FG000|Overall Study|Sponsor's Decision|0|||
19679666|NCT00543725|42127271|FG001|Overall Study|Sponsor's Decision|1|||
19679667|NCT00543725|42127270|FG000|Overall Study|Subject Non-Compliant|4|||
19679668|NCT00543725|42127271|FG001|Overall Study|Subject Non-Compliant|4|||
19679669|NCT00543725|42127270|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
19679670|NCT00543725|42127271|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
19679671|NCT00543725|42127270|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
19679672|NCT00543725|42127271|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
19760887|NCT03593915|42212604|FG000|Overall Study|Physician Decision|0|||
19760888|NCT03593915|42212605|FG001|Overall Study|Physician Decision|0|||
19760889|NCT03593915|42212606|FG002|Overall Study|Physician Decision|0|||
19760890|NCT03593915|42212607|FG003|Overall Study|Physician Decision|0|||
19760891|NCT03593915|42212608|FG004|Overall Study|Physician Decision|0|||
19760892|NCT03593915|42212609|FG005|Overall Study|Physician Decision|1|||
19760893|NCT03593681|42212623|FG000|Overall Study|Inadequate sample collected|12|||
19760894|NCT03593681|42212623|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
19760895|NCT03593681|42212623|FG000|Overall Study|Protocol Violation|3|||
19760896|NCT03593681|42212623|FG000|Overall Study|Withdrawal by Subject|3|||
19760897|NCT03593681|42212623|FG000|Overall Study|Procedure not attempted|3|||
19760898|NCT03593681|42212623|FG000|Overall Study|Adverse Event|2|||
19760899|NCT03593681|42212623|FG000|Overall Study|Physician Decision|1|||
19760900|NCT03592745|42212646|FG000|Overall Study|Adverse Event|0|||
19760901|NCT03592745|42212647|FG001|Overall Study|Adverse Event|2|||
19760902|NCT03592745|42212646|FG000|Overall Study|Lost to Follow-up|2|||
19760903|NCT03592745|42212647|FG001|Overall Study|Lost to Follow-up|0|||
19760904|NCT03592745|42212646|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
19760905|NCT03592745|42212647|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
19760906|NCT03592277|42212655|FG000|Overall Study|Withdrawal by Subject|6|||
19760907|NCT03592277|42212656|FG001|Overall Study|Withdrawal by Subject|8|||
19760908|NCT03401112|42212667|FG000|Overall Study|Adverse Event|1|||
19760909|NCT03401112|42212668|FG001|Overall Study|Adverse Event|2|||
19760910|NCT03401112|42212669|FG002|Overall Study|Adverse Event|3|||
19760911|NCT03401112|42212670|FG003|Overall Study|Adverse Event|2|||
19760912|NCT03401112|42212671|FG004|Overall Study|Adverse Event|0|||
19760913|NCT03401112|42212667|FG000|Overall Study|Lost to Follow-up|1|||
19760914|NCT03401112|42212668|FG001|Overall Study|Lost to Follow-up|0|||
19760915|NCT03401112|42212669|FG002|Overall Study|Lost to Follow-up|0|||
19760916|NCT03401112|42212670|FG003|Overall Study|Lost to Follow-up|0|||
19760917|NCT03401112|42212671|FG004|Overall Study|Lost to Follow-up|0|||
19760918|NCT03401112|42212667|FG000|Overall Study|Noncompliance|1|||
19760919|NCT03401112|42212668|FG001|Overall Study|Noncompliance|2|||
19760920|NCT03401112|42212669|FG002|Overall Study|Noncompliance|3|||
19760921|NCT03401112|42212670|FG003|Overall Study|Noncompliance|0|||
19760922|NCT03401112|42212671|FG004|Overall Study|Noncompliance|0|||
19760923|NCT03401112|42212667|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
19760924|NCT03401112|42212668|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
19760925|NCT03401112|42212669|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
19760926|NCT03401112|42212670|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
19760927|NCT03401112|42212671|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
19679673|NCT00543725|42127270|FG000|Overall Study|Protocol Violation|0|||
19679674|NCT00543725|42127271|FG001|Overall Study|Protocol Violation|1|||
19679675|NCT00543725|42127270|FG000|Overall Study|Withdrawal by Subject|4|||
19760928|NCT03401112|42212667|FG000|Overall Study|Withdrawal by Subject|0|||
19760929|NCT03401112|42212668|FG001|Overall Study|Withdrawal by Subject|3|||
19760930|NCT03401112|42212669|FG002|Overall Study|Withdrawal by Subject|2|||
19760931|NCT03401112|42212670|FG003|Overall Study|Withdrawal by Subject|1|||
19604319|NCT03245840|42053198|FG001|Overall Study|Withdrawal by Subject|1|||
19604320|NCT03245840|42053197|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
19604321|NCT03245840|42053198|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19604322|NCT03245840|42053197|FG000|Overall Study|Physician Decision|4|||
19604323|NCT03245840|42053198|FG001|Overall Study|Physician Decision|1|||
19604324|NCT03245840|42053197|FG000|Overall Study|Study Terminated by Sponsor|56|||
19604325|NCT03245840|42053198|FG001|Overall Study|Study Terminated by Sponsor|6|||
19604326|NCT03245840|42053197|FG000|Overall Study|Site Terminated by Sponsor|4|||
19604327|NCT03245840|42053198|FG001|Overall Study|Site Terminated by Sponsor|0|||
19604328|NCT03245840|42053197|FG000|Overall Study|Lost to Follow-up|12|||
19604329|NCT03245840|42053198|FG001|Overall Study|Lost to Follow-up|2|||
19604330|NCT03245840|42053197|FG000|Overall Study|Pregnancy|2|||
19604331|NCT03245840|42053198|FG001|Overall Study|Pregnancy|0|||
19604332|NCT03245840|42053197|FG000|Overall Study|Non-Compliance with Study Drug|2|||
19604333|NCT03245840|42053198|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19604334|NCT03245840|42053197|FG000|Overall Study|Not treated|1|||
19604335|NCT03245840|42053198|FG001|Overall Study|Not treated|1|||
19604336|NCT00959894|42053204|FG000|Overall Study|Lost to Follow-up|10|||
19604337|NCT00959894|42053204|FG000|Overall Study|Adverse Event|3|||
19604338|NCT00959894|42053204|FG000|Overall Study|Withdrawal by Subject|1|||
19604339|NCT00959894|42053204|FG000|Overall Study|Need for contraindicated medication|1|||
19604340|NCT00959894|42053204|FG000|Overall Study|Subject moved out of town|1|||
19604341|NCT00750880|42053209|FG000|Overall Study|Adverse Event|76|||
19604342|NCT00750880|42053209|FG000|Overall Study|Death|4|||
19604343|NCT00750880|42053209|FG000|Overall Study|Lack of Efficacy|46|||
19604344|NCT00750880|42053209|FG000|Overall Study|Lost to Follow-up|10|||
19604345|NCT00750880|42053209|FG000|Overall Study|Protocol Violation|15|||
19604346|NCT00750880|42053209|FG000|Overall Study|Withdrawal by Subject|33|||
19604347|NCT00750880|42053209|FG000|Overall Study|Physician Decision|20|||
19604348|NCT00750880|42053209|FG000|Overall Study|Administrative|11|||
19604349|NCT00746590|42053214|FG000|Overall Study|Death|1|||
19604350|NCT01032629|42053221|FG000|Overall Study|Closed Site|21|||
19604351|NCT01032629|42053222|FG001|Overall Study|Closed Site|18|||
19604352|NCT01032629|42053223|FG002|Overall Study|Closed Site|16|||
19604353|NCT01032629|42053221|FG000|Overall Study|Withdrawal by Subject|50|||
19604354|NCT01032629|42053222|FG001|Overall Study|Withdrawal by Subject|36|||
19604355|NCT01032629|42053223|FG002|Overall Study|Withdrawal by Subject|35|||
19604356|NCT01032629|42053221|FG000|Overall Study|Lost to Follow-up|74|||
19604357|NCT01032629|42053222|FG001|Overall Study|Lost to Follow-up|47|||
19604358|NCT01032629|42053223|FG002|Overall Study|Lost to Follow-up|37|||
19604359|NCT00749944|42053234|FG000|Overall Study|Lost to Follow-up|2|||
19604360|NCT00749944|42053235|FG001|Overall Study|Lost to Follow-up|1|||
19604361|NCT00749944|42053234|FG000|Overall Study|Other|1|||
19604362|NCT00749944|42053235|FG001|Overall Study|Other|0|||
19604363|NCT00749944|42053234|FG000|Overall Study|Withdrawal by Subject|2|||
19604364|NCT00749944|42053235|FG001|Overall Study|Withdrawal by Subject|0|||
19604365|NCT00746356|42053241|FG000|Overall Study|Withdrawal by Subject|2|||
19604366|NCT00746356|42053242|FG001|Overall Study|Withdrawal by Subject|3|||
19604367|NCT00746356|42053241|FG000|Overall Study|Death|7|||
19604368|NCT00746356|42053242|FG001|Overall Study|Death|3|||
19604369|NCT00746356|42053241|FG000|Overall Study|Lost to Follow-up|1|||
19604370|NCT00746356|42053242|FG001|Overall Study|Lost to Follow-up|0|||
19604371|NCT00746356|42053241|FG000|Overall Study|Removal of Device|0|||
19604372|NCT00746356|42053242|FG001|Overall Study|Removal of Device|1|||
19604373|NCT00746356|42053241|FG000|Overall Study|Patient relocated|1|||
19604374|NCT00746356|42053242|FG001|Overall Study|Patient relocated|0|||
19604375|NCT00749398|42053250|FG000|Overall Study|Lack of Efficacy|7|||
19604376|NCT00749398|42053250|FG000|Overall Study|Adverse Event|4|||
19604377|NCT00749398|42053250|FG000|Overall Study|Serious adverse event|11|||
19604378|NCT00749398|42053250|FG000|Overall Study|Withdrawal by Subject|17|||
19604379|NCT00749398|42053250|FG000|Overall Study|Lost to Follow-up|11|||
19604380|NCT00749398|42053250|FG000|Overall Study|Reason not specified|2|||
19604381|NCT00749398|42053250|FG000|Overall Study|Unknown reason|1|||
19604382|NCT01012973|42053256|FG000|Overall Study|Adverse Event|5|||
19604383|NCT01012973|42053257|FG001|Overall Study|Adverse Event|5|||
19604384|NCT01012973|42053256|FG000|Overall Study|Lack of Efficacy|0|||
19604385|NCT01012973|42053257|FG001|Overall Study|Lack of Efficacy|5|||
19760932|NCT03401112|42212671|FG004|Overall Study|Withdrawal by Subject|0|||
19604386|NCT01012973|42053256|FG000|Overall Study|Lost to Follow-up|1|||
19604387|NCT01012973|42053257|FG001|Overall Study|Lost to Follow-up|0|||
19604388|NCT01012973|42053256|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
19604389|NCT01012973|42053257|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
19604390|NCT01012973|42053256|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
19604391|NCT01012973|42053257|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
19604392|NCT01012973|42053256|FG000|Overall Study|Protocol Violation|5|||
19679676|NCT00543725|42127271|FG001|Overall Study|Withdrawal by Subject|13|||
19679677|NCT00543725|42127270|FG000|Overall Study|Lost to Follow-up|15|||
19679678|NCT00543725|42127271|FG001|Overall Study|Lost to Follow-up|11|||
19760933|NCT03401112|42212667|FG000|Overall Study|Physician Decision|0|||
19760934|NCT03401112|42212668|FG001|Overall Study|Physician Decision|0|||
19760935|NCT03401112|42212669|FG002|Overall Study|Physician Decision|0|||
19760936|NCT03401112|42212670|FG003|Overall Study|Physician Decision|2|||
19760937|NCT03401112|42212671|FG004|Overall Study|Physician Decision|0|||
19760938|NCT03401112|42212667|FG000|Overall Study|Study was Terminated by Sponsor|0|||
19760939|NCT03401112|42212668|FG001|Overall Study|Study was Terminated by Sponsor|0|||
19760940|NCT03401112|42212669|FG002|Overall Study|Study was Terminated by Sponsor|0|||
19760941|NCT03401112|42212670|FG003|Overall Study|Study was Terminated by Sponsor|1|||
19760942|NCT03401112|42212671|FG004|Overall Study|Study was Terminated by Sponsor|0|||
19760943|NCT03401112|42212667|FG000|Overall Study|Day 1 Assessment not Done|1|||
19760944|NCT03401112|42212668|FG001|Overall Study|Day 1 Assessment not Done|0|||
19760945|NCT03401112|42212669|FG002|Overall Study|Day 1 Assessment not Done|0|||
19760946|NCT03401112|42212670|FG003|Overall Study|Day 1 Assessment not Done|0|||
19760947|NCT03401112|42212671|FG004|Overall Study|Day 1 Assessment not Done|0|||
19760948|NCT03401112|42212667|FG000|Overall Study|Not Dosed|0|||
19760949|NCT03401112|42212668|FG001|Overall Study|Not Dosed|0|||
19760950|NCT03401112|42212669|FG002|Overall Study|Not Dosed|1|||
19760951|NCT03401112|42212670|FG003|Overall Study|Not Dosed|0|||
19760952|NCT03401112|42212671|FG004|Overall Study|Not Dosed|0|||
19760953|NCT03401112|42212667|FG000|Overall Study|Missed Clinical Visit|0|||
19760954|NCT03401112|42212668|FG001|Overall Study|Missed Clinical Visit|0|||
19760955|NCT03401112|42212669|FG002|Overall Study|Missed Clinical Visit|1|||
19760956|NCT03401112|42212670|FG003|Overall Study|Missed Clinical Visit|0|||
19760957|NCT03401112|42212671|FG004|Overall Study|Missed Clinical Visit|0|||
19760958|NCT03401112|42212667|FG000|Overall Study|Missed Doses|0|||
19760959|NCT03401112|42212668|FG001|Overall Study|Missed Doses|0|||
19760960|NCT03401112|42212669|FG002|Overall Study|Missed Doses|1|||
19760961|NCT03401112|42212670|FG003|Overall Study|Missed Doses|0|||
19760962|NCT03401112|42212671|FG004|Overall Study|Missed Doses|0|||
19760963|NCT02697916|42212700|FG000|Overall Study|Death|357|||
19760964|NCT02697916|42212701|FG001|Overall Study|Death|315|||
19760965|NCT02697916|42212700|FG000|Overall Study|Withdrawal by Subject|221|||
19760966|NCT02697916|42212701|FG001|Overall Study|Withdrawal by Subject|393|||
19760967|NCT03650387|42212707|FG000|Overall Study|Withdrawal by Subject|13|||
19760968|NCT03650387|42212707|FG000|Overall Study|Lost to Follow-up|12|||
19760969|NCT03650387|42212707|FG000|Overall Study|Adverse Event (Not related)|1|||
19760970|NCT03650387|42212707|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
19760971|NCT03359473|42212733|FG000|Overall Study|Adverse Event|0|||
19760972|NCT03359473|42212734|FG001|Overall Study|Adverse Event|2|||
19760973|NCT03359473|42212735|FG002|Overall Study|Adverse Event|5|||
19760974|NCT03359473|42212736|FG003|Overall Study|Adverse Event|3|||
19760975|NCT03359473|42212733|FG000|Overall Study|Lost to Follow-up|0|||
19760976|NCT03359473|42212734|FG001|Overall Study|Lost to Follow-up|1|||
19760977|NCT03359473|42212735|FG002|Overall Study|Lost to Follow-up|0|||
19760978|NCT03359473|42212736|FG003|Overall Study|Lost to Follow-up|0|||
19760979|NCT03359473|42212733|FG000|Overall Study|Physician Decision|0|||
19760980|NCT03359473|42212734|FG001|Overall Study|Physician Decision|1|||
19760981|NCT03359473|42212735|FG002|Overall Study|Physician Decision|0|||
19760982|NCT03359473|42212736|FG003|Overall Study|Physician Decision|1|||
19760983|NCT03359473|42212733|FG000|Overall Study|Withdrawal by Subject|1|||
19760984|NCT03359473|42212734|FG001|Overall Study|Withdrawal by Subject|2|||
19760985|NCT03359473|42212735|FG002|Overall Study|Withdrawal by Subject|1|||
19760986|NCT03359473|42212736|FG003|Overall Study|Withdrawal by Subject|0|||
19760987|NCT03359473|42212733|FG000|Overall Study|Protocol-defined stopping criteria|1|||
19760988|NCT03359473|42212734|FG001|Overall Study|Protocol-defined stopping criteria|0|||
19760989|NCT03359473|42212735|FG002|Overall Study|Protocol-defined stopping criteria|0|||
19760990|NCT03359473|42212736|FG003|Overall Study|Protocol-defined stopping criteria|1|||
19389081|NCT02670551|41632644|FG002|Overall Study|Withdrawal of Consent|8|||
19679679|NCT00543725|42127270|FG000|Overall Study|Other|3|||
19679680|NCT00543725|42127271|FG001|Overall Study|Other|3|||
19679681|NCT00269152|42127279|FG000|Overall Study|Adverse Event|9|||
19679682|NCT00269152|42127280|FG001|Overall Study|Adverse Event|3|||
19679683|NCT00269152|42127279|FG000|Overall Study|Withdrawal by Subject|7|||
19679684|NCT00269152|42127280|FG001|Overall Study|Withdrawal by Subject|3|||
19679685|NCT00269152|42127279|FG000|Overall Study|Physician Decision|2|||
19679686|NCT00269152|42127280|FG001|Overall Study|Physician Decision|3|||
19760991|NCT03589469|42212749|FG000|Overall Study|Ongoing in study|58|||
19760992|NCT03589469|42212749|FG000|Overall Study|Withdrawal by Subject|6|||
19760993|NCT03589469|42212749|FG000|Overall Study|Physician Decision|1|||
19760994|NCT03589469|42212749|FG000|Overall Study|Death|77|||
19760995|NCT03589469|42212749|FG000|Overall Study|Lost to Follow-up|3|||
19760996|NCT03359395|42212755|FG000|First Intervention A / B|Withdrawal by Subject|1|||
19679687|NCT00269152|42127279|FG000|Overall Study|Protocol Violation|0|||
19679688|NCT00269152|42127280|FG001|Overall Study|Protocol Violation|1|||
19760997|NCT03359395|42212756|FG001|First Intervention A / B|Withdrawal by Subject|0|||
19760998|NCT03359395|42212755|FG000|First Intervention A / B|Lost to Follow-up|2|||
19760999|NCT03359395|42212756|FG001|First Intervention A / B|Lost to Follow-up|3|||
19761000|NCT03359395|42212755|FG000|Second Intervention B/A|Exclusion criteria|0|||
19761001|NCT03359395|42212756|FG001|Second Intervention B/A|Exclusion criteria|1|||
19761002|NCT03359395|42212755|FG000|Second Intervention B/A|Lost to Follow-up|3|||
19761003|NCT03359395|42212756|FG001|Second Intervention B/A|Lost to Follow-up|2|||
19761004|NCT03586427|42212767|FG000|Overall Study|Lost to Follow-up|0|||
19761005|NCT03586427|42212768|FG001|Overall Study|Lost to Follow-up|3|||
19761006|NCT03586427|42212769|FG002|Overall Study|Lost to Follow-up|1|||
19679689|NCT00379899|42127288|FG000|Overall Study|Adverse Event|7|||
19679690|NCT00379899|42127289|FG001|Overall Study|Adverse Event|3|||
19679691|NCT00379899|42127288|FG000|Overall Study|Death|10|||
19679692|NCT00379899|42127289|FG001|Overall Study|Death|10|||
19679693|NCT00379899|42127288|FG000|Overall Study|Lost to Follow-up|2|||
19679694|NCT00379899|42127289|FG001|Overall Study|Lost to Follow-up|4|||
19761007|NCT03586427|42212770|FG003|Overall Study|Lost to Follow-up|3|||
19761008|NCT03586427|42212771|FG004|Overall Study|Lost to Follow-up|3|||
19761009|NCT03586427|42212767|FG000|Overall Study|Withdrawal by Subject|0|||
19761010|NCT03586427|42212768|FG001|Overall Study|Withdrawal by Subject|1|||
19761011|NCT03586427|42212769|FG002|Overall Study|Withdrawal by Subject|2|||
19761012|NCT03586427|42212770|FG003|Overall Study|Withdrawal by Subject|1|||
19761013|NCT03586427|42212771|FG004|Overall Study|Withdrawal by Subject|1|||
19761014|NCT03586427|42212767|FG000|Overall Study|Adverse Event|0|||
19761015|NCT03586427|42212768|FG001|Overall Study|Adverse Event|0|||
19761016|NCT03586427|42212769|FG002|Overall Study|Adverse Event|1|||
19761017|NCT03586427|42212770|FG003|Overall Study|Adverse Event|0|||
19761018|NCT03586427|42212771|FG004|Overall Study|Adverse Event|0|||
19761019|NCT03586427|42212767|FG000|Overall Study|Protocol Violation|0|||
19761020|NCT03586427|42212768|FG001|Overall Study|Protocol Violation|0|||
19761021|NCT03586427|42212769|FG002|Overall Study|Protocol Violation|1|||
19761022|NCT03586427|42212770|FG003|Overall Study|Protocol Violation|0|||
19761023|NCT03586427|42212771|FG004|Overall Study|Protocol Violation|1|||
19761024|NCT03586427|42212767|FG000|Overall Study|Noncompliance with study drug|0|||
19761025|NCT03586427|42212768|FG001|Overall Study|Noncompliance with study drug|0|||
19761026|NCT03586427|42212769|FG002|Overall Study|Noncompliance with study drug|1|||
19761027|NCT03586427|42212770|FG003|Overall Study|Noncompliance with study drug|0|||
19761028|NCT03586427|42212771|FG004|Overall Study|Noncompliance with study drug|0|||
19761029|NCT03648983|42212788|FG000|Overall Study|Study was terminated due to PI departure|95|||
19761030|NCT02695420|42212797|FG000|Overall Study|Death|0|||
19761031|NCT02695420|42212798|FG001|Overall Study|Death|1|||
19761032|NCT02695420|42212799|FG002|Overall Study|Death|0|||
19761033|NCT02695420|42212800|FG003|Overall Study|Death|0|||
19761034|NCT03358147|42212818|FG000|Overall Study|Withdrawal by Subject|13|||
19761035|NCT03358147|42212819|FG001|Overall Study|Withdrawal by Subject|19|||
19761036|NCT03358147|42212820|FG002|Overall Study|Withdrawal by Subject|16|||
19761037|NCT03358147|42212821|FG003|Overall Study|Withdrawal by Subject|10|||
19761038|NCT03358147|42212822|FG004|Overall Study|Withdrawal by Subject|5|||
19477183|NCT01513291|41756111|FG003|Treatment Period|Randomized not treated|0|||
19477184|NCT01513291|41756112|FG004|Treatment Period|Randomized not treated|0|||
19477185|NCT01513291|41756108|FG000|Run-out Period|Lost to Follow-up|0|||
19477186|NCT01513291|41756109|FG001|Run-out Period|Lost to Follow-up|0|||
19477187|NCT01513291|41756110|FG002|Run-out Period|Lost to Follow-up|0|||
19477188|NCT01513291|41756111|FG003|Run-out Period|Lost to Follow-up|1|||
19477189|NCT01513291|41756112|FG004|Run-out Period|Lost to Follow-up|0|||
19477190|NCT01513291|41756108|FG000|Run-out Period|Withdrawal by Subject|0|||
19477191|NCT01513291|41756109|FG001|Run-out Period|Withdrawal by Subject|0|||
19477192|NCT01513291|41756110|FG002|Run-out Period|Withdrawal by Subject|0|||
19477193|NCT01513291|41756111|FG003|Run-out Period|Withdrawal by Subject|1|||
19477194|NCT01513291|41756112|FG004|Run-out Period|Withdrawal by Subject|0|||
19477195|NCT01483937|41756126|FG000|Overall Study|Withdrawal by Subject|4|||
19477196|NCT01483937|41756127|FG001|Overall Study|Withdrawal by Subject|3|||
19477197|NCT01483625|41756138|FG000|Overall Study|Adverse Event|1|||
19477198|NCT01483625|41756139|FG001|Overall Study|Adverse Event|1|||
19477199|NCT01483625|41756138|FG000|Overall Study|Refused to continue medication|2|||
19477200|NCT01483625|41756139|FG001|Overall Study|Refused to continue medication|1|||
19679695|NCT00379899|42127288|FG000|Overall Study|Physician Decision|3|||
19679696|NCT00379899|42127289|FG001|Overall Study|Physician Decision|4|||
19679697|NCT00379899|42127288|FG000|Overall Study|Withdrawal by Subject|5|||
19477201|NCT01483625|41756138|FG000|Overall Study|Due to other reason|1|||
19477202|NCT01483625|41756139|FG001|Overall Study|Due to other reason|0|||
19679698|NCT00379899|42127289|FG001|Overall Study|Withdrawal by Subject|5|||
19761039|NCT03358147|42212818|FG000|Overall Study|Adverse Event|3|||
19761040|NCT03358147|42212819|FG001|Overall Study|Adverse Event|9|||
19761041|NCT03358147|42212820|FG002|Overall Study|Adverse Event|7|||
19679699|NCT00379899|42127288|FG000|Overall Study|Ineligibility determined|0|||
19761042|NCT03358147|42212821|FG003|Overall Study|Adverse Event|5|||
19761043|NCT03358147|42212822|FG004|Overall Study|Adverse Event|2|||
19477203|NCT01485991|41756147|FG000|Overall Study|Adverse Event|0|||
19477204|NCT01485991|41756148|FG001|Overall Study|Adverse Event|4|||
19679700|NCT00379899|42127289|FG001|Overall Study|Ineligibility determined|1|||
19679701|NCT00379899|42127288|FG000|Overall Study|Noncompliance|1|||
19679702|NCT00379899|42127289|FG001|Overall Study|Noncompliance|1|||
19679703|NCT00379899|42127288|FG000|Overall Study|Parathyroidectomy|0|||
19679704|NCT00379899|42127289|FG001|Overall Study|Parathyroidectomy|2|||
19679705|NCT00379899|42127288|FG000|Overall Study|Renal transplantation|5|||
19477205|NCT01485991|41756147|FG000|Overall Study|Lost to Follow-up|13|||
19477206|NCT01485991|41756148|FG001|Overall Study|Lost to Follow-up|10|||
19477207|NCT01485991|41756147|FG000|Overall Study|Withdrawal by Subject|13|||
19477208|NCT01485991|41756148|FG001|Overall Study|Withdrawal by Subject|20|||
19477209|NCT01485991|41756147|FG000|Overall Study|randomized but not treated|6|||
19477210|NCT01485991|41756148|FG001|Overall Study|randomized but not treated|2|||
19477211|NCT01482767|41756180|FG000|Overall Study|Death|1|||
19477212|NCT01482767|41756181|FG001|Overall Study|Death|1|||
19477213|NCT01482767|41756180|FG000|Overall Study|Withdrawal by Subject|7|||
19477214|NCT01482767|41756181|FG001|Overall Study|Withdrawal by Subject|5|||
19477215|NCT01482767|41756180|FG000|Overall Study|Lost to Follow-up|12|||
19477216|NCT01482767|41756181|FG001|Overall Study|Lost to Follow-up|6|||
19477217|NCT01482767|41756180|FG000|Overall Study|Adverse Event|0|||
19679706|NCT00379899|42127289|FG001|Overall Study|Renal transplantation|4|||
19679707|NCT00379899|42127288|FG000|Overall Study|Coronary artery bypass graft|1|||
19477218|NCT01482767|41756181|FG001|Overall Study|Adverse Event|3|||
19679708|NCT00379899|42127289|FG001|Overall Study|Coronary artery bypass graft|1|||
19679709|NCT00379899|42127288|FG000|Overall Study|Other protocol-specified criteria|3|||
19679710|NCT00379899|42127289|FG001|Overall Study|Other protocol-specified criteria|4|||
19679711|NCT00379899|42127288|FG000|Overall Study|Other|3|||
19477219|NCT01482767|41756180|FG000|Overall Study|Site closure|22|||
19477220|NCT01482767|41756181|FG001|Overall Study|Site closure|14|||
19477221|NCT01482767|41756180|FG000|Overall Study|Non-adherence to study requirements|4|||
19477222|NCT01482767|41756181|FG001|Overall Study|Non-adherence to study requirements|7|||
19679712|NCT00379899|42127289|FG001|Overall Study|Other|1|||
19761044|NCT03358147|42212818|FG000|Overall Study|Lost to Follow-up|4|||
19477223|NCT01482767|41756180|FG000|Overall Study|Alternate HCV treatment|7|||
19761045|NCT03358147|42212819|FG001|Overall Study|Lost to Follow-up|3|||
19761046|NCT03358147|42212820|FG002|Overall Study|Lost to Follow-up|7|||
19761047|NCT03358147|42212821|FG003|Overall Study|Lost to Follow-up|6|||
19761048|NCT03358147|42212822|FG004|Overall Study|Lost to Follow-up|4|||
19761049|NCT03358147|42212818|FG000|Overall Study|Major Protocol Deviation|11|||
19761050|NCT03358147|42212819|FG001|Overall Study|Major Protocol Deviation|3|||
19761051|NCT03358147|42212820|FG002|Overall Study|Major Protocol Deviation|2|||
19761052|NCT03358147|42212821|FG003|Overall Study|Major Protocol Deviation|3|||
19761053|NCT03358147|42212822|FG004|Overall Study|Major Protocol Deviation|1|||
19761054|NCT03358147|42212818|FG000|Overall Study|Protocol specified criteria|2|||
19761055|NCT03358147|42212819|FG001|Overall Study|Protocol specified criteria|3|||
19761056|NCT03358147|42212820|FG002|Overall Study|Protocol specified criteria|0|||
19761057|NCT03358147|42212821|FG003|Overall Study|Protocol specified criteria|3|||
19761058|NCT03358147|42212822|FG004|Overall Study|Protocol specified criteria|1|||
19761059|NCT03358147|42212818|FG000|Overall Study|Physician Decision|1|||
19761060|NCT03358147|42212819|FG001|Overall Study|Physician Decision|0|||
19761061|NCT03358147|42212820|FG002|Overall Study|Physician Decision|1|||
19761062|NCT03358147|42212821|FG003|Overall Study|Physician Decision|6|||
19761063|NCT03358147|42212822|FG004|Overall Study|Physician Decision|1|||
19761064|NCT03358147|42212818|FG000|Overall Study|Administrative reasons|0|||
19761065|NCT03358147|42212819|FG001|Overall Study|Administrative reasons|1|||
19761066|NCT03358147|42212820|FG002|Overall Study|Administrative reasons|0|||
19761067|NCT03358147|42212821|FG003|Overall Study|Administrative reasons|3|||
19761068|NCT03358147|42212822|FG004|Overall Study|Administrative reasons|0|||
19761069|NCT03358147|42212818|FG000|Overall Study|Lack of Efficacy|0|||
19761070|NCT03358147|42212819|FG001|Overall Study|Lack of Efficacy|1|||
19761071|NCT03358147|42212820|FG002|Overall Study|Lack of Efficacy|1|||
19761072|NCT03358147|42212821|FG003|Overall Study|Lack of Efficacy|0|||
19761073|NCT03358147|42212822|FG004|Overall Study|Lack of Efficacy|0|||
19761074|NCT03093402|42212838|FG000|Overall Study|Lost to Follow-up|1|||
19761075|NCT03093402|42212839|FG001|Overall Study|Lost to Follow-up|0|||
19761076|NCT03093402|42212840|FG002|Overall Study|Lost to Follow-up|0|||
19761077|NCT03093402|42212841|FG003|Overall Study|Lost to Follow-up|0|||
19477224|NCT01482767|41756181|FG001|Overall Study|Alternate HCV treatment|8|||
19477225|NCT01482767|41756180|FG000|Overall Study|Ineligible|0|||
19679713|NCT00371787|42127297|FG000|Overall Study|Withdrawal by Subject|3|||
19679714|NCT00371787|42127298|FG001|Overall Study|Withdrawal by Subject|1|||
19679715|NCT00363129|42127306|FG000|Overall Study|Withdrawal by Subject|11|||
19761078|NCT03093402|42212838|FG000|Overall Study|Withdrawal by Subject|3|||
19761079|NCT03093402|42212839|FG001|Overall Study|Withdrawal by Subject|3|||
19761080|NCT03093402|42212840|FG002|Overall Study|Withdrawal by Subject|0|||
19761081|NCT03093402|42212841|FG003|Overall Study|Withdrawal by Subject|1|||
19761082|NCT03093402|42212838|FG000|Overall Study|Withdrew prior to dosing|2|||
19761083|NCT03093402|42212839|FG001|Overall Study|Withdrew prior to dosing|1|||
19761084|NCT03093402|42212840|FG002|Overall Study|Withdrew prior to dosing|2|||
19761085|NCT03093402|42212841|FG003|Overall Study|Withdrew prior to dosing|3|||
19761086|NCT03093402|42212838|FG000|Overall Study|Ineligible for study|1|||
19761087|NCT03093402|42212839|FG001|Overall Study|Ineligible for study|0|||
19761088|NCT03093402|42212840|FG002|Overall Study|Ineligible for study|0|||
19761089|NCT03093402|42212841|FG003|Overall Study|Ineligible for study|0|||
19761090|NCT03093402|42212838|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
19761091|NCT03093402|42212839|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
19761092|NCT03093402|42212840|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
19761093|NCT03093402|42212841|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
19761094|NCT03585959|42212851|FG000|Overall Study|Physician Decision|1|||
19761095|NCT03585959|42212851|FG000|Overall Study|Unsuccessful Procedure|2|||
19761096|NCT03584789|42212860|FG000|Overall Study|refused EHR permission|19|||
19761097|NCT03584789|42212861|FG001|Overall Study|refused EHR permission|28|||
19761098|NCT03584789|42212862|FG002|Overall Study|refused EHR permission|23|||
19761099|NCT03584789|42212860|FG000|Overall Study|patients tied to a provider who retired|0|||
19761100|NCT03584789|42212861|FG001|Overall Study|patients tied to a provider who retired|0|||
19761101|NCT03584789|42212862|FG002|Overall Study|patients tied to a provider who retired|3|||
19761102|NCT03343639|42212872|FG000|Overall Study|Withdrawal by Subject|10|||
19761103|NCT03343639|42212873|FG001|Overall Study|Withdrawal by Subject|6|||
19761104|NCT03343639|42212872|FG000|Overall Study|Lost to Follow-up|4|||
19761105|NCT03343639|42212873|FG001|Overall Study|Lost to Follow-up|5|||
19761106|NCT03343639|42212872|FG000|Overall Study|Protocol Violation|0|||
19761107|NCT03343639|42212873|FG001|Overall Study|Protocol Violation|1|||
19761108|NCT03647267|42212881|FG000|Overall Study|Lost to Follow-up|1|||
19761109|NCT03647267|42212882|FG001|Overall Study|Lost to Follow-up|0|||
19761110|NCT03356977|42212890|FG000|Overall Study|Lost to Follow-up|3|||
19761111|NCT03356977|42212890|FG000|Overall Study|Withdrawal by parent/guardian|2|||
19761112|NCT02690974|42212894|FG000|Overall Study|Adverse Event|16|||
19761113|NCT02690974|42212894|FG000|Overall Study|Death|9|||
19761114|NCT02690974|42212894|FG000|Overall Study|Subject/guardian decision|4|||
19761115|NCT02690974|42212894|FG000|Overall Study|Lost to Follow-up|3|||
19761116|NCT02690974|42212894|FG000|Overall Study|Withdrawal of Informed Consent|3|||
19761117|NCT02690974|42212894|FG000|Overall Study|Physician Decision|2|||
19761118|NCT02690974|42212894|FG000|Overall Study|Non-compliance with study treatment|1|||
19761119|NCT02690974|42212894|FG000|Overall Study|Protocol-defined stopping criteria|1|||
19761120|NCT02690974|42212894|FG000|Overall Study|Protocol Deviation|1|||
19679716|NCT00363129|42127307|FG001|Overall Study|Withdrawal by Subject|18|||
19679717|NCT00363129|42127306|FG000|Overall Study|Adverse Event|8|||
19679718|NCT00363129|42127307|FG001|Overall Study|Adverse Event|3|||
19679719|NCT00363129|42127306|FG000|Overall Study|Alternate Treatment|2|||
19679720|NCT00363129|42127307|FG001|Overall Study|Alternate Treatment|4|||
19679721|NCT00363129|42127306|FG000|Overall Study|Other Medical Problems|2|||
19679722|NCT00363129|42127307|FG001|Overall Study|Other Medical Problems|4|||
19679723|NCT00363129|42127306|FG000|Overall Study|Death|0|||
19679724|NCT00363129|42127307|FG001|Overall Study|Death|1|||
19679725|NCT00363129|42127306|FG000|Overall Study|Other Reasons|6|||
19679726|NCT00363129|42127307|FG001|Overall Study|Other Reasons|3|||
19679727|NCT00268996|42127315|FG000|Overall Study|Adverse Event|11|||
19679728|NCT00268996|42127316|FG001|Overall Study|Adverse Event|7|||
19679729|NCT00268996|42127315|FG000|Overall Study|Lost to Follow-up|3|||
19679730|NCT00268996|42127316|FG001|Overall Study|Lost to Follow-up|1|||
19679731|NCT00268996|42127315|FG000|Overall Study|Withdrawal by Subject|5|||
19679732|NCT00268996|42127316|FG001|Overall Study|Withdrawal by Subject|11|||
19679733|NCT00268996|42127315|FG000|Overall Study|Non-compliance|1|||
19679734|NCT00268996|42127316|FG001|Overall Study|Non-compliance|0|||
19679735|NCT00268996|42127315|FG000|Overall Study|Other|1|||
19679736|NCT00268996|42127316|FG001|Overall Study|Other|1|||
19679737|NCT00371397|42127324|FG000|Session 1|Withdrawal by Subject|1|||
19679738|NCT00371397|42127325|FG001|Session 1|Withdrawal by Subject|0|||
19679739|NCT00371397|42127326|FG002|Session 1|Withdrawal by Subject|0|||
19679740|NCT00371397|42127327|FG003|Session 1|Withdrawal by Subject|0|||
19679741|NCT00371397|42127328|FG004|Session 1|Withdrawal by Subject|0|||
19679742|NCT00371397|42127329|FG005|Session 1|Withdrawal by Subject|0|||
19679743|NCT00371397|42127330|FG006|Session 1|Withdrawal by Subject|0|||
19679744|NCT00371397|42127331|FG007|Session 1|Withdrawal by Subject|1|||
19679745|NCT00371397|42127332|FG008|Session 1|Withdrawal by Subject|0|||
19679746|NCT00371397|42127333|FG009|Session 1|Withdrawal by Subject|0|||
19679747|NCT00371397|42127334|FG010|Session 1|Withdrawal by Subject|0|||
19477226|NCT01482767|41756181|FG001|Overall Study|Ineligible|5|||
19761121|NCT03093324|42212900|FG000|Overall Study|Adverse Event|4|||
19679748|NCT00371397|42127335|FG011|Session 1|Withdrawal by Subject|0|||
19679749|NCT00379587|42127341|FG000|Overall Study|Lost to Follow-up|2|||
19679750|NCT00289276|42127347|FG000|Second Part of FAST Study (Expansion)|Death|0|||
19679751|NCT00289276|42127348|FG001|Second Part of FAST Study (Expansion)|Death|2|||
19679752|NCT00289276|42127347|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
19679753|NCT00289276|42127348|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
19679754|NCT00289198|42127356|FG000|Overall Study|Adverse Event|0|||
19679755|NCT00289198|42127357|FG001|Overall Study|Adverse Event|2|||
19679756|NCT00289198|42127356|FG000|Overall Study|Protocol Violation|2|||
19679757|NCT00289198|42127357|FG001|Overall Study|Protocol Violation|1|||
19679758|NCT00289198|42127356|FG000|Overall Study|Withdrawal by Subject|4|||
19679759|NCT00289198|42127357|FG001|Overall Study|Withdrawal by Subject|1|||
19679760|NCT00289198|42127356|FG000|Overall Study|Lack of Efficacy|2|||
19679761|NCT00289198|42127357|FG001|Overall Study|Lack of Efficacy|0|||
19679762|NCT00289198|42127356|FG000|Overall Study|Other: Low compliance|0|||
19679763|NCT00289198|42127357|FG001|Overall Study|Other: Low compliance|1|||
19679764|NCT00289198|42127356|FG000|Overall Study|Other: Physician's decision|0|||
19679765|NCT00289198|42127357|FG001|Overall Study|Other: Physician's decision|1|||
19679766|NCT00289198|42127356|FG000|Overall Study|Other: Unable to attend on schedule|2|||
19679767|NCT00289198|42127357|FG001|Overall Study|Other: Unable to attend on schedule|1|||
19679768|NCT00289198|42127356|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
19679769|NCT00289198|42127357|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
19679770|NCT00289198|42127356|FG000|Overall Study|Other: Impossible to come on visit|0|||
19679771|NCT00289198|42127357|FG001|Overall Study|Other: Impossible to come on visit|1|||
19679772|NCT00363051|42127366|FG000|Overall Study|Adminstrative problems|1|||
19679773|NCT00363051|42127367|FG001|Overall Study|Adminstrative problems|1|||
19679774|NCT00363051|42127366|FG000|Overall Study|Adverse Event|21|||
19679775|NCT00363051|42127367|FG001|Overall Study|Adverse Event|12|||
19679776|NCT00363051|42127366|FG000|Overall Study|New Cancer Therapy|2|||
19679777|NCT00363051|42127367|FG001|Overall Study|New Cancer Therapy|1|||
19679778|NCT00363051|42127366|FG000|Overall Study|Withdrawal by Subject|11|||
19679779|NCT00363051|42127367|FG001|Overall Study|Withdrawal by Subject|3|||
19679780|NCT00363051|42127366|FG000|Overall Study|Lost to Follow-up|0|||
19679781|NCT00363051|42127367|FG001|Overall Study|Lost to Follow-up|1|||
19679782|NCT00363051|42127366|FG000|Overall Study|Protocol Violation|0|||
19679783|NCT00363051|42127367|FG001|Overall Study|Protocol Violation|2|||
19679784|NCT00363051|42127366|FG000|Overall Study|Death|3|||
19679785|NCT00363051|42127367|FG001|Overall Study|Death|2|||
19679786|NCT00379353|42127377|FG000|Overall Study|Hospitalization|3|||
19679787|NCT00379353|42127378|FG001|Overall Study|Hospitalization|3|||
19679788|NCT00379353|42127377|FG000|Overall Study|Withdrawal by Subject|5|||
19679789|NCT00379353|42127378|FG001|Overall Study|Withdrawal by Subject|2|||
19679790|NCT00379353|42127377|FG000|Overall Study|Death|1|||
19679791|NCT00379353|42127378|FG001|Overall Study|Death|0|||
19679792|NCT00379353|42127377|FG000|Overall Study|Cardiac Tamponade|1|||
19761122|NCT03093324|42212901|FG001|Overall Study|Adverse Event|15|||
19679793|NCT00379353|42127378|FG001|Overall Study|Cardiac Tamponade|0|||
19679794|NCT00379353|42127377|FG000|Overall Study|Non-compliance|1|||
19761123|NCT03093324|42212900|FG000|Overall Study|Lost to Follow-up|1|||
19761124|NCT03093324|42212901|FG001|Overall Study|Lost to Follow-up|0|||
19761125|NCT03093324|42212900|FG000|Overall Study|Protocol Deviation|2|||
19761126|NCT03093324|42212901|FG001|Overall Study|Protocol Deviation|2|||
19761127|NCT03093324|42212900|FG000|Overall Study|Withdrawal by Subject|2|||
19761128|NCT03093324|42212901|FG001|Overall Study|Withdrawal by Subject|2|||
19761129|NCT03584009|42212909|FG000|Overall Study|Death|25|||
19761130|NCT03584009|42212910|FG001|Overall Study|Death|18|||
19761131|NCT03584009|42212909|FG000|Overall Study|Lost to Follow-up|0|||
19761132|NCT03584009|42212910|FG001|Overall Study|Lost to Follow-up|1|||
19761133|NCT03584009|42212909|FG000|Overall Study|Physician Decision|1|||
19761134|NCT03584009|42212910|FG001|Overall Study|Physician Decision|1|||
19679795|NCT00379353|42127378|FG001|Overall Study|Non-compliance|0|||
19679796|NCT00379353|42127377|FG000|Overall Study|Conflicting drug treatment|0|||
19679797|NCT00379353|42127378|FG001|Overall Study|Conflicting drug treatment|1|||
19679798|NCT00378573|42127394|FG000|Treatment Period|Adverse Event|9|||
19761135|NCT03584009|42212909|FG000|Overall Study|Study Terminated by Sponsor|22|||
19761136|NCT03584009|42212910|FG001|Overall Study|Study Terminated by Sponsor|30|||
19761137|NCT03584009|42212909|FG000|Overall Study|Withdrawal by Subject|3|||
19761138|NCT03584009|42212910|FG001|Overall Study|Withdrawal by Subject|2|||
19761139|NCT04167462|42212921|FG000|Overall Study|Other reasons|3|||
19761140|NCT04167462|42212922|FG001|Overall Study|Other reasons|2|||
19761141|NCT04167462|42212921|FG000|Overall Study|Withdrawal by Subject|6|||
19761142|NCT04167462|42212922|FG001|Overall Study|Withdrawal by Subject|7|||
19761143|NCT04167462|42212921|FG000|Overall Study|Adverse Event|4|||
19761144|NCT04167462|42212922|FG001|Overall Study|Adverse Event|0|||
19761145|NCT04167462|42212921|FG000|Overall Study|Pregnancy|1|||
19679799|NCT00378573|42127394|FG000|Treatment Period|Physician Decision|1|||
19679800|NCT00378573|42127394|FG000|Treatment Period|Withdrawal by Subject|2|||
19761146|NCT04167462|42212922|FG001|Overall Study|Pregnancy|0|||
19679801|NCT00378573|42127394|FG000|Treatment Period|Disease Progression|4|||
19679802|NCT00378573|42127394|FG000|Treatment Period|Sponsor decision to close study|1|||
19679803|NCT00378573|42127394|FG000|Follow-up|Death|12|||
19679804|NCT00378573|42127394|FG000|Follow-up|Lost to Follow-up|1|||
19679805|NCT00378573|42127394|FG000|Follow-up|Withdrawal by Subject|1|||
19761147|NCT04167462|42212921|FG000|Overall Study|Lack of Efficacy|0|||
19761148|NCT04167462|42212922|FG001|Overall Study|Lack of Efficacy|1|||
19761149|NCT03583385|42212929|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19761150|NCT03583385|42212930|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19761151|NCT03583385|42212929|FG000|Treatment Period 2|Adverse Event|1|||
19761152|NCT03583385|42212930|FG001|Treatment Period 2|Adverse Event|0|||
19761153|NCT04350372|42212936|FG000|Overall Study|Death|1|||
19761154|NCT02949973|42212940|FG000|Overall Study|Physician Decision|1|||
19761155|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
19761156|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
19761157|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Adverse Event|2|||
19761158|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Adverse Event|5|||
19761159|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
19761160|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
19761161|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
19761162|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
19761163|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Randomized by error|0|||
19761164|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Randomized by error|5|||
19761165|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
19761166|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
19761167|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
19761168|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
19761169|NCT02948959|42212946|FG000|52 Weeks Treatment Period|Change of residence location|0|||
19761170|NCT02948959|42212947|FG001|52 Weeks Treatment Period|Change of residence location|1|||
19761171|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
19761172|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
19761173|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
19761174|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
19761175|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
19761176|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
19761177|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
19679806|NCT03831945|42127400|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
19679807|NCT03831945|42127401|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
19679808|NCT03831945|42127400|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
19679809|NCT03831945|42127401|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
19679810|NCT03831945|42127400|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
19679811|NCT03831945|42127401|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
19679812|NCT00457002|42127409|FG000|Overall Study|Death|40|||
19679813|NCT00457002|42127410|FG001|Overall Study|Death|47|||
19679814|NCT00457002|42127409|FG000|Overall Study|Adverse Event|284|||
19761178|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
19761179|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
19761180|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
19761181|NCT02948959|42212946|FG000|12 Weeks Follow-up Period|Study site closure|1|||
19761182|NCT02948959|42212947|FG001|12 Weeks Follow-up Period|Study site closure|0|||
19761183|NCT03582215|42212969|FG000|Overall Study|Adverse Event|1|||
19761184|NCT03582215|42212970|FG001|Overall Study|Adverse Event|0|||
19761185|NCT03582215|42212971|FG002|Overall Study|Adverse Event|0|||
19761186|NCT03582215|42212972|FG003|Overall Study|Adverse Event|0|||
19761187|NCT03582215|42212973|FG004|Overall Study|Adverse Event|0|||
19761188|NCT03582215|42212974|FG005|Overall Study|Adverse Event|0|||
19761189|NCT03582215|42212975|FG006|Overall Study|Adverse Event|2|||
19761190|NCT03582215|42212976|FG007|Overall Study|Adverse Event|2|||
19761191|NCT03089580|42213005|FG000|Overall Study|Lost to Follow-up|2|||
19761192|NCT03645395|42213015|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
19761193|NCT03645395|42213016|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
19761194|NCT03645395|42213017|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
19761195|NCT03645395|42213018|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
19761196|NCT03645395|42213015|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
19761197|NCT03645395|42213016|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
19761198|NCT03645395|42213017|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
19761199|NCT03645395|42213018|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
19761200|NCT03645395|42213015|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
19761201|NCT03645395|42213016|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
19761202|NCT03645395|42213017|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
19761203|NCT03645395|42213018|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
19761204|NCT03645395|42213015|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
19761205|NCT03645395|42213016|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
19761206|NCT03645395|42213017|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
19761207|NCT03645395|42213018|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
19761208|NCT03342469|42213031|FG000|Overall Study|Withdrawal by Subject|0|||
19761209|NCT03342469|42213032|FG001|Overall Study|Withdrawal by Subject|1|||
19761210|NCT03342469|42213033|FG002|Overall Study|Withdrawal by Subject|0|||
19761211|NCT03342469|42213034|FG003|Overall Study|Withdrawal by Subject|0|||
19761212|NCT03581825|42213045|FG000|Period 1|Lens Discomfort|1|||
19761213|NCT03581825|42213046|FG001|Period 1|Lens Discomfort|0|||
19761214|NCT03581825|42213045|FG000|Period 2|Unsatisfactory Vision to Test|0|||
19761215|NCT03581825|42213046|FG001|Period 2|Unsatisfactory Vision to Test|1|||
19761216|NCT03342001|42213052|FG000|Overall Study|Adverse Event|1|||
19761217|NCT03342001|42213052|FG000|Overall Study|Lost to Follow-up|1|||
19761218|NCT03341923|42213056|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
19761219|NCT03341923|42213057|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
19761220|NCT03579719|42213065|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
19761221|NCT03341533|42213071|FG000|Overall Study|Withdrawal by Subject|1|||
19761222|NCT03341533|42213072|FG001|Overall Study|Withdrawal by Subject|1|||
19761223|NCT03341533|42213071|FG000|Overall Study|Not eligible after randomization|2|||
19761224|NCT03341533|42213072|FG001|Overall Study|Not eligible after randomization|1|||
19761225|NCT02688088|42213078|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
19761226|NCT02688088|42213079|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
19761227|NCT02688088|42213080|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
19761228|NCT02688088|42213081|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
19761229|NCT02688088|42213082|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
19761230|NCT02688088|42213078|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
19761231|NCT02688088|42213079|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
19761232|NCT02688088|42213080|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
19761233|NCT02688088|42213081|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
19761234|NCT02688088|42213082|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
19761235|NCT02688088|42213078|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
19761236|NCT02688088|42213079|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
19761237|NCT02688088|42213080|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
19761238|NCT02688088|42213081|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
19761239|NCT02688088|42213082|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
19761240|NCT02688088|42213078|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
19761241|NCT02688088|42213079|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
19761242|NCT02688088|42213080|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
19761243|NCT02688088|42213081|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
19761244|NCT02688088|42213082|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
19761245|NCT02688088|42213078|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
19761246|NCT02688088|42213079|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
19679815|NCT00457002|42127410|FG001|Overall Study|Adverse Event|260|||
19679816|NCT00457002|42127409|FG000|Overall Study|Withdrawal by Subject|299|||
19679817|NCT00457002|42127410|FG001|Overall Study|Withdrawal by Subject|271|||
19679818|NCT00457002|42127409|FG000|Overall Study|Lost to Follow-up|72|||
19679819|NCT00457002|42127410|FG001|Overall Study|Lost to Follow-up|71|||
19679820|NCT00457002|42127409|FG000|Overall Study|Poor/Non-compliance|46|||
19761247|NCT02688088|42213080|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
19761248|NCT02688088|42213081|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
19761249|NCT02688088|42213082|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
19761250|NCT02688088|42213078|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
19761251|NCT02688088|42213079|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
19761252|NCT02688088|42213080|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
19761253|NCT02688088|42213081|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
19761254|NCT02688088|42213082|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
19761255|NCT02688088|42213078|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
19761256|NCT02688088|42213079|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
19761257|NCT02688088|42213080|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
19761258|NCT02688088|42213081|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
19761259|NCT02688088|42213082|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
19679821|NCT00457002|42127410|FG001|Overall Study|Poor/Non-compliance|33|||
19679822|NCT00457002|42127409|FG000|Overall Study|No longer met criteria|41|||
19679823|NCT00457002|42127410|FG001|Overall Study|No longer met criteria|37|||
19679824|NCT00457002|42127409|FG000|Overall Study|Administrative reason by Sponsor|1|||
19761260|NCT02688088|42213078|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
19761261|NCT02688088|42213079|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
19679825|NCT00457002|42127410|FG001|Overall Study|Administrative reason by Sponsor|0|||
19679826|NCT00457002|42127409|FG000|Overall Study|non-specified|29|||
19679827|NCT00457002|42127410|FG001|Overall Study|non-specified|38|||
19761262|NCT02688088|42213080|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
19761263|NCT02688088|42213081|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
19761264|NCT02688088|42213082|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
19761265|NCT02688088|42213078|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
19761266|NCT02688088|42213079|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
19761267|NCT02688088|42213080|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
19761268|NCT02688088|42213081|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
19761269|NCT02688088|42213082|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
19761270|NCT03641651|42213107|FG000|Overall Study|organizational issues at one study site|1|||
19761271|NCT03341299|42213111|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
19761272|NCT03341299|42213112|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
19761273|NCT03341299|42213113|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
19761274|NCT03341299|42213114|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
19761275|NCT02949271|42213128|FG000|Overall Study|Lack of Efficacy|5|||
19761276|NCT02949271|42213129|FG001|Overall Study|Lack of Efficacy|4|||
19761277|NCT02949271|42213128|FG000|Overall Study|Lost to Follow-up|3|||
19761278|NCT02949271|42213129|FG001|Overall Study|Lost to Follow-up|6|||
19761279|NCT02949271|42213128|FG000|Overall Study|Physician Decision|5|||
19761280|NCT02949271|42213129|FG001|Overall Study|Physician Decision|5|||
19679828|NCT00457002|42127409|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
19679829|NCT00457002|42127410|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
19679830|NCT00362115|42127423|FG000|Overall Study|Adverse Event|0|||
19679831|NCT00362115|42127424|FG001|Overall Study|Adverse Event|1|||
19679832|NCT00362115|42127425|FG002|Overall Study|Adverse Event|1|||
19679833|NCT00362115|42127426|FG003|Overall Study|Adverse Event|1|||
19679834|NCT00362115|42127427|FG004|Overall Study|Adverse Event|2|||
19679835|NCT00362115|42127428|FG005|Overall Study|Adverse Event|2|||
19679836|NCT00362115|42127429|FG006|Overall Study|Adverse Event|1|||
19761281|NCT02949271|42213128|FG000|Overall Study|Protocol Violation|6|||
19761282|NCT02949271|42213129|FG001|Overall Study|Protocol Violation|3|||
19761283|NCT02949271|42213128|FG000|Overall Study|Withdrawal by Subject|1|||
19761284|NCT02949271|42213129|FG001|Overall Study|Withdrawal by Subject|0|||
19761285|NCT02949271|42213128|FG000|Overall Study|Delivered prior to intervention|7|||
19761286|NCT02949271|42213129|FG001|Overall Study|Delivered prior to intervention|9|||
19761287|NCT02949271|42213128|FG000|Overall Study|Outside the window for cervical dilation|2|||
19761288|NCT02949271|42213129|FG001|Overall Study|Outside the window for cervical dilation|3|||
19761289|NCT03640559|42213137|FG000|Overall Study|Physician Decision|1|||
19761290|NCT03640559|42213138|FG001|Overall Study|Physician Decision|1|||
19761291|NCT03640559|42213137|FG000|Overall Study|Withdrawal by Subject|1|||
19761292|NCT03640559|42213138|FG001|Overall Study|Withdrawal by Subject|0|||
19761293|NCT03339583|42213146|FG000|First Intervention (14 Days)|Adverse Event|1|||
19761294|NCT03339583|42213147|FG001|First Intervention (14 Days)|Adverse Event|0|||
19761295|NCT03339583|42213146|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
19761296|NCT03339583|42213147|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
19761297|NCT03339583|42213146|FG000|Second Intervention (14 Days)|Adverse Event|0|||
19761298|NCT03339583|42213147|FG001|Second Intervention (14 Days)|Adverse Event|1|||
19761299|NCT03339583|42213146|FG000|Follow-up (14 Days)|Physician Decision|6|||
19761300|NCT03339583|42213147|FG001|Follow-up (14 Days)|Physician Decision|3|||
19761301|NCT03639779|42213155|FG000|Overall Study|Lost to Follow-up|1|||
19761302|NCT03575975|42213164|FG000|Overall Study|Lost to Follow-up|1|||
19761303|NCT03575975|42213165|FG001|Overall Study|Lost to Follow-up|0|||
19761304|NCT03575975|42213166|FG002|Overall Study|Lost to Follow-up|0|||
19761305|NCT03636893|42213174|FG000|Overall Study|Death|0|||
19761306|NCT03636893|42213175|FG001|Overall Study|Death|1|||
19761307|NCT03636893|42213174|FG000|Overall Study|Protocol Violation|0|||
19761308|NCT03636893|42213175|FG001|Overall Study|Protocol Violation|3|||
19761309|NCT03636893|42213174|FG000|Overall Study|Withdrawal by Subject|1|||
19761310|NCT03636893|42213175|FG001|Overall Study|Withdrawal by Subject|2|||
19761311|NCT03636893|42213174|FG000|Overall Study|Refusal to surgery|4|||
19761312|NCT03636893|42213175|FG001|Overall Study|Refusal to surgery|3|||
19761313|NCT03636893|42213174|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
19761314|NCT03636893|42213175|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
19761315|NCT03636893|42213174|FG000|Overall Study|Adverse Event|1|||
19761316|NCT03636893|42213175|FG001|Overall Study|Adverse Event|1|||
19679837|NCT00362115|42127423|FG000|Overall Study|Protocol Violation|0|||
19761317|NCT01353586|42213183|FG000|Overall Study|Procedure terminated prior to ablation|3|||
19761318|NCT01353586|42213184|FG001|Overall Study|Procedure terminated prior to ablation|0|||
19761319|NCT01353586|42213183|FG000|Overall Study|Never had insertion of study catheter|4|||
19761320|NCT01353586|42213184|FG001|Overall Study|Never had insertion of study catheter|1|||
19477227|NCT01482767|41756180|FG000|Overall Study|Nurse error|1|||
19679838|NCT00362115|42127424|FG001|Overall Study|Protocol Violation|0|||
19679839|NCT00362115|42127425|FG002|Overall Study|Protocol Violation|0|||
19679840|NCT00362115|42127426|FG003|Overall Study|Protocol Violation|0|||
19761321|NCT01353586|42213183|FG000|Overall Study|Neurological exam not done|0|||
19761322|NCT01353586|42213184|FG001|Overall Study|Neurological exam not done|1|||
19761323|NCT03091920|42213196|FG000|Overall Study|Adverse Event|0|||
19761324|NCT03091920|42213197|FG001|Overall Study|Adverse Event|1|||
19761325|NCT03091920|42213198|FG002|Overall Study|Adverse Event|0|||
19761326|NCT03338569|42213214|FG000|Overall Study|Physician Decision|8|||
19761327|NCT03338569|42213215|FG001|Overall Study|Physician Decision|3|||
19761328|NCT03338569|42213214|FG000|Overall Study|Withdrawal by Subject|0|||
19761329|NCT03338569|42213215|FG001|Overall Study|Withdrawal by Subject|1|||
19761330|NCT03338569|42213214|FG000|Overall Study|Lost to Follow-up|0|||
19761331|NCT03338569|42213215|FG001|Overall Study|Lost to Follow-up|1|||
19761332|NCT03338023|42213223|FG000|Overall Study|Withdrawal by Subject|3|||
19761333|NCT03338023|42213224|FG001|Overall Study|Withdrawal by Subject|4|||
19761334|NCT03338023|42213223|FG000|Overall Study|Protocol Violation|3|||
19761335|NCT03338023|42213224|FG001|Overall Study|Protocol Violation|3|||
19761336|NCT03338023|42213223|FG000|Overall Study|Lost to Follow-up|2|||
19761337|NCT03338023|42213224|FG001|Overall Study|Lost to Follow-up|1|||
19761338|NCT03338023|42213223|FG000|Overall Study|Physician Decision|1|||
19761339|NCT03338023|42213224|FG001|Overall Study|Physician Decision|2|||
19761340|NCT03337477|42213232|FG000|Overall Study|not categorized into the listed ones|11|||
19761341|NCT03337477|42213233|FG001|Overall Study|not categorized into the listed ones|9|||
19761342|NCT03337477|42213232|FG000|Overall Study|Withdrawal by Subject|0|||
19761343|NCT03337477|42213233|FG001|Overall Study|Withdrawal by Subject|1|||
19761344|NCT03337477|42213232|FG000|Overall Study|Death|0|||
19761345|NCT03337477|42213233|FG001|Overall Study|Death|1|||
19761346|NCT03337477|42213232|FG000|Overall Study|Lost to Follow-up|0|||
19761347|NCT03337477|42213233|FG001|Overall Study|Lost to Follow-up|2|||
19761348|NCT02687542|42213246|FG000|Overall Study|Medication error without associated AEs|0|||
19761349|NCT02687542|42213247|FG001|Overall Study|Medication error without associated AEs|0|||
19761350|NCT02687542|42213248|FG002|Overall Study|Medication error without associated AEs|0|||
19761351|NCT02687542|42213249|FG003|Overall Study|Medication error without associated AEs|0|||
19761352|NCT02687542|42213250|FG004|Overall Study|Medication error without associated AEs|1|||
19761353|NCT02687542|42213246|FG000|Overall Study|Lost to Follow-up|0|||
19761354|NCT02687542|42213247|FG001|Overall Study|Lost to Follow-up|0|||
19761355|NCT02687542|42213248|FG002|Overall Study|Lost to Follow-up|0|||
19761356|NCT02687542|42213249|FG003|Overall Study|Lost to Follow-up|0|||
19761357|NCT02687542|42213250|FG004|Overall Study|Lost to Follow-up|1|||
19761358|NCT02687542|42213246|FG000|Overall Study|Protocol Violation|0|||
19761359|NCT02687542|42213247|FG001|Overall Study|Protocol Violation|1|||
19761360|NCT02687542|42213248|FG002|Overall Study|Protocol Violation|0|||
19761361|NCT02687542|42213249|FG003|Overall Study|Protocol Violation|0|||
19761362|NCT02687542|42213250|FG004|Overall Study|Protocol Violation|0|||
19761363|NCT02687542|42213246|FG000|Overall Study|Other|5|||
19761364|NCT02687542|42213247|FG001|Overall Study|Other|9|||
19761365|NCT02687542|42213248|FG002|Overall Study|Other|10|||
19761366|NCT02687542|42213249|FG003|Overall Study|Other|6|||
19761367|NCT02687542|42213250|FG004|Overall Study|Other|5|||
19761368|NCT02687542|42213246|FG000|Overall Study|Adverse Event|3|||
19761369|NCT02687542|42213247|FG001|Overall Study|Adverse Event|1|||
19761370|NCT02687542|42213248|FG002|Overall Study|Adverse Event|3|||
19761371|NCT02687542|42213249|FG003|Overall Study|Adverse Event|2|||
19761372|NCT02687542|42213250|FG004|Overall Study|Adverse Event|9|||
19761373|NCT02687542|42213246|FG000|Overall Study|Withdrawal by Subject|0|||
19761374|NCT02687542|42213247|FG001|Overall Study|Withdrawal by Subject|1|||
19761375|NCT02687542|42213248|FG002|Overall Study|Withdrawal by Subject|1|||
19761376|NCT02687542|42213249|FG003|Overall Study|Withdrawal by Subject|2|||
19761377|NCT02687542|42213250|FG004|Overall Study|Withdrawal by Subject|4|||
19761378|NCT03336619|42213264|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
19761379|NCT03336619|42213265|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
19761380|NCT03336619|42213264|FG000|Overall Study|Withdrawal by Subject|17|||
19761381|NCT03336619|42213265|FG001|Overall Study|Withdrawal by Subject|16|||
19761382|NCT03336619|42213264|FG000|Overall Study|Adverse Event|2|||
19761383|NCT03336619|42213265|FG001|Overall Study|Adverse Event|5|||
19761384|NCT03336619|42213264|FG000|Overall Study|Physician Decision|3|||
19761385|NCT03336619|42213265|FG001|Overall Study|Physician Decision|0|||
19761386|NCT01353508|42213287|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
19761387|NCT01353508|42213288|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
19761388|NCT01353508|42213289|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
19761389|NCT01353508|42213290|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
19761390|NCT01353508|42213287|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
19761391|NCT01353508|42213288|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
19761392|NCT01353508|42213289|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
19761393|NCT01353508|42213290|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
19761394|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
19761395|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
19761396|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
19761397|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
19761398|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
19761399|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
19761400|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
19761401|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
19761402|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
19761403|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
19761404|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
19761405|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
19761406|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Other|6|||
19761407|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Other|3|||
19761408|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Other|0|||
19761409|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
19761410|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
19761411|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
19761412|NCT03636269|42213302|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
19761413|NCT03636269|42213303|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
19761414|NCT03636269|42213304|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
19761415|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Adverse Event|0|||
19761416|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Adverse Event|0|||
19761417|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Adverse Event|21|||
19761418|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
19761419|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
19389082|NCT02670551|41632642|FG000|Overall Study|Lost to Follow-up|5|||
19679841|NCT00362115|42127427|FG004|Overall Study|Protocol Violation|0|||
19679842|NCT00362115|42127428|FG005|Overall Study|Protocol Violation|1|||
19679843|NCT00362115|42127429|FG006|Overall Study|Protocol Violation|0|||
19679844|NCT00362115|42127423|FG000|Overall Study|Lost to Follow-up|0|||
19679845|NCT00362115|42127424|FG001|Overall Study|Lost to Follow-up|1|||
19679846|NCT00362115|42127425|FG002|Overall Study|Lost to Follow-up|0|||
19679847|NCT00362115|42127426|FG003|Overall Study|Lost to Follow-up|0|||
19679848|NCT00362115|42127427|FG004|Overall Study|Lost to Follow-up|2|||
19679849|NCT00362115|42127428|FG005|Overall Study|Lost to Follow-up|0|||
19679850|NCT00362115|42127429|FG006|Overall Study|Lost to Follow-up|1|||
19679851|NCT00362115|42127423|FG000|Overall Study|Withdrawal by Subject|1|||
19679852|NCT00362115|42127424|FG001|Overall Study|Withdrawal by Subject|3|||
19679853|NCT00362115|42127425|FG002|Overall Study|Withdrawal by Subject|1|||
19679854|NCT00362115|42127426|FG003|Overall Study|Withdrawal by Subject|0|||
19679855|NCT00362115|42127427|FG004|Overall Study|Withdrawal by Subject|1|||
19679856|NCT00362115|42127428|FG005|Overall Study|Withdrawal by Subject|3|||
19679857|NCT00362115|42127429|FG006|Overall Study|Withdrawal by Subject|4|||
19679858|NCT00362115|42127423|FG000|Overall Study|Lack of Efficacy|1|||
19679859|NCT00362115|42127424|FG001|Overall Study|Lack of Efficacy|0|||
19679860|NCT00362115|42127425|FG002|Overall Study|Lack of Efficacy|5|||
19679861|NCT00362115|42127426|FG003|Overall Study|Lack of Efficacy|2|||
19679862|NCT00362115|42127427|FG004|Overall Study|Lack of Efficacy|2|||
19679863|NCT00362115|42127428|FG005|Overall Study|Lack of Efficacy|0|||
19679864|NCT00362115|42127429|FG006|Overall Study|Lack of Efficacy|3|||
19679865|NCT00362115|42127423|FG000|Overall Study|Physician Decision|0|||
19679866|NCT00362115|42127424|FG001|Overall Study|Physician Decision|0|||
19679867|NCT00362115|42127425|FG002|Overall Study|Physician Decision|0|||
19679868|NCT00362115|42127426|FG003|Overall Study|Physician Decision|0|||
19679869|NCT00362115|42127427|FG004|Overall Study|Physician Decision|0|||
19679870|NCT00362115|42127428|FG005|Overall Study|Physician Decision|0|||
19679871|NCT00362115|42127429|FG006|Overall Study|Physician Decision|3|||
19679872|NCT00362115|42127423|FG000|Overall Study|Other|0|||
19679873|NCT00362115|42127424|FG001|Overall Study|Other|1|||
19679874|NCT00362115|42127425|FG002|Overall Study|Other|0|||
19679875|NCT00362115|42127426|FG003|Overall Study|Other|1|||
19679876|NCT00362115|42127427|FG004|Overall Study|Other|0|||
19679877|NCT00362115|42127428|FG005|Overall Study|Other|1|||
19679878|NCT00362115|42127429|FG006|Overall Study|Other|0|||
19761420|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
19679879|NCT00485264|42127451|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
19679880|NCT00485264|42127452|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
19679881|NCT00485264|42127453|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
19679882|NCT00485264|42127454|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
19679883|NCT00485264|42127455|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
19679884|NCT00485264|42127456|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
19679885|NCT00485264|42127451|FG000|Overall Study|Death|1|||
19679886|NCT00485264|42127452|FG001|Overall Study|Death|0|||
19679887|NCT00485264|42127453|FG002|Overall Study|Death|0|||
19679888|NCT00485264|42127454|FG003|Overall Study|Death|0|||
19679889|NCT00485264|42127455|FG004|Overall Study|Death|1|||
19679890|NCT00485264|42127456|FG005|Overall Study|Death|0|||
19679891|NCT00485264|42127451|FG000|Overall Study|Adverse Event|1|||
19679892|NCT00485264|42127452|FG001|Overall Study|Adverse Event|0|||
19679893|NCT00485264|42127453|FG002|Overall Study|Adverse Event|2|||
19679894|NCT00485264|42127454|FG003|Overall Study|Adverse Event|3|||
19679895|NCT00485264|42127455|FG004|Overall Study|Adverse Event|1|||
19679896|NCT00485264|42127456|FG005|Overall Study|Adverse Event|3|||
19679897|NCT00485264|42127451|FG000|Overall Study|Pregnancy|4|||
19679898|NCT00485264|42127452|FG001|Overall Study|Pregnancy|0|||
19679899|NCT00485264|42127453|FG002|Overall Study|Pregnancy|0|||
19679900|NCT00485264|42127454|FG003|Overall Study|Pregnancy|0|||
19679901|NCT00485264|42127455|FG004|Overall Study|Pregnancy|0|||
19679902|NCT00485264|42127456|FG005|Overall Study|Pregnancy|0|||
19679903|NCT00485264|42127451|FG000|Overall Study|Disallowed Medication|0|||
19679904|NCT00485264|42127452|FG001|Overall Study|Disallowed Medication|0|||
19679905|NCT00485264|42127453|FG002|Overall Study|Disallowed Medication|0|||
19679906|NCT00485264|42127454|FG003|Overall Study|Disallowed Medication|0|||
19679907|NCT00485264|42127455|FG004|Overall Study|Disallowed Medication|0|||
19679908|NCT00485264|42127456|FG005|Overall Study|Disallowed Medication|1|||
19679909|NCT00485264|42127451|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
19679910|NCT00485264|42127452|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
19679911|NCT00485264|42127453|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
19679912|NCT00485264|42127454|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
19761421|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
19761422|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
19761423|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
19761424|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
19761425|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
19761426|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
19761427|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Administrative|0|||
19761428|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Administrative|0|||
19761429|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Administrative|36|||
19761430|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Other|0|||
19761431|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Other|0|||
19761432|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Other|9|||
19761433|NCT03636269|42213302|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
19761434|NCT03636269|42213303|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
19761435|NCT03636269|42213304|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
19761436|NCT02685202|42213313|FG000|Overall Study|Lost to Follow-up|9|||
19761437|NCT03087786|42213319|FG000|Overall Study|Withdrawal by Subject|2|||
19761438|NCT03087786|42213320|FG001|Overall Study|Withdrawal by Subject|0|||
19761439|NCT03635957|42213326|FG000|Run-In Period|Lost to Follow-up|1|||
19761440|NCT03635957|42213326|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
19761441|NCT01353274|42213331|FG000|Overall Study|No case report form (CRF) collected|28|||
19761442|NCT02690194|42213338|FG000|Overall Study|Withdrawal by Subject|1|||
19761443|NCT02690194|42213339|FG001|Overall Study|Withdrawal by Subject|4|||
19761444|NCT02690194|42213340|FG002|Overall Study|Withdrawal by Subject|0|||
19761445|NCT02684344|42213350|FG000|Overall Study|Withdrawal by Subject|0|||
19761446|NCT02684344|42213351|FG001|Overall Study|Withdrawal by Subject|1|||
19761447|NCT02683876|42213359|FG000|Overall Study|samples damaged during shipping|2|||
19761448|NCT02683876|42213360|FG001|Overall Study|samples damaged during shipping|0|||
19761449|NCT03974100|42213370|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
19761450|NCT03974100|42213371|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
19761451|NCT03974100|42213372|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
19761452|NCT03974100|42213373|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
19761453|NCT03974100|42213374|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
19761454|NCT03974100|42213370|FG000|TP1 - Day 1 to Week 52|Death|1|||
19761455|NCT03974100|42213371|FG001|TP1 - Day 1 to Week 52|Death|0|||
19761456|NCT03974100|42213372|FG002|TP1 - Day 1 to Week 52|Death|0|||
19761457|NCT03974100|42213373|FG003|TP1 - Day 1 to Week 52|Death|0|||
19761458|NCT03974100|42213374|FG004|TP1 - Day 1 to Week 52|Death|0|||
19761459|NCT03974100|42213370|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
19761460|NCT03974100|42213371|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
19761461|NCT03974100|42213372|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
19761462|NCT03974100|42213373|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
19761463|NCT03974100|42213374|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
19389083|NCT02670551|41632643|FG001|Overall Study|Lost to Follow-up|7|||
19679913|NCT00485264|42127455|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
19679914|NCT00485264|42127456|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
19679915|NCT00485264|42127451|FG000|Overall Study|Lack of Efficacy|0|||
19679916|NCT00485264|42127452|FG001|Overall Study|Lack of Efficacy|1|||
19679917|NCT00485264|42127453|FG002|Overall Study|Lack of Efficacy|0|||
19679918|NCT00485264|42127454|FG003|Overall Study|Lack of Efficacy|0|||
19761464|NCT03974100|42213370|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
19761465|NCT03974100|42213371|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
19761466|NCT03974100|42213372|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
19604393|NCT01012973|42053257|FG001|Overall Study|Protocol Violation|2|||
19604394|NCT01012973|42053256|FG000|Overall Study|Withdrawal by Subject|4|||
19604395|NCT01012973|42053257|FG001|Overall Study|Withdrawal by Subject|6|||
19604396|NCT00748540|42053267|FG000|Overall Study|Physician Decision|1|||
19604397|NCT01012739|42053271|FG000|Treatment Period 1|Adverse Event|0|||
19604398|NCT01012739|42053272|FG001|Treatment Period 1|Adverse Event|0|||
19604399|NCT01012739|42053273|FG002|Treatment Period 1|Adverse Event|0|||
19604400|NCT01012739|42053274|FG003|Treatment Period 1|Adverse Event|1|||
19604401|NCT01012739|42053271|FG000|Treatment Period 2|Abnormal test procedure results|0|||
19679919|NCT00485264|42127455|FG004|Overall Study|Lack of Efficacy|0|||
19679920|NCT00485264|42127456|FG005|Overall Study|Lack of Efficacy|0|||
19679921|NCT00485264|42127451|FG000|Overall Study|Guardian Consent Withdrawn|1|||
19679922|NCT00485264|42127452|FG001|Overall Study|Guardian Consent Withdrawn|0|||
19679923|NCT00485264|42127453|FG002|Overall Study|Guardian Consent Withdrawn|0|||
19679924|NCT00485264|42127454|FG003|Overall Study|Guardian Consent Withdrawn|0|||
19679925|NCT00485264|42127455|FG004|Overall Study|Guardian Consent Withdrawn|1|||
19679926|NCT00485264|42127456|FG005|Overall Study|Guardian Consent Withdrawn|0|||
19679927|NCT00485264|42127451|FG000|Overall Study|Physician Decision|0|||
19679928|NCT00485264|42127452|FG001|Overall Study|Physician Decision|2|||
19679929|NCT00485264|42127453|FG002|Overall Study|Physician Decision|0|||
19679930|NCT00485264|42127454|FG003|Overall Study|Physician Decision|0|||
19679931|NCT00485264|42127455|FG004|Overall Study|Physician Decision|0|||
19679932|NCT00485264|42127456|FG005|Overall Study|Physician Decision|0|||
19604402|NCT01012739|42053272|FG001|Treatment Period 2|Abnormal test procedure results|0|||
19604403|NCT01012739|42053273|FG002|Treatment Period 2|Abnormal test procedure results|0|||
19604404|NCT01012739|42053274|FG003|Treatment Period 2|Abnormal test procedure results|1|||
19604405|NCT00742924|42053289|FG000|Overall Study|Adverse Event|0|||
19604406|NCT00742924|42053290|FG001|Overall Study|Adverse Event|0|||
19761467|NCT03974100|42213373|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
19761468|NCT03974100|42213374|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
19761469|NCT03974100|42213370|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
19761470|NCT03974100|42213371|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
19761471|NCT03974100|42213372|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
19761472|NCT03974100|42213373|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
19761473|NCT03974100|42213374|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
19761474|NCT03974100|42213370|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
19761475|NCT03974100|42213371|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
19761476|NCT03974100|42213372|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
19761477|NCT03974100|42213373|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
19761478|NCT03974100|42213374|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
19761479|NCT03974100|42213370|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
19761480|NCT03974100|42213371|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
19761481|NCT03974100|42213372|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
19761482|NCT03974100|42213373|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
19761483|NCT03974100|42213374|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
19761484|NCT02689804|42213388|FG000|Overall Study|Withdrawal by Subject|2|||
19761485|NCT02689804|42213389|FG001|Overall Study|Withdrawal by Subject|0|||
19761486|NCT02946931|42213398|FG000|Overall Study|Did not require collection of CRFs|588|||
19761487|NCT02946931|42213398|FG000|Overall Study|Other than listed|37|||
19761488|NCT02946931|42213398|FG000|Overall Study|Discharge from hospital|118|||
19761489|NCT02946931|42213398|FG000|Overall Study|Adverse Event|81|||
19761490|NCT02946931|42213398|FG000|Overall Study|CRFs not valid|1|||
19761491|NCT02946931|42213398|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
19761492|NCT02689492|42213402|FG000|Overall Study|Lost to Follow-up|61|||
19761493|NCT02689492|42213402|FG000|Overall Study|Withdrawal by Subject|11|||
19761494|NCT02689492|42213402|FG000|Overall Study|Death|9|||
19761495|NCT02689492|42213402|FG000|Overall Study|Physician Decision|2|||
19761496|NCT02689492|42213402|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
19761497|NCT02689492|42213402|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
19761498|NCT02689492|42213402|FG000|Overall Study|Other than listed|1|||
19761499|NCT01374568|42213420|FG000|Overall Study|Lab unable to analyze BTM|0|||
19761500|NCT01374568|42213421|FG001|Overall Study|Lab unable to analyze BTM|2|||
19761501|NCT02682784|42213431|FG000|Overall Study|Withdrawal by Subject|0|||
19761502|NCT02682784|42213432|FG001|Overall Study|Withdrawal by Subject|2|||
19761503|NCT02682784|42213433|FG002|Overall Study|Withdrawal by Subject|1|||
19761504|NCT02682784|42213434|FG003|Overall Study|Withdrawal by Subject|2|||
19761505|NCT02682784|42213431|FG000|Overall Study|Physician Decision|1|||
19761506|NCT02682784|42213432|FG001|Overall Study|Physician Decision|0|||
19761507|NCT02682784|42213433|FG002|Overall Study|Physician Decision|1|||
19761508|NCT02682784|42213434|FG003|Overall Study|Physician Decision|1|||
19761509|NCT02946463|42213446|FG000|Primary Evaluation Period|Physician Decision|0|||
19761510|NCT02946463|42213447|FG001|Primary Evaluation Period|Physician Decision|1|||
19761511|NCT02946463|42213446|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
19761512|NCT02946463|42213447|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
19761513|NCT03387852|42213457|FG000|Overall Study|Adverse event (AE)|3|||
19761514|NCT03387852|42213458|FG001|Overall Study|Adverse event (AE)|0|||
19761515|NCT03387852|42213459|FG002|Overall Study|Adverse event (AE)|2|||
19761516|NCT03387852|42213460|FG003|Overall Study|Adverse event (AE)|0|||
19761517|NCT03387852|42213457|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
19761518|NCT03387852|42213458|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
19761519|NCT03387852|42213459|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
19761520|NCT03387852|42213460|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
19761521|NCT03387852|42213457|FG000|Overall Study|Withdrawal by participant|1|||
19761522|NCT03387852|42213458|FG001|Overall Study|Withdrawal by participant|1|||
19761523|NCT03387852|42213459|FG002|Overall Study|Withdrawal by participant|3|||
19761524|NCT03387852|42213460|FG003|Overall Study|Withdrawal by participant|2|||
19761525|NCT03387852|42213457|FG000|Overall Study|Other- Unspecified|1|||
19761526|NCT03387852|42213458|FG001|Overall Study|Other- Unspecified|1|||
19761527|NCT03387852|42213459|FG002|Overall Study|Other- Unspecified|2|||
19761528|NCT03387852|42213460|FG003|Overall Study|Other- Unspecified|1|||
19761529|NCT03387852|42213457|FG000|Overall Study|Poor compliance to protocol|0|||
19761530|NCT03387852|42213458|FG001|Overall Study|Poor compliance to protocol|0|||
19761531|NCT03387852|42213459|FG002|Overall Study|Poor compliance to protocol|0|||
19761532|NCT03387852|42213460|FG003|Overall Study|Poor compliance to protocol|1|||
19761533|NCT03387852|42213457|FG000|Overall Study|Randomized and not treated|0|||
19761534|NCT03387852|42213458|FG001|Overall Study|Randomized and not treated|0|||
19761535|NCT03387852|42213459|FG002|Overall Study|Randomized and not treated|0|||
19761536|NCT03387852|42213460|FG003|Overall Study|Randomized and not treated|1|||
19761537|NCT02679274|42213473|FG000|Overall Study|Withdrawal by Subject|1|||
19761538|NCT02679274|42213474|FG001|Overall Study|Withdrawal by Subject|0|||
19761539|NCT05009251|42213485|FG000|Overall Study|Protocol Violation|100|||
19761540|NCT05009251|42213486|FG001|Overall Study|Protocol Violation|105|||
19679933|NCT00485264|42127451|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
19679934|NCT00485264|42127452|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
19679935|NCT00485264|42127453|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
19679936|NCT00485264|42127454|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
19679937|NCT00485264|42127455|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
19679938|NCT00485264|42127456|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
19679939|NCT00485264|42127451|FG000|Overall Study|Not Able to Attend Clinic|5|||
19679940|NCT00485264|42127452|FG001|Overall Study|Not Able to Attend Clinic|0|||
19679941|NCT00485264|42127453|FG002|Overall Study|Not Able to Attend Clinic|0|||
19679942|NCT00485264|42127454|FG003|Overall Study|Not Able to Attend Clinic|1|||
19679943|NCT00485264|42127455|FG004|Overall Study|Not Able to Attend Clinic|1|||
19679944|NCT00485264|42127456|FG005|Overall Study|Not Able to Attend Clinic|2|||
19679945|NCT00485264|42127451|FG000|Overall Study|Non-Compliant|17|||
19679946|NCT00485264|42127452|FG001|Overall Study|Non-Compliant|2|||
19679947|NCT00485264|42127453|FG002|Overall Study|Non-Compliant|1|||
19679948|NCT00485264|42127454|FG003|Overall Study|Non-Compliant|0|||
19679949|NCT00485264|42127455|FG004|Overall Study|Non-Compliant|1|||
19679950|NCT00485264|42127456|FG005|Overall Study|Non-Compliant|0|||
19679951|NCT00485264|42127451|FG000|Overall Study|Lost to Follow-up|2|||
19679952|NCT00485264|42127452|FG001|Overall Study|Lost to Follow-up|1|||
19679953|NCT00485264|42127453|FG002|Overall Study|Lost to Follow-up|1|||
19679954|NCT00485264|42127454|FG003|Overall Study|Lost to Follow-up|0|||
19679955|NCT00485264|42127455|FG004|Overall Study|Lost to Follow-up|0|||
19679956|NCT00485264|42127456|FG005|Overall Study|Lost to Follow-up|1|||
19761541|NCT05009251|42213487|FG002|Overall Study|Protocol Violation|119|||
19761542|NCT05009251|42213488|FG003|Overall Study|Protocol Violation|120|||
19761543|NCT05009251|42213489|FG004|Overall Study|Protocol Violation|119|||
19761544|NCT05009251|42213485|FG000|Overall Study|Death|25|||
19761545|NCT05009251|42213486|FG001|Overall Study|Death|22|||
19761546|NCT05009251|42213487|FG002|Overall Study|Death|24|||
19761547|NCT05009251|42213488|FG003|Overall Study|Death|19|||
19761548|NCT05009251|42213489|FG004|Overall Study|Death|15|||
19761549|NCT04969861|42213503|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
19761550|NCT04969861|42213504|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
19761551|NCT02678416|42213512|FG000|Part 1|Withdrawal by Subject|1|||
19761552|NCT02678416|42213512|FG000|Part 2|Adverse Event|2|||
19761553|NCT02678416|42213512|FG000|Part 2|Withdrawal by Subject|1|||
19604407|NCT00742924|42053291|FG002|Overall Study|Adverse Event|1|||
19604408|NCT00742924|42053292|FG003|Overall Study|Adverse Event|1|||
19604409|NCT00742924|42053289|FG000|Overall Study|Lack of Efficacy|5|||
19604410|NCT00742924|42053290|FG001|Overall Study|Lack of Efficacy|1|||
19604411|NCT00742924|42053291|FG002|Overall Study|Lack of Efficacy|2|||
19604412|NCT00742924|42053292|FG003|Overall Study|Lack of Efficacy|4|||
19604413|NCT00742924|42053289|FG000|Overall Study|Physician Decision|0|||
19604414|NCT00742924|42053290|FG001|Overall Study|Physician Decision|0|||
19604415|NCT00742924|42053291|FG002|Overall Study|Physician Decision|0|||
19604416|NCT00742924|42053292|FG003|Overall Study|Physician Decision|1|||
19604417|NCT00742924|42053289|FG000|Overall Study|Withdrawal by Subject|0|||
19604418|NCT00742924|42053290|FG001|Overall Study|Withdrawal by Subject|1|||
19389084|NCT02670551|41632644|FG002|Overall Study|Lost to Follow-up|6|||
19679957|NCT00485264|42127451|FG000|Overall Study|Other Reason|3|||
19679958|NCT00485264|42127452|FG001|Overall Study|Other Reason|0|||
19679959|NCT00485264|42127453|FG002|Overall Study|Other Reason|0|||
19679960|NCT00485264|42127454|FG003|Overall Study|Other Reason|0|||
19679961|NCT00485264|42127455|FG004|Overall Study|Other Reason|0|||
19679962|NCT00485264|42127456|FG005|Overall Study|Other Reason|0|||
19679963|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
19679964|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
19679965|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
19679966|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
19761554|NCT02680834|42213532|FG000|Overall Study|Physician Decision|5|||
19761555|NCT02680834|42213533|FG001|Overall Study|Physician Decision|2|||
19761556|NCT02680834|42213532|FG000|Overall Study|Withdrawal by Subject|6|||
19679967|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
19679968|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
19761557|NCT02680834|42213533|FG001|Overall Study|Withdrawal by Subject|0|||
19761558|NCT02680834|42213532|FG000|Overall Study|Lost to Follow-up|0|||
19761559|NCT02680834|42213533|FG001|Overall Study|Lost to Follow-up|1|||
19761560|NCT03343704|42213541|FG000|Overall Study|Refused to complete follow up|0|||
19761561|NCT03343704|42213542|FG001|Overall Study|Refused to complete follow up|1|||
19761562|NCT03343704|42213541|FG000|Overall Study|Death|0|||
19761563|NCT03343704|42213542|FG001|Overall Study|Death|1|||
19761564|NCT03343704|42213541|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
19761565|NCT03343704|42213542|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
19761566|NCT02677922|42213556|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
19761567|NCT02677922|42213557|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
19761568|NCT02677922|42213558|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
19761569|NCT02677922|42213559|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
19761570|NCT02677922|42213560|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
19761571|NCT02677922|42213561|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
19761572|NCT02677922|42213556|FG000|Treatment Period|Adverse Event|0|||
19761573|NCT02677922|42213557|FG001|Treatment Period|Adverse Event|0|||
19761574|NCT02677922|42213558|FG002|Treatment Period|Adverse Event|1|||
19761575|NCT02677922|42213559|FG003|Treatment Period|Adverse Event|3|||
19761576|NCT02677922|42213560|FG004|Treatment Period|Adverse Event|5|||
19761577|NCT02677922|42213561|FG005|Treatment Period|Adverse Event|2|||
19761578|NCT02677922|42213556|FG000|Treatment Period|Progressive Disease|1|||
19761579|NCT02677922|42213557|FG001|Treatment Period|Progressive Disease|1|||
19761580|NCT02677922|42213558|FG002|Treatment Period|Progressive Disease|0|||
19761581|NCT02677922|42213559|FG003|Treatment Period|Progressive Disease|0|||
19761582|NCT02677922|42213560|FG004|Treatment Period|Progressive Disease|8|||
19761583|NCT02677922|42213561|FG005|Treatment Period|Progressive Disease|7|||
19761584|NCT02677922|42213556|FG000|Treatment Period|Lack of Efficacy|0|||
19761585|NCT02677922|42213557|FG001|Treatment Period|Lack of Efficacy|0|||
19761586|NCT02677922|42213558|FG002|Treatment Period|Lack of Efficacy|0|||
19761587|NCT02677922|42213559|FG003|Treatment Period|Lack of Efficacy|1|||
19761588|NCT02677922|42213560|FG004|Treatment Period|Lack of Efficacy|1|||
19761589|NCT02677922|42213561|FG005|Treatment Period|Lack of Efficacy|6|||
19679969|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
19679970|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
19679971|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
19679972|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
19679973|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
19679974|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
19679975|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
19679976|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
19679977|NCT00293254|42127477|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
19679978|NCT00293254|42127478|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
19679979|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
19761590|NCT02677922|42213556|FG000|Treatment Period|Withdrawal by Subject|0|||
19761591|NCT02677922|42213557|FG001|Treatment Period|Withdrawal by Subject|0|||
19761592|NCT02677922|42213558|FG002|Treatment Period|Withdrawal by Subject|1|||
19761593|NCT02677922|42213559|FG003|Treatment Period|Withdrawal by Subject|3|||
19761594|NCT02677922|42213560|FG004|Treatment Period|Withdrawal by Subject|5|||
19761595|NCT02677922|42213561|FG005|Treatment Period|Withdrawal by Subject|5|||
19761596|NCT02677922|42213556|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
19761597|NCT02677922|42213557|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
19761598|NCT02677922|42213558|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
19761599|NCT02677922|42213559|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
19761600|NCT02677922|42213560|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
19761601|NCT02677922|42213561|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
19761602|NCT02677922|42213556|FG000|Treatment Period|Disease Relapse|0|||
19761603|NCT02677922|42213557|FG001|Treatment Period|Disease Relapse|0|||
19761604|NCT02677922|42213558|FG002|Treatment Period|Disease Relapse|0|||
19761605|NCT02677922|42213559|FG003|Treatment Period|Disease Relapse|3|||
19761606|NCT02677922|42213560|FG004|Treatment Period|Disease Relapse|6|||
19761607|NCT02677922|42213561|FG005|Treatment Period|Disease Relapse|1|||
19761608|NCT02677922|42213556|FG000|Treatment Period|Allogeneic HSCT|1|||
19761609|NCT02677922|42213557|FG001|Treatment Period|Allogeneic HSCT|0|||
19761610|NCT02677922|42213558|FG002|Treatment Period|Allogeneic HSCT|0|||
19761611|NCT02677922|42213559|FG003|Treatment Period|Allogeneic HSCT|1|||
19761612|NCT02677922|42213560|FG004|Treatment Period|Allogeneic HSCT|4|||
19761613|NCT02677922|42213561|FG005|Treatment Period|Allogeneic HSCT|1|||
19761614|NCT02677922|42213556|FG000|Treatment Period|Other Reasons|0|||
19761615|NCT02677922|42213557|FG001|Treatment Period|Other Reasons|0|||
19761616|NCT02677922|42213558|FG002|Treatment Period|Other Reasons|0|||
19761617|NCT02677922|42213559|FG003|Treatment Period|Other Reasons|1|||
19761618|NCT02677922|42213560|FG004|Treatment Period|Other Reasons|3|||
19761619|NCT02677922|42213561|FG005|Treatment Period|Other Reasons|5|||
19761620|NCT02677922|42213556|FG000|Treatment Period|Death|0|||
19761621|NCT02677922|42213557|FG001|Treatment Period|Death|0|||
19761622|NCT02677922|42213558|FG002|Treatment Period|Death|0|||
19761623|NCT02677922|42213559|FG003|Treatment Period|Death|0|||
19761624|NCT02677922|42213560|FG004|Treatment Period|Death|12|||
19761625|NCT02677922|42213561|FG005|Treatment Period|Death|1|||
19761626|NCT02677922|42213556|FG000|Treatment Period|Non-compliance with Study Drug|0|||
19761627|NCT02677922|42213557|FG001|Treatment Period|Non-compliance with Study Drug|0|||
19761628|NCT02677922|42213558|FG002|Treatment Period|Non-compliance with Study Drug|0|||
19761629|NCT02677922|42213559|FG003|Treatment Period|Non-compliance with Study Drug|0|||
19761630|NCT02677922|42213560|FG004|Treatment Period|Non-compliance with Study Drug|1|||
19761631|NCT02677922|42213561|FG005|Treatment Period|Non-compliance with Study Drug|0|||
19761632|NCT02677922|42213556|FG000|Treatment Period|Physician Decision|0|||
19761633|NCT02677922|42213557|FG001|Treatment Period|Physician Decision|0|||
19761634|NCT02677922|42213558|FG002|Treatment Period|Physician Decision|0|||
19761635|NCT02677922|42213559|FG003|Treatment Period|Physician Decision|0|||
19761636|NCT02677922|42213560|FG004|Treatment Period|Physician Decision|0|||
19761637|NCT02677922|42213561|FG005|Treatment Period|Physician Decision|1|||
19761638|NCT02677922|42213556|FG000|Treatment Period|Symptomatic Deterioration|0|||
19761639|NCT02677922|42213557|FG001|Treatment Period|Symptomatic Deterioration|0|||
19761640|NCT02677922|42213558|FG002|Treatment Period|Symptomatic Deterioration|0|||
19761641|NCT02677922|42213559|FG003|Treatment Period|Symptomatic Deterioration|0|||
19761642|NCT02677922|42213560|FG004|Treatment Period|Symptomatic Deterioration|1|||
19761643|NCT02677922|42213561|FG005|Treatment Period|Symptomatic Deterioration|0|||
19761644|NCT02680756|42213578|FG000|Overall Study|Adverse Event|10|||
19761645|NCT02680756|42213579|FG001|Overall Study|Adverse Event|2|||
19761646|NCT02680756|42213578|FG000|Overall Study|Lost to Follow-up|7|||
19761647|NCT02680756|42213579|FG001|Overall Study|Lost to Follow-up|6|||
19761648|NCT02680756|42213578|FG000|Overall Study|Withdrawal by Subject|5|||
19761649|NCT02680756|42213579|FG001|Overall Study|Withdrawal by Subject|5|||
19761650|NCT02680756|42213578|FG000|Overall Study|Physician Decision|4|||
19761651|NCT02680756|42213579|FG001|Overall Study|Physician Decision|1|||
19761652|NCT02680756|42213578|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
19761653|NCT02680756|42213579|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
19761654|NCT02680756|42213578|FG000|Overall Study|Blood transfusion for any reason|0|||
19761655|NCT02680756|42213579|FG001|Overall Study|Blood transfusion for any reason|1|||
19761656|NCT02680756|42213578|FG000|Overall Study|Death|1|||
19761657|NCT02680756|42213579|FG001|Overall Study|Death|0|||
19761658|NCT02680756|42213578|FG000|Overall Study|Protocol Violation|1|||
19761659|NCT02680756|42213579|FG001|Overall Study|Protocol Violation|0|||
19761660|NCT02680756|42213578|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
19761661|NCT02680756|42213579|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
19761662|NCT02680756|42213578|FG000|Overall Study|None of above or not recorded|3|||
19761663|NCT02680756|42213579|FG001|Overall Study|None of above or not recorded|2|||
19761664|NCT03086460|42213585|FG000|Study Participants|Lost to Follow-up|2|||
19761665|NCT03086460|42213585|FG000|Study Participants|Protocol Violation|1|||
19761666|NCT03086460|42213585|FG000|Study Participants|Withdrawal by Subject|6|||
19761667|NCT03086460|42213585|FG000|Treatment A|Lost to Follow-up|1|||
19761668|NCT03086460|42213585|FG000|Treatment A|Protocol Violation|1|||
19761669|NCT03086460|42213585|FG000|Treatment A|Withdrawal by Subject|2|||
19761670|NCT03086460|42213585|FG000|Treatment C|Withdrawal by Subject|2|||
19761671|NCT03086460|42213585|FG000|Treatment E|Lost to Follow-up|1|||
19761672|NCT03086460|42213585|FG000|Treatment E|Withdrawal by Subject|3|||
19761673|NCT02677714|42213611|FG000|Overall Study|Withdrawal by Subject|2|||
19761674|NCT02677714|42213612|FG001|Overall Study|Withdrawal by Subject|0|||
19761675|NCT02677324|42213618|FG000|Overall Study|Disease Progression|6|||
19761676|NCT02677324|42213618|FG000|Overall Study|Inability to Swallow pills|1|||
19477228|NCT01482767|41756181|FG001|Overall Study|Nurse error|0|||
19477229|NCT01482221|41756210|FG000|Overall Study|Lack of Efficacy|1|||
19761677|NCT02677324|42213618|FG000|Overall Study|Non-compliance|1|||
19761678|NCT02677324|42213618|FG000|Overall Study|Lack of Efficacy|1|||
19761679|NCT02677324|42213618|FG000|Overall Study|Medical insurance coverage|1|||
19761680|NCT02677324|42213618|FG000|Overall Study|Adverse Event|1|||
19761681|NCT02677324|42213618|FG000|Overall Study|IgM Myeloma diagnosis|1|||
19761682|NCT01971008|42213626|FG000|Overall Study|Protocol Violation|2|||
19761683|NCT01971008|42213627|FG001|Overall Study|Protocol Violation|1|||
19761684|NCT01374178|42213636|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
19761685|NCT01374178|42213637|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
19761686|NCT01374178|42213636|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
19761687|NCT01374178|42213637|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
19761688|NCT03025542|42213645|FG000|Overall Study|Adverse Event|0|||
19761689|NCT03025542|42213646|FG001|Overall Study|Adverse Event|2|||
19761690|NCT03025542|42213645|FG000|Overall Study|Lost to Follow-up|1|||
19761691|NCT03025542|42213646|FG001|Overall Study|Lost to Follow-up|0|||
19761692|NCT03025542|42213645|FG000|Overall Study|Withdrawal by Subject|1|||
19761693|NCT03025542|42213646|FG001|Overall Study|Withdrawal by Subject|0|||
19761694|NCT03022370|42213660|FG000|Overall Study|Death|6|||
19761695|NCT03022370|42213661|FG001|Overall Study|Death|12|||
19761696|NCT03022370|42213660|FG000|Overall Study|Lost to Follow-up|174|||
19761697|NCT03022370|42213661|FG001|Overall Study|Lost to Follow-up|109|||
19761698|NCT03021668|42213673|FG000|Overall Study|Physician Decision|0|||
19761699|NCT03021668|42213674|FG001|Overall Study|Physician Decision|1|||
19761700|NCT03020888|42213680|FG000|Overall Study|Physician Decision|4|||
19761701|NCT03020888|42213680|FG000|Overall Study|Withdrawal by Subject|6|||
19761702|NCT03020888|42213680|FG000|Overall Study|Insurance coverage|2|||
19761703|NCT03020888|42213680|FG000|Overall Study|Lost to Follow-up|1|||
19761704|NCT02250300|42213688|FG000|Expansion Phase|Death|6|||
19761705|NCT02250300|42213689|FG001|Expansion Phase|Death|7|||
19761706|NCT02250300|42213690|FG002|Expansion Phase|Death|0|||
19761707|NCT02250300|42213691|FG003|Expansion Phase|Death|0|||
19761708|NCT03020966|42213704|FG000|Overall Study|Withdrawal by Subject|2|||
19761709|NCT03020966|42213705|FG001|Overall Study|Withdrawal by Subject|0|||
19761710|NCT03020576|42213713|FG000|Overall Study|Withdrawal by Subject|1|||
19761711|NCT03020576|42213714|FG001|Overall Study|Withdrawal by Subject|2|||
19761712|NCT03017612|42213720|FG000|Overall Study|Adverse Event|2|||
19761713|NCT03635099|42213732|FG000|Period 1|Adverse Event|1|||
19761714|NCT03635099|42213733|FG001|Period 1|Adverse Event|0|||
19761715|NCT03635099|42213734|FG002|Period 1|Adverse Event|0|||
19761716|NCT03635099|42213735|FG003|Period 1|Adverse Event|1|||
19761717|NCT03635099|42213736|FG004|Period 1|Adverse Event|0|||
19761718|NCT03635099|42213737|FG005|Period 1|Adverse Event|0|||
19761719|NCT03635099|42213738|FG006|Period 1|Adverse Event|0|||
19761720|NCT03635099|42213739|FG007|Period 1|Adverse Event|0|||
19761721|NCT03635099|42213732|FG000|Period 1|Protocol Violation|0|||
19761722|NCT03635099|42213733|FG001|Period 1|Protocol Violation|0|||
19761723|NCT03635099|42213734|FG002|Period 1|Protocol Violation|1|||
19761724|NCT03635099|42213735|FG003|Period 1|Protocol Violation|0|||
19761725|NCT03635099|42213736|FG004|Period 1|Protocol Violation|0|||
19761726|NCT03635099|42213737|FG005|Period 1|Protocol Violation|0|||
19761727|NCT03635099|42213738|FG006|Period 1|Protocol Violation|0|||
19761728|NCT03635099|42213739|FG007|Period 1|Protocol Violation|0|||
19761729|NCT03635099|42213732|FG000|Period 1|Lost to Follow-up|0|||
19761730|NCT03635099|42213733|FG001|Period 1|Lost to Follow-up|0|||
19761731|NCT03635099|42213734|FG002|Period 1|Lost to Follow-up|1|||
19761732|NCT03635099|42213735|FG003|Period 1|Lost to Follow-up|2|||
19761733|NCT03635099|42213736|FG004|Period 1|Lost to Follow-up|1|||
19761734|NCT03635099|42213737|FG005|Period 1|Lost to Follow-up|0|||
19761735|NCT03635099|42213738|FG006|Period 1|Lost to Follow-up|1|||
19761736|NCT03635099|42213739|FG007|Period 1|Lost to Follow-up|2|||
19761737|NCT03635099|42213732|FG000|Period 1|Withdrawal by Subject|3|||
19679980|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
19679981|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Death|4|||
19679982|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Death|1|||
19679983|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
19679984|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
19679985|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
19679986|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
19679987|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
19679988|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
19679989|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
19761738|NCT03635099|42213733|FG001|Period 1|Withdrawal by Subject|3|||
19761739|NCT03635099|42213734|FG002|Period 1|Withdrawal by Subject|5|||
19761740|NCT03635099|42213735|FG003|Period 1|Withdrawal by Subject|2|||
19761741|NCT03635099|42213736|FG004|Period 1|Withdrawal by Subject|2|||
19761742|NCT03635099|42213737|FG005|Period 1|Withdrawal by Subject|0|||
19761743|NCT03635099|42213738|FG006|Period 1|Withdrawal by Subject|3|||
19761744|NCT03635099|42213739|FG007|Period 1|Withdrawal by Subject|0|||
19761745|NCT03635099|42213732|FG000|Period 1|History of suicidal ideation|0|||
19761746|NCT03635099|42213733|FG001|Period 1|History of suicidal ideation|0|||
19761747|NCT03635099|42213734|FG002|Period 1|History of suicidal ideation|1|||
19761748|NCT03635099|42213735|FG003|Period 1|History of suicidal ideation|0|||
19679990|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
19761749|NCT03635099|42213736|FG004|Period 1|History of suicidal ideation|0|||
19761750|NCT03635099|42213737|FG005|Period 1|History of suicidal ideation|0|||
19761751|NCT03635099|42213738|FG006|Period 1|History of suicidal ideation|0|||
19761752|NCT03635099|42213739|FG007|Period 1|History of suicidal ideation|0|||
19761753|NCT03635099|42213732|FG000|Period 1|pursue other treatment options|0|||
19761754|NCT03635099|42213733|FG001|Period 1|pursue other treatment options|0|||
19761755|NCT03635099|42213734|FG002|Period 1|pursue other treatment options|0|||
19761756|NCT03635099|42213735|FG003|Period 1|pursue other treatment options|0|||
19761757|NCT03635099|42213736|FG004|Period 1|pursue other treatment options|0|||
19761758|NCT03635099|42213737|FG005|Period 1|pursue other treatment options|1|||
19761759|NCT03635099|42213738|FG006|Period 1|pursue other treatment options|0|||
19761760|NCT03635099|42213739|FG007|Period 1|pursue other treatment options|0|||
19761761|NCT03635099|42213732|FG000|Not Eligible for Period 2|Pregnancy|0|||
19761762|NCT03635099|42213733|FG001|Not Eligible for Period 2|Pregnancy|0|||
19761763|NCT03635099|42213734|FG002|Not Eligible for Period 2|Pregnancy|0|||
19761764|NCT03635099|42213735|FG003|Not Eligible for Period 2|Pregnancy|1|||
19761765|NCT03635099|42213736|FG004|Not Eligible for Period 2|Pregnancy|0|||
19761766|NCT03635099|42213737|FG005|Not Eligible for Period 2|Pregnancy|0|||
19761767|NCT03635099|42213738|FG006|Not Eligible for Period 2|Pregnancy|0|||
19761768|NCT03635099|42213739|FG007|Not Eligible for Period 2|Pregnancy|0|||
19761769|NCT03635099|42213732|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
19761770|NCT03635099|42213733|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761771|NCT03635099|42213734|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761772|NCT03635099|42213735|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761773|NCT03635099|42213736|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761774|NCT03635099|42213737|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761775|NCT03635099|42213738|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761776|NCT03635099|42213739|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
19761777|NCT03635099|42213732|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
19761778|NCT03635099|42213733|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
19761779|NCT03635099|42213734|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
19761780|NCT03635099|42213735|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
19761781|NCT03635099|42213736|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
19761782|NCT03635099|42213737|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
19761783|NCT03635099|42213738|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
19761784|NCT03635099|42213739|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
19761785|NCT03635099|42213732|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
19761786|NCT03635099|42213733|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
19761787|NCT03635099|42213734|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
19761788|NCT03635099|42213735|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
19761789|NCT03635099|42213736|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
19761790|NCT03635099|42213737|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
19761791|NCT03635099|42213738|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
19761792|NCT03635099|42213739|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
19761793|NCT03635099|42213732|FG000|Period 2|Adverse Event|0|||
19761794|NCT03635099|42213733|FG001|Period 2|Adverse Event|0|||
19761795|NCT03635099|42213734|FG002|Period 2|Adverse Event|1|||
19761796|NCT03635099|42213735|FG003|Period 2|Adverse Event|0|||
19761797|NCT03635099|42213736|FG004|Period 2|Adverse Event|1|||
19761798|NCT03635099|42213737|FG005|Period 2|Adverse Event|0|||
19761799|NCT03635099|42213738|FG006|Period 2|Adverse Event|0|||
19761800|NCT03635099|42213739|FG007|Period 2|Adverse Event|0|||
19761801|NCT03635099|42213732|FG000|Period 2|Lost to Follow-up|0|||
19679991|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
19679992|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
19679993|NCT00293254|42127477|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
19679994|NCT00293254|42127478|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
19679995|NCT00293254|42127477|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
19679996|NCT00293254|42127478|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
19679997|NCT00293254|42127477|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
19679998|NCT00293254|42127478|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
19679999|NCT00293254|42127477|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
19680000|NCT00293254|42127478|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
19680001|NCT00293254|42127477|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
19680002|NCT00293254|42127478|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
19680003|NCT00293254|42127477|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
19680004|NCT00293254|42127478|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
19761802|NCT03635099|42213733|FG001|Period 2|Lost to Follow-up|0|||
19680005|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
19680006|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
19680007|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
19680008|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
19680009|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
19680010|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
19761803|NCT03635099|42213734|FG002|Period 2|Lost to Follow-up|1|||
19761804|NCT03635099|42213735|FG003|Period 2|Lost to Follow-up|0|||
19761805|NCT03635099|42213736|FG004|Period 2|Lost to Follow-up|4|||
19761806|NCT03635099|42213737|FG005|Period 2|Lost to Follow-up|0|||
19761807|NCT03635099|42213738|FG006|Period 2|Lost to Follow-up|0|||
19761808|NCT03635099|42213739|FG007|Period 2|Lost to Follow-up|0|||
19761809|NCT03635099|42213732|FG000|Period 2|Withdrawal by Subject|0|||
19761810|NCT03635099|42213733|FG001|Period 2|Withdrawal by Subject|0|||
19761811|NCT03635099|42213734|FG002|Period 2|Withdrawal by Subject|7|||
19761812|NCT03635099|42213735|FG003|Period 2|Withdrawal by Subject|4|||
19761813|NCT03635099|42213736|FG004|Period 2|Withdrawal by Subject|7|||
19761814|NCT03635099|42213737|FG005|Period 2|Withdrawal by Subject|0|||
19761815|NCT03635099|42213738|FG006|Period 2|Withdrawal by Subject|0|||
19761816|NCT03635099|42213739|FG007|Period 2|Withdrawal by Subject|0|||
19761817|NCT02108652|42213765|FG000|Overall Study|Death|226|||
19761818|NCT02108652|42213765|FG000|Overall Study|Lost to Follow-up|2|||
19761819|NCT02108652|42213765|FG000|Overall Study|Withdrawal by Subject|8|||
19761820|NCT02108652|42213765|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
19761821|NCT03634085|42213771|FG000|Overall Study|Adverse Event|1|||
19761822|NCT03634085|42213772|FG001|Overall Study|Adverse Event|0|||
19761823|NCT03634085|42213771|FG000|Overall Study|Withdrawal by Subject|0|||
19761824|NCT03634085|42213772|FG001|Overall Study|Withdrawal by Subject|2|||
19761825|NCT02676778|42213788|FG000|Overall Study|Disease Progression|7|||
19761826|NCT02676778|42213789|FG001|Overall Study|Disease Progression|3|||
19761827|NCT02676778|42213790|FG002|Overall Study|Disease Progression|1|||
19761828|NCT02676778|42213788|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
19761829|NCT02676778|42213789|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
19761830|NCT02676778|42213790|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
19761831|NCT02676778|42213788|FG000|Overall Study|Withdrawal by Subject|3|||
19761832|NCT02676778|42213789|FG001|Overall Study|Withdrawal by Subject|2|||
19761833|NCT02676778|42213790|FG002|Overall Study|Withdrawal by Subject|0|||
19761834|NCT02676778|42213788|FG000|Overall Study|Other|4|||
19761835|NCT02676778|42213789|FG001|Overall Study|Other|3|||
19761836|NCT02676778|42213790|FG002|Overall Study|Other|0|||
19761837|NCT02676778|42213788|FG000|Overall Study|Adverse Event|2|||
19761838|NCT02676778|42213789|FG001|Overall Study|Adverse Event|3|||
19761839|NCT02676778|42213790|FG002|Overall Study|Adverse Event|0|||
19761840|NCT02946385|42213805|FG000|Overall Study|Lost to Follow-up|0|||
19761841|NCT02946385|42213806|FG001|Overall Study|Lost to Follow-up|0|||
19761842|NCT02946385|42213807|FG002|Overall Study|Lost to Follow-up|3|||
19761843|NCT02946385|42213808|FG003|Overall Study|Lost to Follow-up|0|||
19761844|NCT02946385|42213809|FG004|Overall Study|Lost to Follow-up|2|||
19761845|NCT02946385|42213810|FG005|Overall Study|Lost to Follow-up|1|||
19761846|NCT02694718|42213830|FG000|Overall Study|Death|1|||
19761847|NCT02694718|42213830|FG000|Overall Study|Withdrawal by Subject|1|||
19761848|NCT02944513|42213836|FG000|Overall Study|Withdrawal by Subject|4|||
19761849|NCT02944513|42213837|FG001|Overall Study|Withdrawal by Subject|1|||
19761850|NCT03179761|42213845|FG000|Overall Study|Death|2|||
19761851|NCT03179761|42213846|FG001|Overall Study|Death|5|||
19680011|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
19680012|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
19680013|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
19680014|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
19680015|NCT00293254|42127477|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
19680016|NCT00293254|42127478|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
19680017|NCT00456846|42127492|FG000|Overall Study|Adverse Event|2|||
19680018|NCT00456846|42127493|FG001|Overall Study|Adverse Event|15|||
19680019|NCT00456846|42127492|FG000|Overall Study|Physician Decision|11|||
19680020|NCT00456846|42127493|FG001|Overall Study|Physician Decision|6|||
19680021|NCT00456846|42127492|FG000|Overall Study|Protocol Deviation|2|||
19680022|NCT00456846|42127493|FG001|Overall Study|Protocol Deviation|0|||
19680023|NCT00456846|42127492|FG000|Overall Study|Participant Discretion|1|||
19680024|NCT00456846|42127493|FG001|Overall Study|Participant Discretion|5|||
19680025|NCT00456846|42127492|FG000|Overall Study|Other|0|||
19761852|NCT03179761|42213845|FG000|Overall Study|Lost to Follow-up|2|||
19761853|NCT03179761|42213846|FG001|Overall Study|Lost to Follow-up|2|||
19761854|NCT03179761|42213845|FG000|Overall Study|Protocol Violation|1|||
19680026|NCT00456846|42127493|FG001|Overall Study|Other|2|||
19680027|NCT00448344|42127501|FG000|Overall Study|Lost to Follow-up|20|||
19761855|NCT03179761|42213846|FG001|Overall Study|Protocol Violation|0|||
19761856|NCT03179761|42213845|FG000|Overall Study|Withdrawal by Subject|1|||
19761857|NCT03179761|42213846|FG001|Overall Study|Withdrawal by Subject|4|||
19761858|NCT03179761|42213845|FG000|Overall Study|Investigator Request|0|||
19761859|NCT03179761|42213846|FG001|Overall Study|Investigator Request|2|||
19761860|NCT01772472|42213854|FG000|Overall Study|Death|56|||
19761861|NCT01772472|42213855|FG001|Overall Study|Death|42|||
19761862|NCT01772472|42213854|FG000|Overall Study|Physician Decision|1|||
19761863|NCT01772472|42213855|FG001|Overall Study|Physician Decision|3|||
19761864|NCT01772472|42213854|FG000|Overall Study|Other|5|||
19761865|NCT01772472|42213855|FG001|Overall Study|Other|5|||
19761866|NCT01772472|42213854|FG000|Overall Study|Lost to Follow-up|12|||
19761867|NCT01772472|42213855|FG001|Overall Study|Lost to Follow-up|8|||
19761868|NCT01772472|42213854|FG000|Overall Study|Withdrawal by Subject|72|||
19761869|NCT01772472|42213855|FG001|Overall Study|Withdrawal by Subject|50|||
19761870|NCT01772472|42213854|FG000|Overall Study|Ongoing|597|||
19761871|NCT01772472|42213855|FG001|Overall Study|Ongoing|635|||
19761872|NCT03018938|42213870|FG000|Overall Study|Death|0|||
19761873|NCT03018938|42213871|FG001|Overall Study|Death|1|||
19761874|NCT03018938|42213870|FG000|Overall Study|Lost to Follow-up|21|||
19761875|NCT03018938|42213871|FG001|Overall Study|Lost to Follow-up|32|||
19761876|NCT03018938|42213870|FG000|Overall Study|Withdrawal by Subject|38|||
19761877|NCT03018938|42213871|FG001|Overall Study|Withdrawal by Subject|45|||
19761878|NCT03018938|42213870|FG000|Overall Study|Physician Decision|3|||
19761879|NCT03018938|42213871|FG001|Overall Study|Physician Decision|2|||
19761880|NCT03018938|42213870|FG000|Overall Study|Sponsor Decision|0|||
19761881|NCT03018938|42213871|FG001|Overall Study|Sponsor Decision|1|||
19761882|NCT03018938|42213870|FG000|Overall Study|Screen failure-After randomization|4|||
19761883|NCT03018938|42213871|FG001|Overall Study|Screen failure-After randomization|2|||
19761884|NCT03018938|42213870|FG000|Overall Study|Not recorded|0|||
19761885|NCT03018938|42213871|FG001|Overall Study|Not recorded|2|||
19761886|NCT02943577|42213879|FG000|Overall Study|Protocol Violation|0|||
19761887|NCT02943577|42213880|FG001|Overall Study|Protocol Violation|1|||
19761888|NCT02943577|42213879|FG000|Overall Study|Adverse Event|3|||
19761889|NCT02943577|42213880|FG001|Overall Study|Adverse Event|2|||
19761890|NCT02943577|42213879|FG000|Overall Study|Lost to Follow-up|0|||
19761891|NCT02943577|42213880|FG001|Overall Study|Lost to Follow-up|1|||
19761892|NCT02943577|42213879|FG000|Overall Study|Withdrawal by Subject|1|||
19761893|NCT02943577|42213880|FG001|Overall Study|Withdrawal by Subject|1|||
19761894|NCT02943577|42213879|FG000|Overall Study|Pregnancy|1|||
19761895|NCT02943577|42213880|FG001|Overall Study|Pregnancy|0|||
19761896|NCT03016598|42213888|FG000|Overall Study|Lost to Follow-up|0|||
19761897|NCT03016598|42213889|FG001|Overall Study|Lost to Follow-up|2|||
19761898|NCT03017846|42213895|FG000|Overall Study|Lost to Follow-up|3|||
19761899|NCT03017846|42213895|FG000|Overall Study|Adverse Event|2|||
19761900|NCT03014180|42213901|FG000|Overall Study|Protocol Violation|2|||
19761901|NCT03011840|42213911|FG000|Overall Study|Not received PIL in post PIL phase|0|||
19680028|NCT00448344|42127502|FG001|Overall Study|Lost to Follow-up|22|||
19680029|NCT00448344|42127501|FG000|Overall Study|Withdrawal by Subject|6|||
19680030|NCT00448344|42127502|FG001|Overall Study|Withdrawal by Subject|8|||
19680031|NCT00448344|42127501|FG000|Overall Study|Death|3|||
19680032|NCT00448344|42127502|FG001|Overall Study|Death|4|||
19680033|NCT00448344|42127501|FG000|Overall Study|Physician Decision|1|||
19761902|NCT03011840|42213912|FG001|Overall Study|Not received PIL in post PIL phase|21|||
19761903|NCT02942485|42213920|FG000|Overall Study|Lost to Follow-up|1|||
19761904|NCT02942485|42213921|FG001|Overall Study|Lost to Follow-up|0|||
19761905|NCT02942407|42213929|FG000|Overall Study|Lost to Follow-up|3|||
19761906|NCT02942407|42213930|FG001|Overall Study|Lost to Follow-up|2|||
19761907|NCT02942407|42213929|FG000|Overall Study|Withdrawal by Subject|7|||
19761908|NCT02942407|42213930|FG001|Overall Study|Withdrawal by Subject|9|||
19761909|NCT02942407|42213929|FG000|Overall Study|Death|16|||
19761910|NCT02942407|42213930|FG001|Overall Study|Death|13|||
19761911|NCT03009344|42213944|FG000|Overall Study|Lack of Efficacy|5|||
19761912|NCT03009344|42213944|FG000|Overall Study|Withdrawal by Subject|1|||
19761913|NCT03009344|42213944|FG000|Overall Study|Adverse Event|1|||
19761914|NCT03322423|42213948|FG000|Period 1|Subject no longer eligible|0|||
19761915|NCT03322423|42213949|FG001|Period 1|Subject no longer eligible|1|||
19761916|NCT03322423|42213948|FG000|Period 1|Withdrawal by Subject|0|||
19761917|NCT03322423|42213949|FG001|Period 1|Withdrawal by Subject|1|||
19761918|NCT03322423|42213948|FG000|Period 1|Incorrect Lens Dispensed|1|||
19761919|NCT03322423|42213949|FG001|Period 1|Incorrect Lens Dispensed|0|||
19680034|NCT00448344|42127502|FG001|Overall Study|Physician Decision|2|||
19680035|NCT00484094|42127508|FG000|Overall Study|Discontinued|39|||
19761920|NCT03322423|42213948|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
19761921|NCT03322423|42213949|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
19761922|NCT03322423|42213948|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
19761923|NCT03322423|42213949|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
19761924|NCT03322423|42213948|FG000|Period 2|Protocol Violation|1|||
19680036|NCT00484094|42127508|FG000|Overall Study|Other|3|||
19761925|NCT03322423|42213949|FG001|Period 2|Protocol Violation|0|||
19761926|NCT03322423|42213948|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
19761927|NCT03322423|42213949|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
19761928|NCT03007472|42213955|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
19761929|NCT03007472|42213955|FG000|Overall Study|Death|2|||
19761930|NCT03007472|42213955|FG000|Overall Study|Loss to Follow Up|1|||
19761931|NCT03321721|42213962|FG000|Overall Study|Lost to Follow-up|4|||
19761932|NCT03321721|42213963|FG001|Overall Study|Lost to Follow-up|8|||
19761933|NCT03321721|42213964|FG002|Overall Study|Lost to Follow-up|11|||
19761934|NCT03015116|42213976|FG000|Overall Study|Lost to Follow-up|3|||
19761935|NCT03015116|42213977|FG001|Overall Study|Lost to Follow-up|0|||
19761936|NCT03015116|42213978|FG002|Overall Study|Lost to Follow-up|2|||
19761937|NCT03015116|42213976|FG000|Overall Study|Withdrawal by Subject|3|||
19761938|NCT03015116|42213977|FG001|Overall Study|Withdrawal by Subject|1|||
19761939|NCT03015116|42213978|FG002|Overall Study|Withdrawal by Subject|0|||
19761940|NCT03015116|42213976|FG000|Overall Study|Subject has New Medical Status|1|||
19761941|NCT03015116|42213977|FG001|Overall Study|Subject has New Medical Status|0|||
19761942|NCT03015116|42213978|FG002|Overall Study|Subject has New Medical Status|0|||
19761943|NCT03015116|42213976|FG000|Overall Study|Physician Decision|0|||
19761944|NCT03015116|42213977|FG001|Overall Study|Physician Decision|1|||
19761945|NCT03015116|42213978|FG002|Overall Study|Physician Decision|0|||
19389085|NCT02670551|41632642|FG000|Overall Study|Protocol Violation|1|||
19680037|NCT00447876|42127514|FG000|Overall Study|Withdrawal by Subject|1|||
19680038|NCT00447876|42127515|FG001|Overall Study|Withdrawal by Subject|4|||
19680039|NCT00447876|42127514|FG000|Overall Study|Lost to Follow-up|1|||
19680040|NCT00447876|42127515|FG001|Overall Study|Lost to Follow-up|0|||
19680041|NCT00447876|42127514|FG000|Overall Study|Deterioration of symptomology|1|||
19680042|NCT00447876|42127515|FG001|Overall Study|Deterioration of symptomology|0|||
19680043|NCT00456612|42127521|FG000|Overall Study|Withdrawal by Subject|3|||
19680044|NCT00456300|42127526|FG000|Overall Study|Adverse Event|1|||
19680045|NCT00456300|42127527|FG001|Overall Study|Adverse Event|0|||
19680046|NCT00267748|42127538|FG000|Non-randomized Period|Progressive disease|10|||
19680047|NCT00267748|42127539|FG001|Non-randomized Period|Progressive disease|0|||
19680048|NCT00267748|42127540|FG002|Non-randomized Period|Progressive disease|0|||
19680049|NCT00267748|42127538|FG000|Non-randomized Period|Adverse Event|8|||
19680050|NCT00267748|42127539|FG001|Non-randomized Period|Adverse Event|0|||
19680051|NCT00267748|42127540|FG002|Non-randomized Period|Adverse Event|0|||
19680052|NCT00267748|42127538|FG000|Non-randomized Period|Death|1|||
19680053|NCT00267748|42127539|FG001|Non-randomized Period|Death|0|||
19680054|NCT00267748|42127540|FG002|Non-randomized Period|Death|0|||
19680055|NCT00267748|42127538|FG000|Non-randomized Period|Participant not willing to participate|1|||
19680056|NCT00267748|42127539|FG001|Non-randomized Period|Participant not willing to participate|0|||
19680057|NCT00267748|42127540|FG002|Non-randomized Period|Participant not willing to participate|0|||
19680058|NCT00267748|42127538|FG000|Non-randomized Period|Other|3|||
19680059|NCT00267748|42127539|FG001|Non-randomized Period|Other|0|||
19680060|NCT00267748|42127540|FG002|Non-randomized Period|Other|0|||
19680061|NCT00267748|42127538|FG000|Randomized Period|Death|0|||
19680062|NCT00267748|42127539|FG001|Randomized Period|Death|2|||
19680063|NCT00267748|42127540|FG002|Randomized Period|Death|3|||
19680064|NCT00267748|42127538|FG000|Randomized Period|Adverse Event|0|||
19680065|NCT00267748|42127539|FG001|Randomized Period|Adverse Event|23|||
19680066|NCT00267748|42127540|FG002|Randomized Period|Adverse Event|25|||
19680067|NCT00267748|42127538|FG000|Randomized Period|Global deterioration of health status|0|||
19680068|NCT00267748|42127539|FG001|Randomized Period|Global deterioration of health status|6|||
19680069|NCT00267748|42127540|FG002|Randomized Period|Global deterioration of health status|7|||
19680070|NCT00267748|42127538|FG000|Randomized Period|Lost to Follow-up|0|||
19680071|NCT00267748|42127539|FG001|Randomized Period|Lost to Follow-up|1|||
19680072|NCT00267748|42127540|FG002|Randomized Period|Lost to Follow-up|0|||
19680073|NCT00267748|42127538|FG000|Randomized Period|Objective progression or relapse|0|||
19680074|NCT00267748|42127539|FG001|Randomized Period|Objective progression or relapse|77|||
19680075|NCT00267748|42127540|FG002|Randomized Period|Objective progression or relapse|86|||
19680076|NCT00267748|42127538|FG000|Randomized Period|Withdrawal by Subject|0|||
19680077|NCT00267748|42127539|FG001|Randomized Period|Withdrawal by Subject|9|||
19680078|NCT00267748|42127540|FG002|Randomized Period|Withdrawal by Subject|2|||
19680079|NCT00267748|42127538|FG000|Randomized Period|Other|0|||
19680080|NCT00267748|42127539|FG001|Randomized Period|Other|9|||
19680081|NCT00267748|42127540|FG002|Randomized Period|Other|6|||
19680082|NCT00267748|42127538|FG000|Randomized Period|randomized but not treated|0|||
19680083|NCT00267748|42127539|FG001|Randomized Period|randomized but not treated|0|||
19680084|NCT00267748|42127540|FG002|Randomized Period|randomized but not treated|3|||
19680085|NCT00267202|42127549|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
19680086|NCT00267202|42127550|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
19680087|NCT00267202|42127549|FG000|Overall Study|Withdrawal by Subject|12|||
19680088|NCT00267202|42127550|FG001|Overall Study|Withdrawal by Subject|15|||
19761946|NCT03006848|42213988|FG000|Overall Study|Adverse Event|1|||
19761947|NCT03006848|42213988|FG000|Overall Study|Physician Decision|1|||
19761948|NCT03006848|42213988|FG000|Overall Study|Lack of Efficacy|16|||
19761949|NCT03006458|42213999|FG000|First Intervention|Unsatisfied Vision|0|||
19761950|NCT03006458|42214000|FG001|First Intervention|Unsatisfied Vision|3|||
19761951|NCT03320941|42214011|FG000|Overall Study|subject/guardian decision|0|||
19761952|NCT03320941|42214012|FG001|Overall Study|subject/guardian decision|0|||
19761953|NCT03320941|42214013|FG002|Overall Study|subject/guardian decision|0|||
19761954|NCT03320941|42214014|FG003|Overall Study|subject/guardian decision|1|||
19761955|NCT03320941|42214015|FG004|Overall Study|subject/guardian decision|0|||
19761956|NCT03005288|42214029|FG000|Overall Study|Withdrawal by Subject|7|||
19761957|NCT03005288|42214030|FG001|Overall Study|Withdrawal by Subject|5|||
19761958|NCT03005288|42214029|FG000|Overall Study|Lost to Follow-up|0|||
19761959|NCT03005288|42214030|FG001|Overall Study|Lost to Follow-up|1|||
19761960|NCT03005288|42214029|FG000|Overall Study|Adverse Event|5|||
19761961|NCT03005288|42214030|FG001|Overall Study|Adverse Event|0|||
19761962|NCT03005288|42214029|FG000|Overall Study|Protocol deviation|0|||
19761963|NCT03005288|42214030|FG001|Overall Study|Protocol deviation|1|||
19761964|NCT03005288|42214029|FG000|Overall Study|Physician Decision|0|||
19761965|NCT03005288|42214030|FG001|Overall Study|Physician Decision|1|||
19761966|NCT03003494|42214036|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
19761967|NCT03559699|42214040|FG000|Overall Study|Withdrawal by Subject|6|||
19761968|NCT03559699|42214040|FG000|Overall Study|Lost to Follow-up|1|||
19761969|NCT03085758|42214047|FG000|Overall Study|Death|26|||
19761970|NCT03085758|42214048|FG001|Overall Study|Death|24|||
19761971|NCT03085758|42214049|FG002|Overall Study|Death|53|||
19761972|NCT03085758|42214047|FG000|Overall Study|Lost to Follow-up|1|||
19761973|NCT03085758|42214048|FG001|Overall Study|Lost to Follow-up|1|||
19761974|NCT03085758|42214049|FG002|Overall Study|Lost to Follow-up|1|||
19761975|NCT03085758|42214047|FG000|Overall Study|Withdrawal by Subject|2|||
19761976|NCT03085758|42214048|FG001|Overall Study|Withdrawal by Subject|2|||
19761977|NCT03085758|42214049|FG002|Overall Study|Withdrawal by Subject|1|||
19761978|NCT03085758|42214047|FG000|Overall Study|Refusal to recall it up to day 90|0|||
19761979|NCT03085758|42214048|FG001|Overall Study|Refusal to recall it up to day 90|0|||
19761980|NCT03085758|42214049|FG002|Overall Study|Refusal to recall it up to day 90|1|||
19761981|NCT03085758|42214047|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
19761982|NCT03085758|42214048|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
19761983|NCT03085758|42214049|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
19761984|NCT03935880|42214073|FG000|Overall Study|Lost to Follow-up|0|||
19761985|NCT03935880|42214074|FG001|Overall Study|Lost to Follow-up|1|||
19761986|NCT03315793|42214082|FG000|Overall Study|Adverse Event|4|||
19761987|NCT03315793|42214083|FG001|Overall Study|Adverse Event|2|||
19761988|NCT03315793|42214082|FG000|Overall Study|Protocol Deviation|1|||
19761989|NCT03315793|42214083|FG001|Overall Study|Protocol Deviation|0|||
19761990|NCT03315793|42214082|FG000|Overall Study|Difficult for regular visit|0|||
19761991|NCT03315793|42214083|FG001|Overall Study|Difficult for regular visit|1|||
19761992|NCT02676466|42214099|FG000|Overall Study|Death|0|||
19761993|NCT02676466|42214100|FG001|Overall Study|Death|2|||
19761994|NCT02676466|42214101|FG002|Overall Study|Death|1|||
19761995|NCT02676466|42214102|FG003|Overall Study|Death|0|||
19761996|NCT02676466|42214103|FG004|Overall Study|Death|0|||
19761997|NCT02676466|42214104|FG005|Overall Study|Death|0|||
19761998|NCT02676466|42214105|FG006|Overall Study|Death|0|||
19761999|NCT02676466|42214106|FG007|Overall Study|Death|0|||
19762000|NCT02676466|42214099|FG000|Overall Study|Withdrawal by Subject|4|||
19762001|NCT02676466|42214100|FG001|Overall Study|Withdrawal by Subject|3|||
19762002|NCT02676466|42214101|FG002|Overall Study|Withdrawal by Subject|1|||
19762003|NCT02676466|42214102|FG003|Overall Study|Withdrawal by Subject|0|||
19762004|NCT02676466|42214103|FG004|Overall Study|Withdrawal by Subject|3|||
19762005|NCT02676466|42214104|FG005|Overall Study|Withdrawal by Subject|1|||
19762006|NCT02676466|42214105|FG006|Overall Study|Withdrawal by Subject|1|||
19762007|NCT02676466|42214106|FG007|Overall Study|Withdrawal by Subject|1|||
19762008|NCT03314857|42214128|FG000|Overall Study|Death|4|||
19762009|NCT03314857|42214128|FG000|Overall Study|Physician Decision|1|||
19762010|NCT03633695|42214134|FG000|Overall Study|Lost to Follow-up|4|||
19762011|NCT03633695|42214135|FG001|Overall Study|Lost to Follow-up|5|||
19762012|NCT03633695|42214134|FG000|Overall Study|Discontinued|8|||
19762013|NCT03633695|42214135|FG001|Overall Study|Discontinued|4|||
19762014|NCT03314233|42214157|FG000|Overall Study|No longer eligible at time of delivery|1|||
19762015|NCT02675998|42214165|FG000|8-Week Treatment Period|Adverse Event|6|||
19762016|NCT02675998|42214166|FG001|8-Week Treatment Period|Adverse Event|5|||
19762017|NCT02675998|42214167|FG002|8-Week Treatment Period|Adverse Event|6|||
19762018|NCT02675998|42214168|FG003|8-Week Treatment Period|Adverse Event|0|||
19762019|NCT02675998|42214165|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
19762020|NCT02675998|42214166|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
19762021|NCT02675998|42214167|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
19762022|NCT02675998|42214168|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
19762023|NCT02675998|42214165|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
19762024|NCT02675998|42214166|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
19762025|NCT02675998|42214167|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
19762026|NCT02675998|42214168|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
19762027|NCT02675998|42214165|FG000|8-Week Treatment Period|Physician Decision|1|||
19762028|NCT02675998|42214166|FG001|8-Week Treatment Period|Physician Decision|0|||
19762029|NCT02675998|42214167|FG002|8-Week Treatment Period|Physician Decision|2|||
19762030|NCT02675998|42214168|FG003|8-Week Treatment Period|Physician Decision|0|||
19762031|NCT02675998|42214165|FG000|8-Week Treatment Period|GI side Effects|1|||
19762032|NCT02675998|42214166|FG001|8-Week Treatment Period|GI side Effects|4|||
19762033|NCT02675998|42214167|FG002|8-Week Treatment Period|GI side Effects|2|||
19762034|NCT02675998|42214168|FG003|8-Week Treatment Period|GI side Effects|0|||
19762035|NCT02675998|42214165|FG000|8-Week Treatment Period|Protocol Violation|1|||
19762036|NCT02675998|42214166|FG001|8-Week Treatment Period|Protocol Violation|1|||
19762037|NCT02675998|42214167|FG002|8-Week Treatment Period|Protocol Violation|1|||
19762038|NCT02675998|42214168|FG003|8-Week Treatment Period|Protocol Violation|0|||
19762039|NCT02675998|42214165|FG000|8-Week Treatment Period|Other|3|||
19762040|NCT02675998|42214166|FG001|8-Week Treatment Period|Other|1|||
19762041|NCT02675998|42214167|FG002|8-Week Treatment Period|Other|2|||
19762042|NCT02675998|42214168|FG003|8-Week Treatment Period|Other|0|||
19762043|NCT02675998|42214165|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
19762044|NCT02675998|42214166|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
19762045|NCT02675998|42214167|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
19762046|NCT02675998|42214168|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
19762047|NCT02675998|42214165|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
19762048|NCT02675998|42214166|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
19762049|NCT02675998|42214167|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
19762050|NCT02675998|42214168|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
19762051|NCT02675998|42214165|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
19762052|NCT02675998|42214166|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
19762053|NCT02675998|42214167|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
19762054|NCT02675998|42214168|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
19762055|NCT02675998|42214165|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
19762056|NCT02675998|42214166|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
19762057|NCT02675998|42214167|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
19762058|NCT02675998|42214168|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
19762059|NCT02675998|42214165|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
19762060|NCT02675998|42214166|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
19762061|NCT02675998|42214167|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
19762062|NCT02675998|42214168|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
19762063|NCT02674204|42214184|FG000|Overall Study|Adverse Event|1|||
19762064|NCT02674204|42214185|FG001|Overall Study|Adverse Event|0|||
19762065|NCT03291067|42214195|FG000|Overall Study|Adverse Event|0|||
19762066|NCT03291067|42214196|FG001|Overall Study|Adverse Event|2|||
19762067|NCT03291067|42214197|FG002|Overall Study|Adverse Event|17|||
19762068|NCT03291067|42214198|FG003|Overall Study|Adverse Event|3|||
19762069|NCT03291067|42214195|FG000|Overall Study|Lost to Follow-up|2|||
19762070|NCT03291067|42214196|FG001|Overall Study|Lost to Follow-up|1|||
19762071|NCT03291067|42214197|FG002|Overall Study|Lost to Follow-up|0|||
19762072|NCT03291067|42214198|FG003|Overall Study|Lost to Follow-up|1|||
19762073|NCT03291067|42214195|FG000|Overall Study|Physician Decision|0|||
19762074|NCT03291067|42214196|FG001|Overall Study|Physician Decision|0|||
19762075|NCT03291067|42214197|FG002|Overall Study|Physician Decision|1|||
19762076|NCT03291067|42214198|FG003|Overall Study|Physician Decision|0|||
19762077|NCT03291067|42214195|FG000|Overall Study|Protocol Violation|5|||
19762078|NCT03291067|42214196|FG001|Overall Study|Protocol Violation|3|||
19762079|NCT03291067|42214197|FG002|Overall Study|Protocol Violation|4|||
19762080|NCT03291067|42214198|FG003|Overall Study|Protocol Violation|2|||
19762081|NCT03291067|42214195|FG000|Overall Study|Withdrawal by Subject|3|||
19762082|NCT03291067|42214196|FG001|Overall Study|Withdrawal by Subject|4|||
19762083|NCT03291067|42214197|FG002|Overall Study|Withdrawal by Subject|7|||
19762084|NCT03291067|42214198|FG003|Overall Study|Withdrawal by Subject|5|||
19762085|NCT03291067|42214195|FG000|Overall Study|Other|0|||
19762086|NCT03291067|42214196|FG001|Overall Study|Other|4|||
19762087|NCT03291067|42214197|FG002|Overall Study|Other|4|||
19762088|NCT03291067|42214198|FG003|Overall Study|Other|6|||
19762089|NCT02941627|42214208|FG000|Overall Study|Death|1|||
19762090|NCT02941627|42214208|FG000|Overall Study|Surgical failure|1|||
19762091|NCT02941627|42214208|FG000|Overall Study|cholesteatoma prevented implantation|1|||
19762092|NCT03521934|42214220|FG000|Overall Study|Death|65|||
19762093|NCT03521934|42214221|FG001|Overall Study|Death|73|||
19762094|NCT03521934|42214220|FG000|Overall Study|Withdrawal by Subject|18|||
19762095|NCT03521934|42214221|FG001|Overall Study|Withdrawal by Subject|23|||
19762096|NCT03521934|42214220|FG000|Overall Study|Site Terminated by Sponsor|39|||
19762097|NCT03521934|42214221|FG001|Overall Study|Site Terminated by Sponsor|35|||
19762098|NCT03521934|42214220|FG000|Overall Study|Study Terminated by Sponsor|483|||
19762099|NCT03521934|42214221|FG001|Overall Study|Study Terminated by Sponsor|477|||
19762100|NCT03521934|42214220|FG000|Overall Study|Reason not Specified|3|||
19762101|NCT03521934|42214221|FG001|Overall Study|Reason not Specified|6|||
19762102|NCT03434353|42214232|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
19762103|NCT03434353|42214233|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
19762104|NCT03434353|42214234|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
19762105|NCT03434353|42214235|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
19762106|NCT03434353|42214236|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
19762107|NCT03434353|42214232|FG000|Overall Study|Withdrew consent|1|||
19762108|NCT03434353|42214233|FG001|Overall Study|Withdrew consent|0|||
19762109|NCT03434353|42214234|FG002|Overall Study|Withdrew consent|3|||
19762110|NCT03434353|42214235|FG003|Overall Study|Withdrew consent|0|||
19762111|NCT03434353|42214236|FG004|Overall Study|Withdrew consent|0|||
19762112|NCT03434353|42214232|FG000|Overall Study|Adverse Event|1|||
19762113|NCT03434353|42214233|FG001|Overall Study|Adverse Event|0|||
19762114|NCT03434353|42214234|FG002|Overall Study|Adverse Event|0|||
19762115|NCT03434353|42214235|FG003|Overall Study|Adverse Event|0|||
19762116|NCT03434353|42214236|FG004|Overall Study|Adverse Event|1|||
19762117|NCT03434353|42214232|FG000|Overall Study|Lost to Follow-up|2|||
19762118|NCT03434353|42214233|FG001|Overall Study|Lost to Follow-up|0|||
19762119|NCT03434353|42214234|FG002|Overall Study|Lost to Follow-up|0|||
19762120|NCT03434353|42214235|FG003|Overall Study|Lost to Follow-up|0|||
19762121|NCT03434353|42214236|FG004|Overall Study|Lost to Follow-up|0|||
19762122|NCT02914184|42214252|FG000|Overall Study|Lost to Follow-up|7|||
19762123|NCT02914184|42214253|FG001|Overall Study|Lost to Follow-up|10|||
19762124|NCT02914184|42214254|FG002|Overall Study|Lost to Follow-up|8|||
19762125|NCT02914184|42214255|FG003|Overall Study|Lost to Follow-up|7|||
19762126|NCT02914184|42214252|FG000|Overall Study|Withdrawal by Subject|4|||
19762127|NCT02914184|42214253|FG001|Overall Study|Withdrawal by Subject|2|||
19762128|NCT02914184|42214254|FG002|Overall Study|Withdrawal by Subject|7|||
19762129|NCT02914184|42214255|FG003|Overall Study|Withdrawal by Subject|3|||
19762130|NCT02914184|42214252|FG000|Overall Study|Other|1|||
19762131|NCT02914184|42214253|FG001|Overall Study|Other|0|||
19762132|NCT02914184|42214254|FG002|Overall Study|Other|0|||
19762133|NCT02914184|42214255|FG003|Overall Study|Other|0|||
19762134|NCT02914184|42214252|FG000|Overall Study|Migrated/moved from the study area|2|||
19762135|NCT02914184|42214253|FG001|Overall Study|Migrated/moved from the study area|1|||
19762136|NCT02914184|42214254|FG002|Overall Study|Migrated/moved from the study area|2|||
19762137|NCT02914184|42214255|FG003|Overall Study|Migrated/moved from the study area|1|||
19762138|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
19680089|NCT00267202|42127549|FG000|Overall Study|Adverse Event|13|||
19680090|NCT00267202|42127550|FG001|Overall Study|Adverse Event|7|||
19680091|NCT00267202|42127549|FG000|Overall Study|Protocol Violation|2|||
19680092|NCT00267202|42127550|FG001|Overall Study|Protocol Violation|3|||
19680093|NCT00267202|42127549|FG000|Overall Study|Administrative problems|2|||
19680094|NCT00267202|42127550|FG001|Overall Study|Administrative problems|1|||
19680095|NCT00267202|42127549|FG000|Overall Study|Lost to Follow-up|3|||
19680096|NCT00267202|42127550|FG001|Overall Study|Lost to Follow-up|0|||
19680097|NCT00267046|42127559|FG000|Overall Study|Disease progression|4|||
19680098|NCT00267046|42127560|FG001|Overall Study|Disease progression|2|||
19680099|NCT00267046|42127559|FG000|Overall Study|Chemotoxicity|2|||
19680100|NCT00267046|42127560|FG001|Overall Study|Chemotoxicity|0|||
19680101|NCT00267046|42127559|FG000|Overall Study|Open-label palifermin|2|||
19680102|NCT00267046|42127560|FG001|Overall Study|Open-label palifermin|7|||
19680103|NCT00267046|42127559|FG000|Overall Study|Surgery|3|||
19680104|NCT00267046|42127560|FG001|Overall Study|Surgery|1|||
19762139|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
19762140|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Death|2|||
19762141|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Death|1|||
19680105|NCT00267046|42127559|FG000|Overall Study|Withdrawal by Subject|1|||
19680106|NCT00267046|42127560|FG001|Overall Study|Withdrawal by Subject|0|||
19680107|NCT00267046|42127559|FG000|Overall Study|Radiation|0|||
19680108|NCT00267046|42127560|FG001|Overall Study|Radiation|1|||
19762142|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
19762143|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
19680109|NCT00441090|42127571|FG000|Overall Study|Adverse Event|0|||
19680110|NCT00441090|42127572|FG001|Overall Study|Adverse Event|1|||
19680111|NCT00441090|42127573|FG002|Overall Study|Adverse Event|1|||
19680112|NCT00441090|42127574|FG003|Overall Study|Adverse Event|0|||
19680113|NCT00441090|42127575|FG004|Overall Study|Adverse Event|0|||
19762144|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
19762145|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
19762146|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
19762147|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
19762148|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
19762149|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
19762150|NCT03633227|42214269|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
19762151|NCT03633227|42214270|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
19762152|NCT03633227|42214269|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
19762153|NCT03633227|42214270|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
19762154|NCT03633227|42214269|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
19762155|NCT03633227|42214270|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
19762156|NCT03633227|42214269|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
19762157|NCT03633227|42214270|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
19762158|NCT03633227|42214269|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
19762159|NCT03633227|42214270|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
19762160|NCT03633227|42214269|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
19762161|NCT03633227|42214270|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
19762162|NCT02913326|42214283|FG000|Overall Study|Reason not listed|0|||
19762163|NCT02913326|42214284|FG001|Overall Study|Reason not listed|1|||
19762164|NCT02913326|42214283|FG000|Overall Study|Lost to Follow-up|0|||
19762165|NCT02913326|42214284|FG001|Overall Study|Lost to Follow-up|1|||
19762166|NCT02913326|42214283|FG000|Overall Study|Adverse Event|1|||
19762167|NCT02913326|42214284|FG001|Overall Study|Adverse Event|0|||
19762168|NCT02912468|42214292|FG000|Overall Study|Adverse Event|3|||
19762169|NCT02912468|42214293|FG001|Overall Study|Adverse Event|2|||
19762170|NCT02912468|42214292|FG000|Overall Study|Withdrawal by Subject|6|||
19762171|NCT02912468|42214293|FG001|Overall Study|Withdrawal by Subject|2|||
19762172|NCT02912468|42214292|FG000|Overall Study|Randomized and not treated|0|||
19762173|NCT02912468|42214293|FG001|Overall Study|Randomized and not treated|1|||
19762174|NCT04438499|42214300|FG000|Overall Study|Lack of Efficacy|2|||
19762175|NCT00002874|42214306|FG000|Overall Study|Withdrawal by Subject|1|||
19389086|NCT02670551|41632643|FG001|Overall Study|Protocol Violation|0|||
19680114|NCT00441090|42127571|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
19680115|NCT00441090|42127572|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
19680116|NCT00441090|42127573|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
19680117|NCT00441090|42127574|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
19680118|NCT00441090|42127575|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
19680119|NCT00441090|42127571|FG000|Overall Study|Withdrawal by Subject|1|||
19680120|NCT00441090|42127572|FG001|Overall Study|Withdrawal by Subject|0|||
19680121|NCT00441090|42127573|FG002|Overall Study|Withdrawal by Subject|1|||
19680122|NCT00441090|42127574|FG003|Overall Study|Withdrawal by Subject|0|||
19680123|NCT00441090|42127575|FG004|Overall Study|Withdrawal by Subject|0|||
19680124|NCT00441090|42127571|FG000|Overall Study|Lack of Efficacy|1|||
19680125|NCT00441090|42127572|FG001|Overall Study|Lack of Efficacy|0|||
19680126|NCT00441090|42127573|FG002|Overall Study|Lack of Efficacy|0|||
19680127|NCT00441090|42127574|FG003|Overall Study|Lack of Efficacy|0|||
19680128|NCT00441090|42127575|FG004|Overall Study|Lack of Efficacy|0|||
19680129|NCT00441012|42127589|FG000|Overall Study|Adverse Event|0|||
19680130|NCT00441012|42127590|FG001|Overall Study|Adverse Event|1|||
19680131|NCT00441012|42127589|FG000|Overall Study|Lost to Follow-up|3|||
19680132|NCT00441012|42127590|FG001|Overall Study|Lost to Follow-up|3|||
19762176|NCT00002874|42214307|FG001|Overall Study|Withdrawal by Subject|1|||
19762177|NCT00002874|42214306|FG000|Overall Study|Protocol Violation|44|||
19762178|NCT00002874|42214307|FG001|Overall Study|Protocol Violation|34|||
19762179|NCT03001076|42214315|FG000|Overall Study|Withdrawal by patient|2|||
19762180|NCT03001076|42214316|FG001|Overall Study|Withdrawal by patient|0|||
19762181|NCT03001076|42214315|FG000|Overall Study|Other|1|||
19762182|NCT03001076|42214316|FG001|Overall Study|Other|0|||
19762183|NCT03001076|42214315|FG000|Overall Study|Adverse Event|3|||
19762184|NCT03001076|42214316|FG001|Overall Study|Adverse Event|3|||
19762185|NCT03001076|42214315|FG000|Overall Study|Sponsor decision|1|||
19762186|NCT03001076|42214316|FG001|Overall Study|Sponsor decision|0|||
19762187|NCT03001076|42214315|FG000|Overall Study|Lost to Follow-up|0|||
19762188|NCT03001076|42214316|FG001|Overall Study|Lost to Follow-up|2|||
19762189|NCT03555305|42214322|FG000|Period 1|Physician Decision|0|||
19762190|NCT03555305|42214323|FG001|Period 1|Physician Decision|1|||
19762191|NCT03555305|42214322|FG000|Period 1|Adverse Event|0|||
19762192|NCT03555305|42214323|FG001|Period 1|Adverse Event|1|||
19762193|NCT03553823|42214331|FG000|Overall Study|Physician Decision|0|||
19762194|NCT03553823|42214332|FG001|Overall Study|Physician Decision|1|||
19762195|NCT03000686|42214340|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
19762196|NCT03000686|42214341|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
19762197|NCT03000686|42214342|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
19762198|NCT03000686|42214343|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
19762199|NCT02493660|42214361|FG000|Overall Study|Physician Decision|0|||
19762200|NCT02493660|42214362|FG001|Overall Study|Physician Decision|1|||
19762201|NCT02493660|42214361|FG000|Overall Study|Adverse Event|4|||
19762202|NCT02493660|42214362|FG001|Overall Study|Adverse Event|2|||
19762203|NCT02493660|42214361|FG000|Overall Study|Withdrawal by Subject|2|||
19762204|NCT02493660|42214362|FG001|Overall Study|Withdrawal by Subject|3|||
19762205|NCT02493660|42214361|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
19762206|NCT02493660|42214362|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
19762207|NCT02493660|42214361|FG000|Overall Study|Protocol Violation|0|||
19762208|NCT02493660|42214362|FG001|Overall Study|Protocol Violation|1|||
19762209|NCT02493660|42214361|FG000|Overall Study|Death|0|||
19762210|NCT02493660|42214362|FG001|Overall Study|Death|1|||
19762211|NCT02493660|42214361|FG000|Overall Study|Lost to Follow-up|2|||
19762212|NCT02493660|42214362|FG001|Overall Study|Lost to Follow-up|4|||
19762213|NCT03552029|42214372|FG000|Overall Study|Death|3|||
19762214|NCT03552029|42214373|FG001|Overall Study|Death|0|||
19762215|NCT03552029|42214372|FG000|Overall Study|Adverse Event|1|||
19762216|NCT03552029|42214373|FG001|Overall Study|Adverse Event|0|||
19762217|NCT03552029|42214372|FG000|Overall Study|Lack of Efficacy|0|||
19762218|NCT03552029|42214373|FG001|Overall Study|Lack of Efficacy|2|||
19762219|NCT03552029|42214372|FG000|Overall Study|Physician Decision|0|||
19762220|NCT03552029|42214373|FG001|Overall Study|Physician Decision|1|||
19762221|NCT03552029|42214372|FG000|Overall Study|Study terminated by Sponsor|0|||
19762222|NCT03552029|42214373|FG001|Overall Study|Study terminated by Sponsor|1|||
19762223|NCT03552029|42214372|FG000|Overall Study|Other|0|||
19762224|NCT03552029|42214373|FG001|Overall Study|Other|2|||
19762225|NCT03521141|42214382|FG000|Overall Study|Death|1|||
19762226|NCT03521141|42214383|FG001|Overall Study|Death|0|||
19762227|NCT03521141|42214384|FG002|Overall Study|Death|1|||
19762228|NCT02997176|42214396|FG000|Overall Study|Adverse Event|0|||
19762229|NCT02997176|42214397|FG001|Overall Study|Adverse Event|0|||
19762230|NCT02997176|42214398|FG002|Overall Study|Adverse Event|0|||
19762231|NCT02997176|42214399|FG003|Overall Study|Adverse Event|8|||
19762232|NCT02997176|42214396|FG000|Overall Study|Progressive Disease|1|||
19762233|NCT02997176|42214397|FG001|Overall Study|Progressive Disease|0|||
19762234|NCT02997176|42214398|FG002|Overall Study|Progressive Disease|1|||
19762235|NCT02997176|42214399|FG003|Overall Study|Progressive Disease|1|||
19762236|NCT02997176|42214396|FG000|Overall Study|Death|0|||
19762237|NCT02997176|42214397|FG001|Overall Study|Death|0|||
19762238|NCT02997176|42214398|FG002|Overall Study|Death|1|||
19762239|NCT02997176|42214399|FG003|Overall Study|Death|1|||
19762240|NCT02997176|42214396|FG000|Overall Study|Withdrawal by Subject|0|||
19762241|NCT02997176|42214397|FG001|Overall Study|Withdrawal by Subject|2|||
19762242|NCT02997176|42214398|FG002|Overall Study|Withdrawal by Subject|0|||
19762243|NCT02997176|42214399|FG003|Overall Study|Withdrawal by Subject|1|||
19762244|NCT03000452|42214409|FG000|Treatment Period|Death|1|||
19762245|NCT03000452|42214409|FG000|Treatment Period|Progressive Disease (PD)|14|||
19762246|NCT03000452|42214409|FG000|Treatment Period|Physician Decision|1|||
19762247|NCT03000452|42214409|FG000|Treatment Period|Miscellaneous|2|||
19762248|NCT03000452|42214409|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
19762249|NCT03000452|42214409|FG000|Follow-Up Period|Death|3|||
19762250|NCT03000452|42214409|FG000|Follow-Up Period|Withdrawal by Subject|3|||
19762251|NCT01373164|42214418|FG000|Overall Study|Lost to Follow-up|0|||
19762252|NCT01373164|42214419|FG001|Overall Study|Lost to Follow-up|0|||
19762253|NCT01373164|42214420|FG002|Overall Study|Lost to Follow-up|1|||
19762254|NCT01373164|42214421|FG003|Overall Study|Lost to Follow-up|2|||
19762255|NCT01373164|42214422|FG004|Overall Study|Lost to Follow-up|0|||
19762256|NCT01373164|42214418|FG000|Overall Study|Withdrawal by Subject|0|||
19762257|NCT01373164|42214419|FG001|Overall Study|Withdrawal by Subject|1|||
19762258|NCT01373164|42214420|FG002|Overall Study|Withdrawal by Subject|0|||
19762259|NCT01373164|42214421|FG003|Overall Study|Withdrawal by Subject|10|||
19762260|NCT01373164|42214422|FG004|Overall Study|Withdrawal by Subject|2|||
19762261|NCT02999984|42214437|FG000|Overall Study|Treatment Failure|1|||
19762262|NCT03550313|42214444|FG000|Overall Study|Adverse Event|0|||
19762263|NCT03550313|42214445|FG001|Overall Study|Adverse Event|1|||
19762264|NCT03550313|42214446|FG002|Overall Study|Adverse Event|0|||
19762265|NCT03550313|42214444|FG000|Overall Study|Lost to Follow-up|5|||
19680133|NCT00441012|42127589|FG000|Overall Study|Protocol Violation|10|||
19680134|NCT00441012|42127590|FG001|Overall Study|Protocol Violation|9|||
19680135|NCT00441012|42127589|FG000|Overall Study|Withdrawal by Subject|4|||
19762266|NCT03550313|42214445|FG001|Overall Study|Lost to Follow-up|7|||
19762267|NCT03550313|42214446|FG002|Overall Study|Lost to Follow-up|12|||
19762268|NCT03550313|42214444|FG000|Overall Study|Study terminated by sponsor|44|||
19762269|NCT03550313|42214445|FG001|Overall Study|Study terminated by sponsor|37|||
19762270|NCT03550313|42214446|FG002|Overall Study|Study terminated by sponsor|48|||
19762271|NCT03550313|42214444|FG000|Overall Study|No longer met eligibility criteria|3|||
19762272|NCT03550313|42214445|FG001|Overall Study|No longer met eligibility criteria|5|||
19762273|NCT03550313|42214446|FG002|Overall Study|No longer met eligibility criteria|6|||
19762274|NCT03550313|42214444|FG000|Overall Study|Withdrawal by parent/guardian|20|||
19762275|NCT03550313|42214445|FG001|Overall Study|Withdrawal by parent/guardian|18|||
19762276|NCT03550313|42214446|FG002|Overall Study|Withdrawal by parent/guardian|26|||
19762277|NCT03550313|42214444|FG000|Overall Study|Other|4|||
19762278|NCT03550313|42214445|FG001|Overall Study|Other|2|||
19762279|NCT03550313|42214446|FG002|Overall Study|Other|2|||
19762280|NCT03550313|42214444|FG000|Overall Study|Randomized but not vaccinated|3|||
19762281|NCT03550313|42214445|FG001|Overall Study|Randomized but not vaccinated|23|||
19762282|NCT03550313|42214446|FG002|Overall Study|Randomized but not vaccinated|2|||
19762283|NCT03550313|42214444|FG000|Overall Study|Sites terminated due to quality issues|18|||
19762284|NCT03550313|42214445|FG001|Overall Study|Sites terminated due to quality issues|17|||
19762285|NCT03550313|42214446|FG002|Overall Study|Sites terminated due to quality issues|18|||
19762286|NCT03312907|42214458|FG000|Overall Study|Adverse Event|1|||
19762287|NCT03312907|42214459|FG001|Overall Study|Adverse Event|6|||
19762288|NCT03312907|42214460|FG002|Overall Study|Adverse Event|1|||
19762289|NCT03312907|42214458|FG000|Overall Study|Protocol Violation|2|||
19762290|NCT03312907|42214459|FG001|Overall Study|Protocol Violation|3|||
19762291|NCT03312907|42214460|FG002|Overall Study|Protocol Violation|4|||
19762292|NCT03312907|42214458|FG000|Overall Study|Lost to Follow-up|2|||
19762293|NCT03312907|42214459|FG001|Overall Study|Lost to Follow-up|3|||
19762294|NCT03312907|42214460|FG002|Overall Study|Lost to Follow-up|2|||
19762295|NCT03312907|42214458|FG000|Overall Study|Physician Decision|3|||
19680136|NCT00441012|42127590|FG001|Overall Study|Withdrawal by Subject|0|||
19680137|NCT00441012|42127589|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
19762296|NCT03312907|42214459|FG001|Overall Study|Physician Decision|4|||
19762297|NCT03312907|42214460|FG002|Overall Study|Physician Decision|2|||
19762298|NCT03312907|42214458|FG000|Overall Study|Withdrawal by Subject|9|||
19762299|NCT03312907|42214459|FG001|Overall Study|Withdrawal by Subject|14|||
19762300|NCT03312907|42214460|FG002|Overall Study|Withdrawal by Subject|10|||
19762301|NCT02999672|42214470|FG000|Overall Study|Death|0|||
19762302|NCT02999672|42214471|FG001|Overall Study|Death|1|||
19762303|NCT02999672|42214470|FG000|Overall Study|Study Terminated by Sponsor|0|||
19762304|NCT02999672|42214471|FG001|Overall Study|Study Terminated by Sponsor|1|||
19762305|NCT02999672|42214470|FG000|Overall Study|Progressive Disease|9|||
19762306|NCT02999672|42214471|FG001|Overall Study|Progressive Disease|5|||
19680138|NCT00441012|42127590|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
19680139|NCT00286468|42127599|FG000|Overall Study|Hyperglycemic Rescue|28|||
19680140|NCT00286468|42127600|FG001|Overall Study|Hyperglycemic Rescue|30|||
19680141|NCT00286468|42127601|FG002|Overall Study|Hyperglycemic Rescue|31|||
19680142|NCT00286468|42127599|FG000|Overall Study|Adverse Event|2|||
19680143|NCT00286468|42127600|FG001|Overall Study|Adverse Event|6|||
19680144|NCT00286468|42127601|FG002|Overall Study|Adverse Event|4|||
19680145|NCT00286468|42127599|FG000|Overall Study|Protocol Violation|0|||
19680146|NCT00286468|42127600|FG001|Overall Study|Protocol Violation|3|||
19680147|NCT00286468|42127601|FG002|Overall Study|Protocol Violation|1|||
19762307|NCT02999672|42214470|FG000|Overall Study|Adverse Event|4|||
19762308|NCT02999672|42214471|FG001|Overall Study|Adverse Event|0|||
19762309|NCT01911676|42214481|FG000|Period 1 of Study|Withdrawal by Subject|4|||
19762310|NCT01911676|42214482|FG001|Period 1 of Study|Withdrawal by Subject|2|||
19762311|NCT01911676|42214483|FG002|Period 1 of Study|Withdrawal by Subject|1|||
19762312|NCT01911676|42214484|FG003|Period 1 of Study|Withdrawal by Subject|2|||
19762313|NCT01911676|42214481|FG000|Period 1 of Study|Physician Decision|2|||
19762314|NCT01911676|42214482|FG001|Period 1 of Study|Physician Decision|0|||
19762315|NCT01911676|42214483|FG002|Period 1 of Study|Physician Decision|0|||
19762316|NCT01911676|42214484|FG003|Period 1 of Study|Physician Decision|1|||
19762317|NCT01911676|42214481|FG000|Period 2 of Study|Physician Decision|2|||
19680148|NCT00286468|42127599|FG000|Overall Study|Lost to Follow-up|1|||
19680149|NCT00286468|42127600|FG001|Overall Study|Lost to Follow-up|1|||
19680150|NCT00286468|42127601|FG002|Overall Study|Lost to Follow-up|2|||
19680151|NCT00286468|42127599|FG000|Overall Study|Withdrawal by Subject|3|||
19680152|NCT00286468|42127600|FG001|Overall Study|Withdrawal by Subject|8|||
19680153|NCT00286468|42127601|FG002|Overall Study|Withdrawal by Subject|11|||
19680154|NCT00286468|42127599|FG000|Overall Study|Physician Decision|3|||
19680155|NCT00286468|42127600|FG001|Overall Study|Physician Decision|2|||
19680156|NCT00286468|42127601|FG002|Overall Study|Physician Decision|1|||
19680157|NCT00507026|42127612|FG000|Overall Study|Lack of Efficacy|6|||
19762318|NCT01911676|42214482|FG001|Period 2 of Study|Physician Decision|0|||
19762319|NCT01911676|42214483|FG002|Period 2 of Study|Physician Decision|0|||
19762320|NCT01911676|42214484|FG003|Period 2 of Study|Physician Decision|1|||
19762321|NCT01911676|42214481|FG000|Period 2 of Study|Lost to Follow-up|0|||
19680158|NCT00507026|42127613|FG001|Overall Study|Lack of Efficacy|4|||
19762322|NCT01911676|42214482|FG001|Period 2 of Study|Lost to Follow-up|0|||
19762323|NCT01911676|42214483|FG002|Period 2 of Study|Lost to Follow-up|0|||
19762324|NCT01911676|42214484|FG003|Period 2 of Study|Lost to Follow-up|1|||
19762325|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
19762326|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
19762327|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
19762328|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
19762329|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
19762330|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
19762331|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
19762332|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
19762333|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
19762334|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
19762335|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
19762336|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
19762337|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
19762338|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
19762339|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
19762340|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
19762341|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
19762342|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
19762343|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
19762344|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
19762345|NCT03573323|42214501|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
19762346|NCT03573323|42214502|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
19762347|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
19762348|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
19762349|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
19762350|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
19762351|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
19762352|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
19762353|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
19762354|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
19389087|NCT02670551|41632644|FG002|Overall Study|Protocol Violation|0|||
19680159|NCT00507026|42127614|FG002|Overall Study|Lack of Efficacy|21|||
19680160|NCT00507026|42127612|FG000|Overall Study|Withdrawal by Subject|2|||
19680161|NCT00507026|42127613|FG001|Overall Study|Withdrawal by Subject|0|||
19680162|NCT00507026|42127614|FG002|Overall Study|Withdrawal by Subject|0|||
19680163|NCT00507026|42127612|FG000|Overall Study|Investigator Decision|1|||
19680164|NCT00507026|42127613|FG001|Overall Study|Investigator Decision|0|||
19680165|NCT00507026|42127614|FG002|Overall Study|Investigator Decision|0|||
19680166|NCT00507026|42127612|FG000|Overall Study|Adverse Event|2|||
19680167|NCT00507026|42127613|FG001|Overall Study|Adverse Event|0|||
19680168|NCT00507026|42127614|FG002|Overall Study|Adverse Event|0|||
19680169|NCT00507026|42127612|FG000|Overall Study|Protocol Violation|1|||
19680170|NCT00507026|42127613|FG001|Overall Study|Protocol Violation|0|||
19680171|NCT00507026|42127614|FG002|Overall Study|Protocol Violation|0|||
19680172|NCT00507026|42127612|FG000|Overall Study|Other|1|||
19680173|NCT00507026|42127613|FG001|Overall Study|Other|0|||
19680174|NCT00507026|42127614|FG002|Overall Study|Other|0|||
19680175|NCT00446550|42127624|FG000|Overall Study|Adverse Event|1|||
19762355|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
19680176|NCT00446550|42127625|FG001|Overall Study|Adverse Event|0|||
19680177|NCT03847974|42127632|FG000|Overall Study|relocated out of region|3|||
19680178|NCT03847974|42127632|FG000|Overall Study|Withdrawal by Subject|2|||
19680179|NCT03847974|42127632|FG000|Overall Study|Adverse Event|1|||
19680180|NCT00506948|42127636|FG000|Overall Study|Death|4|||
19680181|NCT00506948|42127636|FG000|Overall Study|Adverse Event|5|||
19680182|NCT00506948|42127636|FG000|Overall Study|Physician Decision|1|||
19680183|NCT00286234|42127644|FG000|Overall Study|Protocol Violation|1|||
19680184|NCT00286234|42127645|FG001|Overall Study|Protocol Violation|2|||
19680185|NCT00286234|42127646|FG002|Overall Study|Protocol Violation|0|||
19680186|NCT00286234|42127647|FG003|Overall Study|Protocol Violation|1|||
19762356|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
19762357|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
19762358|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
19762359|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
19762360|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
19762361|NCT03573323|42214501|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
19762362|NCT03573323|42214502|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
19762363|NCT03306043|42214528|FG000|Overall Study|Adverse Event|1|||
19762364|NCT03306043|42214528|FG000|Overall Study|Lost to Follow-up|1|||
19762365|NCT03306043|42214528|FG000|Overall Study|Withdrawal by Subject|2|||
19762366|NCT01069172|42214532|FG000|Overall Study|Withdrawal by Subject|1|||
19762367|NCT01069172|42214533|FG001|Overall Study|Withdrawal by Subject|0|||
19762368|NCT02911688|42214542|FG000|Washout|Lost to Follow-up|1|||
19762369|NCT02911688|42214543|FG001|Washout|Lost to Follow-up|1|||
19762370|NCT02911688|42214542|FG000|Washout|Withdrawal by Subject|0|||
19762371|NCT02911688|42214543|FG001|Washout|Withdrawal by Subject|1|||
19762372|NCT02670928|42214553|FG000|Overall Study|Adverse Event|3|||
19762373|NCT02670928|42214554|FG001|Overall Study|Adverse Event|1|||
19762374|NCT02670928|42214553|FG000|Overall Study|Withdrawal by Subject|4|||
19762375|NCT02670928|42214554|FG001|Overall Study|Withdrawal by Subject|0|||
19762376|NCT02670928|42214553|FG000|Overall Study|Lost to Follow-up|1|||
19762377|NCT02670928|42214554|FG001|Overall Study|Lost to Follow-up|0|||
19762378|NCT02670928|42214553|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
19762379|NCT02670928|42214554|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
19762380|NCT03305809|42214564|FG000|Overall Study|Adverse Event|2|||
19762381|NCT03305809|42214565|FG001|Overall Study|Adverse Event|2|||
19762382|NCT03305809|42214566|FG002|Overall Study|Adverse Event|6|||
19762383|NCT03305809|42214567|FG003|Overall Study|Adverse Event|6|||
19762384|NCT03305809|42214564|FG000|Overall Study|Death|0|||
19762385|NCT03305809|42214565|FG001|Overall Study|Death|0|||
19762386|NCT03305809|42214566|FG002|Overall Study|Death|1|||
19762387|NCT03305809|42214567|FG003|Overall Study|Death|1|||
19762388|NCT03305809|42214564|FG000|Overall Study|Lost to Follow-up|1|||
19762389|NCT03305809|42214565|FG001|Overall Study|Lost to Follow-up|2|||
19762390|NCT03305809|42214566|FG002|Overall Study|Lost to Follow-up|0|||
19762391|NCT03305809|42214567|FG003|Overall Study|Lost to Follow-up|0|||
19762392|NCT03305809|42214564|FG000|Overall Study|Sponsor Decision|1|||
19762393|NCT03305809|42214565|FG001|Overall Study|Sponsor Decision|0|||
19762394|NCT03305809|42214566|FG002|Overall Study|Sponsor Decision|1|||
19762395|NCT03305809|42214567|FG003|Overall Study|Sponsor Decision|8|||
19762396|NCT03305809|42214564|FG000|Overall Study|Physician Decision|0|||
19762397|NCT03305809|42214565|FG001|Overall Study|Physician Decision|0|||
19762398|NCT03305809|42214566|FG002|Overall Study|Physician Decision|2|||
19680187|NCT00286234|42127644|FG000|Overall Study|Physician Decision|1|||
19680188|NCT00286234|42127645|FG001|Overall Study|Physician Decision|0|||
19680189|NCT00286234|42127646|FG002|Overall Study|Physician Decision|0|||
19680190|NCT00286234|42127647|FG003|Overall Study|Physician Decision|1|||
19680191|NCT00286234|42127644|FG000|Overall Study|Adverse Event|0|||
19680192|NCT00286234|42127645|FG001|Overall Study|Adverse Event|0|||
19680193|NCT00286234|42127646|FG002|Overall Study|Adverse Event|0|||
19680194|NCT00286234|42127647|FG003|Overall Study|Adverse Event|1|||
19680195|NCT00286234|42127644|FG000|Overall Study|Adverse Event|0|||
19680196|NCT00286234|42127645|FG001|Overall Study|Adverse Event|0|||
19680197|NCT00286234|42127646|FG002|Overall Study|Adverse Event|0|||
19680198|NCT00286234|42127647|FG003|Overall Study|Adverse Event|1|||
19680199|NCT00445848|42127657|FG000|Overall Study|Adverse Event|14|||
19680200|NCT00445848|42127657|FG000|Overall Study|Withdrawal by Subject|4|||
19680201|NCT00445848|42127657|FG000|Overall Study|Progression|62|||
19680202|NCT00445848|42127657|FG000|Overall Study|Other-Not protocol specified|5|||
19762399|NCT03305809|42214567|FG003|Overall Study|Physician Decision|4|||
19762400|NCT03305809|42214564|FG000|Overall Study|Progressive Disease|0|||
19762401|NCT03305809|42214565|FG001|Overall Study|Progressive Disease|0|||
19762402|NCT03305809|42214566|FG002|Overall Study|Progressive Disease|1|||
19762403|NCT03305809|42214567|FG003|Overall Study|Progressive Disease|0|||
19762404|NCT03305809|42214564|FG000|Overall Study|Protocol Violation|1|||
19762405|NCT03305809|42214565|FG001|Overall Study|Protocol Violation|0|||
19762406|NCT03305809|42214566|FG002|Overall Study|Protocol Violation|2|||
19762407|NCT03305809|42214567|FG003|Overall Study|Protocol Violation|3|||
19762408|NCT03305809|42214564|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
19680203|NCT00286156|42127664|FG000|Overall Study|Missed 12 month visit|0|||
19680204|NCT00286156|42127665|FG001|Overall Study|Missed 12 month visit|0|||
19680205|NCT00286156|42127666|FG002|Overall Study|Missed 12 month visit|1|||
19762409|NCT03305809|42214565|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
19762410|NCT03305809|42214566|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
19762411|NCT03305809|42214567|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
19762412|NCT03305809|42214564|FG000|Overall Study|Withdrawal by Subject|2|||
19762413|NCT03305809|42214565|FG001|Overall Study|Withdrawal by Subject|4|||
19762414|NCT03305809|42214566|FG002|Overall Study|Withdrawal by Subject|5|||
19762415|NCT03305809|42214567|FG003|Overall Study|Withdrawal by Subject|2|||
19762416|NCT03305809|42214564|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
19762417|NCT03305809|42214565|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
19762418|NCT03305809|42214566|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
19762419|NCT03305809|42214567|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
19762420|NCT02994056|42214580|FG000|Overall Study|Death|8|||
19762421|NCT02994056|42214580|FG000|Overall Study|Withdrew Consent|1|||
19762422|NCT03548051|42214599|FG000|Overall Study|Death|1|||
19762423|NCT03548051|42214600|FG001|Overall Study|Death|1|||
19762424|NCT03548051|42214599|FG000|Overall Study|Withdrawal by Subject|1|||
19762425|NCT03548051|42214600|FG001|Overall Study|Withdrawal by Subject|0|||
19762426|NCT03305731|42214606|FG000|Overall Study|Protocol Violation|1|||
19762427|NCT03305575|42214612|FG000|Overall Study|Physician Decision|1|||
19762428|NCT03305575|42214613|FG001|Overall Study|Physician Decision|0|||
19762429|NCT02993822|42214623|FG000|Overall Study|Lack of Efficacy|1|||
19762430|NCT02993822|42214624|FG001|Overall Study|Lack of Efficacy|1|||
19762431|NCT02993822|42214625|FG002|Overall Study|Lack of Efficacy|0|||
19762432|NCT02993822|42214626|FG003|Overall Study|Lack of Efficacy|0|||
19762433|NCT02993822|42214623|FG000|Overall Study|Protocol Violation|1|||
19762434|NCT02993822|42214624|FG001|Overall Study|Protocol Violation|0|||
19762435|NCT02993822|42214625|FG002|Overall Study|Protocol Violation|0|||
19762436|NCT02993822|42214626|FG003|Overall Study|Protocol Violation|0|||
19762437|NCT02993822|42214623|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
19762438|NCT02993822|42214624|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
19762439|NCT02993822|42214625|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
19762440|NCT02993822|42214626|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
19762441|NCT02993822|42214623|FG000|Overall Study|Adverse Event|3|||
19762442|NCT02993822|42214624|FG001|Overall Study|Adverse Event|1|||
19762443|NCT02993822|42214625|FG002|Overall Study|Adverse Event|7|||
19762444|NCT02993822|42214626|FG003|Overall Study|Adverse Event|0|||
19762445|NCT02993822|42214623|FG000|Overall Study|Withdrawal by Subject|4|||
19762446|NCT02993822|42214624|FG001|Overall Study|Withdrawal by Subject|2|||
19762447|NCT02993822|42214625|FG002|Overall Study|Withdrawal by Subject|2|||
19762448|NCT02993822|42214626|FG003|Overall Study|Withdrawal by Subject|3|||
19762449|NCT02993822|42214623|FG000|Overall Study|Lost to Follow-up|1|||
19762450|NCT02993822|42214624|FG001|Overall Study|Lost to Follow-up|0|||
19762451|NCT02993822|42214625|FG002|Overall Study|Lost to Follow-up|1|||
19762452|NCT02993822|42214626|FG003|Overall Study|Lost to Follow-up|0|||
19762453|NCT02674750|42214639|FG000|Overall Study|Death|4|||
19762454|NCT02674750|42214640|FG001|Overall Study|Death|5|||
19762455|NCT02674750|42214641|FG002|Overall Study|Death|8|||
19762456|NCT02674750|42214639|FG000|Overall Study|Lost to Follow-up|0|||
19762457|NCT02674750|42214640|FG001|Overall Study|Lost to Follow-up|8|||
19762458|NCT02674750|42214641|FG002|Overall Study|Lost to Follow-up|0|||
19762459|NCT02674750|42214639|FG000|Overall Study|Lack of Efficacy|1|||
19762460|NCT02674750|42214640|FG001|Overall Study|Lack of Efficacy|17|||
19762461|NCT02674750|42214641|FG002|Overall Study|Lack of Efficacy|3|||
19762462|NCT02674750|42214639|FG000|Overall Study|Withdrawal by Subject|0|||
19680206|NCT00286156|42127664|FG000|Overall Study|AE: pulmonary embolus|0|||
19680207|NCT00286156|42127665|FG001|Overall Study|AE: pulmonary embolus|1|||
19680208|NCT00286156|42127666|FG002|Overall Study|AE: pulmonary embolus|0|||
19680209|NCT00286156|42127664|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
19680210|NCT00286156|42127665|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
19680211|NCT00286156|42127666|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
19762463|NCT02674750|42214640|FG001|Overall Study|Withdrawal by Subject|7|||
19680212|NCT00286156|42127664|FG000|Overall Study|AE: pneumonia|1|||
19762464|NCT02674750|42214641|FG002|Overall Study|Withdrawal by Subject|1|||
19762465|NCT02674750|42214639|FG000|Overall Study|Other|0|||
19762466|NCT02674750|42214640|FG001|Overall Study|Other|8|||
19762467|NCT02674750|42214641|FG002|Overall Study|Other|0|||
19762468|NCT01068860|42214658|FG000|Overall Study|Withdrawal by Subject|0|||
19680213|NCT00286156|42127665|FG001|Overall Study|AE: pneumonia|0|||
19680214|NCT00286156|42127666|FG002|Overall Study|AE: pneumonia|0|||
19762469|NCT01068860|42214659|FG001|Overall Study|Withdrawal by Subject|0|||
19762470|NCT01068860|42214660|FG002|Overall Study|Withdrawal by Subject|0|||
19762471|NCT01068860|42214661|FG003|Overall Study|Withdrawal by Subject|0|||
19762472|NCT01068860|42214662|FG004|Overall Study|Withdrawal by Subject|0|||
19762473|NCT01068860|42214663|FG005|Overall Study|Withdrawal by Subject|2|||
19762474|NCT01068860|42214664|FG006|Overall Study|Withdrawal by Subject|0|||
19680215|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
19680216|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
19680217|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
19680218|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
19680219|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
19680220|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
19680221|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
19680222|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
19680223|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
19680224|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
19680225|NCT00455520|42127676|FG000|Open Label Tapentadol Extended Release|All other|33|||
19680226|NCT00455520|42127677|FG001|Open Label Tapentadol Extended Release|All other|0|||
19680227|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
19680228|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
19680229|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
19680230|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
19680231|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
19680232|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
19680233|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
19680234|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
19680235|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
19680236|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
19680237|NCT00455520|42127676|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
19680238|NCT00455520|42127677|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
19680239|NCT00440700|42127686|FG000|Overall Study|Withdrawal by Subject|8|||
19680240|NCT00440700|42127687|FG001|Overall Study|Withdrawal by Subject|8|||
19680241|NCT00440700|42127688|FG002|Overall Study|Withdrawal by Subject|4|||
19680242|NCT00284050|42127699|FG000|Overall Study|Adverse Event|1|||
19680243|NCT00284050|42127700|FG001|Overall Study|Adverse Event|1|||
19680244|NCT00284050|42127701|FG002|Overall Study|Adverse Event|1|||
19680245|NCT00284050|42127699|FG000|Overall Study|Lack of Efficacy|0|||
19680246|NCT00284050|42127700|FG001|Overall Study|Lack of Efficacy|1|||
19680247|NCT00284050|42127701|FG002|Overall Study|Lack of Efficacy|3|||
19680248|NCT00284050|42127699|FG000|Overall Study|Protocol Violation|0|||
19680249|NCT00284050|42127700|FG001|Overall Study|Protocol Violation|1|||
19680250|NCT00284050|42127701|FG002|Overall Study|Protocol Violation|2|||
19680251|NCT00284050|42127699|FG000|Overall Study|Withdrawal by Subject|2|||
19680252|NCT00284050|42127700|FG001|Overall Study|Withdrawal by Subject|2|||
19680253|NCT00284050|42127701|FG002|Overall Study|Withdrawal by Subject|2|||
19680254|NCT00284050|42127699|FG000|Overall Study|Lost to Follow-up|1|||
19680255|NCT00284050|42127700|FG001|Overall Study|Lost to Follow-up|0|||
19680256|NCT00284050|42127701|FG002|Overall Study|Lost to Follow-up|1|||
19680257|NCT00284050|42127699|FG000|Overall Study|Death|1|||
19680258|NCT00284050|42127700|FG001|Overall Study|Death|0|||
19680259|NCT00284050|42127701|FG002|Overall Study|Death|0|||
19680260|NCT00293020|42127709|FG000|Overall Study|Withdrawal by Subject|34|||
19680261|NCT00293020|42127709|FG000|Overall Study|Adverse Event|30|||
19680262|NCT00293020|42127709|FG000|Overall Study|Death|32|||
19680263|NCT00293020|42127709|FG000|Overall Study|Lack of Efficacy|12|||
19680264|NCT00293020|42127709|FG000|Overall Study|Lost to Follow-up|4|||
19680265|NCT00293020|42127709|FG000|Overall Study|Protocol Violation|6|||
19680266|NCT00293020|42127709|FG000|Overall Study|Physician Decision|21|||
19680267|NCT00293020|42127709|FG000|Overall Study|Other Reason|22|||
19680268|NCT00293020|42127709|FG000|Overall Study|No dose taken|1|||
19680269|NCT00377637|42127717|FG000|Induction Phase|Adverse Event|12|||
19680270|NCT00377637|42127718|FG001|Induction Phase|Adverse Event|21|||
19680271|NCT00377637|42127719|FG002|Induction Phase|Adverse Event|0|||
19680272|NCT00377637|42127720|FG003|Induction Phase|Adverse Event|0|||
19680273|NCT00377637|42127717|FG000|Induction Phase|Deterioration/serum creatinine|2|||
19680274|NCT00377637|42127718|FG001|Induction Phase|Deterioration/serum creatinine|0|||
19680275|NCT00377637|42127719|FG002|Induction Phase|Deterioration/serum creatinine|0|||
19680276|NCT00377637|42127720|FG003|Induction Phase|Deterioration/serum creatinine|0|||
19762475|NCT01068860|42214665|FG007|Overall Study|Withdrawal by Subject|0|||
19762476|NCT01068860|42214666|FG008|Overall Study|Withdrawal by Subject|0|||
19762477|NCT01068860|42214667|FG009|Overall Study|Withdrawal by Subject|3|||
19680277|NCT00377637|42127717|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
19680278|NCT00377637|42127718|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
19680279|NCT00377637|42127719|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
19680280|NCT00377637|42127720|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
19680281|NCT00377637|42127717|FG000|Induction Phase|Lost to Follow-up|2|||
19680282|NCT00377637|42127718|FG001|Induction Phase|Lost to Follow-up|1|||
19680283|NCT00377637|42127719|FG002|Induction Phase|Lost to Follow-up|0|||
19762478|NCT01068860|42214658|FG000|Overall Study|Administrative problems; misrandomized|0|||
19762479|NCT01068860|42214659|FG001|Overall Study|Administrative problems; misrandomized|0|||
19762480|NCT01068860|42214660|FG002|Overall Study|Administrative problems; misrandomized|0|||
19762481|NCT01068860|42214661|FG003|Overall Study|Administrative problems; misrandomized|1|||
19762482|NCT01068860|42214662|FG004|Overall Study|Administrative problems; misrandomized|0|||
19762483|NCT01068860|42214663|FG005|Overall Study|Administrative problems; misrandomized|0|||
19762484|NCT01068860|42214664|FG006|Overall Study|Administrative problems; misrandomized|0|||
19762485|NCT01068860|42214665|FG007|Overall Study|Administrative problems; misrandomized|0|||
19762486|NCT01068860|42214666|FG008|Overall Study|Administrative problems; misrandomized|0|||
19762487|NCT01068860|42214667|FG009|Overall Study|Administrative problems; misrandomized|1|||
19762488|NCT01068860|42214658|FG000|Overall Study|Lost to Follow-up|0|||
19762489|NCT01068860|42214659|FG001|Overall Study|Lost to Follow-up|1|||
19762490|NCT01068860|42214660|FG002|Overall Study|Lost to Follow-up|0|||
19762491|NCT01068860|42214661|FG003|Overall Study|Lost to Follow-up|0|||
19762492|NCT01068860|42214662|FG004|Overall Study|Lost to Follow-up|0|||
19762493|NCT01068860|42214663|FG005|Overall Study|Lost to Follow-up|0|||
19762494|NCT01068860|42214664|FG006|Overall Study|Lost to Follow-up|0|||
19762495|NCT01068860|42214665|FG007|Overall Study|Lost to Follow-up|0|||
19680284|NCT00377637|42127720|FG003|Induction Phase|Lost to Follow-up|0|||
19680285|NCT00377637|42127717|FG000|Induction Phase|Death|1|||
19680286|NCT00377637|42127718|FG001|Induction Phase|Death|3|||
19680287|NCT00377637|42127719|FG002|Induction Phase|Death|0|||
19680288|NCT00377637|42127720|FG003|Induction Phase|Death|0|||
19680289|NCT00377637|42127717|FG000|Induction Phase|Withdrawal by Subject|5|||
19680290|NCT00377637|42127718|FG001|Induction Phase|Withdrawal by Subject|6|||
19680291|NCT00377637|42127719|FG002|Induction Phase|Withdrawal by Subject|0|||
19680292|NCT00377637|42127720|FG003|Induction Phase|Withdrawal by Subject|0|||
19680293|NCT00377637|42127717|FG000|Induction Phase|Physician Decision|3|||
19680294|NCT00377637|42127718|FG001|Induction Phase|Physician Decision|1|||
19680295|NCT00377637|42127719|FG002|Induction Phase|Physician Decision|0|||
19680296|NCT00377637|42127720|FG003|Induction Phase|Physician Decision|0|||
19680297|NCT00377637|42127717|FG000|Induction Phase|Sponsor decision|1|||
19680298|NCT00377637|42127718|FG001|Induction Phase|Sponsor decision|2|||
19680299|NCT00377637|42127719|FG002|Induction Phase|Sponsor decision|0|||
19680300|NCT00377637|42127720|FG003|Induction Phase|Sponsor decision|0|||
19680301|NCT00377637|42127717|FG000|Induction Phase|Non-Compliance|1|||
19680302|NCT00377637|42127718|FG001|Induction Phase|Non-Compliance|0|||
19680303|NCT00377637|42127719|FG002|Induction Phase|Non-Compliance|0|||
19680304|NCT00377637|42127720|FG003|Induction Phase|Non-Compliance|0|||
19680305|NCT00377637|42127717|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
19680306|NCT00377637|42127718|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
19680307|NCT00377637|42127719|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
19680308|NCT00377637|42127720|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
19680309|NCT00377637|42127717|FG000|Maintenance Phase|Adverse Event|0|||
19680310|NCT00377637|42127718|FG001|Maintenance Phase|Adverse Event|0|||
19680311|NCT00377637|42127719|FG002|Maintenance Phase|Adverse Event|29|||
19680312|NCT00377637|42127720|FG003|Maintenance Phase|Adverse Event|43|||
19680313|NCT00377637|42127717|FG000|Maintenance Phase|Physician Decision|0|||
19680314|NCT00377637|42127718|FG001|Maintenance Phase|Physician Decision|0|||
19680315|NCT00377637|42127719|FG002|Maintenance Phase|Physician Decision|5|||
19680316|NCT00377637|42127720|FG003|Maintenance Phase|Physician Decision|4|||
19680317|NCT00377637|42127717|FG000|Maintenance Phase|Lost to Follow-up|0|||
19680318|NCT00377637|42127718|FG001|Maintenance Phase|Lost to Follow-up|0|||
19680319|NCT00377637|42127719|FG002|Maintenance Phase|Lost to Follow-up|3|||
19680320|NCT00377637|42127720|FG003|Maintenance Phase|Lost to Follow-up|1|||
19680321|NCT00377637|42127717|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19680322|NCT00377637|42127718|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19680323|NCT00377637|42127719|FG002|Maintenance Phase|Withdrawal by Subject|3|||
19680324|NCT00377637|42127720|FG003|Maintenance Phase|Withdrawal by Subject|3|||
19680325|NCT00377637|42127717|FG000|Maintenance Phase|Sponsor decision|0|||
19680326|NCT00377637|42127718|FG001|Maintenance Phase|Sponsor decision|0|||
19680327|NCT00377637|42127719|FG002|Maintenance Phase|Sponsor decision|2|||
19680328|NCT00377637|42127720|FG003|Maintenance Phase|Sponsor decision|3|||
19762496|NCT01068860|42214666|FG008|Overall Study|Lost to Follow-up|0|||
19680329|NCT00377637|42127717|FG000|Maintenance Phase|Non-compliance|0|||
19680330|NCT00377637|42127718|FG001|Maintenance Phase|Non-compliance|0|||
19680331|NCT00377637|42127719|FG002|Maintenance Phase|Non-compliance|1|||
19680332|NCT00377637|42127720|FG003|Maintenance Phase|Non-compliance|1|||
19680333|NCT00377637|42127717|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
19762497|NCT01068860|42214667|FG009|Overall Study|Lost to Follow-up|0|||
19680334|NCT00377637|42127718|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
19680335|NCT00377637|42127719|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
19680336|NCT00377637|42127720|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
19680337|NCT00377637|42127717|FG000|Maintenance Phase|Death|0|||
19762498|NCT02989610|42214689|FG000|Overall Study|Withdrawal/Other reasons|39|||
19762499|NCT01372774|42214695|FG000|Overall Study|Withdrawal prior to treatment|4|||
19762500|NCT01372774|42214696|FG001|Overall Study|Withdrawal prior to treatment|5|||
19762501|NCT02670538|42214707|FG000|Overall Study|Withdrawal of Consent|8|||
19762502|NCT02670538|42214708|FG001|Overall Study|Withdrawal of Consent|6|||
19762503|NCT02670538|42214709|FG002|Overall Study|Withdrawal of Consent|5|||
19762504|NCT02670538|42214707|FG000|Overall Study|Lost to Follow-up|8|||
19762505|NCT02670538|42214708|FG001|Overall Study|Lost to Follow-up|12|||
19762506|NCT02670538|42214709|FG002|Overall Study|Lost to Follow-up|7|||
19762507|NCT02670538|42214707|FG000|Overall Study|Adverse Event|5|||
19762508|NCT02670538|42214708|FG001|Overall Study|Adverse Event|5|||
19762509|NCT02670538|42214709|FG002|Overall Study|Adverse Event|11|||
19762510|NCT02670538|42214707|FG000|Overall Study|Lack of Efficacy|7|||
19762511|NCT02670538|42214708|FG001|Overall Study|Lack of Efficacy|1|||
19762512|NCT02670538|42214709|FG002|Overall Study|Lack of Efficacy|2|||
19762513|NCT02670538|42214707|FG000|Overall Study|Protocol Violation|3|||
19762514|NCT02670538|42214708|FG001|Overall Study|Protocol Violation|4|||
19762515|NCT02670538|42214709|FG002|Overall Study|Protocol Violation|1|||
19762516|NCT02670538|42214707|FG000|Overall Study|Noncompliance with Study Drug|1|||
19762517|NCT02670538|42214708|FG001|Overall Study|Noncompliance with Study Drug|3|||
19762518|NCT02670538|42214709|FG002|Overall Study|Noncompliance with Study Drug|2|||
19762519|NCT02670538|42214707|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19762520|NCT02670538|42214708|FG001|Overall Study|Other Miscellaneous Reasons|1|||
19762521|NCT02670538|42214709|FG002|Overall Study|Other Miscellaneous Reasons|2|||
19762522|NCT03547583|42214720|FG000|Overall Study|Adverse Event|16|||
19762523|NCT03547583|42214721|FG001|Overall Study|Adverse Event|11|||
19762524|NCT03547583|42214722|FG002|Overall Study|Adverse Event|10|||
19762525|NCT03547583|42214720|FG000|Overall Study|Death|11|||
19762526|NCT03547583|42214721|FG001|Overall Study|Death|7|||
19762527|NCT03547583|42214722|FG002|Overall Study|Death|4|||
19762528|NCT03547583|42214720|FG000|Overall Study|Lost to Follow-up|1|||
19762529|NCT03547583|42214721|FG001|Overall Study|Lost to Follow-up|0|||
19762530|NCT03547583|42214722|FG002|Overall Study|Lost to Follow-up|0|||
19762531|NCT03547583|42214720|FG000|Overall Study|Non-compliance with study drug|0|||
19762532|NCT03547583|42214721|FG001|Overall Study|Non-compliance with study drug|0|||
19762533|NCT03547583|42214722|FG002|Overall Study|Non-compliance with study drug|1|||
19762534|NCT03547583|42214720|FG000|Overall Study|Physician Decision|1|||
19762535|NCT03547583|42214721|FG001|Overall Study|Physician Decision|0|||
19762536|NCT03547583|42214722|FG002|Overall Study|Physician Decision|3|||
19762537|NCT03547583|42214720|FG000|Overall Study|Protocol Violation|2|||
19762538|NCT03547583|42214721|FG001|Overall Study|Protocol Violation|1|||
19762539|NCT03547583|42214722|FG002|Overall Study|Protocol Violation|1|||
19762540|NCT03547583|42214720|FG000|Overall Study|Withdrawal by Subject|12|||
19762541|NCT03547583|42214721|FG001|Overall Study|Withdrawal by Subject|19|||
19762542|NCT03547583|42214722|FG002|Overall Study|Withdrawal by Subject|10|||
19762543|NCT03547583|42214720|FG000|Overall Study|Other|2|||
19762544|NCT03547583|42214721|FG001|Overall Study|Other|2|||
19762545|NCT03547583|42214722|FG002|Overall Study|Other|3|||
19762546|NCT02670382|42214733|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
19762547|NCT02670382|42214734|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
19762548|NCT02991482|42214744|FG000|Overall Study|Disease progression|56|||
19762549|NCT02991482|42214745|FG001|Overall Study|Disease progression|47|||
19762550|NCT02991482|42214744|FG000|Overall Study|Death|4|||
19762551|NCT02991482|42214745|FG001|Overall Study|Death|4|||
19762552|NCT02991482|42214744|FG000|Overall Study|Adverse Event|1|||
19762553|NCT02991482|42214745|FG001|Overall Study|Adverse Event|6|||
19762554|NCT02991482|42214744|FG000|Overall Study|Patient decision|1|||
19762555|NCT02991482|42214745|FG001|Overall Study|Patient decision|1|||
19762556|NCT02991482|42214744|FG000|Overall Study|Physician Decision|0|||
19762557|NCT02991482|42214745|FG001|Overall Study|Physician Decision|6|||
19762558|NCT02991482|42214744|FG000|Overall Study|Clinical deterioration|1|||
19762559|NCT02991482|42214745|FG001|Overall Study|Clinical deterioration|0|||
19762560|NCT02991482|42214744|FG000|Overall Study|Patient feeling too unwell|1|||
19762561|NCT02991482|42214745|FG001|Overall Study|Patient feeling too unwell|0|||
19762562|NCT02991482|42214744|FG000|Overall Study|Worsening of performance status|0|||
19762563|NCT02991482|42214745|FG001|Overall Study|Worsening of performance status|1|||
19762564|NCT02991482|42214744|FG000|Overall Study|Death prior to study drug initiation|1|||
19762565|NCT02991482|42214745|FG001|Overall Study|Death prior to study drug initiation|0|||
19762566|NCT02991482|42214744|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
19762567|NCT02991482|42214745|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
19762568|NCT02987972|42214773|FG000|Overall Study|Adverse Event|1|||
19762569|NCT02987972|42214774|FG001|Overall Study|Adverse Event|1|||
19762570|NCT02987972|42214775|FG002|Overall Study|Adverse Event|0|||
19477230|NCT01482221|41756211|FG001|Overall Study|Lack of Efficacy|0|||
19762571|NCT02987972|42214773|FG000|Overall Study|Death|1|||
19762572|NCT02987972|42214774|FG001|Overall Study|Death|0|||
19762573|NCT02987972|42214775|FG002|Overall Study|Death|0|||
19762574|NCT02987972|42214773|FG000|Overall Study|Lack of Efficacy|9|||
19762575|NCT02987972|42214774|FG001|Overall Study|Lack of Efficacy|12|||
19762576|NCT02987972|42214775|FG002|Overall Study|Lack of Efficacy|12|||
19762577|NCT02987972|42214773|FG000|Overall Study|Lost to Follow-up|7|||
19762578|NCT02987972|42214774|FG001|Overall Study|Lost to Follow-up|8|||
19762579|NCT02987972|42214775|FG002|Overall Study|Lost to Follow-up|4|||
19762580|NCT02987972|42214773|FG000|Overall Study|Physician Decision|1|||
19762581|NCT02987972|42214774|FG001|Overall Study|Physician Decision|6|||
19762582|NCT02987972|42214775|FG002|Overall Study|Physician Decision|0|||
19762583|NCT02987972|42214773|FG000|Overall Study|Protocol Violation|2|||
19762584|NCT02987972|42214774|FG001|Overall Study|Protocol Violation|1|||
19762585|NCT02987972|42214775|FG002|Overall Study|Protocol Violation|5|||
19762586|NCT02987972|42214773|FG000|Overall Study|Withdrawal by Subject|22|||
19762587|NCT02987972|42214774|FG001|Overall Study|Withdrawal by Subject|17|||
19762588|NCT02987972|42214775|FG002|Overall Study|Withdrawal by Subject|21|||
19762589|NCT03305419|42214791|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762590|NCT03305419|42214792|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
19762591|NCT03305419|42214793|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762592|NCT03305419|42214794|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762593|NCT03305419|42214795|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762594|NCT03305419|42214796|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762595|NCT03305419|42214797|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762596|NCT03305419|42214798|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
19762597|NCT03305419|42214791|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
19762598|NCT03305419|42214792|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762599|NCT03305419|42214793|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762600|NCT03305419|42214794|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762601|NCT03305419|42214795|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762602|NCT03305419|42214796|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762603|NCT03305419|42214797|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762604|NCT03305419|42214798|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
19762605|NCT03305419|42214791|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
19762606|NCT03305419|42214792|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762607|NCT03305419|42214793|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762608|NCT03305419|42214794|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762609|NCT03305419|42214795|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762610|NCT03305419|42214796|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762611|NCT03305419|42214797|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762612|NCT03305419|42214798|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
19762613|NCT03305419|42214791|FG000|Part B (14 Days)|Adverse Event|0|||
19762614|NCT03305419|42214792|FG001|Part B (14 Days)|Adverse Event|0|||
19762615|NCT03305419|42214793|FG002|Part B (14 Days)|Adverse Event|0|||
19762616|NCT03305419|42214794|FG003|Part B (14 Days)|Adverse Event|0|||
19762617|NCT03305419|42214795|FG004|Part B (14 Days)|Adverse Event|1|||
19762618|NCT03305419|42214796|FG005|Part B (14 Days)|Adverse Event|2|||
19762619|NCT03305419|42214797|FG006|Part B (14 Days)|Adverse Event|4|||
19762620|NCT03305419|42214798|FG007|Part B (14 Days)|Adverse Event|0|||
19762621|NCT03305419|42214791|FG000|Part B (14 Days)|Physician Decision|0|||
19762622|NCT03305419|42214792|FG001|Part B (14 Days)|Physician Decision|0|||
19762623|NCT03305419|42214793|FG002|Part B (14 Days)|Physician Decision|0|||
19762624|NCT03305419|42214794|FG003|Part B (14 Days)|Physician Decision|0|||
19762625|NCT03305419|42214795|FG004|Part B (14 Days)|Physician Decision|2|||
19762626|NCT03305419|42214796|FG005|Part B (14 Days)|Physician Decision|8|||
19762627|NCT03305419|42214797|FG006|Part B (14 Days)|Physician Decision|1|||
19762628|NCT03305419|42214798|FG007|Part B (14 Days)|Physician Decision|0|||
19762629|NCT01372618|42214821|FG000|Overall Study|PI Died. Study Terminated|9|||
19762630|NCT03304873|42214827|FG000|Overall Study|Lost to Follow-up|1|||
19762631|NCT03304873|42214828|FG001|Overall Study|Lost to Follow-up|8|||
19762632|NCT02669758|42214834|FG000|Overall Study|Withdrawal by Subject|43|||
19762633|NCT02669758|42214834|FG000|Overall Study|Lost to Follow-up|19|||
19762634|NCT02669758|42214834|FG000|Overall Study|Adverse Event|16|||
19762635|NCT02669758|42214834|FG000|Overall Study|Non-Compliance with Study Drug|8|||
19762636|NCT02669758|42214834|FG000|Overall Study|Lack of Efficacy|5|||
19762637|NCT02669758|42214834|FG000|Overall Study|Pregnancy|1|||
19762638|NCT02669758|42214834|FG000|Overall Study|Study noncompliance|1|||
19762639|NCT02669758|42214834|FG000|Overall Study|Protocol Violation|1|||
19762640|NCT02987660|42214840|FG000|Overall Study|Study terminated by sponsor|10|||
19762641|NCT02987660|42214841|FG001|Overall Study|Study terminated by sponsor|10|||
19762642|NCT04528069|42214847|FG000|Overall Study|Adverse Event|1|||
19762643|NCT04528069|42214847|FG000|Overall Study|Lost to Follow-up|1|||
19762644|NCT04528069|42214847|FG000|Overall Study|Patient Unable to Come|1|||
19762645|NCT04528069|42214847|FG000|Overall Study|Patient Unable to Attend|1|||
19762646|NCT03303469|42214863|FG000|Overall Study|Lost to Follow-up|2|||
19762647|NCT02990000|42214869|FG000|Overall Study|Failed to provide data beyond baseline|36|||
19762648|NCT02990000|42214870|FG001|Overall Study|Failed to provide data beyond baseline|34|||
19762649|NCT01068626|42214878|FG000|Overall Study|Adverse Event|3|||
19762650|NCT01068626|42214879|FG001|Overall Study|Adverse Event|0|||
19762651|NCT01068626|42214878|FG000|Overall Study|Withdrawal by Subject|0|||
19762652|NCT01068626|42214879|FG001|Overall Study|Withdrawal by Subject|2|||
19762653|NCT02921750|42214887|FG000|Overall Study|Adverse Event|1|||
19762654|NCT02921750|42214888|FG001|Overall Study|Adverse Event|2|||
19762655|NCT02921750|42214887|FG000|Overall Study|Withdrawal by Subject|1|||
19762656|NCT02921750|42214888|FG001|Overall Study|Withdrawal by Subject|1|||
19762657|NCT02921750|42214887|FG000|Overall Study|Lost to Follow-up|3|||
19762658|NCT02921750|42214888|FG001|Overall Study|Lost to Follow-up|3|||
19762659|NCT02921750|42214887|FG000|Overall Study|Wound healed|3|||
19762660|NCT02921750|42214888|FG001|Overall Study|Wound healed|3|||
19762661|NCT02921750|42214887|FG000|Overall Study|Serious Adverse Event|1|||
19762662|NCT02921750|42214888|FG001|Overall Study|Serious Adverse Event|2|||
19762663|NCT02920970|42214897|FG000|First Intervention|Protocol Violation|0|||
19762664|NCT02920970|42214898|FG001|First Intervention|Protocol Violation|1|||
19762665|NCT02920970|42214897|FG000|First Intervention|Adverse Event|0|||
19762666|NCT02920970|42214898|FG001|First Intervention|Adverse Event|1|||
19762667|NCT02920970|42214897|FG000|Second Intervention|Poor Lens Fit|1|||
19762668|NCT02920970|42214898|FG001|Second Intervention|Poor Lens Fit|0|||
19762669|NCT01068158|42214908|FG000|Overall Study|Withdrawal by Subject|1|||
19762670|NCT01068158|42214909|FG001|Overall Study|Withdrawal by Subject|2|||
19762671|NCT01068158|42214908|FG000|Overall Study|Lost to Follow-up|7|||
19762672|NCT01068158|42214909|FG001|Overall Study|Lost to Follow-up|0|||
19762673|NCT01068158|42214908|FG000|Overall Study|Protocol Violation|0|||
19762674|NCT01068158|42214909|FG001|Overall Study|Protocol Violation|2|||
19762675|NCT03303079|42214918|FG000|Overall Study|Adverse Event|0|||
19762676|NCT03303079|42214919|FG001|Overall Study|Adverse Event|1|||
19762677|NCT03303079|42214920|FG002|Overall Study|Adverse Event|3|||
19762678|NCT03303079|42214918|FG000|Overall Study|Protocol Violation|5|||
19762679|NCT03303079|42214919|FG001|Overall Study|Protocol Violation|4|||
19762680|NCT03303079|42214920|FG002|Overall Study|Protocol Violation|7|||
19762681|NCT03303079|42214918|FG000|Overall Study|Withdrawal by Subject|2|||
19762682|NCT03303079|42214919|FG001|Overall Study|Withdrawal by Subject|4|||
19762683|NCT03303079|42214920|FG002|Overall Study|Withdrawal by Subject|2|||
19762684|NCT03303079|42214918|FG000|Overall Study|Other than specified|0|||
19762685|NCT03303079|42214919|FG001|Overall Study|Other than specified|2|||
19762686|NCT03303079|42214920|FG002|Overall Study|Other than specified|0|||
19762687|NCT01067846|42214930|FG000|Overall Study|Lost to Follow-up|17|||
19762688|NCT01067846|42214931|FG001|Overall Study|Lost to Follow-up|19|||
19762689|NCT01067846|42214930|FG000|Overall Study|Withdrawal by Subject|1|||
19762690|NCT01067846|42214931|FG001|Overall Study|Withdrawal by Subject|0|||
19762691|NCT01067846|42214930|FG000|Overall Study|participation in other tx study|1|||
19762692|NCT01067846|42214931|FG001|Overall Study|participation in other tx study|0|||
19762693|NCT03311659|42214937|FG000|Overall Study|Protocol Violation|1|||
19762694|NCT03874234|42214954|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762695|NCT03874234|42214955|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762696|NCT03874234|42214956|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762697|NCT03874234|42214957|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
19762698|NCT03874234|42214958|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762699|NCT03874234|42214959|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762700|NCT03874234|42214960|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762701|NCT03874234|42214961|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762702|NCT03874234|42214962|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762703|NCT03874234|42214963|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762704|NCT03874234|42214964|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762705|NCT03874234|42214965|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762706|NCT03874234|42214966|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
19762707|NCT03874234|42214954|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
19762708|NCT03874234|42214955|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762709|NCT03874234|42214956|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762710|NCT03874234|42214957|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762711|NCT03874234|42214958|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762712|NCT03874234|42214959|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762713|NCT03874234|42214960|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762714|NCT03874234|42214961|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762715|NCT03874234|42214962|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762716|NCT03874234|42214963|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762717|NCT03874234|42214964|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762718|NCT03874234|42214965|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762719|NCT03874234|42214966|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
19762720|NCT03874234|42214954|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762721|NCT03874234|42214955|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762722|NCT03874234|42214956|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762723|NCT03874234|42214957|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
19762724|NCT03874234|42214958|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762725|NCT03874234|42214959|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762726|NCT03874234|42214960|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762727|NCT03874234|42214961|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762728|NCT03874234|42214962|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762729|NCT03874234|42214963|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762730|NCT03874234|42214964|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762731|NCT03874234|42214965|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19762732|NCT03874234|42214966|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
19680338|NCT00377637|42127718|FG001|Maintenance Phase|Death|0|||
19680339|NCT00377637|42127719|FG002|Maintenance Phase|Death|0|||
19680340|NCT00377637|42127720|FG003|Maintenance Phase|Death|1|||
19762733|NCT03874234|42214954|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762734|NCT03874234|42214955|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762735|NCT03874234|42214956|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762736|NCT03874234|42214957|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762737|NCT03874234|42214958|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
19762738|NCT03874234|42214959|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762739|NCT03874234|42214960|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762740|NCT03874234|42214961|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762741|NCT03874234|42214962|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762742|NCT03874234|42214963|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762743|NCT03874234|42214964|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762744|NCT03874234|42214965|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762745|NCT03874234|42214966|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
19762746|NCT03874234|42214954|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762747|NCT03874234|42214955|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762748|NCT03874234|42214956|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762749|NCT03874234|42214957|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762750|NCT03874234|42214958|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762751|NCT03874234|42214959|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762752|NCT03874234|42214960|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762753|NCT03874234|42214961|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
19762754|NCT03874234|42214962|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762755|NCT03874234|42214963|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762756|NCT03874234|42214964|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762757|NCT03874234|42214965|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762758|NCT03874234|42214966|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
19762759|NCT03874234|42214954|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762760|NCT03874234|42214955|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762761|NCT03874234|42214956|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762762|NCT03874234|42214957|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762763|NCT03874234|42214958|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
19680341|NCT00377403|42127736|FG000|Overall Study|Unable to contact for telephone intervie|4|||
19680342|NCT00377403|42127737|FG001|Overall Study|Unable to contact for telephone intervie|7|||
19680343|NCT00370149|42127745|FG000|Overall Study|Physician Decision|16|||
19680344|NCT00370149|42127746|FG001|Overall Study|Physician Decision|16|||
19680345|NCT00370149|42127745|FG000|Overall Study|Protocol Violation|1|||
19680346|NCT00370149|42127746|FG001|Overall Study|Protocol Violation|0|||
19680347|NCT00370149|42127745|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
19680348|NCT00370149|42127746|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
19680349|NCT00370149|42127745|FG000|Overall Study|Pre-existing infection|0|||
19680350|NCT00370149|42127746|FG001|Overall Study|Pre-existing infection|1|||
19680351|NCT00370149|42127745|FG000|Overall Study|Antibiotic coated dressing placed|0|||
19680352|NCT00370149|42127746|FG001|Overall Study|Antibiotic coated dressing placed|1|||
19680353|NCT00292942|42127759|FG000|Overall Study|Withdrawal by Subject|0|||
19680354|NCT00292942|42127760|FG001|Overall Study|Withdrawal by Subject|0|||
19680355|NCT00292942|42127761|FG002|Overall Study|Withdrawal by Subject|1|||
19680356|NCT00292942|42127762|FG003|Overall Study|Withdrawal by Subject|0|||
19680357|NCT00292942|42127759|FG000|Overall Study|Adverse Event|0|||
19680358|NCT00292942|42127760|FG001|Overall Study|Adverse Event|0|||
19680359|NCT00292942|42127761|FG002|Overall Study|Adverse Event|0|||
19680360|NCT00292942|42127762|FG003|Overall Study|Adverse Event|1|||
19680361|NCT00483938|42127782|FG000|Overall Study|Protocol Violation|0|||
19680362|NCT00483938|42127783|FG001|Overall Study|Protocol Violation|0|||
19762764|NCT03874234|42214959|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
19762765|NCT03874234|42214960|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762766|NCT03874234|42214961|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762767|NCT03874234|42214962|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762768|NCT03874234|42214963|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762769|NCT03874234|42214964|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762770|NCT03874234|42214965|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762771|NCT03874234|42214966|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
19762772|NCT03874234|42214954|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762773|NCT03874234|42214955|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762774|NCT03874234|42214956|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762775|NCT03874234|42214957|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762776|NCT03874234|42214958|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762777|NCT03874234|42214959|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762778|NCT03874234|42214960|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
19762779|NCT03874234|42214961|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762780|NCT03874234|42214962|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762781|NCT03874234|42214963|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762782|NCT03874234|42214964|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762783|NCT03874234|42214965|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762784|NCT03874234|42214966|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
19762785|NCT03874234|42214954|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19680363|NCT00483938|42127784|FG002|Overall Study|Protocol Violation|0|||
19680364|NCT00483938|42127785|FG003|Overall Study|Protocol Violation|0|||
19762786|NCT03874234|42214955|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762787|NCT03874234|42214956|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762788|NCT03874234|42214957|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762789|NCT03874234|42214958|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
19762790|NCT03874234|42214959|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762791|NCT03874234|42214960|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762792|NCT03874234|42214961|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19680365|NCT00483938|42127786|FG004|Overall Study|Protocol Violation|0|||
19680366|NCT00483938|42127787|FG005|Overall Study|Protocol Violation|0|||
19680367|NCT00483938|42127788|FG006|Overall Study|Protocol Violation|3|||
19680368|NCT00483938|42127782|FG000|Overall Study|Withdrawal by Subject|1|||
19762793|NCT03874234|42214962|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762794|NCT03874234|42214963|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762795|NCT03874234|42214964|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762796|NCT03874234|42214965|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762797|NCT03874234|42214966|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
19762798|NCT02985398|42215002|FG000|Overall Study|Adverse Event|1|||
19762799|NCT02985398|42215002|FG000|Overall Study|Lost to Follow-up|4|||
19604419|NCT00742924|42053291|FG002|Overall Study|Withdrawal by Subject|1|||
19604420|NCT00742924|42053292|FG003|Overall Study|Withdrawal by Subject|0|||
19604421|NCT00698815|42053305|FG000|Overall Study|Death|1|||
19604422|NCT00698815|42053306|FG001|Overall Study|Death|2|||
19604423|NCT00698815|42053307|FG002|Overall Study|Death|4|||
19604424|NCT00698815|42053305|FG000|Overall Study|Withdrawal by Subject|6|||
19604425|NCT00698815|42053306|FG001|Overall Study|Withdrawal by Subject|3|||
19604426|NCT00698815|42053307|FG002|Overall Study|Withdrawal by Subject|2|||
19604427|NCT00698815|42053305|FG000|Overall Study|MD discretion|2|||
19604428|NCT00698815|42053306|FG001|Overall Study|MD discretion|7|||
19604429|NCT00698815|42053307|FG002|Overall Study|MD discretion|2|||
19604430|NCT00698815|42053305|FG000|Overall Study|Did not receive protocol treatment|1|||
19604431|NCT00698815|42053306|FG001|Overall Study|Did not receive protocol treatment|2|||
19604432|NCT00698815|42053307|FG002|Overall Study|Did not receive protocol treatment|2|||
19604433|NCT00745498|42053318|FG000|Overall Study|Lost to Follow-up|1|||
19680369|NCT00483938|42127783|FG001|Overall Study|Withdrawal by Subject|6|||
19680370|NCT00483938|42127784|FG002|Overall Study|Withdrawal by Subject|0|||
19680371|NCT00483938|42127785|FG003|Overall Study|Withdrawal by Subject|0|||
19680372|NCT00483938|42127786|FG004|Overall Study|Withdrawal by Subject|1|||
19680373|NCT00483938|42127787|FG005|Overall Study|Withdrawal by Subject|3|||
19680374|NCT00483938|42127788|FG006|Overall Study|Withdrawal by Subject|2|||
19680375|NCT00483938|42127782|FG000|Overall Study|Lost to Follow-up|1|||
19680376|NCT00483938|42127783|FG001|Overall Study|Lost to Follow-up|2|||
19680377|NCT00483938|42127784|FG002|Overall Study|Lost to Follow-up|0|||
19680378|NCT00483938|42127785|FG003|Overall Study|Lost to Follow-up|2|||
19680379|NCT00483938|42127786|FG004|Overall Study|Lost to Follow-up|1|||
19604434|NCT00745498|42053319|FG001|Overall Study|Lost to Follow-up|1|||
19680380|NCT00483938|42127787|FG005|Overall Study|Lost to Follow-up|1|||
19680381|NCT00483938|42127788|FG006|Overall Study|Lost to Follow-up|3|||
19680382|NCT00483938|42127782|FG000|Overall Study|Death|0|||
19762800|NCT02985398|42215002|FG000|Overall Study|Withdrawal by Subject|8|||
19762801|NCT02985398|42215002|FG000|Overall Study|Study Burden|9|||
19762802|NCT03310723|42215008|FG000|Overall Study|Withdrawal by Subject|0|||
19762803|NCT03310723|42215009|FG001|Overall Study|Withdrawal by Subject|1|||
19762804|NCT03310723|42215008|FG000|Overall Study|Protocol Violation|0|||
19762805|NCT03310723|42215009|FG001|Overall Study|Protocol Violation|2|||
19762806|NCT02663674|42215017|FG000|Overall Study|Lost to Follow-up|5|||
19762807|NCT02663674|42215018|FG001|Overall Study|Lost to Follow-up|4|||
19762808|NCT02663674|42215017|FG000|Overall Study|Withdrawal by Subject|1|||
19762809|NCT02663674|42215018|FG001|Overall Study|Withdrawal by Subject|4|||
19680383|NCT00483938|42127783|FG001|Overall Study|Death|2|||
19680384|NCT00483938|42127784|FG002|Overall Study|Death|0|||
19680385|NCT00483938|42127785|FG003|Overall Study|Death|0|||
19680386|NCT00483938|42127786|FG004|Overall Study|Death|0|||
19680387|NCT00483938|42127787|FG005|Overall Study|Death|0|||
19680388|NCT00483938|42127788|FG006|Overall Study|Death|0|||
19680389|NCT00483938|42127782|FG000|Overall Study|Other|3|||
19680390|NCT00483938|42127783|FG001|Overall Study|Other|9|||
19680391|NCT00483938|42127784|FG002|Overall Study|Other|0|||
19680392|NCT00483938|42127785|FG003|Overall Study|Other|4|||
19680393|NCT00483938|42127786|FG004|Overall Study|Other|0|||
19762810|NCT02663674|42215017|FG000|Overall Study|Physician Decision|1|||
19762811|NCT02663674|42215018|FG001|Overall Study|Physician Decision|1|||
19762812|NCT02663674|42215017|FG000|Overall Study|Other Event (Health Related)|0|||
19762813|NCT02663674|42215018|FG001|Overall Study|Other Event (Health Related)|1|||
19762814|NCT01005745|42215024|FG000|Overall Study|No TIL growth|1|||
19762815|NCT01005745|42215024|FG000|Overall Study|Disease progressed during TIL growth|3|||
19762816|NCT01005745|42215024|FG000|Overall Study|Death prior to treatment|1|||
19762817|NCT01005745|42215024|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
19762818|NCT02908880|42215028|FG000|Overall Study|Lost to Follow-up|4|||
19762819|NCT02908880|42215028|FG000|Overall Study|Explantation of the device|1|||
19762820|NCT02908880|42215028|FG000|Overall Study|Withdrawal by Subject|17|||
19762821|NCT02908880|42215028|FG000|Overall Study|Death|5|||
19762822|NCT03310411|42215032|FG000|Period 1|Adverse Event|0|||
19762823|NCT03310411|42215033|FG001|Period 1|Adverse Event|0|||
19762824|NCT03310411|42215034|FG002|Period 1|Adverse Event|0|||
19762825|NCT03310411|42215035|FG003|Period 1|Adverse Event|1|||
19762826|NCT03301831|42215053|FG000|Overall Study|Lost to Follow-up|5|||
19762827|NCT03301831|42215054|FG001|Overall Study|Lost to Follow-up|3|||
19762828|NCT03301831|42215053|FG000|Overall Study|Protocol Violation|4|||
19762829|NCT03301831|42215054|FG001|Overall Study|Protocol Violation|0|||
19762830|NCT03301831|42215053|FG000|Overall Study|Withdrawal by Subject|11|||
19762831|NCT03301831|42215054|FG001|Overall Study|Withdrawal by Subject|0|||
19762832|NCT02909504|42215060|FG000|Overall Study|Adverse Event|2|||
19762833|NCT02909504|42215060|FG000|Overall Study|Lack of Efficacy|3|||
19762834|NCT02909504|42215060|FG000|Overall Study|Withdrawal by Subject|4|||
19762835|NCT02909504|42215060|FG000|Overall Study|Pregnancy|1|||
19762836|NCT02909504|42215060|FG000|Overall Study|Subject moved|1|||
19762837|NCT02909504|42215060|FG000|Overall Study|Lost to Follow-up|1|||
19762838|NCT02199691|42215069|FG000|Overall Study|Protocol Violation|3|||
19762839|NCT02199691|42215070|FG001|Overall Study|Protocol Violation|3|||
19762840|NCT02199691|42215071|FG002|Overall Study|Protocol Violation|6|||
19762841|NCT02199691|42215072|FG003|Overall Study|Protocol Violation|7|||
19762842|NCT02199691|42215069|FG000|Overall Study|Withdrawal by Subject|5|||
19762843|NCT02199691|42215070|FG001|Overall Study|Withdrawal by Subject|3|||
19762844|NCT02199691|42215071|FG002|Overall Study|Withdrawal by Subject|12|||
19762845|NCT02199691|42215072|FG003|Overall Study|Withdrawal by Subject|13|||
19762846|NCT02199691|42215069|FG000|Overall Study|Lost to Follow-up|2|||
19762847|NCT02199691|42215070|FG001|Overall Study|Lost to Follow-up|1|||
19762848|NCT02199691|42215071|FG002|Overall Study|Lost to Follow-up|9|||
19680394|NCT00483938|42127787|FG005|Overall Study|Other|4|||
19680395|NCT00483938|42127788|FG006|Overall Study|Other|32|||
19762849|NCT02199691|42215072|FG003|Overall Study|Lost to Follow-up|10|||
19762850|NCT03299881|42215086|FG000|Overall Study|Study Termination|17|||
19762851|NCT03299881|42215087|FG001|Overall Study|Study Termination|13|||
19762852|NCT03299101|42215093|FG000|Overall Study|Lost to Follow-up|1|||
19762853|NCT03299101|42215093|FG000|Overall Study|Withdrawal by Subject|5|||
19762854|NCT03299101|42215093|FG000|Overall Study|Surgery was changed|3|||
19762855|NCT03299101|42215093|FG000|Overall Study|Not enough time to complete prehab|1|||
19762856|NCT02663128|42215099|FG000|Period 2|Physician Decision|0|||
19680396|NCT00370071|42127807|FG000|Overall Study|Withdrawal by Subject|2|||
19680397|NCT00369915|42127813|FG000|Overall Study|expected side effects|2|||
19680398|NCT00369915|42127814|FG001|Overall Study|expected side effects|1|||
19680399|NCT00369915|42127813|FG000|Overall Study|Withdrawal by Subject|4|||
19762857|NCT02663128|42215100|FG001|Period 2|Physician Decision|0|||
19762858|NCT02663128|42215101|FG002|Period 2|Physician Decision|0|||
19762859|NCT02663128|42215102|FG003|Period 2|Physician Decision|0|||
19762860|NCT02663128|42215103|FG004|Period 2|Physician Decision|1|||
19762861|NCT02663128|42215104|FG005|Period 2|Physician Decision|0|||
19762862|NCT03298867|42215115|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
19762863|NCT03298867|42215116|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
19762864|NCT03298867|42215115|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
19762865|NCT03298867|42215116|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
19762866|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
19762867|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
19762868|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
19762869|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
19762870|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
19762871|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
19762872|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
19762873|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
19762874|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
19762875|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
19762876|NCT03298867|42215115|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
19762877|NCT03298867|42215116|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
19762878|NCT03298867|42215115|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
19762879|NCT03298867|42215116|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
19762880|NCT02906930|42215126|FG000|Overall Study|Withdrawal by Subject|0|||
19762881|NCT02906930|42215127|FG001|Overall Study|Withdrawal by Subject|5|||
19762882|NCT02906930|42215128|FG002|Overall Study|Withdrawal by Subject|5|||
19762883|NCT02906930|42215129|FG003|Overall Study|Withdrawal by Subject|4|||
19762884|NCT02906930|42215126|FG000|Overall Study|Lost to Follow-up|5|||
19762885|NCT02906930|42215127|FG001|Overall Study|Lost to Follow-up|7|||
19762886|NCT02906930|42215128|FG002|Overall Study|Lost to Follow-up|5|||
19762887|NCT02906930|42215129|FG003|Overall Study|Lost to Follow-up|2|||
19762888|NCT02906930|42215126|FG000|Overall Study|Death|0|||
19762889|NCT02906930|42215127|FG001|Overall Study|Death|0|||
19762890|NCT02906930|42215128|FG002|Overall Study|Death|1|||
19762891|NCT02906930|42215129|FG003|Overall Study|Death|0|||
19762892|NCT02906930|42215126|FG000|Overall Study|Other|1|||
19762893|NCT02906930|42215127|FG001|Overall Study|Other|2|||
19762894|NCT02906930|42215128|FG002|Overall Study|Other|1|||
19762895|NCT02906930|42215129|FG003|Overall Study|Other|2|||
19762896|NCT02983604|42215143|FG000|Overall Study|Enrolled but not Treated|0|||
19762897|NCT02983604|42215144|FG001|Overall Study|Enrolled but not Treated|0|||
19762898|NCT02983604|42215145|FG002|Overall Study|Enrolled but not Treated|1|||
19680400|NCT00369915|42127814|FG001|Overall Study|Withdrawal by Subject|1|||
19680401|NCT00369915|42127813|FG000|Overall Study|W/drawl by investigators|0|||
19680402|NCT00369915|42127814|FG001|Overall Study|W/drawl by investigators|1|||
19680403|NCT00369681|42127820|FG000|Overall Study|Death|1|||
19680404|NCT00266812|42127826|FG000|Overall Study|Disease Progression|9|||
19680405|NCT00266812|42127827|FG001|Overall Study|Disease Progression|3|||
19680406|NCT00266812|42127826|FG000|Overall Study|Death|5|||
19680407|NCT00266812|42127827|FG001|Overall Study|Death|4|||
19680408|NCT00266812|42127826|FG000|Overall Study|Adverse Event|3|||
19680409|NCT00266812|42127827|FG001|Overall Study|Adverse Event|1|||
19680410|NCT00266812|42127826|FG000|Overall Study|Protocol Violation|0|||
19680411|NCT00266812|42127827|FG001|Overall Study|Protocol Violation|1|||
19680412|NCT00266812|42127826|FG000|Overall Study|Withdrawal by Subject|0|||
19680413|NCT00266812|42127827|FG001|Overall Study|Withdrawal by Subject|2|||
19680414|NCT00266812|42127826|FG000|Overall Study|Discontinued before starting study drug|4|||
19680415|NCT00266812|42127827|FG001|Overall Study|Discontinued before starting study drug|0|||
19680416|NCT00488774|42127837|FG000|Overall Study|Withdrawal of consent|2|||
19680417|NCT00488774|42127838|FG001|Overall Study|Withdrawal of consent|2|||
19680418|NCT00488774|42127839|FG002|Overall Study|Withdrawal of consent|2|||
19680419|NCT00488774|42127840|FG003|Overall Study|Withdrawal of consent|0|||
19680420|NCT00488774|42127837|FG000|Overall Study|Other|6|||
19680421|NCT00488774|42127838|FG001|Overall Study|Other|3|||
19680422|NCT00488774|42127839|FG002|Overall Study|Other|2|||
19680423|NCT00488774|42127840|FG003|Overall Study|Other|2|||
19680424|NCT00488774|42127837|FG000|Overall Study|Lost to Follow-up|0|||
19762899|NCT02983604|42215146|FG003|Overall Study|Enrolled but not Treated|0|||
19762900|NCT02662582|42215158|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
19762901|NCT02662582|42215159|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
19762902|NCT02662582|42215158|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
19762903|NCT02662582|42215159|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
19680425|NCT00488774|42127838|FG001|Overall Study|Lost to Follow-up|0|||
19680426|NCT00488774|42127839|FG002|Overall Study|Lost to Follow-up|1|||
19680427|NCT00488774|42127840|FG003|Overall Study|Lost to Follow-up|1|||
19680428|NCT00361569|42127855|FG000|Overall Study|Protocol Violation|3|||
19680429|NCT00361569|42127856|FG001|Overall Study|Protocol Violation|2|||
19680430|NCT00361569|42127857|FG002|Overall Study|Protocol Violation|4|||
19762904|NCT02662582|42215158|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
19762905|NCT02662582|42215159|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
19762906|NCT02662582|42215158|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19762907|NCT02662582|42215159|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19762908|NCT02908100|42215169|FG000|Overall Study|Adverse Event|7|||
19762909|NCT02908100|42215170|FG001|Overall Study|Adverse Event|6|||
19762910|NCT02908100|42215171|FG002|Overall Study|Adverse Event|9|||
19762911|NCT02908100|42215169|FG000|Overall Study|Death|2|||
19762912|NCT02908100|42215170|FG001|Overall Study|Death|0|||
19762913|NCT02908100|42215171|FG002|Overall Study|Death|0|||
19762914|NCT02908100|42215169|FG000|Overall Study|Lack of Efficacy|2|||
19762915|NCT02908100|42215170|FG001|Overall Study|Lack of Efficacy|3|||
19762916|NCT02908100|42215171|FG002|Overall Study|Lack of Efficacy|3|||
19762917|NCT02908100|42215169|FG000|Overall Study|Lost to Follow-up|0|||
19762918|NCT02908100|42215170|FG001|Overall Study|Lost to Follow-up|1|||
19762919|NCT02908100|42215171|FG002|Overall Study|Lost to Follow-up|2|||
19762920|NCT02908100|42215169|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19680431|NCT00361569|42127858|FG003|Overall Study|Protocol Violation|2|||
19680432|NCT00361569|42127855|FG000|Overall Study|Withdrawal by Subject|2|||
19680433|NCT00361569|42127856|FG001|Overall Study|Withdrawal by Subject|1|||
19680434|NCT00361569|42127857|FG002|Overall Study|Withdrawal by Subject|9|||
19680435|NCT00361569|42127858|FG003|Overall Study|Withdrawal by Subject|14|||
19680436|NCT00361569|42127855|FG000|Overall Study|Adverse Event|3|||
19680437|NCT00361569|42127856|FG001|Overall Study|Adverse Event|5|||
19680438|NCT00361569|42127857|FG002|Overall Study|Adverse Event|2|||
19680439|NCT00361569|42127858|FG003|Overall Study|Adverse Event|2|||
19680440|NCT00361569|42127855|FG000|Overall Study|Lost to Follow-up|2|||
19680441|NCT00361569|42127856|FG001|Overall Study|Lost to Follow-up|3|||
19680442|NCT00361569|42127857|FG002|Overall Study|Lost to Follow-up|3|||
19680443|NCT00361569|42127858|FG003|Overall Study|Lost to Follow-up|2|||
19680444|NCT00361569|42127855|FG000|Overall Study|Not specified by investigator|2|||
19680445|NCT00361569|42127856|FG001|Overall Study|Not specified by investigator|0|||
19680446|NCT00361569|42127857|FG002|Overall Study|Not specified by investigator|0|||
19680447|NCT00361569|42127858|FG003|Overall Study|Not specified by investigator|1|||
19680448|NCT00488618|42127870|FG000|Overall Study|Adverse Event|13|||
19680449|NCT00488618|42127871|FG001|Overall Study|Adverse Event|17|||
19680450|NCT00488618|42127870|FG000|Overall Study|Insufficient Therapeutic Response|18|||
19680451|NCT00488618|42127871|FG001|Overall Study|Insufficient Therapeutic Response|11|||
19680452|NCT00488618|42127870|FG000|Overall Study|Protocol Violation|0|||
19680453|NCT00488618|42127871|FG001|Overall Study|Protocol Violation|2|||
19680454|NCT00488618|42127870|FG000|Overall Study|Withdrawal of Consent|15|||
19680455|NCT00488618|42127871|FG001|Overall Study|Withdrawal of Consent|13|||
19680456|NCT00488618|42127870|FG000|Overall Study|Lost to Follow-up|1|||
19680457|NCT00488618|42127871|FG001|Overall Study|Lost to Follow-up|0|||
19680458|NCT00266656|42127879|FG000|Overall Study|Death|1|||
19680459|NCT00266656|42127880|FG001|Overall Study|Death|0|||
19680460|NCT00266656|42127879|FG000|Overall Study|Lost to Follow-up|4|||
19680461|NCT00266656|42127880|FG001|Overall Study|Lost to Follow-up|1|||
19762921|NCT02908100|42215170|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19762922|NCT02908100|42215171|FG002|Overall Study|Non-Compliance With Study Drug|2|||
19762923|NCT02908100|42215169|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
19762924|NCT02908100|42215170|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
19762925|NCT02908100|42215171|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
19762926|NCT02908100|42215169|FG000|Overall Study|Physician Decision|0|||
19762927|NCT02908100|42215170|FG001|Overall Study|Physician Decision|1|||
19762928|NCT02908100|42215171|FG002|Overall Study|Physician Decision|0|||
19762929|NCT02908100|42215169|FG000|Overall Study|Pregnancy|1|||
19762930|NCT02908100|42215170|FG001|Overall Study|Pregnancy|2|||
19762931|NCT02908100|42215171|FG002|Overall Study|Pregnancy|0|||
19604435|NCT00745498|42053320|FG002|Overall Study|Lost to Follow-up|3|||
19604436|NCT00745498|42053318|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
19604437|NCT00745498|42053319|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
19604438|NCT00745498|42053320|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
19604439|NCT00745498|42053318|FG000|Overall Study|Non-PDR related VH|0|||
19604440|NCT00745498|42053319|FG001|Overall Study|Non-PDR related VH|1|||
19604441|NCT00745498|42053320|FG002|Overall Study|Non-PDR related VH|1|||
19604442|NCT00745498|42053318|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
19604443|NCT00745498|42053319|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
19604444|NCT00745498|42053320|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
19604445|NCT00744874|42053328|FG000|Overall Study|Lost to Follow-up|1|||
19604446|NCT00744874|42053328|FG000|Overall Study|Withdrawal by Subject|1|||
19604447|NCT00744874|42053328|FG000|Overall Study|Study Device not available at procedure|1|||
19680462|NCT00266656|42127879|FG000|Overall Study|Withdrawal by Subject|4|||
19680463|NCT00266656|42127880|FG001|Overall Study|Withdrawal by Subject|2|||
19680464|NCT00266656|42127879|FG000|Overall Study|Did Not Reach Final Height|4|||
19680465|NCT00266656|42127880|FG001|Overall Study|Did Not Reach Final Height|8|||
19762932|NCT02908100|42215169|FG000|Overall Study|Withdrawal by Subject|8|||
19762933|NCT02908100|42215170|FG001|Overall Study|Withdrawal by Subject|7|||
19762934|NCT02908100|42215171|FG002|Overall Study|Withdrawal by Subject|5|||
19762935|NCT02908100|42215169|FG000|Overall Study|Randomised in Error|1|||
19762936|NCT02908100|42215170|FG001|Overall Study|Randomised in Error|0|||
19762937|NCT02908100|42215171|FG002|Overall Study|Randomised in Error|0|||
19762938|NCT02982590|42215195|FG000|Overall Study|Lost to Follow-up|0|||
19762939|NCT02982590|42215196|FG001|Overall Study|Lost to Follow-up|1|||
19762940|NCT02982590|42215195|FG000|Overall Study|Death|4|||
19762941|NCT02982590|42215196|FG001|Overall Study|Death|0|||
19762942|NCT03310021|42215222|FG000|Overall Study|Withdrawal by Subject|0|||
19762943|NCT03310021|42215223|FG001|Overall Study|Withdrawal by Subject|0|||
19762944|NCT03310021|42215224|FG002|Overall Study|Withdrawal by Subject|0|||
19762945|NCT03310021|42215225|FG003|Overall Study|Withdrawal by Subject|0|||
19762946|NCT03310021|42215226|FG004|Overall Study|Withdrawal by Subject|0|||
19762947|NCT03310021|42215227|FG005|Overall Study|Withdrawal by Subject|0|||
19762948|NCT03310021|42215228|FG006|Overall Study|Withdrawal by Subject|1|||
19762949|NCT03310021|42215229|FG007|Overall Study|Withdrawal by Subject|0|||
19762950|NCT03310021|42215230|FG008|Overall Study|Withdrawal by Subject|0|||
19762951|NCT03310021|42215231|FG009|Overall Study|Withdrawal by Subject|0|||
19762952|NCT03310021|42215232|FG010|Overall Study|Withdrawal by Subject|0|||
19762953|NCT03310021|42215233|FG011|Overall Study|Withdrawal by Subject|0|||
19762954|NCT03310021|42215234|FG012|Overall Study|Withdrawal by Subject|0|||
19762955|NCT03310021|42215235|FG013|Overall Study|Withdrawal by Subject|0|||
19762956|NCT03310021|42215236|FG014|Overall Study|Withdrawal by Subject|0|||
19762957|NCT03310021|42215237|FG015|Overall Study|Withdrawal by Subject|0|||
19762958|NCT03310021|42215238|FG016|Overall Study|Withdrawal by Subject|0|||
19762959|NCT03310021|42215239|FG017|Overall Study|Withdrawal by Subject|0|||
19762960|NCT03310021|42215240|FG018|Overall Study|Withdrawal by Subject|0|||
19762961|NCT03310021|42215241|FG019|Overall Study|Withdrawal by Subject|0|||
19762962|NCT03310021|42215222|FG000|Overall Study|Lost to Follow-up|0|||
19762963|NCT03310021|42215223|FG001|Overall Study|Lost to Follow-up|0|||
19762964|NCT03310021|42215224|FG002|Overall Study|Lost to Follow-up|0|||
19762965|NCT03310021|42215225|FG003|Overall Study|Lost to Follow-up|0|||
19762966|NCT03310021|42215226|FG004|Overall Study|Lost to Follow-up|0|||
19762967|NCT03310021|42215227|FG005|Overall Study|Lost to Follow-up|0|||
19762968|NCT03310021|42215228|FG006|Overall Study|Lost to Follow-up|0|||
19762969|NCT03310021|42215229|FG007|Overall Study|Lost to Follow-up|0|||
19762970|NCT03310021|42215230|FG008|Overall Study|Lost to Follow-up|0|||
19762971|NCT03310021|42215231|FG009|Overall Study|Lost to Follow-up|0|||
19762972|NCT03310021|42215232|FG010|Overall Study|Lost to Follow-up|1|||
19762973|NCT03310021|42215233|FG011|Overall Study|Lost to Follow-up|0|||
19680466|NCT00266656|42127879|FG000|Overall Study|Parent/Caregiver Decision|1|||
19680467|NCT00266656|42127880|FG001|Overall Study|Parent/Caregiver Decision|2|||
19762974|NCT03310021|42215234|FG012|Overall Study|Lost to Follow-up|0|||
19762975|NCT03310021|42215235|FG013|Overall Study|Lost to Follow-up|0|||
19762976|NCT03310021|42215236|FG014|Overall Study|Lost to Follow-up|0|||
19762977|NCT03310021|42215237|FG015|Overall Study|Lost to Follow-up|0|||
19762978|NCT03310021|42215238|FG016|Overall Study|Lost to Follow-up|0|||
19762979|NCT03310021|42215239|FG017|Overall Study|Lost to Follow-up|0|||
19762980|NCT03310021|42215240|FG018|Overall Study|Lost to Follow-up|0|||
19762981|NCT03310021|42215241|FG019|Overall Study|Lost to Follow-up|0|||
19762982|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
19762983|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
19762984|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
19762985|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19762986|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19680468|NCT00483704|42127889|FG000|Randomization|Withdrawal by Subject|19|||
19680469|NCT00483704|42127890|FG001|Randomization|Withdrawal by Subject|28|||
19680470|NCT00483704|42127891|FG002|Randomization|Withdrawal by Subject|18|||
19680471|NCT00483704|42127889|FG000|Randomization|Protocol Violation|14|||
19680472|NCT00483704|42127890|FG001|Randomization|Protocol Violation|25|||
19680473|NCT00483704|42127891|FG002|Randomization|Protocol Violation|22|||
19680474|NCT00483704|42127889|FG000|Randomization|Lost to Follow-up|14|||
19762987|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
19762988|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
19762989|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
19762990|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
19762991|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
19762992|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
19762993|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
19762994|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
19762995|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
19762996|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
19680475|NCT00483704|42127890|FG001|Randomization|Lost to Follow-up|14|||
19680476|NCT00483704|42127891|FG002|Randomization|Lost to Follow-up|19|||
19680477|NCT00483704|42127889|FG000|Randomization|Pregnancy|1|||
19680478|NCT00483704|42127890|FG001|Randomization|Pregnancy|0|||
19762997|NCT03333109|42215286|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
19762998|NCT03333109|42215287|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
19762999|NCT03333109|42215288|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
19763000|NCT03333109|42215286|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
19763001|NCT03333109|42215287|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
19763002|NCT03333109|42215288|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
19763003|NCT03333109|42215286|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
19763004|NCT03333109|42215287|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
19763005|NCT03333109|42215288|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
19763006|NCT02940223|42215298|FG000|Overall Study|Failed Requirement|2|||
19680479|NCT00483704|42127891|FG002|Randomization|Pregnancy|0|||
19680480|NCT00483704|42127889|FG000|Randomization|Physician Decision|2|||
19680481|NCT00483704|42127890|FG001|Randomization|Physician Decision|4|||
19680482|NCT00483704|42127891|FG002|Randomization|Physician Decision|0|||
19680483|NCT00483704|42127889|FG000|Randomization|Progressive disease|0|||
19680484|NCT00483704|42127890|FG001|Randomization|Progressive disease|0|||
19680485|NCT00483704|42127891|FG002|Randomization|Progressive disease|1|||
19680486|NCT00483704|42127889|FG000|Randomization|Lack of qualifying migraines|21|||
19680487|NCT00483704|42127890|FG001|Randomization|Lack of qualifying migraines|25|||
19680488|NCT00483704|42127891|FG002|Randomization|Lack of qualifying migraines|31|||
19680489|NCT00483704|42127889|FG000|Treatment|Lack of qualifying migraines|101|||
19680490|NCT00483704|42127890|FG001|Treatment|Lack of qualifying migraines|99|||
19680491|NCT00483704|42127891|FG002|Treatment|Lack of qualifying migraines|116|||
19680492|NCT00483704|42127889|FG000|Treatment|Adverse Event|3|||
19680493|NCT00483704|42127890|FG001|Treatment|Adverse Event|5|||
19680494|NCT00483704|42127891|FG002|Treatment|Adverse Event|4|||
19680495|NCT00483704|42127889|FG000|Treatment|Withdrawal by Subject|16|||
19680496|NCT00483704|42127890|FG001|Treatment|Withdrawal by Subject|12|||
19680497|NCT00483704|42127891|FG002|Treatment|Withdrawal by Subject|21|||
19680498|NCT00483704|42127889|FG000|Treatment|Protocol Violation|6|||
19680499|NCT00483704|42127890|FG001|Treatment|Protocol Violation|3|||
19680500|NCT00483704|42127891|FG002|Treatment|Protocol Violation|5|||
19680501|NCT00483704|42127889|FG000|Treatment|Lost to Follow-up|2|||
19680502|NCT00483704|42127890|FG001|Treatment|Lost to Follow-up|7|||
19680503|NCT00483704|42127891|FG002|Treatment|Lost to Follow-up|5|||
19680504|NCT00483704|42127889|FG000|Treatment|Lack of Efficacy|1|||
19680505|NCT00483704|42127890|FG001|Treatment|Lack of Efficacy|1|||
19680506|NCT00483704|42127891|FG002|Treatment|Lack of Efficacy|1|||
19680507|NCT00483704|42127889|FG000|Treatment|Pregnancy|0|||
19680508|NCT00483704|42127890|FG001|Treatment|Pregnancy|1|||
19680509|NCT00483704|42127891|FG002|Treatment|Pregnancy|0|||
19680510|NCT00483704|42127889|FG000|Treatment|Physician Decision|0|||
19680511|NCT00483704|42127890|FG001|Treatment|Physician Decision|1|||
19680512|NCT00483704|42127891|FG002|Treatment|Physician Decision|4|||
19680513|NCT00483548|42127904|FG000|Overall Study|Randomized; not treated with study drug|1|||
19680514|NCT00483548|42127905|FG001|Overall Study|Randomized; not treated with study drug|3|||
19680515|NCT00483548|42127904|FG000|Overall Study|Adverse Event|25|||
19680516|NCT00483548|42127905|FG001|Overall Study|Adverse Event|14|||
19680517|NCT00483548|42127904|FG000|Overall Study|Laboratory abnormality|1|||
19763007|NCT02940223|42215299|FG001|Overall Study|Failed Requirement|0|||
19763008|NCT03296527|42215307|FG000|Overall Study|Adverse Event|15|||
19763009|NCT03296527|42215308|FG001|Overall Study|Adverse Event|33|||
19763010|NCT03296527|42215307|FG000|Overall Study|Protocol Deviation|4|||
19763011|NCT03296527|42215308|FG001|Overall Study|Protocol Deviation|0|||
19763012|NCT03296527|42215307|FG000|Overall Study|Subject withdrew consent|3|||
19763013|NCT03296527|42215308|FG001|Overall Study|Subject withdrew consent|1|||
19763014|NCT03296527|42215307|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
19763015|NCT03296527|42215308|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
19763016|NCT03296527|42215307|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
19763017|NCT03296527|42215308|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
19763018|NCT03296527|42215307|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
19763019|NCT03296527|42215308|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
19763020|NCT03296527|42215307|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
19680518|NCT00483548|42127905|FG001|Overall Study|Laboratory abnormality|2|||
19680519|NCT00483548|42127904|FG000|Overall Study|Lack of Efficacy|4|||
19680520|NCT00483548|42127905|FG001|Overall Study|Lack of Efficacy|8|||
19680521|NCT00483548|42127904|FG000|Overall Study|Protocol Violation|11|||
19680522|NCT00483548|42127905|FG001|Overall Study|Protocol Violation|7|||
19680523|NCT00483548|42127904|FG000|Overall Study|Pregnancy|1|||
19763021|NCT03296527|42215308|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
19680524|NCT00483548|42127905|FG001|Overall Study|Pregnancy|0|||
19680525|NCT00483548|42127904|FG000|Overall Study|Protocol required discontinuation|6|||
19763022|NCT03296527|42215307|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
19763023|NCT03296527|42215308|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
19763024|NCT03295201|42215317|FG000|Overall Study|Lost to Follow-up|1|||
19763025|NCT03295201|42215318|FG001|Overall Study|Lost to Follow-up|1|||
19763026|NCT03295201|42215317|FG000|Overall Study|Hospital admission|0|||
19763027|NCT03295201|42215318|FG001|Overall Study|Hospital admission|1|||
19763028|NCT03293485|42215324|FG000|Overall Study|Death|1|||
19763029|NCT03293485|42215324|FG000|Overall Study|Screen Failure|2|||
19763030|NCT03293485|42215324|FG000|Overall Study|Withdrawal by Subject|2|||
19763031|NCT03309943|42215332|FG000|Overall Study|Withdrawal by Subject|0|||
19763032|NCT03309943|42215333|FG001|Overall Study|Withdrawal by Subject|1|||
19763033|NCT03309943|42215332|FG000|Overall Study|Inappropriate behavior towards staff|0|||
19763034|NCT03309943|42215333|FG001|Overall Study|Inappropriate behavior towards staff|1|||
19763035|NCT01732627|42215341|FG000|Overall Study|Withdrawal by Subject|1|||
19763036|NCT01732627|42215342|FG001|Overall Study|Withdrawal by Subject|0|||
19763037|NCT03307837|42215354|FG000|Overall Study|Withdrawal by Subject|0|||
19763038|NCT03307837|42215355|FG001|Overall Study|Withdrawal by Subject|0|||
19763039|NCT03307837|42215356|FG002|Overall Study|Withdrawal by Subject|1|||
19763040|NCT03307837|42215357|FG003|Overall Study|Withdrawal by Subject|0|||
19763041|NCT03307837|42215358|FG004|Overall Study|Withdrawal by Subject|0|||
19763042|NCT03307837|42215359|FG005|Overall Study|Withdrawal by Subject|1|||
19763043|NCT03307837|42215354|FG000|Overall Study|Lost to Follow-up|1|||
19763044|NCT03307837|42215355|FG001|Overall Study|Lost to Follow-up|1|||
19763045|NCT03307837|42215356|FG002|Overall Study|Lost to Follow-up|0|||
19763046|NCT03307837|42215357|FG003|Overall Study|Lost to Follow-up|0|||
19763047|NCT03307837|42215358|FG004|Overall Study|Lost to Follow-up|0|||
19763048|NCT03307837|42215359|FG005|Overall Study|Lost to Follow-up|1|||
19763049|NCT03331315|42215380|FG000|Overall Study|Physician Decision|18|||
19763050|NCT03331315|42215381|FG001|Overall Study|Physician Decision|14|||
19763051|NCT03329989|42215389|FG000|Overall Study|Withdrawal by Subject|9|||
19763052|NCT03329989|42215389|FG000|Overall Study|Lost to Follow-up|8|||
19763053|NCT03329989|42215389|FG000|Overall Study|Adverse Event|5|||
19763054|NCT03329989|42215389|FG000|Overall Study|Protocol Violation|1|||
19763055|NCT03287869|42215395|FG000|Overall Study|Adverse Event|14|||
19763056|NCT03287869|42215396|FG001|Overall Study|Adverse Event|12|||
19763057|NCT03287869|42215395|FG000|Overall Study|Lack of Efficacy|1|||
19763058|NCT03287869|42215396|FG001|Overall Study|Lack of Efficacy|0|||
19763059|NCT03287869|42215395|FG000|Overall Study|Lost to Follow-up|13|||
19763060|NCT03287869|42215396|FG001|Overall Study|Lost to Follow-up|19|||
19763061|NCT03287869|42215395|FG000|Overall Study|Non-Compliance With Study Drug|5|||
19763062|NCT03287869|42215396|FG001|Overall Study|Non-Compliance With Study Drug|9|||
19763063|NCT03287869|42215395|FG000|Overall Study|Progressive Disease|1|||
19763064|NCT03287869|42215396|FG001|Overall Study|Progressive Disease|0|||
19763065|NCT03287869|42215395|FG000|Overall Study|Protocol Deviation|2|||
19763066|NCT03287869|42215396|FG001|Overall Study|Protocol Deviation|1|||
19763067|NCT03287869|42215395|FG000|Overall Study|Withdrawal by Subject|36|||
19763068|NCT03287869|42215396|FG001|Overall Study|Withdrawal by Subject|43|||
19763069|NCT03287869|42215395|FG000|Overall Study|Early Closure of the Site|0|||
19763070|NCT03287869|42215396|FG001|Overall Study|Early Closure of the Site|1|||
19763071|NCT03287869|42215395|FG000|Overall Study|Physician Decision|5|||
19763072|NCT03287869|42215396|FG001|Overall Study|Physician Decision|5|||
19763073|NCT03287869|42215395|FG000|Overall Study|Reason not Specified|6|||
19763074|NCT03287869|42215396|FG001|Overall Study|Reason not Specified|3|||
19763075|NCT02661490|42215407|FG000|Overall Study|Lost to Follow-up|0|||
19604448|NCT00744874|42053328|FG000|Overall Study|Unable to accomodate schedule|1|||
19604449|NCT00576901|42053339|FG000|Overall Study|Withdrawal by Subject|1|||
19604450|NCT00576901|42053339|FG000|Overall Study|Disease course|1|||
19604451|NCT00576901|42053339|FG000|Overall Study|Protocol Violation|1|||
19604452|NCT00699283|42053345|FG000|Overall Study|Lack of Efficacy|15|||
19763076|NCT02661490|42215408|FG001|Overall Study|Lost to Follow-up|1|||
19763077|NCT02661490|42215409|FG002|Overall Study|Lost to Follow-up|0|||
19763078|NCT02661490|42215410|FG003|Overall Study|Lost to Follow-up|0|||
19763079|NCT02661490|42215411|FG004|Overall Study|Lost to Follow-up|2|||
19763080|NCT02661490|42215407|FG000|Overall Study|Withdrawal by Subject|2|||
19763081|NCT02661490|42215408|FG001|Overall Study|Withdrawal by Subject|0|||
19604453|NCT00699283|42053346|FG001|Overall Study|Lack of Efficacy|5|||
19604454|NCT00699283|42053345|FG000|Overall Study|Lost to Follow-up|2|||
19604455|NCT00699283|42053346|FG001|Overall Study|Lost to Follow-up|0|||
19604456|NCT00699283|42053345|FG000|Overall Study|Withdrawal by Subject|1|||
19763082|NCT02661490|42215409|FG002|Overall Study|Withdrawal by Subject|2|||
19763083|NCT02661490|42215410|FG003|Overall Study|Withdrawal by Subject|0|||
19763084|NCT02661490|42215411|FG004|Overall Study|Withdrawal by Subject|0|||
19763085|NCT02661490|42215407|FG000|Overall Study|Death|1|||
19763086|NCT02661490|42215408|FG001|Overall Study|Death|1|||
19763087|NCT02661490|42215409|FG002|Overall Study|Death|0|||
19763088|NCT02661490|42215410|FG003|Overall Study|Death|1|||
19763089|NCT02661490|42215411|FG004|Overall Study|Death|0|||
19763090|NCT02661490|42215407|FG000|Overall Study|Reason not Specified|0|||
19763091|NCT02661490|42215408|FG001|Overall Study|Reason not Specified|0|||
19763092|NCT02661490|42215409|FG002|Overall Study|Reason not Specified|0|||
19763093|NCT02661490|42215410|FG003|Overall Study|Reason not Specified|0|||
19763094|NCT02661490|42215411|FG004|Overall Study|Reason not Specified|1|||
19763095|NCT03287791|42215426|FG000|Overall Study|Insufficient Therapeutic Response|0|||
19763096|NCT03287791|42215427|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19763097|NCT03287791|42215428|FG002|Overall Study|Insufficient Therapeutic Response|1|||
19763098|NCT03287791|42215426|FG000|Overall Study|Adverse Event|0|||
19763099|NCT03287791|42215427|FG001|Overall Study|Adverse Event|4|||
19763100|NCT03287791|42215428|FG002|Overall Study|Adverse Event|3|||
19763101|NCT03287791|42215426|FG000|Overall Study|Withdrawal by Subject|12|||
19763102|NCT03287791|42215427|FG001|Overall Study|Withdrawal by Subject|12|||
19763103|NCT03287791|42215428|FG002|Overall Study|Withdrawal by Subject|17|||
19763104|NCT03287791|42215426|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
19763105|NCT03287791|42215427|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
19763106|NCT03287791|42215428|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
19763107|NCT03287791|42215426|FG000|Overall Study|Lost to Follow-up|8|||
19763108|NCT03287791|42215427|FG001|Overall Study|Lost to Follow-up|14|||
19763109|NCT03287791|42215428|FG002|Overall Study|Lost to Follow-up|11|||
19763110|NCT03287791|42215426|FG000|Overall Study|Protocol Violation|7|||
19763111|NCT03287791|42215427|FG001|Overall Study|Protocol Violation|2|||
19763112|NCT03287791|42215428|FG002|Overall Study|Protocol Violation|1|||
19763113|NCT03287791|42215426|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
19763114|NCT03287791|42215427|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
19763115|NCT03287791|42215428|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
19763116|NCT03287791|42215426|FG000|Overall Study|Too much time between 2 visits|0|||
19763117|NCT03287791|42215427|FG001|Overall Study|Too much time between 2 visits|1|||
19763118|NCT03287791|42215428|FG002|Overall Study|Too much time between 2 visits|0|||
19763119|NCT03287791|42215426|FG000|Overall Study|Non-compliance|0|||
19763120|NCT03287791|42215427|FG001|Overall Study|Non-compliance|1|||
19763121|NCT03287791|42215428|FG002|Overall Study|Non-compliance|0|||
19763122|NCT03287791|42215426|FG000|Overall Study|Did not meet inclusion criteria|1|||
19763123|NCT03287791|42215427|FG001|Overall Study|Did not meet inclusion criteria|0|||
19763124|NCT03287791|42215428|FG002|Overall Study|Did not meet inclusion criteria|0|||
19763125|NCT03287635|42215436|FG000|Overall Study|Lost to Follow-up|5|||
19763126|NCT03287635|42215436|FG000|Overall Study|Withdrawal by Subject|1|||
19763127|NCT03287635|42215436|FG000|Overall Study|Physician Decision|1|||
19763128|NCT03287089|42215442|FG000|Overall Study|Lost to Follow-up|0|||
19763129|NCT03287089|42215443|FG001|Overall Study|Lost to Follow-up|2|||
19763130|NCT03287089|42215442|FG000|Overall Study|Physician Decision|0|||
19763131|NCT03287089|42215443|FG001|Overall Study|Physician Decision|2|||
19763132|NCT03287089|42215442|FG000|Overall Study|Withdrawal by Subject|0|||
19763133|NCT03287089|42215443|FG001|Overall Study|Withdrawal by Subject|2|||
19763134|NCT03286543|42215451|FG000|Consented|Screen failure before randomization|2|||
19763135|NCT03286543|42215452|FG001|Consented|Screen failure before randomization|0|||
19763136|NCT03286543|42215453|FG002|Consented|Screen failure before randomization|0|||
19763137|NCT03286543|42215451|FG000|Consented|Screen failure before enrollment|4|||
19763138|NCT03286543|42215452|FG001|Consented|Screen failure before enrollment|0|||
19763139|NCT03286543|42215453|FG002|Consented|Screen failure before enrollment|0|||
19763140|NCT03286543|42215451|FG000|Consented|TKA cancelled after enrollment|1|||
19763141|NCT03286543|42215452|FG001|Consented|TKA cancelled after enrollment|0|||
19763142|NCT03286543|42215453|FG002|Consented|TKA cancelled after enrollment|0|||
19763143|NCT03286543|42215451|FG000|Consented|Withdrawn from study|12|||
19763144|NCT03286543|42215452|FG001|Consented|Withdrawn from study|0|||
19763145|NCT03286543|42215453|FG002|Consented|Withdrawn from study|0|||
19763146|NCT03286543|42215451|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
19763147|NCT03286543|42215452|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
19763148|NCT03286543|42215453|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
19763149|NCT03286543|42215451|FG000|Study Enrollment|Withdrawn from study|0|||
19763150|NCT03286543|42215452|FG001|Study Enrollment|Withdrawn from study|6|||
19763151|NCT03286543|42215453|FG002|Study Enrollment|Withdrawn from study|6|||
19763152|NCT03306433|42215459|FG000|Overall Study|Lost to Follow-up|3|||
19763153|NCT03306433|42215459|FG000|Overall Study|Patient did not have teeth extracted|1|||
19763154|NCT03306433|42215459|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
19763155|NCT02940691|42215467|FG000|Overall Study|Lost to Follow-up|5|||
19763156|NCT02940691|42215467|FG000|Overall Study|Incarceration|1|||
19763157|NCT03306277|42215505|FG000|Overall Study|Death|1|||
19763158|NCT03306277|42215505|FG000|Overall Study|Adverse Event|1|||
19763159|NCT03306277|42215505|FG000|Overall Study|Withdrawal by Subject|1|||
19763160|NCT03130959|42215519|FG000|Overall Study|Disease progression|19|||
19763161|NCT03130959|42215520|FG001|Overall Study|Disease progression|7|||
19763162|NCT03130959|42215521|FG002|Overall Study|Disease progression|12|||
19763163|NCT03130959|42215522|FG003|Overall Study|Disease progression|7|||
19763164|NCT03130959|42215523|FG004|Overall Study|Disease progression|12|||
19763165|NCT03130959|42215524|FG005|Overall Study|Disease progression|3|||
19763166|NCT03130959|42215525|FG006|Overall Study|Disease progression|6|||
19763167|NCT03130959|42215526|FG007|Overall Study|Disease progression|3|||
19763168|NCT03130959|42215527|FG008|Overall Study|Disease progression|15|||
19763169|NCT03130959|42215528|FG009|Overall Study|Disease progression|8|||
19763170|NCT03130959|42215519|FG000|Overall Study|Study drug toxicity|2|||
19763171|NCT03130959|42215520|FG001|Overall Study|Study drug toxicity|2|||
19763172|NCT03130959|42215521|FG002|Overall Study|Study drug toxicity|1|||
19763173|NCT03130959|42215522|FG003|Overall Study|Study drug toxicity|2|||
19763174|NCT03130959|42215523|FG004|Overall Study|Study drug toxicity|1|||
19763175|NCT03130959|42215524|FG005|Overall Study|Study drug toxicity|1|||
19763176|NCT03130959|42215525|FG006|Overall Study|Study drug toxicity|3|||
19763177|NCT03130959|42215526|FG007|Overall Study|Study drug toxicity|0|||
19763178|NCT03130959|42215527|FG008|Overall Study|Study drug toxicity|3|||
19763179|NCT03130959|42215528|FG009|Overall Study|Study drug toxicity|3|||
19763180|NCT03130959|42215519|FG000|Overall Study|Other reasons|0|||
19763181|NCT03130959|42215520|FG001|Overall Study|Other reasons|0|||
19763182|NCT03130959|42215521|FG002|Overall Study|Other reasons|0|||
19763183|NCT03130959|42215522|FG003|Overall Study|Other reasons|0|||
19763184|NCT03130959|42215523|FG004|Overall Study|Other reasons|0|||
19763185|NCT03130959|42215524|FG005|Overall Study|Other reasons|1|||
19763186|NCT03130959|42215525|FG006|Overall Study|Other reasons|1|||
19763187|NCT03130959|42215526|FG007|Overall Study|Other reasons|0|||
19763188|NCT03130959|42215527|FG008|Overall Study|Other reasons|0|||
19763189|NCT03130959|42215528|FG009|Overall Study|Other reasons|0|||
19763190|NCT03130959|42215519|FG000|Overall Study|Subject request to discontinue therapy|0|||
19763191|NCT03130959|42215520|FG001|Overall Study|Subject request to discontinue therapy|0|||
19763192|NCT03130959|42215521|FG002|Overall Study|Subject request to discontinue therapy|1|||
19763193|NCT03130959|42215522|FG003|Overall Study|Subject request to discontinue therapy|1|||
19763194|NCT03130959|42215523|FG004|Overall Study|Subject request to discontinue therapy|0|||
19763195|NCT03130959|42215524|FG005|Overall Study|Subject request to discontinue therapy|0|||
19763196|NCT03130959|42215525|FG006|Overall Study|Subject request to discontinue therapy|1|||
19763197|NCT03130959|42215526|FG007|Overall Study|Subject request to discontinue therapy|1|||
19763198|NCT03130959|42215527|FG008|Overall Study|Subject request to discontinue therapy|0|||
19763199|NCT03130959|42215528|FG009|Overall Study|Subject request to discontinue therapy|0|||
19763200|NCT03130959|42215519|FG000|Overall Study|Not reported|0|||
19763201|NCT03130959|42215520|FG001|Overall Study|Not reported|0|||
19763202|NCT03130959|42215521|FG002|Overall Study|Not reported|0|||
19763203|NCT03130959|42215522|FG003|Overall Study|Not reported|1|||
19763204|NCT03130959|42215523|FG004|Overall Study|Not reported|0|||
19763205|NCT03130959|42215524|FG005|Overall Study|Not reported|1|||
19763206|NCT03130959|42215525|FG006|Overall Study|Not reported|0|||
19763207|NCT03130959|42215526|FG007|Overall Study|Not reported|0|||
19763208|NCT03130959|42215527|FG008|Overall Study|Not reported|0|||
19763209|NCT03130959|42215528|FG009|Overall Study|Not reported|1|||
19763210|NCT03130959|42215519|FG000|Overall Study|Adverse Event unrelated to drug|0|||
19763211|NCT03130959|42215520|FG001|Overall Study|Adverse Event unrelated to drug|0|||
19763212|NCT03130959|42215521|FG002|Overall Study|Adverse Event unrelated to drug|1|||
19763213|NCT03130959|42215522|FG003|Overall Study|Adverse Event unrelated to drug|1|||
19763214|NCT03130959|42215523|FG004|Overall Study|Adverse Event unrelated to drug|1|||
19763215|NCT03130959|42215524|FG005|Overall Study|Adverse Event unrelated to drug|0|||
19763216|NCT03130959|42215525|FG006|Overall Study|Adverse Event unrelated to drug|1|||
19763217|NCT03130959|42215526|FG007|Overall Study|Adverse Event unrelated to drug|0|||
19763218|NCT03130959|42215527|FG008|Overall Study|Adverse Event unrelated to drug|1|||
19763219|NCT03130959|42215528|FG009|Overall Study|Adverse Event unrelated to drug|1|||
19763220|NCT03130959|42215519|FG000|Overall Study|Participant withdrew consent|0|||
19763221|NCT03130959|42215520|FG001|Overall Study|Participant withdrew consent|1|||
19763222|NCT03130959|42215521|FG002|Overall Study|Participant withdrew consent|0|||
19763223|NCT03130959|42215522|FG003|Overall Study|Participant withdrew consent|2|||
19763224|NCT03130959|42215523|FG004|Overall Study|Participant withdrew consent|1|||
19763225|NCT03130959|42215524|FG005|Overall Study|Participant withdrew consent|0|||
19763226|NCT03130959|42215525|FG006|Overall Study|Participant withdrew consent|0|||
19763227|NCT03130959|42215526|FG007|Overall Study|Participant withdrew consent|0|||
19763228|NCT03130959|42215527|FG008|Overall Study|Participant withdrew consent|0|||
19763229|NCT03130959|42215528|FG009|Overall Study|Participant withdrew consent|2|||
19763230|NCT03130959|42215519|FG000|Overall Study|Administrative reason by sponsor|1|||
19763231|NCT03130959|42215520|FG001|Overall Study|Administrative reason by sponsor|0|||
19763232|NCT03130959|42215521|FG002|Overall Study|Administrative reason by sponsor|1|||
19763233|NCT03130959|42215522|FG003|Overall Study|Administrative reason by sponsor|0|||
19763234|NCT03130959|42215523|FG004|Overall Study|Administrative reason by sponsor|0|||
19763235|NCT03130959|42215524|FG005|Overall Study|Administrative reason by sponsor|0|||
19763236|NCT03130959|42215525|FG006|Overall Study|Administrative reason by sponsor|0|||
19763237|NCT03130959|42215526|FG007|Overall Study|Administrative reason by sponsor|0|||
19763238|NCT03130959|42215527|FG008|Overall Study|Administrative reason by sponsor|0|||
19763239|NCT03130959|42215528|FG009|Overall Study|Administrative reason by sponsor|0|||
19763240|NCT03130959|42215519|FG000|Overall Study|Lost to Follow-up|1|||
19763241|NCT03130959|42215520|FG001|Overall Study|Lost to Follow-up|0|||
19763242|NCT03130959|42215521|FG002|Overall Study|Lost to Follow-up|0|||
19763243|NCT03130959|42215522|FG003|Overall Study|Lost to Follow-up|0|||
19763244|NCT03130959|42215523|FG004|Overall Study|Lost to Follow-up|0|||
19763245|NCT03130959|42215524|FG005|Overall Study|Lost to Follow-up|0|||
19763246|NCT03130959|42215525|FG006|Overall Study|Lost to Follow-up|0|||
19763247|NCT03130959|42215526|FG007|Overall Study|Lost to Follow-up|0|||
19763248|NCT03130959|42215527|FG008|Overall Study|Lost to Follow-up|0|||
19763249|NCT03130959|42215528|FG009|Overall Study|Lost to Follow-up|0|||
19763250|NCT03124407|42215567|FG000|Overall Study|Lost to Follow-up|1|||
19763251|NCT03124407|42215568|FG001|Overall Study|Lost to Follow-up|0|||
19763252|NCT03124407|42215569|FG002|Overall Study|Lost to Follow-up|0|||
19763253|NCT03124407|42215570|FG003|Overall Study|Lost to Follow-up|0|||
19763254|NCT03124407|42215567|FG000|Overall Study|Adverse Event|0|||
19763255|NCT03124407|42215568|FG001|Overall Study|Adverse Event|0|||
19763256|NCT03124407|42215569|FG002|Overall Study|Adverse Event|1|||
19763257|NCT03124407|42215570|FG003|Overall Study|Adverse Event|0|||
19763258|NCT02929407|42215584|FG000|Overall Study|Adverse Event|1|||
19763259|NCT03123939|42215588|FG000|Overall Study|Lack of Efficacy|6|||
19763260|NCT03123939|42215588|FG000|Overall Study|Death|5|||
19763261|NCT03123939|42215588|FG000|Overall Study|Physician Decision|2|||
19763262|NCT03123939|42215588|FG000|Overall Study|Subject/guardian decision|2|||
19763263|NCT03123939|42215588|FG000|Overall Study|Lost to Follow-up|1|||
19763264|NCT03123939|42215588|FG000|Overall Study|New therapy for study indication|1|||
19763265|NCT03123939|42215588|FG000|Overall Study|Protocol deviation|1|||
19763266|NCT03123939|42215588|FG000|Overall Study|Progressive disease|18|||
19763267|NCT03123939|42215588|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
19763268|NCT03123939|42215588|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
19763269|NCT03123861|42215603|FG000|Overall Study|Protocol Violation|1|||
19763270|NCT03123861|42215604|FG001|Overall Study|Protocol Violation|1|||
19763271|NCT03123861|42215603|FG000|Overall Study|Withdrawal by Subject|2|||
19763272|NCT03123861|42215604|FG001|Overall Study|Withdrawal by Subject|2|||
19763273|NCT03123471|42215612|FG000|Placebo-controlled Phase|Adverse Event|3|||
19763274|NCT03123471|42215613|FG001|Placebo-controlled Phase|Adverse Event|8|||
19763275|NCT03123471|42215612|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
19763276|NCT03123471|42215613|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
19763277|NCT03123471|42215612|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
19763278|NCT03123471|42215613|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
19763279|NCT03123471|42215612|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
19763280|NCT03123471|42215613|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
19763281|NCT03123471|42215612|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
19763282|NCT03123471|42215613|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
19763283|NCT03123471|42215612|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
19763284|NCT03123471|42215613|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
19763285|NCT03123471|42215612|FG000|Placebo-controlled Phase|Miscellaneous|0|||
19763286|NCT03123471|42215613|FG001|Placebo-controlled Phase|Miscellaneous|1|||
19763287|NCT03123471|42215612|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
19763288|NCT03123471|42215613|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
19477231|NCT01482221|41756212|FG002|Overall Study|Lack of Efficacy|1|||
19763289|NCT03123471|42215612|FG000|Apremilast Extension Phase|Adverse Event|1|||
19763290|NCT03123471|42215613|FG001|Apremilast Extension Phase|Adverse Event|5|||
19763291|NCT03123471|42215612|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
19763292|NCT03123471|42215613|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
19763293|NCT03123471|42215612|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
19763294|NCT03123471|42215613|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
19763295|NCT02661178|42215640|FG000|Part 1|Protocol Violation|1|||
19763296|NCT02661178|42215641|FG001|Part 1|Protocol Violation|0|||
19763297|NCT02661178|42215642|FG002|Part 1|Protocol Violation|0|||
19763298|NCT02661178|42215643|FG003|Part 1|Protocol Violation|0|||
19763299|NCT02661178|42215644|FG004|Part 1|Protocol Violation|0|||
19763300|NCT02661178|42215645|FG005|Part 1|Protocol Violation|0|||
19763301|NCT02661178|42215646|FG006|Part 1|Protocol Violation|0|||
19763302|NCT02661178|42215647|FG007|Part 1|Protocol Violation|0|||
19763303|NCT02661178|42215648|FG008|Part 1|Protocol Violation|0|||
19763304|NCT02661178|42215649|FG009|Part 1|Protocol Violation|0|||
19763305|NCT02661178|42215650|FG010|Part 1|Protocol Violation|0|||
19763306|NCT02661178|42215651|FG011|Part 1|Protocol Violation|0|||
19763307|NCT02661178|42215652|FG012|Part 1|Protocol Violation|0|||
19763308|NCT02661178|42215653|FG013|Part 1|Protocol Violation|0|||
19763309|NCT02661178|42215654|FG014|Part 1|Protocol Violation|0|||
19763310|NCT02660944|42215706|FG000|Overall Study|Adverse Event|3|||
19763311|NCT02660944|42215707|FG001|Overall Study|Adverse Event|4|||
19763312|NCT02660944|42215706|FG000|Overall Study|Physician Decision|3|||
19763313|NCT02660944|42215707|FG001|Overall Study|Physician Decision|1|||
19763314|NCT02660944|42215706|FG000|Overall Study|Withdrawal by Subject|5|||
19763315|NCT02660944|42215707|FG001|Overall Study|Withdrawal by Subject|3|||
19763316|NCT02660944|42215706|FG000|Overall Study|Lost to Follow-up|4|||
19763317|NCT02660944|42215707|FG001|Overall Study|Lost to Follow-up|1|||
19763318|NCT02660944|42215706|FG000|Overall Study|Subject schedule|0|||
19680526|NCT00483548|42127905|FG001|Overall Study|Protocol required discontinuation|6|||
19680527|NCT00483548|42127904|FG000|Overall Study|Unable to comply with protocol schedule|1|||
19680528|NCT00483548|42127905|FG001|Overall Study|Unable to comply with protocol schedule|0|||
19763319|NCT02660944|42215707|FG001|Overall Study|Subject schedule|1|||
19763320|NCT02660944|42215706|FG000|Overall Study|Exclusion criteria met|2|||
19763321|NCT02660944|42215707|FG001|Overall Study|Exclusion criteria met|0|||
19763322|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Adverse Event|16|||
19763323|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Adverse Event|17|||
19763324|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Adverse Event|13|||
19763325|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Adverse Event|18|||
19763326|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Adverse Event|0|||
19763327|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Adverse Event|0|||
19763328|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Adverse Event|0|||
19763329|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Adverse Event|0|||
19763330|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
19763331|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
19763332|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
19763333|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
19763334|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
19763335|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
19763336|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
19763337|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
19763338|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
19763339|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
19763340|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
19763341|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
19763342|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
19763343|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
19763344|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
19763345|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
19763346|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
19763347|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
19763348|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
19763349|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
19763350|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
19763351|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
19763352|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
19763353|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
19763354|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
19680529|NCT00483548|42127904|FG000|Overall Study|Non-compliance with medication|2|||
19680530|NCT00483548|42127905|FG001|Overall Study|Non-compliance with medication|0|||
19680531|NCT00483548|42127904|FG000|Overall Study|Lost to Follow-up|3|||
19680532|NCT00483548|42127905|FG001|Overall Study|Lost to Follow-up|4|||
19680533|NCT00483548|42127904|FG000|Overall Study|Withdrawal by Subject|5|||
19680534|NCT00483548|42127905|FG001|Overall Study|Withdrawal by Subject|2|||
19680535|NCT00445770|42127914|FG000|Overall Study|Adverse Event|9|||
19680536|NCT00445770|42127915|FG001|Overall Study|Adverse Event|15|||
19680537|NCT00445770|42127916|FG002|Overall Study|Adverse Event|19|||
19680538|NCT00445770|42127914|FG000|Overall Study|Lack of Efficacy|38|||
19680539|NCT00445770|42127915|FG001|Overall Study|Lack of Efficacy|13|||
19680540|NCT00445770|42127916|FG002|Overall Study|Lack of Efficacy|6|||
19680541|NCT00445770|42127914|FG000|Overall Study|Lost to Follow-up|0|||
19680542|NCT00445770|42127915|FG001|Overall Study|Lost to Follow-up|2|||
19680543|NCT00445770|42127916|FG002|Overall Study|Lost to Follow-up|0|||
19680544|NCT00445770|42127914|FG000|Overall Study|Other|6|||
19680545|NCT00445770|42127915|FG001|Overall Study|Other|5|||
19763355|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
19763356|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
19763357|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
19763358|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
19763359|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
19763360|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
19763361|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
19763362|NCT02975336|42215717|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
19680546|NCT00445770|42127916|FG002|Overall Study|Other|6|||
19680547|NCT00266032|42127929|FG000|Treatment|Adverse Event|42|||
19680548|NCT00266032|42127930|FG001|Treatment|Adverse Event|26|||
19680549|NCT00266032|42127931|FG002|Treatment|Adverse Event|10|||
19680550|NCT00266032|42127929|FG000|Treatment|Lost to Follow-up|19|||
19680551|NCT00266032|42127930|FG001|Treatment|Lost to Follow-up|4|||
19680552|NCT00266032|42127931|FG002|Treatment|Lost to Follow-up|2|||
19680553|NCT00266032|42127929|FG000|Treatment|Pregnancy|3|||
19680554|NCT00266032|42127930|FG001|Treatment|Pregnancy|2|||
19680555|NCT00266032|42127931|FG002|Treatment|Pregnancy|2|||
19680556|NCT00266032|42127929|FG000|Treatment|Protocol Violation|6|||
19680557|NCT00266032|42127930|FG001|Treatment|Protocol Violation|14|||
19680558|NCT00266032|42127931|FG002|Treatment|Protocol Violation|13|||
19680559|NCT00266032|42127929|FG000|Treatment|Withdrawal by Subject|28|||
19680560|NCT00266032|42127930|FG001|Treatment|Withdrawal by Subject|13|||
19680561|NCT00266032|42127931|FG002|Treatment|Withdrawal by Subject|12|||
19680562|NCT00266032|42127929|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
19680563|NCT00266032|42127930|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
19680564|NCT00266032|42127931|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
19680565|NCT00266032|42127929|FG000|Open-label Safety Extension|Adverse Event|5|||
19680566|NCT00266032|42127930|FG001|Open-label Safety Extension|Adverse Event|0|||
19680567|NCT00266032|42127931|FG002|Open-label Safety Extension|Adverse Event|4|||
19680568|NCT00266032|42127929|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
19680569|NCT00266032|42127930|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
19680570|NCT00266032|42127931|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
19680571|NCT00266032|42127929|FG000|Open-label Safety Extension|Pregnancy|4|||
19680572|NCT00266032|42127930|FG001|Open-label Safety Extension|Pregnancy|1|||
19680573|NCT00266032|42127931|FG002|Open-label Safety Extension|Pregnancy|2|||
19680574|NCT00266032|42127929|FG000|Open-label Safety Extension|Protocol Violation|1|||
19680575|NCT00266032|42127930|FG001|Open-label Safety Extension|Protocol Violation|3|||
19680576|NCT00266032|42127931|FG002|Open-label Safety Extension|Protocol Violation|2|||
19680577|NCT00266032|42127929|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
19680578|NCT00266032|42127930|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
19680579|NCT00266032|42127931|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
19680580|NCT00266032|42127929|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
19680581|NCT00266032|42127930|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
19680582|NCT00266032|42127931|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
19680583|NCT00483002|42127939|FG000|Overall Study|Adverse Event|68|||
19680584|NCT00483002|42127939|FG000|Overall Study|Lack of Efficacy|555|||
19680585|NCT00483002|42127939|FG000|Overall Study|Lost to Follow-up|962|||
19680586|NCT00483002|42127939|FG000|Overall Study|Other|2|||
19680587|NCT00483002|42127939|FG000|Overall Study|Other|967|||
19680588|NCT00482612|42127947|FG000|In-treatment Period|No study medication administered|0|||
19680589|NCT00482612|42127948|FG001|In-treatment Period|No study medication administered|0|||
19680590|NCT00482612|42127949|FG002|In-treatment Period|No study medication administered|1|||
19680591|NCT00482612|42127950|FG003|In-treatment Period|No study medication administered|0|||
19680592|NCT00482612|42127947|FG000|Follow-up Period|Other|4|||
19763363|NCT02975336|42215718|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
19763364|NCT02975336|42215719|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
19763365|NCT02975336|42215720|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
19763366|NCT02975336|42215721|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
19763367|NCT02975336|42215722|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
19763368|NCT02975336|42215723|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
19763369|NCT02975336|42215724|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
19763370|NCT02975336|42215717|FG000|LTE (104 Weeks)|Adverse Event|0|||
19763371|NCT02975336|42215718|FG001|LTE (104 Weeks)|Adverse Event|0|||
19763372|NCT02975336|42215719|FG002|LTE (104 Weeks)|Adverse Event|0|||
19763373|NCT02975336|42215720|FG003|LTE (104 Weeks)|Adverse Event|0|||
19763374|NCT02975336|42215721|FG004|LTE (104 Weeks)|Adverse Event|7|||
19763375|NCT02975336|42215722|FG005|LTE (104 Weeks)|Adverse Event|4|||
19763376|NCT02975336|42215723|FG006|LTE (104 Weeks)|Adverse Event|2|||
19763377|NCT02975336|42215724|FG007|LTE (104 Weeks)|Adverse Event|0|||
19763378|NCT02975336|42215717|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
19763379|NCT02975336|42215718|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
19763380|NCT02975336|42215719|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
19763381|NCT02975336|42215720|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
19763382|NCT02975336|42215721|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
19763383|NCT02975336|42215722|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
19763384|NCT02975336|42215723|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
19763385|NCT02975336|42215724|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
19763386|NCT02975336|42215717|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
19763387|NCT02975336|42215718|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
19763388|NCT02975336|42215719|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
19763389|NCT02975336|42215720|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
19763390|NCT02975336|42215721|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
19763391|NCT02975336|42215722|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
19680593|NCT00482612|42127948|FG001|Follow-up Period|Other|2|||
19680594|NCT00482612|42127949|FG002|Follow-up Period|Other|1|||
19763392|NCT02975336|42215723|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
19763393|NCT02975336|42215724|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
19763394|NCT02975336|42215717|FG000|LTE (104 Weeks)|Other|0|||
19763395|NCT02975336|42215718|FG001|LTE (104 Weeks)|Other|0|||
19763396|NCT02975336|42215719|FG002|LTE (104 Weeks)|Other|0|||
19763397|NCT02975336|42215720|FG003|LTE (104 Weeks)|Other|0|||
19763398|NCT02975336|42215721|FG004|LTE (104 Weeks)|Other|55|||
19763399|NCT02975336|42215722|FG005|LTE (104 Weeks)|Other|63|||
19763400|NCT02975336|42215723|FG006|LTE (104 Weeks)|Other|76|||
19763401|NCT02975336|42215724|FG007|LTE (104 Weeks)|Other|72|||
19763402|NCT03124563|42215740|FG000|Overall Study|Lost to Follow-up|1|||
19763403|NCT03124563|42215741|FG001|Overall Study|Lost to Follow-up|1|||
19763404|NCT03124563|42215740|FG000|Overall Study|Withdrawal by Subject|1|||
19763405|NCT03124563|42215741|FG001|Overall Study|Withdrawal by Subject|1|||
19763406|NCT03079869|42215749|FG000|Overall Study|Adverse Event|6|||
19763407|NCT03079869|42215750|FG001|Overall Study|Adverse Event|8|||
19763408|NCT03079869|42215749|FG000|Overall Study|Withdrawal by Subject|4|||
19763409|NCT03079869|42215750|FG001|Overall Study|Withdrawal by Subject|1|||
19763410|NCT03079869|42215749|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
19763411|NCT03079869|42215750|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
19763412|NCT03085914|42215763|FG000|Overall Study|Death|6|||
19763413|NCT03085914|42215764|FG001|Overall Study|Death|6|||
19763414|NCT03085914|42215765|FG002|Overall Study|Death|4|||
19763415|NCT03085914|42215766|FG003|Overall Study|Death|1|||
19763416|NCT03085914|42215767|FG004|Overall Study|Death|5|||
19763417|NCT03085914|42215768|FG005|Overall Study|Death|2|||
19763418|NCT03085914|42215769|FG006|Overall Study|Death|2|||
19763419|NCT03085914|42215763|FG000|Overall Study|Withdrawal by Subject|1|||
19763420|NCT03085914|42215764|FG001|Overall Study|Withdrawal by Subject|1|||
19763421|NCT03085914|42215765|FG002|Overall Study|Withdrawal by Subject|2|||
19763422|NCT03085914|42215766|FG003|Overall Study|Withdrawal by Subject|2|||
19763423|NCT03085914|42215767|FG004|Overall Study|Withdrawal by Subject|2|||
19763424|NCT03085914|42215768|FG005|Overall Study|Withdrawal by Subject|0|||
19763425|NCT03085914|42215769|FG006|Overall Study|Withdrawal by Subject|1|||
19763426|NCT03085914|42215763|FG000|Overall Study|Lost to Follow-up|0|||
19763427|NCT03085914|42215764|FG001|Overall Study|Lost to Follow-up|0|||
19763428|NCT03085914|42215765|FG002|Overall Study|Lost to Follow-up|1|||
19763429|NCT03085914|42215766|FG003|Overall Study|Lost to Follow-up|0|||
19763430|NCT03085914|42215767|FG004|Overall Study|Lost to Follow-up|0|||
19763431|NCT03085914|42215768|FG005|Overall Study|Lost to Follow-up|1|||
19763432|NCT03085914|42215769|FG006|Overall Study|Lost to Follow-up|1|||
19763433|NCT03085914|42215763|FG000|Overall Study|Reason was not specified,|2|||
19763434|NCT03085914|42215764|FG001|Overall Study|Reason was not specified,|2|||
19763435|NCT03085914|42215765|FG002|Overall Study|Reason was not specified,|2|||
19763436|NCT03085914|42215766|FG003|Overall Study|Reason was not specified,|3|||
19763437|NCT03085914|42215767|FG004|Overall Study|Reason was not specified,|3|||
19763438|NCT03085914|42215768|FG005|Overall Study|Reason was not specified,|3|||
19763439|NCT03085914|42215769|FG006|Overall Study|Reason was not specified,|6|||
19763440|NCT03085914|42215763|FG000|Overall Study|Progressive Disease|0|||
19763441|NCT03085914|42215764|FG001|Overall Study|Progressive Disease|0|||
19763442|NCT03085914|42215765|FG002|Overall Study|Progressive Disease|2|||
19763443|NCT03085914|42215766|FG003|Overall Study|Progressive Disease|2|||
19763444|NCT03085914|42215767|FG004|Overall Study|Progressive Disease|1|||
19763445|NCT03085914|42215768|FG005|Overall Study|Progressive Disease|1|||
19763446|NCT03085914|42215769|FG006|Overall Study|Progressive Disease|1|||
19763447|NCT03085914|42215763|FG000|Overall Study|Study Terminated by the Sponsor|0|||
19763448|NCT03085914|42215764|FG001|Overall Study|Study Terminated by the Sponsor|0|||
19763449|NCT03085914|42215765|FG002|Overall Study|Study Terminated by the Sponsor|0|||
19763450|NCT03085914|42215766|FG003|Overall Study|Study Terminated by the Sponsor|1|||
19763451|NCT03085914|42215767|FG004|Overall Study|Study Terminated by the Sponsor|2|||
19763452|NCT03085914|42215768|FG005|Overall Study|Study Terminated by the Sponsor|1|||
19763453|NCT03085914|42215769|FG006|Overall Study|Study Terminated by the Sponsor|0|||
19763454|NCT03078582|42215788|FG000|Overall Study|Adverse Event|0|||
19763455|NCT03078582|42215789|FG001|Overall Study|Adverse Event|8|||
19763456|NCT03077724|42215797|FG000|Overall Study|Lost to Follow-up|5|||
19763457|NCT03077724|42215798|FG001|Overall Study|Lost to Follow-up|1|||
19763458|NCT03077724|42215797|FG000|Overall Study|Withdrawal by Subject|3|||
19763459|NCT03077724|42215798|FG001|Overall Study|Withdrawal by Subject|1|||
19763460|NCT00979212|42215806|FG000|Overall Study|Protocol Violation|1|||
19763461|NCT00979212|42215807|FG001|Overall Study|Protocol Violation|8|||
19763462|NCT00979212|42215806|FG000|Overall Study|No protocol therapy received|1|||
19763463|NCT00979212|42215807|FG001|Overall Study|No protocol therapy received|0|||
19763464|NCT03080454|42215813|FG000|Baseline|Adverse Event|2|||
19763465|NCT03080454|42215813|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
19763466|NCT03080454|42215813|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
19763467|NCT02981342|42215837|FG000|Overall Study|Adverse Event|0|||
19763468|NCT02981342|42215838|FG001|Overall Study|Adverse Event|0|||
19763469|NCT02981342|42215839|FG002|Overall Study|Adverse Event|0|||
19763470|NCT02981342|42215840|FG003|Overall Study|Adverse Event|1|||
19763471|NCT02981342|42215837|FG000|Overall Study|Death|0|||
19763472|NCT02981342|42215838|FG001|Overall Study|Death|9|||
19763473|NCT02981342|42215839|FG002|Overall Study|Death|9|||
19763474|NCT02981342|42215840|FG003|Overall Study|Death|4|||
19763475|NCT02981342|42215837|FG000|Overall Study|Withdrawal by Subject|0|||
19763476|NCT02981342|42215838|FG001|Overall Study|Withdrawal by Subject|0|||
19763477|NCT02981342|42215839|FG002|Overall Study|Withdrawal by Subject|3|||
19763478|NCT02981342|42215840|FG003|Overall Study|Withdrawal by Subject|1|||
19763479|NCT02981342|42215837|FG000|Overall Study|Study closed by sponsor|0|||
19763480|NCT02981342|42215838|FG001|Overall Study|Study closed by sponsor|0|||
19763481|NCT02981342|42215839|FG002|Overall Study|Study closed by sponsor|1|||
19763482|NCT02981342|42215840|FG003|Overall Study|Study closed by sponsor|1|||
19763483|NCT02981342|42215837|FG000|Overall Study|Randomized, Never Treated|0|||
19763484|NCT02981342|42215838|FG001|Overall Study|Randomized, Never Treated|1|||
19763485|NCT02981342|42215839|FG002|Overall Study|Randomized, Never Treated|0|||
19763486|NCT02981342|42215840|FG003|Overall Study|Randomized, Never Treated|7|||
19763487|NCT02981342|42215837|FG000|Overall Study|Lost to Follow-up|0|||
19763488|NCT02981342|42215838|FG001|Overall Study|Lost to Follow-up|1|||
19763489|NCT02981342|42215839|FG002|Overall Study|Lost to Follow-up|0|||
19763490|NCT02981342|42215840|FG003|Overall Study|Lost to Follow-up|0|||
19763491|NCT02794246|42215852|FG000|Overall Study|Withdrawal by Subject|2|||
19763492|NCT02794246|42215852|FG000|Overall Study|Physician Decision|4|||
19763493|NCT03428100|42215860|FG000|Overall Study|Adverse Event|1|||
19763494|NCT03428100|42215861|FG001|Overall Study|Adverse Event|0|||
19763495|NCT03428100|42215862|FG002|Overall Study|Adverse Event|3|||
19763496|NCT03428100|42215863|FG003|Overall Study|Adverse Event|1|||
19763497|NCT03428100|42215860|FG000|Overall Study|Lack of Efficacy|16|||
19763498|NCT03428100|42215861|FG001|Overall Study|Lack of Efficacy|10|||
19763499|NCT03428100|42215862|FG002|Overall Study|Lack of Efficacy|7|||
19763500|NCT03428100|42215863|FG003|Overall Study|Lack of Efficacy|6|||
19763501|NCT03428100|42215860|FG000|Overall Study|Protocol Deviation|0|||
19763502|NCT03428100|42215861|FG001|Overall Study|Protocol Deviation|2|||
19763503|NCT03428100|42215862|FG002|Overall Study|Protocol Deviation|2|||
19763504|NCT03428100|42215863|FG003|Overall Study|Protocol Deviation|0|||
19763505|NCT03428100|42215860|FG000|Overall Study|Withdrawal by Subject|4|||
19763506|NCT03428100|42215861|FG001|Overall Study|Withdrawal by Subject|0|||
19763507|NCT03428100|42215862|FG002|Overall Study|Withdrawal by Subject|0|||
19763508|NCT03428100|42215863|FG003|Overall Study|Withdrawal by Subject|0|||
19763509|NCT03428100|42215860|FG000|Overall Study|Physician Decision|0|||
19763510|NCT03428100|42215861|FG001|Overall Study|Physician Decision|1|||
19763511|NCT03428100|42215862|FG002|Overall Study|Physician Decision|0|||
19763512|NCT03428100|42215863|FG003|Overall Study|Physician Decision|0|||
19763513|NCT02980874|42215885|FG000|Overall Study|Adverse Event|2|||
19763514|NCT02980874|42215886|FG001|Overall Study|Adverse Event|7|||
19763515|NCT02980874|42215885|FG000|Overall Study|Withdrawal by Subject|7|||
19763516|NCT02980874|42215886|FG001|Overall Study|Withdrawal by Subject|2|||
19763517|NCT02980874|42215885|FG000|Overall Study|Lost to Follow-up|5|||
19763518|NCT02980874|42215886|FG001|Overall Study|Lost to Follow-up|5|||
19763519|NCT02980874|42215885|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
19763520|NCT02980874|42215886|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
19763521|NCT02980874|42215885|FG000|Overall Study|Unknown study completion status|1|||
19763522|NCT02980874|42215886|FG001|Overall Study|Unknown study completion status|0|||
19763523|NCT01066052|42215894|FG000|Overall Study|Enrolled But Not Treated|3|||
19763524|NCT01066052|42215895|FG001|Overall Study|Enrolled But Not Treated|0|||
19763525|NCT03077646|42215903|FG000|Overall Study|Lost to Follow-up|29|||
19763526|NCT03077646|42215904|FG001|Overall Study|Lost to Follow-up|30|||
19763527|NCT03077646|42215905|FG002|Overall Study|Lost to Follow-up|31|||
19763528|NCT02892149|42215915|FG000|Overall Study|Death|262|||
19763529|NCT02892149|42215916|FG001|Overall Study|Death|278|||
19763530|NCT02892149|42215915|FG000|Overall Study|Withdrawal by Subject|53|||
19763531|NCT02892149|42215916|FG001|Overall Study|Withdrawal by Subject|47|||
19763532|NCT02892149|42215915|FG000|Overall Study|Lost to Follow-up|37|||
19763533|NCT02892149|42215916|FG001|Overall Study|Lost to Follow-up|31|||
19763534|NCT04187092|42215924|FG000|Overall Study|Lost to Follow-up|1|||
19763535|NCT04187092|42215925|FG001|Overall Study|Lost to Follow-up|1|||
19763536|NCT04187092|42215924|FG000|Overall Study|Withdrawal by Subject|1|||
19763537|NCT04187092|42215925|FG001|Overall Study|Withdrawal by Subject|1|||
19763538|NCT04187092|42215924|FG000|Overall Study|Adverse Event|0|||
19763539|NCT04187092|42215925|FG001|Overall Study|Adverse Event|1|||
19763540|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Adverse Event|9|||
19763541|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Adverse Event|2|||
19763542|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
19763543|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
19763544|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
19763545|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
19763546|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Physician Decision|1|||
19763547|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Physician Decision|1|||
19763548|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Pregnancy|2|||
19763549|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Pregnancy|0|||
19763550|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
19763551|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
19763552|NCT02896127|42215933|FG000|COMPLETED WEEK 52|Technical problems|1|||
19763553|NCT02896127|42215934|FG001|COMPLETED WEEK 52|Technical problems|0|||
19763554|NCT02896127|42215933|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
19680595|NCT00482612|42127950|FG003|Follow-up Period|Other|2|||
19680596|NCT00482612|42127947|FG000|Follow-up Period|Lack of compliance|0|||
19680597|NCT00482612|42127948|FG001|Follow-up Period|Lack of compliance|0|||
19680598|NCT00482612|42127949|FG002|Follow-up Period|Lack of compliance|1|||
19680599|NCT00482612|42127950|FG003|Follow-up Period|Lack of compliance|0|||
19680600|NCT00482612|42127947|FG000|Follow-up Period|Lost to Follow-up|0|||
19763555|NCT02896127|42215934|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
19763556|NCT02896127|42215933|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
19763557|NCT02896127|42215934|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
19763558|NCT02896127|42215933|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
19763559|NCT02896127|42215934|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
19763560|NCT02896127|42215933|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
19763561|NCT02896127|42215934|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
19763562|NCT02896127|42215933|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
19763563|NCT02896127|42215934|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
19763564|NCT03546647|42215940|FG000|Overall Study|Adverse Event|1|||
19763565|NCT03546647|42215941|FG001|Overall Study|Adverse Event|0|||
19763566|NCT03077412|42215950|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
19763567|NCT03077412|42215951|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
19763568|NCT03077412|42215952|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
19763569|NCT03077412|42215950|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
19763570|NCT03077412|42215951|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
19763571|NCT03077412|42215952|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
19763572|NCT03077412|42215950|FG000|Overall Study|Adverse Event|1|||
19763573|NCT03077412|42215951|FG001|Overall Study|Adverse Event|2|||
19763574|NCT03077412|42215952|FG002|Overall Study|Adverse Event|2|||
19763575|NCT03077412|42215950|FG000|Overall Study|Investigator's Discretion|0|||
19763576|NCT03077412|42215951|FG001|Overall Study|Investigator's Discretion|1|||
19763577|NCT03077412|42215952|FG002|Overall Study|Investigator's Discretion|1|||
19763578|NCT03077412|42215950|FG000|Overall Study|Withdrew Consent|0|||
19763579|NCT03077412|42215951|FG001|Overall Study|Withdrew Consent|2|||
19763580|NCT03077412|42215952|FG002|Overall Study|Withdrew Consent|0|||
19763581|NCT03544229|42215964|FG000|Overall Study|Adverse Event|1|||
19763582|NCT03544229|42215965|FG001|Overall Study|Adverse Event|0|||
19763583|NCT03544229|42215966|FG002|Overall Study|Adverse Event|1|||
19763584|NCT03544229|42215967|FG003|Overall Study|Adverse Event|0|||
19763585|NCT03544229|42215964|FG000|Overall Study|Protocol Deviation|0|||
19763586|NCT03544229|42215965|FG001|Overall Study|Protocol Deviation|0|||
19763587|NCT03544229|42215966|FG002|Overall Study|Protocol Deviation|1|||
19763588|NCT03544229|42215967|FG003|Overall Study|Protocol Deviation|0|||
19763589|NCT03544229|42215964|FG000|Overall Study|Lost to Follow-up|3|||
19763590|NCT03544229|42215965|FG001|Overall Study|Lost to Follow-up|0|||
19763591|NCT03544229|42215966|FG002|Overall Study|Lost to Follow-up|0|||
19763592|NCT03544229|42215967|FG003|Overall Study|Lost to Follow-up|2|||
19763593|NCT03544229|42215964|FG000|Overall Study|Voluntary Withdrawal|2|||
19763594|NCT03544229|42215965|FG001|Overall Study|Voluntary Withdrawal|1|||
19763595|NCT03544229|42215966|FG002|Overall Study|Voluntary Withdrawal|3|||
19763596|NCT03544229|42215967|FG003|Overall Study|Voluntary Withdrawal|0|||
19763597|NCT03544229|42215964|FG000|Overall Study|Lack of Efficacy|0|||
19763598|NCT03544229|42215965|FG001|Overall Study|Lack of Efficacy|1|||
19763599|NCT03544229|42215966|FG002|Overall Study|Lack of Efficacy|0|||
19680601|NCT00482612|42127948|FG001|Follow-up Period|Lost to Follow-up|4|||
19680602|NCT00482612|42127949|FG002|Follow-up Period|Lost to Follow-up|2|||
19680603|NCT00482612|42127950|FG003|Follow-up Period|Lost to Follow-up|1|||
19680604|NCT00482612|42127947|FG000|Follow-up Period|Adverse Event|4|||
19680605|NCT00482612|42127948|FG001|Follow-up Period|Adverse Event|7|||
19680606|NCT00482612|42127949|FG002|Follow-up Period|Adverse Event|9|||
19680607|NCT00482612|42127950|FG003|Follow-up Period|Adverse Event|0|||
19680608|NCT00482612|42127947|FG000|Follow-up Period|Lack of Efficacy|2|||
19680609|NCT00482612|42127948|FG001|Follow-up Period|Lack of Efficacy|0|||
19680610|NCT00482612|42127949|FG002|Follow-up Period|Lack of Efficacy|1|||
19680611|NCT00482612|42127950|FG003|Follow-up Period|Lack of Efficacy|0|||
19680612|NCT00482612|42127947|FG000|Follow-up Period|Withdrawal by Subject|3|||
19763600|NCT03544229|42215967|FG003|Overall Study|Lack of Efficacy|0|||
19763601|NCT03078816|42215977|FG000|Overall Study|Withdrawal by Subject|1|||
19763602|NCT03510455|42215981|FG000|Overall Study|Physician Decision|1|||
19763603|NCT03509675|42215989|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
19763604|NCT03509675|42215990|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
19763605|NCT03509675|42215989|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
19680613|NCT00482612|42127948|FG001|Follow-up Period|Withdrawal by Subject|5|||
19763606|NCT03509675|42215990|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
19763607|NCT03509675|42215989|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
19763608|NCT03509675|42215990|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
19763609|NCT03509675|42215989|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
19763610|NCT03509675|42215990|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
19763611|NCT03509207|42215996|FG000|Overall Study|Death|2|||
19763612|NCT03543137|42216000|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
19763613|NCT03543137|42216001|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
19763614|NCT03543137|42216000|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
19763615|NCT03543137|42216001|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
19763616|NCT03543137|42216000|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
19763617|NCT03543137|42216001|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
19763618|NCT02895347|42216011|FG000|Overall Study|Withdrawal by Subject|3|||
19763619|NCT02895347|42216012|FG001|Overall Study|Withdrawal by Subject|1|||
19763620|NCT03539549|42216019|FG000|Overall Study|Adverse Event|12|||
19763621|NCT03539549|42216019|FG000|Overall Study|Lost to Follow-up|1|||
19763622|NCT03539549|42216019|FG000|Overall Study|Death|2|||
19763623|NCT03539549|42216019|FG000|Overall Study|Progressive Disease|1|||
19763624|NCT03539549|42216019|FG000|Overall Study|Reason not Specified|1|||
19763625|NCT03506477|42216025|FG000|Overall Study|Withdrawal by Subject|1|||
19763626|NCT03506477|42216026|FG001|Overall Study|Withdrawal by Subject|0|||
19763627|NCT03073980|42216035|FG000|Overall Study|Lost to Follow-up|10|||
19763628|NCT03073980|42216036|FG001|Overall Study|Lost to Follow-up|2|||
19763629|NCT03073980|42216037|FG002|Overall Study|Lost to Follow-up|9|||
19763630|NCT03073980|42216035|FG000|Overall Study|No post-procedure data|0|||
19763631|NCT03073980|42216036|FG001|Overall Study|No post-procedure data|0|||
19763632|NCT03073980|42216037|FG002|Overall Study|No post-procedure data|2|||
19763633|NCT03930186|42216049|FG000|Weeks 0 to 16|Adverse Event|6|||
19763634|NCT03930186|42216049|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
19763635|NCT03930186|42216049|FG000|Weeks 16 to 32|Adverse Event|1|||
19763636|NCT03930186|42216049|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
19763637|NCT03504917|42216055|FG000|Blinded Treatment Period|Protocol Violation|1|||
19763638|NCT03504917|42216056|FG001|Blinded Treatment Period|Protocol Violation|0|||
19763639|NCT03504917|42216055|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
19763640|NCT03504917|42216056|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
19763641|NCT03504917|42216055|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
19763642|NCT03504917|42216056|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
19763643|NCT03504917|42216055|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
19763644|NCT03504917|42216056|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
19763645|NCT03504917|42216055|FG000|Blinded Treatment Period|Adverse Event|4|||
19763646|NCT03504917|42216056|FG001|Blinded Treatment Period|Adverse Event|4|||
19763647|NCT03504917|42216055|FG000|Blinded Treatment Period|Physician Decision|1|||
19763648|NCT03504917|42216056|FG001|Blinded Treatment Period|Physician Decision|0|||
19763649|NCT03504917|42216055|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
19763650|NCT03504917|42216056|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
19763651|NCT03504917|42216055|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
19763652|NCT03504917|42216056|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
19763653|NCT03504917|42216055|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
19763654|NCT03504917|42216056|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
19763655|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
19763656|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
19763657|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
19763658|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
19763659|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
19763660|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
19763661|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
19763662|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
19763663|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
19763664|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
19763665|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
19763666|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
19763667|NCT03504917|42216055|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
19763668|NCT03504917|42216056|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
19763669|NCT03536663|42216068|FG000|Endexo|Protocol Violation|1|||
19763670|NCT03565211|42216077|FG000|Overall Study|Withdrawal by Subject|2|||
19763671|NCT03565211|42216077|FG000|Overall Study|Lost to Follow-up|1|||
19763672|NCT03565211|42216077|FG000|Overall Study|Adverse Event|44|||
19763673|NCT03565211|42216077|FG000|Overall Study|Personal issues|1|||
19763674|NCT03740100|42216081|FG000|Overall Study|Adverse Event|1|||
19763675|NCT03740100|42216081|FG000|Overall Study|Death|1|||
19763676|NCT03531905|42216088|FG000|Overall Study|Withdrawal by Subject|3|||
19763677|NCT03531905|42216089|FG001|Overall Study|Withdrawal by Subject|3|||
19763678|NCT03531905|42216090|FG002|Overall Study|Withdrawal by Subject|2|||
19763679|NCT03531905|42216088|FG000|Overall Study|Lost to Follow-up|2|||
19763680|NCT03531905|42216089|FG001|Overall Study|Lost to Follow-up|2|||
19763681|NCT03531905|42216090|FG002|Overall Study|Lost to Follow-up|1|||
19763682|NCT03531905|42216088|FG000|Overall Study|Participant was out of town|1|||
19763683|NCT03531905|42216089|FG001|Overall Study|Participant was out of town|0|||
19763684|NCT03531905|42216090|FG002|Overall Study|Participant was out of town|0|||
19763685|NCT03531905|42216088|FG000|Overall Study|Could not speak with the participant|1|||
19763686|NCT03531905|42216089|FG001|Overall Study|Could not speak with the participant|0|||
19763687|NCT03531905|42216090|FG002|Overall Study|Could not speak with the participant|0|||
19763688|NCT03531827|42216100|FG000|Overall Study|Adverse Event|2|||
19763689|NCT03531827|42216101|FG001|Overall Study|Adverse Event|0|||
19763690|NCT03531827|42216100|FG000|Overall Study|Progressive disease|1|||
19763691|NCT03531827|42216101|FG001|Overall Study|Progressive disease|0|||
19763692|NCT03530345|42216130|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
19763693|NCT03530345|42216131|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
19763694|NCT03530345|42216130|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
19763695|NCT03530345|42216131|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
19763696|NCT03530345|42216130|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
19680614|NCT00482612|42127949|FG002|Follow-up Period|Withdrawal by Subject|7|||
19680615|NCT00482612|42127950|FG003|Follow-up Period|Withdrawal by Subject|2|||
19680616|NCT00482612|42127947|FG000|Follow-up Period|Reasons not related to trial|1|||
19680617|NCT00482612|42127948|FG001|Follow-up Period|Reasons not related to trial|0|||
19680618|NCT00482612|42127949|FG002|Follow-up Period|Reasons not related to trial|1|||
19680619|NCT00482612|42127950|FG003|Follow-up Period|Reasons not related to trial|3|||
19680620|NCT00282568|42127964|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
19680621|NCT00282568|42127964|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
19680622|NCT00282568|42127964|FG000|Extended Treatment Period|Adverse Event|17|||
19680623|NCT00282568|42127964|FG000|Extended Treatment Period|Non-compliance|4|||
19680624|NCT00282568|42127964|FG000|Extended Treatment Period|Physician Decision|1|||
19680625|NCT00282568|42127964|FG000|Extended Treatment Period|Lost to Follow-up|2|||
19680626|NCT00265564|42127970|FG000|Overall Study|Lost to Follow-up|5|||
19680627|NCT00265564|42127971|FG001|Overall Study|Lost to Follow-up|7|||
19680628|NCT00265564|42127970|FG000|Overall Study|met exclusion criteria|5|||
19680629|NCT00265564|42127971|FG001|Overall Study|met exclusion criteria|2|||
19680630|NCT00376623|42127980|FG000|Overall Study|Progressive disease|35|||
19680631|NCT00376623|42127981|FG001|Overall Study|Progressive disease|22|||
19680632|NCT00376623|42127982|FG002|Overall Study|Progressive disease|17|||
19680633|NCT00376623|42127980|FG000|Overall Study|Lost to Follow-up|0|||
19763697|NCT03530345|42216131|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
19763698|NCT03530345|42216130|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
19763699|NCT03530345|42216131|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
19763700|NCT03500159|42216145|FG000|Overall Study|Study Terminated|2|||
19763701|NCT03500159|42216146|FG001|Overall Study|Study Terminated|1|||
19763702|NCT03785340|42216154|FG000|Overall Study|Lost to Follow-up|2|||
19763703|NCT03785340|42216155|FG001|Overall Study|Lost to Follow-up|0|||
19763704|NCT03785340|42216154|FG000|Overall Study|Adverse Event|1|||
19763705|NCT03785340|42216155|FG001|Overall Study|Adverse Event|0|||
19763706|NCT03499067|42216161|FG000|First Intervention|Physician Decision|2|||
19763707|NCT03499067|42216162|FG001|First Intervention|Physician Decision|1|||
19763708|NCT03499067|42216161|FG000|First Intervention|Withdrawal by Subject|3|||
19763709|NCT03499067|42216162|FG001|First Intervention|Withdrawal by Subject|6|||
19763710|NCT03562481|42216170|FG000|First Intervention|Lost to Follow-up|1|||
19763711|NCT03562481|42216171|FG001|First Intervention|Lost to Follow-up|0|||
19763712|NCT03529409|42216197|FG000|Randomized|Lost to Follow-up|0|||
19763713|NCT03529409|42216198|FG001|Randomized|Lost to Follow-up|0|||
19763714|NCT03529409|42216199|FG002|Randomized|Lost to Follow-up|4|||
19763715|NCT03529409|42216197|FG000|Randomized|Excluded|0|||
19763716|NCT03529409|42216198|FG001|Randomized|Excluded|0|||
19680634|NCT00376623|42127981|FG001|Overall Study|Lost to Follow-up|1|||
19680635|NCT00376623|42127982|FG002|Overall Study|Lost to Follow-up|0|||
19680636|NCT00376623|42127980|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
19680637|NCT00376623|42127981|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
19763717|NCT03529409|42216199|FG002|Randomized|Excluded|1|||
19763718|NCT03529409|42216197|FG000|Post-treatment Assessment|Death|1|||
19763719|NCT03529409|42216198|FG001|Post-treatment Assessment|Death|0|||
19763720|NCT03529409|42216199|FG002|Post-treatment Assessment|Death|0|||
19763721|NCT03529409|42216197|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
19763722|NCT03529409|42216198|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
19763723|NCT03529409|42216199|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
19763724|NCT03529409|42216197|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
19763725|NCT03529409|42216198|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
19763726|NCT03529409|42216199|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
19763727|NCT03529409|42216197|FG000|Follow-up Assessment|Death|1|||
19763728|NCT03529409|42216198|FG001|Follow-up Assessment|Death|0|||
19763729|NCT03529409|42216199|FG002|Follow-up Assessment|Death|0|||
19763730|NCT03529409|42216197|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
19763731|NCT03529409|42216198|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
19763732|NCT03529409|42216199|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
19763733|NCT03498287|42216208|FG000|Overall Study|Withdrawal by Subject|3|||
19763734|NCT03498287|42216209|FG001|Overall Study|Withdrawal by Subject|0|||
19763735|NCT03498287|42216208|FG000|Overall Study|Protocol Violation|0|||
19763736|NCT03498287|42216209|FG001|Overall Study|Protocol Violation|4|||
19763737|NCT03498287|42216208|FG000|Overall Study|Adverse Event|0|||
19763738|NCT03498287|42216209|FG001|Overall Study|Adverse Event|1|||
19763739|NCT03497429|42216217|FG000|Overall Study|Progressive disease|3|||
19763740|NCT03497429|42216218|FG001|Overall Study|Progressive disease|4|||
19763741|NCT03497429|42216217|FG000|Overall Study|Adverse Event|0|||
19763742|NCT03497429|42216218|FG001|Overall Study|Adverse Event|2|||
19763743|NCT03497039|42216226|FG000|Overall Study|Withdrawal by Subject|1|||
19763744|NCT03497039|42216227|FG001|Overall Study|Withdrawal by Subject|0|||
19763745|NCT03497039|42216226|FG000|Overall Study|Protocol Violation|0|||
19763746|NCT03497039|42216227|FG001|Overall Study|Protocol Violation|1|||
19763747|NCT03495869|42216246|FG000|Overall Study|Lost to Follow-up|4|||
19763748|NCT03495869|42216247|FG001|Overall Study|Lost to Follow-up|17|||
19763749|NCT03495869|42216248|FG002|Overall Study|Lost to Follow-up|8|||
19763750|NCT03495869|42216249|FG003|Overall Study|Lost to Follow-up|14|||
19763751|NCT03495869|42216246|FG000|Overall Study|Withdrawal by Subject|0|||
19763752|NCT03495869|42216247|FG001|Overall Study|Withdrawal by Subject|3|||
19763753|NCT03495869|42216248|FG002|Overall Study|Withdrawal by Subject|0|||
19763754|NCT03495869|42216249|FG003|Overall Study|Withdrawal by Subject|3|||
19763755|NCT03495869|42216246|FG000|Overall Study|Dropped from study|0|||
19763756|NCT03495869|42216247|FG001|Overall Study|Dropped from study|7|||
19763757|NCT03495869|42216248|FG002|Overall Study|Dropped from study|2|||
19763758|NCT03495869|42216249|FG003|Overall Study|Dropped from study|4|||
19763759|NCT03071094|42216261|FG000|Overall Study|Death|1|||
19763760|NCT03071094|42216262|FG001|Overall Study|Death|1|||
19763761|NCT03071094|42216261|FG000|Overall Study|Adverse Event|1|||
19763762|NCT03071094|42216262|FG001|Overall Study|Adverse Event|0|||
19763763|NCT03559517|42216271|FG000|Overall Study|Withdrawal by Subject|1|||
19763764|NCT03559517|42216272|FG001|Overall Study|Withdrawal by Subject|0|||
19763765|NCT03559517|42216273|FG002|Overall Study|Withdrawal by Subject|0|||
19763766|NCT02509494|42216290|FG000|Overall Study|Lost to Follow-up|8|||
19763767|NCT02509494|42216291|FG001|Overall Study|Lost to Follow-up|47|||
19763768|NCT02509494|42216292|FG002|Overall Study|Lost to Follow-up|19|||
19763769|NCT02509494|42216293|FG003|Overall Study|Lost to Follow-up|6|||
19763770|NCT02509494|42216294|FG004|Overall Study|Lost to Follow-up|3|||
19763771|NCT02509494|42216295|FG005|Overall Study|Lost to Follow-up|3|||
19763772|NCT02509494|42216296|FG006|Overall Study|Lost to Follow-up|1|||
19763773|NCT02509494|42216297|FG007|Overall Study|Lost to Follow-up|3|||
19763774|NCT02509494|42216298|FG008|Overall Study|Lost to Follow-up|1|||
19763775|NCT02509494|42216290|FG000|Overall Study|Physician Decision|2|||
19763776|NCT02509494|42216291|FG001|Overall Study|Physician Decision|1|||
19763777|NCT02509494|42216292|FG002|Overall Study|Physician Decision|0|||
19763778|NCT02509494|42216293|FG003|Overall Study|Physician Decision|0|||
19763779|NCT02509494|42216294|FG004|Overall Study|Physician Decision|0|||
19763780|NCT02509494|42216295|FG005|Overall Study|Physician Decision|0|||
19763781|NCT02509494|42216296|FG006|Overall Study|Physician Decision|0|||
19763782|NCT02509494|42216297|FG007|Overall Study|Physician Decision|0|||
19763783|NCT02509494|42216298|FG008|Overall Study|Physician Decision|0|||
19763784|NCT02509494|42216290|FG000|Overall Study|Withdrawal by Subject|4|||
19763785|NCT02509494|42216291|FG001|Overall Study|Withdrawal by Subject|17|||
19763786|NCT02509494|42216292|FG002|Overall Study|Withdrawal by Subject|7|||
19763787|NCT02509494|42216293|FG003|Overall Study|Withdrawal by Subject|5|||
19763788|NCT02509494|42216294|FG004|Overall Study|Withdrawal by Subject|0|||
19763789|NCT02509494|42216295|FG005|Overall Study|Withdrawal by Subject|6|||
19763790|NCT02509494|42216296|FG006|Overall Study|Withdrawal by Subject|1|||
19763791|NCT02509494|42216297|FG007|Overall Study|Withdrawal by Subject|2|||
19763792|NCT02509494|42216298|FG008|Overall Study|Withdrawal by Subject|1|||
19763793|NCT02509494|42216290|FG000|Overall Study|Death|0|||
19763794|NCT02509494|42216291|FG001|Overall Study|Death|1|||
19763795|NCT02509494|42216292|FG002|Overall Study|Death|0|||
19763796|NCT02509494|42216293|FG003|Overall Study|Death|0|||
19477232|NCT01482221|41756210|FG000|Overall Study|Lost to Follow-up|3|||
19763797|NCT02509494|42216294|FG004|Overall Study|Death|1|||
19763798|NCT02509494|42216295|FG005|Overall Study|Death|0|||
19763799|NCT02509494|42216296|FG006|Overall Study|Death|0|||
19763800|NCT02509494|42216297|FG007|Overall Study|Death|1|||
19763801|NCT02509494|42216298|FG008|Overall Study|Death|0|||
19763802|NCT02509494|42216290|FG000|Overall Study|Other|0|||
19763803|NCT02509494|42216291|FG001|Overall Study|Other|4|||
19763804|NCT02509494|42216292|FG002|Overall Study|Other|5|||
19763805|NCT02509494|42216293|FG003|Overall Study|Other|0|||
19763806|NCT02509494|42216294|FG004|Overall Study|Other|0|||
19763807|NCT02509494|42216295|FG005|Overall Study|Other|0|||
19763808|NCT02509494|42216296|FG006|Overall Study|Other|0|||
19763809|NCT02509494|42216297|FG007|Overall Study|Other|0|||
19763810|NCT02509494|42216298|FG008|Overall Study|Other|0|||
19763811|NCT02509494|42216290|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19763812|NCT02509494|42216291|FG001|Overall Study|Non-Compliance With Study Drug|11|||
19763813|NCT02509494|42216292|FG002|Overall Study|Non-Compliance With Study Drug|7|||
19763814|NCT02509494|42216293|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19763815|NCT02509494|42216294|FG004|Overall Study|Non-Compliance With Study Drug|1|||
19763816|NCT02509494|42216295|FG005|Overall Study|Non-Compliance With Study Drug|2|||
19763817|NCT02509494|42216296|FG006|Overall Study|Non-Compliance With Study Drug|1|||
19763818|NCT02509494|42216297|FG007|Overall Study|Non-Compliance With Study Drug|1|||
19763819|NCT02509494|42216298|FG008|Overall Study|Non-Compliance With Study Drug|0|||
19763820|NCT03493451|42216335|FG000|Overall Study|Death|11|||
19763821|NCT03493451|42216336|FG001|Overall Study|Death|26|||
19763822|NCT03493451|42216337|FG002|Overall Study|Death|3|||
19680638|NCT00376623|42127982|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
19680639|NCT00376623|42127980|FG000|Overall Study|Not treated with BI 2536|1|||
19680640|NCT00376623|42127981|FG001|Overall Study|Not treated with BI 2536|0|||
19680641|NCT00376623|42127982|FG002|Overall Study|Not treated with BI 2536|0|||
19680642|NCT00376623|42127980|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
19680643|NCT00376623|42127981|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680644|NCT00376623|42127982|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680645|NCT00376623|42127980|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
19680646|NCT00376623|42127981|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
19680647|NCT00376623|42127982|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
19763823|NCT03493451|42216335|FG000|Overall Study|Lost to Follow-up|1|||
19763824|NCT03493451|42216336|FG001|Overall Study|Lost to Follow-up|4|||
19763825|NCT03493451|42216337|FG002|Overall Study|Lost to Follow-up|1|||
19763826|NCT03493451|42216335|FG000|Overall Study|Withdrawal by Subject|1|||
19763827|NCT03493451|42216336|FG001|Overall Study|Withdrawal by Subject|1|||
19763828|NCT03493451|42216337|FG002|Overall Study|Withdrawal by Subject|2|||
19763829|NCT03493451|42216335|FG000|Overall Study|Progressive Disease|1|||
19763830|NCT03493451|42216336|FG001|Overall Study|Progressive Disease|0|||
19763831|NCT03493451|42216337|FG002|Overall Study|Progressive Disease|0|||
19763832|NCT03493451|42216335|FG000|Overall Study|Transferred to long term extension study|8|||
19763833|NCT03493451|42216336|FG001|Overall Study|Transferred to long term extension study|13|||
19763834|NCT03493451|42216337|FG002|Overall Study|Transferred to long term extension study|5|||
19763835|NCT03492281|42216348|FG000|Overall Study|Withdrawal by Subject|21|||
19763836|NCT03492281|42216349|FG001|Overall Study|Withdrawal by Subject|14|||
19763837|NCT03492281|42216350|FG002|Overall Study|Withdrawal by Subject|13|||
19763838|NCT03492281|42216348|FG000|Overall Study|Lost to Follow-up|14|||
19680648|NCT00376623|42127980|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
19763839|NCT03492281|42216349|FG001|Overall Study|Lost to Follow-up|15|||
19763840|NCT03492281|42216350|FG002|Overall Study|Lost to Follow-up|10|||
19763841|NCT03492281|42216348|FG000|Overall Study|Adverse Event|6|||
19763842|NCT03492281|42216349|FG001|Overall Study|Adverse Event|8|||
19763843|NCT03492281|42216350|FG002|Overall Study|Adverse Event|13|||
19763844|NCT03492281|42216348|FG000|Overall Study|Lack of Efficacy|3|||
19763845|NCT03492281|42216349|FG001|Overall Study|Lack of Efficacy|0|||
19763846|NCT03492281|42216350|FG002|Overall Study|Lack of Efficacy|1|||
19763847|NCT03492281|42216348|FG000|Overall Study|Physician Decision|1|||
19763848|NCT03492281|42216349|FG001|Overall Study|Physician Decision|0|||
19763849|NCT03492281|42216350|FG002|Overall Study|Physician Decision|3|||
19763850|NCT03492281|42216348|FG000|Overall Study|Protocol Violation|0|||
19763851|NCT03492281|42216349|FG001|Overall Study|Protocol Violation|2|||
19763852|NCT03492281|42216350|FG002|Overall Study|Protocol Violation|1|||
19763853|NCT03492281|42216348|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
19763854|NCT03492281|42216349|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
19763855|NCT03492281|42216350|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
19763856|NCT03492281|42216348|FG000|Overall Study|Death|0|||
19763857|NCT03492281|42216349|FG001|Overall Study|Death|0|||
19763858|NCT03492281|42216350|FG002|Overall Study|Death|1|||
19763859|NCT03492281|42216348|FG000|Overall Study|Captured as Other in Database|8|||
19763860|NCT03492281|42216349|FG001|Overall Study|Captured as Other in Database|6|||
19763861|NCT03492281|42216350|FG002|Overall Study|Captured as Other in Database|3|||
19763862|NCT03070782|42216367|FG000|Overall Study|Adverse Event|3|||
19763863|NCT03070782|42216368|FG001|Overall Study|Adverse Event|0|||
19763864|NCT03070782|42216369|FG002|Overall Study|Adverse Event|3|||
19763865|NCT03070782|42216370|FG003|Overall Study|Adverse Event|1|||
19763866|NCT03070782|42216371|FG004|Overall Study|Adverse Event|6|||
19763867|NCT03070782|42216372|FG005|Overall Study|Adverse Event|2|||
19763868|NCT03070782|42216367|FG000|Overall Study|Withdrawal by Subject|2|||
19763869|NCT03070782|42216368|FG001|Overall Study|Withdrawal by Subject|1|||
19763870|NCT03070782|42216369|FG002|Overall Study|Withdrawal by Subject|1|||
19763871|NCT03070782|42216370|FG003|Overall Study|Withdrawal by Subject|0|||
19763872|NCT03070782|42216371|FG004|Overall Study|Withdrawal by Subject|4|||
19763873|NCT03070782|42216372|FG005|Overall Study|Withdrawal by Subject|3|||
19763874|NCT03070782|42216367|FG000|Overall Study|Reason Not Specified|2|||
19763875|NCT03070782|42216368|FG001|Overall Study|Reason Not Specified|0|||
19763876|NCT03070782|42216369|FG002|Overall Study|Reason Not Specified|0|||
19763877|NCT03070782|42216370|FG003|Overall Study|Reason Not Specified|1|||
19763878|NCT03070782|42216371|FG004|Overall Study|Reason Not Specified|2|||
19763879|NCT03070782|42216372|FG005|Overall Study|Reason Not Specified|1|||
19763880|NCT03070782|42216367|FG000|Overall Study|Ineligibility|0|||
19763881|NCT03070782|42216368|FG001|Overall Study|Ineligibility|0|||
19763882|NCT03070782|42216369|FG002|Overall Study|Ineligibility|0|||
19763883|NCT03070782|42216370|FG003|Overall Study|Ineligibility|1|||
19763884|NCT03070782|42216371|FG004|Overall Study|Ineligibility|0|||
19763885|NCT03070782|42216372|FG005|Overall Study|Ineligibility|1|||
19763886|NCT03070782|42216367|FG000|Overall Study|Pregnancy|0|||
19763887|NCT03070782|42216368|FG001|Overall Study|Pregnancy|0|||
19763888|NCT03070782|42216369|FG002|Overall Study|Pregnancy|0|||
19763889|NCT03070782|42216370|FG003|Overall Study|Pregnancy|1|||
19763890|NCT03070782|42216371|FG004|Overall Study|Pregnancy|0|||
19763891|NCT03070782|42216372|FG005|Overall Study|Pregnancy|0|||
19763892|NCT03070782|42216367|FG000|Overall Study|Investigator Judgement|0|||
19763893|NCT03070782|42216368|FG001|Overall Study|Investigator Judgement|0|||
19763894|NCT03070782|42216369|FG002|Overall Study|Investigator Judgement|0|||
19763895|NCT03070782|42216370|FG003|Overall Study|Investigator Judgement|1|||
19763896|NCT03070782|42216371|FG004|Overall Study|Investigator Judgement|0|||
19763897|NCT03070782|42216372|FG005|Overall Study|Investigator Judgement|0|||
19763898|NCT03525119|42216408|FG000|Overall Study|Adverse Event|0|||
19763899|NCT03525119|42216409|FG001|Overall Study|Adverse Event|1|||
19763900|NCT03525119|42216410|FG002|Overall Study|Adverse Event|0|||
19763901|NCT03525119|42216408|FG000|Overall Study|Lost to Follow-up|32|||
19763902|NCT03525119|42216409|FG001|Overall Study|Lost to Follow-up|33|||
19763903|NCT03525119|42216410|FG002|Overall Study|Lost to Follow-up|37|||
19763904|NCT03525119|42216408|FG000|Overall Study|Withdrawal by Subject|5|||
19763905|NCT03525119|42216409|FG001|Overall Study|Withdrawal by Subject|4|||
19763906|NCT03525119|42216410|FG002|Overall Study|Withdrawal by Subject|2|||
19763907|NCT03525119|42216408|FG000|Overall Study|Reason not Specified|2|||
19763908|NCT03525119|42216409|FG001|Overall Study|Reason not Specified|1|||
19763909|NCT03525119|42216410|FG002|Overall Study|Reason not Specified|2|||
19763910|NCT03525119|42216408|FG000|Overall Study|Randomized but not Vaccinated|1|||
19763911|NCT03525119|42216409|FG001|Overall Study|Randomized but not Vaccinated|0|||
19763912|NCT03525119|42216410|FG002|Overall Study|Randomized but not Vaccinated|2|||
19763913|NCT03558503|42216418|FG000|Overall Study|Adverse Event|1|||
19763914|NCT03558503|42216418|FG000|Overall Study|Death|1|||
19763915|NCT03558503|42216418|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
19680649|NCT00376623|42127981|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680650|NCT00376623|42127982|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680651|NCT00376623|42127980|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
19680652|NCT00376623|42127981|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
19680653|NCT00376623|42127982|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
19680654|NCT00376623|42127980|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680655|NCT00376623|42127981|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
19680656|NCT00376623|42127982|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
19680657|NCT00376623|42127980|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
19680658|NCT00376623|42127981|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
19680659|NCT00376623|42127982|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
19680660|NCT00376623|42127980|FG000|Overall Study|Increase of tumour markers|0|||
19680661|NCT00376623|42127981|FG001|Overall Study|Increase of tumour markers|1|||
19680662|NCT00376623|42127982|FG002|Overall Study|Increase of tumour markers|0|||
19680663|NCT00376623|42127980|FG000|Overall Study|Bone metastasis|1|||
19680664|NCT00376623|42127981|FG001|Overall Study|Bone metastasis|0|||
19680665|NCT00376623|42127982|FG002|Overall Study|Bone metastasis|0|||
19680666|NCT00445692|42127996|FG000|Overall Study|Adverse Event|11|||
19763916|NCT03489863|42216424|FG000|Overall Study|Withdrawal by Subject|0|||
19763917|NCT03489863|42216425|FG001|Overall Study|Withdrawal by Subject|1|||
19763918|NCT03489551|42216431|FG000|Overall Study|Withdrawal by Subject|2|||
19763919|NCT03557801|42216438|FG000|Overall Study|Protocol Violation|1|||
19763920|NCT03557801|42216439|FG001|Overall Study|Protocol Violation|0|||
19680667|NCT00445692|42127996|FG000|Overall Study|Lack of Efficacy|5|||
19680668|NCT03824236|42128005|FG000|Overall Study|Lost to Follow-up|0|||
19680669|NCT03824236|42128006|FG001|Overall Study|Lost to Follow-up|0|||
19680670|NCT03824236|42128007|FG002|Overall Study|Lost to Follow-up|1|||
19680671|NCT00282412|42128015|FG000|Overall Study|Death|2|||
19763921|NCT03557801|42216440|FG002|Overall Study|Protocol Violation|0|||
19763922|NCT03557801|42216438|FG000|Overall Study|Withdrawal by Subject|1|||
19763923|NCT03557801|42216439|FG001|Overall Study|Withdrawal by Subject|0|||
19763924|NCT03557801|42216440|FG002|Overall Study|Withdrawal by Subject|3|||
19763925|NCT03557801|42216438|FG000|Overall Study|Lost to Follow-up|0|||
19763926|NCT03557801|42216439|FG001|Overall Study|Lost to Follow-up|1|||
19763927|NCT03557801|42216440|FG002|Overall Study|Lost to Follow-up|0|||
19763928|NCT04210180|42216448|FG000|Overall Study|Withdrawal by Subject|2|||
19763929|NCT03523871|42216452|FG000|Overall Study|Death|1|||
19763930|NCT03523715|42216458|FG000|Overall Study|Lost to Follow-up|11|||
19763931|NCT03523715|42216459|FG001|Overall Study|Lost to Follow-up|14|||
19763932|NCT03523715|42216458|FG000|Overall Study|Did not meet inclusion criteria|1|||
19763933|NCT03523715|42216459|FG001|Overall Study|Did not meet inclusion criteria|0|||
19763934|NCT03523715|42216458|FG000|Overall Study|Internally inconsistent reporting|0|||
19763935|NCT03523715|42216459|FG001|Overall Study|Internally inconsistent reporting|2|||
19763936|NCT03980730|42216467|FG000|Overall Study|Study Terminated by Sponsor|0|||
19763937|NCT03980730|42216468|FG001|Overall Study|Study Terminated by Sponsor|3|||
19763938|NCT03980730|42216467|FG000|Overall Study|Adverse Event|2|||
19763939|NCT03980730|42216468|FG001|Overall Study|Adverse Event|0|||
19763940|NCT03980730|42216467|FG000|Overall Study|Sponsor Request|0|||
19763941|NCT03980730|42216468|FG001|Overall Study|Sponsor Request|1|||
19763942|NCT03523091|42216476|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
19763943|NCT03523091|42216477|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
19763944|NCT03523091|42216476|FG000|Overall Study|Withdrawal by Subject|0|||
19763945|NCT03523091|42216477|FG001|Overall Study|Withdrawal by Subject|3|||
19763946|NCT03523091|42216476|FG000|Overall Study|Increase Botox dose|0|||
19763947|NCT03523091|42216477|FG001|Overall Study|Increase Botox dose|1|||
19763948|NCT03438383|42216498|FG000|Overall Study|Protocol Violation|9|||
19763949|NCT03438383|42216499|FG001|Overall Study|Protocol Violation|3|||
19680672|NCT00282334|42128021|FG000|Overall Study|Withdrawal by Subject|8|||
19680673|NCT00282334|42128022|FG001|Overall Study|Withdrawal by Subject|5|||
19763950|NCT03478787|42216507|FG000|Overall Study|Adverse Event|5|||
19763951|NCT03478787|42216508|FG001|Overall Study|Adverse Event|1|||
19763952|NCT03478787|42216507|FG000|Overall Study|Protocol Violation|3|||
19763953|NCT03478787|42216508|FG001|Overall Study|Protocol Violation|0|||
19763954|NCT03478787|42216507|FG000|Overall Study|Lack of Efficacy|7|||
19763955|NCT03478787|42216508|FG001|Overall Study|Lack of Efficacy|1|||
19763956|NCT03478787|42216507|FG000|Overall Study|Lost to Follow-up|9|||
19763957|NCT03478787|42216508|FG001|Overall Study|Lost to Follow-up|5|||
19763958|NCT03478787|42216507|FG000|Overall Study|Withdrawal by Subject|2|||
19763959|NCT03478787|42216508|FG001|Overall Study|Withdrawal by Subject|6|||
19763960|NCT03478787|42216507|FG000|Overall Study|Other, Not Specified|3|||
19763961|NCT03478787|42216508|FG001|Overall Study|Other, Not Specified|0|||
19763962|NCT03488927|42216517|FG000|Overall Study|Withdrawal by Subject|44|||
19763963|NCT03488927|42216518|FG001|Overall Study|Withdrawal by Subject|118|||
19763964|NCT03488927|42216519|FG002|Overall Study|Withdrawal by Subject|217|||
19763965|NCT03488225|42216527|FG000|Overall Study|Off Protocol Therapy|2|||
19763966|NCT03488225|42216527|FG000|Overall Study|Stem Cell Transplant|2|||
19763967|NCT03437447|42216534|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19763968|NCT03437447|42216535|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19763969|NCT03437447|42216536|FG002|Treatment Period 1|Withdrawal by Subject|1|||
19763970|NCT03487445|42216559|FG000|Randomization|Not treated for administrative reasons|1|||
19763971|NCT03487445|42216560|FG001|Randomization|Not treated for administrative reasons|0|||
19763972|NCT02109172|42216566|FG000|Overall Study|Withdrawal by Subject|1|||
19763973|NCT02109172|42216567|FG001|Overall Study|Withdrawal by Subject|0|||
19763974|NCT02109172|42216568|FG002|Overall Study|Withdrawal by Subject|0|||
19763975|NCT02109172|42216569|FG003|Overall Study|Withdrawal by Subject|1|||
19763976|NCT02109172|42216570|FG004|Overall Study|Withdrawal by Subject|0|||
19763977|NCT02109172|42216571|FG005|Overall Study|Withdrawal by Subject|0|||
19763978|NCT02109172|42216566|FG000|Overall Study|Adverse Event|0|||
19763979|NCT02109172|42216567|FG001|Overall Study|Adverse Event|0|||
19763980|NCT02109172|42216568|FG002|Overall Study|Adverse Event|1|||
19763981|NCT02109172|42216569|FG003|Overall Study|Adverse Event|0|||
19763982|NCT02109172|42216570|FG004|Overall Study|Adverse Event|0|||
19680674|NCT00282256|42128028|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
19680675|NCT00282256|42128028|FG000|Extension Treatment Period|Adverse Event|2|||
19680676|NCT00265330|42128032|FG000|Overall Study|Adverse Event|41|||
19763983|NCT02109172|42216571|FG005|Overall Study|Adverse Event|1|||
19763984|NCT02109172|42216566|FG000|Overall Study|Death|0|||
19763985|NCT02109172|42216567|FG001|Overall Study|Death|0|||
19763986|NCT02109172|42216568|FG002|Overall Study|Death|0|||
19763987|NCT02109172|42216569|FG003|Overall Study|Death|0|||
19763988|NCT02109172|42216570|FG004|Overall Study|Death|1|||
19763989|NCT02109172|42216571|FG005|Overall Study|Death|0|||
19763990|NCT02974868|42216582|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
19763991|NCT02974868|42216583|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
19763992|NCT02974868|42216584|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
19763993|NCT02974868|42216585|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
19763994|NCT02974868|42216582|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
19763995|NCT02974868|42216583|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
19763996|NCT02974868|42216584|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
19763997|NCT02974868|42216585|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
19763998|NCT02974868|42216582|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
19763999|NCT02974868|42216583|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
19764000|NCT02974868|42216584|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
19764001|NCT02974868|42216585|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
19764002|NCT02974868|42216582|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
19764003|NCT02974868|42216583|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
19764004|NCT02974868|42216584|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
19764005|NCT02974868|42216585|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
19764006|NCT03486899|42216630|FG000|Overall Study|Lost to Follow-up|4|||
19764007|NCT03486899|42216631|FG001|Overall Study|Lost to Follow-up|1|||
19764008|NCT03486899|42216632|FG002|Overall Study|Lost to Follow-up|4|||
19764009|NCT03486899|42216633|FG003|Overall Study|Lost to Follow-up|3|||
19764010|NCT03486899|42216630|FG000|Overall Study|Death|1|||
19764011|NCT03486899|42216631|FG001|Overall Study|Death|0|||
19764012|NCT03486899|42216632|FG002|Overall Study|Death|0|||
19764013|NCT03486899|42216633|FG003|Overall Study|Death|1|||
19764014|NCT03486899|42216630|FG000|Overall Study|Adverse Event|0|||
19680677|NCT00265330|42128032|FG000|Overall Study|Lost to Follow-up|8|||
19680678|NCT00265330|42128032|FG000|Overall Study|Withdrawal by Subject|34|||
19680679|NCT00265330|42128032|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
19680680|NCT00265330|42128032|FG000|Overall Study|Lack of Efficacy|4|||
19680681|NCT00265330|42128032|FG000|Overall Study|Family Scheduling Conflicts|1|||
19680682|NCT00265330|42128032|FG000|Overall Study|Began Taking Formulary Geodon|1|||
19680683|NCT00265330|42128032|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
19680684|NCT00265330|42128032|FG000|Overall Study|Site Closed by Sponsor|1|||
19680685|NCT00265330|42128032|FG000|Overall Study|Principal Investigators Request|1|||
19680686|NCT00265330|42128032|FG000|Overall Study|Withdrew Consent|1|||
19680687|NCT00265330|42128032|FG000|Overall Study|Protocol Violation|1|||
19680688|NCT00292318|42128038|FG000|Overall Study|Study terminated by officials|2|||
19680689|NCT00292318|42128039|FG001|Overall Study|Study terminated by officials|1|||
19680690|NCT00281632|42128045|FG000|Overall Study|Adverse Event|7|||
19680691|NCT00281632|42128045|FG000|Overall Study|Withdrawal by Subject|2|||
19680692|NCT00281632|42128045|FG000|Overall Study|Disease Progression|22|||
19680693|NCT00281632|42128045|FG000|Overall Study|Death|1|||
19680694|NCT00281632|42128045|FG000|Overall Study|Physician Decision|1|||
19764015|NCT03486899|42216631|FG001|Overall Study|Adverse Event|2|||
19764016|NCT03486899|42216632|FG002|Overall Study|Adverse Event|0|||
19764017|NCT03486899|42216633|FG003|Overall Study|Adverse Event|2|||
19764018|NCT03486899|42216630|FG000|Overall Study|Withdrawal by Subject|3|||
19764019|NCT03486899|42216631|FG001|Overall Study|Withdrawal by Subject|7|||
19764020|NCT03486899|42216632|FG002|Overall Study|Withdrawal by Subject|4|||
19764021|NCT03486899|42216633|FG003|Overall Study|Withdrawal by Subject|3|||
19764022|NCT03486899|42216630|FG000|Overall Study|Other Reasons|0|||
19764023|NCT03486899|42216631|FG001|Overall Study|Other Reasons|1|||
19764024|NCT03486899|42216632|FG002|Overall Study|Other Reasons|0|||
19764025|NCT03486899|42216633|FG003|Overall Study|Other Reasons|1|||
19764026|NCT02918552|42216645|FG000|Overall Study|Failed Pharmacokinetics|1|||
19764027|NCT02918552|42216646|FG001|Overall Study|Failed Pharmacokinetics|0|||
19764028|NCT02918552|42216645|FG000|Overall Study|Withdrawal by Subject|0|||
19764029|NCT02918552|42216646|FG001|Overall Study|Withdrawal by Subject|1|||
19764030|NCT02918552|42216645|FG000|Overall Study|Lost to Follow-up|0|||
19764031|NCT02918552|42216646|FG001|Overall Study|Lost to Follow-up|1|||
19764032|NCT03485495|42216654|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
19764033|NCT03485495|42216655|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
19764034|NCT01065818|42216661|FG000|Overall Study|Withdrawal by Subject|1|||
19764035|NCT01065818|42216661|FG000|Overall Study|Not a candidate for surgery|1|||
19764036|NCT03483623|42216665|FG000|Overall Study|43 complete sets achieved|1|||
19764037|NCT02318277|42216677|FG000|Overall Study|Physician Decision|0|||
19764038|NCT02318277|42216678|FG001|Overall Study|Physician Decision|0|||
19680695|NCT00281632|42128045|FG000|Overall Study|Ongoing|3|||
19680696|NCT00543569|42128061|FG000|Overall Study|Death|2|||
19680697|NCT00543569|42128062|FG001|Overall Study|Death|2|||
19680698|NCT00543569|42128063|FG002|Overall Study|Death|3|||
19680699|NCT00543569|42128064|FG003|Overall Study|Death|1|||
19764039|NCT02318277|42216679|FG002|Overall Study|Physician Decision|0|||
19764040|NCT02318277|42216680|FG003|Overall Study|Physician Decision|0|||
19764041|NCT02318277|42216681|FG004|Overall Study|Physician Decision|0|||
19764042|NCT02318277|42216682|FG005|Overall Study|Physician Decision|0|||
19764043|NCT02318277|42216683|FG006|Overall Study|Physician Decision|0|||
19764044|NCT02318277|42216684|FG007|Overall Study|Physician Decision|1|||
19764045|NCT02318277|42216677|FG000|Overall Study|Other|0|||
19680700|NCT00543569|42128061|FG000|Overall Study|Lost to Follow-up|0|||
19680701|NCT00543569|42128062|FG001|Overall Study|Lost to Follow-up|0|||
19680702|NCT00543569|42128063|FG002|Overall Study|Lost to Follow-up|1|||
19764046|NCT02318277|42216678|FG001|Overall Study|Other|0|||
19764047|NCT02318277|42216679|FG002|Overall Study|Other|0|||
19764048|NCT02318277|42216680|FG003|Overall Study|Other|0|||
19764049|NCT02318277|42216681|FG004|Overall Study|Other|0|||
19764050|NCT02318277|42216682|FG005|Overall Study|Other|0|||
19764051|NCT02318277|42216683|FG006|Overall Study|Other|1|||
19764052|NCT02318277|42216684|FG007|Overall Study|Other|0|||
19764053|NCT02318277|42216677|FG000|Overall Study|Withdrawal by Subject|0|||
19764054|NCT02318277|42216678|FG001|Overall Study|Withdrawal by Subject|0|||
19764055|NCT02318277|42216679|FG002|Overall Study|Withdrawal by Subject|1|||
19764056|NCT02318277|42216680|FG003|Overall Study|Withdrawal by Subject|0|||
19764057|NCT02318277|42216681|FG004|Overall Study|Withdrawal by Subject|1|||
19764058|NCT02318277|42216682|FG005|Overall Study|Withdrawal by Subject|1|||
19764059|NCT02318277|42216683|FG006|Overall Study|Withdrawal by Subject|6|||
19764060|NCT02318277|42216684|FG007|Overall Study|Withdrawal by Subject|14|||
19764061|NCT02318277|42216677|FG000|Overall Study|Participant trial terminated by sponsor|0|||
19764062|NCT02318277|42216678|FG001|Overall Study|Participant trial terminated by sponsor|0|||
19764063|NCT02318277|42216679|FG002|Overall Study|Participant trial terminated by sponsor|1|||
19764064|NCT02318277|42216680|FG003|Overall Study|Participant trial terminated by sponsor|0|||
19764065|NCT02318277|42216681|FG004|Overall Study|Participant trial terminated by sponsor|1|||
19764066|NCT02318277|42216682|FG005|Overall Study|Participant trial terminated by sponsor|2|||
19764067|NCT02318277|42216683|FG006|Overall Study|Participant trial terminated by sponsor|5|||
19764068|NCT02318277|42216684|FG007|Overall Study|Participant trial terminated by sponsor|16|||
19764069|NCT02318277|42216677|FG000|Overall Study|Lost to Follow-up|1|||
19764070|NCT02318277|42216678|FG001|Overall Study|Lost to Follow-up|0|||
19764071|NCT02318277|42216679|FG002|Overall Study|Lost to Follow-up|1|||
19764072|NCT02318277|42216680|FG003|Overall Study|Lost to Follow-up|0|||
19764073|NCT02318277|42216681|FG004|Overall Study|Lost to Follow-up|0|||
19764074|NCT02318277|42216682|FG005|Overall Study|Lost to Follow-up|0|||
19764075|NCT02318277|42216683|FG006|Overall Study|Lost to Follow-up|3|||
19764076|NCT02318277|42216684|FG007|Overall Study|Lost to Follow-up|4|||
19764077|NCT02318277|42216677|FG000|Overall Study|Death|5|||
19764078|NCT02318277|42216678|FG001|Overall Study|Death|3|||
19764079|NCT02318277|42216679|FG002|Overall Study|Death|1|||
19764080|NCT02318277|42216680|FG003|Overall Study|Death|4|||
19764081|NCT02318277|42216681|FG004|Overall Study|Death|6|||
19764082|NCT02318277|42216682|FG005|Overall Study|Death|5|||
19680703|NCT00543569|42128064|FG003|Overall Study|Lost to Follow-up|1|||
19680704|NCT00543569|42128061|FG000|Overall Study|Miscellaneous Reasons|7|||
19680705|NCT00543569|42128062|FG001|Overall Study|Miscellaneous Reasons|3|||
19680706|NCT00543569|42128063|FG002|Overall Study|Miscellaneous Reasons|11|||
19680707|NCT00543569|42128064|FG003|Overall Study|Miscellaneous Reasons|4|||
19680708|NCT00543569|42128061|FG000|Overall Study|Randomized but never received study drug|3|||
19680709|NCT00543569|42128062|FG001|Overall Study|Randomized but never received study drug|3|||
19680710|NCT00543569|42128063|FG002|Overall Study|Randomized but never received study drug|5|||
19680711|NCT00543569|42128064|FG003|Overall Study|Randomized but never received study drug|3|||
19680712|NCT00445458|42128078|FG000|Overall Study|Disease Progression|3|||
19680713|NCT00445458|42128079|FG001|Overall Study|Disease Progression|4|||
19680714|NCT00445458|42128080|FG002|Overall Study|Disease Progression|54|||
19680715|NCT00445458|42128081|FG003|Overall Study|Disease Progression|27|||
19680716|NCT00445458|42128078|FG000|Overall Study|Withdrawal by Subject|0|||
19680717|NCT00445458|42128079|FG001|Overall Study|Withdrawal by Subject|0|||
19680718|NCT00445458|42128080|FG002|Overall Study|Withdrawal by Subject|7|||
19680719|NCT00445458|42128081|FG003|Overall Study|Withdrawal by Subject|0|||
19680720|NCT00445458|42128078|FG000|Overall Study|Adverse Event|0|||
19680721|NCT00445458|42128079|FG001|Overall Study|Adverse Event|0|||
19680722|NCT00445458|42128080|FG002|Overall Study|Adverse Event|3|||
19680723|NCT00445458|42128081|FG003|Overall Study|Adverse Event|0|||
19680724|NCT00445458|42128078|FG000|Overall Study|Death|0|||
19680725|NCT00445458|42128079|FG001|Overall Study|Death|1|||
19680726|NCT00445458|42128080|FG002|Overall Study|Death|2|||
19680727|NCT00445458|42128081|FG003|Overall Study|Death|0|||
19680728|NCT00445458|42128078|FG000|Overall Study|Physician Decision|0|||
19764083|NCT02318277|42216683|FG006|Overall Study|Death|34|||
19764084|NCT02318277|42216684|FG007|Overall Study|Death|58|||
19764085|NCT02318277|42216677|FG000|Overall Study|Transitioned to Hospice|0|||
19680729|NCT00445458|42128079|FG001|Overall Study|Physician Decision|0|||
19680730|NCT00445458|42128080|FG002|Overall Study|Physician Decision|1|||
19764086|NCT02318277|42216678|FG001|Overall Study|Transitioned to Hospice|0|||
19764087|NCT02318277|42216679|FG002|Overall Study|Transitioned to Hospice|0|||
19764088|NCT02318277|42216680|FG003|Overall Study|Transitioned to Hospice|0|||
19764089|NCT02318277|42216681|FG004|Overall Study|Transitioned to Hospice|0|||
19764090|NCT02318277|42216682|FG005|Overall Study|Transitioned to Hospice|1|||
19764091|NCT02318277|42216683|FG006|Overall Study|Transitioned to Hospice|0|||
19764092|NCT02318277|42216684|FG007|Overall Study|Transitioned to Hospice|0|||
19764093|NCT01063868|42216729|FG000|Overall Study|Adverse Event|9|||
19764094|NCT01063868|42216730|FG001|Overall Study|Adverse Event|7|||
19764095|NCT01063868|42216729|FG000|Overall Study|Withdrawal by Subject|3|||
19764096|NCT01063868|42216730|FG001|Overall Study|Withdrawal by Subject|1|||
19764097|NCT01063868|42216729|FG000|Overall Study|Study Terminated By Sponsor|23|||
19764098|NCT01063868|42216730|FG001|Overall Study|Study Terminated By Sponsor|4|||
19764099|NCT02974088|42216738|FG000|Overall Study|Lost to Follow-up|0|||
19764100|NCT02974088|42216739|FG001|Overall Study|Lost to Follow-up|2|||
19764101|NCT02974088|42216738|FG000|Overall Study|Adverse Event|0|||
19764102|NCT02974088|42216739|FG001|Overall Study|Adverse Event|1|||
19764103|NCT02385045|42216745|FG000|Overall Study|Endoscopy could not be completed|4|||
19764104|NCT02974010|42216753|FG000|Overall Study|Lost to Follow-up|3|||
19764105|NCT02974010|42216754|FG001|Overall Study|Lost to Follow-up|1|||
19764106|NCT02974010|42216755|FG002|Overall Study|Lost to Follow-up|0|||
19764107|NCT02974010|42216756|FG003|Overall Study|Lost to Follow-up|0|||
19764108|NCT02974010|42216753|FG000|Overall Study|Withdrawal by Subject|2|||
19764109|NCT02974010|42216754|FG001|Overall Study|Withdrawal by Subject|1|||
19764110|NCT02974010|42216755|FG002|Overall Study|Withdrawal by Subject|0|||
19764111|NCT02974010|42216756|FG003|Overall Study|Withdrawal by Subject|0|||
19764112|NCT02974010|42216753|FG000|Overall Study|Adverse Event|0|||
19764113|NCT02974010|42216754|FG001|Overall Study|Adverse Event|1|||
19764114|NCT02974010|42216755|FG002|Overall Study|Adverse Event|0|||
19764115|NCT02974010|42216756|FG003|Overall Study|Adverse Event|0|||
19764116|NCT02974010|42216753|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
19764117|NCT02974010|42216754|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
19764118|NCT02974010|42216755|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
19680731|NCT00445458|42128081|FG003|Overall Study|Physician Decision|1|||
19680732|NCT00445458|42128078|FG000|Overall Study|Surgery|0|||
19680733|NCT00445458|42128079|FG001|Overall Study|Surgery|0|||
19680734|NCT00445458|42128080|FG002|Overall Study|Surgery|1|||
19680735|NCT00445458|42128081|FG003|Overall Study|Surgery|0|||
19680736|NCT03914417|42128094|FG000|Overall Study|Withdrawal by Subject|2|||
19680737|NCT00541385|42128100|FG000|Overall Study|Adverse Event|6|||
19680738|NCT00541385|42128101|FG001|Overall Study|Adverse Event|3|||
19680739|NCT00541385|42128100|FG000|Overall Study|Withdrawal by Subject|2|||
19680740|NCT00541385|42128101|FG001|Overall Study|Withdrawal by Subject|2|||
19680741|NCT00541385|42128100|FG000|Overall Study|Lost to Follow-up|6|||
19680742|NCT00541385|42128101|FG001|Overall Study|Lost to Follow-up|1|||
19680743|NCT00541385|42128100|FG000|Overall Study|Parasite reappearance/malaria|67|||
19680744|NCT00541385|42128101|FG001|Overall Study|Parasite reappearance/malaria|32|||
19680745|NCT00265096|42128110|FG000|Overall Study|Adverse Event|14|||
19680746|NCT00265096|42128111|FG001|Overall Study|Adverse Event|18|||
19680747|NCT00265096|42128112|FG002|Overall Study|Adverse Event|18|||
19680748|NCT00265096|42128110|FG000|Overall Study|Lost to Follow-up|2|||
19680749|NCT00265096|42128111|FG001|Overall Study|Lost to Follow-up|5|||
19680750|NCT00265096|42128112|FG002|Overall Study|Lost to Follow-up|3|||
19680751|NCT00265096|42128110|FG000|Overall Study|Death|0|||
19680752|NCT00265096|42128111|FG001|Overall Study|Death|1|||
19680753|NCT00265096|42128112|FG002|Overall Study|Death|2|||
19680754|NCT00265096|42128110|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
19680755|NCT00265096|42128111|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
19680756|NCT00265096|42128112|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
19680757|NCT00265096|42128110|FG000|Overall Study|Other|11|||
19680758|NCT00265096|42128111|FG001|Overall Study|Other|19|||
19680759|NCT00265096|42128112|FG002|Overall Study|Other|10|||
19680760|NCT02201108|42128124|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
19680761|NCT02201108|42128125|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
19680762|NCT02201108|42128124|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
19680763|NCT02201108|42128125|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
19764119|NCT02974010|42216756|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
19680764|NCT02201108|42128124|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
19680765|NCT02201108|42128125|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
19680766|NCT02201108|42128124|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
19680767|NCT02201108|42128125|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
19680768|NCT02201108|42128124|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
19680769|NCT02201108|42128125|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
19680770|NCT02201108|42128124|FG000|Open Label Period (up to Week 192)|Other reason|4|||
19764120|NCT02974010|42216753|FG000|Overall Study|Lack of Efficacy|0|||
19764121|NCT02974010|42216754|FG001|Overall Study|Lack of Efficacy|0|||
19764122|NCT02974010|42216755|FG002|Overall Study|Lack of Efficacy|1|||
19764123|NCT02974010|42216756|FG003|Overall Study|Lack of Efficacy|0|||
19764124|NCT02030938|42216766|FG000|Overall Study|Lost to Follow-up|4|||
19764125|NCT02030938|42216766|FG000|Overall Study|Withdrawal by Subject|1|||
19764126|NCT03122535|42216774|FG000|Overall Study|Lost to Follow-up|68|||
19764127|NCT03122535|42216775|FG001|Overall Study|Lost to Follow-up|68|||
19764128|NCT03122535|42216774|FG000|Overall Study|Physician Decision|3|||
19764129|NCT03122535|42216775|FG001|Overall Study|Physician Decision|3|||
19764130|NCT03122535|42216774|FG000|Overall Study|Withdrawal by Subject|2|||
19764131|NCT03122535|42216775|FG001|Overall Study|Withdrawal by Subject|2|||
19764132|NCT01061606|42216781|FG000|Overall Study|Adverse Event|1|||
19764133|NCT01061606|42216781|FG000|Overall Study|Death|1|||
19764134|NCT01061606|42216781|FG000|Overall Study|Disease Progression|4|||
19764135|NCT01061606|42216781|FG000|Overall Study|alternative therapy|2|||
19764136|NCT03122457|42216785|FG000|Overall Study|Withdrawal by Subject|6|||
19764137|NCT03482453|42216801|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764138|NCT03482453|42216802|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764139|NCT03482453|42216803|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764140|NCT03482453|42216804|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764141|NCT03482453|42216805|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764142|NCT03482453|42216806|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764143|NCT03482453|42216807|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764144|NCT03482453|42216808|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764145|NCT03482453|42216809|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764146|NCT03482453|42216810|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764147|NCT03482453|42216811|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
19764148|NCT03482453|42216812|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
19764149|NCT03480425|42216848|FG000|Overall Study|Force transducer technical failure|1|||
19764150|NCT03472547|42216852|FG000|Overall Study|Withdrawal by Subject|30|||
19764151|NCT00799396|42216856|FG000|Clopidogrel Treatment|Adverse Event|6|||
19764152|NCT00799396|42216856|FG000|Clopidogrel Treatment|Physician Decision|5|||
19764153|NCT00799396|42216856|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
19764154|NCT00799396|42216856|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
19764155|NCT00799396|42216856|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
19764156|NCT03469349|42216862|FG000|Overall Study|Withdrawal by Subject|1|||
19764157|NCT03469349|42216863|FG001|Overall Study|Withdrawal by Subject|3|||
19764158|NCT03469349|42216862|FG000|Overall Study|Progressive Disease|0|||
19764159|NCT03469349|42216863|FG001|Overall Study|Progressive Disease|1|||
19764160|NCT03469349|42216862|FG000|Overall Study|Lost to Follow-up|2|||
19764161|NCT03469349|42216863|FG001|Overall Study|Lost to Follow-up|2|||
19764162|NCT03469349|42216862|FG000|Overall Study|Adverse Event|2|||
19764163|NCT03469349|42216863|FG001|Overall Study|Adverse Event|4|||
19764164|NCT03467945|42216873|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19764165|NCT03467945|42216874|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19764166|NCT03467945|42216875|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19764167|NCT03467945|42216876|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19764168|NCT03467945|42216873|FG000|Treatment Period 3|Withdrawal by Subject|1|||
19764169|NCT03467945|42216874|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19604457|NCT00699283|42053346|FG001|Overall Study|Withdrawal by Subject|0|||
19680771|NCT02201108|42128125|FG001|Open Label Period (up to Week 192)|Other reason|7|||
19680772|NCT02201108|42128124|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
19680773|NCT02201108|42128125|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
19680774|NCT00281320|42128146|FG000|Overall Study|Adverse Event|12|||
19680775|NCT00281320|42128147|FG001|Overall Study|Adverse Event|9|||
19680776|NCT00281320|42128146|FG000|Overall Study|Lack of Efficacy|4|||
19680777|NCT00281320|42128147|FG001|Overall Study|Lack of Efficacy|3|||
19680778|NCT00281320|42128146|FG000|Overall Study|Withdrawal by Subject|5|||
19680779|NCT00281320|42128147|FG001|Overall Study|Withdrawal by Subject|6|||
19680780|NCT00281320|42128146|FG000|Overall Study|Lost to Follow-up|1|||
19680781|NCT00281320|42128147|FG001|Overall Study|Lost to Follow-up|2|||
19764170|NCT03467945|42216875|FG002|Treatment Period 3|Withdrawal by Subject|2|||
19764171|NCT03467945|42216876|FG003|Treatment Period 3|Withdrawal by Subject|1|||
19764172|NCT00069238|42216887|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
19764173|NCT00069238|42216888|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
19764174|NCT00069238|42216889|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
19764175|NCT00069238|42216887|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
19764176|NCT00069238|42216888|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
19604458|NCT00699283|42053345|FG000|Overall Study|Other Reason|5|||
19604459|NCT00699283|42053346|FG001|Overall Study|Other Reason|1|||
19604460|NCT00699283|42053345|FG000|Overall Study|SAE, non-fatal|1|||
19604461|NCT00699283|42053346|FG001|Overall Study|SAE, non-fatal|1|||
19604462|NCT00699283|42053345|FG000|Overall Study|AE, non-serious non-fatal|8|||
19604463|NCT00699283|42053346|FG001|Overall Study|AE, non-serious non-fatal|1|||
19604464|NCT00699283|42053345|FG000|Overall Study|AE of unknown type|1|||
19604465|NCT00699283|42053346|FG001|Overall Study|AE of unknown type|0|||
19680782|NCT00281320|42128146|FG000|Overall Study|Other|3|||
19680783|NCT00281320|42128147|FG001|Overall Study|Other|1|||
19680784|NCT00541307|42128159|FG000|Overall Study|Death|5|||
19680785|NCT00541307|42128159|FG000|Overall Study|Physician Decision|3|||
19680786|NCT00541307|42128159|FG000|Overall Study|Withdrawal by Subject|6|||
19680787|NCT00541307|42128159|FG000|Overall Study|Lost to Follow-up|4|||
19680788|NCT00541307|42128159|FG000|Overall Study|Subject returned early (outside window)|1|||
19680789|NCT00541307|42128159|FG000|Overall Study|Surgical Bypass|5|||
19680790|NCT00541229|42128169|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
19680791|NCT00541229|42128170|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
19680792|NCT00541229|42128171|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
19680793|NCT00541229|42128172|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
19680794|NCT00541229|42128173|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
19680795|NCT00541229|42128174|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
19680796|NCT00541229|42128169|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
19680797|NCT00541229|42128170|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
19680798|NCT00541229|42128171|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
19680799|NCT00541229|42128172|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
19680800|NCT00541229|42128173|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
19680801|NCT00541229|42128174|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
19680802|NCT00541229|42128169|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
19680803|NCT00541229|42128170|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
19680804|NCT00541229|42128171|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
19680805|NCT00541229|42128172|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
19680806|NCT00541229|42128173|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
19680807|NCT00541229|42128174|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
19680808|NCT00541229|42128169|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
19680809|NCT00541229|42128170|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
19680810|NCT00541229|42128171|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
19680811|NCT00541229|42128172|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
19680812|NCT00541229|42128173|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
19680813|NCT00541229|42128174|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
19680814|NCT00541229|42128169|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
19680815|NCT00541229|42128170|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
19680816|NCT00541229|42128171|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
19680817|NCT00541229|42128172|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
19680818|NCT00541229|42128173|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
19680819|NCT00541229|42128174|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
19680820|NCT00541229|42128169|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
19680821|NCT00541229|42128170|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
19680822|NCT00541229|42128171|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
19764177|NCT00069238|42216889|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
19764178|NCT00069238|42216887|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
19764179|NCT00069238|42216888|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
19764180|NCT00069238|42216889|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
19764181|NCT03435497|42216896|FG000|Overall Study|Lost to Follow-up|1|||
19764182|NCT03435497|42216897|FG001|Overall Study|Lost to Follow-up|0|||
19764183|NCT03435497|42216896|FG000|Overall Study|Death|1|||
19764184|NCT03435497|42216897|FG001|Overall Study|Death|0|||
19764185|NCT03435497|42216896|FG000|Overall Study|Withdrawal by Subject|0|||
19764186|NCT03435497|42216897|FG001|Overall Study|Withdrawal by Subject|4|||
19764187|NCT03435497|42216896|FG000|Overall Study|Wrong survey administered|0|||
19764188|NCT03435497|42216897|FG001|Overall Study|Wrong survey administered|2|||
19764189|NCT03073200|42216906|FG000|Double Blind Treatment Period|Protocol Violation|1|||
19764190|NCT03073200|42216907|FG001|Double Blind Treatment Period|Protocol Violation|0|||
19764191|NCT03073200|42216908|FG002|Double Blind Treatment Period|Protocol Violation|0|||
19764192|NCT03073200|42216909|FG003|Double Blind Treatment Period|Protocol Violation|0|||
19764193|NCT03073200|42216910|FG004|Double Blind Treatment Period|Protocol Violation|0|||
19764194|NCT03073200|42216911|FG005|Double Blind Treatment Period|Protocol Violation|0|||
19604466|NCT00740584|42053351|FG000|Overall Study|Withdrawal by Subject|1|||
19604467|NCT01023815|42053360|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
19604468|NCT01023815|42053361|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
19604469|NCT01023815|42053362|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
19604470|NCT01023815|42053363|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
19604471|NCT01023815|42053360|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
19604472|NCT01023815|42053361|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
19604473|NCT01023815|42053362|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
19604474|NCT01023815|42053363|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
19604475|NCT01023815|42053360|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
19764195|NCT03073200|42216912|FG006|Double Blind Treatment Period|Protocol Violation|0|||
19764196|NCT03073200|42216913|FG007|Double Blind Treatment Period|Protocol Violation|0|||
19764197|NCT03073200|42216914|FG008|Double Blind Treatment Period|Protocol Violation|0|||
19764198|NCT03073200|42216915|FG009|Double Blind Treatment Period|Protocol Violation|0|||
19764199|NCT03073200|42216916|FG010|Double Blind Treatment Period|Protocol Violation|0|||
19764200|NCT03073200|42216917|FG011|Double Blind Treatment Period|Protocol Violation|0|||
19764201|NCT03073200|42216918|FG012|Double Blind Treatment Period|Protocol Violation|0|||
19764202|NCT03073200|42216919|FG013|Double Blind Treatment Period|Protocol Violation|0|||
19764203|NCT03073200|42216920|FG014|Double Blind Treatment Period|Protocol Violation|0|||
19764204|NCT03073200|42216906|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764205|NCT03073200|42216907|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
19764206|NCT03073200|42216908|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764207|NCT03073200|42216909|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764208|NCT03073200|42216910|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764209|NCT03073200|42216911|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764210|NCT03073200|42216912|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764211|NCT03073200|42216913|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764212|NCT03073200|42216914|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764213|NCT03073200|42216915|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19680823|NCT00541229|42128172|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
19680824|NCT00541229|42128173|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
19680825|NCT00541229|42128174|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
19680826|NCT00541229|42128169|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
19680827|NCT00541229|42128170|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
19680828|NCT00541229|42128171|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
19764214|NCT03073200|42216916|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764215|NCT03073200|42216917|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764216|NCT03073200|42216918|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764217|NCT03073200|42216919|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764218|NCT03073200|42216920|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
19764219|NCT03073200|42216906|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
19764220|NCT03073200|42216907|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764221|NCT03073200|42216908|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764222|NCT03073200|42216909|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764223|NCT03073200|42216910|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764224|NCT03073200|42216911|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764225|NCT03073200|42216912|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764226|NCT03073200|42216913|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764227|NCT03073200|42216914|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764228|NCT03073200|42216915|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764229|NCT03073200|42216916|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764230|NCT03073200|42216917|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764231|NCT03073200|42216918|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764232|NCT03073200|42216919|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764233|NCT03073200|42216920|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
19764234|NCT03073200|42216906|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764235|NCT03073200|42216907|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
19604476|NCT01023815|42053361|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
19604477|NCT01023815|42053362|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
19604478|NCT01023815|42053363|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
19604479|NCT01023815|42053360|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
19604480|NCT01023815|42053361|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
19680829|NCT00541229|42128172|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
19680830|NCT00541229|42128173|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
19680831|NCT00541229|42128174|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
19680832|NCT00541229|42128169|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
19680833|NCT00541229|42128170|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
19680834|NCT00541229|42128171|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
19680835|NCT00541229|42128172|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
19680836|NCT00541229|42128173|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
19680837|NCT00541229|42128174|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
19680838|NCT00541229|42128169|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
19680839|NCT00541229|42128170|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
19680840|NCT00541229|42128171|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
19604481|NCT01023815|42053362|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
19604482|NCT01023815|42053363|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
19604483|NCT01023815|42053360|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
19764236|NCT03073200|42216908|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764237|NCT03073200|42216909|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
19764238|NCT03073200|42216910|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
19764239|NCT03073200|42216911|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764240|NCT03073200|42216912|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764241|NCT03073200|42216913|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764242|NCT03073200|42216914|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764243|NCT03073200|42216915|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764244|NCT03073200|42216916|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764245|NCT03073200|42216917|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764246|NCT03073200|42216918|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764247|NCT03073200|42216919|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764248|NCT03073200|42216920|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
19764249|NCT03073200|42216906|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
19764250|NCT03073200|42216907|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
19764251|NCT03073200|42216908|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
19764252|NCT03073200|42216909|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
19764253|NCT03073200|42216910|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
19764254|NCT03073200|42216911|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
19764255|NCT03073200|42216912|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
19764256|NCT03073200|42216913|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
19764257|NCT03073200|42216914|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
19764258|NCT03073200|42216915|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
19764259|NCT03073200|42216916|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
19764260|NCT03073200|42216917|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
19764261|NCT03073200|42216918|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
19764262|NCT03073200|42216919|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
19764263|NCT03073200|42216920|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
19764264|NCT03073200|42216906|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764265|NCT03073200|42216907|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764266|NCT03073200|42216908|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764267|NCT03073200|42216909|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764268|NCT03073200|42216910|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
19764269|NCT03073200|42216911|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764270|NCT03073200|42216912|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764271|NCT03073200|42216913|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764272|NCT03073200|42216914|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764273|NCT03073200|42216915|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764274|NCT03073200|42216916|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764275|NCT03073200|42216917|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764276|NCT03073200|42216918|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764277|NCT03073200|42216919|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764278|NCT03073200|42216920|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
19764279|NCT03073200|42216906|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764280|NCT03073200|42216907|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764281|NCT03073200|42216908|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764282|NCT03073200|42216909|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
19764283|NCT03073200|42216910|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
19764284|NCT03073200|42216911|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764285|NCT03073200|42216912|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764286|NCT03073200|42216913|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764287|NCT03073200|42216914|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764288|NCT03073200|42216915|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764289|NCT03073200|42216916|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764290|NCT03073200|42216917|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764291|NCT03073200|42216918|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764292|NCT03073200|42216919|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764293|NCT03073200|42216920|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
19764294|NCT03073200|42216906|FG000|Extension Period|Lost to Follow-up|0|||
19764295|NCT03073200|42216907|FG001|Extension Period|Lost to Follow-up|0|||
19764296|NCT03073200|42216908|FG002|Extension Period|Lost to Follow-up|0|||
19764297|NCT03073200|42216909|FG003|Extension Period|Lost to Follow-up|0|||
19764298|NCT03073200|42216910|FG004|Extension Period|Lost to Follow-up|0|||
19764299|NCT03073200|42216911|FG005|Extension Period|Lost to Follow-up|0|||
19764300|NCT03073200|42216912|FG006|Extension Period|Lost to Follow-up|1|||
19764301|NCT03073200|42216913|FG007|Extension Period|Lost to Follow-up|1|||
19389088|NCT02670551|41632642|FG000|Overall Study|Noncompliance with study drug|3|||
19764302|NCT03073200|42216914|FG008|Extension Period|Lost to Follow-up|0|||
19680841|NCT00541229|42128172|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
19680842|NCT00541229|42128173|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
19680843|NCT00541229|42128174|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
19680844|NCT00541229|42128169|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
19680845|NCT00541229|42128170|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
19680846|NCT00541229|42128171|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
19680847|NCT00541229|42128172|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
19680848|NCT00541229|42128173|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
19680849|NCT00541229|42128174|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
19680850|NCT00541229|42128169|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
19680851|NCT00541229|42128170|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
19680852|NCT00541229|42128171|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
19680853|NCT00541229|42128172|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
19680854|NCT00541229|42128173|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
19680855|NCT00541229|42128174|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
19680856|NCT00541229|42128169|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
19680857|NCT00541229|42128170|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
19680858|NCT00541229|42128171|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
19680859|NCT00541229|42128172|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
19680860|NCT00541229|42128173|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
19680861|NCT00541229|42128174|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
19680862|NCT00541229|42128169|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
19680863|NCT00541229|42128170|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
19680864|NCT00541229|42128171|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
19680865|NCT00541229|42128172|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
19764303|NCT03073200|42216915|FG009|Extension Period|Lost to Follow-up|0|||
19764304|NCT03073200|42216916|FG010|Extension Period|Lost to Follow-up|0|||
19764305|NCT03073200|42216917|FG011|Extension Period|Lost to Follow-up|0|||
19764306|NCT03073200|42216918|FG012|Extension Period|Lost to Follow-up|0|||
19764307|NCT03073200|42216919|FG013|Extension Period|Lost to Follow-up|0|||
19764308|NCT03073200|42216920|FG014|Extension Period|Lost to Follow-up|0|||
19764309|NCT03073200|42216906|FG000|Extension Period|Sponsor Decision|0|||
19764310|NCT03073200|42216907|FG001|Extension Period|Sponsor Decision|0|||
19764311|NCT03073200|42216908|FG002|Extension Period|Sponsor Decision|0|||
19764312|NCT03073200|42216909|FG003|Extension Period|Sponsor Decision|0|||
19764313|NCT03073200|42216910|FG004|Extension Period|Sponsor Decision|0|||
19764314|NCT03073200|42216911|FG005|Extension Period|Sponsor Decision|0|||
19764315|NCT03073200|42216912|FG006|Extension Period|Sponsor Decision|0|||
19764316|NCT03073200|42216913|FG007|Extension Period|Sponsor Decision|0|||
19764317|NCT03073200|42216914|FG008|Extension Period|Sponsor Decision|1|||
19764318|NCT03073200|42216915|FG009|Extension Period|Sponsor Decision|0|||
19764319|NCT03073200|42216916|FG010|Extension Period|Sponsor Decision|0|||
19764320|NCT03073200|42216917|FG011|Extension Period|Sponsor Decision|0|||
19764321|NCT03073200|42216918|FG012|Extension Period|Sponsor Decision|0|||
19764322|NCT03073200|42216919|FG013|Extension Period|Sponsor Decision|0|||
19764323|NCT03073200|42216920|FG014|Extension Period|Sponsor Decision|0|||
19764324|NCT03073200|42216906|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
19764325|NCT03073200|42216907|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
19764326|NCT03073200|42216908|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
19764327|NCT03073200|42216909|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
19764328|NCT03073200|42216910|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
19764329|NCT03073200|42216911|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
19764330|NCT03073200|42216912|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
19764331|NCT03073200|42216913|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
19764332|NCT03073200|42216914|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
19764333|NCT03073200|42216915|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
19764334|NCT03073200|42216916|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
19764335|NCT03073200|42216917|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
19764336|NCT03073200|42216918|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
19764337|NCT03073200|42216919|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
19764338|NCT03073200|42216920|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
19764339|NCT03073200|42216906|FG000|Extension Period|Withdrawal by Subject|0|||
19764340|NCT03073200|42216907|FG001|Extension Period|Withdrawal by Subject|0|||
19764341|NCT03073200|42216908|FG002|Extension Period|Withdrawal by Subject|0|||
19764342|NCT03073200|42216909|FG003|Extension Period|Withdrawal by Subject|0|||
19764343|NCT03073200|42216910|FG004|Extension Period|Withdrawal by Subject|0|||
19764344|NCT03073200|42216911|FG005|Extension Period|Withdrawal by Subject|0|||
19764345|NCT03073200|42216912|FG006|Extension Period|Withdrawal by Subject|1|||
19764346|NCT03073200|42216913|FG007|Extension Period|Withdrawal by Subject|2|||
19389089|NCT02670551|41632643|FG001|Overall Study|Noncompliance with study drug|3|||
19680866|NCT00541229|42128173|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
19680867|NCT00541229|42128174|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
19680868|NCT00541229|42128169|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
19680869|NCT00541229|42128170|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
19680870|NCT00541229|42128171|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
19680871|NCT00541229|42128172|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
19680872|NCT00541229|42128173|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
19680873|NCT00541229|42128174|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
19680874|NCT00541229|42128169|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
19680875|NCT00541229|42128170|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
19680876|NCT00541229|42128171|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
19680877|NCT00541229|42128172|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
19680878|NCT00541229|42128173|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
19680879|NCT00541229|42128174|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
19680880|NCT00541229|42128169|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
19680881|NCT00541229|42128170|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
19680882|NCT00541229|42128171|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
19680883|NCT00541229|42128172|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
19680884|NCT00541229|42128173|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
19680885|NCT00541229|42128174|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
19680886|NCT00481988|42128184|FG000|Overall Study|Withdrawal by Subject|1|||
19680887|NCT00481988|42128185|FG001|Overall Study|Withdrawal by Subject|1|||
19680888|NCT00481832|42128202|FG000|Enrollment|Physician Decision|8|||
19680889|NCT00481832|42128202|FG000|Enrollment|Unable to collect enough stem cells|2|||
19604484|NCT01023815|42053361|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
19604485|NCT01023815|42053362|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
19604486|NCT01023815|42053363|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
19680890|NCT00481832|42128202|FG000|Inter-transplant Period|Adverse Event|4|||
19680891|NCT00481832|42128202|FG000|Inter-transplant Period|Death|3|||
19680892|NCT00481832|42128202|FG000|Inter-transplant Period|Physician Decision|4|||
19680893|NCT00481832|42128202|FG000|Inter-transplant Period|Disease relapse|11|||
19680894|NCT00481832|42128202|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
19680895|NCT00481676|42128208|FG000|Overall Study|Adverse Event|0|||
19680896|NCT00481676|42128209|FG001|Overall Study|Adverse Event|1|||
19680897|NCT00481676|42128208|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19680898|NCT00481676|42128209|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19680899|NCT00481676|42128208|FG000|Overall Study|Administrative problem|1|||
19680900|NCT00481676|42128209|FG001|Overall Study|Administrative problem|0|||
19604487|NCT01023659|42053377|FG000|Overall Study|Lost to Follow-up|73|||
19604488|NCT01023659|42053378|FG001|Overall Study|Lost to Follow-up|228|||
19604489|NCT01023659|42053379|FG002|Overall Study|Lost to Follow-up|99|||
19604490|NCT00740116|42053390|FG000|Overall Study|Withdrawal by Subject|1|||
19604491|NCT00740116|42053391|FG001|Overall Study|Withdrawal by Subject|1|||
19604492|NCT00740116|42053390|FG000|Overall Study|Protocol Violation|1|||
19604493|NCT00740116|42053391|FG001|Overall Study|Protocol Violation|4|||
19604494|NCT00698581|42053401|FG000|Overall Study|Lack of Efficacy|23|||
19604495|NCT00698581|42053402|FG001|Overall Study|Lack of Efficacy|11|||
19604496|NCT00698581|42053401|FG000|Overall Study|Withdrawal by Subject|6|||
19604497|NCT00698581|42053402|FG001|Overall Study|Withdrawal by Subject|0|||
19604498|NCT00698581|42053401|FG000|Overall Study|Other reason|9|||
19604499|NCT00698581|42053402|FG001|Overall Study|Other reason|1|||
19604500|NCT00698581|42053401|FG000|Overall Study|SAE, non-fatal|1|||
19604501|NCT00698581|42053402|FG001|Overall Study|SAE, non-fatal|0|||
19604502|NCT00698581|42053401|FG000|Overall Study|AE, non-serious non-fatal|4|||
19604503|NCT00698581|42053402|FG001|Overall Study|AE, non-serious non-fatal|0|||
19604504|NCT00698581|42053401|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19604505|NCT00698581|42053402|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19604506|NCT00698581|42053401|FG000|Overall Study|AE of unknown type|1|||
19604507|NCT00698581|42053402|FG001|Overall Study|AE of unknown type|0|||
19604508|NCT01023581|42053416|FG000|Overall Study|Adverse Event|4|||
19604509|NCT01023581|42053417|FG001|Overall Study|Adverse Event|4|||
19604510|NCT01023581|42053418|FG002|Overall Study|Adverse Event|7|||
19604511|NCT01023581|42053419|FG003|Overall Study|Adverse Event|3|||
19604512|NCT01023581|42053420|FG004|Overall Study|Adverse Event|2|||
19604513|NCT01023581|42053421|FG005|Overall Study|Adverse Event|5|||
19604514|NCT01023581|42053422|FG006|Overall Study|Adverse Event|11|||
19680901|NCT00542789|42128217|FG000|Overall Study|Adverse Event|18|||
19680902|NCT00542789|42128218|FG001|Overall Study|Adverse Event|17|||
19680903|NCT00542789|42128217|FG000|Overall Study|Withdrawal by Subject|7|||
19680904|NCT00542789|42128218|FG001|Overall Study|Withdrawal by Subject|3|||
19680905|NCT00542789|42128217|FG000|Overall Study|Protocol Violation|8|||
19680906|NCT00542789|42128218|FG001|Overall Study|Protocol Violation|1|||
19680907|NCT00542789|42128217|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
19680908|NCT00542789|42128218|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
19680909|NCT00464672|42128226|FG000|Overall Study|withdrawal of consent|0|||
19680910|NCT00464672|42128227|FG001|Overall Study|withdrawal of consent|0|||
19680911|NCT00464672|42128228|FG002|Overall Study|withdrawal of consent|0|||
19680912|NCT00464672|42128229|FG003|Overall Study|withdrawal of consent|1|||
19680913|NCT00464672|42128230|FG004|Overall Study|withdrawal of consent|9|||
19680914|NCT00464672|42128231|FG005|Overall Study|withdrawal of consent|4|||
19680915|NCT00464672|42128226|FG000|Overall Study|Lost to Follow-up|25|||
19680916|NCT00464672|42128227|FG001|Overall Study|Lost to Follow-up|10|||
19680917|NCT00464672|42128228|FG002|Overall Study|Lost to Follow-up|0|||
19680918|NCT00464672|42128229|FG003|Overall Study|Lost to Follow-up|0|||
19680919|NCT00464672|42128230|FG004|Overall Study|Lost to Follow-up|1|||
19680920|NCT00464672|42128231|FG005|Overall Study|Lost to Follow-up|0|||
19680921|NCT00473876|42128261|FG000|Overall Study|Lost to Follow-up|3|||
19680922|NCT00473876|42128262|FG001|Overall Study|Lost to Follow-up|1|||
19680923|NCT00463580|42128272|FG000|Overall Study|Lost to Follow-up|1|||
19680924|NCT00463580|42128273|FG001|Overall Study|Lost to Follow-up|0|||
19680925|NCT00463580|42128272|FG000|Overall Study|Schedule conflict|2|||
19680926|NCT00463580|42128273|FG001|Overall Study|Schedule conflict|0|||
19680927|NCT00463580|42128272|FG000|Overall Study|Medical/psychiatric complications|0|||
19764347|NCT03073200|42216914|FG008|Extension Period|Withdrawal by Subject|0|||
19764348|NCT03073200|42216915|FG009|Extension Period|Withdrawal by Subject|0|||
19764349|NCT03073200|42216916|FG010|Extension Period|Withdrawal by Subject|0|||
19764350|NCT03073200|42216917|FG011|Extension Period|Withdrawal by Subject|0|||
19764351|NCT03073200|42216918|FG012|Extension Period|Withdrawal by Subject|0|||
19764352|NCT03073200|42216919|FG013|Extension Period|Withdrawal by Subject|0|||
19764353|NCT03073200|42216920|FG014|Extension Period|Withdrawal by Subject|0|||
19764354|NCT03073200|42216906|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764355|NCT03073200|42216907|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764356|NCT03073200|42216908|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764357|NCT03073200|42216909|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764358|NCT03073200|42216910|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764359|NCT03073200|42216911|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764360|NCT03073200|42216912|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764361|NCT03073200|42216913|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764362|NCT03073200|42216914|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764363|NCT03073200|42216915|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764364|NCT03073200|42216916|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764365|NCT03073200|42216917|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
19764366|NCT03073200|42216918|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764367|NCT03073200|42216919|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764368|NCT03073200|42216920|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
19764369|NCT03073200|42216906|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764370|NCT03073200|42216907|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764371|NCT03073200|42216908|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764372|NCT03073200|42216909|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764373|NCT03073200|42216910|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764374|NCT03073200|42216911|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764375|NCT03073200|42216912|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764376|NCT03073200|42216913|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764377|NCT03073200|42216914|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764378|NCT03073200|42216915|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764379|NCT03073200|42216916|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764380|NCT03073200|42216917|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
19680928|NCT00463580|42128273|FG001|Overall Study|Medical/psychiatric complications|2|||
19680929|NCT00540449|42128287|FG000|Overall Study|Adverse Event|12|||
19680930|NCT00540449|42128288|FG001|Overall Study|Adverse Event|32|||
19680931|NCT00540449|42128287|FG000|Overall Study|Sponsor's Decision|1|||
19680932|NCT00540449|42128288|FG001|Overall Study|Sponsor's Decision|1|||
19764381|NCT03073200|42216918|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764382|NCT03073200|42216919|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19764383|NCT03073200|42216920|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
19680933|NCT00540449|42128287|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
19680934|NCT00540449|42128288|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
19764384|NCT03073200|42216906|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764385|NCT03073200|42216907|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764386|NCT03073200|42216908|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19389090|NCT02670551|41632644|FG002|Overall Study|Noncompliance with study drug|2|||
19680935|NCT00540449|42128287|FG000|Overall Study|Lost to Follow-up|19|||
19680936|NCT00540449|42128288|FG001|Overall Study|Lost to Follow-up|17|||
19680937|NCT00540449|42128287|FG000|Overall Study|Subject Non-Compliant|7|||
19680938|NCT00540449|42128288|FG001|Overall Study|Subject Non-Compliant|5|||
19680939|NCT00540449|42128287|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
19680940|NCT00540449|42128288|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
19680941|NCT00540449|42128287|FG000|Overall Study|Withdrawal by Subject|10|||
19680942|NCT00540449|42128288|FG001|Overall Study|Withdrawal by Subject|10|||
19764387|NCT03073200|42216909|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764388|NCT03073200|42216910|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764389|NCT03073200|42216911|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19680943|NCT00540449|42128287|FG000|Overall Study|Other|1|||
19680944|NCT00540449|42128288|FG001|Overall Study|Other|4|||
19680945|NCT03911843|42128296|FG000|Overall Study|Adverse Event|2|||
19680946|NCT03911843|42128297|FG001|Overall Study|Adverse Event|0|||
19680947|NCT03911843|42128296|FG000|Overall Study|Protocol Violation|2|||
19680948|NCT03911843|42128297|FG001|Overall Study|Protocol Violation|0|||
19680949|NCT03911843|42128296|FG000|Overall Study|Lost to Follow-up|0|||
19680950|NCT03911843|42128297|FG001|Overall Study|Lost to Follow-up|1|||
19680951|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Adverse Event|9|||
19680952|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Adverse Event|4|||
19680953|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Adverse Event|5|||
19680954|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Adverse Event|9|||
19680955|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Adverse Event|8|||
19680956|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Adverse Event|0|||
19680957|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Adverse Event|0|||
19680958|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
19680959|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
19680960|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
19680961|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
19680962|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
19680963|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
19680964|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
19680965|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Death|1|||
19680966|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Death|1|||
19680967|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Death|1|||
19680968|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Death|1|||
19680969|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Death|0|||
19680970|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Death|0|||
19680971|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Death|0|||
19680972|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
19680973|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
19680974|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
19680975|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
19680976|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
19680977|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
19680978|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
19680979|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680980|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680981|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
19680982|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680983|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680984|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680985|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
19680986|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
19680987|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
19680988|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
19680989|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
19680990|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
19680991|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
19680992|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
19680993|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Other|2|||
19680994|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Other|9|||
19680995|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Other|9|||
19680996|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Other|3|||
19680997|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Other|2|||
19680998|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Other|0|||
19680999|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Other|0|||
19681000|NCT00361335|42128308|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
19681001|NCT00361335|42128309|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
19681002|NCT00361335|42128310|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
19681003|NCT00361335|42128311|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
19764390|NCT03073200|42216912|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764391|NCT03073200|42216913|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764392|NCT03073200|42216914|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764393|NCT03073200|42216915|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764394|NCT03073200|42216916|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
19764395|NCT03073200|42216917|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
19764396|NCT03073200|42216918|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764397|NCT03073200|42216919|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764398|NCT03073200|42216920|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
19764399|NCT03073200|42216906|FG000|Randomized Withdrawal Period|Adverse Event|0|||
19764400|NCT03073200|42216907|FG001|Randomized Withdrawal Period|Adverse Event|0|||
19764401|NCT03073200|42216908|FG002|Randomized Withdrawal Period|Adverse Event|0|||
19764402|NCT03073200|42216909|FG003|Randomized Withdrawal Period|Adverse Event|0|||
19764403|NCT03073200|42216910|FG004|Randomized Withdrawal Period|Adverse Event|0|||
19764404|NCT03073200|42216911|FG005|Randomized Withdrawal Period|Adverse Event|0|||
19764405|NCT03073200|42216912|FG006|Randomized Withdrawal Period|Adverse Event|0|||
19764406|NCT03073200|42216913|FG007|Randomized Withdrawal Period|Adverse Event|0|||
19764407|NCT03073200|42216914|FG008|Randomized Withdrawal Period|Adverse Event|0|||
19764408|NCT03073200|42216915|FG009|Randomized Withdrawal Period|Adverse Event|0|||
19764409|NCT03073200|42216916|FG010|Randomized Withdrawal Period|Adverse Event|1|||
19764410|NCT03073200|42216917|FG011|Randomized Withdrawal Period|Adverse Event|0|||
19764411|NCT03073200|42216918|FG012|Randomized Withdrawal Period|Adverse Event|0|||
19764412|NCT03073200|42216919|FG013|Randomized Withdrawal Period|Adverse Event|0|||
19764413|NCT03073200|42216920|FG014|Randomized Withdrawal Period|Adverse Event|0|||
19681004|NCT00361335|42128312|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
19681005|NCT00361335|42128313|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
19681006|NCT00361335|42128314|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
19681007|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
19681008|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
19681009|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
19681010|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
19681011|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
19681012|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
19681013|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
19681014|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
19681015|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
19681016|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
19681017|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
19681018|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
19681019|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
19681020|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
19681021|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Death|0|||
19681022|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Death|0|||
19681023|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Death|0|||
19681024|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Death|0|||
19681025|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Death|0|||
19681026|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Death|0|||
19681027|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Death|1|||
19681028|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
19681029|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
19681030|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
19681031|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
19681032|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
19681033|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
19681034|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
19681035|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Other|1|||
19764414|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764415|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764416|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764417|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764418|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764419|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764420|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764421|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764422|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
19389091|NCT02670551|41632642|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19681036|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Other|0|||
19681037|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Other|0|||
19681038|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Other|1|||
19764423|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764424|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764425|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764426|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764427|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
19764428|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
19764429|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764430|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764431|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764432|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764433|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764434|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764435|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764436|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764437|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764438|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764439|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764440|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764441|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764442|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
19681039|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Other|0|||
19681040|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Other|1|||
19681041|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Other|2|||
19681042|NCT00361335|42128308|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
19681043|NCT00361335|42128309|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
19681044|NCT00361335|42128310|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
19681045|NCT00361335|42128311|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
19681046|NCT00361335|42128312|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
19681047|NCT00361335|42128313|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
19681048|NCT00361335|42128314|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
19681049|NCT00264550|42128334|FG000|Overall Study|Death|0|||
19681050|NCT00264550|42128335|FG001|Overall Study|Death|3|||
19681051|NCT00264550|42128336|FG002|Overall Study|Death|0|||
19681052|NCT00264550|42128337|FG003|Overall Study|Death|0|||
19681053|NCT00264550|42128334|FG000|Overall Study|Lost to Follow-up|3|||
19681054|NCT00264550|42128335|FG001|Overall Study|Lost to Follow-up|1|||
19681055|NCT00264550|42128336|FG002|Overall Study|Lost to Follow-up|1|||
19681056|NCT00264550|42128337|FG003|Overall Study|Lost to Follow-up|1|||
19681057|NCT00264550|42128334|FG000|Overall Study|Adverse Event|23|||
19681058|NCT00264550|42128335|FG001|Overall Study|Adverse Event|18|||
19681059|NCT00264550|42128336|FG002|Overall Study|Adverse Event|9|||
19681060|NCT00264550|42128337|FG003|Overall Study|Adverse Event|14|||
19681061|NCT00264550|42128334|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19681062|NCT00264550|42128335|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
19681063|NCT00264550|42128336|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
19681064|NCT00264550|42128337|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
19681065|NCT00264550|42128334|FG000|Overall Study|Discontinued oral study agent|0|||
19764443|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19764444|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764445|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764446|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764447|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764448|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764449|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764450|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764451|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764452|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764453|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764454|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764455|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764456|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764457|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
19764458|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
19764459|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764460|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764461|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764462|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764463|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764464|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19681066|NCT00264550|42128335|FG001|Overall Study|Discontinued oral study agent|1|||
19681067|NCT00264550|42128336|FG002|Overall Study|Discontinued oral study agent|0|||
19764465|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764466|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764467|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764468|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764469|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764470|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764471|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764472|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
19764473|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
19764474|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764475|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764476|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764477|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764478|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764479|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764480|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764481|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764482|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764483|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764484|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764485|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764486|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764487|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
19764488|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
19764489|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764490|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764491|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764492|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764493|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764494|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764495|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764496|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764497|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764498|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764499|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764500|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764501|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764502|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
19764503|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
19764504|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764505|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764506|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764507|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764508|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764509|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764510|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764511|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764512|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764513|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764514|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764515|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764516|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764517|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
19764518|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
19764519|NCT03073200|42216906|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764520|NCT03073200|42216907|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764521|NCT03073200|42216908|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764522|NCT03073200|42216909|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764523|NCT03073200|42216910|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764524|NCT03073200|42216911|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764525|NCT03073200|42216912|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764526|NCT03073200|42216913|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764527|NCT03073200|42216914|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764528|NCT03073200|42216915|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764529|NCT03073200|42216916|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764530|NCT03073200|42216917|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764531|NCT03073200|42216918|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764532|NCT03073200|42216919|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
19764533|NCT03073200|42216920|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
19764534|NCT03290781|42216949|FG000|Overall Study|Adverse Event|5|||
19764535|NCT03290781|42216950|FG001|Overall Study|Adverse Event|7|||
19764536|NCT03290781|42216951|FG002|Overall Study|Adverse Event|4|||
19764537|NCT03290781|42216952|FG003|Overall Study|Adverse Event|1|||
19764538|NCT03290781|42216953|FG004|Overall Study|Adverse Event|0|||
19764539|NCT03290781|42216954|FG005|Overall Study|Adverse Event|0|||
19764540|NCT03290781|42216955|FG006|Overall Study|Adverse Event|0|||
19764541|NCT03290781|42216949|FG000|Overall Study|Death|0|||
19764542|NCT03290781|42216950|FG001|Overall Study|Death|0|||
19764543|NCT03290781|42216951|FG002|Overall Study|Death|1|||
19764544|NCT03290781|42216952|FG003|Overall Study|Death|0|||
19764545|NCT03290781|42216953|FG004|Overall Study|Death|1|||
19764546|NCT03290781|42216954|FG005|Overall Study|Death|0|||
19764547|NCT03290781|42216955|FG006|Overall Study|Death|0|||
19764548|NCT03290781|42216949|FG000|Overall Study|Withdrawal by Subject|6|||
19764549|NCT03290781|42216950|FG001|Overall Study|Withdrawal by Subject|5|||
19764550|NCT03290781|42216951|FG002|Overall Study|Withdrawal by Subject|9|||
19764551|NCT03290781|42216952|FG003|Overall Study|Withdrawal by Subject|10|||
19764552|NCT03290781|42216953|FG004|Overall Study|Withdrawal by Subject|1|||
19764553|NCT03290781|42216954|FG005|Overall Study|Withdrawal by Subject|2|||
19764554|NCT03290781|42216955|FG006|Overall Study|Withdrawal by Subject|0|||
19764555|NCT03290781|42216949|FG000|Overall Study|Physician Decision|0|||
19764556|NCT03290781|42216950|FG001|Overall Study|Physician Decision|1|||
19764557|NCT03290781|42216951|FG002|Overall Study|Physician Decision|0|||
19764558|NCT03290781|42216952|FG003|Overall Study|Physician Decision|0|||
19764559|NCT03290781|42216953|FG004|Overall Study|Physician Decision|0|||
19764560|NCT03290781|42216954|FG005|Overall Study|Physician Decision|0|||
19764561|NCT03290781|42216955|FG006|Overall Study|Physician Decision|0|||
19764562|NCT03290781|42216949|FG000|Overall Study|Site Terminated by Sponsor|1|||
19764563|NCT03290781|42216950|FG001|Overall Study|Site Terminated by Sponsor|0|||
19764564|NCT03290781|42216951|FG002|Overall Study|Site Terminated by Sponsor|2|||
19764565|NCT03290781|42216952|FG003|Overall Study|Site Terminated by Sponsor|1|||
19764566|NCT03290781|42216953|FG004|Overall Study|Site Terminated by Sponsor|0|||
19764567|NCT03290781|42216954|FG005|Overall Study|Site Terminated by Sponsor|0|||
19764568|NCT03290781|42216955|FG006|Overall Study|Site Terminated by Sponsor|0|||
19764569|NCT03290781|42216949|FG000|Overall Study|Lost to Follow-up|0|||
19764570|NCT03290781|42216950|FG001|Overall Study|Lost to Follow-up|0|||
19764571|NCT03290781|42216951|FG002|Overall Study|Lost to Follow-up|0|||
19764572|NCT03290781|42216952|FG003|Overall Study|Lost to Follow-up|1|||
19764573|NCT03290781|42216953|FG004|Overall Study|Lost to Follow-up|0|||
19764574|NCT03290781|42216954|FG005|Overall Study|Lost to Follow-up|0|||
19764575|NCT03290781|42216955|FG006|Overall Study|Lost to Follow-up|0|||
19764576|NCT03290781|42216949|FG000|Overall Study|Protocol Deviation|2|||
19764577|NCT03290781|42216950|FG001|Overall Study|Protocol Deviation|0|||
19764578|NCT03290781|42216951|FG002|Overall Study|Protocol Deviation|0|||
19764579|NCT03290781|42216952|FG003|Overall Study|Protocol Deviation|1|||
19764580|NCT03290781|42216953|FG004|Overall Study|Protocol Deviation|0|||
19764581|NCT03290781|42216954|FG005|Overall Study|Protocol Deviation|0|||
19764582|NCT03290781|42216955|FG006|Overall Study|Protocol Deviation|0|||
19764583|NCT03290781|42216949|FG000|Overall Study|Disease Relapse|32|||
19764584|NCT03290781|42216950|FG001|Overall Study|Disease Relapse|5|||
19764585|NCT03290781|42216951|FG002|Overall Study|Disease Relapse|38|||
19764586|NCT03290781|42216952|FG003|Overall Study|Disease Relapse|7|||
19764587|NCT03290781|42216953|FG004|Overall Study|Disease Relapse|3|||
19764588|NCT03290781|42216954|FG005|Overall Study|Disease Relapse|1|||
19764589|NCT03290781|42216955|FG006|Overall Study|Disease Relapse|4|||
19764590|NCT03290781|42216949|FG000|Overall Study|Other|3|||
19764591|NCT03290781|42216950|FG001|Overall Study|Other|0|||
19764592|NCT03290781|42216951|FG002|Overall Study|Other|2|||
19764593|NCT03290781|42216952|FG003|Overall Study|Other|2|||
19764594|NCT03290781|42216953|FG004|Overall Study|Other|0|||
19764595|NCT03290781|42216954|FG005|Overall Study|Other|0|||
19764596|NCT03290781|42216955|FG006|Overall Study|Other|0|||
19764597|NCT03466073|42216984|FG000|Overall Study|Death|1|||
19764598|NCT03466073|42216985|FG001|Overall Study|Death|0|||
19764599|NCT03466073|42216986|FG002|Overall Study|Death|0|||
19764600|NCT03466073|42216987|FG003|Overall Study|Death|0|||
19764601|NCT03466073|42216988|FG004|Overall Study|Death|0|||
19764602|NCT03466073|42216989|FG005|Overall Study|Death|1|||
19764603|NCT03412019|42217012|FG000|Overall Study|Withdrawal by Subject|1|||
19764604|NCT03412019|42217013|FG001|Overall Study|Withdrawal by Subject|1|||
19764605|NCT03070002|42217019|FG000|Follow up for 2 Years|Death|1|||
19764606|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
19764607|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
19764608|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
19764609|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
19764610|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
19764611|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
19764612|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
19764613|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
19764614|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
19764615|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
19764616|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
19764617|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
19764618|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
19764619|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
19764620|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
19764621|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
19764622|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
19764623|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
19764624|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
19764625|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
19764626|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
19764627|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
19764628|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
19764629|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
19764630|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
19764631|NCT02918318|42217027|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
19764632|NCT02918318|42217028|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
19764633|NCT02918318|42217029|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
19764634|NCT02918318|42217030|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
19764635|NCT02918318|42217031|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
19764636|NCT02918318|42217027|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
19764637|NCT02918318|42217028|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
19681068|NCT00264550|42128337|FG003|Overall Study|Discontinued oral study agent|0|||
19681069|NCT00264550|42128334|FG000|Overall Study|Other|13|||
19681070|NCT00264550|42128335|FG001|Overall Study|Other|7|||
19681071|NCT00264550|42128336|FG002|Overall Study|Other|3|||
19681072|NCT00264550|42128337|FG003|Overall Study|Other|9|||
19681073|NCT00541931|42128349|FG000|Overall Study|Adverse Event|1|||
19681074|NCT00541931|42128350|FG001|Overall Study|Adverse Event|0|||
19681075|NCT00541931|42128349|FG000|Overall Study|Lost to Follow-up|3|||
19681076|NCT00541931|42128350|FG001|Overall Study|Lost to Follow-up|3|||
19681077|NCT00541931|42128349|FG000|Overall Study|Withdrawal by Subject|1|||
19681078|NCT00541931|42128350|FG001|Overall Study|Withdrawal by Subject|0|||
19681079|NCT00541931|42128349|FG000|Overall Study|Transportation Issue|0|||
19681080|NCT00541931|42128350|FG001|Overall Study|Transportation Issue|1|||
19681081|NCT00368979|42128360|FG000|Overall Study|Adverse Event|9|||
19681082|NCT00368979|42128361|FG001|Overall Study|Adverse Event|16|||
19681083|NCT00368979|42128360|FG000|Overall Study|Lack of Efficacy|5|||
19681084|NCT00368979|42128361|FG001|Overall Study|Lack of Efficacy|3|||
19681085|NCT00368979|42128360|FG000|Overall Study|Other|3|||
19681086|NCT00368979|42128361|FG001|Overall Study|Other|1|||
19681087|NCT00368979|42128360|FG000|Overall Study|Lost to Follow-up|1|||
19681088|NCT00368979|42128361|FG001|Overall Study|Lost to Follow-up|0|||
19681089|NCT00368979|42128360|FG000|Overall Study|Protocol Violation|2|||
19681090|NCT00368979|42128361|FG001|Overall Study|Protocol Violation|1|||
19681091|NCT00368979|42128360|FG000|Overall Study|Withdrawal by Subject|5|||
19681092|NCT00368979|42128361|FG001|Overall Study|Withdrawal by Subject|9|||
19681093|NCT00264238|42128367|FG000|Overall Study|Protocol Violation|1|||
19681094|NCT00540293|42128373|FG000|Overall Study|Adverse event related to study drug|10|||
19681095|NCT00540293|42128373|FG000|Overall Study|Adverse event not related to study drug|7|||
19681096|NCT00540293|42128373|FG000|Overall Study|Withdrawal by Subject|6|||
19681097|NCT00540293|42128373|FG000|Overall Study|Protocol violation, & subject schedule|12|||
19681098|NCT00375609|42128386|FG000|Overall Study|Did not receive treatment|1|||
19681099|NCT00375609|42128387|FG001|Overall Study|Did not receive treatment|0|||
19681100|NCT00375609|42128388|FG002|Overall Study|Did not receive treatment|0|||
19681101|NCT00375609|42128386|FG000|Overall Study|Adverse Event|0|||
19389092|NCT02670551|41632643|FG001|Overall Study|Other Miscellaneous Reasons|3|||
19681102|NCT00375609|42128387|FG001|Overall Study|Adverse Event|3|||
19681103|NCT00375609|42128388|FG002|Overall Study|Adverse Event|0|||
19681104|NCT00375609|42128386|FG000|Overall Study|Lost to Follow-up|1|||
19681105|NCT00375609|42128387|FG001|Overall Study|Lost to Follow-up|0|||
19681106|NCT00375609|42128388|FG002|Overall Study|Lost to Follow-up|0|||
19681107|NCT00375609|42128386|FG000|Overall Study|Physician Decision|0|||
19764638|NCT02918318|42217029|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
19764639|NCT02918318|42217030|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
19764640|NCT02918318|42217031|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
19764641|NCT02918318|42217027|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
19764642|NCT02918318|42217028|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764643|NCT02918318|42217029|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
19764644|NCT02918318|42217030|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
19764645|NCT02918318|42217031|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764646|NCT02918318|42217027|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
19764647|NCT02918318|42217028|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
19764648|NCT02918318|42217029|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
19764649|NCT02918318|42217030|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
19764650|NCT02918318|42217031|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
19764651|NCT02918318|42217027|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
19764652|NCT02918318|42217028|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
19764653|NCT02918318|42217029|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
19764654|NCT02918318|42217030|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
19764655|NCT02918318|42217031|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
19764656|NCT02918318|42217027|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
19764657|NCT02918318|42217028|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
19764658|NCT02918318|42217029|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
19764659|NCT02918318|42217030|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
19764660|NCT02918318|42217031|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
19764661|NCT02918318|42217027|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764662|NCT02918318|42217028|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764663|NCT02918318|42217029|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764664|NCT02918318|42217030|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
19764665|NCT02918318|42217031|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
19764666|NCT03411863|42217076|FG000|Overall Study|Withdrawal by Subject|3|||
19681108|NCT00375609|42128387|FG001|Overall Study|Physician Decision|0|||
19681109|NCT00375609|42128388|FG002|Overall Study|Physician Decision|1|||
19681110|NCT00375609|42128386|FG000|Overall Study|Withdrawal by Subject|1|||
19681111|NCT00375609|42128387|FG001|Overall Study|Withdrawal by Subject|4|||
19681112|NCT00375609|42128388|FG002|Overall Study|Withdrawal by Subject|0|||
19681113|NCT00375609|42128386|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
19681114|NCT00375609|42128387|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
19681115|NCT00375609|42128388|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
19681116|NCT00359073|42128427|FG000|Overall Study|Withdrawal by Subject|1|||
19681117|NCT00359073|42128428|FG001|Overall Study|Withdrawal by Subject|1|||
19681118|NCT00359073|42128427|FG000|Overall Study|Eligibility criteria no longer met|3|||
19681119|NCT00359073|42128428|FG001|Overall Study|Eligibility criteria no longer met|0|||
19681120|NCT00359073|42128427|FG000|Overall Study|developed RV16 antibody|0|||
19681121|NCT00359073|42128428|FG001|Overall Study|developed RV16 antibody|1|||
19681122|NCT03918239|42128438|FG000|Overall Study|Lost to Follow-up|3|||
19681123|NCT03918239|42128439|FG001|Overall Study|Lost to Follow-up|1|||
19681124|NCT03918239|42128438|FG000|Overall Study|Pregnancy|0|||
19681125|NCT03918239|42128439|FG001|Overall Study|Pregnancy|2|||
19681126|NCT03918239|42128438|FG000|Overall Study|Withdrawal by Subject|3|||
19681127|NCT03918239|42128439|FG001|Overall Study|Withdrawal by Subject|3|||
19681128|NCT03918239|42128438|FG000|Overall Study|positive urine drug screening results|4|||
19681129|NCT03918239|42128439|FG001|Overall Study|positive urine drug screening results|1|||
19681130|NCT00368745|42128447|FG000|Double-blind Treatment Period|Adverse Event|6|||
19681131|NCT00368745|42128448|FG001|Double-blind Treatment Period|Adverse Event|6|||
19681132|NCT00368745|42128447|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
19681133|NCT00368745|42128448|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
19681134|NCT00368745|42128447|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
19681135|NCT00368745|42128448|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
19681136|NCT00368745|42128447|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
19681137|NCT00368745|42128448|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
19681138|NCT00368745|42128447|FG000|Double-blind Treatment Period|Other|7|||
19681139|NCT00368745|42128448|FG001|Double-blind Treatment Period|Other|6|||
19681140|NCT00454818|42128462|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
19681141|NCT00454818|42128463|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
19681142|NCT00454818|42128464|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
19764667|NCT03411863|42217077|FG001|Overall Study|Withdrawal by Subject|1|||
19764668|NCT03411863|42217076|FG000|Overall Study|Physician Decision|0|||
19764669|NCT03411863|42217077|FG001|Overall Study|Physician Decision|1|||
19764670|NCT01065350|42217086|FG000|Overall Study|Received incorrect drug allocation|0|||
19681143|NCT00454818|42128465|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
19681144|NCT00454818|42128466|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
19764671|NCT01065350|42217087|FG001|Overall Study|Received incorrect drug allocation|1|||
19764672|NCT03434249|42217095|FG000|Overall Study|Adverse Event|1|||
19764673|NCT03434249|42217096|FG001|Overall Study|Adverse Event|0|||
19764674|NCT03434249|42217095|FG000|Overall Study|Lost to Follow-up|0|||
19764675|NCT03434249|42217096|FG001|Overall Study|Lost to Follow-up|1|||
19764676|NCT03434249|42217095|FG000|Overall Study|Non-compliance of family|2|||
19764677|NCT03434249|42217096|FG001|Overall Study|Non-compliance of family|1|||
19764678|NCT03434249|42217095|FG000|Overall Study|Difficulties in completing daily diary|2|||
19764679|NCT03434249|42217096|FG001|Overall Study|Difficulties in completing daily diary|1|||
19764680|NCT03114969|42217111|FG000|Overall Study|Lost to Follow-up|0|||
19764681|NCT03114969|42217112|FG001|Overall Study|Lost to Follow-up|0|||
19764682|NCT03114969|42217113|FG002|Overall Study|Lost to Follow-up|3|||
19764683|NCT03114969|42217114|FG003|Overall Study|Lost to Follow-up|2|||
19764684|NCT03114969|42217115|FG004|Overall Study|Lost to Follow-up|0|||
19764685|NCT03114969|42217116|FG005|Overall Study|Lost to Follow-up|0|||
19764686|NCT03114969|42217117|FG006|Overall Study|Lost to Follow-up|0|||
19764687|NCT03114969|42217118|FG007|Overall Study|Lost to Follow-up|0|||
19764688|NCT03114969|42217119|FG008|Overall Study|Lost to Follow-up|0|||
19764689|NCT03114969|42217111|FG000|Overall Study|Adverse Event|0|||
19764690|NCT03114969|42217112|FG001|Overall Study|Adverse Event|0|||
19764691|NCT03114969|42217113|FG002|Overall Study|Adverse Event|1|||
19764692|NCT03114969|42217114|FG003|Overall Study|Adverse Event|0|||
19764693|NCT03114969|42217115|FG004|Overall Study|Adverse Event|0|||
19764694|NCT03114969|42217116|FG005|Overall Study|Adverse Event|1|||
19764695|NCT03114969|42217117|FG006|Overall Study|Adverse Event|1|||
19764696|NCT03114969|42217118|FG007|Overall Study|Adverse Event|0|||
19764697|NCT03114969|42217119|FG008|Overall Study|Adverse Event|2|||
19764698|NCT02046096|42217148|FG000|Overall Study|Death|28|||
19764699|NCT02046096|42217149|FG001|Overall Study|Death|45|||
19764700|NCT02046096|42217148|FG000|Overall Study|Lost to Follow-up|9|||
19764701|NCT02046096|42217149|FG001|Overall Study|Lost to Follow-up|20|||
19764702|NCT02046096|42217148|FG000|Overall Study|Withdrawal by Subject|5|||
19764703|NCT02046096|42217149|FG001|Overall Study|Withdrawal by Subject|17|||
19764704|NCT02046096|42217148|FG000|Overall Study|Other endpoint|2|||
19764705|NCT02046096|42217149|FG001|Overall Study|Other endpoint|19|||
19764706|NCT03463577|42217163|FG000|Overall Study|Lost to Follow-up|238|||
19764707|NCT03463577|42217164|FG001|Overall Study|Lost to Follow-up|435|||
19764708|NCT03463577|42217165|FG002|Overall Study|Lost to Follow-up|0|||
19764709|NCT03463577|42217166|FG003|Overall Study|Lost to Follow-up|0|||
19764710|NCT03463577|42217167|FG004|Overall Study|Lost to Follow-up|0|||
19764711|NCT03463577|42217168|FG005|Overall Study|Lost to Follow-up|0|||
19764712|NCT03463577|42217163|FG000|Overall Study|With unknown pregnancy outcome|0|||
19764713|NCT03463577|42217164|FG001|Overall Study|With unknown pregnancy outcome|5|||
19764714|NCT03463577|42217165|FG002|Overall Study|With unknown pregnancy outcome|0|||
19764715|NCT03463577|42217166|FG003|Overall Study|With unknown pregnancy outcome|0|||
19764716|NCT03463577|42217167|FG004|Overall Study|With unknown pregnancy outcome|0|||
19764717|NCT03463577|42217168|FG005|Overall Study|With unknown pregnancy outcome|0|||
19764718|NCT03463577|42217163|FG000|Overall Study|Maternal death|2|||
19764719|NCT03463577|42217164|FG001|Overall Study|Maternal death|0|||
19764720|NCT03463577|42217165|FG002|Overall Study|Maternal death|0|||
19764721|NCT03463577|42217166|FG003|Overall Study|Maternal death|0|||
19764722|NCT03463577|42217167|FG004|Overall Study|Maternal death|0|||
19764723|NCT03463577|42217168|FG005|Overall Study|Maternal death|0|||
19764724|NCT03463577|42217163|FG000|Overall Study|Neonatal death|0|||
19764725|NCT03463577|42217164|FG001|Overall Study|Neonatal death|0|||
19764726|NCT03463577|42217165|FG002|Overall Study|Neonatal death|0|||
19764727|NCT03463577|42217166|FG003|Overall Study|Neonatal death|15|||
19764728|NCT03463577|42217167|FG004|Overall Study|Neonatal death|17|||
19764729|NCT03463577|42217168|FG005|Overall Study|Neonatal death|0|||
19681145|NCT00454818|42128462|FG000|Phase I: Open-label Dose-escalation|Death|0|||
19681146|NCT00454818|42128463|FG001|Phase I: Open-label Dose-escalation|Death|1|||
19681147|NCT00454818|42128464|FG002|Phase I: Open-label Dose-escalation|Death|0|||
19681148|NCT00454818|42128465|FG003|Phase I: Open-label Dose-escalation|Death|0|||
19681149|NCT00454818|42128466|FG004|Phase I: Open-label Dose-escalation|Death|0|||
19681150|NCT00454818|42128462|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
19681151|NCT00454818|42128463|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
19681152|NCT00454818|42128464|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
19681153|NCT00454818|42128465|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
19699015|NCT03824912|42143820|FG002|Overall Study|Non-Compliance with Study Drug|1|||
19764730|NCT03122145|42217184|FG000|Overall Study|Concurrent respiratory disease|3|||
19764731|NCT03122145|42217185|FG001|Overall Study|Concurrent respiratory disease|0|||
19764732|NCT03114657|42217193|FG000|Overall Study|Adverse Event|9|||
19764733|NCT03114657|42217194|FG001|Overall Study|Adverse Event|6|||
19764734|NCT03114657|42217193|FG000|Overall Study|Death|4|||
19764735|NCT03114657|42217194|FG001|Overall Study|Death|0|||
19764736|NCT03114657|42217193|FG000|Overall Study|Multiple Reasons|1|||
19764737|NCT03114657|42217194|FG001|Overall Study|Multiple Reasons|2|||
19764738|NCT03114657|42217193|FG000|Overall Study|Physician Decision|2|||
19764739|NCT03114657|42217194|FG001|Overall Study|Physician Decision|2|||
19764740|NCT03114657|42217193|FG000|Overall Study|Study Terminated By Sponsor|355|||
19764741|NCT03114657|42217194|FG001|Overall Study|Study Terminated By Sponsor|374|||
19764742|NCT03114657|42217193|FG000|Overall Study|Symptomatic Deterioration|0|||
19764743|NCT03114657|42217194|FG001|Overall Study|Symptomatic Deterioration|1|||
19764744|NCT03114657|42217193|FG000|Overall Study|Withdrawal by Subject|28|||
19764745|NCT03114657|42217194|FG001|Overall Study|Withdrawal by Subject|22|||
19764746|NCT02926950|42217203|FG000|Overall Study|Adverse Event|4|||
19764747|NCT02926950|42217204|FG001|Overall Study|Adverse Event|6|||
19764748|NCT02926950|42217203|FG000|Overall Study|At the participant's own request|21|||
19764749|NCT02926950|42217204|FG001|Overall Study|At the participant's own request|25|||
19764750|NCT02926950|42217203|FG000|Overall Study|Reason not Specified|17|||
19764751|NCT02926950|42217204|FG001|Overall Study|Reason not Specified|9|||
19764752|NCT02926950|42217203|FG000|Overall Study|Lost to Follow-up|7|||
19764753|NCT02926950|42217204|FG001|Overall Study|Lost to Follow-up|8|||
19764754|NCT03410693|42217213|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
19764755|NCT03410693|42217214|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
19764756|NCT03410693|42217213|FG000|Overall Study|Disc trt: Lost to follow up|0|||
19764757|NCT03410693|42217214|FG001|Overall Study|Disc trt: Lost to follow up|1|||
19764758|NCT03410693|42217213|FG000|Overall Study|Disc trt: radiological progression|58|||
19764759|NCT03410693|42217214|FG001|Overall Study|Disc trt: radiological progression|50|||
19764760|NCT03410693|42217213|FG000|Overall Study|Disc trt: Other|1|||
19764761|NCT03410693|42217214|FG001|Overall Study|Disc trt: Other|0|||
19764762|NCT03410693|42217213|FG000|Overall Study|Study drug never administered|1|||
19764763|NCT03410693|42217214|FG001|Overall Study|Study drug never administered|6|||
19764764|NCT03410693|42217213|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
19764765|NCT03410693|42217214|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
19764766|NCT03410693|42217213|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
19764767|NCT03410693|42217214|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
19764768|NCT03410693|42217213|FG000|Overall Study|Disc trt: Physician decision|0|||
19764769|NCT03410693|42217214|FG001|Overall Study|Disc trt: Physician decision|5|||
19764770|NCT03410693|42217213|FG000|Overall Study|Disc trt: clinical progression|1|||
19764771|NCT03410693|42217214|FG001|Overall Study|Disc trt: clinical progression|5|||
19764772|NCT03410693|42217213|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
19764773|NCT03410693|42217214|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
19764774|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
19764775|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
19764776|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
19764777|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Death|0|||
19764778|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Death|1|||
19764779|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Death|0|||
19764780|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
19764781|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
19764782|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
19764783|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
19764784|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
19764785|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
19764786|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19764787|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
19681154|NCT00454818|42128466|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
19681155|NCT00454818|42128462|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
19681156|NCT00454818|42128463|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
19681157|NCT00454818|42128464|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
19681158|NCT00454818|42128465|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
19681159|NCT00454818|42128466|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
19681160|NCT00454818|42128462|FG000|Phase 2: Randomized Double-blind|Death|0|||
19681161|NCT00454818|42128463|FG001|Phase 2: Randomized Double-blind|Death|1|||
19681162|NCT00454818|42128464|FG002|Phase 2: Randomized Double-blind|Death|0|||
19681163|NCT00454818|42128465|FG003|Phase 2: Randomized Double-blind|Death|0|||
19681164|NCT00454818|42128466|FG004|Phase 2: Randomized Double-blind|Death|1|||
19681165|NCT00454818|42128462|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
19681166|NCT00454818|42128463|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
19681167|NCT00454818|42128464|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
19681168|NCT00454818|42128465|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
19681169|NCT00454818|42128466|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
19699016|NCT03824912|42143818|FG000|Overall Study|Protocol Violation|1|||
19764788|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
19681170|NCT00454818|42128462|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
19681171|NCT00454818|42128463|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
19681172|NCT00454818|42128464|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
19681173|NCT00454818|42128465|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
19681174|NCT00454818|42128466|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
19681175|NCT00445224|42128485|FG000|Specific Exercises|Withdrawal by Subject|3|||
19681176|NCT00445224|42128486|FG001|Specific Exercises|Withdrawal by Subject|3|||
19681177|NCT00445224|42128485|FG000|Specific Exercises|Withdrawal by Subject|1|||
19681178|NCT00445224|42128486|FG001|Specific Exercises|Withdrawal by Subject|0|||
19681179|NCT00358917|42128503|FG000|Overall Study|Adverse Event|14|||
19681180|NCT00358917|42128504|FG001|Overall Study|Adverse Event|21|||
19681181|NCT00358917|42128503|FG000|Overall Study|Withdrawal by Subject|5|||
19681182|NCT00358917|42128504|FG001|Overall Study|Withdrawal by Subject|7|||
19681183|NCT00358917|42128503|FG000|Overall Study|Lost to Follow-up|20|||
19681184|NCT00358917|42128504|FG001|Overall Study|Lost to Follow-up|17|||
19681185|NCT00358917|42128503|FG000|Overall Study|Noncompliance|12|||
19681186|NCT00358917|42128504|FG001|Overall Study|Noncompliance|11|||
19681187|NCT00358917|42128503|FG000|Overall Study|Death|2|||
19681188|NCT00358917|42128504|FG001|Overall Study|Death|3|||
19681189|NCT00358917|42128503|FG000|Overall Study|Virologic failure|11|||
19681190|NCT00358917|42128504|FG001|Overall Study|Virologic failure|8|||
19681191|NCT00358917|42128503|FG000|Overall Study|Unable to Continue Participation|2|||
19681192|NCT00358917|42128504|FG001|Overall Study|Unable to Continue Participation|2|||
19681193|NCT00264004|42128516|FG000|Overall Study|Adverse Event|2|||
19681194|NCT00264004|42128517|FG001|Overall Study|Adverse Event|3|||
19764789|NCT01064414|42217229|FG000|Core Period: Baseline to Week 26|Other|4|||
19764790|NCT01064414|42217230|FG001|Core Period: Baseline to Week 26|Other|7|||
19764791|NCT01064414|42217231|FG002|Core Period: Baseline to Week 26|Other|2|||
19764792|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
19764793|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
19764794|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
19764795|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Death|0|||
19764796|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Death|1|||
19764797|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Death|0|||
19764798|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
19764799|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19764800|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
19764801|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
19764802|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19764803|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
19764804|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19764805|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
19764806|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
19764807|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
19764808|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
19764809|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
19764810|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19764811|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19764812|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
19764813|NCT01064414|42217229|FG000|Extension Period: Week 26 to Week 52|Other|5|||
19764814|NCT01064414|42217230|FG001|Extension Period: Week 26 to Week 52|Other|2|||
19764815|NCT01064414|42217231|FG002|Extension Period: Week 26 to Week 52|Other|1|||
19764816|NCT03433703|42217242|FG000|Overall Study|Study terminated by Sponsor|2|||
19764817|NCT03463031|42217252|FG000|Overall Study|Withdrawal by Subject|4|||
19764818|NCT03463031|42217253|FG001|Overall Study|Withdrawal by Subject|2|||
19764819|NCT03463031|42217252|FG000|Overall Study|Investigator/Sponsor Decision|0|||
19764820|NCT03463031|42217253|FG001|Overall Study|Investigator/Sponsor Decision|1|||
19764821|NCT03463031|42217252|FG000|Overall Study|Lost to Follow-up|1|||
19764822|NCT03463031|42217253|FG001|Overall Study|Lost to Follow-up|1|||
19764823|NCT03463031|42217252|FG000|Overall Study|Adverse Event|4|||
19764824|NCT03463031|42217253|FG001|Overall Study|Adverse Event|1|||
19764825|NCT03463031|42217252|FG000|Overall Study|Use of prohibited medication by subject|1|||
19764826|NCT03463031|42217253|FG001|Overall Study|Use of prohibited medication by subject|0|||
19764827|NCT03462641|42217261|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
19681195|NCT00264004|42128518|FG002|Overall Study|Adverse Event|6|||
19764828|NCT03462641|42217262|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
19764829|NCT03462641|42217261|FG000|Visit 2|Withdrawal by Subject|0|||
19764830|NCT03462641|42217262|FG001|Visit 2|Withdrawal by Subject|1|||
19764831|NCT02974634|42217272|FG000|Overall Study|Advanced disease|12|||
19764832|NCT02974634|42217273|FG001|Overall Study|Advanced disease|3|||
19764833|NCT02974634|42217272|FG000|Overall Study|Noncompliance|3|||
19764834|NCT02974634|42217273|FG001|Overall Study|Noncompliance|7|||
19764835|NCT02974634|42217272|FG000|Overall Study|intervention technology related issues|5|||
19764836|NCT02974634|42217273|FG001|Overall Study|intervention technology related issues|0|||
19764837|NCT02974634|42217272|FG000|Overall Study|Death|8|||
19764838|NCT02974634|42217273|FG001|Overall Study|Death|11|||
19764839|NCT01060670|42217282|FG000|Run In|screen failure|0|||
19764840|NCT01060670|42217283|FG001|Run In|screen failure|238|||
19764841|NCT02971670|42217295|FG000|Overall Study|Withdrawal by Subject|4|||
19764842|NCT02971670|42217296|FG001|Overall Study|Withdrawal by Subject|1|||
19764843|NCT02971670|42217297|FG002|Overall Study|Withdrawal by Subject|1|||
19764844|NCT02971670|42217298|FG003|Overall Study|Withdrawal by Subject|2|||
19764845|NCT02971202|42217311|FG000|Overall Study|Pregnancy|1|||
19764846|NCT02971202|42217312|FG001|Overall Study|Pregnancy|0|||
19764847|NCT02971202|42217313|FG002|Overall Study|Pregnancy|0|||
19764848|NCT02971202|42217311|FG000|Overall Study|screen fail after consent|1|||
19764849|NCT02971202|42217312|FG001|Overall Study|screen fail after consent|0|||
19764850|NCT02971202|42217313|FG002|Overall Study|screen fail after consent|1|||
19764851|NCT02926638|42217323|FG000|Overall Study|Progression|2|||
19764852|NCT02926638|42217324|FG001|Overall Study|Progression|5|||
19764853|NCT02926638|42217323|FG000|Overall Study|Ineligible|1|||
19764854|NCT02926638|42217324|FG001|Overall Study|Ineligible|0|||
19764855|NCT02926638|42217323|FG000|Overall Study|Not protocol specified|1|||
19764856|NCT02926638|42217324|FG001|Overall Study|Not protocol specified|0|||
19764857|NCT02903030|42217332|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
19764858|NCT02903030|42217333|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
19764859|NCT02969408|42217342|FG000|Overall Study|Adverse Event|2|||
19764860|NCT02969408|42217342|FG000|Overall Study|Withdrawal by Subject|8|||
19764861|NCT02969408|42217342|FG000|Overall Study|Lost to Follow-up|4|||
19764862|NCT02969408|42217342|FG000|Overall Study|Protocol Violation|1|||
19764863|NCT02969408|42217342|FG000|Overall Study|Other than specified|1|||
19764864|NCT03462563|42217348|FG000|Overall Study|Death|1|||
19764865|NCT03462563|42217349|FG001|Overall Study|Death|1|||
19764866|NCT03462563|42217348|FG000|Overall Study|Termination of study|2|||
19764867|NCT03462563|42217349|FG001|Overall Study|Termination of study|1|||
19764868|NCT03462563|42217348|FG000|Overall Study|Adverse Event|1|||
19764869|NCT03462563|42217349|FG001|Overall Study|Adverse Event|3|||
19764870|NCT03462563|42217348|FG000|Overall Study|Unspecified reason|10|||
19764871|NCT03462563|42217349|FG001|Overall Study|Unspecified reason|12|||
19764872|NCT03462563|42217348|FG000|Overall Study|Physician Decision|1|||
19764873|NCT03462563|42217349|FG001|Overall Study|Physician Decision|0|||
19764874|NCT01060124|42217355|FG000|Overall Study|Other|16|||
19764875|NCT01060124|42217355|FG000|Overall Study|Adverse Event|14|||
19764876|NCT01060124|42217355|FG000|Overall Study|Withdrawal by Subject|7|||
19681196|NCT00264004|42128519|FG003|Overall Study|Adverse Event|4|||
19681197|NCT00264004|42128516|FG000|Overall Study|Withdrawal by Subject|0|||
19681198|NCT00264004|42128517|FG001|Overall Study|Withdrawal by Subject|1|||
19681199|NCT00264004|42128518|FG002|Overall Study|Withdrawal by Subject|2|||
19681200|NCT00264004|42128519|FG003|Overall Study|Withdrawal by Subject|2|||
19681201|NCT00264004|42128516|FG000|Overall Study|Other|2|||
19681202|NCT00264004|42128517|FG001|Overall Study|Other|2|||
19681203|NCT00264004|42128518|FG002|Overall Study|Other|0|||
19681204|NCT00264004|42128519|FG003|Overall Study|Other|3|||
19681205|NCT00264004|42128516|FG000|Overall Study|Development study specific disc. crit.|1|||
19681206|NCT00264004|42128517|FG001|Overall Study|Development study specific disc. crit.|0|||
19681207|NCT00264004|42128518|FG002|Overall Study|Development study specific disc. crit.|1|||
19764877|NCT03461003|42217361|FG000|Overall Study|Lost to Follow-up|2|||
19764878|NCT03461003|42217362|FG001|Overall Study|Lost to Follow-up|2|||
19764879|NCT03461003|42217361|FG000|Overall Study|Withdrawal by Subject|3|||
19764880|NCT03461003|42217362|FG001|Overall Study|Withdrawal by Subject|1|||
19764881|NCT02904902|42217368|FG000|Overall Study|Withdrawal by Subject|1|||
19764882|NCT04425720|42217374|FG000|Overall Study|Withdrawal by Subject|0|||
19764883|NCT04425720|42217375|FG001|Overall Study|Withdrawal by Subject|20|||
19764884|NCT03459443|42217382|FG000|Overall Study|Lack of Efficacy|3|||
19764885|NCT03459443|42217382|FG000|Overall Study|Adverse Event|1|||
19764886|NCT03459443|42217382|FG000|Overall Study|Sponsor's decision to close the study|18|||
19681208|NCT00264004|42128519|FG003|Overall Study|Development study specific disc. crit.|0|||
19681209|NCT00264004|42128516|FG000|Overall Study|Cond. under inv. worsened|9|||
19681210|NCT00264004|42128517|FG001|Overall Study|Cond. under inv. worsened|5|||
19681211|NCT00264004|42128518|FG002|Overall Study|Cond. under inv. worsened|3|||
19764887|NCT02904512|42217388|FG000|Overall Study|Withdrawal by Subject|1|||
19764888|NCT02904512|42217389|FG001|Overall Study|Withdrawal by Subject|0|||
19764889|NCT02904512|42217388|FG000|Overall Study|Transferred to ICU|1|||
19764890|NCT02904512|42217389|FG001|Overall Study|Transferred to ICU|0|||
19764891|NCT02904512|42217388|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
19764892|NCT02904512|42217389|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
19764893|NCT02904200|42217395|FG000|Overall Study|Withdrawal by Subject|1|||
19764894|NCT02904200|42217396|FG001|Overall Study|Withdrawal by Subject|0|||
19764895|NCT03432533|42217402|FG000|Overall Study|Lost to Follow-up|1|||
19764896|NCT03432533|42217403|FG001|Overall Study|Lost to Follow-up|2|||
19764897|NCT03432533|42217402|FG000|Overall Study|Withdrawal by Subject|14|||
19764898|NCT03432533|42217403|FG001|Overall Study|Withdrawal by Subject|9|||
19681212|NCT00264004|42128519|FG003|Overall Study|Cond. under inv. worsened|4|||
19681213|NCT00264004|42128516|FG000|Overall Study|Not treated|3|||
19681214|NCT00264004|42128517|FG001|Overall Study|Not treated|0|||
19681215|NCT00264004|42128518|FG002|Overall Study|Not treated|2|||
19681216|NCT00264004|42128519|FG003|Overall Study|Not treated|2|||
19681217|NCT00368355|42128531|FG000|Overall Study|Adverse Event|1|||
19681218|NCT00368355|42128532|FG001|Overall Study|Adverse Event|0|||
19681219|NCT00368355|42128531|FG000|Overall Study|Death|2|||
19681220|NCT00368355|42128532|FG001|Overall Study|Death|4|||
19681221|NCT00368355|42128531|FG000|Overall Study|Relapse|6|||
19681222|NCT00368355|42128532|FG001|Overall Study|Relapse|10|||
19764899|NCT02901548|42217409|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
19764900|NCT02903966|42217415|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
19764901|NCT02903966|42217416|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
19764902|NCT02903966|42217415|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
19764903|NCT02903966|42217416|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
19764904|NCT02903966|42217415|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
19764905|NCT02903966|42217416|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
19764906|NCT03457727|42217432|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
19764907|NCT03457727|42217433|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
19764908|NCT03457727|42217434|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
19764909|NCT03457727|42217435|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
19764910|NCT03431441|42217467|FG000|Overall Study|Withdrawal by Subject|2|||
19764911|NCT03431441|42217467|FG000|Overall Study|Adverse Event|2|||
19764912|NCT03431441|42217467|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
19764913|NCT03457103|42217473|FG000|Overall Study|illness/hospitalization|4|||
19764914|NCT03457103|42217474|FG001|Overall Study|illness/hospitalization|2|||
19764915|NCT03457103|42217473|FG000|Overall Study|Lost to Follow-up|2|||
19764916|NCT03457103|42217474|FG001|Overall Study|Lost to Follow-up|1|||
19764917|NCT03457103|42217473|FG000|Overall Study|Withdrawal by Subject|1|||
19764918|NCT03457103|42217474|FG001|Overall Study|Withdrawal by Subject|2|||
19764919|NCT03457103|42217473|FG000|Overall Study|financial/ insurance issues|1|||
19764920|NCT03457103|42217474|FG001|Overall Study|financial/ insurance issues|1|||
19764921|NCT03455543|42217482|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
19764922|NCT03455543|42217483|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
19764923|NCT03455543|42217484|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
19764924|NCT03455543|42217482|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
19764925|NCT03455543|42217483|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
19764926|NCT03455543|42217484|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
19764927|NCT03455543|42217482|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
19764928|NCT03455543|42217483|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
19764929|NCT03455543|42217484|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
19764930|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
19764931|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
19681223|NCT00368355|42128531|FG000|Overall Study|Subsequent transplant|0|||
19681224|NCT00368355|42128532|FG001|Overall Study|Subsequent transplant|3|||
19764932|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
19764933|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
19764934|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
19764935|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
19764936|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
19764937|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
19764938|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
19764939|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
19681225|NCT00368355|42128531|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
19764940|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
19764941|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
19764942|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
19764943|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
19764944|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
19764945|NCT03455543|42217482|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
19764946|NCT03455543|42217483|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
19764947|NCT03455543|42217484|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
19764948|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
19764949|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
19764950|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
19764951|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
19764952|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Death|2|||
19764953|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Death|2|||
19764954|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Death|0|||
19764955|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Death|0|||
19764956|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
19764957|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
19764958|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
19764959|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
19764960|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
19764961|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
19764962|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
19764963|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
19764964|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
19764965|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
19764966|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
19764967|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
19764968|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
19764969|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
19764970|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
19764971|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
19764972|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
19764973|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
19764974|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
19764975|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
19764976|NCT03068754|42217494|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
19681226|NCT00368355|42128532|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
19681227|NCT00445146|42128538|FG000|Overall Study|Withdrew Consent|29|||
19764977|NCT03068754|42217495|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
19764978|NCT03068754|42217496|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
19764979|NCT03068754|42217497|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
19764980|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
19764981|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
19764982|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
19764983|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
19764984|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Death|0|||
19764985|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Death|0|||
19764986|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Death|0|||
19764987|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Death|1|||
19764988|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
19764989|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
19764990|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
19764991|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
19764992|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
19681228|NCT00445146|42128538|FG000|Overall Study|Lack of Efficacy|28|||
19681229|NCT00445146|42128538|FG000|Overall Study|Investigator's Discretion|22|||
19681230|NCT00445146|42128538|FG000|Overall Study|Adverse Event|13|||
19681231|NCT00445146|42128538|FG000|Overall Study|Lost to Follow-up|13|||
19681232|NCT00445146|42128538|FG000|Overall Study|Death|9|||
19681233|NCT00445146|42128538|FG000|Overall Study|Protocol Violation|4|||
19681234|NCT00445146|42128538|FG000|Overall Study|Pregnancy|1|||
19681235|NCT00368277|42128544|FG000|Overall Study|Adverse Event|33|||
19764993|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
19764994|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
19764995|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
19764996|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
19764997|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
19764998|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
19764999|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
19765000|NCT03068754|42217494|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
19765001|NCT03068754|42217495|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
19765002|NCT03068754|42217496|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
19681236|NCT00368277|42128545|FG001|Overall Study|Adverse Event|49|||
19681237|NCT00368277|42128544|FG000|Overall Study|Death|2|||
19681238|NCT00368277|42128545|FG001|Overall Study|Death|1|||
19681239|NCT00368277|42128544|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
19681240|NCT00368277|42128545|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
19681241|NCT00368277|42128544|FG000|Overall Study|Protocol deviation|7|||
19681242|NCT00368277|42128545|FG001|Overall Study|Protocol deviation|0|||
19681243|NCT00368277|42128544|FG000|Overall Study|Patient withdrew consent|32|||
19765003|NCT03068754|42217497|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
19765004|NCT02965820|42217507|FG000|Period 2, Second 30 Days|Adverse Event|1|||
19765005|NCT02965820|42217508|FG001|Period 2, Second 30 Days|Adverse Event|1|||
19765006|NCT03430895|42217514|FG000|Overall Study|Not Treated|2|||
19765007|NCT03452189|42217518|FG000|First Intervention (3 Months)|Adverse Event|1|||
19765008|NCT03452189|42217519|FG001|First Intervention (3 Months)|Adverse Event|0|||
19765009|NCT03452189|42217518|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
19765010|NCT03452189|42217519|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
19765011|NCT03451721|42217525|FG000|Overall Study|Death|1|||
19765012|NCT00603954|42217531|FG000|Overall Study|Protocol Violation|1|||
19765013|NCT00603954|42217532|FG001|Overall Study|Protocol Violation|2|||
19765014|NCT03427619|42217539|FG000|Overall Study|Physician Decision|3|||
19765015|NCT03427619|42217539|FG000|Overall Study|Withdrawal by Subject|4|||
19765016|NCT03427619|42217539|FG000|Overall Study|Lost to Follow-up|5|||
19765017|NCT03427619|42217539|FG000|Overall Study|Administrative|4|||
19765018|NCT03427619|42217539|FG000|Overall Study|Other|2|||
19765019|NCT03427619|42217539|FG000|Overall Study|Unknown or Missing Completion Status|48|||
19765020|NCT03407729|42217545|FG000|Overall Study|Lost to Follow-up|2|||
19765021|NCT03407729|42217546|FG001|Overall Study|Lost to Follow-up|0|||
19765022|NCT03407729|42217545|FG000|Overall Study|Unable to schedule|0|||
19765023|NCT03407729|42217546|FG001|Overall Study|Unable to schedule|3|||
19765024|NCT02435433|42217557|FG000|Overall Study|Withdrawal by Subject|2|||
19765025|NCT02435433|42217558|FG001|Overall Study|Withdrawal by Subject|3|||
19765026|NCT02435433|42217559|FG002|Overall Study|Withdrawal by Subject|1|||
19765027|NCT02435433|42217560|FG003|Overall Study|Withdrawal by Subject|0|||
19765028|NCT02435433|42217561|FG004|Overall Study|Withdrawal by Subject|0|||
19765029|NCT02435433|42217557|FG000|Overall Study|Lost to Follow-up|2|||
19765030|NCT02435433|42217558|FG001|Overall Study|Lost to Follow-up|2|||
19765031|NCT02435433|42217559|FG002|Overall Study|Lost to Follow-up|4|||
19765032|NCT02435433|42217560|FG003|Overall Study|Lost to Follow-up|1|||
19765033|NCT02435433|42217561|FG004|Overall Study|Lost to Follow-up|0|||
19765034|NCT03120351|42217574|FG000|Overall Study|Physician Decision|1|||
19765035|NCT03120351|42217575|FG001|Overall Study|Physician Decision|1|||
19765036|NCT02354703|42217585|FG000|Overall Study|Withdrawal by Subject|1|||
19765037|NCT02354703|42217586|FG001|Overall Study|Withdrawal by Subject|1|||
19765038|NCT02354703|42217587|FG002|Overall Study|Withdrawal by Subject|1|||
19765039|NCT02354703|42217588|FG003|Overall Study|Withdrawal by Subject|1|||
19765040|NCT02354703|42217585|FG000|Overall Study|Lost to Follow-up|2|||
19765041|NCT02354703|42217586|FG001|Overall Study|Lost to Follow-up|7|||
19765042|NCT02354703|42217587|FG002|Overall Study|Lost to Follow-up|9|||
19765043|NCT02354703|42217588|FG003|Overall Study|Lost to Follow-up|2|||
19765044|NCT02354703|42217585|FG000|Overall Study|Adverse Event|0|||
19681244|NCT00368277|42128545|FG001|Overall Study|Patient withdrew consent|28|||
19681245|NCT00368277|42128544|FG000|Overall Study|Lost to Follow-up|8|||
19681246|NCT00368277|42128545|FG001|Overall Study|Lost to Follow-up|6|||
19681247|NCT00280150|42128555|FG000|Overall Study|Adverse Event|0|||
19681248|NCT00280150|42128556|FG001|Overall Study|Adverse Event|1|||
19765045|NCT02354703|42217586|FG001|Overall Study|Adverse Event|0|||
19765046|NCT02354703|42217587|FG002|Overall Study|Adverse Event|1|||
19765047|NCT02354703|42217588|FG003|Overall Study|Adverse Event|0|||
19765048|NCT00384111|42217604|FG000|Overall Study|Disease Progression|3|||
19765049|NCT00384111|42217604|FG000|Overall Study|Adverse Event|1|||
19765050|NCT00384111|42217604|FG000|Overall Study|Investigator Decision|3|||
19765051|NCT00384111|42217604|FG000|Overall Study|Study Terminated by the Sponsor|19|||
19765052|NCT03113409|42217608|FG000|Overall Study|Withdrawal by Subject|5|||
19765053|NCT03113409|42217609|FG001|Overall Study|Withdrawal by Subject|0|||
19765054|NCT03113409|42217610|FG002|Overall Study|Withdrawal by Subject|0|||
19765055|NCT01319877|42217616|FG000|Overall Study|Lost to Follow-up|100|||
19765056|NCT01319877|42217617|FG001|Overall Study|Lost to Follow-up|37|||
19765057|NCT01319877|42217616|FG000|Overall Study|Physician Decision|2|||
19765058|NCT01319877|42217617|FG001|Overall Study|Physician Decision|0|||
19765059|NCT01319877|42217616|FG000|Overall Study|Disease Progression|2|||
19765060|NCT01319877|42217617|FG001|Overall Study|Disease Progression|2|||
19765061|NCT01319877|42217616|FG000|Overall Study|Withdrawal by Subject|0|||
19765062|NCT01319877|42217617|FG001|Overall Study|Withdrawal by Subject|1|||
19765063|NCT01319877|42217616|FG000|Overall Study|Reason Not Specified|4|||
19765064|NCT01319877|42217617|FG001|Overall Study|Reason Not Specified|5|||
19765065|NCT03427073|42217630|FG000|Overall Study|Disease Progression|1|||
19765066|NCT03427073|42217631|FG001|Overall Study|Disease Progression|1|||
19765067|NCT03427073|42217632|FG002|Overall Study|Disease Progression|1|||
19765068|NCT03427073|42217633|FG003|Overall Study|Disease Progression|3|||
19765069|NCT03427073|42217634|FG004|Overall Study|Disease Progression|3|||
19765070|NCT03427073|42217635|FG005|Overall Study|Disease Progression|4|||
19765071|NCT03427073|42217636|FG006|Overall Study|Disease Progression|2|||
19681249|NCT00280150|42128557|FG002|Overall Study|Adverse Event|2|||
19681250|NCT00280150|42128558|FG003|Overall Study|Adverse Event|3|||
19681251|NCT00280150|42128555|FG000|Overall Study|Lack of Efficacy|0|||
19681252|NCT00280150|42128556|FG001|Overall Study|Lack of Efficacy|0|||
19681253|NCT00280150|42128557|FG002|Overall Study|Lack of Efficacy|0|||
19681254|NCT00280150|42128558|FG003|Overall Study|Lack of Efficacy|3|||
19681255|NCT00280150|42128555|FG000|Overall Study|Physician Decision|0|||
19681256|NCT00280150|42128556|FG001|Overall Study|Physician Decision|0|||
19681257|NCT00280150|42128557|FG002|Overall Study|Physician Decision|0|||
19681258|NCT00280150|42128558|FG003|Overall Study|Physician Decision|1|||
19681259|NCT00280150|42128555|FG000|Overall Study|Protocol Violation|0|||
19681260|NCT00280150|42128556|FG001|Overall Study|Protocol Violation|0|||
19681261|NCT00280150|42128557|FG002|Overall Study|Protocol Violation|0|||
19681262|NCT00280150|42128558|FG003|Overall Study|Protocol Violation|1|||
19681263|NCT00280150|42128555|FG000|Overall Study|Withdrawal by Subject|0|||
19681264|NCT00280150|42128556|FG001|Overall Study|Withdrawal by Subject|0|||
19681265|NCT00280150|42128557|FG002|Overall Study|Withdrawal by Subject|0|||
19681266|NCT00280150|42128558|FG003|Overall Study|Withdrawal by Subject|1|||
19765072|NCT03427073|42217637|FG007|Overall Study|Disease Progression|3|||
19765073|NCT03427073|42217630|FG000|Overall Study|Physician Decision|0|||
19765074|NCT03427073|42217631|FG001|Overall Study|Physician Decision|0|||
19765075|NCT03427073|42217632|FG002|Overall Study|Physician Decision|0|||
19765076|NCT03427073|42217633|FG003|Overall Study|Physician Decision|0|||
19765077|NCT03427073|42217634|FG004|Overall Study|Physician Decision|0|||
19765078|NCT03427073|42217635|FG005|Overall Study|Physician Decision|0|||
19681267|NCT00280150|42128555|FG000|Overall Study|Did not get consolidation therapy|3|||
19681268|NCT00280150|42128556|FG001|Overall Study|Did not get consolidation therapy|0|||
19681269|NCT00280150|42128557|FG002|Overall Study|Did not get consolidation therapy|3|||
19681270|NCT00280150|42128558|FG003|Overall Study|Did not get consolidation therapy|0|||
19681271|NCT00280150|42128555|FG000|Overall Study|Declining Performance Status|0|||
19681272|NCT00280150|42128556|FG001|Overall Study|Declining Performance Status|0|||
19681273|NCT00280150|42128557|FG002|Overall Study|Declining Performance Status|0|||
19681274|NCT00280150|42128558|FG003|Overall Study|Declining Performance Status|1|||
19681275|NCT00279916|42128571|FG000|Overall Study|Withdrawal by Subject|4|||
19681276|NCT00279916|42128572|FG001|Overall Study|Withdrawal by Subject|3|||
19681277|NCT00279916|42128571|FG000|Overall Study|Lost to Follow-up|3|||
19681278|NCT00279916|42128572|FG001|Overall Study|Lost to Follow-up|2|||
19681279|NCT00358527|42128580|FG000|Overall Study|Adverse Event|4|||
19681280|NCT00358527|42128581|FG001|Overall Study|Adverse Event|0|||
19681281|NCT00358527|42128580|FG000|Overall Study|Withdrawal by Subject|1|||
19681282|NCT00358527|42128581|FG001|Overall Study|Withdrawal by Subject|1|||
19681283|NCT00358527|42128580|FG000|Overall Study|Non-compliance with protocol|6|||
19681284|NCT00358527|42128581|FG001|Overall Study|Non-compliance with protocol|1|||
19681285|NCT00358527|42128580|FG000|Overall Study|Administrative|2|||
19681286|NCT00358527|42128581|FG001|Overall Study|Administrative|1|||
19681287|NCT00251758|42128590|FG000|Overall Study|Adverse Event|7|||
19681288|NCT00251758|42128591|FG001|Overall Study|Adverse Event|9|||
19681289|NCT00251758|42128592|FG002|Overall Study|Adverse Event|11|||
19681290|NCT00251758|42128590|FG000|Overall Study|Lost to Follow-up|4|||
19681291|NCT00251758|42128591|FG001|Overall Study|Lost to Follow-up|2|||
19681292|NCT00251758|42128592|FG002|Overall Study|Lost to Follow-up|5|||
19765079|NCT03427073|42217636|FG006|Overall Study|Physician Decision|1|||
19765080|NCT03427073|42217637|FG007|Overall Study|Physician Decision|1|||
19765081|NCT03066804|42217657|FG000|Overall Study|Physician Decision|0|||
19765082|NCT03066804|42217658|FG001|Overall Study|Physician Decision|4|||
19765083|NCT03066804|42217657|FG000|Overall Study|Death|23|||
19681293|NCT00251758|42128590|FG000|Overall Study|Withdrawal by Subject|13|||
19765084|NCT03066804|42217658|FG001|Overall Study|Death|17|||
19765085|NCT03066804|42217657|FG000|Overall Study|Withdrawal by Subject|19|||
19765086|NCT03066804|42217658|FG001|Overall Study|Withdrawal by Subject|25|||
19681294|NCT00251758|42128591|FG001|Overall Study|Withdrawal by Subject|7|||
19681295|NCT00251758|42128592|FG002|Overall Study|Withdrawal by Subject|3|||
19681296|NCT00251758|42128590|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
19681297|NCT00251758|42128591|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
19681298|NCT00251758|42128592|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
19681299|NCT00251758|42128590|FG000|Overall Study|Lack of Efficacy|3|||
19681300|NCT00251758|42128591|FG001|Overall Study|Lack of Efficacy|0|||
19765087|NCT03066804|42217657|FG000|Overall Study|Lost to Follow-up|2|||
19765088|NCT03066804|42217658|FG001|Overall Study|Lost to Follow-up|0|||
19765089|NCT03066804|42217657|FG000|Overall Study|Adverse Event|2|||
19765090|NCT03066804|42217658|FG001|Overall Study|Adverse Event|3|||
19765091|NCT03066804|42217657|FG000|Overall Study|Technical problems|5|||
19765092|NCT03066804|42217658|FG001|Overall Study|Technical problems|1|||
19765093|NCT02954237|42217665|FG000|Overall Study|Withdrawal by Subject|25|||
19765094|NCT02954237|42217665|FG000|Overall Study|Missed visit|16|||
19765095|NCT02954237|42217665|FG000|Overall Study|Death|2|||
19765096|NCT04250337|42217671|FG000|Overall Study|Adverse Event|0|||
19765097|NCT04250337|42217672|FG001|Overall Study|Adverse Event|3|||
19765098|NCT04250337|42217671|FG000|Overall Study|Lack of Efficacy|1|||
19765099|NCT04250337|42217672|FG001|Overall Study|Lack of Efficacy|3|||
19765100|NCT04250337|42217671|FG000|Overall Study|Physician Decision|1|||
19765101|NCT04250337|42217672|FG001|Overall Study|Physician Decision|0|||
19765102|NCT04250337|42217671|FG000|Overall Study|Protocol Deviation|2|||
19765103|NCT04250337|42217672|FG001|Overall Study|Protocol Deviation|2|||
19765104|NCT04250337|42217671|FG000|Overall Study|Withdrawal by Subject|4|||
19765105|NCT04250337|42217672|FG001|Overall Study|Withdrawal by Subject|3|||
19765106|NCT03118947|42217679|FG000|Overall Study|Adverse Event|7|||
19765107|NCT03118947|42217679|FG000|Overall Study|Death|3|||
19765108|NCT03118947|42217679|FG000|Overall Study|Lack of Efficacy|4|||
19765109|NCT03118947|42217679|FG000|Overall Study|Non-compliance with study drug|1|||
19765110|NCT03118947|42217679|FG000|Overall Study|Protocol Violation|2|||
19765111|NCT03118947|42217679|FG000|Overall Study|Withdrawal by Subject|3|||
19765112|NCT03118947|42217679|FG000|Overall Study|Withdrawal by caregiver|3|||
19765113|NCT03118947|42217679|FG000|Overall Study|Change in patient's living situation|4|||
19765114|NCT03118947|42217679|FG000|Overall Study|Lost to Follow-up|2|||
19765115|NCT03953079|42217686|FG000|Core Study|Withdrawal by Subject|1|||
19765116|NCT03953079|42217687|FG001|Core Study|Withdrawal by Subject|2|||
19765117|NCT03953079|42217688|FG002|Core Study|Withdrawal by Subject|1|||
19765118|NCT03953079|42217686|FG000|Core Study|COVID-19|0|||
19681301|NCT00251758|42128592|FG002|Overall Study|Lack of Efficacy|0|||
19681302|NCT00251758|42128590|FG000|Overall Study|Noncompliant|0|||
19681303|NCT00251758|42128591|FG001|Overall Study|Noncompliant|2|||
19681304|NCT00251758|42128592|FG002|Overall Study|Noncompliant|2|||
19681305|NCT00251758|42128590|FG000|Overall Study|Pregnancy|0|||
19681306|NCT00251758|42128591|FG001|Overall Study|Pregnancy|1|||
19681307|NCT00251758|42128592|FG002|Overall Study|Pregnancy|0|||
19681308|NCT00251758|42128590|FG000|Overall Study|Per Subject Request|0|||
19681309|NCT00251758|42128591|FG001|Overall Study|Per Subject Request|0|||
19681310|NCT00251758|42128592|FG002|Overall Study|Per Subject Request|1|||
19681311|NCT00251758|42128590|FG000|Overall Study|Per Investigator Request|1|||
19681312|NCT00251758|42128591|FG001|Overall Study|Per Investigator Request|0|||
19681313|NCT00251758|42128592|FG002|Overall Study|Per Investigator Request|0|||
19681314|NCT00279214|42128602|FG000|Overall Study|Physician Decision|3|||
19681315|NCT00279214|42128603|FG001|Overall Study|Physician Decision|2|||
19681316|NCT00262834|42128611|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
19681317|NCT00262834|42128612|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
19681318|NCT00541775|42128625|FG000|Overall Study|Adverse Event|3|||
19681319|NCT00541775|42128626|FG001|Overall Study|Adverse Event|2|||
19681320|NCT00541775|42128627|FG002|Overall Study|Adverse Event|1|||
19681321|NCT00541775|42128625|FG000|Overall Study|Lack of Efficacy|0|||
19681322|NCT00541775|42128626|FG001|Overall Study|Lack of Efficacy|0|||
19681323|NCT00541775|42128627|FG002|Overall Study|Lack of Efficacy|3|||
19681324|NCT00541775|42128625|FG000|Overall Study|Lost to Follow-up|0|||
19681325|NCT00541775|42128626|FG001|Overall Study|Lost to Follow-up|0|||
19681326|NCT00541775|42128627|FG002|Overall Study|Lost to Follow-up|2|||
19681327|NCT00541775|42128625|FG000|Overall Study|Protocol Violation|1|||
19765119|NCT03953079|42217687|FG001|Core Study|COVID-19|1|||
19765120|NCT03953079|42217688|FG002|Core Study|COVID-19|0|||
19765121|NCT03953079|42217686|FG000|Core Study|Difficulties leaving the house|0|||
19765122|NCT03953079|42217687|FG001|Core Study|Difficulties leaving the house|1|||
19765123|NCT03953079|42217688|FG002|Core Study|Difficulties leaving the house|0|||
19681328|NCT00541775|42128626|FG001|Overall Study|Protocol Violation|0|||
19681329|NCT00541775|42128627|FG002|Overall Study|Protocol Violation|0|||
19681330|NCT00541775|42128625|FG000|Overall Study|Withdrawal by Subject and Other|5|||
19765124|NCT03953079|42217686|FG000|Extension Study|Withdrawal by Subject|1|||
19765125|NCT03953079|42217687|FG001|Extension Study|Withdrawal by Subject|0|||
19765126|NCT03953079|42217688|FG002|Extension Study|Withdrawal by Subject|0|||
19765127|NCT03953079|42217686|FG000|Extension Study|Received Rescue Treatment|5|||
19765128|NCT03953079|42217687|FG001|Extension Study|Received Rescue Treatment|6|||
19765129|NCT03953079|42217688|FG002|Extension Study|Received Rescue Treatment|5|||
19765130|NCT03885999|42217701|FG000|Overall Study|Adverse Event|1|||
19765131|NCT03108027|42217715|FG000|Period 1|Subject/Guardian Decision|0|||
19765132|NCT03108027|42217716|FG001|Period 1|Subject/Guardian Decision|0|||
19765133|NCT03108027|42217717|FG002|Period 1|Subject/Guardian Decision|0|||
19765134|NCT03108027|42217718|FG003|Period 1|Subject/Guardian Decision|2|||
19765135|NCT03108027|42217719|FG004|Period 1|Subject/Guardian Decision|0|||
19765136|NCT03108027|42217720|FG005|Period 1|Subject/Guardian Decision|0|||
19765137|NCT03108027|42217715|FG000|Period 3|Adverse Event|0|||
19765138|NCT03108027|42217716|FG001|Period 3|Adverse Event|1|||
19765139|NCT03108027|42217717|FG002|Period 3|Adverse Event|0|||
19765140|NCT03108027|42217718|FG003|Period 3|Adverse Event|0|||
19765141|NCT03108027|42217719|FG004|Period 3|Adverse Event|0|||
19765142|NCT03108027|42217720|FG005|Period 3|Adverse Event|0|||
19765143|NCT03107715|42217736|FG000|Overall Study|did not deliver at the home hospital|4|||
19765144|NCT03107715|42217737|FG001|Overall Study|did not deliver at the home hospital|6|||
19765145|NCT03107715|42217736|FG000|Overall Study|infant stillborn|0|||
19765146|NCT03107715|42217737|FG001|Overall Study|infant stillborn|1|||
19765147|NCT03567057|42217746|FG000|Overall Study|Adverse Event|56|||
19765148|NCT03567057|42217747|FG001|Overall Study|Adverse Event|53|||
19765149|NCT03567057|42217748|FG002|Overall Study|Adverse Event|28|||
19765150|NCT03567057|42217746|FG000|Overall Study|Withdrawal by Subject|22|||
19765151|NCT03567057|42217747|FG001|Overall Study|Withdrawal by Subject|24|||
19765152|NCT03567057|42217748|FG002|Overall Study|Withdrawal by Subject|13|||
19765153|NCT03567057|42217746|FG000|Overall Study|Lost to Follow-up|3|||
19765154|NCT03567057|42217747|FG001|Overall Study|Lost to Follow-up|5|||
19681331|NCT00541775|42128626|FG001|Overall Study|Withdrawal by Subject and Other|0|||
19681332|NCT00541775|42128627|FG002|Overall Study|Withdrawal by Subject and Other|2|||
19681333|NCT00539513|42128637|FG000|Overall Study|Withdrawal by Subject|2|||
19681334|NCT00539513|42128638|FG001|Overall Study|Withdrawal by Subject|1|||
19681335|NCT00539513|42128637|FG000|Overall Study|Lost to Follow-up|0|||
19681336|NCT00539513|42128638|FG001|Overall Study|Lost to Follow-up|1|||
19681337|NCT02969915|42128648|FG000|Overall Study|Death|104|||
19681338|NCT02969915|42128649|FG001|Overall Study|Death|125|||
19765155|NCT03567057|42217748|FG002|Overall Study|Lost to Follow-up|2|||
19765156|NCT03567057|42217746|FG000|Overall Study|COVID-19 pandemic|4|||
19765157|NCT03567057|42217747|FG001|Overall Study|COVID-19 pandemic|3|||
19765158|NCT03567057|42217748|FG002|Overall Study|COVID-19 pandemic|0|||
19765159|NCT03567057|42217746|FG000|Overall Study|Non-compliance with study drug|4|||
19765160|NCT03567057|42217747|FG001|Overall Study|Non-compliance with study drug|2|||
19765161|NCT03567057|42217748|FG002|Overall Study|Non-compliance with study drug|0|||
19765162|NCT03567057|42217746|FG000|Overall Study|Lack of Efficacy|3|||
19765163|NCT03567057|42217747|FG001|Overall Study|Lack of Efficacy|0|||
19765164|NCT03567057|42217748|FG002|Overall Study|Lack of Efficacy|1|||
19765165|NCT03567057|42217746|FG000|Overall Study|Death|1|||
19765166|NCT03567057|42217747|FG001|Overall Study|Death|0|||
19765167|NCT03567057|42217748|FG002|Overall Study|Death|0|||
19765168|NCT03567057|42217746|FG000|Overall Study|Physician Decision|1|||
19765169|NCT03567057|42217747|FG001|Overall Study|Physician Decision|0|||
19765170|NCT03567057|42217748|FG002|Overall Study|Physician Decision|0|||
19765171|NCT03567057|42217746|FG000|Overall Study|Unstable medical condition|1|||
19765172|NCT03567057|42217747|FG001|Overall Study|Unstable medical condition|0|||
19765173|NCT03567057|42217748|FG002|Overall Study|Unstable medical condition|0|||
19765174|NCT03567057|42217746|FG000|Overall Study|Medical history event|0|||
19765175|NCT03567057|42217747|FG001|Overall Study|Medical history event|0|||
19765176|NCT03567057|42217748|FG002|Overall Study|Medical history event|1|||
19765177|NCT03567057|42217746|FG000|Overall Study|Other|0|||
19765178|NCT03567057|42217747|FG001|Overall Study|Other|0|||
19765179|NCT03567057|42217748|FG002|Overall Study|Other|1|||
19765180|NCT04388787|42217756|FG000|Blinded Period|Patient could not follow instructions|1|||
19765181|NCT04388787|42217756|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
19765182|NCT03057600|42217768|FG000|Overall Study|Adverse Event|0|||
19765183|NCT03057600|42217769|FG001|Overall Study|Adverse Event|0|||
19765184|NCT03057600|42217770|FG002|Overall Study|Adverse Event|4|||
19765185|NCT03057600|42217771|FG003|Overall Study|Adverse Event|0|||
19765186|NCT03057600|42217768|FG000|Overall Study|Radiologic Disease Progression|8|||
19765187|NCT03057600|42217769|FG001|Overall Study|Radiologic Disease Progression|7|||
19765188|NCT03057600|42217770|FG002|Overall Study|Radiologic Disease Progression|13|||
19765189|NCT03057600|42217771|FG003|Overall Study|Radiologic Disease Progression|10|||
19765190|NCT03057600|42217768|FG000|Overall Study|Symptomatic Deterioration|0|||
19765191|NCT03057600|42217769|FG001|Overall Study|Symptomatic Deterioration|1|||
19765192|NCT03057600|42217770|FG002|Overall Study|Symptomatic Deterioration|1|||
19765193|NCT03057600|42217771|FG003|Overall Study|Symptomatic Deterioration|0|||
19765194|NCT03057600|42217768|FG000|Overall Study|Investigator Decision|0|||
19765195|NCT03057600|42217769|FG001|Overall Study|Investigator Decision|0|||
19765196|NCT03057600|42217770|FG002|Overall Study|Investigator Decision|1|||
19681339|NCT02969915|42128648|FG000|Overall Study|Lost to Follow-up|108|||
19765197|NCT03057600|42217771|FG003|Overall Study|Investigator Decision|0|||
19765198|NCT03057600|42217768|FG000|Overall Study|Study Termination by Sponsor|0|||
19765199|NCT03057600|42217769|FG001|Overall Study|Study Termination by Sponsor|0|||
19765200|NCT03057600|42217770|FG002|Overall Study|Study Termination by Sponsor|0|||
19765201|NCT03057600|42217771|FG003|Overall Study|Study Termination by Sponsor|2|||
19765202|NCT03057600|42217768|FG000|Overall Study|Withdrawal by Subject|0|||
19765203|NCT03057600|42217769|FG001|Overall Study|Withdrawal by Subject|1|||
19765204|NCT03057600|42217770|FG002|Overall Study|Withdrawal by Subject|0|||
19765205|NCT03057600|42217771|FG003|Overall Study|Withdrawal by Subject|0|||
19765206|NCT03057600|42217768|FG000|Overall Study|Other, Not Specified|1|||
19765207|NCT03057600|42217769|FG001|Overall Study|Other, Not Specified|1|||
19765208|NCT03057600|42217770|FG002|Overall Study|Other, Not Specified|1|||
19765209|NCT03057600|42217771|FG003|Overall Study|Other, Not Specified|1|||
19765210|NCT03371823|42217801|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
19765211|NCT03371823|42217802|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
19765212|NCT02966301|42217817|FG000|Overall Study|Death|2|||
19765213|NCT02966301|42217817|FG000|Overall Study|Withdrawal by Subject|1|||
19765214|NCT03107091|42217821|FG000|Overall Study|Physician Decision|1|||
19765215|NCT03065400|42217835|FG000|Overall Study|Adverse Event|1|||
19765216|NCT03065400|42217835|FG000|Overall Study|Physician Decision|3|||
19765217|NCT03065400|42217835|FG000|Overall Study|Withdrawal by Subject|1|||
19765218|NCT03065400|42217835|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
19765219|NCT03085095|42217841|FG000|Overall Study|Adverse Event|23|||
19765220|NCT03085095|42217842|FG001|Overall Study|Adverse Event|8|||
19765221|NCT03085095|42217841|FG000|Overall Study|Protocol Violation|0|||
19765222|NCT03085095|42217842|FG001|Overall Study|Protocol Violation|1|||
19765223|NCT03085095|42217841|FG000|Overall Study|Lost to Follow-up|2|||
19765224|NCT03085095|42217842|FG001|Overall Study|Lost to Follow-up|1|||
19765225|NCT03085095|42217841|FG000|Overall Study|Withdrawal by Subject|17|||
19765226|NCT03085095|42217842|FG001|Overall Study|Withdrawal by Subject|6|||
19765227|NCT03085095|42217841|FG000|Overall Study|Physician Decision|9|||
19765228|NCT03085095|42217842|FG001|Overall Study|Physician Decision|3|||
19765229|NCT03085095|42217841|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
19765230|NCT03085095|42217842|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
19765231|NCT03085095|42217841|FG000|Overall Study|Did not Receive Study Drug|2|||
19765232|NCT03085095|42217842|FG001|Overall Study|Did not Receive Study Drug|2|||
19765233|NCT03085095|42217841|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
19765234|NCT03085095|42217842|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
19765235|NCT04097301|42217851|FG000|Overall Study|Death|1|||
19765236|NCT04097301|42217851|FG000|Overall Study|Withdrawal by Subject|1|||
19765237|NCT04097301|42217851|FG000|Overall Study|Screening Failure|5|||
19765238|NCT02276547|42217857|FG000|Overall Study|Death|2|||
19765239|NCT02276547|42217857|FG000|Overall Study|Explant|2|||
19765240|NCT02966834|42217867|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
19765241|NCT02966834|42217868|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
19765242|NCT02966834|42217869|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
19765243|NCT02966834|42217870|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
19765244|NCT02966834|42217871|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
19765245|NCT02966834|42217872|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
19765246|NCT02966834|42217867|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
19765247|NCT02966834|42217868|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19765248|NCT02966834|42217869|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19765249|NCT02966834|42217870|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19765250|NCT02966834|42217871|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19765251|NCT02966834|42217872|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19765252|NCT02966834|42217867|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
19765253|NCT02966834|42217868|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
19765254|NCT02966834|42217869|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
19765255|NCT02966834|42217870|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
19765256|NCT02966834|42217871|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
19765257|NCT02966834|42217872|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
19765258|NCT02966834|42217867|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
19765259|NCT02966834|42217868|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
19765260|NCT02966834|42217869|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
19765261|NCT02966834|42217870|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
19765262|NCT02966834|42217871|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
19765263|NCT02966834|42217872|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
19765264|NCT02966834|42217867|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
19765265|NCT02966834|42217868|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
19765266|NCT02966834|42217869|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
19389093|NCT02670551|41632644|FG002|Overall Study|Other Miscellaneous Reasons|3|||
19765267|NCT02966834|42217870|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
19765268|NCT02966834|42217871|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
19765269|NCT02966834|42217872|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
19765270|NCT02966834|42217867|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
19765271|NCT02966834|42217868|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
19765272|NCT02966834|42217869|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
19765273|NCT02966834|42217870|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
19765274|NCT02966834|42217871|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
19765275|NCT02966834|42217872|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
19765276|NCT03106077|42217921|FG000|Overall Study|Screen Failure|94|||
19765277|NCT03106077|42217922|FG001|Overall Study|Screen Failure|0|||
19765278|NCT03105297|42217927|FG000|Baseline Phase (Day 1)|Other|21|||
19765279|NCT03105297|42217927|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
19765280|NCT03105297|42217927|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
19765281|NCT03426995|42217957|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765282|NCT03426995|42217958|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765283|NCT03426995|42217959|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
19765284|NCT03426995|42217960|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765285|NCT03426995|42217961|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765286|NCT03426995|42217962|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765287|NCT03426995|42217963|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765288|NCT03426995|42217964|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765289|NCT03426995|42217965|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765290|NCT03426995|42217966|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765291|NCT03426995|42217967|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765292|NCT03426995|42217968|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765293|NCT03426995|42217969|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765294|NCT03426995|42217970|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765295|NCT03426995|42217971|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765296|NCT03426995|42217972|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765297|NCT03426995|42217973|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765298|NCT03426995|42217974|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765299|NCT03426995|42217975|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
19765300|NCT03426995|42217957|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765301|NCT03426995|42217958|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765302|NCT03426995|42217959|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765303|NCT03426995|42217960|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765304|NCT03426995|42217961|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765305|NCT03426995|42217962|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
19765306|NCT03426995|42217963|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765307|NCT03426995|42217964|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765308|NCT03426995|42217965|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765309|NCT03426995|42217966|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765310|NCT03426995|42217967|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765311|NCT03426995|42217968|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765312|NCT03426995|42217969|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765313|NCT03426995|42217970|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765314|NCT03426995|42217971|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765315|NCT03426995|42217972|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765316|NCT03426995|42217973|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765317|NCT03426995|42217974|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765318|NCT03426995|42217975|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
19765319|NCT03426995|42217957|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765320|NCT03426995|42217958|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765321|NCT03426995|42217959|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765322|NCT03426995|42217960|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765323|NCT03426995|42217961|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
19765324|NCT03426995|42217962|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
19765325|NCT03426995|42217963|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765326|NCT03426995|42217964|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765327|NCT03426995|42217965|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765328|NCT03426995|42217966|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765329|NCT03426995|42217967|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765330|NCT03426995|42217968|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19477233|NCT01482221|41756211|FG001|Overall Study|Lost to Follow-up|2|||
19765331|NCT03426995|42217969|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765332|NCT03426995|42217970|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765333|NCT03426995|42217971|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765334|NCT03426995|42217972|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765335|NCT03426995|42217973|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765336|NCT03426995|42217974|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19765337|NCT03426995|42217975|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
19681340|NCT02969915|42128649|FG001|Overall Study|Lost to Follow-up|112|||
19765338|NCT03426995|42217957|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765339|NCT03426995|42217958|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765340|NCT03426995|42217959|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765341|NCT03426995|42217960|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765342|NCT03426995|42217961|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765343|NCT03426995|42217962|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765344|NCT03426995|42217963|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765345|NCT03426995|42217964|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765346|NCT03426995|42217965|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765347|NCT03426995|42217966|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765348|NCT03426995|42217967|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
19765349|NCT03426995|42217968|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765350|NCT03426995|42217969|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765351|NCT03426995|42217970|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19681341|NCT02969915|42128648|FG000|Overall Study|Censored due to COVID-19|481|||
19681342|NCT02969915|42128649|FG001|Overall Study|Censored due to COVID-19|471|||
19681343|NCT00454584|42128658|FG000|Controlled Period|Adverse Event|5|||
19681344|NCT00454584|42128659|FG001|Controlled Period|Adverse Event|2|||
19681345|NCT00454584|42128660|FG002|Controlled Period|Adverse Event|1|||
19681346|NCT00454584|42128661|FG003|Controlled Period|Adverse Event|0|||
19681347|NCT00454584|42128662|FG004|Controlled Period|Adverse Event|0|||
19681348|NCT00454584|42128663|FG005|Controlled Period|Adverse Event|0|||
19681349|NCT00454584|42128658|FG000|Controlled Period|Lost to Follow-up|1|||
19681350|NCT00454584|42128659|FG001|Controlled Period|Lost to Follow-up|2|||
19681351|NCT00454584|42128660|FG002|Controlled Period|Lost to Follow-up|2|||
19681352|NCT00454584|42128661|FG003|Controlled Period|Lost to Follow-up|0|||
19681353|NCT00454584|42128662|FG004|Controlled Period|Lost to Follow-up|0|||
19681354|NCT00454584|42128663|FG005|Controlled Period|Lost to Follow-up|0|||
19389094|NCT02670551|41632642|FG000|Overall Study|Did Not Receive Treatment|5|||
19681355|NCT00454584|42128658|FG000|Controlled Period|Other|5|||
19681356|NCT00454584|42128659|FG001|Controlled Period|Other|4|||
19681357|NCT00454584|42128660|FG002|Controlled Period|Other|2|||
19681358|NCT00454584|42128661|FG003|Controlled Period|Other|0|||
19681359|NCT00454584|42128662|FG004|Controlled Period|Other|0|||
19681360|NCT00454584|42128663|FG005|Controlled Period|Other|0|||
19681361|NCT00454584|42128658|FG000|After Controlled Period|Adverse Event|0|||
19681362|NCT00454584|42128659|FG001|After Controlled Period|Adverse Event|0|||
19681363|NCT00454584|42128660|FG002|After Controlled Period|Adverse Event|0|||
19681364|NCT00454584|42128661|FG003|After Controlled Period|Adverse Event|9|||
19681365|NCT00454584|42128662|FG004|After Controlled Period|Adverse Event|3|||
19681366|NCT00454584|42128663|FG005|After Controlled Period|Adverse Event|9|||
19681367|NCT00454584|42128658|FG000|After Controlled Period|Lack of Efficacy|0|||
19681368|NCT00454584|42128659|FG001|After Controlled Period|Lack of Efficacy|0|||
19681369|NCT00454584|42128660|FG002|After Controlled Period|Lack of Efficacy|0|||
19681370|NCT00454584|42128661|FG003|After Controlled Period|Lack of Efficacy|1|||
19681371|NCT00454584|42128662|FG004|After Controlled Period|Lack of Efficacy|0|||
19681372|NCT00454584|42128663|FG005|After Controlled Period|Lack of Efficacy|0|||
19681373|NCT00454584|42128658|FG000|After Controlled Period|Lost to Follow-up|0|||
19681374|NCT00454584|42128659|FG001|After Controlled Period|Lost to Follow-up|0|||
19681375|NCT00454584|42128660|FG002|After Controlled Period|Lost to Follow-up|0|||
19681376|NCT00454584|42128661|FG003|After Controlled Period|Lost to Follow-up|2|||
19681377|NCT00454584|42128662|FG004|After Controlled Period|Lost to Follow-up|4|||
19477234|NCT01482221|41756212|FG002|Overall Study|Lost to Follow-up|1|||
19681378|NCT00454584|42128663|FG005|After Controlled Period|Lost to Follow-up|6|||
19681379|NCT00454584|42128658|FG000|After Controlled Period|Other|0|||
19765352|NCT03426995|42217971|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765353|NCT03426995|42217972|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765354|NCT03426995|42217973|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765355|NCT03426995|42217974|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765356|NCT03426995|42217975|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
19765357|NCT03426995|42217957|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765358|NCT03426995|42217958|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765359|NCT03426995|42217959|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765360|NCT03426995|42217960|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765361|NCT03426995|42217961|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765362|NCT03426995|42217962|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765363|NCT03426995|42217963|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765364|NCT03426995|42217964|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
19765365|NCT03426995|42217965|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765366|NCT03426995|42217966|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765367|NCT03426995|42217967|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765368|NCT03426995|42217968|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765369|NCT03426995|42217969|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765370|NCT03426995|42217970|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765371|NCT03426995|42217971|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765372|NCT03426995|42217972|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765373|NCT03426995|42217973|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765374|NCT03426995|42217974|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765375|NCT03426995|42217975|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
19765376|NCT03426995|42217957|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765377|NCT03426995|42217958|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765378|NCT03426995|42217959|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765379|NCT03426995|42217960|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765380|NCT03426995|42217961|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765381|NCT03426995|42217962|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765382|NCT03426995|42217963|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765383|NCT03426995|42217964|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765384|NCT03426995|42217965|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765385|NCT03426995|42217966|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765386|NCT03426995|42217967|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765387|NCT03426995|42217968|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765388|NCT03426995|42217969|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765389|NCT03426995|42217970|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765390|NCT03426995|42217971|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
19765391|NCT03426995|42217972|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
19765392|NCT03426995|42217973|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765393|NCT03426995|42217974|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765394|NCT03426995|42217975|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
19765395|NCT03426995|42217957|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765396|NCT03426995|42217958|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765397|NCT03426995|42217959|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765398|NCT03426995|42217960|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765399|NCT03426995|42217961|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765400|NCT03426995|42217962|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765401|NCT03426995|42217963|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765402|NCT03426995|42217964|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765403|NCT03426995|42217965|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765404|NCT03426995|42217966|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19681380|NCT00454584|42128659|FG001|After Controlled Period|Other|0|||
19681381|NCT00454584|42128660|FG002|After Controlled Period|Other|0|||
19681382|NCT00454584|42128661|FG003|After Controlled Period|Other|1|||
19765405|NCT03426995|42217967|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765406|NCT03426995|42217968|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765407|NCT03426995|42217969|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765408|NCT03426995|42217970|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765409|NCT03426995|42217971|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
19389095|NCT02670551|41632643|FG001|Overall Study|Did Not Receive Treatment|3|||
19681383|NCT00454584|42128662|FG004|After Controlled Period|Other|0|||
19681384|NCT00454584|42128663|FG005|After Controlled Period|Other|0|||
19681385|NCT00454584|42128658|FG000|After Controlled Period|Other|0|||
19681386|NCT00454584|42128659|FG001|After Controlled Period|Other|0|||
19681387|NCT00454584|42128660|FG002|After Controlled Period|Other|0|||
19765410|NCT03426995|42217972|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
19765411|NCT03426995|42217973|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765412|NCT03426995|42217974|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765413|NCT03426995|42217975|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
19765414|NCT03424265|42218024|FG000|Overall Study|screening failure|1|||
19765415|NCT03424265|42218025|FG001|Overall Study|screening failure|0|||
19765416|NCT03424265|42218024|FG000|Overall Study|Withdrawal by Subject|0|||
19765417|NCT03424265|42218025|FG001|Overall Study|Withdrawal by Subject|2|||
19765418|NCT03322566|42218034|FG000|Overall Study|Death|34|||
19765419|NCT03322566|42218035|FG001|Overall Study|Death|35|||
19765420|NCT03322566|42218036|FG002|Overall Study|Death|23|||
19765421|NCT03322566|42218034|FG000|Overall Study|Physician Decision|6|||
19765422|NCT03322566|42218035|FG001|Overall Study|Physician Decision|7|||
19765423|NCT03322566|42218036|FG002|Overall Study|Physician Decision|2|||
19765424|NCT03322566|42218034|FG000|Overall Study|Withdrawal by Subject|4|||
19765425|NCT03322566|42218035|FG001|Overall Study|Withdrawal by Subject|3|||
19765426|NCT03322566|42218036|FG002|Overall Study|Withdrawal by Subject|6|||
19765427|NCT03322566|42218034|FG000|Overall Study|Lost to Follow-up|0|||
19765428|NCT03322566|42218035|FG001|Overall Study|Lost to Follow-up|0|||
19765429|NCT03322566|42218036|FG002|Overall Study|Lost to Follow-up|1|||
19765430|NCT03322566|42218034|FG000|Overall Study|Study terminated by sponsor|1|||
19765431|NCT03322566|42218035|FG001|Overall Study|Study terminated by sponsor|0|||
19765432|NCT03322566|42218036|FG002|Overall Study|Study terminated by sponsor|1|||
19765433|NCT02969018|42218052|FG000|Overall Study|Adverse Event|2|||
19765434|NCT02969018|42218053|FG001|Overall Study|Adverse Event|4|||
19765435|NCT02969018|42218054|FG002|Overall Study|Adverse Event|1|||
19765436|NCT02969018|42218055|FG003|Overall Study|Adverse Event|2|||
19765437|NCT02969018|42218056|FG004|Overall Study|Adverse Event|0|||
19765438|NCT02969018|42218057|FG005|Overall Study|Adverse Event|1|||
19765439|NCT02969018|42218058|FG006|Overall Study|Adverse Event|2|||
19765440|NCT02969018|42218059|FG007|Overall Study|Adverse Event|0|||
19765441|NCT02969018|42218052|FG000|Overall Study|Lack of Efficacy|0|||
19765442|NCT02969018|42218053|FG001|Overall Study|Lack of Efficacy|1|||
19765443|NCT02969018|42218054|FG002|Overall Study|Lack of Efficacy|0|||
19765444|NCT02969018|42218055|FG003|Overall Study|Lack of Efficacy|0|||
19765445|NCT02969018|42218056|FG004|Overall Study|Lack of Efficacy|1|||
19765446|NCT02969018|42218057|FG005|Overall Study|Lack of Efficacy|1|||
19765447|NCT02969018|42218058|FG006|Overall Study|Lack of Efficacy|1|||
19765448|NCT02969018|42218059|FG007|Overall Study|Lack of Efficacy|1|||
19765449|NCT02969018|42218052|FG000|Overall Study|Lost to Follow-up|1|||
19765450|NCT02969018|42218053|FG001|Overall Study|Lost to Follow-up|2|||
19765451|NCT02969018|42218054|FG002|Overall Study|Lost to Follow-up|2|||
19765452|NCT02969018|42218055|FG003|Overall Study|Lost to Follow-up|0|||
19765453|NCT02969018|42218056|FG004|Overall Study|Lost to Follow-up|1|||
19765454|NCT02969018|42218057|FG005|Overall Study|Lost to Follow-up|1|||
19765455|NCT02969018|42218058|FG006|Overall Study|Lost to Follow-up|0|||
19765456|NCT02969018|42218059|FG007|Overall Study|Lost to Follow-up|1|||
19765457|NCT02969018|42218052|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765458|NCT02969018|42218053|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765459|NCT02969018|42218054|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765460|NCT02969018|42218055|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765461|NCT02969018|42218056|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765462|NCT02969018|42218057|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765463|NCT02969018|42218058|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
19765464|NCT02969018|42218059|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
19765465|NCT02969018|42218052|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19765466|NCT02969018|42218053|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19765467|NCT02969018|42218054|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19765468|NCT02969018|42218055|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19765469|NCT02969018|42218056|FG004|Overall Study|Non-Compliance With Study Drug|0|||
19765470|NCT02969018|42218057|FG005|Overall Study|Non-Compliance With Study Drug|0|||
19765471|NCT02969018|42218058|FG006|Overall Study|Non-Compliance With Study Drug|0|||
19765472|NCT02969018|42218059|FG007|Overall Study|Non-Compliance With Study Drug|0|||
19765473|NCT02969018|42218052|FG000|Overall Study|Other|0|||
19765474|NCT02969018|42218053|FG001|Overall Study|Other|0|||
19765475|NCT02969018|42218054|FG002|Overall Study|Other|0|||
19765476|NCT02969018|42218055|FG003|Overall Study|Other|1|||
19765477|NCT02969018|42218056|FG004|Overall Study|Other|0|||
19765478|NCT02969018|42218057|FG005|Overall Study|Other|0|||
19765479|NCT02969018|42218058|FG006|Overall Study|Other|0|||
19765480|NCT02969018|42218059|FG007|Overall Study|Other|2|||
19765481|NCT02969018|42218052|FG000|Overall Study|Pregnancy|0|||
19765482|NCT02969018|42218053|FG001|Overall Study|Pregnancy|0|||
19765483|NCT02969018|42218054|FG002|Overall Study|Pregnancy|0|||
19765484|NCT02969018|42218055|FG003|Overall Study|Pregnancy|0|||
19765485|NCT02969018|42218056|FG004|Overall Study|Pregnancy|0|||
19765486|NCT02969018|42218057|FG005|Overall Study|Pregnancy|1|||
19765487|NCT02969018|42218058|FG006|Overall Study|Pregnancy|0|||
19765488|NCT02969018|42218059|FG007|Overall Study|Pregnancy|0|||
19765489|NCT02969018|42218052|FG000|Overall Study|Protocol Violation|0|||
19765490|NCT02969018|42218053|FG001|Overall Study|Protocol Violation|0|||
19765491|NCT02969018|42218054|FG002|Overall Study|Protocol Violation|1|||
19765492|NCT02969018|42218055|FG003|Overall Study|Protocol Violation|1|||
19765493|NCT02969018|42218056|FG004|Overall Study|Protocol Violation|0|||
19765494|NCT02969018|42218057|FG005|Overall Study|Protocol Violation|0|||
19765495|NCT02969018|42218058|FG006|Overall Study|Protocol Violation|0|||
19765496|NCT02969018|42218059|FG007|Overall Study|Protocol Violation|0|||
19765497|NCT02969018|42218052|FG000|Overall Study|Withdrawal by Subject|0|||
19765498|NCT02969018|42218053|FG001|Overall Study|Withdrawal by Subject|1|||
19765499|NCT02969018|42218054|FG002|Overall Study|Withdrawal by Subject|2|||
19765500|NCT02969018|42218055|FG003|Overall Study|Withdrawal by Subject|1|||
19765501|NCT02969018|42218056|FG004|Overall Study|Withdrawal by Subject|0|||
19765502|NCT02969018|42218057|FG005|Overall Study|Withdrawal by Subject|4|||
19765503|NCT02969018|42218058|FG006|Overall Study|Withdrawal by Subject|4|||
19765504|NCT02969018|42218059|FG007|Overall Study|Withdrawal by Subject|3|||
19765505|NCT01319721|42218082|FG000|Overall Study|Lost to Follow-up|1|||
19765506|NCT01319721|42218083|FG001|Overall Study|Lost to Follow-up|6|||
19765507|NCT02905032|42218092|FG000|Overall Study|Withdrawal by Subject|2|||
19765508|NCT02905032|42218093|FG001|Overall Study|Withdrawal by Subject|0|||
19765509|NCT02905032|42218094|FG002|Overall Study|Withdrawal by Subject|0|||
19765510|NCT02905032|42218092|FG000|Overall Study|Protocol Violation|6|||
19765511|NCT02905032|42218093|FG001|Overall Study|Protocol Violation|12|||
19765512|NCT02905032|42218094|FG002|Overall Study|Protocol Violation|0|||
19765513|NCT03259425|42218101|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
19765514|NCT03101241|42218107|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
19765515|NCT03101241|42218108|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
19765516|NCT03101241|42218107|FG000|Overall Study|Participant withdrew consent|3|||
19765517|NCT03101241|42218108|FG001|Overall Study|Participant withdrew consent|1|||
19765518|NCT03101241|42218107|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
19765519|NCT03101241|42218108|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
19765520|NCT03101241|42218107|FG000|Overall Study|Lost to Follow-up|2|||
19765521|NCT03101241|42218108|FG001|Overall Study|Lost to Follow-up|0|||
19765522|NCT03101241|42218107|FG000|Overall Study|Lack of Efficacy|0|||
19765523|NCT03101241|42218108|FG001|Overall Study|Lack of Efficacy|1|||
19765524|NCT03101241|42218107|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
19765525|NCT03101241|42218108|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
19765526|NCT03061188|42218118|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
19765527|NCT03061188|42218119|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
19765528|NCT03061188|42218120|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
19765529|NCT03061188|42218121|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
19765530|NCT03061188|42218118|FG000|On Follow-up for 3 Years|Death|0|||
19765531|NCT03061188|42218119|FG001|On Follow-up for 3 Years|Death|3|||
19765532|NCT03061188|42218120|FG002|On Follow-up for 3 Years|Death|5|||
19765533|NCT03061188|42218121|FG003|On Follow-up for 3 Years|Death|2|||
19765534|NCT03061188|42218118|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
19765535|NCT03061188|42218119|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
19765536|NCT03061188|42218120|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
19765537|NCT03061188|42218121|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
19765538|NCT03449147|42218139|FG000|52-week Treatment Period|Death|0|||
19765539|NCT03449147|42218140|FG001|52-week Treatment Period|Death|1|||
19765540|NCT03449147|42218141|FG002|52-week Treatment Period|Death|0|||
19765541|NCT03449147|42218139|FG000|52-week Treatment Period|Lost to Follow-up|6|||
19765542|NCT03449147|42218140|FG001|52-week Treatment Period|Lost to Follow-up|2|||
19765543|NCT03449147|42218141|FG002|52-week Treatment Period|Lost to Follow-up|5|||
19765544|NCT03449147|42218139|FG000|52-week Treatment Period|Other|0|||
19765545|NCT03449147|42218140|FG001|52-week Treatment Period|Other|1|||
19765546|NCT03449147|42218141|FG002|52-week Treatment Period|Other|2|||
19765547|NCT03449147|42218139|FG000|52-week Treatment Period|Physician Decision|1|||
19765548|NCT03449147|42218140|FG001|52-week Treatment Period|Physician Decision|0|||
19765549|NCT03449147|42218141|FG002|52-week Treatment Period|Physician Decision|3|||
19765550|NCT03449147|42218139|FG000|52-week Treatment Period|Screen Failure|1|||
19765551|NCT03449147|42218140|FG001|52-week Treatment Period|Screen Failure|2|||
19765552|NCT03449147|42218141|FG002|52-week Treatment Period|Screen Failure|0|||
19765553|NCT03449147|42218139|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
19765554|NCT03449147|42218140|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
19765555|NCT03449147|42218141|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
19765556|NCT03449147|42218139|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
19765557|NCT03449147|42218140|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
19765558|NCT03449147|42218141|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
19765559|NCT03449147|42218139|FG000|12-Week Off-Treatment Durability Period|Other|0|||
19765560|NCT03449147|42218140|FG001|12-Week Off-Treatment Durability Period|Other|1|||
19765561|NCT03449147|42218141|FG002|12-Week Off-Treatment Durability Period|Other|0|||
19765562|NCT03423173|42218157|FG000|Overall Study|Randomized but not vaccinated|1|||
19765563|NCT03423173|42218158|FG001|Overall Study|Randomized but not vaccinated|0|||
19765564|NCT03423173|42218159|FG002|Overall Study|Randomized but not vaccinated|2|||
19765565|NCT03423173|42218160|FG003|Overall Study|Randomized but not vaccinated|1|||
19765566|NCT03423173|42218157|FG000|Overall Study|Adverse Event|1|||
19765567|NCT03423173|42218158|FG001|Overall Study|Adverse Event|1|||
19765568|NCT03423173|42218159|FG002|Overall Study|Adverse Event|1|||
19765569|NCT03423173|42218160|FG003|Overall Study|Adverse Event|1|||
19765570|NCT03423173|42218157|FG000|Overall Study|Lost to Follow-up|10|||
19765571|NCT03423173|42218158|FG001|Overall Study|Lost to Follow-up|19|||
19765572|NCT03423173|42218159|FG002|Overall Study|Lost to Follow-up|17|||
19765573|NCT03423173|42218160|FG003|Overall Study|Lost to Follow-up|22|||
19765574|NCT03423173|42218157|FG000|Overall Study|Withdrawal of consent|4|||
19765575|NCT03423173|42218158|FG001|Overall Study|Withdrawal of consent|10|||
19765576|NCT03423173|42218159|FG002|Overall Study|Withdrawal of consent|4|||
19765577|NCT03423173|42218160|FG003|Overall Study|Withdrawal of consent|5|||
19765578|NCT03423173|42218157|FG000|Overall Study|Death|1|||
19765579|NCT03423173|42218158|FG001|Overall Study|Death|0|||
19765580|NCT03423173|42218159|FG002|Overall Study|Death|0|||
19765581|NCT03423173|42218160|FG003|Overall Study|Death|0|||
19765582|NCT03423173|42218157|FG000|Overall Study|Reason not Specified|2|||
19765583|NCT03423173|42218158|FG001|Overall Study|Reason not Specified|5|||
19765584|NCT03423173|42218159|FG002|Overall Study|Reason not Specified|3|||
19765585|NCT03423173|42218160|FG003|Overall Study|Reason not Specified|1|||
19765586|NCT03447821|42218173|FG000|Overall Study|Withdrawal by Subject|1|||
19765587|NCT03447821|42218174|FG001|Overall Study|Withdrawal by Subject|1|||
19765588|NCT03447821|42218175|FG002|Overall Study|Withdrawal by Subject|0|||
19765589|NCT03447821|42218173|FG000|Overall Study|Lost to Follow-up|0|||
19765590|NCT03447821|42218174|FG001|Overall Study|Lost to Follow-up|0|||
19765591|NCT03447821|42218175|FG002|Overall Study|Lost to Follow-up|1|||
19765592|NCT03447353|42218189|FG000|Overall Study|Failure at Screening Visit|2|||
19765593|NCT03447353|42218189|FG000|Overall Study|Lost to Follow-up|4|||
19765594|NCT03447353|42218189|FG000|Overall Study|Scheduling Conflicts|3|||
19765595|NCT03447353|42218189|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
19765596|NCT03446885|42218199|FG000|Overall Study|Lost to Follow-up|1|||
19765597|NCT03446885|42218200|FG001|Overall Study|Lost to Follow-up|0|||
19765598|NCT03446885|42218199|FG000|Overall Study|Did not complete entire visit|1|||
19765599|NCT03446885|42218200|FG001|Overall Study|Did not complete entire visit|0|||
19765600|NCT00710970|42218208|FG000|Overall Study|Never took drug|3|||
19765601|NCT03422159|42218214|FG000|Overall Study|Exclusion due to terminal disease|2|||
19765602|NCT03422159|42218215|FG001|Overall Study|Exclusion due to terminal disease|1|||
19765603|NCT03421379|42218225|FG000|Period 1|Withdrawal by Subject|0|||
19765604|NCT03421379|42218226|FG001|Period 1|Withdrawal by Subject|1|||
19765605|NCT03421379|42218225|FG000|Period 1|Physician Decision|1|||
19765606|NCT03421379|42218226|FG001|Period 1|Physician Decision|1|||
19765607|NCT03421379|42218225|FG000|Period 1|Did not receive treatment|1|||
19765608|NCT03421379|42218226|FG001|Period 1|Did not receive treatment|2|||
19765609|NCT02900378|42218234|FG000|Randomization (Visit 2)|Adverse Event|14|||
19765610|NCT02900378|42218235|FG001|Randomization (Visit 2)|Adverse Event|11|||
19765611|NCT02900378|42218234|FG000|Randomization (Visit 2)|Death|1|||
19765612|NCT02900378|42218235|FG001|Randomization (Visit 2)|Death|4|||
19765613|NCT02900378|42218234|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
19765614|NCT02900378|42218235|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
19765615|NCT02900378|42218234|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
19765616|NCT02900378|42218235|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
19765617|NCT02900378|42218234|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
19765618|NCT02900378|42218235|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
19765619|NCT02900378|42218234|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
19765620|NCT02900378|42218235|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
19765621|NCT02900378|42218234|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
19765622|NCT02900378|42218235|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
19765623|NCT03058692|42218243|FG000|Overall Study|Lost to Follow-up|2|||
19765624|NCT03058692|42218244|FG001|Overall Study|Lost to Follow-up|1|||
19765625|NCT03058692|42218243|FG000|Overall Study|Withdrawal by Subject|1|||
19765626|NCT03058692|42218244|FG001|Overall Study|Withdrawal by Subject|1|||
19765627|NCT02964338|42218254|FG000|Overall Study|Sponsor terminated study for futility|12|||
19765628|NCT02964338|42218255|FG001|Overall Study|Sponsor terminated study for futility|15|||
19765629|NCT02964338|42218256|FG002|Overall Study|Sponsor terminated study for futility|14|||
19765630|NCT02964338|42218254|FG000|Overall Study|Lack of Efficacy|0|||
19765631|NCT02964338|42218255|FG001|Overall Study|Lack of Efficacy|3|||
19765632|NCT02964338|42218256|FG002|Overall Study|Lack of Efficacy|0|||
19765633|NCT02964338|42218254|FG000|Overall Study|Lost to Follow-up|1|||
19765634|NCT02964338|42218255|FG001|Overall Study|Lost to Follow-up|0|||
19765635|NCT02964338|42218256|FG002|Overall Study|Lost to Follow-up|3|||
19765636|NCT02964338|42218254|FG000|Overall Study|Protocol Violation|0|||
19765637|NCT02964338|42218255|FG001|Overall Study|Protocol Violation|1|||
19765638|NCT02964338|42218256|FG002|Overall Study|Protocol Violation|0|||
19765639|NCT02964338|42218254|FG000|Overall Study|Withdrawal by Subject|1|||
19765640|NCT02964338|42218255|FG001|Overall Study|Withdrawal by Subject|3|||
19765641|NCT02964338|42218256|FG002|Overall Study|Withdrawal by Subject|1|||
19765642|NCT02964338|42218254|FG000|Overall Study|Adverse Event|2|||
19765643|NCT02964338|42218255|FG001|Overall Study|Adverse Event|1|||
19765644|NCT02964338|42218256|FG002|Overall Study|Adverse Event|1|||
19765645|NCT02964338|42218254|FG000|Overall Study|Non-compliant with e-diary|0|||
19765646|NCT02964338|42218255|FG001|Overall Study|Non-compliant with e-diary|1|||
19765647|NCT02964338|42218256|FG002|Overall Study|Non-compliant with e-diary|0|||
19765648|NCT02964338|42218254|FG000|Overall Study|Did not meet criteria|1|||
19765649|NCT02964338|42218255|FG001|Overall Study|Did not meet criteria|0|||
19765650|NCT02964338|42218256|FG002|Overall Study|Did not meet criteria|0|||
19765651|NCT03056352|42218264|FG000|Overall Study|Lost to Follow-up|1|||
19765652|NCT03446573|42218270|FG000|Overall Study|Withdrawal by Subject|7|||
19765653|NCT03446573|42218271|FG001|Overall Study|Withdrawal by Subject|16|||
19765654|NCT03446573|42218270|FG000|Overall Study|Physician Decision|1|||
19765655|NCT03446573|42218271|FG001|Overall Study|Physician Decision|1|||
19765656|NCT03446573|42218270|FG000|Overall Study|Lost to Follow-up|3|||
19681388|NCT00454584|42128661|FG003|After Controlled Period|Other|13|||
19681389|NCT00454584|42128662|FG004|After Controlled Period|Other|5|||
19681390|NCT00454584|42128663|FG005|After Controlled Period|Other|17|||
19681391|NCT00445068|42128677|FG000|Overall Study|Disease progression|26|||
19681392|NCT00445068|42128677|FG000|Overall Study|Adverse Event|5|||
19681393|NCT00445068|42128677|FG000|Overall Study|Abnormal laboratory value|2|||
19681394|NCT00445068|42128677|FG000|Overall Study|Withdrawal by Subject|2|||
19681395|NCT00445068|42128677|FG000|Overall Study|Death|1|||
19681396|NCT00539279|42128683|FG000|Treatment|Withdrawal by Subject|10|||
19681397|NCT00539279|42128684|FG001|Treatment|Withdrawal by Subject|8|||
19765657|NCT03446573|42218271|FG001|Overall Study|Lost to Follow-up|5|||
19765658|NCT03446573|42218270|FG000|Overall Study|Protocol Violation|3|||
19765659|NCT03446573|42218271|FG001|Overall Study|Protocol Violation|2|||
19765660|NCT03446573|42218270|FG000|Overall Study|Lack of Efficacy|0|||
19765661|NCT03446573|42218271|FG001|Overall Study|Lack of Efficacy|3|||
19765662|NCT03446573|42218270|FG000|Overall Study|Adverse Event|13|||
19765663|NCT03446573|42218271|FG001|Overall Study|Adverse Event|2|||
19765664|NCT03446573|42218270|FG000|Overall Study|Ongoing at the time of interim analysis|342|||
19765665|NCT03446573|42218271|FG001|Overall Study|Ongoing at the time of interim analysis|343|||
19765666|NCT02898662|42218282|FG000|Overall Study|Adverse Event|1|||
19765667|NCT02898662|42218283|FG001|Overall Study|Adverse Event|0|||
19765668|NCT02898662|42218282|FG000|Overall Study|Loss of asthma control|23|||
19765669|NCT02898662|42218283|FG001|Overall Study|Loss of asthma control|24|||
19765670|NCT02898662|42218282|FG000|Overall Study|Withdrawal by Subject|4|||
19765671|NCT02898662|42218283|FG001|Overall Study|Withdrawal by Subject|1|||
19765672|NCT02898662|42218282|FG000|Overall Study|Technical issue|0|||
19765673|NCT02898662|42218283|FG001|Overall Study|Technical issue|1|||
19765674|NCT02898662|42218282|FG000|Overall Study|Randomized in error|0|||
19765675|NCT02898662|42218283|FG001|Overall Study|Randomized in error|1|||
19765676|NCT02898662|42218282|FG000|Overall Study|Subject decision|1|||
19765677|NCT02898662|42218283|FG001|Overall Study|Subject decision|0|||
19765678|NCT02898662|42218282|FG000|Overall Study|Other|0|||
19765679|NCT02898662|42218283|FG001|Overall Study|Other|1|||
19765680|NCT03055338|42218292|FG000|Overall Study|Lost to Follow-up|9|||
19765681|NCT03055338|42218293|FG001|Overall Study|Lost to Follow-up|2|||
19765682|NCT03055338|42218294|FG002|Overall Study|Lost to Follow-up|3|||
19765683|NCT03055338|42218292|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
19765684|NCT03055338|42218293|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
19765685|NCT03055338|42218294|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
19765686|NCT03055338|42218292|FG000|Overall Study|Physician Decision|0|||
19765687|NCT03055338|42218293|FG001|Overall Study|Physician Decision|0|||
19765688|NCT03055338|42218294|FG002|Overall Study|Physician Decision|2|||
19765689|NCT03055338|42218292|FG000|Overall Study|Withdrawal by Subject|9|||
19765690|NCT03055338|42218293|FG001|Overall Study|Withdrawal by Subject|8|||
19765691|NCT03055338|42218294|FG002|Overall Study|Withdrawal by Subject|7|||
19765692|NCT03913130|42218302|FG000|Overall Study|Sponsor Decision|1|||
19765693|NCT03419741|42218308|FG000|Overall Study|Adverse Event|1|||
19765694|NCT03419741|42218309|FG001|Overall Study|Adverse Event|0|||
19765695|NCT03419741|42218308|FG000|Overall Study|Withdrawal by Subject|1|||
19765696|NCT03419741|42218309|FG001|Overall Study|Withdrawal by Subject|2|||
19765697|NCT02896400|42218331|FG000|1 Month Follow-up|Lost to Follow-up|7|||
19765698|NCT02896400|42218332|FG001|1 Month Follow-up|Lost to Follow-up|7|||
19765699|NCT02896400|42218333|FG002|1 Month Follow-up|Lost to Follow-up|5|||
19765700|NCT02896400|42218334|FG003|1 Month Follow-up|Lost to Follow-up|8|||
19681398|NCT00539279|42128683|FG000|Treatment|Death|1|||
19681399|NCT00539279|42128684|FG001|Treatment|Death|0|||
19765701|NCT02896400|42218335|FG004|1 Month Follow-up|Lost to Follow-up|9|||
19765702|NCT02896400|42218336|FG005|1 Month Follow-up|Lost to Follow-up|6|||
19765703|NCT02896400|42218337|FG006|1 Month Follow-up|Lost to Follow-up|5|||
19765704|NCT02896400|42218338|FG007|1 Month Follow-up|Lost to Follow-up|6|||
19765705|NCT02896400|42218339|FG008|1 Month Follow-up|Lost to Follow-up|4|||
19765706|NCT02896400|42218340|FG009|1 Month Follow-up|Lost to Follow-up|7|||
19765707|NCT02896400|42218341|FG010|1 Month Follow-up|Lost to Follow-up|5|||
19765708|NCT02896400|42218342|FG011|1 Month Follow-up|Lost to Follow-up|5|||
19765709|NCT02896400|42218343|FG012|1 Month Follow-up|Lost to Follow-up|3|||
19765710|NCT02896400|42218344|FG013|1 Month Follow-up|Lost to Follow-up|4|||
19765711|NCT02896400|42218345|FG014|1 Month Follow-up|Lost to Follow-up|1|||
19765712|NCT02896400|42218346|FG015|1 Month Follow-up|Lost to Follow-up|2|||
19765713|NCT02896400|42218331|FG000|1 Month Follow-up|Death|0|||
19765714|NCT02896400|42218332|FG001|1 Month Follow-up|Death|0|||
19765715|NCT02896400|42218333|FG002|1 Month Follow-up|Death|0|||
19765716|NCT02896400|42218334|FG003|1 Month Follow-up|Death|0|||
19765717|NCT02896400|42218335|FG004|1 Month Follow-up|Death|0|||
19765718|NCT02896400|42218336|FG005|1 Month Follow-up|Death|0|||
19765719|NCT02896400|42218337|FG006|1 Month Follow-up|Death|0|||
19765720|NCT02896400|42218338|FG007|1 Month Follow-up|Death|0|||
19765721|NCT02896400|42218339|FG008|1 Month Follow-up|Death|0|||
19765722|NCT02896400|42218340|FG009|1 Month Follow-up|Death|0|||
19765723|NCT02896400|42218341|FG010|1 Month Follow-up|Death|0|||
19765724|NCT02896400|42218342|FG011|1 Month Follow-up|Death|0|||
19765725|NCT02896400|42218343|FG012|1 Month Follow-up|Death|0|||
19765726|NCT02896400|42218344|FG013|1 Month Follow-up|Death|0|||
19765727|NCT02896400|42218345|FG014|1 Month Follow-up|Death|0|||
19765728|NCT02896400|42218346|FG015|1 Month Follow-up|Death|1|||
19765729|NCT02896400|42218331|FG000|3 Month Follow-up|Lost to Follow-up|6|||
19765730|NCT02896400|42218332|FG001|3 Month Follow-up|Lost to Follow-up|3|||
19765731|NCT02896400|42218333|FG002|3 Month Follow-up|Lost to Follow-up|6|||
19765732|NCT02896400|42218334|FG003|3 Month Follow-up|Lost to Follow-up|11|||
19765733|NCT02896400|42218335|FG004|3 Month Follow-up|Lost to Follow-up|12|||
19765734|NCT02896400|42218336|FG005|3 Month Follow-up|Lost to Follow-up|6|||
19765735|NCT02896400|42218337|FG006|3 Month Follow-up|Lost to Follow-up|4|||
19765736|NCT02896400|42218338|FG007|3 Month Follow-up|Lost to Follow-up|3|||
19765737|NCT02896400|42218339|FG008|3 Month Follow-up|Lost to Follow-up|6|||
19765738|NCT02896400|42218340|FG009|3 Month Follow-up|Lost to Follow-up|5|||
19765739|NCT02896400|42218341|FG010|3 Month Follow-up|Lost to Follow-up|6|||
19765740|NCT02896400|42218342|FG011|3 Month Follow-up|Lost to Follow-up|6|||
19681400|NCT00539279|42128683|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
19681401|NCT00539279|42128684|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
19681402|NCT00539279|42128683|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
19681403|NCT00539279|42128684|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
19681404|NCT00444912|42128692|FG000|Overall Study|Death|1|||
19681405|NCT00444912|42128693|FG001|Overall Study|Death|2|||
19681406|NCT00444912|42128692|FG000|Overall Study|Lost to Follow-up|1|||
19681407|NCT00444912|42128693|FG001|Overall Study|Lost to Follow-up|0|||
19681408|NCT00444912|42128692|FG000|Overall Study|Participant Failed Mobilization|1|||
19681409|NCT00444912|42128693|FG001|Overall Study|Participant Failed Mobilization|0|||
19681410|NCT00538733|42128699|FG000|Overall Study|Adverse Event|8|||
19681411|NCT00538733|42128699|FG000|Overall Study|Death|1|||
19681412|NCT00538733|42128699|FG000|Overall Study|declined to participate|2|||
19681413|NCT00538733|42128699|FG000|Overall Study|still on therapy|1|||
19681414|NCT00444678|42128706|FG000|Overall Study|Toxicity|11|||
19681415|NCT00444678|42128706|FG000|Overall Study|Disease Progression|12|||
19681416|NCT00444678|42128706|FG000|Overall Study|Death|3|||
19681417|NCT00444678|42128706|FG000|Overall Study|Physician Decision|3|||
19681418|NCT00444678|42128706|FG000|Overall Study|Withdrawal by Subject|2|||
19681419|NCT00358449|42128713|FG000|Overall Study|Adverse Event|1|||
19681420|NCT00358449|42128714|FG001|Overall Study|Adverse Event|0|||
19681421|NCT00358449|42128715|FG002|Overall Study|Adverse Event|1|||
19681422|NCT00358449|42128713|FG000|Overall Study|Lost to Follow-up|1|||
19681423|NCT00358449|42128714|FG001|Overall Study|Lost to Follow-up|0|||
19681424|NCT00358449|42128715|FG002|Overall Study|Lost to Follow-up|0|||
19681425|NCT00358449|42128713|FG000|Overall Study|Withdrawal by Subject|2|||
19681426|NCT00358449|42128714|FG001|Overall Study|Withdrawal by Subject|0|||
19681427|NCT00358449|42128715|FG002|Overall Study|Withdrawal by Subject|0|||
19765741|NCT02896400|42218343|FG012|3 Month Follow-up|Lost to Follow-up|3|||
19765742|NCT02896400|42218344|FG013|3 Month Follow-up|Lost to Follow-up|5|||
19765743|NCT02896400|42218345|FG014|3 Month Follow-up|Lost to Follow-up|3|||
19765744|NCT02896400|42218346|FG015|3 Month Follow-up|Lost to Follow-up|2|||
19765745|NCT02896400|42218331|FG000|3 Month Follow-up|Death|0|||
19765746|NCT02896400|42218332|FG001|3 Month Follow-up|Death|0|||
19681428|NCT00358449|42128713|FG000|Overall Study|Lack of Efficacy|0|||
19765747|NCT02896400|42218333|FG002|3 Month Follow-up|Death|0|||
19765748|NCT02896400|42218334|FG003|3 Month Follow-up|Death|0|||
19765749|NCT02896400|42218335|FG004|3 Month Follow-up|Death|0|||
19765750|NCT02896400|42218336|FG005|3 Month Follow-up|Death|0|||
19765751|NCT02896400|42218337|FG006|3 Month Follow-up|Death|0|||
19765752|NCT02896400|42218338|FG007|3 Month Follow-up|Death|0|||
19765753|NCT02896400|42218339|FG008|3 Month Follow-up|Death|0|||
19765754|NCT02896400|42218340|FG009|3 Month Follow-up|Death|0|||
19765755|NCT02896400|42218341|FG010|3 Month Follow-up|Death|0|||
19765756|NCT02896400|42218342|FG011|3 Month Follow-up|Death|0|||
19765757|NCT02896400|42218343|FG012|3 Month Follow-up|Death|0|||
19765758|NCT02896400|42218344|FG013|3 Month Follow-up|Death|1|||
19765759|NCT02896400|42218345|FG014|3 Month Follow-up|Death|1|||
19765760|NCT02896400|42218346|FG015|3 Month Follow-up|Death|0|||
19765761|NCT02896400|42218331|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765762|NCT02896400|42218332|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
19765763|NCT02896400|42218333|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765764|NCT02896400|42218334|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765765|NCT02896400|42218335|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
19765766|NCT02896400|42218336|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765767|NCT02896400|42218337|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
19765768|NCT02896400|42218338|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
19765769|NCT02896400|42218339|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765770|NCT02896400|42218340|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765771|NCT02896400|42218341|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
19765772|NCT02896400|42218342|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
19765773|NCT02896400|42218343|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765774|NCT02896400|42218344|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
19765775|NCT02896400|42218345|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
19765776|NCT02896400|42218346|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
19765777|NCT02896400|42218331|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
19765778|NCT02896400|42218332|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
19765779|NCT02896400|42218333|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
19765780|NCT02896400|42218334|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
19765781|NCT02896400|42218335|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
19765782|NCT02896400|42218336|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
19765783|NCT02896400|42218337|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
19765784|NCT02896400|42218338|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
19765785|NCT02896400|42218339|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
19765786|NCT02896400|42218340|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
19765787|NCT02896400|42218341|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
19765788|NCT02896400|42218342|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
19765789|NCT02896400|42218343|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
19765790|NCT02896400|42218344|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
19765791|NCT02896400|42218345|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
19765792|NCT02896400|42218346|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
19765793|NCT03405935|42218372|FG000|Overall Study|Adverse Event|3|||
19765794|NCT03405935|42218372|FG000|Overall Study|Death|2|||
19765795|NCT03405935|42218372|FG000|Overall Study|Withdrawal by Subject|1|||
19765796|NCT03405935|42218372|FG000|Overall Study|Lost to Follow-up|2|||
19765797|NCT03055260|42218378|FG000|Overall Study|Withdrawal by Subject|1|||
19765798|NCT03055260|42218379|FG001|Overall Study|Withdrawal by Subject|0|||
19765799|NCT03404843|42218387|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
19765800|NCT03404843|42218388|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
19765801|NCT03444155|42218412|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
19765802|NCT03444155|42218413|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
19765803|NCT02898116|42218419|FG000|Overall Study|Adverse Event|1|||
19681429|NCT00358449|42128714|FG001|Overall Study|Lack of Efficacy|1|||
19681430|NCT00358449|42128715|FG002|Overall Study|Lack of Efficacy|0|||
19681431|NCT00358449|42128713|FG000|Overall Study|Steriod Inhaler was Increased|0|||
19681432|NCT00358449|42128714|FG001|Overall Study|Steriod Inhaler was Increased|0|||
19681433|NCT00358449|42128715|FG002|Overall Study|Steriod Inhaler was Increased|1|||
19681434|NCT00539981|42128727|FG000|Overall Study|Adverse events (AE)|3|||
19681435|NCT00539981|42128728|FG001|Overall Study|Adverse events (AE)|3|||
19681436|NCT00539981|42128727|FG000|Overall Study|Lost to Follow-up|260|||
19681437|NCT00539981|42128728|FG001|Overall Study|Lost to Follow-up|251|||
19681438|NCT00539981|42128727|FG000|Overall Study|Withdrew consent|22|||
19681439|NCT00539981|42128728|FG001|Overall Study|Withdrew consent|14|||
19681440|NCT00539981|42128727|FG000|Overall Study|Death|1|||
19681441|NCT00539981|42128728|FG001|Overall Study|Death|1|||
19681442|NCT00539981|42128727|FG000|Overall Study|Other reason-unspecified|9|||
19681443|NCT00539981|42128728|FG001|Overall Study|Other reason-unspecified|13|||
19681444|NCT00367341|42128739|FG000|Overall Study|Physician Decision|1|||
19681445|NCT00367341|42128740|FG001|Overall Study|Physician Decision|0|||
19765804|NCT02898116|42218419|FG000|Overall Study|Progressive disease|1|||
19765805|NCT03658304|42218423|FG000|Overall Study|participants still on follow up|8|||
19765806|NCT03403751|42218429|FG000|Overall Study|Death|5|||
19765807|NCT03403751|42218430|FG001|Overall Study|Death|6|||
19765808|NCT03403751|42218429|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
19765809|NCT03403751|42218430|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
19765810|NCT02297412|42218440|FG000|Overall Study|Canceled|1|||
19765811|NCT02297412|42218441|FG001|Overall Study|Canceled|1|||
19765812|NCT03418727|42218450|FG000|Overall Study|Adverse Event|1|||
19765813|NCT03418727|42218451|FG001|Overall Study|Adverse Event|2|||
19765814|NCT03418727|42218452|FG002|Overall Study|Adverse Event|0|||
19765815|NCT03418727|42218450|FG000|Overall Study|Withdrawal by Subject|0|||
19765816|NCT03418727|42218451|FG001|Overall Study|Withdrawal by Subject|0|||
19765817|NCT03418727|42218452|FG002|Overall Study|Withdrawal by Subject|2|||
19765818|NCT03418571|42218462|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
19765819|NCT03418571|42218463|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
19765820|NCT03402893|42218469|FG000|Overall Study|Withdrawal by Subject|1|||
19765821|NCT03442985|42218477|FG000|Overall Study|Sponsor Request|55|||
19765822|NCT03442985|42218478|FG001|Overall Study|Sponsor Request|60|||
19765823|NCT03442985|42218479|FG002|Overall Study|Sponsor Request|54|||
19765824|NCT03442985|42218477|FG000|Overall Study|Lost to Follow-up|5|||
19765825|NCT03442985|42218478|FG001|Overall Study|Lost to Follow-up|2|||
19765826|NCT03442985|42218479|FG002|Overall Study|Lost to Follow-up|7|||
19765827|NCT03442985|42218477|FG000|Overall Study|Withdrawal by Subject|2|||
19765828|NCT03442985|42218478|FG001|Overall Study|Withdrawal by Subject|3|||
19765829|NCT03442985|42218479|FG002|Overall Study|Withdrawal by Subject|4|||
19765830|NCT03442985|42218477|FG000|Overall Study|Adverse Event|0|||
19765831|NCT03442985|42218478|FG001|Overall Study|Adverse Event|1|||
19765832|NCT03442985|42218479|FG002|Overall Study|Adverse Event|0|||
19765833|NCT01318122|42218491|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19765834|NCT01318122|42218492|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19765835|NCT01318122|42218493|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
19765836|NCT01318122|42218494|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
19765837|NCT01318122|42218491|FG000|Enrolled - Long-Term Extension Study|Other|1|||
19765838|NCT01318122|42218492|FG001|Enrolled - Long-Term Extension Study|Other|0|||
19765839|NCT01318122|42218493|FG002|Enrolled - Long-Term Extension Study|Other|0|||
19765840|NCT01318122|42218494|FG003|Enrolled - Long-Term Extension Study|Other|0|||
19765841|NCT01318122|42218491|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
19765842|NCT01318122|42218492|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
19765843|NCT01318122|42218493|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
19765844|NCT01318122|42218494|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
19765845|NCT01318122|42218491|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
19765846|NCT01318122|42218492|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19765847|NCT01318122|42218493|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19765848|NCT01318122|42218494|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19765849|NCT01318122|42218491|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19765850|NCT01318122|42218492|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
19765851|NCT01318122|42218493|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19765852|NCT01318122|42218494|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19765853|NCT01318122|42218491|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19765854|NCT01318122|42218492|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
19765855|NCT01318122|42218493|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
19765856|NCT01318122|42218494|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19765857|NCT02954159|42218502|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
19765858|NCT02954159|42218503|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
19765859|NCT02954159|42218502|FG000|Overall Study|Withdrawal by Subject|0|||
19765860|NCT02954159|42218503|FG001|Overall Study|Withdrawal by Subject|1|||
19765861|NCT03442829|42218511|FG000|Overall Study|Scheduling clash|3|||
19765862|NCT03442829|42218512|FG001|Overall Study|Scheduling clash|1|||
19765863|NCT03442829|42218511|FG000|Overall Study|Illness unrelated to study|1|||
19765864|NCT03442829|42218512|FG001|Overall Study|Illness unrelated to study|1|||
19765865|NCT03442595|42218520|FG000|Overall Study|Lost to Follow-up|94|||
19765866|NCT03442595|42218521|FG001|Overall Study|Lost to Follow-up|0|||
19765867|NCT03440411|42218530|FG000|Overall Study|Adverse Event|0|||
19765868|NCT03440411|42218531|FG001|Overall Study|Adverse Event|0|||
19765869|NCT03440411|42218532|FG002|Overall Study|Adverse Event|1|||
19765870|NCT03440411|42218533|FG003|Overall Study|Adverse Event|0|||
19765871|NCT03440411|42218530|FG000|Overall Study|PD|2|||
19765872|NCT03440411|42218531|FG001|Overall Study|PD|1|||
19765873|NCT03440411|42218532|FG002|Overall Study|PD|1|||
19765874|NCT03440411|42218533|FG003|Overall Study|PD|1|||
19765875|NCT03440411|42218530|FG000|Overall Study|Withdrawal by Subject|1|||
19765876|NCT03440411|42218531|FG001|Overall Study|Withdrawal by Subject|0|||
19765877|NCT03440411|42218532|FG002|Overall Study|Withdrawal by Subject|0|||
19765878|NCT03440411|42218533|FG003|Overall Study|Withdrawal by Subject|0|||
19765879|NCT03440411|42218530|FG000|Overall Study|Closed study by sponsor|0|||
19765880|NCT03440411|42218531|FG001|Overall Study|Closed study by sponsor|0|||
19765881|NCT03440411|42218532|FG002|Overall Study|Closed study by sponsor|0|||
19765882|NCT03440411|42218533|FG003|Overall Study|Closed study by sponsor|1|||
19765883|NCT03438539|42218554|FG000|Overall Study|Lost to Follow-up|8|||
19765884|NCT03438539|42218555|FG001|Overall Study|Lost to Follow-up|4|||
19765885|NCT03438539|42218556|FG002|Overall Study|Lost to Follow-up|10|||
19765886|NCT03438539|42218557|FG003|Overall Study|Lost to Follow-up|9|||
19765887|NCT03438539|42218558|FG004|Overall Study|Lost to Follow-up|3|||
19765888|NCT03438539|42218559|FG005|Overall Study|Lost to Follow-up|8|||
19765889|NCT03400787|42218575|FG000|Overall Study|Lost to Follow-up|1|||
19765890|NCT03400787|42218576|FG001|Overall Study|Lost to Follow-up|0|||
19765891|NCT03400787|42218575|FG000|Overall Study|Death|1|||
19765892|NCT03400787|42218576|FG001|Overall Study|Death|0|||
19765893|NCT03400787|42218575|FG000|Overall Study|Protocol Violation|0|||
19765894|NCT03400787|42218576|FG001|Overall Study|Protocol Violation|2|||
19765895|NCT03400787|42218575|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
19765896|NCT03400787|42218576|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
19765897|NCT03417245|42218584|FG000|Overall Study|Adverse Event|1|||
19765898|NCT03417245|42218585|FG001|Overall Study|Adverse Event|0|||
19765899|NCT03417245|42218584|FG000|Overall Study|Protocol Violation|1|||
19765900|NCT03417245|42218585|FG001|Overall Study|Protocol Violation|0|||
19765901|NCT03417245|42218584|FG000|Overall Study|Withdrawal by Subject|1|||
19765902|NCT03417245|42218585|FG001|Overall Study|Withdrawal by Subject|1|||
19765903|NCT03389555|42218593|FG000|Overall Study|Protocol Violation|1|||
19765904|NCT03389555|42218594|FG001|Overall Study|Protocol Violation|3|||
19765905|NCT03389555|42218593|FG000|Overall Study|Death|1|||
19765906|NCT03389555|42218594|FG001|Overall Study|Death|0|||
19765907|NCT03505710|42218603|FG000|Overall Study|Progressive Disease|22|||
19765908|NCT03505710|42218604|FG001|Overall Study|Progressive Disease|9|||
19765909|NCT03505710|42218605|FG002|Overall Study|Progressive Disease|34|||
19765910|NCT03505710|42218603|FG000|Overall Study|Clinical Progression|6|||
19765911|NCT03505710|42218604|FG001|Overall Study|Clinical Progression|6|||
19765912|NCT03505710|42218605|FG002|Overall Study|Clinical Progression|3|||
19765913|NCT03505710|42218603|FG000|Overall Study|Adverse Event|12|||
19765914|NCT03505710|42218604|FG001|Overall Study|Adverse Event|5|||
19765915|NCT03505710|42218605|FG002|Overall Study|Adverse Event|27|||
19765916|NCT03505710|42218603|FG000|Overall Study|Withdrawal by Subject|1|||
19765917|NCT03505710|42218604|FG001|Overall Study|Withdrawal by Subject|3|||
19765918|NCT03505710|42218605|FG002|Overall Study|Withdrawal by Subject|3|||
19765919|NCT03505710|42218603|FG000|Overall Study|Physician Decision|1|||
19765920|NCT03505710|42218604|FG001|Overall Study|Physician Decision|0|||
19765921|NCT03505710|42218605|FG002|Overall Study|Physician Decision|2|||
19765922|NCT03505710|42218603|FG000|Overall Study|Death|4|||
19765923|NCT03505710|42218604|FG001|Overall Study|Death|3|||
19765924|NCT03505710|42218605|FG002|Overall Study|Death|6|||
19765925|NCT03505710|42218603|FG000|Overall Study|Other Reasons|1|||
19765926|NCT03505710|42218604|FG001|Overall Study|Other Reasons|1|||
19765927|NCT03505710|42218605|FG002|Overall Study|Other Reasons|1|||
19765928|NCT03395639|42218615|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
19765929|NCT03395639|42218616|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
19765930|NCT03395639|42218617|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
19765931|NCT03395639|42218615|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
19765932|NCT03395639|42218616|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
19765933|NCT03395639|42218617|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
19765934|NCT03395639|42218615|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
19765935|NCT03395639|42218616|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
19765936|NCT03395639|42218617|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
19765937|NCT03395639|42218615|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
19765938|NCT03395639|42218616|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
19765939|NCT03395639|42218617|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
19765940|NCT03395639|42218615|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
19765941|NCT03395639|42218616|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
19765942|NCT03395639|42218617|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
19765943|NCT03353922|42218624|FG000|Overall Study|Withdrawal by Subject|1|||
19765944|NCT03353922|42218625|FG001|Overall Study|Withdrawal by Subject|0|||
19765945|NCT03353922|42218626|FG002|Overall Study|Withdrawal by Subject|1|||
19765946|NCT03353922|42218627|FG003|Overall Study|Withdrawal by Subject|1|||
19765947|NCT03353922|42218628|FG004|Overall Study|Withdrawal by Subject|0|||
19765948|NCT03353922|42218629|FG005|Overall Study|Withdrawal by Subject|0|||
19765949|NCT03353922|42218624|FG000|Overall Study|Adverse Event|0|||
19765950|NCT03353922|42218625|FG001|Overall Study|Adverse Event|1|||
19765951|NCT03353922|42218626|FG002|Overall Study|Adverse Event|0|||
19765952|NCT03353922|42218627|FG003|Overall Study|Adverse Event|0|||
19765953|NCT03353922|42218628|FG004|Overall Study|Adverse Event|0|||
19765954|NCT03353922|42218629|FG005|Overall Study|Adverse Event|0|||
19765955|NCT03395405|42218642|FG000|Overall Study|Death|0|||
19765956|NCT03395405|42218643|FG001|Overall Study|Death|2|||
19765957|NCT03395405|42218642|FG000|Overall Study|Lost to Follow-up|0|||
19765958|NCT03395405|42218643|FG001|Overall Study|Lost to Follow-up|1|||
19765959|NCT03395405|42218642|FG000|Overall Study|Protocol Violation|0|||
19765960|NCT03395405|42218643|FG001|Overall Study|Protocol Violation|1|||
19765961|NCT03395405|42218642|FG000|Overall Study|Withdrawal by Subject|3|||
19765962|NCT03395405|42218643|FG001|Overall Study|Withdrawal by Subject|1|||
19765963|NCT03395405|42218642|FG000|Overall Study|COVID-19 Pandemic|1|||
19765964|NCT03395405|42218643|FG001|Overall Study|COVID-19 Pandemic|0|||
19765965|NCT03387683|42218651|FG000|Overall Study|In receipt of disallowed medication|1|||
19765966|NCT03387683|42218652|FG001|Overall Study|In receipt of disallowed medication|0|||
19765967|NCT03387683|42218651|FG000|Overall Study|Did not receive treatment|1|||
19765968|NCT03387683|42218652|FG001|Overall Study|Did not receive treatment|0|||
19765969|NCT03387059|42218660|FG000|Overall Study|Study termination|5|||
19765970|NCT03387059|42218661|FG001|Overall Study|Study termination|4|||
19765971|NCT02942004|42218670|FG000|Overall Study|Withdrawal by Subject|0|||
19765972|NCT02942004|42218671|FG001|Overall Study|Withdrawal by Subject|2|||
19765973|NCT02942004|42218672|FG002|Overall Study|Withdrawal by Subject|3|||
19765974|NCT02942004|42218670|FG000|Overall Study|Lost to Follow-up|1|||
19765975|NCT02942004|42218671|FG001|Overall Study|Lost to Follow-up|1|||
19681446|NCT00367341|42128739|FG000|Overall Study|Protocol Violation|1|||
19681447|NCT00367341|42128740|FG001|Overall Study|Protocol Violation|0|||
19681448|NCT00440466|42128749|FG000|Overall Study|Death|3|||
19765976|NCT02942004|42218672|FG002|Overall Study|Lost to Follow-up|2|||
19765977|NCT02942004|42218670|FG000|Overall Study|Randomized but not dosed|3|||
19765978|NCT02942004|42218671|FG001|Overall Study|Randomized but not dosed|9|||
19765979|NCT02942004|42218672|FG002|Overall Study|Randomized but not dosed|4|||
19765980|NCT03394391|42218682|FG000|Overall Study|Lost to Follow-up|1|||
19765981|NCT03394391|42218683|FG001|Overall Study|Lost to Follow-up|2|||
19765982|NCT03386435|42218691|FG000|Overall Study|Protocol Violation|5|||
19765983|NCT03386435|42218692|FG001|Overall Study|Protocol Violation|7|||
19765984|NCT02726880|42218700|FG000|Overall Study|Withdrawal by Subject|2|||
19765985|NCT02726880|42218701|FG001|Overall Study|Withdrawal by Subject|0|||
19765986|NCT02726880|42218700|FG000|Overall Study|Lost to Follow-up|1|||
19765987|NCT02726880|42218701|FG001|Overall Study|Lost to Follow-up|3|||
19765988|NCT03275389|42218718|FG000|Overall Study|Lost to Follow-up|10|||
19765989|NCT03275389|42218719|FG001|Overall Study|Lost to Follow-up|10|||
19765990|NCT03275389|42218720|FG002|Overall Study|Lost to Follow-up|19|||
19765991|NCT03275389|42218721|FG003|Overall Study|Lost to Follow-up|12|||
19765992|NCT03275389|42218722|FG004|Overall Study|Lost to Follow-up|11|||
19765993|NCT03275389|42218723|FG005|Overall Study|Lost to Follow-up|12|||
19765994|NCT03275389|42218724|FG006|Overall Study|Lost to Follow-up|21|||
19765995|NCT03275389|42218725|FG007|Overall Study|Lost to Follow-up|15|||
19765996|NCT03275389|42218726|FG008|Overall Study|Lost to Follow-up|12|||
19765997|NCT03275389|42218727|FG009|Overall Study|Lost to Follow-up|14|||
19765998|NCT03275389|42218718|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19765999|NCT03275389|42218719|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19766000|NCT03275389|42218720|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19766001|NCT03275389|42218721|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19766002|NCT03275389|42218722|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19766003|NCT03275389|42218723|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
19766004|NCT03275389|42218724|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19766005|NCT03275389|42218725|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19681449|NCT00440466|42128750|FG001|Overall Study|Death|2|||
19681450|NCT00440466|42128751|FG002|Overall Study|Death|9|||
19681451|NCT00440466|42128749|FG000|Overall Study|Adverse Event|3|||
19681452|NCT00440466|42128750|FG001|Overall Study|Adverse Event|4|||
19681453|NCT00440466|42128751|FG002|Overall Study|Adverse Event|11|||
19681454|NCT00440466|42128749|FG000|Overall Study|Lost to Follow-up|1|||
19681455|NCT00440466|42128750|FG001|Overall Study|Lost to Follow-up|0|||
19681456|NCT00440466|42128751|FG002|Overall Study|Lost to Follow-up|2|||
19681457|NCT00440466|42128749|FG000|Overall Study|Physician Decision|2|||
19681458|NCT00440466|42128750|FG001|Overall Study|Physician Decision|0|||
19681459|NCT00440466|42128751|FG002|Overall Study|Physician Decision|1|||
19681460|NCT00440466|42128749|FG000|Overall Study|Protocol Violation|2|||
19681461|NCT00440466|42128750|FG001|Overall Study|Protocol Violation|0|||
19766006|NCT03275389|42218726|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
19681462|NCT00440466|42128751|FG002|Overall Study|Protocol Violation|4|||
19681463|NCT00440466|42128749|FG000|Overall Study|Withdrawal by Subject|2|||
19766007|NCT03275389|42218727|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
19766008|NCT03275389|42218718|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
19766009|NCT03275389|42218719|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19766010|NCT03275389|42218720|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19681464|NCT00440466|42128750|FG001|Overall Study|Withdrawal by Subject|5|||
19681465|NCT00440466|42128751|FG002|Overall Study|Withdrawal by Subject|9|||
19681466|NCT00440466|42128749|FG000|Overall Study|Began Dialysis|0|||
19681467|NCT00440466|42128750|FG001|Overall Study|Began Dialysis|0|||
19681468|NCT00440466|42128751|FG002|Overall Study|Began Dialysis|1|||
19766011|NCT03275389|42218721|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
19766012|NCT03275389|42218722|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
19766013|NCT03275389|42218723|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
19766014|NCT03275389|42218724|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
19766015|NCT03275389|42218725|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
19766016|NCT03275389|42218726|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
19766017|NCT03275389|42218727|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
19766018|NCT03275389|42218718|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766019|NCT03275389|42218719|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
19766020|NCT03275389|42218720|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766021|NCT03275389|42218721|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
19766022|NCT03275389|42218722|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766023|NCT03275389|42218723|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766024|NCT03275389|42218724|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19681469|NCT00440466|42128749|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
19681470|NCT00440466|42128750|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
19681471|NCT00440466|42128751|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
19681472|NCT00537485|42128783|FG000|Overall Study|Adverse Event|10|||
19766025|NCT03275389|42218725|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766026|NCT03275389|42218726|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766027|NCT03275389|42218727|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19766028|NCT03275389|42218718|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766029|NCT03275389|42218719|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766030|NCT03275389|42218720|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
19766031|NCT03275389|42218721|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766032|NCT03275389|42218722|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766033|NCT03275389|42218723|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766034|NCT03275389|42218724|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766035|NCT03275389|42218725|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766036|NCT03275389|42218726|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
19766037|NCT03275389|42218727|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
19766038|NCT03275389|42218718|FG000|Overall Study|Other|0|||
19766039|NCT03275389|42218719|FG001|Overall Study|Other|4|||
19766040|NCT03275389|42218720|FG002|Overall Study|Other|3|||
19766041|NCT03275389|42218721|FG003|Overall Study|Other|2|||
19766042|NCT03275389|42218722|FG004|Overall Study|Other|2|||
19766043|NCT03275389|42218723|FG005|Overall Study|Other|2|||
19766044|NCT03275389|42218724|FG006|Overall Study|Other|0|||
19766045|NCT03275389|42218725|FG007|Overall Study|Other|0|||
19766046|NCT03275389|42218726|FG008|Overall Study|Other|1|||
19766047|NCT03275389|42218727|FG009|Overall Study|Other|0|||
19766048|NCT03414983|42218751|FG000|Pre-Treatment|Other reasons|1|||
19766049|NCT03414983|42218752|FG001|Pre-Treatment|Other reasons|0|||
19766050|NCT03414983|42218751|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
19766051|NCT03414983|42218752|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
19681473|NCT00537485|42128784|FG001|Overall Study|Adverse Event|5|||
19604515|NCT01023581|42053416|FG000|Overall Study|Major protocol deviation|2|||
19604516|NCT01023581|42053417|FG001|Overall Study|Major protocol deviation|0|||
19604517|NCT01023581|42053418|FG002|Overall Study|Major protocol deviation|3|||
19604518|NCT01023581|42053419|FG003|Overall Study|Major protocol deviation|0|||
19604519|NCT01023581|42053420|FG004|Overall Study|Major protocol deviation|0|||
19604520|NCT01023581|42053421|FG005|Overall Study|Major protocol deviation|0|||
19604521|NCT01023581|42053422|FG006|Overall Study|Major protocol deviation|0|||
19604522|NCT01023581|42053416|FG000|Overall Study|Lost to Follow-up|4|||
19604523|NCT01023581|42053417|FG001|Overall Study|Lost to Follow-up|8|||
19681474|NCT00537485|42128783|FG000|Overall Study|Withdrawal by Subject|3|||
19681475|NCT00537485|42128784|FG001|Overall Study|Withdrawal by Subject|2|||
19681476|NCT00537485|42128783|FG000|Overall Study|Withdrawal by Subject|1|||
19681477|NCT00537485|42128784|FG001|Overall Study|Withdrawal by Subject|3|||
19681478|NCT00537485|42128783|FG000|Overall Study|Physician Decision|1|||
19681479|NCT00537485|42128784|FG001|Overall Study|Physician Decision|0|||
19681480|NCT00616967|42128792|FG000|Overall Study|Withdrawal by Subject|0|||
19681481|NCT00616967|42128793|FG001|Overall Study|Withdrawal by Subject|0|||
19681482|NCT00616967|42128794|FG002|Overall Study|Withdrawal by Subject|1|||
19681483|NCT00537329|42128812|FG000|Overall Study|Death|10|||
19681484|NCT00537329|42128812|FG000|Overall Study|Adverse Event|3|||
19681485|NCT00537329|42128812|FG000|Overall Study|Lack of Efficacy|2|||
19681486|NCT00537329|42128812|FG000|Overall Study|Lost to Follow-up|6|||
19681487|NCT00537329|42128812|FG000|Overall Study|Withdrawal by Subject|4|||
19681488|NCT00537329|42128812|FG000|Overall Study|Other|1|||
19681489|NCT03897179|42128816|FG000|Overall Study|Withdrawal by Subject|1|||
19681490|NCT03905135|42128822|FG000|Dose Escalation|Adverse Event|1|||
19681491|NCT03905135|42128823|FG001|Dose Escalation|Adverse Event|1|||
19681492|NCT03905135|42128822|FG000|Dose Escalation|Progressive disease|3|||
19681493|NCT03905135|42128823|FG001|Dose Escalation|Progressive disease|1|||
19681494|NCT03905135|42128822|FG000|Dose Escalation|Intercurrent illness|1|||
19681495|NCT03905135|42128823|FG001|Dose Escalation|Intercurrent illness|0|||
19681496|NCT00357903|42128833|FG000|Overall Study|Adverse Event|87|||
19681497|NCT00357903|42128834|FG001|Overall Study|Adverse Event|4|||
19681498|NCT00357903|42128833|FG000|Overall Study|Death|33|||
19766052|NCT03414983|42218751|FG000|Pre-Treatment|Participant withdrew consent|1|||
19766053|NCT03414983|42218752|FG001|Pre-Treatment|Participant withdrew consent|3|||
19766054|NCT03414983|42218751|FG000|Treatment|Participant withdrew consent|4|||
19766055|NCT03414983|42218752|FG001|Treatment|Participant withdrew consent|3|||
19766056|NCT03414983|42218751|FG000|Treatment|Participant request to discontinue study treatment|8|||
19766057|NCT03414983|42218752|FG001|Treatment|Participant request to discontinue study treatment|10|||
19766058|NCT03414983|42218751|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
19766059|NCT03414983|42218752|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
19766060|NCT03414983|42218751|FG000|Treatment|Death|0|||
19766061|NCT03414983|42218752|FG001|Treatment|Death|2|||
19766062|NCT03414983|42218751|FG000|Treatment|Study Drug Toxicity|11|||
19766063|NCT03414983|42218752|FG001|Treatment|Study Drug Toxicity|4|||
19766064|NCT03414983|42218751|FG000|Treatment|Disease Progression|72|||
19766065|NCT03414983|42218752|FG001|Treatment|Disease Progression|27|||
19766066|NCT03414983|42218751|FG000|Treatment|Not reported|1|||
19766067|NCT03414983|42218752|FG001|Treatment|Not reported|0|||
19766068|NCT03414983|42218751|FG000|Treatment|Other reasons|3|||
19766069|NCT03414983|42218752|FG001|Treatment|Other reasons|2|||
19766070|NCT03414983|42218751|FG000|Treatment|Completed treatment as per protocol|8|||
19766071|NCT03414983|42218752|FG001|Treatment|Completed treatment as per protocol|0|||
19766072|NCT03414983|42218751|FG000|Treatment|Poor/non-compliance|2|||
19766073|NCT03414983|42218752|FG001|Treatment|Poor/non-compliance|0|||
19766074|NCT03414983|42218751|FG000|Treatment|Maximum clinical benefit|5|||
19766075|NCT03414983|42218752|FG001|Treatment|Maximum clinical benefit|9|||
19766076|NCT03414983|42218751|FG000|Treatment|Lost to Follow-up|0|||
19766077|NCT03414983|42218752|FG001|Treatment|Lost to Follow-up|1|||
19766078|NCT03414359|42218760|FG000|Overall Study|Lack of Efficacy|1|||
19766079|NCT03414359|42218761|FG001|Overall Study|Lack of Efficacy|1|||
19766080|NCT03414359|42218760|FG000|Overall Study|Protocol Violation|0|||
19766081|NCT03414359|42218761|FG001|Overall Study|Protocol Violation|1|||
19766082|NCT03285295|42218772|FG000|Alinity s HBsAg|Protocol Violation|11|||
19766083|NCT03285295|42218773|FG001|Alinity s HBsAg|Protocol Violation|0|||
19766084|NCT03285295|42218774|FG002|Alinity s HBsAg|Protocol Violation|0|||
19766085|NCT03285295|42218775|FG003|Alinity s HBsAg|Protocol Violation|0|||
19766086|NCT03285295|42218776|FG004|Alinity s HBsAg|Protocol Violation|0|||
19766087|NCT03285295|42218772|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
19766088|NCT03285295|42218773|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
19766089|NCT03285295|42218774|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
19766090|NCT03285295|42218775|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
19766091|NCT03285295|42218776|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
19766092|NCT03285295|42218772|FG000|Alinity s HBsAg|No Results Generated|74|||
19766093|NCT03285295|42218773|FG001|Alinity s HBsAg|No Results Generated|6|||
19766094|NCT03285295|42218774|FG002|Alinity s HBsAg|No Results Generated|0|||
19766095|NCT03285295|42218775|FG003|Alinity s HBsAg|No Results Generated|0|||
19766096|NCT03285295|42218776|FG004|Alinity s HBsAg|No Results Generated|0|||
19766097|NCT03285295|42218772|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
19766098|NCT03285295|42218773|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
19766099|NCT03285295|42218774|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
19766100|NCT03285295|42218775|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
19766101|NCT03285295|42218776|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
19766102|NCT03285295|42218772|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
19766103|NCT03285295|42218773|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
19766104|NCT03285295|42218774|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
19477235|NCT01482221|41756210|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
19477236|NCT01482221|41756211|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
19477237|NCT01482221|41756212|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
19477238|NCT01482221|41756210|FG000|Overall Study|Condition under Investigation Worsened|3|||
19477239|NCT01482221|41756211|FG001|Overall Study|Condition under Investigation Worsened|2|||
19477240|NCT01482221|41756212|FG002|Overall Study|Condition under Investigation Worsened|4|||
19477241|NCT01482221|41756210|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
19477242|NCT01482221|41756211|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
19477243|NCT01482221|41756212|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
19766105|NCT03285295|42218775|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
19766106|NCT03285295|42218776|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
19766107|NCT03285295|42218772|FG000|Alinity s HTLV I/II|No Results Generated|70|||
19766108|NCT03285295|42218773|FG001|Alinity s HTLV I/II|No Results Generated|0|||
19766109|NCT03285295|42218774|FG002|Alinity s HTLV I/II|No Results Generated|0|||
19766110|NCT03285295|42218775|FG003|Alinity s HTLV I/II|No Results Generated|0|||
19766111|NCT03285295|42218776|FG004|Alinity s HTLV I/II|No Results Generated|0|||
19766112|NCT03285295|42218772|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
19766113|NCT03285295|42218773|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
19766114|NCT03285295|42218774|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
19766115|NCT03285295|42218775|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
19766116|NCT03285295|42218776|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
19766117|NCT03285295|42218772|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
19766118|NCT03285295|42218773|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
19766119|NCT03285295|42218774|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
19766120|NCT03285295|42218775|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
19766121|NCT03285295|42218776|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
19766122|NCT03285295|42218772|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
19766123|NCT03285295|42218773|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
19766124|NCT03285295|42218774|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
19766125|NCT03285295|42218775|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
19766126|NCT03285295|42218776|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
19766127|NCT03285295|42218772|FG000|Alinity s Anti-HCV|No Results Generated|71|||
19766128|NCT03285295|42218773|FG001|Alinity s Anti-HCV|No Results Generated|0|||
19766129|NCT03285295|42218774|FG002|Alinity s Anti-HCV|No Results Generated|0|||
19766130|NCT03285295|42218775|FG003|Alinity s Anti-HCV|No Results Generated|0|||
19766131|NCT03285295|42218776|FG004|Alinity s Anti-HCV|No Results Generated|0|||
19766132|NCT03285295|42218772|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
19766133|NCT03285295|42218773|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
19681499|NCT00357903|42128834|FG001|Overall Study|Death|0|||
19681500|NCT00357903|42128833|FG000|Overall Study|Lost to Follow-up|23|||
19766134|NCT03285295|42218774|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
19766135|NCT03285295|42218775|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
19766136|NCT03285295|42218776|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
19681501|NCT00357903|42128834|FG001|Overall Study|Lost to Follow-up|4|||
19681502|NCT00357903|42128833|FG000|Overall Study|Physician Decision|39|||
19681503|NCT00357903|42128834|FG001|Overall Study|Physician Decision|5|||
19681504|NCT00357903|42128833|FG000|Overall Study|Withdrawal by Subject|57|||
19766137|NCT03285295|42218772|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
19766138|NCT03285295|42218773|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
19681505|NCT00357903|42128834|FG001|Overall Study|Withdrawal by Subject|7|||
19681506|NCT00357903|42128833|FG000|Overall Study|Completed month 12 only|0|||
19681507|NCT00357903|42128834|FG001|Overall Study|Completed month 12 only|1|||
19681508|NCT00357903|42128833|FG000|Overall Study|Protocol issues|14|||
19681509|NCT00357903|42128834|FG001|Overall Study|Protocol issues|3|||
19681510|NCT00357903|42128833|FG000|Overall Study|Response status|61|||
19681511|NCT00357903|42128834|FG001|Overall Study|Response status|9|||
19681512|NCT00357903|42128833|FG000|Overall Study|Other|49|||
19681513|NCT00357903|42128834|FG001|Overall Study|Other|10|||
19681514|NCT00348933|42128841|FG000|Overall Study|Withdrawal by Subject|10|||
19681515|NCT00348933|42128841|FG000|Overall Study|Lost to Follow-up|6|||
19681516|NCT00348933|42128841|FG000|Overall Study|Protocol Violation|2|||
19681517|NCT00348933|42128841|FG000|Overall Study|Adverse Event|7|||
19681518|NCT03896477|42128849|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
19681519|NCT03896477|42128850|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
19681520|NCT03896477|42128851|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
19681521|NCT03896477|42128849|FG000|Overall Study|Parent Requested Withdrawal|8|||
19681522|NCT03896477|42128850|FG001|Overall Study|Parent Requested Withdrawal|12|||
19681523|NCT03896477|42128851|FG002|Overall Study|Parent Requested Withdrawal|9|||
19681524|NCT03896477|42128849|FG000|Overall Study|Adverse Event|0|||
19681525|NCT03896477|42128850|FG001|Overall Study|Adverse Event|0|||
19681526|NCT03896477|42128851|FG002|Overall Study|Adverse Event|1|||
19681527|NCT03896477|42128849|FG000|Overall Study|Death|1|||
19681528|NCT03896477|42128850|FG001|Overall Study|Death|0|||
19681529|NCT03896477|42128851|FG002|Overall Study|Death|0|||
19681530|NCT03896477|42128849|FG000|Overall Study|Other|5|||
19766139|NCT03285295|42218774|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
19766140|NCT03285295|42218775|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
19681531|NCT03896477|42128850|FG001|Overall Study|Other|6|||
19681532|NCT03896477|42128851|FG002|Overall Study|Other|7|||
19681533|NCT03896477|42128849|FG000|Overall Study|Lost to Follow-up|2|||
19681534|NCT03896477|42128850|FG001|Overall Study|Lost to Follow-up|1|||
19681535|NCT03896477|42128851|FG002|Overall Study|Lost to Follow-up|1|||
19681536|NCT00444600|42128866|FG000|Overall Study|Death|7|||
19681537|NCT00444600|42128867|FG001|Overall Study|Death|5|||
19681538|NCT00444600|42128868|FG002|Overall Study|Death|3|||
19766141|NCT03285295|42218776|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
19766142|NCT03285295|42218772|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
19766143|NCT03285295|42218773|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
19766144|NCT03285295|42218774|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
19766145|NCT03285295|42218775|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
19766146|NCT03285295|42218776|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
19766147|NCT03285295|42218772|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
19766148|NCT03285295|42218773|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
19766149|NCT03285295|42218774|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
19766150|NCT03285295|42218775|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
19766151|NCT03285295|42218776|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
19766152|NCT03285295|42218772|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
19766153|NCT03285295|42218773|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
19766154|NCT03285295|42218774|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
19766155|NCT03285295|42218775|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
19766156|NCT03285295|42218776|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
19766157|NCT03285295|42218772|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
19766158|NCT03285295|42218773|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
19766159|NCT03285295|42218774|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
19766160|NCT03285295|42218775|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
19766161|NCT03285295|42218776|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
19766162|NCT03285295|42218772|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
19766163|NCT03285295|42218773|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
19766164|NCT03285295|42218774|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
19766165|NCT03285295|42218775|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
19766166|NCT03285295|42218776|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
19766167|NCT03285295|42218772|FG000|Alinity s Anti-HBc|No Results Generated|70|||
19766168|NCT03285295|42218773|FG001|Alinity s Anti-HBc|No Results Generated|0|||
19766169|NCT03285295|42218774|FG002|Alinity s Anti-HBc|No Results Generated|0|||
19766170|NCT03285295|42218775|FG003|Alinity s Anti-HBc|No Results Generated|0|||
19766171|NCT03285295|42218776|FG004|Alinity s Anti-HBc|No Results Generated|0|||
19766172|NCT03285295|42218772|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
19766173|NCT03285295|42218773|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
19766174|NCT03285295|42218774|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
19766175|NCT03285295|42218775|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
19766176|NCT03285295|42218776|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
19766177|NCT03285295|42218772|FG000|Alinity s Chagas|Protocol Violation|76|||
19766178|NCT03285295|42218773|FG001|Alinity s Chagas|Protocol Violation|0|||
19766179|NCT03285295|42218774|FG002|Alinity s Chagas|Protocol Violation|0|||
19766180|NCT03285295|42218775|FG003|Alinity s Chagas|Protocol Violation|0|||
19766181|NCT03285295|42218776|FG004|Alinity s Chagas|Protocol Violation|0|||
19766182|NCT03285295|42218772|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
19766183|NCT03285295|42218773|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
19766184|NCT03285295|42218774|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
19766185|NCT03285295|42218775|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
19766186|NCT03285295|42218776|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
19766187|NCT03285295|42218772|FG000|Alinity s Chagas|No Results Generated|105|||
19766188|NCT03285295|42218773|FG001|Alinity s Chagas|No Results Generated|0|||
19766189|NCT03285295|42218774|FG002|Alinity s Chagas|No Results Generated|0|||
19766190|NCT03285295|42218775|FG003|Alinity s Chagas|No Results Generated|0|||
19766191|NCT03285295|42218776|FG004|Alinity s Chagas|No Results Generated|0|||
19766192|NCT03285295|42218772|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
19766193|NCT03285295|42218773|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
19766194|NCT03285295|42218774|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
19766195|NCT03285295|42218775|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
19766196|NCT03285295|42218776|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
19766197|NCT02583048|42218808|FG000|Overall Study|Withdrawal by Subject|0|||
19766198|NCT02583048|42218809|FG001|Overall Study|Withdrawal by Subject|1|||
19766199|NCT02583048|42218810|FG002|Overall Study|Withdrawal by Subject|0|||
19766200|NCT02583048|42218808|FG000|Overall Study|Failed to meet eligibility criterion|0|||
19766201|NCT02583048|42218809|FG001|Overall Study|Failed to meet eligibility criterion|0|||
19766202|NCT02583048|42218810|FG002|Overall Study|Failed to meet eligibility criterion|1|||
19766203|NCT02939599|42218823|FG000|Overall Study|Adverse Event|1|||
19766204|NCT02939599|42218824|FG001|Overall Study|Adverse Event|0|||
19766205|NCT02939599|42218823|FG000|Overall Study|Study Terminated By Sponsor|2|||
19766206|NCT02939599|42218824|FG001|Overall Study|Study Terminated By Sponsor|2|||
19766207|NCT01318512|42218831|FG000|Maintenance Period (6 Months)|Death|2|||
19766208|NCT01318512|42218831|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
19766209|NCT03274687|42218852|FG000|Overall Study|Protocol Violation|1|||
19766210|NCT03274687|42218853|FG001|Overall Study|Protocol Violation|1|||
19766211|NCT04651218|42218859|FG000|Overall Study|Withdrawal by Subject|0|||
19766212|NCT04651218|42218860|FG001|Overall Study|Withdrawal by Subject|2|||
19766213|NCT03274453|42218870|FG000|Overall Study|Lost to Follow-up|2|||
19766214|NCT03274453|42218871|FG001|Overall Study|Lost to Follow-up|5|||
19766215|NCT03274453|42218872|FG002|Overall Study|Lost to Follow-up|4|||
19766216|NCT03274453|42218873|FG003|Overall Study|Lost to Follow-up|1|||
19766217|NCT03274453|42218870|FG000|Overall Study|Physician Decision|2|||
19766218|NCT03274453|42218871|FG001|Overall Study|Physician Decision|0|||
19766219|NCT03274453|42218872|FG002|Overall Study|Physician Decision|0|||
19766220|NCT03274453|42218873|FG003|Overall Study|Physician Decision|3|||
19766221|NCT03274453|42218870|FG000|Overall Study|Surgery Cancelled|0|||
19766222|NCT03274453|42218871|FG001|Overall Study|Surgery Cancelled|1|||
19766223|NCT03274453|42218872|FG002|Overall Study|Surgery Cancelled|0|||
19766224|NCT03274453|42218873|FG003|Overall Study|Surgery Cancelled|0|||
19766225|NCT03273907|42218883|FG000|Overall Study|Death|1|||
19766226|NCT03273907|42218883|FG000|Overall Study|Lost to Follow-up|4|||
19766227|NCT03273907|42218883|FG000|Overall Study|Withdrawal by Subject|2|||
19766228|NCT03273907|42218883|FG000|Overall Study|COVID 19|2|||
19766229|NCT00659646|42218905|FG000|Overall Study|Protocol Violation|12|||
19766230|NCT00659646|42218906|FG001|Overall Study|Protocol Violation|8|||
19766231|NCT00659646|42218905|FG000|Overall Study|Adverse Event|1|||
19766232|NCT00659646|42218906|FG001|Overall Study|Adverse Event|0|||
19766233|NCT00659646|42218905|FG000|Overall Study|Lost to Follow-up|1|||
19766234|NCT00659646|42218906|FG001|Overall Study|Lost to Follow-up|0|||
19766235|NCT00659646|42218905|FG000|Overall Study|protocol noncompliance after randomized|1|||
19766236|NCT00659646|42218906|FG001|Overall Study|protocol noncompliance after randomized|0|||
19766237|NCT02236572|42218914|FG000|Overall Study|Withdrawal by Subject|1|||
19766238|NCT02236572|42218914|FG000|Overall Study|Protocol Violation|1|||
19766239|NCT02236572|42218914|FG000|Overall Study|Lost to Follow-up|1|||
19766240|NCT03054870|42218918|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
19766241|NCT03054870|42218918|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
19766242|NCT03414047|42218937|FG000|Overall Study|Adverse Event|0|||
19766243|NCT03414047|42218938|FG001|Overall Study|Adverse Event|0|||
19766244|NCT03414047|42218939|FG002|Overall Study|Adverse Event|1|||
19766245|NCT03414047|42218940|FG003|Overall Study|Adverse Event|1|||
19766246|NCT03414047|42218937|FG000|Overall Study|Physician Decision|1|||
19766247|NCT03414047|42218938|FG001|Overall Study|Physician Decision|0|||
19766248|NCT03414047|42218939|FG002|Overall Study|Physician Decision|0|||
19766249|NCT03414047|42218940|FG003|Overall Study|Physician Decision|1|||
19766250|NCT03414047|42218937|FG000|Overall Study|Withdrawal by Subject|1|||
19766251|NCT03414047|42218938|FG001|Overall Study|Withdrawal by Subject|0|||
19766252|NCT03414047|42218939|FG002|Overall Study|Withdrawal by Subject|2|||
19766253|NCT03414047|42218940|FG003|Overall Study|Withdrawal by Subject|0|||
19766254|NCT01411332|42218953|FG000|Overall Study|Lost to Follow-up|1|||
19766255|NCT01411332|42218954|FG001|Overall Study|Lost to Follow-up|0|||
19766256|NCT01411332|42218953|FG000|Overall Study|Protocol Violation|1|||
19766257|NCT01411332|42218954|FG001|Overall Study|Protocol Violation|1|||
19766258|NCT01411332|42218953|FG000|Overall Study|Withdrawal by Subject|0|||
19766259|NCT01411332|42218954|FG001|Overall Study|Withdrawal by Subject|1|||
19766260|NCT03351335|42218963|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
19766261|NCT03351335|42218964|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
19766262|NCT03351335|42218965|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
19766263|NCT03055806|42218977|FG000|Overall Study|Adverse Event|0|||
19766264|NCT03055806|42218978|FG001|Overall Study|Adverse Event|0|||
19766265|NCT03055806|42218979|FG002|Overall Study|Adverse Event|1|||
19766266|NCT03055806|42218980|FG003|Overall Study|Adverse Event|1|||
19766267|NCT03055806|42218977|FG000|Overall Study|Lost to Follow-up|0|||
19766268|NCT03055806|42218978|FG001|Overall Study|Lost to Follow-up|3|||
19766269|NCT03055806|42218979|FG002|Overall Study|Lost to Follow-up|6|||
19477244|NCT01482221|41756210|FG000|Overall Study|Adverse Event|1|||
19766270|NCT03055806|42218980|FG003|Overall Study|Lost to Follow-up|7|||
19766271|NCT03055806|42218977|FG000|Overall Study|Physician Decision|1|||
19766272|NCT03055806|42218978|FG001|Overall Study|Physician Decision|0|||
19766273|NCT03055806|42218979|FG002|Overall Study|Physician Decision|0|||
19766274|NCT03055806|42218980|FG003|Overall Study|Physician Decision|1|||
19766275|NCT03055806|42218977|FG000|Overall Study|Protocol Violation|1|||
19766276|NCT03055806|42218978|FG001|Overall Study|Protocol Violation|0|||
19766277|NCT03055806|42218979|FG002|Overall Study|Protocol Violation|0|||
19766278|NCT03055806|42218980|FG003|Overall Study|Protocol Violation|0|||
19766279|NCT03055806|42218977|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
19766280|NCT03055806|42218978|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
19766281|NCT03055806|42218979|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
19766282|NCT03055806|42218980|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
19766283|NCT03055806|42218977|FG000|Overall Study|Withdrawal of consent to continue study|2|||
19766284|NCT03055806|42218978|FG001|Overall Study|Withdrawal of consent to continue study|3|||
19766285|NCT03055806|42218979|FG002|Overall Study|Withdrawal of consent to continue study|4|||
19766286|NCT03055806|42218980|FG003|Overall Study|Withdrawal of consent to continue study|6|||
19766287|NCT03055806|42218977|FG000|Overall Study|Partner not willing to try intercourse|1|||
19766288|NCT03055806|42218978|FG001|Overall Study|Partner not willing to try intercourse|0|||
19766289|NCT03055806|42218979|FG002|Overall Study|Partner not willing to try intercourse|0|||
19766290|NCT03055806|42218980|FG003|Overall Study|Partner not willing to try intercourse|0|||
19766291|NCT04620798|42218992|FG000|Overall Study|Lost to Follow-up|126|||
19766292|NCT04620798|42218993|FG001|Overall Study|Lost to Follow-up|138|||
19766293|NCT03052764|42219001|FG000|Double-Blind Treatment Period|Adverse Event|2|||
19766294|NCT03052764|42219002|FG001|Double-Blind Treatment Period|Adverse Event|0|||
19766295|NCT03052764|42219001|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
19766296|NCT03052764|42219002|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
19766297|NCT03052764|42219001|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
19766298|NCT03052764|42219002|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
19766299|NCT03052764|42219001|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
19766300|NCT03052764|42219002|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19766301|NCT03052764|42219001|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
19766302|NCT03052764|42219002|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
19766303|NCT02951819|42219012|FG000|Overall Study|Death|9|||
19766304|NCT02951819|42219013|FG001|Overall Study|Death|7|||
19766305|NCT02951819|42219012|FG000|Overall Study|Withdrawal by Subject|3|||
19766306|NCT02951819|42219013|FG001|Overall Study|Withdrawal by Subject|0|||
19766307|NCT02951819|42219012|FG000|Overall Study|Adverse Event|1|||
19766308|NCT02951819|42219013|FG001|Overall Study|Adverse Event|0|||
19766309|NCT02951819|42219012|FG000|Overall Study|Lack of Efficacy|4|||
19766310|NCT02951819|42219013|FG001|Overall Study|Lack of Efficacy|0|||
19766311|NCT02951819|42219012|FG000|Overall Study|Lost to Follow-up|1|||
19766312|NCT02951819|42219013|FG001|Overall Study|Lost to Follow-up|0|||
19766313|NCT02951819|42219012|FG000|Overall Study|Progressive Disease|1|||
19766314|NCT02951819|42219013|FG001|Overall Study|Progressive Disease|0|||
19766315|NCT02951819|42219012|FG000|Overall Study|Other|9|||
19766316|NCT02951819|42219013|FG001|Overall Study|Other|0|||
19766317|NCT03383783|42219019|FG000|Overall Study|Withdrawal by Subject|2|||
19766318|NCT03334721|42219037|FG000|Overall Study|Withdrawal by Subject|1|||
19766319|NCT03334721|42219038|FG001|Overall Study|Withdrawal by Subject|0|||
19766320|NCT03334721|42219037|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
19766321|NCT03334721|42219038|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
19766322|NCT03515551|42219051|FG000|Overall Study|Death|4|||
19766323|NCT03515551|42219052|FG001|Overall Study|Death|1|||
19766324|NCT03515551|42219053|FG002|Overall Study|Death|2|||
19766325|NCT03515551|42219054|FG003|Overall Study|Death|2|||
19766326|NCT03515551|42219055|FG004|Overall Study|Death|2|||
19766327|NCT03515551|42219056|FG005|Overall Study|Death|4|||
19766328|NCT03515551|42219057|FG006|Overall Study|Death|1|||
19766329|NCT03515551|42219051|FG000|Overall Study|Lost to Follow-up|0|||
19766330|NCT03515551|42219052|FG001|Overall Study|Lost to Follow-up|0|||
19766331|NCT03515551|42219053|FG002|Overall Study|Lost to Follow-up|1|||
19766332|NCT03515551|42219054|FG003|Overall Study|Lost to Follow-up|0|||
19766333|NCT03515551|42219055|FG004|Overall Study|Lost to Follow-up|0|||
19766334|NCT03515551|42219056|FG005|Overall Study|Lost to Follow-up|0|||
19766335|NCT03515551|42219057|FG006|Overall Study|Lost to Follow-up|0|||
19766336|NCT03515551|42219051|FG000|Overall Study|Withdrawal by Subject|0|||
19766337|NCT03515551|42219052|FG001|Overall Study|Withdrawal by Subject|1|||
19389096|NCT02670551|41632644|FG002|Overall Study|Did Not Receive Treatment|0|||
19766338|NCT03515551|42219053|FG002|Overall Study|Withdrawal by Subject|0|||
19766339|NCT03515551|42219054|FG003|Overall Study|Withdrawal by Subject|0|||
19766340|NCT03515551|42219055|FG004|Overall Study|Withdrawal by Subject|0|||
19766341|NCT03515551|42219056|FG005|Overall Study|Withdrawal by Subject|0|||
19766342|NCT03515551|42219057|FG006|Overall Study|Withdrawal by Subject|1|||
19766343|NCT03515551|42219051|FG000|Overall Study|Study ended by sponsor|0|||
19766344|NCT03515551|42219052|FG001|Overall Study|Study ended by sponsor|0|||
19766345|NCT03515551|42219053|FG002|Overall Study|Study ended by sponsor|2|||
19766346|NCT03515551|42219054|FG003|Overall Study|Study ended by sponsor|1|||
19766347|NCT03515551|42219055|FG004|Overall Study|Study ended by sponsor|3|||
19766348|NCT03515551|42219056|FG005|Overall Study|Study ended by sponsor|0|||
19766349|NCT03515551|42219057|FG006|Overall Study|Study ended by sponsor|3|||
19766350|NCT03515551|42219051|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766351|NCT03515551|42219052|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
19766352|NCT03515551|42219053|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766353|NCT03515551|42219054|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766354|NCT03515551|42219055|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766355|NCT03515551|42219056|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766356|NCT03515551|42219057|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
19766357|NCT03380429|42219083|FG000|Overall Study|Physician Decision|0|||
19766358|NCT03380429|42219084|FG001|Overall Study|Physician Decision|1|||
19766359|NCT03380429|42219085|FG002|Overall Study|Physician Decision|0|||
19766360|NCT03380429|42219086|FG003|Overall Study|Physician Decision|1|||
19766361|NCT03380429|42219087|FG004|Overall Study|Physician Decision|1|||
19766362|NCT03380429|42219083|FG000|Overall Study|Withdrawal by Subject|3|||
19766363|NCT03380429|42219084|FG001|Overall Study|Withdrawal by Subject|3|||
19766364|NCT03380429|42219085|FG002|Overall Study|Withdrawal by Subject|5|||
19766365|NCT03380429|42219086|FG003|Overall Study|Withdrawal by Subject|2|||
19766366|NCT03380429|42219087|FG004|Overall Study|Withdrawal by Subject|1|||
19766367|NCT03380429|42219083|FG000|Overall Study|Lost to Follow-up|0|||
19766368|NCT03380429|42219084|FG001|Overall Study|Lost to Follow-up|2|||
19766369|NCT03380429|42219085|FG002|Overall Study|Lost to Follow-up|4|||
19766370|NCT03380429|42219086|FG003|Overall Study|Lost to Follow-up|3|||
19766371|NCT03380429|42219087|FG004|Overall Study|Lost to Follow-up|1|||
19766372|NCT03380429|42219083|FG000|Overall Study|Protocol Violation|1|||
19766373|NCT03380429|42219084|FG001|Overall Study|Protocol Violation|0|||
19766374|NCT03380429|42219085|FG002|Overall Study|Protocol Violation|1|||
19766375|NCT03380429|42219086|FG003|Overall Study|Protocol Violation|0|||
19766376|NCT03380429|42219087|FG004|Overall Study|Protocol Violation|1|||
19766377|NCT03380429|42219083|FG000|Overall Study|Lack of Efficacy|0|||
19766378|NCT03380429|42219084|FG001|Overall Study|Lack of Efficacy|0|||
19766379|NCT03380429|42219085|FG002|Overall Study|Lack of Efficacy|0|||
19766380|NCT03380429|42219086|FG003|Overall Study|Lack of Efficacy|2|||
19766381|NCT03380429|42219087|FG004|Overall Study|Lack of Efficacy|1|||
19766382|NCT03380429|42219083|FG000|Overall Study|Adverse Event|1|||
19766383|NCT03380429|42219084|FG001|Overall Study|Adverse Event|1|||
19766384|NCT03380429|42219085|FG002|Overall Study|Adverse Event|1|||
19766385|NCT03380429|42219086|FG003|Overall Study|Adverse Event|2|||
19766386|NCT03380429|42219087|FG004|Overall Study|Adverse Event|0|||
19766387|NCT03280615|42219106|FG000|Overall Study|Lost to Follow-up|1|||
19766388|NCT03280615|42219107|FG001|Overall Study|Lost to Follow-up|2|||
19766389|NCT03280615|42219106|FG000|Overall Study|Adverse Event|1|||
19766390|NCT03280615|42219107|FG001|Overall Study|Adverse Event|1|||
19766391|NCT03280615|42219106|FG000|Overall Study|Withdrawal by Subject|2|||
19766392|NCT03280615|42219107|FG001|Overall Study|Withdrawal by Subject|2|||
19766393|NCT03280537|42219115|FG000|Overall Study|Withdrawal by Subject|2|||
19766394|NCT03280537|42219116|FG001|Overall Study|Withdrawal by Subject|4|||
19766395|NCT03280381|42219124|FG000|Overall Study|Physician Decision|0|||
19766396|NCT03280381|42219125|FG001|Overall Study|Physician Decision|2|||
19766397|NCT03270085|42219134|FG000|Overall Study|Withdrawal by Subject|1|||
19766398|NCT03270085|42219135|FG001|Overall Study|Withdrawal by Subject|0|||
19766399|NCT03267511|42219145|FG000|Overall Study|Lost to Follow-up|0|||
19766400|NCT03267511|42219146|FG001|Overall Study|Lost to Follow-up|0|||
19766401|NCT03267511|42219147|FG002|Overall Study|Lost to Follow-up|0|||
19766402|NCT03267511|42219148|FG003|Overall Study|Lost to Follow-up|1|||
19766403|NCT03379259|42219175|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
19766404|NCT03379259|42219176|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
19766405|NCT03379259|42219177|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
19766406|NCT03379259|42219178|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
19766407|NCT03379259|42219179|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
19766408|NCT03379259|42219180|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
19766409|NCT03379259|42219175|FG000|Overall Study|Death|0|||
19766410|NCT03379259|42219176|FG001|Overall Study|Death|1|||
19477245|NCT01482221|41756211|FG001|Overall Study|Adverse Event|7|||
19766411|NCT03379259|42219177|FG002|Overall Study|Death|2|||
19766412|NCT03379259|42219178|FG003|Overall Study|Death|1|||
19766413|NCT03379259|42219179|FG004|Overall Study|Death|4|||
19766414|NCT03379259|42219180|FG005|Overall Study|Death|2|||
19766415|NCT03379259|42219175|FG000|Overall Study|Withdrawal by Subject|0|||
19766416|NCT03379259|42219176|FG001|Overall Study|Withdrawal by Subject|0|||
19766417|NCT03379259|42219177|FG002|Overall Study|Withdrawal by Subject|1|||
19766418|NCT03379259|42219178|FG003|Overall Study|Withdrawal by Subject|0|||
19766419|NCT03379259|42219179|FG004|Overall Study|Withdrawal by Subject|2|||
19766420|NCT03379259|42219180|FG005|Overall Study|Withdrawal by Subject|0|||
19766421|NCT03379259|42219175|FG000|Overall Study|Study terminated by sponsor|0|||
19766422|NCT03379259|42219176|FG001|Overall Study|Study terminated by sponsor|0|||
19766423|NCT03379259|42219177|FG002|Overall Study|Study terminated by sponsor|0|||
19766424|NCT03379259|42219178|FG003|Overall Study|Study terminated by sponsor|1|||
19766425|NCT03379259|42219179|FG004|Overall Study|Study terminated by sponsor|1|||
19681539|NCT00444600|42128869|FG003|Overall Study|Death|2|||
19681540|NCT00444600|42128866|FG000|Overall Study|Dropped|11|||
19681541|NCT00444600|42128867|FG001|Overall Study|Dropped|11|||
19681542|NCT00444600|42128868|FG002|Overall Study|Dropped|7|||
19681543|NCT00444600|42128869|FG003|Overall Study|Dropped|7|||
19681544|NCT00444600|42128866|FG000|Overall Study|Missed visit|1|||
19766426|NCT03379259|42219180|FG005|Overall Study|Study terminated by sponsor|4|||
19766427|NCT03379259|42219175|FG000|Overall Study|Disease progression|0|||
19766428|NCT03379259|42219176|FG001|Overall Study|Disease progression|0|||
19766429|NCT03379259|42219177|FG002|Overall Study|Disease progression|0|||
19766430|NCT03379259|42219178|FG003|Overall Study|Disease progression|1|||
19766431|NCT03379259|42219179|FG004|Overall Study|Disease progression|0|||
19766432|NCT03379259|42219180|FG005|Overall Study|Disease progression|1|||
19766433|NCT03379259|42219175|FG000|Overall Study|Lost to Follow-up|0|||
19766434|NCT03379259|42219176|FG001|Overall Study|Lost to Follow-up|0|||
19766435|NCT03379259|42219177|FG002|Overall Study|Lost to Follow-up|0|||
19766436|NCT03379259|42219178|FG003|Overall Study|Lost to Follow-up|0|||
19766437|NCT03379259|42219179|FG004|Overall Study|Lost to Follow-up|1|||
19766438|NCT03379259|42219180|FG005|Overall Study|Lost to Follow-up|0|||
19766439|NCT03379259|42219175|FG000|Overall Study|Deteriorating condition|0|||
19766440|NCT03379259|42219176|FG001|Overall Study|Deteriorating condition|0|||
19766441|NCT03379259|42219177|FG002|Overall Study|Deteriorating condition|0|||
19766442|NCT03379259|42219178|FG003|Overall Study|Deteriorating condition|0|||
19766443|NCT03379259|42219179|FG004|Overall Study|Deteriorating condition|1|||
19766444|NCT03379259|42219180|FG005|Overall Study|Deteriorating condition|0|||
19766445|NCT03328897|42219200|FG000|Randomized-treatment Epoch|Adverse Event|4|||
19766446|NCT03328897|42219201|FG001|Randomized-treatment Epoch|Adverse Event|1|||
19766447|NCT03328897|42219202|FG002|Randomized-treatment Epoch|Adverse Event|1|||
19766448|NCT03328897|42219200|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
19766449|NCT03328897|42219201|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
19766450|NCT03328897|42219202|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
19766451|NCT03328897|42219200|FG000|Randomized-treatment Epoch|Pregnancy|3|||
19766452|NCT03328897|42219201|FG001|Randomized-treatment Epoch|Pregnancy|0|||
19766453|NCT03328897|42219202|FG002|Randomized-treatment Epoch|Pregnancy|0|||
19766454|NCT03328897|42219200|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
19766455|NCT03328897|42219201|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
19766456|NCT03328897|42219202|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
19766457|NCT03328897|42219200|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
19766458|NCT03328897|42219201|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
19766459|NCT03328897|42219202|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
19766460|NCT03328897|42219200|FG000|Follow-up Epoch|Adverse Event|4|||
19766461|NCT03328897|42219201|FG001|Follow-up Epoch|Adverse Event|0|||
19766462|NCT03328897|42219202|FG002|Follow-up Epoch|Adverse Event|1|||
19766463|NCT03328897|42219200|FG000|Follow-up Epoch|Lack of Efficacy|1|||
19766464|NCT03328897|42219201|FG001|Follow-up Epoch|Lack of Efficacy|1|||
19766465|NCT03328897|42219202|FG002|Follow-up Epoch|Lack of Efficacy|1|||
19681545|NCT00444600|42128867|FG001|Overall Study|Missed visit|0|||
19681546|NCT00444600|42128868|FG002|Overall Study|Missed visit|0|||
19681547|NCT00444600|42128869|FG003|Overall Study|Missed visit|1|||
19681548|NCT00537095|42128887|FG000|Overall Study|surgery|1|||
19681549|NCT00537095|42128888|FG001|Overall Study|surgery|0|||
19766466|NCT03328897|42219200|FG000|Follow-up Epoch|Lost to Follow-up|0|||
19766467|NCT03328897|42219201|FG001|Follow-up Epoch|Lost to Follow-up|1|||
19766468|NCT03328897|42219202|FG002|Follow-up Epoch|Lost to Follow-up|0|||
19766469|NCT03328897|42219200|FG000|Follow-up Epoch|Pregnancy|1|||
19766470|NCT03328897|42219201|FG001|Follow-up Epoch|Pregnancy|0|||
19604524|NCT01023581|42053418|FG002|Overall Study|Lost to Follow-up|7|||
19604525|NCT01023581|42053419|FG003|Overall Study|Lost to Follow-up|2|||
19766471|NCT03328897|42219202|FG002|Follow-up Epoch|Pregnancy|0|||
19766472|NCT03328897|42219200|FG000|Follow-up Epoch|Patient/guardian decision|2|||
19766473|NCT03328897|42219201|FG001|Follow-up Epoch|Patient/guardian decision|1|||
19766474|NCT03328897|42219202|FG002|Follow-up Epoch|Patient/guardian decision|0|||
19766475|NCT03266107|42219210|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
19766476|NCT03266107|42219210|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
19766477|NCT03266107|42219210|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
19604526|NCT01023581|42053420|FG004|Overall Study|Lost to Follow-up|5|||
19604527|NCT01023581|42053421|FG005|Overall Study|Lost to Follow-up|2|||
19604528|NCT01023581|42053422|FG006|Overall Study|Lost to Follow-up|2|||
19604529|NCT01023581|42053416|FG000|Overall Study|Withdrawal by Subject|13|||
19604530|NCT01023581|42053417|FG001|Overall Study|Withdrawal by Subject|8|||
19604531|NCT01023581|42053418|FG002|Overall Study|Withdrawal by Subject|16|||
19604532|NCT01023581|42053419|FG003|Overall Study|Withdrawal by Subject|10|||
19604533|NCT01023581|42053420|FG004|Overall Study|Withdrawal by Subject|6|||
19604534|NCT01023581|42053421|FG005|Overall Study|Withdrawal by Subject|8|||
19681550|NCT00537095|42128887|FG000|Overall Study|Adverse Event|24|||
19681551|NCT00537095|42128888|FG001|Overall Study|Adverse Event|4|||
19766478|NCT03266107|42219210|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
19766479|NCT03378635|42219219|FG000|Overall Study|Adverse Event|1|||
19766480|NCT03378635|42219220|FG001|Overall Study|Adverse Event|0|||
19766481|NCT03378635|42219221|FG002|Overall Study|Adverse Event|0|||
19766482|NCT03378635|42219219|FG000|Overall Study|Withdrawal by Subject|1|||
19766483|NCT03378635|42219220|FG001|Overall Study|Withdrawal by Subject|0|||
19766484|NCT03378635|42219221|FG002|Overall Study|Withdrawal by Subject|0|||
19766485|NCT03326869|42219232|FG000|Overall Study|Study data has been lost to natural disa|1|||
19766486|NCT03326869|42219233|FG001|Overall Study|Study data has been lost to natural disa|1|||
19766487|NCT03334409|42219245|FG000|Overall Study|Did not meet inclusion criteria|1|||
19766488|NCT03334409|42219246|FG001|Overall Study|Did not meet inclusion criteria|0|||
19766489|NCT02891915|42219254|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
19766490|NCT02891915|42219255|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
19766491|NCT02891915|42219254|FG000|Overall Study|Withdrawal by Subject|3|||
19766492|NCT02891915|42219255|FG001|Overall Study|Withdrawal by Subject|3|||
19766493|NCT02891915|42219254|FG000|Overall Study|Became Ineligible After Enrollment|2|||
19766494|NCT02891915|42219255|FG001|Overall Study|Became Ineligible After Enrollment|1|||
19766495|NCT02891915|42219254|FG000|Overall Study|Lost to Follow-up|1|||
19766496|NCT02891915|42219255|FG001|Overall Study|Lost to Follow-up|4|||
19766497|NCT02891915|42219254|FG000|Overall Study|Physician Decision|1|||
19766498|NCT02891915|42219255|FG001|Overall Study|Physician Decision|0|||
19766499|NCT02891681|42219264|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
19766500|NCT02891681|42219265|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
19766501|NCT02891681|42219266|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
19766502|NCT02891681|42219264|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
19766503|NCT02891681|42219265|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
19766504|NCT02891681|42219266|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
19766505|NCT02891681|42219264|FG000|Overall Study|Taken off study after first imaging appointment|1|||
19766506|NCT02891681|42219265|FG001|Overall Study|Taken off study after first imaging appointment|0|||
19766507|NCT02891681|42219266|FG002|Overall Study|Taken off study after first imaging appointment|0|||
19766508|NCT04671342|42219274|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
19766509|NCT04671342|42219274|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
19766510|NCT04671342|42219274|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
19766511|NCT04671342|42219274|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
19766512|NCT04671342|42219274|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
19766513|NCT04671342|42219274|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
19766514|NCT03046446|42219278|FG000|Overall Study|Lack of Efficacy|7|||
19766515|NCT03046446|42219278|FG000|Overall Study|Adverse Event|6|||
19766516|NCT03046446|42219278|FG000|Overall Study|Lost to Follow-up|3|||
19766517|NCT03046446|42219278|FG000|Overall Study|Withdrawal by Subject|14|||
19766518|NCT03046446|42219278|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
19766519|NCT03046446|42219278|FG000|Overall Study|Disease Progression (see caveats)|25|||
19766520|NCT03046446|42219278|FG000|Overall Study|Non OA related knee surgery|1|||
19766521|NCT03051217|42219285|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
19766522|NCT03051217|42219286|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19766523|NCT03051217|42219287|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
19766524|NCT03051217|42219288|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19766525|NCT03051217|42219289|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19766526|NCT03051217|42219290|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19766527|NCT03051217|42219291|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19766528|NCT03051217|42219285|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766529|NCT03051217|42219286|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
19766530|NCT03051217|42219287|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766531|NCT03051217|42219288|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766532|NCT03051217|42219289|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766533|NCT03051217|42219290|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766534|NCT03051217|42219291|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
19766535|NCT03051217|42219285|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
19766536|NCT03051217|42219286|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
19766537|NCT03051217|42219287|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
19766538|NCT03051217|42219288|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19766539|NCT03051217|42219289|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19766540|NCT03051217|42219290|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19766541|NCT03051217|42219291|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19766542|NCT03051217|42219285|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
19766543|NCT03051217|42219286|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
19766544|NCT03051217|42219287|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
19604535|NCT01023581|42053422|FG006|Overall Study|Withdrawal by Subject|5|||
19766545|NCT03051217|42219288|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
19766546|NCT03051217|42219289|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
19766547|NCT03051217|42219290|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
19766548|NCT03051217|42219291|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
19766549|NCT03051217|42219285|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766550|NCT03051217|42219286|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766551|NCT03051217|42219287|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766552|NCT03051217|42219288|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
19766553|NCT03051217|42219289|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766554|NCT03051217|42219290|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766555|NCT03051217|42219291|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
19766556|NCT03051217|42219285|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766557|NCT03051217|42219286|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766558|NCT03051217|42219287|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766559|NCT03051217|42219288|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
19766560|NCT03051217|42219289|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766561|NCT03051217|42219290|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766562|NCT03051217|42219291|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
19766563|NCT03051217|42219285|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19681552|NCT00537095|42128887|FG000|Overall Study|disease progression|21|||
19681553|NCT00537095|42128888|FG001|Overall Study|disease progression|48|||
19681554|NCT00537095|42128887|FG000|Overall Study|Death|3|||
19681555|NCT00537095|42128888|FG001|Overall Study|Death|1|||
19681556|NCT00537095|42128887|FG000|Overall Study|Withdrawal by Subject|2|||
19681557|NCT00537095|42128888|FG001|Overall Study|Withdrawal by Subject|2|||
19766564|NCT03051217|42219286|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19766565|NCT03051217|42219287|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19766566|NCT03051217|42219288|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19766567|NCT03051217|42219289|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
19766568|NCT03051217|42219290|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19766569|NCT03051217|42219291|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
19766570|NCT03051217|42219285|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766571|NCT03051217|42219286|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766572|NCT03051217|42219287|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766573|NCT03051217|42219288|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766574|NCT03051217|42219289|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766575|NCT03051217|42219290|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
19766576|NCT03051217|42219291|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
19766577|NCT03046056|42219317|FG000|Overall Study|Non-responder at Week 10|6|||
19766578|NCT03046056|42219318|FG001|Overall Study|Non-responder at Week 10|6|||
19766579|NCT03046056|42219319|FG002|Overall Study|Non-responder at Week 10|4|||
19766580|NCT03046056|42219317|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
19766581|NCT03046056|42219318|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
19766582|NCT03046056|42219319|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
19766583|NCT03046056|42219317|FG000|Overall Study|Adverse Event|1|||
19766584|NCT03046056|42219318|FG001|Overall Study|Adverse Event|5|||
19766585|NCT03046056|42219319|FG002|Overall Study|Adverse Event|0|||
19766586|NCT03046056|42219317|FG000|Overall Study|Non-compliance With Study Drug|0|||
19766587|NCT03046056|42219318|FG001|Overall Study|Non-compliance With Study Drug|0|||
19766588|NCT03046056|42219319|FG002|Overall Study|Non-compliance With Study Drug|2|||
19766589|NCT03046056|42219317|FG000|Overall Study|Protocol Violation|1|||
19766590|NCT03046056|42219318|FG001|Overall Study|Protocol Violation|1|||
19766591|NCT03046056|42219319|FG002|Overall Study|Protocol Violation|0|||
19766592|NCT03046056|42219317|FG000|Overall Study|Investigator's Discretion|0|||
19766593|NCT03046056|42219318|FG001|Overall Study|Investigator's Discretion|1|||
19604536|NCT01023581|42053416|FG000|Overall Study|Pregnancy|0|||
19604537|NCT01023581|42053417|FG001|Overall Study|Pregnancy|0|||
19604538|NCT01023581|42053418|FG002|Overall Study|Pregnancy|0|||
19604539|NCT01023581|42053419|FG003|Overall Study|Pregnancy|2|||
19604540|NCT01023581|42053420|FG004|Overall Study|Pregnancy|0|||
19604541|NCT01023581|42053421|FG005|Overall Study|Pregnancy|1|||
19604542|NCT01023581|42053422|FG006|Overall Study|Pregnancy|0|||
19681558|NCT00537095|42128887|FG000|Overall Study|subjective disease progression|0|||
19681559|NCT00537095|42128888|FG001|Overall Study|subjective disease progression|1|||
19604543|NCT01023581|42053416|FG000|Overall Study|Lack of Efficacy|9|||
19604544|NCT01023581|42053417|FG001|Overall Study|Lack of Efficacy|3|||
19681560|NCT00537095|42128887|FG000|Overall Study|Incorrect enrolment|0|||
19604545|NCT01023581|42053418|FG002|Overall Study|Lack of Efficacy|6|||
19604546|NCT01023581|42053419|FG003|Overall Study|Lack of Efficacy|2|||
19681561|NCT00537095|42128888|FG001|Overall Study|Incorrect enrolment|1|||
19766594|NCT03046056|42219319|FG002|Overall Study|Investigator's Discretion|0|||
19766595|NCT03046056|42219317|FG000|Overall Study|Withdrew Consent|1|||
19766596|NCT03046056|42219318|FG001|Overall Study|Withdrew Consent|0|||
19766597|NCT03046056|42219319|FG002|Overall Study|Withdrew Consent|0|||
19766598|NCT02849587|42219330|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
19766599|NCT02849587|42219331|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
19766600|NCT02849587|42219332|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
19766601|NCT02849587|42219330|FG000|Overall Study|Withdrawal by Subject|0|||
19766602|NCT02849587|42219331|FG001|Overall Study|Withdrawal by Subject|1|||
19766603|NCT02849587|42219332|FG002|Overall Study|Withdrawal by Subject|0|||
19766604|NCT03347279|42219346|FG000|Overall Study|Withdrawal by Subject|8|||
19766605|NCT03347279|42219347|FG001|Overall Study|Withdrawal by Subject|15|||
19766606|NCT03347279|42219346|FG000|Overall Study|Death|0|||
19766607|NCT03347279|42219347|FG001|Overall Study|Death|2|||
19766608|NCT03347279|42219346|FG000|Overall Study|Lost to Follow-up|5|||
19766609|NCT03347279|42219347|FG001|Overall Study|Lost to Follow-up|2|||
19766610|NCT03347279|42219346|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
19766611|NCT03347279|42219347|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
19766612|NCT03262441|42219353|FG000|Overall Study|Withdrawal by Subject|1|||
19766613|NCT04580394|42219357|FG000|First Intervention|Incorrectly Randomized|1|||
19766614|NCT04580394|42219357|FG000|First Intervention|Physician Decision|1|||
19766615|NCT04580394|42219357|FG000|First Intervention|Lost to Follow-up|1|||
19766616|NCT04580394|42219357|FG000|Washout (One Week)|Withdrawal by Subject|1|||
19766617|NCT04580394|42219357|FG000|Washout (One Week)|Adverse Event|1|||
19766618|NCT04580394|42219357|FG000|Washout (One Week)|Withdrawal by Subject|2|||
19766619|NCT04580394|42219357|FG000|Third Intervention|Adverse Event|1|||
19766620|NCT04580394|42219357|FG000|Third Intervention|Withdrawal by Subject|1|||
19766621|NCT04580394|42219357|FG000|Washout (One Week)|Withdrawal by Subject|2|||
19766622|NCT02781727|42219369|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
19766623|NCT02781727|42219370|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
19766624|NCT02781727|42219369|FG000|Treatment Period|Withdrawal by Subject|1|||
19766625|NCT02781727|42219370|FG001|Treatment Period|Withdrawal by Subject|0|||
19766626|NCT02781727|42219369|FG000|Treatment Period|Lost to Follow-up|0|||
19766627|NCT02781727|42219370|FG001|Treatment Period|Lost to Follow-up|1|||
19766628|NCT01343082|42219376|FG000|The run-in Period|Not meeting criteria|3|||
19766629|NCT01343082|42219377|FG001|The run-in Period|Not meeting criteria|4|||
19766630|NCT01343082|42219378|FG002|The run-in Period|Not meeting criteria|5|||
19766631|NCT01343082|42219376|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
19766632|NCT01343082|42219377|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
19766633|NCT01343082|42219378|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
19766634|NCT01343082|42219376|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
19766635|NCT01343082|42219377|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
19766636|NCT01343082|42219378|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
19766637|NCT01343082|42219376|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
19766638|NCT01343082|42219377|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
19766639|NCT01343082|42219378|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
19766640|NCT01343082|42219376|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
19766641|NCT01343082|42219377|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
19766642|NCT01343082|42219378|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
19766643|NCT03374189|42219384|FG000|Overall Study|Lost to Follow-up|1|||
19766644|NCT03374189|42219385|FG001|Overall Study|Lost to Follow-up|0|||
19766645|NCT03261037|42219395|FG000|Overall Study|Withdrawal by Subject|2|||
19766646|NCT03261037|42219396|FG001|Overall Study|Withdrawal by Subject|13|||
19766647|NCT03261037|42219397|FG002|Overall Study|Withdrawal by Subject|0|||
19766648|NCT03261037|42219398|FG003|Overall Study|Withdrawal by Subject|18|||
19766649|NCT03261037|42219395|FG000|Overall Study|Non-compliance with study procedures|0|||
19766650|NCT03261037|42219396|FG001|Overall Study|Non-compliance with study procedures|2|||
19766651|NCT03261037|42219397|FG002|Overall Study|Non-compliance with study procedures|0|||
19766652|NCT03261037|42219398|FG003|Overall Study|Non-compliance with study procedures|6|||
19766653|NCT03261037|42219395|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
19766654|NCT03261037|42219396|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
19766655|NCT03261037|42219397|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
19766656|NCT03261037|42219398|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
19766657|NCT03261037|42219395|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
19766658|NCT03261037|42219396|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
19766659|NCT03261037|42219397|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
19766660|NCT03261037|42219398|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
19766661|NCT03261037|42219395|FG000|Overall Study|Diagnosed but protocol deviation|1|||
19766662|NCT03261037|42219396|FG001|Overall Study|Diagnosed but protocol deviation|0|||
19766663|NCT03261037|42219397|FG002|Overall Study|Diagnosed but protocol deviation|0|||
19766664|NCT03261037|42219398|FG003|Overall Study|Diagnosed but protocol deviation|0|||
19766665|NCT03261037|42219395|FG000|Overall Study|Participant did not want to continue the study|0|||
19766666|NCT03261037|42219396|FG001|Overall Study|Participant did not want to continue the study|1|||
19766667|NCT03261037|42219397|FG002|Overall Study|Participant did not want to continue the study|0|||
19766668|NCT03261037|42219398|FG003|Overall Study|Participant did not want to continue the study|0|||
19766669|NCT03261037|42219395|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
19766670|NCT03261037|42219396|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
19766671|NCT03261037|42219397|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
19766672|NCT03261037|42219398|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
19766673|NCT03261037|42219395|FG000|Overall Study|Participant presented clinical improvement|0|||
19766674|NCT03261037|42219396|FG001|Overall Study|Participant presented clinical improvement|2|||
19766675|NCT03261037|42219397|FG002|Overall Study|Participant presented clinical improvement|0|||
19766676|NCT03261037|42219398|FG003|Overall Study|Participant presented clinical improvement|0|||
19766677|NCT03261037|42219395|FG000|Overall Study|Technical difficulties|0|||
19766678|NCT03261037|42219396|FG001|Overall Study|Technical difficulties|0|||
19766679|NCT03261037|42219397|FG002|Overall Study|Technical difficulties|0|||
19766680|NCT03261037|42219398|FG003|Overall Study|Technical difficulties|1|||
19766681|NCT03261037|42219395|FG000|Overall Study|Equipment failed to work|0|||
19766682|NCT03261037|42219396|FG001|Overall Study|Equipment failed to work|0|||
19766683|NCT03261037|42219397|FG002|Overall Study|Equipment failed to work|0|||
19766684|NCT03261037|42219398|FG003|Overall Study|Equipment failed to work|1|||
19766685|NCT03261037|42219395|FG000|Overall Study|End of study for participant and no follow up|0|||
19766686|NCT03261037|42219396|FG001|Overall Study|End of study for participant and no follow up|0|||
19766687|NCT03261037|42219397|FG002|Overall Study|End of study for participant and no follow up|0|||
19766688|NCT03261037|42219398|FG003|Overall Study|End of study for participant and no follow up|1|||
19766689|NCT03261037|42219395|FG000|Overall Study|Participant was too weak to continue in study|1|||
19766690|NCT03261037|42219396|FG001|Overall Study|Participant was too weak to continue in study|0|||
19766691|NCT03261037|42219397|FG002|Overall Study|Participant was too weak to continue in study|0|||
19766692|NCT03261037|42219398|FG003|Overall Study|Participant was too weak to continue in study|0|||
19766693|NCT03372551|42219409|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
19766694|NCT03372551|42219410|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
19766695|NCT03326323|42219423|FG000|Overall Study|Unable to receive ANH protocol|3|||
19766696|NCT03259789|42219434|FG000|Overall Study|Adverse Event|3|||
19766697|NCT03259789|42219435|FG001|Overall Study|Adverse Event|2|||
19766698|NCT03259789|42219436|FG002|Overall Study|Adverse Event|1|||
19766699|NCT03259789|42219434|FG000|Overall Study|Withdrawal by Subject|9|||
19766700|NCT03259789|42219435|FG001|Overall Study|Withdrawal by Subject|5|||
19766701|NCT03259789|42219436|FG002|Overall Study|Withdrawal by Subject|1|||
19766702|NCT03259789|42219434|FG000|Overall Study|Lost to Follow-up|5|||
19766703|NCT03259789|42219435|FG001|Overall Study|Lost to Follow-up|9|||
19766704|NCT03259789|42219436|FG002|Overall Study|Lost to Follow-up|4|||
19766705|NCT03259789|42219434|FG000|Overall Study|Physician Decision|0|||
19766706|NCT03259789|42219435|FG001|Overall Study|Physician Decision|1|||
19766707|NCT03259789|42219436|FG002|Overall Study|Physician Decision|0|||
19766708|NCT03259555|42219447|FG000|Overall Study|Adverse Event|6|||
19766709|NCT03259555|42219448|FG001|Overall Study|Adverse Event|4|||
19766710|NCT03259555|42219447|FG000|Overall Study|Lack of Efficacy|6|||
19766711|NCT03259555|42219448|FG001|Overall Study|Lack of Efficacy|4|||
19766712|NCT03259555|42219447|FG000|Overall Study|Lost to Follow-up|0|||
19766713|NCT03259555|42219448|FG001|Overall Study|Lost to Follow-up|2|||
19766714|NCT03259555|42219447|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19766715|NCT03259555|42219448|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19766716|NCT03259555|42219447|FG000|Overall Study|Progressive Disease|0|||
19766717|NCT03259555|42219448|FG001|Overall Study|Progressive Disease|2|||
19766718|NCT03259555|42219447|FG000|Overall Study|Withdrawal by Subject|19|||
19766719|NCT03259555|42219448|FG001|Overall Study|Withdrawal by Subject|16|||
19766720|NCT03259555|42219447|FG000|Overall Study|Physician Decision|1|||
19766721|NCT03259555|42219448|FG001|Overall Study|Physician Decision|2|||
19766722|NCT03259555|42219447|FG000|Overall Study|Other|1|||
19766723|NCT03259555|42219448|FG001|Overall Study|Other|0|||
19766724|NCT03259087|42219459|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
19766725|NCT03259087|42219460|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
19766726|NCT03259087|42219461|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
19766727|NCT03259087|42219462|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
19766728|NCT03259087|42219463|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
19766729|NCT03259087|42219459|FG000|Period 2 of Part 2|Adverse Event|0|||
19766730|NCT03259087|42219460|FG001|Period 2 of Part 2|Adverse Event|0|||
19766731|NCT03259087|42219461|FG002|Period 2 of Part 2|Adverse Event|0|||
19766732|NCT03259087|42219462|FG003|Period 2 of Part 2|Adverse Event|0|||
19766733|NCT03259087|42219463|FG004|Period 2 of Part 2|Adverse Event|1|||
19766734|NCT03257995|42219485|FG000|Overall Study|Adverse Event|0|||
19766735|NCT03257995|42219486|FG001|Overall Study|Adverse Event|1|||
19766736|NCT03257995|42219487|FG002|Overall Study|Adverse Event|0|||
19766737|NCT03257995|42219488|FG003|Overall Study|Adverse Event|0|||
19766738|NCT03257995|42219489|FG004|Overall Study|Adverse Event|0|||
19766739|NCT03257995|42219490|FG005|Overall Study|Adverse Event|0|||
19766740|NCT03257995|42219485|FG000|Overall Study|Protocol deviation|0|||
19766741|NCT03257995|42219486|FG001|Overall Study|Protocol deviation|0|||
19766742|NCT03257995|42219487|FG002|Overall Study|Protocol deviation|0|||
19766743|NCT03257995|42219488|FG003|Overall Study|Protocol deviation|0|||
19766744|NCT03257995|42219489|FG004|Overall Study|Protocol deviation|0|||
19766745|NCT03257995|42219490|FG005|Overall Study|Protocol deviation|2|||
19766746|NCT03049488|42219508|FG000|Overall Study|Lost to Follow-up|1|||
19766747|NCT03049488|42219509|FG001|Overall Study|Lost to Follow-up|1|||
19766748|NCT03049488|42219510|FG002|Overall Study|Lost to Follow-up|0|||
19766749|NCT03049488|42219511|FG003|Overall Study|Lost to Follow-up|0|||
19766750|NCT03049488|42219512|FG004|Overall Study|Lost to Follow-up|0|||
19766751|NCT03049488|42219513|FG005|Overall Study|Lost to Follow-up|0|||
19766752|NCT03049488|42219508|FG000|Overall Study|Moved from Area|1|||
19766753|NCT03049488|42219509|FG001|Overall Study|Moved from Area|0|||
19766754|NCT03049488|42219510|FG002|Overall Study|Moved from Area|0|||
19766755|NCT03049488|42219511|FG003|Overall Study|Moved from Area|1|||
19766756|NCT03049488|42219512|FG004|Overall Study|Moved from Area|1|||
19766757|NCT03049488|42219513|FG005|Overall Study|Moved from Area|0|||
19766758|NCT03049488|42219508|FG000|Overall Study|Physician Decision|0|||
19766759|NCT03049488|42219509|FG001|Overall Study|Physician Decision|1|||
19766760|NCT03049488|42219510|FG002|Overall Study|Physician Decision|0|||
19766761|NCT03049488|42219511|FG003|Overall Study|Physician Decision|0|||
19766762|NCT03049488|42219512|FG004|Overall Study|Physician Decision|0|||
19766763|NCT03049488|42219513|FG005|Overall Study|Physician Decision|0|||
19766764|NCT03049488|42219508|FG000|Overall Study|Withdrawal by Subject|0|||
19766765|NCT03049488|42219509|FG001|Overall Study|Withdrawal by Subject|0|||
19766766|NCT03049488|42219510|FG002|Overall Study|Withdrawal by Subject|0|||
19766767|NCT03049488|42219511|FG003|Overall Study|Withdrawal by Subject|1|||
19766768|NCT03049488|42219512|FG004|Overall Study|Withdrawal by Subject|1|||
19766769|NCT03049488|42219513|FG005|Overall Study|Withdrawal by Subject|0|||
19766770|NCT03257371|42219528|FG000|Overall Study|Lost to Follow-up|1|||
19766771|NCT03242863|42219532|FG000|Study Week 1|Withdrawal by Subject|0|||
19766772|NCT03242863|42219533|FG001|Study Week 1|Withdrawal by Subject|1|||
19766773|NCT03242863|42219534|FG002|Study Week 1|Withdrawal by Subject|0|||
19766774|NCT03242863|42219535|FG003|Study Week 1|Withdrawal by Subject|0|||
19766775|NCT03242863|42219536|FG004|Study Week 1|Withdrawal by Subject|3|||
19766776|NCT03242863|42219537|FG005|Study Week 1|Withdrawal by Subject|0|||
19766777|NCT03044106|42219545|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
19766778|NCT03044106|42219546|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
19766779|NCT03043560|42219572|FG000|Overall Study|Discontinued Intervention|1|||
19766780|NCT03043560|42219573|FG001|Overall Study|Discontinued Intervention|2|||
19766781|NCT03043560|42219572|FG000|Overall Study|Lost to Follow-up|0|||
19766782|NCT03043560|42219573|FG001|Overall Study|Lost to Follow-up|1|||
19766783|NCT03255733|42219599|FG000|Overall Study|Lost to Follow-up|4|||
19766784|NCT03255655|42219605|FG000|Overall Study|Lost to Follow-up|7|||
19766785|NCT03255655|42219606|FG001|Overall Study|Lost to Follow-up|4|||
19766786|NCT02899988|42219616|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
19766787|NCT02899988|42219617|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
19766788|NCT02899988|42219618|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766789|NCT02899988|42219619|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766790|NCT02899988|42219620|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766791|NCT02899988|42219621|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766792|NCT02899988|42219622|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766793|NCT02899988|42219623|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766794|NCT02899988|42219624|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766795|NCT02899988|42219625|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766796|NCT02899988|42219626|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19766797|NCT02899988|42219616|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
19766798|NCT02899988|42219617|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
19766799|NCT02899988|42219618|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
19766800|NCT02899988|42219619|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
19766801|NCT02899988|42219620|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
19389097|NCT02670473|41632652|FG000|Overall Study|Withdrawal by Subject|1|||
19766802|NCT02899988|42219621|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
19766803|NCT02899988|42219622|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
19766804|NCT02899988|42219623|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
19766805|NCT02899988|42219624|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
19766806|NCT02899988|42219625|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
19766807|NCT02899988|42219626|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
19766808|NCT02899988|42219616|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
19766809|NCT02899988|42219617|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
19766810|NCT02899988|42219618|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
19766811|NCT02899988|42219619|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
19766812|NCT02899988|42219620|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
19766813|NCT02899988|42219621|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
19766814|NCT02899988|42219622|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
19766815|NCT02899988|42219623|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
19766816|NCT02899988|42219624|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
19766817|NCT02899988|42219625|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
19766818|NCT02899988|42219626|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
19766819|NCT02899988|42219616|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
19766820|NCT02899988|42219617|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
19766821|NCT02899988|42219618|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
19766822|NCT02899988|42219619|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
19766823|NCT02899988|42219620|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
19766824|NCT02899988|42219621|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
19766825|NCT02899988|42219622|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
19766826|NCT02899988|42219623|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
19766827|NCT02899988|42219624|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
19766828|NCT02899988|42219625|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
19766829|NCT02899988|42219626|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
19766830|NCT02899988|42219616|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766831|NCT02899988|42219617|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766832|NCT02899988|42219618|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766833|NCT02899988|42219619|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766834|NCT02899988|42219620|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766835|NCT02899988|42219621|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
19766836|NCT02899988|42219622|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19681562|NCT00443898|42128898|FG000|Overall Study|Adverse Event|0|||
19681563|NCT00443898|42128899|FG001|Overall Study|Adverse Event|0|||
19681564|NCT00443898|42128900|FG002|Overall Study|Adverse Event|1|||
19681565|NCT00443898|42128901|FG003|Overall Study|Adverse Event|1|||
19681566|NCT00443898|42128898|FG000|Overall Study|Lack of Efficacy|2|||
19681567|NCT00443898|42128899|FG001|Overall Study|Lack of Efficacy|3|||
19681568|NCT00443898|42128900|FG002|Overall Study|Lack of Efficacy|3|||
19681569|NCT00443898|42128901|FG003|Overall Study|Lack of Efficacy|1|||
19681570|NCT00443898|42128898|FG000|Overall Study|Protocol Violation|1|||
19681571|NCT00443898|42128899|FG001|Overall Study|Protocol Violation|1|||
19681572|NCT00443898|42128900|FG002|Overall Study|Protocol Violation|1|||
19681573|NCT00443898|42128901|FG003|Overall Study|Protocol Violation|0|||
19681574|NCT00443898|42128898|FG000|Overall Study|Withdrawal by Subject|11|||
19681575|NCT00443898|42128899|FG001|Overall Study|Withdrawal by Subject|10|||
19681576|NCT00443898|42128900|FG002|Overall Study|Withdrawal by Subject|10|||
19681577|NCT00443898|42128901|FG003|Overall Study|Withdrawal by Subject|6|||
19681578|NCT00443898|42128898|FG000|Overall Study|Lost to Follow-up|10|||
19681579|NCT00443898|42128899|FG001|Overall Study|Lost to Follow-up|10|||
19681580|NCT00443898|42128900|FG002|Overall Study|Lost to Follow-up|14|||
19681581|NCT00443898|42128901|FG003|Overall Study|Lost to Follow-up|10|||
19681582|NCT00443898|42128898|FG000|Overall Study|Death|0|||
19681583|NCT00443898|42128899|FG001|Overall Study|Death|1|||
19681584|NCT00443898|42128900|FG002|Overall Study|Death|0|||
19681585|NCT00443898|42128901|FG003|Overall Study|Death|0|||
19681586|NCT00537017|42128911|FG000|Treatment Phase|Adverse Event|19|||
19681587|NCT00537017|42128911|FG000|Treatment Phase|Withdrawal by Subject|13|||
19681588|NCT00537017|42128911|FG000|Treatment Phase|Protocol Violation|2|||
19681589|NCT00537017|42128911|FG000|Follow-up Phase|Withdrawal by Subject|9|||
19681590|NCT00348309|42128918|FG000|Overall Study|Adverse Event|56|||
19681591|NCT00348309|42128919|FG001|Overall Study|Adverse Event|28|||
19681592|NCT00348309|42128920|FG002|Overall Study|Adverse Event|63|||
19681593|NCT00348309|42128918|FG000|Overall Study|Lost to Follow-up|6|||
19681594|NCT00348309|42128919|FG001|Overall Study|Lost to Follow-up|7|||
19681595|NCT00348309|42128920|FG002|Overall Study|Lost to Follow-up|4|||
19681596|NCT00348309|42128918|FG000|Overall Study|Protocol Violation|7|||
19681597|NCT00348309|42128919|FG001|Overall Study|Protocol Violation|12|||
19681598|NCT00348309|42128920|FG002|Overall Study|Protocol Violation|7|||
19681599|NCT00348309|42128918|FG000|Overall Study|Withdrawal by Subject|33|||
19681600|NCT00348309|42128919|FG001|Overall Study|Withdrawal by Subject|37|||
19681601|NCT00348309|42128920|FG002|Overall Study|Withdrawal by Subject|40|||
19681602|NCT00348309|42128918|FG000|Overall Study|Non-compliance|8|||
19681603|NCT00348309|42128919|FG001|Overall Study|Non-compliance|6|||
19681604|NCT00348309|42128920|FG002|Overall Study|Non-compliance|8|||
19681605|NCT00348309|42128918|FG000|Overall Study|Death of caregiver|1|||
19766837|NCT02899988|42219623|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
19766838|NCT02899988|42219624|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766839|NCT02899988|42219625|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766840|NCT02899988|42219626|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
19766841|NCT02899988|42219616|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766842|NCT02899988|42219617|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766843|NCT02899988|42219618|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766844|NCT02899988|42219619|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766845|NCT02899988|42219620|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
19766846|NCT02899988|42219621|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766847|NCT02899988|42219622|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
19766848|NCT02899988|42219623|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
19766849|NCT02899988|42219624|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
19766850|NCT02899988|42219625|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
19766851|NCT02899988|42219626|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
19766852|NCT02939131|42219660|FG000|Overall Study|Unable to get to clinic|6|||
19766853|NCT02939131|42219661|FG001|Overall Study|Unable to get to clinic|4|||
19766854|NCT02939131|42219660|FG000|Overall Study|Lost to Follow-up|2|||
19766855|NCT02939131|42219661|FG001|Overall Study|Lost to Follow-up|4|||
19766856|NCT02939131|42219660|FG000|Overall Study|severe debilitation|1|||
19766857|NCT02939131|42219661|FG001|Overall Study|severe debilitation|0|||
19766858|NCT02939131|42219660|FG000|Overall Study|Other|0|||
19766859|NCT02939131|42219661|FG001|Overall Study|Other|1|||
19766860|NCT02939131|42219660|FG000|Overall Study|not willing to adhere to protocol|2|||
19766861|NCT02939131|42219661|FG001|Overall Study|not willing to adhere to protocol|0|||
19766862|NCT04373460|42219670|FG000|Overall Study|Did not receive tranfusion|18|||
19766863|NCT04373460|42219671|FG001|Overall Study|Did not receive tranfusion|26|||
19766864|NCT03345407|42219688|FG000|Overall Study|Withdrawal by Subject|11|||
19766865|NCT03345407|42219689|FG001|Overall Study|Withdrawal by Subject|1|||
19766866|NCT03345407|42219690|FG002|Overall Study|Withdrawal by Subject|5|||
19766867|NCT03345407|42219691|FG003|Overall Study|Withdrawal by Subject|6|||
19766868|NCT03345407|42219692|FG004|Overall Study|Withdrawal by Subject|3|||
19766869|NCT03345407|42219693|FG005|Overall Study|Withdrawal by Subject|6|||
19766870|NCT03345407|42219694|FG006|Overall Study|Withdrawal by Subject|16|||
19766871|NCT03345407|42219688|FG000|Overall Study|Physician Decision|3|||
19766872|NCT03345407|42219689|FG001|Overall Study|Physician Decision|1|||
19766873|NCT03345407|42219690|FG002|Overall Study|Physician Decision|0|||
19766874|NCT03345407|42219691|FG003|Overall Study|Physician Decision|0|||
19766875|NCT03345407|42219692|FG004|Overall Study|Physician Decision|1|||
19766876|NCT03345407|42219693|FG005|Overall Study|Physician Decision|2|||
19766877|NCT03345407|42219694|FG006|Overall Study|Physician Decision|3|||
19766878|NCT03345407|42219688|FG000|Overall Study|Lost to Follow-up|2|||
19766879|NCT03345407|42219689|FG001|Overall Study|Lost to Follow-up|0|||
19766880|NCT03345407|42219690|FG002|Overall Study|Lost to Follow-up|1|||
19766881|NCT03345407|42219691|FG003|Overall Study|Lost to Follow-up|0|||
19766882|NCT03345407|42219692|FG004|Overall Study|Lost to Follow-up|1|||
19766883|NCT03345407|42219693|FG005|Overall Study|Lost to Follow-up|2|||
19766884|NCT03345407|42219694|FG006|Overall Study|Lost to Follow-up|3|||
19766885|NCT03345407|42219688|FG000|Overall Study|Protocol-defined stopping criteria|9|||
19766886|NCT03345407|42219689|FG001|Overall Study|Protocol-defined stopping criteria|0|||
19766887|NCT03345407|42219690|FG002|Overall Study|Protocol-defined stopping criteria|0|||
19766888|NCT03345407|42219691|FG003|Overall Study|Protocol-defined stopping criteria|0|||
19766889|NCT03345407|42219692|FG004|Overall Study|Protocol-defined stopping criteria|2|||
19766890|NCT03345407|42219693|FG005|Overall Study|Protocol-defined stopping criteria|1|||
19766891|NCT03345407|42219694|FG006|Overall Study|Protocol-defined stopping criteria|1|||
19766892|NCT03345407|42219688|FG000|Overall Study|Protocol Violation|2|||
19766893|NCT03345407|42219689|FG001|Overall Study|Protocol Violation|0|||
19766894|NCT03345407|42219690|FG002|Overall Study|Protocol Violation|0|||
19766895|NCT03345407|42219691|FG003|Overall Study|Protocol Violation|0|||
19766896|NCT03345407|42219692|FG004|Overall Study|Protocol Violation|1|||
19766897|NCT03345407|42219693|FG005|Overall Study|Protocol Violation|0|||
19766898|NCT03345407|42219694|FG006|Overall Study|Protocol Violation|3|||
19766899|NCT03345407|42219688|FG000|Overall Study|Lack of Efficacy|1|||
19766900|NCT03345407|42219689|FG001|Overall Study|Lack of Efficacy|1|||
19766901|NCT03345407|42219690|FG002|Overall Study|Lack of Efficacy|1|||
19766902|NCT03345407|42219691|FG003|Overall Study|Lack of Efficacy|1|||
19766903|NCT03345407|42219692|FG004|Overall Study|Lack of Efficacy|1|||
19766904|NCT03345407|42219693|FG005|Overall Study|Lack of Efficacy|0|||
19766905|NCT03345407|42219694|FG006|Overall Study|Lack of Efficacy|3|||
19766906|NCT03345407|42219688|FG000|Overall Study|Adverse Event|4|||
19766907|NCT03345407|42219689|FG001|Overall Study|Adverse Event|0|||
19766908|NCT03345407|42219690|FG002|Overall Study|Adverse Event|5|||
19766909|NCT03345407|42219691|FG003|Overall Study|Adverse Event|4|||
19766910|NCT03345407|42219692|FG004|Overall Study|Adverse Event|6|||
19766911|NCT03345407|42219693|FG005|Overall Study|Adverse Event|5|||
19766912|NCT03345407|42219694|FG006|Overall Study|Adverse Event|16|||
19766913|NCT03255187|42219718|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
19766914|NCT03255187|42219719|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
19766915|NCT03255187|42219718|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
19766916|NCT03255187|42219719|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
19766917|NCT02929329|42219727|FG000|Overall Study|Withdrawal by Subject|24|||
19766918|NCT02929329|42219728|FG001|Overall Study|Withdrawal by Subject|21|||
19766919|NCT02929329|42219727|FG000|Overall Study|Lost to Follow-up|26|||
19766920|NCT02929329|42219728|FG001|Overall Study|Lost to Follow-up|20|||
19766921|NCT02929329|42219727|FG000|Overall Study|Death|1054|||
19766922|NCT02929329|42219728|FG001|Overall Study|Death|1051|||
19766923|NCT03240133|42219741|FG000|Overall Study|Withdrawal by Subject|0|||
19766924|NCT03240133|42219742|FG001|Overall Study|Withdrawal by Subject|1|||
19766925|NCT03240133|42219743|FG002|Overall Study|Withdrawal by Subject|0|||
19766926|NCT03240133|42219741|FG000|Overall Study|Adverse Event|1|||
19766927|NCT03240133|42219742|FG001|Overall Study|Adverse Event|1|||
19766928|NCT03240133|42219743|FG002|Overall Study|Adverse Event|0|||
19766929|NCT03240133|42219741|FG000|Overall Study|Rash|1|||
19766930|NCT03240133|42219742|FG001|Overall Study|Rash|0|||
19766931|NCT03240133|42219743|FG002|Overall Study|Rash|0|||
19766932|NCT03240133|42219741|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
19766933|NCT03240133|42219742|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
19766934|NCT03240133|42219743|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
19766935|NCT03240133|42219741|FG000|Overall Study|Intercurrent illness.|0|||
19766936|NCT03240133|42219742|FG001|Overall Study|Intercurrent illness.|1|||
19766937|NCT03240133|42219743|FG002|Overall Study|Intercurrent illness.|0|||
19766938|NCT03240133|42219741|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
19766939|NCT03240133|42219742|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
19766940|NCT03240133|42219743|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
19766941|NCT03372083|42219767|FG000|Overall Study|Adverse Event|3|||
19766942|NCT03372083|42219767|FG000|Overall Study|Physician Decision|1|||
19766943|NCT03372083|42219767|FG000|Overall Study|Withdrawal by Subject|1|||
19766944|NCT03044886|42219774|FG000|Overall Study|Lost to Follow-up|15|||
19766945|NCT03044886|42219775|FG001|Overall Study|Lost to Follow-up|10|||
19766946|NCT03044886|42219776|FG002|Overall Study|Lost to Follow-up|12|||
19766947|NCT02961764|42219786|FG000|Overall Study|Protocol Violation|0|||
19766948|NCT02961764|42219787|FG001|Overall Study|Protocol Violation|1|||
19766949|NCT02961764|42219786|FG000|Overall Study|Death|2|||
19766950|NCT02961764|42219787|FG001|Overall Study|Death|0|||
19766951|NCT02961764|42219786|FG000|Overall Study|Lost to Follow-up|35|||
19766952|NCT02961764|42219787|FG001|Overall Study|Lost to Follow-up|24|||
19766953|NCT02961764|42219786|FG000|Overall Study|Withdrawal by Subject|2|||
19766954|NCT02961764|42219787|FG001|Overall Study|Withdrawal by Subject|0|||
19766955|NCT03371459|42219793|FG000|Washout|Lost to Follow-up|0|||
19766956|NCT03371459|42219794|FG001|Washout|Lost to Follow-up|1|||
19766957|NCT02961920|42219802|FG000|Overall Study|did not achive stydy protocol schedule|1|||
19766958|NCT02961920|42219803|FG001|Overall Study|did not achive stydy protocol schedule|1|||
19766959|NCT03371381|42219809|FG000|Overall Study|Death|5|||
19766960|NCT03371381|42219809|FG000|Overall Study|Study terminated by sponsor|3|||
19766961|NCT03371381|42219809|FG000|Overall Study|Other|4|||
19766962|NCT03044730|42219813|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
19766963|NCT03044730|42219813|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
19766964|NCT03044730|42219813|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
19766965|NCT03044730|42219813|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
19766966|NCT03044730|42219813|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
19766967|NCT03044730|42219813|FG000|Cycles 4 and Beyond|Adverse Event|1|||
19766968|NCT03044730|42219813|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
19766969|NCT03044730|42219813|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
19766970|NCT03044730|42219813|FG000|On Follow-up for 2 Years|Death|17|||
19766971|NCT02961374|42219818|FG000|Overall Study|Adverse Event|4|||
19766972|NCT02951429|42219824|FG000|Overall Study|Adverse Event|3|||
19766973|NCT02951429|42219825|FG001|Overall Study|Adverse Event|7|||
19766974|NCT02951429|42219824|FG000|Overall Study|Death|28|||
19766975|NCT02951429|42219825|FG001|Overall Study|Death|36|||
19766976|NCT02951429|42219824|FG000|Overall Study|Lack of Efficacy|0|||
19766977|NCT02951429|42219825|FG001|Overall Study|Lack of Efficacy|1|||
19766978|NCT02951429|42219824|FG000|Overall Study|Lost to Follow-up|0|||
19766979|NCT02951429|42219825|FG001|Overall Study|Lost to Follow-up|1|||
19766980|NCT02951429|42219824|FG000|Overall Study|Lung Transplantation|9|||
19766981|NCT02951429|42219825|FG001|Overall Study|Lung Transplantation|6|||
19766982|NCT02951429|42219824|FG000|Overall Study|Other|1|||
19766983|NCT02951429|42219825|FG001|Overall Study|Other|3|||
19766984|NCT02951429|42219824|FG000|Overall Study|Progressive Disease|1|||
19766985|NCT02951429|42219825|FG001|Overall Study|Progressive Disease|1|||
19766986|NCT02951429|42219824|FG000|Overall Study|Withdrawal by Subject|7|||
19766987|NCT02951429|42219825|FG001|Overall Study|Withdrawal by Subject|11|||
19766988|NCT02951429|42219824|FG000|Overall Study|Participant ongoing in the study|23|||
19766989|NCT02951429|42219825|FG001|Overall Study|Participant ongoing in the study|17|||
19766990|NCT03343067|42219838|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
19766991|NCT03343067|42219839|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
19766992|NCT03343067|42219840|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
19766993|NCT03103503|42219848|FG000|Overall Study|Death|64|||
19766994|NCT03103503|42219848|FG000|Overall Study|Physician Decision|57|||
19766995|NCT03103503|42219848|FG000|Overall Study|Withdrawal by Subject|10|||
19766996|NCT03103503|42219848|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
19766997|NCT03103503|42219848|FG000|Overall Study|Lost to Follow-up|3|||
19766998|NCT03103503|42219848|FG000|Overall Study|Study Closure|757|||
19766999|NCT02961218|42219854|FG000|Overall Study|Lost to Follow-up|0|||
19767000|NCT02961218|42219855|FG001|Overall Study|Lost to Follow-up|2|||
19767001|NCT02961218|42219854|FG000|Overall Study|Physician Decision|0|||
19767002|NCT02961218|42219855|FG001|Overall Study|Physician Decision|2|||
19767003|NCT02961218|42219854|FG000|Overall Study|Subject/Guardian Decision|3|||
19767004|NCT02961218|42219855|FG001|Overall Study|Subject/Guardian Decision|1|||
19767005|NCT02949947|42219865|FG000|Overall Study|Non Compliance|0|||
19767006|NCT02949947|42219866|FG001|Overall Study|Non Compliance|1|||
19767007|NCT02949947|42219865|FG000|Overall Study|Insurance change|1|||
19767008|NCT02949947|42219866|FG001|Overall Study|Insurance change|0|||
19767009|NCT03341507|42219872|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
19767010|NCT03341273|42219878|FG000|Overall Study|Lost to Follow-up|7|||
19767011|NCT03341273|42219879|FG001|Overall Study|Lost to Follow-up|7|||
19767012|NCT03341273|42219878|FG000|Overall Study|Withdrawal by Subject|4|||
19767013|NCT03341273|42219879|FG001|Overall Study|Withdrawal by Subject|2|||
19767014|NCT03341273|42219878|FG000|Overall Study|Physician Decision|1|||
19767015|NCT03341273|42219879|FG001|Overall Study|Physician Decision|0|||
19767016|NCT03341273|42219878|FG000|Overall Study|Protocol Violation|0|||
19767017|NCT03341273|42219879|FG001|Overall Study|Protocol Violation|1|||
19767018|NCT03341273|42219878|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
19767019|NCT03341273|42219879|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
19767020|NCT03341273|42219878|FG000|Overall Study|Became ineligible after enrollment|1|||
19767021|NCT03341273|42219879|FG001|Overall Study|Became ineligible after enrollment|0|||
19767022|NCT03341273|42219878|FG000|Overall Study|Not Eligible at Enrollment|0|||
19767023|NCT03341273|42219879|FG001|Overall Study|Not Eligible at Enrollment|1|||
19767024|NCT03341273|42219878|FG000|Overall Study|Participant incarcerated|1|||
19767025|NCT03341273|42219879|FG001|Overall Study|Participant incarcerated|0|||
19767026|NCT01345058|42219887|FG000|Overall Study|Withdrawal by Subject|1|||
19767027|NCT01345058|42219888|FG001|Overall Study|Withdrawal by Subject|0|||
19767028|NCT01345058|42219887|FG000|Overall Study|Participant Reported Increase in Events|1|||
19767029|NCT01345058|42219888|FG001|Overall Study|Participant Reported Increase in Events|0|||
19767030|NCT01345058|42219887|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
19767031|NCT01345058|42219888|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
19767032|NCT01345058|42219887|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
19767033|NCT01345058|42219888|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
19767034|NCT01345058|42219887|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
19767035|NCT01345058|42219888|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
19767036|NCT01345292|42219897|FG000|Overall Study|Withdrawal by Subject|2|||
19767037|NCT01345292|42219898|FG001|Overall Study|Withdrawal by Subject|0|||
19767038|NCT01345292|42219899|FG002|Overall Study|Withdrawal by Subject|1|||
19767039|NCT03340961|42219911|FG000|Overall Study|Adverse Event|1|||
19767040|NCT03340961|42219912|FG001|Overall Study|Adverse Event|3|||
19767041|NCT03340961|42219913|FG002|Overall Study|Adverse Event|2|||
19767042|NCT03340961|42219914|FG003|Overall Study|Adverse Event|4|||
19767043|NCT03340961|42219911|FG000|Overall Study|Lost to Follow-up|0|||
19767044|NCT03340961|42219912|FG001|Overall Study|Lost to Follow-up|1|||
19767045|NCT03340961|42219913|FG002|Overall Study|Lost to Follow-up|0|||
19767046|NCT03340961|42219914|FG003|Overall Study|Lost to Follow-up|1|||
19767047|NCT03340961|42219911|FG000|Overall Study|Withdrawal by Subject|3|||
19767048|NCT03340961|42219912|FG001|Overall Study|Withdrawal by Subject|2|||
19767049|NCT03340961|42219913|FG002|Overall Study|Withdrawal by Subject|4|||
19767050|NCT03340961|42219914|FG003|Overall Study|Withdrawal by Subject|7|||
19767051|NCT03340961|42219911|FG000|Overall Study|Use of prohibited treatment|0|||
19767052|NCT03340961|42219912|FG001|Overall Study|Use of prohibited treatment|3|||
19767053|NCT03340961|42219913|FG002|Overall Study|Use of prohibited treatment|2|||
19767054|NCT03340961|42219914|FG003|Overall Study|Use of prohibited treatment|4|||
19767055|NCT03340961|42219911|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
19767056|NCT03340961|42219912|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
19767057|NCT03340961|42219913|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
19767058|NCT03340961|42219914|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
19767059|NCT03340961|42219911|FG000|Overall Study|Subject developed an exclusion criterion|0|||
19604547|NCT01023581|42053420|FG004|Overall Study|Lack of Efficacy|1|||
19767060|NCT03340961|42219912|FG001|Overall Study|Subject developed an exclusion criterion|1|||
19767061|NCT03340961|42219913|FG002|Overall Study|Subject developed an exclusion criterion|0|||
19767062|NCT03340961|42219914|FG003|Overall Study|Subject developed an exclusion criterion|0|||
19767063|NCT03340961|42219911|FG000|Overall Study|Protocol Violation|1|||
19767064|NCT03340961|42219912|FG001|Overall Study|Protocol Violation|0|||
19767065|NCT03340961|42219913|FG002|Overall Study|Protocol Violation|1|||
19767066|NCT03340961|42219914|FG003|Overall Study|Protocol Violation|0|||
19767067|NCT03340961|42219911|FG000|Overall Study|Adverse Event|1|||
19767068|NCT03340961|42219912|FG001|Overall Study|Adverse Event|1|||
19767069|NCT03340961|42219913|FG002|Overall Study|Adverse Event|0|||
19767070|NCT03340961|42219914|FG003|Overall Study|Adverse Event|0|||
19767071|NCT03340961|42219911|FG000|Overall Study|Lack of Efficacy|0|||
19767072|NCT03340961|42219912|FG001|Overall Study|Lack of Efficacy|0|||
19767073|NCT03340961|42219913|FG002|Overall Study|Lack of Efficacy|0|||
19767074|NCT03340961|42219914|FG003|Overall Study|Lack of Efficacy|1|||
19767075|NCT03340025|42219926|FG000|Overall Study|Lost to Follow-up|2|||
19767076|NCT03340025|42219927|FG001|Overall Study|Lost to Follow-up|2|||
19767077|NCT03339713|42219935|FG000|Overall Study|Lost to Follow-up|2|||
19767078|NCT03339713|42219936|FG001|Overall Study|Lost to Follow-up|1|||
19767079|NCT03339713|42219935|FG000|Overall Study|Protocol Violation|1|||
19767080|NCT03339713|42219936|FG001|Overall Study|Protocol Violation|0|||
19767081|NCT03339713|42219935|FG000|Overall Study|Withdrawal by Subject|1|||
19767082|NCT03339713|42219936|FG001|Overall Study|Withdrawal by Subject|1|||
19767083|NCT03254485|42219948|FG000|Overall Study|Adverse Event|3|||
19767084|NCT03254485|42219949|FG001|Overall Study|Adverse Event|0|||
19767085|NCT03254485|42219950|FG002|Overall Study|Adverse Event|0|||
19767086|NCT03254485|42219951|FG003|Overall Study|Adverse Event|6|||
19767087|NCT03254485|42219948|FG000|Overall Study|Protocol Violation|6|||
19767088|NCT03254485|42219949|FG001|Overall Study|Protocol Violation|0|||
19767089|NCT03254485|42219950|FG002|Overall Study|Protocol Violation|0|||
19767090|NCT03254485|42219951|FG003|Overall Study|Protocol Violation|2|||
19767091|NCT03254485|42219948|FG000|Overall Study|Withdrawal by Subject|1|||
19767092|NCT03254485|42219949|FG001|Overall Study|Withdrawal by Subject|0|||
19767093|NCT03254485|42219950|FG002|Overall Study|Withdrawal by Subject|0|||
19767094|NCT03254485|42219951|FG003|Overall Study|Withdrawal by Subject|4|||
19767095|NCT03254485|42219948|FG000|Overall Study|Death|0|||
19767096|NCT03254485|42219949|FG001|Overall Study|Death|0|||
19767097|NCT03254485|42219950|FG002|Overall Study|Death|0|||
19767098|NCT03254485|42219951|FG003|Overall Study|Death|1|||
19767099|NCT03254485|42219948|FG000|Overall Study|Lost to Follow-up|1|||
19767100|NCT03254485|42219949|FG001|Overall Study|Lost to Follow-up|0|||
19767101|NCT03254485|42219950|FG002|Overall Study|Lost to Follow-up|0|||
19767102|NCT03254485|42219951|FG003|Overall Study|Lost to Follow-up|0|||
19767103|NCT03254485|42219948|FG000|Overall Study|Other|1|||
19767104|NCT03254485|42219949|FG001|Overall Study|Other|0|||
19767105|NCT03254485|42219950|FG002|Overall Study|Other|0|||
19767106|NCT03254485|42219951|FG003|Overall Study|Other|2|||
19767107|NCT03339401|42219974|FG000|Overall Study|Death|2|||
19767108|NCT03339401|42219975|FG001|Overall Study|Death|1|||
19767109|NCT03339401|42219974|FG000|Overall Study|Withdrawal by Subject|2|||
19767110|NCT03339401|42219975|FG001|Overall Study|Withdrawal by Subject|0|||
19767111|NCT03339401|42219974|FG000|Overall Study|Study terminated|4|||
19767112|NCT03339401|42219975|FG001|Overall Study|Study terminated|3|||
19767113|NCT03339401|42219974|FG000|Overall Study|Investigator Decision|1|||
19767114|NCT03339401|42219975|FG001|Overall Study|Investigator Decision|0|||
19767115|NCT03370289|42219981|FG000|Overall Study|Screen Failure|1|||
19767116|NCT03370289|42219981|FG000|Overall Study|Sample Size Sufficient|4|||
19767117|NCT01344824|42219985|FG000|Overall Study|Adverse Event|15|||
19767118|NCT01344824|42219985|FG000|Overall Study|Withdrawal by Subject|6|||
19767119|NCT01344824|42219985|FG000|Overall Study|Other complicating disease|1|||
19767120|NCT01344824|42219985|FG000|Overall Study|Progression|15|||
19767121|NCT03339245|42219992|FG000|Overall Study|Adverse Event|1|||
19767122|NCT03339245|42219993|FG001|Overall Study|Adverse Event|1|||
19767123|NCT03339245|42219992|FG000|Overall Study|Withdrawal by Subject|1|||
19767124|NCT03339245|42219993|FG001|Overall Study|Withdrawal by Subject|0|||
19767125|NCT03044574|42220001|FG000|Overall Study|Lost to Follow-up|37|||
19767126|NCT03044574|42220002|FG001|Overall Study|Lost to Follow-up|45|||
19767127|NCT02959892|42220010|FG000|Overall Study|PET tracer synthesis failure|1|||
19767128|NCT02959892|42220011|FG001|Overall Study|PET tracer synthesis failure|0|||
19767129|NCT02959892|42220010|FG000|Overall Study|Study termination|0|||
19767130|NCT02959892|42220011|FG001|Overall Study|Study termination|1|||
19767131|NCT03252145|42220019|FG000|Overall Study|Withdrawal by Subject|1|||
19767132|NCT03252145|42220020|FG001|Overall Study|Withdrawal by Subject|0|||
19767133|NCT03252145|42220019|FG000|Overall Study|Complicating Disease|1|||
19767134|NCT03252145|42220020|FG001|Overall Study|Complicating Disease|2|||
19767135|NCT02959814|42220026|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
19767136|NCT02959814|42220026|FG000|Overall Study|Excluded based on anatomical criteria|2|||
19767137|NCT02959814|42220026|FG000|Overall Study|Protocol Violation|7|||
19767138|NCT02959814|42220026|FG000|Overall Study|FFR not measured|2|||
19767139|NCT02959814|42220026|FG000|Overall Study|In-procedure QFR not computed|6|||
19767140|NCT02959814|42220026|FG000|Overall Study|Excluded by FFR core-lab|24|||
19767141|NCT03666624|42220033|FG000|Overall Study|participant grieving over recent death of parent|1|||
19767142|NCT03666624|42220034|FG001|Overall Study|participant grieving over recent death of parent|0|||
19767143|NCT03368807|42220040|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
19767144|NCT03368807|42220040|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
19767145|NCT03368807|42220040|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
19767146|NCT03368807|42220040|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
19767147|NCT03338855|42220048|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
19767148|NCT03338855|42220049|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
19767149|NCT03367793|42220061|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
19767150|NCT03367793|42220062|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
19767151|NCT03367793|42220063|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
19767152|NCT03367793|42220064|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
19767153|NCT03367793|42220065|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
19767154|NCT03367793|42220066|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
19767155|NCT01347307|42220088|FG000|Overall Study|Death|0|||
19767156|NCT01347307|42220089|FG001|Overall Study|Death|4|||
19767157|NCT01347307|42220088|FG000|Overall Study|Physician Decision|0|||
19767158|NCT01347307|42220089|FG001|Overall Study|Physician Decision|1|||
19767159|NCT03247543|42220146|FG000|Overall Study|Adverse Event|3|||
19767160|NCT03247543|42220147|FG001|Overall Study|Adverse Event|6|||
19767161|NCT03247543|42220148|FG002|Overall Study|Adverse Event|4|||
19767162|NCT03247543|42220146|FG000|Overall Study|Lost to Follow-up|10|||
19767163|NCT03247543|42220147|FG001|Overall Study|Lost to Follow-up|7|||
19767164|NCT03247543|42220148|FG002|Overall Study|Lost to Follow-up|8|||
19767165|NCT03247543|42220146|FG000|Overall Study|Consent withdrawn by caregiver|2|||
19767166|NCT03247543|42220147|FG001|Overall Study|Consent withdrawn by caregiver|2|||
19767167|NCT03247543|42220148|FG002|Overall Study|Consent withdrawn by caregiver|9|||
19767168|NCT03247543|42220146|FG000|Overall Study|Withdrawal by Subject|0|||
19767169|NCT03247543|42220147|FG001|Overall Study|Withdrawal by Subject|0|||
19767170|NCT03247543|42220148|FG002|Overall Study|Withdrawal by Subject|1|||
19767171|NCT03247543|42220146|FG000|Overall Study|Failure to Follow study procedures|1|||
19767172|NCT03247543|42220147|FG001|Overall Study|Failure to Follow study procedures|3|||
19767173|NCT03247543|42220148|FG002|Overall Study|Failure to Follow study procedures|1|||
19767174|NCT03247543|42220146|FG000|Overall Study|Lack of Efficacy|1|||
19767175|NCT03247543|42220147|FG001|Overall Study|Lack of Efficacy|0|||
19767176|NCT03247543|42220148|FG002|Overall Study|Lack of Efficacy|0|||
19767177|NCT03247543|42220146|FG000|Overall Study|Non-compliance with study visits|0|||
19767178|NCT03247543|42220147|FG001|Overall Study|Non-compliance with study visits|1|||
19767179|NCT03247543|42220148|FG002|Overall Study|Non-compliance with study visits|0|||
19767180|NCT01347073|42220158|FG000|Overall Study|Adverse Event|1|||
19767181|NCT01347073|42220158|FG000|Overall Study|Liver Transplant|1|||
19767182|NCT01315236|42220170|FG000|Double-blind Phase|Death|1|||
19767183|NCT01315236|42220171|FG001|Double-blind Phase|Death|0|||
19767184|NCT01315236|42220170|FG000|Double-blind Phase|Adverse Event|1|||
19767185|NCT01315236|42220171|FG001|Double-blind Phase|Adverse Event|0|||
19767186|NCT01315236|42220170|FG000|Double-blind Phase|Withdrawal of Consent|1|||
19767187|NCT01315236|42220171|FG001|Double-blind Phase|Withdrawal of Consent|0|||
19767188|NCT01315236|42220170|FG000|Double-blind Phase|Lost to Follow-up|1|||
19767189|NCT01315236|42220171|FG001|Double-blind Phase|Lost to Follow-up|0|||
19767190|NCT01315236|42220170|FG000|Open-label Phase|Death|1|||
19767191|NCT01315236|42220171|FG001|Open-label Phase|Death|0|||
19767192|NCT01315236|42220170|FG000|Open-label Phase|Adverse Event|0|||
19767193|NCT01315236|42220171|FG001|Open-label Phase|Adverse Event|1|||
19767194|NCT01315236|42220170|FG000|Open-label Phase|Other|0|||
19767195|NCT01315236|42220171|FG001|Open-label Phase|Other|1|||
19767196|NCT01315236|42220170|FG000|12-Month Follow-up Period|Death|0|||
19767197|NCT01315236|42220171|FG001|12-Month Follow-up Period|Death|1|||
19767198|NCT01315236|42220170|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
19767199|NCT01315236|42220171|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
19767200|NCT03232567|42220183|FG000|Overall Study|Withdrawal by Subject|0|||
19767201|NCT03232567|42220184|FG001|Overall Study|Withdrawal by Subject|1|||
19767202|NCT03232567|42220185|FG002|Overall Study|Withdrawal by Subject|0|||
19767203|NCT03232567|42220186|FG003|Overall Study|Withdrawal by Subject|0|||
19767204|NCT01348490|42220207|FG000|Overall Study|Death|1|||
19767205|NCT01348490|42220207|FG000|Overall Study|Adverse Event|3|||
19767206|NCT01348490|42220207|FG000|Overall Study|Consent withdrawn|7|||
19767207|NCT01348490|42220207|FG000|Overall Study|Disease progression|3|||
19767208|NCT01348490|42220207|FG000|Overall Study|Lost to Follow-up|1|||
19767209|NCT01348490|42220207|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
19767210|NCT01348490|42220207|FG000|Overall Study|Other Unspecified|8|||
19767211|NCT03040674|42220228|FG000|Overall Study|Lost to Follow-up|225|||
19767212|NCT03040674|42220228|FG000|Overall Study|Death|23|||
19767213|NCT03232333|42220233|FG000|Overall Study|Infection or Osteomyelitis|9|||
19767214|NCT03232333|42220233|FG000|Overall Study|Lost to Follow-up|4|||
19767215|NCT03232333|42220233|FG000|Overall Study|Withdrawal by Subject|2|||
19767216|NCT03364049|42220241|FG000|Overall Study|Death|6|||
19767217|NCT03364049|42220242|FG001|Overall Study|Death|4|||
19767218|NCT03364049|42220243|FG002|Overall Study|Death|5|||
19767219|NCT03364049|42220244|FG003|Overall Study|Death|14|||
19767220|NCT03364049|42220241|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
19767221|NCT03364049|42220242|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
19767222|NCT03364049|42220243|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
19767223|NCT03364049|42220244|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
19767224|NCT03364049|42220241|FG000|Overall Study|Withdrawal by Subject|0|||
19767225|NCT03364049|42220242|FG001|Overall Study|Withdrawal by Subject|1|||
19767226|NCT03364049|42220243|FG002|Overall Study|Withdrawal by Subject|1|||
19767227|NCT03364049|42220244|FG003|Overall Study|Withdrawal by Subject|1|||
19767228|NCT03238963|42220256|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
19767229|NCT03238963|42220257|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
19767230|NCT03238963|42220256|FG000|Overall Study|Withdrawal by Subject|1|||
19767231|NCT03238963|42220257|FG001|Overall Study|Withdrawal by Subject|1|||
19767232|NCT03238963|42220256|FG000|Overall Study|Lost to Follow-up|1|||
19767233|NCT03238963|42220257|FG001|Overall Study|Lost to Follow-up|0|||
19767234|NCT03238963|42220256|FG000|Overall Study|Protocol Violation|1|||
19767235|NCT03238963|42220257|FG001|Overall Study|Protocol Violation|1|||
19767236|NCT03238963|42220256|FG000|Overall Study|Adverse Event|1|||
19767237|NCT03238963|42220257|FG001|Overall Study|Adverse Event|0|||
19767238|NCT03337139|42220265|FG000|Phase I|Withdrawal by Subject|10|||
19767239|NCT03337139|42220266|FG001|Phase I|Withdrawal by Subject|0|||
19767240|NCT03042312|42220274|FG000|Overall Study|Administrative Reason|1|||
19767241|NCT03042312|42220275|FG001|Overall Study|Administrative Reason|1|||
19767242|NCT03042312|42220274|FG000|Overall Study|Adverse Event|0|||
19767243|NCT03042312|42220275|FG001|Overall Study|Adverse Event|1|||
19767244|NCT03042312|42220274|FG000|Overall Study|Lost to Follow-up|1|||
19767245|NCT03042312|42220275|FG001|Overall Study|Lost to Follow-up|3|||
19767246|NCT03042312|42220274|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
19767247|NCT03042312|42220275|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
19767248|NCT03042312|42220274|FG000|Overall Study|Withdrawal by Subject|4|||
19767249|NCT03042312|42220275|FG001|Overall Study|Withdrawal by Subject|5|||
19767250|NCT03360071|42220283|FG000|Overall Study|Lost to Follow-up|1|||
19767251|NCT03360071|42220284|FG001|Overall Study|Lost to Follow-up|0|||
19767252|NCT02949011|42220293|FG000|Overall Study|Adverse Event|6|||
19767253|NCT02949011|42220294|FG001|Overall Study|Adverse Event|7|||
19767254|NCT02949011|42220295|FG002|Overall Study|Adverse Event|3|||
19767255|NCT02949011|42220293|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
19767256|NCT02949011|42220294|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
19767257|NCT02949011|42220295|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
19767258|NCT02949011|42220293|FG000|Overall Study|Protocol Deviation|5|||
19767259|NCT02949011|42220294|FG001|Overall Study|Protocol Deviation|3|||
19767260|NCT02949011|42220295|FG002|Overall Study|Protocol Deviation|3|||
19767261|NCT02949011|42220293|FG000|Overall Study|Lack of Efficacy|0|||
19767262|NCT02949011|42220294|FG001|Overall Study|Lack of Efficacy|2|||
19767263|NCT02949011|42220295|FG002|Overall Study|Lack of Efficacy|0|||
19767264|NCT02949011|42220293|FG000|Overall Study|Withdrawal by Subject|13|||
19767265|NCT02949011|42220294|FG001|Overall Study|Withdrawal by Subject|13|||
19767266|NCT02949011|42220295|FG002|Overall Study|Withdrawal by Subject|21|||
19767267|NCT02949011|42220293|FG000|Overall Study|Lost to Follow-up|7|||
19767268|NCT02949011|42220294|FG001|Overall Study|Lost to Follow-up|5|||
19767269|NCT02949011|42220295|FG002|Overall Study|Lost to Follow-up|5|||
19681606|NCT00348309|42128919|FG001|Overall Study|Death of caregiver|0|||
19681607|NCT00348309|42128920|FG002|Overall Study|Death of caregiver|1|||
19681608|NCT00348309|42128918|FG000|Overall Study|Lack of insight, dementia|1|||
19681609|NCT00348309|42128919|FG001|Overall Study|Lack of insight, dementia|0|||
19681610|NCT00348309|42128920|FG002|Overall Study|Lack of insight, dementia|0|||
19681611|NCT00348309|42128918|FG000|Overall Study|Wrong bottle allocated|1|||
19681612|NCT00348309|42128919|FG001|Overall Study|Wrong bottle allocated|0|||
19681613|NCT00348309|42128920|FG002|Overall Study|Wrong bottle allocated|0|||
19681614|NCT00348309|42128918|FG000|Overall Study|Caregiver sick|1|||
19681615|NCT00348309|42128919|FG001|Overall Study|Caregiver sick|0|||
19681616|NCT00348309|42128920|FG002|Overall Study|Caregiver sick|0|||
19767270|NCT02949011|42220293|FG000|Overall Study|Death|0|||
19767271|NCT02949011|42220294|FG001|Overall Study|Death|0|||
19767272|NCT02949011|42220295|FG002|Overall Study|Death|1|||
19767273|NCT02949011|42220293|FG000|Overall Study|Miscellaneous|2|||
19767274|NCT02949011|42220294|FG001|Overall Study|Miscellaneous|4|||
19767275|NCT02949011|42220295|FG002|Overall Study|Miscellaneous|6|||
19767276|NCT03357731|42220307|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
19767277|NCT03357731|42220308|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
19767278|NCT03357731|42220309|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
19767279|NCT03357731|42220310|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
19767280|NCT03357731|42220311|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
19767281|NCT03357731|42220312|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
19767282|NCT03357731|42220307|FG000|Overall Study|Acute bradycardia and hypotension|0|||
19767283|NCT03357731|42220308|FG001|Overall Study|Acute bradycardia and hypotension|0|||
19767284|NCT03357731|42220309|FG002|Overall Study|Acute bradycardia and hypotension|0|||
19767285|NCT03357731|42220310|FG003|Overall Study|Acute bradycardia and hypotension|1|||
19767286|NCT03357731|42220311|FG004|Overall Study|Acute bradycardia and hypotension|0|||
19767287|NCT03357731|42220312|FG005|Overall Study|Acute bradycardia and hypotension|0|||
19767288|NCT03357731|42220307|FG000|Overall Study|Adverse Event|0|||
19767289|NCT03357731|42220308|FG001|Overall Study|Adverse Event|0|||
19767290|NCT03357731|42220309|FG002|Overall Study|Adverse Event|0|||
19767291|NCT03357731|42220310|FG003|Overall Study|Adverse Event|0|||
19767292|NCT03357731|42220311|FG004|Overall Study|Adverse Event|0|||
19767293|NCT03357731|42220312|FG005|Overall Study|Adverse Event|1|||
19767294|NCT03357731|42220307|FG000|Overall Study|Hypotension|0|||
19767295|NCT03357731|42220308|FG001|Overall Study|Hypotension|0|||
19767296|NCT03357731|42220309|FG002|Overall Study|Hypotension|1|||
19767297|NCT03357731|42220310|FG003|Overall Study|Hypotension|1|||
19767298|NCT03357731|42220311|FG004|Overall Study|Hypotension|0|||
19767299|NCT03357731|42220312|FG005|Overall Study|Hypotension|0|||
19767300|NCT03357731|42220307|FG000|Overall Study|Lost to Follow-up|0|||
19767301|NCT03357731|42220308|FG001|Overall Study|Lost to Follow-up|0|||
19767302|NCT03357731|42220309|FG002|Overall Study|Lost to Follow-up|0|||
19767303|NCT03357731|42220310|FG003|Overall Study|Lost to Follow-up|1|||
19767304|NCT03357731|42220311|FG004|Overall Study|Lost to Follow-up|0|||
19767305|NCT03357731|42220312|FG005|Overall Study|Lost to Follow-up|0|||
19767306|NCT03357341|42220322|FG000|Overall Study|Withdrawal by Subject|3|||
19767307|NCT03357341|42220323|FG001|Overall Study|Withdrawal by Subject|6|||
19767308|NCT03357341|42220322|FG000|Overall Study|Lost to Follow-up|4|||
19767309|NCT03357341|42220323|FG001|Overall Study|Lost to Follow-up|5|||
19767310|NCT03357341|42220322|FG000|Overall Study|Death|0|||
19767311|NCT03357341|42220323|FG001|Overall Study|Death|1|||
19767312|NCT03039738|42220332|FG000|Overall Study|Incomplete data sets|54|||
19767313|NCT03039738|42220333|FG001|Overall Study|Incomplete data sets|0|||
19767314|NCT02946515|42220350|FG000|Overall Study|Lost to Follow-up|2|||
19767315|NCT02946515|42220351|FG001|Overall Study|Lost to Follow-up|1|||
19767316|NCT03036852|42220363|FG000|Overall Study|Death|2|||
19767317|NCT03036852|42220363|FG000|Overall Study|Lack of Efficacy|2|||
19767318|NCT03036852|42220363|FG000|Overall Study|Adverse Event|1|||
19767319|NCT03036852|42220363|FG000|Overall Study|Lost to Follow-up|1|||
19767320|NCT02945657|42220374|FG000|Overall Study|Adverse Event|1|||
19767321|NCT02945657|42220374|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
19767322|NCT02948777|42220379|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
19681617|NCT00348309|42128918|FG000|Overall Study|Use of prohibited medication|5|||
19681618|NCT00348309|42128919|FG001|Overall Study|Use of prohibited medication|2|||
19681619|NCT00348309|42128920|FG002|Overall Study|Use of prohibited medication|2|||
19681620|NCT00348309|42128918|FG000|Overall Study|Caregiver withdrawal|3|||
19681621|NCT00348309|42128919|FG001|Overall Study|Caregiver withdrawal|0|||
19681622|NCT00348309|42128920|FG002|Overall Study|Caregiver withdrawal|7|||
19681623|NCT00348309|42128918|FG000|Overall Study|Unable to complete ET visit|1|||
19681624|NCT00348309|42128919|FG001|Overall Study|Unable to complete ET visit|0|||
19681625|NCT00348309|42128920|FG002|Overall Study|Unable to complete ET visit|0|||
19681626|NCT00348309|42128918|FG000|Overall Study|PI closing medical practice|1|||
19681627|NCT00348309|42128919|FG001|Overall Study|PI closing medical practice|0|||
19681628|NCT00348309|42128920|FG002|Overall Study|PI closing medical practice|0|||
19681629|NCT00348309|42128918|FG000|Overall Study|Principal investigator's decision|1|||
19681630|NCT00348309|42128919|FG001|Overall Study|Principal investigator's decision|0|||
19681631|NCT00348309|42128920|FG002|Overall Study|Principal investigator's decision|0|||
19681632|NCT00348309|42128918|FG000|Overall Study|No disponibility of medication|1|||
19681633|NCT00348309|42128919|FG001|Overall Study|No disponibility of medication|0|||
19681634|NCT00348309|42128920|FG002|Overall Study|No disponibility of medication|0|||
19681635|NCT00348309|42128918|FG000|Overall Study|Worsened neurodegenerative disease|1|||
19767323|NCT03324581|42220387|FG000|Overall Study|Adverse Event|18|||
19767324|NCT03324581|42220388|FG001|Overall Study|Adverse Event|11|||
19767325|NCT03324581|42220389|FG002|Overall Study|Adverse Event|7|||
19767326|NCT03324581|42220387|FG000|Overall Study|Lack of Efficacy|0|||
19681636|NCT00348309|42128919|FG001|Overall Study|Worsened neurodegenerative disease|0|||
19767327|NCT03324581|42220388|FG001|Overall Study|Lack of Efficacy|1|||
19767328|NCT03324581|42220389|FG002|Overall Study|Lack of Efficacy|0|||
19767329|NCT03324581|42220387|FG000|Overall Study|Lost to Follow-up|5|||
19767330|NCT03324581|42220388|FG001|Overall Study|Lost to Follow-up|3|||
19767331|NCT03324581|42220389|FG002|Overall Study|Lost to Follow-up|6|||
19767332|NCT03324581|42220387|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
19767333|NCT03324581|42220388|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
19767334|NCT03324581|42220389|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
19767335|NCT03324581|42220387|FG000|Overall Study|Physician Decision|0|||
19767336|NCT03324581|42220388|FG001|Overall Study|Physician Decision|1|||
19767337|NCT03324581|42220389|FG002|Overall Study|Physician Decision|2|||
19767338|NCT03324581|42220387|FG000|Overall Study|Protocol Deviation|8|||
19767339|NCT03324581|42220388|FG001|Overall Study|Protocol Deviation|9|||
19767340|NCT03324581|42220389|FG002|Overall Study|Protocol Deviation|4|||
19767341|NCT03324581|42220387|FG000|Overall Study|Withdrawal by Subject|6|||
19767342|NCT03324581|42220388|FG001|Overall Study|Withdrawal by Subject|8|||
19767343|NCT03324581|42220389|FG002|Overall Study|Withdrawal by Subject|6|||
19767344|NCT03324581|42220387|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
19767345|NCT03324581|42220388|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
19767346|NCT03324581|42220389|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
19767347|NCT02943473|42220397|FG000|Overall Study|enrolled but not dosed|1|||
19767348|NCT02943473|42220397|FG000|Overall Study|screen failure|1|||
19767349|NCT02943473|42220397|FG000|Overall Study|Physician Decision|4|||
19767350|NCT03073733|42220404|FG000|Overall Study|Lost to Follow-up|1|||
19767351|NCT03073733|42220405|FG001|Overall Study|Lost to Follow-up|0|||
19767352|NCT03073733|42220406|FG002|Overall Study|Lost to Follow-up|0|||
19767353|NCT03073733|42220404|FG000|Overall Study|Physician Decision|0|||
19767354|NCT03073733|42220405|FG001|Overall Study|Physician Decision|1|||
19767355|NCT03073733|42220406|FG002|Overall Study|Physician Decision|0|||
19767356|NCT03073733|42220404|FG000|Overall Study|Withdrawal by Subject|0|||
19767357|NCT03073733|42220405|FG001|Overall Study|Withdrawal by Subject|0|||
19767358|NCT03073733|42220406|FG002|Overall Study|Withdrawal by Subject|1|||
19767359|NCT03320369|42220416|FG000|Overall Study|Adverse Event|1|||
19767360|NCT03320369|42220416|FG000|Overall Study|Withdrawal by Subject|2|||
19767361|NCT02650895|42220426|FG000|Overall Study|Withdrawal by Subject|0|||
19767362|NCT02650895|42220427|FG001|Overall Study|Withdrawal by Subject|1|||
19767363|NCT02650895|42220428|FG002|Overall Study|Withdrawal by Subject|0|||
19767364|NCT02650895|42220429|FG003|Overall Study|Withdrawal by Subject|0|||
19767365|NCT02650895|42220430|FG004|Overall Study|Withdrawal by Subject|0|||
19767366|NCT02650895|42220431|FG005|Overall Study|Withdrawal by Subject|0|||
19767367|NCT03320057|42220450|FG000|Overall Study|Lost to Follow-up|4|||
19767368|NCT03320057|42220451|FG001|Overall Study|Lost to Follow-up|17|||
19767369|NCT03320057|42220450|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
19767370|NCT03320057|42220451|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
19767371|NCT03316547|42220459|FG000|Overall Study|Death|3|||
19767372|NCT03316547|42220460|FG001|Overall Study|Death|1|||
19767373|NCT03316547|42220459|FG000|Overall Study|Lost to Follow-up|6|||
19767374|NCT03316547|42220460|FG001|Overall Study|Lost to Follow-up|6|||
19767375|NCT03316547|42220459|FG000|Overall Study|Withdrawal by Subject|3|||
19767376|NCT03316547|42220460|FG001|Overall Study|Withdrawal by Subject|2|||
19767377|NCT03316547|42220459|FG000|Overall Study|Transfer to another hospital|6|||
19767378|NCT03316547|42220460|FG001|Overall Study|Transfer to another hospital|4|||
19767379|NCT02227199|42220484|FG000|Overall Study|Physician Decision|0|||
19767380|NCT02227199|42220485|FG001|Overall Study|Physician Decision|0|||
19767381|NCT02227199|42220486|FG002|Overall Study|Physician Decision|1|||
19767382|NCT02227199|42220484|FG000|Overall Study|Adverse Event|0|||
19767383|NCT02227199|42220485|FG001|Overall Study|Adverse Event|0|||
19767384|NCT02227199|42220486|FG002|Overall Study|Adverse Event|3|||
19767385|NCT03315689|42220500|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
19767386|NCT03315689|42220501|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
19767387|NCT03315689|42220500|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
19767388|NCT03315689|42220501|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
19767389|NCT03315689|42220500|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
19681637|NCT00348309|42128920|FG002|Overall Study|Worsened neurodegenerative disease|0|||
19681638|NCT00348309|42128918|FG000|Overall Study|Cognitive and behaviour worsening|2|||
19681639|NCT00348309|42128919|FG001|Overall Study|Cognitive and behaviour worsening|0|||
19681640|NCT00348309|42128920|FG002|Overall Study|Cognitive and behaviour worsening|0|||
19681641|NCT00348309|42128918|FG000|Overall Study|Worsening of alzheimer|1|||
19681642|NCT00348309|42128919|FG001|Overall Study|Worsening of alzheimer|0|||
19681643|NCT00348309|42128920|FG002|Overall Study|Worsening of alzheimer|1|||
19767390|NCT03315689|42220501|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
19767391|NCT03314519|42220511|FG000|Overall Study|Protocol Violation|3|||
19767392|NCT03314519|42220512|FG001|Overall Study|Protocol Violation|2|||
19767393|NCT03313037|42220524|FG000|Overall Study|Protocol Violation|4|||
19767394|NCT03313037|42220525|FG001|Overall Study|Protocol Violation|1|||
19681644|NCT00348309|42128918|FG000|Overall Study|Did not appear in time for Visit 3|1|||
19681645|NCT00348309|42128919|FG001|Overall Study|Did not appear in time for Visit 3|0|||
19681646|NCT00348309|42128920|FG002|Overall Study|Did not appear in time for Visit 3|0|||
19681647|NCT00348309|42128918|FG000|Overall Study|Participant died|2|||
19681648|NCT00348309|42128919|FG001|Overall Study|Participant died|1|||
19681649|NCT00348309|42128920|FG002|Overall Study|Participant died|1|||
19681650|NCT00348309|42128918|FG000|Overall Study|Decision of sponsor|1|||
19681651|NCT00348309|42128919|FG001|Overall Study|Decision of sponsor|0|||
19681652|NCT00348309|42128920|FG002|Overall Study|Decision of sponsor|0|||
19681653|NCT00348309|42128918|FG000|Overall Study|Ineffectiveness of treatment|0|||
19681654|NCT00348309|42128919|FG001|Overall Study|Ineffectiveness of treatment|1|||
19681655|NCT00348309|42128920|FG002|Overall Study|Ineffectiveness of treatment|0|||
19767395|NCT03313037|42220524|FG000|Overall Study|Other|1|||
19767396|NCT03313037|42220525|FG001|Overall Study|Other|1|||
19767397|NCT03313037|42220524|FG000|Overall Study|Withdrawal by Subject|4|||
19767398|NCT03313037|42220525|FG001|Overall Study|Withdrawal by Subject|3|||
19767399|NCT03313037|42220524|FG000|Overall Study|No longer meets eligibility criteria|1|||
19767400|NCT03313037|42220525|FG001|Overall Study|No longer meets eligibility criteria|7|||
19767401|NCT03313037|42220524|FG000|Overall Study|Lost to Follow-up|9|||
19767402|NCT03313037|42220525|FG001|Overall Study|Lost to Follow-up|8|||
19767403|NCT03313037|42220524|FG000|Overall Study|Randomized but not treated|1|||
19767404|NCT03313037|42220525|FG001|Overall Study|Randomized but not treated|0|||
19767405|NCT02420795|42220534|FG000|Overall Study|Withdrawal by Subject|1|||
19767406|NCT02420795|42220535|FG001|Overall Study|Withdrawal by Subject|0|||
19767407|NCT02420795|42220536|FG002|Overall Study|Withdrawal by Subject|0|||
19767408|NCT02420795|42220534|FG000|Overall Study|Adverse Event|1|||
19767409|NCT02420795|42220535|FG001|Overall Study|Adverse Event|0|||
19767410|NCT02420795|42220536|FG002|Overall Study|Adverse Event|0|||
19767411|NCT02420795|42220534|FG000|Overall Study|Progressive disease|2|||
19767412|NCT02420795|42220535|FG001|Overall Study|Progressive disease|2|||
19767413|NCT02420795|42220536|FG002|Overall Study|Progressive disease|4|||
19767414|NCT02420795|42220534|FG000|Overall Study|Death|0|||
19767415|NCT02420795|42220535|FG001|Overall Study|Death|0|||
19767416|NCT02420795|42220536|FG002|Overall Study|Death|1|||
19767417|NCT03334175|42220548|FG000|Overall Study|Lost to Follow-up|0|||
19767418|NCT03334175|42220549|FG001|Overall Study|Lost to Follow-up|1|||
19767419|NCT03333941|42220555|FG000|Overall Study|Lost to Follow-up|10|||
19767420|NCT03333941|42220555|FG000|Overall Study|Death|2|||
19767421|NCT03333941|42220555|FG000|Overall Study|Adverse Event|1|||
19767422|NCT02942771|42220564|FG000|Overall Study|Adverse Event|1|||
19767423|NCT02942771|42220565|FG001|Overall Study|Adverse Event|0|||
19767424|NCT02942771|42220566|FG002|Overall Study|Adverse Event|0|||
19767425|NCT02942771|42220567|FG003|Overall Study|Adverse Event|0|||
19767426|NCT02942771|42220568|FG004|Overall Study|Adverse Event|2|||
19681656|NCT00348309|42128918|FG000|Overall Study|A foul of exclusion criteria|0|||
19681657|NCT00348309|42128919|FG001|Overall Study|A foul of exclusion criteria|1|||
19681658|NCT00348309|42128920|FG002|Overall Study|A foul of exclusion criteria|0|||
19681659|NCT00348309|42128918|FG000|Overall Study|Participant was hospitalized|0|||
19681660|NCT00348309|42128919|FG001|Overall Study|Participant was hospitalized|1|||
19681661|NCT00348309|42128920|FG002|Overall Study|Participant was hospitalized|0|||
19681662|NCT00348309|42128918|FG000|Overall Study|Sponsor refuseal|0|||
19681663|NCT00348309|42128919|FG001|Overall Study|Sponsor refuseal|1|||
19681664|NCT00348309|42128920|FG002|Overall Study|Sponsor refuseal|1|||
19681665|NCT00348309|42128918|FG000|Overall Study|Forgot often medication|0|||
19681666|NCT00348309|42128919|FG001|Overall Study|Forgot often medication|1|||
19681667|NCT00348309|42128920|FG002|Overall Study|Forgot often medication|0|||
19681668|NCT00348309|42128918|FG000|Overall Study|Medical Monitor decision|0|||
19681669|NCT00348309|42128919|FG001|Overall Study|Medical Monitor decision|0|||
19681670|NCT00348309|42128920|FG002|Overall Study|Medical Monitor decision|1|||
19681671|NCT00348309|42128918|FG000|Overall Study|Increased dose of Aricept|0|||
19681672|NCT00348309|42128919|FG001|Overall Study|Increased dose of Aricept|0|||
19681673|NCT00348309|42128920|FG002|Overall Study|Increased dose of Aricept|1|||
19681674|NCT00348309|42128918|FG000|Overall Study|Site closure|0|||
19681675|NCT00348309|42128919|FG001|Overall Study|Site closure|0|||
19681676|NCT00348309|42128920|FG002|Overall Study|Site closure|1|||
19681677|NCT00348309|42128918|FG000|Overall Study|Adverse event not attended|0|||
19681678|NCT00348309|42128919|FG001|Overall Study|Adverse event not attended|0|||
19681679|NCT00348309|42128920|FG002|Overall Study|Adverse event not attended|1|||
19681680|NCT00348309|42128918|FG000|Overall Study|ECG abnormal|0|||
19767427|NCT02942771|42220564|FG000|Overall Study|Lost to Follow-up|1|||
19767428|NCT02942771|42220565|FG001|Overall Study|Lost to Follow-up|0|||
19767429|NCT02942771|42220566|FG002|Overall Study|Lost to Follow-up|0|||
19681681|NCT00348309|42128919|FG001|Overall Study|ECG abnormal|0|||
19681682|NCT00348309|42128920|FG002|Overall Study|ECG abnormal|2|||
19681683|NCT00348309|42128918|FG000|Overall Study|Cardiologist recommendations|0|||
19681684|NCT00348309|42128919|FG001|Overall Study|Cardiologist recommendations|0|||
19767430|NCT02942771|42220567|FG003|Overall Study|Lost to Follow-up|0|||
19767431|NCT02942771|42220568|FG004|Overall Study|Lost to Follow-up|0|||
19767432|NCT02942771|42220564|FG000|Overall Study|Withdrawal by Subject|1|||
19767433|NCT02942771|42220565|FG001|Overall Study|Withdrawal by Subject|0|||
19767434|NCT02942771|42220566|FG002|Overall Study|Withdrawal by Subject|0|||
19767435|NCT02942771|42220567|FG003|Overall Study|Withdrawal by Subject|0|||
19767436|NCT02942771|42220568|FG004|Overall Study|Withdrawal by Subject|2|||
19767437|NCT03036150|42220582|FG000|Overall Study|Withdrawal by Subject|8|||
19767438|NCT03036150|42220583|FG001|Overall Study|Withdrawal by Subject|3|||
19681685|NCT00348309|42128920|FG002|Overall Study|Cardiologist recommendations|1|||
19681686|NCT00348309|42128918|FG000|Overall Study|HCV career|0|||
19681687|NCT00348309|42128919|FG001|Overall Study|HCV career|0|||
19681688|NCT00348309|42128920|FG002|Overall Study|HCV career|1|||
19767439|NCT03036150|42220582|FG000|Overall Study|Lost to Follow-up|2|||
19767440|NCT03036150|42220583|FG001|Overall Study|Lost to Follow-up|2|||
19767441|NCT03332771|42220593|FG000|Overall Study|Adverse Event|6|||
19767442|NCT03332771|42220594|FG001|Overall Study|Adverse Event|4|||
19767443|NCT03332771|42220595|FG002|Overall Study|Adverse Event|1|||
19767444|NCT03332771|42220596|FG003|Overall Study|Adverse Event|3|||
19767445|NCT03332771|42220593|FG000|Overall Study|Poor Compliance to Protocol|0|||
19767446|NCT03332771|42220594|FG001|Overall Study|Poor Compliance to Protocol|1|||
19767447|NCT03332771|42220595|FG002|Overall Study|Poor Compliance to Protocol|0|||
19767448|NCT03332771|42220596|FG003|Overall Study|Poor Compliance to Protocol|1|||
19681689|NCT00440310|42128931|FG000|Overall Study|Lost to Follow-up|4|||
19681690|NCT00440310|42128932|FG001|Overall Study|Lost to Follow-up|5|||
19681691|NCT00440310|42128931|FG000|Overall Study|Protocol Violation|0|||
19681692|NCT00440310|42128932|FG001|Overall Study|Protocol Violation|1|||
19681693|NCT00440310|42128931|FG000|Overall Study|Withdrawal by Subject|15|||
19681694|NCT00440310|42128932|FG001|Overall Study|Withdrawal by Subject|14|||
19681695|NCT00440310|42128931|FG000|Overall Study|No Reply at EOS|7|||
19681696|NCT00440310|42128932|FG001|Overall Study|No Reply at EOS|7|||
19681697|NCT00440310|42128931|FG000|Overall Study|Other|1|||
19681698|NCT00440310|42128932|FG001|Overall Study|Other|0|||
19681699|NCT00440310|42128931|FG000|Overall Study|Status Unknown|1|||
19681700|NCT00440310|42128932|FG001|Overall Study|Status Unknown|3|||
19681701|NCT00440232|42128940|FG000|Overall Study|Lost to Follow-up|1|||
19681702|NCT00440232|42128941|FG001|Overall Study|Lost to Follow-up|1|||
19767449|NCT03332771|42220593|FG000|Overall Study|Lost to Follow-up|2|||
19767450|NCT03332771|42220594|FG001|Overall Study|Lost to Follow-up|2|||
19767451|NCT03332771|42220595|FG002|Overall Study|Lost to Follow-up|1|||
19767452|NCT03332771|42220596|FG003|Overall Study|Lost to Follow-up|2|||
19767453|NCT03332771|42220593|FG000|Overall Study|At the Participant's own request|20|||
19767454|NCT03332771|42220594|FG001|Overall Study|At the Participant's own request|26|||
19767455|NCT03332771|42220595|FG002|Overall Study|At the Participant's own request|14|||
19767456|NCT03332771|42220596|FG003|Overall Study|At the Participant's own request|23|||
19767457|NCT03332771|42220593|FG000|Overall Study|Reason Not Specified|6|||
19767458|NCT03332771|42220594|FG001|Overall Study|Reason Not Specified|18|||
19767459|NCT03332771|42220595|FG002|Overall Study|Reason Not Specified|16|||
19767460|NCT03332771|42220596|FG003|Overall Study|Reason Not Specified|19|||
19767461|NCT03310775|42220608|FG000|Overall Study|Lost to Follow-up|2|||
19767462|NCT03310775|42220609|FG001|Overall Study|Lost to Follow-up|3|||
19681703|NCT00440232|42128940|FG000|Overall Study|Unable to treat within allowed time|0|||
19681704|NCT00440232|42128941|FG001|Overall Study|Unable to treat within allowed time|1|||
19681705|NCT00440232|42128940|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
19681706|NCT00440232|42128941|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
19681707|NCT00356889|42128947|FG000|Overall Study|Protocol Violation|2|||
19681708|NCT00356889|42128947|FG000|Overall Study|Adverse Event|1|||
19681709|NCT00356811|42128952|FG000|Overall Study|Death|35|||
19681710|NCT00356811|42128952|FG000|Overall Study|Lost to Follow-up|2|||
19681711|NCT00356811|42128952|FG000|Overall Study|Withdrawal by Subject|6|||
19681712|NCT00356811|42128952|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
19681713|NCT00356811|42128952|FG000|Overall Study|Study Is Terminating|3|||
19681714|NCT00356811|42128952|FG000|Overall Study|Site Closed during Follow-up|2|||
19681715|NCT00439218|42128957|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
19681716|NCT00535223|42128976|FG000|Overall Study|Withdrawal by Subject|4|||
19681717|NCT00535223|42128977|FG001|Overall Study|Withdrawal by Subject|1|||
19681718|NCT00536939|42128983|FG000|Overall Study|Withdrawal by Subject|1|||
19681719|NCT00536939|42128984|FG001|Overall Study|Withdrawal by Subject|0|||
19767463|NCT03310775|42220608|FG000|Overall Study|aggravation of depression|0|||
19767464|NCT03310775|42220609|FG001|Overall Study|aggravation of depression|1|||
19767465|NCT03330119|42220621|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
19767466|NCT03330119|42220622|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
19681720|NCT00536939|42128983|FG000|Overall Study|Other Complicating Disease|1|||
19681721|NCT00536939|42128984|FG001|Overall Study|Other Complicating Disease|0|||
19681722|NCT00347919|42128992|FG000|Overall Study|Lost to Follow-up|11|||
19681723|NCT00347919|42128993|FG001|Overall Study|Lost to Follow-up|13|||
19681724|NCT00347919|42128994|FG002|Overall Study|Lost to Follow-up|0|||
19681725|NCT00347919|42128992|FG000|Overall Study|Withdrawal by Subject|6|||
19681726|NCT00347919|42128993|FG001|Overall Study|Withdrawal by Subject|8|||
19767467|NCT03040986|42220630|FG000|Overall Study|Hospice|1|||
19767468|NCT03040986|42220631|FG001|Overall Study|Hospice|0|||
19767469|NCT03040986|42220630|FG000|Overall Study|Adverse Event|2|||
19767470|NCT03040986|42220631|FG001|Overall Study|Adverse Event|1|||
19767471|NCT03040986|42220630|FG000|Overall Study|Disease progression on study|3|||
19767472|NCT03040986|42220631|FG001|Overall Study|Disease progression on study|1|||
19767473|NCT03039192|42220641|FG000|Overall Study|Lost to Follow-up|4|||
19767474|NCT03039192|42220642|FG001|Overall Study|Lost to Follow-up|4|||
19767475|NCT03039192|42220641|FG000|Overall Study|Adverse event, serious fatal|0|||
19767476|NCT03039192|42220642|FG001|Overall Study|Adverse event, serious fatal|1|||
19767477|NCT03039192|42220641|FG000|Overall Study|Adverse event, non-fatal|0|||
19767478|NCT03039192|42220642|FG001|Overall Study|Adverse event, non-fatal|2|||
19767479|NCT03039192|42220641|FG000|Overall Study|Withdrawal by Subject|6|||
19767480|NCT03039192|42220642|FG001|Overall Study|Withdrawal by Subject|9|||
19767481|NCT03039192|42220641|FG000|Overall Study|Discontinued from treatment phase|19|||
19767482|NCT03039192|42220642|FG001|Overall Study|Discontinued from treatment phase|12|||
19767483|NCT03039192|42220641|FG000|Overall Study|Other|3|||
19767484|NCT03039192|42220642|FG001|Overall Study|Other|2|||
19767485|NCT03698279|42220654|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19767486|NCT03698279|42220655|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19767487|NCT03698279|42220656|FG002|Overall Study|Withdrawal by parent/guardian|1|||
19767488|NCT03698279|42220657|FG003|Overall Study|Withdrawal by parent/guardian|1|||
19767489|NCT03698279|42220658|FG004|Overall Study|Withdrawal by parent/guardian|0|||
19767490|NCT03698279|42220659|FG005|Overall Study|Withdrawal by parent/guardian|0|||
19767491|NCT03698279|42220654|FG000|Overall Study|Protocol deviation|1|||
19767492|NCT03698279|42220655|FG001|Overall Study|Protocol deviation|0|||
19767493|NCT03698279|42220656|FG002|Overall Study|Protocol deviation|1|||
19767494|NCT03698279|42220657|FG003|Overall Study|Protocol deviation|0|||
19767495|NCT03698279|42220658|FG004|Overall Study|Protocol deviation|0|||
19767496|NCT03698279|42220659|FG005|Overall Study|Protocol deviation|0|||
19767497|NCT03698279|42220654|FG000|Overall Study|Withdrawal by Subject|0|||
19767498|NCT03698279|42220655|FG001|Overall Study|Withdrawal by Subject|0|||
19767499|NCT03698279|42220656|FG002|Overall Study|Withdrawal by Subject|1|||
19767500|NCT03698279|42220657|FG003|Overall Study|Withdrawal by Subject|0|||
19767501|NCT03698279|42220658|FG004|Overall Study|Withdrawal by Subject|0|||
19767502|NCT03698279|42220659|FG005|Overall Study|Withdrawal by Subject|0|||
19767503|NCT03698279|42220654|FG000|Overall Study|Lost to Follow-up|3|||
19767504|NCT03698279|42220655|FG001|Overall Study|Lost to Follow-up|1|||
19767505|NCT03698279|42220656|FG002|Overall Study|Lost to Follow-up|4|||
19767506|NCT03698279|42220657|FG003|Overall Study|Lost to Follow-up|5|||
19767507|NCT03698279|42220658|FG004|Overall Study|Lost to Follow-up|0|||
19767508|NCT03698279|42220659|FG005|Overall Study|Lost to Follow-up|0|||
19767509|NCT01529034|42220678|FG000|Overall Study|Discontinued prior to study treatment|14|||
19767510|NCT01529034|42220678|FG000|Overall Study|Site closure|62|||
19767511|NCT01529034|42220678|FG000|Overall Study|Study termination|29|||
19767512|NCT01529034|42220678|FG000|Overall Study|Withdrawal by Subject|25|||
19767513|NCT01529034|42220678|FG000|Overall Study|No treated SCs within protocol window|13|||
19767514|NCT01529034|42220678|FG000|Overall Study|Noncompliance|8|||
19767515|NCT01529034|42220678|FG000|Overall Study|Caregiver no longer available|7|||
19767516|NCT01529034|42220678|FG000|Overall Study|Adverse Event|4|||
19767517|NCT01529034|42220678|FG000|Overall Study|Protocol Violation|4|||
19767518|NCT01529034|42220678|FG000|Overall Study|Lack of Efficacy|4|||
19767519|NCT01529034|42220678|FG000|Overall Study|Investigator no longer available|2|||
19767520|NCT01529034|42220678|FG000|Overall Study|Study drug not available|2|||
19767521|NCT03036072|42220685|FG000|Overall Study|Death|0|||
19767522|NCT03036072|42220686|FG001|Overall Study|Death|1|||
19767523|NCT03036072|42220685|FG000|Overall Study|Withdrawal by Subject|0|||
19767524|NCT03036072|42220686|FG001|Overall Study|Withdrawal by Subject|1|||
19767525|NCT03036072|42220685|FG000|Overall Study|Physician Decision|0|||
19767526|NCT03036072|42220686|FG001|Overall Study|Physician Decision|1|||
19767527|NCT03038880|42220695|FG000|Overall Study|Death|1|||
19767528|NCT03038880|42220696|FG001|Overall Study|Death|2|||
19767529|NCT03038880|42220697|FG002|Overall Study|Death|0|||
19767530|NCT03038880|42220695|FG000|Overall Study|Physician Decision|2|||
19767531|NCT03038880|42220696|FG001|Overall Study|Physician Decision|1|||
19767532|NCT03038880|42220697|FG002|Overall Study|Physician Decision|0|||
19767533|NCT03035916|42220708|FG000|Overall Study|Puncture failed|0|||
19767534|NCT03035916|42220709|FG001|Overall Study|Puncture failed|2|||
19767535|NCT03035916|42220710|FG002|Overall Study|Puncture failed|0|||
19767536|NCT01702571|42220720|FG000|Overall Study|Death|1067|||
19767537|NCT01702571|42220721|FG001|Overall Study|Death|76|||
19767538|NCT01702571|42220720|FG000|Overall Study|Lost to Follow-up|144|||
19767539|NCT01702571|42220721|FG001|Overall Study|Lost to Follow-up|10|||
19767540|NCT01702571|42220720|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
19767541|NCT01702571|42220721|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
19767542|NCT01702571|42220720|FG000|Overall Study|Investigator Decision|5|||
19767543|NCT01702571|42220721|FG001|Overall Study|Investigator Decision|0|||
19767544|NCT01702571|42220720|FG000|Overall Study|Not Classifiable|1|||
19767545|NCT01702571|42220721|FG001|Overall Study|Not Classifiable|0|||
19767546|NCT01702571|42220720|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
19767547|NCT01702571|42220721|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
19767548|NCT01702571|42220720|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
19767549|NCT01702571|42220721|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
19767550|NCT01702571|42220720|FG000|Overall Study|Progressive Disease|3|||
19767551|NCT01702571|42220721|FG001|Overall Study|Progressive Disease|0|||
19767552|NCT01702571|42220720|FG000|Overall Study|Protocol Violation|2|||
19767553|NCT01702571|42220721|FG001|Overall Study|Protocol Violation|0|||
19767554|NCT01702571|42220720|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
19767555|NCT01702571|42220721|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
19767556|NCT01702571|42220720|FG000|Overall Study|Termination By Sponsor|4|||
19767557|NCT01702571|42220721|FG001|Overall Study|Termination By Sponsor|0|||
19767558|NCT01702571|42220720|FG000|Overall Study|Withdrawal by Subject|177|||
19767559|NCT01702571|42220721|FG001|Overall Study|Withdrawal by Subject|29|||
19767560|NCT03231943|42220744|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767561|NCT03231943|42220745|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
19767562|NCT03231943|42220746|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
19767563|NCT03231943|42220747|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767564|NCT03231943|42220748|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767565|NCT03231943|42220749|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767566|NCT03231943|42220750|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767567|NCT03231943|42220751|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767568|NCT03231943|42220752|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767569|NCT03231943|42220753|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767570|NCT03231943|42220754|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767571|NCT03231943|42220755|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767572|NCT03231943|42220756|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
19767573|NCT03231943|42220744|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19681727|NCT00347919|42128994|FG002|Overall Study|Withdrawal by Subject|0|||
19681728|NCT00347919|42128992|FG000|Overall Study|Physician Decision|1|||
19681729|NCT00347919|42128993|FG001|Overall Study|Physician Decision|1|||
19681730|NCT00347919|42128994|FG002|Overall Study|Physician Decision|0|||
19681731|NCT00347919|42128992|FG000|Overall Study|Sponsor terminated study|15|||
19681732|NCT00347919|42128993|FG001|Overall Study|Sponsor terminated study|10|||
19681733|NCT00347919|42128994|FG002|Overall Study|Sponsor terminated study|16|||
19681734|NCT00347919|42128992|FG000|Overall Study|Death|35|||
19767574|NCT03231943|42220745|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
19767575|NCT03231943|42220746|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767576|NCT03231943|42220747|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767577|NCT03231943|42220748|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767578|NCT03231943|42220749|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767579|NCT03231943|42220750|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767580|NCT03231943|42220751|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19681735|NCT00347919|42128993|FG001|Overall Study|Death|42|||
19681736|NCT00347919|42128994|FG002|Overall Study|Death|19|||
19681737|NCT00347919|42128992|FG000|Overall Study|Par. Started Other Treatment|1|||
19681738|NCT00347919|42128993|FG001|Overall Study|Par. Started Other Treatment|1|||
19681739|NCT00347919|42128994|FG002|Overall Study|Par. Started Other Treatment|1|||
19681740|NCT00347919|42128992|FG000|Overall Study|Missing|2|||
19681741|NCT00347919|42128993|FG001|Overall Study|Missing|1|||
19681742|NCT00347919|42128994|FG002|Overall Study|Missing|2|||
19681743|NCT00439140|42129007|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
19681744|NCT00439140|42129008|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
19681745|NCT00439140|42129009|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
19681746|NCT00439140|42129007|FG000|Treatment Cycle 1|Personal reasons|0|||
19681747|NCT00439140|42129008|FG001|Treatment Cycle 1|Personal reasons|2|||
19681748|NCT00439140|42129009|FG002|Treatment Cycle 1|Personal reasons|0|||
19681749|NCT00439140|42129007|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
19681750|NCT00439140|42129008|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
19681751|NCT00439140|42129009|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
19681752|NCT00439140|42129007|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
19681753|NCT00439140|42129008|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
19681754|NCT00439140|42129009|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
19681755|NCT00439140|42129007|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
19681756|NCT00439140|42129008|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
19681757|NCT00439140|42129009|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
19681758|NCT00356421|42129019|FG000|Overall Study|Lack of Efficacy|3|||
19681759|NCT00356421|42129020|FG001|Overall Study|Lack of Efficacy|0|||
19681760|NCT00356421|42129019|FG000|Overall Study|Withdrawal by Subject|9|||
19767581|NCT03231943|42220752|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767582|NCT03231943|42220753|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767583|NCT03231943|42220754|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767584|NCT03231943|42220755|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767585|NCT03231943|42220756|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
19767586|NCT03231943|42220744|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
19767587|NCT03231943|42220745|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767588|NCT03231943|42220746|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767589|NCT03231943|42220747|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767590|NCT03231943|42220748|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767591|NCT03231943|42220749|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767592|NCT03231943|42220750|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767593|NCT03231943|42220751|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767594|NCT03231943|42220752|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767595|NCT03231943|42220753|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767596|NCT03231943|42220754|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767597|NCT03231943|42220755|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767598|NCT03231943|42220756|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
19767599|NCT03231943|42220744|FG000|Part 2|Adverse Event|0|||
19767600|NCT03231943|42220745|FG001|Part 2|Adverse Event|0|||
19767601|NCT03231943|42220746|FG002|Part 2|Adverse Event|0|||
19767602|NCT03231943|42220747|FG003|Part 2|Adverse Event|0|||
19767603|NCT03231943|42220748|FG004|Part 2|Adverse Event|0|||
19767604|NCT03231943|42220749|FG005|Part 2|Adverse Event|0|||
19767605|NCT03231943|42220750|FG006|Part 2|Adverse Event|0|||
19767606|NCT03231943|42220751|FG007|Part 2|Adverse Event|0|||
19767607|NCT03231943|42220752|FG008|Part 2|Adverse Event|0|||
19767608|NCT03231943|42220753|FG009|Part 2|Adverse Event|0|||
19767609|NCT03231943|42220754|FG010|Part 2|Adverse Event|1|||
19767610|NCT03231943|42220755|FG011|Part 2|Adverse Event|0|||
19767611|NCT03231943|42220756|FG012|Part 2|Adverse Event|0|||
19767612|NCT03231943|42220744|FG000|Part 2|Withdrawal by Subject|0|||
19767613|NCT03231943|42220745|FG001|Part 2|Withdrawal by Subject|0|||
19767614|NCT03231943|42220746|FG002|Part 2|Withdrawal by Subject|0|||
19767615|NCT03231943|42220747|FG003|Part 2|Withdrawal by Subject|0|||
19767616|NCT03231943|42220748|FG004|Part 2|Withdrawal by Subject|0|||
19767617|NCT03231943|42220749|FG005|Part 2|Withdrawal by Subject|0|||
19681761|NCT00356421|42129020|FG001|Overall Study|Withdrawal by Subject|2|||
19681762|NCT00356421|42129019|FG000|Overall Study|Related to study drug|15|||
19681763|NCT00356421|42129020|FG001|Overall Study|Related to study drug|12|||
19681764|NCT00356421|42129019|FG000|Overall Study|Not related to study drug|5|||
19681765|NCT00356421|42129020|FG001|Overall Study|Not related to study drug|3|||
19681766|NCT00443820|42129030|FG000|Overall Study|Adverse Event|1|||
19681767|NCT00443820|42129031|FG001|Overall Study|Adverse Event|1|||
19681768|NCT00443820|42129032|FG002|Overall Study|Adverse Event|0|||
19681769|NCT00443820|42129033|FG003|Overall Study|Adverse Event|0|||
19681770|NCT00443820|42129030|FG000|Overall Study|Lack of Efficacy|3|||
19681771|NCT00443820|42129031|FG001|Overall Study|Lack of Efficacy|2|||
19681772|NCT00443820|42129032|FG002|Overall Study|Lack of Efficacy|1|||
19681773|NCT00443820|42129033|FG003|Overall Study|Lack of Efficacy|1|||
19681774|NCT00443820|42129030|FG000|Overall Study|Protocol Violation|2|||
19681775|NCT00443820|42129031|FG001|Overall Study|Protocol Violation|1|||
19681776|NCT00443820|42129032|FG002|Overall Study|Protocol Violation|2|||
19767618|NCT03231943|42220750|FG006|Part 2|Withdrawal by Subject|0|||
19767619|NCT03231943|42220751|FG007|Part 2|Withdrawal by Subject|0|||
19767620|NCT03231943|42220752|FG008|Part 2|Withdrawal by Subject|0|||
19767621|NCT03231943|42220753|FG009|Part 2|Withdrawal by Subject|0|||
19767622|NCT03231943|42220754|FG010|Part 2|Withdrawal by Subject|0|||
19767623|NCT03231943|42220755|FG011|Part 2|Withdrawal by Subject|1|||
19767624|NCT03231943|42220756|FG012|Part 2|Withdrawal by Subject|0|||
19767625|NCT01578239|42220788|FG000|Treatment Period|Progressive Disease|19|||
19767626|NCT01578239|42220789|FG001|Treatment Period|Progressive Disease|64|||
19767627|NCT01578239|42220788|FG000|Treatment Period|Physician Decision|17|||
19767628|NCT01578239|42220789|FG001|Treatment Period|Physician Decision|17|||
19681777|NCT00443820|42129033|FG003|Overall Study|Protocol Violation|1|||
19681778|NCT00443820|42129030|FG000|Overall Study|Withdrawal by Subject|6|||
19681779|NCT00443820|42129031|FG001|Overall Study|Withdrawal by Subject|7|||
19681780|NCT00443820|42129032|FG002|Overall Study|Withdrawal by Subject|8|||
19699017|NCT03824912|42143819|FG001|Overall Study|Protocol Violation|4|||
19767629|NCT01578239|42220788|FG000|Treatment Period|Adverse Event|13|||
19767630|NCT01578239|42220789|FG001|Treatment Period|Adverse Event|10|||
19767631|NCT01578239|42220788|FG000|Treatment Period|Non-compliance|2|||
19767632|NCT01578239|42220789|FG001|Treatment Period|Non-compliance|0|||
19767633|NCT01578239|42220788|FG000|Treatment Period|Withdrawal by Subject|10|||
19767634|NCT01578239|42220789|FG001|Treatment Period|Withdrawal by Subject|9|||
19767635|NCT01578239|42220788|FG000|Treatment Period|Other|6|||
19767636|NCT01578239|42220789|FG001|Treatment Period|Other|1|||
19767637|NCT01578239|42220788|FG000|Long-term Follow-Up Period|Death|69|||
19767638|NCT01578239|42220789|FG001|Long-term Follow-Up Period|Death|64|||
19767639|NCT01578239|42220788|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
19767640|NCT01578239|42220789|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
19767641|NCT01578239|42220788|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
19767642|NCT01578239|42220789|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
19767643|NCT01578239|42220788|FG000|Long-term Follow-Up Period|Other|2|||
19767644|NCT01578239|42220789|FG001|Long-term Follow-Up Period|Other|2|||
19767645|NCT03231709|42220797|FG000|Treatment Period 1|Reason not Specified|0|||
19767646|NCT03231709|42220798|FG001|Treatment Period 1|Reason not Specified|1|||
19767647|NCT03231709|42220797|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
19767648|NCT03231709|42220798|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
19767649|NCT03241927|42220808|FG000|Overall Study|study terminated|1|||
19767650|NCT03241927|42220809|FG001|Overall Study|study terminated|0|||
19767651|NCT03329885|42220821|FG000|Overall Study|Sponsor discontinued the study early|0|||
19681781|NCT00443820|42129033|FG003|Overall Study|Withdrawal by Subject|9|||
19681782|NCT00443820|42129030|FG000|Overall Study|Lost to Follow-up|9|||
19681783|NCT00443820|42129031|FG001|Overall Study|Lost to Follow-up|8|||
19681784|NCT00443820|42129032|FG002|Overall Study|Lost to Follow-up|6|||
19767652|NCT03329885|42220822|FG001|Overall Study|Sponsor discontinued the study early|0|||
19767653|NCT03329885|42220823|FG002|Overall Study|Sponsor discontinued the study early|0|||
19767654|NCT03329885|42220824|FG003|Overall Study|Sponsor discontinued the study early|0|||
19767655|NCT03329885|42220825|FG004|Overall Study|Sponsor discontinued the study early|0|||
19767656|NCT03329885|42220826|FG005|Overall Study|Sponsor discontinued the study early|0|||
19767657|NCT03329885|42220827|FG006|Overall Study|Sponsor discontinued the study early|1|||
19767658|NCT03329885|42220828|FG007|Overall Study|Sponsor discontinued the study early|1|||
19767659|NCT03329885|42220829|FG008|Overall Study|Sponsor discontinued the study early|0|||
19767660|NCT02941523|42220851|FG000|Monotherapy|Withdrawal by Subject|0|||
19767661|NCT02941523|42220852|FG001|Monotherapy|Withdrawal by Subject|1|||
19767662|NCT02941523|42220851|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
19767663|NCT02941523|42220852|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
19767664|NCT02941523|42220851|FG000|Carboplatin Combination Therapy|Death|1|||
19767665|NCT02941523|42220852|FG001|Carboplatin Combination Therapy|Death|2|||
19767666|NCT02941523|42220851|FG000|Carboplatin Combination Therapy|Disease progression|2|||
19767667|NCT02941523|42220852|FG001|Carboplatin Combination Therapy|Disease progression|0|||
19767668|NCT02941523|42220851|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
19767669|NCT02941523|42220852|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
19767670|NCT02938585|42220870|FG000|Overall Study|Withdrawal by parent or guardian|0|||
19767671|NCT02938585|42220871|FG001|Overall Study|Withdrawal by parent or guardian|1|||
19767672|NCT02938585|42220872|FG002|Overall Study|Withdrawal by parent or guardian|0|||
19767673|NCT02938585|42220873|FG003|Overall Study|Withdrawal by parent or guardian|0|||
19681785|NCT00443820|42129033|FG003|Overall Study|Lost to Follow-up|5|||
19681786|NCT00443820|42129030|FG000|Overall Study|Administrative problems|0|||
19681787|NCT00443820|42129031|FG001|Overall Study|Administrative problems|0|||
19681788|NCT00443820|42129032|FG002|Overall Study|Administrative problems|0|||
19681789|NCT00443820|42129033|FG003|Overall Study|Administrative problems|1|||
19681790|NCT00443820|42129030|FG000|Overall Study|Death|0|||
19681791|NCT00443820|42129031|FG001|Overall Study|Death|0|||
19681792|NCT00443820|42129032|FG002|Overall Study|Death|1|||
19681793|NCT00443820|42129033|FG003|Overall Study|Death|0|||
19681794|NCT00438672|42129045|FG000|Overall Study|Lost to Follow-up|7|||
19681795|NCT00438672|42129046|FG001|Overall Study|Lost to Follow-up|9|||
19681796|NCT00438360|42129054|FG000|Overall Study|Adverse Event|6|||
19681797|NCT00438360|42129055|FG001|Overall Study|Adverse Event|1|||
19681798|NCT00438360|42129054|FG000|Overall Study|Lack of Efficacy|42|||
19681799|NCT00438360|42129055|FG001|Overall Study|Lack of Efficacy|27|||
19681800|NCT00438360|42129054|FG000|Overall Study|Other|24|||
19681801|NCT00438360|42129055|FG001|Overall Study|Other|15|||
19681802|NCT00536471|42129065|FG000|Overall Study|Lost to Follow-up|48|||
19681803|NCT00536471|42129066|FG001|Overall Study|Lost to Follow-up|23|||
19681804|NCT00536471|42129067|FG002|Overall Study|Lost to Follow-up|48|||
19681805|NCT00536471|42129068|FG003|Overall Study|Lost to Follow-up|22|||
19681806|NCT00536471|42129065|FG000|Overall Study|Adverse Event|32|||
19681807|NCT00536471|42129066|FG001|Overall Study|Adverse Event|16|||
19681808|NCT00536471|42129067|FG002|Overall Study|Adverse Event|28|||
19767674|NCT02938585|42220870|FG000|Overall Study|Withdrawal by Subject|0|||
19681809|NCT00536471|42129068|FG003|Overall Study|Adverse Event|13|||
19681810|NCT00536471|42129065|FG000|Overall Study|Withdrawal by Subject|40|||
19681811|NCT00536471|42129066|FG001|Overall Study|Withdrawal by Subject|24|||
19681812|NCT00536471|42129067|FG002|Overall Study|Withdrawal by Subject|43|||
19681813|NCT00536471|42129068|FG003|Overall Study|Withdrawal by Subject|21|||
19681814|NCT00536471|42129065|FG000|Overall Study|Lack of Efficacy|17|||
19681815|NCT00536471|42129066|FG001|Overall Study|Lack of Efficacy|18|||
19681816|NCT00536471|42129067|FG002|Overall Study|Lack of Efficacy|11|||
19681817|NCT00536471|42129068|FG003|Overall Study|Lack of Efficacy|9|||
19681818|NCT00536471|42129065|FG000|Overall Study|Protocol Violation|8|||
19767675|NCT02938585|42220871|FG001|Overall Study|Withdrawal by Subject|0|||
19767676|NCT02938585|42220872|FG002|Overall Study|Withdrawal by Subject|0|||
19767677|NCT02938585|42220873|FG003|Overall Study|Withdrawal by Subject|5|||
19767678|NCT03229759|42220897|FG000|Overall Study|Screen Failure|30|||
19767679|NCT03228433|42220909|FG000|Overall Study|Lost to Follow-up|1|||
19767680|NCT03228433|42220910|FG001|Overall Study|Lost to Follow-up|0|||
19767681|NCT03228433|42220911|FG002|Overall Study|Lost to Follow-up|0|||
19767682|NCT03228433|42220912|FG003|Overall Study|Lost to Follow-up|0|||
19767683|NCT03228433|42220913|FG004|Overall Study|Lost to Follow-up|0|||
19767684|NCT03228433|42220914|FG005|Overall Study|Lost to Follow-up|0|||
19767685|NCT03228433|42220909|FG000|Overall Study|Positive alcohol test|0|||
19767686|NCT03228433|42220910|FG001|Overall Study|Positive alcohol test|0|||
19767687|NCT03228433|42220911|FG002|Overall Study|Positive alcohol test|0|||
19767688|NCT03228433|42220912|FG003|Overall Study|Positive alcohol test|1|||
19604548|NCT01023581|42053421|FG005|Overall Study|Lack of Efficacy|2|||
19604549|NCT01023581|42053422|FG006|Overall Study|Lack of Efficacy|1|||
19604550|NCT01023581|42053416|FG000|Overall Study|Physician Decision|2|||
19604551|NCT01023581|42053417|FG001|Overall Study|Physician Decision|0|||
19604552|NCT01023581|42053418|FG002|Overall Study|Physician Decision|2|||
19604553|NCT01023581|42053419|FG003|Overall Study|Physician Decision|1|||
19604554|NCT01023581|42053420|FG004|Overall Study|Physician Decision|1|||
19604555|NCT01023581|42053421|FG005|Overall Study|Physician Decision|1|||
19604556|NCT01023581|42053422|FG006|Overall Study|Physician Decision|1|||
19604557|NCT01023581|42053416|FG000|Overall Study|Other|1|||
19604558|NCT01023581|42053417|FG001|Overall Study|Other|0|||
19604559|NCT01023581|42053418|FG002|Overall Study|Other|1|||
19681819|NCT00536471|42129066|FG001|Overall Study|Protocol Violation|1|||
19681820|NCT00536471|42129067|FG002|Overall Study|Protocol Violation|2|||
19681821|NCT00536471|42129068|FG003|Overall Study|Protocol Violation|3|||
19681822|NCT00536471|42129065|FG000|Overall Study|Physician Decision|11|||
19681823|NCT00536471|42129066|FG001|Overall Study|Physician Decision|1|||
19681824|NCT00536471|42129067|FG002|Overall Study|Physician Decision|3|||
19681825|NCT00536471|42129068|FG003|Overall Study|Physician Decision|2|||
19767689|NCT03228433|42220913|FG004|Overall Study|Positive alcohol test|0|||
19767690|NCT03228433|42220914|FG005|Overall Study|Positive alcohol test|0|||
19767691|NCT01496118|42220944|FG000|Overall Study|Disease progression|3|||
19604560|NCT01023581|42053419|FG003|Overall Study|Other|0|||
19681826|NCT00536471|42129065|FG000|Overall Study|Death|0|||
19604561|NCT01023581|42053420|FG004|Overall Study|Other|1|||
19604562|NCT01023581|42053421|FG005|Overall Study|Other|0|||
19681827|NCT00536471|42129066|FG001|Overall Study|Death|0|||
19681828|NCT00536471|42129067|FG002|Overall Study|Death|1|||
19681829|NCT00536471|42129068|FG003|Overall Study|Death|2|||
19681830|NCT00536471|42129065|FG000|Overall Study|Sponsor Decision|0|||
19681831|NCT00536471|42129066|FG001|Overall Study|Sponsor Decision|1|||
19681832|NCT00536471|42129067|FG002|Overall Study|Sponsor Decision|3|||
19681833|NCT00536471|42129068|FG003|Overall Study|Sponsor Decision|2|||
19681834|NCT00359619|42129092|FG000|Overall Study|Adverse Event|0|||
19681835|NCT00359619|42129093|FG001|Overall Study|Adverse Event|0|||
19767692|NCT01496118|42220945|FG001|Overall Study|Disease progression|2|||
19767693|NCT01496118|42220946|FG002|Overall Study|Disease progression|3|||
19767694|NCT01496118|42220947|FG003|Overall Study|Disease progression|1|||
19767695|NCT01496118|42220948|FG004|Overall Study|Disease progression|2|||
19767696|NCT01496118|42220949|FG005|Overall Study|Disease progression|2|||
19767697|NCT01496118|42220950|FG006|Overall Study|Disease progression|14|||
19767698|NCT01496118|42220951|FG007|Overall Study|Disease progression|10|||
19767699|NCT01496118|42220944|FG000|Overall Study|Physician Decision|0|||
19767700|NCT01496118|42220945|FG001|Overall Study|Physician Decision|0|||
19767701|NCT01496118|42220946|FG002|Overall Study|Physician Decision|0|||
19767702|NCT01496118|42220947|FG003|Overall Study|Physician Decision|0|||
19767703|NCT01496118|42220948|FG004|Overall Study|Physician Decision|1|||
19767704|NCT01496118|42220949|FG005|Overall Study|Physician Decision|0|||
19767705|NCT01496118|42220950|FG006|Overall Study|Physician Decision|3|||
19767706|NCT01496118|42220951|FG007|Overall Study|Physician Decision|6|||
19767707|NCT01496118|42220944|FG000|Overall Study|Adverse Event|1|||
19767708|NCT01496118|42220945|FG001|Overall Study|Adverse Event|1|||
19767709|NCT01496118|42220946|FG002|Overall Study|Adverse Event|0|||
19767710|NCT01496118|42220947|FG003|Overall Study|Adverse Event|0|||
19767711|NCT01496118|42220948|FG004|Overall Study|Adverse Event|0|||
19767712|NCT01496118|42220949|FG005|Overall Study|Adverse Event|0|||
19767713|NCT01496118|42220950|FG006|Overall Study|Adverse Event|6|||
19767714|NCT01496118|42220951|FG007|Overall Study|Adverse Event|10|||
19767715|NCT01496118|42220944|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767716|NCT01496118|42220945|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767717|NCT01496118|42220946|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767718|NCT01496118|42220947|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767719|NCT01496118|42220948|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767720|NCT01496118|42220949|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767721|NCT01496118|42220950|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
19767722|NCT01496118|42220951|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
19767723|NCT01496118|42220944|FG000|Overall Study|Death|0|||
19767724|NCT01496118|42220945|FG001|Overall Study|Death|0|||
19767725|NCT01496118|42220946|FG002|Overall Study|Death|0|||
19767726|NCT01496118|42220947|FG003|Overall Study|Death|0|||
19767727|NCT01496118|42220948|FG004|Overall Study|Death|0|||
19767728|NCT01496118|42220949|FG005|Overall Study|Death|0|||
19767729|NCT01496118|42220950|FG006|Overall Study|Death|1|||
19767730|NCT01496118|42220951|FG007|Overall Study|Death|1|||
19767731|NCT01496118|42220944|FG000|Overall Study|Withdrawal by Subject|0|||
19767732|NCT01496118|42220945|FG001|Overall Study|Withdrawal by Subject|0|||
19767733|NCT01496118|42220946|FG002|Overall Study|Withdrawal by Subject|0|||
19767734|NCT01496118|42220947|FG003|Overall Study|Withdrawal by Subject|2|||
19767735|NCT01496118|42220948|FG004|Overall Study|Withdrawal by Subject|0|||
19767736|NCT01496118|42220949|FG005|Overall Study|Withdrawal by Subject|1|||
19767737|NCT01496118|42220950|FG006|Overall Study|Withdrawal by Subject|6|||
19767738|NCT01496118|42220951|FG007|Overall Study|Withdrawal by Subject|3|||
19767739|NCT02936869|42220971|FG000|Overall Study|Lost to Follow-up|1|||
19767740|NCT02936869|42220972|FG001|Overall Study|Lost to Follow-up|3|||
19767741|NCT02936869|42220971|FG000|Overall Study|Death|0|||
19681836|NCT00359619|42129094|FG002|Overall Study|Adverse Event|1|||
19681837|NCT00359619|42129095|FG003|Overall Study|Adverse Event|0|||
19767742|NCT02936869|42220972|FG001|Overall Study|Death|1|||
19767743|NCT02936869|42220971|FG000|Overall Study|Legal Case|0|||
19767744|NCT02936869|42220972|FG001|Overall Study|Legal Case|1|||
19767745|NCT02936869|42220971|FG000|Overall Study|Protocol Violation|1|||
19767746|NCT02936869|42220972|FG001|Overall Study|Protocol Violation|0|||
19767747|NCT03309605|42220987|FG000|Overall Study|Adverse Event|0|||
19767748|NCT03309605|42220988|FG001|Overall Study|Adverse Event|0|||
19767749|NCT03309605|42220989|FG002|Overall Study|Adverse Event|0|||
19767750|NCT03309605|42220990|FG003|Overall Study|Adverse Event|1|||
19681838|NCT00359619|42129096|FG004|Overall Study|Adverse Event|0|||
19681839|NCT00359619|42129097|FG005|Overall Study|Adverse Event|0|||
19681840|NCT00359619|42129098|FG006|Overall Study|Adverse Event|1|||
19681841|NCT00359619|42129092|FG000|Overall Study|Withdrawal by Subject|3|||
19681842|NCT00359619|42129093|FG001|Overall Study|Withdrawal by Subject|1|||
19767751|NCT03309605|42220991|FG004|Overall Study|Adverse Event|0|||
19681843|NCT00359619|42129094|FG002|Overall Study|Withdrawal by Subject|4|||
19681844|NCT00359619|42129095|FG003|Overall Study|Withdrawal by Subject|2|||
19681845|NCT00359619|42129096|FG004|Overall Study|Withdrawal by Subject|2|||
19681846|NCT00359619|42129097|FG005|Overall Study|Withdrawal by Subject|0|||
19681847|NCT00359619|42129098|FG006|Overall Study|Withdrawal by Subject|3|||
19681848|NCT00359619|42129092|FG000|Overall Study|Other|1|||
19681849|NCT00359619|42129093|FG001|Overall Study|Other|0|||
19767752|NCT03309605|42220992|FG005|Overall Study|Adverse Event|0|||
19767753|NCT03309605|42220993|FG006|Overall Study|Adverse Event|2|||
19767754|NCT03309605|42220994|FG007|Overall Study|Adverse Event|1|||
19767755|NCT03309605|42220987|FG000|Overall Study|Withdrawal by Subject|0|||
19767756|NCT03309605|42220988|FG001|Overall Study|Withdrawal by Subject|0|||
19767757|NCT03309605|42220989|FG002|Overall Study|Withdrawal by Subject|0|||
19767758|NCT03309605|42220990|FG003|Overall Study|Withdrawal by Subject|0|||
19389098|NCT02667119|41632667|FG000|Overall Study|Lost to Follow-up|3|||
19604563|NCT01023581|42053422|FG006|Overall Study|Other|0|||
19604564|NCT00962780|42053440|FG000|Overall Study|Death|0|||
19604565|NCT00962780|42053441|FG001|Overall Study|Death|1|||
19604566|NCT00962780|42053440|FG000|Overall Study|Protocol Violation|9|||
19604567|NCT00962780|42053441|FG001|Overall Study|Protocol Violation|4|||
19604568|NCT00962780|42053440|FG000|Overall Study|Withdrawal by Subject|1|||
19681850|NCT00359619|42129094|FG002|Overall Study|Other|0|||
19681851|NCT00359619|42129095|FG003|Overall Study|Other|0|||
19681852|NCT00359619|42129096|FG004|Overall Study|Other|0|||
19681853|NCT00359619|42129097|FG005|Overall Study|Other|0|||
19681854|NCT00359619|42129098|FG006|Overall Study|Other|0|||
19681855|NCT00359619|42129092|FG000|Overall Study|Lost to Follow-up|4|||
19681856|NCT00359619|42129093|FG001|Overall Study|Lost to Follow-up|4|||
19681857|NCT00359619|42129094|FG002|Overall Study|Lost to Follow-up|2|||
19681858|NCT00359619|42129095|FG003|Overall Study|Lost to Follow-up|1|||
19681859|NCT00359619|42129096|FG004|Overall Study|Lost to Follow-up|1|||
19681860|NCT00359619|42129097|FG005|Overall Study|Lost to Follow-up|5|||
19604569|NCT00962780|42053441|FG001|Overall Study|Withdrawal by Subject|8|||
19604570|NCT00962780|42053440|FG000|Overall Study|Other|0|||
19604571|NCT00962780|42053441|FG001|Overall Study|Other|1|||
19604572|NCT00739882|42053455|FG000|Double-blind Period|Adverse Event|1|||
19604573|NCT00739882|42053456|FG001|Double-blind Period|Adverse Event|2|||
19604574|NCT00739882|42053455|FG000|Double-blind Period|Protocol Violation|1|||
19604575|NCT00739882|42053456|FG001|Double-blind Period|Protocol Violation|0|||
19604576|NCT00739882|42053455|FG000|Double-blind Period|Lack of Efficacy|1|||
19604577|NCT00739882|42053456|FG001|Double-blind Period|Lack of Efficacy|1|||
19604578|NCT00739882|42053455|FG000|Double-blind Period|Other|16|||
19604579|NCT00739882|42053456|FG001|Double-blind Period|Other|8|||
19604580|NCT00739882|42053455|FG000|Open-label Period|Adverse Event|1|||
19604581|NCT00739882|42053456|FG001|Open-label Period|Adverse Event|0|||
19604582|NCT00739882|42053455|FG000|Open-label Period|Other|9|||
19604583|NCT00739882|42053456|FG001|Open-label Period|Other|5|||
19604584|NCT00961220|42053464|FG000|Overall Study|Adverse Event|3|||
19604585|NCT00961220|42053464|FG000|Overall Study|Lack of Efficacy|1|||
19604586|NCT00961220|42053464|FG000|Overall Study|No IV access for O6BG|1|||
19604587|NCT00961220|42053464|FG000|Overall Study|O6BG no longer supplied|1|||
19604588|NCT00961220|42053464|FG000|Overall Study|Complete Response prior to 12 courses|1|||
19604589|NCT00734656|42053470|FG000|Lab Session 1|Withdrawal by Subject|2|||
19604590|NCT00734656|42053471|FG001|Lab Session 1|Withdrawal by Subject|0|||
19604591|NCT00734656|42053472|FG002|Lab Session 1|Withdrawal by Subject|0|||
19604592|NCT00734656|42053473|FG003|Lab Session 1|Withdrawal by Subject|0|||
19604593|NCT00734656|42053470|FG000|Washout 1|Withdrawal by Subject|1|||
19604594|NCT00734656|42053471|FG001|Washout 1|Withdrawal by Subject|5|||
19604595|NCT00734656|42053472|FG002|Washout 1|Withdrawal by Subject|2|||
19604596|NCT00734656|42053473|FG003|Washout 1|Withdrawal by Subject|3|||
19604597|NCT00734656|42053470|FG000|Lab Session 2|Withdrawal by Subject|1|||
19604598|NCT00734656|42053471|FG001|Lab Session 2|Withdrawal by Subject|0|||
19604599|NCT00734656|42053472|FG002|Lab Session 2|Withdrawal by Subject|0|||
19604600|NCT00734656|42053473|FG003|Lab Session 2|Withdrawal by Subject|1|||
19604601|NCT00734656|42053470|FG000|Washout 2|Withdrawal by Subject|1|||
19604602|NCT00734656|42053471|FG001|Washout 2|Withdrawal by Subject|1|||
19604603|NCT00734656|42053472|FG002|Washout 2|Withdrawal by Subject|1|||
19604604|NCT00734656|42053473|FG003|Washout 2|Withdrawal by Subject|0|||
19604605|NCT00734656|42053470|FG000|Washout 3|Withdrawal by Subject|1|||
19604606|NCT00734656|42053471|FG001|Washout 3|Withdrawal by Subject|0|||
19604607|NCT00734656|42053472|FG002|Washout 3|Withdrawal by Subject|0|||
19604608|NCT00734656|42053473|FG003|Washout 3|Withdrawal by Subject|1|||
19681861|NCT00359619|42129098|FG006|Overall Study|Lost to Follow-up|0|||
19681862|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
19604609|NCT00734656|42053470|FG000|Lab Session 4|Withdrawal by Subject|0|||
19681863|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
19767759|NCT03309605|42220991|FG004|Overall Study|Withdrawal by Subject|1|||
19767760|NCT03309605|42220992|FG005|Overall Study|Withdrawal by Subject|0|||
19767761|NCT03309605|42220993|FG006|Overall Study|Withdrawal by Subject|1|||
19767762|NCT03309605|42220994|FG007|Overall Study|Withdrawal by Subject|1|||
19767763|NCT02936635|42221010|FG000|Overall Study|Adverse Event|43|||
19767764|NCT02936635|42221011|FG001|Overall Study|Adverse Event|25|||
19767765|NCT02936635|42221010|FG000|Overall Study|Progressive Disease|10|||
19767766|NCT02936635|42221011|FG001|Overall Study|Progressive Disease|18|||
19767767|NCT02936635|42221010|FG000|Overall Study|Sponsor Discretion|10|||
19767768|NCT02936635|42221011|FG001|Overall Study|Sponsor Discretion|16|||
19767769|NCT02936635|42221010|FG000|Overall Study|Death|9|||
19767770|NCT02936635|42221011|FG001|Overall Study|Death|15|||
19767771|NCT02936635|42221010|FG000|Overall Study|Withdrawal by Subject|8|||
19767772|NCT02936635|42221011|FG001|Overall Study|Withdrawal by Subject|15|||
19767773|NCT02936635|42221010|FG000|Overall Study|Physician Decision|2|||
19767774|NCT02936635|42221011|FG001|Overall Study|Physician Decision|9|||
19767775|NCT02936635|42221010|FG000|Overall Study|Lost to Follow-up|1|||
19767776|NCT02936635|42221011|FG001|Overall Study|Lost to Follow-up|2|||
19767777|NCT02936635|42221010|FG000|Overall Study|Protocol Violation|1|||
19767778|NCT02936635|42221011|FG001|Overall Study|Protocol Violation|0|||
19767779|NCT02936635|42221010|FG000|Overall Study|Lack of effect/Entry into other study|31|||
19767780|NCT02936635|42221011|FG001|Overall Study|Lack of effect/Entry into other study|65|||
19767781|NCT03227029|42221020|FG000|Overall Study|Child Wheezed (no treatment)|0|||
19767782|NCT03227029|42221021|FG001|Overall Study|Child Wheezed (no treatment)|1|||
19767783|NCT03227029|42221022|FG002|Overall Study|Child Wheezed (no treatment)|0|||
19767784|NCT03227029|42221020|FG000|Overall Study|No post RSV season visit due to COVID|3|||
19767785|NCT03227029|42221021|FG001|Overall Study|No post RSV season visit due to COVID|3|||
19767786|NCT03227029|42221022|FG002|Overall Study|No post RSV season visit due to COVID|2|||
19767787|NCT03227029|42221020|FG000|Overall Study|Not able to get to clinic|0|||
19767788|NCT03227029|42221021|FG001|Overall Study|Not able to get to clinic|0|||
19767789|NCT03227029|42221022|FG002|Overall Study|Not able to get to clinic|1|||
19767790|NCT03227029|42221020|FG000|Overall Study|Withdrawal by Subject|1|||
19767791|NCT03227029|42221021|FG001|Overall Study|Withdrawal by Subject|0|||
19767792|NCT03227029|42221022|FG002|Overall Study|Withdrawal by Subject|0|||
19767793|NCT03227029|42221020|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
19767794|NCT03227029|42221021|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
19767795|NCT03227029|42221022|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
19681864|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
19681865|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
19681866|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
19681867|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
19681868|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
19681869|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
19681870|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
19767796|NCT03329573|42221034|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
19767797|NCT03329573|42221035|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
19767798|NCT03329573|42221036|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
19767799|NCT03329573|42221037|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
19767800|NCT03329573|42221034|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
19767801|NCT03329573|42221035|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
19767802|NCT03329573|42221036|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19767803|NCT03329573|42221037|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
19767804|NCT03329573|42221034|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
19767805|NCT03329573|42221035|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
19767806|NCT03329573|42221036|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
19767807|NCT03329573|42221037|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
19767808|NCT03329573|42221034|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
19767809|NCT03329573|42221035|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
19681871|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
19767810|NCT03329573|42221036|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
19767811|NCT03329573|42221037|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
19767812|NCT03308825|42221068|FG000|Overall Study|Lost to Follow-up|2|||
19767813|NCT03308825|42221069|FG001|Overall Study|Lost to Follow-up|2|||
19767814|NCT03308825|42221070|FG002|Overall Study|Lost to Follow-up|1|||
19767815|NCT03308825|42221071|FG003|Overall Study|Lost to Follow-up|0|||
19767816|NCT03308825|42221068|FG000|Overall Study|Protocol Violation|0|||
19767817|NCT03308825|42221069|FG001|Overall Study|Protocol Violation|2|||
19767818|NCT03308825|42221070|FG002|Overall Study|Protocol Violation|0|||
19767819|NCT03308825|42221071|FG003|Overall Study|Protocol Violation|0|||
19767820|NCT03238417|42221087|FG000|Overall|non-response|955|||
19767821|NCT03238417|42221088|FG001|Overall|non-response|1920|||
19767822|NCT03238417|42221087|FG000|Overall|partial completion|48|||
19767823|NCT03238417|42221088|FG001|Overall|partial completion|68|||
19767824|NCT03238417|42221087|FG000|Baseline|Partial completion|17|||
19767825|NCT03238417|42221088|FG001|Baseline|Partial completion|48|||
19767826|NCT03238417|42221087|FG000|Baseline|non-response|372|||
19767827|NCT03238417|42221088|FG001|Baseline|non-response|669|||
19767828|NCT03238417|42221087|FG000|12-month|non-response|296|||
19767829|NCT03238417|42221088|FG001|12-month|non-response|669|||
19767830|NCT03238417|42221087|FG000|12-month|partial completion|23|||
19767831|NCT03238417|42221088|FG001|12-month|partial completion|37|||
19767832|NCT03238417|42221087|FG000|24-month|non-response|287|||
19767833|NCT03238417|42221088|FG001|24-month|non-response|594|||
19767834|NCT03238417|42221087|FG000|24-month|partial completion|8|||
19767835|NCT03238417|42221088|FG001|24-month|partial completion|31|||
19767836|NCT03328325|42221094|FG000|Overall Study|Lost to Follow-up|4|||
19767837|NCT03328325|42221094|FG000|Overall Study|Physician Decision|1|||
19767838|NCT03328325|42221094|FG000|Overall Study|Withdrawal by Subject|3|||
19767839|NCT03328325|42221094|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
19767840|NCT03226249|42221102|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
19767841|NCT03226249|42221102|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
19767842|NCT03226249|42221102|FG000|Survival Follow-up|Patients still in follow-up.|30|||
19767843|NCT03305081|42221108|FG000|Overall Study|Lost to Follow-up|10|||
19767844|NCT03305081|42221109|FG001|Overall Study|Lost to Follow-up|15|||
19767845|NCT03325673|42221127|FG000|Overall Study|Adverse Event|4|||
19767846|NCT03325673|42221128|FG001|Overall Study|Adverse Event|0|||
19767847|NCT03223909|42221137|FG000|Overall Study|Protocol Violation|48|||
19767848|NCT03223909|42221138|FG001|Overall Study|Protocol Violation|45|||
19767849|NCT03223909|42221139|FG002|Overall Study|Protocol Violation|16|||
19767850|NCT03733925|42221147|FG000|Overall Study|Lost to Follow-up|1|||
19767851|NCT03733925|42221147|FG000|Overall Study|Withdrawal by Subject|2|||
19767852|NCT03733925|42221147|FG000|Overall Study|Adverse Event|2|||
19767853|NCT03733925|42221147|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19767854|NCT03649711|42221154|FG000|Overall Study|Adverse Event|0|||
19767855|NCT03649711|42221155|FG001|Overall Study|Adverse Event|1|||
19767856|NCT03649711|42221156|FG002|Overall Study|Adverse Event|0|||
19767857|NCT03649711|42221154|FG000|Overall Study|Kidney Transplant|1|||
19767858|NCT03649711|42221155|FG001|Overall Study|Kidney Transplant|0|||
19767859|NCT03649711|42221156|FG002|Overall Study|Kidney Transplant|0|||
19767860|NCT03303521|42221166|FG000|Overall Study|Withdrawal by Subject|2|||
19767861|NCT03303521|42221167|FG001|Overall Study|Withdrawal by Subject|0|||
19767862|NCT03303521|42221166|FG000|Overall Study|Death|1|||
19767863|NCT03303521|42221167|FG001|Overall Study|Death|0|||
19767864|NCT03303521|42221166|FG000|Overall Study|Kidney transplantation|0|||
19767865|NCT03303521|42221167|FG001|Overall Study|Kidney transplantation|1|||
19767866|NCT03303521|42221166|FG000|Overall Study|Investigational product discontinuation|0|||
19767867|NCT03303521|42221167|FG001|Overall Study|Investigational product discontinuation|1|||
19767868|NCT03303521|42221166|FG000|Overall Study|Transferred to non-study dialysis center|1|||
19767869|NCT03303521|42221167|FG001|Overall Study|Transferred to non-study dialysis center|0|||
19767870|NCT03303521|42221166|FG000|Overall Study|Non-comliance to study protocol|0|||
19767871|NCT03303521|42221167|FG001|Overall Study|Non-comliance to study protocol|1|||
19767872|NCT03303521|42221166|FG000|Overall Study|Adverse Event|1|||
19767873|NCT03303521|42221167|FG001|Overall Study|Adverse Event|0|||
19767874|NCT03214081|42221173|FG000|Overall Study|Case Report Forms Uncollected|9|||
19767875|NCT03214081|42221173|FG000|Overall Study|Protocol Deviation|54|||
19767876|NCT02888171|42221179|FG000|Overall Study|Lost to Follow-up|2|||
19767877|NCT02888171|42221180|FG001|Overall Study|Lost to Follow-up|1|||
19767878|NCT02888171|42221179|FG000|Overall Study|Withdrawal by Subject|3|||
19767879|NCT02888171|42221180|FG001|Overall Study|Withdrawal by Subject|2|||
19767880|NCT02888171|42221179|FG000|Overall Study|Adverse Event|0|||
19767881|NCT02888171|42221180|FG001|Overall Study|Adverse Event|1|||
19767882|NCT02932891|42221186|FG000|Overall Study|Lost to Follow-up|2|||
19767883|NCT02932891|42221186|FG000|Overall Study|HPA Suppress|2|||
19767884|NCT03302975|42221190|FG000|Overall Study|Lost to Follow-up|4|||
19767885|NCT03212521|42221194|FG000|Overall Study|Adverse Event|1|||
19767886|NCT03212521|42221194|FG000|Overall Study|Lost to Follow-up|4|||
19767887|NCT03212521|42221194|FG000|Overall Study|Withdrawal by Subject|1|||
19767888|NCT03212521|42221194|FG000|Overall Study|Other|1|||
19767889|NCT03212365|42221200|FG000|Overall Study|Discharged prior to Xa level|12|||
19767890|NCT03212365|42221201|FG001|Overall Study|Discharged prior to Xa level|8|||
19767891|NCT03212365|42221200|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
19767892|NCT03212365|42221201|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
19767893|NCT03212365|42221200|FG000|Overall Study|Refused study medication|3|||
19767894|NCT03212365|42221201|FG001|Overall Study|Refused study medication|0|||
19767895|NCT03212365|42221200|FG000|Overall Study|Initiated heparin infusion on floor|1|||
19767896|NCT03212365|42221201|FG001|Overall Study|Initiated heparin infusion on floor|1|||
19767897|NCT03212365|42221200|FG000|Overall Study|Unexpected return to OR|1|||
19767898|NCT03212365|42221201|FG001|Overall Study|Unexpected return to OR|1|||
19767899|NCT03212365|42221200|FG000|Overall Study|Medication distribution error|1|||
19767900|NCT03212365|42221201|FG001|Overall Study|Medication distribution error|0|||
19767901|NCT03212365|42221200|FG000|Overall Study|Required epidural placement|1|||
19767902|NCT03212365|42221201|FG001|Overall Study|Required epidural placement|0|||
19767903|NCT03212365|42221200|FG000|Overall Study|Withdrawal by Subject|0|||
19767904|NCT03212365|42221201|FG001|Overall Study|Withdrawal by Subject|1|||
19767905|NCT03212365|42221200|FG000|Overall Study|developed acute renal failure|0|||
19767906|NCT03212365|42221201|FG001|Overall Study|developed acute renal failure|1|||
19767907|NCT03273257|42221209|FG000|Overall Study|Death|0|||
19767908|NCT03273257|42221210|FG001|Overall Study|Death|1|||
19767909|NCT03273257|42221209|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
19767910|NCT03273257|42221210|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
19767911|NCT03273257|42221209|FG000|Overall Study|Study terminated|3|||
19767912|NCT03273257|42221210|FG001|Overall Study|Study terminated|2|||
19767913|NCT04316741|42221218|FG000|Baseline Enrollment|Lost to Follow-up|1|||
19767914|NCT04316741|42221219|FG001|Baseline Enrollment|Lost to Follow-up|1|||
19767915|NCT04316741|42221218|FG000|Immediate Post-Test|Lost to Follow-up|5|||
19767916|NCT04316741|42221219|FG001|Immediate Post-Test|Lost to Follow-up|1|||
19767917|NCT04316741|42221218|FG000|1-month Post-test|Lost to Follow-up|7|||
19767918|NCT04316741|42221219|FG001|1-month Post-test|Lost to Follow-up|2|||
19767919|NCT04316741|42221218|FG000|3-month Follow-up|Lost to Follow-up|10|||
19767920|NCT04316741|42221219|FG001|3-month Follow-up|Lost to Follow-up|2|||
19767921|NCT03271307|42221229|FG000|Overall Study|Lost to Follow-up|0|||
19767922|NCT03271307|42221230|FG001|Overall Study|Lost to Follow-up|0|||
19767923|NCT03271307|42221231|FG002|Overall Study|Lost to Follow-up|0|||
19767924|NCT03271307|42221232|FG003|Overall Study|Lost to Follow-up|28|||
19389099|NCT02667119|41632668|FG001|Overall Study|Lost to Follow-up|0|||
19681872|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
19681873|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
19681874|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
19681875|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
19681876|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
19681877|NCT00437658|42129117|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
19681878|NCT00437658|42129118|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
19681879|NCT00437658|42129119|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
19681880|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
19681881|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
19681882|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
19681883|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
19681884|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
19681885|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
19681886|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
19681887|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
19681888|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
19681889|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
19681890|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
19681891|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
19681892|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
19681893|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
19681894|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
19681895|NCT00437658|42129117|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
19681896|NCT00437658|42129118|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
19681897|NCT00437658|42129119|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
19681898|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Adverse Event|6|||
19681899|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Adverse Event|6|||
19681900|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Death|1|||
19681901|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Death|2|||
19681902|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19681903|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
19699018|NCT03824912|42143820|FG002|Overall Study|Protocol Violation|1|||
19767925|NCT03271307|42221233|FG004|Overall Study|Lost to Follow-up|91|||
19767926|NCT03271151|42221250|FG000|Overall Study|Lost to Follow-up|1|||
19767927|NCT03271151|42221251|FG001|Overall Study|Lost to Follow-up|3|||
19767928|NCT03271151|42221250|FG000|Overall Study|Withdrawal by Subject|1|||
19767929|NCT03271151|42221251|FG001|Overall Study|Withdrawal by Subject|0|||
19767930|NCT03245723|42221259|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
19767931|NCT03245723|42221260|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
19767932|NCT03245723|42221259|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
19767933|NCT03245723|42221260|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
19767934|NCT03245723|42221259|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
19767935|NCT03245723|42221260|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
19767936|NCT03245723|42221259|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
19767937|NCT03245723|42221260|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
19767938|NCT03301649|42221269|FG000|Overall Study|Need alternate therapy due to live lice|17|||
19767939|NCT03301649|42221270|FG001|Overall Study|Need alternate therapy due to live lice|25|||
19767940|NCT03301649|42221271|FG002|Overall Study|Need alternate therapy due to live lice|81|||
19767941|NCT03301649|42221269|FG000|Overall Study|Lost to Follow-up|11|||
19767942|NCT03301649|42221270|FG001|Overall Study|Lost to Follow-up|11|||
19767943|NCT03301649|42221271|FG002|Overall Study|Lost to Follow-up|3|||
19767944|NCT03301649|42221269|FG000|Overall Study|Protocol Violation|0|||
19767945|NCT03301649|42221270|FG001|Overall Study|Protocol Violation|1|||
19767946|NCT03301649|42221271|FG002|Overall Study|Protocol Violation|1|||
19767947|NCT03301649|42221269|FG000|Overall Study|Withdrawal by Subject|10|||
19767948|NCT03301649|42221270|FG001|Overall Study|Withdrawal by Subject|4|||
19767949|NCT03301649|42221271|FG002|Overall Study|Withdrawal by Subject|0|||
19767950|NCT03301649|42221269|FG000|Overall Study|Other than specified|5|||
19767951|NCT03301649|42221270|FG001|Overall Study|Other than specified|3|||
19767952|NCT03301649|42221271|FG002|Overall Study|Other than specified|0|||
19767953|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
19767954|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
19767955|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
19767956|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
19767957|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
19767958|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
19767959|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
19767960|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
19767961|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
19767962|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
19767963|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
19767964|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
19767965|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
19767966|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
19767967|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
19767968|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
19767969|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
19767970|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
19767971|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
19767972|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
19767973|NCT03222973|42221281|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
19767974|NCT03222973|42221282|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
19767975|NCT03222973|42221283|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
19767976|NCT03222973|42221284|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
19767977|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
19767978|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
19767979|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
19767980|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
19767981|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
19767982|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
19767983|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
19767984|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
19767985|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
19767986|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
19767987|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
19767988|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
19767989|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
19767990|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
19767991|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
19767992|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
19767993|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
19767994|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
19767995|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
19767996|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
19767997|NCT03222973|42221281|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
19767998|NCT03222973|42221282|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
19767999|NCT03222973|42221283|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
19768000|NCT03222973|42221284|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
19768001|NCT01144416|42221296|FG000|Intervention Period|Adverse Event|5|||
19768002|NCT01144416|42221297|FG001|Intervention Period|Adverse Event|6|||
19768003|NCT01144416|42221296|FG000|Intervention Period|Insufficient ovarian response|11|||
19768004|NCT01144416|42221297|FG001|Intervention Period|Insufficient ovarian response|17|||
19768005|NCT01144416|42221296|FG000|Intervention Period|Risk of OHSS|0|||
19768006|NCT01144416|42221297|FG001|Intervention Period|Risk of OHSS|1|||
19768007|NCT01144416|42221296|FG000|Intervention Period|Too high ovarian response|4|||
19768008|NCT01144416|42221297|FG001|Intervention Period|Too high ovarian response|2|||
19768009|NCT01144416|42221296|FG000|Intervention Period|No/too few/bad oocytes|7|||
19768010|NCT01144416|42221297|FG001|Intervention Period|No/too few/bad oocytes|5|||
19768011|NCT01144416|42221296|FG000|Intervention Period|No or abnormal fertilization|25|||
19768012|NCT01144416|42221297|FG001|Intervention Period|No or abnormal fertilization|10|||
19768013|NCT01144416|42221296|FG000|Intervention Period|No/too few/bad quality embryos|3|||
19768014|NCT01144416|42221297|FG001|Intervention Period|No/too few/bad quality embryos|3|||
19768015|NCT01144416|42221296|FG000|Intervention Period|Other|7|||
19768016|NCT01144416|42221297|FG001|Intervention Period|Other|5|||
19681904|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
19681905|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
19681906|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Physician Decision|0|||
19681907|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Physician Decision|3|||
19681908|NCT03828747|42129129|FG000|Double-Blind Treatment Period|Various reasons|5|||
19681909|NCT03828747|42129130|FG001|Double-Blind Treatment Period|Various reasons|3|||
19681910|NCT03828747|42129129|FG000|Open-Label Extension|Continuing on Study|77|||
19681911|NCT03828747|42129130|FG001|Open-Label Extension|Continuing on Study|72|||
19681912|NCT03828747|42129129|FG000|Open-Label Extension|Adverse Event|3|||
19681913|NCT03828747|42129130|FG001|Open-Label Extension|Adverse Event|4|||
19681914|NCT03828747|42129129|FG000|Open-Label Extension|Death|0|||
19681915|NCT03828747|42129130|FG001|Open-Label Extension|Death|2|||
19681916|NCT03828747|42129129|FG000|Open-Label Extension|Lost to Follow-up|4|||
19681917|NCT03828747|42129130|FG001|Open-Label Extension|Lost to Follow-up|0|||
19681918|NCT03828747|42129129|FG000|Open-Label Extension|Withdrawal by Subject|19|||
19681919|NCT03828747|42129130|FG001|Open-Label Extension|Withdrawal by Subject|16|||
19681920|NCT03828747|42129129|FG000|Open-Label Extension|Various reasons|1|||
19681921|NCT03828747|42129130|FG001|Open-Label Extension|Various reasons|1|||
19681922|NCT00356265|42129140|FG000|Overall Study|Withdrawal by Subject|0|||
19681923|NCT00356265|42129141|FG001|Overall Study|Withdrawal by Subject|0|||
19681924|NCT00356265|42129142|FG002|Overall Study|Withdrawal by Subject|1|||
19768017|NCT00335777|42221307|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
19768018|NCT00335777|42221307|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
19768019|NCT00335777|42221307|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
19768020|NCT00335777|42221307|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
19768021|NCT00335777|42221307|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
19681925|NCT00535145|42129151|FG000|Phase I|Adverse Event|3|||
19681926|NCT00535145|42129151|FG000|Phase I|Lost to Follow-up|7|||
19681927|NCT00535145|42129151|FG000|Phase I|Withdrawal by Subject|6|||
19681928|NCT00535145|42129151|FG000|Phase I|(eligibility)|8|||
19681929|NCT00535145|42129151|FG000|Phase I|(protocol violation)|1|||
19681930|NCT00535145|42129151|FG000|Phase I|(PI decision)|1|||
19681931|NCT00535145|42129151|FG000|Phase I|(diagnosis)|3|||
19681932|NCT00535145|42129151|FG000|Phase II|Adverse Event|2|||
19681933|NCT00535145|42129151|FG000|Phase II|Lack of Efficacy|1|||
19681934|NCT00535145|42129151|FG000|Phase II|Lost to Follow-up|5|||
19681935|NCT00535145|42129151|FG000|Phase II|Withdrawal by Subject|5|||
19681936|NCT00535145|42129151|FG000|Phase II|Subject non-compliance|2|||
19681937|NCT00437268|42129161|FG000|Overall Study|Adverse Event|1|||
19681938|NCT00437268|42129162|FG001|Overall Study|Adverse Event|1|||
19681939|NCT00437268|42129161|FG000|Overall Study|Withdrawal by Subject|2|||
19681940|NCT00437268|42129162|FG001|Overall Study|Withdrawal by Subject|2|||
19681941|NCT00437268|42129161|FG000|Overall Study|Progressive disease|9|||
19681942|NCT00437268|42129162|FG001|Overall Study|Progressive disease|9|||
19681943|NCT00437268|42129161|FG000|Overall Study|Physician Decision|1|||
19681944|NCT00437268|42129162|FG001|Overall Study|Physician Decision|0|||
19681945|NCT00437268|42129161|FG000|Overall Study|Death|0|||
19681946|NCT00437268|42129162|FG001|Overall Study|Death|1|||
19681947|NCT00437034|42129170|FG000|Overall Study|Adverse Event|1|||
19681948|NCT00437034|42129170|FG000|Overall Study|Disease progression during treatment|5|||
19681949|NCT00337467|42129174|FG000|Overall Study|Adverse Event|3|||
19681950|NCT00337467|42129174|FG000|Overall Study|Subject Withdrew Consent|2|||
19681951|NCT00337467|42129174|FG000|Overall Study|Pregnancy|1|||
19681952|NCT00337467|42129174|FG000|Overall Study|Lost to Follow-up|2|||
19681953|NCT00337467|42129174|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
19681954|NCT00337077|42129184|FG000|Overall Study|Progressive disease|25|||
19681955|NCT00337077|42129185|FG001|Overall Study|Progressive disease|37|||
19681956|NCT00337077|42129186|FG002|Overall Study|Progressive disease|19|||
19768022|NCT01140048|42221312|FG000|Overall Study|Physician Decision|1|||
19768023|NCT01140048|42221312|FG000|Overall Study|Withdrawal by Subject|13|||
19768024|NCT01140048|42221312|FG000|Overall Study|Lost to Follow-up|31|||
19768025|NCT02889809|42221318|FG000|Overall Study|Withdrawal by Subject|30|||
19768026|NCT02889809|42221319|FG001|Overall Study|Withdrawal by Subject|21|||
19768027|NCT02889809|42221318|FG000|Overall Study|Lost to Follow-up|1|||
19768028|NCT02889809|42221319|FG001|Overall Study|Lost to Follow-up|1|||
19768029|NCT02889809|42221318|FG000|Overall Study|Site Closed|12|||
19768030|NCT02889809|42221319|FG001|Overall Study|Site Closed|11|||
19768031|NCT00972738|42221332|FG000|Overall Study|Adverse Event|7|||
19768032|NCT00972738|42221333|FG001|Overall Study|Adverse Event|1|||
19768033|NCT00972738|42221334|FG002|Overall Study|Adverse Event|8|||
19768034|NCT00972738|42221332|FG000|Overall Study|Protocol Violation|2|||
19768035|NCT00972738|42221333|FG001|Overall Study|Protocol Violation|1|||
19768036|NCT00972738|42221334|FG002|Overall Study|Protocol Violation|3|||
19768037|NCT00972738|42221332|FG000|Overall Study|Lost to Follow-up|1|||
19768038|NCT00972738|42221333|FG001|Overall Study|Lost to Follow-up|0|||
19768039|NCT00972738|42221334|FG002|Overall Study|Lost to Follow-up|1|||
19768040|NCT00972738|42221332|FG000|Overall Study|Lack of Efficacy|5|||
19768041|NCT00972738|42221333|FG001|Overall Study|Lack of Efficacy|1|||
19768042|NCT00972738|42221334|FG002|Overall Study|Lack of Efficacy|11|||
19768043|NCT00972738|42221332|FG000|Overall Study|Withdrawal by Subject|5|||
19768044|NCT00972738|42221333|FG001|Overall Study|Withdrawal by Subject|1|||
19768045|NCT00972738|42221334|FG002|Overall Study|Withdrawal by Subject|4|||
19768046|NCT00972738|42221332|FG000|Overall Study|Moved|0|||
19768047|NCT00972738|42221333|FG001|Overall Study|Moved|0|||
19768048|NCT00972738|42221334|FG002|Overall Study|Moved|1|||
19768049|NCT00972738|42221332|FG000|Overall Study|Other|1|||
19768050|NCT00972738|42221333|FG001|Overall Study|Other|2|||
19768051|NCT00972738|42221334|FG002|Overall Study|Other|1|||
19768052|NCT03243305|42221342|FG000|Overall Study|Lost to Follow-up|250|||
19768053|NCT03243305|42221342|FG000|Overall Study|Withdrawal by Subject|170|||
19768054|NCT03243305|42221342|FG000|Overall Study|Pregnancy|104|||
19768055|NCT03243305|42221342|FG000|Overall Study|Non-Compliance with Study Drug|38|||
19768056|NCT03243305|42221342|FG000|Overall Study|Adverse Event|23|||
19604610|NCT00734656|42053471|FG001|Lab Session 4|Withdrawal by Subject|0|||
19604611|NCT00734656|42053472|FG002|Lab Session 4|Withdrawal by Subject|0|||
19604612|NCT00734656|42053473|FG003|Lab Session 4|Withdrawal by Subject|1|||
19604613|NCT00961064|42053483|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
19604614|NCT00961064|42053483|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
19604615|NCT00961064|42053483|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
19604616|NCT00961064|42053483|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
19604617|NCT00961064|42053483|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
19604618|NCT00961064|42053483|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
19604619|NCT00961064|42053483|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
19604620|NCT00961064|42053483|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
19681957|NCT00337077|42129184|FG000|Overall Study|Adverse Event|7|||
19681958|NCT00337077|42129185|FG001|Overall Study|Adverse Event|7|||
19681959|NCT00337077|42129186|FG002|Overall Study|Adverse Event|1|||
19681960|NCT00337077|42129184|FG000|Overall Study|Death|0|||
19681961|NCT00337077|42129185|FG001|Overall Study|Death|1|||
19681962|NCT00337077|42129186|FG002|Overall Study|Death|0|||
19681963|NCT00337077|42129184|FG000|Overall Study|Withdrawal by Subject|7|||
19681964|NCT00337077|42129185|FG001|Overall Study|Withdrawal by Subject|2|||
19681965|NCT00337077|42129186|FG002|Overall Study|Withdrawal by Subject|2|||
19681966|NCT00337077|42129184|FG000|Overall Study|Alternative therapy|1|||
19681967|NCT00337077|42129185|FG001|Overall Study|Alternative therapy|0|||
19681968|NCT00337077|42129186|FG002|Overall Study|Alternative therapy|0|||
19681969|NCT00337077|42129184|FG000|Overall Study|Physician Decision|1|||
19768057|NCT03243305|42221342|FG000|Overall Study|No sexually active|26|||
19768058|NCT03243305|42221342|FG000|Overall Study|Physician Decision|22|||
19768059|NCT03243305|42221342|FG000|Overall Study|Protocol Violation|22|||
19604621|NCT00739648|42053490|FG000|Overall Study|Adverse Event|3|||
19604622|NCT00739648|42053491|FG001|Overall Study|Adverse Event|15|||
19604623|NCT00739648|42053490|FG000|Overall Study|Withdrawal by Subject|13|||
19604624|NCT00739648|42053491|FG001|Overall Study|Withdrawal by Subject|25|||
19604625|NCT00739648|42053490|FG000|Overall Study|Lost to Follow-up|4|||
19604626|NCT00739648|42053491|FG001|Overall Study|Lost to Follow-up|7|||
19768060|NCT03243305|42221342|FG000|Overall Study|Study method no longer primary method|12|||
19768061|NCT03243305|42221342|FG000|Overall Study|Study Terminated by Sponsor|1|||
19768062|NCT03243305|42221342|FG000|Overall Study|Early terminations|267|||
19768063|NCT03222583|42221348|FG000|Overall Study|Withdrawal by Subject|3|||
19768064|NCT03222583|42221349|FG001|Overall Study|Withdrawal by Subject|3|||
19768065|NCT03222583|42221348|FG000|Overall Study|Lost to Follow-up|1|||
19768066|NCT03222583|42221349|FG001|Overall Study|Lost to Follow-up|0|||
19768067|NCT03222583|42221348|FG000|Overall Study|Other|1|||
19768068|NCT03222583|42221349|FG001|Overall Study|Other|3|||
19768069|NCT03295721|42221358|FG000|Overall Study|Adverse Event|1|||
19768070|NCT03295721|42221359|FG001|Overall Study|Adverse Event|0|||
19768071|NCT03295721|42221360|FG002|Overall Study|Adverse Event|0|||
19768072|NCT03295721|42221358|FG000|Overall Study|Lost to Follow-up|1|||
19768073|NCT03295721|42221359|FG001|Overall Study|Lost to Follow-up|1|||
19768074|NCT03295721|42221360|FG002|Overall Study|Lost to Follow-up|1|||
19768075|NCT03295721|42221358|FG000|Overall Study|Withdrawal by Subject|1|||
19768076|NCT03295721|42221359|FG001|Overall Study|Withdrawal by Subject|0|||
19768077|NCT03295721|42221360|FG002|Overall Study|Withdrawal by Subject|1|||
19768078|NCT03295721|42221358|FG000|Overall Study|Death|0|||
19768079|NCT03295721|42221359|FG001|Overall Study|Death|0|||
19768080|NCT03295721|42221360|FG002|Overall Study|Death|1|||
19768081|NCT00803790|42221371|FG000|Period 1|Adverse Event|0|||
19768082|NCT00803790|42221372|FG001|Period 1|Adverse Event|1|||
19768083|NCT00803790|42221373|FG002|Period 1|Adverse Event|0|||
19768084|NCT00803790|42221374|FG003|Period 1|Adverse Event|0|||
19768085|NCT00803790|42221371|FG000|Period 1|Lost to Follow-up|1|||
19768086|NCT00803790|42221372|FG001|Period 1|Lost to Follow-up|2|||
19768087|NCT00803790|42221373|FG002|Period 1|Lost to Follow-up|0|||
19768088|NCT00803790|42221374|FG003|Period 1|Lost to Follow-up|0|||
19768089|NCT00803790|42221371|FG000|Period 1|Withdrawal by Subject|8|||
19768090|NCT00803790|42221372|FG001|Period 1|Withdrawal by Subject|6|||
19768091|NCT00803790|42221373|FG002|Period 1|Withdrawal by Subject|0|||
19768092|NCT00803790|42221374|FG003|Period 1|Withdrawal by Subject|0|||
19768093|NCT00803790|42221371|FG000|Period 1|positive drug screen or personal reasons|0|||
19768094|NCT00803790|42221372|FG001|Period 1|positive drug screen or personal reasons|3|||
19768095|NCT00803790|42221373|FG002|Period 1|positive drug screen or personal reasons|0|||
19768096|NCT00803790|42221374|FG003|Period 1|positive drug screen or personal reasons|4|||
19768097|NCT00803790|42221371|FG000|Period 1|Protocol Violation|0|||
19768098|NCT00803790|42221372|FG001|Period 1|Protocol Violation|0|||
19768099|NCT00803790|42221373|FG002|Period 1|Protocol Violation|1|||
19768100|NCT00803790|42221374|FG003|Period 1|Protocol Violation|0|||
19768101|NCT00803790|42221371|FG000|Period 2|Adverse Event|0|||
19768102|NCT00803790|42221372|FG001|Period 2|Adverse Event|0|||
19768103|NCT00803790|42221373|FG002|Period 2|Adverse Event|1|||
19768104|NCT00803790|42221374|FG003|Period 2|Adverse Event|1|||
19768105|NCT00803790|42221371|FG000|Period 2|Withdrawal by Subject|1|||
19768106|NCT00803790|42221372|FG001|Period 2|Withdrawal by Subject|0|||
19768107|NCT00803790|42221373|FG002|Period 2|Withdrawal by Subject|0|||
19768108|NCT00803790|42221374|FG003|Period 2|Withdrawal by Subject|0|||
19768109|NCT00803790|42221371|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
19768110|NCT00803790|42221372|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
19768111|NCT00803790|42221373|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
19768112|NCT00803790|42221374|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
19768113|NCT00250458|42221422|FG000|Overall Study|Lost to Follow-up|4|||
19768114|NCT00250458|42221423|FG001|Overall Study|Lost to Follow-up|2|||
19768115|NCT00250458|42221422|FG000|Overall Study|Protocol Violation|0|||
19768116|NCT00250458|42221423|FG001|Overall Study|Protocol Violation|1|||
19768117|NCT00250458|42221422|FG000|Overall Study|Withdrawal by Subject|4|||
19604627|NCT00739648|42053490|FG000|Overall Study|Death|2|||
19604628|NCT00739648|42053491|FG001|Overall Study|Death|0|||
19768118|NCT00250458|42221423|FG001|Overall Study|Withdrawal by Subject|2|||
19768119|NCT00250458|42221422|FG000|Overall Study|Lack of Migraine Attack|20|||
19768120|NCT00250458|42221423|FG001|Overall Study|Lack of Migraine Attack|9|||
19768121|NCT00250458|42221422|FG000|Overall Study|Qualifying migraine but did not treat|3|||
19768122|NCT00250458|42221423|FG001|Overall Study|Qualifying migraine but did not treat|3|||
19768123|NCT00250458|42221422|FG000|Overall Study|Other|1|||
19768124|NCT00250458|42221423|FG001|Overall Study|Other|0|||
19768125|NCT01667133|42221441|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
19768126|NCT01667133|42221442|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
19768127|NCT01667133|42221443|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
19768128|NCT01667133|42221444|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
19768129|NCT01667133|42221445|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
19768130|NCT01667133|42221446|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
19768131|NCT01667133|42221447|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
19768132|NCT01667133|42221448|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
19604629|NCT00739648|42053490|FG000|Overall Study|Do not know|4|||
19604630|NCT00739648|42053491|FG001|Overall Study|Do not know|6|||
19768133|NCT01667133|42221449|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
19768134|NCT01667133|42221450|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
19768135|NCT01667133|42221451|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
19768136|NCT01667133|42221452|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
19768137|NCT01667133|42221441|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768138|NCT01667133|42221442|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768139|NCT01667133|42221443|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
19768140|NCT01667133|42221444|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768141|NCT01667133|42221445|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768142|NCT01667133|42221446|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768143|NCT01667133|42221447|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768144|NCT01667133|42221448|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768145|NCT01667133|42221449|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768146|NCT01667133|42221450|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768147|NCT01667133|42221451|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768148|NCT01667133|42221452|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
19768149|NCT01667133|42221441|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
19768150|NCT01667133|42221442|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
19768151|NCT01667133|42221443|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
19768152|NCT01667133|42221444|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
19604631|NCT01032239|42053503|FG000|Overall Study|Lost to Follow-up|3|||
19604632|NCT01032239|42053504|FG001|Overall Study|Lost to Follow-up|2|||
19604633|NCT01032239|42053503|FG000|Overall Study|Withdrawal by Subject|2|||
19604634|NCT01032239|42053504|FG001|Overall Study|Withdrawal by Subject|3|||
19604635|NCT01032239|42053503|FG000|Overall Study|Death|1|||
19604636|NCT01032239|42053504|FG001|Overall Study|Death|0|||
19604637|NCT01032239|42053503|FG000|Overall Study|Protocol Violation|1|||
19604638|NCT01032239|42053504|FG001|Overall Study|Protocol Violation|0|||
19604639|NCT00734578|42053513|FG000|Overall Study|Adverse Event|4|||
19604640|NCT00734578|42053514|FG001|Overall Study|Adverse Event|6|||
19604641|NCT00734578|42053515|FG002|Overall Study|Adverse Event|1|||
19604642|NCT00734578|42053513|FG000|Overall Study|Protocol Violation|8|||
19604643|NCT00734578|42053514|FG001|Overall Study|Protocol Violation|6|||
19604644|NCT00734578|42053515|FG002|Overall Study|Protocol Violation|3|||
19604645|NCT00734578|42053513|FG000|Overall Study|Withdrawal by Subject|7|||
19604646|NCT00734578|42053514|FG001|Overall Study|Withdrawal by Subject|8|||
19604647|NCT00734578|42053515|FG002|Overall Study|Withdrawal by Subject|11|||
19604648|NCT00734578|42053513|FG000|Overall Study|Lost to Follow-up|9|||
19604649|NCT00734578|42053514|FG001|Overall Study|Lost to Follow-up|3|||
19604650|NCT00734578|42053515|FG002|Overall Study|Lost to Follow-up|5|||
19604651|NCT00734578|42053513|FG000|Overall Study|Lack of Efficacy|3|||
19604652|NCT00734578|42053514|FG001|Overall Study|Lack of Efficacy|2|||
19681970|NCT00337077|42129185|FG001|Overall Study|Physician Decision|4|||
19681971|NCT00337077|42129186|FG002|Overall Study|Physician Decision|2|||
19681972|NCT00337077|42129184|FG000|Overall Study|Never started treatment|1|||
19681973|NCT00337077|42129185|FG001|Overall Study|Never started treatment|1|||
19681974|NCT00337077|42129186|FG002|Overall Study|Never started treatment|0|||
19681975|NCT00337077|42129184|FG000|Overall Study|Ineligible|1|||
19681976|NCT00337077|42129185|FG001|Overall Study|Ineligible|1|||
19681977|NCT00337077|42129186|FG002|Overall Study|Ineligible|1|||
19681978|NCT00428220|42129192|FG000|Overall Study|Participant died|8|||
19768153|NCT01667133|42221445|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
19768154|NCT01667133|42221446|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
19768155|NCT01667133|42221447|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
19604653|NCT00734578|42053515|FG002|Overall Study|Lack of Efficacy|5|||
19604654|NCT00734578|42053513|FG000|Overall Study|Randomized in error|1|||
19681979|NCT00428220|42129192|FG000|Overall Study|Global deterioration of health status|7|||
19681980|NCT00428220|42129192|FG000|Overall Study|Lost to Follow-up|4|||
19768156|NCT01667133|42221448|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
19604655|NCT00734578|42053514|FG001|Overall Study|Randomized in error|0|||
19604656|NCT00734578|42053515|FG002|Overall Study|Randomized in error|0|||
19604657|NCT00734578|42053513|FG000|Overall Study|Exclusion criteria|1|||
19768157|NCT01667133|42221449|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
19768158|NCT01667133|42221450|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
19768159|NCT01667133|42221451|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
19768160|NCT01667133|42221452|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
19768161|NCT01667133|42221441|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768162|NCT01667133|42221442|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768163|NCT01667133|42221443|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768164|NCT01667133|42221444|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
19768165|NCT01667133|42221445|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768166|NCT01667133|42221446|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768167|NCT01667133|42221447|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768168|NCT01667133|42221448|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768169|NCT01667133|42221449|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768170|NCT01667133|42221450|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768171|NCT01667133|42221451|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768172|NCT01667133|42221452|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
19768173|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
19768174|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
19768175|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
19768176|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
19768177|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
19768178|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
19768179|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
19768180|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
19768181|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
19768182|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
19768183|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
19768184|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
19768185|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768186|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768187|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768188|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768189|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768190|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768191|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768192|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768193|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768194|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
19768195|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768196|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
19768197|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
19768198|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
19768199|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
19768200|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
19768201|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
19768202|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
19768203|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
19768204|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
19768205|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
19768206|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
19768207|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
19768208|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
19768209|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768210|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768211|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768212|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768213|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768214|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768215|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768216|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768217|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768218|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
19768219|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768220|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
19768221|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Death|0|||
19768222|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Death|0|||
19768223|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Death|0|||
19768224|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Death|0|||
19768225|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Death|0|||
19768226|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Death|0|||
19768227|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Death|0|||
19768228|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Death|0|||
19768229|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Death|0|||
19768230|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Death|1|||
19768231|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Death|0|||
19768232|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Death|0|||
19768233|NCT01667133|42221441|FG000|Phase 2: Dose-expansion|Other|0|||
19768234|NCT01667133|42221442|FG001|Phase 2: Dose-expansion|Other|0|||
19768235|NCT01667133|42221443|FG002|Phase 2: Dose-expansion|Other|0|||
19768236|NCT01667133|42221444|FG003|Phase 2: Dose-expansion|Other|0|||
19768237|NCT01667133|42221445|FG004|Phase 2: Dose-expansion|Other|0|||
19768238|NCT01667133|42221446|FG005|Phase 2: Dose-expansion|Other|0|||
19768239|NCT01667133|42221447|FG006|Phase 2: Dose-expansion|Other|0|||
19768240|NCT01667133|42221448|FG007|Phase 2: Dose-expansion|Other|0|||
19768241|NCT01667133|42221449|FG008|Phase 2: Dose-expansion|Other|0|||
19768242|NCT01667133|42221450|FG009|Phase 2: Dose-expansion|Other|0|||
19768243|NCT01667133|42221451|FG010|Phase 2: Dose-expansion|Other|0|||
19768244|NCT01667133|42221452|FG011|Phase 2: Dose-expansion|Other|1|||
19768245|NCT01891344|42221517|FG000|Overall Study|Ongoing|6|||
19768246|NCT01891344|42221518|FG001|Overall Study|Ongoing|2|||
19768247|NCT01891344|42221519|FG002|Overall Study|Ongoing|0|||
19768248|NCT01891344|42221520|FG003|Overall Study|Ongoing|1|||
19768249|NCT01891344|42221521|FG004|Overall Study|Ongoing|4|||
19768250|NCT01891344|42221522|FG005|Overall Study|Ongoing|1|||
19768251|NCT01891344|42221523|FG006|Overall Study|Ongoing|0|||
19768252|NCT01891344|42221524|FG007|Overall Study|Ongoing|0|||
19768253|NCT01181778|42221546|FG000|Overall Study|Physician Decision|48|||
19768254|NCT00092118|42221554|FG000|Overall Study|Adverse Event|35|||
19768255|NCT00092118|42221555|FG001|Overall Study|Adverse Event|32|||
19768256|NCT00092118|42221554|FG000|Overall Study|Lack of Efficacy|12|||
19681981|NCT00428220|42129192|FG000|Overall Study|Objective progression or relapse|123|||
19681982|NCT00428220|42129192|FG000|Overall Study|Participant refused continued treatment|7|||
19681983|NCT00428220|42129192|FG000|Overall Study|Adverse Event|51|||
19681984|NCT00428220|42129192|FG000|Overall Study|Other|23|||
19681985|NCT00345579|42129222|FG000|Overall Study|Adverse Event|9|||
19681986|NCT00345579|42129223|FG001|Overall Study|Adverse Event|6|||
19681987|NCT00345579|42129222|FG000|Overall Study|Protocol Violation|14|||
19681988|NCT00345579|42129223|FG001|Overall Study|Protocol Violation|5|||
19681989|NCT00345579|42129222|FG000|Overall Study|Withdrawal by Subject|50|||
19681990|NCT00345579|42129223|FG001|Overall Study|Withdrawal by Subject|17|||
19681991|NCT00345579|42129222|FG000|Overall Study|Lost to Follow-up|82|||
19681992|NCT00345579|42129223|FG001|Overall Study|Lost to Follow-up|36|||
19681993|NCT00345579|42129222|FG000|Overall Study|Other|9|||
19681994|NCT00345579|42129223|FG001|Overall Study|Other|1|||
19681995|NCT00335829|42129230|FG000|Overall Study|Withdrawal by Subject|1|||
19681996|NCT00335829|42129230|FG000|Overall Study|Lost to Follow-up|1|||
19681997|NCT00335829|42129230|FG000|Overall Study|Adverse Event|1|||
19681998|NCT00344019|42129237|FG000|Overall Study|did not meet final inclusion criteria|0|||
19681999|NCT00344019|42129238|FG001|Overall Study|did not meet final inclusion criteria|0|||
19682000|NCT00344019|42129239|FG002|Overall Study|did not meet final inclusion criteria|74|||
19682001|NCT00535847|42129253|FG000|Overall Study|Adverse Event|5|||
19682002|NCT00535847|42129254|FG001|Overall Study|Adverse Event|3|||
19682003|NCT00535847|42129255|FG002|Overall Study|Adverse Event|2|||
19682004|NCT00535847|42129253|FG000|Overall Study|Non compliance|1|||
19682005|NCT00535847|42129254|FG001|Overall Study|Non compliance|1|||
19682006|NCT00535847|42129255|FG002|Overall Study|Non compliance|0|||
19682007|NCT00535847|42129253|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
19682008|NCT00535847|42129254|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
19682009|NCT00535847|42129255|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
19682010|NCT00334893|42129269|FG000|Overall Study|Not Treated|1|||
19682011|NCT00334893|42129270|FG001|Overall Study|Not Treated|0|||
19682012|NCT00334737|42129281|FG000|Hospital Phase|Death|1|||
19682013|NCT00334737|42129282|FG001|Hospital Phase|Death|2|||
19682014|NCT00334737|42129283|FG002|Hospital Phase|Death|3|||
19682015|NCT00334737|42129281|FG000|Hospital Phase|Withdrawal by Subject|0|||
19682016|NCT00334737|42129282|FG001|Hospital Phase|Withdrawal by Subject|0|||
19682017|NCT00334737|42129283|FG002|Hospital Phase|Withdrawal by Subject|1|||
19682018|NCT00334737|42129281|FG000|Hospital Phase|Did not receive study drug|1|||
19682019|NCT00334737|42129282|FG001|Hospital Phase|Did not receive study drug|0|||
19682020|NCT00334737|42129283|FG002|Hospital Phase|Did not receive study drug|0|||
19682021|NCT00334737|42129281|FG000|Follow up Phase|Lost to Follow-up|5|||
19682022|NCT00334737|42129282|FG001|Follow up Phase|Lost to Follow-up|3|||
19682023|NCT00334737|42129283|FG002|Follow up Phase|Lost to Follow-up|6|||
19682024|NCT00427908|42129295|FG000|Primary Phase|Lost to Follow-up|4|||
19682025|NCT00427908|42129296|FG001|Primary Phase|Lost to Follow-up|0|||
19682026|NCT00427908|42129297|FG002|Primary Phase|Lost to Follow-up|2|||
19682027|NCT00427908|42129298|FG003|Primary Phase|Lost to Follow-up|0|||
19682028|NCT00427908|42129295|FG000|Primary Phase|Withdrawal by Subject|1|||
19768257|NCT00092118|42221555|FG001|Overall Study|Lack of Efficacy|14|||
19768258|NCT00092118|42221554|FG000|Overall Study|Lost to Follow-up|4|||
19768259|NCT00092118|42221555|FG001|Overall Study|Lost to Follow-up|3|||
19768260|NCT00092118|42221554|FG000|Overall Study|Protocol Violation|23|||
19768261|NCT00092118|42221555|FG001|Overall Study|Protocol Violation|25|||
19768262|NCT00092118|42221554|FG000|Overall Study|Withdrawal by Subject|4|||
19768263|NCT00092118|42221555|FG001|Overall Study|Withdrawal by Subject|10|||
19768264|NCT00092118|42221554|FG000|Overall Study|Other|6|||
19768265|NCT00092118|42221555|FG001|Overall Study|Other|5|||
19768266|NCT03261947|42221566|FG000|Overall Study|Death|10|||
19682029|NCT00427908|42129296|FG001|Primary Phase|Withdrawal by Subject|2|||
19682030|NCT00427908|42129297|FG002|Primary Phase|Withdrawal by Subject|1|||
19682031|NCT00427908|42129298|FG003|Primary Phase|Withdrawal by Subject|0|||
19682032|NCT00427908|42129295|FG000|Primary Phase|Adverse Event|0|||
19682033|NCT00427908|42129296|FG001|Primary Phase|Adverse Event|1|||
19682034|NCT00427908|42129297|FG002|Primary Phase|Adverse Event|0|||
19768267|NCT03261947|42221567|FG001|Overall Study|Death|13|||
19768268|NCT03261947|42221568|FG002|Overall Study|Death|17|||
19768269|NCT03261947|42221569|FG003|Overall Study|Death|12|||
19768270|NCT03261947|42221570|FG004|Overall Study|Death|8|||
19768271|NCT03261947|42221566|FG000|Overall Study|Lost to Follow-up|0|||
19768272|NCT03261947|42221567|FG001|Overall Study|Lost to Follow-up|0|||
19768273|NCT03261947|42221568|FG002|Overall Study|Lost to Follow-up|2|||
19768274|NCT03261947|42221569|FG003|Overall Study|Lost to Follow-up|1|||
19768275|NCT03261947|42221570|FG004|Overall Study|Lost to Follow-up|0|||
19768276|NCT03261947|42221566|FG000|Overall Study|Withdrawal by Subject|0|||
19768277|NCT03261947|42221567|FG001|Overall Study|Withdrawal by Subject|0|||
19768278|NCT03261947|42221568|FG002|Overall Study|Withdrawal by Subject|3|||
19768279|NCT03261947|42221569|FG003|Overall Study|Withdrawal by Subject|0|||
19768280|NCT03261947|42221570|FG004|Overall Study|Withdrawal by Subject|1|||
19768281|NCT03261947|42221566|FG000|Overall Study|Site Terminated by Sponsor|0|||
19768282|NCT03261947|42221567|FG001|Overall Study|Site Terminated by Sponsor|0|||
19768283|NCT03261947|42221568|FG002|Overall Study|Site Terminated by Sponsor|4|||
19768284|NCT03261947|42221569|FG003|Overall Study|Site Terminated by Sponsor|7|||
19768285|NCT03261947|42221570|FG004|Overall Study|Site Terminated by Sponsor|5|||
19768286|NCT03261947|42221566|FG000|Overall Study|Reason not Specified|2|||
19768287|NCT03261947|42221567|FG001|Overall Study|Reason not Specified|0|||
19768288|NCT03261947|42221568|FG002|Overall Study|Reason not Specified|4|||
19768289|NCT03261947|42221569|FG003|Overall Study|Reason not Specified|1|||
19768290|NCT03261947|42221570|FG004|Overall Study|Reason not Specified|3|||
19768291|NCT03034044|42221586|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
19768292|NCT03098979|42221596|FG000|Overall Study|Adverse Event|1|||
19477246|NCT01482221|41756212|FG002|Overall Study|Adverse Event|3|||
19477247|NCT01482221|41756210|FG000|Overall Study|Withdrawal by Subject|10|||
19768293|NCT03098979|42221597|FG001|Overall Study|Adverse Event|0|||
19682035|NCT00427908|42129298|FG003|Primary Phase|Adverse Event|0|||
19682036|NCT00334113|42129335|FG000|Overall Study|Lost to Follow-up|2|||
19682037|NCT00334113|42129336|FG001|Overall Study|Lost to Follow-up|2|||
19682038|NCT00334113|42129335|FG000|Overall Study|Withdrawal by Subject|0|||
19682039|NCT00334113|42129336|FG001|Overall Study|Withdrawal by Subject|1|||
19682040|NCT00416598|42129342|FG000|Induction & Intensification|Adverse Event|38|||
19682041|NCT00416598|42129342|FG000|Induction & Intensification|Death|32|||
19768294|NCT03098979|42221598|FG002|Overall Study|Adverse Event|1|||
19768295|NCT03098979|42221599|FG003|Overall Study|Adverse Event|4|||
19768296|NCT03098979|42221600|FG004|Overall Study|Adverse Event|6|||
19768297|NCT03098979|42221601|FG005|Overall Study|Adverse Event|1|||
19768298|NCT03098979|42221596|FG000|Overall Study|Withdrawal by Subject|2|||
19768299|NCT03098979|42221597|FG001|Overall Study|Withdrawal by Subject|1|||
19768300|NCT03098979|42221598|FG002|Overall Study|Withdrawal by Subject|1|||
19768301|NCT03098979|42221599|FG003|Overall Study|Withdrawal by Subject|1|||
19768302|NCT03098979|42221600|FG004|Overall Study|Withdrawal by Subject|2|||
19768303|NCT03098979|42221601|FG005|Overall Study|Withdrawal by Subject|1|||
19768304|NCT03098979|42221596|FG000|Overall Study|Death|1|||
19768305|NCT03098979|42221597|FG001|Overall Study|Death|0|||
19768306|NCT03098979|42221598|FG002|Overall Study|Death|2|||
19768307|NCT03098979|42221599|FG003|Overall Study|Death|0|||
19768308|NCT03098979|42221600|FG004|Overall Study|Death|1|||
19768309|NCT03098979|42221601|FG005|Overall Study|Death|0|||
19768310|NCT03098979|42221596|FG000|Overall Study|Physician Decision|2|||
19768311|NCT03098979|42221597|FG001|Overall Study|Physician Decision|1|||
19768312|NCT03098979|42221598|FG002|Overall Study|Physician Decision|0|||
19682042|NCT00416598|42129342|FG000|Induction & Intensification|Withdrawal by Subject|46|||
19768313|NCT03098979|42221599|FG003|Overall Study|Physician Decision|0|||
19768314|NCT03098979|42221600|FG004|Overall Study|Physician Decision|0|||
19768315|NCT03098979|42221601|FG005|Overall Study|Physician Decision|0|||
19768316|NCT03098979|42221596|FG000|Overall Study|Non-compliance|0|||
19768317|NCT03098979|42221597|FG001|Overall Study|Non-compliance|0|||
19768318|NCT03098979|42221598|FG002|Overall Study|Non-compliance|0|||
19768319|NCT03098979|42221599|FG003|Overall Study|Non-compliance|0|||
19768320|NCT03098979|42221600|FG004|Overall Study|Non-compliance|0|||
19768321|NCT03098979|42221601|FG005|Overall Study|Non-compliance|1|||
19768322|NCT03098979|42221596|FG000|Overall Study|Protocol Violation|0|||
19768323|NCT03098979|42221597|FG001|Overall Study|Protocol Violation|0|||
19768324|NCT03098979|42221598|FG002|Overall Study|Protocol Violation|0|||
19768325|NCT03098979|42221599|FG003|Overall Study|Protocol Violation|0|||
19768326|NCT03098979|42221600|FG004|Overall Study|Protocol Violation|0|||
19768327|NCT03098979|42221601|FG005|Overall Study|Protocol Violation|1|||
19768328|NCT03261167|42221617|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
19768329|NCT03261167|42221618|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
19768330|NCT03261167|42221617|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
19682043|NCT00416598|42129342|FG000|Induction & Intensification|Alternative Treatment|135|||
19682044|NCT00416598|42129342|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
19682045|NCT00416598|42129342|FG000|Induction & Intensification|Relapse/progression|29|||
19682046|NCT00416598|42129342|FG000|Induction & Intensification|Failed induction|87|||
19682047|NCT00416598|42129342|FG000|Decitabine Maintenance|Adverse Event|5|||
19682048|NCT00416598|42129342|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
19682049|NCT00416598|42129342|FG000|Decitabine Maintenance|Progression/relapse|38|||
19682050|NCT00416598|42129342|FG000|Decitabine Maintenance|Alternative treatment|2|||
19682051|NCT00416598|42129342|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
19682052|NCT00534599|42129348|FG000|Overall Study|Adverse Event|25|||
19682053|NCT00534599|42129349|FG001|Overall Study|Adverse Event|4|||
19682054|NCT00534599|42129348|FG000|Overall Study|Incorrect enrollment|2|||
19682055|NCT00534599|42129349|FG001|Overall Study|Incorrect enrollment|1|||
19682056|NCT00534599|42129348|FG000|Overall Study|Mis-randomization|2|||
19682057|NCT00534599|42129349|FG001|Overall Study|Mis-randomization|2|||
19682058|NCT00534599|42129348|FG000|Overall Study|Developed study-specific d/c criteria|5|||
19682059|NCT00534599|42129349|FG001|Overall Study|Developed study-specific d/c criteria|0|||
19682060|NCT00534599|42129348|FG000|Overall Study|Lack of Efficacy|0|||
19682061|NCT00534599|42129349|FG001|Overall Study|Lack of Efficacy|1|||
19682062|NCT00534599|42129348|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
19682063|NCT00534599|42129349|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
19682064|NCT00534599|42129348|FG000|Overall Study|Protocol Violation|1|||
19682065|NCT00534599|42129349|FG001|Overall Study|Protocol Violation|3|||
19682066|NCT00534599|42129348|FG000|Overall Study|Lost to Follow-up|11|||
19682067|NCT00534599|42129349|FG001|Overall Study|Lost to Follow-up|14|||
19682068|NCT00534599|42129348|FG000|Overall Study|Withdrawal by Subject|4|||
19682069|NCT00534599|42129349|FG001|Overall Study|Withdrawal by Subject|6|||
19682070|NCT00534599|42129348|FG000|Overall Study|Other|7|||
19682071|NCT00534599|42129349|FG001|Overall Study|Other|0|||
19682072|NCT03892889|42129372|FG000|Overall Study|Adverse Event|17|||
19682073|NCT03892889|42129372|FG000|Overall Study|Lack of Efficacy|1|||
19682074|NCT03892889|42129372|FG000|Overall Study|Lost to Follow-up|46|||
19768331|NCT03261167|42221618|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
19768332|NCT03261167|42221617|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
19768333|NCT03261167|42221618|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
19768334|NCT03261167|42221617|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
19768335|NCT03261167|42221618|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
19768336|NCT03261167|42221617|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
19768337|NCT03261167|42221618|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
19768338|NCT03294941|42221632|FG000|Overall Study|Withdrawal by Subject|0|||
19768339|NCT03294941|42221633|FG001|Overall Study|Withdrawal by Subject|2|||
19768340|NCT03098433|42221640|FG000|Overall Study|Withdrawal by Subject|10|||
19768341|NCT03294317|42221645|FG000|Overall Study|Physician Decision|1|||
19768342|NCT03294317|42221645|FG000|Overall Study|Withdrawal by Subject|6|||
19768343|NCT03294317|42221645|FG000|Overall Study|Lost to Follow-up|1|||
19682075|NCT03892889|42129372|FG000|Overall Study|Non-compliance with study drug|22|||
19682076|NCT03892889|42129372|FG000|Overall Study|Pregnancy|1|||
19682077|NCT03892889|42129372|FG000|Overall Study|Protocol Deviation|3|||
19682078|NCT03892889|42129372|FG000|Overall Study|Withdrawal by Subject|50|||
19682079|NCT03892889|42129372|FG000|Overall Study|Withdrawal by Caregiver|1|||
19682080|NCT03892889|42129372|FG000|Overall Study|Study Terminated by Sponsor|50|||
19682081|NCT03892889|42129372|FG000|Overall Study|Physician Decision|8|||
19682082|NCT03892889|42129372|FG000|Overall Study|Reason not Specified|5|||
19682083|NCT00473330|42129379|FG000|Core Study|Adverse Event|4|||
19682084|NCT00473330|42129380|FG001|Core Study|Adverse Event|4|||
19682085|NCT00473330|42129381|FG002|Core Study|Adverse Event|1|||
19682086|NCT00473330|42129379|FG000|Core Study|Death|6|||
19682087|NCT00473330|42129380|FG001|Core Study|Death|4|||
19682088|NCT00473330|42129381|FG002|Core Study|Death|4|||
19682089|NCT00473330|42129379|FG000|Core Study|Lost to Follow-up|5|||
19682090|NCT00473330|42129380|FG001|Core Study|Lost to Follow-up|5|||
19682091|NCT00473330|42129381|FG002|Core Study|Lost to Follow-up|10|||
19682092|NCT00473330|42129379|FG000|Core Study|Physician Decision|2|||
19682093|NCT00473330|42129380|FG001|Core Study|Physician Decision|1|||
19682094|NCT00473330|42129381|FG002|Core Study|Physician Decision|3|||
19682095|NCT00473330|42129379|FG000|Core Study|Subject Non-compliance|1|||
19682096|NCT00473330|42129380|FG001|Core Study|Subject Non-compliance|2|||
19682097|NCT00473330|42129381|FG002|Core Study|Subject Non-compliance|1|||
19682098|NCT00473330|42129379|FG000|Core Study|Subject Required Other Therapy|0|||
19682099|NCT00473330|42129380|FG001|Core Study|Subject Required Other Therapy|1|||
19682100|NCT00473330|42129381|FG002|Core Study|Subject Required Other Therapy|3|||
19682101|NCT00473330|42129379|FG000|Core Study|Subject's Decision|9|||
19682102|NCT00473330|42129380|FG001|Core Study|Subject's Decision|8|||
19682103|NCT00473330|42129381|FG002|Core Study|Subject's Decision|19|||
19682104|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
19682105|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
19682106|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
19682107|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Death|2|||
19682108|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Death|0|||
19682109|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Death|0|||
19682110|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
19682111|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
19682112|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
19604658|NCT00734578|42053514|FG001|Overall Study|Exclusion criteria|0|||
19604659|NCT00734578|42053515|FG002|Overall Study|Exclusion criteria|0|||
19604660|NCT00739102|42053523|FG000|Overall Study|Death|5|||
19604661|NCT00739102|42053523|FG000|Overall Study|Withdrawal by Subject|10|||
19604662|NCT00959192|42053531|FG000|Overall Study|Adverse Event|1|||
19604663|NCT00959192|42053532|FG001|Overall Study|Adverse Event|1|||
19604664|NCT00959192|42053533|FG002|Overall Study|Adverse Event|1|||
19604665|NCT00959192|42053534|FG003|Overall Study|Adverse Event|0|||
19604666|NCT00959192|42053531|FG000|Overall Study|Investigator Request|1|||
19604667|NCT00959192|42053532|FG001|Overall Study|Investigator Request|0|||
19604668|NCT00959192|42053533|FG002|Overall Study|Investigator Request|0|||
19604669|NCT00959192|42053534|FG003|Overall Study|Investigator Request|0|||
19604670|NCT00959192|42053531|FG000|Overall Study|Caregiver Request|0|||
19604671|NCT00959192|42053532|FG001|Overall Study|Caregiver Request|0|||
19604672|NCT00959192|42053533|FG002|Overall Study|Caregiver Request|2|||
19604673|NCT00959192|42053534|FG003|Overall Study|Caregiver Request|1|||
19682113|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
19682114|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
19682115|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
19682116|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
19682117|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
19682118|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
19682119|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
19682120|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
19682121|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
19604674|NCT00696787|42053548|FG000|Overall Study|Adverse Event|1|||
19604675|NCT00696787|42053549|FG001|Overall Study|Adverse Event|0|||
19604676|NCT00696787|42053550|FG002|Overall Study|Adverse Event|6|||
19604677|NCT00696787|42053548|FG000|Overall Study|Discontinuation by Sponsor|9|||
19604678|NCT00696787|42053549|FG001|Overall Study|Discontinuation by Sponsor|13|||
19604679|NCT00696787|42053550|FG002|Overall Study|Discontinuation by Sponsor|14|||
19604680|NCT00696787|42053548|FG000|Overall Study|Lack of Efficacy|0|||
19604681|NCT00696787|42053549|FG001|Overall Study|Lack of Efficacy|1|||
19604682|NCT00696787|42053550|FG002|Overall Study|Lack of Efficacy|0|||
19604683|NCT00696787|42053548|FG000|Overall Study|Lost to Follow-up|4|||
19604684|NCT00696787|42053549|FG001|Overall Study|Lost to Follow-up|0|||
19604685|NCT00696787|42053550|FG002|Overall Study|Lost to Follow-up|3|||
19682122|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
19682123|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
19682124|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
19682125|NCT00473330|42129379|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
19682126|NCT00473330|42129380|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
19682127|NCT00473330|42129381|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
19604686|NCT00696787|42053548|FG000|Overall Study|Withdrawal by Subject|0|||
19604687|NCT00696787|42053549|FG001|Overall Study|Withdrawal by Subject|3|||
19604688|NCT00696787|42053550|FG002|Overall Study|Withdrawal by Subject|2|||
19682128|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
19604689|NCT00696787|42053548|FG000|Overall Study|Failed to return|1|||
19604690|NCT00696787|42053549|FG001|Overall Study|Failed to return|3|||
19604691|NCT00696787|42053550|FG002|Overall Study|Failed to return|1|||
19604692|NCT01012037|42053561|FG000|Overall Study|Adverse Event|0|||
19604693|NCT01012037|42053562|FG001|Overall Study|Adverse Event|8|||
19604694|NCT01012037|42053563|FG002|Overall Study|Adverse Event|3|||
19604695|NCT01012037|42053561|FG000|Overall Study|Protocol Violation|0|||
19604696|NCT01012037|42053562|FG001|Overall Study|Protocol Violation|3|||
19604697|NCT01012037|42053563|FG002|Overall Study|Protocol Violation|5|||
19604698|NCT01012037|42053561|FG000|Overall Study|Withdrawal by Subject|0|||
19604699|NCT01012037|42053562|FG001|Overall Study|Withdrawal by Subject|4|||
19604700|NCT01012037|42053563|FG002|Overall Study|Withdrawal by Subject|1|||
19604701|NCT01012037|42053561|FG000|Overall Study|Other reason (not specified)|1|||
19604702|NCT01012037|42053562|FG001|Overall Study|Other reason (not specified)|1|||
19604703|NCT01012037|42053563|FG002|Overall Study|Other reason (not specified)|1|||
19682129|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
19682130|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
19682131|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Death|2|||
19682132|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Death|2|||
19682133|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Death|1|||
19682134|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
19682135|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
19682136|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
19682137|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
19682138|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
19682139|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
19682140|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
19682141|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
19682142|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
19682143|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
19682144|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
19682145|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
19682146|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
19682147|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
19682148|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
19682149|NCT00473330|42129379|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
19682150|NCT00473330|42129380|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
19682151|NCT00473330|42129381|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
19682152|NCT00416520|42129411|FG000|Open-label Period|Adverse Event|28|||
19682153|NCT00416520|42129412|FG001|Open-label Period|Adverse Event|10|||
19682154|NCT00416520|42129413|FG002|Open-label Period|Adverse Event|0|||
19682155|NCT00416520|42129414|FG003|Open-label Period|Adverse Event|0|||
19682156|NCT00416520|42129411|FG000|Open-label Period|Death|2|||
19682157|NCT00416520|42129412|FG001|Open-label Period|Death|1|||
19682158|NCT00416520|42129413|FG002|Open-label Period|Death|0|||
19682159|NCT00416520|42129414|FG003|Open-label Period|Death|0|||
19682160|NCT00416520|42129411|FG000|Open-label Period|Lack of Efficacy|8|||
19768344|NCT03294317|42221645|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
19768345|NCT03294317|42221645|FG000|Overall Study|Failed HB lead implant|8|||
19768346|NCT03294317|42221645|FG000|Overall Study|Received CRT instead|1|||
19768347|NCT03294317|42221645|FG000|Overall Study|Exited after lead revision|2|||
19768348|NCT03292913|42221651|FG000|Overall Study|Death|9|||
19768349|NCT03292913|42221652|FG001|Overall Study|Death|3|||
19604704|NCT00734032|42053575|FG000|Overall Study|Adverse Event|0|||
19604705|NCT00734032|42053576|FG001|Overall Study|Adverse Event|1|||
19682161|NCT00416520|42129412|FG001|Open-label Period|Lack of Efficacy|1|||
19682162|NCT00416520|42129413|FG002|Open-label Period|Lack of Efficacy|0|||
19682163|NCT00416520|42129414|FG003|Open-label Period|Lack of Efficacy|0|||
19768350|NCT03292913|42221651|FG000|Overall Study|Lost to Follow-up|49|||
19682164|NCT00416520|42129411|FG000|Open-label Period|Protocol Violation|3|||
19682165|NCT00416520|42129412|FG001|Open-label Period|Protocol Violation|3|||
19682166|NCT00416520|42129413|FG002|Open-label Period|Protocol Violation|0|||
19682167|NCT00416520|42129414|FG003|Open-label Period|Protocol Violation|0|||
19682168|NCT00416520|42129411|FG000|Open-label Period|Withdrawal by Subject|16|||
19682169|NCT00416520|42129412|FG001|Open-label Period|Withdrawal by Subject|5|||
19682170|NCT00416520|42129413|FG002|Open-label Period|Withdrawal by Subject|0|||
19682171|NCT00416520|42129414|FG003|Open-label Period|Withdrawal by Subject|0|||
19682172|NCT00416520|42129411|FG000|Open-label Period|Other Reasons|3|||
19682173|NCT00416520|42129412|FG001|Open-label Period|Other Reasons|12|||
19682174|NCT00416520|42129413|FG002|Open-label Period|Other Reasons|0|||
19682175|NCT00416520|42129414|FG003|Open-label Period|Other Reasons|0|||
19682176|NCT00416520|42129411|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
19682177|NCT00416520|42129412|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
19682178|NCT00416520|42129413|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
19682179|NCT00416520|42129414|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
19682180|NCT00416520|42129411|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
19604706|NCT00734032|42053577|FG002|Overall Study|Adverse Event|0|||
19682181|NCT00416520|42129412|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
19682182|NCT00416520|42129413|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
19682183|NCT00416520|42129414|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
19682184|NCT00416520|42129411|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
19682185|NCT00416520|42129412|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
19768351|NCT03292913|42221652|FG001|Overall Study|Lost to Follow-up|49|||
19604707|NCT00734032|42053578|FG003|Overall Study|Adverse Event|0|||
19768352|NCT03292913|42221651|FG000|Overall Study|Withdrawal by Subject|2|||
19768353|NCT03292913|42221652|FG001|Overall Study|Withdrawal by Subject|0|||
19768354|NCT03292913|42221651|FG000|Overall Study|Clinic closed due to COVID|22|||
19768355|NCT03292913|42221652|FG001|Overall Study|Clinic closed due to COVID|36|||
19768356|NCT03291587|42221664|FG000|Overall Study|Lost to Follow-up|62|||
19768357|NCT03291587|42221665|FG001|Overall Study|Lost to Follow-up|43|||
19768358|NCT03291587|42221664|FG000|Overall Study|Refused to Answer|5|||
19768359|NCT03291587|42221665|FG001|Overall Study|Refused to Answer|2|||
19768360|NCT03291587|42221664|FG000|Overall Study|Death|2|||
19604708|NCT01010633|42053590|FG000|Overall Study|Adverse Event|1|||
19604709|NCT01010633|42053591|FG001|Overall Study|Adverse Event|1|||
19604710|NCT01010633|42053590|FG000|Overall Study|Protocol Violation|1|||
19604711|NCT01010633|42053591|FG001|Overall Study|Protocol Violation|2|||
19604712|NCT01010633|42053590|FG000|Overall Study|Withdrawal by Subject|2|||
19604713|NCT01010633|42053591|FG001|Overall Study|Withdrawal by Subject|1|||
19604714|NCT01010633|42053590|FG000|Overall Study|Investigator decision|0|||
19604715|NCT01010633|42053591|FG001|Overall Study|Investigator decision|1|||
19604716|NCT00733954|42053599|FG000|Overall Study|Lost to Follow-up|5|||
19604717|NCT00733954|42053600|FG001|Overall Study|Lost to Follow-up|2|||
19604718|NCT00733954|42053599|FG000|Overall Study|Protocol Violation|1|||
19604719|NCT00733954|42053600|FG001|Overall Study|Protocol Violation|0|||
19604720|NCT00733954|42053599|FG000|Overall Study|Withdrawal by Subject|2|||
19604721|NCT00733954|42053600|FG001|Overall Study|Withdrawal by Subject|0|||
19604722|NCT00733408|42053606|FG000|Overall Study|Adverse Event|4|||
19604723|NCT01010867|42053610|FG000|Overall Study|< 50% adherence to probiotic|1|||
19604724|NCT00576823|42053617|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
19604725|NCT00576823|42053618|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
19604726|NCT00576823|42053619|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
19604727|NCT00576823|42053617|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
19604728|NCT00576823|42053618|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
19604729|NCT00576823|42053619|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
19604730|NCT00732940|42053632|FG000|Overall Study|Withdrawal by Subject|1|||
19604731|NCT00732940|42053633|FG001|Overall Study|Withdrawal by Subject|2|||
19604732|NCT00732940|42053632|FG000|Overall Study|Adverse Event|0|||
19604733|NCT00732940|42053633|FG001|Overall Study|Adverse Event|1|||
19604734|NCT00732940|42053632|FG000|Overall Study|Lost to Follow-up|1|||
19604735|NCT00732940|42053633|FG001|Overall Study|Lost to Follow-up|0|||
19604736|NCT00962390|42053643|FG000|Overall Study|Adverse Event|0|||
19604737|NCT00962390|42053644|FG001|Overall Study|Adverse Event|0|||
19604738|NCT00962390|42053645|FG002|Overall Study|Adverse Event|3|||
19604739|NCT00962390|42053646|FG003|Overall Study|Adverse Event|1|||
19604740|NCT00962390|42053643|FG000|Overall Study|Lost to Follow-up|2|||
19604741|NCT00962390|42053644|FG001|Overall Study|Lost to Follow-up|2|||
19604742|NCT00962390|42053645|FG002|Overall Study|Lost to Follow-up|0|||
19604743|NCT00962390|42053646|FG003|Overall Study|Lost to Follow-up|0|||
19604744|NCT00962390|42053643|FG000|Overall Study|Protocol Violation|1|||
19604745|NCT00962390|42053644|FG001|Overall Study|Protocol Violation|0|||
19604746|NCT00962390|42053645|FG002|Overall Study|Protocol Violation|0|||
19682186|NCT00416520|42129413|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
19604747|NCT00962390|42053646|FG003|Overall Study|Protocol Violation|0|||
19604748|NCT00962390|42053643|FG000|Overall Study|Withdrawal by Subject|1|||
19604749|NCT00962390|42053644|FG001|Overall Study|Withdrawal by Subject|1|||
19604750|NCT00962390|42053645|FG002|Overall Study|Withdrawal by Subject|1|||
19604751|NCT00962390|42053646|FG003|Overall Study|Withdrawal by Subject|0|||
19768361|NCT03291587|42221665|FG001|Overall Study|Death|4|||
19768362|NCT03291587|42221664|FG000|Overall Study|Not interested in participating|8|||
19768363|NCT03291587|42221665|FG001|Overall Study|Not interested in participating|6|||
19768364|NCT03291587|42221664|FG000|Overall Study|Too busy to participate|4|||
19768365|NCT03291587|42221665|FG001|Overall Study|Too busy to participate|2|||
19768366|NCT03210961|42221696|FG000|Overall Study|Adverse Event|0|||
19768367|NCT03210961|42221697|FG001|Overall Study|Adverse Event|0|||
19768368|NCT03210961|42221698|FG002|Overall Study|Adverse Event|0|||
19768369|NCT03210961|42221699|FG003|Overall Study|Adverse Event|0|||
19768370|NCT03210961|42221700|FG004|Overall Study|Adverse Event|0|||
19768371|NCT03210961|42221701|FG005|Overall Study|Adverse Event|0|||
19768372|NCT03210961|42221702|FG006|Overall Study|Adverse Event|0|||
19768373|NCT03210961|42221703|FG007|Overall Study|Adverse Event|0|||
19768374|NCT03210961|42221704|FG008|Overall Study|Adverse Event|0|||
19768375|NCT03210961|42221705|FG009|Overall Study|Adverse Event|0|||
19768376|NCT03210961|42221706|FG010|Overall Study|Adverse Event|0|||
19768377|NCT03210961|42221707|FG011|Overall Study|Adverse Event|0|||
19768378|NCT03210961|42221708|FG012|Overall Study|Adverse Event|0|||
19768379|NCT03210961|42221709|FG013|Overall Study|Adverse Event|1|||
19768380|NCT03210961|42221710|FG014|Overall Study|Adverse Event|0|||
19768381|NCT03210961|42221696|FG000|Overall Study|Lost to Follow-up|0|||
19768382|NCT03210961|42221697|FG001|Overall Study|Lost to Follow-up|0|||
19768383|NCT03210961|42221698|FG002|Overall Study|Lost to Follow-up|0|||
19604752|NCT00732472|42053660|FG000|Overall Study|Adverse Event|0|||
19604753|NCT00732472|42053661|FG001|Overall Study|Adverse Event|1|||
19604754|NCT00732472|42053662|FG002|Overall Study|Adverse Event|1|||
19604755|NCT00732472|42053663|FG003|Overall Study|Adverse Event|1|||
19604756|NCT00732472|42053660|FG000|Overall Study|Protocol Violation|0|||
19604757|NCT00732472|42053661|FG001|Overall Study|Protocol Violation|0|||
19604758|NCT00732472|42053662|FG002|Overall Study|Protocol Violation|0|||
19682187|NCT00416520|42129414|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
19682188|NCT00533429|42129426|FG000|Overall Study|Adverse Event|3|||
19682189|NCT00533429|42129427|FG001|Overall Study|Adverse Event|1|||
19682190|NCT00533429|42129426|FG000|Overall Study|Death|1|||
19682191|NCT00533429|42129427|FG001|Overall Study|Death|0|||
19682192|NCT00533429|42129426|FG000|Overall Study|Withdrawal by Subject|2|||
19682193|NCT00533429|42129427|FG001|Overall Study|Withdrawal by Subject|0|||
19682194|NCT00533429|42129426|FG000|Overall Study|Progressive Disease|12|||
19682195|NCT00533429|42129427|FG001|Overall Study|Progressive Disease|13|||
19682196|NCT00533429|42129426|FG000|Overall Study|Symptomatic deterioration|1|||
19604759|NCT00732472|42053663|FG003|Overall Study|Protocol Violation|1|||
19604760|NCT00732472|42053660|FG000|Overall Study|Withdrawal by Subject|0|||
19604761|NCT00732472|42053661|FG001|Overall Study|Withdrawal by Subject|2|||
19604762|NCT00732472|42053662|FG002|Overall Study|Withdrawal by Subject|0|||
19604763|NCT00732472|42053663|FG003|Overall Study|Withdrawal by Subject|1|||
19604764|NCT00960986|42053678|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
19604765|NCT00960986|42053679|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
19604766|NCT00960986|42053680|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
19604767|NCT00960986|42053681|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
19604768|NCT00960986|42053678|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
19604769|NCT00960986|42053679|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
19604770|NCT00960986|42053680|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
19604771|NCT00960986|42053681|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
19604772|NCT00960986|42053678|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
19604773|NCT00960986|42053679|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
19604774|NCT00960986|42053680|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
19604775|NCT00960986|42053681|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
19604776|NCT00960986|42053678|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
19604777|NCT00960986|42053679|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
19604778|NCT00960986|42053680|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
19604779|NCT00960986|42053681|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
19604780|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
19604781|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
19682197|NCT00533429|42129427|FG001|Overall Study|Symptomatic deterioration|2|||
19768384|NCT03210961|42221699|FG003|Overall Study|Lost to Follow-up|0|||
19768385|NCT03210961|42221700|FG004|Overall Study|Lost to Follow-up|0|||
19768386|NCT03210961|42221701|FG005|Overall Study|Lost to Follow-up|0|||
19768387|NCT03210961|42221702|FG006|Overall Study|Lost to Follow-up|0|||
19682198|NCT00533273|42129437|FG000|Double-blind|Withdrew consent|0|||
19768388|NCT03210961|42221703|FG007|Overall Study|Lost to Follow-up|0|||
19768389|NCT03210961|42221704|FG008|Overall Study|Lost to Follow-up|0|||
19768390|NCT03210961|42221705|FG009|Overall Study|Lost to Follow-up|0|||
19682199|NCT00533273|42129438|FG001|Double-blind|Withdrew consent|2|||
19682200|NCT00533273|42129437|FG000|Open-label|Withdrawal by Subject|6|||
19682201|NCT00533273|42129438|FG001|Open-label|Withdrawal by Subject|0|||
19682202|NCT03891641|42129446|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
19682203|NCT03891641|42129447|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
19682204|NCT00339183|42129455|FG000|Overall Study|Adverse Event|5|||
19682205|NCT00339183|42129456|FG001|Overall Study|Adverse Event|3|||
19682206|NCT00339183|42129455|FG000|Overall Study|Withdrawal by Subject|16|||
19682207|NCT00339183|42129456|FG001|Overall Study|Withdrawal by Subject|19|||
19682208|NCT00339183|42129455|FG000|Overall Study|Physician Decision|2|||
19682209|NCT00339183|42129456|FG001|Overall Study|Physician Decision|4|||
19682210|NCT00339183|42129455|FG000|Overall Study|Lost to Follow-up|17|||
19682211|NCT00339183|42129456|FG001|Overall Study|Lost to Follow-up|17|||
19682212|NCT00339183|42129455|FG000|Overall Study|Protocol-specified criteria|12|||
19682213|NCT00339183|42129456|FG001|Overall Study|Protocol-specified criteria|8|||
19682214|NCT00339183|42129455|FG000|Overall Study|Missing reason|3|||
19682215|NCT00339183|42129456|FG001|Overall Study|Missing reason|1|||
19682216|NCT00339183|42129455|FG000|Overall Study|Other|46|||
19682217|NCT00339183|42129456|FG001|Overall Study|Other|40|||
19682218|NCT00339183|42129455|FG000|Overall Study|Ongoing|20|||
19682219|NCT00339183|42129456|FG001|Overall Study|Ongoing|13|||
19682220|NCT00333801|42129468|FG000|Overall Study|Moved to another state|5|||
19682221|NCT00333801|42129469|FG001|Overall Study|Moved to another state|3|||
19682222|NCT00333801|42129468|FG000|Overall Study|Lost to Follow-up|2|||
19682223|NCT00333801|42129469|FG001|Overall Study|Lost to Follow-up|0|||
19682224|NCT00333801|42129468|FG000|Overall Study|Incarcerated|1|||
19682225|NCT00333801|42129469|FG001|Overall Study|Incarcerated|2|||
19682226|NCT00333801|42129468|FG000|Overall Study|Withdrawal by Subject|0|||
19682227|NCT00333801|42129469|FG001|Overall Study|Withdrawal by Subject|1|||
19682228|NCT00532883|42129479|FG000|Overall Study|Adverse Event|1|||
19682229|NCT00532883|42129480|FG001|Overall Study|Adverse Event|0|||
19682230|NCT00532883|42129481|FG002|Overall Study|Adverse Event|0|||
19682231|NCT00532883|42129482|FG003|Overall Study|Adverse Event|1|||
19682232|NCT00532883|42129479|FG000|Overall Study|Lost to Follow-up|1|||
19682233|NCT00532883|42129480|FG001|Overall Study|Lost to Follow-up|1|||
19682234|NCT00532883|42129481|FG002|Overall Study|Lost to Follow-up|1|||
19682235|NCT00532883|42129482|FG003|Overall Study|Lost to Follow-up|0|||
19682236|NCT00532883|42129479|FG000|Overall Study|Withdrawal by Subject|0|||
19682237|NCT00532883|42129480|FG001|Overall Study|Withdrawal by Subject|1|||
19682238|NCT00532883|42129481|FG002|Overall Study|Withdrawal by Subject|1|||
19682239|NCT00532883|42129482|FG003|Overall Study|Withdrawal by Subject|0|||
19682240|NCT00532883|42129479|FG000|Overall Study|Subject was Nonadherent|0|||
19682241|NCT00532883|42129480|FG001|Overall Study|Subject was Nonadherent|1|||
19682242|NCT00532883|42129481|FG002|Overall Study|Subject was Nonadherent|1|||
19682243|NCT00532883|42129482|FG003|Overall Study|Subject was Nonadherent|0|||
19682244|NCT00532883|42129479|FG000|Overall Study|Early Study Termination|4|||
19682245|NCT00532883|42129480|FG001|Overall Study|Early Study Termination|4|||
19682246|NCT00532883|42129481|FG002|Overall Study|Early Study Termination|1|||
19682247|NCT00532883|42129482|FG003|Overall Study|Early Study Termination|4|||
19682248|NCT00354159|42129494|FG000|Randomized Study Period|Withdrawal by Subject|5|||
19682249|NCT00354159|42129495|FG001|Randomized Study Period|Withdrawal by Subject|3|||
19682250|NCT00354159|42129494|FG000|Randomized Study Period|Physician Decision|6|||
19682251|NCT00354159|42129495|FG001|Randomized Study Period|Physician Decision|10|||
19682252|NCT00354159|42129494|FG000|Randomized Study Period|Lost to Follow-up|4|||
19682253|NCT00354159|42129495|FG001|Randomized Study Period|Lost to Follow-up|0|||
19682254|NCT00354159|42129494|FG000|Randomized Study Period|Death|7|||
19682255|NCT00354159|42129495|FG001|Randomized Study Period|Death|9|||
19682256|NCT00354159|42129494|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
19682257|NCT00354159|42129495|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
19682258|NCT00354159|42129494|FG000|Long-term Follow-up|Physician Decision|127|||
19682259|NCT00354159|42129495|FG001|Long-term Follow-up|Physician Decision|122|||
19682260|NCT00354159|42129494|FG000|Long-term Follow-up|Lost to Follow-up|1|||
19682261|NCT00354159|42129495|FG001|Long-term Follow-up|Lost to Follow-up|0|||
19682262|NCT00354159|42129494|FG000|Long-term Follow-up|Death|14|||
19682263|NCT00354159|42129495|FG001|Long-term Follow-up|Death|11|||
19682264|NCT00354159|42129494|FG000|Long-term Follow-up|Study Closed|29|||
19682265|NCT00354159|42129495|FG001|Long-term Follow-up|Study Closed|34|||
19682266|NCT00338949|42129510|FG000|Subject Screening|Screen failures|11|||
19682267|NCT00338949|42129511|FG001|Subject Screening|Screen failures|11|||
19682268|NCT00338949|42129510|FG000|Randomization|Withdrawal by Subject|1|||
19682269|NCT00338949|42129511|FG001|Randomization|Withdrawal by Subject|0|||
19682270|NCT00338949|42129510|FG000|Randomization|Adverse Event|0|||
19682271|NCT00338949|42129511|FG001|Randomization|Adverse Event|5|||
19682272|NCT00332709|42129519|FG000|Overall Study|Adverse Event|11|||
19682273|NCT00332709|42129520|FG001|Overall Study|Adverse Event|14|||
19682274|NCT00332709|42129519|FG000|Overall Study|Withdrawal by Subject|2|||
19682275|NCT00332709|42129520|FG001|Overall Study|Withdrawal by Subject|3|||
19682276|NCT00332709|42129519|FG000|Overall Study|Lost to Follow-up|2|||
19682277|NCT00332709|42129520|FG001|Overall Study|Lost to Follow-up|0|||
19604782|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
19604783|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
19604784|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Death|0|||
19682278|NCT00332709|42129519|FG000|Overall Study|Administrative Problems|0|||
19682279|NCT00332709|42129520|FG001|Overall Study|Administrative Problems|3|||
19682280|NCT00332709|42129519|FG000|Overall Study|Abnormal test procedure result|1|||
19682281|NCT00332709|42129520|FG001|Overall Study|Abnormal test procedure result|0|||
19682282|NCT00332241|42129528|FG000|Overall Study|Lack of Efficacy|6|||
19682283|NCT00332241|42129529|FG001|Overall Study|Lack of Efficacy|1|||
19682284|NCT00332241|42129528|FG000|Overall Study|Adverse Event|3|||
19682285|NCT00332241|42129529|FG001|Overall Study|Adverse Event|5|||
19682286|NCT00332241|42129528|FG000|Overall Study|Withdrawal by Subject|2|||
19768391|NCT03210961|42221706|FG010|Overall Study|Lost to Follow-up|0|||
19768392|NCT03210961|42221707|FG011|Overall Study|Lost to Follow-up|0|||
19768393|NCT03210961|42221708|FG012|Overall Study|Lost to Follow-up|0|||
19768394|NCT03210961|42221709|FG013|Overall Study|Lost to Follow-up|0|||
19768395|NCT03210961|42221710|FG014|Overall Study|Lost to Follow-up|1|||
19768396|NCT03210961|42221696|FG000|Overall Study|Withdrawal by Subject|0|||
19768397|NCT03210961|42221697|FG001|Overall Study|Withdrawal by Subject|0|||
19768398|NCT03210961|42221698|FG002|Overall Study|Withdrawal by Subject|0|||
19768399|NCT03210961|42221699|FG003|Overall Study|Withdrawal by Subject|0|||
19768400|NCT03210961|42221700|FG004|Overall Study|Withdrawal by Subject|0|||
19768401|NCT03210961|42221701|FG005|Overall Study|Withdrawal by Subject|0|||
19768402|NCT03210961|42221702|FG006|Overall Study|Withdrawal by Subject|0|||
19768403|NCT03210961|42221703|FG007|Overall Study|Withdrawal by Subject|0|||
19768404|NCT03210961|42221704|FG008|Overall Study|Withdrawal by Subject|0|||
19768405|NCT03210961|42221705|FG009|Overall Study|Withdrawal by Subject|0|||
19768406|NCT03210961|42221706|FG010|Overall Study|Withdrawal by Subject|0|||
19768407|NCT03210961|42221707|FG011|Overall Study|Withdrawal by Subject|0|||
19768408|NCT03210961|42221708|FG012|Overall Study|Withdrawal by Subject|0|||
19768409|NCT03210961|42221709|FG013|Overall Study|Withdrawal by Subject|0|||
19604785|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Death|0|||
19604786|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Death|1|||
19604787|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Death|0|||
19604788|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
19604789|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
19604790|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
19604791|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
19604792|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
19604793|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
19604794|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
19604795|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
19604796|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
19604797|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
19682287|NCT00332241|42129529|FG001|Overall Study|Withdrawal by Subject|1|||
19682288|NCT00332241|42129528|FG000|Overall Study|Lost to Follow-up|4|||
19604798|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
19604799|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
19604800|NCT00960986|42053678|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
19604801|NCT00960986|42053679|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
19604802|NCT00960986|42053680|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
19604803|NCT00960986|42053681|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
19604804|NCT00732238|42053693|FG000|Overall Study|Bacteremia|4|||
19604805|NCT00732238|42053694|FG001|Overall Study|Bacteremia|1|||
19682289|NCT00332241|42129529|FG001|Overall Study|Lost to Follow-up|1|||
19682290|NCT00337935|42129537|FG000|Overall Study|Adverse Event|2|||
19682291|NCT00337935|42129538|FG001|Overall Study|Adverse Event|5|||
19682292|NCT00337935|42129537|FG000|Overall Study|Death|2|||
19682293|NCT00337935|42129538|FG001|Overall Study|Death|8|||
19682294|NCT00337935|42129537|FG000|Overall Study|Physician Decision|1|||
19682295|NCT00337935|42129538|FG001|Overall Study|Physician Decision|1|||
19682296|NCT00337935|42129537|FG000|Overall Study|Lost to Follow-up|0|||
19682297|NCT00337935|42129538|FG001|Overall Study|Lost to Follow-up|1|||
19682298|NCT00337935|42129537|FG000|Overall Study|Protocol Violation|4|||
19682299|NCT00337935|42129538|FG001|Overall Study|Protocol Violation|3|||
19682300|NCT00337935|42129537|FG000|Overall Study|Withdrawal by Subject|1|||
19768410|NCT03210961|42221710|FG014|Overall Study|Withdrawal by Subject|1|||
19768411|NCT03210961|42221696|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768412|NCT03210961|42221697|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768413|NCT03210961|42221698|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
19682301|NCT00337935|42129538|FG001|Overall Study|Withdrawal by Subject|7|||
19682302|NCT00337935|42129537|FG000|Overall Study|Other|0|||
19682303|NCT00337935|42129538|FG001|Overall Study|Other|1|||
19682304|NCT00337935|42129537|FG000|Overall Study|Lack of Efficacy|0|||
19682305|NCT00337935|42129538|FG001|Overall Study|Lack of Efficacy|1|||
19682306|NCT00337779|42129547|FG000|Overall Study|Withdrawal by Subject|10|||
19682307|NCT00337779|42129548|FG001|Overall Study|Withdrawal by Subject|12|||
19682308|NCT00337779|42129547|FG000|Overall Study|Sponsor decision|1|||
19682309|NCT00337779|42129548|FG001|Overall Study|Sponsor decision|1|||
19682310|NCT00337779|42129547|FG000|Overall Study|Physician Decision|3|||
19682311|NCT00337779|42129548|FG001|Overall Study|Physician Decision|6|||
19682312|NCT00337779|42129547|FG000|Overall Study|Protocol Violation|1|||
19682313|NCT00337779|42129548|FG001|Overall Study|Protocol Violation|1|||
19682314|NCT00337779|42129547|FG000|Overall Study|Lost to Follow-up|6|||
19682315|NCT00337779|42129548|FG001|Overall Study|Lost to Follow-up|5|||
19682316|NCT00337779|42129547|FG000|Overall Study|Adverse Event|28|||
19682317|NCT00337779|42129548|FG001|Overall Study|Adverse Event|51|||
19682318|NCT00337779|42129547|FG000|Overall Study|Pregnancy|3|||
19682319|NCT00337779|42129548|FG001|Overall Study|Pregnancy|2|||
19682320|NCT00337779|42129547|FG000|Overall Study|Death|0|||
19682321|NCT00337779|42129548|FG001|Overall Study|Death|1|||
19682322|NCT00352755|42129554|FG000|Overall Study|Physician Decision|1|||
19682323|NCT00352755|42129554|FG000|Overall Study|Adverse Event|1|||
19682324|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
19768414|NCT03210961|42221699|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
19682325|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
19682326|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
19682327|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
19682328|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
19682329|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
19604806|NCT00732238|42053693|FG000|Overall Study|Asymptomatic bacteriuria|1|||
19682330|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
19682331|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
19682332|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
19604807|NCT00732238|42053694|FG001|Overall Study|Asymptomatic bacteriuria|0|||
19682333|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682334|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682335|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682336|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682337|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682338|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19682339|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
19604808|NCT00958880|42053704|FG000|Overall Study|Lost to Follow-up|2|||
19682340|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
19682341|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682342|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682343|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682344|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682345|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682346|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682347|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
19682348|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
19604809|NCT00958880|42053705|FG001|Overall Study|Lost to Follow-up|2|||
19604810|NCT00732160|42053715|FG000|Overall Study|Adverse Event|1|||
19604811|NCT00732160|42053716|FG001|Overall Study|Adverse Event|0|||
19604812|NCT00732160|42053717|FG002|Overall Study|Adverse Event|1|||
19604813|NCT00732160|42053718|FG003|Overall Study|Adverse Event|1|||
19604814|NCT00732160|42053715|FG000|Overall Study|scheduling|4|||
19604815|NCT00732160|42053716|FG001|Overall Study|scheduling|4|||
19604816|NCT00732160|42053717|FG002|Overall Study|scheduling|2|||
19682349|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682350|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19604817|NCT00732160|42053718|FG003|Overall Study|scheduling|1|||
19604818|NCT00958724|42053728|FG000|Overall Study|Disease Progression|6|||
19682351|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682352|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682353|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682354|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682355|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
19682356|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
19682357|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682358|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682359|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682360|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682361|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682362|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682363|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
19682364|NCT00533897|42129561|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
19682365|NCT00533897|42129562|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682366|NCT00533897|42129563|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682367|NCT00533897|42129564|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682368|NCT00533897|42129565|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682369|NCT00533897|42129566|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682370|NCT00533897|42129567|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19682371|NCT00533897|42129568|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
19768415|NCT03210961|42221700|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768416|NCT03210961|42221701|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768417|NCT03210961|42221702|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768418|NCT03210961|42221703|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768419|NCT03210961|42221704|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768420|NCT03210961|42221705|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768421|NCT03210961|42221706|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768422|NCT03210961|42221707|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768423|NCT03210961|42221708|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768424|NCT03210961|42221709|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
19604819|NCT00738400|42053734|FG000|Overall Study|Adverse Event|3|||
19604820|NCT00738400|42053735|FG001|Overall Study|Adverse Event|1|||
19604821|NCT00738400|42053734|FG000|Overall Study|Withdrawal by Subject|0|||
19604822|NCT00738400|42053735|FG001|Overall Study|Withdrawal by Subject|1|||
19604823|NCT00738400|42053734|FG000|Overall Study|Lack of Efficacy|0|||
19604824|NCT00738400|42053735|FG001|Overall Study|Lack of Efficacy|1|||
19604825|NCT00738400|42053734|FG000|Overall Study|Lost to Follow-up|0|||
19604826|NCT00738400|42053735|FG001|Overall Study|Lost to Follow-up|3|||
19604827|NCT00738400|42053734|FG000|Overall Study|Protocol Violation|1|||
19604828|NCT00738400|42053735|FG001|Overall Study|Protocol Violation|0|||
19604829|NCT00738400|42053734|FG000|Overall Study|Non-compliant with study medication|0|||
19604830|NCT00738400|42053735|FG001|Overall Study|Non-compliant with study medication|1|||
19604831|NCT01009463|42053745|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
19604832|NCT01009463|42053746|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19604833|NCT01009463|42053747|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19604834|NCT01009463|42053748|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19604835|NCT01009463|42053749|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
19604836|NCT01009463|42053745|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
19604837|NCT01009463|42053746|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
19604838|NCT01009463|42053747|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
19604839|NCT01009463|42053748|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
19604840|NCT01009463|42053749|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
19604841|NCT01009463|42053745|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
19604842|NCT01009463|42053746|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19604843|NCT01009463|42053747|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19604844|NCT01009463|42053748|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19604845|NCT01009463|42053749|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
19604846|NCT01009463|42053745|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
19604847|NCT01009463|42053746|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
19604848|NCT01009463|42053747|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
19604849|NCT01009463|42053748|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
19604850|NCT01009463|42053749|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
19604851|NCT01009463|42053745|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
19604852|NCT01009463|42053746|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19604853|NCT01009463|42053747|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19604854|NCT01009463|42053748|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19604855|NCT01009463|42053749|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
19604856|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
19604857|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
19604858|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
19604859|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
19604860|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
19604861|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19604862|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
19604863|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
19604864|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
19604865|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
19604866|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
19604867|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
19604868|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
19604869|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
19604870|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
19604871|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
19604872|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
19604873|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
19604874|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
19604875|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
19604876|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
19608729|NCT00871377|42057777|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608730|NCT00871377|42057778|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608731|NCT00871377|42057773|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608732|NCT00871377|42057774|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608733|NCT00871377|42057775|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608734|NCT00871377|42057776|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608735|NCT00871377|42057777|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
19608736|NCT00871377|42057778|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
19608737|NCT00871377|42057773|FG000|Third Intervention (10 Weeks)|Death|0|||
19608738|NCT00871377|42057774|FG001|Third Intervention (10 Weeks)|Death|0|||
19608739|NCT00871377|42057775|FG002|Third Intervention (10 Weeks)|Death|0|||
19608740|NCT00871377|42057776|FG003|Third Intervention (10 Weeks)|Death|1|||
19608741|NCT00871377|42057777|FG004|Third Intervention (10 Weeks)|Death|0|||
19608742|NCT00871377|42057778|FG005|Third Intervention (10 Weeks)|Death|0|||
19608743|NCT00977561|42057788|FG000|Overall Study|Death|3|||
19608744|NCT00977561|42057789|FG001|Overall Study|Death|2|||
19608745|NCT00977561|42057788|FG000|Overall Study|Study terminated|0|||
19608746|NCT00977561|42057789|FG001|Overall Study|Study terminated|2|||
19608747|NCT00977561|42057788|FG000|Overall Study|Other|2|||
19608748|NCT00977561|42057789|FG001|Overall Study|Other|0|||
19608749|NCT00594165|42057797|FG000|Overall Study|Major protocol violation|1|||
19608750|NCT00594165|42057797|FG000|Overall Study|Lack of Efficacy|12|||
19608751|NCT00594165|42057797|FG000|Overall Study|Adverse Event|52|||
19608752|NCT00594165|42057797|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
19608753|NCT00594165|42057797|FG000|Overall Study|Subject withdrew consent|27|||
19608754|NCT00594165|42057797|FG000|Overall Study|Study ended per sponsor|102|||
19608755|NCT00594165|42057797|FG000|Overall Study|Lost to Follow-up|4|||
19608756|NCT00594165|42057797|FG000|Overall Study|Other: PI discretion|5|||
19608757|NCT00594165|42057797|FG000|Overall Study|Other: Subject moving|3|||
19608758|NCT00594165|42057797|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
19608759|NCT00594165|42057797|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
19608760|NCT00594165|42057797|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
19608761|NCT00594165|42057797|FG000|Overall Study|Other: Site terminated participation|2|||
19608762|NCT00975923|42057803|FG000|Overall Study|Withdrawal by Subject|0|||
19608763|NCT00975923|42057804|FG001|Overall Study|Withdrawal by Subject|1|||
19608764|NCT00928070|42057813|FG000|Overall Study|Lost to Follow-up|1|||
19608765|NCT00928070|42057814|FG001|Overall Study|Lost to Follow-up|2|||
19608766|NCT00928070|42057813|FG000|Overall Study|Withdrawal by Subject|10|||
19608767|NCT00928070|42057814|FG001|Overall Study|Withdrawal by Subject|3|||
19608768|NCT00928070|42057813|FG000|Overall Study|Adverse Event|14|||
19608769|NCT00928070|42057814|FG001|Overall Study|Adverse Event|26|||
19608770|NCT00928070|42057813|FG000|Overall Study|Lack of Efficacy|9|||
19608771|NCT00928070|42057814|FG001|Overall Study|Lack of Efficacy|5|||
19608772|NCT00928070|42057813|FG000|Overall Study|Did not meet entrance criteria|16|||
19608773|NCT00928070|42057814|FG001|Overall Study|Did not meet entrance criteria|9|||
19608774|NCT00928070|42057813|FG000|Overall Study|Protocol Violation|6|||
19608775|NCT00928070|42057814|FG001|Overall Study|Protocol Violation|5|||
19608776|NCT00928070|42057813|FG000|Overall Study|Randomized but not treated|2|||
19682372|NCT00533897|42129561|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682373|NCT00533897|42129562|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
19682374|NCT00533897|42129563|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
19682375|NCT00533897|42129564|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682376|NCT00533897|42129565|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682377|NCT00533897|42129566|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682378|NCT00533897|42129567|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682379|NCT00533897|42129568|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
19682380|NCT00533897|42129561|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682381|NCT00533897|42129562|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682382|NCT00533897|42129563|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
19682383|NCT00533897|42129564|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682384|NCT00533897|42129565|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682385|NCT00533897|42129566|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682386|NCT00533897|42129567|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682387|NCT00533897|42129568|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
19682388|NCT00533897|42129561|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682389|NCT00533897|42129562|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682390|NCT00533897|42129563|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682391|NCT00533897|42129564|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682392|NCT00533897|42129565|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682393|NCT00533897|42129566|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
19682394|NCT00533897|42129567|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682395|NCT00533897|42129568|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
19682396|NCT00533897|42129561|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682397|NCT00533897|42129562|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682398|NCT00533897|42129563|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682399|NCT00533897|42129564|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682400|NCT00533897|42129565|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682401|NCT00533897|42129566|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
19682402|NCT00533897|42129567|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682403|NCT00533897|42129568|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
19682404|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19682405|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19604877|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
19604878|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
19604879|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
19604880|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
19604881|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19604882|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
19604883|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19604884|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
19604885|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
19604886|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19604887|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
19604888|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
19604889|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
19604890|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
19604891|NCT01009463|42053745|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
19604892|NCT01009463|42053746|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
19604893|NCT01009463|42053747|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
19604894|NCT01009463|42053748|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
19604895|NCT01009463|42053749|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
19604896|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
19604897|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
19604898|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
19604899|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
19604900|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
19604901|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
19604902|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
19604903|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
19604904|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
19604905|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
19604906|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
19604907|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
19604908|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
19604909|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
19604910|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
19604911|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
19604912|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
19604913|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
19604914|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
19604915|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
19604916|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
19604917|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
19682406|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19682407|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19682408|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19682409|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
19604918|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
19604919|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
19604920|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
19604921|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
19604922|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
19604923|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
19604924|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
19604925|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
19604926|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
19604927|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
19604928|NCT00958568|42053760|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
19604929|NCT00958568|42053761|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
19604930|NCT00958568|42053762|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
19604931|NCT00958568|42053763|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
19768425|NCT03210961|42221710|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
19768426|NCT03210961|42221696|FG000|Overall Study|Other|0|||
19768427|NCT03210961|42221697|FG001|Overall Study|Other|0|||
19768428|NCT03210961|42221698|FG002|Overall Study|Other|0|||
19768429|NCT03210961|42221699|FG003|Overall Study|Other|1|||
19768430|NCT03210961|42221700|FG004|Overall Study|Other|0|||
19768431|NCT03210961|42221701|FG005|Overall Study|Other|0|||
19768432|NCT03210961|42221702|FG006|Overall Study|Other|1|||
19768433|NCT03210961|42221703|FG007|Overall Study|Other|0|||
19768434|NCT03210961|42221704|FG008|Overall Study|Other|0|||
19768435|NCT03210961|42221705|FG009|Overall Study|Other|0|||
19768436|NCT03210961|42221706|FG010|Overall Study|Other|1|||
19768437|NCT03210961|42221707|FG011|Overall Study|Other|0|||
19768438|NCT03210961|42221708|FG012|Overall Study|Other|2|||
19768439|NCT03210961|42221709|FG013|Overall Study|Other|2|||
19604932|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
19604933|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
19682410|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
19682411|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
19682412|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Death|0|||
19682413|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Death|0|||
19682414|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Death|0|||
19682415|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Death|0|||
19682416|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Death|0|||
19682417|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Death|0|||
19768440|NCT03210961|42221710|FG014|Overall Study|Other|0|||
19768441|NCT03242759|42221763|FG000|Overall Study|Adverse Event|5|||
19768442|NCT03242759|42221764|FG001|Overall Study|Adverse Event|1|||
19604934|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
19604935|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
19682418|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Death|1|||
19682419|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Death|3|||
19682420|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
19682421|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
19682422|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
19682423|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
19768443|NCT03242759|42221763|FG000|Overall Study|Withdrawal by Subject|4|||
19768444|NCT03242759|42221764|FG001|Overall Study|Withdrawal by Subject|3|||
19768445|NCT03242759|42221763|FG000|Overall Study|Lost to Follow-up|3|||
19768446|NCT03242759|42221764|FG001|Overall Study|Lost to Follow-up|1|||
19682424|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
19682425|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
19682426|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
19682427|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
19682428|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682429|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19768447|NCT03242759|42221763|FG000|Overall Study|Administrative problems|1|||
19768448|NCT03242759|42221764|FG001|Overall Study|Administrative problems|1|||
19768449|NCT03242759|42221763|FG000|Overall Study|Death|22|||
19768450|NCT03242759|42221764|FG001|Overall Study|Death|0|||
19768451|NCT03242759|42221763|FG000|Overall Study|Change visit schedule|0|||
19768452|NCT03242759|42221764|FG001|Overall Study|Change visit schedule|1|||
19768453|NCT03097029|42221770|FG000|Overall Study|Withdrawal by Subject|1|||
19768454|NCT03257813|42221776|FG000|Overall Study|Protocol Violation|6|||
19768455|NCT03257813|42221777|FG001|Overall Study|Protocol Violation|3|||
19768456|NCT03210259|42221788|FG000|12-Week Run-in Period|Adverse Event|1|||
19768457|NCT03210259|42221789|FG001|12-Week Run-in Period|Adverse Event|0|||
19768458|NCT03210259|42221790|FG002|12-Week Run-in Period|Adverse Event|0|||
19768459|NCT03210259|42221788|FG000|12-Week Run-in Period|Death|1|||
19768460|NCT03210259|42221789|FG001|12-Week Run-in Period|Death|0|||
19768461|NCT03210259|42221790|FG002|12-Week Run-in Period|Death|0|||
19768462|NCT03210259|42221788|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
19768463|NCT03210259|42221789|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
19768464|NCT03210259|42221790|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
19768465|NCT03210259|42221788|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
19768466|NCT03210259|42221789|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
19768467|NCT03210259|42221790|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
19768468|NCT03210259|42221788|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
19682430|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682431|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682432|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682433|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682434|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
19682435|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
19682436|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Adverse Event|0|||
19682437|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Adverse Event|0|||
19682438|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Adverse Event|0|||
19682439|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Adverse Event|0|||
19682440|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Adverse Event|0|||
19682441|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Adverse Event|0|||
19682442|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Adverse Event|2|||
19682443|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Adverse Event|5|||
19682444|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Pregnancy|0|||
19682445|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Pregnancy|0|||
19682446|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Pregnancy|0|||
19682447|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Pregnancy|0|||
19682448|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Pregnancy|0|||
19682449|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Pregnancy|0|||
19682450|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Pregnancy|0|||
19682451|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Pregnancy|2|||
19682452|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682453|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682454|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682455|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682456|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682457|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
19682458|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
19682459|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
19682460|NCT00533897|42129561|FG000|Long Term Extension (LTE)|Other|0|||
19682461|NCT00533897|42129562|FG001|Long Term Extension (LTE)|Other|0|||
19682462|NCT00533897|42129563|FG002|Long Term Extension (LTE)|Other|0|||
19682463|NCT00533897|42129564|FG003|Long Term Extension (LTE)|Other|0|||
19682464|NCT00533897|42129565|FG004|Long Term Extension (LTE)|Other|0|||
19682465|NCT00533897|42129566|FG005|Long Term Extension (LTE)|Other|0|||
19682466|NCT00533897|42129567|FG006|Long Term Extension (LTE)|Other|1|||
19682467|NCT00533897|42129568|FG007|Long Term Extension (LTE)|Other|6|||
19682468|NCT00426660|42129599|FG000|Overall Study|Death|14|||
19682469|NCT00426660|42129599|FG000|Overall Study|Adverse Event|23|||
19682470|NCT00426660|42129599|FG000|Overall Study|Insufficient Clinical Response|22|||
19682471|NCT00426660|42129599|FG000|Overall Study|Lost to Follow-up|15|||
19682472|NCT00426660|42129599|FG000|Overall Study|Other|23|||
19682473|NCT00426660|42129599|FG000|Overall Study|Withdrawal by Subject|18|||
19682474|NCT00426660|42129599|FG000|Overall Study|Protocol Violation|1|||
19768469|NCT03210259|42221789|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
19768470|NCT03210259|42221790|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
19682475|NCT00426660|42129599|FG000|Overall Study|Enrolled Not Treated|15|||
19682476|NCT00426270|42129603|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
19682477|NCT00426270|42129603|FG000|Overall Study|Adverse Event|5|||
19682478|NCT00330681|42129609|FG000|Overall Study|Adverse Event|3|||
19682479|NCT00330681|42129610|FG001|Overall Study|Adverse Event|6|||
19682480|NCT00330681|42129609|FG000|Overall Study|Protocol Violation|0|||
19768471|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
19768472|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
19768473|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
19768474|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
19768475|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
19768476|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
19768477|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
19768478|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
19768479|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
19768480|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
19768481|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
19768482|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
19768483|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
19768484|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
19768485|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
19768486|NCT03210259|42221788|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
19768487|NCT03210259|42221789|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
19768488|NCT03210259|42221790|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
19768489|NCT03257657|42221799|FG000|Overall Study|Lost to Follow-up|0|||
19768490|NCT03257657|42221800|FG001|Overall Study|Lost to Follow-up|3|||
19768491|NCT03257657|42221799|FG000|Overall Study|Withdrawn|0|||
19768492|NCT03257657|42221800|FG001|Overall Study|Withdrawn|1|||
19768493|NCT03257657|42221799|FG000|Overall Study|Noted not eligible right after enrolled|0|||
19768494|NCT03257657|42221800|FG001|Overall Study|Noted not eligible right after enrolled|1|||
19768495|NCT02496611|42221809|FG000|Overall Study|Lost to Follow-up|2|||
19768496|NCT02496611|42221810|FG001|Overall Study|Lost to Follow-up|1|||
19768497|NCT02496611|42221809|FG000|Overall Study|Withdrawal by Subject|5|||
19768498|NCT02496611|42221810|FG001|Overall Study|Withdrawal by Subject|2|||
19768499|NCT03237481|42221820|FG000|Overall Study|Lost to Follow-up|1|||
19768500|NCT03237481|42221821|FG001|Overall Study|Lost to Follow-up|0|||
19768501|NCT03237481|42221822|FG002|Overall Study|Lost to Follow-up|0|||
19768502|NCT03237481|42221820|FG000|Overall Study|Protocol Violation|1|||
19768503|NCT03237481|42221821|FG001|Overall Study|Protocol Violation|0|||
19768504|NCT03237481|42221822|FG002|Overall Study|Protocol Violation|0|||
19768505|NCT03237481|42221820|FG000|Overall Study|Withdrawal by Subject|3|||
19768506|NCT03237481|42221821|FG001|Overall Study|Withdrawal by Subject|2|||
19768507|NCT03237481|42221822|FG002|Overall Study|Withdrawal by Subject|1|||
19768508|NCT03222349|42221830|FG000|Overall Study|Treatment B not done|5|||
19768509|NCT03222349|42221831|FG001|Overall Study|Treatment B not done|0|||
19768510|NCT03222349|42221830|FG000|Overall Study|Lost to Follow-up|1|||
19768511|NCT03222349|42221831|FG001|Overall Study|Lost to Follow-up|2|||
19768512|NCT03222349|42221830|FG000|Overall Study|Withdrawal by Subject|1|||
19604936|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
19604937|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
19604938|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
19604939|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
19604940|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
19604941|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
19604942|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
19604943|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
19604944|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
19604945|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
19604946|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
19604947|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
19604948|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
19604949|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
19604950|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
19682481|NCT00330681|42129610|FG001|Overall Study|Protocol Violation|1|||
19682482|NCT00330681|42129609|FG000|Overall Study|Withdrawal by Subject|5|||
19682483|NCT00330681|42129610|FG001|Overall Study|Withdrawal by Subject|5|||
19682484|NCT00330681|42129609|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
19682485|NCT00330681|42129610|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
19768513|NCT03222349|42221831|FG001|Overall Study|Withdrawal by Subject|0|||
19768514|NCT03222349|42221830|FG000|Overall Study|Treatment A not done|0|||
19682486|NCT00329901|42129619|FG000|Overall Study|Withdrawal by Subject|4|||
19682487|NCT00329901|42129620|FG001|Overall Study|Withdrawal by Subject|3|||
19682488|NCT00329901|42129621|FG002|Overall Study|Withdrawal by Subject|2|||
19682489|NCT00329901|42129619|FG000|Overall Study|Lost to Follow-up|2|||
19768515|NCT03222349|42221831|FG001|Overall Study|Treatment A not done|5|||
19768516|NCT03222349|42221830|FG000|Overall Study|Study terminated by sponsor|1|||
19768517|NCT03222349|42221831|FG001|Overall Study|Study terminated by sponsor|0|||
19768518|NCT02927925|42221844|FG000|Overall Study|Death|16|||
19682490|NCT00329901|42129620|FG001|Overall Study|Lost to Follow-up|0|||
19682491|NCT00329901|42129621|FG002|Overall Study|Lost to Follow-up|1|||
19682492|NCT00329901|42129619|FG000|Overall Study|Protocol Violation|1|||
19768519|NCT02927925|42221844|FG000|Overall Study|Physician Decision|1|||
19768520|NCT02927925|42221844|FG000|Overall Study|Withdrawal by Subject|11|||
19768521|NCT02927925|42221844|FG000|Overall Study|Other|3|||
19768522|NCT02927925|42221844|FG000|Overall Study|Disease progression at clinical cutoff|1|||
19768523|NCT03208933|42221848|FG000|Overall Study|Death|3|||
19604951|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
19604952|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
19604953|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
19604954|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
19604955|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
19604956|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
19604957|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
19604958|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
19604959|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
19604960|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
19604961|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
19604962|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
19604963|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
19604964|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
19604965|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
19682493|NCT00329901|42129620|FG001|Overall Study|Protocol Violation|0|||
19682494|NCT00329901|42129621|FG002|Overall Study|Protocol Violation|1|||
19682495|NCT00329901|42129619|FG000|Overall Study|Unable to classify|2|||
19682496|NCT00329901|42129620|FG001|Overall Study|Unable to classify|2|||
19682497|NCT00329901|42129621|FG002|Overall Study|Unable to classify|0|||
19682498|NCT00436956|42129633|FG000|Overall Study|Not evaluable|1|||
19682499|NCT00436956|42129634|FG001|Overall Study|Not evaluable|0|||
19682500|NCT00329745|42129643|FG000|Overall Study|Protocol Violation|1|||
19682501|NCT00329745|42129644|FG001|Overall Study|Protocol Violation|0|||
19682502|NCT00329745|42129643|FG000|Overall Study|Withdrawal by Subject|0|||
19682503|NCT00329745|42129644|FG001|Overall Study|Withdrawal by Subject|1|||
19682504|NCT00329745|42129643|FG000|Overall Study|Lost to Follow-up|86|||
19682505|NCT00329745|42129644|FG001|Overall Study|Lost to Follow-up|101|||
19682506|NCT00436644|42129650|FG000|Overall Study|Adverse Event|2|||
19682507|NCT00436644|42129650|FG000|Overall Study|Death|1|||
19682508|NCT00324987|42129656|FG000|Overall Study|Adverse Event|2|||
19682509|NCT00324987|42129657|FG001|Overall Study|Adverse Event|1|||
19682510|NCT00324987|42129656|FG000|Overall Study|Withdrawal by Subject|1|||
19682511|NCT00324987|42129657|FG001|Overall Study|Withdrawal by Subject|1|||
19682512|NCT00324987|42129656|FG000|Overall Study|Progression|1|||
19682513|NCT00324987|42129657|FG001|Overall Study|Progression|1|||
19682514|NCT00324987|42129656|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
19682515|NCT00324987|42129657|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
19682516|NCT00324675|42129665|FG000|Overall Study|Adverse Event|1|||
19682517|NCT00324675|42129666|FG001|Overall Study|Adverse Event|0|||
19682518|NCT00436566|42129672|FG000|Overall Study|Withdrawal by Subject|2|||
19682519|NCT00436566|42129672|FG000|Overall Study|Protocol Violation|1|||
19682520|NCT00352365|42129676|FG000|Induction Therapy|Adverse Event|7|||
19682521|NCT00352365|42129676|FG000|Induction Therapy|Progression/Relapse|8|||
19682522|NCT00352365|42129676|FG000|Induction Therapy|Death|7|||
19682523|NCT00352365|42129676|FG000|Induction Therapy|Not protocol specified|1|||
19682524|NCT00352365|42129676|FG000|Induction Therapy|Not eligible|3|||
19682525|NCT00352365|42129676|FG000|Induction Therapy|Death before starting protocol therapy|1|||
19682526|NCT00352365|42129676|FG000|Maintenance Therapy|Progression/Relapse|3|||
19682527|NCT00352365|42129676|FG000|Maintenance Therapy|Death|2|||
19682528|NCT00352365|42129676|FG000|Maintenance Therapy|Not protocol specified|3|||
19682529|NCT00352365|42129676|FG000|Maintenance Therapy|Not eligible|4|||
19682530|NCT00532493|42129686|FG000|Overall Study|Death|1|||
19682531|NCT00532493|42129687|FG001|Overall Study|Death|1|||
19682532|NCT00532493|42129686|FG000|Overall Study|Lost to Follow-up|10|||
19682533|NCT00532493|42129687|FG001|Overall Study|Lost to Follow-up|7|||
19682534|NCT00532493|42129686|FG000|Overall Study|Withdrawal by Subject|7|||
19768524|NCT03208933|42221848|FG000|Overall Study|Withdrawal by Subject|3|||
19768525|NCT03208933|42221848|FG000|Overall Study|Adverse Event|1|||
19682535|NCT00532493|42129687|FG001|Overall Study|Withdrawal by Subject|9|||
19682536|NCT00532493|42129686|FG000|Overall Study|Physician Decision|1|||
19682537|NCT00532493|42129687|FG001|Overall Study|Physician Decision|6|||
19682538|NCT00532493|42129686|FG000|Overall Study|Adverse Event|6|||
19682539|NCT00532493|42129687|FG001|Overall Study|Adverse Event|5|||
19682540|NCT00532493|42129686|FG000|Overall Study|Protocol Deviation|1|||
19682541|NCT00532493|42129687|FG001|Overall Study|Protocol Deviation|0|||
19682542|NCT00532493|42129686|FG000|Overall Study|Subject Moved Away|3|||
19682543|NCT00532493|42129687|FG001|Overall Study|Subject Moved Away|1|||
19682544|NCT00532493|42129686|FG000|Overall Study|Contraindicative Medication|1|||
19682545|NCT00532493|42129687|FG001|Overall Study|Contraindicative Medication|0|||
19682546|NCT00533507|42129695|FG000|Overall Study|Withdrawal by Subject|1|||
19682547|NCT03886493|42129699|FG000|Overall Study|Adverse Event|1|||
19682548|NCT00352053|42129705|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
19682549|NCT00352053|42129706|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
19682550|NCT00352053|42129705|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
19682551|NCT00352053|42129706|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
19682552|NCT00352053|42129705|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
19682553|NCT00352053|42129706|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
19682554|NCT00352053|42129705|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
19682555|NCT00352053|42129706|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
19682556|NCT00352053|42129705|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
19682557|NCT00352053|42129706|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
19682558|NCT00352053|42129705|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
19682559|NCT00352053|42129706|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
19682560|NCT00352053|42129705|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
19682561|NCT00352053|42129706|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
19682562|NCT00352053|42129705|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
19682563|NCT00352053|42129706|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
19682564|NCT00352053|42129705|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
19682565|NCT00352053|42129706|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
19682566|NCT00352053|42129705|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
19682567|NCT00352053|42129706|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
19682568|NCT00352053|42129705|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
19682569|NCT00352053|42129706|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
19682570|NCT00352053|42129705|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
19682571|NCT00352053|42129706|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
19682572|NCT00352053|42129705|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
19682573|NCT00352053|42129706|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
19682574|NCT00351819|42129722|FG000|Overall Study|Lost to Follow-up|4|||
19682575|NCT00351819|42129723|FG001|Overall Study|Lost to Follow-up|4|||
19682576|NCT00351819|42129722|FG000|Overall Study|Withdrawal by Subject|0|||
19682577|NCT00351819|42129723|FG001|Overall Study|Withdrawal by Subject|4|||
19682578|NCT00351819|42129722|FG000|Overall Study|Elevated PSA|1|||
19682579|NCT00351819|42129723|FG001|Overall Study|Elevated PSA|1|||
19682580|NCT00351819|42129722|FG000|Overall Study|Traumatic ankle fracture|1|||
19682581|NCT00351819|42129723|FG001|Overall Study|Traumatic ankle fracture|0|||
19682582|NCT00351819|42129722|FG000|Overall Study|Unprofessional behavior|1|||
19682583|NCT00351819|42129723|FG001|Overall Study|Unprofessional behavior|0|||
19682584|NCT00351819|42129722|FG000|Overall Study|Non-compliance|0|||
19682585|NCT00351819|42129723|FG001|Overall Study|Non-compliance|1|||
19682586|NCT00351819|42129722|FG000|Overall Study|Incarcerated|0|||
19682587|NCT00351819|42129723|FG001|Overall Study|Incarcerated|1|||
19682588|NCT00351819|42129722|FG000|Overall Study|Enrolled in another trial|0|||
19682589|NCT00351819|42129723|FG001|Overall Study|Enrolled in another trial|1|||
19682590|NCT00351351|42129731|FG000|Overall Study|surgical access pbs; device issues|9|||
19682591|NCT00351351|42129732|FG001|Overall Study|surgical access pbs; device issues|4|||
19682592|NCT00323115|42129738|FG000|Vaccine Administration|Adverse Event|1|||
19768526|NCT03208933|42221848|FG000|Overall Study|Lost to Follow-up|2|||
19768527|NCT03208933|42221848|FG000|Overall Study|Physician Decision|3|||
19768528|NCT03208933|42221848|FG000|Overall Study|Protocol Violation|1|||
19768529|NCT02499120|42221854|FG000|Overall Study|Death|45|||
19682593|NCT00323115|42129738|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
19682594|NCT00322881|42129747|FG000|Overall Study|Death|2|||
19682595|NCT00322881|42129747|FG000|Overall Study|Adverse Event|1|||
19682596|NCT00322881|42129747|FG000|Overall Study|Disease Progression|2|||
19682597|NCT00415194|42129753|FG000|Overall Study|Adverse Event|37|||
19682598|NCT00415194|42129754|FG001|Overall Study|Adverse Event|32|||
19682599|NCT00415194|42129753|FG000|Overall Study|Entry Criteria Not Met|4|||
19682600|NCT00415194|42129754|FG001|Overall Study|Entry Criteria Not Met|8|||
19682601|NCT00415194|42129753|FG000|Overall Study|Lost to Follow-up|1|||
19768530|NCT02499120|42221855|FG001|Overall Study|Death|42|||
19768531|NCT02499120|42221854|FG000|Overall Study|Lost to Follow-up|1|||
19682602|NCT00415194|42129754|FG001|Overall Study|Lost to Follow-up|0|||
19682603|NCT00415194|42129753|FG000|Overall Study|Physician Decision|10|||
19682604|NCT00415194|42129754|FG001|Overall Study|Physician Decision|16|||
19682605|NCT00415194|42129753|FG000|Overall Study|Progressive Disease|180|||
19604966|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
19604967|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
19682606|NCT00415194|42129754|FG001|Overall Study|Progressive Disease|217|||
19682607|NCT00415194|42129753|FG000|Overall Study|Protocol Violation|4|||
19682608|NCT00415194|42129754|FG001|Overall Study|Protocol Violation|2|||
19682609|NCT00415194|42129753|FG000|Overall Study|Withdrawal by Subject|28|||
19682610|NCT00415194|42129754|FG001|Overall Study|Withdrawal by Subject|21|||
19682611|NCT00415194|42129753|FG000|Overall Study|Death Due to Study Disease|26|||
19682612|NCT00415194|42129754|FG001|Overall Study|Death Due to Study Disease|29|||
19682613|NCT00415194|42129753|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
19682614|NCT00415194|42129754|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
19682615|NCT00415194|42129753|FG000|Overall Study|Death Due to Procedural Related AE|0|||
19682616|NCT00415194|42129754|FG001|Overall Study|Death Due to Procedural Related AE|1|||
19682617|NCT00415194|42129753|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
19682618|NCT00415194|42129754|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
19682619|NCT00436332|42129760|FG000|Overall Study|Adverse Event|9|||
19682620|NCT00436332|42129760|FG000|Overall Study|Withdrawal by Subject|2|||
19682621|NCT00436332|42129760|FG000|Overall Study|Progression|59|||
19682622|NCT00436332|42129760|FG000|Overall Study|Death|2|||
19682623|NCT00436332|42129760|FG000|Overall Study|Not Protocol Specified|6|||
19682624|NCT00436332|42129760|FG000|Overall Study|Ineligible|2|||
19682625|NCT00436332|42129760|FG000|Overall Study|Never Received Treatment|3|||
19682626|NCT00532259|42129764|FG000|Overall Study|Withdrawal by Subject|2|||
19682627|NCT00532259|42129764|FG000|Overall Study|Adverse Event|1|||
19768532|NCT02499120|42221855|FG001|Overall Study|Lost to Follow-up|2|||
19682628|NCT00532259|42129764|FG000|Overall Study|Death|1|||
19682629|NCT00532259|42129764|FG000|Overall Study|Lack of Efficacy|21|||
19682630|NCT00532259|42129764|FG000|Overall Study|Lost to Follow-up|3|||
19682631|NCT00532259|42129764|FG000|Overall Study|Physician Decision|3|||
19682632|NCT00532259|42129764|FG000|Overall Study|Protocol Violation|1|||
19604968|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
19604969|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
19604970|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
19604971|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
19604972|NCT00958568|42053760|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
19604973|NCT00958568|42053761|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
19604974|NCT00958568|42053762|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
19604975|NCT00958568|42053763|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
19604976|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
19604977|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
19604978|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
19682633|NCT00322491|42129771|FG000|Overall Study|Adverse Event|1|||
19682634|NCT00322491|42129772|FG001|Overall Study|Adverse Event|0|||
19682635|NCT00322491|42129771|FG000|Overall Study|Death|1|||
19682636|NCT00322491|42129772|FG001|Overall Study|Death|2|||
19604979|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
19604980|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
19604981|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
19604982|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
19604983|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
19604984|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
19682637|NCT00322023|42129782|FG000|Overall Study|various|0|||
19682638|NCT00322023|42129783|FG001|Overall Study|various|2|||
19768533|NCT02499120|42221854|FG000|Overall Study|Participant refused further follow-up|1|||
19768534|NCT02499120|42221855|FG001|Overall Study|Participant refused further follow-up|0|||
19768535|NCT02499120|42221854|FG000|Overall Study|Withdrawal by Subject|2|||
19768536|NCT02499120|42221855|FG001|Overall Study|Withdrawal by Subject|5|||
19682639|NCT00322023|42129784|FG002|Overall Study|various|6|||
19682640|NCT00414960|42129794|FG000|Overall Study|Adverse Event|4|||
19682641|NCT00414960|42129795|FG001|Overall Study|Adverse Event|0|||
19682642|NCT00414960|42129794|FG000|Overall Study|Withdrawal by Subject|3|||
19682643|NCT00414960|42129795|FG001|Overall Study|Withdrawal by Subject|0|||
19682644|NCT00414960|42129794|FG000|Overall Study|Physician Decision|0|||
19682645|NCT00414960|42129795|FG001|Overall Study|Physician Decision|1|||
19682646|NCT00321789|42129803|FG000|Overall Study|Lost to Follow-up|4|||
19682647|NCT00321789|42129804|FG001|Overall Study|Lost to Follow-up|7|||
19682648|NCT00321789|42129803|FG000|Overall Study|Withdrawal by Subject|6|||
19682649|NCT00321789|42129804|FG001|Overall Study|Withdrawal by Subject|6|||
19682650|NCT00321789|42129803|FG000|Overall Study|Protocol Violation|5|||
19682651|NCT00321789|42129804|FG001|Overall Study|Protocol Violation|3|||
19682652|NCT00414726|42129812|FG000|Overall Study|Withdrawal by Subject|0|||
19682653|NCT00414726|42129813|FG001|Overall Study|Withdrawal by Subject|1|||
19682654|NCT00531947|42129821|FG000|Overall Study|Adverse Event|5|||
19682655|NCT00531947|42129822|FG001|Overall Study|Adverse Event|10|||
19682656|NCT00531947|42129821|FG000|Overall Study|Lost to Follow-up|12|||
19682657|NCT00531947|42129822|FG001|Overall Study|Lost to Follow-up|9|||
19682658|NCT00531947|42129821|FG000|Overall Study|Withdrawal by Subject|14|||
19682659|NCT00531947|42129822|FG001|Overall Study|Withdrawal by Subject|19|||
19682660|NCT00531947|42129821|FG000|Overall Study|Protocol Violation|2|||
19682661|NCT00531947|42129822|FG001|Overall Study|Protocol Violation|1|||
19682662|NCT00531947|42129821|FG000|Overall Study|Non-Compliance|4|||
19682663|NCT00531947|42129822|FG001|Overall Study|Non-Compliance|7|||
19682664|NCT00531947|42129821|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
19682665|NCT00531947|42129822|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
19682666|NCT00530855|42129828|FG000|Overall Study|Lack of Efficacy|20|||
19682667|NCT00530855|42129828|FG000|Overall Study|Withdrawal by Subject|30|||
19682668|NCT00530855|42129828|FG000|Overall Study|Fatal Serious AE|3|||
19682669|NCT00530855|42129828|FG000|Overall Study|Non Fatal Serious AE|7|||
19682670|NCT00530855|42129828|FG000|Overall Study|Non Fatal Non Serious AE|12|||
19682671|NCT00530855|42129828|FG000|Overall Study|Protocol Violation|3|||
19682672|NCT00530855|42129828|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
19682673|NCT00530855|42129828|FG000|Overall Study|Lost to Follow-up|9|||
19682674|NCT00530855|42129828|FG000|Overall Study|Other reason for premature termination|17|||
19682675|NCT00530777|42129834|FG000|Overall Study|Lost to Follow-up|0|||
19682676|NCT00530777|42129835|FG001|Overall Study|Lost to Follow-up|1|||
19682677|NCT00530777|42129834|FG000|Overall Study|Death|1|||
19682678|NCT00530777|42129835|FG001|Overall Study|Death|2|||
19682679|NCT00530777|42129834|FG000|Overall Study|Physician Decision|1|||
19682680|NCT00530777|42129835|FG001|Overall Study|Physician Decision|0|||
19604985|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
19604986|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
19604987|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
19604988|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
19604989|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
19604990|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
19604991|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
19604992|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
19604993|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
19604994|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
19604995|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
19604996|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
19604997|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
19604998|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
19604999|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
19682681|NCT00530777|42129834|FG000|Overall Study|Withdrawal by Subject|0|||
19682682|NCT00530777|42129835|FG001|Overall Study|Withdrawal by Subject|1|||
19682683|NCT00530777|42129834|FG000|Overall Study|Unable to adhere to visit schedule|5|||
19682684|NCT00530777|42129835|FG001|Overall Study|Unable to adhere to visit schedule|1|||
19682685|NCT03882047|42129844|FG000|Overall Study|Adverse Event|0|||
19682686|NCT03882047|42129845|FG001|Overall Study|Adverse Event|2|||
19682687|NCT03882047|42129846|FG002|Overall Study|Adverse Event|2|||
19682688|NCT03882047|42129844|FG000|Overall Study|Treatment Failure|3|||
19682689|NCT03882047|42129845|FG001|Overall Study|Treatment Failure|3|||
19682690|NCT03882047|42129846|FG002|Overall Study|Treatment Failure|12|||
19682691|NCT03882047|42129844|FG000|Overall Study|Lost to Follow-up|0|||
19682692|NCT03882047|42129845|FG001|Overall Study|Lost to Follow-up|1|||
19682693|NCT03882047|42129846|FG002|Overall Study|Lost to Follow-up|0|||
19682694|NCT03882047|42129844|FG000|Overall Study|Did Not Wish to Continue|1|||
19682695|NCT03882047|42129845|FG001|Overall Study|Did Not Wish to Continue|4|||
19682696|NCT03882047|42129846|FG002|Overall Study|Did Not Wish to Continue|1|||
19682697|NCT03882047|42129844|FG000|Overall Study|Noncompliance With Protocol|2|||
19682698|NCT03882047|42129845|FG001|Overall Study|Noncompliance With Protocol|0|||
19682699|NCT03882047|42129846|FG002|Overall Study|Noncompliance With Protocol|0|||
19682700|NCT03882047|42129844|FG000|Overall Study|Did Not Meet Eligibility|0|||
19682701|NCT03882047|42129845|FG001|Overall Study|Did Not Meet Eligibility|0|||
19682702|NCT03882047|42129846|FG002|Overall Study|Did Not Meet Eligibility|1|||
19682703|NCT00530621|42129856|FG000|Overall Study|Adverse Event|11|||
19682704|NCT00530621|42129857|FG001|Overall Study|Adverse Event|8|||
19682705|NCT00530621|42129856|FG000|Overall Study|Physician Decision|2|||
19682706|NCT00530621|42129857|FG001|Overall Study|Physician Decision|4|||
19682707|NCT00530621|42129856|FG000|Overall Study|Progressive Disease (PD)|47|||
19682708|NCT00530621|42129857|FG001|Overall Study|Progressive Disease (PD)|40|||
19682709|NCT00530621|42129856|FG000|Overall Study|Sponsor Decision|12|||
19682710|NCT00530621|42129857|FG001|Overall Study|Sponsor Decision|15|||
19682711|NCT00530621|42129856|FG000|Overall Study|Subject Decision|4|||
19682712|NCT00530621|42129857|FG001|Overall Study|Subject Decision|7|||
19682713|NCT00530621|42129856|FG000|Overall Study|Death|3|||
19682714|NCT00530621|42129857|FG001|Overall Study|Death|6|||
19682715|NCT00530621|42129856|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
19682716|NCT00530621|42129857|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
19682717|NCT00531479|42129869|FG000|Overall Study|Death|68|||
19682718|NCT00531479|42129870|FG001|Overall Study|Death|71|||
19682719|NCT00531479|42129869|FG000|Overall Study|Lost to Follow-up|0|||
19682720|NCT00531479|42129870|FG001|Overall Study|Lost to Follow-up|2|||
19682721|NCT00531479|42129869|FG000|Overall Study|Other|0|||
19682722|NCT00531479|42129870|FG001|Overall Study|Other|1|||
19682723|NCT00531479|42129869|FG000|Overall Study|Withdrawal by Subject|6|||
19682724|NCT00531479|42129870|FG001|Overall Study|Withdrawal by Subject|6|||
19682725|NCT00531479|42129869|FG000|Overall Study|Did not receive treatment|2|||
19682726|NCT00531479|42129870|FG001|Overall Study|Did not receive treatment|3|||
19682727|NCT00530075|42129876|FG000|Overall Study|Adverse Event|1|||
19682728|NCT00530075|42129876|FG000|Overall Study|Death|1|||
19605000|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
19605001|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
19605002|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
19605003|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
19605004|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
19605005|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
19605006|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
19605007|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
19605008|NCT00958568|42053760|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
19605009|NCT00958568|42053761|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
19605010|NCT00958568|42053762|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
19605011|NCT00958568|42053763|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
19605012|NCT00958412|42053774|FG000|Overall Study|Study prematurely terminated|18|||
19605013|NCT00958256|42053778|FG000|Overall Study|Adverse Event|3|||
19605014|NCT00696709|42053787|FG000|Overall Study|Withdrawal by Subject|1|||
19682729|NCT00530075|42129876|FG000|Overall Study|Lack of Efficacy|3|||
19682730|NCT00530075|42129876|FG000|Overall Study|Protocol Violation|1|||
19682731|NCT00530075|42129876|FG000|Overall Study|Withdrawal by Subject|1|||
19682732|NCT00531011|42129882|FG000|Overall Study|Withdrawal by Subject|2|||
19682733|NCT00531011|42129883|FG001|Overall Study|Withdrawal by Subject|4|||
19682734|NCT00531011|42129882|FG000|Overall Study|Death|1|||
19682735|NCT00531011|42129883|FG001|Overall Study|Death|0|||
19682736|NCT00531011|42129882|FG000|Overall Study|Lost to Follow-up|1|||
19682737|NCT00531011|42129883|FG001|Overall Study|Lost to Follow-up|0|||
19682738|NCT00531011|42129882|FG000|Overall Study|Physician Decision|0|||
19682739|NCT00531011|42129883|FG001|Overall Study|Physician Decision|3|||
19682740|NCT00529217|42129889|FG000|Overall Study|Lack of Efficacy|2|||
19682741|NCT00529217|42129889|FG000|Overall Study|Unable to adhere to study schedule|2|||
19682742|NCT00471146|42129896|FG000|Overall Study|Adverse Event|32|||
19605015|NCT00696709|42053788|FG001|Overall Study|Withdrawal by Subject|2|||
19682743|NCT00471146|42129897|FG001|Overall Study|Adverse Event|33|||
19682744|NCT00471146|42129896|FG000|Overall Study|Withdrawal by Subject|14|||
19768537|NCT02499120|42221854|FG000|Overall Study|Other|1|||
19605016|NCT00696709|42053789|FG002|Overall Study|Withdrawal by Subject|1|||
19605017|NCT00696709|42053790|FG003|Overall Study|Withdrawal by Subject|4|||
19605018|NCT00696709|42053791|FG004|Overall Study|Withdrawal by Subject|3|||
19605019|NCT00696709|42053787|FG000|Overall Study|Protocol Violation|1|||
19605020|NCT00696709|42053788|FG001|Overall Study|Protocol Violation|0|||
19605021|NCT00696709|42053789|FG002|Overall Study|Protocol Violation|0|||
19605022|NCT00696709|42053790|FG003|Overall Study|Protocol Violation|0|||
19605023|NCT00696709|42053791|FG004|Overall Study|Protocol Violation|0|||
19605024|NCT00696709|42053787|FG000|Overall Study|Lost to Follow-up|1|||
19682745|NCT00471146|42129897|FG001|Overall Study|Withdrawal by Subject|11|||
19682746|NCT00471146|42129896|FG000|Overall Study|Death|11|||
19682747|NCT00471146|42129897|FG001|Overall Study|Death|12|||
19682748|NCT00471146|42129896|FG000|Overall Study|Lost to Follow-up|4|||
19682749|NCT00471146|42129897|FG001|Overall Study|Lost to Follow-up|2|||
19682750|NCT00471146|42129896|FG000|Overall Study|Protocol Violation|2|||
19682751|NCT00471146|42129897|FG001|Overall Study|Protocol Violation|2|||
19682752|NCT00471146|42129896|FG000|Overall Study|Objective progression or relapse|84|||
19682753|NCT00471146|42129897|FG001|Overall Study|Objective progression or relapse|87|||
19682754|NCT00471146|42129896|FG000|Overall Study|Global deterioration of health status|12|||
19682755|NCT00471146|42129897|FG001|Overall Study|Global deterioration of health status|14|||
19682756|NCT00471146|42129896|FG000|Overall Study|Randomized but not treated|9|||
19682757|NCT00471146|42129897|FG001|Overall Study|Randomized but not treated|8|||
19682758|NCT00471146|42129896|FG000|Overall Study|Other|4|||
19682759|NCT00471146|42129897|FG001|Overall Study|Other|5|||
19682760|NCT00469898|42129903|FG000|Overall Study|Adverse Event|7|||
19682761|NCT00469898|42129903|FG000|Overall Study|Withdrawal by Subject|4|||
19682762|NCT00469898|42129903|FG000|Overall Study|Death|4|||
19682763|NCT00469898|42129903|FG000|Overall Study|Disease progression|9|||
19682764|NCT00469898|42129903|FG000|Overall Study|Decreased performance status|1|||
19682765|NCT00529763|42129910|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
19682766|NCT00529763|42129911|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
19682767|NCT00529763|42129912|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
19682768|NCT00529763|42129910|FG000|Overall Study|Death|0|||
19682769|NCT00529763|42129911|FG001|Overall Study|Death|1|||
19682770|NCT00529763|42129912|FG002|Overall Study|Death|1|||
19682771|NCT00529763|42129910|FG000|Overall Study|Disease Progression|6|||
19768538|NCT02499120|42221855|FG001|Overall Study|Other|0|||
19768539|NCT02499120|42221854|FG000|Overall Study|Ongoing on study|15|||
19682772|NCT00529763|42129911|FG001|Overall Study|Disease Progression|16|||
19682773|NCT00529763|42129912|FG002|Overall Study|Disease Progression|1|||
19682774|NCT00529763|42129910|FG000|Overall Study|Lost to Follow-up|0|||
19682775|NCT00529763|42129911|FG001|Overall Study|Lost to Follow-up|1|||
19682776|NCT00529763|42129912|FG002|Overall Study|Lost to Follow-up|1|||
19682777|NCT00529763|42129910|FG000|Overall Study|Stem Cell Transplant|0|||
19682778|NCT00529763|42129911|FG001|Overall Study|Stem Cell Transplant|3|||
19682779|NCT00529763|42129912|FG002|Overall Study|Stem Cell Transplant|0|||
19682780|NCT00529763|42129910|FG000|Overall Study|Study Drug Toxicity|1|||
19682781|NCT00529763|42129911|FG001|Overall Study|Study Drug Toxicity|6|||
19682782|NCT00529763|42129912|FG002|Overall Study|Study Drug Toxicity|1|||
19682783|NCT00529763|42129910|FG000|Overall Study|Patient Withdrew Consent|2|||
19682784|NCT00529763|42129911|FG001|Overall Study|Patient Withdrew Consent|3|||
19682785|NCT00529763|42129912|FG002|Overall Study|Patient Withdrew Consent|2|||
19682786|NCT00486902|42129929|FG000|Overall Study|Withdrawal by Subject|1|||
19682787|NCT00486902|42129930|FG001|Overall Study|Withdrawal by Subject|2|||
19682788|NCT00486902|42129929|FG000|Overall Study|decision for postpartum tubal ligation|3|||
19682789|NCT00486902|42129930|FG001|Overall Study|decision for postpartum tubal ligation|1|||
19682790|NCT00486902|42129929|FG000|Overall Study|spinal anesthetic protocal violation|1|||
19682791|NCT00486902|42129930|FG001|Overall Study|spinal anesthetic protocal violation|1|||
19682792|NCT00486902|42129929|FG000|Overall Study|Did not meet inclusion criteria|1|||
19682793|NCT00486902|42129930|FG001|Overall Study|Did not meet inclusion criteria|0|||
19682794|NCT00486902|42129929|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
19768540|NCT02499120|42221855|FG001|Overall Study|Ongoing on study|11|||
19682795|NCT00486902|42129930|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
19682796|NCT03687827|42129936|FG000|Treatment Period 1|Death|0|||
19682797|NCT03687827|42129937|FG001|Treatment Period 1|Death|1|||
19605025|NCT00696709|42053788|FG001|Overall Study|Lost to Follow-up|1|||
19605026|NCT00696709|42053789|FG002|Overall Study|Lost to Follow-up|0|||
19605027|NCT00696709|42053790|FG003|Overall Study|Lost to Follow-up|0|||
19605028|NCT00696709|42053791|FG004|Overall Study|Lost to Follow-up|0|||
19605029|NCT00696709|42053787|FG000|Overall Study|Adverse Event|0|||
19605030|NCT00696709|42053788|FG001|Overall Study|Adverse Event|0|||
19605031|NCT00696709|42053789|FG002|Overall Study|Adverse Event|0|||
19605032|NCT00696709|42053790|FG003|Overall Study|Adverse Event|1|||
19605033|NCT00696709|42053791|FG004|Overall Study|Adverse Event|0|||
19605034|NCT01006265|42053811|FG000|Overall Study|Lost to Follow-up|1|||
19605035|NCT01006265|42053812|FG001|Overall Study|Lost to Follow-up|0|||
19605036|NCT01006265|42053813|FG002|Overall Study|Lost to Follow-up|1|||
19605037|NCT01006265|42053814|FG003|Overall Study|Lost to Follow-up|0|||
19605038|NCT01006265|42053811|FG000|Overall Study|Withdrawal by Subject|4|||
19605039|NCT01006265|42053812|FG001|Overall Study|Withdrawal by Subject|7|||
19605040|NCT01006265|42053813|FG002|Overall Study|Withdrawal by Subject|5|||
19605041|NCT01006265|42053814|FG003|Overall Study|Withdrawal by Subject|5|||
19605042|NCT01006265|42053811|FG000|Overall Study|Administrative reason|1|||
19605043|NCT01006265|42053812|FG001|Overall Study|Administrative reason|2|||
19605044|NCT01006265|42053813|FG002|Overall Study|Administrative reason|3|||
19682798|NCT03687827|42129936|FG000|Treatment Period 1|Lost to Follow-up|2|||
19682799|NCT03687827|42129937|FG001|Treatment Period 1|Lost to Follow-up|2|||
19682800|NCT03687827|42129936|FG000|Treatment Period 1|Physician Decision|5|||
19682801|NCT03687827|42129937|FG001|Treatment Period 1|Physician Decision|2|||
19682802|NCT03687827|42129936|FG000|Treatment Period 1|Withdrawal by Subject|7|||
19682803|NCT03687827|42129937|FG001|Treatment Period 1|Withdrawal by Subject|3|||
19682804|NCT03687827|42129936|FG000|Treatment Period 2|Physician Decision|4|||
19682805|NCT03687827|42129937|FG001|Treatment Period 2|Physician Decision|1|||
19682806|NCT03687827|42129936|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19682807|NCT03687827|42129937|FG001|Treatment Period 2|Withdrawal by Subject|2|||
19682808|NCT00529529|42129946|FG000|Overall Study|Adverse Event|12|||
19682809|NCT00529529|42129947|FG001|Overall Study|Adverse Event|17|||
19682810|NCT00529529|42129948|FG002|Overall Study|Adverse Event|8|||
19682811|NCT00529529|42129946|FG000|Overall Study|Subject withdrew consent|12|||
19682812|NCT00529529|42129947|FG001|Overall Study|Subject withdrew consent|9|||
19682813|NCT00529529|42129948|FG002|Overall Study|Subject withdrew consent|12|||
19682814|NCT00529529|42129946|FG000|Overall Study|Protocol deviation|8|||
19682815|NCT00529529|42129947|FG001|Overall Study|Protocol deviation|12|||
19682816|NCT00529529|42129948|FG002|Overall Study|Protocol deviation|5|||
19682817|NCT00529529|42129946|FG000|Overall Study|Lost to Follow-up|5|||
19682818|NCT00529529|42129947|FG001|Overall Study|Lost to Follow-up|3|||
19682819|NCT00529529|42129948|FG002|Overall Study|Lost to Follow-up|1|||
19682820|NCT00529529|42129946|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19682821|NCT00529529|42129947|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19682822|NCT00529529|42129948|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19682823|NCT00529529|42129946|FG000|Overall Study|Death|2|||
19682824|NCT00529529|42129947|FG001|Overall Study|Death|0|||
19682825|NCT00529529|42129948|FG002|Overall Study|Death|0|||
19682826|NCT00529529|42129946|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19682827|NCT00529529|42129947|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19682828|NCT00529529|42129948|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19682829|NCT00529529|42129946|FG000|Overall Study|Administrative problems|1|||
19682830|NCT00529529|42129947|FG001|Overall Study|Administrative problems|0|||
19682831|NCT00529529|42129948|FG002|Overall Study|Administrative problems|3|||
19682832|NCT05655377|42129956|FG000|Overall Study|Withdrawal by Subject|2|||
19682833|NCT00486434|42129962|FG000|Overall Study|Withdrawal by Subject|34|||
19768541|NCT03207763|42221863|FG000|Overall Study|Lost to Follow-up|1|||
19768542|NCT03207763|42221864|FG001|Overall Study|Lost to Follow-up|0|||
19682834|NCT00486434|42129963|FG001|Overall Study|Withdrawal by Subject|39|||
19682835|NCT00486434|42129962|FG000|Overall Study|Adverse Event|118|||
19682836|NCT00486434|42129963|FG001|Overall Study|Adverse Event|44|||
19682837|NCT00486434|42129962|FG000|Overall Study|Protocol Violation|22|||
19682838|NCT00486434|42129963|FG001|Overall Study|Protocol Violation|21|||
19605045|NCT01006265|42053814|FG003|Overall Study|Administrative reason|0|||
19605046|NCT01008995|42053826|FG000|Controlled Period|Adverse Event|1|||
19605047|NCT01008995|42053827|FG001|Controlled Period|Adverse Event|2|||
19682839|NCT00486434|42129962|FG000|Overall Study|Lack of Efficacy|12|||
19682840|NCT00486434|42129963|FG001|Overall Study|Lack of Efficacy|19|||
19682841|NCT00486434|42129962|FG000|Overall Study|Lost to Follow-up|2|||
19682842|NCT00486434|42129963|FG001|Overall Study|Lost to Follow-up|3|||
19682843|NCT00486434|42129962|FG000|Overall Study|Death|1|||
19682844|NCT00486434|42129963|FG001|Overall Study|Death|2|||
19682845|NCT00486434|42129962|FG000|Overall Study|Personal reasons|5|||
19682846|NCT00486434|42129963|FG001|Overall Study|Personal reasons|6|||
19682847|NCT00424632|42129972|FG000|Overall Study|Death|0|||
19682848|NCT00424632|42129973|FG001|Overall Study|Death|0|||
19682849|NCT00424632|42129974|FG002|Overall Study|Death|0|||
19682850|NCT00424632|42129975|FG003|Overall Study|Death|0|||
19682851|NCT00424632|42129976|FG004|Overall Study|Death|0|||
19682852|NCT00424632|42129977|FG005|Overall Study|Death|2|||
19682853|NCT00424632|42129978|FG006|Overall Study|Death|0|||
19682854|NCT00424632|42129979|FG007|Overall Study|Death|0|||
19682855|NCT00424632|42129980|FG008|Overall Study|Death|0|||
19682856|NCT00424632|42129981|FG009|Overall Study|Death|0|||
19682857|NCT00424632|42129972|FG000|Overall Study|Adverse Event|0|||
19682858|NCT00424632|42129973|FG001|Overall Study|Adverse Event|0|||
19682859|NCT00424632|42129974|FG002|Overall Study|Adverse Event|0|||
19682860|NCT00424632|42129975|FG003|Overall Study|Adverse Event|0|||
19682861|NCT00424632|42129976|FG004|Overall Study|Adverse Event|0|||
19682862|NCT00424632|42129977|FG005|Overall Study|Adverse Event|0|||
19682863|NCT00424632|42129978|FG006|Overall Study|Adverse Event|0|||
19682864|NCT00424632|42129979|FG007|Overall Study|Adverse Event|0|||
19682865|NCT00424632|42129980|FG008|Overall Study|Adverse Event|3|||
19682866|NCT00424632|42129981|FG009|Overall Study|Adverse Event|2|||
19682867|NCT00424632|42129972|FG000|Overall Study|Global deterioration of health status|0|||
19682868|NCT00424632|42129973|FG001|Overall Study|Global deterioration of health status|0|||
19682869|NCT00424632|42129974|FG002|Overall Study|Global deterioration of health status|0|||
19682870|NCT00424632|42129975|FG003|Overall Study|Global deterioration of health status|1|||
19682871|NCT00424632|42129976|FG004|Overall Study|Global deterioration of health status|1|||
19682872|NCT00424632|42129977|FG005|Overall Study|Global deterioration of health status|0|||
19682873|NCT00424632|42129978|FG006|Overall Study|Global deterioration of health status|0|||
19682874|NCT00424632|42129979|FG007|Overall Study|Global deterioration of health status|0|||
19682875|NCT00424632|42129980|FG008|Overall Study|Global deterioration of health status|0|||
19682876|NCT00424632|42129981|FG009|Overall Study|Global deterioration of health status|0|||
19682877|NCT00424632|42129972|FG000|Overall Study|Objective progression or relapse|1|||
19682878|NCT00424632|42129973|FG001|Overall Study|Objective progression or relapse|1|||
19682879|NCT00424632|42129974|FG002|Overall Study|Objective progression or relapse|1|||
19682880|NCT00424632|42129975|FG003|Overall Study|Objective progression or relapse|2|||
19682881|NCT00424632|42129976|FG004|Overall Study|Objective progression or relapse|2|||
19682882|NCT00424632|42129977|FG005|Overall Study|Objective progression or relapse|13|||
19682883|NCT00424632|42129978|FG006|Overall Study|Objective progression or relapse|7|||
19682884|NCT00424632|42129979|FG007|Overall Study|Objective progression or relapse|3|||
19682885|NCT00424632|42129980|FG008|Overall Study|Objective progression or relapse|12|||
19682886|NCT00424632|42129981|FG009|Overall Study|Objective progression or relapse|4|||
19682887|NCT00424632|42129972|FG000|Overall Study|Other|0|||
19682888|NCT00424632|42129973|FG001|Overall Study|Other|0|||
19682889|NCT00424632|42129974|FG002|Overall Study|Other|0|||
19682890|NCT00424632|42129975|FG003|Overall Study|Other|1|||
19682891|NCT00424632|42129976|FG004|Overall Study|Other|0|||
19682892|NCT00424632|42129977|FG005|Overall Study|Other|0|||
19768543|NCT04766034|42221883|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
19768544|NCT04766034|42221884|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
19768545|NCT04766034|42221885|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
19768546|NCT04766034|42221886|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
19682893|NCT00424632|42129978|FG006|Overall Study|Other|0|||
19682894|NCT00424632|42129979|FG007|Overall Study|Other|0|||
19682895|NCT00424632|42129980|FG008|Overall Study|Other|1|||
19682896|NCT00424632|42129981|FG009|Overall Study|Other|0|||
19682897|NCT00529451|42130016|FG000|Overall Study|Subject withdrew consent|16|||
19682898|NCT00529451|42130017|FG001|Overall Study|Subject withdrew consent|21|||
19682899|NCT00529451|42130018|FG002|Overall Study|Subject withdrew consent|13|||
19682900|NCT00529451|42130019|FG003|Overall Study|Subject withdrew consent|12|||
19682901|NCT00529451|42130016|FG000|Overall Study|Adverse Event|9|||
19682902|NCT00529451|42130017|FG001|Overall Study|Adverse Event|16|||
19682903|NCT00529451|42130018|FG002|Overall Study|Adverse Event|14|||
19682904|NCT00529451|42130019|FG003|Overall Study|Adverse Event|8|||
19682905|NCT00529451|42130016|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
19682906|NCT00529451|42130017|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
19682907|NCT00529451|42130018|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
19682908|NCT00529451|42130019|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
19682909|NCT00529451|42130016|FG000|Overall Study|Lost to Follow-up|4|||
19682910|NCT00529451|42130017|FG001|Overall Study|Lost to Follow-up|7|||
19682911|NCT00529451|42130018|FG002|Overall Study|Lost to Follow-up|4|||
19682912|NCT00529451|42130019|FG003|Overall Study|Lost to Follow-up|4|||
19682913|NCT00529451|42130016|FG000|Overall Study|Protocol deviation|1|||
19682914|NCT00529451|42130017|FG001|Overall Study|Protocol deviation|1|||
19682915|NCT00529451|42130018|FG002|Overall Study|Protocol deviation|4|||
19682916|NCT00529451|42130019|FG003|Overall Study|Protocol deviation|1|||
19682917|NCT00529451|42130016|FG000|Overall Study|Administrative problems|1|||
19682918|NCT00529451|42130017|FG001|Overall Study|Administrative problems|1|||
19682919|NCT00529451|42130018|FG002|Overall Study|Administrative problems|0|||
19682920|NCT00529451|42130019|FG003|Overall Study|Administrative problems|2|||
19682921|NCT03876743|42130036|FG000|Overall Study|Lost to Follow-up|6|||
19682922|NCT03876743|42130037|FG001|Overall Study|Lost to Follow-up|4|||
19682923|NCT03876743|42130038|FG002|Overall Study|Lost to Follow-up|4|||
19682924|NCT03876743|42130039|FG003|Overall Study|Lost to Follow-up|7|||
19682925|NCT00486278|42130053|FG000|Overall Study|Adverse Event|5|||
19682926|NCT00486278|42130053|FG000|Overall Study|Withdrawal by Subject|2|||
19682927|NCT00486278|42130053|FG000|Overall Study|Physician Decision|2|||
19682928|NCT00321711|42130072|FG000|Part A|Adverse Event|3|||
19682929|NCT00321711|42130073|FG001|Part A|Adverse Event|3|||
19682930|NCT00321711|42130074|FG002|Part A|Adverse Event|2|||
19682931|NCT00321711|42130075|FG003|Part A|Adverse Event|0|||
19682932|NCT00321711|42130076|FG004|Part A|Adverse Event|0|||
19682933|NCT00321711|42130072|FG000|Part A|Withdrawal by Subject|1|||
19682934|NCT00321711|42130073|FG001|Part A|Withdrawal by Subject|1|||
19682935|NCT00321711|42130074|FG002|Part A|Withdrawal by Subject|1|||
19682936|NCT00321711|42130075|FG003|Part A|Withdrawal by Subject|0|||
19682937|NCT00321711|42130076|FG004|Part A|Withdrawal by Subject|0|||
19682938|NCT00321711|42130072|FG000|Part A|Disease progression|0|||
19682939|NCT00321711|42130073|FG001|Part A|Disease progression|1|||
19682940|NCT00321711|42130074|FG002|Part A|Disease progression|0|||
19605048|NCT01008995|42053828|FG002|Controlled Period|Adverse Event|0|||
19605049|NCT01008995|42053829|FG003|Controlled Period|Adverse Event|0|||
19605050|NCT01008995|42053826|FG000|Controlled Period|Other|2|||
19605051|NCT01008995|42053827|FG001|Controlled Period|Other|1|||
19682941|NCT00321711|42130075|FG003|Part A|Disease progression|0|||
19682942|NCT00321711|42130076|FG004|Part A|Disease progression|0|||
19682943|NCT00321711|42130072|FG000|Part A|Requirement for alternative therapy|0|||
19682944|NCT00321711|42130073|FG001|Part A|Requirement for alternative therapy|2|||
19682945|NCT00321711|42130074|FG002|Part A|Requirement for alternative therapy|1|||
19682946|NCT00321711|42130075|FG003|Part A|Requirement for alternative therapy|0|||
19682947|NCT00321711|42130076|FG004|Part A|Requirement for alternative therapy|0|||
19682948|NCT00321711|42130072|FG000|Part A|Physician Decision|0|||
19682949|NCT00321711|42130073|FG001|Part A|Physician Decision|1|||
19682950|NCT00321711|42130074|FG002|Part A|Physician Decision|3|||
19682951|NCT00321711|42130075|FG003|Part A|Physician Decision|0|||
19682952|NCT00321711|42130076|FG004|Part A|Physician Decision|0|||
19682953|NCT00321711|42130072|FG000|Part A|Other|1|||
19682954|NCT00321711|42130073|FG001|Part A|Other|2|||
19682955|NCT00321711|42130074|FG002|Part A|Other|3|||
19682956|NCT00321711|42130075|FG003|Part A|Other|0|||
19682957|NCT00321711|42130076|FG004|Part A|Other|0|||
19682958|NCT00321711|42130072|FG000|Part A|Protocol deviation|0|||
19682959|NCT00321711|42130073|FG001|Part A|Protocol deviation|0|||
19682960|NCT00321711|42130074|FG002|Part A|Protocol deviation|1|||
19768547|NCT04766034|42221887|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
19768548|NCT04766034|42221883|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
19682961|NCT00321711|42130075|FG003|Part A|Protocol deviation|0|||
19682962|NCT00321711|42130076|FG004|Part A|Protocol deviation|0|||
19682963|NCT00321711|42130072|FG000|Part B|Noncompliance|0|||
19682964|NCT00321711|42130073|FG001|Part B|Noncompliance|0|||
19605052|NCT01008995|42053828|FG002|Controlled Period|Other|0|||
19605053|NCT01008995|42053829|FG003|Controlled Period|Other|0|||
19605054|NCT01008995|42053826|FG000|After Controlled Period|Adverse Event|0|||
19605055|NCT01008995|42053827|FG001|After Controlled Period|Adverse Event|0|||
19605056|NCT01008995|42053828|FG002|After Controlled Period|Adverse Event|1|||
19605057|NCT01008995|42053829|FG003|After Controlled Period|Adverse Event|1|||
19682965|NCT00321711|42130074|FG002|Part B|Noncompliance|0|||
19682966|NCT00321711|42130075|FG003|Part B|Noncompliance|0|||
19682967|NCT00321711|42130076|FG004|Part B|Noncompliance|1|||
19682968|NCT00321711|42130072|FG000|Part B|Adverse Event|0|||
19682969|NCT00321711|42130073|FG001|Part B|Adverse Event|0|||
19605058|NCT01008995|42053826|FG000|After Controlled Period|Other|0|||
19605059|NCT01008995|42053827|FG001|After Controlled Period|Other|0|||
19605060|NCT01008995|42053828|FG002|After Controlled Period|Other|1|||
19605061|NCT01008995|42053829|FG003|After Controlled Period|Other|0|||
19682970|NCT00321711|42130074|FG002|Part B|Adverse Event|0|||
19682971|NCT00321711|42130075|FG003|Part B|Adverse Event|2|||
19682972|NCT00321711|42130076|FG004|Part B|Adverse Event|1|||
19682973|NCT00321711|42130072|FG000|Part B|Disease progression|0|||
19682974|NCT00321711|42130073|FG001|Part B|Disease progression|0|||
19682975|NCT00321711|42130074|FG002|Part B|Disease progression|0|||
19682976|NCT00321711|42130075|FG003|Part B|Disease progression|1|||
19682977|NCT00321711|42130076|FG004|Part B|Disease progression|0|||
19682978|NCT00321711|42130072|FG000|Part B|Physician Decision|0|||
19682979|NCT00321711|42130073|FG001|Part B|Physician Decision|0|||
19682980|NCT00321711|42130074|FG002|Part B|Physician Decision|0|||
19682981|NCT00321711|42130075|FG003|Part B|Physician Decision|1|||
19605062|NCT00957944|42053839|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
19605063|NCT00957944|42053840|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
19768549|NCT04766034|42221884|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
19768550|NCT04766034|42221885|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
19768551|NCT04766034|42221886|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
19768552|NCT04766034|42221887|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
19768553|NCT04766034|42221883|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
19768554|NCT04766034|42221884|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
19768555|NCT04766034|42221885|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
19768556|NCT04766034|42221886|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
19768557|NCT04766034|42221887|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
19768558|NCT04766034|42221883|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
19768559|NCT04766034|42221884|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
19768560|NCT04766034|42221885|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
19768561|NCT04766034|42221886|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
19768562|NCT04766034|42221887|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
19768563|NCT03237013|42221902|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
19768564|NCT03237013|42221903|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
19768565|NCT03237013|42221904|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
19768566|NCT03236779|42221914|FG000|Overall Study|Lost to Follow-up|13|||
19768567|NCT03236779|42221915|FG001|Overall Study|Lost to Follow-up|21|||
19768568|NCT03096483|42221923|FG000|Overall Study|Withdrawal by site|1|||
19768569|NCT03257267|42221929|FG000|Overall Study|Adverse Event|9|||
19768570|NCT03257267|42221930|FG001|Overall Study|Adverse Event|7|||
19768571|NCT03257267|42221929|FG000|Overall Study|Death|92|||
19768572|NCT03257267|42221930|FG001|Overall Study|Death|95|||
19682982|NCT00321711|42130076|FG004|Part B|Physician Decision|2|||
19682983|NCT00321711|42130072|FG000|Part B|Death|0|||
19682984|NCT00321711|42130073|FG001|Part B|Death|0|||
19682985|NCT00321711|42130074|FG002|Part B|Death|0|||
19682986|NCT00321711|42130075|FG003|Part B|Death|2|||
19768573|NCT03257267|42221929|FG000|Overall Study|Lost to Follow-up|2|||
19768574|NCT03257267|42221930|FG001|Overall Study|Lost to Follow-up|2|||
19682987|NCT00321711|42130076|FG004|Part B|Death|1|||
19682988|NCT00486044|42130090|FG000|Overall Study|Withdrawal by Subject|2|||
19768575|NCT03257267|42221929|FG000|Overall Study|Non-compliance with Study Drug|0|||
19768576|NCT03257267|42221930|FG001|Overall Study|Non-compliance with Study Drug|1|||
19768577|NCT03257267|42221929|FG000|Overall Study|Participant Decision|34|||
19768578|NCT03257267|42221930|FG001|Overall Study|Participant Decision|42|||
19768579|NCT03257267|42221929|FG000|Overall Study|Physician Decision|1|||
19768580|NCT03257267|42221930|FG001|Overall Study|Physician Decision|3|||
19768581|NCT03257267|42221929|FG000|Overall Study|Disease Progression|98|||
19768582|NCT03257267|42221930|FG001|Overall Study|Disease Progression|117|||
19768583|NCT03257267|42221929|FG000|Overall Study|Withdrawal of Consent|8|||
19768584|NCT03257267|42221930|FG001|Overall Study|Withdrawal of Consent|26|||
19768585|NCT03257267|42221929|FG000|Overall Study|Study Ongoing|53|||
19768586|NCT03257267|42221930|FG001|Overall Study|Study Ongoing|11|||
19768587|NCT02932579|42221938|FG000|Overall Study|Withdrawal by Subject|4|||
19605064|NCT01005875|42053846|FG000|Overall Study|Death|3|||
19605065|NCT01005719|42053850|FG000|Period 1|Adverse Event|0|||
19605066|NCT01005719|42053851|FG001|Period 1|Adverse Event|0|||
19605067|NCT01005719|42053852|FG002|Period 1|Adverse Event|0|||
19605068|NCT01005719|42053853|FG003|Period 1|Adverse Event|1|||
19605069|NCT01005719|42053854|FG004|Period 1|Adverse Event|0|||
19605070|NCT01005719|42053855|FG005|Period 1|Adverse Event|0|||
19605071|NCT01005719|42053850|FG000|Period 1|Delay in completing study procedures|0|||
19605072|NCT01005719|42053851|FG001|Period 1|Delay in completing study procedures|0|||
19682989|NCT00486044|42130091|FG001|Overall Study|Withdrawal by Subject|1|||
19682990|NCT00486044|42130090|FG000|Overall Study|Adverse Event|0|||
19605073|NCT01005719|42053852|FG002|Period 1|Delay in completing study procedures|0|||
19605074|NCT01005719|42053853|FG003|Period 1|Delay in completing study procedures|0|||
19605075|NCT01005719|42053854|FG004|Period 1|Delay in completing study procedures|0|||
19605076|NCT01005719|42053855|FG005|Period 1|Delay in completing study procedures|1|||
19682991|NCT00486044|42130091|FG001|Overall Study|Adverse Event|1|||
19768588|NCT02932579|42221939|FG001|Overall Study|Withdrawal by Subject|1|||
19768589|NCT03207451|42221949|FG000|Overall Study|scheduling conflict|1|||
19768590|NCT03207451|42221950|FG001|Overall Study|scheduling conflict|0|||
19768591|NCT03207451|42221951|FG002|Overall Study|scheduling conflict|2|||
19768592|NCT03207451|42221952|FG003|Overall Study|scheduling conflict|2|||
19682992|NCT00486044|42130090|FG000|Overall Study|Lost to Follow-up|0|||
19682993|NCT00486044|42130091|FG001|Overall Study|Lost to Follow-up|1|||
19682994|NCT00351273|42130100|FG000|Overall Study|Lost to Follow-up|1|||
19682995|NCT00351273|42130101|FG001|Overall Study|Lost to Follow-up|2|||
19682996|NCT00351273|42130102|FG002|Overall Study|Lost to Follow-up|5|||
19682997|NCT00327717|42130117|FG000|Overall Study|Adverse Event|6|||
19682998|NCT00327717|42130118|FG001|Overall Study|Adverse Event|6|||
19682999|NCT00327717|42130117|FG000|Overall Study|Lack of Efficacy|0|||
19683000|NCT00327717|42130118|FG001|Overall Study|Lack of Efficacy|1|||
19683001|NCT00327717|42130117|FG000|Overall Study|Withdrawal by Subject|3|||
19683002|NCT00327717|42130118|FG001|Overall Study|Withdrawal by Subject|7|||
19683003|NCT00463346|42130126|FG000|Overall Study|Withdrawal by Subject|3|||
19683004|NCT00463346|42130127|FG001|Overall Study|Withdrawal by Subject|3|||
19683005|NCT00462488|42130137|FG000|Overall Study|Protocol Violation|1|||
19683006|NCT00462488|42130138|FG001|Overall Study|Protocol Violation|0|||
19683007|NCT00462488|42130137|FG000|Overall Study|Lack of Efficacy|19|||
19683008|NCT00462488|42130138|FG001|Overall Study|Lack of Efficacy|17|||
19683009|NCT00454142|42130144|FG000|Overall Study|Withdrawal by Subject|1|||
19683010|NCT00424476|42130153|FG000|Overall Study|Withdrawal by Subject|7|||
19683011|NCT00424476|42130154|FG001|Overall Study|Withdrawal by Subject|6|||
19683012|NCT00424476|42130155|FG002|Overall Study|Withdrawal by Subject|3|||
19683013|NCT00424476|42130153|FG000|Overall Study|Adverse Event|19|||
19683014|NCT00424476|42130154|FG001|Overall Study|Adverse Event|16|||
19683015|NCT00424476|42130155|FG002|Overall Study|Adverse Event|15|||
19683016|NCT00424476|42130153|FG000|Overall Study|Lack of Efficacy|16|||
19683017|NCT00424476|42130154|FG001|Overall Study|Lack of Efficacy|12|||
19683018|NCT00424476|42130155|FG002|Overall Study|Lack of Efficacy|12|||
19683019|NCT00424476|42130153|FG000|Overall Study|Lack of Compliance|1|||
19683020|NCT00424476|42130154|FG001|Overall Study|Lack of Compliance|1|||
19683021|NCT00424476|42130155|FG002|Overall Study|Lack of Compliance|1|||
19683022|NCT00424476|42130153|FG000|Overall Study|Lost to Follow-up|4|||
19683023|NCT00424476|42130154|FG001|Overall Study|Lost to Follow-up|6|||
19683024|NCT00424476|42130155|FG002|Overall Study|Lost to Follow-up|3|||
19683025|NCT00424476|42130153|FG000|Overall Study|Protocol Violation|7|||
19683026|NCT00424476|42130154|FG001|Overall Study|Protocol Violation|2|||
19683027|NCT00424476|42130155|FG002|Overall Study|Protocol Violation|3|||
19683028|NCT00424476|42130153|FG000|Overall Study|Physician Decision|3|||
19683029|NCT00424476|42130154|FG001|Overall Study|Physician Decision|2|||
19683030|NCT00424476|42130155|FG002|Overall Study|Physician Decision|3|||
19683031|NCT00424476|42130153|FG000|Overall Study|Other|4|||
19683032|NCT00424476|42130154|FG001|Overall Study|Other|3|||
19683033|NCT00424476|42130155|FG002|Overall Study|Other|9|||
19683034|NCT00453986|42130168|FG000|Overall Study|Lost to Follow-up|6|||
19683035|NCT00453986|42130169|FG001|Overall Study|Lost to Follow-up|5|||
19683036|NCT00453986|42130170|FG002|Overall Study|Lost to Follow-up|6|||
19683037|NCT00453986|42130171|FG003|Overall Study|Lost to Follow-up|2|||
19683038|NCT00453986|42130172|FG004|Overall Study|Lost to Follow-up|0|||
19683039|NCT00435942|42130190|FG000|Overall Study|Death|17|||
19605077|NCT01005719|42053850|FG000|Period 2|Adverse Event|0|||
19605078|NCT01005719|42053851|FG001|Period 2|Adverse Event|0|||
19605079|NCT01005719|42053852|FG002|Period 2|Adverse Event|0|||
19605080|NCT01005719|42053853|FG003|Period 2|Adverse Event|0|||
19683040|NCT00435942|42130191|FG001|Overall Study|Death|10|||
19683041|NCT00435942|42130190|FG000|Overall Study|Withdrawal by Subject|2|||
19768593|NCT03207451|42221949|FG000|Overall Study|Adverse Event|0|||
19605081|NCT01005719|42053854|FG004|Period 2|Adverse Event|1|||
19605082|NCT01005719|42053855|FG005|Period 2|Adverse Event|1|||
19605083|NCT00953576|42053866|FG000|Overall Study|Adverse Event|0|||
19605084|NCT00953576|42053867|FG001|Overall Study|Adverse Event|1|||
19683042|NCT00435942|42130191|FG001|Overall Study|Withdrawal by Subject|0|||
19683043|NCT00435942|42130190|FG000|Overall Study|Lost to Follow-up|0|||
19683044|NCT00435942|42130191|FG001|Overall Study|Lost to Follow-up|16|||
19683045|NCT00435942|42130190|FG000|Overall Study|Conversion to Open Repair|1|||
19683046|NCT00435942|42130191|FG001|Overall Study|Conversion to Open Repair|0|||
19683047|NCT00435942|42130190|FG000|Overall Study|Technical Failure|3|||
19683048|NCT00435942|42130191|FG001|Overall Study|Technical Failure|0|||
19683049|NCT00435942|42130190|FG000|Overall Study|Other|0|||
19768594|NCT03207451|42221950|FG001|Overall Study|Adverse Event|0|||
19605085|NCT00953576|42053866|FG000|Overall Study|Ineligible after Consent|2|||
19605086|NCT00953576|42053867|FG001|Overall Study|Ineligible after Consent|0|||
19605087|NCT01005329|42053882|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
19605088|NCT01005251|42053892|FG000|Overall Study|Withdrawal by Subject|2|||
19683050|NCT00435942|42130191|FG001|Overall Study|Other|1|||
19683051|NCT00453362|42130197|FG000|Overall Study|Adverse Event|5|||
19683052|NCT00453362|42130197|FG000|Overall Study|Death|7|||
19768595|NCT03207451|42221951|FG002|Overall Study|Adverse Event|0|||
19683053|NCT00453362|42130197|FG000|Overall Study|Physician Decision|2|||
19683054|NCT00453362|42130197|FG000|Overall Study|Withdrawal by Subject|3|||
19683055|NCT00453362|42130197|FG000|Overall Study|Progression of disease|56|||
19683056|NCT00453362|42130197|FG000|Overall Study|Screening Failure|14|||
19683057|NCT00424398|42130216|FG000|Overall Study|Withdrawal by Subject|2|||
19683058|NCT00424398|42130217|FG001|Overall Study|Withdrawal by Subject|1|||
19683059|NCT00424398|42130218|FG002|Overall Study|Withdrawal by Subject|0|||
19768596|NCT03207451|42221952|FG003|Overall Study|Adverse Event|1|||
19768597|NCT03350503|42221979|FG000|Overall Study|Adverse Event|5|||
19768598|NCT03350503|42221979|FG000|Overall Study|Withdrawal by Subject|5|||
19768599|NCT03350503|42221979|FG000|Overall Study|Continuation impossible due to move|4|||
19768600|NCT03350503|42221979|FG000|Overall Study|Physician Decision|3|||
19768601|NCT03288779|42222002|FG000|Overall Study|Withdrawal by Subject|3|||
19683060|NCT00424398|42130216|FG000|Overall Study|Subject met exclusion criteria|1|||
19683061|NCT00424398|42130217|FG001|Overall Study|Subject met exclusion criteria|0|||
19683062|NCT00424398|42130218|FG002|Overall Study|Subject met exclusion criteria|0|||
19683063|NCT00461786|42130226|FG000|Overall Study|Entry Criteria Not Met|2|||
19683064|NCT00461786|42130226|FG000|Overall Study|Inevaluable (Never Treated)|1|||
19683065|NCT00435162|42130233|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
19683066|NCT00435162|42130234|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
19683067|NCT00435162|42130235|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
19683068|NCT00435162|42130236|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
19683069|NCT00435162|42130237|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
19683070|NCT00435162|42130238|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
19683071|NCT03836664|42130253|FG000|Overall Study|Didn't complete forms and lost drug|3|||
19683072|NCT03836664|42130254|FG001|Overall Study|Didn't complete forms and lost drug|3|||
19683073|NCT00350727|42130267|FG000|Phase I: Dose Escalation|Adverse Event|4|||
19683074|NCT00350727|42130268|FG001|Phase I: Dose Escalation|Adverse Event|0|||
19683075|NCT00350727|42130269|FG002|Phase I: Dose Escalation|Adverse Event|0|||
19768602|NCT03206749|42222009|FG000|Overall Study|Withdrawal of consent|5|||
19683076|NCT00350727|42130267|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
19683077|NCT00350727|42130268|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
19683078|NCT00350727|42130269|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
19683079|NCT00350727|42130267|FG000|Phase I: Dose Escalation|Death|1|||
19683080|NCT00350727|42130268|FG001|Phase I: Dose Escalation|Death|0|||
19683081|NCT00350727|42130269|FG002|Phase I: Dose Escalation|Death|0|||
19683082|NCT00350727|42130267|FG000|Phase I: Dose Escalation|Physician Decision|1|||
19683083|NCT00350727|42130268|FG001|Phase I: Dose Escalation|Physician Decision|0|||
19768603|NCT03206749|42222010|FG001|Overall Study|Withdrawal of consent|3|||
19768604|NCT03206749|42222011|FG002|Overall Study|Withdrawal of consent|6|||
19768605|NCT03206749|42222009|FG000|Overall Study|Lost to Follow-up|0|||
19768606|NCT03206749|42222010|FG001|Overall Study|Lost to Follow-up|0|||
19768607|NCT03206749|42222011|FG002|Overall Study|Lost to Follow-up|1|||
19768608|NCT03255941|42222031|FG000|Overall Study|Not eligible or refused injection|37|||
19768609|NCT03255941|42222032|FG001|Overall Study|Not eligible or refused injection|44|||
19768610|NCT03255941|42222033|FG002|Overall Study|Not eligible or refused injection|5|||
19768611|NCT03255941|42222034|FG003|Overall Study|Not eligible or refused injection|6|||
19768612|NCT03255941|42222031|FG000|Overall Study|Did not complete exit interview|1|||
19605089|NCT01005251|42053893|FG001|Overall Study|Withdrawal by Subject|5|||
19605090|NCT01005251|42053894|FG002|Overall Study|Withdrawal by Subject|3|||
19683084|NCT00350727|42130269|FG002|Phase I: Dose Escalation|Physician Decision|0|||
19683085|NCT00350727|42130267|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
19683086|NCT00350727|42130268|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
19683087|NCT00350727|42130269|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
19683088|NCT00350727|42130267|FG000|Phase II|Disease Progression|0|||
19683089|NCT00350727|42130268|FG001|Phase II|Disease Progression|15|||
19683090|NCT00350727|42130269|FG002|Phase II|Disease Progression|16|||
19683091|NCT00350727|42130267|FG000|Phase II|Clinical Deterioration|0|||
19683092|NCT00350727|42130268|FG001|Phase II|Clinical Deterioration|1|||
19683093|NCT00350727|42130269|FG002|Phase II|Clinical Deterioration|0|||
19683094|NCT00350727|42130267|FG000|Phase II|Withdrawal by Subject|0|||
19683095|NCT00350727|42130268|FG001|Phase II|Withdrawal by Subject|2|||
19605091|NCT01005251|42053895|FG003|Overall Study|Withdrawal by Subject|4|||
19605092|NCT01005251|42053896|FG004|Overall Study|Withdrawal by Subject|9|||
19605093|NCT01005251|42053892|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
19605094|NCT01005251|42053893|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19605095|NCT01005251|42053894|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
19605096|NCT01005251|42053895|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
19683096|NCT00350727|42130269|FG002|Phase II|Withdrawal by Subject|1|||
19768613|NCT03255941|42222032|FG001|Overall Study|Did not complete exit interview|2|||
19605097|NCT01005251|42053896|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
19683097|NCT00350727|42130267|FG000|Phase II|Adverse Event|0|||
19683098|NCT00350727|42130268|FG001|Phase II|Adverse Event|1|||
19683099|NCT00350727|42130269|FG002|Phase II|Adverse Event|1|||
19683100|NCT00350727|42130267|FG000|Phase II|Death|0|||
19768614|NCT03255941|42222033|FG002|Overall Study|Did not complete exit interview|0|||
19683101|NCT00350727|42130268|FG001|Phase II|Death|0|||
19683102|NCT00350727|42130269|FG002|Phase II|Death|2|||
19683103|NCT00350727|42130267|FG000|Phase II|Sponsor Terminated Study|0|||
19683104|NCT00350727|42130268|FG001|Phase II|Sponsor Terminated Study|0|||
19683105|NCT00350727|42130269|FG002|Phase II|Sponsor Terminated Study|1|||
19683106|NCT00350727|42130267|FG000|Phase II|Enrolled in Rollover Study|0|||
19683107|NCT00350727|42130268|FG001|Phase II|Enrolled in Rollover Study|0|||
19683108|NCT00350727|42130269|FG002|Phase II|Enrolled in Rollover Study|1|||
19683109|NCT00434304|42130288|FG000|Overall Study|Adverse Event|14|||
19683110|NCT00434304|42130288|FG000|Overall Study|Lack of Efficacy|2|||
19683111|NCT00434304|42130288|FG000|Overall Study|Withdrawal by Subject|4|||
19683112|NCT00424008|42130295|FG000|Overall Study|Adverse Event|8|||
19683113|NCT00424008|42130296|FG001|Overall Study|Adverse Event|6|||
19683114|NCT00424008|42130295|FG000|Overall Study|Lack of Efficacy|40|||
19683115|NCT00424008|42130296|FG001|Overall Study|Lack of Efficacy|34|||
19683116|NCT00424008|42130295|FG000|Overall Study|Lost to Follow-up|1|||
19683117|NCT00424008|42130296|FG001|Overall Study|Lost to Follow-up|2|||
19768615|NCT03255941|42222034|FG003|Overall Study|Did not complete exit interview|0|||
19768616|NCT03255629|42222056|FG000|Overall Study|Adverse Event|1|||
19768617|NCT03255629|42222057|FG001|Overall Study|Adverse Event|0|||
19768618|NCT03255629|42222056|FG000|Overall Study|did not experience hypoglycemia|2|||
19768619|NCT03255629|42222057|FG001|Overall Study|did not experience hypoglycemia|1|||
19605098|NCT01005251|42053892|FG000|Overall Study|Adverse Event|2|||
19605099|NCT01005251|42053893|FG001|Overall Study|Adverse Event|6|||
19605100|NCT01005251|42053894|FG002|Overall Study|Adverse Event|8|||
19605101|NCT01005251|42053895|FG003|Overall Study|Adverse Event|5|||
19605102|NCT01005251|42053896|FG004|Overall Study|Adverse Event|4|||
19605103|NCT01005251|42053892|FG000|Overall Study|Protocol Violation|1|||
19605104|NCT01005251|42053893|FG001|Overall Study|Protocol Violation|0|||
19605105|NCT01005251|42053894|FG002|Overall Study|Protocol Violation|0|||
19605106|NCT01005251|42053895|FG003|Overall Study|Protocol Violation|0|||
19605107|NCT01005251|42053896|FG004|Overall Study|Protocol Violation|2|||
19605108|NCT01005251|42053892|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
19605109|NCT01005251|42053893|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
19605110|NCT01005251|42053894|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
19605111|NCT01005251|42053895|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
19605112|NCT01005251|42053896|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
19605113|NCT01005251|42053892|FG000|Overall Study|Lost to Follow-up|1|||
19605114|NCT01005251|42053893|FG001|Overall Study|Lost to Follow-up|4|||
19605115|NCT01005251|42053894|FG002|Overall Study|Lost to Follow-up|2|||
19683118|NCT00424008|42130295|FG000|Overall Study|Withdrawal by Subject|5|||
19683119|NCT00424008|42130296|FG001|Overall Study|Withdrawal by Subject|8|||
19683120|NCT00424008|42130295|FG000|Overall Study|Noncompliance with protocol|13|||
19683121|NCT00424008|42130296|FG001|Overall Study|Noncompliance with protocol|7|||
19683122|NCT00424008|42130295|FG000|Overall Study|Did not meet protocol eligibility|16|||
19683123|NCT00424008|42130296|FG001|Overall Study|Did not meet protocol eligibility|21|||
19683124|NCT00424008|42130295|FG000|Overall Study|Administrative|266|||
19683125|NCT00424008|42130296|FG001|Overall Study|Administrative|257|||
19683126|NCT00423930|42130303|FG000|Overall Study|Withdrawal by Subject|2|||
19683127|NCT00423852|42130307|FG000|Overall Study|Removed pior to the high-dose portion|3|||
19683128|NCT00461708|42130313|FG000|Overall Study|Adverse Event|17|||
19683129|NCT00461708|42130314|FG001|Overall Study|Adverse Event|7|||
19683130|NCT00461708|42130313|FG000|Overall Study|Lack of Efficacy|68|||
19683131|NCT00461708|42130314|FG001|Overall Study|Lack of Efficacy|20|||
19683132|NCT00461708|42130313|FG000|Overall Study|Physician Decision|10|||
19683133|NCT00461708|42130314|FG001|Overall Study|Physician Decision|4|||
19683134|NCT00461708|42130313|FG000|Overall Study|Withdrawal by Subject|8|||
19683135|NCT00461708|42130314|FG001|Overall Study|Withdrawal by Subject|2|||
19683136|NCT00461708|42130313|FG000|Overall Study|Other|4|||
19683137|NCT00461708|42130314|FG001|Overall Study|Other|4|||
19683138|NCT00461708|42130313|FG000|Overall Study|Death|8|||
19683139|NCT00461708|42130314|FG001|Overall Study|Death|1|||
19683140|NCT00327171|42130325|FG000|Overall Study|Did not receive study medication|3|||
19683141|NCT00327171|42130326|FG001|Overall Study|Did not receive study medication|0|||
19683142|NCT00327171|42130325|FG000|Overall Study|Adverse Event|23|||
19683143|NCT00327171|42130326|FG001|Overall Study|Adverse Event|23|||
19768620|NCT03031938|42222066|FG000|Overall Study|Death|1|||
19605116|NCT01005251|42053895|FG003|Overall Study|Lost to Follow-up|0|||
19605117|NCT01005251|42053896|FG004|Overall Study|Lost to Follow-up|0|||
19605118|NCT01005251|42053892|FG000|Overall Study|Physician Decision|0|||
19605119|NCT01005251|42053893|FG001|Overall Study|Physician Decision|0|||
19605120|NCT01005251|42053894|FG002|Overall Study|Physician Decision|0|||
19605121|NCT01005251|42053895|FG003|Overall Study|Physician Decision|0|||
19605122|NCT01005251|42053896|FG004|Overall Study|Physician Decision|2|||
19683144|NCT00327171|42130325|FG000|Overall Study|Disease progression/lack of efficacy|68|||
19683145|NCT00327171|42130326|FG001|Overall Study|Disease progression/lack of efficacy|69|||
19683146|NCT00327171|42130325|FG000|Overall Study|Investigator/participant request|1|||
19683147|NCT00327171|42130326|FG001|Overall Study|Investigator/participant request|8|||
19768621|NCT03031938|42222067|FG001|Overall Study|Death|0|||
19768622|NCT01137773|42222075|FG000|Overall Study|Death|3|||
19768623|NCT01137773|42222076|FG001|Overall Study|Death|3|||
19768624|NCT01137773|42222075|FG000|Overall Study|Lost to Follow-up|6|||
19768625|NCT01137773|42222076|FG001|Overall Study|Lost to Follow-up|0|||
19768626|NCT03094611|42222084|FG000|Overall Study|Lack of Efficacy|1|||
19768627|NCT03094611|42222084|FG000|Overall Study|Stem Cell Transplant|1|||
19768628|NCT04105725|42222108|FG000|Primary Intervention|Lost to Follow-up|0|||
19768629|NCT04105725|42222109|FG001|Primary Intervention|Lost to Follow-up|2|||
19768630|NCT04105725|42222108|FG000|Primary Intervention|Withdrawal by Subject|0|||
19768631|NCT04105725|42222109|FG001|Primary Intervention|Withdrawal by Subject|1|||
19768632|NCT04066023|42222118|FG000|Overall Study|Adverse Event|0|||
19768633|NCT04066023|42222119|FG001|Overall Study|Adverse Event|0|||
19768634|NCT04066023|42222120|FG002|Overall Study|Adverse Event|1|||
19768635|NCT04066023|42222118|FG000|Overall Study|Sponsor decision|3|||
19768636|NCT04066023|42222119|FG001|Overall Study|Sponsor decision|6|||
19768637|NCT04066023|42222120|FG002|Overall Study|Sponsor decision|2|||
19768638|NCT04066023|42222118|FG000|Overall Study|Physician Decision|0|||
19768639|NCT04066023|42222119|FG001|Overall Study|Physician Decision|0|||
19768640|NCT04066023|42222120|FG002|Overall Study|Physician Decision|1|||
19768641|NCT04066023|42222118|FG000|Overall Study|Lost to Follow-up|0|||
19768642|NCT04066023|42222119|FG001|Overall Study|Lost to Follow-up|1|||
19768643|NCT04066023|42222120|FG002|Overall Study|Lost to Follow-up|1|||
19768644|NCT04066023|42222118|FG000|Overall Study|Noncompliance|0|||
19768645|NCT04066023|42222119|FG001|Overall Study|Noncompliance|1|||
19768646|NCT04066023|42222120|FG002|Overall Study|Noncompliance|1|||
19768647|NCT03106987|42222132|FG000|Overall Study|Death|37|||
19768648|NCT03106987|42222133|FG001|Overall Study|Death|22|||
19768649|NCT03106987|42222134|FG002|Overall Study|Death|12|||
19768650|NCT03106987|42222135|FG003|Overall Study|Death|8|||
19768651|NCT03106987|42222132|FG000|Overall Study|Lost to Follow-up|2|||
19768652|NCT03106987|42222133|FG001|Overall Study|Lost to Follow-up|0|||
19768653|NCT03106987|42222134|FG002|Overall Study|Lost to Follow-up|2|||
19768654|NCT03106987|42222135|FG003|Overall Study|Lost to Follow-up|2|||
19768655|NCT03106987|42222132|FG000|Overall Study|Withdrawal by Subject|5|||
19768656|NCT03106987|42222133|FG001|Overall Study|Withdrawal by Subject|1|||
19768657|NCT03106987|42222134|FG002|Overall Study|Withdrawal by Subject|4|||
19768658|NCT03106987|42222135|FG003|Overall Study|Withdrawal by Subject|1|||
19768659|NCT02932267|42222145|FG000|Overall Study|Withdrawal by Subject|3|||
19768660|NCT02932267|42222145|FG000|Overall Study|Lost to Follow-up|4|||
19768661|NCT02932267|42222145|FG000|Overall Study|Pregnancy|1|||
19768662|NCT03217591|42222152|FG000|Overall Study|Adverse Event|1|||
19768663|NCT03217591|42222153|FG001|Overall Study|Adverse Event|2|||
19768664|NCT03217591|42222154|FG002|Overall Study|Adverse Event|6|||
19768665|NCT03217591|42222152|FG000|Overall Study|Withdrawal by Subject|0|||
19768666|NCT03217591|42222153|FG001|Overall Study|Withdrawal by Subject|1|||
19768667|NCT03217591|42222154|FG002|Overall Study|Withdrawal by Subject|3|||
19768668|NCT03217591|42222152|FG000|Overall Study|Lost to Follow-up|1|||
19768669|NCT03217591|42222153|FG001|Overall Study|Lost to Follow-up|0|||
19768670|NCT03217591|42222154|FG002|Overall Study|Lost to Follow-up|0|||
19605123|NCT01005251|42053892|FG000|Overall Study|Patient moved|1|||
19768671|NCT03217591|42222152|FG000|Overall Study|Protocol Violation|1|||
19768672|NCT03217591|42222153|FG001|Overall Study|Protocol Violation|0|||
19768673|NCT03217591|42222154|FG002|Overall Study|Protocol Violation|1|||
19768674|NCT03031782|42222163|FG000|Treatment Period 1|Lack of Efficacy|3|||
19768675|NCT03031782|42222164|FG001|Treatment Period 1|Lack of Efficacy|0|||
19768676|NCT03031782|42222165|FG002|Treatment Period 1|Lack of Efficacy|0|||
19605124|NCT01005251|42053893|FG001|Overall Study|Patient moved|0|||
19605125|NCT01005251|42053894|FG002|Overall Study|Patient moved|0|||
19605126|NCT01005251|42053895|FG003|Overall Study|Patient moved|0|||
19605127|NCT01005251|42053896|FG004|Overall Study|Patient moved|0|||
19605128|NCT01005251|42053892|FG000|Overall Study|Wrong drug dispensed|0|||
19605129|NCT01005251|42053893|FG001|Overall Study|Wrong drug dispensed|1|||
19605130|NCT01005251|42053894|FG002|Overall Study|Wrong drug dispensed|0|||
19605131|NCT01005251|42053895|FG003|Overall Study|Wrong drug dispensed|0|||
19605132|NCT01005251|42053896|FG004|Overall Study|Wrong drug dispensed|0|||
19605133|NCT01005251|42053892|FG000|Overall Study|Randomized in error|0|||
19605134|NCT01005251|42053893|FG001|Overall Study|Randomized in error|0|||
19605135|NCT01005251|42053894|FG002|Overall Study|Randomized in error|1|||
19605136|NCT01005251|42053895|FG003|Overall Study|Randomized in error|1|||
19605137|NCT01005251|42053896|FG004|Overall Study|Randomized in error|0|||
19605138|NCT01005251|42053892|FG000|Overall Study|Lack of Efficacy|0|||
19605139|NCT01005251|42053893|FG001|Overall Study|Lack of Efficacy|0|||
19605140|NCT01005251|42053894|FG002|Overall Study|Lack of Efficacy|1|||
19605141|NCT01005251|42053895|FG003|Overall Study|Lack of Efficacy|1|||
19605142|NCT01005251|42053896|FG004|Overall Study|Lack of Efficacy|0|||
19768677|NCT03031782|42222166|FG003|Treatment Period 1|Lack of Efficacy|0|||
19605143|NCT03048578|42053910|FG000|Overall Study|Withdrawal by Subject|5|||
19768678|NCT03031782|42222167|FG004|Treatment Period 1|Lack of Efficacy|0|||
19768679|NCT03031782|42222163|FG000|Treatment Period 2|Physician Decision|0|||
19683148|NCT00327171|42130325|FG000|Overall Study|Clinical progression|12|||
19683149|NCT00327171|42130326|FG001|Overall Study|Clinical progression|8|||
19683150|NCT00327171|42130325|FG000|Overall Study|Undisclosed history of ischemia|0|||
19683151|NCT00327171|42130326|FG001|Overall Study|Undisclosed history of ischemia|1|||
19683152|NCT00327171|42130325|FG000|Overall Study|Other|1|||
19683153|NCT00327171|42130326|FG001|Overall Study|Other|0|||
19683154|NCT00461630|42130334|FG000|Overall Study|Death|798|||
19683155|NCT00461630|42130335|FG001|Overall Study|Death|732|||
19683156|NCT00461630|42130334|FG000|Overall Study|Lost to Follow-up|108|||
19683157|NCT00461630|42130335|FG001|Overall Study|Lost to Follow-up|95|||
19683158|NCT00461552|42130343|FG000|Overall Study|Drug Dispensing error|0|||
19683159|NCT00461552|42130344|FG001|Overall Study|Drug Dispensing error|2|||
19683160|NCT00453206|42130350|FG000|Overall Study|Death|1|||
19768680|NCT03031782|42222164|FG001|Treatment Period 2|Physician Decision|1|||
19768681|NCT03031782|42222165|FG002|Treatment Period 2|Physician Decision|0|||
19768682|NCT03031782|42222166|FG003|Treatment Period 2|Physician Decision|0|||
19605144|NCT03048578|42053911|FG001|Overall Study|Withdrawal by Subject|6|||
19605145|NCT03048578|42053910|FG000|Overall Study|Lost to Follow-up|22|||
19605146|NCT03048578|42053911|FG001|Overall Study|Lost to Follow-up|10|||
19605147|NCT03048578|42053910|FG000|Overall Study|Adverse Event|1|||
19605148|NCT03048578|42053911|FG001|Overall Study|Adverse Event|2|||
19605149|NCT03048578|42053910|FG000|Overall Study|Terminated|3|||
19605150|NCT03048578|42053911|FG001|Overall Study|Terminated|2|||
19605151|NCT01008449|42053919|FG000|Overall Study|Lost to Follow-up|29|||
19605152|NCT01008449|42053920|FG001|Overall Study|Lost to Follow-up|19|||
19605153|NCT00696241|42053931|FG000|Overall Study|Adverse Event|11|||
19605154|NCT00696241|42053932|FG001|Overall Study|Adverse Event|3|||
19605155|NCT00696241|42053933|FG002|Overall Study|Adverse Event|6|||
19605156|NCT00696241|42053934|FG003|Overall Study|Adverse Event|4|||
19605157|NCT00696241|42053935|FG004|Overall Study|Adverse Event|5|||
19605158|NCT00696241|42053931|FG000|Overall Study|Protocol Violation|1|||
19605159|NCT00696241|42053932|FG001|Overall Study|Protocol Violation|1|||
19605160|NCT00696241|42053933|FG002|Overall Study|Protocol Violation|2|||
19605161|NCT00696241|42053934|FG003|Overall Study|Protocol Violation|0|||
19605162|NCT00696241|42053935|FG004|Overall Study|Protocol Violation|3|||
19605163|NCT00696241|42053931|FG000|Overall Study|Lost to Follow-up|1|||
19605164|NCT00696241|42053932|FG001|Overall Study|Lost to Follow-up|4|||
19605165|NCT00696241|42053933|FG002|Overall Study|Lost to Follow-up|1|||
19605166|NCT00696241|42053934|FG003|Overall Study|Lost to Follow-up|2|||
19605167|NCT00696241|42053935|FG004|Overall Study|Lost to Follow-up|0|||
19605168|NCT00696241|42053931|FG000|Overall Study|Withdrawal by Subject|4|||
19605169|NCT00696241|42053932|FG001|Overall Study|Withdrawal by Subject|8|||
19605170|NCT00696241|42053933|FG002|Overall Study|Withdrawal by Subject|6|||
19605171|NCT00696241|42053934|FG003|Overall Study|Withdrawal by Subject|1|||
19605172|NCT00696241|42053935|FG004|Overall Study|Withdrawal by Subject|0|||
19605173|NCT00696241|42053931|FG000|Overall Study|Lack of Efficacy|1|||
19605174|NCT00696241|42053932|FG001|Overall Study|Lack of Efficacy|5|||
19605175|NCT00696241|42053933|FG002|Overall Study|Lack of Efficacy|4|||
19605176|NCT00696241|42053934|FG003|Overall Study|Lack of Efficacy|5|||
19605177|NCT00696241|42053935|FG004|Overall Study|Lack of Efficacy|3|||
19605178|NCT00696241|42053931|FG000|Overall Study|Other|6|||
19605179|NCT00696241|42053932|FG001|Overall Study|Other|1|||
19605180|NCT00696241|42053933|FG002|Overall Study|Other|5|||
19605181|NCT00696241|42053934|FG003|Overall Study|Other|2|||
19605182|NCT00696241|42053935|FG004|Overall Study|Other|1|||
19605183|NCT00957008|42053951|FG000|Overall Study|Withdrawal by Subject|13|||
19605184|NCT00957008|42053952|FG001|Overall Study|Withdrawal by Subject|10|||
19605185|NCT00957008|42053953|FG002|Overall Study|Withdrawal by Subject|12|||
19605186|NCT00957008|42053954|FG003|Overall Study|Withdrawal by Subject|16|||
19605187|NCT00957008|42053951|FG000|Overall Study|Lost to Follow-up|3|||
19605188|NCT00957008|42053952|FG001|Overall Study|Lost to Follow-up|1|||
19683161|NCT03850496|42130357|FG000|Overall Study|Withdrawal by Subject|1|||
19683162|NCT03850496|42130358|FG001|Overall Study|Withdrawal by Subject|0|||
19683163|NCT03850496|42130359|FG002|Overall Study|Withdrawal by Subject|0|||
19683164|NCT03850496|42130357|FG000|Overall Study|Lost to Follow-up|0|||
19605189|NCT00957008|42053953|FG002|Overall Study|Lost to Follow-up|3|||
19605190|NCT00957008|42053954|FG003|Overall Study|Lost to Follow-up|4|||
19605191|NCT00957008|42053951|FG000|Overall Study|Physician Decision|1|||
19605192|NCT00957008|42053952|FG001|Overall Study|Physician Decision|0|||
19605193|NCT00957008|42053953|FG002|Overall Study|Physician Decision|1|||
19605194|NCT00957008|42053954|FG003|Overall Study|Physician Decision|1|||
19605195|NCT00957008|42053951|FG000|Overall Study|Relocated; Family conflict|4|||
19605196|NCT00957008|42053952|FG001|Overall Study|Relocated; Family conflict|1|||
19605197|NCT00957008|42053953|FG002|Overall Study|Relocated; Family conflict|1|||
19605198|NCT00957008|42053954|FG003|Overall Study|Relocated; Family conflict|3|||
19605199|NCT00952484|42053971|FG000|Overall Study|Withdrawal by Subject|0|||
19605200|NCT00952484|42053972|FG001|Overall Study|Withdrawal by Subject|1|||
19605201|NCT00952484|42053973|FG002|Overall Study|Withdrawal by Subject|0|||
19683165|NCT03850496|42130358|FG001|Overall Study|Lost to Follow-up|1|||
19605202|NCT00689611|42053984|FG000|Overall Study|Death|6|||
19605203|NCT00689611|42053985|FG001|Overall Study|Death|9|||
19605204|NCT00689611|42053984|FG000|Overall Study|Withdrawal by Subject|8|||
19605205|NCT00689611|42053985|FG001|Overall Study|Withdrawal by Subject|9|||
19605206|NCT00689611|42053984|FG000|Overall Study|Lost to Follow-up|27|||
19605207|NCT00689611|42053985|FG001|Overall Study|Lost to Follow-up|28|||
19605208|NCT00689299|42053994|FG000|Overall Study|Adverse Event|2|||
19605209|NCT00689299|42053995|FG001|Overall Study|Adverse Event|1|||
19605210|NCT00689299|42053996|FG002|Overall Study|Adverse Event|1|||
19605211|NCT00689299|42053994|FG000|Overall Study|Lost to Follow-up|0|||
19605212|NCT00689299|42053995|FG001|Overall Study|Lost to Follow-up|1|||
19605213|NCT00689299|42053996|FG002|Overall Study|Lost to Follow-up|1|||
19605214|NCT00689299|42053994|FG000|Overall Study|Withdrawal by Subject|4|||
19605215|NCT00689299|42053995|FG001|Overall Study|Withdrawal by Subject|1|||
19605216|NCT00689299|42053996|FG002|Overall Study|Withdrawal by Subject|3|||
19605217|NCT00689299|42053994|FG000|Overall Study|Protocol Violation|1|||
19605218|NCT00689299|42053995|FG001|Overall Study|Protocol Violation|0|||
19605219|NCT00689299|42053996|FG002|Overall Study|Protocol Violation|0|||
19605220|NCT02506244|42054007|FG000|Overall Study|Did not undergo active monitoring|458|||
19605221|NCT02506244|42054008|FG001|Overall Study|Did not undergo active monitoring|459|||
19605222|NCT02506244|42054009|FG002|Overall Study|Did not undergo active monitoring|0|||
19605223|NCT00948974|42054019|FG000|Overall Study|Lost to Follow-up|23|||
19605224|NCT00948974|42054020|FG001|Overall Study|Lost to Follow-up|20|||
19605225|NCT01007435|42054030|FG000|Overall Study|Adverse Event|16|||
19605226|NCT01007435|42054031|FG001|Overall Study|Adverse Event|25|||
19605227|NCT01007435|42054032|FG002|Overall Study|Adverse Event|47|||
19605228|NCT01007435|42054033|FG003|Overall Study|Adverse Event|31|||
19605229|NCT01007435|42054030|FG000|Overall Study|Death|2|||
19605230|NCT01007435|42054031|FG001|Overall Study|Death|4|||
19605231|NCT01007435|42054032|FG002|Overall Study|Death|2|||
19605232|NCT01007435|42054033|FG003|Overall Study|Death|1|||
19605233|NCT01007435|42054030|FG000|Overall Study|Insufficient Therapeutic Response|21|||
19605234|NCT01007435|42054031|FG001|Overall Study|Insufficient Therapeutic Response|7|||
19605235|NCT01007435|42054032|FG002|Overall Study|Insufficient Therapeutic Response|2|||
19605236|NCT01007435|42054033|FG003|Overall Study|Insufficient Therapeutic Response|9|||
19605237|NCT01007435|42054030|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
19768683|NCT03031782|42222167|FG004|Treatment Period 2|Physician Decision|3|||
19768684|NCT03031782|42222163|FG000|Treatment Period 2|Lack of Efficacy|0|||
19683166|NCT03850496|42130359|FG002|Overall Study|Lost to Follow-up|4|||
19683167|NCT00327015|42130371|FG000|Overall Study|Lack of Efficacy|18|||
19683168|NCT00327015|42130372|FG001|Overall Study|Lack of Efficacy|18|||
19683169|NCT00327015|42130373|FG002|Overall Study|Lack of Efficacy|35|||
19683170|NCT00327015|42130374|FG003|Overall Study|Lack of Efficacy|29|||
19683171|NCT00327015|42130371|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
19683172|NCT00327015|42130372|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
19683173|NCT00327015|42130373|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
19683174|NCT00327015|42130374|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
19683175|NCT00327015|42130371|FG000|Overall Study|Lost to Follow-up|22|||
19683176|NCT00327015|42130372|FG001|Overall Study|Lost to Follow-up|23|||
19683177|NCT00327015|42130373|FG002|Overall Study|Lost to Follow-up|29|||
19683178|NCT00327015|42130374|FG003|Overall Study|Lost to Follow-up|22|||
19683179|NCT00327015|42130371|FG000|Overall Study|Adverse Event|14|||
19683180|NCT00327015|42130372|FG001|Overall Study|Adverse Event|10|||
19683181|NCT00327015|42130373|FG002|Overall Study|Adverse Event|14|||
19683182|NCT00327015|42130374|FG003|Overall Study|Adverse Event|14|||
19683183|NCT00327015|42130371|FG000|Overall Study|Subject no longer meets study criteria|4|||
19683184|NCT00327015|42130372|FG001|Overall Study|Subject no longer meets study criteria|2|||
19683185|NCT00327015|42130373|FG002|Overall Study|Subject no longer meets study criteria|8|||
19683186|NCT00327015|42130374|FG003|Overall Study|Subject no longer meets study criteria|7|||
19768685|NCT03031782|42222164|FG001|Treatment Period 2|Lack of Efficacy|1|||
19683187|NCT00327015|42130371|FG000|Overall Study|Poor/Noncompliance|11|||
19683188|NCT00327015|42130372|FG001|Overall Study|Poor/Noncompliance|8|||
19683189|NCT00327015|42130373|FG002|Overall Study|Poor/Noncompliance|4|||
19683190|NCT00327015|42130374|FG003|Overall Study|Poor/Noncompliance|5|||
19683191|NCT00327015|42130371|FG000|Overall Study|Physician Decision|0|||
19605238|NCT01007435|42054031|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
19605239|NCT01007435|42054032|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
19683192|NCT00327015|42130372|FG001|Overall Study|Physician Decision|1|||
19683193|NCT00327015|42130373|FG002|Overall Study|Physician Decision|3|||
19683194|NCT00327015|42130374|FG003|Overall Study|Physician Decision|2|||
19683195|NCT00327015|42130371|FG000|Overall Study|Death|1|||
19605240|NCT01007435|42054033|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
19605241|NCT01007435|42054030|FG000|Overall Study|Other Protocol Violation|2|||
19605242|NCT01007435|42054031|FG001|Overall Study|Other Protocol Violation|0|||
19605243|NCT01007435|42054032|FG002|Overall Study|Other Protocol Violation|1|||
19683196|NCT00327015|42130372|FG001|Overall Study|Death|2|||
19683197|NCT00327015|42130373|FG002|Overall Study|Death|2|||
19683198|NCT00327015|42130374|FG003|Overall Study|Death|3|||
19683199|NCT00327015|42130371|FG000|Overall Study|Pregnancy|0|||
19683200|NCT00327015|42130372|FG001|Overall Study|Pregnancy|2|||
19683201|NCT00327015|42130373|FG002|Overall Study|Pregnancy|1|||
19683202|NCT00327015|42130374|FG003|Overall Study|Pregnancy|1|||
19683203|NCT00327015|42130371|FG000|Overall Study|Administrative Reason by Sponsor|1|||
19683204|NCT00327015|42130372|FG001|Overall Study|Administrative Reason by Sponsor|2|||
19683205|NCT00327015|42130373|FG002|Overall Study|Administrative Reason by Sponsor|2|||
19683206|NCT00327015|42130374|FG003|Overall Study|Administrative Reason by Sponsor|1|||
19683207|NCT00434148|42130386|FG000|Overall Study|Adverse Event|18|||
19605244|NCT01007435|42054033|FG003|Overall Study|Other Protocol Violation|0|||
19605245|NCT01007435|42054030|FG000|Overall Study|Refused Treatment|13|||
19605246|NCT01007435|42054031|FG001|Overall Study|Refused Treatment|13|||
19605247|NCT01007435|42054032|FG002|Overall Study|Refused Treatment|5|||
19605248|NCT01007435|42054033|FG003|Overall Study|Refused Treatment|8|||
19605249|NCT01007435|42054030|FG000|Overall Study|Failure to Return|5|||
19605250|NCT01007435|42054031|FG001|Overall Study|Failure to Return|4|||
19605251|NCT01007435|42054032|FG002|Overall Study|Failure to Return|3|||
19605252|NCT01007435|42054033|FG003|Overall Study|Failure to Return|6|||
19605253|NCT01007435|42054030|FG000|Overall Study|Reason not Specified|1|||
19605254|NCT01007435|42054031|FG001|Overall Study|Reason not Specified|1|||
19605255|NCT01007435|42054032|FG002|Overall Study|Reason not Specified|2|||
19605256|NCT01007435|42054033|FG003|Overall Study|Reason not Specified|1|||
19605257|NCT00948896|42054051|FG000|Randomization to 24 Months of Age|Death|1|||
19605258|NCT00948896|42054052|FG001|Randomization to 24 Months of Age|Death|0|||
19605259|NCT00948896|42054053|FG002|Randomization to 24 Months of Age|Death|0|||
19605260|NCT00948896|42054054|FG003|Randomization to 24 Months of Age|Death|0|||
19605261|NCT00948896|42054055|FG004|Randomization to 24 Months of Age|Death|2|||
19605262|NCT00948896|42054056|FG005|Randomization to 24 Months of Age|Death|1|||
19605263|NCT00948896|42054057|FG006|Randomization to 24 Months of Age|Death|2|||
19605264|NCT00948896|42054058|FG007|Randomization to 24 Months of Age|Death|1|||
19605265|NCT00948896|42054051|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
19605266|NCT00948896|42054052|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
19605267|NCT00948896|42054053|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
19605268|NCT00948896|42054054|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
19605269|NCT00948896|42054055|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
19605270|NCT00948896|42054056|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
19605271|NCT00948896|42054057|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
19605272|NCT00948896|42054058|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
19605273|NCT00948896|42054051|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
19605274|NCT00948896|42054052|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
19605275|NCT00948896|42054053|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
19605276|NCT00948896|42054054|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
19605277|NCT00948896|42054055|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
19605278|NCT00948896|42054056|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
19605279|NCT00948896|42054057|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
19605280|NCT00948896|42054058|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
19605281|NCT00948896|42054051|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
19605282|NCT00948896|42054052|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
19605283|NCT00948896|42054053|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
19605284|NCT00948896|42054054|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
19605285|NCT00948896|42054055|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
19605286|NCT00948896|42054056|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
19605287|NCT00948896|42054057|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
19605288|NCT00948896|42054058|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
19683208|NCT00434148|42130387|FG001|Overall Study|Adverse Event|18|||
19683209|NCT00434148|42130386|FG000|Overall Study|Lack of Efficacy|25|||
19683210|NCT00434148|42130387|FG001|Overall Study|Lack of Efficacy|28|||
19683211|NCT00434148|42130386|FG000|Overall Study|Withdrawal by Subject|15|||
19683212|NCT00434148|42130387|FG001|Overall Study|Withdrawal by Subject|15|||
19683213|NCT00434148|42130386|FG000|Overall Study|Protocol Violation|4|||
19683214|NCT00434148|42130387|FG001|Overall Study|Protocol Violation|0|||
19683215|NCT00434148|42130386|FG000|Overall Study|Administrative problems|6|||
19683216|NCT00434148|42130387|FG001|Overall Study|Administrative problems|10|||
19683217|NCT00434148|42130386|FG000|Overall Study|Lost to Follow-up|0|||
19683218|NCT00434148|42130387|FG001|Overall Study|Lost to Follow-up|1|||
19683219|NCT00434148|42130386|FG000|Overall Study|Condition no longer requires study drug|1|||
19768686|NCT03031782|42222165|FG002|Treatment Period 2|Lack of Efficacy|0|||
19683220|NCT00434148|42130387|FG001|Overall Study|Condition no longer requires study drug|0|||
19683221|NCT00434148|42130386|FG000|Overall Study|Abnormal test procedure result|0|||
19683222|NCT00434148|42130387|FG001|Overall Study|Abnormal test procedure result|1|||
19683223|NCT00468728|42130395|FG000|Treatment|criteria for mITT population|4|||
19683224|NCT00468728|42130396|FG001|Treatment|criteria for mITT population|11|||
19683225|NCT00468728|42130395|FG000|Follow-up|mITT failure|34|||
19683226|NCT00468728|42130396|FG001|Follow-up|mITT failure|31|||
19683227|NCT00433914|42130406|FG000|Overall Study|Withdrawal by Subject|0|||
19683228|NCT00433914|42130407|FG001|Overall Study|Withdrawal by Subject|2|||
19683229|NCT00433914|42130406|FG000|Overall Study|Lost to Follow-up|0|||
19683230|NCT00433914|42130407|FG001|Overall Study|Lost to Follow-up|1|||
19683231|NCT00321555|42130413|FG000|Overall Study|Developed antibodies|1|||
19683232|NCT00321555|42130413|FG000|Overall Study|Switched to alternative treatment|3|||
19683233|NCT00321555|42130413|FG000|Overall Study|Physician Decision|1|||
19683234|NCT00321555|42130413|FG000|Overall Study|Disease progression on study|1|||
19683235|NCT00468650|42130417|FG000|Overall Study|Lost to Follow-up|4|||
19683236|NCT00468650|42130417|FG000|Overall Study|Withdrawal by Subject|2|||
19683237|NCT00468650|42130417|FG000|Overall Study|Protocol Violation|1|||
19683238|NCT00423150|42130422|FG000|Overall Study|Adverse Event|11|||
19683239|NCT00423150|42130422|FG000|Overall Study|Progression of disease being studied|69|||
19683240|NCT00423150|42130422|FG000|Overall Study|Withdrawal by Subject|1|||
19683241|NCT00423150|42130422|FG000|Overall Study|Non-compliance with protocol|1|||
19683242|NCT00423150|42130422|FG000|Overall Study|Administrative|4|||
19683243|NCT00433836|42130428|FG000|Overall Study|Adverse Event|7|||
19683244|NCT00433836|42130429|FG001|Overall Study|Adverse Event|0|||
19683245|NCT00433836|42130428|FG000|Overall Study|Lost to Follow-up|3|||
19683246|NCT00433836|42130429|FG001|Overall Study|Lost to Follow-up|0|||
19683247|NCT00433836|42130428|FG000|Overall Study|Withdrawal by Subject|2|||
19683248|NCT00433836|42130429|FG001|Overall Study|Withdrawal by Subject|1|||
19683249|NCT00433836|42130428|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19683250|NCT00433836|42130429|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19683251|NCT00433836|42130428|FG000|Overall Study|Protocol Violation|0|||
19683252|NCT00433836|42130429|FG001|Overall Study|Protocol Violation|2|||
19683253|NCT00433836|42130428|FG000|Overall Study|Condition no longer requires study drug|0|||
19683254|NCT00433836|42130429|FG001|Overall Study|Condition no longer requires study drug|1|||
19683255|NCT00433836|42130428|FG000|Overall Study|Abnormal laboratory values|0|||
19683256|NCT00433836|42130429|FG001|Overall Study|Abnormal laboratory values|1|||
19683257|NCT00433446|42130435|FG000|Overall Study|Adverse Event|4|||
19683258|NCT00433446|42130435|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
19683259|NCT00433446|42130435|FG000|Overall Study|Progression|44|||
19683260|NCT00433446|42130435|FG000|Overall Study|Other - Not Protocol specified|3|||
19683261|NCT00433446|42130435|FG000|Overall Study|Ineligible|9|||
19683262|NCT00468104|42130439|FG000|First Intervention|Protocol Violation|2|||
19683263|NCT00468104|42130440|FG001|First Intervention|Protocol Violation|1|||
19683264|NCT00468104|42130439|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
19768687|NCT03031782|42222166|FG003|Treatment Period 2|Lack of Efficacy|0|||
19768688|NCT03031782|42222167|FG004|Treatment Period 2|Lack of Efficacy|1|||
19768689|NCT03031782|42222163|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19768690|NCT03031782|42222164|FG001|Treatment Period 2|Withdrawal by Subject|3|||
19768691|NCT03031782|42222165|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19768692|NCT03031782|42222166|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19768693|NCT03031782|42222167|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19768694|NCT03031782|42222163|FG000|Treatment Period 2|Adverse Event|0|||
19768695|NCT03031782|42222164|FG001|Treatment Period 2|Adverse Event|1|||
19683265|NCT00468104|42130440|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
19683266|NCT00468104|42130439|FG000|First Intervention|died within 3 weeks|1|||
19683267|NCT00468104|42130440|FG001|First Intervention|died within 3 weeks|0|||
19683268|NCT00468104|42130439|FG000|First Intervention|malposition/blocked chest tube tube|2|||
19683269|NCT00468104|42130440|FG001|First Intervention|malposition/blocked chest tube tube|0|||
19389100|NCT02670083|41632676|FG000|Overall Study|Adverse Event|16|||
19389101|NCT02670083|41632677|FG001|Overall Study|Adverse Event|13|||
19389102|NCT02670083|41632676|FG000|Overall Study|Death|4|||
19389103|NCT02670083|41632677|FG001|Overall Study|Death|6|||
19389104|NCT02670083|41632676|FG000|Overall Study|Lost to Follow-up|2|||
19389105|NCT02670083|41632677|FG001|Overall Study|Lost to Follow-up|2|||
19389106|NCT02670083|41632676|FG000|Overall Study|Multiple Reasons|9|||
19389107|NCT02670083|41632677|FG001|Overall Study|Multiple Reasons|9|||
19389108|NCT02670083|41632676|FG000|Overall Study|Physician Decision|0|||
19389109|NCT02670083|41632677|FG001|Overall Study|Physician Decision|2|||
19389110|NCT02670083|41632676|FG000|Overall Study|Study Terminated By Sponsor|257|||
19389111|NCT02670083|41632677|FG001|Overall Study|Study Terminated By Sponsor|254|||
19389112|NCT02670083|41632676|FG000|Overall Study|Symptomatic Deterioration|0|||
19389113|NCT02670083|41632677|FG001|Overall Study|Symptomatic Deterioration|2|||
19389114|NCT02670083|41632676|FG000|Overall Study|Withdrawal by Subject|32|||
19389115|NCT02670083|41632677|FG001|Overall Study|Withdrawal by Subject|31|||
19683270|NCT00468104|42130439|FG000|First Intervention|large lung mass with minimal effusion|1|||
19683271|NCT00468104|42130440|FG001|First Intervention|large lung mass with minimal effusion|0|||
19605289|NCT00948896|42054051|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
19605290|NCT00948896|42054052|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
19605291|NCT00948896|42054053|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
19605292|NCT00948896|42054054|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
19605293|NCT00948896|42054055|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
19605294|NCT00948896|42054056|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
19605295|NCT00948896|42054057|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
19683272|NCT00468104|42130439|FG000|First Intervention|associated prolonged pneumothorax|1|||
19683273|NCT00468104|42130440|FG001|First Intervention|associated prolonged pneumothorax|0|||
19683274|NCT00468104|42130439|FG000|First Intervention|trapped lung|1|||
19683275|NCT00468104|42130440|FG001|First Intervention|trapped lung|0|||
19683276|NCT00468104|42130439|FG000|Second Intervention|Withdrawal by Subject|5|||
19683277|NCT00468104|42130440|FG001|Second Intervention|Withdrawal by Subject|2|||
19683278|NCT00468104|42130439|FG000|Second Intervention|discarded for malposition of chest tube|0|||
19683279|NCT00468104|42130440|FG001|Second Intervention|discarded for malposition of chest tube|2|||
19683280|NCT00326625|42130451|FG000|Overall Study|Adverse Event|20|||
19683281|NCT00326625|42130452|FG001|Overall Study|Adverse Event|9|||
19683282|NCT00326625|42130451|FG000|Overall Study|Withdrawal by Subject|15|||
19683283|NCT00326625|42130452|FG001|Overall Study|Withdrawal by Subject|12|||
19683284|NCT00326625|42130451|FG000|Overall Study|Death|18|||
19683285|NCT00326625|42130452|FG001|Overall Study|Death|16|||
19683286|NCT00326625|42130451|FG000|Overall Study|Lost to Follow-up|1|||
19683287|NCT00326625|42130452|FG001|Overall Study|Lost to Follow-up|0|||
19683288|NCT00326625|42130451|FG000|Overall Study|prescheduled medical intervention|0|||
19683289|NCT00326625|42130452|FG001|Overall Study|prescheduled medical intervention|1|||
19389116|NCT02670083|41632676|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19389117|NCT02670083|41632677|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19389118|NCT02669849|41632687|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
19389119|NCT02669849|41632688|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
19683290|NCT00433290|42130460|FG000|Overall Study|Adverse Event|24|||
19683291|NCT00433290|42130461|FG001|Overall Study|Adverse Event|7|||
19683292|NCT00433290|42130460|FG000|Overall Study|Lack of Efficacy|1|||
19683293|NCT00433290|42130461|FG001|Overall Study|Lack of Efficacy|5|||
19683294|NCT00433290|42130460|FG000|Overall Study|Withdrawal by Subject|4|||
19683295|NCT00433290|42130461|FG001|Overall Study|Withdrawal by Subject|2|||
19683296|NCT00433290|42130460|FG000|Overall Study|Protocol Violation|3|||
19683297|NCT00433290|42130461|FG001|Overall Study|Protocol Violation|2|||
19683298|NCT00433290|42130460|FG000|Overall Study|Physician Decision|2|||
19683299|NCT00433290|42130461|FG001|Overall Study|Physician Decision|0|||
19683300|NCT00433290|42130460|FG000|Overall Study|Entry Criteria Not Met|0|||
19683301|NCT00433290|42130461|FG001|Overall Study|Entry Criteria Not Met|1|||
19683302|NCT00433290|42130460|FG000|Overall Study|Lost to Follow-up|1|||
19683303|NCT00433290|42130461|FG001|Overall Study|Lost to Follow-up|0|||
19683304|NCT00467870|42130473|FG000|Overall Study|Adverse Event|13|||
19683305|NCT00467870|42130474|FG001|Overall Study|Adverse Event|9|||
19683306|NCT00467870|42130475|FG002|Overall Study|Adverse Event|1|||
19683307|NCT00467870|42130476|FG003|Overall Study|Adverse Event|15|||
19683308|NCT00467870|42130477|FG004|Overall Study|Adverse Event|15|||
19683309|NCT00467870|42130478|FG005|Overall Study|Adverse Event|1|||
19683310|NCT00467870|42130473|FG000|Overall Study|Protocol Violation|2|||
19683311|NCT00467870|42130474|FG001|Overall Study|Protocol Violation|1|||
19683312|NCT00467870|42130475|FG002|Overall Study|Protocol Violation|1|||
19683313|NCT00467870|42130476|FG003|Overall Study|Protocol Violation|2|||
19683314|NCT00467870|42130477|FG004|Overall Study|Protocol Violation|0|||
19683315|NCT00467870|42130478|FG005|Overall Study|Protocol Violation|0|||
19683316|NCT00467870|42130473|FG000|Overall Study|Withdrawal by Subject|14|||
19683317|NCT00467870|42130474|FG001|Overall Study|Withdrawal by Subject|21|||
19683318|NCT00467870|42130475|FG002|Overall Study|Withdrawal by Subject|0|||
19683319|NCT00467870|42130476|FG003|Overall Study|Withdrawal by Subject|9|||
19683320|NCT00467870|42130477|FG004|Overall Study|Withdrawal by Subject|10|||
19477248|NCT01482221|41756211|FG001|Overall Study|Withdrawal by Subject|7|||
19605296|NCT00948896|42054058|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
19605297|NCT00948896|42054051|FG000|24 Months of Age to 36 Months of Age|Death|0|||
19605298|NCT00948896|42054052|FG001|24 Months of Age to 36 Months of Age|Death|2|||
19605299|NCT00948896|42054053|FG002|24 Months of Age to 36 Months of Age|Death|2|||
19605300|NCT00948896|42054054|FG003|24 Months of Age to 36 Months of Age|Death|0|||
19605301|NCT00948896|42054055|FG004|24 Months of Age to 36 Months of Age|Death|0|||
19605302|NCT00948896|42054056|FG005|24 Months of Age to 36 Months of Age|Death|1|||
19605303|NCT00948896|42054057|FG006|24 Months of Age to 36 Months of Age|Death|0|||
19605304|NCT00948896|42054058|FG007|24 Months of Age to 36 Months of Age|Death|0|||
19605305|NCT00948896|42054051|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
19605306|NCT00948896|42054052|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
19605307|NCT00948896|42054053|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
19605308|NCT00948896|42054054|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
19605309|NCT00948896|42054055|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
19605310|NCT00948896|42054056|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
19605311|NCT00948896|42054057|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
19605312|NCT00948896|42054058|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
19605313|NCT00948896|42054051|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
19605314|NCT00948896|42054052|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
19605315|NCT00948896|42054053|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
19605316|NCT00948896|42054054|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
19605317|NCT00948896|42054055|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
19605318|NCT00948896|42054056|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
19605319|NCT00948896|42054057|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
19605320|NCT00948896|42054058|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
19605321|NCT00948896|42054051|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605322|NCT00948896|42054052|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605323|NCT00948896|42054053|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
19605324|NCT00948896|42054054|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605325|NCT00948896|42054055|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605326|NCT00948896|42054056|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
19605327|NCT00948896|42054057|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605328|NCT00948896|42054058|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
19605329|NCT00948896|42054051|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605330|NCT00948896|42054052|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605331|NCT00948896|42054053|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605332|NCT00948896|42054054|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
19605333|NCT00948896|42054055|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19683321|NCT00467870|42130478|FG005|Overall Study|Withdrawal by Subject|1|||
19683322|NCT00467870|42130473|FG000|Overall Study|Lost to Follow-up|5|||
19683323|NCT00467870|42130474|FG001|Overall Study|Lost to Follow-up|3|||
19683324|NCT00467870|42130475|FG002|Overall Study|Lost to Follow-up|1|||
19389120|NCT02669849|41632689|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
19683325|NCT00467870|42130476|FG003|Overall Study|Lost to Follow-up|1|||
19683326|NCT00467870|42130477|FG004|Overall Study|Lost to Follow-up|3|||
19683327|NCT00467870|42130478|FG005|Overall Study|Lost to Follow-up|0|||
19683328|NCT00467870|42130473|FG000|Overall Study|Subject Non-compliance|3|||
19683329|NCT00467870|42130474|FG001|Overall Study|Subject Non-compliance|4|||
19683330|NCT00467870|42130475|FG002|Overall Study|Subject Non-compliance|0|||
19683331|NCT00467870|42130476|FG003|Overall Study|Subject Non-compliance|1|||
19683332|NCT00467870|42130477|FG004|Overall Study|Subject Non-compliance|5|||
19683333|NCT00467870|42130478|FG005|Overall Study|Subject Non-compliance|0|||
19683334|NCT00467870|42130473|FG000|Overall Study|Other/Unknown|8|||
19683335|NCT00467870|42130474|FG001|Overall Study|Other/Unknown|5|||
19683336|NCT00467870|42130475|FG002|Overall Study|Other/Unknown|1|||
19683337|NCT00467870|42130476|FG003|Overall Study|Other/Unknown|5|||
19683338|NCT00467870|42130477|FG004|Overall Study|Other/Unknown|4|||
19683339|NCT00467870|42130478|FG005|Overall Study|Other/Unknown|0|||
19683340|NCT00467558|42130490|FG000|Overall Study|Lost to Follow-up|2|||
19683341|NCT00467558|42130491|FG001|Overall Study|Lost to Follow-up|0|||
19605334|NCT00948896|42054056|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605335|NCT00948896|42054057|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605336|NCT00948896|42054058|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
19605337|NCT01004159|42054080|FG000|Overall Study|Adverse Event|2|||
19605338|NCT01004159|42054080|FG000|Overall Study|Disease Progression|18|||
19605339|NCT00948818|42054086|FG000|Overall Study|Adverse Event|10|||
19605340|NCT00948818|42054087|FG001|Overall Study|Adverse Event|32|||
19605341|NCT00948818|42054086|FG000|Overall Study|Protocol Violation|9|||
19605342|NCT00948818|42054087|FG001|Overall Study|Protocol Violation|10|||
19605343|NCT00948818|42054086|FG000|Overall Study|Withdrawal by Subject|25|||
19389121|NCT02669849|41632687|FG000|Overall Study|Lost to Follow-up|1|||
19683342|NCT00422292|42130501|FG000|Overall Study|Serious adverse events|1|||
19683343|NCT00422292|42130502|FG001|Overall Study|Serious adverse events|4|||
19683344|NCT00422292|42130503|FG002|Overall Study|Serious adverse events|0|||
19683345|NCT00422292|42130504|FG003|Overall Study|Serious adverse events|0|||
19683346|NCT00422292|42130501|FG000|Overall Study|Adverse Event|1|||
19683347|NCT00422292|42130502|FG001|Overall Study|Adverse Event|0|||
19683348|NCT00422292|42130503|FG002|Overall Study|Adverse Event|1|||
19683349|NCT00422292|42130504|FG003|Overall Study|Adverse Event|0|||
19683350|NCT00422292|42130501|FG000|Overall Study|Protocol Violation|4|||
19683351|NCT00422292|42130502|FG001|Overall Study|Protocol Violation|25|||
19683352|NCT00422292|42130503|FG002|Overall Study|Protocol Violation|8|||
19683353|NCT00422292|42130504|FG003|Overall Study|Protocol Violation|5|||
19683354|NCT00422292|42130501|FG000|Overall Study|Lost to Follow-up|6|||
19683355|NCT00422292|42130502|FG001|Overall Study|Lost to Follow-up|12|||
19683356|NCT00422292|42130503|FG002|Overall Study|Lost to Follow-up|6|||
19683357|NCT00422292|42130504|FG003|Overall Study|Lost to Follow-up|6|||
19683358|NCT00422292|42130501|FG000|Overall Study|Withdrawal by Subject|6|||
19683359|NCT00422292|42130502|FG001|Overall Study|Withdrawal by Subject|25|||
19683360|NCT00422292|42130503|FG002|Overall Study|Withdrawal by Subject|7|||
19683361|NCT00422292|42130504|FG003|Overall Study|Withdrawal by Subject|13|||
19683362|NCT00452348|42130516|FG000|Overall Study|Adverse Event|6|||
19683363|NCT00452348|42130517|FG001|Overall Study|Adverse Event|9|||
19683364|NCT00452348|42130516|FG000|Overall Study|Lack of Efficacy|10|||
19683365|NCT00452348|42130517|FG001|Overall Study|Lack of Efficacy|9|||
19683366|NCT00452348|42130516|FG000|Overall Study|Lost to Follow-up|14|||
19683367|NCT00452348|42130517|FG001|Overall Study|Lost to Follow-up|8|||
19683368|NCT00452348|42130516|FG000|Overall Study|Protocol Violation|22|||
19683369|NCT00452348|42130517|FG001|Overall Study|Protocol Violation|28|||
19683370|NCT00452348|42130516|FG000|Overall Study|Withdrawal by Subject|18|||
19683371|NCT00452348|42130517|FG001|Overall Study|Withdrawal by Subject|21|||
19683372|NCT00452348|42130516|FG000|Overall Study|Other|9|||
19683373|NCT00452348|42130517|FG001|Overall Study|Other|9|||
19683374|NCT00452114|42130525|FG000|Overall Study|Physician Decision|3|||
19683375|NCT00452114|42130526|FG001|Overall Study|Physician Decision|3|||
19683376|NCT00320541|42130534|FG000|Overall Study|Adverse Event|21|||
19683377|NCT00320541|42130535|FG001|Overall Study|Adverse Event|19|||
19683378|NCT00320541|42130534|FG000|Overall Study|Protocol Violation|0|||
19683379|NCT00320541|42130535|FG001|Overall Study|Protocol Violation|1|||
19683380|NCT00320541|42130534|FG000|Overall Study|Withdrawal by Subject|12|||
19683381|NCT00320541|42130535|FG001|Overall Study|Withdrawal by Subject|16|||
19683382|NCT00320541|42130534|FG000|Overall Study|Physician Decision|9|||
19683383|NCT00320541|42130535|FG001|Overall Study|Physician Decision|13|||
19683384|NCT00320541|42130534|FG000|Overall Study|Other|3|||
19683385|NCT00320541|42130535|FG001|Overall Study|Other|4|||
19683386|NCT00320541|42130534|FG000|Overall Study|Sponsor Decision|2|||
19683387|NCT00320541|42130535|FG001|Overall Study|Sponsor Decision|1|||
19683388|NCT00320541|42130534|FG000|Overall Study|Death due to Study Disease|1|||
19683389|NCT00320541|42130535|FG001|Overall Study|Death due to Study Disease|3|||
19683390|NCT00320541|42130534|FG000|Overall Study|Death due to Adverse Event(s)|1|||
19683391|NCT00320541|42130535|FG001|Overall Study|Death due to Adverse Event(s)|0|||
19683392|NCT00320541|42130534|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
19683393|NCT00320541|42130535|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
19683394|NCT00320385|42130543|FG000|Overall Study|Lost to Follow-up|7|||
19683395|NCT00320385|42130544|FG001|Overall Study|Lost to Follow-up|10|||
19683396|NCT00320385|42130543|FG000|Overall Study|Withdrawal by Subject|6|||
19683397|NCT00320385|42130544|FG001|Overall Study|Withdrawal by Subject|7|||
19683398|NCT00320385|42130543|FG000|Overall Study|Sponsor Terminated Study|2|||
19683399|NCT00320385|42130544|FG001|Overall Study|Sponsor Terminated Study|1|||
19683400|NCT00320385|42130543|FG000|Overall Study|Investigator Decision|0|||
19683401|NCT00320385|42130544|FG001|Overall Study|Investigator Decision|1|||
19683402|NCT00320385|42130543|FG000|Overall Study|Death|1|||
19683403|NCT00320385|42130544|FG001|Overall Study|Death|2|||
19768696|NCT03031782|42222165|FG002|Treatment Period 2|Adverse Event|2|||
19768697|NCT03031782|42222166|FG003|Treatment Period 2|Adverse Event|0|||
19683404|NCT00320385|42130543|FG000|Overall Study|Serious Adverse Event|1|||
19683405|NCT00320385|42130544|FG001|Overall Study|Serious Adverse Event|0|||
19683406|NCT00320385|42130543|FG000|Overall Study|Withdrew Consent|1|||
19683407|NCT00320385|42130544|FG001|Overall Study|Withdrew Consent|0|||
19683408|NCT00320385|42130543|FG000|Overall Study|Adverse Event|0|||
19683409|NCT00320385|42130544|FG001|Overall Study|Adverse Event|1|||
19683410|NCT00326001|42130552|FG000|Overall Study|Adverse Event|4|||
19683411|NCT00326001|42130553|FG001|Overall Study|Adverse Event|5|||
19683412|NCT00326001|42130552|FG000|Overall Study|Physician Decision|3|||
19683413|NCT00326001|42130553|FG001|Overall Study|Physician Decision|3|||
19683414|NCT00309777|42130563|FG000|Overall Study|Adverse Event|13|||
19683415|NCT00309777|42130564|FG001|Overall Study|Adverse Event|2|||
19683416|NCT00309777|42130565|FG002|Overall Study|Adverse Event|8|||
19683417|NCT00309777|42130566|FG003|Overall Study|Adverse Event|1|||
19683418|NCT00309777|42130563|FG000|Overall Study|Protocol Violation|4|||
19683419|NCT00309777|42130564|FG001|Overall Study|Protocol Violation|1|||
19683420|NCT00309777|42130565|FG002|Overall Study|Protocol Violation|3|||
19683421|NCT00309777|42130566|FG003|Overall Study|Protocol Violation|1|||
19683422|NCT00309777|42130563|FG000|Overall Study|Withdrawal by Subject|6|||
19683423|NCT00309777|42130564|FG001|Overall Study|Withdrawal by Subject|5|||
19683424|NCT00309777|42130565|FG002|Overall Study|Withdrawal by Subject|7|||
19683425|NCT00309777|42130566|FG003|Overall Study|Withdrawal by Subject|2|||
19683426|NCT00309777|42130563|FG000|Overall Study|Lost to Follow-up|0|||
19683427|NCT00309777|42130564|FG001|Overall Study|Lost to Follow-up|0|||
19683428|NCT00309777|42130565|FG002|Overall Study|Lost to Follow-up|1|||
19683429|NCT00309777|42130566|FG003|Overall Study|Lost to Follow-up|0|||
19683430|NCT00309777|42130563|FG000|Overall Study|Death|0|||
19683431|NCT00309777|42130564|FG001|Overall Study|Death|1|||
19683432|NCT00309777|42130565|FG002|Overall Study|Death|0|||
19683433|NCT00309777|42130566|FG003|Overall Study|Death|0|||
19683434|NCT00309387|42130578|FG000|Overall Study|Death|72|||
19768698|NCT03031782|42222167|FG004|Treatment Period 2|Adverse Event|0|||
19768699|NCT03031782|42222163|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19768700|NCT03031782|42222164|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19768701|NCT03031782|42222165|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19768702|NCT03031782|42222166|FG003|Treatment Period 3|Withdrawal by Subject|1|||
19768703|NCT03031782|42222167|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19768704|NCT03216265|42222184|FG000|Overall Study|Adverse Event|2|||
19768705|NCT03216265|42222185|FG001|Overall Study|Adverse Event|0|||
19768706|NCT03216265|42222186|FG002|Overall Study|Adverse Event|2|||
19768707|NCT03216265|42222184|FG000|Overall Study|Lost to Follow-up|0|||
19768708|NCT03216265|42222185|FG001|Overall Study|Lost to Follow-up|1|||
19605344|NCT00948818|42054087|FG001|Overall Study|Withdrawal by Subject|25|||
19605345|NCT00948818|42054086|FG000|Overall Study|Lost to Follow-up|10|||
19605346|NCT00948818|42054087|FG001|Overall Study|Lost to Follow-up|17|||
19605347|NCT00948818|42054086|FG000|Overall Study|Lack of Efficacy|4|||
19683435|NCT00309387|42130579|FG001|Overall Study|Death|73|||
19683436|NCT00309387|42130578|FG000|Overall Study|Lost to Follow-up|70|||
19683437|NCT00309387|42130579|FG001|Overall Study|Lost to Follow-up|86|||
19605348|NCT00948818|42054087|FG001|Overall Study|Lack of Efficacy|5|||
19605349|NCT00948818|42054086|FG000|Overall Study|Other Reason|4|||
19605350|NCT00948818|42054087|FG001|Overall Study|Other Reason|5|||
19605351|NCT00948506|42054098|FG000|Overall Study|Withdrawal by Subject|3|||
19605352|NCT00948506|42054099|FG001|Overall Study|Withdrawal by Subject|1|||
19683438|NCT00325143|42130586|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
19683439|NCT00325143|42130586|FG000|Overall Study|Migrated/moved from study area|1|||
19683440|NCT00325143|42130586|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
19683441|NCT00325143|42130586|FG000|Overall Study|Withdrawal by Subject|8|||
19683442|NCT00319839|42130590|FG000|Overall Study|Adverse Event|5|||
19683443|NCT00319839|42130590|FG000|Overall Study|Withdrawal by Subject|1|||
19683444|NCT00319449|42130596|FG000|Overall Study|Subject did not wish to continue|1|||
19683445|NCT00319449|42130597|FG001|Overall Study|Subject did not wish to continue|0|||
19683446|NCT00319449|42130596|FG000|Overall Study|Noncompliance with the protocol|1|||
19683447|NCT00319449|42130597|FG001|Overall Study|Noncompliance with the protocol|0|||
19683448|NCT00308997|42130605|FG000|Overall Study|Subject feigned clinical data|0|||
19683449|NCT00308997|42130606|FG001|Overall Study|Subject feigned clinical data|1|||
19683450|NCT00308997|42130605|FG000|Overall Study|Unable to tolerate intervention|1|||
19683451|NCT00308997|42130606|FG001|Overall Study|Unable to tolerate intervention|0|||
19683452|NCT00308685|42130614|FG000|Overall Study|Lost to Follow-up|1|||
19683453|NCT00308685|42130615|FG001|Overall Study|Lost to Follow-up|0|||
19683454|NCT00308685|42130614|FG000|Overall Study|Need to administer prohibited medication|1|||
19683455|NCT00308685|42130615|FG001|Overall Study|Need to administer prohibited medication|2|||
19683456|NCT00308685|42130614|FG000|Overall Study|Other than specified|1|||
19683457|NCT00308685|42130615|FG001|Overall Study|Other than specified|3|||
19683458|NCT00317109|42130623|FG000|Overall Study|Withdrawal by Subject|2|||
19683459|NCT00317109|42130624|FG001|Overall Study|Withdrawal by Subject|0|||
19683460|NCT00317109|42130623|FG000|Overall Study|Migated/moved from study area|1|||
19683461|NCT00317109|42130624|FG001|Overall Study|Migated/moved from study area|0|||
19683462|NCT00316719|42130632|FG000|Overall Study|Adverse Event|0|||
19683463|NCT00316719|42130633|FG001|Overall Study|Adverse Event|6|||
19683464|NCT00316719|42130632|FG000|Overall Study|Consent withdrawn|2|||
19683465|NCT00316719|42130633|FG001|Overall Study|Consent withdrawn|0|||
19683466|NCT00422058|42130645|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
19683467|NCT00422058|42130646|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
19683468|NCT00422058|42130647|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
19683469|NCT00422058|42130648|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
19768709|NCT03216265|42222186|FG002|Overall Study|Lost to Follow-up|0|||
19768710|NCT03216265|42222184|FG000|Overall Study|Withdrawal by Subject|0|||
19683470|NCT00422058|42130649|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
19683471|NCT00422058|42130650|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
19683472|NCT00422058|42130645|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
19683473|NCT00422058|42130646|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
19683474|NCT00422058|42130647|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
19683475|NCT00422058|42130648|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
19768711|NCT03216265|42222185|FG001|Overall Study|Withdrawal by Subject|0|||
19768712|NCT03216265|42222186|FG002|Overall Study|Withdrawal by Subject|1|||
19768713|NCT04486950|42222208|FG000|Overall Study|Lost to Follow-up|0|||
19768714|NCT04486950|42222209|FG001|Overall Study|Lost to Follow-up|0|||
19683476|NCT00422058|42130649|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
19683477|NCT00422058|42130650|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
19683478|NCT00422058|42130645|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
19683479|NCT00422058|42130646|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
19683480|NCT00422058|42130647|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
19683481|NCT00422058|42130648|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
19683482|NCT00422058|42130649|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
19683483|NCT00422058|42130650|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
19683484|NCT00422058|42130645|FG000|Double-Blind, Week 0-20|Other|11|||
19683485|NCT00422058|42130646|FG001|Double-Blind, Week 0-20|Other|3|||
19683486|NCT00422058|42130647|FG002|Double-Blind, Week 0-20|Other|8|||
19683487|NCT00422058|42130648|FG003|Double-Blind, Week 0-20|Other|8|||
19683488|NCT00422058|42130649|FG004|Double-Blind, Week 0-20|Other|4|||
19683489|NCT00422058|42130650|FG005|Double-Blind, Week 0-20|Other|10|||
19683490|NCT00422058|42130645|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
19683491|NCT00422058|42130646|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
19683492|NCT00422058|42130647|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
19683493|NCT00422058|42130648|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
19683494|NCT00422058|42130649|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
19683495|NCT00422058|42130650|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
19683496|NCT00422058|42130645|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
19683497|NCT00422058|42130646|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
19683498|NCT00422058|42130647|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
19683499|NCT00422058|42130648|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
19683500|NCT00422058|42130649|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
19683501|NCT00422058|42130650|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
19683502|NCT00422058|42130645|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
19683503|NCT00422058|42130646|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
19683504|NCT00422058|42130647|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
19683505|NCT00422058|42130648|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
19683506|NCT00422058|42130649|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
19683507|NCT00422058|42130650|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
19683508|NCT00422058|42130645|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
19683509|NCT00422058|42130646|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
19683510|NCT00422058|42130647|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
19683511|NCT00422058|42130648|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
19683512|NCT00422058|42130649|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
19683513|NCT00422058|42130650|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
19683514|NCT00422058|42130645|FG000|Open-Label Extension, Week 20-104|Other|13|||
19683515|NCT00422058|42130646|FG001|Open-Label Extension, Week 20-104|Other|14|||
19683516|NCT00422058|42130647|FG002|Open-Label Extension, Week 20-104|Other|6|||
19768715|NCT04486950|42222210|FG002|Overall Study|Lost to Follow-up|0|||
19768716|NCT04486950|42222211|FG003|Overall Study|Lost to Follow-up|0|||
19605353|NCT00955682|42054110|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
19605354|NCT00955682|42054111|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
19605355|NCT00689221|42054127|FG000|Overall Study|Ongoing at cut-off date|39|||
19605356|NCT00689221|42054128|FG001|Overall Study|Ongoing at cut-off date|36|||
19605357|NCT01875445|42054136|FG000|Overall Study|Lost to Follow-up|5|||
19605358|NCT01875445|42054137|FG001|Overall Study|Lost to Follow-up|0|||
19605359|NCT01875445|42054136|FG000|Overall Study|Withdrawal by Subject|2|||
19605360|NCT01875445|42054137|FG001|Overall Study|Withdrawal by Subject|0|||
19605361|NCT00688909|42054143|FG000|Overall Study|Adverse Event|28|||
19683517|NCT00422058|42130648|FG003|Open-Label Extension, Week 20-104|Other|13|||
19683518|NCT00422058|42130649|FG004|Open-Label Extension, Week 20-104|Other|16|||
19683519|NCT00422058|42130650|FG005|Open-Label Extension, Week 20-104|Other|18|||
19683520|NCT00413244|42130674|FG000|Overall Study|Withdrawal by Subject|10|||
19683521|NCT00413244|42130675|FG001|Overall Study|Withdrawal by Subject|1|||
19683522|NCT00420420|42130703|FG000|Overall Study|Adverse Event|5|||
19768717|NCT04486950|42222212|FG004|Overall Study|Lost to Follow-up|0|||
19768718|NCT04486950|42222213|FG005|Overall Study|Lost to Follow-up|1|||
19768719|NCT04486950|42222214|FG006|Overall Study|Lost to Follow-up|0|||
19605362|NCT00688909|42054143|FG000|Overall Study|Patient withdrew consent|2|||
19605363|NCT00688909|42054143|FG000|Overall Study|Administrative problems|1|||
19605364|NCT00688909|42054143|FG000|Overall Study|Protocol Violation|2|||
19605365|NCT00948428|42054151|FG000|Overall Study|Withdrawal by Subject|6|||
19605366|NCT00948428|42054152|FG001|Overall Study|Withdrawal by Subject|12|||
19605367|NCT00948428|42054153|FG002|Overall Study|Withdrawal by Subject|7|||
19605368|NCT00948428|42054151|FG000|Overall Study|Adverse Event|6|||
19605369|NCT00948428|42054152|FG001|Overall Study|Adverse Event|3|||
19605370|NCT00948428|42054153|FG002|Overall Study|Adverse Event|0|||
19605371|NCT00948428|42054151|FG000|Overall Study|Lost to Follow-up|2|||
19605372|NCT00948428|42054152|FG001|Overall Study|Lost to Follow-up|1|||
19605373|NCT00948428|42054153|FG002|Overall Study|Lost to Follow-up|1|||
19605374|NCT00948428|42054151|FG000|Overall Study|Death|2|||
19683523|NCT00420420|42130704|FG001|Overall Study|Adverse Event|3|||
19683524|NCT00420420|42130703|FG000|Overall Study|Protocol Violation|1|||
19683525|NCT00420420|42130704|FG001|Overall Study|Protocol Violation|1|||
19768720|NCT04693416|42222236|FG000|Overall Study|Lost to Follow-up|13|||
19768721|NCT04693416|42222237|FG001|Overall Study|Lost to Follow-up|0|||
19683526|NCT00420420|42130703|FG000|Overall Study|Withdrawal by Subject|1|||
19683527|NCT00420420|42130704|FG001|Overall Study|Withdrawal by Subject|0|||
19683528|NCT00420420|42130703|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
19683529|NCT00420420|42130704|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
19683530|NCT00420342|42130713|FG000|Overall Study|Lost to Follow-up|1|||
19683531|NCT00420342|42130714|FG001|Overall Study|Lost to Follow-up|0|||
19683532|NCT00420342|42130715|FG002|Overall Study|Lost to Follow-up|1|||
19683533|NCT00420342|42130713|FG000|Overall Study|Withdrawal by Subject|0|||
19683534|NCT00420342|42130714|FG001|Overall Study|Withdrawal by Subject|2|||
19683535|NCT00420342|42130715|FG002|Overall Study|Withdrawal by Subject|0|||
19683536|NCT00432744|42130725|FG000|Months 0-6|Withdrawal by Subject|4|||
19683537|NCT00432744|42130726|FG001|Months 0-6|Withdrawal by Subject|4|||
19683538|NCT00432744|42130725|FG000|Months 0-6|Too disabled to score|1|||
19683539|NCT00432744|42130726|FG001|Months 0-6|Too disabled to score|0|||
19683540|NCT00432744|42130725|FG000|Months 7 - 12|Withdrawal by Subject|1|||
19683541|NCT00432744|42130726|FG001|Months 7 - 12|Withdrawal by Subject|0|||
19683542|NCT00432744|42130725|FG000|Months 7 - 12|Too disabled to score|0|||
19683543|NCT00432744|42130726|FG001|Months 7 - 12|Too disabled to score|1|||
19683544|NCT00432666|42130734|FG000|Main Period|Adverse Event|1|||
19683545|NCT00432666|42130735|FG001|Main Period|Adverse Event|1|||
19683546|NCT00432666|42130734|FG000|Main Period|Consent Withdrawn|1|||
19683547|NCT00432666|42130735|FG001|Main Period|Consent Withdrawn|0|||
19683548|NCT00432666|42130734|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
19683549|NCT00432666|42130735|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
19683550|NCT00432666|42130734|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
19683551|NCT00432666|42130735|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
19683552|NCT00432666|42130734|FG000|Open-Label Extension Period|Adverse Event|5|||
19683553|NCT00432666|42130735|FG001|Open-Label Extension Period|Adverse Event|0|||
19683554|NCT00432666|42130734|FG000|Open-Label Extension Period|Consent withdrawn|10|||
19683555|NCT00432666|42130735|FG001|Open-Label Extension Period|Consent withdrawn|0|||
19683556|NCT00432666|42130734|FG000|Open-Label Extension Period|Physician Decision|3|||
19683557|NCT00432666|42130735|FG001|Open-Label Extension Period|Physician Decision|0|||
19683558|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Adverse Event|21|||
19683559|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Adverse Event|34|||
19683560|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Adverse Event|14|||
19768722|NCT00265941|42222245|FG000|Overall Study|Protocol Violation|22|||
19768723|NCT00265941|42222246|FG001|Overall Study|Protocol Violation|25|||
19768724|NCT00265941|42222245|FG000|Overall Study|Lost to Follow-up|1|||
19768725|NCT00265941|42222246|FG001|Overall Study|Lost to Follow-up|1|||
19768726|NCT03203473|42222260|FG000|Induction Phase|Never started primary treatment|2|||
19768727|NCT03203473|42222261|FG001|Induction Phase|Never started primary treatment|0|||
19768728|NCT03203473|42222262|FG002|Induction Phase|Never started primary treatment|0|||
19768729|NCT03203473|42222260|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
19768730|NCT03203473|42222261|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
19768731|NCT03203473|42222262|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
19768732|NCT03203473|42222260|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
19768733|NCT03203473|42222261|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
19768734|NCT03203473|42222262|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
19768735|NCT03203473|42222260|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
19683561|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Adverse Event|17|||
19768736|NCT03203473|42222261|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
19768737|NCT03203473|42222262|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
19605375|NCT00948428|42054152|FG001|Overall Study|Death|0|||
19605376|NCT00948428|42054153|FG002|Overall Study|Death|0|||
19605377|NCT00948428|42054151|FG000|Overall Study|Intercurrent Illness|1|||
19605378|NCT00948428|42054152|FG001|Overall Study|Intercurrent Illness|0|||
19605379|NCT00948428|42054153|FG002|Overall Study|Intercurrent Illness|0|||
19768738|NCT03203473|42222260|FG000|Arm Allocation Phase|started salvage therapy|0|||
19768739|NCT03203473|42222261|FG001|Arm Allocation Phase|started salvage therapy|5|||
19768740|NCT03203473|42222262|FG002|Arm Allocation Phase|started salvage therapy|0|||
19768741|NCT03203473|42222260|FG000|Arm Allocation Phase|Disease progression|0|||
19768742|NCT03203473|42222261|FG001|Arm Allocation Phase|Disease progression|0|||
19768743|NCT03203473|42222262|FG002|Arm Allocation Phase|Disease progression|37|||
19768744|NCT03203473|42222260|FG000|Arm Allocation Phase|Adverse Event|0|||
19768745|NCT03203473|42222261|FG001|Arm Allocation Phase|Adverse Event|0|||
19768746|NCT03203473|42222262|FG002|Arm Allocation Phase|Adverse Event|11|||
19768747|NCT03203473|42222260|FG000|Arm Allocation Phase|Physician Decision|0|||
19768748|NCT03203473|42222261|FG001|Arm Allocation Phase|Physician Decision|0|||
19768749|NCT03203473|42222262|FG002|Arm Allocation Phase|Physician Decision|3|||
19768750|NCT03203473|42222260|FG000|Arm Allocation Phase|Death|0|||
19683562|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Adverse Event|0|||
19683563|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
19683564|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
19683565|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
19683566|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
19683567|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
19683568|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
19683569|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
19683570|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
19683571|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
19683572|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
19683573|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Physician Decision|2|||
19683574|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Physician Decision|4|||
19683575|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Physician Decision|4|||
19683576|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Physician Decision|4|||
19683577|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Physician Decision|0|||
19683578|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
19683579|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
19683580|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
19683581|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
19683582|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
19683583|NCT00451958|42130745|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
19683584|NCT00451958|42130746|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
19683585|NCT00451958|42130747|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
19683586|NCT00451958|42130748|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
19683587|NCT00451958|42130749|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
19683588|NCT00432276|42130765|FG000|Overall Study|Hyperglycemic Rescue|44|||
19683589|NCT00432276|42130766|FG001|Overall Study|Hyperglycemic Rescue|87|||
19683590|NCT00432276|42130765|FG000|Overall Study|Adverse Event|13|||
19683591|NCT00432276|42130766|FG001|Overall Study|Adverse Event|16|||
19683592|NCT00432276|42130765|FG000|Overall Study|Protocol Violation|25|||
19683593|NCT00432276|42130766|FG001|Overall Study|Protocol Violation|20|||
19683594|NCT00432276|42130765|FG000|Overall Study|Lost to Follow-up|6|||
19683595|NCT00432276|42130766|FG001|Overall Study|Lost to Follow-up|2|||
19683596|NCT00432276|42130765|FG000|Overall Study|Withdrawal by Subject|25|||
19683597|NCT00432276|42130766|FG001|Overall Study|Withdrawal by Subject|20|||
19683598|NCT00432276|42130765|FG000|Overall Study|Physician Decision|6|||
19683599|NCT00432276|42130766|FG001|Overall Study|Physician Decision|8|||
19683600|NCT00432276|42130765|FG000|Overall Study|Other|2|||
19683601|NCT00432276|42130766|FG001|Overall Study|Other|3|||
19683602|NCT00413010|42130774|FG000|Overall Study|Adverse Event|8|||
19683603|NCT00413010|42130775|FG001|Overall Study|Adverse Event|4|||
19683604|NCT00413010|42130774|FG000|Overall Study|Laboratory abnormality|0|||
19683605|NCT00413010|42130775|FG001|Overall Study|Laboratory abnormality|2|||
19683606|NCT00413010|42130774|FG000|Overall Study|Lack of Efficacy|0|||
19683607|NCT00413010|42130775|FG001|Overall Study|Lack of Efficacy|3|||
19683608|NCT00413010|42130774|FG000|Overall Study|Lost to Follow-up|3|||
19683609|NCT00413010|42130775|FG001|Overall Study|Lost to Follow-up|0|||
19683610|NCT00413010|42130774|FG000|Overall Study|Withdrawal by Subject|7|||
19683611|NCT00413010|42130775|FG001|Overall Study|Withdrawal by Subject|2|||
19683612|NCT00413010|42130774|FG000|Overall Study|Due to termination of the study|54|||
19683613|NCT00413010|42130775|FG001|Overall Study|Due to termination of the study|52|||
19683614|NCT00459290|42130781|FG000|Overall Study|Adverse Event|3|||
19683615|NCT00459290|42130781|FG000|Overall Study|Ineligible|2|||
19683616|NCT00443534|42130792|FG000|Overall Study|Lack of Efficacy|67|||
19768751|NCT03203473|42222261|FG001|Arm Allocation Phase|Death|0|||
19683617|NCT00443534|42130792|FG000|Overall Study|Adverse Event|16|||
19683618|NCT00443534|42130792|FG000|Overall Study|Death|9|||
19768752|NCT03203473|42222262|FG002|Arm Allocation Phase|Death|1|||
19683619|NCT00443534|42130792|FG000|Overall Study|Withdrawal by Subject|8|||
19683620|NCT00443534|42130792|FG000|Overall Study|Study Terminated by Sponsor|12|||
19683621|NCT00443534|42130792|FG000|Overall Study|Other|10|||
19683622|NCT00443534|42130792|FG000|Overall Study|Enrolled, Not Treated|1|||
19768753|NCT03203473|42222260|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
19683623|NCT00419952|42130798|FG000|Overall Study|Adverse Event|8|||
19683624|NCT00419952|42130799|FG001|Overall Study|Adverse Event|10|||
19683625|NCT00419952|42130798|FG000|Overall Study|Withdrawal by Subject|44|||
19683626|NCT00419952|42130799|FG001|Overall Study|Withdrawal by Subject|43|||
19683627|NCT00419952|42130798|FG000|Overall Study|Lost to Follow-up|43|||
19683628|NCT00419952|42130799|FG001|Overall Study|Lost to Follow-up|34|||
19683629|NCT00419952|42130798|FG000|Overall Study|Protocol Violation|32|||
19683630|NCT00419952|42130799|FG001|Overall Study|Protocol Violation|24|||
19683631|NCT00419952|42130798|FG000|Overall Study|Pregnancy|4|||
19683632|NCT00419952|42130799|FG001|Overall Study|Pregnancy|2|||
19683633|NCT00419952|42130798|FG000|Overall Study|Physician Decision|1|||
19683634|NCT00419952|42130799|FG001|Overall Study|Physician Decision|3|||
19683635|NCT00419952|42130798|FG000|Overall Study|Incorrectly enrolled|10|||
19683636|NCT00419952|42130799|FG001|Overall Study|Incorrectly enrolled|3|||
19683637|NCT00419952|42130798|FG000|Overall Study|Intake of prohibited medication|2|||
19683638|NCT00419952|42130799|FG001|Overall Study|Intake of prohibited medication|2|||
19683639|NCT00419952|42130798|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
19683640|NCT00419952|42130799|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
19683641|NCT00419952|42130798|FG000|Overall Study|Diary or medication non-compliance|2|||
19683642|NCT00419952|42130799|FG001|Overall Study|Diary or medication non-compliance|4|||
19683643|NCT00419952|42130798|FG000|Overall Study|Abnormal ECG|1|||
19683644|NCT00419952|42130799|FG001|Overall Study|Abnormal ECG|0|||
19605380|NCT00948428|42054151|FG000|Overall Study|Non-compliance|1|||
19683645|NCT00443456|42130805|FG000|Overall Study|Adverse Event|16|||
19683646|NCT00443456|42130805|FG000|Overall Study|Move|1|||
19683647|NCT00443456|42130805|FG000|Overall Study|Withdrawal by Subject|1|||
19683648|NCT00419562|42130815|FG000|Overall Study|Lost to Follow-up|12|||
19683649|NCT00419562|42130816|FG001|Overall Study|Lost to Follow-up|13|||
19683650|NCT00419562|42130815|FG000|Overall Study|Withdrawal by Subject|20|||
19683651|NCT00419562|42130816|FG001|Overall Study|Withdrawal by Subject|18|||
19683652|NCT00419562|42130815|FG000|Overall Study|Participant Institutionalized|1|||
19683653|NCT00419562|42130816|FG001|Overall Study|Participant Institutionalized|0|||
19683654|NCT00432042|42130825|FG000|Overall Study|Protocol Violation|2|||
19683655|NCT00432042|42130826|FG001|Overall Study|Protocol Violation|0|||
19683656|NCT00432042|42130827|FG002|Overall Study|Protocol Violation|0|||
19683657|NCT00432042|42130825|FG000|Overall Study|Withdrawal by Subject|0|||
19683658|NCT00432042|42130826|FG001|Overall Study|Withdrawal by Subject|0|||
19683659|NCT00432042|42130827|FG002|Overall Study|Withdrawal by Subject|2|||
19683660|NCT00432042|42130825|FG000|Overall Study|Lost to Follow-up|5|||
19683661|NCT00432042|42130826|FG001|Overall Study|Lost to Follow-up|1|||
19683662|NCT00432042|42130827|FG002|Overall Study|Lost to Follow-up|0|||
19683663|NCT00308139|42130837|FG000|Overall Study|Adverse Event|20|||
19683664|NCT00308139|42130838|FG001|Overall Study|Adverse Event|14|||
19683665|NCT00308139|42130837|FG000|Overall Study|Lost to Follow-up|13|||
19683666|NCT00308139|42130838|FG001|Overall Study|Lost to Follow-up|8|||
19683667|NCT00308139|42130837|FG000|Overall Study|Protocol Violation|3|||
19683668|NCT00308139|42130838|FG001|Overall Study|Protocol Violation|2|||
19683669|NCT00308139|42130837|FG000|Overall Study|Withdrawal of Consent|40|||
19683670|NCT00308139|42130838|FG001|Overall Study|Withdrawal of Consent|42|||
19683671|NCT00308139|42130837|FG000|Overall Study|Investigator Decision|11|||
19683672|NCT00308139|42130838|FG001|Overall Study|Investigator Decision|10|||
19683673|NCT00308139|42130837|FG000|Overall Study|Loss of Glucose Control|5|||
19683674|NCT00308139|42130838|FG001|Overall Study|Loss of Glucose Control|7|||
19683675|NCT00308139|42130837|FG000|Overall Study|Administrative|1|||
19683676|NCT00308139|42130838|FG001|Overall Study|Administrative|4|||
19683677|NCT00308139|42130837|FG000|Overall Study|Other|1|||
19683678|NCT00308139|42130838|FG001|Overall Study|Other|0|||
19683679|NCT00459134|42130866|FG000|Overall Study|Physician Decision|1|||
19683680|NCT00459134|42130867|FG001|Overall Study|Physician Decision|1|||
19683681|NCT00459134|42130866|FG000|Overall Study|Withdrawal by Subject|8|||
19683682|NCT00459134|42130867|FG001|Overall Study|Withdrawal by Subject|7|||
19683683|NCT00459134|42130866|FG000|Overall Study|Lost to Follow-up|6|||
19605381|NCT00948428|42054152|FG001|Overall Study|Non-compliance|2|||
19605382|NCT00948428|42054153|FG002|Overall Study|Non-compliance|0|||
19605383|NCT00948194|42054163|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
19605384|NCT00948194|42054164|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
19605385|NCT00691483|42054172|FG000|Overall Study|Adverse Event|14|||
19605386|NCT00691483|42054173|FG001|Overall Study|Adverse Event|6|||
19605387|NCT00691483|42054172|FG000|Overall Study|Lost to Follow-up|17|||
19605388|NCT00691483|42054173|FG001|Overall Study|Lost to Follow-up|10|||
19683684|NCT00459134|42130867|FG001|Overall Study|Lost to Follow-up|7|||
19683685|NCT00459134|42130866|FG000|Overall Study|Surgery|1|||
19683686|NCT00459134|42130867|FG001|Overall Study|Surgery|2|||
19683687|NCT00459134|42130866|FG000|Overall Study|Toxicity|4|||
19683688|NCT00459134|42130867|FG001|Overall Study|Toxicity|5|||
19605389|NCT00691483|42054172|FG000|Overall Study|Withdrawal by Subject|24|||
19683689|NCT00459134|42130866|FG000|Overall Study|Progression|1|||
19683690|NCT00459134|42130867|FG001|Overall Study|Progression|0|||
19683691|NCT00459134|42130866|FG000|Overall Study|Multiple Reasons|2|||
19683692|NCT00459134|42130867|FG001|Overall Study|Multiple Reasons|3|||
19683693|NCT00459056|42130875|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
19683694|NCT00459056|42130876|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
19683695|NCT00431964|42130884|FG000|Overall Study|Adverse Event|1|||
19683696|NCT00431964|42130885|FG001|Overall Study|Adverse Event|0|||
19683697|NCT00431964|42130884|FG000|Overall Study|Lost to Follow-up|1|||
19683698|NCT00431964|42130885|FG001|Overall Study|Lost to Follow-up|2|||
19683699|NCT00431964|42130884|FG000|Overall Study|Physician Decision|2|||
19683700|NCT00431964|42130885|FG001|Overall Study|Physician Decision|2|||
19683701|NCT00431964|42130884|FG000|Overall Study|Withdrawal by Subject|2|||
19683702|NCT00431964|42130885|FG001|Overall Study|Withdrawal by Subject|1|||
19683703|NCT00431964|42130884|FG000|Overall Study|Parental Consent Withdrawn|0|||
19683704|NCT00431964|42130885|FG001|Overall Study|Parental Consent Withdrawn|2|||
19683705|NCT00431964|42130884|FG000|Overall Study|Due to Unstable Health|0|||
19683706|NCT00431964|42130885|FG001|Overall Study|Due to Unstable Health|1|||
19683707|NCT00412854|42130893|FG000|Overall Study|Withdrawn due to adverse events|1|||
19683708|NCT00412854|42130894|FG001|Overall Study|Withdrawn due to adverse events|5|||
19683709|NCT00412854|42130893|FG000|Overall Study|Withdrawn for other reasons|13|||
19683710|NCT00412854|42130894|FG001|Overall Study|Withdrawn for other reasons|11|||
19683711|NCT00431496|42130900|FG000|Overall Study|Adverse Event|3|||
19683712|NCT00431496|42130900|FG000|Overall Study|Lost to Follow-up|1|||
19683713|NCT00431496|42130900|FG000|Overall Study|Withdrawal by Subject|2|||
19683714|NCT00431496|42130900|FG000|Overall Study|Protocol-specified criteria|5|||
19683715|NCT00316173|42130906|FG000|Run-in Phase|Adverse Event|1|||
19683716|NCT00316173|42130907|FG001|Run-in Phase|Adverse Event|0|||
19683717|NCT00316173|42130906|FG000|Run-in Phase|Protocol Violation|1|||
19683718|NCT00316173|42130907|FG001|Run-in Phase|Protocol Violation|0|||
19683719|NCT00316173|42130906|FG000|Run-in Phase|Study Follow-up Stopped|5|||
19683720|NCT00316173|42130907|FG001|Run-in Phase|Study Follow-up Stopped|0|||
19683721|NCT00316173|42130906|FG000|Treatment Phase|Adverse Event|0|||
19683722|NCT00316173|42130907|FG001|Treatment Phase|Adverse Event|1|||
19683723|NCT00316173|42130906|FG000|Treatment Phase|Lack of Efficacy|0|||
19683724|NCT00316173|42130907|FG001|Treatment Phase|Lack of Efficacy|3|||
19683725|NCT00316173|42130906|FG000|Treatment Phase|Lost to Follow-up|0|||
19683726|NCT00316173|42130907|FG001|Treatment Phase|Lost to Follow-up|3|||
19683727|NCT00316173|42130906|FG000|Treatment Phase|Withdrawal by Subject|0|||
19683728|NCT00316173|42130907|FG001|Treatment Phase|Withdrawal by Subject|1|||
19683729|NCT00316173|42130906|FG000|Treatment Phase|Study Follow-up Stopped|0|||
19683730|NCT00316173|42130907|FG001|Treatment Phase|Study Follow-up Stopped|34|||
19683731|NCT00412542|42130914|FG000|Overall Study|Withdrawal by Subject|0|||
19683732|NCT00412542|42130915|FG001|Overall Study|Withdrawal by Subject|2|||
19683733|NCT00412542|42130914|FG000|Overall Study|Not Eligible|0|||
19683734|NCT00412542|42130915|FG001|Overall Study|Not Eligible|1|||
19683735|NCT00316017|42130922|FG000|Overall Study|Protocol Violation|11|||
19683736|NCT00316017|42130923|FG001|Overall Study|Protocol Violation|13|||
19683737|NCT00316017|42130924|FG002|Overall Study|Protocol Violation|19|||
19683738|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
19768754|NCT03203473|42222261|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
19768755|NCT03203473|42222262|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
19768756|NCT03203473|42222260|FG000|Arm Allocation Phase|Intercurrent illness|0|||
19768757|NCT03203473|42222261|FG001|Arm Allocation Phase|Intercurrent illness|0|||
19768758|NCT03203473|42222262|FG002|Arm Allocation Phase|Intercurrent illness|1|||
19768759|NCT03203473|42222260|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
19683739|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
19768760|NCT03203473|42222261|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
19768761|NCT03203473|42222262|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
19768762|NCT03882957|42222273|FG000|Overall Study|Did not complete all three arms|1|||
19768763|NCT03201211|42222285|FG000|Overall Study|Adverse Event|1|||
19768764|NCT03201211|42222286|FG001|Overall Study|Adverse Event|0|||
19768765|NCT03201211|42222287|FG002|Overall Study|Adverse Event|0|||
19683740|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
19683741|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
19683742|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
19683743|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
19768766|NCT03201211|42222285|FG000|Overall Study|Protocol Violation|1|||
19768767|NCT03201211|42222286|FG001|Overall Study|Protocol Violation|0|||
19389122|NCT02669849|41632688|FG001|Overall Study|Lost to Follow-up|0|||
19389123|NCT02669849|41632689|FG002|Overall Study|Lost to Follow-up|3|||
19768768|NCT03201211|42222287|FG002|Overall Study|Protocol Violation|0|||
19389124|NCT02669849|41632687|FG000|Overall Study|Death|1|||
19683744|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
19683745|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
19683746|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
19768769|NCT03201211|42222285|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19768770|NCT03201211|42222286|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19768771|NCT03201211|42222287|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
19768772|NCT03201211|42222285|FG000|Overall Study|OTHER unknown reasons|0|||
19768773|NCT03201211|42222286|FG001|Overall Study|OTHER unknown reasons|1|||
19768774|NCT03201211|42222287|FG002|Overall Study|OTHER unknown reasons|0|||
19768775|NCT04633837|42222297|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
19768776|NCT04633837|42222298|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
19768777|NCT03929913|42222304|FG000|Overall Study|Death|4|||
19768778|NCT03929913|42222304|FG000|Overall Study|Lost to Follow-up|1|||
19768779|NCT03929913|42222304|FG000|Overall Study|Failed Procedure|2|||
19768780|NCT03029832|42222310|FG000|Overall Study|Safety Follow-Up Completed|2|||
19768781|NCT03029832|42222311|FG001|Overall Study|Safety Follow-Up Completed|0|||
19768782|NCT03029832|42222310|FG000|Overall Study|Death due to Disease Progression|1|||
19768783|NCT03029832|42222311|FG001|Overall Study|Death due to Disease Progression|0|||
19768784|NCT03029832|42222310|FG000|Overall Study|Study Terminated By Sponsor|1|||
19768785|NCT03029832|42222311|FG001|Overall Study|Study Terminated By Sponsor|1|||
19768786|NCT03089697|42222319|FG000|Overall Study|Adverse Event|1|||
19768787|NCT03089697|42222320|FG001|Overall Study|Adverse Event|2|||
19768788|NCT03089697|42222319|FG000|Overall Study|Withdrawal by Subject|1|||
19768789|NCT03089697|42222320|FG001|Overall Study|Withdrawal by Subject|0|||
19768790|NCT03199963|42222328|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
19768791|NCT03199963|42222329|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
19768792|NCT03199963|42222328|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
19768793|NCT03199963|42222329|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
19768794|NCT03199963|42222328|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
19768795|NCT03199963|42222329|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
19768796|NCT03199963|42222328|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
19768797|NCT03199963|42222329|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
19768798|NCT03199963|42222328|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
19768799|NCT03199963|42222329|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
19768800|NCT03199963|42222328|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
19768801|NCT03199963|42222329|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
19768802|NCT03257631|42222345|FG000|Overall Study|Death|8|||
19768803|NCT03257631|42222346|FG001|Overall Study|Death|5|||
19768804|NCT03257631|42222347|FG002|Overall Study|Death|13|||
19768805|NCT03257631|42222348|FG003|Overall Study|Death|5|||
19768806|NCT03257631|42222345|FG000|Overall Study|Progressive Disease|0|||
19768807|NCT03257631|42222346|FG001|Overall Study|Progressive Disease|0|||
19768808|NCT03257631|42222347|FG002|Overall Study|Progressive Disease|1|||
19768809|NCT03257631|42222348|FG003|Overall Study|Progressive Disease|0|||
19768810|NCT03257631|42222345|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19768811|NCT03257631|42222346|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
19768812|NCT03257631|42222347|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
19683747|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
19683748|NCT00451178|42130934|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
19683749|NCT00451178|42130935|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
19683750|NCT00451178|42130934|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
19683751|NCT00451178|42130935|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
19683752|NCT00451178|42130934|FG000|Prior to Maintenance Therapy|PD|2|||
19683753|NCT00451178|42130935|FG001|Prior to Maintenance Therapy|PD|0|||
19683754|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
19683755|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
19683756|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
19683757|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
19683758|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
19683759|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
19683760|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
19683761|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
19683762|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
19683763|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
19683764|NCT00451178|42130934|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
19683765|NCT00451178|42130935|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
19683766|NCT00451178|42130934|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
19683767|NCT00451178|42130935|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
19683768|NCT00450866|42130945|FG000|Overall Study|Adverse Event|0|||
19683769|NCT00450866|42130946|FG001|Overall Study|Adverse Event|1|||
19768813|NCT03257631|42222348|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
19768814|NCT03257631|42222345|FG000|Overall Study|Lost to Follow-up|0|||
19768815|NCT03257631|42222346|FG001|Overall Study|Lost to Follow-up|0|||
19683770|NCT00450866|42130945|FG000|Overall Study|Withdrawal by Subject|5|||
19683771|NCT00450866|42130946|FG001|Overall Study|Withdrawal by Subject|2|||
19683772|NCT00450866|42130945|FG000|Overall Study|Death|1|||
19683773|NCT00450866|42130946|FG001|Overall Study|Death|0|||
19683774|NCT00450866|42130945|FG000|Overall Study|Physician Decision|1|||
19683775|NCT00450866|42130946|FG001|Overall Study|Physician Decision|0|||
19683776|NCT00442598|42130955|FG000|Overall Study|Adverse Event|1|||
19683777|NCT00442598|42130956|FG001|Overall Study|Adverse Event|0|||
19683778|NCT00442598|42130957|FG002|Overall Study|Adverse Event|0|||
19683779|NCT00442598|42130955|FG000|Overall Study|Tumor progression|3|||
19683780|NCT00442598|42130956|FG001|Overall Study|Tumor progression|4|||
19683781|NCT00442598|42130957|FG002|Overall Study|Tumor progression|0|||
19683782|NCT00442598|42130955|FG000|Overall Study|Clinical deterioration|1|||
19683783|NCT00442598|42130956|FG001|Overall Study|Clinical deterioration|2|||
19683784|NCT00442598|42130957|FG002|Overall Study|Clinical deterioration|0|||
19683785|NCT00442598|42130955|FG000|Overall Study|CA125 progression|0|||
19683786|NCT00442598|42130956|FG001|Overall Study|CA125 progression|1|||
19683787|NCT00442598|42130957|FG002|Overall Study|CA125 progression|0|||
19683788|NCT00442598|42130955|FG000|Overall Study|Reduced creatinine clearance|1|||
19683789|NCT00442598|42130956|FG001|Overall Study|Reduced creatinine clearance|0|||
19683790|NCT00442598|42130957|FG002|Overall Study|Reduced creatinine clearance|0|||
19683791|NCT00442598|42130955|FG000|Overall Study|Death|0|||
19683792|NCT00442598|42130956|FG001|Overall Study|Death|1|||
19683793|NCT00442598|42130957|FG002|Overall Study|Death|0|||
19683794|NCT00442286|42130967|FG000|Overall Study|Death|2|||
19683795|NCT00442286|42130968|FG001|Overall Study|Death|2|||
19683796|NCT00442286|42130967|FG000|Overall Study|Lost to Follow-up|1|||
19683797|NCT00442286|42130968|FG001|Overall Study|Lost to Follow-up|0|||
19683798|NCT00442286|42130967|FG000|Overall Study|Withdrawal by Subject|2|||
19683799|NCT00442286|42130968|FG001|Overall Study|Withdrawal by Subject|0|||
19683800|NCT00442286|42130967|FG000|Overall Study|System explanted|1|||
19683801|NCT00442286|42130968|FG001|Overall Study|System explanted|0|||
19683802|NCT00442286|42130967|FG000|Overall Study|Patient Injury|1|||
19768816|NCT03257631|42222347|FG002|Overall Study|Lost to Follow-up|1|||
19768817|NCT03257631|42222348|FG003|Overall Study|Lost to Follow-up|0|||
19683803|NCT00442286|42130968|FG001|Overall Study|Patient Injury|0|||
19683804|NCT00441974|42130976|FG000|Overall Study|Adverse Event|6|||
19683805|NCT00441974|42130976|FG000|Overall Study|Consent Withdrawn|35|||
19683806|NCT00441974|42130976|FG000|Overall Study|Lost to Follow-up|80|||
19683807|NCT00441974|42130976|FG000|Overall Study|Protocol Violation|7|||
19683808|NCT00441584|42130983|FG000|Overall Study|Lack of Efficacy|79|||
19683809|NCT00441584|42130983|FG000|Overall Study|Withdrawal by Subject|8|||
19683810|NCT00441584|42130983|FG000|Overall Study|Adverse Event|6|||
19683811|NCT00441584|42130983|FG000|Overall Study|Protocol Violation|5|||
19683812|NCT00441584|42130983|FG000|Overall Study|Lost to Follow-up|4|||
19683813|NCT00441584|42130983|FG000|Overall Study|Failure to meet eligibility criteria|3|||
19683814|NCT00430716|42130990|FG000|Double Blind Phase|Death|1|||
19683815|NCT00430716|42130991|FG001|Double Blind Phase|Death|0|||
19683816|NCT00430716|42130992|FG002|Double Blind Phase|Death|0|||
19683817|NCT00430716|42130990|FG000|Double Blind Phase|No longer willing to participate|2|||
19683818|NCT00430716|42130991|FG001|Double Blind Phase|No longer willing to participate|1|||
19683819|NCT00430716|42130992|FG002|Double Blind Phase|No longer willing to participate|1|||
19683820|NCT00430716|42130990|FG000|Double Blind Phase|Other|0|||
19683821|NCT00430716|42130991|FG001|Double Blind Phase|Other|2|||
19683822|NCT00430716|42130992|FG002|Double Blind Phase|Other|0|||
19683823|NCT00430716|42130990|FG000|Double Blind Phase|Study terminated by sponsor|1|||
19683824|NCT00430716|42130991|FG001|Double Blind Phase|Study terminated by sponsor|1|||
19683825|NCT00430716|42130992|FG002|Double Blind Phase|Study terminated by sponsor|2|||
19683826|NCT00430716|42130990|FG000|Double Blind Phase|Adverse Event|1|||
19683827|NCT00430716|42130991|FG001|Double Blind Phase|Adverse Event|1|||
19683828|NCT00430716|42130992|FG002|Double Blind Phase|Adverse Event|3|||
19683829|NCT00430716|42130990|FG000|Double Blind Phase|Not treated|1|||
19683830|NCT00430716|42130991|FG001|Double Blind Phase|Not treated|0|||
19683831|NCT00430716|42130992|FG002|Double Blind Phase|Not treated|0|||
19683832|NCT00430716|42130990|FG000|Open Label Phase|Lost to Follow-up|1|||
19683833|NCT00430716|42130991|FG001|Open Label Phase|Lost to Follow-up|0|||
19683834|NCT00430716|42130992|FG002|Open Label Phase|Lost to Follow-up|1|||
19683835|NCT00430716|42130990|FG000|Open Label Phase|No longer willing to participate|0|||
19683836|NCT00430716|42130991|FG001|Open Label Phase|No longer willing to participate|1|||
19683837|NCT00430716|42130992|FG002|Open Label Phase|No longer willing to participate|1|||
19683838|NCT00430716|42130990|FG000|Open Label Phase|Other|3|||
19683839|NCT00430716|42130991|FG001|Open Label Phase|Other|1|||
19683840|NCT00430716|42130992|FG002|Open Label Phase|Other|1|||
19683841|NCT00430716|42130990|FG000|Open Label Phase|Protocol Violation|1|||
19683842|NCT00430716|42130991|FG001|Open Label Phase|Protocol Violation|0|||
19683843|NCT00430716|42130992|FG002|Open Label Phase|Protocol Violation|0|||
19683844|NCT00430716|42130990|FG000|Open Label Phase|Study terminated by sponsor|4|||
19683845|NCT00430716|42130991|FG001|Open Label Phase|Study terminated by sponsor|5|||
19768818|NCT03257631|42222345|FG000|Overall Study|Still on Study|3|||
19683846|NCT00430716|42130992|FG002|Open Label Phase|Study terminated by sponsor|4|||
19683847|NCT00441272|42131002|FG000|Overall Study|Study terminated prior to enrollment|25|||
19683848|NCT00441272|42131003|FG001|Overall Study|Study terminated prior to enrollment|25|||
19683849|NCT00430638|42131011|FG000|Overall Study|Adverse Event|15|||
19683850|NCT00430638|42131012|FG001|Overall Study|Adverse Event|15|||
19683851|NCT00430638|42131011|FG000|Overall Study|Uncontrolled blood pressure|48|||
19683852|NCT00430638|42131012|FG001|Overall Study|Uncontrolled blood pressure|13|||
19683853|NCT00430638|42131011|FG000|Overall Study|Lost to Follow-up|1|||
19683854|NCT00430638|42131012|FG001|Overall Study|Lost to Follow-up|7|||
19683855|NCT00430638|42131011|FG000|Overall Study|Protocol Violation|6|||
19683856|NCT00430638|42131012|FG001|Overall Study|Protocol Violation|4|||
19683857|NCT00430638|42131011|FG000|Overall Study|Withdrawal by Subject|4|||
19683858|NCT00430638|42131012|FG001|Overall Study|Withdrawal by Subject|6|||
19683859|NCT00430638|42131011|FG000|Overall Study|Non-compliant|2|||
19683860|NCT00430638|42131012|FG001|Overall Study|Non-compliant|1|||
19683861|NCT00430638|42131011|FG000|Overall Study|Other|2|||
19768819|NCT03257631|42222346|FG001|Overall Study|Still on Study|2|||
19768820|NCT03257631|42222347|FG002|Overall Study|Still on Study|4|||
19683862|NCT00430638|42131012|FG001|Overall Study|Other|2|||
19683863|NCT00430482|42131024|FG000|Completed Treatment|Insufficient Treatment|7|||
19683864|NCT00430482|42131025|FG001|Completed Treatment|Insufficient Treatment|11|||
19683865|NCT00449930|42131033|FG000|Overall Study|Adverse Event|9|||
19683866|NCT00449930|42131034|FG001|Overall Study|Adverse Event|19|||
19683867|NCT00449930|42131033|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
19683868|NCT00449930|42131034|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
19683869|NCT00449930|42131033|FG000|Overall Study|Lack of Efficacy|10|||
19683870|NCT00449930|42131034|FG001|Overall Study|Lack of Efficacy|1|||
19683871|NCT00449930|42131033|FG000|Overall Study|Lost to Follow-up|9|||
19683872|NCT00449930|42131034|FG001|Overall Study|Lost to Follow-up|14|||
19683873|NCT00449930|42131033|FG000|Overall Study|Physician Decision|1|||
19683874|NCT00449930|42131034|FG001|Overall Study|Physician Decision|2|||
19683875|NCT00449930|42131033|FG000|Overall Study|Protocol Violation|14|||
19683876|NCT00449930|42131034|FG001|Overall Study|Protocol Violation|15|||
19683877|NCT00449930|42131033|FG000|Overall Study|Withdrawal by Subject|16|||
19683878|NCT00449930|42131034|FG001|Overall Study|Withdrawal by Subject|23|||
19683879|NCT00449930|42131033|FG000|Overall Study|Glycemic discontinuation criteria|1|||
19683880|NCT00449930|42131034|FG001|Overall Study|Glycemic discontinuation criteria|1|||
19683881|NCT00449696|42131042|FG000|Overall Study|Other Treatment Required|6|||
19683882|NCT00449696|42131043|FG001|Overall Study|Other Treatment Required|1|||
19683883|NCT00449696|42131042|FG000|Overall Study|Withdrawal by Subject|5|||
19683884|NCT00449696|42131043|FG001|Overall Study|Withdrawal by Subject|5|||
19683885|NCT00449696|42131042|FG000|Overall Study|Lost to Follow-up|2|||
19683886|NCT00449696|42131043|FG001|Overall Study|Lost to Follow-up|3|||
19683887|NCT00449696|42131042|FG000|Overall Study|Others|7|||
19683888|NCT00449696|42131043|FG001|Overall Study|Others|0|||
19683889|NCT00441116|42131051|FG000|Overall Study|Adverse Event|1|||
19683890|NCT00441116|42131052|FG001|Overall Study|Adverse Event|1|||
19683891|NCT00441116|42131051|FG000|Overall Study|Withdrawal by Subject|1|||
19683892|NCT00441116|42131052|FG001|Overall Study|Withdrawal by Subject|0|||
19683893|NCT00441116|42131051|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
19683894|NCT00441116|42131052|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
19683895|NCT00430248|42131061|FG000|Overall Study|Adverse Event|49|||
19683896|NCT00430248|42131062|FG001|Overall Study|Adverse Event|61|||
19683897|NCT00430248|42131063|FG002|Overall Study|Adverse Event|64|||
19683898|NCT00430248|42131061|FG000|Overall Study|Protocol Violation|10|||
19683899|NCT00430248|42131062|FG001|Overall Study|Protocol Violation|2|||
19683900|NCT00430248|42131063|FG002|Overall Study|Protocol Violation|4|||
19683901|NCT00430248|42131061|FG000|Overall Study|Personal Reasons|12|||
19683902|NCT00430248|42131062|FG001|Overall Study|Personal Reasons|24|||
19683903|NCT00430248|42131063|FG002|Overall Study|Personal Reasons|9|||
19683904|NCT00430248|42131061|FG000|Overall Study|Lost to Follow-up|28|||
19683905|NCT00430248|42131062|FG001|Overall Study|Lost to Follow-up|33|||
19683906|NCT00430248|42131063|FG002|Overall Study|Lost to Follow-up|28|||
19683907|NCT00430248|42131061|FG000|Overall Study|Therapeutic Failure|1|||
19683908|NCT00430248|42131062|FG001|Overall Study|Therapeutic Failure|1|||
19683909|NCT00430248|42131063|FG002|Overall Study|Therapeutic Failure|1|||
19683910|NCT00430248|42131061|FG000|Overall Study|Withdrawal by Subject|14|||
19683911|NCT00430248|42131062|FG001|Overall Study|Withdrawal by Subject|20|||
19683912|NCT00430248|42131063|FG002|Overall Study|Withdrawal by Subject|16|||
19683913|NCT00430248|42131061|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19683914|NCT00430248|42131062|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
19683915|NCT00430248|42131063|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19683916|NCT00430248|42131061|FG000|Overall Study|Gout Flare|3|||
19683917|NCT00430248|42131062|FG001|Overall Study|Gout Flare|7|||
19683918|NCT00430248|42131063|FG002|Overall Study|Gout Flare|2|||
19683919|NCT00430248|42131061|FG000|Overall Study|Reason Not Specified|8|||
19683920|NCT00430248|42131062|FG001|Overall Study|Reason Not Specified|8|||
19768821|NCT03257631|42222348|FG003|Overall Study|Still on Study|4|||
19683921|NCT00430248|42131063|FG002|Overall Study|Reason Not Specified|11|||
19683922|NCT00449540|42131073|FG000|Pretreatment Phase|No migraine experienced|66|||
19683923|NCT00449540|42131074|FG001|Pretreatment Phase|No migraine experienced|0|||
19683924|NCT00449540|42131075|FG002|Pretreatment Phase|No migraine experienced|0|||
19683925|NCT00449540|42131073|FG000|Treatment Phase|did not experience or treat migraine|0|||
19605390|NCT00691483|42054173|FG001|Overall Study|Withdrawal by Subject|7|||
19605391|NCT00691483|42054172|FG000|Overall Study|Other known cause|6|||
19605392|NCT00691483|42054173|FG001|Overall Study|Other known cause|1|||
19605393|NCT00691483|42054172|FG000|Overall Study|Randomized by not treated|7|||
19605394|NCT00691483|42054173|FG001|Overall Study|Randomized by not treated|1|||
19605395|NCT00691093|42054179|FG000|Overall Study|Adverse Event|1|||
19605396|NCT00691093|42054179|FG000|Overall Study|Lost to Follow-up|1|||
19768822|NCT03883581|42222358|FG000|Overall Study|Withdrawal by Subject|4|||
19605397|NCT00691093|42054179|FG000|Overall Study|Lack of Efficacy|1|||
19605398|NCT00691093|42054179|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
19605399|NCT00947882|42054192|FG000|Overall Study|Adverse Event|0|||
19605400|NCT00947882|42054193|FG001|Overall Study|Adverse Event|1|||
19605401|NCT00947882|42054194|FG002|Overall Study|Adverse Event|4|||
19605402|NCT00947882|42054195|FG003|Overall Study|Adverse Event|4|||
19605403|NCT00947882|42054192|FG000|Overall Study|Withdrawal by Subject|2|||
19605404|NCT00947882|42054193|FG001|Overall Study|Withdrawal by Subject|0|||
19605405|NCT00947882|42054194|FG002|Overall Study|Withdrawal by Subject|8|||
19605406|NCT00947882|42054195|FG003|Overall Study|Withdrawal by Subject|2|||
19605407|NCT00947882|42054192|FG000|Overall Study|Protocol Violation|0|||
19605408|NCT00947882|42054193|FG001|Overall Study|Protocol Violation|0|||
19605409|NCT00947882|42054194|FG002|Overall Study|Protocol Violation|1|||
19605410|NCT00947882|42054195|FG003|Overall Study|Protocol Violation|0|||
19605411|NCT00947882|42054192|FG000|Overall Study|Lost to Follow-up|0|||
19605412|NCT00947882|42054193|FG001|Overall Study|Lost to Follow-up|2|||
19605413|NCT00947882|42054194|FG002|Overall Study|Lost to Follow-up|1|||
19768823|NCT03029208|42222364|FG000|Overall Study|Withdrawal by Subject|2|||
19768824|NCT03029208|42222365|FG001|Overall Study|Withdrawal by Subject|3|||
19768825|NCT03029208|42222364|FG000|Overall Study|Lost to Follow-up|0|||
19768826|NCT03029208|42222365|FG001|Overall Study|Lost to Follow-up|1|||
19768827|NCT03198715|42222385|FG000|Overall Study|Death|0|||
19768828|NCT03198715|42222386|FG001|Overall Study|Death|0|||
19768829|NCT03198715|42222387|FG002|Overall Study|Death|1|||
19768830|NCT03198715|42222388|FG003|Overall Study|Death|0|||
19768831|NCT03198715|42222389|FG004|Overall Study|Death|2|||
19768832|NCT03198715|42222385|FG000|Overall Study|Other|0|||
19768833|NCT03198715|42222386|FG001|Overall Study|Other|1|||
19768834|NCT03198715|42222387|FG002|Overall Study|Other|1|||
19768835|NCT03198715|42222388|FG003|Overall Study|Other|0|||
19768836|NCT03198715|42222389|FG004|Overall Study|Other|0|||
19768837|NCT03197935|42222412|FG000|Overall Study|Death due to any cause|9|||
19768838|NCT03197935|42222413|FG001|Overall Study|Death due to any cause|7|||
19768839|NCT03197935|42222412|FG000|Overall Study|Lost to Follow-up|0|||
19768840|NCT03197935|42222413|FG001|Overall Study|Lost to Follow-up|3|||
19768841|NCT03197935|42222412|FG000|Overall Study|Physician Decision|0|||
19389125|NCT02669849|41632688|FG001|Overall Study|Death|1|||
19605414|NCT00947882|42054195|FG003|Overall Study|Lost to Follow-up|0|||
19605415|NCT00947882|42054192|FG000|Overall Study|Other/Unknown|10|||
19605416|NCT00947882|42054193|FG001|Overall Study|Other/Unknown|13|||
19605417|NCT00947882|42054194|FG002|Overall Study|Other/Unknown|3|||
19605418|NCT00947882|42054195|FG003|Overall Study|Other/Unknown|6|||
19605419|NCT00947882|42054192|FG000|Overall Study|Trial Terminated by Sponsor|62|||
19605420|NCT00947882|42054193|FG001|Overall Study|Trial Terminated by Sponsor|61|||
19605421|NCT00947882|42054194|FG002|Overall Study|Trial Terminated by Sponsor|62|||
19605422|NCT00947882|42054195|FG003|Overall Study|Trial Terminated by Sponsor|70|||
19605423|NCT00688753|42054206|FG000|Overall Study|Disease progression|55|||
19605424|NCT00688753|42054206|FG000|Overall Study|Missing|1|||
19605425|NCT00688753|42054206|FG000|Overall Study|Death|9|||
19605426|NCT00688753|42054206|FG000|Overall Study|Withdrawal by Subject|3|||
19605427|NCT00688753|42054206|FG000|Overall Study|Adverse Event|20|||
19605428|NCT00688753|42054206|FG000|Overall Study|Protocol Violation|1|||
19605429|NCT00688753|42054206|FG000|Overall Study|Lost to Follow-up|3|||
19605430|NCT00951080|42054212|FG000|Overall Study|Adverse Event|3|||
19605431|NCT00951080|42054213|FG001|Overall Study|Adverse Event|3|||
19683926|NCT00449540|42131074|FG001|Treatment Phase|did not experience or treat migraine|20|||
19683927|NCT00449540|42131075|FG002|Treatment Phase|did not experience or treat migraine|17|||
19683928|NCT00411762|42131083|FG000|Overall Study|Withdrawal by Subject|5|||
19768842|NCT03197935|42222413|FG001|Overall Study|Physician Decision|1|||
19768843|NCT03197935|42222412|FG000|Overall Study|Withdrawal by Subject|11|||
19605432|NCT00951080|42054212|FG000|Overall Study|Lost to Follow-up|0|||
19605433|NCT00951080|42054213|FG001|Overall Study|Lost to Follow-up|1|||
19605434|NCT00951080|42054212|FG000|Overall Study|Physician Decision|4|||
19605435|NCT00951080|42054213|FG001|Overall Study|Physician Decision|1|||
19768844|NCT03197935|42222413|FG001|Overall Study|Withdrawal by Subject|7|||
19768845|NCT03197935|42222412|FG000|Overall Study|On-Going in Study|147|||
19768846|NCT03197935|42222413|FG001|Overall Study|On-Going in Study|146|||
19768847|NCT03197935|42222412|FG000|Overall Study|Did not receive any study treatment|1|||
19768848|NCT03197935|42222413|FG001|Overall Study|Did not receive any study treatment|1|||
19768849|NCT03088917|42222420|FG000|Overall Study|In care/cured elsewhere|15|||
19605436|NCT00951080|42054212|FG000|Overall Study|Other|19|||
19605437|NCT00951080|42054213|FG001|Overall Study|Other|22|||
19605438|NCT00946322|42054219|FG000|Pre-treatment|participant failure to follow up|1|||
19605439|NCT00946322|42054219|FG000|Post-treatment|participant failure to follow up|2|||
19605440|NCT00950690|42054223|FG000|Overall Study|Death|4|||
19605441|NCT00950690|42054223|FG000|Overall Study|Adverse Event|15|||
19605442|NCT00950690|42054223|FG000|Overall Study|Lack of Efficacy|22|||
19605443|NCT00950690|42054223|FG000|Overall Study|Lost to Follow-up|40|||
19605444|NCT00950690|42054223|FG000|Overall Study|Other|163|||
19605445|NCT00694369|42054232|FG000|Overall Study|Adverse Event|0|||
19605446|NCT00694369|42054233|FG001|Overall Study|Adverse Event|1|||
19605447|NCT00694369|42054234|FG002|Overall Study|Adverse Event|0|||
19605448|NCT00694369|42054235|FG003|Overall Study|Adverse Event|1|||
19605449|NCT00694369|42054236|FG004|Overall Study|Adverse Event|3|||
19605450|NCT00694369|42054232|FG000|Overall Study|Lost to Follow-up|0|||
19605451|NCT00694369|42054233|FG001|Overall Study|Lost to Follow-up|0|||
19605452|NCT00694369|42054234|FG002|Overall Study|Lost to Follow-up|1|||
19605453|NCT00694369|42054235|FG003|Overall Study|Lost to Follow-up|1|||
19605454|NCT00694369|42054236|FG004|Overall Study|Lost to Follow-up|0|||
19768850|NCT03088917|42222420|FG000|Overall Study|Refuse re-evaluation|13|||
19768851|NCT03088917|42222420|FG000|Overall Study|Contact not established|13|||
19768852|NCT03088917|42222420|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
19768853|NCT03088917|42222420|FG000|Overall Study|Moved outside study region|50|||
19768854|NCT03087513|42222426|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
19768855|NCT02917629|42222441|FG000|Overall Study|Withdrawal by Subject|0|||
19768856|NCT02917629|42222442|FG001|Overall Study|Withdrawal by Subject|1|||
19605455|NCT00694369|42054232|FG000|Overall Study|Physician Decision|0|||
19683929|NCT00429858|42131087|FG000|Overall Study|Withdrawal by Subject|1|||
19683930|NCT00429858|42131087|FG000|Overall Study|Study Termination|1|||
19683931|NCT00449150|42131095|FG000|Overall Study|Adverse Event|11|||
19683932|NCT00449150|42131096|FG001|Overall Study|Adverse Event|18|||
19683933|NCT00449150|42131097|FG002|Overall Study|Adverse Event|9|||
19683934|NCT00449150|42131095|FG000|Overall Study|Lack of Efficacy|1|||
19683935|NCT00449150|42131096|FG001|Overall Study|Lack of Efficacy|2|||
19683936|NCT00449150|42131097|FG002|Overall Study|Lack of Efficacy|2|||
19768857|NCT02927847|42222451|FG000|Overall Study|Lost to Follow-up|1|||
19768858|NCT02927847|42222452|FG001|Overall Study|Lost to Follow-up|0|||
19768859|NCT02927847|42222451|FG000|Overall Study|Withdrawal by Subject|4|||
19768860|NCT02927847|42222452|FG001|Overall Study|Withdrawal by Subject|2|||
19768861|NCT02927847|42222451|FG000|Overall Study|PI withdrawn due to missed visits|1|||
19768862|NCT02927847|42222452|FG001|Overall Study|PI withdrawn due to missed visits|1|||
19768863|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
19768864|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
19768865|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
19768866|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
19768867|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
19683937|NCT00449150|42131095|FG000|Overall Study|Other|16|||
19683938|NCT00449150|42131096|FG001|Overall Study|Other|13|||
19683939|NCT00449150|42131097|FG002|Overall Study|Other|14|||
19683940|NCT00449150|42131095|FG000|Overall Study|Withdrawal by Subject|17|||
19683941|NCT00449150|42131096|FG001|Overall Study|Withdrawal by Subject|18|||
19683942|NCT00449150|42131097|FG002|Overall Study|Withdrawal by Subject|21|||
19683943|NCT00449150|42131095|FG000|Overall Study|Protocol Violation|1|||
19683944|NCT00449150|42131096|FG001|Overall Study|Protocol Violation|2|||
19683945|NCT00449150|42131097|FG002|Overall Study|Protocol Violation|1|||
19683946|NCT00428844|42131111|FG000|Completed Study Drug Treatment|Adverse Event|2|||
19683947|NCT00428844|42131112|FG001|Completed Study Drug Treatment|Adverse Event|4|||
19683948|NCT00428844|42131113|FG002|Completed Study Drug Treatment|Adverse Event|4|||
19683949|NCT00428844|42131111|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
19683950|NCT00428844|42131112|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
19683951|NCT00428844|42131113|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
19683952|NCT00428844|42131111|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
19683953|NCT00428844|42131112|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
19683954|NCT00428844|42131113|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
19683955|NCT00428844|42131111|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
19683956|NCT00428844|42131112|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
19768868|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
19768869|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
19605456|NCT00694369|42054233|FG001|Overall Study|Physician Decision|0|||
19605457|NCT00694369|42054234|FG002|Overall Study|Physician Decision|0|||
19605458|NCT00694369|42054235|FG003|Overall Study|Physician Decision|0|||
19683957|NCT00428844|42131113|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
19683958|NCT00428844|42131111|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
19683959|NCT00428844|42131112|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
19683960|NCT00428844|42131113|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
19683961|NCT00428844|42131111|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
19683962|NCT00428844|42131112|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
19683963|NCT00428844|42131113|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
19683964|NCT00428844|42131111|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
19683965|NCT00428844|42131112|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
19683966|NCT00428844|42131113|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
19683967|NCT00428844|42131111|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
19683968|NCT00428844|42131112|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
19683969|NCT00428844|42131113|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
19683970|NCT00428844|42131111|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
19683971|NCT00428844|42131112|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
19683972|NCT00428844|42131113|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
19683973|NCT00457418|42131121|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
19683974|NCT00457418|42131121|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
19683975|NCT00457418|42131121|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
19683976|NCT00457418|42131121|FG000|Post PK Maintenance|Adverse Event|10|||
19683977|NCT00457418|42131121|FG000|Post PK Maintenance|Progression of Disease|6|||
19683978|NCT00457418|42131121|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
19683979|NCT00457418|42131121|FG000|Post PK Maintenance|Lost to Follow-up|1|||
19683980|NCT00449072|42131127|FG000|Overall Study|Adverse Event|3|||
19683981|NCT00449072|42131128|FG001|Overall Study|Adverse Event|1|||
19683982|NCT00449072|42131127|FG000|Overall Study|Protocol Violation|14|||
19683983|NCT00449072|42131128|FG001|Overall Study|Protocol Violation|12|||
19683984|NCT00449072|42131127|FG000|Overall Study|Lost to Follow-up|5|||
19683985|NCT00449072|42131128|FG001|Overall Study|Lost to Follow-up|7|||
19683986|NCT00449072|42131127|FG000|Overall Study|Withdrawal by Subject|11|||
19683987|NCT00449072|42131128|FG001|Overall Study|Withdrawal by Subject|8|||
19683988|NCT00449072|42131127|FG000|Overall Study|Lack of Efficacy|1|||
19683989|NCT00449072|42131128|FG001|Overall Study|Lack of Efficacy|1|||
19683990|NCT00449072|42131127|FG000|Overall Study|Physician Decision|1|||
19683991|NCT00449072|42131128|FG001|Overall Study|Physician Decision|0|||
19683992|NCT00449072|42131127|FG000|Overall Study|Not treated|0|||
19683993|NCT00449072|42131128|FG001|Overall Study|Not treated|1|||
19683994|NCT00449072|42131127|FG000|Overall Study|Excluded medication|0|||
19683995|NCT00449072|42131128|FG001|Overall Study|Excluded medication|2|||
19683996|NCT00449072|42131127|FG000|Overall Study|Non-compliance|2|||
19683997|NCT00449072|42131128|FG001|Overall Study|Non-compliance|5|||
19683998|NCT00449072|42131127|FG000|Overall Study|Sponsor decision|1|||
19683999|NCT00449072|42131128|FG001|Overall Study|Sponsor decision|3|||
19684000|NCT00449072|42131127|FG000|Overall Study|Relocation|3|||
19684001|NCT00449072|42131128|FG001|Overall Study|Relocation|2|||
19684002|NCT00428610|42131137|FG000|Overall Study|Death Due to Adverse Event|3|||
19684003|NCT00428610|42131138|FG001|Overall Study|Death Due to Adverse Event|0|||
19684004|NCT00428610|42131139|FG002|Overall Study|Death Due to Adverse Event|5|||
19684005|NCT00428610|42131137|FG000|Overall Study|Death Due to Progressive Disease|0|||
19684006|NCT00428610|42131138|FG001|Overall Study|Death Due to Progressive Disease|0|||
19684007|NCT00428610|42131139|FG002|Overall Study|Death Due to Progressive Disease|2|||
19684008|NCT00428610|42131137|FG000|Overall Study|Adverse Event|2|||
19684009|NCT00428610|42131138|FG001|Overall Study|Adverse Event|3|||
19684010|NCT00428610|42131139|FG002|Overall Study|Adverse Event|2|||
19684011|NCT00428610|42131137|FG000|Overall Study|Investigator Decision|2|||
19684012|NCT00428610|42131138|FG001|Overall Study|Investigator Decision|1|||
19684013|NCT00428610|42131139|FG002|Overall Study|Investigator Decision|1|||
19684014|NCT00428610|42131137|FG000|Overall Study|Progressive Disease|42|||
19684015|NCT00428610|42131138|FG001|Overall Study|Progressive Disease|14|||
19684016|NCT00428610|42131139|FG002|Overall Study|Progressive Disease|22|||
19684017|NCT00428610|42131137|FG000|Overall Study|Withdrawal by Subject|4|||
19684018|NCT00428610|42131138|FG001|Overall Study|Withdrawal by Subject|0|||
19684019|NCT00428610|42131139|FG002|Overall Study|Withdrawal by Subject|0|||
19684020|NCT00419094|42131149|FG000|Overall Study|Adverse Event|3|||
19768870|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
19684021|NCT00419094|42131150|FG001|Overall Study|Adverse Event|7|||
19684022|NCT00419094|42131149|FG000|Overall Study|Lack of Efficacy|1|||
19684023|NCT00419094|42131150|FG001|Overall Study|Lack of Efficacy|0|||
19684024|NCT00419094|42131149|FG000|Overall Study|Lost to Follow-up|0|||
19684025|NCT00419094|42131150|FG001|Overall Study|Lost to Follow-up|2|||
19684026|NCT00419094|42131149|FG000|Overall Study|Protocol Violation|1|||
19684027|NCT00419094|42131150|FG001|Overall Study|Protocol Violation|14|||
19684028|NCT00419094|42131149|FG000|Overall Study|Withdrawal of consent|1|||
19684029|NCT00419094|42131150|FG001|Overall Study|Withdrawal of consent|5|||
19684030|NCT00419094|42131149|FG000|Overall Study|Other: Error determining exit criteria|1|||
19684031|NCT00419094|42131150|FG001|Overall Study|Other: Error determining exit criteria|0|||
19684032|NCT00419094|42131149|FG000|Overall Study|Other: Patient non-compliant|0|||
19684033|NCT00419094|42131150|FG001|Overall Study|Other: Patient non-compliant|1|||
19684034|NCT00419094|42131149|FG000|Overall Study|Other: No contact for extended period|0|||
19684035|NCT00419094|42131150|FG001|Overall Study|Other: No contact for extended period|1|||
19684036|NCT00448916|42131160|FG000|Overall Study|Adverse Event|2|||
19684037|NCT00448916|42131161|FG001|Overall Study|Adverse Event|2|||
19684038|NCT00448916|42131162|FG002|Overall Study|Adverse Event|3|||
19684039|NCT00448916|42131163|FG003|Overall Study|Adverse Event|2|||
19684040|NCT00448916|42131160|FG000|Overall Study|Lack of Efficacy|1|||
19684041|NCT00448916|42131161|FG001|Overall Study|Lack of Efficacy|0|||
19684042|NCT00448916|42131162|FG002|Overall Study|Lack of Efficacy|2|||
19684043|NCT00448916|42131163|FG003|Overall Study|Lack of Efficacy|1|||
19684044|NCT00448916|42131160|FG000|Overall Study|Withdrawal by Subject|3|||
19684045|NCT00448916|42131161|FG001|Overall Study|Withdrawal by Subject|3|||
19684046|NCT00448916|42131162|FG002|Overall Study|Withdrawal by Subject|1|||
19684047|NCT00448916|42131163|FG003|Overall Study|Withdrawal by Subject|1|||
19684048|NCT00448916|42131160|FG000|Overall Study|Other|1|||
19684049|NCT00448916|42131161|FG001|Overall Study|Other|0|||
19684050|NCT00448916|42131162|FG002|Overall Study|Other|0|||
19684051|NCT00448916|42131163|FG003|Overall Study|Other|0|||
19684052|NCT00448916|42131160|FG000|Overall Study|Lost to Follow-up|0|||
19684053|NCT00448916|42131161|FG001|Overall Study|Lost to Follow-up|1|||
19684054|NCT00448916|42131162|FG002|Overall Study|Lost to Follow-up|0|||
19684055|NCT00448916|42131163|FG003|Overall Study|Lost to Follow-up|1|||
19684056|NCT00448916|42131160|FG000|Overall Study|Protocol Violation|0|||
19684057|NCT00448916|42131161|FG001|Overall Study|Protocol Violation|0|||
19684058|NCT00448916|42131162|FG002|Overall Study|Protocol Violation|0|||
19684059|NCT00448916|42131163|FG003|Overall Study|Protocol Violation|1|||
19684060|NCT00418938|42131177|FG000|Overall Study|Reimbursement|1|||
19684061|NCT00418938|42131178|FG001|Overall Study|Reimbursement|0|||
19684062|NCT00418938|42131177|FG000|Overall Study|Administrative decision|3|||
19684063|NCT00418938|42131178|FG001|Overall Study|Administrative decision|3|||
19684064|NCT00418938|42131177|FG000|Overall Study|Withdrawal by Subject|16|||
19684065|NCT00418938|42131178|FG001|Overall Study|Withdrawal by Subject|15|||
19684066|NCT00418938|42131177|FG000|Overall Study|Lost to Follow-up|1|||
19684067|NCT00418938|42131178|FG001|Overall Study|Lost to Follow-up|3|||
19684068|NCT00418938|42131177|FG000|Overall Study|Adverse Event|1|||
19684069|NCT00418938|42131178|FG001|Overall Study|Adverse Event|1|||
19684070|NCT00418938|42131177|FG000|Overall Study|On-going|1|||
19684071|NCT00418938|42131178|FG001|Overall Study|On-going|1|||
19684072|NCT00418938|42131177|FG000|Overall Study|Ineligibility Determined|1|||
19684073|NCT00418938|42131178|FG001|Overall Study|Ineligibility Determined|0|||
19684074|NCT00448760|42131184|FG000|Overall Study|Death|3|||
19684075|NCT00418314|42131190|FG000|Overall Study|Withdrawal by Subject|1|||
19684076|NCT00418314|42131191|FG001|Overall Study|Withdrawal by Subject|2|||
19684077|NCT00448448|42131199|FG000|Overall Study|Withdrawal by Subject|13|||
19684078|NCT00448448|42131200|FG001|Overall Study|Withdrawal by Subject|2|||
19684079|NCT00448448|42131199|FG000|Overall Study|On protocol when study ended|83|||
19684080|NCT00448448|42131200|FG001|Overall Study|On protocol when study ended|36|||
19684081|NCT00448448|42131199|FG000|Overall Study|Lost to Follow-up|2|||
19684082|NCT00448448|42131200|FG001|Overall Study|Lost to Follow-up|1|||
19684083|NCT00448448|42131199|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
19684084|NCT00448448|42131200|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
19684085|NCT00448448|42131199|FG000|Overall Study|Signed consent lost|0|||
19684086|NCT00448448|42131200|FG001|Overall Study|Signed consent lost|1|||
19684087|NCT00405912|42131209|FG000|Overall Study|Withdrawal by Subject|12|||
19684088|NCT00405912|42131210|FG001|Overall Study|Withdrawal by Subject|11|||
19684089|NCT00405912|42131211|FG002|Overall Study|Withdrawal by Subject|12|||
19684090|NCT00405912|42131209|FG000|Overall Study|Lost to Follow-up|4|||
19684091|NCT00405912|42131210|FG001|Overall Study|Lost to Follow-up|8|||
19684092|NCT00405912|42131211|FG002|Overall Study|Lost to Follow-up|4|||
19684093|NCT00448136|42131221|FG000|Overall Study|Death|3|||
19684094|NCT00448136|42131222|FG001|Overall Study|Death|8|||
19684095|NCT00448136|42131221|FG000|Overall Study|Investigator's decision (progression)|1|||
19684096|NCT00448136|42131222|FG001|Overall Study|Investigator's decision (progression)|0|||
19684097|NCT00447902|42131230|FG000|Overall Study|Adverse Event|0|||
19684098|NCT00447902|42131231|FG001|Overall Study|Adverse Event|3|||
19684099|NCT00447902|42131230|FG000|Overall Study|Protocol Violation|1|||
19684100|NCT00447902|42131231|FG001|Overall Study|Protocol Violation|0|||
19684101|NCT00447902|42131230|FG000|Overall Study|Withdrawal by Subject|0|||
19684102|NCT00447902|42131231|FG001|Overall Study|Withdrawal by Subject|1|||
19684103|NCT00447902|42131230|FG000|Overall Study|included patients who discontinued|1|||
19684104|NCT00447902|42131231|FG001|Overall Study|included patients who discontinued|1|||
19684105|NCT00447902|42131230|FG000|Overall Study|Lack of Efficacy|2|||
19684106|NCT00447902|42131231|FG001|Overall Study|Lack of Efficacy|1|||
19684107|NCT00307437|42131240|FG000|Controlled Period|Adverse Event|7|||
19684108|NCT00307437|42131241|FG001|Controlled Period|Adverse Event|2|||
19684109|NCT00307437|42131242|FG002|Controlled Period|Adverse Event|5|||
19684110|NCT00307437|42131243|FG003|Controlled Period|Adverse Event|0|||
19684111|NCT00307437|42131244|FG004|Controlled Period|Adverse Event|0|||
19684112|NCT00307437|42131245|FG005|Controlled Period|Adverse Event|0|||
19684113|NCT00307437|42131246|FG006|Controlled Period|Adverse Event|0|||
19684114|NCT00307437|42131240|FG000|Controlled Period|Death|0|||
19684115|NCT00307437|42131241|FG001|Controlled Period|Death|0|||
19684116|NCT00307437|42131242|FG002|Controlled Period|Death|1|||
19684117|NCT00307437|42131243|FG003|Controlled Period|Death|0|||
19684118|NCT00307437|42131244|FG004|Controlled Period|Death|0|||
19684119|NCT00307437|42131245|FG005|Controlled Period|Death|0|||
19684120|NCT00307437|42131246|FG006|Controlled Period|Death|0|||
19684121|NCT00307437|42131240|FG000|Controlled Period|Lack of Efficacy|2|||
19684122|NCT00307437|42131241|FG001|Controlled Period|Lack of Efficacy|0|||
19684123|NCT00307437|42131242|FG002|Controlled Period|Lack of Efficacy|0|||
19684124|NCT00307437|42131243|FG003|Controlled Period|Lack of Efficacy|0|||
19684125|NCT00307437|42131244|FG004|Controlled Period|Lack of Efficacy|0|||
19684126|NCT00307437|42131245|FG005|Controlled Period|Lack of Efficacy|0|||
19684127|NCT00307437|42131246|FG006|Controlled Period|Lack of Efficacy|0|||
19684128|NCT00307437|42131240|FG000|Controlled Period|Lost to Follow-up|2|||
19768871|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
19768872|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
19684129|NCT00307437|42131241|FG001|Controlled Period|Lost to Follow-up|3|||
19768873|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
19768874|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
19768875|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
19768876|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
19768877|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
19768878|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
19768879|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
19768880|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
19768881|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
19768882|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
19768883|NCT02960438|42222462|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
19768884|NCT02960438|42222463|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
19768885|NCT02960438|42222464|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
19768886|NCT02960438|42222465|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
19768887|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
19768888|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
19768889|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
19768890|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
19768891|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
19768892|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
19768893|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
19768894|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
19768895|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
19768896|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
19768897|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
19768898|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
19768899|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
19768900|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
19768901|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
19768902|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
19768903|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
19768904|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
19768905|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
19768906|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
19768907|NCT02960438|42222462|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
19768908|NCT02960438|42222463|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
19768909|NCT02960438|42222464|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
19768910|NCT02960438|42222465|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
19768911|NCT02957942|42222485|FG000|Overall Study|Withdrawal by Subject|0|||
19768912|NCT02957942|42222486|FG001|Overall Study|Withdrawal by Subject|1|||
19768913|NCT02957942|42222485|FG000|Overall Study|Practicing experiment protocol|0|||
19684130|NCT00307437|42131242|FG002|Controlled Period|Lost to Follow-up|0|||
19684131|NCT00307437|42131243|FG003|Controlled Period|Lost to Follow-up|0|||
19684132|NCT00307437|42131244|FG004|Controlled Period|Lost to Follow-up|0|||
19684133|NCT00307437|42131245|FG005|Controlled Period|Lost to Follow-up|0|||
19768914|NCT02957942|42222486|FG001|Overall Study|Practicing experiment protocol|6|||
19768915|NCT02959970|42222494|FG000|Overall Study|Adverse Event|1|||
19768916|NCT02959970|42222495|FG001|Overall Study|Adverse Event|0|||
19768917|NCT02959970|42222494|FG000|Overall Study|Withdrawal by Subject|0|||
19768918|NCT02959970|42222495|FG001|Overall Study|Withdrawal by Subject|2|||
19768919|NCT02959970|42222494|FG000|Overall Study|Lost to Follow-up|1|||
19768920|NCT02959970|42222495|FG001|Overall Study|Lost to Follow-up|5|||
19768921|NCT03580369|42222521|FG000|Overall Study|No treatment due to mis-randomization|1|||
19768922|NCT03580369|42222522|FG001|Overall Study|No treatment due to mis-randomization|0|||
19768923|NCT03580369|42222523|FG002|Overall Study|No treatment due to mis-randomization|0|||
19768924|NCT03580369|42222524|FG003|Overall Study|No treatment due to mis-randomization|0|||
19768925|NCT03580369|42222525|FG004|Overall Study|No treatment due to mis-randomization|3|||
19768926|NCT03580369|42222526|FG005|Overall Study|No treatment due to mis-randomization|0|||
19768927|NCT03580369|42222527|FG006|Overall Study|No treatment due to mis-randomization|0|||
19768928|NCT03580369|42222528|FG007|Overall Study|No treatment due to mis-randomization|0|||
19768929|NCT03580369|42222521|FG000|Overall Study|Reason unknown|0|||
19768930|NCT03580369|42222522|FG001|Overall Study|Reason unknown|0|||
19684134|NCT00307437|42131246|FG006|Controlled Period|Lost to Follow-up|0|||
19684135|NCT00307437|42131240|FG000|Controlled Period|Other|5|||
19684136|NCT00307437|42131241|FG001|Controlled Period|Other|1|||
19684137|NCT00307437|42131242|FG002|Controlled Period|Other|3|||
19684138|NCT00307437|42131243|FG003|Controlled Period|Other|0|||
19684139|NCT00307437|42131244|FG004|Controlled Period|Other|0|||
19684140|NCT00307437|42131245|FG005|Controlled Period|Other|0|||
19684141|NCT00307437|42131246|FG006|Controlled Period|Other|0|||
19684142|NCT00307437|42131240|FG000|After Controlled Period|Adverse Event|0|||
19684143|NCT00307437|42131241|FG001|After Controlled Period|Adverse Event|0|||
19684144|NCT00307437|42131242|FG002|After Controlled Period|Adverse Event|0|||
19684145|NCT00307437|42131243|FG003|After Controlled Period|Adverse Event|18|||
19684146|NCT00307437|42131244|FG004|After Controlled Period|Adverse Event|16|||
19684147|NCT00307437|42131245|FG005|After Controlled Period|Adverse Event|31|||
19684148|NCT00307437|42131246|FG006|After Controlled Period|Adverse Event|40|||
19684149|NCT00307437|42131240|FG000|After Controlled Period|Death|0|||
19684150|NCT00307437|42131241|FG001|After Controlled Period|Death|0|||
19684151|NCT00307437|42131242|FG002|After Controlled Period|Death|0|||
19684152|NCT00307437|42131243|FG003|After Controlled Period|Death|3|||
19684153|NCT00307437|42131244|FG004|After Controlled Period|Death|1|||
19684154|NCT00307437|42131245|FG005|After Controlled Period|Death|1|||
19684155|NCT00307437|42131246|FG006|After Controlled Period|Death|3|||
19684156|NCT00307437|42131240|FG000|After Controlled Period|Lack of Efficacy|0|||
19684157|NCT00307437|42131241|FG001|After Controlled Period|Lack of Efficacy|0|||
19684158|NCT00307437|42131242|FG002|After Controlled Period|Lack of Efficacy|0|||
19684159|NCT00307437|42131243|FG003|After Controlled Period|Lack of Efficacy|15|||
19684160|NCT00307437|42131244|FG004|After Controlled Period|Lack of Efficacy|17|||
19684161|NCT00307437|42131245|FG005|After Controlled Period|Lack of Efficacy|37|||
19684162|NCT00307437|42131246|FG006|After Controlled Period|Lack of Efficacy|24|||
19684163|NCT00307437|42131240|FG000|After Controlled Period|Lost to Follow-up|0|||
19684164|NCT00307437|42131241|FG001|After Controlled Period|Lost to Follow-up|0|||
19684165|NCT00307437|42131242|FG002|After Controlled Period|Lost to Follow-up|0|||
19684166|NCT00307437|42131243|FG003|After Controlled Period|Lost to Follow-up|7|||
19684167|NCT00307437|42131244|FG004|After Controlled Period|Lost to Follow-up|12|||
19684168|NCT00307437|42131245|FG005|After Controlled Period|Lost to Follow-up|13|||
19684169|NCT00307437|42131246|FG006|After Controlled Period|Lost to Follow-up|18|||
19684170|NCT00307437|42131240|FG000|After Controlled Period|Other|0|||
19684171|NCT00307437|42131241|FG001|After Controlled Period|Other|0|||
19684172|NCT00307437|42131242|FG002|After Controlled Period|Other|0|||
19684173|NCT00307437|42131243|FG003|After Controlled Period|Other|15|||
19684174|NCT00307437|42131244|FG004|After Controlled Period|Other|9|||
19768931|NCT03580369|42222523|FG002|Overall Study|Reason unknown|1|||
19768932|NCT03580369|42222524|FG003|Overall Study|Reason unknown|0|||
19768933|NCT03580369|42222525|FG004|Overall Study|Reason unknown|0|||
19768934|NCT03580369|42222526|FG005|Overall Study|Reason unknown|0|||
19768935|NCT03580369|42222527|FG006|Overall Study|Reason unknown|0|||
19768936|NCT03580369|42222528|FG007|Overall Study|Reason unknown|0|||
19768937|NCT03580369|42222521|FG000|Overall Study|Technical problems|0|||
19768938|NCT03580369|42222522|FG001|Overall Study|Technical problems|0|||
19768939|NCT03580369|42222523|FG002|Overall Study|Technical problems|0|||
19768940|NCT03580369|42222524|FG003|Overall Study|Technical problems|0|||
19768941|NCT03580369|42222525|FG004|Overall Study|Technical problems|1|||
19768942|NCT03580369|42222526|FG005|Overall Study|Technical problems|0|||
19768943|NCT03580369|42222527|FG006|Overall Study|Technical problems|2|||
19768944|NCT03580369|42222528|FG007|Overall Study|Technical problems|0|||
19768945|NCT03580369|42222521|FG000|Overall Study|Pregnancy|2|||
19768946|NCT03580369|42222522|FG001|Overall Study|Pregnancy|0|||
19768947|NCT03580369|42222523|FG002|Overall Study|Pregnancy|3|||
19684175|NCT00307437|42131245|FG005|After Controlled Period|Other|40|||
19684176|NCT00307437|42131246|FG006|After Controlled Period|Other|28|||
19768948|NCT03580369|42222524|FG003|Overall Study|Pregnancy|0|||
19768949|NCT03580369|42222525|FG004|Overall Study|Pregnancy|2|||
19768950|NCT03580369|42222526|FG005|Overall Study|Pregnancy|0|||
19684177|NCT00440726|42131271|FG000|Phase 1|Dose-Limiting Toxicity|0|||
19684178|NCT00440726|42131272|FG001|Phase 1|Dose-Limiting Toxicity|1|||
19684179|NCT00440726|42131273|FG002|Phase 1|Dose-Limiting Toxicity|0|||
19684180|NCT00440726|42131271|FG000|Phase 1|Physician Decision|1|||
19684181|NCT00440726|42131272|FG001|Phase 1|Physician Decision|0|||
19684182|NCT00440726|42131273|FG002|Phase 1|Physician Decision|0|||
19684183|NCT00440726|42131271|FG000|Phase 2|Death|0|||
19684184|NCT00440726|42131272|FG001|Phase 2|Death|0|||
19684185|NCT00440726|42131273|FG002|Phase 2|Death|1|||
19684186|NCT00440726|42131271|FG000|Phase 2|Adverse Event|0|||
19684187|NCT00440726|42131272|FG001|Phase 2|Adverse Event|0|||
19684188|NCT00440726|42131273|FG002|Phase 2|Adverse Event|1|||
19684189|NCT00447590|42131284|FG000|Overall Study|Withdrawal by Subject|26|||
19684190|NCT00447590|42131284|FG000|Overall Study|Lost to Follow-up|24|||
19684191|NCT00447590|42131284|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
19684192|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
19684193|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
19684194|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
19684195|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
19684196|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
19684197|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
19684198|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
19684199|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
19684200|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
19684201|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
19684202|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
19684203|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
19684204|NCT00447278|42131290|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
19684205|NCT00447278|42131291|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
19684206|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
19684207|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
19684208|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
19684209|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
19684210|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
19684211|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
19684212|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
19684213|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
19684214|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
19684215|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
19684216|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
19684217|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
19684218|NCT00447278|42131290|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
19684219|NCT00447278|42131291|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
19684220|NCT00446966|42131300|FG000|Overall Study|Lost to Follow-up|10|||
19684221|NCT00446966|42131301|FG001|Overall Study|Lost to Follow-up|7|||
19684222|NCT00446654|42131309|FG000|Overall Study|Withdrawal by Subject|1|||
19684223|NCT00446654|42131310|FG001|Overall Study|Withdrawal by Subject|0|||
19684224|NCT00446654|42131309|FG000|Overall Study|Adverse Event|1|||
19684225|NCT00446654|42131310|FG001|Overall Study|Adverse Event|0|||
19684226|NCT00405756|42131319|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
19684227|NCT00405756|42131320|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
19684228|NCT00405756|42131321|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
19684229|NCT00405756|42131319|FG000|Double-blind Treatment|Adverse Event|31|||
19684230|NCT00405756|42131320|FG001|Double-blind Treatment|Adverse Event|27|||
19684231|NCT00405756|42131321|FG002|Double-blind Treatment|Adverse Event|12|||
19684232|NCT00405756|42131319|FG000|Double-blind Treatment|Disease Progression|47|||
19684233|NCT00405756|42131320|FG001|Double-blind Treatment|Disease Progression|81|||
19684234|NCT00405756|42131321|FG002|Double-blind Treatment|Disease Progression|102|||
19684235|NCT00405756|42131319|FG000|Double-blind Treatment|Lack of Efficacy|1|||
19684236|NCT00405756|42131320|FG001|Double-blind Treatment|Lack of Efficacy|4|||
19684237|NCT00405756|42131321|FG002|Double-blind Treatment|Lack of Efficacy|2|||
19684238|NCT00405756|42131319|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
19684239|NCT00405756|42131320|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
19684240|NCT00405756|42131321|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
19684241|NCT00405756|42131319|FG000|Double-blind Treatment|Lost to Follow-up|1|||
19684242|NCT00405756|42131320|FG001|Double-blind Treatment|Lost to Follow-up|0|||
19684243|NCT00405756|42131321|FG002|Double-blind Treatment|Lost to Follow-up|0|||
19768951|NCT03580369|42222527|FG006|Overall Study|Pregnancy|0|||
19768952|NCT03580369|42222528|FG007|Overall Study|Pregnancy|0|||
19768953|NCT03580369|42222521|FG000|Overall Study|Lost to Follow-up|2|||
19684244|NCT00405756|42131319|FG000|Double-blind Treatment|Death|4|||
19684245|NCT00405756|42131320|FG001|Double-blind Treatment|Death|4|||
19684246|NCT00405756|42131321|FG002|Double-blind Treatment|Death|4|||
19684247|NCT00405756|42131319|FG000|Double-blind Treatment|Protocol Violation|1|||
19684248|NCT00405756|42131320|FG001|Double-blind Treatment|Protocol Violation|0|||
19684249|NCT00405756|42131321|FG002|Double-blind Treatment|Protocol Violation|2|||
19684250|NCT00405756|42131319|FG000|Double-blind Treatment|Other|7|||
19684251|NCT00405756|42131320|FG001|Double-blind Treatment|Other|4|||
19684252|NCT00405756|42131321|FG002|Double-blind Treatment|Other|4|||
19684253|NCT00405756|42131319|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
19684254|NCT00405756|42131320|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
19684255|NCT00405756|42131321|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
19684256|NCT00405756|42131319|FG000|Open-label Extension|Adverse Event|1|||
19768954|NCT03580369|42222522|FG001|Overall Study|Lost to Follow-up|0|||
19768955|NCT03580369|42222523|FG002|Overall Study|Lost to Follow-up|2|||
19768956|NCT03580369|42222524|FG003|Overall Study|Lost to Follow-up|0|||
19768957|NCT03580369|42222525|FG004|Overall Study|Lost to Follow-up|3|||
19768958|NCT03580369|42222526|FG005|Overall Study|Lost to Follow-up|0|||
19768959|NCT03580369|42222527|FG006|Overall Study|Lost to Follow-up|1|||
19768960|NCT03580369|42222528|FG007|Overall Study|Lost to Follow-up|0|||
19768961|NCT03580369|42222521|FG000|Overall Study|Physician Decision|4|||
19768962|NCT03580369|42222522|FG001|Overall Study|Physician Decision|0|||
19768963|NCT03580369|42222523|FG002|Overall Study|Physician Decision|4|||
19768964|NCT03580369|42222524|FG003|Overall Study|Physician Decision|1|||
19768965|NCT03580369|42222525|FG004|Overall Study|Physician Decision|1|||
19768966|NCT03580369|42222526|FG005|Overall Study|Physician Decision|0|||
19768967|NCT03580369|42222527|FG006|Overall Study|Physician Decision|0|||
19768968|NCT03580369|42222528|FG007|Overall Study|Physician Decision|0|||
19768969|NCT03580369|42222521|FG000|Overall Study|Lack of Efficacy|3|||
19768970|NCT03580369|42222522|FG001|Overall Study|Lack of Efficacy|0|||
19768971|NCT03580369|42222523|FG002|Overall Study|Lack of Efficacy|7|||
19768972|NCT03580369|42222524|FG003|Overall Study|Lack of Efficacy|0|||
19768973|NCT03580369|42222525|FG004|Overall Study|Lack of Efficacy|2|||
19768974|NCT03580369|42222526|FG005|Overall Study|Lack of Efficacy|0|||
19768975|NCT03580369|42222527|FG006|Overall Study|Lack of Efficacy|3|||
19768976|NCT03580369|42222528|FG007|Overall Study|Lack of Efficacy|0|||
19768977|NCT03580369|42222521|FG000|Overall Study|Protocol Violation|6|||
19768978|NCT03580369|42222522|FG001|Overall Study|Protocol Violation|0|||
19768979|NCT03580369|42222523|FG002|Overall Study|Protocol Violation|6|||
19768980|NCT03580369|42222524|FG003|Overall Study|Protocol Violation|1|||
19768981|NCT03580369|42222525|FG004|Overall Study|Protocol Violation|8|||
19768982|NCT03580369|42222526|FG005|Overall Study|Protocol Violation|2|||
19768983|NCT03580369|42222527|FG006|Overall Study|Protocol Violation|1|||
19768984|NCT03580369|42222528|FG007|Overall Study|Protocol Violation|0|||
19768985|NCT03580369|42222521|FG000|Overall Study|Adverse Event|7|||
19768986|NCT03580369|42222522|FG001|Overall Study|Adverse Event|0|||
19768987|NCT03580369|42222523|FG002|Overall Study|Adverse Event|14|||
19768988|NCT03580369|42222524|FG003|Overall Study|Adverse Event|1|||
19768989|NCT03580369|42222525|FG004|Overall Study|Adverse Event|6|||
19768990|NCT03580369|42222526|FG005|Overall Study|Adverse Event|0|||
19768991|NCT03580369|42222527|FG006|Overall Study|Adverse Event|1|||
19768992|NCT03580369|42222528|FG007|Overall Study|Adverse Event|0|||
19768993|NCT03580369|42222521|FG000|Overall Study|Withdrawal by Subject|19|||
19768994|NCT03580369|42222522|FG001|Overall Study|Withdrawal by Subject|0|||
19768995|NCT03580369|42222523|FG002|Overall Study|Withdrawal by Subject|17|||
19768996|NCT03580369|42222524|FG003|Overall Study|Withdrawal by Subject|0|||
19768997|NCT03580369|42222525|FG004|Overall Study|Withdrawal by Subject|16|||
19768998|NCT03580369|42222526|FG005|Overall Study|Withdrawal by Subject|1|||
19768999|NCT03580369|42222527|FG006|Overall Study|Withdrawal by Subject|7|||
19769000|NCT03580369|42222528|FG007|Overall Study|Withdrawal by Subject|0|||
19769001|NCT02925312|42222541|FG000|Overall Study|Lost to Follow-up|25|||
19769002|NCT02925312|42222542|FG001|Overall Study|Lost to Follow-up|0|||
19769003|NCT02925312|42222541|FG000|Overall Study|Adverse Event|2|||
19684257|NCT00405756|42131320|FG001|Open-label Extension|Adverse Event|3|||
19769004|NCT02925312|42222542|FG001|Overall Study|Adverse Event|0|||
19769005|NCT03196297|42222557|FG000|Main Period|Withdrawal by Subject|4|||
19769006|NCT03196297|42222557|FG000|Extension Period|Withdrawal by Subject|1|||
19769007|NCT03196297|42222557|FG000|Extension Period|Lack of Efficacy|2|||
19769008|NCT03192475|42222582|FG000|Overall Study|Death|0|||
19769009|NCT03192475|42222583|FG001|Overall Study|Death|1|||
19769010|NCT03192475|42222582|FG000|Overall Study|Lost to Follow-up|13|||
19769011|NCT03192475|42222583|FG001|Overall Study|Lost to Follow-up|8|||
19769012|NCT03189745|42222592|FG000|Overall Study|Conflict in work schedule of participant|1|||
19769013|NCT03189745|42222593|FG001|Overall Study|Conflict in work schedule of participant|1|||
19769014|NCT03188263|42222601|FG000|Overall Study|Withdrawal by Subject|3|||
19769015|NCT03188263|42222602|FG001|Overall Study|Withdrawal by Subject|0|||
19684258|NCT00405756|42131321|FG002|Open-label Extension|Adverse Event|7|||
19769016|NCT03188263|42222601|FG000|Overall Study|Physician Decision|1|||
19769017|NCT03188263|42222602|FG001|Overall Study|Physician Decision|0|||
19769018|NCT03188185|42222610|FG000|Stage 1|Adverse Event|4|||
19769019|NCT03188185|42222611|FG001|Stage 1|Adverse Event|12|||
19769020|NCT03188185|42222612|FG002|Stage 1|Adverse Event|0|||
19769021|NCT03188185|42222613|FG003|Stage 1|Adverse Event|0|||
19769022|NCT03188185|42222610|FG000|Stage 1|Lack of Efficacy|0|||
19769023|NCT03188185|42222611|FG001|Stage 1|Lack of Efficacy|2|||
19769024|NCT03188185|42222612|FG002|Stage 1|Lack of Efficacy|0|||
19769025|NCT03188185|42222613|FG003|Stage 1|Lack of Efficacy|0|||
19769026|NCT03188185|42222610|FG000|Stage 1|Lost to Follow-up|6|||
19769027|NCT03188185|42222611|FG001|Stage 1|Lost to Follow-up|1|||
19769028|NCT03188185|42222612|FG002|Stage 1|Lost to Follow-up|0|||
19769029|NCT03188185|42222613|FG003|Stage 1|Lost to Follow-up|0|||
19769030|NCT03188185|42222610|FG000|Stage 1|Withdrawal by Subject|9|||
19769031|NCT03188185|42222611|FG001|Stage 1|Withdrawal by Subject|0|||
19769032|NCT03188185|42222612|FG002|Stage 1|Withdrawal by Subject|0|||
19769033|NCT03188185|42222613|FG003|Stage 1|Withdrawal by Subject|0|||
19769034|NCT03188185|42222610|FG000|Stage 1|Identified as a professional patient|0|||
19769035|NCT03188185|42222611|FG001|Stage 1|Identified as a professional patient|1|||
19769036|NCT03188185|42222612|FG002|Stage 1|Identified as a professional patient|0|||
19769037|NCT03188185|42222613|FG003|Stage 1|Identified as a professional patient|0|||
19769038|NCT03188185|42222610|FG000|Stage 2|Adverse Event|0|||
19769039|NCT03188185|42222611|FG001|Stage 2|Adverse Event|0|||
19769040|NCT03188185|42222612|FG002|Stage 2|Adverse Event|2|||
19769041|NCT03188185|42222613|FG003|Stage 2|Adverse Event|4|||
19769042|NCT03188185|42222610|FG000|Stage 2|Lack of Efficacy|0|||
19769043|NCT03188185|42222611|FG001|Stage 2|Lack of Efficacy|0|||
19769044|NCT03188185|42222612|FG002|Stage 2|Lack of Efficacy|3|||
19769045|NCT03188185|42222613|FG003|Stage 2|Lack of Efficacy|0|||
19769046|NCT03188185|42222610|FG000|Stage 2|Lost to Follow-up|0|||
19769047|NCT03188185|42222611|FG001|Stage 2|Lost to Follow-up|0|||
19769048|NCT03188185|42222612|FG002|Stage 2|Lost to Follow-up|1|||
19769049|NCT03188185|42222613|FG003|Stage 2|Lost to Follow-up|0|||
19769050|NCT03188185|42222610|FG000|Stage 2|Physician Decision|0|||
19769051|NCT03188185|42222611|FG001|Stage 2|Physician Decision|0|||
19769052|NCT03188185|42222612|FG002|Stage 2|Physician Decision|0|||
19769053|NCT03188185|42222613|FG003|Stage 2|Physician Decision|1|||
19769054|NCT03188185|42222610|FG000|Stage 2|Withdrawal by Subject|0|||
19769055|NCT03188185|42222611|FG001|Stage 2|Withdrawal by Subject|0|||
19769056|NCT03188185|42222612|FG002|Stage 2|Withdrawal by Subject|3|||
19769057|NCT03188185|42222613|FG003|Stage 2|Withdrawal by Subject|1|||
19769058|NCT03186781|42222629|FG000|Overall Study|Lost to Follow-up|0|||
19769059|NCT03186781|42222630|FG001|Overall Study|Lost to Follow-up|0|||
19769060|NCT03186781|42222631|FG002|Overall Study|Lost to Follow-up|1|||
19769061|NCT03186781|42222632|FG003|Overall Study|Lost to Follow-up|0|||
19769062|NCT03186781|42222633|FG004|Overall Study|Lost to Follow-up|1|||
19769063|NCT03186781|42222634|FG005|Overall Study|Lost to Follow-up|0|||
19769064|NCT03186781|42222629|FG000|Overall Study|Moved from Area|0|||
19769065|NCT03186781|42222630|FG001|Overall Study|Moved from Area|0|||
19769066|NCT03186781|42222631|FG002|Overall Study|Moved from Area|0|||
19769067|NCT03186781|42222632|FG003|Overall Study|Moved from Area|0|||
19769068|NCT03186781|42222633|FG004|Overall Study|Moved from Area|1|||
19769069|NCT03186781|42222634|FG005|Overall Study|Moved from Area|0|||
19769070|NCT03186781|42222629|FG000|Overall Study|Withdrawal by Subject|0|||
19769071|NCT03186781|42222630|FG001|Overall Study|Withdrawal by Subject|0|||
19769072|NCT03186781|42222631|FG002|Overall Study|Withdrawal by Subject|0|||
19769073|NCT03186781|42222632|FG003|Overall Study|Withdrawal by Subject|0|||
19769074|NCT03186781|42222633|FG004|Overall Study|Withdrawal by Subject|1|||
19769075|NCT03186781|42222634|FG005|Overall Study|Withdrawal by Subject|0|||
19769076|NCT03184987|42222661|FG000|Overall Study|Withdrawal by Subject|0|||
19769077|NCT03184987|42222662|FG001|Overall Study|Withdrawal by Subject|1|||
19769078|NCT03184987|42222663|FG002|Overall Study|Withdrawal by Subject|2|||
19769079|NCT03184987|42222661|FG000|Overall Study|Physician Decision|0|||
19769080|NCT03184987|42222662|FG001|Overall Study|Physician Decision|0|||
19769081|NCT03184987|42222663|FG002|Overall Study|Physician Decision|1|||
19769082|NCT03184987|42222661|FG000|Overall Study|Adverse Event|1|||
19769083|NCT03184987|42222662|FG001|Overall Study|Adverse Event|0|||
19769084|NCT03184987|42222663|FG002|Overall Study|Adverse Event|1|||
19769085|NCT03184519|42222671|FG000|Overall Study|Lost to Follow-up|6|||
19769086|NCT03184519|42222671|FG000|Overall Study|Physician Decision|21|||
19769087|NCT03184441|42222675|FG000|Overall Study|Withdrawal by Subject|1|||
19769088|NCT03026166|42222684|FG000|Overall Study|Death|22|||
19769089|NCT03026166|42222685|FG001|Overall Study|Death|7|||
19769090|NCT03026166|42222684|FG000|Overall Study|Physician Decision|2|||
19769091|NCT03026166|42222685|FG001|Overall Study|Physician Decision|0|||
19769092|NCT03026166|42222684|FG000|Overall Study|Withdrawal by Subject|1|||
19769093|NCT03026166|42222685|FG001|Overall Study|Withdrawal by Subject|2|||
19769094|NCT03026166|42222684|FG000|Overall Study|Lost to Follow-up|1|||
19769095|NCT03026166|42222685|FG001|Overall Study|Lost to Follow-up|0|||
19769096|NCT03026166|42222684|FG000|Overall Study|Study Terminated by Sponsor|3|||
19684259|NCT00405756|42131319|FG000|Open-label Extension|Disease Progression|8|||
19684260|NCT00405756|42131320|FG001|Open-label Extension|Disease Progression|23|||
19684261|NCT00405756|42131321|FG002|Open-label Extension|Disease Progression|26|||
19684262|NCT00405756|42131319|FG000|Open-label Extension|Withdrawal by Subject|2|||
19684263|NCT00405756|42131320|FG001|Open-label Extension|Withdrawal by Subject|3|||
19684264|NCT00405756|42131321|FG002|Open-label Extension|Withdrawal by Subject|3|||
19684265|NCT00405756|42131319|FG000|Open-label Extension|Death|1|||
19684266|NCT00405756|42131320|FG001|Open-label Extension|Death|2|||
19684267|NCT00405756|42131321|FG002|Open-label Extension|Death|4|||
19684268|NCT00405756|42131319|FG000|Open-label Extension|Other|0|||
19684269|NCT00405756|42131320|FG001|Open-label Extension|Other|1|||
19684270|NCT00405756|42131321|FG002|Open-label Extension|Other|7|||
19684271|NCT00405756|42131319|FG000|Follow-up|Ongoing in Follow-up Period|52|||
19684272|NCT00405756|42131320|FG001|Follow-up|Ongoing in Follow-up Period|51|||
19684273|NCT00405756|42131321|FG002|Follow-up|Ongoing in Follow-up Period|60|||
19684274|NCT00405756|42131319|FG000|Follow-up|Death|21|||
19684275|NCT00405756|42131320|FG001|Follow-up|Death|31|||
19684276|NCT00405756|42131321|FG002|Follow-up|Death|24|||
19684277|NCT00405756|42131319|FG000|Follow-up|Lost to Follow-up|2|||
19684278|NCT00405756|42131320|FG001|Follow-up|Lost to Follow-up|8|||
19684279|NCT00405756|42131321|FG002|Follow-up|Lost to Follow-up|4|||
19684280|NCT00456092|42131332|FG000|Extension Phase|Grade 2 or Greater AE|2|||
19684281|NCT00456092|42131333|FG001|Extension Phase|Grade 2 or Greater AE|2|||
19684282|NCT00456092|42131334|FG002|Extension Phase|Grade 2 or Greater AE|0|||
19684283|NCT00456092|42131335|FG003|Extension Phase|Grade 2 or Greater AE|0|||
19684284|NCT00456092|42131336|FG004|Extension Phase|Grade 2 or Greater AE|2|||
19684285|NCT00456092|42131332|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
19684286|NCT00456092|42131333|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
19684287|NCT00456092|42131334|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
19684288|NCT00456092|42131335|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
19684289|NCT00456092|42131336|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
19684290|NCT00456092|42131332|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
19684291|NCT00456092|42131333|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
19684292|NCT00456092|42131334|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
19684293|NCT00456092|42131335|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
19684294|NCT00456092|42131336|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
19769097|NCT03026166|42222685|FG001|Overall Study|Study Terminated by Sponsor|3|||
19769098|NCT03026166|42222684|FG000|Overall Study|Other|1|||
19769099|NCT03026166|42222685|FG001|Overall Study|Other|0|||
19769100|NCT03026088|42222691|FG000|Overall Study|Study termination|20|||
19769101|NCT03181789|42222699|FG000|Overall Study|Withdrawal by Subject|0|||
19769102|NCT03181789|42222700|FG001|Overall Study|Withdrawal by Subject|1|||
19769103|NCT03181789|42222701|FG002|Overall Study|Withdrawal by Subject|1|||
19769104|NCT03181789|42222702|FG003|Overall Study|Withdrawal by Subject|0|||
19684295|NCT00456092|42131332|FG000|Extension Phase|Withdrew Consent|2|||
19684296|NCT00456092|42131333|FG001|Extension Phase|Withdrew Consent|0|||
19684297|NCT00456092|42131334|FG002|Extension Phase|Withdrew Consent|0|||
19684298|NCT00456092|42131335|FG003|Extension Phase|Withdrew Consent|0|||
19684299|NCT00456092|42131336|FG004|Extension Phase|Withdrew Consent|0|||
19684300|NCT00456092|42131332|FG000|Extension Phase|Lost to Follow-up|1|||
19684301|NCT00456092|42131333|FG001|Extension Phase|Lost to Follow-up|1|||
19684302|NCT00456092|42131334|FG002|Extension Phase|Lost to Follow-up|0|||
19684303|NCT00456092|42131335|FG003|Extension Phase|Lost to Follow-up|0|||
19684304|NCT00456092|42131336|FG004|Extension Phase|Lost to Follow-up|1|||
19684305|NCT00456092|42131332|FG000|Extension Phase|Other|2|||
19684306|NCT00456092|42131333|FG001|Extension Phase|Other|0|||
19684307|NCT00456092|42131334|FG002|Extension Phase|Other|0|||
19684308|NCT00456092|42131335|FG003|Extension Phase|Other|1|||
19684309|NCT00456092|42131336|FG004|Extension Phase|Other|1|||
19684310|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
19684311|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
19684312|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
19684313|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
19684314|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
19684315|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
19684316|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
19684317|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
19684318|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
19769105|NCT03181789|42222699|FG000|Overall Study|Lost to Follow-up|7|||
19769106|NCT03181789|42222700|FG001|Overall Study|Lost to Follow-up|1|||
19684319|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
19769107|NCT03181789|42222701|FG002|Overall Study|Lost to Follow-up|0|||
19684320|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
19684321|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
19684322|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
19684323|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
19684324|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
19684325|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
19684326|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
19684327|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
19684328|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
19684329|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
19684330|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
19684331|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
19684332|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
19684333|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
19684334|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
19684335|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
19684336|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
19684337|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
19684338|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
19684339|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
19684340|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
19684341|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
19684342|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
19684343|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
19684344|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
19684345|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
19684346|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
19684347|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
19684348|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
19684349|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
19684350|NCT00456092|42131332|FG000|Treatment Phase (12 Weeks)|Other|1|||
19684351|NCT00456092|42131333|FG001|Treatment Phase (12 Weeks)|Other|0|||
19684352|NCT00456092|42131334|FG002|Treatment Phase (12 Weeks)|Other|1|||
19684353|NCT00456092|42131335|FG003|Treatment Phase (12 Weeks)|Other|0|||
19684354|NCT00456092|42131336|FG004|Treatment Phase (12 Weeks)|Other|0|||
19684355|NCT00411450|42131350|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
19684356|NCT00404820|42131358|FG000|Overall Study|Adverse Event|4|||
19684357|NCT00404820|42131359|FG001|Overall Study|Adverse Event|16|||
19684358|NCT00404820|42131358|FG000|Overall Study|Withdrawal by Subject|5|||
19684359|NCT00404820|42131359|FG001|Overall Study|Withdrawal by Subject|3|||
19684360|NCT00404820|42131358|FG000|Overall Study|Lost to Follow-up|7|||
19684361|NCT00404820|42131359|FG001|Overall Study|Lost to Follow-up|3|||
19684362|NCT00404820|42131358|FG000|Overall Study|Administrative problems|2|||
19684363|NCT00404820|42131359|FG001|Overall Study|Administrative problems|0|||
19684364|NCT00404820|42131358|FG000|Overall Study|Death|1|||
19684365|NCT00404820|42131359|FG001|Overall Study|Death|0|||
19684366|NCT00404820|42131358|FG000|Overall Study|Other|0|||
19684367|NCT00404820|42131359|FG001|Overall Study|Other|2|||
19684368|NCT00417612|42131367|FG000|Overall Study|Errant diagnosis|0|||
19684369|NCT00417612|42131368|FG001|Overall Study|Errant diagnosis|1|||
19684370|NCT00417612|42131367|FG000|Overall Study|Adverse Event|2|||
19684371|NCT00417612|42131368|FG001|Overall Study|Adverse Event|0|||
19684372|NCT00417612|42131367|FG000|Overall Study|Protocol Violation|0|||
19684373|NCT00417612|42131368|FG001|Overall Study|Protocol Violation|2|||
19684374|NCT00417612|42131367|FG000|Overall Study|Lost to Follow-up|1|||
19684375|NCT00417612|42131368|FG001|Overall Study|Lost to Follow-up|0|||
19684376|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
19684377|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
19684378|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
19684379|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
19684380|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
19684381|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
19684382|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
19684383|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
19684384|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
19684385|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
19684386|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
19684387|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
19684388|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
19684389|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
19684390|NCT00446030|42131378|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
19684391|NCT00446030|42131379|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
19684392|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
19684393|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
19684394|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
19684395|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
19684396|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
19684397|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
19684398|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
19684399|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
19684400|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
19684401|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
19684402|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
19684403|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
19684404|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
19684405|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
19684406|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
19684407|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
19684408|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
19684409|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
19684410|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
19684411|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
19684412|NCT00446030|42131378|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
19684413|NCT00446030|42131379|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
19684414|NCT00411216|42131387|FG000|Overall Study|Ten participants were entered into the c|0|||
19684415|NCT00411216|42131388|FG001|Overall Study|Ten participants were entered into the c|2|||
19684416|NCT00410514|42131397|FG000|Overall Study|Adverse Event|2|||
19684417|NCT00410514|42131398|FG001|Overall Study|Adverse Event|2|||
19684418|NCT00410514|42131399|FG002|Overall Study|Adverse Event|2|||
19684419|NCT00410514|42131397|FG000|Overall Study|Protocol Violation|0|||
19684420|NCT00410514|42131398|FG001|Overall Study|Protocol Violation|1|||
19684421|NCT00410514|42131399|FG002|Overall Study|Protocol Violation|1|||
19684422|NCT00410514|42131397|FG000|Overall Study|Lost to Follow-up|0|||
19684423|NCT00410514|42131398|FG001|Overall Study|Lost to Follow-up|0|||
19684424|NCT00410514|42131399|FG002|Overall Study|Lost to Follow-up|2|||
19684425|NCT00410514|42131397|FG000|Overall Study|Non-compliant with study procedures|0|||
19684426|NCT00410514|42131398|FG001|Overall Study|Non-compliant with study procedures|0|||
19684427|NCT00410514|42131399|FG002|Overall Study|Non-compliant with study procedures|2|||
19684428|NCT03847610|42131407|FG000|Overall Study|Withdrawal by Subject|1|||
19684429|NCT03843632|42131415|FG000|Overall Study|Withdrawal by Subject|1|||
19684430|NCT03843632|42131416|FG001|Overall Study|Withdrawal by Subject|0|||
19684431|NCT03843632|42131417|FG002|Overall Study|Withdrawal by Subject|0|||
19684432|NCT03843632|42131418|FG003|Overall Study|Withdrawal by Subject|0|||
19684433|NCT00455858|42131428|FG000|Overall Study|Lost to Follow-up|2|||
19684434|NCT00455858|42131428|FG000|Overall Study|Protocol Violation|1|||
19684435|NCT00455858|42131428|FG000|Overall Study|Lack of Efficacy|1|||
19684436|NCT00455858|42131428|FG000|Overall Study|Well controlled FPG without insulin|1|||
19684437|NCT00455858|42131428|FG000|Overall Study|Withdrawal|1|||
19684438|NCT00439556|42131435|FG000|Overall Study|Patient was taken off study for non-comp|0|||
19684439|NCT00439556|42131436|FG001|Overall Study|Patient was taken off study for non-comp|1|||
19684440|NCT00439556|42131437|FG002|Overall Study|Patient was taken off study for non-comp|0|||
19684441|NCT00410202|42131449|FG000|On-Treatment|Continuing treatment|69|||
19684442|NCT00410202|42131450|FG001|On-Treatment|Continuing treatment|71|||
19684443|NCT00410202|42131451|FG002|On-Treatment|Continuing treatment|66|||
19684444|NCT00410202|42131449|FG000|On-Treatment|Adverse Event|1|||
19684445|NCT00410202|42131450|FG001|On-Treatment|Adverse Event|3|||
19684446|NCT00410202|42131451|FG002|On-Treatment|Adverse Event|2|||
19684447|NCT00410202|42131449|FG000|On-Treatment|Death|1|||
19684448|NCT00410202|42131450|FG001|On-Treatment|Death|0|||
19684449|NCT00410202|42131451|FG002|On-Treatment|Death|0|||
19684450|NCT00410202|42131449|FG000|On-Treatment|Lost to Follow-up|1|||
19684451|NCT00410202|42131450|FG001|On-Treatment|Lost to Follow-up|0|||
19684452|NCT00410202|42131451|FG002|On-Treatment|Lost to Follow-up|1|||
19684453|NCT00410202|42131449|FG000|On-Treatment|Lack of Efficacy|1|||
19684454|NCT00410202|42131450|FG001|On-Treatment|Lack of Efficacy|4|||
19684455|NCT00410202|42131451|FG002|On-Treatment|Lack of Efficacy|0|||
19684456|NCT00410202|42131449|FG000|On-Treatment|Withdrawal by Subject|2|||
19684457|NCT00410202|42131450|FG001|On-Treatment|Withdrawal by Subject|1|||
19684458|NCT00410202|42131451|FG002|On-Treatment|Withdrawal by Subject|1|||
19684459|NCT00410202|42131449|FG000|On-Treatment|Other Reason|0|||
19684460|NCT00410202|42131450|FG001|On-Treatment|Other Reason|0|||
19684461|NCT00410202|42131451|FG002|On-Treatment|Other Reason|1|||
19684462|NCT00410202|42131449|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
19684463|NCT00410202|42131450|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
19769108|NCT03181789|42222702|FG003|Overall Study|Lost to Follow-up|0|||
19684464|NCT00410202|42131451|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
19684465|NCT00410202|42131449|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
19684466|NCT00410202|42131450|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
19684467|NCT00410202|42131451|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
19684468|NCT00410202|42131449|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
19684469|NCT00410202|42131450|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
19684470|NCT00410202|42131451|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
19684471|NCT00445328|42131462|FG000|Overall Study|Death|0|||
19684472|NCT00445328|42131463|FG001|Overall Study|Death|1|||
19684473|NCT00445328|42131462|FG000|Overall Study|Adverse Event|0|||
19684474|NCT00445328|42131463|FG001|Overall Study|Adverse Event|3|||
19684475|NCT00445328|42131462|FG000|Overall Study|Other|0|||
19684476|NCT00445328|42131463|FG001|Overall Study|Other|2|||
19684477|NCT00445328|42131462|FG000|Overall Study|Withdrawal by Subject|2|||
19684478|NCT00445328|42131463|FG001|Overall Study|Withdrawal by Subject|0|||
19684479|NCT00445328|42131462|FG000|Overall Study|Protocol Violation|1|||
19684480|NCT00445328|42131463|FG001|Overall Study|Protocol Violation|0|||
19684481|NCT00455312|42131471|FG000|Overall Study|Death|0|||
19684482|NCT00455312|42131472|FG001|Overall Study|Death|1|||
19684483|NCT00444626|42131478|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
19684484|NCT00444626|42131478|FG000|Initial Treatment Period|Adverse Event|1|||
19684485|NCT00444626|42131478|FG000|Initial Treatment Period|Lost to Follow-up|9|||
19684486|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
19684487|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
19684488|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
19684489|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
19684490|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
19684491|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
19684492|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
19684493|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
19684494|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
19684495|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
19684496|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
19684497|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
19684498|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
19684499|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
19684500|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
19684501|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
19684502|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
19684503|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
19684504|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Death|0|||
19684505|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Death|0|||
19684506|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Death|1|||
19684507|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Death|0|||
19684508|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Death|0|||
19684509|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Death|0|||
19684510|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Death|0|||
19684511|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Death|0|||
19684512|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Death|0|||
19684513|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
19684514|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
19684515|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
19477249|NCT01482221|41756212|FG002|Overall Study|Withdrawal by Subject|12|||
19477250|NCT01482221|41756210|FG000|Overall Study|Incorrect randomization|0|||
19477251|NCT01482221|41756211|FG001|Overall Study|Incorrect randomization|1|||
19477252|NCT01482221|41756212|FG002|Overall Study|Incorrect randomization|0|||
19477253|NCT01482221|41756210|FG000|Overall Study|Physician Decision|0|||
19477254|NCT01482221|41756211|FG001|Overall Study|Physician Decision|1|||
19477255|NCT01482221|41756212|FG002|Overall Study|Physician Decision|0|||
19477256|NCT01482065|41756222|FG000|Overall Study|Withdrawal by Subject|0|||
19477257|NCT01482065|41756223|FG001|Overall Study|Withdrawal by Subject|1|||
19477258|NCT01545817|41756238|FG000|Pazopanib|Disease progression|51|||
19477259|NCT01545817|41756239|FG001|Pazopanib|Disease progression|0|||
19477260|NCT01545817|41756238|FG000|Pazopanib|Adverse Event|19|||
19477261|NCT01545817|41756239|FG001|Pazopanib|Adverse Event|0|||
19477262|NCT01545817|41756238|FG000|Pazopanib|Other reason|4|||
19477263|NCT01545817|41756239|FG001|Pazopanib|Other reason|0|||
19477264|NCT01545817|41756238|FG000|Everolimus|Other reason|0|||
19477265|NCT01545817|41756239|FG001|Everolimus|Other reason|7|||
19477266|NCT01545817|41756238|FG000|Everolimus|Disease progression|0|||
19477267|NCT01545817|41756239|FG001|Everolimus|Disease progression|25|||
19477268|NCT01545817|41756238|FG000|Everolimus|Adverse Event|0|||
19477269|NCT01545817|41756239|FG001|Everolimus|Adverse Event|6|||
19477270|NCT01512979|41756258|FG000|Overall Study|Adverse Event|2|||
19477271|NCT01512979|41756259|FG001|Overall Study|Adverse Event|2|||
19477272|NCT01512979|41756258|FG000|Overall Study|Protocol Violation|1|||
19477273|NCT01512979|41756259|FG001|Overall Study|Protocol Violation|4|||
19477274|NCT01512979|41756258|FG000|Overall Study|Lost to Follow-up|2|||
19477275|NCT01512979|41756259|FG001|Overall Study|Lost to Follow-up|5|||
19477276|NCT01512979|41756258|FG000|Overall Study|Withdrawal by Subject|1|||
19477277|NCT01512979|41756259|FG001|Overall Study|Withdrawal by Subject|2|||
19477278|NCT01512979|41756258|FG000|Overall Study|Reason other than stated above|13|||
19477279|NCT01512979|41756259|FG001|Overall Study|Reason other than stated above|9|||
19684516|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684517|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684518|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684519|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684520|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684521|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
19684522|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
19684523|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
19684524|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
19684525|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684526|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684527|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684528|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684529|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684530|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
19684531|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
19684532|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
19684533|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
19684534|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
19684535|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
19684536|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
19684537|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
19684538|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
19684539|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
19684540|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
19684541|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
19684542|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
19684543|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
19684544|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
19684545|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
19684546|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
19684547|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
19684548|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
19684549|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
19684550|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
19684551|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
19684552|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684553|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684554|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684555|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684556|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684557|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
19684558|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684559|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
19684560|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684561|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684562|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684563|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684564|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684565|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684566|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
19684567|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
19684568|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
19684569|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
19684570|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
19684571|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
19684572|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
19684573|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
19684574|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
19684575|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
19477280|NCT01512745|41756271|FG000|Overall Study|Adverse Event|22|||
19684576|NCT00404352|42131505|FG000|Double Blind (up to 24 Month)|Other|0|||
19684577|NCT00404352|42131506|FG001|Double Blind (up to 24 Month)|Other|1|||
19684578|NCT00404352|42131507|FG002|Double Blind (up to 24 Month)|Other|0|||
19684579|NCT00404352|42131508|FG003|Double Blind (up to 24 Month)|Other|0|||
19684580|NCT00404352|42131509|FG004|Double Blind (up to 24 Month)|Other|0|||
19684581|NCT00404352|42131510|FG005|Double Blind (up to 24 Month)|Other|0|||
19684582|NCT00404352|42131511|FG006|Double Blind (up to 24 Month)|Other|0|||
19684583|NCT00404352|42131512|FG007|Double Blind (up to 24 Month)|Other|0|||
19684584|NCT00404352|42131513|FG008|Double Blind (up to 24 Month)|Other|0|||
19684585|NCT00404352|42131505|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
19684586|NCT00404352|42131506|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
19684587|NCT00404352|42131507|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
19684588|NCT00404352|42131508|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
19684589|NCT00404352|42131509|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
19684590|NCT00404352|42131510|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
19684591|NCT00404352|42131511|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
19684592|NCT00404352|42131512|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
19684593|NCT00404352|42131513|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
19684594|NCT00404352|42131505|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
19684595|NCT00404352|42131506|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
19684596|NCT00404352|42131507|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
19684597|NCT00404352|42131508|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
19684598|NCT00404352|42131509|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
19684599|NCT00404352|42131510|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
19684600|NCT00404352|42131511|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
19684601|NCT00404352|42131512|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
19684602|NCT00404352|42131513|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
19684603|NCT00404352|42131505|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684604|NCT00404352|42131506|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684605|NCT00404352|42131507|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684606|NCT00404352|42131508|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684607|NCT00404352|42131509|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
19684608|NCT00404352|42131510|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684609|NCT00404352|42131511|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684610|NCT00404352|42131512|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684611|NCT00404352|42131513|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
19684612|NCT00404352|42131505|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684613|NCT00404352|42131506|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684614|NCT00404352|42131507|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684615|NCT00404352|42131508|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684616|NCT00404352|42131509|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684617|NCT00404352|42131510|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
19684618|NCT00404352|42131511|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684619|NCT00404352|42131512|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684620|NCT00404352|42131513|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
19684621|NCT00404352|42131505|FG000|Open Label (up to 24 Month)|Disease progression|0|||
19684622|NCT00404352|42131506|FG001|Open Label (up to 24 Month)|Disease progression|0|||
19684623|NCT00404352|42131507|FG002|Open Label (up to 24 Month)|Disease progression|0|||
19684624|NCT00404352|42131508|FG003|Open Label (up to 24 Month)|Disease progression|1|||
19684625|NCT00404352|42131509|FG004|Open Label (up to 24 Month)|Disease progression|0|||
19684626|NCT00404352|42131510|FG005|Open Label (up to 24 Month)|Disease progression|0|||
19684627|NCT00404352|42131511|FG006|Open Label (up to 24 Month)|Disease progression|0|||
19684628|NCT00404352|42131512|FG007|Open Label (up to 24 Month)|Disease progression|0|||
19684629|NCT00404352|42131513|FG008|Open Label (up to 24 Month)|Disease progression|0|||
19684630|NCT00404352|42131505|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684631|NCT00404352|42131506|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684632|NCT00404352|42131507|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684633|NCT00404352|42131508|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684634|NCT00404352|42131509|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684635|NCT00404352|42131510|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684636|NCT00404352|42131511|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
19684637|NCT00404352|42131512|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
19684638|NCT00404352|42131513|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
19684639|NCT00404352|42131505|FG000|Open Label Extension (up to 36 Months)|Other|0|||
19684640|NCT00404352|42131506|FG001|Open Label Extension (up to 36 Months)|Other|0|||
19684641|NCT00404352|42131507|FG002|Open Label Extension (up to 36 Months)|Other|0|||
19684642|NCT00404352|42131508|FG003|Open Label Extension (up to 36 Months)|Other|0|||
19684643|NCT00404352|42131509|FG004|Open Label Extension (up to 36 Months)|Other|0|||
19684644|NCT00404352|42131510|FG005|Open Label Extension (up to 36 Months)|Other|0|||
19684645|NCT00404352|42131511|FG006|Open Label Extension (up to 36 Months)|Other|0|||
19684646|NCT00404352|42131512|FG007|Open Label Extension (up to 36 Months)|Other|0|||
19684647|NCT00404352|42131513|FG008|Open Label Extension (up to 36 Months)|Other|2|||
19684648|NCT00439244|42131533|FG000|Overall Study|Adverse Event|5|||
19684649|NCT00439244|42131534|FG001|Overall Study|Adverse Event|2|||
19684650|NCT00439244|42131535|FG002|Overall Study|Adverse Event|3|||
19684651|NCT00439244|42131533|FG000|Overall Study|Withdrawal by Subject|3|||
19684652|NCT00439244|42131534|FG001|Overall Study|Withdrawal by Subject|1|||
19684653|NCT00439244|42131535|FG002|Overall Study|Withdrawal by Subject|2|||
19684654|NCT00439244|42131533|FG000|Overall Study|Lost to Follow-up|2|||
19684655|NCT00439244|42131534|FG001|Overall Study|Lost to Follow-up|1|||
19684656|NCT00439244|42131535|FG002|Overall Study|Lost to Follow-up|2|||
19684657|NCT00439244|42131533|FG000|Overall Study|Death|0|||
19684658|NCT00439244|42131534|FG001|Overall Study|Death|1|||
19684659|NCT00439244|42131535|FG002|Overall Study|Death|0|||
19684660|NCT00439244|42131533|FG000|Overall Study|Protocol Violation|0|||
19684661|NCT00439244|42131534|FG001|Overall Study|Protocol Violation|1|||
19684662|NCT00439244|42131535|FG002|Overall Study|Protocol Violation|0|||
19684663|NCT00439244|42131533|FG000|Overall Study|Administrative problems|1|||
19684664|NCT00439244|42131534|FG001|Overall Study|Administrative problems|0|||
19684665|NCT00439244|42131535|FG002|Overall Study|Administrative problems|0|||
19684666|NCT00438464|42131554|FG000|Overall Study|Terminated Early|14|||
19684667|NCT00438464|42131555|FG001|Overall Study|Terminated Early|5|||
19684668|NCT00438464|42131554|FG000|Overall Study|Incomplete data submission|0|||
19684669|NCT00438464|42131555|FG001|Overall Study|Incomplete data submission|2|||
19684670|NCT00437294|42131575|FG000|Overall Study|Adverse Event|5|||
19684671|NCT00437294|42131576|FG001|Overall Study|Adverse Event|4|||
19684672|NCT00437294|42131575|FG000|Overall Study|Death|5|||
19684673|NCT00437294|42131576|FG001|Overall Study|Death|2|||
19684674|NCT00437294|42131575|FG000|Overall Study|Physician Decision|0|||
19684675|NCT00437294|42131576|FG001|Overall Study|Physician Decision|3|||
19684676|NCT00437294|42131575|FG000|Overall Study|Withdrawal by Subject|5|||
19684677|NCT00437294|42131576|FG001|Overall Study|Withdrawal by Subject|0|||
19684678|NCT00437294|42131575|FG000|Overall Study|Progressive Disease|19|||
19684679|NCT00437294|42131576|FG001|Overall Study|Progressive Disease|23|||
19684680|NCT00437294|42131575|FG000|Overall Study|Sponsor Decision|8|||
19684681|NCT00437294|42131576|FG001|Overall Study|Sponsor Decision|9|||
19684682|NCT00437294|42131575|FG000|Overall Study|Protocol Violation|0|||
19684683|NCT00437294|42131576|FG001|Overall Study|Protocol Violation|1|||
19684684|NCT00437294|42131575|FG000|Overall Study|Entry criteria not met|1|||
19684685|NCT00437294|42131576|FG001|Overall Study|Entry criteria not met|1|||
19684686|NCT00436982|42131590|FG000|Overall Study|Withdrawal by Subject|3|||
19684687|NCT00436982|42131591|FG001|Overall Study|Withdrawal by Subject|1|||
19684688|NCT00436982|42131590|FG000|Overall Study|Did not receive allocated intervention|0|||
19684689|NCT00436982|42131591|FG001|Overall Study|Did not receive allocated intervention|1|||
19684690|NCT00436982|42131590|FG000|Overall Study|no RSA data|1|||
19684691|NCT00436982|42131591|FG001|Overall Study|no RSA data|2|||
19684692|NCT00443846|42131603|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
19684693|NCT00443846|42131604|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
19684694|NCT00443846|42131603|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
19684695|NCT00443846|42131604|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
19684696|NCT00443846|42131603|FG000|Overall Study|Adverse Event|0|||
19684697|NCT00443846|42131604|FG001|Overall Study|Adverse Event|1|||
19684698|NCT00443846|42131603|FG000|Overall Study|Personal reason|8|||
19684699|NCT00443846|42131604|FG001|Overall Study|Personal reason|3|||
19684700|NCT00443846|42131603|FG000|Overall Study|Lost to Follow-up|1|||
19684701|NCT00443846|42131604|FG001|Overall Study|Lost to Follow-up|2|||
19684702|NCT00436826|42131612|FG000|Double Blind Period (DBP)|Adverse Event|2|||
19684703|NCT00436826|42131613|FG001|Double Blind Period (DBP)|Adverse Event|0|||
19684704|NCT00436826|42131614|FG002|Double Blind Period (DBP)|Adverse Event|0|||
19684705|NCT00436826|42131615|FG003|Double Blind Period (DBP)|Adverse Event|0|||
19684706|NCT00436826|42131616|FG004|Double Blind Period (DBP)|Adverse Event|0|||
19684707|NCT00436826|42131617|FG005|Double Blind Period (DBP)|Adverse Event|0|||
19684708|NCT00436826|42131612|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
19684709|NCT00436826|42131613|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
19684710|NCT00436826|42131614|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
19684711|NCT00436826|42131615|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
19684712|NCT00436826|42131616|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
19684713|NCT00436826|42131617|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
19684714|NCT00436826|42131612|FG000|Double Blind Period (DBP)|Other|10|||
19684715|NCT00436826|42131613|FG001|Double Blind Period (DBP)|Other|11|||
19684716|NCT00436826|42131614|FG002|Double Blind Period (DBP)|Other|0|||
19684717|NCT00436826|42131615|FG003|Double Blind Period (DBP)|Other|0|||
19684718|NCT00436826|42131616|FG004|Double Blind Period (DBP)|Other|0|||
19684719|NCT00436826|42131617|FG005|Double Blind Period (DBP)|Other|0|||
19684720|NCT00436826|42131612|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
19684721|NCT00436826|42131613|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
19684722|NCT00436826|42131614|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
19684723|NCT00436826|42131615|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
19684724|NCT00436826|42131616|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
19684725|NCT00436826|42131617|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
19684726|NCT00436826|42131612|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
19684727|NCT00436826|42131613|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
19684728|NCT00436826|42131614|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
19684729|NCT00436826|42131615|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
19769109|NCT03181789|42222699|FG000|Overall Study|Participant unable to adhere to visit|0|||
19769110|NCT03181789|42222700|FG001|Overall Study|Participant unable to adhere to visit|1|||
19684730|NCT00436826|42131616|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
19684731|NCT00436826|42131617|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
19684732|NCT00436826|42131612|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
19684733|NCT00436826|42131613|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
19684734|NCT00436826|42131614|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
19684735|NCT00436826|42131615|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
19684736|NCT00436826|42131616|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
19684737|NCT00436826|42131617|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
19684738|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
19684739|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
19684740|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
19684741|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
19684742|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
19684743|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
19684744|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
19684745|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
19684746|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
19684747|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
19684748|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
19684749|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
19684750|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Death|7|||
19684751|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Death|4|||
19684752|NCT00410124|42131635|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
19684753|NCT00410124|42131636|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
19684754|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
19684755|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
19684756|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
19684757|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
19684758|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
19684759|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
19684760|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
19684761|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
19684762|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
19684763|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
19684764|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
19684765|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
19684766|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
19684767|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
19684768|NCT00410124|42131635|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
19684769|NCT00410124|42131636|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
19684770|NCT00410046|42131646|FG000|Overall Study|Adverse Event|3|||
19684771|NCT00410046|42131646|FG000|Overall Study|Withdrawal by Subject|1|||
19684772|NCT00410046|42131646|FG000|Overall Study|Lost to Follow-up|1|||
19684773|NCT00416624|42131655|FG000|Overall Study|Withdrawal by Subject|1|||
19684774|NCT00416624|42131656|FG001|Overall Study|Withdrawal by Subject|6|||
19684775|NCT00416624|42131657|FG002|Overall Study|Withdrawal by Subject|4|||
19684776|NCT00416624|42131658|FG003|Overall Study|Withdrawal by Subject|9|||
19684777|NCT00416624|42131655|FG000|Overall Study|Death|4|||
19684778|NCT00416624|42131656|FG001|Overall Study|Death|7|||
19684779|NCT00416624|42131657|FG002|Overall Study|Death|7|||
19684780|NCT00416624|42131658|FG003|Overall Study|Death|1|||
19684781|NCT00416624|42131655|FG000|Overall Study|Adverse Event|8|||
19684782|NCT00416624|42131656|FG001|Overall Study|Adverse Event|3|||
19684783|NCT00416624|42131657|FG002|Overall Study|Adverse Event|2|||
19684784|NCT00416624|42131658|FG003|Overall Study|Adverse Event|2|||
19684785|NCT00416624|42131655|FG000|Overall Study|Other|8|||
19684786|NCT00416624|42131656|FG001|Overall Study|Other|11|||
19684787|NCT00416624|42131657|FG002|Overall Study|Other|5|||
19684788|NCT00416624|42131658|FG003|Overall Study|Other|5|||
19684789|NCT00416624|42131655|FG000|Overall Study|Cancel|1|||
19684790|NCT00416624|42131656|FG001|Overall Study|Cancel|0|||
19684791|NCT00416624|42131657|FG002|Overall Study|Cancel|0|||
19684792|NCT00416624|42131658|FG003|Overall Study|Cancel|0|||
19684793|NCT00262600|42131671|FG000|Overall Study|Lost to Follow-up|17|||
19684794|NCT00262600|42131672|FG001|Overall Study|Lost to Follow-up|31|||
19684795|NCT00262600|42131673|FG002|Overall Study|Lost to Follow-up|41|||
19684796|NCT00262600|42131671|FG000|Overall Study|Withdrawal by Subject|128|||
19684797|NCT00262600|42131672|FG001|Overall Study|Withdrawal by Subject|145|||
19684798|NCT00262600|42131673|FG002|Overall Study|Withdrawal by Subject|139|||
19684799|NCT00262600|42131671|FG000|Overall Study|Not Treated|32|||
19684800|NCT00262600|42131672|FG001|Overall Study|Not Treated|17|||
19684801|NCT00262600|42131673|FG002|Overall Study|Not Treated|24|||
19684802|NCT00262600|42131671|FG000|Overall Study|Other|58|||
19684803|NCT00262600|42131672|FG001|Overall Study|Other|59|||
19684804|NCT00262600|42131673|FG002|Overall Study|Other|62|||
19684805|NCT00409578|42131685|FG000|Overall Study|Adverse Event|27|||
19684806|NCT00409578|42131686|FG001|Overall Study|Adverse Event|37|||
19684807|NCT00409578|42131687|FG002|Overall Study|Adverse Event|25|||
19684808|NCT00409578|42131688|FG003|Overall Study|Adverse Event|33|||
19684809|NCT00409578|42131685|FG000|Overall Study|Abnormal laboratory value(s)|2|||
19684810|NCT00409578|42131686|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19684811|NCT00409578|42131687|FG002|Overall Study|Abnormal laboratory value(s)|2|||
19684812|NCT00409578|42131688|FG003|Overall Study|Abnormal laboratory value(s)|4|||
19684813|NCT00409578|42131685|FG000|Overall Study|Lack of Efficacy|0|||
19684814|NCT00409578|42131686|FG001|Overall Study|Lack of Efficacy|0|||
19684815|NCT00409578|42131687|FG002|Overall Study|Lack of Efficacy|0|||
19684816|NCT00409578|42131688|FG003|Overall Study|Lack of Efficacy|2|||
19684817|NCT00409578|42131685|FG000|Overall Study|Subject no longer requires study drug|0|||
19684818|NCT00409578|42131686|FG001|Overall Study|Subject no longer requires study drug|0|||
19684819|NCT00409578|42131687|FG002|Overall Study|Subject no longer requires study drug|0|||
19684820|NCT00409578|42131688|FG003|Overall Study|Subject no longer requires study drug|1|||
19769111|NCT03181789|42222701|FG002|Overall Study|Participant unable to adhere to visit|0|||
19769112|NCT03181789|42222702|FG003|Overall Study|Participant unable to adhere to visit|0|||
19769113|NCT03259074|42222715|FG000|Overall Study|Adverse Event|9|||
19769114|NCT03259074|42222716|FG001|Overall Study|Adverse Event|12|||
19769115|NCT03259074|42222717|FG002|Overall Study|Adverse Event|8|||
19769116|NCT03259074|42222715|FG000|Overall Study|Death|1|||
19769117|NCT03259074|42222716|FG001|Overall Study|Death|1|||
19769118|NCT03259074|42222717|FG002|Overall Study|Death|3|||
19769119|NCT03259074|42222715|FG000|Overall Study|Lost to Follow-up|2|||
19684821|NCT00409578|42131685|FG000|Overall Study|Withdrawal by Subject|8|||
19684822|NCT00409578|42131686|FG001|Overall Study|Withdrawal by Subject|15|||
19684823|NCT00409578|42131687|FG002|Overall Study|Withdrawal by Subject|16|||
19684824|NCT00409578|42131688|FG003|Overall Study|Withdrawal by Subject|17|||
19684825|NCT00409578|42131685|FG000|Overall Study|Lost to Follow-up|2|||
19684826|NCT00409578|42131686|FG001|Overall Study|Lost to Follow-up|0|||
19684827|NCT00409578|42131687|FG002|Overall Study|Lost to Follow-up|2|||
19684828|NCT00409578|42131688|FG003|Overall Study|Lost to Follow-up|2|||
19684829|NCT00409578|42131685|FG000|Overall Study|Administrative problems|8|||
19684830|NCT00409578|42131686|FG001|Overall Study|Administrative problems|9|||
19684831|NCT00409578|42131687|FG002|Overall Study|Administrative problems|2|||
19684832|NCT00409578|42131688|FG003|Overall Study|Administrative problems|4|||
19684833|NCT00409578|42131685|FG000|Overall Study|Death|2|||
19684834|NCT00409578|42131686|FG001|Overall Study|Death|4|||
19684835|NCT00409578|42131687|FG002|Overall Study|Death|4|||
19684836|NCT00409578|42131688|FG003|Overall Study|Death|2|||
19684837|NCT00409578|42131685|FG000|Overall Study|Protocol Violation|3|||
19684838|NCT00409578|42131686|FG001|Overall Study|Protocol Violation|2|||
19684839|NCT00409578|42131687|FG002|Overall Study|Protocol Violation|3|||
19684840|NCT00409578|42131688|FG003|Overall Study|Protocol Violation|1|||
19684841|NCT00409578|42131685|FG000|Overall Study|Missing|0|||
19684842|NCT00409578|42131686|FG001|Overall Study|Missing|1|||
19684843|NCT00409578|42131687|FG002|Overall Study|Missing|0|||
19684844|NCT00409578|42131688|FG003|Overall Study|Missing|1|||
19684845|NCT00428090|42131702|FG000|Overall Study|Adverse Event|10|||
19684846|NCT00428090|42131703|FG001|Overall Study|Adverse Event|8|||
19684847|NCT00428090|42131704|FG002|Overall Study|Adverse Event|10|||
19684848|NCT00428090|42131705|FG003|Overall Study|Adverse Event|11|||
19684849|NCT00428090|42131702|FG000|Overall Study|Lost to Follow-up|3|||
19684850|NCT00428090|42131703|FG001|Overall Study|Lost to Follow-up|6|||
19684851|NCT00428090|42131704|FG002|Overall Study|Lost to Follow-up|1|||
19684852|NCT00428090|42131705|FG003|Overall Study|Lost to Follow-up|4|||
19684853|NCT00428090|42131702|FG000|Overall Study|Protocol Violation|3|||
19684854|NCT00428090|42131703|FG001|Overall Study|Protocol Violation|1|||
19684855|NCT00428090|42131704|FG002|Overall Study|Protocol Violation|3|||
19769120|NCT03259074|42222716|FG001|Overall Study|Lost to Follow-up|4|||
19684856|NCT00428090|42131705|FG003|Overall Study|Protocol Violation|3|||
19769121|NCT03259074|42222717|FG002|Overall Study|Lost to Follow-up|3|||
19769122|NCT03259074|42222715|FG000|Overall Study|New Therapy For Study Indication|1|||
19684857|NCT00428090|42131702|FG000|Overall Study|Withdrawal by Subject|10|||
19684858|NCT00428090|42131703|FG001|Overall Study|Withdrawal by Subject|12|||
19684859|NCT00428090|42131704|FG002|Overall Study|Withdrawal by Subject|15|||
19684860|NCT00428090|42131705|FG003|Overall Study|Withdrawal by Subject|5|||
19684861|NCT00428090|42131702|FG000|Overall Study|Sponsor terminated study|0|||
19684862|NCT00428090|42131703|FG001|Overall Study|Sponsor terminated study|1|||
19684863|NCT00428090|42131704|FG002|Overall Study|Sponsor terminated study|0|||
19684864|NCT00428090|42131705|FG003|Overall Study|Sponsor terminated study|0|||
19684865|NCT00428090|42131702|FG000|Overall Study|Non-compliance|4|||
19684866|NCT00428090|42131703|FG001|Overall Study|Non-compliance|0|||
19684867|NCT00428090|42131704|FG002|Overall Study|Non-compliance|1|||
19684868|NCT00428090|42131705|FG003|Overall Study|Non-compliance|3|||
19769123|NCT03259074|42222716|FG001|Overall Study|New Therapy For Study Indication|2|||
19769124|NCT03259074|42222717|FG002|Overall Study|New Therapy For Study Indication|2|||
19769125|NCT03259074|42222715|FG000|Overall Study|Physician Decision|4|||
19769126|NCT03259074|42222716|FG001|Overall Study|Physician Decision|12|||
19769127|NCT03259074|42222717|FG002|Overall Study|Physician Decision|10|||
19769128|NCT03259074|42222715|FG000|Overall Study|Pregnancy|1|||
19769129|NCT03259074|42222716|FG001|Overall Study|Pregnancy|1|||
19769130|NCT03259074|42222717|FG002|Overall Study|Pregnancy|0|||
19769131|NCT03259074|42222715|FG000|Overall Study|Progressive Disease|1|||
19769132|NCT03259074|42222716|FG001|Overall Study|Progressive Disease|0|||
19769133|NCT03259074|42222717|FG002|Overall Study|Progressive Disease|0|||
19769134|NCT03259074|42222715|FG000|Overall Study|Protocol Deviation|1|||
19769135|NCT03259074|42222716|FG001|Overall Study|Protocol Deviation|1|||
19769136|NCT03259074|42222717|FG002|Overall Study|Protocol Deviation|3|||
19769137|NCT03259074|42222715|FG000|Overall Study|Subject/Guardian Decision|13|||
19769138|NCT03259074|42222716|FG001|Overall Study|Subject/Guardian Decision|16|||
19769139|NCT03259074|42222717|FG002|Overall Study|Subject/Guardian Decision|14|||
19769140|NCT03024606|42222727|FG000|Overall Study|Withdrawal by Subject|9|||
19769141|NCT03024606|42222728|FG001|Overall Study|Withdrawal by Subject|10|||
19769142|NCT03180619|42222737|FG000|Overall Study|Withdrew Consent|5|||
19769143|NCT03180619|42222738|FG001|Overall Study|Withdrew Consent|0|||
19769144|NCT03180619|42222739|FG002|Overall Study|Withdrew Consent|2|||
19769145|NCT03180619|42222737|FG000|Overall Study|Death|2|||
19769146|NCT03180619|42222738|FG001|Overall Study|Death|1|||
19769147|NCT03180619|42222739|FG002|Overall Study|Death|2|||
19769148|NCT03180619|42222737|FG000|Overall Study|Adverse Event|2|||
19769149|NCT03180619|42222738|FG001|Overall Study|Adverse Event|0|||
19769150|NCT03180619|42222739|FG002|Overall Study|Adverse Event|1|||
19769151|NCT03180619|42222737|FG000|Overall Study|Investigator's discretion|2|||
19769152|NCT03180619|42222738|FG001|Overall Study|Investigator's discretion|0|||
19769153|NCT03180619|42222739|FG002|Overall Study|Investigator's discretion|1|||
19769154|NCT02915874|42222756|FG000|Overall Study|Lost to Follow-up|5|||
19769155|NCT02915874|42222757|FG001|Overall Study|Lost to Follow-up|4|||
19769156|NCT02915874|42222756|FG000|Overall Study|Withdrawal by Subject|1|||
19769157|NCT02915874|42222757|FG001|Overall Study|Withdrawal by Subject|1|||
19769158|NCT02915874|42222756|FG000|Overall Study|Started New Anxiety Medication|0|||
19769159|NCT02915874|42222757|FG001|Overall Study|Started New Anxiety Medication|1|||
19769160|NCT03022578|42222763|FG000|Overall Study|Adverse Event|1|||
19769161|NCT03022578|42222763|FG000|Overall Study|Lack of Efficacy|2|||
19769162|NCT03022578|42222763|FG000|Overall Study|Withdrawal by Subject|1|||
19769163|NCT03022422|42222773|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
19769164|NCT03022422|42222774|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
19769165|NCT03022422|42222775|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
19769166|NCT03022422|42222776|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
19769167|NCT03022422|42222777|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
19769168|NCT03022422|42222778|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
19769169|NCT03023826|42222794|FG000|Period 1|Withdrawal by Subject|0|||
19769170|NCT03023826|42222795|FG001|Period 1|Withdrawal by Subject|0|||
19769171|NCT03023826|42222796|FG002|Period 1|Withdrawal by Subject|0|||
19769172|NCT03023826|42222797|FG003|Period 1|Withdrawal by Subject|0|||
19769173|NCT03023826|42222798|FG004|Period 1|Withdrawal by Subject|1|||
19769174|NCT03023826|42222799|FG005|Period 1|Withdrawal by Subject|0|||
19769175|NCT03166735|42222812|FG000|Overall Study|Not Treated|1|||
19769176|NCT03166735|42222813|FG001|Overall Study|Not Treated|0|||
19769177|NCT03166735|42222814|FG002|Overall Study|Not Treated|0|||
19769178|NCT03166735|42222815|FG003|Overall Study|Not Treated|0|||
19769179|NCT03166735|42222816|FG004|Overall Study|Not Treated|0|||
19684869|NCT00428090|42131702|FG000|Overall Study|Par. did not returned to visit|1|||
19684870|NCT00428090|42131703|FG001|Overall Study|Par. did not returned to visit|0|||
19684871|NCT00428090|42131704|FG002|Overall Study|Par. did not returned to visit|0|||
19684872|NCT00428090|42131705|FG003|Overall Study|Par. did not returned to visit|1|||
19684873|NCT00428090|42131702|FG000|Overall Study|Follow-Up visit not possible|1|||
19684874|NCT00428090|42131703|FG001|Overall Study|Follow-Up visit not possible|0|||
19769180|NCT03166735|42222812|FG000|Overall Study|follow-up not completed as planned|0|||
19769181|NCT03166735|42222813|FG001|Overall Study|follow-up not completed as planned|1|||
19769182|NCT03166735|42222814|FG002|Overall Study|follow-up not completed as planned|1|||
19769183|NCT03166735|42222815|FG003|Overall Study|follow-up not completed as planned|0|||
19684875|NCT00428090|42131704|FG002|Overall Study|Follow-Up visit not possible|0|||
19684876|NCT00428090|42131705|FG003|Overall Study|Follow-Up visit not possible|0|||
19769184|NCT03166735|42222816|FG004|Overall Study|follow-up not completed as planned|1|||
19769185|NCT03166735|42222812|FG000|Overall Study|Withdrawal by Subject|0|||
19769186|NCT03166735|42222813|FG001|Overall Study|Withdrawal by Subject|0|||
19769187|NCT03166735|42222814|FG002|Overall Study|Withdrawal by Subject|1|||
19769188|NCT03166735|42222815|FG003|Overall Study|Withdrawal by Subject|1|||
19769189|NCT03166735|42222816|FG004|Overall Study|Withdrawal by Subject|2|||
19769190|NCT03166735|42222812|FG000|Overall Study|Lost to Follow-up|0|||
19769191|NCT03166735|42222813|FG001|Overall Study|Lost to Follow-up|2|||
19684877|NCT00428090|42131702|FG000|Overall Study|Prohibited medication used for SAE|1|||
19684878|NCT00428090|42131703|FG001|Overall Study|Prohibited medication used for SAE|0|||
19684879|NCT00428090|42131704|FG002|Overall Study|Prohibited medication used for SAE|0|||
19684880|NCT00428090|42131705|FG003|Overall Study|Prohibited medication used for SAE|0|||
19684881|NCT00428090|42131702|FG000|Overall Study|Death of par.|1|||
19684882|NCT00428090|42131703|FG001|Overall Study|Death of par.|0|||
19684883|NCT00428090|42131704|FG002|Overall Study|Death of par.|1|||
19684884|NCT00428090|42131705|FG003|Overall Study|Death of par.|0|||
19684885|NCT00428090|42131702|FG000|Overall Study|Visit 7 exceed the visit window|0|||
19684886|NCT00428090|42131703|FG001|Overall Study|Visit 7 exceed the visit window|1|||
19684887|NCT00428090|42131704|FG002|Overall Study|Visit 7 exceed the visit window|0|||
19769192|NCT03166735|42222814|FG002|Overall Study|Lost to Follow-up|1|||
19769193|NCT03166735|42222815|FG003|Overall Study|Lost to Follow-up|0|||
19769194|NCT03166735|42222816|FG004|Overall Study|Lost to Follow-up|1|||
19769195|NCT03165955|42222829|FG000|Treatment|Withdrawal by Subject|3|||
19769196|NCT03165955|42222829|FG000|Treatment|Death|1|||
19769197|NCT03165955|42222829|FG000|Treatment|Adverse Event|1|||
19769198|NCT03165955|42222829|FG000|Treatment|Progressive disease|3|||
19769199|NCT03055494|42222835|FG000|Overall Study|Lost to Follow-up|6|||
19769200|NCT03055494|42222836|FG001|Overall Study|Lost to Follow-up|0|||
19769201|NCT03055494|42222835|FG000|Overall Study|Physician Decision|2|||
19769202|NCT03055494|42222836|FG001|Overall Study|Physician Decision|0|||
19769203|NCT03055494|42222835|FG000|Overall Study|Withdrawal by Subject|1|||
19769204|NCT03055494|42222836|FG001|Overall Study|Withdrawal by Subject|0|||
19684888|NCT00428090|42131705|FG003|Overall Study|Visit 7 exceed the visit window|0|||
19684889|NCT00428090|42131702|FG000|Overall Study|Medical monitor terminated par.|0|||
19684890|NCT00428090|42131703|FG001|Overall Study|Medical monitor terminated par.|1|||
19684891|NCT00428090|42131704|FG002|Overall Study|Medical monitor terminated par.|0|||
19684892|NCT00428090|42131705|FG003|Overall Study|Medical monitor terminated par.|0|||
19684893|NCT00428090|42131702|FG000|Overall Study|Mental status of par. was|0|||
19684894|NCT00428090|42131703|FG001|Overall Study|Mental status of par. was|1|||
19684895|NCT00428090|42131704|FG002|Overall Study|Mental status of par. was|0|||
19684896|NCT00428090|42131705|FG003|Overall Study|Mental status of par. was|0|||
19684897|NCT00428090|42131702|FG000|Overall Study|Worsening of AD|0|||
19684898|NCT00428090|42131703|FG001|Overall Study|Worsening of AD|0|||
19684899|NCT00428090|42131704|FG002|Overall Study|Worsening of AD|1|||
19684900|NCT00428090|42131705|FG003|Overall Study|Worsening of AD|0|||
19684901|NCT00428090|42131702|FG000|Overall Study|Excluded for concerning QTc value|0|||
19684902|NCT00428090|42131703|FG001|Overall Study|Excluded for concerning QTc value|0|||
19684903|NCT00428090|42131704|FG002|Overall Study|Excluded for concerning QTc value|1|||
19684904|NCT00428090|42131705|FG003|Overall Study|Excluded for concerning QTc value|0|||
19684905|NCT00428090|42131702|FG000|Overall Study|Insufficient AD documentation|0|||
19684906|NCT00428090|42131703|FG001|Overall Study|Insufficient AD documentation|0|||
19684907|NCT00428090|42131704|FG002|Overall Study|Insufficient AD documentation|1|||
19684908|NCT00428090|42131705|FG003|Overall Study|Insufficient AD documentation|0|||
19684909|NCT00428090|42131702|FG000|Overall Study|High MMSE scores|0|||
19684910|NCT00428090|42131703|FG001|Overall Study|High MMSE scores|0|||
19684911|NCT00428090|42131704|FG002|Overall Study|High MMSE scores|1|||
19684912|NCT00428090|42131705|FG003|Overall Study|High MMSE scores|0|||
19684913|NCT00428090|42131702|FG000|Overall Study|Deterioration of cognitive status|0|||
19684914|NCT00428090|42131703|FG001|Overall Study|Deterioration of cognitive status|0|||
19769205|NCT03055494|42222835|FG000|Overall Study|Adverse Event|0|||
19769206|NCT03055494|42222836|FG001|Overall Study|Adverse Event|1|||
19684915|NCT00428090|42131704|FG002|Overall Study|Deterioration of cognitive status|1|||
19684916|NCT00428090|42131705|FG003|Overall Study|Deterioration of cognitive status|0|||
19684917|NCT00428090|42131702|FG000|Overall Study|Serious adverse event|0|||
19684918|NCT00428090|42131703|FG001|Overall Study|Serious adverse event|0|||
19684919|NCT00428090|42131704|FG002|Overall Study|Serious adverse event|1|||
19684920|NCT00428090|42131705|FG003|Overall Study|Serious adverse event|0|||
19769207|NCT03055494|42222835|FG000|Overall Study|Non-compliance with study treatment|1|||
19769208|NCT03055494|42222836|FG001|Overall Study|Non-compliance with study treatment|0|||
19769209|NCT02914548|42222846|FG000|Overall Study|Adverse Event|15|||
19769210|NCT02914548|42222847|FG001|Overall Study|Adverse Event|7|||
19684921|NCT00428090|42131702|FG000|Overall Study|Excluded for heart insufficiency|0|||
19684922|NCT00428090|42131703|FG001|Overall Study|Excluded for heart insufficiency|0|||
19684923|NCT00428090|42131704|FG002|Overall Study|Excluded for heart insufficiency|1|||
19684924|NCT00428090|42131705|FG003|Overall Study|Excluded for heart insufficiency|0|||
19684925|NCT00428090|42131702|FG000|Overall Study|Raised Creatinine Value|0|||
19684926|NCT00428090|42131703|FG001|Overall Study|Raised Creatinine Value|0|||
19684927|NCT00428090|42131704|FG002|Overall Study|Raised Creatinine Value|0|||
19684928|NCT00428090|42131705|FG003|Overall Study|Raised Creatinine Value|1|||
19684929|NCT00416312|42131723|FG000|Overall Study|tumors not visible on imaging|2|||
19684930|NCT00436436|42131727|FG000|Overall Study|Progression|4|||
19684931|NCT00436436|42131727|FG000|Overall Study|Adverse Event|2|||
19684932|NCT00436436|42131727|FG000|Overall Study|Death|6|||
19684933|NCT00262522|42131735|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
19684934|NCT00262522|42131736|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
19684935|NCT00262522|42131737|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
19684936|NCT00262522|42131738|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
19684937|NCT00262522|42131735|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
19684938|NCT00262522|42131736|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
19684939|NCT00262522|42131737|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
19684940|NCT00262522|42131738|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
19684941|NCT00262522|42131735|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
19684942|NCT00262522|42131736|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
19684943|NCT00262522|42131737|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
19684944|NCT00262522|42131738|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
19684945|NCT00262522|42131735|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
19684946|NCT00262522|42131736|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
19684947|NCT00262522|42131737|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
19684948|NCT00262522|42131738|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
19684949|NCT00262522|42131735|FG000|Study Start Through 8 Weeks|Death|1|||
19684950|NCT00262522|42131736|FG001|Study Start Through 8 Weeks|Death|0|||
19684951|NCT00262522|42131737|FG002|Study Start Through 8 Weeks|Death|0|||
19389126|NCT02669849|41632689|FG002|Overall Study|Death|2|||
19389127|NCT02669849|41632687|FG000|Overall Study|Study terminated by sponsor|16|||
19684952|NCT00262522|42131738|FG003|Study Start Through 8 Weeks|Death|0|||
19684953|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
19684954|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
19684955|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
19684956|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
19684957|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
19684958|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
19684959|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
19684960|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
19684961|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
19684962|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
19684963|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
19684964|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
19684965|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
19684966|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
19684967|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
19684968|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
19684969|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Death|2|||
19684970|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Death|0|||
19684971|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Death|1|||
19684972|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Death|0|||
19684973|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
19684974|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
19684975|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
19684976|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
19684977|NCT00262522|42131735|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
19684978|NCT00262522|42131736|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
19684979|NCT00262522|42131737|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
19684980|NCT00262522|42131738|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
19684981|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
19684982|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
19684983|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
19684984|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
19684985|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
19684986|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
19684987|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
19684988|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
19684989|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
19684990|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
19684991|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
19684992|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
19684993|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
19684994|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
19684995|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
19684996|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
19684997|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Death|2|||
19684998|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Death|0|||
19684999|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Death|2|||
19685000|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Death|0|||
19685001|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
19685002|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
19685003|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
19685004|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
19685005|NCT00262522|42131735|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
19685006|NCT00262522|42131736|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
19685007|NCT00262522|42131737|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
19685008|NCT00262522|42131738|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
19685009|NCT00436280|42131746|FG000|Period 1: Induction|Adverse Event|8|||
19685010|NCT00436280|42131746|FG000|Period 1: Induction|Progressive Disease|12|||
19685011|NCT00436280|42131746|FG000|Period 1: Induction|Stable Disease|6|||
19685012|NCT00436280|42131746|FG000|Period 1: Induction|Withdrawal by Subject|1|||
19685013|NCT00436280|42131746|FG000|Period 1: Induction|Death|1|||
19685014|NCT00436280|42131746|FG000|Period 2: Consolidation|Adverse Event|1|||
19685015|NCT00436280|42131746|FG000|Period 2: Consolidation|Progressive Disease|10|||
19685016|NCT00436280|42131746|FG000|Period 2: Consolidation|Stable Disease|1|||
19685017|NCT00436280|42131746|FG000|Period 2: Consolidation|Physician Decision|2|||
19685018|NCT00436280|42131746|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
19685019|NCT00436280|42131746|FG000|Period 2: Consolidation|Death|1|||
19685020|NCT00436280|42131746|FG000|Period 3: Maintenance|Adverse Event|6|||
19685021|NCT00436280|42131746|FG000|Period 3: Maintenance|Progressive Disease|12|||
19685022|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
19685023|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
19685024|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
19685025|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
19685026|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
19685027|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
19685028|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
19685029|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
19685030|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Death|0|||
19685031|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Death|1|||
19685032|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
19685033|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
19685034|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
19685035|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
19685036|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
19685037|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
19685038|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
19685039|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
19685040|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
19685041|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
19685042|NCT00394836|42131752|FG000|Teatment or Follow-up Phase|Non compliance|0|||
19685043|NCT00394836|42131753|FG001|Teatment or Follow-up Phase|Non compliance|1|||
19685044|NCT00394836|42131752|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
19685045|NCT00394836|42131753|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
19685046|NCT00394836|42131752|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
19685047|NCT00394836|42131753|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
19685048|NCT00394836|42131752|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
19685049|NCT00394836|42131753|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
19685050|NCT00394836|42131752|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
19685051|NCT00394836|42131753|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
19685052|NCT00250588|42131764|FG000|Overall Study|Withdrawal by Subject|3|||
19685053|NCT00250588|42131765|FG001|Overall Study|Withdrawal by Subject|6|||
19685054|NCT00250588|42131766|FG002|Overall Study|Withdrawal by Subject|0|||
19685055|NCT00250588|42131764|FG000|Overall Study|Lost to Follow-up|6|||
19685056|NCT00250588|42131765|FG001|Overall Study|Lost to Follow-up|13|||
19685057|NCT00250588|42131766|FG002|Overall Study|Lost to Follow-up|13|||
19685058|NCT00416078|42131776|FG000|Overall Study|Death|3|||
19685059|NCT00416078|42131777|FG001|Overall Study|Death|4|||
19685060|NCT00416078|42131776|FG000|Overall Study|Withdrawal by Subject|3|||
19769211|NCT02914548|42222848|FG002|Overall Study|Adverse Event|15|||
19769212|NCT02914548|42222846|FG000|Overall Study|Physician Decision|2|||
19769213|NCT02914548|42222847|FG001|Overall Study|Physician Decision|2|||
19769214|NCT02914548|42222848|FG002|Overall Study|Physician Decision|0|||
19769215|NCT02914548|42222846|FG000|Overall Study|Protocol Violation|1|||
19769216|NCT02914548|42222847|FG001|Overall Study|Protocol Violation|0|||
19769217|NCT02914548|42222848|FG002|Overall Study|Protocol Violation|0|||
19769218|NCT02914548|42222846|FG000|Overall Study|Withdrawal by Subject|3|||
19769219|NCT02914548|42222847|FG001|Overall Study|Withdrawal by Subject|4|||
19769220|NCT02914548|42222848|FG002|Overall Study|Withdrawal by Subject|4|||
19769221|NCT02914548|42222846|FG000|Overall Study|>40% of body surface area|0|||
19769222|NCT02914548|42222847|FG001|Overall Study|>40% of body surface area|1|||
19769223|NCT02914548|42222848|FG002|Overall Study|>40% of body surface area|1|||
19769224|NCT03165721|42222864|FG000|Overall Study|Refused further treatment|3|||
19769225|NCT03165721|42222865|FG001|Overall Study|Refused further treatment|0|||
19769226|NCT03165721|42222866|FG002|Overall Study|Refused further treatment|0|||
19769227|NCT03165721|42222864|FG000|Overall Study|Physician Decision|1|||
19769228|NCT03165721|42222865|FG001|Overall Study|Physician Decision|0|||
19769229|NCT03165721|42222866|FG002|Overall Study|Physician Decision|0|||
19769230|NCT02187198|42222882|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
19769231|NCT02187198|42222883|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
19769232|NCT02187198|42222882|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
19769233|NCT02187198|42222883|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
19769234|NCT02642029|42222889|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
19769235|NCT02642029|42222890|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
19769236|NCT02642029|42222891|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
19769237|NCT02642029|42222892|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
19769238|NCT02642029|42222893|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
19769239|NCT02642029|42222894|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
19769240|NCT02642029|42222889|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
19685061|NCT00416078|42131777|FG001|Overall Study|Withdrawal by Subject|2|||
19685062|NCT00416078|42131776|FG000|Overall Study|Physician Decision|1|||
19685063|NCT00416078|42131777|FG001|Overall Study|Physician Decision|0|||
19685064|NCT00416078|42131776|FG000|Overall Study|Lost to Follow-up|4|||
19685065|NCT00416078|42131777|FG001|Overall Study|Lost to Follow-up|2|||
19685066|NCT00394524|42131785|FG000|Overall Study|Protocol Violation|2|||
19685067|NCT00394524|42131786|FG001|Overall Study|Protocol Violation|3|||
19685068|NCT00394524|42131785|FG000|Overall Study|Death|1|||
19685069|NCT00394524|42131786|FG001|Overall Study|Death|0|||
19685070|NCT00394524|42131785|FG000|Overall Study|Withdrawal by Subject|0|||
19685071|NCT00394524|42131786|FG001|Overall Study|Withdrawal by Subject|1|||
19685072|NCT00409344|42131796|FG000|Overall Study|no enrollment|0|||
19685073|NCT00409344|42131797|FG001|Overall Study|no enrollment|0|||
19685074|NCT00415610|42131806|FG000|Overall Study|Death|3|||
19685075|NCT00415610|42131807|FG001|Overall Study|Death|2|||
19685076|NCT00415610|42131808|FG002|Overall Study|Death|5|||
19685077|NCT00394212|42131818|FG000|Overall Study|Lost to Follow-up|3|||
19685078|NCT00394212|42131819|FG001|Overall Study|Lost to Follow-up|0|||
19685079|NCT00394212|42131818|FG000|Overall Study|Withdrawal by Subject|4|||
19685080|NCT00394212|42131819|FG001|Overall Study|Withdrawal by Subject|1|||
19685081|NCT00250432|42131827|FG000|Overall Study|Adverse Event|25|||
19685082|NCT00250432|42131828|FG001|Overall Study|Adverse Event|29|||
19685083|NCT00250432|42131827|FG000|Overall Study|Lack of Efficacy|2|||
19685084|NCT00250432|42131828|FG001|Overall Study|Lack of Efficacy|1|||
19685085|NCT00250432|42131827|FG000|Overall Study|Lost to Follow-up|6|||
19685086|NCT00250432|42131828|FG001|Overall Study|Lost to Follow-up|5|||
19685087|NCT00250432|42131827|FG000|Overall Study|Patient Moved|0|||
19685088|NCT00250432|42131828|FG001|Overall Study|Patient Moved|1|||
19685089|NCT00250432|42131827|FG000|Overall Study|Protocol Violation|0|||
19685090|NCT00250432|42131828|FG001|Overall Study|Protocol Violation|3|||
19685091|NCT00250432|42131827|FG000|Overall Study|Withdrawal by Subject|6|||
19685092|NCT00250432|42131828|FG001|Overall Study|Withdrawal by Subject|2|||
19685093|NCT00250432|42131827|FG000|Overall Study|Pt died out of posttherapy report period|6|||
19685094|NCT00250432|42131828|FG001|Overall Study|Pt died out of posttherapy report period|5|||
19685095|NCT00250432|42131827|FG000|Overall Study|Pt was considered untreatable|0|||
19685096|NCT00250432|42131828|FG001|Overall Study|Pt was considered untreatable|1|||
19685097|NCT00250276|42131838|FG000|Overall Study|Serious Adverse Event|0|||
19685098|NCT00250276|42131839|FG001|Overall Study|Serious Adverse Event|0|||
19685099|NCT00250276|42131840|FG002|Overall Study|Serious Adverse Event|1|||
19685100|NCT00250276|42131841|FG003|Overall Study|Serious Adverse Event|0|||
19685101|NCT00250276|42131838|FG000|Overall Study|Non-serious Adverse Event|2|||
19685102|NCT00250276|42131839|FG001|Overall Study|Non-serious Adverse Event|0|||
19685103|NCT00250276|42131840|FG002|Overall Study|Non-serious Adverse Event|0|||
19685104|NCT00250276|42131841|FG003|Overall Study|Non-serious Adverse Event|2|||
19685105|NCT00250276|42131838|FG000|Overall Study|Protocol Violation|0|||
19685106|NCT00250276|42131839|FG001|Overall Study|Protocol Violation|1|||
19685107|NCT00250276|42131840|FG002|Overall Study|Protocol Violation|0|||
19685108|NCT00250276|42131841|FG003|Overall Study|Protocol Violation|0|||
19685109|NCT00250276|42131838|FG000|Overall Study|Withdrawal by Subject|1|||
19685110|NCT00250276|42131839|FG001|Overall Study|Withdrawal by Subject|2|||
19685111|NCT00250276|42131840|FG002|Overall Study|Withdrawal by Subject|3|||
19685112|NCT00250276|42131841|FG003|Overall Study|Withdrawal by Subject|2|||
19685113|NCT00250276|42131838|FG000|Overall Study|Migrated/moved from study area|3|||
19685114|NCT00250276|42131839|FG001|Overall Study|Migrated/moved from study area|0|||
19685115|NCT00250276|42131840|FG002|Overall Study|Migrated/moved from study area|2|||
19685116|NCT00250276|42131841|FG003|Overall Study|Migrated/moved from study area|7|||
19685117|NCT00250276|42131838|FG000|Overall Study|Lost to Follow-up|11|||
19685118|NCT00250276|42131839|FG001|Overall Study|Lost to Follow-up|18|||
19685119|NCT00250276|42131840|FG002|Overall Study|Lost to Follow-up|13|||
19685120|NCT00250276|42131841|FG003|Overall Study|Lost to Follow-up|8|||
19685121|NCT00249808|42131856|FG000|Overall Study|Other|27|||
19685122|NCT00249808|42131856|FG000|Overall Study|Protocol Violation|3|||
19685123|NCT00249808|42131856|FG000|Overall Study|Lost to Follow-up|8|||
19685124|NCT00249808|42131856|FG000|Overall Study|Adverse Event|81|||
19685125|NCT00249808|42131856|FG000|Overall Study|Lack of Efficacy|52|||
19685126|NCT00249808|42131856|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
19685127|NCT00278512|42131862|FG000|Overall Study|Death|1|||
19685128|NCT00278512|42131863|FG001|Overall Study|Death|0|||
19685129|NCT00427934|42131873|FG000|Overall Study|Adverse Event|1|||
19685130|NCT00427934|42131874|FG001|Overall Study|Adverse Event|0|||
19685131|NCT00427934|42131875|FG002|Overall Study|Adverse Event|5|||
19685132|NCT00427934|42131876|FG003|Overall Study|Adverse Event|4|||
19685133|NCT00427934|42131873|FG000|Overall Study|Lack of Efficacy|0|||
19685134|NCT00427934|42131874|FG001|Overall Study|Lack of Efficacy|0|||
19685135|NCT00427934|42131875|FG002|Overall Study|Lack of Efficacy|5|||
19685136|NCT00427934|42131876|FG003|Overall Study|Lack of Efficacy|2|||
19685137|NCT00427934|42131873|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
19685138|NCT00427934|42131874|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
19685139|NCT00427934|42131875|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
19685140|NCT00427934|42131876|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
19685141|NCT00427934|42131873|FG000|Overall Study|Other|0|||
19685142|NCT00427934|42131874|FG001|Overall Study|Other|0|||
19685143|NCT00427934|42131875|FG002|Overall Study|Other|11|||
19685144|NCT00427934|42131876|FG003|Overall Study|Other|5|||
19685145|NCT00427934|42131873|FG000|Overall Study|Withdrawal by Subject|0|||
19685146|NCT00427934|42131874|FG001|Overall Study|Withdrawal by Subject|0|||
19685147|NCT00427934|42131875|FG002|Overall Study|Withdrawal by Subject|1|||
19685148|NCT00427934|42131876|FG003|Overall Study|Withdrawal by Subject|3|||
19685149|NCT00435188|42131890|FG000|Overall Study|Death|1|||
19685150|NCT00435188|42131891|FG001|Overall Study|Death|6|||
19685151|NCT00435188|42131890|FG000|Overall Study|Withdrawal by Subject|16|||
19685152|NCT00435188|42131891|FG001|Overall Study|Withdrawal by Subject|11|||
19685153|NCT00435188|42131890|FG000|Overall Study|Lost to Follow-up|5|||
19685154|NCT00435188|42131891|FG001|Overall Study|Lost to Follow-up|6|||
19685155|NCT00427778|42131899|FG000|First Intervention (4 Weeks)|no longer interested|1|||
19685156|NCT00427778|42131900|FG001|First Intervention (4 Weeks)|no longer interested|0|||
19685157|NCT00427778|42131899|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
19685158|NCT00427778|42131900|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
19685159|NCT00427778|42131899|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
19685160|NCT00427778|42131900|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
19685161|NCT00427778|42131899|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
19685162|NCT00427778|42131900|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
19685163|NCT00427700|42131921|FG000|Overall Study|Lost to Follow-up|2|||
19685164|NCT00427700|42131922|FG001|Overall Study|Lost to Follow-up|5|||
19685165|NCT00427700|42131921|FG000|Overall Study|no induction of menses|1|||
19685166|NCT00427700|42131922|FG001|Overall Study|no induction of menses|4|||
19685167|NCT00427700|42131921|FG000|Overall Study|Pregnancy|0|||
19685168|NCT00427700|42131922|FG001|Overall Study|Pregnancy|2|||
19685169|NCT00409188|42131931|FG000|Overall Study|Ongoing at data cut-off|383|||
19685170|NCT00409188|42131932|FG001|Overall Study|Ongoing at data cut-off|175|||
19685171|NCT00434954|42131940|FG000|Overall Study|Adverse Event|17|||
19685172|NCT00434954|42131941|FG001|Overall Study|Adverse Event|2|||
19685173|NCT00434954|42131940|FG000|Overall Study|Entry criteria not met|14|||
19685174|NCT00434954|42131941|FG001|Overall Study|Entry criteria not met|16|||
19685175|NCT00434954|42131940|FG000|Overall Study|Lost to Follow-up|0|||
19685176|NCT00434954|42131941|FG001|Overall Study|Lost to Follow-up|1|||
19685177|NCT00434954|42131940|FG000|Overall Study|Physician Decision|6|||
19685178|NCT00434954|42131941|FG001|Overall Study|Physician Decision|3|||
19685179|NCT00434954|42131940|FG000|Overall Study|Protocol Violation|36|||
19685180|NCT00434954|42131941|FG001|Overall Study|Protocol Violation|27|||
19685181|NCT00434954|42131940|FG000|Overall Study|Sponsor decision|1|||
19685182|NCT00434954|42131941|FG001|Overall Study|Sponsor decision|0|||
19685183|NCT00434954|42131940|FG000|Overall Study|Subject decision|8|||
19685184|NCT00434954|42131941|FG001|Overall Study|Subject decision|22|||
19685185|NCT00276484|42131949|FG000|Overall Study|Adverse Event|4|||
19685186|NCT00276484|42131950|FG001|Overall Study|Adverse Event|7|||
19685187|NCT00276484|42131949|FG000|Overall Study|Lost to Follow-up|1|||
19685188|NCT00276484|42131950|FG001|Overall Study|Lost to Follow-up|1|||
19685189|NCT00276484|42131949|FG000|Overall Study|Protocol Violation|0|||
19685190|NCT00276484|42131950|FG001|Overall Study|Protocol Violation|1|||
19685191|NCT00276484|42131949|FG000|Overall Study|Withdrawal by Subject|4|||
19685192|NCT00276484|42131950|FG001|Overall Study|Withdrawal by Subject|3|||
19685193|NCT00276484|42131949|FG000|Overall Study|Could not take time off work|0|||
19685194|NCT00276484|42131950|FG001|Overall Study|Could not take time off work|1|||
19685195|NCT00426842|42131956|FG000|Overall Study|Lost to Follow-up|1|||
19685196|NCT00434876|42131964|FG000|Overall Study|Lost to Follow-up|1|||
19685197|NCT00434876|42131965|FG001|Overall Study|Lost to Follow-up|1|||
19685198|NCT00276094|42131974|FG000|Overall Study|Adverse Event|15|||
19685199|NCT00276094|42131975|FG001|Overall Study|Adverse Event|13|||
19685200|NCT00276094|42131976|FG002|Overall Study|Adverse Event|11|||
19685201|NCT00276094|42131974|FG000|Overall Study|Withdrawal by Subject|14|||
19685202|NCT00276094|42131975|FG001|Overall Study|Withdrawal by Subject|14|||
19685203|NCT00276094|42131976|FG002|Overall Study|Withdrawal by Subject|12|||
19685204|NCT00276094|42131974|FG000|Overall Study|Protocol Violation|16|||
19685205|NCT00276094|42131975|FG001|Overall Study|Protocol Violation|7|||
19685206|NCT00276094|42131976|FG002|Overall Study|Protocol Violation|10|||
19685207|NCT00276094|42131974|FG000|Overall Study|Lost to Follow-up|8|||
19685208|NCT00276094|42131975|FG001|Overall Study|Lost to Follow-up|6|||
19685209|NCT00276094|42131976|FG002|Overall Study|Lost to Follow-up|4|||
19685210|NCT00276094|42131974|FG000|Overall Study|Other-Subject moved out of country|1|||
19685211|NCT00276094|42131975|FG001|Overall Study|Other-Subject moved out of country|0|||
19685212|NCT00276094|42131976|FG002|Overall Study|Other-Subject moved out of country|0|||
19685213|NCT00276094|42131974|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
19685214|NCT00276094|42131975|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
19685215|NCT00276094|42131976|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
19685216|NCT00276094|42131974|FG000|Overall Study|Other-Lack of efficacy|1|||
19685217|NCT00276094|42131975|FG001|Overall Study|Other-Lack of efficacy|0|||
19685218|NCT00276094|42131976|FG002|Overall Study|Other-Lack of efficacy|0|||
19685219|NCT00276094|42131974|FG000|Overall Study|Other-Refused follow-up visit|1|||
19685220|NCT00276094|42131975|FG001|Overall Study|Other-Refused follow-up visit|0|||
19685221|NCT00276094|42131976|FG002|Overall Study|Other-Refused follow-up visit|0|||
19685222|NCT00276094|42131974|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
19685223|NCT00276094|42131975|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
19685224|NCT00276094|42131976|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
19685225|NCT00276094|42131974|FG000|Overall Study|Other-Relocation|0|||
19685226|NCT00276094|42131975|FG001|Overall Study|Other-Relocation|1|||
19685227|NCT00276094|42131976|FG002|Overall Study|Other-Relocation|0|||
19685228|NCT00276094|42131974|FG000|Overall Study|Other-Study medication lost|0|||
19685229|NCT00276094|42131975|FG001|Overall Study|Other-Study medication lost|0|||
19685230|NCT00276094|42131976|FG002|Overall Study|Other-Study medication lost|1|||
19685231|NCT00276016|42131990|FG000|Intervention 1|Withdrawal by Subject|0|||
19685232|NCT00276016|42131991|FG001|Intervention 1|Withdrawal by Subject|1|||
19685233|NCT00276016|42131992|FG002|Intervention 1|Withdrawal by Subject|0|||
19685234|NCT00276016|42131993|FG003|Intervention 1|Withdrawal by Subject|0|||
19685235|NCT00276016|42131994|FG004|Intervention 1|Withdrawal by Subject|0|||
19685236|NCT00276016|42131995|FG005|Intervention 1|Withdrawal by Subject|0|||
19685237|NCT00434642|42132006|FG000|Blinded Treatment Phase|Adverse Event|12|||
19685238|NCT00434642|42132007|FG001|Blinded Treatment Phase|Adverse Event|58|||
19685239|NCT00434642|42132006|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
19685240|NCT00434642|42132007|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
19685241|NCT00434642|42132006|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
19685242|NCT00434642|42132007|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
19685243|NCT00434642|42132006|FG000|Blinded Treatment Phase|Physician Decision|19|||
19685244|NCT00434642|42132007|FG001|Blinded Treatment Phase|Physician Decision|27|||
19685245|NCT00434642|42132006|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
19685246|NCT00434642|42132007|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
19685247|NCT00434642|42132006|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
19685248|NCT00434642|42132007|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
19685249|NCT00434642|42132006|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
19685250|NCT00434642|42132007|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
19685251|NCT00434642|42132006|FG000|Open-label Treatment Phase|Adverse Event|0|||
19685252|NCT00434642|42132007|FG001|Open-label Treatment Phase|Adverse Event|5|||
19685253|NCT00434642|42132006|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
19685254|NCT00434642|42132007|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
19685255|NCT00434330|42132019|FG000|Overall Study|Adverse Event|0|||
19685256|NCT00434330|42132020|FG001|Overall Study|Adverse Event|0|||
19685257|NCT00434330|42132021|FG002|Overall Study|Adverse Event|1|||
19685258|NCT00434330|42132022|FG003|Overall Study|Adverse Event|0|||
19685259|NCT00434330|42132023|FG004|Overall Study|Adverse Event|0|||
19685260|NCT00434330|42132024|FG005|Overall Study|Adverse Event|0|||
19685261|NCT00434330|42132019|FG000|Overall Study|Death|1|||
19685262|NCT00434330|42132020|FG001|Overall Study|Death|0|||
19685263|NCT00434330|42132021|FG002|Overall Study|Death|0|||
19685264|NCT00434330|42132022|FG003|Overall Study|Death|0|||
19685265|NCT00434330|42132023|FG004|Overall Study|Death|1|||
19685266|NCT00434330|42132024|FG005|Overall Study|Death|1|||
19685267|NCT00434330|42132019|FG000|Overall Study|Withdrawal by Subject|0|||
19685268|NCT00434330|42132020|FG001|Overall Study|Withdrawal by Subject|0|||
19685269|NCT00434330|42132021|FG002|Overall Study|Withdrawal by Subject|1|||
19685270|NCT00434330|42132022|FG003|Overall Study|Withdrawal by Subject|1|||
19685271|NCT00434330|42132023|FG004|Overall Study|Withdrawal by Subject|0|||
19685272|NCT00434330|42132024|FG005|Overall Study|Withdrawal by Subject|0|||
19685273|NCT00434330|42132019|FG000|Overall Study|Renal transplant|0|||
19685274|NCT00434330|42132020|FG001|Overall Study|Renal transplant|0|||
19685275|NCT00434330|42132021|FG002|Overall Study|Renal transplant|0|||
19685276|NCT00434330|42132022|FG003|Overall Study|Renal transplant|1|||
19685277|NCT00434330|42132023|FG004|Overall Study|Renal transplant|0|||
19685278|NCT00434330|42132024|FG005|Overall Study|Renal transplant|0|||
19685279|NCT00434330|42132019|FG000|Overall Study|Subject Not Compliant With Study|0|||
19685280|NCT00434330|42132020|FG001|Overall Study|Subject Not Compliant With Study|0|||
19685281|NCT00434330|42132021|FG002|Overall Study|Subject Not Compliant With Study|1|||
19685282|NCT00434330|42132022|FG003|Overall Study|Subject Not Compliant With Study|0|||
19685283|NCT00434330|42132023|FG004|Overall Study|Subject Not Compliant With Study|0|||
19685284|NCT00434330|42132024|FG005|Overall Study|Subject Not Compliant With Study|0|||
19685285|NCT00426764|42132038|FG000|Overall Study|Protocol Violation|1|||
19685286|NCT00426764|42132038|FG000|Overall Study|Withdrawal by Subject|4|||
19685287|NCT00426764|42132038|FG000|Overall Study|Physician Decision|6|||
19685288|NCT00426764|42132038|FG000|Overall Study|Compassionate Use|1|||
19685289|NCT00426764|42132038|FG000|Overall Study|Progressive Disease|83|||
19685290|NCT00426764|42132038|FG000|Overall Study|Adverse Event|24|||
19685291|NCT00426764|42132038|FG000|Overall Study|Other|1|||
19685292|NCT00426764|42132038|FG000|Overall Study|Death|1|||
19685293|NCT00426764|42132038|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
19685294|NCT00434252|42132050|FG000|Overall Study|Lack of Efficacy|50|||
19685295|NCT00434252|42132051|FG001|Overall Study|Lack of Efficacy|100|||
19685296|NCT00434252|42132050|FG000|Overall Study|Adverse Event|6|||
19685297|NCT00434252|42132051|FG001|Overall Study|Adverse Event|13|||
19685298|NCT00434252|42132050|FG000|Overall Study|Death|1|||
19685299|NCT00434252|42132051|FG001|Overall Study|Death|2|||
19685300|NCT00434252|42132050|FG000|Overall Study|Lost to Follow-up|0|||
19685301|NCT00434252|42132051|FG001|Overall Study|Lost to Follow-up|1|||
19685302|NCT00434252|42132050|FG000|Overall Study|Physician Decision|4|||
19685303|NCT00434252|42132051|FG001|Overall Study|Physician Decision|8|||
19685304|NCT00434252|42132050|FG000|Overall Study|Withdrawal by Subject|3|||
19685305|NCT00434252|42132051|FG001|Overall Study|Withdrawal by Subject|7|||
19389128|NCT02669849|41632688|FG001|Overall Study|Study terminated by sponsor|1|||
19389129|NCT02669849|41632689|FG002|Overall Study|Study terminated by sponsor|14|||
19389130|NCT02669849|41632687|FG000|Overall Study|Other|0|||
19389131|NCT02669849|41632688|FG001|Overall Study|Other|0|||
19389132|NCT02669849|41632689|FG002|Overall Study|Other|2|||
19389133|NCT03625895|41632697|FG000|Overall Study|Protocol Violation|585|||
19685306|NCT00425750|42132057|FG000|Overall Study|Death|1|||
19685307|NCT00425750|42132057|FG000|Overall Study|Withdrawal by Subject|3|||
19685308|NCT00425750|42132057|FG000|Overall Study|Adverse Event|3|||
19685309|NCT00425750|42132057|FG000|Overall Study|Progression of disease|18|||
19685310|NCT00414908|42132063|FG000|Overall Study|Protocol Violation|1|||
19685311|NCT00414908|42132064|FG001|Overall Study|Protocol Violation|1|||
19389134|NCT02663687|41632706|FG000|Overall Study|Adverse Event|1|||
19389135|NCT02663687|41632707|FG001|Overall Study|Adverse Event|0|||
19605459|NCT00694369|42054236|FG004|Overall Study|Physician Decision|1|||
19605460|NCT00694369|42054232|FG000|Overall Study|Protocol Violation|0|||
19605461|NCT00694369|42054233|FG001|Overall Study|Protocol Violation|1|||
19605462|NCT00694369|42054234|FG002|Overall Study|Protocol Violation|0|||
19605463|NCT00694369|42054235|FG003|Overall Study|Protocol Violation|0|||
19605464|NCT00694369|42054236|FG004|Overall Study|Protocol Violation|0|||
19605465|NCT00694369|42054232|FG000|Overall Study|Withdrawal by Subject|1|||
19605466|NCT00694369|42054233|FG001|Overall Study|Withdrawal by Subject|1|||
19605467|NCT00694369|42054234|FG002|Overall Study|Withdrawal by Subject|1|||
19685312|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Adverse Event|30|||
19685313|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Adverse Event|25|||
19685314|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Adverse Event|23|||
19685315|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Adverse Event|14|||
19685316|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Death|0|||
19685317|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Death|0|||
19685318|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Death|1|||
19685319|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Death|0|||
19685320|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Physician Decision|0|||
19685321|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Physician Decision|1|||
19685322|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Physician Decision|0|||
19685323|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Physician Decision|1|||
19685324|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
19685325|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
19685326|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
19685327|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
19685328|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Other|6|||
19685329|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Other|1|||
19685330|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Other|0|||
19685331|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Other|2|||
19685332|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
19685333|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
19685334|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
19685335|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
19685336|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
19685337|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
19685338|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
19685339|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
19685340|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
19685341|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
19685342|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
19685343|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
19685344|NCT00242710|42132076|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
19685345|NCT00242710|42132077|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
19685346|NCT00242710|42132078|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
19685347|NCT00242710|42132079|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
19685348|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Adverse Event|2|||
19685349|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Adverse Event|3|||
19685350|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Adverse Event|5|||
19685351|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Adverse Event|2|||
19685352|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Physician Decision|1|||
19685353|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Physician Decision|1|||
19685354|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Physician Decision|0|||
19685355|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Physician Decision|0|||
19685356|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Other|24|||
19685357|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Other|24|||
19685358|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Other|9|||
19685359|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Other|11|||
19685360|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Extension not Available|17|||
19685361|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Extension not Available|21|||
19685362|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Extension not Available|8|||
19685363|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Extension not Available|7|||
19685364|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
19685365|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
19685366|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
19685367|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
19685368|NCT00242710|42132076|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
19685369|NCT00242710|42132077|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
19685370|NCT00242710|42132078|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
19769241|NCT02642029|42222890|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
19769242|NCT02642029|42222891|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
19769243|NCT02642029|42222892|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
19769244|NCT02642029|42222893|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
19769245|NCT02642029|42222894|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
19769246|NCT02642029|42222889|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
19769247|NCT02642029|42222890|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
19769248|NCT02642029|42222891|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
19769249|NCT02642029|42222892|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
19769250|NCT02642029|42222893|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
19769251|NCT02642029|42222894|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
19769252|NCT02642029|42222889|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
19769253|NCT02642029|42222890|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
19769254|NCT02642029|42222891|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
19769255|NCT02642029|42222892|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
19769256|NCT02642029|42222893|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
19685371|NCT00242710|42132079|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
19685372|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
19685373|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
19685374|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
19685375|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
19685376|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Death|0|||
19685377|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Death|0|||
19685378|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Death|0|||
19685379|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Death|1|||
19685380|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
19685381|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
19685382|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
19685383|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
19685384|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Other|3|||
19685385|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Other|5|||
19685386|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Other|4|||
19685387|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Other|3|||
19685388|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
19685389|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
19685390|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
19685391|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
19685392|NCT00242710|42132076|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
19685393|NCT00242710|42132077|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
19685394|NCT00242710|42132078|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
19685395|NCT00242710|42132079|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
19685396|NCT00408876|42132093|FG000|Overall Study|Adverse Event|9|||
19685397|NCT00408876|42132094|FG001|Overall Study|Adverse Event|17|||
19685398|NCT00408876|42132095|FG002|Overall Study|Adverse Event|27|||
19685399|NCT00408876|42132096|FG003|Overall Study|Adverse Event|10|||
19685400|NCT00408876|42132093|FG000|Overall Study|Withdrawal by Subject|3|||
19685401|NCT00408876|42132094|FG001|Overall Study|Withdrawal by Subject|6|||
19685402|NCT00408876|42132095|FG002|Overall Study|Withdrawal by Subject|6|||
19685403|NCT00408876|42132096|FG003|Overall Study|Withdrawal by Subject|14|||
19685404|NCT00408876|42132093|FG000|Overall Study|Lack of Efficacy|2|||
19685405|NCT00408876|42132094|FG001|Overall Study|Lack of Efficacy|4|||
19685406|NCT00408876|42132095|FG002|Overall Study|Lack of Efficacy|5|||
19685407|NCT00408876|42132096|FG003|Overall Study|Lack of Efficacy|6|||
19685408|NCT00408876|42132093|FG000|Overall Study|Lost to Follow-up|1|||
19685409|NCT00408876|42132094|FG001|Overall Study|Lost to Follow-up|6|||
19685410|NCT00408876|42132095|FG002|Overall Study|Lost to Follow-up|5|||
19685411|NCT00408876|42132096|FG003|Overall Study|Lost to Follow-up|2|||
19685412|NCT00408876|42132093|FG000|Overall Study|Protocol Violation|0|||
19685413|NCT00408876|42132094|FG001|Overall Study|Protocol Violation|3|||
19685414|NCT00408876|42132095|FG002|Overall Study|Protocol Violation|4|||
19685415|NCT00408876|42132096|FG003|Overall Study|Protocol Violation|3|||
19685416|NCT00408876|42132093|FG000|Overall Study|Physician Decision|1|||
19685417|NCT00408876|42132094|FG001|Overall Study|Physician Decision|0|||
19685418|NCT00408876|42132095|FG002|Overall Study|Physician Decision|3|||
19685419|NCT00408876|42132096|FG003|Overall Study|Physician Decision|0|||
19685420|NCT00240994|42132106|FG000|Overall Study|Lost to Follow-up|1|||
19685421|NCT00240994|42132106|FG000|Overall Study|Protocol Violation|1|||
19685422|NCT00240994|42132106|FG000|Overall Study|Graft failure|1|||
19685423|NCT00239590|42132110|FG000|Randomized|Lost to Follow-up|0|||
19685424|NCT00239590|42132111|FG001|Randomized|Lost to Follow-up|1|||
19685425|NCT00239590|42132110|FG000|Randomized|Withdrawal by Subject|0|||
19685426|NCT00239590|42132111|FG001|Randomized|Withdrawal by Subject|1|||
19685427|NCT00239590|42132110|FG000|Completed Study Protocol|Adverse Event|1|||
19685428|NCT00239590|42132111|FG001|Completed Study Protocol|Adverse Event|1|||
19685429|NCT00239590|42132110|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
19685430|NCT00239590|42132111|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
19685431|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
19685432|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
19685433|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Death|0|||
19685434|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Death|0|||
19685435|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
19685436|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
19685437|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
19685438|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
19685439|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
19685440|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
19685441|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
19685442|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
19685443|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
19685444|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
19685445|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
19685446|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
19685447|NCT00433160|42132121|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
19685448|NCT00433160|42132122|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
19685449|NCT00433160|42132121|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
19685450|NCT00433160|42132122|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
19685451|NCT00433160|42132121|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
19685452|NCT00433160|42132122|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
19685453|NCT00433160|42132121|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
19685454|NCT00433160|42132122|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
19685455|NCT00433160|42132121|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
19685456|NCT00433160|42132122|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
19685457|NCT00433160|42132121|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
19685458|NCT00433160|42132122|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
19685459|NCT00433160|42132121|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
19685460|NCT00433160|42132122|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
19685461|NCT00433160|42132121|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
19685462|NCT00433160|42132122|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
19685463|NCT00239356|42132134|FG000|Overall Study|Lack of Efficacy|1|||
19685464|NCT00239356|42132135|FG001|Overall Study|Lack of Efficacy|0|||
19685465|NCT00239356|42132134|FG000|Overall Study|Adverse Event|6|||
19685466|NCT00239356|42132135|FG001|Overall Study|Adverse Event|0|||
19685467|NCT00239356|42132134|FG000|Overall Study|Withdrawal by Subject|15|||
19685468|NCT00239356|42132135|FG001|Overall Study|Withdrawal by Subject|6|||
19685469|NCT00239356|42132134|FG000|Overall Study|Lost to Follow-up|3|||
19685470|NCT00239356|42132135|FG001|Overall Study|Lost to Follow-up|0|||
19685471|NCT00239356|42132134|FG000|Overall Study|poor/non-compliance|2|||
19685472|NCT00239356|42132135|FG001|Overall Study|poor/non-compliance|0|||
19685473|NCT00239356|42132134|FG000|Overall Study|Pregnancy|1|||
19685474|NCT00239356|42132135|FG001|Overall Study|Pregnancy|0|||
19685475|NCT00239356|42132134|FG000|Overall Study|Administrative reason|0|||
19685476|NCT00239356|42132135|FG001|Overall Study|Administrative reason|1|||
19685477|NCT00239356|42132134|FG000|Overall Study|Drug available on market|11|||
19685478|NCT00239356|42132135|FG001|Overall Study|Drug available on market|2|||
19685479|NCT00393510|42132143|FG000|Overall Study|Physician Decision|3|||
19685480|NCT00393510|42132144|FG001|Overall Study|Physician Decision|9|||
19685481|NCT00425438|42132152|FG000|Overall Study|Termination by Sponsor|25|||
19685482|NCT00425438|42132153|FG001|Overall Study|Termination by Sponsor|27|||
19685483|NCT00275002|42132161|FG000|Overall Study|Death|1|||
19685484|NCT00275002|42132162|FG001|Overall Study|Death|0|||
19685485|NCT00275002|42132161|FG000|Overall Study|Disease progression|21|||
19769257|NCT02642029|42222894|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
19769258|NCT02642029|42222889|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
19769259|NCT02642029|42222890|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
19685486|NCT00275002|42132162|FG001|Overall Study|Disease progression|15|||
19685487|NCT00275002|42132161|FG000|Overall Study|Adverse Event|0|||
19685488|NCT00275002|42132162|FG001|Overall Study|Adverse Event|1|||
19685489|NCT00433004|42132170|FG000|Overall Study|Lost to Follow-up|5|||
19685490|NCT00433004|42132171|FG001|Overall Study|Lost to Follow-up|7|||
19685491|NCT00238264|42132177|FG000|Overall Study|Death|7|||
19685492|NCT00238264|42132177|FG000|Overall Study|Lost to Follow-up|18|||
19685493|NCT00238264|42132177|FG000|Overall Study|Withdrawal by Subject|4|||
19685494|NCT00238264|42132177|FG000|Overall Study|Ineligible|7|||
19685495|NCT00414596|42132181|FG000|Overall Study|Protocol Violation|2|||
19685496|NCT00393042|42132185|FG000|First Intervention|Withdrawal by Subject|1|||
19685497|NCT00393042|42132186|FG001|First Intervention|Withdrawal by Subject|2|||
19685498|NCT00393042|42132185|FG000|First Intervention|Lost to Follow-up|3|||
19685499|NCT00393042|42132186|FG001|First Intervention|Lost to Follow-up|3|||
19685500|NCT00393042|42132185|FG000|First Intervention|Protocol Violation|1|||
19685501|NCT00393042|42132186|FG001|First Intervention|Protocol Violation|0|||
19685502|NCT00393042|42132185|FG000|First Intervention|Adverse Event|0|||
19685503|NCT00393042|42132186|FG001|First Intervention|Adverse Event|1|||
19685504|NCT00393042|42132185|FG000|Second Intervetion|Adverse Event|0|||
19685505|NCT00393042|42132186|FG001|Second Intervetion|Adverse Event|3|||
19685506|NCT00393042|42132185|FG000|Second Intervetion|Withdrawal by Subject|0|||
19685507|NCT00393042|42132186|FG001|Second Intervetion|Withdrawal by Subject|2|||
19685508|NCT00393042|42132185|FG000|Second Intervetion|Lack of Efficacy|1|||
19685509|NCT00393042|42132186|FG001|Second Intervetion|Lack of Efficacy|0|||
19685510|NCT00393042|42132185|FG000|Second Intervetion|Lost to Follow-up|0|||
19685511|NCT00393042|42132186|FG001|Second Intervetion|Lost to Follow-up|2|||
19685512|NCT00393042|42132185|FG000|Second Intervetion|Protocol Violation|1|||
19769260|NCT02642029|42222891|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
19685513|NCT00393042|42132186|FG001|Second Intervetion|Protocol Violation|1|||
19685514|NCT00392808|42132244|FG000|Overall Study|Lost to Follow-up|3|||
19685515|NCT00392808|42132245|FG001|Overall Study|Lost to Follow-up|2|||
19685516|NCT00392808|42132246|FG002|Overall Study|Lost to Follow-up|1|||
19685517|NCT00392808|42132247|FG003|Overall Study|Lost to Follow-up|2|||
19685518|NCT00392808|42132244|FG000|Overall Study|Unable to withdraw blood|3|||
19685519|NCT00392808|42132245|FG001|Overall Study|Unable to withdraw blood|1|||
19685520|NCT00392808|42132246|FG002|Overall Study|Unable to withdraw blood|1|||
19685521|NCT00392808|42132247|FG003|Overall Study|Unable to withdraw blood|2|||
19685522|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
19685523|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
19685524|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
19685525|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
19685526|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
19685527|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
19685528|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
19685529|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
19685530|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
19685531|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
19685532|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
19685533|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
19685534|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
19685535|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
19685536|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
19685537|NCT00274924|42132269|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
19685538|NCT00274924|42132270|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
19685539|NCT00274924|42132271|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
19685540|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
19685541|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
19685542|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
19685543|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
19685544|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
19685545|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
19685546|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
19685547|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
19685548|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
19685549|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
19685550|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
19685551|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
19685552|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
19685553|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
19685554|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
19685555|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
19685556|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
19685557|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
19769261|NCT02642029|42222892|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
19769262|NCT02642029|42222893|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
19769263|NCT02642029|42222894|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
19769264|NCT02642029|42222889|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
19769265|NCT02642029|42222890|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
19769266|NCT02642029|42222891|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
19769267|NCT02642029|42222892|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
19769268|NCT02642029|42222893|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
19769269|NCT02642029|42222894|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
19769270|NCT03178669|42222907|FG000|Overall Study|Adverse Event|4|||
19769271|NCT03178669|42222908|FG001|Overall Study|Adverse Event|1|||
19769272|NCT03178669|42222909|FG002|Overall Study|Adverse Event|4|||
19769273|NCT03178669|42222910|FG003|Overall Study|Adverse Event|2|||
19685558|NCT00274924|42132269|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
19685559|NCT00274924|42132270|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
19685560|NCT00274924|42132271|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
19685561|NCT00274846|42132278|FG000|Overall Study|Did not receive adequate NK cells|1|||
19685562|NCT00237796|42132285|FG000|Overall Study|Baseline and one other ILSS required|10|||
19685563|NCT00237796|42132286|FG001|Overall Study|Baseline and one other ILSS required|5|||
19685564|NCT00414440|42132295|FG000|Core Period|Withdrawal by Subject|70|||
19685565|NCT00414440|42132296|FG001|Core Period|Withdrawal by Subject|32|||
19685566|NCT00414440|42132295|FG000|Extension Period|Lost to Follow-up|44|||
19685567|NCT00414440|42132296|FG001|Extension Period|Lost to Follow-up|52|||
19685568|NCT00414440|42132295|FG000|Extension Period|Did not consent to continue follow up|61|||
19685569|NCT00414440|42132296|FG001|Extension Period|Did not consent to continue follow up|54|||
19685570|NCT00414440|42132295|FG000|Extension Period|Other|1|||
19685571|NCT00414440|42132296|FG001|Extension Period|Other|1|||
19685572|NCT00414440|42132295|FG000|Extension Period|Administrative|16|||
19685573|NCT00414440|42132296|FG001|Extension Period|Administrative|16|||
19685574|NCT00414440|42132295|FG000|Extension Period|Death|1|||
19685575|NCT00414440|42132296|FG001|Extension Period|Death|2|||
19685576|NCT00414440|42132295|FG000|Extension Period|Withdrawal by Subject|9|||
19769274|NCT03178669|42222911|FG004|Overall Study|Adverse Event|2|||
19769275|NCT03178669|42222907|FG000|Overall Study|Lack of Efficacy|0|||
19769276|NCT03178669|42222908|FG001|Overall Study|Lack of Efficacy|0|||
19769277|NCT03178669|42222909|FG002|Overall Study|Lack of Efficacy|2|||
19769278|NCT03178669|42222910|FG003|Overall Study|Lack of Efficacy|0|||
19769279|NCT03178669|42222911|FG004|Overall Study|Lack of Efficacy|1|||
19769280|NCT03178669|42222907|FG000|Overall Study|Physician Decision|0|||
19769281|NCT03178669|42222908|FG001|Overall Study|Physician Decision|0|||
19769282|NCT03178669|42222909|FG002|Overall Study|Physician Decision|0|||
19769283|NCT03178669|42222910|FG003|Overall Study|Physician Decision|0|||
19769284|NCT03178669|42222911|FG004|Overall Study|Physician Decision|1|||
19769285|NCT03178669|42222907|FG000|Overall Study|Withdrawal by Subject|1|||
19605468|NCT00694369|42054235|FG003|Overall Study|Withdrawal by Subject|1|||
19605469|NCT00694369|42054236|FG004|Overall Study|Withdrawal by Subject|2|||
19605470|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
19685577|NCT00414440|42132296|FG001|Extension Period|Withdrawal by Subject|7|||
19685578|NCT00414440|42132295|FG000|Extension Period|Not included in follow up period|18|||
19685579|NCT00414440|42132296|FG001|Extension Period|Not included in follow up period|8|||
19685580|NCT00209560|42132304|FG000|Overall Study|Lack of Efficacy|1|||
19685581|NCT00209560|42132305|FG001|Overall Study|Lack of Efficacy|0|||
19685582|NCT00236080|42132316|FG000|Overall Study|Adverse Event|0|||
19685583|NCT00236080|42132317|FG001|Overall Study|Adverse Event|0|||
19685584|NCT00236080|42132318|FG002|Overall Study|Adverse Event|3|||
19685585|NCT00236080|42132319|FG003|Overall Study|Adverse Event|1|||
19685586|NCT00236080|42132320|FG004|Overall Study|Adverse Event|0|||
19685587|NCT00236080|42132316|FG000|Overall Study|Lost to Follow-up|0|||
19685588|NCT00236080|42132317|FG001|Overall Study|Lost to Follow-up|1|||
19685589|NCT00236080|42132318|FG002|Overall Study|Lost to Follow-up|0|||
19685590|NCT00236080|42132319|FG003|Overall Study|Lost to Follow-up|0|||
19685591|NCT00236080|42132320|FG004|Overall Study|Lost to Follow-up|0|||
19685592|NCT00236080|42132316|FG000|Overall Study|Physician Decision|1|||
19685593|NCT00236080|42132317|FG001|Overall Study|Physician Decision|0|||
19685594|NCT00236080|42132318|FG002|Overall Study|Physician Decision|1|||
19685595|NCT00236080|42132319|FG003|Overall Study|Physician Decision|1|||
19685596|NCT00236080|42132320|FG004|Overall Study|Physician Decision|1|||
19685597|NCT00236080|42132316|FG000|Overall Study|Withdrawal by Subject|1|||
19685598|NCT00236080|42132317|FG001|Overall Study|Withdrawal by Subject|0|||
19605471|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
19605472|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
19605473|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
19605474|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
19605475|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
19605476|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
19605477|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
19605478|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
19605479|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
19605480|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
19605481|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
19605482|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
19605483|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
19605484|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
19605485|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
19605486|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
19605487|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
19685599|NCT00236080|42132318|FG002|Overall Study|Withdrawal by Subject|0|||
19685600|NCT00236080|42132319|FG003|Overall Study|Withdrawal by Subject|0|||
19685601|NCT00236080|42132320|FG004|Overall Study|Withdrawal by Subject|0|||
19685602|NCT00236080|42132316|FG000|Overall Study|Miscellaneous|0|||
19685603|NCT00236080|42132317|FG001|Overall Study|Miscellaneous|0|||
19685604|NCT00236080|42132318|FG002|Overall Study|Miscellaneous|1|||
19769286|NCT03178669|42222908|FG001|Overall Study|Withdrawal by Subject|0|||
19685605|NCT00236080|42132319|FG003|Overall Study|Miscellaneous|0|||
19685606|NCT00236080|42132320|FG004|Overall Study|Miscellaneous|0|||
19685607|NCT00432380|42132335|FG000|Overall Study|Migrated/moved from study area|3|||
19685608|NCT00432380|42132336|FG001|Overall Study|Migrated/moved from study area|4|||
19769287|NCT03178669|42222909|FG002|Overall Study|Withdrawal by Subject|1|||
19769288|NCT03178669|42222910|FG003|Overall Study|Withdrawal by Subject|1|||
19685609|NCT00432380|42132337|FG002|Overall Study|Migrated/moved from study area|1|||
19685610|NCT00432380|42132335|FG000|Overall Study|Adverse Event|1|||
19685611|NCT00432380|42132336|FG001|Overall Study|Adverse Event|0|||
19685612|NCT00432380|42132337|FG002|Overall Study|Adverse Event|0|||
19685613|NCT00234052|42132346|FG000|Treatment|Withdrawal by Subject|3|||
19685614|NCT00234052|42132346|FG000|Treatment|Adverse Event|5|||
19685615|NCT00234052|42132346|FG000|Treatment|Death|2|||
19685616|NCT00234052|42132346|FG000|Treatment|Progressive Disease|11|||
19769289|NCT03178669|42222911|FG004|Overall Study|Withdrawal by Subject|0|||
19769290|NCT03178669|42222907|FG000|Overall Study|Lost to Follow-up|0|||
19769291|NCT03178669|42222908|FG001|Overall Study|Lost to Follow-up|0|||
19769292|NCT03178669|42222909|FG002|Overall Study|Lost to Follow-up|0|||
19769293|NCT03178669|42222910|FG003|Overall Study|Lost to Follow-up|1|||
19769294|NCT03178669|42222911|FG004|Overall Study|Lost to Follow-up|0|||
19769295|NCT03178201|42222923|FG000|Overall Study|Off study|5|||
19769296|NCT02085408|42222929|FG000|Step 1: Induction|Disease Progression|19|||
19685617|NCT00234052|42132346|FG000|Follow-up for 5 Years|Death|41|||
19685618|NCT00234052|42132346|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
19685619|NCT00234052|42132346|FG000|Follow-up for 5 Years|Other|7|||
19685620|NCT00408408|42132356|FG000|Overall Study|No follow up data|2|||
19685621|NCT00408408|42132357|FG001|Overall Study|No follow up data|3|||
19685622|NCT00408408|42132358|FG002|Overall Study|No follow up data|0|||
19685623|NCT00408408|42132359|FG003|Overall Study|No follow up data|7|||
19685624|NCT00408408|42132360|FG004|Overall Study|No follow up data|5|||
19685625|NCT00408408|42132361|FG005|Overall Study|No follow up data|3|||
19685626|NCT00414050|42132379|FG000|Overall Study|Adverse Event|1|||
19685627|NCT00414050|42132380|FG001|Overall Study|Adverse Event|1|||
19685628|NCT00414050|42132381|FG002|Overall Study|Adverse Event|1|||
19685629|NCT00414050|42132382|FG003|Overall Study|Adverse Event|1|||
19685630|NCT00414050|42132379|FG000|Overall Study|Lost to Follow-up|2|||
19685631|NCT00414050|42132380|FG001|Overall Study|Lost to Follow-up|2|||
19685632|NCT00414050|42132381|FG002|Overall Study|Lost to Follow-up|1|||
19685633|NCT00414050|42132382|FG003|Overall Study|Lost to Follow-up|1|||
19685634|NCT00414050|42132379|FG000|Overall Study|Withdrawal by Subject|5|||
19685635|NCT00414050|42132380|FG001|Overall Study|Withdrawal by Subject|3|||
19685636|NCT00414050|42132381|FG002|Overall Study|Withdrawal by Subject|2|||
19685637|NCT00414050|42132382|FG003|Overall Study|Withdrawal by Subject|4|||
19685638|NCT00414050|42132379|FG000|Overall Study|Subject discontinued for other reason|1|||
19685639|NCT00414050|42132380|FG001|Overall Study|Subject discontinued for other reason|2|||
19685640|NCT00414050|42132381|FG002|Overall Study|Subject discontinued for other reason|2|||
19685641|NCT00414050|42132382|FG003|Overall Study|Subject discontinued for other reason|1|||
19685642|NCT00414050|42132379|FG000|Overall Study|Subject Moved|0|||
19685643|NCT00414050|42132380|FG001|Overall Study|Subject Moved|0|||
19685644|NCT00414050|42132381|FG002|Overall Study|Subject Moved|0|||
19685645|NCT00414050|42132382|FG003|Overall Study|Subject Moved|1|||
19685646|NCT00413972|42132396|FG000|Overall Study|Adverse Event|2|||
19685647|NCT00413972|42132397|FG001|Overall Study|Adverse Event|1|||
19685648|NCT00413972|42132398|FG002|Overall Study|Adverse Event|0|||
19685649|NCT00413972|42132399|FG003|Overall Study|Adverse Event|0|||
19685650|NCT00413972|42132396|FG000|Overall Study|Lost to Follow-up|1|||
19685651|NCT00413972|42132397|FG001|Overall Study|Lost to Follow-up|2|||
19685652|NCT00413972|42132398|FG002|Overall Study|Lost to Follow-up|1|||
19685653|NCT00413972|42132399|FG003|Overall Study|Lost to Follow-up|0|||
19685654|NCT00413972|42132396|FG000|Overall Study|Withdrawal by Subject|4|||
19685655|NCT00413972|42132397|FG001|Overall Study|Withdrawal by Subject|5|||
19685656|NCT00413972|42132398|FG002|Overall Study|Withdrawal by Subject|7|||
19685657|NCT00413972|42132399|FG003|Overall Study|Withdrawal by Subject|2|||
19685658|NCT00413972|42132396|FG000|Overall Study|Protocol Violation|0|||
19685659|NCT00413972|42132397|FG001|Overall Study|Protocol Violation|0|||
19685660|NCT00413972|42132398|FG002|Overall Study|Protocol Violation|2|||
19685661|NCT00413972|42132399|FG003|Overall Study|Protocol Violation|0|||
19685662|NCT00413972|42132396|FG000|Overall Study|Other|0|||
19685663|NCT00413972|42132397|FG001|Overall Study|Other|0|||
19685664|NCT00413972|42132398|FG002|Overall Study|Other|0|||
19685665|NCT00413972|42132399|FG003|Overall Study|Other|1|||
19769297|NCT02085408|42222930|FG001|Step 1: Induction|Disease Progression|19|||
19769298|NCT02085408|42222929|FG000|Step 1: Induction|Adverse Event|18|||
19769299|NCT02085408|42222930|FG001|Step 1: Induction|Adverse Event|17|||
19685666|NCT00259012|42132411|FG000|Overall Study|Adverse Event|0|||
19685667|NCT00259012|42132412|FG001|Overall Study|Adverse Event|1|||
19685668|NCT00259012|42132411|FG000|Overall Study|Withdrawal by Subject|1|||
19685669|NCT00259012|42132412|FG001|Overall Study|Withdrawal by Subject|0|||
19685670|NCT00259012|42132411|FG000|Overall Study|Physician Decision|0|||
19685671|NCT00259012|42132412|FG001|Overall Study|Physician Decision|1|||
19685672|NCT00259012|42132411|FG000|Overall Study|Lost to Follow-up|0|||
19685673|NCT00259012|42132412|FG001|Overall Study|Lost to Follow-up|1|||
19685674|NCT00259012|42132411|FG000|Overall Study|Protocol Violation|1|||
19769300|NCT02085408|42222929|FG000|Step 1: Induction|Death|33|||
19769301|NCT02085408|42222930|FG001|Step 1: Induction|Death|30|||
19685675|NCT00259012|42132412|FG001|Overall Study|Protocol Violation|1|||
19685676|NCT00209170|42132420|FG000|Overall Study|Adverse Event|0|||
19685677|NCT00209170|42132421|FG001|Overall Study|Adverse Event|1|||
19685678|NCT00209170|42132420|FG000|Overall Study|Withdrawal by Subject|2|||
19685679|NCT00209170|42132421|FG001|Overall Study|Withdrawal by Subject|1|||
19685680|NCT00209170|42132420|FG000|Overall Study|Lack of Efficacy|0|||
19685681|NCT00209170|42132421|FG001|Overall Study|Lack of Efficacy|1|||
19685682|NCT00413894|42132427|FG000|Overall Study|Withdrawal by Subject|10|||
19685683|NCT00413894|42132427|FG000|Overall Study|Administrative Reasons|1|||
19685684|NCT00413894|42132427|FG000|Overall Study|Hb <10 grams/deciliter|12|||
19685685|NCT00413894|42132427|FG000|Overall Study|Adverse Event|28|||
19685686|NCT00413894|42132427|FG000|Overall Study|Protocol Violation|11|||
19685687|NCT00413894|42132427|FG000|Overall Study|Other|18|||
19685688|NCT00407550|42132436|FG000|Overall Study|Adverse Event|0|||
19685689|NCT00407550|42132437|FG001|Overall Study|Adverse Event|1|||
19685690|NCT00407550|42132436|FG000|Overall Study|Withdrawal by Subject|0|||
19685691|NCT00407550|42132437|FG001|Overall Study|Withdrawal by Subject|2|||
19685692|NCT00407550|42132436|FG000|Overall Study|Death|1|||
19685693|NCT00407550|42132437|FG001|Overall Study|Death|0|||
19685694|NCT00407550|42132436|FG000|Overall Study|Insurance or Other medical condition|2|||
19685695|NCT00407550|42132437|FG001|Overall Study|Insurance or Other medical condition|1|||
19685696|NCT00209092|42132445|FG000|Overall Study|Progression of disease|7|||
19685697|NCT00209092|42132446|FG001|Overall Study|Progression of disease|1|||
19685698|NCT00209092|42132445|FG000|Overall Study|Adverse Event|0|||
19685699|NCT00209092|42132446|FG001|Overall Study|Adverse Event|1|||
19685700|NCT00209092|42132445|FG000|Overall Study|Withdrawal by Subject|1|||
19685701|NCT00209092|42132446|FG001|Overall Study|Withdrawal by Subject|0|||
19685702|NCT00403494|42132454|FG000|Overall Study|Adverse Event|10|||
19685703|NCT00403494|42132455|FG001|Overall Study|Adverse Event|8|||
19685704|NCT00403494|42132454|FG000|Overall Study|Withdrew Consent|3|||
19685705|NCT00403494|42132455|FG001|Overall Study|Withdrew Consent|2|||
19685706|NCT00403494|42132454|FG000|Overall Study|Inappropriately enrolled|0|||
19685707|NCT00403494|42132455|FG001|Overall Study|Inappropriately enrolled|1|||
19685708|NCT00403494|42132454|FG000|Overall Study|Lost to Follow-up|0|||
19685709|NCT00403494|42132455|FG001|Overall Study|Lost to Follow-up|2|||
19685710|NCT00403494|42132454|FG000|Overall Study|Protocol noncompliance|0|||
19685711|NCT00403494|42132455|FG001|Overall Study|Protocol noncompliance|1|||
19685712|NCT00403494|42132454|FG000|Overall Study|Death|1|||
19685713|NCT00403494|42132455|FG001|Overall Study|Death|0|||
19685714|NCT00403494|42132454|FG000|Overall Study|Sponsor Request|1|||
19685715|NCT00403494|42132455|FG001|Overall Study|Sponsor Request|0|||
19685716|NCT00403260|42132465|FG000|Overall Study|Adverse Event|5|||
19685717|NCT00403260|42132466|FG001|Overall Study|Adverse Event|4|||
19685718|NCT00403260|42132465|FG000|Overall Study|Withdrawal by Subject|5|||
19685719|NCT00403260|42132466|FG001|Overall Study|Withdrawal by Subject|6|||
19685720|NCT00403260|42132465|FG000|Overall Study|Lost to Follow-up|49|||
19685721|NCT00403260|42132466|FG001|Overall Study|Lost to Follow-up|25|||
19685722|NCT00403260|42132465|FG000|Overall Study|Re-appearance of P. falciparum|34|||
19685723|NCT00403260|42132466|FG001|Overall Study|Re-appearance of P. falciparum|25|||
19685724|NCT00403260|42132465|FG000|Overall Study|P. vivax infection|26|||
19685725|NCT00403260|42132466|FG001|Overall Study|P. vivax infection|4|||
19685726|NCT00403260|42132465|FG000|Overall Study|Mixed infection with P. vivax|2|||
19685727|NCT00403260|42132466|FG001|Overall Study|Mixed infection with P. vivax|0|||
19685728|NCT00403260|42132465|FG000|Overall Study|Mixed infection with P. falciparum|1|||
19685729|NCT00403260|42132466|FG001|Overall Study|Mixed infection with P. falciparum|0|||
19685730|NCT00403260|42132465|FG000|Overall Study|P. vivax infection at screening|1|||
19685731|NCT00403260|42132466|FG001|Overall Study|P. vivax infection at screening|0|||
19685732|NCT00403260|42132465|FG000|Overall Study|P. ovale infection|1|||
19685733|NCT00403260|42132466|FG001|Overall Study|P. ovale infection|0|||
19685734|NCT00403260|42132465|FG000|Overall Study|Gametocyte re-appearance|1|||
19685735|NCT00403260|42132466|FG001|Overall Study|Gametocyte re-appearance|1|||
19685736|NCT00403260|42132465|FG000|Overall Study|Withdrawn from study accidentally|0|||
19685737|NCT00403260|42132466|FG001|Overall Study|Withdrawn from study accidentally|1|||
19685738|NCT00406848|42132474|FG000|Overall Study|Withdrawal by Subject|27|||
19685739|NCT00406848|42132475|FG001|Overall Study|Withdrawal by Subject|22|||
19685740|NCT00406848|42132474|FG000|Overall Study|Adverse Event|38|||
19685741|NCT00406848|42132475|FG001|Overall Study|Adverse Event|7|||
19685742|NCT00406848|42132474|FG000|Overall Study|Lack of Efficacy|9|||
19685743|NCT00406848|42132475|FG001|Overall Study|Lack of Efficacy|14|||
19685744|NCT00406848|42132474|FG000|Overall Study|Protocol Violation|10|||
19685745|NCT00406848|42132475|FG001|Overall Study|Protocol Violation|6|||
19685746|NCT00406848|42132474|FG000|Overall Study|Lost to Follow-up|6|||
19685747|NCT00406848|42132475|FG001|Overall Study|Lost to Follow-up|2|||
19685748|NCT00406848|42132474|FG000|Overall Study|Physician Decision|2|||
19685749|NCT00406848|42132475|FG001|Overall Study|Physician Decision|2|||
19769302|NCT02085408|42222929|FG000|Step 1: Induction|Withdrawal by Subject|16|||
19685750|NCT00406848|42132474|FG000|Overall Study|Sponsor Decision|1|||
19685751|NCT00406848|42132475|FG001|Overall Study|Sponsor Decision|1|||
19685752|NCT00406692|42132484|FG000|Overall Study|Withdrawal by Subject|4|||
19685753|NCT00406692|42132484|FG000|Overall Study|Physician Decision|1|||
19685754|NCT00406692|42132484|FG000|Overall Study|Adverse Event|1|||
19685755|NCT00406692|42132484|FG000|Overall Study|Lack of Efficacy|1|||
19769303|NCT02085408|42222930|FG001|Step 1: Induction|Withdrawal by Subject|8|||
19769304|NCT02085408|42222929|FG000|Step 1: Induction|Alternative Therapy|15|||
19769305|NCT02085408|42222930|FG001|Step 1: Induction|Alternative Therapy|19|||
19605488|NCT03412747|42054251|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
19685756|NCT00315705|42132490|FG000|Phase 1|Refused further treatment|1|||
19685757|NCT00315705|42132490|FG000|Phase 1|Failure to achieve response|8|||
19685758|NCT00315705|42132490|FG000|Phase 1|Disease relapse|4|||
19685759|NCT00315705|42132490|FG000|Phase 1|Scheduled for transplant|9|||
19685760|NCT00315705|42132490|FG000|Phase 1|Death|3|||
19685761|NCT00315705|42132490|FG000|Phase 2|Physician Decision|4|||
19685762|NCT00315705|42132490|FG000|Phase 2|Adverse Event|1|||
19685763|NCT00315705|42132490|FG000|Phase 2|Failure to achieve response|3|||
19685764|NCT00315705|42132490|FG000|Phase 2|Disease relapse|1|||
19685765|NCT00315705|42132490|FG000|Phase 2|Scheduled for transplant|8|||
19685766|NCT00315705|42132490|FG000|Phase 2|Other|1|||
19685767|NCT00315705|42132490|FG000|Phase 2|Death|7|||
19685768|NCT00307125|42132509|FG000|Screening Phase|Adverse Event|1|||
19685769|NCT00307125|42132510|FG001|Screening Phase|Adverse Event|0|||
19685770|NCT00307125|42132511|FG002|Screening Phase|Adverse Event|0|||
19685771|NCT00307125|42132509|FG000|Screening Phase|Protocol Violation|27|||
19685772|NCT00307125|42132510|FG001|Screening Phase|Protocol Violation|0|||
19685773|NCT00307125|42132511|FG002|Screening Phase|Protocol Violation|0|||
19685774|NCT00307125|42132509|FG000|Screening Phase|Lost to Follow-up|87|||
19685775|NCT00307125|42132510|FG001|Screening Phase|Lost to Follow-up|0|||
19685776|NCT00307125|42132511|FG002|Screening Phase|Lost to Follow-up|0|||
19685777|NCT00307125|42132509|FG000|Screening Phase|Death|10|||
19685778|NCT00307125|42132510|FG001|Screening Phase|Death|0|||
19685779|NCT00307125|42132511|FG002|Screening Phase|Death|0|||
19685780|NCT00307125|42132509|FG000|Screening Phase|Withdrawal by Subject|77|||
19685781|NCT00307125|42132510|FG001|Screening Phase|Withdrawal by Subject|0|||
19685782|NCT00307125|42132511|FG002|Screening Phase|Withdrawal by Subject|0|||
19685783|NCT00307125|42132509|FG000|Screening Phase|Physician Decision|26|||
19685784|NCT00307125|42132510|FG001|Screening Phase|Physician Decision|0|||
19685785|NCT00307125|42132511|FG002|Screening Phase|Physician Decision|0|||
19685786|NCT00307125|42132509|FG000|Screening Phase|Sponsor Decision|4|||
19685787|NCT00307125|42132510|FG001|Screening Phase|Sponsor Decision|0|||
19685788|NCT00307125|42132511|FG002|Screening Phase|Sponsor Decision|0|||
19685789|NCT00307125|42132509|FG000|Screening Phase|Study Terminated|17|||
19685790|NCT00307125|42132510|FG001|Screening Phase|Study Terminated|0|||
19685791|NCT00307125|42132511|FG002|Screening Phase|Study Terminated|0|||
19685792|NCT00307125|42132509|FG000|Screening Phase|Graft Loss|3|||
19605489|NCT03412747|42054252|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
19605490|NCT03412747|42054253|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
19605491|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
19605492|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
19605493|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
19605494|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
19605495|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
19605496|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
19605497|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
19605498|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
19605499|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
19605500|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
19605501|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
19605502|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
19605503|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
19605504|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
19605505|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
19605506|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
19685793|NCT00307125|42132510|FG001|Screening Phase|Graft Loss|0|||
19685794|NCT00307125|42132511|FG002|Screening Phase|Graft Loss|0|||
19685795|NCT00307125|42132509|FG000|Screening Phase|Graft Failure|8|||
19685796|NCT00307125|42132510|FG001|Screening Phase|Graft Failure|0|||
19769306|NCT02085408|42222929|FG000|Step 1: Induction|Complicating Disease|2|||
19685797|NCT00307125|42132511|FG002|Screening Phase|Graft Failure|0|||
19685798|NCT00307125|42132509|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
19685799|NCT00307125|42132510|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
19685800|NCT00307125|42132511|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
19685801|NCT00307125|42132509|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
19685802|NCT00307125|42132510|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
19685803|NCT00307125|42132511|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
19685804|NCT00307125|42132509|FG000|Screening Phase|Moved or transferred facilities|34|||
19685805|NCT00307125|42132510|FG001|Screening Phase|Moved or transferred facilities|0|||
19685806|NCT00307125|42132511|FG002|Screening Phase|Moved or transferred facilities|0|||
19685807|NCT00307125|42132509|FG000|Screening Phase|Received Pancreas Transplant|8|||
19685808|NCT00307125|42132510|FG001|Screening Phase|Received Pancreas Transplant|0|||
19685809|NCT00307125|42132511|FG002|Screening Phase|Received Pancreas Transplant|0|||
19685810|NCT00307125|42132509|FG000|Screening Phase|Ineligible for pilot|4|||
19685811|NCT00307125|42132510|FG001|Screening Phase|Ineligible for pilot|0|||
19685812|NCT00307125|42132511|FG002|Screening Phase|Ineligible for pilot|0|||
19685813|NCT00307125|42132509|FG000|Screening Phase|Try to get pregnant|1|||
19685814|NCT00307125|42132510|FG001|Screening Phase|Try to get pregnant|0|||
19685815|NCT00307125|42132511|FG002|Screening Phase|Try to get pregnant|0|||
19685816|NCT00307125|42132509|FG000|Screening Phase|Developed acute leukemia|1|||
19685817|NCT00307125|42132510|FG001|Screening Phase|Developed acute leukemia|0|||
19685818|NCT00307125|42132511|FG002|Screening Phase|Developed acute leukemia|0|||
19685819|NCT00307125|42132509|FG000|Screening Phase|Metastatic colon cancer|1|||
19685820|NCT00307125|42132510|FG001|Screening Phase|Metastatic colon cancer|0|||
19685821|NCT00307125|42132511|FG002|Screening Phase|Metastatic colon cancer|0|||
19685822|NCT00307125|42132509|FG000|Screening Phase|Malignancy|1|||
19685823|NCT00307125|42132510|FG001|Screening Phase|Malignancy|0|||
19685824|NCT00307125|42132511|FG002|Screening Phase|Malignancy|0|||
19685825|NCT00307125|42132509|FG000|Screening Phase|PAK|1|||
19685826|NCT00307125|42132510|FG001|Screening Phase|PAK|0|||
19685827|NCT00307125|42132511|FG002|Screening Phase|PAK|0|||
19685828|NCT00307125|42132509|FG000|Screening Phase|Ineligible|1|||
19685829|NCT00307125|42132510|FG001|Screening Phase|Ineligible|0|||
19685830|NCT00307125|42132511|FG002|Screening Phase|Ineligible|0|||
19685831|NCT00307125|42132509|FG000|Screening Phase|Screen Error|1|||
19685832|NCT00307125|42132510|FG001|Screening Phase|Screen Error|0|||
19685833|NCT00307125|42132511|FG002|Screening Phase|Screen Error|0|||
19685834|NCT00307125|42132509|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
19685835|NCT00307125|42132510|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
19685836|NCT00307125|42132511|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
19685837|NCT00307125|42132509|FG000|Screening Phase|AMR and treated with rituximab|1|||
19685838|NCT00307125|42132510|FG001|Screening Phase|AMR and treated with rituximab|0|||
19685839|NCT00307125|42132511|FG002|Screening Phase|AMR and treated with rituximab|0|||
19685840|NCT00307125|42132509|FG000|Screening Phase|Coronary artery bypass|1|||
19685841|NCT00307125|42132510|FG001|Screening Phase|Coronary artery bypass|0|||
19685842|NCT00307125|42132511|FG002|Screening Phase|Coronary artery bypass|0|||
19685843|NCT00307125|42132509|FG000|Pilot Phase|Lost to Follow-up|0|||
19685844|NCT00307125|42132510|FG001|Pilot Phase|Lost to Follow-up|1|||
19685845|NCT00307125|42132511|FG002|Pilot Phase|Lost to Follow-up|0|||
19685846|NCT00307125|42132509|FG000|Pilot Phase|Withdrawal by Subject|0|||
19685847|NCT00307125|42132510|FG001|Pilot Phase|Withdrawal by Subject|1|||
19685848|NCT00307125|42132511|FG002|Pilot Phase|Withdrawal by Subject|1|||
19685849|NCT00307047|42132523|FG000|Overall Study|Lost to Follow-up|35|||
19685850|NCT00307047|42132524|FG001|Overall Study|Lost to Follow-up|24|||
19685851|NCT00307047|42132523|FG000|Overall Study|Withdrawal by Subject|6|||
19685852|NCT00307047|42132524|FG001|Overall Study|Withdrawal by Subject|6|||
19685853|NCT00307047|42132523|FG000|Overall Study|Physician Decision|1|||
19685854|NCT00307047|42132524|FG001|Overall Study|Physician Decision|2|||
19685855|NCT00307047|42132523|FG000|Overall Study|Lost to follow-up for other reasons|0|||
19685856|NCT00307047|42132524|FG001|Overall Study|Lost to follow-up for other reasons|1|||
19685857|NCT00307047|42132523|FG000|Overall Study|All death, all MI, all Revascularization|27|||
19685858|NCT00307047|42132524|FG001|Overall Study|All death, all MI, all Revascularization|16|||
19685859|NCT00306891|42132534|FG000|Part A|Withdrawal by Subject|1|||
19685860|NCT00306891|42132535|FG001|Part A|Withdrawal by Subject|1|||
19685861|NCT00306891|42132536|FG002|Part A|Withdrawal by Subject|0|||
19685862|NCT00306891|42132537|FG003|Part A|Withdrawal by Subject|0|||
19685863|NCT00306891|42132534|FG000|Part A|Condition under investigation worsened|2|||
19685864|NCT00306891|42132535|FG001|Part A|Condition under investigation worsened|2|||
19685865|NCT00306891|42132536|FG002|Part A|Condition under investigation worsened|0|||
19685866|NCT00306891|42132537|FG003|Part A|Condition under investigation worsened|0|||
19685867|NCT00306891|42132534|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
19685868|NCT00306891|42132535|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
19685869|NCT00306891|42132536|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
19685870|NCT00306891|42132537|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
19685871|NCT00306891|42132534|FG000|Part A|Partial bowel obstruction|1|||
19685872|NCT00306891|42132535|FG001|Part A|Partial bowel obstruction|0|||
19685873|NCT00306891|42132536|FG002|Part A|Partial bowel obstruction|0|||
19685874|NCT00306891|42132537|FG003|Part A|Partial bowel obstruction|0|||
19685875|NCT00306891|42132534|FG000|Part A|Reaccumul. of ascites following drainage|0|||
19685876|NCT00306891|42132535|FG001|Part A|Reaccumul. of ascites following drainage|1|||
19685877|NCT00306891|42132536|FG002|Part A|Reaccumul. of ascites following drainage|0|||
19685878|NCT00306891|42132537|FG003|Part A|Reaccumul. of ascites following drainage|0|||
19685879|NCT00306891|42132534|FG000|Part A|Suspicion of second malignancy|0|||
19685880|NCT00306891|42132535|FG001|Part A|Suspicion of second malignancy|1|||
19685881|NCT00306891|42132536|FG002|Part A|Suspicion of second malignancy|0|||
19685882|NCT00306891|42132537|FG003|Part A|Suspicion of second malignancy|0|||
19685883|NCT00306891|42132534|FG000|Part A|QTC interval outwith elig. criteria|1|||
19685884|NCT00306891|42132535|FG001|Part A|QTC interval outwith elig. criteria|0|||
19685885|NCT00306891|42132536|FG002|Part A|QTC interval outwith elig. criteria|0|||
19685886|NCT00306891|42132537|FG003|Part A|QTC interval outwith elig. criteria|0|||
19685887|NCT00306891|42132534|FG000|Part B|Death|0|||
19769307|NCT02085408|42222930|FG001|Step 1: Induction|Complicating Disease|3|||
19769308|NCT02085408|42222929|FG000|Step 1: Induction|Other|27|||
19769309|NCT02085408|42222930|FG001|Step 1: Induction|Other|39|||
19685888|NCT00306891|42132535|FG001|Part B|Death|0|||
19685889|NCT00306891|42132536|FG002|Part B|Death|1|||
19685890|NCT00306891|42132537|FG003|Part B|Death|2|||
19685891|NCT00306891|42132534|FG000|Part B|Adverse Event|0|||
19769310|NCT02085408|42222929|FG000|Step 1: Induction|Never started treatment|6|||
19769311|NCT02085408|42222930|FG001|Step 1: Induction|Never started treatment|4|||
19769312|NCT02085408|42222929|FG000|Step 2: Consolidation|Disease Progression|5|||
19769313|NCT02085408|42222930|FG001|Step 2: Consolidation|Disease Progression|20|||
19769314|NCT02085408|42222929|FG000|Step 2: Consolidation|Adverse Event|9|||
19769315|NCT02085408|42222930|FG001|Step 2: Consolidation|Adverse Event|8|||
19769316|NCT02085408|42222929|FG000|Step 2: Consolidation|Death|4|||
19769317|NCT02085408|42222930|FG001|Step 2: Consolidation|Death|3|||
19769318|NCT02085408|42222929|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
19769319|NCT02085408|42222930|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
19685892|NCT00306891|42132535|FG001|Part B|Adverse Event|0|||
19685893|NCT00306891|42132536|FG002|Part B|Adverse Event|5|||
19685894|NCT00306891|42132537|FG003|Part B|Adverse Event|5|||
19685895|NCT00306891|42132534|FG000|Part B|Withdrawal by Subject|0|||
19685896|NCT00306891|42132535|FG001|Part B|Withdrawal by Subject|0|||
19685897|NCT00306891|42132536|FG002|Part B|Withdrawal by Subject|3|||
19685898|NCT00306891|42132537|FG003|Part B|Withdrawal by Subject|1|||
19685899|NCT00306891|42132534|FG000|Part B|Condition under investigation worsened|0|||
19685900|NCT00306891|42132535|FG001|Part B|Condition under investigation worsened|0|||
19685901|NCT00306891|42132536|FG002|Part B|Condition under investigation worsened|2|||
19685902|NCT00306891|42132537|FG003|Part B|Condition under investigation worsened|8|||
19685903|NCT00306891|42132534|FG000|Part B|Development of study specific disc crit.|0|||
19685904|NCT00306891|42132535|FG001|Part B|Development of study specific disc crit.|0|||
19685905|NCT00306891|42132536|FG002|Part B|Development of study specific disc crit.|0|||
19685906|NCT00306891|42132537|FG003|Part B|Development of study specific disc crit.|1|||
19685907|NCT00314145|42132550|FG000|Overall Study|Withdrawal by Subject|8|||
19685908|NCT00314145|42132551|FG001|Overall Study|Withdrawal by Subject|10|||
19685909|NCT00314145|42132550|FG000|Overall Study|Lost to Follow-up|5|||
19685910|NCT00314145|42132551|FG001|Overall Study|Lost to Follow-up|12|||
19685911|NCT00314145|42132550|FG000|Overall Study|Physician Decision|3|||
19685912|NCT00314145|42132551|FG001|Overall Study|Physician Decision|4|||
19685913|NCT00314145|42132550|FG000|Overall Study|Adverse Event|0|||
19685914|NCT00314145|42132551|FG001|Overall Study|Adverse Event|3|||
19685915|NCT00314145|42132550|FG000|Overall Study|Protocol Violation|3|||
19685916|NCT00314145|42132551|FG001|Overall Study|Protocol Violation|0|||
19685917|NCT00314145|42132550|FG000|Overall Study|Sponsor Decision|2|||
19685918|NCT00314145|42132551|FG001|Overall Study|Sponsor Decision|0|||
19685919|NCT00313911|42132560|FG000|Overall Study|Serious adverse event|6|||
19685920|NCT00313911|42132561|FG001|Overall Study|Serious adverse event|1|||
19685921|NCT00313911|42132560|FG000|Overall Study|Adverse Event|2|||
19685922|NCT00313911|42132561|FG001|Overall Study|Adverse Event|3|||
19685923|NCT00313911|42132560|FG000|Overall Study|Protocol Violation|19|||
19685924|NCT00313911|42132561|FG001|Overall Study|Protocol Violation|10|||
19685925|NCT00313911|42132560|FG000|Overall Study|Lost to Follow-up|27|||
19685926|NCT00313911|42132561|FG001|Overall Study|Lost to Follow-up|14|||
19685927|NCT00313911|42132560|FG000|Overall Study|Withdrawal by Subject|39|||
19685928|NCT00313911|42132561|FG001|Overall Study|Withdrawal by Subject|12|||
19685929|NCT00313911|42132560|FG000|Overall Study|Did not meet age criteria|1|||
19685930|NCT00313911|42132561|FG001|Overall Study|Did not meet age criteria|1|||
19685931|NCT00391872|42132569|FG000|Overall Study|Protocol Violation|7|||
19685932|NCT00391872|42132570|FG001|Overall Study|Protocol Violation|2|||
19685933|NCT00391872|42132569|FG000|Overall Study|Withdrawal by Subject|296|||
19769320|NCT02085408|42222929|FG000|Step 2: Consolidation|Alternative Therapy|9|||
19769321|NCT02085408|42222930|FG001|Step 2: Consolidation|Alternative Therapy|3|||
19769322|NCT02085408|42222929|FG000|Step 2: Consolidation|Complicating Disease|0|||
19685934|NCT00391872|42132570|FG001|Overall Study|Withdrawal by Subject|249|||
19685935|NCT00391872|42132569|FG000|Overall Study|Reason unknown|2|||
19685936|NCT00391872|42132570|FG001|Overall Study|Reason unknown|4|||
19685937|NCT00391872|42132569|FG000|Overall Study|Lost to Follow-up|2|||
19685938|NCT00391872|42132570|FG001|Overall Study|Lost to Follow-up|0|||
19685939|NCT00391170|42132578|FG000|Overall Study|Withdrawal by Subject|1|||
19685940|NCT00391170|42132579|FG001|Overall Study|Withdrawal by Subject|0|||
19685941|NCT00391170|42132578|FG000|Overall Study|Adverse Event|3|||
19685942|NCT00391170|42132579|FG001|Overall Study|Adverse Event|2|||
19685943|NCT00391170|42132578|FG000|Overall Study|Physician Decision|2|||
19685944|NCT00391170|42132579|FG001|Overall Study|Physician Decision|2|||
19685945|NCT00402324|42132587|FG000|Overall Study|Lost to Follow-up|11|||
19685946|NCT00402324|42132588|FG001|Overall Study|Lost to Follow-up|11|||
19685947|NCT00402324|42132587|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
19685948|NCT00402324|42132588|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
19685949|NCT00402324|42132587|FG000|Overall Study|Protocol Violation|8|||
19685950|NCT00402324|42132588|FG001|Overall Study|Protocol Violation|7|||
19685951|NCT00402324|42132587|FG000|Overall Study|Withdrawal by Subject|5|||
19685952|NCT00402324|42132588|FG001|Overall Study|Withdrawal by Subject|2|||
19685953|NCT00402324|42132587|FG000|Overall Study|Physician Decision|2|||
19685954|NCT00402324|42132588|FG001|Overall Study|Physician Decision|4|||
19685955|NCT00402324|42132587|FG000|Overall Study|Sponsor Decision|4|||
19685956|NCT00402324|42132588|FG001|Overall Study|Sponsor Decision|5|||
19685957|NCT00402324|42132587|FG000|Overall Study|Lack of Efficacy|1|||
19685958|NCT00402324|42132588|FG001|Overall Study|Lack of Efficacy|4|||
19685959|NCT00402324|42132587|FG000|Overall Study|Adverse Event|6|||
19685960|NCT00402324|42132588|FG001|Overall Study|Adverse Event|4|||
19685961|NCT00402324|42132587|FG000|Overall Study|Death|1|||
19685962|NCT00402324|42132588|FG001|Overall Study|Death|0|||
19685963|NCT00294723|42132597|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
19685964|NCT00294723|42132598|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
19769323|NCT02085408|42222930|FG001|Step 2: Consolidation|Complicating Disease|2|||
19769324|NCT02085408|42222929|FG000|Step 2: Consolidation|Other|6|||
19769325|NCT02085408|42222930|FG001|Step 2: Consolidation|Other|6|||
19769326|NCT02085408|42222929|FG000|Step 2: Consolidation|Never started treatment|4|||
19685965|NCT00294723|42132599|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
19685966|NCT00294723|42132597|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
19685967|NCT00294723|42132598|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
19685968|NCT00294723|42132599|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
19685969|NCT00294723|42132597|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
19685970|NCT00294723|42132598|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
19685971|NCT00294723|42132599|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
19685972|NCT00294723|42132597|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
19685973|NCT00294723|42132598|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
19685974|NCT00294723|42132599|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
19685975|NCT00294723|42132597|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
19685976|NCT00294723|42132598|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
19685977|NCT00294723|42132599|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
19685978|NCT00294723|42132597|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
19685979|NCT00294723|42132598|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
19685980|NCT00294723|42132599|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
19685981|NCT00294723|42132597|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
19685982|NCT00294723|42132598|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
19685983|NCT00294723|42132599|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
19685984|NCT00294723|42132597|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
19685985|NCT00294723|42132598|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
19685986|NCT00294723|42132599|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
19685987|NCT00294723|42132597|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
19685988|NCT00294723|42132598|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
19685989|NCT00294723|42132599|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
19685990|NCT00294723|42132597|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
19685991|NCT00294723|42132598|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
19685992|NCT00294723|42132599|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
19769327|NCT02085408|42222930|FG001|Step 2: Consolidation|Never started treatment|3|||
19769328|NCT02085408|42222929|FG000|Step 3: Maintenance|Disease Progression|13|||
19769329|NCT02085408|42222930|FG001|Step 3: Maintenance|Disease Progression|11|||
19769330|NCT02085408|42222929|FG000|Step 3: Maintenance|Adverse Event|2|||
19769331|NCT02085408|42222930|FG001|Step 3: Maintenance|Adverse Event|4|||
19769332|NCT02085408|42222929|FG000|Step 3: Maintenance|Death|1|||
19685993|NCT00294723|42132597|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
19769333|NCT02085408|42222930|FG001|Step 3: Maintenance|Death|2|||
19769334|NCT02085408|42222929|FG000|Step 3: Maintenance|Alternative Therapy|1|||
19769335|NCT02085408|42222930|FG001|Step 3: Maintenance|Alternative Therapy|1|||
19769336|NCT02085408|42222929|FG000|Step 3: Maintenance|Complicating Disease|0|||
19769337|NCT02085408|42222930|FG001|Step 3: Maintenance|Complicating Disease|1|||
19769338|NCT02085408|42222929|FG000|Step 3: Maintenance|Other|3|||
19769339|NCT02085408|42222930|FG001|Step 3: Maintenance|Other|2|||
19769340|NCT02085408|42222929|FG000|Step 3: Maintenance|Never started treatment|5|||
19769341|NCT02085408|42222930|FG001|Step 3: Maintenance|Never started treatment|1|||
19769342|NCT03021642|42222945|FG000|Washout Period (21 Days)|Adverse Event|1|||
19769343|NCT03021642|42222946|FG001|Washout Period (21 Days)|Adverse Event|1|||
19769344|NCT03021564|42222954|FG000|Overall Study|Death|84|||
19769345|NCT03021564|42222955|FG001|Overall Study|Death|466|||
19769346|NCT03021564|42222954|FG000|Overall Study|Lost to Follow-up|0|||
19769347|NCT03021564|42222955|FG001|Overall Study|Lost to Follow-up|2|||
19769348|NCT03023046|42222965|FG000|Overall Study|Withdrawal by Subject|1|||
19769349|NCT03019458|42222973|FG000|Overall Study|Death|0|||
19769350|NCT03019458|42222974|FG001|Overall Study|Death|1|||
19769351|NCT02923830|42222984|FG000|Overall Study|Physician Decision|13|||
19769352|NCT02923830|42222985|FG001|Overall Study|Physician Decision|15|||
19769353|NCT03021018|42222994|FG000|Overall Study|Adverse Event|1|||
19769354|NCT03021018|42222995|FG001|Overall Study|Adverse Event|0|||
19769355|NCT03021018|42222996|FG002|Overall Study|Adverse Event|0|||
19769356|NCT03021018|42222994|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
19769357|NCT03021018|42222995|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
19769358|NCT03021018|42222996|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
19769359|NCT02509507|42223013|FG000|Overall Study|Death|21|||
19769360|NCT02509507|42223014|FG001|Overall Study|Death|3|||
19769361|NCT02509507|42223015|FG002|Overall Study|Death|22|||
19769362|NCT02509507|42223016|FG003|Overall Study|Death|13|||
19769363|NCT02509507|42223017|FG004|Overall Study|Death|6|||
19769364|NCT02509507|42223018|FG005|Overall Study|Death|9|||
19769365|NCT02509507|42223019|FG006|Overall Study|Death|4|||
19769366|NCT02509507|42223020|FG007|Overall Study|Death|3|||
19769367|NCT02509507|42223021|FG008|Overall Study|Death|7|||
19769368|NCT02509507|42223013|FG000|Overall Study|Lost to Follow-up|0|||
19769369|NCT02509507|42223014|FG001|Overall Study|Lost to Follow-up|1|||
19769370|NCT02509507|42223015|FG002|Overall Study|Lost to Follow-up|0|||
19769371|NCT02509507|42223016|FG003|Overall Study|Lost to Follow-up|0|||
19769372|NCT02509507|42223017|FG004|Overall Study|Lost to Follow-up|0|||
19769373|NCT02509507|42223018|FG005|Overall Study|Lost to Follow-up|1|||
19769374|NCT02509507|42223019|FG006|Overall Study|Lost to Follow-up|0|||
19769375|NCT02509507|42223020|FG007|Overall Study|Lost to Follow-up|0|||
19769376|NCT02509507|42223021|FG008|Overall Study|Lost to Follow-up|0|||
19769377|NCT02509507|42223013|FG000|Overall Study|Withdrawal by Subject|2|||
19769378|NCT02509507|42223014|FG001|Overall Study|Withdrawal by Subject|0|||
19769379|NCT02509507|42223015|FG002|Overall Study|Withdrawal by Subject|1|||
19769380|NCT02509507|42223016|FG003|Overall Study|Withdrawal by Subject|4|||
19769381|NCT02509507|42223017|FG004|Overall Study|Withdrawal by Subject|0|||
19769382|NCT02509507|42223018|FG005|Overall Study|Withdrawal by Subject|3|||
19769383|NCT02509507|42223019|FG006|Overall Study|Withdrawal by Subject|3|||
19769384|NCT02509507|42223020|FG007|Overall Study|Withdrawal by Subject|0|||
19769385|NCT02509507|42223021|FG008|Overall Study|Withdrawal by Subject|0|||
19769386|NCT02509507|42223013|FG000|Overall Study|Continuing Study|0|||
19769387|NCT02509507|42223014|FG001|Overall Study|Continuing Study|1|||
19769388|NCT02509507|42223015|FG002|Overall Study|Continuing Study|1|||
19769389|NCT02509507|42223016|FG003|Overall Study|Continuing Study|5|||
19769390|NCT02509507|42223017|FG004|Overall Study|Continuing Study|4|||
19769391|NCT02509507|42223018|FG005|Overall Study|Continuing Study|5|||
19769392|NCT02509507|42223019|FG006|Overall Study|Continuing Study|3|||
19769393|NCT02509507|42223020|FG007|Overall Study|Continuing Study|2|||
19769394|NCT02509507|42223021|FG008|Overall Study|Continuing Study|3|||
19769395|NCT03178045|42223048|FG000|Overall Study|Withdrawal by Subject|5|||
19769396|NCT03178045|42223049|FG001|Overall Study|Withdrawal by Subject|7|||
19769397|NCT03178045|42223048|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
19769398|NCT03178045|42223049|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
19769399|NCT03178045|42223048|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
19769400|NCT03178045|42223049|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
19769401|NCT03176407|42223056|FG000|Overall Study|Protocol Violation|1|||
19769402|NCT03176407|42223056|FG000|Overall Study|human failure|1|||
19769403|NCT03176407|42223056|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
19769404|NCT03175549|42223064|FG000|Overall Study|Lost to Follow-up|2|||
19769405|NCT03175549|42223065|FG001|Overall Study|Lost to Follow-up|2|||
19769406|NCT03175549|42223064|FG000|Overall Study|Medication non-compliance|2|||
19769407|NCT03175549|42223065|FG001|Overall Study|Medication non-compliance|2|||
19769408|NCT03174925|42223073|FG000|Overall Study|Elastographic images not retrievable|2|||
19769409|NCT03174925|42223073|FG000|Overall Study|Elastography image not interpretable|1|||
19769410|NCT02924688|42223083|FG000|Overall Study|Adverse Event|9|||
19769411|NCT02924688|42223084|FG001|Overall Study|Adverse Event|3|||
19769412|NCT02924688|42223085|FG002|Overall Study|Adverse Event|2|||
19769413|NCT02924688|42223086|FG003|Overall Study|Adverse Event|2|||
19769414|NCT02924688|42223087|FG004|Overall Study|Adverse Event|3|||
19769415|NCT02924688|42223088|FG005|Overall Study|Adverse Event|2|||
19769416|NCT02924688|42223083|FG000|Overall Study|Lack of Efficacy|2|||
19769417|NCT02924688|42223084|FG001|Overall Study|Lack of Efficacy|3|||
19769418|NCT02924688|42223085|FG002|Overall Study|Lack of Efficacy|4|||
19769419|NCT02924688|42223086|FG003|Overall Study|Lack of Efficacy|2|||
19769420|NCT02924688|42223087|FG004|Overall Study|Lack of Efficacy|1|||
19769421|NCT02924688|42223088|FG005|Overall Study|Lack of Efficacy|1|||
19769422|NCT02924688|42223083|FG000|Overall Study|Protocol Violation|3|||
19769423|NCT02924688|42223084|FG001|Overall Study|Protocol Violation|7|||
19769424|NCT02924688|42223085|FG002|Overall Study|Protocol Violation|5|||
19769425|NCT02924688|42223086|FG003|Overall Study|Protocol Violation|6|||
19769426|NCT02924688|42223087|FG004|Overall Study|Protocol Violation|2|||
19685994|NCT00294723|42132598|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
19685995|NCT00294723|42132599|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
19685996|NCT00294723|42132597|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
19685997|NCT00294723|42132598|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
19685998|NCT00294723|42132599|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
19685999|NCT00402246|42132612|FG000|Overall Study|Death|62|||
19686000|NCT00402246|42132613|FG001|Overall Study|Death|58|||
19686001|NCT00402246|42132612|FG000|Overall Study|Lost to Follow-up|20|||
19686002|NCT00402246|42132613|FG001|Overall Study|Lost to Follow-up|28|||
19769427|NCT02924688|42223088|FG005|Overall Study|Protocol Violation|2|||
19769428|NCT02924688|42223083|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
19769429|NCT02924688|42223084|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
19769430|NCT02924688|42223085|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
19769431|NCT02924688|42223086|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
19769432|NCT02924688|42223087|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
19769433|NCT02924688|42223088|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
19769434|NCT02924688|42223083|FG000|Overall Study|Lost to Follow-up|2|||
19769435|NCT02924688|42223084|FG001|Overall Study|Lost to Follow-up|4|||
19769436|NCT02924688|42223085|FG002|Overall Study|Lost to Follow-up|2|||
19769437|NCT02924688|42223086|FG003|Overall Study|Lost to Follow-up|4|||
19769438|NCT02924688|42223087|FG004|Overall Study|Lost to Follow-up|2|||
19769439|NCT02924688|42223088|FG005|Overall Study|Lost to Follow-up|4|||
19769440|NCT02924688|42223083|FG000|Overall Study|Physician Decision|2|||
19769441|NCT02924688|42223084|FG001|Overall Study|Physician Decision|1|||
19769442|NCT02924688|42223085|FG002|Overall Study|Physician Decision|0|||
19769443|NCT02924688|42223086|FG003|Overall Study|Physician Decision|1|||
19769444|NCT02924688|42223087|FG004|Overall Study|Physician Decision|1|||
19769445|NCT02924688|42223088|FG005|Overall Study|Physician Decision|1|||
19769446|NCT02924688|42223083|FG000|Overall Study|Withdrawal by Subject|14|||
19769447|NCT02924688|42223084|FG001|Overall Study|Withdrawal by Subject|13|||
19769448|NCT02924688|42223085|FG002|Overall Study|Withdrawal by Subject|9|||
19769449|NCT02924688|42223086|FG003|Overall Study|Withdrawal by Subject|12|||
19769450|NCT02924688|42223087|FG004|Overall Study|Withdrawal by Subject|13|||
19769451|NCT02924688|42223088|FG005|Overall Study|Withdrawal by Subject|14|||
19769452|NCT02177695|42223107|FG000|ITT Analysis|Ineligible|5|||
19769453|NCT02177695|42223108|FG001|ITT Analysis|Ineligible|5|||
19769454|NCT02177695|42223107|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
19769455|NCT02177695|42223108|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
19769456|NCT02177695|42223107|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
19769457|NCT02177695|42223108|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
19769458|NCT02177695|42223107|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
19769459|NCT02177695|42223108|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
19769460|NCT03011892|42223122|FG000|Double Blind (DB) Period|Adverse Event|0|||
19769461|NCT03011892|42223123|FG001|Double Blind (DB) Period|Adverse Event|1|||
19769462|NCT03011892|42223124|FG002|Double Blind (DB) Period|Adverse Event|1|||
19769463|NCT03011892|42223125|FG003|Double Blind (DB) Period|Adverse Event|0|||
19769464|NCT03011892|42223126|FG004|Double Blind (DB) Period|Adverse Event|0|||
19769465|NCT03011892|42223127|FG005|Double Blind (DB) Period|Adverse Event|0|||
19769466|NCT03011892|42223128|FG006|Double Blind (DB) Period|Adverse Event|0|||
19686003|NCT00402246|42132612|FG000|Overall Study|Withdrawal by Subject|72|||
19769467|NCT03011892|42223129|FG007|Double Blind (DB) Period|Adverse Event|0|||
19769468|NCT03011892|42223130|FG008|Double Blind (DB) Period|Adverse Event|0|||
19769469|NCT03011892|42223131|FG009|Double Blind (DB) Period|Adverse Event|0|||
19769470|NCT03011892|42223132|FG010|Double Blind (DB) Period|Adverse Event|0|||
19769471|NCT03011892|42223133|FG011|Double Blind (DB) Period|Adverse Event|0|||
19769472|NCT03011892|42223122|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
19769473|NCT03011892|42223123|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
19769474|NCT03011892|42223124|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
19769475|NCT03011892|42223125|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
19769476|NCT03011892|42223126|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
19769477|NCT03011892|42223127|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
19769478|NCT03011892|42223128|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
19769479|NCT03011892|42223129|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
19769480|NCT03011892|42223130|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
19769481|NCT03011892|42223131|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
19686004|NCT00402246|42132613|FG001|Overall Study|Withdrawal by Subject|87|||
19686005|NCT00402246|42132612|FG000|Overall Study|Physician Decision|24|||
19686006|NCT00402246|42132613|FG001|Overall Study|Physician Decision|26|||
19686007|NCT00402246|42132612|FG000|Overall Study|Protocol Violation|25|||
19686008|NCT00402246|42132613|FG001|Overall Study|Protocol Violation|24|||
19686009|NCT00402246|42132612|FG000|Overall Study|Missed Final Visit|1|||
19686010|NCT00402246|42132613|FG001|Overall Study|Missed Final Visit|2|||
19686011|NCT00402246|42132612|FG000|Overall Study|Insurance Issues|2|||
19686012|NCT00402246|42132613|FG001|Overall Study|Insurance Issues|1|||
19686013|NCT00402246|42132612|FG000|Overall Study|Heart Transplant|0|||
19686014|NCT00402246|42132613|FG001|Overall Study|Heart Transplant|1|||
19686015|NCT00402246|42132612|FG000|Overall Study|Patient's device explanted|6|||
19686016|NCT00402246|42132613|FG001|Overall Study|Patient's device explanted|2|||
19686017|NCT00402246|42132612|FG000|Overall Study|Center Closure|5|||
19686018|NCT00402246|42132613|FG001|Overall Study|Center Closure|3|||
19686019|NCT00402246|42132612|FG000|Overall Study|Deterioriating Condition|3|||
19686020|NCT00402246|42132613|FG001|Overall Study|Deterioriating Condition|2|||
19686021|NCT00375492|42132623|FG000|Overall Study|Adverse Event|4|||
19686022|NCT00375492|42132624|FG001|Overall Study|Adverse Event|5|||
19686023|NCT00375492|42132623|FG000|Overall Study|Entry Criteria Not Met|0|||
19686024|NCT00375492|42132624|FG001|Overall Study|Entry Criteria Not Met|1|||
19686025|NCT00375492|42132623|FG000|Overall Study|Loss of Glucose Control|0|||
19686026|NCT00375492|42132624|FG001|Overall Study|Loss of Glucose Control|1|||
19686027|NCT00375492|42132623|FG000|Overall Study|Lost to Follow-up|10|||
19686028|NCT00375492|42132624|FG001|Overall Study|Lost to Follow-up|5|||
19769482|NCT03011892|42223132|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
19769483|NCT03011892|42223133|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
19769484|NCT03011892|42223122|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
19769485|NCT03011892|42223123|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
19769486|NCT03011892|42223124|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
19686029|NCT00375492|42132623|FG000|Overall Study|Physician Decision|0|||
19686030|NCT00375492|42132624|FG001|Overall Study|Physician Decision|4|||
19686031|NCT00375492|42132623|FG000|Overall Study|Protocol Violation|6|||
19686032|NCT00375492|42132624|FG001|Overall Study|Protocol Violation|3|||
19686033|NCT00375492|42132623|FG000|Overall Study|Sponsor Decision|0|||
19686034|NCT00375492|42132624|FG001|Overall Study|Sponsor Decision|1|||
19686035|NCT00375492|42132623|FG000|Overall Study|Withdrawal by Subject|6|||
19686036|NCT00375492|42132624|FG001|Overall Study|Withdrawal by Subject|6|||
19686037|NCT00306189|42132634|FG000|Overall Study|Physician Decision|0|||
19769487|NCT03011892|42223125|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
19769488|NCT03011892|42223126|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
19769489|NCT03011892|42223127|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
19769490|NCT03011892|42223128|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
19769491|NCT03011892|42223129|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
19769492|NCT03011892|42223130|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
19769493|NCT03011892|42223131|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
19769494|NCT03011892|42223132|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
19769495|NCT03011892|42223133|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
19686038|NCT00306189|42132635|FG001|Overall Study|Physician Decision|0|||
19686039|NCT00306189|42132636|FG002|Overall Study|Physician Decision|0|||
19686040|NCT00306189|42132637|FG003|Overall Study|Physician Decision|1|||
19769496|NCT03011892|42223122|FG000|Double Blind (DB) Period|Other|1|||
19769497|NCT03011892|42223123|FG001|Double Blind (DB) Period|Other|1|||
19769498|NCT03011892|42223124|FG002|Double Blind (DB) Period|Other|1|||
19769499|NCT03011892|42223125|FG003|Double Blind (DB) Period|Other|0|||
19769500|NCT03011892|42223126|FG004|Double Blind (DB) Period|Other|1|||
19769501|NCT03011892|42223127|FG005|Double Blind (DB) Period|Other|0|||
19769502|NCT03011892|42223128|FG006|Double Blind (DB) Period|Other|0|||
19769503|NCT03011892|42223129|FG007|Double Blind (DB) Period|Other|0|||
19769504|NCT03011892|42223130|FG008|Double Blind (DB) Period|Other|0|||
19769505|NCT03011892|42223131|FG009|Double Blind (DB) Period|Other|0|||
19686041|NCT00306189|42132634|FG000|Overall Study|Adverse Event|3|||
19686042|NCT00306189|42132635|FG001|Overall Study|Adverse Event|3|||
19769506|NCT03011892|42223132|FG010|Double Blind (DB) Period|Other|0|||
19769507|NCT03011892|42223133|FG011|Double Blind (DB) Period|Other|0|||
19769508|NCT03011892|42223122|FG000|Double Blind (DB) Period|Physician Decision|1|||
19686043|NCT00306189|42132636|FG002|Overall Study|Adverse Event|2|||
19686044|NCT00306189|42132637|FG003|Overall Study|Adverse Event|2|||
19686045|NCT00306189|42132634|FG000|Overall Study|Withdrawal by Subject|4|||
19686046|NCT00306189|42132635|FG001|Overall Study|Withdrawal by Subject|2|||
19769509|NCT03011892|42223123|FG001|Double Blind (DB) Period|Physician Decision|0|||
19769510|NCT03011892|42223124|FG002|Double Blind (DB) Period|Physician Decision|1|||
19686047|NCT00306189|42132636|FG002|Overall Study|Withdrawal by Subject|8|||
19686048|NCT00306189|42132637|FG003|Overall Study|Withdrawal by Subject|1|||
19686049|NCT00306189|42132634|FG000|Overall Study|Ineligibility determined|1|||
19686050|NCT00306189|42132635|FG001|Overall Study|Ineligibility determined|1|||
19686051|NCT00306189|42132636|FG002|Overall Study|Ineligibility determined|1|||
19686052|NCT00306189|42132637|FG003|Overall Study|Ineligibility determined|1|||
19686053|NCT00306189|42132634|FG000|Overall Study|Other|1|||
19686054|NCT00306189|42132635|FG001|Overall Study|Other|0|||
19686055|NCT00306189|42132636|FG002|Overall Study|Other|0|||
19686056|NCT00306189|42132637|FG003|Overall Study|Other|0|||
19686057|NCT00312897|42132649|FG000|Overall Study|Adverse Event|1|||
19686058|NCT00312897|42132650|FG001|Overall Study|Adverse Event|0|||
19686059|NCT00312897|42132649|FG000|Overall Study|Lost to Follow-up|2|||
19686060|NCT00312897|42132650|FG001|Overall Study|Lost to Follow-up|0|||
19686061|NCT00312897|42132649|FG000|Overall Study|Physician Decision|1|||
19686062|NCT00312897|42132650|FG001|Overall Study|Physician Decision|0|||
19686063|NCT00312897|42132649|FG000|Overall Study|Withdrawal by Subject|1|||
19686064|NCT00312897|42132650|FG001|Overall Study|Withdrawal by Subject|3|||
19686065|NCT00312897|42132649|FG000|Overall Study|Pregnancy|1|||
19686066|NCT00312897|42132650|FG001|Overall Study|Pregnancy|0|||
19686067|NCT00312897|42132649|FG000|Overall Study|discontinued prior to getting treatment|0|||
19686068|NCT00312897|42132650|FG001|Overall Study|discontinued prior to getting treatment|3|||
19686069|NCT00312663|42132659|FG000|Immunization Phase|Adverse Event|0|||
19686070|NCT00312663|42132660|FG001|Immunization Phase|Adverse Event|1|||
19686071|NCT00312663|42132661|FG002|Immunization Phase|Adverse Event|0|||
19686072|NCT00294645|42132672|FG000|Overall Study|Death|10|||
19686073|NCT00294645|42132673|FG001|Overall Study|Death|18|||
19686074|NCT00294645|42132672|FG000|Overall Study|Lost to Follow-up|1|||
19686075|NCT00294645|42132673|FG001|Overall Study|Lost to Follow-up|10|||
19686076|NCT00294645|42132672|FG000|Overall Study|Withdrawal by Subject|18|||
19686077|NCT00294645|42132673|FG001|Overall Study|Withdrawal by Subject|34|||
19686078|NCT00294645|42132672|FG000|Overall Study|Physician Decision|15|||
19686079|NCT00294645|42132673|FG001|Overall Study|Physician Decision|20|||
19686080|NCT00294645|42132672|FG000|Overall Study|Other|4|||
19686081|NCT00294645|42132673|FG001|Overall Study|Other|10|||
19686082|NCT00305877|42132681|FG000|Overall Study|Lack of Efficacy|6|||
19686083|NCT00305877|42132682|FG001|Overall Study|Lack of Efficacy|9|||
19686084|NCT00305877|42132681|FG000|Overall Study|Adverse Event|9|||
19686085|NCT00305877|42132682|FG001|Overall Study|Adverse Event|14|||
19686086|NCT00305877|42132681|FG000|Overall Study|Death|0|||
19686087|NCT00305877|42132682|FG001|Overall Study|Death|1|||
19686088|NCT00305877|42132681|FG000|Overall Study|Withdrawal by Subject|4|||
19686089|NCT00305877|42132682|FG001|Overall Study|Withdrawal by Subject|2|||
19686090|NCT00305877|42132681|FG000|Overall Study|Physician Decision|1|||
19686091|NCT00305877|42132682|FG001|Overall Study|Physician Decision|1|||
19686092|NCT00305877|42132681|FG000|Overall Study|Never start treatment|2|||
19686093|NCT00305877|42132682|FG001|Overall Study|Never start treatment|5|||
19686094|NCT00305877|42132681|FG000|Overall Study|Ineligible|2|||
19686095|NCT00305877|42132682|FG001|Overall Study|Ineligible|1|||
19686096|NCT00305877|42132681|FG000|Overall Study|Transportation issue with daily RT|0|||
19686097|NCT00305877|42132682|FG001|Overall Study|Transportation issue with daily RT|1|||
19686098|NCT00312195|42132690|FG000|Overall Study|Adverse Event|4|||
19686099|NCT00312195|42132691|FG001|Overall Study|Adverse Event|6|||
19686100|NCT00312195|42132690|FG000|Overall Study|Lost to Follow-up|1|||
19686101|NCT00312195|42132691|FG001|Overall Study|Lost to Follow-up|0|||
19686102|NCT00312195|42132690|FG000|Overall Study|Protocol Violation|1|||
19686103|NCT00312195|42132691|FG001|Overall Study|Protocol Violation|0|||
19686104|NCT00305253|42132701|FG000|Overall Study|Withdrawal by Subject|0|||
19686105|NCT00305253|42132702|FG001|Overall Study|Withdrawal by Subject|1|||
19686106|NCT00293709|42132708|FG000|Overall Study|Other|47|||
19686107|NCT00311181|42132712|FG000|Overall Study|Final DFTs were not obtained|96|||
19686108|NCT00293397|42132716|FG000|Overall Study|Death|2|||
19686109|NCT00290745|42132721|FG000|Overall Study|Withdrawal by Subject|4|||
19686110|NCT00290745|42132721|FG000|Overall Study|Physician Decision|2|||
19686111|NCT00290745|42132721|FG000|Overall Study|Surgery after 3 months for progression|3|||
19686112|NCT00290745|42132721|FG000|Overall Study|Baseline MRI not available|3|||
19686113|NCT00402168|42132727|FG000|Randomized|Lost to Follow-up|1|||
19686114|NCT00402168|42132728|FG001|Randomized|Lost to Follow-up|0|||
19686115|NCT00402168|42132727|FG000|Randomized|Withdrawal by Subject|0|||
19686116|NCT00402168|42132728|FG001|Randomized|Withdrawal by Subject|1|||
19686117|NCT00402168|42132727|FG000|Treatment (up to 12 Months)|Death|0|||
19686118|NCT00402168|42132728|FG001|Treatment (up to 12 Months)|Death|1|||
19686119|NCT00402168|42132727|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
19686120|NCT00402168|42132728|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
19686121|NCT00402168|42132727|FG000|Treatment (up to 12 Months)|non-specified|0|||
19686122|NCT00402168|42132728|FG001|Treatment (up to 12 Months)|non-specified|1|||
19686123|NCT00402168|42132727|FG000|Long Term (LT)|Adverse Event|1|||
19686124|NCT00402168|42132728|FG001|Long Term (LT)|Adverse Event|5|||
19686125|NCT00402168|42132727|FG000|Long Term (LT)|Withdrawal by Subject|4|||
19686126|NCT00402168|42132728|FG001|Long Term (LT)|Withdrawal by Subject|7|||
19769511|NCT03011892|42223125|FG003|Double Blind (DB) Period|Physician Decision|0|||
19769512|NCT03011892|42223126|FG004|Double Blind (DB) Period|Physician Decision|0|||
19769513|NCT03011892|42223127|FG005|Double Blind (DB) Period|Physician Decision|0|||
19769514|NCT03011892|42223128|FG006|Double Blind (DB) Period|Physician Decision|0|||
19769515|NCT03011892|42223129|FG007|Double Blind (DB) Period|Physician Decision|0|||
19769516|NCT03011892|42223130|FG008|Double Blind (DB) Period|Physician Decision|0|||
19769517|NCT03011892|42223131|FG009|Double Blind (DB) Period|Physician Decision|0|||
19769518|NCT03011892|42223132|FG010|Double Blind (DB) Period|Physician Decision|0|||
19769519|NCT03011892|42223133|FG011|Double Blind (DB) Period|Physician Decision|0|||
19769520|NCT03011892|42223122|FG000|Double Blind (DB) Period|Pregnancy|0|||
19686127|NCT00402168|42132727|FG000|Long Term (LT)|Pregnancy|0|||
19686128|NCT00402168|42132728|FG001|Long Term (LT)|Pregnancy|1|||
19686129|NCT00402168|42132727|FG000|Long Term (LT)|Lost to Follow-up|1|||
19686130|NCT00402168|42132728|FG001|Long Term (LT)|Lost to Follow-up|0|||
19686131|NCT00402168|42132727|FG000|Long Term (LT)|Death|4|||
19686132|NCT00402168|42132728|FG001|Long Term (LT)|Death|0|||
19686133|NCT00402168|42132727|FG000|Long Term (LT)|Lack of Efficacy|0|||
19769521|NCT03011892|42223123|FG001|Double Blind (DB) Period|Pregnancy|0|||
19769522|NCT03011892|42223124|FG002|Double Blind (DB) Period|Pregnancy|0|||
19769523|NCT03011892|42223125|FG003|Double Blind (DB) Period|Pregnancy|0|||
19769524|NCT03011892|42223126|FG004|Double Blind (DB) Period|Pregnancy|1|||
19769525|NCT03011892|42223127|FG005|Double Blind (DB) Period|Pregnancy|0|||
19769526|NCT03011892|42223128|FG006|Double Blind (DB) Period|Pregnancy|0|||
19769527|NCT03011892|42223129|FG007|Double Blind (DB) Period|Pregnancy|0|||
19769528|NCT03011892|42223130|FG008|Double Blind (DB) Period|Pregnancy|0|||
19769529|NCT03011892|42223131|FG009|Double Blind (DB) Period|Pregnancy|0|||
19605507|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
19605508|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
19605509|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
19605510|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
19605511|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
19605512|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
19605513|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
19605514|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
19605515|NCT03412747|42054251|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
19605516|NCT03412747|42054252|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
19605517|NCT03412747|42054253|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
19605518|NCT00513019|42054273|FG000|Overall Study|Adverse Event|1|||
19605519|NCT00513019|42054274|FG001|Overall Study|Adverse Event|0|||
19605520|NCT00513019|42054273|FG000|Overall Study|Withdrawal by Subject|4|||
19605521|NCT00513019|42054274|FG001|Overall Study|Withdrawal by Subject|5|||
19605522|NCT00954512|42054295|FG000|Overall Study|Withdrawal by Subject|0|||
19605523|NCT00954512|42054296|FG001|Overall Study|Withdrawal by Subject|0|||
19605524|NCT00954512|42054297|FG002|Overall Study|Withdrawal by Subject|0|||
19605525|NCT00954512|42054298|FG003|Overall Study|Withdrawal by Subject|0|||
19605526|NCT00954512|42054299|FG004|Overall Study|Withdrawal by Subject|0|||
19605527|NCT00954512|42054300|FG005|Overall Study|Withdrawal by Subject|1|||
19605528|NCT00954512|42054295|FG000|Overall Study|Adverse Event|0|||
19605529|NCT00954512|42054296|FG001|Overall Study|Adverse Event|0|||
19605530|NCT00954512|42054297|FG002|Overall Study|Adverse Event|0|||
19605531|NCT00954512|42054298|FG003|Overall Study|Adverse Event|0|||
19605532|NCT00954512|42054299|FG004|Overall Study|Adverse Event|1|||
19605533|NCT00954512|42054300|FG005|Overall Study|Adverse Event|2|||
19605534|NCT00954512|42054295|FG000|Overall Study|Physician Decision|0|||
19605535|NCT00954512|42054296|FG001|Overall Study|Physician Decision|1|||
19605536|NCT00954512|42054297|FG002|Overall Study|Physician Decision|0|||
19605537|NCT00954512|42054298|FG003|Overall Study|Physician Decision|1|||
19605538|NCT00954512|42054299|FG004|Overall Study|Physician Decision|0|||
19605539|NCT00954512|42054300|FG005|Overall Study|Physician Decision|0|||
19605540|NCT00954512|42054295|FG000|Overall Study|Symptomatic Deterioration|0|||
19605541|NCT00954512|42054296|FG001|Overall Study|Symptomatic Deterioration|1|||
19605542|NCT00954512|42054297|FG002|Overall Study|Symptomatic Deterioration|0|||
19605543|NCT00954512|42054298|FG003|Overall Study|Symptomatic Deterioration|0|||
19605544|NCT00954512|42054299|FG004|Overall Study|Symptomatic Deterioration|2|||
19605545|NCT00954512|42054300|FG005|Overall Study|Symptomatic Deterioration|0|||
19605546|NCT00954512|42054295|FG000|Overall Study|Progression of Disease|2|||
19605547|NCT00954512|42054296|FG001|Overall Study|Progression of Disease|1|||
19605548|NCT00954512|42054297|FG002|Overall Study|Progression of Disease|0|||
19605549|NCT00954512|42054298|FG003|Overall Study|Progression of Disease|1|||
19686134|NCT00402168|42132728|FG001|Long Term (LT)|Lack of Efficacy|2|||
19686135|NCT00402168|42132727|FG000|Long Term (LT)|non-specified|1|||
19686136|NCT00402168|42132728|FG001|Long Term (LT)|non-specified|2|||
19686137|NCT00402168|42132727|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
19686138|NCT00402168|42132728|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
19686139|NCT00402168|42132727|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
19686140|NCT00402168|42132728|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
19686141|NCT00290589|42132744|FG000|Overall Study|Lost to Follow-up|2|||
19686142|NCT00290589|42132745|FG001|Overall Study|Lost to Follow-up|2|||
19686143|NCT00290511|42132751|FG000|Overall Study|Adverse Event|1|||
19686144|NCT00290511|42132751|FG000|Overall Study|Death|1|||
19686145|NCT00290511|42132751|FG000|Overall Study|Physician Decision|1|||
19686146|NCT00290511|42132751|FG000|Overall Study|Withdrawal by Subject|1|||
19686147|NCT00290433|42132755|FG000|Overall Study|Disease Progression|13|||
19686148|NCT00290433|42132755|FG000|Overall Study|Adverse Event|14|||
19686149|NCT00290433|42132755|FG000|Overall Study|Withdrawal by Subject|1|||
19686150|NCT00290433|42132755|FG000|Overall Study|Non-Compliance|1|||
19686151|NCT00290433|42132755|FG000|Overall Study|Congestive Heart Failure|1|||
19686152|NCT00290433|42132755|FG000|Overall Study|Transplant in CR|5|||
19686153|NCT00290433|42132755|FG000|Overall Study|Unrelated Infection/Death|1|||
19686154|NCT00304083|42132761|FG000|Overall Study|Withdrawal by Subject|4|||
19686155|NCT00304083|42132762|FG001|Overall Study|Withdrawal by Subject|2|||
19686156|NCT00304083|42132761|FG000|Overall Study|Physician Decision|8|||
19686157|NCT00304083|42132762|FG001|Overall Study|Physician Decision|3|||
19686158|NCT00304083|42132761|FG000|Overall Study|Disease Progression|5|||
19686159|NCT00304083|42132762|FG001|Overall Study|Disease Progression|1|||
19686160|NCT00304083|42132761|FG000|Overall Study|Other|5|||
19686161|NCT00304083|42132762|FG001|Overall Study|Other|2|||
19686162|NCT00293241|42132770|FG000|Overall Study|Lost to Follow-up|9|||
19686163|NCT00293241|42132771|FG001|Overall Study|Lost to Follow-up|16|||
19686164|NCT00293241|42132770|FG000|Overall Study|Physician Decision|23|||
19686165|NCT00293241|42132771|FG001|Overall Study|Physician Decision|17|||
19686166|NCT00293241|42132770|FG000|Overall Study|Withdrawal by Subject|4|||
19686167|NCT00293241|42132771|FG001|Overall Study|Withdrawal by Subject|8|||
19686168|NCT00391092|42132782|FG000|Overall Study|Death|78|||
19769530|NCT03011892|42223132|FG010|Double Blind (DB) Period|Pregnancy|0|||
19686169|NCT00391092|42132783|FG001|Overall Study|Death|81|||
19686170|NCT00391092|42132782|FG000|Overall Study|Lost to Follow-up|13|||
19686171|NCT00391092|42132783|FG001|Overall Study|Lost to Follow-up|18|||
19686172|NCT00391092|42132782|FG000|Overall Study|Alive on treatment|29|||
19686173|NCT00391092|42132783|FG001|Overall Study|Alive on treatment|33|||
19686174|NCT00391092|42132782|FG000|Overall Study|Alive in follow-up|88|||
19686175|NCT00391092|42132783|FG001|Overall Study|Alive in follow-up|84|||
19686176|NCT00374868|42132789|FG000|Overall Study|Adverse Event|12|||
19686177|NCT00374868|42132789|FG000|Overall Study|Progressive Disease|7|||
19686178|NCT00374868|42132789|FG000|Overall Study|Physician Decision|13|||
19686179|NCT00374868|42132789|FG000|Overall Study|Lost to Follow-up|1|||
19686180|NCT00374868|42132789|FG000|Overall Study|Death|2|||
19686181|NCT00374868|42132789|FG000|Overall Study|Other - Not Specified|1|||
19686182|NCT00374556|42132795|FG000|Overall Study|Lost to Follow-up|1|||
19686183|NCT00374556|42132796|FG001|Overall Study|Lost to Follow-up|0|||
19686184|NCT00374556|42132795|FG000|Overall Study|Removed at baseline due to medical cond|0|||
19686185|NCT00374556|42132796|FG001|Overall Study|Removed at baseline due to medical cond|1|||
19686186|NCT00290355|42132804|FG000|Overall Study|Serious adverse event|7|||
19686187|NCT00290355|42132805|FG001|Overall Study|Serious adverse event|4|||
19686188|NCT00290355|42132804|FG000|Overall Study|Study product reactogenicity|1|||
19686189|NCT00290355|42132805|FG001|Overall Study|Study product reactogenicity|0|||
19686190|NCT00290355|42132804|FG000|Overall Study|Protocol Violation|1|||
19686191|NCT00290355|42132805|FG001|Overall Study|Protocol Violation|0|||
19686192|NCT00290355|42132804|FG000|Overall Study|Withdrawal by Subject|2|||
19686193|NCT00290355|42132805|FG001|Overall Study|Withdrawal by Subject|0|||
19686194|NCT00290355|42132804|FG000|Overall Study|Migrated / moved from the study area|1|||
19686195|NCT00290355|42132805|FG001|Overall Study|Migrated / moved from the study area|0|||
19686196|NCT00290355|42132804|FG000|Overall Study|Lost to Follow-up|3|||
19686197|NCT00290355|42132805|FG001|Overall Study|Lost to Follow-up|1|||
19686198|NCT00290355|42132804|FG000|Overall Study|Other|2|||
19686199|NCT00290355|42132805|FG001|Overall Study|Other|0|||
19769531|NCT03011892|42223133|FG011|Double Blind (DB) Period|Pregnancy|0|||
19686200|NCT00374322|42132813|FG000|Overall Study|Lost to Follow-up|92|||
19686201|NCT00374322|42132814|FG001|Overall Study|Lost to Follow-up|90|||
19686202|NCT00374322|42132813|FG000|Overall Study|Protocol Violation|8|||
19686203|NCT00374322|42132814|FG001|Overall Study|Protocol Violation|3|||
19686204|NCT00374322|42132813|FG000|Overall Study|Withdrawal by Subject|235|||
19686205|NCT00374322|42132814|FG001|Overall Study|Withdrawal by Subject|167|||
19686206|NCT00374322|42132813|FG000|Overall Study|Sponsor Terminated Study|866|||
19686207|NCT00374322|42132814|FG001|Overall Study|Sponsor Terminated Study|990|||
19686208|NCT00374322|42132813|FG000|Overall Study|Physician Decision|36|||
19686209|NCT00374322|42132814|FG001|Overall Study|Physician Decision|32|||
19686210|NCT00374322|42132813|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
19686211|NCT00374322|42132814|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
19686212|NCT00374322|42132813|FG000|Overall Study|Sponsor Decision|2|||
19686213|NCT00374322|42132814|FG001|Overall Study|Sponsor Decision|3|||
19686214|NCT00374322|42132813|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
19686215|NCT00374322|42132814|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
19686216|NCT00374322|42132813|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
19686217|NCT00374322|42132814|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
19686218|NCT00374322|42132813|FG000|Overall Study|Severe Toxicity|1|||
19686219|NCT00374322|42132814|FG001|Overall Study|Severe Toxicity|0|||
19686220|NCT00374322|42132813|FG000|Overall Study|Site Closed|2|||
19686221|NCT00374322|42132814|FG001|Overall Study|Site Closed|2|||
19686222|NCT00374322|42132813|FG000|Overall Study|Participant Changed Physician|1|||
19686223|NCT00374322|42132814|FG001|Overall Study|Participant Changed Physician|0|||
19686224|NCT00374322|42132813|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
19686225|NCT00374322|42132814|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
19686226|NCT00374322|42132813|FG000|Overall Study|Noncompliance with Study Requirements|0|||
19686227|NCT00374322|42132814|FG001|Overall Study|Noncompliance with Study Requirements|1|||
19686228|NCT00374322|42132813|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
19686229|NCT00374322|42132814|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
19686230|NCT00374322|42132813|FG000|Overall Study|Did Not Receive Study Medication|8|||
19686231|NCT00374322|42132814|FG001|Overall Study|Did Not Receive Study Medication|6|||
19686232|NCT00303459|42132823|FG000|Overall Study|Death|33|||
19686233|NCT00303459|42132824|FG001|Overall Study|Death|44|||
19686234|NCT00303459|42132823|FG000|Overall Study|Withdrawal of consent|32|||
19686235|NCT00303459|42132824|FG001|Overall Study|Withdrawal of consent|26|||
19686236|NCT00303459|42132823|FG000|Overall Study|Lost to Follow-up|5|||
19686237|NCT00303459|42132824|FG001|Overall Study|Lost to Follow-up|4|||
19686238|NCT00303459|42132823|FG000|Overall Study|Administrative reason|7|||
19686239|NCT00303459|42132824|FG001|Overall Study|Administrative reason|7|||
19686240|NCT00303459|42132823|FG000|Overall Study|Decision by the investigator|5|||
19686241|NCT00303459|42132824|FG001|Overall Study|Decision by the investigator|7|||
19686242|NCT00303459|42132823|FG000|Overall Study|Lung transplantation|1|||
19686243|NCT00303459|42132824|FG001|Overall Study|Lung transplantation|1|||
19686244|NCT00289887|42132833|FG000|Overall Study|Adverse Event|3|||
19686245|NCT00289887|42132834|FG001|Overall Study|Adverse Event|3|||
19686246|NCT00289887|42132833|FG000|Overall Study|Lack of Efficacy|3|||
19686247|NCT00289887|42132834|FG001|Overall Study|Lack of Efficacy|11|||
19686248|NCT00289887|42132833|FG000|Overall Study|Lost to Follow-up|3|||
19686249|NCT00289887|42132834|FG001|Overall Study|Lost to Follow-up|3|||
19686250|NCT00289887|42132833|FG000|Overall Study|Protocol Violation|3|||
19686251|NCT00289887|42132834|FG001|Overall Study|Protocol Violation|1|||
19686252|NCT00289887|42132833|FG000|Overall Study|Withdrawal by Subject|3|||
19686253|NCT00289887|42132834|FG001|Overall Study|Withdrawal by Subject|8|||
19686254|NCT00289887|42132833|FG000|Overall Study|Other|7|||
19686255|NCT00289887|42132834|FG001|Overall Study|Other|3|||
19686256|NCT00303069|42132844|FG000|Overall Study|Lost to Follow-up|1|||
19686257|NCT00303069|42132845|FG001|Overall Study|Lost to Follow-up|0|||
19686258|NCT00303069|42132846|FG002|Overall Study|Lost to Follow-up|0|||
19686259|NCT00303069|42132847|FG003|Overall Study|Lost to Follow-up|2|||
19686260|NCT00303069|42132844|FG000|Overall Study|subject moved|1|||
19686261|NCT00303069|42132845|FG001|Overall Study|subject moved|0|||
19686262|NCT00303069|42132846|FG002|Overall Study|subject moved|0|||
19686263|NCT00303069|42132847|FG003|Overall Study|subject moved|0|||
19686264|NCT00303069|42132844|FG000|Overall Study|Recruitment into Army Reserves|0|||
19686265|NCT00303069|42132845|FG001|Overall Study|Recruitment into Army Reserves|0|||
19686266|NCT00303069|42132846|FG002|Overall Study|Recruitment into Army Reserves|1|||
19686267|NCT00303069|42132847|FG003|Overall Study|Recruitment into Army Reserves|0|||
19686268|NCT00401544|42132861|FG000|Overall Study|Adverse Event|5|||
19686269|NCT00401544|42132862|FG001|Overall Study|Adverse Event|1|||
19686270|NCT00401544|42132863|FG002|Overall Study|Adverse Event|1|||
19686271|NCT00401544|42132864|FG003|Overall Study|Adverse Event|1|||
19686272|NCT00401544|42132861|FG000|Overall Study|Death|3|||
19686273|NCT00401544|42132862|FG001|Overall Study|Death|6|||
19686274|NCT00401544|42132863|FG002|Overall Study|Death|2|||
19686275|NCT00401544|42132864|FG003|Overall Study|Death|5|||
19686276|NCT00401544|42132861|FG000|Overall Study|Lost to Follow-up|2|||
19686277|NCT00401544|42132862|FG001|Overall Study|Lost to Follow-up|0|||
19769532|NCT03011892|42223122|FG000|Double Blind (DB) Period|Protocol Violation|1|||
19686278|NCT00401544|42132863|FG002|Overall Study|Lost to Follow-up|1|||
19686279|NCT00401544|42132864|FG003|Overall Study|Lost to Follow-up|1|||
19686280|NCT00401544|42132861|FG000|Overall Study|Withdrawal by Subject|7|||
19686281|NCT00401544|42132862|FG001|Overall Study|Withdrawal by Subject|6|||
19686282|NCT00401544|42132863|FG002|Overall Study|Withdrawal by Subject|6|||
19686283|NCT00401544|42132864|FG003|Overall Study|Withdrawal by Subject|5|||
19686284|NCT00401544|42132861|FG000|Overall Study|Physician Decision|1|||
19686285|NCT00401544|42132862|FG001|Overall Study|Physician Decision|3|||
19686286|NCT00401544|42132863|FG002|Overall Study|Physician Decision|0|||
19686287|NCT00401544|42132864|FG003|Overall Study|Physician Decision|0|||
19686288|NCT00401544|42132861|FG000|Overall Study|Ineligibility determined|0|||
19686289|NCT00401544|42132862|FG001|Overall Study|Ineligibility determined|1|||
19686290|NCT00401544|42132863|FG002|Overall Study|Ineligibility determined|0|||
19686291|NCT00401544|42132864|FG003|Overall Study|Ineligibility determined|2|||
19686292|NCT00401544|42132861|FG000|Overall Study|Disease progression|0|||
19686293|NCT00401544|42132862|FG001|Overall Study|Disease progression|1|||
19686294|NCT00401544|42132863|FG002|Overall Study|Disease progression|0|||
19686295|NCT00401544|42132864|FG003|Overall Study|Disease progression|0|||
19686296|NCT00401544|42132861|FG000|Overall Study|Other|0|||
19686297|NCT00401544|42132862|FG001|Overall Study|Other|0|||
19686298|NCT00401544|42132863|FG002|Overall Study|Other|2|||
19686299|NCT00401544|42132864|FG003|Overall Study|Other|2|||
19686300|NCT00289731|42132882|FG000|Overall Study|Adverse Event|1|||
19686301|NCT00289731|42132883|FG001|Overall Study|Adverse Event|2|||
19686302|NCT00289731|42132884|FG002|Overall Study|Adverse Event|2|||
19686303|NCT00289731|42132882|FG000|Overall Study|Other|1|||
19686304|NCT00289731|42132883|FG001|Overall Study|Other|0|||
19686305|NCT00289731|42132884|FG002|Overall Study|Other|0|||
19686306|NCT00289185|42132896|FG000|Overall Study|Withdrawal by Subject|4|||
19686307|NCT00289185|42132897|FG001|Overall Study|Withdrawal by Subject|8|||
19769533|NCT03011892|42223123|FG001|Double Blind (DB) Period|Protocol Violation|0|||
19769534|NCT03011892|42223124|FG002|Double Blind (DB) Period|Protocol Violation|0|||
19769535|NCT03011892|42223125|FG003|Double Blind (DB) Period|Protocol Violation|0|||
19769536|NCT03011892|42223126|FG004|Double Blind (DB) Period|Protocol Violation|0|||
19769537|NCT03011892|42223127|FG005|Double Blind (DB) Period|Protocol Violation|0|||
19686308|NCT00289185|42132896|FG000|Overall Study|Lost to Follow-up|23|||
19686309|NCT00289185|42132897|FG001|Overall Study|Lost to Follow-up|17|||
19686310|NCT00289185|42132896|FG000|Overall Study|Death|1|||
19686311|NCT00289185|42132897|FG001|Overall Study|Death|1|||
19686312|NCT00292461|42132906|FG000|Overall Study|Adverse Event|4|||
19686313|NCT00292461|42132907|FG001|Overall Study|Adverse Event|2|||
19686314|NCT00292461|42132906|FG000|Overall Study|Lack of Efficacy|1|||
19686315|NCT00292461|42132907|FG001|Overall Study|Lack of Efficacy|0|||
19686316|NCT00292461|42132906|FG000|Overall Study|Withdrawal by Subject|0|||
19686317|NCT00292461|42132907|FG001|Overall Study|Withdrawal by Subject|1|||
19686318|NCT00292461|42132906|FG000|Overall Study|Protocol Violation|4|||
19686319|NCT00292461|42132907|FG001|Overall Study|Protocol Violation|3|||
19686320|NCT00292461|42132906|FG000|Overall Study|Lost to Follow-up|1|||
19686321|NCT00292461|42132907|FG001|Overall Study|Lost to Follow-up|0|||
19686322|NCT00288639|42132913|FG000|Overall Study|Adverse Event|5|||
19686323|NCT00288639|42132913|FG000|Overall Study|Lack of Efficacy|4|||
19686324|NCT00288639|42132913|FG000|Overall Study|Withdrawal by Subject|2|||
19686325|NCT00288639|42132913|FG000|Overall Study|Other|1|||
19686326|NCT00390858|42132919|FG000|Overall Study|Adverse Event|6|||
19686327|NCT00390858|42132920|FG001|Overall Study|Adverse Event|2|||
19686328|NCT00390858|42132919|FG000|Overall Study|Lack of Efficacy|0|||
19686329|NCT00390858|42132920|FG001|Overall Study|Lack of Efficacy|1|||
19686330|NCT00390858|42132919|FG000|Overall Study|Withdrawal by Subject|3|||
19686331|NCT00390858|42132920|FG001|Overall Study|Withdrawal by Subject|4|||
19686332|NCT00390780|42132928|FG000|Overall Study|Not completed|10|||
19686333|NCT00390780|42132929|FG001|Overall Study|Not completed|4|||
19686334|NCT00390780|42132928|FG000|Overall Study|Protocol Violation|6|||
19686335|NCT00390780|42132929|FG001|Overall Study|Protocol Violation|4|||
19686336|NCT00390780|42132928|FG000|Overall Study|Lost to Follow-up|3|||
19686337|NCT00390780|42132929|FG001|Overall Study|Lost to Follow-up|6|||
19686338|NCT00390780|42132928|FG000|Overall Study|Adverse Event|2|||
19686339|NCT00390780|42132929|FG001|Overall Study|Adverse Event|3|||
19686340|NCT00390780|42132928|FG000|Overall Study|Death|1|||
19686341|NCT00390780|42132929|FG001|Overall Study|Death|3|||
19686342|NCT00390780|42132928|FG000|Overall Study|Withdrawal by Subject|1|||
19769538|NCT03011892|42223128|FG006|Double Blind (DB) Period|Protocol Violation|0|||
19769539|NCT03011892|42223129|FG007|Double Blind (DB) Period|Protocol Violation|0|||
19769540|NCT03011892|42223130|FG008|Double Blind (DB) Period|Protocol Violation|0|||
19686343|NCT00390780|42132929|FG001|Overall Study|Withdrawal by Subject|2|||
19769541|NCT03011892|42223131|FG009|Double Blind (DB) Period|Protocol Violation|0|||
19769542|NCT03011892|42223132|FG010|Double Blind (DB) Period|Protocol Violation|0|||
19686344|NCT00390780|42132928|FG000|Overall Study|Inclusion criteria not satisfied|0|||
19686345|NCT00390780|42132929|FG001|Overall Study|Inclusion criteria not satisfied|2|||
19686346|NCT00390780|42132928|FG000|Overall Study|Lost to follow up and other reasons|0|||
19686347|NCT00390780|42132929|FG001|Overall Study|Lost to follow up and other reasons|1|||
19686348|NCT00390780|42132928|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
19686349|NCT00390780|42132929|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
19686350|NCT00390780|42132928|FG000|Overall Study|SAE, death|0|||
19686351|NCT00390780|42132929|FG001|Overall Study|SAE, death|1|||
19686352|NCT00390546|42132937|FG000|Overall Study|Renal impairment|1|||
19686353|NCT00390546|42132938|FG001|Overall Study|Renal impairment|0|||
19686354|NCT00390546|42132937|FG000|Overall Study|Physician Decision|5|||
19686355|NCT00390546|42132938|FG001|Overall Study|Physician Decision|5|||
19686356|NCT00390468|42132945|FG000|Overall Study|Protocol Violation|2|||
19686357|NCT00390468|42132945|FG000|Overall Study|Lack of Efficacy|1|||
19686358|NCT00400764|42132954|FG000|Phase Ib|Adverse Event|1|||
19686359|NCT00400764|42132955|FG001|Phase Ib|Adverse Event|0|||
19686360|NCT00400764|42132956|FG002|Phase Ib|Adverse Event|0|||
19686361|NCT00400764|42132957|FG003|Phase Ib|Adverse Event|0|||
19686362|NCT00400764|42132958|FG004|Phase Ib|Adverse Event|0|||
19686363|NCT00400764|42132954|FG000|Phase Ib|Death|1|||
19686364|NCT00400764|42132955|FG001|Phase Ib|Death|0|||
19686365|NCT00400764|42132956|FG002|Phase Ib|Death|0|||
19686366|NCT00400764|42132957|FG003|Phase Ib|Death|0|||
19686367|NCT00400764|42132958|FG004|Phase Ib|Death|0|||
19686368|NCT00400764|42132954|FG000|Phase Ib|Disease Progression|4|||
19686369|NCT00400764|42132955|FG001|Phase Ib|Disease Progression|4|||
19686370|NCT00400764|42132956|FG002|Phase Ib|Disease Progression|0|||
19686371|NCT00400764|42132957|FG003|Phase Ib|Disease Progression|0|||
19686372|NCT00400764|42132958|FG004|Phase Ib|Disease Progression|0|||
19686373|NCT00400764|42132954|FG000|Phase II|Death|0|||
19769543|NCT03011892|42223133|FG011|Double Blind (DB) Period|Protocol Violation|0|||
19769544|NCT03011892|42223122|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
19769545|NCT03011892|42223123|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
19769546|NCT03011892|42223124|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
19769547|NCT03011892|42223125|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
19769548|NCT03011892|42223126|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
19769549|NCT03011892|42223127|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
19686374|NCT00400764|42132955|FG001|Phase II|Death|0|||
19686375|NCT00400764|42132956|FG002|Phase II|Death|1|||
19686376|NCT00400764|42132957|FG003|Phase II|Death|2|||
19686377|NCT00400764|42132958|FG004|Phase II|Death|0|||
19686378|NCT00400764|42132954|FG000|Phase II|Lost to Follow-up|0|||
19686379|NCT00400764|42132955|FG001|Phase II|Lost to Follow-up|0|||
19686380|NCT00400764|42132956|FG002|Phase II|Lost to Follow-up|1|||
19686381|NCT00400764|42132957|FG003|Phase II|Lost to Follow-up|0|||
19686382|NCT00400764|42132958|FG004|Phase II|Lost to Follow-up|0|||
19686383|NCT00400764|42132954|FG000|Phase II|Physician Decision|0|||
19686384|NCT00400764|42132955|FG001|Phase II|Physician Decision|0|||
19686385|NCT00400764|42132956|FG002|Phase II|Physician Decision|1|||
19686386|NCT00400764|42132957|FG003|Phase II|Physician Decision|1|||
19686387|NCT00400764|42132958|FG004|Phase II|Physician Decision|0|||
19686388|NCT00400764|42132954|FG000|Phase II|Sponsor's decision to terminate|0|||
19686389|NCT00400764|42132955|FG001|Phase II|Sponsor's decision to terminate|0|||
19769550|NCT03011892|42223128|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
19769551|NCT03011892|42223129|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
19769552|NCT03011892|42223130|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
19769553|NCT03011892|42223131|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
19686390|NCT00400764|42132956|FG002|Phase II|Sponsor's decision to terminate|18|||
19686391|NCT00400764|42132957|FG003|Phase II|Sponsor's decision to terminate|22|||
19686392|NCT00400764|42132958|FG004|Phase II|Sponsor's decision to terminate|11|||
19769554|NCT03011892|42223132|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
19769555|NCT03011892|42223133|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
19769556|NCT03011892|42223122|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
19769557|NCT03011892|42223123|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
19769558|NCT03011892|42223124|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
19769559|NCT03011892|42223125|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
19769560|NCT03011892|42223126|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
19769561|NCT03011892|42223127|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
19769562|NCT03011892|42223128|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
19769563|NCT03011892|42223129|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
19769564|NCT03011892|42223130|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
19769565|NCT03011892|42223131|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
19769566|NCT03011892|42223132|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
19769567|NCT03011892|42223133|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
19769568|NCT03011892|42223122|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
19769569|NCT03011892|42223123|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
19769570|NCT03011892|42223124|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
19769571|NCT03011892|42223125|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
19686393|NCT00400764|42132954|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
19769572|NCT03011892|42223126|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
19769573|NCT03011892|42223127|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
19686394|NCT00400764|42132955|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
19686395|NCT00400764|42132956|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
19686396|NCT00400764|42132957|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
19686397|NCT00400764|42132958|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
19686398|NCT00400764|42132954|FG000|Phase II|Withdrawal by Subject|0|||
19686399|NCT00400764|42132955|FG001|Phase II|Withdrawal by Subject|0|||
19686400|NCT00400764|42132956|FG002|Phase II|Withdrawal by Subject|1|||
19686401|NCT00400764|42132957|FG003|Phase II|Withdrawal by Subject|1|||
19686402|NCT00400764|42132958|FG004|Phase II|Withdrawal by Subject|0|||
19686403|NCT00302211|42132978|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
19686404|NCT00302211|42132979|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
19686405|NCT00302211|42132980|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
19686406|NCT00302211|42132981|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
19686407|NCT00302211|42132982|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
19686408|NCT00302211|42132978|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
19769574|NCT03011892|42223128|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
19769575|NCT03011892|42223129|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
19686409|NCT00302211|42132979|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
19686410|NCT00302211|42132980|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
19686411|NCT00302211|42132981|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
19686412|NCT00302211|42132982|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
19769576|NCT03011892|42223130|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
19769577|NCT03011892|42223131|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
19769578|NCT03011892|42223132|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
19769579|NCT03011892|42223133|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
19686413|NCT00302211|42132978|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
19686414|NCT00302211|42132979|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
19686415|NCT00302211|42132980|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
19686416|NCT00302211|42132981|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
19686417|NCT00302211|42132982|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
19686418|NCT00302211|42132978|FG000|Double Blind Period (New Patients)|Disease progression|0|||
19686419|NCT00302211|42132979|FG001|Double Blind Period (New Patients)|Disease progression|1|||
19686420|NCT00302211|42132980|FG002|Double Blind Period (New Patients)|Disease progression|1|||
19686421|NCT00302211|42132981|FG003|Double Blind Period (New Patients)|Disease progression|0|||
19686422|NCT00302211|42132982|FG004|Double Blind Period (New Patients)|Disease progression|0|||
19686423|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
19686424|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
19686425|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
19686426|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
19686427|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
19686428|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
19686429|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
19686430|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
19686431|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
19686432|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
19686433|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
19686434|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
19769580|NCT03011892|42223122|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
19686435|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
19686436|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
19686437|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
19769581|NCT03011892|42223123|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
19769582|NCT03011892|42223124|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
19769583|NCT03011892|42223125|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
19769584|NCT03011892|42223126|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
19769585|NCT03011892|42223127|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
19769586|NCT03011892|42223128|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
19769587|NCT03011892|42223129|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
19769588|NCT03011892|42223130|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
19769589|NCT03011892|42223131|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
19769590|NCT03011892|42223132|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
19769591|NCT03011892|42223133|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
19769592|NCT03011892|42223122|FG000|Open Label (OL) Period|Reason not specified|0|||
19769593|NCT03011892|42223123|FG001|Open Label (OL) Period|Reason not specified|0|||
19769594|NCT03011892|42223124|FG002|Open Label (OL) Period|Reason not specified|0|||
19769595|NCT03011892|42223125|FG003|Open Label (OL) Period|Reason not specified|0|||
19769596|NCT03011892|42223126|FG004|Open Label (OL) Period|Reason not specified|0|||
19769597|NCT03011892|42223127|FG005|Open Label (OL) Period|Reason not specified|0|||
19769598|NCT03011892|42223128|FG006|Open Label (OL) Period|Reason not specified|0|||
19769599|NCT03011892|42223129|FG007|Open Label (OL) Period|Reason not specified|1|||
19769600|NCT03011892|42223130|FG008|Open Label (OL) Period|Reason not specified|0|||
19769601|NCT03011892|42223131|FG009|Open Label (OL) Period|Reason not specified|0|||
19769602|NCT03011892|42223132|FG010|Open Label (OL) Period|Reason not specified|0|||
19769603|NCT03011892|42223133|FG011|Open Label (OL) Period|Reason not specified|0|||
19769604|NCT03017742|42223160|FG000|Overall Study|Protocol Violation|36|||
19769605|NCT03017742|42223160|FG000|Overall Study|Withdrawal by Subject|37|||
19769606|NCT03012828|42223170|FG000|Overall Study|Lost to Follow-up|1|||
19686438|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
19686439|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
19686440|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
19686441|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
19686442|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
19686443|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Death|0|||
19686444|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Death|0|||
19686445|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Death|0|||
19686446|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Death|1|||
19686447|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Death|1|||
19686448|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
19686449|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
19686450|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
19686451|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
19686452|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
19686453|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
19686454|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
19686455|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
19686456|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
19686457|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
19686458|NCT00302211|42132978|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
19686459|NCT00302211|42132979|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
19686460|NCT00302211|42132980|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
19686461|NCT00302211|42132981|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
19686462|NCT00302211|42132982|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
19686463|NCT00288015|42132994|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
19686464|NCT00288015|42132994|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
19686465|NCT00288015|42132994|FG000|First Response Assessment|Withdrawal by Subject|1|||
19686466|NCT00288015|42132994|FG000|First Response Assessment|Death|1|||
19686467|NCT00288015|42132994|FG000|First Response Assessment|Physician Decision|2|||
19686468|NCT00288015|42132994|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
19686469|NCT00288015|42132994|FG000|Follow up for Survival x 2 Years|Death|13|||
19686470|NCT00288015|42132994|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
19686471|NCT00288015|42132994|FG000|Follow up for Survival x 2 Years|Other|9|||
19686472|NCT00389064|42133000|FG000|Overall Study|Adverse Event|11|||
19686473|NCT00389064|42133001|FG001|Overall Study|Adverse Event|3|||
19686474|NCT00389064|42133000|FG000|Overall Study|Lack of Efficacy|3|||
19686475|NCT00389064|42133001|FG001|Overall Study|Lack of Efficacy|14|||
19769607|NCT03012828|42223171|FG001|Overall Study|Lost to Follow-up|0|||
19769608|NCT03012828|42223172|FG002|Overall Study|Lost to Follow-up|1|||
19769609|NCT03012828|42223173|FG003|Overall Study|Lost to Follow-up|0|||
19769610|NCT03012828|42223174|FG004|Overall Study|Lost to Follow-up|1|||
19769611|NCT03012828|42223175|FG005|Overall Study|Lost to Follow-up|0|||
19769612|NCT03012828|42223170|FG000|Overall Study|Withdrawal by Subject|0|||
19769613|NCT03012828|42223171|FG001|Overall Study|Withdrawal by Subject|0|||
19769614|NCT03012828|42223172|FG002|Overall Study|Withdrawal by Subject|1|||
19769615|NCT03012828|42223173|FG003|Overall Study|Withdrawal by Subject|0|||
19769616|NCT03012828|42223174|FG004|Overall Study|Withdrawal by Subject|0|||
19769617|NCT03012828|42223175|FG005|Overall Study|Withdrawal by Subject|1|||
19769618|NCT03012828|42223170|FG000|Overall Study|Non-compliance with protocol|0|||
19686476|NCT00389064|42133000|FG000|Overall Study|Withdrawal by Subject|17|||
19686477|NCT00389064|42133001|FG001|Overall Study|Withdrawal by Subject|27|||
19686478|NCT00389064|42133000|FG000|Overall Study|Physician Decision|2|||
19686479|NCT00389064|42133001|FG001|Overall Study|Physician Decision|2|||
19686480|NCT00389064|42133000|FG000|Overall Study|Lost to Follow-up|1|||
19686481|NCT00389064|42133001|FG001|Overall Study|Lost to Follow-up|2|||
19686482|NCT00389064|42133000|FG000|Overall Study|Protocol Violation|2|||
19686483|NCT00389064|42133001|FG001|Overall Study|Protocol Violation|0|||
19686484|NCT00389064|42133000|FG000|Overall Study|Multiple Reasons|9|||
19686485|NCT00389064|42133001|FG001|Overall Study|Multiple Reasons|11|||
19686486|NCT00388674|42133009|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
19686487|NCT00388674|42133010|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
19686488|NCT00388674|42133009|FG000|Initial Treatment|Adverse Event|22|||
19769619|NCT03012828|42223171|FG001|Overall Study|Non-compliance with protocol|0|||
19769620|NCT03012828|42223172|FG002|Overall Study|Non-compliance with protocol|0|||
19769621|NCT03012828|42223173|FG003|Overall Study|Non-compliance with protocol|0|||
19769622|NCT03012828|42223174|FG004|Overall Study|Non-compliance with protocol|1|||
19769623|NCT03012828|42223175|FG005|Overall Study|Non-compliance with protocol|0|||
19769624|NCT03012828|42223170|FG000|Overall Study|Delay to last visit would delay DBL|0|||
19769625|NCT03012828|42223171|FG001|Overall Study|Delay to last visit would delay DBL|0|||
19686489|NCT00388674|42133010|FG001|Initial Treatment|Adverse Event|87|||
19686490|NCT00388674|42133009|FG000|Initial Treatment|Death|215|||
19686491|NCT00388674|42133010|FG001|Initial Treatment|Death|216|||
19686492|NCT00388674|42133009|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
19686493|NCT00388674|42133010|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
19686494|NCT00388674|42133009|FG000|Initial Treatment|HCC|12|||
19686495|NCT00388674|42133010|FG001|Initial Treatment|HCC|20|||
19686496|NCT00388674|42133009|FG000|Initial Treatment|Lost to Follow-up|526|||
19686497|NCT00388674|42133010|FG001|Initial Treatment|Lost to Follow-up|624|||
19686498|NCT00388674|42133009|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
19686499|NCT00388674|42133010|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
19686500|NCT00388674|42133009|FG000|Initial Treatment|Never Treated with Study Medication|1|||
19686501|NCT00388674|42133010|FG001|Initial Treatment|Never Treated with Study Medication|7|||
19686502|NCT00388674|42133009|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
19686503|NCT00388674|42133010|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
19686504|NCT00388674|42133009|FG000|Initial Treatment|Not Defined|125|||
19686505|NCT00388674|42133010|FG001|Initial Treatment|Not Defined|172|||
19686506|NCT00388674|42133009|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
19769626|NCT03012828|42223172|FG002|Overall Study|Delay to last visit would delay DBL|0|||
19769627|NCT03012828|42223173|FG003|Overall Study|Delay to last visit would delay DBL|0|||
19477281|NCT01512745|41756272|FG001|Overall Study|Adverse Event|3|||
19477282|NCT01512745|41756271|FG000|Overall Study|Death|9|||
19477283|NCT01512745|41756272|FG001|Overall Study|Death|13|||
19477284|NCT01512745|41756271|FG000|Overall Study|Withdrawal by Subject|2|||
19477285|NCT01512745|41756272|FG001|Overall Study|Withdrawal by Subject|2|||
19477286|NCT01512745|41756271|FG000|Overall Study|Lost to Follow-up|4|||
19477287|NCT01512745|41756272|FG001|Overall Study|Lost to Follow-up|0|||
19477288|NCT01512745|41756271|FG000|Overall Study|Lack of Efficacy|2|||
19477289|NCT01512745|41756272|FG001|Overall Study|Lack of Efficacy|2|||
19477290|NCT01512745|41756271|FG000|Overall Study|Protocol Violation|1|||
19477291|NCT01512745|41756272|FG001|Overall Study|Protocol Violation|0|||
19477292|NCT01478321|41756278|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
19477293|NCT01478321|41756278|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
19686507|NCT00388674|42133010|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
19686508|NCT00388674|42133009|FG000|Initial Treatment|Pregnancy|26|||
19686509|NCT00388674|42133010|FG001|Initial Treatment|Pregnancy|16|||
19686510|NCT00388674|42133009|FG000|Initial Treatment|Study Drug Toxicity|5|||
19686511|NCT00388674|42133010|FG001|Initial Treatment|Study Drug Toxicity|92|||
19686512|NCT00388674|42133009|FG000|Initial Treatment|Participant Request|501|||
19686513|NCT00388674|42133010|FG001|Initial Treatment|Participant Request|673|||
19686514|NCT00388674|42133009|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
19686515|NCT00388674|42133010|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
19686516|NCT00388674|42133009|FG000|Initial Treatment|Not Reported|10|||
19686517|NCT00388674|42133010|FG001|Initial Treatment|Not Reported|12|||
19686518|NCT00388674|42133009|FG000|End of Study|Administrative Reason By Sponsor|299|||
19686519|NCT00388674|42133010|FG001|End of Study|Administrative Reason By Sponsor|253|||
19686520|NCT00388674|42133009|FG000|End of Study|Death|239|||
19686521|NCT00388674|42133010|FG001|End of Study|Death|262|||
19686522|NCT00388674|42133009|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
19686523|NCT00388674|42133010|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
19686524|NCT00388674|42133009|FG000|End of Study|HCC|8|||
19686525|NCT00388674|42133010|FG001|End of Study|HCC|7|||
19686526|NCT00388674|42133009|FG000|End of Study|Lost to Follow-up|587|||
19686527|NCT00388674|42133010|FG001|End of Study|Lost to Follow-up|715|||
19686528|NCT00388674|42133009|FG000|End of Study|Malignancy (Non-HCC)|1|||
19686529|NCT00388674|42133010|FG001|End of Study|Malignancy (Non-HCC)|1|||
19686530|NCT00388674|42133009|FG000|End of Study|Non-Study Related Comorbidities|3|||
19686531|NCT00388674|42133010|FG001|End of Study|Non-Study Related Comorbidities|4|||
19686532|NCT00388674|42133009|FG000|End of Study|Not Defined|135|||
19686533|NCT00388674|42133010|FG001|End of Study|Not Defined|214|||
19686534|NCT00388674|42133009|FG000|End of Study|Participant Withdrew Consent|437|||
19686535|NCT00388674|42133010|FG001|End of Study|Participant Withdrew Consent|673|||
19686536|NCT00388674|42133009|FG000|End of Study|No Off-Treatment Status Data|22|||
19686537|NCT00388674|42133010|FG001|End of Study|No Off-Treatment Status Data|30|||
19686538|NCT00388674|42133009|FG000|End of Study|Not Reported|0|||
19686539|NCT00388674|42133010|FG001|End of Study|Not Reported|1|||
19686540|NCT00388362|42133016|FG000|Enrolled|Ineligible|1|||
19686541|NCT00388362|42133016|FG000|Enrolled|Adverse Event|9|||
19686542|NCT00388362|42133016|FG000|Enrolled|Death|1|||
19686543|NCT00388362|42133016|FG000|Enrolled|Loss insurance|1|||
19686544|NCT00388362|42133016|FG000|Enrolled|Withdrawal by Subject|1|||
19477294|NCT01478321|41756278|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
19477295|NCT01478321|41756278|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
19686545|NCT00388362|42133016|FG000|Remained on Study Median of 514 Days|Death|2|||
19686546|NCT00387894|42133020|FG000|Overall Study|Withdrawal by Subject|1|||
19686547|NCT00387426|42133024|FG000|Overall Study|Lack of Response|7|||
19477296|NCT01478321|41756278|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
19686548|NCT00387426|42133024|FG000|Overall Study|Toxicities|4|||
19686549|NCT00387426|42133024|FG000|Overall Study|Disease Progression|3|||
19686550|NCT00387348|42133031|FG000|Overall Study|Death|1|||
19686551|NCT00387348|42133032|FG001|Overall Study|Death|1|||
19686552|NCT00387348|42133033|FG002|Overall Study|Death|0|||
19769628|NCT03012828|42223174|FG004|Overall Study|Delay to last visit would delay DBL|0|||
19686553|NCT00387348|42133031|FG000|Overall Study|Physician Decision|1|||
19686554|NCT00387348|42133032|FG001|Overall Study|Physician Decision|0|||
19769629|NCT03012828|42223175|FG005|Overall Study|Delay to last visit would delay DBL|1|||
19686555|NCT00387348|42133033|FG002|Overall Study|Physician Decision|1|||
19686556|NCT00387348|42133031|FG000|Overall Study|Withdrawal by Subject|0|||
19686557|NCT00387348|42133032|FG001|Overall Study|Withdrawal by Subject|2|||
19769630|NCT03010254|42223193|FG000|Overall Study|Adverse Event|0|||
19769631|NCT03010254|42223194|FG001|Overall Study|Adverse Event|1|||
19769632|NCT03010254|42223193|FG000|Overall Study|Lost to Follow-up|4|||
19477297|NCT01478321|41756278|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
19477298|NCT01478321|41756278|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
19477299|NCT01478321|41756278|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
19477300|NCT01544491|41756284|FG000|Overall Study|Withdrawal by Subject|3|||
19477301|NCT01544491|41756285|FG001|Overall Study|Withdrawal by Subject|2|||
19477302|NCT01544491|41756284|FG000|Overall Study|Lost to Follow-up|0|||
19477303|NCT01544491|41756285|FG001|Overall Study|Lost to Follow-up|1|||
19477304|NCT01544491|41756284|FG000|Overall Study|administrative problems|2|||
19477305|NCT01544491|41756285|FG001|Overall Study|administrative problems|0|||
19477306|NCT01478087|41756304|FG000|Overall Study|due to sponsor closing study|1|||
19477307|NCT01477853|41756322|FG000|Phase A|Adverse Event|1|||
19477308|NCT01477853|41756323|FG001|Phase A|Adverse Event|2|||
19769633|NCT03010254|42223194|FG001|Overall Study|Lost to Follow-up|0|||
19769634|NCT03010254|42223193|FG000|Overall Study|Withdrawal by Subject|1|||
19477309|NCT01477853|41756324|FG002|Phase A|Adverse Event|2|||
19477310|NCT01477853|41756322|FG000|Phase A|Lost to Follow-up|4|||
19477311|NCT01477853|41756323|FG001|Phase A|Lost to Follow-up|3|||
19477312|NCT01477853|41756324|FG002|Phase A|Lost to Follow-up|2|||
19477313|NCT01477853|41756322|FG000|Phase A|Physician Decision|1|||
19477314|NCT01477853|41756323|FG001|Phase A|Physician Decision|0|||
19477315|NCT01477853|41756324|FG002|Phase A|Physician Decision|1|||
19477316|NCT01477853|41756322|FG000|Phase A|Study terminated by sponsor|37|||
19477317|NCT01477853|41756323|FG001|Phase A|Study terminated by sponsor|40|||
19477318|NCT01477853|41756324|FG002|Phase A|Study terminated by sponsor|39|||
19477319|NCT01477853|41756322|FG000|Phase B|Lost to Follow-up|0|||
19477320|NCT01477853|41756323|FG001|Phase B|Lost to Follow-up|1|||
19477321|NCT01477853|41756324|FG002|Phase B|Lost to Follow-up|0|||
19477322|NCT01477853|41756322|FG000|Phase B|Study terminated by sponsor|12|||
19477323|NCT01477853|41756323|FG001|Phase B|Study terminated by sponsor|10|||
19477324|NCT01477853|41756324|FG002|Phase B|Study terminated by sponsor|11|||
19477325|NCT01511419|41756356|FG000|Dose 2|Physician Decision|1|||
19477326|NCT01511419|41756357|FG001|Dose 2|Physician Decision|0|||
19477327|NCT01511107|41756419|FG000|Overall Study|Ineligible|3|||
19477328|NCT01511107|41756420|FG001|Overall Study|Ineligible|2|||
19477329|NCT01511107|41756419|FG000|Overall Study|Lost to Follow-up|10|||
19477330|NCT01511107|41756420|FG001|Overall Study|Lost to Follow-up|19|||
19477331|NCT01511107|41756419|FG000|Overall Study|Withdrawal by Subject|9|||
19477332|NCT01511107|41756420|FG001|Overall Study|Withdrawal by Subject|20|||
19477333|NCT01484977|41756455|FG000|Overall Study|Adverse Event|8|||
19477334|NCT01484977|41756455|FG000|Overall Study|Lack of Efficacy|4|||
19477335|NCT01484977|41756455|FG000|Overall Study|Protocol Violation|6|||
19477336|NCT01484977|41756455|FG000|Overall Study|Lost to Follow-up|1|||
19477337|NCT01484977|41756455|FG000|Overall Study|Withdrawal by Subject|4|||
19477338|NCT01484977|41756455|FG000|Overall Study|Subject Protocol Non-compliant|1|||
19477339|NCT01484977|41756455|FG000|Overall Study|Moving Overseas|1|||
19477340|NCT01484977|41756455|FG000|Overall Study|Low White Blood Cell Count|1|||
19477341|NCT01484977|41756455|FG000|Overall Study|Lack of Compliance|1|||
19477342|NCT01475825|41756535|FG000|Overall Study|Adverse Event|41|||
19477343|NCT01475825|41756536|FG001|Overall Study|Adverse Event|15|||
19477344|NCT01475825|41756537|FG002|Overall Study|Adverse Event|27|||
19477345|NCT01475825|41756538|FG003|Overall Study|Adverse Event|11|||
19477346|NCT01475825|41756535|FG000|Overall Study|Death|1|||
19477347|NCT01475825|41756536|FG001|Overall Study|Death|0|||
19477348|NCT01475825|41756537|FG002|Overall Study|Death|1|||
19477349|NCT01475825|41756538|FG003|Overall Study|Death|0|||
19605550|NCT00954512|42054299|FG004|Overall Study|Progression of Disease|1|||
19605551|NCT00954512|42054300|FG005|Overall Study|Progression of Disease|1|||
19605552|NCT00691015|42054313|FG000|Overall Study|Refused further treatment|1|||
19605553|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
19605554|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
19605555|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
19605556|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
19605557|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
19477350|NCT01475825|41756535|FG000|Overall Study|Lack of Efficacy|0|||
19477351|NCT01475825|41756536|FG001|Overall Study|Lack of Efficacy|0|||
19477352|NCT01475825|41756537|FG002|Overall Study|Lack of Efficacy|1|||
19477353|NCT01475825|41756538|FG003|Overall Study|Lack of Efficacy|0|||
19477354|NCT01475825|41756535|FG000|Overall Study|Lost to Follow-up|0|||
19477355|NCT01475825|41756536|FG001|Overall Study|Lost to Follow-up|0|||
19477356|NCT01475825|41756537|FG002|Overall Study|Lost to Follow-up|3|||
19477357|NCT01475825|41756538|FG003|Overall Study|Lost to Follow-up|1|||
19477358|NCT01475825|41756535|FG000|Overall Study|Non-compliance with Study Drug|1|||
19477359|NCT01475825|41756536|FG001|Overall Study|Non-compliance with Study Drug|2|||
19477360|NCT01475825|41756537|FG002|Overall Study|Non-compliance with Study Drug|4|||
19477361|NCT01475825|41756538|FG003|Overall Study|Non-compliance with Study Drug|0|||
19477362|NCT01475825|41756535|FG000|Overall Study|Other: Not available|0|||
19477363|NCT01475825|41756536|FG001|Overall Study|Other: Not available|0|||
19477364|NCT01475825|41756537|FG002|Overall Study|Other: Not available|2|||
19477365|NCT01475825|41756538|FG003|Overall Study|Other: Not available|0|||
19477366|NCT01475825|41756535|FG000|Overall Study|Protocol Violation|1|||
19477367|NCT01475825|41756536|FG001|Overall Study|Protocol Violation|0|||
19477368|NCT01475825|41756537|FG002|Overall Study|Protocol Violation|0|||
19477369|NCT01475825|41756538|FG003|Overall Study|Protocol Violation|0|||
19477370|NCT01475825|41756535|FG000|Overall Study|Physician Decision|0|||
19477371|NCT01475825|41756536|FG001|Overall Study|Physician Decision|1|||
19477372|NCT01475825|41756537|FG002|Overall Study|Physician Decision|0|||
19477373|NCT01475825|41756538|FG003|Overall Study|Physician Decision|0|||
19477374|NCT01475825|41756535|FG000|Overall Study|Withdrawal by Subject|8|||
19477375|NCT01475825|41756536|FG001|Overall Study|Withdrawal by Subject|3|||
19477376|NCT01475825|41756537|FG002|Overall Study|Withdrawal by Subject|11|||
19477377|NCT01475825|41756538|FG003|Overall Study|Withdrawal by Subject|7|||
19477378|NCT01475825|41756535|FG000|Overall Study|Did not enter OLC|15|||
19477379|NCT01475825|41756536|FG001|Overall Study|Did not enter OLC|11|||
19477380|NCT01475825|41756537|FG002|Overall Study|Did not enter OLC|15|||
19477381|NCT01475825|41756538|FG003|Overall Study|Did not enter OLC|11|||
19477382|NCT01484431|41756560|FG000|Period 1: High Dose|Physician Decision|0|||
19477383|NCT01484431|41756561|FG001|Period 1: High Dose|Physician Decision|1|||
19477384|NCT01484431|41756562|FG002|Period 1: High Dose|Physician Decision|0|||
19477385|NCT01484431|41756560|FG000|Period 2|Death|0|||
19477386|NCT01484431|41756561|FG001|Period 2|Death|1|||
19477387|NCT01484431|41756562|FG002|Period 2|Death|1|||
19477388|NCT01484431|41756560|FG000|Period 2|Physician Decision|0|||
19477389|NCT01484431|41756561|FG001|Period 2|Physician Decision|0|||
19477390|NCT01484431|41756562|FG002|Period 2|Physician Decision|1|||
19477391|NCT01484431|41756560|FG000|Period 2|Non-Compliance with Study Drug|1|||
19477392|NCT01484431|41756561|FG001|Period 2|Non-Compliance with Study Drug|0|||
19477393|NCT01484431|41756562|FG002|Period 2|Non-Compliance with Study Drug|0|||
19477394|NCT01473953|41756610|FG000|Overall Study|Other|1|||
19477395|NCT01473953|41756611|FG001|Overall Study|Other|0|||
19477396|NCT01473953|41756612|FG002|Overall Study|Other|0|||
19477397|NCT01473953|41756613|FG003|Overall Study|Other|0|||
19477398|NCT01473953|41756614|FG004|Overall Study|Other|0|||
19477399|NCT01510717|41756628|FG000|Overall Study|Adverse Event|1|||
19686558|NCT00387348|42133033|FG002|Overall Study|Withdrawal by Subject|2|||
19686559|NCT00387348|42133031|FG000|Overall Study|Adverse Event|1|||
19686560|NCT00387348|42133032|FG001|Overall Study|Adverse Event|0|||
19686561|NCT00387348|42133033|FG002|Overall Study|Adverse Event|1|||
19686562|NCT00413660|42133053|FG000|Up To Week 12|Adverse Event|1|||
19686563|NCT00413660|42133054|FG001|Up To Week 12|Adverse Event|3|||
19686564|NCT00413660|42133055|FG002|Up To Week 12|Adverse Event|1|||
19686565|NCT00413660|42133056|FG003|Up To Week 12|Adverse Event|4|||
19686566|NCT00413660|42133057|FG004|Up To Week 12|Adverse Event|6|||
19686567|NCT00413660|42133058|FG005|Up To Week 12|Adverse Event|4|||
19686568|NCT00413660|42133059|FG006|Up To Week 12|Adverse Event|1|||
19686569|NCT00413660|42133060|FG007|Up To Week 12|Adverse Event|0|||
19686570|NCT00413660|42133061|FG008|Up To Week 12|Adverse Event|0|||
19686571|NCT00413660|42133062|FG009|Up To Week 12|Adverse Event|0|||
19686572|NCT00413660|42133063|FG010|Up To Week 12|Adverse Event|0|||
19686573|NCT00413660|42133053|FG000|Up To Week 12|Lack of Efficacy|2|||
19686574|NCT00413660|42133054|FG001|Up To Week 12|Lack of Efficacy|0|||
19686575|NCT00413660|42133055|FG002|Up To Week 12|Lack of Efficacy|0|||
19686576|NCT00413660|42133056|FG003|Up To Week 12|Lack of Efficacy|0|||
19686577|NCT00413660|42133057|FG004|Up To Week 12|Lack of Efficacy|0|||
19686578|NCT00413660|42133058|FG005|Up To Week 12|Lack of Efficacy|0|||
19686579|NCT00413660|42133059|FG006|Up To Week 12|Lack of Efficacy|5|||
19686580|NCT00413660|42133060|FG007|Up To Week 12|Lack of Efficacy|0|||
19477400|NCT01510717|41756629|FG001|Overall Study|Adverse Event|2|||
19477401|NCT01510717|41756628|FG000|Overall Study|Death|1|||
19477402|NCT01510717|41756629|FG001|Overall Study|Death|0|||
19477403|NCT01510717|41756628|FG000|Overall Study|Lost to Follow-up|0|||
19477404|NCT01510717|41756629|FG001|Overall Study|Lost to Follow-up|1|||
19686581|NCT00413660|42133061|FG008|Up To Week 12|Lack of Efficacy|0|||
19477405|NCT01510717|41756628|FG000|Overall Study|Withdrawal by Subject|0|||
19477406|NCT01510717|41756629|FG001|Overall Study|Withdrawal by Subject|2|||
19477407|NCT01473563|41756645|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
19477408|NCT01484275|41756663|FG000|Overall Study|Study terminated by sponsor|28|||
19477409|NCT01484275|41756664|FG001|Overall Study|Study terminated by sponsor|32|||
19477410|NCT01484275|41756663|FG000|Overall Study|Other|10|||
19477411|NCT01484275|41756664|FG001|Overall Study|Other|0|||
19477412|NCT01484275|41756663|FG000|Overall Study|Death|3|||
19477413|NCT01484275|41756664|FG001|Overall Study|Death|4|||
19477414|NCT01484275|41756663|FG000|Overall Study|Withdrawal by Subject|1|||
19477415|NCT01484275|41756664|FG001|Overall Study|Withdrawal by Subject|5|||
19477416|NCT01484275|41756663|FG000|Overall Study|Lost to Follow-up|1|||
19477417|NCT01484275|41756664|FG001|Overall Study|Lost to Follow-up|1|||
19477418|NCT01544335|41756670|FG000|Overall Study|Lost to Follow-up|27|||
19477419|NCT01544335|41756670|FG000|Overall Study|Death|4|||
19477420|NCT01544335|41756670|FG000|Overall Study|Disease progression|3|||
19477421|NCT01544335|41756670|FG000|Overall Study|Baseline Measurements not Available|19|||
19477422|NCT01484197|41756674|FG000|Treatment Period 1|Adverse Event|1|||
19477423|NCT01484197|41756675|FG001|Treatment Period 1|Adverse Event|0|||
19477424|NCT01484197|41756676|FG002|Treatment Period 1|Adverse Event|0|||
19477425|NCT01484197|41756677|FG003|Treatment Period 1|Adverse Event|0|||
19477426|NCT01484197|41756674|FG000|Treatment Period 2|Subject withdrew consent|0|||
19477427|NCT01484197|41756675|FG001|Treatment Period 2|Subject withdrew consent|0|||
19477428|NCT01484197|41756676|FG002|Treatment Period 2|Subject withdrew consent|0|||
19477429|NCT01484197|41756677|FG003|Treatment Period 2|Subject withdrew consent|1|||
19477430|NCT01473407|41756689|FG000|Overall Study|Physician Decision|1|||
19477431|NCT01473407|41756690|FG001|Overall Study|Physician Decision|4|||
19477432|NCT01473407|41756689|FG000|Overall Study|Lost to Follow-up|10|||
19477433|NCT01473407|41756690|FG001|Overall Study|Lost to Follow-up|4|||
19477434|NCT01473407|41756689|FG000|Overall Study|Adverse Event|8|||
19477435|NCT01473407|41756690|FG001|Overall Study|Adverse Event|8|||
19477436|NCT01473407|41756689|FG000|Overall Study|Randomization Error|3|||
19477437|NCT01473407|41756690|FG001|Overall Study|Randomization Error|1|||
19477438|NCT01473407|41756689|FG000|Overall Study|Withdrawal by Subject|4|||
19477439|NCT01473407|41756690|FG001|Overall Study|Withdrawal by Subject|7|||
19477440|NCT01473407|41756689|FG000|Overall Study|Kidney Transplant|7|||
19477441|NCT01473407|41756690|FG001|Overall Study|Kidney Transplant|6|||
19477442|NCT01473407|41756689|FG000|Overall Study|Vacation/Travel|1|||
19477443|NCT01473407|41756690|FG001|Overall Study|Vacation/Travel|1|||
19477444|NCT01473407|41756689|FG000|Overall Study|Elevated Hemoglobin|1|||
19477445|NCT01473407|41756690|FG001|Overall Study|Elevated Hemoglobin|0|||
19477446|NCT01473407|41756689|FG000|Overall Study|Patient Received Aranesp|1|||
19477447|NCT01473407|41756690|FG001|Overall Study|Patient Received Aranesp|0|||
19477448|NCT01473407|41756689|FG000|Overall Study|Patient Lost Green Card Status|1|||
19477449|NCT01473407|41756690|FG001|Overall Study|Patient Lost Green Card Status|0|||
19477450|NCT01473407|41756689|FG000|Overall Study|Temperature Excursion|2|||
19477451|NCT01473407|41756690|FG001|Overall Study|Temperature Excursion|3|||
19477452|NCT01473407|41756689|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
19477453|NCT01473407|41756690|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
19477454|NCT01473407|41756689|FG000|Overall Study|Sponsor's Decision|10|||
19477455|NCT01473407|41756690|FG001|Overall Study|Sponsor's Decision|10|||
19477456|NCT01473407|41756689|FG000|Overall Study|Site Closure|1|||
19477457|NCT01473407|41756690|FG001|Overall Study|Site Closure|0|||
19477458|NCT01472939|41756700|FG000|Overall Study|Adverse Event|3|||
19477459|NCT01472939|41756701|FG001|Overall Study|Adverse Event|7|||
19477460|NCT01472939|41756702|FG002|Overall Study|Adverse Event|7|||
19477461|NCT01472939|41756703|FG003|Overall Study|Adverse Event|14|||
19477462|NCT01472939|41756700|FG000|Overall Study|Lack of Efficacy|1|||
19477463|NCT01472939|41756701|FG001|Overall Study|Lack of Efficacy|0|||
19477464|NCT01472939|41756702|FG002|Overall Study|Lack of Efficacy|0|||
19477465|NCT01472939|41756703|FG003|Overall Study|Lack of Efficacy|1|||
19477466|NCT01472939|41756700|FG000|Overall Study|Lost to Follow-up|3|||
19477467|NCT01472939|41756701|FG001|Overall Study|Lost to Follow-up|0|||
19477468|NCT01472939|41756702|FG002|Overall Study|Lost to Follow-up|2|||
19477469|NCT01472939|41756703|FG003|Overall Study|Lost to Follow-up|0|||
19477470|NCT01472939|41756700|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
19477471|NCT01472939|41756701|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
19477472|NCT01472939|41756702|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
19477473|NCT01472939|41756703|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
19477474|NCT01472939|41756700|FG000|Overall Study|Prohibited Medication|0|||
19477475|NCT01472939|41756701|FG001|Overall Study|Prohibited Medication|1|||
19477476|NCT01472939|41756702|FG002|Overall Study|Prohibited Medication|0|||
19477477|NCT01472939|41756703|FG003|Overall Study|Prohibited Medication|0|||
19477478|NCT01472939|41756700|FG000|Overall Study|Withdrawal By PI|1|||
19477479|NCT01472939|41756701|FG001|Overall Study|Withdrawal By PI|0|||
19477480|NCT01472939|41756702|FG002|Overall Study|Withdrawal By PI|0|||
19477481|NCT01472939|41756703|FG003|Overall Study|Withdrawal By PI|0|||
19477482|NCT01472939|41756700|FG000|Overall Study|Protocol Violation|3|||
19477483|NCT01472939|41756701|FG001|Overall Study|Protocol Violation|3|||
19477484|NCT01472939|41756702|FG002|Overall Study|Protocol Violation|0|||
19477485|NCT01472939|41756703|FG003|Overall Study|Protocol Violation|1|||
19477486|NCT01472939|41756700|FG000|Overall Study|Withdrawal by Subject|9|||
19477487|NCT01472939|41756701|FG001|Overall Study|Withdrawal by Subject|3|||
19477488|NCT01472939|41756702|FG002|Overall Study|Withdrawal by Subject|1|||
19477489|NCT01472939|41756703|FG003|Overall Study|Withdrawal by Subject|4|||
19477490|NCT01544179|41756718|FG000|Overall Study|Death|50|||
19477491|NCT01544179|41756719|FG001|Overall Study|Death|37|||
19477492|NCT01544179|41756718|FG000|Overall Study|Lost to Follow-up|0|||
19477493|NCT01544179|41756719|FG001|Overall Study|Lost to Follow-up|1|||
19477494|NCT01544179|41756718|FG000|Overall Study|Adverse Event|0|||
19477495|NCT01544179|41756719|FG001|Overall Study|Adverse Event|1|||
19477496|NCT01544179|41756718|FG000|Overall Study|Withdrawal by Subject|12|||
19477497|NCT01544179|41756719|FG001|Overall Study|Withdrawal by Subject|7|||
19477498|NCT01544179|41756718|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
19477499|NCT01544179|41756719|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19477500|NCT01483651|41756725|FG000|Overall Study|Withdrawal by Subject|0|||
19477501|NCT01483651|41756726|FG001|Overall Study|Withdrawal by Subject|1|||
19477502|NCT01483651|41756727|FG002|Overall Study|Withdrawal by Subject|1|||
19477503|NCT01483651|41756728|FG003|Overall Study|Withdrawal by Subject|0|||
19477504|NCT01483651|41756729|FG004|Overall Study|Withdrawal by Subject|0|||
19477505|NCT01483651|41756730|FG005|Overall Study|Withdrawal by Subject|1|||
19477506|NCT01464307|41756740|FG000|Main Period|Death|0|||
19477507|NCT01464307|41756741|FG001|Main Period|Death|1|||
19477508|NCT01464307|41756740|FG000|Main Period|Adverse Event|6|||
19477509|NCT01464307|41756741|FG001|Main Period|Adverse Event|1|||
19477510|NCT01464307|41756740|FG000|Main Period|Lack of Efficacy|2|||
19477511|NCT01464307|41756741|FG001|Main Period|Lack of Efficacy|0|||
19477512|NCT01464307|41756740|FG000|Main Period|Withdrawal by Subject|5|||
19477513|NCT01464307|41756741|FG001|Main Period|Withdrawal by Subject|2|||
19477514|NCT01464307|41756740|FG000|Main Period|Predefined discontinuation criteria|2|||
19477515|NCT01464307|41756741|FG001|Main Period|Predefined discontinuation criteria|1|||
19477516|NCT01464307|41756740|FG000|Open-Label Extension Period|Adverse Event|15|||
19477517|NCT01464307|41756741|FG001|Open-Label Extension Period|Adverse Event|0|||
19477518|NCT01464307|41756740|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
19477519|NCT01464307|41756741|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
19477520|NCT01464307|41756740|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
19477521|NCT01464307|41756741|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
19477522|NCT01464307|41756740|FG000|Open-Label Extension Period|Death|1|||
19477523|NCT01464307|41756741|FG001|Open-Label Extension Period|Death|0|||
19477524|NCT01464307|41756740|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
19477525|NCT01464307|41756741|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
19477526|NCT01464307|41756740|FG000|Open-Label Extension Period|Non-compliance|9|||
19477527|NCT01464307|41756741|FG001|Open-Label Extension Period|Non-compliance|0|||
19477528|NCT01464307|41756740|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
19477529|NCT01464307|41756741|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
19477530|NCT01483183|41756758|FG000|Overall Study|Physician Decision|0|||
19477531|NCT01483183|41756759|FG001|Overall Study|Physician Decision|0|||
19477532|NCT01483183|41756760|FG002|Overall Study|Physician Decision|0|||
19477533|NCT01483183|41756761|FG003|Overall Study|Physician Decision|0|||
19477534|NCT01483183|41756762|FG004|Overall Study|Physician Decision|0|||
19477535|NCT01483183|41756763|FG005|Overall Study|Physician Decision|0|||
19477536|NCT01483183|41756764|FG006|Overall Study|Physician Decision|2|||
19477537|NCT01483183|41756765|FG007|Overall Study|Physician Decision|0|||
19477538|NCT01483183|41756766|FG008|Overall Study|Physician Decision|0|||
19477539|NCT01483183|41756767|FG009|Overall Study|Physician Decision|0|||
19477540|NCT01483183|41756758|FG000|Overall Study|Withdrawal by Subject|0|||
19477541|NCT01483183|41756759|FG001|Overall Study|Withdrawal by Subject|0|||
19477542|NCT01483183|41756760|FG002|Overall Study|Withdrawal by Subject|0|||
19477543|NCT01483183|41756761|FG003|Overall Study|Withdrawal by Subject|0|||
19477544|NCT01483183|41756762|FG004|Overall Study|Withdrawal by Subject|0|||
19477545|NCT01483183|41756763|FG005|Overall Study|Withdrawal by Subject|0|||
19477546|NCT01483183|41756764|FG006|Overall Study|Withdrawal by Subject|0|||
19686582|NCT00413660|42133062|FG009|Up To Week 12|Lack of Efficacy|0|||
19686583|NCT00413660|42133063|FG010|Up To Week 12|Lack of Efficacy|0|||
19686584|NCT00413660|42133053|FG000|Up To Week 12|Lost to Follow-up|0|||
19686585|NCT00413660|42133054|FG001|Up To Week 12|Lost to Follow-up|1|||
19477547|NCT01483183|41756765|FG007|Overall Study|Withdrawal by Subject|0|||
19477548|NCT01483183|41756766|FG008|Overall Study|Withdrawal by Subject|0|||
19477549|NCT01483183|41756767|FG009|Overall Study|Withdrawal by Subject|1|||
19477550|NCT01483027|41756797|FG000|Overall Study|Administrative Reasons|2|||
19477551|NCT01483027|41756798|FG001|Overall Study|Administrative Reasons|1|||
19477552|NCT01483027|41756797|FG000|Overall Study|Withdrawal by Subject|21|||
19477553|NCT01483027|41756798|FG001|Overall Study|Withdrawal by Subject|32|||
19477554|NCT01483027|41756797|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
19686586|NCT00413660|42133055|FG002|Up To Week 12|Lost to Follow-up|0|||
19477555|NCT01483027|41756798|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
19477556|NCT01483027|41756797|FG000|Overall Study|Lost to Follow-up|1|||
19477557|NCT01483027|41756798|FG001|Overall Study|Lost to Follow-up|1|||
19477558|NCT01483027|41756797|FG000|Overall Study|Adverse Event|0|||
19477559|NCT01483027|41756798|FG001|Overall Study|Adverse Event|1|||
19477560|NCT01483027|41756797|FG000|Overall Study|Withdrawal by Subject|0|||
19477561|NCT01483027|41756798|FG001|Overall Study|Withdrawal by Subject|1|||
19477562|NCT01463683|41756807|FG000|Overall Study|Adverse Event|2|||
19477563|NCT01463683|41756808|FG001|Overall Study|Adverse Event|0|||
19477564|NCT01463683|41756809|FG002|Overall Study|Adverse Event|0|||
19477565|NCT01463683|41756807|FG000|Overall Study|Lost to Follow-up|10|||
19477566|NCT01463683|41756808|FG001|Overall Study|Lost to Follow-up|9|||
19477567|NCT01463683|41756809|FG002|Overall Study|Lost to Follow-up|7|||
19477568|NCT01463683|41756807|FG000|Overall Study|Physician Decision|0|||
19477569|NCT01463683|41756808|FG001|Overall Study|Physician Decision|3|||
19477570|NCT01463683|41756809|FG002|Overall Study|Physician Decision|1|||
19477571|NCT01463683|41756807|FG000|Overall Study|Pregnancy|2|||
19477572|NCT01463683|41756808|FG001|Overall Study|Pregnancy|2|||
19477573|NCT01463683|41756809|FG002|Overall Study|Pregnancy|1|||
19477574|NCT01463683|41756807|FG000|Overall Study|Withdrawal by Subject|5|||
19477575|NCT01463683|41756808|FG001|Overall Study|Withdrawal by Subject|17|||
19477576|NCT01463683|41756809|FG002|Overall Study|Withdrawal by Subject|2|||
19477577|NCT01482169|41756817|FG000|Overall Study|Physician Decision|2|||
19477578|NCT01481779|41756826|FG000|Overall Study|Adverse Event|23|||
19477579|NCT01481779|41756827|FG001|Overall Study|Adverse Event|5|||
19477580|NCT01481779|41756826|FG000|Overall Study|Lost to Follow-up|3|||
19477581|NCT01481779|41756827|FG001|Overall Study|Lost to Follow-up|2|||
19477582|NCT01481779|41756826|FG000|Overall Study|Protocol Violation|2|||
19477583|NCT01481779|41756827|FG001|Overall Study|Protocol Violation|3|||
19477584|NCT01481779|41756826|FG000|Overall Study|Withdrawal by Subject|26|||
19477585|NCT01481779|41756827|FG001|Overall Study|Withdrawal by Subject|13|||
19477586|NCT01481779|41756826|FG000|Overall Study|Physician Decision|13|||
19477587|NCT01481779|41756827|FG001|Overall Study|Physician Decision|4|||
19477588|NCT01481779|41756826|FG000|Overall Study|Sponsor Decision|3|||
19477589|NCT01481779|41756827|FG001|Overall Study|Sponsor Decision|1|||
19477590|NCT01463527|41756835|FG000|Overall Study|Protocol Violation|1|||
19477591|NCT01463527|41756836|FG001|Overall Study|Protocol Violation|1|||
19477592|NCT01463527|41756835|FG000|Overall Study|Crying >20% of sedation|5|||
19477593|NCT01463527|41756836|FG001|Overall Study|Crying >20% of sedation|6|||
19477594|NCT01509547|41756844|FG000|Overall Study|Lost to Follow-up|24|||
19477595|NCT01509547|41756845|FG001|Overall Study|Lost to Follow-up|14|||
19477596|NCT01509547|41756844|FG000|Overall Study|Withdrawal by Subject|11|||
19477597|NCT01509547|41756845|FG001|Overall Study|Withdrawal by Subject|24|||
19477598|NCT01509547|41756844|FG000|Overall Study|Physician Decision|0|||
19477599|NCT01509547|41756845|FG001|Overall Study|Physician Decision|1|||
19477600|NCT01509079|41756853|FG000|Overall Study|Lack of Efficacy|0|||
19477601|NCT01509079|41756854|FG001|Overall Study|Lack of Efficacy|2|||
19477602|NCT01509079|41756853|FG000|Overall Study|started an excluded medication|0|||
19477603|NCT01509079|41756854|FG001|Overall Study|started an excluded medication|1|||
19477604|NCT01463293|41756863|FG000|Overall Study|Lost to Follow-up|1|||
19477605|NCT01463293|41756864|FG001|Overall Study|Lost to Follow-up|4|||
19477606|NCT01463293|41756865|FG002|Overall Study|Lost to Follow-up|5|||
19477607|NCT01463293|41756863|FG000|Overall Study|Adverse Event|1|||
19477608|NCT01463293|41756864|FG001|Overall Study|Adverse Event|2|||
19605558|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
19605559|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
19605560|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
19605561|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
19605562|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
19605563|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
19605564|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
19605565|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
19477609|NCT01463293|41756865|FG002|Overall Study|Adverse Event|0|||
19477610|NCT01463293|41756863|FG000|Overall Study|Withdrawal by Subject|4|||
19477611|NCT01463293|41756864|FG001|Overall Study|Withdrawal by Subject|10|||
19477612|NCT01463293|41756865|FG002|Overall Study|Withdrawal by Subject|5|||
19477613|NCT01463293|41756863|FG000|Overall Study|Other|0|||
19605566|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
19477614|NCT01463293|41756864|FG001|Overall Study|Other|0|||
19477615|NCT01463293|41756865|FG002|Overall Study|Other|2|||
19477616|NCT01479985|41756896|FG000|Overall Study|Tablet malfunction, no data saved|1|||
19477617|NCT01479985|41756897|FG001|Overall Study|Tablet malfunction, no data saved|1|||
19477618|NCT01479985|41756896|FG000|Overall Study|No decisional conflict scale responses|0|||
19477619|NCT01479985|41756897|FG001|Overall Study|No decisional conflict scale responses|2|||
19477620|NCT01479985|41756896|FG000|Overall Study|No post-visit survey|5|||
19477621|NCT01479985|41756897|FG001|Overall Study|No post-visit survey|3|||
19477622|NCT01462435|41756911|FG000|Overall Study|Lack of Efficacy|1|||
19477623|NCT01462435|41756912|FG001|Overall Study|Lack of Efficacy|0|||
19477624|NCT01462435|41756913|FG002|Overall Study|Lack of Efficacy|0|||
19477625|NCT01462435|41756914|FG003|Overall Study|Lack of Efficacy|3|||
19477626|NCT01462435|41756911|FG000|Overall Study|Physician Decision|0|||
19477627|NCT01462435|41756912|FG001|Overall Study|Physician Decision|0|||
19477628|NCT01462435|41756913|FG002|Overall Study|Physician Decision|1|||
19686587|NCT00413660|42133056|FG003|Up To Week 12|Lost to Follow-up|0|||
19686588|NCT00413660|42133057|FG004|Up To Week 12|Lost to Follow-up|1|||
19686589|NCT00413660|42133058|FG005|Up To Week 12|Lost to Follow-up|0|||
19686590|NCT00413660|42133059|FG006|Up To Week 12|Lost to Follow-up|0|||
19686591|NCT00413660|42133060|FG007|Up To Week 12|Lost to Follow-up|0|||
19686592|NCT00413660|42133061|FG008|Up To Week 12|Lost to Follow-up|0|||
19686593|NCT00413660|42133062|FG009|Up To Week 12|Lost to Follow-up|0|||
19686594|NCT00413660|42133063|FG010|Up To Week 12|Lost to Follow-up|0|||
19686595|NCT00413660|42133053|FG000|Up To Week 12|Withdrawal by Subject|0|||
19686596|NCT00413660|42133054|FG001|Up To Week 12|Withdrawal by Subject|2|||
19769635|NCT03010254|42223194|FG001|Overall Study|Withdrawal by Subject|1|||
19769636|NCT03010254|42223193|FG000|Overall Study|Other|2|||
19769637|NCT03010254|42223194|FG001|Overall Study|Other|3|||
19769638|NCT03008460|42223209|FG000|Overall Study|Protocol deviation|0|||
19769639|NCT03008460|42223210|FG001|Overall Study|Protocol deviation|2|||
19769640|NCT03008460|42223209|FG000|Overall Study|Study drug not dispensed|0|||
19769641|NCT03008460|42223210|FG001|Overall Study|Study drug not dispensed|1|||
19605567|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
19769642|NCT03008460|42223209|FG000|Overall Study|Adverse Event|0|||
19769643|NCT03008460|42223210|FG001|Overall Study|Adverse Event|1|||
19769644|NCT03008460|42223209|FG000|Overall Study|Withdrawal by Subject|5|||
19769645|NCT03008460|42223210|FG001|Overall Study|Withdrawal by Subject|6|||
19769646|NCT03008460|42223209|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
19769647|NCT03008460|42223210|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
19769648|NCT03008460|42223209|FG000|Overall Study|End of study visit outside permitted time window|0|||
19769649|NCT03008460|42223210|FG001|Overall Study|End of study visit outside permitted time window|1|||
19769650|NCT03008460|42223209|FG000|Overall Study|Lost to Follow-up|1|||
19769651|NCT03008460|42223210|FG001|Overall Study|Lost to Follow-up|3|||
19769652|NCT03008070|42223219|FG000|Overall Study|Adverse Event|3|||
19769653|NCT03008070|42223220|FG001|Overall Study|Adverse Event|3|||
19769654|NCT03008070|42223221|FG002|Overall Study|Adverse Event|3|||
19769655|NCT03008070|42223219|FG000|Overall Study|Lost to Follow-up|1|||
19769656|NCT03008070|42223220|FG001|Overall Study|Lost to Follow-up|1|||
19769657|NCT03008070|42223221|FG002|Overall Study|Lost to Follow-up|0|||
19769658|NCT03008070|42223219|FG000|Overall Study|Non compliance|0|||
19769659|NCT03008070|42223220|FG001|Overall Study|Non compliance|1|||
19769660|NCT03008070|42223221|FG002|Overall Study|Non compliance|1|||
19769661|NCT03008070|42223219|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
19769662|NCT03008070|42223220|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
19477629|NCT01462435|41756914|FG003|Overall Study|Physician Decision|0|||
19605568|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
19605569|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
19605570|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
19605571|NCT00950300|42054319|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
19605572|NCT00950300|42054320|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
19605573|NCT00950300|42054319|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
19605574|NCT00950300|42054320|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
19605575|NCT00950300|42054319|FG000|TFFU Period|Death|4|||
19605576|NCT00950300|42054320|FG001|TFFU Period|Death|1|||
19605577|NCT00950300|42054319|FG000|TFFU Period|Refused Treatment|10|||
19686597|NCT00413660|42133055|FG002|Up To Week 12|Withdrawal by Subject|0|||
19686598|NCT00413660|42133056|FG003|Up To Week 12|Withdrawal by Subject|2|||
19686599|NCT00413660|42133057|FG004|Up To Week 12|Withdrawal by Subject|0|||
19686600|NCT00413660|42133058|FG005|Up To Week 12|Withdrawal by Subject|2|||
19769663|NCT03008070|42223221|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
19477630|NCT01462435|41756911|FG000|Overall Study|Withdrawal by Subject|0|||
19686601|NCT00413660|42133059|FG006|Up To Week 12|Withdrawal by Subject|2|||
19686602|NCT00413660|42133060|FG007|Up To Week 12|Withdrawal by Subject|0|||
19686603|NCT00413660|42133061|FG008|Up To Week 12|Withdrawal by Subject|0|||
19686604|NCT00413660|42133062|FG009|Up To Week 12|Withdrawal by Subject|0|||
19686605|NCT00413660|42133063|FG010|Up To Week 12|Withdrawal by Subject|0|||
19686606|NCT00413660|42133053|FG000|Up To Week 12|Randomized, Not Treated|1|||
19686607|NCT00413660|42133054|FG001|Up To Week 12|Randomized, Not Treated|0|||
19686608|NCT00413660|42133055|FG002|Up To Week 12|Randomized, Not Treated|0|||
19686609|NCT00413660|42133056|FG003|Up To Week 12|Randomized, Not Treated|1|||
19686610|NCT00413660|42133057|FG004|Up To Week 12|Randomized, Not Treated|0|||
19686611|NCT00413660|42133058|FG005|Up To Week 12|Randomized, Not Treated|0|||
19686612|NCT00413660|42133059|FG006|Up To Week 12|Randomized, Not Treated|0|||
19686613|NCT00413660|42133060|FG007|Up To Week 12|Randomized, Not Treated|0|||
19686614|NCT00413660|42133061|FG008|Up To Week 12|Randomized, Not Treated|0|||
19686615|NCT00413660|42133062|FG009|Up To Week 12|Randomized, Not Treated|0|||
19686616|NCT00413660|42133063|FG010|Up To Week 12|Randomized, Not Treated|0|||
19686617|NCT00413660|42133053|FG000|Up To Week 12|Other|3|||
19686618|NCT00413660|42133054|FG001|Up To Week 12|Other|1|||
19686619|NCT00413660|42133055|FG002|Up To Week 12|Other|6|||
19686620|NCT00413660|42133056|FG003|Up To Week 12|Other|1|||
19686621|NCT00413660|42133057|FG004|Up To Week 12|Other|2|||
19686622|NCT00413660|42133058|FG005|Up To Week 12|Other|4|||
19686623|NCT00413660|42133059|FG006|Up To Week 12|Other|3|||
19686624|NCT00413660|42133060|FG007|Up To Week 12|Other|0|||
19686625|NCT00413660|42133061|FG008|Up To Week 12|Other|0|||
19686626|NCT00413660|42133062|FG009|Up To Week 12|Other|0|||
19686627|NCT00413660|42133063|FG010|Up To Week 12|Other|0|||
19686628|NCT00413660|42133053|FG000|Post Week 12|Adverse Event|2|||
19686629|NCT00413660|42133054|FG001|Post Week 12|Adverse Event|0|||
19686630|NCT00413660|42133055|FG002|Post Week 12|Adverse Event|2|||
19686631|NCT00413660|42133056|FG003|Post Week 12|Adverse Event|1|||
19686632|NCT00413660|42133057|FG004|Post Week 12|Adverse Event|4|||
19686633|NCT00413660|42133058|FG005|Post Week 12|Adverse Event|2|||
19686634|NCT00413660|42133059|FG006|Post Week 12|Adverse Event|2|||
19686635|NCT00413660|42133060|FG007|Post Week 12|Adverse Event|0|||
19686636|NCT00413660|42133061|FG008|Post Week 12|Adverse Event|0|||
19686637|NCT00413660|42133062|FG009|Post Week 12|Adverse Event|0|||
19686638|NCT00413660|42133063|FG010|Post Week 12|Adverse Event|0|||
19769664|NCT03008070|42223219|FG000|Overall Study|Withdrawal by Subject|2|||
19769665|NCT03008070|42223220|FG001|Overall Study|Withdrawal by Subject|0|||
19769666|NCT03008070|42223221|FG002|Overall Study|Withdrawal by Subject|1|||
19769667|NCT03008070|42223219|FG000|Overall Study|Use of prohibited drug|0|||
19769668|NCT03008070|42223220|FG001|Overall Study|Use of prohibited drug|0|||
19769669|NCT03008070|42223221|FG002|Overall Study|Use of prohibited drug|2|||
19769670|NCT02914236|42223231|FG000|Overall Study|Lost to Follow-up|1|||
19769671|NCT03003390|42223237|FG000|Overall Study|Physician Decision|2|||
19769672|NCT03003390|42223238|FG001|Overall Study|Physician Decision|0|||
19769673|NCT03003390|42223237|FG000|Overall Study|Parent refused intervention|2|||
19769674|NCT03003390|42223238|FG001|Overall Study|Parent refused intervention|0|||
19769675|NCT03003000|42223252|FG000|Overall Study|Adverse Event|1|||
19769676|NCT03003000|42223253|FG001|Overall Study|Adverse Event|2|||
19769677|NCT03003000|42223254|FG002|Overall Study|Adverse Event|3|||
19769678|NCT03003000|42223252|FG000|Overall Study|Lack of Efficacy|1|||
19769679|NCT03003000|42223253|FG001|Overall Study|Lack of Efficacy|0|||
19769680|NCT03003000|42223254|FG002|Overall Study|Lack of Efficacy|0|||
19769681|NCT03003000|42223252|FG000|Overall Study|Non-compliant with protocol|0|||
19769682|NCT03003000|42223253|FG001|Overall Study|Non-compliant with protocol|1|||
19769683|NCT03003000|42223254|FG002|Overall Study|Non-compliant with protocol|1|||
19769684|NCT03003000|42223252|FG000|Overall Study|Refused to continue medication|2|||
19769685|NCT03003000|42223253|FG001|Overall Study|Refused to continue medication|0|||
19769686|NCT03003000|42223254|FG002|Overall Study|Refused to continue medication|0|||
19769687|NCT03003000|42223252|FG000|Overall Study|Other than listed|1|||
19686639|NCT00413660|42133053|FG000|Post Week 12|Lack of Efficacy|0|||
19769688|NCT03003000|42223253|FG001|Overall Study|Other than listed|1|||
19769689|NCT03003000|42223254|FG002|Overall Study|Other than listed|1|||
19769690|NCT03002610|42223265|FG000|Overall Study|Withdrawal by Subject|6|||
19769691|NCT03002610|42223266|FG001|Overall Study|Withdrawal by Subject|25|||
19769692|NCT03002610|42223267|FG002|Overall Study|Withdrawal by Subject|13|||
19769693|NCT03005106|42223275|FG000|Overall Study|Lost to Follow-up|16|||
19686640|NCT00413660|42133054|FG001|Post Week 12|Lack of Efficacy|0|||
19686641|NCT00413660|42133055|FG002|Post Week 12|Lack of Efficacy|1|||
19686642|NCT00413660|42133056|FG003|Post Week 12|Lack of Efficacy|0|||
19686643|NCT00413660|42133057|FG004|Post Week 12|Lack of Efficacy|0|||
19686644|NCT00413660|42133058|FG005|Post Week 12|Lack of Efficacy|0|||
19769694|NCT03005106|42223275|FG000|Overall Study|Adverse Event|1|||
19686645|NCT00413660|42133059|FG006|Post Week 12|Lack of Efficacy|0|||
19686646|NCT00413660|42133060|FG007|Post Week 12|Lack of Efficacy|0|||
19686647|NCT00413660|42133061|FG008|Post Week 12|Lack of Efficacy|0|||
19686648|NCT00413660|42133062|FG009|Post Week 12|Lack of Efficacy|1|||
19686649|NCT00413660|42133063|FG010|Post Week 12|Lack of Efficacy|0|||
19686650|NCT00413660|42133053|FG000|Post Week 12|Lost to Follow-up|0|||
19686651|NCT00413660|42133054|FG001|Post Week 12|Lost to Follow-up|1|||
19686652|NCT00413660|42133055|FG002|Post Week 12|Lost to Follow-up|1|||
19686653|NCT00413660|42133056|FG003|Post Week 12|Lost to Follow-up|0|||
19686654|NCT00413660|42133057|FG004|Post Week 12|Lost to Follow-up|0|||
19686655|NCT00413660|42133058|FG005|Post Week 12|Lost to Follow-up|0|||
19686656|NCT00413660|42133059|FG006|Post Week 12|Lost to Follow-up|0|||
19686657|NCT00413660|42133060|FG007|Post Week 12|Lost to Follow-up|0|||
19686658|NCT00413660|42133061|FG008|Post Week 12|Lost to Follow-up|0|||
19686659|NCT00413660|42133062|FG009|Post Week 12|Lost to Follow-up|0|||
19686660|NCT00413660|42133063|FG010|Post Week 12|Lost to Follow-up|0|||
19686661|NCT00413660|42133053|FG000|Post Week 12|Withdrawal by Subject|0|||
19686662|NCT00413660|42133054|FG001|Post Week 12|Withdrawal by Subject|1|||
19686663|NCT00413660|42133055|FG002|Post Week 12|Withdrawal by Subject|1|||
19686664|NCT00413660|42133056|FG003|Post Week 12|Withdrawal by Subject|0|||
19686665|NCT00413660|42133057|FG004|Post Week 12|Withdrawal by Subject|1|||
19686666|NCT00413660|42133058|FG005|Post Week 12|Withdrawal by Subject|0|||
19686667|NCT00413660|42133059|FG006|Post Week 12|Withdrawal by Subject|0|||
19686668|NCT00413660|42133060|FG007|Post Week 12|Withdrawal by Subject|0|||
19686669|NCT00413660|42133061|FG008|Post Week 12|Withdrawal by Subject|0|||
19686670|NCT00413660|42133062|FG009|Post Week 12|Withdrawal by Subject|0|||
19686671|NCT00413660|42133063|FG010|Post Week 12|Withdrawal by Subject|1|||
19686672|NCT00413660|42133053|FG000|Post Week 12|Other|1|||
19686673|NCT00413660|42133054|FG001|Post Week 12|Other|2|||
19686674|NCT00413660|42133055|FG002|Post Week 12|Other|3|||
19686675|NCT00413660|42133056|FG003|Post Week 12|Other|0|||
19686676|NCT00413660|42133057|FG004|Post Week 12|Other|1|||
19686677|NCT00413660|42133058|FG005|Post Week 12|Other|1|||
19686678|NCT00413660|42133059|FG006|Post Week 12|Other|1|||
19686679|NCT00413660|42133060|FG007|Post Week 12|Other|0|||
19686680|NCT00413660|42133061|FG008|Post Week 12|Other|0|||
19686681|NCT00413660|42133062|FG009|Post Week 12|Other|0|||
19686682|NCT00413660|42133063|FG010|Post Week 12|Other|0|||
19686683|NCT00431834|42133097|FG000|Overall Study|Withdrawal by Subject|7|||
19686684|NCT00431834|42133097|FG000|Overall Study|Death|3|||
19686685|NCT00431834|42133097|FG000|Overall Study|Missed Endpoint Visit|2|||
19686686|NCT00431834|42133097|FG000|Overall Study|Lost to Follow-up|1|||
19686687|NCT00431444|42133106|FG000|Overall Study|Protocol Violation|1|||
19686688|NCT00431444|42133107|FG001|Overall Study|Protocol Violation|4|||
19686689|NCT00431444|42133106|FG000|Overall Study|Adverse Event|2|||
19686690|NCT00431444|42133107|FG001|Overall Study|Adverse Event|1|||
19686691|NCT00431444|42133106|FG000|Overall Study|Withdrawal by Subject|1|||
19686692|NCT00431444|42133107|FG001|Overall Study|Withdrawal by Subject|1|||
19686693|NCT00431444|42133106|FG000|Overall Study|Lost to Follow-up|1|||
19686694|NCT00431444|42133107|FG001|Overall Study|Lost to Follow-up|0|||
19686695|NCT00431444|42133106|FG000|Overall Study|Administrative Problems|0|||
19686696|NCT00431444|42133107|FG001|Overall Study|Administrative Problems|1|||
19686697|NCT00430352|42133113|FG000|Overall Study|Disease progression|58|||
19686698|NCT00430352|42133113|FG000|Overall Study|Withdrawal by Subject|11|||
19686699|NCT00430352|42133113|FG000|Overall Study|Adverse Event|16|||
19686700|NCT00430352|42133113|FG000|Overall Study|Death|5|||
19686701|NCT00430352|42133113|FG000|Overall Study|Other|48|||
19686702|NCT00287469|42133119|FG000|Overall Study|serious adverse event|1|||
19686703|NCT00287469|42133120|FG001|Overall Study|serious adverse event|6|||
19686704|NCT00287469|42133119|FG000|Overall Study|Adverse Event|1|||
19686705|NCT00287469|42133120|FG001|Overall Study|Adverse Event|1|||
19769695|NCT03005106|42223275|FG000|Overall Study|Physician Decision|1|||
19769696|NCT03005106|42223275|FG000|Overall Study|Death|2|||
19769697|NCT01004861|42223292|FG000|Overall Study|Disease progression|3|||
19769698|NCT01004861|42223293|FG001|Overall Study|Disease progression|4|||
19686706|NCT00287469|42133119|FG000|Overall Study|moved from area|144|||
19686707|NCT00287469|42133120|FG001|Overall Study|moved from area|138|||
19686708|NCT00287469|42133119|FG000|Overall Study|Lost to Follow-up|74|||
19686709|NCT00287469|42133120|FG001|Overall Study|Lost to Follow-up|69|||
19769699|NCT01004861|42223294|FG002|Overall Study|Disease progression|5|||
19769700|NCT01004861|42223295|FG003|Overall Study|Disease progression|4|||
19769701|NCT01004861|42223296|FG004|Overall Study|Disease progression|4|||
19686710|NCT00429572|42133128|FG000|Overall Study|Disease progression|1|||
19686711|NCT00287079|42133134|FG000|Overall Study|Qualifying relapse|12|||
19686712|NCT00287079|42133135|FG001|Overall Study|Qualifying relapse|1|||
19686713|NCT00287079|42133134|FG000|Overall Study|Non-qualifying relapse|1|||
19686714|NCT00287079|42133135|FG001|Overall Study|Non-qualifying relapse|0|||
19686715|NCT00287079|42133134|FG000|Overall Study|Adverse Event|5|||
19686716|NCT00287079|42133135|FG001|Overall Study|Adverse Event|0|||
19769702|NCT01004861|42223297|FG005|Overall Study|Disease progression|4|||
19769703|NCT01004861|42223298|FG006|Overall Study|Disease progression|5|||
19769704|NCT01004861|42223299|FG007|Overall Study|Disease progression|1|||
19769705|NCT01004861|42223300|FG008|Overall Study|Disease progression|4|||
19769706|NCT01004861|42223301|FG009|Overall Study|Disease progression|7|||
19769707|NCT01004861|42223302|FG010|Overall Study|Disease progression|6|||
19769708|NCT01004861|42223303|FG011|Overall Study|Disease progression|3|||
19769709|NCT01004861|42223304|FG012|Overall Study|Disease progression|8|||
19769710|NCT01004861|42223292|FG000|Overall Study|Physician Decision|0|||
19769711|NCT01004861|42223293|FG001|Overall Study|Physician Decision|2|||
19769712|NCT01004861|42223294|FG002|Overall Study|Physician Decision|1|||
19769713|NCT01004861|42223295|FG003|Overall Study|Physician Decision|1|||
19686717|NCT00287079|42133134|FG000|Overall Study|Protocol Violation|1|||
19686718|NCT00287079|42133135|FG001|Overall Study|Protocol Violation|0|||
19686719|NCT00287079|42133134|FG000|Overall Study|Other|3|||
19686720|NCT00287079|42133135|FG001|Overall Study|Other|0|||
19686721|NCT00429494|42133141|FG000|Overall Study|Withdrawal by Subject|9|||
19686722|NCT00429494|42133141|FG000|Overall Study|Death|6|||
19686723|NCT00429416|42133145|FG000|Overall Study|Death|1|||
19686724|NCT00429182|42133149|FG000|Overall Study|Not evaluable, Disease Progression|2|||
19686725|NCT00429182|42133149|FG000|Overall Study|Not eligible|5|||
19686726|NCT00429104|42133153|FG000|Overall Study|Protocol Violation|1|||
19686727|NCT00429026|42133157|FG000|Overall Study|Inevaluable for response.|40|||
19686728|NCT00301821|42133161|FG000|Overall Study|Ineligible|25|||
19686729|NCT00301821|42133161|FG000|Overall Study|Cancel|1|||
19686730|NCT00372996|42133167|FG000|Overall Study|Death|11|||
19686731|NCT00372996|42133168|FG001|Overall Study|Death|4|||
19686732|NCT00372996|42133169|FG002|Overall Study|Death|8|||
19686733|NCT00372996|42133170|FG003|Overall Study|Death|7|||
19686734|NCT00372996|42133167|FG000|Overall Study|Lost to Follow-up|0|||
19686735|NCT00372996|42133168|FG001|Overall Study|Lost to Follow-up|2|||
19686736|NCT00372996|42133169|FG002|Overall Study|Lost to Follow-up|0|||
19686737|NCT00372996|42133170|FG003|Overall Study|Lost to Follow-up|1|||
19686738|NCT00372996|42133167|FG000|Overall Study|Withdrawal by Subject|12|||
19686739|NCT00372996|42133168|FG001|Overall Study|Withdrawal by Subject|6|||
19686740|NCT00372996|42133169|FG002|Overall Study|Withdrawal by Subject|9|||
19686741|NCT00372996|42133170|FG003|Overall Study|Withdrawal by Subject|5|||
19686742|NCT00372996|42133167|FG000|Overall Study|Study Terminated by Sponsor|4|||
19686743|NCT00372996|42133168|FG001|Overall Study|Study Terminated by Sponsor|0|||
19686744|NCT00372996|42133169|FG002|Overall Study|Study Terminated by Sponsor|4|||
19686745|NCT00372996|42133170|FG003|Overall Study|Study Terminated by Sponsor|0|||
19686746|NCT00372996|42133167|FG000|Overall Study|Other|10|||
19686747|NCT00372996|42133168|FG001|Overall Study|Other|2|||
19686748|NCT00372996|42133169|FG002|Overall Study|Other|7|||
19769714|NCT01004861|42223296|FG004|Overall Study|Physician Decision|1|||
19769715|NCT01004861|42223297|FG005|Overall Study|Physician Decision|0|||
19769716|NCT01004861|42223298|FG006|Overall Study|Physician Decision|0|||
19769717|NCT01004861|42223299|FG007|Overall Study|Physician Decision|1|||
19769718|NCT01004861|42223300|FG008|Overall Study|Physician Decision|0|||
19769719|NCT01004861|42223301|FG009|Overall Study|Physician Decision|0|||
19769720|NCT01004861|42223302|FG010|Overall Study|Physician Decision|0|||
19769721|NCT01004861|42223303|FG011|Overall Study|Physician Decision|0|||
19769722|NCT01004861|42223304|FG012|Overall Study|Physician Decision|3|||
19769723|NCT01004861|42223292|FG000|Overall Study|Adverse Event|0|||
19769724|NCT01004861|42223293|FG001|Overall Study|Adverse Event|0|||
19769725|NCT01004861|42223294|FG002|Overall Study|Adverse Event|0|||
19769726|NCT01004861|42223295|FG003|Overall Study|Adverse Event|1|||
19769727|NCT01004861|42223296|FG004|Overall Study|Adverse Event|0|||
19769728|NCT01004861|42223297|FG005|Overall Study|Adverse Event|2|||
19769729|NCT01004861|42223298|FG006|Overall Study|Adverse Event|1|||
19769730|NCT01004861|42223299|FG007|Overall Study|Adverse Event|1|||
19769731|NCT01004861|42223300|FG008|Overall Study|Adverse Event|13|||
19769732|NCT01004861|42223301|FG009|Overall Study|Adverse Event|1|||
19769733|NCT01004861|42223302|FG010|Overall Study|Adverse Event|1|||
19769734|NCT01004861|42223303|FG011|Overall Study|Adverse Event|0|||
19769735|NCT01004861|42223304|FG012|Overall Study|Adverse Event|2|||
19769736|NCT01004861|42223292|FG000|Overall Study|Protocol Violation|0|||
19769737|NCT01004861|42223293|FG001|Overall Study|Protocol Violation|0|||
19769738|NCT01004861|42223294|FG002|Overall Study|Protocol Violation|0|||
19769739|NCT01004861|42223295|FG003|Overall Study|Protocol Violation|0|||
19769740|NCT01004861|42223296|FG004|Overall Study|Protocol Violation|1|||
19686749|NCT00372996|42133170|FG003|Overall Study|Other|7|||
19686750|NCT00399516|42133180|FG000|Overall Study|Lost to Follow-up|2|||
19686751|NCT00399360|42133188|FG000|Overall Study|Lost to Follow-up|2|||
19686752|NCT00399360|42133189|FG001|Overall Study|Lost to Follow-up|1|||
19686753|NCT00399360|42133190|FG002|Overall Study|Lost to Follow-up|2|||
19686754|NCT00399360|42133191|FG003|Overall Study|Lost to Follow-up|4|||
19686755|NCT00399360|42133188|FG000|Overall Study|Adverse Event|0|||
19686756|NCT00399360|42133189|FG001|Overall Study|Adverse Event|0|||
19769741|NCT01004861|42223297|FG005|Overall Study|Protocol Violation|0|||
19769742|NCT01004861|42223298|FG006|Overall Study|Protocol Violation|0|||
19769743|NCT01004861|42223299|FG007|Overall Study|Protocol Violation|0|||
19769744|NCT01004861|42223300|FG008|Overall Study|Protocol Violation|0|||
19769745|NCT01004861|42223301|FG009|Overall Study|Protocol Violation|0|||
19769746|NCT01004861|42223302|FG010|Overall Study|Protocol Violation|0|||
19769747|NCT01004861|42223303|FG011|Overall Study|Protocol Violation|0|||
19769748|NCT01004861|42223304|FG012|Overall Study|Protocol Violation|0|||
19769749|NCT01004861|42223292|FG000|Overall Study|Lost to Follow-up|0|||
19769750|NCT01004861|42223293|FG001|Overall Study|Lost to Follow-up|0|||
19769751|NCT01004861|42223294|FG002|Overall Study|Lost to Follow-up|0|||
19769752|NCT01004861|42223295|FG003|Overall Study|Lost to Follow-up|0|||
19769753|NCT01004861|42223296|FG004|Overall Study|Lost to Follow-up|0|||
19769754|NCT01004861|42223297|FG005|Overall Study|Lost to Follow-up|0|||
19769755|NCT01004861|42223298|FG006|Overall Study|Lost to Follow-up|0|||
19769756|NCT01004861|42223299|FG007|Overall Study|Lost to Follow-up|1|||
19769757|NCT01004861|42223300|FG008|Overall Study|Lost to Follow-up|3|||
19769758|NCT01004861|42223301|FG009|Overall Study|Lost to Follow-up|0|||
19769759|NCT01004861|42223302|FG010|Overall Study|Lost to Follow-up|0|||
19686757|NCT00399360|42133190|FG002|Overall Study|Adverse Event|1|||
19686758|NCT00399360|42133191|FG003|Overall Study|Adverse Event|0|||
19686759|NCT00399360|42133188|FG000|Overall Study|Withdrawal by Subject|0|||
19686760|NCT00399360|42133189|FG001|Overall Study|Withdrawal by Subject|2|||
19686761|NCT00399360|42133190|FG002|Overall Study|Withdrawal by Subject|0|||
19686762|NCT00399360|42133191|FG003|Overall Study|Withdrawal by Subject|2|||
19686763|NCT00428948|42133208|FG000|Overall Study|Lost to Follow-up|15|||
19686764|NCT00428948|42133209|FG001|Overall Study|Lost to Follow-up|8|||
19686765|NCT00428948|42133208|FG000|Overall Study|Adverse Event|148|||
19686766|NCT00428948|42133209|FG001|Overall Study|Adverse Event|24|||
19686767|NCT00428948|42133208|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
19686768|NCT00428948|42133209|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
19686769|NCT00428948|42133208|FG000|Overall Study|Investigator Withdrew Subject|3|||
19605578|NCT00950300|42054320|FG001|TFFU Period|Refused Treatment|11|||
19769760|NCT01004861|42223303|FG011|Overall Study|Lost to Follow-up|1|||
19769761|NCT01004861|42223304|FG012|Overall Study|Lost to Follow-up|0|||
19769762|NCT01004861|42223292|FG000|Overall Study|Non-compliance|0|||
19769763|NCT01004861|42223293|FG001|Overall Study|Non-compliance|0|||
19769764|NCT01004861|42223294|FG002|Overall Study|Non-compliance|0|||
19769765|NCT01004861|42223295|FG003|Overall Study|Non-compliance|0|||
19769766|NCT01004861|42223296|FG004|Overall Study|Non-compliance|0|||
19769767|NCT01004861|42223297|FG005|Overall Study|Non-compliance|0|||
19769768|NCT01004861|42223298|FG006|Overall Study|Non-compliance|0|||
19769769|NCT01004861|42223299|FG007|Overall Study|Non-compliance|0|||
19769770|NCT01004861|42223300|FG008|Overall Study|Non-compliance|5|||
19769771|NCT01004861|42223301|FG009|Overall Study|Non-compliance|0|||
19686770|NCT00428948|42133209|FG001|Overall Study|Investigator Withdrew Subject|4|||
19686771|NCT00428948|42133208|FG000|Overall Study|Subject Withdrew Consent|50|||
19686772|NCT00428948|42133209|FG001|Overall Study|Subject Withdrew Consent|30|||
19686773|NCT00428948|42133208|FG000|Overall Study|Protocol Deviation|1|||
19686774|NCT00428948|42133209|FG001|Overall Study|Protocol Deviation|1|||
19686775|NCT00428792|42133217|FG000|Overall Study|Lack of Efficacy|1|||
19686776|NCT00428792|42133218|FG001|Overall Study|Lack of Efficacy|3|||
19686777|NCT00428792|42133217|FG000|Overall Study|Lost to Follow-up|0|||
19686778|NCT00428792|42133218|FG001|Overall Study|Lost to Follow-up|1|||
19686779|NCT00300885|42133226|FG000|Treatment|Adverse Event|134|||
19686780|NCT00300885|42133227|FG001|Treatment|Adverse Event|82|||
19686781|NCT00300885|42133226|FG000|Treatment|Death|20|||
19686782|NCT00300885|42133227|FG001|Treatment|Death|7|||
19686783|NCT00300885|42133226|FG000|Treatment|Lack of Efficacy|1|||
19686784|NCT00300885|42133227|FG001|Treatment|Lack of Efficacy|1|||
19686785|NCT00300885|42133226|FG000|Treatment|Lost to Follow-up|3|||
19686786|NCT00300885|42133227|FG001|Treatment|Lost to Follow-up|2|||
19686787|NCT00300885|42133226|FG000|Treatment|Physician Decision|4|||
19686788|NCT00300885|42133227|FG001|Treatment|Physician Decision|5|||
19605579|NCT00950300|42054319|FG000|TFFU Period|Failure to Return|16|||
19605580|NCT00950300|42054320|FG001|TFFU Period|Failure to Return|16|||
19605581|NCT00950300|42054319|FG000|TFFU Period|Recurrence of Disease|63|||
19605582|NCT00950300|42054320|FG001|TFFU Period|Recurrence of Disease|72|||
19605583|NCT00950300|42054319|FG000|TFFU Period|Other|4|||
19605584|NCT00950300|42054320|FG001|TFFU Period|Other|3|||
19605585|NCT00950300|42054319|FG000|SFU Period|Death|44|||
19605586|NCT00950300|42054320|FG001|SFU Period|Death|42|||
19769772|NCT01004861|42223302|FG010|Overall Study|Non-compliance|0|||
19686789|NCT00300885|42133226|FG000|Treatment|Protocol Violation|11|||
19686790|NCT00300885|42133227|FG001|Treatment|Protocol Violation|11|||
19686791|NCT00300885|42133226|FG000|Treatment|Withdrawal by Subject|26|||
19686792|NCT00300885|42133227|FG001|Treatment|Withdrawal by Subject|23|||
19686793|NCT00300885|42133226|FG000|Treatment|Disease progression|171|||
19769773|NCT01004861|42223303|FG011|Overall Study|Non-compliance|0|||
19769774|NCT01004861|42223304|FG012|Overall Study|Non-compliance|1|||
19769775|NCT01004861|42223292|FG000|Overall Study|Other|0|||
19769776|NCT01004861|42223293|FG001|Overall Study|Other|0|||
19605587|NCT00950300|42054319|FG000|SFU Period|Lost to Follow-up|30|||
19769777|NCT01004861|42223294|FG002|Overall Study|Other|0|||
19769778|NCT01004861|42223295|FG003|Overall Study|Other|0|||
19605588|NCT00950300|42054320|FG001|SFU Period|Lost to Follow-up|28|||
19605589|NCT00950300|42054319|FG000|SFU Period|Withdrawal by Subject|4|||
19605590|NCT00950300|42054320|FG001|SFU Period|Withdrawal by Subject|8|||
19605591|NCT00949988|42054327|FG000|Overall Study|Withdrawal by Subject|3|||
19605592|NCT00731692|42054334|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
19605593|NCT00731692|42054335|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
19605594|NCT00731692|42054336|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
19605595|NCT00731692|42054334|FG000|Core Study (36 Months)|Physician Decision|1|||
19605596|NCT00731692|42054335|FG001|Core Study (36 Months)|Physician Decision|0|||
19605597|NCT00731692|42054336|FG002|Core Study (36 Months)|Physician Decision|2|||
19605598|NCT00731692|42054334|FG000|Core Study (36 Months)|Death|2|||
19605599|NCT00731692|42054335|FG001|Core Study (36 Months)|Death|1|||
19605600|NCT00731692|42054336|FG002|Core Study (36 Months)|Death|2|||
19605601|NCT00731692|42054334|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
19605602|NCT00731692|42054335|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
19605603|NCT00731692|42054336|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
19605604|NCT00731692|42054334|FG000|Core Study (36 Months)|Administrative|2|||
19605605|NCT00731692|42054335|FG001|Core Study (36 Months)|Administrative|2|||
19605606|NCT00731692|42054336|FG002|Core Study (36 Months)|Administrative|6|||
19605607|NCT00731692|42054334|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
19686794|NCT00300885|42133227|FG001|Treatment|Disease progression|238|||
19686795|NCT00300885|42133226|FG000|Treatment|Random code broken (subject died)|0|||
19686796|NCT00300885|42133227|FG001|Treatment|Random code broken (subject died)|1|||
19686797|NCT00300885|42133226|FG000|Treatment|Non-compliant with study medication|3|||
19686798|NCT00300885|42133227|FG001|Treatment|Non-compliant with study medication|4|||
19686799|NCT00300885|42133226|FG000|Follow-up|Death|141|||
19686800|NCT00300885|42133227|FG001|Follow-up|Death|163|||
19686801|NCT00300885|42133226|FG000|Follow-up|Lost to Follow-up|11|||
19686802|NCT00300885|42133227|FG001|Follow-up|Lost to Follow-up|7|||
19686803|NCT00300885|42133226|FG000|Follow-up|Withdrawal by Subject|26|||
19686804|NCT00300885|42133227|FG001|Follow-up|Withdrawal by Subject|25|||
19686805|NCT00386334|42133235|FG000|Double Blind Period|Adverse Event|9|||
19686806|NCT00386334|42133236|FG001|Double Blind Period|Adverse Event|14|||
19686807|NCT00386334|42133235|FG000|Double Blind Period|Protocol Violation|1|||
19686808|NCT00386334|42133236|FG001|Double Blind Period|Protocol Violation|1|||
19686809|NCT00386334|42133235|FG000|Double Blind Period|Withdrawal by Subject|9|||
19686810|NCT00386334|42133236|FG001|Double Blind Period|Withdrawal by Subject|13|||
19686811|NCT00386334|42133235|FG000|Double Blind Period|Lack of Efficacy|20|||
19686812|NCT00386334|42133236|FG001|Double Blind Period|Lack of Efficacy|11|||
19686813|NCT00386334|42133235|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
19686814|NCT00386334|42133236|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
19686815|NCT00386334|42133235|FG000|Double Blind Period|Other|3|||
19686816|NCT00386334|42133236|FG001|Double Blind Period|Other|3|||
19686817|NCT00386334|42133235|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
19686818|NCT00386334|42133236|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
19686819|NCT00428714|42133253|FG000|Overall Study|Progressive Disease|28|||
19686820|NCT00428714|42133254|FG001|Overall Study|Progressive Disease|36|||
19686821|NCT00428714|42133253|FG000|Overall Study|Withdrawal by Subject|0|||
19686822|NCT00428714|42133254|FG001|Overall Study|Withdrawal by Subject|3|||
19686823|NCT00428714|42133253|FG000|Overall Study|Adverse Event|0|||
19686824|NCT00428714|42133254|FG001|Overall Study|Adverse Event|2|||
19686825|NCT00428714|42133253|FG000|Overall Study|Physician Decision|1|||
19686826|NCT00428714|42133254|FG001|Overall Study|Physician Decision|1|||
19769779|NCT01004861|42223296|FG004|Overall Study|Other|0|||
19769780|NCT01004861|42223297|FG005|Overall Study|Other|0|||
19769781|NCT01004861|42223298|FG006|Overall Study|Other|0|||
19769782|NCT01004861|42223299|FG007|Overall Study|Other|0|||
19686827|NCT00428714|42133253|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
19686828|NCT00428714|42133254|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
19686829|NCT00428714|42133253|FG000|Overall Study|Death due to other then PD|1|||
19686830|NCT00428714|42133254|FG001|Overall Study|Death due to other then PD|0|||
19686831|NCT00292227|42133263|FG000|Patch Period|Adverse Event|1|||
19686832|NCT00292227|42133264|FG001|Patch Period|Adverse Event|0|||
19686833|NCT00292227|42133265|FG002|Patch Period|Adverse Event|2|||
19686834|NCT00292227|42133263|FG000|Patch Period|Withdrawal by Subject|0|||
19686835|NCT00292227|42133264|FG001|Patch Period|Withdrawal by Subject|0|||
19686836|NCT00292227|42133265|FG002|Patch Period|Withdrawal by Subject|1|||
19686837|NCT00386100|42133275|FG000|Overall Study|Did not receive study medication|6|||
19686838|NCT00386100|42133276|FG001|Overall Study|Did not receive study medication|4|||
19686839|NCT00386100|42133275|FG000|Overall Study|Adverse Event|15|||
19686840|NCT00386100|42133276|FG001|Overall Study|Adverse Event|25|||
19605608|NCT00731692|42054335|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
19605609|NCT00731692|42054336|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
19686841|NCT00386100|42133275|FG000|Overall Study|Death|0|||
19686842|NCT00386100|42133276|FG001|Overall Study|Death|1|||
19769783|NCT01004861|42223300|FG008|Overall Study|Other|0|||
19769784|NCT01004861|42223301|FG009|Overall Study|Other|2|||
19686843|NCT00386100|42133275|FG000|Overall Study|Insufficient therapeutic effect|30|||
19686844|NCT00386100|42133276|FG001|Overall Study|Insufficient therapeutic effect|6|||
19686845|NCT00386100|42133275|FG000|Overall Study|Lost to Follow-up|29|||
19686846|NCT00386100|42133276|FG001|Overall Study|Lost to Follow-up|29|||
19686847|NCT00386100|42133275|FG000|Overall Study|Non-compliance|18|||
19686848|NCT00386100|42133276|FG001|Overall Study|Non-compliance|19|||
19686849|NCT00386100|42133275|FG000|Overall Study|Protocol Violation|5|||
19769785|NCT01004861|42223302|FG010|Overall Study|Other|1|||
19769786|NCT01004861|42223303|FG011|Overall Study|Other|2|||
19769787|NCT01004861|42223304|FG012|Overall Study|Other|3|||
19686850|NCT00386100|42133276|FG001|Overall Study|Protocol Violation|3|||
19686851|NCT00386100|42133275|FG000|Overall Study|Withdrawal by Subject|32|||
19686852|NCT00386100|42133276|FG001|Overall Study|Withdrawal by Subject|31|||
19686853|NCT00386100|42133275|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
19686854|NCT00386100|42133276|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
19686855|NCT00386100|42133275|FG000|Overall Study|BMD <2.5|1|||
19686856|NCT00386100|42133276|FG001|Overall Study|BMD <2.5|0|||
19686857|NCT00386100|42133275|FG000|Overall Study|Consecutive elevated Hba1C|1|||
19686858|NCT00386100|42133276|FG001|Overall Study|Consecutive elevated Hba1C|0|||
19686859|NCT00386100|42133275|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
19686860|NCT00386100|42133276|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
19686861|NCT00386100|42133275|FG000|Overall Study|Laboratory findings|1|||
19686862|NCT00386100|42133276|FG001|Overall Study|Laboratory findings|0|||
19686863|NCT00386100|42133275|FG000|Overall Study|Participant's concern due to CPK levels|1|||
19686864|NCT00386100|42133276|FG001|Overall Study|Participant's concern due to CPK levels|0|||
19686865|NCT00386100|42133275|FG000|Overall Study|Participant moving out of state|2|||
19686866|NCT00386100|42133276|FG001|Overall Study|Participant moving out of state|0|||
19686867|NCT00386100|42133275|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
19686868|NCT00386100|42133276|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
19686869|NCT00386100|42133275|FG000|Overall Study|Didn't meet entry criteria|1|||
19686870|NCT00386100|42133276|FG001|Overall Study|Didn't meet entry criteria|1|||
19686871|NCT00386100|42133275|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
19686872|NCT00386100|42133276|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
19686873|NCT00386100|42133275|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
19686874|NCT00386100|42133276|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
19686875|NCT00386100|42133275|FG000|Overall Study|Bad metabolic control & patient security|1|||
19686876|NCT00386100|42133276|FG001|Overall Study|Bad metabolic control & patient security|0|||
19686877|NCT00386100|42133275|FG000|Overall Study|Bone loss by DXA bone scan|1|||
19686878|NCT00386100|42133276|FG001|Overall Study|Bone loss by DXA bone scan|0|||
19686879|NCT00386100|42133275|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
19686880|NCT00386100|42133276|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
19686881|NCT00386100|42133275|FG000|Overall Study|7.6% bone loss|1|||
19686882|NCT00386100|42133276|FG001|Overall Study|7.6% bone loss|0|||
19686883|NCT00386100|42133275|FG000|Overall Study|Osteoporosis|0|||
19686884|NCT00386100|42133276|FG001|Overall Study|Osteoporosis|1|||
19769788|NCT01004861|42223292|FG000|Overall Study|Patient decision|0|||
19686885|NCT00386100|42133275|FG000|Overall Study|Positive pregnancy test|1|||
19686886|NCT00386100|42133276|FG001|Overall Study|Positive pregnancy test|3|||
19686887|NCT00386100|42133275|FG000|Overall Study|Out of country for 5 months|1|||
19686888|NCT00386100|42133276|FG001|Overall Study|Out of country for 5 months|0|||
19686889|NCT00386100|42133275|FG000|Overall Study|Hb1Ac >8%|0|||
19686890|NCT00386100|42133276|FG001|Overall Study|Hb1Ac >8%|1|||
19686891|NCT00386100|42133275|FG000|Overall Study|Participant randomized in error|1|||
19686892|NCT00386100|42133276|FG001|Overall Study|Participant randomized in error|0|||
19686893|NCT00300495|42133284|FG000|Overall Study|Protocol Violation|4|||
19686894|NCT00300495|42133285|FG001|Overall Study|Protocol Violation|1|||
19686895|NCT00386022|42133293|FG000|Plus Estrogen|Lost to Follow-up|2|||
19686896|NCT00386022|42133294|FG001|Plus Estrogen|Lost to Follow-up|0|||
19686897|NCT00386022|42133293|FG000|Plus Estrogen|Adverse Event|0|||
19686898|NCT00386022|42133294|FG001|Plus Estrogen|Adverse Event|1|||
19769789|NCT01004861|42223293|FG001|Overall Study|Patient decision|0|||
19769790|NCT01004861|42223294|FG002|Overall Study|Patient decision|0|||
19769791|NCT01004861|42223295|FG003|Overall Study|Patient decision|0|||
19769792|NCT01004861|42223296|FG004|Overall Study|Patient decision|1|||
19769793|NCT01004861|42223297|FG005|Overall Study|Patient decision|0|||
19769794|NCT01004861|42223298|FG006|Overall Study|Patient decision|1|||
19769795|NCT01004861|42223299|FG007|Overall Study|Patient decision|0|||
19769796|NCT01004861|42223300|FG008|Overall Study|Patient decision|7|||
19769797|NCT01004861|42223301|FG009|Overall Study|Patient decision|1|||
19769798|NCT01004861|42223302|FG010|Overall Study|Patient decision|1|||
19769799|NCT01004861|42223303|FG011|Overall Study|Patient decision|2|||
19769800|NCT01004861|42223304|FG012|Overall Study|Patient decision|3|||
19769801|NCT01004861|42223292|FG000|Overall Study|Transitioned to Phase 4 study|0|||
19769802|NCT01004861|42223293|FG001|Overall Study|Transitioned to Phase 4 study|0|||
19769803|NCT01004861|42223294|FG002|Overall Study|Transitioned to Phase 4 study|0|||
19686899|NCT00286455|42133305|FG000|Overall Study|Hyperglycemia rescue|19|||
19686900|NCT00286455|42133306|FG001|Overall Study|Hyperglycemia rescue|13|||
19686901|NCT00286455|42133307|FG002|Overall Study|Hyperglycemia rescue|10|||
19686902|NCT00286455|42133305|FG000|Overall Study|Adverse Event|1|||
19686903|NCT00286455|42133306|FG001|Overall Study|Adverse Event|3|||
19686904|NCT00286455|42133307|FG002|Overall Study|Adverse Event|2|||
19686905|NCT00286455|42133305|FG000|Overall Study|Lost to Follow-up|0|||
19686906|NCT00286455|42133306|FG001|Overall Study|Lost to Follow-up|3|||
19686907|NCT00286455|42133307|FG002|Overall Study|Lost to Follow-up|3|||
19686908|NCT00286455|42133305|FG000|Overall Study|Physician Decision|3|||
19686909|NCT00286455|42133306|FG001|Overall Study|Physician Decision|0|||
19686910|NCT00286455|42133307|FG002|Overall Study|Physician Decision|2|||
19686911|NCT00286455|42133305|FG000|Overall Study|Protocol Violation|1|||
19686912|NCT00286455|42133306|FG001|Overall Study|Protocol Violation|1|||
19686913|NCT00286455|42133307|FG002|Overall Study|Protocol Violation|0|||
19686914|NCT00286455|42133305|FG000|Overall Study|Participant Non-compliance|1|||
19686915|NCT00286455|42133306|FG001|Overall Study|Participant Non-compliance|0|||
19686916|NCT00286455|42133307|FG002|Overall Study|Participant Non-compliance|0|||
19686917|NCT00286455|42133305|FG000|Overall Study|Withdrawal by Subject|0|||
19686918|NCT00286455|42133306|FG001|Overall Study|Withdrawal by Subject|8|||
19686919|NCT00286455|42133307|FG002|Overall Study|Withdrawal by Subject|7|||
19686920|NCT00385944|42133317|FG000|1st Maintenance Dose Period|Physician Decision|1|||
19686921|NCT00385944|42133318|FG001|1st Maintenance Dose Period|Physician Decision|0|||
19686922|NCT00385944|42133319|FG002|1st Maintenance Dose Period|Physician Decision|0|||
19686923|NCT00385944|42133317|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
19686924|NCT00385944|42133318|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
19686925|NCT00385944|42133319|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
19686926|NCT00385944|42133317|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
19686927|NCT00385944|42133318|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
19686928|NCT00385944|42133319|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
19686929|NCT00385944|42133317|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
19686930|NCT00385944|42133318|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
19686931|NCT00385944|42133319|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
19686932|NCT00286221|42133338|FG000|Overall Study|Protocol Violation|2|||
19686933|NCT00286221|42133339|FG001|Overall Study|Protocol Violation|1|||
19686934|NCT00286221|42133340|FG002|Overall Study|Protocol Violation|6|||
19686935|NCT00286221|42133341|FG003|Overall Study|Protocol Violation|4|||
19686936|NCT00286221|42133338|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
19686937|NCT00286221|42133339|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
19686938|NCT00286221|42133340|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
19686939|NCT00286221|42133341|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
19769804|NCT01004861|42223295|FG003|Overall Study|Transitioned to Phase 4 study|0|||
19769805|NCT01004861|42223296|FG004|Overall Study|Transitioned to Phase 4 study|0|||
19769806|NCT01004861|42223297|FG005|Overall Study|Transitioned to Phase 4 study|0|||
19769807|NCT01004861|42223298|FG006|Overall Study|Transitioned to Phase 4 study|0|||
19769808|NCT01004861|42223299|FG007|Overall Study|Transitioned to Phase 4 study|0|||
19769809|NCT01004861|42223300|FG008|Overall Study|Transitioned to Phase 4 study|2|||
19769810|NCT01004861|42223301|FG009|Overall Study|Transitioned to Phase 4 study|0|||
19769811|NCT01004861|42223302|FG010|Overall Study|Transitioned to Phase 4 study|0|||
19769812|NCT01004861|42223303|FG011|Overall Study|Transitioned to Phase 4 study|0|||
19769813|NCT01004861|42223304|FG012|Overall Study|Transitioned to Phase 4 study|0|||
19769814|NCT01004861|42223292|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769815|NCT01004861|42223293|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769816|NCT01004861|42223294|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19477631|NCT01462435|41756912|FG001|Overall Study|Withdrawal by Subject|0|||
19605610|NCT00731692|42054334|FG000|Core Study (36 Months)|Protocol Violation|4|||
19605611|NCT00731692|42054335|FG001|Core Study (36 Months)|Protocol Violation|5|||
19605612|NCT00731692|42054336|FG002|Core Study (36 Months)|Protocol Violation|8|||
19605613|NCT00731692|42054334|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
19605614|NCT00731692|42054335|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
19605615|NCT00731692|42054336|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
19605616|NCT00731692|42054334|FG000|Core Study (36 Months)|Adverse Event|25|||
19605617|NCT00731692|42054335|FG001|Core Study (36 Months)|Adverse Event|28|||
19605618|NCT00731692|42054336|FG002|Core Study (36 Months)|Adverse Event|29|||
19605619|NCT00731692|42054334|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
19605620|NCT00731692|42054335|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
19605621|NCT00731692|42054336|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
19605622|NCT00731692|42054334|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
19686940|NCT00286221|42133338|FG000|Overall Study|Inability to trigger PCA|2|||
19686941|NCT00286221|42133339|FG001|Overall Study|Inability to trigger PCA|0|||
19686942|NCT00286221|42133340|FG002|Overall Study|Inability to trigger PCA|0|||
19686943|NCT00286221|42133341|FG003|Overall Study|Inability to trigger PCA|0|||
19769817|NCT01004861|42223295|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769818|NCT01004861|42223296|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19686944|NCT00286221|42133338|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
19686945|NCT00286221|42133339|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
19686946|NCT00286221|42133340|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
19686947|NCT00286221|42133341|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
19769819|NCT01004861|42223297|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769820|NCT01004861|42223298|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769821|NCT01004861|42223299|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769822|NCT01004861|42223300|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
19769823|NCT01004861|42223301|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769824|NCT01004861|42223302|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19686948|NCT00285207|42133353|FG000|Overall Study|Lost to Follow-up|3|||
19686949|NCT00285207|42133354|FG001|Overall Study|Lost to Follow-up|2|||
19769825|NCT01004861|42223303|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769826|NCT01004861|42223304|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
19769827|NCT01004861|42223292|FG000|Overall Study|Patient withdrew|0|||
19769828|NCT01004861|42223293|FG001|Overall Study|Patient withdrew|0|||
19769829|NCT01004861|42223294|FG002|Overall Study|Patient withdrew|0|||
19769830|NCT01004861|42223295|FG003|Overall Study|Patient withdrew|0|||
19769831|NCT01004861|42223296|FG004|Overall Study|Patient withdrew|0|||
19769832|NCT01004861|42223297|FG005|Overall Study|Patient withdrew|0|||
19769833|NCT01004861|42223298|FG006|Overall Study|Patient withdrew|0|||
19769834|NCT01004861|42223299|FG007|Overall Study|Patient withdrew|0|||
19769835|NCT01004861|42223300|FG008|Overall Study|Patient withdrew|1|||
19769836|NCT01004861|42223301|FG009|Overall Study|Patient withdrew|0|||
19769837|NCT01004861|42223302|FG010|Overall Study|Patient withdrew|0|||
19769838|NCT01004861|42223303|FG011|Overall Study|Patient withdrew|0|||
19769839|NCT01004861|42223304|FG012|Overall Study|Patient withdrew|0|||
19769840|NCT01004861|42223292|FG000|Overall Study|Surgical resection|0|||
19769841|NCT01004861|42223293|FG001|Overall Study|Surgical resection|0|||
19769842|NCT01004861|42223294|FG002|Overall Study|Surgical resection|0|||
19769843|NCT01004861|42223295|FG003|Overall Study|Surgical resection|0|||
19769844|NCT01004861|42223296|FG004|Overall Study|Surgical resection|0|||
19769845|NCT01004861|42223297|FG005|Overall Study|Surgical resection|0|||
19686950|NCT00285207|42133353|FG000|Overall Study|Withdrawal by Subject|5|||
19686951|NCT00285207|42133354|FG001|Overall Study|Withdrawal by Subject|2|||
19686952|NCT00285207|42133353|FG000|Overall Study|Pregnancy|1|||
19686953|NCT00285207|42133354|FG001|Overall Study|Pregnancy|1|||
19686954|NCT00285207|42133353|FG000|Overall Study|non-compliance|0|||
19686955|NCT00285207|42133354|FG001|Overall Study|non-compliance|1|||
19686956|NCT00398112|42133360|FG000|Overall Study|Adverse Event|4|||
19686957|NCT00398112|42133360|FG000|Overall Study|Disease progression|9|||
19686958|NCT00398112|42133360|FG000|Overall Study|Alternative treatment|1|||
19686959|NCT00398112|42133360|FG000|Overall Study|Withdrawal by Subject|3|||
19686960|NCT00398112|42133360|FG000|Overall Study|Death|1|||
19686961|NCT00424346|42133368|FG000|Core Study|Adverse Event|5|||
19686962|NCT00424346|42133369|FG001|Core Study|Adverse Event|3|||
19686963|NCT00424346|42133370|FG002|Core Study|Adverse Event|1|||
19686964|NCT00424346|42133371|FG003|Core Study|Adverse Event|1|||
19686965|NCT00424346|42133368|FG000|Core Study|Abnormal Laboratory Values|0|||
19686966|NCT00424346|42133369|FG001|Core Study|Abnormal Laboratory Values|1|||
19686967|NCT00424346|42133370|FG002|Core Study|Abnormal Laboratory Values|0|||
19686968|NCT00424346|42133371|FG003|Core Study|Abnormal Laboratory Values|0|||
19686969|NCT00424346|42133368|FG000|Core Study|Lack of Efficacy|1|||
19686970|NCT00424346|42133369|FG001|Core Study|Lack of Efficacy|3|||
19769846|NCT01004861|42223298|FG006|Overall Study|Surgical resection|0|||
19769847|NCT01004861|42223299|FG007|Overall Study|Surgical resection|0|||
19769848|NCT01004861|42223300|FG008|Overall Study|Surgical resection|1|||
19769849|NCT01004861|42223301|FG009|Overall Study|Surgical resection|0|||
19769850|NCT01004861|42223302|FG010|Overall Study|Surgical resection|0|||
19769851|NCT01004861|42223303|FG011|Overall Study|Surgical resection|0|||
19769852|NCT01004861|42223304|FG012|Overall Study|Surgical resection|0|||
19769853|NCT01004861|42223292|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769854|NCT01004861|42223293|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19686971|NCT00424346|42133370|FG002|Core Study|Lack of Efficacy|0|||
19686972|NCT00424346|42133371|FG003|Core Study|Lack of Efficacy|4|||
19686973|NCT00424346|42133368|FG000|Core Study|Withdrawal by Subject|1|||
19769855|NCT01004861|42223294|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19686974|NCT00424346|42133369|FG001|Core Study|Withdrawal by Subject|0|||
19686975|NCT00424346|42133370|FG002|Core Study|Withdrawal by Subject|0|||
19686976|NCT00424346|42133371|FG003|Core Study|Withdrawal by Subject|2|||
19769856|NCT01004861|42223295|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769857|NCT01004861|42223296|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769858|NCT01004861|42223297|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769859|NCT01004861|42223298|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769860|NCT01004861|42223299|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19686977|NCT00424346|42133368|FG000|Core Study|Lost to Follow-up|1|||
19686978|NCT00424346|42133369|FG001|Core Study|Lost to Follow-up|1|||
19686979|NCT00424346|42133370|FG002|Core Study|Lost to Follow-up|0|||
19686980|NCT00424346|42133371|FG003|Core Study|Lost to Follow-up|0|||
19686981|NCT00424346|42133368|FG000|Core Study|Administrative Problems|1|||
19686982|NCT00424346|42133369|FG001|Core Study|Administrative Problems|0|||
19686983|NCT00424346|42133370|FG002|Core Study|Administrative Problems|1|||
19686984|NCT00424346|42133371|FG003|Core Study|Administrative Problems|0|||
19686985|NCT00424346|42133368|FG000|Core Study|Protocol Violation|0|||
19686986|NCT00424346|42133369|FG001|Core Study|Protocol Violation|0|||
19686987|NCT00424346|42133370|FG002|Core Study|Protocol Violation|2|||
19686988|NCT00424346|42133371|FG003|Core Study|Protocol Violation|0|||
19769861|NCT01004861|42223300|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
19769862|NCT01004861|42223301|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769863|NCT01004861|42223302|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769864|NCT01004861|42223303|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769865|NCT01004861|42223304|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
19769866|NCT01004861|42223292|FG000|Overall Study|Study termination by Sponsor|0|||
19769867|NCT01004861|42223293|FG001|Overall Study|Study termination by Sponsor|0|||
19769868|NCT01004861|42223294|FG002|Overall Study|Study termination by Sponsor|0|||
19769869|NCT01004861|42223295|FG003|Overall Study|Study termination by Sponsor|0|||
19769870|NCT01004861|42223296|FG004|Overall Study|Study termination by Sponsor|0|||
19769871|NCT01004861|42223297|FG005|Overall Study|Study termination by Sponsor|0|||
19769872|NCT01004861|42223298|FG006|Overall Study|Study termination by Sponsor|0|||
19769873|NCT01004861|42223299|FG007|Overall Study|Study termination by Sponsor|0|||
19769874|NCT01004861|42223300|FG008|Overall Study|Study termination by Sponsor|1|||
19769875|NCT01004861|42223301|FG009|Overall Study|Study termination by Sponsor|0|||
19769876|NCT01004861|42223302|FG010|Overall Study|Study termination by Sponsor|0|||
19769877|NCT01004861|42223303|FG011|Overall Study|Study termination by Sponsor|0|||
19686989|NCT00424346|42133368|FG000|Extension Phase|Adverse Event|0|||
19686990|NCT00424346|42133369|FG001|Extension Phase|Adverse Event|9|||
19686991|NCT00424346|42133370|FG002|Extension Phase|Adverse Event|5|||
19686992|NCT00424346|42133371|FG003|Extension Phase|Adverse Event|4|||
19686993|NCT00424346|42133368|FG000|Extension Phase|Lack of Efficacy|0|||
19686994|NCT00424346|42133369|FG001|Extension Phase|Lack of Efficacy|16|||
19686995|NCT00424346|42133370|FG002|Extension Phase|Lack of Efficacy|14|||
19686996|NCT00424346|42133371|FG003|Extension Phase|Lack of Efficacy|11|||
19686997|NCT00424346|42133368|FG000|Extension Phase|Withdrawal by Subject|0|||
19686998|NCT00424346|42133369|FG001|Extension Phase|Withdrawal by Subject|5|||
19686999|NCT00424346|42133370|FG002|Extension Phase|Withdrawal by Subject|3|||
19687000|NCT00424346|42133371|FG003|Extension Phase|Withdrawal by Subject|4|||
19687001|NCT00424346|42133368|FG000|Extension Phase|Lost to Follow-up|0|||
19687002|NCT00424346|42133369|FG001|Extension Phase|Lost to Follow-up|2|||
19687003|NCT00424346|42133370|FG002|Extension Phase|Lost to Follow-up|0|||
19687004|NCT00424346|42133371|FG003|Extension Phase|Lost to Follow-up|0|||
19687005|NCT00424346|42133368|FG000|Extension Phase|Administrative Problems|0|||
19687006|NCT00424346|42133369|FG001|Extension Phase|Administrative Problems|69|||
19687007|NCT00424346|42133370|FG002|Extension Phase|Administrative Problems|32|||
19687008|NCT00424346|42133371|FG003|Extension Phase|Administrative Problems|35|||
19687009|NCT00424346|42133368|FG000|Extension Phase|Death|0|||
19687010|NCT00424346|42133369|FG001|Extension Phase|Death|0|||
19687011|NCT00424346|42133370|FG002|Extension Phase|Death|0|||
19687012|NCT00424346|42133371|FG003|Extension Phase|Death|1|||
19687013|NCT00424346|42133368|FG000|Extension Phase|Protocol Violation|0|||
19687014|NCT00424346|42133369|FG001|Extension Phase|Protocol Violation|1|||
19687015|NCT00424346|42133370|FG002|Extension Phase|Protocol Violation|1|||
19687016|NCT00424346|42133371|FG003|Extension Phase|Protocol Violation|0|||
19687017|NCT00283959|42133384|FG000|Extension Period|Low Compliance|1|||
19687018|NCT00372528|42133388|FG000|Overall Study|Lack of Efficacy|1|||
19687019|NCT00372528|42133388|FG000|Overall Study|Adverse Event|1|||
19687020|NCT00372528|42133388|FG000|Overall Study|Study Terminated by Sponsor|18|||
19687021|NCT00372528|42133388|FG000|Overall Study|Other|1|||
19687022|NCT00283803|42133392|FG000|Overall Study|Physician Decision|9|||
19687023|NCT00283803|42133392|FG000|Overall Study|Withdrawal by Subject|4|||
19687024|NCT00397488|42133396|FG000|Overall Study|Withdrawal by Subject|3|||
19687025|NCT00397488|42133396|FG000|Overall Study|Adverse Event|3|||
19687026|NCT00397488|42133396|FG000|Overall Study|Death|1|||
19687027|NCT00424190|42133402|FG000|Overall Study|Withdrew consent|3|||
19687028|NCT00424190|42133403|FG001|Overall Study|Withdrew consent|4|||
19687029|NCT00424190|42133402|FG000|Overall Study|Death|3|||
19687030|NCT00424190|42133403|FG001|Overall Study|Death|0|||
19687031|NCT00424190|42133402|FG000|Overall Study|Noncompliance|1|||
19687032|NCT00424190|42133403|FG001|Overall Study|Noncompliance|2|||
19687033|NCT00424190|42133402|FG000|Overall Study|Request of sponsor or investigator|0|||
19687034|NCT00424190|42133403|FG001|Overall Study|Request of sponsor or investigator|2|||
19687035|NCT00424190|42133402|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
19687036|NCT00424190|42133403|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
19687037|NCT00424190|42133402|FG000|Overall Study|Other|15|||
19687038|NCT00424190|42133403|FG001|Overall Study|Other|21|||
19687039|NCT00428246|42133412|FG000|Overall Study|Withdrawal by Subject|0|||
19687040|NCT00428246|42133413|FG001|Overall Study|Withdrawal by Subject|0|||
19687041|NCT00428246|42133414|FG002|Overall Study|Withdrawal by Subject|1|||
19687042|NCT00428246|42133412|FG000|Overall Study|Adverse Event|1|||
19687043|NCT00428246|42133413|FG001|Overall Study|Adverse Event|0|||
19687044|NCT00428246|42133414|FG002|Overall Study|Adverse Event|0|||
19687045|NCT00274287|42133422|FG000|Overall Study|Withdrawal by Subject|1|||
19687046|NCT00274287|42133422|FG000|Overall Study|subject non-compliance|1|||
19687047|NCT00423800|42133429|FG000|Overall Study|Protocol Violation|0|||
19687048|NCT00423800|42133430|FG001|Overall Study|Protocol Violation|1|||
19687049|NCT00405548|42133439|FG000|Overall Study|Cognitive Memory problems on study day|1|||
19687050|NCT00405548|42133440|FG001|Overall Study|Cognitive Memory problems on study day|0|||
19687051|NCT00405548|42133439|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
19687052|NCT00405548|42133440|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
19687053|NCT00405548|42133439|FG000|Overall Study|Unable to self-administer shots|1|||
19687054|NCT00405548|42133440|FG001|Overall Study|Unable to self-administer shots|0|||
19687055|NCT00405548|42133439|FG000|Overall Study|Venous access failed during study day|1|||
19687056|NCT00405548|42133440|FG001|Overall Study|Venous access failed during study day|0|||
19687057|NCT00405548|42133439|FG000|Overall Study|Withdrawal by Subject|1|||
19687058|NCT00405548|42133440|FG001|Overall Study|Withdrawal by Subject|0|||
19687059|NCT00405392|42133448|FG000|Overall Study|Adverse Event|15|||
19687060|NCT00405392|42133449|FG001|Overall Study|Adverse Event|14|||
19687061|NCT00405392|42133448|FG000|Overall Study|Did not meet Eligibility criteria|7|||
19687062|NCT00405392|42133449|FG001|Overall Study|Did not meet Eligibility criteria|2|||
19769878|NCT01004861|42223304|FG012|Overall Study|Study termination by Sponsor|0|||
19769879|NCT03254459|42223351|FG000|Overall Study|Adverse Event|7|||
19769880|NCT03254459|42223352|FG001|Overall Study|Adverse Event|20|||
19769881|NCT03254459|42223351|FG000|Overall Study|Withdrawal by Subject Consent|3|||
19769882|NCT03254459|42223352|FG001|Overall Study|Withdrawal by Subject Consent|1|||
19769883|NCT03254459|42223351|FG000|Overall Study|Lost to Follow-up|0|||
19769884|NCT03254459|42223352|FG001|Overall Study|Lost to Follow-up|1|||
19769885|NCT03254459|42223351|FG000|Overall Study|Miscellaneous|0|||
19769886|NCT03254459|42223352|FG001|Overall Study|Miscellaneous|1|||
19769887|NCT02736617|42223358|FG000|Treatment|Adverse Event|1|||
19769888|NCT02736617|42223358|FG000|Treatment|Lack of Efficacy|1|||
19769889|NCT02736617|42223358|FG000|Treatment|Withdrawal by Subject|1|||
19769890|NCT02736617|42223358|FG000|Maintenance|Lack of Efficacy|4|||
19769891|NCT02736617|42223358|FG000|Maintenance|Physician Decision|1|||
19769892|NCT03251963|42223365|FG000|Overall Study|inappropriate Xa level timing|6|||
19769893|NCT03251963|42223366|FG001|Overall Study|inappropriate Xa level timing|3|||
19769894|NCT03251963|42223365|FG000|Overall Study|no peak Xa level drawn|2|||
19769895|NCT03251963|42223366|FG001|Overall Study|no peak Xa level drawn|0|||
19769896|NCT03251963|42223365|FG000|Overall Study|bled prior to Xa level|1|||
19769897|NCT03251963|42223366|FG001|Overall Study|bled prior to Xa level|2|||
19769898|NCT03287219|42223374|FG000|Overall Study|Protocol Violation|0|||
19769899|NCT03287219|42223375|FG001|Overall Study|Protocol Violation|2|||
19769900|NCT03286751|42223414|FG000|Washout Period 1|Withdrawal by Subject|0|||
19769901|NCT03286751|42223415|FG001|Washout Period 1|Withdrawal by Subject|0|||
19769902|NCT03286751|42223416|FG002|Washout Period 1|Withdrawal by Subject|0|||
19769903|NCT03286751|42223417|FG003|Washout Period 1|Withdrawal by Subject|0|||
19769904|NCT03286751|42223418|FG004|Washout Period 1|Withdrawal by Subject|1|||
19769905|NCT03286751|42223419|FG005|Washout Period 1|Withdrawal by Subject|0|||
19687063|NCT00405392|42133448|FG000|Overall Study|Withdrawal by Subject|4|||
19687064|NCT00405392|42133449|FG001|Overall Study|Withdrawal by Subject|3|||
19687065|NCT00405392|42133448|FG000|Overall Study|Lost to Follow-up|1|||
19687066|NCT00405392|42133449|FG001|Overall Study|Lost to Follow-up|2|||
19769906|NCT03286751|42223414|FG000|Washout Period 2|Personal Reasons|0|||
19769907|NCT03286751|42223415|FG001|Washout Period 2|Personal Reasons|1|||
19769908|NCT03286751|42223416|FG002|Washout Period 2|Personal Reasons|0|||
19769909|NCT03286751|42223417|FG003|Washout Period 2|Personal Reasons|0|||
19769910|NCT03286751|42223418|FG004|Washout Period 2|Personal Reasons|0|||
19769911|NCT03286751|42223419|FG005|Washout Period 2|Personal Reasons|0|||
19687067|NCT00405392|42133448|FG000|Overall Study|Data missing|2|||
19687068|NCT00405392|42133449|FG001|Overall Study|Data missing|0|||
19687069|NCT00405392|42133448|FG000|Overall Study|Non-compliance|0|||
19769912|NCT03286751|42223414|FG000|Washout Period 5|Adverse Event|0|||
19687070|NCT00405392|42133449|FG001|Overall Study|Non-compliance|1|||
19687071|NCT00405392|42133448|FG000|Overall Study|Other|1|||
19687072|NCT00405392|42133449|FG001|Overall Study|Other|5|||
19687073|NCT00282243|42133455|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
19687074|NCT00282243|42133455|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
19687075|NCT00282243|42133455|FG000|Extension Treatment Period|Adverse Event|15|||
19687076|NCT00282243|42133455|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
19687077|NCT00282243|42133455|FG000|Extension Treatment Period|Non-compliance|2|||
19687078|NCT00282243|42133455|FG000|Extension Treatment Period|Physician Decision|1|||
19687079|NCT00272961|42133464|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
19687080|NCT00272961|42133465|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
19687081|NCT00272961|42133466|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
19769913|NCT03286751|42223415|FG001|Washout Period 5|Adverse Event|0|||
19769914|NCT03286751|42223416|FG002|Washout Period 5|Adverse Event|0|||
19769915|NCT03286751|42223417|FG003|Washout Period 5|Adverse Event|0|||
19769916|NCT03286751|42223418|FG004|Washout Period 5|Adverse Event|1|||
19769917|NCT03286751|42223419|FG005|Washout Period 5|Adverse Event|0|||
19769918|NCT03249935|42223433|FG000|Overall Study|Discharged from facility early|36|||
19769919|NCT03249935|42223433|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
19769920|NCT03249935|42223433|FG000|Overall Study|Protocol Violation|5|||
19769921|NCT03285113|42223439|FG000|Overall Study|Unable to implant leads|2|||
19769922|NCT03000348|42223449|FG000|Overall Study|Adverse Event|1|||
19769923|NCT03000348|42223450|FG001|Overall Study|Adverse Event|1|||
19769924|NCT03000348|42223451|FG002|Overall Study|Adverse Event|1|||
19769925|NCT03000348|42223452|FG003|Overall Study|Adverse Event|1|||
19769926|NCT03000348|42223453|FG004|Overall Study|Adverse Event|1|||
19769927|NCT03000348|42223454|FG005|Overall Study|Adverse Event|1|||
19769928|NCT03000348|42223449|FG000|Overall Study|Lost to Follow-up|0|||
19769929|NCT03000348|42223450|FG001|Overall Study|Lost to Follow-up|0|||
19769930|NCT03000348|42223451|FG002|Overall Study|Lost to Follow-up|1|||
19769931|NCT03000348|42223452|FG003|Overall Study|Lost to Follow-up|0|||
19769932|NCT03000348|42223453|FG004|Overall Study|Lost to Follow-up|0|||
19769933|NCT03000348|42223454|FG005|Overall Study|Lost to Follow-up|0|||
19769934|NCT03000348|42223449|FG000|Overall Study|Withdrawal by Subject|0|||
19769935|NCT03000348|42223450|FG001|Overall Study|Withdrawal by Subject|1|||
19769936|NCT03000348|42223451|FG002|Overall Study|Withdrawal by Subject|0|||
19769937|NCT03000348|42223452|FG003|Overall Study|Withdrawal by Subject|0|||
19769938|NCT03000348|42223453|FG004|Overall Study|Withdrawal by Subject|0|||
19769939|NCT03000348|42223454|FG005|Overall Study|Withdrawal by Subject|0|||
19769940|NCT03000348|42223449|FG000|Overall Study|Consent|0|||
19769941|NCT03000348|42223450|FG001|Overall Study|Consent|0|||
19769942|NCT03000348|42223451|FG002|Overall Study|Consent|0|||
19769943|NCT03000348|42223452|FG003|Overall Study|Consent|0|||
19769944|NCT03000348|42223453|FG004|Overall Study|Consent|1|||
19769945|NCT03000348|42223454|FG005|Overall Study|Consent|0|||
19769946|NCT03000348|42223449|FG000|Overall Study|Failure to expectorate sputum|1|||
19769947|NCT03000348|42223450|FG001|Overall Study|Failure to expectorate sputum|0|||
19769948|NCT03000348|42223451|FG002|Overall Study|Failure to expectorate sputum|1|||
19687082|NCT00272961|42133467|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
19687083|NCT00272961|42133468|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
19687084|NCT00272961|42133464|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
19687085|NCT00272961|42133465|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
19687086|NCT00272961|42133466|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
19687087|NCT00272961|42133467|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
19687088|NCT00272961|42133468|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
19687089|NCT00272961|42133464|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
19687090|NCT00272961|42133465|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
19687091|NCT00272961|42133466|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
19687092|NCT00272961|42133467|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
19687093|NCT00272961|42133468|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
19687094|NCT00272961|42133464|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
19687095|NCT00272961|42133465|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
19687096|NCT00272961|42133466|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
19687097|NCT00272961|42133467|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
19687098|NCT00272961|42133468|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
19687099|NCT00272961|42133464|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
19687100|NCT00272961|42133465|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
19769949|NCT03000348|42223452|FG003|Overall Study|Failure to expectorate sputum|0|||
19769950|NCT03000348|42223453|FG004|Overall Study|Failure to expectorate sputum|1|||
19769951|NCT03000348|42223454|FG005|Overall Study|Failure to expectorate sputum|0|||
19769952|NCT03000348|42223449|FG000|Overall Study|No gram negative|1|||
19769953|NCT03000348|42223450|FG001|Overall Study|No gram negative|2|||
19769954|NCT03000348|42223451|FG002|Overall Study|No gram negative|1|||
19687101|NCT00272961|42133466|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
19687102|NCT00272961|42133467|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
19687103|NCT00272961|42133468|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
19687104|NCT00272961|42133464|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
19687105|NCT00272961|42133465|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
19687106|NCT00272961|42133466|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
19687107|NCT00272961|42133467|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
19687108|NCT00272961|42133468|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
19687109|NCT00272961|42133464|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
19687110|NCT00272961|42133465|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
19687111|NCT00272961|42133466|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
19769955|NCT03000348|42223452|FG003|Overall Study|No gram negative|1|||
19769956|NCT03000348|42223453|FG004|Overall Study|No gram negative|1|||
19769957|NCT03000348|42223454|FG005|Overall Study|No gram negative|1|||
19769958|NCT03000348|42223449|FG000|Overall Study|Patient had no transport|0|||
19769959|NCT03000348|42223450|FG001|Overall Study|Patient had no transport|0|||
19769960|NCT03000348|42223451|FG002|Overall Study|Patient had no transport|0|||
19687112|NCT00272961|42133467|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
19687113|NCT00272961|42133468|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
19687114|NCT00272961|42133464|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
19769961|NCT03000348|42223452|FG003|Overall Study|Patient had no transport|1|||
19769962|NCT03000348|42223453|FG004|Overall Study|Patient had no transport|0|||
19769963|NCT03000348|42223454|FG005|Overall Study|Patient had no transport|0|||
19769964|NCT03000348|42223449|FG000|Overall Study|Dosing|0|||
19769965|NCT03000348|42223450|FG001|Overall Study|Dosing|0|||
19769966|NCT03000348|42223451|FG002|Overall Study|Dosing|0|||
19769967|NCT03000348|42223452|FG003|Overall Study|Dosing|0|||
19769968|NCT03000348|42223453|FG004|Overall Study|Dosing|1|||
19769969|NCT03000348|42223454|FG005|Overall Study|Dosing|0|||
19769970|NCT03283709|42223473|FG000|Overall Study|trial terminated|0|||
19769971|NCT03283709|42223474|FG001|Overall Study|trial terminated|1|||
19769972|NCT03247673|42223483|FG000|Overall Study|Withdrawal by Subject|1|||
19769973|NCT03247673|42223484|FG001|Overall Study|Withdrawal by Subject|0|||
19769974|NCT03247673|42223485|FG002|Overall Study|Withdrawal by Subject|3|||
19769975|NCT03247673|42223483|FG000|Overall Study|Lost to Follow-up|0|||
19687115|NCT00272961|42133465|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
19687116|NCT00272961|42133466|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
19687117|NCT00272961|42133467|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
19687118|NCT00272961|42133468|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
19769976|NCT03247673|42223484|FG001|Overall Study|Lost to Follow-up|0|||
19769977|NCT03247673|42223485|FG002|Overall Study|Lost to Follow-up|1|||
19769978|NCT03247517|42223496|FG000|Overall Study|Adverse Event|0|||
19769979|NCT03247517|42223497|FG001|Overall Study|Adverse Event|4|||
19687119|NCT00282087|42133480|FG000|Overall Study|Death|1|||
19687120|NCT00404924|42133487|FG000|Overall Study|Adverse Event|75|||
19687121|NCT00404924|42133488|FG001|Overall Study|Adverse Event|16|||
19769980|NCT03247517|42223498|FG002|Overall Study|Adverse Event|2|||
19769981|NCT03247517|42223496|FG000|Overall Study|Lost to Follow-up|2|||
19687122|NCT00404924|42133487|FG000|Overall Study|Condition under investigation worsened|475|||
19687123|NCT00404924|42133488|FG001|Overall Study|Condition under investigation worsened|264|||
19687124|NCT00404924|42133487|FG000|Overall Study|Lost to Follow-up|1|||
19687125|NCT00404924|42133488|FG001|Overall Study|Lost to Follow-up|1|||
19687126|NCT00404924|42133487|FG000|Overall Study|Withdrawal by Subject|26|||
19687127|NCT00404924|42133488|FG001|Overall Study|Withdrawal by Subject|13|||
19687128|NCT00404924|42133487|FG000|Overall Study|Other|25|||
19687129|NCT00404924|42133488|FG001|Overall Study|Other|11|||
19687130|NCT00404924|42133487|FG000|Overall Study|Randomised but not received treatment|1|||
19687131|NCT00404924|42133488|FG001|Overall Study|Randomised but not received treatment|1|||
19687132|NCT00281697|42133496|FG000|Overall Study|> 60 days since last dose of study drug|4|||
19687133|NCT00281697|42133497|FG001|Overall Study|> 60 days since last dose of study drug|4|||
19687134|NCT00281697|42133496|FG000|Overall Study|Adverse Event|54|||
19687135|NCT00281697|42133497|FG001|Overall Study|Adverse Event|15|||
19687136|NCT00281697|42133496|FG000|Overall Study|Death|8|||
19687137|NCT00281697|42133497|FG001|Overall Study|Death|3|||
19687138|NCT00281697|42133496|FG000|Overall Study|Disease progression|279|||
19687139|NCT00281697|42133497|FG001|Overall Study|Disease progression|149|||
19687140|NCT00281697|42133496|FG000|Overall Study|Other|5|||
19687141|NCT00281697|42133497|FG001|Overall Study|Other|6|||
19769982|NCT03247517|42223497|FG001|Overall Study|Lost to Follow-up|6|||
19769983|NCT03247517|42223498|FG002|Overall Study|Lost to Follow-up|4|||
19769984|NCT03247517|42223496|FG000|Overall Study|Consent withdrawn by caregiver|1|||
19769985|NCT03247517|42223497|FG001|Overall Study|Consent withdrawn by caregiver|4|||
19769986|NCT03247517|42223498|FG002|Overall Study|Consent withdrawn by caregiver|7|||
19769987|NCT03247517|42223496|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
19769988|NCT03247517|42223497|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
19687142|NCT00281697|42133496|FG000|Overall Study|Physician's decision to withdraw|15|||
19687143|NCT00281697|42133497|FG001|Overall Study|Physician's decision to withdraw|12|||
19687144|NCT00281697|42133496|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
19687145|NCT00281697|42133497|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
19687146|NCT00281697|42133496|FG000|Overall Study|Did not receive study drug|3|||
19687147|NCT00281697|42133497|FG001|Overall Study|Did not receive study drug|2|||
19687148|NCT00271947|42133503|FG000|Overall Study|Lost to Follow-up|1|||
19687149|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Death|186|||
19687150|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Death|222|||
19769989|NCT03247517|42223498|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
19769990|NCT03247517|42223496|FG000|Overall Study|Protocol Violation|0|||
19769991|NCT03247517|42223497|FG001|Overall Study|Protocol Violation|2|||
19769992|NCT03247517|42223498|FG002|Overall Study|Protocol Violation|0|||
19769993|NCT03247517|42223496|FG000|Overall Study|Multiple reasons|3|||
19769994|NCT03247517|42223497|FG001|Overall Study|Multiple reasons|1|||
19769995|NCT03247517|42223498|FG002|Overall Study|Multiple reasons|0|||
19769996|NCT03283553|42223508|FG000|Patient Participant Flow|Death|5|||
19769997|NCT03283553|42223509|FG001|Patient Participant Flow|Death|10|||
19769998|NCT03283553|42223508|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
19769999|NCT03283553|42223509|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
19770000|NCT03283553|42223508|FG000|Patient Participant Flow|Lost to Follow-up|1|||
19770001|NCT03283553|42223509|FG001|Patient Participant Flow|Lost to Follow-up|1|||
19770002|NCT03283553|42223508|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
19770003|NCT03283553|42223509|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
19770004|NCT03283553|42223508|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
19770005|NCT03283553|42223509|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
19770006|NCT03283553|42223508|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
19770007|NCT03283553|42223509|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
19770008|NCT03283319|42223523|FG000|Overall Study|Lost to Follow-up|5|||
19770009|NCT03283319|42223524|FG001|Overall Study|Lost to Follow-up|4|||
19770010|NCT03283319|42223525|FG002|Overall Study|Lost to Follow-up|5|||
19770011|NCT03283319|42223526|FG003|Overall Study|Lost to Follow-up|5|||
19770012|NCT03283319|42223527|FG004|Overall Study|Lost to Follow-up|4|||
19770013|NCT03283319|42223528|FG005|Overall Study|Lost to Follow-up|3|||
19770014|NCT03283319|42223523|FG000|Overall Study|Withdrawal by Subject|2|||
19770015|NCT03283319|42223524|FG001|Overall Study|Withdrawal by Subject|2|||
19770016|NCT03283319|42223525|FG002|Overall Study|Withdrawal by Subject|2|||
19770017|NCT03283319|42223526|FG003|Overall Study|Withdrawal by Subject|1|||
19770018|NCT03283319|42223527|FG004|Overall Study|Withdrawal by Subject|0|||
19770019|NCT03283319|42223528|FG005|Overall Study|Withdrawal by Subject|1|||
19770020|NCT03283319|42223523|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
19770021|NCT03283319|42223524|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
19770022|NCT03283319|42223525|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
19770023|NCT03283319|42223526|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
19770024|NCT03283319|42223527|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
19687151|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Death|0|||
19687152|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
19687153|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
19687154|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
19687155|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
19687156|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
19770025|NCT03283319|42223528|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
19770026|NCT03282227|42223542|FG000|Overall Study|Exposure Goals Achieved|60|||
19770027|NCT03282227|42223542|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
19770028|NCT03282227|42223542|FG000|Overall Study|Adverse Event|15|||
19770029|NCT03282227|42223542|FG000|Overall Study|Lost to Follow-up|21|||
19770030|NCT03282227|42223542|FG000|Overall Study|Withdrawal by Subject|20|||
19770031|NCT03282227|42223542|FG000|Overall Study|Lack of Efficacy|12|||
19770032|NCT03282227|42223542|FG000|Overall Study|Sponsor decision|3|||
19770033|NCT03282227|42223542|FG000|Overall Study|Physician Decision|2|||
19770034|NCT03282227|42223542|FG000|Overall Study|Pregnancy|2|||
19770035|NCT03282227|42223542|FG000|Overall Study|Other|1|||
19770036|NCT03240575|42223550|FG000|Overall Study|Adverse Event|0|||
19687157|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
19687158|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
19687159|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
19687160|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
19687161|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Adverse Event|83|||
19770037|NCT03240575|42223551|FG001|Overall Study|Adverse Event|2|||
19770038|NCT03240575|42223552|FG002|Overall Study|Adverse Event|0|||
19770039|NCT03240575|42223553|FG003|Overall Study|Adverse Event|1|||
19687162|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Adverse Event|100|||
19687163|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Adverse Event|0|||
19687164|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Other|70|||
19687165|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Other|75|||
19687166|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Other|0|||
19687167|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
19687168|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
19687169|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
19687170|NCT00232180|42133509|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
19687171|NCT00232180|42133510|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
19687172|NCT00232180|42133511|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
19687173|NCT00232180|42133509|FG000|Open Label Phase|Death|0|||
19687174|NCT00232180|42133510|FG001|Open Label Phase|Death|0|||
19687175|NCT00232180|42133511|FG002|Open Label Phase|Death|48|||
19687176|NCT00232180|42133509|FG000|Open Label Phase|Lost to Follow-up|0|||
19687177|NCT00232180|42133510|FG001|Open Label Phase|Lost to Follow-up|0|||
19687178|NCT00232180|42133511|FG002|Open Label Phase|Lost to Follow-up|5|||
19687179|NCT00232180|42133509|FG000|Open Label Phase|Protocol Violation|0|||
19687180|NCT00232180|42133510|FG001|Open Label Phase|Protocol Violation|0|||
19687181|NCT00232180|42133511|FG002|Open Label Phase|Protocol Violation|3|||
19687182|NCT00232180|42133509|FG000|Open Label Phase|Study terminated by sponsor|0|||
19687183|NCT00232180|42133510|FG001|Open Label Phase|Study terminated by sponsor|0|||
19687184|NCT00232180|42133511|FG002|Open Label Phase|Study terminated by sponsor|3|||
19687185|NCT00232180|42133509|FG000|Open Label Phase|Withdrawal by Subject|0|||
19687186|NCT00232180|42133510|FG001|Open Label Phase|Withdrawal by Subject|0|||
19687187|NCT00232180|42133511|FG002|Open Label Phase|Withdrawal by Subject|37|||
19687188|NCT00232180|42133509|FG000|Open Label Phase|Other|0|||
19687189|NCT00232180|42133510|FG001|Open Label Phase|Other|0|||
19687190|NCT00232180|42133511|FG002|Open Label Phase|Other|16|||
19687191|NCT00232180|42133509|FG000|Open Label Phase|Adverse Event|0|||
19687192|NCT00232180|42133510|FG001|Open Label Phase|Adverse Event|0|||
19687193|NCT00232180|42133511|FG002|Open Label Phase|Adverse Event|25|||
19687194|NCT00232180|42133509|FG000|Open Label Phase|Laboratory abnormality|0|||
19687195|NCT00232180|42133510|FG001|Open Label Phase|Laboratory abnormality|0|||
19687196|NCT00232180|42133511|FG002|Open Label Phase|Laboratory abnormality|10|||
19687197|NCT00232180|42133509|FG000|Open Label Phase|Randomized but not treated|0|||
19687198|NCT00232180|42133510|FG001|Open Label Phase|Randomized but not treated|0|||
19687199|NCT00232180|42133511|FG002|Open Label Phase|Randomized but not treated|1|||
19687200|NCT00280917|42133524|FG000|Overall Study|Adverse Event|1|||
19687201|NCT00280917|42133525|FG001|Overall Study|Adverse Event|1|||
19770040|NCT03240575|42223550|FG000|Overall Study|Withdrawal by Subject|2|||
19770041|NCT03240575|42223551|FG001|Overall Study|Withdrawal by Subject|11|||
19770042|NCT03240575|42223552|FG002|Overall Study|Withdrawal by Subject|0|||
19770043|NCT03240575|42223553|FG003|Overall Study|Withdrawal by Subject|1|||
19770044|NCT03240575|42223550|FG000|Overall Study|Other|0|||
19770045|NCT03240575|42223551|FG001|Overall Study|Other|1|||
19770046|NCT03240575|42223552|FG002|Overall Study|Other|0|||
19770047|NCT03240575|42223553|FG003|Overall Study|Other|0|||
19770048|NCT03385265|42223565|FG000|Overall Study|Withdrawal by Subject|5|||
19687202|NCT00280917|42133526|FG002|Overall Study|Adverse Event|4|||
19687203|NCT00280917|42133527|FG003|Overall Study|Adverse Event|1|||
19687204|NCT00280917|42133524|FG000|Overall Study|Change Therapy|1|||
19687205|NCT00280917|42133525|FG001|Overall Study|Change Therapy|2|||
19687206|NCT00280917|42133526|FG002|Overall Study|Change Therapy|0|||
19687207|NCT00280917|42133527|FG003|Overall Study|Change Therapy|0|||
19687208|NCT00280917|42133524|FG000|Overall Study|Withdrawal by Subject|0|||
19687209|NCT00280917|42133525|FG001|Overall Study|Withdrawal by Subject|2|||
19687210|NCT00280917|42133526|FG002|Overall Study|Withdrawal by Subject|0|||
19687211|NCT00280917|42133527|FG003|Overall Study|Withdrawal by Subject|1|||
19687212|NCT00280917|42133524|FG000|Overall Study|Noncompliance|0|||
19687213|NCT00280917|42133525|FG001|Overall Study|Noncompliance|1|||
19687214|NCT00280917|42133526|FG002|Overall Study|Noncompliance|2|||
19687215|NCT00280917|42133527|FG003|Overall Study|Noncompliance|0|||
19687216|NCT00280683|42133539|FG000|Overall Study|Withdrawal by Subject|1|||
19687217|NCT00280683|42133540|FG001|Overall Study|Withdrawal by Subject|2|||
19687218|NCT00280683|42133539|FG000|Overall Study|Adverse Event|1|||
19687219|NCT00280683|42133540|FG001|Overall Study|Adverse Event|1|||
19687220|NCT00270855|42133550|FG000|Overall Study|Withdrawal by Subject|8|||
19687221|NCT00270855|42133551|FG001|Overall Study|Withdrawal by Subject|8|||
19687222|NCT00404768|42133563|FG000|Part A and B|Withdrawn due to labor progression|1|||
19687223|NCT00404768|42133564|FG001|Part A and B|Withdrawn due to labor progression|0|||
19687224|NCT00404768|42133565|FG002|Part A and B|Withdrawn due to labor progression|0|||
19687225|NCT00404768|42133566|FG003|Part A and B|Withdrawn due to labor progression|0|||
19687226|NCT00404768|42133563|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
19770049|NCT03385265|42223566|FG001|Overall Study|Withdrawal by Subject|2|||
19687227|NCT00404768|42133564|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
19687228|NCT00404768|42133565|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
19687229|NCT00404768|42133566|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
19687230|NCT00404768|42133563|FG000|Part C|Adverse Event|0|||
19687231|NCT00404768|42133564|FG001|Part C|Adverse Event|0|||
19687232|NCT00404768|42133565|FG002|Part C|Adverse Event|0|||
19687233|NCT00404768|42133566|FG003|Part C|Adverse Event|3|||
19687234|NCT00404768|42133563|FG000|Part C|Lost to Follow-up|0|||
19687235|NCT00404768|42133564|FG001|Part C|Lost to Follow-up|0|||
19687236|NCT00404768|42133565|FG002|Part C|Lost to Follow-up|3|||
19687237|NCT00404768|42133566|FG003|Part C|Lost to Follow-up|1|||
19687238|NCT00404768|42133563|FG000|Part C|Withdrawal by Subject|0|||
19687239|NCT00404768|42133564|FG001|Part C|Withdrawal by Subject|0|||
19687240|NCT00404768|42133565|FG002|Part C|Withdrawal by Subject|2|||
19687241|NCT00404768|42133566|FG003|Part C|Withdrawal by Subject|1|||
19687242|NCT00404768|42133563|FG000|Part C|Early withdrawal from study medication|0|||
19687243|NCT00404768|42133564|FG001|Part C|Early withdrawal from study medication|0|||
19687244|NCT00404768|42133565|FG002|Part C|Early withdrawal from study medication|1|||
19687245|NCT00404768|42133566|FG003|Part C|Early withdrawal from study medication|0|||
19687246|NCT00404768|42133563|FG000|Part C|Participant did not respond to therapy|0|||
19687247|NCT00404768|42133564|FG001|Part C|Participant did not respond to therapy|0|||
19687248|NCT00404768|42133565|FG002|Part C|Participant did not respond to therapy|1|||
19687249|NCT00404768|42133566|FG003|Part C|Participant did not respond to therapy|1|||
19687250|NCT00404768|42133563|FG000|Part C|Physician withdrew the study medication|0|||
19687251|NCT00404768|42133564|FG001|Part C|Physician withdrew the study medication|0|||
19687252|NCT00404768|42133565|FG002|Part C|Physician withdrew the study medication|1|||
19687253|NCT00404768|42133566|FG003|Part C|Physician withdrew the study medication|0|||
19687254|NCT00404768|42133563|FG000|Part C|Participant delivered baby|0|||
19687255|NCT00404768|42133564|FG001|Part C|Participant delivered baby|0|||
19687256|NCT00404768|42133565|FG002|Part C|Participant delivered baby|0|||
19687257|NCT00404768|42133566|FG003|Part C|Participant delivered baby|1|||
19687258|NCT00404768|42133563|FG000|Part C|Unsatisfactory uterine response to IP|0|||
19687259|NCT00404768|42133564|FG001|Part C|Unsatisfactory uterine response to IP|0|||
19687260|NCT00404768|42133565|FG002|Part C|Unsatisfactory uterine response to IP|0|||
19687261|NCT00404768|42133566|FG003|Part C|Unsatisfactory uterine response to IP|1|||
19687262|NCT00404768|42133563|FG000|Part C|Active labor|0|||
19687263|NCT00404768|42133564|FG001|Part C|Active labor|0|||
19770050|NCT03385265|42223567|FG002|Overall Study|Withdrawal by Subject|5|||
19687264|NCT00404768|42133565|FG002|Part C|Active labor|0|||
19687265|NCT00404768|42133566|FG003|Part C|Active labor|1|||
19687266|NCT00404768|42133563|FG000|Part C|Lack of Efficacy|0|||
19687267|NCT00404768|42133564|FG001|Part C|Lack of Efficacy|0|||
19687268|NCT00404768|42133565|FG002|Part C|Lack of Efficacy|0|||
19687269|NCT00404768|42133566|FG003|Part C|Lack of Efficacy|2|||
19687270|NCT00404768|42133563|FG000|Part C|Treatment failure|0|||
19687271|NCT00404768|42133564|FG001|Part C|Treatment failure|0|||
19687272|NCT00404768|42133565|FG002|Part C|Treatment failure|0|||
19770051|NCT03385265|42223568|FG003|Overall Study|Withdrawal by Subject|2|||
19687273|NCT00404768|42133566|FG003|Part C|Treatment failure|1|||
19687274|NCT00404768|42133563|FG000|Part C|Investigator discretion|0|||
19687275|NCT00404768|42133564|FG001|Part C|Investigator discretion|0|||
19687276|NCT00404768|42133565|FG002|Part C|Investigator discretion|0|||
19687277|NCT00404768|42133566|FG003|Part C|Investigator discretion|1|||
19687278|NCT00404768|42133563|FG000|Part C|Researcher suspended study medication|0|||
19687279|NCT00404768|42133564|FG001|Part C|Researcher suspended study medication|0|||
19687280|NCT00404768|42133565|FG002|Part C|Researcher suspended study medication|0|||
19687281|NCT00404768|42133566|FG003|Part C|Researcher suspended study medication|1|||
19687282|NCT00270231|42133581|FG000|First Intervention|Lost to Follow-up|1|||
19687283|NCT00270231|42133582|FG001|First Intervention|Lost to Follow-up|1|||
19687284|NCT00270231|42133581|FG000|Washout Period|Lost to Follow-up|1|||
19687285|NCT00270231|42133582|FG001|Washout Period|Lost to Follow-up|0|||
19687286|NCT00270231|42133581|FG000|Second Intervention|Lost to Follow-up|0|||
19687287|NCT00270231|42133582|FG001|Second Intervention|Lost to Follow-up|1|||
19687288|NCT00258856|42133592|FG000|Overall Study|Lost to Follow-up|1|||
19687289|NCT00258856|42133593|FG001|Overall Study|Lost to Follow-up|0|||
19687290|NCT00258856|42133594|FG002|Overall Study|Lost to Follow-up|2|||
19687291|NCT00258856|42133595|FG003|Overall Study|Lost to Follow-up|0|||
19687292|NCT00258856|42133592|FG000|Overall Study|Non-compliance|2|||
19687293|NCT00258856|42133593|FG001|Overall Study|Non-compliance|0|||
19687294|NCT00258856|42133594|FG002|Overall Study|Non-compliance|0|||
19687295|NCT00258856|42133595|FG003|Overall Study|Non-compliance|1|||
19687296|NCT00269919|42133605|FG000|Overall Study|Other|26|||
19687297|NCT00269919|42133605|FG000|Overall Study|Started but not treated|1|||
19687298|NCT00258154|42133612|FG000|Overall Study|Adverse Event|1|||
19687299|NCT00258154|42133613|FG001|Overall Study|Adverse Event|0|||
19687300|NCT00258154|42133612|FG000|Overall Study|Lost to Follow-up|0|||
19687301|NCT00258154|42133613|FG001|Overall Study|Lost to Follow-up|1|||
19687302|NCT00258154|42133612|FG000|Overall Study|Protocol Violation|2|||
19770052|NCT03280121|42223580|FG000|Overall Study|Physician Decision|1|||
19687303|NCT00258154|42133613|FG001|Overall Study|Protocol Violation|1|||
19687304|NCT00258154|42133612|FG000|Overall Study|Withdrawal by Subject|3|||
19687305|NCT00258154|42133613|FG001|Overall Study|Withdrawal by Subject|4|||
19687306|NCT00258154|42133612|FG000|Overall Study|Patient Moved|3|||
19687307|NCT00258154|42133613|FG001|Overall Study|Patient Moved|1|||
19687308|NCT00257920|42133621|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
19687309|NCT00257920|42133622|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
19687310|NCT00257920|42133621|FG000|Period: Second Intervention|Other|2|||
19687311|NCT00257920|42133622|FG001|Period: Second Intervention|Other|1|||
19687312|NCT00268983|42133631|FG000|Overall Study|Death|3|||
19687313|NCT00268983|42133632|FG001|Overall Study|Death|0|||
19687314|NCT00257608|42133640|FG000|Chemotherapy Phase|Adverse Event|138|||
19687315|NCT00257608|42133641|FG001|Chemotherapy Phase|Adverse Event|0|||
19687316|NCT00257608|42133642|FG002|Chemotherapy Phase|Adverse Event|0|||
19687317|NCT00257608|42133640|FG000|Chemotherapy Phase|Disease progression|139|||
19687318|NCT00257608|42133641|FG001|Chemotherapy Phase|Disease progression|0|||
19687319|NCT00257608|42133642|FG002|Chemotherapy Phase|Disease progression|0|||
19687320|NCT00257608|42133640|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
19687321|NCT00257608|42133641|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
19687322|NCT00257608|42133642|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
19687323|NCT00257608|42133640|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
19687324|NCT00257608|42133641|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
19687325|NCT00257608|42133642|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
19687326|NCT00257608|42133640|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
19770053|NCT03280121|42223580|FG000|Overall Study|Lost to Follow-up|1|||
19770054|NCT03280121|42223580|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
19687327|NCT00257608|42133641|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
19687328|NCT00257608|42133642|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
19687329|NCT00257608|42133640|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
19687330|NCT00257608|42133641|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
19687331|NCT00257608|42133642|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
19687332|NCT00257608|42133640|FG000|Chemotherapy Phase|Physician Decision|28|||
19687333|NCT00257608|42133641|FG001|Chemotherapy Phase|Physician Decision|0|||
19687334|NCT00257608|42133642|FG002|Chemotherapy Phase|Physician Decision|0|||
19770055|NCT03233009|42223584|FG000|Overall Study|Lost to Follow-up|1|||
19770056|NCT04034225|42223599|FG000|Overall Study|Death|3|||
19770057|NCT04034225|42223599|FG000|Overall Study|Withdrawal by Subject|2|||
19770058|NCT04034225|42223599|FG000|Overall Study|Study termination by Sponsor|18|||
19770059|NCT04034225|42223599|FG000|Overall Study|Physician Decision|1|||
19770060|NCT04034225|42223599|FG000|Overall Study|Lack of Efficacy|1|||
19770061|NCT02999178|42223607|FG000|Overall Study|Adverse Event|85|||
19770062|NCT02999178|42223608|FG001|Overall Study|Adverse Event|62|||
19770063|NCT02999178|42223607|FG000|Overall Study|Protocol Violation|1|||
19770064|NCT02999178|42223608|FG001|Overall Study|Protocol Violation|2|||
19770065|NCT02999178|42223607|FG000|Overall Study|Lost to Follow-up|0|||
19770066|NCT02999178|42223608|FG001|Overall Study|Lost to Follow-up|2|||
19770067|NCT02999178|42223607|FG000|Overall Study|Withdrawal by Subject|21|||
19770068|NCT02999178|42223608|FG001|Overall Study|Withdrawal by Subject|21|||
19770069|NCT02999178|42223607|FG000|Overall Study|Other reason not defined above|7|||
19770070|NCT02999178|42223608|FG001|Overall Study|Other reason not defined above|13|||
19687335|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Adverse Event|0|||
19687336|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Adverse Event|34|||
19687337|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Adverse Event|38|||
19687338|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Disease progression|0|||
19687339|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Disease progression|204|||
19770071|NCT02959190|42223620|FG000|Open Label|Adverse Event|5|||
19687340|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Disease progression|168|||
19687341|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
19687342|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
19687343|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
19687344|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
19687345|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
19687346|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
19687347|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
19687348|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
19687349|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
19770072|NCT02959190|42223621|FG001|Open Label|Adverse Event|7|||
19770073|NCT02959190|42223622|FG002|Open Label|Adverse Event|3|||
19770074|NCT02959190|42223623|FG003|Open Label|Adverse Event|4|||
19770075|NCT02959190|42223620|FG000|Open Label|Pregnancy|0|||
19770076|NCT02959190|42223621|FG001|Open Label|Pregnancy|1|||
19770077|NCT02959190|42223622|FG002|Open Label|Pregnancy|0|||
19687350|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
19687351|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
19687352|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
19770078|NCT02959190|42223623|FG003|Open Label|Pregnancy|0|||
19770079|NCT02959190|42223620|FG000|Open Label|Withdrawal by Subject|2|||
19687353|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
19687354|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
19687355|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
19687356|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Physician Decision|0|||
19687357|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Physician Decision|8|||
19687358|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Physician Decision|11|||
19687359|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
19687360|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
19687361|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
19687362|NCT00257608|42133640|FG000|Post Chemotherapy Phase|Not treated|0|||
19687363|NCT00257608|42133641|FG001|Post Chemotherapy Phase|Not treated|4|||
19687364|NCT00257608|42133642|FG002|Post Chemotherapy Phase|Not treated|7|||
19687365|NCT00231478|42133657|FG000|Overall Study|Protocol Violation|3|||
19687366|NCT00231478|42133658|FG001|Overall Study|Protocol Violation|2|||
19687367|NCT00231478|42133657|FG000|Overall Study|Refused Treatment|1|||
19687368|NCT00231478|42133658|FG001|Overall Study|Refused Treatment|1|||
19687369|NCT00231478|42133657|FG000|Overall Study|Withdrawal by Subject|1|||
19687370|NCT00231478|42133658|FG001|Overall Study|Withdrawal by Subject|0|||
19687371|NCT00231478|42133657|FG000|Overall Study|Adverse Event|0|||
19687372|NCT00231478|42133658|FG001|Overall Study|Adverse Event|1|||
19687373|NCT00231478|42133657|FG000|Overall Study|Administrative|3|||
19687374|NCT00231478|42133658|FG001|Overall Study|Administrative|2|||
19687375|NCT00413192|42133668|FG000|Overall Study|Disease progression|26|||
19687376|NCT00413192|42133669|FG001|Overall Study|Disease progression|31|||
19687377|NCT00413192|42133670|FG002|Overall Study|Disease progression|16|||
19687378|NCT00413192|42133671|FG003|Overall Study|Disease progression|25|||
19687379|NCT00413192|42133668|FG000|Overall Study|Toxicity|3|||
19687380|NCT00413192|42133669|FG001|Overall Study|Toxicity|2|||
19687381|NCT00413192|42133670|FG002|Overall Study|Toxicity|2|||
19687382|NCT00413192|42133671|FG003|Overall Study|Toxicity|2|||
19687383|NCT00413192|42133668|FG000|Overall Study|Withdrawal by Subject|3|||
19687384|NCT00413192|42133669|FG001|Overall Study|Withdrawal by Subject|5|||
19687385|NCT00413192|42133670|FG002|Overall Study|Withdrawal by Subject|0|||
19687386|NCT00413192|42133671|FG003|Overall Study|Withdrawal by Subject|1|||
19687387|NCT00413192|42133668|FG000|Overall Study|Intercurrent illness|0|||
19687388|NCT00413192|42133669|FG001|Overall Study|Intercurrent illness|0|||
19687389|NCT00413192|42133670|FG002|Overall Study|Intercurrent illness|0|||
19687390|NCT00413192|42133671|FG003|Overall Study|Intercurrent illness|1|||
19687391|NCT00413192|42133668|FG000|Overall Study|Intercurrent death|0|||
19687392|NCT00413192|42133669|FG001|Overall Study|Intercurrent death|1|||
19687393|NCT00413192|42133670|FG002|Overall Study|Intercurrent death|0|||
19687394|NCT00413192|42133671|FG003|Overall Study|Intercurrent death|0|||
19687395|NCT00413192|42133668|FG000|Overall Study|Other|5|||
19687396|NCT00413192|42133669|FG001|Overall Study|Other|1|||
19770080|NCT02959190|42223621|FG001|Open Label|Withdrawal by Subject|8|||
19770081|NCT02959190|42223622|FG002|Open Label|Withdrawal by Subject|0|||
19687397|NCT00413192|42133670|FG002|Overall Study|Other|1|||
19687398|NCT00413192|42133671|FG003|Overall Study|Other|2|||
19687399|NCT00413192|42133668|FG000|Overall Study|Not treated|0|||
19687400|NCT00413192|42133669|FG001|Overall Study|Not treated|0|||
19687401|NCT00413192|42133670|FG002|Overall Study|Not treated|0|||
19687402|NCT00413192|42133671|FG003|Overall Study|Not treated|1|||
19687403|NCT00207142|42133684|FG000|Induction Phase|Adverse Event|9|||
19687404|NCT00207142|42133685|FG001|Induction Phase|Adverse Event|0|||
19687405|NCT00207142|42133686|FG002|Induction Phase|Adverse Event|0|||
19687406|NCT00207142|42133687|FG003|Induction Phase|Adverse Event|0|||
19687407|NCT00207142|42133684|FG000|Induction Phase|Death|1|||
19687408|NCT00207142|42133685|FG001|Induction Phase|Death|0|||
19687409|NCT00207142|42133686|FG002|Induction Phase|Death|0|||
19687410|NCT00207142|42133687|FG003|Induction Phase|Death|0|||
19687411|NCT00207142|42133684|FG000|Induction Phase|Lack of Efficacy|1|||
19687412|NCT00207142|42133685|FG001|Induction Phase|Lack of Efficacy|0|||
19687413|NCT00207142|42133686|FG002|Induction Phase|Lack of Efficacy|0|||
19687414|NCT00207142|42133687|FG003|Induction Phase|Lack of Efficacy|0|||
19687415|NCT00207142|42133684|FG000|Induction Phase|Lost to Follow-up|5|||
19687416|NCT00207142|42133685|FG001|Induction Phase|Lost to Follow-up|0|||
19687417|NCT00207142|42133686|FG002|Induction Phase|Lost to Follow-up|0|||
19687418|NCT00207142|42133687|FG003|Induction Phase|Lost to Follow-up|0|||
19687419|NCT00207142|42133684|FG000|Induction Phase|Physician Decision|2|||
19687420|NCT00207142|42133685|FG001|Induction Phase|Physician Decision|0|||
19687421|NCT00207142|42133686|FG002|Induction Phase|Physician Decision|0|||
19687422|NCT00207142|42133687|FG003|Induction Phase|Physician Decision|0|||
19687423|NCT00207142|42133684|FG000|Induction Phase|Poor/noncompliance|2|||
19687424|NCT00207142|42133685|FG001|Induction Phase|Poor/noncompliance|0|||
19687425|NCT00207142|42133686|FG002|Induction Phase|Poor/noncompliance|0|||
19687426|NCT00207142|42133687|FG003|Induction Phase|Poor/noncompliance|0|||
19687427|NCT00207142|42133684|FG000|Induction Phase|Pregnancy|1|||
19687428|NCT00207142|42133685|FG001|Induction Phase|Pregnancy|0|||
19687429|NCT00207142|42133686|FG002|Induction Phase|Pregnancy|0|||
19687430|NCT00207142|42133687|FG003|Induction Phase|Pregnancy|0|||
19687431|NCT00207142|42133684|FG000|Induction Phase|Subject no longer meets study criteria|3|||
19687432|NCT00207142|42133685|FG001|Induction Phase|Subject no longer meets study criteria|0|||
19687433|NCT00207142|42133686|FG002|Induction Phase|Subject no longer meets study criteria|0|||
19687434|NCT00207142|42133687|FG003|Induction Phase|Subject no longer meets study criteria|0|||
19687435|NCT00207142|42133684|FG000|Induction Phase|Withdrawal by Subject|4|||
19687436|NCT00207142|42133685|FG001|Induction Phase|Withdrawal by Subject|0|||
19687437|NCT00207142|42133686|FG002|Induction Phase|Withdrawal by Subject|0|||
19687438|NCT00207142|42133687|FG003|Induction Phase|Withdrawal by Subject|0|||
19687439|NCT00207142|42133684|FG000|Induction Phase|Incarceration|1|||
19687440|NCT00207142|42133685|FG001|Induction Phase|Incarceration|0|||
19687441|NCT00207142|42133686|FG002|Induction Phase|Incarceration|0|||
19687442|NCT00207142|42133687|FG003|Induction Phase|Incarceration|0|||
19687443|NCT00207142|42133684|FG000|Induction Phase|Missing lab data|1|||
19687444|NCT00207142|42133685|FG001|Induction Phase|Missing lab data|0|||
19687445|NCT00207142|42133686|FG002|Induction Phase|Missing lab data|0|||
19687446|NCT00207142|42133687|FG003|Induction Phase|Missing lab data|0|||
19687447|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
19687448|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
19687449|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
19687450|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
19687451|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
19687452|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
19687453|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
19687454|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
19687455|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
19687456|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
19687457|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
19687458|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
19687459|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
19687460|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
19687461|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
19687462|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
19770082|NCT02959190|42223623|FG003|Open Label|Withdrawal by Subject|0|||
19770083|NCT02959190|42223620|FG000|Open Label|Physician Decision|0|||
19770084|NCT02959190|42223621|FG001|Open Label|Physician Decision|0|||
19770085|NCT02959190|42223622|FG002|Open Label|Physician Decision|1|||
19770086|NCT02959190|42223623|FG003|Open Label|Physician Decision|0|||
19770087|NCT02959190|42223620|FG000|Open Label|Protocol Violation|0|||
19687463|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
19687464|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
19687465|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
19687466|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
19687467|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
19687468|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
19687469|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
19687470|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
19687471|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
19687472|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
19687473|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
19687474|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
19687475|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Death|0|||
19687476|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Death|0|||
19687477|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Death|0|||
19687478|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Death|1|||
19687479|NCT00207142|42133684|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
19687480|NCT00207142|42133685|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
19687481|NCT00207142|42133686|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
19687482|NCT00207142|42133687|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
19687483|NCT00268905|42133705|FG000|Overall Study|Adverse Event|3|||
19687484|NCT00268905|42133706|FG001|Overall Study|Adverse Event|0|||
19687485|NCT00268905|42133707|FG002|Overall Study|Adverse Event|4|||
19687486|NCT00268905|42133705|FG000|Overall Study|Lost to Follow-up|0|||
19687487|NCT00268905|42133706|FG001|Overall Study|Lost to Follow-up|1|||
19687488|NCT00268905|42133707|FG002|Overall Study|Lost to Follow-up|0|||
19687489|NCT00268905|42133705|FG000|Overall Study|Withdrawal by Subject|0|||
19687490|NCT00268905|42133706|FG001|Overall Study|Withdrawal by Subject|0|||
19687491|NCT00268905|42133707|FG002|Overall Study|Withdrawal by Subject|3|||
19687492|NCT00268905|42133705|FG000|Overall Study|Progressive Disease|28|||
19687493|NCT00268905|42133706|FG001|Overall Study|Progressive Disease|4|||
19687494|NCT00268905|42133707|FG002|Overall Study|Progressive Disease|3|||
19687495|NCT00268905|42133705|FG000|Overall Study|Physician Decision|3|||
19687496|NCT00268905|42133706|FG001|Overall Study|Physician Decision|0|||
19687497|NCT00268905|42133707|FG002|Overall Study|Physician Decision|1|||
19687498|NCT00268905|42133705|FG000|Overall Study|Clinical Progression|9|||
19687499|NCT00268905|42133706|FG001|Overall Study|Clinical Progression|4|||
19687500|NCT00268905|42133707|FG002|Overall Study|Clinical Progression|1|||
19687501|NCT00206518|42133717|FG000|Overall Study|Lack of Efficacy|6|||
19770088|NCT02959190|42223621|FG001|Open Label|Protocol Violation|0|||
19770089|NCT02959190|42223622|FG002|Open Label|Protocol Violation|0|||
19770090|NCT02959190|42223623|FG003|Open Label|Protocol Violation|2|||
19770091|NCT02959190|42223620|FG000|Post Treatment Follow Up|Adverse Event|1|||
19770092|NCT02959190|42223621|FG001|Post Treatment Follow Up|Adverse Event|1|||
19770093|NCT02959190|42223622|FG002|Post Treatment Follow Up|Adverse Event|0|||
19770094|NCT02959190|42223623|FG003|Post Treatment Follow Up|Adverse Event|0|||
19770095|NCT02959190|42223620|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
19770096|NCT02959190|42223621|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
19770097|NCT02959190|42223622|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
19770098|NCT02959190|42223623|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
19770099|NCT01344356|42223644|FG000|Overall Study|Physician Decision|0|||
19770100|NCT01344356|42223645|FG001|Overall Study|Physician Decision|3|||
19770101|NCT01344356|42223644|FG000|Overall Study|Lost to Follow-up|0|||
19770102|NCT01344356|42223645|FG001|Overall Study|Lost to Follow-up|6|||
19770103|NCT02956460|42223671|FG000|Lens 1|Lost to Follow-up|1|||
19770104|NCT02956460|42223672|FG001|Lens 1|Lost to Follow-up|0|||
19770105|NCT02999100|42223684|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
19770106|NCT02999100|42223685|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
19770107|NCT02999100|42223686|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
19770108|NCT02999100|42223687|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
19770109|NCT02999100|42223688|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
19770110|NCT02999100|42223689|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
19770111|NCT02999100|42223684|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
19770112|NCT02999100|42223685|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
19770113|NCT02999100|42223686|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
19770114|NCT02999100|42223687|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
19770115|NCT02999100|42223688|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
19770116|NCT02999100|42223689|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
19770117|NCT02999100|42223684|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
19770118|NCT02999100|42223685|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
19770119|NCT02999100|42223686|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
19770120|NCT02999100|42223687|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
19770121|NCT02999100|42223688|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
19770122|NCT02999100|42223689|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
19687502|NCT00206518|42133718|FG001|Overall Study|Lack of Efficacy|4|||
19687503|NCT00206518|42133717|FG000|Overall Study|Adverse Event|2|||
19687504|NCT00206518|42133718|FG001|Overall Study|Adverse Event|1|||
19687505|NCT00206518|42133717|FG000|Overall Study|Physician Decision|1|||
19687506|NCT00206518|42133718|FG001|Overall Study|Physician Decision|0|||
19687507|NCT00206518|42133717|FG000|Overall Study|Protocol Violation|1|||
19687508|NCT00206518|42133718|FG001|Overall Study|Protocol Violation|1|||
19687509|NCT00423722|42133726|FG000|Overall Study|Death|4|||
19687510|NCT00423722|42133727|FG001|Overall Study|Death|4|||
19687511|NCT00423722|42133726|FG000|Overall Study|Declined to participate|2|||
19687512|NCT00423722|42133727|FG001|Overall Study|Declined to participate|3|||
19687513|NCT00423722|42133726|FG000|Overall Study|Unable to complete questionnaires|4|||
19687514|NCT00423722|42133727|FG001|Overall Study|Unable to complete questionnaires|4|||
19687515|NCT00423722|42133726|FG000|Overall Study|Withdrawal by Subject|4|||
19687516|NCT00423722|42133727|FG001|Overall Study|Withdrawal by Subject|2|||
19687517|NCT00206440|42133741|FG000|Overall Study|Protocol Violation|1|||
19687518|NCT00206440|42133742|FG001|Overall Study|Protocol Violation|2|||
19687519|NCT00206440|42133741|FG000|Overall Study|Adverse Event|4|||
19687520|NCT00206440|42133742|FG001|Overall Study|Adverse Event|2|||
19687521|NCT00268437|42133748|FG000|Overall Study|Ineligible|1|||
19687522|NCT00423488|42133755|FG000|Overall Study|No evidence of study drug intake|2|||
19687523|NCT00423488|42133756|FG001|Overall Study|No evidence of study drug intake|1|||
19687524|NCT00423488|42133755|FG000|Overall Study|No post baseline data|3|||
19687525|NCT00423488|42133756|FG001|Overall Study|No post baseline data|0|||
19687526|NCT00404066|42133762|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
19687527|NCT00404066|42133762|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
19687528|NCT00423332|42133768|FG000|Overall Study|Adverse Event|6|||
19687529|NCT00423332|42133769|FG001|Overall Study|Adverse Event|2|||
19770123|NCT02749370|42223711|FG000|Overall Study|Withdrawal by Subject|11|||
19770124|NCT02749370|42223711|FG000|Overall Study|Lost to Follow-up|3|||
19687530|NCT00423332|42133768|FG000|Overall Study|Withdrawal by Subject|1|||
19687531|NCT00423332|42133769|FG001|Overall Study|Withdrawal by Subject|0|||
19687532|NCT00423332|42133768|FG000|Overall Study|Condition under investigation worsened|1|||
19687533|NCT00423332|42133769|FG001|Overall Study|Condition under investigation worsened|1|||
19687534|NCT00423332|42133768|FG000|Overall Study|Progressive at Week 6|0|||
19687535|NCT00423332|42133769|FG001|Overall Study|Progressive at Week 6|1|||
19687536|NCT00423332|42133768|FG000|Overall Study|Unblinded before 12 weeks|1|||
19687537|NCT00423332|42133769|FG001|Overall Study|Unblinded before 12 weeks|3|||
19687538|NCT00413036|42133776|FG000|Overall Study|Adverse Event|44|||
19687539|NCT00413036|42133776|FG000|Overall Study|Lack of Efficacy|129|||
19687540|NCT00413036|42133776|FG000|Overall Study|Withdrawal by Subject|7|||
19687541|NCT00413036|42133776|FG000|Overall Study|Death|9|||
19687542|NCT00413036|42133776|FG000|Overall Study|Other|26|||
19687543|NCT00413036|42133776|FG000|Overall Study|Missing|2|||
19687544|NCT00412958|42133784|FG000|Overall Study|Withdrawal by Subject|3|||
19687545|NCT00412958|42133785|FG001|Overall Study|Withdrawal by Subject|0|||
19687546|NCT00412958|42133786|FG002|Overall Study|Withdrawal by Subject|0|||
19687547|NCT00412958|42133787|FG003|Overall Study|Withdrawal by Subject|1|||
19687548|NCT00412958|42133784|FG000|Overall Study|Adverse Event|0|||
19687549|NCT00412958|42133785|FG001|Overall Study|Adverse Event|1|||
19687550|NCT00412958|42133786|FG002|Overall Study|Adverse Event|0|||
19687551|NCT00412958|42133787|FG003|Overall Study|Adverse Event|0|||
19687552|NCT00412958|42133784|FG000|Overall Study|Lost to Follow-up|0|||
19687553|NCT00412958|42133785|FG001|Overall Study|Lost to Follow-up|1|||
19687554|NCT00412958|42133786|FG002|Overall Study|Lost to Follow-up|0|||
19687555|NCT00412958|42133787|FG003|Overall Study|Lost to Follow-up|0|||
19687556|NCT00412958|42133784|FG000|Overall Study|Death|0|||
19687557|NCT00412958|42133785|FG001|Overall Study|Death|1|||
19687558|NCT00412958|42133786|FG002|Overall Study|Death|0|||
19687559|NCT00412958|42133787|FG003|Overall Study|Death|0|||
19687560|NCT00412958|42133784|FG000|Overall Study|Transport issue|0|||
19687561|NCT00412958|42133785|FG001|Overall Study|Transport issue|1|||
19687562|NCT00412958|42133786|FG002|Overall Study|Transport issue|0|||
19687563|NCT00412958|42133787|FG003|Overall Study|Transport issue|0|||
19687564|NCT00423176|42133799|FG000|Overall Study|Adverse Event|4|||
19687565|NCT00423176|42133800|FG001|Overall Study|Adverse Event|6|||
19687566|NCT00423176|42133799|FG000|Overall Study|Treatment Failure|1|||
19687567|NCT00423176|42133800|FG001|Overall Study|Treatment Failure|6|||
19687568|NCT00423176|42133799|FG000|Overall Study|Lost to Follow-up|4|||
19687569|NCT00423176|42133800|FG001|Overall Study|Lost to Follow-up|7|||
19687570|NCT00423176|42133799|FG000|Overall Study|Withdrawal by Subject|4|||
19687571|NCT00423176|42133800|FG001|Overall Study|Withdrawal by Subject|3|||
19687572|NCT00423176|42133799|FG000|Overall Study|Protocol Violation|1|||
19687573|NCT00423176|42133800|FG001|Overall Study|Protocol Violation|3|||
19687574|NCT00423176|42133799|FG000|Overall Study|Did not meet protocol eligibility|2|||
19687575|NCT00423176|42133800|FG001|Overall Study|Did not meet protocol eligibility|4|||
19687576|NCT00412880|42133806|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
19687577|NCT00412880|42133806|FG000|Overall Study|Consent withdrawn|1|||
19687578|NCT00412880|42133806|FG000|Overall Study|Adverse Event|1|||
19687579|NCT00412880|42133806|FG000|Overall Study|Progressive disease|20|||
19687580|NCT00268203|42133810|FG000|Overall Study|Lost to Follow-up|92|||
19687581|NCT00268203|42133810|FG000|Overall Study|Withdrawal by Subject|9|||
19687582|NCT00268203|42133810|FG000|Overall Study|Received Other NHL Therapy|7|||
19687583|NCT00268203|42133810|FG000|Overall Study|Progressive Disease|359|||
19687584|NCT00268203|42133810|FG000|Overall Study|Death|84|||
19687585|NCT00268203|42133810|FG000|Overall Study|Reason Not Specified|34|||
19687586|NCT00268203|42133810|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
19687587|NCT00384930|42133819|FG000|Overall Study|Adverse Event|5|||
19687588|NCT00384930|42133820|FG001|Overall Study|Adverse Event|4|||
19687589|NCT00384930|42133821|FG002|Overall Study|Adverse Event|12|||
19687590|NCT00384930|42133822|FG003|Overall Study|Adverse Event|11|||
19687591|NCT00384930|42133823|FG004|Overall Study|Adverse Event|14|||
19687592|NCT00384930|42133819|FG000|Overall Study|Entry Criteria Not Met|2|||
19687593|NCT00384930|42133820|FG001|Overall Study|Entry Criteria Not Met|6|||
19687594|NCT00384930|42133821|FG002|Overall Study|Entry Criteria Not Met|7|||
19687595|NCT00384930|42133822|FG003|Overall Study|Entry Criteria Not Met|8|||
19687596|NCT00384930|42133823|FG004|Overall Study|Entry Criteria Not Met|4|||
19687597|NCT00384930|42133819|FG000|Overall Study|Lack of Efficacy|1|||
19687598|NCT00384930|42133820|FG001|Overall Study|Lack of Efficacy|1|||
19687599|NCT00384930|42133821|FG002|Overall Study|Lack of Efficacy|2|||
19687600|NCT00384930|42133822|FG003|Overall Study|Lack of Efficacy|1|||
19687601|NCT00384930|42133823|FG004|Overall Study|Lack of Efficacy|2|||
19687602|NCT00384930|42133819|FG000|Overall Study|Lost to Follow-up|5|||
19687603|NCT00384930|42133820|FG001|Overall Study|Lost to Follow-up|3|||
19687604|NCT00384930|42133821|FG002|Overall Study|Lost to Follow-up|0|||
19687605|NCT00384930|42133822|FG003|Overall Study|Lost to Follow-up|4|||
19687606|NCT00384930|42133823|FG004|Overall Study|Lost to Follow-up|6|||
19687607|NCT00384930|42133819|FG000|Overall Study|Physician Decision|0|||
19687608|NCT00384930|42133820|FG001|Overall Study|Physician Decision|1|||
19687609|NCT00384930|42133821|FG002|Overall Study|Physician Decision|1|||
19687610|NCT00384930|42133822|FG003|Overall Study|Physician Decision|0|||
19687611|NCT00384930|42133823|FG004|Overall Study|Physician Decision|1|||
19687612|NCT00384930|42133819|FG000|Overall Study|Protocol Violation|1|||
19687613|NCT00384930|42133820|FG001|Overall Study|Protocol Violation|0|||
19770125|NCT03607994|42223717|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
19770126|NCT03607994|42223718|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
19770127|NCT02996682|42223726|FG000|Overall Study|Death|0|||
19770128|NCT02996682|42223727|FG001|Overall Study|Death|3|||
19770129|NCT02873702|42223735|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
19770130|NCT02873702|42223736|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
19687614|NCT00384930|42133821|FG002|Overall Study|Protocol Violation|1|||
19687615|NCT00384930|42133822|FG003|Overall Study|Protocol Violation|6|||
19687616|NCT00384930|42133823|FG004|Overall Study|Protocol Violation|4|||
19687617|NCT00384930|42133819|FG000|Overall Study|Sponsor Decision|3|||
19687618|NCT00384930|42133820|FG001|Overall Study|Sponsor Decision|4|||
19687619|NCT00384930|42133821|FG002|Overall Study|Sponsor Decision|0|||
19687620|NCT00384930|42133822|FG003|Overall Study|Sponsor Decision|5|||
19687621|NCT00384930|42133823|FG004|Overall Study|Sponsor Decision|0|||
19687622|NCT00384930|42133819|FG000|Overall Study|Withdrawal by Subject|9|||
19687623|NCT00384930|42133820|FG001|Overall Study|Withdrawal by Subject|7|||
19687624|NCT00384930|42133821|FG002|Overall Study|Withdrawal by Subject|7|||
19687625|NCT00384930|42133822|FG003|Overall Study|Withdrawal by Subject|6|||
19687626|NCT00384930|42133823|FG004|Overall Study|Withdrawal by Subject|16|||
19687627|NCT00384930|42133819|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
19687628|NCT00384930|42133820|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
19687629|NCT00384930|42133821|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
19687630|NCT00384930|42133822|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
19687631|NCT00384930|42133823|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
19687632|NCT00423098|42133840|FG000|Overall Study|Adverse Event|1|||
19687633|NCT00423098|42133841|FG001|Overall Study|Adverse Event|2|||
19687634|NCT00423098|42133840|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19687635|NCT00423098|42133841|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19687636|NCT00423098|42133840|FG000|Overall Study|Administrative problems|0|||
19770131|NCT02873702|42223737|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
19770132|NCT02873702|42223738|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
19770133|NCT02873702|42223735|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
19770134|NCT02873702|42223736|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
19770135|NCT02873702|42223737|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
19770136|NCT02873702|42223738|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
19770137|NCT02873702|42223735|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
19770138|NCT02873702|42223736|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
19770139|NCT02873702|42223737|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
19770140|NCT02873702|42223738|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
19770141|NCT02873702|42223735|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
19770142|NCT02873702|42223736|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
19770143|NCT02873702|42223737|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
19770144|NCT02873702|42223738|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
19770145|NCT02873702|42223735|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
19770146|NCT02873702|42223736|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
19770147|NCT02873702|42223737|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
19770148|NCT02873702|42223738|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
19770149|NCT02911116|42223750|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19770150|NCT02911116|42223751|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19770151|NCT02911116|42223750|FG000|Overall Study|Lost to Follow-up|0|||
19770152|NCT02911116|42223751|FG001|Overall Study|Lost to Follow-up|1|||
19770153|NCT02998554|42223759|FG000|Overall Study|Adverse Event|8|||
19770154|NCT02998554|42223760|FG001|Overall Study|Adverse Event|3|||
19770155|NCT02998554|42223759|FG000|Overall Study|Protocol deviation|1|||
19687637|NCT00423098|42133841|FG001|Overall Study|Administrative problems|1|||
19687638|NCT00423098|42133840|FG000|Overall Study|Death|2|||
19687639|NCT00423098|42133841|FG001|Overall Study|Death|0|||
19687640|NCT00411788|42133856|FG000|Overall Study|Protocol Violation|1|||
19687641|NCT00411788|42133856|FG000|Overall Study|Adverse Event|1|||
19687642|NCT00422942|42133860|FG000|Overall Study|Study terminated by Sponsor|3|||
19687643|NCT00422162|42133866|FG000|Overall Study|Adverse Event|11|||
19687644|NCT00422162|42133867|FG001|Overall Study|Adverse Event|9|||
19687645|NCT00422162|42133866|FG000|Overall Study|Lack of Efficacy|4|||
19687646|NCT00422162|42133867|FG001|Overall Study|Lack of Efficacy|10|||
19687647|NCT00422162|42133866|FG000|Overall Study|Withdrawal by Subject|7|||
19687648|NCT00422162|42133867|FG001|Overall Study|Withdrawal by Subject|6|||
19687649|NCT00422162|42133866|FG000|Overall Study|Lost to Follow-up|1|||
19687650|NCT00422162|42133867|FG001|Overall Study|Lost to Follow-up|2|||
19687651|NCT00422162|42133866|FG000|Overall Study|Non-Compliant with Protocol|1|||
19687652|NCT00422162|42133867|FG001|Overall Study|Non-Compliant with Protocol|1|||
19687653|NCT00422162|42133866|FG000|Overall Study|Other|0|||
19687654|NCT00422162|42133867|FG001|Overall Study|Other|1|||
19687655|NCT00422162|42133866|FG000|Overall Study|Didn't Receive Treatment|0|||
19687656|NCT00422162|42133867|FG001|Overall Study|Didn't Receive Treatment|1|||
19687657|NCT00411632|42133883|FG000|Overall Study|Death|1|||
19687658|NCT00422084|42133889|FG000|Overall Study|Adverse Event|21|||
19687659|NCT00422084|42133890|FG001|Overall Study|Adverse Event|7|||
19687660|NCT00422084|42133889|FG000|Overall Study|Withdrawal by Subject|12|||
19687661|NCT00422084|42133890|FG001|Overall Study|Withdrawal by Subject|9|||
19687662|NCT00422084|42133889|FG000|Overall Study|Lost to Follow-up|14|||
19687663|NCT00422084|42133890|FG001|Overall Study|Lost to Follow-up|9|||
19687664|NCT00422084|42133889|FG000|Overall Study|Protocol Violation|4|||
19687665|NCT00422084|42133890|FG001|Overall Study|Protocol Violation|1|||
19687666|NCT00422084|42133889|FG000|Overall Study|Lack of Efficacy|40|||
19687667|NCT00422084|42133890|FG001|Overall Study|Lack of Efficacy|42|||
19687668|NCT00422084|42133889|FG000|Overall Study|P. vivax infection|3|||
19687669|NCT00422084|42133890|FG001|Overall Study|P. vivax infection|6|||
19687670|NCT00422084|42133889|FG000|Overall Study|Cyesis|1|||
19687671|NCT00422084|42133890|FG001|Overall Study|Cyesis|0|||
19687672|NCT00422084|42133889|FG000|Overall Study|Withdrawn from study accidentally|1|||
19687673|NCT00422084|42133890|FG001|Overall Study|Withdrawn from study accidentally|0|||
19687674|NCT00422084|42133889|FG000|Overall Study|Non-compliance|1|||
19687675|NCT00422084|42133890|FG001|Overall Study|Non-compliance|0|||
19687676|NCT00422084|42133889|FG000|Overall Study|Re-location|0|||
19687677|NCT00422084|42133890|FG001|Overall Study|Re-location|1|||
19687678|NCT00422084|42133889|FG000|Overall Study|Not defined|1|||
19687679|NCT00422084|42133890|FG001|Overall Study|Not defined|1|||
19687680|NCT00421928|42133899|FG000|Overall Study|Adverse Event|61|||
19687681|NCT00421928|42133900|FG001|Overall Study|Adverse Event|140|||
19687682|NCT00421928|42133901|FG002|Overall Study|Adverse Event|22|||
19687683|NCT00421928|42133899|FG000|Overall Study|Lost to Follow-up|5|||
19687684|NCT00421928|42133900|FG001|Overall Study|Lost to Follow-up|0|||
19687685|NCT00421928|42133901|FG002|Overall Study|Lost to Follow-up|3|||
19687686|NCT00421928|42133899|FG000|Overall Study|Withdrawal by Subject|50|||
19687687|NCT00421928|42133900|FG001|Overall Study|Withdrawal by Subject|48|||
19687688|NCT00421928|42133901|FG002|Overall Study|Withdrawal by Subject|43|||
19687689|NCT00421928|42133899|FG000|Overall Study|Lack of Efficacy|15|||
19687690|NCT00421928|42133900|FG001|Overall Study|Lack of Efficacy|7|||
19687691|NCT00421928|42133901|FG002|Overall Study|Lack of Efficacy|35|||
19687692|NCT00421928|42133899|FG000|Overall Study|Study drug non-compliant|6|||
19687693|NCT00421928|42133900|FG001|Overall Study|Study drug non-compliant|7|||
19687694|NCT00421928|42133901|FG002|Overall Study|Study drug non-compliant|4|||
19687695|NCT00421928|42133899|FG000|Overall Study|All other|26|||
19687696|NCT00421928|42133900|FG001|Overall Study|All other|21|||
19687697|NCT00421928|42133901|FG002|Overall Study|All other|27|||
19687698|NCT00421928|42133899|FG000|Overall Study|Death|0|||
19687699|NCT00421928|42133900|FG001|Overall Study|Death|1|||
19687700|NCT00421928|42133901|FG002|Overall Study|Death|0|||
19687701|NCT00383292|42133912|FG000|Overall Study|Adverse Event|4|||
19687702|NCT00383292|42133913|FG001|Overall Study|Adverse Event|1|||
19687703|NCT00383292|42133914|FG002|Overall Study|Adverse Event|2|||
19687704|NCT00383292|42133912|FG000|Overall Study|Death|3|||
19687705|NCT00383292|42133913|FG001|Overall Study|Death|3|||
19687706|NCT00383292|42133914|FG002|Overall Study|Death|3|||
19687707|NCT00383292|42133912|FG000|Overall Study|Physician Decision|4|||
19687708|NCT00383292|42133913|FG001|Overall Study|Physician Decision|0|||
19687709|NCT00383292|42133914|FG002|Overall Study|Physician Decision|1|||
19687710|NCT00383292|42133912|FG000|Overall Study|Withdrawal by Subject|3|||
19687711|NCT00383292|42133913|FG001|Overall Study|Withdrawal by Subject|2|||
19687712|NCT00383292|42133914|FG002|Overall Study|Withdrawal by Subject|2|||
19687713|NCT00383292|42133912|FG000|Overall Study|Other|1|||
19687714|NCT00383292|42133913|FG001|Overall Study|Other|0|||
19687715|NCT00383292|42133914|FG002|Overall Study|Other|0|||
19687716|NCT00372060|42133925|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
19687717|NCT00372060|42133926|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
19687718|NCT00372060|42133925|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
19687719|NCT00372060|42133926|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
19687720|NCT00372060|42133925|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
19687721|NCT00372060|42133926|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
19687722|NCT00372060|42133925|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
19687723|NCT00372060|42133926|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
19687724|NCT00372060|42133925|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
19687725|NCT00372060|42133926|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
19687726|NCT00372060|42133925|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
19687727|NCT00372060|42133926|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
19389136|NCT02663687|41632708|FG002|Overall Study|Adverse Event|0|||
19687728|NCT00421304|42133938|FG000|Overall Study|Lost to Follow-up|5|||
19687729|NCT00421304|42133939|FG001|Overall Study|Lost to Follow-up|2|||
19687730|NCT00421304|42133940|FG002|Overall Study|Lost to Follow-up|5|||
19687731|NCT00421304|42133938|FG000|Overall Study|Withdrawal by Subject|2|||
19687732|NCT00421304|42133939|FG001|Overall Study|Withdrawal by Subject|2|||
19687733|NCT00421304|42133940|FG002|Overall Study|Withdrawal by Subject|2|||
19687734|NCT00421304|42133938|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
19687735|NCT00421304|42133939|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
19687736|NCT00421304|42133940|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
19687737|NCT00421304|42133938|FG000|Overall Study|Did not attend Day 360 visit|0|||
19687738|NCT00421304|42133939|FG001|Overall Study|Did not attend Day 360 visit|0|||
19770156|NCT02998554|42223760|FG001|Overall Study|Protocol deviation|0|||
19770157|NCT02998554|42223759|FG000|Overall Study|Withdrawal by Subject|2|||
19770158|NCT02998554|42223760|FG001|Overall Study|Withdrawal by Subject|6|||
19770159|NCT02998554|42223759|FG000|Overall Study|Lost to Follow-up|0|||
19770160|NCT02998554|42223760|FG001|Overall Study|Lost to Follow-up|1|||
19770161|NCT02998554|42223759|FG000|Overall Study|Lack of Efficacy|0|||
19770162|NCT02998554|42223760|FG001|Overall Study|Lack of Efficacy|1|||
19770163|NCT02996448|42223768|FG000|Overall Study|Study terminated due to adverse effects|3|||
19770164|NCT02995980|42223773|FG000|Overall Study|Lost to Follow-up|14|||
19770165|NCT02872142|42223778|FG000|Overall Study|Adverse Event|2|||
19770166|NCT02872142|42223778|FG000|Overall Study|Death|1|||
19770167|NCT02872142|42223778|FG000|Overall Study|Participant Decision|3|||
19770168|NCT02994654|42223782|FG000|Overall Study|Lost to Follow-up|1|||
19770169|NCT02870972|42223792|FG000|Overall Study|Adverse Event|1|||
19770170|NCT02870972|42223793|FG001|Overall Study|Adverse Event|0|||
19770171|NCT02870972|42223794|FG002|Overall Study|Adverse Event|0|||
19770172|NCT02870972|42223795|FG003|Overall Study|Adverse Event|0|||
19770173|NCT02870972|42223796|FG004|Overall Study|Adverse Event|0|||
19770174|NCT03214367|42223816|FG000|Lead-in Period|Withdrawal by Subject|50|||
19770175|NCT03214367|42223817|FG001|Lead-in Period|Withdrawal by Subject|0|||
19770176|NCT03214367|42223818|FG002|Lead-in Period|Withdrawal by Subject|0|||
19770177|NCT03214367|42223819|FG003|Lead-in Period|Withdrawal by Subject|0|||
19770178|NCT03214367|42223820|FG004|Lead-in Period|Withdrawal by Subject|2|||
19770179|NCT03214367|42223821|FG005|Lead-in Period|Withdrawal by Subject|0|||
19770180|NCT03214367|42223822|FG006|Lead-in Period|Withdrawal by Subject|0|||
19770181|NCT03214367|42223823|FG007|Lead-in Period|Withdrawal by Subject|0|||
19770182|NCT03214367|42223816|FG000|Lead-in Period|Adverse Event|3|||
19770183|NCT03214367|42223817|FG001|Lead-in Period|Adverse Event|0|||
19770184|NCT03214367|42223818|FG002|Lead-in Period|Adverse Event|0|||
19770185|NCT03214367|42223819|FG003|Lead-in Period|Adverse Event|0|||
19770186|NCT03214367|42223820|FG004|Lead-in Period|Adverse Event|0|||
19770187|NCT03214367|42223821|FG005|Lead-in Period|Adverse Event|0|||
19770188|NCT03214367|42223822|FG006|Lead-in Period|Adverse Event|0|||
19770189|NCT03214367|42223823|FG007|Lead-in Period|Adverse Event|0|||
19770190|NCT03214367|42223816|FG000|Lead-in Period|Lost to Follow-up|12|||
19770191|NCT03214367|42223817|FG001|Lead-in Period|Lost to Follow-up|0|||
19770192|NCT03214367|42223818|FG002|Lead-in Period|Lost to Follow-up|0|||
19770193|NCT03214367|42223819|FG003|Lead-in Period|Lost to Follow-up|0|||
19770194|NCT03214367|42223820|FG004|Lead-in Period|Lost to Follow-up|0|||
19770195|NCT03214367|42223821|FG005|Lead-in Period|Lost to Follow-up|0|||
19770196|NCT03214367|42223822|FG006|Lead-in Period|Lost to Follow-up|0|||
19770197|NCT03214367|42223823|FG007|Lead-in Period|Lost to Follow-up|0|||
19770198|NCT03214367|42223816|FG000|Lead-in Period|Sponsor Decision|11|||
19770199|NCT03214367|42223817|FG001|Lead-in Period|Sponsor Decision|0|||
19770200|NCT03214367|42223818|FG002|Lead-in Period|Sponsor Decision|0|||
19770201|NCT03214367|42223819|FG003|Lead-in Period|Sponsor Decision|0|||
19770202|NCT03214367|42223820|FG004|Lead-in Period|Sponsor Decision|0|||
19770203|NCT03214367|42223821|FG005|Lead-in Period|Sponsor Decision|0|||
19770204|NCT03214367|42223822|FG006|Lead-in Period|Sponsor Decision|0|||
19770205|NCT03214367|42223823|FG007|Lead-in Period|Sponsor Decision|0|||
19770206|NCT03214367|42223816|FG000|Lead-in Period|Physician Decision|12|||
19770207|NCT03214367|42223817|FG001|Lead-in Period|Physician Decision|0|||
19770208|NCT03214367|42223818|FG002|Lead-in Period|Physician Decision|0|||
19770209|NCT03214367|42223819|FG003|Lead-in Period|Physician Decision|0|||
19770210|NCT03214367|42223820|FG004|Lead-in Period|Physician Decision|0|||
19770211|NCT03214367|42223821|FG005|Lead-in Period|Physician Decision|0|||
19770212|NCT03214367|42223822|FG006|Lead-in Period|Physician Decision|0|||
19770213|NCT03214367|42223823|FG007|Lead-in Period|Physician Decision|0|||
19770214|NCT03214367|42223816|FG000|Lead-in Period|Protocol Violation|5|||
19770215|NCT03214367|42223817|FG001|Lead-in Period|Protocol Violation|0|||
19770216|NCT03214367|42223818|FG002|Lead-in Period|Protocol Violation|0|||
19770217|NCT03214367|42223819|FG003|Lead-in Period|Protocol Violation|0|||
19770218|NCT03214367|42223820|FG004|Lead-in Period|Protocol Violation|0|||
19770219|NCT03214367|42223821|FG005|Lead-in Period|Protocol Violation|0|||
19770220|NCT03214367|42223822|FG006|Lead-in Period|Protocol Violation|0|||
19770221|NCT03214367|42223823|FG007|Lead-in Period|Protocol Violation|0|||
19770222|NCT03214367|42223816|FG000|Lead-in Period|Treatment Interruption|1|||
19770223|NCT03214367|42223817|FG001|Lead-in Period|Treatment Interruption|0|||
19770224|NCT03214367|42223818|FG002|Lead-in Period|Treatment Interruption|0|||
19770225|NCT03214367|42223819|FG003|Lead-in Period|Treatment Interruption|0|||
19770226|NCT03214367|42223820|FG004|Lead-in Period|Treatment Interruption|0|||
19770227|NCT03214367|42223821|FG005|Lead-in Period|Treatment Interruption|0|||
19770228|NCT03214367|42223822|FG006|Lead-in Period|Treatment Interruption|0|||
19770229|NCT03214367|42223823|FG007|Lead-in Period|Treatment Interruption|0|||
19770230|NCT03214367|42223816|FG000|Treatment Period|Adverse Event|0|||
19770231|NCT03214367|42223817|FG001|Treatment Period|Adverse Event|1|||
19770232|NCT03214367|42223818|FG002|Treatment Period|Adverse Event|4|||
19770233|NCT03214367|42223819|FG003|Treatment Period|Adverse Event|2|||
19770234|NCT03214367|42223820|FG004|Treatment Period|Adverse Event|0|||
19770235|NCT03214367|42223821|FG005|Treatment Period|Adverse Event|0|||
19687739|NCT00421304|42133940|FG002|Overall Study|Did not attend Day 360 visit|1|||
19687740|NCT00396630|42133952|FG000|Overall Study|Lost to Follow-up|1|||
19687741|NCT00396630|42133953|FG001|Overall Study|Lost to Follow-up|1|||
19687742|NCT00396630|42133952|FG000|Overall Study|Withdrawal by Subject|1|||
19687743|NCT00396630|42133953|FG001|Overall Study|Withdrawal by Subject|1|||
19687744|NCT00396630|42133952|FG000|Overall Study|Not vaccinated at Visit 3|3|||
19687745|NCT00396630|42133953|FG001|Overall Study|Not vaccinated at Visit 3|3|||
19687746|NCT00396318|42133960|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
19687747|NCT00396162|42133966|FG000|Overall Study|Withdrawal by Subject|2|||
19687748|NCT00396162|42133967|FG001|Overall Study|Withdrawal by Subject|3|||
19687749|NCT00381888|42133977|FG000|Overall Study|Death|1|||
19687750|NCT00381888|42133977|FG000|Overall Study|Withdrawal by Subject|1|||
19687751|NCT00381888|42133977|FG000|Overall Study|Physician Decision|1|||
19687752|NCT00381888|42133977|FG000|Overall Study|Protocol Violation|9|||
19687753|NCT00381888|42133977|FG000|Overall Study|Had laparoscopic surgery|2|||
19687754|NCT00381888|42133977|FG000|Overall Study|Surgery was cancelled|2|||
19687755|NCT00381888|42133977|FG000|Overall Study|Adverse Event|1|||
19687756|NCT00267969|42133984|FG000|Controlled Period|Adverse Event|6|||
19687757|NCT00267969|42133985|FG001|Controlled Period|Adverse Event|0|||
19770236|NCT03214367|42223822|FG006|Treatment Period|Adverse Event|0|||
19770237|NCT03214367|42223823|FG007|Treatment Period|Adverse Event|0|||
19770238|NCT03214367|42223816|FG000|Treatment Period|Death|0|||
19770239|NCT03214367|42223817|FG001|Treatment Period|Death|1|||
19770240|NCT03214367|42223818|FG002|Treatment Period|Death|1|||
19770241|NCT03214367|42223819|FG003|Treatment Period|Death|1|||
19770242|NCT03214367|42223820|FG004|Treatment Period|Death|0|||
19770243|NCT03214367|42223821|FG005|Treatment Period|Death|0|||
19770244|NCT03214367|42223822|FG006|Treatment Period|Death|0|||
19605623|NCT00731692|42054335|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
19605624|NCT00731692|42054336|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
19605625|NCT00731692|42054334|FG000|Extension Phase|Abnormal test procedure|0|||
19605626|NCT00731692|42054335|FG001|Extension Phase|Abnormal test procedure|0|||
19605627|NCT00731692|42054336|FG002|Extension Phase|Abnormal test procedure|1|||
19605628|NCT00731692|42054334|FG000|Extension Phase|Abnormal lab values|0|||
19605629|NCT00731692|42054335|FG001|Extension Phase|Abnormal lab values|0|||
19605630|NCT00731692|42054336|FG002|Extension Phase|Abnormal lab values|1|||
19605631|NCT00731692|42054334|FG000|Extension Phase|Lost to Follow-up|0|||
19605632|NCT00731692|42054335|FG001|Extension Phase|Lost to Follow-up|1|||
19605633|NCT00731692|42054336|FG002|Extension Phase|Lost to Follow-up|4|||
19605634|NCT00731692|42054334|FG000|Extension Phase|Withdrawal by Subject|4|||
19605635|NCT00731692|42054335|FG001|Extension Phase|Withdrawal by Subject|5|||
19605636|NCT00731692|42054336|FG002|Extension Phase|Withdrawal by Subject|3|||
19605637|NCT00731692|42054334|FG000|Extension Phase|Adverse Event|1|||
19605638|NCT00731692|42054335|FG001|Extension Phase|Adverse Event|1|||
19605639|NCT00731692|42054336|FG002|Extension Phase|Adverse Event|15|||
19605640|NCT00687193|42054358|FG000|Overall Study|Adverse Event|0|||
19605641|NCT00687193|42054359|FG001|Overall Study|Adverse Event|1|||
19605642|NCT00687193|42054360|FG002|Overall Study|Adverse Event|2|||
19605643|NCT00687193|42054361|FG003|Overall Study|Adverse Event|3|||
19605644|NCT00687193|42054362|FG004|Overall Study|Adverse Event|0|||
19605645|NCT00687193|42054363|FG005|Overall Study|Adverse Event|2|||
19605646|NCT00687193|42054358|FG000|Overall Study|Lack of Efficacy|1|||
19605647|NCT00687193|42054359|FG001|Overall Study|Lack of Efficacy|1|||
19605648|NCT00687193|42054360|FG002|Overall Study|Lack of Efficacy|0|||
19605649|NCT00687193|42054361|FG003|Overall Study|Lack of Efficacy|0|||
19605650|NCT00687193|42054362|FG004|Overall Study|Lack of Efficacy|0|||
19605651|NCT00687193|42054363|FG005|Overall Study|Lack of Efficacy|2|||
19605652|NCT00687193|42054358|FG000|Overall Study|Protocol Violation|1|||
19687758|NCT00267969|42133986|FG002|Controlled Period|Adverse Event|2|||
19687759|NCT00267969|42133987|FG003|Controlled Period|Adverse Event|0|||
19687760|NCT00267969|42133988|FG004|Controlled Period|Adverse Event|0|||
19770245|NCT03214367|42223823|FG007|Treatment Period|Death|0|||
19770246|NCT03214367|42223816|FG000|Treatment Period|Lost to Follow-up|0|||
19687761|NCT00267969|42133989|FG005|Controlled Period|Adverse Event|0|||
19770247|NCT03214367|42223817|FG001|Treatment Period|Lost to Follow-up|5|||
19770248|NCT03214367|42223818|FG002|Treatment Period|Lost to Follow-up|3|||
19770249|NCT03214367|42223819|FG003|Treatment Period|Lost to Follow-up|2|||
19770250|NCT03214367|42223820|FG004|Treatment Period|Lost to Follow-up|0|||
19770251|NCT03214367|42223821|FG005|Treatment Period|Lost to Follow-up|2|||
19687762|NCT00267969|42133990|FG006|Controlled Period|Adverse Event|0|||
19687763|NCT00267969|42133984|FG000|Controlled Period|Lack of Efficacy|3|||
19687764|NCT00267969|42133985|FG001|Controlled Period|Lack of Efficacy|0|||
19687765|NCT00267969|42133986|FG002|Controlled Period|Lack of Efficacy|1|||
19687766|NCT00267969|42133987|FG003|Controlled Period|Lack of Efficacy|0|||
19687767|NCT00267969|42133988|FG004|Controlled Period|Lack of Efficacy|0|||
19687768|NCT00267969|42133989|FG005|Controlled Period|Lack of Efficacy|0|||
19687769|NCT00267969|42133990|FG006|Controlled Period|Lack of Efficacy|0|||
19687770|NCT00267969|42133984|FG000|Controlled Period|Lost to Follow-up|1|||
19687771|NCT00267969|42133985|FG001|Controlled Period|Lost to Follow-up|0|||
19770252|NCT03214367|42223822|FG006|Treatment Period|Lost to Follow-up|1|||
19770253|NCT03214367|42223823|FG007|Treatment Period|Lost to Follow-up|0|||
19770254|NCT03214367|42223816|FG000|Treatment Period|Sponsor Decision|0|||
19770255|NCT03214367|42223817|FG001|Treatment Period|Sponsor Decision|3|||
19770256|NCT03214367|42223818|FG002|Treatment Period|Sponsor Decision|0|||
19770257|NCT03214367|42223819|FG003|Treatment Period|Sponsor Decision|0|||
19687772|NCT00267969|42133986|FG002|Controlled Period|Lost to Follow-up|1|||
19687773|NCT00267969|42133987|FG003|Controlled Period|Lost to Follow-up|0|||
19687774|NCT00267969|42133988|FG004|Controlled Period|Lost to Follow-up|0|||
19687775|NCT00267969|42133989|FG005|Controlled Period|Lost to Follow-up|0|||
19687776|NCT00267969|42133990|FG006|Controlled Period|Lost to Follow-up|0|||
19687777|NCT00267969|42133984|FG000|Controlled Period|Randomized but not treated|0|||
19687778|NCT00267969|42133985|FG001|Controlled Period|Randomized but not treated|0|||
19687779|NCT00267969|42133986|FG002|Controlled Period|Randomized but not treated|1|||
19687780|NCT00267969|42133987|FG003|Controlled Period|Randomized but not treated|0|||
19687781|NCT00267969|42133988|FG004|Controlled Period|Randomized but not treated|0|||
19687782|NCT00267969|42133989|FG005|Controlled Period|Randomized but not treated|0|||
19687783|NCT00267969|42133990|FG006|Controlled Period|Randomized but not treated|0|||
19687784|NCT00267969|42133984|FG000|Controlled Period|Other|2|||
19687785|NCT00267969|42133985|FG001|Controlled Period|Other|1|||
19687786|NCT00267969|42133986|FG002|Controlled Period|Other|6|||
19687787|NCT00267969|42133987|FG003|Controlled Period|Other|0|||
19687788|NCT00267969|42133988|FG004|Controlled Period|Other|0|||
19687789|NCT00267969|42133989|FG005|Controlled Period|Other|0|||
19687790|NCT00267969|42133990|FG006|Controlled Period|Other|0|||
19687791|NCT00267969|42133984|FG000|After Controlled Period|Adverse Event|0|||
19687792|NCT00267969|42133985|FG001|After Controlled Period|Adverse Event|0|||
19687793|NCT00267969|42133986|FG002|After Controlled Period|Adverse Event|0|||
19770258|NCT03214367|42223820|FG004|Treatment Period|Sponsor Decision|0|||
19770259|NCT03214367|42223821|FG005|Treatment Period|Sponsor Decision|0|||
19770260|NCT03214367|42223822|FG006|Treatment Period|Sponsor Decision|0|||
19770261|NCT03214367|42223823|FG007|Treatment Period|Sponsor Decision|0|||
19770262|NCT03214367|42223816|FG000|Treatment Period|Physician Decision|0|||
19770263|NCT03214367|42223817|FG001|Treatment Period|Physician Decision|1|||
19770264|NCT03214367|42223818|FG002|Treatment Period|Physician Decision|2|||
19770265|NCT03214367|42223819|FG003|Treatment Period|Physician Decision|0|||
19770266|NCT03214367|42223820|FG004|Treatment Period|Physician Decision|0|||
19770267|NCT03214367|42223821|FG005|Treatment Period|Physician Decision|0|||
19770268|NCT03214367|42223822|FG006|Treatment Period|Physician Decision|0|||
19770269|NCT03214367|42223823|FG007|Treatment Period|Physician Decision|0|||
19770270|NCT03214367|42223816|FG000|Treatment Period|Protocol Violation|0|||
19770271|NCT03214367|42223817|FG001|Treatment Period|Protocol Violation|3|||
19770272|NCT03214367|42223818|FG002|Treatment Period|Protocol Violation|0|||
19770273|NCT03214367|42223819|FG003|Treatment Period|Protocol Violation|0|||
19770274|NCT03214367|42223820|FG004|Treatment Period|Protocol Violation|0|||
19770275|NCT03214367|42223821|FG005|Treatment Period|Protocol Violation|0|||
19687794|NCT00267969|42133987|FG003|After Controlled Period|Adverse Event|7|||
19687795|NCT00267969|42133988|FG004|After Controlled Period|Adverse Event|8|||
19687796|NCT00267969|42133989|FG005|After Controlled Period|Adverse Event|23|||
19687797|NCT00267969|42133990|FG006|After Controlled Period|Adverse Event|21|||
19687798|NCT00267969|42133984|FG000|After Controlled Period|Death|0|||
19687799|NCT00267969|42133985|FG001|After Controlled Period|Death|0|||
19687800|NCT00267969|42133986|FG002|After Controlled Period|Death|0|||
19687801|NCT00267969|42133987|FG003|After Controlled Period|Death|1|||
19687802|NCT00267969|42133988|FG004|After Controlled Period|Death|2|||
19687803|NCT00267969|42133989|FG005|After Controlled Period|Death|0|||
19687804|NCT00267969|42133990|FG006|After Controlled Period|Death|1|||
19687805|NCT00267969|42133984|FG000|After Controlled Period|Lack of Efficacy|0|||
19687806|NCT00267969|42133985|FG001|After Controlled Period|Lack of Efficacy|0|||
19687807|NCT00267969|42133986|FG002|After Controlled Period|Lack of Efficacy|0|||
19770276|NCT03214367|42223822|FG006|Treatment Period|Protocol Violation|0|||
19770277|NCT03214367|42223823|FG007|Treatment Period|Protocol Violation|0|||
19770278|NCT03214367|42223816|FG000|Treatment Period|Withdrawal by Subject|0|||
19687808|NCT00267969|42133987|FG003|After Controlled Period|Lack of Efficacy|10|||
19687809|NCT00267969|42133988|FG004|After Controlled Period|Lack of Efficacy|6|||
19687810|NCT00267969|42133989|FG005|After Controlled Period|Lack of Efficacy|28|||
19770279|NCT03214367|42223817|FG001|Treatment Period|Withdrawal by Subject|20|||
19687811|NCT00267969|42133990|FG006|After Controlled Period|Lack of Efficacy|15|||
19687812|NCT00267969|42133984|FG000|After Controlled Period|Lost to Follow-up|0|||
19687813|NCT00267969|42133985|FG001|After Controlled Period|Lost to Follow-up|0|||
19687814|NCT00267969|42133986|FG002|After Controlled Period|Lost to Follow-up|0|||
19687815|NCT00267969|42133987|FG003|After Controlled Period|Lost to Follow-up|5|||
19687816|NCT00267969|42133988|FG004|After Controlled Period|Lost to Follow-up|8|||
19687817|NCT00267969|42133989|FG005|After Controlled Period|Lost to Follow-up|9|||
19687818|NCT00267969|42133990|FG006|After Controlled Period|Lost to Follow-up|10|||
19687819|NCT00267969|42133984|FG000|After Controlled Period|Other|0|||
19687820|NCT00267969|42133985|FG001|After Controlled Period|Other|0|||
19687821|NCT00267969|42133986|FG002|After Controlled Period|Other|0|||
19687822|NCT00267969|42133987|FG003|After Controlled Period|Other|13|||
19687823|NCT00267969|42133988|FG004|After Controlled Period|Other|11|||
19687824|NCT00267969|42133989|FG005|After Controlled Period|Other|22|||
19687825|NCT00267969|42133990|FG006|After Controlled Period|Other|25|||
19687826|NCT00280293|42134010|FG000|Overall Study|Protocol Violation|3|||
19687827|NCT00280293|42134011|FG001|Overall Study|Protocol Violation|0|||
19687828|NCT00280293|42134010|FG000|Overall Study|Physician Decision|5|||
19687829|NCT00280293|42134011|FG001|Overall Study|Physician Decision|4|||
19687830|NCT00280293|42134010|FG000|Overall Study|Lost to Follow-up|14|||
19687831|NCT00280293|42134011|FG001|Overall Study|Lost to Follow-up|12|||
19687832|NCT00280293|42134010|FG000|Overall Study|Withdrawal by Subject|3|||
19687833|NCT00280293|42134011|FG001|Overall Study|Withdrawal by Subject|5|||
19687834|NCT00280293|42134010|FG000|Overall Study|Incarceration/Legal Reasons|1|||
19687835|NCT00280293|42134011|FG001|Overall Study|Incarceration/Legal Reasons|1|||
19687836|NCT00280293|42134010|FG000|Overall Study|Adverse Event|0|||
19687837|NCT00280293|42134011|FG001|Overall Study|Adverse Event|1|||
19699019|NCT03824912|42143818|FG000|Overall Study|Withdrawal by Subject|3|||
19699020|NCT03824912|42143819|FG001|Overall Study|Withdrawal by Subject|2|||
19699021|NCT03824912|42143820|FG002|Overall Study|Withdrawal by Subject|1|||
19699022|NCT03824912|42143818|FG000|Overall Study|Participation in another study|0|||
19699023|NCT03824912|42143819|FG001|Overall Study|Participation in another study|1|||
19699024|NCT03824912|42143820|FG002|Overall Study|Participation in another study|0|||
19699025|NCT00461123|42143830|FG000|Overall Study|Adverse Event|1|||
19699026|NCT00461123|42143831|FG001|Overall Study|Adverse Event|0|||
19699027|NCT00461123|42143830|FG000|Overall Study|Lost to Follow-up|1|||
19699028|NCT00461123|42143831|FG001|Overall Study|Lost to Follow-up|1|||
19699029|NCT00461123|42143830|FG000|Overall Study|Protocol Violation|3|||
19699030|NCT00461123|42143831|FG001|Overall Study|Protocol Violation|2|||
19699031|NCT00461123|42143830|FG000|Overall Study|Withdrawal by Subject|1|||
19699032|NCT00461123|42143831|FG001|Overall Study|Withdrawal by Subject|3|||
19699033|NCT00290342|42143839|FG000|Overall Study|Other|0|||
19699034|NCT00290342|42143840|FG001|Overall Study|Other|1|||
19699035|NCT00290342|42143839|FG000|Overall Study|Withdrawal by Subject|6|||
19699036|NCT00290342|42143840|FG001|Overall Study|Withdrawal by Subject|4|||
19699037|NCT00290342|42143839|FG000|Overall Study|Lost to Follow-up|1|||
19699038|NCT00290342|42143840|FG001|Overall Study|Lost to Follow-up|0|||
19699039|NCT00460811|42143851|FG000|Overall Study|Adverse Event|4|||
19699040|NCT00460811|42143852|FG001|Overall Study|Adverse Event|6|||
19699041|NCT00460811|42143853|FG002|Overall Study|Adverse Event|3|||
19699042|NCT00460811|42143854|FG003|Overall Study|Adverse Event|10|||
19699043|NCT00460811|42143855|FG004|Overall Study|Adverse Event|2|||
19699044|NCT00460811|42143851|FG000|Overall Study|Noncompliance|1|||
19699045|NCT00460811|42143852|FG001|Overall Study|Noncompliance|0|||
19699046|NCT00460811|42143853|FG002|Overall Study|Noncompliance|0|||
19699047|NCT00460811|42143854|FG003|Overall Study|Noncompliance|2|||
19699048|NCT00460811|42143855|FG004|Overall Study|Noncompliance|1|||
19699049|NCT00460811|42143851|FG000|Overall Study|Withdrawal by Subject|7|||
19699050|NCT00460811|42143852|FG001|Overall Study|Withdrawal by Subject|7|||
19699051|NCT00460811|42143853|FG002|Overall Study|Withdrawal by Subject|6|||
19699052|NCT00460811|42143854|FG003|Overall Study|Withdrawal by Subject|3|||
19699053|NCT00460811|42143855|FG004|Overall Study|Withdrawal by Subject|11|||
19699054|NCT00460811|42143851|FG000|Overall Study|Physician Decision|1|||
19699055|NCT00460811|42143852|FG001|Overall Study|Physician Decision|0|||
19699056|NCT00460811|42143853|FG002|Overall Study|Physician Decision|0|||
19699057|NCT00460811|42143854|FG003|Overall Study|Physician Decision|0|||
19699058|NCT00460811|42143855|FG004|Overall Study|Physician Decision|0|||
19699059|NCT00460811|42143851|FG000|Overall Study|Lost to Follow-up|3|||
19699060|NCT00460811|42143852|FG001|Overall Study|Lost to Follow-up|2|||
19770280|NCT03214367|42223818|FG002|Treatment Period|Withdrawal by Subject|23|||
19770281|NCT03214367|42223819|FG003|Treatment Period|Withdrawal by Subject|14|||
19699061|NCT00460811|42143853|FG002|Overall Study|Lost to Follow-up|5|||
19699062|NCT00460811|42143854|FG003|Overall Study|Lost to Follow-up|3|||
19699063|NCT00460811|42143855|FG004|Overall Study|Lost to Follow-up|6|||
19699064|NCT00290186|42143874|FG000|Overall Study|Adverse Event|1|||
19699065|NCT00290186|42143875|FG001|Overall Study|Adverse Event|1|||
19770282|NCT03214367|42223820|FG004|Treatment Period|Withdrawal by Subject|0|||
19770283|NCT03214367|42223821|FG005|Treatment Period|Withdrawal by Subject|1|||
19699066|NCT00290186|42143874|FG000|Overall Study|Lost to Follow-up|3|||
19770284|NCT03214367|42223822|FG006|Treatment Period|Withdrawal by Subject|1|||
19687838|NCT00421148|42134037|FG000|Overall Study|Lost to Follow-up|0|||
19687839|NCT00421148|42134038|FG001|Overall Study|Lost to Follow-up|0|||
19687840|NCT00421148|42134039|FG002|Overall Study|Lost to Follow-up|0|||
19687841|NCT00421148|42134040|FG003|Overall Study|Lost to Follow-up|0|||
19687842|NCT00421148|42134041|FG004|Overall Study|Lost to Follow-up|0|||
19687843|NCT00421148|42134042|FG005|Overall Study|Lost to Follow-up|0|||
19687844|NCT00421148|42134043|FG006|Overall Study|Lost to Follow-up|0|||
19687845|NCT00421148|42134044|FG007|Overall Study|Lost to Follow-up|0|||
19687846|NCT00421148|42134045|FG008|Overall Study|Lost to Follow-up|0|||
19687847|NCT00421148|42134046|FG009|Overall Study|Lost to Follow-up|0|||
19687848|NCT00421148|42134047|FG010|Overall Study|Lost to Follow-up|0|||
19687849|NCT00421148|42134048|FG011|Overall Study|Lost to Follow-up|0|||
19687850|NCT00421148|42134049|FG012|Overall Study|Lost to Follow-up|0|||
19687851|NCT00421148|42134050|FG013|Overall Study|Lost to Follow-up|0|||
19687852|NCT00421148|42134051|FG014|Overall Study|Lost to Follow-up|0|||
19687853|NCT00421148|42134052|FG015|Overall Study|Lost to Follow-up|0|||
19687854|NCT00421148|42134053|FG016|Overall Study|Lost to Follow-up|0|||
19687855|NCT00421148|42134054|FG017|Overall Study|Lost to Follow-up|1|||
19477632|NCT01462435|41756913|FG002|Overall Study|Withdrawal by Subject|0|||
19687856|NCT00421148|42134055|FG018|Overall Study|Lost to Follow-up|0|||
19687857|NCT00421148|42134056|FG019|Overall Study|Lost to Follow-up|0|||
19687858|NCT00421148|42134037|FG000|Overall Study|Withdrawal by Subject|0|||
19687859|NCT00421148|42134038|FG001|Overall Study|Withdrawal by Subject|0|||
19687860|NCT00421148|42134039|FG002|Overall Study|Withdrawal by Subject|0|||
19687861|NCT00421148|42134040|FG003|Overall Study|Withdrawal by Subject|0|||
19687862|NCT00421148|42134041|FG004|Overall Study|Withdrawal by Subject|0|||
19687863|NCT00421148|42134042|FG005|Overall Study|Withdrawal by Subject|0|||
19687864|NCT00421148|42134043|FG006|Overall Study|Withdrawal by Subject|0|||
19687865|NCT00421148|42134044|FG007|Overall Study|Withdrawal by Subject|0|||
19687866|NCT00421148|42134045|FG008|Overall Study|Withdrawal by Subject|0|||
19687867|NCT00421148|42134046|FG009|Overall Study|Withdrawal by Subject|0|||
19687868|NCT00421148|42134047|FG010|Overall Study|Withdrawal by Subject|0|||
19687869|NCT00421148|42134048|FG011|Overall Study|Withdrawal by Subject|0|||
19687870|NCT00421148|42134049|FG012|Overall Study|Withdrawal by Subject|0|||
19687871|NCT00421148|42134050|FG013|Overall Study|Withdrawal by Subject|0|||
19687872|NCT00421148|42134051|FG014|Overall Study|Withdrawal by Subject|0|||
19687873|NCT00421148|42134052|FG015|Overall Study|Withdrawal by Subject|0|||
19687874|NCT00421148|42134053|FG016|Overall Study|Withdrawal by Subject|0|||
19687875|NCT00421148|42134054|FG017|Overall Study|Withdrawal by Subject|1|||
19687876|NCT00421148|42134055|FG018|Overall Study|Withdrawal by Subject|0|||
19687877|NCT00421148|42134056|FG019|Overall Study|Withdrawal by Subject|0|||
19687878|NCT00421148|42134037|FG000|Overall Study|Protocol Violation|0|||
19687879|NCT00421148|42134038|FG001|Overall Study|Protocol Violation|0|||
19687880|NCT00421148|42134039|FG002|Overall Study|Protocol Violation|0|||
19687881|NCT00421148|42134040|FG003|Overall Study|Protocol Violation|0|||
19687882|NCT00421148|42134041|FG004|Overall Study|Protocol Violation|0|||
19687883|NCT00421148|42134042|FG005|Overall Study|Protocol Violation|1|||
19687884|NCT00421148|42134043|FG006|Overall Study|Protocol Violation|0|||
19687885|NCT00421148|42134044|FG007|Overall Study|Protocol Violation|0|||
19687886|NCT00421148|42134045|FG008|Overall Study|Protocol Violation|0|||
19605653|NCT00687193|42054359|FG001|Overall Study|Protocol Violation|2|||
19605654|NCT00687193|42054360|FG002|Overall Study|Protocol Violation|0|||
19605655|NCT00687193|42054361|FG003|Overall Study|Protocol Violation|1|||
19605656|NCT00687193|42054362|FG004|Overall Study|Protocol Violation|2|||
19605657|NCT00687193|42054363|FG005|Overall Study|Protocol Violation|0|||
19605658|NCT00730912|42054383|FG000|Overall Study|Discontinued|0|||
19605659|NCT00730912|42054384|FG001|Overall Study|Discontinued|0|||
19605660|NCT00730912|42054385|FG002|Overall Study|Discontinued|1|||
19605661|NCT00737698|42054396|FG000|Overall Study|Withdrawal by Subject|6|||
19605662|NCT00737698|42054397|FG001|Overall Study|Withdrawal by Subject|5|||
19605663|NCT00737698|42054398|FG002|Overall Study|Withdrawal by Subject|3|||
19605664|NCT00737698|42054396|FG000|Overall Study|Death|0|||
19605665|NCT00737698|42054397|FG001|Overall Study|Death|0|||
19605666|NCT00737698|42054398|FG002|Overall Study|Death|1|||
19605667|NCT00730756|42054408|FG000|Overall Study|Adverse Event|2|||
19687887|NCT00421148|42134046|FG009|Overall Study|Protocol Violation|0|||
19687888|NCT00421148|42134047|FG010|Overall Study|Protocol Violation|0|||
19687889|NCT00421148|42134048|FG011|Overall Study|Protocol Violation|0|||
19687890|NCT00421148|42134049|FG012|Overall Study|Protocol Violation|0|||
19687891|NCT00421148|42134050|FG013|Overall Study|Protocol Violation|0|||
19687892|NCT00421148|42134051|FG014|Overall Study|Protocol Violation|0|||
19687893|NCT00421148|42134052|FG015|Overall Study|Protocol Violation|0|||
19605668|NCT00730756|42054409|FG001|Overall Study|Adverse Event|0|||
19605669|NCT00730756|42054408|FG000|Overall Study|Lack of Efficacy|1|||
19605670|NCT00730756|42054409|FG001|Overall Study|Lack of Efficacy|1|||
19687894|NCT00421148|42134053|FG016|Overall Study|Protocol Violation|0|||
19605671|NCT00730756|42054408|FG000|Overall Study|Protocol Deviation|1|||
19687895|NCT00421148|42134054|FG017|Overall Study|Protocol Violation|0|||
19687896|NCT00421148|42134055|FG018|Overall Study|Protocol Violation|1|||
19687897|NCT00421148|42134056|FG019|Overall Study|Protocol Violation|0|||
19687898|NCT00403754|42134098|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
19770285|NCT03214367|42223823|FG007|Treatment Period|Withdrawal by Subject|1|||
19770286|NCT02994108|42223839|FG000|Intervention Messages|Withdrawal by Subject|2|||
19770287|NCT02994108|42223840|FG001|Intervention Messages|Withdrawal by Subject|0|||
19770288|NCT02994108|42223839|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
19770289|NCT02994108|42223840|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
19770290|NCT02994108|42223839|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
19770291|NCT02994108|42223840|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
19770292|NCT02994108|42223839|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
19770293|NCT02994108|42223840|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
19770294|NCT03231371|42223847|FG000|Overall Study|Withdrawal by Subject|1|||
19770295|NCT03231371|42223847|FG000|Overall Study|chose or were ineligible to have MRI|12|||
19770296|NCT02870348|42223851|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
19770297|NCT03239873|42223857|FG000|Overall Study|Lost to Follow-up|15|||
19770298|NCT03239873|42223858|FG001|Overall Study|Lost to Follow-up|16|||
19770299|NCT03239873|42223857|FG000|Overall Study|Physician Decision|1|||
19770300|NCT03239873|42223858|FG001|Overall Study|Physician Decision|0|||
19770301|NCT03239873|42223857|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
19770302|NCT03239873|42223858|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
19770303|NCT03239873|42223857|FG000|Overall Study|Withdrawal by Subject|2|||
19770304|NCT03239873|42223858|FG001|Overall Study|Withdrawal by Subject|0|||
19770305|NCT03239873|42223857|FG000|Overall Study|Contraindication to study medication|1|||
19770306|NCT03239873|42223858|FG001|Overall Study|Contraindication to study medication|0|||
19770307|NCT03239873|42223857|FG000|Overall Study|Protocol Violation|1|||
19770308|NCT03239873|42223858|FG001|Overall Study|Protocol Violation|0|||
19770309|NCT03213509|42223866|FG000|Overall Study|Did not consent for verbal autopsy|4|||
19770310|NCT03213509|42223867|FG001|Overall Study|Did not consent for verbal autopsy|5|||
19687899|NCT00403754|42134099|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
19687900|NCT00403754|42134100|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
19687901|NCT00403754|42134101|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
19687902|NCT00403754|42134098|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
19687903|NCT00403754|42134099|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
19687904|NCT00403754|42134100|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
19687905|NCT00403754|42134101|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
19687906|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Death|2|||
19687907|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Death|0|||
19687908|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Adverse Event|33|||
19687909|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Adverse Event|31|||
19687910|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
19687911|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
19687912|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
19687913|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
19687914|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
19687915|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
19687916|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Other|7|||
19687917|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Other|8|||
19687918|NCT00280059|42134115|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
19687919|NCT00280059|42134116|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
19687920|NCT00403130|42134130|FG000|2 Years From Start of Treatment|Not Eligible|3|||
19687921|NCT00403130|42134130|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
19687922|NCT00403130|42134130|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
19687923|NCT00403130|42134130|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
19687924|NCT00402740|42134134|FG000|Overall Study|Withdrawal by Subject|18|||
19687925|NCT00402740|42134134|FG000|Overall Study|Death|50|||
19687926|NCT00402740|42134134|FG000|Overall Study|Lost to Follow-up|6|||
19687927|NCT00402740|42134134|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
19687928|NCT00402740|42134134|FG000|Overall Study|Subject disposition unknown.|1|||
19687929|NCT00420290|42134144|FG000|Overall Study|Adverse Event|3|||
19687930|NCT00420290|42134145|FG001|Overall Study|Adverse Event|1|||
19687931|NCT00420290|42134144|FG000|Overall Study|Withdrawal by Subject|0|||
19687932|NCT00420290|42134145|FG001|Overall Study|Withdrawal by Subject|2|||
19770311|NCT03239483|42223876|FG000|Overall Study|Lost to Follow-up|1|||
19770312|NCT03239483|42223877|FG001|Overall Study|Lost to Follow-up|0|||
19770313|NCT03239483|42223876|FG000|Overall Study|Withdrawal by Subject|1|||
19770314|NCT03239483|42223877|FG001|Overall Study|Withdrawal by Subject|0|||
19770315|NCT02868554|42223886|FG000|Overall Study|Lost to Follow-up|3|||
19770316|NCT02868554|42223887|FG001|Overall Study|Lost to Follow-up|0|||
19389137|NCT02663687|41632709|FG003|Overall Study|Adverse Event|0|||
19687933|NCT00420290|42134144|FG000|Overall Study|did not meet inclusion/exclusion|1|||
19687934|NCT00420290|42134145|FG001|Overall Study|did not meet inclusion/exclusion|1|||
19687935|NCT00267189|42134153|FG000|Overall Study|Patient withdrew consent|1|||
19687936|NCT00267189|42134154|FG001|Overall Study|Patient withdrew consent|1|||
19687937|NCT00267189|42134153|FG000|Overall Study|Death|1|||
19687938|NCT00267189|42134154|FG001|Overall Study|Death|0|||
19687939|NCT00267189|42134153|FG000|Overall Study|Missing|3|||
19687940|NCT00267189|42134154|FG001|Overall Study|Missing|0|||
19687941|NCT03834350|42134160|FG000|Overall Study|Withdrawal by Subject|1|||
19687942|NCT00402116|42134168|FG000|Overall Study|Jaw infection after surgery-other|1|||
19687943|NCT00402116|42134169|FG001|Overall Study|Jaw infection after surgery-other|0|||
19687944|NCT00402116|42134170|FG002|Overall Study|Jaw infection after surgery-other|0|||
19770317|NCT02868554|42223888|FG002|Overall Study|Lost to Follow-up|1|||
19770318|NCT01068912|42223899|FG000|Overall Study|Adverse Event|2|||
19770319|NCT01068912|42223900|FG001|Overall Study|Adverse Event|3|||
19770320|NCT01068912|42223901|FG002|Overall Study|Adverse Event|2|||
19770321|NCT01068912|42223899|FG000|Overall Study|Withdrawal by Subject|5|||
19770322|NCT01068912|42223900|FG001|Overall Study|Withdrawal by Subject|6|||
19770323|NCT01068912|42223901|FG002|Overall Study|Withdrawal by Subject|6|||
19770324|NCT01068912|42223899|FG000|Overall Study|Lost to Follow-up|3|||
19770325|NCT01068912|42223900|FG001|Overall Study|Lost to Follow-up|7|||
19770326|NCT01068912|42223901|FG002|Overall Study|Lost to Follow-up|3|||
19770327|NCT01068912|42223899|FG000|Overall Study|Protocol Violation|0|||
19770328|NCT01068912|42223900|FG001|Overall Study|Protocol Violation|2|||
19770329|NCT01068912|42223901|FG002|Overall Study|Protocol Violation|0|||
19770330|NCT01068912|42223899|FG000|Overall Study|aggravation influenza|1|||
19770331|NCT01068912|42223900|FG001|Overall Study|aggravation influenza|1|||
19770332|NCT01068912|42223901|FG002|Overall Study|aggravation influenza|1|||
19770333|NCT01068912|42223899|FG000|Overall Study|other underlying illness|0|||
19770334|NCT01068912|42223900|FG001|Overall Study|other underlying illness|3|||
19770335|NCT01068912|42223901|FG002|Overall Study|other underlying illness|3|||
19770336|NCT03229109|42223913|FG000|Overall Study|Withdrawal by Subject|0|||
19770337|NCT03229109|42223914|FG001|Overall Study|Withdrawal by Subject|0|||
19770338|NCT03229109|42223915|FG002|Overall Study|Withdrawal by Subject|0|||
19770339|NCT03229109|42223916|FG003|Overall Study|Withdrawal by Subject|1|||
19770340|NCT03212261|42223926|FG000|Overall Study|Became ineligible d/t tech|2|||
19770341|NCT03212261|42223926|FG000|Overall Study|Tech Trouble- No first study visit|1|||
19770342|NCT03212261|42223926|FG000|Overall Study|Lost to Follow-up|7|||
19770343|NCT03212261|42223926|FG000|Overall Study|Family Emergency|1|||
19687945|NCT00402116|42134168|FG000|Overall Study|Withdrawal by Subject|1|||
19687946|NCT00402116|42134169|FG001|Overall Study|Withdrawal by Subject|0|||
19687947|NCT00402116|42134170|FG002|Overall Study|Withdrawal by Subject|5|||
19687948|NCT00402116|42134168|FG000|Overall Study|Treatment completed per protocol|1|||
19687949|NCT00402116|42134169|FG001|Overall Study|Treatment completed per protocol|1|||
19687950|NCT00402116|42134170|FG002|Overall Study|Treatment completed per protocol|2|||
19687951|NCT00402116|42134168|FG000|Overall Study|other complicating disease|0|||
19687952|NCT00402116|42134169|FG001|Overall Study|other complicating disease|0|||
19687953|NCT00402116|42134170|FG002|Overall Study|other complicating disease|2|||
19687954|NCT00402116|42134168|FG000|Overall Study|Disease Progression|0|||
19687955|NCT00402116|42134169|FG001|Overall Study|Disease Progression|4|||
19687956|NCT00402116|42134170|FG002|Overall Study|Disease Progression|38|||
19687957|NCT00402116|42134168|FG000|Overall Study|mistaken thrombocytopenia|0|||
19687958|NCT00402116|42134169|FG001|Overall Study|mistaken thrombocytopenia|0|||
19687959|NCT00402116|42134170|FG002|Overall Study|mistaken thrombocytopenia|1|||
19687960|NCT00402116|42134168|FG000|Overall Study|decline related hyponatremia/tumor|0|||
19687961|NCT00402116|42134169|FG001|Overall Study|decline related hyponatremia/tumor|0|||
19687962|NCT00402116|42134170|FG002|Overall Study|decline related hyponatremia/tumor|1|||
19687963|NCT00402116|42134168|FG000|Overall Study|Adverse Event|0|||
19687964|NCT00402116|42134169|FG001|Overall Study|Adverse Event|1|||
19687965|NCT00402116|42134170|FG002|Overall Study|Adverse Event|6|||
19687966|NCT00401960|42134200|FG000|Overall Study|Lost to Follow-up|3|||
19687967|NCT00401960|42134201|FG001|Overall Study|Lost to Follow-up|0|||
19687968|NCT00401960|42134200|FG000|Overall Study|Death|2|||
19770344|NCT03212261|42223926|FG000|Overall Study|Too busy/ No time|5|||
19770345|NCT02993250|42223933|FG000|Overall Study|Lost to Follow-up|0|||
19687969|NCT00401960|42134201|FG001|Overall Study|Death|0|||
19687970|NCT00401726|42134211|FG000|Overall Study|Adverse Event|34|||
19687971|NCT00401726|42134212|FG001|Overall Study|Adverse Event|45|||
19687972|NCT00401726|42134211|FG000|Overall Study|Death|0|||
19687973|NCT00401726|42134212|FG001|Overall Study|Death|3|||
19687974|NCT00401726|42134211|FG000|Overall Study|Sponsor Request|0|||
19770346|NCT02993250|42223934|FG001|Overall Study|Lost to Follow-up|1|||
19770347|NCT02989194|42223943|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
19770348|NCT02989194|42223944|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
19770349|NCT02989194|42223945|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
19770350|NCT02989194|42223943|FG000|Overall Study|Lost to Follow-up|0|||
19770351|NCT02989194|42223944|FG001|Overall Study|Lost to Follow-up|1|||
19770352|NCT02989194|42223945|FG002|Overall Study|Lost to Follow-up|0|||
19770353|NCT02989194|42223943|FG000|Overall Study|Withdrawal by Subject|0|||
19770354|NCT02989194|42223944|FG001|Overall Study|Withdrawal by Subject|1|||
19770355|NCT02989194|42223945|FG002|Overall Study|Withdrawal by Subject|0|||
19770356|NCT02990910|42223966|FG000|Overall Study|Lack of Efficacy|6|||
19770357|NCT02990910|42223967|FG001|Overall Study|Lack of Efficacy|10|||
19770358|NCT03227861|42223973|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
19770359|NCT03227861|42223973|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
19770360|NCT03227861|42223973|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
19770361|NCT03227861|42223973|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
19770362|NCT03227861|42223973|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
19770363|NCT03227861|42223973|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
19770364|NCT03227861|42223973|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
19770365|NCT03227861|42223973|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
19770366|NCT03227861|42223973|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
19770367|NCT03227861|42223973|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
19770368|NCT01336712|42223979|FG000|Overall Study|Death|2|||
19770369|NCT01336712|42223979|FG000|Overall Study|Lack of Efficacy|1|||
19770370|NCT03208127|42223983|FG000|Overall Study|Death|1|||
19770371|NCT02865122|42223990|FG000|Overall Study|Adverse Event|1|||
19687975|NCT00401726|42134212|FG001|Overall Study|Sponsor Request|1|||
19687976|NCT00401726|42134211|FG000|Overall Study|Physician Decision|3|||
19687977|NCT00401726|42134212|FG001|Overall Study|Physician Decision|6|||
19687978|NCT00401726|42134211|FG000|Overall Study|Lost to Follow-up|23|||
19687979|NCT00401726|42134212|FG001|Overall Study|Lost to Follow-up|20|||
19687980|NCT00401726|42134211|FG000|Overall Study|Protocol Violation|6|||
19687981|NCT00401726|42134212|FG001|Overall Study|Protocol Violation|3|||
19687982|NCT00401726|42134211|FG000|Overall Study|Withdrawal by Subject|18|||
19687983|NCT00401726|42134212|FG001|Overall Study|Withdrawal by Subject|24|||
19770372|NCT02865122|42223991|FG001|Overall Study|Adverse Event|0|||
19770373|NCT02865122|42223992|FG002|Overall Study|Adverse Event|0|||
19687984|NCT00401726|42134211|FG000|Overall Study|Lack of Efficacy|4|||
19687985|NCT00401726|42134212|FG001|Overall Study|Lack of Efficacy|6|||
19687986|NCT00401726|42134211|FG000|Overall Study|Protocol Deviation|9|||
19687987|NCT00401726|42134212|FG001|Overall Study|Protocol Deviation|4|||
19687988|NCT00371826|42134221|FG000|Core Phase (12 Months)|Adverse Event|15|||
19687989|NCT00371826|42134222|FG001|Core Phase (12 Months)|Adverse Event|4|||
19687990|NCT00371826|42134223|FG002|Core Phase (12 Months)|Adverse Event|9|||
19687991|NCT00371826|42134221|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
19687992|NCT00371826|42134222|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
19687993|NCT00371826|42134223|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
19687994|NCT00371826|42134221|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
19687995|NCT00371826|42134222|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
19687996|NCT00371826|42134223|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
19687997|NCT00371826|42134221|FG000|Core Phase (12 Months)|Protocol Violation|1|||
19770374|NCT02864498|42224003|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
19770375|NCT02864498|42224004|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
19770376|NCT02864498|42224005|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
19770377|NCT02864498|42224003|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
19687998|NCT00371826|42134222|FG001|Core Phase (12 Months)|Protocol Violation|0|||
19770378|NCT02864498|42224004|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
19770379|NCT02864498|42224005|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
19770380|NCT02864498|42224003|FG000|Overall Study|Investigator Discretion|0|||
19770381|NCT02864498|42224004|FG001|Overall Study|Investigator Discretion|2|||
19770382|NCT02864498|42224005|FG002|Overall Study|Investigator Discretion|1|||
19770383|NCT02864498|42224003|FG000|Overall Study|Lost to Follow-up|8|||
19770384|NCT02864498|42224004|FG001|Overall Study|Lost to Follow-up|6|||
19770385|NCT02864498|42224005|FG002|Overall Study|Lost to Follow-up|3|||
19770386|NCT02864498|42224003|FG000|Overall Study|Lack of Efficacy|5|||
19770387|NCT02864498|42224004|FG001|Overall Study|Lack of Efficacy|3|||
19770388|NCT02864498|42224005|FG002|Overall Study|Lack of Efficacy|3|||
19770389|NCT02864498|42224003|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
19605672|NCT00730756|42054409|FG001|Overall Study|Protocol Deviation|2|||
19687999|NCT00371826|42134223|FG002|Core Phase (12 Months)|Protocol Violation|1|||
19770390|NCT02864498|42224004|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
19770391|NCT02864498|42224005|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
19770392|NCT02864498|42224003|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
19770393|NCT02864498|42224004|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
19770394|NCT02864498|42224005|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
19688000|NCT00371826|42134221|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
19688001|NCT00371826|42134222|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
19770395|NCT02864498|42224003|FG000|Overall Study|Subject moved out of the country.|0|||
19770396|NCT02864498|42224004|FG001|Overall Study|Subject moved out of the country.|0|||
19770397|NCT02864498|42224005|FG002|Overall Study|Subject moved out of the country.|1|||
19688002|NCT00371826|42134223|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
19688003|NCT00371826|42134221|FG000|Core Phase (12 Months)|Administrative problems|1|||
19688004|NCT00371826|42134222|FG001|Core Phase (12 Months)|Administrative problems|0|||
19688005|NCT00371826|42134223|FG002|Core Phase (12 Months)|Administrative problems|8|||
19688006|NCT00371826|42134221|FG000|Core Phase (12 Months)|Graft Loss|0|||
19688007|NCT00371826|42134222|FG001|Core Phase (12 Months)|Graft Loss|1|||
19688008|NCT00371826|42134223|FG002|Core Phase (12 Months)|Graft Loss|0|||
19688009|NCT00371826|42134221|FG000|Extension Phase (24 Months)|Adverse Event|4|||
19688010|NCT00371826|42134222|FG001|Extension Phase (24 Months)|Adverse Event|5|||
19688011|NCT00371826|42134223|FG002|Extension Phase (24 Months)|Adverse Event|0|||
19688012|NCT00371826|42134221|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
19688013|NCT00371826|42134222|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
19688014|NCT00371826|42134223|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
19688015|NCT00371826|42134221|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
19688016|NCT00371826|42134222|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
19688017|NCT00371826|42134223|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
19688018|NCT00371826|42134221|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
19688019|NCT00371826|42134222|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
19688020|NCT00371826|42134223|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
19688021|NCT00371826|42134221|FG000|Extension Phase (24 Months)|Administrative problems|0|||
19688022|NCT00371826|42134222|FG001|Extension Phase (24 Months)|Administrative problems|0|||
19688023|NCT00371826|42134223|FG002|Extension Phase (24 Months)|Administrative problems|2|||
19688024|NCT00396084|42134237|FG000|Overall Study|Adverse Event|0|||
19688025|NCT00396084|42134238|FG001|Overall Study|Adverse Event|0|||
19688026|NCT00396084|42134239|FG002|Overall Study|Adverse Event|0|||
19688027|NCT00396084|42134240|FG003|Overall Study|Adverse Event|0|||
19688028|NCT00396084|42134241|FG004|Overall Study|Adverse Event|1|||
19688029|NCT00396084|42134242|FG005|Overall Study|Adverse Event|2|||
19688030|NCT00396084|42134237|FG000|Overall Study|Withdrawal by Subject|0|||
19688031|NCT00396084|42134238|FG001|Overall Study|Withdrawal by Subject|0|||
19688032|NCT00396084|42134239|FG002|Overall Study|Withdrawal by Subject|0|||
19688033|NCT00396084|42134240|FG003|Overall Study|Withdrawal by Subject|1|||
19688034|NCT00396084|42134241|FG004|Overall Study|Withdrawal by Subject|0|||
19688035|NCT00396084|42134242|FG005|Overall Study|Withdrawal by Subject|0|||
19688036|NCT00395850|42134264|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
19688037|NCT00395850|42134265|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
19688038|NCT00395850|42134266|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
19688039|NCT00395850|42134267|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
19688040|NCT00395850|42134264|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
19688041|NCT00395850|42134265|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
19688042|NCT00395850|42134266|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
19688043|NCT00395850|42134267|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
19688044|NCT00395850|42134264|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
19688045|NCT00395850|42134265|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
19688046|NCT00395850|42134266|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
19688047|NCT00395850|42134267|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
19688048|NCT00395850|42134264|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
19688049|NCT00395850|42134265|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
19688050|NCT00395850|42134266|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
19688051|NCT00395850|42134267|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
19688052|NCT00395850|42134264|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
19688053|NCT00395850|42134265|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
19688054|NCT00395850|42134266|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
19688055|NCT00395850|42134267|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
19688056|NCT00395850|42134264|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
19688057|NCT00395850|42134265|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
19688058|NCT00395850|42134266|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
19688059|NCT00395850|42134267|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
19688060|NCT00395850|42134264|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
19688061|NCT00395850|42134265|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
19688062|NCT00395850|42134266|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
19688063|NCT00395850|42134267|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
19688064|NCT00420212|42134280|FG000|Overall Study|Adverse Event|22|||
19688065|NCT00420212|42134281|FG001|Overall Study|Adverse Event|40|||
19688066|NCT00420212|42134282|FG002|Overall Study|Adverse Event|36|||
19688067|NCT00420212|42134280|FG000|Overall Study|Lost to Follow-up|9|||
19688068|NCT00420212|42134281|FG001|Overall Study|Lost to Follow-up|11|||
19688069|NCT00420212|42134282|FG002|Overall Study|Lost to Follow-up|11|||
19688070|NCT00420212|42134280|FG000|Overall Study|Withdrawal by Subject|31|||
19688071|NCT00420212|42134281|FG001|Overall Study|Withdrawal by Subject|22|||
19688072|NCT00420212|42134282|FG002|Overall Study|Withdrawal by Subject|19|||
19688073|NCT00420212|42134280|FG000|Overall Study|Physician Decision|4|||
19688074|NCT00420212|42134281|FG001|Overall Study|Physician Decision|4|||
19688075|NCT00420212|42134282|FG002|Overall Study|Physician Decision|3|||
19688076|NCT00420212|42134280|FG000|Overall Study|Protocol Violation|4|||
19688077|NCT00420212|42134281|FG001|Overall Study|Protocol Violation|4|||
19688078|NCT00420212|42134282|FG002|Overall Study|Protocol Violation|8|||
19688079|NCT00420212|42134280|FG000|Overall Study|Death|0|||
19688080|NCT00420212|42134281|FG001|Overall Study|Death|0|||
19688081|NCT00420212|42134282|FG002|Overall Study|Death|1|||
19688082|NCT00420212|42134280|FG000|Overall Study|Other-Unspecified|21|||
19688083|NCT00420212|42134281|FG001|Overall Study|Other-Unspecified|14|||
19688084|NCT00420212|42134282|FG002|Overall Study|Other-Unspecified|18|||
19688085|NCT00401258|42134293|FG000|Overall Study|Adverse Event|7|||
19688086|NCT00380874|42134299|FG000|Overall Study|Adverse Event|7|||
19688087|NCT00380874|42134300|FG001|Overall Study|Adverse Event|7|||
19688088|NCT00380874|42134299|FG000|Overall Study|Death|1|||
19688089|NCT00380874|42134300|FG001|Overall Study|Death|0|||
19688090|NCT00380874|42134299|FG000|Overall Study|Withdrawal by Subject|2|||
19688091|NCT00380874|42134300|FG001|Overall Study|Withdrawal by Subject|1|||
19688092|NCT00380874|42134299|FG000|Overall Study|Not related to study drug|3|||
19688093|NCT00380874|42134300|FG001|Overall Study|Not related to study drug|2|||
19688094|NCT00420056|42134306|FG000|Overall Study|Objective progression or relapse|17|||
19688095|NCT00411554|42134312|FG000|Overall Study|Adverse Event|2|||
19688096|NCT00411554|42134313|FG001|Overall Study|Adverse Event|4|||
19688097|NCT00411554|42134312|FG000|Overall Study|Lack of Efficacy|2|||
19688098|NCT00411554|42134313|FG001|Overall Study|Lack of Efficacy|5|||
19688099|NCT00411554|42134312|FG000|Overall Study|Withdrawal by Subject|3|||
19688100|NCT00411554|42134313|FG001|Overall Study|Withdrawal by Subject|0|||
19688101|NCT00411554|42134312|FG000|Overall Study|Patient Moved|1|||
19688102|NCT00411554|42134313|FG001|Overall Study|Patient Moved|0|||
19688103|NCT00400712|42134321|FG000|Overall Study|Death|1|||
19688104|NCT00400712|42134322|FG001|Overall Study|Death|0|||
19688105|NCT00400712|42134321|FG000|Overall Study|Withdrawal by Subject|11|||
19688106|NCT00400712|42134322|FG001|Overall Study|Withdrawal by Subject|12|||
19688107|NCT00400712|42134321|FG000|Overall Study|Physician Decision|5|||
19770398|NCT03238781|42224016|FG000|Overall Study|Adverse Event|1|||
19770399|NCT03238781|42224017|FG001|Overall Study|Adverse Event|1|||
19770400|NCT03238781|42224018|FG002|Overall Study|Adverse Event|2|||
19770401|NCT03238781|42224016|FG000|Overall Study|Lost to Follow-up|2|||
19770402|NCT03238781|42224017|FG001|Overall Study|Lost to Follow-up|1|||
19770403|NCT03238781|42224018|FG002|Overall Study|Lost to Follow-up|2|||
19770404|NCT03238781|42224016|FG000|Overall Study|Withdrawal by Subject|23|||
19770405|NCT03238781|42224017|FG001|Overall Study|Withdrawal by Subject|14|||
19770406|NCT03238781|42224018|FG002|Overall Study|Withdrawal by Subject|16|||
19688108|NCT00400712|42134322|FG001|Overall Study|Physician Decision|4|||
19688109|NCT00380718|42134330|FG000|Overall Study|Adverse Event|1|||
19688110|NCT00380718|42134330|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
19688111|NCT00380250|42134336|FG000|Overall Study|Withdrawal by Subject|39|||
19688112|NCT00380250|42134337|FG001|Overall Study|Withdrawal by Subject|28|||
19688113|NCT00380250|42134336|FG000|Overall Study|Adverse Event|20|||
19770407|NCT03238781|42224016|FG000|Overall Study|Decision by sponsor|0|||
19770408|NCT03238781|42224017|FG001|Overall Study|Decision by sponsor|1|||
19770409|NCT03238781|42224018|FG002|Overall Study|Decision by sponsor|0|||
19770410|NCT02097121|42224029|FG000|Overall Study|Other, not specified|4|||
19389138|NCT02663687|41632710|FG004|Overall Study|Adverse Event|0|||
19688114|NCT00380250|42134337|FG001|Overall Study|Adverse Event|9|||
19688115|NCT00380250|42134336|FG000|Overall Study|Lack of Efficacy|10|||
19688116|NCT00380250|42134337|FG001|Overall Study|Lack of Efficacy|8|||
19688117|NCT00380250|42134336|FG000|Overall Study|Protocol Violation|15|||
19688118|NCT00380250|42134337|FG001|Overall Study|Protocol Violation|5|||
19688119|NCT00380250|42134336|FG000|Overall Study|Lost to Follow-up|14|||
19688120|NCT00380250|42134337|FG001|Overall Study|Lost to Follow-up|5|||
19688121|NCT00380250|42134336|FG000|Overall Study|Physician Decision|1|||
19688122|NCT00380250|42134337|FG001|Overall Study|Physician Decision|0|||
19688123|NCT00400400|42134345|FG000|Overall Study|Adverse Event|9|||
19688124|NCT00400400|42134346|FG001|Overall Study|Adverse Event|8|||
19688125|NCT00400400|42134345|FG000|Overall Study|Protocol Violation|2|||
19688126|NCT00400400|42134346|FG001|Overall Study|Protocol Violation|0|||
19688127|NCT00400400|42134345|FG000|Overall Study|Withdrawal by Subject|1|||
19770411|NCT02097121|42224030|FG001|Overall Study|Other, not specified|2|||
19770412|NCT02097121|42224031|FG002|Overall Study|Other, not specified|3|||
19770413|NCT02097121|42224029|FG000|Overall Study|Lack of Efficacy|2|||
19688128|NCT00400400|42134346|FG001|Overall Study|Withdrawal by Subject|3|||
19770414|NCT02097121|42224030|FG001|Overall Study|Lack of Efficacy|1|||
19770415|NCT02097121|42224031|FG002|Overall Study|Lack of Efficacy|3|||
19770416|NCT02097121|42224029|FG000|Overall Study|Withdrawal by Subject|0|||
19770417|NCT02097121|42224030|FG001|Overall Study|Withdrawal by Subject|1|||
19770418|NCT02097121|42224031|FG002|Overall Study|Withdrawal by Subject|2|||
19770419|NCT02097121|42224029|FG000|Overall Study|Adverse Event|0|||
19770420|NCT02097121|42224030|FG001|Overall Study|Adverse Event|1|||
19770421|NCT02097121|42224031|FG002|Overall Study|Adverse Event|0|||
19770422|NCT02097121|42224029|FG000|Overall Study|Lost to Follow-up|1|||
19770423|NCT02097121|42224030|FG001|Overall Study|Lost to Follow-up|1|||
19770424|NCT02097121|42224031|FG002|Overall Study|Lost to Follow-up|2|||
19770425|NCT02747420|42224060|FG000|Overall Study|Lost to Follow-up|4|||
19770426|NCT02747420|42224061|FG001|Overall Study|Lost to Follow-up|2|||
19770427|NCT02747420|42224060|FG000|Overall Study|Withdrawal by Subject|3|||
19770428|NCT02747420|42224061|FG001|Overall Study|Withdrawal by Subject|2|||
19770429|NCT03238001|42224067|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
19770430|NCT03238001|42224067|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
19770431|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
19770432|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
19770433|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
19770434|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
19770435|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
19770436|NCT03238001|42224067|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
19770437|NCT02747108|42224081|FG000|Overall Study|Death|2|||
19770438|NCT02747108|42224082|FG001|Overall Study|Death|2|||
19770439|NCT02747108|42224081|FG000|Overall Study|Withdrawal by Subject|1|||
19770440|NCT02747108|42224082|FG001|Overall Study|Withdrawal by Subject|0|||
19770441|NCT02747108|42224081|FG000|Overall Study|Protocol Violation|2|||
19770442|NCT02747108|42224082|FG001|Overall Study|Protocol Violation|0|||
19688129|NCT00400400|42134345|FG000|Overall Study|Administrative Problem|1|||
19688130|NCT00400400|42134346|FG001|Overall Study|Administrative Problem|0|||
19688131|NCT00400400|42134345|FG000|Overall Study|Lost to Follow-up|0|||
19770443|NCT03226769|42224110|FG000|Overall Study|Withdrawal by Subject|0|||
19770444|NCT03226769|42224111|FG001|Overall Study|Withdrawal by Subject|1|||
19770445|NCT02864342|42224119|FG000|Overall Study|Eligibility Criteria Deviation|2|||
19770446|NCT02864342|42224120|FG001|Overall Study|Eligibility Criteria Deviation|3|||
19770447|NCT02864342|42224119|FG000|Overall Study|Withdrawal by Subject|4|||
19770448|NCT02864342|42224120|FG001|Overall Study|Withdrawal by Subject|2|||
19770449|NCT02864342|42224119|FG000|Overall Study|Device Technology Issue|6|||
19770450|NCT02864342|42224120|FG001|Overall Study|Device Technology Issue|7|||
19770451|NCT02864342|42224119|FG000|Overall Study|Death|0|||
19770452|NCT02864342|42224120|FG001|Overall Study|Death|1|||
19770453|NCT02864342|42224119|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
19770454|NCT02864342|42224120|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
19770455|NCT02864342|42224119|FG000|Overall Study|Lost to Follow-up|1|||
19770456|NCT02864342|42224120|FG001|Overall Study|Lost to Follow-up|5|||
19770457|NCT02864342|42224119|FG000|Overall Study|Lost Device|1|||
19770458|NCT02864342|42224120|FG001|Overall Study|Lost Device|0|||
19770459|NCT02864342|42224119|FG000|Overall Study|Adverse Event|1|||
19770460|NCT02864342|42224120|FG001|Overall Study|Adverse Event|0|||
19770461|NCT03237065|42224129|FG000|Overall Study|Adverse Event|0|||
19770462|NCT03237065|42224130|FG001|Overall Study|Adverse Event|2|||
19770463|NCT03237065|42224129|FG000|Overall Study|Protocol Violation|0|||
19770464|NCT03237065|42224130|FG001|Overall Study|Protocol Violation|1|||
19770465|NCT03237065|42224129|FG000|Overall Study|Withdrawal by Subject|3|||
19770466|NCT03237065|42224130|FG001|Overall Study|Withdrawal by Subject|0|||
19770467|NCT03237065|42224129|FG000|Overall Study|Lost to Follow-up|1|||
19770468|NCT03237065|42224130|FG001|Overall Study|Lost to Follow-up|0|||
19688132|NCT00400400|42134346|FG001|Overall Study|Lost to Follow-up|1|||
19688133|NCT00400400|42134345|FG000|Overall Study|Did not receive study drug|1|||
19688134|NCT00400400|42134346|FG001|Overall Study|Did not receive study drug|3|||
19688135|NCT00395694|42134354|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
19688136|NCT00395694|42134355|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
19688137|NCT00395694|42134354|FG000|Continuation Phase|Adverse Event|1|||
19688138|NCT00395694|42134355|FG001|Continuation Phase|Adverse Event|0|||
19688139|NCT00395694|42134354|FG000|Continuation Phase|Lack of Efficacy|12|||
19688140|NCT00395694|42134355|FG001|Continuation Phase|Lack of Efficacy|11|||
19688141|NCT00395694|42134354|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
19688142|NCT00395694|42134355|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
19688143|NCT00395694|42134354|FG000|Continuation Phase|Poor Compliance|1|||
19770469|NCT03237065|42224129|FG000|Overall Study|Unable to obtain venous access|0|||
19770470|NCT03237065|42224130|FG001|Overall Study|Unable to obtain venous access|1|||
19688144|NCT00395694|42134355|FG001|Continuation Phase|Poor Compliance|0|||
19770471|NCT03171415|42224141|FG000|Overall Study|Lost to Follow-up|0|||
19688145|NCT00395694|42134354|FG000|Continuation Phase|Withdrawal by Subject|0|||
19688146|NCT00395694|42134355|FG001|Continuation Phase|Withdrawal by Subject|2|||
19770472|NCT03171415|42224142|FG001|Overall Study|Lost to Follow-up|0|||
19770473|NCT03171415|42224143|FG002|Overall Study|Lost to Follow-up|0|||
19770474|NCT03171415|42224144|FG003|Overall Study|Lost to Follow-up|0|||
19770475|NCT03171415|42224145|FG004|Overall Study|Lost to Follow-up|2|||
19770476|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
19770477|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
19770478|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
19770479|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
19770480|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
19770481|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
19770482|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
19770483|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
19770484|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
19770485|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
19770486|NCT03829241|42224170|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
19770487|NCT03829241|42224171|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
19770488|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
19770489|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
19770490|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
19770491|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
19770492|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
19770493|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
19770494|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
19770495|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
19770496|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
19770497|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
19770498|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
19770499|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
19770500|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
19770501|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
19770502|NCT03829241|42224170|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
19688147|NCT00419744|42134367|FG000|Overall Study|Adverse Event|39|||
19688148|NCT00419744|42134368|FG001|Overall Study|Adverse Event|40|||
19688149|NCT00419744|42134369|FG002|Overall Study|Adverse Event|50|||
19688150|NCT00419744|42134367|FG000|Overall Study|Withdrawal by Subject|45|||
19688151|NCT00419744|42134368|FG001|Overall Study|Withdrawal by Subject|49|||
19688152|NCT00419744|42134369|FG002|Overall Study|Withdrawal by Subject|52|||
19688153|NCT00419744|42134367|FG000|Overall Study|Lost to Follow-up|8|||
19688154|NCT00419744|42134368|FG001|Overall Study|Lost to Follow-up|10|||
19688155|NCT00419744|42134369|FG002|Overall Study|Lost to Follow-up|6|||
19688156|NCT00419744|42134367|FG000|Overall Study|Protocol Violation|4|||
19688157|NCT00419744|42134368|FG001|Overall Study|Protocol Violation|7|||
19688158|NCT00419744|42134369|FG002|Overall Study|Protocol Violation|8|||
19688159|NCT00419744|42134367|FG000|Overall Study|Randomized in error|9|||
19688160|NCT00419744|42134368|FG001|Overall Study|Randomized in error|6|||
19688161|NCT00419744|42134369|FG002|Overall Study|Randomized in error|7|||
19688162|NCT00419744|42134367|FG000|Overall Study|Moving out of state|2|||
19688163|NCT00419744|42134368|FG001|Overall Study|Moving out of state|0|||
19688164|NCT00419744|42134369|FG002|Overall Study|Moving out of state|1|||
19688165|NCT00419744|42134367|FG000|Overall Study|Physician Decision|10|||
19688166|NCT00419744|42134368|FG001|Overall Study|Physician Decision|5|||
19688167|NCT00419744|42134369|FG002|Overall Study|Physician Decision|6|||
19688168|NCT00419744|42134367|FG000|Overall Study|Spirometry mouthpiece issues|0|||
19688169|NCT00419744|42134368|FG001|Overall Study|Spirometry mouthpiece issues|1|||
19688170|NCT00419744|42134369|FG002|Overall Study|Spirometry mouthpiece issues|2|||
19688171|NCT00419744|42134367|FG000|Overall Study|Incorrect medication kit dispensed|0|||
19688172|NCT00419744|42134368|FG001|Overall Study|Incorrect medication kit dispensed|0|||
19688173|NCT00419744|42134369|FG002|Overall Study|Incorrect medication kit dispensed|1|||
19688174|NCT00395538|42134380|FG000|Overall Study|Did not re-consent to revised protocol|1|||
19688175|NCT00395538|42134381|FG001|Overall Study|Did not re-consent to revised protocol|10|||
19688176|NCT00395538|42134382|FG002|Overall Study|Did not re-consent to revised protocol|0|||
19688177|NCT00395538|42134380|FG000|Overall Study|FDA partial hold on PTH|0|||
19688178|NCT00395538|42134381|FG001|Overall Study|FDA partial hold on PTH|0|||
19688179|NCT00395538|42134382|FG002|Overall Study|FDA partial hold on PTH|11|||
19688180|NCT00395538|42134380|FG000|Overall Study|Failed screening|0|||
19688181|NCT00395538|42134381|FG001|Overall Study|Failed screening|0|||
19688182|NCT00395538|42134382|FG002|Overall Study|Failed screening|4|||
19688183|NCT00395538|42134380|FG000|Overall Study|Switch to Natpara|0|||
19688184|NCT00395538|42134381|FG001|Overall Study|Switch to Natpara|0|||
19688185|NCT00395538|42134382|FG002|Overall Study|Switch to Natpara|3|||
19770503|NCT03829241|42224171|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
19770504|NCT03164551|42224183|FG000|Overall Study|Imaging discontinued prior completion|8|||
19770505|NCT03164551|42224184|FG001|Overall Study|Imaging discontinued prior completion|0|||
19770506|NCT03164551|42224183|FG000|Overall Study|Participant was non-compliant|1|||
19770507|NCT03164551|42224184|FG001|Overall Study|Participant was non-compliant|0|||
19770508|NCT03164551|42224183|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
19770509|NCT03164551|42224184|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
19770510|NCT03164551|42224183|FG000|Overall Study|Other|8|||
19770511|NCT03164551|42224184|FG001|Overall Study|Other|2|||
19770512|NCT02863328|42224192|FG000|Overall Study|Lost to Follow-up|4|||
19770513|NCT02863328|42224193|FG001|Overall Study|Lost to Follow-up|10|||
19770514|NCT02863328|42224192|FG000|Overall Study|Withdrawal by Subject|7|||
19770515|NCT02863328|42224193|FG001|Overall Study|Withdrawal by Subject|12|||
19770516|NCT02863328|42224192|FG000|Overall Study|Died|0|||
19770517|NCT02863328|42224193|FG001|Overall Study|Died|1|||
19770518|NCT03040141|42224202|FG000|Overall Study|Death|1|||
19770519|NCT03040141|42224203|FG001|Overall Study|Death|2|||
19770520|NCT03040141|42224204|FG002|Overall Study|Death|3|||
19770521|NCT03040141|42224202|FG000|Overall Study|Withdrawal by Subject|3|||
19770522|NCT03040141|42224203|FG001|Overall Study|Withdrawal by Subject|1|||
19770523|NCT03040141|42224204|FG002|Overall Study|Withdrawal by Subject|1|||
19770524|NCT03040141|42224202|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
19770525|NCT03040141|42224203|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
19770526|NCT03040141|42224204|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
19770527|NCT03040141|42224202|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
19770528|NCT03040141|42224203|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
19770529|NCT03040141|42224204|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
19770530|NCT02937701|42224218|FG000|Day 1 to Week 22|Adverse Event|11|||
19770531|NCT02937701|42224219|FG001|Day 1 to Week 22|Adverse Event|14|||
19770532|NCT02937701|42224220|FG002|Day 1 to Week 22|Adverse Event|0|||
19770533|NCT02937701|42224221|FG003|Day 1 to Week 22|Adverse Event|0|||
19770534|NCT02937701|42224222|FG004|Day 1 to Week 22|Adverse Event|0|||
19770535|NCT02937701|42224218|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
19770536|NCT02937701|42224219|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
19770537|NCT02937701|42224220|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
19770538|NCT02937701|42224221|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
19770539|NCT02937701|42224222|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
19770540|NCT02937701|42224218|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
19770541|NCT02937701|42224219|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
19770542|NCT02937701|42224220|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
19770543|NCT02937701|42224221|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
19770544|NCT02937701|42224222|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
19770545|NCT02937701|42224218|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
19770546|NCT02937701|42224219|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
19688186|NCT00395538|42134380|FG000|Overall Study|Adverse Event|1|||
19688187|NCT00395538|42134381|FG001|Overall Study|Adverse Event|0|||
19688188|NCT00395538|42134382|FG002|Overall Study|Adverse Event|2|||
19688189|NCT00395538|42134380|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
19688190|NCT00395538|42134381|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
19688191|NCT00395538|42134382|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
19688192|NCT00395538|42134380|FG000|Overall Study|Non-compliance with study protocol|0|||
19688193|NCT00395538|42134381|FG001|Overall Study|Non-compliance with study protocol|1|||
19688194|NCT00395538|42134382|FG002|Overall Study|Non-compliance with study protocol|0|||
19688195|NCT00395538|42134380|FG000|Overall Study|PTH resistance|0|||
19688196|NCT00395538|42134381|FG001|Overall Study|PTH resistance|0|||
19688197|NCT00395538|42134382|FG002|Overall Study|PTH resistance|1|||
19688198|NCT00395538|42134380|FG000|Overall Study|Pregnancy|1|||
19688199|NCT00395538|42134381|FG001|Overall Study|Pregnancy|0|||
19688200|NCT00395538|42134382|FG002|Overall Study|Pregnancy|0|||
19688201|NCT00395538|42134380|FG000|Overall Study|Partial recovery of parathyroid function|0|||
19688202|NCT00395538|42134381|FG001|Overall Study|Partial recovery of parathyroid function|0|||
19688203|NCT00395538|42134382|FG002|Overall Study|Partial recovery of parathyroid function|1|||
19688204|NCT00395538|42134380|FG000|Overall Study|Participant elected to discontinue|0|||
19688205|NCT00395538|42134381|FG001|Overall Study|Participant elected to discontinue|0|||
19688206|NCT00395538|42134382|FG002|Overall Study|Participant elected to discontinue|1|||
19688207|NCT00395460|42134392|FG000|Overall Study|Withdrawal by Subject|1|||
19688208|NCT00395460|42134393|FG001|Overall Study|Withdrawal by Subject|0|||
19688209|NCT00395304|42134399|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19688210|NCT00395304|42134400|FG001|Treatment Period 1|Withdrawal by Subject|3|||
19688211|NCT00395304|42134401|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19688212|NCT00395304|42134402|FG003|Treatment Period 1|Withdrawal by Subject|2|||
19688213|NCT00395304|42134403|FG004|Treatment Period 1|Withdrawal by Subject|1|||
19688214|NCT00395304|42134404|FG005|Treatment Period 1|Withdrawal by Subject|1|||
19688215|NCT00395304|42134399|FG000|Treatment Period 1|Lost to Follow-up|1|||
19688216|NCT00395304|42134400|FG001|Treatment Period 1|Lost to Follow-up|0|||
19688217|NCT00395304|42134401|FG002|Treatment Period 1|Lost to Follow-up|0|||
19688218|NCT00395304|42134402|FG003|Treatment Period 1|Lost to Follow-up|1|||
19688219|NCT00395304|42134403|FG004|Treatment Period 1|Lost to Follow-up|0|||
19688220|NCT00395304|42134404|FG005|Treatment Period 1|Lost to Follow-up|1|||
19688221|NCT00395304|42134399|FG000|Treatment Period 1|Physician Decision|0|||
19688222|NCT00395304|42134400|FG001|Treatment Period 1|Physician Decision|1|||
19688223|NCT00395304|42134401|FG002|Treatment Period 1|Physician Decision|0|||
19688224|NCT00395304|42134402|FG003|Treatment Period 1|Physician Decision|0|||
19688225|NCT00395304|42134403|FG004|Treatment Period 1|Physician Decision|0|||
19688226|NCT00395304|42134404|FG005|Treatment Period 1|Physician Decision|0|||
19688227|NCT00395304|42134399|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19688228|NCT00395304|42134400|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19770547|NCT02937701|42224220|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
19770548|NCT02937701|42224221|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
19770549|NCT02937701|42224222|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
19770550|NCT02937701|42224218|FG000|Day 1 to Week 22|Death|1|||
19770551|NCT02937701|42224219|FG001|Day 1 to Week 22|Death|1|||
19770552|NCT02937701|42224220|FG002|Day 1 to Week 22|Death|0|||
19770553|NCT02937701|42224221|FG003|Day 1 to Week 22|Death|0|||
19770554|NCT02937701|42224222|FG004|Day 1 to Week 22|Death|0|||
19770555|NCT02937701|42224218|FG000|Day 1 to Week 22|Protocol Violation|1|||
19688229|NCT00395304|42134401|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19688230|NCT00395304|42134402|FG003|Treatment Period 2|Withdrawal by Subject|1|||
19688231|NCT00395304|42134403|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19688232|NCT00395304|42134404|FG005|Treatment Period 2|Withdrawal by Subject|2|||
19688233|NCT00395304|42134399|FG000|Treatment Period 2|Lost to Follow-up|0|||
19688234|NCT00395304|42134400|FG001|Treatment Period 2|Lost to Follow-up|3|||
19688235|NCT00395304|42134401|FG002|Treatment Period 2|Lost to Follow-up|0|||
19688236|NCT00395304|42134402|FG003|Treatment Period 2|Lost to Follow-up|0|||
19688237|NCT00395304|42134403|FG004|Treatment Period 2|Lost to Follow-up|0|||
19688238|NCT00395304|42134404|FG005|Treatment Period 2|Lost to Follow-up|0|||
19688239|NCT00395304|42134399|FG000|Treatment Period 2|Physician Decision|0|||
19688240|NCT00395304|42134400|FG001|Treatment Period 2|Physician Decision|0|||
19688241|NCT00395304|42134401|FG002|Treatment Period 2|Physician Decision|1|||
19688242|NCT00395304|42134402|FG003|Treatment Period 2|Physician Decision|0|||
19688243|NCT00395304|42134403|FG004|Treatment Period 2|Physician Decision|0|||
19688244|NCT00395304|42134404|FG005|Treatment Period 2|Physician Decision|0|||
19688245|NCT00395304|42134399|FG000|Treatment Period 2|Other|0|||
19688246|NCT00395304|42134400|FG001|Treatment Period 2|Other|1|||
19688247|NCT00395304|42134401|FG002|Treatment Period 2|Other|0|||
19688248|NCT00395304|42134402|FG003|Treatment Period 2|Other|0|||
19688249|NCT00395304|42134403|FG004|Treatment Period 2|Other|0|||
19688250|NCT00395304|42134404|FG005|Treatment Period 2|Other|0|||
19688251|NCT00395304|42134399|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19688252|NCT00395304|42134400|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19688253|NCT00395304|42134401|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19688254|NCT00395304|42134402|FG003|Treatment Period 3|Withdrawal by Subject|1|||
19688255|NCT00395304|42134403|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19688256|NCT00395304|42134404|FG005|Treatment Period 3|Withdrawal by Subject|1|||
19688257|NCT00395304|42134399|FG000|Treatment Period 3|Lost to Follow-up|1|||
19688258|NCT00395304|42134400|FG001|Treatment Period 3|Lost to Follow-up|1|||
19688259|NCT00395304|42134401|FG002|Treatment Period 3|Lost to Follow-up|0|||
19688260|NCT00395304|42134402|FG003|Treatment Period 3|Lost to Follow-up|0|||
19688261|NCT00395304|42134403|FG004|Treatment Period 3|Lost to Follow-up|0|||
19688262|NCT00395304|42134404|FG005|Treatment Period 3|Lost to Follow-up|0|||
19688263|NCT00395304|42134399|FG000|Treatment Period 3|Physician Decision|0|||
19688264|NCT00395304|42134400|FG001|Treatment Period 3|Physician Decision|1|||
19688265|NCT00395304|42134401|FG002|Treatment Period 3|Physician Decision|0|||
19688266|NCT00395304|42134402|FG003|Treatment Period 3|Physician Decision|0|||
19688267|NCT00395304|42134403|FG004|Treatment Period 3|Physician Decision|0|||
19770556|NCT02937701|42224219|FG001|Day 1 to Week 22|Protocol Violation|1|||
19770557|NCT02937701|42224220|FG002|Day 1 to Week 22|Protocol Violation|0|||
19770558|NCT02937701|42224221|FG003|Day 1 to Week 22|Protocol Violation|0|||
19688268|NCT00395304|42134404|FG005|Treatment Period 3|Physician Decision|0|||
19688269|NCT00395304|42134399|FG000|Treatment Period 3|Other|0|||
19688270|NCT00395304|42134400|FG001|Treatment Period 3|Other|0|||
19688271|NCT00395304|42134401|FG002|Treatment Period 3|Other|0|||
19688272|NCT00395304|42134402|FG003|Treatment Period 3|Other|1|||
19688273|NCT00395304|42134403|FG004|Treatment Period 3|Other|0|||
19688274|NCT00395304|42134404|FG005|Treatment Period 3|Other|0|||
19688275|NCT00395226|42134413|FG000|Overall Study|Adverse Event|4|||
19688276|NCT00395226|42134414|FG001|Overall Study|Adverse Event|3|||
19688277|NCT00395226|42134413|FG000|Overall Study|Withdrawal by Subject|0|||
19770559|NCT02937701|42224222|FG004|Day 1 to Week 22|Protocol Violation|0|||
19688278|NCT00395226|42134414|FG001|Overall Study|Withdrawal by Subject|1|||
19688279|NCT00395226|42134413|FG000|Overall Study|Lost to Follow-up|0|||
19688280|NCT00395226|42134414|FG001|Overall Study|Lost to Follow-up|1|||
19688281|NCT00394914|42134422|FG000|Treatment Period|Adverse Event|0|||
19688282|NCT00394914|42134423|FG001|Treatment Period|Adverse Event|3|||
19688283|NCT00394914|42134424|FG002|Treatment Period|Adverse Event|1|||
19688284|NCT00394914|42134422|FG000|Treatment Period|Lost to Follow-up|0|||
19770560|NCT02937701|42224218|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
19770561|NCT02937701|42224219|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
19770562|NCT02937701|42224220|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
19770563|NCT02937701|42224221|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
19770564|NCT02937701|42224222|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
19770565|NCT02937701|42224218|FG000|Day 1 to Week 22|Physician Decision|2|||
19770566|NCT02937701|42224219|FG001|Day 1 to Week 22|Physician Decision|0|||
19770567|NCT02937701|42224220|FG002|Day 1 to Week 22|Physician Decision|0|||
19770568|NCT02937701|42224221|FG003|Day 1 to Week 22|Physician Decision|0|||
19770569|NCT02937701|42224222|FG004|Day 1 to Week 22|Physician Decision|0|||
19770570|NCT02937701|42224218|FG000|Day 1 to Week 22|Other|1|||
19770571|NCT02937701|42224219|FG001|Day 1 to Week 22|Other|0|||
19770572|NCT02937701|42224220|FG002|Day 1 to Week 22|Other|0|||
19770573|NCT02937701|42224221|FG003|Day 1 to Week 22|Other|0|||
19770574|NCT02937701|42224222|FG004|Day 1 to Week 22|Other|0|||
19770575|NCT02937701|42224218|FG000|Week 22 to Week 50|Adverse Event|0|||
19770576|NCT02937701|42224219|FG001|Week 22 to Week 50|Adverse Event|0|||
19770577|NCT02937701|42224220|FG002|Week 22 to Week 50|Adverse Event|10|||
19770578|NCT02937701|42224221|FG003|Week 22 to Week 50|Adverse Event|3|||
19770579|NCT02937701|42224222|FG004|Week 22 to Week 50|Adverse Event|3|||
19770580|NCT02937701|42224218|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
19770581|NCT02937701|42224219|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
19770582|NCT02937701|42224220|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
19770583|NCT02937701|42224221|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
19770584|NCT02937701|42224222|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
19770585|NCT02937701|42224218|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
19770586|NCT02937701|42224219|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
19770587|NCT02937701|42224220|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
19770588|NCT02937701|42224221|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
19770589|NCT02937701|42224222|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
19770590|NCT02937701|42224218|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
19770591|NCT02937701|42224219|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
19770592|NCT02937701|42224220|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
19770593|NCT02937701|42224221|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
19770594|NCT02937701|42224222|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
19770595|NCT02937701|42224218|FG000|Week 22 to Week 50|Physician Decision|0|||
19770596|NCT02937701|42224219|FG001|Week 22 to Week 50|Physician Decision|0|||
19770597|NCT02937701|42224220|FG002|Week 22 to Week 50|Physician Decision|2|||
19770598|NCT02937701|42224221|FG003|Week 22 to Week 50|Physician Decision|0|||
19770599|NCT02937701|42224222|FG004|Week 22 to Week 50|Physician Decision|1|||
19770600|NCT02937701|42224218|FG000|Week 22 to Week 50|Other|0|||
19770601|NCT02937701|42224219|FG001|Week 22 to Week 50|Other|0|||
19770602|NCT02937701|42224220|FG002|Week 22 to Week 50|Other|0|||
19770603|NCT02937701|42224221|FG003|Week 22 to Week 50|Other|0|||
19770604|NCT02937701|42224222|FG004|Week 22 to Week 50|Other|1|||
19770605|NCT03169153|42224234|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
19770606|NCT03169153|42224235|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
19770607|NCT03169153|42224234|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
19770608|NCT03169153|42224235|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
19770609|NCT03169153|42224234|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
19770610|NCT03169153|42224235|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
19688285|NCT00394914|42134423|FG001|Treatment Period|Lost to Follow-up|1|||
19688286|NCT00394914|42134424|FG002|Treatment Period|Lost to Follow-up|0|||
19688287|NCT00394914|42134422|FG000|Treatment Period|Withdrawal by Subject|0|||
19688288|NCT00394914|42134423|FG001|Treatment Period|Withdrawal by Subject|2|||
19688289|NCT00394914|42134424|FG002|Treatment Period|Withdrawal by Subject|2|||
19688290|NCT00394914|42134422|FG000|Treatment Period|Noncompliance with protocol|0|||
19688291|NCT00394914|42134423|FG001|Treatment Period|Noncompliance with protocol|3|||
19770611|NCT03169153|42224234|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
19770612|NCT03169153|42224235|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
19770613|NCT03168919|42224241|FG000|Overall Study|Withdrawal by Subject|2|||
19770614|NCT03205163|42224251|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
19770615|NCT03205163|42224252|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
19770616|NCT01759537|42224267|FG000|Overall Study|Death|1|||
19770617|NCT01759537|42224268|FG001|Overall Study|Death|1|||
19770618|NCT01759537|42224267|FG000|Overall Study|Pregnancy|1|||
19770619|NCT01759537|42224268|FG001|Overall Study|Pregnancy|1|||
19770620|NCT01759537|42224267|FG000|Overall Study|Lost to Follow-up|9|||
19699067|NCT00290186|42143875|FG001|Overall Study|Lost to Follow-up|2|||
19770621|NCT01759537|42224268|FG001|Overall Study|Lost to Follow-up|9|||
19770622|NCT01759537|42224267|FG000|Overall Study|Accident involving jaw fracture|1|||
19770623|NCT01759537|42224268|FG001|Overall Study|Accident involving jaw fracture|1|||
19770624|NCT01759537|42224267|FG000|Overall Study|Subcrestal implant too coronal|1|||
19770625|NCT01759537|42224268|FG001|Overall Study|Subcrestal implant too coronal|1|||
19770626|NCT03204539|42224276|FG000|Overall Study|Loss of funding|0|||
19770627|NCT03204539|42224277|FG001|Overall Study|Loss of funding|1|||
19770628|NCT03502681|42224294|FG000|Overall Study|Adverse Event|1|||
19770629|NCT03502681|42224295|FG001|Overall Study|Adverse Event|1|||
19770630|NCT03502681|42224294|FG000|Overall Study|Disease Progression|2|||
19770631|NCT03502681|42224295|FG001|Overall Study|Disease Progression|1|||
19770632|NCT02860130|42224302|FG000|Overall Study|Adverse Event|2|||
19770633|NCT02860130|42224303|FG001|Overall Study|Adverse Event|3|||
19770634|NCT02860130|42224302|FG000|Overall Study|Protocol Violation|1|||
19770635|NCT02860130|42224303|FG001|Overall Study|Protocol Violation|1|||
19770636|NCT02860130|42224302|FG000|Overall Study|Withdrawal by Subject|0|||
19770637|NCT02860130|42224303|FG001|Overall Study|Withdrawal by Subject|2|||
19770638|NCT02860130|42224302|FG000|Overall Study|Physician Decision|2|||
19770639|NCT02860130|42224303|FG001|Overall Study|Physician Decision|2|||
19770640|NCT02860130|42224302|FG000|Overall Study|Other|2|||
19770641|NCT02860130|42224303|FG001|Overall Study|Other|1|||
19770642|NCT00788671|42224309|FG000|Overall Study|Death|2|||
19770643|NCT00788671|42224309|FG000|Overall Study|Unable to biopsy|1|||
19770644|NCT00788671|42224309|FG000|Overall Study|Withdrawal by Subject|4|||
19770645|NCT00788671|42224309|FG000|Overall Study|IUD expulsed|1|||
19770646|NCT00788671|42224309|FG000|Overall Study|Lost to follow up|2|||
19770647|NCT02986854|42224316|FG000|Overall Study|Withdrawal by Subject|0|||
19770648|NCT02986854|42224317|FG001|Overall Study|Withdrawal by Subject|1|||
19770649|NCT02986854|42224318|FG002|Overall Study|Withdrawal by Subject|1|||
19770650|NCT02986854|42224316|FG000|Overall Study|Lost to Follow-up|3|||
19770651|NCT02986854|42224317|FG001|Overall Study|Lost to Follow-up|11|||
19770652|NCT02986854|42224318|FG002|Overall Study|Lost to Follow-up|2|||
19770653|NCT02887183|42224328|FG000|Overall Study|Adverse Event|44|||
19770654|NCT02887183|42224328|FG000|Overall Study|Death|30|||
19770655|NCT02887183|42224328|FG000|Overall Study|Pregnancy|1|||
19770656|NCT02887183|42224328|FG000|Overall Study|Protocol Violation|6|||
19770657|NCT02887183|42224328|FG000|Overall Study|Technical Problems|2|||
19770658|NCT02887183|42224328|FG000|Overall Study|Lost to Follow-up|13|||
19770659|NCT02887183|42224328|FG000|Overall Study|Physician Decision|10|||
19770660|NCT02887183|42224328|FG000|Overall Study|Withdrawal by Subject|35|||
19770661|NCT03167359|42224336|FG000|Overall Study|Physician Decision|1|||
19770662|NCT03167359|42224336|FG000|Overall Study|Lost to Follow-up|1|||
19770663|NCT01068600|42224342|FG000|Overall Study|Withdrawal by Subject|5|||
19770664|NCT01068600|42224343|FG001|Overall Study|Withdrawal by Subject|6|||
19770665|NCT01068600|42224342|FG000|Overall Study|Adverse Event|3|||
19770666|NCT01068600|42224343|FG001|Overall Study|Adverse Event|3|||
19770667|NCT01068600|42224342|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19770668|NCT01068600|42224343|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19770669|NCT01068600|42224342|FG000|Overall Study|Lost to Follow-up|1|||
19770670|NCT01068600|42224343|FG001|Overall Study|Lost to Follow-up|2|||
19770671|NCT01068600|42224342|FG000|Overall Study|Protocol deviation|1|||
19770672|NCT01068600|42224343|FG001|Overall Study|Protocol deviation|1|||
19770673|NCT01068600|42224342|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19770674|NCT01068600|42224343|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19770675|NCT01068600|42224342|FG000|Overall Study|Administrative problems|0|||
19770676|NCT01068600|42224343|FG001|Overall Study|Administrative problems|1|||
19770677|NCT01067976|42224349|FG000|Overall Study|Study drug never administered|20|||
19770678|NCT01067976|42224349|FG000|Overall Study|Study prematurely discontinued|2|||
19770679|NCT02858492|42224371|FG000|Overall Study|Withdrawal by Subject|0|||
19770680|NCT02858492|42224372|FG001|Overall Study|Withdrawal by Subject|1|||
19770681|NCT02858492|42224373|FG002|Overall Study|Withdrawal by Subject|0|||
19770682|NCT02858492|42224374|FG003|Overall Study|Withdrawal by Subject|1|||
19770683|NCT02858492|42224371|FG000|Overall Study|Adverse Event|0|||
19770684|NCT02858492|42224372|FG001|Overall Study|Adverse Event|0|||
19770685|NCT02858492|42224373|FG002|Overall Study|Adverse Event|0|||
19770686|NCT02858492|42224374|FG003|Overall Study|Adverse Event|3|||
19770687|NCT02858492|42224371|FG000|Overall Study|Lack of Efficacy|0|||
19770688|NCT02858492|42224372|FG001|Overall Study|Lack of Efficacy|0|||
19770689|NCT02858492|42224373|FG002|Overall Study|Lack of Efficacy|0|||
19770690|NCT02858492|42224374|FG003|Overall Study|Lack of Efficacy|1|||
19770691|NCT02858492|42224371|FG000|Overall Study|Protocol defined stopping criteria|0|||
19770692|NCT02858492|42224372|FG001|Overall Study|Protocol defined stopping criteria|0|||
19770693|NCT02858492|42224373|FG002|Overall Study|Protocol defined stopping criteria|0|||
19770694|NCT02858492|42224374|FG003|Overall Study|Protocol defined stopping criteria|1|||
19770695|NCT01067508|42224388|FG000|Overall Study|Physician Decision|0|||
19770696|NCT01067508|42224389|FG001|Overall Study|Physician Decision|1|||
19770697|NCT01067508|42224388|FG000|Overall Study|Withdrawal by Subject|0|||
19770698|NCT01067508|42224389|FG001|Overall Study|Withdrawal by Subject|1|||
19770699|NCT01067352|42224398|FG000|Overall Study|Withdrawal by Subject|1|||
19770700|NCT01067352|42224399|FG001|Overall Study|Withdrawal by Subject|2|||
19770701|NCT01067352|42224400|FG002|Overall Study|Withdrawal by Subject|1|||
19770702|NCT01067352|42224398|FG000|Overall Study|Physician Decision|0|||
19770703|NCT01067352|42224399|FG001|Overall Study|Physician Decision|1|||
19770704|NCT01067352|42224400|FG002|Overall Study|Physician Decision|0|||
19770705|NCT02986074|42224408|FG000|First Trial Period|Adverse Event|1|||
19770706|NCT02986074|42224409|FG001|First Trial Period|Adverse Event|0|||
19770707|NCT02986074|42224410|FG002|First Trial Period|Adverse Event|0|||
19770708|NCT02986074|42224411|FG003|First Trial Period|Adverse Event|0|||
19770709|NCT02986074|42224408|FG000|Follow up Period|system explant|0|||
19770710|NCT02986074|42224409|FG001|Follow up Period|system explant|0|||
19770711|NCT02986074|42224410|FG002|Follow up Period|system explant|1|||
19770712|NCT02986074|42224411|FG003|Follow up Period|system explant|2|||
19770713|NCT02986074|42224408|FG000|Follow up Period|Physician Decision|0|||
19770714|NCT02986074|42224409|FG001|Follow up Period|Physician Decision|0|||
19770715|NCT02986074|42224410|FG002|Follow up Period|Physician Decision|0|||
19770716|NCT02986074|42224411|FG003|Follow up Period|Physician Decision|1|||
19770717|NCT02920242|42224419|FG000|Overall Study|Withdrawal by Subject|1|||
19770718|NCT02920242|42224420|FG001|Overall Study|Withdrawal by Subject|0|||
19770719|NCT02920242|42224421|FG002|Overall Study|Withdrawal by Subject|1|||
19770720|NCT02920242|42224419|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
19770721|NCT02920242|42224420|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
19770722|NCT02920242|42224421|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
19770723|NCT02985996|42224434|FG000|Overall Study|Withdrawal by Subject|0|||
19770724|NCT02985996|42224435|FG001|Overall Study|Withdrawal by Subject|0|||
19770725|NCT02985996|42224436|FG002|Overall Study|Withdrawal by Subject|1|||
19770726|NCT02985996|42224437|FG003|Overall Study|Withdrawal by Subject|0|||
19770727|NCT02985996|42224438|FG004|Overall Study|Withdrawal by Subject|0|||
19770728|NCT02985996|42224434|FG000|Overall Study|Protocol Violation|0|||
19770729|NCT02985996|42224435|FG001|Overall Study|Protocol Violation|1|||
19770730|NCT02985996|42224436|FG002|Overall Study|Protocol Violation|0|||
19770731|NCT02985996|42224437|FG003|Overall Study|Protocol Violation|0|||
19770732|NCT02985996|42224438|FG004|Overall Study|Protocol Violation|0|||
19770733|NCT03225833|42224460|FG000|Overall Study|Adverse Event|0|||
19770734|NCT03225833|42224461|FG001|Overall Study|Adverse Event|1|||
19770735|NCT03225833|42224462|FG002|Overall Study|Adverse Event|2|||
19770736|NCT03225833|42224463|FG003|Overall Study|Adverse Event|0|||
19770737|NCT03225833|42224464|FG004|Overall Study|Adverse Event|0|||
19770738|NCT03225833|42224465|FG005|Overall Study|Adverse Event|2|||
19770739|NCT03225833|42224460|FG000|Overall Study|Withdrawal by Subject|1|||
19770740|NCT03225833|42224461|FG001|Overall Study|Withdrawal by Subject|0|||
19770741|NCT03225833|42224462|FG002|Overall Study|Withdrawal by Subject|0|||
19770742|NCT03225833|42224463|FG003|Overall Study|Withdrawal by Subject|0|||
19770743|NCT03225833|42224464|FG004|Overall Study|Withdrawal by Subject|1|||
19770744|NCT03225833|42224465|FG005|Overall Study|Withdrawal by Subject|0|||
19770745|NCT03225833|42224460|FG000|Overall Study|Termination of Study by Sponsor|4|||
19770746|NCT03225833|42224461|FG001|Overall Study|Termination of Study by Sponsor|0|||
19770747|NCT03225833|42224462|FG002|Overall Study|Termination of Study by Sponsor|0|||
19770748|NCT03225833|42224463|FG003|Overall Study|Termination of Study by Sponsor|0|||
19770749|NCT03225833|42224464|FG004|Overall Study|Termination of Study by Sponsor|0|||
19770750|NCT03225833|42224465|FG005|Overall Study|Termination of Study by Sponsor|7|||
19770751|NCT03225833|42224460|FG000|Overall Study|Sponsor Decision|0|||
19770752|NCT03225833|42224461|FG001|Overall Study|Sponsor Decision|0|||
19770753|NCT03225833|42224462|FG002|Overall Study|Sponsor Decision|0|||
19770754|NCT03225833|42224463|FG003|Overall Study|Sponsor Decision|0|||
19770755|NCT03225833|42224464|FG004|Overall Study|Sponsor Decision|0|||
19770756|NCT03225833|42224465|FG005|Overall Study|Sponsor Decision|1|||
19770757|NCT03203447|42224486|FG000|Overall Study|Withdrawal by Subject|2|||
19770758|NCT03203447|42224487|FG001|Overall Study|Withdrawal by Subject|1|||
19770759|NCT03203447|42224486|FG000|Overall Study|Lost to Follow-up|1|||
19770760|NCT03203447|42224487|FG001|Overall Study|Lost to Follow-up|10|||
19770761|NCT03203447|42224486|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
19770762|NCT03203447|42224487|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
19770763|NCT02858726|42224497|FG000|Overall Study|Adverse Event|4|||
19770764|NCT02858726|42224498|FG001|Overall Study|Adverse Event|4|||
19770765|NCT02858726|42224499|FG002|Overall Study|Adverse Event|9|||
19770766|NCT02858726|42224500|FG003|Overall Study|Adverse Event|1|||
19770767|NCT02858726|42224497|FG000|Overall Study|Physician Decision|0|||
19770768|NCT02858726|42224498|FG001|Overall Study|Physician Decision|0|||
19770769|NCT02858726|42224499|FG002|Overall Study|Physician Decision|1|||
19770770|NCT02858726|42224500|FG003|Overall Study|Physician Decision|0|||
19770771|NCT02858726|42224497|FG000|Overall Study|Protocol Violation|0|||
19770772|NCT02858726|42224498|FG001|Overall Study|Protocol Violation|0|||
19770773|NCT02858726|42224499|FG002|Overall Study|Protocol Violation|0|||
19770774|NCT02858726|42224500|FG003|Overall Study|Protocol Violation|1|||
19770775|NCT02858726|42224497|FG000|Overall Study|Study Terminated by Sponsor|0|||
19770776|NCT02858726|42224498|FG001|Overall Study|Study Terminated by Sponsor|0|||
19770777|NCT02858726|42224499|FG002|Overall Study|Study Terminated by Sponsor|0|||
19770778|NCT02858726|42224500|FG003|Overall Study|Study Terminated by Sponsor|1|||
19770779|NCT02858726|42224497|FG000|Overall Study|Withdrawal by Subject|1|||
19770780|NCT02858726|42224498|FG001|Overall Study|Withdrawal by Subject|2|||
19770781|NCT02858726|42224499|FG002|Overall Study|Withdrawal by Subject|1|||
19770782|NCT02858726|42224500|FG003|Overall Study|Withdrawal by Subject|0|||
19770783|NCT02858726|42224497|FG000|Overall Study|Noncompliance|0|||
19770784|NCT02858726|42224498|FG001|Overall Study|Noncompliance|1|||
19770785|NCT02858726|42224499|FG002|Overall Study|Noncompliance|0|||
19770786|NCT02858726|42224500|FG003|Overall Study|Noncompliance|0|||
19770787|NCT03203291|42224514|FG000|Overall Study|Withdrawal by Subject|1|||
19770788|NCT01068678|42224520|FG000|Overall Study|Lack of Efficacy|3|||
19770789|NCT01068678|42224521|FG001|Overall Study|Lack of Efficacy|2|||
19770790|NCT01068678|42224520|FG000|Overall Study|Protocol Violation|5|||
19770791|NCT01068678|42224521|FG001|Overall Study|Protocol Violation|1|||
19770792|NCT01068678|42224520|FG000|Overall Study|Withdrawal criteria|12|||
19770793|NCT01068678|42224521|FG001|Overall Study|Withdrawal criteria|6|||
19770794|NCT01068678|42224520|FG000|Overall Study|Unclassified|18|||
19770795|NCT01068678|42224521|FG001|Overall Study|Unclassified|15|||
19770796|NCT03202511|42224527|FG000|Overall Study|Withdrawal by Subject|1|||
19770797|NCT03202511|42224528|FG001|Overall Study|Withdrawal by Subject|0|||
19770798|NCT02919696|42224549|FG000|Overall Study|Adverse Event|1|||
19770799|NCT02919696|42224550|FG001|Overall Study|Adverse Event|2|||
19770800|NCT02919696|42224549|FG000|Overall Study|Withdrawal by Subject|2|||
19770801|NCT02919696|42224550|FG001|Overall Study|Withdrawal by Subject|1|||
19770802|NCT02919696|42224549|FG000|Overall Study|Sponsor Decision|1|||
19770803|NCT02919696|42224550|FG001|Overall Study|Sponsor Decision|1|||
19770804|NCT02919696|42224549|FG000|Overall Study|Never Treated|0|||
19770805|NCT02919696|42224550|FG001|Overall Study|Never Treated|1|||
19770806|NCT02935673|42224565|FG000|Overall Study|Adverse Event|0|||
19770807|NCT02935673|42224566|FG001|Overall Study|Adverse Event|1|||
19770808|NCT02935673|42224567|FG002|Overall Study|Adverse Event|0|||
19770809|NCT02935673|42224565|FG000|Overall Study|Withdrawal by Subject|1|||
19770810|NCT02935673|42224566|FG001|Overall Study|Withdrawal by Subject|2|||
19770811|NCT02935673|42224567|FG002|Overall Study|Withdrawal by Subject|0|||
19770812|NCT03201809|42224579|FG000|Overall Study|Lost to Follow-up|2|||
19770813|NCT03201809|42224580|FG001|Overall Study|Lost to Follow-up|0|||
19770814|NCT02919618|42224586|FG000|Overall Study|Death|1|||
19770815|NCT02985684|42224606|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
19770816|NCT02985684|42224606|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
19770817|NCT02985684|42224606|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
19770818|NCT02985450|42224610|FG000|Overall Study|Lost to Follow-up|7|||
19770819|NCT02908464|42224619|FG000|Overall Study|Withdrawal by Subject|2|||
19770820|NCT02908464|42224620|FG001|Overall Study|Withdrawal by Subject|1|||
19770821|NCT02908464|42224619|FG000|Overall Study|Found ineligible after randomization|0|||
19770822|NCT02908464|42224620|FG001|Overall Study|Found ineligible after randomization|2|||
19770823|NCT02907216|42224629|FG000|Overall Study|No benefit to be obtained by continuing|0|||
19770824|NCT02907216|42224630|FG001|Overall Study|No benefit to be obtained by continuing|1|||
19770825|NCT02907216|42224629|FG000|Overall Study|Withdrawal by Subject|1|||
19770826|NCT02907216|42224630|FG001|Overall Study|Withdrawal by Subject|0|||
19770827|NCT02984982|42224638|FG000|Overall Study|Adverse Event|2|||
19770828|NCT02984982|42224639|FG001|Overall Study|Adverse Event|5|||
19770829|NCT02984982|42224638|FG000|Overall Study|Poor Compliance to Protocol|4|||
19770830|NCT02984982|42224639|FG001|Overall Study|Poor Compliance to Protocol|4|||
19770831|NCT02984982|42224638|FG000|Overall Study|Withdrawal by Subject|2|||
19770832|NCT02984982|42224639|FG001|Overall Study|Withdrawal by Subject|0|||
19770833|NCT02984982|42224638|FG000|Overall Study|Randomized but not treated|0|||
19770834|NCT02984982|42224639|FG001|Overall Study|Randomized but not treated|1|||
19770835|NCT02981472|42224648|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
19770836|NCT02981472|42224649|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
19770837|NCT02981472|42224648|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19770838|NCT02981472|42224649|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19770839|NCT02981472|42224648|FG000|Treatment Period|Adverse Event|6|||
19770840|NCT02981472|42224649|FG001|Treatment Period|Adverse Event|1|||
19770841|NCT02981472|42224648|FG000|Treatment Period|Participant withdrew consent|1|||
19770842|NCT02981472|42224649|FG001|Treatment Period|Participant withdrew consent|0|||
19770843|NCT02981472|42224648|FG000|Treatment Period|Lost to Follow-up|0|||
19770844|NCT02981472|42224649|FG001|Treatment Period|Lost to Follow-up|1|||
19770845|NCT02982720|42224661|FG000|Overall Study|Adverse Event|3|||
19770846|NCT02982720|42224661|FG000|Overall Study|Death|1|||
19770847|NCT00849667|42224668|FG000|Overall Study|Withdrawal by Subject|16|||
19770848|NCT00849667|42224669|FG001|Overall Study|Withdrawal by Subject|33|||
19770849|NCT00849667|42224670|FG002|Overall Study|Withdrawal by Subject|35|||
19770850|NCT00849667|42224668|FG000|Overall Study|Lost to Follow-up|8|||
19389139|NCT02663687|41632706|FG000|Overall Study|Other|1|||
19770851|NCT00849667|42224669|FG001|Overall Study|Lost to Follow-up|8|||
19770852|NCT00849667|42224670|FG002|Overall Study|Lost to Follow-up|8|||
19770853|NCT00849667|42224668|FG000|Overall Study|Adverse Event|1|||
19770854|NCT00849667|42224669|FG001|Overall Study|Adverse Event|2|||
19770855|NCT00849667|42224670|FG002|Overall Study|Adverse Event|0|||
19688292|NCT00394914|42134424|FG002|Treatment Period|Noncompliance with protocol|2|||
19688293|NCT00394914|42134422|FG000|Treatment Period|Did not meet protocol eligibility|0|||
19688294|NCT00394914|42134423|FG001|Treatment Period|Did not meet protocol eligibility|1|||
19688295|NCT00394914|42134424|FG002|Treatment Period|Did not meet protocol eligibility|1|||
19688296|NCT00366444|42134432|FG000|Overall Study|Withdrawal by Subject|1|||
19688297|NCT00366444|42134433|FG001|Overall Study|Withdrawal by Subject|1|||
19770856|NCT00849667|42224668|FG000|Overall Study|Other|18|||
19770857|NCT00849667|42224669|FG001|Overall Study|Other|19|||
19770858|NCT00849667|42224670|FG002|Overall Study|Other|18|||
19770859|NCT00849667|42224668|FG000|Overall Study|Progressive disease|119|||
19770860|NCT00849667|42224669|FG001|Overall Study|Progressive disease|100|||
19770861|NCT00849667|42224670|FG002|Overall Study|Progressive disease|112|||
19770862|NCT00849667|42224668|FG000|Overall Study|Sponsor decision|208|||
19770863|NCT00849667|42224669|FG001|Overall Study|Sponsor decision|204|||
19770864|NCT00849667|42224670|FG002|Overall Study|Sponsor decision|190|||
19770865|NCT00849667|42224668|FG000|Overall Study|Investigator discretion|0|||
19770866|NCT00849667|42224669|FG001|Overall Study|Investigator discretion|0|||
19770867|NCT00849667|42224670|FG002|Overall Study|Investigator discretion|1|||
19770868|NCT03201419|42224689|FG000|Overall Study|Adverse Event|3|||
19770869|NCT03201419|42224690|FG001|Overall Study|Adverse Event|1|||
19770870|NCT03201419|42224691|FG002|Overall Study|Adverse Event|0|||
19770871|NCT03201419|42224692|FG003|Overall Study|Adverse Event|0|||
19770872|NCT03201419|42224693|FG004|Overall Study|Adverse Event|1|||
19770873|NCT03201419|42224694|FG005|Overall Study|Adverse Event|1|||
19688298|NCT00366444|42134432|FG000|Overall Study|Lack of Efficacy|0|||
19688299|NCT00366444|42134433|FG001|Overall Study|Lack of Efficacy|1|||
19688300|NCT00365976|42134441|FG000|Overall Study|Withdrawal by Subject|1|||
19688301|NCT00365976|42134442|FG001|Overall Study|Withdrawal by Subject|5|||
19688302|NCT00379236|42134450|FG000|Double-blind|Adverse Event|11|||
19688303|NCT00379236|42134451|FG001|Double-blind|Adverse Event|6|||
19688304|NCT00379236|42134452|FG002|Double-blind|Adverse Event|0|||
19688305|NCT00379236|42134450|FG000|Double-blind|Protocol Violation|3|||
19770874|NCT03201419|42224695|FG006|Overall Study|Adverse Event|5|||
19770875|NCT03201419|42224696|FG007|Overall Study|Adverse Event|0|||
19770876|NCT03201419|42224697|FG008|Overall Study|Adverse Event|0|||
19770877|NCT03201419|42224689|FG000|Overall Study|Lost to Follow-up|1|||
19770878|NCT03201419|42224690|FG001|Overall Study|Lost to Follow-up|0|||
19770879|NCT03201419|42224691|FG002|Overall Study|Lost to Follow-up|0|||
19770880|NCT03201419|42224692|FG003|Overall Study|Lost to Follow-up|0|||
19770881|NCT03201419|42224693|FG004|Overall Study|Lost to Follow-up|0|||
19770882|NCT03201419|42224694|FG005|Overall Study|Lost to Follow-up|0|||
19770883|NCT03201419|42224695|FG006|Overall Study|Lost to Follow-up|0|||
19770884|NCT03201419|42224696|FG007|Overall Study|Lost to Follow-up|0|||
19770885|NCT03201419|42224697|FG008|Overall Study|Lost to Follow-up|0|||
19770886|NCT03201419|42224689|FG000|Overall Study|Protocol Deviation|0|||
19770887|NCT03201419|42224690|FG001|Overall Study|Protocol Deviation|0|||
19770888|NCT03201419|42224691|FG002|Overall Study|Protocol Deviation|0|||
19770889|NCT03201419|42224692|FG003|Overall Study|Protocol Deviation|0|||
19770890|NCT03201419|42224693|FG004|Overall Study|Protocol Deviation|0|||
19770891|NCT03201419|42224694|FG005|Overall Study|Protocol Deviation|0|||
19770892|NCT03201419|42224695|FG006|Overall Study|Protocol Deviation|1|||
19770893|NCT03201419|42224696|FG007|Overall Study|Protocol Deviation|0|||
19688306|NCT00379236|42134451|FG001|Double-blind|Protocol Violation|3|||
19688307|NCT00379236|42134452|FG002|Double-blind|Protocol Violation|0|||
19688308|NCT00379236|42134450|FG000|Double-blind|Withdrawal by Subject|12|||
19688309|NCT00379236|42134451|FG001|Double-blind|Withdrawal by Subject|13|||
19688310|NCT00379236|42134452|FG002|Double-blind|Withdrawal by Subject|0|||
19688311|NCT00379236|42134450|FG000|Double-blind|Lost to Follow-up|4|||
19688312|NCT00379236|42134451|FG001|Double-blind|Lost to Follow-up|3|||
19688313|NCT00379236|42134452|FG002|Double-blind|Lost to Follow-up|0|||
19688314|NCT00379236|42134450|FG000|Double-blind|Use of exclusionary medication|1|||
19770894|NCT03201419|42224697|FG008|Overall Study|Protocol Deviation|0|||
19688315|NCT00379236|42134451|FG001|Double-blind|Use of exclusionary medication|2|||
19688316|NCT00379236|42134452|FG002|Double-blind|Use of exclusionary medication|0|||
19688317|NCT00379236|42134450|FG000|Double-blind|Other|3|||
19688318|NCT00379236|42134451|FG001|Double-blind|Other|7|||
19688319|NCT00379236|42134452|FG002|Double-blind|Other|0|||
19688320|NCT00379236|42134450|FG000|Double-blind|Data could not be retrieved|2|||
19688321|NCT00379236|42134451|FG001|Double-blind|Data could not be retrieved|2|||
19770895|NCT03201419|42224689|FG000|Overall Study|Withdrawal by Subject|4|||
19770896|NCT03201419|42224690|FG001|Overall Study|Withdrawal by Subject|2|||
19770897|NCT03201419|42224691|FG002|Overall Study|Withdrawal by Subject|1|||
19770898|NCT03201419|42224692|FG003|Overall Study|Withdrawal by Subject|0|||
19770899|NCT03201419|42224693|FG004|Overall Study|Withdrawal by Subject|0|||
19770900|NCT03201419|42224694|FG005|Overall Study|Withdrawal by Subject|0|||
19770901|NCT03201419|42224695|FG006|Overall Study|Withdrawal by Subject|0|||
19770902|NCT03201419|42224696|FG007|Overall Study|Withdrawal by Subject|1|||
19770903|NCT03201419|42224697|FG008|Overall Study|Withdrawal by Subject|2|||
19770904|NCT03201419|42224689|FG000|Overall Study|Other|0|||
19770905|NCT03201419|42224690|FG001|Overall Study|Other|0|||
19770906|NCT03201419|42224691|FG002|Overall Study|Other|1|||
19770907|NCT03201419|42224692|FG003|Overall Study|Other|0|||
19770908|NCT03201419|42224693|FG004|Overall Study|Other|0|||
19688322|NCT00379236|42134452|FG002|Double-blind|Data could not be retrieved|0|||
19688323|NCT00379236|42134450|FG000|Open-label Extension|Adverse Event|0|||
19688324|NCT00379236|42134451|FG001|Open-label Extension|Adverse Event|0|||
19688325|NCT00379236|42134452|FG002|Open-label Extension|Adverse Event|13|||
19688326|NCT00379236|42134450|FG000|Open-label Extension|Protocol Violation|0|||
19688327|NCT00379236|42134451|FG001|Open-label Extension|Protocol Violation|0|||
19688328|NCT00379236|42134452|FG002|Open-label Extension|Protocol Violation|7|||
19688329|NCT00379236|42134450|FG000|Open-label Extension|Withdrawal by Subject|0|||
19688330|NCT00379236|42134451|FG001|Open-label Extension|Withdrawal by Subject|0|||
19688331|NCT00379236|42134452|FG002|Open-label Extension|Withdrawal by Subject|13|||
19688332|NCT00379236|42134450|FG000|Open-label Extension|Lost to Follow-up|0|||
19770909|NCT03201419|42224694|FG005|Overall Study|Other|0|||
19688333|NCT00379236|42134451|FG001|Open-label Extension|Lost to Follow-up|0|||
19770910|NCT03201419|42224695|FG006|Overall Study|Other|0|||
19770911|NCT03201419|42224696|FG007|Overall Study|Other|0|||
19770912|NCT03201419|42224697|FG008|Overall Study|Other|0|||
19770913|NCT01764633|42224733|FG000|Overall Study|Withdrawal by Subject|105|||
19770914|NCT01764633|42224734|FG001|Overall Study|Withdrawal by Subject|88|||
19770915|NCT01764633|42224733|FG000|Overall Study|Lost to Follow-up|13|||
19770916|NCT01764633|42224734|FG001|Overall Study|Lost to Follow-up|5|||
19770917|NCT02924389|42224742|FG000|Overall Study|Lost to Follow-up|1|||
19688334|NCT00379236|42134452|FG002|Open-label Extension|Lost to Follow-up|12|||
19688335|NCT00379236|42134450|FG000|Open-label Extension|Use of exclusionary medication|0|||
19688336|NCT00379236|42134451|FG001|Open-label Extension|Use of exclusionary medication|0|||
19688337|NCT00379236|42134452|FG002|Open-label Extension|Use of exclusionary medication|3|||
19688338|NCT00379236|42134450|FG000|Open-label Extension|Other|0|||
19688339|NCT00379236|42134451|FG001|Open-label Extension|Other|0|||
19688340|NCT00379236|42134452|FG002|Open-label Extension|Other|7|||
19688341|NCT00379080|42134467|FG000|Overall Study|Withdrawal by Subject|0|||
19688342|NCT00379080|42134468|FG001|Overall Study|Withdrawal by Subject|4|||
19688343|NCT00379080|42134469|FG002|Overall Study|Withdrawal by Subject|0|||
19688344|NCT00378534|42134494|FG000|Overall Study|Participants did not receive transplant|3|||
19688345|NCT00378534|42134495|FG001|Overall Study|Participants did not receive transplant|0|||
19688346|NCT00377676|42134502|FG000|Overall Study|Adverse Event|498|||
19688347|NCT00377676|42134503|FG001|Overall Study|Adverse Event|107|||
19688348|NCT00377676|42134502|FG000|Overall Study|Protocol Violation|33|||
19688349|NCT00377676|42134503|FG001|Overall Study|Protocol Violation|27|||
19688350|NCT00377676|42134502|FG000|Overall Study|Death|5|||
19688351|NCT00377676|42134503|FG001|Overall Study|Death|2|||
19688352|NCT00377676|42134502|FG000|Overall Study|Withdrawal by Subject|187|||
19688353|NCT00377676|42134503|FG001|Overall Study|Withdrawal by Subject|72|||
19688354|NCT00377676|42134502|FG000|Overall Study|Lost to Follow-up|120|||
19688355|NCT00377676|42134503|FG001|Overall Study|Lost to Follow-up|56|||
19688356|NCT00377676|42134502|FG000|Overall Study|Other|118|||
19688357|NCT00377676|42134503|FG001|Overall Study|Other|58|||
19688358|NCT00377520|42134509|FG000|Overall Study|Ineligible (Prior radiation)|1|||
19688359|NCT00377364|42134515|FG000|Overall Study|Lost to Follow-up|1|||
19688360|NCT00377364|42134516|FG001|Overall Study|Lost to Follow-up|0|||
19688361|NCT00377364|42134515|FG000|Overall Study|Withdrawal by Subject|1|||
19688362|NCT00377364|42134516|FG001|Overall Study|Withdrawal by Subject|0|||
19688363|NCT03831282|42134524|FG000|Overall Study|Could not place sensor|1|||
19688364|NCT00365508|42134530|FG000|Overall Study|Lost to Follow-up|139|||
19688365|NCT00365508|42134531|FG001|Overall Study|Lost to Follow-up|154|||
19688366|NCT00365352|42134540|FG000|Overall Study|Adverse Event|6|||
19688367|NCT00365352|42134541|FG001|Overall Study|Adverse Event|7|||
19688368|NCT00365352|42134542|FG002|Overall Study|Adverse Event|8|||
19688369|NCT00365352|42134540|FG000|Overall Study|Participant Withdrew Consent|8|||
19770918|NCT02924389|42224743|FG001|Overall Study|Lost to Follow-up|0|||
19770919|NCT02924389|42224742|FG000|Overall Study|Physician Decision|2|||
19389140|NCT02663687|41632707|FG001|Overall Study|Other|0|||
19688370|NCT00365352|42134541|FG001|Overall Study|Participant Withdrew Consent|3|||
19688371|NCT00365352|42134542|FG002|Overall Study|Participant Withdrew Consent|4|||
19688372|NCT00365352|42134540|FG000|Overall Study|Lack of Efficacy|3|||
19688373|NCT00365352|42134541|FG001|Overall Study|Lack of Efficacy|0|||
19688374|NCT00365352|42134542|FG002|Overall Study|Lack of Efficacy|0|||
19688375|NCT00365352|42134540|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
19688376|NCT00365352|42134541|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
19770920|NCT02924389|42224743|FG001|Overall Study|Physician Decision|0|||
19770921|NCT02924389|42224742|FG000|Overall Study|Withdrawal by Subject|3|||
19688377|NCT00365352|42134542|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
19688378|NCT00365352|42134540|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
19688379|NCT00365352|42134541|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
19688380|NCT00365352|42134542|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
19688381|NCT00365352|42134540|FG000|Overall Study|Lost to Follow-up|1|||
19688382|NCT00365352|42134541|FG001|Overall Study|Lost to Follow-up|1|||
19688383|NCT00365352|42134542|FG002|Overall Study|Lost to Follow-up|0|||
19688384|NCT00365352|42134540|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
19688385|NCT00365352|42134541|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
19688386|NCT00365352|42134542|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
19688387|NCT00376506|42134555|FG000|Overall Study|Death|0|||
19688388|NCT00376506|42134556|FG001|Overall Study|Death|2|||
19688389|NCT00410384|42134568|FG000|Overall Study|Withdrawal by Subject|28|||
19688390|NCT00410384|42134569|FG001|Overall Study|Withdrawal by Subject|17|||
19688391|NCT00410384|42134570|FG002|Overall Study|Withdrawal by Subject|20|||
19688392|NCT00410384|42134568|FG000|Overall Study|Adverse Event|23|||
19688393|NCT00410384|42134569|FG001|Overall Study|Adverse Event|18|||
19688394|NCT00410384|42134570|FG002|Overall Study|Adverse Event|23|||
19688395|NCT00410384|42134568|FG000|Overall Study|Lack of Efficacy|20|||
19688396|NCT00410384|42134569|FG001|Overall Study|Lack of Efficacy|12|||
19688397|NCT00410384|42134570|FG002|Overall Study|Lack of Efficacy|17|||
19688398|NCT00410384|42134568|FG000|Overall Study|Lack of Compliance|2|||
19688399|NCT00410384|42134569|FG001|Overall Study|Lack of Compliance|2|||
19688400|NCT00410384|42134570|FG002|Overall Study|Lack of Compliance|2|||
19688401|NCT00410384|42134568|FG000|Overall Study|Lost to Follow-up|4|||
19688402|NCT00410384|42134569|FG001|Overall Study|Lost to Follow-up|6|||
19688403|NCT00410384|42134570|FG002|Overall Study|Lost to Follow-up|6|||
19688404|NCT00410384|42134568|FG000|Overall Study|Protocol Violation|6|||
19688405|NCT00410384|42134569|FG001|Overall Study|Protocol Violation|6|||
19688406|NCT00410384|42134570|FG002|Overall Study|Protocol Violation|6|||
19688407|NCT00410384|42134568|FG000|Overall Study|Physician Decision|3|||
19688408|NCT00410384|42134569|FG001|Overall Study|Physician Decision|3|||
19688409|NCT00410384|42134570|FG002|Overall Study|Physician Decision|4|||
19688410|NCT00410384|42134568|FG000|Overall Study|Other|3|||
19770922|NCT02924389|42224743|FG001|Overall Study|Withdrawal by Subject|0|||
19770923|NCT02924389|42224742|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
19770924|NCT02924389|42224743|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
19770925|NCT03235349|42224750|FG000|Overall Study|Adverse Event|1|||
19770926|NCT03235349|42224750|FG000|Overall Study|Other|1|||
19770927|NCT03235115|42224754|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
19770928|NCT03235115|42224755|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
19605673|NCT00730756|42054408|FG000|Overall Study|Lost to Follow-up|0|||
19605674|NCT00730756|42054409|FG001|Overall Study|Lost to Follow-up|1|||
19605675|NCT00730756|42054408|FG000|Overall Study|Withdrew Consent|0|||
19605676|NCT00730756|42054409|FG001|Overall Study|Withdrew Consent|1|||
19605677|NCT00730132|42054415|FG000|Overall Study|Protocol Violation|154|||
19605678|NCT00730132|42054415|FG000|Overall Study|Death|1|||
19605679|NCT00737464|42054422|FG000|Overall Study|Adverse Event|1|||
19605680|NCT00737464|42054422|FG000|Overall Study|Death|6|||
19605681|NCT00737464|42054422|FG000|Overall Study|Other - Failure to Return|1|||
19605682|NCT00737464|42054422|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
19605683|NCT00737464|42054422|FG000|Overall Study|Other reasons|4|||
19605684|NCT00729586|42054428|FG000|Overall Study|Ineligible|0|||
19605685|NCT00729586|42054429|FG001|Overall Study|Ineligible|1|||
19605686|NCT00729586|42054428|FG000|Overall Study|never treated|1|||
19605687|NCT00729586|42054429|FG001|Overall Study|never treated|0|||
19605688|NCT00949910|42054436|FG000|Overall Study|Progressive Disease|3750|||
19605689|NCT00949910|42054436|FG000|Overall Study|Symptomatic Deterioration|1088|||
19605690|NCT00949910|42054436|FG000|Overall Study|Lost to Follow-up|100|||
19605691|NCT00949910|42054436|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
19605692|NCT00949910|42054436|FG000|Overall Study|Participant Refusal|390|||
19605693|NCT00949910|42054436|FG000|Overall Study|Death Due to Malignant Disease|456|||
19605694|NCT00949910|42054436|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
19605695|NCT00949910|42054436|FG000|Overall Study|Death Due to Adverse Event|115|||
19605696|NCT00949910|42054436|FG000|Overall Study|Death Due to Toxicity|3|||
19605697|NCT00949910|42054436|FG000|Overall Study|Death from Unknown Cause|5|||
19605698|NCT00949910|42054436|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
19605699|NCT00949910|42054436|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
19605700|NCT00949910|42054436|FG000|Overall Study|Switched to Commercial Treatment|4|||
19605701|NCT00949910|42054436|FG000|Overall Study|Violation of Eligibility|23|||
19605702|NCT00949910|42054436|FG000|Overall Study|Logistical Reasons|13|||
19688411|NCT00410384|42134569|FG001|Overall Study|Other|8|||
19688412|NCT00410384|42134570|FG002|Overall Study|Other|4|||
19688413|NCT00370032|42134580|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
19688414|NCT00370032|42134581|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
19688415|NCT00370032|42134580|FG000|Washout Period|Withdrawal by Subject|0|||
19770929|NCT03235115|42224756|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
19770930|NCT03235115|42224757|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
19770931|NCT03235115|42224758|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
19770932|NCT03235115|42224759|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
19770933|NCT02923531|42224767|FG000|Overall Study|Adverse Event|4|||
19770934|NCT02923531|42224767|FG000|Overall Study|Clinical Deterioration|1|||
19770935|NCT02923531|42224767|FG000|Overall Study|Disease Progression|3|||
19770936|NCT02923531|42224767|FG000|Overall Study|Study Termination|1|||
19770937|NCT02934503|42224772|FG000|Overall Study|progression of disease|3|||
19770938|NCT02934503|42224772|FG000|Overall Study|Withdrawal by Subject|1|||
19770939|NCT02937545|42224778|FG000|Overall Study|Withdrawal by Subject|1|||
19770940|NCT02937545|42224779|FG001|Overall Study|Withdrawal by Subject|2|||
19770941|NCT02937545|42224780|FG002|Overall Study|Withdrawal by Subject|6|||
19770942|NCT02937545|42224781|FG003|Overall Study|Withdrawal by Subject|7|||
19770943|NCT02937545|42224778|FG000|Overall Study|Lost to Follow-up|1|||
19688416|NCT00370032|42134581|FG001|Washout Period|Withdrawal by Subject|1|||
19688417|NCT00370032|42134580|FG000|Washout Period|Lost to Follow-up|0|||
19688418|NCT00370032|42134581|FG001|Washout Period|Lost to Follow-up|1|||
19688419|NCT00370032|42134580|FG000|Washout Period|Adverse Event|1|||
19688420|NCT00370032|42134581|FG001|Washout Period|Adverse Event|0|||
19688421|NCT00370032|42134580|FG000|Follow-up Period|Withdrawal by Subject|1|||
19688422|NCT00370032|42134581|FG001|Follow-up Period|Withdrawal by Subject|0|||
19688423|NCT00410072|42134598|FG000|Day 1 to Week 48|Adverse Event|1|||
19688424|NCT00410072|42134599|FG001|Day 1 to Week 48|Adverse Event|2|||
19688425|NCT00410072|42134598|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
19688426|NCT00410072|42134599|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
19688427|NCT00410072|42134598|FG000|Day 1 to Week 48|Other|0|||
19688428|NCT00410072|42134599|FG001|Day 1 to Week 48|Other|1|||
19688429|NCT00410072|42134598|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
19688430|NCT00410072|42134599|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
19688431|NCT00410072|42134598|FG000|Day 1 to Week 48|Pregnancy|0|||
19688432|NCT00410072|42134599|FG001|Day 1 to Week 48|Pregnancy|2|||
19688433|NCT00410072|42134598|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
19688434|NCT00410072|42134599|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
19688435|NCT00410072|42134598|FG000|After Week 48 to Week 96|Adverse Event|1|||
19688436|NCT00410072|42134599|FG001|After Week 48 to Week 96|Adverse Event|2|||
19688437|NCT00410072|42134598|FG000|After Week 48 to Week 96|Death|0|||
19688438|NCT00410072|42134599|FG001|After Week 48 to Week 96|Death|1|||
19688439|NCT00410072|42134598|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
19688440|NCT00410072|42134599|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
19688441|NCT00410072|42134598|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
19688442|NCT00410072|42134599|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
19770944|NCT02937545|42224779|FG001|Overall Study|Lost to Follow-up|0|||
19770945|NCT02937545|42224780|FG002|Overall Study|Lost to Follow-up|0|||
19770946|NCT02937545|42224781|FG003|Overall Study|Lost to Follow-up|0|||
19770947|NCT03199391|42224792|FG000|Overall Study|Death|1|||
19770948|NCT03199391|42224792|FG000|Overall Study|Lost to Follow-up|3|||
19770949|NCT03199391|42224792|FG000|Overall Study|Adverse Event|2|||
19770950|NCT03199391|42224792|FG000|Overall Study|Withdrawal by Subject|10|||
19770951|NCT03198767|42224803|FG000|Overall Study|Protocol Violation|0|||
19770952|NCT03198767|42224804|FG001|Overall Study|Protocol Violation|0|||
19770953|NCT03198767|42224805|FG002|Overall Study|Protocol Violation|0|||
19770954|NCT03198767|42224806|FG003|Overall Study|Protocol Violation|6|||
19770955|NCT03198767|42224807|FG004|Overall Study|Protocol Violation|0|||
19770956|NCT03198767|42224808|FG005|Overall Study|Protocol Violation|0|||
19770957|NCT03198767|42224809|FG006|Overall Study|Protocol Violation|0|||
19770958|NCT03162055|42224826|FG000|Overall Study|Adverse Event|6|||
19770959|NCT03162055|42224827|FG001|Overall Study|Adverse Event|5|||
19770960|NCT03162055|42224826|FG000|Overall Study|Death|3|||
19770961|NCT03162055|42224827|FG001|Overall Study|Death|3|||
19770962|NCT03162055|42224826|FG000|Overall Study|Lost to Follow-up|0|||
19770963|NCT03162055|42224827|FG001|Overall Study|Lost to Follow-up|1|||
19770964|NCT03162055|42224826|FG000|Overall Study|Study-specific withdrawal criteria|22|||
19770965|NCT03162055|42224827|FG001|Overall Study|Study-specific withdrawal criteria|14|||
19770966|NCT03162055|42224826|FG000|Overall Study|Withdrawal by Subject|17|||
19770967|NCT03162055|42224827|FG001|Overall Study|Withdrawal by Subject|2|||
19770968|NCT03162055|42224826|FG000|Overall Study|Did not receive treatment|2|||
19770969|NCT03162055|42224827|FG001|Overall Study|Did not receive treatment|0|||
19770970|NCT03162055|42224826|FG000|Overall Study|Incorrect randomization|4|||
19770971|NCT03162055|42224827|FG001|Overall Study|Incorrect randomization|3|||
19770972|NCT03162055|42224826|FG000|Overall Study|Other|8|||
19770973|NCT03162055|42224827|FG001|Overall Study|Other|15|||
19688443|NCT00410072|42134598|FG000|After Week 48 to Week 96|Other|2|||
19688444|NCT00410072|42134599|FG001|After Week 48 to Week 96|Other|0|||
19688445|NCT00410072|42134598|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
19688446|NCT00410072|42134599|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
19688447|NCT00410072|42134598|FG000|After Week 48 to Week 96|Pregnancy|0|||
19770974|NCT02927145|42224840|FG000|Initial Recruitment|Withdrawal by Subject|0|||
19770975|NCT02927145|42224841|FG001|Initial Recruitment|Withdrawal by Subject|1|||
19770976|NCT02927145|42224842|FG002|Initial Recruitment|Withdrawal by Subject|1|||
19770977|NCT02927145|42224843|FG003|Initial Recruitment|Withdrawal by Subject|4|||
19770978|NCT02927145|42224844|FG004|Initial Recruitment|Withdrawal by Subject|1|||
19770979|NCT02927145|42224845|FG005|Initial Recruitment|Withdrawal by Subject|1|||
19770980|NCT02927145|42224846|FG006|Initial Recruitment|Withdrawal by Subject|0|||
19770981|NCT02927145|42224847|FG007|Initial Recruitment|Withdrawal by Subject|0|||
19770982|NCT02927145|42224848|FG008|Initial Recruitment|Withdrawal by Subject|2|||
19770983|NCT02927145|42224840|FG000|Initial Recruitment|Adverse Event|0|||
19770984|NCT02927145|42224841|FG001|Initial Recruitment|Adverse Event|0|||
19770985|NCT02927145|42224842|FG002|Initial Recruitment|Adverse Event|0|||
19770986|NCT02927145|42224843|FG003|Initial Recruitment|Adverse Event|0|||
19770987|NCT02927145|42224844|FG004|Initial Recruitment|Adverse Event|2|||
19770988|NCT02927145|42224845|FG005|Initial Recruitment|Adverse Event|0|||
19770989|NCT02927145|42224846|FG006|Initial Recruitment|Adverse Event|0|||
19770990|NCT02927145|42224847|FG007|Initial Recruitment|Adverse Event|0|||
19770991|NCT02927145|42224848|FG008|Initial Recruitment|Adverse Event|0|||
19770992|NCT02927145|42224840|FG000|Invitation for Additional Challenge|Pregnancy|0|||
19688448|NCT00410072|42134599|FG001|After Week 48 to Week 96|Pregnancy|2|||
19688449|NCT00410072|42134598|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
19688450|NCT00410072|42134599|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
19688451|NCT00409838|42134607|FG000|Short-term Period|Adverse Event|0|||
19688452|NCT00409838|42134608|FG001|Short-term Period|Adverse Event|1|||
19688453|NCT00409838|42134607|FG000|Short-term Period|Lost to Follow-up|0|||
19688454|NCT00409838|42134608|FG001|Short-term Period|Lost to Follow-up|1|||
19688455|NCT00409838|42134607|FG000|Short-term Period|Withdrawal by Subject|2|||
19688456|NCT00409838|42134608|FG001|Short-term Period|Withdrawal by Subject|3|||
19688457|NCT00409838|42134607|FG000|Short-term Period|Never Treated|1|||
19688458|NCT00409838|42134608|FG001|Short-term Period|Never Treated|0|||
19688459|NCT00409838|42134607|FG000|Long-term Extension Period|Adverse Event|10|||
19770993|NCT02927145|42224841|FG001|Invitation for Additional Challenge|Pregnancy|0|||
19770994|NCT02927145|42224842|FG002|Invitation for Additional Challenge|Pregnancy|0|||
19770995|NCT02927145|42224843|FG003|Invitation for Additional Challenge|Pregnancy|0|||
19770996|NCT02927145|42224844|FG004|Invitation for Additional Challenge|Pregnancy|0|||
19770997|NCT02927145|42224845|FG005|Invitation for Additional Challenge|Pregnancy|0|||
19770998|NCT02927145|42224846|FG006|Invitation for Additional Challenge|Pregnancy|1|||
19770999|NCT02927145|42224847|FG007|Invitation for Additional Challenge|Pregnancy|0|||
19771000|NCT02927145|42224848|FG008|Invitation for Additional Challenge|Pregnancy|0|||
19771001|NCT03688919|42224871|FG000|Overall Study|Lost to Follow-up|2|||
19771002|NCT03688919|42224872|FG001|Overall Study|Lost to Follow-up|1|||
19771003|NCT03688919|42224871|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
19771004|NCT03688919|42224872|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
19771005|NCT02888119|42224895|FG000|Overall Study|Lost to Follow-up|5|||
19771006|NCT02888119|42224896|FG001|Overall Study|Lost to Follow-up|4|||
19771007|NCT02888119|42224897|FG002|Overall Study|Lost to Follow-up|0|||
19771008|NCT03197129|42224906|FG000|Overall Study|did not answer the VPT: shyness|4|||
19771009|NCT03197129|42224907|FG001|Overall Study|did not answer the VPT: shyness|5|||
19771010|NCT03196973|42224916|FG000|Overall Study|Adverse Event|1|||
19771011|NCT03196973|42224917|FG001|Overall Study|Adverse Event|1|||
19771012|NCT03196973|42224918|FG002|Overall Study|Adverse Event|2|||
19771013|NCT03196973|42224916|FG000|Overall Study|Lack of Efficacy|2|||
19771014|NCT03196973|42224917|FG001|Overall Study|Lack of Efficacy|6|||
19771015|NCT03196973|42224918|FG002|Overall Study|Lack of Efficacy|1|||
19771016|NCT03196973|42224916|FG000|Overall Study|Lost to Follow-up|4|||
19771017|NCT03196973|42224917|FG001|Overall Study|Lost to Follow-up|3|||
19771018|NCT03196973|42224918|FG002|Overall Study|Lost to Follow-up|2|||
19771019|NCT03196973|42224916|FG000|Overall Study|Consent withdrawn|2|||
19771020|NCT03196973|42224917|FG001|Overall Study|Consent withdrawn|1|||
19771021|NCT03196973|42224918|FG002|Overall Study|Consent withdrawn|0|||
19771022|NCT03196973|42224916|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
19771023|NCT03196973|42224917|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
19771024|NCT03196973|42224918|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
19771025|NCT03196505|42224928|FG000|Overall Study|Physician Decision|26|||
19771026|NCT03196505|42224929|FG001|Overall Study|Physician Decision|26|||
19771027|NCT03196349|42224938|FG000|Overall Study|Did not receive study drug|0|||
19771028|NCT03196349|42224939|FG001|Overall Study|Did not receive study drug|1|||
19771029|NCT03196349|42224940|FG002|Overall Study|Did not receive study drug|2|||
19771030|NCT03196349|42224938|FG000|Overall Study|No data entered|2|||
19771031|NCT03196349|42224939|FG001|Overall Study|No data entered|4|||
19771032|NCT03196349|42224940|FG002|Overall Study|No data entered|0|||
19771033|NCT03196349|42224938|FG000|Overall Study|Study Terminated early|15|||
19771034|NCT03196349|42224939|FG001|Overall Study|Study Terminated early|9|||
19389141|NCT02663687|41632708|FG002|Overall Study|Other|1|||
19688460|NCT00409838|42134608|FG001|Long-term Extension Period|Adverse Event|0|||
19688461|NCT00409838|42134607|FG000|Long-term Extension Period|Death|1|||
19771035|NCT03196349|42224940|FG002|Overall Study|Study Terminated early|11|||
19771036|NCT02886715|42224951|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19771037|NCT02886715|42224952|FG001|Overall Study|Non-Compliance With Study Drug|2|||
19771038|NCT02886715|42224953|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19771039|NCT02886715|42224951|FG000|Overall Study|Adverse Event|4|||
19771040|NCT02886715|42224952|FG001|Overall Study|Adverse Event|2|||
19771041|NCT02886715|42224953|FG002|Overall Study|Adverse Event|0|||
19771042|NCT02886715|42224951|FG000|Overall Study|Lack of Efficacy|0|||
19771043|NCT02886715|42224952|FG001|Overall Study|Lack of Efficacy|2|||
19771044|NCT02886715|42224953|FG002|Overall Study|Lack of Efficacy|1|||
19771045|NCT02886715|42224951|FG000|Overall Study|Lost to Follow-up|29|||
19771046|NCT02886715|42224952|FG001|Overall Study|Lost to Follow-up|26|||
19771047|NCT02886715|42224953|FG002|Overall Study|Lost to Follow-up|10|||
19688462|NCT00409838|42134608|FG001|Long-term Extension Period|Death|0|||
19688463|NCT00409838|42134607|FG000|Long-term Extension Period|Lack of Efficacy|2|||
19688464|NCT00409838|42134608|FG001|Long-term Extension Period|Lack of Efficacy|0|||
19688465|NCT00409838|42134607|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
19688466|NCT00409838|42134608|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
19688467|NCT00409838|42134607|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
19688468|NCT00409838|42134608|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
19688469|NCT00409838|42134607|FG000|Long-term Extension Period|Pregnancy|1|||
19771048|NCT02886715|42224951|FG000|Overall Study|Pregnancy|1|||
19771049|NCT02886715|42224952|FG001|Overall Study|Pregnancy|1|||
19771050|NCT02886715|42224953|FG002|Overall Study|Pregnancy|1|||
19771051|NCT02886715|42224951|FG000|Overall Study|Protocol Violation|3|||
19771052|NCT02886715|42224952|FG001|Overall Study|Protocol Violation|2|||
19771053|NCT02886715|42224953|FG002|Overall Study|Protocol Violation|1|||
19771054|NCT02886715|42224951|FG000|Overall Study|Withdrawal by Subject|20|||
19771055|NCT02886715|42224952|FG001|Overall Study|Withdrawal by Subject|18|||
19771056|NCT02886715|42224953|FG002|Overall Study|Withdrawal by Subject|5|||
19771057|NCT02886715|42224951|FG000|Overall Study|missing|7|||
19771058|NCT02886715|42224952|FG001|Overall Study|missing|2|||
19771059|NCT02886715|42224953|FG002|Overall Study|missing|2|||
19771060|NCT03085797|42224963|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
19771061|NCT03085797|42224964|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
19771062|NCT03085797|42224963|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
19771063|NCT03085797|42224964|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
19771064|NCT03085797|42224963|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
19771065|NCT03085797|42224964|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
19771066|NCT03157531|42224972|FG000|Overall Study|Death|2|||
19771067|NCT03157531|42224972|FG000|Overall Study|Lost to Follow-up|4|||
19771068|NCT03633617|42224981|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
19771069|NCT03633617|42224982|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
19771070|NCT03633617|42224983|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
19771071|NCT03633617|42224984|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
19771072|NCT03633617|42224985|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
19771073|NCT03633617|42224981|FG000|Part A|Unconfirmed early termination visit|1|||
19771074|NCT03633617|42224982|FG001|Part A|Unconfirmed early termination visit|0|||
19771075|NCT03633617|42224983|FG002|Part A|Unconfirmed early termination visit|0|||
19771076|NCT03633617|42224984|FG003|Part A|Unconfirmed early termination visit|0|||
19771077|NCT03633617|42224985|FG004|Part A|Unconfirmed early termination visit|0|||
19771078|NCT03633617|42224981|FG000|Part A|Adverse Event|0|||
19771079|NCT03633617|42224982|FG001|Part A|Adverse Event|1|||
19771080|NCT03633617|42224983|FG002|Part A|Adverse Event|0|||
19688470|NCT00409838|42134608|FG001|Long-term Extension Period|Pregnancy|0|||
19688471|NCT00399542|42134633|FG000|Overall Study|Adverse Event|18|||
19688472|NCT00399542|42134634|FG001|Overall Study|Adverse Event|15|||
19688473|NCT00399542|42134633|FG000|Overall Study|Protocol Violation|13|||
19688474|NCT00399542|42134634|FG001|Overall Study|Protocol Violation|3|||
19688475|NCT00399542|42134633|FG000|Overall Study|Withdrawal by Subject|28|||
19688476|NCT00399542|42134634|FG001|Overall Study|Withdrawal by Subject|10|||
19688477|NCT00399542|42134633|FG000|Overall Study|Lack of Efficacy|18|||
19688478|NCT00399542|42134634|FG001|Overall Study|Lack of Efficacy|8|||
19688479|NCT00399542|42134633|FG000|Overall Study|Lost to Follow-up|6|||
19688480|NCT00399542|42134634|FG001|Overall Study|Lost to Follow-up|6|||
19688481|NCT00399542|42134633|FG000|Overall Study|Other|1|||
19688482|NCT00399542|42134634|FG001|Overall Study|Other|0|||
19771081|NCT03633617|42224984|FG003|Part A|Adverse Event|0|||
19771082|NCT03633617|42224985|FG004|Part A|Adverse Event|0|||
19771083|NCT03633617|42224981|FG000|Part A|Pregnancy|1|||
19771084|NCT03633617|42224982|FG001|Part A|Pregnancy|0|||
19771085|NCT03633617|42224983|FG002|Part A|Pregnancy|0|||
19771086|NCT03633617|42224984|FG003|Part A|Pregnancy|0|||
19771087|NCT03633617|42224985|FG004|Part A|Pregnancy|0|||
19688483|NCT00399542|42134633|FG000|Overall Study|Physician Decision|0|||
19688484|NCT00399542|42134634|FG001|Overall Study|Physician Decision|1|||
19771088|NCT03633617|42224981|FG000|Part A|Withdrawal by Subject|0|||
19771089|NCT03633617|42224982|FG001|Part A|Withdrawal by Subject|1|||
19771090|NCT03633617|42224983|FG002|Part A|Withdrawal by Subject|0|||
19771091|NCT03633617|42224984|FG003|Part A|Withdrawal by Subject|0|||
19771092|NCT03633617|42224985|FG004|Part A|Withdrawal by Subject|0|||
19771093|NCT03633617|42224981|FG000|Part B|Adverse Event|0|||
19771094|NCT03633617|42224982|FG001|Part B|Adverse Event|0|||
19771095|NCT03633617|42224983|FG002|Part B|Adverse Event|2|||
19771096|NCT03633617|42224984|FG003|Part B|Adverse Event|2|||
19771097|NCT03633617|42224985|FG004|Part B|Adverse Event|1|||
19771098|NCT03633617|42224981|FG000|Part B|Withdrawal by Subject|0|||
19771099|NCT03633617|42224982|FG001|Part B|Withdrawal by Subject|0|||
19771100|NCT03633617|42224983|FG002|Part B|Withdrawal by Subject|1|||
19771101|NCT03633617|42224984|FG003|Part B|Withdrawal by Subject|0|||
19771102|NCT03633617|42224985|FG004|Part B|Withdrawal by Subject|2|||
19771103|NCT03633617|42224981|FG000|Part B|Lost to Follow-up|0|||
19771104|NCT03633617|42224982|FG001|Part B|Lost to Follow-up|0|||
19771105|NCT03633617|42224983|FG002|Part B|Lost to Follow-up|0|||
19771106|NCT03633617|42224984|FG003|Part B|Lost to Follow-up|0|||
19771107|NCT03633617|42224985|FG004|Part B|Lost to Follow-up|1|||
19771108|NCT03633617|42224981|FG000|Part B|Physician Decision|0|||
19771109|NCT03633617|42224982|FG001|Part B|Physician Decision|0|||
19771110|NCT03633617|42224983|FG002|Part B|Physician Decision|0|||
19771111|NCT03633617|42224984|FG003|Part B|Physician Decision|0|||
19771112|NCT03633617|42224985|FG004|Part B|Physician Decision|1|||
19771113|NCT03633617|42224981|FG000|Part B|COVID-19 Restrictions|0|||
19771114|NCT03633617|42224982|FG001|Part B|COVID-19 Restrictions|0|||
19771115|NCT03633617|42224983|FG002|Part B|COVID-19 Restrictions|1|||
19771116|NCT03633617|42224984|FG003|Part B|COVID-19 Restrictions|0|||
19771117|NCT03633617|42224985|FG004|Part B|COVID-19 Restrictions|0|||
19771118|NCT03633617|42224981|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
19771119|NCT03633617|42224982|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
19771120|NCT03633617|42224983|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
19771121|NCT03633617|42224984|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
19771122|NCT03633617|42224985|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
19771123|NCT03159091|42224999|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
19771124|NCT03159091|42225000|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
19771125|NCT03159091|42224999|FG000|Overall Study|Patient has taken no dose of study drug|0|||
19771126|NCT03159091|42225000|FG001|Overall Study|Patient has taken no dose of study drug|1|||
19771127|NCT03196193|42225008|FG000|Overall Study|Adverse Event|1|||
19771128|NCT03196193|42225009|FG001|Overall Study|Adverse Event|0|||
19771129|NCT03196193|42225008|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
19771130|NCT03196193|42225009|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
19771131|NCT03621761|42225018|FG000|Overall Study|Lost to Follow-up|1|||
19771132|NCT03621761|42225019|FG001|Overall Study|Lost to Follow-up|1|||
19771133|NCT03621761|42225020|FG002|Overall Study|Lost to Follow-up|2|||
19771134|NCT03621761|42225018|FG000|Overall Study|Withdrawal by Subject|2|||
19771135|NCT03621761|42225019|FG001|Overall Study|Withdrawal by Subject|1|||
19771136|NCT03621761|42225020|FG002|Overall Study|Withdrawal by Subject|1|||
19771137|NCT03621761|42225018|FG000|Overall Study|Became Ineligible|0|||
19771138|NCT03621761|42225019|FG001|Overall Study|Became Ineligible|2|||
19771139|NCT03621761|42225020|FG002|Overall Study|Became Ineligible|0|||
19771140|NCT03221387|42225028|FG000|Overall Study|Lost to Follow-up|1|||
19771141|NCT03221387|42225028|FG000|Overall Study|Lung transplant|1|||
19771142|NCT03318861|42225037|FG000|Overall Study|Death|1|||
19771143|NCT03318861|42225038|FG001|Overall Study|Death|2|||
19771144|NCT03318861|42225039|FG002|Overall Study|Death|2|||
19771145|NCT03318861|42225040|FG003|Overall Study|Death|1|||
19771146|NCT03318861|42225041|FG004|Overall Study|Death|1|||
19771147|NCT03318861|42225037|FG000|Overall Study|Still on Study|2|||
19771148|NCT03318861|42225038|FG001|Overall Study|Still on Study|1|||
19771149|NCT03318861|42225039|FG002|Overall Study|Still on Study|1|||
19771150|NCT03318861|42225040|FG003|Overall Study|Still on Study|2|||
19771151|NCT03318861|42225041|FG004|Overall Study|Still on Study|1|||
19771152|NCT03318861|42225037|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
19771153|NCT03318861|42225038|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
19771154|NCT03318861|42225039|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
19771155|NCT03318861|42225040|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
19771156|NCT03318861|42225041|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
19771157|NCT03084315|42225055|FG000|Overall Study|Lost to Follow-up|8|||
19771158|NCT03084315|42225056|FG001|Overall Study|Lost to Follow-up|7|||
19771159|NCT03084315|42225055|FG000|Overall Study|Withdrawal by Subject|2|||
19771160|NCT03084315|42225056|FG001|Overall Study|Withdrawal by Subject|2|||
19771161|NCT03187301|42225062|FG000|Titration Period|Adverse Event|0|||
19771162|NCT03187301|42225063|FG001|Titration Period|Adverse Event|0|||
19771163|NCT03187301|42225064|FG002|Titration Period|Adverse Event|0|||
19771164|NCT03187301|42225065|FG003|Titration Period|Adverse Event|0|||
19771165|NCT03187301|42225066|FG004|Titration Period|Adverse Event|0|||
19771166|NCT03187301|42225067|FG005|Titration Period|Adverse Event|0|||
19771167|NCT03187301|42225068|FG006|Titration Period|Adverse Event|5|||
19771168|NCT03187301|42225062|FG000|Titration Period|Withdrawal by Subject|0|||
19771169|NCT03187301|42225063|FG001|Titration Period|Withdrawal by Subject|0|||
19771170|NCT03187301|42225064|FG002|Titration Period|Withdrawal by Subject|0|||
19771171|NCT03187301|42225065|FG003|Titration Period|Withdrawal by Subject|0|||
19771172|NCT03187301|42225066|FG004|Titration Period|Withdrawal by Subject|0|||
19771173|NCT03187301|42225067|FG005|Titration Period|Withdrawal by Subject|0|||
19771174|NCT03187301|42225068|FG006|Titration Period|Withdrawal by Subject|1|||
19771175|NCT03187301|42225062|FG000|Titration Period|Exclusion Criteria Met|0|||
19771176|NCT03187301|42225063|FG001|Titration Period|Exclusion Criteria Met|0|||
19771177|NCT03187301|42225064|FG002|Titration Period|Exclusion Criteria Met|0|||
19771178|NCT03187301|42225065|FG003|Titration Period|Exclusion Criteria Met|0|||
19771179|NCT03187301|42225066|FG004|Titration Period|Exclusion Criteria Met|0|||
19771180|NCT03187301|42225067|FG005|Titration Period|Exclusion Criteria Met|0|||
19771181|NCT03187301|42225068|FG006|Titration Period|Exclusion Criteria Met|1|||
19771182|NCT03187301|42225062|FG000|Pre-Intervention|Withdrawal by Subject|1|||
19771183|NCT03187301|42225063|FG001|Pre-Intervention|Withdrawal by Subject|0|||
19771184|NCT03187301|42225064|FG002|Pre-Intervention|Withdrawal by Subject|0|||
19771185|NCT03187301|42225065|FG003|Pre-Intervention|Withdrawal by Subject|0|||
19771186|NCT03187301|42225066|FG004|Pre-Intervention|Withdrawal by Subject|0|||
19771187|NCT03187301|42225067|FG005|Pre-Intervention|Withdrawal by Subject|0|||
19771188|NCT03187301|42225068|FG006|Pre-Intervention|Withdrawal by Subject|0|||
19771189|NCT02946047|42225093|FG000|Overall Study|Adverse Event|1|||
19771190|NCT02946047|42225094|FG001|Overall Study|Adverse Event|0|||
19771191|NCT02946047|42225095|FG002|Overall Study|Adverse Event|0|||
19771192|NCT02946047|42225096|FG003|Overall Study|Adverse Event|0|||
19771193|NCT03077919|42225108|FG000|Overall Study|Lost to Follow-up|4|||
19771194|NCT03077919|42225109|FG001|Overall Study|Lost to Follow-up|1|||
19771195|NCT03220217|42225118|FG000|Overall Study|Withdrawal by Subject|0|||
19771196|NCT03220217|42225119|FG001|Overall Study|Withdrawal by Subject|1|||
19771197|NCT03220217|42225120|FG002|Overall Study|Withdrawal by Subject|0|||
19771198|NCT03220217|42225118|FG000|Overall Study|Subject Missed Procedure|0|||
19771199|NCT03220217|42225119|FG001|Overall Study|Subject Missed Procedure|0|||
19771200|NCT03220217|42225120|FG002|Overall Study|Subject Missed Procedure|1|||
19771201|NCT03192137|42225151|FG000|Overall Study|Adverse Event|10|||
19771202|NCT03192137|42225152|FG001|Overall Study|Adverse Event|11|||
19771203|NCT03192137|42225151|FG000|Overall Study|Physician Decision|1|||
19771204|NCT03192137|42225152|FG001|Overall Study|Physician Decision|0|||
19771205|NCT03192137|42225151|FG000|Overall Study|Lack of Efficacy|20|||
19771206|NCT03192137|42225152|FG001|Overall Study|Lack of Efficacy|37|||
19771207|NCT03192137|42225151|FG000|Overall Study|Withdrawal by Subject|3|||
19771208|NCT03192137|42225152|FG001|Overall Study|Withdrawal by Subject|3|||
19771209|NCT03192137|42225151|FG000|Overall Study|Protocol Violation|4|||
19771210|NCT03192137|42225152|FG001|Overall Study|Protocol Violation|3|||
19771211|NCT03192137|42225151|FG000|Overall Study|Surgery Cancelled|4|||
19771212|NCT03192137|42225152|FG001|Overall Study|Surgery Cancelled|1|||
19771213|NCT03192137|42225151|FG000|Overall Study|Other - Various Administrative Reasons|8|||
19771214|NCT03192137|42225152|FG001|Overall Study|Other - Various Administrative Reasons|3|||
19771215|NCT03881059|42225172|FG000|Treatment Period - Part A|Adverse Event|1|||
19771216|NCT03881059|42225173|FG001|Treatment Period - Part A|Adverse Event|3|||
19771217|NCT03881059|42225174|FG002|Treatment Period - Part A|Adverse Event|4|||
19771218|NCT03881059|42225172|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
19771219|NCT03881059|42225173|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
19771220|NCT03881059|42225174|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
19688485|NCT00409682|42134643|FG000|Open-label Induction Period|Adverse Event|1|||
19688486|NCT00409682|42134644|FG001|Open-label Induction Period|Adverse Event|0|||
19688487|NCT00409682|42134645|FG002|Open-label Induction Period|Adverse Event|0|||
19688488|NCT00409682|42134643|FG000|Open-label Induction Period|Lack of Efficacy|1|||
19688489|NCT00409682|42134644|FG001|Open-label Induction Period|Lack of Efficacy|0|||
19688490|NCT00409682|42134645|FG002|Open-label Induction Period|Lack of Efficacy|0|||
19688491|NCT00409682|42134643|FG000|Open-label Induction Period|Protocol Violation|1|||
19688492|NCT00409682|42134644|FG001|Open-label Induction Period|Protocol Violation|0|||
19688493|NCT00409682|42134645|FG002|Open-label Induction Period|Protocol Violation|0|||
19771221|NCT03881059|42225172|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
19771222|NCT03881059|42225173|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
19771223|NCT03881059|42225174|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
19771224|NCT03881059|42225172|FG000|Treatment Period - Part A|Other reasons|2|||
19771225|NCT03881059|42225173|FG001|Treatment Period - Part A|Other reasons|1|||
19771226|NCT03881059|42225174|FG002|Treatment Period - Part A|Other reasons|0|||
19771227|NCT03881059|42225172|FG000|Treatment Period - Part B|Adverse Event|0|||
19688494|NCT00409682|42134643|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
19771228|NCT03881059|42225173|FG001|Treatment Period - Part B|Adverse Event|0|||
19771229|NCT03881059|42225174|FG002|Treatment Period - Part B|Adverse Event|3|||
19771230|NCT03881059|42225172|FG000|Treatment Period - Part B|Death|0|||
19771231|NCT03881059|42225173|FG001|Treatment Period - Part B|Death|1|||
19771232|NCT03881059|42225174|FG002|Treatment Period - Part B|Death|1|||
19771233|NCT03881059|42225172|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
19771234|NCT03881059|42225173|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
19771235|NCT03881059|42225174|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
19771236|NCT03881059|42225172|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
19771237|NCT03881059|42225173|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
19771238|NCT03881059|42225174|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
19771239|NCT03881059|42225172|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
19771240|NCT03881059|42225173|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
19771241|NCT03881059|42225174|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
19771242|NCT03881059|42225172|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
19771243|NCT03881059|42225173|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
19771244|NCT03881059|42225174|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
19771245|NCT03881059|42225172|FG000|Treatment Period - Part B|Other reasons|4|||
19771246|NCT03881059|42225173|FG001|Treatment Period - Part B|Other reasons|3|||
19771247|NCT03881059|42225174|FG002|Treatment Period - Part B|Other reasons|3|||
19771248|NCT02861534|42225189|FG000|Overall Study|Death|541|||
19771249|NCT02861534|42225190|FG001|Overall Study|Death|552|||
19771250|NCT02861534|42225189|FG000|Overall Study|Lost to Follow-up|14|||
19771251|NCT02861534|42225190|FG001|Overall Study|Lost to Follow-up|14|||
19771252|NCT02861534|42225189|FG000|Overall Study|Site Terminated by Sponsor|4|||
19771253|NCT02861534|42225190|FG001|Overall Study|Site Terminated by Sponsor|3|||
19771254|NCT02861534|42225189|FG000|Overall Study|Withdrawal by Subject|15|||
19771255|NCT02861534|42225190|FG001|Overall Study|Withdrawal by Subject|18|||
19605703|NCT00949910|42054436|FG000|Overall Study|Non-Compliance|10|||
19605704|NCT00949910|42054436|FG000|Overall Study|Prolonged Dosing Interruption|4|||
19605705|NCT00949910|42054436|FG000|Overall Study|Adverse Event|83|||
19605706|NCT00949910|42054436|FG000|Overall Study|Serious Adverse Event|6|||
19688495|NCT00409682|42134644|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
19688496|NCT00409682|42134645|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
19688497|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
19688498|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
19688499|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
19688500|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
19688501|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
19688502|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
19688503|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
19688504|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
19688505|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
19688506|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
19688507|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
19688508|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
19688509|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
19688510|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
19688511|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
19688512|NCT00409682|42134643|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
19688513|NCT00409682|42134644|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
19688514|NCT00409682|42134645|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
19688515|NCT00398216|42134657|FG000|Overall Study|Adverse Event|4|||
19688516|NCT00398216|42134658|FG001|Overall Study|Adverse Event|2|||
19688517|NCT00398216|42134659|FG002|Overall Study|Adverse Event|5|||
19688518|NCT00398216|42134660|FG003|Overall Study|Adverse Event|7|||
19688519|NCT00398216|42134661|FG004|Overall Study|Adverse Event|2|||
19688520|NCT00398216|42134657|FG000|Overall Study|Protocol Violation|2|||
19688521|NCT00398216|42134658|FG001|Overall Study|Protocol Violation|4|||
19688522|NCT00398216|42134659|FG002|Overall Study|Protocol Violation|5|||
19771256|NCT03083847|42225231|FG000|Main|Physician Decision|0|||
19771257|NCT03083847|42225232|FG001|Main|Physician Decision|0|||
19605707|NCT00949910|42054436|FG000|Overall Study|Physician/Participant Decision|7|||
19605708|NCT00949910|42054436|FG000|Overall Study|Other|4|||
19605709|NCT00949910|42054436|FG000|Overall Study|No Data|9|||
19605710|NCT00686959|42054442|FG000|Overall Study|Participants censored (no death events)|124|||
19688523|NCT00398216|42134660|FG003|Overall Study|Protocol Violation|7|||
19688524|NCT00398216|42134661|FG004|Overall Study|Protocol Violation|5|||
19688525|NCT00398216|42134657|FG000|Overall Study|Lost to Follow-up|1|||
19688526|NCT00398216|42134658|FG001|Overall Study|Lost to Follow-up|6|||
19688527|NCT00398216|42134659|FG002|Overall Study|Lost to Follow-up|4|||
19771258|NCT03083847|42225233|FG002|Main|Physician Decision|0|||
19771259|NCT03083847|42225234|FG003|Main|Physician Decision|0|||
19771260|NCT03083847|42225235|FG004|Main|Physician Decision|0|||
19771261|NCT03083847|42225236|FG005|Main|Physician Decision|1|||
19605711|NCT00686959|42054443|FG001|Overall Study|Participants censored (no death events)|117|||
19605712|NCT00946088|42054451|FG000|Overall Study|Withdrawal by Subject|0|||
19605713|NCT00946088|42054452|FG001|Overall Study|Withdrawal by Subject|1|||
19605714|NCT00736996|42054463|FG000|Overall Study|Lost to Follow-up|1|||
19688528|NCT00398216|42134660|FG003|Overall Study|Lost to Follow-up|4|||
19688529|NCT00398216|42134661|FG004|Overall Study|Lost to Follow-up|1|||
19688530|NCT00398216|42134657|FG000|Overall Study|Death|0|||
19688531|NCT00398216|42134658|FG001|Overall Study|Death|3|||
19771262|NCT03083847|42225237|FG006|Main|Physician Decision|0|||
19771263|NCT03083847|42225238|FG007|Main|Physician Decision|0|||
19771264|NCT03083847|42225239|FG008|Main|Physician Decision|0|||
19771265|NCT03083847|42225240|FG009|Main|Physician Decision|0|||
19771266|NCT03083847|42225231|FG000|Main|Pregnancy|0|||
19771267|NCT03083847|42225232|FG001|Main|Pregnancy|0|||
19771268|NCT03083847|42225233|FG002|Main|Pregnancy|0|||
19771269|NCT03083847|42225234|FG003|Main|Pregnancy|0|||
19771270|NCT03083847|42225235|FG004|Main|Pregnancy|0|||
19771271|NCT03083847|42225236|FG005|Main|Pregnancy|0|||
19771272|NCT03083847|42225237|FG006|Main|Pregnancy|0|||
19771273|NCT03083847|42225238|FG007|Main|Pregnancy|1|||
19771274|NCT03083847|42225239|FG008|Main|Pregnancy|0|||
19771275|NCT03083847|42225240|FG009|Main|Pregnancy|0|||
19771276|NCT03083847|42225231|FG000|Main|Adverse Event|0|||
19771277|NCT03083847|42225232|FG001|Main|Adverse Event|0|||
19771278|NCT03083847|42225233|FG002|Main|Adverse Event|0|||
19771279|NCT03083847|42225234|FG003|Main|Adverse Event|0|||
19771280|NCT03083847|42225235|FG004|Main|Adverse Event|0|||
19771281|NCT03083847|42225236|FG005|Main|Adverse Event|0|||
19771282|NCT03083847|42225237|FG006|Main|Adverse Event|0|||
19771283|NCT03083847|42225238|FG007|Main|Adverse Event|2|||
19771284|NCT03083847|42225239|FG008|Main|Adverse Event|0|||
19771285|NCT03083847|42225240|FG009|Main|Adverse Event|0|||
19771286|NCT03083847|42225231|FG000|Main|Withdrawal by Subject|0|||
19771287|NCT03083847|42225232|FG001|Main|Withdrawal by Subject|0|||
19771288|NCT03083847|42225233|FG002|Main|Withdrawal by Subject|0|||
19771289|NCT03083847|42225234|FG003|Main|Withdrawal by Subject|0|||
19771290|NCT03083847|42225235|FG004|Main|Withdrawal by Subject|0|||
19771291|NCT03083847|42225236|FG005|Main|Withdrawal by Subject|0|||
19771292|NCT03083847|42225237|FG006|Main|Withdrawal by Subject|1|||
19771293|NCT03083847|42225238|FG007|Main|Withdrawal by Subject|1|||
19771294|NCT03083847|42225239|FG008|Main|Withdrawal by Subject|0|||
19771295|NCT03083847|42225240|FG009|Main|Withdrawal by Subject|0|||
19771296|NCT03082677|42225268|FG000|Overall Study|Not Treated|2|||
19771297|NCT02858180|42225283|FG000|Overall Study|Lost to Follow-up|0|||
19605715|NCT00736996|42054464|FG001|Overall Study|Lost to Follow-up|9|||
19605716|NCT00736996|42054465|FG002|Overall Study|Lost to Follow-up|2|||
19688532|NCT00398216|42134659|FG002|Overall Study|Death|0|||
19688533|NCT00398216|42134660|FG003|Overall Study|Death|0|||
19688534|NCT00398216|42134661|FG004|Overall Study|Death|0|||
19688535|NCT00398216|42134657|FG000|Overall Study|Withdrawal by Subject|1|||
19688536|NCT00398216|42134658|FG001|Overall Study|Withdrawal by Subject|0|||
19688537|NCT00398216|42134659|FG002|Overall Study|Withdrawal by Subject|3|||
19688538|NCT00398216|42134660|FG003|Overall Study|Withdrawal by Subject|1|||
19688539|NCT00398216|42134661|FG004|Overall Study|Withdrawal by Subject|2|||
19688540|NCT00398216|42134657|FG000|Overall Study|administrative reasons|3|||
19688541|NCT00398216|42134658|FG001|Overall Study|administrative reasons|4|||
19688542|NCT00398216|42134659|FG002|Overall Study|administrative reasons|4|||
19688543|NCT00398216|42134660|FG003|Overall Study|administrative reasons|3|||
19688544|NCT00398216|42134661|FG004|Overall Study|administrative reasons|3|||
19688545|NCT00398216|42134657|FG000|Overall Study|entrance criteria|0|||
19688546|NCT00398216|42134658|FG001|Overall Study|entrance criteria|0|||
19688547|NCT00398216|42134659|FG002|Overall Study|entrance criteria|0|||
19688548|NCT00398216|42134660|FG003|Overall Study|entrance criteria|0|||
19688549|NCT00398216|42134661|FG004|Overall Study|entrance criteria|2|||
19688550|NCT00398138|42134673|FG000|Overall Study|Adverse Event|2|||
19688551|NCT00397982|42134677|FG000|Overall Study|Withdrawal by Subject|1|||
19688552|NCT00397982|42134677|FG000|Overall Study|Adverse Event|1|||
19771298|NCT02858180|42225284|FG001|Overall Study|Lost to Follow-up|2|||
19771299|NCT03082599|42225292|FG000|Overall Study|Lost to Follow-up|1|||
19605717|NCT00728962|42054479|FG000|Implant Placement Surgery|Adverse Event|8|||
19605718|NCT00728962|42054479|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
19605719|NCT00728962|42054479|FG000|Implant Placement Surgery|Protocol Violation|1|||
19771300|NCT03082599|42225293|FG001|Overall Study|Lost to Follow-up|0|||
19771301|NCT01346501|42225301|FG000|Overall Study|Initiated Other Biological Agents|3|||
19771302|NCT01346501|42225302|FG001|Overall Study|Initiated Other Biological Agents|1|||
19771303|NCT01346501|42225301|FG000|Overall Study|Other|8|||
19688553|NCT00397982|42134677|FG000|Overall Study|noncompliance|1|||
19771304|NCT01346501|42225302|FG001|Overall Study|Other|12|||
19771305|NCT03160885|42225312|FG000|Initial Treatment Period|Not dosed|2|||
19771306|NCT03160885|42225313|FG001|Initial Treatment Period|Not dosed|0|||
19771307|NCT03160885|42225314|FG002|Initial Treatment Period|Not dosed|0|||
19771308|NCT03160885|42225315|FG003|Initial Treatment Period|Not dosed|0|||
19688554|NCT00397982|42134677|FG000|Overall Study|Unrelated health issues|1|||
19688555|NCT00408902|42134682|FG000|Overall Study|Lack of Efficacy|7|||
19688556|NCT00408902|42134682|FG000|Overall Study|Adverse Event|3|||
19688557|NCT00397514|42134687|FG000|Overall Study|Withdrawal by Subject|1|||
19688558|NCT00397514|42134687|FG000|Overall Study|Pacing wire malfunction|1|||
19688559|NCT00397514|42134687|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
19688560|NCT00397514|42134687|FG000|Overall Study|early extubation|2|||
19688561|NCT00397514|42134687|FG000|Overall Study|poor echocardiographic windows|1|||
19688562|NCT00397046|42134701|FG000|Overall Study|Disease Progression|3|||
19688563|NCT00397046|42134702|FG001|Overall Study|Disease Progression|3|||
19688564|NCT00397046|42134703|FG002|Overall Study|Disease Progression|10|||
19688565|NCT00397046|42134704|FG003|Overall Study|Disease Progression|5|||
19688566|NCT00419120|42134715|FG000|Long Term Follow up Period|study ongoing|10|||
19688567|NCT00396812|42134719|FG000|Overall Study|Physician Decision|1|||
19688568|NCT00396656|42134723|FG000|First Treatment Period|Withdrawal by Subject|0|||
19688569|NCT00396656|42134724|FG001|First Treatment Period|Withdrawal by Subject|2|||
19688570|NCT00396656|42134723|FG000|Second Treatment Period|Adverse Event|0|||
19688571|NCT00396656|42134724|FG001|Second Treatment Period|Adverse Event|1|||
19688572|NCT00408434|42134737|FG000|Overall Study|Adverse Event|0|||
19688573|NCT00408434|42134738|FG001|Overall Study|Adverse Event|0|||
19688574|NCT00408434|42134739|FG002|Overall Study|Adverse Event|1|||
19688575|NCT00408434|42134740|FG003|Overall Study|Adverse Event|0|||
19688576|NCT00408434|42134741|FG004|Overall Study|Adverse Event|0|||
19688577|NCT00408434|42134742|FG005|Overall Study|Adverse Event|0|||
19688578|NCT00408434|42134743|FG006|Overall Study|Adverse Event|0|||
19688579|NCT00408434|42134737|FG000|Overall Study|Progressive disease|6|||
19688580|NCT00408434|42134738|FG001|Overall Study|Progressive disease|3|||
19688581|NCT00408434|42134739|FG002|Overall Study|Progressive disease|4|||
19688582|NCT00408434|42134740|FG003|Overall Study|Progressive disease|3|||
19688583|NCT00408434|42134741|FG004|Overall Study|Progressive disease|3|||
19688584|NCT00408434|42134742|FG005|Overall Study|Progressive disease|1|||
19688585|NCT00408434|42134743|FG006|Overall Study|Progressive disease|4|||
19688586|NCT00408434|42134737|FG000|Overall Study|Other|0|||
19688587|NCT00408434|42134738|FG001|Overall Study|Other|0|||
19688588|NCT00408434|42134739|FG002|Overall Study|Other|1|||
19688589|NCT00408434|42134740|FG003|Overall Study|Other|0|||
19688590|NCT00408434|42134741|FG004|Overall Study|Other|2|||
19688591|NCT00408434|42134742|FG005|Overall Study|Other|1|||
19688592|NCT00408434|42134743|FG006|Overall Study|Other|0|||
19688593|NCT00408434|42134737|FG000|Overall Study|Terminated by Investigator|0|||
19688594|NCT00408434|42134738|FG001|Overall Study|Terminated by Investigator|0|||
19688595|NCT00408434|42134739|FG002|Overall Study|Terminated by Investigator|0|||
19688596|NCT00408434|42134740|FG003|Overall Study|Terminated by Investigator|0|||
19688597|NCT00408434|42134741|FG004|Overall Study|Terminated by Investigator|1|||
19688598|NCT00408434|42134742|FG005|Overall Study|Terminated by Investigator|1|||
19771309|NCT03160885|42225316|FG004|Initial Treatment Period|Not dosed|0|||
19771310|NCT03160885|42225317|FG005|Initial Treatment Period|Not dosed|0|||
19771311|NCT03160885|42225318|FG006|Initial Treatment Period|Not dosed|0|||
19771312|NCT03160885|42225312|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
19771313|NCT03160885|42225313|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
19771314|NCT03160885|42225314|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19771315|NCT03160885|42225315|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19771316|NCT03160885|42225316|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19771317|NCT03160885|42225317|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19771318|NCT03160885|42225318|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
19771319|NCT03160885|42225312|FG000|Open-label Treatment|Not dosed|0|||
19771320|NCT03160885|42225313|FG001|Open-label Treatment|Not dosed|0|||
19771321|NCT03160885|42225314|FG002|Open-label Treatment|Not dosed|0|||
19771322|NCT03160885|42225315|FG003|Open-label Treatment|Not dosed|0|||
19771323|NCT03160885|42225316|FG004|Open-label Treatment|Not dosed|0|||
19771324|NCT03160885|42225317|FG005|Open-label Treatment|Not dosed|0|||
19605720|NCT00728962|42054479|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
19605721|NCT00728962|42054479|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
19605722|NCT00954122|42054483|FG000|Overall Study|Withdrawal by Subject|5|||
19605723|NCT00954122|42054483|FG000|Overall Study|Adverse Event|1|||
19605724|NCT00954122|42054483|FG000|Overall Study|Safety Reason|1|||
19605725|NCT00586066|42054490|FG000|Overall Study|Lost to Follow-up|6|||
19605726|NCT00586066|42054491|FG001|Overall Study|Lost to Follow-up|3|||
19605727|NCT00586066|42054490|FG000|Overall Study|Lack of Efficacy|5|||
19605728|NCT00586066|42054491|FG001|Overall Study|Lack of Efficacy|3|||
19605729|NCT00586066|42054490|FG000|Overall Study|Adverse Event|2|||
19605730|NCT00586066|42054491|FG001|Overall Study|Adverse Event|2|||
19688599|NCT00408434|42134743|FG006|Overall Study|Terminated by Investigator|0|||
19688600|NCT00418886|42134762|FG000|Overall Study|discontinue treatment survival follow up|90|||
19688601|NCT00418886|42134763|FG001|Overall Study|discontinue treatment survival follow up|91|||
19688602|NCT00418886|42134762|FG000|Overall Study|Death|122|||
19771325|NCT03160885|42225318|FG006|Open-label Treatment|Not dosed|2|||
19771326|NCT03160885|42225312|FG000|Open-label Treatment|Discontinued IMP|0|||
19771327|NCT03160885|42225313|FG001|Open-label Treatment|Discontinued IMP|0|||
19771328|NCT03160885|42225314|FG002|Open-label Treatment|Discontinued IMP|0|||
19771329|NCT03160885|42225315|FG003|Open-label Treatment|Discontinued IMP|0|||
19771330|NCT03160885|42225316|FG004|Open-label Treatment|Discontinued IMP|0|||
19771331|NCT03160885|42225317|FG005|Open-label Treatment|Discontinued IMP|0|||
19771332|NCT03160885|42225318|FG006|Open-label Treatment|Discontinued IMP|131|||
19771333|NCT03160885|42225312|FG000|Open-label Treatment|Completed Week 50|0|||
19771334|NCT03160885|42225313|FG001|Open-label Treatment|Completed Week 50|0|||
19771335|NCT03160885|42225314|FG002|Open-label Treatment|Completed Week 50|0|||
19771336|NCT03160885|42225315|FG003|Open-label Treatment|Completed Week 50|0|||
19771337|NCT03160885|42225316|FG004|Open-label Treatment|Completed Week 50|0|||
19771338|NCT03160885|42225317|FG005|Open-label Treatment|Completed Week 50|0|||
19771339|NCT03160885|42225318|FG006|Open-label Treatment|Completed Week 50|4|||
19771340|NCT03160885|42225312|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19688603|NCT00418886|42134763|FG001|Overall Study|Death|147|||
19688604|NCT00418886|42134762|FG000|Overall Study|Withdrawal by Subject|9|||
19688605|NCT00418886|42134763|FG001|Overall Study|Withdrawal by Subject|10|||
19688606|NCT00418886|42134762|FG000|Overall Study|Lost to Follow-up|4|||
19688607|NCT00418886|42134763|FG001|Overall Study|Lost to Follow-up|6|||
19688608|NCT00418886|42134762|FG000|Overall Study|withdrawn due to other reason|1|||
19688609|NCT00418886|42134763|FG001|Overall Study|withdrawn due to other reason|0|||
19688610|NCT00418886|42134762|FG000|Overall Study|randomised but no treatment received|0|||
19688611|NCT00418886|42134763|FG001|Overall Study|randomised but no treatment received|1|||
19688612|NCT00418184|42134775|FG000|Double-blind Phase|Withdrawal by Subject|22|||
19688613|NCT00418184|42134776|FG001|Double-blind Phase|Withdrawal by Subject|9|||
19688614|NCT00418184|42134775|FG000|Double-blind Phase|Adverse Event|2|||
19688615|NCT00418184|42134776|FG001|Double-blind Phase|Adverse Event|1|||
19688616|NCT00418184|42134775|FG000|Double-blind Phase|Poor compliance|3|||
19688617|NCT00418184|42134776|FG001|Double-blind Phase|Poor compliance|1|||
19688618|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
19688619|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
19688620|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
19688621|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
19688622|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
19688623|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
19688624|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
19688625|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
19688626|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
19688627|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
19688628|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
19688629|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
19688630|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
19688631|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
19688632|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
19688633|NCT00407030|42134785|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
19688634|NCT00407030|42134786|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
19688635|NCT00407030|42134787|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
19688636|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
19688637|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
19688638|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
19688639|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
19688640|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
19688641|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
19688642|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
19688643|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
19688644|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
19688645|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
19688646|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
19688647|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
19688648|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
19688649|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
19688650|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
19688651|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
19688652|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
19688653|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
19688654|NCT00407030|42134785|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
19688655|NCT00407030|42134786|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
19688656|NCT00407030|42134787|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
19771341|NCT03160885|42225313|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19688657|NCT00406718|42134800|FG000|Overall Study|Withdrawal by Subject|2|||
19688658|NCT00406718|42134801|FG001|Overall Study|Withdrawal by Subject|9|||
19688659|NCT00406718|42134802|FG002|Overall Study|Withdrawal by Subject|4|||
19688660|NCT00406718|42134800|FG000|Overall Study|Lost to Follow-up|2|||
19688661|NCT00406718|42134801|FG001|Overall Study|Lost to Follow-up|5|||
19688662|NCT00406718|42134802|FG002|Overall Study|Lost to Follow-up|4|||
19688663|NCT00406640|42134814|FG000|Acute Phase|Adverse Event|18|||
19688664|NCT00406640|42134815|FG001|Acute Phase|Adverse Event|13|||
19688665|NCT00406640|42134814|FG000|Acute Phase|Failed to Return|5|||
19688666|NCT00406640|42134815|FG001|Acute Phase|Failed to Return|1|||
19688667|NCT00406640|42134814|FG000|Acute Phase|Physician Decision|0|||
19688668|NCT00406640|42134815|FG001|Acute Phase|Physician Decision|1|||
19688669|NCT00406640|42134814|FG000|Acute Phase|Lost to Follow-up|7|||
19688670|NCT00406640|42134815|FG001|Acute Phase|Lost to Follow-up|4|||
19688671|NCT00406640|42134814|FG000|Acute Phase|Protocol deviation|4|||
19688672|NCT00406640|42134815|FG001|Acute Phase|Protocol deviation|10|||
19688673|NCT00406640|42134814|FG000|Acute Phase|Protocol Violation|3|||
19688674|NCT00406640|42134815|FG001|Acute Phase|Protocol Violation|2|||
19688675|NCT00406640|42134814|FG000|Acute Phase|Withdrawal by Subject|11|||
19688676|NCT00406640|42134815|FG001|Acute Phase|Withdrawal by Subject|9|||
19688677|NCT00406640|42134814|FG000|Acute Phase|Lack of Efficacy|3|||
19688678|NCT00406640|42134815|FG001|Acute Phase|Lack of Efficacy|3|||
19688679|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
19688680|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
19771342|NCT03160885|42225314|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19771343|NCT03160885|42225315|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
19771344|NCT03160885|42225316|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19771345|NCT03160885|42225317|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19771346|NCT03160885|42225318|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
19688681|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Death|1|||
19688682|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Death|0|||
19688683|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
19688684|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
19688685|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
19688686|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
19688687|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
19771347|NCT03160885|42225312|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
19771348|NCT03160885|42225313|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
19771349|NCT03160885|42225314|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
19771350|NCT03160885|42225315|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
19771351|NCT03160885|42225316|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
19771352|NCT03160885|42225317|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
19771353|NCT03160885|42225318|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
19771354|NCT03160885|42225312|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19771355|NCT03160885|42225313|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19771356|NCT03160885|42225314|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
19771357|NCT03160885|42225315|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
19771358|NCT03160885|42225316|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
19688688|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
19688689|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|non-compliance|7|||
19771359|NCT03160885|42225317|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
19771360|NCT03160885|42225318|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
19688690|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|non-compliance|5|||
19688691|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
19688692|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
19688693|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
19688694|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
19688695|NCT00406640|42134814|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
19688696|NCT00406640|42134815|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
19688697|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
19688698|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
19688699|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
19688700|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
19771361|NCT03160885|42225312|FG000|Maintenance Treatment Period|Completed Week 50|0|||
19771362|NCT03160885|42225313|FG001|Maintenance Treatment Period|Completed Week 50|0|||
19771363|NCT03160885|42225314|FG002|Maintenance Treatment Period|Completed Week 50|1|||
19771364|NCT03160885|42225315|FG003|Maintenance Treatment Period|Completed Week 50|0|||
19771365|NCT03160885|42225316|FG004|Maintenance Treatment Period|Completed Week 50|0|||
19771366|NCT03160885|42225317|FG005|Maintenance Treatment Period|Completed Week 50|0|||
19771367|NCT03160885|42225318|FG006|Maintenance Treatment Period|Completed Week 50|0|||
19688701|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
19688702|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
19771368|NCT03181451|42225338|FG000|Overall Study|Adverse Event|0|||
19771369|NCT03181451|42225339|FG001|Overall Study|Adverse Event|1|||
19771370|NCT03181451|42225340|FG002|Overall Study|Adverse Event|0|||
19771371|NCT03181451|42225338|FG000|Overall Study|Withdrawal by Subject|0|||
19771372|NCT03181451|42225339|FG001|Overall Study|Withdrawal by Subject|1|||
19771373|NCT03181451|42225340|FG002|Overall Study|Withdrawal by Subject|0|||
19771374|NCT00406783|42225352|FG000|Overall Study|Adverse Event|4|||
19771375|NCT00406783|42225353|FG001|Overall Study|Adverse Event|4|||
19771376|NCT00406783|42225352|FG000|Overall Study|Treatment Failure|2|||
19771377|NCT00406783|42225353|FG001|Overall Study|Treatment Failure|3|||
19771378|NCT00406783|42225352|FG000|Overall Study|Lost to Follow-up|3|||
19771379|NCT00406783|42225353|FG001|Overall Study|Lost to Follow-up|0|||
19771380|NCT00406783|42225352|FG000|Overall Study|Withdrawal by Subject|1|||
19771381|NCT00406783|42225353|FG001|Overall Study|Withdrawal by Subject|4|||
19771382|NCT00406783|42225352|FG000|Overall Study|Protocol Violation|4|||
19771383|NCT00406783|42225353|FG001|Overall Study|Protocol Violation|4|||
19771384|NCT03179891|42225359|FG000|First Intervention|Withdrawal by Subject|1|||
19771385|NCT03179891|42225360|FG001|First Intervention|Withdrawal by Subject|1|||
19771386|NCT03179891|42225359|FG000|First Intervention|Unspecified reason|1|||
19771387|NCT03179891|42225360|FG001|First Intervention|Unspecified reason|0|||
19771388|NCT03179891|42225359|FG000|First Intervention|Protocol Violation|0|||
19771389|NCT03179891|42225360|FG001|First Intervention|Protocol Violation|1|||
19771390|NCT02973815|42225371|FG000|Post Intervention|Death|1|||
19771391|NCT02973815|42225372|FG001|Post Intervention|Death|0|||
19771392|NCT02973815|42225371|FG000|Post Intervention|Lost to Follow-up|7|||
19771393|NCT02973815|42225372|FG001|Post Intervention|Lost to Follow-up|24|||
19771394|NCT02973815|42225371|FG000|Follow-up|Lost to Follow-up|2|||
19771395|NCT02973815|42225372|FG001|Follow-up|Lost to Follow-up|0|||
19771396|NCT03160573|42225382|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
19771397|NCT03160573|42225383|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
19771398|NCT03160573|42225384|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
19771399|NCT03160573|42225385|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
19771400|NCT02736227|42225398|FG000|Overall Study|Withdrawal by Subject|0|||
19771401|NCT02736227|42225399|FG001|Overall Study|Withdrawal by Subject|0|||
19688703|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
19688704|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
19688705|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
19688706|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
19688707|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
19688708|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
19688709|NCT00406640|42134814|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
19688710|NCT00406640|42134815|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
19688711|NCT00394706|42134835|FG000|Overall Study|Withdrawal by Subject|2|||
19688712|NCT00394706|42134836|FG001|Overall Study|Withdrawal by Subject|0|||
19688713|NCT00394706|42134837|FG002|Overall Study|Withdrawal by Subject|1|||
19688714|NCT00394706|42134838|FG003|Overall Study|Withdrawal by Subject|0|||
19688715|NCT00394706|42134839|FG004|Overall Study|Withdrawal by Subject|0|||
19688716|NCT00394706|42134840|FG005|Overall Study|Withdrawal by Subject|2|||
19688717|NCT00394706|42134841|FG006|Overall Study|Withdrawal by Subject|1|||
19688718|NCT00394706|42134842|FG007|Overall Study|Withdrawal by Subject|0|||
19688719|NCT00394706|42134835|FG000|Overall Study|Lost to Follow-up|2|||
19688720|NCT00394706|42134836|FG001|Overall Study|Lost to Follow-up|2|||
19688721|NCT00394706|42134837|FG002|Overall Study|Lost to Follow-up|8|||
19688722|NCT00394706|42134838|FG003|Overall Study|Lost to Follow-up|1|||
19688723|NCT00394706|42134839|FG004|Overall Study|Lost to Follow-up|2|||
19688724|NCT00394706|42134840|FG005|Overall Study|Lost to Follow-up|5|||
19688725|NCT00394706|42134841|FG006|Overall Study|Lost to Follow-up|2|||
19688726|NCT00394706|42134842|FG007|Overall Study|Lost to Follow-up|0|||
19688727|NCT00394472|42134858|FG000|Overall Study|Protocol Violation|1|||
19688728|NCT00394472|42134859|FG001|Overall Study|Protocol Violation|3|||
19688729|NCT00394472|42134858|FG000|Overall Study|incorrect enrolment|4|||
19688730|NCT00394472|42134859|FG001|Overall Study|incorrect enrolment|2|||
19688731|NCT00394472|42134858|FG000|Overall Study|Adverse Event|4|||
19771402|NCT02736227|42225400|FG002|Overall Study|Withdrawal by Subject|1|||
19771403|NCT02736227|42225398|FG000|Overall Study|Physician Decision|0|||
19771404|NCT02736227|42225399|FG001|Overall Study|Physician Decision|0|||
19771405|NCT02736227|42225400|FG002|Overall Study|Physician Decision|5|||
19771406|NCT02736227|42225398|FG000|Overall Study|Non Compliant|0|||
19771407|NCT02736227|42225399|FG001|Overall Study|Non Compliant|0|||
19688732|NCT00394472|42134859|FG001|Overall Study|Adverse Event|2|||
19688733|NCT00394472|42134858|FG000|Overall Study|Withdrawal by Subject|0|||
19688734|NCT00394472|42134859|FG001|Overall Study|Withdrawal by Subject|2|||
19771408|NCT02736227|42225400|FG002|Overall Study|Non Compliant|2|||
19771409|NCT03176459|42225409|FG000|Overall Study|Lost to Follow-up|5|||
19688735|NCT00394472|42134858|FG000|Overall Study|Physician Decision|0|||
19688736|NCT00394472|42134859|FG001|Overall Study|Physician Decision|1|||
19688737|NCT00394472|42134858|FG000|Overall Study|Lost to Follow-up|0|||
19688738|NCT00394472|42134859|FG001|Overall Study|Lost to Follow-up|1|||
19688739|NCT00395642|42134865|FG000|Overall Study|Death|4|||
19688740|NCT00395642|42134865|FG000|Overall Study|Lost to Follow-up|1|||
19688741|NCT00395642|42134865|FG000|Overall Study|Physician Decision|7|||
19688742|NCT00395642|42134865|FG000|Overall Study|Withdrawal by Subject|1|||
19688743|NCT00395486|42134871|FG000|Overall Study|Adverse Event|1|||
19688744|NCT00395486|42134872|FG001|Overall Study|Adverse Event|2|||
19688745|NCT00395486|42134871|FG000|Overall Study|Withdrawal by Subject|5|||
19688746|NCT00395486|42134872|FG001|Overall Study|Withdrawal by Subject|2|||
19688747|NCT00395486|42134871|FG000|Overall Study|Lost to Follow-up|0|||
19688748|NCT00395486|42134872|FG001|Overall Study|Lost to Follow-up|1|||
19688749|NCT00395018|42134878|FG000|On-Treatment|Death|4|||
19688750|NCT00395018|42134878|FG000|On-Treatment|Other Reason|2|||
19688751|NCT00395018|42134878|FG000|On-Treatment|Poor/non-compliance|2|||
19688752|NCT00395018|42134878|FG000|On-Treatment|Subject no longer meets study criteria|2|||
19688753|NCT00395018|42134878|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
19688754|NCT00395018|42134878|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
19688755|NCT00395018|42134878|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
19688756|NCT00375518|42134884|FG000|Overall Study|Withdrawal by Subject|2|||
19688757|NCT00375518|42134885|FG001|Overall Study|Withdrawal by Subject|10|||
19688758|NCT00375518|42134884|FG000|Overall Study|Patient Not Treated|6|||
19688759|NCT00375518|42134885|FG001|Overall Study|Patient Not Treated|6|||
19688760|NCT00375518|42134884|FG000|Overall Study|Death|0|||
19688761|NCT00375518|42134885|FG001|Overall Study|Death|1|||
19688762|NCT00256750|42134894|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
19688763|NCT00256750|42134895|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
19688764|NCT00256750|42134896|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
19688765|NCT00256750|42134894|FG000|Transplanted Pre-Treatment|Other|2|||
19688766|NCT00256750|42134895|FG001|Transplanted Pre-Treatment|Other|0|||
19688767|NCT00256750|42134896|FG002|Transplanted Pre-Treatment|Other|0|||
19688768|NCT00256750|42134894|FG000|Transplanted Pre-Treatment|Death|1|||
19771410|NCT03176459|42225410|FG001|Overall Study|Lost to Follow-up|7|||
19771411|NCT03155269|42225418|FG000|Overall Study|Withdrawal by Subject|4|||
19771412|NCT03155269|42225419|FG001|Overall Study|Withdrawal by Subject|5|||
19771413|NCT03155269|42225418|FG000|Overall Study|Lost to Follow-up|1|||
19771414|NCT03155269|42225419|FG001|Overall Study|Lost to Follow-up|2|||
19771415|NCT02906670|42225435|FG000|Cohort 1, QW|Radiological Progression|1|||
19771416|NCT02906670|42225436|FG001|Cohort 1, QW|Radiological Progression|0|||
19771417|NCT02906670|42225437|FG002|Cohort 1, QW|Radiological Progression|0|||
19771418|NCT02906670|42225438|FG003|Cohort 1, QW|Radiological Progression|0|||
19771419|NCT02906670|42225439|FG004|Cohort 1, QW|Radiological Progression|0|||
19771420|NCT02906670|42225440|FG005|Cohort 1, QW|Radiological Progression|0|||
19771421|NCT02906670|42225441|FG006|Cohort 1, QW|Radiological Progression|0|||
19771422|NCT02906670|42225442|FG007|Cohort 1, QW|Radiological Progression|0|||
19771423|NCT02906670|42225443|FG008|Cohort 1, QW|Radiological Progression|0|||
19771424|NCT02906670|42225444|FG009|Cohort 1, QW|Radiological Progression|0|||
19771425|NCT02906670|42225435|FG000|Cohort 2, QW|Radiological Progression|0|||
19771426|NCT02906670|42225436|FG001|Cohort 2, QW|Radiological Progression|1|||
19771427|NCT02906670|42225437|FG002|Cohort 2, QW|Radiological Progression|0|||
19771428|NCT02906670|42225438|FG003|Cohort 2, QW|Radiological Progression|0|||
19688769|NCT00256750|42134895|FG001|Transplanted Pre-Treatment|Death|0|||
19688770|NCT00256750|42134896|FG002|Transplanted Pre-Treatment|Death|0|||
19688771|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
19688772|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
19688773|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
19688774|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Death|3|||
19688775|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Death|2|||
19688776|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Death|4|||
19688777|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
19688778|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
19688779|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
19688780|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
19688781|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
19688782|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
19688783|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Other|5|||
19688784|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Other|4|||
19688785|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Other|2|||
19688786|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
19688787|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
19688788|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
19688789|NCT00256750|42134894|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
19688790|NCT00256750|42134895|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
19688791|NCT00256750|42134896|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
19688792|NCT00256750|42134894|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
19688793|NCT00256750|42134895|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
19688794|NCT00256750|42134896|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
19688795|NCT00256750|42134894|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
19688796|NCT00256750|42134895|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
19688797|NCT00256750|42134896|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
19688798|NCT00256750|42134894|FG000|Post-Transplant Treated (24 Months)|Death|3|||
19688799|NCT00256750|42134895|FG001|Post-Transplant Treated (24 Months)|Death|0|||
19688800|NCT00256750|42134896|FG002|Post-Transplant Treated (24 Months)|Death|0|||
19688801|NCT00256750|42134894|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
19688802|NCT00256750|42134895|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
19688803|NCT00256750|42134896|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
19688804|NCT00256750|42134894|FG000|Post-Transplant Treated (24 Months)|Other|2|||
19688805|NCT00256750|42134895|FG001|Post-Transplant Treated (24 Months)|Other|0|||
19688806|NCT00256750|42134896|FG002|Post-Transplant Treated (24 Months)|Other|1|||
19688807|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
19688808|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
19688809|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
19688810|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
19688811|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
19688812|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
19688813|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Death|0|||
19688814|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Death|2|||
19688815|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Death|1|||
19688816|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
19771429|NCT02906670|42225439|FG004|Cohort 2, QW|Radiological Progression|0|||
19771430|NCT02906670|42225440|FG005|Cohort 2, QW|Radiological Progression|0|||
19771431|NCT02906670|42225441|FG006|Cohort 2, QW|Radiological Progression|0|||
19688817|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
19688818|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
19688819|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
19688820|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
19688821|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
19688822|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
19688823|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
19688824|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
19688825|NCT00256750|42134894|FG000|Post-Transplant Treated (36 Months)|Other|0|||
19688826|NCT00256750|42134895|FG001|Post-Transplant Treated (36 Months)|Other|1|||
19688827|NCT00256750|42134896|FG002|Post-Transplant Treated (36 Months)|Other|1|||
19688828|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
19688829|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
19688830|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
19688831|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
19688832|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
19688833|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
19688834|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
19688835|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
19688836|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
19688837|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
19688838|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
19688839|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
19688840|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
19688841|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
19688842|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
19688843|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
19688844|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
19688845|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
19688846|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
19688847|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
19688848|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
19771432|NCT02906670|42225442|FG007|Cohort 2, QW|Radiological Progression|0|||
19688849|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
19688850|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
19771433|NCT02906670|42225443|FG008|Cohort 2, QW|Radiological Progression|0|||
19688851|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
19688852|NCT00256750|42134894|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
19688853|NCT00256750|42134895|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
19688854|NCT00256750|42134896|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
19688855|NCT00279201|42134907|FG000|Initiation|Death|1|||
19688856|NCT00279201|42134908|FG001|Initiation|Death|5|||
19688857|NCT00279201|42134909|FG002|Initiation|Death|0|||
19688858|NCT00279201|42134910|FG003|Initiation|Death|0|||
19688859|NCT00279201|42134911|FG004|Initiation|Death|0|||
19688860|NCT00279201|42134912|FG005|Initiation|Death|0|||
19688861|NCT00279201|42134907|FG000|Initiation|Adverse Event|6|||
19688862|NCT00279201|42134908|FG001|Initiation|Adverse Event|15|||
19688863|NCT00279201|42134909|FG002|Initiation|Adverse Event|0|||
19688864|NCT00279201|42134910|FG003|Initiation|Adverse Event|0|||
19688865|NCT00279201|42134911|FG004|Initiation|Adverse Event|0|||
19688866|NCT00279201|42134912|FG005|Initiation|Adverse Event|0|||
19688867|NCT00279201|42134907|FG000|Initiation|Lost to Follow-up|42|||
19688868|NCT00279201|42134908|FG001|Initiation|Lost to Follow-up|41|||
19688869|NCT00279201|42134909|FG002|Initiation|Lost to Follow-up|0|||
19688870|NCT00279201|42134910|FG003|Initiation|Lost to Follow-up|0|||
19688871|NCT00279201|42134911|FG004|Initiation|Lost to Follow-up|0|||
19688872|NCT00279201|42134912|FG005|Initiation|Lost to Follow-up|0|||
19688873|NCT00279201|42134907|FG000|Initiation|Entry Criteria Exclusion|7|||
19771434|NCT02906670|42225444|FG009|Cohort 2, QW|Radiological Progression|0|||
19771435|NCT02906670|42225435|FG000|Cohort 3, QW|Radiological Progression|0|||
19771436|NCT02906670|42225436|FG001|Cohort 3, QW|Radiological Progression|0|||
19771437|NCT02906670|42225437|FG002|Cohort 3, QW|Radiological Progression|2|||
19771438|NCT02906670|42225438|FG003|Cohort 3, QW|Radiological Progression|0|||
19771439|NCT02906670|42225439|FG004|Cohort 3, QW|Radiological Progression|0|||
19771440|NCT02906670|42225440|FG005|Cohort 3, QW|Radiological Progression|0|||
19771441|NCT02906670|42225441|FG006|Cohort 3, QW|Radiological Progression|0|||
19771442|NCT02906670|42225442|FG007|Cohort 3, QW|Radiological Progression|0|||
19771443|NCT02906670|42225443|FG008|Cohort 3, QW|Radiological Progression|0|||
19771444|NCT02906670|42225444|FG009|Cohort 3, QW|Radiological Progression|0|||
19771445|NCT02906670|42225435|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771446|NCT02906670|42225436|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771447|NCT02906670|42225437|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
19771448|NCT02906670|42225438|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771449|NCT02906670|42225439|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771450|NCT02906670|42225440|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771451|NCT02906670|42225441|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771452|NCT02906670|42225442|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771453|NCT02906670|42225443|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771454|NCT02906670|42225444|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
19771455|NCT02906670|42225435|FG000|Cohort 4, Q2W|Radiological Progression|0|||
19771456|NCT02906670|42225436|FG001|Cohort 4, Q2W|Radiological Progression|0|||
19771457|NCT02906670|42225437|FG002|Cohort 4, Q2W|Radiological Progression|0|||
19771458|NCT02906670|42225438|FG003|Cohort 4, Q2W|Radiological Progression|0|||
19771459|NCT02906670|42225439|FG004|Cohort 4, Q2W|Radiological Progression|0|||
19771460|NCT02906670|42225440|FG005|Cohort 4, Q2W|Radiological Progression|1|||
19688874|NCT00279201|42134908|FG001|Initiation|Entry Criteria Exclusion|9|||
19688875|NCT00279201|42134909|FG002|Initiation|Entry Criteria Exclusion|0|||
19688876|NCT00279201|42134910|FG003|Initiation|Entry Criteria Exclusion|0|||
19688877|NCT00279201|42134911|FG004|Initiation|Entry Criteria Exclusion|0|||
19688878|NCT00279201|42134912|FG005|Initiation|Entry Criteria Exclusion|0|||
19688879|NCT00279201|42134907|FG000|Initiation|Protocol Violation|9|||
19688880|NCT00279201|42134908|FG001|Initiation|Protocol Violation|10|||
19688881|NCT00279201|42134909|FG002|Initiation|Protocol Violation|0|||
19771461|NCT02906670|42225441|FG006|Cohort 4, Q2W|Radiological Progression|0|||
19771462|NCT02906670|42225442|FG007|Cohort 4, Q2W|Radiological Progression|0|||
19771463|NCT02906670|42225443|FG008|Cohort 4, Q2W|Radiological Progression|0|||
19389142|NCT02663687|41632709|FG003|Overall Study|Other|0|||
19688882|NCT00279201|42134910|FG003|Initiation|Protocol Violation|0|||
19688883|NCT00279201|42134911|FG004|Initiation|Protocol Violation|0|||
19688884|NCT00279201|42134912|FG005|Initiation|Protocol Violation|0|||
19688885|NCT00279201|42134907|FG000|Initiation|Withdrawal by Subject|35|||
19688886|NCT00279201|42134908|FG001|Initiation|Withdrawal by Subject|41|||
19688887|NCT00279201|42134909|FG002|Initiation|Withdrawal by Subject|0|||
19688888|NCT00279201|42134910|FG003|Initiation|Withdrawal by Subject|0|||
19688889|NCT00279201|42134911|FG004|Initiation|Withdrawal by Subject|0|||
19688890|NCT00279201|42134912|FG005|Initiation|Withdrawal by Subject|0|||
19688891|NCT00279201|42134907|FG000|Initiation|Physician Decision|15|||
19688892|NCT00279201|42134908|FG001|Initiation|Physician Decision|18|||
19688893|NCT00279201|42134909|FG002|Initiation|Physician Decision|0|||
19688894|NCT00279201|42134910|FG003|Initiation|Physician Decision|0|||
19688895|NCT00279201|42134911|FG004|Initiation|Physician Decision|0|||
19688896|NCT00279201|42134912|FG005|Initiation|Physician Decision|0|||
19688897|NCT00279201|42134907|FG000|Initiation|Sponsor Decision|13|||
19771464|NCT02906670|42225444|FG009|Cohort 4, Q2W|Radiological Progression|0|||
19771465|NCT02906670|42225435|FG000|Cohort 4, Q2W|Clinical Progression|0|||
19771466|NCT02906670|42225436|FG001|Cohort 4, Q2W|Clinical Progression|0|||
19688898|NCT00279201|42134908|FG001|Initiation|Sponsor Decision|5|||
19688899|NCT00279201|42134909|FG002|Initiation|Sponsor Decision|0|||
19688900|NCT00279201|42134910|FG003|Initiation|Sponsor Decision|0|||
19771467|NCT02906670|42225437|FG002|Cohort 4, Q2W|Clinical Progression|0|||
19771468|NCT02906670|42225438|FG003|Cohort 4, Q2W|Clinical Progression|0|||
19771469|NCT02906670|42225439|FG004|Cohort 4, Q2W|Clinical Progression|0|||
19771470|NCT02906670|42225440|FG005|Cohort 4, Q2W|Clinical Progression|2|||
19771471|NCT02906670|42225441|FG006|Cohort 4, Q2W|Clinical Progression|0|||
19771472|NCT02906670|42225442|FG007|Cohort 4, Q2W|Clinical Progression|0|||
19771473|NCT02906670|42225443|FG008|Cohort 4, Q2W|Clinical Progression|0|||
19771474|NCT02906670|42225444|FG009|Cohort 4, Q2W|Clinical Progression|0|||
19771475|NCT02906670|42225435|FG000|Cohort 5, Q2W|Radiological Progression|0|||
19771476|NCT02906670|42225436|FG001|Cohort 5, Q2W|Radiological Progression|0|||
19771477|NCT02906670|42225437|FG002|Cohort 5, Q2W|Radiological Progression|0|||
19688901|NCT00279201|42134911|FG004|Initiation|Sponsor Decision|0|||
19688902|NCT00279201|42134912|FG005|Initiation|Sponsor Decision|0|||
19771478|NCT02906670|42225438|FG003|Cohort 5, Q2W|Radiological Progression|0|||
19771479|NCT02906670|42225439|FG004|Cohort 5, Q2W|Radiological Progression|0|||
19771480|NCT02906670|42225440|FG005|Cohort 5, Q2W|Radiological Progression|0|||
19771481|NCT02906670|42225441|FG006|Cohort 5, Q2W|Radiological Progression|4|||
19771482|NCT02906670|42225442|FG007|Cohort 5, Q2W|Radiological Progression|0|||
19771483|NCT02906670|42225443|FG008|Cohort 5, Q2W|Radiological Progression|0|||
19771484|NCT02906670|42225444|FG009|Cohort 5, Q2W|Radiological Progression|0|||
19771485|NCT02906670|42225435|FG000|Cohort 5, Q2W|Clinical Progression|0|||
19605731|NCT00586066|42054490|FG000|Overall Study|Physician Decision|1|||
19605732|NCT00586066|42054491|FG001|Overall Study|Physician Decision|0|||
19605733|NCT00586066|42054490|FG000|Overall Study|Withdrawal of consent|4|||
19605734|NCT00586066|42054491|FG001|Overall Study|Withdrawal of consent|2|||
19605735|NCT01186016|42054499|FG000|Overall Study|Withdrawal by Subject|46|||
19605736|NCT01186016|42054500|FG001|Overall Study|Withdrawal by Subject|29|||
19605737|NCT00728884|42054506|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
19605738|NCT00728884|42054506|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
19605739|NCT00728494|42054512|FG000|Overall Study|Adverse Event|7|||
19605740|NCT00728494|42054513|FG001|Overall Study|Adverse Event|0|||
19605741|NCT00728494|42054512|FG000|Overall Study|Withdrawal by Subject|0|||
19605742|NCT00728494|42054513|FG001|Overall Study|Withdrawal by Subject|2|||
19688903|NCT00279201|42134907|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
19688904|NCT00279201|42134908|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
19688905|NCT00279201|42134909|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
19688906|NCT00279201|42134910|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
19688907|NCT00279201|42134911|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
19688908|NCT00279201|42134912|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
19688909|NCT00279201|42134907|FG000|Maintenance|Lack of Efficacy|32|||
19688910|NCT00279201|42134908|FG001|Maintenance|Lack of Efficacy|30|||
19688911|NCT00279201|42134909|FG002|Maintenance|Lack of Efficacy|0|||
19688912|NCT00279201|42134910|FG003|Maintenance|Lack of Efficacy|0|||
19688913|NCT00279201|42134911|FG004|Maintenance|Lack of Efficacy|0|||
19605743|NCT00728494|42054512|FG000|Overall Study|Lack of Efficacy|2|||
19605744|NCT00728494|42054513|FG001|Overall Study|Lack of Efficacy|4|||
19605745|NCT00728494|42054512|FG000|Overall Study|No data available|0|||
19605746|NCT00728494|42054513|FG001|Overall Study|No data available|1|||
19605747|NCT00728416|42054521|FG000|Overall Study|Adverse Event|1|||
19605748|NCT00728416|42054522|FG001|Overall Study|Adverse Event|1|||
19605749|NCT00728416|42054521|FG000|Overall Study|Treatment Failure|0|||
19605750|NCT00728416|42054522|FG001|Overall Study|Treatment Failure|1|||
19605751|NCT00728416|42054521|FG000|Overall Study|Withdrawal by Subject|1|||
19605752|NCT00728416|42054522|FG001|Overall Study|Withdrawal by Subject|0|||
19605753|NCT00728182|42054530|FG000|Overall Study|Adverse Event|1|||
19605754|NCT00728182|42054531|FG001|Overall Study|Adverse Event|0|||
19605755|NCT00728182|42054530|FG000|Overall Study|Lost to Follow-up|2|||
19605756|NCT00728182|42054531|FG001|Overall Study|Lost to Follow-up|0|||
19605757|NCT00728182|42054530|FG000|Overall Study|Death|0|||
19605758|NCT00728182|42054531|FG001|Overall Study|Death|2|||
19605759|NCT00728182|42054530|FG000|Overall Study|Protocol Noncompliance|0|||
19605760|NCT00728182|42054531|FG001|Overall Study|Protocol Noncompliance|1|||
19605761|NCT00941330|42054541|FG000|Overall Study|Other|1|||
19605762|NCT00941330|42054542|FG001|Overall Study|Other|0|||
19688914|NCT00279201|42134912|FG005|Maintenance|Lack of Efficacy|0|||
19605763|NCT00941330|42054541|FG000|Overall Study|Physician Decision|0|||
19605764|NCT00941330|42054542|FG001|Overall Study|Physician Decision|2|||
19605765|NCT00736450|42054548|FG000|Overall Study|Not ABC gene eligible|19|||
19605766|NCT00736450|42054548|FG000|Overall Study|Withdrawal by Subject|5|||
19688915|NCT00279201|42134907|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
19771486|NCT02906670|42225436|FG001|Cohort 5, Q2W|Clinical Progression|0|||
19771487|NCT02906670|42225437|FG002|Cohort 5, Q2W|Clinical Progression|0|||
19771488|NCT02906670|42225438|FG003|Cohort 5, Q2W|Clinical Progression|0|||
19771489|NCT02906670|42225439|FG004|Cohort 5, Q2W|Clinical Progression|0|||
19605767|NCT00736450|42054548|FG000|Overall Study|Physician Decision|1|||
19688916|NCT00279201|42134908|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
19688917|NCT00279201|42134909|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
19688918|NCT00279201|42134910|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
19688919|NCT00279201|42134911|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
19688920|NCT00279201|42134912|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
19688921|NCT00279201|42134907|FG000|Maintenance|Adverse Event|4|||
19688922|NCT00279201|42134908|FG001|Maintenance|Adverse Event|4|||
19688923|NCT00279201|42134909|FG002|Maintenance|Adverse Event|0|||
19688924|NCT00279201|42134910|FG003|Maintenance|Adverse Event|0|||
19688925|NCT00279201|42134911|FG004|Maintenance|Adverse Event|0|||
19688926|NCT00279201|42134912|FG005|Maintenance|Adverse Event|0|||
19688927|NCT00279201|42134907|FG000|Maintenance|Death|4|||
19688928|NCT00279201|42134908|FG001|Maintenance|Death|4|||
19688929|NCT00279201|42134909|FG002|Maintenance|Death|0|||
19688930|NCT00279201|42134910|FG003|Maintenance|Death|0|||
19688931|NCT00279201|42134911|FG004|Maintenance|Death|0|||
19688932|NCT00279201|42134912|FG005|Maintenance|Death|0|||
19688933|NCT00279201|42134907|FG000|Maintenance|Lost to Follow-up|17|||
19688934|NCT00279201|42134908|FG001|Maintenance|Lost to Follow-up|13|||
19688935|NCT00279201|42134909|FG002|Maintenance|Lost to Follow-up|0|||
19688936|NCT00279201|42134910|FG003|Maintenance|Lost to Follow-up|0|||
19688937|NCT00279201|42134911|FG004|Maintenance|Lost to Follow-up|0|||
19688938|NCT00279201|42134912|FG005|Maintenance|Lost to Follow-up|0|||
19688939|NCT00279201|42134907|FG000|Maintenance|Entry Criteria Exclusion|1|||
19688940|NCT00279201|42134908|FG001|Maintenance|Entry Criteria Exclusion|4|||
19688941|NCT00279201|42134909|FG002|Maintenance|Entry Criteria Exclusion|0|||
19688942|NCT00279201|42134910|FG003|Maintenance|Entry Criteria Exclusion|0|||
19688943|NCT00279201|42134911|FG004|Maintenance|Entry Criteria Exclusion|0|||
19688944|NCT00279201|42134912|FG005|Maintenance|Entry Criteria Exclusion|0|||
19688945|NCT00279201|42134907|FG000|Maintenance|Protocol Violation|16|||
19688946|NCT00279201|42134908|FG001|Maintenance|Protocol Violation|24|||
19688947|NCT00279201|42134909|FG002|Maintenance|Protocol Violation|0|||
19688948|NCT00279201|42134910|FG003|Maintenance|Protocol Violation|0|||
19688949|NCT00279201|42134911|FG004|Maintenance|Protocol Violation|0|||
19688950|NCT00279201|42134912|FG005|Maintenance|Protocol Violation|0|||
19688951|NCT00279201|42134907|FG000|Maintenance|Withdrawal by Subject|18|||
19688952|NCT00279201|42134908|FG001|Maintenance|Withdrawal by Subject|18|||
19688953|NCT00279201|42134909|FG002|Maintenance|Withdrawal by Subject|0|||
19688954|NCT00279201|42134910|FG003|Maintenance|Withdrawal by Subject|0|||
19688955|NCT00279201|42134911|FG004|Maintenance|Withdrawal by Subject|0|||
19688956|NCT00279201|42134912|FG005|Maintenance|Withdrawal by Subject|0|||
19688957|NCT00279201|42134907|FG000|Maintenance|Physician Decision|9|||
19688958|NCT00279201|42134908|FG001|Maintenance|Physician Decision|9|||
19688959|NCT00279201|42134909|FG002|Maintenance|Physician Decision|0|||
19688960|NCT00279201|42134910|FG003|Maintenance|Physician Decision|0|||
19688961|NCT00279201|42134911|FG004|Maintenance|Physician Decision|0|||
19688962|NCT00279201|42134912|FG005|Maintenance|Physician Decision|0|||
19688963|NCT00279201|42134907|FG000|Maintenance|Sponsor Decision|4|||
19688964|NCT00279201|42134908|FG001|Maintenance|Sponsor Decision|0|||
19688965|NCT00279201|42134909|FG002|Maintenance|Sponsor Decision|0|||
19688966|NCT00279201|42134910|FG003|Maintenance|Sponsor Decision|0|||
19688967|NCT00279201|42134911|FG004|Maintenance|Sponsor Decision|0|||
19688968|NCT00279201|42134912|FG005|Maintenance|Sponsor Decision|0|||
19688969|NCT00279201|42134907|FG000|Maintenance|HbA1c>7.5%|123|||
19688970|NCT00279201|42134908|FG001|Maintenance|HbA1c>7.5%|126|||
19688971|NCT00279201|42134909|FG002|Maintenance|HbA1c>7.5%|0|||
19688972|NCT00279201|42134910|FG003|Maintenance|HbA1c>7.5%|0|||
19688973|NCT00279201|42134911|FG004|Maintenance|HbA1c>7.5%|0|||
19688974|NCT00279201|42134912|FG005|Maintenance|HbA1c>7.5%|0|||
19688975|NCT00279201|42134907|FG000|Intensification Addendum|Withdrawal by Subject|0|||
19688976|NCT00279201|42134908|FG001|Intensification Addendum|Withdrawal by Subject|0|||
19688977|NCT00279201|42134909|FG002|Intensification Addendum|Withdrawal by Subject|12|||
19688978|NCT00279201|42134910|FG003|Intensification Addendum|Withdrawal by Subject|14|||
19688979|NCT00279201|42134911|FG004|Intensification Addendum|Withdrawal by Subject|9|||
19688980|NCT00279201|42134912|FG005|Intensification Addendum|Withdrawal by Subject|18|||
19389143|NCT02663687|41632710|FG004|Overall Study|Other|0|||
19688981|NCT00279201|42134907|FG000|Intensification Addendum|Lost to Follow-up|0|||
19605768|NCT00686881|42054554|FG000|Overall Study|Withdrawal by Subject|11|||
19605769|NCT00686881|42054555|FG001|Overall Study|Withdrawal by Subject|18|||
19605770|NCT00686881|42054554|FG000|Overall Study|Lost to Follow-up|0|||
19605771|NCT00686881|42054555|FG001|Overall Study|Lost to Follow-up|1|||
19605772|NCT00686881|42054554|FG000|Overall Study|Treatment-related adverse event|10|||
19605773|NCT00686881|42054555|FG001|Overall Study|Treatment-related adverse event|9|||
19605774|NCT00686881|42054554|FG000|Overall Study|Met discontinuation criteria|5|||
19688982|NCT00279201|42134908|FG001|Intensification Addendum|Lost to Follow-up|0|||
19688983|NCT00279201|42134909|FG002|Intensification Addendum|Lost to Follow-up|4|||
19688984|NCT00279201|42134910|FG003|Intensification Addendum|Lost to Follow-up|6|||
19688985|NCT00279201|42134911|FG004|Intensification Addendum|Lost to Follow-up|7|||
19688986|NCT00279201|42134912|FG005|Intensification Addendum|Lost to Follow-up|7|||
19688987|NCT00279201|42134907|FG000|Intensification Addendum|Protocol Violation|0|||
19688988|NCT00279201|42134908|FG001|Intensification Addendum|Protocol Violation|0|||
19688989|NCT00279201|42134909|FG002|Intensification Addendum|Protocol Violation|2|||
19688990|NCT00279201|42134910|FG003|Intensification Addendum|Protocol Violation|2|||
19688991|NCT00279201|42134911|FG004|Intensification Addendum|Protocol Violation|6|||
19688992|NCT00279201|42134912|FG005|Intensification Addendum|Protocol Violation|6|||
19688993|NCT00279201|42134907|FG000|Intensification Addendum|Adverse Event|0|||
19688994|NCT00279201|42134908|FG001|Intensification Addendum|Adverse Event|0|||
19688995|NCT00279201|42134909|FG002|Intensification Addendum|Adverse Event|0|||
19688996|NCT00279201|42134910|FG003|Intensification Addendum|Adverse Event|4|||
19688997|NCT00279201|42134911|FG004|Intensification Addendum|Adverse Event|1|||
19688998|NCT00279201|42134912|FG005|Intensification Addendum|Adverse Event|3|||
19688999|NCT00279201|42134907|FG000|Intensification Addendum|Physician Decision|0|||
19689000|NCT00279201|42134908|FG001|Intensification Addendum|Physician Decision|0|||
19689001|NCT00279201|42134909|FG002|Intensification Addendum|Physician Decision|4|||
19689002|NCT00279201|42134910|FG003|Intensification Addendum|Physician Decision|1|||
19689003|NCT00279201|42134911|FG004|Intensification Addendum|Physician Decision|3|||
19689004|NCT00279201|42134912|FG005|Intensification Addendum|Physician Decision|2|||
19689005|NCT00279201|42134907|FG000|Intensification Addendum|Sponsor Decision|0|||
19689006|NCT00279201|42134908|FG001|Intensification Addendum|Sponsor Decision|0|||
19689007|NCT00279201|42134909|FG002|Intensification Addendum|Sponsor Decision|0|||
19689008|NCT00279201|42134910|FG003|Intensification Addendum|Sponsor Decision|0|||
19689009|NCT00279201|42134911|FG004|Intensification Addendum|Sponsor Decision|1|||
19689010|NCT00279201|42134912|FG005|Intensification Addendum|Sponsor Decision|1|||
19689011|NCT00279201|42134907|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
19689012|NCT00279201|42134908|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
19689013|NCT00279201|42134909|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
19689014|NCT00279201|42134910|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
19689015|NCT00279201|42134911|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
19689016|NCT00279201|42134912|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
19689017|NCT00279201|42134907|FG000|Intensification Addendum|Lack of Efficacy|0|||
19689018|NCT00279201|42134908|FG001|Intensification Addendum|Lack of Efficacy|0|||
19689019|NCT00279201|42134909|FG002|Intensification Addendum|Lack of Efficacy|0|||
19689020|NCT00279201|42134910|FG003|Intensification Addendum|Lack of Efficacy|1|||
19689021|NCT00279201|42134911|FG004|Intensification Addendum|Lack of Efficacy|1|||
19689022|NCT00279201|42134912|FG005|Intensification Addendum|Lack of Efficacy|0|||
19689023|NCT00279201|42134907|FG000|Intensification Addendum|Death|0|||
19689024|NCT00279201|42134908|FG001|Intensification Addendum|Death|0|||
19689025|NCT00279201|42134909|FG002|Intensification Addendum|Death|0|||
19689026|NCT00279201|42134910|FG003|Intensification Addendum|Death|0|||
19689027|NCT00279201|42134911|FG004|Intensification Addendum|Death|1|||
19689028|NCT00279201|42134912|FG005|Intensification Addendum|Death|0|||
19689029|NCT00203476|42134948|FG000|Overall Study|Lost to Follow-up|1|||
19689030|NCT00203476|42134949|FG001|Overall Study|Lost to Follow-up|0|||
19689031|NCT00203476|42134950|FG002|Overall Study|Lost to Follow-up|0|||
19689032|NCT00203476|42134948|FG000|Overall Study|Withdrawal by Subject|0|||
19689033|NCT00203476|42134949|FG001|Overall Study|Withdrawal by Subject|1|||
19689034|NCT00203476|42134950|FG002|Overall Study|Withdrawal by Subject|0|||
19689035|NCT00203242|42134958|FG000|Overall Study|Lost to Follow-up|1|||
19689036|NCT00200356|42134964|FG000|Overall Study|Lack of Efficacy|3|||
19689037|NCT00200356|42134965|FG001|Overall Study|Lack of Efficacy|3|||
19689038|NCT00200356|42134964|FG000|Overall Study|Protocol Violation|4|||
19689039|NCT00200356|42134965|FG001|Overall Study|Protocol Violation|4|||
19689040|NCT00200356|42134964|FG000|Overall Study|Nontreatment|1|||
19689041|NCT00200356|42134965|FG001|Overall Study|Nontreatment|0|||
19689042|NCT00227344|42134973|FG000|Overall Study|study terminated early|12|||
19689043|NCT00227344|42134974|FG001|Overall Study|study terminated early|5|||
19689044|NCT00227266|42134983|FG000|Overall Study|Withdrawal by Subject|0|||
19689045|NCT00227266|42134984|FG001|Overall Study|Withdrawal by Subject|0|||
19689046|NCT00227266|42134985|FG002|Overall Study|Withdrawal by Subject|1|||
19689047|NCT00227266|42134983|FG000|Overall Study|Protocol Violation|1|||
19689048|NCT00227266|42134984|FG001|Overall Study|Protocol Violation|0|||
19689049|NCT00227266|42134985|FG002|Overall Study|Protocol Violation|1|||
19689050|NCT00227266|42134983|FG000|Overall Study|Excessive weight gain|0|||
19689051|NCT00227266|42134984|FG001|Overall Study|Excessive weight gain|0|||
19689052|NCT00227266|42134985|FG002|Overall Study|Excessive weight gain|2|||
19389144|NCT02663453|41632741|FG000|Overall Study|Death|4|||
19689053|NCT00256282|42134996|FG000|Overall Study|Disease progression, relapse during acti|12|||
19689054|NCT00256282|42134996|FG000|Overall Study|Adverse Event|3|||
19689055|NCT00256282|42134996|FG000|Overall Study|Physician Decision|1|||
19689056|NCT00266877|42135003|FG000|Overall Study|Death|1|||
19689057|NCT00266877|42135004|FG001|Overall Study|Death|1|||
19689058|NCT00266877|42135005|FG002|Overall Study|Death|1|||
19689059|NCT00266877|42135003|FG000|Overall Study|Adverse Event|6|||
19689060|NCT00266877|42135004|FG001|Overall Study|Adverse Event|4|||
19689061|NCT00266877|42135005|FG002|Overall Study|Adverse Event|1|||
19689062|NCT00266877|42135003|FG000|Overall Study|Physician Decision|2|||
19689063|NCT00266877|42135004|FG001|Overall Study|Physician Decision|1|||
19689064|NCT00266877|42135005|FG002|Overall Study|Physician Decision|1|||
19689065|NCT00266877|42135003|FG000|Overall Study|Withdrawal by Subject|3|||
19689066|NCT00266877|42135004|FG001|Overall Study|Withdrawal by Subject|1|||
19689067|NCT00266877|42135005|FG002|Overall Study|Withdrawal by Subject|1|||
19689068|NCT00266877|42135003|FG000|Overall Study|Disease Progression|72|||
19689069|NCT00266877|42135004|FG001|Overall Study|Disease Progression|37|||
19689070|NCT00266877|42135005|FG002|Overall Study|Disease Progression|23|||
19689071|NCT00266877|42135003|FG000|Overall Study|Symptomatic Deterioration|6|||
19689072|NCT00266877|42135004|FG001|Overall Study|Symptomatic Deterioration|3|||
19689073|NCT00266877|42135005|FG002|Overall Study|Symptomatic Deterioration|1|||
19689074|NCT00266877|42135003|FG000|Overall Study|Hospitalization|1|||
19689075|NCT00266877|42135004|FG001|Overall Study|Hospitalization|0|||
19689076|NCT00266877|42135005|FG002|Overall Study|Hospitalization|0|||
19689077|NCT00266877|42135003|FG000|Overall Study|Concomitant Radiotherapy|0|||
19689078|NCT00266877|42135004|FG001|Overall Study|Concomitant Radiotherapy|1|||
19689079|NCT00266877|42135005|FG002|Overall Study|Concomitant Radiotherapy|0|||
19689080|NCT00256204|42135017|FG000|Overall Study|Adverse Event|10|||
19689081|NCT00256204|42135018|FG001|Overall Study|Adverse Event|14|||
19689082|NCT00256204|42135019|FG002|Overall Study|Adverse Event|16|||
19689083|NCT00256204|42135020|FG003|Overall Study|Adverse Event|14|||
19689084|NCT00256204|42135017|FG000|Overall Study|Death|0|||
19689085|NCT00256204|42135018|FG001|Overall Study|Death|1|||
19689086|NCT00256204|42135019|FG002|Overall Study|Death|0|||
19689087|NCT00256204|42135020|FG003|Overall Study|Death|0|||
19689088|NCT00256204|42135017|FG000|Overall Study|Lost to Follow-up|1|||
19689089|NCT00256204|42135018|FG001|Overall Study|Lost to Follow-up|1|||
19689090|NCT00256204|42135019|FG002|Overall Study|Lost to Follow-up|1|||
19689091|NCT00256204|42135020|FG003|Overall Study|Lost to Follow-up|2|||
19689092|NCT00256204|42135017|FG000|Overall Study|Protocol Violation|1|||
19689093|NCT00256204|42135018|FG001|Overall Study|Protocol Violation|0|||
19689094|NCT00256204|42135019|FG002|Overall Study|Protocol Violation|2|||
19689095|NCT00256204|42135020|FG003|Overall Study|Protocol Violation|1|||
19689096|NCT00256204|42135017|FG000|Overall Study|Physician Decision|0|||
19689097|NCT00256204|42135018|FG001|Overall Study|Physician Decision|0|||
19689098|NCT00256204|42135019|FG002|Overall Study|Physician Decision|1|||
19689099|NCT00256204|42135020|FG003|Overall Study|Physician Decision|2|||
19689100|NCT00256204|42135017|FG000|Overall Study|Withdrawal by Subject|17|||
19689101|NCT00256204|42135018|FG001|Overall Study|Withdrawal by Subject|6|||
19689102|NCT00256204|42135019|FG002|Overall Study|Withdrawal by Subject|7|||
19689103|NCT00256204|42135020|FG003|Overall Study|Withdrawal by Subject|5|||
19689104|NCT00256204|42135017|FG000|Overall Study|Need for additional prohibited treatment|38|||
19689105|NCT00256204|42135018|FG001|Overall Study|Need for additional prohibited treatment|28|||
19689106|NCT00256204|42135019|FG002|Overall Study|Need for additional prohibited treatment|27|||
19689107|NCT00256204|42135020|FG003|Overall Study|Need for additional prohibited treatment|25|||
19689108|NCT00256126|42135035|FG000|Overall Study|Adverse Event|1|||
19689109|NCT00256126|42135036|FG001|Overall Study|Adverse Event|0|||
19689110|NCT00256126|42135035|FG000|Overall Study|Other|1|||
19689111|NCT00256126|42135036|FG001|Overall Study|Other|2|||
19689112|NCT00278889|42135045|FG000|Overall Study|Withdrawal by Subject|0|||
19689113|NCT00278889|42135046|FG001|Overall Study|Withdrawal by Subject|5|||
19689114|NCT00278889|42135047|FG002|Overall Study|Withdrawal by Subject|3|||
19689115|NCT00278889|42135045|FG000|Overall Study|Lost to Follow-up|1|||
19689116|NCT00278889|42135046|FG001|Overall Study|Lost to Follow-up|1|||
19689117|NCT00278889|42135047|FG002|Overall Study|Lost to Follow-up|0|||
19689118|NCT00278889|42135045|FG000|Overall Study|Death|24|||
19689119|NCT00278889|42135046|FG001|Overall Study|Death|21|||
19689120|NCT00278889|42135047|FG002|Overall Study|Death|17|||
19689121|NCT00278109|42135055|FG000|Overall Study|Adverse Event|3|||
19689122|NCT00278109|42135055|FG000|Overall Study|social circumstances|1|||
19689123|NCT00296517|42135061|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
19689124|NCT00296517|42135062|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
19689125|NCT00296517|42135061|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
19689126|NCT00296517|42135062|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
19689127|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
19689128|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
19689129|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
19689130|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
19689131|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
19689132|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
19689133|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
19689134|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
19689135|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
19689136|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
19689137|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
19689138|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
19689139|NCT00296517|42135061|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
19689140|NCT00296517|42135062|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
19689141|NCT00224770|42135071|FG000|Overall Study|Lost to Follow-up|4|||
19689142|NCT00224770|42135072|FG001|Overall Study|Lost to Follow-up|2|||
19689143|NCT00224770|42135073|FG002|Overall Study|Lost to Follow-up|0|||
19689144|NCT00266409|42135086|FG000|Overall Study|Lack of Efficacy|2|||
19689145|NCT00266409|42135087|FG001|Overall Study|Lack of Efficacy|6|||
19689146|NCT00266409|42135088|FG002|Overall Study|Lack of Efficacy|1|||
19689147|NCT00266409|42135089|FG003|Overall Study|Lack of Efficacy|2|||
19689148|NCT00266409|42135086|FG000|Overall Study|Adverse Event|7|||
19689149|NCT00266409|42135087|FG001|Overall Study|Adverse Event|2|||
19689150|NCT00266409|42135088|FG002|Overall Study|Adverse Event|1|||
19689151|NCT00266409|42135089|FG003|Overall Study|Adverse Event|1|||
19689152|NCT00266409|42135086|FG000|Overall Study|Lost to Follow-up|18|||
19689153|NCT00266409|42135087|FG001|Overall Study|Lost to Follow-up|21|||
19689154|NCT00266409|42135088|FG002|Overall Study|Lost to Follow-up|6|||
19689155|NCT00266409|42135089|FG003|Overall Study|Lost to Follow-up|8|||
19689156|NCT00266409|42135086|FG000|Overall Study|Withdrawal by Subject|6|||
19689157|NCT00266409|42135087|FG001|Overall Study|Withdrawal by Subject|10|||
19689158|NCT00266409|42135088|FG002|Overall Study|Withdrawal by Subject|3|||
19689159|NCT00266409|42135089|FG003|Overall Study|Withdrawal by Subject|9|||
19689160|NCT00266409|42135086|FG000|Overall Study|Protocol Violation|5|||
19689161|NCT00266409|42135087|FG001|Overall Study|Protocol Violation|3|||
19689162|NCT00266409|42135088|FG002|Overall Study|Protocol Violation|4|||
19689163|NCT00266409|42135089|FG003|Overall Study|Protocol Violation|2|||
19689164|NCT00266409|42135086|FG000|Overall Study|Other|7|||
19689165|NCT00266409|42135087|FG001|Overall Study|Other|4|||
19689166|NCT00266409|42135088|FG002|Overall Study|Other|2|||
19689167|NCT00266409|42135089|FG003|Overall Study|Other|0|||
19689168|NCT00277095|42135099|FG000|Overall Study|Death|2|||
19689169|NCT00277095|42135099|FG000|Overall Study|Explanted|7|||
19689170|NCT00277095|42135099|FG000|Overall Study|Lost to Follow-up|2|||
19689171|NCT00277095|42135099|FG000|Overall Study|Missed Follow-up|9|||
19689172|NCT00277095|42135099|FG000|Overall Study|Physician Decision|1|||
19689173|NCT00265785|42135103|FG000|Overall Study|Adverse Event|4|||
19689174|NCT00265785|42135103|FG000|Overall Study|Withdrawal by Subject|3|||
19689175|NCT00265785|42135103|FG000|Overall Study|Progression/Relapse|15|||
19689176|NCT00265785|42135103|FG000|Overall Study|Not protocol specified|2|||
19689177|NCT00265785|42135103|FG000|Overall Study|Ineligible|1|||
19689178|NCT00265785|42135103|FG000|Overall Study|Did not receive protocol treatment|2|||
19689179|NCT00276159|42135107|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
19689180|NCT00265395|42135113|FG000|Overall Study|Adverse Event|3|||
19689181|NCT00265395|42135114|FG001|Overall Study|Adverse Event|6|||
19689182|NCT00265395|42135113|FG000|Overall Study|Lost to Follow-up|2|||
19689183|NCT00265395|42135114|FG001|Overall Study|Lost to Follow-up|1|||
19689184|NCT00265395|42135113|FG000|Overall Study|Withdrawal by Subject|1|||
19689185|NCT00265395|42135114|FG001|Overall Study|Withdrawal by Subject|6|||
19689186|NCT00265395|42135113|FG000|Overall Study|Protocol Violation|2|||
19689187|NCT00265395|42135114|FG001|Overall Study|Protocol Violation|2|||
19689188|NCT00265395|42135113|FG000|Overall Study|Lack of Efficacy|0|||
19689189|NCT00265395|42135114|FG001|Overall Study|Lack of Efficacy|1|||
19689190|NCT00265395|42135113|FG000|Overall Study|Administrative|0|||
19689191|NCT00265395|42135114|FG001|Overall Study|Administrative|1|||
19689192|NCT00195442|42135119|FG000|Overall Study|Less than expected therapeutic effect|38|||
19689193|NCT00195442|42135119|FG000|Overall Study|Lost to Follow-up|27|||
19771490|NCT02906670|42225440|FG005|Cohort 5, Q2W|Clinical Progression|0|||
19771491|NCT02906670|42225441|FG006|Cohort 5, Q2W|Clinical Progression|1|||
19771492|NCT02906670|42225442|FG007|Cohort 5, Q2W|Clinical Progression|0|||
19771493|NCT02906670|42225443|FG008|Cohort 5, Q2W|Clinical Progression|0|||
19771494|NCT02906670|42225444|FG009|Cohort 5, Q2W|Clinical Progression|0|||
19771495|NCT02906670|42225435|FG000|Cohort 5, Q2W|Adverse Event|0|||
19771496|NCT02906670|42225436|FG001|Cohort 5, Q2W|Adverse Event|0|||
19771497|NCT02906670|42225437|FG002|Cohort 5, Q2W|Adverse Event|0|||
19477633|NCT01462435|41756914|FG003|Overall Study|Withdrawal by Subject|1|||
19689194|NCT00195442|42135119|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
19689195|NCT00195442|42135119|FG000|Overall Study|Intermittent product shortage|21|||
19689196|NCT00195442|42135119|FG000|Overall Study|Death|7|||
19689197|NCT00195442|42135119|FG000|Overall Study|No reason specified|4|||
19689198|NCT00195442|42135119|FG000|Overall Study|Poor cooperation|2|||
19689199|NCT00195442|42135119|FG000|Overall Study|Other|14|||
19689200|NCT00275301|42135123|FG000|Overall Study|Adverse Event|5|||
19689201|NCT00251745|42135130|FG000|Overall Study|Adverse Event|7|||
19689202|NCT00251745|42135131|FG001|Overall Study|Adverse Event|9|||
19689203|NCT00251745|42135132|FG002|Overall Study|Adverse Event|11|||
19689204|NCT00251745|42135130|FG000|Overall Study|Lost to Follow-up|4|||
19689205|NCT00251745|42135131|FG001|Overall Study|Lost to Follow-up|2|||
19689206|NCT00251745|42135132|FG002|Overall Study|Lost to Follow-up|5|||
19689207|NCT00251745|42135130|FG000|Overall Study|Withdrawal by Subject|13|||
19771498|NCT02906670|42225438|FG003|Cohort 5, Q2W|Adverse Event|0|||
19689208|NCT00251745|42135131|FG001|Overall Study|Withdrawal by Subject|7|||
19689209|NCT00251745|42135132|FG002|Overall Study|Withdrawal by Subject|3|||
19689210|NCT00251745|42135130|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
19689211|NCT00251745|42135131|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
19689212|NCT00251745|42135132|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
19689213|NCT00251745|42135130|FG000|Overall Study|Lack of Efficacy|3|||
19689214|NCT00251745|42135131|FG001|Overall Study|Lack of Efficacy|0|||
19689215|NCT00251745|42135132|FG002|Overall Study|Lack of Efficacy|0|||
19689216|NCT00251745|42135130|FG000|Overall Study|Noncompliant|0|||
19689217|NCT00251745|42135131|FG001|Overall Study|Noncompliant|2|||
19689218|NCT00251745|42135132|FG002|Overall Study|Noncompliant|2|||
19689219|NCT00251745|42135130|FG000|Overall Study|Pregnancy|0|||
19689220|NCT00251745|42135131|FG001|Overall Study|Pregnancy|1|||
19689221|NCT00251745|42135132|FG002|Overall Study|Pregnancy|0|||
19689222|NCT00251745|42135130|FG000|Overall Study|Per Subject Request|0|||
19689223|NCT00251745|42135131|FG001|Overall Study|Per Subject Request|0|||
19689224|NCT00251745|42135132|FG002|Overall Study|Per Subject Request|1|||
19689225|NCT00251745|42135130|FG000|Overall Study|Per Investigator Request|1|||
19689226|NCT00251745|42135131|FG001|Overall Study|Per Investigator Request|0|||
19689227|NCT00251745|42135132|FG002|Overall Study|Per Investigator Request|0|||
19689228|NCT00255190|42135142|FG000|Overall Study|Adverse Event|17|||
19689229|NCT00255190|42135143|FG001|Overall Study|Adverse Event|36|||
19689230|NCT00255190|42135142|FG000|Overall Study|Protocol Violation|2|||
19689231|NCT00255190|42135143|FG001|Overall Study|Protocol Violation|2|||
19689232|NCT00255190|42135142|FG000|Overall Study|Lost to Follow-up|10|||
19689233|NCT00255190|42135143|FG001|Overall Study|Lost to Follow-up|27|||
19689234|NCT00255190|42135142|FG000|Overall Study|Withdrew Consent|17|||
19689235|NCT00255190|42135143|FG001|Overall Study|Withdrew Consent|48|||
19689236|NCT00255190|42135142|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
19689237|NCT00255190|42135143|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
19689238|NCT00255190|42135142|FG000|Overall Study|Erosive esophagitis not healed|0|||
19689239|NCT00255190|42135143|FG001|Overall Study|Erosive esophagitis not healed|20|||
19689240|NCT00255190|42135142|FG000|Overall Study|Various|4|||
19689241|NCT00255190|42135143|FG001|Overall Study|Various|23|||
19689242|NCT00359424|42135151|FG000|Overall Study|Death|99|||
19689243|NCT00359424|42135152|FG001|Overall Study|Death|58|||
19689244|NCT00359424|42135151|FG000|Overall Study|Lost to Follow-up|19|||
19689245|NCT00359424|42135152|FG001|Overall Study|Lost to Follow-up|7|||
19689246|NCT00359424|42135151|FG000|Overall Study|Withdrawal by Subject|10|||
19689247|NCT00359424|42135152|FG001|Overall Study|Withdrawal by Subject|2|||
19689248|NCT00359424|42135151|FG000|Overall Study|follow up not conducted|2|||
19689249|NCT00359424|42135152|FG001|Overall Study|follow up not conducted|0|||
19689250|NCT00255034|42135160|FG000|Overall Study|Withdrawal by Subject|15|||
19689251|NCT00255034|42135161|FG001|Overall Study|Withdrawal by Subject|38|||
19689252|NCT00254566|42135169|FG000|Overall Study|Death|1|||
19689253|NCT00254566|42135170|FG001|Overall Study|Death|0|||
19689254|NCT00254566|42135169|FG000|Overall Study|Adverse Event|5|||
19689255|NCT00254566|42135170|FG001|Overall Study|Adverse Event|4|||
19689256|NCT00254566|42135169|FG000|Overall Study|Lack of Efficacy|12|||
19689257|NCT00254566|42135170|FG001|Overall Study|Lack of Efficacy|9|||
19689258|NCT00254566|42135169|FG000|Overall Study|Other|1|||
19689259|NCT00254566|42135170|FG001|Overall Study|Other|5|||
19689260|NCT00254566|42135169|FG000|Overall Study|Withdrawal by Subject|5|||
19689261|NCT00254566|42135170|FG001|Overall Study|Withdrawal by Subject|6|||
19689262|NCT00254566|42135169|FG000|Overall Study|Lost to Follow-up|7|||
19689263|NCT00254566|42135170|FG001|Overall Study|Lost to Follow-up|2|||
19689264|NCT00358956|42135176|FG000|Overall Study|Adverse Event|3|||
19689265|NCT00358956|42135176|FG000|Overall Study|condition under investigation worsened|4|||
19689266|NCT00358956|42135176|FG000|Overall Study|Withdrawal by Subject|1|||
19689267|NCT03830892|42135182|FG000|Overall Study|Physician Decision|2|||
19689268|NCT03830892|42135183|FG001|Overall Study|Physician Decision|3|||
19689269|NCT03830892|42135182|FG000|Overall Study|Study terminated due to COVID|4|||
19689270|NCT03830892|42135183|FG001|Overall Study|Study terminated due to COVID|0|||
19689271|NCT03830892|42135182|FG000|Overall Study|Protocol Violation|0|||
19689272|NCT03830892|42135183|FG001|Overall Study|Protocol Violation|1|||
19689273|NCT03830892|42135182|FG000|Overall Study|Withdrawal by Subject|0|||
19689274|NCT03830892|42135183|FG001|Overall Study|Withdrawal by Subject|2|||
19689275|NCT00253630|42135189|FG000|Overall Study|ineligible|2|||
19689276|NCT00358644|42135193|FG000|Overall Study|Progressive Disease|21|||
19689277|NCT00358644|42135193|FG000|Overall Study|Adverse Event|7|||
19689278|NCT00358644|42135193|FG000|Overall Study|Death|11|||
19689279|NCT00358644|42135193|FG000|Overall Study|Withdrawal by Subject|4|||
19689280|NCT00358644|42135193|FG000|Overall Study|Physician Decision|6|||
19689281|NCT00358644|42135193|FG000|Overall Study|Patient not eligible for study|1|||
19689282|NCT00364182|42135200|FG000|First Intervention|Secondary prophylaxis|1|||
19689283|NCT00364182|42135201|FG001|First Intervention|Secondary prophylaxis|0|||
19689284|NCT00364182|42135202|FG002|First Intervention|Secondary prophylaxis|0|||
19689285|NCT00364182|42135200|FG000|First Intervention|Withdrawal by Subject|2|||
19771499|NCT02906670|42225439|FG004|Cohort 5, Q2W|Adverse Event|0|||
19689286|NCT00364182|42135201|FG001|First Intervention|Withdrawal by Subject|0|||
19689287|NCT00364182|42135202|FG002|First Intervention|Withdrawal by Subject|0|||
19689288|NCT00364182|42135200|FG000|Second Intervention|non-compliance|0|||
19689289|NCT00364182|42135201|FG001|Second Intervention|non-compliance|1|||
19689290|NCT00364182|42135202|FG002|Second Intervention|non-compliance|1|||
19689291|NCT00364182|42135200|FG000|Second Intervention|Protocol Violation|0|||
19689292|NCT00364182|42135201|FG001|Second Intervention|Protocol Violation|1|||
19689293|NCT00364182|42135202|FG002|Second Intervention|Protocol Violation|0|||
19689294|NCT00364182|42135200|FG000|Second Intervention|Adverse Event|0|||
19689295|NCT00364182|42135201|FG001|Second Intervention|Adverse Event|0|||
19689296|NCT00364182|42135202|FG002|Second Intervention|Adverse Event|1|||
19689297|NCT00364182|42135200|FG000|Third Intervention|non-compliance|0|||
19689298|NCT00364182|42135201|FG001|Third Intervention|non-compliance|1|||
19689299|NCT00364182|42135202|FG002|Third Intervention|non-compliance|0|||
19689300|NCT00364182|42135200|FG000|Third Intervention|Lost to Follow-up|0|||
19689301|NCT00364182|42135201|FG001|Third Intervention|Lost to Follow-up|0|||
19689302|NCT00364182|42135202|FG002|Third Intervention|Lost to Follow-up|1|||
19689303|NCT00369486|42135217|FG000|4-Week Visit|Missed visit|2|||
19689304|NCT00369486|42135218|FG001|4-Week Visit|Missed visit|2|||
19689305|NCT00369486|42135219|FG002|4-Week Visit|Missed visit|0|||
19689306|NCT00369486|42135220|FG003|4-Week Visit|Missed visit|2|||
19689307|NCT00369486|42135221|FG004|4-Week Visit|Missed visit|1|||
19771500|NCT02906670|42225440|FG005|Cohort 5, Q2W|Adverse Event|0|||
19771501|NCT02906670|42225441|FG006|Cohort 5, Q2W|Adverse Event|1|||
19771502|NCT02906670|42225442|FG007|Cohort 5, Q2W|Adverse Event|0|||
19771503|NCT02906670|42225443|FG008|Cohort 5, Q2W|Adverse Event|0|||
19771504|NCT02906670|42225444|FG009|Cohort 5, Q2W|Adverse Event|0|||
19771505|NCT02906670|42225435|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771506|NCT02906670|42225436|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771507|NCT02906670|42225437|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771508|NCT02906670|42225438|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771509|NCT02906670|42225439|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771510|NCT02906670|42225440|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771511|NCT02906670|42225441|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
19771512|NCT02906670|42225442|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771513|NCT02906670|42225443|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771514|NCT02906670|42225444|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
19771515|NCT02906670|42225435|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
19771516|NCT02906670|42225436|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
19771517|NCT02906670|42225437|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
19771518|NCT02906670|42225438|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
19477634|NCT01462435|41756911|FG000|Overall Study|Lost to Follow-up|0|||
19477635|NCT01462435|41756912|FG001|Overall Study|Lost to Follow-up|0|||
19477636|NCT01462435|41756913|FG002|Overall Study|Lost to Follow-up|0|||
19477637|NCT01462435|41756914|FG003|Overall Study|Lost to Follow-up|1|||
19477638|NCT01472081|41756930|FG000|Overall Study|Continuing treatment at time of analysis|1|||
19477639|NCT01472081|41756931|FG001|Overall Study|Continuing treatment at time of analysis|4|||
19477640|NCT01472081|41756932|FG002|Overall Study|Continuing treatment at time of analysis|1|||
19477641|NCT01472081|41756933|FG003|Overall Study|Continuing treatment at time of analysis|8|||
19477642|NCT01472081|41756934|FG004|Overall Study|Continuing treatment at time of analysis|9|||
19477643|NCT01472081|41756935|FG005|Overall Study|Continuing treatment at time of analysis|0|||
19477644|NCT01472081|41756930|FG000|Overall Study|Disease Progression|4|||
19477645|NCT01472081|41756931|FG001|Overall Study|Disease Progression|10|||
19477646|NCT01472081|41756932|FG002|Overall Study|Disease Progression|12|||
19477647|NCT01472081|41756933|FG003|Overall Study|Disease Progression|31|||
19477648|NCT01472081|41756934|FG004|Overall Study|Disease Progression|22|||
19477649|NCT01472081|41756935|FG005|Overall Study|Disease Progression|3|||
19477650|NCT01472081|41756930|FG000|Overall Study|Study drug toxicity|2|||
19477651|NCT01472081|41756931|FG001|Overall Study|Study drug toxicity|9|||
19477652|NCT01472081|41756932|FG002|Overall Study|Study drug toxicity|4|||
19477653|NCT01472081|41756933|FG003|Overall Study|Study drug toxicity|6|||
19477654|NCT01472081|41756934|FG004|Overall Study|Study drug toxicity|13|||
19477655|NCT01472081|41756935|FG005|Overall Study|Study drug toxicity|2|||
19771519|NCT02906670|42225439|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
19771520|NCT02906670|42225440|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
19771521|NCT02906670|42225441|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
19771522|NCT02906670|42225442|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
19771523|NCT02906670|42225443|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
19771524|NCT02906670|42225444|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
19477656|NCT01472081|41756930|FG000|Overall Study|Death|0|||
19477657|NCT01472081|41756931|FG001|Overall Study|Death|0|||
19477658|NCT01472081|41756932|FG002|Overall Study|Death|0|||
19689308|NCT00369486|42135217|FG000|4-Week Visit|Dropped|0|||
19689309|NCT00369486|42135218|FG001|4-Week Visit|Dropped|0|||
19689310|NCT00369486|42135219|FG002|4-Week Visit|Dropped|1|||
19689311|NCT00369486|42135220|FG003|4-Week Visit|Dropped|0|||
19689312|NCT00369486|42135221|FG004|4-Week Visit|Dropped|0|||
19771525|NCT02906670|42225435|FG000|Cohort 5P, Q2W|Adverse Event|0|||
19771526|NCT02906670|42225436|FG001|Cohort 5P, Q2W|Adverse Event|0|||
19771527|NCT02906670|42225437|FG002|Cohort 5P, Q2W|Adverse Event|0|||
19771528|NCT02906670|42225438|FG003|Cohort 5P, Q2W|Adverse Event|0|||
19771529|NCT02906670|42225439|FG004|Cohort 5P, Q2W|Adverse Event|0|||
19771530|NCT02906670|42225440|FG005|Cohort 5P, Q2W|Adverse Event|0|||
19771531|NCT02906670|42225441|FG006|Cohort 5P, Q2W|Adverse Event|0|||
19771532|NCT02906670|42225442|FG007|Cohort 5P, Q2W|Adverse Event|1|||
19689313|NCT00369486|42135217|FG000|8-Week Visit|Missed visit|0|||
19689314|NCT00369486|42135218|FG001|8-Week Visit|Missed visit|1|||
19771533|NCT02906670|42225443|FG008|Cohort 5P, Q2W|Adverse Event|0|||
19771534|NCT02906670|42225444|FG009|Cohort 5P, Q2W|Adverse Event|0|||
19771535|NCT02906670|42225435|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
19771536|NCT02906670|42225436|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
19771537|NCT02906670|42225437|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
19771538|NCT02906670|42225438|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
19771539|NCT02906670|42225439|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
19771540|NCT02906670|42225440|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
19771541|NCT02906670|42225441|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
19771542|NCT02906670|42225442|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
19771543|NCT02906670|42225443|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
19771544|NCT02906670|42225444|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
19771545|NCT02906670|42225435|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
19771546|NCT02906670|42225436|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
19771547|NCT02906670|42225437|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
19771548|NCT02906670|42225438|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
19771549|NCT02906670|42225439|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
19689315|NCT00369486|42135219|FG002|8-Week Visit|Missed visit|0|||
19689316|NCT00369486|42135220|FG003|8-Week Visit|Missed visit|0|||
19689317|NCT00369486|42135221|FG004|8-Week Visit|Missed visit|1|||
19689318|NCT00369486|42135217|FG000|8-Week Visit|Dropped|0|||
19689319|NCT00369486|42135218|FG001|8-Week Visit|Dropped|0|||
19689320|NCT00369486|42135219|FG002|8-Week Visit|Dropped|0|||
19689321|NCT00369486|42135220|FG003|8-Week Visit|Dropped|1|||
19689322|NCT00369486|42135221|FG004|8-Week Visit|Dropped|0|||
19689323|NCT00369486|42135217|FG000|17-Week Visit|Missed visit|0|||
19689324|NCT00369486|42135218|FG001|17-Week Visit|Missed visit|0|||
19689325|NCT00369486|42135219|FG002|17-Week Visit|Missed visit|1|||
19689326|NCT00369486|42135220|FG003|17-Week Visit|Missed visit|1|||
19689327|NCT00369486|42135221|FG004|17-Week Visit|Missed visit|1|||
19689328|NCT00369486|42135217|FG000|34-Week Visit|Dropped|0|||
19689329|NCT00369486|42135218|FG001|34-Week Visit|Dropped|1|||
19689330|NCT00369486|42135219|FG002|34-Week Visit|Dropped|1|||
19689331|NCT00369486|42135220|FG003|34-Week Visit|Dropped|3|||
19689332|NCT00369486|42135221|FG004|34-Week Visit|Dropped|3|||
19689333|NCT00363480|42135233|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
19689334|NCT00363480|42135233|FG000|Overall Study|Adverse Event|4|||
19689335|NCT00363480|42135233|FG000|Overall Study|Lost to Follow-up|5|||
19689336|NCT00363480|42135233|FG000|Overall Study|Withdrawal by Subject|5|||
19689337|NCT00363480|42135233|FG000|Overall Study|Non-compliance of subject|1|||
19689338|NCT00363480|42135233|FG000|Overall Study|Participant discontinued on its own|1|||
19689339|NCT00363246|42135237|FG000|Overall Study|Death|40|||
19689340|NCT00363246|42135237|FG000|Overall Study|Withdrawal by Subject|19|||
19689341|NCT00363246|42135237|FG000|Overall Study|Lost to Follow-up|14|||
19689342|NCT00363246|42135237|FG000|Overall Study|Bad health|6|||
19689343|NCT00363246|42135237|FG000|Overall Study|Stopped using wheelchair|11|||
19689344|NCT00363246|42135237|FG000|Overall Study|Subject expressed security concerns|2|||
19689345|NCT00363246|42135237|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
19689346|NCT00223990|42135244|FG000|Overall Study|Moved from area|2|||
19689347|NCT00223990|42135245|FG001|Overall Study|Moved from area|1|||
19689348|NCT00223990|42135244|FG000|Overall Study|Withdrawal by Subject|4|||
19689349|NCT00223990|42135245|FG001|Overall Study|Withdrawal by Subject|8|||
19689350|NCT00223990|42135244|FG000|Overall Study|Lost to Follow-up|1|||
19689351|NCT00223990|42135245|FG001|Overall Study|Lost to Follow-up|0|||
19689352|NCT00221104|42135253|FG000|Overall Study|Adverse Event|1|||
19689353|NCT00221104|42135254|FG001|Overall Study|Adverse Event|0|||
19689354|NCT00221104|42135253|FG000|Overall Study|Physician Decision|1|||
19689355|NCT00221104|42135254|FG001|Overall Study|Physician Decision|0|||
19689356|NCT00221104|42135253|FG000|Overall Study|Protocol Violation|2|||
19689357|NCT00221104|42135254|FG001|Overall Study|Protocol Violation|0|||
19771550|NCT02906670|42225440|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
19689358|NCT00221104|42135253|FG000|Overall Study|Withdrawal by Subject|42|||
19689359|NCT00221104|42135254|FG001|Overall Study|Withdrawal by Subject|29|||
19689360|NCT00221104|42135253|FG000|Overall Study|Others|37|||
19689361|NCT00221104|42135254|FG001|Overall Study|Others|47|||
19689362|NCT00189202|42135262|FG000|Overall Study|Physician Decision|5|||
19689363|NCT00187486|42135266|FG000|Overall Study|Protocol Violation|1|||
19771551|NCT02906670|42225441|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
19771552|NCT02906670|42225442|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
19771553|NCT02906670|42225443|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
19689364|NCT00220636|42135270|FG000|Overall Study|Withdrawal by Subject|4|||
19689365|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
19689366|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
19689367|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Death|1|||
19689368|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Death|3|||
19689369|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
19689370|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
19689371|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
19689372|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
19689373|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
19689374|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
19689375|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
19689376|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
19689377|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
19689378|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
19689379|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
19689380|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
19689381|NCT00362232|42135277|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
19689382|NCT00362232|42135278|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
19689383|NCT00362232|42135277|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
19689384|NCT00362232|42135278|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
19689385|NCT00362232|42135277|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
19689386|NCT00362232|42135278|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
19689387|NCT00362232|42135277|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
19689388|NCT00362232|42135278|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
19689389|NCT00362232|42135277|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
19689390|NCT00362232|42135278|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
19689391|NCT00219544|42135284|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
19689392|NCT00219544|42135285|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
19689393|NCT00219544|42135284|FG000|Single Blind Treatment Period|Adverse Event|9|||
19689394|NCT00219544|42135285|FG001|Single Blind Treatment Period|Adverse Event|0|||
19689395|NCT00219544|42135284|FG000|Single Blind Treatment Period|Protocol Violation|4|||
19689396|NCT00219544|42135285|FG001|Single Blind Treatment Period|Protocol Violation|0|||
19689397|NCT00219544|42135284|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
19689398|NCT00219544|42135285|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
19689399|NCT00219544|42135284|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
19689400|NCT00219544|42135285|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
19689401|NCT00219544|42135284|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
19689402|NCT00219544|42135285|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
19689403|NCT00357552|42135293|FG000|Screening|Did not meet eligibility criteria|84|||
19689404|NCT00357552|42135293|FG000|Weeks 0 to 24|Death|1|||
19689405|NCT00357552|42135293|FG000|Weeks 24 to 104|Death|3|||
19689406|NCT00357552|42135293|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
19689407|NCT00187096|42135304|FG000|Overall Study|unacceptable toxicity|0|||
19689408|NCT00187096|42135305|FG001|Overall Study|unacceptable toxicity|0|||
19689409|NCT00187096|42135306|FG002|Overall Study|unacceptable toxicity|1|||
19689410|NCT00357396|42135316|FG000|Overall Study|Adverse Event|1|||
19689411|NCT00357396|42135317|FG001|Overall Study|Adverse Event|0|||
19689412|NCT00186628|42135322|FG000|Overall Study|Death|2|||
19689413|NCT00186628|42135322|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
19689414|NCT00368550|42135330|FG000|Overall Study|Adverse Event|7|||
19689415|NCT00368550|42135331|FG001|Overall Study|Adverse Event|4|||
19689416|NCT00368550|42135330|FG000|Overall Study|Lack of Efficacy|4|||
19689417|NCT00368550|42135331|FG001|Overall Study|Lack of Efficacy|9|||
19689418|NCT00368550|42135330|FG000|Overall Study|Withdrawal by Subject|17|||
19689419|NCT00368550|42135331|FG001|Overall Study|Withdrawal by Subject|10|||
19689420|NCT00368472|42135337|FG000|Overall Study|Adverse Event|22|||
19689421|NCT00368472|42135337|FG000|Overall Study|Medication non-compliance|4|||
19689422|NCT00368472|42135337|FG000|Overall Study|Protocol Violation|2|||
19689423|NCT00368472|42135337|FG000|Overall Study|Request of Investigator or Sponsor|3|||
19689424|NCT00368472|42135337|FG000|Overall Study|Withdrawal by Subject|40|||
19689425|NCT00368472|42135337|FG000|Overall Study|Diary non-compliance|1|||
19689426|NCT00368472|42135337|FG000|Overall Study|Other|32|||
19689427|NCT00368472|42135337|FG000|Overall Study|Missing Final Disposition Date|1|||
19689428|NCT00357006|42135344|FG000|Overall Study|Lost to Follow-up|1|||
19689429|NCT00357006|42135345|FG001|Overall Study|Lost to Follow-up|2|||
19689430|NCT00357006|42135346|FG002|Overall Study|Lost to Follow-up|1|||
19689431|NCT00357006|42135344|FG000|Overall Study|Withdrawal by Subject|1|||
19689432|NCT00357006|42135345|FG001|Overall Study|Withdrawal by Subject|3|||
19689433|NCT00357006|42135346|FG002|Overall Study|Withdrawal by Subject|2|||
19689434|NCT00165646|42135357|FG000|Overall Study|Adverse Event|1|||
19689435|NCT00165646|42135358|FG001|Overall Study|Adverse Event|1|||
19689436|NCT00165646|42135359|FG002|Overall Study|Adverse Event|1|||
19689437|NCT00165646|42135357|FG000|Overall Study|Lack of Efficacy|1|||
19689438|NCT00165646|42135358|FG001|Overall Study|Lack of Efficacy|2|||
19689439|NCT00165646|42135359|FG002|Overall Study|Lack of Efficacy|0|||
19689440|NCT00165646|42135357|FG000|Overall Study|Withdrawal by Subject|0|||
19689441|NCT00165646|42135358|FG001|Overall Study|Withdrawal by Subject|2|||
19689442|NCT00165646|42135359|FG002|Overall Study|Withdrawal by Subject|1|||
19689443|NCT00165646|42135357|FG000|Overall Study|Physician Decision|2|||
19689444|NCT00165646|42135358|FG001|Overall Study|Physician Decision|0|||
19689445|NCT00165646|42135359|FG002|Overall Study|Physician Decision|2|||
19689446|NCT00165646|42135357|FG000|Overall Study|Protocol Violation|1|||
19689447|NCT00165646|42135358|FG001|Overall Study|Protocol Violation|0|||
19689448|NCT00165646|42135359|FG002|Overall Study|Protocol Violation|0|||
19689449|NCT00367770|42135367|FG000|Overall Study|Adverse Event|1|||
19689450|NCT00367770|42135367|FG000|Overall Study|Withdrawal by Subject|1|||
19689451|NCT00185614|42135371|FG000|Inter-treatment Period|Physician Decision|1|||
19689452|NCT00185614|42135371|FG000|Inter-treatment Period|Relapse|2|||
19689453|NCT00185614|42135371|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
19689454|NCT00162370|42135375|FG000|Efficacy Population|Lost to Follow-up|51|||
19689455|NCT00361842|42135384|FG000|Overall Study|Withdrawal by Subject|2|||
19689456|NCT00361842|42135385|FG001|Overall Study|Withdrawal by Subject|3|||
19689457|NCT00361842|42135384|FG000|Overall Study|Death|2|||
19689458|NCT00361842|42135385|FG001|Overall Study|Death|1|||
19689459|NCT00361842|42135384|FG000|Overall Study|Disease progression|19|||
19689460|NCT00361842|42135385|FG001|Overall Study|Disease progression|20|||
19689461|NCT00361842|42135384|FG000|Overall Study|Adverse Event|2|||
19689462|NCT00361842|42135385|FG001|Overall Study|Adverse Event|3|||
19689463|NCT00361842|42135384|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
19689464|NCT00361842|42135385|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
19689465|NCT00361842|42135384|FG000|Overall Study|Other|1|||
19689466|NCT00361842|42135385|FG001|Overall Study|Other|0|||
19689467|NCT00361842|42135384|FG000|Overall Study|Other|0|||
19689468|NCT00361842|42135385|FG001|Overall Study|Other|2|||
19689469|NCT00361296|42135393|FG000|Overall Study|Physician Decision|1|||
19689470|NCT00361296|42135393|FG000|Overall Study|Lack of Efficacy|2|||
19689471|NCT00356148|42135399|FG000|Overall Study|Reoperation within 30 days|2|||
19689472|NCT00356148|42135400|FG001|Overall Study|Reoperation within 30 days|1|||
19689473|NCT00361218|42135407|FG000|Overall Study|Lost to Follow-up|11|||
19689474|NCT00361218|42135407|FG000|Overall Study|Personal Reasons|7|||
19689475|NCT00361218|42135407|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
19689476|NCT00367458|42135413|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
19689477|NCT00367458|42135414|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
19689478|NCT00162136|42135426|FG000|Overall Study|Adverse Event|1|||
19689479|NCT00162136|42135426|FG000|Overall Study|Death|1|||
19689480|NCT00162136|42135426|FG000|Overall Study|Disease Progression/Relapse|23|||
19689481|NCT00162136|42135426|FG000|Overall Study|Investigator Request|5|||
19689482|NCT00162136|42135426|FG000|Overall Study|Study Drug Toxicity|4|||
19689483|NCT00162136|42135426|FG000|Overall Study|Withdrawal by Subject|1|||
19689484|NCT00252694|42135452|FG000|Overall Study|Withdrawal by Subject|83|||
19689485|NCT00252694|42135453|FG001|Overall Study|Withdrawal by Subject|91|||
19689486|NCT00252694|42135452|FG000|Overall Study|Death|36|||
19689487|NCT00252694|42135453|FG001|Overall Study|Death|34|||
19689488|NCT00252694|42135452|FG000|Overall Study|Mostly Lost to Follow Up|8|||
19689489|NCT00252694|42135453|FG001|Overall Study|Mostly Lost to Follow Up|13|||
19689490|NCT00252694|42135452|FG000|Overall Study|Patient Moving|17|||
19689491|NCT00252694|42135453|FG001|Overall Study|Patient Moving|16|||
19689492|NCT00185458|42135459|FG000|Contraception Phase|Adverse Event|37|||
19689493|NCT00185458|42135459|FG000|Contraception Phase|Lost to Follow-up|10|||
19689494|NCT00185458|42135459|FG000|Contraception Phase|Protocol Violation|2|||
19689495|NCT00185458|42135459|FG000|Contraception Phase|Physician Decision|2|||
19689496|NCT00185458|42135459|FG000|Contraception Phase|Withdrawal by Subject|7|||
19689497|NCT00185458|42135459|FG000|HRT Phase|Adverse Event|18|||
19689498|NCT00185458|42135459|FG000|HRT Phase|Lost to Follow-up|4|||
19689499|NCT00185458|42135459|FG000|HRT Phase|Protocol Violation|2|||
19689500|NCT00185458|42135459|FG000|HRT Phase|Withdrawal by Subject|3|||
19689501|NCT00185380|42135474|FG000|Overall Study|Adverse Event|41|||
19689502|NCT00185380|42135475|FG001|Overall Study|Adverse Event|43|||
19689503|NCT00185380|42135476|FG002|Overall Study|Adverse Event|48|||
19689504|NCT00185380|42135474|FG000|Overall Study|Lost to Follow-up|0|||
19689505|NCT00185380|42135475|FG001|Overall Study|Lost to Follow-up|4|||
19689506|NCT00185380|42135476|FG002|Overall Study|Lost to Follow-up|3|||
19689507|NCT00185380|42135474|FG000|Overall Study|Pregnancy|1|||
19689508|NCT00185380|42135475|FG001|Overall Study|Pregnancy|4|||
19689509|NCT00185380|42135476|FG002|Overall Study|Pregnancy|0|||
19689510|NCT00185380|42135474|FG000|Overall Study|Protocol Violation|2|||
19689511|NCT00185380|42135475|FG001|Overall Study|Protocol Violation|2|||
19689512|NCT00185380|42135476|FG002|Overall Study|Protocol Violation|1|||
19689513|NCT00185380|42135474|FG000|Overall Study|Withdrawal by Subject|1|||
19689514|NCT00185380|42135475|FG001|Overall Study|Withdrawal by Subject|2|||
19689515|NCT00185380|42135476|FG002|Overall Study|Withdrawal by Subject|0|||
19689516|NCT00185380|42135474|FG000|Overall Study|Failed insertion|1|||
19689517|NCT00185380|42135475|FG001|Overall Study|Failed insertion|1|||
19689518|NCT00185380|42135476|FG002|Overall Study|Failed insertion|2|||
19689519|NCT00185380|42135474|FG000|Overall Study|Planned pregnancy|9|||
19689520|NCT00185380|42135475|FG001|Overall Study|Planned pregnancy|12|||
19689521|NCT00185380|42135476|FG002|Overall Study|Planned pregnancy|12|||
19689522|NCT00185380|42135474|FG000|Overall Study|No need for contraception|3|||
19689523|NCT00185380|42135475|FG001|Overall Study|No need for contraception|3|||
19689524|NCT00185380|42135476|FG002|Overall Study|No need for contraception|3|||
19689525|NCT00185380|42135474|FG000|Overall Study|Could not attend visits|2|||
19689526|NCT00185380|42135475|FG001|Overall Study|Could not attend visits|0|||
19689527|NCT00185380|42135476|FG002|Overall Study|Could not attend visits|4|||
19689528|NCT00185380|42135474|FG000|Overall Study|personal reason|6|||
19689529|NCT00185380|42135475|FG001|Overall Study|personal reason|1|||
19689530|NCT00185380|42135476|FG002|Overall Study|personal reason|1|||
19689531|NCT00160654|42135484|FG000|Overall Study|Adverse Event|14|||
19689532|NCT00160654|42135484|FG000|Overall Study|Lack of Efficacy|4|||
19689533|NCT00160654|42135484|FG000|Overall Study|Lost to Follow-up|2|||
19689534|NCT00160654|42135484|FG000|Overall Study|Intake of expired drug|7|||
19689535|NCT00160654|42135484|FG000|Overall Study|Psychological trauma|1|||
19689536|NCT00160654|42135484|FG000|Overall Study|Sponsor decision|1|||
19689537|NCT00160654|42135484|FG000|Overall Study|Patient met exclusion criteria|1|||
19689538|NCT00160654|42135484|FG000|Overall Study|Patient decision|1|||
19689539|NCT00160654|42135484|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
19689540|NCT00160654|42135484|FG000|Overall Study|Met exclusion criteria|1|||
19689541|NCT00366678|42135490|FG000|Infant Series|Withdrawal by Subject|8|||
19689542|NCT00366678|42135491|FG001|Infant Series|Withdrawal by Subject|6|||
19689543|NCT00366678|42135492|FG002|Infant Series|Withdrawal by Subject|0|||
19689544|NCT00366678|42135490|FG000|Infant Series|Protocol Violation|4|||
19689545|NCT00366678|42135491|FG001|Infant Series|Protocol Violation|3|||
19689546|NCT00366678|42135492|FG002|Infant Series|Protocol Violation|0|||
19689547|NCT00366678|42135490|FG000|Infant Series|Failed to return|1|||
19689548|NCT00366678|42135491|FG001|Infant Series|Failed to return|1|||
19689549|NCT00366678|42135492|FG002|Infant Series|Failed to return|0|||
19689550|NCT00366678|42135490|FG000|Infant Series|Adverse Event|1|||
19689551|NCT00366678|42135491|FG001|Infant Series|Adverse Event|0|||
19689552|NCT00366678|42135492|FG002|Infant Series|Adverse Event|0|||
19689553|NCT00366678|42135490|FG000|After Infant|Withdrawal by Subject|8|||
19689554|NCT00366678|42135491|FG001|After Infant|Withdrawal by Subject|4|||
19689555|NCT00366678|42135492|FG002|After Infant|Withdrawal by Subject|0|||
19689556|NCT00366678|42135490|FG000|After Infant|Lost to Follow-up|2|||
19689557|NCT00366678|42135491|FG001|After Infant|Lost to Follow-up|1|||
19689558|NCT00366678|42135492|FG002|After Infant|Lost to Follow-up|0|||
19689559|NCT00366678|42135490|FG000|After Infant|Failed to return|5|||
19689560|NCT00366678|42135491|FG001|After Infant|Failed to return|5|||
19689561|NCT00366678|42135492|FG002|After Infant|Failed to return|0|||
19689562|NCT00366678|42135490|FG000|After Infant|Adverse Event|1|||
19689563|NCT00366678|42135491|FG001|After Infant|Adverse Event|0|||
19689564|NCT00366678|42135492|FG002|After Infant|Adverse Event|0|||
19689565|NCT00366678|42135490|FG000|After Infant|Protocol Violation|1|||
19689566|NCT00366678|42135491|FG001|After Infant|Protocol Violation|0|||
19689567|NCT00366678|42135492|FG002|After Infant|Protocol Violation|0|||
19689568|NCT00366678|42135490|FG000|Toddler Dose|Protocol Violation|2|||
19689569|NCT00366678|42135491|FG001|Toddler Dose|Protocol Violation|1|||
19689570|NCT00366678|42135492|FG002|Toddler Dose|Protocol Violation|0|||
19689571|NCT00366678|42135490|FG000|Toddler Dose|Failed to return|1|||
19689572|NCT00366678|42135491|FG001|Toddler Dose|Failed to return|0|||
19689573|NCT00366678|42135492|FG002|Toddler Dose|Failed to return|0|||
19689574|NCT00366678|42135490|FG000|Toddler Dose|Withdrawal by Subject|1|||
19689575|NCT00366678|42135491|FG001|Toddler Dose|Withdrawal by Subject|0|||
19689576|NCT00366678|42135492|FG002|Toddler Dose|Withdrawal by Subject|0|||
19689577|NCT00366678|42135490|FG000|Toddler Dose|protocol deviation|1|||
19689578|NCT00366678|42135491|FG001|Toddler Dose|protocol deviation|0|||
19689579|NCT00366678|42135492|FG002|Toddler Dose|protocol deviation|0|||
19689580|NCT00355368|42135539|FG000|Overall Study|Protocol Violation|8|||
19689581|NCT00355368|42135540|FG001|Overall Study|Protocol Violation|7|||
19689582|NCT00355368|42135539|FG000|Overall Study|cardiac arrest prior to intubation|2|||
19689583|NCT00355368|42135540|FG001|Overall Study|cardiac arrest prior to intubation|2|||
19689584|NCT00360282|42135546|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
19689585|NCT00360282|42135547|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
19689586|NCT00360282|42135548|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
19689587|NCT00360282|42135549|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
19689588|NCT00360282|42135546|FG000|Second Intervention|Adverse Event|0|||
19689589|NCT00360282|42135547|FG001|Second Intervention|Adverse Event|1|||
19689590|NCT00360282|42135548|FG002|Second Intervention|Adverse Event|0|||
19689591|NCT00360282|42135549|FG003|Second Intervention|Adverse Event|0|||
19689592|NCT00373958|42135559|FG000|Infant Series|Withdrawal by Subject|13|||
19689593|NCT00373958|42135560|FG001|Infant Series|Withdrawal by Subject|15|||
19689594|NCT00373958|42135559|FG000|Infant Series|Failed to return|8|||
19689595|NCT00373958|42135560|FG001|Infant Series|Failed to return|13|||
19689596|NCT00373958|42135559|FG000|Infant Series|Lost to Follow-up|6|||
19689597|NCT00373958|42135560|FG001|Infant Series|Lost to Follow-up|5|||
19689598|NCT00373958|42135559|FG000|Infant Series|Protocol Violation|3|||
19689599|NCT00373958|42135560|FG001|Infant Series|Protocol Violation|7|||
19689600|NCT00373958|42135559|FG000|Infant Series|Lost Kaiser coverage|4|||
19689601|NCT00373958|42135560|FG001|Infant Series|Lost Kaiser coverage|0|||
19689602|NCT00373958|42135559|FG000|Infant Series|Child relocated|1|||
19689603|NCT00373958|42135560|FG001|Infant Series|Child relocated|0|||
19689604|NCT00373958|42135559|FG000|Infant Series|Consent was not received|1|||
19689605|NCT00373958|42135560|FG001|Infant Series|Consent was not received|0|||
19689606|NCT00373958|42135559|FG000|Infant Series|Adverse Event|3|||
19689607|NCT00373958|42135560|FG001|Infant Series|Adverse Event|1|||
19689608|NCT00373958|42135559|FG000|Infant Series|Physician Decision|1|||
19689609|NCT00373958|42135560|FG001|Infant Series|Physician Decision|1|||
19689610|NCT00373958|42135559|FG000|Toddler Dose|Lost to Follow-up|5|||
19689611|NCT00373958|42135560|FG001|Toddler Dose|Lost to Follow-up|8|||
19689612|NCT00373958|42135559|FG000|Toddler Dose|Withdrawal by Subject|2|||
19689613|NCT00373958|42135560|FG001|Toddler Dose|Withdrawal by Subject|2|||
19689614|NCT00373958|42135559|FG000|Toddler Dose|Failed to return|1|||
19689615|NCT00373958|42135560|FG001|Toddler Dose|Failed to return|2|||
19689616|NCT00373958|42135559|FG000|Toddler Dose|Protocol Violation|0|||
19689617|NCT00373958|42135560|FG001|Toddler Dose|Protocol Violation|1|||
19689618|NCT00373958|42135559|FG000|Toddler Dose|Withdrawn after infant series|22|||
19689619|NCT00373958|42135560|FG001|Toddler Dose|Withdrawn after infant series|25|||
19689620|NCT00373880|42135589|FG000|Overall Study|Physician Decision|3|||
19689621|NCT00373880|42135589|FG000|Overall Study|Arrested|1|||
19689622|NCT00373880|42135589|FG000|Overall Study|Protocol Violation|14|||
19689623|NCT00184600|42135604|FG000|Overall Study|Adverse Event|9|||
19689624|NCT00184600|42135605|FG001|Overall Study|Adverse Event|0|||
19689625|NCT00184600|42135606|FG002|Overall Study|Adverse Event|5|||
19689626|NCT00184600|42135604|FG000|Overall Study|Death|3|||
19689627|NCT00184600|42135605|FG001|Overall Study|Death|9|||
19689628|NCT00184600|42135606|FG002|Overall Study|Death|7|||
19689629|NCT00184600|42135604|FG000|Overall Study|Lack of Efficacy|3|||
19689630|NCT00184600|42135605|FG001|Overall Study|Lack of Efficacy|1|||
19689631|NCT00184600|42135606|FG002|Overall Study|Lack of Efficacy|3|||
19689632|NCT00184600|42135604|FG000|Overall Study|Lost to Follow-up|4|||
19689633|NCT00184600|42135605|FG001|Overall Study|Lost to Follow-up|6|||
19689634|NCT00184600|42135606|FG002|Overall Study|Lost to Follow-up|1|||
19689635|NCT00184600|42135604|FG000|Overall Study|Protocol Violation|2|||
19689636|NCT00184600|42135605|FG001|Overall Study|Protocol Violation|2|||
19689637|NCT00184600|42135606|FG002|Overall Study|Protocol Violation|3|||
19689638|NCT00184600|42135604|FG000|Overall Study|Withdrawal by Subject|20|||
19689639|NCT00184600|42135605|FG001|Overall Study|Withdrawal by Subject|28|||
19689640|NCT00184600|42135606|FG002|Overall Study|Withdrawal by Subject|12|||
19689641|NCT00184600|42135604|FG000|Overall Study|Unclassified|4|||
19689642|NCT00184600|42135605|FG001|Overall Study|Unclassified|5|||
19689643|NCT00184600|42135606|FG002|Overall Study|Unclassified|3|||
19689644|NCT00265317|42135618|FG000|Lead-In|Objective progression or relapse|6|||
19689645|NCT00265317|42135619|FG001|Lead-In|Objective progression or relapse|11|||
19689646|NCT00265317|42135620|FG002|Lead-In|Objective progression or relapse|0|||
19689647|NCT00265317|42135621|FG003|Lead-In|Objective progression or relapse|0|||
19689648|NCT00265317|42135618|FG000|Lead-In|Adverse Event|2|||
19689649|NCT00265317|42135619|FG001|Lead-In|Adverse Event|1|||
19689650|NCT00265317|42135620|FG002|Lead-In|Adverse Event|0|||
19689651|NCT00265317|42135621|FG003|Lead-In|Adverse Event|0|||
19689652|NCT00265317|42135618|FG000|Lead-In|Death|3|||
19689653|NCT00265317|42135619|FG001|Lead-In|Death|5|||
19689654|NCT00265317|42135620|FG002|Lead-In|Death|0|||
19689655|NCT00265317|42135621|FG003|Lead-In|Death|0|||
19689656|NCT00265317|42135618|FG000|Lead-In|Withdrawal/other than adverse event|1|||
19689657|NCT00265317|42135619|FG001|Lead-In|Withdrawal/other than adverse event|0|||
19689658|NCT00265317|42135620|FG002|Lead-In|Withdrawal/other than adverse event|0|||
19689659|NCT00265317|42135621|FG003|Lead-In|Withdrawal/other than adverse event|0|||
19689660|NCT00265317|42135618|FG000|Phase 2|Objective progression or relapse|0|||
19689661|NCT00265317|42135619|FG001|Phase 2|Objective progression or relapse|0|||
19689662|NCT00265317|42135620|FG002|Phase 2|Objective progression or relapse|37|||
19689663|NCT00265317|42135621|FG003|Phase 2|Objective progression or relapse|38|||
19689664|NCT00265317|42135618|FG000|Phase 2|Global deterioration of health status|0|||
19689665|NCT00265317|42135619|FG001|Phase 2|Global deterioration of health status|0|||
19689666|NCT00265317|42135620|FG002|Phase 2|Global deterioration of health status|3|||
19689667|NCT00265317|42135621|FG003|Phase 2|Global deterioration of health status|0|||
19689668|NCT00265317|42135618|FG000|Phase 2|Adverse Event|0|||
19689669|NCT00265317|42135619|FG001|Phase 2|Adverse Event|0|||
19689670|NCT00265317|42135620|FG002|Phase 2|Adverse Event|7|||
19689671|NCT00265317|42135621|FG003|Phase 2|Adverse Event|5|||
19689672|NCT00265317|42135618|FG000|Phase 2|Death|0|||
19689673|NCT00265317|42135619|FG001|Phase 2|Death|0|||
19689674|NCT00265317|42135620|FG002|Phase 2|Death|12|||
19689675|NCT00265317|42135621|FG003|Phase 2|Death|15|||
19689676|NCT00265317|42135618|FG000|Phase 2|Protocol Violation|0|||
19689677|NCT00265317|42135619|FG001|Phase 2|Protocol Violation|0|||
19689678|NCT00265317|42135620|FG002|Phase 2|Protocol Violation|1|||
19689679|NCT00265317|42135621|FG003|Phase 2|Protocol Violation|4|||
19689680|NCT00265317|42135618|FG000|Phase 2|Lost to Follow-up|0|||
19689681|NCT00265317|42135619|FG001|Phase 2|Lost to Follow-up|0|||
19689682|NCT00265317|42135620|FG002|Phase 2|Lost to Follow-up|0|||
19689683|NCT00265317|42135621|FG003|Phase 2|Lost to Follow-up|1|||
19689684|NCT00265317|42135618|FG000|Phase 2|Withdrawal/other than adverse event|0|||
19689685|NCT00265317|42135619|FG001|Phase 2|Withdrawal/other than adverse event|0|||
19689686|NCT00265317|42135620|FG002|Phase 2|Withdrawal/other than adverse event|2|||
19689687|NCT00265317|42135621|FG003|Phase 2|Withdrawal/other than adverse event|1|||
19689688|NCT00265317|42135618|FG000|Phase 2|Study terminated by sponsor|0|||
19689689|NCT00265317|42135619|FG001|Phase 2|Study terminated by sponsor|0|||
19689690|NCT00265317|42135620|FG002|Phase 2|Study terminated by sponsor|1|||
19689691|NCT00265317|42135621|FG003|Phase 2|Study terminated by sponsor|0|||
19689692|NCT00265317|42135618|FG000|Phase 2|Other|0|||
19689693|NCT00265317|42135619|FG001|Phase 2|Other|0|||
19689694|NCT00265317|42135620|FG002|Phase 2|Other|1|||
19689695|NCT00265317|42135621|FG003|Phase 2|Other|1|||
19689696|NCT00373490|42135642|FG000|Overall Study|Adverse Event|0|||
19689697|NCT00373490|42135643|FG001|Overall Study|Adverse Event|1|||
19689698|NCT00373490|42135642|FG000|Overall Study|Lack of Efficacy|9|||
19689699|NCT00373490|42135643|FG001|Overall Study|Lack of Efficacy|4|||
19689700|NCT00373490|42135642|FG000|Overall Study|Withdrawal by Subject|0|||
19689701|NCT00373490|42135643|FG001|Overall Study|Withdrawal by Subject|1|||
19689702|NCT00251589|42135653|FG000|Overall Study|Adverse Event|5|||
19689703|NCT00251589|42135654|FG001|Overall Study|Adverse Event|1|||
19689704|NCT00251589|42135655|FG002|Overall Study|Adverse Event|2|||
19689705|NCT00251589|42135656|FG003|Overall Study|Adverse Event|1|||
19689706|NCT00251589|42135653|FG000|Overall Study|Withdrawal by Subject|1|||
19689707|NCT00251589|42135654|FG001|Overall Study|Withdrawal by Subject|1|||
19689708|NCT00251589|42135655|FG002|Overall Study|Withdrawal by Subject|0|||
19689709|NCT00251589|42135656|FG003|Overall Study|Withdrawal by Subject|0|||
19689710|NCT00251589|42135653|FG000|Overall Study|Discontinued due to progressive disease|9|||
19689711|NCT00251589|42135654|FG001|Overall Study|Discontinued due to progressive disease|1|||
19689712|NCT00251589|42135655|FG002|Overall Study|Discontinued due to progressive disease|0|||
19689713|NCT00251589|42135656|FG003|Overall Study|Discontinued due to progressive disease|1|||
19689714|NCT00265239|42135668|FG000|Overall Study|Adverse Event|2|||
19689715|NCT00265239|42135669|FG001|Overall Study|Adverse Event|1|||
19689716|NCT00350298|42135677|FG000|Overall Study|Death|7|||
19689717|NCT00350298|42135678|FG001|Overall Study|Death|8|||
19689718|NCT00350298|42135677|FG000|Overall Study|Lost to Follow-up|1|||
19689719|NCT00350298|42135678|FG001|Overall Study|Lost to Follow-up|2|||
19689720|NCT00350298|42135677|FG000|Overall Study|Withdrawal by Subject|1|||
19689721|NCT00350298|42135678|FG001|Overall Study|Withdrawal by Subject|3|||
19689722|NCT00159874|42135691|FG000|Overall Study|Adverse Event|2|||
19689723|NCT00159874|42135692|FG001|Overall Study|Adverse Event|2|||
19689724|NCT00159874|42135693|FG002|Overall Study|Adverse Event|5|||
19689725|NCT00159874|42135694|FG003|Overall Study|Adverse Event|1|||
19689726|NCT00159874|42135695|FG004|Overall Study|Adverse Event|1|||
19689727|NCT00159874|42135696|FG005|Overall Study|Adverse Event|2|||
19689728|NCT00159874|42135697|FG006|Overall Study|Adverse Event|0|||
19689729|NCT00159874|42135691|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
19689730|NCT00159874|42135692|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
19689731|NCT00159874|42135693|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
19689732|NCT00159874|42135694|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
19605775|NCT00686881|42054555|FG001|Overall Study|Met discontinuation criteria|0|||
19605776|NCT00686881|42054554|FG000|Overall Study|Onset of malignant tumor|11|||
19605777|NCT00686881|42054555|FG001|Overall Study|Onset of malignant tumor|11|||
19605778|NCT00686881|42054554|FG000|Overall Study|Lack of Efficacy|4|||
19605779|NCT00686881|42054555|FG001|Overall Study|Lack of Efficacy|3|||
19605780|NCT00686881|42054554|FG000|Overall Study|Physician Decision|1|||
19605781|NCT00686881|42054555|FG001|Overall Study|Physician Decision|0|||
19605782|NCT00686881|42054554|FG000|Overall Study|Circumstances of site|1|||
19605783|NCT00686881|42054555|FG001|Overall Study|Circumstances of site|1|||
19605784|NCT00686881|42054554|FG000|Overall Study|Did not meet protocol eligibility|1|||
19605785|NCT00686881|42054555|FG001|Overall Study|Did not meet protocol eligibility|0|||
19605786|NCT00686881|42054554|FG000|Overall Study|Irregular visits|1|||
19605787|NCT00686881|42054555|FG001|Overall Study|Irregular visits|0|||
19605788|NCT00686881|42054554|FG000|Overall Study|Study discontinuation|35|||
19605789|NCT00686881|42054555|FG001|Overall Study|Study discontinuation|32|||
19605790|NCT00686881|42054554|FG000|Overall Study|Never received study drug|2|||
19477659|NCT01472081|41756933|FG003|Overall Study|Death|0|||
19689733|NCT00159874|42135695|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
19689734|NCT00159874|42135696|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
19689735|NCT00159874|42135697|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
19689736|NCT00159874|42135691|FG000|Overall Study|Lack of Efficacy|2|||
19689737|NCT00159874|42135692|FG001|Overall Study|Lack of Efficacy|0|||
19689738|NCT00159874|42135693|FG002|Overall Study|Lack of Efficacy|1|||
19689739|NCT00159874|42135694|FG003|Overall Study|Lack of Efficacy|1|||
19689740|NCT00159874|42135695|FG004|Overall Study|Lack of Efficacy|0|||
19689741|NCT00159874|42135696|FG005|Overall Study|Lack of Efficacy|3|||
19689742|NCT00159874|42135697|FG006|Overall Study|Lack of Efficacy|0|||
19689743|NCT00159874|42135691|FG000|Overall Study|Lost to Follow-up|1|||
19689744|NCT00159874|42135692|FG001|Overall Study|Lost to Follow-up|0|||
19689745|NCT00159874|42135693|FG002|Overall Study|Lost to Follow-up|3|||
19689746|NCT00159874|42135694|FG003|Overall Study|Lost to Follow-up|0|||
19689747|NCT00159874|42135695|FG004|Overall Study|Lost to Follow-up|1|||
19689748|NCT00159874|42135696|FG005|Overall Study|Lost to Follow-up|2|||
19689749|NCT00159874|42135697|FG006|Overall Study|Lost to Follow-up|1|||
19689750|NCT00159874|42135691|FG000|Overall Study|Other|8|||
19689751|NCT00159874|42135692|FG001|Overall Study|Other|8|||
19689752|NCT00159874|42135693|FG002|Overall Study|Other|8|||
19689753|NCT00159874|42135694|FG003|Overall Study|Other|0|||
19689754|NCT00159874|42135695|FG004|Overall Study|Other|2|||
19689755|NCT00159874|42135696|FG005|Overall Study|Other|1|||
19689756|NCT00159874|42135697|FG006|Overall Study|Other|3|||
19689757|NCT00159874|42135691|FG000|Overall Study|Protocol Violation|0|||
19689758|NCT00159874|42135692|FG001|Overall Study|Protocol Violation|5|||
19689759|NCT00159874|42135693|FG002|Overall Study|Protocol Violation|2|||
19689760|NCT00159874|42135694|FG003|Overall Study|Protocol Violation|0|||
19689761|NCT00159874|42135695|FG004|Overall Study|Protocol Violation|0|||
19689762|NCT00159874|42135696|FG005|Overall Study|Protocol Violation|0|||
19689763|NCT00159874|42135697|FG006|Overall Study|Protocol Violation|0|||
19689764|NCT00159874|42135691|FG000|Overall Study|Death|3|||
19689765|NCT00159874|42135692|FG001|Overall Study|Death|8|||
19689766|NCT00159874|42135693|FG002|Overall Study|Death|15|||
19689767|NCT00159874|42135694|FG003|Overall Study|Death|0|||
19689768|NCT00159874|42135695|FG004|Overall Study|Death|1|||
19689769|NCT00159874|42135696|FG005|Overall Study|Death|2|||
19689770|NCT00159874|42135697|FG006|Overall Study|Death|0|||
19689771|NCT00159874|42135691|FG000|Overall Study|Withdrawal by Subject|2|||
19689772|NCT00159874|42135692|FG001|Overall Study|Withdrawal by Subject|6|||
19689773|NCT00159874|42135693|FG002|Overall Study|Withdrawal by Subject|8|||
19689774|NCT00159874|42135694|FG003|Overall Study|Withdrawal by Subject|4|||
19689775|NCT00159874|42135695|FG004|Overall Study|Withdrawal by Subject|3|||
19689776|NCT00159874|42135696|FG005|Overall Study|Withdrawal by Subject|2|||
19689777|NCT00159874|42135697|FG006|Overall Study|Withdrawal by Subject|1|||
19689778|NCT00159874|42135691|FG000|Overall Study|Pregnancy|1|||
19689779|NCT00159874|42135692|FG001|Overall Study|Pregnancy|1|||
19689780|NCT00159874|42135693|FG002|Overall Study|Pregnancy|0|||
19689781|NCT00159874|42135694|FG003|Overall Study|Pregnancy|0|||
19689782|NCT00159874|42135695|FG004|Overall Study|Pregnancy|0|||
19689783|NCT00159874|42135696|FG005|Overall Study|Pregnancy|0|||
19689784|NCT00159874|42135697|FG006|Overall Study|Pregnancy|0|||
19689785|NCT00349908|42135715|FG000|Overall Study|Withdrawal by Subject|0|||
19689786|NCT00349908|42135716|FG001|Overall Study|Withdrawal by Subject|4|||
19689787|NCT00184054|42135723|FG000|Overall Study|Adverse Event|1|||
19689788|NCT00183430|42135729|FG000|Overall Study|Adverse Event|1|||
19689789|NCT00183430|42135730|FG001|Overall Study|Adverse Event|0|||
19689790|NCT00183430|42135729|FG000|Overall Study|Lost to Follow-up|3|||
19689791|NCT00183430|42135730|FG001|Overall Study|Lost to Follow-up|0|||
19689792|NCT00183430|42135729|FG000|Overall Study|did not meet inclusion criteria|1|||
19689793|NCT00183430|42135730|FG001|Overall Study|did not meet inclusion criteria|0|||
19689794|NCT00183430|42135729|FG000|Overall Study|Withdrawal by Subject|1|||
19689795|NCT00183430|42135730|FG001|Overall Study|Withdrawal by Subject|0|||
19689796|NCT00183274|42135736|FG000|Phase 1: Open-Label|Adverse Event|31|||
19689797|NCT00183274|42135737|FG001|Phase 1: Open-Label|Adverse Event|0|||
19689798|NCT00183274|42135738|FG002|Phase 1: Open-Label|Adverse Event|0|||
19689799|NCT00183274|42135739|FG003|Phase 1: Open-Label|Adverse Event|0|||
19689800|NCT00183274|42135740|FG004|Phase 1: Open-Label|Adverse Event|0|||
19689801|NCT00183274|42135741|FG005|Phase 1: Open-Label|Adverse Event|0|||
19689802|NCT00183274|42135736|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
19689803|NCT00183274|42135737|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
19689804|NCT00183274|42135738|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
19689805|NCT00183274|42135739|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
19689806|NCT00183274|42135740|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
19689807|NCT00183274|42135741|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
19689808|NCT00183274|42135736|FG000|Phase 1: Open-Label|Protocol Violation|11|||
19771554|NCT02906670|42225444|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
19771555|NCT02906670|42225435|FG000|Cohort 4P, QW|Radiological Progression|0|||
19771556|NCT02906670|42225436|FG001|Cohort 4P, QW|Radiological Progression|0|||
19771557|NCT02906670|42225437|FG002|Cohort 4P, QW|Radiological Progression|0|||
19771558|NCT02906670|42225438|FG003|Cohort 4P, QW|Radiological Progression|3|||
19771559|NCT02906670|42225439|FG004|Cohort 4P, QW|Radiological Progression|0|||
19771560|NCT02906670|42225440|FG005|Cohort 4P, QW|Radiological Progression|0|||
19771561|NCT02906670|42225441|FG006|Cohort 4P, QW|Radiological Progression|0|||
19771562|NCT02906670|42225442|FG007|Cohort 4P, QW|Radiological Progression|0|||
19771563|NCT02906670|42225443|FG008|Cohort 4P, QW|Radiological Progression|0|||
19771564|NCT02906670|42225444|FG009|Cohort 4P, QW|Radiological Progression|0|||
19771565|NCT02906670|42225435|FG000|Cohort 7P, Q2W|Adverse Event|0|||
19771566|NCT02906670|42225436|FG001|Cohort 7P, Q2W|Adverse Event|0|||
19771567|NCT02906670|42225437|FG002|Cohort 7P, Q2W|Adverse Event|0|||
19771568|NCT02906670|42225438|FG003|Cohort 7P, Q2W|Adverse Event|0|||
19771569|NCT02906670|42225439|FG004|Cohort 7P, Q2W|Adverse Event|0|||
19771570|NCT02906670|42225440|FG005|Cohort 7P, Q2W|Adverse Event|0|||
19771571|NCT02906670|42225441|FG006|Cohort 7P, Q2W|Adverse Event|0|||
19771572|NCT02906670|42225442|FG007|Cohort 7P, Q2W|Adverse Event|0|||
19771573|NCT02906670|42225443|FG008|Cohort 7P, Q2W|Adverse Event|0|||
19771574|NCT02906670|42225444|FG009|Cohort 7P, Q2W|Adverse Event|1|||
19689809|NCT00183274|42135737|FG001|Phase 1: Open-Label|Protocol Violation|0|||
19689810|NCT00183274|42135738|FG002|Phase 1: Open-Label|Protocol Violation|0|||
19689811|NCT00183274|42135739|FG003|Phase 1: Open-Label|Protocol Violation|0|||
19689812|NCT00183274|42135740|FG004|Phase 1: Open-Label|Protocol Violation|0|||
19689813|NCT00183274|42135741|FG005|Phase 1: Open-Label|Protocol Violation|0|||
19689814|NCT00183274|42135736|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
19689815|NCT00183274|42135737|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
19689816|NCT00183274|42135738|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
19689817|NCT00183274|42135739|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
19605791|NCT00686881|42054555|FG001|Overall Study|Never received study drug|6|||
19605792|NCT00727714|42054563|FG000|Overall Study|Lost to Follow-up|2|||
19605793|NCT00727558|42054569|FG000|Overall Study|Lens issue|0|||
19689818|NCT00183274|42135740|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
19605794|NCT00727558|42054570|FG001|Overall Study|Lens issue|1|||
19605795|NCT00727558|42054569|FG000|Overall Study|Adverse Event|0|||
19605796|NCT00727558|42054570|FG001|Overall Study|Adverse Event|1|||
19605797|NCT00727558|42054569|FG000|Overall Study|Subject unable to return for follow-up|1|||
19605798|NCT00727558|42054570|FG001|Overall Study|Subject unable to return for follow-up|1|||
19605799|NCT00727558|42054569|FG000|Overall Study|Lost to Follow-up|1|||
19605800|NCT00727558|42054570|FG001|Overall Study|Lost to Follow-up|0|||
19605801|NCT00688597|42054579|FG000|Overall Study|Adverse Event|2|||
19605802|NCT00688597|42054580|FG001|Overall Study|Adverse Event|0|||
19605803|NCT00688597|42054581|FG002|Overall Study|Adverse Event|0|||
19605804|NCT00688597|42054579|FG000|Overall Study|Physician Decision|1|||
19605805|NCT00688597|42054580|FG001|Overall Study|Physician Decision|0|||
19689819|NCT00183274|42135741|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
19689820|NCT00183274|42135736|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
19689821|NCT00183274|42135737|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
19771575|NCT02906670|42225435|FG000|Cohort 7P, Q2W|Physician Decision|0|||
19771576|NCT02906670|42225436|FG001|Cohort 7P, Q2W|Physician Decision|0|||
19771577|NCT02906670|42225437|FG002|Cohort 7P, Q2W|Physician Decision|0|||
19689822|NCT00183274|42135738|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
19605806|NCT00688597|42054581|FG002|Overall Study|Physician Decision|0|||
19605807|NCT00735904|42054589|FG000|Overall Study|Adverse Event|3|||
19605808|NCT00735904|42054589|FG000|Overall Study|Death|20|||
19605809|NCT00735904|42054589|FG000|Overall Study|Protocol Violation|1|||
19605810|NCT00735904|42054589|FG000|Overall Study|Withdrawal by Subject|1|||
19605811|NCT00735904|42054589|FG000|Overall Study|Study Terminated by Sponsor|5|||
19605812|NCT00735904|42054589|FG000|Overall Study|Other|8|||
19605813|NCT00688519|42054595|FG000|Overall Study|Adverse Event|2|||
19605814|NCT00688519|42054596|FG001|Overall Study|Adverse Event|3|||
19605815|NCT00688519|42054595|FG000|Overall Study|Lost to Follow-up|3|||
19605816|NCT00688519|42054596|FG001|Overall Study|Lost to Follow-up|3|||
19605817|NCT00688519|42054595|FG000|Overall Study|Lack of Efficacy|3|||
19605818|NCT00688519|42054596|FG001|Overall Study|Lack of Efficacy|1|||
19605819|NCT00688519|42054595|FG000|Overall Study|Withdrawal by Subject|7|||
19605820|NCT00688519|42054596|FG001|Overall Study|Withdrawal by Subject|6|||
19605821|NCT00688519|42054595|FG000|Overall Study|Prohibited medication|1|||
19605822|NCT00688519|42054596|FG001|Overall Study|Prohibited medication|0|||
19605823|NCT00688519|42054595|FG000|Overall Study|Non-compliance|0|||
19605824|NCT00688519|42054596|FG001|Overall Study|Non-compliance|1|||
19605825|NCT00688519|42054595|FG000|Overall Study|Subject moved out of state|1|||
19605826|NCT00688519|42054596|FG001|Overall Study|Subject moved out of state|0|||
19605827|NCT00688519|42054595|FG000|Overall Study|Investigator decision|1|||
19605828|NCT00688519|42054596|FG001|Overall Study|Investigator decision|0|||
19605829|NCT00688519|42054595|FG000|Overall Study|Subject moved out of area|1|||
19605830|NCT00688519|42054596|FG001|Overall Study|Subject moved out of area|0|||
19605831|NCT00688519|42054595|FG000|Overall Study|Pregnancy|0|||
19605832|NCT00688519|42054596|FG001|Overall Study|Pregnancy|1|||
19605833|NCT00721630|42054602|FG000|Overall Study|Participant found to be ineligible|1|||
19605834|NCT00686725|42054608|FG000|Overall Study|Adverse Event|1|||
19605835|NCT00686725|42054609|FG001|Overall Study|Adverse Event|1|||
19605836|NCT00686725|42054608|FG000|Overall Study|Progressive Disease|17|||
19605837|NCT00686725|42054609|FG001|Overall Study|Progressive Disease|23|||
19605838|NCT00686725|42054608|FG000|Overall Study|Lost to Follow-up|7|||
19605839|NCT00686725|42054609|FG001|Overall Study|Lost to Follow-up|5|||
19605840|NCT00686725|42054608|FG000|Overall Study|Death|6|||
19605841|NCT00686725|42054609|FG001|Overall Study|Death|3|||
19605842|NCT00686725|42054608|FG000|Overall Study|Withdrawal by Subject|13|||
19605843|NCT00686725|42054609|FG001|Overall Study|Withdrawal by Subject|4|||
19605844|NCT00686725|42054608|FG000|Overall Study|Protocol Violation|1|||
19605845|NCT00686725|42054609|FG001|Overall Study|Protocol Violation|3|||
19605846|NCT00686725|42054608|FG000|Overall Study|Other|1|||
19605847|NCT00686725|42054609|FG001|Overall Study|Other|3|||
19605848|NCT00727402|42054615|FG000|Overall Study|Physician Decision|116|||
19605849|NCT00727246|42054623|FG000|Overall Study|could not complete MRI|0|||
19605850|NCT00727246|42054624|FG001|Overall Study|could not complete MRI|1|||
19605851|NCT00727246|42054625|FG002|Overall Study|could not complete MRI|0|||
19605852|NCT00727246|42054626|FG003|Overall Study|could not complete MRI|1|||
19605853|NCT00727246|42054623|FG000|Overall Study|incidental finding|0|||
19605854|NCT00727246|42054624|FG001|Overall Study|incidental finding|0|||
19605855|NCT00727246|42054625|FG002|Overall Study|incidental finding|0|||
19605856|NCT00727246|42054626|FG003|Overall Study|incidental finding|1|||
19605857|NCT00727246|42054623|FG000|Overall Study|withdrawn|0|||
19605858|NCT00727246|42054624|FG001|Overall Study|withdrawn|0|||
19605859|NCT00727246|42054625|FG002|Overall Study|withdrawn|1|||
19605860|NCT00727246|42054626|FG003|Overall Study|withdrawn|0|||
19605861|NCT00686647|42054636|FG000|Overall Study|Lost to Follow-up|1|||
19605862|NCT00686647|42054636|FG000|Overall Study|Death|1|||
19605863|NCT00687973|42054643|FG000|Overall Study|Adverse Event|18|||
19605864|NCT00687973|42054644|FG001|Overall Study|Adverse Event|28|||
19605865|NCT00687973|42054643|FG000|Overall Study|Lack of Efficacy|2|||
19605866|NCT00687973|42054644|FG001|Overall Study|Lack of Efficacy|3|||
19605867|NCT00687973|42054643|FG000|Overall Study|Protocol Violation|1|||
19605868|NCT00687973|42054644|FG001|Overall Study|Protocol Violation|2|||
19605869|NCT00687973|42054643|FG000|Overall Study|Administrative Reasons|0|||
19605870|NCT00687973|42054644|FG001|Overall Study|Administrative Reasons|2|||
19689823|NCT00183274|42135739|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
19605871|NCT00687973|42054643|FG000|Overall Study|Withdrawal by Subject|3|||
19605872|NCT00687973|42054644|FG001|Overall Study|Withdrawal by Subject|3|||
19605873|NCT00721396|42054655|FG000|Overall Study|Adverse Event|4|||
19605874|NCT00721396|42054656|FG001|Overall Study|Adverse Event|7|||
19605875|NCT00721396|42054657|FG002|Overall Study|Adverse Event|2|||
19605876|NCT00721396|42054658|FG003|Overall Study|Adverse Event|0|||
19605877|NCT00721396|42054655|FG000|Overall Study|Withdrawal by Subject|12|||
19605878|NCT00721396|42054656|FG001|Overall Study|Withdrawal by Subject|15|||
19605879|NCT00721396|42054657|FG002|Overall Study|Withdrawal by Subject|3|||
19605880|NCT00721396|42054658|FG003|Overall Study|Withdrawal by Subject|7|||
19605881|NCT00721396|42054655|FG000|Overall Study|Lost to Follow-up|7|||
19605882|NCT00721396|42054656|FG001|Overall Study|Lost to Follow-up|9|||
19605883|NCT00721396|42054657|FG002|Overall Study|Lost to Follow-up|3|||
19689824|NCT00183274|42135740|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
19689825|NCT00183274|42135741|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
19689826|NCT00183274|42135736|FG000|Phase 1: Open-Label|Other|9|||
19689827|NCT00183274|42135737|FG001|Phase 1: Open-Label|Other|0|||
19689828|NCT00183274|42135738|FG002|Phase 1: Open-Label|Other|0|||
19689829|NCT00183274|42135739|FG003|Phase 1: Open-Label|Other|0|||
19689830|NCT00183274|42135740|FG004|Phase 1: Open-Label|Other|0|||
19689831|NCT00183274|42135741|FG005|Phase 1: Open-Label|Other|0|||
19689832|NCT00183274|42135736|FG000|Phase 2: Double-Blind|Relapsed|0|||
19689833|NCT00183274|42135737|FG001|Phase 2: Double-Blind|Relapsed|8|||
19689834|NCT00183274|42135738|FG002|Phase 2: Double-Blind|Relapsed|29|||
19689835|NCT00183274|42135739|FG003|Phase 2: Double-Blind|Relapsed|0|||
19689836|NCT00183274|42135740|FG004|Phase 2: Double-Blind|Relapsed|0|||
19689837|NCT00183274|42135741|FG005|Phase 2: Double-Blind|Relapsed|0|||
19689838|NCT00183274|42135736|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
19689839|NCT00183274|42135737|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
19689840|NCT00183274|42135738|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
19689841|NCT00183274|42135739|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
19689842|NCT00183274|42135740|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
19689843|NCT00183274|42135741|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
19689844|NCT00183274|42135736|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
19689845|NCT00183274|42135737|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
19689846|NCT00183274|42135738|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
19689847|NCT00183274|42135739|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
19689848|NCT00183274|42135740|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
19689849|NCT00183274|42135741|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
19689850|NCT00183274|42135736|FG000|Phase 3: Double-Blind|Relapsed|0|||
19689851|NCT00183274|42135737|FG001|Phase 3: Double-Blind|Relapsed|0|||
19689852|NCT00183274|42135738|FG002|Phase 3: Double-Blind|Relapsed|0|||
19689853|NCT00183274|42135739|FG003|Phase 3: Double-Blind|Relapsed|1|||
19689854|NCT00183274|42135740|FG004|Phase 3: Double-Blind|Relapsed|11|||
19689855|NCT00183274|42135741|FG005|Phase 3: Double-Blind|Relapsed|2|||
19689856|NCT00183196|42135759|FG000|Overall Study|Withdrawal by Subject|18|||
19689857|NCT00183196|42135760|FG001|Overall Study|Withdrawal by Subject|11|||
19689858|NCT00183196|42135761|FG002|Overall Study|Withdrawal by Subject|13|||
19689859|NCT00183196|42135759|FG000|Overall Study|Adverse Event|1|||
19689860|NCT00183196|42135760|FG001|Overall Study|Adverse Event|2|||
19689861|NCT00183196|42135761|FG002|Overall Study|Adverse Event|2|||
19689862|NCT00183196|42135759|FG000|Overall Study|Legal event|1|||
19689863|NCT00183196|42135760|FG001|Overall Study|Legal event|1|||
19689864|NCT00183196|42135761|FG002|Overall Study|Legal event|1|||
19689865|NCT00183196|42135759|FG000|Overall Study|Required more intensive care|0|||
19689866|NCT00183196|42135760|FG001|Overall Study|Required more intensive care|1|||
19605884|NCT00721396|42054658|FG003|Overall Study|Lost to Follow-up|3|||
19605885|NCT00721396|42054655|FG000|Overall Study|Protocol Violation|4|||
19605886|NCT00721396|42054656|FG001|Overall Study|Protocol Violation|3|||
19605887|NCT00721396|42054657|FG002|Overall Study|Protocol Violation|1|||
19689867|NCT00183196|42135761|FG002|Overall Study|Required more intensive care|2|||
19689868|NCT00349752|42135771|FG000|Overall Study|Adverse Event|8|||
19689869|NCT00349752|42135772|FG001|Overall Study|Adverse Event|12|||
19689870|NCT00349752|42135771|FG000|Overall Study|Lack of Efficacy|37|||
19689871|NCT00349752|42135772|FG001|Overall Study|Lack of Efficacy|42|||
19689872|NCT00349752|42135771|FG000|Overall Study|Lost to Follow-up|4|||
19689873|NCT00349752|42135772|FG001|Overall Study|Lost to Follow-up|2|||
19771578|NCT02906670|42225438|FG003|Cohort 7P, Q2W|Physician Decision|0|||
19771579|NCT02906670|42225439|FG004|Cohort 7P, Q2W|Physician Decision|0|||
19771580|NCT02906670|42225440|FG005|Cohort 7P, Q2W|Physician Decision|0|||
19771581|NCT02906670|42225441|FG006|Cohort 7P, Q2W|Physician Decision|0|||
19771582|NCT02906670|42225442|FG007|Cohort 7P, Q2W|Physician Decision|0|||
19771583|NCT02906670|42225443|FG008|Cohort 7P, Q2W|Physician Decision|0|||
19605888|NCT00721396|42054658|FG003|Overall Study|Protocol Violation|0|||
19605889|NCT00721396|42054655|FG000|Overall Study|Inappropriate enrollment|0|||
19605890|NCT00721396|42054656|FG001|Overall Study|Inappropriate enrollment|2|||
19605891|NCT00721396|42054657|FG002|Overall Study|Inappropriate enrollment|0|||
19605892|NCT00721396|42054658|FG003|Overall Study|Inappropriate enrollment|0|||
19689874|NCT00349752|42135771|FG000|Overall Study|Personal reasons|6|||
19689875|NCT00349752|42135772|FG001|Overall Study|Personal reasons|5|||
19689876|NCT00349752|42135771|FG000|Overall Study|Other: Required exclusionary medication|0|||
19689877|NCT00349752|42135772|FG001|Overall Study|Other: Required exclusionary medication|1|||
19689878|NCT00349752|42135771|FG000|Overall Study|Other: Non compliance|0|||
19689879|NCT00349752|42135772|FG001|Overall Study|Other: Non compliance|1|||
19689880|NCT00349752|42135771|FG000|Overall Study|Other: Patient stopped steroids|0|||
19689881|NCT00349752|42135772|FG001|Overall Study|Other: Patient stopped steroids|1|||
19689882|NCT00349752|42135771|FG000|Overall Study|Other: Patient's steroid use|1|||
19689883|NCT00349752|42135772|FG001|Overall Study|Other: Patient's steroid use|0|||
19605893|NCT00721396|42054655|FG000|Overall Study|Administrative reason|3|||
19605894|NCT00721396|42054656|FG001|Overall Study|Administrative reason|0|||
19771584|NCT02906670|42225444|FG009|Cohort 7P, Q2W|Physician Decision|1|||
19771585|NCT02906670|42225435|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771586|NCT02906670|42225436|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771587|NCT02906670|42225437|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771588|NCT02906670|42225438|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771589|NCT02906670|42225439|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771590|NCT02906670|42225440|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771591|NCT02906670|42225441|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771592|NCT02906670|42225442|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771593|NCT02906670|42225443|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
19771594|NCT02906670|42225444|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
19771595|NCT02906670|42225435|FG000|Cohort 5P, QW|Radiological Progression|0|||
19771596|NCT02906670|42225436|FG001|Cohort 5P, QW|Radiological Progression|0|||
19771597|NCT02906670|42225437|FG002|Cohort 5P, QW|Radiological Progression|0|||
19771598|NCT02906670|42225438|FG003|Cohort 5P, QW|Radiological Progression|0|||
19771599|NCT02906670|42225439|FG004|Cohort 5P, QW|Radiological Progression|3|||
19771600|NCT02906670|42225440|FG005|Cohort 5P, QW|Radiological Progression|0|||
19771601|NCT02906670|42225441|FG006|Cohort 5P, QW|Radiological Progression|0|||
19771602|NCT02906670|42225442|FG007|Cohort 5P, QW|Radiological Progression|0|||
19771603|NCT02906670|42225443|FG008|Cohort 5P, QW|Radiological Progression|0|||
19771604|NCT02906670|42225444|FG009|Cohort 5P, QW|Radiological Progression|0|||
19771605|NCT02906358|42225496|FG000|Overall Study|Withdrawal by Subject|10|||
19771606|NCT02906358|42225497|FG001|Overall Study|Withdrawal by Subject|7|||
19771607|NCT02906358|42225496|FG000|Overall Study|Lost to Follow-up|12|||
19771608|NCT02906358|42225497|FG001|Overall Study|Lost to Follow-up|15|||
19771609|NCT02186834|42225503|FG000|Dose Escalation|Death|0|||
19771610|NCT02186834|42225504|FG001|Dose Escalation|Death|0|||
19771611|NCT02186834|42225505|FG002|Dose Escalation|Death|0|||
19771612|NCT02186834|42225506|FG003|Dose Escalation|Death|1|||
19771613|NCT02186834|42225507|FG004|Dose Escalation|Death|0|||
19771614|NCT02186834|42225508|FG005|Dose Escalation|Death|0|||
19771615|NCT02186834|42225503|FG000|Treatment at RP2D|Died prior to treatment|0|||
19771616|NCT02186834|42225504|FG001|Treatment at RP2D|Died prior to treatment|0|||
19771617|NCT02186834|42225505|FG002|Treatment at RP2D|Died prior to treatment|0|||
19771618|NCT02186834|42225506|FG003|Treatment at RP2D|Died prior to treatment|0|||
19771619|NCT02186834|42225507|FG004|Treatment at RP2D|Died prior to treatment|0|||
19771620|NCT02186834|42225508|FG005|Treatment at RP2D|Died prior to treatment|1|||
19771621|NCT03144687|42225519|FG000|Overall Study|Death|0|||
19771622|NCT03144687|42225520|FG001|Overall Study|Death|2|||
19771623|NCT03144687|42225519|FG000|Overall Study|Lost to Follow-up|0|||
19771624|NCT03144687|42225520|FG001|Overall Study|Lost to Follow-up|1|||
19771625|NCT03144687|42225519|FG000|Overall Study|Physician Decision|0|||
19771626|NCT03144687|42225520|FG001|Overall Study|Physician Decision|1|||
19771627|NCT03144687|42225519|FG000|Overall Study|Withdrawal by Subject|1|||
19771628|NCT03144687|42225520|FG001|Overall Study|Withdrawal by Subject|3|||
19771629|NCT03144687|42225519|FG000|Overall Study|Not Reported|2|||
19771630|NCT03144687|42225520|FG001|Overall Study|Not Reported|0|||
19771631|NCT03080961|42225530|FG000|Overall Study|Withdrawal by Subject|3|||
19771632|NCT02905266|42225554|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
19771633|NCT02905266|42225555|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
19771634|NCT02905266|42225554|FG000|Treatment Phase Part 1|Disease Progression|6|||
19771635|NCT02905266|42225555|FG001|Treatment Phase Part 1|Disease Progression|7|||
19771636|NCT02905266|42225554|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
19771637|NCT02905266|42225555|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
19771638|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
19771639|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
19771640|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
19771641|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
19771642|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
19771643|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
19771644|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Death|0|||
19771645|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Death|1|||
19771646|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
19771647|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
19771648|NCT02905266|42225554|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
19771649|NCT02905266|42225555|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
19771650|NCT02905266|42225554|FG000|Maintenance Phase Part 2|Disease Progression|9|||
19771651|NCT02905266|42225555|FG001|Maintenance Phase Part 2|Disease Progression|2|||
19771652|NCT02905266|42225554|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
19771653|NCT02905266|42225555|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
19771654|NCT02905266|42225554|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
19771655|NCT02905266|42225555|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
19771656|NCT02982018|42225563|FG000|Overall Study|Incorrect Lens Dispensed|1|||
19771657|NCT02982018|42225564|FG001|Overall Study|Incorrect Lens Dispensed|0|||
19771658|NCT02982018|42225563|FG000|Overall Study|Protocol Violation|1|||
19771659|NCT02982018|42225564|FG001|Overall Study|Protocol Violation|1|||
19771660|NCT02982018|42225563|FG000|Overall Study|Adverse Event|1|||
19771661|NCT02982018|42225564|FG001|Overall Study|Adverse Event|1|||
19771662|NCT02982018|42225563|FG000|Overall Study|Lens Discomfort|2|||
19771663|NCT02982018|42225564|FG001|Overall Study|Lens Discomfort|0|||
19771664|NCT02982018|42225563|FG000|Overall Study|Withdrawal by Subject|0|||
19771665|NCT02982018|42225564|FG001|Overall Study|Withdrawal by Subject|1|||
19771666|NCT03080493|42225572|FG000|Overall Study|Did not provide NRS pain results|1|||
19771667|NCT03080493|42225573|FG001|Overall Study|Did not provide NRS pain results|0|||
19771668|NCT03080493|42225572|FG000|Overall Study|Adverse Event|0|||
19771669|NCT03080493|42225573|FG001|Overall Study|Adverse Event|1|||
19771670|NCT03080493|42225572|FG000|Overall Study|Randomization error (parity group)|0|||
19771671|NCT03080493|42225573|FG001|Overall Study|Randomization error (parity group)|1|||
19771672|NCT01339910|42225581|FG000|Overall Study|Withdrawal by Subject|1|||
19771673|NCT01339910|42225582|FG001|Overall Study|Withdrawal by Subject|0|||
19771674|NCT01339910|42225581|FG000|Overall Study|Physician Decision|1|||
19771675|NCT01339910|42225582|FG001|Overall Study|Physician Decision|0|||
19771676|NCT01339910|42225581|FG000|Overall Study|Disease relapse|1|||
19771677|NCT01339910|42225582|FG001|Overall Study|Disease relapse|4|||
19771678|NCT02981082|42225590|FG000|Overall Study|Withdrawal by Subject|2|||
19771679|NCT02981082|42225591|FG001|Overall Study|Withdrawal by Subject|0|||
19771680|NCT02981082|42225590|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
19771681|NCT02981082|42225591|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
19771682|NCT02981082|42225590|FG000|Overall Study|Adverse Event|0|||
19771683|NCT02981082|42225591|FG001|Overall Study|Adverse Event|1|||
19771684|NCT02975700|42225597|FG000|Overall Study|Adverse Event|1|||
19771685|NCT02975700|42225597|FG000|Overall Study|Progressive disease|3|||
19771686|NCT02975700|42225597|FG000|Overall Study|Failed screening criteria|2|||
19771687|NCT01066104|42225603|FG000|Overall Study|Adverse Event|1|||
19771688|NCT01066104|42225604|FG001|Overall Study|Adverse Event|1|||
19771689|NCT01066104|42225603|FG000|Overall Study|Protocol Violation|1|||
19771690|NCT01066104|42225604|FG001|Overall Study|Protocol Violation|0|||
19771691|NCT02736968|42225615|FG000|Overall Study|Lost to Follow-up|0|||
19771692|NCT02736968|42225616|FG001|Overall Study|Lost to Follow-up|0|||
19771693|NCT02736968|42225617|FG002|Overall Study|Lost to Follow-up|0|||
19771694|NCT02736968|42225618|FG003|Overall Study|Lost to Follow-up|0|||
19771695|NCT02736968|42225619|FG004|Overall Study|Lost to Follow-up|0|||
19771696|NCT02736968|42225620|FG005|Overall Study|Lost to Follow-up|0|||
19771697|NCT02736968|42225621|FG006|Overall Study|Lost to Follow-up|5|||
19771698|NCT02736968|42225622|FG007|Overall Study|Lost to Follow-up|2|||
19771699|NCT02736968|42225615|FG000|Overall Study|COVID-19 Pandemic|0|||
19771700|NCT02736968|42225616|FG001|Overall Study|COVID-19 Pandemic|0|||
19771701|NCT02736968|42225617|FG002|Overall Study|COVID-19 Pandemic|0|||
19771702|NCT02736968|42225618|FG003|Overall Study|COVID-19 Pandemic|0|||
19771703|NCT02736968|42225619|FG004|Overall Study|COVID-19 Pandemic|0|||
19771704|NCT02736968|42225620|FG005|Overall Study|COVID-19 Pandemic|0|||
19771705|NCT02736968|42225621|FG006|Overall Study|COVID-19 Pandemic|2|||
19771706|NCT02736968|42225622|FG007|Overall Study|COVID-19 Pandemic|0|||
19771707|NCT02736968|42225615|FG000|Overall Study|Withdrawal by Subject|0|||
19771708|NCT02736968|42225616|FG001|Overall Study|Withdrawal by Subject|0|||
19771709|NCT02736968|42225617|FG002|Overall Study|Withdrawal by Subject|0|||
19771710|NCT02736968|42225618|FG003|Overall Study|Withdrawal by Subject|0|||
19771711|NCT02736968|42225619|FG004|Overall Study|Withdrawal by Subject|0|||
19771712|NCT02736968|42225620|FG005|Overall Study|Withdrawal by Subject|0|||
19771713|NCT02736968|42225621|FG006|Overall Study|Withdrawal by Subject|1|||
19689884|NCT00349752|42135771|FG000|Overall Study|Other: Ineligible|1|||
19689885|NCT00349752|42135772|FG001|Overall Study|Other: Ineligible|0|||
19689886|NCT00349752|42135771|FG000|Overall Study|Other: Inadvertently unblinded|1|||
19689887|NCT00349752|42135772|FG001|Overall Study|Other: Inadvertently unblinded|0|||
19689888|NCT00349752|42135771|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
19689889|NCT00349752|42135772|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
19689890|NCT00174460|42135780|FG000|Overall Study|Withdrawal by Subject|0|||
19689891|NCT00174460|42135781|FG001|Overall Study|Withdrawal by Subject|1|||
19689892|NCT00348816|42135788|FG000|Overall Study|Noncompliance with radiation treatment|1|||
19771714|NCT02736968|42225622|FG007|Overall Study|Withdrawal by Subject|0|||
19771715|NCT02980224|42225635|FG000|Overall Study|Adverse Event|4|||
19771716|NCT02980224|42225636|FG001|Overall Study|Adverse Event|1|||
19771717|NCT02980224|42225635|FG000|Overall Study|Withdrawal by Subject|0|||
19771718|NCT02980224|42225636|FG001|Overall Study|Withdrawal by Subject|2|||
19771719|NCT02591615|42225646|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
19771720|NCT02591615|42225647|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
19771721|NCT02591615|42225648|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
19771722|NCT02591615|42225649|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
19771723|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
19771724|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
19771725|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
19771726|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
19771727|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
19771728|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
19771729|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
19771730|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
19771731|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
19771732|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
19771733|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
19771734|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
19771735|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
19689893|NCT00265083|42135797|FG000|Overall Study|Adverse Event|5|||
19689894|NCT00265083|42135798|FG001|Overall Study|Adverse Event|13|||
19689895|NCT00265083|42135799|FG002|Overall Study|Adverse Event|15|||
19689896|NCT00265083|42135797|FG000|Overall Study|Lost to Follow-up|3|||
19689897|NCT00265083|42135798|FG001|Overall Study|Lost to Follow-up|4|||
19689898|NCT00265083|42135799|FG002|Overall Study|Lost to Follow-up|4|||
19771736|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
19771737|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
19771738|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
19771739|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
19771740|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
19771741|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
19771742|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
19771743|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
19689899|NCT00265083|42135797|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
19689900|NCT00265083|42135798|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
19689901|NCT00265083|42135799|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
19689902|NCT00265083|42135797|FG000|Overall Study|Other|1|||
19689903|NCT00265083|42135798|FG001|Overall Study|Other|12|||
19689904|NCT00265083|42135799|FG002|Overall Study|Other|9|||
19689905|NCT00264849|42135810|FG000|Overall Study|Adverse Event|7|||
19689906|NCT00264849|42135811|FG001|Overall Study|Adverse Event|2|||
19689907|NCT00264849|42135810|FG000|Overall Study|Withdrawal by Subject|7|||
19689908|NCT00264849|42135811|FG001|Overall Study|Withdrawal by Subject|11|||
19689909|NCT00264849|42135810|FG000|Overall Study|Protocol Violation|5|||
19689910|NCT00264849|42135811|FG001|Overall Study|Protocol Violation|3|||
19689911|NCT00264849|42135810|FG000|Overall Study|Lack of Efficacy|1|||
19689912|NCT00264849|42135811|FG001|Overall Study|Lack of Efficacy|6|||
19689913|NCT00264849|42135810|FG000|Overall Study|Lost to Follow-up|0|||
19689914|NCT00264849|42135811|FG001|Overall Study|Lost to Follow-up|2|||
19689915|NCT00264849|42135810|FG000|Overall Study|Death|0|||
19689916|NCT00264849|42135811|FG001|Overall Study|Death|1|||
19689917|NCT00264849|42135810|FG000|Overall Study|Administrative Problems|2|||
19689918|NCT00264849|42135811|FG001|Overall Study|Administrative Problems|0|||
19689919|NCT00211809|42135817|FG000|Overall Study|Lack of Efficacy|1|||
19689920|NCT00211809|42135817|FG000|Overall Study|Lost to Follow-up|2|||
19689921|NCT00211809|42135817|FG000|Overall Study|Pregnancy|1|||
19689922|NCT00211809|42135817|FG000|Overall Study|side effects|2|||
19689923|NCT00129766|42135825|FG000|Overall Study|Death|3|||
19689924|NCT00129766|42135826|FG001|Overall Study|Death|8|||
19689925|NCT00129766|42135825|FG000|Overall Study|Withdrawal of consent|31|||
19689926|NCT00129766|42135826|FG001|Overall Study|Withdrawal of consent|30|||
19689927|NCT00129766|42135825|FG000|Overall Study|Lost to Follow-up|26|||
19689928|NCT00129766|42135826|FG001|Overall Study|Lost to Follow-up|21|||
19689929|NCT00150592|42135835|FG000|Overall Study|Adverse Event|4|||
19689930|NCT00150592|42135836|FG001|Overall Study|Adverse Event|1|||
19689931|NCT00150592|42135835|FG000|Overall Study|Protocol Violation|1|||
19689932|NCT00150592|42135836|FG001|Overall Study|Protocol Violation|0|||
19689933|NCT00150592|42135835|FG000|Overall Study|Withdrawal by Subject|1|||
19689934|NCT00150592|42135836|FG001|Overall Study|Withdrawal by Subject|2|||
19689935|NCT00150592|42135835|FG000|Overall Study|Non-compliance|1|||
19689936|NCT00150592|42135836|FG001|Overall Study|Non-compliance|0|||
19689937|NCT00149890|42135844|FG000|Overall Study|Adverse Event|1|||
19689938|NCT00149890|42135845|FG001|Overall Study|Adverse Event|8|||
19689939|NCT00149890|42135844|FG000|Overall Study|Lack of Efficacy|8|||
19689940|NCT00149890|42135845|FG001|Overall Study|Lack of Efficacy|9|||
19689941|NCT00149890|42135844|FG000|Overall Study|Protocol Violation|1|||
19689942|NCT00149890|42135845|FG001|Overall Study|Protocol Violation|0|||
19689943|NCT00149890|42135844|FG000|Overall Study|Lost to Follow-up|1|||
19689944|NCT00149890|42135845|FG001|Overall Study|Lost to Follow-up|0|||
19689945|NCT00149890|42135844|FG000|Overall Study|Graft Loss|2|||
19689946|NCT00149890|42135845|FG001|Overall Study|Graft Loss|1|||
19689947|NCT00174382|42135851|FG000|Overall Study|Death|2|||
19689948|NCT00174382|42135851|FG000|Overall Study|Adverse Event|19|||
19771744|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
19771745|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
19771746|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
19771747|NCT02591615|42225646|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
19605895|NCT00721396|42054657|FG002|Overall Study|Administrative reason|1|||
19605896|NCT00721396|42054658|FG003|Overall Study|Administrative reason|0|||
19605897|NCT00943826|42054675|FG000|Concurrent Phase|Adverse Event|50|||
19605898|NCT00943826|42054676|FG001|Concurrent Phase|Adverse Event|27|||
19689949|NCT00174382|42135851|FG000|Overall Study|Withdrawal by Subject|6|||
19771748|NCT02591615|42225647|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
19771749|NCT02591615|42225648|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
19771750|NCT02591615|42225649|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
19771751|NCT02591615|42225646|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
19771752|NCT02591615|42225647|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
19771753|NCT02591615|42225648|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
19771754|NCT02591615|42225649|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
19771755|NCT02591615|42225646|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
19771756|NCT02591615|42225647|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
19771757|NCT02591615|42225648|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
19771758|NCT02591615|42225649|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
19771759|NCT02591615|42225646|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
19771760|NCT02591615|42225647|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
19771761|NCT02591615|42225648|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
19771762|NCT02591615|42225649|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
19771763|NCT02591615|42225646|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
19771764|NCT02591615|42225647|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
19771765|NCT02591615|42225648|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
19771766|NCT02591615|42225649|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
19771767|NCT02591615|42225646|FG000|Maintenance MK-3475|Adverse Event|0|||
19771768|NCT02591615|42225647|FG001|Maintenance MK-3475|Adverse Event|3|||
19771769|NCT02591615|42225648|FG002|Maintenance MK-3475|Adverse Event|1|||
19771770|NCT02591615|42225649|FG003|Maintenance MK-3475|Adverse Event|2|||
19771771|NCT02591615|42225646|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
19771772|NCT02591615|42225647|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
19771773|NCT02591615|42225648|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
19771774|NCT02591615|42225649|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
19771775|NCT02591615|42225646|FG000|Maintenance MK-3475|Death|0|||
19771776|NCT02591615|42225647|FG001|Maintenance MK-3475|Death|1|||
19771777|NCT02591615|42225648|FG002|Maintenance MK-3475|Death|1|||
19771778|NCT02591615|42225649|FG003|Maintenance MK-3475|Death|0|||
19771779|NCT02591615|42225646|FG000|Maintenance MK-3475|Physician discretion|0|||
19771780|NCT02591615|42225647|FG001|Maintenance MK-3475|Physician discretion|0|||
19771781|NCT02591615|42225648|FG002|Maintenance MK-3475|Physician discretion|1|||
19771782|NCT02591615|42225649|FG003|Maintenance MK-3475|Physician discretion|0|||
19771783|NCT02591615|42225646|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
19771784|NCT02591615|42225647|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
19771785|NCT02591615|42225648|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
19771786|NCT02591615|42225649|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
19771787|NCT02591615|42225646|FG000|Maintenance MK-3475|In active treatment|2|||
19771788|NCT02591615|42225647|FG001|Maintenance MK-3475|In active treatment|0|||
19771789|NCT02591615|42225648|FG002|Maintenance MK-3475|In active treatment|0|||
19689950|NCT00174382|42135851|FG000|Overall Study|Protocol Violation|3|||
19689951|NCT00174382|42135851|FG000|Overall Study|Arrived early for last visit in error|1|||
19689952|NCT00174382|42135851|FG000|Overall Study|Subject felt pill not effective enough|1|||
19689953|NCT00174382|42135851|FG000|Overall Study|Lost to Follow-up|1|||
19689954|NCT00355134|42135860|FG000|Core Phase|Withdrawal by Subject|35|||
19689955|NCT00355134|42135861|FG001|Core Phase|Withdrawal by Subject|24|||
19771790|NCT02591615|42225649|FG003|Maintenance MK-3475|In active treatment|1|||
19771791|NCT03077607|42225664|FG000|Period 1 (15 Days)|Adverse Event|1|||
19771792|NCT03077607|42225665|FG001|Period 1 (15 Days)|Adverse Event|0|||
19771793|NCT03077607|42225664|FG000|Period 1 (15 Days)|Death|1|||
19771794|NCT03077607|42225665|FG001|Period 1 (15 Days)|Death|0|||
19771795|NCT03077607|42225664|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
19771796|NCT03077607|42225665|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
19771797|NCT03077607|42225664|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
19605899|NCT00943826|42054675|FG000|Concurrent Phase|Withdrew consent|3|||
19605900|NCT00943826|42054676|FG001|Concurrent Phase|Withdrew consent|7|||
19605901|NCT00943826|42054675|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
19605902|NCT00943826|42054676|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
19605903|NCT00943826|42054675|FG000|Concurrent Phase|Administrative reasons|2|||
19689956|NCT00355134|42135862|FG002|Core Phase|Withdrawal by Subject|35|||
19689957|NCT00355134|42135863|FG003|Core Phase|Withdrawal by Subject|0|||
19689958|NCT00355134|42135864|FG004|Core Phase|Withdrawal by Subject|0|||
19771798|NCT03077607|42225665|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
19771799|NCT02977572|42225684|FG000|Overall Study|Exclusion criterion|2|||
19771800|NCT02977572|42225685|FG001|Overall Study|Exclusion criterion|2|||
19771801|NCT02746874|42225697|FG000|Overall Study|Withdrawal by Subject|0|||
19771802|NCT02746874|42225698|FG001|Overall Study|Withdrawal by Subject|1|||
19771803|NCT02746874|42225697|FG000|Overall Study|Surgery Date Changed|0|||
19771804|NCT02746874|42225698|FG001|Overall Study|Surgery Date Changed|2|||
19771805|NCT03217175|42225704|FG000|Overall Study|Physician Decision|4|||
19771806|NCT03217175|42225705|FG001|Overall Study|Physician Decision|1|||
19771807|NCT01062126|42225711|FG000|Overall Study|Death|209|||
19771808|NCT01062126|42225711|FG000|Overall Study|All Withdrawals|324|||
19771809|NCT02522429|42225715|FG000|Overall Study|Lost to Follow-up|8|||
19771810|NCT02522429|42225715|FG000|Overall Study|Adverse Event|2|||
19771811|NCT02522429|42225715|FG000|Overall Study|Death|1|||
19771812|NCT02522429|42225715|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
19771813|NCT02974140|42225719|FG000|Overall Study|Adverse Event|2|||
19771814|NCT02974140|42225719|FG000|Overall Study|Lost to Follow-up|1|||
19771815|NCT02974140|42225719|FG000|Overall Study|Study Terminated by Sponsor|36|||
19771816|NCT02974842|42225726|FG000|Overall Study|Withdrawal by Subject|4|||
19771817|NCT02974842|42225726|FG000|Overall Study|Screen failures|4|||
19771818|NCT03172481|42225732|FG000|Double-blind|Withdrawal by Subject|1|||
19771819|NCT03172481|42225733|FG001|Double-blind|Withdrawal by Subject|0|||
19771820|NCT02855450|42225741|FG000|Overall Study|Adverse Event|1|||
19771821|NCT02855450|42225742|FG001|Overall Study|Adverse Event|0|||
19771822|NCT02855450|42225741|FG000|Overall Study|Lost to Follow-up|4|||
19771823|NCT02855450|42225742|FG001|Overall Study|Lost to Follow-up|0|||
19771824|NCT03172325|42225750|FG000|Overall Study|Adverse Event|2|||
19771825|NCT03172325|42225751|FG001|Overall Study|Adverse Event|3|||
19771826|NCT03172325|42225750|FG000|Overall Study|Positive PPD|1|||
19689959|NCT00355134|42135860|FG000|Core Phase|Adverse Event|28|||
19689960|NCT00355134|42135861|FG001|Core Phase|Adverse Event|22|||
19771827|NCT03172325|42225751|FG001|Overall Study|Positive PPD|0|||
19771828|NCT03172325|42225750|FG000|Overall Study|Poor Compliance|1|||
19771829|NCT03172325|42225751|FG001|Overall Study|Poor Compliance|1|||
19771830|NCT03085017|42225759|FG000|Overall Study|Death|0|||
19771831|NCT03085017|42225760|FG001|Overall Study|Death|3|||
19771832|NCT03215771|42225766|FG000|Overall Study|Withdrawal by Subject|2|||
19771833|NCT03215771|42225766|FG000|Overall Study|Physician Decision|1|||
19771834|NCT02745392|42225775|FG000|Overall Study|Lost to Follow-up|0|||
19771835|NCT02745392|42225776|FG001|Overall Study|Lost to Follow-up|1|||
19771836|NCT02745392|42225777|FG002|Overall Study|Lost to Follow-up|0|||
19771837|NCT02745392|42225778|FG003|Overall Study|Lost to Follow-up|0|||
19771838|NCT03076515|42225790|FG000|Overall Study|DMC decision based on interim analysis|25|||
19771839|NCT03076515|42225791|FG001|Overall Study|DMC decision based on interim analysis|29|||
19689961|NCT00355134|42135862|FG002|Core Phase|Adverse Event|16|||
19689962|NCT00355134|42135863|FG003|Core Phase|Adverse Event|0|||
19689963|NCT00355134|42135864|FG004|Core Phase|Adverse Event|0|||
19689964|NCT00355134|42135860|FG000|Core Phase|Lost to Follow-up|17|||
19771840|NCT03170609|42225804|FG000|Overall Study|Death|0|||
19771841|NCT03170609|42225805|FG001|Overall Study|Death|0|||
19771842|NCT03170609|42225806|FG002|Overall Study|Death|1|||
19771843|NCT03170609|42225807|FG003|Overall Study|Death|0|||
19771844|NCT03170609|42225808|FG004|Overall Study|Death|0|||
19771845|NCT03170609|42225809|FG005|Overall Study|Death|0|||
19771846|NCT03170609|42225810|FG006|Overall Study|Death|0|||
19771847|NCT03170609|42225804|FG000|Overall Study|Withdrawal by Subject|1|||
19771848|NCT03170609|42225805|FG001|Overall Study|Withdrawal by Subject|2|||
19771849|NCT03170609|42225806|FG002|Overall Study|Withdrawal by Subject|0|||
19771850|NCT03170609|42225807|FG003|Overall Study|Withdrawal by Subject|0|||
19771851|NCT03170609|42225808|FG004|Overall Study|Withdrawal by Subject|0|||
19771852|NCT03170609|42225809|FG005|Overall Study|Withdrawal by Subject|0|||
19689965|NCT00355134|42135861|FG001|Core Phase|Lost to Follow-up|13|||
19689966|NCT00355134|42135862|FG002|Core Phase|Lost to Follow-up|21|||
19689967|NCT00355134|42135863|FG003|Core Phase|Lost to Follow-up|0|||
19689968|NCT00355134|42135864|FG004|Core Phase|Lost to Follow-up|0|||
19771853|NCT03170609|42225810|FG006|Overall Study|Withdrawal by Subject|1|||
19771854|NCT03170609|42225804|FG000|Overall Study|Lost to Follow-up|1|||
19771855|NCT03170609|42225805|FG001|Overall Study|Lost to Follow-up|0|||
19771856|NCT03170609|42225806|FG002|Overall Study|Lost to Follow-up|5|||
19771857|NCT03170609|42225807|FG003|Overall Study|Lost to Follow-up|2|||
19771858|NCT03170609|42225808|FG004|Overall Study|Lost to Follow-up|1|||
19689969|NCT00355134|42135860|FG000|Core Phase|Abnormal laboratory value(s)|19|||
19771859|NCT03170609|42225809|FG005|Overall Study|Lost to Follow-up|1|||
19389145|NCT02663453|41632742|FG001|Overall Study|Death|4|||
19689970|NCT00355134|42135861|FG001|Core Phase|Abnormal laboratory value(s)|14|||
19771860|NCT03170609|42225810|FG006|Overall Study|Lost to Follow-up|0|||
19771861|NCT03170609|42225804|FG000|Overall Study|Other|1|||
19771862|NCT03170609|42225805|FG001|Overall Study|Other|0|||
19771863|NCT03170609|42225806|FG002|Overall Study|Other|0|||
19771864|NCT03170609|42225807|FG003|Overall Study|Other|0|||
19771865|NCT03170609|42225808|FG004|Overall Study|Other|0|||
19771866|NCT03170609|42225809|FG005|Overall Study|Other|1|||
19771867|NCT03170609|42225810|FG006|Overall Study|Other|0|||
19771868|NCT01141712|42225826|FG000|Overall Study|Disease progression|3|||
19771869|NCT00004445|42225834|FG000|Overall Study|Physician Decision|2|||
19771870|NCT00004445|42225834|FG000|Overall Study|Withdrawal by Subject|1|||
19771871|NCT03219333|42225840|FG000|Overall Study|Withdrawal by Subject|8|||
19771872|NCT03219333|42225841|FG001|Overall Study|Withdrawal by Subject|3|||
19771873|NCT03219333|42225840|FG000|Overall Study|Lost to Follow-up|1|||
19771874|NCT03219333|42225841|FG001|Overall Study|Lost to Follow-up|0|||
19771875|NCT03219333|42225840|FG000|Overall Study|Death|94|||
19771876|NCT03219333|42225841|FG001|Overall Study|Death|44|||
19771877|NCT03219333|42225840|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
19771878|NCT03219333|42225841|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
19771879|NCT03168867|42225849|FG000|Overall Study|Withdrawal by Subject|1|||
19771880|NCT03168867|42225850|FG001|Overall Study|Withdrawal by Subject|5|||
19771881|NCT01064622|42225859|FG000|Randomized Phase II|Withdrawal by Subject|2|||
19771882|NCT01064622|42225860|FG001|Randomized Phase II|Withdrawal by Subject|2|||
19771883|NCT01064622|42225859|FG000|Randomized Phase II|Protocol Violation|0|||
19771884|NCT01064622|42225860|FG001|Randomized Phase II|Protocol Violation|1|||
19771885|NCT04163718|42225869|FG000|Overall Study|Study terminated|12|||
19771886|NCT01063764|42225873|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
19771887|NCT01063764|42225873|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
19771888|NCT01063764|42225873|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
19771889|NCT01063764|42225873|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
19771890|NCT01063764|42225873|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
19771891|NCT01063764|42225873|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
19771892|NCT01063764|42225873|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
19771893|NCT03075891|42225883|FG000|Overall Study|Withdrawal by Subject|3|||
19771894|NCT03075891|42225884|FG001|Overall Study|Withdrawal by Subject|6|||
19771895|NCT03075891|42225883|FG000|Overall Study|Lost to Follow-up|1|||
19771896|NCT03075891|42225884|FG001|Overall Study|Lost to Follow-up|0|||
19771897|NCT03075891|42225883|FG000|Overall Study|Pregnancy|3|||
19771898|NCT03075891|42225884|FG001|Overall Study|Pregnancy|1|||
19771899|NCT03075891|42225883|FG000|Overall Study|visits not performed (no time)|1|||
19771900|NCT03075891|42225884|FG001|Overall Study|visits not performed (no time)|0|||
19771901|NCT03075891|42225883|FG000|Overall Study|Drug abuse relapse issue|0|||
19771902|NCT03075891|42225884|FG001|Overall Study|Drug abuse relapse issue|1|||
19771903|NCT03075891|42225883|FG000|Overall Study|Participant requiring study withdrawal|0|||
19771904|NCT03075891|42225884|FG001|Overall Study|Participant requiring study withdrawal|1|||
19771905|NCT03075891|42225883|FG000|Overall Study|Adverse event, non-fatal|1|||
19689971|NCT00355134|42135862|FG002|Core Phase|Abnormal laboratory value(s)|2|||
19689972|NCT00355134|42135863|FG003|Core Phase|Abnormal laboratory value(s)|0|||
19689973|NCT00355134|42135864|FG004|Core Phase|Abnormal laboratory value(s)|0|||
19689974|NCT00355134|42135860|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
19689975|NCT00355134|42135861|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
19689976|NCT00355134|42135862|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
19689977|NCT00355134|42135863|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
19689978|NCT00355134|42135864|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
19689979|NCT00355134|42135860|FG000|Core Phase|Administrative problems|5|||
19771906|NCT03075891|42225884|FG001|Overall Study|Adverse event, non-fatal|4|||
19771907|NCT02013167|42225894|FG000|Overall Study|Withdrawal by Subject|15|||
19771908|NCT02013167|42225895|FG001|Overall Study|Withdrawal by Subject|14|||
19771909|NCT02013167|42225894|FG000|Overall Study|Sponsor Decision|1|||
19771910|NCT02013167|42225895|FG001|Overall Study|Sponsor Decision|3|||
19771911|NCT02013167|42225894|FG000|Overall Study|Lost to Follow-up|0|||
19771912|NCT02013167|42225895|FG001|Overall Study|Lost to Follow-up|1|||
19771913|NCT02013167|42225894|FG000|Overall Study|Death|85|||
19771914|NCT02013167|42225895|FG001|Overall Study|Death|160|||
19771915|NCT01063062|42225904|FG000|Overall Study|Patient withdrew consent|0|||
19771916|NCT01063062|42225905|FG001|Overall Study|Patient withdrew consent|1|||
19771917|NCT01063062|42225904|FG000|Overall Study|Adverse Event|2|||
19771918|NCT01063062|42225905|FG001|Overall Study|Adverse Event|4|||
19771919|NCT01063062|42225904|FG000|Overall Study|Protocol Violation|5|||
19771920|NCT01063062|42225905|FG001|Overall Study|Protocol Violation|4|||
19771921|NCT01063062|42225904|FG000|Overall Study|Investigator's request|1|||
19771922|NCT01063062|42225905|FG001|Overall Study|Investigator's request|0|||
19771923|NCT01063062|42225904|FG000|Overall Study|Lost to Follow-up|0|||
19771924|NCT01063062|42225905|FG001|Overall Study|Lost to Follow-up|2|||
19689980|NCT00355134|42135861|FG001|Core Phase|Administrative problems|3|||
19771925|NCT01063062|42225904|FG000|Overall Study|Miscellaneous reason|0|||
19771926|NCT01063062|42225905|FG001|Overall Study|Miscellaneous reason|1|||
19771927|NCT02973048|42225914|FG000|Overall Study|Epidural catheter insertion failure|1|||
19771928|NCT02973048|42225915|FG001|Overall Study|Epidural catheter insertion failure|0|||
19771929|NCT02973048|42225914|FG000|Overall Study|Withdrawal by Subject|0|||
19771930|NCT02973048|42225915|FG001|Overall Study|Withdrawal by Subject|3|||
19771931|NCT02932943|42225923|FG000|Overall Study|Lost to Follow-up|0|||
19771932|NCT02932943|42225924|FG001|Overall Study|Lost to Follow-up|2|||
19771933|NCT02932943|42225923|FG000|Overall Study|Adverse Event|2|||
19771934|NCT02932943|42225924|FG001|Overall Study|Adverse Event|2|||
19771935|NCT02932943|42225923|FG000|Overall Study|Withdrawal by Subject|3|||
19771936|NCT02932943|42225924|FG001|Overall Study|Withdrawal by Subject|3|||
19771937|NCT02972658|42225949|FG000|Overall Study|Adverse Event|0|||
19689981|NCT00355134|42135862|FG002|Core Phase|Administrative problems|5|||
19689982|NCT00355134|42135863|FG003|Core Phase|Administrative problems|0|||
19689983|NCT00355134|42135864|FG004|Core Phase|Administrative problems|0|||
19689984|NCT00355134|42135860|FG000|Core Phase|Protocol Violation|3|||
19689985|NCT00355134|42135861|FG001|Core Phase|Protocol Violation|2|||
19689986|NCT00355134|42135862|FG002|Core Phase|Protocol Violation|2|||
19771938|NCT02972658|42225950|FG001|Overall Study|Adverse Event|3|||
19771939|NCT02972658|42225951|FG002|Overall Study|Adverse Event|0|||
19771940|NCT02972658|42225952|FG003|Overall Study|Adverse Event|2|||
19771941|NCT02972658|42225949|FG000|Overall Study|Other-determined by Investigator|1|||
19771942|NCT02972658|42225950|FG001|Overall Study|Other-determined by Investigator|1|||
19771943|NCT02972658|42225951|FG002|Overall Study|Other-determined by Investigator|0|||
19771944|NCT02972658|42225952|FG003|Overall Study|Other-determined by Investigator|0|||
19771945|NCT02972658|42225949|FG000|Overall Study|Death|0|||
19771946|NCT02972658|42225950|FG001|Overall Study|Death|0|||
19771947|NCT02972658|42225951|FG002|Overall Study|Death|0|||
19771948|NCT02972658|42225952|FG003|Overall Study|Death|1|||
19771949|NCT02972658|42225949|FG000|Overall Study|Lost to Follow-up|0|||
19771950|NCT02972658|42225950|FG001|Overall Study|Lost to Follow-up|1|||
19771951|NCT02972658|42225951|FG002|Overall Study|Lost to Follow-up|1|||
19771952|NCT02972658|42225952|FG003|Overall Study|Lost to Follow-up|2|||
19771953|NCT02972658|42225949|FG000|Overall Study|Progressive Disease|0|||
19771954|NCT02972658|42225950|FG001|Overall Study|Progressive Disease|1|||
19771955|NCT02972658|42225951|FG002|Overall Study|Progressive Disease|0|||
19771956|NCT02972658|42225952|FG003|Overall Study|Progressive Disease|1|||
19771957|NCT02972658|42225949|FG000|Overall Study|Withdrawal by Subject|4|||
19771958|NCT02972658|42225950|FG001|Overall Study|Withdrawal by Subject|4|||
19771959|NCT02972658|42225951|FG002|Overall Study|Withdrawal by Subject|1|||
19771960|NCT02972658|42225952|FG003|Overall Study|Withdrawal by Subject|6|||
19771961|NCT02972658|42225949|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
19771962|NCT02972658|42225950|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
19771963|NCT02972658|42225951|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
19771964|NCT02972658|42225952|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
19771965|NCT02972658|42225949|FG000|Overall Study|Sponsor Decision|70|||
19771966|NCT02972658|42225950|FG001|Overall Study|Sponsor Decision|127|||
19771967|NCT02972658|42225951|FG002|Overall Study|Sponsor Decision|72|||
19771968|NCT02972658|42225952|FG003|Overall Study|Sponsor Decision|119|||
19771969|NCT02853032|42225964|FG000|Overall Study|Adverse Event|4|||
19771970|NCT02853032|42225965|FG001|Overall Study|Adverse Event|0|||
19771971|NCT02853032|42225964|FG000|Overall Study|Withdrawal by Subject|3|||
19771972|NCT02853032|42225965|FG001|Overall Study|Withdrawal by Subject|1|||
19771973|NCT02853032|42225964|FG000|Overall Study|Requested to withdraw from all treatment|2|||
19771974|NCT02853032|42225965|FG001|Overall Study|Requested to withdraw from all treatment|2|||
19771975|NCT02232087|42225973|FG000|Overall Study|Withdrawal by Subject|2|||
19771976|NCT02232087|42225974|FG001|Overall Study|Withdrawal by Subject|0|||
19771977|NCT02232087|42225975|FG002|Overall Study|Withdrawal by Subject|0|||
19771978|NCT02232087|42225976|FG003|Overall Study|Withdrawal by Subject|0|||
19771979|NCT02232087|42225977|FG004|Overall Study|Withdrawal by Subject|0|||
19771980|NCT02232087|42225978|FG005|Overall Study|Withdrawal by Subject|1|||
19771981|NCT02232087|42225973|FG000|Overall Study|poor inhalation technique|0|||
19771982|NCT02232087|42225974|FG001|Overall Study|poor inhalation technique|1|||
19771983|NCT02232087|42225975|FG002|Overall Study|poor inhalation technique|0|||
19689987|NCT00355134|42135863|FG003|Core Phase|Protocol Violation|0|||
19689988|NCT00355134|42135864|FG004|Core Phase|Protocol Violation|0|||
19689989|NCT00355134|42135860|FG000|Core Phase|Abnormal test procedure result(s)|1|||
19689990|NCT00355134|42135861|FG001|Core Phase|Abnormal test procedure result(s)|2|||
19689991|NCT00355134|42135862|FG002|Core Phase|Abnormal test procedure result(s)|1|||
19689992|NCT00355134|42135863|FG003|Core Phase|Abnormal test procedure result(s)|0|||
19689993|NCT00355134|42135864|FG004|Core Phase|Abnormal test procedure result(s)|0|||
19771984|NCT02232087|42225976|FG003|Overall Study|poor inhalation technique|0|||
19771985|NCT02232087|42225977|FG004|Overall Study|poor inhalation technique|0|||
19771986|NCT02232087|42225978|FG005|Overall Study|poor inhalation technique|2|||
19771987|NCT02232087|42225973|FG000|Overall Study|protocol stop criteria|0|||
19771988|NCT02232087|42225974|FG001|Overall Study|protocol stop criteria|1|||
19771989|NCT02232087|42225975|FG002|Overall Study|protocol stop criteria|0|||
19771990|NCT02232087|42225976|FG003|Overall Study|protocol stop criteria|1|||
19771991|NCT02232087|42225977|FG004|Overall Study|protocol stop criteria|0|||
19771992|NCT02232087|42225978|FG005|Overall Study|protocol stop criteria|0|||
19771993|NCT02232087|42225973|FG000|Overall Study|Adverse Event|0|||
19771994|NCT02232087|42225974|FG001|Overall Study|Adverse Event|0|||
19771995|NCT02232087|42225975|FG002|Overall Study|Adverse Event|0|||
19771996|NCT02232087|42225976|FG003|Overall Study|Adverse Event|0|||
19771997|NCT02232087|42225977|FG004|Overall Study|Adverse Event|1|||
19771998|NCT02232087|42225978|FG005|Overall Study|Adverse Event|0|||
19771999|NCT03168425|42225999|FG000|Overall Study|Lost to Follow-up|5|||
19772000|NCT03168425|42226000|FG001|Overall Study|Lost to Follow-up|8|||
19689994|NCT00355134|42135860|FG000|Core Phase|Condition no longer requires study drug|1|||
19689995|NCT00355134|42135861|FG001|Core Phase|Condition no longer requires study drug|0|||
19689996|NCT00355134|42135862|FG002|Core Phase|Condition no longer requires study drug|1|||
19689997|NCT00355134|42135863|FG003|Core Phase|Condition no longer requires study drug|0|||
19689998|NCT00355134|42135864|FG004|Core Phase|Condition no longer requires study drug|0|||
19689999|NCT00355134|42135860|FG000|Extension Phase|Withdrawal by Subject|7|||
19690000|NCT00355134|42135861|FG001|Extension Phase|Withdrawal by Subject|11|||
19690001|NCT00355134|42135862|FG002|Extension Phase|Withdrawal by Subject|0|||
19690002|NCT00355134|42135863|FG003|Extension Phase|Withdrawal by Subject|7|||
19690003|NCT00355134|42135864|FG004|Extension Phase|Withdrawal by Subject|5|||
19690004|NCT00355134|42135860|FG000|Extension Phase|Adverse Event|13|||
19690005|NCT00355134|42135861|FG001|Extension Phase|Adverse Event|9|||
19690006|NCT00355134|42135862|FG002|Extension Phase|Adverse Event|0|||
19772001|NCT03168425|42225999|FG000|Overall Study|unable to confirm post op opioids|2|||
19772002|NCT03168425|42226000|FG001|Overall Study|unable to confirm post op opioids|3|||
19772003|NCT02972502|42226013|FG000|Overall Study|Lost to Follow-up|3|||
19772004|NCT02972502|42226014|FG001|Overall Study|Lost to Follow-up|1|||
19772005|NCT02972502|42226013|FG000|Overall Study|Withdrawal by Subject|1|||
19772006|NCT02972502|42226014|FG001|Overall Study|Withdrawal by Subject|1|||
19772007|NCT02971800|42226020|FG000|Overall Study|Protocol Violation|1|||
19772008|NCT02971800|42226020|FG000|Overall Study|Withdrawal by Subject|1|||
19772009|NCT02971800|42226020|FG000|Overall Study|Exclusion criteria prior intervention|1|||
19772010|NCT02971800|42226020|FG000|Overall Study|Number evaluable participant already reached|4|||
19772011|NCT03163667|42226026|FG000|Overall Study|Death|15|||
19772012|NCT03163667|42226027|FG001|Overall Study|Death|27|||
19772013|NCT03163667|42226026|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
19772014|NCT03163667|42226027|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
19772015|NCT03167411|42226035|FG000|Overall Study|Adverse Event|0|||
19772016|NCT03167411|42226036|FG001|Overall Study|Adverse Event|1|||
19772017|NCT01952847|42226046|FG000|Overall Study|Ineligible|1|||
19772018|NCT01952847|42226047|FG001|Overall Study|Ineligible|0|||
19772019|NCT01952847|42226048|FG002|Overall Study|Ineligible|0|||
19772020|NCT01952847|42226049|FG003|Overall Study|Ineligible|0|||
19772021|NCT01952847|42226046|FG000|Overall Study|Lack of Insurance Coverage|0|||
19772022|NCT01952847|42226047|FG001|Overall Study|Lack of Insurance Coverage|1|||
19772023|NCT01952847|42226048|FG002|Overall Study|Lack of Insurance Coverage|0|||
19772024|NCT01952847|42226049|FG003|Overall Study|Lack of Insurance Coverage|0|||
19772025|NCT01952847|42226046|FG000|Overall Study|Withdrawal by Subject|1|||
19772026|NCT01952847|42226047|FG001|Overall Study|Withdrawal by Subject|1|||
19772027|NCT01952847|42226048|FG002|Overall Study|Withdrawal by Subject|0|||
19772028|NCT01952847|42226049|FG003|Overall Study|Withdrawal by Subject|1|||
19772029|NCT01560585|42226061|FG000|Overall Study|Physician Decision|3|||
19772030|NCT03075501|42226068|FG000|Overall Study|Scheduling difficulties|15|||
19772031|NCT03075501|42226069|FG001|Overall Study|Scheduling difficulties|9|||
19772032|NCT02317991|42226076|FG000|Overall Study|Adverse Event|12|||
19772033|NCT02317991|42226076|FG000|Overall Study|Death|4|||
19772034|NCT02317991|42226076|FG000|Overall Study|Withdrawal by Subject|8|||
19772035|NCT02317991|42226076|FG000|Overall Study|Progressive Disease|41|||
19772036|NCT03075267|42226083|FG000|Overall Study|Protocol Violation|1|||
19772037|NCT03075267|42226084|FG001|Overall Study|Protocol Violation|0|||
19772038|NCT03075267|42226085|FG002|Overall Study|Protocol Violation|0|||
19772039|NCT03074331|42226093|FG000|Overall Study|Enrolled but Not Treated|1|||
19772040|NCT03074331|42226093|FG000|Overall Study|Lost to Follow-up|5|||
19772041|NCT03074331|42226093|FG000|Overall Study|Withdrew Consent|1|||
19772042|NCT02260193|42226100|FG000|Overall Study|Lack of Efficacy|0|||
19772043|NCT02260193|42226101|FG001|Overall Study|Lack of Efficacy|1|||
19772044|NCT02260193|42226102|FG002|Overall Study|Lack of Efficacy|6|||
19772045|NCT02260193|42226100|FG000|Overall Study|Adverse Event|3|||
19772046|NCT02260193|42226101|FG001|Overall Study|Adverse Event|4|||
19772047|NCT02260193|42226102|FG002|Overall Study|Adverse Event|1|||
19772048|NCT02260193|42226100|FG000|Overall Study|Protocol Violation|0|||
19605904|NCT00943826|42054676|FG001|Concurrent Phase|Administrative reasons|1|||
19605905|NCT00943826|42054675|FG000|Concurrent Phase|Protocol Violation|1|||
19605906|NCT00943826|42054676|FG001|Concurrent Phase|Protocol Violation|0|||
19605907|NCT00943826|42054675|FG000|Maintenance Phase|Adverse Event|31|||
19605908|NCT00943826|42054676|FG001|Maintenance Phase|Adverse Event|30|||
19605909|NCT00943826|42054675|FG000|Maintenance Phase|Withdrew consent|2|||
19605910|NCT00943826|42054676|FG001|Maintenance Phase|Withdrew consent|4|||
19690007|NCT00355134|42135863|FG003|Extension Phase|Adverse Event|3|||
19690008|NCT00355134|42135864|FG004|Extension Phase|Adverse Event|5|||
19690009|NCT00355134|42135860|FG000|Extension Phase|Lost to Follow-up|2|||
19690010|NCT00355134|42135861|FG001|Extension Phase|Lost to Follow-up|6|||
19690011|NCT00355134|42135862|FG002|Extension Phase|Lost to Follow-up|0|||
19690012|NCT00355134|42135863|FG003|Extension Phase|Lost to Follow-up|2|||
19690013|NCT00355134|42135864|FG004|Extension Phase|Lost to Follow-up|4|||
19690014|NCT00355134|42135860|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
19690015|NCT00355134|42135861|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
19690016|NCT00355134|42135862|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
19690017|NCT00355134|42135863|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
19690018|NCT00355134|42135864|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
19690019|NCT00355134|42135860|FG000|Extension Phase|Administrative problems|2|||
19690020|NCT00355134|42135861|FG001|Extension Phase|Administrative problems|4|||
19690021|NCT00355134|42135862|FG002|Extension Phase|Administrative problems|0|||
19690022|NCT00355134|42135863|FG003|Extension Phase|Administrative problems|1|||
19690023|NCT00355134|42135864|FG004|Extension Phase|Administrative problems|1|||
19690024|NCT00355134|42135860|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
19690025|NCT00355134|42135861|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
19690026|NCT00355134|42135862|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
19690027|NCT00355134|42135863|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
19690028|NCT00355134|42135864|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
19690029|NCT00355134|42135860|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
19690030|NCT00355134|42135861|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
19690031|NCT00355134|42135862|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
19690032|NCT00355134|42135863|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
19690033|NCT00355134|42135864|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
19690034|NCT00355134|42135860|FG000|Extension Phase|Protocol Violation|0|||
19690035|NCT00355134|42135861|FG001|Extension Phase|Protocol Violation|0|||
19690036|NCT00355134|42135862|FG002|Extension Phase|Protocol Violation|0|||
19690037|NCT00355134|42135863|FG003|Extension Phase|Protocol Violation|1|||
19690038|NCT00355134|42135864|FG004|Extension Phase|Protocol Violation|0|||
19690039|NCT00171730|42135874|FG000|Overall Study|Adverse Event|3|||
19690040|NCT00171730|42135874|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
19690041|NCT00171730|42135874|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
19690042|NCT00171730|42135874|FG000|Overall Study|Withdrawal by Subject|3|||
19690043|NCT00355056|42135886|FG000|Randomization Period|Early Termination|4|||
19690044|NCT00355056|42135887|FG001|Randomization Period|Early Termination|6|||
19690045|NCT00348348|42135903|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
19690046|NCT00348348|42135904|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
19690047|NCT00348348|42135903|FG000|Overall Study|Lack of Efficacy|1|||
19690048|NCT00348348|42135904|FG001|Overall Study|Lack of Efficacy|1|||
19690049|NCT00348348|42135903|FG000|Overall Study|Lost to Follow-up|8|||
19690050|NCT00348348|42135904|FG001|Overall Study|Lost to Follow-up|10|||
19690051|NCT00348348|42135903|FG000|Overall Study|Withdrawal by Subject|4|||
19690052|NCT00348348|42135904|FG001|Overall Study|Withdrawal by Subject|1|||
19690053|NCT00348348|42135903|FG000|Overall Study|Other|7|||
19690054|NCT00348348|42135904|FG001|Overall Study|Other|4|||
19690055|NCT00348348|42135903|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
19690056|NCT00348348|42135904|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
19690057|NCT00348348|42135903|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
19690058|NCT00348348|42135904|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
19690059|NCT00348348|42135903|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
19690060|NCT00348348|42135904|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
19690061|NCT00348348|42135903|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
19690062|NCT00348348|42135904|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
19690063|NCT00348348|42135903|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
19690064|NCT00348348|42135904|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
19690065|NCT00348348|42135903|FG000|Overall Study|Adverse event probably related to study|1|||
19690066|NCT00348348|42135904|FG001|Overall Study|Adverse event probably related to study|0|||
19690067|NCT00347958|42135910|FG000|Overall Study|Adverse Event|1|||
19690068|NCT00347958|42135910|FG000|Overall Study|Protocol Violation|2|||
19690069|NCT00347958|42135910|FG000|Overall Study|Withdrawal by Subject|1|||
19690070|NCT00354744|42135914|FG000|Overall Study|Adverse Event|2|||
19605911|NCT00943826|42054675|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
19605912|NCT00943826|42054676|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
19605913|NCT00943826|42054675|FG000|Maintenance Phase|Administrative reasons|4|||
19605914|NCT00943826|42054676|FG001|Maintenance Phase|Administrative reasons|1|||
19605915|NCT00943826|42054675|FG000|Maintenance Phase|Failure to return|0|||
19605916|NCT00943826|42054676|FG001|Maintenance Phase|Failure to return|1|||
19605917|NCT00943826|42054675|FG000|Monotherapy Phase|Adverse Event|42|||
19477660|NCT01472081|41756934|FG004|Overall Study|Death|1|||
19772049|NCT02260193|42226101|FG001|Overall Study|Protocol Violation|4|||
19772050|NCT02260193|42226102|FG002|Overall Study|Protocol Violation|0|||
19772051|NCT02260193|42226100|FG000|Overall Study|Withdrawal by Subject|3|||
19772052|NCT02260193|42226101|FG001|Overall Study|Withdrawal by Subject|0|||
19772053|NCT02260193|42226102|FG002|Overall Study|Withdrawal by Subject|2|||
19772054|NCT02260193|42226100|FG000|Overall Study|Kidney Transplantation|0|||
19772055|NCT02260193|42226101|FG001|Overall Study|Kidney Transplantation|0|||
19772056|NCT02260193|42226102|FG002|Overall Study|Kidney Transplantation|1|||
19772057|NCT02849678|42226112|FG000|Overall Study|Protocol Violation|3|||
19772058|NCT02849678|42226113|FG001|Overall Study|Protocol Violation|6|||
19772059|NCT01596257|42226121|FG000|Overall Study|Inadequate Collection|23|||
19772060|NCT01596257|42226122|FG001|Overall Study|Inadequate Collection|19|||
19772061|NCT04577781|42226132|FG000|Overall Study|Adverse Event|2|||
19772062|NCT04577781|42226133|FG001|Overall Study|Adverse Event|2|||
19772063|NCT04577781|42226132|FG000|Overall Study|Physician Decision|1|||
19772064|NCT04577781|42226133|FG001|Overall Study|Physician Decision|0|||
19772065|NCT02737826|42226140|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
19772066|NCT02737826|42226141|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
19772067|NCT02737826|42226142|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
19772068|NCT03070431|42226169|FG000|Overall Study|Withdrawal by Subject|2|||
19772069|NCT03070431|42226169|FG000|Overall Study|Lost to Follow-up|2|||
19772070|NCT01071395|42226180|FG000|Overall Study|Withdrawal by Subject|2|||
19772071|NCT01071395|42226181|FG001|Overall Study|Withdrawal by Subject|1|||
19772072|NCT01071395|42226180|FG000|Overall Study|Adverse Event|3|||
19772073|NCT01071395|42226181|FG001|Overall Study|Adverse Event|1|||
19772074|NCT02970942|42226191|FG000|Overall Study|Death|0|||
19772075|NCT02970942|42226192|FG001|Overall Study|Death|1|||
19772076|NCT02970942|42226193|FG002|Overall Study|Death|0|||
19772077|NCT02970942|42226194|FG003|Overall Study|Death|0|||
19772078|NCT02970942|42226191|FG000|Overall Study|Lost to Follow-up|1|||
19772079|NCT02970942|42226192|FG001|Overall Study|Lost to Follow-up|0|||
19772080|NCT02970942|42226193|FG002|Overall Study|Lost to Follow-up|2|||
19772081|NCT02970942|42226194|FG003|Overall Study|Lost to Follow-up|1|||
19772082|NCT02970942|42226191|FG000|Overall Study|Withdrawal by Subject|3|||
19772083|NCT02970942|42226192|FG001|Overall Study|Withdrawal by Subject|5|||
19772084|NCT02970942|42226193|FG002|Overall Study|Withdrawal by Subject|3|||
19772085|NCT02970942|42226194|FG003|Overall Study|Withdrawal by Subject|2|||
19772086|NCT03073005|42226208|FG000|Overall Study|Death|6|||
19772087|NCT03073005|42226209|FG001|Overall Study|Death|0|||
19772088|NCT03073005|42226210|FG002|Overall Study|Death|7|||
19605918|NCT00943826|42054676|FG001|Monotherapy Phase|Adverse Event|5|||
19605919|NCT00943826|42054675|FG000|Monotherapy Phase|Administrative reasons|11|||
19605920|NCT00943826|42054676|FG001|Monotherapy Phase|Administrative reasons|5|||
19605921|NCT00943826|42054675|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
19772089|NCT03073005|42226211|FG003|Overall Study|Death|0|||
19772090|NCT03073005|42226208|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
19772091|NCT03073005|42226209|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
19772092|NCT03073005|42226210|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
19772093|NCT03073005|42226211|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
19772094|NCT03073005|42226208|FG000|Overall Study|Lost to Follow-up|2|||
19772095|NCT03073005|42226209|FG001|Overall Study|Lost to Follow-up|2|||
19772096|NCT03073005|42226210|FG002|Overall Study|Lost to Follow-up|1|||
19772097|NCT03073005|42226211|FG003|Overall Study|Lost to Follow-up|2|||
19772098|NCT03073005|42226208|FG000|Overall Study|Withdrawal by Subject|0|||
19690071|NCT00354744|42135914|FG000|Overall Study|Death|2|||
19690072|NCT00354744|42135914|FG000|Overall Study|Lack of Efficacy|11|||
19690073|NCT00354744|42135914|FG000|Overall Study|Lost to Follow-up|2|||
19690074|NCT00354744|42135914|FG000|Overall Study|Physician Decision|11|||
19690075|NCT00354744|42135914|FG000|Overall Study|Withdrawal by Subject|14|||
19690076|NCT00373256|42135922|FG000|Overall Study|Adverse Event (AE)|1|||
19690077|NCT00373256|42135923|FG001|Overall Study|Adverse Event (AE)|5|||
19690078|NCT00373256|42135922|FG000|Overall Study|Lost to Follow-up|2|||
19690079|NCT00373256|42135923|FG001|Overall Study|Lost to Follow-up|1|||
19690080|NCT00373256|42135922|FG000|Overall Study|Death|9|||
19605922|NCT00943826|42054676|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
19605923|NCT00943826|42054675|FG000|Monotherapy Phase|Withdrew Consent|2|||
19605924|NCT00943826|42054676|FG001|Monotherapy Phase|Withdrew Consent|3|||
19690081|NCT00373256|42135923|FG001|Overall Study|Death|8|||
19690082|NCT00373256|42135922|FG000|Overall Study|Objective Progression or Relapse|111|||
19690083|NCT00373256|42135923|FG001|Overall Study|Objective Progression or Relapse|104|||
19690084|NCT00373256|42135922|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
19690085|NCT00373256|42135923|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
19690086|NCT00373256|42135922|FG000|Overall Study|Other|73|||
19690087|NCT00373256|42135923|FG001|Overall Study|Other|107|||
19690088|NCT00373256|42135922|FG000|Overall Study|Protocol Violation|0|||
19772099|NCT03073005|42226209|FG001|Overall Study|Withdrawal by Subject|4|||
19772100|NCT03073005|42226210|FG002|Overall Study|Withdrawal by Subject|4|||
19772101|NCT03073005|42226211|FG003|Overall Study|Withdrawal by Subject|4|||
19772102|NCT02849171|42226224|FG000|Overall Study|Withdrawal by Subject|1|||
19772103|NCT02849171|42226224|FG000|Overall Study|Not treated|1|||
19772104|NCT02848664|42226237|FG000|Overall Study|Withdrawal by Subject|2|||
19772105|NCT02848664|42226237|FG000|Overall Study|Adverse Event|1|||
19772106|NCT02848664|42226237|FG000|Overall Study|no assistance for device training|1|||
19772107|NCT02969382|42226247|FG000|Overall Study|Adverse Event|8|||
19772108|NCT02969382|42226248|FG001|Overall Study|Adverse Event|10|||
19772109|NCT02969382|42226247|FG000|Overall Study|Lack of Efficacy|4|||
19772110|NCT02969382|42226248|FG001|Overall Study|Lack of Efficacy|5|||
19772111|NCT02969382|42226247|FG000|Overall Study|Death|0|||
19772112|NCT02969382|42226248|FG001|Overall Study|Death|1|||
19772113|NCT02969382|42226247|FG000|Overall Study|PROTOCOL DEVIATION|0|||
19772114|NCT02969382|42226248|FG001|Overall Study|PROTOCOL DEVIATION|1|||
19772115|NCT02969382|42226247|FG000|Overall Study|Withdrawal by Subject|14|||
19772116|NCT02969382|42226248|FG001|Overall Study|Withdrawal by Subject|9|||
19772117|NCT01989104|42226259|FG000|Overall Study|Withdrawal by Subject|3|||
19772118|NCT01989104|42226260|FG001|Overall Study|Withdrawal by Subject|0|||
19772119|NCT01989104|42226261|FG002|Overall Study|Withdrawal by Subject|0|||
19772120|NCT01989104|42226262|FG003|Overall Study|Withdrawal by Subject|0|||
19772121|NCT01989104|42226263|FG004|Overall Study|Withdrawal by Subject|0|||
19772122|NCT02903238|42226275|FG000|Overall Study|Lost to Follow-up|4|||
19772123|NCT02847260|42226280|FG000|Overall Study|Adverse Event|3|||
19772124|NCT02847260|42226280|FG000|Overall Study|Withdrawal by Subject|2|||
19772125|NCT02847260|42226280|FG000|Overall Study|Clinical Deterioration|1|||
19772126|NCT02847260|42226280|FG000|Overall Study|Physician Decision|1|||
19772127|NCT02968563|42226286|FG000|Overall Study|Adverse Event|0|||
19772128|NCT02968563|42226287|FG001|Overall Study|Adverse Event|6|||
19772129|NCT02968563|42226286|FG000|Overall Study|Death|1|||
19772130|NCT02968563|42226287|FG001|Overall Study|Death|1|||
19772131|NCT02968563|42226286|FG000|Overall Study|Lost to Follow-up|0|||
19772132|NCT02968563|42226287|FG001|Overall Study|Lost to Follow-up|1|||
19772133|NCT02904096|42226295|FG000|Overall Study|Adverse Event|1|||
19772134|NCT02904096|42226296|FG001|Overall Study|Adverse Event|0|||
19772135|NCT02904096|42226295|FG000|Overall Study|Withdrawal by Subject|4|||
19772136|NCT02904096|42226296|FG001|Overall Study|Withdrawal by Subject|3|||
19772137|NCT02904096|42226295|FG000|Overall Study|Lost to Follow-up|10|||
19772138|NCT02904096|42226296|FG001|Overall Study|Lost to Follow-up|17|||
19772139|NCT02904096|42226295|FG000|Overall Study|Non-compliant|3|||
19772140|NCT02904096|42226296|FG001|Overall Study|Non-compliant|1|||
19772141|NCT02904096|42226295|FG000|Overall Study|Sponsor instructed|1|||
19772142|NCT02904096|42226296|FG001|Overall Study|Sponsor instructed|0|||
19772143|NCT03161483|42226306|FG000|Overall Study|Death|1|||
19772144|NCT03161483|42226307|FG001|Overall Study|Death|0|||
19772145|NCT03161483|42226308|FG002|Overall Study|Death|0|||
19772146|NCT03161483|42226309|FG003|Overall Study|Death|0|||
19772147|NCT03161483|42226306|FG000|Overall Study|Adverse Event|5|||
19772148|NCT03161483|42226307|FG001|Overall Study|Adverse Event|1|||
19772149|NCT03161483|42226308|FG002|Overall Study|Adverse Event|11|||
19772150|NCT03161483|42226309|FG003|Overall Study|Adverse Event|2|||
19772151|NCT03161483|42226306|FG000|Overall Study|Pregnancy|1|||
19772152|NCT03161483|42226307|FG001|Overall Study|Pregnancy|0|||
19772153|NCT03161483|42226308|FG002|Overall Study|Pregnancy|0|||
19772154|NCT03161483|42226309|FG003|Overall Study|Pregnancy|0|||
19772155|NCT03161483|42226306|FG000|Overall Study|Lack of Efficacy|0|||
19772156|NCT03161483|42226307|FG001|Overall Study|Lack of Efficacy|0|||
19772157|NCT03161483|42226308|FG002|Overall Study|Lack of Efficacy|1|||
19772158|NCT03161483|42226309|FG003|Overall Study|Lack of Efficacy|0|||
19772159|NCT03161483|42226306|FG000|Overall Study|Withdrawal by Subject|2|||
19772160|NCT03161483|42226307|FG001|Overall Study|Withdrawal by Subject|2|||
19772161|NCT03161483|42226308|FG002|Overall Study|Withdrawal by Subject|6|||
19772162|NCT03161483|42226309|FG003|Overall Study|Withdrawal by Subject|5|||
19690089|NCT00373256|42135923|FG001|Overall Study|Protocol Violation|2|||
19772163|NCT03161483|42226306|FG000|Overall Study|Lost to Follow-up|0|||
19772164|NCT03161483|42226307|FG001|Overall Study|Lost to Follow-up|0|||
19690090|NCT00373256|42135922|FG000|Overall Study|Study Terminated by Sponsor|41|||
19690091|NCT00373256|42135923|FG001|Overall Study|Study Terminated by Sponsor|13|||
19690092|NCT00394082|42135929|FG000|Overall Study|Unacceptable toxicity|15|||
19690093|NCT00394082|42135929|FG000|Overall Study|Adverse Event|4|||
19690094|NCT00394082|42135929|FG000|Overall Study|Physician Decision|4|||
19690095|NCT00394082|42135929|FG000|Overall Study|Withdrawal by Subject|2|||
19690096|NCT00394082|42135929|FG000|Overall Study|Other|1|||
19690097|NCT00393848|42135937|FG000|Overall Study|Surgical schedule|0|||
19690098|NCT00393848|42135938|FG001|Overall Study|Surgical schedule|0|||
19772165|NCT03161483|42226308|FG002|Overall Study|Lost to Follow-up|1|||
19772166|NCT03161483|42226309|FG003|Overall Study|Lost to Follow-up|0|||
19772167|NCT03161483|42226306|FG000|Overall Study|Protocol Violation|0|||
19772168|NCT03161483|42226307|FG001|Overall Study|Protocol Violation|0|||
19772169|NCT03161483|42226308|FG002|Overall Study|Protocol Violation|1|||
19772170|NCT03161483|42226309|FG003|Overall Study|Protocol Violation|0|||
19772171|NCT03161483|42226306|FG000|Overall Study|Other reasons|1|||
19772172|NCT03161483|42226307|FG001|Overall Study|Other reasons|0|||
19772173|NCT03161483|42226308|FG002|Overall Study|Other reasons|0|||
19772174|NCT03161483|42226309|FG003|Overall Study|Other reasons|1|||
19772175|NCT03161405|42226323|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
19772176|NCT01813929|42226332|FG000|Overall Study|Withdrawal by Subject|0|||
19772177|NCT01813929|42226333|FG001|Overall Study|Withdrawal by Subject|1|||
19772178|NCT02901054|42226343|FG000|Overall Study|Physician Decision|1|||
19772179|NCT02901054|42226343|FG000|Overall Study|Withdrawal by Subject|3|||
19772180|NCT03068715|42226349|FG000|Overall Study|No longer met inclusion criteria|1|||
19772181|NCT03068715|42226350|FG001|Overall Study|No longer met inclusion criteria|0|||
19772182|NCT02966340|42226358|FG000|Overall Study|Adverse Event|0|||
19772183|NCT02966340|42226359|FG001|Overall Study|Adverse Event|1|||
19772184|NCT02966340|42226358|FG000|Overall Study|Lost to Follow-up|0|||
19772185|NCT02966340|42226359|FG001|Overall Study|Lost to Follow-up|1|||
19772186|NCT02966340|42226358|FG000|Overall Study|Withdrawal by Subject|1|||
19772187|NCT02966340|42226359|FG001|Overall Study|Withdrawal by Subject|0|||
19772188|NCT02966340|42226358|FG000|Overall Study|data acquisition error|1|||
19772189|NCT02966340|42226359|FG001|Overall Study|data acquisition error|0|||
19772190|NCT02966340|42226358|FG000|Overall Study|startle non-responder|1|||
19772191|NCT02966340|42226359|FG001|Overall Study|startle non-responder|1|||
19772192|NCT03067311|42226367|FG000|Overall Study|Lost to Follow-up|1|||
19772193|NCT03067311|42226368|FG001|Overall Study|Lost to Follow-up|1|||
19772194|NCT03067311|42226367|FG000|Overall Study|Moved away|1|||
19772195|NCT03067311|42226368|FG001|Overall Study|Moved away|1|||
19772196|NCT04380519|42226377|FG000|Overall Study|Withdrawal by Subject|4|||
19772197|NCT04380519|42226378|FG001|Overall Study|Withdrawal by Subject|0|||
19772198|NCT04380519|42226379|FG002|Overall Study|Withdrawal by Subject|1|||
19772199|NCT04380519|42226377|FG000|Overall Study|Death|14|||
19772200|NCT04380519|42226378|FG001|Overall Study|Death|9|||
19772201|NCT04380519|42226379|FG002|Overall Study|Death|6|||
19772202|NCT04380519|42226377|FG000|Overall Study|Adverse Event|0|||
19772203|NCT04380519|42226378|FG001|Overall Study|Adverse Event|1|||
19772204|NCT04380519|42226379|FG002|Overall Study|Adverse Event|0|||
19772205|NCT04380519|42226377|FG000|Overall Study|relatives' decision|0|||
19772206|NCT04380519|42226378|FG001|Overall Study|relatives' decision|1|||
19772207|NCT04380519|42226379|FG002|Overall Study|relatives' decision|0|||
19772208|NCT02847182|42226389|FG000|Overall Study|Withdrawal by Subject|0|||
19772209|NCT02847182|42226390|FG001|Overall Study|Withdrawal by Subject|1|||
19772210|NCT02846558|42226406|FG000|Overall Study|Adverse Event|1|||
19772211|NCT02846558|42226407|FG001|Overall Study|Adverse Event|0|||
19772212|NCT02846558|42226408|FG002|Overall Study|Adverse Event|0|||
19772213|NCT02846558|42226409|FG003|Overall Study|Adverse Event|0|||
19772214|NCT02846558|42226406|FG000|Overall Study|Withdrawal by Subject|5|||
19772215|NCT02846558|42226407|FG001|Overall Study|Withdrawal by Subject|4|||
19772216|NCT02846558|42226408|FG002|Overall Study|Withdrawal by Subject|2|||
19772217|NCT02846558|42226409|FG003|Overall Study|Withdrawal by Subject|2|||
19772218|NCT02846558|42226406|FG000|Overall Study|Lost to Follow-up|2|||
19772219|NCT02846558|42226407|FG001|Overall Study|Lost to Follow-up|0|||
19772220|NCT02846558|42226408|FG002|Overall Study|Lost to Follow-up|0|||
19772221|NCT02846558|42226409|FG003|Overall Study|Lost to Follow-up|0|||
19772222|NCT04362813|42226428|FG000|Overall Study|Death|12|||
19772223|NCT04362813|42226429|FG001|Overall Study|Death|16|||
19772224|NCT04362813|42226428|FG000|Overall Study|Withdrawal by Subject|3|||
19772225|NCT04362813|42226429|FG001|Overall Study|Withdrawal by Subject|1|||
19772226|NCT04362813|42226428|FG000|Overall Study|Protocol Violation|0|||
19772227|NCT04362813|42226429|FG001|Overall Study|Protocol Violation|3|||
19772228|NCT04362813|42226428|FG000|Overall Study|Lost to Follow-up|1|||
19772229|NCT04362813|42226429|FG001|Overall Study|Lost to Follow-up|1|||
19772230|NCT04362813|42226428|FG000|Overall Study|Enrolled but did not receive treatment|2|||
19690099|NCT00393848|42135939|FG002|Overall Study|Surgical schedule|0|||
19690100|NCT00393848|42135940|FG003|Overall Study|Surgical schedule|1|||
19690101|NCT00393848|42135937|FG000|Overall Study|Personal reasons|0|||
19690102|NCT00393848|42135938|FG001|Overall Study|Personal reasons|0|||
19690103|NCT00393848|42135939|FG002|Overall Study|Personal reasons|2|||
19690104|NCT00393848|42135940|FG003|Overall Study|Personal reasons|0|||
19690105|NCT00393458|42135955|FG000|Overall Study|Adverse Event|35|||
19690106|NCT00393458|42135956|FG001|Overall Study|Adverse Event|24|||
19690107|NCT00393458|42135957|FG002|Overall Study|Adverse Event|40|||
19690108|NCT00393458|42135958|FG003|Overall Study|Adverse Event|35|||
19772231|NCT04362813|42226429|FG001|Overall Study|Enrolled but did not receive treatment|4|||
19772232|NCT02966028|42226438|FG000|Overall Study|Adverse Event|7|||
19772233|NCT02966028|42226439|FG001|Overall Study|Adverse Event|13|||
19772234|NCT02966028|42226440|FG002|Overall Study|Adverse Event|10|||
19772235|NCT02966028|42226438|FG000|Overall Study|Physician Decision|1|||
19772236|NCT02966028|42226439|FG001|Overall Study|Physician Decision|0|||
19772237|NCT02966028|42226440|FG002|Overall Study|Physician Decision|2|||
19772238|NCT02966028|42226438|FG000|Overall Study|Withdrawal by Subject|7|||
19772239|NCT02966028|42226439|FG001|Overall Study|Withdrawal by Subject|5|||
19772240|NCT02966028|42226440|FG002|Overall Study|Withdrawal by Subject|5|||
19772241|NCT02966028|42226438|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
19772242|NCT02966028|42226439|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
19690109|NCT00393458|42135955|FG000|Overall Study|Subject withdrew consent|27|||
19690110|NCT00393458|42135956|FG001|Overall Study|Subject withdrew consent|40|||
19690111|NCT00393458|42135957|FG002|Overall Study|Subject withdrew consent|33|||
19690112|NCT00393458|42135958|FG003|Overall Study|Subject withdrew consent|50|||
19690113|NCT00393458|42135955|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
19690114|NCT00393458|42135956|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
19690115|NCT00393458|42135957|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
19772243|NCT02966028|42226440|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
19772244|NCT02925741|42226454|FG000|Overall Study|Withdrawal by Subject|11|||
19772245|NCT02925741|42226455|FG001|Overall Study|Withdrawal by Subject|0|||
19772246|NCT02964312|42226464|FG000|Overall Study|Lost to Follow-up|28|||
19772247|NCT02964312|42226464|FG000|Overall Study|Withdrawal by Subject|11|||
19772248|NCT02964312|42226464|FG000|Overall Study|Lack of Efficacy|10|||
19690116|NCT00393458|42135958|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
19690117|NCT00393458|42135955|FG000|Overall Study|Protocol deviation|11|||
19690118|NCT00393458|42135956|FG001|Overall Study|Protocol deviation|11|||
19690119|NCT00393458|42135957|FG002|Overall Study|Protocol deviation|11|||
19690120|NCT00393458|42135958|FG003|Overall Study|Protocol deviation|10|||
19690121|NCT00393458|42135955|FG000|Overall Study|Administrative problems|7|||
19690122|NCT00393458|42135956|FG001|Overall Study|Administrative problems|8|||
19690123|NCT00393458|42135957|FG002|Overall Study|Administrative problems|5|||
19690124|NCT00393458|42135958|FG003|Overall Study|Administrative problems|2|||
19690125|NCT00393458|42135955|FG000|Overall Study|Lost to Follow-up|5|||
19690126|NCT00393458|42135956|FG001|Overall Study|Lost to Follow-up|6|||
19690127|NCT00393458|42135957|FG002|Overall Study|Lost to Follow-up|5|||
19690128|NCT00393458|42135958|FG003|Overall Study|Lost to Follow-up|3|||
19690129|NCT00393458|42135955|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19690130|NCT00393458|42135956|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19690131|NCT00393458|42135957|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19772249|NCT02964312|42226464|FG000|Overall Study|Did not consent to long-term FU|14|||
19772250|NCT02964312|42226464|FG000|Overall Study|Death|1|||
19772251|NCT02899962|42226488|FG000|Open-label Phase|Adverse Event|2|||
19772252|NCT02899962|42226489|FG001|Open-label Phase|Adverse Event|0|||
19772253|NCT02899962|42226490|FG002|Open-label Phase|Adverse Event|0|||
19772254|NCT02899962|42226488|FG000|Open-label Phase|Lost to Follow-up|9|||
19772255|NCT02899962|42226489|FG001|Open-label Phase|Lost to Follow-up|0|||
19690132|NCT00393458|42135958|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19690133|NCT00393458|42135955|FG000|Overall Study|Death|1|||
19690134|NCT00393458|42135956|FG001|Overall Study|Death|1|||
19690135|NCT00393458|42135957|FG002|Overall Study|Death|5|||
19772256|NCT02899962|42226490|FG002|Open-label Phase|Lost to Follow-up|0|||
19772257|NCT02899962|42226488|FG000|Open-label Phase|Other reasons|9|||
19772258|NCT02899962|42226489|FG001|Open-label Phase|Other reasons|0|||
19772259|NCT02899962|42226490|FG002|Open-label Phase|Other reasons|0|||
19772260|NCT02899962|42226488|FG000|Open-label Phase|Withdrawal by Subject|7|||
19772261|NCT02899962|42226489|FG001|Open-label Phase|Withdrawal by Subject|0|||
19772262|NCT02899962|42226490|FG002|Open-label Phase|Withdrawal by Subject|0|||
19772263|NCT02899962|42226488|FG000|Maintenance Phase|Adverse Event|0|||
19772264|NCT02899962|42226489|FG001|Maintenance Phase|Adverse Event|2|||
19772265|NCT02899962|42226490|FG002|Maintenance Phase|Adverse Event|1|||
19772266|NCT02899962|42226488|FG000|Maintenance Phase|Death|0|||
19772267|NCT02899962|42226489|FG001|Maintenance Phase|Death|0|||
19772268|NCT02899962|42226490|FG002|Maintenance Phase|Death|1|||
19772269|NCT02899962|42226488|FG000|Maintenance Phase|Lack of Efficacy|0|||
19772270|NCT02899962|42226489|FG001|Maintenance Phase|Lack of Efficacy|20|||
19690136|NCT00393458|42135958|FG003|Overall Study|Death|5|||
19772271|NCT02899962|42226490|FG002|Maintenance Phase|Lack of Efficacy|16|||
19772272|NCT02899962|42226488|FG000|Maintenance Phase|Lost to Follow-up|0|||
19690137|NCT00393458|42135955|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19690138|NCT00393458|42135956|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19772273|NCT02899962|42226489|FG001|Maintenance Phase|Lost to Follow-up|12|||
19772274|NCT02899962|42226490|FG002|Maintenance Phase|Lost to Follow-up|14|||
19772275|NCT02899962|42226488|FG000|Maintenance Phase|Other reasons|0|||
19772276|NCT02899962|42226489|FG001|Maintenance Phase|Other reasons|9|||
19772277|NCT02899962|42226490|FG002|Maintenance Phase|Other reasons|13|||
19772278|NCT02899962|42226488|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
19772279|NCT02899962|42226489|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
19772280|NCT02899962|42226490|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
19772281|NCT02899962|42226488|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
19772282|NCT02899962|42226489|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
19772283|NCT02899962|42226490|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
19772284|NCT02899962|42226488|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19772285|NCT02899962|42226489|FG001|Maintenance Phase|Withdrawal by Subject|30|||
19772286|NCT02899962|42226490|FG002|Maintenance Phase|Withdrawal by Subject|36|||
19772287|NCT02899728|42226499|FG000|Overall Study|Withdrawal by Subject|1|||
19772288|NCT02899728|42226500|FG001|Overall Study|Withdrawal by Subject|1|||
19772289|NCT02899338|42226508|FG000|Overall Study|Adverse Event|1|||
19772290|NCT02899338|42226509|FG001|Overall Study|Adverse Event|2|||
19772291|NCT02899338|42226508|FG000|Overall Study|Withdrawal by Subject|2|||
19772292|NCT02899338|42226509|FG001|Overall Study|Withdrawal by Subject|0|||
19772293|NCT03066609|42226518|FG000|INDUCTION|Pregnancy|0|||
19772294|NCT03066609|42226519|FG001|INDUCTION|Pregnancy|0|||
19772295|NCT03066609|42226520|FG002|INDUCTION|Pregnancy|1|||
19772296|NCT03066609|42226521|FG003|INDUCTION|Pregnancy|0|||
19772297|NCT03066609|42226518|FG000|INDUCTION|Lack of Efficacy|0|||
19772298|NCT03066609|42226519|FG001|INDUCTION|Lack of Efficacy|0|||
19772299|NCT03066609|42226520|FG002|INDUCTION|Lack of Efficacy|1|||
19772300|NCT03066609|42226521|FG003|INDUCTION|Lack of Efficacy|0|||
19772301|NCT03066609|42226518|FG000|INDUCTION|Adverse Event|2|||
19772302|NCT03066609|42226519|FG001|INDUCTION|Adverse Event|2|||
19605925|NCT00943826|42054675|FG000|Monotherapy Phase|Failure to return|2|||
19605926|NCT00943826|42054676|FG001|Monotherapy Phase|Failure to return|1|||
19605927|NCT00943826|42054675|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
19605928|NCT00943826|42054676|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
19605929|NCT00943826|42054675|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
19605930|NCT00943826|42054676|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
19605931|NCT00943826|42054675|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
19605932|NCT00943826|42054676|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
19605933|NCT00943826|42054675|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
19605934|NCT00943826|42054676|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
19605935|NCT01004003|42054692|FG000|Overall Study|Progressive disease|2|||
19605936|NCT01004003|42054693|FG001|Overall Study|Progressive disease|1|||
19605937|NCT01004003|42054694|FG002|Overall Study|Progressive disease|1|||
19605938|NCT01004003|42054695|FG003|Overall Study|Progressive disease|0|||
19605939|NCT01004003|42054696|FG004|Overall Study|Progressive disease|2|||
19605940|NCT01004003|42054697|FG005|Overall Study|Progressive disease|1|||
19605941|NCT01004003|42054698|FG006|Overall Study|Progressive disease|1|||
19605942|NCT01004003|42054699|FG007|Overall Study|Progressive disease|39|||
19605943|NCT01004003|42054700|FG008|Overall Study|Progressive disease|22|||
19605944|NCT01004003|42054692|FG000|Overall Study|Adverse Event|4|||
19605945|NCT01004003|42054693|FG001|Overall Study|Adverse Event|2|||
19690139|NCT00393458|42135957|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19690140|NCT00393458|42135958|FG003|Overall Study|Abnormal test procedure result(s)|2|||
19690141|NCT00393458|42135955|FG000|Overall Study|Subject no longer requires study drug|0|||
19690142|NCT00393458|42135956|FG001|Overall Study|Subject no longer requires study drug|1|||
19690143|NCT00393458|42135957|FG002|Overall Study|Subject no longer requires study drug|0|||
19605946|NCT01004003|42054694|FG002|Overall Study|Adverse Event|3|||
19690144|NCT00393458|42135958|FG003|Overall Study|Subject no longer requires study drug|0|||
19690145|NCT00392990|42135970|FG000|Treatment on Study|Adverse Event|3|||
19690146|NCT00392990|42135971|FG001|Treatment on Study|Adverse Event|1|||
19690147|NCT00392990|42135970|FG000|Follow up for 2 Years|Death|4|||
19690148|NCT00392990|42135971|FG001|Follow up for 2 Years|Death|0|||
19690149|NCT00417482|42135980|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
19690150|NCT00417482|42135981|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
19690151|NCT00417482|42135982|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
19772303|NCT03066609|42226520|FG002|INDUCTION|Adverse Event|0|||
19605947|NCT01004003|42054695|FG003|Overall Study|Adverse Event|3|||
19772304|NCT03066609|42226521|FG003|INDUCTION|Adverse Event|0|||
19772305|NCT03066609|42226518|FG000|MAINTENANCE|Adverse Event|0|||
19772306|NCT03066609|42226519|FG001|MAINTENANCE|Adverse Event|0|||
19772307|NCT03066609|42226520|FG002|MAINTENANCE|Adverse Event|0|||
19772308|NCT03066609|42226521|FG003|MAINTENANCE|Adverse Event|1|||
19690152|NCT00417482|42135980|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
19690153|NCT00417482|42135981|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
19690154|NCT00417482|42135982|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
19690155|NCT00417482|42135980|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
19772309|NCT03066609|42226518|FG000|MAINTENANCE|Withdrawal by Subject|4|||
19772310|NCT03066609|42226519|FG001|MAINTENANCE|Withdrawal by Subject|2|||
19772311|NCT03066609|42226520|FG002|MAINTENANCE|Withdrawal by Subject|1|||
19772312|NCT03066609|42226521|FG003|MAINTENANCE|Withdrawal by Subject|1|||
19772313|NCT03066609|42226518|FG000|MAINTENANCE|Lost to Follow-up|0|||
19772314|NCT03066609|42226519|FG001|MAINTENANCE|Lost to Follow-up|1|||
19772315|NCT03066609|42226520|FG002|MAINTENANCE|Lost to Follow-up|1|||
19772316|NCT03066609|42226521|FG003|MAINTENANCE|Lost to Follow-up|0|||
19772317|NCT03066609|42226518|FG000|MAINTENANCE|Pregnancy|1|||
19772318|NCT03066609|42226519|FG001|MAINTENANCE|Pregnancy|0|||
19772319|NCT03066609|42226520|FG002|MAINTENANCE|Pregnancy|0|||
19772320|NCT03066609|42226521|FG003|MAINTENANCE|Pregnancy|0|||
19772321|NCT03066609|42226518|FG000|MAINTENANCE|Lack of Efficacy|2|||
19772322|NCT03066609|42226519|FG001|MAINTENANCE|Lack of Efficacy|1|||
19772323|NCT03066609|42226520|FG002|MAINTENANCE|Lack of Efficacy|0|||
19772324|NCT03066609|42226521|FG003|MAINTENANCE|Lack of Efficacy|1|||
19772325|NCT03066609|42226518|FG000|OVERALL STUDY|Adverse Event|2|||
19772326|NCT03066609|42226519|FG001|OVERALL STUDY|Adverse Event|2|||
19772327|NCT03066609|42226520|FG002|OVERALL STUDY|Adverse Event|0|||
19772328|NCT03066609|42226521|FG003|OVERALL STUDY|Adverse Event|1|||
19772329|NCT03066609|42226518|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
19772330|NCT03066609|42226519|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
19772331|NCT03066609|42226520|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
19772332|NCT03066609|42226521|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
19772333|NCT03066609|42226518|FG000|OVERALL STUDY|Lost to Follow-up|1|||
19772334|NCT03066609|42226519|FG001|OVERALL STUDY|Lost to Follow-up|1|||
19772335|NCT03066609|42226520|FG002|OVERALL STUDY|Lost to Follow-up|1|||
19772336|NCT03066609|42226521|FG003|OVERALL STUDY|Lost to Follow-up|1|||
19772337|NCT03066609|42226518|FG000|OVERALL STUDY|Pregnancy|1|||
19772338|NCT03066609|42226519|FG001|OVERALL STUDY|Pregnancy|0|||
19772339|NCT03066609|42226520|FG002|OVERALL STUDY|Pregnancy|1|||
19772340|NCT03066609|42226521|FG003|OVERALL STUDY|Pregnancy|0|||
19772341|NCT03066609|42226518|FG000|OVERALL STUDY|Lack of Efficacy|2|||
19772342|NCT03066609|42226519|FG001|OVERALL STUDY|Lack of Efficacy|1|||
19772343|NCT03066609|42226520|FG002|OVERALL STUDY|Lack of Efficacy|1|||
19772344|NCT03066609|42226521|FG003|OVERALL STUDY|Lack of Efficacy|1|||
19772345|NCT03066609|42226518|FG000|OVERALL STUDY|discontinued follow up|0|||
19772346|NCT03066609|42226519|FG001|OVERALL STUDY|discontinued follow up|2|||
19772347|NCT03066609|42226520|FG002|OVERALL STUDY|discontinued follow up|0|||
19772348|NCT03066609|42226521|FG003|OVERALL STUDY|discontinued follow up|0|||
19772349|NCT02964234|42226538|FG000|Overall Study|Lost to Follow-up|22|||
19772350|NCT02964234|42226539|FG001|Overall Study|Lost to Follow-up|13|||
19772351|NCT01345188|42226545|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
19772352|NCT01345188|42226545|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
19772353|NCT03852459|42226554|FG000|Overall Study|Adverse Event|2|||
19772354|NCT03852459|42226555|FG001|Overall Study|Adverse Event|2|||
19772355|NCT03852459|42226554|FG000|Overall Study|Withdrawal by Subject|1|||
19772356|NCT03852459|42226555|FG001|Overall Study|Withdrawal by Subject|1|||
19772357|NCT02896296|42226561|FG000|Overall Study|Adverse Event|1|||
19772358|NCT02896296|42226561|FG000|Overall Study|Lost to Follow-up|19|||
19772359|NCT02896296|42226561|FG000|Overall Study|Pregnancy|1|||
19772360|NCT02896296|42226561|FG000|Overall Study|Physician Decision|2|||
19772361|NCT02896296|42226561|FG000|Overall Study|Withdrawal by Subject|10|||
19690156|NCT00417482|42135981|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
19690157|NCT00417482|42135982|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
19690158|NCT00417482|42135980|FG000|Phase B 1st 16 Weeks|Death|1|||
19690159|NCT00417482|42135981|FG001|Phase B 1st 16 Weeks|Death|0|||
19690160|NCT00417482|42135982|FG002|Phase B 1st 16 Weeks|Death|0|||
19690161|NCT00417482|42135980|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
19690162|NCT00417482|42135981|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
19690163|NCT00417482|42135982|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
19690164|NCT00417482|42135980|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
19690165|NCT00417482|42135981|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
19690166|NCT00417482|42135982|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
19690167|NCT00417482|42135980|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
19690168|NCT00417482|42135981|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
19690169|NCT00417482|42135982|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
19690170|NCT00417482|42135980|FG000|Phase B 2nd 16 Weeks|Death|1|||
19772362|NCT02896296|42226561|FG000|Overall Study|Site closing|7|||
19772363|NCT02896296|42226561|FG000|Overall Study|Incarceration|1|||
19772364|NCT02896296|42226561|FG000|Overall Study|Relocation|1|||
19772365|NCT03740919|42226568|FG000|Lead-in Period|Lost to Follow-up|1|||
19772366|NCT03740919|42226569|FG001|Lead-in Period|Lost to Follow-up|0|||
19772367|NCT03740919|42226570|FG002|Lead-in Period|Lost to Follow-up|0|||
19772368|NCT03740919|42226571|FG003|Lead-in Period|Lost to Follow-up|0|||
19772369|NCT03740919|42226568|FG000|Lead-in Period|Physician Decision|2|||
19772370|NCT03740919|42226569|FG001|Lead-in Period|Physician Decision|0|||
19772371|NCT03740919|42226570|FG002|Lead-in Period|Physician Decision|0|||
19772372|NCT03740919|42226571|FG003|Lead-in Period|Physician Decision|0|||
19772373|NCT03740919|42226568|FG000|Lead-in Period|Protocol Violation|1|||
19772374|NCT03740919|42226569|FG001|Lead-in Period|Protocol Violation|0|||
19772375|NCT03740919|42226570|FG002|Lead-in Period|Protocol Violation|0|||
19772376|NCT03740919|42226571|FG003|Lead-in Period|Protocol Violation|0|||
19772377|NCT03740919|42226568|FG000|Lead-in Period|Withdrawal by Subject|10|||
19772378|NCT03740919|42226569|FG001|Lead-in Period|Withdrawal by Subject|0|||
19772379|NCT03740919|42226570|FG002|Lead-in Period|Withdrawal by Subject|0|||
19772380|NCT03740919|42226571|FG003|Lead-in Period|Withdrawal by Subject|0|||
19690171|NCT00417482|42135981|FG001|Phase B 2nd 16 Weeks|Death|1|||
19690172|NCT00417482|42135982|FG002|Phase B 2nd 16 Weeks|Death|0|||
19690173|NCT00417248|42135996|FG000|Overall Study|Study Terminated|6|||
19690174|NCT00417248|42135996|FG000|Overall Study|Death|1|||
19690175|NCT00417248|42135996|FG000|Overall Study|Lack of Efficacy|1|||
19690176|NCT00392288|42136004|FG000|Overall Study|Adverse Event|17|||
19690177|NCT00392288|42136005|FG001|Overall Study|Adverse Event|7|||
19690178|NCT00392288|42136006|FG002|Overall Study|Adverse Event|8|||
19690179|NCT00392288|42136004|FG000|Overall Study|Lack of Efficacy|8|||
19690180|NCT00392288|42136005|FG001|Overall Study|Lack of Efficacy|5|||
19690181|NCT00392288|42136006|FG002|Overall Study|Lack of Efficacy|3|||
19690182|NCT00392288|42136004|FG000|Overall Study|Protocol Violation|1|||
19690183|NCT00392288|42136005|FG001|Overall Study|Protocol Violation|3|||
19690184|NCT00392288|42136006|FG002|Overall Study|Protocol Violation|1|||
19690185|NCT00392288|42136004|FG000|Overall Study|Lost to Follow-up|1|||
19690186|NCT00392288|42136005|FG001|Overall Study|Lost to Follow-up|1|||
19690187|NCT00392288|42136006|FG002|Overall Study|Lost to Follow-up|1|||
19690188|NCT00392288|42136004|FG000|Overall Study|Withdrawal by Subject|1|||
19690189|NCT00392288|42136005|FG001|Overall Study|Withdrawal by Subject|0|||
19690190|NCT00392288|42136006|FG002|Overall Study|Withdrawal by Subject|2|||
19772381|NCT03740919|42226568|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
19772382|NCT03740919|42226569|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
19772383|NCT03740919|42226570|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
19772384|NCT03740919|42226571|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
19772385|NCT03740919|42226568|FG000|Lead-in Period|Study Task Too Burdensome|1|||
19772386|NCT03740919|42226569|FG001|Lead-in Period|Study Task Too Burdensome|0|||
19772387|NCT03740919|42226570|FG002|Lead-in Period|Study Task Too Burdensome|0|||
19772388|NCT03740919|42226571|FG003|Lead-in Period|Study Task Too Burdensome|0|||
19772389|NCT03740919|42226568|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
19772390|NCT03740919|42226569|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
19772391|NCT03740919|42226570|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
19772392|NCT03740919|42226571|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
19772393|NCT03740919|42226568|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
19772394|NCT03740919|42226569|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
19772395|NCT03740919|42226570|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
19772396|NCT03740919|42226571|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
19772397|NCT03740919|42226568|FG000|Treatment Period|Adverse Event|0|||
19772398|NCT03740919|42226569|FG001|Treatment Period|Adverse Event|0|||
19772399|NCT03740919|42226570|FG002|Treatment Period|Adverse Event|2|||
19772400|NCT03740919|42226571|FG003|Treatment Period|Adverse Event|0|||
19772401|NCT03740919|42226568|FG000|Treatment Period|Protocol Violation|0|||
19772402|NCT03740919|42226569|FG001|Treatment Period|Protocol Violation|1|||
19772403|NCT03740919|42226570|FG002|Treatment Period|Protocol Violation|0|||
19772404|NCT03740919|42226571|FG003|Treatment Period|Protocol Violation|0|||
19772405|NCT03740919|42226568|FG000|Treatment Period|Withdrawal by Subject|0|||
19772406|NCT03740919|42226569|FG001|Treatment Period|Withdrawal by Subject|7|||
19772407|NCT03740919|42226570|FG002|Treatment Period|Withdrawal by Subject|6|||
19772408|NCT03740919|42226571|FG003|Treatment Period|Withdrawal by Subject|2|||
19772409|NCT03740919|42226568|FG000|Treatment Period|Terminated by Sponsor|0|||
19772410|NCT03740919|42226569|FG001|Treatment Period|Terminated by Sponsor|1|||
19772411|NCT03740919|42226570|FG002|Treatment Period|Terminated by Sponsor|0|||
19772412|NCT03740919|42226571|FG003|Treatment Period|Terminated by Sponsor|0|||
19772413|NCT03740919|42226568|FG000|Treatment Period|Issue with Insulin Pump|0|||
19772414|NCT03740919|42226569|FG001|Treatment Period|Issue with Insulin Pump|1|||
19772415|NCT03740919|42226570|FG002|Treatment Period|Issue with Insulin Pump|0|||
19772416|NCT03740919|42226571|FG003|Treatment Period|Issue with Insulin Pump|0|||
19690191|NCT00392288|42136004|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
19690192|NCT00392288|42136005|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
19772417|NCT03740919|42226568|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
19772418|NCT03740919|42226569|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
19772419|NCT03740919|42226570|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
19772420|NCT03740919|42226571|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
19772421|NCT03740919|42226568|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
19772422|NCT03740919|42226569|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
19772423|NCT03740919|42226570|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
19772424|NCT03740919|42226571|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
19772425|NCT03740919|42226568|FG000|Treatment Period|Not Completing Diary|0|||
19605948|NCT01004003|42054696|FG004|Overall Study|Adverse Event|2|||
19605949|NCT01004003|42054697|FG005|Overall Study|Adverse Event|2|||
19605950|NCT01004003|42054698|FG006|Overall Study|Adverse Event|7|||
19605951|NCT01004003|42054699|FG007|Overall Study|Adverse Event|21|||
19605952|NCT01004003|42054700|FG008|Overall Study|Adverse Event|6|||
19605953|NCT01004003|42054692|FG000|Overall Study|Refused to continue taking trial med.|0|||
19605954|NCT01004003|42054693|FG001|Overall Study|Refused to continue taking trial med.|0|||
19605955|NCT01004003|42054694|FG002|Overall Study|Refused to continue taking trial med.|0|||
19605956|NCT01004003|42054695|FG003|Overall Study|Refused to continue taking trial med.|0|||
19605957|NCT01004003|42054696|FG004|Overall Study|Refused to continue taking trial med.|0|||
19605958|NCT01004003|42054697|FG005|Overall Study|Refused to continue taking trial med.|0|||
19605959|NCT01004003|42054698|FG006|Overall Study|Refused to continue taking trial med.|0|||
19605960|NCT01004003|42054699|FG007|Overall Study|Refused to continue taking trial med.|0|||
19605961|NCT01004003|42054700|FG008|Overall Study|Refused to continue taking trial med.|2|||
19605962|NCT01004003|42054692|FG000|Overall Study|Other|0|||
19605963|NCT01004003|42054693|FG001|Overall Study|Other|0|||
19605964|NCT01004003|42054694|FG002|Overall Study|Other|0|||
19605965|NCT01004003|42054695|FG003|Overall Study|Other|0|||
19605966|NCT01004003|42054696|FG004|Overall Study|Other|0|||
19605967|NCT01004003|42054697|FG005|Overall Study|Other|1|||
19605968|NCT01004003|42054698|FG006|Overall Study|Other|0|||
19605969|NCT01004003|42054699|FG007|Overall Study|Other|0|||
19605970|NCT01004003|42054700|FG008|Overall Study|Other|0|||
19605971|NCT00943670|42054722|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
19605972|NCT00943670|42054722|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
19605973|NCT00943670|42054722|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
19605974|NCT00943670|42054722|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
19605975|NCT00943670|42054722|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
19605976|NCT00943670|42054722|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
19605977|NCT00943670|42054722|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
19605978|NCT00943670|42054722|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
19605979|NCT00943670|42054722|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
19605980|NCT00943670|42054722|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
19605981|NCT00938366|42054739|FG000|Overall Study|Withdrawal by Subject|1|||
19605982|NCT00938366|42054740|FG001|Overall Study|Withdrawal by Subject|0|||
19605983|NCT00943592|42054746|FG000|Overall Study|Death|3|||
19605984|NCT00943124|42054750|FG000|Period 1|Withdrawal by Subject|1|||
19605985|NCT00943124|42054751|FG001|Period 1|Withdrawal by Subject|1|||
19605986|NCT00943124|42054750|FG000|Period 1|Did Not Follow Study Procedures|1|||
19605987|NCT00943124|42054751|FG001|Period 1|Did Not Follow Study Procedures|0|||
19605988|NCT00943124|42054750|FG000|Period 1|Personal Reasons|0|||
19605989|NCT00943124|42054751|FG001|Period 1|Personal Reasons|1|||
19605990|NCT00492050|42054757|FG000|Overall Study|Adverse Event|1|||
19605991|NCT00492050|42054757|FG000|Overall Study|Lack of Efficacy|1|||
19605992|NCT00492050|42054757|FG000|Overall Study|Withdrawal by Subject|3|||
19605993|NCT00492050|42054757|FG000|Overall Study|Unable to collect SCT|2|||
19605994|NCT00492050|42054757|FG000|Overall Study|Progressive Disease|2|||
19605995|NCT00726622|42054763|FG000|Overall Study|Withdrawal by Subject|16|||
19605996|NCT00726622|42054764|FG001|Overall Study|Withdrawal by Subject|2|||
19605997|NCT00726622|42054763|FG000|Overall Study|Physician Decision|0|||
19605998|NCT00726622|42054764|FG001|Overall Study|Physician Decision|1|||
19605999|NCT00726622|42054763|FG000|Overall Study|Metastasis|2|||
19606000|NCT00726622|42054764|FG001|Overall Study|Metastasis|0|||
19606001|NCT00940316|42054773|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
19606002|NCT00940316|42054774|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
19606003|NCT00940316|42054775|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
19606004|NCT00940316|42054773|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
19606005|NCT00940316|42054774|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
19606006|NCT00940316|42054775|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
19606007|NCT00940316|42054773|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
19606008|NCT00940316|42054774|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
19606009|NCT00940316|42054775|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
19606010|NCT00940316|42054773|FG000|Treated After Cycle 5|Adverse Event|0|||
19606011|NCT00940316|42054774|FG001|Treated After Cycle 5|Adverse Event|0|||
19606012|NCT00940316|42054775|FG002|Treated After Cycle 5|Adverse Event|1|||
19606013|NCT00940316|42054773|FG000|Treated After Cycle 5|Progressive disease|0|||
19772426|NCT03740919|42226569|FG001|Treatment Period|Not Completing Diary|0|||
19606014|NCT00940316|42054774|FG001|Treated After Cycle 5|Progressive disease|1|||
19606015|NCT00940316|42054775|FG002|Treated After Cycle 5|Progressive disease|0|||
19606016|NCT00726388|42054791|FG000|Overall Study|Withdrawal by Subject|5|||
19606017|NCT00726388|42054791|FG000|Overall Study|Adverse Event|3|||
19606018|NCT00726388|42054791|FG000|Overall Study|Lost to Follow-up|10|||
19606019|NCT00726388|42054791|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
19606020|NCT00726388|42054791|FG000|Overall Study|Other|5|||
19606021|NCT00726388|42054791|FG000|Overall Study|Enrolled, Not Treated|79|||
19606022|NCT00572455|42054809|FG000|Stage I (14 Days)|Adverse Event|0|||
19606023|NCT00572455|42054810|FG001|Stage I (14 Days)|Adverse Event|0|||
19606024|NCT00572455|42054811|FG002|Stage I (14 Days)|Adverse Event|0|||
19606025|NCT00572455|42054812|FG003|Stage I (14 Days)|Adverse Event|0|||
19606026|NCT00572455|42054813|FG004|Stage I (14 Days)|Adverse Event|0|||
19606027|NCT00572455|42054814|FG005|Stage I (14 Days)|Adverse Event|3|||
19606028|NCT00572455|42054815|FG006|Stage I (14 Days)|Adverse Event|0|||
19606029|NCT00572455|42054816|FG007|Stage I (14 Days)|Adverse Event|0|||
19606030|NCT00572455|42054817|FG008|Stage I (14 Days)|Adverse Event|0|||
19606031|NCT00572455|42054818|FG009|Stage I (14 Days)|Adverse Event|0|||
19606032|NCT00572455|42054819|FG010|Stage I (14 Days)|Adverse Event|0|||
19606033|NCT00572455|42054820|FG011|Stage I (14 Days)|Adverse Event|0|||
19606034|NCT00572455|42054821|FG012|Stage I (14 Days)|Adverse Event|0|||
19606035|NCT00572455|42054822|FG013|Stage I (14 Days)|Adverse Event|0|||
19606036|NCT00572455|42054809|FG000|Stage I (14 Days)|Other|0|||
19606037|NCT00572455|42054810|FG001|Stage I (14 Days)|Other|0|||
19606038|NCT00572455|42054811|FG002|Stage I (14 Days)|Other|0|||
19606039|NCT00572455|42054812|FG003|Stage I (14 Days)|Other|0|||
19606040|NCT00572455|42054813|FG004|Stage I (14 Days)|Other|1|||
19606041|NCT00572455|42054814|FG005|Stage I (14 Days)|Other|0|||
19606042|NCT00572455|42054815|FG006|Stage I (14 Days)|Other|0|||
19606043|NCT00572455|42054816|FG007|Stage I (14 Days)|Other|0|||
19606044|NCT00572455|42054817|FG008|Stage I (14 Days)|Other|0|||
19606045|NCT00572455|42054818|FG009|Stage I (14 Days)|Other|0|||
19606046|NCT00572455|42054819|FG010|Stage I (14 Days)|Other|0|||
19606047|NCT00572455|42054820|FG011|Stage I (14 Days)|Other|0|||
19606048|NCT00572455|42054821|FG012|Stage I (14 Days)|Other|0|||
19606049|NCT00572455|42054822|FG013|Stage I (14 Days)|Other|0|||
19772427|NCT03740919|42226570|FG002|Treatment Period|Not Completing Diary|1|||
19772428|NCT03740919|42226571|FG003|Treatment Period|Not Completing Diary|0|||
19772429|NCT03740919|42226568|FG000|Treatment Period|Insulin Painful to Participant|0|||
19772430|NCT03740919|42226569|FG001|Treatment Period|Insulin Painful to Participant|0|||
19772431|NCT03740919|42226570|FG002|Treatment Period|Insulin Painful to Participant|1|||
19772432|NCT03740919|42226571|FG003|Treatment Period|Insulin Painful to Participant|0|||
19772433|NCT01335685|42226586|FG000|Overall Study|Study Terminated by Sponsor|2|||
19772434|NCT01335685|42226587|FG001|Overall Study|Study Terminated by Sponsor|1|||
19772435|NCT01335685|42226588|FG002|Overall Study|Study Terminated by Sponsor|1|||
19772436|NCT01335685|42226589|FG003|Overall Study|Study Terminated by Sponsor|10|||
19772437|NCT01335685|42226590|FG004|Overall Study|Study Terminated by Sponsor|0|||
19772438|NCT01335685|42226591|FG005|Overall Study|Study Terminated by Sponsor|4|||
19772439|NCT01335685|42226592|FG006|Overall Study|Study Terminated by Sponsor|2|||
19772440|NCT01335685|42226593|FG007|Overall Study|Study Terminated by Sponsor|3|||
19772441|NCT01335685|42226586|FG000|Overall Study|Withdrawal by Subject|1|||
19772442|NCT01335685|42226587|FG001|Overall Study|Withdrawal by Subject|0|||
19772443|NCT01335685|42226588|FG002|Overall Study|Withdrawal by Subject|0|||
19772444|NCT01335685|42226589|FG003|Overall Study|Withdrawal by Subject|1|||
19772445|NCT01335685|42226590|FG004|Overall Study|Withdrawal by Subject|0|||
19772446|NCT01335685|42226591|FG005|Overall Study|Withdrawal by Subject|0|||
19772447|NCT01335685|42226592|FG006|Overall Study|Withdrawal by Subject|0|||
19772448|NCT01335685|42226593|FG007|Overall Study|Withdrawal by Subject|0|||
19772449|NCT01335685|42226586|FG000|Overall Study|Reason not Specified|0|||
19772450|NCT01335685|42226587|FG001|Overall Study|Reason not Specified|0|||
19772451|NCT01335685|42226588|FG002|Overall Study|Reason not Specified|1|||
19772452|NCT01335685|42226589|FG003|Overall Study|Reason not Specified|0|||
19772453|NCT01335685|42226590|FG004|Overall Study|Reason not Specified|0|||
19606050|NCT00572455|42054809|FG000|Stage II (28 Days)|Adverse Event|0|||
19606051|NCT00572455|42054810|FG001|Stage II (28 Days)|Adverse Event|0|||
19606052|NCT00572455|42054811|FG002|Stage II (28 Days)|Adverse Event|0|||
19606053|NCT00572455|42054812|FG003|Stage II (28 Days)|Adverse Event|0|||
19606054|NCT00572455|42054813|FG004|Stage II (28 Days)|Adverse Event|0|||
19606055|NCT00572455|42054814|FG005|Stage II (28 Days)|Adverse Event|0|||
19606056|NCT00572455|42054815|FG006|Stage II (28 Days)|Adverse Event|0|||
19606057|NCT00572455|42054816|FG007|Stage II (28 Days)|Adverse Event|0|||
19772454|NCT01335685|42226591|FG005|Overall Study|Reason not Specified|1|||
19772455|NCT01335685|42226592|FG006|Overall Study|Reason not Specified|0|||
19772456|NCT01335685|42226593|FG007|Overall Study|Reason not Specified|0|||
19772457|NCT02926209|42226616|FG000|Study Cohort|Poor Bowel Preparation|1|||
19772458|NCT02926209|42226617|FG001|Study Cohort|Poor Bowel Preparation|0|||
19606058|NCT00572455|42054817|FG008|Stage II (28 Days)|Adverse Event|1|||
19606059|NCT00572455|42054818|FG009|Stage II (28 Days)|Adverse Event|3|||
19606060|NCT00572455|42054819|FG010|Stage II (28 Days)|Adverse Event|3|||
19772459|NCT03066999|42226626|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
19772460|NCT03066999|42226627|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
19772461|NCT02963922|42226641|FG000|Overall Study|Adverse Event|15|||
19772462|NCT02963922|42226642|FG001|Overall Study|Adverse Event|6|||
19772463|NCT02963922|42226641|FG000|Overall Study|Protocol deviation|6|||
19772464|NCT02963922|42226642|FG001|Overall Study|Protocol deviation|6|||
19772465|NCT02963922|42226641|FG000|Overall Study|Lack of Efficacy|1|||
19772466|NCT02963922|42226642|FG001|Overall Study|Lack of Efficacy|1|||
19772467|NCT02963922|42226641|FG000|Overall Study|Lost to Follow-up|2|||
19772468|NCT02963922|42226642|FG001|Overall Study|Lost to Follow-up|3|||
19772469|NCT02963922|42226641|FG000|Overall Study|Other|8|||
19772470|NCT02963922|42226642|FG001|Overall Study|Other|14|||
19772471|NCT02881567|42226648|FG000|Overall Study|Adverse Event|1|||
19690193|NCT00392288|42136006|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
19690194|NCT00392288|42136004|FG000|Overall Study|Other|3|||
19690195|NCT00392288|42136005|FG001|Overall Study|Other|4|||
19690196|NCT00392288|42136006|FG002|Overall Study|Other|1|||
19690197|NCT00417170|42136016|FG000|Overall Study|Adverse Event|1|||
19690198|NCT00417170|42136017|FG001|Overall Study|Adverse Event|1|||
19690199|NCT00417170|42136016|FG000|Overall Study|Withdrawal by Subject|1|||
19690200|NCT00417170|42136017|FG001|Overall Study|Withdrawal by Subject|1|||
19772472|NCT02881567|42226648|FG000|Overall Study|Lost to Follow-up|3|||
19690201|NCT00417170|42136016|FG000|Overall Study|Lost to Follow-up|0|||
19690202|NCT00417170|42136017|FG001|Overall Study|Lost to Follow-up|1|||
19690203|NCT00249873|42136025|FG000|Overall Study|Not treated|7|||
19690204|NCT00249873|42136026|FG001|Overall Study|Not treated|8|||
19690205|NCT00249873|42136025|FG000|Overall Study|Significant thrombocytopenia|9|||
19690206|NCT00249873|42136026|FG001|Overall Study|Significant thrombocytopenia|8|||
19690207|NCT00249873|42136025|FG000|Overall Study|Severe allergic reaction|8|||
19690208|NCT00249873|42136026|FG001|Overall Study|Severe allergic reaction|1|||
19690209|NCT00249873|42136025|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
19690210|NCT00249873|42136026|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
19690211|NCT00249873|42136025|FG000|Overall Study|Other Serious Adverse Event|86|||
19690212|NCT00249873|42136026|FG001|Overall Study|Other Serious Adverse Event|97|||
19690213|NCT00249873|42136025|FG000|Overall Study|Qualifying condition not present|20|||
19690214|NCT00249873|42136026|FG001|Overall Study|Qualifying condition not present|23|||
19690215|NCT00249873|42136025|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
19690216|NCT00249873|42136026|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
19690217|NCT00249873|42136025|FG000|Overall Study|Withdrawal by Subject|504|||
19690218|NCT00249873|42136026|FG001|Overall Study|Withdrawal by Subject|466|||
19690219|NCT00249873|42136025|FG000|Overall Study|Lost to Follow-up|4|||
19690220|NCT00249873|42136026|FG001|Overall Study|Lost to Follow-up|7|||
19690221|NCT00249873|42136025|FG000|Overall Study|Minor bleeding|99|||
19690222|NCT00249873|42136026|FG001|Overall Study|Minor bleeding|37|||
19690223|NCT00249873|42136025|FG000|Overall Study|Non-compliance|41|||
19690224|NCT00249873|42136026|FG001|Overall Study|Non-compliance|46|||
19690225|NCT00249873|42136025|FG000|Overall Study|Other non serious Adverse Event|112|||
19690226|NCT00249873|42136026|FG001|Overall Study|Other non serious Adverse Event|108|||
19690227|NCT00249873|42136025|FG000|Overall Study|Other contraindicated medication|1|||
19690228|NCT00249873|42136026|FG001|Overall Study|Other contraindicated medication|0|||
19690229|NCT00249873|42136025|FG000|Overall Study|Patient not wish to continue after May08|3|||
19690230|NCT00249873|42136026|FG001|Overall Study|Patient not wish to continue after May08|4|||
19690231|NCT00249873|42136025|FG000|Overall Study|Physician withdrew consent|59|||
19690232|NCT00249873|42136026|FG001|Overall Study|Physician withdrew consent|60|||
19690233|NCT00249873|42136025|FG000|Overall Study|Open label clopidogrel required|31|||
19690234|NCT00249873|42136026|FG001|Overall Study|Open label clopidogrel required|42|||
19690235|NCT00249873|42136025|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
19690236|NCT00249873|42136026|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
19690237|NCT00249873|42136025|FG000|Overall Study|Oral anticoagulant required|159|||
19690238|NCT00249873|42136026|FG001|Overall Study|Oral anticoagulant required|157|||
19690239|NCT00249873|42136025|FG000|Overall Study|Study drug intolerance|5|||
19690240|NCT00249873|42136026|FG001|Overall Study|Study drug intolerance|0|||
19690241|NCT00249873|42136025|FG000|Overall Study|Surgery/ procedure|9|||
19690242|NCT00249873|42136026|FG001|Overall Study|Surgery/ procedure|9|||
19690243|NCT00249873|42136025|FG000|Overall Study|Event related to cardiac condition|12|||
19690244|NCT00249873|42136026|FG001|Overall Study|Event related to cardiac condition|21|||
19690245|NCT00249873|42136025|FG000|Overall Study|Thromboembolic/outcome event|82|||
19690246|NCT00249873|42136026|FG001|Overall Study|Thromboembolic/outcome event|122|||
19690247|NCT00392210|42136034|FG000|First Voiding Trial|Physician Decision|2|||
19690248|NCT00392210|42136035|FG001|First Voiding Trial|Physician Decision|2|||
19690249|NCT00391976|42136044|FG000|Overall Study|Adverse Event|0|||
19690250|NCT00391976|42136045|FG001|Overall Study|Adverse Event|0|||
19772473|NCT02881567|42226648|FG000|Overall Study|Consent withdrawn|1|||
19772474|NCT02881567|42226648|FG000|Overall Study|Investigator decision|1|||
19772475|NCT02881567|42226648|FG000|Overall Study|Study terminated by sponsor|9|||
19772476|NCT02881567|42226648|FG000|Overall Study|Reason not Specified|3|||
19690251|NCT00391976|42136046|FG002|Overall Study|Adverse Event|1|||
19690252|NCT00391976|42136044|FG000|Overall Study|Withdrawal of consent|0|||
19690253|NCT00391976|42136045|FG001|Overall Study|Withdrawal of consent|1|||
19690254|NCT00391976|42136046|FG002|Overall Study|Withdrawal of consent|1|||
19690255|NCT00391976|42136044|FG000|Overall Study|Lost to Follow-up|1|||
19690256|NCT00391976|42136045|FG001|Overall Study|Lost to Follow-up|2|||
19690257|NCT00391976|42136046|FG002|Overall Study|Lost to Follow-up|0|||
19690258|NCT00391976|42136044|FG000|Overall Study|Inappropriate enrollment|1|||
19690259|NCT00391976|42136045|FG001|Overall Study|Inappropriate enrollment|1|||
19690260|NCT00391976|42136046|FG002|Overall Study|Inappropriate enrollment|0|||
19690261|NCT00391976|42136044|FG000|Overall Study|Protocol deviation/violation|4|||
19690262|NCT00391976|42136045|FG001|Overall Study|Protocol deviation/violation|2|||
19690263|NCT00391976|42136046|FG002|Overall Study|Protocol deviation/violation|1|||
19690264|NCT00391976|42136044|FG000|Overall Study|Recurrence/no eradication of infection|21|||
19690265|NCT00391976|42136045|FG001|Overall Study|Recurrence/no eradication of infection|19|||
19690266|NCT00391976|42136046|FG002|Overall Study|Recurrence/no eradication of infection|0|||
19690267|NCT00391976|42136044|FG000|Overall Study|Unable to classify|0|||
19690268|NCT00391976|42136045|FG001|Overall Study|Unable to classify|0|||
19690269|NCT00391976|42136046|FG002|Overall Study|Unable to classify|1|||
19690270|NCT00391976|42136044|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
19690271|NCT00391976|42136045|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
19690272|NCT00391976|42136046|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
19690273|NCT00391898|42136058|FG000|Overall Study|Adverse Event|3|||
19690274|NCT00391898|42136059|FG001|Overall Study|Adverse Event|0|||
19690275|NCT00391898|42136058|FG000|Overall Study|Other|8|||
19690276|NCT00391898|42136059|FG001|Overall Study|Other|10|||
19690277|NCT00391586|42136065|FG000|Overall Study|Progressive disease|13|||
19690278|NCT00391586|42136065|FG000|Overall Study|Adverse Event|5|||
19690279|NCT00391586|42136065|FG000|Overall Study|Physician Decision|2|||
19690280|NCT00391586|42136065|FG000|Overall Study|Death|4|||
19690281|NCT00391430|42136072|FG000|Overall Study|Withdrawal by Subject|3|||
19690282|NCT00391430|42136073|FG001|Overall Study|Withdrawal by Subject|0|||
19690283|NCT00391430|42136074|FG002|Overall Study|Withdrawal by Subject|12|||
19690284|NCT00391274|42136084|FG000|Overall Study|Death Due to Study Disease|55|||
19690285|NCT00391274|42136085|FG001|Overall Study|Death Due to Study Disease|45|||
19690286|NCT00391274|42136084|FG000|Overall Study|Lost to Follow-up|0|||
19690287|NCT00391274|42136085|FG001|Overall Study|Lost to Follow-up|3|||
19690288|NCT00391274|42136084|FG000|Overall Study|Physician Decision|4|||
19690289|NCT00391274|42136085|FG001|Overall Study|Physician Decision|2|||
19690290|NCT00391274|42136084|FG000|Overall Study|Withdrawal by Subject|0|||
19690291|NCT00391274|42136085|FG001|Overall Study|Withdrawal by Subject|3|||
19690292|NCT00391274|42136084|FG000|Overall Study|Death Due to Adverse Event|1|||
19690293|NCT00391274|42136085|FG001|Overall Study|Death Due to Adverse Event|3|||
19690294|NCT00391274|42136084|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
19690295|NCT00391274|42136085|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
19690296|NCT00391274|42136084|FG000|Overall Study|Death Not Study Related|0|||
19690297|NCT00391274|42136085|FG001|Overall Study|Death Not Study Related|1|||
19690298|NCT00391118|42136094|FG000|Overall Study|Adverse Event|3|||
19690299|NCT00391118|42136095|FG001|Overall Study|Adverse Event|10|||
19690300|NCT00391118|42136096|FG002|Overall Study|Adverse Event|7|||
19690301|NCT00391118|42136094|FG000|Overall Study|Lost to Follow-up|0|||
19690302|NCT00391118|42136095|FG001|Overall Study|Lost to Follow-up|2|||
19690303|NCT00391118|42136096|FG002|Overall Study|Lost to Follow-up|3|||
19690304|NCT00391118|42136094|FG000|Overall Study|Withdrawal by Subject|0|||
19690305|NCT00391118|42136095|FG001|Overall Study|Withdrawal by Subject|9|||
19690306|NCT00391118|42136096|FG002|Overall Study|Withdrawal by Subject|1|||
19690307|NCT00391118|42136094|FG000|Overall Study|Death|0|||
19690308|NCT00391118|42136095|FG001|Overall Study|Death|1|||
19690309|NCT00391118|42136096|FG002|Overall Study|Death|0|||
19690310|NCT00391118|42136094|FG000|Overall Study|Physician Decision|0|||
19690311|NCT00391118|42136095|FG001|Overall Study|Physician Decision|3|||
19690312|NCT00391118|42136096|FG002|Overall Study|Physician Decision|0|||
19690313|NCT00391118|42136094|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
19690314|NCT00391118|42136095|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
19690315|NCT00391118|42136096|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
19690316|NCT00391118|42136094|FG000|Overall Study|Progressive Disease|7|||
19690317|NCT00391118|42136095|FG001|Overall Study|Progressive Disease|26|||
19690318|NCT00391118|42136096|FG002|Overall Study|Progressive Disease|43|||
19690319|NCT00391118|42136094|FG000|Overall Study|Sponsor Decision|0|||
19690320|NCT00391118|42136095|FG001|Overall Study|Sponsor Decision|1|||
19690321|NCT00391118|42136096|FG002|Overall Study|Sponsor Decision|3|||
19690322|NCT00391118|42136094|FG000|Overall Study|Protocol Violation|1|||
19690323|NCT00391118|42136095|FG001|Overall Study|Protocol Violation|0|||
19690324|NCT00391118|42136096|FG002|Overall Study|Protocol Violation|0|||
19690325|NCT00390884|42136109|FG000|Overall Study|Withdrawal by Subject|2|||
19690326|NCT00390884|42136110|FG001|Overall Study|Withdrawal by Subject|2|||
19690327|NCT00365846|42136116|FG000|Overall Study|Lost to Follow-up|1|||
19690328|NCT00264537|42136126|FG000|Overall Study|Death|0|||
19690329|NCT00264537|42136127|FG001|Overall Study|Death|3|||
19690330|NCT00264537|42136128|FG002|Overall Study|Death|3|||
19690331|NCT00264537|42136129|FG003|Overall Study|Death|2|||
19690332|NCT00264537|42136126|FG000|Overall Study|Lost to Follow-up|3|||
19690333|NCT00264537|42136127|FG001|Overall Study|Lost to Follow-up|4|||
19690334|NCT00264537|42136128|FG002|Overall Study|Lost to Follow-up|7|||
19690335|NCT00264537|42136129|FG003|Overall Study|Lost to Follow-up|6|||
19690336|NCT00264537|42136126|FG000|Overall Study|Adverse Event|21|||
19690337|NCT00264537|42136127|FG001|Overall Study|Adverse Event|32|||
19690338|NCT00264537|42136128|FG002|Overall Study|Adverse Event|24|||
19690339|NCT00264537|42136129|FG003|Overall Study|Adverse Event|34|||
19690340|NCT00264537|42136126|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
19690341|NCT00264537|42136127|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
19690342|NCT00264537|42136128|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
19690343|NCT00264537|42136129|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
19690344|NCT00264537|42136126|FG000|Overall Study|Other|21|||
19690345|NCT00264537|42136127|FG001|Overall Study|Other|11|||
19690346|NCT00264537|42136128|FG002|Overall Study|Other|10|||
19690347|NCT00264537|42136129|FG003|Overall Study|Other|11|||
19690348|NCT00264537|42136126|FG000|Overall Study|Not treated|0|||
19690349|NCT00264537|42136127|FG001|Overall Study|Not treated|2|||
19690350|NCT00264537|42136128|FG002|Overall Study|Not treated|1|||
19690351|NCT00264537|42136129|FG003|Overall Study|Not treated|0|||
19690352|NCT00371462|42136143|FG000|Overall Study|Withdrawal by Subject|1|||
19690353|NCT00371462|42136144|FG001|Overall Study|Withdrawal by Subject|0|||
19690354|NCT00371462|42136143|FG000|Overall Study|Other|7|||
19690355|NCT00371462|42136144|FG001|Overall Study|Other|8|||
19690356|NCT00371150|42136152|FG000|Overall Study|Lost to Follow-up|3|||
19690357|NCT00371150|42136153|FG001|Overall Study|Lost to Follow-up|2|||
19690358|NCT00264303|42136165|FG000|Overall Study|Adverse Event|4|||
19690359|NCT00264303|42136166|FG001|Overall Study|Adverse Event|3|||
19690360|NCT00264303|42136165|FG000|Overall Study|Lack of Efficacy|10|||
19690361|NCT00264303|42136166|FG001|Overall Study|Lack of Efficacy|13|||
19690362|NCT00264303|42136165|FG000|Overall Study|Lost to Follow-up|3|||
19690363|NCT00264303|42136166|FG001|Overall Study|Lost to Follow-up|3|||
19690364|NCT00264303|42136165|FG000|Overall Study|Withdrawal by Subject|2|||
19690365|NCT00264303|42136166|FG001|Overall Study|Withdrawal by Subject|3|||
19690366|NCT00264303|42136165|FG000|Overall Study|Various reasons listed in study report|6|||
19690367|NCT00264303|42136166|FG001|Overall Study|Various reasons listed in study report|7|||
19690368|NCT00370682|42136175|FG000|Overall Study|Moved from area|0|||
19690369|NCT00370682|42136176|FG001|Overall Study|Moved from area|2|||
19690370|NCT00370682|42136177|FG002|Overall Study|Moved from area|0|||
19690371|NCT00370682|42136175|FG000|Overall Study|Lost to Follow-up|0|||
19690372|NCT00370682|42136176|FG001|Overall Study|Lost to Follow-up|1|||
19690373|NCT00370682|42136177|FG002|Overall Study|Lost to Follow-up|1|||
19690374|NCT00264147|42136194|FG000|Treatment I Period|Adverse Event|3|||
19690375|NCT00264147|42136195|FG001|Treatment I Period|Adverse Event|6|||
19690376|NCT00264147|42136196|FG002|Treatment I Period|Adverse Event|3|||
19690377|NCT00264147|42136197|FG003|Treatment I Period|Adverse Event|5|||
19690378|NCT00264147|42136198|FG004|Treatment I Period|Adverse Event|7|||
19690379|NCT00264147|42136199|FG005|Treatment I Period|Adverse Event|0|||
19690380|NCT00264147|42136194|FG000|Treatment I Period|Laboratory Adverse Event|0|||
19690381|NCT00264147|42136195|FG001|Treatment I Period|Laboratory Adverse Event|0|||
19690382|NCT00264147|42136196|FG002|Treatment I Period|Laboratory Adverse Event|0|||
19690383|NCT00264147|42136197|FG003|Treatment I Period|Laboratory Adverse Event|1|||
19690384|NCT00264147|42136198|FG004|Treatment I Period|Laboratory Adverse Event|0|||
19690385|NCT00264147|42136199|FG005|Treatment I Period|Laboratory Adverse Event|0|||
19690386|NCT00264147|42136194|FG000|Treatment I Period|Lack of Efficacy|6|||
19690387|NCT00264147|42136195|FG001|Treatment I Period|Lack of Efficacy|2|||
19690388|NCT00264147|42136196|FG002|Treatment I Period|Lack of Efficacy|8|||
19690389|NCT00264147|42136197|FG003|Treatment I Period|Lack of Efficacy|0|||
19690390|NCT00264147|42136198|FG004|Treatment I Period|Lack of Efficacy|1|||
19690391|NCT00264147|42136199|FG005|Treatment I Period|Lack of Efficacy|0|||
19690392|NCT00264147|42136194|FG000|Treatment I Period|Lost to Follow-up|1|||
19690393|NCT00264147|42136195|FG001|Treatment I Period|Lost to Follow-up|0|||
19690394|NCT00264147|42136196|FG002|Treatment I Period|Lost to Follow-up|0|||
19690395|NCT00264147|42136197|FG003|Treatment I Period|Lost to Follow-up|1|||
19690396|NCT00264147|42136198|FG004|Treatment I Period|Lost to Follow-up|1|||
19690397|NCT00264147|42136199|FG005|Treatment I Period|Lost to Follow-up|0|||
19690398|NCT00264147|42136194|FG000|Treatment I Period|Protocol Violation|2|||
19690399|NCT00264147|42136195|FG001|Treatment I Period|Protocol Violation|2|||
19690400|NCT00264147|42136196|FG002|Treatment I Period|Protocol Violation|0|||
19690401|NCT00264147|42136197|FG003|Treatment I Period|Protocol Violation|0|||
19690402|NCT00264147|42136198|FG004|Treatment I Period|Protocol Violation|0|||
19690403|NCT00264147|42136199|FG005|Treatment I Period|Protocol Violation|0|||
19690404|NCT00264147|42136194|FG000|Treatment I Period|Withdrawal by Subject|2|||
19690405|NCT00264147|42136195|FG001|Treatment I Period|Withdrawal by Subject|0|||
19690406|NCT00264147|42136196|FG002|Treatment I Period|Withdrawal by Subject|0|||
19690407|NCT00264147|42136197|FG003|Treatment I Period|Withdrawal by Subject|2|||
19690408|NCT00264147|42136198|FG004|Treatment I Period|Withdrawal by Subject|2|||
19690409|NCT00264147|42136199|FG005|Treatment I Period|Withdrawal by Subject|0|||
19690410|NCT00264147|42136194|FG000|Treatment I Period|Patient out of town for an extended time|0|||
19690411|NCT00264147|42136195|FG001|Treatment I Period|Patient out of town for an extended time|1|||
19690412|NCT00264147|42136196|FG002|Treatment I Period|Patient out of town for an extended time|0|||
19690413|NCT00264147|42136197|FG003|Treatment I Period|Patient out of town for an extended time|0|||
19690414|NCT00264147|42136198|FG004|Treatment I Period|Patient out of town for an extended time|0|||
19690415|NCT00264147|42136199|FG005|Treatment I Period|Patient out of town for an extended time|0|||
19690416|NCT00264147|42136194|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
19690417|NCT00264147|42136195|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
19690418|NCT00264147|42136196|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
19690419|NCT00264147|42136197|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
19690420|NCT00264147|42136198|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
19690421|NCT00264147|42136199|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
19690422|NCT00264147|42136194|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
19690423|NCT00264147|42136195|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
19690424|NCT00264147|42136196|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
19690425|NCT00264147|42136197|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
19690426|NCT00264147|42136198|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
19690427|NCT00264147|42136199|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
19690428|NCT00264147|42136194|FG000|Treatment II Period|Adverse Event|0|||
19690429|NCT00264147|42136195|FG001|Treatment II Period|Adverse Event|0|||
19690430|NCT00264147|42136196|FG002|Treatment II Period|Adverse Event|0|||
19690431|NCT00264147|42136197|FG003|Treatment II Period|Adverse Event|0|||
19690432|NCT00264147|42136198|FG004|Treatment II Period|Adverse Event|9|||
19690433|NCT00264147|42136199|FG005|Treatment II Period|Adverse Event|9|||
19690434|NCT00264147|42136194|FG000|Treatment II Period|Laboratory Adverse Event|0|||
19690435|NCT00264147|42136195|FG001|Treatment II Period|Laboratory Adverse Event|0|||
19690436|NCT00264147|42136196|FG002|Treatment II Period|Laboratory Adverse Event|0|||
19690437|NCT00264147|42136197|FG003|Treatment II Period|Laboratory Adverse Event|0|||
19606061|NCT00572455|42054820|FG011|Stage II (28 Days)|Adverse Event|4|||
19606062|NCT00572455|42054821|FG012|Stage II (28 Days)|Adverse Event|5|||
19606063|NCT00572455|42054822|FG013|Stage II (28 Days)|Adverse Event|1|||
19606064|NCT00572455|42054809|FG000|Stage II (28 Days)|Death|0|||
19606065|NCT00572455|42054810|FG001|Stage II (28 Days)|Death|0|||
19606066|NCT00572455|42054811|FG002|Stage II (28 Days)|Death|0|||
19606067|NCT00572455|42054812|FG003|Stage II (28 Days)|Death|0|||
19606068|NCT00572455|42054813|FG004|Stage II (28 Days)|Death|0|||
19606069|NCT00572455|42054814|FG005|Stage II (28 Days)|Death|0|||
19606070|NCT00572455|42054815|FG006|Stage II (28 Days)|Death|0|||
19606071|NCT00572455|42054816|FG007|Stage II (28 Days)|Death|0|||
19606072|NCT00572455|42054817|FG008|Stage II (28 Days)|Death|1|||
19606073|NCT00572455|42054818|FG009|Stage II (28 Days)|Death|0|||
19606074|NCT00572455|42054819|FG010|Stage II (28 Days)|Death|0|||
19606075|NCT00572455|42054820|FG011|Stage II (28 Days)|Death|0|||
19606076|NCT00572455|42054821|FG012|Stage II (28 Days)|Death|0|||
19606077|NCT00572455|42054822|FG013|Stage II (28 Days)|Death|0|||
19606078|NCT00572455|42054809|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
19606079|NCT00572455|42054810|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
19606080|NCT00572455|42054811|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
19606081|NCT00572455|42054812|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
19606082|NCT00572455|42054813|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
19606083|NCT00572455|42054814|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
19606084|NCT00572455|42054815|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
19606085|NCT00572455|42054816|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
19606086|NCT00572455|42054817|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
19606087|NCT00572455|42054818|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
19606088|NCT00572455|42054819|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
19606089|NCT00572455|42054820|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
19606090|NCT00572455|42054821|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
19606091|NCT00572455|42054822|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
19606092|NCT00572455|42054809|FG000|Stage II (28 Days)|Other|0|||
19606093|NCT00572455|42054810|FG001|Stage II (28 Days)|Other|0|||
19606094|NCT00572455|42054811|FG002|Stage II (28 Days)|Other|0|||
19606095|NCT00572455|42054812|FG003|Stage II (28 Days)|Other|0|||
19606096|NCT00572455|42054813|FG004|Stage II (28 Days)|Other|0|||
19606097|NCT00572455|42054814|FG005|Stage II (28 Days)|Other|0|||
19606098|NCT00572455|42054815|FG006|Stage II (28 Days)|Other|0|||
19606099|NCT00572455|42054816|FG007|Stage II (28 Days)|Other|0|||
19606100|NCT00572455|42054817|FG008|Stage II (28 Days)|Other|1|||
19606101|NCT00572455|42054818|FG009|Stage II (28 Days)|Other|0|||
19606102|NCT00572455|42054819|FG010|Stage II (28 Days)|Other|0|||
19606103|NCT00572455|42054820|FG011|Stage II (28 Days)|Other|0|||
19690438|NCT00264147|42136198|FG004|Treatment II Period|Laboratory Adverse Event|0|||
19690439|NCT00264147|42136199|FG005|Treatment II Period|Laboratory Adverse Event|1|||
19690440|NCT00264147|42136194|FG000|Treatment II Period|Lack of Efficacy|0|||
19690441|NCT00264147|42136195|FG001|Treatment II Period|Lack of Efficacy|0|||
19690442|NCT00264147|42136196|FG002|Treatment II Period|Lack of Efficacy|0|||
19690443|NCT00264147|42136197|FG003|Treatment II Period|Lack of Efficacy|0|||
19690444|NCT00264147|42136198|FG004|Treatment II Period|Lack of Efficacy|20|||
19772477|NCT02962674|42226652|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
19772478|NCT02962908|42226662|FG000|Overall Study|Lost to Follow-up|0|||
19772479|NCT02962908|42226663|FG001|Overall Study|Lost to Follow-up|3|||
19772480|NCT02962908|42226664|FG002|Overall Study|Lost to Follow-up|0|||
19772481|NCT02962908|42226665|FG003|Overall Study|Lost to Follow-up|1|||
19772482|NCT02962908|42226662|FG000|Overall Study|Withdrawal by Subject|0|||
19772483|NCT02962908|42226663|FG001|Overall Study|Withdrawal by Subject|3|||
19772484|NCT02962908|42226664|FG002|Overall Study|Withdrawal by Subject|0|||
19772485|NCT02962908|42226665|FG003|Overall Study|Withdrawal by Subject|2|||
19772486|NCT02962908|42226662|FG000|Overall Study|Protocol Violation|0|||
19772487|NCT02962908|42226663|FG001|Overall Study|Protocol Violation|1|||
19772488|NCT02962908|42226664|FG002|Overall Study|Protocol Violation|0|||
19772489|NCT02962908|42226665|FG003|Overall Study|Protocol Violation|0|||
19772490|NCT02962908|42226662|FG000|Overall Study|Physician Decision|0|||
19772491|NCT02962908|42226663|FG001|Overall Study|Physician Decision|1|||
19772492|NCT02962908|42226664|FG002|Overall Study|Physician Decision|0|||
19772493|NCT02962908|42226665|FG003|Overall Study|Physician Decision|0|||
19772494|NCT02962284|42226683|FG000|Overall Study|Death|2|||
19772495|NCT02962284|42226684|FG001|Overall Study|Death|0|||
19772496|NCT02962284|42226683|FG000|Overall Study|Progressive disease|2|||
19772497|NCT02962284|42226684|FG001|Overall Study|Progressive disease|3|||
19772498|NCT02962284|42226683|FG000|Overall Study|Withdrawal by Subject|1|||
19772499|NCT02962284|42226684|FG001|Overall Study|Withdrawal by Subject|0|||
19772500|NCT01344876|42226692|FG000|Overall Study|Adverse Event|0|||
19772501|NCT01344876|42226693|FG001|Overall Study|Adverse Event|0|||
19772502|NCT01344876|42226694|FG002|Overall Study|Adverse Event|0|||
19772503|NCT01344876|42226695|FG003|Overall Study|Adverse Event|0|||
19772504|NCT01344876|42226696|FG004|Overall Study|Adverse Event|1|||
19772505|NCT01344876|42226692|FG000|Overall Study|Withdrawal by Subject|0|||
19772506|NCT01344876|42226693|FG001|Overall Study|Withdrawal by Subject|0|||
19772507|NCT01344876|42226694|FG002|Overall Study|Withdrawal by Subject|1|||
19772508|NCT01344876|42226695|FG003|Overall Study|Withdrawal by Subject|0|||
19772509|NCT01344876|42226696|FG004|Overall Study|Withdrawal by Subject|0|||
19772510|NCT01344876|42226692|FG000|Overall Study|Definite progression of primary disease|1|||
19772511|NCT01344876|42226693|FG001|Overall Study|Definite progression of primary disease|0|||
19772512|NCT01344876|42226694|FG002|Overall Study|Definite progression of primary disease|0|||
19772513|NCT01344876|42226695|FG003|Overall Study|Definite progression of primary disease|3|||
19772514|NCT01344876|42226696|FG004|Overall Study|Definite progression of primary disease|0|||
19772515|NCT00026312|42226711|FG000|Overall Study|Adverse Event|0|||
19772516|NCT00026312|42226712|FG001|Overall Study|Adverse Event|32|||
19772517|NCT00026312|42226711|FG000|Overall Study|Death|1|||
19772518|NCT00026312|42226712|FG001|Overall Study|Death|7|||
19772519|NCT00026312|42226711|FG000|Overall Study|Lack of Efficacy|19|||
19772520|NCT00026312|42226712|FG001|Overall Study|Lack of Efficacy|114|||
19772521|NCT00026312|42226711|FG000|Overall Study|Lost to Follow-up|0|||
19772522|NCT00026312|42226712|FG001|Overall Study|Lost to Follow-up|5|||
19772523|NCT00026312|42226711|FG000|Overall Study|Physician Decision|1|||
19772524|NCT00026312|42226712|FG001|Overall Study|Physician Decision|37|||
19772525|NCT00026312|42226711|FG000|Overall Study|Protocol Violation|0|||
19772526|NCT00026312|42226712|FG001|Overall Study|Protocol Violation|3|||
19772527|NCT00026312|42226711|FG000|Overall Study|Withdrawal by Subject|1|||
19606104|NCT00572455|42054821|FG012|Stage II (28 Days)|Other|0|||
19606105|NCT00572455|42054822|FG013|Stage II (28 Days)|Other|0|||
19606106|NCT00572455|42054809|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
19606107|NCT00572455|42054810|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
19690445|NCT00264147|42136199|FG005|Treatment II Period|Lack of Efficacy|19|||
19690446|NCT00264147|42136194|FG000|Treatment II Period|Lost to Follow-up|0|||
19690447|NCT00264147|42136195|FG001|Treatment II Period|Lost to Follow-up|0|||
19690448|NCT00264147|42136196|FG002|Treatment II Period|Lost to Follow-up|0|||
19772528|NCT00026312|42226712|FG001|Overall Study|Withdrawal by Subject|6|||
19772529|NCT00026312|42226711|FG000|Overall Study|Ineligible|4|||
19772530|NCT00026312|42226712|FG001|Overall Study|Ineligible|5|||
19772531|NCT00026312|42226711|FG000|Overall Study|Entry onto another COG study|0|||
19772532|NCT00026312|42226712|FG001|Overall Study|Entry onto another COG study|1|||
19772533|NCT00026312|42226711|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
19772534|NCT00026312|42226712|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
19772535|NCT02846324|42226726|FG000|Overall Study|Other|1|||
19772536|NCT02846324|42226727|FG001|Overall Study|Other|0|||
19772537|NCT02846324|42226728|FG002|Overall Study|Other|0|||
19772538|NCT02846324|42226729|FG003|Overall Study|Other|0|||
19772539|NCT02846324|42226726|FG000|Overall Study|Withdrawal by Subject|1|||
19772540|NCT02846324|42226727|FG001|Overall Study|Withdrawal by Subject|0|||
19772541|NCT02846324|42226728|FG002|Overall Study|Withdrawal by Subject|4|||
19772542|NCT02846324|42226729|FG003|Overall Study|Withdrawal by Subject|0|||
19772543|NCT03161093|42226754|FG000|Overall Study|Protocol Violation|11|||
19772544|NCT03161093|42226755|FG001|Overall Study|Protocol Violation|14|||
19772545|NCT03161093|42226756|FG002|Overall Study|Protocol Violation|6|||
19772546|NCT03161093|42226757|FG003|Overall Study|Protocol Violation|13|||
19772547|NCT03161093|42226758|FG004|Overall Study|Protocol Violation|1|||
19772548|NCT03161093|42226759|FG005|Overall Study|Protocol Violation|0|||
19772549|NCT03161093|42226754|FG000|Overall Study|Adverse Event|5|||
19690449|NCT00264147|42136197|FG003|Treatment II Period|Lost to Follow-up|0|||
19690450|NCT00264147|42136198|FG004|Treatment II Period|Lost to Follow-up|1|||
19690451|NCT00264147|42136199|FG005|Treatment II Period|Lost to Follow-up|1|||
19690452|NCT00264147|42136194|FG000|Treatment II Period|Withdrawal by Subject|0|||
19690453|NCT00264147|42136195|FG001|Treatment II Period|Withdrawal by Subject|0|||
19690454|NCT00264147|42136196|FG002|Treatment II Period|Withdrawal by Subject|0|||
19690455|NCT00264147|42136197|FG003|Treatment II Period|Withdrawal by Subject|0|||
19772550|NCT03161093|42226755|FG001|Overall Study|Adverse Event|21|||
19772551|NCT03161093|42226756|FG002|Overall Study|Adverse Event|16|||
19772552|NCT03161093|42226757|FG003|Overall Study|Adverse Event|35|||
19772553|NCT03161093|42226758|FG004|Overall Study|Adverse Event|2|||
19772554|NCT03161093|42226759|FG005|Overall Study|Adverse Event|1|||
19772555|NCT03161093|42226754|FG000|Overall Study|Lack of Efficacy|9|||
19772556|NCT03161093|42226755|FG001|Overall Study|Lack of Efficacy|13|||
19772557|NCT03161093|42226756|FG002|Overall Study|Lack of Efficacy|9|||
19772558|NCT03161093|42226757|FG003|Overall Study|Lack of Efficacy|24|||
19772559|NCT03161093|42226758|FG004|Overall Study|Lack of Efficacy|4|||
19772560|NCT03161093|42226759|FG005|Overall Study|Lack of Efficacy|1|||
19772561|NCT03161093|42226754|FG000|Overall Study|Physician Decision|0|||
19772562|NCT03161093|42226755|FG001|Overall Study|Physician Decision|1|||
19772563|NCT03161093|42226756|FG002|Overall Study|Physician Decision|0|||
19772564|NCT03161093|42226757|FG003|Overall Study|Physician Decision|2|||
19772565|NCT03161093|42226758|FG004|Overall Study|Physician Decision|17|||
19772566|NCT03161093|42226759|FG005|Overall Study|Physician Decision|15|||
19772567|NCT03161093|42226754|FG000|Overall Study|Withdrawal by Subject|24|||
19772568|NCT03161093|42226755|FG001|Overall Study|Withdrawal by Subject|73|||
19772569|NCT03161093|42226756|FG002|Overall Study|Withdrawal by Subject|44|||
19772570|NCT03161093|42226757|FG003|Overall Study|Withdrawal by Subject|97|||
19772571|NCT03161093|42226758|FG004|Overall Study|Withdrawal by Subject|11|||
19772572|NCT03161093|42226759|FG005|Overall Study|Withdrawal by Subject|10|||
19772573|NCT03161093|42226754|FG000|Overall Study|Lost to Follow-up|3|||
19772574|NCT03161093|42226755|FG001|Overall Study|Lost to Follow-up|12|||
19772575|NCT03161093|42226756|FG002|Overall Study|Lost to Follow-up|4|||
19772576|NCT03161093|42226757|FG003|Overall Study|Lost to Follow-up|7|||
19772577|NCT03161093|42226758|FG004|Overall Study|Lost to Follow-up|8|||
19772578|NCT03161093|42226759|FG005|Overall Study|Lost to Follow-up|13|||
19772579|NCT03161093|42226754|FG000|Overall Study|Death|3|||
19772580|NCT03161093|42226755|FG001|Overall Study|Death|9|||
19772581|NCT03161093|42226756|FG002|Overall Study|Death|7|||
19772582|NCT03161093|42226757|FG003|Overall Study|Death|9|||
19772583|NCT03161093|42226758|FG004|Overall Study|Death|0|||
19772584|NCT03161093|42226759|FG005|Overall Study|Death|0|||
19772585|NCT03161093|42226754|FG000|Overall Study|Unknown - Not reported|0|||
19772586|NCT03161093|42226755|FG001|Overall Study|Unknown - Not reported|1|||
19772587|NCT03161093|42226756|FG002|Overall Study|Unknown - Not reported|0|||
19772588|NCT03161093|42226757|FG003|Overall Study|Unknown - Not reported|0|||
19772589|NCT03161093|42226758|FG004|Overall Study|Unknown - Not reported|0|||
19772590|NCT03161093|42226759|FG005|Overall Study|Unknown - Not reported|1|||
19772591|NCT02847650|42226780|FG000|Overall Study|Adverse Event|2|||
19772592|NCT02847650|42226781|FG001|Overall Study|Adverse Event|4|||
19772593|NCT02847650|42226780|FG000|Overall Study|Lost to Follow-up|1|||
19690456|NCT00264147|42136198|FG004|Treatment II Period|Withdrawal by Subject|3|||
19690457|NCT00264147|42136199|FG005|Treatment II Period|Withdrawal by Subject|2|||
19772594|NCT02847650|42226781|FG001|Overall Study|Lost to Follow-up|0|||
19772595|NCT02847650|42226780|FG000|Overall Study|Protocol Violation|0|||
19772596|NCT02847650|42226781|FG001|Overall Study|Protocol Violation|1|||
19772597|NCT02847650|42226780|FG000|Overall Study|Withdrawal by Subject|1|||
19772598|NCT02847650|42226781|FG001|Overall Study|Withdrawal by Subject|1|||
19772599|NCT02847494|42226789|FG000|Overall Study|Lost to Follow-up|8|||
19772600|NCT02847494|42226790|FG001|Overall Study|Lost to Follow-up|5|||
19772601|NCT02554253|42226798|FG000|Overall Study|ineligible after enrollment|1|||
19772602|NCT02554253|42226799|FG001|Overall Study|ineligible after enrollment|0|||
19772603|NCT02554253|42226798|FG000|Overall Study|converted to transcatheter procedure|0|||
19772604|NCT02554253|42226799|FG001|Overall Study|converted to transcatheter procedure|1|||
19772605|NCT02554253|42226798|FG000|Overall Study|received both drugs|0|||
19772606|NCT02554253|42226799|FG001|Overall Study|received both drugs|1|||
19772607|NCT03157583|42226806|FG000|Overall Study|Other (did not meet study criteria)|1|||
19772608|NCT02842736|42226824|FG000|Overall Study|Lost to Follow-up|13|||
19772609|NCT02842736|42226824|FG000|Overall Study|Intervention for menstrual bleeding|17|||
19772610|NCT02842736|42226824|FG000|Overall Study|Withdrawal by Subject|4|||
19772611|NCT02842736|42226824|FG000|Overall Study|Pregnancy|3|||
19772612|NCT02842736|42226824|FG000|Overall Study|Hysterectomy for fibroids|2|||
19772613|NCT02842736|42226824|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
19772614|NCT02842736|42226824|FG000|Overall Study|IUD: Mirena|1|||
19690458|NCT00264147|42136194|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
19772615|NCT01307033|42226830|FG000|8-week Double-blind Period|Adverse Event|2|||
19772616|NCT01307033|42226831|FG001|8-week Double-blind Period|Adverse Event|0|||
19772617|NCT01307033|42226832|FG002|8-week Double-blind Period|Adverse Event|0|||
19772618|NCT01307033|42226833|FG003|8-week Double-blind Period|Adverse Event|0|||
19772619|NCT01307033|42226830|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
19772620|NCT01307033|42226831|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
19772621|NCT01307033|42226832|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
19772622|NCT01307033|42226833|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
19772623|NCT01307033|42226830|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
19772624|NCT01307033|42226831|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
19772625|NCT01307033|42226832|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
19772626|NCT01307033|42226833|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
19772627|NCT01307033|42226830|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
19772628|NCT01307033|42226831|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
19772629|NCT01307033|42226832|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
19772630|NCT01307033|42226833|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
19772631|NCT01307033|42226830|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
19772632|NCT01307033|42226831|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
19772633|NCT01307033|42226832|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
19772634|NCT01307033|42226833|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
19772635|NCT01307033|42226830|FG000|44-week Open-label Extension|Adverse Event|0|||
19772636|NCT01307033|42226831|FG001|44-week Open-label Extension|Adverse Event|0|||
19772637|NCT01307033|42226832|FG002|44-week Open-label Extension|Adverse Event|2|||
19772638|NCT01307033|42226833|FG003|44-week Open-label Extension|Adverse Event|1|||
19772639|NCT01307033|42226830|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
19772640|NCT01307033|42226831|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
19772641|NCT01307033|42226832|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
19772642|NCT01307033|42226833|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
19772643|NCT01307033|42226830|FG000|44-week Open-label Extension|Physician Decision|0|||
19772644|NCT01307033|42226831|FG001|44-week Open-label Extension|Physician Decision|0|||
19690459|NCT00264147|42136195|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
19690460|NCT00264147|42136196|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
19690461|NCT00264147|42136197|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
19690462|NCT00264147|42136198|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
19690463|NCT00264147|42136199|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
19690464|NCT00263757|42136215|FG000|Overall Study|Withdrawal by Subject|5|||
19690465|NCT00263757|42136216|FG001|Overall Study|Withdrawal by Subject|4|||
19690466|NCT00263757|42136215|FG000|Overall Study|Screen failure|0|||
19690467|NCT00263757|42136216|FG001|Overall Study|Screen failure|1|||
19690468|NCT00263757|42136215|FG000|Overall Study|Adverse Event|3|||
19690469|NCT00263757|42136216|FG001|Overall Study|Adverse Event|3|||
19690470|NCT00263211|42136224|FG000|Overall Study|Death|1|||
19690471|NCT00263211|42136225|FG001|Overall Study|Death|0|||
19690472|NCT00263211|42136224|FG000|Overall Study|Withdrawal by Subject|3|||
19690473|NCT00263211|42136225|FG001|Overall Study|Withdrawal by Subject|0|||
19690474|NCT00263211|42136224|FG000|Overall Study|Protocol Violation|1|||
19690475|NCT00263211|42136225|FG001|Overall Study|Protocol Violation|0|||
19690476|NCT00263211|42136224|FG000|Overall Study|Disease Progression|0|||
19772645|NCT01307033|42226832|FG002|44-week Open-label Extension|Physician Decision|1|||
19772646|NCT01307033|42226833|FG003|44-week Open-label Extension|Physician Decision|0|||
19772647|NCT01307033|42226830|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
19772648|NCT01307033|42226831|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
19772649|NCT01307033|42226832|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
19772650|NCT01307033|42226833|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
19772651|NCT01307033|42226830|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
19772652|NCT01307033|42226831|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
19772653|NCT01307033|42226832|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
19690477|NCT00263211|42136225|FG001|Overall Study|Disease Progression|1|||
19690478|NCT00248625|42136236|FG000|Overall Study|Withdrawal by Subject|0|||
19772654|NCT01307033|42226833|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
19772655|NCT01307033|42226830|FG000|44-week Open-label Extension|Death|0|||
19772656|NCT01307033|42226831|FG001|44-week Open-label Extension|Death|0|||
19772657|NCT01307033|42226832|FG002|44-week Open-label Extension|Death|0|||
19772658|NCT01307033|42226833|FG003|44-week Open-label Extension|Death|1|||
19772659|NCT02844920|42226845|FG000|Overall Study|Lost to Follow-up|2|||
19772660|NCT03158311|42226852|FG000|Overall Study|Subject/Guardian Decision|10|||
19772661|NCT03158311|42226853|FG001|Overall Study|Subject/Guardian Decision|6|||
19772662|NCT03158311|42226854|FG002|Overall Study|Subject/Guardian Decision|11|||
19772663|NCT03158311|42226852|FG000|Overall Study|Adverse Event|5|||
19772664|NCT03158311|42226853|FG001|Overall Study|Adverse Event|3|||
19772665|NCT03158311|42226854|FG002|Overall Study|Adverse Event|3|||
19772666|NCT03158311|42226852|FG000|Overall Study|Techinical Problems|3|||
19772667|NCT03158311|42226853|FG001|Overall Study|Techinical Problems|1|||
19772668|NCT03158311|42226854|FG002|Overall Study|Techinical Problems|5|||
19772669|NCT03158311|42226852|FG000|Overall Study|Physician Decision|2|||
19772670|NCT03158311|42226853|FG001|Overall Study|Physician Decision|3|||
19772671|NCT03158311|42226854|FG002|Overall Study|Physician Decision|7|||
19690479|NCT00248625|42136237|FG001|Overall Study|Withdrawal by Subject|2|||
19690480|NCT00262821|42136245|FG000|Overall Study|Ineligible - wrong stage|0|||
19690481|NCT00262821|42136246|FG001|Overall Study|Ineligible - wrong stage|3|||
19690482|NCT00262821|42136245|FG000|Overall Study|Ineligible - wrong cell type|2|||
19690483|NCT00262821|42136246|FG001|Overall Study|Ineligible - wrong cell type|2|||
19690484|NCT00262821|42136245|FG000|Overall Study|Ineligible - wrong primary|0|||
19690485|NCT00262821|42136246|FG001|Overall Study|Ineligible - wrong primary|1|||
19690486|NCT00262821|42136245|FG000|Overall Study|Ineligible - inadequate pathology|1|||
19690487|NCT00262821|42136246|FG001|Overall Study|Ineligible - inadequate pathology|3|||
19690488|NCT00262821|42136245|FG000|Overall Study|Ineligible - elevated creatinine|0|||
19690489|NCT00262821|42136246|FG001|Overall Study|Ineligible - elevated creatinine|2|||
19690490|NCT00262821|42136245|FG000|Overall Study|Ineligible - required test not done|1|||
19690491|NCT00262821|42136246|FG001|Overall Study|Ineligible - required test not done|4|||
19690492|NCT00262821|42136245|FG000|Overall Study|Inevaluable - inadequate data|0|||
19690493|NCT00262821|42136246|FG001|Overall Study|Inevaluable - inadequate data|4|||
19690494|NCT00262743|42136254|FG000|Overall Study|Adverse Event|0|||
19690495|NCT00262743|42136255|FG001|Overall Study|Adverse Event|9|||
19690496|NCT00262743|42136254|FG000|Overall Study|Disease progression|0|||
19690497|NCT00262743|42136255|FG001|Overall Study|Disease progression|3|||
19690498|NCT00262119|42136262|FG000|Overall Study|Lost to Follow-up|38|||
19690499|NCT00262119|42136263|FG001|Overall Study|Lost to Follow-up|51|||
19690500|NCT00262119|42136264|FG002|Overall Study|Lost to Follow-up|42|||
19690501|NCT00262119|42136262|FG000|Overall Study|Death|20|||
19690502|NCT00262119|42136263|FG001|Overall Study|Death|19|||
19690503|NCT00262119|42136264|FG002|Overall Study|Death|16|||
19690504|NCT00170950|42136274|FG000|Overall Study|Death|236|||
19690505|NCT00170950|42136275|FG001|Overall Study|Death|274|||
19690506|NCT00170950|42136274|FG000|Overall Study|Withdrawal by Subject|496|||
19690507|NCT00170950|42136275|FG001|Overall Study|Withdrawal by Subject|498|||
19690508|NCT00170950|42136274|FG000|Overall Study|Lost to Follow-up|134|||
19690509|NCT00170950|42136275|FG001|Overall Study|Lost to Follow-up|115|||
19690510|NCT00170950|42136274|FG000|Overall Study|Missing|2|||
19690511|NCT00170950|42136275|FG001|Overall Study|Missing|1|||
19690512|NCT00170950|42136274|FG000|Overall Study|Termination Data Not Recorded|17|||
19690513|NCT00170950|42136275|FG001|Overall Study|Termination Data Not Recorded|22|||
19690514|NCT00239577|42136285|FG000|Primary Phase|Adverse Event|0|||
19690515|NCT00239577|42136286|FG001|Primary Phase|Adverse Event|0|||
19690516|NCT00239577|42136287|FG002|Primary Phase|Adverse Event|1|||
19690517|NCT00239577|42136288|FG003|Primary Phase|Adverse Event|0|||
19690518|NCT00239577|42136285|FG000|Primary Phase|Other|5|||
19690519|NCT00239577|42136286|FG001|Primary Phase|Other|3|||
19690520|NCT00239577|42136287|FG002|Primary Phase|Other|2|||
19690521|NCT00239577|42136288|FG003|Primary Phase|Other|0|||
19690522|NCT00262041|42136304|FG000|Overall Study|Withdrawal by Subject|0|||
19690523|NCT00262041|42136305|FG001|Overall Study|Withdrawal by Subject|3|||
19690524|NCT00262041|42136306|FG002|Overall Study|Withdrawal by Subject|1|||
19690525|NCT00262041|42136304|FG000|Overall Study|Lost to Follow-up|1|||
19690526|NCT00262041|42136305|FG001|Overall Study|Lost to Follow-up|1|||
19690527|NCT00262041|42136306|FG002|Overall Study|Lost to Follow-up|5|||
19690528|NCT00262041|42136304|FG000|Overall Study|Unable to classify|1|||
19690529|NCT00262041|42136305|FG001|Overall Study|Unable to classify|0|||
19690530|NCT00262041|42136306|FG002|Overall Study|Unable to classify|0|||
19690531|NCT00208767|42136322|FG000|Overall Study|Adverse Event|9|||
19690532|NCT00208767|42136323|FG001|Overall Study|Adverse Event|1|||
19690533|NCT00208767|42136322|FG000|Overall Study|Withdrawal by Subject|14|||
19690534|NCT00208767|42136323|FG001|Overall Study|Withdrawal by Subject|3|||
19690535|NCT00208767|42136322|FG000|Overall Study|Death|1|||
19690536|NCT00208767|42136323|FG001|Overall Study|Death|0|||
19690537|NCT00208767|42136322|FG000|Overall Study|Lost to Follow-up|3|||
19690538|NCT00208767|42136323|FG001|Overall Study|Lost to Follow-up|3|||
19690539|NCT00390806|42136331|FG000|Overall Study|Lost to Follow-up|7|||
19690540|NCT00390806|42136332|FG001|Overall Study|Lost to Follow-up|6|||
19690541|NCT00390806|42136331|FG000|Overall Study|Protocol Violation|2|||
19690542|NCT00390806|42136332|FG001|Overall Study|Protocol Violation|2|||
19690543|NCT00390806|42136331|FG000|Overall Study|Withdrawal by Subject|12|||
19690544|NCT00390806|42136332|FG001|Overall Study|Withdrawal by Subject|15|||
19690545|NCT00390806|42136331|FG000|Overall Study|Investigator Decision|4|||
19690546|NCT00390806|42136332|FG001|Overall Study|Investigator Decision|6|||
19690547|NCT00390806|42136331|FG000|Overall Study|Death|1|||
19690548|NCT00390806|42136332|FG001|Overall Study|Death|0|||
19690549|NCT00390806|42136331|FG000|Overall Study|Physician Decision|0|||
19690550|NCT00390806|42136332|FG001|Overall Study|Physician Decision|1|||
19690551|NCT00390806|42136331|FG000|Overall Study|Ongoing|4|||
19690552|NCT00390806|42136332|FG001|Overall Study|Ongoing|2|||
19690553|NCT00390572|42136340|FG000|Overall Study|Lost to Follow-up|8|||
19690554|NCT00390572|42136341|FG001|Overall Study|Lost to Follow-up|4|||
19690555|NCT00390572|42136340|FG000|Overall Study|health condition|0|||
19690556|NCT00390572|42136341|FG001|Overall Study|health condition|1|||
19690557|NCT00390416|42136351|FG000|Overall Study|Withdrawal by Subject|1|||
19690558|NCT00390416|42136351|FG000|Overall Study|Not treated|3|||
19690559|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
19690560|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
19690561|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
19690562|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
19690563|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
19690564|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
19690565|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
19690566|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
19690567|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
19690568|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
19690569|NCT00261495|42136357|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
19690570|NCT00261495|42136358|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
19690571|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
19690572|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
19690573|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
19690574|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
19690575|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
19690576|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
19690577|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
19690578|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
19690579|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
19690580|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
19690581|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
19690582|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
19690583|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
19690584|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
19690585|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
19690586|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
19690587|NCT00261495|42136357|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
19690588|NCT00261495|42136358|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
19690589|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
19690590|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
19690591|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
19690592|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
19690593|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
19690594|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
19690595|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19690596|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
19690597|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
19690598|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
19690599|NCT00261495|42136357|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
19690600|NCT00261495|42136358|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19772672|NCT03158311|42226852|FG000|Overall Study|Lost to Follow-up|1|||
19772673|NCT03158311|42226853|FG001|Overall Study|Lost to Follow-up|1|||
19772674|NCT03158311|42226854|FG002|Overall Study|Lost to Follow-up|1|||
19772675|NCT03158311|42226852|FG000|Overall Study|Sponsor decision|1|||
19772676|NCT03158311|42226853|FG001|Overall Study|Sponsor decision|0|||
19772677|NCT03158311|42226854|FG002|Overall Study|Sponsor decision|0|||
19772678|NCT03158311|42226852|FG000|Overall Study|Pregnancy|0|||
19772679|NCT03158311|42226853|FG001|Overall Study|Pregnancy|2|||
19772680|NCT03158311|42226854|FG002|Overall Study|Pregnancy|0|||
19772681|NCT03158311|42226852|FG000|Overall Study|Randomized in error|0|||
19772682|NCT03158311|42226853|FG001|Overall Study|Randomized in error|0|||
19772683|NCT03158311|42226854|FG002|Overall Study|Randomized in error|1|||
19772684|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
19772685|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
19772686|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
19772687|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
19772688|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
19690601|NCT00168844|42136367|FG000|Overall Study|Adverse Event|31|||
19690602|NCT00168844|42136368|FG001|Overall Study|Adverse Event|32|||
19690603|NCT00168844|42136369|FG002|Overall Study|Adverse Event|48|||
19690604|NCT00168844|42136367|FG000|Overall Study|Lost to Follow-up|4|||
19690605|NCT00168844|42136368|FG001|Overall Study|Lost to Follow-up|5|||
19690606|NCT00168844|42136369|FG002|Overall Study|Lost to Follow-up|11|||
19690607|NCT00168844|42136367|FG000|Overall Study|Withdrawal by Subject|12|||
19772689|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
19772690|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
19772691|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
19772692|NCT01336621|42226866|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
19772693|NCT01336621|42226866|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
19772694|NCT01336621|42226866|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
19772695|NCT01336621|42226866|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
19772696|NCT01336621|42226866|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
19772697|NCT01336621|42226866|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
19772698|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
19772699|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
19772700|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
19772701|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
19772702|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
19772703|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
19772704|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
19772705|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
19772706|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
19772707|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
19690608|NCT00168844|42136368|FG001|Overall Study|Withdrawal by Subject|9|||
19690609|NCT00168844|42136369|FG002|Overall Study|Withdrawal by Subject|19|||
19690610|NCT00168844|42136367|FG000|Overall Study|Protocol Violation|2|||
19690611|NCT00168844|42136368|FG001|Overall Study|Protocol Violation|2|||
19690612|NCT00168844|42136369|FG002|Overall Study|Protocol Violation|4|||
19690613|NCT00168844|42136367|FG000|Overall Study|Other|6|||
19690614|NCT00168844|42136368|FG001|Overall Study|Other|7|||
19690615|NCT00168844|42136369|FG002|Overall Study|Other|9|||
19690616|NCT00365456|42136377|FG000|Trial Period I (12 Months)|Adverse Event|84|||
19690617|NCT00365456|42136378|FG001|Trial Period I (12 Months)|Adverse Event|0|||
19690618|NCT00365456|42136377|FG000|Trial Period I (12 Months)|Non-compliance|3|||
19690619|NCT00365456|42136378|FG001|Trial Period I (12 Months)|Non-compliance|0|||
19690620|NCT00365456|42136377|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
19690621|NCT00365456|42136378|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
19690622|NCT00365456|42136377|FG000|Trial Period I (12 Months)|Other|11|||
19690623|NCT00365456|42136378|FG001|Trial Period I (12 Months)|Other|0|||
19690624|NCT00365456|42136377|FG000|Trial Period II (12 Months)|Adverse Event|0|||
19690625|NCT00365456|42136378|FG001|Trial Period II (12 Months)|Adverse Event|6|||
19690626|NCT00365456|42136377|FG000|Trial Period II (12 Months)|Non-compliance|0|||
19690627|NCT00365456|42136378|FG001|Trial Period II (12 Months)|Non-compliance|2|||
19690628|NCT00365456|42136377|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
19690629|NCT00365456|42136378|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
19690630|NCT00365456|42136377|FG000|Trial Period II (12 Months)|Other|0|||
19690631|NCT00365456|42136378|FG001|Trial Period II (12 Months)|Other|1|||
19690632|NCT00365456|42136377|FG000|Trial Period III (12 Months)|Adverse Event|13|||
19690633|NCT00365456|42136378|FG001|Trial Period III (12 Months)|Adverse Event|3|||
19690634|NCT00365456|42136377|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
19690635|NCT00365456|42136378|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
19690636|NCT00365456|42136377|FG000|Trial Period III (12 Months)|Other|1|||
19690637|NCT00365456|42136378|FG001|Trial Period III (12 Months)|Other|1|||
19690638|NCT00147238|42136384|FG000|Overall Study|Inevaluable|8|||
19690639|NCT00206427|42136388|FG000|Overall Study|Adverse Event|2|||
19690640|NCT00146848|42136395|FG000|Pre-randomization|Death|19|||
19690641|NCT00146848|42136396|FG001|Pre-randomization|Death|0|||
19690642|NCT00146848|42136397|FG002|Pre-randomization|Death|0|||
19690643|NCT00146848|42136395|FG000|Pre-randomization|Lost to Follow-up|70|||
19690644|NCT00146848|42136396|FG001|Pre-randomization|Lost to Follow-up|0|||
19690645|NCT00146848|42136397|FG002|Pre-randomization|Lost to Follow-up|0|||
19690646|NCT00146848|42136395|FG000|Pre-randomization|Physician Decision|8|||
19690647|NCT00146848|42136396|FG001|Pre-randomization|Physician Decision|0|||
19690648|NCT00146848|42136397|FG002|Pre-randomization|Physician Decision|0|||
19690649|NCT00146848|42136395|FG000|Pre-randomization|Protocol Violation|172|||
19690650|NCT00146848|42136396|FG001|Pre-randomization|Protocol Violation|0|||
19690651|NCT00146848|42136397|FG002|Pre-randomization|Protocol Violation|0|||
19690652|NCT00146848|42136395|FG000|Pre-randomization|Withdrawal by Subject|40|||
19690653|NCT00146848|42136396|FG001|Pre-randomization|Withdrawal by Subject|0|||
19690654|NCT00146848|42136397|FG002|Pre-randomization|Withdrawal by Subject|0|||
19690655|NCT00146848|42136395|FG000|Post-randomization|Lost to Follow-up|12|||
19690656|NCT00146848|42136396|FG001|Post-randomization|Lost to Follow-up|15|||
19690657|NCT00146848|42136397|FG002|Post-randomization|Lost to Follow-up|12|||
19690658|NCT00146848|42136395|FG000|Post-randomization|Withdrawn|26|||
19690659|NCT00146848|42136396|FG001|Post-randomization|Withdrawn|32|||
19690660|NCT00146848|42136397|FG002|Post-randomization|Withdrawn|27|||
19690661|NCT00205881|42136405|FG000|Overall Study|Withdrawal by Subject|16|||
19690662|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
19690663|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
19690664|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
19772708|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
19772709|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
19772710|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
19772711|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
19772712|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
19772713|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
19772714|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
19772715|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
19772716|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
19772717|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
19690665|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
19690666|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
19690667|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
19690668|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
19690669|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
19690670|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
19690671|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
19690672|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
19690673|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
19690674|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
19690675|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
19690676|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
19690677|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
19690678|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
19690679|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
19690680|NCT00365378|42136412|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
19690681|NCT00365378|42136413|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
19690682|NCT00365378|42136414|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
19690683|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
19690684|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
19690685|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
19690686|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
19690687|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
19690688|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
19690689|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
19690690|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
19690691|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
19690692|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
19690693|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
19690694|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
19772718|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
19772719|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
19772720|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
19772721|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
19772722|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
19772723|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
19690695|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
19690696|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
19690697|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
19690698|NCT00365378|42136412|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
19690699|NCT00365378|42136413|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
19690700|NCT00365378|42136414|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
19690701|NCT00365378|42136412|FG000|Extension|Adverse Event|0|||
19690702|NCT00365378|42136413|FG001|Extension|Adverse Event|0|||
19690703|NCT00365378|42136414|FG002|Extension|Adverse Event|1|||
19772724|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
19772725|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
19772726|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
19772727|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
19772728|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
19772729|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
19772730|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
19772731|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
19772732|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
19772733|NCT00383435|42226878|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
19772734|NCT00383435|42226879|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
19690704|NCT00365378|42136412|FG000|Extension|Moved|0|||
19690705|NCT00365378|42136413|FG001|Extension|Moved|0|||
19690706|NCT00365378|42136414|FG002|Extension|Moved|8|||
19690707|NCT00365378|42136412|FG000|Extension|Lost to Follow-up|0|||
19772735|NCT00383435|42226880|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
19772736|NCT00383435|42226881|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
19772737|NCT00383435|42226882|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
19772738|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
19772739|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
19772740|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
19772741|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
19772742|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
19772743|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
19772744|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
19690708|NCT00365378|42136413|FG001|Extension|Lost to Follow-up|0|||
19690709|NCT00365378|42136414|FG002|Extension|Lost to Follow-up|57|||
19772745|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
19772746|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
19772747|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
19772748|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
19772749|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
19772750|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
19772751|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
19772752|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
19772753|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
19772754|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
19772755|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
19772756|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
19772757|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
19772758|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19772759|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
19772760|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
19772761|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
19772762|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
19772763|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
19772764|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
19772765|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
19772766|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
19772767|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
19772768|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
19772769|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
19772770|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
19772771|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
19772772|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
19772773|NCT00383435|42226878|FG000|26-Week Treatment Safety Extension|Administrative|1|||
19772774|NCT00383435|42226879|FG001|26-Week Treatment Safety Extension|Administrative|1|||
19772775|NCT00383435|42226880|FG002|26-Week Treatment Safety Extension|Administrative|0|||
19772776|NCT00383435|42226881|FG003|26-Week Treatment Safety Extension|Administrative|1|||
19690710|NCT00365378|42136412|FG000|Extension|Protocol Violation|0|||
19690711|NCT00365378|42136413|FG001|Extension|Protocol Violation|0|||
19690712|NCT00365378|42136414|FG002|Extension|Protocol Violation|2|||
19690713|NCT00365378|42136412|FG000|Extension|Withdrawal by Subject|0|||
19690714|NCT00365378|42136413|FG001|Extension|Withdrawal by Subject|0|||
19690715|NCT00365378|42136414|FG002|Extension|Withdrawal by Subject|98|||
19690716|NCT00365378|42136412|FG000|Extension|Other|0|||
19690717|NCT00365378|42136413|FG001|Extension|Other|0|||
19690718|NCT00365378|42136414|FG002|Extension|Other|31|||
19690719|NCT00389324|42136421|FG000|Run-In Phase|Adverse Event|1|||
19690720|NCT00389324|42136421|FG000|Run-In Phase|Lost to Follow-up|1|||
19690721|NCT00389324|42136421|FG000|Run-In Phase|Withdrawal by Subject|1|||
19690722|NCT00389324|42136421|FG000|Subcutaneous Phase|Adverse Event|2|||
19690723|NCT00389324|42136421|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
19690724|NCT00389324|42136421|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
19690725|NCT00389324|42136421|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
19690726|NCT00365300|42136430|FG000|Open-label Phase|Adverse Event|4|||
19690727|NCT00365300|42136431|FG001|Open-label Phase|Adverse Event|0|||
19690728|NCT00365300|42136430|FG000|Open-label Phase|Failed to Return|1|||
19690729|NCT00365300|42136431|FG001|Open-label Phase|Failed to Return|0|||
19690730|NCT00365300|42136430|FG000|Open-label Phase|Physician Decision|1|||
19690731|NCT00365300|42136431|FG001|Open-label Phase|Physician Decision|0|||
19690732|NCT00365300|42136430|FG000|Open-label Phase|Noncompliance|9|||
19690733|NCT00365300|42136431|FG001|Open-label Phase|Noncompliance|0|||
19690734|NCT00365300|42136430|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
19772777|NCT00383435|42226882|FG004|26-Week Treatment Safety Extension|Administrative|0|||
19772778|NCT03157037|42226894|FG000|Overall Study|Death|1|||
19772779|NCT00381485|42226916|FG000|Open-Label Run-In Period|Adverse Event|9|||
19772780|NCT00381485|42226917|FG001|Open-Label Run-In Period|Adverse Event|0|||
19690735|NCT00365300|42136431|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
19690736|NCT00365300|42136430|FG000|Open-label Phase|Protocol Violation|1|||
19690737|NCT00365300|42136431|FG001|Open-label Phase|Protocol Violation|0|||
19690738|NCT00365300|42136430|FG000|Open-label Phase|Lack of Efficacy|1|||
19690739|NCT00365300|42136431|FG001|Open-label Phase|Lack of Efficacy|0|||
19690740|NCT00365300|42136430|FG000|Open-label Phase|Patient skipped open label phase|1|||
19690741|NCT00365300|42136431|FG001|Open-label Phase|Patient skipped open label phase|0|||
19690742|NCT00365300|42136430|FG000|Double-blind Phase|Failed to return|1|||
19690743|NCT00365300|42136431|FG001|Double-blind Phase|Failed to return|0|||
19690744|NCT00365300|42136430|FG000|Double-blind Phase|Noncompliance|1|||
19690745|NCT00365300|42136431|FG001|Double-blind Phase|Noncompliance|1|||
19690746|NCT00365300|42136430|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19690747|NCT00365300|42136431|FG001|Double-blind Phase|Withdrawal by Subject|1|||
19690748|NCT00365300|42136430|FG000|Double-blind Phase|Protocol Violation|3|||
19690749|NCT00365300|42136431|FG001|Double-blind Phase|Protocol Violation|1|||
19690750|NCT00365300|42136430|FG000|Double-blind Phase|Lack of Efficacy|6|||
19690751|NCT00365300|42136431|FG001|Double-blind Phase|Lack of Efficacy|6|||
19690752|NCT00370292|42136442|FG000|Overall Study|Disease Progression|4|||
19690753|NCT00370292|42136442|FG000|Overall Study|Adverse Event|7|||
19772781|NCT00381485|42226918|FG002|Open-Label Run-In Period|Adverse Event|0|||
19772782|NCT00381485|42226919|FG003|Open-Label Run-In Period|Adverse Event|0|||
19772783|NCT00381485|42226916|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
19772784|NCT00381485|42226917|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
19772785|NCT00381485|42226918|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
19772786|NCT00381485|42226919|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
19772787|NCT00381485|42226916|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
19772788|NCT00381485|42226917|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
19772789|NCT00381485|42226918|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
19772790|NCT00381485|42226919|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
19772791|NCT00381485|42226916|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
19772792|NCT00381485|42226917|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
19772793|NCT00381485|42226918|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
19772794|NCT00381485|42226919|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
19772795|NCT00381485|42226916|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
19772796|NCT00381485|42226917|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
19772797|NCT00381485|42226918|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
19772798|NCT00381485|42226919|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
19772799|NCT00381485|42226916|FG000|Open-Label Run-In Period|Treatment failure|1|||
19389146|NCT02663453|41632741|FG000|Overall Study|Withdrawal by Subject|1|||
19690754|NCT00370292|42136442|FG000|Overall Study|Physician Decision|2|||
19690755|NCT00369824|42136459|FG000|Overall Study|Adverse Event|0|||
19772800|NCT00381485|42226917|FG001|Open-Label Run-In Period|Treatment failure|0|||
19772801|NCT00381485|42226918|FG002|Open-Label Run-In Period|Treatment failure|0|||
19772802|NCT00381485|42226919|FG003|Open-Label Run-In Period|Treatment failure|0|||
19772803|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19389147|NCT02663453|41632742|FG001|Overall Study|Withdrawal by Subject|0|||
19690756|NCT00369824|42136460|FG001|Overall Study|Adverse Event|2|||
19690757|NCT00369824|42136461|FG002|Overall Study|Adverse Event|0|||
19772804|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Adverse Event|2|||
19772805|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Adverse Event|2|||
19772806|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Adverse Event|5|||
19772807|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
19772808|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
19772809|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
19772810|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
19772811|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19772812|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
19772813|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
19772814|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
19772815|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
19772816|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
19772817|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
19772818|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
19772819|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
19772820|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
19772821|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
19772822|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
19772823|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
19690758|NCT00369824|42136462|FG003|Overall Study|Adverse Event|0|||
19690759|NCT00369824|42136463|FG004|Overall Study|Adverse Event|1|||
19690760|NCT00369824|42136464|FG005|Overall Study|Adverse Event|0|||
19772824|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
19772825|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
19772826|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
19772827|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
19772828|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
19772829|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
19772830|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
19772831|NCT00381485|42226916|FG000|Double-Blind Treatment Period|Administrative|0|||
19772832|NCT00381485|42226917|FG001|Double-Blind Treatment Period|Administrative|1|||
19772833|NCT00381485|42226918|FG002|Double-Blind Treatment Period|Administrative|0|||
19772834|NCT00381485|42226919|FG003|Double-Blind Treatment Period|Administrative|1|||
19772835|NCT02840474|42226930|FG000|Overall Study|Lost to Follow-up|1|||
19772836|NCT02840474|42226931|FG001|Overall Study|Lost to Follow-up|0|||
19772837|NCT03155945|42226939|FG000|Overall Study|Lost to Follow-up|0|||
19772838|NCT03155945|42226940|FG001|Overall Study|Lost to Follow-up|1|||
19772839|NCT03155945|42226939|FG000|Overall Study|Withdrawal by Subject|0|||
19772840|NCT03155945|42226940|FG001|Overall Study|Withdrawal by Subject|1|||
19606108|NCT00572455|42054811|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
19606109|NCT00572455|42054812|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
19606110|NCT00572455|42054813|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
19606111|NCT00572455|42054814|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
19606112|NCT00572455|42054815|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
19606113|NCT00572455|42054816|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
19606114|NCT00572455|42054817|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
19690761|NCT00369824|42136459|FG000|Overall Study|Protocol Violation|0|||
19690762|NCT00369824|42136460|FG001|Overall Study|Protocol Violation|1|||
19690763|NCT00369824|42136461|FG002|Overall Study|Protocol Violation|0|||
19690764|NCT00369824|42136462|FG003|Overall Study|Protocol Violation|1|||
19690765|NCT00369824|42136463|FG004|Overall Study|Protocol Violation|1|||
19690766|NCT00369824|42136464|FG005|Overall Study|Protocol Violation|0|||
19690767|NCT00369824|42136459|FG000|Overall Study|Withdrawal by Subject|9|||
19690768|NCT00369824|42136460|FG001|Overall Study|Withdrawal by Subject|5|||
19690769|NCT00369824|42136461|FG002|Overall Study|Withdrawal by Subject|5|||
19690770|NCT00369824|42136462|FG003|Overall Study|Withdrawal by Subject|4|||
19690771|NCT00369824|42136463|FG004|Overall Study|Withdrawal by Subject|6|||
19690772|NCT00369824|42136464|FG005|Overall Study|Withdrawal by Subject|2|||
19690773|NCT00369824|42136459|FG000|Overall Study|Lost to Follow-up|6|||
19690774|NCT00369824|42136460|FG001|Overall Study|Lost to Follow-up|11|||
19690775|NCT00369824|42136461|FG002|Overall Study|Lost to Follow-up|7|||
19690776|NCT00369824|42136462|FG003|Overall Study|Lost to Follow-up|8|||
19690777|NCT00369824|42136463|FG004|Overall Study|Lost to Follow-up|9|||
19690778|NCT00369824|42136464|FG005|Overall Study|Lost to Follow-up|6|||
19690779|NCT00369824|42136459|FG000|Overall Study|Other|0|||
19690780|NCT00369824|42136460|FG001|Overall Study|Other|0|||
19690781|NCT00369824|42136461|FG002|Overall Study|Other|0|||
19690782|NCT00369824|42136462|FG003|Overall Study|Other|2|||
19690783|NCT00369824|42136463|FG004|Overall Study|Other|1|||
19690784|NCT00369824|42136464|FG005|Overall Study|Other|3|||
19690785|NCT00369668|42136481|FG000|Overall Study|Lack of Efficacy|4|||
19772841|NCT03155945|42226939|FG000|Overall Study|Other Reason|0|||
19772842|NCT03155945|42226940|FG001|Overall Study|Other Reason|1|||
19772843|NCT03160703|42226950|FG000|Overall Study|Withdrawal by Subject|0|||
19772844|NCT03160703|42226951|FG001|Overall Study|Withdrawal by Subject|0|||
19772845|NCT03160703|42226952|FG002|Overall Study|Withdrawal by Subject|0|||
19772846|NCT03160703|42226953|FG003|Overall Study|Withdrawal by Subject|1|||
19772847|NCT03159611|42226965|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
19772848|NCT03159611|42226966|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
19772849|NCT03159611|42226965|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
19772850|NCT03159611|42226966|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
19772851|NCT03159611|42226965|FG000|Overall Study|Protocol Violation|7|||
19772852|NCT03159611|42226966|FG001|Overall Study|Protocol Violation|4|||
19772853|NCT03159611|42226965|FG000|Overall Study|Adverse Event|1|||
19772854|NCT03159611|42226966|FG001|Overall Study|Adverse Event|0|||
19772855|NCT03159611|42226965|FG000|Overall Study|Withdrawal by Subject|1|||
19772856|NCT03159611|42226966|FG001|Overall Study|Withdrawal by Subject|1|||
19772857|NCT03159611|42226965|FG000|Overall Study|Non-compliance with protocol requirement|3|||
19772858|NCT03159611|42226966|FG001|Overall Study|Non-compliance with protocol requirement|2|||
19772859|NCT03159611|42226965|FG000|Overall Study|Inability to perform procedures|1|||
19772860|NCT03159611|42226966|FG001|Overall Study|Inability to perform procedures|0|||
19772861|NCT03159455|42226978|FG000|Overall Study|Adverse Event|0|||
19772862|NCT03159455|42226979|FG001|Overall Study|Adverse Event|0|||
19772863|NCT03159455|42226980|FG002|Overall Study|Adverse Event|0|||
19772864|NCT03159455|42226981|FG003|Overall Study|Adverse Event|0|||
19772865|NCT03159455|42226982|FG004|Overall Study|Adverse Event|0|||
19772866|NCT03159455|42226983|FG005|Overall Study|Adverse Event|1|||
19772867|NCT02838134|42227003|FG000|Overall Study|Lost to Follow-up|1|||
19772868|NCT02838134|42227004|FG001|Overall Study|Lost to Follow-up|2|||
19690786|NCT00369668|42136482|FG001|Overall Study|Lack of Efficacy|5|||
19690787|NCT00369668|42136483|FG002|Overall Study|Lack of Efficacy|7|||
19690788|NCT00388154|42136494|FG000|Overall Study|Withdrawal by Subject|1|||
19690789|NCT00387764|42136498|FG000|Overall Study|Adverse Event|12|||
19690790|NCT00387764|42136498|FG000|Overall Study|Withdrawal by Subject|8|||
19690791|NCT00387764|42136498|FG000|Overall Study|Sponsor Terminated Study|1|||
19690792|NCT00387764|42136498|FG000|Overall Study|Physician Decision|1|||
19690793|NCT00387764|42136498|FG000|Overall Study|Other|2|||
19690794|NCT00387764|42136498|FG000|Overall Study|Death|7|||
19690795|NCT00386360|42136504|FG000|Overall Study|Adverse Event|4|||
19690796|NCT00386360|42136505|FG001|Overall Study|Adverse Event|2|||
19690797|NCT00386360|42136504|FG000|Overall Study|Physician Decision|2|||
19690798|NCT00386360|42136505|FG001|Overall Study|Physician Decision|2|||
19772869|NCT02838134|42227003|FG000|Overall Study|logistic problems|1|||
19772870|NCT02838134|42227004|FG001|Overall Study|logistic problems|1|||
19772871|NCT03150589|42227012|FG000|Overall Study|Withdrawal by Subject|16|||
19772872|NCT03150589|42227013|FG001|Overall Study|Withdrawal by Subject|9|||
19772873|NCT03150589|42227012|FG000|Overall Study|Adverse Event|7|||
19772874|NCT03150589|42227013|FG001|Overall Study|Adverse Event|6|||
19772875|NCT03150589|42227012|FG000|Overall Study|Protocol Violation|4|||
19772876|NCT03150589|42227013|FG001|Overall Study|Protocol Violation|3|||
19772877|NCT03150589|42227012|FG000|Overall Study|Lost to Follow-up|3|||
19772878|NCT03150589|42227013|FG001|Overall Study|Lost to Follow-up|3|||
19772879|NCT03150589|42227012|FG000|Overall Study|Death|2|||
19772880|NCT03150589|42227013|FG001|Overall Study|Death|3|||
19772881|NCT03150589|42227012|FG000|Overall Study|IP non-compliance and other reasons|12|||
19772882|NCT03150589|42227013|FG001|Overall Study|IP non-compliance and other reasons|3|||
19772883|NCT02835092|42227022|FG000|Overall Study|Withdrawal by Subject|3|||
19772884|NCT02835092|42227023|FG001|Overall Study|Withdrawal by Subject|6|||
19772885|NCT02835092|42227024|FG002|Overall Study|Withdrawal by Subject|3|||
19772886|NCT02835092|42227022|FG000|Overall Study|Lost to Follow-up|0|||
19772887|NCT02835092|42227023|FG001|Overall Study|Lost to Follow-up|2|||
19772888|NCT02835092|42227024|FG002|Overall Study|Lost to Follow-up|0|||
19772889|NCT03145207|42227032|FG000|Overall Study|volunteer started taking allergy shots|1|||
19772890|NCT03145207|42227032|FG000|Overall Study|baseline blood pressure high|1|||
19772891|NCT02836652|42227049|FG000|Overall Study|Death|3|||
19772892|NCT02836652|42227050|FG001|Overall Study|Death|3|||
19690799|NCT00386360|42136504|FG000|Overall Study|Lost to Follow-up|0|||
19690800|NCT00386360|42136505|FG001|Overall Study|Lost to Follow-up|2|||
19690801|NCT00386360|42136504|FG000|Overall Study|Protocol Violation|0|||
19690802|NCT00386360|42136505|FG001|Overall Study|Protocol Violation|3|||
19772893|NCT02836652|42227049|FG000|Overall Study|Transplant/Explant|3|||
19772894|NCT02836652|42227050|FG001|Overall Study|Transplant/Explant|4|||
19772895|NCT02836652|42227049|FG000|Overall Study|Withdrawn|9|||
19772896|NCT02836652|42227050|FG001|Overall Study|Withdrawn|9|||
19772897|NCT02836652|42227049|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
19477661|NCT01472081|41756935|FG005|Overall Study|Death|0|||
19690803|NCT00386360|42136504|FG000|Overall Study|Withdrawal by Subject|3|||
19772898|NCT02836652|42227050|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
19772899|NCT02836496|42227058|FG000|Overall Study|Adverse Event|2|||
19772900|NCT02836496|42227059|FG001|Overall Study|Adverse Event|1|||
19772901|NCT02836496|42227058|FG000|Overall Study|Withdrawal by Subject|0|||
19772902|NCT02836496|42227059|FG001|Overall Study|Withdrawal by Subject|1|||
19772903|NCT04213807|42227068|FG000|Overall Study|Physician Decision|0|||
19772904|NCT04213807|42227069|FG001|Overall Study|Physician Decision|0|||
19772905|NCT04213807|42227070|FG002|Overall Study|Physician Decision|1|||
19690804|NCT00386360|42136505|FG001|Overall Study|Withdrawal by Subject|6|||
19690805|NCT00386360|42136504|FG000|Overall Study|Did not take any study medication|0|||
19690806|NCT00386360|42136505|FG001|Overall Study|Did not take any study medication|2|||
19690807|NCT00369278|42136513|FG000|Overall Study|Adverse Event|14|||
19690808|NCT00369278|42136514|FG001|Overall Study|Adverse Event|11|||
19772906|NCT00577577|42227089|FG000|Overall Study|Adverse Event|3|||
19772907|NCT00577577|42227090|FG001|Overall Study|Adverse Event|2|||
19772908|NCT00577577|42227089|FG000|Overall Study|Lost to Follow-up|1|||
19772909|NCT00577577|42227090|FG001|Overall Study|Lost to Follow-up|0|||
19772910|NCT00577577|42227089|FG000|Overall Study|Protocol Violation|0|||
19772911|NCT00577577|42227090|FG001|Overall Study|Protocol Violation|3|||
19772912|NCT00577577|42227089|FG000|Overall Study|Transportation|1|||
19772913|NCT00577577|42227090|FG001|Overall Study|Transportation|0|||
19690809|NCT00369278|42136513|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19690810|NCT00369278|42136514|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
19690811|NCT00369278|42136513|FG000|Overall Study|Protocol Violation|2|||
19690812|NCT00369278|42136514|FG001|Overall Study|Protocol Violation|1|||
19690813|NCT00369278|42136513|FG000|Overall Study|Withdrawal by Subject|2|||
19690814|NCT00369278|42136514|FG001|Overall Study|Withdrawal by Subject|2|||
19690815|NCT00369278|42136513|FG000|Overall Study|Lost to Follow-up|1|||
19690816|NCT00369278|42136514|FG001|Overall Study|Lost to Follow-up|0|||
19690817|NCT00369278|42136513|FG000|Overall Study|Graft loss|1|||
19690818|NCT00369278|42136514|FG001|Overall Study|Graft loss|2|||
19690819|NCT00529373|42136522|FG000|Base Study|Adverse Event|525|||
19690820|NCT00529373|42136523|FG001|Base Study|Adverse Event|470|||
19690821|NCT00529373|42136522|FG000|Base Study|Lack of Efficacy|16|||
19690822|NCT00529373|42136523|FG001|Base Study|Lack of Efficacy|75|||
19690823|NCT00529373|42136522|FG000|Base Study|Lost to Follow-up|221|||
19690824|NCT00529373|42136523|FG001|Base Study|Lost to Follow-up|208|||
19690825|NCT00529373|42136522|FG000|Base Study|Other Protocol Specified Criteria|19|||
19690826|NCT00529373|42136523|FG001|Base Study|Other Protocol Specified Criteria|20|||
19690827|NCT00529373|42136522|FG000|Base Study|Physician Decision|60|||
19690828|NCT00529373|42136523|FG001|Base Study|Physician Decision|52|||
19772914|NCT02833844|42227098|FG000|Double-Blind Period|Withdrawal by Subject|2|||
19772915|NCT02833844|42227099|FG001|Double-Blind Period|Withdrawal by Subject|3|||
19772916|NCT02833844|42227098|FG000|Double-Blind Period|Protocol Violation|0|||
19772917|NCT02833844|42227099|FG001|Double-Blind Period|Protocol Violation|4|||
19772918|NCT02833844|42227098|FG000|Open-Label Period|Death|0|||
19772919|NCT02833844|42227099|FG001|Open-Label Period|Death|2|||
19772920|NCT02833844|42227098|FG000|Open-Label Period|Lost to Follow-up|1|||
19772921|NCT02833844|42227099|FG001|Open-Label Period|Lost to Follow-up|0|||
19772922|NCT02833844|42227098|FG000|Open-Label Period|Withdrawal by Subject|1|||
19772923|NCT02833844|42227099|FG001|Open-Label Period|Withdrawal by Subject|0|||
19772924|NCT01341782|42227109|FG000|Overall Study|Adverse Event|1|||
19690829|NCT00529373|42136522|FG000|Base Study|Protocol Violation|48|||
19690830|NCT00529373|42136523|FG001|Base Study|Protocol Violation|38|||
19690831|NCT00529373|42136522|FG000|Base Study|Withdrawal by Subject|1062|||
19772925|NCT01341782|42227110|FG001|Overall Study|Adverse Event|1|||
19772926|NCT01341782|42227109|FG000|Overall Study|Withdrawal by Subject|6|||
19772927|NCT01341782|42227110|FG001|Overall Study|Withdrawal by Subject|5|||
19772928|NCT01341782|42227109|FG000|Overall Study|Missed 3 consecutive doses|0|||
19772929|NCT01341782|42227110|FG001|Overall Study|Missed 3 consecutive doses|4|||
19690832|NCT00529373|42136523|FG001|Base Study|Withdrawal by Subject|967|||
19690833|NCT00529373|42136522|FG000|Base Study|Did not continue into Extension|1795|||
19690834|NCT00529373|42136523|FG001|Base Study|Did not continue into Extension|2238|||
19690835|NCT00529373|42136522|FG000|First Extension Study|Adverse Event|162|||
19690836|NCT00529373|42136523|FG001|First Extension Study|Adverse Event|142|||
19690837|NCT00529373|42136522|FG000|First Extension Study|Lack of Efficacy|65|||
19690838|NCT00529373|42136523|FG001|First Extension Study|Lack of Efficacy|427|||
19690839|NCT00529373|42136522|FG000|First Extension Study|Lost to Follow-up|41|||
19690840|NCT00529373|42136523|FG001|First Extension Study|Lost to Follow-up|37|||
19690841|NCT00529373|42136522|FG000|First Extension Study|Other|27|||
19690842|NCT00529373|42136523|FG001|First Extension Study|Other|47|||
19690843|NCT00529373|42136522|FG000|First Extension Study|Physician Decision|50|||
19690844|NCT00529373|42136523|FG001|First Extension Study|Physician Decision|45|||
19690845|NCT00529373|42136522|FG000|First Extension Study|Protocol Violation|16|||
19690846|NCT00529373|42136523|FG001|First Extension Study|Protocol Violation|13|||
19690847|NCT00529373|42136522|FG000|First Extension Study|Withdrawal by Subject|296|||
19690848|NCT00529373|42136523|FG001|First Extension Study|Withdrawal by Subject|287|||
19690849|NCT00529373|42136522|FG000|First Extension Study|Disposition record non-existing|0|||
19690850|NCT00529373|42136523|FG001|First Extension Study|Disposition record non-existing|1|||
19690851|NCT00529373|42136522|FG000|First Extension Study|Discontinued after 5 years completion|208|||
19690852|NCT00529373|42136523|FG001|First Extension Study|Discontinued after 5 years completion|346|||
19690853|NCT00529373|42136522|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
19690854|NCT00529373|42136523|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
19690855|NCT00529373|42136522|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
19690856|NCT00529373|42136523|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
19772930|NCT01341782|42227109|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
19690857|NCT00529373|42136522|FG000|Second Extension Study|Adverse Event|101|||
19690858|NCT00529373|42136523|FG001|Second Extension Study|Adverse Event|51|||
19690859|NCT00529373|42136522|FG000|Second Extension Study|Lack of Efficacy|7|||
19690860|NCT00529373|42136523|FG001|Second Extension Study|Lack of Efficacy|15|||
19690861|NCT00529373|42136522|FG000|Second Extension Study|Lost to Follow-up|18|||
19690862|NCT00529373|42136523|FG001|Second Extension Study|Lost to Follow-up|12|||
19690863|NCT00529373|42136522|FG000|Second Extension Study|Other|7|||
19690864|NCT00529373|42136523|FG001|Second Extension Study|Other|12|||
19690865|NCT00529373|42136522|FG000|Second Extension Study|Physician Decision|63|||
19690866|NCT00529373|42136523|FG001|Second Extension Study|Physician Decision|26|||
19690867|NCT00529373|42136522|FG000|Second Extension Study|Protocol Violation|2|||
19690868|NCT00529373|42136523|FG001|Second Extension Study|Protocol Violation|1|||
19690869|NCT00529373|42136522|FG000|Second Extension Study|Withdrawal by Subject|97|||
19690870|NCT00529373|42136523|FG001|Second Extension Study|Withdrawal by Subject|75|||
19772931|NCT01341782|42227110|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
19772932|NCT01341782|42227109|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
19606115|NCT00572455|42054818|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
19606116|NCT00572455|42054819|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
19606117|NCT00572455|42054820|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
19606118|NCT00572455|42054821|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
19606119|NCT00572455|42054822|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
19606120|NCT01003691|42054856|FG000|Overall Study|Adverse Event|0|||
19606121|NCT01003691|42054857|FG001|Overall Study|Adverse Event|0|||
19606122|NCT01003691|42054858|FG002|Overall Study|Adverse Event|0|||
19606123|NCT01003691|42054859|FG003|Overall Study|Adverse Event|1|||
19606124|NCT00686335|42054870|FG000|Run-in Period|Adverse Event|1|||
19606125|NCT00686335|42054870|FG000|Run-in Period|asthma exacerbation|1|||
19606126|NCT00686335|42054870|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
19690871|NCT00529373|42136522|FG000|Second Extension Study|Status Missing|5|||
19690872|NCT00529373|42136523|FG001|Second Extension Study|Status Missing|5|||
19690873|NCT00369122|42136537|FG000|Overall Study|Ineligible|10|||
19690874|NCT00369122|42136537|FG000|Overall Study|No protocol treatment|1|||
19690875|NCT03687125|42136543|FG000|Overall Study|Progressive Disease|2|||
19690876|NCT03687125|42136544|FG001|Overall Study|Progressive Disease|1|||
19690877|NCT03687125|42136543|FG000|Overall Study|Protocol Violation|1|||
19690878|NCT03687125|42136544|FG001|Overall Study|Protocol Violation|0|||
19690879|NCT03872843|42136554|FG000|Overall Study|Lost to Follow-up|5|||
19690880|NCT03872843|42136555|FG001|Overall Study|Lost to Follow-up|7|||
19690881|NCT00146770|42136563|FG000|Overall Study|Adverse Event|2|||
19690882|NCT00146770|42136564|FG001|Overall Study|Adverse Event|0|||
19690883|NCT00146770|42136563|FG000|Overall Study|Pregnancy|1|||
19690884|NCT00146770|42136564|FG001|Overall Study|Pregnancy|0|||
19690885|NCT00146770|42136563|FG000|Overall Study|Withdrawal by Subject|2|||
19690886|NCT00146770|42136564|FG001|Overall Study|Withdrawal by Subject|0|||
19690887|NCT03874013|42136572|FG000|Overall Study|Adverse Event|0|||
19772933|NCT01341782|42227110|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
19772934|NCT01341782|42227109|FG000|Overall Study|Other|5|||
19772935|NCT01341782|42227110|FG001|Overall Study|Other|0|||
19772936|NCT01341470|42227122|FG000|Overall Study|Sponsor decision|0|||
19772937|NCT01341470|42227123|FG001|Overall Study|Sponsor decision|0|||
19772938|NCT01341470|42227124|FG002|Overall Study|Sponsor decision|1|||
19772939|NCT01341470|42227125|FG003|Overall Study|Sponsor decision|1|||
19772940|NCT01341470|42227126|FG004|Overall Study|Sponsor decision|0|||
19772941|NCT01341470|42227127|FG005|Overall Study|Sponsor decision|1|||
19772942|NCT03143101|42227146|FG000|Overall Study|Withdrawal by Subject|0|||
19772943|NCT03143101|42227147|FG001|Overall Study|Withdrawal by Subject|1|||
19772944|NCT03143101|42227148|FG002|Overall Study|Withdrawal by Subject|0|||
19772945|NCT03143101|42227146|FG000|Overall Study|Lost to Follow-up|2|||
19772946|NCT03143101|42227147|FG001|Overall Study|Lost to Follow-up|2|||
19772947|NCT03143101|42227148|FG002|Overall Study|Lost to Follow-up|0|||
19772948|NCT00871351|42227159|FG000|Overall Study|Withdrawal by Subject|1|||
19772949|NCT00871351|42227160|FG001|Overall Study|Withdrawal by Subject|0|||
19772950|NCT00871351|42227161|FG002|Overall Study|Withdrawal by Subject|0|||
19772951|NCT00871351|42227159|FG000|Overall Study|Adverse Event|3|||
19772952|NCT00871351|42227160|FG001|Overall Study|Adverse Event|1|||
19690888|NCT03874013|42136573|FG001|Overall Study|Adverse Event|1|||
19690889|NCT00168064|42136581|FG000|Overall Study|Adverse Event|26|||
19772953|NCT00871351|42227161|FG002|Overall Study|Adverse Event|0|||
19772954|NCT02745080|42227171|FG000|Overall Study|Adverse Event|13|||
19772955|NCT02745080|42227172|FG001|Overall Study|Adverse Event|21|||
19772956|NCT02745080|42227171|FG000|Overall Study|Lack of Efficacy|11|||
19772957|NCT02745080|42227172|FG001|Overall Study|Lack of Efficacy|23|||
19772958|NCT02745080|42227171|FG000|Overall Study|Lost to Follow-up|3|||
19772959|NCT02745080|42227172|FG001|Overall Study|Lost to Follow-up|3|||
19772960|NCT02745080|42227171|FG000|Overall Study|Physician Decision|3|||
19772961|NCT02745080|42227172|FG001|Overall Study|Physician Decision|0|||
19772962|NCT02745080|42227171|FG000|Overall Study|Protocol Violation|3|||
19772963|NCT02745080|42227172|FG001|Overall Study|Protocol Violation|1|||
19772964|NCT02745080|42227171|FG000|Overall Study|Withdrawal by Subject|22|||
19690890|NCT00168064|42136582|FG001|Overall Study|Adverse Event|22|||
19690891|NCT00168064|42136581|FG000|Overall Study|Withdrawal by Subject|3|||
19690892|NCT00168064|42136582|FG001|Overall Study|Withdrawal by Subject|4|||
19690893|NCT00168064|42136581|FG000|Overall Study|Lack of Efficacy|4|||
19690894|NCT00168064|42136582|FG001|Overall Study|Lack of Efficacy|4|||
19690895|NCT00168064|42136581|FG000|Overall Study|Lost to Follow-up|4|||
19772965|NCT02745080|42227172|FG001|Overall Study|Withdrawal by Subject|41|||
19690896|NCT00168064|42136582|FG001|Overall Study|Lost to Follow-up|3|||
19690897|NCT00168064|42136581|FG000|Overall Study|Non-compliance|2|||
19690898|NCT00168064|42136582|FG001|Overall Study|Non-compliance|3|||
19690899|NCT00168064|42136581|FG000|Overall Study|Concurrent Illness|4|||
19690900|NCT00168064|42136582|FG001|Overall Study|Concurrent Illness|3|||
19690901|NCT00168064|42136581|FG000|Overall Study|Subject's Best interest|2|||
19690902|NCT00168064|42136582|FG001|Overall Study|Subject's Best interest|2|||
19690903|NCT00168064|42136581|FG000|Overall Study|Various|4|||
19772966|NCT00521599|42227182|FG000|Overall Study|Adverse Event|5|||
19772967|NCT00521599|42227183|FG001|Overall Study|Adverse Event|7|||
19772968|NCT00521599|42227184|FG002|Overall Study|Adverse Event|6|||
19772969|NCT00521599|42227182|FG000|Overall Study|Treatment Failure|8|||
19690904|NCT00168064|42136582|FG001|Overall Study|Various|3|||
19690905|NCT00166114|42136592|FG000|Overall Study|Protocol Violation|2|||
19690906|NCT00166114|42136593|FG001|Overall Study|Protocol Violation|1|||
19772970|NCT00521599|42227183|FG001|Overall Study|Treatment Failure|9|||
19690907|NCT00166114|42136592|FG000|Overall Study|Withdrawal by Subject|10|||
19690908|NCT00166114|42136593|FG001|Overall Study|Withdrawal by Subject|4|||
19772971|NCT00521599|42227184|FG002|Overall Study|Treatment Failure|22|||
19772972|NCT00521599|42227182|FG000|Overall Study|Lost to Follow-up|2|||
19772973|NCT00521599|42227183|FG001|Overall Study|Lost to Follow-up|1|||
19772974|NCT00521599|42227184|FG002|Overall Study|Lost to Follow-up|2|||
19772975|NCT00521599|42227182|FG000|Overall Study|Withdrawal by Subject|3|||
19772976|NCT00521599|42227183|FG001|Overall Study|Withdrawal by Subject|5|||
19772977|NCT00521599|42227184|FG002|Overall Study|Withdrawal by Subject|1|||
19772978|NCT00521599|42227182|FG000|Overall Study|Withdrawal by subject treatment related|3|||
19772979|NCT00521599|42227183|FG001|Overall Study|Withdrawal by subject treatment related|1|||
19772980|NCT00521599|42227184|FG002|Overall Study|Withdrawal by subject treatment related|2|||
19772981|NCT00521599|42227182|FG000|Overall Study|Protocol Violation|2|||
19772982|NCT00521599|42227183|FG001|Overall Study|Protocol Violation|4|||
19690909|NCT00166114|42136592|FG000|Overall Study|Adverse Event|2|||
19690910|NCT00166114|42136593|FG001|Overall Study|Adverse Event|1|||
19690911|NCT03686969|42136601|FG000|Overall Study|Study terminated|1|||
19772983|NCT00521599|42227184|FG002|Overall Study|Protocol Violation|2|||
19772984|NCT00521599|42227182|FG000|Overall Study|Did not meet protocol eligibility|2|||
19772985|NCT00521599|42227183|FG001|Overall Study|Did not meet protocol eligibility|2|||
19772986|NCT00521599|42227184|FG002|Overall Study|Did not meet protocol eligibility|1|||
19772987|NCT00442897|42227195|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
19772988|NCT00442897|42227196|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
19772989|NCT00442897|42227195|FG000|Base Study (12 Week Follow-up)|Death|0|||
19772990|NCT00442897|42227196|FG001|Base Study (12 Week Follow-up)|Death|1|||
19690912|NCT03686969|42136602|FG001|Overall Study|Study terminated|0|||
19690913|NCT00145600|42136612|FG000|Overall Study|Death|1|||
19690914|NCT00145600|42136613|FG001|Overall Study|Death|2|||
19690915|NCT00145600|42136614|FG002|Overall Study|Death|2|||
19690916|NCT00145600|42136615|FG003|Overall Study|Death|6|||
19690917|NCT00145600|42136612|FG000|Overall Study|Ineligible|3|||
19690918|NCT00145600|42136613|FG001|Overall Study|Ineligible|0|||
19772991|NCT00442897|42227195|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
19772992|NCT00442897|42227196|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
19772993|NCT00442897|42227195|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
19772994|NCT00442897|42227196|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
19772995|NCT00442897|42227195|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
19772996|NCT00442897|42227196|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
19772997|NCT00442897|42227195|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
19772998|NCT00442897|42227196|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
19772999|NCT00442897|42227195|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
19773000|NCT00442897|42227196|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
19773001|NCT00442897|42227195|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
19773002|NCT00442897|42227196|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
19773003|NCT02834390|42227204|FG000|Induction Phase|Progressive disease|0|||
19773004|NCT02834390|42227205|FG001|Induction Phase|Progressive disease|1|||
19773005|NCT02834390|42227204|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
19773006|NCT02834390|42227205|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
19773007|NCT02834390|42227204|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
19773008|NCT02834390|42227205|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
19773009|NCT02834390|42227204|FG000|Consolidation Phase|Physician Decision|1|||
19773010|NCT02834390|42227205|FG001|Consolidation Phase|Physician Decision|1|||
19773011|NCT03141151|42227213|FG000|Overall Study|Lost to Follow-up|3|||
19773012|NCT03141151|42227214|FG001|Overall Study|Lost to Follow-up|2|||
19773013|NCT03141151|42227213|FG000|Overall Study|Withdrawal by Subject|3|||
19773014|NCT03141151|42227214|FG001|Overall Study|Withdrawal by Subject|2|||
19773015|NCT01358708|42227222|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
19773016|NCT01358708|42227223|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19773017|NCT01358708|42227222|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
19773018|NCT01358708|42227223|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
19773019|NCT01356602|42227236|FG000|Overall Study|Protocol Deviation|0|||
19773020|NCT01356602|42227237|FG001|Overall Study|Protocol Deviation|1|||
19773021|NCT01356602|42227238|FG002|Overall Study|Protocol Deviation|1|||
19773022|NCT01356602|42227236|FG000|Overall Study|Administrative Problems|1|||
19773023|NCT01356602|42227237|FG001|Overall Study|Administrative Problems|4|||
19773024|NCT01356602|42227238|FG002|Overall Study|Administrative Problems|5|||
19773025|NCT01356602|42227236|FG000|Overall Study|Lost to Follow-up|4|||
19773026|NCT01356602|42227237|FG001|Overall Study|Lost to Follow-up|5|||
19773027|NCT01356602|42227238|FG002|Overall Study|Lost to Follow-up|6|||
19690919|NCT00145600|42136614|FG002|Overall Study|Ineligible|1|||
19690920|NCT00145600|42136615|FG003|Overall Study|Ineligible|5|||
19690921|NCT00145600|42136612|FG000|Overall Study|Lost to Follow-up|2|||
19690922|NCT00145600|42136613|FG001|Overall Study|Lost to Follow-up|6|||
19773028|NCT01356602|42227236|FG000|Overall Study|Withdrawal by Subject|4|||
19773029|NCT01356602|42227237|FG001|Overall Study|Withdrawal by Subject|3|||
19773030|NCT01356602|42227238|FG002|Overall Study|Withdrawal by Subject|7|||
19773031|NCT01356602|42227236|FG000|Overall Study|Lack of Efficacy|0|||
19773032|NCT01356602|42227237|FG001|Overall Study|Lack of Efficacy|1|||
19773033|NCT01356602|42227238|FG002|Overall Study|Lack of Efficacy|4|||
19773034|NCT01356602|42227236|FG000|Overall Study|Adverse Event|0|||
19773035|NCT01356602|42227237|FG001|Overall Study|Adverse Event|1|||
19773036|NCT01356602|42227238|FG002|Overall Study|Adverse Event|1|||
19773037|NCT02830880|42227246|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
19773038|NCT02830880|42227246|FG000|Overall Study|Death|1|||
19773039|NCT02830880|42227246|FG000|Overall Study|Physician Decision|1|||
19690923|NCT00145600|42136614|FG002|Overall Study|Lost to Follow-up|2|||
19690924|NCT00145600|42136615|FG003|Overall Study|Lost to Follow-up|4|||
19690925|NCT00145600|42136612|FG000|Overall Study|Noncompliance|1|||
19690926|NCT00145600|42136613|FG001|Overall Study|Noncompliance|0|||
19690927|NCT00145600|42136614|FG002|Overall Study|Noncompliance|0|||
19690928|NCT00145600|42136615|FG003|Overall Study|Noncompliance|0|||
19690929|NCT00145600|42136612|FG000|Overall Study|Withdrawal by Subject|1|||
19773040|NCT03141307|42227252|FG000|In-Hospital|Withdrawal by Subject|0|||
19773041|NCT03141307|42227253|FG001|In-Hospital|Withdrawal by Subject|2|||
19773042|NCT03141307|42227252|FG000|In-Hospital|Protocol Violation|4|||
19690930|NCT00145600|42136613|FG001|Overall Study|Withdrawal by Subject|2|||
19690931|NCT00145600|42136614|FG002|Overall Study|Withdrawal by Subject|0|||
19773043|NCT03141307|42227253|FG001|In-Hospital|Protocol Violation|0|||
19773044|NCT03141307|42227252|FG000|Follow-Up|Lost to Follow-up|97|||
19773045|NCT03141307|42227253|FG001|Follow-Up|Lost to Follow-up|54|||
19773046|NCT02825420|42227261|FG000|Overall Study|Death|30|||
19773047|NCT02825420|42227262|FG001|Overall Study|Death|12|||
19773048|NCT02825420|42227261|FG000|Overall Study|Progressive disease|6|||
19773049|NCT02825420|42227262|FG001|Overall Study|Progressive disease|1|||
19773050|NCT02825420|42227261|FG000|Overall Study|Lost to Follow-up|2|||
19773051|NCT02825420|42227262|FG001|Overall Study|Lost to Follow-up|2|||
19773052|NCT02825420|42227261|FG000|Overall Study|Withdrawal by Subject|1|||
19773053|NCT02825420|42227262|FG001|Overall Study|Withdrawal by Subject|1|||
19773054|NCT02825420|42227261|FG000|Overall Study|Protocol amendment not signed|1|||
19773055|NCT02825420|42227262|FG001|Overall Study|Protocol amendment not signed|1|||
19773056|NCT02825420|42227261|FG000|Overall Study|Physician Decision|1|||
19773057|NCT02825420|42227262|FG001|Overall Study|Physician Decision|0|||
19773058|NCT02825420|42227261|FG000|Overall Study|Did not receive PLD|2|||
19773059|NCT02825420|42227262|FG001|Overall Study|Did not receive PLD|0|||
19773060|NCT02829944|42227275|FG000|Overall Study|Physician Decision|0|||
19773061|NCT02829944|42227276|FG001|Overall Study|Physician Decision|1|||
19773062|NCT02829944|42227275|FG000|Overall Study|Screen Failure|2|||
19773063|NCT02829944|42227276|FG001|Overall Study|Screen Failure|2|||
19690932|NCT00145600|42136615|FG003|Overall Study|Withdrawal by Subject|1|||
19690933|NCT00129376|42136639|FG000|Overall Study|Adverse Event|1|||
19690934|NCT00129376|42136639|FG000|Overall Study|Lack of Efficacy|1|||
19690935|NCT00129220|42136646|FG000|Study Period II|Adverse Event|9|||
19690936|NCT00129220|42136647|FG001|Study Period II|Adverse Event|5|||
19773064|NCT02829944|42227275|FG000|Overall Study|Inadequate Neuraxial Block|1|||
19773065|NCT02829944|42227276|FG001|Overall Study|Inadequate Neuraxial Block|1|||
19773066|NCT02829944|42227275|FG000|Overall Study|Withdrawal by Subject|2|||
19773067|NCT02829944|42227276|FG001|Overall Study|Withdrawal by Subject|1|||
19773068|NCT02829944|42227275|FG000|Overall Study|Catheter Displacement|1|||
19773069|NCT02829944|42227276|FG001|Overall Study|Catheter Displacement|0|||
19773070|NCT02829944|42227275|FG000|Overall Study|Catheter broke|0|||
19773071|NCT02829944|42227276|FG001|Overall Study|Catheter broke|1|||
19773072|NCT02829944|42227275|FG000|Overall Study|Staff unavailable|0|||
19773073|NCT02829944|42227276|FG001|Overall Study|Staff unavailable|1|||
19773074|NCT02824562|42227284|FG000|Overall Study|Lost to Follow-up|3|||
19773075|NCT02824562|42227285|FG001|Overall Study|Lost to Follow-up|4|||
19773076|NCT02824562|42227284|FG000|Overall Study|Death|0|||
19773077|NCT02824562|42227285|FG001|Overall Study|Death|1|||
19773078|NCT02744066|42227293|FG000|Overall Study|Withdrawal by parent|0|||
19773079|NCT02744066|42227294|FG001|Overall Study|Withdrawal by parent|1|||
19773080|NCT02744066|42227293|FG000|Overall Study|Discharged from NICU prior to completion|0|||
19773081|NCT02744066|42227294|FG001|Overall Study|Discharged from NICU prior to completion|4|||
19773082|NCT01338818|42227302|FG000|Overall Study|Adverse Event|8|||
19773083|NCT01338818|42227302|FG000|Overall Study|Lack of Efficacy|5|||
19773084|NCT01338818|42227302|FG000|Overall Study|no longer require study drug|1|||
19773085|NCT01338818|42227302|FG000|Overall Study|Withdrawal by Subject|11|||
19773086|NCT01338818|42227302|FG000|Overall Study|Lost to Follow-up|4|||
19773087|NCT01338818|42227302|FG000|Overall Study|Administrative problems|3|||
19773088|NCT01338818|42227302|FG000|Overall Study|Protocol Deviation|4|||
19690937|NCT00129220|42136648|FG002|Study Period II|Adverse Event|7|||
19690938|NCT00129220|42136646|FG000|Study Period II|Lack of Efficacy|15|||
19773089|NCT02823470|42227308|FG000|Overall Study|Adverse Event|1|||
19773090|NCT02823470|42227309|FG001|Overall Study|Adverse Event|0|||
19773091|NCT02823470|42227308|FG000|Overall Study|Study terminated by sponsor|8|||
19773092|NCT02823470|42227309|FG001|Overall Study|Study terminated by sponsor|15|||
19773093|NCT01371656|42227320|FG000|Overall Study|Death|7|||
19773094|NCT01371656|42227321|FG001|Overall Study|Death|4|||
19690939|NCT00129220|42136647|FG001|Study Period II|Lack of Efficacy|1|||
19690940|NCT00129220|42136648|FG002|Study Period II|Lack of Efficacy|28|||
19690941|NCT00129220|42136646|FG000|Study Period II|Entry Criteria Not Met|2|||
19690942|NCT00129220|42136647|FG001|Study Period II|Entry Criteria Not Met|0|||
19690943|NCT00129220|42136648|FG002|Study Period II|Entry Criteria Not Met|2|||
19690944|NCT00129220|42136646|FG000|Study Period II|Protocol Violation|4|||
19773095|NCT01371656|42227320|FG000|Overall Study|Physician Decision|46|||
19773096|NCT01371656|42227321|FG001|Overall Study|Physician Decision|7|||
19773097|NCT01371656|42227320|FG000|Overall Study|Withdrawal by Subject|7|||
19773098|NCT01371656|42227321|FG001|Overall Study|Withdrawal by Subject|0|||
19773099|NCT01371656|42227320|FG000|Overall Study|Ineligible|4|||
19773100|NCT01371656|42227321|FG001|Overall Study|Ineligible|3|||
19773101|NCT01354106|42227327|FG000|Overall Study|Withdrawal by Subject|2|||
19773102|NCT01354028|42227333|FG000|Overall Study|Physician Decision|0|||
19690945|NCT00129220|42136647|FG001|Study Period II|Protocol Violation|2|||
19690946|NCT00129220|42136648|FG002|Study Period II|Protocol Violation|1|||
19690947|NCT00129220|42136646|FG000|Study Period II|Physician Decision|0|||
19690948|NCT00129220|42136647|FG001|Study Period II|Physician Decision|1|||
19690949|NCT00129220|42136648|FG002|Study Period II|Physician Decision|0|||
19690950|NCT00129220|42136646|FG000|Study Period II|Withdrawal by Subject|1|||
19690951|NCT00129220|42136647|FG001|Study Period II|Withdrawal by Subject|3|||
19690952|NCT00129220|42136648|FG002|Study Period II|Withdrawal by Subject|4|||
19690953|NCT00129220|42136646|FG000|Study Period II|Reason Not Specified|2|||
19690954|NCT00129220|42136647|FG001|Study Period II|Reason Not Specified|0|||
19690955|NCT00129220|42136648|FG002|Study Period II|Reason Not Specified|5|||
19773103|NCT01354028|42227334|FG001|Overall Study|Physician Decision|2|||
19773104|NCT01354028|42227333|FG000|Overall Study|Discharged before study start|2|||
19773105|NCT01354028|42227334|FG001|Overall Study|Discharged before study start|2|||
19773106|NCT01354028|42227333|FG000|Overall Study|No quiet alert state|0|||
19773107|NCT01354028|42227334|FG001|Overall Study|No quiet alert state|1|||
19773108|NCT01354964|42227348|FG000|Overall Study|Lost to Follow-up|2|||
19773109|NCT01354964|42227349|FG001|Overall Study|Lost to Follow-up|0|||
19773110|NCT01354964|42227348|FG000|Overall Study|IV access issues|1|||
19773111|NCT01354964|42227349|FG001|Overall Study|IV access issues|1|||
19773112|NCT01354964|42227348|FG000|Overall Study|Physician Decision|1|||
19773113|NCT01354964|42227349|FG001|Overall Study|Physician Decision|0|||
19773114|NCT01354496|42227359|FG000|Period 1|Adverse Event|0|||
19773115|NCT01354496|42227360|FG001|Period 1|Adverse Event|0|||
19773116|NCT01354496|42227361|FG002|Period 1|Adverse Event|1|||
19773117|NCT01354496|42227362|FG003|Period 1|Adverse Event|0|||
19773118|NCT01354496|42227363|FG004|Period 1|Adverse Event|0|||
19773119|NCT01354496|42227364|FG005|Period 1|Adverse Event|0|||
19773120|NCT01354496|42227359|FG000|Period 1|Physician Decision|0|||
19773121|NCT01354496|42227360|FG001|Period 1|Physician Decision|0|||
19773122|NCT01354496|42227361|FG002|Period 1|Physician Decision|1|||
19773123|NCT01354496|42227362|FG003|Period 1|Physician Decision|0|||
19690956|NCT00129220|42136646|FG000|Study Period III|Adverse Event|1|||
19690957|NCT00129220|42136647|FG001|Study Period III|Adverse Event|0|||
19690958|NCT00129220|42136648|FG002|Study Period III|Adverse Event|3|||
19690959|NCT00129220|42136646|FG000|Study Period III|Protocol Violation|1|||
19690960|NCT00129220|42136647|FG001|Study Period III|Protocol Violation|1|||
19690961|NCT00129220|42136648|FG002|Study Period III|Protocol Violation|2|||
19690962|NCT00129220|42136646|FG000|Study Period III|Withdrawal by Subject|1|||
19477662|NCT01472081|41756930|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
19477663|NCT01472081|41756931|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
19477664|NCT01472081|41756932|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
19606127|NCT01002989|42054876|FG000|Overall Study|exclusion criteria, no consent|5|||
19606128|NCT00685945|42054880|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
19606129|NCT01007123|42054894|FG000|Overall Study|Adverse Event|3|||
19606130|NCT01007123|42054895|FG001|Overall Study|Adverse Event|4|||
19690963|NCT00129220|42136647|FG001|Study Period III|Withdrawal by Subject|0|||
19690964|NCT00129220|42136648|FG002|Study Period III|Withdrawal by Subject|3|||
19690965|NCT00129220|42136646|FG000|Study Period III|Sponsor Decision|1|||
19606131|NCT01007123|42054896|FG002|Overall Study|Adverse Event|7|||
19606132|NCT01007123|42054897|FG003|Overall Study|Adverse Event|1|||
19606133|NCT01007123|42054894|FG000|Overall Study|Lack of Efficacy|1|||
19606134|NCT01007123|42054895|FG001|Overall Study|Lack of Efficacy|0|||
19606135|NCT01007123|42054896|FG002|Overall Study|Lack of Efficacy|1|||
19606136|NCT01007123|42054897|FG003|Overall Study|Lack of Efficacy|4|||
19606137|NCT01007123|42054894|FG000|Overall Study|Protocol Violation|1|||
19606138|NCT01007123|42054895|FG001|Overall Study|Protocol Violation|1|||
19690966|NCT00129220|42136647|FG001|Study Period III|Sponsor Decision|0|||
19690967|NCT00129220|42136648|FG002|Study Period III|Sponsor Decision|0|||
19690968|NCT00129220|42136646|FG000|Study Period III|Reason Not Specified|9|||
19690969|NCT00129220|42136647|FG001|Study Period III|Reason Not Specified|0|||
19773124|NCT01354496|42227363|FG004|Period 1|Physician Decision|0|||
19773125|NCT01354496|42227364|FG005|Period 1|Physician Decision|0|||
19773126|NCT01354496|42227359|FG000|Period 2|Adverse Event|0|||
19773127|NCT01354496|42227360|FG001|Period 2|Adverse Event|0|||
19389148|NCT02055118|41632751|FG000|Overall Study|Withdrawal by Subject|0|||
19690970|NCT00129220|42136648|FG002|Study Period III|Reason Not Specified|2|||
19773128|NCT01354496|42227361|FG002|Period 2|Adverse Event|0|||
19773129|NCT01354496|42227362|FG003|Period 2|Adverse Event|1|||
19773130|NCT01354496|42227363|FG004|Period 2|Adverse Event|0|||
19690971|NCT00128830|42136668|FG000|Overall Study|Adverse Event|10|||
19773131|NCT01354496|42227364|FG005|Period 2|Adverse Event|0|||
19773132|NCT01354496|42227359|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
19773133|NCT01354496|42227360|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
19773134|NCT01354496|42227361|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
19773135|NCT01354496|42227362|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
19773136|NCT01354496|42227363|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
19773137|NCT01354496|42227364|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
19773138|NCT02822222|42227387|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
19773139|NCT02822222|42227388|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
19773140|NCT02821910|42227400|FG000|Overall Study|Withdrawal by Subject|0|||
19773141|NCT02821910|42227401|FG001|Overall Study|Withdrawal by Subject|0|||
19773142|NCT02821910|42227402|FG002|Overall Study|Withdrawal by Subject|1|||
19690972|NCT00128830|42136668|FG000|Overall Study|Withdrawal by Subject|14|||
19690973|NCT00128830|42136668|FG000|Overall Study|Lost to Follow-up|4|||
19690974|NCT00128830|42136668|FG000|Overall Study|Reached a virologic endpoint|29|||
19690975|NCT00128830|42136668|FG000|Overall Study|Non-compliant|4|||
19690976|NCT00128830|42136668|FG000|Overall Study|Discontinued or ineligible for study|2|||
19690977|NCT00128830|42136668|FG000|Overall Study|Other|9|||
19690978|NCT03686033|42136674|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
19690979|NCT03686033|42136675|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
19690980|NCT03686033|42136676|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
19690981|NCT03686033|42136677|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
19690982|NCT03686033|42136678|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
19690983|NCT03686033|42136679|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
19690984|NCT00128206|42136695|FG000|Overall Study|Lost to Follow-up|137|||
19773143|NCT02821910|42227403|FG003|Overall Study|Withdrawal by Subject|0|||
19690985|NCT00128206|42136696|FG001|Overall Study|Lost to Follow-up|118|||
19690986|NCT00128206|42136695|FG000|Overall Study|Adverse Event|0|||
19690987|NCT00128206|42136696|FG001|Overall Study|Adverse Event|2|||
19690988|NCT03685643|42136704|FG000|Overall Study|Lost to Follow-up|14|||
19690989|NCT03685643|42136705|FG001|Overall Study|Lost to Follow-up|22|||
19690990|NCT03823378|42136717|FG000|Overall Study|Adverse Event|2|||
19690991|NCT03823378|42136718|FG001|Overall Study|Adverse Event|2|||
19690992|NCT03823378|42136719|FG002|Overall Study|Adverse Event|0|||
19690993|NCT03823378|42136720|FG003|Overall Study|Adverse Event|0|||
19690994|NCT03823378|42136721|FG004|Overall Study|Adverse Event|0|||
19690995|NCT03823378|42136722|FG005|Overall Study|Adverse Event|0|||
19690996|NCT03823378|42136717|FG000|Overall Study|Lost to Follow-up|0|||
19389149|NCT02055118|41632752|FG001|Overall Study|Withdrawal by Subject|2|||
19389150|NCT02055118|41632753|FG002|Overall Study|Withdrawal by Subject|0|||
19389151|NCT02084056|41632764|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
19690997|NCT03823378|42136718|FG001|Overall Study|Lost to Follow-up|1|||
19690998|NCT03823378|42136719|FG002|Overall Study|Lost to Follow-up|0|||
19690999|NCT03823378|42136720|FG003|Overall Study|Lost to Follow-up|0|||
19691000|NCT03823378|42136721|FG004|Overall Study|Lost to Follow-up|1|||
19691001|NCT03823378|42136722|FG005|Overall Study|Lost to Follow-up|0|||
19691002|NCT03823378|42136717|FG000|Overall Study|Withdrawal by Subject|0|||
19691003|NCT03823378|42136718|FG001|Overall Study|Withdrawal by Subject|1|||
19773144|NCT02821910|42227404|FG004|Overall Study|Withdrawal by Subject|0|||
19773145|NCT02821910|42227405|FG005|Overall Study|Withdrawal by Subject|1|||
19773146|NCT02821910|42227400|FG000|Overall Study|Other than specified|1|||
19773147|NCT02821910|42227401|FG001|Overall Study|Other than specified|0|||
19691004|NCT03823378|42136719|FG002|Overall Study|Withdrawal by Subject|4|||
19773148|NCT02821910|42227402|FG002|Overall Study|Other than specified|1|||
19691005|NCT03823378|42136720|FG003|Overall Study|Withdrawal by Subject|2|||
19691006|NCT03823378|42136721|FG004|Overall Study|Withdrawal by Subject|0|||
19691007|NCT03823378|42136722|FG005|Overall Study|Withdrawal by Subject|1|||
19691008|NCT03823378|42136717|FG000|Overall Study|Other, not specified|19|||
19691009|NCT03823378|42136718|FG001|Overall Study|Other, not specified|12|||
19691010|NCT03823378|42136719|FG002|Overall Study|Other, not specified|6|||
19691011|NCT03823378|42136720|FG003|Overall Study|Other, not specified|8|||
19773149|NCT02821910|42227403|FG003|Overall Study|Other than specified|0|||
19773150|NCT02821910|42227404|FG004|Overall Study|Other than specified|0|||
19773151|NCT02821910|42227405|FG005|Overall Study|Other than specified|0|||
19773152|NCT02817776|42227419|FG000|Overall Study|Excluded|33|||
19773153|NCT02817776|42227419|FG000|Overall Study|Lost to Follow-up|20|||
19773154|NCT02817776|42227419|FG000|Overall Study|Withdrawal by Subject|33|||
19773155|NCT02817776|42227419|FG000|Overall Study|Death|2|||
19773156|NCT03138655|42227431|FG000|Overall Study|Adverse Event|2|||
19773157|NCT03138655|42227432|FG001|Overall Study|Adverse Event|1|||
19773158|NCT03138655|42227433|FG002|Overall Study|Adverse Event|2|||
19773159|NCT03138655|42227434|FG003|Overall Study|Adverse Event|1|||
19773160|NCT03138655|42227435|FG004|Overall Study|Adverse Event|1|||
19773161|NCT03138655|42227436|FG005|Overall Study|Adverse Event|4|||
19773162|NCT03138655|42227437|FG006|Overall Study|Adverse Event|2|||
19773163|NCT03138655|42227438|FG007|Overall Study|Adverse Event|2|||
19773164|NCT03138655|42227431|FG000|Overall Study|Withdrawal by Subject|0|||
19773165|NCT03138655|42227432|FG001|Overall Study|Withdrawal by Subject|1|||
19773166|NCT03138655|42227433|FG002|Overall Study|Withdrawal by Subject|0|||
19773167|NCT03138655|42227434|FG003|Overall Study|Withdrawal by Subject|0|||
19773168|NCT03138655|42227435|FG004|Overall Study|Withdrawal by Subject|0|||
19773169|NCT03138655|42227436|FG005|Overall Study|Withdrawal by Subject|0|||
19773170|NCT03138655|42227437|FG006|Overall Study|Withdrawal by Subject|1|||
19773171|NCT03138655|42227438|FG007|Overall Study|Withdrawal by Subject|0|||
19773172|NCT03138655|42227431|FG000|Overall Study|Reason not Specified|1|||
19773173|NCT03138655|42227432|FG001|Overall Study|Reason not Specified|0|||
19773174|NCT03138655|42227433|FG002|Overall Study|Reason not Specified|0|||
19773175|NCT03138655|42227434|FG003|Overall Study|Reason not Specified|2|||
19773176|NCT03138655|42227435|FG004|Overall Study|Reason not Specified|1|||
19773177|NCT03138655|42227436|FG005|Overall Study|Reason not Specified|1|||
19477665|NCT01472081|41756933|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
19477666|NCT01472081|41756934|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
19477667|NCT01472081|41756935|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
19477668|NCT01472081|41756930|FG000|Overall Study|Withdrawal by Subject|0|||
19477669|NCT01472081|41756931|FG001|Overall Study|Withdrawal by Subject|0|||
19691012|NCT03823378|42136721|FG004|Overall Study|Other, not specified|17|||
19691013|NCT03823378|42136722|FG005|Overall Study|Other, not specified|7|||
19691014|NCT00142792|42136739|FG000|Overall Study|Death|0|||
19691015|NCT00142792|42136740|FG001|Overall Study|Death|0|||
19691016|NCT00142792|42136741|FG002|Overall Study|Death|1|||
19773178|NCT03138655|42227437|FG006|Overall Study|Reason not Specified|0|||
19773179|NCT03138655|42227438|FG007|Overall Study|Reason not Specified|0|||
19477670|NCT01472081|41756932|FG002|Overall Study|Withdrawal by Subject|0|||
19477671|NCT01472081|41756933|FG003|Overall Study|Withdrawal by Subject|0|||
19477672|NCT01472081|41756934|FG004|Overall Study|Withdrawal by Subject|0|||
19477673|NCT01472081|41756935|FG005|Overall Study|Withdrawal by Subject|1|||
19477674|NCT01472081|41756930|FG000|Overall Study|Poor/non-compliance|0|||
19691017|NCT00142792|42136739|FG000|Overall Study|Withdrawal by Subject|3|||
19773180|NCT02820038|42227464|FG000|Overall Study|Lost to Follow-up|7|||
19773181|NCT02820038|42227465|FG001|Overall Study|Lost to Follow-up|11|||
19773182|NCT02820038|42227466|FG002|Overall Study|Lost to Follow-up|2|||
19773183|NCT02820038|42227467|FG003|Overall Study|Lost to Follow-up|9|||
19773184|NCT02820038|42227464|FG000|Overall Study|Withdrawal by Subject|3|||
19773185|NCT02820038|42227465|FG001|Overall Study|Withdrawal by Subject|14|||
19773186|NCT02820038|42227466|FG002|Overall Study|Withdrawal by Subject|3|||
19773187|NCT02820038|42227467|FG003|Overall Study|Withdrawal by Subject|13|||
19773188|NCT02819804|42227478|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
19773189|NCT02819726|42227485|FG000|Part A (All Participants)|Lost to Follow-up|0|||
19691018|NCT00142792|42136740|FG001|Overall Study|Withdrawal by Subject|2|||
19691019|NCT00142792|42136741|FG002|Overall Study|Withdrawal by Subject|3|||
19773190|NCT02819726|42227486|FG001|Part A (All Participants)|Lost to Follow-up|1|||
19773191|NCT02819726|42227487|FG002|Part A (All Participants)|Lost to Follow-up|0|||
19773192|NCT02819726|42227488|FG003|Part A (All Participants)|Lost to Follow-up|0|||
19773193|NCT02819726|42227485|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
19773194|NCT02819726|42227486|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
19773195|NCT02819726|42227487|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
19691020|NCT00142792|42136739|FG000|Overall Study|Lost to Follow-up|8|||
19691021|NCT00142792|42136740|FG001|Overall Study|Lost to Follow-up|11|||
19691022|NCT00142792|42136741|FG002|Overall Study|Lost to Follow-up|7|||
19691023|NCT00142792|42136739|FG000|Overall Study|No category|1|||
19691024|NCT00142792|42136740|FG001|Overall Study|No category|2|||
19691025|NCT00142792|42136741|FG002|Overall Study|No category|1|||
19691026|NCT00141778|42136752|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
19691027|NCT00141778|42136753|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
19691028|NCT00141778|42136754|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
19691029|NCT00141778|42136752|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
19691030|NCT00141778|42136753|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
19691031|NCT00141778|42136754|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
19691032|NCT00141778|42136752|FG000|Started Study Medication|Withdrawal by Subject|0|||
19691033|NCT00141778|42136753|FG001|Started Study Medication|Withdrawal by Subject|2|||
19691034|NCT00141778|42136754|FG002|Started Study Medication|Withdrawal by Subject|0|||
19691035|NCT00141778|42136752|FG000|Started Study Medication|Difficulty Swallowing|0|||
19691036|NCT00141778|42136753|FG001|Started Study Medication|Difficulty Swallowing|1|||
19691037|NCT00141778|42136754|FG002|Started Study Medication|Difficulty Swallowing|0|||
19691038|NCT00141778|42136752|FG000|Started Study Medication|Chest Discomfort|0|||
19691039|NCT00141778|42136753|FG001|Started Study Medication|Chest Discomfort|0|||
19691040|NCT00141778|42136754|FG002|Started Study Medication|Chest Discomfort|1|||
19691041|NCT00127660|42136766|FG000|Overall Study|Protocol Violation|3|||
19691042|NCT00127660|42136767|FG001|Overall Study|Protocol Violation|3|||
19773196|NCT02819726|42227488|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
19773197|NCT02819726|42227485|FG000|Part A (All Participants)|Protocol non-compliance|3|||
19773198|NCT02819726|42227486|FG001|Part A (All Participants)|Protocol non-compliance|4|||
19773199|NCT02819726|42227487|FG002|Part A (All Participants)|Protocol non-compliance|5|||
19691043|NCT00127660|42136768|FG002|Overall Study|Protocol Violation|5|||
19691044|NCT00127660|42136769|FG003|Overall Study|Protocol Violation|0|||
19691045|NCT03817528|42136779|FG000|Overall Study|Withdrawal by Subject|1|||
19691046|NCT03817528|42136779|FG000|Overall Study|Adverse Event|2|||
19691047|NCT00115336|42136785|FG000|Overall Study|Hospital discharge before study drug|0|||
19691048|NCT00115336|42136786|FG001|Overall Study|Hospital discharge before study drug|1|||
19691049|NCT00205803|42136796|FG000|Infant Series|Lost to Follow-up|10|||
19691050|NCT00205803|42136797|FG001|Infant Series|Lost to Follow-up|4|||
19691051|NCT00205803|42136796|FG000|Infant Series|Withdrawal by Subject|2|||
19691052|NCT00205803|42136797|FG001|Infant Series|Withdrawal by Subject|5|||
19691053|NCT00205803|42136796|FG000|Infant Series|Physician Decision|3|||
19691054|NCT00205803|42136797|FG001|Infant Series|Physician Decision|1|||
19691055|NCT00205803|42136796|FG000|Infant Series|Protocol Violation|1|||
19691056|NCT00205803|42136797|FG001|Infant Series|Protocol Violation|0|||
19691057|NCT00205803|42136796|FG000|Infant Series|Lost Kaiser coverage|0|||
19691058|NCT00205803|42136797|FG001|Infant Series|Lost Kaiser coverage|1|||
19691059|NCT00205803|42136796|FG000|Infant Series|Non-compliant|1|||
19691060|NCT00205803|42136797|FG001|Infant Series|Non-compliant|0|||
19691061|NCT00205803|42136796|FG000|Infant Series|Sponsor request|1|||
19691062|NCT00205803|42136797|FG001|Infant Series|Sponsor request|0|||
19691063|NCT00205803|42136796|FG000|After Infant Series|Adverse Event|1|||
19773200|NCT02819726|42227488|FG003|Part A (All Participants)|Protocol non-compliance|0|||
19773201|NCT02819726|42227485|FG000|Part B (All Participants)|Lost to Follow-up|1|||
19773202|NCT02819726|42227486|FG001|Part B (All Participants)|Lost to Follow-up|1|||
19773203|NCT02819726|42227487|FG002|Part B (All Participants)|Lost to Follow-up|2|||
19773204|NCT02819726|42227488|FG003|Part B (All Participants)|Lost to Follow-up|2|||
19773205|NCT02819726|42227485|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
19773206|NCT02819726|42227486|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
19773207|NCT02819726|42227487|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
19773208|NCT02819726|42227488|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
19773209|NCT02819726|42227485|FG000|Part B (All Participants)|Protocol non-compliance|0|||
19773210|NCT02819726|42227486|FG001|Part B (All Participants)|Protocol non-compliance|0|||
19606139|NCT01007123|42054896|FG002|Overall Study|Protocol Violation|2|||
19606140|NCT01007123|42054897|FG003|Overall Study|Protocol Violation|1|||
19606141|NCT01007123|42054894|FG000|Overall Study|Withdrawal by Subject|1|||
19606142|NCT01007123|42054895|FG001|Overall Study|Withdrawal by Subject|0|||
19606143|NCT01007123|42054896|FG002|Overall Study|Withdrawal by Subject|1|||
19606144|NCT01007123|42054897|FG003|Overall Study|Withdrawal by Subject|0|||
19606145|NCT01007123|42054894|FG000|Overall Study|Lost to Follow-up|0|||
19606146|NCT01007123|42054895|FG001|Overall Study|Lost to Follow-up|1|||
19606147|NCT01007123|42054896|FG002|Overall Study|Lost to Follow-up|0|||
19606148|NCT01007123|42054897|FG003|Overall Study|Lost to Follow-up|0|||
19606149|NCT00687739|42054912|FG000|Overall Study|Lost to Follow-up|2|||
19606150|NCT00687739|42054913|FG001|Overall Study|Lost to Follow-up|2|||
19606151|NCT00687739|42054914|FG002|Overall Study|Lost to Follow-up|1|||
19691064|NCT00205803|42136797|FG001|After Infant Series|Adverse Event|1|||
19691065|NCT00205803|42136796|FG000|After Infant Series|Protocol Violation|1|||
19773211|NCT02819726|42227487|FG002|Part B (All Participants)|Protocol non-compliance|1|||
19773212|NCT02819726|42227488|FG003|Part B (All Participants)|Protocol non-compliance|0|||
19691066|NCT00205803|42136797|FG001|After Infant Series|Protocol Violation|1|||
19691067|NCT00205803|42136796|FG000|After Infant Series|Lost to Follow-up|2|||
19691068|NCT00205803|42136797|FG001|After Infant Series|Lost to Follow-up|1|||
19691069|NCT00205803|42136796|FG000|After Infant Series|Physician Decision|3|||
19691070|NCT00205803|42136797|FG001|After Infant Series|Physician Decision|2|||
19691071|NCT00205803|42136796|FG000|After Infant Series|Withdrawal by Subject|1|||
19691072|NCT00205803|42136797|FG001|After Infant Series|Withdrawal by Subject|4|||
19691073|NCT00205803|42136796|FG000|After Infant Series|Other|10|||
19773213|NCT02816138|42227496|FG000|Overall Study|Adverse Event|1|||
19773214|NCT02815670|42227500|FG000|Overall Study|Prematurely discontinued of the trial|1|||
19606152|NCT00687739|42054915|FG003|Overall Study|Lost to Follow-up|2|||
19606153|NCT00687739|42054912|FG000|Overall Study|Adverse Event|0|||
19606154|NCT00687739|42054913|FG001|Overall Study|Adverse Event|1|||
19606155|NCT00687739|42054914|FG002|Overall Study|Adverse Event|1|||
19606156|NCT00687739|42054915|FG003|Overall Study|Adverse Event|0|||
19606157|NCT01006889|42054927|FG000|Overall Study|Withdrawal by Subject|3|||
19606158|NCT01001429|42054934|FG000|Overall Study|surgery cancelled|0|||
19606159|NCT01001429|42054935|FG001|Overall Study|surgery cancelled|1|||
19606160|NCT01000961|42054965|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
19606161|NCT01000961|42054966|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19606162|NCT01000961|42054965|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
19606163|NCT01000961|42054966|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
19606164|NCT01000805|42054976|FG000|Overall Study|Adverse Event|21|||
19606165|NCT01000805|42054977|FG001|Overall Study|Adverse Event|9|||
19606166|NCT01000805|42054976|FG000|Overall Study|Lack of Efficacy|5|||
19606167|NCT01000805|42054977|FG001|Overall Study|Lack of Efficacy|16|||
19606168|NCT01000805|42054976|FG000|Overall Study|Lost to Follow-up|16|||
19606169|NCT01000805|42054977|FG001|Overall Study|Lost to Follow-up|21|||
19606170|NCT01000805|42054976|FG000|Overall Study|Physician Decision|0|||
19606171|NCT01000805|42054977|FG001|Overall Study|Physician Decision|1|||
19606172|NCT01000805|42054976|FG000|Overall Study|Protocol Violation|12|||
19606173|NCT01000805|42054977|FG001|Overall Study|Protocol Violation|8|||
19606174|NCT01000805|42054976|FG000|Overall Study|Withdrawal by Subject|16|||
19606175|NCT01000805|42054977|FG001|Overall Study|Withdrawal by Subject|6|||
19606176|NCT01000805|42054976|FG000|Overall Study|Sponsor Decision|0|||
19606177|NCT01000805|42054977|FG001|Overall Study|Sponsor Decision|1|||
19606178|NCT00684307|42054989|FG000|Overall Study|Adverse Event|11|||
19606179|NCT00684307|42054990|FG001|Overall Study|Adverse Event|6|||
19606180|NCT00684307|42054991|FG002|Overall Study|Adverse Event|15|||
19606181|NCT00684307|42054992|FG003|Overall Study|Adverse Event|16|||
19691074|NCT00205803|42136797|FG001|After Infant Series|Other|4|||
19606182|NCT00684307|42054993|FG004|Overall Study|Adverse Event|8|||
19691075|NCT00205803|42136796|FG000|Toddler Dose|Lost to Follow-up|2|||
19606183|NCT00684307|42054989|FG000|Overall Study|Development of increasing Liver Function|0|||
19606184|NCT00684307|42054990|FG001|Overall Study|Development of increasing Liver Function|2|||
19606185|NCT00684307|42054991|FG002|Overall Study|Development of increasing Liver Function|0|||
19606186|NCT00684307|42054992|FG003|Overall Study|Development of increasing Liver Function|1|||
19606187|NCT00684307|42054993|FG004|Overall Study|Development of increasing Liver Function|0|||
19606188|NCT00684307|42054989|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
19606189|NCT00684307|42054990|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
19606190|NCT00684307|42054991|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
19606191|NCT00684307|42054992|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
19606192|NCT00684307|42054993|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
19606193|NCT00684307|42054989|FG000|Overall Study|Incorrect enrolment or randomization|4|||
19606194|NCT00684307|42054990|FG001|Overall Study|Incorrect enrolment or randomization|0|||
19691076|NCT00205803|42136797|FG001|Toddler Dose|Lost to Follow-up|3|||
19773215|NCT02809976|42227504|FG000|Overall Study|Lost to Follow-up|1|||
19773216|NCT02809976|42227504|FG000|Overall Study|Withdrawal by Subject|1|||
19365233|NCT02824627|41605260|FG000|Overall Study|Adverse Event|1|||
19365234|NCT02824627|41605261|FG001|Overall Study|Adverse Event|2|||
19365235|NCT02824627|41605260|FG000|Overall Study|Lost to Follow-up|2|||
19365236|NCT02824627|41605261|FG001|Overall Study|Lost to Follow-up|1|||
19365237|NCT01338493|41605267|FG000|Enrolled|Withdrawal by Subject|1|||
19365238|NCT01338493|41605267|FG000|Enrolled|Patient not implanted|4|||
19365239|NCT01338493|41605267|FG000|Discharge|Death|1|||
19365240|NCT01338493|41605267|FG000|Discharge|Missed visit|1|||
19365241|NCT01338493|41605267|FG000|6 Months Follow up|Lost to Follow-up|11|||
19365242|NCT01338493|41605267|FG000|6 Months Follow up|Missed visit|8|||
19365243|NCT01338493|41605267|FG000|12 Months Follow up|Lost to Follow-up|9|||
19365244|NCT01362296|41605273|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
19365245|NCT01362296|41605274|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
19365246|NCT01362296|41605275|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
19365247|NCT01362296|41605276|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
19365248|NCT01362296|41605273|FG000|Randomized Phase (RP)|Physician Decision|1|||
19365249|NCT01362296|41605274|FG001|Randomized Phase (RP)|Physician Decision|9|||
19365250|NCT01362296|41605275|FG002|Randomized Phase (RP)|Physician Decision|0|||
19365251|NCT01362296|41605276|FG003|Randomized Phase (RP)|Physician Decision|0|||
19365252|NCT01362296|41605273|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
19365253|NCT01362296|41605274|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
19365254|NCT01362296|41605275|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
19365255|NCT01362296|41605276|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
19365256|NCT01362296|41605273|FG000|Randomized Phase (RP)|Adverse Event|20|||
19365257|NCT01362296|41605274|FG001|Randomized Phase (RP)|Adverse Event|4|||
19365258|NCT01362296|41605275|FG002|Randomized Phase (RP)|Adverse Event|0|||
19365259|NCT01362296|41605276|FG003|Randomized Phase (RP)|Adverse Event|0|||
19365260|NCT01362296|41605273|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
19365261|NCT01362296|41605274|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
19365262|NCT01362296|41605275|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
19365263|NCT01362296|41605276|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
19365264|NCT01362296|41605273|FG000|Crossover Phase|PD including Death due to PD|0|||
19365265|NCT01362296|41605274|FG001|Crossover Phase|PD including Death due to PD|0|||
19691077|NCT00127192|42136826|FG000|Overall Study|Adverse Event|0|||
19691078|NCT00127192|42136827|FG001|Overall Study|Adverse Event|1|||
19606195|NCT00684307|42054991|FG002|Overall Study|Incorrect enrolment or randomization|0|||
19606196|NCT00684307|42054992|FG003|Overall Study|Incorrect enrolment or randomization|0|||
19606197|NCT00684307|42054993|FG004|Overall Study|Incorrect enrolment or randomization|0|||
19606198|NCT00684307|42054989|FG000|Overall Study|Interupted IP for more than 7 days|0|||
19606199|NCT00684307|42054990|FG001|Overall Study|Interupted IP for more than 7 days|4|||
19606200|NCT00684307|42054991|FG002|Overall Study|Interupted IP for more than 7 days|1|||
19606201|NCT00684307|42054992|FG003|Overall Study|Interupted IP for more than 7 days|3|||
19606202|NCT00684307|42054993|FG004|Overall Study|Interupted IP for more than 7 days|3|||
19606203|NCT00684307|42054989|FG000|Overall Study|Severe non compliance to protocol|1|||
19606204|NCT00684307|42054990|FG001|Overall Study|Severe non compliance to protocol|0|||
19606205|NCT00684307|42054991|FG002|Overall Study|Severe non compliance to protocol|0|||
19606206|NCT00684307|42054992|FG003|Overall Study|Severe non compliance to protocol|1|||
19606207|NCT00684307|42054993|FG004|Overall Study|Severe non compliance to protocol|2|||
19606208|NCT00684307|42054989|FG000|Overall Study|Participant not willing to continue|7|||
19606209|NCT00684307|42054990|FG001|Overall Study|Participant not willing to continue|10|||
19606210|NCT00684307|42054991|FG002|Overall Study|Participant not willing to continue|11|||
19606211|NCT00684307|42054992|FG003|Overall Study|Participant not willing to continue|5|||
19606212|NCT00684307|42054993|FG004|Overall Study|Participant not willing to continue|8|||
19606213|NCT00684307|42054989|FG000|Overall Study|Criteria from the CSR|0|||
19606214|NCT00684307|42054990|FG001|Overall Study|Criteria from the CSR|0|||
19606215|NCT00684307|42054991|FG002|Overall Study|Criteria from the CSR|1|||
19691079|NCT00127192|42136828|FG002|Overall Study|Adverse Event|1|||
19691080|NCT00127192|42136829|FG003|Overall Study|Adverse Event|1|||
19691081|NCT00127192|42136830|FG004|Overall Study|Adverse Event|0|||
19691082|NCT00127192|42136826|FG000|Overall Study|Lack of Efficacy|2|||
19691083|NCT00127192|42136827|FG001|Overall Study|Lack of Efficacy|0|||
19691084|NCT00127192|42136828|FG002|Overall Study|Lack of Efficacy|0|||
19691085|NCT00127192|42136829|FG003|Overall Study|Lack of Efficacy|0|||
19691086|NCT00127192|42136830|FG004|Overall Study|Lack of Efficacy|2|||
19691087|NCT00127192|42136826|FG000|Overall Study|Withdrawal by Subject|0|||
19691088|NCT00127192|42136827|FG001|Overall Study|Withdrawal by Subject|0|||
19691089|NCT00127192|42136828|FG002|Overall Study|Withdrawal by Subject|1|||
19691090|NCT00127192|42136829|FG003|Overall Study|Withdrawal by Subject|0|||
19691091|NCT00127192|42136830|FG004|Overall Study|Withdrawal by Subject|3|||
19773217|NCT02880865|42227510|FG000|Overall Study|Adverse Event|1|||
19365266|NCT01362296|41605275|FG002|Crossover Phase|PD including Death due to PD|16|||
19365267|NCT01362296|41605276|FG003|Crossover Phase|PD including Death due to PD|1|||
19773218|NCT02880865|42227511|FG001|Overall Study|Adverse Event|0|||
19773219|NCT02880865|42227510|FG000|Overall Study|Withdrawal by Subject|0|||
19773220|NCT02880865|42227511|FG001|Overall Study|Withdrawal by Subject|2|||
19773221|NCT02880865|42227510|FG000|Overall Study|Physician Decision|0|||
19773222|NCT02880865|42227511|FG001|Overall Study|Physician Decision|1|||
19773223|NCT01854385|42227538|FG000|Pre-Treatment|Withdrawal by Subject|4|||
19773224|NCT01854385|42227538|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
19773225|NCT01854385|42227538|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
19773226|NCT01854385|42227538|FG000|Pre-Treatment|Unable to come for study visits|1|||
19365268|NCT01362296|41605273|FG000|Crossover Phase|Withdrawal by Subject|0|||
19365269|NCT01362296|41605274|FG001|Crossover Phase|Withdrawal by Subject|0|||
19773227|NCT01854385|42227538|FG000|Treatment|Lost to Follow-up|1|||
19773228|NCT02809118|42227545|FG000|Overall Study|Withdrawal by Subject|0|||
19773229|NCT02809118|42227546|FG001|Overall Study|Withdrawal by Subject|1|||
19773230|NCT02809118|42227547|FG002|Overall Study|Withdrawal by Subject|1|||
19773231|NCT03604159|42227557|FG000|Overall Study|Lost to Follow-up|6|||
19773232|NCT03604159|42227558|FG001|Overall Study|Lost to Follow-up|7|||
19773233|NCT02808338|42227564|FG000|Screening|Screen Failure|10|||
19773234|NCT02808338|42227564|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
19365270|NCT01362296|41605275|FG002|Crossover Phase|Withdrawal by Subject|2|||
19365271|NCT01362296|41605276|FG003|Crossover Phase|Withdrawal by Subject|1|||
19365272|NCT01362296|41605273|FG000|Crossover Phase|Adverse Event|0|||
19365273|NCT01362296|41605274|FG001|Crossover Phase|Adverse Event|0|||
19365274|NCT01362296|41605275|FG002|Crossover Phase|Adverse Event|4|||
19365275|NCT01362296|41605276|FG003|Crossover Phase|Adverse Event|0|||
19691092|NCT00127192|42136826|FG000|Overall Study|Adverse event in pre-treatment period|1|||
19691093|NCT00127192|42136827|FG001|Overall Study|Adverse event in pre-treatment period|0|||
19691094|NCT00127192|42136828|FG002|Overall Study|Adverse event in pre-treatment period|0|||
19691095|NCT00127192|42136829|FG003|Overall Study|Adverse event in pre-treatment period|0|||
19691096|NCT00127192|42136830|FG004|Overall Study|Adverse event in pre-treatment period|0|||
19691097|NCT00205179|42136844|FG000|Overall Study|Death|0|||
19691098|NCT00205179|42136845|FG001|Overall Study|Death|2|||
19773235|NCT02808338|42227564|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
19365276|NCT01362296|41605273|FG000|Crossover Phase|Study Closed/Terminated|0|||
19365277|NCT01362296|41605274|FG001|Crossover Phase|Study Closed/Terminated|0|||
19606216|NCT00684307|42054992|FG003|Overall Study|Criteria from the CSR|3|||
19606217|NCT00684307|42054993|FG004|Overall Study|Criteria from the CSR|3|||
19691099|NCT00205179|42136844|FG000|Overall Study|Physician Decision|1|||
19691100|NCT00205179|42136845|FG001|Overall Study|Physician Decision|1|||
19691101|NCT00205179|42136844|FG000|Overall Study|Adverse Event|1|||
19691102|NCT00205179|42136845|FG001|Overall Study|Adverse Event|1|||
19691103|NCT00127036|42136854|FG000|Overall Study|Insufficient Data for Analysis|6|||
19691104|NCT00127036|42136855|FG001|Overall Study|Insufficient Data for Analysis|11|||
19691105|NCT00127036|42136854|FG000|Overall Study|Screen Failure|2|||
19691106|NCT00127036|42136855|FG001|Overall Study|Screen Failure|0|||
19691107|NCT00259857|42136863|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
19691108|NCT00259857|42136864|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
19773236|NCT02807948|42227575|FG000|Overall Study|Physician Decision|1|||
19773237|NCT02807948|42227576|FG001|Overall Study|Physician Decision|0|||
19773238|NCT02879383|42227585|FG000|First 24 Weeks|Physician Decision|0|||
19773239|NCT02879383|42227586|FG001|First 24 Weeks|Physician Decision|1|||
19773240|NCT02879383|42227587|FG002|First 24 Weeks|Physician Decision|0|||
19365278|NCT01362296|41605275|FG002|Crossover Phase|Study Closed/Terminated|1|||
19365279|NCT01362296|41605276|FG003|Crossover Phase|Study Closed/Terminated|0|||
19365280|NCT01338415|41605288|FG000|Core + Extension|Adverse Event|8|||
19365281|NCT01338415|41605289|FG001|Core + Extension|Adverse Event|6|||
19365282|NCT01338415|41605290|FG002|Core + Extension|Adverse Event|0|||
19365283|NCT01338415|41605288|FG000|Core + Extension|Withdrawal by Subject|1|||
19365284|NCT01338415|41605289|FG001|Core + Extension|Withdrawal by Subject|1|||
19365285|NCT01338415|41605290|FG002|Core + Extension|Withdrawal by Subject|0|||
19365286|NCT01338415|41605288|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
19691109|NCT00259857|42136863|FG000|24 Months Treatment|Lost to Follow-up|0|||
19773241|NCT02879383|42227588|FG003|First 24 Weeks|Physician Decision|0|||
19773242|NCT02049710|42227602|FG000|Overall Study|Lost to Follow-up|319|||
19773243|NCT02049710|42227603|FG001|Overall Study|Lost to Follow-up|324|||
19773244|NCT02806232|42227631|FG000|Overall Study|Lost to Follow-up|1|||
19773245|NCT02806232|42227632|FG001|Overall Study|Lost to Follow-up|2|||
19773246|NCT02806232|42227633|FG002|Overall Study|Lost to Follow-up|1|||
19773247|NCT02806232|42227634|FG003|Overall Study|Lost to Follow-up|0|||
19773248|NCT02806232|42227635|FG004|Overall Study|Lost to Follow-up|0|||
19773249|NCT02806232|42227636|FG005|Overall Study|Lost to Follow-up|1|||
19773250|NCT02806232|42227637|FG006|Overall Study|Lost to Follow-up|0|||
19773251|NCT02806232|42227638|FG007|Overall Study|Lost to Follow-up|0|||
19773252|NCT02806232|42227639|FG008|Overall Study|Lost to Follow-up|0|||
19773253|NCT02806232|42227631|FG000|Overall Study|Withdrawal by Subject|0|||
19773254|NCT02806232|42227632|FG001|Overall Study|Withdrawal by Subject|2|||
19773255|NCT02806232|42227633|FG002|Overall Study|Withdrawal by Subject|0|||
19389152|NCT02084056|41632765|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19691110|NCT00259857|42136864|FG001|24 Months Treatment|Lost to Follow-up|3|||
19691111|NCT00203307|42136872|FG000|First Intervention|Adverse Event|2|||
19691112|NCT00203307|42136873|FG001|First Intervention|Adverse Event|0|||
19691113|NCT00126568|42136879|FG000|Overall Study|Death|2|||
19691114|NCT00114634|42136884|FG000|Overall Study|failure to return forms|3|||
19691115|NCT00202839|42136892|FG000|Overall Study|Adverse Event|1|||
19691116|NCT00202839|42136893|FG001|Overall Study|Adverse Event|5|||
19691117|NCT00202839|42136892|FG000|Overall Study|Physician Decision|12|||
19691118|NCT00202839|42136893|FG001|Overall Study|Physician Decision|0|||
19691119|NCT00202839|42136892|FG000|Overall Study|Withdrawal by Subject|6|||
19691120|NCT00202839|42136893|FG001|Overall Study|Withdrawal by Subject|2|||
19691121|NCT00202839|42136892|FG000|Overall Study|Protocol Violation|2|||
19691122|NCT00202839|42136893|FG001|Overall Study|Protocol Violation|1|||
19691123|NCT00202839|42136892|FG000|Overall Study|Lost to Follow-up|3|||
19691124|NCT00202839|42136893|FG001|Overall Study|Lost to Follow-up|2|||
19691125|NCT00201201|42136901|FG000|Overall Study|Death|0|||
19691126|NCT00201201|42136902|FG001|Overall Study|Death|2|||
19691127|NCT00201201|42136901|FG000|Overall Study|Withdrawal by Subject|5|||
19691128|NCT00201201|42136902|FG001|Overall Study|Withdrawal by Subject|5|||
19691129|NCT00126490|42136908|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
19691130|NCT00346632|42136914|FG000|Overall Study|Progressive Disease|2|||
19691131|NCT00346632|42136915|FG001|Overall Study|Progressive Disease|2|||
19691132|NCT00346632|42136916|FG002|Overall Study|Progressive Disease|4|||
19691133|NCT00346632|42136917|FG003|Overall Study|Progressive Disease|3|||
19691134|NCT00346632|42136918|FG004|Overall Study|Progressive Disease|3|||
19691135|NCT00346632|42136919|FG005|Overall Study|Progressive Disease|1|||
19691136|NCT00346632|42136920|FG006|Overall Study|Progressive Disease|2|||
19691137|NCT00346632|42136921|FG007|Overall Study|Progressive Disease|2|||
19691138|NCT00346632|42136922|FG008|Overall Study|Progressive Disease|2|||
19773256|NCT02806232|42227634|FG003|Overall Study|Withdrawal by Subject|0|||
19773257|NCT02806232|42227635|FG004|Overall Study|Withdrawal by Subject|2|||
19691139|NCT00346632|42136923|FG009|Overall Study|Progressive Disease|2|||
19691140|NCT00346632|42136914|FG000|Overall Study|Adverse Event|0|||
19691141|NCT00346632|42136915|FG001|Overall Study|Adverse Event|0|||
19691142|NCT00346632|42136916|FG002|Overall Study|Adverse Event|0|||
19691143|NCT00346632|42136917|FG003|Overall Study|Adverse Event|0|||
19691144|NCT00346632|42136918|FG004|Overall Study|Adverse Event|1|||
19691145|NCT00346632|42136919|FG005|Overall Study|Adverse Event|1|||
19691146|NCT00346632|42136920|FG006|Overall Study|Adverse Event|1|||
19691147|NCT00346632|42136921|FG007|Overall Study|Adverse Event|0|||
19691148|NCT00346632|42136922|FG008|Overall Study|Adverse Event|0|||
19691149|NCT00346632|42136923|FG009|Overall Study|Adverse Event|0|||
19691150|NCT00346632|42136914|FG000|Overall Study|Death|0|||
19691151|NCT00346632|42136915|FG001|Overall Study|Death|0|||
19691152|NCT00346632|42136916|FG002|Overall Study|Death|1|||
19691153|NCT00346632|42136917|FG003|Overall Study|Death|0|||
19691154|NCT00346632|42136918|FG004|Overall Study|Death|0|||
19691155|NCT00346632|42136919|FG005|Overall Study|Death|0|||
19691156|NCT00346632|42136920|FG006|Overall Study|Death|0|||
19691157|NCT00346632|42136921|FG007|Overall Study|Death|0|||
19691158|NCT00346632|42136922|FG008|Overall Study|Death|0|||
19691159|NCT00346632|42136923|FG009|Overall Study|Death|0|||
19691160|NCT00346632|42136914|FG000|Overall Study|Protocol Violation|0|||
19691161|NCT00346632|42136915|FG001|Overall Study|Protocol Violation|0|||
19691162|NCT00346632|42136916|FG002|Overall Study|Protocol Violation|0|||
19691163|NCT00346632|42136917|FG003|Overall Study|Protocol Violation|0|||
19691164|NCT00346632|42136918|FG004|Overall Study|Protocol Violation|0|||
19691165|NCT00346632|42136919|FG005|Overall Study|Protocol Violation|0|||
19691166|NCT00346632|42136920|FG006|Overall Study|Protocol Violation|1|||
19691167|NCT00346632|42136921|FG007|Overall Study|Protocol Violation|0|||
19691168|NCT00346632|42136922|FG008|Overall Study|Protocol Violation|0|||
19691169|NCT00346632|42136923|FG009|Overall Study|Protocol Violation|0|||
19365287|NCT01338415|41605289|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
19365288|NCT01338415|41605290|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
19691170|NCT00346632|42136914|FG000|Overall Study|Withdrawal by Subject|0|||
19691171|NCT00346632|42136915|FG001|Overall Study|Withdrawal by Subject|0|||
19691172|NCT00346632|42136916|FG002|Overall Study|Withdrawal by Subject|0|||
19691173|NCT00346632|42136917|FG003|Overall Study|Withdrawal by Subject|0|||
19691174|NCT00346632|42136918|FG004|Overall Study|Withdrawal by Subject|0|||
19691175|NCT00346632|42136919|FG005|Overall Study|Withdrawal by Subject|0|||
19691176|NCT00346632|42136920|FG006|Overall Study|Withdrawal by Subject|1|||
19691177|NCT00346632|42136921|FG007|Overall Study|Withdrawal by Subject|0|||
19691178|NCT00346632|42136922|FG008|Overall Study|Withdrawal by Subject|0|||
19691179|NCT00346632|42136923|FG009|Overall Study|Withdrawal by Subject|0|||
19691180|NCT00346632|42136914|FG000|Overall Study|Switched to alternative treatment|0|||
19691181|NCT00346632|42136915|FG001|Overall Study|Switched to alternative treatment|0|||
19365289|NCT01338415|41605288|FG000|Core + Extension|Other (administrative reason)|1|||
19365290|NCT01338415|41605289|FG001|Core + Extension|Other (administrative reason)|0|||
19365291|NCT01338415|41605290|FG002|Core + Extension|Other (administrative reason)|0|||
19365292|NCT01338415|41605288|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
19365293|NCT01338415|41605289|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
19365294|NCT01338415|41605290|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
19365295|NCT01338415|41605288|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
19365296|NCT01338415|41605289|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
19365297|NCT01338415|41605290|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
19365298|NCT01338415|41605288|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
19365299|NCT01338415|41605289|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
19365300|NCT01338415|41605290|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
19365301|NCT01338415|41605288|FG000|Exceptional Use Treatment Period|Death|0|||
19365302|NCT01338415|41605289|FG001|Exceptional Use Treatment Period|Death|0|||
19365303|NCT01338415|41605290|FG002|Exceptional Use Treatment Period|Death|1|||
19365304|NCT01371643|41605300|FG000|Overall Study|Withdrawal by Subject|3|||
19365305|NCT01371643|41605301|FG001|Overall Study|Withdrawal by Subject|0|||
19691182|NCT00346632|42136916|FG002|Overall Study|Switched to alternative treatment|1|||
19691183|NCT00346632|42136917|FG003|Overall Study|Switched to alternative treatment|0|||
19691184|NCT00346632|42136918|FG004|Overall Study|Switched to alternative treatment|0|||
19365306|NCT01371565|41605307|FG000|Overall Study|Withdrawal by Subject|1|||
19691185|NCT00346632|42136919|FG005|Overall Study|Switched to alternative treatment|0|||
19691186|NCT00346632|42136920|FG006|Overall Study|Switched to alternative treatment|0|||
19691187|NCT00346632|42136921|FG007|Overall Study|Switched to alternative treatment|0|||
19691188|NCT00346632|42136922|FG008|Overall Study|Switched to alternative treatment|0|||
19691189|NCT00346632|42136923|FG009|Overall Study|Switched to alternative treatment|0|||
19691190|NCT00346632|42136914|FG000|Overall Study|Not Stated|1|||
19691191|NCT00346632|42136915|FG001|Overall Study|Not Stated|1|||
19691192|NCT00346632|42136916|FG002|Overall Study|Not Stated|0|||
19365307|NCT01371565|41605307|FG000|Overall Study|Death|1|||
19691193|NCT00346632|42136917|FG003|Overall Study|Not Stated|0|||
19691194|NCT00346632|42136918|FG004|Overall Study|Not Stated|0|||
19691195|NCT00346632|42136919|FG005|Overall Study|Not Stated|0|||
19691196|NCT00346632|42136920|FG006|Overall Study|Not Stated|0|||
19691197|NCT00346632|42136921|FG007|Overall Study|Not Stated|2|||
19691198|NCT00346632|42136922|FG008|Overall Study|Not Stated|2|||
19691199|NCT00346632|42136923|FG009|Overall Study|Not Stated|1|||
19691200|NCT00200967|42136987|FG000|First Treatment Period|Withdrawal by Subject|5|||
19365308|NCT01371565|41605307|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
19365309|NCT02821819|41605315|FG000|Overall Study|Protocol Violation|1|||
19365310|NCT03926611|41605326|FG000|Overall Study|Adverse Event|0|||
19365311|NCT03926611|41605327|FG001|Overall Study|Adverse Event|0|||
19606218|NCT00683917|42055008|FG000|Overall Study|Study prematurely terminated|10|||
19691201|NCT00200967|42136988|FG001|First Treatment Period|Withdrawal by Subject|1|||
19691202|NCT00200967|42136987|FG000|First Treatment Period|Pregnancy|1|||
19691203|NCT00200967|42136988|FG001|First Treatment Period|Pregnancy|0|||
19691204|NCT00200967|42136987|FG000|Wash-out Period|Lost to Follow-up|0|||
19691205|NCT00200967|42136988|FG001|Wash-out Period|Lost to Follow-up|1|||
19691206|NCT00200967|42136987|FG000|Second Treatment Period|Withdrawal by Subject|1|||
19691207|NCT00200967|42136988|FG001|Second Treatment Period|Withdrawal by Subject|2|||
19691208|NCT00200967|42136987|FG000|Run-out Period|Lost to Follow-up|1|||
19691209|NCT00200967|42136988|FG001|Run-out Period|Lost to Follow-up|0|||
19691210|NCT00354432|42136998|FG000|Overall Study|Adverse Event|3|||
19691211|NCT00354432|42136999|FG001|Overall Study|Adverse Event|1|||
19691212|NCT00354432|42137000|FG002|Overall Study|Adverse Event|5|||
19691213|NCT00354432|42137001|FG003|Overall Study|Adverse Event|5|||
19691214|NCT00354432|42136998|FG000|Overall Study|Off/Toxicity|3|||
19691215|NCT00354432|42136999|FG001|Overall Study|Off/Toxicity|7|||
19691216|NCT00354432|42137000|FG002|Overall Study|Off/Toxicity|5|||
19691217|NCT00354432|42137001|FG003|Overall Study|Off/Toxicity|5|||
19773258|NCT02806232|42227636|FG005|Overall Study|Withdrawal by Subject|1|||
19773259|NCT02806232|42227637|FG006|Overall Study|Withdrawal by Subject|0|||
19773260|NCT02806232|42227638|FG007|Overall Study|Withdrawal by Subject|0|||
19773261|NCT02806232|42227639|FG008|Overall Study|Withdrawal by Subject|0|||
19773262|NCT02807402|42227659|FG000|Overall Study|Failure to Return|1|||
19773263|NCT02807402|42227659|FG000|Overall Study|Death|3|||
19773264|NCT02807402|42227659|FG000|Overall Study|Other|2|||
19773265|NCT00392327|42227679|FG000|Overall Study|Death|1|||
19773266|NCT00392327|42227680|FG001|Overall Study|Death|0|||
19773267|NCT00392327|42227681|FG002|Overall Study|Death|1|||
19773268|NCT00392327|42227682|FG003|Overall Study|Death|0|||
19773269|NCT00392327|42227683|FG004|Overall Study|Death|0|||
19773270|NCT00392327|42227684|FG005|Overall Study|Death|0|||
19773271|NCT00392327|42227685|FG006|Overall Study|Death|0|||
19773272|NCT00392327|42227686|FG007|Overall Study|Death|0|||
19773273|NCT00392327|42227679|FG000|Overall Study|Lack of Efficacy|8|||
19773274|NCT00392327|42227680|FG001|Overall Study|Lack of Efficacy|8|||
19773275|NCT00392327|42227681|FG002|Overall Study|Lack of Efficacy|9|||
19773276|NCT00392327|42227682|FG003|Overall Study|Lack of Efficacy|6|||
19773277|NCT00392327|42227683|FG004|Overall Study|Lack of Efficacy|3|||
19773278|NCT00392327|42227684|FG005|Overall Study|Lack of Efficacy|3|||
19773279|NCT00392327|42227685|FG006|Overall Study|Lack of Efficacy|3|||
19773280|NCT00392327|42227686|FG007|Overall Study|Lack of Efficacy|3|||
19773281|NCT00392327|42227679|FG000|Overall Study|Physician Decision|3|||
19773282|NCT00392327|42227680|FG001|Overall Study|Physician Decision|5|||
19773283|NCT00392327|42227681|FG002|Overall Study|Physician Decision|2|||
19773284|NCT00392327|42227682|FG003|Overall Study|Physician Decision|2|||
19773285|NCT00392327|42227683|FG004|Overall Study|Physician Decision|0|||
19773286|NCT00392327|42227684|FG005|Overall Study|Physician Decision|1|||
19773287|NCT00392327|42227685|FG006|Overall Study|Physician Decision|5|||
19773288|NCT00392327|42227686|FG007|Overall Study|Physician Decision|3|||
19773289|NCT00392327|42227679|FG000|Overall Study|Protocol Violation|0|||
19365312|NCT03926611|41605328|FG002|Overall Study|Adverse Event|0|||
19606219|NCT00687271|42055020|FG000|Overall Study|Adverse Event|1|||
19606220|NCT00687271|42055021|FG001|Overall Study|Adverse Event|3|||
19606221|NCT00687271|42055022|FG002|Overall Study|Adverse Event|1|||
19606222|NCT00687271|42055023|FG003|Overall Study|Adverse Event|0|||
19606223|NCT00687271|42055020|FG000|Overall Study|Lost to Follow-up|0|||
19606224|NCT00687271|42055021|FG001|Overall Study|Lost to Follow-up|1|||
19606225|NCT00687271|42055022|FG002|Overall Study|Lost to Follow-up|0|||
19606226|NCT00687271|42055023|FG003|Overall Study|Lost to Follow-up|0|||
19606227|NCT00687271|42055020|FG000|Overall Study|Protocol Violation|2|||
19606228|NCT00687271|42055021|FG001|Overall Study|Protocol Violation|1|||
19606229|NCT00687271|42055022|FG002|Overall Study|Protocol Violation|1|||
19606230|NCT00687271|42055023|FG003|Overall Study|Protocol Violation|0|||
19606231|NCT00687271|42055020|FG000|Overall Study|Withdrawal by Subject|0|||
19606232|NCT00687271|42055021|FG001|Overall Study|Withdrawal by Subject|1|||
19606233|NCT00687271|42055022|FG002|Overall Study|Withdrawal by Subject|3|||
19606234|NCT00687271|42055023|FG003|Overall Study|Withdrawal by Subject|0|||
19691218|NCT00140140|42137014|FG000|Overall Study|Unacceptable toxicity|1|||
19691219|NCT00140140|42137015|FG001|Overall Study|Unacceptable toxicity|1|||
19691220|NCT00140140|42137016|FG002|Overall Study|Unacceptable toxicity|2|||
19691221|NCT00140140|42137014|FG000|Overall Study|Physician Decision|1|||
19773290|NCT00392327|42227680|FG001|Overall Study|Protocol Violation|0|||
19773291|NCT00392327|42227681|FG002|Overall Study|Protocol Violation|1|||
19773292|NCT00392327|42227682|FG003|Overall Study|Protocol Violation|0|||
19365313|NCT03926611|41605329|FG003|Overall Study|Adverse Event|3|||
19773293|NCT00392327|42227683|FG004|Overall Study|Protocol Violation|0|||
19773294|NCT00392327|42227684|FG005|Overall Study|Protocol Violation|0|||
19773295|NCT00392327|42227685|FG006|Overall Study|Protocol Violation|0|||
19773296|NCT00392327|42227686|FG007|Overall Study|Protocol Violation|0|||
19773297|NCT00392327|42227679|FG000|Overall Study|Withdrawal by Subject|3|||
19773298|NCT00392327|42227680|FG001|Overall Study|Withdrawal by Subject|2|||
19773299|NCT00392327|42227681|FG002|Overall Study|Withdrawal by Subject|4|||
19773300|NCT00392327|42227682|FG003|Overall Study|Withdrawal by Subject|6|||
19773301|NCT00392327|42227683|FG004|Overall Study|Withdrawal by Subject|0|||
19773302|NCT00392327|42227684|FG005|Overall Study|Withdrawal by Subject|1|||
19773303|NCT00392327|42227685|FG006|Overall Study|Withdrawal by Subject|1|||
19773304|NCT00392327|42227686|FG007|Overall Study|Withdrawal by Subject|5|||
19773305|NCT00392327|42227679|FG000|Overall Study|Ineligible|0|||
19773306|NCT00392327|42227680|FG001|Overall Study|Ineligible|4|||
19773307|NCT00392327|42227681|FG002|Overall Study|Ineligible|3|||
19773308|NCT00392327|42227682|FG003|Overall Study|Ineligible|2|||
19773309|NCT00392327|42227683|FG004|Overall Study|Ineligible|0|||
19691222|NCT00140140|42137015|FG001|Overall Study|Physician Decision|1|||
19691223|NCT00140140|42137016|FG002|Overall Study|Physician Decision|0|||
19691224|NCT00346398|42137025|FG000|Overall Study|Lost to Follow-up|3|||
19691225|NCT00346398|42137026|FG001|Overall Study|Lost to Follow-up|0|||
19691226|NCT00346398|42137025|FG000|Overall Study|Withdrawal by Subject|0|||
19691227|NCT00346398|42137026|FG001|Overall Study|Withdrawal by Subject|2|||
19691228|NCT00346164|42137036|FG000|Overall Study|Adverse Event|0|||
19691229|NCT00346164|42137037|FG001|Overall Study|Adverse Event|0|||
19691230|NCT00346164|42137038|FG002|Overall Study|Adverse Event|0|||
19691231|NCT00346164|42137039|FG003|Overall Study|Adverse Event|1|||
19691232|NCT00346164|42137036|FG000|Overall Study|Lack of Efficacy|0|||
19691233|NCT00346164|42137037|FG001|Overall Study|Lack of Efficacy|1|||
19691234|NCT00346164|42137038|FG002|Overall Study|Lack of Efficacy|7|||
19691235|NCT00346164|42137039|FG003|Overall Study|Lack of Efficacy|25|||
19691236|NCT00346164|42137036|FG000|Overall Study|Physician Decision|0|||
19691237|NCT00346164|42137037|FG001|Overall Study|Physician Decision|1|||
19691238|NCT00346164|42137038|FG002|Overall Study|Physician Decision|2|||
19691239|NCT00346164|42137039|FG003|Overall Study|Physician Decision|27|||
19691240|NCT00346164|42137036|FG000|Overall Study|Protocol Violation|6|||
19691241|NCT00346164|42137037|FG001|Overall Study|Protocol Violation|2|||
19691242|NCT00346164|42137038|FG002|Overall Study|Protocol Violation|10|||
19691243|NCT00346164|42137039|FG003|Overall Study|Protocol Violation|4|||
19691244|NCT00346164|42137036|FG000|Overall Study|Withdrawal by Subject|0|||
19691245|NCT00346164|42137037|FG001|Overall Study|Withdrawal by Subject|0|||
19691246|NCT00346164|42137038|FG002|Overall Study|Withdrawal by Subject|2|||
19691247|NCT00346164|42137039|FG003|Overall Study|Withdrawal by Subject|0|||
19691248|NCT00346164|42137036|FG000|Overall Study|Ineligible|11|||
19691249|NCT00346164|42137037|FG001|Overall Study|Ineligible|2|||
19691250|NCT00346164|42137038|FG002|Overall Study|Ineligible|2|||
19691251|NCT00346164|42137039|FG003|Overall Study|Ineligible|23|||
19691252|NCT00346164|42137036|FG000|Overall Study|Refusal of further protocol therapy|0|||
19691253|NCT00346164|42137037|FG001|Overall Study|Refusal of further protocol therapy|1|||
19691254|NCT00346164|42137038|FG002|Overall Study|Refusal of further protocol therapy|3|||
19691255|NCT00346164|42137039|FG003|Overall Study|Refusal of further protocol therapy|15|||
19691256|NCT00346164|42137036|FG000|Overall Study|Inability to start week 16 tx on time|0|||
19691257|NCT00346164|42137037|FG001|Overall Study|Inability to start week 16 tx on time|0|||
19691258|NCT00346164|42137038|FG002|Overall Study|Inability to start week 16 tx on time|0|||
19691259|NCT00346164|42137039|FG003|Overall Study|Inability to start week 16 tx on time|11|||
19691260|NCT00114244|42137067|FG000|Overall Study|Adverse Event|2|||
19691261|NCT00114244|42137068|FG001|Overall Study|Adverse Event|5|||
19691262|NCT00114244|42137067|FG000|Overall Study|Withdrawal by Subject|0|||
19691263|NCT00114244|42137068|FG001|Overall Study|Withdrawal by Subject|2|||
19691264|NCT00138658|42137074|FG000|Overall Study|Adverse Event|23|||
19691265|NCT00138658|42137074|FG000|Overall Study|Death|1|||
19691266|NCT00138658|42137074|FG000|Overall Study|Disease Progression|21|||
19691267|NCT00138658|42137074|FG000|Overall Study|Physician Decision|11|||
19691268|NCT00138658|42137074|FG000|Overall Study|Withdrawal by Subject|5|||
19691269|NCT00337662|42137083|FG000|Study Period II|Lost to Follow-up|0|||
19691270|NCT00337662|42137084|FG001|Study Period II|Lost to Follow-up|0|||
19691271|NCT00337662|42137085|FG002|Study Period II|Lost to Follow-up|0|||
19691272|NCT00337662|42137086|FG003|Study Period II|Lost to Follow-up|35|||
19691273|NCT00337662|42137083|FG000|Study Period II|Withdrawal by Subject|0|||
19691274|NCT00337662|42137084|FG001|Study Period II|Withdrawal by Subject|0|||
19691275|NCT00337662|42137085|FG002|Study Period II|Withdrawal by Subject|0|||
19691276|NCT00337662|42137086|FG003|Study Period II|Withdrawal by Subject|20|||
19691277|NCT00337662|42137083|FG000|Study Period II|Adverse Event|0|||
19691278|NCT00337662|42137084|FG001|Study Period II|Adverse Event|0|||
19691279|NCT00337662|42137085|FG002|Study Period II|Adverse Event|0|||
19691280|NCT00337662|42137086|FG003|Study Period II|Adverse Event|16|||
19773310|NCT00392327|42227684|FG005|Overall Study|Ineligible|0|||
19691281|NCT00337662|42137083|FG000|Study Period II|Physician Decision|0|||
19773311|NCT00392327|42227685|FG006|Overall Study|Ineligible|0|||
19773312|NCT00392327|42227686|FG007|Overall Study|Ineligible|0|||
19773313|NCT02960490|42227706|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
19773314|NCT02960490|42227707|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
19773315|NCT02960490|42227708|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19691282|NCT00337662|42137084|FG001|Study Period II|Physician Decision|0|||
19691283|NCT00337662|42137085|FG002|Study Period II|Physician Decision|0|||
19691284|NCT00337662|42137086|FG003|Study Period II|Physician Decision|13|||
19691285|NCT00337662|42137083|FG000|Study Period II|Entry Criteria Not Met|0|||
19691286|NCT00337662|42137084|FG001|Study Period II|Entry Criteria Not Met|0|||
19691287|NCT00337662|42137085|FG002|Study Period II|Entry Criteria Not Met|0|||
19691288|NCT00337662|42137086|FG003|Study Period II|Entry Criteria Not Met|6|||
19691289|NCT00337662|42137083|FG000|Study Period II|Protocol Violation|0|||
19773316|NCT02960490|42227709|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773317|NCT02960490|42227710|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773318|NCT02960490|42227711|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773319|NCT02960490|42227712|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773320|NCT02960490|42227713|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773321|NCT02960490|42227714|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773322|NCT02960490|42227715|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
19773323|NCT02960490|42227706|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773324|NCT02960490|42227707|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
19773325|NCT02960490|42227708|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773326|NCT02960490|42227709|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773327|NCT02960490|42227710|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773328|NCT02960490|42227711|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773329|NCT02960490|42227712|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773330|NCT02960490|42227713|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773331|NCT02960490|42227714|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773332|NCT02960490|42227715|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
19773333|NCT02960490|42227706|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
19773334|NCT02960490|42227707|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
19773335|NCT02960490|42227708|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773336|NCT02960490|42227709|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773337|NCT02960490|42227710|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773338|NCT02960490|42227711|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773339|NCT02960490|42227712|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773340|NCT02960490|42227713|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773341|NCT02960490|42227714|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773342|NCT02960490|42227715|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
19773343|NCT02960490|42227706|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
19773344|NCT02960490|42227707|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
19773345|NCT02960490|42227708|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773346|NCT02960490|42227709|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773347|NCT02960490|42227710|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773348|NCT02960490|42227711|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773349|NCT02960490|42227712|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773350|NCT02960490|42227713|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19365314|NCT03926611|41605330|FG004|Overall Study|Adverse Event|1|||
19365315|NCT03926611|41605331|FG005|Overall Study|Adverse Event|3|||
19365316|NCT03926611|41605332|FG006|Overall Study|Adverse Event|0|||
19365317|NCT03926611|41605326|FG000|Overall Study|Lack of Efficacy|1|||
19365318|NCT03926611|41605327|FG001|Overall Study|Lack of Efficacy|2|||
19365319|NCT03926611|41605328|FG002|Overall Study|Lack of Efficacy|0|||
19365320|NCT03926611|41605329|FG003|Overall Study|Lack of Efficacy|0|||
19365321|NCT03926611|41605330|FG004|Overall Study|Lack of Efficacy|1|||
19606235|NCT04617275|42055041|FG000|Treatment Period|Adverse Event|1|||
19606236|NCT04617275|42055042|FG001|Treatment Period|Adverse Event|6|||
19606237|NCT04617275|42055043|FG002|Treatment Period|Adverse Event|4|||
19606238|NCT04617275|42055044|FG003|Treatment Period|Adverse Event|6|||
19606239|NCT04617275|42055045|FG004|Treatment Period|Adverse Event|7|||
19606240|NCT04617275|42055046|FG005|Treatment Period|Adverse Event|8|||
19606241|NCT04617275|42055047|FG006|Treatment Period|Adverse Event|0|||
19691290|NCT00337662|42137084|FG001|Study Period II|Protocol Violation|0|||
19365322|NCT03926611|41605331|FG005|Overall Study|Lack of Efficacy|0|||
19365323|NCT03926611|41605332|FG006|Overall Study|Lack of Efficacy|1|||
19365324|NCT03926611|41605326|FG000|Overall Study|Physician Decision|0|||
19365325|NCT03926611|41605327|FG001|Overall Study|Physician Decision|0|||
19365326|NCT03926611|41605328|FG002|Overall Study|Physician Decision|0|||
19477675|NCT01472081|41756931|FG001|Overall Study|Poor/non-compliance|0|||
19606242|NCT04617275|42055048|FG007|Treatment Period|Adverse Event|12|||
19606243|NCT04617275|42055041|FG000|Treatment Period|Lost to Follow-up|0|||
19365327|NCT03926611|41605329|FG003|Overall Study|Physician Decision|0|||
19365328|NCT03926611|41605330|FG004|Overall Study|Physician Decision|0|||
19365329|NCT03926611|41605331|FG005|Overall Study|Physician Decision|1|||
19365330|NCT03926611|41605332|FG006|Overall Study|Physician Decision|0|||
19365331|NCT03926611|41605326|FG000|Overall Study|Protocol Violation|1|||
19365332|NCT03926611|41605327|FG001|Overall Study|Protocol Violation|0|||
19365333|NCT03926611|41605328|FG002|Overall Study|Protocol Violation|0|||
19365334|NCT03926611|41605329|FG003|Overall Study|Protocol Violation|1|||
19365335|NCT03926611|41605330|FG004|Overall Study|Protocol Violation|1|||
19365336|NCT03926611|41605331|FG005|Overall Study|Protocol Violation|1|||
19365337|NCT03926611|41605332|FG006|Overall Study|Protocol Violation|1|||
19773351|NCT02960490|42227714|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773352|NCT02960490|42227715|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
19773353|NCT02960490|42227706|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19773354|NCT02960490|42227707|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19691291|NCT00337662|42137085|FG002|Study Period II|Protocol Violation|0|||
19691292|NCT00337662|42137086|FG003|Study Period II|Protocol Violation|6|||
19691293|NCT00337662|42137083|FG000|Study Period II|Lack of Efficacy|0|||
19691294|NCT00337662|42137084|FG001|Study Period II|Lack of Efficacy|0|||
19691295|NCT00337662|42137085|FG002|Study Period II|Lack of Efficacy|0|||
19691296|NCT00337662|42137086|FG003|Study Period II|Lack of Efficacy|7|||
19691297|NCT00337662|42137083|FG000|Study Period II|Sponsor Decision|0|||
19691298|NCT00337662|42137084|FG001|Study Period II|Sponsor Decision|0|||
19691299|NCT00337662|42137085|FG002|Study Period II|Sponsor Decision|0|||
19691300|NCT00337662|42137086|FG003|Study Period II|Sponsor Decision|2|||
19691301|NCT00337662|42137083|FG000|Study Period II|Parent/Caregiver Decision|0|||
19691302|NCT00337662|42137084|FG001|Study Period II|Parent/Caregiver Decision|0|||
19691303|NCT00337662|42137085|FG002|Study Period II|Parent/Caregiver Decision|0|||
19691304|NCT00337662|42137086|FG003|Study Period II|Parent/Caregiver Decision|1|||
19691305|NCT00337662|42137083|FG000|Study Period III|Lost to Follow-up|14|||
19691306|NCT00337662|42137084|FG001|Study Period III|Lost to Follow-up|16|||
19691307|NCT00337662|42137085|FG002|Study Period III|Lost to Follow-up|14|||
19691308|NCT00337662|42137086|FG003|Study Period III|Lost to Follow-up|0|||
19691309|NCT00337662|42137083|FG000|Study Period III|Withdrawal by Subject|18|||
19691310|NCT00337662|42137084|FG001|Study Period III|Withdrawal by Subject|14|||
19691311|NCT00337662|42137085|FG002|Study Period III|Withdrawal by Subject|12|||
19691312|NCT00337662|42137086|FG003|Study Period III|Withdrawal by Subject|0|||
19691313|NCT00337662|42137083|FG000|Study Period III|Adverse Event|9|||
19691314|NCT00337662|42137084|FG001|Study Period III|Adverse Event|10|||
19691315|NCT00337662|42137085|FG002|Study Period III|Adverse Event|8|||
19691316|NCT00337662|42137086|FG003|Study Period III|Adverse Event|0|||
19691317|NCT00337662|42137083|FG000|Study Period III|Protocol Violation|3|||
19691318|NCT00337662|42137084|FG001|Study Period III|Protocol Violation|8|||
19691319|NCT00337662|42137085|FG002|Study Period III|Protocol Violation|2|||
19691320|NCT00337662|42137086|FG003|Study Period III|Protocol Violation|0|||
19691321|NCT00337662|42137083|FG000|Study Period III|Physician Decision|6|||
19691322|NCT00337662|42137084|FG001|Study Period III|Physician Decision|5|||
19691323|NCT00337662|42137085|FG002|Study Period III|Physician Decision|0|||
19691324|NCT00337662|42137086|FG003|Study Period III|Physician Decision|0|||
19691325|NCT00337662|42137083|FG000|Study Period III|Entry Criteria Not Met|4|||
19691326|NCT00337662|42137084|FG001|Study Period III|Entry Criteria Not Met|1|||
19691327|NCT00337662|42137085|FG002|Study Period III|Entry Criteria Not Met|3|||
19691328|NCT00337662|42137086|FG003|Study Period III|Entry Criteria Not Met|0|||
19691329|NCT00337662|42137083|FG000|Study Period III|Lack of Efficacy|4|||
19691330|NCT00337662|42137084|FG001|Study Period III|Lack of Efficacy|4|||
19691331|NCT00337662|42137085|FG002|Study Period III|Lack of Efficacy|2|||
19691332|NCT00337662|42137086|FG003|Study Period III|Lack of Efficacy|0|||
19365338|NCT03926611|41605326|FG000|Overall Study|Technical problems|0|||
19365339|NCT03926611|41605327|FG001|Overall Study|Technical problems|0|||
19365340|NCT03926611|41605328|FG002|Overall Study|Technical problems|0|||
19365341|NCT03926611|41605329|FG003|Overall Study|Technical problems|0|||
19365342|NCT03926611|41605330|FG004|Overall Study|Technical problems|0|||
19365343|NCT03926611|41605331|FG005|Overall Study|Technical problems|1|||
19365344|NCT03926611|41605332|FG006|Overall Study|Technical problems|0|||
19691333|NCT00337662|42137083|FG000|Study Period III|Parent/Caregiver Decision|0|||
19691334|NCT00337662|42137084|FG001|Study Period III|Parent/Caregiver Decision|0|||
19691335|NCT00337662|42137085|FG002|Study Period III|Parent/Caregiver Decision|2|||
19477676|NCT01472081|41756932|FG002|Overall Study|Poor/non-compliance|1|||
19691336|NCT00337662|42137086|FG003|Study Period III|Parent/Caregiver Decision|0|||
19691337|NCT00337662|42137083|FG000|Study Period III|Sponsor Decision|1|||
19691338|NCT00337662|42137084|FG001|Study Period III|Sponsor Decision|0|||
19691339|NCT00337662|42137085|FG002|Study Period III|Sponsor Decision|1|||
19691340|NCT00337662|42137086|FG003|Study Period III|Sponsor Decision|0|||
19691341|NCT00337662|42137083|FG000|Study Period III|Clinical Relapse|1|||
19365345|NCT03926611|41605326|FG000|Overall Study|Withdrawal by Subject|1|||
19365346|NCT03926611|41605327|FG001|Overall Study|Withdrawal by Subject|1|||
19365347|NCT03926611|41605328|FG002|Overall Study|Withdrawal by Subject|1|||
19365348|NCT03926611|41605329|FG003|Overall Study|Withdrawal by Subject|0|||
19365349|NCT03926611|41605330|FG004|Overall Study|Withdrawal by Subject|0|||
19365350|NCT03926611|41605331|FG005|Overall Study|Withdrawal by Subject|1|||
19365351|NCT03926611|41605332|FG006|Overall Study|Withdrawal by Subject|3|||
19365352|NCT03926611|41605326|FG000|Overall Study|Covid-19 pandemic|0|||
19365353|NCT03926611|41605327|FG001|Overall Study|Covid-19 pandemic|0|||
19365354|NCT03926611|41605328|FG002|Overall Study|Covid-19 pandemic|1|||
19606244|NCT04617275|42055042|FG001|Treatment Period|Lost to Follow-up|0|||
19606245|NCT04617275|42055043|FG002|Treatment Period|Lost to Follow-up|2|||
19606246|NCT04617275|42055044|FG003|Treatment Period|Lost to Follow-up|0|||
19606247|NCT04617275|42055045|FG004|Treatment Period|Lost to Follow-up|0|||
19606248|NCT04617275|42055046|FG005|Treatment Period|Lost to Follow-up|3|||
19606249|NCT04617275|42055047|FG006|Treatment Period|Lost to Follow-up|0|||
19606250|NCT04617275|42055048|FG007|Treatment Period|Lost to Follow-up|2|||
19606251|NCT04617275|42055041|FG000|Treatment Period|No longer meets eligibility criteria|0|||
19606252|NCT04617275|42055042|FG001|Treatment Period|No longer meets eligibility criteria|0|||
19606253|NCT04617275|42055043|FG002|Treatment Period|No longer meets eligibility criteria|0|||
19606254|NCT04617275|42055044|FG003|Treatment Period|No longer meets eligibility criteria|1|||
19606255|NCT04617275|42055045|FG004|Treatment Period|No longer meets eligibility criteria|0|||
19606256|NCT04617275|42055046|FG005|Treatment Period|No longer meets eligibility criteria|0|||
19606257|NCT04617275|42055047|FG006|Treatment Period|No longer meets eligibility criteria|0|||
19606258|NCT04617275|42055048|FG007|Treatment Period|No longer meets eligibility criteria|0|||
19606259|NCT04617275|42055041|FG000|Treatment Period|Other|0|||
19606260|NCT04617275|42055042|FG001|Treatment Period|Other|1|||
19606261|NCT04617275|42055043|FG002|Treatment Period|Other|0|||
19606262|NCT04617275|42055044|FG003|Treatment Period|Other|0|||
19606263|NCT04617275|42055045|FG004|Treatment Period|Other|0|||
19606264|NCT04617275|42055046|FG005|Treatment Period|Other|0|||
19606265|NCT04617275|42055047|FG006|Treatment Period|Other|0|||
19606266|NCT04617275|42055048|FG007|Treatment Period|Other|0|||
19691342|NCT00337662|42137084|FG001|Study Period III|Clinical Relapse|0|||
19691343|NCT00337662|42137085|FG002|Study Period III|Clinical Relapse|0|||
19691344|NCT00337662|42137086|FG003|Study Period III|Clinical Relapse|0|||
19691345|NCT00138424|42137101|FG000|Overall Study|Physician Decision|0|||
19691346|NCT00138424|42137102|FG001|Overall Study|Physician Decision|1|||
19691347|NCT00138424|42137103|FG002|Overall Study|Physician Decision|0|||
19691348|NCT00138424|42137104|FG003|Overall Study|Physician Decision|0|||
19691349|NCT00368966|42137118|FG000|Infant Series|Withdrawal by Subject|11|||
19691350|NCT00368966|42137119|FG001|Infant Series|Withdrawal by Subject|6|||
19691351|NCT00368966|42137118|FG000|Infant Series|Protocol Violation|2|||
19691352|NCT00368966|42137119|FG001|Infant Series|Protocol Violation|1|||
19691353|NCT00368966|42137118|FG000|Infant Series|Lost to Follow-up|2|||
19691354|NCT00368966|42137119|FG001|Infant Series|Lost to Follow-up|0|||
19691355|NCT00368966|42137118|FG000|Infant Series|Randomization error|0|||
19691356|NCT00368966|42137119|FG001|Infant Series|Randomization error|1|||
19691357|NCT00368966|42137118|FG000|Infant Series|Failed to meet eligibility criteria|0|||
19691358|NCT00368966|42137119|FG001|Infant Series|Failed to meet eligibility criteria|1|||
19691359|NCT00368966|42137118|FG000|Infant Series|Adverse Event|0|||
19691360|NCT00368966|42137119|FG001|Infant Series|Adverse Event|1|||
19691361|NCT00368966|42137118|FG000|Infant Series|Failed to return|1|||
19691362|NCT00368966|42137119|FG001|Infant Series|Failed to return|0|||
19691363|NCT00368966|42137118|FG000|After Infant|Failed to return|3|||
19606267|NCT04617275|42055041|FG000|Treatment Period|Withdrawal by Subject|2|||
19606268|NCT04617275|42055042|FG001|Treatment Period|Withdrawal by Subject|0|||
19606269|NCT04617275|42055043|FG002|Treatment Period|Withdrawal by Subject|0|||
19606270|NCT04617275|42055044|FG003|Treatment Period|Withdrawal by Subject|2|||
19606271|NCT04617275|42055045|FG004|Treatment Period|Withdrawal by Subject|2|||
19606272|NCT04617275|42055046|FG005|Treatment Period|Withdrawal by Subject|0|||
19606273|NCT04617275|42055047|FG006|Treatment Period|Withdrawal by Subject|1|||
19606274|NCT04617275|42055048|FG007|Treatment Period|Withdrawal by Subject|2|||
19606275|NCT04617275|42055041|FG000|Follow-up Period|Adverse Event|1|||
19606276|NCT04617275|42055042|FG001|Follow-up Period|Adverse Event|1|||
19606277|NCT04617275|42055043|FG002|Follow-up Period|Adverse Event|2|||
19691364|NCT00368966|42137119|FG001|After Infant|Failed to return|1|||
19365355|NCT03926611|41605329|FG003|Overall Study|Covid-19 pandemic|0|||
19606278|NCT04617275|42055044|FG003|Follow-up Period|Adverse Event|3|||
19606279|NCT04617275|42055045|FG004|Follow-up Period|Adverse Event|4|||
19606280|NCT04617275|42055046|FG005|Follow-up Period|Adverse Event|3|||
19606281|NCT04617275|42055047|FG006|Follow-up Period|Adverse Event|0|||
19606282|NCT04617275|42055048|FG007|Follow-up Period|Adverse Event|3|||
19606283|NCT04617275|42055041|FG000|Follow-up Period|Lost to Follow-up|0|||
19606284|NCT04617275|42055042|FG001|Follow-up Period|Lost to Follow-up|1|||
19691365|NCT00368966|42137118|FG000|After Infant|Adverse Event|1|||
19691366|NCT00368966|42137119|FG001|After Infant|Adverse Event|2|||
19691367|NCT00368966|42137118|FG000|After Infant|Withdrawal by Subject|1|||
19365356|NCT03926611|41605330|FG004|Overall Study|Covid-19 pandemic|1|||
19691368|NCT00368966|42137119|FG001|After Infant|Withdrawal by Subject|1|||
19691369|NCT00368966|42137118|FG000|After Infant|Death|1|||
19365357|NCT03926611|41605331|FG005|Overall Study|Covid-19 pandemic|2|||
19365358|NCT03926611|41605332|FG006|Overall Study|Covid-19 pandemic|0|||
19365359|NCT02818777|41605352|FG000|Overall Study|Adverse Event|3|||
19365360|NCT02817841|41605366|FG000|Overall Study|Lost to Follow-up|287|||
19606285|NCT04617275|42055043|FG002|Follow-up Period|Lost to Follow-up|2|||
19606286|NCT04617275|42055044|FG003|Follow-up Period|Lost to Follow-up|0|||
19606287|NCT04617275|42055045|FG004|Follow-up Period|Lost to Follow-up|0|||
19606288|NCT04617275|42055046|FG005|Follow-up Period|Lost to Follow-up|4|||
19606289|NCT04617275|42055047|FG006|Follow-up Period|Lost to Follow-up|0|||
19606290|NCT04617275|42055048|FG007|Follow-up Period|Lost to Follow-up|3|||
19606291|NCT04617275|42055041|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
19606292|NCT04617275|42055042|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
19606293|NCT04617275|42055043|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
19606294|NCT04617275|42055044|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
19606295|NCT04617275|42055045|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
19606296|NCT04617275|42055046|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
19606297|NCT04617275|42055047|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
19606298|NCT04617275|42055048|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
19606299|NCT04617275|42055041|FG000|Follow-up Period|Other|0|||
19691370|NCT00368966|42137119|FG001|After Infant|Death|0|||
19691371|NCT00368966|42137118|FG000|After Infant|Lost to Follow-up|0|||
19691372|NCT00368966|42137119|FG001|After Infant|Lost to Follow-up|1|||
19691373|NCT00368966|42137118|FG000|Toddler Dose|Withdrawal by Subject|1|||
19691374|NCT00368966|42137119|FG001|Toddler Dose|Withdrawal by Subject|1|||
19691375|NCT00368966|42137118|FG000|Toddler Dose|Lost to Follow-up|0|||
19606300|NCT04617275|42055042|FG001|Follow-up Period|Other|1|||
19606301|NCT04617275|42055043|FG002|Follow-up Period|Other|0|||
19691376|NCT00368966|42137119|FG001|Toddler Dose|Lost to Follow-up|2|||
19691377|NCT00114166|42137152|FG000|Overall Study|Wrong primary|0|||
19691378|NCT00114166|42137153|FG001|Overall Study|Wrong primary|1|||
19691379|NCT00125242|42137163|FG000|Overall Study|did not qualify|7|||
19691380|NCT00125242|42137164|FG001|Overall Study|did not qualify|2|||
19691381|NCT00337428|42137171|FG000|Overall Study|Withdrawal by Subject|1|||
19606302|NCT04617275|42055044|FG003|Follow-up Period|Other|0|||
19606303|NCT04617275|42055045|FG004|Follow-up Period|Other|0|||
19606304|NCT04617275|42055046|FG005|Follow-up Period|Other|0|||
19606305|NCT04617275|42055047|FG006|Follow-up Period|Other|0|||
19606306|NCT04617275|42055048|FG007|Follow-up Period|Other|0|||
19606307|NCT04617275|42055041|FG000|Follow-up Period|Withdrawal by Subject|2|||
19691382|NCT00337428|42137172|FG001|Overall Study|Withdrawal by Subject|2|||
19691383|NCT00337428|42137171|FG000|Overall Study|Lack of Time|1|||
19691384|NCT00337428|42137172|FG001|Overall Study|Lack of Time|1|||
19691385|NCT00337428|42137171|FG000|Overall Study|Unwilling to Continue|1|||
19691386|NCT00337428|42137172|FG001|Overall Study|Unwilling to Continue|0|||
19691387|NCT00337428|42137171|FG000|Overall Study|Anorexia|1|||
19691388|NCT00337428|42137172|FG001|Overall Study|Anorexia|0|||
19691389|NCT00235989|42137182|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
19691390|NCT00235989|42137183|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
19691391|NCT00235989|42137184|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
19691392|NCT00235989|42137185|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
19691393|NCT00235989|42137186|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
19691394|NCT00235989|42137187|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
19691395|NCT00235989|42137182|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
19691396|NCT00235989|42137183|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
19691397|NCT00235989|42137184|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
19691398|NCT00235989|42137185|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
19691399|NCT00235989|42137186|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
19691400|NCT00235989|42137187|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
19691401|NCT00235989|42137182|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
19691402|NCT00235989|42137183|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
19691403|NCT00235989|42137184|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
19691404|NCT00235989|42137185|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
19691405|NCT00235989|42137186|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
19477677|NCT01472081|41756933|FG003|Overall Study|Poor/non-compliance|0|||
19606308|NCT04617275|42055042|FG001|Follow-up Period|Withdrawal by Subject|0|||
19365361|NCT02817841|41605366|FG000|Overall Study|Withdrawal by Subject|183|||
19365362|NCT02817841|41605366|FG000|Overall Study|Adverse event not related to bleeding|131|||
19477678|NCT01472081|41756934|FG004|Overall Study|Poor/non-compliance|1|||
19606309|NCT04617275|42055043|FG002|Follow-up Period|Withdrawal by Subject|0|||
19606310|NCT04617275|42055044|FG003|Follow-up Period|Withdrawal by Subject|2|||
19606311|NCT04617275|42055045|FG004|Follow-up Period|Withdrawal by Subject|2|||
19691406|NCT00235989|42137187|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
19691407|NCT00235989|42137182|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
19691408|NCT00235989|42137183|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
19691409|NCT00235989|42137184|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
19365363|NCT02817841|41605366|FG000|Overall Study|Adverse event related to bleeding|51|||
19365364|NCT02817841|41605366|FG000|Overall Study|Pregnancy|32|||
19365365|NCT02817841|41605366|FG000|Overall Study|Pregnancy wish|17|||
19365366|NCT02817841|41605366|FG000|Overall Study|Other reasons|53|||
19365367|NCT02817841|41605366|FG000|Overall Study|Protocol Violation|94|||
19477679|NCT01472081|41756935|FG005|Overall Study|Poor/non-compliance|0|||
19477680|NCT01472081|41756930|FG000|Overall Study|No longer meets study criteria|0|||
19477681|NCT01472081|41756931|FG001|Overall Study|No longer meets study criteria|0|||
19477682|NCT01472081|41756932|FG002|Overall Study|No longer meets study criteria|1|||
19477683|NCT01472081|41756933|FG003|Overall Study|No longer meets study criteria|0|||
19477684|NCT01472081|41756934|FG004|Overall Study|No longer meets study criteria|0|||
19477685|NCT01472081|41756935|FG005|Overall Study|No longer meets study criteria|0|||
19477686|NCT01472081|41756930|FG000|Overall Study|Subject request to discontinue treatment|0|||
19477687|NCT01472081|41756931|FG001|Overall Study|Subject request to discontinue treatment|3|||
19477688|NCT01472081|41756932|FG002|Overall Study|Subject request to discontinue treatment|1|||
19477689|NCT01472081|41756933|FG003|Overall Study|Subject request to discontinue treatment|1|||
19477690|NCT01472081|41756934|FG004|Overall Study|Subject request to discontinue treatment|0|||
19477691|NCT01472081|41756935|FG005|Overall Study|Subject request to discontinue treatment|0|||
19477692|NCT01471691|41756950|FG000|Overall Study|Lack of Efficacy|0|||
19477693|NCT01471691|41756951|FG001|Overall Study|Lack of Efficacy|1|||
19477694|NCT01471379|41756960|FG000|Overall Study|Adverse Event|1|||
19477695|NCT01471379|41756961|FG001|Overall Study|Adverse Event|0|||
19477696|NCT01471379|41756962|FG002|Overall Study|Adverse Event|0|||
19477697|NCT01471379|41756960|FG000|Overall Study|Study terminated|0|||
19477698|NCT01471379|41756961|FG001|Overall Study|Study terminated|1|||
19477699|NCT01471379|41756962|FG002|Overall Study|Study terminated|0|||
19477700|NCT01470989|41756973|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
19477701|NCT01470989|41756974|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
19477702|NCT01470989|41756973|FG000|Overall Study|Adverse Event|2|||
19477703|NCT01470989|41756974|FG001|Overall Study|Adverse Event|5|||
19477704|NCT01470989|41756973|FG000|Overall Study|Abnormal laboratory value|1|||
19365368|NCT02814565|41605376|FG000|Overall Study|Lack of Efficacy|0|||
19365369|NCT02814565|41605377|FG001|Overall Study|Lack of Efficacy|1|||
19365370|NCT02814565|41605376|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
19365371|NCT02814565|41605377|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
19365372|NCT02650466|41605383|FG000|Overall Study|Physician Decision|1|||
19365373|NCT02650466|41605383|FG000|Overall Study|Withdrawal by Subject|5|||
19365374|NCT02650466|41605383|FG000|Overall Study|Lost to Follow-up|1|||
19365375|NCT02815735|41605389|FG000|First Intervention (4 Weeks)|Discomfort|1|||
19365376|NCT02815735|41605390|FG001|First Intervention (4 Weeks)|Discomfort|0|||
19365377|NCT02815735|41605389|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
19365378|NCT02815735|41605390|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
19365379|NCT02815735|41605389|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
19365380|NCT02815735|41605390|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
19365381|NCT02815735|41605389|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
19365382|NCT02815735|41605390|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
19365383|NCT02814643|41605407|FG000|Overall Study|Lost to Follow-up|0|||
19365384|NCT02814643|41605408|FG001|Overall Study|Lost to Follow-up|1|||
19365385|NCT02814643|41605407|FG000|Overall Study|Withdrawal by Subject|1|||
19365386|NCT02814643|41605408|FG001|Overall Study|Withdrawal by Subject|2|||
19365387|NCT02724111|41605416|FG000|Overall Study|Protocol Violation|2|||
19365388|NCT02724111|41605417|FG001|Overall Study|Protocol Violation|5|||
19365389|NCT02649218|41605423|FG000|Overall Study|Adverse Event|8|||
19365390|NCT02649218|41605423|FG000|Overall Study|Lack of Efficacy|8|||
19365391|NCT02649218|41605423|FG000|Overall Study|Pregnancy|3|||
19365392|NCT02649218|41605423|FG000|Overall Study|Protocol Violation|3|||
19365393|NCT02649218|41605423|FG000|Overall Study|Physician Decision|1|||
19365394|NCT02649218|41605423|FG000|Overall Study|Withdrawal by Subject|2|||
19365395|NCT02814175|41605430|FG000|Part 1|Adverse Event|2|||
19365396|NCT02814175|41605431|FG001|Part 1|Adverse Event|3|||
19365397|NCT02814175|41605432|FG002|Part 1|Adverse Event|0|||
19477705|NCT01470989|41756974|FG001|Overall Study|Abnormal laboratory value|1|||
19365398|NCT02814175|41605433|FG003|Part 1|Adverse Event|0|||
19365399|NCT02814175|41605434|FG004|Part 1|Adverse Event|0|||
19365400|NCT02814175|41605435|FG005|Part 1|Adverse Event|0|||
19365401|NCT02814175|41605430|FG000|Part 1|Withdrawal Consent|8|||
19365402|NCT02814175|41605431|FG001|Part 1|Withdrawal Consent|1|||
19477706|NCT01470989|41756973|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19477707|NCT01470989|41756974|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
19477708|NCT01470989|41756973|FG000|Overall Study|Withdrawal by Subject|19|||
19477709|NCT01470989|41756974|FG001|Overall Study|Withdrawal by Subject|17|||
19365403|NCT02814175|41605432|FG002|Part 1|Withdrawal Consent|0|||
19365404|NCT02814175|41605433|FG003|Part 1|Withdrawal Consent|0|||
19365405|NCT02814175|41605434|FG004|Part 1|Withdrawal Consent|0|||
19365406|NCT02814175|41605435|FG005|Part 1|Withdrawal Consent|0|||
19365407|NCT02814175|41605430|FG000|Part 1|Lost to Follow-up|1|||
19606312|NCT04617275|42055046|FG005|Follow-up Period|Withdrawal by Subject|0|||
19477710|NCT01470989|41756973|FG000|Overall Study|Lost to Follow-up|18|||
19477711|NCT01470989|41756974|FG001|Overall Study|Lost to Follow-up|13|||
19477712|NCT01470989|41756973|FG000|Overall Study|Administrative problems|2|||
19477713|NCT01470989|41756974|FG001|Overall Study|Administrative problems|4|||
19477714|NCT01470989|41756973|FG000|Overall Study|Death|2|||
19477715|NCT01470989|41756974|FG001|Overall Study|Death|2|||
19477716|NCT01470989|41756973|FG000|Overall Study|Protocol deviation|1|||
19477717|NCT01470989|41756974|FG001|Overall Study|Protocol deviation|2|||
19477718|NCT01470599|41756984|FG000|Overall Study|Did not meet entrance criteria|1|||
19477719|NCT01470599|41756985|FG001|Overall Study|Did not meet entrance criteria|0|||
19477720|NCT01470599|41756984|FG000|Overall Study|Lost to Follow-up|2|||
19477721|NCT01470599|41756985|FG001|Overall Study|Lost to Follow-up|1|||
19477722|NCT01470599|41756984|FG000|Overall Study|Withdrawal by Subject|3|||
19477723|NCT01470599|41756985|FG001|Overall Study|Withdrawal by Subject|4|||
19477724|NCT01470599|41756984|FG000|Overall Study|Other|1|||
19477725|NCT01470599|41756985|FG001|Overall Study|Other|0|||
19606313|NCT04617275|42055047|FG006|Follow-up Period|Withdrawal by Subject|1|||
19606314|NCT04617275|42055048|FG007|Follow-up Period|Withdrawal by Subject|2|||
19606315|NCT01031537|42055083|FG000|Overall Study|medical reasons not related to study|3|||
19606316|NCT01031537|42055083|FG000|Overall Study|Lack of Efficacy|1|||
19606317|NCT01031537|42055083|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
19606318|NCT01031537|42055083|FG000|Overall Study|moved, met exclusion criteria|10|||
19606319|NCT01031537|42055083|FG000|Overall Study|Withdrawal by Subject|5|||
19606320|NCT01031537|42055083|FG000|Overall Study|PI removal, no longer met eligibility|12|||
19606321|NCT01031381|42055087|FG000|Overall Study|Physician Decision|3|||
19606322|NCT01031381|42055087|FG000|Overall Study|Withdrawal by Subject|6|||
19606323|NCT00685399|42055099|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19606324|NCT00685399|42055100|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19606325|NCT00685399|42055101|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19606326|NCT00685399|42055102|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19606327|NCT00685399|42055103|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19606328|NCT00685399|42055104|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19606329|NCT00685399|42055105|FG006|Treatment Period 1|Withdrawal by Subject|0|||
19606330|NCT00685399|42055106|FG007|Treatment Period 1|Withdrawal by Subject|0|||
19606331|NCT00685399|42055099|FG000|Treatment Period 1|Protocol Violation|1|||
19606332|NCT00685399|42055100|FG001|Treatment Period 1|Protocol Violation|0|||
19606333|NCT00685399|42055101|FG002|Treatment Period 1|Protocol Violation|0|||
19606334|NCT00685399|42055102|FG003|Treatment Period 1|Protocol Violation|0|||
19606335|NCT00685399|42055103|FG004|Treatment Period 1|Protocol Violation|0|||
19606336|NCT00685399|42055104|FG005|Treatment Period 1|Protocol Violation|0|||
19606337|NCT00685399|42055105|FG006|Treatment Period 1|Protocol Violation|0|||
19606338|NCT00685399|42055106|FG007|Treatment Period 1|Protocol Violation|0|||
19606339|NCT00685399|42055099|FG000|Treatment Period 1|Administrative|2|||
19606340|NCT00685399|42055100|FG001|Treatment Period 1|Administrative|0|||
19606341|NCT00685399|42055101|FG002|Treatment Period 1|Administrative|0|||
19606342|NCT00685399|42055102|FG003|Treatment Period 1|Administrative|0|||
19606343|NCT00685399|42055103|FG004|Treatment Period 1|Administrative|0|||
19606344|NCT00685399|42055104|FG005|Treatment Period 1|Administrative|0|||
19606345|NCT00685399|42055105|FG006|Treatment Period 1|Administrative|0|||
19606346|NCT00685399|42055106|FG007|Treatment Period 1|Administrative|0|||
19606347|NCT00685399|42055099|FG000|Treatment Period 1|Lack of Efficacy|1|||
19606348|NCT00685399|42055100|FG001|Treatment Period 1|Lack of Efficacy|0|||
19606349|NCT00685399|42055101|FG002|Treatment Period 1|Lack of Efficacy|0|||
19606350|NCT00685399|42055102|FG003|Treatment Period 1|Lack of Efficacy|0|||
19606351|NCT00685399|42055103|FG004|Treatment Period 1|Lack of Efficacy|0|||
19606352|NCT00685399|42055104|FG005|Treatment Period 1|Lack of Efficacy|0|||
19606353|NCT00685399|42055105|FG006|Treatment Period 1|Lack of Efficacy|0|||
19606354|NCT00685399|42055106|FG007|Treatment Period 1|Lack of Efficacy|0|||
19606355|NCT00685399|42055099|FG000|Treatment Period 2|Administrative Problems|0|||
19606356|NCT00685399|42055100|FG001|Treatment Period 2|Administrative Problems|2|||
19606357|NCT00685399|42055101|FG002|Treatment Period 2|Administrative Problems|1|||
19606358|NCT00685399|42055102|FG003|Treatment Period 2|Administrative Problems|0|||
19606359|NCT00685399|42055103|FG004|Treatment Period 2|Administrative Problems|0|||
19606360|NCT00685399|42055104|FG005|Treatment Period 2|Administrative Problems|0|||
19606361|NCT00685399|42055105|FG006|Treatment Period 2|Administrative Problems|0|||
19606362|NCT00685399|42055106|FG007|Treatment Period 2|Administrative Problems|0|||
19606363|NCT00685399|42055099|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19606364|NCT00685399|42055100|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19606365|NCT00685399|42055101|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19606366|NCT00685399|42055102|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19606367|NCT00685399|42055103|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19606368|NCT00685399|42055104|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19606369|NCT00685399|42055105|FG006|Treatment Period 2|Withdrawal by Subject|0|||
19606370|NCT00685399|42055106|FG007|Treatment Period 2|Withdrawal by Subject|2|||
19477726|NCT01470599|41756984|FG000|Overall Study|Protocol Violation|3|||
19365408|NCT02814175|41605431|FG001|Part 1|Lost to Follow-up|0|||
19365409|NCT02814175|41605432|FG002|Part 1|Lost to Follow-up|0|||
19365410|NCT02814175|41605433|FG003|Part 1|Lost to Follow-up|0|||
19365411|NCT02814175|41605434|FG004|Part 1|Lost to Follow-up|0|||
19365412|NCT02814175|41605435|FG005|Part 1|Lost to Follow-up|0|||
19365413|NCT02814175|41605430|FG000|Part 1|Lack of Efficacy|1|||
19365414|NCT02814175|41605431|FG001|Part 1|Lack of Efficacy|2|||
19477727|NCT01470599|41756985|FG001|Overall Study|Protocol Violation|1|||
19477728|NCT01470599|41756984|FG000|Overall Study|Adverse event related to study drug|2|||
19477729|NCT01470599|41756985|FG001|Overall Study|Adverse event related to study drug|5|||
19477730|NCT01470599|41756984|FG000|Overall Study|Insufficient clinical response|6|||
19477731|NCT01470599|41756985|FG001|Overall Study|Insufficient clinical response|27|||
19477732|NCT01470599|41756984|FG000|Overall Study|Adverse event not related to study drug|1|||
19365415|NCT02814175|41605432|FG002|Part 1|Lack of Efficacy|0|||
19365416|NCT02814175|41605433|FG003|Part 1|Lack of Efficacy|0|||
19365417|NCT02814175|41605434|FG004|Part 1|Lack of Efficacy|0|||
19365418|NCT02814175|41605435|FG005|Part 1|Lack of Efficacy|0|||
19365419|NCT02814175|41605430|FG000|Part 2|Adverse Event|0|||
19365420|NCT02814175|41605431|FG001|Part 2|Adverse Event|0|||
19365421|NCT02814175|41605432|FG002|Part 2|Adverse Event|0|||
19365422|NCT02814175|41605433|FG003|Part 2|Adverse Event|1|||
19365423|NCT02814175|41605434|FG004|Part 2|Adverse Event|1|||
19365424|NCT02814175|41605435|FG005|Part 2|Adverse Event|2|||
19365425|NCT02814175|41605430|FG000|Part 2|Withdrawal Consent|0|||
19477733|NCT01470599|41756985|FG001|Overall Study|Adverse event not related to study drug|5|||
19691410|NCT00235989|42137185|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
19691411|NCT00235989|42137186|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
19691412|NCT00235989|42137187|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
19691413|NCT00235989|42137182|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
19691414|NCT00235989|42137183|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
19691415|NCT00235989|42137184|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
19691416|NCT00235989|42137185|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
19691417|NCT00235989|42137186|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
19691418|NCT00235989|42137187|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
19691419|NCT00113386|42137199|FG000|Overall Study|Withdrawal by Subject|1|||
19691420|NCT00113386|42137200|FG001|Overall Study|Withdrawal by Subject|0|||
19691421|NCT00113386|42137199|FG000|Overall Study|Physician Decision|0|||
19691422|NCT00113386|42137200|FG001|Overall Study|Physician Decision|1|||
19691423|NCT00113386|42137199|FG000|Overall Study|Toxicity|3|||
19691424|NCT00113386|42137200|FG001|Overall Study|Toxicity|0|||
19691425|NCT00113386|42137199|FG000|Overall Study|Ineligible|1|||
19691426|NCT00113386|42137200|FG001|Overall Study|Ineligible|2|||
19691427|NCT00113386|42137199|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
19691428|NCT00113386|42137200|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
19773355|NCT02960490|42227708|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
19773356|NCT02960490|42227709|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
19773357|NCT02960490|42227710|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19365426|NCT02814175|41605431|FG001|Part 2|Withdrawal Consent|0|||
19365427|NCT02814175|41605432|FG002|Part 2|Withdrawal Consent|0|||
19365428|NCT02814175|41605433|FG003|Part 2|Withdrawal Consent|2|||
19365429|NCT02814175|41605434|FG004|Part 2|Withdrawal Consent|1|||
19365430|NCT02814175|41605435|FG005|Part 2|Withdrawal Consent|1|||
19365431|NCT02814175|41605430|FG000|Part 2|Lost to Follow-up|0|||
19365432|NCT02814175|41605431|FG001|Part 2|Lost to Follow-up|0|||
19365433|NCT02814175|41605432|FG002|Part 2|Lost to Follow-up|0|||
19365434|NCT02814175|41605433|FG003|Part 2|Lost to Follow-up|1|||
19365435|NCT02814175|41605434|FG004|Part 2|Lost to Follow-up|0|||
19365436|NCT02814175|41605435|FG005|Part 2|Lost to Follow-up|0|||
19365437|NCT02814175|41605430|FG000|Part 2|Lack of Efficacy|0|||
19365438|NCT02814175|41605431|FG001|Part 2|Lack of Efficacy|0|||
19365439|NCT02814175|41605432|FG002|Part 2|Lack of Efficacy|0|||
19365440|NCT02814175|41605433|FG003|Part 2|Lack of Efficacy|0|||
19365441|NCT02814175|41605434|FG004|Part 2|Lack of Efficacy|0|||
19477734|NCT01469819|41756991|FG000|Overall Study|Withdrawal by Subject|1|||
19606371|NCT00685399|42055099|FG000|Treatment Period 2|Adverse Event|0|||
19606372|NCT00685399|42055100|FG001|Treatment Period 2|Adverse Event|0|||
19606373|NCT00685399|42055101|FG002|Treatment Period 2|Adverse Event|0|||
19606374|NCT00685399|42055102|FG003|Treatment Period 2|Adverse Event|0|||
19606375|NCT00685399|42055103|FG004|Treatment Period 2|Adverse Event|0|||
19606376|NCT00685399|42055104|FG005|Treatment Period 2|Adverse Event|1|||
19606377|NCT00685399|42055105|FG006|Treatment Period 2|Adverse Event|0|||
19606378|NCT00685399|42055106|FG007|Treatment Period 2|Adverse Event|0|||
19606379|NCT00685399|42055099|FG000|Treatment Period 2|Lack of Efficacy|0|||
19606380|NCT00685399|42055100|FG001|Treatment Period 2|Lack of Efficacy|10|||
19691429|NCT00353262|42137206|FG000|Overall Study|Adverse Event|8|||
19365442|NCT02814175|41605435|FG005|Part 2|Lack of Efficacy|3|||
19365443|NCT01335997|41605451|FG000|Period I and II|Adverse Event|63|||
19365444|NCT01335997|41605452|FG001|Period I and II|Adverse Event|43|||
19691430|NCT00353262|42137206|FG000|Overall Study|Withdrawal by Subject|2|||
19477735|NCT01469819|41756991|FG000|Overall Study|Did not meet inclusionary criteria|2|||
19477736|NCT01469819|41756991|FG000|Overall Study|Could not swallow SmartPill|2|||
19477737|NCT01469819|41756991|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
19691431|NCT00353262|42137206|FG000|Overall Study|Insufficient Therapeutic Response|13|||
19365445|NCT01335997|41605451|FG000|Period I and II|Noncompliance with Study Drug|1|||
19365446|NCT01335997|41605452|FG001|Period I and II|Noncompliance with Study Drug|1|||
19365447|NCT01335997|41605451|FG000|Period I and II|Lost to Follow-up|3|||
19365448|NCT01335997|41605452|FG001|Period I and II|Lost to Follow-up|5|||
19365449|NCT01335997|41605451|FG000|Period I and II|Withdrawal by Subject|9|||
19365450|NCT01335997|41605452|FG001|Period I and II|Withdrawal by Subject|4|||
19365451|NCT01335997|41605451|FG000|Period I and II|Study Terminated by Sponsor|406|||
19365452|NCT01335997|41605452|FG001|Period I and II|Study Terminated by Sponsor|415|||
19365453|NCT01335997|41605451|FG000|Period I and II|Protocol Violation|9|||
19365454|NCT01335997|41605452|FG001|Period I and II|Protocol Violation|10|||
19365455|NCT01335997|41605451|FG000|Period I and II|Physician Decision|2|||
19365456|NCT01335997|41605452|FG001|Period I and II|Physician Decision|1|||
19365457|NCT01335997|41605451|FG000|Period III|Adverse Event|0|||
19365458|NCT01335997|41605452|FG001|Period III|Adverse Event|2|||
19365459|NCT01335997|41605451|FG000|Period III|Study Terminated by Sponsor|77|||
19365460|NCT01335997|41605452|FG001|Period III|Study Terminated by Sponsor|76|||
19365461|NCT01335997|41605451|FG000|Period III|Protocol Violation|0|||
19365462|NCT01335997|41605452|FG001|Period III|Protocol Violation|1|||
19365463|NCT01335997|41605451|FG000|Period III|Lost to Follow-up|1|||
19365464|NCT01335997|41605452|FG001|Period III|Lost to Follow-up|0|||
19365465|NCT02725671|41605460|FG000|Overall Study|Lost to Follow-up|1|||
19365466|NCT02446990|41605468|FG000|Overall Study|Death|485|||
19365467|NCT02446990|41605469|FG001|Overall Study|Death|458|||
19365468|NCT02446990|41605468|FG000|Overall Study|Lost to Follow-up|3|||
19365469|NCT02446990|41605469|FG001|Overall Study|Lost to Follow-up|1|||
19365470|NCT02446990|41605468|FG000|Overall Study|Physician Decision|1|||
19365471|NCT02446990|41605469|FG001|Overall Study|Physician Decision|0|||
19365472|NCT02446990|41605468|FG000|Overall Study|Withdrawal by Subject|231|||
19365473|NCT02446990|41605469|FG001|Overall Study|Withdrawal by Subject|199|||
19365474|NCT02725515|41605477|FG000|Overall Study|Refused infusion (no study treatment)|1|||
19365475|NCT02725515|41605478|FG001|Overall Study|Refused infusion (no study treatment)|0|||
19365476|NCT02725515|41605477|FG000|Overall Study|Loss of Improvement per Protocol|14|||
19691432|NCT00353262|42137206|FG000|Overall Study|Progression|1|||
19691433|NCT00353262|42137206|FG000|Overall Study|Surgery|4|||
19691434|NCT00353262|42137206|FG000|Overall Study|Break from Chemotherapy|1|||
19691435|NCT00337272|42137212|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
19691436|NCT00337272|42137213|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
19691437|NCT00337272|42137212|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
19691438|NCT00337272|42137213|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
19691439|NCT00337272|42137212|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
19691440|NCT00337272|42137213|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
19691441|NCT00337272|42137212|FG000|Treatment Period|Non-compliance|1|||
19691442|NCT00337272|42137213|FG001|Treatment Period|Non-compliance|1|||
19691443|NCT00337272|42137212|FG000|Treatment Period|Withdrawal by Subject|0|||
19691444|NCT00337272|42137213|FG001|Treatment Period|Withdrawal by Subject|1|||
19691445|NCT00337272|42137212|FG000|Withdrawal Period|Non-compliance|0|||
19691446|NCT00337272|42137213|FG001|Withdrawal Period|Non-compliance|1|||
19691447|NCT00125164|42137223|FG000|Overall Study|Adverse Event|0|||
19691448|NCT00125164|42137224|FG001|Overall Study|Adverse Event|0|||
19691449|NCT00125164|42137225|FG002|Overall Study|Adverse Event|2|||
19691450|NCT00125164|42137226|FG003|Overall Study|Adverse Event|4|||
19773358|NCT02960490|42227711|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
19773359|NCT02960490|42227712|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19773360|NCT02960490|42227713|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19773361|NCT02960490|42227714|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19691451|NCT00125164|42137223|FG000|Overall Study|Lost to Follow-up|0|||
19691452|NCT00125164|42137224|FG001|Overall Study|Lost to Follow-up|0|||
19691453|NCT00125164|42137225|FG002|Overall Study|Lost to Follow-up|1|||
19773362|NCT02960490|42227715|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
19365477|NCT02725515|41605478|FG001|Overall Study|Loss of Improvement per Protocol|25|||
19691454|NCT00125164|42137226|FG003|Overall Study|Lost to Follow-up|1|||
19773363|NCT02960490|42227706|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773364|NCT02960490|42227707|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19365478|NCT02725515|41605477|FG000|Overall Study|Withdrawal by Subject|2|||
19691455|NCT00125164|42137223|FG000|Overall Study|Withdrawal by Subject|2|||
19691456|NCT00125164|42137224|FG001|Overall Study|Withdrawal by Subject|0|||
19365479|NCT02725515|41605478|FG001|Overall Study|Withdrawal by Subject|1|||
19365480|NCT02725515|41605477|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19691457|NCT00125164|42137225|FG002|Overall Study|Withdrawal by Subject|1|||
19691458|NCT00125164|42137226|FG003|Overall Study|Withdrawal by Subject|1|||
19691459|NCT00136318|42137238|FG000|Overall Study|Adverse Event|5|||
19365481|NCT02725515|41605478|FG001|Overall Study|Non-Compliance With Study Drug|3|||
19365482|NCT02725515|41605477|FG000|Overall Study|Lost to Follow-up|1|||
19365483|NCT02725515|41605478|FG001|Overall Study|Lost to Follow-up|1|||
19365484|NCT02725515|41605477|FG000|Overall Study|Adverse Event|7|||
19365485|NCT02725515|41605478|FG001|Overall Study|Adverse Event|2|||
19773365|NCT02960490|42227708|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
19773366|NCT02960490|42227709|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773367|NCT02960490|42227710|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
19773368|NCT02960490|42227711|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773369|NCT02960490|42227712|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773370|NCT02960490|42227713|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773371|NCT02960490|42227714|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19691460|NCT00136318|42137239|FG001|Overall Study|Adverse Event|5|||
19691461|NCT00136318|42137238|FG000|Overall Study|Withdrawal by Subject|2|||
19773372|NCT02960490|42227715|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
19773373|NCT02960490|42227706|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
19773374|NCT02960490|42227707|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
19773375|NCT02960490|42227708|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
19773376|NCT02960490|42227709|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
19773377|NCT02960490|42227710|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
19773378|NCT02960490|42227711|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
19773379|NCT02960490|42227712|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
19773380|NCT02960490|42227713|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
19773381|NCT02960490|42227714|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
19773382|NCT02960490|42227715|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
19773383|NCT02960490|42227706|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773384|NCT02960490|42227707|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773385|NCT02960490|42227708|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773386|NCT02960490|42227709|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773387|NCT02960490|42227710|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773388|NCT02960490|42227711|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773389|NCT02960490|42227712|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
19773390|NCT02960490|42227713|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
19773391|NCT02960490|42227714|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
19773392|NCT02960490|42227715|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
19773393|NCT02960490|42227706|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773394|NCT02960490|42227707|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773395|NCT02960490|42227708|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773396|NCT02960490|42227709|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773397|NCT02960490|42227710|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773398|NCT02960490|42227711|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773399|NCT02960490|42227712|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773400|NCT02960490|42227713|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
19773401|NCT02960490|42227714|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773402|NCT02960490|42227715|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
19773403|NCT02960490|42227706|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773404|NCT02960490|42227707|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773405|NCT02960490|42227708|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773406|NCT02960490|42227709|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773407|NCT02960490|42227710|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773408|NCT02960490|42227711|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
19773409|NCT02960490|42227712|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
19773410|NCT02960490|42227713|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
19773411|NCT02960490|42227714|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
19773412|NCT02960490|42227715|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
19773413|NCT02960490|42227706|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773414|NCT02960490|42227707|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19365486|NCT02725515|41605477|FG000|Overall Study|No Documented Disease Improvement|0|||
19365487|NCT02725515|41605478|FG001|Overall Study|No Documented Disease Improvement|1|||
19365488|NCT02725515|41605477|FG000|Overall Study|Completed Study Under Original Protocol|0|||
19691462|NCT00136318|42137239|FG001|Overall Study|Withdrawal by Subject|2|||
19691463|NCT00136084|42137248|FG000|Overall Study|Death|12|||
19691464|NCT00136084|42137249|FG001|Overall Study|Death|5|||
19691465|NCT00136084|42137248|FG000|Overall Study|Unacceptable toxicity|8|||
19691466|NCT00136084|42137249|FG001|Overall Study|Unacceptable toxicity|11|||
19773415|NCT02960490|42227708|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19365489|NCT02725515|41605478|FG001|Overall Study|Completed Study Under Original Protocol|1|||
19691467|NCT00136084|42137248|FG000|Overall Study|Relapse|20|||
19365490|NCT02725515|41605477|FG000|Overall Study|Lack of Response|0|||
19365491|NCT02725515|41605478|FG001|Overall Study|Lack of Response|1|||
19365492|NCT02416180|41605484|FG000|Overall Study|Withdrawal by Subject|1|||
19365493|NCT02473510|41605490|FG000|Overall Study|Lost to Follow-up|1|||
19365494|NCT02473510|41605491|FG001|Overall Study|Lost to Follow-up|2|||
19365495|NCT02445586|41605497|FG000|Overall Study|Death|14|||
19365496|NCT02445586|41605497|FG000|Overall Study|Withdrawal by Subject|13|||
19365497|NCT02445586|41605497|FG000|Overall Study|Disease Progression|10|||
19365498|NCT02445586|41605497|FG000|Overall Study|Protocol Violation|1|||
19365499|NCT02445586|41605497|FG000|Overall Study|Medical Condition|1|||
19365500|NCT01674062|41605503|FG000|Overall Study|Insufficient Therapeutic Response|56|||
19365501|NCT01674062|41605504|FG001|Overall Study|Insufficient Therapeutic Response|26|||
19365502|NCT01674062|41605503|FG000|Overall Study|Other|8|||
19365503|NCT01674062|41605504|FG001|Overall Study|Other|1|||
19365504|NCT01674062|41605503|FG000|Overall Study|Adverse Event|1|||
19365505|NCT01674062|41605504|FG001|Overall Study|Adverse Event|1|||
19365506|NCT01674062|41605503|FG000|Overall Study|Death|0|||
19365507|NCT01674062|41605504|FG001|Overall Study|Death|1|||
19365508|NCT01674062|41605503|FG000|Overall Study|Programming Error|1|||
19365509|NCT01674062|41605504|FG001|Overall Study|Programming Error|0|||
19365510|NCT02472886|41605513|FG000|Overall Study|Lack of Efficacy|0|||
19365511|NCT02472886|41605514|FG001|Overall Study|Lack of Efficacy|2|||
19365512|NCT02472886|41605515|FG002|Overall Study|Lack of Efficacy|1|||
19606381|NCT00685399|42055101|FG002|Treatment Period 2|Lack of Efficacy|2|||
19606382|NCT00685399|42055102|FG003|Treatment Period 2|Lack of Efficacy|0|||
19606383|NCT00685399|42055103|FG004|Treatment Period 2|Lack of Efficacy|0|||
19606384|NCT00685399|42055104|FG005|Treatment Period 2|Lack of Efficacy|1|||
19691468|NCT00136084|42137249|FG001|Overall Study|Relapse|23|||
19691469|NCT00136084|42137248|FG000|Overall Study|Lost to Follow-up|2|||
19691470|NCT00136084|42137249|FG001|Overall Study|Lost to Follow-up|0|||
19691471|NCT00136084|42137248|FG000|Overall Study|No Response|1|||
19691472|NCT00136084|42137249|FG001|Overall Study|No Response|2|||
19691473|NCT00136084|42137248|FG000|Overall Study|Withdrawal by Subject|5|||
19365513|NCT02472652|41605528|FG000|Overall Study|Lost to Follow-up|1|||
19606385|NCT00685399|42055105|FG006|Treatment Period 2|Lack of Efficacy|0|||
19606386|NCT00685399|42055106|FG007|Treatment Period 2|Lack of Efficacy|0|||
19606387|NCT00685399|42055099|FG000|Extension|Administrative Issues|0|||
19606388|NCT00685399|42055100|FG001|Extension|Administrative Issues|0|||
19606389|NCT00685399|42055101|FG002|Extension|Administrative Issues|0|||
19606390|NCT00685399|42055102|FG003|Extension|Administrative Issues|1|||
19606391|NCT00685399|42055103|FG004|Extension|Administrative Issues|0|||
19606392|NCT00685399|42055104|FG005|Extension|Administrative Issues|0|||
19606393|NCT00685399|42055105|FG006|Extension|Administrative Issues|0|||
19606394|NCT00685399|42055106|FG007|Extension|Administrative Issues|0|||
19606395|NCT00685399|42055099|FG000|Extension|Withdrawal by Subject|0|||
19606396|NCT00685399|42055100|FG001|Extension|Withdrawal by Subject|0|||
19606397|NCT00685399|42055101|FG002|Extension|Withdrawal by Subject|0|||
19606398|NCT00685399|42055102|FG003|Extension|Withdrawal by Subject|1|||
19606399|NCT00685399|42055103|FG004|Extension|Withdrawal by Subject|0|||
19606400|NCT00685399|42055104|FG005|Extension|Withdrawal by Subject|0|||
19606401|NCT00685399|42055105|FG006|Extension|Withdrawal by Subject|0|||
19606402|NCT00685399|42055106|FG007|Extension|Withdrawal by Subject|0|||
19606403|NCT00685399|42055099|FG000|Extension|Protocol Violation|0|||
19606404|NCT00685399|42055100|FG001|Extension|Protocol Violation|0|||
19606405|NCT00685399|42055101|FG002|Extension|Protocol Violation|0|||
19606406|NCT00685399|42055102|FG003|Extension|Protocol Violation|1|||
19606407|NCT00685399|42055103|FG004|Extension|Protocol Violation|0|||
19606408|NCT00685399|42055104|FG005|Extension|Protocol Violation|0|||
19606409|NCT00685399|42055105|FG006|Extension|Protocol Violation|0|||
19606410|NCT00685399|42055106|FG007|Extension|Protocol Violation|0|||
19606411|NCT00685399|42055099|FG000|Extension|Lack of Efficacy|0|||
19606412|NCT00685399|42055100|FG001|Extension|Lack of Efficacy|0|||
19606413|NCT00685399|42055101|FG002|Extension|Lack of Efficacy|0|||
19606414|NCT00685399|42055102|FG003|Extension|Lack of Efficacy|2|||
19606415|NCT00685399|42055103|FG004|Extension|Lack of Efficacy|0|||
19606416|NCT00685399|42055104|FG005|Extension|Lack of Efficacy|0|||
19606417|NCT00685399|42055105|FG006|Extension|Lack of Efficacy|0|||
19773416|NCT02960490|42227709|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19365514|NCT02807857|41605532|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
19365515|NCT02807857|41605532|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
19365516|NCT02807857|41605532|FG000|Follow-Up Set|Withdrawal by Subject|8|||
19606418|NCT00685399|42055106|FG007|Extension|Lack of Efficacy|0|||
19606419|NCT00685399|42055099|FG000|Extension|Adverse Event|0|||
19606420|NCT00685399|42055100|FG001|Extension|Adverse Event|0|||
19606421|NCT00685399|42055101|FG002|Extension|Adverse Event|0|||
19606422|NCT00685399|42055102|FG003|Extension|Adverse Event|2|||
19606423|NCT00685399|42055103|FG004|Extension|Adverse Event|0|||
19606424|NCT00685399|42055104|FG005|Extension|Adverse Event|0|||
19606425|NCT00685399|42055105|FG006|Extension|Adverse Event|0|||
19606426|NCT00685399|42055106|FG007|Extension|Adverse Event|0|||
19691474|NCT00136084|42137249|FG001|Overall Study|Withdrawal by Subject|1|||
19773417|NCT02960490|42227710|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773418|NCT02960490|42227711|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773419|NCT02960490|42227712|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
19773420|NCT02960490|42227713|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773421|NCT02960490|42227714|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773422|NCT02960490|42227715|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
19773423|NCT02960490|42227706|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773424|NCT02960490|42227707|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773425|NCT02960490|42227708|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773426|NCT02960490|42227709|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773427|NCT02960490|42227710|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773428|NCT02960490|42227711|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773429|NCT02960490|42227712|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773430|NCT02960490|42227713|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
19773431|NCT02960490|42227714|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
19365517|NCT02807857|41605532|FG000|Follow-Up Set|Lost to Follow-up|7|||
19773432|NCT02960490|42227715|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
19773433|NCT02804750|42227739|FG000|Period 1|Adverse Event|0|||
19773434|NCT02804750|42227740|FG001|Period 1|Adverse Event|2|||
19773435|NCT02804750|42227739|FG000|Period 1|Withdrawal by Subject|0|||
19773436|NCT02804750|42227740|FG001|Period 1|Withdrawal by Subject|1|||
19773437|NCT02804750|42227739|FG000|Period 2|Adverse Event|1|||
19773438|NCT02804750|42227740|FG001|Period 2|Adverse Event|0|||
19773439|NCT02804750|42227739|FG000|Period 3|Adverse Event|0|||
19773440|NCT02804750|42227740|FG001|Period 3|Adverse Event|2|||
19773441|NCT02804750|42227739|FG000|Period 4|Adverse Event|0|||
19773442|NCT02804750|42227740|FG001|Period 4|Adverse Event|5|||
19773443|NCT02959866|42227748|FG000|Overall Study|Withdrawal by Subject|1|||
19773444|NCT02748512|42227755|FG000|Overall Study|Lost to Follow-up|1|||
19773445|NCT02748512|42227756|FG001|Overall Study|Lost to Follow-up|1|||
19773446|NCT02748356|42227762|FG000|Overall Study|Withdrawal by Subject|1|||
19773447|NCT03439657|42227768|FG000|Overall Study|Adverse Event|2|||
19773448|NCT03439657|42227769|FG001|Overall Study|Adverse Event|3|||
19773449|NCT03439657|42227768|FG000|Overall Study|Lost to Follow-up|1|||
19773450|NCT03439657|42227769|FG001|Overall Study|Lost to Follow-up|0|||
19773451|NCT03439657|42227768|FG000|Overall Study|Protocol Violation|1|||
19691475|NCT00364832|42137270|FG000|Core Period|Early Withdrawals|2|||
19691476|NCT00364832|42137271|FG001|Core Period|Early Withdrawals|2|||
19691477|NCT00364832|42137272|FG002|Core Period|Early Withdrawals|1|||
19691478|NCT00364832|42137273|FG003|Core Period|Early Withdrawals|1|||
19691479|NCT00364832|42137274|FG004|Core Period|Early Withdrawals|0|||
19691480|NCT00364832|42137275|FG005|Core Period|Early Withdrawals|0|||
19773452|NCT03439657|42227769|FG001|Overall Study|Protocol Violation|1|||
19773453|NCT03439657|42227768|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
19773454|NCT03439657|42227769|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
19773455|NCT02803580|42227777|FG000|Overall Study|Death|13|||
19773456|NCT02803580|42227777|FG000|Overall Study|Lost to Follow-up|19|||
19773457|NCT02803580|42227777|FG000|Overall Study|Withdrawal by Subject|3|||
19365518|NCT02807857|41605532|FG000|Follow-Up Set|Physician Decision|6|||
19365519|NCT02807857|41605532|FG000|Follow-Up Set|Adverse Event|3|||
19365520|NCT02807857|41605532|FG000|Follow-Up Set|Death|27|||
19365521|NCT02807857|41605532|FG000|Follow-Up Set|Relocation|2|||
19365522|NCT02648438|41605545|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19365523|NCT02648438|41605546|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
19365524|NCT02648438|41605547|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
19365525|NCT02648438|41605545|FG000|Overall Study|Protocol Violation|2|||
19365526|NCT02648438|41605546|FG001|Overall Study|Protocol Violation|0|||
19691481|NCT00364832|42137276|FG006|Core Period|Early Withdrawals|4|||
19691482|NCT00364832|42137277|FG007|Core Period|Early Withdrawals|1|||
19691483|NCT00364832|42137278|FG008|Core Period|Early Withdrawals|0|||
19691484|NCT00364832|42137279|FG009|Core Period|Early Withdrawals|0|||
19691485|NCT00364832|42137280|FG010|Core Period|Early Withdrawals|0|||
19691486|NCT00364832|42137281|FG011|Core Period|Early Withdrawals|0|||
19691487|NCT00364832|42137270|FG000|Extension Year 1|Early Withdrawals|0|||
19773458|NCT02803580|42227777|FG000|Overall Study|Inclusion in clinical trial|1|||
19773459|NCT02878213|42227781|FG000|Overall Study|Withdrawal by Subject|2|||
19773460|NCT02878213|42227781|FG000|Overall Study|Adverse Event|1|||
19773461|NCT02802878|42227788|FG000|Overall Study|Withdrawal by Subject|3|||
19773462|NCT02802878|42227789|FG001|Overall Study|Withdrawal by Subject|3|||
19773463|NCT02802878|42227788|FG000|Overall Study|Protocol Violation|1|||
19773464|NCT02802878|42227789|FG001|Overall Study|Protocol Violation|0|||
19691488|NCT00364832|42137271|FG001|Extension Year 1|Early Withdrawals|0|||
19773465|NCT02801396|42227795|FG000|Period 1|Withdrawal by Subject|0|||
19691489|NCT00364832|42137272|FG002|Extension Year 1|Early Withdrawals|0|||
19691490|NCT00364832|42137273|FG003|Extension Year 1|Early Withdrawals|0|||
19691491|NCT00364832|42137274|FG004|Extension Year 1|Early Withdrawals|0|||
19691492|NCT00364832|42137275|FG005|Extension Year 1|Early Withdrawals|0|||
19691493|NCT00364832|42137276|FG006|Extension Year 1|Early Withdrawals|0|||
19691494|NCT00364832|42137277|FG007|Extension Year 1|Early Withdrawals|0|||
19691495|NCT00364832|42137278|FG008|Extension Year 1|Early Withdrawals|0|||
19691496|NCT00364832|42137279|FG009|Extension Year 1|Early Withdrawals|4|||
19691497|NCT00364832|42137280|FG010|Extension Year 1|Early Withdrawals|2|||
19691498|NCT00364832|42137281|FG011|Extension Year 1|Early Withdrawals|10|||
19691499|NCT00364832|42137270|FG000|Extension Year 2|Early Withdrawals|0|||
19691500|NCT00364832|42137271|FG001|Extension Year 2|Early Withdrawals|0|||
19691501|NCT00364832|42137272|FG002|Extension Year 2|Early Withdrawals|0|||
19365527|NCT02648438|41605547|FG002|Overall Study|Protocol Violation|0|||
19365528|NCT02648438|41605545|FG000|Overall Study|Withdrawal by Subject|1|||
19365529|NCT02648438|41605546|FG001|Overall Study|Withdrawal by Subject|1|||
19365530|NCT02648438|41605547|FG002|Overall Study|Withdrawal by Subject|0|||
19365531|NCT02415556|41605567|FG000|Overall Study|Adverse Event|3|||
19365532|NCT02415556|41605568|FG001|Overall Study|Adverse Event|4|||
19365533|NCT02415556|41605569|FG002|Overall Study|Adverse Event|2|||
19365534|NCT02415556|41605570|FG003|Overall Study|Adverse Event|4|||
19365535|NCT02415556|41605567|FG000|Overall Study|Lost to Follow-up|4|||
19365536|NCT02415556|41605568|FG001|Overall Study|Lost to Follow-up|5|||
19365537|NCT02415556|41605569|FG002|Overall Study|Lost to Follow-up|4|||
19365538|NCT02415556|41605570|FG003|Overall Study|Lost to Follow-up|1|||
19365539|NCT02415556|41605567|FG000|Overall Study|Withdrawal by Subject|13|||
19365540|NCT02415556|41605568|FG001|Overall Study|Withdrawal by Subject|4|||
19365541|NCT02415556|41605569|FG002|Overall Study|Withdrawal by Subject|14|||
19365542|NCT02415556|41605570|FG003|Overall Study|Withdrawal by Subject|12|||
19365543|NCT02415556|41605567|FG000|Overall Study|Physician Decision|1|||
19691502|NCT00364832|42137273|FG003|Extension Year 2|Early Withdrawals|0|||
19691503|NCT00364832|42137274|FG004|Extension Year 2|Early Withdrawals|0|||
19691504|NCT00364832|42137275|FG005|Extension Year 2|Early Withdrawals|0|||
19691505|NCT00364832|42137276|FG006|Extension Year 2|Early Withdrawals|0|||
19691506|NCT00364832|42137277|FG007|Extension Year 2|Early Withdrawals|0|||
19691507|NCT00364832|42137278|FG008|Extension Year 2|Early Withdrawals|0|||
19691508|NCT00364832|42137279|FG009|Extension Year 2|Early Withdrawals|5|||
19691509|NCT00364832|42137280|FG010|Extension Year 2|Early Withdrawals|5|||
19691510|NCT00364832|42137281|FG011|Extension Year 2|Early Withdrawals|3|||
19691511|NCT00235755|42137301|FG000|4-Week Titration Phase|Adverse Event|6|||
19691512|NCT00235755|42137302|FG001|4-Week Titration Phase|Adverse Event|14|||
19691513|NCT00235755|42137303|FG002|4-Week Titration Phase|Adverse Event|20|||
19691514|NCT00235755|42137301|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
19691515|NCT00235755|42137302|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
19691516|NCT00235755|42137303|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
19691517|NCT00235755|42137301|FG000|4-Week Titration Phase|Protocol Violation|2|||
19606427|NCT00685165|42055133|FG000|Washout Period of 14 Days|Adverse Event|1|||
19365544|NCT02415556|41605568|FG001|Overall Study|Physician Decision|3|||
19365545|NCT02415556|41605569|FG002|Overall Study|Physician Decision|1|||
19365546|NCT02415556|41605570|FG003|Overall Study|Physician Decision|2|||
19365547|NCT02415556|41605567|FG000|Overall Study|Censored - study completion|4|||
19691518|NCT00235755|42137302|FG001|4-Week Titration Phase|Protocol Violation|2|||
19691519|NCT00235755|42137303|FG002|4-Week Titration Phase|Protocol Violation|1|||
19691520|NCT00235755|42137301|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
19365548|NCT02415556|41605568|FG001|Overall Study|Censored - study completion|5|||
19365549|NCT02415556|41605569|FG002|Overall Study|Censored - study completion|1|||
19365550|NCT02415556|41605570|FG003|Overall Study|Censored - study completion|0|||
19365551|NCT02415556|41605567|FG000|Overall Study|Family-related issues|0|||
19365552|NCT02415556|41605568|FG001|Overall Study|Family-related issues|0|||
19365553|NCT02415556|41605569|FG002|Overall Study|Family-related issues|0|||
19365554|NCT02415556|41605570|FG003|Overall Study|Family-related issues|1|||
19365555|NCT02807623|41605583|FG000|Overall Study|Lost to Follow-up|23|||
19365556|NCT02807623|41605584|FG001|Overall Study|Lost to Follow-up|18|||
19365557|NCT02807623|41605585|FG002|Overall Study|Lost to Follow-up|22|||
19365558|NCT02807623|41605583|FG000|Overall Study|Drug intolerance|0|||
19606428|NCT00685165|42055134|FG001|Washout Period of 14 Days|Adverse Event|0|||
19606429|NCT00683449|42055145|FG000|Overall Study|Lost to Follow-up|0|||
19606430|NCT00683449|42055146|FG001|Overall Study|Lost to Follow-up|1|||
19606431|NCT00683449|42055147|FG002|Overall Study|Lost to Follow-up|0|||
19691521|NCT00235755|42137302|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
19691522|NCT00235755|42137303|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
19691523|NCT00235755|42137301|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
19365559|NCT02807623|41605584|FG001|Overall Study|Drug intolerance|1|||
19365560|NCT02807623|41605585|FG002|Overall Study|Drug intolerance|0|||
19606432|NCT00683449|42055148|FG003|Overall Study|Lost to Follow-up|0|||
19606433|NCT00683449|42055149|FG004|Overall Study|Lost to Follow-up|0|||
19606434|NCT00683293|42055168|FG000|Overall Study|Withdrawal by Subject|2|||
19365561|NCT02807623|41605583|FG000|Overall Study|incomplete blood draw|0|||
19365562|NCT02807623|41605584|FG001|Overall Study|incomplete blood draw|2|||
19365563|NCT02807623|41605585|FG002|Overall Study|incomplete blood draw|1|||
19773466|NCT02801396|42227796|FG001|Period 1|Withdrawal by Subject|0|||
19365564|NCT02805907|41605604|FG000|Overall Study|Lost to Follow-up|3|||
19365565|NCT02805907|41605605|FG001|Overall Study|Lost to Follow-up|3|||
19365566|NCT02723175|41605613|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
19365567|NCT02723175|41605614|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
19365568|NCT02723175|41605613|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
19365569|NCT02723175|41605614|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
19365570|NCT02801617|41605622|FG000|Overall Study|Protocol Violation|2|||
19365571|NCT02801617|41605623|FG001|Overall Study|Protocol Violation|6|||
19365572|NCT01334515|41605635|FG000|Overall Study|Adverse Event|1|||
19365573|NCT01334515|41605636|FG001|Overall Study|Adverse Event|6|||
19365574|NCT01334515|41605635|FG000|Overall Study|Death|1|||
19365575|NCT01334515|41605636|FG001|Overall Study|Death|0|||
19365576|NCT01334515|41605635|FG000|Overall Study|Lack of Efficacy|8|||
19365577|NCT01334515|41605636|FG001|Overall Study|Lack of Efficacy|21|||
19365578|NCT01334515|41605635|FG000|Overall Study|Physician Decision|1|||
19365579|NCT01334515|41605636|FG001|Overall Study|Physician Decision|1|||
19365580|NCT01334515|41605635|FG000|Overall Study|Withdrawal by Subject|1|||
19365581|NCT01334515|41605636|FG001|Overall Study|Withdrawal by Subject|1|||
19365582|NCT02802319|41605644|FG000|Overall Study|Physician Decision|2|||
19365583|NCT02802319|41605645|FG001|Overall Study|Physician Decision|1|||
19365584|NCT02802319|41605644|FG000|Overall Study|Lost to Follow-up|0|||
19365585|NCT02802319|41605645|FG001|Overall Study|Lost to Follow-up|4|||
19365586|NCT02415400|41605655|FG000|Overall Study|Adverse Event|0|||
19365587|NCT02415400|41605656|FG001|Overall Study|Adverse Event|1|||
19365588|NCT02415400|41605657|FG002|Overall Study|Adverse Event|1|||
19365589|NCT02415400|41605658|FG003|Overall Study|Adverse Event|2|||
19365590|NCT02415400|41605655|FG000|Overall Study|Participant request to stop therapy|4|||
19365591|NCT02415400|41605656|FG001|Overall Study|Participant request to stop therapy|3|||
19365592|NCT02415400|41605657|FG002|Overall Study|Participant request to stop therapy|8|||
19365593|NCT02415400|41605658|FG003|Overall Study|Participant request to stop therapy|6|||
19691524|NCT00235755|42137302|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
19691525|NCT00235755|42137303|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
19691526|NCT00235755|42137301|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
19691527|NCT00235755|42137302|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
19365594|NCT02415400|41605655|FG000|Overall Study|Participant withdrew consent|14|||
19365595|NCT02415400|41605656|FG001|Overall Study|Participant withdrew consent|12|||
19365596|NCT02415400|41605657|FG002|Overall Study|Participant withdrew consent|30|||
19365597|NCT02415400|41605658|FG003|Overall Study|Participant withdrew consent|21|||
19365598|NCT02415400|41605655|FG000|Overall Study|Death|39|||
19365599|NCT02415400|41605656|FG001|Overall Study|Death|41|||
19365600|NCT02415400|41605657|FG002|Overall Study|Death|35|||
19365601|NCT02415400|41605658|FG003|Overall Study|Death|42|||
19365602|NCT02415400|41605655|FG000|Overall Study|Lost to Follow-up|3|||
19365603|NCT02415400|41605656|FG001|Overall Study|Lost to Follow-up|3|||
19365604|NCT02415400|41605657|FG002|Overall Study|Lost to Follow-up|2|||
19365605|NCT02415400|41605658|FG003|Overall Study|Lost to Follow-up|5|||
19365606|NCT02415400|41605655|FG000|Overall Study|Poor/Non-Compliance|0|||
19365607|NCT02415400|41605656|FG001|Overall Study|Poor/Non-Compliance|1|||
19365608|NCT02415400|41605657|FG002|Overall Study|Poor/Non-Compliance|3|||
19365609|NCT02415400|41605658|FG003|Overall Study|Poor/Non-Compliance|4|||
19365610|NCT02415400|41605655|FG000|Overall Study|Participant no longer meets criteria|2|||
19365611|NCT02415400|41605656|FG001|Overall Study|Participant no longer meets criteria|0|||
19365612|NCT02415400|41605657|FG002|Overall Study|Participant no longer meets criteria|0|||
19365613|NCT02415400|41605658|FG003|Overall Study|Participant no longer meets criteria|1|||
19365614|NCT02415400|41605655|FG000|Overall Study|Participant doesn't answer phone|1|||
19365615|NCT02415400|41605656|FG001|Overall Study|Participant doesn't answer phone|0|||
19365616|NCT02415400|41605657|FG002|Overall Study|Participant doesn't answer phone|0|||
19365617|NCT02415400|41605658|FG003|Overall Study|Participant doesn't answer phone|0|||
19365618|NCT02415400|41605655|FG000|Overall Study|Participant wanted home visits|1|||
19365619|NCT02415400|41605656|FG001|Overall Study|Participant wanted home visits|0|||
19365620|NCT02415400|41605657|FG002|Overall Study|Participant wanted home visits|0|||
19365621|NCT02415400|41605658|FG003|Overall Study|Participant wanted home visits|0|||
19365622|NCT02415400|41605655|FG000|Overall Study|Randomized in error|2|||
19365623|NCT02415400|41605656|FG001|Overall Study|Randomized in error|0|||
19365624|NCT02415400|41605657|FG002|Overall Study|Randomized in error|0|||
19773467|NCT02801396|42227797|FG002|Period 1|Withdrawal by Subject|0|||
19606435|NCT00683293|42055169|FG001|Overall Study|Withdrawal by Subject|3|||
19606436|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Death|0|||
19606437|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Death|0|||
19606438|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Death|0|||
19606439|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Death|0|||
19606440|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Death|1|||
19606441|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Death|0|||
19606442|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Death|0|||
19606443|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Death|0|||
19606444|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
19365625|NCT02415400|41605658|FG003|Overall Study|Randomized in error|0|||
19365626|NCT02415400|41605655|FG000|Overall Study|No study drug on site|0|||
19365627|NCT02415400|41605656|FG001|Overall Study|No study drug on site|1|||
19365628|NCT02415400|41605657|FG002|Overall Study|No study drug on site|0|||
19365629|NCT02415400|41605658|FG003|Overall Study|No study drug on site|0|||
19365630|NCT02415400|41605655|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
19365631|NCT02415400|41605656|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
19365632|NCT02415400|41605657|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
19365633|NCT02415400|41605658|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
19365634|NCT02415400|41605655|FG000|Overall Study|Coagulation values cannot be set|0|||
19365635|NCT02415400|41605656|FG001|Overall Study|Coagulation values cannot be set|0|||
19365636|NCT02415400|41605657|FG002|Overall Study|Coagulation values cannot be set|1|||
19365637|NCT02415400|41605658|FG003|Overall Study|Coagulation values cannot be set|0|||
19365638|NCT02415400|41605655|FG000|Overall Study|State regulations prevent participation|0|||
19365639|NCT02415400|41605656|FG001|Overall Study|State regulations prevent participation|0|||
19365640|NCT02415400|41605657|FG002|Overall Study|State regulations prevent participation|1|||
19365641|NCT02415400|41605658|FG003|Overall Study|State regulations prevent participation|0|||
19365642|NCT02415400|41605655|FG000|Overall Study|Poor treatment monitoring|0|||
19365643|NCT02415400|41605656|FG001|Overall Study|Poor treatment monitoring|0|||
19365644|NCT02415400|41605657|FG002|Overall Study|Poor treatment monitoring|1|||
19691528|NCT00235755|42137303|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
19365645|NCT02415400|41605658|FG003|Overall Study|Poor treatment monitoring|0|||
19365646|NCT02415400|41605655|FG000|Overall Study|Participant in jail|0|||
19365647|NCT02415400|41605656|FG001|Overall Study|Participant in jail|0|||
19365648|NCT02415400|41605657|FG002|Overall Study|Participant in jail|1|||
19365649|NCT02415400|41605658|FG003|Overall Study|Participant in jail|0|||
19365650|NCT02415400|41605655|FG000|Overall Study|Investigator decision|0|||
19365651|NCT02415400|41605656|FG001|Overall Study|Investigator decision|0|||
19365652|NCT02415400|41605657|FG002|Overall Study|Investigator decision|1|||
19365653|NCT02415400|41605658|FG003|Overall Study|Investigator decision|1|||
19365654|NCT02415400|41605655|FG000|Overall Study|Site closure; participant won't transfer|0|||
19691529|NCT00235755|42137301|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
19691530|NCT00235755|42137302|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
19691531|NCT00235755|42137303|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
19691532|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Adverse Event|8|||
19691533|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Adverse Event|12|||
19691534|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Adverse Event|26|||
19773468|NCT02801396|42227798|FG003|Period 1|Withdrawal by Subject|0|||
19773469|NCT02801396|42227799|FG004|Period 1|Withdrawal by Subject|1|||
19773470|NCT02801396|42227800|FG005|Period 1|Withdrawal by Subject|0|||
19773471|NCT02800928|42227808|FG000|Overall Study|Withdrawal by Subject|1|||
19365655|NCT02415400|41605656|FG001|Overall Study|Site closure; participant won't transfer|0|||
19365656|NCT02415400|41605657|FG002|Overall Study|Site closure; participant won't transfer|0|||
19365657|NCT02415400|41605658|FG003|Overall Study|Site closure; participant won't transfer|1|||
19773472|NCT02800928|42227809|FG001|Overall Study|Withdrawal by Subject|1|||
19773473|NCT02800928|42227808|FG000|Overall Study|Protocol Violation|1|||
19773474|NCT02800928|42227809|FG001|Overall Study|Protocol Violation|1|||
19773475|NCT03148691|42227818|FG000|Overall Study|Protocol Violation|1|||
19773476|NCT03148691|42227819|FG001|Overall Study|Protocol Violation|2|||
19773477|NCT03148691|42227820|FG002|Overall Study|Protocol Violation|7|||
19773478|NCT03148691|42227818|FG000|Overall Study|Lost to Follow-up|0|||
19773479|NCT03148691|42227819|FG001|Overall Study|Lost to Follow-up|0|||
19773480|NCT03148691|42227820|FG002|Overall Study|Lost to Follow-up|1|||
19773481|NCT03148691|42227818|FG000|Overall Study|Other|1|||
19773482|NCT03148691|42227819|FG001|Overall Study|Other|0|||
19773483|NCT03148691|42227820|FG002|Overall Study|Other|0|||
19773484|NCT03148691|42227818|FG000|Overall Study|Withdrawal by Subject|1|||
19773485|NCT03148691|42227819|FG001|Overall Study|Withdrawal by Subject|0|||
19365658|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
19365659|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
19691535|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
19691536|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
19691537|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
19691538|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
19691539|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
19691540|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
19691541|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
19773486|NCT03148691|42227820|FG002|Overall Study|Withdrawal by Subject|0|||
19773487|NCT03148067|42227828|FG000|Overall Study|Lost to Follow-up|3|||
19691542|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
19773488|NCT03148067|42227828|FG000|Overall Study|Death|1|||
19773489|NCT03146741|42227842|FG000|Overall Study|Txp with non-HCV+ heart|4|||
19773490|NCT03146741|42227842|FG000|Overall Study|Listeted for MOT|2|||
19773491|NCT03146741|42227842|FG000|Overall Study|Physician Decision|2|||
19365660|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
19365661|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
19365662|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
19365663|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
19365664|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
19365665|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
19365666|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
19365667|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
19365668|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
19365669|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
19365670|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
19365671|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
19365672|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
19365673|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
19365674|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
19365675|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
19365676|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
19365677|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
19365678|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
19365679|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
19365680|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
19365681|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
19365682|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
19365683|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
19365684|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
19365685|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
19365686|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
19365687|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
19365688|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
19365689|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
19365690|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
19365691|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
19365692|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
19365693|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
19365694|NCT04194801|41605675|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
19606445|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
19606446|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
19606447|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
19606448|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
19606449|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
19606450|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
19606451|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
19606452|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
19606453|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
19606454|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
19606455|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
19691543|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
19691544|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
19691545|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
19691546|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
19691547|NCT00235755|42137301|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
19691548|NCT00235755|42137302|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
19691549|NCT00235755|42137303|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
19691550|NCT00337194|42137328|FG000|Overall Study|Adverse Event|5|||
19691551|NCT00337194|42137329|FG001|Overall Study|Adverse Event|1|||
19691552|NCT00337194|42137328|FG000|Overall Study|Death|2|||
19691553|NCT00337194|42137329|FG001|Overall Study|Death|0|||
19691554|NCT00337194|42137328|FG000|Overall Study|Withdrawal by Subject|1|||
19691555|NCT00337194|42137329|FG001|Overall Study|Withdrawal by Subject|0|||
19691556|NCT00337194|42137328|FG000|Overall Study|Disease progression|1|||
19773492|NCT03146741|42227842|FG000|Overall Study|Awaiting txp|2|||
19773493|NCT03150719|42227848|FG000|Overall Study|Adverse Event|0|||
19773494|NCT03150719|42227849|FG001|Overall Study|Adverse Event|1|||
19773495|NCT03150719|42227848|FG000|Overall Study|Death|0|||
19773496|NCT03150719|42227849|FG001|Overall Study|Death|1|||
19773497|NCT03150719|42227848|FG000|Overall Study|Other|1|||
19773498|NCT03150719|42227849|FG001|Overall Study|Other|0|||
19773499|NCT04039217|42227855|FG000|Overall Study|Lost to Follow-up|1|||
19365695|NCT04194801|41605676|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
19365696|NCT04194801|41605677|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
19365697|NCT04194801|41605675|FG000|Part Ib/II End of Study|Death|2|||
19365698|NCT04194801|41605676|FG001|Part Ib/II End of Study|Death|3|||
19773500|NCT00982111|42227865|FG000|Overall Study|Adverse Event|1|||
19773501|NCT00982111|42227866|FG001|Overall Study|Adverse Event|1|||
19773502|NCT00982111|42227865|FG000|Overall Study|Progressive Disease|46|||
19773503|NCT00982111|42227866|FG001|Overall Study|Progressive Disease|39|||
19773504|NCT00982111|42227865|FG000|Overall Study|Lost to Follow-up|9|||
19773505|NCT00982111|42227866|FG001|Overall Study|Lost to Follow-up|6|||
19773506|NCT00982111|42227865|FG000|Overall Study|New Anti-Cancer Therapy|5|||
19773507|NCT00982111|42227866|FG001|Overall Study|New Anti-Cancer Therapy|5|||
19773508|NCT00982111|42227865|FG000|Overall Study|Medical Decision|1|||
19773509|NCT00982111|42227866|FG001|Overall Study|Medical Decision|0|||
19773510|NCT00982111|42227865|FG000|Overall Study|Withdrawal by Subject|17|||
19773511|NCT00982111|42227866|FG001|Overall Study|Withdrawal by Subject|19|||
19773512|NCT00982111|42227865|FG000|Overall Study|Global Study End|0|||
19773513|NCT00982111|42227866|FG001|Overall Study|Global Study End|1|||
19773514|NCT00982111|42227865|FG000|Overall Study|Sponsor's Decision|0|||
19773515|NCT00982111|42227866|FG001|Overall Study|Sponsor's Decision|1|||
19773516|NCT02957682|42227875|FG000|Overall Study|Adverse Event|64|||
19773517|NCT02957682|42227876|FG001|Overall Study|Adverse Event|67|||
19773518|NCT02957682|42227875|FG000|Overall Study|Poor Compliance to Protocol|30|||
19773519|NCT02957682|42227876|FG001|Overall Study|Poor Compliance to Protocol|26|||
19773520|NCT02957682|42227875|FG000|Overall Study|Physician Decision|4|||
19773521|NCT02957682|42227876|FG001|Overall Study|Physician Decision|4|||
19773522|NCT02957682|42227875|FG000|Overall Study|Study Terminated by Sponsor|4|||
19773523|NCT02957682|42227876|FG001|Overall Study|Study Terminated by Sponsor|3|||
19773524|NCT02957682|42227875|FG000|Overall Study|Subject Moved|10|||
19773525|NCT02957682|42227876|FG001|Overall Study|Subject Moved|16|||
19773526|NCT02957682|42227875|FG000|Overall Study|Withdrawal by Subject|64|||
19773527|NCT02957682|42227876|FG001|Overall Study|Withdrawal by Subject|33|||
19773528|NCT02957682|42227875|FG000|Overall Study|Related to IMP Administration|3|||
19773529|NCT02957682|42227876|FG001|Overall Study|Related to IMP Administration|6|||
19773530|NCT02957682|42227875|FG000|Overall Study|Non-disclosed|16|||
19773531|NCT02957682|42227876|FG001|Overall Study|Non-disclosed|12|||
19773532|NCT02957682|42227875|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
19773533|NCT02957682|42227876|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
19773534|NCT03057951|42227884|FG000|Overall Study|Adverse Event|553|||
19773535|NCT03057951|42227885|FG001|Overall Study|Adverse Event|575|||
19773536|NCT03057951|42227884|FG000|Overall Study|Protocol Violation|30|||
19773537|NCT03057951|42227885|FG001|Overall Study|Protocol Violation|24|||
19773538|NCT03057951|42227884|FG000|Overall Study|Lost to Follow-up|6|||
19773539|NCT03057951|42227885|FG001|Overall Study|Lost to Follow-up|16|||
19773540|NCT03057951|42227884|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
19773541|NCT03057951|42227885|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
19773542|NCT03057951|42227884|FG000|Overall Study|Study drug stopped, reason missing|6|||
19365699|NCT04194801|41605677|FG002|Part Ib/II End of Study|Death|3|||
19365700|NCT04194801|41605675|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
19773543|NCT03057951|42227885|FG001|Overall Study|Study drug stopped, reason missing|1|||
19773544|NCT03057951|42227884|FG000|Overall Study|Medical advice|6|||
19773545|NCT03057951|42227885|FG001|Overall Study|Medical advice|2|||
19773546|NCT03057951|42227884|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
19773547|NCT03057951|42227885|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
19773548|NCT03057951|42227884|FG000|Overall Study|Investigator decision|2|||
19773549|NCT03057951|42227885|FG001|Overall Study|Investigator decision|0|||
19773550|NCT03057951|42227884|FG000|Overall Study|Patient decision|5|||
19773551|NCT03057951|42227885|FG001|Overall Study|Patient decision|2|||
19773552|NCT03057951|42227884|FG000|Overall Study|Not attending study visits|3|||
19773553|NCT03057951|42227885|FG001|Overall Study|Not attending study visits|0|||
19773554|NCT03057951|42227884|FG000|Overall Study|Patient moved away|3|||
19773555|NCT03057951|42227885|FG001|Overall Study|Patient moved away|4|||
19773556|NCT03057951|42227884|FG000|Overall Study|Other reason than stated above|23|||
19365701|NCT04194801|41605676|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
19365702|NCT04194801|41605677|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
19365703|NCT04194801|41605675|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
19773557|NCT03057951|42227885|FG001|Overall Study|Other reason than stated above|29|||
19773558|NCT03057951|42227884|FG000|Overall Study|Not treated|2|||
19773559|NCT03057951|42227885|FG001|Overall Study|Not treated|1|||
19773560|NCT03146663|42227893|FG000|Overall Study|Did not receive study treatment|1|||
19773561|NCT03146663|42227894|FG001|Overall Study|Did not receive study treatment|1|||
19773562|NCT02956278|42227904|FG000|Overall Study|Withdrawal by Subject|6|||
19773563|NCT02956278|42227905|FG001|Overall Study|Withdrawal by Subject|2|||
19773564|NCT02956278|42227906|FG002|Overall Study|Withdrawal by Subject|0|||
19773565|NCT02957136|42227916|FG000|Overall Study|Withdrawal by Subject|2|||
19773566|NCT02957136|42227917|FG001|Overall Study|Withdrawal by Subject|1|||
19773567|NCT03150485|42227923|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
19773568|NCT03150485|42227924|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
19773569|NCT03150485|42227925|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
19773570|NCT03150485|42227926|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
19773571|NCT03150485|42227927|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
19773572|NCT03150485|42227928|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
19773573|NCT03134911|42227935|FG000|Overall Study|Screen failure|31|||
19773574|NCT03134911|42227935|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
19691557|NCT00337194|42137329|FG001|Overall Study|Disease progression|2|||
19691558|NCT00337194|42137328|FG000|Overall Study|Subsequent non-protocol therapy|3|||
19691559|NCT00337194|42137329|FG001|Overall Study|Subsequent non-protocol therapy|1|||
19691560|NCT03826914|42137339|FG000|Overall Study|Withdrawal by Subject|1|||
19691561|NCT03826914|42137340|FG001|Overall Study|Withdrawal by Subject|1|||
19691562|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
19773575|NCT03488472|42227943|FG000|Overall Study|disease progression additional mets|1|||
19773576|NCT03134599|42227958|FG000|Week 1|Lost to Follow-up|0|||
19773577|NCT03134599|42227959|FG001|Week 1|Lost to Follow-up|0|||
19773578|NCT03134599|42227960|FG002|Week 1|Lost to Follow-up|0|||
19773579|NCT03134599|42227961|FG003|Week 1|Lost to Follow-up|0|||
19773580|NCT03134599|42227962|FG004|Week 1|Lost to Follow-up|1|||
19773581|NCT03134599|42227963|FG005|Week 1|Lost to Follow-up|0|||
19773582|NCT03134599|42227958|FG000|Week 2|Lost to Follow-up|1|||
19773583|NCT03134599|42227959|FG001|Week 2|Lost to Follow-up|0|||
19773584|NCT03134599|42227960|FG002|Week 2|Lost to Follow-up|0|||
19773585|NCT03134599|42227961|FG003|Week 2|Lost to Follow-up|1|||
19773586|NCT03134599|42227962|FG004|Week 2|Lost to Follow-up|1|||
19773587|NCT03134599|42227963|FG005|Week 2|Lost to Follow-up|0|||
19691563|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
19691564|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
19773588|NCT03134599|42227958|FG000|Week 3|Lost to Follow-up|0|||
19365704|NCT04194801|41605676|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
19365705|NCT04194801|41605677|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
19365706|NCT04194801|41605675|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
19365707|NCT04194801|41605676|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
19365708|NCT04194801|41605677|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
19365709|NCT04194801|41605675|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
19365710|NCT04194801|41605676|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
19365711|NCT04194801|41605677|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
19365712|NCT02802865|41605701|FG000|Overall Study|Pregnancy|1|||
19365713|NCT02802865|41605702|FG001|Overall Study|Pregnancy|1|||
19365714|NCT02802865|41605701|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
19365715|NCT02802865|41605702|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
19365716|NCT02414932|41605710|FG000|Overall Study|Withdrawal by Subject|2|||
19773589|NCT03134599|42227959|FG001|Week 3|Lost to Follow-up|0|||
19773590|NCT03134599|42227960|FG002|Week 3|Lost to Follow-up|0|||
19773591|NCT03134599|42227961|FG003|Week 3|Lost to Follow-up|1|||
19773592|NCT03134599|42227962|FG004|Week 3|Lost to Follow-up|0|||
19773593|NCT03134599|42227963|FG005|Week 3|Lost to Follow-up|1|||
19773594|NCT03153137|42227973|FG000|Overall Study|Lost to Follow-up|1|||
19773595|NCT03153137|42227974|FG001|Overall Study|Lost to Follow-up|0|||
19365717|NCT02414932|41605711|FG001|Overall Study|Withdrawal by Subject|3|||
19365718|NCT02414932|41605710|FG000|Overall Study|Adverse Event|1|||
19691565|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
19691566|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
19691567|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
19691568|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
19691569|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
19691570|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
19691571|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
19691572|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
19691573|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
19773596|NCT03153137|42227973|FG000|Overall Study|Withdrawal by Subject|2|||
19773597|NCT03153137|42227974|FG001|Overall Study|Withdrawal by Subject|1|||
19691574|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
19773598|NCT03153137|42227973|FG000|Overall Study|Physician Decision|0|||
19773599|NCT03153137|42227974|FG001|Overall Study|Physician Decision|3|||
19773600|NCT03136861|42227987|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
19691575|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
19773601|NCT03136861|42227988|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
19773602|NCT03136861|42227989|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
19773603|NCT03136861|42227990|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
19773604|NCT03136861|42227991|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
19773605|NCT03136861|42227992|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
19773606|NCT03136861|42227993|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
19773607|NCT03136861|42227987|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
19773608|NCT03136861|42227988|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
19773609|NCT03136861|42227989|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
19773610|NCT03136861|42227990|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
19773611|NCT03136861|42227991|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
19773612|NCT03136861|42227992|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
19773613|NCT03136861|42227993|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
19773614|NCT03136861|42227987|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
19773615|NCT03136861|42227988|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
19773616|NCT03136861|42227989|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
19773617|NCT03136861|42227990|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
19773618|NCT03136861|42227991|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
19773619|NCT03136861|42227992|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
19773620|NCT03136861|42227993|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
19773621|NCT03136861|42227987|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773622|NCT03136861|42227988|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
19773623|NCT03136861|42227989|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773624|NCT03136861|42227990|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773625|NCT03136861|42227991|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773626|NCT03136861|42227992|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773627|NCT03136861|42227993|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
19773628|NCT03136861|42227987|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
19773629|NCT03136861|42227988|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
19773630|NCT03136861|42227989|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
19773631|NCT03136861|42227990|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
19773632|NCT03136861|42227991|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
19773633|NCT03136861|42227992|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
19773634|NCT03136861|42227993|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
19773635|NCT03136861|42227987|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
19773636|NCT03136861|42227988|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
19773637|NCT03136861|42227989|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
19773638|NCT03136861|42227990|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
19773639|NCT03136861|42227991|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
19773640|NCT03136861|42227992|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
19773641|NCT03136861|42227993|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
19773642|NCT03136861|42227987|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773643|NCT03136861|42227988|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773644|NCT03136861|42227989|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
19773645|NCT03136861|42227990|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773646|NCT03136861|42227991|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773647|NCT03136861|42227992|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773648|NCT03136861|42227993|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
19773649|NCT03136861|42227987|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773650|NCT03136861|42227988|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773651|NCT03136861|42227989|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
19773652|NCT03136861|42227990|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773653|NCT03136861|42227991|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773654|NCT03136861|42227992|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773655|NCT03136861|42227993|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
19773656|NCT03316950|42228021|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
19773657|NCT03316950|42228022|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
19773658|NCT03316950|42228023|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
19773659|NCT03316950|42228024|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
19773660|NCT03316950|42228021|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
19773661|NCT03316950|42228022|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
19773662|NCT03316950|42228023|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
19773663|NCT03316950|42228024|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
19773664|NCT03316950|42228021|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
19773665|NCT03316950|42228022|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
19773666|NCT03316950|42228023|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
19773667|NCT03316950|42228024|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
19773668|NCT03139279|42228038|FG000|Overall Study|Physician Decision|2|||
19365719|NCT02414932|41605711|FG001|Overall Study|Adverse Event|0|||
19773669|NCT03139279|42228039|FG001|Overall Study|Physician Decision|0|||
19773670|NCT03139279|42228038|FG000|Overall Study|Protocol Violation|5|||
19773671|NCT03139279|42228039|FG001|Overall Study|Protocol Violation|4|||
19773672|NCT03139279|42228038|FG000|Overall Study|Withdrawal by Subject|0|||
19773673|NCT03139279|42228039|FG001|Overall Study|Withdrawal by Subject|2|||
19773674|NCT01370642|42228048|FG000|Overall Study|Adverse Event|2|||
19773675|NCT01370642|42228049|FG001|Overall Study|Adverse Event|1|||
19773676|NCT01370642|42228050|FG002|Overall Study|Adverse Event|1|||
19691576|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
19691577|NCT00385736|42137351|FG000|Efficacy Analysis Set - Induction|Other|0|||
19691578|NCT00385736|42137352|FG001|Efficacy Analysis Set - Induction|Other|0|||
19691579|NCT00385736|42137353|FG002|Efficacy Analysis Set - Induction|Other|1|||
19773677|NCT01370642|42228048|FG000|Overall Study|Detectable HCV RNA|0|||
19773678|NCT01370642|42228049|FG001|Overall Study|Detectable HCV RNA|0|||
19773679|NCT01370642|42228050|FG002|Overall Study|Detectable HCV RNA|22|||
19773680|NCT01370642|42228048|FG000|Overall Study|Lost to Follow-up|0|||
19773681|NCT01370642|42228049|FG001|Overall Study|Lost to Follow-up|0|||
19773682|NCT01370642|42228050|FG002|Overall Study|Lost to Follow-up|1|||
19691580|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
19691581|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
19691582|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
19691583|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
19691584|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
19691585|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
19691586|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
19691587|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
19691588|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
19691589|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
19691590|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
19691591|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
19691592|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
19691593|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
19691594|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
19691595|NCT00385736|42137351|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
19691596|NCT00385736|42137352|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
19691597|NCT00385736|42137353|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
19773683|NCT01370642|42228048|FG000|Overall Study|Physician Decision|4|||
19773684|NCT01370642|42228049|FG001|Overall Study|Physician Decision|1|||
19365720|NCT00704535|41605717|FG000|Overall Study|Adverse Event|2|||
19365721|NCT00704535|41605717|FG000|Overall Study|Death|2|||
19365722|NCT00704535|41605717|FG000|Overall Study|Lost to Follow-up|8|||
19691598|NCT00385736|42137351|FG000|Safety Analysis Set|Adverse Event|23|||
19691599|NCT00385736|42137352|FG001|Safety Analysis Set|Adverse Event|15|||
19773685|NCT01370642|42228050|FG002|Overall Study|Physician Decision|2|||
19773686|NCT01370642|42228048|FG000|Overall Study|Withdrawal by Subject|2|||
19773687|NCT01370642|42228049|FG001|Overall Study|Withdrawal by Subject|4|||
19773688|NCT01370642|42228050|FG002|Overall Study|Withdrawal by Subject|3|||
19773689|NCT02873208|42228058|FG000|Overall Study|Withdrawal by Subject|36|||
19773690|NCT02873208|42228058|FG000|Overall Study|Lost to Follow-up|22|||
19773691|NCT02873208|42228058|FG000|Overall Study|Adverse Event|15|||
19773692|NCT02873208|42228058|FG000|Overall Study|Non-compliance with study drug|12|||
19773693|NCT02873208|42228058|FG000|Overall Study|Protocol Violation|8|||
19773694|NCT02873208|42228058|FG000|Overall Study|Pregnancy|2|||
19773695|NCT02873208|42228058|FG000|Overall Study|Incarceration|1|||
19773696|NCT02873208|42228058|FG000|Overall Study|Lack of Efficacy|1|||
19773697|NCT02873208|42228058|FG000|Overall Study|Physician Decision|1|||
19773698|NCT03138967|42228064|FG000|Overall Study|Death|0|||
19773699|NCT03138967|42228065|FG001|Overall Study|Death|1|||
19773700|NCT03138967|42228064|FG000|Overall Study|Physician Decision|1|||
19773701|NCT03138967|42228065|FG001|Overall Study|Physician Decision|3|||
19773702|NCT01547117|42228075|FG000|Overall Study|Physician Decision|0|||
19773703|NCT01547117|42228076|FG001|Overall Study|Physician Decision|1|||
19773704|NCT01547117|42228077|FG002|Overall Study|Physician Decision|1|||
19773705|NCT01547117|42228078|FG003|Overall Study|Physician Decision|3|||
19773706|NCT01547117|42228075|FG000|Overall Study|Withdrawal by Subject|1|||
19773707|NCT01547117|42228076|FG001|Overall Study|Withdrawal by Subject|2|||
19773708|NCT01547117|42228077|FG002|Overall Study|Withdrawal by Subject|1|||
19773709|NCT01547117|42228078|FG003|Overall Study|Withdrawal by Subject|2|||
19773710|NCT03136159|42228106|FG000|Overall Study|chorioamnionitis|2|||
19773711|NCT03136159|42228107|FG001|Overall Study|chorioamnionitis|0|||
19773712|NCT03136159|42228106|FG000|Overall Study|vertical skin incision|1|||
19773713|NCT03136159|42228107|FG001|Overall Study|vertical skin incision|0|||
19773714|NCT03136159|42228106|FG000|Overall Study|additional dressing|1|||
19773715|NCT03136159|42228107|FG001|Overall Study|additional dressing|0|||
19773716|NCT03136159|42228106|FG000|Overall Study|never got dressing placed|1|||
19773717|NCT03136159|42228107|FG001|Overall Study|never got dressing placed|0|||
19773718|NCT01986933|42228118|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
19773719|NCT01986933|42228119|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
19773720|NCT01986933|42228120|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
19773721|NCT01986933|42228121|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
19773722|NCT01986933|42228122|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
19773723|NCT01986933|42228118|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
19773724|NCT01986933|42228119|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
19773725|NCT01986933|42228120|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
19773726|NCT01986933|42228121|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
19773727|NCT01986933|42228122|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
19773728|NCT01986933|42228118|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
19773729|NCT01986933|42228119|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
19773730|NCT01986933|42228120|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
19773731|NCT01986933|42228121|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
19773732|NCT01986933|42228122|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
19773733|NCT01986933|42228118|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
19773734|NCT01986933|42228119|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
19773735|NCT01986933|42228120|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
19773736|NCT01986933|42228121|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
19773737|NCT01986933|42228122|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
19773738|NCT01986933|42228118|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
19773739|NCT01986933|42228119|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
19773740|NCT01986933|42228120|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
19773741|NCT01986933|42228121|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
19773742|NCT01986933|42228122|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
19773743|NCT01986933|42228118|FG000|Active-to-active (Part B)|Adverse Event|0|||
19773744|NCT01986933|42228119|FG001|Active-to-active (Part B)|Adverse Event|2|||
19773745|NCT01986933|42228120|FG002|Active-to-active (Part B)|Adverse Event|0|||
19773746|NCT01986933|42228121|FG003|Active-to-active (Part B)|Adverse Event|1|||
19773747|NCT01986933|42228122|FG004|Active-to-active (Part B)|Adverse Event|3|||
19773748|NCT01986933|42228118|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
19773749|NCT01986933|42228119|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
19773750|NCT01986933|42228120|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
19773751|NCT01986933|42228121|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
19773752|NCT01986933|42228122|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
19773753|NCT01986933|42228118|FG000|Active-to-active (Part B)|Pregnancy|0|||
19773754|NCT01986933|42228119|FG001|Active-to-active (Part B)|Pregnancy|0|||
19773755|NCT01986933|42228120|FG002|Active-to-active (Part B)|Pregnancy|0|||
19773756|NCT01986933|42228121|FG003|Active-to-active (Part B)|Pregnancy|0|||
19773757|NCT01986933|42228122|FG004|Active-to-active (Part B)|Pregnancy|1|||
19773758|NCT01986933|42228118|FG000|Active-to-active (Part B)|Physician Decision|0|||
19691600|NCT00385736|42137353|FG002|Safety Analysis Set|Adverse Event|23|||
19691601|NCT00385736|42137351|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
19691602|NCT00385736|42137352|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
19691603|NCT00385736|42137353|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
19691604|NCT00385736|42137351|FG000|Safety Analysis Set|Lost to Follow-up|0|||
19691605|NCT00385736|42137352|FG001|Safety Analysis Set|Lost to Follow-up|2|||
19691606|NCT00385736|42137353|FG002|Safety Analysis Set|Lost to Follow-up|2|||
19691607|NCT00385736|42137351|FG000|Safety Analysis Set|Lack of Efficacy|38|||
19691608|NCT00385736|42137352|FG001|Safety Analysis Set|Lack of Efficacy|16|||
19691609|NCT00385736|42137353|FG002|Safety Analysis Set|Lack of Efficacy|31|||
19691610|NCT00385736|42137351|FG000|Safety Analysis Set|Protocol Violation|2|||
19691611|NCT00385736|42137352|FG001|Safety Analysis Set|Protocol Violation|1|||
19691612|NCT00385736|42137353|FG002|Safety Analysis Set|Protocol Violation|6|||
19691613|NCT00385736|42137351|FG000|Safety Analysis Set|Other|1|||
19691614|NCT00385736|42137352|FG001|Safety Analysis Set|Other|4|||
19691615|NCT00385736|42137353|FG002|Safety Analysis Set|Other|4|||
19691616|NCT00195819|42137364|FG000|Double-Blind|Withdrawal by Subject|1|||
19691617|NCT00195819|42137365|FG001|Double-Blind|Withdrawal by Subject|0|||
19691618|NCT00195819|42137364|FG000|Double-Blind|Moved|1|||
19691619|NCT00195819|42137365|FG001|Double-Blind|Moved|0|||
19691620|NCT00195819|42137364|FG000|Open-label|Adverse Event|0|||
19691621|NCT00195819|42137365|FG001|Open-label|Adverse Event|9|||
19691622|NCT00195819|42137364|FG000|Open-label|Lack of Efficacy|0|||
19691623|NCT00195819|42137365|FG001|Open-label|Lack of Efficacy|2|||
19691624|NCT00195819|42137364|FG000|Open-label|Pregnancy|0|||
19691625|NCT00195819|42137365|FG001|Open-label|Pregnancy|1|||
19691626|NCT00195819|42137364|FG000|Open-label|Protocol Violation|0|||
19691627|NCT00195819|42137365|FG001|Open-label|Protocol Violation|2|||
19365723|NCT00704535|41605717|FG000|Overall Study|Protocol Violation|10|||
19691628|NCT00195819|42137364|FG000|Open-label|Moved|0|||
19691629|NCT00195819|42137365|FG001|Open-label|Moved|1|||
19691630|NCT00195819|42137364|FG000|Open-label|Withdrawal by Subject|0|||
19691631|NCT00195819|42137365|FG001|Open-label|Withdrawal by Subject|5|||
19691632|NCT00527735|42137380|FG000|Overall Study|Disease progression|47|||
19365724|NCT00704535|41605717|FG000|Overall Study|Completed status not on Case Report Form|124|||
19365725|NCT01740687|41605721|FG000|Overall Study|Lost to Follow-up|11|||
19365726|NCT01740687|41605721|FG000|Overall Study|Withdrawal by Subject|2|||
19365727|NCT01740687|41605721|FG000|Overall Study|other reason|22|||
19365728|NCT01740687|41605721|FG000|Overall Study|treatment not received|2|||
19365729|NCT02648204|41605729|FG000|Overall Study|Withdrawal by Subject|12|||
19365730|NCT02648204|41605730|FG001|Overall Study|Withdrawal by Subject|8|||
19365731|NCT02648204|41605731|FG002|Overall Study|Withdrawal by Subject|2|||
19365732|NCT02648204|41605732|FG003|Overall Study|Withdrawal by Subject|6|||
19365733|NCT02648204|41605729|FG000|Overall Study|Lost to Follow-up|5|||
19365734|NCT02648204|41605730|FG001|Overall Study|Lost to Follow-up|8|||
19365735|NCT02648204|41605731|FG002|Overall Study|Lost to Follow-up|4|||
19365736|NCT02648204|41605732|FG003|Overall Study|Lost to Follow-up|6|||
19365737|NCT02648204|41605729|FG000|Overall Study|Missing follow-up information|4|||
19365738|NCT02648204|41605730|FG001|Overall Study|Missing follow-up information|4|||
19365739|NCT02648204|41605731|FG002|Overall Study|Missing follow-up information|4|||
19365740|NCT02648204|41605732|FG003|Overall Study|Missing follow-up information|2|||
19365741|NCT02648204|41605729|FG000|Overall Study|Death|1|||
19365742|NCT02648204|41605730|FG001|Overall Study|Death|1|||
19365743|NCT02648204|41605731|FG002|Overall Study|Death|2|||
19365744|NCT02648204|41605732|FG003|Overall Study|Death|2|||
19365745|NCT02648204|41605729|FG000|Overall Study|Adverse Event|0|||
19365746|NCT02648204|41605730|FG001|Overall Study|Adverse Event|0|||
19365747|NCT02648204|41605731|FG002|Overall Study|Adverse Event|1|||
19365748|NCT02648204|41605732|FG003|Overall Study|Adverse Event|0|||
19365749|NCT02799745|41605744|FG000|Overall Study|Participant moved out of state|1|||
19365750|NCT02799745|41605745|FG001|Overall Study|Participant moved out of state|0|||
19365751|NCT02799745|41605744|FG000|Overall Study|Discontinued due to planned surgery|1|||
19365752|NCT02799745|41605745|FG001|Overall Study|Discontinued due to planned surgery|0|||
19365753|NCT02799745|41605744|FG000|Overall Study|Withdrawal by Subject|16|||
19365754|NCT02799745|41605745|FG001|Overall Study|Withdrawal by Subject|25|||
19365755|NCT02799745|41605744|FG000|Overall Study|Protocol Deviation|4|||
19365756|NCT02799745|41605745|FG001|Overall Study|Protocol Deviation|5|||
19365757|NCT02799745|41605744|FG000|Overall Study|Progressive Disease|28|||
19365758|NCT02799745|41605745|FG001|Overall Study|Progressive Disease|38|||
19365759|NCT02799745|41605744|FG000|Overall Study|Lost to Follow-up|3|||
19365760|NCT02799745|41605745|FG001|Overall Study|Lost to Follow-up|2|||
19365761|NCT02799745|41605744|FG000|Overall Study|Death|3|||
19365762|NCT02799745|41605745|FG001|Overall Study|Death|0|||
19365763|NCT02799745|41605744|FG000|Overall Study|Adverse Event|0|||
19365764|NCT02799745|41605745|FG001|Overall Study|Adverse Event|1|||
19365765|NCT00705159|41605755|FG000|Overall Study|Withdrawal by Subject|0|||
19365766|NCT00705159|41605756|FG001|Overall Study|Withdrawal by Subject|1|||
19365767|NCT00705159|41605757|FG002|Overall Study|Withdrawal by Subject|1|||
19365768|NCT00705159|41605758|FG003|Overall Study|Withdrawal by Subject|1|||
19365769|NCT00705159|41605755|FG000|Overall Study|Protocol Violation|0|||
19365770|NCT00705159|41605756|FG001|Overall Study|Protocol Violation|1|||
19365771|NCT00705159|41605757|FG002|Overall Study|Protocol Violation|0|||
19365772|NCT00705159|41605758|FG003|Overall Study|Protocol Violation|0|||
19606456|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
19773759|NCT01986933|42228119|FG001|Active-to-active (Part B)|Physician Decision|0|||
19773760|NCT01986933|42228120|FG002|Active-to-active (Part B)|Physician Decision|1|||
19773761|NCT01986933|42228121|FG003|Active-to-active (Part B)|Physician Decision|1|||
19773762|NCT01986933|42228122|FG004|Active-to-active (Part B)|Physician Decision|0|||
19773763|NCT01986933|42228118|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
19773764|NCT01986933|42228119|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
19773765|NCT01986933|42228120|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
19773766|NCT01986933|42228121|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
19773767|NCT01986933|42228122|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
19773768|NCT01986933|42228118|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
19773769|NCT01986933|42228119|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
19773770|NCT01986933|42228120|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
19773771|NCT01986933|42228121|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
19773772|NCT01986933|42228122|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
19773773|NCT01986933|42228118|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
19773774|NCT01986933|42228119|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
19773775|NCT01986933|42228120|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
19773776|NCT01986933|42228121|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
19773777|NCT01986933|42228122|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
19773778|NCT01986933|42228118|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
19773779|NCT01986933|42228119|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
19365773|NCT00705159|41605755|FG000|Overall Study|Adverse Event|0|||
19365774|NCT00705159|41605756|FG001|Overall Study|Adverse Event|0|||
19365775|NCT00705159|41605757|FG002|Overall Study|Adverse Event|1|||
19365776|NCT00705159|41605758|FG003|Overall Study|Adverse Event|0|||
19365777|NCT00705159|41605755|FG000|Overall Study|Lost to Follow-up|0|||
19365778|NCT00705159|41605756|FG001|Overall Study|Lost to Follow-up|0|||
19365779|NCT00705159|41605757|FG002|Overall Study|Lost to Follow-up|3|||
19365780|NCT00705159|41605758|FG003|Overall Study|Lost to Follow-up|2|||
19365781|NCT00705159|41605755|FG000|Overall Study|Screen Failure|0|||
19365782|NCT00705159|41605756|FG001|Overall Study|Screen Failure|0|||
19365783|NCT00705159|41605757|FG002|Overall Study|Screen Failure|0|||
19365784|NCT00705159|41605758|FG003|Overall Study|Screen Failure|1|||
19365785|NCT01673984|41605770|FG000|Overall Study|Adverse Event|1|||
19365786|NCT01673984|41605771|FG001|Overall Study|Adverse Event|0|||
19365787|NCT01673984|41605770|FG000|Overall Study|Study termination|9|||
19365788|NCT01673984|41605771|FG001|Overall Study|Study termination|6|||
19365789|NCT02332928|41605790|FG000|Overall Study|Withdrawal by Subject|0|||
19365790|NCT02332928|41605791|FG001|Overall Study|Withdrawal by Subject|2|||
19365791|NCT02332928|41605790|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
19365792|NCT02332928|41605791|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
19365793|NCT02647658|41605799|FG000|Overall Study|Consent refusal|15|||
19365794|NCT02647658|41605800|FG001|Overall Study|Consent refusal|24|||
19365795|NCT00703677|41605806|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
19365796|NCT00703911|41605814|FG000|Overall Study|Death|1|||
19365797|NCT00703911|41605814|FG000|Overall Study|Physician Decision|6|||
19365798|NCT00703911|41605814|FG000|Overall Study|Lost to Follow-up|1|||
19365799|NCT00703911|41605814|FG000|Overall Study|Withdrawal by Subject|2|||
19365800|NCT02055547|41605818|FG000|Overall Study|Protocol Violation|0|||
19365801|NCT02055547|41605819|FG001|Overall Study|Protocol Violation|0|||
19365802|NCT02055547|41605820|FG002|Overall Study|Protocol Violation|1|||
19365803|NCT02055547|41605821|FG003|Overall Study|Protocol Violation|0|||
19365804|NCT02055547|41605822|FG004|Overall Study|Protocol Violation|0|||
19365805|NCT02055547|41605823|FG005|Overall Study|Protocol Violation|0|||
19773780|NCT01986933|42228120|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
19773781|NCT01986933|42228121|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
19773782|NCT01986933|42228122|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
19773783|NCT01986933|42228118|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
19773784|NCT01986933|42228119|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
19773785|NCT01986933|42228120|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
19773786|NCT01986933|42228121|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
19773787|NCT01986933|42228122|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
19773788|NCT01986933|42228118|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
19773789|NCT01986933|42228119|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
19773790|NCT01986933|42228120|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
19773791|NCT01986933|42228121|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
19773792|NCT01986933|42228122|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
19773793|NCT01986933|42228118|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
19773794|NCT01986933|42228119|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
19773795|NCT01986933|42228120|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
19773796|NCT01986933|42228121|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
19773797|NCT01986933|42228122|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
19365806|NCT02055547|41605824|FG006|Overall Study|Protocol Violation|1|||
19365807|NCT02055547|41605825|FG007|Overall Study|Protocol Violation|0|||
19365808|NCT02055547|41605826|FG008|Overall Study|Protocol Violation|0|||
19365809|NCT02055547|41605827|FG009|Overall Study|Protocol Violation|0|||
19365810|NCT02055547|41605828|FG010|Overall Study|Protocol Violation|0|||
19365811|NCT02055547|41605829|FG011|Overall Study|Protocol Violation|0|||
19365812|NCT02055547|41605830|FG012|Overall Study|Protocol Violation|0|||
19365813|NCT02055547|41605831|FG013|Overall Study|Protocol Violation|0|||
19365814|NCT02055547|41605832|FG014|Overall Study|Protocol Violation|0|||
19365815|NCT02055547|41605833|FG015|Overall Study|Protocol Violation|0|||
19365816|NCT02055547|41605834|FG016|Overall Study|Protocol Violation|0|||
19365817|NCT02055547|41605835|FG017|Overall Study|Protocol Violation|0|||
19365818|NCT02055547|41605836|FG018|Overall Study|Protocol Violation|0|||
19365819|NCT02055547|41605818|FG000|Overall Study|Physician Decision|0|||
19365820|NCT02055547|41605819|FG001|Overall Study|Physician Decision|1|||
19365821|NCT02055547|41605820|FG002|Overall Study|Physician Decision|1|||
19365822|NCT02055547|41605821|FG003|Overall Study|Physician Decision|0|||
19365823|NCT02055547|41605822|FG004|Overall Study|Physician Decision|1|||
19365824|NCT02055547|41605823|FG005|Overall Study|Physician Decision|0|||
19365825|NCT02055547|41605824|FG006|Overall Study|Physician Decision|0|||
19365826|NCT02055547|41605825|FG007|Overall Study|Physician Decision|0|||
19365827|NCT02055547|41605826|FG008|Overall Study|Physician Decision|0|||
19365828|NCT02055547|41605827|FG009|Overall Study|Physician Decision|1|||
19365829|NCT02055547|41605828|FG010|Overall Study|Physician Decision|1|||
19365830|NCT02055547|41605829|FG011|Overall Study|Physician Decision|0|||
19773798|NCT01986933|42228118|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
19365831|NCT02055547|41605830|FG012|Overall Study|Physician Decision|0|||
19365832|NCT02055547|41605831|FG013|Overall Study|Physician Decision|0|||
19365833|NCT02055547|41605832|FG014|Overall Study|Physician Decision|0|||
19365834|NCT02055547|41605833|FG015|Overall Study|Physician Decision|0|||
19365835|NCT02055547|41605834|FG016|Overall Study|Physician Decision|0|||
19365836|NCT02055547|41605835|FG017|Overall Study|Physician Decision|0|||
19365837|NCT02055547|41605836|FG018|Overall Study|Physician Decision|0|||
19365838|NCT02055547|41605818|FG000|Overall Study|Adverse Event|0|||
19365839|NCT02055547|41605819|FG001|Overall Study|Adverse Event|0|||
19365840|NCT02055547|41605820|FG002|Overall Study|Adverse Event|0|||
19365841|NCT02055547|41605821|FG003|Overall Study|Adverse Event|0|||
19365842|NCT02055547|41605822|FG004|Overall Study|Adverse Event|0|||
19365843|NCT02055547|41605823|FG005|Overall Study|Adverse Event|0|||
19365844|NCT02055547|41605824|FG006|Overall Study|Adverse Event|1|||
19365845|NCT02055547|41605825|FG007|Overall Study|Adverse Event|0|||
19365846|NCT02055547|41605826|FG008|Overall Study|Adverse Event|1|||
19365847|NCT02055547|41605827|FG009|Overall Study|Adverse Event|0|||
19365848|NCT02055547|41605828|FG010|Overall Study|Adverse Event|0|||
19365849|NCT02055547|41605829|FG011|Overall Study|Adverse Event|0|||
19365850|NCT02055547|41605830|FG012|Overall Study|Adverse Event|0|||
19365851|NCT02055547|41605831|FG013|Overall Study|Adverse Event|0|||
19365852|NCT02055547|41605832|FG014|Overall Study|Adverse Event|0|||
19365853|NCT02055547|41605833|FG015|Overall Study|Adverse Event|0|||
19365854|NCT02055547|41605834|FG016|Overall Study|Adverse Event|0|||
19365855|NCT02055547|41605835|FG017|Overall Study|Adverse Event|0|||
19365856|NCT02055547|41605836|FG018|Overall Study|Adverse Event|0|||
19365857|NCT02055547|41605818|FG000|Overall Study|Withdrawal by Subject|0|||
19365858|NCT02055547|41605819|FG001|Overall Study|Withdrawal by Subject|0|||
19365859|NCT02055547|41605820|FG002|Overall Study|Withdrawal by Subject|0|||
19365860|NCT02055547|41605821|FG003|Overall Study|Withdrawal by Subject|0|||
19365861|NCT02055547|41605822|FG004|Overall Study|Withdrawal by Subject|0|||
19365862|NCT02055547|41605823|FG005|Overall Study|Withdrawal by Subject|1|||
19365863|NCT02055547|41605824|FG006|Overall Study|Withdrawal by Subject|0|||
19365864|NCT02055547|41605825|FG007|Overall Study|Withdrawal by Subject|0|||
19365865|NCT02055547|41605826|FG008|Overall Study|Withdrawal by Subject|1|||
19365866|NCT02055547|41605827|FG009|Overall Study|Withdrawal by Subject|0|||
19365867|NCT02055547|41605828|FG010|Overall Study|Withdrawal by Subject|0|||
19365868|NCT02055547|41605829|FG011|Overall Study|Withdrawal by Subject|0|||
19365869|NCT02055547|41605830|FG012|Overall Study|Withdrawal by Subject|0|||
19365870|NCT02055547|41605831|FG013|Overall Study|Withdrawal by Subject|1|||
19365871|NCT02055547|41605832|FG014|Overall Study|Withdrawal by Subject|0|||
19365872|NCT02055547|41605833|FG015|Overall Study|Withdrawal by Subject|1|||
19365873|NCT02055547|41605834|FG016|Overall Study|Withdrawal by Subject|0|||
19365874|NCT02055547|41605835|FG017|Overall Study|Withdrawal by Subject|0|||
19365875|NCT02055547|41605836|FG018|Overall Study|Withdrawal by Subject|0|||
19365876|NCT02055547|41605818|FG000|Overall Study|Lost to Follow-up|0|||
19365877|NCT02055547|41605819|FG001|Overall Study|Lost to Follow-up|0|||
19365878|NCT02055547|41605820|FG002|Overall Study|Lost to Follow-up|1|||
19365879|NCT02055547|41605821|FG003|Overall Study|Lost to Follow-up|0|||
19365880|NCT02055547|41605822|FG004|Overall Study|Lost to Follow-up|0|||
19365881|NCT02055547|41605823|FG005|Overall Study|Lost to Follow-up|0|||
19365882|NCT02055547|41605824|FG006|Overall Study|Lost to Follow-up|0|||
19773799|NCT01986933|42228119|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
19773800|NCT01986933|42228120|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
19773801|NCT01986933|42228121|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
19773802|NCT01986933|42228122|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
19773803|NCT00394355|42228166|FG000|Overall Study|Adverse Event|10|||
19773804|NCT00394355|42228167|FG001|Overall Study|Adverse Event|6|||
19773805|NCT00394355|42228168|FG002|Overall Study|Adverse Event|7|||
19773806|NCT00394355|42228169|FG003|Overall Study|Adverse Event|8|||
19773807|NCT00394355|42228166|FG000|Overall Study|Did not meet protocol eligibility|1|||
19773808|NCT00394355|42228167|FG001|Overall Study|Did not meet protocol eligibility|5|||
19773809|NCT00394355|42228168|FG002|Overall Study|Did not meet protocol eligibility|4|||
19773810|NCT00394355|42228169|FG003|Overall Study|Did not meet protocol eligibility|2|||
19773811|NCT00394355|42228166|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
19773812|NCT00394355|42228167|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
19773813|NCT00394355|42228168|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
19773814|NCT00394355|42228169|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
19773815|NCT00394355|42228166|FG000|Overall Study|Subject withdrawal - related to drug|1|||
19773816|NCT00394355|42228167|FG001|Overall Study|Subject withdrawal - related to drug|0|||
19773817|NCT00394355|42228168|FG002|Overall Study|Subject withdrawal - related to drug|0|||
19365883|NCT02055547|41605825|FG007|Overall Study|Lost to Follow-up|0|||
19365884|NCT02055547|41605826|FG008|Overall Study|Lost to Follow-up|0|||
19365885|NCT02055547|41605827|FG009|Overall Study|Lost to Follow-up|0|||
19365886|NCT02055547|41605828|FG010|Overall Study|Lost to Follow-up|0|||
19365887|NCT02055547|41605829|FG011|Overall Study|Lost to Follow-up|0|||
19365888|NCT02055547|41605830|FG012|Overall Study|Lost to Follow-up|0|||
19606457|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
19773818|NCT00394355|42228169|FG003|Overall Study|Subject withdrawal - related to drug|0|||
19365889|NCT02055547|41605831|FG013|Overall Study|Lost to Follow-up|0|||
19773819|NCT00394355|42228166|FG000|Overall Study|Lost to Follow-up|7|||
19773820|NCT00394355|42228167|FG001|Overall Study|Lost to Follow-up|5|||
19773821|NCT00394355|42228168|FG002|Overall Study|Lost to Follow-up|4|||
19773822|NCT00394355|42228169|FG003|Overall Study|Lost to Follow-up|3|||
19773823|NCT00394355|42228166|FG000|Overall Study|Noncompliance with protocol|4|||
19773824|NCT00394355|42228167|FG001|Overall Study|Noncompliance with protocol|3|||
19773825|NCT00394355|42228168|FG002|Overall Study|Noncompliance with protocol|10|||
19773826|NCT00394355|42228169|FG003|Overall Study|Noncompliance with protocol|8|||
19773827|NCT00394355|42228166|FG000|Overall Study|Administrative|0|||
19773828|NCT00394355|42228167|FG001|Overall Study|Administrative|1|||
19773829|NCT00394355|42228168|FG002|Overall Study|Administrative|1|||
19773830|NCT00394355|42228169|FG003|Overall Study|Administrative|1|||
19773831|NCT00394355|42228166|FG000|Overall Study|Lack of Efficacy|0|||
19773832|NCT00394355|42228167|FG001|Overall Study|Lack of Efficacy|0|||
19773833|NCT00394355|42228168|FG002|Overall Study|Lack of Efficacy|2|||
19773834|NCT00394355|42228169|FG003|Overall Study|Lack of Efficacy|3|||
19773835|NCT02797808|42228181|FG000|Overall Study|Withdrawal by Subject|1|||
19773836|NCT02797808|42228182|FG001|Overall Study|Withdrawal by Subject|1|||
19773837|NCT02797808|42228181|FG000|Overall Study|Physician Decision|6|||
19773838|NCT02797808|42228182|FG001|Overall Study|Physician Decision|2|||
19773839|NCT02796560|42228190|FG000|Overall Study|Adverse Event|2|||
19773840|NCT02796560|42228191|FG001|Overall Study|Adverse Event|0|||
19773841|NCT02796560|42228190|FG000|Overall Study|Withdrawal by Subject|2|||
19773842|NCT02796560|42228191|FG001|Overall Study|Withdrawal by Subject|2|||
19773843|NCT00344487|42228197|FG000|Overall Study|immunologic failure|1|||
19773844|NCT02871492|42228206|FG000|Overall Study|Lost to Follow-up|6|||
19773845|NCT02871492|42228207|FG001|Overall Study|Lost to Follow-up|3|||
19773846|NCT02871492|42228208|FG002|Overall Study|Lost to Follow-up|5|||
19773847|NCT02871492|42228206|FG000|Overall Study|Withdrawal by Subject|0|||
19773848|NCT02871492|42228207|FG001|Overall Study|Withdrawal by Subject|0|||
19773849|NCT02871492|42228208|FG002|Overall Study|Withdrawal by Subject|1|||
19773850|NCT03143855|42228218|FG000|Overall Study|Withdrawal by Subject|4|||
19773851|NCT03143855|42228219|FG001|Overall Study|Withdrawal by Subject|3|||
19773852|NCT03143855|42228218|FG000|Overall Study|Protocol Violation|1|||
19773853|NCT03143855|42228219|FG001|Overall Study|Protocol Violation|0|||
19773854|NCT03143855|42228218|FG000|Overall Study|Participant experienced withdrawal|0|||
19773855|NCT03143855|42228219|FG001|Overall Study|Participant experienced withdrawal|1|||
19773856|NCT02878603|42228227|FG000|Overall Study|Lost to Follow-up|4|||
19773857|NCT02878603|42228228|FG001|Overall Study|Lost to Follow-up|1|||
19365890|NCT02055547|41605832|FG014|Overall Study|Lost to Follow-up|0|||
19365891|NCT02055547|41605833|FG015|Overall Study|Lost to Follow-up|0|||
19365892|NCT02055547|41605834|FG016|Overall Study|Lost to Follow-up|0|||
19365893|NCT02055547|41605835|FG017|Overall Study|Lost to Follow-up|0|||
19365894|NCT02055547|41605836|FG018|Overall Study|Lost to Follow-up|0|||
19365895|NCT02414854|41605874|FG000|Overall Study|Adverse Event|9|||
19365896|NCT02414854|41605875|FG001|Overall Study|Adverse Event|7|||
19365897|NCT02414854|41605876|FG002|Overall Study|Adverse Event|1|||
19365898|NCT02414854|41605877|FG003|Overall Study|Adverse Event|12|||
19365899|NCT02414854|41605874|FG000|Overall Study|Poor compliance to protocol|1|||
19365900|NCT02414854|41605875|FG001|Overall Study|Poor compliance to protocol|1|||
19365901|NCT02414854|41605876|FG002|Overall Study|Poor compliance to protocol|2|||
19365902|NCT02414854|41605877|FG003|Overall Study|Poor compliance to protocol|2|||
19365903|NCT02414854|41605874|FG000|Overall Study|Other than specified above|12|||
19365904|NCT02414854|41605875|FG001|Overall Study|Other than specified above|37|||
19365905|NCT02414854|41605876|FG002|Overall Study|Other than specified above|17|||
19365906|NCT02414854|41605877|FG003|Overall Study|Other than specified above|37|||
19365907|NCT03332498|41605890|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
19365908|NCT03332498|41605891|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
19365909|NCT03332498|41605892|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
19365910|NCT01334125|41605901|FG000|Overall Study|Lost to Follow-up|3|||
19365911|NCT01334125|41605902|FG001|Overall Study|Lost to Follow-up|3|||
19365912|NCT02414152|41605909|FG000|Overall Study|Withdrawal by Subject|1|||
19365913|NCT02414152|41605909|FG000|Overall Study|Lack of Efficacy|1|||
19365914|NCT02413996|41605915|FG000|Overall Study|not comfortable with the intervention|9|||
19773858|NCT02878603|42228227|FG000|Overall Study|Withdrawal by Subject|1|||
19773859|NCT02878603|42228228|FG001|Overall Study|Withdrawal by Subject|1|||
19773860|NCT02878603|42228227|FG000|Overall Study|Death|1|||
19773861|NCT02878603|42228228|FG001|Overall Study|Death|0|||
19365915|NCT02413996|41605916|FG001|Overall Study|not comfortable with the intervention|2|||
19365916|NCT01333501|41605924|FG000|Overall Study|Adverse Event|3|||
19365917|NCT01333501|41605925|FG001|Overall Study|Adverse Event|1|||
19365918|NCT01333501|41605924|FG000|Overall Study|Abnormal laboratory value|2|||
19773862|NCT02878603|42228227|FG000|Overall Study|Physician Decision|0|||
19773863|NCT02878603|42228228|FG001|Overall Study|Physician Decision|3|||
19365919|NCT01333501|41605925|FG001|Overall Study|Abnormal laboratory value|1|||
19773864|NCT01370408|42228234|FG000|Overall Study|treatment failure|9|||
19773865|NCT03294109|42228240|FG000|Overall Study|Withdrawal by Subject|6|||
19773866|NCT03294109|42228241|FG001|Overall Study|Withdrawal by Subject|5|||
19365920|NCT01333501|41605924|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19365921|NCT01333501|41605925|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
19365922|NCT01333501|41605924|FG000|Overall Study|Withdrawn consent|3|||
19365923|NCT01333501|41605925|FG001|Overall Study|Withdrawn consent|12|||
19365924|NCT01362140|41605933|FG000|Overall Study|Noncompliance|1|||
19365925|NCT01362140|41605934|FG001|Overall Study|Noncompliance|0|||
19365926|NCT01362140|41605933|FG000|Overall Study|Adverse Event|2|||
19365927|NCT01362140|41605934|FG001|Overall Study|Adverse Event|2|||
19365928|NCT01362140|41605933|FG000|Overall Study|Withdrawal by Subject|3|||
19365929|NCT01362140|41605934|FG001|Overall Study|Withdrawal by Subject|3|||
19365930|NCT01362140|41605933|FG000|Overall Study|Administrative Decision|0|||
19365931|NCT01362140|41605934|FG001|Overall Study|Administrative Decision|1|||
19365932|NCT01362140|41605933|FG000|Overall Study|Death|2|||
19365933|NCT01362140|41605934|FG001|Overall Study|Death|1|||
19773867|NCT02868216|42228259|FG000|Overall Study|Death|0|||
19773868|NCT02868216|42228260|FG001|Overall Study|Death|1|||
19365934|NCT01362140|41605933|FG000|Overall Study|Other|1|||
19365935|NCT01362140|41605934|FG001|Overall Study|Other|1|||
19773869|NCT02868216|42228259|FG000|Overall Study|coronary artery bypass|1|||
19773870|NCT02868216|42228260|FG001|Overall Study|coronary artery bypass|0|||
19773871|NCT02868216|42228259|FG000|Overall Study|Withdrawal by Subject|7|||
19773872|NCT02868216|42228260|FG001|Overall Study|Withdrawal by Subject|5|||
19773873|NCT03132805|42228269|FG000|Overall Study|Lost to Follow-up|142|||
19773874|NCT03132805|42228270|FG001|Overall Study|Lost to Follow-up|141|||
19773875|NCT03132805|42228271|FG002|Overall Study|Lost to Follow-up|113|||
19773876|NCT02793128|42228279|FG000|Overall Study|Death|4|||
19773877|NCT02793128|42228279|FG000|Overall Study|Withdrawal by Subject|2|||
19773878|NCT02793128|42228279|FG000|Overall Study|Physician Decision|1|||
19773879|NCT02793128|42228279|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
19773880|NCT02793128|42228279|FG000|Overall Study|Patient elected nephroureterectomy|1|||
19773881|NCT02524171|42228293|FG000|6-month Follow-up|Lost to Follow-up|53|||
19773882|NCT02524171|42228294|FG001|6-month Follow-up|Lost to Follow-up|45|||
19773883|NCT02524171|42228293|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
19773884|NCT02524171|42228294|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
19773885|NCT03142451|42228302|FG000|Overall Study|Adverse Event|5|||
19773886|NCT03142451|42228303|FG001|Overall Study|Adverse Event|2|||
19365936|NCT01362140|41605933|FG000|Overall Study|Protocol-specified Criteria|1|||
19365937|NCT01362140|41605934|FG001|Overall Study|Protocol-specified Criteria|2|||
19365938|NCT01362140|41605933|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
19365939|NCT01362140|41605934|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
19365940|NCT01333189|41605942|FG000|Overall Study|Time constraints|1|||
19365941|NCT01333189|41605943|FG001|Overall Study|Time constraints|0|||
19365942|NCT01333189|41605942|FG000|Overall Study|Adverse Event|1|||
19365943|NCT01333189|41605943|FG001|Overall Study|Adverse Event|0|||
19365944|NCT01333189|41605942|FG000|Overall Study|Transportation difficulties|0|||
19365945|NCT01333189|41605943|FG001|Overall Study|Transportation difficulties|1|||
19365946|NCT01333189|41605942|FG000|Overall Study|Moved from region|0|||
19365947|NCT01333189|41605943|FG001|Overall Study|Moved from region|1|||
19365948|NCT01333111|41605952|FG000|Overall Study|patient undergoing major surgery|0|||
19365949|NCT01333111|41605953|FG001|Overall Study|patient undergoing major surgery|2|||
19365950|NCT01333111|41605954|FG002|Overall Study|patient undergoing major surgery|0|||
19365951|NCT01333111|41605952|FG000|Overall Study|personal reasons|0|||
19365952|NCT01333111|41605953|FG001|Overall Study|personal reasons|0|||
19365953|NCT01333111|41605954|FG002|Overall Study|personal reasons|1|||
19365954|NCT01333111|41605952|FG000|Overall Study|unclassified|1|||
19365955|NCT01333111|41605953|FG001|Overall Study|unclassified|0|||
19365956|NCT01333111|41605954|FG002|Overall Study|unclassified|0|||
19365957|NCT01333111|41605952|FG000|Overall Study|withdrawal criteria|0|||
19365958|NCT01333111|41605953|FG001|Overall Study|withdrawal criteria|1|||
19365959|NCT01333111|41605954|FG002|Overall Study|withdrawal criteria|0|||
19365960|NCT01333111|41605952|FG000|Overall Study|Non-compliance|1|||
19365961|NCT01333111|41605953|FG001|Overall Study|Non-compliance|0|||
19365962|NCT01333111|41605954|FG002|Overall Study|Non-compliance|0|||
19365963|NCT01333111|41605952|FG000|Overall Study|Ineffective therapy|0|||
19365964|NCT01333111|41605953|FG001|Overall Study|Ineffective therapy|0|||
19365965|NCT01333111|41605954|FG002|Overall Study|Ineffective therapy|1|||
19365966|NCT00702507|41605962|FG000|Initial Treatment Phase|Adverse Event|2|||
19773887|NCT03142451|42228302|FG000|Overall Study|Lost to Follow-up|25|||
19773888|NCT03142451|42228303|FG001|Overall Study|Lost to Follow-up|8|||
19773889|NCT03142451|42228302|FG000|Overall Study|Participant request|24|||
19773890|NCT03142451|42228303|FG001|Overall Study|Participant request|12|||
19773891|NCT03142451|42228302|FG000|Overall Study|Protocol Violation|3|||
19773892|NCT03142451|42228303|FG001|Overall Study|Protocol Violation|1|||
19365967|NCT00702507|41605962|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
19365968|NCT00702507|41605962|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
19773893|NCT03142451|42228302|FG000|Overall Study|Other|1|||
19773894|NCT03142451|42228303|FG001|Overall Study|Other|1|||
19365969|NCT00702507|41605962|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
19773895|NCT03141905|42228311|FG000|Overall Study|Death|3|||
19773896|NCT03141905|42228312|FG001|Overall Study|Death|2|||
19773897|NCT03141905|42228311|FG000|Overall Study|Withdrawal by Subject|1|||
19773898|NCT03141905|42228312|FG001|Overall Study|Withdrawal by Subject|0|||
19773899|NCT03141905|42228311|FG000|Overall Study|Lost to Follow-up|3|||
19773900|NCT03141905|42228312|FG001|Overall Study|Lost to Follow-up|7|||
19365970|NCT00702507|41605962|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
19365971|NCT00702507|41605962|FG000|Follow-up Phase|Protocol Violation|2|||
19365972|NCT00702507|41605962|FG000|Follow-up Phase|Lost to Follow-up|23|||
19365973|NCT00702507|41605962|FG000|Follow-up Phase|Late Enrollment|1|||
19365974|NCT01673594|41605978|FG000|Overall Study|Adverse Event|3|||
19365975|NCT01673594|41605979|FG001|Overall Study|Adverse Event|1|||
19365976|NCT01673594|41605978|FG000|Overall Study|Lost to Follow-up|1|||
19365977|NCT01673594|41605979|FG001|Overall Study|Lost to Follow-up|0|||
19365978|NCT01673594|41605978|FG000|Overall Study|Physician Decision|2|||
19365979|NCT01673594|41605979|FG001|Overall Study|Physician Decision|4|||
19365980|NCT01673594|41605978|FG000|Overall Study|Withdrawal by Subject|0|||
19365981|NCT01673594|41605979|FG001|Overall Study|Withdrawal by Subject|1|||
19365982|NCT02721147|41605988|FG000|Overall Study|Lost to Follow-up|2|||
19773901|NCT03141905|42228311|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
19773902|NCT03141905|42228312|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
19365983|NCT02721147|41605989|FG001|Overall Study|Lost to Follow-up|0|||
19365984|NCT02721147|41605990|FG002|Overall Study|Lost to Follow-up|0|||
19365985|NCT02720757|41605998|FG000|Overall Study|Other reason|5|||
19365986|NCT02720757|41605998|FG000|Overall Study|Loss of contact|4|||
19365987|NCT02720757|41605998|FG000|Overall Study|Informed consent withdrawal|1|||
19365988|NCT02720757|41605998|FG000|Overall Study|Patients wish to withdraw|2|||
19365989|NCT02720757|41605998|FG000|Overall Study|Missing|3|||
19365990|NCT02720757|41605998|FG000|Overall Study|General exclusion|3|||
19365991|NCT02646566|41606028|FG000|Overall Study|Lost to Follow-up|5|||
19365992|NCT02646566|41606029|FG001|Overall Study|Lost to Follow-up|4|||
19691633|NCT00527735|42137381|FG001|Overall Study|Disease progression|61|||
19691634|NCT00527735|42137382|FG002|Overall Study|Disease progression|53|||
19691635|NCT00527735|42137380|FG000|Overall Study|Death|23|||
19691636|NCT00527735|42137381|FG001|Overall Study|Death|13|||
19691637|NCT00527735|42137382|FG002|Overall Study|Death|15|||
19691638|NCT00527735|42137380|FG000|Overall Study|Completed treatment in treatment phase|14|||
19365993|NCT02646566|41606030|FG002|Overall Study|Lost to Follow-up|5|||
19365994|NCT02646566|41606028|FG000|Overall Study|Treatment failure|1|||
19365995|NCT02646566|41606029|FG001|Overall Study|Treatment failure|0|||
19365996|NCT02646566|41606030|FG002|Overall Study|Treatment failure|0|||
19365997|NCT02720523|41606046|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
19365998|NCT02720523|41606047|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
19365999|NCT02720523|41606048|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
19366000|NCT02720523|41606049|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
19366001|NCT02720523|41606050|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
19366002|NCT02720523|41606051|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
19366003|NCT02720523|41606052|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
19691639|NCT00527735|42137381|FG001|Overall Study|Completed treatment in treatment phase|13|||
19691640|NCT00527735|42137382|FG002|Overall Study|Completed treatment in treatment phase|18|||
19691641|NCT00527735|42137380|FG000|Overall Study|Adverse Event|10|||
19691642|NCT00527735|42137381|FG001|Overall Study|Adverse Event|6|||
19691643|NCT00527735|42137382|FG002|Overall Study|Adverse Event|7|||
19691644|NCT00527735|42137380|FG000|Overall Study|Not identified|5|||
19691645|NCT00527735|42137381|FG001|Overall Study|Not identified|5|||
19691646|NCT00527735|42137382|FG002|Overall Study|Not identified|5|||
19691647|NCT00527735|42137380|FG000|Overall Study|Withdrawal by Subject|5|||
19691648|NCT00527735|42137381|FG001|Overall Study|Withdrawal by Subject|4|||
19691649|NCT00527735|42137382|FG002|Overall Study|Withdrawal by Subject|3|||
19691650|NCT00527735|42137380|FG000|Overall Study|No longer met study criteria|2|||
19691651|NCT00527735|42137381|FG001|Overall Study|No longer met study criteria|2|||
19691652|NCT00527735|42137382|FG002|Overall Study|No longer met study criteria|1|||
19691653|NCT00527735|42137380|FG000|Overall Study|Lost to Follow-up|0|||
19691654|NCT00527735|42137381|FG001|Overall Study|Lost to Follow-up|0|||
19691655|NCT00527735|42137382|FG002|Overall Study|Lost to Follow-up|3|||
19691656|NCT00527735|42137380|FG000|Overall Study|Poor compliance or noncompliance|0|||
19691657|NCT00527735|42137381|FG001|Overall Study|Poor compliance or noncompliance|1|||
19773903|NCT01370018|42228319|FG000|Overall Study|Did not meet criteria for analysis|1|||
19773904|NCT04034355|42228325|FG000|Overall Study|Study terminated by Sponsor|10|||
19366004|NCT02720523|41606046|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
19366005|NCT02720523|41606047|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19366006|NCT02720523|41606048|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19366007|NCT02720523|41606049|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19691658|NCT00527735|42137382|FG002|Overall Study|Poor compliance or noncompliance|1|||
19691659|NCT00527735|42137380|FG000|Overall Study|Completed treatment during maintenance|2|||
19691660|NCT00527735|42137381|FG001|Overall Study|Completed treatment during maintenance|2|||
19691661|NCT00527735|42137382|FG002|Overall Study|Completed treatment during maintenance|1|||
19691662|NCT00336492|42137405|FG000|Overall Study|Adverse Event|4|||
19691663|NCT00336492|42137406|FG001|Overall Study|Adverse Event|3|||
19691664|NCT00336492|42137407|FG002|Overall Study|Adverse Event|6|||
19691665|NCT00336492|42137405|FG000|Overall Study|Lack of Efficacy|6|||
19691666|NCT00336492|42137406|FG001|Overall Study|Lack of Efficacy|1|||
19691667|NCT00336492|42137407|FG002|Overall Study|Lack of Efficacy|4|||
19691668|NCT00336492|42137405|FG000|Overall Study|Other|5|||
19691669|NCT00336492|42137406|FG001|Overall Study|Other|0|||
19691670|NCT00336492|42137407|FG002|Overall Study|Other|1|||
19691671|NCT00194025|42137415|FG000|Overall Study|Adverse Event|1|||
19691672|NCT00194025|42137415|FG000|Overall Study|non-adherence with study medication|4|||
19691673|NCT00368108|42137422|FG000|Overall Study|Adverse Event|38|||
19691674|NCT00368108|42137423|FG001|Overall Study|Adverse Event|26|||
19691675|NCT00368108|42137424|FG002|Overall Study|Adverse Event|44|||
19691676|NCT00368108|42137422|FG000|Overall Study|Abnormal Laboratory Value|0|||
19691677|NCT00368108|42137423|FG001|Overall Study|Abnormal Laboratory Value|0|||
19691678|NCT00368108|42137424|FG002|Overall Study|Abnormal Laboratory Value|3|||
19691679|NCT00368108|42137422|FG000|Overall Study|Protocol Violation|5|||
19691680|NCT00368108|42137423|FG001|Overall Study|Protocol Violation|9|||
19773905|NCT04034355|42228326|FG001|Overall Study|Study terminated by Sponsor|17|||
19366008|NCT02720523|41606050|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19366009|NCT02720523|41606051|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19366010|NCT02720523|41606052|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
19366011|NCT02720523|41606046|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
19366012|NCT02720523|41606047|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366013|NCT02720523|41606048|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366014|NCT02720523|41606049|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366015|NCT02720523|41606050|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366016|NCT02720523|41606051|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366017|NCT02720523|41606052|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
19366018|NCT02720523|41606046|FG000|Period 1: Placebo-controlled Period|Other|0|||
19366019|NCT02720523|41606047|FG001|Period 1: Placebo-controlled Period|Other|0|||
19366020|NCT02720523|41606048|FG002|Period 1: Placebo-controlled Period|Other|1|||
19366021|NCT02720523|41606049|FG003|Period 1: Placebo-controlled Period|Other|1|||
19366022|NCT02720523|41606050|FG004|Period 1: Placebo-controlled Period|Other|0|||
19366023|NCT02720523|41606051|FG005|Period 1: Placebo-controlled Period|Other|0|||
19366024|NCT02720523|41606052|FG006|Period 1: Placebo-controlled Period|Other|0|||
19366025|NCT02720523|41606046|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
19366026|NCT02720523|41606047|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
19366027|NCT02720523|41606048|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
19366028|NCT02720523|41606049|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
19773906|NCT04034355|42228325|FG000|Overall Study|Withdrawal by Subject|12|||
19773907|NCT04034355|42228326|FG001|Overall Study|Withdrawal by Subject|11|||
19773908|NCT04034355|42228325|FG000|Overall Study|Site terminated by Sponsor|4|||
19773909|NCT04034355|42228326|FG001|Overall Study|Site terminated by Sponsor|5|||
19773910|NCT04034355|42228325|FG000|Overall Study|Adverse Event|2|||
19773911|NCT04034355|42228326|FG001|Overall Study|Adverse Event|0|||
19773912|NCT04034355|42228325|FG000|Overall Study|Death|1|||
19773913|NCT04034355|42228326|FG001|Overall Study|Death|1|||
19773914|NCT04034355|42228325|FG000|Overall Study|Not reported|2|||
19773915|NCT04034355|42228326|FG001|Overall Study|Not reported|0|||
19773916|NCT04034355|42228325|FG000|Overall Study|Lost to Follow-up|1|||
19773917|NCT04034355|42228326|FG001|Overall Study|Lost to Follow-up|0|||
19773918|NCT04034355|42228325|FG000|Overall Study|Physician Decision|1|||
19773919|NCT04034355|42228326|FG001|Overall Study|Physician Decision|0|||
19773920|NCT04034355|42228325|FG000|Overall Study|Protocol Violation|0|||
19773921|NCT04034355|42228326|FG001|Overall Study|Protocol Violation|1|||
19773922|NCT04034355|42228325|FG000|Overall Study|Progressive disease|1|||
19773923|NCT04034355|42228326|FG001|Overall Study|Progressive disease|0|||
19773924|NCT01336764|42228343|FG000|Overall Study|Withdrawal by Subject|5|||
19773925|NCT01336764|42228344|FG001|Overall Study|Withdrawal by Subject|5|||
19773926|NCT01336608|42228353|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
19773927|NCT01336608|42228354|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19773928|NCT01336608|42228355|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19773929|NCT01336608|42228356|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19773930|NCT01336608|42228353|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
19773931|NCT01336608|42228354|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19773932|NCT01336608|42228355|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19691681|NCT00368108|42137424|FG002|Overall Study|Protocol Violation|9|||
19691682|NCT00368108|42137422|FG000|Overall Study|Withdrawal by Subject|9|||
19691683|NCT00368108|42137423|FG001|Overall Study|Withdrawal by Subject|3|||
19691684|NCT00368108|42137424|FG002|Overall Study|Withdrawal by Subject|5|||
19773933|NCT01336608|42228356|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19773934|NCT01336608|42228353|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
19773935|NCT01336608|42228354|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
19773936|NCT01336608|42228355|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
19773937|NCT01336608|42228356|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
19773938|NCT01336608|42228353|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
19773939|NCT01336608|42228354|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
19773940|NCT01336608|42228355|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
19773941|NCT01336608|42228356|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
19773942|NCT01336608|42228353|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
19773943|NCT01336608|42228354|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19773944|NCT01336608|42228355|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19773945|NCT01336608|42228356|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19773946|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
19773947|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
19773948|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
19773949|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
19773950|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19773951|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
19773952|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19773953|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19773954|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
19773955|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
19773956|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
19773957|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
19773958|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
19691685|NCT00368108|42137422|FG000|Overall Study|Lack of Efficacy|7|||
19691686|NCT00368108|42137423|FG001|Overall Study|Lack of Efficacy|8|||
19691687|NCT00368108|42137424|FG002|Overall Study|Lack of Efficacy|5|||
19691688|NCT00368108|42137422|FG000|Overall Study|Physician Decision|2|||
19691689|NCT00368108|42137423|FG001|Overall Study|Physician Decision|0|||
19691690|NCT00368108|42137424|FG002|Overall Study|Physician Decision|1|||
19691691|NCT00368108|42137422|FG000|Overall Study|Other|3|||
19691692|NCT00368108|42137423|FG001|Overall Study|Other|7|||
19691693|NCT00368108|42137424|FG002|Overall Study|Other|1|||
19691694|NCT00364130|42137434|FG000|Intervention Period|Lost to Follow-up|4|||
19691695|NCT00364130|42137435|FG001|Intervention Period|Lost to Follow-up|3|||
19691696|NCT00364130|42137434|FG000|Intervention Period|Pregnancy|1|||
19691697|NCT00364130|42137435|FG001|Intervention Period|Pregnancy|0|||
19691698|NCT00364130|42137434|FG000|Intervention Period|Withdrawal by Subject|4|||
19691699|NCT00364130|42137435|FG001|Intervention Period|Withdrawal by Subject|5|||
19691700|NCT00364130|42137434|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
19773959|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
19691701|NCT00364130|42137435|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
19366029|NCT02720523|41606050|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
19366030|NCT02720523|41606051|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
19691702|NCT00521339|42137443|FG000|Treatment Phase|Adverse Event|2|||
19691703|NCT00521339|42137444|FG001|Treatment Phase|Adverse Event|0|||
19691704|NCT00521339|42137445|FG002|Treatment Phase|Adverse Event|0|||
19773960|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
19773961|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
19773962|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
19773963|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
19773964|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
19773965|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
19773966|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19773967|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
19773968|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19773969|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19691705|NCT00521339|42137443|FG000|Treatment Phase|Intolerability to study drug|2|||
19691706|NCT00521339|42137444|FG001|Treatment Phase|Intolerability to study drug|0|||
19691707|NCT00521339|42137445|FG002|Treatment Phase|Intolerability to study drug|0|||
19773970|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
19691708|NCT00521339|42137443|FG000|Treatment Phase|Lack of Efficacy|3|||
19691709|NCT00521339|42137444|FG001|Treatment Phase|Lack of Efficacy|0|||
19691710|NCT00521339|42137445|FG002|Treatment Phase|Lack of Efficacy|0|||
19691711|NCT00521339|42137443|FG000|Treatment Phase|Withdrawal by Subject|3|||
19691712|NCT00521339|42137444|FG001|Treatment Phase|Withdrawal by Subject|0|||
19773971|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
19773972|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
19773973|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
19773974|NCT01336608|42228353|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19773975|NCT01336608|42228354|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
19773976|NCT01336608|42228355|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
19773977|NCT01336608|42228356|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
19773978|NCT01346371|42228375|FG000|Overall Study|Lost to Follow-up|2|||
19773979|NCT01346371|42228376|FG001|Overall Study|Lost to Follow-up|0|||
19773980|NCT03644849|42228394|FG000|Overall Study|Lost to Follow-up|1|||
19773981|NCT03644849|42228395|FG001|Overall Study|Lost to Follow-up|3|||
19773982|NCT03131479|42228406|FG000|Overall Study|Adverse Event|0|||
19773983|NCT03131479|42228407|FG001|Overall Study|Adverse Event|0|||
19773984|NCT03131479|42228408|FG002|Overall Study|Adverse Event|1|||
19773985|NCT03131479|42228409|FG003|Overall Study|Adverse Event|1|||
19773986|NCT03131479|42228410|FG004|Overall Study|Adverse Event|0|||
19773987|NCT03131479|42228406|FG000|Overall Study|Subject/Guardian Decision|0|||
19773988|NCT03131479|42228407|FG001|Overall Study|Subject/Guardian Decision|0|||
19773989|NCT03131479|42228408|FG002|Overall Study|Subject/Guardian Decision|0|||
19773990|NCT03131479|42228409|FG003|Overall Study|Subject/Guardian Decision|1|||
19773991|NCT03131479|42228410|FG004|Overall Study|Subject/Guardian Decision|0|||
19773992|NCT03602885|42228424|FG000|Overall Study|Lost to Follow-up|3|||
19773993|NCT03602885|42228425|FG001|Overall Study|Lost to Follow-up|0|||
19773994|NCT02880761|42228433|FG000|Overall Study|Death|6|||
19773995|NCT02880761|42228434|FG001|Overall Study|Death|8|||
19773996|NCT02880761|42228433|FG000|Overall Study|Withdrawal by Subject|3|||
19773997|NCT02880761|42228434|FG001|Overall Study|Withdrawal by Subject|6|||
19773998|NCT02880761|42228433|FG000|Overall Study|Protocol Violation|4|||
19773999|NCT02880761|42228434|FG001|Overall Study|Protocol Violation|3|||
19774000|NCT02880761|42228433|FG000|Overall Study|Lost to Follow-up|3|||
19774001|NCT02880761|42228434|FG001|Overall Study|Lost to Follow-up|4|||
19774002|NCT02930941|42228442|FG000|Overall Study|Lost to Follow-up|1|||
19774003|NCT02930941|42228443|FG001|Overall Study|Lost to Follow-up|2|||
19774004|NCT03137537|42228455|FG000|Overall Study|Adverse Event|0|||
19774005|NCT03137537|42228456|FG001|Overall Study|Adverse Event|1|||
19774006|NCT03137459|42228464|FG000|2-month Assessment|Withdrawal by Subject|13|||
19774007|NCT03137459|42228465|FG001|2-month Assessment|Withdrawal by Subject|3|||
19774008|NCT03137459|42228464|FG000|2-month Assessment|Unable to reach|42|||
19774009|NCT03137459|42228465|FG001|2-month Assessment|Unable to reach|32|||
19774010|NCT03137459|42228464|FG000|2-month Assessment|Refused assessment|7|||
19774011|NCT03137459|42228465|FG001|2-month Assessment|Refused assessment|5|||
19774012|NCT03137459|42228464|FG000|2-month Assessment|Acutely ill|6|||
19774013|NCT03137459|42228465|FG001|2-month Assessment|Acutely ill|2|||
19774014|NCT03137459|42228464|FG000|4-month Assessment|Death|4|||
19774015|NCT03137459|42228465|FG001|4-month Assessment|Death|2|||
19774016|NCT03137459|42228464|FG000|4-month Assessment|Withdrawal by Subject|4|||
19366031|NCT02720523|41606052|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
19366032|NCT02720523|41606046|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
19366033|NCT02720523|41606047|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
19366034|NCT02720523|41606048|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
19366035|NCT02720523|41606049|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
19366036|NCT02720523|41606050|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
19366037|NCT02720523|41606051|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
19366038|NCT02720523|41606052|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
19366039|NCT02720523|41606046|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
19366040|NCT02720523|41606047|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
19366041|NCT02720523|41606048|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
19691713|NCT00521339|42137445|FG002|Treatment Phase|Withdrawal by Subject|0|||
19691714|NCT00521339|42137443|FG000|Treatment Phase|Lost to Follow-up|1|||
19691715|NCT00521339|42137444|FG001|Treatment Phase|Lost to Follow-up|0|||
19691716|NCT00521339|42137445|FG002|Treatment Phase|Lost to Follow-up|0|||
19691717|NCT00521339|42137443|FG000|Treatment Phase|Protocol Violation|1|||
19691718|NCT00521339|42137444|FG001|Treatment Phase|Protocol Violation|0|||
19691719|NCT00521339|42137445|FG002|Treatment Phase|Protocol Violation|0|||
19691720|NCT00521339|42137443|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
19691721|NCT00521339|42137444|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
19691722|NCT00521339|42137445|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
19774017|NCT03137459|42228465|FG001|4-month Assessment|Withdrawal by Subject|2|||
19774018|NCT03137459|42228464|FG000|4-month Assessment|Unable to reach|44|||
19774019|NCT03137459|42228465|FG001|4-month Assessment|Unable to reach|29|||
19774020|NCT03137459|42228464|FG000|4-month Assessment|Refused assessment|24|||
19774021|NCT03137459|42228465|FG001|4-month Assessment|Refused assessment|10|||
19774022|NCT03137459|42228464|FG000|4-month Assessment|Acutely ill|2|||
19774023|NCT03137459|42228465|FG001|4-month Assessment|Acutely ill|3|||
19366042|NCT02720523|41606049|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
19366043|NCT02720523|41606050|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
19366044|NCT02720523|41606051|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
19366045|NCT02720523|41606052|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
19366046|NCT02720523|41606046|FG000|Period 2: Long-term Extension Period|Other|0|||
19366047|NCT02720523|41606047|FG001|Period 2: Long-term Extension Period|Other|0|||
19366048|NCT02720523|41606048|FG002|Period 2: Long-term Extension Period|Other|0|||
19366049|NCT02720523|41606049|FG003|Period 2: Long-term Extension Period|Other|0|||
19366050|NCT02720523|41606050|FG004|Period 2: Long-term Extension Period|Other|2|||
19366051|NCT02720523|41606051|FG005|Period 2: Long-term Extension Period|Other|0|||
19366052|NCT02720523|41606052|FG006|Period 2: Long-term Extension Period|Other|3|||
19366053|NCT02646332|41606067|FG000|Overall Study|Lost to Follow-up|0|||
19366054|NCT02646332|41606068|FG001|Overall Study|Lost to Follow-up|3|||
19366055|NCT02471716|41606079|FG000|Overall Study|Withdrawal by Subject|0|||
19366056|NCT02471716|41606080|FG001|Overall Study|Withdrawal by Subject|1|||
19366057|NCT02471716|41606081|FG002|Overall Study|Withdrawal by Subject|0|||
19366058|NCT02471716|41606082|FG003|Overall Study|Withdrawal by Subject|2|||
19774024|NCT03137459|42228464|FG000|6-months|Lost to Follow-up|14|||
19774025|NCT03137459|42228465|FG001|6-months|Lost to Follow-up|11|||
19774026|NCT03137459|42228464|FG000|6-months|Death|0|||
19774027|NCT03137459|42228465|FG001|6-months|Death|2|||
19774028|NCT03137459|42228464|FG000|6-months|Refused assessment|6|||
19691723|NCT00521339|42137443|FG000|Treatment Extension Phase|Death|0|||
19691724|NCT00521339|42137444|FG001|Treatment Extension Phase|Death|0|||
19691725|NCT00521339|42137445|FG002|Treatment Extension Phase|Death|1|||
19691726|NCT00363896|42137468|FG000|Overall Study|Withdrawal by Subject|29|||
19691727|NCT00363896|42137469|FG001|Overall Study|Withdrawal by Subject|16|||
19691728|NCT00363896|42137468|FG000|Overall Study|Adverse Event|24|||
19691729|NCT00363896|42137469|FG001|Overall Study|Adverse Event|13|||
19691730|NCT00363896|42137468|FG000|Overall Study|COPD exacerbation|13|||
19691731|NCT00363896|42137469|FG001|Overall Study|COPD exacerbation|7|||
19691732|NCT00363896|42137468|FG000|Overall Study|Lack of Efficacy|12|||
19691733|NCT00363896|42137469|FG001|Overall Study|Lack of Efficacy|8|||
19691734|NCT00363896|42137468|FG000|Overall Study|Protocol Violation|6|||
19691735|NCT00363896|42137469|FG001|Overall Study|Protocol Violation|1|||
19774029|NCT03137459|42228465|FG001|6-months|Refused assessment|3|||
19774030|NCT03137459|42228464|FG000|6-months|Acutely ill|1|||
19774031|NCT03137459|42228465|FG001|6-months|Acutely ill|1|||
19774032|NCT03131713|42228474|FG000|Overall Study|Lost to Follow-up|5|||
19774033|NCT03131713|42228475|FG001|Overall Study|Lost to Follow-up|0|||
19774034|NCT02930005|42228483|FG000|Overall Study|Lost to Follow-up|1|||
19774035|NCT02930005|42228484|FG001|Overall Study|Lost to Follow-up|5|||
19774036|NCT03637491|42228494|FG000|Overall Study|Death|9|||
19366059|NCT02471716|41606083|FG004|Overall Study|Withdrawal by Subject|5|||
19366060|NCT02471716|41606079|FG000|Overall Study|Study Terminiated by sponsor|0|||
19366061|NCT02471716|41606080|FG001|Overall Study|Study Terminiated by sponsor|0|||
19366062|NCT02471716|41606081|FG002|Overall Study|Study Terminiated by sponsor|0|||
19366063|NCT02471716|41606082|FG003|Overall Study|Study Terminiated by sponsor|1|||
19366064|NCT02471716|41606083|FG004|Overall Study|Study Terminiated by sponsor|0|||
19366065|NCT02471716|41606079|FG000|Overall Study|Lost to Follow-up|0|||
19366066|NCT02471716|41606080|FG001|Overall Study|Lost to Follow-up|0|||
19366067|NCT02471716|41606081|FG002|Overall Study|Lost to Follow-up|0|||
19366068|NCT02471716|41606082|FG003|Overall Study|Lost to Follow-up|3|||
19366069|NCT02471716|41606083|FG004|Overall Study|Lost to Follow-up|2|||
19366070|NCT02471716|41606079|FG000|Overall Study|Death|0|||
19366071|NCT02471716|41606080|FG001|Overall Study|Death|0|||
19366072|NCT02471716|41606081|FG002|Overall Study|Death|0|||
19366073|NCT02471716|41606082|FG003|Overall Study|Death|1|||
19366074|NCT02471716|41606083|FG004|Overall Study|Death|0|||
19366075|NCT02471716|41606079|FG000|Overall Study|Other|0|||
19366076|NCT02471716|41606080|FG001|Overall Study|Other|0|||
19366077|NCT02471716|41606081|FG002|Overall Study|Other|0|||
19366078|NCT02471716|41606082|FG003|Overall Study|Other|8|||
19691736|NCT00363896|42137468|FG000|Overall Study|Lost to Follow-up|3|||
19691737|NCT00363896|42137469|FG001|Overall Study|Lost to Follow-up|0|||
19774037|NCT03637491|42228495|FG001|Overall Study|Death|9|||
19774038|NCT03637491|42228496|FG002|Overall Study|Death|5|||
19366079|NCT02471716|41606083|FG004|Overall Study|Other|9|||
19366080|NCT01370863|41606099|FG000|Overall Study|Adverse Event|1|||
19366081|NCT01370863|41606100|FG001|Overall Study|Adverse Event|1|||
19366082|NCT01370863|41606099|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
19366083|NCT01370863|41606100|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
19691738|NCT00363896|42137468|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
19691739|NCT00363896|42137469|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
19691740|NCT00363896|42137468|FG000|Overall Study|Other|1|||
19691741|NCT00363896|42137469|FG001|Overall Study|Other|2|||
19691742|NCT00527423|42137478|FG000|Overall Study|Protocol Violation|1|||
19774039|NCT03637491|42228497|FG003|Overall Study|Death|3|||
19366084|NCT01370863|41606099|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
19366085|NCT01370863|41606100|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
19366086|NCT02444182|41606108|FG000|Overall Study|non-compliance|2|||
19366087|NCT02444182|41606109|FG001|Overall Study|non-compliance|1|||
19366088|NCT02444182|41606108|FG000|Overall Study|Lost to Follow-up|0|||
19366089|NCT02444182|41606109|FG001|Overall Study|Lost to Follow-up|4|||
19366090|NCT02471404|41606118|FG000|Overall Study|Adverse Event|7|||
19366091|NCT02471404|41606119|FG001|Overall Study|Adverse Event|1|||
19366092|NCT02471404|41606120|FG002|Overall Study|Adverse Event|2|||
19366093|NCT02471404|41606118|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
19366094|NCT02471404|41606119|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
19366095|NCT02471404|41606120|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
19366096|NCT02471404|41606118|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
19366097|NCT02471404|41606119|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
19366098|NCT02471404|41606120|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
19366099|NCT02471404|41606118|FG000|Overall Study|Lost to Follow-up|1|||
19366100|NCT02471404|41606119|FG001|Overall Study|Lost to Follow-up|1|||
19366101|NCT02471404|41606120|FG002|Overall Study|Lost to Follow-up|3|||
19366102|NCT02471404|41606118|FG000|Overall Study|Protocol Violation|1|||
19691743|NCT00527423|42137478|FG000|Overall Study|Adverse Event|5|||
19691744|NCT00527423|42137478|FG000|Overall Study|Physician Decision|4|||
19774040|NCT03637491|42228494|FG000|Overall Study|Lost to Follow-up|0|||
19774041|NCT03637491|42228495|FG001|Overall Study|Lost to Follow-up|1|||
19774042|NCT03637491|42228496|FG002|Overall Study|Lost to Follow-up|0|||
19774043|NCT03637491|42228497|FG003|Overall Study|Lost to Follow-up|1|||
19774044|NCT03637491|42228494|FG000|Overall Study|Study Terminated By Sponsor|0|||
19774045|NCT03637491|42228495|FG001|Overall Study|Study Terminated By Sponsor|2|||
19774046|NCT03637491|42228496|FG002|Overall Study|Study Terminated By Sponsor|1|||
19774047|NCT03637491|42228497|FG003|Overall Study|Study Terminated By Sponsor|0|||
19774048|NCT03637491|42228494|FG000|Overall Study|Withdrawal by Subject|1|||
19774049|NCT03637491|42228495|FG001|Overall Study|Withdrawal by Subject|0|||
19774050|NCT03637491|42228496|FG002|Overall Study|Withdrawal by Subject|1|||
19774051|NCT03637491|42228497|FG003|Overall Study|Withdrawal by Subject|2|||
19774052|NCT03334539|42228531|FG000|Overall Study|Adverse Event|3|||
19774053|NCT03334539|42228532|FG001|Overall Study|Adverse Event|5|||
19774054|NCT03334539|42228533|FG002|Overall Study|Adverse Event|0|||
19774055|NCT03334539|42228531|FG000|Overall Study|Withdrawal by Subject|0|||
19691745|NCT00527423|42137478|FG000|Overall Study|Withdrawal by Subject|10|||
19691746|NCT00527423|42137478|FG000|Overall Study|Lost to Follow-up|4|||
19691747|NCT00527423|42137478|FG000|Overall Study|OTHER|4|||
19691748|NCT00527423|42137478|FG000|Overall Study|Death|9|||
19691749|NCT00527111|42137486|FG000|Overall Study|Adverse Event|14|||
19691750|NCT00527111|42137487|FG001|Overall Study|Adverse Event|13|||
19691751|NCT00527111|42137486|FG000|Overall Study|Death|0|||
19691752|NCT00527111|42137487|FG001|Overall Study|Death|1|||
19691753|NCT00527111|42137486|FG000|Overall Study|Investigator Request|2|||
19691754|NCT00527111|42137487|FG001|Overall Study|Investigator Request|1|||
19691755|NCT00527111|42137486|FG000|Overall Study|Patient Request|2|||
19691756|NCT00527111|42137487|FG001|Overall Study|Patient Request|5|||
19691757|NCT00527111|42137486|FG000|Overall Study|Other|2|||
19691758|NCT00527111|42137487|FG001|Overall Study|Other|2|||
19691759|NCT00336024|42137495|FG000|Overall Study|Death|2|||
19691760|NCT00336024|42137496|FG001|Overall Study|Death|1|||
19691761|NCT00336024|42137495|FG000|Overall Study|Physician Decision|4|||
19691762|NCT00336024|42137496|FG001|Overall Study|Physician Decision|1|||
19691763|NCT00336024|42137495|FG000|Overall Study|Protocol Violation|1|||
19691764|NCT00336024|42137496|FG001|Overall Study|Protocol Violation|0|||
19691765|NCT00336024|42137495|FG000|Overall Study|Withdrawal by Subject|1|||
19691766|NCT00336024|42137496|FG001|Overall Study|Withdrawal by Subject|2|||
19691767|NCT00336024|42137495|FG000|Overall Study|Failure to fulfill consolidation|1|||
19691768|NCT00336024|42137496|FG001|Overall Study|Failure to fulfill consolidation|1|||
19691769|NCT00336024|42137495|FG000|Overall Study|Progressive Disease|4|||
19691770|NCT00336024|42137496|FG001|Overall Study|Progressive Disease|7|||
19691771|NCT00336024|42137495|FG000|Overall Study|Ineligible|7|||
19774056|NCT03334539|42228532|FG001|Overall Study|Withdrawal by Subject|1|||
19774057|NCT03334539|42228533|FG002|Overall Study|Withdrawal by Subject|1|||
19774058|NCT03334539|42228531|FG000|Overall Study|Administrative Reasons|1|||
19774059|NCT03334539|42228532|FG001|Overall Study|Administrative Reasons|0|||
19366103|NCT02471404|41606119|FG001|Overall Study|Protocol Violation|0|||
19691772|NCT00336024|42137496|FG001|Overall Study|Ineligible|7|||
19691773|NCT00384956|42137502|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
19691774|NCT00367640|42137510|FG000|Overall Study|Adverse Event|3|||
19691775|NCT00367640|42137511|FG001|Overall Study|Adverse Event|6|||
19691776|NCT00367640|42137512|FG002|Overall Study|Adverse Event|8|||
19691777|NCT00367640|42137513|FG003|Overall Study|Adverse Event|0|||
19691778|NCT00367640|42137510|FG000|Overall Study|Withdrawal by Subject|8|||
19691779|NCT00367640|42137511|FG001|Overall Study|Withdrawal by Subject|11|||
19774060|NCT03334539|42228533|FG002|Overall Study|Administrative Reasons|0|||
19366104|NCT02471404|41606120|FG002|Overall Study|Protocol Violation|0|||
19366105|NCT02471404|41606118|FG000|Overall Study|Withdrawal by Subject|8|||
19366106|NCT02471404|41606119|FG001|Overall Study|Withdrawal by Subject|4|||
19366107|NCT02471404|41606120|FG002|Overall Study|Withdrawal by Subject|5|||
19366108|NCT02471404|41606118|FG000|Overall Study|Other reasons not specified|10|||
19366109|NCT02471404|41606119|FG001|Overall Study|Other reasons not specified|7|||
19366110|NCT02471404|41606120|FG002|Overall Study|Other reasons not specified|12|||
19366111|NCT02471014|41606130|FG000|Overall Study|Lost to Follow-up|2|||
19366112|NCT02471014|41606131|FG001|Overall Study|Lost to Follow-up|2|||
19366113|NCT02413372|41606140|FG000|Treatment|Lost to Follow-up|0|||
19366114|NCT02413372|41606141|FG001|Treatment|Lost to Follow-up|2|||
19366115|NCT02413372|41606142|FG002|Treatment|Lost to Follow-up|1|||
19366116|NCT02413372|41606140|FG000|Treatment|Withdrawal by Subject|1|||
19366117|NCT02413372|41606141|FG001|Treatment|Withdrawal by Subject|0|||
19366118|NCT02413372|41606142|FG002|Treatment|Withdrawal by Subject|0|||
19366119|NCT02413372|41606140|FG000|Follow-up|Lost to Follow-up|1|||
19366120|NCT02413372|41606141|FG001|Follow-up|Lost to Follow-up|1|||
19366121|NCT02413372|41606142|FG002|Follow-up|Lost to Follow-up|0|||
19366122|NCT02413372|41606140|FG000|Follow-up|Subject Withdrew Consent|1|||
19366123|NCT02413372|41606141|FG001|Follow-up|Subject Withdrew Consent|0|||
19366124|NCT02413372|41606142|FG002|Follow-up|Subject Withdrew Consent|1|||
19366125|NCT02413372|41606140|FG000|Follow-up|Subject unable to return for visit|0|||
19366126|NCT02413372|41606141|FG001|Follow-up|Subject unable to return for visit|0|||
19366127|NCT02413372|41606142|FG002|Follow-up|Subject unable to return for visit|1|||
19366128|NCT02413294|41606150|FG000|Overall Study|Withdrawal by Subject|1|||
19366129|NCT02719353|41606163|FG000|First Intervention|Physician Decision|0|||
19366130|NCT02719353|41606164|FG001|First Intervention|Physician Decision|1|||
19366131|NCT01362062|41606173|FG000|Overall Study|Adverse Event|1|||
19366132|NCT01362062|41606174|FG001|Overall Study|Adverse Event|0|||
19366133|NCT01362062|41606173|FG000|Overall Study|Lost to Follow-up|11|||
19366134|NCT01362062|41606174|FG001|Overall Study|Lost to Follow-up|0|||
19366135|NCT01362062|41606173|FG000|Overall Study|Withdrawal by Subject|2|||
19366136|NCT01362062|41606174|FG001|Overall Study|Withdrawal by Subject|0|||
19366137|NCT01362062|41606173|FG000|Overall Study|Non-compliant participant|2|||
19366138|NCT01362062|41606174|FG001|Overall Study|Non-compliant participant|0|||
19366139|NCT01362062|41606173|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
19366140|NCT01362062|41606174|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
19366141|NCT01362062|41606173|FG000|Overall Study|Had significant improvement|9|||
19774061|NCT03334539|42228531|FG000|Overall Study|Hypertension Not Controlled|0|||
19774062|NCT03334539|42228532|FG001|Overall Study|Hypertension Not Controlled|1|||
19774063|NCT03334539|42228533|FG002|Overall Study|Hypertension Not Controlled|0|||
19774064|NCT03137303|42228548|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
19774065|NCT03137303|42228549|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
19774066|NCT03137303|42228548|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
19774067|NCT03137303|42228549|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
19366142|NCT01362062|41606174|FG001|Overall Study|Had significant improvement|0|||
19366143|NCT01361594|41606181|FG000|Overall Study|Withdrawal by Subject|1|||
19366144|NCT01361594|41606182|FG001|Overall Study|Withdrawal by Subject|2|||
19366145|NCT02642432|41606188|FG000|Overall Study|Adverse Event|2|||
19366146|NCT02642432|41606188|FG000|Overall Study|Withdrew Consent|1|||
19366147|NCT02642432|41606188|FG000|Overall Study|Lost to Follow-up|2|||
19366148|NCT02642432|41606188|FG000|Overall Study|Other|3|||
19366149|NCT02640482|41606194|FG000|Overall Study|Lost to Follow-up|3|||
19366150|NCT02640482|41606195|FG001|Overall Study|Lost to Follow-up|0|||
19366151|NCT02719743|41606206|FG000|Overall Study|Consent withdrawal|0|||
19366152|NCT02719743|41606207|FG001|Overall Study|Consent withdrawal|2|||
19366153|NCT02719743|41606208|FG002|Overall Study|Consent withdrawal|0|||
19366154|NCT02719743|41606209|FG003|Overall Study|Consent withdrawal|1|||
19366155|NCT02719743|41606210|FG004|Overall Study|Consent withdrawal|0|||
19366156|NCT02719743|41606206|FG000|Overall Study|Migrated/moved from study area|0|||
19366157|NCT02719743|41606207|FG001|Overall Study|Migrated/moved from study area|0|||
19366158|NCT02719743|41606208|FG002|Overall Study|Migrated/moved from study area|0|||
19366159|NCT02719743|41606209|FG003|Overall Study|Migrated/moved from study area|0|||
19366160|NCT02719743|41606210|FG004|Overall Study|Migrated/moved from study area|2|||
19366161|NCT02719743|41606206|FG000|Overall Study|Lost to Follow-up|1|||
19366162|NCT02719743|41606207|FG001|Overall Study|Lost to Follow-up|1|||
19366163|NCT02719743|41606208|FG002|Overall Study|Lost to Follow-up|0|||
19366164|NCT02719743|41606209|FG003|Overall Study|Lost to Follow-up|0|||
19774068|NCT03137303|42228548|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
19774069|NCT03137303|42228549|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
19774070|NCT03137303|42228548|FG000|T3: 9-month Follow-up|Death|1|||
19774071|NCT03137303|42228549|FG001|T3: 9-month Follow-up|Death|0|||
19366165|NCT02719743|41606210|FG004|Overall Study|Lost to Follow-up|0|||
19366166|NCT02641730|41606225|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
19366167|NCT02641730|41606226|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19366168|NCT02641730|41606227|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19774072|NCT03137303|42228548|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
19774073|NCT03137303|42228549|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
19774074|NCT03137303|42228548|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
19366169|NCT02641730|41606228|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
19366170|NCT02641730|41606229|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
19366171|NCT02641730|41606225|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
19366172|NCT02641730|41606226|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
19366173|NCT02641730|41606227|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
19366174|NCT02641730|41606228|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
19366175|NCT02641730|41606229|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
19366176|NCT02641730|41606225|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
19366177|NCT02641730|41606226|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
19366178|NCT02641730|41606227|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
19366179|NCT02641730|41606228|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
19366180|NCT02641730|41606229|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
19366181|NCT02641730|41606225|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19366182|NCT02641730|41606226|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19366183|NCT02641730|41606227|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19366184|NCT02641730|41606228|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
19366185|NCT02641730|41606229|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
19366186|NCT02641730|41606225|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
19366187|NCT02641730|41606226|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
19366188|NCT02641730|41606227|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
19366189|NCT02641730|41606228|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
19366190|NCT02641730|41606229|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
19366191|NCT02641730|41606225|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
19366192|NCT02641730|41606226|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
19366193|NCT02641730|41606227|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
19366194|NCT02641730|41606228|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
19366195|NCT02641730|41606229|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
19366196|NCT02797171|41606249|FG000|Overall Study|Lost to Follow-up|2|||
19366197|NCT02797171|41606250|FG001|Overall Study|Lost to Follow-up|0|||
19366198|NCT02797171|41606251|FG002|Overall Study|Lost to Follow-up|2|||
19366199|NCT02797171|41606252|FG003|Overall Study|Lost to Follow-up|1|||
19366200|NCT02797171|41606253|FG004|Overall Study|Lost to Follow-up|2|||
19366201|NCT02797171|41606254|FG005|Overall Study|Lost to Follow-up|0|||
19366202|NCT02797171|41606249|FG000|Overall Study|Withdrawal by Subject|1|||
19366203|NCT02797171|41606250|FG001|Overall Study|Withdrawal by Subject|1|||
19366204|NCT02797171|41606251|FG002|Overall Study|Withdrawal by Subject|0|||
19366205|NCT02797171|41606252|FG003|Overall Study|Withdrawal by Subject|0|||
19366206|NCT02797171|41606253|FG004|Overall Study|Withdrawal by Subject|0|||
19366207|NCT02797171|41606254|FG005|Overall Study|Withdrawal by Subject|0|||
19366208|NCT02797171|41606249|FG000|Overall Study|Protocol Violation|1|||
19366209|NCT02797171|41606250|FG001|Overall Study|Protocol Violation|0|||
19366210|NCT02797171|41606251|FG002|Overall Study|Protocol Violation|0|||
19366211|NCT02797171|41606252|FG003|Overall Study|Protocol Violation|0|||
19366212|NCT02797171|41606253|FG004|Overall Study|Protocol Violation|0|||
19366213|NCT02797171|41606254|FG005|Overall Study|Protocol Violation|0|||
19366214|NCT02797171|41606249|FG000|Overall Study|Participant unable to adhere|0|||
19366215|NCT02797171|41606250|FG001|Overall Study|Participant unable to adhere|1|||
19366216|NCT02797171|41606251|FG002|Overall Study|Participant unable to adhere|0|||
19366217|NCT02797171|41606252|FG003|Overall Study|Participant unable to adhere|0|||
19366218|NCT02797171|41606253|FG004|Overall Study|Participant unable to adhere|0|||
19366219|NCT02797171|41606254|FG005|Overall Study|Participant unable to adhere|0|||
19366220|NCT02797171|41606249|FG000|Overall Study|Not Randomized|0|||
19366221|NCT02797171|41606250|FG001|Overall Study|Not Randomized|0|||
19366222|NCT02797171|41606251|FG002|Overall Study|Not Randomized|0|||
19691780|NCT00367640|42137512|FG002|Overall Study|Withdrawal by Subject|8|||
19691781|NCT00367640|42137513|FG003|Overall Study|Withdrawal by Subject|6|||
19691782|NCT00367640|42137510|FG000|Overall Study|Any other reason not above-mentioned|7|||
19691783|NCT00367640|42137511|FG001|Overall Study|Any other reason not above-mentioned|5|||
19691784|NCT00367640|42137512|FG002|Overall Study|Any other reason not above-mentioned|3|||
19691785|NCT00367640|42137513|FG003|Overall Study|Any other reason not above-mentioned|4|||
19691786|NCT00367484|42137523|FG000|Overall Study|Adverse Event|7|||
19691787|NCT00367484|42137523|FG000|Overall Study|Withdrew informed consent|5|||
19691788|NCT00367484|42137523|FG000|Overall Study|Travel to USA|1|||
19691789|NCT00367484|42137523|FG000|Overall Study|Lost to Follow-up|1|||
19691790|NCT00367484|42137523|FG000|Overall Study|Protocol Violation|1|||
19774075|NCT03137303|42228549|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
19366223|NCT02797171|41606252|FG003|Overall Study|Not Randomized|0|||
19366224|NCT02797171|41606253|FG004|Overall Study|Not Randomized|0|||
19366225|NCT02797171|41606254|FG005|Overall Study|Not Randomized|1|||
19691791|NCT00367484|42137523|FG000|Overall Study|The choice of the patient|1|||
19366226|NCT02797951|41606268|FG000|Overall Study|Adverse Event|4|||
19366227|NCT02797951|41606268|FG000|Overall Study|Death|1|||
19366228|NCT02797951|41606268|FG000|Overall Study|Lack of Efficacy|19|||
19366229|NCT02797951|41606268|FG000|Overall Study|Lost to Follow-up|4|||
19366230|NCT02797951|41606268|FG000|Overall Study|Physician Decision|6|||
19366231|NCT02797951|41606268|FG000|Overall Study|Withdrawal by Subject|15|||
19366232|NCT00701805|41606276|FG000|Overall Study|Withdrawal by Subject|3|||
19366233|NCT00701805|41606277|FG001|Overall Study|Withdrawal by Subject|1|||
19366234|NCT00701805|41606278|FG002|Overall Study|Withdrawal by Subject|4|||
19366235|NCT00701805|41606279|FG003|Overall Study|Withdrawal by Subject|3|||
19366236|NCT00701805|41606276|FG000|Overall Study|Adverse Event|0|||
19366237|NCT00701805|41606277|FG001|Overall Study|Adverse Event|1|||
19366238|NCT00701805|41606278|FG002|Overall Study|Adverse Event|1|||
19366239|NCT00701805|41606279|FG003|Overall Study|Adverse Event|0|||
19366240|NCT00701805|41606276|FG000|Overall Study|Missed 7 consecutive doses|0|||
19366241|NCT00701805|41606277|FG001|Overall Study|Missed 7 consecutive doses|1|||
19366242|NCT00701805|41606278|FG002|Overall Study|Missed 7 consecutive doses|0|||
19366243|NCT00701805|41606279|FG003|Overall Study|Missed 7 consecutive doses|0|||
19366244|NCT00701805|41606276|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
19366245|NCT00701805|41606277|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
19366246|NCT00701805|41606278|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
19366247|NCT00701805|41606279|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
19366248|NCT00701805|41606276|FG000|Overall Study|Physician decision, change of therapy|0|||
19366249|NCT00701805|41606277|FG001|Overall Study|Physician decision, change of therapy|0|||
19366250|NCT00701805|41606278|FG002|Overall Study|Physician decision, change of therapy|0|||
19366251|NCT00701805|41606279|FG003|Overall Study|Physician decision, change of therapy|1|||
19366252|NCT00701805|41606276|FG000|Overall Study|Difficult to travel to dialysis site|0|||
19366253|NCT00701805|41606277|FG001|Overall Study|Difficult to travel to dialysis site|0|||
19366254|NCT00701805|41606278|FG002|Overall Study|Difficult to travel to dialysis site|1|||
19366255|NCT00701805|41606279|FG003|Overall Study|Difficult to travel to dialysis site|0|||
19366256|NCT00701805|41606276|FG000|Overall Study|Resumption criteria were not met|0|||
19366257|NCT00701805|41606277|FG001|Overall Study|Resumption criteria were not met|1|||
19366258|NCT00701805|41606278|FG002|Overall Study|Resumption criteria were not met|0|||
19366259|NCT00701805|41606279|FG003|Overall Study|Resumption criteria were not met|0|||
19366260|NCT02715765|41606292|FG000|Overall Study|Study Termination|3|||
19366261|NCT02715765|41606293|FG001|Overall Study|Study Termination|0|||
19366262|NCT02715765|41606294|FG002|Overall Study|Study Termination|0|||
19366263|NCT04542291|41606302|FG000|Overall Study|Adverse Event|1|||
19366264|NCT04542291|41606302|FG000|Overall Study|Physician Decision|2|||
19366265|NCT02795767|41606309|FG000|Overall Study|Received Commercial Emicizumab|1|||
19366266|NCT02795767|41606310|FG001|Overall Study|Received Commercial Emicizumab|0|||
19366267|NCT02795767|41606311|FG002|Overall Study|Received Commercial Emicizumab|0|||
19366268|NCT02639559|41606325|FG000|Overall Study|Mobilization failure|0|||
19366269|NCT02639559|41606326|FG001|Overall Study|Mobilization failure|3|||
19366270|NCT02639559|41606325|FG000|Overall Study|Issues with vascular acess|1|||
19366271|NCT02639559|41606326|FG001|Overall Study|Issues with vascular acess|0|||
19366272|NCT02796391|41606347|FG000|Overall Study|Lost to Follow-up|2|||
19366273|NCT02796391|41606348|FG001|Overall Study|Lost to Follow-up|2|||
19366274|NCT02796391|41606349|FG002|Overall Study|Lost to Follow-up|13|||
19366275|NCT02796391|41606350|FG003|Overall Study|Lost to Follow-up|8|||
19366276|NCT02796391|41606351|FG004|Overall Study|Lost to Follow-up|14|||
19366277|NCT02796391|41606352|FG005|Overall Study|Lost to Follow-up|13|||
19366278|NCT02796391|41606347|FG000|Overall Study|COVID|0|||
19366279|NCT02796391|41606348|FG001|Overall Study|COVID|0|||
19366280|NCT02796391|41606349|FG002|Overall Study|COVID|5|||
19366281|NCT02796391|41606350|FG003|Overall Study|COVID|5|||
19366282|NCT02796391|41606351|FG004|Overall Study|COVID|2|||
19366283|NCT02796391|41606352|FG005|Overall Study|COVID|4|||
19691792|NCT00367484|42137523|FG000|Overall Study|Lack of Efficacy|1|||
19774076|NCT03137303|42228548|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
19774077|NCT03137303|42228549|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
19774078|NCT03296553|42228557|FG000|Overall Study|Withdrawal by Subject|1|||
19774079|NCT03296553|42228558|FG001|Overall Study|Withdrawal by Subject|1|||
19774080|NCT03296553|42228557|FG000|Overall Study|Death|1|||
19774081|NCT03296553|42228558|FG001|Overall Study|Death|0|||
19774082|NCT03131167|42228577|FG000|Overall Study|Other (Unspecified)|0|||
19774083|NCT03131167|42228578|FG001|Overall Study|Other (Unspecified)|0|||
19366284|NCT02796391|41606347|FG000|Overall Study|Participant did not like study cigarettes|0|||
19366285|NCT02796391|41606348|FG001|Overall Study|Participant did not like study cigarettes|0|||
19366286|NCT02796391|41606349|FG002|Overall Study|Participant did not like study cigarettes|3|||
19366287|NCT02796391|41606350|FG003|Overall Study|Participant did not like study cigarettes|0|||
19366288|NCT02796391|41606351|FG004|Overall Study|Participant did not like study cigarettes|0|||
19366289|NCT02796391|41606352|FG005|Overall Study|Participant did not like study cigarettes|0|||
19366290|NCT02796391|41606347|FG000|Overall Study|Withdrawal by Subject|1|||
19366291|NCT02796391|41606348|FG001|Overall Study|Withdrawal by Subject|1|||
19774084|NCT03131167|42228579|FG002|Overall Study|Other (Unspecified)|0|||
19774085|NCT03131167|42228580|FG003|Overall Study|Other (Unspecified)|0|||
19366292|NCT02796391|41606349|FG002|Overall Study|Withdrawal by Subject|4|||
19366293|NCT02796391|41606350|FG003|Overall Study|Withdrawal by Subject|3|||
19366294|NCT02796391|41606351|FG004|Overall Study|Withdrawal by Subject|4|||
19366295|NCT02796391|41606352|FG005|Overall Study|Withdrawal by Subject|3|||
19366296|NCT02796391|41606347|FG000|Overall Study|Adverse Event|0|||
19366297|NCT02796391|41606348|FG001|Overall Study|Adverse Event|0|||
19366298|NCT02796391|41606349|FG002|Overall Study|Adverse Event|0|||
19366299|NCT02796391|41606350|FG003|Overall Study|Adverse Event|1|||
19366300|NCT02796391|41606351|FG004|Overall Study|Adverse Event|0|||
19366301|NCT02796391|41606352|FG005|Overall Study|Adverse Event|0|||
19366302|NCT02796391|41606347|FG000|Overall Study|Protocol Violation|0|||
19366303|NCT02796391|41606348|FG001|Overall Study|Protocol Violation|0|||
19366304|NCT02796391|41606349|FG002|Overall Study|Protocol Violation|0|||
19366305|NCT02796391|41606350|FG003|Overall Study|Protocol Violation|1|||
19366306|NCT02796391|41606351|FG004|Overall Study|Protocol Violation|0|||
19366307|NCT02796391|41606352|FG005|Overall Study|Protocol Violation|0|||
19366308|NCT01370317|41606368|FG000|Overall Study|Participant withdrew consent|1|||
19366309|NCT01370317|41606369|FG001|Overall Study|Participant withdrew consent|0|||
19366310|NCT01370317|41606368|FG000|Overall Study|Protocol deviation|0|||
19366311|NCT01370317|41606369|FG001|Overall Study|Protocol deviation|1|||
19366312|NCT01370083|41606377|FG000|Overall Study|Lost to Follow-up|2|||
19366313|NCT01370083|41606378|FG001|Overall Study|Lost to Follow-up|0|||
19366314|NCT01370083|41606377|FG000|Overall Study|Adverse Event|0|||
19366315|NCT01370083|41606378|FG001|Overall Study|Adverse Event|1|||
19366316|NCT03350815|41606384|FG000|Period 1|Adverse Event|10|||
19366317|NCT03350815|41606385|FG001|Period 1|Adverse Event|0|||
19366318|NCT03350815|41606386|FG002|Period 1|Adverse Event|0|||
19366319|NCT03350815|41606387|FG003|Period 1|Adverse Event|0|||
19366320|NCT03350815|41606384|FG000|Period 1|Technical problems|1|||
19366321|NCT03350815|41606385|FG001|Period 1|Technical problems|0|||
19691793|NCT00526799|42137529|FG000|Overall Study|Withdrawal by Subject|1|||
19691794|NCT00526799|42137530|FG001|Overall Study|Withdrawal by Subject|0|||
19691795|NCT00526799|42137529|FG000|Overall Study|Intercurrent Complicating Disease|0|||
19691796|NCT00526799|42137530|FG001|Overall Study|Intercurrent Complicating Disease|1|||
19691797|NCT00526331|42137536|FG000|Overall Study|Sponsor Termination|55|||
19691798|NCT00520481|42137542|FG000|Overall Study|Adverse Event|4|||
19691799|NCT00520481|42137543|FG001|Overall Study|Adverse Event|1|||
19691800|NCT00520481|42137542|FG000|Overall Study|Withdrawal by Subject|3|||
19691801|NCT00520481|42137543|FG001|Overall Study|Withdrawal by Subject|0|||
19691802|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
19691803|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
19691804|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
19691805|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
19691806|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
19691807|NCT00520403|42137551|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
19691808|NCT00520403|42137551|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
19691809|NCT00520403|42137551|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
19691810|NCT00520013|42137558|FG000|Overall Study|Withdrawal by Subject|0|||
19691811|NCT00520013|42137559|FG001|Overall Study|Withdrawal by Subject|0|||
19691812|NCT00520013|42137560|FG002|Overall Study|Withdrawal by Subject|1|||
19691813|NCT00520013|42137558|FG000|Overall Study|Adverse Event|2|||
19691814|NCT00520013|42137559|FG001|Overall Study|Adverse Event|10|||
19691815|NCT00520013|42137560|FG002|Overall Study|Adverse Event|7|||
19691816|NCT00520013|42137558|FG000|Overall Study|Progressive Disease|7|||
19691817|NCT00520013|42137559|FG001|Overall Study|Progressive Disease|3|||
19691818|NCT00520013|42137560|FG002|Overall Study|Progressive Disease|0|||
19691819|NCT00520013|42137558|FG000|Overall Study|Clinical Progression|3|||
19691820|NCT00520013|42137559|FG001|Overall Study|Clinical Progression|1|||
19691821|NCT00520013|42137560|FG002|Overall Study|Clinical Progression|0|||
19691822|NCT00520013|42137558|FG000|Overall Study|Death|0|||
19691823|NCT00520013|42137559|FG001|Overall Study|Death|1|||
19691824|NCT00520013|42137560|FG002|Overall Study|Death|0|||
19691825|NCT00520013|42137558|FG000|Overall Study|Physician Decision|0|||
19691826|NCT00520013|42137559|FG001|Overall Study|Physician Decision|0|||
19691827|NCT00520013|42137560|FG002|Overall Study|Physician Decision|3|||
19691828|NCT00519779|42137568|FG000|Overall Study|Withdrawal by Subject|0|||
19691829|NCT00519779|42137569|FG001|Overall Study|Withdrawal by Subject|1|||
19691830|NCT00526097|42137577|FG000|Overall Study|Adverse Event|6|||
19691831|NCT00526097|42137578|FG001|Overall Study|Adverse Event|44|||
19366322|NCT03350815|41606386|FG002|Period 1|Technical problems|0|||
19366323|NCT03350815|41606387|FG003|Period 1|Technical problems|0|||
19366324|NCT03350815|41606384|FG000|Period 1|Lost to Follow-up|3|||
19366325|NCT03350815|41606385|FG001|Period 1|Lost to Follow-up|0|||
19366326|NCT03350815|41606386|FG002|Period 1|Lost to Follow-up|0|||
19691832|NCT00526097|42137577|FG000|Overall Study|Protocol Violation|4|||
19691833|NCT00526097|42137578|FG001|Overall Study|Protocol Violation|10|||
19366327|NCT03350815|41606387|FG003|Period 1|Lost to Follow-up|0|||
19366328|NCT03350815|41606384|FG000|Period 1|Physician Decision|1|||
19366329|NCT03350815|41606385|FG001|Period 1|Physician Decision|0|||
19366330|NCT03350815|41606386|FG002|Period 1|Physician Decision|0|||
19366331|NCT03350815|41606387|FG003|Period 1|Physician Decision|0|||
19366332|NCT03350815|41606384|FG000|Period 1|Withdrawal by Subject|8|||
19366333|NCT03350815|41606385|FG001|Period 1|Withdrawal by Subject|0|||
19366334|NCT03350815|41606386|FG002|Period 1|Withdrawal by Subject|0|||
19366335|NCT03350815|41606387|FG003|Period 1|Withdrawal by Subject|0|||
19366336|NCT03350815|41606384|FG000|Period 1|Lack of Efficacy|15|||
19366337|NCT03350815|41606385|FG001|Period 1|Lack of Efficacy|0|||
19366338|NCT03350815|41606386|FG002|Period 1|Lack of Efficacy|0|||
19366339|NCT03350815|41606387|FG003|Period 1|Lack of Efficacy|0|||
19366340|NCT03350815|41606384|FG000|Period 1|Non-compliance with study treatment|2|||
19366341|NCT03350815|41606385|FG001|Period 1|Non-compliance with study treatment|0|||
19366342|NCT03350815|41606386|FG002|Period 1|Non-compliance with study treatment|0|||
19366343|NCT03350815|41606387|FG003|Period 1|Non-compliance with study treatment|0|||
19366344|NCT03350815|41606384|FG000|Period 1|Protocol Violation|3|||
19366345|NCT03350815|41606385|FG001|Period 1|Protocol Violation|0|||
19366346|NCT03350815|41606386|FG002|Period 1|Protocol Violation|0|||
19366347|NCT03350815|41606387|FG003|Period 1|Protocol Violation|0|||
19366348|NCT03350815|41606384|FG000|Period 2|Adverse Event|0|||
19366349|NCT03350815|41606385|FG001|Period 2|Adverse Event|3|||
19366350|NCT03350815|41606386|FG002|Period 2|Adverse Event|5|||
19366351|NCT03350815|41606387|FG003|Period 2|Adverse Event|0|||
19366352|NCT03350815|41606384|FG000|Period 2|Technical problem|0|||
19366353|NCT03350815|41606385|FG001|Period 2|Technical problem|1|||
19366354|NCT03350815|41606386|FG002|Period 2|Technical problem|0|||
19366355|NCT03350815|41606387|FG003|Period 2|Technical problem|0|||
19774086|NCT03131167|42228581|FG004|Overall Study|Other (Unspecified)|0|||
19774087|NCT03131167|42228582|FG005|Overall Study|Other (Unspecified)|1|||
19774088|NCT03131167|42228583|FG006|Overall Study|Other (Unspecified)|0|||
19774089|NCT03131167|42228584|FG007|Overall Study|Other (Unspecified)|0|||
19774090|NCT03131167|42228585|FG008|Overall Study|Other (Unspecified)|0|||
19774091|NCT03131167|42228586|FG009|Overall Study|Other (Unspecified)|0|||
19774092|NCT03131167|42228587|FG010|Overall Study|Other (Unspecified)|0|||
19366356|NCT03350815|41606384|FG000|Period 2|Lost to Follow-up|0|||
19366357|NCT03350815|41606385|FG001|Period 2|Lost to Follow-up|3|||
19366358|NCT03350815|41606386|FG002|Period 2|Lost to Follow-up|3|||
19366359|NCT03350815|41606387|FG003|Period 2|Lost to Follow-up|0|||
19366360|NCT03350815|41606384|FG000|Period 2|Physician Decision|0|||
19366361|NCT03350815|41606385|FG001|Period 2|Physician Decision|0|||
19366362|NCT03350815|41606386|FG002|Period 2|Physician Decision|1|||
19366363|NCT03350815|41606387|FG003|Period 2|Physician Decision|0|||
19366364|NCT03350815|41606384|FG000|Period 2|Withdrawal by Subject|0|||
19366365|NCT03350815|41606385|FG001|Period 2|Withdrawal by Subject|3|||
19366366|NCT03350815|41606386|FG002|Period 2|Withdrawal by Subject|4|||
19366367|NCT03350815|41606387|FG003|Period 2|Withdrawal by Subject|0|||
19366368|NCT03350815|41606384|FG000|Period 2|Lack of Efficacy|0|||
19366369|NCT03350815|41606385|FG001|Period 2|Lack of Efficacy|6|||
19366370|NCT03350815|41606386|FG002|Period 2|Lack of Efficacy|2|||
19366371|NCT03350815|41606387|FG003|Period 2|Lack of Efficacy|0|||
19366372|NCT03350815|41606384|FG000|Period 2|Protocol Violation|0|||
19366373|NCT03350815|41606385|FG001|Period 2|Protocol Violation|0|||
19366374|NCT03350815|41606386|FG002|Period 2|Protocol Violation|1|||
19366375|NCT03350815|41606387|FG003|Period 2|Protocol Violation|0|||
19366376|NCT03350815|41606384|FG000|Period 2|New therapy for study indication|0|||
19366377|NCT03350815|41606385|FG001|Period 2|New therapy for study indication|0|||
19366378|NCT03350815|41606386|FG002|Period 2|New therapy for study indication|1|||
19366379|NCT03350815|41606387|FG003|Period 2|New therapy for study indication|0|||
19691834|NCT00526097|42137577|FG000|Overall Study|Withdrawal by Subject|3|||
19691835|NCT00526097|42137578|FG001|Overall Study|Withdrawal by Subject|1|||
19691836|NCT00526097|42137577|FG000|Overall Study|Other|2|||
19691837|NCT00526097|42137578|FG001|Overall Study|Other|1|||
19691838|NCT00525785|42137584|FG000|Overall Study|Withdrawal by Subject|1|||
19691839|NCT00525785|42137584|FG000|Overall Study|Lack of Efficacy|1|||
19691840|NCT00525785|42137584|FG000|Overall Study|Physician Decision|1|||
19691841|NCT00525161|42137588|FG000|Overall Study|Adverse Event|1|||
19691842|NCT00524771|42137594|FG000|Overall Study|Protocol Violation|220|||
19691843|NCT00524771|42137595|FG001|Overall Study|Protocol Violation|585|||
19691844|NCT00135694|42137605|FG000|Overall Study|Adverse Event|17|||
19366380|NCT00854295|41606402|FG000|Overall Study|Death|7|||
19366381|NCT00854295|41606403|FG001|Overall Study|Death|0|||
19366382|NCT00854295|41606404|FG002|Overall Study|Death|1|||
19691845|NCT00135694|42137606|FG001|Overall Study|Adverse Event|4|||
19366383|NCT00854295|41606405|FG003|Overall Study|Death|1|||
19366384|NCT00854295|41606402|FG000|Overall Study|Adverse Event|6|||
19366385|NCT00854295|41606403|FG001|Overall Study|Adverse Event|1|||
19366386|NCT00854295|41606404|FG002|Overall Study|Adverse Event|1|||
19366387|NCT00854295|41606405|FG003|Overall Study|Adverse Event|3|||
19691846|NCT00135694|42137607|FG002|Overall Study|Adverse Event|0|||
19366388|NCT00854295|41606402|FG000|Overall Study|Lost to Follow-up|18|||
19366389|NCT00854295|41606403|FG001|Overall Study|Lost to Follow-up|5|||
19366390|NCT00854295|41606404|FG002|Overall Study|Lost to Follow-up|21|||
19774093|NCT03131167|42228588|FG011|Overall Study|Other (Unspecified)|0|||
19774094|NCT03131167|42228589|FG012|Overall Study|Other (Unspecified)|0|||
19774095|NCT03060447|42228620|FG000|Overall Study|Withdrawal by Subject|2|||
19774096|NCT03060447|42228621|FG001|Overall Study|Withdrawal by Subject|0|||
19774097|NCT01712789|42228633|FG000|Overall Study|Lack of Efficacy|2|||
19774098|NCT01712789|42228633|FG000|Overall Study|Lost to Follow-up|1|||
19774099|NCT01712789|42228633|FG000|Overall Study|Progressive Disease|504|||
19774100|NCT01712789|42228633|FG000|Overall Study|Death|57|||
19774101|NCT01712789|42228633|FG000|Overall Study|Adverse Event|52|||
19774102|NCT01712789|42228633|FG000|Overall Study|Miscellaneous|31|||
19774103|NCT01712789|42228633|FG000|Overall Study|Withdrawal by Subject|21|||
19774104|NCT01712789|42228633|FG000|Overall Study|Transition to Commercial Treatment|8|||
19774105|NCT01712789|42228633|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
19774106|NCT02978781|42228640|FG000|Part A|Adverse Event|1|||
19774107|NCT02978781|42228641|FG001|Part A|Adverse Event|1|||
19774108|NCT02978781|42228642|FG002|Part A|Adverse Event|0|||
19774109|NCT02978781|42228643|FG003|Part A|Adverse Event|0|||
19774110|NCT02978781|42228644|FG004|Part A|Adverse Event|0|||
19774111|NCT02978781|42228640|FG000|Part A|Withdrawal by Subject|0|||
19774112|NCT02978781|42228641|FG001|Part A|Withdrawal by Subject|1|||
19774113|NCT02978781|42228642|FG002|Part A|Withdrawal by Subject|0|||
19774114|NCT02978781|42228643|FG003|Part A|Withdrawal by Subject|0|||
19774115|NCT02978781|42228644|FG004|Part A|Withdrawal by Subject|0|||
19774116|NCT02978781|42228640|FG000|Part B|Withdrawal by Subject|0|||
19774117|NCT02978781|42228641|FG001|Part B|Withdrawal by Subject|0|||
19774118|NCT02978781|42228642|FG002|Part B|Withdrawal by Subject|0|||
19774119|NCT02978781|42228643|FG003|Part B|Withdrawal by Subject|1|||
19774120|NCT02978781|42228644|FG004|Part B|Withdrawal by Subject|0|||
19774121|NCT02978781|42228640|FG000|Part C|Adverse Event|0|||
19774122|NCT02978781|42228641|FG001|Part C|Adverse Event|0|||
19774123|NCT02978781|42228642|FG002|Part C|Adverse Event|0|||
19774124|NCT02978781|42228643|FG003|Part C|Adverse Event|0|||
19774125|NCT02978781|42228644|FG004|Part C|Adverse Event|2|||
19774126|NCT02978781|42228640|FG000|Part C|Withdrawal by Subject|0|||
19774127|NCT02978781|42228641|FG001|Part C|Withdrawal by Subject|0|||
19774128|NCT02978781|42228642|FG002|Part C|Withdrawal by Subject|0|||
19366391|NCT00854295|41606405|FG003|Overall Study|Lost to Follow-up|21|||
19366392|NCT00854295|41606402|FG000|Overall Study|Physician Decision|10|||
19366393|NCT00854295|41606403|FG001|Overall Study|Physician Decision|0|||
19366394|NCT00854295|41606404|FG002|Overall Study|Physician Decision|0|||
19366395|NCT00854295|41606405|FG003|Overall Study|Physician Decision|0|||
19366396|NCT02792959|41606416|FG000|Overall Study|Protocol Violation|1|||
19366397|NCT01652872|41606422|FG000|Overall Study|Death|36|||
19366398|NCT01652872|41606423|FG001|Overall Study|Death|39|||
19606458|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
19606459|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
19774129|NCT02978781|42228643|FG003|Part C|Withdrawal by Subject|0|||
19774130|NCT02978781|42228644|FG004|Part C|Withdrawal by Subject|1|||
19366399|NCT01652872|41606422|FG000|Overall Study|Lost to Follow-up|28|||
19606460|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
19606461|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
19606462|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
19606463|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
19606464|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
19606465|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
19691847|NCT00135694|42137605|FG000|Overall Study|Death|14|||
19691848|NCT00135694|42137606|FG001|Overall Study|Death|1|||
19691849|NCT00135694|42137607|FG002|Overall Study|Death|2|||
19691850|NCT00135694|42137605|FG000|Overall Study|Lost to Follow-up|8|||
19691851|NCT00135694|42137606|FG001|Overall Study|Lost to Follow-up|7|||
19691852|NCT00135694|42137607|FG002|Overall Study|Lost to Follow-up|1|||
19691853|NCT00135694|42137605|FG000|Overall Study|Withdrawal by Subject|41|||
19691854|NCT00135694|42137606|FG001|Overall Study|Withdrawal by Subject|7|||
19691855|NCT00135694|42137607|FG002|Overall Study|Withdrawal by Subject|4|||
19691856|NCT00135694|42137605|FG000|Overall Study|Protocol Violation|19|||
19691857|NCT00135694|42137606|FG001|Overall Study|Protocol Violation|1|||
19691858|NCT00135694|42137607|FG002|Overall Study|Protocol Violation|0|||
19774131|NCT02978781|42228640|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
19774132|NCT02978781|42228641|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
19774133|NCT02978781|42228642|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
19774134|NCT02978781|42228643|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
19774135|NCT02978781|42228644|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
19366400|NCT01652872|41606423|FG001|Overall Study|Lost to Follow-up|23|||
19691859|NCT00135694|42137605|FG000|Overall Study|Hepatitis C related reasons|39|||
19366401|NCT01652872|41606422|FG000|Overall Study|Decision by sponsor|5|||
19774136|NCT03074318|42228674|FG000|Overall Study|Adverse Event|0|||
19774137|NCT03074318|42228675|FG001|Overall Study|Adverse Event|1|||
19774138|NCT03074318|42228676|FG002|Overall Study|Adverse Event|1|||
19774139|NCT03074318|42228677|FG003|Overall Study|Adverse Event|1|||
19774140|NCT03074318|42228674|FG000|Overall Study|Death|1|||
19774141|NCT03074318|42228675|FG001|Overall Study|Death|0|||
19774142|NCT03074318|42228676|FG002|Overall Study|Death|0|||
19774143|NCT03074318|42228677|FG003|Overall Study|Death|0|||
19774144|NCT03074318|42228674|FG000|Overall Study|Withdrawal by Subject|1|||
19774145|NCT03074318|42228675|FG001|Overall Study|Withdrawal by Subject|2|||
19774146|NCT03074318|42228676|FG002|Overall Study|Withdrawal by Subject|2|||
19774147|NCT03074318|42228677|FG003|Overall Study|Withdrawal by Subject|4|||
19774148|NCT03074318|42228674|FG000|Overall Study|Trial Closure|2|||
19774149|NCT03074318|42228675|FG001|Overall Study|Trial Closure|2|||
19774150|NCT03074318|42228676|FG002|Overall Study|Trial Closure|3|||
19774151|NCT03074318|42228677|FG003|Overall Study|Trial Closure|11|||
19774152|NCT03135119|42228698|FG000|Overall Study|Lost to Follow-up|2|||
19774153|NCT03135119|42228699|FG001|Overall Study|Lost to Follow-up|0|||
19774154|NCT03135119|42228698|FG000|Overall Study|Physician Decision|1|||
19774155|NCT03135119|42228699|FG001|Overall Study|Physician Decision|1|||
19774156|NCT03135119|42228698|FG000|Overall Study|COVID-19 Shutdown|2|||
19774157|NCT03135119|42228699|FG001|Overall Study|COVID-19 Shutdown|2|||
19774158|NCT01369784|42228705|FG000|Overall Study|Protocol Violation|12|||
19774159|NCT03353675|42228709|FG000|Overall Study|Adverse Event|4|||
19774160|NCT03137069|42228719|FG000|Overall Study|Withdrawal by Subject|1|||
19774161|NCT03137069|42228720|FG001|Overall Study|Withdrawal by Subject|2|||
19774162|NCT03137069|42228721|FG002|Overall Study|Withdrawal by Subject|2|||
19774163|NCT03137069|42228722|FG003|Overall Study|Withdrawal by Subject|2|||
19774164|NCT03137069|42228723|FG004|Overall Study|Withdrawal by Subject|0|||
19774165|NCT03137069|42228724|FG005|Overall Study|Withdrawal by Subject|0|||
19774166|NCT03137069|42228719|FG000|Overall Study|Adverse Event|0|||
19774167|NCT03137069|42228720|FG001|Overall Study|Adverse Event|3|||
19774168|NCT03137069|42228721|FG002|Overall Study|Adverse Event|1|||
19774169|NCT03137069|42228722|FG003|Overall Study|Adverse Event|1|||
19366402|NCT01652872|41606423|FG001|Overall Study|Decision by sponsor|7|||
19691860|NCT00135694|42137606|FG001|Overall Study|Hepatitis C related reasons|1|||
19691861|NCT00135694|42137607|FG002|Overall Study|Hepatitis C related reasons|0|||
19691862|NCT00135694|42137605|FG000|Overall Study|Ineligible for Random assignment|42|||
19691863|NCT00135694|42137606|FG001|Overall Study|Ineligible for Random assignment|0|||
19691864|NCT00135694|42137607|FG002|Overall Study|Ineligible for Random assignment|0|||
19366403|NCT01652872|41606422|FG000|Overall Study|Withdrawal by Subject|76|||
19366404|NCT01652872|41606423|FG001|Overall Study|Withdrawal by Subject|84|||
19366405|NCT04251273|41606431|FG000|Overall Study|Lost to Follow-up|331|||
19366406|NCT04251273|41606432|FG001|Overall Study|Lost to Follow-up|290|||
19366407|NCT02443402|41606440|FG000|Overall Study|Withdrawal by Subject|3|||
19606466|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
19606467|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
19606468|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
19606469|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
19606470|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
19606471|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
19606472|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
19606473|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
19606474|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
19606475|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
19606476|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
19606477|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
19606478|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
19606479|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
19606480|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
19606481|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
19606482|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
19606483|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
19606484|NCT00726232|42055181|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
19606485|NCT00726232|42055182|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
19691865|NCT00524459|42137615|FG000|Overall Study|Withdrawal by Subject|1|||
19691866|NCT00524459|42137615|FG000|Overall Study|Other|1|||
19691867|NCT00519623|42137619|FG000|Overall Study|Adverse Event|1|||
19691868|NCT00519077|42137623|FG000|Overall Study|Death|6|||
19691869|NCT00519077|42137623|FG000|Overall Study|Other|2|||
19774170|NCT03137069|42228723|FG004|Overall Study|Adverse Event|0|||
19774171|NCT03137069|42228724|FG005|Overall Study|Adverse Event|1|||
19774172|NCT03137069|42228719|FG000|Overall Study|Protocol Violation|0|||
19774173|NCT03137069|42228720|FG001|Overall Study|Protocol Violation|1|||
19774174|NCT03137069|42228721|FG002|Overall Study|Protocol Violation|0|||
19366408|NCT02443402|41606441|FG001|Overall Study|Withdrawal by Subject|1|||
19366409|NCT02443402|41606440|FG000|Overall Study|Screen Failure|1|||
19366410|NCT02443402|41606441|FG001|Overall Study|Screen Failure|2|||
19366411|NCT02412670|41606449|FG000|Overall Study|Adverse Event|4|||
19366412|NCT02412670|41606450|FG001|Overall Study|Adverse Event|1|||
19366413|NCT02412670|41606449|FG000|Overall Study|Physician Decision|1|||
19366414|NCT02412670|41606450|FG001|Overall Study|Physician Decision|0|||
19774175|NCT03137069|42228722|FG003|Overall Study|Protocol Violation|1|||
19774176|NCT03137069|42228723|FG004|Overall Study|Protocol Violation|1|||
19774177|NCT03137069|42228724|FG005|Overall Study|Protocol Violation|1|||
19774178|NCT03137069|42228719|FG000|Overall Study|Physician Decision|0|||
19774179|NCT03137069|42228720|FG001|Overall Study|Physician Decision|0|||
19774180|NCT03137069|42228721|FG002|Overall Study|Physician Decision|0|||
19774181|NCT03137069|42228722|FG003|Overall Study|Physician Decision|1|||
19774182|NCT03137069|42228723|FG004|Overall Study|Physician Decision|0|||
19774183|NCT03137069|42228724|FG005|Overall Study|Physician Decision|0|||
19774184|NCT03137069|42228719|FG000|Overall Study|Study Terminated by Sponsor|0|||
19774185|NCT03137069|42228720|FG001|Overall Study|Study Terminated by Sponsor|0|||
19774186|NCT03137069|42228721|FG002|Overall Study|Study Terminated by Sponsor|0|||
19774187|NCT03137069|42228722|FG003|Overall Study|Study Terminated by Sponsor|0|||
19774188|NCT03137069|42228723|FG004|Overall Study|Study Terminated by Sponsor|1|||
19774189|NCT03137069|42228724|FG005|Overall Study|Study Terminated by Sponsor|0|||
19774190|NCT03137069|42228719|FG000|Overall Study|Data Entry Error|0|||
19774191|NCT03137069|42228720|FG001|Overall Study|Data Entry Error|0|||
19774192|NCT03137069|42228721|FG002|Overall Study|Data Entry Error|0|||
19774193|NCT03137069|42228722|FG003|Overall Study|Data Entry Error|1|||
19774194|NCT03137069|42228723|FG004|Overall Study|Data Entry Error|0|||
19774195|NCT03137069|42228724|FG005|Overall Study|Data Entry Error|0|||
19774196|NCT02792504|42228742|FG000|Overall Study|Lost to Follow-up|24|||
19366415|NCT02412670|41606449|FG000|Overall Study|Withdrawal by Subject|1|||
19366416|NCT02412670|41606450|FG001|Overall Study|Withdrawal by Subject|0|||
19366417|NCT02412670|41606449|FG000|Overall Study|Ineligible|1|||
19366418|NCT02412670|41606450|FG001|Overall Study|Ineligible|0|||
19366419|NCT01370005|41606459|FG000|Overall Study|Not treated|1|||
19366420|NCT01370005|41606460|FG001|Overall Study|Not treated|0|||
19366421|NCT01370005|41606461|FG002|Overall Study|Not treated|0|||
19366422|NCT01370005|41606459|FG000|Overall Study|Adverse Event|5|||
19366423|NCT01370005|41606460|FG001|Overall Study|Adverse Event|5|||
19366424|NCT01370005|41606461|FG002|Overall Study|Adverse Event|6|||
19366425|NCT01370005|41606459|FG000|Overall Study|Lack of Efficacy|1|||
19366426|NCT01370005|41606460|FG001|Overall Study|Lack of Efficacy|0|||
19366427|NCT01370005|41606461|FG002|Overall Study|Lack of Efficacy|0|||
19366428|NCT01370005|41606459|FG000|Overall Study|Non compliant with protocol|0|||
19366429|NCT01370005|41606460|FG001|Overall Study|Non compliant with protocol|1|||
19366430|NCT01370005|41606461|FG002|Overall Study|Non compliant with protocol|2|||
19366431|NCT01370005|41606459|FG000|Overall Study|Lost to Follow-up|1|||
19366432|NCT01370005|41606460|FG001|Overall Study|Lost to Follow-up|1|||
19366433|NCT01370005|41606461|FG002|Overall Study|Lost to Follow-up|1|||
19366434|NCT01370005|41606459|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
19366435|NCT01370005|41606460|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
19366436|NCT01370005|41606461|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
19366437|NCT01370005|41606459|FG000|Overall Study|Other reason not defined above|3|||
19366438|NCT01370005|41606460|FG001|Overall Study|Other reason not defined above|0|||
19366439|NCT01370005|41606461|FG002|Overall Study|Other reason not defined above|2|||
19366440|NCT02442778|41606472|FG000|Overall Study|Adverse Event|2|||
19366441|NCT02442778|41606473|FG001|Overall Study|Adverse Event|6|||
19366442|NCT02442778|41606474|FG002|Overall Study|Adverse Event|6|||
19366443|NCT02442778|41606472|FG000|Overall Study|Death|0|||
19366444|NCT02442778|41606473|FG001|Overall Study|Death|2|||
19366445|NCT02442778|41606474|FG002|Overall Study|Death|0|||
19366446|NCT02442778|41606472|FG000|Overall Study|Lack of Efficacy|1|||
19366447|NCT02442778|41606473|FG001|Overall Study|Lack of Efficacy|0|||
19366448|NCT02442778|41606474|FG002|Overall Study|Lack of Efficacy|0|||
19366449|NCT02442778|41606472|FG000|Overall Study|Lost to Follow-up|1|||
19366450|NCT02442778|41606473|FG001|Overall Study|Lost to Follow-up|1|||
19366451|NCT02442778|41606474|FG002|Overall Study|Lost to Follow-up|1|||
19366452|NCT02442778|41606472|FG000|Overall Study|Non-compliance with study drug|2|||
19366453|NCT02442778|41606473|FG001|Overall Study|Non-compliance with study drug|0|||
19691870|NCT00124618|42137627|FG000|Overall Study|Ineligible|1|||
19691871|NCT00124462|42137633|FG000|Overall Study|Lost to Follow-up|3|||
19691872|NCT00124462|42137634|FG001|Overall Study|Lost to Follow-up|3|||
19691873|NCT00124462|42137633|FG000|Overall Study|Physician Decision|3|||
19691874|NCT00124462|42137634|FG001|Overall Study|Physician Decision|4|||
19691875|NCT00124462|42137633|FG000|Overall Study|Withdrawal by Subject|4|||
19691876|NCT00124462|42137634|FG001|Overall Study|Withdrawal by Subject|5|||
19691877|NCT00124462|42137633|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
19691878|NCT00124462|42137634|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
19691879|NCT00124072|42137644|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
19366454|NCT02442778|41606474|FG002|Overall Study|Non-compliance with study drug|1|||
19366455|NCT02442778|41606472|FG000|Overall Study|Physician Decision|1|||
19366456|NCT02442778|41606473|FG001|Overall Study|Physician Decision|1|||
19366457|NCT02442778|41606474|FG002|Overall Study|Physician Decision|1|||
19366458|NCT02442778|41606472|FG000|Overall Study|Protocol Deviation|3|||
19366459|NCT02442778|41606473|FG001|Overall Study|Protocol Deviation|0|||
19366460|NCT02442778|41606474|FG002|Overall Study|Protocol Deviation|1|||
19366461|NCT02442778|41606472|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
19366462|NCT02442778|41606473|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
19366463|NCT02442778|41606474|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
19366464|NCT02442778|41606472|FG000|Overall Study|Withdrawal by Subject|4|||
19366465|NCT02442778|41606473|FG001|Overall Study|Withdrawal by Subject|4|||
19366466|NCT02442778|41606474|FG002|Overall Study|Withdrawal by Subject|3|||
19366467|NCT02442778|41606472|FG000|Overall Study|Reason not specified|1|||
19366468|NCT02442778|41606473|FG001|Overall Study|Reason not specified|4|||
19366469|NCT02442778|41606474|FG002|Overall Study|Reason not specified|0|||
19366470|NCT02412436|41606482|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
19366471|NCT02412436|41606482|FG000|Overall Study|Lost to Follow-up|6|||
19366472|NCT02412436|41606482|FG000|Overall Study|Unable to get to clinic|3|||
19606486|NCT00726232|42055183|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
19606487|NCT00726232|42055184|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
19606488|NCT00726232|42055185|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
19691880|NCT00124072|42137645|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
19691881|NCT00124072|42137646|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
19691882|NCT00124072|42137647|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
19691883|NCT00124072|42137644|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
19691884|NCT00124072|42137645|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
19691885|NCT00124072|42137646|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
19691886|NCT00124072|42137647|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
19691887|NCT00124072|42137644|FG000|Overall Study|Death|499|||
19691888|NCT00124072|42137645|FG001|Overall Study|Death|484|||
19691889|NCT00124072|42137646|FG002|Overall Study|Death|471|||
19691890|NCT00124072|42137647|FG003|Overall Study|Death|480|||
19691891|NCT00362648|42137661|FG000|Overall Study|Adverse Event|12|||
19691892|NCT00362648|42137662|FG001|Overall Study|Adverse Event|21|||
19691893|NCT00362648|42137663|FG002|Overall Study|Adverse Event|1|||
19691894|NCT00362648|42137664|FG003|Overall Study|Adverse Event|0|||
19691895|NCT00362648|42137661|FG000|Overall Study|Lost to Follow-up|62|||
19691896|NCT00362648|42137662|FG001|Overall Study|Lost to Follow-up|69|||
19691897|NCT00362648|42137663|FG002|Overall Study|Lost to Follow-up|4|||
19691898|NCT00362648|42137664|FG003|Overall Study|Lost to Follow-up|3|||
19366473|NCT02412436|41606482|FG000|Overall Study|Death|1|||
19606489|NCT00726232|42055186|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
19606490|NCT00726232|42055187|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
19606491|NCT00726232|42055188|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
19606492|NCT00726232|42055181|FG000|Expansion Phase|Death|0|||
19606493|NCT00726232|42055182|FG001|Expansion Phase|Death|0|||
19606494|NCT00726232|42055183|FG002|Expansion Phase|Death|0|||
19606495|NCT00726232|42055184|FG003|Expansion Phase|Death|0|||
19606496|NCT00726232|42055185|FG004|Expansion Phase|Death|0|||
19606497|NCT00726232|42055186|FG005|Expansion Phase|Death|0|||
19606498|NCT00726232|42055187|FG006|Expansion Phase|Death|0|||
19606499|NCT00726232|42055188|FG007|Expansion Phase|Death|1|||
19606500|NCT00726232|42055181|FG000|Expansion Phase|Adverse Event|0|||
19606501|NCT00726232|42055182|FG001|Expansion Phase|Adverse Event|0|||
19606502|NCT00726232|42055183|FG002|Expansion Phase|Adverse Event|0|||
19606503|NCT00726232|42055184|FG003|Expansion Phase|Adverse Event|0|||
19606504|NCT00726232|42055185|FG004|Expansion Phase|Adverse Event|0|||
19606505|NCT00726232|42055186|FG005|Expansion Phase|Adverse Event|0|||
19606506|NCT00726232|42055187|FG006|Expansion Phase|Adverse Event|6|||
19606507|NCT00726232|42055188|FG007|Expansion Phase|Adverse Event|11|||
19606508|NCT00726232|42055181|FG000|Expansion Phase|Withdrawal by Subject|0|||
19606509|NCT00726232|42055182|FG001|Expansion Phase|Withdrawal by Subject|0|||
19606510|NCT00726232|42055183|FG002|Expansion Phase|Withdrawal by Subject|0|||
19606511|NCT00726232|42055184|FG003|Expansion Phase|Withdrawal by Subject|0|||
19606512|NCT00726232|42055185|FG004|Expansion Phase|Withdrawal by Subject|0|||
19606513|NCT00726232|42055186|FG005|Expansion Phase|Withdrawal by Subject|0|||
19606514|NCT00726232|42055187|FG006|Expansion Phase|Withdrawal by Subject|2|||
19606515|NCT00726232|42055188|FG007|Expansion Phase|Withdrawal by Subject|3|||
19366474|NCT02412436|41606482|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
19606516|NCT00726232|42055181|FG000|Expansion Phase|Disease progression|0|||
19606517|NCT00726232|42055182|FG001|Expansion Phase|Disease progression|0|||
19691899|NCT00362648|42137661|FG000|Overall Study|Protocol Violation|4|||
19606518|NCT00726232|42055183|FG002|Expansion Phase|Disease progression|0|||
19606519|NCT00726232|42055184|FG003|Expansion Phase|Disease progression|0|||
19691900|NCT00362648|42137662|FG001|Overall Study|Protocol Violation|2|||
19691901|NCT00362648|42137663|FG002|Overall Study|Protocol Violation|2|||
19366475|NCT01651000|41606488|FG000|Overall Study|Adverse Event|2|||
19366476|NCT01651000|41606489|FG001|Overall Study|Adverse Event|8|||
19366477|NCT01651000|41606488|FG000|Overall Study|Lost to Follow-up|3|||
19366478|NCT01651000|41606489|FG001|Overall Study|Lost to Follow-up|2|||
19366479|NCT01651000|41606488|FG000|Overall Study|Protocol Violation|0|||
19366480|NCT01651000|41606489|FG001|Overall Study|Protocol Violation|3|||
19366481|NCT01651000|41606488|FG000|Overall Study|Withdrawal by Subject|2|||
19366482|NCT01651000|41606489|FG001|Overall Study|Withdrawal by Subject|10|||
19366483|NCT01651000|41606488|FG000|Overall Study|Subject noncompliance|0|||
19366484|NCT01651000|41606489|FG001|Overall Study|Subject noncompliance|3|||
19366485|NCT01651000|41606488|FG000|Overall Study|Lack of Efficacy|1|||
19366486|NCT01651000|41606489|FG001|Overall Study|Lack of Efficacy|1|||
19774197|NCT02792504|42228742|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
19774198|NCT03124459|42228752|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
19774199|NCT03124459|42228753|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
19774200|NCT03124459|42228754|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
19774201|NCT03124459|42228755|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
19774202|NCT03124459|42228756|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
19774203|NCT03124459|42228757|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
19774204|NCT03124459|42228752|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
19366487|NCT01651000|41606488|FG000|Overall Study|Physician Decision|1|||
19691902|NCT00362648|42137664|FG003|Overall Study|Protocol Violation|2|||
19691903|NCT00362648|42137661|FG000|Overall Study|Withdrawal by Subject|48|||
19691904|NCT00362648|42137662|FG001|Overall Study|Withdrawal by Subject|42|||
19691905|NCT00362648|42137663|FG002|Overall Study|Withdrawal by Subject|2|||
19366488|NCT01651000|41606489|FG001|Overall Study|Physician Decision|0|||
19366489|NCT01651000|41606488|FG000|Overall Study|Administrative reason|1|||
19366490|NCT01651000|41606489|FG001|Overall Study|Administrative reason|0|||
19366491|NCT01651000|41606488|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
19366492|NCT01651000|41606489|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
19366493|NCT02469610|41606497|FG000|Overall Study|Death|1|||
19366494|NCT02469610|41606498|FG001|Overall Study|Death|0|||
19366495|NCT02469610|41606497|FG000|Overall Study|Lost to Follow-up|1|||
19366496|NCT02469610|41606498|FG001|Overall Study|Lost to Follow-up|0|||
19691906|NCT00362648|42137664|FG003|Overall Study|Withdrawal by Subject|6|||
19691907|NCT00524303|42137681|FG000|Overall Study|Lost to Follow-up|6|||
19366497|NCT02469610|41606497|FG000|Overall Study|exclusion criteria|2|||
19366498|NCT02469610|41606498|FG001|Overall Study|exclusion criteria|1|||
19366499|NCT02469298|41606508|FG000|Overall Study|Protocol Violation|0|||
19366500|NCT02469298|41606509|FG001|Overall Study|Protocol Violation|1|||
19691908|NCT00524303|42137682|FG001|Overall Study|Lost to Follow-up|0|||
19691909|NCT00524303|42137683|FG002|Overall Study|Lost to Follow-up|3|||
19366501|NCT02469298|41606510|FG002|Overall Study|Protocol Violation|1|||
19366502|NCT02469298|41606511|FG003|Overall Study|Protocol Violation|0|||
19366503|NCT02469298|41606508|FG000|Overall Study|Lost to Follow-up|1|||
19366504|NCT02469298|41606509|FG001|Overall Study|Lost to Follow-up|0|||
19366505|NCT02469298|41606510|FG002|Overall Study|Lost to Follow-up|1|||
19366506|NCT02469298|41606511|FG003|Overall Study|Lost to Follow-up|0|||
19366507|NCT02469298|41606508|FG000|Overall Study|Physician Decision|0|||
19366508|NCT02469298|41606509|FG001|Overall Study|Physician Decision|0|||
19366509|NCT02469298|41606510|FG002|Overall Study|Physician Decision|0|||
19366510|NCT02469298|41606511|FG003|Overall Study|Physician Decision|1|||
19691910|NCT00524303|42137681|FG000|Overall Study|Protocol Violation|0|||
19691911|NCT00524303|42137682|FG001|Overall Study|Protocol Violation|1|||
19691912|NCT00524303|42137683|FG002|Overall Study|Protocol Violation|1|||
19691913|NCT00524303|42137681|FG000|Overall Study|Withdrawal by Subject|3|||
19691914|NCT00524303|42137682|FG001|Overall Study|Withdrawal by Subject|0|||
19691915|NCT00524303|42137683|FG002|Overall Study|Withdrawal by Subject|4|||
19691916|NCT00524303|42137681|FG000|Overall Study|Death|0|||
19691917|NCT00524303|42137682|FG001|Overall Study|Death|2|||
19691918|NCT00524303|42137683|FG002|Overall Study|Death|3|||
19691919|NCT00524303|42137681|FG000|Overall Study|Adverse Event|1|||
19691920|NCT00524303|42137682|FG001|Overall Study|Adverse Event|2|||
19691921|NCT00524303|42137683|FG002|Overall Study|Adverse Event|3|||
19691922|NCT00524303|42137681|FG000|Overall Study|Did not Complete Study Dosing|1|||
19691923|NCT00524303|42137682|FG001|Overall Study|Did not Complete Study Dosing|0|||
19691924|NCT00524303|42137683|FG002|Overall Study|Did not Complete Study Dosing|0|||
19691925|NCT00524303|42137681|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
19691926|NCT00524303|42137682|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
19691927|NCT00524303|42137683|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
19691928|NCT00524303|42137681|FG000|Overall Study|Disease Progression|0|||
19691929|NCT00524303|42137682|FG001|Overall Study|Disease Progression|4|||
19691930|NCT00524303|42137683|FG002|Overall Study|Disease Progression|1|||
19691931|NCT00524303|42137681|FG000|Overall Study|Disease Recurrence|0|||
19366511|NCT02469298|41606508|FG000|Overall Study|Withdrawal by Subject|0|||
19366512|NCT02469298|41606509|FG001|Overall Study|Withdrawal by Subject|0|||
19691932|NCT00524303|42137682|FG001|Overall Study|Disease Recurrence|1|||
19774205|NCT03124459|42228753|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
19774206|NCT03124459|42228754|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
19774207|NCT03124459|42228755|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
19774208|NCT03124459|42228756|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
19774209|NCT03124459|42228757|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
19774210|NCT03124459|42228752|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
19691933|NCT00524303|42137683|FG002|Overall Study|Disease Recurrence|0|||
19691934|NCT00524303|42137681|FG000|Overall Study|Sponsor Request|0|||
19691935|NCT00524303|42137682|FG001|Overall Study|Sponsor Request|0|||
19691936|NCT00524303|42137683|FG002|Overall Study|Sponsor Request|1|||
19691937|NCT00524303|42137681|FG000|Overall Study|Physician Decision|0|||
19691938|NCT00524303|42137682|FG001|Overall Study|Physician Decision|0|||
19774211|NCT03124459|42228753|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
19774212|NCT03124459|42228754|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
19774213|NCT03124459|42228755|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
19774214|NCT03124459|42228756|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
19366513|NCT02469298|41606510|FG002|Overall Study|Withdrawal by Subject|0|||
19366514|NCT02469298|41606511|FG003|Overall Study|Withdrawal by Subject|1|||
19366515|NCT04163991|41606533|FG000|Overall Study|Adverse Event|0|||
19366516|NCT04163991|41606534|FG001|Overall Study|Adverse Event|0|||
19366517|NCT04163991|41606535|FG002|Overall Study|Adverse Event|0|||
19366518|NCT04163991|41606536|FG003|Overall Study|Adverse Event|1|||
19366519|NCT04163991|41606537|FG004|Overall Study|Adverse Event|0|||
19366520|NCT04163991|41606533|FG000|Overall Study|Death|0|||
19366521|NCT04163991|41606534|FG001|Overall Study|Death|0|||
19366522|NCT04163991|41606535|FG002|Overall Study|Death|1|||
19366523|NCT04163991|41606536|FG003|Overall Study|Death|0|||
19366524|NCT04163991|41606537|FG004|Overall Study|Death|0|||
19366525|NCT04163991|41606533|FG000|Overall Study|Lost to Follow-up|0|||
19366526|NCT04163991|41606534|FG001|Overall Study|Lost to Follow-up|1|||
19366527|NCT04163991|41606535|FG002|Overall Study|Lost to Follow-up|0|||
19366528|NCT04163991|41606536|FG003|Overall Study|Lost to Follow-up|0|||
19366529|NCT04163991|41606537|FG004|Overall Study|Lost to Follow-up|0|||
19366530|NCT04163991|41606533|FG000|Overall Study|Withdrawal by Subject|1|||
19366531|NCT04163991|41606534|FG001|Overall Study|Withdrawal by Subject|1|||
19366532|NCT04163991|41606535|FG002|Overall Study|Withdrawal by Subject|3|||
19366533|NCT04163991|41606536|FG003|Overall Study|Withdrawal by Subject|1|||
19366534|NCT04163991|41606537|FG004|Overall Study|Withdrawal by Subject|1|||
19366535|NCT04163991|41606533|FG000|Overall Study|Other, Not Specified|0|||
19366536|NCT04163991|41606534|FG001|Overall Study|Other, Not Specified|1|||
19366537|NCT04163991|41606535|FG002|Overall Study|Other, Not Specified|1|||
19366538|NCT04163991|41606536|FG003|Overall Study|Other, Not Specified|1|||
19366539|NCT04163991|41606537|FG004|Overall Study|Other, Not Specified|0|||
19366540|NCT02442622|41606555|FG000|Overall Study|Withdrawal by Subject|3|||
19366541|NCT02442622|41606556|FG001|Overall Study|Withdrawal by Subject|1|||
19366542|NCT02411578|41606564|FG000|Crossover Trial Phase|Pregnancy|0|||
19366543|NCT02411578|41606565|FG001|Crossover Trial Phase|Pregnancy|1|||
19366544|NCT02442310|41606573|FG000|Overall Study|Adverse Event|2|||
19366545|NCT02442310|41606573|FG000|Overall Study|Withdrawal by Subject|1|||
19366546|NCT02411110|41606585|FG000|Treatment Period 1|Adverse Event|4|||
19366547|NCT02411110|41606586|FG001|Treatment Period 1|Adverse Event|2|||
19366548|NCT02411110|41606585|FG000|Treatment Period 1|Lost to Follow-up|1|||
19366549|NCT02411110|41606586|FG001|Treatment Period 1|Lost to Follow-up|0|||
19366550|NCT02411110|41606585|FG000|Treatment Period 1|Personal Reasons|2|||
19366551|NCT02411110|41606586|FG001|Treatment Period 1|Personal Reasons|5|||
19366552|NCT02411110|41606585|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
19366553|NCT02411110|41606586|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
19366554|NCT02411110|41606585|FG000|Treatment Period 2|Adverse Event|1|||
19366555|NCT02411110|41606586|FG001|Treatment Period 2|Adverse Event|0|||
19366556|NCT02411110|41606585|FG000|Treatment Period 2|Lost to Follow-up|0|||
19366557|NCT02411110|41606586|FG001|Treatment Period 2|Lost to Follow-up|2|||
19366558|NCT02411110|41606585|FG000|Treatment Period 2|Personal Reasons|0|||
19366559|NCT02411110|41606586|FG001|Treatment Period 2|Personal Reasons|2|||
19691939|NCT00524303|42137683|FG002|Overall Study|Physician Decision|1|||
19691940|NCT00524303|42137681|FG000|Overall Study|Completed 5 years|0|||
19366560|NCT01369849|41606597|FG000|Overall Study|Ineligible prior to treatment|0|||
19366561|NCT01369849|41606598|FG001|Overall Study|Ineligible prior to treatment|0|||
19366562|NCT01369849|41606599|FG002|Overall Study|Ineligible prior to treatment|1|||
19366563|NCT01369849|41606597|FG000|Overall Study|Ineligible after receiving treatment|0|||
19366564|NCT01369849|41606598|FG001|Overall Study|Ineligible after receiving treatment|1|||
19366565|NCT01369849|41606599|FG002|Overall Study|Ineligible after receiving treatment|0|||
19366566|NCT02716779|41606612|FG000|Monotherapy|Adverse Event|0|||
19691941|NCT00524303|42137682|FG001|Overall Study|Completed 5 years|0|||
19366567|NCT02716779|41606613|FG001|Monotherapy|Adverse Event|1|||
19691942|NCT00524303|42137683|FG002|Overall Study|Completed 5 years|1|||
19366568|NCT02716779|41606614|FG002|Monotherapy|Adverse Event|1|||
19366569|NCT02716779|41606612|FG000|Combination Therapy|Adverse Event|0|||
19366570|NCT02716779|41606613|FG001|Combination Therapy|Adverse Event|2|||
19366571|NCT02716779|41606614|FG002|Combination Therapy|Adverse Event|1|||
19366572|NCT01369615|41606630|FG000|Overall Study|Withdrawal by Subject|0|||
19366573|NCT01369615|41606631|FG001|Overall Study|Withdrawal by Subject|1|||
19366574|NCT01369615|41606630|FG000|Overall Study|Lost to Follow-up|0|||
19366575|NCT01369615|41606631|FG001|Overall Study|Lost to Follow-up|1|||
19366576|NCT02468674|41606655|FG000|Overall Study|Adverse Event|0|||
19366577|NCT02468674|41606656|FG001|Overall Study|Adverse Event|0|||
19366578|NCT02468674|41606657|FG002|Overall Study|Adverse Event|0|||
19366579|NCT02468674|41606658|FG003|Overall Study|Adverse Event|1|||
19366580|NCT02468674|41606659|FG004|Overall Study|Adverse Event|0|||
19366581|NCT02468674|41606660|FG005|Overall Study|Adverse Event|1|||
19366582|NCT02468674|41606661|FG006|Overall Study|Adverse Event|0|||
19366583|NCT02468674|41606662|FG007|Overall Study|Adverse Event|0|||
19366584|NCT02468674|41606663|FG008|Overall Study|Adverse Event|0|||
19366585|NCT02468674|41606655|FG000|Overall Study|Lost to Follow-up|1|||
19366586|NCT02468674|41606656|FG001|Overall Study|Lost to Follow-up|0|||
19366587|NCT02468674|41606657|FG002|Overall Study|Lost to Follow-up|0|||
19366588|NCT02468674|41606658|FG003|Overall Study|Lost to Follow-up|0|||
19366589|NCT02468674|41606659|FG004|Overall Study|Lost to Follow-up|0|||
19366590|NCT02468674|41606660|FG005|Overall Study|Lost to Follow-up|0|||
19366591|NCT02468674|41606661|FG006|Overall Study|Lost to Follow-up|0|||
19366592|NCT02468674|41606662|FG007|Overall Study|Lost to Follow-up|1|||
19366593|NCT02468674|41606663|FG008|Overall Study|Lost to Follow-up|1|||
19366594|NCT02468674|41606655|FG000|Overall Study|Physician Decision|0|||
19366595|NCT02468674|41606656|FG001|Overall Study|Physician Decision|0|||
19366596|NCT02468674|41606657|FG002|Overall Study|Physician Decision|0|||
19366597|NCT02468674|41606658|FG003|Overall Study|Physician Decision|0|||
19366598|NCT02468674|41606659|FG004|Overall Study|Physician Decision|0|||
19366599|NCT02468674|41606660|FG005|Overall Study|Physician Decision|0|||
19366600|NCT02468674|41606661|FG006|Overall Study|Physician Decision|1|||
19366601|NCT02468674|41606662|FG007|Overall Study|Physician Decision|0|||
19366602|NCT02468674|41606663|FG008|Overall Study|Physician Decision|0|||
19366603|NCT02468674|41606655|FG000|Overall Study|Patient/Guardian Decision|0|||
19366604|NCT02468674|41606656|FG001|Overall Study|Patient/Guardian Decision|0|||
19366605|NCT02468674|41606657|FG002|Overall Study|Patient/Guardian Decision|0|||
19366606|NCT02468674|41606658|FG003|Overall Study|Patient/Guardian Decision|0|||
19366607|NCT02468674|41606659|FG004|Overall Study|Patient/Guardian Decision|1|||
19366608|NCT02468674|41606660|FG005|Overall Study|Patient/Guardian Decision|0|||
19366609|NCT02468674|41606661|FG006|Overall Study|Patient/Guardian Decision|0|||
19366610|NCT02468674|41606662|FG007|Overall Study|Patient/Guardian Decision|2|||
19366611|NCT02468674|41606663|FG008|Overall Study|Patient/Guardian Decision|1|||
19366612|NCT02468674|41606655|FG000|Overall Study|Protocol Deviation|0|||
19366613|NCT02468674|41606656|FG001|Overall Study|Protocol Deviation|0|||
19366614|NCT02468674|41606657|FG002|Overall Study|Protocol Deviation|0|||
19366615|NCT02468674|41606658|FG003|Overall Study|Protocol Deviation|0|||
19366616|NCT02468674|41606659|FG004|Overall Study|Protocol Deviation|0|||
19366617|NCT02468674|41606660|FG005|Overall Study|Protocol Deviation|0|||
19366618|NCT02468674|41606661|FG006|Overall Study|Protocol Deviation|0|||
19366619|NCT02468674|41606662|FG007|Overall Study|Protocol Deviation|1|||
19366620|NCT02468674|41606663|FG008|Overall Study|Protocol Deviation|1|||
19366621|NCT02467192|41606683|FG000|Overall Study|Death|1|||
19366622|NCT02467192|41606683|FG000|Overall Study|revealed to have pneumonia before|2|||
19366623|NCT02410954|41606693|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
19366624|NCT02410954|41606694|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
19366625|NCT02410954|41606693|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
19366626|NCT02410954|41606694|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
19366627|NCT02689453|41606703|FG000|Overall Study|Progressive disease|0|||
19366628|NCT02689453|41606704|FG001|Overall Study|Progressive disease|1|||
19366629|NCT02689453|41606705|FG002|Overall Study|Progressive disease|1|||
19366630|NCT00701103|41606736|FG000|Overall Study|Adverse Event|0|||
19366631|NCT00701103|41606737|FG001|Overall Study|Adverse Event|0|||
19366632|NCT00701103|41606738|FG002|Overall Study|Adverse Event|1|||
19366633|NCT00701103|41606739|FG003|Overall Study|Adverse Event|1|||
19366634|NCT00701103|41606740|FG004|Overall Study|Adverse Event|0|||
19366635|NCT00701103|41606741|FG005|Overall Study|Adverse Event|1|||
19366636|NCT00701103|41606742|FG006|Overall Study|Adverse Event|1|||
19366637|NCT00701103|41606743|FG007|Overall Study|Adverse Event|0|||
19366638|NCT00701103|41606744|FG008|Overall Study|Adverse Event|0|||
19366639|NCT00701103|41606745|FG009|Overall Study|Adverse Event|2|||
19366640|NCT00701103|41606746|FG010|Overall Study|Adverse Event|0|||
19366641|NCT00701103|41606736|FG000|Overall Study|Progressive Disease|5|||
19366642|NCT00701103|41606737|FG001|Overall Study|Progressive Disease|2|||
19366643|NCT00701103|41606738|FG002|Overall Study|Progressive Disease|6|||
19366644|NCT00701103|41606739|FG003|Overall Study|Progressive Disease|5|||
19366645|NCT00701103|41606740|FG004|Overall Study|Progressive Disease|6|||
19366646|NCT00701103|41606741|FG005|Overall Study|Progressive Disease|5|||
19366647|NCT00701103|41606742|FG006|Overall Study|Progressive Disease|7|||
19366648|NCT00701103|41606743|FG007|Overall Study|Progressive Disease|7|||
19366649|NCT00701103|41606744|FG008|Overall Study|Progressive Disease|8|||
19366650|NCT00701103|41606745|FG009|Overall Study|Progressive Disease|8|||
19366651|NCT00701103|41606746|FG010|Overall Study|Progressive Disease|11|||
19366652|NCT00701103|41606736|FG000|Overall Study|Withdrawal by Subject|0|||
19366653|NCT00701103|41606737|FG001|Overall Study|Withdrawal by Subject|1|||
19366654|NCT00701103|41606738|FG002|Overall Study|Withdrawal by Subject|1|||
19366655|NCT00701103|41606739|FG003|Overall Study|Withdrawal by Subject|0|||
19366656|NCT00701103|41606740|FG004|Overall Study|Withdrawal by Subject|0|||
19366657|NCT00701103|41606741|FG005|Overall Study|Withdrawal by Subject|0|||
19366658|NCT00701103|41606742|FG006|Overall Study|Withdrawal by Subject|0|||
19366659|NCT00701103|41606743|FG007|Overall Study|Withdrawal by Subject|0|||
19366660|NCT00701103|41606744|FG008|Overall Study|Withdrawal by Subject|0|||
19366661|NCT00701103|41606745|FG009|Overall Study|Withdrawal by Subject|0|||
19366662|NCT00701103|41606746|FG010|Overall Study|Withdrawal by Subject|0|||
19366663|NCT00701103|41606736|FG000|Overall Study|Other|0|||
19366664|NCT00701103|41606737|FG001|Overall Study|Other|0|||
19366665|NCT00701103|41606738|FG002|Overall Study|Other|0|||
19366666|NCT00701103|41606739|FG003|Overall Study|Other|0|||
19366667|NCT00701103|41606740|FG004|Overall Study|Other|0|||
19366668|NCT00701103|41606741|FG005|Overall Study|Other|0|||
19366669|NCT00701103|41606742|FG006|Overall Study|Other|0|||
19366670|NCT00701103|41606743|FG007|Overall Study|Other|0|||
19366671|NCT00701103|41606744|FG008|Overall Study|Other|1|||
19366672|NCT00701103|41606745|FG009|Overall Study|Other|1|||
19366673|NCT00701103|41606746|FG010|Overall Study|Other|0|||
19366674|NCT01369225|41606780|FG000|Overall Study|Withdrawal by Subject|1|||
19366675|NCT01369225|41606781|FG001|Overall Study|Withdrawal by Subject|0|||
19366676|NCT01369225|41606782|FG002|Overall Study|Withdrawal by Subject|2|||
19366677|NCT01369225|41606783|FG003|Overall Study|Withdrawal by Subject|1|||
19366678|NCT01369225|41606784|FG004|Overall Study|Withdrawal by Subject|0|||
19366679|NCT01369225|41606785|FG005|Overall Study|Withdrawal by Subject|0|||
19366680|NCT01369225|41606780|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
19366681|NCT01369225|41606781|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
19366682|NCT01369225|41606782|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
19366683|NCT01369225|41606783|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
19366684|NCT01369225|41606784|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
19366685|NCT01369225|41606785|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
19366686|NCT01369225|41606780|FG000|Overall Study|Other|1|||
19366687|NCT01369225|41606781|FG001|Overall Study|Other|0|||
19366688|NCT01369225|41606782|FG002|Overall Study|Other|0|||
19366689|NCT01369225|41606783|FG003|Overall Study|Other|0|||
19366690|NCT01369225|41606784|FG004|Overall Study|Other|1|||
19366691|NCT01369225|41606785|FG005|Overall Study|Other|0|||
19366692|NCT01369225|41606780|FG000|Overall Study|Adverse Event|0|||
19366693|NCT01369225|41606781|FG001|Overall Study|Adverse Event|0|||
19774215|NCT03124459|42228757|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
19774216|NCT03124459|42228752|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
19774217|NCT03124459|42228753|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
19774218|NCT03124459|42228754|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
19774219|NCT03124459|42228755|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
19774220|NCT03124459|42228756|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
19774221|NCT03124459|42228757|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
19774222|NCT03124459|42228752|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
19774223|NCT03124459|42228753|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
19774224|NCT03124459|42228754|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
19774225|NCT03124459|42228755|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
19774226|NCT03124459|42228756|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
19774227|NCT03124459|42228757|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
19774228|NCT03124459|42228752|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
19774229|NCT03124459|42228753|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
19774230|NCT03124459|42228754|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
19774231|NCT03124459|42228755|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
19774232|NCT03124459|42228756|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
19774233|NCT03124459|42228757|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
19366694|NCT01369225|41606782|FG002|Overall Study|Adverse Event|0|||
19366695|NCT01369225|41606783|FG003|Overall Study|Adverse Event|1|||
19366696|NCT01369225|41606784|FG004|Overall Study|Adverse Event|1|||
19366697|NCT01369225|41606785|FG005|Overall Study|Adverse Event|0|||
19366698|NCT02639546|41606807|FG000|Overall Study|Death|2|||
19366699|NCT02639546|41606808|FG001|Overall Study|Death|2|||
19366700|NCT02639546|41606809|FG002|Overall Study|Death|1|||
19366701|NCT02639546|41606810|FG003|Overall Study|Death|2|||
19366702|NCT02639546|41606811|FG004|Overall Study|Death|2|||
19366703|NCT02639546|41606812|FG005|Overall Study|Death|2|||
19366704|NCT02639546|41606813|FG006|Overall Study|Death|0|||
19366705|NCT02639546|41606814|FG007|Overall Study|Death|0|||
19366706|NCT02639546|41606807|FG000|Overall Study|Lost to Follow-up|0|||
19366707|NCT02639546|41606808|FG001|Overall Study|Lost to Follow-up|0|||
19366708|NCT02639546|41606809|FG002|Overall Study|Lost to Follow-up|1|||
19366709|NCT02639546|41606810|FG003|Overall Study|Lost to Follow-up|0|||
19366710|NCT02639546|41606811|FG004|Overall Study|Lost to Follow-up|1|||
19366711|NCT02639546|41606812|FG005|Overall Study|Lost to Follow-up|1|||
19366712|NCT02639546|41606813|FG006|Overall Study|Lost to Follow-up|0|||
19366713|NCT02639546|41606814|FG007|Overall Study|Lost to Follow-up|1|||
19366714|NCT02639546|41606807|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
19366715|NCT02639546|41606808|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
19366716|NCT02639546|41606809|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
19366717|NCT02639546|41606810|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
19366718|NCT02639546|41606811|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
19366719|NCT02639546|41606812|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
19366720|NCT02639546|41606813|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
19366721|NCT02639546|41606814|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
19366722|NCT02639546|41606807|FG000|Overall Study|Study Terminated By Sponsor|0|||
19366723|NCT02639546|41606808|FG001|Overall Study|Study Terminated By Sponsor|2|||
19366724|NCT02639546|41606809|FG002|Overall Study|Study Terminated By Sponsor|3|||
19366725|NCT02639546|41606810|FG003|Overall Study|Study Terminated By Sponsor|4|||
19366726|NCT02639546|41606811|FG004|Overall Study|Study Terminated By Sponsor|4|||
19366727|NCT02639546|41606812|FG005|Overall Study|Study Terminated By Sponsor|3|||
19366728|NCT02639546|41606813|FG006|Overall Study|Study Terminated By Sponsor|3|||
19366729|NCT02639546|41606814|FG007|Overall Study|Study Terminated By Sponsor|9|||
19366730|NCT02639546|41606807|FG000|Overall Study|Withdrawal by Subject|2|||
19366731|NCT02639546|41606808|FG001|Overall Study|Withdrawal by Subject|2|||
19366732|NCT02639546|41606809|FG002|Overall Study|Withdrawal by Subject|1|||
19366733|NCT02639546|41606810|FG003|Overall Study|Withdrawal by Subject|0|||
19366734|NCT02639546|41606811|FG004|Overall Study|Withdrawal by Subject|0|||
19366735|NCT02639546|41606812|FG005|Overall Study|Withdrawal by Subject|1|||
19366736|NCT02639546|41606813|FG006|Overall Study|Withdrawal by Subject|2|||
19366737|NCT02639546|41606814|FG007|Overall Study|Withdrawal by Subject|1|||
19366738|NCT02639390|41606848|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
19366739|NCT02639390|41606849|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
19366740|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
19366741|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
19366742|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
19366743|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
19366744|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
19366745|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
19366746|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
19366747|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
19606520|NCT00726232|42055185|FG004|Expansion Phase|Disease progression|0|||
19606521|NCT00726232|42055186|FG005|Expansion Phase|Disease progression|0|||
19606522|NCT00726232|42055187|FG006|Expansion Phase|Disease progression|4|||
19606523|NCT00726232|42055188|FG007|Expansion Phase|Disease progression|0|||
19606524|NCT00726232|42055181|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
19606525|NCT00726232|42055182|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
19606526|NCT00726232|42055183|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
19606527|NCT00726232|42055184|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
19606528|NCT00726232|42055185|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
19606529|NCT00726232|42055186|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
19606530|NCT00726232|42055187|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
19606531|NCT00726232|42055188|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
19606532|NCT00726232|42055181|FG000|Expansion Phase|Per Investigator: lack of response|0|||
19606533|NCT00726232|42055182|FG001|Expansion Phase|Per Investigator: lack of response|0|||
19606534|NCT00726232|42055183|FG002|Expansion Phase|Per Investigator: lack of response|0|||
19606535|NCT00726232|42055184|FG003|Expansion Phase|Per Investigator: lack of response|0|||
19606536|NCT00726232|42055185|FG004|Expansion Phase|Per Investigator: lack of response|0|||
19606537|NCT00726232|42055186|FG005|Expansion Phase|Per Investigator: lack of response|0|||
19606538|NCT00726232|42055187|FG006|Expansion Phase|Per Investigator: lack of response|1|||
19606539|NCT00726232|42055188|FG007|Expansion Phase|Per Investigator: lack of response|7|||
19606540|NCT00726232|42055181|FG000|Expansion Phase|Unspecified reason|0|||
19606541|NCT00726232|42055182|FG001|Expansion Phase|Unspecified reason|0|||
19606542|NCT00726232|42055183|FG002|Expansion Phase|Unspecified reason|0|||
19606543|NCT00726232|42055184|FG003|Expansion Phase|Unspecified reason|0|||
19691943|NCT00335556|42137700|FG000|Overall Study|Death|0|||
19366748|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
19366749|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
19366750|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
19366751|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
19366752|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
19366753|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
19366754|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
19366755|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
19366756|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
19366757|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
19366758|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
19366759|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
19366760|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
19366761|NCT02718417|41606858|FG000|Chemotherapy Phase (CP)|Other|2|||
19366762|NCT02718417|41606859|FG001|Chemotherapy Phase (CP)|Other|0|||
19366763|NCT02718417|41606860|FG002|Chemotherapy Phase (CP)|Other|1|||
19774234|NCT03134183|42228772|FG000|Overall Study|Withdrawal by Subject|1|||
19774235|NCT03134183|42228773|FG001|Overall Study|Withdrawal by Subject|1|||
19774236|NCT03136367|42228782|FG000|T1 Consultation|discontinued mistakenly included|2|||
19774237|NCT03136367|42228783|FG001|T1 Consultation|discontinued mistakenly included|6|||
19774238|NCT03136367|42228784|FG002|T1 Consultation|discontinued mistakenly included|1|||
19774239|NCT03136367|42228782|FG000|T1 Consultation|Discontinued other|0|||
19774240|NCT03136367|42228783|FG001|T1 Consultation|Discontinued other|1|||
19774241|NCT03136367|42228784|FG002|T1 Consultation|Discontinued other|0|||
19774242|NCT03136367|42228782|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
19774243|NCT03136367|42228783|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
19774244|NCT03136367|42228784|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
19774245|NCT03136367|42228782|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
19774246|NCT03136367|42228783|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
19774247|NCT03136367|42228784|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
19366764|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Adverse Event|21|||
19366765|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Adverse Event|26|||
19366766|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Adverse Event|0|||
19366767|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
19774248|NCT03136367|42228782|FG000|T2 Post-consultation|Discontinued other|0|||
19774249|NCT03136367|42228783|FG001|T2 Post-consultation|Discontinued other|2|||
19774250|NCT03136367|42228784|FG002|T2 Post-consultation|Discontinued other|6|||
19774251|NCT03136367|42228782|FG000|T2 Post-consultation|Discontinued transferred care|0|||
19774252|NCT03136367|42228783|FG001|T2 Post-consultation|Discontinued transferred care|0|||
19774253|NCT03136367|42228784|FG002|T2 Post-consultation|Discontinued transferred care|3|||
19774254|NCT03136367|42228782|FG000|T2 Post-consultation|Discontinued lost contact|0|||
19774255|NCT03136367|42228783|FG001|T2 Post-consultation|Discontinued lost contact|1|||
19774256|NCT03136367|42228784|FG002|T2 Post-consultation|Discontinued lost contact|0|||
19774257|NCT03136367|42228782|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
19366768|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
19366769|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
19366770|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
19366771|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
19366772|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
19366773|NCT02718417|41606858|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
19366774|NCT02718417|41606859|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
19366775|NCT02718417|41606860|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
19366776|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Physician's decision|6|||
19366777|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Physician's decision|7|||
19366778|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Physician's decision|0|||
19366779|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Progressive disease|100|||
19366780|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Progressive disease|88|||
19366781|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Progressive disease|0|||
19366782|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Other|2|||
19366783|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Other|1|||
19366784|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Other|0|||
19366785|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
19366786|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
19366787|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
19366788|NCT02718417|41606858|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
19366789|NCT02718417|41606859|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
19366790|NCT02718417|41606860|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
19691944|NCT00335556|42137701|FG001|Overall Study|Death|5|||
19774258|NCT03136367|42228783|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
19366791|NCT02718417|41606858|FG000|Observation Phase (OP)|Adverse Event|0|||
19366792|NCT02718417|41606859|FG001|Observation Phase (OP)|Adverse Event|0|||
19774259|NCT03136367|42228784|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
19366793|NCT02718417|41606860|FG002|Observation Phase (OP)|Adverse Event|1|||
19366794|NCT02718417|41606858|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
19366795|NCT02718417|41606859|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
19366796|NCT02718417|41606860|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
19366797|NCT02718417|41606858|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
19366798|NCT02718417|41606859|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
19366799|NCT02718417|41606860|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
19366800|NCT02718417|41606858|FG000|Observation Phase (OP)|Physician Decision|0|||
19366801|NCT02718417|41606859|FG001|Observation Phase (OP)|Physician Decision|0|||
19366802|NCT02718417|41606860|FG002|Observation Phase (OP)|Physician Decision|9|||
19366803|NCT02718417|41606858|FG000|Observation Phase (OP)|Progressive disease|0|||
19366804|NCT02718417|41606859|FG001|Observation Phase (OP)|Progressive disease|0|||
19366805|NCT02718417|41606860|FG002|Observation Phase (OP)|Progressive disease|92|||
19366806|NCT02718417|41606858|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
19366807|NCT02718417|41606859|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
19366808|NCT02718417|41606860|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
19389153|NCT02084056|41632766|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19389154|NCT02084056|41632767|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19606544|NCT00726232|42055185|FG004|Expansion Phase|Unspecified reason|0|||
19606545|NCT00726232|42055186|FG005|Expansion Phase|Unspecified reason|0|||
19606546|NCT00726232|42055187|FG006|Expansion Phase|Unspecified reason|1|||
19606547|NCT00726232|42055188|FG007|Expansion Phase|Unspecified reason|0|||
19606548|NCT00720382|42055209|FG000|Overall Study|Adverse Event|54|||
19606549|NCT00720382|42055210|FG001|Overall Study|Adverse Event|17|||
19606550|NCT00720382|42055209|FG000|Overall Study|Lack of Efficacy|18|||
19606551|NCT00720382|42055210|FG001|Overall Study|Lack of Efficacy|7|||
19606552|NCT00720382|42055209|FG000|Overall Study|Non-Compliance|15|||
19606553|NCT00720382|42055210|FG001|Overall Study|Non-Compliance|5|||
19606554|NCT00720382|42055209|FG000|Overall Study|Withdrawal by Subject|47|||
19606555|NCT00720382|42055210|FG001|Overall Study|Withdrawal by Subject|11|||
19606556|NCT00720382|42055209|FG000|Overall Study|Lost to Follow-up|28|||
19606557|NCT00720382|42055210|FG001|Overall Study|Lost to Follow-up|14|||
19606558|NCT00720382|42055209|FG000|Overall Study|administrative|14|||
19606559|NCT00720382|42055210|FG001|Overall Study|administrative|5|||
19606560|NCT00720226|42055218|FG000|Overall Study|Withdrawal by Subject|7|||
19606561|NCT00720226|42055219|FG001|Overall Study|Withdrawal by Subject|4|||
19606562|NCT00725920|42055227|FG000|Overall Study|Lack of Efficacy|3|||
19606563|NCT00725920|42055228|FG001|Overall Study|Lack of Efficacy|6|||
19606564|NCT00725842|42055234|FG000|Overall Study|Lost to Follow-up|19|||
19606565|NCT00725842|42055234|FG000|Overall Study|Death|1|||
19606566|NCT00725842|42055234|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
19606567|NCT00725842|42055234|FG000|Overall Study|Consent date prior to study start date|5|||
19606568|NCT00725842|42055234|FG000|Overall Study|Inclusion criterion not met|1|||
19606569|NCT00725842|42055234|FG000|Overall Study|No Visit 1 data|1|||
19606570|NCT00725764|42055238|FG000|Overall Study|Withdrawal by Subject|2|||
19606571|NCT00725764|42055238|FG000|Overall Study|Physician Decision|1|||
19606572|NCT00725764|42055238|FG000|Overall Study|Progressive Disease|7|||
19606573|NCT00725764|42055238|FG000|Overall Study|Lost to Follow-up|1|||
19606574|NCT00725764|42055238|FG000|Overall Study|Death|1|||
19606575|NCT00725764|42055238|FG000|Overall Study|Participant non compliant with protocol|1|||
19606576|NCT00725764|42055238|FG000|Overall Study|Decline in performance status|1|||
19606577|NCT00725608|42055243|FG000|Overall Study|Lost to Follow-up|60|||
19606578|NCT00725608|42055243|FG000|Overall Study|Adverse Event|14|||
19606579|NCT00725608|42055243|FG000|Overall Study|Individual reasons|86|||
19606580|NCT00725608|42055243|FG000|Overall Study|Other|7|||
19606581|NCT00725452|42055247|FG000|Overall Study|Adverse Event|3|||
19606582|NCT00725452|42055247|FG000|Overall Study|Lack of Efficacy|2|||
19606583|NCT00725452|42055247|FG000|Overall Study|Reason not specified|1|||
19606584|NCT00725452|42055247|FG000|Overall Study|Physician Decision|1|||
19606585|NCT00725452|42055247|FG000|Overall Study|Withdrawal by Subject|3|||
19606586|NCT00725452|42055247|FG000|Overall Study|Lost to Follow-up|1|||
19606587|NCT00725296|42055251|FG000|Overall Study|Adverse Event|11|||
19606588|NCT00725296|42055251|FG000|Overall Study|Lack of Efficacy|7|||
19606589|NCT00725296|42055251|FG000|Overall Study|Withdrawal by Subject|3|||
19606590|NCT00725296|42055251|FG000|Overall Study|Non-Compliance|2|||
19606591|NCT00725296|42055251|FG000|Overall Study|Lost to Follow-up|1|||
19606592|NCT00725296|42055251|FG000|Overall Study|Other|38|||
19606593|NCT00719680|42055256|FG000|Overall Study|Adverse Event|1|||
19606594|NCT00719680|42055256|FG000|Overall Study|Lost to Follow-up|1|||
19606595|NCT00719680|42055256|FG000|Overall Study|Withdrawal by Subject|3|||
19606596|NCT00719212|42055260|FG000|Overall Study|Death|41|||
19606597|NCT00719212|42055260|FG000|Overall Study|Lost to Follow-up|2|||
19606598|NCT00719212|42055260|FG000|Overall Study|Withdrawal by Subject|1|||
19606599|NCT00585052|42055264|FG000|Overall Study|Withdrawal by Subject|1|||
19366809|NCT02718417|41606858|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
19366810|NCT02718417|41606859|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
19366811|NCT02718417|41606860|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
19366812|NCT02718417|41606858|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
19366813|NCT02718417|41606859|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
19366814|NCT02718417|41606860|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
19366815|NCT02718417|41606858|FG000|Observation Phase (OP)|Other|0|||
19366816|NCT02718417|41606859|FG001|Observation Phase (OP)|Other|0|||
19366817|NCT02718417|41606860|FG002|Observation Phase (OP)|Other|7|||
19366818|NCT02718417|41606858|FG000|Follow-up Phase|Adverse Event|3|||
19366819|NCT02718417|41606859|FG001|Follow-up Phase|Adverse Event|1|||
19366820|NCT02718417|41606860|FG002|Follow-up Phase|Adverse Event|1|||
19366821|NCT02718417|41606858|FG000|Follow-up Phase|Other|4|||
19366822|NCT02718417|41606859|FG001|Follow-up Phase|Other|6|||
19366823|NCT02718417|41606860|FG002|Follow-up Phase|Other|4|||
19366824|NCT02718417|41606858|FG000|Follow-up Phase|Withdrawal by Subject|19|||
19366825|NCT02718417|41606859|FG001|Follow-up Phase|Withdrawal by Subject|17|||
19366826|NCT02718417|41606860|FG002|Follow-up Phase|Withdrawal by Subject|5|||
19366827|NCT02718417|41606858|FG000|Follow-up Phase|Study terminated by sponsor|100|||
19774260|NCT03136367|42228782|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
19774261|NCT03136367|42228783|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
19774262|NCT03136367|42228784|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
19774263|NCT03136367|42228782|FG000|T3 1 Week After Surgery|other discontinued|2|||
19366828|NCT02718417|41606859|FG001|Follow-up Phase|Study terminated by sponsor|138|||
19366829|NCT02718417|41606860|FG002|Follow-up Phase|Study terminated by sponsor|6|||
19366830|NCT02718417|41606858|FG000|Follow-up Phase|Lost to Follow-up|2|||
19366831|NCT02718417|41606859|FG001|Follow-up Phase|Lost to Follow-up|3|||
19366832|NCT02718417|41606860|FG002|Follow-up Phase|Lost to Follow-up|0|||
19366833|NCT02718417|41606858|FG000|Follow-up Phase|Death leading to discontinuation|7|||
19366834|NCT02718417|41606859|FG001|Follow-up Phase|Death leading to discontinuation|7|||
19366835|NCT02718417|41606860|FG002|Follow-up Phase|Death leading to discontinuation|3|||
19366836|NCT02718417|41606858|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
19366837|NCT02718417|41606859|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
19366838|NCT02718417|41606860|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
19366839|NCT02718417|41606858|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
19366840|NCT02718417|41606859|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
19366841|NCT02718417|41606860|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
19366842|NCT02718417|41606858|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
19366843|NCT02718417|41606859|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
19366844|NCT02718417|41606860|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
19366845|NCT02718417|41606858|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
19366846|NCT02718417|41606859|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
19366847|NCT02718417|41606860|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
19366848|NCT02718417|41606858|FG000|Long-term Follow-up Phase|Other|0|||
19366849|NCT02718417|41606859|FG001|Long-term Follow-up Phase|Other|2|||
19366850|NCT02718417|41606860|FG002|Long-term Follow-up Phase|Other|0|||
19366851|NCT02640404|41606877|FG000|Overall Study|Protocol Violation|1|||
19366852|NCT02640404|41606878|FG001|Overall Study|Protocol Violation|0|||
19366853|NCT02640404|41606877|FG000|Overall Study|Withdrawal by Subject|1|||
19366854|NCT02640404|41606878|FG001|Overall Study|Withdrawal by Subject|0|||
19366855|NCT00701727|41606884|FG000|First Treatment Period|Adverse Event|0|||
19366856|NCT00701727|41606885|FG001|First Treatment Period|Adverse Event|0|||
19366857|NCT00701727|41606884|FG000|First Treatment Period|Withdrawal by Subject|1|||
19366858|NCT00701727|41606885|FG001|First Treatment Period|Withdrawal by Subject|0|||
19366859|NCT00701727|41606884|FG000|First Treatment Period|sponsor decision|0|||
19366860|NCT00701727|41606885|FG001|First Treatment Period|sponsor decision|1|||
19366861|NCT00701727|41606884|FG000|First Treatment Period|Lost to Follow-up|0|||
19366862|NCT00701727|41606885|FG001|First Treatment Period|Lost to Follow-up|1|||
19366863|NCT00701727|41606884|FG000|Second Treatment Period|Withdrawal by Subject|2|||
19691945|NCT00335556|42137702|FG002|Overall Study|Death|0|||
19691946|NCT00335556|42137703|FG003|Overall Study|Death|0|||
19691947|NCT00335556|42137704|FG004|Overall Study|Death|1|||
19691948|NCT00335556|42137705|FG005|Overall Study|Death|0|||
19691949|NCT00335556|42137700|FG000|Overall Study|Lack of Efficacy|0|||
19691950|NCT00335556|42137701|FG001|Overall Study|Lack of Efficacy|19|||
19691951|NCT00335556|42137702|FG002|Overall Study|Lack of Efficacy|3|||
19366864|NCT00701727|41606885|FG001|Second Treatment Period|Withdrawal by Subject|0|||
19691952|NCT00335556|42137703|FG003|Overall Study|Lack of Efficacy|3|||
19691953|NCT00335556|42137704|FG004|Overall Study|Lack of Efficacy|0|||
19691954|NCT00335556|42137705|FG005|Overall Study|Lack of Efficacy|1|||
19691955|NCT00335556|42137700|FG000|Overall Study|Physician Decision|0|||
19691956|NCT00335556|42137701|FG001|Overall Study|Physician Decision|6|||
19691957|NCT00335556|42137702|FG002|Overall Study|Physician Decision|2|||
19691958|NCT00335556|42137703|FG003|Overall Study|Physician Decision|1|||
19691959|NCT00335556|42137704|FG004|Overall Study|Physician Decision|0|||
19774264|NCT03136367|42228783|FG001|T3 1 Week After Surgery|other discontinued|4|||
19366865|NCT01369069|41606902|FG000|Overall Study|Lost to Follow-up|8|||
19366866|NCT01369069|41606903|FG001|Overall Study|Lost to Follow-up|9|||
19366867|NCT01369069|41606902|FG000|Overall Study|Withdrawal by Subject|9|||
19366868|NCT01369069|41606903|FG001|Overall Study|Withdrawal by Subject|7|||
19366869|NCT02441218|41606911|FG000|Overall Study|Death|503|||
19366870|NCT02441218|41606912|FG001|Overall Study|Death|553|||
19366871|NCT02441218|41606911|FG000|Overall Study|Withdrawal by Subject|73|||
19366872|NCT02441218|41606912|FG001|Overall Study|Withdrawal by Subject|58|||
19366873|NCT02441218|41606911|FG000|Overall Study|Lost to Follow-up|2|||
19366874|NCT02441218|41606912|FG001|Overall Study|Lost to Follow-up|1|||
19366875|NCT02410252|41606918|FG000|Overall Study|Withdrawal by Subject|4|||
19366876|NCT02410252|41606918|FG000|Overall Study|Physician Decision|2|||
19366877|NCT02440594|41606932|FG000|Overall Study|Lost to Follow-up|34|||
19366878|NCT02440594|41606933|FG001|Overall Study|Lost to Follow-up|33|||
19366879|NCT02440594|41606934|FG002|Overall Study|Lost to Follow-up|54|||
19366880|NCT02440594|41606935|FG003|Overall Study|Lost to Follow-up|47|||
19366881|NCT02440594|41606936|FG004|Overall Study|Lost to Follow-up|5|||
19366882|NCT02440594|41606937|FG005|Overall Study|Lost to Follow-up|4|||
19366883|NCT02440594|41606938|FG006|Overall Study|Lost to Follow-up|28|||
19366884|NCT02440594|41606939|FG007|Overall Study|Lost to Follow-up|48|||
19366885|NCT02440594|41606932|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
19366886|NCT02440594|41606933|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
19366887|NCT02440594|41606934|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
19366888|NCT02440594|41606935|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
19366889|NCT02440594|41606936|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
19366890|NCT02440594|41606937|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
19366891|NCT02440594|41606938|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
19366892|NCT02440594|41606939|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
19366893|NCT02440594|41606932|FG000|Overall Study|Withdrawal by Subject|81|||
19366894|NCT02440594|41606933|FG001|Overall Study|Withdrawal by Subject|67|||
19366895|NCT02440594|41606934|FG002|Overall Study|Withdrawal by Subject|59|||
19366896|NCT02440594|41606935|FG003|Overall Study|Withdrawal by Subject|38|||
19366897|NCT02440594|41606936|FG004|Overall Study|Withdrawal by Subject|2|||
19366898|NCT02440594|41606937|FG005|Overall Study|Withdrawal by Subject|2|||
19366899|NCT02440594|41606938|FG006|Overall Study|Withdrawal by Subject|7|||
19774265|NCT03136367|42228784|FG002|T3 1 Week After Surgery|other discontinued|3|||
19366900|NCT02440594|41606939|FG007|Overall Study|Withdrawal by Subject|7|||
19366901|NCT02440594|41606932|FG000|Overall Study|Administratively w/drawn|3|||
19366902|NCT02440594|41606933|FG001|Overall Study|Administratively w/drawn|2|||
19366903|NCT02440594|41606934|FG002|Overall Study|Administratively w/drawn|0|||
19366904|NCT02440594|41606935|FG003|Overall Study|Administratively w/drawn|0|||
19366905|NCT02440594|41606936|FG004|Overall Study|Administratively w/drawn|0|||
19366906|NCT02440594|41606937|FG005|Overall Study|Administratively w/drawn|0|||
19366907|NCT02440594|41606938|FG006|Overall Study|Administratively w/drawn|2|||
19366908|NCT02440594|41606939|FG007|Overall Study|Administratively w/drawn|1|||
19366909|NCT03836001|41606966|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
19366910|NCT03836001|41606967|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
19366911|NCT03836001|41606968|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
19366912|NCT03836001|41606966|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
19366913|NCT03836001|41606967|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
19366914|NCT03836001|41606968|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
19366915|NCT03836001|41606966|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
19366916|NCT03836001|41606967|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
19366917|NCT03836001|41606968|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
19366918|NCT03836001|41606966|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
19366919|NCT03836001|41606967|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
19366920|NCT03836001|41606968|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
19366921|NCT02465866|41606975|FG000|Period 3|Withdrawal by Subject|0|||
19366922|NCT02465866|41606976|FG001|Period 3|Withdrawal by Subject|1|||
19366923|NCT02465866|41606977|FG002|Period 3|Withdrawal by Subject|0|||
19366924|NCT02465866|41606978|FG003|Period 3|Withdrawal by Subject|0|||
19366925|NCT02439970|41606990|FG000|Overall Study|Study Terminated|2|||
19366926|NCT02439970|41606991|FG001|Overall Study|Study Terminated|3|||
19366927|NCT02437864|41606999|FG000|Overall Study|Protocol Violation|4|||
19366928|NCT02437864|41607000|FG001|Overall Study|Protocol Violation|0|||
19366929|NCT02408068|41607006|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
19366930|NCT02408068|41607007|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
19366931|NCT02408068|41607008|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
19366932|NCT02408068|41607009|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
19366933|NCT02408068|41607010|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
19366934|NCT02408068|41607011|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
19366935|NCT01361126|41607024|FG000|Overall Study|Sponsor decision|0|||
19366936|NCT01361126|41607025|FG001|Overall Study|Sponsor decision|2|||
19366937|NCT04428645|41607032|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
19366938|NCT01368835|41607036|FG000|Overall Study|Inclusion criteria/photography quality|22|||
19366939|NCT01368835|41607036|FG000|Overall Study|Lost to Follow-up|11|||
19366940|NCT02407990|41607055|FG000|Overall Study|Death|2|||
19366941|NCT02407990|41607056|FG001|Overall Study|Death|22|||
19366942|NCT02407990|41607057|FG002|Overall Study|Death|23|||
19366943|NCT02407990|41607058|FG003|Overall Study|Death|7|||
19366944|NCT02407990|41607059|FG004|Overall Study|Death|17|||
19366945|NCT02407990|41607060|FG005|Overall Study|Death|16|||
19366946|NCT02407990|41607061|FG006|Overall Study|Death|10|||
19366947|NCT02407990|41607062|FG007|Overall Study|Death|248|||
19366948|NCT02407990|41607055|FG000|Overall Study|Lost to Follow-up|0|||
19366949|NCT02407990|41607056|FG001|Overall Study|Lost to Follow-up|1|||
19366950|NCT02407990|41607057|FG002|Overall Study|Lost to Follow-up|0|||
19366951|NCT02407990|41607058|FG003|Overall Study|Lost to Follow-up|0|||
19366952|NCT02407990|41607059|FG004|Overall Study|Lost to Follow-up|0|||
19366953|NCT02407990|41607060|FG005|Overall Study|Lost to Follow-up|0|||
19366954|NCT02407990|41607061|FG006|Overall Study|Lost to Follow-up|0|||
19366955|NCT02407990|41607062|FG007|Overall Study|Lost to Follow-up|17|||
19366956|NCT02407990|41607055|FG000|Overall Study|Progressive Disease|0|||
19366957|NCT02407990|41607056|FG001|Overall Study|Progressive Disease|0|||
19366958|NCT02407990|41607057|FG002|Overall Study|Progressive Disease|0|||
19366959|NCT02407990|41607058|FG003|Overall Study|Progressive Disease|0|||
19366960|NCT02407990|41607059|FG004|Overall Study|Progressive Disease|0|||
19366961|NCT02407990|41607060|FG005|Overall Study|Progressive Disease|0|||
19366962|NCT02407990|41607061|FG006|Overall Study|Progressive Disease|0|||
19366963|NCT02407990|41607062|FG007|Overall Study|Progressive Disease|1|||
19366964|NCT02407990|41607055|FG000|Overall Study|Withdrawal by Subject|0|||
19366965|NCT02407990|41607056|FG001|Overall Study|Withdrawal by Subject|0|||
19366966|NCT02407990|41607057|FG002|Overall Study|Withdrawal by Subject|0|||
19366967|NCT02407990|41607058|FG003|Overall Study|Withdrawal by Subject|0|||
19366968|NCT02407990|41607059|FG004|Overall Study|Withdrawal by Subject|1|||
19366969|NCT02407990|41607060|FG005|Overall Study|Withdrawal by Subject|0|||
19366970|NCT02407990|41607061|FG006|Overall Study|Withdrawal by Subject|0|||
19366971|NCT02407990|41607062|FG007|Overall Study|Withdrawal by Subject|30|||
19366972|NCT02407990|41607055|FG000|Overall Study|Study Terminated by Sponsor|1|||
19366973|NCT02407990|41607056|FG001|Overall Study|Study Terminated by Sponsor|3|||
19366974|NCT02407990|41607057|FG002|Overall Study|Study Terminated by Sponsor|3|||
19366975|NCT02407990|41607058|FG003|Overall Study|Study Terminated by Sponsor|0|||
19366976|NCT02407990|41607059|FG004|Overall Study|Study Terminated by Sponsor|3|||
19366977|NCT02407990|41607060|FG005|Overall Study|Study Terminated by Sponsor|4|||
19366978|NCT02407990|41607061|FG006|Overall Study|Study Terminated by Sponsor|3|||
19366979|NCT02407990|41607062|FG007|Overall Study|Study Terminated by Sponsor|37|||
19366980|NCT02407990|41607055|FG000|Overall Study|Logistics|0|||
19366981|NCT02407990|41607056|FG001|Overall Study|Logistics|0|||
19366982|NCT02407990|41607057|FG002|Overall Study|Logistics|0|||
19366983|NCT02407990|41607058|FG003|Overall Study|Logistics|0|||
19366984|NCT02407990|41607059|FG004|Overall Study|Logistics|0|||
19366985|NCT02407990|41607060|FG005|Overall Study|Logistics|0|||
19691960|NCT00335556|42137705|FG005|Overall Study|Physician Decision|0|||
19691961|NCT00335556|42137700|FG000|Overall Study|Ineligible|2|||
19691962|NCT00335556|42137701|FG001|Overall Study|Ineligible|0|||
19691963|NCT00335556|42137702|FG002|Overall Study|Ineligible|0|||
19691964|NCT00335556|42137703|FG003|Overall Study|Ineligible|0|||
19691965|NCT00335556|42137704|FG004|Overall Study|Ineligible|0|||
19691966|NCT00335556|42137705|FG005|Overall Study|Ineligible|0|||
19691967|NCT00335556|42137700|FG000|Overall Study|Refusal of further protocol therapy|0|||
19691968|NCT00335556|42137701|FG001|Overall Study|Refusal of further protocol therapy|4|||
19691969|NCT00335556|42137702|FG002|Overall Study|Refusal of further protocol therapy|0|||
19691970|NCT00335556|42137703|FG003|Overall Study|Refusal of further protocol therapy|1|||
19691971|NCT00335556|42137704|FG004|Overall Study|Refusal of further protocol therapy|0|||
19691972|NCT00335556|42137705|FG005|Overall Study|Refusal of further protocol therapy|0|||
19691973|NCT00518687|42137726|FG000|Overall Study|Adverse Event|201|||
19691974|NCT00518687|42137727|FG001|Overall Study|Adverse Event|177|||
19691975|NCT00518687|42137726|FG000|Overall Study|Lost to Follow-up|144|||
19691976|NCT00518687|42137727|FG001|Overall Study|Lost to Follow-up|155|||
19691977|NCT00518687|42137726|FG000|Overall Study|Physician Decision|42|||
19691978|NCT00518687|42137727|FG001|Overall Study|Physician Decision|48|||
19691979|NCT00518687|42137726|FG000|Overall Study|Progressive disease|2|||
19366986|NCT02407990|41607061|FG006|Overall Study|Logistics|0|||
19366987|NCT02407990|41607062|FG007|Overall Study|Logistics|1|||
19366988|NCT02407990|41607055|FG000|Overall Study|Rolled into long-term extension study|0|||
19366989|NCT02407990|41607056|FG001|Overall Study|Rolled into long-term extension study|0|||
19366990|NCT02407990|41607057|FG002|Overall Study|Rolled into long-term extension study|0|||
19366991|NCT02407990|41607058|FG003|Overall Study|Rolled into long-term extension study|0|||
19366992|NCT02407990|41607059|FG004|Overall Study|Rolled into long-term extension study|0|||
19366993|NCT02407990|41607060|FG005|Overall Study|Rolled into long-term extension study|0|||
19691980|NCT00518687|42137727|FG001|Overall Study|Progressive disease|2|||
19691981|NCT00518687|42137726|FG000|Overall Study|Protocol Violation|8|||
19366994|NCT02407990|41607061|FG006|Overall Study|Rolled into long-term extension study|0|||
19366995|NCT02407990|41607062|FG007|Overall Study|Rolled into long-term extension study|1|||
19366996|NCT03288129|41607086|FG000|Overall Study|Adverse Event|10|||
19366997|NCT03288129|41607086|FG000|Overall Study|Lost to Follow-up|3|||
19366998|NCT03288129|41607086|FG000|Overall Study|Withdrawal by Subject|3|||
19366999|NCT03288129|41607086|FG000|Overall Study|Withdrawal of consent/assent|1|||
19367000|NCT03288129|41607086|FG000|Overall Study|Other|5|||
19367001|NCT02437318|41607092|FG000|Overall Study|Progressive disease|173|||
19367002|NCT02437318|41607093|FG001|Overall Study|Progressive disease|208|||
19367003|NCT02437318|41607092|FG000|Overall Study|Subject/guardian decision|22|||
19367004|NCT02437318|41607093|FG001|Overall Study|Subject/guardian decision|10|||
19367005|NCT02437318|41607092|FG000|Overall Study|Physician Decision|11|||
19367006|NCT02437318|41607093|FG001|Overall Study|Physician Decision|10|||
19367007|NCT02437318|41607092|FG000|Overall Study|Adverse Event|14|||
19606600|NCT00724282|42055268|FG000|Overall Study|Withdrawal by Subject|3|||
19606601|NCT00724282|42055268|FG000|Overall Study|Physician Decision|1|||
19606602|NCT00724126|42055274|FG000|Overall Study|Adverse Event|2|||
19606603|NCT00724126|42055275|FG001|Overall Study|Adverse Event|0|||
19606604|NCT00724126|42055274|FG000|Overall Study|Withdrawal by Subject|8|||
19606605|NCT00724126|42055275|FG001|Overall Study|Withdrawal by Subject|6|||
19606606|NCT00724126|42055274|FG000|Overall Study|Lost to Follow-up|6|||
19606607|NCT00724126|42055275|FG001|Overall Study|Lost to Follow-up|6|||
19606608|NCT00724126|42055274|FG000|Overall Study|Noncompliance|2|||
19606609|NCT00724126|42055275|FG001|Overall Study|Noncompliance|1|||
19606610|NCT00724126|42055274|FG000|Overall Study|Subject randomized although ineligible|1|||
19606611|NCT00724126|42055275|FG001|Overall Study|Subject randomized although ineligible|1|||
19606612|NCT00724126|42055274|FG000|Overall Study|Subject had to leave vicinity of site|0|||
19606613|NCT00724126|42055275|FG001|Overall Study|Subject had to leave vicinity of site|1|||
19606614|NCT00723892|42055283|FG000|Overall Study|Participant not tracked|33|||
19606615|NCT00723892|42055284|FG001|Overall Study|Participant not tracked|35|||
19606616|NCT00723892|42055283|FG000|Overall Study|Virological criterion|24|||
19606617|NCT00723892|42055284|FG001|Overall Study|Virological criterion|9|||
19606618|NCT00723892|42055283|FG000|Overall Study|Withdrawal by Subject|6|||
19606619|NCT00723892|42055284|FG001|Overall Study|Withdrawal by Subject|9|||
19606620|NCT00723892|42055283|FG000|Overall Study|End planned|11|||
19606621|NCT00723892|42055284|FG001|Overall Study|End planned|7|||
19606622|NCT00723892|42055283|FG000|Overall Study|Bad tolerance|5|||
19606623|NCT00723892|42055284|FG001|Overall Study|Bad tolerance|5|||
19606624|NCT00723892|42055283|FG000|Overall Study|Multiple reasons|17|||
19606625|NCT00723892|42055284|FG001|Overall Study|Multiple reasons|12|||
19606626|NCT00723892|42055283|FG000|Overall Study|Other|6|||
19606627|NCT00723892|42055284|FG001|Overall Study|Other|3|||
19606628|NCT00723892|42055283|FG000|Overall Study|Study end|1|||
19606629|NCT00723892|42055284|FG001|Overall Study|Study end|3|||
19606630|NCT00723892|42055283|FG000|Overall Study|Weight loss|1|||
19606631|NCT00723892|42055284|FG001|Overall Study|Weight loss|3|||
19606632|NCT00723892|42055283|FG000|Overall Study|Alcohol abuse|0|||
19606633|NCT00723892|42055284|FG001|Overall Study|Alcohol abuse|1|||
19606634|NCT00723892|42055283|FG000|Overall Study|Intercurrent infection|2|||
19606635|NCT00723892|42055284|FG001|Overall Study|Intercurrent infection|0|||
19606636|NCT00723892|42055283|FG000|Overall Study|Drug addiction|1|||
19606637|NCT00723892|42055284|FG001|Overall Study|Drug addiction|0|||
19606638|NCT00718666|42055293|FG000|Booster Phase Year 5|No active participation request|0|||
19606639|NCT00718666|42055294|FG001|Booster Phase Year 5|No active participation request|0|||
19606640|NCT00718666|42055295|FG002|Booster Phase Year 5|No active participation request|1|||
19606641|NCT00718666|42055293|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
19606642|NCT00718666|42055294|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
19606643|NCT00718666|42055295|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
19606644|NCT00718666|42055293|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
19691982|NCT00518687|42137727|FG001|Overall Study|Protocol Violation|10|||
19691983|NCT00518687|42137726|FG000|Overall Study|Study terminated by sponsor|930|||
19691984|NCT00518687|42137727|FG001|Overall Study|Study terminated by sponsor|918|||
19606645|NCT00718666|42055294|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
19606646|NCT00718666|42055295|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
19606647|NCT00718666|42055293|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
19606648|NCT00718666|42055294|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
19606649|NCT00718666|42055295|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
19606650|NCT03950440|42055316|FG000|Overall Study|Death|8|||
19606651|NCT03950440|42055317|FG001|Overall Study|Death|2|||
19606652|NCT03950440|42055318|FG002|Overall Study|Death|1|||
19606653|NCT00718510|42055328|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
19606654|NCT00718510|42055329|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19606655|NCT00718510|42055328|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
19606656|NCT00718510|42055329|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
19691985|NCT00518687|42137726|FG000|Overall Study|Withdrawal by Subject|110|||
19606657|NCT00585286|42055335|FG000|Overall Study|Lost to Follow-up|1|||
19606658|NCT00723190|42055339|FG000|Overall Study|Withdrawal by Subject|45|||
19367008|NCT02437318|41607093|FG001|Overall Study|Adverse Event|3|||
19367009|NCT02437318|41607092|FG000|Overall Study|Death|4|||
19367010|NCT02437318|41607093|FG001|Overall Study|Death|4|||
19774266|NCT03136367|42228782|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
19774267|NCT03136367|42228783|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
19774268|NCT03136367|42228784|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
19774269|NCT03136367|42228782|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
19774270|NCT03136367|42228783|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
19774271|NCT03136367|42228784|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
19774272|NCT03136367|42228782|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
19774273|NCT03136367|42228783|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
19774274|NCT03136367|42228784|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
19367011|NCT02437318|41607092|FG000|Overall Study|Protocol Violation|5|||
19367012|NCT02437318|41607093|FG001|Overall Study|Protocol Violation|6|||
19367013|NCT02437318|41607092|FG000|Overall Study|Untreated|0|||
19367014|NCT02437318|41607093|FG001|Overall Study|Untreated|1|||
19367015|NCT01673282|41607101|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
19367016|NCT01673282|41607102|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
19367017|NCT01673282|41607101|FG000|Overall Study|Lack of Efficacy|9|||
19367018|NCT01673282|41607102|FG001|Overall Study|Lack of Efficacy|2|||
19367019|NCT01673282|41607101|FG000|Overall Study|Lost to Follow-up|11|||
19367020|NCT01673282|41607102|FG001|Overall Study|Lost to Follow-up|10|||
19367021|NCT01673282|41607101|FG000|Overall Study|Withdrawal by Subject|3|||
19367022|NCT01673282|41607102|FG001|Overall Study|Withdrawal by Subject|3|||
19367023|NCT01673282|41607101|FG000|Overall Study|Other|1|||
19367024|NCT01673282|41607102|FG001|Overall Study|Other|6|||
19367025|NCT04157751|41607110|FG000|Overall Study|Withdrawal by Subject|12|||
19367026|NCT04157751|41607111|FG001|Overall Study|Withdrawal by Subject|17|||
19367027|NCT04157751|41607110|FG000|Overall Study|Lost to Follow-up|6|||
19367028|NCT04157751|41607111|FG001|Overall Study|Lost to Follow-up|2|||
19367029|NCT04157751|41607110|FG000|Overall Study|Adverse Event|34|||
19367030|NCT04157751|41607111|FG001|Overall Study|Adverse Event|23|||
19367031|NCT04157751|41607110|FG000|Overall Study|Not treated|1|||
19367032|NCT04157751|41607111|FG001|Overall Study|Not treated|5|||
19367033|NCT04157751|41607110|FG000|Overall Study|Other reason not stated above|10|||
19367034|NCT04157751|41607111|FG001|Overall Study|Other reason not stated above|10|||
19367035|NCT01673126|41607119|FG000|Overall Study|change of diagnosis|4|||
19367036|NCT01673126|41607120|FG001|Overall Study|change of diagnosis|3|||
19367037|NCT02407054|41607129|FG000|Overall Study|Adverse Event|1|||
19367038|NCT02407054|41607130|FG001|Overall Study|Adverse Event|4|||
19367039|NCT02407054|41607131|FG002|Overall Study|Adverse Event|1|||
19367040|NCT02407054|41607129|FG000|Overall Study|Non-compliance with Study|0|||
19367041|NCT02407054|41607130|FG001|Overall Study|Non-compliance with Study|2|||
19367042|NCT02407054|41607131|FG002|Overall Study|Non-compliance with Study|1|||
19367043|NCT02407054|41607129|FG000|Overall Study|Physician Decision|1|||
19367044|NCT02407054|41607130|FG001|Overall Study|Physician Decision|3|||
19367045|NCT02407054|41607131|FG002|Overall Study|Physician Decision|3|||
19367046|NCT02407054|41607129|FG000|Overall Study|Withdrawal by Subject|5|||
19367047|NCT02407054|41607130|FG001|Overall Study|Withdrawal by Subject|9|||
19367048|NCT02407054|41607131|FG002|Overall Study|Withdrawal by Subject|2|||
19367049|NCT01652716|41607142|FG000|Overall Study|Loss of glucose control|1|||
19367050|NCT01652716|41607143|FG001|Overall Study|Loss of glucose control|0|||
19367051|NCT01652716|41607142|FG000|Overall Study|Administrative|0|||
19367052|NCT01652716|41607143|FG001|Overall Study|Administrative|2|||
19367053|NCT01652716|41607142|FG000|Overall Study|Investigator decision|1|||
19367054|NCT01652716|41607143|FG001|Overall Study|Investigator decision|4|||
19691986|NCT00518687|42137727|FG001|Overall Study|Withdrawal by Subject|110|||
19691987|NCT00134056|42137735|FG000|Randomization|Not eligible for assigned treatment|22|||
19691988|NCT00134056|42137736|FG001|Randomization|Not eligible for assigned treatment|20|||
19691989|NCT00134056|42137735|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
19691990|NCT00134056|42137736|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
19691991|NCT00134056|42137735|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
19691992|NCT00134056|42137736|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
19691993|NCT00134056|42137735|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
19691994|NCT00134056|42137736|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
19691995|NCT00134056|42137735|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
19691996|NCT00134056|42137736|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
19691997|NCT00518531|42137747|FG000|Treatment Period 1|Adverse Event|5|||
19691998|NCT00518531|42137748|FG001|Treatment Period 1|Adverse Event|0|||
19691999|NCT00518531|42137747|FG000|Treatment Period 1|Lost to Follow-up|5|||
19692000|NCT00518531|42137748|FG001|Treatment Period 1|Lost to Follow-up|3|||
19692001|NCT00518531|42137747|FG000|Treatment Period 1|Physician Decision|1|||
19774275|NCT03136367|42228782|FG000|T4 12 Weeks After Surgery|Death|0|||
19774276|NCT03136367|42228783|FG001|T4 12 Weeks After Surgery|Death|1|||
19367055|NCT01652716|41607142|FG000|Overall Study|Lost to Follow-up|12|||
19367056|NCT01652716|41607143|FG001|Overall Study|Lost to Follow-up|11|||
19367057|NCT01652716|41607142|FG000|Overall Study|Protocol Violation|2|||
19367058|NCT01652716|41607143|FG001|Overall Study|Protocol Violation|1|||
19367059|NCT01652716|41607142|FG000|Overall Study|Adverse Event|7|||
19367060|NCT01652716|41607143|FG001|Overall Study|Adverse Event|10|||
19774277|NCT03136367|42228784|FG002|T4 12 Weeks After Surgery|Death|3|||
19774278|NCT03136367|42228782|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
19774279|NCT03136367|42228783|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
19774280|NCT03136367|42228784|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
19774281|NCT03136367|42228782|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
19774282|NCT03136367|42228783|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
19774283|NCT03136367|42228784|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
19774284|NCT03136367|42228782|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
19774285|NCT03136367|42228783|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
19774286|NCT03136367|42228784|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
19774287|NCT03136367|42228782|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
19774288|NCT03136367|42228783|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
19774289|NCT03136367|42228784|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
19774290|NCT03136367|42228782|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
19774291|NCT03136367|42228783|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
19774292|NCT03136367|42228784|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
19774293|NCT03136367|42228782|FG000|T5 1 Year After Surgery|Death|0|||
19774294|NCT03136367|42228783|FG001|T5 1 Year After Surgery|Death|0|||
19774295|NCT03136367|42228784|FG002|T5 1 Year After Surgery|Death|1|||
19774296|NCT03136367|42228782|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
19774297|NCT03136367|42228783|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
19774298|NCT03136367|42228784|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
19774299|NCT03136367|42228782|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
19774300|NCT03136367|42228783|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
19367061|NCT01652716|41607142|FG000|Overall Study|Withdrawal by Subject|33|||
19367062|NCT01652716|41607143|FG001|Overall Study|Withdrawal by Subject|18|||
19367063|NCT02790073|41607149|FG000|Overall Study|Death|1|||
19367064|NCT02790073|41607149|FG000|Overall Study|Withdrawal from HD|1|||
19367065|NCT02790073|41607149|FG000|Overall Study|Withdrawal by Subject|1|||
19367066|NCT02789137|41607153|FG000|Overall Study|Dropped out/Died|58|||
19367067|NCT01672970|41607158|FG000|Overall Study|Lack of Efficacy|12|||
19367068|NCT01672970|41607158|FG000|Overall Study|Adverse Event|18|||
19367069|NCT01672970|41607158|FG000|Overall Study|Withdrawal by Subject|2|||
19367070|NCT01672970|41607158|FG000|Overall Study|Lost to Follow-up|5|||
19367071|NCT01672970|41607158|FG000|Overall Study|Other|9|||
19367072|NCT01672970|41607158|FG000|Overall Study|Enrolled but not treated|1|||
19367073|NCT02788747|41607182|FG000|Overall Study|Adverse Event|1|||
19367074|NCT02788747|41607183|FG001|Overall Study|Adverse Event|0|||
19367075|NCT02788747|41607184|FG002|Overall Study|Adverse Event|0|||
19367076|NCT02406742|41607198|FG000|Overall Study|Progression of Disease|5|||
19367077|NCT02406742|41607199|FG001|Overall Study|Progression of Disease|1|||
19389155|NCT02084056|41632764|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
19606659|NCT00723190|42055339|FG000|Overall Study|Lost to Follow-up|37|||
19606660|NCT00723190|42055339|FG000|Overall Study|Adverse Event|18|||
19606661|NCT00723190|42055339|FG000|Overall Study|Lack of Efficacy|16|||
19606662|NCT00723190|42055339|FG000|Overall Study|Protocol Violation|15|||
19606663|NCT00723190|42055339|FG000|Overall Study|Other-Premature Discontinuation|9|||
19606664|NCT00723190|42055339|FG000|Overall Study|Other-Not included in safety population|2|||
19606665|NCT00722800|42055345|FG000|Overall Study|Withdrawal by Subject|1|||
19606666|NCT00722800|42055346|FG001|Overall Study|Withdrawal by Subject|0|||
19606667|NCT00722800|42055345|FG000|Overall Study|Physician Decision|1|||
19606668|NCT00722800|42055346|FG001|Overall Study|Physician Decision|0|||
19606669|NCT00718042|42055358|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
19606670|NCT00718042|42055359|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
19606671|NCT00718042|42055360|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
19606672|NCT00718042|42055361|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
19606673|NCT00718042|42055362|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
19606674|NCT00718042|42055363|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
19606675|NCT00718042|42055358|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
19606676|NCT00718042|42055359|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
19367078|NCT02406742|41607200|FG002|Overall Study|Progression of Disease|6|||
19367079|NCT02406742|41607198|FG000|Overall Study|Adverse Event|3|||
19367080|NCT02406742|41607199|FG001|Overall Study|Adverse Event|0|||
19367081|NCT02406742|41607200|FG002|Overall Study|Adverse Event|2|||
19367082|NCT02406742|41607198|FG000|Overall Study|Death|1|||
19367083|NCT02406742|41607199|FG001|Overall Study|Death|0|||
19367084|NCT02406742|41607200|FG002|Overall Study|Death|0|||
19389156|NCT02084056|41632765|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19367085|NCT02406742|41607198|FG000|Overall Study|Lack of Efficacy|0|||
19367086|NCT02406742|41607199|FG001|Overall Study|Lack of Efficacy|0|||
19367087|NCT02406742|41607200|FG002|Overall Study|Lack of Efficacy|1|||
19367088|NCT02406742|41607198|FG000|Overall Study|Withdrawal by Participant|1|||
19367089|NCT02406742|41607199|FG001|Overall Study|Withdrawal by Participant|2|||
19367090|NCT02406742|41607200|FG002|Overall Study|Withdrawal by Participant|0|||
19367091|NCT02406742|41607198|FG000|Overall Study|Physician Decision|1|||
19367092|NCT02406742|41607199|FG001|Overall Study|Physician Decision|2|||
19367093|NCT02406742|41607200|FG002|Overall Study|Physician Decision|1|||
19367094|NCT02406742|41607198|FG000|Overall Study|Transition to other treatment|2|||
19367095|NCT02406742|41607199|FG001|Overall Study|Transition to other treatment|0|||
19367096|NCT02406742|41607200|FG002|Overall Study|Transition to other treatment|1|||
19367097|NCT02406742|41607198|FG000|Overall Study|Other Reasons|1|||
19367098|NCT02406742|41607199|FG001|Overall Study|Other Reasons|11|||
19367099|NCT02406742|41607200|FG002|Overall Study|Other Reasons|5|||
19367100|NCT02714595|41607210|FG000|Overall Study|Lost to Follow-up|1|||
19367101|NCT02714595|41607211|FG001|Overall Study|Lost to Follow-up|0|||
19367102|NCT02714595|41607210|FG000|Overall Study|Withdrawal by Subject|1|||
19367103|NCT02714595|41607211|FG001|Overall Study|Withdrawal by Subject|2|||
19367104|NCT02714595|41607210|FG000|Overall Study|Lack of Efficacy|0|||
19367105|NCT02714595|41607211|FG001|Overall Study|Lack of Efficacy|1|||
19367106|NCT02714595|41607210|FG000|Overall Study|Death|30|||
19367107|NCT02714595|41607211|FG001|Overall Study|Death|9|||
19367108|NCT02714595|41607210|FG000|Overall Study|Other-Miscellaneous|0|||
19367109|NCT02714595|41607211|FG001|Overall Study|Other-Miscellaneous|1|||
19367110|NCT02437162|41607238|FG000|Overall Study|Protocol Violation|0|||
19367111|NCT02437162|41607239|FG001|Overall Study|Protocol Violation|1|||
19367112|NCT02437162|41607240|FG002|Overall Study|Protocol Violation|0|||
19367113|NCT02437162|41607238|FG000|Overall Study|Randomized but not treated|0|||
19367114|NCT02437162|41607239|FG001|Overall Study|Randomized but not treated|0|||
19367115|NCT02437162|41607240|FG002|Overall Study|Randomized but not treated|1|||
19367116|NCT02437162|41607238|FG000|Overall Study|Study discontinued by Sponsor|93|||
19367117|NCT02437162|41607239|FG001|Overall Study|Study discontinued by Sponsor|98|||
19367118|NCT02437162|41607240|FG002|Overall Study|Study discontinued by Sponsor|97|||
19367119|NCT02437162|41607238|FG000|Overall Study|Withdrawal by Subject|13|||
19367120|NCT02437162|41607239|FG001|Overall Study|Withdrawal by Subject|7|||
19367121|NCT02437162|41607240|FG002|Overall Study|Withdrawal by Subject|9|||
19367122|NCT02437162|41607238|FG000|Overall Study|Adverse Event|0|||
19367123|NCT02437162|41607239|FG001|Overall Study|Adverse Event|1|||
19367124|NCT02437162|41607240|FG002|Overall Study|Adverse Event|0|||
19367125|NCT02437162|41607238|FG000|Overall Study|Lost to Follow-up|1|||
19367126|NCT02437162|41607239|FG001|Overall Study|Lost to Follow-up|0|||
19367127|NCT02437162|41607240|FG002|Overall Study|Lost to Follow-up|1|||
19367128|NCT02437162|41607238|FG000|Overall Study|Death|0|||
19367129|NCT02437162|41607239|FG001|Overall Study|Death|1|||
19367130|NCT02437162|41607240|FG002|Overall Study|Death|0|||
19367131|NCT02437162|41607238|FG000|Overall Study|Other|0|||
19367132|NCT02437162|41607239|FG001|Overall Study|Other|0|||
19367133|NCT02437162|41607240|FG002|Overall Study|Other|1|||
19367134|NCT01368211|41607255|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
19367135|NCT01368211|41607256|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
19367136|NCT02437084|41607262|FG000|Overall Study|Withdrawal by Subject|2|||
19367137|NCT02437084|41607262|FG000|Overall Study|Physician Decision|1|||
19367138|NCT02406586|41607269|FG000|Overall Study|Lost to Follow-up|0|||
19367139|NCT02406586|41607270|FG001|Overall Study|Lost to Follow-up|4|||
19367140|NCT02406586|41607271|FG002|Overall Study|Lost to Follow-up|2|||
19367141|NCT02406586|41607269|FG000|Overall Study|Withdrawal by Subject|1|||
19367142|NCT02406586|41607270|FG001|Overall Study|Withdrawal by Subject|0|||
19367143|NCT02406586|41607271|FG002|Overall Study|Withdrawal by Subject|0|||
19367144|NCT02460562|41607284|FG000|Overall Study|Lost to Follow-up|15|||
19367145|NCT02460562|41607285|FG001|Overall Study|Lost to Follow-up|16|||
19692002|NCT00518531|42137748|FG001|Treatment Period 1|Physician Decision|0|||
19692003|NCT00518531|42137747|FG000|Treatment Period 1|Protocol Violation|2|||
19692004|NCT00518531|42137748|FG001|Treatment Period 1|Protocol Violation|0|||
19692005|NCT00518531|42137747|FG000|Treatment Period 1|Withdrawal by Subject|4|||
19692006|NCT00518531|42137748|FG001|Treatment Period 1|Withdrawal by Subject|6|||
19692007|NCT00518531|42137747|FG000|Treatment Period 1|Early crossover|1|||
19692008|NCT00518531|42137748|FG001|Treatment Period 1|Early crossover|3|||
19692009|NCT00518531|42137747|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19692010|NCT00518531|42137748|FG001|Treatment Period 2|Withdrawal by Subject|8|||
19692011|NCT00518531|42137747|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
19692012|NCT00518531|42137748|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
19367146|NCT02788357|41607293|FG000|Overall Study|Lost to Follow-up|3|||
19692013|NCT00518531|42137747|FG000|Treatment Period 2|Adverse Event|1|||
19367147|NCT02788357|41607294|FG001|Overall Study|Lost to Follow-up|0|||
19367148|NCT02457910|41607306|FG000|Overall Study|Withdrawal by Subject|0|||
19367149|NCT02457910|41607307|FG001|Overall Study|Withdrawal by Subject|0|||
19367150|NCT02457910|41607308|FG002|Overall Study|Withdrawal by Subject|0|||
19367151|NCT02457910|41607309|FG003|Overall Study|Withdrawal by Subject|0|||
19367152|NCT02457910|41607310|FG004|Overall Study|Withdrawal by Subject|0|||
19367153|NCT02457910|41607311|FG005|Overall Study|Withdrawal by Subject|1|||
19367154|NCT02457910|41607306|FG000|Overall Study|Adverse Event|0|||
19367155|NCT02457910|41607307|FG001|Overall Study|Adverse Event|2|||
19367156|NCT02457910|41607308|FG002|Overall Study|Adverse Event|1|||
19367157|NCT02457910|41607309|FG003|Overall Study|Adverse Event|1|||
19367158|NCT02457910|41607310|FG004|Overall Study|Adverse Event|1|||
19367159|NCT02457910|41607311|FG005|Overall Study|Adverse Event|3|||
19367160|NCT02457910|41607306|FG000|Overall Study|Disease progression|3|||
19367161|NCT02457910|41607307|FG001|Overall Study|Disease progression|3|||
19367162|NCT02457910|41607308|FG002|Overall Study|Disease progression|1|||
19367163|NCT02457910|41607309|FG003|Overall Study|Disease progression|1|||
19367164|NCT02457910|41607310|FG004|Overall Study|Disease progression|4|||
19367165|NCT02457910|41607311|FG005|Overall Study|Disease progression|6|||
19367166|NCT02457910|41607306|FG000|Overall Study|Other complicating illness|0|||
19367167|NCT02457910|41607307|FG001|Overall Study|Other complicating illness|0|||
19367168|NCT02457910|41607308|FG002|Overall Study|Other complicating illness|0|||
19367169|NCT02457910|41607309|FG003|Overall Study|Other complicating illness|0|||
19367170|NCT02457910|41607310|FG004|Overall Study|Other complicating illness|0|||
19367171|NCT02457910|41607311|FG005|Overall Study|Other complicating illness|1|||
19367172|NCT02457910|41607306|FG000|Overall Study|Death|0|||
19367173|NCT02457910|41607307|FG001|Overall Study|Death|0|||
19367174|NCT02457910|41607308|FG002|Overall Study|Death|1|||
19367175|NCT02457910|41607309|FG003|Overall Study|Death|0|||
19367176|NCT02457910|41607310|FG004|Overall Study|Death|0|||
19367177|NCT02457910|41607311|FG005|Overall Study|Death|0|||
19367178|NCT02405962|41607330|FG000|Overall Study|Lost to Follow-up|1|||
19367179|NCT02405962|41607331|FG001|Overall Study|Lost to Follow-up|4|||
19367180|NCT02405962|41607330|FG000|Overall Study|A participant has moved to another place|0|||
19367181|NCT02405962|41607331|FG001|Overall Study|A participant has moved to another place|1|||
19367182|NCT02436304|41607340|FG000|Overall Study|Lost to Follow-up|0|||
19367183|NCT02436304|41607341|FG001|Overall Study|Lost to Follow-up|1|||
19774301|NCT03136367|42228784|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
19367184|NCT02436304|41607342|FG002|Overall Study|Lost to Follow-up|0|||
19367185|NCT02436304|41607340|FG000|Overall Study|Withdrawal by Subject|0|||
19774302|NCT03136367|42228782|FG000|T5 1 Year After Surgery|study ended before due|31|||
19774303|NCT03136367|42228783|FG001|T5 1 Year After Surgery|study ended before due|103|||
19774304|NCT03136367|42228784|FG002|T5 1 Year After Surgery|study ended before due|110|||
19774305|NCT03136367|42228782|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
19774306|NCT03136367|42228783|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
19774307|NCT03136367|42228784|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
19367186|NCT02436304|41607341|FG001|Overall Study|Withdrawal by Subject|1|||
19774308|NCT03124381|42228797|FG000|Overall Study|Lost to Follow-up|1|||
19774309|NCT03124381|42228798|FG001|Overall Study|Lost to Follow-up|1|||
19774310|NCT03124381|42228797|FG000|Overall Study|Withdrawal by Subject|6|||
19774311|NCT03124381|42228798|FG001|Overall Study|Withdrawal by Subject|3|||
19774312|NCT03124381|42228797|FG000|Overall Study|Protocol Violation|0|||
19774313|NCT03124381|42228798|FG001|Overall Study|Protocol Violation|1|||
19774314|NCT03124381|42228797|FG000|Overall Study|Adverse Event|1|||
19774315|NCT03124381|42228798|FG001|Overall Study|Adverse Event|1|||
19774316|NCT03124381|42228797|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
19774317|NCT03124381|42228798|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
19774318|NCT02576574|42228807|FG000|Overall Study|still ongoing|65|||
19774319|NCT02576574|42228808|FG001|Overall Study|still ongoing|66|||
19774320|NCT02576574|42228809|FG002|Overall Study|still ongoing|73|||
19774321|NCT02576574|42228807|FG000|Overall Study|Randomized, not treated|5|||
19774322|NCT02576574|42228808|FG001|Overall Study|Randomized, not treated|4|||
19774323|NCT02576574|42228809|FG002|Overall Study|Randomized, not treated|26|||
19774324|NCT03133793|42228823|FG000|Overall Study|Withdrawal by Subject|0|||
19692014|NCT00518531|42137748|FG001|Treatment Period 2|Adverse Event|7|||
19692015|NCT00518531|42137747|FG000|Treatment Period 2|Protocol-specified criteria|0|||
19774325|NCT03133793|42228824|FG001|Overall Study|Withdrawal by Subject|4|||
19774326|NCT03133793|42228825|FG002|Overall Study|Withdrawal by Subject|2|||
19774327|NCT03133793|42228826|FG003|Overall Study|Withdrawal by Subject|4|||
19692016|NCT00518531|42137748|FG001|Treatment Period 2|Protocol-specified criteria|1|||
19692017|NCT00518531|42137747|FG000|Treatment Period 2|Non-compliance|1|||
19692018|NCT00518531|42137748|FG001|Treatment Period 2|Non-compliance|2|||
19367187|NCT02436304|41607342|FG002|Overall Study|Withdrawal by Subject|0|||
19692019|NCT00351468|42137756|FG000|Overall Study|Adverse Event|42|||
19692020|NCT00351468|42137756|FG000|Overall Study|Withdrawal by Subject|39|||
19774328|NCT03133793|42228823|FG000|Overall Study|Lost to Follow-up|1|||
19774329|NCT03133793|42228824|FG001|Overall Study|Lost to Follow-up|0|||
19367188|NCT02436304|41607340|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
19367189|NCT02436304|41607341|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
19692021|NCT00351468|42137756|FG000|Overall Study|Various -follow up w clinical team|39|||
19367190|NCT02436304|41607342|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
19367191|NCT02402218|41607354|FG000|Overall Study|Did not pickup study medication|12|||
19367192|NCT02402218|41607355|FG001|Overall Study|Did not pickup study medication|9|||
19774330|NCT03133793|42228825|FG002|Overall Study|Lost to Follow-up|2|||
19774331|NCT03133793|42228826|FG003|Overall Study|Lost to Follow-up|0|||
19774332|NCT03133793|42228823|FG000|Overall Study|Death|0|||
19774333|NCT03133793|42228824|FG001|Overall Study|Death|0|||
19774334|NCT03133793|42228825|FG002|Overall Study|Death|0|||
19774335|NCT03133793|42228826|FG003|Overall Study|Death|1|||
19774336|NCT02747238|42228842|FG000|Overall Study|Lack of Efficacy|0|||
19367193|NCT02402218|41607356|FG002|Overall Study|Did not pickup study medication|13|||
19367194|NCT02402218|41607354|FG000|Overall Study|Lack of Efficacy|0|||
19774337|NCT02747238|42228843|FG001|Overall Study|Lack of Efficacy|1|||
19774338|NCT02747238|42228842|FG000|Overall Study|Data lost|3|||
19774339|NCT02747238|42228843|FG001|Overall Study|Data lost|5|||
19774340|NCT03133481|42228851|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
19774341|NCT03133481|42228852|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
19774342|NCT02864316|42228860|FG000|Overall Study|Progressive Disease|2|||
19774343|NCT02864316|42228861|FG001|Overall Study|Progressive Disease|1|||
19774344|NCT02864316|42228860|FG000|Overall Study|Adverse Event|0|||
19774345|NCT02864316|42228861|FG001|Overall Study|Adverse Event|1|||
19774346|NCT02862600|42228867|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
19774347|NCT02862600|42228867|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
19774348|NCT02862600|42228867|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
19774349|NCT02862600|42228867|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
19774350|NCT02864082|42228875|FG000|Overall Study|Adverse Event|1|||
19774351|NCT02864082|42228876|FG001|Overall Study|Adverse Event|1|||
19774352|NCT02864082|42228875|FG000|Overall Study|Lost to Follow-up|0|||
19774353|NCT02864082|42228876|FG001|Overall Study|Lost to Follow-up|1|||
19774354|NCT02864082|42228875|FG000|Overall Study|Withdrawal by Subject|2|||
19774355|NCT02864082|42228876|FG001|Overall Study|Withdrawal by Subject|2|||
19774356|NCT02792192|42228900|FG000|Overall Study|Death|1|||
19774357|NCT02792192|42228901|FG001|Overall Study|Death|0|||
19774358|NCT02792192|42228902|FG002|Overall Study|Death|0|||
19774359|NCT02792192|42228903|FG003|Overall Study|Death|0|||
19367195|NCT02402218|41607355|FG001|Overall Study|Lack of Efficacy|1|||
19692022|NCT00351468|42137756|FG000|Overall Study|Lack of Efficacy|32|||
19774360|NCT02792192|42228900|FG000|Overall Study|Informed Consent Withdrawn|4|||
19774361|NCT02792192|42228901|FG001|Overall Study|Informed Consent Withdrawn|0|||
19774362|NCT02792192|42228902|FG002|Overall Study|Informed Consent Withdrawn|0|||
19774363|NCT02792192|42228903|FG003|Overall Study|Informed Consent Withdrawn|0|||
19774364|NCT02792192|42228900|FG000|Overall Study|Physician Decision|1|||
19774365|NCT02792192|42228901|FG001|Overall Study|Physician Decision|0|||
19774366|NCT02792192|42228902|FG002|Overall Study|Physician Decision|0|||
19774367|NCT02792192|42228903|FG003|Overall Study|Physician Decision|0|||
19774368|NCT02792192|42228900|FG000|Overall Study|Progressive Disease|0|||
19774369|NCT02792192|42228901|FG001|Overall Study|Progressive Disease|1|||
19774370|NCT02792192|42228902|FG002|Overall Study|Progressive Disease|0|||
19774371|NCT02792192|42228903|FG003|Overall Study|Progressive Disease|0|||
19774372|NCT02792192|42228900|FG000|Overall Study|Study Terminated By Sponsor|6|||
19774373|NCT02792192|42228901|FG001|Overall Study|Study Terminated By Sponsor|10|||
19774374|NCT02792192|42228902|FG002|Overall Study|Study Terminated By Sponsor|0|||
19774375|NCT02792192|42228903|FG003|Overall Study|Study Terminated By Sponsor|0|||
19367196|NCT02402218|41607356|FG002|Overall Study|Lack of Efficacy|1|||
19692023|NCT00351468|42137756|FG000|Overall Study|Non-compliance|8|||
19692024|NCT00351468|42137756|FG000|Overall Study|Lost to Follow-up|4|||
19692025|NCT00351468|42137756|FG000|Overall Study|Protocol Violation|3|||
19692026|NCT00523991|42137763|FG000|Overall Study|Adverse Event|6|||
19692027|NCT00523991|42137764|FG001|Overall Study|Adverse Event|5|||
19692028|NCT00523991|42137763|FG000|Overall Study|Protocol Violation|1|||
19692029|NCT00523991|42137764|FG001|Overall Study|Protocol Violation|4|||
19692030|NCT00523991|42137763|FG000|Overall Study|Lost to Follow-up|4|||
19692031|NCT00523991|42137764|FG001|Overall Study|Lost to Follow-up|1|||
19692032|NCT00523991|42137763|FG000|Overall Study|Withdrawal by Subject|7|||
19692033|NCT00523991|42137764|FG001|Overall Study|Withdrawal by Subject|17|||
19692034|NCT00523991|42137763|FG000|Overall Study|Other reason (not specified)|3|||
19692035|NCT00523991|42137764|FG001|Overall Study|Other reason (not specified)|0|||
19692036|NCT00350844|42137770|FG000|Overall Study|Lost to Follow-up|1|||
19774376|NCT02964507|42228922|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
19774377|NCT02964507|42228923|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
19774378|NCT02964507|42228924|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
19774379|NCT02964507|42228925|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
19692037|NCT00345540|42137774|FG000|Overall Study|Withdrawal by Subject|1|||
19692038|NCT00335322|42137781|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
19774380|NCT02964507|42228926|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
19774381|NCT02964507|42228927|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
19774382|NCT02964507|42228928|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
19774383|NCT02964507|42228929|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
19774384|NCT02964507|42228922|FG000|Overall Study|Ongoing at the time of analysis|1|||
19774385|NCT02964507|42228923|FG001|Overall Study|Ongoing at the time of analysis|0|||
19774386|NCT02964507|42228924|FG002|Overall Study|Ongoing at the time of analysis|2|||
19774387|NCT02964507|42228925|FG003|Overall Study|Ongoing at the time of analysis|0|||
19774388|NCT02964507|42228926|FG004|Overall Study|Ongoing at the time of analysis|0|||
19774389|NCT02964507|42228927|FG005|Overall Study|Ongoing at the time of analysis|0|||
19774390|NCT02964507|42228928|FG006|Overall Study|Ongoing at the time of analysis|0|||
19774391|NCT02964507|42228929|FG007|Overall Study|Ongoing at the time of analysis|0|||
19774392|NCT02964507|42228922|FG000|Overall Study|Study terminated by Sponsor|9|||
19774393|NCT02964507|42228923|FG001|Overall Study|Study terminated by Sponsor|1|||
19774394|NCT02964507|42228924|FG002|Overall Study|Study terminated by Sponsor|9|||
19774395|NCT02964507|42228925|FG003|Overall Study|Study terminated by Sponsor|3|||
19774396|NCT02964507|42228926|FG004|Overall Study|Study terminated by Sponsor|3|||
19774397|NCT02964507|42228927|FG005|Overall Study|Study terminated by Sponsor|2|||
19774398|NCT02964507|42228928|FG006|Overall Study|Study terminated by Sponsor|0|||
19774399|NCT02964507|42228929|FG007|Overall Study|Study terminated by Sponsor|0|||
19774400|NCT02964507|42228922|FG000|Overall Study|Other|3|||
19774401|NCT02964507|42228923|FG001|Overall Study|Other|0|||
19774402|NCT02964507|42228924|FG002|Overall Study|Other|0|||
19774403|NCT02964507|42228925|FG003|Overall Study|Other|0|||
19774404|NCT02964507|42228926|FG004|Overall Study|Other|1|||
19774405|NCT02964507|42228927|FG005|Overall Study|Other|0|||
19774406|NCT02964507|42228928|FG006|Overall Study|Other|0|||
19774407|NCT02964507|42228929|FG007|Overall Study|Other|0|||
19367197|NCT02402218|41607354|FG000|Overall Study|Death|1|||
19367198|NCT02402218|41607355|FG001|Overall Study|Death|0|||
19367199|NCT02402218|41607356|FG002|Overall Study|Death|0|||
19367200|NCT02402218|41607354|FG000|Overall Study|Reinfection|0|||
19367201|NCT02402218|41607355|FG001|Overall Study|Reinfection|0|||
19367202|NCT02402218|41607356|FG002|Overall Study|Reinfection|1|||
19367203|NCT02402218|41607354|FG000|Overall Study|Adverse Event|0|||
19367204|NCT02402218|41607355|FG001|Overall Study|Adverse Event|2|||
19367205|NCT02402218|41607356|FG002|Overall Study|Adverse Event|1|||
19389157|NCT02084056|41632766|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19606677|NCT00718042|42055360|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
19606678|NCT00718042|42055361|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
19606679|NCT00718042|42055362|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
19606680|NCT00718042|42055363|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
19606681|NCT00718042|42055358|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
19606682|NCT00718042|42055359|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
19606683|NCT00718042|42055360|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
19606684|NCT00718042|42055361|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
19606685|NCT00718042|42055362|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
19606686|NCT00718042|42055363|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
19606687|NCT00718042|42055358|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
19606688|NCT00718042|42055359|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
19606689|NCT00718042|42055360|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
19606690|NCT00718042|42055361|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
19606691|NCT00718042|42055362|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
19606692|NCT00718042|42055363|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
19606693|NCT00718042|42055358|FG000|Donor Follow-up|Lost to Follow-up|13|||
19692039|NCT00335322|42137782|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
19692040|NCT00335322|42137783|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
19692041|NCT00523367|42137794|FG000|Overall Study|19 screen failures|19|||
19692042|NCT00523367|42137794|FG000|Overall Study|4 Withdrawn by PI|4|||
19692043|NCT03755765|42137801|FG000|Overall Study|Withdrawal by Subject|2|||
19692044|NCT03755765|42137802|FG001|Overall Study|Withdrawal by Subject|4|||
19692045|NCT03755765|42137803|FG002|Overall Study|Withdrawal by Subject|4|||
19692046|NCT00344448|42137811|FG000|Screening|Withdrawal by Subject|0|||
19692047|NCT00344448|42137812|FG001|Screening|Withdrawal by Subject|1|||
19692048|NCT00344448|42137811|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
19692049|NCT00344448|42137812|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
19692050|NCT00344448|42137811|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
19692051|NCT00344448|42137812|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
19692052|NCT00344448|42137811|FG000|Open Label|Withdrawal by Subject|1|||
19692053|NCT00344448|42137812|FG001|Open Label|Withdrawal by Subject|1|||
19692054|NCT00344448|42137811|FG000|Open Label|Study terminated|1|||
19692055|NCT00344448|42137812|FG001|Open Label|Study terminated|0|||
19774408|NCT02964507|42228922|FG000|Overall Study|Death|11|||
19774409|NCT02964507|42228923|FG001|Overall Study|Death|9|||
19774410|NCT02964507|42228924|FG002|Overall Study|Death|12|||
19774411|NCT02964507|42228925|FG003|Overall Study|Death|2|||
19774412|NCT02964507|42228926|FG004|Overall Study|Death|10|||
19367206|NCT02402218|41607354|FG000|Overall Study|Withdrawal by Subject|1|||
19367207|NCT02402218|41607355|FG001|Overall Study|Withdrawal by Subject|1|||
19367208|NCT02402218|41607356|FG002|Overall Study|Withdrawal by Subject|1|||
19367209|NCT02457520|41607364|FG000|Active Treatment Phase|Adverse Event|10|||
19367210|NCT02457520|41607364|FG000|Active Treatment Phase|Lost to Follow-up|8|||
19367211|NCT02457520|41607364|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
19367212|NCT02457520|41607364|FG000|Active Treatment Phase|other|4|||
19367213|NCT02457520|41607364|FG000|Active Treatment Phase|Physician Decision|1|||
19367214|NCT02457520|41607364|FG000|Active Treatment Phase|Protocol Violation|1|||
19367215|NCT02457520|41607364|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
19367216|NCT02457520|41607364|FG000|Post-treatment Period|Other: Retreatment Required|7|||
19367217|NCT02457520|41607364|FG000|Post-treatment Period|Lost to Follow-up|23|||
19367218|NCT02457520|41607364|FG000|Post-treatment Period|Other|3|||
19367219|NCT02457520|41607364|FG000|Post-treatment Period|Physician Decision|1|||
19367220|NCT02457520|41607364|FG000|Post-treatment Period|Withdrawal by Subject|14|||
19367221|NCT02788279|41607397|FG000|Overall Study|Death|62|||
19367222|NCT02788279|41607398|FG001|Overall Study|Death|136|||
19367223|NCT02788279|41607399|FG002|Overall Study|Death|72|||
19367224|NCT02788279|41607397|FG000|Overall Study|Withdrawal by Subject|10|||
19367225|NCT02788279|41607398|FG001|Overall Study|Withdrawal by Subject|15|||
19774413|NCT02964507|42228927|FG005|Overall Study|Death|5|||
19774414|NCT02964507|42228928|FG006|Overall Study|Death|0|||
19774415|NCT02964507|42228929|FG007|Overall Study|Death|0|||
19774416|NCT02964507|42228922|FG000|Overall Study|Withdrawal by Subject|1|||
19774417|NCT02964507|42228923|FG001|Overall Study|Withdrawal by Subject|0|||
19774418|NCT02964507|42228924|FG002|Overall Study|Withdrawal by Subject|1|||
19774419|NCT02964507|42228925|FG003|Overall Study|Withdrawal by Subject|1|||
19774420|NCT02964507|42228926|FG004|Overall Study|Withdrawal by Subject|0|||
19774421|NCT02964507|42228927|FG005|Overall Study|Withdrawal by Subject|1|||
19367226|NCT02788279|41607399|FG002|Overall Study|Withdrawal by Subject|5|||
19367227|NCT02788279|41607397|FG000|Overall Study|Lost to Follow-up|0|||
19367228|NCT02788279|41607398|FG001|Overall Study|Lost to Follow-up|3|||
19367229|NCT02788279|41607399|FG002|Overall Study|Lost to Follow-up|2|||
19367230|NCT02788279|41607397|FG000|Overall Study|Sponsor decision|18|||
19367231|NCT02788279|41607398|FG001|Overall Study|Sponsor decision|29|||
19367232|NCT02788279|41607399|FG002|Overall Study|Sponsor decision|11|||
19774422|NCT02964507|42228928|FG006|Overall Study|Withdrawal by Subject|0|||
19774423|NCT02964507|42228929|FG007|Overall Study|Withdrawal by Subject|0|||
19692056|NCT00324168|42137820|FG000|Overall Study|Lost to Follow-up|19|||
19692057|NCT00324168|42137821|FG001|Overall Study|Lost to Follow-up|18|||
19692058|NCT00324168|42137820|FG000|Overall Study|Death|3|||
19692059|NCT00324168|42137821|FG001|Overall Study|Death|3|||
19692060|NCT00324168|42137820|FG000|Overall Study|Patient did not visit in f/u window|6|||
19692061|NCT00324168|42137821|FG001|Overall Study|Patient did not visit in f/u window|9|||
19774424|NCT02964507|42228922|FG000|Overall Study|Physician Decision|1|||
19774425|NCT02964507|42228923|FG001|Overall Study|Physician Decision|0|||
19774426|NCT02964507|42228924|FG002|Overall Study|Physician Decision|1|||
19774427|NCT02964507|42228925|FG003|Overall Study|Physician Decision|0|||
19774428|NCT02964507|42228926|FG004|Overall Study|Physician Decision|1|||
19774429|NCT02964507|42228927|FG005|Overall Study|Physician Decision|0|||
19774430|NCT02964507|42228928|FG006|Overall Study|Physician Decision|0|||
19774431|NCT02964507|42228929|FG007|Overall Study|Physician Decision|0|||
19774432|NCT03170869|42228948|FG000|Overall Study|Protocol Violation|5|||
19774433|NCT03170869|42228948|FG000|Overall Study|Early study termination|3|||
19774434|NCT02440464|42228955|FG000|Overall Study|Withdrawal by Subject|3|||
19774435|NCT02440464|42228956|FG001|Overall Study|Withdrawal by Subject|2|||
19774436|NCT03103321|42228967|FG000|Overall Study|Protocol Violation|1|||
19774437|NCT03103321|42228968|FG001|Overall Study|Protocol Violation|1|||
19774438|NCT03103321|42228969|FG002|Overall Study|Protocol Violation|1|||
19774439|NCT03103321|42228970|FG003|Overall Study|Protocol Violation|0|||
19774440|NCT03131453|42228983|FG000|Overall Study|Study terminated by Sponsor|424|||
19774441|NCT03131453|42228984|FG001|Overall Study|Study terminated by Sponsor|222|||
19774442|NCT03131453|42228985|FG002|Overall Study|Study terminated by Sponsor|438|||
19606694|NCT00718042|42055359|FG001|Donor Follow-up|Lost to Follow-up|0|||
19774443|NCT03131453|42228983|FG000|Overall Study|Withdrawal by Subject|18|||
19367233|NCT02435992|41607415|FG000|Overall Study|non compliance with protocol|2|||
19367234|NCT02435992|41607416|FG001|Overall Study|non compliance with protocol|0|||
19367235|NCT02435992|41607417|FG002|Overall Study|non compliance with protocol|1|||
19367236|NCT02435992|41607418|FG003|Overall Study|non compliance with protocol|0|||
19692062|NCT00517829|42137829|FG000|Overall Study|Adverse Event|22|||
19692063|NCT00517829|42137830|FG001|Overall Study|Adverse Event|34|||
19774444|NCT03131453|42228984|FG001|Overall Study|Withdrawal by Subject|7|||
19367237|NCT02435992|41607419|FG004|Overall Study|non compliance with protocol|0|||
19606695|NCT00718042|42055360|FG002|Donor Follow-up|Lost to Follow-up|0|||
19606696|NCT00718042|42055361|FG003|Donor Follow-up|Lost to Follow-up|0|||
19606697|NCT00718042|42055362|FG004|Donor Follow-up|Lost to Follow-up|19|||
19606698|NCT00718042|42055363|FG005|Donor Follow-up|Lost to Follow-up|0|||
19606699|NCT00741598|42055377|FG000|Overall Study|Lost to Follow-up|3|||
19606700|NCT00741598|42055378|FG001|Overall Study|Lost to Follow-up|4|||
19606701|NCT00741598|42055377|FG000|Overall Study|Lack of Efficacy|1|||
19774445|NCT03131453|42228985|FG002|Overall Study|Withdrawal by Subject|13|||
19774446|NCT03131453|42228983|FG000|Overall Study|Adverse Event|10|||
19774447|NCT03131453|42228984|FG001|Overall Study|Adverse Event|3|||
19774448|NCT03131453|42228985|FG002|Overall Study|Adverse Event|3|||
19774449|NCT03131453|42228983|FG000|Overall Study|Lost to Follow-up|1|||
19774450|NCT03131453|42228984|FG001|Overall Study|Lost to Follow-up|0|||
19774451|NCT03131453|42228985|FG002|Overall Study|Lost to Follow-up|1|||
19774452|NCT03131453|42228983|FG000|Overall Study|Physician Decision|1|||
19774453|NCT03131453|42228984|FG001|Overall Study|Physician Decision|0|||
19774454|NCT03131453|42228985|FG002|Overall Study|Physician Decision|1|||
19774455|NCT03131453|42228983|FG000|Overall Study|Non-compliance with study treatment|1|||
19774456|NCT03131453|42228984|FG001|Overall Study|Non-compliance with study treatment|0|||
19774457|NCT03131453|42228985|FG002|Overall Study|Non-compliance with study treatment|0|||
19774458|NCT03131453|42228983|FG000|Overall Study|Technical problems|1|||
19774459|NCT03131453|42228984|FG001|Overall Study|Technical problems|0|||
19367238|NCT02435992|41607415|FG000|Overall Study|Adverse Event|11|||
19774460|NCT03131453|42228985|FG002|Overall Study|Technical problems|0|||
19774461|NCT03131453|42228983|FG000|Overall Study|Protocol deviation|0|||
19774462|NCT03131453|42228984|FG001|Overall Study|Protocol deviation|1|||
19774463|NCT03131453|42228985|FG002|Overall Study|Protocol deviation|0|||
19774464|NCT02942277|42229013|FG000|Year 1|Withdrawal by Subject|0|||
19774465|NCT02942277|42229014|FG001|Year 1|Withdrawal by Subject|0|||
19774466|NCT02942277|42229015|FG002|Year 1|Withdrawal by Subject|0|||
19774467|NCT02942277|42229016|FG003|Year 1|Withdrawal by Subject|0|||
19692064|NCT00517829|42137829|FG000|Overall Study|Disease Progression|39|||
19692065|NCT00517829|42137830|FG001|Overall Study|Disease Progression|32|||
19774468|NCT02942277|42229017|FG004|Year 1|Withdrawal by Subject|1|||
19774469|NCT02942277|42229018|FG005|Year 1|Withdrawal by Subject|3|||
19774470|NCT02942277|42229019|FG006|Year 1|Withdrawal by Subject|0|||
19774471|NCT02942277|42229020|FG007|Year 1|Withdrawal by Subject|1|||
19774472|NCT02942277|42229021|FG008|Year 1|Withdrawal by Subject|0|||
19774473|NCT02942277|42229022|FG009|Year 1|Withdrawal by Subject|0|||
19774474|NCT02942277|42229023|FG010|Year 1|Withdrawal by Subject|3|||
19774475|NCT02942277|42229013|FG000|Year 1|Travel|0|||
19774476|NCT02942277|42229014|FG001|Year 1|Travel|1|||
19774477|NCT02942277|42229015|FG002|Year 1|Travel|0|||
19774478|NCT02942277|42229016|FG003|Year 1|Travel|0|||
19774479|NCT02942277|42229017|FG004|Year 1|Travel|4|||
19774480|NCT02942277|42229018|FG005|Year 1|Travel|5|||
19774481|NCT02942277|42229019|FG006|Year 1|Travel|0|||
19774482|NCT02942277|42229020|FG007|Year 1|Travel|0|||
19774483|NCT02942277|42229021|FG008|Year 1|Travel|0|||
19774484|NCT02942277|42229022|FG009|Year 1|Travel|0|||
19774485|NCT02942277|42229023|FG010|Year 1|Travel|8|||
19774486|NCT02942277|42229013|FG000|Year 1|Joined Army|0|||
19774487|NCT02942277|42229014|FG001|Year 1|Joined Army|1|||
19774488|NCT02942277|42229015|FG002|Year 1|Joined Army|0|||
19774489|NCT02942277|42229016|FG003|Year 1|Joined Army|0|||
19774490|NCT02942277|42229017|FG004|Year 1|Joined Army|0|||
19774491|NCT02942277|42229018|FG005|Year 1|Joined Army|0|||
19774492|NCT02942277|42229019|FG006|Year 1|Joined Army|0|||
19774493|NCT02942277|42229020|FG007|Year 1|Joined Army|0|||
19774494|NCT02942277|42229021|FG008|Year 1|Joined Army|0|||
19774495|NCT02942277|42229022|FG009|Year 1|Joined Army|0|||
19774496|NCT02942277|42229023|FG010|Year 1|Joined Army|0|||
19774497|NCT02942277|42229013|FG000|Year 1|Subject met withdrawal criteria|0|||
19774498|NCT02942277|42229014|FG001|Year 1|Subject met withdrawal criteria|0|||
19774499|NCT02942277|42229015|FG002|Year 1|Subject met withdrawal criteria|0|||
19774500|NCT02942277|42229016|FG003|Year 1|Subject met withdrawal criteria|1|||
19774501|NCT02942277|42229017|FG004|Year 1|Subject met withdrawal criteria|0|||
19774502|NCT02942277|42229018|FG005|Year 1|Subject met withdrawal criteria|0|||
19774503|NCT02942277|42229019|FG006|Year 1|Subject met withdrawal criteria|0|||
19774504|NCT02942277|42229020|FG007|Year 1|Subject met withdrawal criteria|0|||
19692066|NCT00517829|42137829|FG000|Overall Study|Patient Request|6|||
19692067|NCT00517829|42137830|FG001|Overall Study|Patient Request|5|||
19692068|NCT00517829|42137829|FG000|Overall Study|Investigator Request|5|||
19692069|NCT00517829|42137830|FG001|Overall Study|Investigator Request|3|||
19774505|NCT02942277|42229021|FG008|Year 1|Subject met withdrawal criteria|0|||
19774506|NCT02942277|42229022|FG009|Year 1|Subject met withdrawal criteria|0|||
19774507|NCT02942277|42229023|FG010|Year 1|Subject met withdrawal criteria|0|||
19774508|NCT02942277|42229013|FG000|Year 1|Lost to Follow-up|0|||
19774509|NCT02942277|42229014|FG001|Year 1|Lost to Follow-up|0|||
19692070|NCT00517829|42137829|FG000|Overall Study|Other|3|||
19692071|NCT00517829|42137830|FG001|Overall Study|Other|1|||
19774510|NCT02942277|42229015|FG002|Year 1|Lost to Follow-up|0|||
19692072|NCT00343512|42137836|FG000|Overall Study|Withdrawal by Subject|2|||
19692073|NCT00334542|42137841|FG000|Overall Study|Adverse Event|3|||
19692074|NCT00334542|42137841|FG000|Overall Study|Withdrawal by Subject|1|||
19774511|NCT02942277|42229016|FG003|Year 1|Lost to Follow-up|0|||
19774512|NCT02942277|42229017|FG004|Year 1|Lost to Follow-up|1|||
19774513|NCT02942277|42229018|FG005|Year 1|Lost to Follow-up|0|||
19774514|NCT02942277|42229019|FG006|Year 1|Lost to Follow-up|0|||
19774515|NCT02942277|42229020|FG007|Year 1|Lost to Follow-up|0|||
19774516|NCT02942277|42229021|FG008|Year 1|Lost to Follow-up|0|||
19774517|NCT02942277|42229022|FG009|Year 1|Lost to Follow-up|0|||
19774518|NCT02942277|42229023|FG010|Year 1|Lost to Follow-up|2|||
19774519|NCT02942277|42229013|FG000|Year 1|Protocol Violation|0|||
19774520|NCT02942277|42229014|FG001|Year 1|Protocol Violation|0|||
19774521|NCT02942277|42229015|FG002|Year 1|Protocol Violation|0|||
19774522|NCT02942277|42229016|FG003|Year 1|Protocol Violation|0|||
19774523|NCT02942277|42229017|FG004|Year 1|Protocol Violation|1|||
19774524|NCT02942277|42229018|FG005|Year 1|Protocol Violation|1|||
19774525|NCT02942277|42229019|FG006|Year 1|Protocol Violation|0|||
19774526|NCT02942277|42229020|FG007|Year 1|Protocol Violation|0|||
19692075|NCT00334542|42137841|FG000|Overall Study|New cancer diagnosis|1|||
19692076|NCT00112294|42137848|FG000|Overall Study|Still on study|5|||
19692077|NCT00112294|42137849|FG001|Overall Study|Still on study|0|||
19692078|NCT00235443|42137861|FG000|Overall Study|Adverse Event|4|||
19692079|NCT00235443|42137862|FG001|Overall Study|Adverse Event|12|||
19692080|NCT00235443|42137863|FG002|Overall Study|Adverse Event|17|||
19692081|NCT00235443|42137864|FG003|Overall Study|Adverse Event|44|||
19692082|NCT00235443|42137865|FG004|Overall Study|Adverse Event|10|||
19692083|NCT00235443|42137866|FG005|Overall Study|Adverse Event|15|||
19692084|NCT00235443|42137861|FG000|Overall Study|Lack of Efficacy|0|||
19692085|NCT00235443|42137862|FG001|Overall Study|Lack of Efficacy|1|||
19692086|NCT00235443|42137863|FG002|Overall Study|Lack of Efficacy|5|||
19692087|NCT00235443|42137864|FG003|Overall Study|Lack of Efficacy|12|||
19692088|NCT00235443|42137865|FG004|Overall Study|Lack of Efficacy|2|||
19692089|NCT00235443|42137866|FG005|Overall Study|Lack of Efficacy|9|||
19692090|NCT00235443|42137861|FG000|Overall Study|Withdrawal by Subject|3|||
19692091|NCT00235443|42137862|FG001|Overall Study|Withdrawal by Subject|9|||
19692092|NCT00235443|42137863|FG002|Overall Study|Withdrawal by Subject|25|||
19692093|NCT00235443|42137864|FG003|Overall Study|Withdrawal by Subject|24|||
19692094|NCT00235443|42137865|FG004|Overall Study|Withdrawal by Subject|10|||
19692095|NCT00235443|42137866|FG005|Overall Study|Withdrawal by Subject|12|||
19692096|NCT00235443|42137861|FG000|Overall Study|Lost to Follow-up|0|||
19692097|NCT00235443|42137862|FG001|Overall Study|Lost to Follow-up|8|||
19692098|NCT00235443|42137863|FG002|Overall Study|Lost to Follow-up|6|||
19692099|NCT00235443|42137864|FG003|Overall Study|Lost to Follow-up|6|||
19692100|NCT00235443|42137865|FG004|Overall Study|Lost to Follow-up|4|||
19692101|NCT00235443|42137866|FG005|Overall Study|Lost to Follow-up|3|||
19692102|NCT00235443|42137861|FG000|Overall Study|Unsatisfactory compliance|0|||
19692103|NCT00235443|42137862|FG001|Overall Study|Unsatisfactory compliance|2|||
19692104|NCT00235443|42137863|FG002|Overall Study|Unsatisfactory compliance|3|||
19692105|NCT00235443|42137864|FG003|Overall Study|Unsatisfactory compliance|4|||
19692106|NCT00235443|42137865|FG004|Overall Study|Unsatisfactory compliance|1|||
19692107|NCT00235443|42137866|FG005|Overall Study|Unsatisfactory compliance|0|||
19692108|NCT00235443|42137861|FG000|Overall Study|Other reasons for premature termination|1|||
19692109|NCT00235443|42137862|FG001|Overall Study|Other reasons for premature termination|6|||
19692110|NCT00235443|42137863|FG002|Overall Study|Other reasons for premature termination|6|||
19692111|NCT00235443|42137864|FG003|Overall Study|Other reasons for premature termination|7|||
19692112|NCT00235443|42137865|FG004|Overall Study|Other reasons for premature termination|3|||
19692113|NCT00235443|42137866|FG005|Overall Study|Other reasons for premature termination|6|||
19692114|NCT00234039|42137882|FG000|Overall Study|Adverse Event|2|||
19692115|NCT00234039|42137882|FG000|Overall Study|Progression/relapse|34|||
19692116|NCT00234039|42137882|FG000|Overall Study|Other - Not Protocol Specified|3|||
19692117|NCT00234039|42137882|FG000|Overall Study|Ineligible|9|||
19692118|NCT00234039|42137882|FG000|Overall Study|No Protocol Treatment Received|2|||
19692119|NCT00323622|42137894|FG000|Overall Study|Other|30|||
19692120|NCT00323622|42137895|FG001|Overall Study|Other|91|||
19692121|NCT00323622|42137896|FG002|Overall Study|Other|4|||
19692122|NCT00323622|42137897|FG003|Overall Study|Other|12|||
19692123|NCT00323622|42137898|FG004|Overall Study|Other|32|||
19692124|NCT00323622|42137899|FG005|Overall Study|Other|74|||
19692125|NCT00323622|42137900|FG006|Overall Study|Other|5|||
19692126|NCT00323622|42137901|FG007|Overall Study|Other|13|||
19692127|NCT00323622|42137894|FG000|Overall Study|Death|1|||
19692128|NCT00323622|42137895|FG001|Overall Study|Death|1|||
19692129|NCT00323622|42137896|FG002|Overall Study|Death|0|||
19692130|NCT00323622|42137897|FG003|Overall Study|Death|0|||
19692131|NCT00323622|42137898|FG004|Overall Study|Death|7|||
19692132|NCT00323622|42137899|FG005|Overall Study|Death|0|||
19692133|NCT00323622|42137900|FG006|Overall Study|Death|0|||
19692134|NCT00323622|42137901|FG007|Overall Study|Death|2|||
19774527|NCT02942277|42229021|FG008|Year 1|Protocol Violation|0|||
19692135|NCT00189423|42137929|FG000|Overall Study|Death|746|||
19692136|NCT00189423|42137930|FG001|Overall Study|Death|747|||
19692137|NCT00189423|42137929|FG000|Overall Study|Withdrawal by Subject|9|||
19692138|NCT00189423|42137930|FG001|Overall Study|Withdrawal by Subject|9|||
19692139|NCT00189423|42137929|FG000|Overall Study|Lost to Follow-up|10|||
19692140|NCT00189423|42137930|FG001|Overall Study|Lost to Follow-up|10|||
19774528|NCT02942277|42229022|FG009|Year 1|Protocol Violation|0|||
19774529|NCT02942277|42229023|FG010|Year 1|Protocol Violation|2|||
19774530|NCT02942277|42229013|FG000|Year 1|Pregnancy|0|||
19692141|NCT00323310|42137936|FG000|Overall Study|Withdrawal by Subject|1|||
19692142|NCT00323310|42137936|FG000|Overall Study|a parent refused blood draw|1|||
19692143|NCT00323310|42137936|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
19692144|NCT00186537|42137943|FG000|Overall Study|Withdrawal by Subject|4|||
19692145|NCT00186537|42137944|FG001|Overall Study|Withdrawal by Subject|0|||
19692146|NCT00186537|42137945|FG002|Overall Study|Withdrawal by Subject|3|||
19692147|NCT00186537|42137943|FG000|Overall Study|ALT > 1.5 x ULN|3|||
19692148|NCT00186537|42137944|FG001|Overall Study|ALT > 1.5 x ULN|0|||
19692149|NCT00186537|42137945|FG002|Overall Study|ALT > 1.5 x ULN|0|||
19692150|NCT00517751|42137953|FG000|Overall Study|Death|3|||
19692151|NCT00517751|42137953|FG000|Overall Study|Withdrawal by Subject|37|||
19692152|NCT00517751|42137953|FG000|Overall Study|Lost to Follow-up|4|||
19692153|NCT00517751|42137953|FG000|Overall Study|patient not over due|6|||
19692154|NCT00517751|42137953|FG000|Overall Study|Patient not due for visit|76|||
19692155|NCT00517751|42137953|FG000|Overall Study|Missing|3|||
19692156|NCT00322842|42137959|FG000|Overall Study|Withdrawal by Subject|0|||
19692157|NCT00322842|42137960|FG001|Overall Study|Withdrawal by Subject|1|||
19692158|NCT00322842|42137959|FG000|Overall Study|Lost to Follow-up|0|||
19692159|NCT00322842|42137960|FG001|Overall Study|Lost to Follow-up|1|||
19692160|NCT00322842|42137959|FG000|Overall Study|Refused transplant|1|||
19692161|NCT00322842|42137960|FG001|Overall Study|Refused transplant|0|||
19692162|NCT00322842|42137959|FG000|Overall Study|Death|1|||
19692163|NCT00322842|42137960|FG001|Overall Study|Death|0|||
19692164|NCT00255723|42137969|FG000|Overall Study|Adverse Event|1|||
19692165|NCT00255723|42137970|FG001|Overall Study|Adverse Event|1|||
19692166|NCT00255723|42137969|FG000|Overall Study|Death|0|||
19692167|NCT00255723|42137970|FG001|Overall Study|Death|1|||
19692168|NCT00255723|42137969|FG000|Overall Study|Response Data Not Available|1|||
19692169|NCT00255723|42137970|FG001|Overall Study|Response Data Not Available|0|||
19692170|NCT00132808|42137979|FG000|Stratum I|Adverse Event|2|||
19692171|NCT00132808|42137980|FG001|Stratum I|Adverse Event|1|||
19692172|NCT00132808|42137981|FG002|Stratum I|Adverse Event|0|||
19692173|NCT00132808|42137979|FG000|Stratum I|Lost to Follow-up|3|||
19692174|NCT00132808|42137980|FG001|Stratum I|Lost to Follow-up|4|||
19692175|NCT00132808|42137981|FG002|Stratum I|Lost to Follow-up|1|||
19692176|NCT00132808|42137979|FG000|Stratum I|Withdrawal by Subject|4|||
19692177|NCT00132808|42137980|FG001|Stratum I|Withdrawal by Subject|7|||
19692178|NCT00132808|42137981|FG002|Stratum I|Withdrawal by Subject|3|||
19692179|NCT00132808|42137979|FG000|Stratum I|Abnormal test procedure result (s)|0|||
19692180|NCT00132808|42137980|FG001|Stratum I|Abnormal test procedure result (s)|0|||
19692181|NCT00132808|42137981|FG002|Stratum I|Abnormal test procedure result (s)|1|||
19692182|NCT00132808|42137979|FG000|Stratum II|Adverse Event|1|||
19692183|NCT00132808|42137980|FG001|Stratum II|Adverse Event|2|||
19692184|NCT00132808|42137981|FG002|Stratum II|Adverse Event|1|||
19774531|NCT02942277|42229014|FG001|Year 1|Pregnancy|0|||
19774532|NCT02942277|42229015|FG002|Year 1|Pregnancy|0|||
19774533|NCT02942277|42229016|FG003|Year 1|Pregnancy|0|||
19774534|NCT02942277|42229017|FG004|Year 1|Pregnancy|0|||
19774535|NCT02942277|42229018|FG005|Year 1|Pregnancy|1|||
19774536|NCT02942277|42229019|FG006|Year 1|Pregnancy|0|||
19774537|NCT02942277|42229020|FG007|Year 1|Pregnancy|0|||
19774538|NCT02942277|42229021|FG008|Year 1|Pregnancy|0|||
19774539|NCT02942277|42229022|FG009|Year 1|Pregnancy|0|||
19774540|NCT02942277|42229023|FG010|Year 1|Pregnancy|0|||
19774541|NCT02942277|42229013|FG000|Year 2|Lost to Follow-up|0|||
19774542|NCT02942277|42229014|FG001|Year 2|Lost to Follow-up|0|||
19774543|NCT02942277|42229015|FG002|Year 2|Lost to Follow-up|0|||
19774544|NCT02942277|42229016|FG003|Year 2|Lost to Follow-up|0|||
19774545|NCT02942277|42229017|FG004|Year 2|Lost to Follow-up|2|||
19774546|NCT02942277|42229018|FG005|Year 2|Lost to Follow-up|1|||
19774547|NCT02942277|42229019|FG006|Year 2|Lost to Follow-up|0|||
19774548|NCT02942277|42229020|FG007|Year 2|Lost to Follow-up|0|||
19774549|NCT02942277|42229021|FG008|Year 2|Lost to Follow-up|0|||
19367239|NCT02435992|41607416|FG001|Overall Study|Adverse Event|6|||
19692185|NCT00132808|42137979|FG000|Stratum II|Death|1|||
19692186|NCT00132808|42137980|FG001|Stratum II|Death|0|||
19692187|NCT00132808|42137981|FG002|Stratum II|Death|0|||
19692188|NCT00132808|42137979|FG000|Stratum II|Lost to Follow-up|2|||
19692189|NCT00132808|42137980|FG001|Stratum II|Lost to Follow-up|2|||
19692190|NCT00132808|42137981|FG002|Stratum II|Lost to Follow-up|1|||
19692191|NCT00132808|42137979|FG000|Stratum II|Protocol Violation|0|||
19692192|NCT00132808|42137980|FG001|Stratum II|Protocol Violation|2|||
19692193|NCT00132808|42137981|FG002|Stratum II|Protocol Violation|1|||
19692194|NCT00132808|42137979|FG000|Stratum II|Withdrawal by Subject|4|||
19692195|NCT00132808|42137980|FG001|Stratum II|Withdrawal by Subject|9|||
19692196|NCT00132808|42137981|FG002|Stratum II|Withdrawal by Subject|6|||
19692197|NCT00517361|42137989|FG000|Overall Study|Death|6|||
19692198|NCT00517361|42137989|FG000|Overall Study|The study was terminated|5|||
19774550|NCT02942277|42229022|FG009|Year 2|Lost to Follow-up|0|||
19774551|NCT02942277|42229023|FG010|Year 2|Lost to Follow-up|0|||
19774552|NCT02942277|42229013|FG000|Year 2|Did not rescreen|0|||
19774553|NCT02942277|42229014|FG001|Year 2|Did not rescreen|0|||
19774554|NCT02942277|42229015|FG002|Year 2|Did not rescreen|1|||
19774555|NCT02942277|42229016|FG003|Year 2|Did not rescreen|1|||
19774556|NCT02942277|42229017|FG004|Year 2|Did not rescreen|9|||
19774557|NCT02942277|42229018|FG005|Year 2|Did not rescreen|6|||
19774558|NCT02942277|42229019|FG006|Year 2|Did not rescreen|0|||
19774559|NCT02942277|42229020|FG007|Year 2|Did not rescreen|1|||
19774560|NCT02942277|42229021|FG008|Year 2|Did not rescreen|0|||
19774561|NCT02942277|42229022|FG009|Year 2|Did not rescreen|0|||
19774562|NCT02942277|42229023|FG010|Year 2|Did not rescreen|21|||
19774563|NCT02942277|42229013|FG000|Year 2|Met withdrawal criteria|0|||
19774564|NCT02942277|42229014|FG001|Year 2|Met withdrawal criteria|0|||
19774565|NCT02942277|42229015|FG002|Year 2|Met withdrawal criteria|0|||
19774566|NCT02942277|42229016|FG003|Year 2|Met withdrawal criteria|0|||
19774567|NCT02942277|42229017|FG004|Year 2|Met withdrawal criteria|1|||
19774568|NCT02942277|42229018|FG005|Year 2|Met withdrawal criteria|2|||
19774569|NCT02942277|42229019|FG006|Year 2|Met withdrawal criteria|0|||
19774570|NCT02942277|42229020|FG007|Year 2|Met withdrawal criteria|0|||
19774571|NCT02942277|42229021|FG008|Year 2|Met withdrawal criteria|0|||
19774572|NCT02942277|42229022|FG009|Year 2|Met withdrawal criteria|0|||
19774573|NCT02942277|42229023|FG010|Year 2|Met withdrawal criteria|1|||
19774574|NCT02942277|42229013|FG000|Year 2|Travel|0|||
19692199|NCT00516893|42137993|FG000|Overall Study|Lost to Follow-up|4|||
19692200|NCT00516893|42137993|FG000|Overall Study|Adverse Event|3|||
19692201|NCT00516893|42137993|FG000|Overall Study|Withdrawal by Subject|2|||
19692202|NCT00516893|42137993|FG000|Overall Study|Noncompliance|2|||
19692203|NCT00516893|42137993|FG000|Overall Study|Death|1|||
19692204|NCT00516893|42137993|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
19692205|NCT00516893|42137993|FG000|Overall Study|Relocated|1|||
19692206|NCT00516893|42137993|FG000|Overall Study|Pregnancy|1|||
19774575|NCT02942277|42229014|FG001|Year 2|Travel|1|||
19774576|NCT02942277|42229015|FG002|Year 2|Travel|0|||
19774577|NCT02942277|42229016|FG003|Year 2|Travel|0|||
19774578|NCT02942277|42229017|FG004|Year 2|Travel|0|||
19774579|NCT02942277|42229018|FG005|Year 2|Travel|1|||
19774580|NCT02942277|42229019|FG006|Year 2|Travel|0|||
19774581|NCT02942277|42229020|FG007|Year 2|Travel|0|||
19774582|NCT02942277|42229021|FG008|Year 2|Travel|0|||
19774583|NCT02942277|42229022|FG009|Year 2|Travel|1|||
19774584|NCT02942277|42229023|FG010|Year 2|Travel|3|||
19774585|NCT02942277|42229013|FG000|Year 2|Non-compliant|0|||
19774586|NCT02942277|42229014|FG001|Year 2|Non-compliant|0|||
19774587|NCT02942277|42229015|FG002|Year 2|Non-compliant|0|||
19774588|NCT02942277|42229016|FG003|Year 2|Non-compliant|0|||
19774589|NCT02942277|42229017|FG004|Year 2|Non-compliant|1|||
19774590|NCT02942277|42229018|FG005|Year 2|Non-compliant|1|||
19774591|NCT02942277|42229019|FG006|Year 2|Non-compliant|0|||
19774592|NCT02942277|42229020|FG007|Year 2|Non-compliant|0|||
19774593|NCT02942277|42229021|FG008|Year 2|Non-compliant|0|||
19774594|NCT02942277|42229022|FG009|Year 2|Non-compliant|0|||
19774595|NCT02942277|42229023|FG010|Year 2|Non-compliant|0|||
19774596|NCT02942277|42229013|FG000|Year 2|Withdrawal by Subject|0|||
19774597|NCT02942277|42229014|FG001|Year 2|Withdrawal by Subject|0|||
19774598|NCT02942277|42229015|FG002|Year 2|Withdrawal by Subject|0|||
19774599|NCT02942277|42229016|FG003|Year 2|Withdrawal by Subject|0|||
19774600|NCT02942277|42229017|FG004|Year 2|Withdrawal by Subject|0|||
19774601|NCT02942277|42229018|FG005|Year 2|Withdrawal by Subject|0|||
19774602|NCT02942277|42229019|FG006|Year 2|Withdrawal by Subject|1|||
19774603|NCT02942277|42229020|FG007|Year 2|Withdrawal by Subject|0|||
19774604|NCT02942277|42229021|FG008|Year 2|Withdrawal by Subject|0|||
19774605|NCT02942277|42229022|FG009|Year 2|Withdrawal by Subject|0|||
19774606|NCT02942277|42229023|FG010|Year 2|Withdrawal by Subject|0|||
19774607|NCT03131219|42229052|FG000|Initial Evaluation Period|Adverse Event|1|||
19774608|NCT03131219|42229053|FG001|Initial Evaluation Period|Adverse Event|0|||
19774609|NCT03131219|42229052|FG000|Initial Evaluation Period|Protocol Violation|1|||
19774610|NCT03131219|42229053|FG001|Initial Evaluation Period|Protocol Violation|0|||
19774611|NCT03131219|42229052|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
19774612|NCT03131219|42229053|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
19692207|NCT00516893|42137993|FG000|Overall Study|Received Medication From Another Study|1|||
19692208|NCT00522431|42137997|FG000|Overall Study|Adverse Event|5|||
19774613|NCT02859324|42229083|FG000|Overall Study|Death|4|||
19774614|NCT02859324|42229084|FG001|Overall Study|Death|6|||
19774615|NCT02859324|42229085|FG002|Overall Study|Death|5|||
19774616|NCT02859324|42229083|FG000|Overall Study|Other reasons|3|||
19774617|NCT02859324|42229084|FG001|Overall Study|Other reasons|3|||
19774618|NCT02859324|42229085|FG002|Overall Study|Other reasons|0|||
19774619|NCT02143063|42229096|FG000|Overall Study|Lost to Follow-up|16|||
19774620|NCT02143063|42229097|FG001|Overall Study|Lost to Follow-up|28|||
19774621|NCT02143063|42229098|FG002|Overall Study|Lost to Follow-up|29|||
19774622|NCT02143063|42229096|FG000|Overall Study|Withdrawal by Subject|0|||
19774623|NCT02143063|42229097|FG001|Overall Study|Withdrawal by Subject|1|||
19367240|NCT02435992|41607417|FG002|Overall Study|Adverse Event|12|||
19774624|NCT02143063|42229098|FG002|Overall Study|Withdrawal by Subject|0|||
19774625|NCT02143063|42229096|FG000|Overall Study|Death|0|||
19774626|NCT02143063|42229097|FG001|Overall Study|Death|1|||
19774627|NCT02143063|42229098|FG002|Overall Study|Death|1|||
19774628|NCT02859246|42229106|FG000|Overall Study|Screen fails|3|||
19774629|NCT02859246|42229106|FG000|Overall Study|Adverse Event|1|||
19774630|NCT02859246|42229106|FG000|Overall Study|Withdrawal by Subject|1|||
19774631|NCT01083433|42229129|FG000|Overall Study|Lost to Follow-up|2|||
19774632|NCT01083433|42229130|FG001|Overall Study|Lost to Follow-up|1|||
19774633|NCT01083433|42229131|FG002|Overall Study|Lost to Follow-up|1|||
19774634|NCT01083433|42229129|FG000|Overall Study|Withdrawal by Subject|0|||
19774635|NCT01083433|42229130|FG001|Overall Study|Withdrawal by Subject|5|||
19692209|NCT00522431|42137997|FG000|Overall Study|Protocol Violation|2|||
19692210|NCT00522431|42137997|FG000|Overall Study|Withdrawal by Subject|2|||
19692211|NCT00522431|42137997|FG000|Overall Study|Subject non-compliance|1|||
19692212|NCT00522431|42137997|FG000|Overall Study|Other/unknown|1|||
19692213|NCT00185211|42138003|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
19692214|NCT00185211|42138004|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
19692215|NCT00185211|42138003|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
19692216|NCT00185211|42138004|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
19692217|NCT00185211|42138003|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
19692218|NCT00185211|42138004|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
19692219|NCT00185211|42138003|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
19774636|NCT01083433|42229131|FG002|Overall Study|Withdrawal by Subject|3|||
19774637|NCT01083433|42229129|FG000|Overall Study|Pregnancy|0|||
19774638|NCT01083433|42229130|FG001|Overall Study|Pregnancy|0|||
19774639|NCT01083433|42229131|FG002|Overall Study|Pregnancy|1|||
19774640|NCT02791490|42229145|FG000|Overall Study|Lost to Follow-up|1|||
19774641|NCT02791490|42229146|FG001|Overall Study|Lost to Follow-up|2|||
19774642|NCT02791490|42229145|FG000|Overall Study|Withdrawal by Subject|2|||
19774643|NCT02791490|42229146|FG001|Overall Study|Withdrawal by Subject|6|||
19774644|NCT02507973|42229161|FG000|Overall Study|Adverse Event|1|||
19774645|NCT02425644|42229169|FG000|Overall Study|Lost to Follow-up|2|||
19774646|NCT02425644|42229170|FG001|Overall Study|Lost to Follow-up|3|||
19774647|NCT02425644|42229169|FG000|Overall Study|Withdrawal by Subject|41|||
19774648|NCT02425644|42229170|FG001|Overall Study|Withdrawal by Subject|36|||
19774649|NCT02425644|42229169|FG000|Overall Study|Lack of Efficacy|3|||
19774650|NCT02425644|42229170|FG001|Overall Study|Lack of Efficacy|10|||
19774651|NCT02425644|42229169|FG000|Overall Study|Adverse Event|13|||
19774652|NCT02425644|42229170|FG001|Overall Study|Adverse Event|3|||
19774653|NCT02425644|42229169|FG000|Overall Study|Death|0|||
19774654|NCT02425644|42229170|FG001|Overall Study|Death|2|||
19774655|NCT02425644|42229169|FG000|Overall Study|Other|18|||
19774656|NCT02425644|42229170|FG001|Overall Study|Other|17|||
19774657|NCT02861664|42229182|FG000|Overall Study|Withdrawal of Consent|0|||
19774658|NCT02861664|42229183|FG001|Overall Study|Withdrawal of Consent|1|||
19774659|NCT01307787|42229191|FG000|Overall Study|Withdrawal by Subject|2|||
19774660|NCT01307787|42229192|FG001|Overall Study|Withdrawal by Subject|0|||
19774661|NCT03284853|42229205|FG000|Overall Study|Adverse Event|40|||
19774662|NCT03284853|42229206|FG001|Overall Study|Adverse Event|4|||
19774663|NCT03284853|42229205|FG000|Overall Study|Withdrawal by Subject|5|||
19774664|NCT03284853|42229206|FG001|Overall Study|Withdrawal by Subject|1|||
19774665|NCT03284853|42229205|FG000|Overall Study|Lost to Follow-up|1|||
19774666|NCT03284853|42229206|FG001|Overall Study|Lost to Follow-up|0|||
19774667|NCT03284853|42229205|FG000|Overall Study|Lack of Efficacy|1|||
19774668|NCT03284853|42229206|FG001|Overall Study|Lack of Efficacy|0|||
19774669|NCT03284853|42229205|FG000|Overall Study|Disallowed Concurrent Medication|1|||
19774670|NCT03284853|42229206|FG001|Overall Study|Disallowed Concurrent Medication|1|||
19774671|NCT03284853|42229205|FG000|Overall Study|Protocol Violation|3|||
19774672|NCT03284853|42229206|FG001|Overall Study|Protocol Violation|3|||
19774673|NCT03284853|42229205|FG000|Overall Study|Death|0|||
19774674|NCT03284853|42229206|FG001|Overall Study|Death|1|||
19774675|NCT03284853|42229205|FG000|Overall Study|Other - Reason not reported in CSR|4|||
19774676|NCT03284853|42229206|FG001|Overall Study|Other - Reason not reported in CSR|3|||
19774677|NCT03126019|42229214|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
19774678|NCT03126019|42229215|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
19774679|NCT03126019|42229214|FG000|Overall Study|Death|2|||
19774680|NCT03126019|42229215|FG001|Overall Study|Death|7|||
19774681|NCT03126019|42229214|FG000|Overall Study|Lost to Follow-up|2|||
19692220|NCT00185211|42138004|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
19774682|NCT03126019|42229215|FG001|Overall Study|Lost to Follow-up|3|||
19774683|NCT03126019|42229214|FG000|Overall Study|Withdrawal by Participant|1|||
19774684|NCT03126019|42229215|FG001|Overall Study|Withdrawal by Participant|3|||
19774685|NCT03126019|42229214|FG000|Overall Study|Reason not Specified|1|||
19774686|NCT03126019|42229215|FG001|Overall Study|Reason not Specified|3|||
19774687|NCT03055221|42229222|FG000|Overall Study|Adverse Event|2|||
19774688|NCT03055221|42229222|FG000|Overall Study|Withdrawal by Subject|4|||
19774689|NCT03055221|42229222|FG000|Overall Study|Death|6|||
19774690|NCT03055221|42229222|FG000|Overall Study|Physician Decision|1|||
19774691|NCT03055221|42229222|FG000|Overall Study|Study terminated by Sponsor|3|||
19774692|NCT04497415|42229248|FG000|Overall Study|Lost to Follow-up|43|||
19774693|NCT04497415|42229249|FG001|Overall Study|Lost to Follow-up|27|||
19774694|NCT03125941|42229257|FG000|Overall Study|did not receive intervention|1|||
19774695|NCT03125941|42229258|FG001|Overall Study|did not receive intervention|2|||
19774696|NCT02774889|42229266|FG000|Overall Study|Lost to Follow-up|2|||
19774697|NCT02774889|42229267|FG001|Overall Study|Lost to Follow-up|1|||
19774698|NCT03125629|42229275|FG000|Overall Study|Withdrawal by Subject|2|||
19774699|NCT03125629|42229275|FG000|Overall Study|Equipment malfunction|1|||
19774700|NCT03125395|42229287|FG000|Overall Study|Adverse Event|2|||
19774701|NCT03125395|42229287|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
19774702|NCT03125395|42229287|FG000|Overall Study|Physician Decision|2|||
19774703|NCT03125395|42229287|FG000|Overall Study|Commercial drug is available|5|||
19774704|NCT00261807|42229301|FG000|Overall Study|Lost to Follow-up|2|||
19774705|NCT00261807|42229301|FG000|Overall Study|Adverse Event|2|||
19774706|NCT00261807|42229301|FG000|Overall Study|Death|1|||
19774707|NCT00261807|42229301|FG000|Overall Study|Protocol Violation|2|||
19774708|NCT02820753|42229308|FG000|2 Month|Withdrawal by Subject|3|||
19774709|NCT02820753|42229309|FG001|2 Month|Withdrawal by Subject|3|||
19774710|NCT02820753|42229308|FG000|2 Month|Lost to Follow-up|24|||
19774711|NCT02820753|42229309|FG001|2 Month|Lost to Follow-up|26|||
19774712|NCT02820753|42229308|FG000|2 Month|Stopped per NIH Hold|51|||
19774713|NCT02820753|42229309|FG001|2 Month|Stopped per NIH Hold|13|||
19774714|NCT02820753|42229308|FG000|6 Month|Withdrawal by Subject|2|||
19774715|NCT02820753|42229309|FG001|6 Month|Withdrawal by Subject|2|||
19774716|NCT02820753|42229308|FG000|6 Month|Lost to Follow-up|20|||
19774717|NCT02820753|42229309|FG001|6 Month|Lost to Follow-up|27|||
19774718|NCT02820753|42229308|FG000|6 Month|Stopped per NIH Hold|81|||
19774719|NCT02820753|42229309|FG001|6 Month|Stopped per NIH Hold|81|||
19692221|NCT00185211|42138003|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
19692222|NCT00185211|42138004|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
19692223|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
19692224|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
19692225|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
19692226|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
19692227|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
19692228|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
19692229|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
19692230|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
19692231|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
19692232|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
19692233|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
19692234|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
19692235|NCT00185211|42138003|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
19692236|NCT00185211|42138004|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
19692237|NCT00516737|42138013|FG000|Overall Study|Lost to Follow-up|2|||
19692238|NCT00516737|42138014|FG001|Overall Study|Lost to Follow-up|0|||
19692239|NCT00516737|42138013|FG000|Overall Study|Physician Decision|0|||
19692240|NCT00516737|42138014|FG001|Overall Study|Physician Decision|1|||
19692241|NCT00516737|42138013|FG000|Overall Study|Withdrawal by Subject|0|||
19692242|NCT00516737|42138014|FG001|Overall Study|Withdrawal by Subject|1|||
19692243|NCT00516737|42138013|FG000|Overall Study|Lack of Qualifying Event|9|||
19692244|NCT00516737|42138014|FG001|Overall Study|Lack of Qualifying Event|6|||
19692245|NCT00132730|42138024|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
19692246|NCT00132730|42138025|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
19692247|NCT00132730|42138026|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
19692248|NCT00132730|42138027|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
19692249|NCT00132730|42138028|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
19692250|NCT00132730|42138029|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
19692251|NCT00132730|42138024|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
19692252|NCT00132730|42138025|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
19692253|NCT00132730|42138026|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
19692254|NCT00132730|42138027|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
19692255|NCT00132730|42138028|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
19774720|NCT02820753|42229308|FG000|6 Month|Death|0|||
19692256|NCT00132730|42138029|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
19774721|NCT02820753|42229309|FG001|6 Month|Death|1|||
19774722|NCT02861586|42229323|FG000|Overall Study|Withdrawal by Subject|1|||
19774723|NCT02861586|42229324|FG001|Overall Study|Withdrawal by Subject|2|||
19774724|NCT02861586|42229325|FG002|Overall Study|Withdrawal by Subject|0|||
19774725|NCT02861586|42229326|FG003|Overall Study|Withdrawal by Subject|0|||
19774726|NCT02861586|42229327|FG004|Overall Study|Withdrawal by Subject|0|||
19774727|NCT02861586|42229328|FG005|Overall Study|Withdrawal by Subject|1|||
19774728|NCT02861586|42229329|FG006|Overall Study|Withdrawal by Subject|1|||
19774729|NCT02861586|42229330|FG007|Overall Study|Withdrawal by Subject|0|||
19774730|NCT02861586|42229323|FG000|Overall Study|Lost to Follow-up|3|||
19774731|NCT02861586|42229324|FG001|Overall Study|Lost to Follow-up|1|||
19774732|NCT02861586|42229325|FG002|Overall Study|Lost to Follow-up|1|||
19774733|NCT02861586|42229326|FG003|Overall Study|Lost to Follow-up|0|||
19774734|NCT02861586|42229327|FG004|Overall Study|Lost to Follow-up|0|||
19774735|NCT02861586|42229328|FG005|Overall Study|Lost to Follow-up|3|||
19774736|NCT02861586|42229329|FG006|Overall Study|Lost to Follow-up|0|||
19774737|NCT02861586|42229330|FG007|Overall Study|Lost to Follow-up|0|||
19774738|NCT02861586|42229323|FG000|Overall Study|Adverse Event|0|||
19774739|NCT02861586|42229324|FG001|Overall Study|Adverse Event|0|||
19774740|NCT02861586|42229325|FG002|Overall Study|Adverse Event|0|||
19774741|NCT02861586|42229326|FG003|Overall Study|Adverse Event|0|||
19774742|NCT02861586|42229327|FG004|Overall Study|Adverse Event|0|||
19774743|NCT02861586|42229328|FG005|Overall Study|Adverse Event|1|||
19774744|NCT02861586|42229329|FG006|Overall Study|Adverse Event|0|||
19774745|NCT02861586|42229330|FG007|Overall Study|Adverse Event|0|||
19774746|NCT03120949|42229366|FG000|Overall Study|randomized in error|1|||
19774747|NCT03120949|42229367|FG001|Overall Study|randomized in error|0|||
19774748|NCT03120949|42229366|FG000|Overall Study|Death|13|||
19774749|NCT03120949|42229367|FG001|Overall Study|Death|13|||
19774750|NCT03120949|42229366|FG000|Overall Study|Lost to Follow-up|23|||
19774751|NCT03120949|42229367|FG001|Overall Study|Lost to Follow-up|13|||
19774752|NCT03120949|42229366|FG000|Overall Study|Withdrawal by Subject|139|||
19774753|NCT03120949|42229367|FG001|Overall Study|Withdrawal by Subject|124|||
19774754|NCT03120949|42229366|FG000|Overall Study|Covid-19|43|||
19774755|NCT03120949|42229367|FG001|Overall Study|Covid-19|34|||
19774756|NCT03120949|42229366|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
19774757|NCT03120949|42229367|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
19774758|NCT03120949|42229366|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
19774759|NCT03120949|42229367|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
19774760|NCT03120949|42229366|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
19774761|NCT03120949|42229367|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
19774762|NCT03120949|42229366|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
19774763|NCT03120949|42229367|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
19774764|NCT03120949|42229366|FG000|Overall Study|Site was closed|2|||
19774765|NCT03120949|42229367|FG001|Overall Study|Site was closed|3|||
19774766|NCT03120949|42229366|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
19774767|NCT03120949|42229367|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
19774768|NCT03120949|42229366|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
19774769|NCT03120949|42229367|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
19774770|NCT03120949|42229366|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
19774771|NCT03120949|42229367|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
19774772|NCT03120949|42229366|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
19774773|NCT03120949|42229367|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
19774774|NCT03120949|42229366|FG000|Overall Study|Other: Adverse Event|0|||
19774775|NCT03120949|42229367|FG001|Overall Study|Other: Adverse Event|1|||
19774776|NCT03120949|42229366|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
19774777|NCT03120949|42229367|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
19774778|NCT03120949|42229366|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
19774779|NCT03120949|42229367|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
19774780|NCT03120949|42229366|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
19774781|NCT03120949|42229367|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
19774782|NCT03120949|42229366|FG000|Overall Study|Personal Reasons|0|||
19774783|NCT03120949|42229367|FG001|Overall Study|Personal Reasons|1|||
19774784|NCT03120949|42229366|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
19774785|NCT03120949|42229367|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
19774786|NCT03120949|42229366|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
19774787|NCT03120949|42229367|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
19774788|NCT03120949|42229366|FG000|Overall Study|Compliance With Medication|0|||
19774789|NCT03120949|42229367|FG001|Overall Study|Compliance With Medication|1|||
19774790|NCT03120949|42229366|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
19774791|NCT03120949|42229367|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
19774792|NCT03120949|42229366|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
19774793|NCT03120949|42229367|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
19774794|NCT03120949|42229366|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
19774795|NCT03120949|42229367|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
19774796|NCT03124537|42229386|FG000|Overall Study|Lost to Follow-up|3|||
19774797|NCT03124537|42229387|FG001|Overall Study|Lost to Follow-up|5|||
19774798|NCT03124537|42229386|FG000|Overall Study|App Crash, Incomplete Data|7|||
19774799|NCT03124537|42229387|FG001|Overall Study|App Crash, Incomplete Data|8|||
19774800|NCT03118297|42229395|FG000|Overall Study|Lost to Follow-up|0|||
19774801|NCT03118297|42229396|FG001|Overall Study|Lost to Follow-up|2|||
19774802|NCT03117361|42229402|FG000|Overall Study|Progressive disease|5|||
19774803|NCT03117361|42229402|FG000|Overall Study|Death|1|||
19774804|NCT03117361|42229402|FG000|Overall Study|Physician Decision|2|||
19774805|NCT03117361|42229402|FG000|Overall Study|On study treatment at the end of study|1|||
19774806|NCT03117361|42229402|FG000|Overall Study|Treatment-related adverse event|1|||
19774807|NCT01368614|42229406|FG000|Screening Period|Screen Failure|58|||
19774808|NCT01368614|42229407|FG001|Screening Period|Screen Failure|0|||
19774809|NCT01368614|42229408|FG002|Screening Period|Screen Failure|0|||
19774810|NCT01368614|42229409|FG003|Screening Period|Screen Failure|0|||
19774811|NCT01368614|42229406|FG000|Study Period|Withdrawal by Subject|0|||
19774812|NCT01368614|42229407|FG001|Study Period|Withdrawal by Subject|1|||
19774813|NCT01368614|42229408|FG002|Study Period|Withdrawal by Subject|1|||
19774814|NCT01368614|42229409|FG003|Study Period|Withdrawal by Subject|3|||
19774815|NCT01368614|42229406|FG000|Study Period|Lost to Follow-up|0|||
19774816|NCT01368614|42229407|FG001|Study Period|Lost to Follow-up|0|||
19774817|NCT01368614|42229408|FG002|Study Period|Lost to Follow-up|1|||
19774818|NCT01368614|42229409|FG003|Study Period|Lost to Follow-up|0|||
19774819|NCT03053427|42229419|FG000|Overall Study|Adverse Event|4|||
19774820|NCT03053427|42229420|FG001|Overall Study|Adverse Event|4|||
19774821|NCT03053427|42229419|FG000|Overall Study|Lack of Efficacy|1|||
19774822|NCT03053427|42229420|FG001|Overall Study|Lack of Efficacy|3|||
19774823|NCT03053427|42229419|FG000|Overall Study|Lost to Follow-up|2|||
19774824|NCT03053427|42229420|FG001|Overall Study|Lost to Follow-up|2|||
19774825|NCT03053427|42229419|FG000|Overall Study|Worsening of the target disease|0|||
19774826|NCT03053427|42229420|FG001|Overall Study|Worsening of the target disease|1|||
19774827|NCT03053427|42229419|FG000|Overall Study|Protocol Deviation|3|||
19774828|NCT03053427|42229420|FG001|Overall Study|Protocol Deviation|3|||
19774829|NCT03053427|42229419|FG000|Overall Study|Withdrawal by Subject|3|||
19774830|NCT03053427|42229420|FG001|Overall Study|Withdrawal by Subject|2|||
19774831|NCT03053427|42229419|FG000|Overall Study|Miscellaneous|0|||
19774832|NCT03053427|42229420|FG001|Overall Study|Miscellaneous|1|||
19774833|NCT03052959|42229437|FG000|Overall Study|Lost to Follow-up|4|||
19774834|NCT03052959|42229438|FG001|Overall Study|Lost to Follow-up|5|||
19774835|NCT03120013|42229445|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
19774836|NCT03120013|42229446|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
19774837|NCT01845649|42229454|FG000|Overall Study|Adverse Event|7|||
19774838|NCT01845649|42229455|FG001|Overall Study|Adverse Event|10|||
19774839|NCT01845649|42229454|FG000|Overall Study|Lack of Efficacy|1|||
19774840|NCT01845649|42229455|FG001|Overall Study|Lack of Efficacy|1|||
19774841|NCT01845649|42229454|FG000|Overall Study|Lost to Follow-up|2|||
19774842|NCT01845649|42229455|FG001|Overall Study|Lost to Follow-up|2|||
19774843|NCT01845649|42229454|FG000|Overall Study|Withdrew Consent|12|||
19774844|NCT01845649|42229455|FG001|Overall Study|Withdrew Consent|4|||
19692257|NCT00132730|42138024|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
19692258|NCT00132730|42138025|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
19692259|NCT00132730|42138026|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
19692260|NCT00132730|42138027|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
19692261|NCT00132730|42138028|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
19692262|NCT00132730|42138029|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
19692263|NCT00132730|42138024|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
19692264|NCT00132730|42138025|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
19692265|NCT00132730|42138026|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
19692266|NCT00132730|42138027|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
19692267|NCT00132730|42138028|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
19692268|NCT00132730|42138029|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
19692269|NCT00132730|42138024|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
19692270|NCT00132730|42138025|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
19692271|NCT00132730|42138026|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
19692272|NCT00132730|42138027|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
19774845|NCT01845649|42229454|FG000|Overall Study|Protocol Deviation|7|||
19774846|NCT01845649|42229455|FG001|Overall Study|Protocol Deviation|4|||
19774847|NCT01845649|42229454|FG000|Overall Study|Reason not Specified|2|||
19774848|NCT01845649|42229455|FG001|Overall Study|Reason not Specified|1|||
19774849|NCT01345929|42229463|FG000|Overall Study|Withdrawal by Subject|9|||
19774850|NCT01345929|42229464|FG001|Overall Study|Withdrawal by Subject|8|||
19692273|NCT00132730|42138028|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
19692274|NCT00132730|42138029|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
19692275|NCT00132730|42138024|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
19692276|NCT00132730|42138025|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
19692277|NCT00132730|42138026|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
19692278|NCT00132730|42138027|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
19692279|NCT00132730|42138028|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
19692280|NCT00132730|42138029|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
19692281|NCT00132730|42138024|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
19692282|NCT00132730|42138025|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
19774851|NCT01345929|42229463|FG000|Overall Study|Lost to Follow-up|9|||
19774852|NCT01345929|42229464|FG001|Overall Study|Lost to Follow-up|9|||
19774853|NCT01345929|42229463|FG000|Overall Study|Adverse Event|0|||
19774854|NCT01345929|42229464|FG001|Overall Study|Adverse Event|1|||
19774855|NCT01345929|42229463|FG000|Overall Study|Didn't meet eligibility criteria|2|||
19774856|NCT01345929|42229464|FG001|Overall Study|Didn't meet eligibility criteria|0|||
19774857|NCT01345929|42229463|FG000|Overall Study|40,000 CFU/ML|1|||
19774858|NCT01345929|42229464|FG001|Overall Study|40,000 CFU/ML|0|||
19774859|NCT01345929|42229463|FG000|Overall Study|Patient withdrawal|0|||
19774860|NCT01345929|42229464|FG001|Overall Study|Patient withdrawal|1|||
19774861|NCT01343901|42229470|FG000|Overall Study|Death|85|||
19774862|NCT01343901|42229470|FG000|Overall Study|Physician Decision|4|||
19774863|NCT01343901|42229470|FG000|Overall Study|Lost to Follow-up|12|||
19774864|NCT01343901|42229470|FG000|Overall Study|Management by another medical team|11|||
19774865|NCT01343901|42229470|FG000|Overall Study|Participant decision|1|||
19774866|NCT03053271|42229474|FG000|Overall Study|Did not meet randomization criteria|3|||
19774867|NCT03053271|42229474|FG000|Overall Study|Withdrawal by Subject|1|||
19774868|NCT01343823|42229482|FG000|Overall Study|Study Terminated|1|||
19774869|NCT01343823|42229483|FG001|Overall Study|Study Terminated|0|||
19774870|NCT01343823|42229484|FG002|Overall Study|Study Terminated|0|||
19774871|NCT01343823|42229485|FG003|Overall Study|Study Terminated|1|||
19774872|NCT01343823|42229482|FG000|Overall Study|Withdrawal by Subject|1|||
19774873|NCT01343823|42229483|FG001|Overall Study|Withdrawal by Subject|0|||
19774874|NCT01343823|42229484|FG002|Overall Study|Withdrawal by Subject|0|||
19774875|NCT01343823|42229485|FG003|Overall Study|Withdrawal by Subject|0|||
19774876|NCT01318083|42229498|FG000|Overall Study|Adverse Event|4|||
19774877|NCT01318083|42229499|FG001|Overall Study|Adverse Event|1|||
19774878|NCT01318083|42229500|FG002|Overall Study|Adverse Event|2|||
19774879|NCT01318083|42229498|FG000|Overall Study|Withdrawal by Subject|1|||
19774880|NCT01318083|42229499|FG001|Overall Study|Withdrawal by Subject|0|||
19774881|NCT01318083|42229500|FG002|Overall Study|Withdrawal by Subject|2|||
19774882|NCT01318083|42229498|FG000|Overall Study|Lack of Efficacy|0|||
19774883|NCT01318083|42229499|FG001|Overall Study|Lack of Efficacy|0|||
19774884|NCT01318083|42229500|FG002|Overall Study|Lack of Efficacy|1|||
19774885|NCT01318083|42229498|FG000|Overall Study|Treatment Complications|1|||
19774886|NCT01318083|42229499|FG001|Overall Study|Treatment Complications|0|||
19774887|NCT01318083|42229500|FG002|Overall Study|Treatment Complications|0|||
19692283|NCT00132730|42138026|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
19692284|NCT00132730|42138027|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
19692285|NCT00132730|42138028|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
19692286|NCT00132730|42138029|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
19692287|NCT00132730|42138024|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
19692288|NCT00132730|42138025|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
19692289|NCT00132730|42138026|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
19692290|NCT00132730|42138027|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
19692291|NCT00132730|42138028|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
19692292|NCT00132730|42138029|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
19692293|NCT00132730|42138024|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
19692294|NCT00132730|42138025|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
19692295|NCT00132730|42138026|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
19692296|NCT00132730|42138027|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
19692297|NCT00132730|42138028|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
19774888|NCT01318083|42229498|FG000|Overall Study|Lack of Study Medication Compliance|0|||
19774889|NCT01318083|42229499|FG001|Overall Study|Lack of Study Medication Compliance|1|||
19774890|NCT01318083|42229500|FG002|Overall Study|Lack of Study Medication Compliance|0|||
19774891|NCT01376323|42229513|FG000|Overall Study|Adverse Event|1|||
19774892|NCT01376323|42229514|FG001|Overall Study|Adverse Event|0|||
19774893|NCT01376323|42229515|FG002|Overall Study|Adverse Event|0|||
19774894|NCT01376323|42229516|FG003|Overall Study|Adverse Event|2|||
19774895|NCT01376323|42229517|FG004|Overall Study|Adverse Event|0|||
19774896|NCT01376323|42229513|FG000|Overall Study|Lost to Follow-up|0|||
19774897|NCT01376323|42229514|FG001|Overall Study|Lost to Follow-up|0|||
19774898|NCT01376323|42229515|FG002|Overall Study|Lost to Follow-up|0|||
19774899|NCT01376323|42229516|FG003|Overall Study|Lost to Follow-up|2|||
19774900|NCT01376323|42229517|FG004|Overall Study|Lost to Follow-up|0|||
19774901|NCT01376323|42229513|FG000|Overall Study|Physician Decision|1|||
19774902|NCT01376323|42229514|FG001|Overall Study|Physician Decision|0|||
19692298|NCT00132730|42138029|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
19692299|NCT00132730|42138024|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
19692300|NCT00132730|42138025|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
19692301|NCT00132730|42138026|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
19692302|NCT00132730|42138027|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
19692303|NCT00132730|42138028|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
19774903|NCT01376323|42229515|FG002|Overall Study|Physician Decision|2|||
19774904|NCT01376323|42229516|FG003|Overall Study|Physician Decision|1|||
19774905|NCT01376323|42229517|FG004|Overall Study|Physician Decision|1|||
19774906|NCT01376323|42229513|FG000|Overall Study|Withdrawal by Subject|0|||
19774907|NCT01376323|42229514|FG001|Overall Study|Withdrawal by Subject|1|||
19774908|NCT01376323|42229515|FG002|Overall Study|Withdrawal by Subject|1|||
19774909|NCT01376323|42229516|FG003|Overall Study|Withdrawal by Subject|0|||
19774910|NCT01376323|42229517|FG004|Overall Study|Withdrawal by Subject|0|||
19774911|NCT03725293|42229554|FG000|Overall Study|Physician Decision|9|||
19774912|NCT03725293|42229555|FG001|Overall Study|Physician Decision|6|||
19774913|NCT03725293|42229554|FG000|Overall Study|alternative vascular access needs|1|||
19774914|NCT03725293|42229555|FG001|Overall Study|alternative vascular access needs|2|||
19774915|NCT03725293|42229554|FG000|Overall Study|venous anatomy screen failures|2|||
19774916|NCT03725293|42229555|FG001|Overall Study|venous anatomy screen failures|1|||
19774917|NCT01368536|42229564|FG000|Overall Study|Adverse Event|5|||
19774918|NCT01368536|42229565|FG001|Overall Study|Adverse Event|6|||
19774919|NCT01368536|42229566|FG002|Overall Study|Adverse Event|8|||
19774920|NCT01368536|42229564|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19774921|NCT01368536|42229565|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19774922|NCT01368536|42229566|FG002|Overall Study|Abnormal laboratory value(s)|2|||
19774923|NCT01368536|42229564|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19774924|NCT01368536|42229565|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19774925|NCT01368536|42229566|FG002|Overall Study|Abnormal test procedure result(s)|1|||
19774926|NCT01368536|42229564|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
19774927|NCT01368536|42229565|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19774928|NCT01368536|42229566|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19774929|NCT01368536|42229564|FG000|Overall Study|No longer required study medication|0|||
19774930|NCT01368536|42229565|FG001|Overall Study|No longer required study medication|0|||
19774931|NCT01368536|42229566|FG002|Overall Study|No longer required study medication|1|||
19774932|NCT01368536|42229564|FG000|Overall Study|Withdrawal by Subject|2|||
19774933|NCT01368536|42229565|FG001|Overall Study|Withdrawal by Subject|5|||
19774934|NCT01368536|42229566|FG002|Overall Study|Withdrawal by Subject|4|||
19774935|NCT01368536|42229564|FG000|Overall Study|Lost to Follow-up|3|||
19774936|NCT01368536|42229565|FG001|Overall Study|Lost to Follow-up|3|||
19774937|NCT01368536|42229566|FG002|Overall Study|Lost to Follow-up|5|||
19774938|NCT01368536|42229564|FG000|Overall Study|Administrative problems|34|||
19774939|NCT01368536|42229565|FG001|Overall Study|Administrative problems|39|||
19774940|NCT01368536|42229566|FG002|Overall Study|Administrative problems|35|||
19774941|NCT01368536|42229564|FG000|Overall Study|Protocol deviation|0|||
19774942|NCT01368536|42229565|FG001|Overall Study|Protocol deviation|3|||
19774943|NCT01368536|42229566|FG002|Overall Study|Protocol deviation|1|||
19774944|NCT03051165|42229575|FG000|Overall Study|Withdrawal by Subject|1|||
19774945|NCT03051165|42229575|FG000|Overall Study|Early termination of study|12|||
19774946|NCT01319929|42229581|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
19774947|NCT01319929|42229582|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
19774948|NCT01319929|42229581|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
19774949|NCT01319929|42229582|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
19389158|NCT02084056|41632767|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19692304|NCT00132730|42138029|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
19692305|NCT00132730|42138024|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
19692306|NCT00132730|42138025|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
19692307|NCT00132730|42138026|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
19692308|NCT00132730|42138027|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
19774950|NCT01319929|42229581|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
19774951|NCT01319929|42229582|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
19774952|NCT01319929|42229581|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
19774953|NCT01319929|42229582|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
19774954|NCT01319929|42229581|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
19774955|NCT01319929|42229582|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
19774956|NCT03110185|42229591|FG000|Overall Study|Death|0|||
19774957|NCT03110185|42229592|FG001|Overall Study|Death|1|||
19774958|NCT03110185|42229591|FG000|Overall Study|Withdrawal by Subject|2|||
19774959|NCT03110185|42229592|FG001|Overall Study|Withdrawal by Subject|7|||
19774960|NCT03110185|42229591|FG000|Overall Study|Time Constraints|0|||
19774961|NCT03110185|42229592|FG001|Overall Study|Time Constraints|6|||
19774962|NCT03110185|42229591|FG000|Overall Study|Conflict with care|5|||
19774963|NCT03110185|42229592|FG001|Overall Study|Conflict with care|12|||
19774964|NCT03110185|42229591|FG000|Overall Study|Protocol Violation|1|||
19774965|NCT03110185|42229592|FG001|Overall Study|Protocol Violation|4|||
19774966|NCT03110185|42229591|FG000|Overall Study|MRI Incompatible|2|||
19774967|NCT03110185|42229592|FG001|Overall Study|MRI Incompatible|0|||
19774968|NCT03110185|42229591|FG000|Overall Study|Patient Refusal|0|||
19774969|NCT03110185|42229592|FG001|Overall Study|Patient Refusal|1|||
19774970|NCT02858076|42229603|FG000|Overall Study|Death|6|||
19774971|NCT02858076|42229604|FG001|Overall Study|Death|3|||
19774972|NCT02858076|42229603|FG000|Overall Study|Withdrawal by Subject|1|||
19774973|NCT02858076|42229604|FG001|Overall Study|Withdrawal by Subject|5|||
19774974|NCT02858076|42229603|FG000|Overall Study|Lost to Follow-up|2|||
19774975|NCT02858076|42229604|FG001|Overall Study|Lost to Follow-up|7|||
19774976|NCT02858076|42229603|FG000|Overall Study|Completed Out of Window|1|||
19774977|NCT02858076|42229604|FG001|Overall Study|Completed Out of Window|3|||
19774978|NCT04594759|42229612|FG000|Overall Study|Lost to Follow-up|3|||
19774979|NCT02856282|42229616|FG000|Overall Study|Withdrawal by Subject|1|||
19774980|NCT03833817|42229622|FG000|Overall Study|Withdrawal by Subject|3|||
19774981|NCT03833817|42229623|FG001|Overall Study|Withdrawal by Subject|3|||
19774982|NCT03833817|42229622|FG000|Overall Study|Lost to Follow-up|3|||
19774983|NCT03833817|42229623|FG001|Overall Study|Lost to Follow-up|3|||
19774984|NCT03119701|42229631|FG000|6-day Dosing|Death|4|||
19774985|NCT03119701|42229632|FG001|6-day Dosing|Death|1|||
19774986|NCT03119701|42229631|FG000|6-day Dosing|Adverse Event|3|||
19774987|NCT03119701|42229632|FG001|6-day Dosing|Adverse Event|0|||
19774988|NCT03119701|42229631|FG000|6-day Dosing|Physician Decision|0|||
19774989|NCT03119701|42229632|FG001|6-day Dosing|Physician Decision|1|||
19774990|NCT03119701|42229631|FG000|6-day Dosing|Withdrawal by Subject|0|||
19774991|NCT03119701|42229632|FG001|6-day Dosing|Withdrawal by Subject|1|||
19774992|NCT03119701|42229631|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
19774993|NCT03119701|42229632|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
19774994|NCT02679781|42229646|FG000|Overall Study|Lost to Follow-up|1|||
19774995|NCT02679781|42229647|FG001|Overall Study|Lost to Follow-up|2|||
19774996|NCT02679781|42229646|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
19774997|NCT02679781|42229647|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
19774998|NCT02624869|42229656|FG000|Overall Study|Lost to Follow-up|0|||
19774999|NCT02624869|42229657|FG001|Overall Study|Lost to Follow-up|0|||
19775000|NCT02624869|42229658|FG002|Overall Study|Lost to Follow-up|1|||
19775001|NCT02624869|42229656|FG000|Overall Study|Withdrawal by Subject|1|||
19775002|NCT02624869|42229657|FG001|Overall Study|Withdrawal by Subject|3|||
19775003|NCT02624869|42229658|FG002|Overall Study|Withdrawal by Subject|1|||
19775004|NCT03110029|42229678|FG000|Overall Study|Withdrawal by Subject|1|||
19775005|NCT03110029|42229679|FG001|Overall Study|Withdrawal by Subject|1|||
19775006|NCT02747004|42229688|FG000|Overall Study|Withdrawal by Subject|8|||
19775007|NCT02747004|42229689|FG001|Overall Study|Withdrawal by Subject|5|||
19775008|NCT02747004|42229690|FG002|Overall Study|Withdrawal by Subject|4|||
19775009|NCT02747004|42229688|FG000|Overall Study|Lost to Follow-up|1|||
19775010|NCT02747004|42229689|FG001|Overall Study|Lost to Follow-up|2|||
19692309|NCT00132730|42138028|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
19692310|NCT00132730|42138029|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
19692311|NCT00132730|42138024|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
19692312|NCT00132730|42138025|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
19692313|NCT00132730|42138026|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
19692314|NCT00132730|42138027|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
19692315|NCT00132730|42138028|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
19692316|NCT00132730|42138029|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
19692317|NCT00232557|42138045|FG000|Overall Study|Lost to Follow-up|3|||
19692318|NCT00232557|42138046|FG001|Overall Study|Lost to Follow-up|5|||
19692319|NCT00522275|42138052|FG000|Overall Study|Adverse Event|35|||
19692320|NCT00522275|42138052|FG000|Overall Study|Lack of Efficacy|80|||
19692321|NCT00522275|42138052|FG000|Overall Study|Subject withdrew consent|16|||
19692322|NCT00522275|42138052|FG000|Overall Study|Protocol deviation|1|||
19692323|NCT00522275|42138052|FG000|Overall Study|Unsatisfactory compliance|11|||
19692324|NCT00522275|42138052|FG000|Overall Study|Lost to Follow-up|8|||
19692325|NCT00522275|42138052|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
19775011|NCT02747004|42229690|FG002|Overall Study|Lost to Follow-up|2|||
19775012|NCT02747004|42229688|FG000|Overall Study|on study treatment/follow-up|48|||
19775013|NCT02747004|42229689|FG001|Overall Study|on study treatment/follow-up|42|||
19775014|NCT02747004|42229690|FG002|Overall Study|on study treatment/follow-up|41|||
19775015|NCT04207749|42229700|FG000|Overall Study|Lost to Follow-up|0|||
19775016|NCT04207749|42229701|FG001|Overall Study|Lost to Follow-up|2|||
19775017|NCT04207749|42229700|FG000|Overall Study|Protocol Violation|0|||
19775018|NCT04207749|42229701|FG001|Overall Study|Protocol Violation|1|||
19775019|NCT04207749|42229700|FG000|Overall Study|Withdrawal by Subject|3|||
19775020|NCT04207749|42229701|FG001|Overall Study|Withdrawal by Subject|0|||
19775021|NCT04207749|42229700|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
19775022|NCT04207749|42229701|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
19775023|NCT03043365|42229712|FG000|Weeks 0 to Week 8|Adverse Event|1|||
19775024|NCT03043365|42229713|FG001|Weeks 0 to Week 8|Adverse Event|3|||
19775025|NCT03043365|42229712|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
19775026|NCT03043365|42229713|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
19775027|NCT03043365|42229712|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
19775028|NCT03043365|42229713|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
19775029|NCT03108157|42229723|FG000|Overall Study|Protocol Violation|15|||
19775030|NCT03108157|42229724|FG001|Overall Study|Protocol Violation|4|||
19775031|NCT04421131|42229731|FG000|Overall Study|Lost to Follow-up|1|||
19775032|NCT04421131|42229731|FG000|Overall Study|Protocol Violation|2|||
19775033|NCT04421131|42229731|FG000|Overall Study|App crashed|5|||
19775034|NCT04167345|42229740|FG000|Overall Study|Other|1|||
19775035|NCT04167345|42229741|FG001|Overall Study|Other|1|||
19775036|NCT04167345|42229742|FG002|Overall Study|Other|0|||
19775037|NCT04167345|42229743|FG003|Overall Study|Other|0|||
19775038|NCT04167345|42229744|FG004|Overall Study|Other|0|||
19775039|NCT02854800|42229763|FG000|Overall Study|Protocol Violation|16|||
19775040|NCT02854800|42229764|FG001|Overall Study|Protocol Violation|11|||
19775041|NCT02854800|42229765|FG002|Overall Study|Protocol Violation|3|||
19775042|NCT02854800|42229763|FG000|Overall Study|Withdrawal by Subject|4|||
19775043|NCT02854800|42229764|FG001|Overall Study|Withdrawal by Subject|2|||
19775044|NCT02854800|42229765|FG002|Overall Study|Withdrawal by Subject|3|||
19775045|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
19775046|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
19775047|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
19775048|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Adverse Event|5|||
19775049|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Adverse Event|1|||
19775050|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Adverse Event|0|||
19775051|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
19775052|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
19775053|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
19775054|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Death|8|||
19775055|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Death|24|||
19775056|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Death|0|||
19775057|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
19775058|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
19775059|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
19775060|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
19775061|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
19775062|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
19775063|NCT02931539|42229778|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
19775064|NCT02931539|42229779|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
19775065|NCT02931539|42229780|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
19775066|NCT02931539|42229778|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
19775067|NCT02931539|42229779|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
19775068|NCT02931539|42229780|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
19775069|NCT04042077|42229797|FG000|Overall Study|Adverse Event|0|||
19775070|NCT04042077|42229798|FG001|Overall Study|Adverse Event|1|||
19775071|NCT04042077|42229797|FG000|Overall Study|Death|2|||
19775072|NCT04042077|42229798|FG001|Overall Study|Death|1|||
19389159|NCT01625182|41632779|FG000|Overall Study|Administrative problems|1|||
19692326|NCT00522275|42138052|FG000|Overall Study|Other: Subject is pregnant|2|||
19692327|NCT00522275|42138052|FG000|Overall Study|Other: Subject relocated|2|||
19692328|NCT00522275|42138052|FG000|Overall Study|Other: Subject arrested|1|||
19692329|NCT00522275|42138052|FG000|Overall Study|Other: Site / clinic closed|4|||
19692330|NCT00522275|42138052|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
19692331|NCT00522275|42138052|FG000|Overall Study|Other: Sponsor request|2|||
19692332|NCT00522275|42138052|FG000|Overall Study|Other: Subject ran out of medication|1|||
19692333|NCT00522275|42138052|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
19692334|NCT00522041|42138058|FG000|Overall Study|Adverse Event|9|||
19775073|NCT04042077|42229797|FG000|Overall Study|Physician Decision|2|||
19775074|NCT04042077|42229798|FG001|Overall Study|Physician Decision|0|||
19775075|NCT04042077|42229797|FG000|Overall Study|Withdrawal by Subject|3|||
19775076|NCT04042077|42229798|FG001|Overall Study|Withdrawal by Subject|2|||
19775077|NCT04042077|42229797|FG000|Overall Study|Lack of Efficacy|0|||
19775078|NCT04042077|42229798|FG001|Overall Study|Lack of Efficacy|1|||
19775079|NCT02853318|42229819|FG000|Overall Study|Withdrawal by Subject|1|||
19775080|NCT03113071|42229829|FG000|Overall Study|Withdrawal by Subject|1|||
19775081|NCT03113071|42229830|FG001|Overall Study|Withdrawal by Subject|0|||
19775082|NCT03050307|42229838|FG000|Overall Study|Adverse Event|4|||
19775083|NCT03050307|42229839|FG001|Overall Study|Adverse Event|2|||
19775084|NCT03050307|42229838|FG000|Overall Study|Significant Protocol Deviation|0|||
19775085|NCT03050307|42229839|FG001|Overall Study|Significant Protocol Deviation|1|||
19775086|NCT03050307|42229838|FG000|Overall Study|Lost to Follow-up|0|||
19775087|NCT03050307|42229839|FG001|Overall Study|Lost to Follow-up|1|||
19775088|NCT03050307|42229838|FG000|Overall Study|Voluntary Withdrawal|3|||
19775089|NCT03050307|42229839|FG001|Overall Study|Voluntary Withdrawal|4|||
19775090|NCT03050307|42229838|FG000|Overall Study|Reason not Specified|1|||
19775091|NCT03050307|42229839|FG001|Overall Study|Reason not Specified|1|||
19775092|NCT03118765|42229865|FG000|Overall Study|Withdrawal by Subject|0|||
19775093|NCT03118765|42229866|FG001|Overall Study|Withdrawal by Subject|0|||
19775094|NCT03118765|42229867|FG002|Overall Study|Withdrawal by Subject|1|||
19775095|NCT03118765|42229868|FG003|Overall Study|Withdrawal by Subject|0|||
19775096|NCT03118765|42229869|FG004|Overall Study|Withdrawal by Subject|0|||
19775097|NCT03118765|42229865|FG000|Overall Study|Adverse Event|1|||
19775098|NCT03118765|42229866|FG001|Overall Study|Adverse Event|1|||
19775099|NCT03118765|42229867|FG002|Overall Study|Adverse Event|1|||
19775100|NCT03118765|42229868|FG003|Overall Study|Adverse Event|1|||
19775101|NCT03118765|42229869|FG004|Overall Study|Adverse Event|1|||
19775102|NCT03118765|42229865|FG000|Overall Study|Non compliance with Study Procedures|0|||
19775103|NCT03118765|42229866|FG001|Overall Study|Non compliance with Study Procedures|0|||
19775104|NCT03118765|42229867|FG002|Overall Study|Non compliance with Study Procedures|0|||
19775105|NCT03118765|42229868|FG003|Overall Study|Non compliance with Study Procedures|1|||
19775106|NCT03118765|42229869|FG004|Overall Study|Non compliance with Study Procedures|0|||
19775107|NCT03118765|42229865|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
19775108|NCT03118765|42229866|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
19775109|NCT03118765|42229867|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
19775110|NCT03118765|42229868|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
19775111|NCT03118765|42229869|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
19775112|NCT03118765|42229865|FG000|Overall Study|COPD Exacerbation|1|||
19775113|NCT03118765|42229866|FG001|Overall Study|COPD Exacerbation|0|||
19775114|NCT03118765|42229867|FG002|Overall Study|COPD Exacerbation|0|||
19775115|NCT03118765|42229868|FG003|Overall Study|COPD Exacerbation|1|||
19775116|NCT03118765|42229869|FG004|Overall Study|COPD Exacerbation|0|||
19775117|NCT03118765|42229865|FG000|Overall Study|Lost to Follow-up|1|||
19775118|NCT03118765|42229866|FG001|Overall Study|Lost to Follow-up|0|||
19775119|NCT03118765|42229867|FG002|Overall Study|Lost to Follow-up|1|||
19775120|NCT03118765|42229868|FG003|Overall Study|Lost to Follow-up|0|||
19775121|NCT03118765|42229869|FG004|Overall Study|Lost to Follow-up|0|||
19775122|NCT03118765|42229865|FG000|Overall Study|Sponsor Decision|1|||
19775123|NCT03118765|42229866|FG001|Overall Study|Sponsor Decision|0|||
19775124|NCT03118765|42229867|FG002|Overall Study|Sponsor Decision|1|||
19775125|NCT03118765|42229868|FG003|Overall Study|Sponsor Decision|0|||
19775126|NCT03118765|42229869|FG004|Overall Study|Sponsor Decision|1|||
19775127|NCT05222880|42229884|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
19775128|NCT05222880|42229884|FG000|Overall Study|Withdrew Consent during Study|1|||
19775129|NCT05222880|42229884|FG000|Overall Study|COVID-19 Related|1|||
19775130|NCT04606134|42229926|FG000|Overall Study|Adverse Event|0|||
19775131|NCT04606134|42229927|FG001|Overall Study|Adverse Event|1|||
19775132|NCT04426825|42229933|FG000|Overall Study|Continuing on study|6|||
19775133|NCT04426825|42229933|FG000|Overall Study|Death|17|||
19775134|NCT04399538|42229942|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
19775135|NCT04399538|42229943|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
19775136|NCT04399538|42229944|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
19775137|NCT04399538|42229945|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
19775138|NCT04399538|42229946|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
19775139|NCT04399538|42229942|FG000|Double-Blind Treatment|Adverse Event|0|||
19775140|NCT04399538|42229943|FG001|Double-Blind Treatment|Adverse Event|0|||
19775141|NCT04399538|42229944|FG002|Double-Blind Treatment|Adverse Event|0|||
19775142|NCT04399538|42229945|FG003|Double-Blind Treatment|Adverse Event|0|||
19775143|NCT04399538|42229946|FG004|Double-Blind Treatment|Adverse Event|1|||
19775144|NCT04399538|42229942|FG000|Follow-Up|Adverse Event|0|||
19775145|NCT04399538|42229943|FG001|Follow-Up|Adverse Event|0|||
19775146|NCT04399538|42229944|FG002|Follow-Up|Adverse Event|0|||
19775147|NCT04399538|42229945|FG003|Follow-Up|Adverse Event|0|||
19775148|NCT04399538|42229946|FG004|Follow-Up|Adverse Event|1|||
19775149|NCT04399538|42229942|FG000|Follow-Up|Withdrawal by Subject|0|||
19775150|NCT04399538|42229943|FG001|Follow-Up|Withdrawal by Subject|0|||
19775151|NCT04399538|42229944|FG002|Follow-Up|Withdrawal by Subject|0|||
19775152|NCT04399538|42229945|FG003|Follow-Up|Withdrawal by Subject|2|||
19775153|NCT04399538|42229946|FG004|Follow-Up|Withdrawal by Subject|0|||
19775154|NCT03875235|42229964|FG000|Overall Study|Ongoing study treatment|63|||
19775155|NCT03875235|42229965|FG001|Overall Study|Ongoing study treatment|20|||
19775156|NCT03875235|42229964|FG000|Overall Study|Off treatment|77|||
19775157|NCT03875235|42229965|FG001|Overall Study|Off treatment|91|||
19775158|NCT03875235|42229964|FG000|Overall Study|Withdrawal by Subject|3|||
19775159|NCT03875235|42229965|FG001|Overall Study|Withdrawal by Subject|10|||
19775160|NCT03875235|42229964|FG000|Overall Study|Death|198|||
19775161|NCT03875235|42229965|FG001|Overall Study|Death|223|||
19775162|NCT03775486|42229973|FG000|Initial Therapy Phase|Other reason provided|0|||
19775163|NCT03775486|42229974|FG001|Initial Therapy Phase|Other reason provided|15|||
19775164|NCT03775486|42229973|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
19775165|NCT03775486|42229974|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
19775166|NCT03775486|42229973|FG000|Initial Therapy Phase|Protocol Violation|0|||
19775167|NCT03775486|42229974|FG001|Initial Therapy Phase|Protocol Violation|2|||
19775168|NCT03775486|42229973|FG000|Initial Therapy Phase|Adverse Event|0|||
19775169|NCT03775486|42229974|FG001|Initial Therapy Phase|Adverse Event|34|||
19775170|NCT03775486|42229973|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
19775171|NCT03775486|42229974|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
19775172|NCT03775486|42229973|FG000|Maintenance Phase|Withdrawal by Subject|13|||
19775173|NCT03775486|42229974|FG001|Maintenance Phase|Withdrawal by Subject|12|||
19775174|NCT03775486|42229973|FG000|Maintenance Phase|Death|44|||
19775175|NCT03775486|42229974|FG001|Maintenance Phase|Death|45|||
19775176|NCT03412565|42229998|FG000|Overall Study|Other|0|||
19775177|NCT03412565|42229999|FG001|Overall Study|Other|0|||
19775178|NCT03412565|42230000|FG002|Overall Study|Other|0|||
19775179|NCT03412565|42230001|FG003|Overall Study|Other|3|||
19775180|NCT03412565|42229998|FG000|Overall Study|Withdrawal by Subject|0|||
19775181|NCT03412565|42229999|FG001|Overall Study|Withdrawal by Subject|0|||
19775182|NCT03412565|42230000|FG002|Overall Study|Withdrawal by Subject|1|||
19775183|NCT03412565|42230001|FG003|Overall Study|Withdrawal by Subject|5|||
19775184|NCT03412565|42229998|FG000|Overall Study|Physician Decision|0|||
19775185|NCT03412565|42229999|FG001|Overall Study|Physician Decision|1|||
19775186|NCT03412565|42230000|FG002|Overall Study|Physician Decision|0|||
19775187|NCT03412565|42230001|FG003|Overall Study|Physician Decision|1|||
19775188|NCT03412565|42229998|FG000|Overall Study|Death|1|||
19775189|NCT03412565|42229999|FG001|Overall Study|Death|2|||
19775190|NCT03412565|42230000|FG002|Overall Study|Death|2|||
19775191|NCT03412565|42230001|FG003|Overall Study|Death|4|||
19775192|NCT03412565|42229998|FG000|Overall Study|Still ongoing|0|||
19775193|NCT03412565|42229999|FG001|Overall Study|Still ongoing|62|||
19775194|NCT03412565|42230000|FG002|Overall Study|Still ongoing|59|||
19775195|NCT03412565|42230001|FG003|Overall Study|Still ongoing|41|||
19775196|NCT03277105|42230030|FG000|Overall Study|Death|77|||
19692335|NCT00522041|42138059|FG001|Overall Study|Adverse Event|3|||
19692336|NCT00522041|42138058|FG000|Overall Study|Protocol Violation|2|||
19692337|NCT00522041|42138059|FG001|Overall Study|Protocol Violation|0|||
19775197|NCT03277105|42230031|FG001|Overall Study|Death|73|||
19775198|NCT03277105|42230030|FG000|Overall Study|Lost to Follow-up|0|||
19775199|NCT03277105|42230031|FG001|Overall Study|Lost to Follow-up|3|||
19775200|NCT03277105|42230030|FG000|Overall Study|Withdrawal by Subject|10|||
19775201|NCT03277105|42230031|FG001|Overall Study|Withdrawal by Subject|9|||
19775202|NCT03277105|42230030|FG000|Overall Study|Other|1|||
19775203|NCT03277105|42230031|FG001|Overall Study|Other|3|||
19692338|NCT00522041|42138058|FG000|Overall Study|Lost to Follow-up|1|||
19692339|NCT00522041|42138059|FG001|Overall Study|Lost to Follow-up|4|||
19692340|NCT00522041|42138058|FG000|Overall Study|Voluntary withdrawal|5|||
19692341|NCT00522041|42138059|FG001|Overall Study|Voluntary withdrawal|4|||
19692342|NCT00522041|42138058|FG000|Overall Study|Did not receive treatment|0|||
19692343|NCT00522041|42138059|FG001|Overall Study|Did not receive treatment|1|||
19692344|NCT00122980|42138068|FG000|Overall Study|Death|0|||
19692345|NCT00122980|42138069|FG001|Overall Study|Death|1|||
19692346|NCT00122980|42138068|FG000|Overall Study|Physician Decision|2|||
19692347|NCT00122980|42138069|FG001|Overall Study|Physician Decision|0|||
19692348|NCT00122980|42138068|FG000|Overall Study|Protocol Violation|5|||
19692349|NCT00122980|42138069|FG001|Overall Study|Protocol Violation|1|||
19692350|NCT00122980|42138068|FG000|Overall Study|Withdrawal by Subject|2|||
19692351|NCT00122980|42138069|FG001|Overall Study|Withdrawal by Subject|3|||
19692352|NCT00122980|42138068|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
19692353|NCT00122980|42138069|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
19692354|NCT00122980|42138068|FG000|Overall Study|Study termination|27|||
19692355|NCT00122980|42138069|FG001|Overall Study|Study termination|35|||
19692356|NCT03868631|42138077|FG000|Baseline to Week 6|Adverse Event|0|||
19692357|NCT03868631|42138078|FG001|Baseline to Week 6|Adverse Event|3|||
19692358|NCT03868631|42138077|FG000|Baseline to Week 6|Protocol Violation|1|||
19692359|NCT03868631|42138078|FG001|Baseline to Week 6|Protocol Violation|1|||
19692360|NCT03868631|42138077|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
19775204|NCT03277105|42230030|FG000|Overall Study|Ongoing|171|||
19775205|NCT03277105|42230031|FG001|Overall Study|Ongoing|175|||
19775206|NCT03201965|42230040|FG000|Overall Study|Death|5|||
19775207|NCT03201965|42230041|FG001|Overall Study|Death|27|||
19775208|NCT03201965|42230042|FG002|Overall Study|Death|27|||
19775209|NCT03201965|42230040|FG000|Overall Study|Lost to Follow-up|0|||
19775210|NCT03201965|42230041|FG001|Overall Study|Lost to Follow-up|1|||
19775211|NCT03201965|42230042|FG002|Overall Study|Lost to Follow-up|0|||
19775212|NCT03201965|42230040|FG000|Overall Study|Withdrawal by Subject|3|||
19775213|NCT03201965|42230041|FG001|Overall Study|Withdrawal by Subject|13|||
19775214|NCT03201965|42230042|FG002|Overall Study|Withdrawal by Subject|4|||
19775215|NCT03201965|42230040|FG000|Overall Study|Ongoing|20|||
19775216|NCT03201965|42230041|FG001|Overall Study|Ongoing|152|||
19775217|NCT03201965|42230042|FG002|Overall Study|Ongoing|164|||
19775218|NCT03106779|42230051|FG000|Overall Study|Lack of Efficacy|33|||
19775219|NCT03106779|42230052|FG001|Overall Study|Lack of Efficacy|24|||
19775220|NCT03106779|42230051|FG000|Overall Study|Adverse Event|8|||
19775221|NCT03106779|42230052|FG001|Overall Study|Adverse Event|16|||
19775222|NCT03106779|42230051|FG000|Overall Study|Physician Decision|10|||
19775223|NCT03106779|42230052|FG001|Overall Study|Physician Decision|6|||
19775224|NCT03106779|42230051|FG000|Overall Study|Patient/guardian decision|4|||
19775225|NCT03106779|42230052|FG001|Overall Study|Patient/guardian decision|3|||
19775226|NCT03106779|42230051|FG000|Overall Study|Progressive disease|1|||
19775227|NCT03106779|42230052|FG001|Overall Study|Progressive disease|3|||
19775228|NCT03106779|42230051|FG000|Overall Study|Lost to Follow-up|1|||
19775229|NCT03106779|42230052|FG001|Overall Study|Lost to Follow-up|2|||
19775230|NCT03106779|42230051|FG000|Overall Study|Death|1|||
19775231|NCT03106779|42230052|FG001|Overall Study|Death|0|||
19775232|NCT03106779|42230051|FG000|Overall Study|Protocol Violation|1|||
19775233|NCT03106779|42230052|FG001|Overall Study|Protocol Violation|0|||
19775234|NCT03106779|42230051|FG000|Overall Study|Not treated|1|||
19775235|NCT03106779|42230052|FG001|Overall Study|Not treated|0|||
19775236|NCT03094832|42230063|FG000|Overall Study|Lost to Follow-up|0|||
19775237|NCT03094832|42230064|FG001|Overall Study|Lost to Follow-up|0|||
19775238|NCT03094832|42230065|FG002|Overall Study|Lost to Follow-up|0|||
19775239|NCT03094832|42230066|FG003|Overall Study|Lost to Follow-up|1|||
19775240|NCT03094832|42230067|FG004|Overall Study|Lost to Follow-up|1|||
19775241|NCT03094832|42230063|FG000|Overall Study|Death|1|||
19775242|NCT03094832|42230064|FG001|Overall Study|Death|0|||
19775243|NCT03094832|42230065|FG002|Overall Study|Death|0|||
19775244|NCT03094832|42230066|FG003|Overall Study|Death|0|||
19775245|NCT03094832|42230067|FG004|Overall Study|Death|0|||
19775246|NCT03094832|42230063|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19775247|NCT03094832|42230064|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19775248|NCT03094832|42230065|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
19775249|NCT03094832|42230066|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
19775250|NCT03094832|42230067|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
19775251|NCT03094832|42230063|FG000|Overall Study|Other|13|||
19775252|NCT03094832|42230064|FG001|Overall Study|Other|20|||
19775253|NCT03094832|42230065|FG002|Overall Study|Other|1|||
19775254|NCT03094832|42230066|FG003|Overall Study|Other|7|||
19606702|NCT00741598|42055378|FG001|Overall Study|Lack of Efficacy|2|||
19606703|NCT00741598|42055377|FG000|Overall Study|Physician Decision|1|||
19606704|NCT00741598|42055378|FG001|Overall Study|Physician Decision|1|||
19606705|NCT00741598|42055377|FG000|Overall Study|Pregnancy|1|||
19606706|NCT00741598|42055378|FG001|Overall Study|Pregnancy|0|||
19606707|NCT00741598|42055377|FG000|Overall Study|Withdrawal by Subject|3|||
19606708|NCT00741598|42055378|FG001|Overall Study|Withdrawal by Subject|2|||
19606709|NCT00717886|42055385|FG000|Overall Study|Withdrawal by Subject|3|||
19606710|NCT00717886|42055385|FG000|Overall Study|Treatment Failure|1|||
19606711|NCT00741286|42055391|FG000|Overall Study|Lost to Follow-up|15|||
19606712|NCT00741286|42055392|FG001|Overall Study|Lost to Follow-up|10|||
19692361|NCT03868631|42138078|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
19692362|NCT03868631|42138077|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
19692363|NCT03868631|42138078|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
19692364|NCT03868631|42138077|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
19606713|NCT00741286|42055391|FG000|Overall Study|Adverse Event|1|||
19606714|NCT00741286|42055392|FG001|Overall Study|Adverse Event|6|||
19606715|NCT00741286|42055391|FG000|Overall Study|Protocol Violation|3|||
19606716|NCT00741286|42055392|FG001|Overall Study|Protocol Violation|2|||
19606717|NCT00741286|42055391|FG000|Overall Study|Primary Outcome|1|||
19606718|NCT00741286|42055392|FG001|Overall Study|Primary Outcome|1|||
19606719|NCT00716482|42055398|FG000|Overall Study|Lost to Follow-up|6|||
19606720|NCT00716482|42055398|FG000|Overall Study|Inadequate acquisition or analysis|50|||
19606721|NCT00716482|42055398|FG000|Overall Study|no pathology obtained|10|||
19692365|NCT03868631|42138078|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
19692366|NCT03868631|42138077|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
19692367|NCT03868631|42138078|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
19692368|NCT00340704|42138093|FG000|PK Study|Adverse Event|0|||
19692369|NCT00340704|42138094|FG001|PK Study|Adverse Event|1|||
19692370|NCT00340704|42138095|FG002|PK Study|Adverse Event|0|||
19775255|NCT03094832|42230067|FG004|Overall Study|Other|1|||
19775256|NCT03091192|42230081|FG000|Overall Study|Study terminated by sponsor|21|||
19775257|NCT03091192|42230082|FG001|Overall Study|Study terminated by sponsor|14|||
19775258|NCT03091192|42230081|FG000|Overall Study|Death|9|||
19775259|NCT03091192|42230082|FG001|Overall Study|Death|13|||
19775260|NCT03091192|42230081|FG000|Overall Study|Withdrawal by Subject|2|||
19775261|NCT03091192|42230082|FG001|Overall Study|Withdrawal by Subject|0|||
19775262|NCT03091192|42230081|FG000|Overall Study|Lost to Follow-up|1|||
19775263|NCT03091192|42230082|FG001|Overall Study|Lost to Follow-up|0|||
19775264|NCT03036579|42230090|FG000|2 Years|Lost to Follow-up|1|||
19775265|NCT03036579|42230091|FG001|2 Years|Lost to Follow-up|0|||
19775266|NCT03036579|42230090|FG000|3 Years|Lost to Follow-up|0|||
19775267|NCT03036579|42230091|FG001|3 Years|Lost to Follow-up|1|||
19775268|NCT02867761|42230099|FG000|Overall Study|Participant withdrawn by investigator|0|||
19775269|NCT02867761|42230100|FG001|Overall Study|Participant withdrawn by investigator|1|||
19775270|NCT02867761|42230099|FG000|Overall Study|Lost to Follow-up|25|||
19775271|NCT02867761|42230100|FG001|Overall Study|Lost to Follow-up|18|||
19775272|NCT02867761|42230099|FG000|Overall Study|Unable to complete protocol|3|||
19775273|NCT02867761|42230100|FG001|Overall Study|Unable to complete protocol|7|||
19775274|NCT02854436|42230115|FG000|Overall Study|Adverse Event|1|||
19775275|NCT02854436|42230115|FG000|Overall Study|Death|208|||
19775276|NCT02854436|42230115|FG000|Overall Study|Lost to Follow-up|5|||
19775277|NCT02854436|42230115|FG000|Overall Study|Withdrawal by Subject|12|||
19775278|NCT02854436|42230115|FG000|Overall Study|Other|45|||
19775279|NCT02854436|42230115|FG000|Overall Study|Ongoing|18|||
19775280|NCT02719990|42230119|FG000|Overall Study|Physician Decision|2|||
19775281|NCT02719990|42230119|FG000|Overall Study|Withdrawal by Subject|2|||
19775282|NCT02719990|42230119|FG000|Overall Study|Study Terminated By Sponsor|32|||
19775283|NCT02494583|42230126|FG000|Overall Study|Death|224|||
19775284|NCT02494583|42230127|FG001|Overall Study|Death|214|||
19775285|NCT02494583|42230128|FG002|Overall Study|Death|225|||
19775286|NCT02494583|42230126|FG000|Overall Study|Lost to Follow-up|1|||
19775287|NCT02494583|42230127|FG001|Overall Study|Lost to Follow-up|0|||
19775288|NCT02494583|42230128|FG002|Overall Study|Lost to Follow-up|0|||
19775289|NCT02494583|42230126|FG000|Overall Study|Protocol Violation|1|||
19775290|NCT02494583|42230127|FG001|Overall Study|Protocol Violation|2|||
19775291|NCT02494583|42230128|FG002|Overall Study|Protocol Violation|0|||
19692371|NCT00340704|42138096|FG003|PK Study|Adverse Event|0|||
19692372|NCT00340704|42138097|FG004|PK Study|Adverse Event|0|||
19692373|NCT00340704|42138098|FG005|PK Study|Adverse Event|0|||
19692374|NCT00340704|42138099|FG006|PK Study|Adverse Event|0|||
19692375|NCT00340704|42138100|FG007|PK Study|Adverse Event|0|||
19692376|NCT00340704|42138101|FG008|PK Study|Adverse Event|0|||
19692377|NCT00340704|42138093|FG000|PK Study|Not treated|0|||
19692378|NCT00340704|42138094|FG001|PK Study|Not treated|0|||
19692379|NCT00340704|42138095|FG002|PK Study|Not treated|1|||
19692380|NCT00340704|42138096|FG003|PK Study|Not treated|0|||
19692381|NCT00340704|42138097|FG004|PK Study|Not treated|0|||
19692382|NCT00340704|42138098|FG005|PK Study|Not treated|0|||
19692383|NCT00340704|42138099|FG006|PK Study|Not treated|0|||
19692384|NCT00340704|42138100|FG007|PK Study|Not treated|0|||
19692385|NCT00340704|42138101|FG008|PK Study|Not treated|0|||
19692386|NCT00340704|42138093|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
19692387|NCT00340704|42138094|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
19692388|NCT00340704|42138095|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
19692389|NCT00340704|42138096|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
19692390|NCT00340704|42138097|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
19692391|NCT00340704|42138098|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
19692392|NCT00340704|42138099|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
19692393|NCT00340704|42138100|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
19692394|NCT00340704|42138101|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
19692395|NCT00340704|42138093|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692396|NCT00340704|42138094|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692397|NCT00340704|42138095|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692398|NCT00340704|42138096|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692399|NCT00340704|42138097|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692400|NCT00340704|42138098|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
19692401|NCT00340704|42138099|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692402|NCT00340704|42138100|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692403|NCT00340704|42138101|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
19692404|NCT00340704|42138093|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692405|NCT00340704|42138094|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692406|NCT00340704|42138095|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692407|NCT00340704|42138096|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692408|NCT00340704|42138097|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
19775292|NCT02494583|42230126|FG000|Overall Study|Screen Failure|0|||
19775293|NCT02494583|42230127|FG001|Overall Study|Screen Failure|1|||
19775294|NCT02494583|42230128|FG002|Overall Study|Screen Failure|0|||
19775295|NCT02494583|42230126|FG000|Overall Study|Transferred to Extension Study|15|||
19692409|NCT00340704|42138098|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
19692410|NCT00340704|42138099|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692411|NCT00340704|42138100|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692412|NCT00340704|42138101|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
19692413|NCT00340704|42138093|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
19692414|NCT00340704|42138094|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
19692415|NCT00340704|42138095|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
19692416|NCT00340704|42138096|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
19692417|NCT00340704|42138097|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
19692418|NCT00340704|42138098|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
19692419|NCT00340704|42138099|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
19692420|NCT00340704|42138100|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
19692421|NCT00340704|42138101|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
19692422|NCT00132496|42138129|FG000|Overall Study|Withdrawal by Subject|1|||
19692423|NCT00132496|42138130|FG001|Overall Study|Withdrawal by Subject|2|||
19692424|NCT00132496|42138129|FG000|Overall Study|Physician Decision|1|||
19692425|NCT00132496|42138130|FG001|Overall Study|Physician Decision|0|||
19692426|NCT00231777|42138138|FG000|Overall Study|Lost to Follow-up|3|||
19692427|NCT00231777|42138139|FG001|Overall Study|Lost to Follow-up|0|||
19692428|NCT00231777|42138138|FG000|Overall Study|Other|3|||
19692429|NCT00231777|42138139|FG001|Overall Study|Other|2|||
19692430|NCT00231465|42138145|FG000|Overall Study|Completed only one cycle|1|||
19692431|NCT00231465|42138145|FG000|Overall Study|Did not have follow up CT scans|1|||
19692432|NCT00254397|42138153|FG000|Overall Study|Disease Progression|4|||
19692433|NCT00254397|42138154|FG001|Overall Study|Disease Progression|1|||
19692434|NCT00254397|42138155|FG002|Overall Study|Disease Progression|16|||
19692435|NCT00254397|42138156|FG003|Overall Study|Disease Progression|23|||
19692436|NCT00254397|42138153|FG000|Overall Study|Non-Compliant|0|||
19692437|NCT00254397|42138154|FG001|Overall Study|Non-Compliant|0|||
19692438|NCT00254397|42138155|FG002|Overall Study|Non-Compliant|0|||
19692439|NCT00254397|42138156|FG003|Overall Study|Non-Compliant|1|||
19692440|NCT00254397|42138153|FG000|Overall Study|Adverse Event|2|||
19692441|NCT00254397|42138154|FG001|Overall Study|Adverse Event|0|||
19692442|NCT00254397|42138155|FG002|Overall Study|Adverse Event|3|||
19692443|NCT00254397|42138156|FG003|Overall Study|Adverse Event|1|||
19692444|NCT00254163|42138167|FG000|Overall Study|Adverse Event|29|||
19692445|NCT00254163|42138168|FG001|Overall Study|Adverse Event|26|||
19692446|NCT00254163|42138167|FG000|Overall Study|Patient request/withdrew consent|6|||
19692447|NCT00254163|42138168|FG001|Overall Study|Patient request/withdrew consent|4|||
19692448|NCT00254163|42138167|FG000|Overall Study|Investigator request|1|||
19692449|NCT00254163|42138168|FG001|Overall Study|Investigator request|3|||
19692450|NCT00254163|42138167|FG000|Overall Study|Failed entry|1|||
19692451|NCT00254163|42138168|FG001|Overall Study|Failed entry|3|||
19692452|NCT00254163|42138167|FG000|Overall Study|Progressive disease|0|||
19692453|NCT00254163|42138168|FG001|Overall Study|Progressive disease|1|||
19692454|NCT00254163|42138167|FG000|Overall Study|Death|0|||
19692455|NCT00254163|42138168|FG001|Overall Study|Death|1|||
19692456|NCT00254163|42138167|FG000|Overall Study|Other|8|||
19692457|NCT00254163|42138168|FG001|Overall Study|Other|8|||
19692458|NCT03869333|42138178|FG000|Overall Study|Lost to Follow-up|1|||
19692459|NCT03869333|42138179|FG001|Overall Study|Lost to Follow-up|0|||
19692460|NCT03869333|42138180|FG002|Overall Study|Lost to Follow-up|0|||
19692461|NCT03869333|42138181|FG003|Overall Study|Lost to Follow-up|0|||
19692462|NCT03869333|42138178|FG000|Overall Study|Pregnancy|1|||
19692463|NCT03869333|42138179|FG001|Overall Study|Pregnancy|0|||
19775296|NCT02494583|42230127|FG001|Overall Study|Transferred to Extension Study|15|||
19775297|NCT02494583|42230128|FG002|Overall Study|Transferred to Extension Study|6|||
19775298|NCT02494583|42230126|FG000|Overall Study|Did Not Continue on Extension Study|8|||
19775299|NCT02494583|42230127|FG001|Overall Study|Did Not Continue on Extension Study|10|||
19775300|NCT02494583|42230128|FG002|Overall Study|Did Not Continue on Extension Study|4|||
19775301|NCT02494583|42230126|FG000|Overall Study|Withdrawal by Subject|7|||
19775302|NCT02494583|42230127|FG001|Overall Study|Withdrawal by Subject|15|||
19775303|NCT02494583|42230128|FG002|Overall Study|Withdrawal by Subject|15|||
19775304|NCT02489318|42230140|FG000|Randomized|Withdrawal by Subject|0|||
19775305|NCT02489318|42230141|FG001|Randomized|Withdrawal by Subject|1|||
19775306|NCT02489318|42230140|FG000|Treated|Adverse Event|19|||
19775307|NCT02489318|42230141|FG001|Treated|Adverse Event|62|||
19775308|NCT02489318|42230140|FG000|Treated|Death|13|||
19692464|NCT03869333|42138180|FG002|Overall Study|Pregnancy|0|||
19775309|NCT02489318|42230141|FG001|Treated|Death|11|||
19775310|NCT02489318|42230140|FG000|Treated|Physician Decision|4|||
19692465|NCT03869333|42138181|FG003|Overall Study|Pregnancy|0|||
19692466|NCT03869333|42138178|FG000|Overall Study|Physician Decision|0|||
19692467|NCT03869333|42138179|FG001|Overall Study|Physician Decision|1|||
19692468|NCT03869333|42138180|FG002|Overall Study|Physician Decision|0|||
19692469|NCT03869333|42138181|FG003|Overall Study|Physician Decision|0|||
19775311|NCT02489318|42230141|FG001|Treated|Physician Decision|6|||
19775312|NCT02489318|42230140|FG000|Treated|Protocol Violation|1|||
19775313|NCT02489318|42230141|FG001|Treated|Protocol Violation|2|||
19775314|NCT02489318|42230140|FG000|Treated|Withdrawal by Subject|37|||
19775315|NCT02489318|42230141|FG001|Treated|Withdrawal by Subject|36|||
19775316|NCT02489318|42230140|FG000|Treated|Other: Progressive Disease|245|||
19775317|NCT02489318|42230141|FG001|Treated|Other: Progressive Disease|138|||
19775318|NCT02489318|42230140|FG000|Treated|Other|0|||
19775319|NCT02489318|42230141|FG001|Treated|Other|2|||
19775320|NCT02489318|42230140|FG000|Treated|Ongoing|0|||
19775321|NCT02489318|42230141|FG001|Treated|Ongoing|267|||
19775322|NCT02476916|42230150|FG000|Core Period|Adverse Event|2|||
19775323|NCT02476916|42230151|FG001|Core Period|Adverse Event|2|||
19775324|NCT02476916|42230150|FG000|Core Period|Investigator decision|1|||
19775325|NCT02476916|42230151|FG001|Core Period|Investigator decision|1|||
19775326|NCT02476916|42230150|FG000|Core Period|Withdrawal by Subject|3|||
19775327|NCT02476916|42230151|FG001|Core Period|Withdrawal by Subject|0|||
19775328|NCT02476916|42230150|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
19775329|NCT02476916|42230151|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
19775330|NCT02476916|42230150|FG000|Extension Period|On Treatment|12|||
19775331|NCT02476916|42230151|FG001|Extension Period|On Treatment|17|||
19775332|NCT02322814|42230163|FG000|Overall Study|Death|7|||
19775333|NCT02322814|42230164|FG001|Overall Study|Death|29|||
19775334|NCT02322814|42230165|FG002|Overall Study|Death|32|||
19775335|NCT02322814|42230166|FG003|Overall Study|Death|23|||
19775336|NCT02322814|42230167|FG004|Overall Study|Death|14|||
19775337|NCT02322814|42230163|FG000|Overall Study|Lost to Follow-up|1|||
19775338|NCT02322814|42230164|FG001|Overall Study|Lost to Follow-up|3|||
19775339|NCT02322814|42230165|FG002|Overall Study|Lost to Follow-up|3|||
19775340|NCT02322814|42230166|FG003|Overall Study|Lost to Follow-up|1|||
19775341|NCT02322814|42230167|FG004|Overall Study|Lost to Follow-up|0|||
19775342|NCT02322814|42230163|FG000|Overall Study|Various Reasons|2|||
19775343|NCT02322814|42230164|FG001|Overall Study|Various Reasons|0|||
19775344|NCT02322814|42230165|FG002|Overall Study|Various Reasons|1|||
19775345|NCT02322814|42230166|FG003|Overall Study|Various Reasons|1|||
19775346|NCT02322814|42230167|FG004|Overall Study|Various Reasons|0|||
19606722|NCT00716482|42055398|FG000|Overall Study|technical/machine error|28|||
19606723|NCT00716482|42055398|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
19606724|NCT00716092|42055411|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
19606725|NCT00716092|42055412|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
19606726|NCT00716092|42055413|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
19606727|NCT00715624|42055423|FG000|Overall Study|Adverse Event|12|||
19606728|NCT00715624|42055424|FG001|Overall Study|Adverse Event|37|||
19606729|NCT00715624|42055423|FG000|Overall Study|Lack of Efficacy|11|||
19606730|NCT00715624|42055424|FG001|Overall Study|Lack of Efficacy|11|||
19606731|NCT00715624|42055423|FG000|Overall Study|Lost to Follow-up|1|||
19606732|NCT00715624|42055424|FG001|Overall Study|Lost to Follow-up|2|||
19606733|NCT00715624|42055423|FG000|Overall Study|Protocol Violation|1|||
19606734|NCT00715624|42055424|FG001|Overall Study|Protocol Violation|0|||
19606735|NCT00715624|42055423|FG000|Overall Study|Withdrawal by Subject|11|||
19606736|NCT00715624|42055424|FG001|Overall Study|Withdrawal by Subject|25|||
19606737|NCT00715624|42055423|FG000|Overall Study|Familial and personal reasons|10|||
19606738|NCT00715624|42055424|FG001|Overall Study|Familial and personal reasons|22|||
19606739|NCT00715624|42055423|FG000|Overall Study|Poor compliance|6|||
19606740|NCT00715624|42055424|FG001|Overall Study|Poor compliance|13|||
19606741|NCT00715624|42055423|FG000|Overall Study|Sponsor decision|0|||
19606742|NCT00715624|42055424|FG001|Overall Study|Sponsor decision|4|||
19606743|NCT00715624|42055423|FG000|Overall Study|Incorrect randomization (not treated)|0|||
19692470|NCT00110890|42138193|FG000|Overall Study|Adverse Event|30|||
19692471|NCT00110890|42138194|FG001|Overall Study|Adverse Event|7|||
19775347|NCT02322814|42230163|FG000|Overall Study|Progressive Disease|0|||
19775348|NCT02322814|42230164|FG001|Overall Study|Progressive Disease|0|||
19775349|NCT02322814|42230165|FG002|Overall Study|Progressive Disease|0|||
19775350|NCT02322814|42230166|FG003|Overall Study|Progressive Disease|1|||
19775351|NCT02322814|42230167|FG004|Overall Study|Progressive Disease|1|||
19775352|NCT02322814|42230163|FG000|Overall Study|Protocol Violation|1|||
19775353|NCT02322814|42230164|FG001|Overall Study|Protocol Violation|0|||
19775354|NCT02322814|42230165|FG002|Overall Study|Protocol Violation|0|||
19775355|NCT02322814|42230166|FG003|Overall Study|Protocol Violation|0|||
19367241|NCT02435992|41607418|FG003|Overall Study|Adverse Event|0|||
19692472|NCT00110890|42138193|FG000|Overall Study|Death|16|||
19692473|NCT00110890|42138194|FG001|Overall Study|Death|9|||
19692474|NCT00110890|42138193|FG000|Overall Study|Lost to Follow-up|3|||
19692475|NCT00110890|42138194|FG001|Overall Study|Lost to Follow-up|1|||
19692476|NCT00110890|42138193|FG000|Overall Study|Physician Decision|4|||
19692477|NCT00110890|42138194|FG001|Overall Study|Physician Decision|5|||
19692478|NCT00110890|42138193|FG000|Overall Study|Withdrawal by Subject|17|||
19692479|NCT00110890|42138194|FG001|Overall Study|Withdrawal by Subject|5|||
19692480|NCT00110890|42138193|FG000|Overall Study|Protocol Deviation|1|||
19692481|NCT00110890|42138194|FG001|Overall Study|Protocol Deviation|0|||
19775356|NCT02322814|42230167|FG004|Overall Study|Protocol Violation|0|||
19775357|NCT02322814|42230163|FG000|Overall Study|Study Terminated by Sponsor|0|||
19775358|NCT02322814|42230164|FG001|Overall Study|Study Terminated by Sponsor|7|||
19775359|NCT02322814|42230165|FG002|Overall Study|Study Terminated by Sponsor|9|||
19775360|NCT02322814|42230166|FG003|Overall Study|Study Terminated by Sponsor|5|||
19775361|NCT02322814|42230167|FG004|Overall Study|Study Terminated by Sponsor|13|||
19775362|NCT02322814|42230163|FG000|Overall Study|Withdrawal by Subject|5|||
19775363|NCT02322814|42230164|FG001|Overall Study|Withdrawal by Subject|4|||
19775364|NCT02322814|42230165|FG002|Overall Study|Withdrawal by Subject|2|||
19775365|NCT02322814|42230166|FG003|Overall Study|Withdrawal by Subject|1|||
19775366|NCT02322814|42230167|FG004|Overall Study|Withdrawal by Subject|3|||
19775367|NCT02277444|42230187|FG000|Overall Study|Adverse Event|10|||
19775368|NCT02277444|42230187|FG000|Overall Study|Withdrawal by Subject|3|||
19775369|NCT02277444|42230187|FG000|Overall Study|Other|1|||
19775370|NCT02277444|42230187|FG000|Overall Study|Enrolled and not Treated|3|||
19775371|NCT02277444|42230187|FG000|Overall Study|Ongoing|113|||
19775372|NCT02257736|42230193|FG000|Overall Study|Progressive disease|365|||
19775373|NCT02257736|42230194|FG001|Overall Study|Progressive disease|327|||
19775374|NCT02257736|42230193|FG000|Overall Study|Adverse Event|45|||
19775375|NCT02257736|42230194|FG001|Overall Study|Adverse Event|56|||
19775376|NCT02257736|42230193|FG000|Overall Study|Withdrawal by Subject|21|||
19775377|NCT02257736|42230194|FG001|Overall Study|Withdrawal by Subject|38|||
19775378|NCT02257736|42230193|FG000|Overall Study|Death|11|||
19775379|NCT02257736|42230194|FG001|Overall Study|Death|6|||
19775380|NCT02257736|42230193|FG000|Overall Study|Physician Decision|5|||
19775381|NCT02257736|42230194|FG001|Overall Study|Physician Decision|9|||
19775382|NCT02257736|42230193|FG000|Overall Study|Non-Compliance with study drug|1|||
19775383|NCT02257736|42230194|FG001|Overall Study|Non-Compliance with study drug|2|||
19775384|NCT02257736|42230193|FG000|Overall Study|Protocol Violation|1|||
19775385|NCT02257736|42230194|FG001|Overall Study|Protocol Violation|0|||
19775386|NCT02257736|42230193|FG000|Overall Study|Other|1|||
19775387|NCT02257736|42230194|FG001|Overall Study|Other|7|||
19775388|NCT02257736|42230193|FG000|Overall Study|Randomized, not treated|1|||
19775389|NCT02257736|42230194|FG001|Overall Study|Randomized, not treated|2|||
19775390|NCT02252172|42230202|FG000|Overall Study|Lost to Follow-up|3|||
19775391|NCT02252172|42230203|FG001|Overall Study|Lost to Follow-up|1|||
19775392|NCT02252172|42230202|FG000|Overall Study|Ongoing|276|||
19775393|NCT02252172|42230203|FG001|Overall Study|Ongoing|298|||
19775394|NCT02195479|42230211|FG000|Overall Study|Lost to Follow-up|3|||
19775395|NCT02195479|42230212|FG001|Overall Study|Lost to Follow-up|0|||
19775396|NCT02195479|42230211|FG000|Overall Study|Death|48|||
19775397|NCT02195479|42230212|FG001|Overall Study|Death|45|||
19775398|NCT02195479|42230211|FG000|Overall Study|Physician Decision|1|||
19775399|NCT02195479|42230212|FG001|Overall Study|Physician Decision|0|||
19775400|NCT02195479|42230211|FG000|Overall Study|Withdrawal by Subject|11|||
19775401|NCT02195479|42230212|FG001|Overall Study|Withdrawal by Subject|6|||
19775402|NCT02195479|42230211|FG000|Overall Study|Other|2|||
19775403|NCT02195479|42230212|FG001|Overall Study|Other|2|||
19775404|NCT02195479|42230211|FG000|Overall Study|Ongoing|291|||
19775405|NCT02195479|42230212|FG001|Overall Study|Ongoing|297|||
19775406|NCT02136134|42230220|FG000|Overall Study|Death|35|||
19775407|NCT02136134|42230221|FG001|Overall Study|Death|29|||
19775408|NCT02136134|42230220|FG000|Overall Study|Withdrawal by Subject|14|||
19775409|NCT02136134|42230221|FG001|Overall Study|Withdrawal by Subject|4|||
19775410|NCT02136134|42230220|FG000|Overall Study|Other|3|||
19775411|NCT02136134|42230221|FG001|Overall Study|Other|3|||
19775412|NCT02136134|42230220|FG000|Overall Study|Ongoing|185|||
19775413|NCT02136134|42230221|FG001|Overall Study|Ongoing|207|||
19775414|NCT02136134|42230220|FG000|Overall Study|Subjects randomized but not treated|10|||
19775415|NCT02136134|42230221|FG001|Overall Study|Subjects randomized but not treated|8|||
19775416|NCT02108964|42230235|FG000|Overall Study|Progressive disease|12|||
19775417|NCT02108964|42230236|FG001|Overall Study|Progressive disease|25|||
19775418|NCT02108964|42230237|FG002|Overall Study|Progressive disease|50|||
19775419|NCT02108964|42230238|FG003|Overall Study|Progressive disease|6|||
19775420|NCT02108964|42230239|FG004|Overall Study|Progressive disease|18|||
19775421|NCT02108964|42230240|FG005|Overall Study|Progressive disease|5|||
19775422|NCT02108964|42230241|FG006|Overall Study|Progressive disease|7|||
19775423|NCT02108964|42230242|FG007|Overall Study|Progressive disease|9|||
19775424|NCT02108964|42230235|FG000|Overall Study|Physician Decision|1|||
19775425|NCT02108964|42230236|FG001|Overall Study|Physician Decision|5|||
19775426|NCT02108964|42230237|FG002|Overall Study|Physician Decision|6|||
19775427|NCT02108964|42230238|FG003|Overall Study|Physician Decision|0|||
19775428|NCT02108964|42230239|FG004|Overall Study|Physician Decision|1|||
19775429|NCT02108964|42230240|FG005|Overall Study|Physician Decision|0|||
19775430|NCT02108964|42230241|FG006|Overall Study|Physician Decision|0|||
19775431|NCT02108964|42230242|FG007|Overall Study|Physician Decision|0|||
19775432|NCT02108964|42230235|FG000|Overall Study|Adverse Event|0|||
19775433|NCT02108964|42230236|FG001|Overall Study|Adverse Event|0|||
19775434|NCT02108964|42230237|FG002|Overall Study|Adverse Event|4|||
19775435|NCT02108964|42230238|FG003|Overall Study|Adverse Event|0|||
19775436|NCT02108964|42230239|FG004|Overall Study|Adverse Event|1|||
19775437|NCT02108964|42230240|FG005|Overall Study|Adverse Event|0|||
19775438|NCT02108964|42230241|FG006|Overall Study|Adverse Event|3|||
19775439|NCT02108964|42230242|FG007|Overall Study|Adverse Event|1|||
19775440|NCT02108964|42230235|FG000|Overall Study|Death|1|||
19775441|NCT02108964|42230236|FG001|Overall Study|Death|1|||
19775442|NCT02108964|42230237|FG002|Overall Study|Death|2|||
19775443|NCT02108964|42230238|FG003|Overall Study|Death|0|||
19775444|NCT02108964|42230239|FG004|Overall Study|Death|3|||
19775445|NCT02108964|42230240|FG005|Overall Study|Death|0|||
19775446|NCT02108964|42230241|FG006|Overall Study|Death|0|||
19775447|NCT02108964|42230242|FG007|Overall Study|Death|1|||
19775448|NCT02108964|42230235|FG000|Overall Study|Subject/Guardian decision|0|||
19775449|NCT02108964|42230236|FG001|Overall Study|Subject/Guardian decision|1|||
19775450|NCT02108964|42230237|FG002|Overall Study|Subject/Guardian decision|3|||
19775451|NCT02108964|42230238|FG003|Overall Study|Subject/Guardian decision|0|||
19775452|NCT02108964|42230239|FG004|Overall Study|Subject/Guardian decision|2|||
19775453|NCT02108964|42230240|FG005|Overall Study|Subject/Guardian decision|0|||
19775454|NCT02108964|42230241|FG006|Overall Study|Subject/Guardian decision|1|||
19775455|NCT02108964|42230242|FG007|Overall Study|Subject/Guardian decision|1|||
19775456|NCT02076009|42230263|FG000|Overall Study|Death|44|||
19775457|NCT02076009|42230264|FG001|Overall Study|Death|30|||
19775458|NCT02076009|42230263|FG000|Overall Study|Withdrawal by Subject|9|||
19775459|NCT02076009|42230264|FG001|Overall Study|Withdrawal by Subject|3|||
19775460|NCT02076009|42230263|FG000|Overall Study|Lost to Follow-up|1|||
19775461|NCT02076009|42230264|FG001|Overall Study|Lost to Follow-up|1|||
19775462|NCT02076009|42230263|FG000|Overall Study|Progressive disease|1|||
19775463|NCT02076009|42230264|FG001|Overall Study|Progressive disease|0|||
19775464|NCT02076009|42230263|FG000|Overall Study|Ongoing|226|||
19775465|NCT02076009|42230264|FG001|Overall Study|Ongoing|249|||
19775466|NCT02076009|42230263|FG000|Overall Study|Subjects randomized but not treated|2|||
19775467|NCT02076009|42230264|FG001|Overall Study|Subjects randomized but not treated|3|||
19775468|NCT01946204|42230272|FG000|Overall Study|Death|38|||
19775469|NCT01946204|42230273|FG001|Overall Study|Death|59|||
19775470|NCT01946204|42230272|FG000|Overall Study|Withdrawal by Subject|37|||
19775471|NCT01946204|42230273|FG001|Overall Study|Withdrawal by Subject|50|||
19775472|NCT01946204|42230272|FG000|Overall Study|Lost to Follow-up|3|||
19775473|NCT01946204|42230273|FG001|Overall Study|Lost to Follow-up|7|||
19775474|NCT01946204|42230272|FG000|Overall Study|Ongoing|316|||
19775475|NCT01946204|42230273|FG001|Overall Study|Ongoing|687|||
19775476|NCT01946204|42230272|FG000|Overall Study|Other|7|||
19775477|NCT01946204|42230273|FG001|Overall Study|Other|3|||
19775478|NCT01776840|42230281|FG000|Overall Study|Lost to Follow-up|4|||
19775479|NCT01776840|42230282|FG001|Overall Study|Lost to Follow-up|4|||
19775480|NCT01776840|42230281|FG000|Overall Study|Withdrawal by Subject|42|||
19775481|NCT01776840|42230282|FG001|Overall Study|Withdrawal by Subject|22|||
19775482|NCT01776840|42230281|FG000|Overall Study|Ongoing|112|||
19775483|NCT01776840|42230282|FG001|Overall Study|Ongoing|129|||
19775484|NCT01615029|42230293|FG000|Overall Study|Adverse Event|0|||
19775485|NCT01615029|42230294|FG001|Overall Study|Adverse Event|0|||
19775486|NCT01615029|42230295|FG002|Overall Study|Adverse Event|0|||
19775487|NCT01615029|42230296|FG003|Overall Study|Adverse Event|0|||
19775488|NCT01615029|42230297|FG004|Overall Study|Adverse Event|1|||
19775489|NCT01615029|42230293|FG000|Overall Study|Death|0|||
19775490|NCT01615029|42230294|FG001|Overall Study|Death|0|||
19775491|NCT01615029|42230295|FG002|Overall Study|Death|0|||
19775492|NCT01615029|42230296|FG003|Overall Study|Death|0|||
19775493|NCT01615029|42230297|FG004|Overall Study|Death|1|||
19775494|NCT01615029|42230293|FG000|Overall Study|Lost to Follow-up|0|||
19775495|NCT01615029|42230294|FG001|Overall Study|Lost to Follow-up|0|||
19775496|NCT01615029|42230295|FG002|Overall Study|Lost to Follow-up|0|||
19775497|NCT01615029|42230296|FG003|Overall Study|Lost to Follow-up|0|||
19775498|NCT01615029|42230297|FG004|Overall Study|Lost to Follow-up|1|||
19775499|NCT01615029|42230293|FG000|Overall Study|Progressive disease|2|||
19775500|NCT01615029|42230294|FG001|Overall Study|Progressive disease|1|||
19775501|NCT01615029|42230295|FG002|Overall Study|Progressive disease|1|||
19775502|NCT01615029|42230296|FG003|Overall Study|Progressive disease|1|||
19775503|NCT01615029|42230297|FG004|Overall Study|Progressive disease|5|||
19775504|NCT01615029|42230293|FG000|Overall Study|Physician Decision|0|||
19775505|NCT01615029|42230294|FG001|Overall Study|Physician Decision|0|||
19775506|NCT01615029|42230295|FG002|Overall Study|Physician Decision|0|||
19367242|NCT02435992|41607419|FG004|Overall Study|Adverse Event|0|||
19775507|NCT01615029|42230296|FG003|Overall Study|Physician Decision|0|||
19775508|NCT01615029|42230297|FG004|Overall Study|Physician Decision|1|||
19775509|NCT01615029|42230293|FG000|Overall Study|Ongoing|1|||
19775510|NCT01615029|42230294|FG001|Overall Study|Ongoing|2|||
19775511|NCT01615029|42230295|FG002|Overall Study|Ongoing|3|||
19775512|NCT01615029|42230296|FG003|Overall Study|Ongoing|2|||
19775513|NCT01615029|42230297|FG004|Overall Study|Ongoing|23|||
19775514|NCT01333033|42230311|FG000|Overall Study|Ineligible|0|||
19775515|NCT01333033|42230312|FG001|Overall Study|Ineligible|0|||
19775516|NCT01333033|42230313|FG002|Overall Study|Ineligible|0|||
19775517|NCT01333033|42230314|FG003|Overall Study|Ineligible|0|||
19775518|NCT01333033|42230315|FG004|Overall Study|Ineligible|6|||
19775519|NCT01333033|42230316|FG005|Overall Study|Ineligible|8|||
19775520|NCT01333033|42230311|FG000|Overall Study|Withdrawal by Subject|0|||
19775521|NCT01333033|42230312|FG001|Overall Study|Withdrawal by Subject|0|||
19775522|NCT01333033|42230313|FG002|Overall Study|Withdrawal by Subject|0|||
19775523|NCT01333033|42230314|FG003|Overall Study|Withdrawal by Subject|0|||
19775524|NCT01333033|42230315|FG004|Overall Study|Withdrawal by Subject|4|||
19775525|NCT01333033|42230316|FG005|Overall Study|Withdrawal by Subject|2|||
19775526|NCT01333033|42230311|FG000|Overall Study|PET inevaluable|0|||
19775527|NCT01333033|42230312|FG001|Overall Study|PET inevaluable|0|||
19775528|NCT01333033|42230313|FG002|Overall Study|PET inevaluable|0|||
19775529|NCT01333033|42230314|FG003|Overall Study|PET inevaluable|0|||
19775530|NCT01333033|42230315|FG004|Overall Study|PET inevaluable|2|||
19775531|NCT01333033|42230316|FG005|Overall Study|PET inevaluable|4|||
19775532|NCT01333033|42230311|FG000|Overall Study|Adverse Event|0|||
19775533|NCT01333033|42230312|FG001|Overall Study|Adverse Event|0|||
19775534|NCT01333033|42230313|FG002|Overall Study|Adverse Event|0|||
19775535|NCT01333033|42230314|FG003|Overall Study|Adverse Event|0|||
19775536|NCT01333033|42230315|FG004|Overall Study|Adverse Event|2|||
19775537|NCT01333033|42230316|FG005|Overall Study|Adverse Event|1|||
19775538|NCT01333033|42230311|FG000|Overall Study|Progression|0|||
19775539|NCT01333033|42230312|FG001|Overall Study|Progression|0|||
19775540|NCT01333033|42230313|FG002|Overall Study|Progression|0|||
19775541|NCT01333033|42230314|FG003|Overall Study|Progression|0|||
19775542|NCT01333033|42230315|FG004|Overall Study|Progression|0|||
19775543|NCT01333033|42230316|FG005|Overall Study|Progression|1|||
19775544|NCT01333033|42230311|FG000|Overall Study|MD Decision|0|||
19775545|NCT01333033|42230312|FG001|Overall Study|MD Decision|0|||
19775546|NCT01333033|42230313|FG002|Overall Study|MD Decision|0|||
19775547|NCT01333033|42230314|FG003|Overall Study|MD Decision|0|||
19775548|NCT01333033|42230315|FG004|Overall Study|MD Decision|0|||
19775549|NCT01333033|42230316|FG005|Overall Study|MD Decision|2|||
19775550|NCT01314118|42230334|FG000|Overall Study|Adverse Event|9|||
19775551|NCT01314118|42230334|FG000|Overall Study|Progressive disease|27|||
19775552|NCT01314118|42230334|FG000|Overall Study|Physician Decision|11|||
19775553|NCT01314118|42230334|FG000|Overall Study|Death|4|||
19775554|NCT01314118|42230334|FG000|Overall Study|Protocol Violation|5|||
19775555|NCT01314118|42230334|FG000|Overall Study|Withdrawal by Subject|11|||
19775556|NCT01314118|42230334|FG000|Overall Study|Other|2|||
19775557|NCT01314118|42230334|FG000|Overall Study|Ongoing|62|||
19775558|NCT01192776|42230342|FG000|Overall Study|Death|8|||
19775559|NCT01192776|42230343|FG001|Overall Study|Death|15|||
19775560|NCT01192776|42230344|FG002|Overall Study|Death|18|||
19775561|NCT01192776|42230345|FG003|Overall Study|Death|15|||
19692482|NCT00110890|42138193|FG000|Overall Study|Noncompliance|10|||
19692483|NCT00110890|42138194|FG001|Overall Study|Noncompliance|0|||
19692484|NCT00110890|42138193|FG000|Overall Study|Kidney Transplant|16|||
19692485|NCT00110890|42138194|FG001|Overall Study|Kidney Transplant|12|||
19692486|NCT00110890|42138193|FG000|Overall Study|Invest. Product Commercially Available|217|||
19692487|NCT00110890|42138194|FG001|Overall Study|Invest. Product Commercially Available|110|||
19692488|NCT00110890|42138193|FG000|Overall Study|Other|34|||
19692489|NCT00110890|42138194|FG001|Overall Study|Other|23|||
19692490|NCT00110890|42138193|FG000|Overall Study|Ineligibility determined|3|||
19692491|NCT00110890|42138194|FG001|Overall Study|Ineligibility determined|0|||
19692492|NCT00110890|42138193|FG000|Overall Study|Requirement for alternative therapy|0|||
19692493|NCT00110890|42138194|FG001|Overall Study|Requirement for alternative therapy|1|||
19692494|NCT00110890|42138193|FG000|Overall Study|Disease progression|0|||
19692495|NCT00110890|42138194|FG001|Overall Study|Disease progression|1|||
19692496|NCT00110890|42138193|FG000|Overall Study|Parathyroidectomy|0|||
19692497|NCT00110890|42138194|FG001|Overall Study|Parathyroidectomy|1|||
19692498|NCT00110890|42138193|FG000|Overall Study|Did not enter follow-up phase|10|||
19692499|NCT00110890|42138194|FG001|Overall Study|Did not enter follow-up phase|4|||
19692500|NCT00182637|42138200|FG000|Overall Study|Adverse Event|2|||
19692501|NCT00182637|42138200|FG000|Overall Study|Disease Progression|1|||
19692502|NCT00182325|42138207|FG000|Overall Study|Lost to Follow-up|7|||
19775562|NCT01192776|42230342|FG000|Overall Study|Lost to Follow-up|3|||
19775563|NCT01192776|42230343|FG001|Overall Study|Lost to Follow-up|6|||
19775564|NCT01192776|42230344|FG002|Overall Study|Lost to Follow-up|3|||
19692503|NCT00182325|42138208|FG001|Overall Study|Lost to Follow-up|7|||
19692504|NCT00182325|42138207|FG000|Overall Study|Miscarriage|5|||
19692505|NCT00182325|42138208|FG001|Overall Study|Miscarriage|3|||
19692506|NCT00182325|42138207|FG000|Overall Study|Did not complete survey|22|||
19692507|NCT00182325|42138208|FG001|Overall Study|Did not complete survey|43|||
19775565|NCT01192776|42230345|FG003|Overall Study|Lost to Follow-up|5|||
19775566|NCT01171898|42230361|FG000|Overall Study|Death|0|||
19775567|NCT01171898|42230362|FG001|Overall Study|Death|0|||
19775568|NCT01171898|42230363|FG002|Overall Study|Death|2|||
19775569|NCT01171898|42230364|FG003|Overall Study|Death|0|||
19775570|NCT01171898|42230361|FG000|Overall Study|Lost to Follow-up|0|||
19775571|NCT01171898|42230362|FG001|Overall Study|Lost to Follow-up|1|||
19775572|NCT01171898|42230363|FG002|Overall Study|Lost to Follow-up|1|||
19775573|NCT01171898|42230364|FG003|Overall Study|Lost to Follow-up|1|||
19775574|NCT01171898|42230361|FG000|Overall Study|Withdrawal by Subject|1|||
19775575|NCT01171898|42230362|FG001|Overall Study|Withdrawal by Subject|4|||
19775576|NCT01171898|42230363|FG002|Overall Study|Withdrawal by Subject|6|||
19775577|NCT01171898|42230364|FG003|Overall Study|Withdrawal by Subject|3|||
19775578|NCT01171898|42230361|FG000|Overall Study|Terminated by Sponsor|1|||
19775579|NCT01171898|42230362|FG001|Overall Study|Terminated by Sponsor|0|||
19775580|NCT01171898|42230363|FG002|Overall Study|Terminated by Sponsor|0|||
19775581|NCT01171898|42230364|FG003|Overall Study|Terminated by Sponsor|0|||
19775582|NCT01171898|42230361|FG000|Overall Study|Ongoing|1|||
19775583|NCT01171898|42230362|FG001|Overall Study|Ongoing|9|||
19775584|NCT01171898|42230363|FG002|Overall Study|Ongoing|3|||
19775585|NCT01171898|42230364|FG003|Overall Study|Ongoing|0|||
19775586|NCT01171898|42230361|FG000|Overall Study|Other|1|||
19775587|NCT01171898|42230362|FG001|Overall Study|Other|5|||
19775588|NCT01171898|42230363|FG002|Overall Study|Other|0|||
19775589|NCT01171898|42230364|FG003|Overall Study|Other|2|||
19775590|NCT00980538|42230377|FG000|Overall Study|Lost to Follow-up|20|||
19775591|NCT00980538|42230377|FG000|Overall Study|Sponsor's Decision|4|||
19775592|NCT00980538|42230377|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
19775593|NCT00980538|42230377|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
19775594|NCT00980538|42230377|FG000|Overall Study|Switch to Commercially Available Medication|25|||
19775595|NCT00980538|42230377|FG000|Overall Study|Participant Non-Compliant|9|||
19775596|NCT00980538|42230377|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
19775597|NCT00980538|42230377|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
19775598|NCT00980538|42230377|FG000|Overall Study|Other|60|||
19775599|NCT00980538|42230377|FG000|Overall Study|Other|1|||
19775600|NCT01367834|42230402|FG000|Overall Study|Withdrawal by Subject|2|||
19775601|NCT01367834|42230403|FG001|Overall Study|Withdrawal by Subject|2|||
19775602|NCT01367834|42230402|FG000|Overall Study|Study was ended.|0|||
19775603|NCT01367834|42230403|FG001|Overall Study|Study was ended.|1|||
19775604|NCT03106753|42230411|FG000|Overall Study|Withdrawal by Subject|0|||
19775605|NCT03106753|42230412|FG001|Overall Study|Withdrawal by Subject|1|||
19775606|NCT03045081|42230422|FG000|Overall Study|Withdrawal by Subject|6|||
19775607|NCT03045081|42230423|FG001|Overall Study|Withdrawal by Subject|11|||
19775608|NCT03107377|42230431|FG000|Overall Study|Adverse Event|3|||
19775609|NCT03107377|42230432|FG001|Overall Study|Adverse Event|3|||
19775610|NCT03107377|42230431|FG000|Overall Study|Protocol Violation|9|||
19775611|NCT03107377|42230432|FG001|Overall Study|Protocol Violation|12|||
19692508|NCT00122278|42138216|FG000|Overall Study|Lost to Follow-up|2|||
19692509|NCT00122278|42138217|FG001|Overall Study|Lost to Follow-up|0|||
19692510|NCT00182091|42138227|FG000|Overall Study|Withdrawal by Subject|1|||
19692511|NCT00182091|42138228|FG001|Overall Study|Withdrawal by Subject|0|||
19692512|NCT00182091|42138229|FG002|Overall Study|Withdrawal by Subject|0|||
19692513|NCT00182091|42138230|FG003|Overall Study|Withdrawal by Subject|0|||
19692514|NCT00181155|42138238|FG000|Overall Study|Physician Decision|1|||
19692515|NCT00181155|42138239|FG001|Overall Study|Physician Decision|0|||
19692516|NCT00181155|42138238|FG000|Overall Study|Withdrawal by Subject|1|||
19692517|NCT00181155|42138239|FG001|Overall Study|Withdrawal by Subject|0|||
19692518|NCT00322452|42138248|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19692519|NCT00322452|42138249|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19692520|NCT00322452|42138248|FG000|Overall Study|Lost to Follow-up|5|||
19692521|NCT00322452|42138249|FG001|Overall Study|Lost to Follow-up|2|||
19692522|NCT00322452|42138248|FG000|Overall Study|Withdrawal by Subject|19|||
19692523|NCT00322452|42138249|FG001|Overall Study|Withdrawal by Subject|46|||
19692524|NCT00322452|42138248|FG000|Overall Study|Death|223|||
19692525|NCT00322452|42138249|FG001|Overall Study|Death|227|||
19692526|NCT00110812|42138258|FG000|Main Study|Death|0|||
19692527|NCT00110812|42138259|FG001|Main Study|Death|0|||
19692528|NCT00110812|42138260|FG002|Main Study|Death|2|||
19692529|NCT00110812|42138258|FG000|Main Study|Withdrawal by Subject|0|||
19692530|NCT00110812|42138259|FG001|Main Study|Withdrawal by Subject|0|||
19692531|NCT00110812|42138260|FG002|Main Study|Withdrawal by Subject|1|||
19692532|NCT00110812|42138258|FG000|Main Study|Lost to Follow-up|8|||
19692533|NCT00110812|42138259|FG001|Main Study|Lost to Follow-up|11|||
19692534|NCT00110812|42138260|FG002|Main Study|Lost to Follow-up|10|||
19692535|NCT00110812|42138258|FG000|Extended Follow-up|Death|1|||
19692536|NCT00110812|42138259|FG001|Extended Follow-up|Death|0|||
19692537|NCT00110812|42138260|FG002|Extended Follow-up|Death|3|||
19692538|NCT00110812|42138258|FG000|Extended Follow-up|Withdrawal by Subject|0|||
19775612|NCT03107377|42230431|FG000|Overall Study|Physician Decision|3|||
19692539|NCT00110812|42138259|FG001|Extended Follow-up|Withdrawal by Subject|1|||
19692540|NCT00110812|42138260|FG002|Extended Follow-up|Withdrawal by Subject|0|||
19692541|NCT00110812|42138258|FG000|Extended Follow-up|Lost to Follow-up|1|||
19692542|NCT00110812|42138259|FG001|Extended Follow-up|Lost to Follow-up|3|||
19692543|NCT00110812|42138260|FG002|Extended Follow-up|Lost to Follow-up|1|||
19692544|NCT00516269|42138275|FG000|Overall Study|Adverse Event|2|||
19692545|NCT00516269|42138276|FG001|Overall Study|Adverse Event|1|||
19775613|NCT03107377|42230432|FG001|Overall Study|Physician Decision|6|||
19775614|NCT03107377|42230431|FG000|Overall Study|Pregnancy|7|||
19775615|NCT03107377|42230432|FG001|Overall Study|Pregnancy|7|||
19775616|NCT03107377|42230431|FG000|Overall Study|Withdrawal by Subject|16|||
19775617|NCT03107377|42230432|FG001|Overall Study|Withdrawal by Subject|22|||
19775618|NCT03107377|42230431|FG000|Overall Study|Lost to Follow-up|37|||
19775619|NCT03107377|42230432|FG001|Overall Study|Lost to Follow-up|34|||
19775620|NCT03107377|42230431|FG000|Overall Study|Other reason not specified|16|||
19775621|NCT03107377|42230432|FG001|Overall Study|Other reason not specified|15|||
19775622|NCT02545283|42230440|FG000|Overall Study|Lost to Follow-up|2|||
19775623|NCT02545283|42230441|FG001|Overall Study|Lost to Follow-up|4|||
19775624|NCT02545283|42230440|FG000|Overall Study|Withdrawal by Subject|5|||
19775625|NCT02545283|42230441|FG001|Overall Study|Withdrawal by Subject|9|||
19775626|NCT02545283|42230440|FG000|Overall Study|Death|109|||
19775627|NCT02545283|42230441|FG001|Overall Study|Death|211|||
19775628|NCT02545283|42230440|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
19775629|NCT02545283|42230441|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
19775630|NCT02545283|42230440|FG000|Overall Study|Study Terminated By Sponsor|33|||
19775631|NCT02545283|42230441|FG001|Overall Study|Study Terminated By Sponsor|71|||
19775632|NCT03282565|42230452|FG000|Overall Study|COVID-19 Research Shutdown|0|||
19775633|NCT03282565|42230453|FG001|Overall Study|COVID-19 Research Shutdown|2|||
19775634|NCT03282565|42230454|FG002|Overall Study|COVID-19 Research Shutdown|2|||
19775635|NCT02875613|42230462|FG000|Overall Study|Withdrawal by Subject|1|||
19775636|NCT02815267|42230472|FG000|Double-Blind Phase|Adverse Event|0|||
19775637|NCT02815267|42230473|FG001|Double-Blind Phase|Adverse Event|3|||
19775638|NCT02815267|42230472|FG000|Double-Blind Phase|Lost to Follow-up|17|||
19775639|NCT02815267|42230473|FG001|Double-Blind Phase|Lost to Follow-up|9|||
19775640|NCT02815267|42230472|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
19775641|NCT02815267|42230473|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
19775642|NCT02815267|42230472|FG000|Double-Blind Phase|Protocol Violation|3|||
19775643|NCT02815267|42230473|FG001|Double-Blind Phase|Protocol Violation|2|||
19775644|NCT02815267|42230472|FG000|Double-Blind Phase|Site withdrawal|1|||
19775645|NCT02815267|42230473|FG001|Double-Blind Phase|Site withdrawal|6|||
19775646|NCT02815267|42230472|FG000|Double-Blind Phase|Received a disallowed medication|1|||
19775647|NCT02815267|42230473|FG001|Double-Blind Phase|Received a disallowed medication|1|||
19775648|NCT02815267|42230472|FG000|Open-Label Phase|Adverse Event|1|||
19775649|NCT02815267|42230473|FG001|Open-Label Phase|Adverse Event|1|||
19775650|NCT02815267|42230472|FG000|Open-Label Phase|Lost to Follow-up|23|||
19775651|NCT02815267|42230473|FG001|Open-Label Phase|Lost to Follow-up|9|||
19775652|NCT02815267|42230472|FG000|Open-Label Phase|Withdrawal by Subject|24|||
19775653|NCT02815267|42230473|FG001|Open-Label Phase|Withdrawal by Subject|13|||
19775654|NCT02815267|42230472|FG000|Open-Label Phase|Protocol Violation|0|||
19775655|NCT02815267|42230473|FG001|Open-Label Phase|Protocol Violation|1|||
19775656|NCT02815267|42230472|FG000|Open-Label Phase|Administrative|21|||
19775657|NCT02815267|42230473|FG001|Open-Label Phase|Administrative|12|||
19775658|NCT02815267|42230472|FG000|Open-Label Phase|Other|2|||
19775659|NCT02815267|42230473|FG001|Open-Label Phase|Other|5|||
19775660|NCT02930837|42230483|FG000|Overall Study|Adverse Event|6|||
19775661|NCT02930837|42230483|FG000|Overall Study|Lost to Follow-up|5|||
19775662|NCT02930837|42230483|FG000|Overall Study|Withdrawal by Subject|1|||
19775663|NCT01343277|42230489|FG000|Overall Study|Other|3|||
19775664|NCT01343277|42230490|FG001|Overall Study|Other|3|||
19775665|NCT01343277|42230489|FG000|Overall Study|Withdrawal by Subject|18|||
19775666|NCT01343277|42230490|FG001|Overall Study|Withdrawal by Subject|13|||
19775667|NCT01343277|42230489|FG000|Overall Study|Physician Decision|1|||
19775668|NCT01343277|42230490|FG001|Overall Study|Physician Decision|2|||
19775669|NCT01343277|42230489|FG000|Overall Study|Death|10|||
19775670|NCT01343277|42230490|FG001|Overall Study|Death|1|||
19775671|NCT01343277|42230489|FG000|Overall Study|Adverse Event|67|||
19775672|NCT01343277|42230490|FG001|Overall Study|Adverse Event|13|||
19775673|NCT01343277|42230489|FG000|Overall Study|Disease progression|270|||
19775674|NCT01343277|42230490|FG001|Overall Study|Disease progression|138|||
19775675|NCT01343277|42230489|FG000|Overall Study|Randomized not treated|6|||
19775676|NCT01343277|42230490|FG001|Overall Study|Randomized not treated|21|||
19367243|NCT02435992|41607415|FG000|Overall Study|Lack of Efficacy|4|||
19692546|NCT00516269|42138275|FG000|Overall Study|Lost to Follow-up|0|||
19692547|NCT00516269|42138276|FG001|Overall Study|Lost to Follow-up|1|||
19692548|NCT00516269|42138275|FG000|Overall Study|Protocol Violation|0|||
19692549|NCT00516269|42138276|FG001|Overall Study|Protocol Violation|1|||
19692550|NCT00229203|42138284|FG000|Overall Study|Progressive disease|18|||
19692551|NCT00229203|42138285|FG001|Overall Study|Progressive disease|9|||
19692552|NCT00229203|42138284|FG000|Overall Study|Toxicity|6|||
19692553|NCT00229203|42138285|FG001|Overall Study|Toxicity|1|||
19692554|NCT00229203|42138284|FG000|Overall Study|Death|4|||
19692555|NCT00229203|42138285|FG001|Overall Study|Death|2|||
19692556|NCT00229203|42138284|FG000|Overall Study|Other|3|||
19775677|NCT01343277|42230489|FG000|Overall Study|Treatment ongoing|8|||
19775678|NCT01343277|42230490|FG001|Overall Study|Treatment ongoing|2|||
19775679|NCT01343277|42230489|FG000|Overall Study|Subsequent anticancer therapy|1|||
19775680|NCT01343277|42230490|FG001|Overall Study|Subsequent anticancer therapy|0|||
19775681|NCT03135899|42230504|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775682|NCT03135899|42230505|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775683|NCT03135899|42230506|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775684|NCT03135899|42230507|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775685|NCT03135899|42230508|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775686|NCT03135899|42230509|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775687|NCT03135899|42230510|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
19775688|NCT03135899|42230511|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
19775689|NCT03135899|42230504|FG000|Overall Study|Withdrawal by Subject|0|||
19775690|NCT03135899|42230505|FG001|Overall Study|Withdrawal by Subject|0|||
19775691|NCT03135899|42230506|FG002|Overall Study|Withdrawal by Subject|0|||
19775692|NCT03135899|42230507|FG003|Overall Study|Withdrawal by Subject|0|||
19775693|NCT03135899|42230508|FG004|Overall Study|Withdrawal by Subject|0|||
19775694|NCT03135899|42230509|FG005|Overall Study|Withdrawal by Subject|2|||
19775695|NCT03135899|42230510|FG006|Overall Study|Withdrawal by Subject|0|||
19775696|NCT03135899|42230511|FG007|Overall Study|Withdrawal by Subject|0|||
19775697|NCT02487979|42230525|FG000|Overall Study|Physician Decision|2|||
19775698|NCT02487979|42230525|FG000|Overall Study|Withdrawal by Subject|2|||
19775699|NCT02487979|42230525|FG000|Overall Study|Progressive Disease|17|||
19775700|NCT03103087|42230536|FG000|Overall Study|Did not receive any study drug|1|||
19775701|NCT03103087|42230537|FG001|Overall Study|Did not receive any study drug|0|||
19775702|NCT03103087|42230538|FG002|Overall Study|Did not receive any study drug|0|||
19775703|NCT03103087|42230536|FG000|Overall Study|Protocol Violation|1|||
19775704|NCT03103087|42230537|FG001|Overall Study|Protocol Violation|2|||
19775705|NCT03103087|42230538|FG002|Overall Study|Protocol Violation|1|||
19775706|NCT03103087|42230536|FG000|Overall Study|Lack of Efficacy|2|||
19775707|NCT03103087|42230537|FG001|Overall Study|Lack of Efficacy|1|||
19775708|NCT03103087|42230538|FG002|Overall Study|Lack of Efficacy|1|||
19775709|NCT03103087|42230536|FG000|Overall Study|Pregnancy|0|||
19775710|NCT03103087|42230537|FG001|Overall Study|Pregnancy|0|||
19775711|NCT03103087|42230538|FG002|Overall Study|Pregnancy|1|||
19775712|NCT03103087|42230536|FG000|Overall Study|Adverse Event|2|||
19775713|NCT03103087|42230537|FG001|Overall Study|Adverse Event|15|||
19775714|NCT03103087|42230538|FG002|Overall Study|Adverse Event|6|||
19775715|NCT03103087|42230536|FG000|Overall Study|Withdrawal by Subject|13|||
19775716|NCT03103087|42230537|FG001|Overall Study|Withdrawal by Subject|6|||
19775717|NCT03103087|42230538|FG002|Overall Study|Withdrawal by Subject|6|||
19775718|NCT03103087|42230536|FG000|Overall Study|Lost to Follow-up|4|||
19692557|NCT00229203|42138285|FG001|Overall Study|Other|3|||
19775719|NCT03103087|42230537|FG001|Overall Study|Lost to Follow-up|2|||
19775720|NCT03103087|42230538|FG002|Overall Study|Lost to Follow-up|7|||
19775721|NCT03103087|42230536|FG000|Overall Study|Other reason not reported|1|||
19775722|NCT03103087|42230537|FG001|Overall Study|Other reason not reported|3|||
19775723|NCT03103087|42230538|FG002|Overall Study|Other reason not reported|5|||
19775724|NCT03132467|42230548|FG000|Overall Study|Adverse Event|2|||
19775725|NCT03132467|42230548|FG000|Overall Study|Withdrawal by Subject|2|||
19775726|NCT03131999|42230555|FG000|Overall Study|Withdrawal by Subject|0|||
19775727|NCT03131999|42230556|FG001|Overall Study|Withdrawal by Subject|1|||
19692558|NCT00229203|42138284|FG000|Overall Study|Withdrawal by Subject|1|||
19692559|NCT00229203|42138285|FG001|Overall Study|Withdrawal by Subject|4|||
19692560|NCT00228813|42138291|FG000|Overall Study|Death|4|||
19692561|NCT00322374|42138298|FG000|Starting Dose|Physician Decision|2|||
19692562|NCT00322374|42138299|FG001|Starting Dose|Physician Decision|0|||
19692563|NCT00322374|42138300|FG002|Starting Dose|Physician Decision|0|||
19775728|NCT02263885|42230571|FG000|Overall Study|Withdrawal by Subject|7|||
19775729|NCT02263885|42230571|FG000|Overall Study|Alternative Treatment|3|||
19775730|NCT02895360|42230582|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
19775731|NCT02895360|42230583|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
19775732|NCT02895360|42230584|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
19775733|NCT02895360|42230585|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
19775734|NCT02895360|42230586|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
19775735|NCT02895360|42230587|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
19775736|NCT02895360|42230582|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
19775737|NCT02895360|42230583|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
19775738|NCT02895360|42230584|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
19775739|NCT02895360|42230585|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
19692564|NCT00322374|42138301|FG003|Starting Dose|Physician Decision|0|||
19775740|NCT02895360|42230586|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
19775741|NCT02895360|42230587|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
19692565|NCT00322374|42138298|FG000|Starting Dose|Study Drug Toxicity|4|||
19692566|NCT00322374|42138299|FG001|Starting Dose|Study Drug Toxicity|0|||
19692567|NCT00322374|42138300|FG002|Starting Dose|Study Drug Toxicity|0|||
19775742|NCT02895360|42230582|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
19775743|NCT02895360|42230583|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
19775744|NCT02895360|42230584|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
19775745|NCT02895360|42230585|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
19775746|NCT02895360|42230586|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
19775747|NCT02895360|42230587|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
19775748|NCT02895360|42230582|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
19775749|NCT02895360|42230583|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
19775750|NCT02895360|42230584|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
19775751|NCT02895360|42230585|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
19775752|NCT02895360|42230586|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
19775753|NCT02895360|42230587|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
19775754|NCT02895360|42230582|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
19775755|NCT02895360|42230583|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
19606744|NCT00715624|42055424|FG001|Overall Study|Incorrect randomization (not treated)|1|||
19692568|NCT00322374|42138301|FG003|Starting Dose|Study Drug Toxicity|0|||
19692569|NCT00322374|42138298|FG000|First Escalation|Documented Disease Progression|0|||
19692570|NCT00322374|42138299|FG001|First Escalation|Documented Disease Progression|6|||
19692571|NCT00322374|42138300|FG002|First Escalation|Documented Disease Progression|0|||
19692572|NCT00322374|42138301|FG003|First Escalation|Documented Disease Progression|0|||
19692573|NCT00322374|42138298|FG000|First Escalation|Physician Decision|0|||
19692574|NCT00322374|42138299|FG001|First Escalation|Physician Decision|12|||
19692575|NCT00322374|42138300|FG002|First Escalation|Physician Decision|0|||
19692576|NCT00322374|42138301|FG003|First Escalation|Physician Decision|0|||
19692577|NCT00322374|42138298|FG000|First Escalation|Study Drug Toxicity|0|||
19692578|NCT00322374|42138299|FG001|First Escalation|Study Drug Toxicity|11|||
19692579|NCT00322374|42138300|FG002|First Escalation|Study Drug Toxicity|0|||
19692580|NCT00322374|42138301|FG003|First Escalation|Study Drug Toxicity|0|||
19692581|NCT00322374|42138298|FG000|First Escalation|Participant Request|0|||
19692582|NCT00322374|42138299|FG001|First Escalation|Participant Request|1|||
19692583|NCT00322374|42138300|FG002|First Escalation|Participant Request|0|||
19692584|NCT00322374|42138301|FG003|First Escalation|Participant Request|0|||
19692585|NCT00322374|42138298|FG000|Second Escalation|Physician Decision|0|||
19692586|NCT00322374|42138299|FG001|Second Escalation|Physician Decision|0|||
19692587|NCT00322374|42138300|FG002|Second Escalation|Physician Decision|5|||
19367244|NCT02435992|41607416|FG001|Overall Study|Lack of Efficacy|10|||
19606745|NCT00715624|42055423|FG000|Overall Study|Other|0|||
19606746|NCT00715624|42055424|FG001|Overall Study|Other|1|||
19606747|NCT00679783|42055437|FG000|Overall Study|Adverse Event|0|||
19606748|NCT00679783|42055438|FG001|Overall Study|Adverse Event|0|||
19606749|NCT00679783|42055439|FG002|Overall Study|Adverse Event|0|||
19606750|NCT00679783|42055440|FG003|Overall Study|Adverse Event|3|||
19606751|NCT00679783|42055441|FG004|Overall Study|Adverse Event|0|||
19606752|NCT00679783|42055442|FG005|Overall Study|Adverse Event|0|||
19606753|NCT00679783|42055443|FG006|Overall Study|Adverse Event|1|||
19606754|NCT00679783|42055437|FG000|Overall Study|Lack of Efficacy|0|||
19606755|NCT00679783|42055438|FG001|Overall Study|Lack of Efficacy|1|||
19606756|NCT00679783|42055439|FG002|Overall Study|Lack of Efficacy|0|||
19606757|NCT00679783|42055440|FG003|Overall Study|Lack of Efficacy|2|||
19606758|NCT00679783|42055441|FG004|Overall Study|Lack of Efficacy|0|||
19606759|NCT00679783|42055442|FG005|Overall Study|Lack of Efficacy|0|||
19606760|NCT00679783|42055443|FG006|Overall Study|Lack of Efficacy|0|||
19606761|NCT00679783|42055437|FG000|Overall Study|Withdrawal by Subject|0|||
19606762|NCT00679783|42055438|FG001|Overall Study|Withdrawal by Subject|0|||
19606763|NCT00679783|42055439|FG002|Overall Study|Withdrawal by Subject|1|||
19606764|NCT00679783|42055440|FG003|Overall Study|Withdrawal by Subject|1|||
19606765|NCT00679783|42055441|FG004|Overall Study|Withdrawal by Subject|0|||
19606766|NCT00679783|42055442|FG005|Overall Study|Withdrawal by Subject|0|||
19606767|NCT00679783|42055443|FG006|Overall Study|Withdrawal by Subject|0|||
19606768|NCT00679783|42055437|FG000|Overall Study|Not Captured|0|||
19606769|NCT00679783|42055438|FG001|Overall Study|Not Captured|0|||
19606770|NCT00679783|42055439|FG002|Overall Study|Not Captured|0|||
19606771|NCT00679783|42055440|FG003|Overall Study|Not Captured|5|||
19606772|NCT00679783|42055441|FG004|Overall Study|Not Captured|0|||
19606773|NCT00679783|42055442|FG005|Overall Study|Not Captured|0|||
19606774|NCT00679783|42055443|FG006|Overall Study|Not Captured|0|||
19606775|NCT00679783|42055437|FG000|Overall Study|Ongoing at data cut-off|2|||
19606776|NCT00679783|42055438|FG001|Overall Study|Ongoing at data cut-off|2|||
19606777|NCT00679783|42055439|FG002|Overall Study|Ongoing at data cut-off|0|||
19606778|NCT00679783|42055440|FG003|Overall Study|Ongoing at data cut-off|9|||
19606779|NCT00679783|42055441|FG004|Overall Study|Ongoing at data cut-off|1|||
19606780|NCT00679783|42055442|FG005|Overall Study|Ongoing at data cut-off|0|||
19692588|NCT00322374|42138301|FG003|Second Escalation|Physician Decision|0|||
19692589|NCT00322374|42138298|FG000|Second Escalation|Study Drug Toxicity|0|||
19692590|NCT00322374|42138299|FG001|Second Escalation|Study Drug Toxicity|0|||
19692591|NCT00322374|42138300|FG002|Second Escalation|Study Drug Toxicity|1|||
19692592|NCT00322374|42138301|FG003|Second Escalation|Study Drug Toxicity|0|||
19775756|NCT02895360|42230584|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
19692593|NCT00174447|42138314|FG000|Overall Study|Adverse Event|19|||
19692594|NCT00174447|42138314|FG000|Overall Study|Withdrawal by Subject|15|||
19692595|NCT00174447|42138314|FG000|Overall Study|Protocol Violation|1|||
19692596|NCT00174447|42138314|FG000|Overall Study|Lack of Efficacy|1|||
19775757|NCT02895360|42230585|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
19775758|NCT02895360|42230586|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
19775759|NCT02895360|42230587|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
19775760|NCT02895360|42230582|FG000|Phase 2a|Adverse Event|0|||
19775761|NCT02895360|42230583|FG001|Phase 2a|Adverse Event|0|||
19775762|NCT02895360|42230584|FG002|Phase 2a|Adverse Event|0|||
19775763|NCT02895360|42230585|FG003|Phase 2a|Adverse Event|0|||
19775764|NCT02895360|42230586|FG004|Phase 2a|Adverse Event|0|||
19775765|NCT02895360|42230587|FG005|Phase 2a|Adverse Event|1|||
19775766|NCT02895360|42230582|FG000|Phase 2a|Progressive disease|0|||
19775767|NCT02895360|42230583|FG001|Phase 2a|Progressive disease|0|||
19775768|NCT02895360|42230584|FG002|Phase 2a|Progressive disease|0|||
19775769|NCT02895360|42230585|FG003|Phase 2a|Progressive disease|0|||
19775770|NCT02895360|42230586|FG004|Phase 2a|Progressive disease|11|||
19775771|NCT02895360|42230587|FG005|Phase 2a|Progressive disease|11|||
19775772|NCT02000219|42230619|FG000|14-Week Study Period|Physician Decision|1|||
19775773|NCT02000219|42230619|FG000|14-Week Study Period|Adverse Event|1|||
19775774|NCT02000219|42230619|FG000|14-Week Study Period|Underwent transplantation|1|||
19692597|NCT00174447|42138314|FG000|Overall Study|Administrative reason/Other|2|||
19692598|NCT00321984|42138321|FG000|Overall Study|Adverse Event|9|||
19692599|NCT00321984|42138322|FG001|Overall Study|Adverse Event|6|||
19692600|NCT00321984|42138323|FG002|Overall Study|Adverse Event|8|||
19775775|NCT02000219|42230619|FG000|Continuation Period|Withdrawal by Subject|1|||
19775776|NCT02000219|42230619|FG000|Continuation Period|Had liver transplant|2|||
19775777|NCT02000219|42230619|FG000|Continuation Period|Non-compliance with study drug|2|||
19775778|NCT03101371|42230625|FG000|Overall Study|Physician Decision|0|||
19775779|NCT03101371|42230626|FG001|Overall Study|Physician Decision|1|||
19775780|NCT03101371|42230625|FG000|Overall Study|Lost to Follow-up|1|||
19775781|NCT03101371|42230626|FG001|Overall Study|Lost to Follow-up|4|||
19775782|NCT03101371|42230625|FG000|Overall Study|Did not meet eligibility criteria|2|||
19775783|NCT03101371|42230626|FG001|Overall Study|Did not meet eligibility criteria|1|||
19775784|NCT02850276|42230632|FG000|Overall Study|screen failure|43|||
19775785|NCT02850276|42230632|FG000|Overall Study|Withdrawal by Subject|14|||
19775786|NCT02850276|42230632|FG000|Overall Study|Physician Decision|2|||
19775787|NCT02850276|42230632|FG000|Overall Study|Lost to Follow-up|2|||
19775788|NCT02783768|42230637|FG000|Overall Study|Lost to Follow-up|1|||
19775789|NCT02783768|42230638|FG001|Overall Study|Lost to Follow-up|0|||
19775790|NCT03131687|42230650|FG000|Overall Study|Adverse Event|0|||
19775791|NCT03131687|42230651|FG001|Overall Study|Adverse Event|1|||
19775792|NCT03131687|42230652|FG002|Overall Study|Adverse Event|0|||
19775793|NCT03131687|42230653|FG003|Overall Study|Adverse Event|1|||
19775794|NCT03131687|42230654|FG004|Overall Study|Adverse Event|2|||
19775795|NCT03131687|42230655|FG005|Overall Study|Adverse Event|2|||
19775796|NCT03131687|42230650|FG000|Overall Study|Death|1|||
19775797|NCT03131687|42230651|FG001|Overall Study|Death|0|||
19775798|NCT03131687|42230652|FG002|Overall Study|Death|0|||
19775799|NCT03131687|42230653|FG003|Overall Study|Death|0|||
19775800|NCT03131687|42230654|FG004|Overall Study|Death|0|||
19775801|NCT03131687|42230655|FG005|Overall Study|Death|0|||
19775802|NCT03131687|42230650|FG000|Overall Study|Withdrawal by Subject|3|||
19775803|NCT03131687|42230651|FG001|Overall Study|Withdrawal by Subject|3|||
19775804|NCT03131687|42230652|FG002|Overall Study|Withdrawal by Subject|3|||
19775805|NCT03131687|42230653|FG003|Overall Study|Withdrawal by Subject|1|||
19775806|NCT03131687|42230654|FG004|Overall Study|Withdrawal by Subject|2|||
19775807|NCT03131687|42230655|FG005|Overall Study|Withdrawal by Subject|1|||
19775808|NCT03131687|42230650|FG000|Overall Study|Lost to Follow-up|1|||
19775809|NCT03131687|42230651|FG001|Overall Study|Lost to Follow-up|4|||
19775810|NCT03131687|42230652|FG002|Overall Study|Lost to Follow-up|0|||
19775811|NCT03131687|42230653|FG003|Overall Study|Lost to Follow-up|1|||
19775812|NCT03131687|42230654|FG004|Overall Study|Lost to Follow-up|4|||
19775813|NCT03131687|42230655|FG005|Overall Study|Lost to Follow-up|2|||
19775814|NCT03131687|42230650|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
19775815|NCT03131687|42230651|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
19775816|NCT03131687|42230652|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
19775817|NCT03131687|42230653|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
19775818|NCT03131687|42230654|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
19692601|NCT00321984|42138321|FG000|Overall Study|Protocol Violation|0|||
19692602|NCT00321984|42138322|FG001|Overall Study|Protocol Violation|1|||
19775819|NCT03131687|42230655|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
19692603|NCT00321984|42138323|FG002|Overall Study|Protocol Violation|1|||
19692604|NCT00321984|42138321|FG000|Overall Study|Lost to Follow-up|2|||
19775820|NCT03131687|42230650|FG000|Overall Study|Principle Investigator Decision|0|||
19775821|NCT03131687|42230651|FG001|Overall Study|Principle Investigator Decision|1|||
19775822|NCT03131687|42230652|FG002|Overall Study|Principle Investigator Decision|0|||
19692605|NCT00321984|42138322|FG001|Overall Study|Lost to Follow-up|4|||
19692606|NCT00321984|42138323|FG002|Overall Study|Lost to Follow-up|2|||
19692607|NCT00321984|42138321|FG000|Overall Study|Withdrawal by Subject|8|||
19692608|NCT00321984|42138322|FG001|Overall Study|Withdrawal by Subject|6|||
19692609|NCT00321984|42138323|FG002|Overall Study|Withdrawal by Subject|5|||
19692610|NCT00321984|42138321|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
19692611|NCT00321984|42138322|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
19692612|NCT00321984|42138323|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
19692613|NCT00321984|42138321|FG000|Overall Study|Lack of Efficacy|3|||
19692614|NCT00321984|42138322|FG001|Overall Study|Lack of Efficacy|1|||
19692615|NCT00321984|42138323|FG002|Overall Study|Lack of Efficacy|3|||
19692616|NCT00321984|42138321|FG000|Overall Study|Noncompliant|0|||
19692617|NCT00321984|42138322|FG001|Overall Study|Noncompliant|0|||
19692618|NCT00321984|42138323|FG002|Overall Study|Noncompliant|2|||
19692619|NCT00321984|42138321|FG000|Overall Study|Pregnancy|0|||
19692620|NCT00321984|42138322|FG001|Overall Study|Pregnancy|1|||
19692621|NCT00321984|42138323|FG002|Overall Study|Pregnancy|0|||
19692622|NCT00321984|42138321|FG000|Overall Study|Per Subject Request|1|||
19692623|NCT00321984|42138322|FG001|Overall Study|Per Subject Request|0|||
19692624|NCT00321984|42138323|FG002|Overall Study|Per Subject Request|0|||
19692625|NCT00321984|42138321|FG000|Overall Study|Per Investigator Request|1|||
19692626|NCT00321984|42138322|FG001|Overall Study|Per Investigator Request|0|||
19692627|NCT00321984|42138323|FG002|Overall Study|Per Investigator Request|0|||
19692628|NCT00321984|42138321|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
19692629|NCT00321984|42138322|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
19692630|NCT00321984|42138323|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
19692631|NCT00515099|42138333|FG000|Overall Study|Lost to Follow-up|0|||
19692632|NCT00515099|42138334|FG001|Overall Study|Lost to Follow-up|4|||
19692633|NCT00515099|42138333|FG000|Overall Study|Withdrawal by Subject|2|||
19692634|NCT00515099|42138334|FG001|Overall Study|Withdrawal by Subject|0|||
19692635|NCT00515099|42138333|FG000|Overall Study|IRB Recommendation|1|||
19692636|NCT00515099|42138334|FG001|Overall Study|IRB Recommendation|0|||
19692637|NCT00110266|42138340|FG000|Overall Study|Adverse Event|27|||
19692638|NCT00110266|42138340|FG000|Overall Study|Abnormal laboratory value|15|||
19692639|NCT00110266|42138340|FG000|Overall Study|Withdrawal by Subject|16|||
19692640|NCT00110266|42138340|FG000|Overall Study|Death|17|||
19692641|NCT00110266|42138340|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19692642|NCT00110266|42138340|FG000|Overall Study|Participant condition no longer requires study drug|1|||
19692643|NCT00174291|42138347|FG000|Overall Study|Lost to Follow-up|1|||
19692644|NCT00174291|42138348|FG001|Overall Study|Lost to Follow-up|1|||
19692645|NCT00174291|42138347|FG000|Overall Study|Protocol Violation|0|||
19692646|NCT00174291|42138348|FG001|Overall Study|Protocol Violation|2|||
19692647|NCT00174291|42138347|FG000|Overall Study|Study terminated by sponsor|1|||
19692648|NCT00174291|42138348|FG001|Overall Study|Study terminated by sponsor|0|||
19692649|NCT00174291|42138347|FG000|Overall Study|Withdrawal by Subject|3|||
19692650|NCT00174291|42138348|FG001|Overall Study|Withdrawal by Subject|3|||
19692651|NCT00366548|42138356|FG000|Infant Series|Adverse Event|1|||
19692652|NCT00366548|42138357|FG001|Infant Series|Adverse Event|3|||
19692653|NCT00366548|42138356|FG000|Infant Series|Protocol Violation|0|||
19692654|NCT00366548|42138357|FG001|Infant Series|Protocol Violation|1|||
19692655|NCT00366548|42138356|FG000|Infant Series|Withdrawal by Subject|3|||
19692656|NCT00366548|42138357|FG001|Infant Series|Withdrawal by Subject|1|||
19692657|NCT00366548|42138356|FG000|After Infant Series|Withdrawal by Subject|3|||
19692658|NCT00366548|42138357|FG001|After Infant Series|Withdrawal by Subject|1|||
19692659|NCT00366548|42138356|FG000|After Infant Series|Adverse Event|2|||
19692660|NCT00366548|42138357|FG001|After Infant Series|Adverse Event|0|||
19692661|NCT00366548|42138356|FG000|After Infant Series|Lost to Follow-up|1|||
19692662|NCT00366548|42138357|FG001|After Infant Series|Lost to Follow-up|0|||
19692663|NCT00252057|42138383|FG000|Overall Study|Withdrawal by Subject|2|||
19692664|NCT00252057|42138384|FG001|Overall Study|Withdrawal by Subject|5|||
19692665|NCT00252057|42138383|FG000|Overall Study|Death|1|||
19692666|NCT00252057|42138384|FG001|Overall Study|Death|2|||
19692667|NCT00252057|42138383|FG000|Overall Study|Participant previously enrolled|0|||
19692668|NCT00252057|42138384|FG001|Overall Study|Participant previously enrolled|1|||
19692669|NCT00132028|42138390|FG000|Overall Study|Adverse Event|7|||
19692670|NCT00132028|42138390|FG000|Overall Study|Death|2|||
19692671|NCT00132028|42138390|FG000|Overall Study|Lack of Efficacy|11|||
19692672|NCT00132028|42138390|FG000|Overall Study|Withdrawal by Subject|2|||
19692673|NCT00132028|42138390|FG000|Overall Study|not eligible|2|||
19692674|NCT00132028|42138390|FG000|Overall Study|Physician Decision|3|||
19692675|NCT00131248|42138394|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
19692676|NCT00131248|42138395|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
19692677|NCT00362414|42138401|FG000|Overall Study|Death|2|||
19692678|NCT00362414|42138401|FG000|Overall Study|Adverse Event|1|||
19692679|NCT00096382|42138410|FG000|Overall Study|Not treated|1|||
19692680|NCT00096382|42138411|FG001|Overall Study|Not treated|0|||
19692681|NCT00096382|42138410|FG000|Overall Study|Death during treatment|1|||
19692682|NCT00096382|42138411|FG001|Overall Study|Death during treatment|0|||
19775823|NCT03131687|42230653|FG003|Overall Study|Principle Investigator Decision|0|||
19775824|NCT03131687|42230654|FG004|Overall Study|Principle Investigator Decision|0|||
19775825|NCT03131687|42230655|FG005|Overall Study|Principle Investigator Decision|0|||
19775826|NCT03131687|42230650|FG000|Overall Study|Inadvertent Enrollment|0|||
19775827|NCT03131687|42230651|FG001|Overall Study|Inadvertent Enrollment|0|||
19775828|NCT03131687|42230652|FG002|Overall Study|Inadvertent Enrollment|0|||
19775829|NCT03131687|42230653|FG003|Overall Study|Inadvertent Enrollment|1|||
19775830|NCT03131687|42230654|FG004|Overall Study|Inadvertent Enrollment|0|||
19775831|NCT03131687|42230655|FG005|Overall Study|Inadvertent Enrollment|0|||
19775832|NCT03101293|42230684|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
19775833|NCT03101293|42230685|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
19775834|NCT02850978|42230691|FG000|Overall Study|Uncollectable CRF|27|||
19775835|NCT02850978|42230691|FG000|Overall Study|No visit since the first visit|35|||
19775836|NCT02850978|42230691|FG000|Overall Study|Adverse Event|81|||
19775837|NCT02850978|42230691|FG000|Overall Study|Lack of Efficacy|40|||
19775838|NCT02850978|42230691|FG000|Overall Study|Improvement in condition|34|||
19775839|NCT02850978|42230691|FG000|Overall Study|Lost to Follow-up|121|||
19775840|NCT02850978|42230691|FG000|Overall Study|Reason not listed|88|||
19775841|NCT03135431|42230697|FG000|Overall Study|Study Surgeon not available|2|||
19775842|NCT03135431|42230698|FG001|Overall Study|Study Surgeon not available|0|||
19775843|NCT04534517|42230720|FG000|Overall Study|Adverse Event|1|||
19775844|NCT04534517|42230720|FG000|Overall Study|Withdrawal by Subject|1|||
19775845|NCT04534517|42230720|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
19775846|NCT04534517|42230720|FG000|Overall Study|COVID-19 Related|1|||
19775847|NCT02831257|42230724|FG000|Overall Study|Lack of Efficacy|3|||
19775848|NCT02831257|42230724|FG000|Overall Study|Adverse Event|2|||
19775849|NCT02831257|42230724|FG000|Overall Study|Physician Decision|1|||
19775850|NCT02831257|42230724|FG000|Overall Study|Withdrawal by Subject|6|||
19775851|NCT03100825|42230728|FG000|Overall Study|Participant/Guardian Decision|7|||
19775852|NCT03100825|42230728|FG000|Overall Study|Physician Decision|1|||
19775853|NCT02250534|42230735|FG000|Overall Study|Lost to Follow-up|18|||
19775854|NCT02250534|42230736|FG001|Overall Study|Lost to Follow-up|28|||
19775855|NCT02250534|42230737|FG002|Overall Study|Lost to Follow-up|33|||
19775856|NCT02250534|42230735|FG000|Overall Study|Personal reasons|7|||
19775857|NCT02250534|42230736|FG001|Overall Study|Personal reasons|8|||
19775858|NCT02250534|42230737|FG002|Overall Study|Personal reasons|14|||
19775859|NCT02250534|42230735|FG000|Overall Study|Adverse Event|6|||
19775860|NCT02250534|42230736|FG001|Overall Study|Adverse Event|3|||
19775861|NCT02250534|42230737|FG002|Overall Study|Adverse Event|8|||
19775862|NCT02250534|42230735|FG000|Overall Study|incarcerated|2|||
19775863|NCT02250534|42230736|FG001|Overall Study|incarcerated|1|||
19775864|NCT02250534|42230737|FG002|Overall Study|incarcerated|2|||
19775865|NCT02250534|42230735|FG000|Overall Study|Withdrawal by Subject|0|||
19775866|NCT02250534|42230736|FG001|Overall Study|Withdrawal by Subject|1|||
19775867|NCT02250534|42230737|FG002|Overall Study|Withdrawal by Subject|2|||
19775868|NCT02250534|42230735|FG000|Overall Study|Death|0|||
19775869|NCT02250534|42230736|FG001|Overall Study|Death|1|||
19775870|NCT02250534|42230737|FG002|Overall Study|Death|1|||
19775871|NCT02250534|42230735|FG000|Overall Study|Physician Decision|1|||
19775872|NCT02250534|42230736|FG001|Overall Study|Physician Decision|3|||
19775873|NCT02250534|42230737|FG002|Overall Study|Physician Decision|1|||
19775874|NCT02250534|42230735|FG000|Overall Study|Protocol Violation|1|||
19775875|NCT02250534|42230736|FG001|Overall Study|Protocol Violation|0|||
19775876|NCT02250534|42230737|FG002|Overall Study|Protocol Violation|1|||
19775877|NCT02250534|42230735|FG000|Overall Study|Reason unknown|1|||
19775878|NCT02250534|42230736|FG001|Overall Study|Reason unknown|0|||
19775879|NCT02250534|42230737|FG002|Overall Study|Reason unknown|0|||
19775880|NCT02848326|42230751|FG000|Treatment Period|Adverse Event|5|||
19775881|NCT02848326|42230752|FG001|Treatment Period|Adverse Event|4|||
19775882|NCT02848326|42230753|FG002|Treatment Period|Adverse Event|11|||
19775883|NCT02848326|42230754|FG003|Treatment Period|Adverse Event|6|||
19692683|NCT00359294|42138422|FG000|Overall Study|Progressive disease|1|||
19692684|NCT00359294|42138423|FG001|Overall Study|Progressive disease|1|||
19692685|NCT00359294|42138424|FG002|Overall Study|Progressive disease|2|||
19692686|NCT00359294|42138425|FG003|Overall Study|Progressive disease|3|||
19692687|NCT00359294|42138426|FG004|Overall Study|Progressive disease|2|||
19692688|NCT00359294|42138422|FG000|Overall Study|Withdrawal by Subject|0|||
19692689|NCT00359294|42138423|FG001|Overall Study|Withdrawal by Subject|0|||
19692690|NCT00359294|42138424|FG002|Overall Study|Withdrawal by Subject|0|||
19692691|NCT00359294|42138425|FG003|Overall Study|Withdrawal by Subject|0|||
19775884|NCT02848326|42230755|FG004|Treatment Period|Adverse Event|5|||
19692692|NCT00359294|42138426|FG004|Overall Study|Withdrawal by Subject|1|||
19692693|NCT00359294|42138422|FG000|Overall Study|Not treated|0|||
19775885|NCT02848326|42230756|FG005|Treatment Period|Adverse Event|7|||
19367245|NCT02435992|41607417|FG002|Overall Study|Lack of Efficacy|9|||
19775886|NCT02848326|42230751|FG000|Treatment Period|Withdrawal of Consent|20|||
19775887|NCT02848326|42230752|FG001|Treatment Period|Withdrawal of Consent|6|||
19775888|NCT02848326|42230753|FG002|Treatment Period|Withdrawal of Consent|9|||
19775889|NCT02848326|42230754|FG003|Treatment Period|Withdrawal of Consent|6|||
19775890|NCT02848326|42230755|FG004|Treatment Period|Withdrawal of Consent|9|||
19775891|NCT02848326|42230756|FG005|Treatment Period|Withdrawal of Consent|6|||
19775892|NCT02848326|42230751|FG000|Treatment Period|Lost to Follow-up|5|||
19775893|NCT02848326|42230752|FG001|Treatment Period|Lost to Follow-up|1|||
19775894|NCT02848326|42230753|FG002|Treatment Period|Lost to Follow-up|11|||
19775895|NCT02848326|42230754|FG003|Treatment Period|Lost to Follow-up|7|||
19775896|NCT02848326|42230755|FG004|Treatment Period|Lost to Follow-up|2|||
19775897|NCT02848326|42230756|FG005|Treatment Period|Lost to Follow-up|3|||
19692694|NCT00359294|42138423|FG001|Overall Study|Not treated|0|||
19692695|NCT00359294|42138424|FG002|Overall Study|Not treated|0|||
19692696|NCT00359294|42138425|FG003|Overall Study|Not treated|1|||
19692697|NCT00359294|42138426|FG004|Overall Study|Not treated|0|||
19775898|NCT02848326|42230751|FG000|Treatment Period|Pregnancy|0|||
19775899|NCT02848326|42230752|FG001|Treatment Period|Pregnancy|0|||
19775900|NCT02848326|42230753|FG002|Treatment Period|Pregnancy|1|||
19775901|NCT02848326|42230754|FG003|Treatment Period|Pregnancy|1|||
19775902|NCT02848326|42230755|FG004|Treatment Period|Pregnancy|0|||
19775903|NCT02848326|42230756|FG005|Treatment Period|Pregnancy|1|||
19775904|NCT02848326|42230751|FG000|Treatment Period|Protocol Violation|4|||
19775905|NCT02848326|42230752|FG001|Treatment Period|Protocol Violation|3|||
19692698|NCT00359294|42138422|FG000|Overall Study|Physician Decision|0|||
19692699|NCT00359294|42138423|FG001|Overall Study|Physician Decision|0|||
19775906|NCT02848326|42230753|FG002|Treatment Period|Protocol Violation|4|||
19775907|NCT02848326|42230754|FG003|Treatment Period|Protocol Violation|2|||
19775908|NCT02848326|42230755|FG004|Treatment Period|Protocol Violation|3|||
19775909|NCT02848326|42230756|FG005|Treatment Period|Protocol Violation|3|||
19775910|NCT02848326|42230751|FG000|Treatment Period|Non-compliance with Study Drug|4|||
19775911|NCT02848326|42230752|FG001|Treatment Period|Non-compliance with Study Drug|0|||
19775912|NCT02848326|42230753|FG002|Treatment Period|Non-compliance with Study Drug|0|||
19775913|NCT02848326|42230754|FG003|Treatment Period|Non-compliance with Study Drug|1|||
19775914|NCT02848326|42230755|FG004|Treatment Period|Non-compliance with Study Drug|0|||
19775915|NCT02848326|42230756|FG005|Treatment Period|Non-compliance with Study Drug|0|||
19775916|NCT02848326|42230751|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
19775917|NCT02848326|42230752|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
19775918|NCT02848326|42230753|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
19775919|NCT02848326|42230754|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
19775920|NCT02848326|42230755|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
19775921|NCT02848326|42230756|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
19775922|NCT02848326|42230751|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
19775923|NCT02848326|42230752|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
19775924|NCT02848326|42230753|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
19775925|NCT02848326|42230754|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
19775926|NCT02848326|42230755|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
19775927|NCT02848326|42230756|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
19775928|NCT03128723|42230770|FG000|Overall Study|Withdrawal by Subject|2|||
19775929|NCT03128411|42230774|FG000|Treatment Phase|Adverse Event|21|||
19775930|NCT03128411|42230774|FG000|Treatment Phase|Physician Decision|1|||
19775931|NCT03128411|42230774|FG000|Treatment Phase|Other|2|||
19775932|NCT03128411|42230774|FG000|Long Term Follow-up Phase|Death|2|||
19775933|NCT02847858|42230780|FG000|Overall Study|Lost to Follow-up|401|||
19775934|NCT02847858|42230781|FG001|Overall Study|Lost to Follow-up|269|||
19775935|NCT03124199|42230792|FG000|Overall Study|Lost to Follow-up|4|||
19775936|NCT04465916|42230798|FG000|Overall Study|Withdrawal by Subject|0|||
19775937|NCT04465916|42230799|FG001|Overall Study|Withdrawal by Subject|1|||
19692700|NCT00359294|42138424|FG002|Overall Study|Physician Decision|1|||
19692701|NCT00359294|42138425|FG003|Overall Study|Physician Decision|0|||
19692702|NCT00359294|42138426|FG004|Overall Study|Physician Decision|0|||
19692703|NCT00384332|42138436|FG000|Overall Study|Lost to Follow-up|4|||
19692704|NCT00384332|42138437|FG001|Overall Study|Lost to Follow-up|0|||
19775938|NCT05090852|42230805|FG000|Overall Study|Physician Decision|5|||
19775939|NCT00075816|42230811|FG000|Overall Study|Did not undergo transplantation|14|||
19775940|NCT00075816|42230812|FG001|Overall Study|Did not undergo transplantation|11|||
19775941|NCT00109772|42230826|FG000|Double-blind Treatment|Adverse Event|14|||
19775942|NCT00109772|42230827|FG001|Double-blind Treatment|Adverse Event|5|||
19775943|NCT00109772|42230826|FG000|Double-blind Treatment|Lack of Efficacy|1|||
19775944|NCT00109772|42230827|FG001|Double-blind Treatment|Lack of Efficacy|0|||
19775945|NCT00109772|42230826|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
19775946|NCT00109772|42230827|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
19775947|NCT00109772|42230826|FG000|Double-blind Treatment|Lost to Follow-up|2|||
19775948|NCT00109772|42230827|FG001|Double-blind Treatment|Lost to Follow-up|3|||
19775949|NCT00109772|42230826|FG000|Double-blind Treatment|Protocol Violation|0|||
19692705|NCT00096226|42138445|FG000|Overall Study|Ineligible|2|||
19775950|NCT00109772|42230827|FG001|Double-blind Treatment|Protocol Violation|1|||
19692706|NCT00096226|42138445|FG000|Overall Study|Protocol treatment not started|1|||
19692707|NCT00105508|42138451|FG000|Overall Study|Prephase Dropout|1|||
19775951|NCT00109772|42230826|FG000|Double-blind Treatment|Other|0|||
19775952|NCT00109772|42230827|FG001|Double-blind Treatment|Other|4|||
19775953|NCT00109772|42230826|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
19775954|NCT00109772|42230827|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
19775955|NCT00109772|42230826|FG000|Open-label Extension|Adverse Event|10|||
19775956|NCT00109772|42230827|FG001|Open-label Extension|Adverse Event|19|||
19775957|NCT00109772|42230826|FG000|Open-label Extension|Lack of Efficacy|19|||
19775958|NCT00109772|42230827|FG001|Open-label Extension|Lack of Efficacy|11|||
19775959|NCT00109772|42230826|FG000|Open-label Extension|Withdrawal by Subject|9|||
19775960|NCT00109772|42230827|FG001|Open-label Extension|Withdrawal by Subject|6|||
19775961|NCT00109772|42230826|FG000|Open-label Extension|Lost to Follow-up|1|||
19775962|NCT00109772|42230827|FG001|Open-label Extension|Lost to Follow-up|0|||
19775963|NCT00109772|42230826|FG000|Open-label Extension|Death|0|||
19775964|NCT00109772|42230827|FG001|Open-label Extension|Death|1|||
19775965|NCT00109772|42230826|FG000|Open-label Extension|Protocol Violation|2|||
19775966|NCT00109772|42230827|FG001|Open-label Extension|Protocol Violation|2|||
19775967|NCT00109772|42230826|FG000|Open-label Extension|Other|4|||
19775968|NCT00109772|42230827|FG001|Open-label Extension|Other|10|||
19775969|NCT02783066|42230833|FG000|Overall Study|Withdrawal by Subject|13|||
19799421|NCT01344629|42257498|FG000|Crossover Period 2|Withdrawal by Subject|0|||
19799422|NCT01344629|42257499|FG001|Crossover Period 2|Withdrawal by Subject|1|||
19799423|NCT01092117|42257505|FG000|Index Procedure to 1 Month|Death|1|||
19799424|NCT01092117|42257505|FG000|1 Month|Death|1|||
19799425|NCT01092117|42257505|FG000|1 Month|Withdrawal by Subject|1|||
19799426|NCT01092117|42257505|FG000|1 Month|Lost to Follow-up|1|||
19799427|NCT01092117|42257505|FG000|6 Months|Death|2|||
19799428|NCT01092117|42257505|FG000|6 Months|Withdrawal by Subject|3|||
19799429|NCT01092117|42257505|FG000|12 Month|Death|11|||
19799430|NCT01092117|42257505|FG000|12 Month|Withdrawal by Subject|2|||
19799431|NCT01092117|42257505|FG000|12 Month|Lost to Follow-up|1|||
19799432|NCT01092117|42257505|FG000|Year 2|Death|5|||
19799433|NCT01092117|42257505|FG000|Year 2|Withdrawal by Subject|4|||
19799434|NCT01092117|42257505|FG000|Year 2|Lost to Follow-up|1|||
19692708|NCT00105508|42138452|FG001|Overall Study|Prephase Dropout|0|||
19692709|NCT00105508|42138451|FG000|Overall Study|Adverse Event|16|||
19692710|NCT00105508|42138452|FG001|Overall Study|Adverse Event|19|||
19692711|NCT00105508|42138451|FG000|Overall Study|Insufficient Efficacy|1|||
19692712|NCT00105508|42138452|FG001|Overall Study|Insufficient Efficacy|0|||
19692713|NCT00105508|42138451|FG000|Overall Study|Withdrawal by Subject|10|||
19799435|NCT01092117|42257505|FG000|Year 3|Death|7|||
19799436|NCT01092117|42257505|FG000|Year 3|Withdrawal by Subject|9|||
19799437|NCT01092117|42257505|FG000|Year 3|Lost to Follow-up|3|||
19799438|NCT01092117|42257505|FG000|Year 4|Death|8|||
19799439|NCT01092117|42257505|FG000|Year 4|Withdrawal by Subject|4|||
19799440|NCT01092117|42257505|FG000|Year 4|Lost to Follow-up|4|||
19799441|NCT01065779|42257518|FG000|Overall Study|Duplicate Investigation|1|||
19799442|NCT01065779|42257518|FG000|Overall Study|Investigation Before Contract Date|37|||
19799443|NCT01065779|42257518|FG000|Overall Study|Non-enrollment Period Administration|10|||
19799444|NCT01065779|42257518|FG000|Overall Study|Not Administered With Study Drug|17|||
19799445|NCT01065779|42257518|FG000|Overall Study|Failed to Follow-up|10|||
19799446|NCT01065779|42257518|FG000|Overall Study|Inclusion Criteria Violation|7|||
19799447|NCT02963441|42257522|FG000|Overall Study|Protocol violation or withdrawn|8|||
19799448|NCT02963441|42257522|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
19692714|NCT00105508|42138452|FG001|Overall Study|Withdrawal by Subject|6|||
19692715|NCT00105508|42138451|FG000|Overall Study|Lost to Follow-up|3|||
19692716|NCT00105508|42138452|FG001|Overall Study|Lost to Follow-up|0|||
19692717|NCT00105508|42138451|FG000|Overall Study|Protocol Violation|1|||
19692718|NCT00105508|42138452|FG001|Overall Study|Protocol Violation|2|||
19692719|NCT00105508|42138451|FG000|Overall Study|Other|8|||
19692720|NCT00105508|42138452|FG001|Overall Study|Other|9|||
19692721|NCT00105196|42138460|FG000|Overall Study|Lack of Efficacy|2|||
19692722|NCT00105196|42138461|FG001|Overall Study|Lack of Efficacy|3|||
19692723|NCT00105196|42138460|FG000|Overall Study|Adverse Event|11|||
19692724|NCT00105196|42138461|FG001|Overall Study|Adverse Event|3|||
19799449|NCT02963441|42257522|FG000|Overall Study|IDx-DR insufficient quality|33|||
19799450|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
19799451|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
19799452|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
19799453|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
19799454|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
19799455|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
19799456|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
19692725|NCT00105196|42138460|FG000|Overall Study|Withdrawal by Subject|6|||
19692726|NCT00105196|42138461|FG001|Overall Study|Withdrawal by Subject|6|||
19692727|NCT00105196|42138460|FG000|Overall Study|Lost to Follow-up|3|||
19799457|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
19692728|NCT00105196|42138461|FG001|Overall Study|Lost to Follow-up|2|||
19775970|NCT01371305|42230844|FG000|Overall Study|Adverse Event|0|||
19775971|NCT01371305|42230845|FG001|Overall Study|Adverse Event|0|||
19775972|NCT01371305|42230846|FG002|Overall Study|Adverse Event|0|||
19775973|NCT01371305|42230847|FG003|Overall Study|Adverse Event|2|||
19775974|NCT01371305|42230848|FG004|Overall Study|Adverse Event|1|||
19775975|NCT01371305|42230849|FG005|Overall Study|Adverse Event|0|||
19775976|NCT01371305|42230844|FG000|Overall Study|Study terminated by sponsor|0|||
19775977|NCT01371305|42230845|FG001|Overall Study|Study terminated by sponsor|0|||
19775978|NCT01371305|42230846|FG002|Overall Study|Study terminated by sponsor|0|||
19775979|NCT01371305|42230847|FG003|Overall Study|Study terminated by sponsor|0|||
19775980|NCT01371305|42230848|FG004|Overall Study|Study terminated by sponsor|3|||
19775981|NCT01371305|42230849|FG005|Overall Study|Study terminated by sponsor|1|||
19775982|NCT01371305|42230844|FG000|Overall Study|Subject request|0|||
19775983|NCT01371305|42230845|FG001|Overall Study|Subject request|0|||
19775984|NCT01371305|42230846|FG002|Overall Study|Subject request|0|||
19775985|NCT01371305|42230847|FG003|Overall Study|Subject request|0|||
19775986|NCT01371305|42230848|FG004|Overall Study|Subject request|0|||
19775987|NCT01371305|42230849|FG005|Overall Study|Subject request|1|||
19775988|NCT00109928|42230864|FG000|Overall Study|Adverse Event|2|||
19775989|NCT00109928|42230864|FG000|Overall Study|Progression|6|||
19775990|NCT00109928|42230864|FG000|Overall Study|Death|2|||
19775991|NCT00109928|42230864|FG000|Overall Study|not protocol specified|2|||
19775992|NCT00109928|42230864|FG000|Overall Study|not eligible|1|||
19775993|NCT00109850|42230869|FG000|Overall Study|Adverse Event|1|||
19775994|NCT00109850|42230869|FG000|Overall Study|Death|2|||
19775995|NCT00109850|42230869|FG000|Overall Study|Ineligible|1|||
19775996|NCT01342926|42230877|FG000|Overall Study|Adverse Event|5|||
19775997|NCT01342926|42230878|FG001|Overall Study|Adverse Event|8|||
19775998|NCT01342926|42230879|FG002|Overall Study|Adverse Event|10|||
19775999|NCT01342926|42230880|FG003|Overall Study|Adverse Event|7|||
19776000|NCT01342926|42230877|FG000|Overall Study|Lost to Follow-up|0|||
19776001|NCT01342926|42230878|FG001|Overall Study|Lost to Follow-up|1|||
19692729|NCT00105196|42138460|FG000|Overall Study|Poor/noncompliance|3|||
19692730|NCT00105196|42138461|FG001|Overall Study|Poor/noncompliance|4|||
19692731|NCT00105196|42138460|FG000|Overall Study|Protocol Violation|5|||
19692732|NCT00105196|42138461|FG001|Overall Study|Protocol Violation|2|||
19692733|NCT00105196|42138460|FG000|Overall Study|pending surgery|0|||
19692734|NCT00105196|42138461|FG001|Overall Study|pending surgery|1|||
19692735|NCT00105196|42138460|FG000|Overall Study|marijuana use|0|||
19692736|NCT00105196|42138461|FG001|Overall Study|marijuana use|1|||
19776002|NCT01342926|42230879|FG002|Overall Study|Lost to Follow-up|1|||
19776003|NCT01342926|42230880|FG003|Overall Study|Lost to Follow-up|0|||
19776004|NCT01342926|42230877|FG000|Overall Study|Investigator Discretion|2|||
19776005|NCT01342926|42230878|FG001|Overall Study|Investigator Discretion|2|||
19776006|NCT01342926|42230879|FG002|Overall Study|Investigator Discretion|0|||
19776007|NCT01342926|42230880|FG003|Overall Study|Investigator Discretion|0|||
19776008|NCT01342926|42230877|FG000|Overall Study|Withdrawal by Subject|2|||
19776009|NCT01342926|42230878|FG001|Overall Study|Withdrawal by Subject|4|||
19776010|NCT01342926|42230879|FG002|Overall Study|Withdrawal by Subject|3|||
19776011|NCT01342926|42230880|FG003|Overall Study|Withdrawal by Subject|5|||
19776012|NCT01810016|42230893|FG000|Overall Study|Progressive disease|1|||
19776013|NCT01810016|42230894|FG001|Overall Study|Progressive disease|1|||
19776014|NCT01810016|42230895|FG002|Overall Study|Progressive disease|0|||
19776015|NCT01810016|42230893|FG000|Overall Study|Death|0|||
19776016|NCT01810016|42230894|FG001|Overall Study|Death|0|||
19776017|NCT01810016|42230895|FG002|Overall Study|Death|1|||
19776018|NCT02843178|42230907|FG000|Overall Study|Lost to Follow-up|8|||
19776019|NCT02843178|42230908|FG001|Overall Study|Lost to Follow-up|8|||
19776020|NCT02843178|42230909|FG002|Overall Study|Lost to Follow-up|6|||
19776021|NCT02843178|42230910|FG003|Overall Study|Lost to Follow-up|3|||
19776022|NCT02843178|42230907|FG000|Overall Study|Withdrawal by Subject|0|||
19776023|NCT02843178|42230908|FG001|Overall Study|Withdrawal by Subject|0|||
19776024|NCT02843178|42230909|FG002|Overall Study|Withdrawal by Subject|1|||
19776025|NCT02843178|42230910|FG003|Overall Study|Withdrawal by Subject|1|||
19776026|NCT01722266|42230924|FG000|Overall Study|Withdrawal by Subject|1|||
19776027|NCT01722266|42230925|FG001|Overall Study|Withdrawal by Subject|2|||
19776028|NCT01722266|42230926|FG002|Overall Study|Withdrawal by Subject|0|||
19776029|NCT01722266|42230927|FG003|Overall Study|Withdrawal by Subject|0|||
19776030|NCT01722266|42230924|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
19776031|NCT01722266|42230925|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
19776032|NCT01722266|42230926|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
19776033|NCT01722266|42230927|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
19776034|NCT01722266|42230924|FG000|Overall Study|Dropped out due to Nausea|0|||
19776035|NCT01722266|42230925|FG001|Overall Study|Dropped out due to Nausea|0|||
19776036|NCT01722266|42230926|FG002|Overall Study|Dropped out due to Nausea|2|||
19776037|NCT01722266|42230927|FG003|Overall Study|Dropped out due to Nausea|0|||
19692737|NCT00105196|42138460|FG000|Overall Study|Subject became unblinded|0|||
19692738|NCT00105196|42138461|FG001|Overall Study|Subject became unblinded|1|||
19776038|NCT03123185|42230951|FG000|Overall Study|Withdrawal by Subject|0|||
19776039|NCT03123185|42230952|FG001|Overall Study|Withdrawal by Subject|0|||
19776040|NCT03123185|42230953|FG002|Overall Study|Withdrawal by Subject|0|||
19776041|NCT03123185|42230954|FG003|Overall Study|Withdrawal by Subject|0|||
19776042|NCT03123185|42230955|FG004|Overall Study|Withdrawal by Subject|0|||
19776043|NCT03123185|42230956|FG005|Overall Study|Withdrawal by Subject|0|||
19776044|NCT03123185|42230957|FG006|Overall Study|Withdrawal by Subject|0|||
19776045|NCT03123185|42230958|FG007|Overall Study|Withdrawal by Subject|0|||
19776046|NCT03123185|42230959|FG008|Overall Study|Withdrawal by Subject|0|||
19776047|NCT03123185|42230960|FG009|Overall Study|Withdrawal by Subject|0|||
19776048|NCT03123185|42230961|FG010|Overall Study|Withdrawal by Subject|0|||
19776049|NCT03123185|42230962|FG011|Overall Study|Withdrawal by Subject|0|||
19776050|NCT03123185|42230963|FG012|Overall Study|Withdrawal by Subject|1|||
19776051|NCT03123185|42230964|FG013|Overall Study|Withdrawal by Subject|0|||
19776052|NCT02842866|42231023|FG000|Overall Study|Serious Adverse Event|0|||
19776053|NCT02842866|42231024|FG001|Overall Study|Serious Adverse Event|1|||
19776054|NCT02842866|42231023|FG000|Overall Study|Protocol Violation|4|||
19776055|NCT02842866|42231024|FG001|Overall Study|Protocol Violation|2|||
19776056|NCT02842866|42231023|FG000|Overall Study|Lost to Follow-up|2|||
19776057|NCT02842866|42231024|FG001|Overall Study|Lost to Follow-up|0|||
19776058|NCT02842866|42231023|FG000|Overall Study|Withdrawal by Subject|1|||
19776059|NCT02842866|42231024|FG001|Overall Study|Withdrawal by Subject|0|||
19776060|NCT01316913|42231034|FG000|Overall Study|Adverse Event|17|||
19776061|NCT01316913|42231035|FG001|Overall Study|Adverse Event|20|||
19776062|NCT01316913|42231036|FG002|Overall Study|Adverse Event|15|||
19776063|NCT01316913|42231037|FG003|Overall Study|Adverse Event|11|||
19776064|NCT01316913|42231034|FG000|Overall Study|Lack of Efficacy|22|||
19776065|NCT01316913|42231035|FG001|Overall Study|Lack of Efficacy|12|||
19776066|NCT01316913|42231036|FG002|Overall Study|Lack of Efficacy|9|||
19776067|NCT01316913|42231037|FG003|Overall Study|Lack of Efficacy|13|||
19776068|NCT01316913|42231034|FG000|Overall Study|Protocol Violation|1|||
19776069|NCT01316913|42231035|FG001|Overall Study|Protocol Violation|4|||
19776070|NCT01316913|42231036|FG002|Overall Study|Protocol Violation|4|||
19776071|NCT01316913|42231037|FG003|Overall Study|Protocol Violation|1|||
19776072|NCT01316913|42231034|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
19776073|NCT01316913|42231035|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
19776074|NCT01316913|42231036|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
19776075|NCT01316913|42231037|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
19776076|NCT01316913|42231034|FG000|Overall Study|Lost to Follow-up|0|||
19776077|NCT01316913|42231035|FG001|Overall Study|Lost to Follow-up|1|||
19776078|NCT01316913|42231036|FG002|Overall Study|Lost to Follow-up|0|||
19776079|NCT01316913|42231037|FG003|Overall Study|Lost to Follow-up|2|||
19776080|NCT01316913|42231034|FG000|Overall Study|Withdrawal by Subject|10|||
19776081|NCT01316913|42231035|FG001|Overall Study|Withdrawal by Subject|9|||
19776082|NCT01316913|42231036|FG002|Overall Study|Withdrawal by Subject|10|||
19776083|NCT01316913|42231037|FG003|Overall Study|Withdrawal by Subject|6|||
19776084|NCT02875067|42231048|FG000|Overall Study|Withdrawal by Subject|1|||
19776085|NCT02875067|42231048|FG000|Overall Study|Withdrawal by Termination of Study|5|||
19776086|NCT02781506|42231052|FG000|Overall Study|Adverse Event|5|||
19776087|NCT03132753|42231058|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
19776088|NCT03132753|42231059|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
19776089|NCT03132753|42231058|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
19692739|NCT03820024|42138469|FG000|Overall Study|Physician Decision|1|||
19692740|NCT03820024|42138470|FG001|Overall Study|Physician Decision|2|||
19692741|NCT03819634|42138476|FG000|Overall Study|Physician Decision|2|||
19692742|NCT00104572|42138483|FG000|Overall Study|Withdrawal by Subject|3|||
19692743|NCT00104572|42138484|FG001|Overall Study|Withdrawal by Subject|3|||
19692744|NCT00104572|42138485|FG002|Overall Study|Withdrawal by Subject|0|||
19692745|NCT00514943|42138495|FG000|Stage 1|Progressive disease|4|||
19692746|NCT00514943|42138496|FG001|Stage 1|Progressive disease|8|||
19692747|NCT00514943|42138495|FG000|Stage 1|Other Adverse Event|16|||
19692748|NCT00514943|42138496|FG001|Stage 1|Other Adverse Event|6|||
19692749|NCT00514943|42138495|FG000|Stage 1|Not treated|1|||
19776090|NCT03132753|42231059|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
19776091|NCT01468454|42231065|FG000|Overall Study|Did not have surgery after PET|9|||
19776092|NCT03067077|42231070|FG000|Overall Study|Did not receive surgery|4|||
19776093|NCT03067077|42231071|FG001|Overall Study|Did not receive surgery|5|||
19776094|NCT03067077|42231070|FG000|Overall Study|Lost to Follow-up|3|||
19776095|NCT03067077|42231071|FG001|Overall Study|Lost to Follow-up|2|||
19776096|NCT03096847|42231080|FG000|Overall Study|Other|2|||
19776097|NCT03096847|42231081|FG001|Overall Study|Other|1|||
19776098|NCT03096847|42231082|FG002|Overall Study|Other|2|||
19776099|NCT03096847|42231080|FG000|Overall Study|Lost to Follow-up|1|||
19776100|NCT03096847|42231081|FG001|Overall Study|Lost to Follow-up|0|||
19776101|NCT03096847|42231082|FG002|Overall Study|Lost to Follow-up|1|||
19776102|NCT03096847|42231080|FG000|Overall Study|Death|6|||
19692750|NCT00514943|42138496|FG001|Stage 1|Not treated|2|||
19692751|NCT00514943|42138495|FG000|Stage 1|Patient refused to continue study meds|8|||
19776103|NCT03096847|42231081|FG001|Overall Study|Death|0|||
19776104|NCT03096847|42231082|FG002|Overall Study|Death|2|||
19776105|NCT03096847|42231080|FG000|Overall Study|Protocol Violation|3|||
19776106|NCT03096847|42231081|FG001|Overall Study|Protocol Violation|0|||
19776107|NCT03096847|42231082|FG002|Overall Study|Protocol Violation|6|||
19776108|NCT03096847|42231080|FG000|Overall Study|Physician Decision|12|||
19776109|NCT03096847|42231081|FG001|Overall Study|Physician Decision|2|||
19776110|NCT03096847|42231082|FG002|Overall Study|Physician Decision|8|||
19692752|NCT00514943|42138496|FG001|Stage 1|Patient refused to continue study meds|3|||
19692753|NCT00514943|42138495|FG000|Stage 1|Other than stated above|1|||
19692754|NCT00514943|42138496|FG001|Stage 1|Other than stated above|7|||
19692755|NCT00514943|42138495|FG000|Stage 2|Progressive disease|27|||
19692756|NCT00514943|42138496|FG001|Stage 2|Progressive disease|24|||
19692757|NCT00514943|42138495|FG000|Stage 2|Other Adverse Event|3|||
19692758|NCT00514943|42138496|FG001|Stage 2|Other Adverse Event|10|||
19692759|NCT00514943|42138495|FG000|Stage 2|Patient refused to continue study meds|2|||
19692760|NCT00514943|42138496|FG001|Stage 2|Patient refused to continue study meds|0|||
19692761|NCT00514943|42138495|FG000|Stage 2|Other than stated above|0|||
19692762|NCT00514943|42138496|FG001|Stage 2|Other than stated above|2|||
19692763|NCT03864653|42138517|FG000|Overall Study|Withdrawal by Subject|1|||
19776111|NCT03096847|42231080|FG000|Overall Study|Withdrawal by Subject|24|||
19776112|NCT03096847|42231081|FG001|Overall Study|Withdrawal by Subject|1|||
19776113|NCT03096847|42231082|FG002|Overall Study|Withdrawal by Subject|12|||
19776114|NCT03096847|42231080|FG000|Overall Study|Adverse Event|72|||
19776115|NCT03096847|42231081|FG001|Overall Study|Adverse Event|6|||
19776116|NCT03096847|42231082|FG002|Overall Study|Adverse Event|28|||
19776117|NCT03096847|42231080|FG000|Overall Study|Progressive disease|97|||
19776118|NCT03096847|42231081|FG001|Overall Study|Progressive disease|10|||
19776119|NCT03096847|42231082|FG002|Overall Study|Progressive disease|78|||
19776120|NCT03096847|42231080|FG000|Overall Study|Non-compliance with study medication|1|||
19606781|NCT00679783|42055443|FG006|Overall Study|Ongoing at data cut-off|0|||
19606782|NCT00576199|42055459|FG000|Overall Study|Adverse Event|12|||
19606783|NCT00576199|42055459|FG000|Overall Study|Insufficient Therapeutic Response|14|||
19606784|NCT00576199|42055459|FG000|Overall Study|Refused Treatment|2|||
19606785|NCT00576199|42055459|FG000|Overall Study|Reason Unspecified|2|||
19776121|NCT03096847|42231081|FG001|Overall Study|Non-compliance with study medication|0|||
19776122|NCT03096847|42231082|FG002|Overall Study|Non-compliance with study medication|0|||
19776123|NCT03096847|42231080|FG000|Overall Study|New therapy for study indication|1|||
19776124|NCT03096847|42231081|FG001|Overall Study|New therapy for study indication|0|||
19776125|NCT03096847|42231082|FG002|Overall Study|New therapy for study indication|1|||
19776126|NCT01365182|42231101|FG000|Overall Study|Withdrawal by Subject|10|||
19776127|NCT01365182|42231102|FG001|Overall Study|Withdrawal by Subject|13|||
19776128|NCT01365182|42231103|FG002|Overall Study|Withdrawal by Subject|12|||
19776129|NCT03128099|42231121|FG000|Overall Study|High dose task was too long|0|||
19776130|NCT03128099|42231122|FG001|Overall Study|High dose task was too long|4|||
19776131|NCT03128099|42231123|FG002|Overall Study|High dose task was too long|0|||
19776132|NCT03128099|42231121|FG000|Overall Study|Participant got a full time job.|1|||
19776133|NCT03128099|42231122|FG001|Overall Study|Participant got a full time job.|0|||
19776134|NCT03128099|42231123|FG002|Overall Study|Participant got a full time job.|0|||
19776135|NCT03128099|42231121|FG000|Overall Study|Became homeless and lost contact|1|||
19776136|NCT03128099|42231122|FG001|Overall Study|Became homeless and lost contact|0|||
19776137|NCT03128099|42231123|FG002|Overall Study|Became homeless and lost contact|0|||
19776138|NCT03128099|42231121|FG000|Overall Study|Did not complete all the assessments|0|||
19776139|NCT03128099|42231122|FG001|Overall Study|Did not complete all the assessments|0|||
19776140|NCT03128099|42231123|FG002|Overall Study|Did not complete all the assessments|1|||
19776141|NCT02886494|42231131|FG000|Overall Study|Adverse Event|1|||
19776142|NCT02886494|42231132|FG001|Overall Study|Adverse Event|0|||
19776143|NCT02886494|42231131|FG000|Overall Study|Withdrawal by Subject|12|||
19776144|NCT02886494|42231132|FG001|Overall Study|Withdrawal by Subject|3|||
19776145|NCT02886494|42231131|FG000|Overall Study|Protocol Violation|4|||
19776146|NCT02886494|42231132|FG001|Overall Study|Protocol Violation|1|||
19776147|NCT02846532|42231144|FG000|Overall Study|Lost to Follow-up|0|||
19776148|NCT02846532|42231145|FG001|Overall Study|Lost to Follow-up|1|||
19776149|NCT02846532|42231146|FG002|Overall Study|Lost to Follow-up|1|||
19776150|NCT02846532|42231144|FG000|Overall Study|Withdrawal by Subject|1|||
19776151|NCT02846532|42231145|FG001|Overall Study|Withdrawal by Subject|2|||
19776152|NCT02846532|42231146|FG002|Overall Study|Withdrawal by Subject|0|||
19776153|NCT00842348|42231165|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
19776154|NCT00842348|42231166|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
19776155|NCT00842348|42231165|FG000|Study 729|Disease progression/death|19|||
19776156|NCT00842348|42231166|FG001|Study 729|Disease progression/death|30|||
19776157|NCT00842348|42231165|FG000|Study 729|Adverse Event|1|||
19776158|NCT00842348|42231166|FG001|Study 729|Adverse Event|1|||
19776159|NCT00842348|42231165|FG000|Study 729|Protocol Violation|1|||
19776160|NCT00842348|42231166|FG001|Study 729|Protocol Violation|1|||
19776161|NCT00842348|42231165|FG000|Study 729|Withdrawal by Subject|2|||
19692764|NCT00103402|42138523|FG000|Overall Study|Adverse Event|3|||
19776162|NCT00842348|42231166|FG001|Study 729|Withdrawal by Subject|4|||
19776163|NCT00842348|42231165|FG000|Study 729|Due to Sponsor stopping the study|1|||
19776164|NCT00842348|42231166|FG001|Study 729|Due to Sponsor stopping the study|1|||
19776165|NCT00842348|42231165|FG000|Study 729|Due to non-availability of IP|0|||
19776166|NCT00842348|42231166|FG001|Study 729|Due to non-availability of IP|1|||
19776167|NCT00842348|42231165|FG000|Study 729|Sponsor's decision|1|||
19776168|NCT00842348|42231166|FG001|Study 729|Sponsor's decision|0|||
19776169|NCT00842348|42231165|FG000|Study 729|Surgical resection|1|||
19776170|NCT00842348|42231166|FG001|Study 729|Surgical resection|0|||
19776171|NCT03095599|42231178|FG000|Overall Study|Withdrawal by Subject|1|||
19776172|NCT03095599|42231179|FG001|Overall Study|Withdrawal by Subject|0|||
19776173|NCT03095599|42231178|FG000|Overall Study|Lost to Follow-up|1|||
19776174|NCT03095599|42231179|FG001|Overall Study|Lost to Follow-up|0|||
19776175|NCT03095599|42231178|FG000|Overall Study|Withdrawal prior to vaccination|1|||
19776176|NCT03095599|42231179|FG001|Overall Study|Withdrawal prior to vaccination|0|||
19776177|NCT03095521|42231189|FG000|Overall Study|Withdrawal by Subject|0|||
19776178|NCT03095521|42231190|FG001|Overall Study|Withdrawal by Subject|1|||
19776179|NCT03095521|42231189|FG000|Overall Study|Lost to Follow-up|0|||
19776180|NCT03095521|42231190|FG001|Overall Study|Lost to Follow-up|1|||
19776181|NCT03033875|42231199|FG000|Overall Study|Withdrawal by Subject|5|||
19776182|NCT03033875|42231200|FG001|Overall Study|Withdrawal by Subject|9|||
19776183|NCT03033875|42231201|FG002|Overall Study|Withdrawal by Subject|4|||
19776184|NCT03033875|42231199|FG000|Overall Study|Other|14|||
19776185|NCT03033875|42231200|FG001|Overall Study|Other|15|||
19776186|NCT03033875|42231201|FG002|Overall Study|Other|8|||
19776187|NCT01968785|42231219|FG000|Overall Study|Withdrawal by Subject|1|||
19776188|NCT01968785|42231220|FG001|Overall Study|Withdrawal by Subject|0|||
19776189|NCT03095287|42231226|FG000|Overall Study|Treatment Failure|1|||
19776190|NCT03095287|42231226|FG000|Overall Study|Adverse Event|1|||
19776191|NCT02839746|42231244|FG000|Overall Study|Not met selection criteria|12|||
19776192|NCT00033293|42231250|FG000|Overall Study|Death|0|||
19776193|NCT00033293|42231251|FG001|Overall Study|Death|1|||
19776194|NCT00033293|42231250|FG000|Overall Study|Lack of Efficacy|5|||
19776195|NCT00033293|42231251|FG001|Overall Study|Lack of Efficacy|8|||
19776196|NCT00033293|42231250|FG000|Overall Study|Lost to Follow-up|0|||
19776197|NCT00033293|42231251|FG001|Overall Study|Lost to Follow-up|1|||
19776198|NCT00033293|42231250|FG000|Overall Study|Physician Decision|3|||
19776199|NCT00033293|42231251|FG001|Overall Study|Physician Decision|1|||
19776200|NCT00033293|42231250|FG000|Overall Study|Withdrawal by Subject|1|||
19776201|NCT00033293|42231251|FG001|Overall Study|Withdrawal by Subject|0|||
19776202|NCT00033293|42231250|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
19776203|NCT00033293|42231251|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
19776204|NCT00033293|42231250|FG000|Overall Study|Treatment refused|0|||
19776205|NCT00033293|42231251|FG001|Overall Study|Treatment refused|6|||
19776206|NCT02836236|42231261|FG000|Overall Study|Randomized but Never Treated|1|||
19776207|NCT02836236|42231262|FG001|Overall Study|Randomized but Never Treated|0|||
19776208|NCT02836236|42231261|FG000|Overall Study|Withdrew Consent|2|||
19776209|NCT02836236|42231262|FG001|Overall Study|Withdrew Consent|0|||
19776210|NCT02836236|42231261|FG000|Overall Study|Adverse Event|0|||
19776211|NCT02836236|42231262|FG001|Overall Study|Adverse Event|1|||
19776212|NCT02836236|42231261|FG000|Overall Study|Investigator's Discretion|1|||
19776213|NCT02836236|42231262|FG001|Overall Study|Investigator's Discretion|0|||
19776214|NCT02836236|42231261|FG000|Overall Study|Still on Study|101|||
19389160|NCT01625182|41632780|FG001|Overall Study|Administrative problems|0|||
19692765|NCT00103402|42138524|FG001|Overall Study|Adverse Event|4|||
19692766|NCT00103402|42138523|FG000|Overall Study|Lost to Follow-up|8|||
19692767|NCT00103402|42138524|FG001|Overall Study|Lost to Follow-up|7|||
19692768|NCT00103402|42138523|FG000|Overall Study|Dissatisfied/No longer interested|6|||
19692769|NCT00103402|42138524|FG001|Overall Study|Dissatisfied/No longer interested|6|||
19692770|NCT00103402|42138523|FG000|Overall Study|Personal constraints/Other|5|||
19692771|NCT00103402|42138524|FG001|Overall Study|Personal constraints/Other|0|||
19692772|NCT03864341|42138530|FG000|Overall Study|Withdrawal by Subject|1|||
19692773|NCT01739309|42138534|FG000|Overall Study|On study treatment|3|||
19692774|NCT00095836|42138540|FG000|Overall Study|Lost to Follow-up|1|||
19692775|NCT00095836|42138540|FG000|Overall Study|Adverse Event|1|||
19692776|NCT00095836|42138540|FG000|Overall Study|Death|2|||
19692777|NCT00168831|42138547|FG000|Overall Study|Adverse Event|36|||
19692778|NCT00168831|42138548|FG001|Overall Study|Adverse Event|47|||
19692779|NCT00168831|42138549|FG002|Overall Study|Adverse Event|74|||
19692780|NCT00168831|42138547|FG000|Overall Study|Lost to Follow-up|5|||
19692781|NCT00168831|42138548|FG001|Overall Study|Lost to Follow-up|6|||
19692782|NCT00168831|42138549|FG002|Overall Study|Lost to Follow-up|4|||
19776215|NCT02836236|42231262|FG001|Overall Study|Still on Study|49|||
19776216|NCT02039674|42231282|FG000|Overall Study|Adverse Event|0|||
19692783|NCT00168831|42138547|FG000|Overall Study|Withdrawal by Subject|7|||
19692784|NCT00168831|42138548|FG001|Overall Study|Withdrawal by Subject|14|||
19692785|NCT00168831|42138549|FG002|Overall Study|Withdrawal by Subject|19|||
19692786|NCT00168831|42138547|FG000|Overall Study|Protocol Violation|6|||
19776217|NCT02039674|42231283|FG001|Overall Study|Adverse Event|0|||
19776218|NCT02039674|42231284|FG002|Overall Study|Adverse Event|0|||
19776219|NCT02039674|42231285|FG003|Overall Study|Adverse Event|1|||
19776220|NCT02039674|42231286|FG004|Overall Study|Adverse Event|0|||
19776221|NCT02039674|42231287|FG005|Overall Study|Adverse Event|0|||
19776222|NCT02039674|42231288|FG006|Overall Study|Adverse Event|0|||
19776223|NCT02039674|42231289|FG007|Overall Study|Adverse Event|0|||
19776224|NCT02039674|42231290|FG008|Overall Study|Adverse Event|2|||
19776225|NCT02039674|42231291|FG009|Overall Study|Adverse Event|1|||
19692787|NCT00168831|42138548|FG001|Overall Study|Protocol Violation|11|||
19692788|NCT00168831|42138549|FG002|Overall Study|Protocol Violation|11|||
19692789|NCT00168831|42138547|FG000|Overall Study|Other|6|||
19692790|NCT00168831|42138548|FG001|Overall Study|Other|3|||
19692791|NCT00168831|42138549|FG002|Overall Study|Other|6|||
19692792|NCT00103012|42138560|FG000|Overall Study|Withdrawal by Subject|2|||
19692793|NCT00103012|42138561|FG001|Overall Study|Withdrawal by Subject|1|||
19692794|NCT00103012|42138562|FG002|Overall Study|Withdrawal by Subject|2|||
19692795|NCT00103012|42138560|FG000|Overall Study|Pregnancy|1|||
19692796|NCT00103012|42138561|FG001|Overall Study|Pregnancy|0|||
19692797|NCT00103012|42138562|FG002|Overall Study|Pregnancy|0|||
19692798|NCT00103012|42138560|FG000|Overall Study|Adverse Event|0|||
19692799|NCT00103012|42138561|FG001|Overall Study|Adverse Event|0|||
19692800|NCT00103012|42138562|FG002|Overall Study|Adverse Event|1|||
19692801|NCT00103012|42138560|FG000|Overall Study|Subject non-compliant with medications|0|||
19692802|NCT00103012|42138561|FG001|Overall Study|Subject non-compliant with medications|0|||
19692803|NCT00103012|42138562|FG002|Overall Study|Subject non-compliant with medications|1|||
19692804|NCT00512135|42138570|FG000|Overall Study|Not Treated|5|||
19776226|NCT02039674|42231292|FG010|Overall Study|Adverse Event|0|||
19776227|NCT02039674|42231293|FG011|Overall Study|Adverse Event|2|||
19776228|NCT02039674|42231294|FG012|Overall Study|Adverse Event|3|||
19776229|NCT02039674|42231295|FG013|Overall Study|Adverse Event|1|||
19776230|NCT02039674|42231282|FG000|Overall Study|Death|2|||
19776231|NCT02039674|42231283|FG001|Overall Study|Death|0|||
19776232|NCT02039674|42231284|FG002|Overall Study|Death|2|||
19776233|NCT02039674|42231285|FG003|Overall Study|Death|3|||
19776234|NCT02039674|42231286|FG004|Overall Study|Death|0|||
19776235|NCT02039674|42231287|FG005|Overall Study|Death|0|||
19776236|NCT02039674|42231288|FG006|Overall Study|Death|1|||
19776237|NCT02039674|42231289|FG007|Overall Study|Death|0|||
19776238|NCT02039674|42231290|FG008|Overall Study|Death|2|||
19776239|NCT02039674|42231291|FG009|Overall Study|Death|0|||
19776240|NCT02039674|42231292|FG010|Overall Study|Death|1|||
19776241|NCT02039674|42231293|FG011|Overall Study|Death|3|||
19776242|NCT02039674|42231294|FG012|Overall Study|Death|2|||
19776243|NCT02039674|42231295|FG013|Overall Study|Death|8|||
19776244|NCT02039674|42231282|FG000|Overall Study|Excluded Medication|1|||
19776245|NCT02039674|42231283|FG001|Overall Study|Excluded Medication|1|||
19776246|NCT02039674|42231284|FG002|Overall Study|Excluded Medication|0|||
19776247|NCT02039674|42231285|FG003|Overall Study|Excluded Medication|1|||
19776248|NCT02039674|42231286|FG004|Overall Study|Excluded Medication|0|||
19776249|NCT02039674|42231287|FG005|Overall Study|Excluded Medication|1|||
19776250|NCT02039674|42231288|FG006|Overall Study|Excluded Medication|0|||
19776251|NCT02039674|42231289|FG007|Overall Study|Excluded Medication|0|||
19776252|NCT02039674|42231290|FG008|Overall Study|Excluded Medication|2|||
19776253|NCT02039674|42231291|FG009|Overall Study|Excluded Medication|3|||
19776254|NCT02039674|42231292|FG010|Overall Study|Excluded Medication|5|||
19776255|NCT02039674|42231293|FG011|Overall Study|Excluded Medication|6|||
19776256|NCT02039674|42231294|FG012|Overall Study|Excluded Medication|8|||
19776257|NCT02039674|42231295|FG013|Overall Study|Excluded Medication|3|||
19776258|NCT02039674|42231282|FG000|Overall Study|Lost to Follow-up|0|||
19776259|NCT02039674|42231283|FG001|Overall Study|Lost to Follow-up|0|||
19776260|NCT02039674|42231284|FG002|Overall Study|Lost to Follow-up|0|||
19776261|NCT02039674|42231285|FG003|Overall Study|Lost to Follow-up|0|||
19776262|NCT02039674|42231286|FG004|Overall Study|Lost to Follow-up|1|||
19776263|NCT02039674|42231287|FG005|Overall Study|Lost to Follow-up|1|||
19776264|NCT02039674|42231288|FG006|Overall Study|Lost to Follow-up|0|||
19776265|NCT02039674|42231289|FG007|Overall Study|Lost to Follow-up|0|||
19776266|NCT02039674|42231290|FG008|Overall Study|Lost to Follow-up|0|||
19389161|NCT01625182|41632779|FG000|Overall Study|Protocol deviation|0|||
19389162|NCT01625182|41632780|FG001|Overall Study|Protocol deviation|2|||
19776267|NCT02039674|42231291|FG009|Overall Study|Lost to Follow-up|0|||
19692805|NCT00512135|42138570|FG000|Overall Study|Lack of Efficacy|2|||
19692806|NCT00512135|42138570|FG000|Overall Study|Adverse Event|6|||
19692807|NCT00512135|42138570|FG000|Overall Study|Withdrawal by Subject|22|||
19692808|NCT00512135|42138570|FG000|Overall Study|Lost to Follow-up|27|||
19692809|NCT00512135|42138570|FG000|Overall Study|Other|22|||
19692810|NCT00251979|42138577|FG000|Overall Study|Protocol Violation|3|||
19692811|NCT00251979|42138578|FG001|Overall Study|Protocol Violation|5|||
19776268|NCT02039674|42231292|FG010|Overall Study|Lost to Follow-up|0|||
19776269|NCT02039674|42231293|FG011|Overall Study|Lost to Follow-up|2|||
19776270|NCT02039674|42231294|FG012|Overall Study|Lost to Follow-up|2|||
19776271|NCT02039674|42231295|FG013|Overall Study|Lost to Follow-up|1|||
19692812|NCT00251979|42138577|FG000|Overall Study|Adverse Event|11|||
19692813|NCT00251979|42138578|FG001|Overall Study|Adverse Event|17|||
19692814|NCT00251979|42138577|FG000|Overall Study|Withdrawal by Subject|13|||
19692815|NCT00251979|42138578|FG001|Overall Study|Withdrawal by Subject|7|||
19692816|NCT00251979|42138577|FG000|Overall Study|Lost to Follow-up|8|||
19692817|NCT00251979|42138578|FG001|Overall Study|Lost to Follow-up|6|||
19692818|NCT00251979|42138577|FG000|Overall Study|Death|3|||
19692819|NCT00251979|42138578|FG001|Overall Study|Death|5|||
19692820|NCT00511901|42138586|FG000|Overall Study|Withdrawal by Subject|1|||
19776272|NCT02039674|42231282|FG000|Overall Study|Physician Decision|0|||
19776273|NCT02039674|42231283|FG001|Overall Study|Physician Decision|0|||
19776274|NCT02039674|42231284|FG002|Overall Study|Physician Decision|0|||
19776275|NCT02039674|42231285|FG003|Overall Study|Physician Decision|0|||
19776276|NCT02039674|42231286|FG004|Overall Study|Physician Decision|0|||
19692821|NCT00511901|42138587|FG001|Overall Study|Withdrawal by Subject|3|||
19692822|NCT03862625|42138595|FG000|Overall Study|Lost to Follow-up|0|||
19692823|NCT03862625|42138596|FG001|Overall Study|Lost to Follow-up|1|||
19692824|NCT00163215|42138602|FG000|Overall Study|Lack of Efficacy|3|||
19692825|NCT00163215|42138602|FG000|Overall Study|Withdrawal by Subject|5|||
19692826|NCT00163215|42138602|FG000|Overall Study|Other|7|||
19692827|NCT00228423|42138608|FG000|Overall Study|Adverse Event|2|||
19692828|NCT00228423|42138609|FG001|Overall Study|Adverse Event|5|||
19692829|NCT00228423|42138608|FG000|Overall Study|Withdrawal by Subject|7|||
19692830|NCT00228423|42138609|FG001|Overall Study|Withdrawal by Subject|3|||
19692831|NCT00228423|42138608|FG000|Overall Study|Protocol Violation|1|||
19692832|NCT00228423|42138609|FG001|Overall Study|Protocol Violation|3|||
19692833|NCT00228423|42138608|FG000|Overall Study|Physician Decision|0|||
19692834|NCT00228423|42138609|FG001|Overall Study|Physician Decision|1|||
19692835|NCT00511667|42138617|FG000|Overall Study|Adverse Event|1|||
19692836|NCT00511667|42138618|FG001|Overall Study|Adverse Event|0|||
19692837|NCT00511667|42138617|FG000|Overall Study|Protocol Violation|1|||
19692838|NCT00511667|42138618|FG001|Overall Study|Protocol Violation|1|||
19692839|NCT00511667|42138617|FG000|Overall Study|Withdrawal by Subject|2|||
19692840|NCT00511667|42138618|FG001|Overall Study|Withdrawal by Subject|0|||
19692841|NCT00511667|42138617|FG000|Overall Study|Site terminated|6|||
19692842|NCT00511667|42138618|FG001|Overall Study|Site terminated|1|||
19692843|NCT00511667|42138617|FG000|Overall Study|Other|2|||
19692844|NCT00511667|42138618|FG001|Overall Study|Other|1|||
19692845|NCT00227877|42138634|FG000|Pre-visit Assessment|Technical difficulties|7|||
19692846|NCT00227877|42138635|FG001|Pre-visit Assessment|Technical difficulties|3|||
19692847|NCT00227877|42138636|FG002|Pre-visit Assessment|Technical difficulties|0|||
19692848|NCT00227877|42138637|FG003|Pre-visit Assessment|Technical difficulties|0|||
19692849|NCT00227877|42138634|FG000|Post-visit Checklist|Lost to Follow-up|24|||
19692850|NCT00227877|42138635|FG001|Post-visit Checklist|Lost to Follow-up|13|||
19692851|NCT00227877|42138636|FG002|Post-visit Checklist|Lost to Follow-up|1|||
19692852|NCT00227877|42138637|FG003|Post-visit Checklist|Lost to Follow-up|0|||
19692853|NCT00227877|42138634|FG000|3-months Follow-up|Completed late|135|||
19692854|NCT00227877|42138635|FG001|3-months Follow-up|Completed late|128|||
19692855|NCT00227877|42138636|FG002|3-months Follow-up|Completed late|34|||
19692856|NCT00227877|42138637|FG003|3-months Follow-up|Completed late|8|||
19692857|NCT00227877|42138634|FG000|3-months Follow-up|Lost to Follow-up|178|||
19692858|NCT00227877|42138635|FG001|3-months Follow-up|Lost to Follow-up|139|||
19692859|NCT00227877|42138636|FG002|3-months Follow-up|Lost to Follow-up|18|||
19692860|NCT00227877|42138637|FG003|3-months Follow-up|Lost to Follow-up|13|||
19692861|NCT00227877|42138634|FG000|12-months Follow-up|Completed late|78|||
19692862|NCT00227877|42138635|FG001|12-months Follow-up|Completed late|74|||
19692863|NCT00227877|42138636|FG002|12-months Follow-up|Completed late|1|||
19692864|NCT00227877|42138637|FG003|12-months Follow-up|Completed late|0|||
19692865|NCT00227877|42138634|FG000|12-months Follow-up|Lost to Follow-up|232|||
19692866|NCT00227877|42138635|FG001|12-months Follow-up|Lost to Follow-up|189|||
19692867|NCT00227877|42138636|FG002|12-months Follow-up|Lost to Follow-up|30|||
19692868|NCT00227877|42138637|FG003|12-months Follow-up|Lost to Follow-up|26|||
19776277|NCT02039674|42231287|FG005|Overall Study|Physician Decision|0|||
19692869|NCT00513695|42138649|FG000|Overall Study|Discontinued therapy|2|||
19692870|NCT00513695|42138649|FG000|Overall Study|Progression prior to surgery|3|||
19692871|NCT00162981|42138655|FG000|Overall Study|Adverse Event|2|||
19692872|NCT00162981|42138656|FG001|Overall Study|Adverse Event|5|||
19692873|NCT00162981|42138655|FG000|Overall Study|Withdrawal by Subject|1|||
19692874|NCT00162981|42138656|FG001|Overall Study|Withdrawal by Subject|1|||
19692875|NCT00162981|42138655|FG000|Overall Study|Physician Decision|1|||
19692876|NCT00162981|42138656|FG001|Overall Study|Physician Decision|0|||
19692877|NCT00511433|42138664|FG000|Overall Study|Adverse Event|5|||
19692878|NCT00511433|42138665|FG001|Overall Study|Adverse Event|0|||
19692879|NCT00511433|42138664|FG000|Overall Study|Other Reason|1|||
19692880|NCT00511433|42138665|FG001|Overall Study|Other Reason|1|||
19692881|NCT00099268|42138675|FG000|Overall Study|Withdrawal by Subject|46|||
19692882|NCT00099268|42138676|FG001|Overall Study|Withdrawal by Subject|28|||
19692883|NCT00099268|42138675|FG000|Overall Study|Adverse Event|19|||
19776278|NCT02039674|42231288|FG006|Overall Study|Physician Decision|0|||
19776279|NCT02039674|42231289|FG007|Overall Study|Physician Decision|0|||
19776280|NCT02039674|42231290|FG008|Overall Study|Physician Decision|0|||
19776281|NCT02039674|42231291|FG009|Overall Study|Physician Decision|0|||
19776282|NCT02039674|42231292|FG010|Overall Study|Physician Decision|0|||
19776283|NCT02039674|42231293|FG011|Overall Study|Physician Decision|1|||
19776284|NCT02039674|42231294|FG012|Overall Study|Physician Decision|1|||
19776285|NCT02039674|42231295|FG013|Overall Study|Physician Decision|0|||
19776286|NCT02039674|42231282|FG000|Overall Study|Progressive Disease|8|||
19776287|NCT02039674|42231283|FG001|Overall Study|Progressive Disease|8|||
19776288|NCT02039674|42231284|FG002|Overall Study|Progressive Disease|6|||
19776289|NCT02039674|42231285|FG003|Overall Study|Progressive Disease|7|||
19776290|NCT02039674|42231286|FG004|Overall Study|Progressive Disease|9|||
19776291|NCT02039674|42231287|FG005|Overall Study|Progressive Disease|10|||
19776292|NCT02039674|42231288|FG006|Overall Study|Progressive Disease|1|||
19776293|NCT02039674|42231289|FG007|Overall Study|Progressive Disease|3|||
19776294|NCT02039674|42231290|FG008|Overall Study|Progressive Disease|6|||
19776295|NCT02039674|42231291|FG009|Overall Study|Progressive Disease|4|||
19776296|NCT02039674|42231292|FG010|Overall Study|Progressive Disease|0|||
19776297|NCT02039674|42231293|FG011|Overall Study|Progressive Disease|34|||
19776298|NCT02039674|42231294|FG012|Overall Study|Progressive Disease|34|||
19776299|NCT02039674|42231295|FG013|Overall Study|Progressive Disease|18|||
19776300|NCT02039674|42231282|FG000|Overall Study|Withdrawal by Subject|1|||
19776301|NCT02039674|42231283|FG001|Overall Study|Withdrawal by Subject|2|||
19776302|NCT02039674|42231284|FG002|Overall Study|Withdrawal by Subject|3|||
19776303|NCT02039674|42231285|FG003|Overall Study|Withdrawal by Subject|0|||
19776304|NCT02039674|42231286|FG004|Overall Study|Withdrawal by Subject|1|||
19776305|NCT02039674|42231287|FG005|Overall Study|Withdrawal by Subject|0|||
19776306|NCT02039674|42231288|FG006|Overall Study|Withdrawal by Subject|0|||
19776307|NCT02039674|42231289|FG007|Overall Study|Withdrawal by Subject|0|||
19776308|NCT02039674|42231290|FG008|Overall Study|Withdrawal by Subject|0|||
19776309|NCT02039674|42231291|FG009|Overall Study|Withdrawal by Subject|1|||
19776310|NCT02039674|42231292|FG010|Overall Study|Withdrawal by Subject|1|||
19776311|NCT02039674|42231293|FG011|Overall Study|Withdrawal by Subject|4|||
19776312|NCT02039674|42231294|FG012|Overall Study|Withdrawal by Subject|6|||
19776313|NCT02039674|42231295|FG013|Overall Study|Withdrawal by Subject|2|||
19776314|NCT02039674|42231282|FG000|Overall Study|Clinical Progression|0|||
19776315|NCT02039674|42231283|FG001|Overall Study|Clinical Progression|0|||
19776316|NCT02039674|42231284|FG002|Overall Study|Clinical Progression|0|||
19776317|NCT02039674|42231285|FG003|Overall Study|Clinical Progression|0|||
19776318|NCT02039674|42231286|FG004|Overall Study|Clinical Progression|0|||
19776319|NCT02039674|42231287|FG005|Overall Study|Clinical Progression|0|||
19776320|NCT02039674|42231288|FG006|Overall Study|Clinical Progression|1|||
19776321|NCT02039674|42231289|FG007|Overall Study|Clinical Progression|0|||
19776322|NCT02039674|42231290|FG008|Overall Study|Clinical Progression|0|||
19776323|NCT02039674|42231291|FG009|Overall Study|Clinical Progression|0|||
19776324|NCT02039674|42231292|FG010|Overall Study|Clinical Progression|0|||
19776325|NCT02039674|42231293|FG011|Overall Study|Clinical Progression|0|||
19776326|NCT02039674|42231294|FG012|Overall Study|Clinical Progression|1|||
19776327|NCT02039674|42231295|FG013|Overall Study|Clinical Progression|0|||
19776328|NCT02039674|42231282|FG000|Overall Study|Sponsor Decision|1|||
19776329|NCT02039674|42231283|FG001|Overall Study|Sponsor Decision|1|||
19776330|NCT02039674|42231284|FG002|Overall Study|Sponsor Decision|1|||
19776331|NCT02039674|42231285|FG003|Overall Study|Sponsor Decision|1|||
19776332|NCT02039674|42231286|FG004|Overall Study|Sponsor Decision|1|||
19776333|NCT02039674|42231287|FG005|Overall Study|Sponsor Decision|0|||
19776334|NCT02039674|42231288|FG006|Overall Study|Sponsor Decision|0|||
19776335|NCT02039674|42231289|FG007|Overall Study|Sponsor Decision|0|||
19776336|NCT02039674|42231290|FG008|Overall Study|Sponsor Decision|0|||
19776337|NCT02039674|42231291|FG009|Overall Study|Sponsor Decision|3|||
19776338|NCT02039674|42231292|FG010|Overall Study|Sponsor Decision|0|||
19776339|NCT02039674|42231293|FG011|Overall Study|Sponsor Decision|8|||
19776340|NCT02039674|42231294|FG012|Overall Study|Sponsor Decision|5|||
19776341|NCT02039674|42231295|FG013|Overall Study|Sponsor Decision|0|||
19776342|NCT02039674|42231282|FG000|Overall Study|Other|0|||
19776343|NCT02039674|42231283|FG001|Overall Study|Other|0|||
19776344|NCT02039674|42231284|FG002|Overall Study|Other|0|||
19776345|NCT02039674|42231285|FG003|Overall Study|Other|0|||
19776346|NCT02039674|42231286|FG004|Overall Study|Other|0|||
19776347|NCT02039674|42231287|FG005|Overall Study|Other|0|||
19776348|NCT02039674|42231288|FG006|Overall Study|Other|0|||
19776349|NCT02039674|42231289|FG007|Overall Study|Other|0|||
19776350|NCT02039674|42231290|FG008|Overall Study|Other|0|||
19776351|NCT02039674|42231291|FG009|Overall Study|Other|0|||
19776352|NCT02039674|42231292|FG010|Overall Study|Other|0|||
19776353|NCT02039674|42231293|FG011|Overall Study|Other|0|||
19776354|NCT02039674|42231294|FG012|Overall Study|Other|1|||
19776355|NCT02039674|42231295|FG013|Overall Study|Other|0|||
19776356|NCT03126227|42231335|FG000|Overall Study|Adverse Event|43|||
19776357|NCT03126227|42231336|FG001|Overall Study|Adverse Event|4|||
19776358|NCT03126227|42231335|FG000|Overall Study|Death|0|||
19776359|NCT03126227|42231336|FG001|Overall Study|Death|1|||
19776360|NCT03126227|42231335|FG000|Overall Study|Lost to Follow-up|0|||
19692884|NCT00099268|42138676|FG001|Overall Study|Adverse Event|19|||
19692885|NCT00099268|42138675|FG000|Overall Study|Protocol Violation|9|||
19776361|NCT03126227|42231336|FG001|Overall Study|Lost to Follow-up|1|||
19776362|NCT03126227|42231335|FG000|Overall Study|Physician Decision|2|||
19776363|NCT03126227|42231336|FG001|Overall Study|Physician Decision|0|||
19776364|NCT03126227|42231335|FG000|Overall Study|Protocol Violation|1|||
19776365|NCT03126227|42231336|FG001|Overall Study|Protocol Violation|0|||
19776366|NCT03126227|42231335|FG000|Overall Study|Withdrawal by Subject|19|||
19776367|NCT03126227|42231336|FG001|Overall Study|Withdrawal by Subject|3|||
19776368|NCT03126227|42231335|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
19776369|NCT03126227|42231336|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
19606786|NCT00715078|42055466|FG000|Overall Study|Death|29|||
19606787|NCT00715078|42055467|FG001|Overall Study|Death|36|||
19606788|NCT00715078|42055468|FG002|Overall Study|Death|36|||
19606789|NCT00715078|42055466|FG000|Overall Study|Withdrawal by Subject|1|||
19606790|NCT00715078|42055467|FG001|Overall Study|Withdrawal by Subject|0|||
19606791|NCT00715078|42055468|FG002|Overall Study|Withdrawal by Subject|1|||
19606792|NCT00715078|42055466|FG000|Overall Study|Unable to start due to disease prog.|0|||
19606793|NCT00715078|42055467|FG001|Overall Study|Unable to start due to disease prog.|0|||
19606794|NCT00715078|42055468|FG002|Overall Study|Unable to start due to disease prog.|1|||
19606795|NCT00679627|42055478|FG000|Overall Study|Death|41|||
19606796|NCT00679627|42055479|FG001|Overall Study|Death|29|||
19606797|NCT00679627|42055478|FG000|Overall Study|Adverse Event|43|||
19606798|NCT00679627|42055479|FG001|Overall Study|Adverse Event|53|||
19692886|NCT00099268|42138676|FG001|Overall Study|Protocol Violation|8|||
19692887|NCT00099268|42138675|FG000|Overall Study|Lost to Follow-up|6|||
19692888|NCT00099268|42138676|FG001|Overall Study|Lost to Follow-up|4|||
19692889|NCT00099268|42138675|FG000|Overall Study|Lack of Efficacy|5|||
19692890|NCT00099268|42138676|FG001|Overall Study|Lack of Efficacy|18|||
19692891|NCT00099268|42138675|FG000|Overall Study|Administrative problems|4|||
19692892|NCT00099268|42138676|FG001|Overall Study|Administrative problems|4|||
19692893|NCT00099268|42138675|FG000|Overall Study|Death|3|||
19692894|NCT00099268|42138676|FG001|Overall Study|Death|1|||
19692895|NCT00511355|42138684|FG000|Overall Study|Adverse Event|4|||
19692896|NCT00511355|42138685|FG001|Overall Study|Adverse Event|4|||
19692897|NCT00511355|42138684|FG000|Overall Study|Pregnancy Wish|1|||
19692898|NCT00511355|42138685|FG001|Overall Study|Pregnancy Wish|0|||
19692899|NCT00511355|42138684|FG000|Overall Study|Lost to Follow-up|2|||
19692900|NCT00511355|42138685|FG001|Overall Study|Lost to Follow-up|1|||
19692901|NCT00511355|42138684|FG000|Overall Study|Other Reason|0|||
19692902|NCT00511355|42138685|FG001|Overall Study|Other Reason|1|||
19692903|NCT00511355|42138684|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
19692904|NCT00511355|42138685|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
19692905|NCT00511355|42138684|FG000|Overall Study|Withdrawal of informed consent|0|||
19692906|NCT00511355|42138685|FG001|Overall Study|Withdrawal of informed consent|1|||
19692907|NCT00511355|42138684|FG000|Overall Study|Other reason pre-treatment|0|||
19692908|NCT00511355|42138685|FG001|Overall Study|Other reason pre-treatment|1|||
19692909|NCT00095212|42138695|FG000|Overall Study|Withdrawal by Subject|1|||
19692910|NCT00095212|42138696|FG001|Overall Study|Withdrawal by Subject|3|||
19692911|NCT00120874|42138704|FG000|Overall Study|Death|0|||
19692912|NCT00120874|42138705|FG001|Overall Study|Death|1|||
19692913|NCT00120406|42138713|FG000|Overall Study|Death|9|||
19692914|NCT00120406|42138714|FG001|Overall Study|Death|4|||
19692915|NCT00120406|42138713|FG000|Overall Study|Withdrawal by Subject|5|||
19692916|NCT00120406|42138714|FG001|Overall Study|Withdrawal by Subject|7|||
19692917|NCT00120406|42138713|FG000|Overall Study|Lost to Follow-up|5|||
19692918|NCT00120406|42138714|FG001|Overall Study|Lost to Follow-up|2|||
19692919|NCT00120406|42138713|FG000|Overall Study|received non-study stent|0|||
19692920|NCT00120406|42138714|FG001|Overall Study|received non-study stent|2|||
19692921|NCT00120406|42138713|FG000|Overall Study|patient moved but has not withdrawn|0|||
19692922|NCT00120406|42138714|FG001|Overall Study|patient moved but has not withdrawn|1|||
19692923|NCT00120250|42138720|FG000|Overall Study|Lost to Follow-up|1|||
19692924|NCT00120250|42138721|FG001|Overall Study|Lost to Follow-up|1|||
19692925|NCT00120250|42138720|FG000|Overall Study|Protocol Violation|0|||
19692926|NCT00120250|42138721|FG001|Overall Study|Protocol Violation|1|||
19692927|NCT00511199|42138730|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
19692928|NCT00511199|42138731|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
19692929|NCT00511199|42138730|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
19606799|NCT00679627|42055478|FG000|Overall Study|Withdrawal by Subject|168|||
19692930|NCT00511199|42138731|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
19692931|NCT00511199|42138730|FG000|Overall Study|Withdrawal of Informed Consent|19|||
19692932|NCT00511199|42138731|FG001|Overall Study|Withdrawal of Informed Consent|4|||
19692933|NCT00511199|42138730|FG000|Overall Study|Pregnancy|6|||
19692934|NCT00511199|42138731|FG001|Overall Study|Pregnancy|3|||
19692935|NCT00511199|42138730|FG000|Overall Study|Pregnancy Wish|16|||
19692936|NCT00511199|42138731|FG001|Overall Study|Pregnancy Wish|8|||
19692937|NCT00511199|42138730|FG000|Overall Study|Lost to Follow-up|40|||
19776370|NCT03126227|42231335|FG000|Overall Study|Lack of dosing compliance|2|||
19776371|NCT03126227|42231336|FG001|Overall Study|Lack of dosing compliance|0|||
19776372|NCT03126227|42231335|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
19776373|NCT03126227|42231336|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
19776374|NCT03126227|42231335|FG000|Overall Study|Scheduling conflict|1|||
19776375|NCT03126227|42231336|FG001|Overall Study|Scheduling conflict|0|||
19776376|NCT03099187|42231344|FG000|Double-blind Treatment|Adverse Event|19|||
19776377|NCT03099187|42231345|FG001|Double-blind Treatment|Adverse Event|1|||
19776378|NCT03099187|42231346|FG002|Double-blind Treatment|Adverse Event|0|||
19776379|NCT03099187|42231347|FG003|Double-blind Treatment|Adverse Event|0|||
19776380|NCT03099187|42231344|FG000|Double-blind Treatment|Death|1|||
19776381|NCT03099187|42231345|FG001|Double-blind Treatment|Death|3|||
19776382|NCT03099187|42231346|FG002|Double-blind Treatment|Death|0|||
19776383|NCT03099187|42231347|FG003|Double-blind Treatment|Death|0|||
19776384|NCT03099187|42231344|FG000|Double-blind Treatment|Lack of Efficacy|1|||
19776385|NCT03099187|42231345|FG001|Double-blind Treatment|Lack of Efficacy|0|||
19776386|NCT03099187|42231346|FG002|Double-blind Treatment|Lack of Efficacy|0|||
19776387|NCT03099187|42231347|FG003|Double-blind Treatment|Lack of Efficacy|0|||
19776388|NCT03099187|42231344|FG000|Double-blind Treatment|Physician Decision|2|||
19776389|NCT03099187|42231345|FG001|Double-blind Treatment|Physician Decision|1|||
19776390|NCT03099187|42231346|FG002|Double-blind Treatment|Physician Decision|0|||
19776391|NCT03099187|42231347|FG003|Double-blind Treatment|Physician Decision|0|||
19776392|NCT03099187|42231344|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
19776393|NCT03099187|42231345|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
19776394|NCT03099187|42231346|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
19776395|NCT03099187|42231347|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
19776396|NCT03099187|42231344|FG000|Double-blind Treatment|Lung transplantation|0|||
19776397|NCT03099187|42231345|FG001|Double-blind Treatment|Lung transplantation|1|||
19776398|NCT03099187|42231346|FG002|Double-blind Treatment|Lung transplantation|0|||
19776399|NCT03099187|42231347|FG003|Double-blind Treatment|Lung transplantation|0|||
19776400|NCT03099187|42231344|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
19776401|NCT03099187|42231345|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
19776402|NCT03099187|42231346|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
19776403|NCT03099187|42231347|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
19776404|NCT03099187|42231344|FG000|Double-blind Treatment|Disease progression|0|||
19776405|NCT03099187|42231345|FG001|Double-blind Treatment|Disease progression|1|||
19776406|NCT03099187|42231346|FG002|Double-blind Treatment|Disease progression|0|||
19776407|NCT03099187|42231347|FG003|Double-blind Treatment|Disease progression|0|||
19776408|NCT03099187|42231344|FG000|Double-blind Treatment|Randomization error|0|||
19776409|NCT03099187|42231345|FG001|Double-blind Treatment|Randomization error|2|||
19776410|NCT03099187|42231346|FG002|Double-blind Treatment|Randomization error|0|||
19776411|NCT03099187|42231347|FG003|Double-blind Treatment|Randomization error|0|||
19776412|NCT03099187|42231344|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
19776413|NCT03099187|42231345|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
19776414|NCT03099187|42231346|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
19776415|NCT03099187|42231347|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
19776416|NCT03099187|42231344|FG000|12-month Safety Follow-up|Adverse Event|0|||
19692938|NCT00511199|42138731|FG001|Overall Study|Lost to Follow-up|17|||
19692939|NCT00511199|42138730|FG000|Overall Study|Other Reason|78|||
19692940|NCT00511199|42138731|FG001|Overall Study|Other Reason|37|||
19692941|NCT00384176|42138742|FG000|Overall Study|Death|239|||
19692942|NCT00384176|42138743|FG001|Overall Study|Death|247|||
19776417|NCT03099187|42231345|FG001|12-month Safety Follow-up|Adverse Event|0|||
19776418|NCT03099187|42231346|FG002|12-month Safety Follow-up|Adverse Event|5|||
19606800|NCT00679627|42055479|FG001|Overall Study|Withdrawal by Subject|172|||
19606801|NCT00679627|42055478|FG000|Overall Study|Lost to Follow-up|22|||
19606802|NCT00679627|42055479|FG001|Overall Study|Lost to Follow-up|26|||
19606803|NCT00679627|42055478|FG000|Overall Study|Early Study Closure|425|||
19606804|NCT00679627|42055479|FG001|Overall Study|Early Study Closure|405|||
19606805|NCT00714688|42055488|FG000|Overall Study|Lack of Efficacy|14|||
19606806|NCT00714688|42055489|FG001|Overall Study|Lack of Efficacy|1|||
19606807|NCT00714688|42055490|FG002|Overall Study|Lack of Efficacy|4|||
19606808|NCT00714688|42055488|FG000|Overall Study|Withdrawal by Subject|4|||
19606809|NCT00714688|42055489|FG001|Overall Study|Withdrawal by Subject|3|||
19606810|NCT00714688|42055490|FG002|Overall Study|Withdrawal by Subject|3|||
19606811|NCT00714688|42055488|FG000|Overall Study|Lost to Follow-up|5|||
19692943|NCT00384176|42138744|FG002|Overall Study|Death|105|||
19692944|NCT00384176|42138742|FG000|Overall Study|Withdrawal by Subject|52|||
19692945|NCT00384176|42138743|FG001|Overall Study|Withdrawal by Subject|48|||
19692946|NCT00384176|42138744|FG002|Overall Study|Withdrawal by Subject|22|||
19776419|NCT03099187|42231347|FG003|12-month Safety Follow-up|Adverse Event|12|||
19776420|NCT03099187|42231344|FG000|12-month Safety Follow-up|Death|0|||
19776421|NCT03099187|42231345|FG001|12-month Safety Follow-up|Death|0|||
19776422|NCT03099187|42231346|FG002|12-month Safety Follow-up|Death|7|||
19776423|NCT03099187|42231347|FG003|12-month Safety Follow-up|Death|9|||
19776424|NCT03099187|42231344|FG000|12-month Safety Follow-up|Lung transplantation|0|||
19776425|NCT03099187|42231345|FG001|12-month Safety Follow-up|Lung transplantation|0|||
19776426|NCT03099187|42231346|FG002|12-month Safety Follow-up|Lung transplantation|2|||
19776427|NCT03099187|42231347|FG003|12-month Safety Follow-up|Lung transplantation|1|||
19776428|NCT03099187|42231344|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
19776429|NCT03099187|42231345|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
19776430|NCT03099187|42231346|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
19776431|NCT03099187|42231347|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
19776432|NCT03099187|42231344|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
19776433|NCT03099187|42231345|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
19776434|NCT03099187|42231346|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
19776435|NCT03099187|42231347|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
19776436|NCT03099187|42231344|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
19776437|NCT03099187|42231345|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
19776438|NCT03099187|42231346|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
19776439|NCT03099187|42231347|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
19776440|NCT03099187|42231344|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
19776441|NCT03099187|42231345|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
19776442|NCT03099187|42231346|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
19776443|NCT03099187|42231347|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
19776444|NCT04463069|42231359|FG000|Overall Study|Withdrawal by Subject|2|||
19776445|NCT04463069|42231360|FG001|Overall Study|Withdrawal by Subject|10|||
19776446|NCT04463069|42231359|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
19776447|NCT04463069|42231360|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
19776448|NCT03521687|42231366|FG000|Overall Study|Adverse Event|4|||
19776449|NCT03521687|42231366|FG000|Overall Study|Physician Decision|1|||
19776450|NCT03125915|42231374|FG000|1 Month Follow up|Lost to Follow-up|3|||
19776451|NCT03125915|42231375|FG001|1 Month Follow up|Lost to Follow-up|3|||
19776452|NCT03125915|42231376|FG002|1 Month Follow up|Lost to Follow-up|2|||
19776453|NCT03125915|42231377|FG003|1 Month Follow up|Lost to Follow-up|3|||
19776454|NCT03125915|42231374|FG000|3 Month Follow-up|Lost to Follow-up|6|||
19776455|NCT03125915|42231375|FG001|3 Month Follow-up|Lost to Follow-up|4|||
19776456|NCT03125915|42231376|FG002|3 Month Follow-up|Lost to Follow-up|4|||
19776457|NCT03125915|42231377|FG003|3 Month Follow-up|Lost to Follow-up|2|||
19776458|NCT03125915|42231374|FG000|6 Month Follow-up|Lost to Follow-up|7|||
19776459|NCT03125915|42231375|FG001|6 Month Follow-up|Lost to Follow-up|3|||
19776460|NCT03125915|42231376|FG002|6 Month Follow-up|Lost to Follow-up|6|||
19776461|NCT03125915|42231377|FG003|6 Month Follow-up|Lost to Follow-up|3|||
19776462|NCT03122171|42231387|FG000|Overall Study|Withdrawal by Subject|1|||
19776463|NCT01427725|42231391|FG000|Overall Study|Lost to Follow-up|17|||
19776464|NCT01427725|42231391|FG000|Overall Study|Protocol Violation|1|||
19776465|NCT01427725|42231391|FG000|Overall Study|Drug not administered|1|||
19776466|NCT01427725|42231391|FG000|Overall Study|Failure to visit|7|||
19776467|NCT01427725|42231391|FG000|Overall Study|Adverse Event|46|||
19776468|NCT01427725|42231391|FG000|Overall Study|Failure to visit after administration|40|||
19776469|NCT01427725|42231391|FG000|Overall Study|Patient's rejection|27|||
19776470|NCT01427725|42231391|FG000|Overall Study|Transfer to a different hospital|17|||
19776471|NCT01427725|42231391|FG000|Overall Study|Lack of Efficacy|8|||
19776472|NCT01427725|42231391|FG000|Overall Study|Death|7|||
19776473|NCT01427725|42231391|FG000|Overall Study|Symptom improvement|6|||
19776474|NCT01427725|42231391|FG000|Overall Study|AE and Patient's rejection|5|||
19776475|NCT01427725|42231391|FG000|Overall Study|Physician Decision|5|||
19776476|NCT01427725|42231391|FG000|Overall Study|Exacerbation of underlying disease|5|||
19776477|NCT01427725|42231391|FG000|Overall Study|Oral feeding difficulty|5|||
19776478|NCT01427725|42231391|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
19776479|NCT01427725|42231391|FG000|Overall Study|Forgetting prescription|1|||
19776480|NCT01427725|42231391|FG000|Overall Study|Other|2|||
19776481|NCT02839200|42231402|FG000|Overall Study|Withdrawal by Subject|2|||
19776482|NCT02839200|42231403|FG001|Overall Study|Withdrawal by Subject|0|||
19776483|NCT02839200|42231404|FG002|Overall Study|Withdrawal by Subject|1|||
19776484|NCT02839200|42231405|FG003|Overall Study|Withdrawal by Subject|0|||
19776485|NCT02839200|42231406|FG004|Overall Study|Withdrawal by Subject|0|||
19776486|NCT02839200|42231407|FG005|Overall Study|Withdrawal by Subject|1|||
19776487|NCT02839200|42231402|FG000|Overall Study|Lost to Follow-up|2|||
19776488|NCT02839200|42231403|FG001|Overall Study|Lost to Follow-up|0|||
19776489|NCT02839200|42231404|FG002|Overall Study|Lost to Follow-up|0|||
19776490|NCT02839200|42231405|FG003|Overall Study|Lost to Follow-up|0|||
19776491|NCT02839200|42231406|FG004|Overall Study|Lost to Follow-up|1|||
19776492|NCT02839200|42231407|FG005|Overall Study|Lost to Follow-up|0|||
19776493|NCT02839200|42231402|FG000|Overall Study|Adverse Event|0|||
19776494|NCT02839200|42231403|FG001|Overall Study|Adverse Event|0|||
19776495|NCT02839200|42231404|FG002|Overall Study|Adverse Event|0|||
19776496|NCT02839200|42231405|FG003|Overall Study|Adverse Event|0|||
19776497|NCT02839200|42231406|FG004|Overall Study|Adverse Event|1|||
19776498|NCT02839200|42231407|FG005|Overall Study|Adverse Event|0|||
19776499|NCT02839200|42231402|FG000|Overall Study|Randomized in error|0|||
19776500|NCT02839200|42231403|FG001|Overall Study|Randomized in error|1|||
19776501|NCT02839200|42231404|FG002|Overall Study|Randomized in error|0|||
19776502|NCT02839200|42231405|FG003|Overall Study|Randomized in error|0|||
19776503|NCT02839200|42231406|FG004|Overall Study|Randomized in error|0|||
19776504|NCT02839200|42231407|FG005|Overall Study|Randomized in error|0|||
19692947|NCT00384176|42138742|FG000|Overall Study|Lost to Follow-up|16|||
19692948|NCT00384176|42138743|FG001|Overall Study|Lost to Follow-up|18|||
19692949|NCT00384176|42138744|FG002|Overall Study|Lost to Follow-up|4|||
19692950|NCT00384176|42138742|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
19692951|NCT00384176|42138743|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
19692952|NCT00384176|42138744|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
19692953|NCT00384176|42138742|FG000|Overall Study|Longer QTC as Visit 1|1|||
19692954|NCT00384176|42138743|FG001|Overall Study|Longer QTC as Visit 1|0|||
19692955|NCT00384176|42138744|FG002|Overall Study|Longer QTC as Visit 1|0|||
19692956|NCT00384176|42138742|FG000|Overall Study|Toxicity of treatment|1|||
19692957|NCT00384176|42138743|FG001|Overall Study|Toxicity of treatment|0|||
19692958|NCT00384176|42138744|FG002|Overall Study|Toxicity of treatment|0|||
19692959|NCT00384176|42138742|FG000|Overall Study|Did not receive study treatment|0|||
19692960|NCT00384176|42138743|FG001|Overall Study|Did not receive study treatment|1|||
19776505|NCT03118739|42231423|FG000|Overall Study|Physician Decision|0|||
19776506|NCT03118739|42231424|FG001|Overall Study|Physician Decision|1|||
19776507|NCT03118739|42231423|FG000|Overall Study|Withdrawal by Subject|5|||
19776508|NCT03118739|42231424|FG001|Overall Study|Withdrawal by Subject|3|||
19776509|NCT03118739|42231423|FG000|Overall Study|Lost to Follow-up|2|||
19776510|NCT03118739|42231424|FG001|Overall Study|Lost to Follow-up|0|||
19776511|NCT03094195|42231433|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
19776512|NCT03094195|42231434|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
19776513|NCT03094195|42231435|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
19776514|NCT03094195|42231436|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19776515|NCT03094195|42231437|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19776516|NCT03094195|42231438|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19776517|NCT03094195|42231439|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19776518|NCT03094195|42231440|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
19776519|NCT03094195|42231433|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
19776520|NCT03094195|42231434|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
19776521|NCT03094195|42231435|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
19776522|NCT03094195|42231436|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19776523|NCT03094195|42231437|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19776524|NCT03094195|42231438|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19776525|NCT03094195|42231439|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19776526|NCT03094195|42231440|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
19776527|NCT03094195|42231433|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776528|NCT03094195|42231434|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776529|NCT03094195|42231435|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
19776530|NCT03094195|42231436|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776531|NCT03094195|42231437|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776532|NCT03094195|42231438|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776533|NCT03094195|42231439|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776534|NCT03094195|42231440|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
19776535|NCT03094195|42231433|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776536|NCT03094195|42231434|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
19776537|NCT03094195|42231435|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
19776538|NCT03094195|42231436|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776539|NCT03094195|42231437|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776540|NCT03094195|42231438|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776541|NCT03094195|42231439|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776542|NCT03094195|42231440|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
19776543|NCT02835690|42231461|FG000|Overall Study|Death|12|||
19776544|NCT02835690|42231462|FG001|Overall Study|Death|11|||
19776545|NCT02835690|42231463|FG002|Overall Study|Death|13|||
19776546|NCT02835690|42231461|FG000|Overall Study|Transferred to Extension Study|2|||
19776547|NCT02835690|42231462|FG001|Overall Study|Transferred to Extension Study|2|||
19776548|NCT02835690|42231463|FG002|Overall Study|Transferred to Extension Study|1|||
19692961|NCT00384176|42138744|FG002|Overall Study|Did not receive study treatment|1|||
19776549|NCT02835690|42231461|FG000|Overall Study|Did Not Continue on Extension Study|0|||
19776550|NCT02835690|42231462|FG001|Overall Study|Did Not Continue on Extension Study|0|||
19776551|NCT02835690|42231463|FG002|Overall Study|Did Not Continue on Extension Study|1|||
19776552|NCT02835690|42231461|FG000|Overall Study|Not Treated|0|||
19776553|NCT02835690|42231462|FG001|Overall Study|Not Treated|2|||
19776554|NCT02835690|42231463|FG002|Overall Study|Not Treated|0|||
19776555|NCT02837952|42231478|FG000|Overall Study|Adverse Event|0|||
19776556|NCT02837952|42231479|FG001|Overall Study|Adverse Event|1|||
19776557|NCT02837952|42231478|FG000|Overall Study|Withdrawal by Subject|4|||
19776558|NCT02837952|42231479|FG001|Overall Study|Withdrawal by Subject|5|||
19776559|NCT02837952|42231478|FG000|Overall Study|Medication Error|1|||
19776560|NCT02837952|42231479|FG001|Overall Study|Medication Error|0|||
19776561|NCT02832167|42231485|FG000|Treatment Period 1|Disease progression|90|||
19776562|NCT02832167|42231485|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
19776563|NCT02832167|42231485|FG000|Treatment Period 1|Death|2|||
19776564|NCT02832167|42231485|FG000|Treatment Period 1|Study Drug Toxicity|6|||
19776565|NCT02832167|42231485|FG000|Treatment Period 1|Participant request to discontinue|9|||
19776566|NCT02832167|42231485|FG000|Treatment Period 1|No longer meet study criteria|1|||
19776567|NCT02832167|42231485|FG000|Treatment Period 1|Participant withdrew consent|3|||
19776568|NCT02832167|42231485|FG000|Treatment Period 1|Other reasons|6|||
19776569|NCT02832167|42231485|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
19776570|NCT02832167|42231485|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
19776571|NCT02832167|42231485|FG000|Transition From Period 1 to Period 2|Death|2|||
19692962|NCT00384176|42138742|FG000|Overall Study|Physician Decision|0|||
19692963|NCT00384176|42138743|FG001|Overall Study|Physician Decision|2|||
19692964|NCT00384176|42138744|FG002|Overall Study|Physician Decision|0|||
19692965|NCT00384176|42138742|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
19692966|NCT00384176|42138743|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
19692967|NCT00384176|42138744|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
19692968|NCT00513305|42138754|FG000|Overall Study|Adverse Event|6|||
19692969|NCT00513305|42138755|FG001|Overall Study|Adverse Event|2|||
19692970|NCT00513305|42138754|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
19776572|NCT02832167|42231485|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
19776573|NCT02832167|42231485|FG000|Treatment Period 2|Disease progression|69|||
19776574|NCT02832167|42231485|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
19776575|NCT02832167|42231485|FG000|Treatment Period 2|Maximum clinical benefit|1|||
19776576|NCT02832167|42231485|FG000|Treatment Period 2|Study Drug Toxicity|5|||
19776577|NCT02832167|42231485|FG000|Treatment Period 2|Participant request to discontinue|2|||
19776578|NCT02832167|42231485|FG000|Treatment Period 2|Participant withdrew consent|3|||
19776579|NCT02832167|42231485|FG000|Treatment Period 2|Other reasons|3|||
19776580|NCT02674529|42231491|FG000|Overall Study|Lost to Follow-up|1|||
19776581|NCT02674529|42231492|FG001|Overall Study|Lost to Follow-up|2|||
19776582|NCT02674529|42231491|FG000|Overall Study|Withdrawal by Subject|2|||
19776583|NCT02674529|42231492|FG001|Overall Study|Withdrawal by Subject|1|||
19692971|NCT00513305|42138755|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
19776584|NCT02674529|42231491|FG000|Overall Study|Physician Decision|0|||
19776585|NCT02674529|42231492|FG001|Overall Study|Physician Decision|1|||
19776586|NCT02674529|42231491|FG000|Overall Study|Protocol Violation|0|||
19776587|NCT02674529|42231492|FG001|Overall Study|Protocol Violation|1|||
19776588|NCT02626949|42231503|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
19776589|NCT02626949|42231504|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
19776590|NCT02626949|42231503|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
19776591|NCT02626949|42231504|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
19776592|NCT02626949|42231503|FG000|Enrolled|Lost to Follow-up|7|||
19776593|NCT02626949|42231504|FG001|Enrolled|Lost to Follow-up|6|||
19776594|NCT02626949|42231503|FG000|Enrolled|Withdrawal by Subject|3|||
19776595|NCT02626949|42231504|FG001|Enrolled|Withdrawal by Subject|2|||
19776596|NCT02838420|42231512|FG000|Overall Study|Ongoing in Study|113|||
19776597|NCT02838420|42231513|FG001|Overall Study|Ongoing in Study|45|||
19776598|NCT02838420|42231512|FG000|Overall Study|Lost to Follow-up|1|||
19776599|NCT02838420|42231513|FG001|Overall Study|Lost to Follow-up|0|||
19776600|NCT02838420|42231512|FG000|Overall Study|Withdrawal by Subject|3|||
19776601|NCT02838420|42231513|FG001|Overall Study|Withdrawal by Subject|4|||
19776602|NCT02838420|42231512|FG000|Overall Study|Death|8|||
19776603|NCT02838420|42231513|FG001|Overall Study|Death|13|||
19776604|NCT03116399|42231521|FG000|Overall Study|Death|8|||
19776605|NCT03116399|42231522|FG001|Overall Study|Death|3|||
19776606|NCT03116399|42231521|FG000|Overall Study|Lost to Follow-up|7|||
19776607|NCT03116399|42231522|FG001|Overall Study|Lost to Follow-up|11|||
19776608|NCT03116399|42231521|FG000|Overall Study|Investigator Decision|1|||
19776609|NCT03116399|42231522|FG001|Overall Study|Investigator Decision|1|||
19776610|NCT03116399|42231521|FG000|Overall Study|Withdrawal by Subject|24|||
19776611|NCT03116399|42231522|FG001|Overall Study|Withdrawal by Subject|9|||
19692972|NCT00513305|42138754|FG000|Overall Study|Lack of Efficacy|8|||
19692973|NCT00513305|42138755|FG001|Overall Study|Lack of Efficacy|13|||
19776612|NCT03097861|42231531|FG000|Overall Study|Adverse Event|3|||
19776613|NCT03097861|42231532|FG001|Overall Study|Adverse Event|8|||
19776614|NCT03097861|42231533|FG002|Overall Study|Adverse Event|4|||
19776615|NCT03097861|42231531|FG000|Overall Study|Investigator Decision|0|||
19776616|NCT03097861|42231532|FG001|Overall Study|Investigator Decision|1|||
19776617|NCT03097861|42231533|FG002|Overall Study|Investigator Decision|0|||
19776618|NCT03097861|42231531|FG000|Overall Study|Lost to Follow-up|0|||
19692974|NCT00513305|42138754|FG000|Overall Study|Withdrawal by Subject|1|||
19692975|NCT00513305|42138755|FG001|Overall Study|Withdrawal by Subject|2|||
19692976|NCT00513305|42138754|FG000|Overall Study|Disease progression|8|||
19776619|NCT03097861|42231532|FG001|Overall Study|Lost to Follow-up|7|||
19776620|NCT03097861|42231533|FG002|Overall Study|Lost to Follow-up|1|||
19776621|NCT03097861|42231531|FG000|Overall Study|Withdrawal by Subject|1|||
19776622|NCT03097861|42231532|FG001|Overall Study|Withdrawal by Subject|5|||
19776623|NCT03097861|42231533|FG002|Overall Study|Withdrawal by Subject|3|||
19776624|NCT03097861|42231531|FG000|Overall Study|Reason not provided|3|||
19776625|NCT03097861|42231532|FG001|Overall Study|Reason not provided|1|||
19776626|NCT03097861|42231533|FG002|Overall Study|Reason not provided|1|||
19776627|NCT03910673|42231548|FG000|Overall Study|Adverse Event|0|||
19776628|NCT03910673|42231549|FG001|Overall Study|Adverse Event|0|||
19776629|NCT03910673|42231550|FG002|Overall Study|Adverse Event|0|||
19776630|NCT03910673|42231551|FG003|Overall Study|Adverse Event|2|||
19692977|NCT00513305|42138755|FG001|Overall Study|Disease progression|5|||
19692978|NCT00513305|42138754|FG000|Overall Study|Eligible for stem cell transplant|1|||
19776631|NCT03910673|42231552|FG004|Overall Study|Adverse Event|0|||
19776632|NCT01816139|42231558|FG000|Overall Study|Adverse Event|6|||
19776633|NCT01816139|42231559|FG001|Overall Study|Adverse Event|8|||
19776634|NCT01816139|42231558|FG000|Overall Study|Lack of Efficacy|1|||
19776635|NCT01816139|42231559|FG001|Overall Study|Lack of Efficacy|2|||
19776636|NCT01816139|42231558|FG000|Overall Study|Lost to Follow-up|5|||
19776637|NCT01816139|42231559|FG001|Overall Study|Lost to Follow-up|3|||
19776638|NCT01816139|42231558|FG000|Overall Study|Withdrew Consent|6|||
19776639|NCT01816139|42231559|FG001|Overall Study|Withdrew Consent|4|||
19776640|NCT01816139|42231558|FG000|Overall Study|Protocol Violation|6|||
19776641|NCT01816139|42231559|FG001|Overall Study|Protocol Violation|3|||
19776642|NCT01816139|42231558|FG000|Overall Study|Reason not Specified|4|||
19776643|NCT01816139|42231559|FG001|Overall Study|Reason not Specified|2|||
19776644|NCT02833350|42231602|FG000|Overall Study|Adverse Event|0|||
19776645|NCT02833350|42231603|FG001|Overall Study|Adverse Event|3|||
19776646|NCT02833350|42231604|FG002|Overall Study|Adverse Event|4|||
19776647|NCT02833350|42231605|FG003|Overall Study|Adverse Event|4|||
19776648|NCT02833350|42231606|FG004|Overall Study|Adverse Event|1|||
19776649|NCT02833350|42231607|FG005|Overall Study|Adverse Event|0|||
19776650|NCT02833350|42231608|FG006|Overall Study|Adverse Event|1|||
19776651|NCT02833350|42231602|FG000|Overall Study|Death|0|||
19776652|NCT02833350|42231603|FG001|Overall Study|Death|0|||
19776653|NCT02833350|42231604|FG002|Overall Study|Death|1|||
19776654|NCT02833350|42231605|FG003|Overall Study|Death|0|||
19776655|NCT02833350|42231606|FG004|Overall Study|Death|0|||
19776656|NCT02833350|42231607|FG005|Overall Study|Death|0|||
19776657|NCT02833350|42231608|FG006|Overall Study|Death|0|||
19776658|NCT02833350|42231602|FG000|Overall Study|Lack of Efficacy|0|||
19776659|NCT02833350|42231603|FG001|Overall Study|Lack of Efficacy|2|||
19776660|NCT02833350|42231604|FG002|Overall Study|Lack of Efficacy|1|||
19776661|NCT02833350|42231605|FG003|Overall Study|Lack of Efficacy|4|||
19776662|NCT02833350|42231606|FG004|Overall Study|Lack of Efficacy|0|||
19776663|NCT02833350|42231607|FG005|Overall Study|Lack of Efficacy|1|||
19776664|NCT02833350|42231608|FG006|Overall Study|Lack of Efficacy|1|||
19776665|NCT02833350|42231602|FG000|Overall Study|Lost to Follow-up|0|||
19692979|NCT00513305|42138755|FG001|Overall Study|Eligible for stem cell transplant|0|||
19692980|NCT00513305|42138754|FG000|Overall Study|Hematologic counts did not recover|1|||
19692981|NCT00513305|42138755|FG001|Overall Study|Hematologic counts did not recover|0|||
19692982|NCT00513305|42138754|FG000|Overall Study|Physician Decision|1|||
19692983|NCT00513305|42138755|FG001|Overall Study|Physician Decision|0|||
19692984|NCT00513305|42138754|FG000|Overall Study|Persistent hypocellularity|0|||
19692985|NCT00513305|42138755|FG001|Overall Study|Persistent hypocellularity|1|||
19692986|NCT00513305|42138754|FG000|Overall Study|Sponsor Decision|0|||
19692987|NCT00513305|42138755|FG001|Overall Study|Sponsor Decision|2|||
19692988|NCT00513071|42138761|FG000|Overall Study|Adverse Event|1|||
19776666|NCT02833350|42231603|FG001|Overall Study|Lost to Follow-up|1|||
19776667|NCT02833350|42231604|FG002|Overall Study|Lost to Follow-up|0|||
19776668|NCT02833350|42231605|FG003|Overall Study|Lost to Follow-up|0|||
19776669|NCT02833350|42231606|FG004|Overall Study|Lost to Follow-up|0|||
19776670|NCT02833350|42231607|FG005|Overall Study|Lost to Follow-up|0|||
19776671|NCT02833350|42231608|FG006|Overall Study|Lost to Follow-up|1|||
19776672|NCT02833350|42231602|FG000|Overall Study|Withdrawal by Subject|3|||
19776673|NCT02833350|42231603|FG001|Overall Study|Withdrawal by Subject|3|||
19776674|NCT02833350|42231604|FG002|Overall Study|Withdrawal by Subject|2|||
19692989|NCT00513071|42138761|FG000|Overall Study|Withdrawal by Subject|1|||
19692990|NCT00513071|42138761|FG000|Overall Study|Physician Decision|3|||
19776675|NCT02833350|42231605|FG003|Overall Study|Withdrawal by Subject|0|||
19776676|NCT02833350|42231606|FG004|Overall Study|Withdrawal by Subject|2|||
19776677|NCT02833350|42231607|FG005|Overall Study|Withdrawal by Subject|0|||
19776678|NCT02833350|42231608|FG006|Overall Study|Withdrawal by Subject|2|||
19776679|NCT01343043|42231631|FG000|Overall Study|Disease progression before treatment|1|||
19776680|NCT01343043|42231632|FG001|Overall Study|Disease progression before treatment|0|||
19776681|NCT01343043|42231633|FG002|Overall Study|Disease progression before treatment|0|||
19776682|NCT01343043|42231634|FG003|Overall Study|Disease progression before treatment|0|||
19776683|NCT01343043|42231631|FG000|Overall Study|Withdrawal by Subject|1|||
19776684|NCT01343043|42231632|FG001|Overall Study|Withdrawal by Subject|0|||
19776685|NCT01343043|42231633|FG002|Overall Study|Withdrawal by Subject|0|||
19776686|NCT01343043|42231634|FG003|Overall Study|Withdrawal by Subject|0|||
19776687|NCT01343043|42231631|FG000|Overall Study|Death|1|||
19776688|NCT01343043|42231632|FG001|Overall Study|Death|1|||
19776689|NCT01343043|42231633|FG002|Overall Study|Death|0|||
19776690|NCT01343043|42231634|FG003|Overall Study|Death|1|||
19776691|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
19776692|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
19776693|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
19776694|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
19776695|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
19776696|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
19776697|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
19776698|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
19776699|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
19776700|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
19776701|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
19776702|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
19776703|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
19776704|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
19776705|NCT03548987|42231649|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
19776706|NCT03548987|42231650|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
19776707|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
19776708|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
19776709|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
19776710|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
19776711|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
19776712|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
19776713|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
19776714|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
19776715|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
19776716|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
19776717|NCT03548987|42231649|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
19776718|NCT03548987|42231650|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
19776719|NCT01358760|42231660|FG000|Overall Study|Adverse Event|3|||
19776720|NCT01358760|42231661|FG001|Overall Study|Adverse Event|4|||
19776721|NCT01358760|42231662|FG002|Overall Study|Adverse Event|3|||
19776722|NCT01358760|42231660|FG000|Overall Study|Lost to Follow-up|1|||
19776723|NCT01358760|42231661|FG001|Overall Study|Lost to Follow-up|1|||
19776724|NCT01358760|42231662|FG002|Overall Study|Lost to Follow-up|3|||
19776725|NCT01358760|42231660|FG000|Overall Study|Withdrawal by Subject|5|||
19776726|NCT01358760|42231661|FG001|Overall Study|Withdrawal by Subject|3|||
19776727|NCT01358760|42231662|FG002|Overall Study|Withdrawal by Subject|2|||
19776728|NCT01358760|42231660|FG000|Overall Study|Physician Decision|1|||
19776729|NCT01358760|42231661|FG001|Overall Study|Physician Decision|0|||
19776730|NCT01358760|42231662|FG002|Overall Study|Physician Decision|1|||
19776731|NCT01358760|42231660|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
19776732|NCT01358760|42231661|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
19776733|NCT01358760|42231662|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
19776734|NCT01341990|42231672|FG000|Overall Study|Adverse Event|0|||
19776735|NCT01341990|42231673|FG001|Overall Study|Adverse Event|1|||
19776736|NCT01341990|42231672|FG000|Overall Study|Torn Study Lens|1|||
19776737|NCT01341990|42231673|FG001|Overall Study|Torn Study Lens|0|||
19776738|NCT01341990|42231672|FG000|Overall Study|Withdrawal by Subject|2|||
19776739|NCT01341990|42231673|FG001|Overall Study|Withdrawal by Subject|0|||
19776740|NCT03048747|42231679|FG000|Overall Study|Adverse Event|2|||
19776741|NCT03048747|42231679|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
19776742|NCT03048747|42231679|FG000|Overall Study|Physician Decision|1|||
19776743|NCT01991067|42231741|FG000|Overall Study|Lost to Follow-up|6|||
19776744|NCT01991067|42231742|FG001|Overall Study|Lost to Follow-up|5|||
19776745|NCT01709331|42231748|FG000|Overall Study|Adverse Event|1|||
19776746|NCT03255083|42231756|FG000|Overall Study|Clinical progression|1|||
19776747|NCT03255083|42231757|FG001|Overall Study|Clinical progression|0|||
19776748|NCT03255083|42231758|FG002|Overall Study|Clinical progression|0|||
19776749|NCT03255083|42231759|FG003|Overall Study|Clinical progression|0|||
19776750|NCT03255083|42231756|FG000|Overall Study|Adverse Event|0|||
19776751|NCT03255083|42231757|FG001|Overall Study|Adverse Event|1|||
19776752|NCT03255083|42231758|FG002|Overall Study|Adverse Event|0|||
19776753|NCT03255083|42231759|FG003|Overall Study|Adverse Event|0|||
19776754|NCT03255083|42231756|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
19776755|NCT03255083|42231757|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
19776756|NCT03255083|42231758|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
19776757|NCT03255083|42231759|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
19776758|NCT03255083|42231756|FG000|Overall Study|Withdrawal by Subject|1|||
19776759|NCT03255083|42231757|FG001|Overall Study|Withdrawal by Subject|1|||
19776760|NCT03255083|42231758|FG002|Overall Study|Withdrawal by Subject|1|||
19776761|NCT03255083|42231759|FG003|Overall Study|Withdrawal by Subject|0|||
19776762|NCT04552587|42231775|FG000|Overall Study|Lost to Follow-up|4|||
19776763|NCT01316055|42231791|FG000|Overall Study|Lost to Follow-up|1|||
19776764|NCT01316055|42231792|FG001|Overall Study|Lost to Follow-up|0|||
19776765|NCT01316055|42231793|FG002|Overall Study|Lost to Follow-up|0|||
19776766|NCT01340976|42231810|FG000|Overall Study|Physician Decision|2|||
19776767|NCT01340976|42231811|FG001|Overall Study|Physician Decision|0|||
19776768|NCT01340976|42231812|FG002|Overall Study|Physician Decision|1|||
19776769|NCT01340976|42231813|FG003|Overall Study|Physician Decision|1|||
19776770|NCT01340976|42231814|FG004|Overall Study|Physician Decision|1|||
19776771|NCT01340976|42231815|FG005|Overall Study|Physician Decision|0|||
19776772|NCT01340976|42231810|FG000|Overall Study|Death|0|||
19776773|NCT01340976|42231811|FG001|Overall Study|Death|1|||
19776774|NCT01340976|42231812|FG002|Overall Study|Death|0|||
19776775|NCT01340976|42231813|FG003|Overall Study|Death|0|||
19776776|NCT01340976|42231814|FG004|Overall Study|Death|0|||
19776777|NCT01340976|42231815|FG005|Overall Study|Death|0|||
19776778|NCT01340976|42231810|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
19776779|NCT01340976|42231811|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
19776780|NCT01340976|42231812|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
19776781|NCT01340976|42231813|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
19776782|NCT01340976|42231814|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
19776783|NCT01340976|42231815|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
19776784|NCT01340976|42231810|FG000|Overall Study|Withdrawal by Subject|0|||
19776785|NCT01340976|42231811|FG001|Overall Study|Withdrawal by Subject|0|||
19776786|NCT01340976|42231812|FG002|Overall Study|Withdrawal by Subject|0|||
19776787|NCT01340976|42231813|FG003|Overall Study|Withdrawal by Subject|1|||
19776788|NCT01340976|42231814|FG004|Overall Study|Withdrawal by Subject|1|||
19776789|NCT01340976|42231815|FG005|Overall Study|Withdrawal by Subject|0|||
19776790|NCT01340976|42231810|FG000|Overall Study|Other anemia treatment|1|||
19776791|NCT01340976|42231811|FG001|Overall Study|Other anemia treatment|0|||
19776792|NCT01340976|42231812|FG002|Overall Study|Other anemia treatment|2|||
19776793|NCT01340976|42231813|FG003|Overall Study|Other anemia treatment|1|||
19776794|NCT01340976|42231814|FG004|Overall Study|Other anemia treatment|0|||
19776795|NCT01340976|42231815|FG005|Overall Study|Other anemia treatment|1|||
19776796|NCT01340976|42231810|FG000|Overall Study|Adverse Event|0|||
19776797|NCT01340976|42231811|FG001|Overall Study|Adverse Event|1|||
19776798|NCT01340976|42231812|FG002|Overall Study|Adverse Event|0|||
19776799|NCT01340976|42231813|FG003|Overall Study|Adverse Event|0|||
19776800|NCT01340976|42231814|FG004|Overall Study|Adverse Event|0|||
19776801|NCT01340976|42231815|FG005|Overall Study|Adverse Event|0|||
19776802|NCT01680016|42231837|FG000|Overall Study|Adverse Event|0|||
19776803|NCT01680016|42231838|FG001|Overall Study|Adverse Event|0|||
19776804|NCT01680016|42231839|FG002|Overall Study|Adverse Event|1|||
19776805|NCT01680016|42231840|FG003|Overall Study|Adverse Event|4|||
19776806|NCT01680016|42231837|FG000|Overall Study|The Subject went out of The Trial|1|||
19776807|NCT01680016|42231838|FG001|Overall Study|The Subject went out of The Trial|0|||
19776808|NCT01680016|42231839|FG002|Overall Study|The Subject went out of The Trial|3|||
19776809|NCT01680016|42231840|FG003|Overall Study|The Subject went out of The Trial|0|||
19776810|NCT01680016|42231837|FG000|Overall Study|Protocol Violation|0|||
19776811|NCT01680016|42231838|FG001|Overall Study|Protocol Violation|1|||
19776812|NCT01680016|42231839|FG002|Overall Study|Protocol Violation|0|||
19776813|NCT01680016|42231840|FG003|Overall Study|Protocol Violation|0|||
19776814|NCT01680016|42231837|FG000|Overall Study|Withdrawal by Subject|5|||
19776815|NCT01680016|42231838|FG001|Overall Study|Withdrawal by Subject|7|||
19776816|NCT01680016|42231839|FG002|Overall Study|Withdrawal by Subject|1|||
19776817|NCT01680016|42231840|FG003|Overall Study|Withdrawal by Subject|1|||
19776818|NCT01340898|42231865|FG000|Primary Phase|Serious Adverse Events|0|||
19776819|NCT01340898|42231866|FG001|Primary Phase|Serious Adverse Events|0|||
19776820|NCT01340898|42231867|FG002|Primary Phase|Serious Adverse Events|1|||
19776821|NCT01340898|42231865|FG000|Primary Phase|Withdrawal by Subject|8|||
19776822|NCT01340898|42231866|FG001|Primary Phase|Withdrawal by Subject|7|||
19776823|NCT01340898|42231867|FG002|Primary Phase|Withdrawal by Subject|5|||
19776824|NCT01340898|42231865|FG000|Primary Phase|Migrated/moved from study area|4|||
19776825|NCT01340898|42231866|FG001|Primary Phase|Migrated/moved from study area|1|||
19776826|NCT01340898|42231867|FG002|Primary Phase|Migrated/moved from study area|0|||
19776827|NCT01340898|42231865|FG000|Primary Phase|Lost to Follow-up|4|||
19776828|NCT01340898|42231866|FG001|Primary Phase|Lost to Follow-up|1|||
19776829|NCT01340898|42231867|FG002|Primary Phase|Lost to Follow-up|0|||
19776830|NCT01340898|42231865|FG000|Booster Phase|Withdrawal by Subject|3|||
19776831|NCT01340898|42231866|FG001|Booster Phase|Withdrawal by Subject|0|||
19776832|NCT01340898|42231867|FG002|Booster Phase|Withdrawal by Subject|4|||
19776833|NCT01340898|42231865|FG000|Booster Phase|Migrated/moved from study area|3|||
19776834|NCT01340898|42231866|FG001|Booster Phase|Migrated/moved from study area|0|||
19776835|NCT01340898|42231867|FG002|Booster Phase|Migrated/moved from study area|0|||
19776836|NCT01340898|42231865|FG000|Booster Phase|Lost to Follow-up|4|||
19776837|NCT01340898|42231866|FG001|Booster Phase|Lost to Follow-up|2|||
19776838|NCT01340898|42231867|FG002|Booster Phase|Lost to Follow-up|3|||
19776839|NCT02470585|42231880|FG000|Overall Study|Death|82|||
19776840|NCT02470585|42231881|FG001|Overall Study|Death|87|||
19776841|NCT02470585|42231882|FG002|Overall Study|Death|86|||
19776842|NCT02470585|42231880|FG000|Overall Study|Withdrawal by Subject|19|||
19776843|NCT02470585|42231881|FG001|Overall Study|Withdrawal by Subject|21|||
19776844|NCT02470585|42231882|FG002|Overall Study|Withdrawal by Subject|29|||
19776845|NCT02470585|42231880|FG000|Overall Study|Lost to Follow-up|2|||
19776846|NCT02470585|42231881|FG001|Overall Study|Lost to Follow-up|5|||
19776847|NCT02470585|42231882|FG002|Overall Study|Lost to Follow-up|4|||
19776848|NCT02470585|42231880|FG000|Overall Study|Other|4|||
19776849|NCT02470585|42231881|FG001|Overall Study|Other|4|||
19776850|NCT02470585|42231882|FG002|Overall Study|Other|6|||
19776851|NCT02744898|42231901|FG000|Overall Study|Progressive Disease|2|||
19776852|NCT02744898|42231901|FG000|Overall Study|Physician Decision|1|||
19776853|NCT02744898|42231901|FG000|Overall Study|Toxicity|1|||
19776854|NCT03036813|42231908|FG000|Overall Study|Adverse Event|6|||
19776855|NCT03036813|42231909|FG001|Overall Study|Adverse Event|11|||
19776856|NCT03036813|42231910|FG002|Overall Study|Adverse Event|6|||
19606812|NCT00714688|42055489|FG001|Overall Study|Lost to Follow-up|2|||
19606813|NCT00714688|42055490|FG002|Overall Study|Lost to Follow-up|0|||
19776857|NCT03036813|42231908|FG000|Overall Study|Withdrawal by Subject|12|||
19776858|NCT03036813|42231909|FG001|Overall Study|Withdrawal by Subject|6|||
19776859|NCT03036813|42231910|FG002|Overall Study|Withdrawal by Subject|10|||
19776860|NCT03036813|42231908|FG000|Overall Study|Lost to Follow-up|1|||
19776861|NCT03036813|42231909|FG001|Overall Study|Lost to Follow-up|1|||
19776862|NCT03036813|42231910|FG002|Overall Study|Lost to Follow-up|0|||
19776863|NCT03036813|42231908|FG000|Overall Study|Physician Decision|2|||
19776864|NCT03036813|42231909|FG001|Overall Study|Physician Decision|1|||
19776865|NCT03036813|42231910|FG002|Overall Study|Physician Decision|1|||
19776866|NCT03036813|42231908|FG000|Overall Study|Non-Compliance|1|||
19776867|NCT03036813|42231909|FG001|Overall Study|Non-Compliance|5|||
19776868|NCT03036813|42231910|FG002|Overall Study|Non-Compliance|3|||
19776869|NCT03036813|42231908|FG000|Overall Study|Pregnancy|0|||
19776870|NCT03036813|42231909|FG001|Overall Study|Pregnancy|0|||
19776871|NCT03036813|42231910|FG002|Overall Study|Pregnancy|1|||
19776872|NCT03036813|42231908|FG000|Overall Study|Other|0|||
19776873|NCT03036813|42231909|FG001|Overall Study|Other|3|||
19776874|NCT03036813|42231910|FG002|Overall Study|Other|5|||
19776875|NCT03097315|42231921|FG000|Overall Study|Withdrawal by Subject|1|||
19776876|NCT03039699|42231927|FG000|Overall Study|Incorrect inclusion|5|||
19776877|NCT03039699|42231928|FG001|Overall Study|Incorrect inclusion|4|||
19776878|NCT03039699|42231927|FG000|Overall Study|Lack of data to assess study endpoint|5|||
19776879|NCT03039699|42231928|FG001|Overall Study|Lack of data to assess study endpoint|3|||
19776880|NCT03039699|42231927|FG000|Overall Study|Bacterial infection|12|||
19776881|NCT03039699|42231928|FG001|Overall Study|Bacterial infection|28|||
19776882|NCT02833974|42231936|FG000|Overall Study|Lost to Follow-up|1|||
19776883|NCT02833974|42231937|FG001|Overall Study|Lost to Follow-up|0|||
19776884|NCT02833974|42231936|FG000|Overall Study|Adverse Event|0|||
19776885|NCT02833974|42231937|FG001|Overall Study|Adverse Event|3|||
19776886|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
19776887|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
19776888|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
19776889|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
19776890|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
19776891|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
19776892|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
19776893|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
19776894|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
19776895|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
19776896|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
19776897|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
19776898|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
19776899|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
19776900|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
19776901|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
19776902|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
19776903|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
19776904|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
19776905|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
19776906|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
19776907|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
19776908|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
19776909|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
19776910|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
19776911|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
19776912|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
19776913|NCT03093415|42231946|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
19776914|NCT03093415|42231947|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
19776915|NCT03093415|42231948|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
19776916|NCT03093415|42231946|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
19776917|NCT03093415|42231947|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
19776918|NCT03093415|42231948|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
19776919|NCT01358526|42231958|FG000|Open-label Titration Period|Adverse Event|95|||
19776920|NCT01358526|42231959|FG001|Open-label Titration Period|Adverse Event|0|||
19776921|NCT01358526|42231960|FG002|Open-label Titration Period|Adverse Event|0|||
19776922|NCT01358526|42231958|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
19776923|NCT01358526|42231959|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
19776924|NCT01358526|42231960|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
19776925|NCT01358526|42231958|FG000|Open-label Titration Period|Lost to Follow-up|25|||
19776926|NCT01358526|42231959|FG001|Open-label Titration Period|Lost to Follow-up|0|||
19776927|NCT01358526|42231960|FG002|Open-label Titration Period|Lost to Follow-up|0|||
19776928|NCT01358526|42231958|FG000|Open-label Titration Period|Lack of Efficacy|107|||
19776929|NCT01358526|42231959|FG001|Open-label Titration Period|Lack of Efficacy|0|||
19776930|NCT01358526|42231960|FG002|Open-label Titration Period|Lack of Efficacy|0|||
19776931|NCT01358526|42231958|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
19776932|NCT01358526|42231959|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
19776933|NCT01358526|42231960|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
19776934|NCT01358526|42231958|FG000|Open-label Titration Period|Administrative|8|||
19776935|NCT01358526|42231959|FG001|Open-label Titration Period|Administrative|0|||
19776936|NCT01358526|42231960|FG002|Open-label Titration Period|Administrative|0|||
19776937|NCT01358526|42231958|FG000|Open-label Titration Period|Did not qualify|178|||
19776938|NCT01358526|42231959|FG001|Open-label Titration Period|Did not qualify|0|||
19776939|NCT01358526|42231960|FG002|Open-label Titration Period|Did not qualify|0|||
19776940|NCT01358526|42231958|FG000|Double-blind Phase|Adverse Event|0|||
19776941|NCT01358526|42231959|FG001|Double-blind Phase|Adverse Event|24|||
19776942|NCT01358526|42231960|FG002|Double-blind Phase|Adverse Event|23|||
19776943|NCT01358526|42231958|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19776944|NCT01358526|42231959|FG001|Double-blind Phase|Withdrawal by Subject|10|||
19776945|NCT01358526|42231960|FG002|Double-blind Phase|Withdrawal by Subject|8|||
19776946|NCT01358526|42231958|FG000|Double-blind Phase|Lost to Follow-up|0|||
19776947|NCT01358526|42231959|FG001|Double-blind Phase|Lost to Follow-up|4|||
19776948|NCT01358526|42231960|FG002|Double-blind Phase|Lost to Follow-up|1|||
19776949|NCT01358526|42231958|FG000|Double-blind Phase|Lack of Efficacy|0|||
19776950|NCT01358526|42231959|FG001|Double-blind Phase|Lack of Efficacy|31|||
19776951|NCT01358526|42231960|FG002|Double-blind Phase|Lack of Efficacy|73|||
19776952|NCT01358526|42231958|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
19776953|NCT01358526|42231959|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
19776954|NCT01358526|42231960|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
19776955|NCT01358526|42231958|FG000|Double-blind Phase|Administrative|0|||
19776956|NCT01358526|42231959|FG001|Double-blind Phase|Administrative|6|||
19776957|NCT01358526|42231960|FG002|Double-blind Phase|Administrative|10|||
19776958|NCT02830776|42231967|FG000|Overall Study|Lost to Follow-up|1|||
19776959|NCT03039621|42231974|FG000|Overall Study|Violation of inclusion criteria|3|||
19776960|NCT03039621|42231975|FG001|Overall Study|Violation of inclusion criteria|2|||
19776961|NCT03039621|42231974|FG000|Overall Study|Non-compliance with protocol requirement|4|||
19776962|NCT03039621|42231975|FG001|Overall Study|Non-compliance with protocol requirement|5|||
19776963|NCT03039621|42231974|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
19776964|NCT03039621|42231975|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
19776965|NCT03039621|42231974|FG000|Overall Study|Violation of non-inclusion criteria|1|||
19776966|NCT03039621|42231975|FG001|Overall Study|Violation of non-inclusion criteria|2|||
19776967|NCT03041181|42231983|FG000|Overall Study|Disease Progression|1|||
19776968|NCT03041181|42231984|FG001|Overall Study|Disease Progression|2|||
19776969|NCT02828436|42231990|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
19776970|NCT02828436|42231991|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
19776971|NCT02828436|42231990|FG000|Period 1|Lost to Follow-up|0|||
19776972|NCT02828436|42231991|FG001|Period 1|Lost to Follow-up|1|||
19776973|NCT02828436|42231990|FG000|Period 2|Withdrawal by Subject|4|||
19776974|NCT02828436|42231991|FG001|Period 2|Withdrawal by Subject|0|||
19776975|NCT02828436|42231990|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
19776976|NCT02828436|42231991|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
19776977|NCT02828436|42231990|FG000|Period 2|Lost to Follow-up|1|||
19776978|NCT02828436|42231991|FG001|Period 2|Lost to Follow-up|0|||
19776979|NCT02828124|42232005|FG000|Overall Study|Disease Progression|1|||
19776980|NCT02828124|42232006|FG001|Overall Study|Disease Progression|2|||
19776981|NCT02828124|42232007|FG002|Overall Study|Disease Progression|1|||
19776982|NCT02828124|42232008|FG003|Overall Study|Disease Progression|4|||
19692991|NCT00510887|42138765|FG000|Overall Study|Lost to Follow-up|1|||
19692992|NCT00358826|42138773|FG000|Core Study|Adverse Event|1|||
19692993|NCT00358826|42138774|FG001|Core Study|Adverse Event|3|||
19692994|NCT00358826|42138775|FG002|Core Study|Adverse Event|1|||
19692995|NCT00358826|42138776|FG003|Core Study|Adverse Event|1|||
19692996|NCT00358826|42138777|FG004|Core Study|Adverse Event|0|||
19692997|NCT00358826|42138778|FG005|Core Study|Adverse Event|0|||
19692998|NCT00358826|42138779|FG006|Core Study|Adverse Event|0|||
19692999|NCT00358826|42138780|FG007|Core Study|Adverse Event|0|||
19776983|NCT02828124|42232005|FG000|Overall Study|AE Unrelated to Study Drug|0|||
19776984|NCT02828124|42232006|FG001|Overall Study|AE Unrelated to Study Drug|0|||
19776985|NCT02828124|42232007|FG002|Overall Study|AE Unrelated to Study Drug|0|||
19776986|NCT02828124|42232008|FG003|Overall Study|AE Unrelated to Study Drug|1|||
19776987|NCT02828124|42232005|FG000|Overall Study|Subject Withdrew Consent|0|||
19776988|NCT02828124|42232006|FG001|Overall Study|Subject Withdrew Consent|0|||
19776989|NCT02828124|42232007|FG002|Overall Study|Subject Withdrew Consent|0|||
19776990|NCT02828124|42232008|FG003|Overall Study|Subject Withdrew Consent|1|||
19776991|NCT02829996|42232023|FG000|Overall Study|Withdrawal by Subject|1|||
19776992|NCT02829996|42232024|FG001|Overall Study|Withdrawal by Subject|0|||
19776993|NCT02829996|42232025|FG002|Overall Study|Withdrawal by Subject|0|||
19776994|NCT02829996|42232026|FG003|Overall Study|Withdrawal by Subject|0|||
19776995|NCT02829996|42232027|FG004|Overall Study|Withdrawal by Subject|0|||
19776996|NCT02827500|42232041|FG000|Overall Study|Death|7|||
19776997|NCT02827500|42232042|FG001|Overall Study|Death|3|||
19776998|NCT02827500|42232041|FG000|Overall Study|Lost to Follow-up|1|||
19776999|NCT02827500|42232042|FG001|Overall Study|Lost to Follow-up|1|||
19777000|NCT02827500|42232041|FG000|Overall Study|Withdrawal by Subject|3|||
19777001|NCT02827500|42232042|FG001|Overall Study|Withdrawal by Subject|1|||
19777002|NCT02827500|42232041|FG000|Overall Study|Missing primary endpoint data|3|||
19777003|NCT02827500|42232042|FG001|Overall Study|Missing primary endpoint data|1|||
19777004|NCT02827500|42232041|FG000|Overall Study|Other|5|||
19777005|NCT02827500|42232042|FG001|Overall Study|Other|1|||
19777006|NCT02826798|42232053|FG000|Overall Study|Withdrawal by Subject|0|||
19777007|NCT02826798|42232054|FG001|Overall Study|Withdrawal by Subject|1|||
19777008|NCT02826798|42232055|FG002|Overall Study|Withdrawal by Subject|0|||
19777009|NCT02826798|42232056|FG003|Overall Study|Withdrawal by Subject|1|||
19777010|NCT02826798|42232057|FG004|Overall Study|Withdrawal by Subject|0|||
19777011|NCT02829138|42232071|FG000|Overall Study|Withdrawal by Subject|1|||
19777012|NCT02829138|42232072|FG001|Overall Study|Withdrawal by Subject|0|||
19777013|NCT02825550|42232078|FG000|Overall Study|Physician Decision|1|||
19777014|NCT02744040|42232087|FG000|Overall Study|Withdrawal by Subject|3|||
19777015|NCT02744040|42232088|FG001|Overall Study|Withdrawal by Subject|2|||
19777016|NCT02744040|42232089|FG002|Overall Study|Withdrawal by Subject|2|||
19777017|NCT02744040|42232087|FG000|Overall Study|Physician Decision|0|||
19777018|NCT02744040|42232088|FG001|Overall Study|Physician Decision|8|||
19777019|NCT02744040|42232089|FG002|Overall Study|Physician Decision|13|||
19777020|NCT02744040|42232087|FG000|Overall Study|Lost to Follow-up|3|||
19777021|NCT02744040|42232088|FG001|Overall Study|Lost to Follow-up|1|||
19777022|NCT02744040|42232089|FG002|Overall Study|Lost to Follow-up|7|||
19777023|NCT02743962|42232099|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
19777024|NCT02743962|42232100|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
19777025|NCT03094416|42232109|FG000|Run-in|Screening failure|8|||
19777026|NCT03094416|42232109|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
19777027|NCT03094416|42232109|FG000|Run-in|Withdrawal by Subject|3|||
19777028|NCT03094416|42232109|FG000|Treatment Period|Withdrawal by Subject|2|||
19693000|NCT00358826|42138773|FG000|Core Study|Withdrawal by Subject|2|||
19693001|NCT00358826|42138774|FG001|Core Study|Withdrawal by Subject|2|||
19693002|NCT00358826|42138775|FG002|Core Study|Withdrawal by Subject|0|||
19777029|NCT03041025|42232117|FG000|Overall Study|Adverse Event|0|||
19777030|NCT03041025|42232118|FG001|Overall Study|Adverse Event|0|||
19777031|NCT03041025|42232119|FG002|Overall Study|Adverse Event|1|||
19777032|NCT03041025|42232117|FG000|Overall Study|Lost to Follow-up|1|||
19777033|NCT03041025|42232118|FG001|Overall Study|Lost to Follow-up|0|||
19777034|NCT03041025|42232119|FG002|Overall Study|Lost to Follow-up|0|||
19777035|NCT03041025|42232117|FG000|Overall Study|Withdrawal by Subject|0|||
19777036|NCT03041025|42232118|FG001|Overall Study|Withdrawal by Subject|0|||
19777037|NCT03041025|42232119|FG002|Overall Study|Withdrawal by Subject|1|||
19777038|NCT01338870|42232136|FG000|Overall Study|Lost to Follow-up|0|||
19777039|NCT01338870|42232137|FG001|Overall Study|Lost to Follow-up|0|||
19777040|NCT01338870|42232138|FG002|Overall Study|Lost to Follow-up|1|||
19777041|NCT01338870|42232139|FG003|Overall Study|Lost to Follow-up|0|||
19777042|NCT01338870|42232140|FG004|Overall Study|Lost to Follow-up|1|||
19777043|NCT01338870|42232141|FG005|Overall Study|Lost to Follow-up|0|||
19777044|NCT01338870|42232136|FG000|Overall Study|Withdrawal by Subject|2|||
19777045|NCT01338870|42232137|FG001|Overall Study|Withdrawal by Subject|3|||
19777046|NCT01338870|42232138|FG002|Overall Study|Withdrawal by Subject|4|||
19777047|NCT01338870|42232139|FG003|Overall Study|Withdrawal by Subject|0|||
19777048|NCT01338870|42232140|FG004|Overall Study|Withdrawal by Subject|0|||
19777049|NCT01338870|42232141|FG005|Overall Study|Withdrawal by Subject|2|||
19777050|NCT01338870|42232136|FG000|Overall Study|Other|3|||
19777051|NCT01338870|42232137|FG001|Overall Study|Other|3|||
19777052|NCT01338870|42232138|FG002|Overall Study|Other|3|||
19777053|NCT01338870|42232139|FG003|Overall Study|Other|2|||
19777054|NCT01338870|42232140|FG004|Overall Study|Other|0|||
19777055|NCT01338870|42232141|FG005|Overall Study|Other|2|||
19777056|NCT01338870|42232136|FG000|Overall Study|Protocol Violation|0|||
19777057|NCT01338870|42232137|FG001|Overall Study|Protocol Violation|2|||
19777058|NCT01338870|42232138|FG002|Overall Study|Protocol Violation|2|||
19777059|NCT01338870|42232139|FG003|Overall Study|Protocol Violation|2|||
19777060|NCT01338870|42232140|FG004|Overall Study|Protocol Violation|1|||
19777061|NCT01338870|42232141|FG005|Overall Study|Protocol Violation|1|||
19777062|NCT01338870|42232136|FG000|Overall Study|Adverse Event|4|||
19777063|NCT01338870|42232137|FG001|Overall Study|Adverse Event|4|||
19777064|NCT01338870|42232138|FG002|Overall Study|Adverse Event|1|||
19777065|NCT01338870|42232139|FG003|Overall Study|Adverse Event|5|||
19777066|NCT01338870|42232140|FG004|Overall Study|Adverse Event|4|||
19777067|NCT01338870|42232141|FG005|Overall Study|Adverse Event|1|||
19777068|NCT02824224|42232157|FG000|Overall Study|Discontinued, IUS expulsion|0|||
19777069|NCT02824224|42232158|FG001|Overall Study|Discontinued, IUS expulsion|1|||
19777070|NCT02824224|42232157|FG000|Overall Study|Did not show up for allocation visit|2|||
19777071|NCT02824224|42232158|FG001|Overall Study|Did not show up for allocation visit|0|||
19777072|NCT01338792|42232164|FG000|Overall Study|Adverse Event|2|||
19777073|NCT01338792|42232164|FG000|Overall Study|Death|1|||
19777074|NCT01338792|42232164|FG000|Overall Study|Withdrawal by Subject|1|||
19777075|NCT01314105|42232170|FG000|Overall Study|Progressive Disease|6|||
19777076|NCT01314105|42232171|FG001|Overall Study|Progressive Disease|10|||
19777077|NCT01314105|42232170|FG000|Overall Study|Refused to continue taking medication|0|||
19777078|NCT01314105|42232171|FG001|Overall Study|Refused to continue taking medication|1|||
19777079|NCT01314105|42232170|FG000|Overall Study|Other Adverse Event|1|||
19777080|NCT01314105|42232171|FG001|Overall Study|Other Adverse Event|1|||
19777081|NCT03040713|42232179|FG000|Overall Study|Positive amyloid scan|3|||
19777082|NCT01966471|42232185|FG000|Overall Study|Death|44|||
19777083|NCT01966471|42232186|FG001|Overall Study|Death|56|||
19777084|NCT01966471|42232185|FG000|Overall Study|Lost to Follow-up|46|||
19777085|NCT01966471|42232186|FG001|Overall Study|Lost to Follow-up|39|||
19777086|NCT01966471|42232185|FG000|Overall Study|Various reasons|4|||
19777087|NCT01966471|42232186|FG001|Overall Study|Various reasons|4|||
19777088|NCT01966471|42232185|FG000|Overall Study|Physician Decision|7|||
19777089|NCT01966471|42232186|FG001|Overall Study|Physician Decision|5|||
19777090|NCT01966471|42232185|FG000|Overall Study|Study Terminated By Sponsor|758|||
19777091|NCT01966471|42232186|FG001|Overall Study|Study Terminated By Sponsor|773|||
19777092|NCT01966471|42232185|FG000|Overall Study|Withdrawal by Subject|59|||
19777093|NCT01966471|42232186|FG001|Overall Study|Withdrawal by Subject|51|||
19777094|NCT03227471|42232207|FG000|Overall Study|Withdrawal by Subject|0|||
19777095|NCT03227471|42232208|FG001|Overall Study|Withdrawal by Subject|0|||
19777096|NCT03227471|42232209|FG002|Overall Study|Withdrawal by Subject|0|||
19777097|NCT03227471|42232210|FG003|Overall Study|Withdrawal by Subject|0|||
19777098|NCT03227471|42232211|FG004|Overall Study|Withdrawal by Subject|1|||
19777099|NCT03227471|42232212|FG005|Overall Study|Withdrawal by Subject|0|||
19777100|NCT03227471|42232213|FG006|Overall Study|Withdrawal by Subject|0|||
19777101|NCT03227471|42232214|FG007|Overall Study|Withdrawal by Subject|0|||
19777102|NCT03227471|42232215|FG008|Overall Study|Withdrawal by Subject|0|||
19777103|NCT03227471|42232216|FG009|Overall Study|Withdrawal by Subject|0|||
19777104|NCT03227471|42232217|FG010|Overall Study|Withdrawal by Subject|0|||
19777105|NCT03227471|42232218|FG011|Overall Study|Withdrawal by Subject|0|||
19777106|NCT03227471|42232219|FG012|Overall Study|Withdrawal by Subject|1|||
19777107|NCT03227471|42232220|FG013|Overall Study|Withdrawal by Subject|0|||
19777108|NCT03227471|42232221|FG014|Overall Study|Withdrawal by Subject|0|||
19777109|NCT03227471|42232207|FG000|Overall Study|Randomized, Never Dosed|0|||
19777110|NCT03227471|42232208|FG001|Overall Study|Randomized, Never Dosed|0|||
19777111|NCT03227471|42232209|FG002|Overall Study|Randomized, Never Dosed|0|||
19777112|NCT03227471|42232210|FG003|Overall Study|Randomized, Never Dosed|0|||
19777113|NCT03227471|42232211|FG004|Overall Study|Randomized, Never Dosed|0|||
19777114|NCT03227471|42232212|FG005|Overall Study|Randomized, Never Dosed|0|||
19777115|NCT03227471|42232213|FG006|Overall Study|Randomized, Never Dosed|0|||
19777116|NCT03227471|42232214|FG007|Overall Study|Randomized, Never Dosed|0|||
19777117|NCT03227471|42232215|FG008|Overall Study|Randomized, Never Dosed|0|||
19777118|NCT03227471|42232216|FG009|Overall Study|Randomized, Never Dosed|0|||
19777119|NCT03227471|42232217|FG010|Overall Study|Randomized, Never Dosed|0|||
19777120|NCT03227471|42232218|FG011|Overall Study|Randomized, Never Dosed|0|||
19777121|NCT03227471|42232219|FG012|Overall Study|Randomized, Never Dosed|0|||
19777122|NCT03227471|42232220|FG013|Overall Study|Randomized, Never Dosed|0|||
19777123|NCT03227471|42232221|FG014|Overall Study|Randomized, Never Dosed|1|||
19777124|NCT01354314|42232286|FG000|Overall Study|Lost to Follow-up|1|||
19777125|NCT01354314|42232287|FG001|Overall Study|Lost to Follow-up|0|||
19777126|NCT01354314|42232288|FG002|Overall Study|Lost to Follow-up|1|||
19777127|NCT01354314|42232289|FG003|Overall Study|Lost to Follow-up|1|||
19777128|NCT01354314|42232286|FG000|Overall Study|Withdrawal by Subject|0|||
19777129|NCT01354314|42232287|FG001|Overall Study|Withdrawal by Subject|0|||
19777130|NCT01354314|42232288|FG002|Overall Study|Withdrawal by Subject|1|||
19777131|NCT01354314|42232289|FG003|Overall Study|Withdrawal by Subject|0|||
19777132|NCT01354314|42232286|FG000|Overall Study|Adverse Event|0|||
19777133|NCT01354314|42232287|FG001|Overall Study|Adverse Event|0|||
19777134|NCT01354314|42232288|FG002|Overall Study|Adverse Event|0|||
19777135|NCT01354314|42232289|FG003|Overall Study|Adverse Event|1|||
19777136|NCT01354314|42232286|FG000|Overall Study|Protocol Violation|1|||
19777137|NCT01354314|42232287|FG001|Overall Study|Protocol Violation|1|||
19777138|NCT01354314|42232288|FG002|Overall Study|Protocol Violation|0|||
19777139|NCT01354314|42232289|FG003|Overall Study|Protocol Violation|0|||
19777140|NCT01354314|42232286|FG000|Overall Study|Less than 90% Adherence|4|||
19777141|NCT01354314|42232287|FG001|Overall Study|Less than 90% Adherence|2|||
19777142|NCT01354314|42232288|FG002|Overall Study|Less than 90% Adherence|6|||
19777143|NCT01354314|42232289|FG003|Overall Study|Less than 90% Adherence|4|||
19777144|NCT03194321|42232301|FG000|Overall Study|Withdrawal by Subject|1|||
19693003|NCT00358826|42138776|FG003|Core Study|Withdrawal by Subject|0|||
19693004|NCT00358826|42138777|FG004|Core Study|Withdrawal by Subject|0|||
19693005|NCT00358826|42138778|FG005|Core Study|Withdrawal by Subject|0|||
19693006|NCT00358826|42138779|FG006|Core Study|Withdrawal by Subject|0|||
19693007|NCT00358826|42138780|FG007|Core Study|Withdrawal by Subject|0|||
19693008|NCT00358826|42138773|FG000|Core Study|Lost to Follow-up|0|||
19693009|NCT00358826|42138774|FG001|Core Study|Lost to Follow-up|0|||
19693010|NCT00358826|42138775|FG002|Core Study|Lost to Follow-up|0|||
19693011|NCT00358826|42138776|FG003|Core Study|Lost to Follow-up|1|||
19693012|NCT00358826|42138777|FG004|Core Study|Lost to Follow-up|0|||
19693013|NCT00358826|42138778|FG005|Core Study|Lost to Follow-up|0|||
19693014|NCT00358826|42138779|FG006|Core Study|Lost to Follow-up|0|||
19693015|NCT00358826|42138780|FG007|Core Study|Lost to Follow-up|0|||
19693016|NCT00358826|42138773|FG000|Core Study|Physician Decision|0|||
19693017|NCT00358826|42138774|FG001|Core Study|Physician Decision|0|||
19693018|NCT00358826|42138775|FG002|Core Study|Physician Decision|1|||
19693019|NCT00358826|42138776|FG003|Core Study|Physician Decision|0|||
19693020|NCT00358826|42138777|FG004|Core Study|Physician Decision|0|||
19693021|NCT00358826|42138778|FG005|Core Study|Physician Decision|0|||
19693022|NCT00358826|42138779|FG006|Core Study|Physician Decision|0|||
19693023|NCT00358826|42138780|FG007|Core Study|Physician Decision|0|||
19693024|NCT00358826|42138773|FG000|MDCT Substudy|Adverse Event|0|||
19693025|NCT00358826|42138774|FG001|MDCT Substudy|Adverse Event|0|||
19693026|NCT00358826|42138775|FG002|MDCT Substudy|Adverse Event|0|||
19693027|NCT00358826|42138776|FG003|MDCT Substudy|Adverse Event|0|||
19693028|NCT00358826|42138777|FG004|MDCT Substudy|Adverse Event|1|||
19693029|NCT00358826|42138778|FG005|MDCT Substudy|Adverse Event|0|||
19693030|NCT00358826|42138779|FG006|MDCT Substudy|Adverse Event|0|||
19693031|NCT00358826|42138780|FG007|MDCT Substudy|Adverse Event|0|||
19693032|NCT00358826|42138773|FG000|MDCT Substudy|Lost to Follow-up|0|||
19693033|NCT00358826|42138774|FG001|MDCT Substudy|Lost to Follow-up|0|||
19693034|NCT00358826|42138775|FG002|MDCT Substudy|Lost to Follow-up|0|||
19693035|NCT00358826|42138776|FG003|MDCT Substudy|Lost to Follow-up|0|||
19693036|NCT00358826|42138777|FG004|MDCT Substudy|Lost to Follow-up|0|||
19693037|NCT00358826|42138778|FG005|MDCT Substudy|Lost to Follow-up|1|||
19693038|NCT00358826|42138779|FG006|MDCT Substudy|Lost to Follow-up|0|||
19693039|NCT00358826|42138780|FG007|MDCT Substudy|Lost to Follow-up|0|||
19693040|NCT00358826|42138773|FG000|MDCT Substudy|Withdrawal by Subject|0|||
19693041|NCT00358826|42138774|FG001|MDCT Substudy|Withdrawal by Subject|0|||
19693042|NCT00358826|42138775|FG002|MDCT Substudy|Withdrawal by Subject|0|||
19693043|NCT00358826|42138776|FG003|MDCT Substudy|Withdrawal by Subject|0|||
19777145|NCT03194321|42232301|FG000|Overall Study|Lost to Follow-up|1|||
19777146|NCT03194321|42232301|FG000|Overall Study|Travel for Follow-up|1|||
19777147|NCT01354938|42232305|FG000|Overall Study|Lost to Follow-up|1|||
19777148|NCT03092791|42232328|FG000|Overall Study|Lost to Follow-up|0|||
19777149|NCT03092791|42232329|FG001|Overall Study|Lost to Follow-up|0|||
19777150|NCT03092791|42232330|FG002|Overall Study|Lost to Follow-up|0|||
19777151|NCT03092791|42232331|FG003|Overall Study|Lost to Follow-up|0|||
19777152|NCT03092791|42232332|FG004|Overall Study|Lost to Follow-up|0|||
19777153|NCT03092791|42232333|FG005|Overall Study|Lost to Follow-up|0|||
19777154|NCT03092791|42232334|FG006|Overall Study|Lost to Follow-up|1|||
19777155|NCT03092791|42232335|FG007|Overall Study|Lost to Follow-up|0|||
19777156|NCT03092791|42232328|FG000|Overall Study|Withdrawal of Consent|0|||
19777157|NCT03092791|42232329|FG001|Overall Study|Withdrawal of Consent|0|||
19777158|NCT03092791|42232330|FG002|Overall Study|Withdrawal of Consent|0|||
19777159|NCT03092791|42232331|FG003|Overall Study|Withdrawal of Consent|0|||
19777160|NCT03092791|42232332|FG004|Overall Study|Withdrawal of Consent|4|||
19777161|NCT03092791|42232333|FG005|Overall Study|Withdrawal of Consent|12|||
19777162|NCT03092791|42232334|FG006|Overall Study|Withdrawal of Consent|6|||
19777163|NCT03092791|42232335|FG007|Overall Study|Withdrawal of Consent|4|||
19777164|NCT03092791|42232328|FG000|Overall Study|Study Termination|0|||
19777165|NCT03092791|42232329|FG001|Overall Study|Study Termination|0|||
19777166|NCT03092791|42232330|FG002|Overall Study|Study Termination|0|||
19777167|NCT03092791|42232331|FG003|Overall Study|Study Termination|0|||
19777168|NCT03092791|42232332|FG004|Overall Study|Study Termination|55|||
19777169|NCT03092791|42232333|FG005|Overall Study|Study Termination|46|||
19777170|NCT03092791|42232334|FG006|Overall Study|Study Termination|53|||
19777171|NCT03092791|42232335|FG007|Overall Study|Study Termination|55|||
19777172|NCT03092791|42232328|FG000|Overall Study|Death|0|||
19777173|NCT03092791|42232329|FG001|Overall Study|Death|0|||
19777174|NCT03092791|42232330|FG002|Overall Study|Death|0|||
19777175|NCT03092791|42232331|FG003|Overall Study|Death|0|||
19777176|NCT03092791|42232332|FG004|Overall Study|Death|0|||
19777177|NCT03092791|42232333|FG005|Overall Study|Death|1|||
19777178|NCT03092791|42232334|FG006|Overall Study|Death|0|||
19777179|NCT03092791|42232335|FG007|Overall Study|Death|1|||
19777180|NCT03092791|42232328|FG000|Overall Study|Reason Not Specified|0|||
19777181|NCT03092791|42232329|FG001|Overall Study|Reason Not Specified|0|||
19777182|NCT03092791|42232330|FG002|Overall Study|Reason Not Specified|0|||
19777183|NCT03092791|42232331|FG003|Overall Study|Reason Not Specified|0|||
19777184|NCT03092791|42232332|FG004|Overall Study|Reason Not Specified|1|||
19777185|NCT03092791|42232333|FG005|Overall Study|Reason Not Specified|1|||
19777186|NCT03092791|42232334|FG006|Overall Study|Reason Not Specified|0|||
19777187|NCT03092791|42232335|FG007|Overall Study|Reason Not Specified|0|||
19777188|NCT02505425|42232362|FG000|Overall Study|Lost to Follow-up|41|||
19777189|NCT02505425|42232363|FG001|Overall Study|Lost to Follow-up|61|||
19777190|NCT02505425|42232364|FG002|Overall Study|Lost to Follow-up|31|||
19777191|NCT02505425|42232365|FG003|Overall Study|Lost to Follow-up|19|||
19777192|NCT02505425|42232362|FG000|Overall Study|Withdrawal by Subject|39|||
19777193|NCT02505425|42232363|FG001|Overall Study|Withdrawal by Subject|9|||
19777194|NCT02505425|42232364|FG002|Overall Study|Withdrawal by Subject|19|||
19777195|NCT02505425|42232365|FG003|Overall Study|Withdrawal by Subject|7|||
19693044|NCT00358826|42138777|FG004|MDCT Substudy|Withdrawal by Subject|0|||
19693045|NCT00358826|42138778|FG005|MDCT Substudy|Withdrawal by Subject|1|||
19693046|NCT00358826|42138779|FG006|MDCT Substudy|Withdrawal by Subject|0|||
19693047|NCT00358826|42138780|FG007|MDCT Substudy|Withdrawal by Subject|0|||
19693048|NCT00510653|42138794|FG000|Overall Study|Withdrawal by Subject|8|||
19693049|NCT00510653|42138794|FG000|Overall Study|Monetary|3|||
19693050|NCT00362336|42138801|FG000|Overall Study|Serious Adverse Event|1|||
19693051|NCT00362336|42138802|FG001|Overall Study|Serious Adverse Event|0|||
19693052|NCT00362336|42138803|FG002|Overall Study|Serious Adverse Event|1|||
19693053|NCT00362336|42138801|FG000|Overall Study|Protocol Violation|0|||
19693054|NCT00362336|42138802|FG001|Overall Study|Protocol Violation|0|||
19693055|NCT00362336|42138803|FG002|Overall Study|Protocol Violation|1|||
19693056|NCT00362336|42138801|FG000|Overall Study|Lost to Follow-up|6|||
19693057|NCT00362336|42138802|FG001|Overall Study|Lost to Follow-up|4|||
19693058|NCT00362336|42138803|FG002|Overall Study|Lost to Follow-up|0|||
19777196|NCT02505425|42232362|FG000|Overall Study|Death|8|||
19777197|NCT02505425|42232363|FG001|Overall Study|Death|12|||
19777198|NCT02505425|42232364|FG002|Overall Study|Death|0|||
19777199|NCT02505425|42232365|FG003|Overall Study|Death|0|||
19777200|NCT03089047|42232377|FG000|Overall Study|Lost to Follow-up|1|||
19777201|NCT03089047|42232378|FG001|Overall Study|Lost to Follow-up|0|||
19777202|NCT01371006|42232386|FG000|Overall Study|Adverse Event|1|||
19777203|NCT01371006|42232387|FG001|Overall Study|Adverse Event|0|||
19777204|NCT01371552|42232422|FG000|Part 1, First 3 Days|Inconvenience|0|||
19777205|NCT01371552|42232423|FG001|Part 1, First 3 Days|Inconvenience|0|||
19777206|NCT01371552|42232424|FG002|Part 1, First 3 Days|Inconvenience|1|||
19777207|NCT01371552|42232425|FG003|Part 1, First 3 Days|Inconvenience|0|||
19777208|NCT01371552|42232426|FG004|Part 1, First 3 Days|Inconvenience|0|||
19777209|NCT01371552|42232427|FG005|Part 1, First 3 Days|Inconvenience|0|||
19777210|NCT02819310|42232436|FG000|Overall Study|Withdrawal by Subject|37|||
19777211|NCT02819310|42232436|FG000|Overall Study|Lost to Follow-up|16|||
19777212|NCT02819310|42232436|FG000|Overall Study|Adverse Event|13|||
19777213|NCT02819310|42232436|FG000|Overall Study|Lack of Efficacy|5|||
19777214|NCT02819310|42232436|FG000|Overall Study|Physician Decision|8|||
19777215|NCT02819310|42232436|FG000|Overall Study|Protocol Violation|30|||
19777216|NCT03087643|42232442|FG000|Overall Study|Withdrawal by Subject|2|||
19777217|NCT03087643|42232443|FG001|Overall Study|Withdrawal by Subject|4|||
19777218|NCT03087643|42232442|FG000|Overall Study|Death|2|||
19777219|NCT03087643|42232443|FG001|Overall Study|Death|2|||
19777220|NCT02821962|42232451|FG000|Overall Study|Lost to Follow-up|2|||
19777221|NCT02821962|42232452|FG001|Overall Study|Lost to Follow-up|0|||
19777222|NCT03092479|42232460|FG000|Overall Study|Lost to Follow-up|3|||
19777223|NCT03092479|42232461|FG001|Overall Study|Lost to Follow-up|2|||
19777224|NCT03092479|42232460|FG000|Overall Study|Withdrawal by Subject|4|||
19777225|NCT03092479|42232461|FG001|Overall Study|Withdrawal by Subject|0|||
19777226|NCT03086551|42232469|FG000|First Intervention|Failure to meet inclusion criterion|1|||
19777227|NCT03086551|42232470|FG001|First Intervention|Failure to meet inclusion criterion|0|||
19777228|NCT03086551|42232469|FG000|First Intervention|Lost to Follow-up|0|||
19777229|NCT03086551|42232470|FG001|First Intervention|Lost to Follow-up|1|||
19777230|NCT03086551|42232469|FG000|Washout|Lost to Follow-up|1|||
19777231|NCT03086551|42232470|FG001|Washout|Lost to Follow-up|2|||
19777232|NCT03086551|42232469|FG000|Washout|Withdrawal by Subject|2|||
19777233|NCT03086551|42232470|FG001|Washout|Withdrawal by Subject|1|||
19777234|NCT03265249|42232478|FG000|Overall Study|Withdrawal by Subject|0|||
19777235|NCT03265249|42232479|FG001|Overall Study|Withdrawal by Subject|1|||
19777236|NCT02951767|42232485|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
19777237|NCT02951767|42232485|FG000|Overall Study|Withdrawal by Subject|5|||
19777238|NCT02951767|42232485|FG000|Overall Study|Death|59|||
19777239|NCT02951767|42232485|FG000|Overall Study|Lost to Follow-up|1|||
19777240|NCT03093181|42232492|FG000|Overall Study|Withdrawal by Subject|2|||
19777241|NCT03093181|42232493|FG001|Overall Study|Withdrawal by Subject|1|||
19777242|NCT03093181|42232494|FG002|Overall Study|Withdrawal by Subject|2|||
19777243|NCT03093181|42232492|FG000|Overall Study|Other (Not specified)|1|||
19777244|NCT03093181|42232493|FG001|Overall Study|Other (Not specified)|0|||
19777245|NCT03093181|42232494|FG002|Overall Study|Other (Not specified)|0|||
19777246|NCT03093181|42232492|FG000|Overall Study|Adverse Event|0|||
19777247|NCT03093181|42232493|FG001|Overall Study|Adverse Event|1|||
19777248|NCT03093181|42232494|FG002|Overall Study|Adverse Event|0|||
19777249|NCT03093181|42232492|FG000|Overall Study|Other (Protocol violation)|0|||
19777250|NCT03093181|42232493|FG001|Overall Study|Other (Protocol violation)|0|||
19777251|NCT03093181|42232494|FG002|Overall Study|Other (Protocol violation)|1|||
19777252|NCT03091777|42232505|FG000|Overall Study|Pregnancy|2|||
19777253|NCT03091777|42232506|FG001|Overall Study|Pregnancy|1|||
19777254|NCT03091777|42232507|FG002|Overall Study|Pregnancy|0|||
19777255|NCT03091777|42232505|FG000|Overall Study|Adverse Event|2|||
19777256|NCT03091777|42232506|FG001|Overall Study|Adverse Event|1|||
19777257|NCT03091777|42232507|FG002|Overall Study|Adverse Event|4|||
19777258|NCT03091777|42232505|FG000|Overall Study|Withdrawal by Subject|4|||
19777259|NCT03091777|42232506|FG001|Overall Study|Withdrawal by Subject|2|||
19777260|NCT03091777|42232507|FG002|Overall Study|Withdrawal by Subject|6|||
19777261|NCT03091777|42232505|FG000|Overall Study|Protocol Violation|2|||
19777262|NCT03091777|42232506|FG001|Overall Study|Protocol Violation|1|||
19777263|NCT03091777|42232507|FG002|Overall Study|Protocol Violation|1|||
19777264|NCT03091777|42232505|FG000|Overall Study|Lost to Follow-up|12|||
19777265|NCT03091777|42232506|FG001|Overall Study|Lost to Follow-up|14|||
19777266|NCT03091777|42232507|FG002|Overall Study|Lost to Follow-up|7|||
19777267|NCT03091777|42232505|FG000|Overall Study|Lack of Efficacy|0|||
19777268|NCT03091777|42232506|FG001|Overall Study|Lack of Efficacy|0|||
19777269|NCT03091777|42232507|FG002|Overall Study|Lack of Efficacy|5|||
19777270|NCT03091777|42232505|FG000|Overall Study|Noncompliance with study drug|2|||
19777271|NCT03091777|42232506|FG001|Overall Study|Noncompliance with study drug|3|||
19777272|NCT03091777|42232507|FG002|Overall Study|Noncompliance with study drug|1|||
19777273|NCT03091777|42232505|FG000|Overall Study|Physician Decision|1|||
19389163|NCT01625182|41632779|FG000|Overall Study|Adverse Event|2|||
19777274|NCT03091777|42232506|FG001|Overall Study|Physician Decision|0|||
19777275|NCT03091777|42232507|FG002|Overall Study|Physician Decision|1|||
19777276|NCT03091777|42232505|FG000|Overall Study|Abnormal Laboratory Value|7|||
19777277|NCT03091777|42232506|FG001|Overall Study|Abnormal Laboratory Value|11|||
19777278|NCT03091777|42232507|FG002|Overall Study|Abnormal Laboratory Value|12|||
19777279|NCT02818998|42232518|FG000|Overall Study|Adverse Event|3|||
19777280|NCT02818998|42232519|FG001|Overall Study|Adverse Event|2|||
19777281|NCT02818998|42232520|FG002|Overall Study|Adverse Event|1|||
19777282|NCT02818998|42232518|FG000|Overall Study|Lost to Follow-up|4|||
19777283|NCT02818998|42232519|FG001|Overall Study|Lost to Follow-up|1|||
19777284|NCT02818998|42232520|FG002|Overall Study|Lost to Follow-up|2|||
19777285|NCT02818998|42232518|FG000|Overall Study|Withdrawal by sponsor|0|||
19777286|NCT02818998|42232519|FG001|Overall Study|Withdrawal by sponsor|1|||
19777287|NCT02818998|42232520|FG002|Overall Study|Withdrawal by sponsor|1|||
19777288|NCT02818998|42232518|FG000|Overall Study|Death|3|||
19777289|NCT02818998|42232519|FG001|Overall Study|Death|6|||
19777290|NCT02818998|42232520|FG002|Overall Study|Death|8|||
19777291|NCT02818998|42232518|FG000|Overall Study|Withdrawal by Subject|7|||
19777292|NCT02818998|42232519|FG001|Overall Study|Withdrawal by Subject|6|||
19777293|NCT02818998|42232520|FG002|Overall Study|Withdrawal by Subject|6|||
19777294|NCT02818998|42232518|FG000|Overall Study|Physician Decision|1|||
19777295|NCT02818998|42232519|FG001|Overall Study|Physician Decision|0|||
19777296|NCT02818998|42232520|FG002|Overall Study|Physician Decision|0|||
19777297|NCT02821416|42232530|FG000|Overall Study|Adverse Event|0|||
19777298|NCT02821416|42232531|FG001|Overall Study|Adverse Event|1|||
19777299|NCT02821416|42232530|FG000|Overall Study|Withdrawal by Subject|2|||
19777300|NCT02821416|42232531|FG001|Overall Study|Withdrawal by Subject|0|||
19777301|NCT02821416|42232530|FG000|Overall Study|Lost to Follow-up|1|||
19777302|NCT02821416|42232531|FG001|Overall Study|Lost to Follow-up|0|||
19777303|NCT03108521|42232540|FG000|Overall Study|Lost to Follow-up|3|||
19777304|NCT03108521|42232541|FG001|Overall Study|Lost to Follow-up|0|||
19777305|NCT03108521|42232540|FG000|Overall Study|Lack of Efficacy|2|||
19777306|NCT03108521|42232541|FG001|Overall Study|Lack of Efficacy|0|||
19777307|NCT03108521|42232540|FG000|Overall Study|Physician Decision|4|||
19777308|NCT03108521|42232541|FG001|Overall Study|Physician Decision|0|||
19777309|NCT03108521|42232540|FG000|Overall Study|Adverse Event|3|||
19777310|NCT03108521|42232541|FG001|Overall Study|Adverse Event|0|||
19777311|NCT02817828|42232564|FG000|Overall Study|Lost to Follow-up|41|||
19777312|NCT02817828|42232564|FG000|Overall Study|Adverse event not related to bleeding|104|||
19777313|NCT02817828|42232564|FG000|Overall Study|Adverse event related to bleeding|53|||
19777314|NCT02817828|42232564|FG000|Overall Study|Protocol Violation|11|||
19777315|NCT02817828|42232564|FG000|Overall Study|Pregnancy|7|||
19777316|NCT02817828|42232564|FG000|Overall Study|Pregnancy wish|15|||
19693059|NCT00362336|42138801|FG000|Overall Study|Withdrawal by Subject|3|||
19693060|NCT00362336|42138802|FG001|Overall Study|Withdrawal by Subject|3|||
19777317|NCT02817828|42232564|FG000|Overall Study|Withdrawal by Subject|78|||
19777318|NCT02817828|42232564|FG000|Overall Study|Other|26|||
19777319|NCT02817906|42232575|FG000|Overall Study|Adverse Event|3|||
19777320|NCT02817906|42232576|FG001|Overall Study|Adverse Event|0|||
19777321|NCT02817906|42232575|FG000|Overall Study|Lack of Efficacy|1|||
19777322|NCT02817906|42232576|FG001|Overall Study|Lack of Efficacy|0|||
19777323|NCT02817906|42232575|FG000|Overall Study|Protocol Violation|1|||
19777324|NCT02817906|42232576|FG001|Overall Study|Protocol Violation|1|||
19777325|NCT02817906|42232575|FG000|Overall Study|Study Terminated by Sponsor|2|||
19777326|NCT02817906|42232576|FG001|Overall Study|Study Terminated by Sponsor|2|||
19367246|NCT02435992|41607418|FG003|Overall Study|Lack of Efficacy|0|||
19367247|NCT02435992|41607419|FG004|Overall Study|Lack of Efficacy|0|||
19606814|NCT00714688|42055488|FG000|Overall Study|Adverse Event|2|||
19606815|NCT00714688|42055489|FG001|Overall Study|Adverse Event|15|||
19606816|NCT00714688|42055490|FG002|Overall Study|Adverse Event|19|||
19606817|NCT00714688|42055488|FG000|Overall Study|Subject Non-compliant|3|||
19606818|NCT00714688|42055489|FG001|Overall Study|Subject Non-compliant|5|||
19606819|NCT00714688|42055490|FG002|Overall Study|Subject Non-compliant|5|||
19606820|NCT00714688|42055488|FG000|Overall Study|Ineligible to Continue the Study|0|||
19606821|NCT00714688|42055489|FG001|Overall Study|Ineligible to Continue the Study|1|||
19606822|NCT00714688|42055490|FG002|Overall Study|Ineligible to Continue the Study|1|||
19606823|NCT00714688|42055488|FG000|Overall Study|Sponsor's Decision|0|||
19606824|NCT00714688|42055489|FG001|Overall Study|Sponsor's Decision|2|||
19606825|NCT00714688|42055490|FG002|Overall Study|Sponsor's Decision|0|||
19606826|NCT00714688|42055488|FG000|Overall Study|Other|1|||
19606827|NCT00714688|42055489|FG001|Overall Study|Other|6|||
19606828|NCT00714688|42055490|FG002|Overall Study|Other|5|||
19606829|NCT00679549|42055500|FG000|Overall Study|dropout|2|||
19606830|NCT00679549|42055501|FG001|Overall Study|dropout|4|||
19606831|NCT00679549|42055500|FG000|Overall Study|missing outcome echocardiograms|4|||
19693061|NCT00362336|42138803|FG002|Overall Study|Withdrawal by Subject|1|||
19693062|NCT00506285|42138820|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
19693063|NCT00506285|42138821|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
19693064|NCT00506285|42138820|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
19693065|NCT00506285|42138821|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
19693066|NCT00506285|42138820|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
19693067|NCT00506285|42138821|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
19693068|NCT00506285|42138820|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
19693069|NCT00506285|42138821|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
19693070|NCT00506285|42138820|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
19693071|NCT00506285|42138821|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
19777327|NCT02817906|42232575|FG000|Overall Study|Withdrawal by Subject|7|||
19606832|NCT00679549|42055501|FG001|Overall Study|missing outcome echocardiograms|5|||
19777328|NCT02817906|42232576|FG001|Overall Study|Withdrawal by Subject|0|||
19777329|NCT02817906|42232575|FG000|Overall Study|Other|2|||
19777330|NCT02817906|42232576|FG001|Overall Study|Other|2|||
19777331|NCT02817594|42232587|FG000|Overall Study|Withdrawal by Subject|1|||
19777332|NCT02817594|42232587|FG000|Overall Study|Other|1|||
19777333|NCT02817594|42232587|FG000|Overall Study|Did Not Receive Treatment|1|||
19606833|NCT01031069|42055511|FG000|Overall Study|Serious Adverse Event|0|||
19606834|NCT01031069|42055512|FG001|Overall Study|Serious Adverse Event|1|||
19606835|NCT01031069|42055513|FG002|Overall Study|Serious Adverse Event|0|||
19606836|NCT01031069|42055514|FG003|Overall Study|Serious Adverse Event|0|||
19606837|NCT01031069|42055511|FG000|Overall Study|Withdrawal by Subject|2|||
19606838|NCT01031069|42055512|FG001|Overall Study|Withdrawal by Subject|3|||
19606839|NCT01031069|42055513|FG002|Overall Study|Withdrawal by Subject|18|||
19606840|NCT01031069|42055514|FG003|Overall Study|Withdrawal by Subject|18|||
19606841|NCT01031069|42055511|FG000|Overall Study|Migrated/moved from study area|1|||
19606842|NCT01031069|42055512|FG001|Overall Study|Migrated/moved from study area|2|||
19606843|NCT01031069|42055513|FG002|Overall Study|Migrated/moved from study area|1|||
19606844|NCT01031069|42055514|FG003|Overall Study|Migrated/moved from study area|1|||
19606845|NCT01031069|42055511|FG000|Overall Study|Lost to Follow-up|9|||
19606846|NCT01031069|42055512|FG001|Overall Study|Lost to Follow-up|5|||
19606847|NCT01031069|42055513|FG002|Overall Study|Lost to Follow-up|21|||
19606848|NCT01031069|42055514|FG003|Overall Study|Lost to Follow-up|15|||
19606849|NCT01031069|42055511|FG000|Overall Study|Other|0|||
19606850|NCT01031069|42055512|FG001|Overall Study|Other|0|||
19606851|NCT01031069|42055513|FG002|Overall Study|Other|1|||
19606852|NCT01031069|42055514|FG003|Overall Study|Other|0|||
19606853|NCT00679081|42055526|FG000|Overall Study|Lost to Follow-up|1|||
19606854|NCT00682435|42055534|FG000|Overall Study|Insufficient data|5|||
19606855|NCT00682435|42055534|FG000|Overall Study|Erroneously enrolled twice|2|||
19606856|NCT00713830|42055540|FG000|Overall Study|Adverse Event|23|||
19606857|NCT00713830|42055541|FG001|Overall Study|Adverse Event|71|||
19606858|NCT00713830|42055540|FG000|Overall Study|Lack of Efficacy|24|||
19606859|NCT00713830|42055541|FG001|Overall Study|Lack of Efficacy|16|||
19606860|NCT00713830|42055540|FG000|Overall Study|Lost to Follow-up|2|||
19606861|NCT00713830|42055541|FG001|Overall Study|Lost to Follow-up|9|||
19606862|NCT00713830|42055540|FG000|Overall Study|Withdrawal by Subject|13|||
19606863|NCT00713830|42055541|FG001|Overall Study|Withdrawal by Subject|23|||
19606864|NCT00713830|42055540|FG000|Overall Study|Poor Compliance to Protocol|7|||
19606865|NCT00713830|42055541|FG001|Overall Study|Poor Compliance to Protocol|14|||
19606866|NCT00713830|42055540|FG000|Overall Study|Familial and Personal Reasons|9|||
19606867|NCT00713830|42055541|FG001|Overall Study|Familial and Personal Reasons|34|||
19606868|NCT00713830|42055540|FG000|Overall Study|Sponsor Decision|4|||
19606869|NCT00713830|42055541|FG001|Overall Study|Sponsor Decision|10|||
19606870|NCT00681811|42055549|FG000|Overall Study|Adverse Event|1|||
19606871|NCT00681811|42055550|FG001|Overall Study|Adverse Event|1|||
19606872|NCT00681811|42055549|FG000|Overall Study|Withdrawal by Subject|2|||
19606873|NCT00681811|42055550|FG001|Overall Study|Withdrawal by Subject|2|||
19606874|NCT00681811|42055549|FG000|Overall Study|Non-compliance|0|||
19606875|NCT00681811|42055550|FG001|Overall Study|Non-compliance|1|||
19606876|NCT00681187|42055569|FG000|Overall Study|Withdrawal by Subject|1|||
19606877|NCT00681187|42055570|FG001|Overall Study|Withdrawal by Subject|0|||
19606878|NCT00681187|42055569|FG000|Overall Study|Death|0|||
19606879|NCT00681187|42055570|FG001|Overall Study|Death|1|||
19606880|NCT00681187|42055569|FG000|Overall Study|Adverse Event|0|||
19606881|NCT00681187|42055570|FG001|Overall Study|Adverse Event|1|||
19606882|NCT00681109|42055592|FG000|Overall Study|Lost to Follow-up|2|||
19606883|NCT00681109|42055593|FG001|Overall Study|Lost to Follow-up|6|||
19606884|NCT00681109|42055594|FG002|Overall Study|Lost to Follow-up|0|||
19606885|NCT00680407|42055608|FG000|Overall Study|Lost to Follow-up|3|||
19606886|NCT00680407|42055609|FG001|Overall Study|Lost to Follow-up|3|||
19606887|NCT00680407|42055610|FG002|Overall Study|Lost to Follow-up|1|||
19606888|NCT00680407|42055608|FG000|Overall Study|Withdrawal by Subject|5|||
19606889|NCT00680407|42055609|FG001|Overall Study|Withdrawal by Subject|2|||
19606890|NCT00680407|42055610|FG002|Overall Study|Withdrawal by Subject|2|||
19606891|NCT00677365|42055622|FG000|Overall Study|Adverse Event|2|||
19606892|NCT00677365|42055623|FG001|Overall Study|Adverse Event|1|||
19606893|NCT00677365|42055624|FG002|Overall Study|Adverse Event|1|||
19606894|NCT00677365|42055625|FG003|Overall Study|Adverse Event|2|||
19606895|NCT00677365|42055622|FG000|Overall Study|Withdrawal by Subject|0|||
19606896|NCT00677365|42055623|FG001|Overall Study|Withdrawal by Subject|0|||
19606897|NCT00677365|42055624|FG002|Overall Study|Withdrawal by Subject|1|||
19606898|NCT00677365|42055625|FG003|Overall Study|Withdrawal by Subject|0|||
19606899|NCT00677365|42055622|FG000|Overall Study|Other reason|0|||
19606900|NCT00677365|42055623|FG001|Overall Study|Other reason|0|||
19606901|NCT00677365|42055624|FG002|Overall Study|Other reason|0|||
19606902|NCT00677365|42055625|FG003|Overall Study|Other reason|1|||
19606903|NCT00680017|42055637|FG000|Overall Study|Adverse Event|13|||
19606904|NCT00680017|42055638|FG001|Overall Study|Adverse Event|7|||
19606905|NCT00680017|42055637|FG000|Overall Study|Withdrawal by Subject|2|||
19606906|NCT00680017|42055638|FG001|Overall Study|Withdrawal by Subject|5|||
19606907|NCT00680017|42055637|FG000|Overall Study|Lost to Follow-up|2|||
19777334|NCT02813694|42232597|FG000|Overall Study|Physician Decision|0|||
19693072|NCT00506129|42138829|FG000|Overall Study|Disease Progression/Relapse|15|||
19693073|NCT00506129|42138829|FG000|Overall Study|Death|7|||
19693074|NCT00358670|42138835|FG000|Overall Study|Adverse Event|26|||
19693075|NCT00358670|42138836|FG001|Overall Study|Adverse Event|29|||
19693076|NCT00358670|42138835|FG000|Overall Study|Lack of Efficacy|20|||
19693077|NCT00358670|42138836|FG001|Overall Study|Lack of Efficacy|23|||
19693078|NCT00358670|42138835|FG000|Overall Study|Protocol Violation|6|||
19693079|NCT00358670|42138836|FG001|Overall Study|Protocol Violation|9|||
19693080|NCT00358670|42138835|FG000|Overall Study|Lost to Follow-up|4|||
19693081|NCT00358670|42138836|FG001|Overall Study|Lost to Follow-up|5|||
19693082|NCT00358670|42138835|FG000|Overall Study|Withdrawal by Subject|13|||
19693083|NCT00358670|42138836|FG001|Overall Study|Withdrawal by Subject|24|||
19693084|NCT00358670|42138835|FG000|Overall Study|Protocol Defined Clinical Event|0|||
19693085|NCT00358670|42138836|FG001|Overall Study|Protocol Defined Clinical Event|1|||
19693086|NCT00358670|42138835|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
19693087|NCT00358670|42138836|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
19693088|NCT00358670|42138835|FG000|Overall Study|Administrative|153|||
19693089|NCT00358670|42138836|FG001|Overall Study|Administrative|125|||
19693090|NCT00505661|42138842|FG000|Overall Study|Not Eligible|4|||
19693091|NCT00383786|42138848|FG000|Overall Study|Protocol Violation|2|||
19693092|NCT00383786|42138849|FG001|Overall Study|Protocol Violation|6|||
19693093|NCT00383786|42138848|FG000|Overall Study|Withdrawal by Subject|2|||
19693094|NCT00383786|42138849|FG001|Overall Study|Withdrawal by Subject|5|||
19693095|NCT00383786|42138848|FG000|Overall Study|Physician Decision|0|||
19693096|NCT00383786|42138849|FG001|Overall Study|Physician Decision|1|||
19693097|NCT00383708|42138855|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
19693098|NCT00383708|42138855|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
19693099|NCT00383708|42138855|FG000|Run-in Period|Protocol Violation|4|||
19693100|NCT00383708|42138855|FG000|Run-in Period|Adverse Event|2|||
19693101|NCT00383708|42138855|FG000|Run-in Period|Claustrophobia|1|||
19693102|NCT00383708|42138855|FG000|Co-administration Period|Adverse Event|5|||
19693103|NCT00504881|42138862|FG000|Overall Study|Lack of Efficacy|1|||
19693104|NCT00504881|42138863|FG001|Overall Study|Lack of Efficacy|5|||
19693105|NCT00504881|42138862|FG000|Overall Study|Lost to Follow-up|0|||
19693106|NCT00504881|42138863|FG001|Overall Study|Lost to Follow-up|2|||
19693107|NCT00504881|42138862|FG000|Overall Study|Withdrawal by Subject|1|||
19693108|NCT00504881|42138863|FG001|Overall Study|Withdrawal by Subject|4|||
19693109|NCT00504881|42138862|FG000|Overall Study|Non-Compliance|1|||
19693110|NCT00504881|42138863|FG001|Overall Study|Non-Compliance|0|||
19693111|NCT00504881|42138862|FG000|Overall Study|No Birth Control|0|||
19693112|NCT00504881|42138863|FG001|Overall Study|No Birth Control|1|||
19693113|NCT00504881|42138862|FG000|Overall Study|Safety Visit not performed|0|||
19693114|NCT00504881|42138863|FG001|Overall Study|Safety Visit not performed|1|||
19693115|NCT00504881|42138862|FG000|Overall Study|AE, serious fatal|0|||
19693116|NCT00504881|42138863|FG001|Overall Study|AE, serious fatal|1|||
19693117|NCT00504881|42138862|FG000|Overall Study|SAE, non-fatal|2|||
19693118|NCT00504881|42138863|FG001|Overall Study|SAE, non-fatal|6|||
19693119|NCT00504881|42138862|FG000|Overall Study|AE, non-serious non-fatal|4|||
19693120|NCT00504881|42138863|FG001|Overall Study|AE, non-serious non-fatal|14|||
19693121|NCT00504881|42138862|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19693122|NCT00504881|42138863|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
19693123|NCT00504881|42138862|FG000|Overall Study|AE of unknown type|1|||
19693124|NCT00504881|42138863|FG001|Overall Study|AE of unknown type|0|||
19693125|NCT00504725|42138873|FG000|Overall Study|Protocol Violation|1|||
19693126|NCT00504725|42138874|FG001|Overall Study|Protocol Violation|0|||
19693127|NCT00383240|42138884|FG000|Overall Study|Adverse Event|4|||
19693128|NCT00383240|42138885|FG001|Overall Study|Adverse Event|6|||
19693129|NCT00383240|42138886|FG002|Overall Study|Adverse Event|9|||
19693130|NCT00383240|42138887|FG003|Overall Study|Adverse Event|7|||
19693131|NCT00383240|42138884|FG000|Overall Study|Treatment Failure|8|||
19693132|NCT00383240|42138885|FG001|Overall Study|Treatment Failure|13|||
19693133|NCT00383240|42138886|FG002|Overall Study|Treatment Failure|47|||
19693134|NCT00383240|42138887|FG003|Overall Study|Treatment Failure|46|||
19693135|NCT00383240|42138884|FG000|Overall Study|Lost to Follow-up|3|||
19693136|NCT00383240|42138885|FG001|Overall Study|Lost to Follow-up|0|||
19693137|NCT00383240|42138886|FG002|Overall Study|Lost to Follow-up|0|||
19693138|NCT00383240|42138887|FG003|Overall Study|Lost to Follow-up|2|||
19693139|NCT00383240|42138884|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
19693140|NCT00383240|42138885|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
19693141|NCT00383240|42138886|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
19693142|NCT00383240|42138887|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
19693143|NCT00383240|42138884|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
19693144|NCT00383240|42138885|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
19693145|NCT00383240|42138886|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
19693146|NCT00383240|42138887|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
19693147|NCT00383240|42138884|FG000|Overall Study|Protocol Violation|4|||
19693148|NCT00383240|42138885|FG001|Overall Study|Protocol Violation|5|||
19777335|NCT02813694|42232598|FG001|Overall Study|Physician Decision|1|||
19777336|NCT02813694|42232597|FG000|Overall Study|Withdrawal by Subject|10|||
19777337|NCT02813694|42232598|FG001|Overall Study|Withdrawal by Subject|9|||
19777338|NCT02813694|42232597|FG000|Overall Study|Lost to Follow-up|1|||
19777339|NCT02813694|42232598|FG001|Overall Study|Lost to Follow-up|1|||
19777340|NCT02813694|42232597|FG000|Overall Study|Death|3|||
19777341|NCT02813694|42232598|FG001|Overall Study|Death|3|||
19777342|NCT02813694|42232597|FG000|Overall Study|Randomized- did not receive study drug|2|||
19777343|NCT02813694|42232598|FG001|Overall Study|Randomized- did not receive study drug|0|||
19777344|NCT02813694|42232597|FG000|Overall Study|Patient hospitalized|1|||
19777345|NCT02813694|42232598|FG001|Overall Study|Patient hospitalized|0|||
19777346|NCT03103919|42232606|FG000|Overall Study|Adverse Event|2|||
19777347|NCT03103919|42232607|FG001|Overall Study|Adverse Event|2|||
19777348|NCT02810964|42232617|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
19777349|NCT02810964|42232618|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
19777350|NCT02810964|42232617|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
19777351|NCT02810964|42232618|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
19777352|NCT02810964|42232617|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
19777353|NCT02810964|42232618|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
19777354|NCT02810964|42232617|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
19777355|NCT02810964|42232618|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
19777356|NCT03103763|42232627|FG000|Overall Study|Death|15|||
19777357|NCT03103763|42232628|FG001|Overall Study|Death|5|||
19777358|NCT03103763|42232629|FG002|Overall Study|Death|5|||
19777359|NCT03103763|42232627|FG000|Overall Study|Withdrawal by Subject|0|||
19777360|NCT03103763|42232628|FG001|Overall Study|Withdrawal by Subject|3|||
19777361|NCT03103763|42232629|FG002|Overall Study|Withdrawal by Subject|2|||
19777362|NCT03101267|42232653|FG000|Primary Study Period|Withdrawal by Subject|1|||
19777363|NCT03101267|42232654|FG001|Primary Study Period|Withdrawal by Subject|2|||
19777364|NCT03101267|42232655|FG002|Primary Study Period|Withdrawal by Subject|3|||
19777365|NCT03101267|42232653|FG000|Primary Study Period|Miscellaneous|2|||
19777366|NCT03101267|42232654|FG001|Primary Study Period|Miscellaneous|0|||
19777367|NCT03101267|42232655|FG002|Primary Study Period|Miscellaneous|0|||
19777368|NCT02810418|42232670|FG000|Arm A Dose Escalation|Adverse Event|2|||
19777369|NCT02810418|42232671|FG001|Arm A Dose Escalation|Adverse Event|1|||
19777370|NCT02810418|42232672|FG002|Arm A Dose Escalation|Adverse Event|0|||
19777371|NCT02810418|42232673|FG003|Arm A Dose Escalation|Adverse Event|0|||
19777372|NCT02810418|42232674|FG004|Arm A Dose Escalation|Adverse Event|0|||
19777373|NCT02810418|42232675|FG005|Arm A Dose Escalation|Adverse Event|0|||
19777374|NCT02810418|42232676|FG006|Arm A Dose Escalation|Adverse Event|0|||
19777375|NCT02810418|42232670|FG000|Dose Expansion|Adverse Event|0|||
19777376|NCT02810418|42232671|FG001|Dose Expansion|Adverse Event|1|||
19777377|NCT02810418|42232672|FG002|Dose Expansion|Adverse Event|1|||
19777378|NCT02810418|42232673|FG003|Dose Expansion|Adverse Event|0|||
19777379|NCT02810418|42232674|FG004|Dose Expansion|Adverse Event|0|||
19777380|NCT02810418|42232675|FG005|Dose Expansion|Adverse Event|0|||
19777381|NCT02810418|42232676|FG006|Dose Expansion|Adverse Event|0|||
19777382|NCT02810418|42232670|FG000|Dose Expansion|Physician Decision|0|||
19777383|NCT02810418|42232671|FG001|Dose Expansion|Physician Decision|0|||
19777384|NCT02810418|42232672|FG002|Dose Expansion|Physician Decision|2|||
19777385|NCT02810418|42232673|FG003|Dose Expansion|Physician Decision|0|||
19777386|NCT02810418|42232674|FG004|Dose Expansion|Physician Decision|0|||
19777387|NCT02810418|42232675|FG005|Dose Expansion|Physician Decision|0|||
19777388|NCT02810418|42232676|FG006|Dose Expansion|Physician Decision|0|||
19777389|NCT02810418|42232670|FG000|Arm B Dose Escalation|Adverse Event|0|||
19777390|NCT02810418|42232671|FG001|Arm B Dose Escalation|Adverse Event|0|||
19777391|NCT02810418|42232672|FG002|Arm B Dose Escalation|Adverse Event|0|||
19777392|NCT02810418|42232673|FG003|Arm B Dose Escalation|Adverse Event|0|||
19777393|NCT02810418|42232674|FG004|Arm B Dose Escalation|Adverse Event|1|||
19777394|NCT02810418|42232675|FG005|Arm B Dose Escalation|Adverse Event|2|||
19777395|NCT02810418|42232676|FG006|Arm B Dose Escalation|Adverse Event|0|||
19777396|NCT02810340|42232742|FG000|Overall Study|Withdrawal by Subject|1|||
19777397|NCT02810340|42232743|FG001|Overall Study|Withdrawal by Subject|0|||
19777398|NCT02810340|42232744|FG002|Overall Study|Withdrawal by Subject|0|||
19777399|NCT02810340|42232742|FG000|Overall Study|Incarceration|0|||
19777400|NCT02810340|42232743|FG001|Overall Study|Incarceration|1|||
19777401|NCT02810340|42232744|FG002|Overall Study|Incarceration|0|||
19777402|NCT02810340|42232742|FG000|Overall Study|Lost to Follow-up|0|||
19777403|NCT02810340|42232743|FG001|Overall Study|Lost to Follow-up|0|||
19777404|NCT02810340|42232744|FG002|Overall Study|Lost to Follow-up|1|||
19777405|NCT02817516|42232756|FG000|Overall Study|Other|0|||
19777406|NCT02817516|42232757|FG001|Overall Study|Other|0|||
19777407|NCT02817516|42232758|FG002|Overall Study|Other|1|||
19777408|NCT02817516|42232759|FG003|Overall Study|Other|0|||
19777409|NCT02928029|42232774|FG000|Overall Study|Withdrawal by Subject|0|||
19777410|NCT02928029|42232775|FG001|Overall Study|Withdrawal by Subject|1|||
19777411|NCT02928029|42232774|FG000|Overall Study|Radiological progression|1|||
19777412|NCT02928029|42232775|FG001|Overall Study|Radiological progression|0|||
19777413|NCT02928029|42232774|FG000|Overall Study|Clinical progression|1|||
19777414|NCT02928029|42232775|FG001|Overall Study|Clinical progression|2|||
19777415|NCT02928029|42232774|FG000|Overall Study|AE not related to clinical progression|1|||
19777416|NCT02928029|42232775|FG001|Overall Study|AE not related to clinical progression|1|||
19777417|NCT02806986|42232781|FG000|Treatment Stage 1|Adverse Event|1|||
19777418|NCT02806986|42232781|FG000|Treatment Stage 2|Adverse Event|3|||
19777419|NCT02806986|42232781|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
19777420|NCT03095651|42232797|FG000|Overall Study|Lost to Follow-up|1|||
19777421|NCT03095651|42232798|FG001|Overall Study|Lost to Follow-up|1|||
19777422|NCT03095651|42232799|FG002|Overall Study|Lost to Follow-up|0|||
19777423|NCT03095651|42232800|FG003|Overall Study|Lost to Follow-up|1|||
19777424|NCT03095651|42232801|FG004|Overall Study|Lost to Follow-up|0|||
19777425|NCT03095651|42232802|FG005|Overall Study|Lost to Follow-up|0|||
19777426|NCT03095651|42232803|FG006|Overall Study|Lost to Follow-up|0|||
19777427|NCT03095651|42232804|FG007|Overall Study|Lost to Follow-up|0|||
19777428|NCT03095651|42232797|FG000|Overall Study|Withdrawal by Subject|0|||
19777429|NCT03095651|42232798|FG001|Overall Study|Withdrawal by Subject|0|||
19777430|NCT03095651|42232799|FG002|Overall Study|Withdrawal by Subject|0|||
19777431|NCT03095651|42232800|FG003|Overall Study|Withdrawal by Subject|0|||
19777432|NCT03095651|42232801|FG004|Overall Study|Withdrawal by Subject|0|||
19777433|NCT03095651|42232802|FG005|Overall Study|Withdrawal by Subject|1|||
19777434|NCT03095651|42232803|FG006|Overall Study|Withdrawal by Subject|0|||
19777435|NCT03095651|42232804|FG007|Overall Study|Withdrawal by Subject|0|||
19777436|NCT02808312|42232827|FG000|Overall Study|Enrolled but Never Treated|0|||
19777437|NCT02808312|42232828|FG001|Overall Study|Enrolled but Never Treated|0|||
19777438|NCT02808312|42232829|FG002|Overall Study|Enrolled but Never Treated|1|||
19777439|NCT02808312|42232830|FG003|Overall Study|Enrolled but Never Treated|0|||
19777440|NCT02808312|42232831|FG004|Overall Study|Enrolled but Never Treated|0|||
19777441|NCT03099161|42232851|FG000|Overall Study|Adverse Event|0|||
19777442|NCT03099161|42232852|FG001|Overall Study|Adverse Event|0|||
19777443|NCT03099161|42232853|FG002|Overall Study|Adverse Event|2|||
19777444|NCT03099161|42232851|FG000|Overall Study|Physician Decision|2|||
19777445|NCT03099161|42232852|FG001|Overall Study|Physician Decision|0|||
19777446|NCT03099161|42232853|FG002|Overall Study|Physician Decision|0|||
19777447|NCT03099161|42232851|FG000|Overall Study|Progressive Disease|1|||
19777448|NCT03099161|42232852|FG001|Overall Study|Progressive Disease|4|||
19693149|NCT00383240|42138886|FG002|Overall Study|Protocol Violation|9|||
19693150|NCT00383240|42138887|FG003|Overall Study|Protocol Violation|6|||
19693151|NCT00383240|42138884|FG000|Overall Study|Did not meet protocol eligibility|9|||
19693152|NCT00383240|42138885|FG001|Overall Study|Did not meet protocol eligibility|4|||
19693153|NCT00383240|42138886|FG002|Overall Study|Did not meet protocol eligibility|9|||
19693154|NCT00383240|42138887|FG003|Overall Study|Did not meet protocol eligibility|3|||
19777449|NCT03099161|42232853|FG002|Overall Study|Progressive Disease|1|||
19777450|NCT03095027|42232861|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
19777451|NCT03095027|42232862|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
19777452|NCT04227197|42232870|FG000|Randomization|Protocol Violation|1|||
19777453|NCT04227197|42232871|FG001|Randomization|Protocol Violation|0|||
19777454|NCT04227197|42232870|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
19777455|NCT04227197|42232871|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
19777456|NCT04227197|42232870|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
19777457|NCT04227197|42232871|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
19777458|NCT04227197|42232870|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
19777459|NCT04227197|42232871|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
19693155|NCT00383240|42138884|FG000|Overall Study|Administrative|1|||
19693156|NCT00383240|42138885|FG001|Overall Study|Administrative|1|||
19693157|NCT00383240|42138886|FG002|Overall Study|Administrative|0|||
19693158|NCT00383240|42138887|FG003|Overall Study|Administrative|0|||
19693159|NCT00362180|42138907|FG000|Treated Period|Withdrawal by Subject|1|||
19693160|NCT00362180|42138908|FG001|Treated Period|Withdrawal by Subject|0|||
19693161|NCT00362180|42138909|FG002|Treated Period|Withdrawal by Subject|0|||
19693162|NCT00362180|42138910|FG003|Treated Period|Withdrawal by Subject|0|||
19777460|NCT04227197|42232870|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
19777461|NCT04227197|42232871|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
19777462|NCT04227197|42232870|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
19777463|NCT04227197|42232871|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
19777464|NCT04227197|42232870|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
19777465|NCT04227197|42232871|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
19777466|NCT03080935|42232882|FG000|Overall Study|Death|34|||
19693163|NCT00362180|42138911|FG004|Treated Period|Withdrawal by Subject|0|||
19693164|NCT00362180|42138912|FG005|Treated Period|Withdrawal by Subject|0|||
19777467|NCT03080935|42232883|FG001|Overall Study|Death|50|||
19777468|NCT03080935|42232882|FG000|Overall Study|Lost to Follow-up|5|||
19693165|NCT00362180|42138913|FG006|Treated Period|Withdrawal by Subject|0|||
19777469|NCT03080935|42232883|FG001|Overall Study|Lost to Follow-up|4|||
19777470|NCT03080935|42232882|FG000|Overall Study|Withdrawal by Subject|11|||
19777471|NCT03080935|42232883|FG001|Overall Study|Withdrawal by Subject|15|||
19777472|NCT03148795|42232893|FG000|Overall Study|Death|6|||
19777473|NCT03148795|42232893|FG000|Overall Study|Adverse Event|5|||
19777474|NCT03148795|42232893|FG000|Overall Study|Other|15|||
19777475|NCT03148795|42232893|FG000|Overall Study|No Longer Clinically Benefitting|2|||
19777476|NCT03148795|42232893|FG000|Overall Study|Global Deterioration Of Health Status|6|||
19777477|NCT03148795|42232893|FG000|Overall Study|Withdrawal by Subject|2|||
19777478|NCT03148795|42232893|FG000|Overall Study|Progressive Disease|62|||
19777479|NCT03148795|42232893|FG000|Overall Study|Ongoing|30|||
19777480|NCT02921789|42232899|FG000|Overall Study|Adverse Event|0|||
19777481|NCT02921789|42232900|FG001|Overall Study|Adverse Event|1|||
19777482|NCT02921789|42232899|FG000|Overall Study|Lost to Follow-up|1|||
19777483|NCT02921789|42232900|FG001|Overall Study|Lost to Follow-up|0|||
19777484|NCT02921789|42232899|FG000|Overall Study|Protocol Deviation|2|||
19777485|NCT02921789|42232900|FG001|Overall Study|Protocol Deviation|0|||
19777486|NCT02921789|42232899|FG000|Overall Study|Withdrawal by Subject|2|||
19777487|NCT02921789|42232900|FG001|Overall Study|Withdrawal by Subject|1|||
19777488|NCT02921789|42232899|FG000|Overall Study|Miscellaneous|3|||
19777489|NCT02921789|42232900|FG001|Overall Study|Miscellaneous|2|||
19777490|NCT02564900|42232921|FG000|Dose Escalation|Progressive disease per RECIST|2|||
19777491|NCT02564900|42232922|FG001|Dose Escalation|Progressive disease per RECIST|3|||
19777492|NCT02564900|42232923|FG002|Dose Escalation|Progressive disease per RECIST|3|||
19777493|NCT02564900|42232924|FG003|Dose Escalation|Progressive disease per RECIST|3|||
19367248|NCT02435992|41607415|FG000|Overall Study|Withdrawal by Subject|10|||
19367249|NCT02435992|41607416|FG001|Overall Study|Withdrawal by Subject|8|||
19367250|NCT02435992|41607417|FG002|Overall Study|Withdrawal by Subject|20|||
19606908|NCT00680017|42055638|FG001|Overall Study|Lost to Follow-up|0|||
19606909|NCT00676663|42055646|FG000|Overall Study|Death|43|||
19606910|NCT00676663|42055647|FG001|Overall Study|Death|27|||
19606911|NCT00676663|42055646|FG000|Overall Study|Withdrew Consent|1|||
19606912|NCT00676663|42055647|FG001|Overall Study|Withdrew Consent|8|||
19606913|NCT00676663|42055646|FG000|Overall Study|Lost to Follow-up|1|||
19606914|NCT00676663|42055647|FG001|Overall Study|Lost to Follow-up|3|||
19606915|NCT00678691|42055657|FG000|Overall Study|Adverse Event|6|||
19606916|NCT00678691|42055658|FG001|Overall Study|Adverse Event|4|||
19606917|NCT00679939|42055666|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
19606918|NCT00679939|42055667|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
19606919|NCT00679939|42055666|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
19606920|NCT00679939|42055667|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
19693166|NCT00362180|42138914|FG007|Treated Period|Withdrawal by Subject|0|||
19693167|NCT00362180|42138915|FG008|Treated Period|Withdrawal by Subject|0|||
19693168|NCT00362180|42138907|FG000|Treated Period|Adverse Event|0|||
19693169|NCT00362180|42138908|FG001|Treated Period|Adverse Event|0|||
19693170|NCT00362180|42138909|FG002|Treated Period|Adverse Event|0|||
19693171|NCT00362180|42138910|FG003|Treated Period|Adverse Event|0|||
19693172|NCT00362180|42138911|FG004|Treated Period|Adverse Event|0|||
19693173|NCT00362180|42138912|FG005|Treated Period|Adverse Event|1|||
19693174|NCT00362180|42138913|FG006|Treated Period|Adverse Event|0|||
19693175|NCT00362180|42138914|FG007|Treated Period|Adverse Event|1|||
19693176|NCT00362180|42138915|FG008|Treated Period|Adverse Event|0|||
19693177|NCT00383162|42138933|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
19693178|NCT00383162|42138934|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
19693179|NCT00383162|42138933|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
19693180|NCT00383162|42138934|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
19693181|NCT00383162|42138933|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
19693182|NCT00383162|42138934|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
19693183|NCT00383162|42138933|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
19693184|NCT00383162|42138934|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
19693185|NCT00383162|42138933|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
19693186|NCT00383162|42138934|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
19693187|NCT00383162|42138933|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
19693188|NCT00383162|42138934|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
19693189|NCT00383162|42138933|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
19693190|NCT00383162|42138934|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
19693191|NCT00383162|42138933|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
19693192|NCT00383162|42138934|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
19693193|NCT00383162|42138933|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
19693194|NCT00383162|42138934|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
19693195|NCT00358436|42138942|FG000|Overall Study|Adverse Event|29|||
19606921|NCT00679939|42055666|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
19693196|NCT00358436|42138943|FG001|Overall Study|Adverse Event|13|||
19693197|NCT00358436|42138942|FG000|Overall Study|Lack of Efficacy|34|||
19777494|NCT02564900|42232925|FG004|Dose Escalation|Progressive disease per RECIST|3|||
19777495|NCT02564900|42232926|FG005|Dose Escalation|Progressive disease per RECIST|1|||
19777496|NCT02564900|42232927|FG006|Dose Escalation|Progressive disease per RECIST|0|||
19777497|NCT02564900|42232928|FG007|Dose Escalation|Progressive disease per RECIST|0|||
19777498|NCT02564900|42232929|FG008|Dose Escalation|Progressive disease per RECIST|0|||
19777499|NCT02564900|42232930|FG009|Dose Escalation|Progressive disease per RECIST|0|||
19777500|NCT02564900|42232931|FG010|Dose Escalation|Progressive disease per RECIST|0|||
19777501|NCT02564900|42232932|FG011|Dose Escalation|Progressive disease per RECIST|0|||
19777502|NCT02564900|42232933|FG012|Dose Escalation|Progressive disease per RECIST|0|||
19777503|NCT02564900|42232934|FG013|Dose Escalation|Progressive disease per RECIST|0|||
19777504|NCT02564900|42232935|FG014|Dose Escalation|Progressive disease per RECIST|0|||
19777505|NCT02564900|42232921|FG000|Dose Escalation|Ongoing|1|||
19777506|NCT02564900|42232922|FG001|Dose Escalation|Ongoing|0|||
19777507|NCT02564900|42232923|FG002|Dose Escalation|Ongoing|0|||
19777508|NCT02564900|42232924|FG003|Dose Escalation|Ongoing|2|||
19777509|NCT02564900|42232925|FG004|Dose Escalation|Ongoing|2|||
19777510|NCT02564900|42232926|FG005|Dose Escalation|Ongoing|2|||
19777511|NCT02564900|42232927|FG006|Dose Escalation|Ongoing|0|||
19777512|NCT02564900|42232928|FG007|Dose Escalation|Ongoing|0|||
19777513|NCT02564900|42232929|FG008|Dose Escalation|Ongoing|0|||
19777514|NCT02564900|42232930|FG009|Dose Escalation|Ongoing|0|||
19777515|NCT02564900|42232931|FG010|Dose Escalation|Ongoing|0|||
19777516|NCT02564900|42232932|FG011|Dose Escalation|Ongoing|0|||
19777517|NCT02564900|42232933|FG012|Dose Escalation|Ongoing|0|||
19777518|NCT02564900|42232934|FG013|Dose Escalation|Ongoing|0|||
19777519|NCT02564900|42232935|FG014|Dose Escalation|Ongoing|0|||
19777520|NCT02564900|42232921|FG000|Dose Escalation|Adverse Event|0|||
19777521|NCT02564900|42232922|FG001|Dose Escalation|Adverse Event|0|||
19777522|NCT02564900|42232923|FG002|Dose Escalation|Adverse Event|0|||
19777523|NCT02564900|42232924|FG003|Dose Escalation|Adverse Event|1|||
19777524|NCT02564900|42232925|FG004|Dose Escalation|Adverse Event|1|||
19777525|NCT02564900|42232926|FG005|Dose Escalation|Adverse Event|3|||
19777526|NCT02564900|42232927|FG006|Dose Escalation|Adverse Event|0|||
19777527|NCT02564900|42232928|FG007|Dose Escalation|Adverse Event|0|||
19777528|NCT02564900|42232929|FG008|Dose Escalation|Adverse Event|0|||
19777529|NCT02564900|42232930|FG009|Dose Escalation|Adverse Event|0|||
19777530|NCT02564900|42232931|FG010|Dose Escalation|Adverse Event|0|||
19777531|NCT02564900|42232932|FG011|Dose Escalation|Adverse Event|0|||
19777532|NCT02564900|42232933|FG012|Dose Escalation|Adverse Event|0|||
19777533|NCT02564900|42232934|FG013|Dose Escalation|Adverse Event|0|||
19777534|NCT02564900|42232935|FG014|Dose Escalation|Adverse Event|0|||
19777535|NCT02564900|42232921|FG000|Dose Expansion|Progressive disease per RECIST|0|||
19777536|NCT02564900|42232922|FG001|Dose Expansion|Progressive disease per RECIST|0|||
19777537|NCT02564900|42232923|FG002|Dose Expansion|Progressive disease per RECIST|0|||
19777538|NCT02564900|42232924|FG003|Dose Expansion|Progressive disease per RECIST|0|||
19777539|NCT02564900|42232925|FG004|Dose Expansion|Progressive disease per RECIST|0|||
19777540|NCT02564900|42232926|FG005|Dose Expansion|Progressive disease per RECIST|0|||
19777541|NCT02564900|42232927|FG006|Dose Expansion|Progressive disease per RECIST|19|||
19777542|NCT02564900|42232928|FG007|Dose Expansion|Progressive disease per RECIST|17|||
19777543|NCT02564900|42232929|FG008|Dose Expansion|Progressive disease per RECIST|8|||
19777544|NCT02564900|42232930|FG009|Dose Expansion|Progressive disease per RECIST|16|||
19777545|NCT02564900|42232931|FG010|Dose Expansion|Progressive disease per RECIST|13|||
19777546|NCT02564900|42232932|FG011|Dose Expansion|Progressive disease per RECIST|19|||
19777547|NCT02564900|42232933|FG012|Dose Expansion|Progressive disease per RECIST|10|||
19777548|NCT02564900|42232934|FG013|Dose Expansion|Progressive disease per RECIST|13|||
19777549|NCT02564900|42232935|FG014|Dose Expansion|Progressive disease per RECIST|11|||
19777550|NCT02564900|42232921|FG000|Dose Expansion|Clinical progression|0|||
19777551|NCT02564900|42232922|FG001|Dose Expansion|Clinical progression|0|||
19777552|NCT02564900|42232923|FG002|Dose Expansion|Clinical progression|0|||
19777553|NCT02564900|42232924|FG003|Dose Expansion|Clinical progression|0|||
19777554|NCT02564900|42232925|FG004|Dose Expansion|Clinical progression|0|||
19777555|NCT02564900|42232926|FG005|Dose Expansion|Clinical progression|0|||
19777556|NCT02564900|42232927|FG006|Dose Expansion|Clinical progression|5|||
19777557|NCT02564900|42232928|FG007|Dose Expansion|Clinical progression|12|||
19777558|NCT02564900|42232929|FG008|Dose Expansion|Clinical progression|0|||
19777559|NCT02564900|42232930|FG009|Dose Expansion|Clinical progression|3|||
19777560|NCT02564900|42232931|FG010|Dose Expansion|Clinical progression|2|||
19777561|NCT02564900|42232932|FG011|Dose Expansion|Clinical progression|0|||
19777562|NCT02564900|42232933|FG012|Dose Expansion|Clinical progression|1|||
19777563|NCT02564900|42232934|FG013|Dose Expansion|Clinical progression|3|||
19777564|NCT02564900|42232935|FG014|Dose Expansion|Clinical progression|1|||
19777565|NCT02564900|42232921|FG000|Dose Expansion|Adverse Event|0|||
19777566|NCT02564900|42232922|FG001|Dose Expansion|Adverse Event|0|||
19777567|NCT02564900|42232923|FG002|Dose Expansion|Adverse Event|0|||
19777568|NCT02564900|42232924|FG003|Dose Expansion|Adverse Event|0|||
19777569|NCT02564900|42232925|FG004|Dose Expansion|Adverse Event|0|||
19777570|NCT02564900|42232926|FG005|Dose Expansion|Adverse Event|0|||
19777571|NCT02564900|42232927|FG006|Dose Expansion|Adverse Event|9|||
19777572|NCT02564900|42232928|FG007|Dose Expansion|Adverse Event|22|||
19777573|NCT02564900|42232929|FG008|Dose Expansion|Adverse Event|0|||
19777574|NCT02564900|42232930|FG009|Dose Expansion|Adverse Event|11|||
19777575|NCT02564900|42232931|FG010|Dose Expansion|Adverse Event|0|||
19777576|NCT02564900|42232932|FG011|Dose Expansion|Adverse Event|5|||
19777577|NCT02564900|42232933|FG012|Dose Expansion|Adverse Event|2|||
19777578|NCT02564900|42232934|FG013|Dose Expansion|Adverse Event|2|||
19777579|NCT02564900|42232935|FG014|Dose Expansion|Adverse Event|1|||
19777580|NCT02564900|42232921|FG000|Dose Expansion|Ongoing|0|||
19777581|NCT02564900|42232922|FG001|Dose Expansion|Ongoing|0|||
19777582|NCT02564900|42232923|FG002|Dose Expansion|Ongoing|0|||
19777583|NCT02564900|42232924|FG003|Dose Expansion|Ongoing|0|||
19777584|NCT02564900|42232925|FG004|Dose Expansion|Ongoing|0|||
19777585|NCT02564900|42232926|FG005|Dose Expansion|Ongoing|0|||
19777586|NCT02564900|42232927|FG006|Dose Expansion|Ongoing|9|||
19777587|NCT02564900|42232928|FG007|Dose Expansion|Ongoing|10|||
19777588|NCT02564900|42232929|FG008|Dose Expansion|Ongoing|11|||
19777589|NCT02564900|42232930|FG009|Dose Expansion|Ongoing|3|||
19777590|NCT02564900|42232931|FG010|Dose Expansion|Ongoing|0|||
19777591|NCT02564900|42232932|FG011|Dose Expansion|Ongoing|0|||
19777592|NCT02564900|42232933|FG012|Dose Expansion|Ongoing|4|||
19777593|NCT02564900|42232934|FG013|Dose Expansion|Ongoing|0|||
19777594|NCT02564900|42232935|FG014|Dose Expansion|Ongoing|6|||
19777595|NCT02564900|42232921|FG000|Dose Expansion|Death|0|||
19777596|NCT02564900|42232922|FG001|Dose Expansion|Death|0|||
19777597|NCT02564900|42232923|FG002|Dose Expansion|Death|0|||
19777598|NCT02564900|42232924|FG003|Dose Expansion|Death|0|||
19777599|NCT02564900|42232925|FG004|Dose Expansion|Death|0|||
19777600|NCT02564900|42232926|FG005|Dose Expansion|Death|0|||
19777601|NCT02564900|42232927|FG006|Dose Expansion|Death|1|||
19777602|NCT02564900|42232928|FG007|Dose Expansion|Death|0|||
19777603|NCT02564900|42232929|FG008|Dose Expansion|Death|0|||
19777604|NCT02564900|42232930|FG009|Dose Expansion|Death|0|||
19777605|NCT02564900|42232931|FG010|Dose Expansion|Death|1|||
19777606|NCT02564900|42232932|FG011|Dose Expansion|Death|0|||
19777607|NCT02564900|42232933|FG012|Dose Expansion|Death|1|||
19777608|NCT02564900|42232934|FG013|Dose Expansion|Death|1|||
19777609|NCT02564900|42232935|FG014|Dose Expansion|Death|0|||
19777610|NCT02564900|42232921|FG000|Dose Expansion|Withdrawal by Subject|0|||
19777611|NCT02564900|42232922|FG001|Dose Expansion|Withdrawal by Subject|0|||
19777612|NCT02564900|42232923|FG002|Dose Expansion|Withdrawal by Subject|0|||
19777613|NCT02564900|42232924|FG003|Dose Expansion|Withdrawal by Subject|0|||
19777614|NCT02564900|42232925|FG004|Dose Expansion|Withdrawal by Subject|0|||
19777615|NCT02564900|42232926|FG005|Dose Expansion|Withdrawal by Subject|0|||
19777616|NCT02564900|42232927|FG006|Dose Expansion|Withdrawal by Subject|4|||
19777617|NCT02564900|42232928|FG007|Dose Expansion|Withdrawal by Subject|0|||
19777618|NCT02564900|42232929|FG008|Dose Expansion|Withdrawal by Subject|0|||
19777619|NCT02564900|42232930|FG009|Dose Expansion|Withdrawal by Subject|0|||
19693198|NCT00358436|42138943|FG001|Overall Study|Lack of Efficacy|36|||
19693199|NCT00358436|42138942|FG000|Overall Study|Lost to Follow-up|11|||
19693200|NCT00358436|42138943|FG001|Overall Study|Lost to Follow-up|6|||
19693201|NCT00358436|42138942|FG000|Overall Study|Protocol Violation|8|||
19693202|NCT00358436|42138943|FG001|Overall Study|Protocol Violation|3|||
19693203|NCT00358436|42138942|FG000|Overall Study|Withdrawal by Subject|40|||
19693204|NCT00358436|42138943|FG001|Overall Study|Withdrawal by Subject|17|||
19693205|NCT00358436|42138942|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
19693206|NCT00358436|42138943|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
19693207|NCT00358436|42138942|FG000|Overall Study|COPD exacerbation|22|||
19693208|NCT00358436|42138943|FG001|Overall Study|COPD exacerbation|10|||
19693209|NCT00358436|42138942|FG000|Overall Study|Other|6|||
19693210|NCT00358436|42138943|FG001|Overall Study|Other|1|||
19693211|NCT00383084|42138953|FG000|Overall Study|Withdrawal by Subject|12|||
19693212|NCT00383084|42138954|FG001|Overall Study|Withdrawal by Subject|10|||
19693213|NCT00361634|42138960|FG000|Overall Study|Lost to Follow-up|1|||
19693214|NCT00361634|42138960|FG000|Overall Study|Withdrawal by Subject|1|||
19693215|NCT00357968|42138966|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
19693216|NCT00357968|42138967|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
19777620|NCT02564900|42232931|FG010|Dose Expansion|Withdrawal by Subject|1|||
19777621|NCT02564900|42232932|FG011|Dose Expansion|Withdrawal by Subject|0|||
19777622|NCT02564900|42232933|FG012|Dose Expansion|Withdrawal by Subject|0|||
19777623|NCT02564900|42232934|FG013|Dose Expansion|Withdrawal by Subject|1|||
19777624|NCT02564900|42232935|FG014|Dose Expansion|Withdrawal by Subject|1|||
19777625|NCT02564900|42232921|FG000|Dose Expansion|Other|0|||
19777626|NCT02564900|42232922|FG001|Dose Expansion|Other|0|||
19777627|NCT02564900|42232923|FG002|Dose Expansion|Other|0|||
19777628|NCT02564900|42232924|FG003|Dose Expansion|Other|0|||
19777629|NCT02564900|42232925|FG004|Dose Expansion|Other|0|||
19777630|NCT02564900|42232926|FG005|Dose Expansion|Other|0|||
19777631|NCT02564900|42232927|FG006|Dose Expansion|Other|1|||
19777632|NCT02564900|42232928|FG007|Dose Expansion|Other|0|||
19777633|NCT02564900|42232929|FG008|Dose Expansion|Other|1|||
19777634|NCT02564900|42232930|FG009|Dose Expansion|Other|0|||
19777635|NCT02564900|42232931|FG010|Dose Expansion|Other|0|||
19777636|NCT02564900|42232932|FG011|Dose Expansion|Other|0|||
19777637|NCT02564900|42232933|FG012|Dose Expansion|Other|0|||
19777638|NCT02564900|42232934|FG013|Dose Expansion|Other|0|||
19777639|NCT02564900|42232935|FG014|Dose Expansion|Other|1|||
19777640|NCT02564900|42232921|FG000|Dose Expansion|Did not receive treatment|0|||
19777641|NCT02564900|42232922|FG001|Dose Expansion|Did not receive treatment|0|||
19777642|NCT02564900|42232923|FG002|Dose Expansion|Did not receive treatment|0|||
19777643|NCT02564900|42232924|FG003|Dose Expansion|Did not receive treatment|0|||
19777644|NCT02564900|42232925|FG004|Dose Expansion|Did not receive treatment|0|||
19777645|NCT02564900|42232926|FG005|Dose Expansion|Did not receive treatment|0|||
19777646|NCT02564900|42232927|FG006|Dose Expansion|Did not receive treatment|1|||
19777647|NCT02564900|42232928|FG007|Dose Expansion|Did not receive treatment|1|||
19777648|NCT02564900|42232929|FG008|Dose Expansion|Did not receive treatment|0|||
19777649|NCT02564900|42232930|FG009|Dose Expansion|Did not receive treatment|0|||
19777650|NCT02564900|42232931|FG010|Dose Expansion|Did not receive treatment|0|||
19777651|NCT02564900|42232932|FG011|Dose Expansion|Did not receive treatment|0|||
19777652|NCT02564900|42232933|FG012|Dose Expansion|Did not receive treatment|0|||
19777653|NCT02564900|42232934|FG013|Dose Expansion|Did not receive treatment|0|||
19777654|NCT02564900|42232935|FG014|Dose Expansion|Did not receive treatment|1|||
19777655|NCT03364673|42232985|FG000|Overall Study|Withdrawal by Subject|2|||
19777656|NCT03364673|42232985|FG000|Overall Study|Injury unrelated to study|3|||
19777657|NCT03097289|42232989|FG000|Overall Study|Adverse Event|1|||
19777658|NCT03097289|42232989|FG000|Overall Study|Equipment failure|2|||
19777659|NCT03097289|42232989|FG000|Overall Study|Collected platelet product unusable|3|||
19777660|NCT02419742|42233011|FG000|Overall Study|Adverse Event|2|||
19777661|NCT02419742|42233012|FG001|Overall Study|Adverse Event|0|||
19777662|NCT02419742|42233011|FG000|Overall Study|Disease Progression|0|||
19777663|NCT02419742|42233012|FG001|Overall Study|Disease Progression|1|||
19777664|NCT02419742|42233011|FG000|Overall Study|Withdrew Consent|2|||
19777665|NCT02419742|42233012|FG001|Overall Study|Withdrew Consent|1|||
19777666|NCT02419742|42233011|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
19777667|NCT02419742|42233012|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
19777668|NCT02898077|42233020|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
19777669|NCT02898077|42233021|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
19777670|NCT02898077|42233020|FG000|Overall Study|Lost to Follow-up|4|||
19777671|NCT02898077|42233021|FG001|Overall Study|Lost to Follow-up|3|||
19777672|NCT02898077|42233020|FG000|Overall Study|Physician Decision|0|||
19777673|NCT02898077|42233021|FG001|Overall Study|Physician Decision|2|||
19777674|NCT02898077|42233020|FG000|Overall Study|Sponsor Decision|32|||
19777675|NCT02898077|42233021|FG001|Overall Study|Sponsor Decision|13|||
19777676|NCT02898077|42233020|FG000|Overall Study|Withdrawal by Subject|6|||
19777677|NCT02898077|42233021|FG001|Overall Study|Withdrawal by Subject|3|||
19777678|NCT02898077|42233020|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
19777679|NCT02898077|42233021|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
19777680|NCT02898077|42233020|FG000|Overall Study|Ended extension period|3|||
19777681|NCT02898077|42233021|FG001|Overall Study|Ended extension period|0|||
19777682|NCT03097133|42233029|FG000|Overall Study|Lost to Follow-up|3|||
19777683|NCT03097133|42233030|FG001|Overall Study|Lost to Follow-up|2|||
19777684|NCT03097133|42233029|FG000|Overall Study|Withdrawal by Subject|2|||
19777685|NCT03097133|42233030|FG001|Overall Study|Withdrawal by Subject|5|||
19777686|NCT03097133|42233029|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
19777687|NCT03097133|42233030|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
19777688|NCT03097133|42233029|FG000|Overall Study|Other|3|||
19777689|NCT03097133|42233030|FG001|Overall Study|Other|2|||
19777690|NCT03097133|42233029|FG000|Overall Study|Adverse Event|1|||
19777691|NCT03097133|42233030|FG001|Overall Study|Adverse Event|0|||
19777692|NCT03889639|42233044|FG000|Overall Study|Withdrawal by Subject|0|||
19777693|NCT03889639|42233045|FG001|Overall Study|Withdrawal by Subject|0|||
19777694|NCT03889639|42233046|FG002|Overall Study|Withdrawal by Subject|0|||
19777695|NCT03889639|42233047|FG003|Overall Study|Withdrawal by Subject|0|||
19777696|NCT03889639|42233048|FG004|Overall Study|Withdrawal by Subject|0|||
19777697|NCT03889639|42233049|FG005|Overall Study|Withdrawal by Subject|0|||
19777698|NCT03889639|42233050|FG006|Overall Study|Withdrawal by Subject|0|||
19777699|NCT03889639|42233051|FG007|Overall Study|Withdrawal by Subject|1|||
19777700|NCT03265145|42233074|FG000|Overall Study|Protocol Violation|2|||
19777701|NCT03265145|42233075|FG001|Overall Study|Protocol Violation|0|||
19777702|NCT03265145|42233074|FG000|Overall Study|Adverse Event|1|||
19777703|NCT03265145|42233075|FG001|Overall Study|Adverse Event|0|||
19777704|NCT03265145|42233074|FG000|Overall Study|Withdrawal by Subject|23|||
19777705|NCT03265145|42233075|FG001|Overall Study|Withdrawal by Subject|19|||
19777706|NCT03265145|42233074|FG000|Overall Study|Death|12|||
19777707|NCT03265145|42233075|FG001|Overall Study|Death|12|||
19777708|NCT03265145|42233074|FG000|Overall Study|Lost to Follow-up|13|||
19777709|NCT03265145|42233075|FG001|Overall Study|Lost to Follow-up|9|||
19777710|NCT03265145|42233074|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
19777711|NCT03265145|42233075|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
19777712|NCT03265145|42233074|FG000|Overall Study|Switched back to previous medication|1|||
19777713|NCT03265145|42233075|FG001|Overall Study|Switched back to previous medication|0|||
19777714|NCT03265145|42233074|FG000|Overall Study|Did not want to take medication|1|||
19777715|NCT03265145|42233075|FG001|Overall Study|Did not want to take medication|0|||
19777716|NCT03265145|42233074|FG000|Overall Study|Subject could not afford medication|0|||
19777717|NCT03265145|42233075|FG001|Overall Study|Subject could not afford medication|1|||
19777718|NCT03265145|42233074|FG000|Overall Study|Site closed|2|||
19777719|NCT03265145|42233075|FG001|Overall Study|Site closed|3|||
19777720|NCT03265145|42233074|FG000|Overall Study|Incorrectly randomized|16|||
19777721|NCT03265145|42233075|FG001|Overall Study|Incorrectly randomized|6|||
19777722|NCT03265145|42233074|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
19777723|NCT03265145|42233075|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
19777724|NCT03265145|42233074|FG000|Overall Study|Physician Decision|0|||
19777725|NCT03265145|42233075|FG001|Overall Study|Physician Decision|3|||
19777726|NCT03265145|42233074|FG000|Overall Study|Subject transferred to another facility|0|||
19777727|NCT03265145|42233075|FG001|Overall Study|Subject transferred to another facility|1|||
19777728|NCT03064763|42233082|FG000|Overall Study|Ongoing in study|10|||
19777729|NCT03064763|42233082|FG000|Overall Study|Death|8|||
19777730|NCT02782676|42233086|FG000|Overall Study|Lost to Follow-up|0|||
19777731|NCT02782676|42233087|FG001|Overall Study|Lost to Follow-up|1|||
19777732|NCT02471339|42233095|FG000|Overall Study|Did not provide follow-up data|2|||
19777733|NCT02471339|42233096|FG001|Overall Study|Did not provide follow-up data|0|||
19777734|NCT00107978|42233104|FG000|Overall Study|Adverse Event|1|||
19777735|NCT00107978|42233105|FG001|Overall Study|Adverse Event|5|||
19777736|NCT00107978|42233104|FG000|Overall Study|Death|3|||
19777737|NCT00107978|42233105|FG001|Overall Study|Death|3|||
19777738|NCT00107978|42233104|FG000|Overall Study|Lost to Follow-up|20|||
19777739|NCT00107978|42233105|FG001|Overall Study|Lost to Follow-up|28|||
19777740|NCT00107978|42233104|FG000|Overall Study|Withdrawal by Subject|4|||
19777741|NCT00107978|42233105|FG001|Overall Study|Withdrawal by Subject|9|||
19777742|NCT00107978|42233104|FG000|Overall Study|Protocol Violation|0|||
19777743|NCT00107978|42233105|FG001|Overall Study|Protocol Violation|1|||
19777744|NCT00107978|42233104|FG000|Overall Study|Other|5|||
19777745|NCT00107978|42233105|FG001|Overall Study|Other|4|||
19777746|NCT02781818|42233114|FG000|Overall Study|Lost to Follow-up|4|||
19777747|NCT02781818|42233115|FG001|Overall Study|Lost to Follow-up|2|||
19777748|NCT02781818|42233116|FG002|Overall Study|Lost to Follow-up|1|||
19777749|NCT02927873|42233130|FG000|Overall Study|Lost to Follow-up|0|||
19777750|NCT02927873|42233131|FG001|Overall Study|Lost to Follow-up|1|||
19777751|NCT02927873|42233132|FG002|Overall Study|Lost to Follow-up|0|||
19777752|NCT02927873|42233133|FG003|Overall Study|Lost to Follow-up|0|||
19777753|NCT02927873|42233134|FG004|Overall Study|Lost to Follow-up|0|||
19777754|NCT02927873|42233135|FG005|Overall Study|Lost to Follow-up|0|||
19777755|NCT02927873|42233130|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19777756|NCT02927873|42233131|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
19777757|NCT02927873|42233132|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19606922|NCT00679939|42055667|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
19693217|NCT00357968|42138966|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
19693218|NCT00357968|42138967|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
19693219|NCT00357656|42138990|FG000|Overall Study|Other, No surgery performed|0|||
19693220|NCT00357656|42138991|FG001|Overall Study|Other, No surgery performed|3|||
19693221|NCT00357500|42139009|FG000|Overall Study|Adverse Event|3|||
19693222|NCT00357500|42139009|FG000|Overall Study|Withdrawal by Subject|5|||
19693223|NCT00357500|42139009|FG000|Overall Study|Progressive Disease|65|||
19606923|NCT00679939|42055666|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
19606924|NCT00679939|42055667|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
19606925|NCT00679939|42055666|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
19606926|NCT00679939|42055667|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
19606927|NCT00679939|42055666|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
19606928|NCT00679939|42055667|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
19606929|NCT00679939|42055666|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
19606930|NCT00679939|42055667|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
19606931|NCT00679939|42055666|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
19606932|NCT00679939|42055667|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
19606933|NCT00679939|42055666|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
19606934|NCT00679939|42055667|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
19606935|NCT00679939|42055666|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
19606936|NCT00679939|42055667|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
19606937|NCT00673933|42055677|FG000|Overall Study|Withdrawal by Subject|2|||
19606938|NCT00673933|42055677|FG000|Overall Study|Lost to Follow-up|1|||
19693224|NCT00357500|42139009|FG000|Overall Study|Not Started Protocol Therapy|4|||
19777758|NCT02927873|42233133|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19777759|NCT02927873|42233134|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19777760|NCT02927873|42233135|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
19777761|NCT02927873|42233130|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19777762|NCT02927873|42233131|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19777763|NCT02927873|42233132|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19777764|NCT02927873|42233133|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19777765|NCT02927873|42233134|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19777766|NCT02927873|42233135|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19777767|NCT02927873|42233130|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
19777768|NCT02927873|42233131|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
19777769|NCT02927873|42233132|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
19777770|NCT02927873|42233133|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
19777771|NCT02927873|42233134|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
19777772|NCT02927873|42233135|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
19777773|NCT02927873|42233130|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
19777774|NCT02927873|42233131|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
19777775|NCT02927873|42233132|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
19777776|NCT02927873|42233133|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
19777777|NCT02927873|42233134|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
19777778|NCT02927873|42233135|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
19777779|NCT02927873|42233130|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
19777780|NCT02927873|42233131|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
19777781|NCT02927873|42233132|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
19777782|NCT02927873|42233133|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
19777783|NCT02927873|42233134|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
19777784|NCT02927873|42233135|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
19777785|NCT01220999|42233154|FG000|Overall Study|Progressive disease|0|||
19777786|NCT01220999|42233155|FG001|Overall Study|Progressive disease|0|||
19777787|NCT01220999|42233156|FG002|Overall Study|Progressive disease|1|||
19777788|NCT01220999|42233157|FG003|Overall Study|Progressive disease|0|||
19777789|NCT01220999|42233158|FG004|Overall Study|Progressive disease|0|||
19777790|NCT00142415|42233176|FG000|Overall Study|Physician Decision|0|||
19777791|NCT00142415|42233177|FG001|Overall Study|Physician Decision|0|||
19777792|NCT00142415|42233178|FG002|Overall Study|Physician Decision|0|||
19777793|NCT00142415|42233179|FG003|Overall Study|Physician Decision|0|||
19777794|NCT00142415|42233180|FG004|Overall Study|Physician Decision|1|||
19777795|NCT00142415|42233181|FG005|Overall Study|Physician Decision|2|||
19777796|NCT02781584|42233223|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
19777797|NCT02781584|42233224|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
19777798|NCT02781584|42233225|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
19777799|NCT02781584|42233226|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
19777800|NCT02781584|42233227|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
19777801|NCT02781584|42233228|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
19777802|NCT02781584|42233229|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
19777803|NCT02781584|42233230|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
19777804|NCT02781584|42233231|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
19606939|NCT00571519|42055690|FG000|Overall Study|Subject withdrew consent|0|||
19606940|NCT00571519|42055691|FG001|Overall Study|Subject withdrew consent|1|||
19693225|NCT00357110|42139015|FG000|Overall Study|Early study termination|5|||
19693226|NCT00357110|42139016|FG001|Overall Study|Early study termination|5|||
19693227|NCT00098722|42139025|FG000|Double Blind Phase|Adverse Event|7|||
19693228|NCT00098722|42139026|FG001|Double Blind Phase|Adverse Event|7|||
19693229|NCT00098722|42139027|FG002|Double Blind Phase|Adverse Event|3|||
19693230|NCT00098722|42139028|FG003|Double Blind Phase|Adverse Event|0|||
19606941|NCT00571519|42055692|FG002|Overall Study|Subject withdrew consent|0|||
19606942|NCT00571519|42055693|FG003|Overall Study|Subject withdrew consent|2|||
19606943|NCT00571519|42055694|FG004|Overall Study|Subject withdrew consent|1|||
19606944|NCT00571519|42055695|FG005|Overall Study|Subject withdrew consent|1|||
19606945|NCT00571519|42055696|FG006|Overall Study|Subject withdrew consent|2|||
19606946|NCT00571519|42055690|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
19606947|NCT00571519|42055691|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
19606948|NCT00571519|42055692|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
19606949|NCT00571519|42055693|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
19606950|NCT00571519|42055694|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
19606951|NCT00571519|42055695|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
19693231|NCT00098722|42139029|FG004|Double Blind Phase|Adverse Event|0|||
19693232|NCT00098722|42139030|FG005|Double Blind Phase|Adverse Event|0|||
19606952|NCT00571519|42055696|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
19693233|NCT00098722|42139031|FG006|Double Blind Phase|Adverse Event|0|||
19693234|NCT00098722|42139025|FG000|Double Blind Phase|Death|2|||
19693235|NCT00098722|42139026|FG001|Double Blind Phase|Death|5|||
19693236|NCT00098722|42139027|FG002|Double Blind Phase|Death|0|||
19693237|NCT00098722|42139028|FG003|Double Blind Phase|Death|0|||
19693238|NCT00098722|42139029|FG004|Double Blind Phase|Death|0|||
19693239|NCT00098722|42139030|FG005|Double Blind Phase|Death|0|||
19693240|NCT00098722|42139031|FG006|Double Blind Phase|Death|0|||
19693241|NCT00098722|42139025|FG000|Double Blind Phase|Lack of Efficacy|21|||
19693242|NCT00098722|42139026|FG001|Double Blind Phase|Lack of Efficacy|23|||
19693243|NCT00098722|42139027|FG002|Double Blind Phase|Lack of Efficacy|15|||
19693244|NCT00098722|42139028|FG003|Double Blind Phase|Lack of Efficacy|0|||
19693245|NCT00098722|42139029|FG004|Double Blind Phase|Lack of Efficacy|0|||
19693246|NCT00098722|42139030|FG005|Double Blind Phase|Lack of Efficacy|0|||
19693247|NCT00098722|42139031|FG006|Double Blind Phase|Lack of Efficacy|0|||
19693248|NCT00098722|42139025|FG000|Double Blind Phase|Participant defaulted|16|||
19693249|NCT00098722|42139026|FG001|Double Blind Phase|Participant defaulted|11|||
19693250|NCT00098722|42139027|FG002|Double Blind Phase|Participant defaulted|9|||
19693251|NCT00098722|42139028|FG003|Double Blind Phase|Participant defaulted|0|||
19693252|NCT00098722|42139029|FG004|Double Blind Phase|Participant defaulted|0|||
19693253|NCT00098722|42139030|FG005|Double Blind Phase|Participant defaulted|0|||
19693254|NCT00098722|42139031|FG006|Double Blind Phase|Participant defaulted|0|||
19693255|NCT00098722|42139025|FG000|Double Blind Phase|Pregnancy|1|||
19693256|NCT00098722|42139026|FG001|Double Blind Phase|Pregnancy|0|||
19693257|NCT00098722|42139027|FG002|Double Blind Phase|Pregnancy|0|||
19693258|NCT00098722|42139028|FG003|Double Blind Phase|Pregnancy|0|||
19693259|NCT00098722|42139029|FG004|Double Blind Phase|Pregnancy|0|||
19693260|NCT00098722|42139030|FG005|Double Blind Phase|Pregnancy|0|||
19693261|NCT00098722|42139031|FG006|Double Blind Phase|Pregnancy|0|||
19693262|NCT00098722|42139025|FG000|Double Blind Phase|Randomized, not treated|4|||
19693263|NCT00098722|42139026|FG001|Double Blind Phase|Randomized, not treated|3|||
19693264|NCT00098722|42139027|FG002|Double Blind Phase|Randomized, not treated|3|||
19693265|NCT00098722|42139028|FG003|Double Blind Phase|Randomized, not treated|0|||
19693266|NCT00098722|42139029|FG004|Double Blind Phase|Randomized, not treated|0|||
19693267|NCT00098722|42139030|FG005|Double Blind Phase|Randomized, not treated|0|||
19693268|NCT00098722|42139031|FG006|Double Blind Phase|Randomized, not treated|0|||
19693269|NCT00098722|42139025|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
19693270|NCT00098722|42139026|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
19693271|NCT00098722|42139027|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
19693272|NCT00098722|42139028|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
19693273|NCT00098722|42139029|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
19693274|NCT00098722|42139030|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
19693275|NCT00098722|42139031|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
19693276|NCT00098722|42139025|FG000|Double Blind Phase|Other|7|||
19693277|NCT00098722|42139026|FG001|Double Blind Phase|Other|8|||
19693278|NCT00098722|42139027|FG002|Double Blind Phase|Other|7|||
19693279|NCT00098722|42139028|FG003|Double Blind Phase|Other|0|||
19693280|NCT00098722|42139029|FG004|Double Blind Phase|Other|0|||
19693281|NCT00098722|42139030|FG005|Double Blind Phase|Other|0|||
19693282|NCT00098722|42139031|FG006|Double Blind Phase|Other|0|||
19693283|NCT00098722|42139025|FG000|Open Label Phase|Adverse Event|0|||
19693284|NCT00098722|42139026|FG001|Open Label Phase|Adverse Event|0|||
19693285|NCT00098722|42139027|FG002|Open Label Phase|Adverse Event|0|||
19693286|NCT00098722|42139028|FG003|Open Label Phase|Adverse Event|5|||
19693287|NCT00098722|42139029|FG004|Open Label Phase|Adverse Event|0|||
19693288|NCT00098722|42139030|FG005|Open Label Phase|Adverse Event|0|||
19693289|NCT00098722|42139031|FG006|Open Label Phase|Adverse Event|0|||
19693290|NCT00098722|42139025|FG000|Open Label Phase|Death|0|||
19693291|NCT00098722|42139026|FG001|Open Label Phase|Death|0|||
19693292|NCT00098722|42139027|FG002|Open Label Phase|Death|0|||
19693293|NCT00098722|42139028|FG003|Open Label Phase|Death|2|||
19693294|NCT00098722|42139029|FG004|Open Label Phase|Death|0|||
19693295|NCT00098722|42139030|FG005|Open Label Phase|Death|0|||
19693296|NCT00098722|42139031|FG006|Open Label Phase|Death|0|||
19693297|NCT00098722|42139025|FG000|Open Label Phase|Lack of Efficacy|0|||
19606953|NCT00571519|42055690|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
19606954|NCT00571519|42055691|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
19606955|NCT00571519|42055692|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
19606956|NCT00571519|42055693|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
19606957|NCT00571519|42055694|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
19606958|NCT00571519|42055695|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
19606959|NCT00571519|42055696|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
19693298|NCT00098722|42139026|FG001|Open Label Phase|Lack of Efficacy|0|||
19693299|NCT00098722|42139027|FG002|Open Label Phase|Lack of Efficacy|0|||
19693300|NCT00098722|42139028|FG003|Open Label Phase|Lack of Efficacy|8|||
19693301|NCT00098722|42139029|FG004|Open Label Phase|Lack of Efficacy|0|||
19693302|NCT00098722|42139030|FG005|Open Label Phase|Lack of Efficacy|0|||
19777805|NCT02781584|42233232|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
19777806|NCT02781584|42233233|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
19777807|NCT02781584|42233234|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
19777808|NCT02781584|42233235|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
19777809|NCT02781584|42233223|FG000|Pre-treatment Phase|Adverse Event|0|||
19777810|NCT02781584|42233224|FG001|Pre-treatment Phase|Adverse Event|0|||
19777811|NCT02781584|42233225|FG002|Pre-treatment Phase|Adverse Event|0|||
19777812|NCT02781584|42233226|FG003|Pre-treatment Phase|Adverse Event|0|||
19777813|NCT02781584|42233227|FG004|Pre-treatment Phase|Adverse Event|0|||
19777814|NCT02781584|42233228|FG005|Pre-treatment Phase|Adverse Event|0|||
19777815|NCT02781584|42233229|FG006|Pre-treatment Phase|Adverse Event|0|||
19777816|NCT02781584|42233230|FG007|Pre-treatment Phase|Adverse Event|0|||
19777817|NCT02781584|42233231|FG008|Pre-treatment Phase|Adverse Event|0|||
19777818|NCT02781584|42233232|FG009|Pre-treatment Phase|Adverse Event|0|||
19777819|NCT02781584|42233233|FG010|Pre-treatment Phase|Adverse Event|0|||
19777820|NCT02781584|42233234|FG011|Pre-treatment Phase|Adverse Event|1|||
19777821|NCT02781584|42233235|FG012|Pre-treatment Phase|Adverse Event|0|||
19777822|NCT02781584|42233223|FG000|Treatment Phase|Withdrew Consent|0|||
19777823|NCT02781584|42233224|FG001|Treatment Phase|Withdrew Consent|0|||
19777824|NCT02781584|42233225|FG002|Treatment Phase|Withdrew Consent|0|||
19777825|NCT02781584|42233226|FG003|Treatment Phase|Withdrew Consent|0|||
19777826|NCT02781584|42233227|FG004|Treatment Phase|Withdrew Consent|0|||
19777827|NCT02781584|42233228|FG005|Treatment Phase|Withdrew Consent|1|||
19777828|NCT02781584|42233229|FG006|Treatment Phase|Withdrew Consent|0|||
19777829|NCT02781584|42233230|FG007|Treatment Phase|Withdrew Consent|0|||
19777830|NCT02781584|42233231|FG008|Treatment Phase|Withdrew Consent|0|||
19777831|NCT02781584|42233232|FG009|Treatment Phase|Withdrew Consent|0|||
19777832|NCT02781584|42233233|FG010|Treatment Phase|Withdrew Consent|1|||
19777833|NCT02781584|42233234|FG011|Treatment Phase|Withdrew Consent|2|||
19777834|NCT02781584|42233235|FG012|Treatment Phase|Withdrew Consent|0|||
19777835|NCT02781584|42233223|FG000|Treatment Phase|Adverse Event|0|||
19777836|NCT02781584|42233224|FG001|Treatment Phase|Adverse Event|0|||
19777837|NCT02781584|42233225|FG002|Treatment Phase|Adverse Event|0|||
19777838|NCT02781584|42233226|FG003|Treatment Phase|Adverse Event|0|||
19777839|NCT02781584|42233227|FG004|Treatment Phase|Adverse Event|0|||
19777840|NCT02781584|42233228|FG005|Treatment Phase|Adverse Event|0|||
19777841|NCT02781584|42233229|FG006|Treatment Phase|Adverse Event|0|||
19777842|NCT02781584|42233230|FG007|Treatment Phase|Adverse Event|1|||
19777843|NCT02781584|42233231|FG008|Treatment Phase|Adverse Event|0|||
19777844|NCT02781584|42233232|FG009|Treatment Phase|Adverse Event|0|||
19777845|NCT02781584|42233233|FG010|Treatment Phase|Adverse Event|0|||
19777846|NCT02781584|42233234|FG011|Treatment Phase|Adverse Event|0|||
19777847|NCT02781584|42233235|FG012|Treatment Phase|Adverse Event|0|||
19777848|NCT02776670|42233265|FG000|Overall Study|Adverse Event|0|||
19777849|NCT02776670|42233266|FG001|Overall Study|Adverse Event|2|||
19777850|NCT02776670|42233265|FG000|Overall Study|Protocol Violation|0|||
19777851|NCT02776670|42233266|FG001|Overall Study|Protocol Violation|2|||
19777852|NCT02776670|42233265|FG000|Overall Study|Withdrawal by Subject|0|||
19777853|NCT02776670|42233266|FG001|Overall Study|Withdrawal by Subject|1|||
19777854|NCT02776670|42233265|FG000|Overall Study|Other - Reason not given|0|||
19777855|NCT02776670|42233266|FG001|Overall Study|Other - Reason not given|1|||
19693303|NCT00098722|42139031|FG006|Open Label Phase|Lack of Efficacy|0|||
19693304|NCT00098722|42139025|FG000|Open Label Phase|Pregnancy|0|||
19693305|NCT00098722|42139026|FG001|Open Label Phase|Pregnancy|0|||
19693306|NCT00098722|42139027|FG002|Open Label Phase|Pregnancy|0|||
19693307|NCT00098722|42139028|FG003|Open Label Phase|Pregnancy|1|||
19693308|NCT00098722|42139029|FG004|Open Label Phase|Pregnancy|0|||
19693309|NCT00098722|42139030|FG005|Open Label Phase|Pregnancy|0|||
19693310|NCT00098722|42139031|FG006|Open Label Phase|Pregnancy|0|||
19693311|NCT00098722|42139025|FG000|Open Label Phase|Participant defaulted|0|||
19693312|NCT00098722|42139026|FG001|Open Label Phase|Participant defaulted|0|||
19693313|NCT00098722|42139027|FG002|Open Label Phase|Participant defaulted|0|||
19693314|NCT00098722|42139028|FG003|Open Label Phase|Participant defaulted|18|||
19693315|NCT00098722|42139029|FG004|Open Label Phase|Participant defaulted|0|||
19693316|NCT00098722|42139030|FG005|Open Label Phase|Participant defaulted|0|||
19693317|NCT00098722|42139031|FG006|Open Label Phase|Participant defaulted|0|||
19693318|NCT00098722|42139025|FG000|Open Label Phase|Ongoing at cut-off date|0|||
19693319|NCT00098722|42139026|FG001|Open Label Phase|Ongoing at cut-off date|0|||
19693320|NCT00098722|42139027|FG002|Open Label Phase|Ongoing at cut-off date|0|||
19693321|NCT00098722|42139028|FG003|Open Label Phase|Ongoing at cut-off date|220|||
19693322|NCT00098722|42139029|FG004|Open Label Phase|Ongoing at cut-off date|50|||
19693323|NCT00098722|42139030|FG005|Open Label Phase|Ongoing at cut-off date|0|||
19693324|NCT00098722|42139031|FG006|Open Label Phase|Ongoing at cut-off date|0|||
19693325|NCT00098722|42139025|FG000|Open Label Phase|Other|0|||
19693326|NCT00098722|42139026|FG001|Open Label Phase|Other|0|||
19693327|NCT00098722|42139027|FG002|Open Label Phase|Other|0|||
19693328|NCT00098722|42139028|FG003|Open Label Phase|Other|18|||
19693329|NCT00098722|42139029|FG004|Open Label Phase|Other|0|||
19693330|NCT00098722|42139030|FG005|Open Label Phase|Other|0|||
19777856|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
19777857|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
19777858|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
19777859|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19693331|NCT00098722|42139031|FG006|Open Label Phase|Other|0|||
19693332|NCT00098722|42139025|FG000|Observation Phase|Death|0|||
19693333|NCT00098722|42139026|FG001|Observation Phase|Death|0|||
19693334|NCT00098722|42139027|FG002|Observation Phase|Death|0|||
19693335|NCT00098722|42139028|FG003|Observation Phase|Death|0|||
19693336|NCT00098722|42139029|FG004|Observation Phase|Death|0|||
19693337|NCT00098722|42139030|FG005|Observation Phase|Death|5|||
19693338|NCT00098722|42139031|FG006|Observation Phase|Death|3|||
19693339|NCT00098722|42139025|FG000|Observation Phase|Lack of Efficacy|0|||
19693340|NCT00098722|42139026|FG001|Observation Phase|Lack of Efficacy|0|||
19693341|NCT00098722|42139027|FG002|Observation Phase|Lack of Efficacy|0|||
19693342|NCT00098722|42139028|FG003|Observation Phase|Lack of Efficacy|0|||
19777860|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19777861|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19777862|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19777863|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19777864|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19777865|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
19777866|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
19777867|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
19777868|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777869|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777870|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777871|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777872|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777873|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19777874|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
19777875|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
19777876|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
19777877|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777878|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777879|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777880|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777881|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777882|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19777883|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777884|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777885|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
19777886|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777887|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777888|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777889|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777890|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777891|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19777892|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
19777893|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
19777894|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
19777895|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777896|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777897|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777898|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777899|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777900|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19777901|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
19777902|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777903|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19606960|NCT00571519|42055690|FG000|Overall Study|Termination of study by Sponsor|2|||
19606961|NCT00571519|42055691|FG001|Overall Study|Termination of study by Sponsor|7|||
19606962|NCT00571519|42055692|FG002|Overall Study|Termination of study by Sponsor|10|||
19606963|NCT00571519|42055693|FG003|Overall Study|Termination of study by Sponsor|24|||
19606964|NCT00571519|42055694|FG004|Overall Study|Termination of study by Sponsor|8|||
19693343|NCT00098722|42139029|FG004|Observation Phase|Lack of Efficacy|0|||
19777904|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777905|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777906|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777907|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777908|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777909|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19777910|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
19777911|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
19777912|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777913|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777914|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777915|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777916|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777917|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777918|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19777919|NCT01307423|42233275|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777920|NCT01307423|42233276|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
19777921|NCT01307423|42233277|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
19777922|NCT01307423|42233278|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777923|NCT01307423|42233279|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777924|NCT01307423|42233280|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777925|NCT01307423|42233281|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777926|NCT01307423|42233282|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777927|NCT01307423|42233283|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
19777928|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
19777929|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
19777930|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
19777931|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
19777932|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
19777933|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
19777934|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
19777935|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
19777936|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
19777937|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
19777938|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
19777939|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
19777940|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
19777941|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
19777942|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
19777943|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
19777944|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
19777945|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
19777946|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777947|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777948|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777949|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777950|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777951|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
19777952|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777953|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777954|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
19777955|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
19777956|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
19777957|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
19777958|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
19777959|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
19777960|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
19777961|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
19777962|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
19777963|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
19777964|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777965|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777966|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777967|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
19777968|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777969|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777970|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777971|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777972|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
19777973|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
19777974|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
19777975|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
19777976|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
19777977|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
19777978|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
19777979|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
19777980|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
19777981|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
19777982|NCT01307423|42233275|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777983|NCT01307423|42233276|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777984|NCT01307423|42233277|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777985|NCT01307423|42233278|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777986|NCT01307423|42233279|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777987|NCT01307423|42233280|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
19777988|NCT01307423|42233281|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777989|NCT01307423|42233282|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777990|NCT01307423|42233283|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
19777991|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19777992|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
19777993|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
19777994|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19693344|NCT00098722|42139030|FG005|Observation Phase|Lack of Efficacy|2|||
19693345|NCT00098722|42139031|FG006|Observation Phase|Lack of Efficacy|0|||
19693346|NCT00098722|42139025|FG000|Observation Phase|Participant defaulted|0|||
19693347|NCT00098722|42139026|FG001|Observation Phase|Participant defaulted|0|||
19693348|NCT00098722|42139027|FG002|Observation Phase|Participant defaulted|0|||
19693349|NCT00098722|42139028|FG003|Observation Phase|Participant defaulted|0|||
19693350|NCT00098722|42139029|FG004|Observation Phase|Participant defaulted|0|||
19693351|NCT00098722|42139030|FG005|Observation Phase|Participant defaulted|17|||
19777995|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19777996|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19777997|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
19777998|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
19777999|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
19778000|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19778001|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
19778002|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
19778003|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19778004|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19778005|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19693352|NCT00098722|42139031|FG006|Observation Phase|Participant defaulted|4|||
19693353|NCT00098722|42139025|FG000|Observation Phase|Other|0|||
19693354|NCT00098722|42139026|FG001|Observation Phase|Other|0|||
19778006|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
19778007|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
19778008|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
19778009|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778010|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778011|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
19778012|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778013|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778014|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778015|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778016|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778017|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
19778018|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19778019|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
19778020|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
19778021|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19778022|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19778023|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19693355|NCT00098722|42139027|FG002|Observation Phase|Other|0|||
19778024|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19693356|NCT00098722|42139028|FG003|Observation Phase|Other|0|||
19778025|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
19778026|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
19778027|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778028|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
19778029|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778030|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778031|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778032|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778033|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
19778034|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
19778035|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
19778036|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19778037|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
19778038|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
19778039|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19778040|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19778041|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19778042|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
19778043|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
19778044|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
19778045|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19778046|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
19778047|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
19778048|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19778049|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19778050|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19778051|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
19693357|NCT00098722|42139029|FG004|Observation Phase|Other|0|||
19693358|NCT00098722|42139030|FG005|Observation Phase|Other|21|||
19693359|NCT00098722|42139031|FG006|Observation Phase|Other|10|||
19693360|NCT00098254|42139043|FG000|Overall Study|Adverse Event|2|||
19693361|NCT00098254|42139043|FG000|Overall Study|Death|1|||
19693362|NCT00095056|42139049|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
19693363|NCT00095056|42139050|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
19693364|NCT00095056|42139049|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
19778052|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
19778053|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
19778054|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778055|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
19778056|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
19778057|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778058|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778059|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778060|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778061|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778062|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
19778063|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19778064|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
19778065|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
19778066|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19778067|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19778068|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19778069|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19693365|NCT00095056|42139050|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
19693366|NCT00095056|42139049|FG000|Phase A (Weeks 0-12)|Death|1|||
19693367|NCT00095056|42139050|FG001|Phase A (Weeks 0-12)|Death|0|||
19778070|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
19778071|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
19778072|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19778073|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
19778074|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
19778075|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19778076|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19778077|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19778078|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
19778079|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
19778080|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
19693368|NCT00095056|42139049|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
19693369|NCT00095056|42139050|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
19778081|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778082|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
19778083|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19606965|NCT00571519|42055695|FG005|Overall Study|Termination of study by Sponsor|9|||
19606966|NCT00571519|42055696|FG006|Overall Study|Termination of study by Sponsor|22|||
19606967|NCT00571519|42055690|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606968|NCT00571519|42055691|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606969|NCT00571519|42055692|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
19606970|NCT00571519|42055693|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606971|NCT00571519|42055694|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606972|NCT00571519|42055695|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606973|NCT00571519|42055696|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
19606974|NCT00676195|42055712|FG000|Overall Study|Lost to Follow-up|1|||
19606975|NCT00676195|42055712|FG000|Overall Study|Adverse Event|1|||
19606976|NCT00676195|42055712|FG000|Overall Study|Physician Decision|1|||
19606977|NCT00675103|42055717|FG000|Overall Study|Lack of Efficacy|2|||
19606978|NCT00675103|42055717|FG000|Overall Study|Adverse Event|1|||
19606979|NCT00675025|42055723|FG000|Overall Study|Study Terminated by Sponsor|38|||
19606980|NCT00675025|42055724|FG001|Overall Study|Study Terminated by Sponsor|42|||
19606981|NCT00675025|42055723|FG000|Overall Study|Adverse Event|6|||
19606982|NCT00675025|42055724|FG001|Overall Study|Adverse Event|11|||
19606983|NCT00675025|42055723|FG000|Overall Study|Lost to Follow-up|6|||
19606984|NCT00675025|42055724|FG001|Overall Study|Lost to Follow-up|4|||
19606985|NCT00675025|42055723|FG000|Overall Study|Withdrawal by Subject|4|||
19606986|NCT00675025|42055724|FG001|Overall Study|Withdrawal by Subject|6|||
19606987|NCT00678379|42055742|FG000|Overall Study|Injection performed after tonsillectomy|2|||
19606988|NCT00678379|42055743|FG001|Overall Study|Injection performed after tonsillectomy|0|||
19606989|NCT00678379|42055744|FG002|Overall Study|Injection performed after tonsillectomy|1|||
19606990|NCT00678379|42055742|FG000|Overall Study|Incomplete Data|4|||
19606991|NCT00678379|42055743|FG001|Overall Study|Incomplete Data|3|||
19606992|NCT00678379|42055744|FG002|Overall Study|Incomplete Data|3|||
19606993|NCT00674323|42055755|FG000|Overall Study|Adverse Event|0|||
19606994|NCT00674323|42055756|FG001|Overall Study|Adverse Event|1|||
19606995|NCT00674323|42055757|FG002|Overall Study|Adverse Event|0|||
19606996|NCT00674323|42055755|FG000|Overall Study|Protocol Violation|1|||
19606997|NCT00674323|42055756|FG001|Overall Study|Protocol Violation|0|||
19606998|NCT00674323|42055757|FG002|Overall Study|Protocol Violation|0|||
19606999|NCT00678301|42055767|FG000|Overall Study|Non-compliance with study procedures|0|||
19607000|NCT00678301|42055768|FG001|Overall Study|Non-compliance with study procedures|1|||
19607001|NCT00678301|42055767|FG000|Overall Study|Adverse Event|1|||
19607002|NCT00678301|42055768|FG001|Overall Study|Adverse Event|0|||
19607003|NCT00678301|42055767|FG000|Overall Study|Withdrawal by Subject|4|||
19607004|NCT00678301|42055768|FG001|Overall Study|Withdrawal by Subject|0|||
19607005|NCT00678301|42055767|FG000|Overall Study|Lost to Follow-up|3|||
19607006|NCT00678301|42055768|FG001|Overall Study|Lost to Follow-up|1|||
19607007|NCT00939770|42055782|FG000|Overall Study|Adverse Event|1|||
19607008|NCT00939770|42055783|FG001|Overall Study|Adverse Event|1|||
19607009|NCT00939770|42055784|FG002|Overall Study|Adverse Event|0|||
19607010|NCT00939770|42055785|FG003|Overall Study|Adverse Event|0|||
19607011|NCT00939770|42055786|FG004|Overall Study|Adverse Event|6|||
19607012|NCT00939770|42055787|FG005|Overall Study|Adverse Event|2|||
19607013|NCT00939770|42055788|FG006|Overall Study|Adverse Event|1|||
19607014|NCT00939770|42055789|FG007|Overall Study|Adverse Event|1|||
19607015|NCT00939770|42055782|FG000|Overall Study|Lack of Efficacy|4|||
19607016|NCT00939770|42055783|FG001|Overall Study|Lack of Efficacy|6|||
19607017|NCT00939770|42055784|FG002|Overall Study|Lack of Efficacy|13|||
19607018|NCT00939770|42055785|FG003|Overall Study|Lack of Efficacy|9|||
19607019|NCT00939770|42055786|FG004|Overall Study|Lack of Efficacy|16|||
19607020|NCT00939770|42055787|FG005|Overall Study|Lack of Efficacy|8|||
19607021|NCT00939770|42055788|FG006|Overall Study|Lack of Efficacy|11|||
19607022|NCT00939770|42055789|FG007|Overall Study|Lack of Efficacy|1|||
19607023|NCT00939770|42055782|FG000|Overall Study|Lost to Follow-up|0|||
19607024|NCT00939770|42055783|FG001|Overall Study|Lost to Follow-up|0|||
19607025|NCT00939770|42055784|FG002|Overall Study|Lost to Follow-up|0|||
19607026|NCT00939770|42055785|FG003|Overall Study|Lost to Follow-up|0|||
19607027|NCT00939770|42055786|FG004|Overall Study|Lost to Follow-up|1|||
19607028|NCT00939770|42055787|FG005|Overall Study|Lost to Follow-up|0|||
19607029|NCT00939770|42055788|FG006|Overall Study|Lost to Follow-up|0|||
19607030|NCT00939770|42055789|FG007|Overall Study|Lost to Follow-up|0|||
19693370|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
19693371|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
19693372|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
19693373|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
19607031|NCT00939770|42055782|FG000|Overall Study|Physician Decision|0|||
19607032|NCT00939770|42055783|FG001|Overall Study|Physician Decision|0|||
19778084|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778085|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778086|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778087|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778088|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
19778089|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
19778090|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778091|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
19778092|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778093|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778094|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778095|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778096|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778097|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778098|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
19778099|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778100|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
19778101|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778102|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778103|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778104|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778105|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778106|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
19778107|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
19778108|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19778109|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
19778110|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
19778111|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19778112|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19778113|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19778114|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19778115|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
19778116|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
19778117|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19693374|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
19693375|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
19778118|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778119|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
19778120|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778121|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778122|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778123|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778124|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778125|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
19778126|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778127|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778128|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778129|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778130|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778131|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778132|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778133|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
19778134|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
19778135|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778136|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
19778137|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
19778138|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778139|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778140|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778141|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778142|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
19778143|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
19693376|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
19693377|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
19693378|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Death|3|||
19693379|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Death|1|||
19693380|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
19693381|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
19693382|NCT00095056|42139049|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
19693383|NCT00095056|42139050|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
19778144|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778145|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
19778146|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
19778147|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778148|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778149|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778150|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778151|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778152|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
19778153|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778154|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
19778155|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
19778156|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778157|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778158|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778159|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778160|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19778161|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
19778162|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778163|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
19778164|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778165|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778166|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778167|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778168|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778169|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19693384|NCT00098020|42139056|FG000|Overall Study|Adverse Event|2|||
19693385|NCT00098020|42139056|FG000|Overall Study|Lost to Follow-up|1|||
19778170|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
19778171|NCT01307423|42233275|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778172|NCT01307423|42233276|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778173|NCT01307423|42233277|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
19778174|NCT01307423|42233278|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778175|NCT01307423|42233279|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778176|NCT01307423|42233280|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778177|NCT01307423|42233281|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
19778178|NCT01307423|42233282|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
19778179|NCT01307423|42233283|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
19778180|NCT02778074|42233317|FG000|Overall Study|Lost to Follow-up|7|||
19778181|NCT02778074|42233318|FG001|Overall Study|Lost to Follow-up|10|||
19778182|NCT02768792|42233333|FG000|Overall Study|Adverse Event|1|||
19778183|NCT02775344|42233339|FG000|Overall Study|No ovarian cyst identified|3|||
19778184|NCT02775344|42233340|FG001|Overall Study|No ovarian cyst identified|2|||
19778185|NCT02777918|42233348|FG000|Overall Study|Medical reasons|1|||
19778186|NCT02777918|42233349|FG001|Overall Study|Medical reasons|2|||
19778187|NCT02777918|42233348|FG000|Overall Study|Too busy / stressed|1|||
19778188|NCT02777918|42233349|FG001|Overall Study|Too busy / stressed|1|||
19778189|NCT02777918|42233348|FG000|Overall Study|Withdrawal by Subject|1|||
19778190|NCT02777918|42233349|FG001|Overall Study|Withdrawal by Subject|1|||
19778191|NCT02927795|42233355|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
19778192|NCT02927795|42233355|FG000|Overall Study|Not Treated|4|||
19778193|NCT02767856|42233361|FG000|Overall Study|Lost to Follow-up|9|||
19778194|NCT02767856|42233362|FG001|Overall Study|Lost to Follow-up|1|||
19778195|NCT02767856|42233361|FG000|Overall Study|Withdrawal by Subject|2|||
19778196|NCT02767856|42233362|FG001|Overall Study|Withdrawal by Subject|1|||
19778197|NCT03087851|42233371|FG000|Overall Study|Withdraw on medical grounds|0|||
19778198|NCT03087851|42233372|FG001|Overall Study|Withdraw on medical grounds|1|||
19778199|NCT03087851|42233373|FG002|Overall Study|Withdraw on medical grounds|2|||
19778200|NCT03092375|42233385|FG000|Overall Study|Lack of Efficacy|0|||
19693386|NCT00098020|42139056|FG000|Overall Study|elevated liver enzymes|1|||
19693387|NCT00098020|42139056|FG000|Overall Study|Low urine PCR|1|||
19693388|NCT00098020|42139056|FG000|Overall Study|Low epidermal growth factor receptor|1|||
19693389|NCT00381680|42139062|FG000|Overall Study|Adverse Event|9|||
19693390|NCT00381680|42139063|FG001|Overall Study|Adverse Event|3|||
19693391|NCT00381680|42139062|FG000|Overall Study|Death|10|||
19693392|NCT00381680|42139063|FG001|Overall Study|Death|7|||
19693393|NCT00381680|42139062|FG000|Overall Study|Lost to Follow-up|3|||
19693394|NCT00381680|42139063|FG001|Overall Study|Lost to Follow-up|2|||
19693395|NCT00381680|42139062|FG000|Overall Study|Physician Decision|25|||
19778201|NCT03092375|42233386|FG001|Overall Study|Lack of Efficacy|1|||
19778202|NCT03092375|42233387|FG002|Overall Study|Lack of Efficacy|1|||
19693396|NCT00381680|42139063|FG001|Overall Study|Physician Decision|6|||
19778203|NCT03092375|42233388|FG003|Overall Study|Lack of Efficacy|0|||
19778204|NCT01995513|42233405|FG000|Open Label Treatment Period|Other|9|||
19778205|NCT01995513|42233406|FG001|Open Label Treatment Period|Other|0|||
19778206|NCT01995513|42233407|FG002|Open Label Treatment Period|Other|0|||
19778207|NCT01995513|42233405|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
19778208|NCT01995513|42233406|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
19778209|NCT01995513|42233407|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
19778210|NCT01995513|42233405|FG000|Open Label Treatment Period|Protocol Violation|1|||
19778211|NCT01995513|42233406|FG001|Open Label Treatment Period|Protocol Violation|0|||
19778212|NCT01995513|42233407|FG002|Open Label Treatment Period|Protocol Violation|0|||
19778213|NCT01995513|42233405|FG000|Open Label Treatment Period|Disease Progression|64|||
19778214|NCT01995513|42233406|FG001|Open Label Treatment Period|Disease Progression|0|||
19778215|NCT01995513|42233407|FG002|Open Label Treatment Period|Disease Progression|0|||
19778216|NCT01995513|42233405|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
19778217|NCT01995513|42233406|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
19778218|NCT01995513|42233407|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
19778219|NCT01995513|42233405|FG000|Open Label Treatment Period|Adverse Event|35|||
19778220|NCT01995513|42233406|FG001|Open Label Treatment Period|Adverse Event|0|||
19778221|NCT01995513|42233407|FG002|Open Label Treatment Period|Adverse Event|0|||
19778222|NCT01995513|42233405|FG000|Open Label Treatment Period|Death|8|||
19778223|NCT01995513|42233406|FG001|Open Label Treatment Period|Death|0|||
19778224|NCT01995513|42233407|FG002|Open Label Treatment Period|Death|0|||
19778225|NCT01995513|42233405|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
19778226|NCT01995513|42233406|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
19778227|NCT01995513|42233407|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
19778228|NCT01995513|42233405|FG000|Double Blind Treatment Period|Adverse Event|0|||
19778229|NCT01995513|42233406|FG001|Double Blind Treatment Period|Adverse Event|12|||
19778230|NCT01995513|42233407|FG002|Double Blind Treatment Period|Adverse Event|5|||
19778231|NCT01995513|42233405|FG000|Double Blind Treatment Period|Other|0|||
19778232|NCT01995513|42233406|FG001|Double Blind Treatment Period|Other|1|||
19778233|NCT01995513|42233407|FG002|Double Blind Treatment Period|Other|2|||
19778234|NCT01995513|42233405|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
19778235|NCT01995513|42233406|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
19693397|NCT00381680|42139062|FG000|Overall Study|Withdrawal by Subject|3|||
19693398|NCT00381680|42139063|FG001|Overall Study|Withdrawal by Subject|1|||
19693399|NCT00381680|42139062|FG000|Overall Study|Entry onto another COG Trial|1|||
19778236|NCT01995513|42233407|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
19778237|NCT01995513|42233405|FG000|Double Blind Treatment Period|Death|0|||
19778238|NCT01995513|42233406|FG001|Double Blind Treatment Period|Death|0|||
19778239|NCT01995513|42233407|FG002|Double Blind Treatment Period|Death|1|||
19778240|NCT01995513|42233405|FG000|Double Blind Treatment Period|Disease Progression|0|||
19778241|NCT01995513|42233406|FG001|Double Blind Treatment Period|Disease Progression|82|||
19778242|NCT01995513|42233407|FG002|Double Blind Treatment Period|Disease Progression|93|||
19778243|NCT01995513|42233405|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
19778244|NCT01995513|42233406|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
19778245|NCT01995513|42233407|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
19778246|NCT02927171|42233419|FG000|Overall Study|Lost to Follow-up|0|||
19778247|NCT02927171|42233420|FG001|Overall Study|Lost to Follow-up|1|||
19778248|NCT03035409|42233426|FG000|Overall Study|Adverse Event|5|||
19778249|NCT03035409|42233426|FG000|Overall Study|Death|2|||
19778250|NCT03035409|42233426|FG000|Overall Study|Withdrawal by Subject|2|||
19778251|NCT03035409|42233426|FG000|Overall Study|Non compliance|4|||
19778252|NCT03035409|42233426|FG000|Overall Study|Patient was jittery|1|||
19778253|NCT03035409|42233426|FG000|Overall Study|Did not like Questionnaire|1|||
19778254|NCT03035409|42233426|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
19778255|NCT03035409|42233426|FG000|Overall Study|Did not like taking drugs|1|||
19778256|NCT03087617|42233434|FG000|Overall Study|Lost to Follow-up|32|||
19778257|NCT03087617|42233435|FG001|Overall Study|Lost to Follow-up|30|||
19778258|NCT03087617|42233436|FG002|Overall Study|Lost to Follow-up|30|||
19693400|NCT00381680|42139063|FG001|Overall Study|Entry onto another COG Trial|2|||
19693401|NCT00381680|42139062|FG000|Overall Study|Alternative Therapy|11|||
19693402|NCT00381680|42139063|FG001|Overall Study|Alternative Therapy|5|||
19693403|NCT00381680|42139062|FG000|Overall Study|Secondary Malignancy|3|||
19693404|NCT00381680|42139063|FG001|Overall Study|Secondary Malignancy|0|||
19693405|NCT00381680|42139062|FG000|Overall Study|Delay initiation|1|||
19693406|NCT00381680|42139063|FG001|Overall Study|Delay initiation|0|||
19693407|NCT00381680|42139062|FG000|Overall Study|Stem Cell Transplant|26|||
19778259|NCT03087617|42233437|FG003|Overall Study|Lost to Follow-up|39|||
19778260|NCT00103610|42233449|FG000|Overall Study|Entered Rescue Procedure|10|||
19778261|NCT00103610|42233450|FG001|Overall Study|Entered Rescue Procedure|52|||
19778262|NCT00103610|42233449|FG000|Overall Study|Death|16|||
19778263|NCT00103610|42233450|FG001|Overall Study|Death|12|||
19778264|NCT00103610|42233449|FG000|Overall Study|Elective Withdrawal|4|||
19778265|NCT00103610|42233450|FG001|Overall Study|Elective Withdrawal|0|||
19778266|NCT00103610|42233449|FG000|Overall Study|Lost to Follow-up|3|||
19778267|NCT00103610|42233450|FG001|Overall Study|Lost to Follow-up|1|||
19778268|NCT00103610|42233449|FG000|Overall Study|Adverse Event|2|||
19778269|NCT00103610|42233450|FG001|Overall Study|Adverse Event|2|||
19778270|NCT00103610|42233449|FG000|Overall Study|Other|2|||
19778271|NCT00103610|42233450|FG001|Overall Study|Other|7|||
19778272|NCT00103610|42233449|FG000|Overall Study|Failed mobilization|1|||
19778273|NCT00103610|42233450|FG001|Overall Study|Failed mobilization|5|||
19778274|NCT00103610|42233449|FG000|Overall Study|Noncompliance|0|||
19778275|NCT00103610|42233450|FG001|Overall Study|Noncompliance|1|||
19778276|NCT03091439|42233459|FG000|Overall Study|Study Terminated by the Sponsor|1|||
19778277|NCT03091439|42233460|FG001|Overall Study|Study Terminated by the Sponsor|0|||
19778278|NCT03086447|42233468|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19778279|NCT03086447|42233469|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
19778280|NCT03086447|42233468|FG000|Overall Study|Lost Lens|2|||
19778281|NCT03086447|42233469|FG001|Overall Study|Lost Lens|5|||
19778282|NCT03086447|42233468|FG000|Overall Study|Product quality complaint|0|||
19778283|NCT03086447|42233469|FG001|Overall Study|Product quality complaint|1|||
19778284|NCT03086447|42233468|FG000|Overall Study|Lens Damage|1|||
19778285|NCT03086447|42233469|FG001|Overall Study|Lens Damage|6|||
19778286|NCT03086447|42233468|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
19778287|NCT03086447|42233469|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
19778288|NCT03086447|42233468|FG000|Overall Study|Test Article No Longer Available|1|||
19778289|NCT03086447|42233469|FG001|Overall Study|Test Article No Longer Available|0|||
19778290|NCT03086447|42233468|FG000|Overall Study|Protocol Violation|2|||
19778291|NCT03086447|42233469|FG001|Overall Study|Protocol Violation|4|||
19778292|NCT03086447|42233468|FG000|Overall Study|Lost to Follow-up|0|||
19778293|NCT03086447|42233469|FG001|Overall Study|Lost to Follow-up|1|||
19778294|NCT03086447|42233468|FG000|Overall Study|Adverse Event|3|||
19778295|NCT03086447|42233469|FG001|Overall Study|Adverse Event|0|||
19778296|NCT03086447|42233468|FG000|Overall Study|Lens Discomfort|2|||
19778297|NCT03086447|42233469|FG001|Overall Study|Lens Discomfort|1|||
19778298|NCT03083639|42233500|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
19778299|NCT03083639|42233501|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
19778300|NCT03083639|42233500|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
19778301|NCT03083639|42233501|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
19778302|NCT02927431|42233510|FG000|Overall Study|Withdrawal by Subject|0|||
19778303|NCT02927431|42233511|FG001|Overall Study|Withdrawal by Subject|0|||
19778304|NCT02927431|42233512|FG002|Overall Study|Withdrawal by Subject|1|||
19778305|NCT03083483|42233525|FG000|Overall Study|Adverse Event|1|||
19778306|NCT03083483|42233526|FG001|Overall Study|Adverse Event|1|||
19778307|NCT03083483|42233527|FG002|Overall Study|Adverse Event|1|||
19778308|NCT03083483|42233525|FG000|Overall Study|Lost to Follow-up|2|||
19778309|NCT03083483|42233526|FG001|Overall Study|Lost to Follow-up|1|||
19778310|NCT03083483|42233527|FG002|Overall Study|Lost to Follow-up|1|||
19778311|NCT03083483|42233525|FG000|Overall Study|technological issues|1|||
19778312|NCT03083483|42233526|FG001|Overall Study|technological issues|0|||
19778313|NCT03083483|42233527|FG002|Overall Study|technological issues|1|||
19778314|NCT03085927|42233539|FG000|Overall Study|Withdrawal by Subject|1|||
19778315|NCT03085927|42233540|FG001|Overall Study|Withdrawal by Subject|4|||
19778316|NCT03085927|42233539|FG000|Overall Study|Lost to Follow-up|3|||
19778317|NCT03085927|42233540|FG001|Overall Study|Lost to Follow-up|1|||
19778318|NCT03085927|42233539|FG000|Overall Study|Death|1|||
19778319|NCT03085927|42233540|FG001|Overall Study|Death|0|||
19778320|NCT03085927|42233539|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
19778321|NCT03085927|42233540|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
19778322|NCT03085927|42233539|FG000|Overall Study|Dyad Became Ineligible|0|||
19778323|NCT03085927|42233540|FG001|Overall Study|Dyad Became Ineligible|1|||
19778324|NCT04392583|42233548|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
19778325|NCT04497987|42233554|FG000|Overall Study|Adverse Event|1|||
19778326|NCT04497987|42233555|FG001|Overall Study|Adverse Event|0|||
19778327|NCT04497987|42233554|FG000|Overall Study|Death|21|||
19778328|NCT04497987|42233555|FG001|Overall Study|Death|13|||
19778329|NCT04497987|42233554|FG000|Overall Study|Lost to Follow-up|19|||
19778330|NCT04497987|42233555|FG001|Overall Study|Lost to Follow-up|17|||
19778331|NCT04497987|42233554|FG000|Overall Study|Other - as reported by the investigator|22|||
19367251|NCT02435992|41607418|FG003|Overall Study|Withdrawal by Subject|0|||
19778332|NCT04497987|42233555|FG001|Overall Study|Other - as reported by the investigator|16|||
19778333|NCT04497987|42233554|FG000|Overall Study|Physician Decision|1|||
19778334|NCT04497987|42233555|FG001|Overall Study|Physician Decision|0|||
19778335|NCT04497987|42233554|FG000|Overall Study|Withdrawal by Subject|35|||
19778336|NCT04497987|42233555|FG001|Overall Study|Withdrawal by Subject|21|||
19778337|NCT00974571|42233565|FG000|Overall Study|Adverse Event|31|||
19778338|NCT00974571|42233566|FG001|Overall Study|Adverse Event|4|||
19778339|NCT00974571|42233567|FG002|Overall Study|Adverse Event|27|||
19778340|NCT00974571|42233565|FG000|Overall Study|Lack of Efficacy|3|||
19778341|NCT00974571|42233566|FG001|Overall Study|Lack of Efficacy|2|||
19778342|NCT00974571|42233567|FG002|Overall Study|Lack of Efficacy|9|||
19778343|NCT00974571|42233565|FG000|Overall Study|Lost to Follow-up|2|||
19778344|NCT00974571|42233566|FG001|Overall Study|Lost to Follow-up|1|||
19778345|NCT00974571|42233567|FG002|Overall Study|Lost to Follow-up|2|||
19778346|NCT00974571|42233565|FG000|Overall Study|Protocol Violation|13|||
19778347|NCT00974571|42233566|FG001|Overall Study|Protocol Violation|4|||
19778348|NCT00974571|42233567|FG002|Overall Study|Protocol Violation|18|||
19778349|NCT00974571|42233565|FG000|Overall Study|Withdrawal by Subject|14|||
19778350|NCT00974571|42233566|FG001|Overall Study|Withdrawal by Subject|5|||
19778351|NCT00974571|42233567|FG002|Overall Study|Withdrawal by Subject|16|||
19778352|NCT00974571|42233565|FG000|Overall Study|Patient Moved|1|||
19778353|NCT00974571|42233566|FG001|Overall Study|Patient Moved|0|||
19778354|NCT00974571|42233567|FG002|Overall Study|Patient Moved|1|||
19778355|NCT00974571|42233565|FG000|Overall Study|Other|4|||
19778356|NCT00974571|42233566|FG001|Overall Study|Other|0|||
19778357|NCT00974571|42233567|FG002|Overall Study|Other|10|||
19778358|NCT02766608|42233580|FG000|Overall Study|Adverse Event|27|||
19778359|NCT02766608|42233581|FG001|Overall Study|Adverse Event|22|||
19778360|NCT02766608|42233582|FG002|Overall Study|Adverse Event|17|||
19778361|NCT02766608|42233583|FG003|Overall Study|Adverse Event|13|||
19778362|NCT02766608|42233584|FG004|Overall Study|Adverse Event|12|||
19778363|NCT02766608|42233580|FG000|Overall Study|Withdrawal by Subject|21|||
19778364|NCT02766608|42233581|FG001|Overall Study|Withdrawal by Subject|20|||
19778365|NCT02766608|42233582|FG002|Overall Study|Withdrawal by Subject|24|||
19778366|NCT02766608|42233583|FG003|Overall Study|Withdrawal by Subject|13|||
19778367|NCT02766608|42233584|FG004|Overall Study|Withdrawal by Subject|10|||
19778368|NCT02766608|42233580|FG000|Overall Study|Lack of Efficacy|16|||
19778369|NCT02766608|42233581|FG001|Overall Study|Lack of Efficacy|15|||
19778370|NCT02766608|42233582|FG002|Overall Study|Lack of Efficacy|32|||
19778371|NCT02766608|42233583|FG003|Overall Study|Lack of Efficacy|8|||
19778372|NCT02766608|42233584|FG004|Overall Study|Lack of Efficacy|2|||
19778373|NCT02766608|42233580|FG000|Overall Study|Lost to Follow-up|6|||
19778374|NCT02766608|42233581|FG001|Overall Study|Lost to Follow-up|3|||
19778375|NCT02766608|42233582|FG002|Overall Study|Lost to Follow-up|5|||
19778376|NCT02766608|42233583|FG003|Overall Study|Lost to Follow-up|2|||
19778377|NCT02766608|42233584|FG004|Overall Study|Lost to Follow-up|2|||
19778378|NCT02766608|42233580|FG000|Overall Study|Physician Decision|3|||
19778379|NCT02766608|42233581|FG001|Overall Study|Physician Decision|2|||
19778380|NCT02766608|42233582|FG002|Overall Study|Physician Decision|3|||
19778381|NCT02766608|42233583|FG003|Overall Study|Physician Decision|1|||
19778382|NCT02766608|42233584|FG004|Overall Study|Physician Decision|2|||
19778383|NCT02766608|42233580|FG000|Overall Study|Protocol disc criteria|3|||
19778384|NCT02766608|42233581|FG001|Overall Study|Protocol disc criteria|3|||
19778385|NCT02766608|42233582|FG002|Overall Study|Protocol disc criteria|4|||
19778386|NCT02766608|42233583|FG003|Overall Study|Protocol disc criteria|0|||
19778387|NCT02766608|42233584|FG004|Overall Study|Protocol disc criteria|0|||
19778388|NCT02766608|42233580|FG000|Overall Study|Protocol Violation|0|||
19778389|NCT02766608|42233581|FG001|Overall Study|Protocol Violation|4|||
19778390|NCT02766608|42233582|FG002|Overall Study|Protocol Violation|4|||
19778391|NCT02766608|42233583|FG003|Overall Study|Protocol Violation|0|||
19778392|NCT02766608|42233584|FG004|Overall Study|Protocol Violation|1|||
19778393|NCT02766608|42233580|FG000|Overall Study|Administrative Reasons|3|||
19778394|NCT02766608|42233581|FG001|Overall Study|Administrative Reasons|1|||
19778395|NCT02766608|42233582|FG002|Overall Study|Administrative Reasons|1|||
19693408|NCT00381680|42139063|FG001|Overall Study|Stem Cell Transplant|10|||
19693409|NCT00381680|42139062|FG000|Overall Study|Relapse|18|||
19693410|NCT00381680|42139063|FG001|Overall Study|Relapse|9|||
19693411|NCT00381680|42139062|FG000|Overall Study|Induction Failure|4|||
19693412|NCT00381680|42139063|FG001|Overall Study|Induction Failure|1|||
19693413|NCT00381680|42139062|FG000|Overall Study|Progression|1|||
19693414|NCT00381680|42139063|FG001|Overall Study|Progression|1|||
19693415|NCT00381680|42139062|FG000|Overall Study|Other not otherwise specified|7|||
19693416|NCT00381680|42139063|FG001|Overall Study|Other not otherwise specified|2|||
19693417|NCT00381680|42139062|FG000|Overall Study|Ineligible|3|||
19693418|NCT00381680|42139063|FG001|Overall Study|Ineligible|1|||
19693419|NCT00360698|42139075|FG000|Run-In|Physician Decision|0|||
19693420|NCT00360698|42139076|FG001|Run-In|Physician Decision|1|||
19693421|NCT00360698|42139075|FG000|Run-In|Withdrawal by Subject|0|||
19778396|NCT02766608|42233583|FG003|Overall Study|Administrative Reasons|0|||
19693422|NCT00360698|42139076|FG001|Run-In|Withdrawal by Subject|2|||
19693423|NCT00360698|42139075|FG000|Run-In|Non compliance with treatment procedure|0|||
19693424|NCT00360698|42139076|FG001|Run-In|Non compliance with treatment procedure|1|||
19693425|NCT00360698|42139075|FG000|Run-In|Sponsor request|0|||
19693426|NCT00360698|42139076|FG001|Run-In|Sponsor request|2|||
19778397|NCT02766608|42233584|FG004|Overall Study|Administrative Reasons|0|||
19778398|NCT00960141|42233602|FG000|Overall Study|Adverse Event|4|||
19778399|NCT00960141|42233603|FG001|Overall Study|Adverse Event|8|||
19778400|NCT00960141|42233604|FG002|Overall Study|Adverse Event|2|||
19778401|NCT00960141|42233602|FG000|Overall Study|Lack of Efficacy|3|||
19778402|NCT00960141|42233603|FG001|Overall Study|Lack of Efficacy|4|||
19778403|NCT00960141|42233604|FG002|Overall Study|Lack of Efficacy|2|||
19693427|NCT00360698|42139075|FG000|Run-In|Patient did not meet inclusion criteria|0|||
19693428|NCT00360698|42139076|FG001|Run-In|Patient did not meet inclusion criteria|1|||
19693429|NCT00360698|42139075|FG000|Run-In|Patient personal reasons|0|||
19693430|NCT00360698|42139076|FG001|Run-In|Patient personal reasons|2|||
19693431|NCT00360698|42139075|FG000|Run-In|Need of insulin with meals|0|||
19693432|NCT00360698|42139076|FG001|Run-In|Need of insulin with meals|1|||
19693433|NCT00360698|42139075|FG000|Treatment Period|Non compliance with treatment procedure|1|||
19693434|NCT00360698|42139076|FG001|Treatment Period|Non compliance with treatment procedure|0|||
19693435|NCT00360698|42139075|FG000|Treatment Period|Early termination by error|0|||
19693436|NCT00360698|42139076|FG001|Treatment Period|Early termination by error|1|||
19693437|NCT00380978|42139084|FG000|Overall Study|Refused allocated intervention|0|||
19693438|NCT00380978|42139085|FG001|Overall Study|Refused allocated intervention|6|||
19693439|NCT00380978|42139084|FG000|Overall Study|Wrong study envelope|0|||
19693440|NCT00380978|42139085|FG001|Overall Study|Wrong study envelope|2|||
19693441|NCT00380978|42139084|FG000|Overall Study|Allocation prior to analgesia request|1|||
19693442|NCT00380978|42139085|FG001|Overall Study|Allocation prior to analgesia request|2|||
19693443|NCT00380978|42139084|FG000|Overall Study|Parous patient|1|||
19693444|NCT00380978|42139085|FG001|Overall Study|Parous patient|0|||
19693445|NCT00162123|42139099|FG000|Overall Study|Disease progression|27|||
19693446|NCT00162123|42139100|FG001|Overall Study|Disease progression|19|||
19693447|NCT00162123|42139101|FG002|Overall Study|Disease progression|10|||
19693448|NCT00162123|42139102|FG003|Overall Study|Disease progression|4|||
19693449|NCT00162123|42139103|FG004|Overall Study|Disease progression|8|||
19693450|NCT00162123|42139104|FG005|Overall Study|Disease progression|3|||
19693451|NCT00162123|42139105|FG006|Overall Study|Disease progression|1|||
19693452|NCT00162123|42139106|FG007|Overall Study|Disease progression|0|||
19693453|NCT00162123|42139099|FG000|Overall Study|Study drug toxicity|6|||
19778404|NCT00960141|42233602|FG000|Overall Study|Lost to Follow-up|1|||
19778405|NCT00960141|42233603|FG001|Overall Study|Lost to Follow-up|0|||
19778406|NCT00960141|42233604|FG002|Overall Study|Lost to Follow-up|0|||
19778407|NCT00960141|42233602|FG000|Overall Study|Protocol Violation|1|||
19778408|NCT00960141|42233603|FG001|Overall Study|Protocol Violation|3|||
19778409|NCT00960141|42233604|FG002|Overall Study|Protocol Violation|2|||
19778410|NCT00960141|42233602|FG000|Overall Study|Withdrawal by Subject|1|||
19778411|NCT00960141|42233603|FG001|Overall Study|Withdrawal by Subject|2|||
19778412|NCT00960141|42233604|FG002|Overall Study|Withdrawal by Subject|1|||
19778413|NCT02771522|42233612|FG000|Overall Study|Lost to Follow-up|3|||
19778414|NCT02771522|42233612|FG000|Overall Study|Withdrawal by Subject|2|||
19778415|NCT02771522|42233612|FG000|Overall Study|No white spot lesions|3|||
19778416|NCT00759655|42233621|FG000|Overall Study|Termination of the study by sponsor|1|||
19778417|NCT02771366|42233627|FG000|Period 1|Withdrawal by Subject|0|||
19778418|NCT02771366|42233628|FG001|Period 1|Withdrawal by Subject|2|||
19778419|NCT02771366|42233627|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
19778420|NCT02771366|42233628|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
19778421|NCT03396471|42233635|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
19778422|NCT03396471|42233635|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
19778423|NCT03396471|42233635|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
19778424|NCT03396471|42233635|FG000|Study Treatment - Up to 22 Months|Death|2|||
19778425|NCT03396471|42233635|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
19778426|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|Death|9|||
19778427|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
19778428|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
19778429|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|study terminated|1|||
19778430|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
19778431|NCT03396471|42233635|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
19778432|NCT00103142|42233641|FG000|Overall Study|Adverse Event|1|||
19778433|NCT00103142|42233642|FG001|Overall Study|Adverse Event|0|||
19778434|NCT00103142|42233641|FG000|Overall Study|Progression of disease|2|||
19778435|NCT00103142|42233642|FG001|Overall Study|Progression of disease|1|||
19778436|NCT00943683|42233652|FG000|Overall Study|Adverse Event|3|||
19778437|NCT00943683|42233653|FG001|Overall Study|Adverse Event|3|||
19778438|NCT00943683|42233652|FG000|Overall Study|Lost to Follow-up|1|||
19778439|NCT00943683|42233653|FG001|Overall Study|Lost to Follow-up|1|||
19778440|NCT00943683|42233652|FG000|Overall Study|Protocol Violation|1|||
19778441|NCT00943683|42233653|FG001|Overall Study|Protocol Violation|2|||
19778442|NCT00943683|42233652|FG000|Overall Study|Withdrawal by Subject|1|||
19778443|NCT00943683|42233653|FG001|Overall Study|Withdrawal by Subject|0|||
19778444|NCT00943683|42233652|FG000|Overall Study|Patient Moved|1|||
19778445|NCT00943683|42233653|FG001|Overall Study|Patient Moved|0|||
19778446|NCT00911547|42233663|FG000|Overall Study|Adverse Event|8|||
19778447|NCT00911547|42233664|FG001|Overall Study|Adverse Event|27|||
19778448|NCT00911547|42233665|FG002|Overall Study|Adverse Event|11|||
19778449|NCT00911547|42233666|FG003|Overall Study|Adverse Event|6|||
19778450|NCT00911547|42233663|FG000|Overall Study|Lost to Follow-up|0|||
19778451|NCT00911547|42233664|FG001|Overall Study|Lost to Follow-up|0|||
19607033|NCT00939770|42055784|FG002|Overall Study|Physician Decision|2|||
19607034|NCT00939770|42055785|FG003|Overall Study|Physician Decision|0|||
19778452|NCT00911547|42233665|FG002|Overall Study|Lost to Follow-up|2|||
19778453|NCT00911547|42233666|FG003|Overall Study|Lost to Follow-up|1|||
19778454|NCT00911547|42233663|FG000|Overall Study|Protocol Violation|0|||
19778455|NCT00911547|42233664|FG001|Overall Study|Protocol Violation|5|||
19778456|NCT00911547|42233665|FG002|Overall Study|Protocol Violation|5|||
19778457|NCT00911547|42233666|FG003|Overall Study|Protocol Violation|1|||
19778458|NCT00911547|42233663|FG000|Overall Study|Withdrawal by Subject|3|||
19778459|NCT00911547|42233664|FG001|Overall Study|Withdrawal by Subject|10|||
19778460|NCT00911547|42233665|FG002|Overall Study|Withdrawal by Subject|4|||
19778461|NCT00911547|42233666|FG003|Overall Study|Withdrawal by Subject|8|||
19778462|NCT00899379|42233681|FG000|Overall Study|Adverse Event|2|||
19778463|NCT00899379|42233682|FG001|Overall Study|Adverse Event|2|||
19778464|NCT00899379|42233683|FG002|Overall Study|Adverse Event|1|||
19778465|NCT00899379|42233684|FG003|Overall Study|Adverse Event|1|||
19778466|NCT00899379|42233685|FG004|Overall Study|Adverse Event|2|||
19778467|NCT00899379|42233681|FG000|Overall Study|Lack of Efficacy|0|||
19778468|NCT00899379|42233682|FG001|Overall Study|Lack of Efficacy|4|||
19778469|NCT00899379|42233683|FG002|Overall Study|Lack of Efficacy|3|||
19778470|NCT00899379|42233684|FG003|Overall Study|Lack of Efficacy|0|||
19778471|NCT00899379|42233685|FG004|Overall Study|Lack of Efficacy|1|||
19778472|NCT00899379|42233681|FG000|Overall Study|Lost to Follow-up|9|||
19778473|NCT00899379|42233682|FG001|Overall Study|Lost to Follow-up|3|||
19778474|NCT00899379|42233683|FG002|Overall Study|Lost to Follow-up|0|||
19778475|NCT00899379|42233684|FG003|Overall Study|Lost to Follow-up|6|||
19778476|NCT00899379|42233685|FG004|Overall Study|Lost to Follow-up|2|||
19778477|NCT00899379|42233681|FG000|Overall Study|Protocol Violation|0|||
19778478|NCT00899379|42233682|FG001|Overall Study|Protocol Violation|0|||
19778479|NCT00899379|42233683|FG002|Overall Study|Protocol Violation|1|||
19778480|NCT00899379|42233684|FG003|Overall Study|Protocol Violation|1|||
19778481|NCT00899379|42233685|FG004|Overall Study|Protocol Violation|0|||
19778482|NCT00899379|42233681|FG000|Overall Study|Withdrawal by Subject|2|||
19778483|NCT00899379|42233682|FG001|Overall Study|Withdrawal by Subject|4|||
19778484|NCT00899379|42233683|FG002|Overall Study|Withdrawal by Subject|2|||
19778485|NCT00899379|42233684|FG003|Overall Study|Withdrawal by Subject|3|||
19778486|NCT00899379|42233685|FG004|Overall Study|Withdrawal by Subject|6|||
19778487|NCT00899379|42233681|FG000|Overall Study|Pregnancy|0|||
19693454|NCT00162123|42139100|FG001|Overall Study|Study drug toxicity|1|||
19693455|NCT00162123|42139101|FG002|Overall Study|Study drug toxicity|5|||
19778488|NCT00899379|42233682|FG001|Overall Study|Pregnancy|0|||
19778489|NCT00899379|42233683|FG002|Overall Study|Pregnancy|1|||
19778490|NCT00899379|42233684|FG003|Overall Study|Pregnancy|0|||
19778491|NCT00899379|42233685|FG004|Overall Study|Pregnancy|1|||
19778492|NCT00899379|42233681|FG000|Overall Study|Patient Uncooperative|0|||
19778493|NCT00899379|42233682|FG001|Overall Study|Patient Uncooperative|1|||
19778494|NCT00899379|42233683|FG002|Overall Study|Patient Uncooperative|0|||
19778495|NCT00899379|42233684|FG003|Overall Study|Patient Uncooperative|1|||
19778496|NCT00899379|42233685|FG004|Overall Study|Patient Uncooperative|2|||
19778497|NCT00899379|42233681|FG000|Overall Study|Abnormal Baseline ECG|0|||
19693456|NCT00162123|42139102|FG003|Overall Study|Study drug toxicity|0|||
19693457|NCT00162123|42139103|FG004|Overall Study|Study drug toxicity|4|||
19693458|NCT00162123|42139104|FG005|Overall Study|Study drug toxicity|1|||
19693459|NCT00162123|42139105|FG006|Overall Study|Study drug toxicity|1|||
19693460|NCT00162123|42139106|FG007|Overall Study|Study drug toxicity|0|||
19693461|NCT00162123|42139099|FG000|Overall Study|Death|3|||
19693462|NCT00162123|42139100|FG001|Overall Study|Death|3|||
19693463|NCT00162123|42139101|FG002|Overall Study|Death|1|||
19693464|NCT00162123|42139102|FG003|Overall Study|Death|1|||
19693465|NCT00162123|42139103|FG004|Overall Study|Death|1|||
19693466|NCT00162123|42139104|FG005|Overall Study|Death|1|||
19693467|NCT00162123|42139105|FG006|Overall Study|Death|0|||
19693468|NCT00162123|42139106|FG007|Overall Study|Death|0|||
19693469|NCT00162123|42139099|FG000|Overall Study|Withdrawal by Subject|2|||
19693470|NCT00162123|42139100|FG001|Overall Study|Withdrawal by Subject|0|||
19693471|NCT00162123|42139101|FG002|Overall Study|Withdrawal by Subject|2|||
19778498|NCT00899379|42233682|FG001|Overall Study|Abnormal Baseline ECG|0|||
19778499|NCT00899379|42233683|FG002|Overall Study|Abnormal Baseline ECG|0|||
19778500|NCT00899379|42233684|FG003|Overall Study|Abnormal Baseline ECG|1|||
19778501|NCT00899379|42233685|FG004|Overall Study|Abnormal Baseline ECG|0|||
19778502|NCT00899379|42233681|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
19389164|NCT01625182|41632780|FG001|Overall Study|Adverse Event|0|||
19607035|NCT00939770|42055786|FG004|Overall Study|Physician Decision|7|||
19607036|NCT00939770|42055787|FG005|Overall Study|Physician Decision|1|||
19607037|NCT00939770|42055788|FG006|Overall Study|Physician Decision|0|||
19607038|NCT00939770|42055789|FG007|Overall Study|Physician Decision|6|||
19607039|NCT00939770|42055782|FG000|Overall Study|Protocol Violation|0|||
19607040|NCT00939770|42055783|FG001|Overall Study|Protocol Violation|0|||
19607041|NCT00939770|42055784|FG002|Overall Study|Protocol Violation|0|||
19607042|NCT00939770|42055785|FG003|Overall Study|Protocol Violation|0|||
19693472|NCT00162123|42139102|FG003|Overall Study|Withdrawal by Subject|1|||
19693473|NCT00162123|42139103|FG004|Overall Study|Withdrawal by Subject|1|||
19693474|NCT00162123|42139104|FG005|Overall Study|Withdrawal by Subject|2|||
19693475|NCT00162123|42139105|FG006|Overall Study|Withdrawal by Subject|1|||
19693476|NCT00162123|42139106|FG007|Overall Study|Withdrawal by Subject|0|||
19693477|NCT00162123|42139099|FG000|Overall Study|Deterioration without progression|2|||
19693478|NCT00162123|42139100|FG001|Overall Study|Deterioration without progression|2|||
19693479|NCT00162123|42139101|FG002|Overall Study|Deterioration without progression|3|||
19693480|NCT00162123|42139102|FG003|Overall Study|Deterioration without progression|0|||
19693481|NCT00162123|42139103|FG004|Overall Study|Deterioration without progression|1|||
19693482|NCT00162123|42139104|FG005|Overall Study|Deterioration without progression|0|||
19778503|NCT00899379|42233682|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
19778504|NCT00899379|42233683|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
19778505|NCT00899379|42233684|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778506|NCT00899379|42233685|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778507|NCT00899379|42233681|FG000|Overall Study|Not Completed/Entered Extn|5|||
19778508|NCT00899379|42233682|FG001|Overall Study|Not Completed/Entered Extn|1|||
19778509|NCT00899379|42233683|FG002|Overall Study|Not Completed/Entered Extn|6|||
19778510|NCT00899379|42233684|FG003|Overall Study|Not Completed/Entered Extn|4|||
19778511|NCT00899379|42233685|FG004|Overall Study|Not Completed/Entered Extn|3|||
19778512|NCT00899379|42233681|FG000|Overall Study|Study Terminated|3|||
19778513|NCT00899379|42233682|FG001|Overall Study|Study Terminated|0|||
19778514|NCT00899379|42233683|FG002|Overall Study|Study Terminated|3|||
19778515|NCT00899379|42233684|FG003|Overall Study|Study Terminated|3|||
19778516|NCT00899379|42233685|FG004|Overall Study|Study Terminated|1|||
19693483|NCT00162123|42139105|FG006|Overall Study|Deterioration without progression|0|||
19693484|NCT00162123|42139106|FG007|Overall Study|Deterioration without progression|0|||
19693485|NCT00162123|42139099|FG000|Overall Study|Adverse Event|1|||
19693486|NCT00162123|42139100|FG001|Overall Study|Adverse Event|2|||
19693487|NCT00162123|42139101|FG002|Overall Study|Adverse Event|0|||
19693488|NCT00162123|42139102|FG003|Overall Study|Adverse Event|2|||
19693489|NCT00162123|42139103|FG004|Overall Study|Adverse Event|1|||
19693490|NCT00162123|42139104|FG005|Overall Study|Adverse Event|0|||
19693491|NCT00162123|42139105|FG006|Overall Study|Adverse Event|0|||
19693492|NCT00162123|42139106|FG007|Overall Study|Adverse Event|0|||
19693493|NCT00162123|42139099|FG000|Overall Study|Not specified (before treatment)|2|||
19693494|NCT00162123|42139100|FG001|Overall Study|Not specified (before treatment)|0|||
19778517|NCT00899379|42233681|FG000|Overall Study|Lost to Follow-up|3|||
19778518|NCT00899379|42233682|FG001|Overall Study|Lost to Follow-up|1|||
19778519|NCT00899379|42233683|FG002|Overall Study|Lost to Follow-up|0|||
19778520|NCT00899379|42233684|FG003|Overall Study|Lost to Follow-up|2|||
19778521|NCT00899379|42233685|FG004|Overall Study|Lost to Follow-up|5|||
19778522|NCT00899379|42233681|FG000|Overall Study|Withdrawal by Subject|4|||
19778523|NCT00899379|42233682|FG001|Overall Study|Withdrawal by Subject|7|||
19778524|NCT00899379|42233683|FG002|Overall Study|Withdrawal by Subject|4|||
19778525|NCT00899379|42233684|FG003|Overall Study|Withdrawal by Subject|7|||
19778526|NCT00899379|42233685|FG004|Overall Study|Withdrawal by Subject|2|||
19778527|NCT00899379|42233681|FG000|Overall Study|Pregnancy|1|||
19778528|NCT00899379|42233682|FG001|Overall Study|Pregnancy|0|||
19778529|NCT00899379|42233683|FG002|Overall Study|Pregnancy|0|||
19778530|NCT00899379|42233684|FG003|Overall Study|Pregnancy|0|||
19778531|NCT00899379|42233685|FG004|Overall Study|Pregnancy|0|||
19778532|NCT00899379|42233681|FG000|Overall Study|Patient Uncooperative|0|||
19778533|NCT00899379|42233682|FG001|Overall Study|Patient Uncooperative|0|||
19778534|NCT00899379|42233683|FG002|Overall Study|Patient Uncooperative|0|||
19778535|NCT00899379|42233684|FG003|Overall Study|Patient Uncooperative|1|||
19778536|NCT00899379|42233685|FG004|Overall Study|Patient Uncooperative|0|||
19778537|NCT00899379|42233681|FG000|Overall Study|Abnormal Prestudy Labs|0|||
19778538|NCT00899379|42233682|FG001|Overall Study|Abnormal Prestudy Labs|0|||
19778539|NCT00899379|42233683|FG002|Overall Study|Abnormal Prestudy Labs|0|||
19778540|NCT00899379|42233684|FG003|Overall Study|Abnormal Prestudy Labs|0|||
19778541|NCT00899379|42233685|FG004|Overall Study|Abnormal Prestudy Labs|2|||
19778542|NCT00899379|42233681|FG000|Overall Study|Abnormal Baseline ECG|0|||
19778543|NCT00899379|42233682|FG001|Overall Study|Abnormal Baseline ECG|0|||
19778544|NCT00899379|42233683|FG002|Overall Study|Abnormal Baseline ECG|1|||
19778545|NCT00899379|42233684|FG003|Overall Study|Abnormal Baseline ECG|1|||
19778546|NCT00899379|42233685|FG004|Overall Study|Abnormal Baseline ECG|0|||
19778547|NCT00899379|42233681|FG000|Overall Study|No Attack Pretreatment|3|||
19778548|NCT00899379|42233682|FG001|Overall Study|No Attack Pretreatment|5|||
19778549|NCT00899379|42233683|FG002|Overall Study|No Attack Pretreatment|5|||
19778550|NCT00899379|42233684|FG003|Overall Study|No Attack Pretreatment|6|||
19778551|NCT00899379|42233685|FG004|Overall Study|No Attack Pretreatment|4|||
19693495|NCT00162123|42139101|FG002|Overall Study|Not specified (before treatment)|0|||
19693496|NCT00162123|42139102|FG003|Overall Study|Not specified (before treatment)|0|||
19778552|NCT00899379|42233681|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
19778553|NCT00899379|42233682|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778554|NCT00899379|42233683|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778555|NCT00899379|42233684|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778556|NCT00899379|42233685|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
19778557|NCT00899379|42233681|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
19778558|NCT00899379|42233682|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
19778559|NCT00899379|42233683|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
19778560|NCT00899379|42233684|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
19778561|NCT00899379|42233685|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
19778562|NCT04326439|42233693|FG000|Overall Study|Withdrawal by Subject|1|||
19778563|NCT04326439|42233694|FG001|Overall Study|Withdrawal by Subject|0|||
19778564|NCT04326439|42233693|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
19778565|NCT04326439|42233694|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
19778566|NCT04326439|42233693|FG000|Overall Study|Relapse after Induction 2|0|||
19778567|NCT04326439|42233694|FG001|Overall Study|Relapse after Induction 2|1|||
19778568|NCT04326439|42233693|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
19778569|NCT04326439|42233694|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
19778570|NCT00145795|42233708|FG000|Overall Study|Adverse Event|1|||
19778571|NCT00145795|42233709|FG001|Overall Study|Adverse Event|0|||
19778572|NCT02771210|42233717|FG000|Period 1|Adverse Event|5|||
19778573|NCT02771210|42233718|FG001|Period 1|Adverse Event|3|||
19778574|NCT02771210|42233717|FG000|Period 1|Lack of Efficacy|3|||
19778575|NCT02771210|42233718|FG001|Period 1|Lack of Efficacy|6|||
19778576|NCT02771210|42233717|FG000|Period 1|Lost to Follow-up|2|||
19778577|NCT02771210|42233718|FG001|Period 1|Lost to Follow-up|0|||
19778578|NCT02771210|42233717|FG000|Period 1|Physician Decision|0|||
19778579|NCT02771210|42233718|FG001|Period 1|Physician Decision|1|||
19778580|NCT02771210|42233717|FG000|Period 1|Withdrawal by Subject|0|||
19778581|NCT02771210|42233718|FG001|Period 1|Withdrawal by Subject|3|||
19778582|NCT02771210|42233717|FG000|Period 1|Withdrawal of informed consent|1|||
19778583|NCT02771210|42233718|FG001|Period 1|Withdrawal of informed consent|5|||
19778584|NCT02771210|42233717|FG000|Period 2|Adverse Event|1|||
19778585|NCT02771210|42233718|FG001|Period 2|Adverse Event|0|||
19778586|NCT02771210|42233717|FG000|Period 2|Lack of Efficacy|0|||
19778587|NCT02771210|42233718|FG001|Period 2|Lack of Efficacy|1|||
19778588|NCT02771210|42233717|FG000|Period 2|Withdrawal by Subject|1|||
19778589|NCT02771210|42233718|FG001|Period 2|Withdrawal by Subject|0|||
19778590|NCT02771210|42233717|FG000|Period 2|Withdrawal of informed consent|0|||
19778591|NCT02771210|42233718|FG001|Period 2|Withdrawal of informed consent|2|||
19778592|NCT00898677|42233728|FG000|Overall Study|Adverse Event|0|||
19778593|NCT00898677|42233729|FG001|Overall Study|Adverse Event|0|||
19778594|NCT00898677|42233730|FG002|Overall Study|Adverse Event|1|||
19693497|NCT00162123|42139103|FG004|Overall Study|Not specified (before treatment)|12|||
19693498|NCT00162123|42139104|FG005|Overall Study|Not specified (before treatment)|1|||
19693499|NCT00162123|42139105|FG006|Overall Study|Not specified (before treatment)|0|||
19693500|NCT00162123|42139106|FG007|Overall Study|Not specified (before treatment)|0|||
19693501|NCT00162123|42139099|FG000|Overall Study|Not specified (after start of treatment)|0|||
19693502|NCT00162123|42139100|FG001|Overall Study|Not specified (after start of treatment)|0|||
19693503|NCT00162123|42139101|FG002|Overall Study|Not specified (after start of treatment)|0|||
19693504|NCT00162123|42139102|FG003|Overall Study|Not specified (after start of treatment)|0|||
19693505|NCT00162123|42139103|FG004|Overall Study|Not specified (after start of treatment)|3|||
19693506|NCT00162123|42139104|FG005|Overall Study|Not specified (after start of treatment)|0|||
19693507|NCT00162123|42139105|FG006|Overall Study|Not specified (after start of treatment)|0|||
19778595|NCT00898677|42233731|FG003|Overall Study|Adverse Event|0|||
19778596|NCT00898677|42233728|FG000|Overall Study|Lost to Follow-up|0|||
19778597|NCT00898677|42233729|FG001|Overall Study|Lost to Follow-up|0|||
19778598|NCT00898677|42233730|FG002|Overall Study|Lost to Follow-up|2|||
19778599|NCT00898677|42233731|FG003|Overall Study|Lost to Follow-up|0|||
19778600|NCT00898677|42233728|FG000|Overall Study|Protocol Violation|1|||
19693508|NCT00162123|42139106|FG007|Overall Study|Not specified (after start of treatment)|0|||
19693509|NCT00162123|42139099|FG000|Overall Study|Physician Decision|1|||
19778601|NCT00898677|42233729|FG001|Overall Study|Protocol Violation|1|||
19778602|NCT00898677|42233730|FG002|Overall Study|Protocol Violation|2|||
19367252|NCT02435992|41607419|FG004|Overall Study|Withdrawal by Subject|0|||
19367253|NCT02435992|41607415|FG000|Overall Study|Other Reason|1|||
19367254|NCT02435992|41607416|FG001|Overall Study|Other Reason|0|||
19367255|NCT02435992|41607417|FG002|Overall Study|Other Reason|0|||
19778603|NCT00898677|42233731|FG003|Overall Study|Protocol Violation|0|||
19778604|NCT00898677|42233728|FG000|Overall Study|Withdrawal by Subject|0|||
19778605|NCT00898677|42233729|FG001|Overall Study|Withdrawal by Subject|0|||
19778606|NCT00898677|42233730|FG002|Overall Study|Withdrawal by Subject|0|||
19778607|NCT00898677|42233731|FG003|Overall Study|Withdrawal by Subject|1|||
19778608|NCT00898677|42233728|FG000|Overall Study|Not Treated: Adverse Event|0|||
19778609|NCT00898677|42233729|FG001|Overall Study|Not Treated: Adverse Event|2|||
19778610|NCT00898677|42233730|FG002|Overall Study|Not Treated: Adverse Event|1|||
19778611|NCT00898677|42233731|FG003|Overall Study|Not Treated: Adverse Event|0|||
19778612|NCT00898677|42233728|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
19778613|NCT00898677|42233729|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
19778614|NCT00898677|42233730|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
19778615|NCT00898677|42233731|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
19778616|NCT00898677|42233728|FG000|Overall Study|Not Treated: Pregnancy|0|||
19778617|NCT00898677|42233729|FG001|Overall Study|Not Treated: Pregnancy|0|||
19778618|NCT00898677|42233730|FG002|Overall Study|Not Treated: Pregnancy|1|||
19778619|NCT00898677|42233731|FG003|Overall Study|Not Treated: Pregnancy|0|||
19778620|NCT00898677|42233728|FG000|Overall Study|Not Treated: Protocol Violation|2|||
19778621|NCT00898677|42233729|FG001|Overall Study|Not Treated: Protocol Violation|0|||
19778622|NCT00898677|42233730|FG002|Overall Study|Not Treated: Protocol Violation|2|||
19778623|NCT00898677|42233731|FG003|Overall Study|Not Treated: Protocol Violation|0|||
19778624|NCT00898677|42233728|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
19778625|NCT00898677|42233729|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
19778626|NCT00898677|42233730|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
19778627|NCT00898677|42233731|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
19778628|NCT00898677|42233728|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
19778629|NCT00898677|42233729|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
19778630|NCT00898677|42233730|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
19778631|NCT00898677|42233731|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
19778632|NCT00898677|42233728|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
19778633|NCT00898677|42233729|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
19778634|NCT00898677|42233730|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
19778635|NCT00898677|42233731|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
19778636|NCT00898677|42233728|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
19778637|NCT00898677|42233729|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
19778638|NCT00898677|42233730|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
19778639|NCT00898677|42233731|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
19778640|NCT00898677|42233728|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
19778641|NCT00898677|42233729|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
19778642|NCT00898677|42233730|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
19778643|NCT00898677|42233731|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
19778644|NCT00898677|42233728|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
19778645|NCT00898677|42233729|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
19778646|NCT00898677|42233730|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
19778647|NCT00898677|42233731|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
19778648|NCT00898677|42233728|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
19778649|NCT00898677|42233729|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
19778650|NCT00898677|42233730|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
19778651|NCT00898677|42233731|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
19778652|NCT02770820|42233741|FG000|Overall Study|Death|1|||
19778653|NCT02770820|42233741|FG000|Overall Study|Physician Decision|2|||
19778654|NCT03082729|42233745|FG000|Overall Study|Lost to Follow-up|7|||
19778655|NCT03082729|42233745|FG000|Overall Study|Physician Decision|2|||
19778656|NCT03082729|42233745|FG000|Overall Study|Withdrawal by Subject|1|||
19778657|NCT03082729|42233745|FG000|Overall Study|Lack of Efficacy|9|||
19778658|NCT03082729|42233745|FG000|Overall Study|Adverse Event|4|||
19778659|NCT03082729|42233745|FG000|Overall Study|Protocol Violation|6|||
19778660|NCT03082729|42233745|FG000|Overall Study|Fear of study procedure|1|||
19778661|NCT03082729|42233745|FG000|Overall Study|Scheduling conflict|1|||
19778662|NCT02764190|42233757|FG000|Overall Study|Lost to Follow-up|17|||
19778663|NCT02764190|42233758|FG001|Overall Study|Lost to Follow-up|13|||
19778664|NCT03077659|42233767|FG000|Overall Study|Withdrawal by Subject|0|||
19778665|NCT03077659|42233768|FG001|Overall Study|Withdrawal by Subject|0|||
19778666|NCT03077659|42233769|FG002|Overall Study|Withdrawal by Subject|1|||
19778667|NCT02807883|42233780|FG000|Overall Study|Withdrawal by Subject|2|||
19778668|NCT03082261|42233784|FG000|Overall Study|Death|4|||
19693510|NCT00162123|42139100|FG001|Overall Study|Physician Decision|2|||
19693511|NCT00162123|42139101|FG002|Overall Study|Physician Decision|0|||
19693512|NCT00162123|42139102|FG003|Overall Study|Physician Decision|0|||
19693513|NCT00162123|42139103|FG004|Overall Study|Physician Decision|0|||
19693514|NCT00162123|42139104|FG005|Overall Study|Physician Decision|1|||
19693515|NCT00162123|42139105|FG006|Overall Study|Physician Decision|1|||
19693516|NCT00162123|42139106|FG007|Overall Study|Physician Decision|0|||
19693517|NCT00162123|42139099|FG000|Overall Study|Tumor assessment only (not treated)|0|||
19693518|NCT00162123|42139100|FG001|Overall Study|Tumor assessment only (not treated)|0|||
19693519|NCT00162123|42139101|FG002|Overall Study|Tumor assessment only (not treated)|0|||
19778669|NCT03082261|42233784|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
19778670|NCT03082261|42233784|FG000|Overall Study|Insurance denial|1|||
19778671|NCT03082261|42233784|FG000|Overall Study|Peripheral lead added|1|||
19778672|NCT03082261|42233784|FG000|Overall Study|Withdrawal by Subject|40|||
19778673|NCT03082261|42233784|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
19778674|NCT03082261|42233784|FG000|Overall Study|Subject implanted with device other than study device|1|||
19693520|NCT00162123|42139102|FG003|Overall Study|Tumor assessment only (not treated)|0|||
19693521|NCT00162123|42139103|FG004|Overall Study|Tumor assessment only (not treated)|0|||
19607043|NCT00939770|42055786|FG004|Overall Study|Protocol Violation|1|||
19607044|NCT00939770|42055787|FG005|Overall Study|Protocol Violation|0|||
19607045|NCT00939770|42055788|FG006|Overall Study|Protocol Violation|0|||
19607046|NCT00939770|42055789|FG007|Overall Study|Protocol Violation|0|||
19607047|NCT00939770|42055782|FG000|Overall Study|Withdrawal by Subject|0|||
19693522|NCT00162123|42139104|FG005|Overall Study|Tumor assessment only (not treated)|0|||
19693523|NCT00162123|42139105|FG006|Overall Study|Tumor assessment only (not treated)|0|||
19693524|NCT00162123|42139106|FG007|Overall Study|Tumor assessment only (not treated)|1|||
19693525|NCT00162123|42139099|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
19778675|NCT03082261|42233784|FG000|Overall Study|Lost to Follow-up|14|||
19778676|NCT03082261|42233784|FG000|Overall Study|Subject moved to a different state|1|||
19778677|NCT03082261|42233784|FG000|Overall Study|Subject non-compliance|2|||
19778678|NCT03082261|42233784|FG000|Overall Study|Subject participation terminated by investigator|9|||
19778679|NCT03082261|42233784|FG000|Overall Study|Subject participation terminated by sponsor|4|||
19778680|NCT03082261|42233784|FG000|Overall Study|System explant|19|||
19778681|NCT03082261|42233784|FG000|Overall Study|Unable to place lead(s)|2|||
19778682|NCT03082261|42233784|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
19778683|NCT00102440|42233791|FG000|Overall Study|Lost to Follow-up|25|||
19778684|NCT00102440|42233792|FG001|Overall Study|Lost to Follow-up|18|||
19778685|NCT00102440|42233793|FG002|Overall Study|Lost to Follow-up|21|||
19778686|NCT00102440|42233791|FG000|Overall Study|Adverse Event|16|||
19778687|NCT00102440|42233792|FG001|Overall Study|Adverse Event|23|||
19778688|NCT00102440|42233793|FG002|Overall Study|Adverse Event|8|||
19778689|NCT00102440|42233791|FG000|Overall Study|Gout Flare|10|||
19778690|NCT00102440|42233792|FG001|Overall Study|Gout Flare|28|||
19778691|NCT00102440|42233793|FG002|Overall Study|Gout Flare|9|||
19778692|NCT00102440|42233791|FG000|Overall Study|Personal Reason(s)|19|||
19778693|NCT00102440|42233792|FG001|Overall Study|Personal Reason(s)|13|||
19778694|NCT00102440|42233793|FG002|Overall Study|Personal Reason(s)|13|||
19778695|NCT00102440|42233791|FG000|Overall Study|Other|11|||
19778696|NCT00102440|42233792|FG001|Overall Study|Other|14|||
19778697|NCT00102440|42233793|FG002|Overall Study|Other|14|||
19778698|NCT00102440|42233791|FG000|Overall Study|Protocol Violation|7|||
19778699|NCT00102440|42233792|FG001|Overall Study|Protocol Violation|2|||
19778700|NCT00102440|42233793|FG002|Overall Study|Protocol Violation|1|||
19778701|NCT02762084|42233817|FG000|Overall Study|Withdrawal by Subject|1|||
19778702|NCT02762084|42233818|FG001|Overall Study|Withdrawal by Subject|0|||
19778703|NCT02762084|42233819|FG002|Overall Study|Withdrawal by Subject|0|||
19778704|NCT02762084|42233817|FG000|Overall Study|Adverse Event|0|||
19607048|NCT00939770|42055783|FG001|Overall Study|Withdrawal by Subject|1|||
19607049|NCT00939770|42055784|FG002|Overall Study|Withdrawal by Subject|5|||
19607050|NCT00939770|42055785|FG003|Overall Study|Withdrawal by Subject|2|||
19607051|NCT00939770|42055786|FG004|Overall Study|Withdrawal by Subject|6|||
19607052|NCT00939770|42055787|FG005|Overall Study|Withdrawal by Subject|0|||
19607053|NCT00939770|42055788|FG006|Overall Study|Withdrawal by Subject|2|||
19693526|NCT00162123|42139100|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
19693527|NCT00162123|42139101|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
19693528|NCT00162123|42139102|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
19693529|NCT00162123|42139103|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
19693530|NCT00162123|42139104|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
19693531|NCT00162123|42139105|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
19693532|NCT00162123|42139106|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
19693533|NCT00227721|42139125|FG000|Overall Study|On study, but never treated.|1|||
19693534|NCT00226941|42139133|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
19693535|NCT00226941|42139134|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
19693536|NCT00226941|42139135|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
19693537|NCT00226941|42139136|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
19693538|NCT00226941|42139133|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
19693539|NCT00226941|42139134|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
19693540|NCT00226941|42139135|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
19693541|NCT00226941|42139136|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
19778705|NCT02762084|42233818|FG001|Overall Study|Adverse Event|0|||
19778706|NCT02762084|42233819|FG002|Overall Study|Adverse Event|1|||
19778707|NCT02763644|42233831|FG000|Overall Study|Patient/guardian decision|1|||
19778708|NCT02763644|42233832|FG001|Overall Study|Patient/guardian decision|0|||
19778709|NCT02763644|42233831|FG000|Overall Study|Death|1|||
19778710|NCT02763644|42233832|FG001|Overall Study|Death|1|||
19778711|NCT02763644|42233831|FG000|Overall Study|Adverse Event|1|||
19778712|NCT02763644|42233832|FG001|Overall Study|Adverse Event|1|||
19778713|NCT04576455|42233842|FG000|Overall Study|Ongoing in the Study|122|||
19778714|NCT04576455|42233843|FG001|Overall Study|Ongoing in the Study|135|||
19607054|NCT00939770|42055789|FG007|Overall Study|Withdrawal by Subject|2|||
19607055|NCT00939692|42055822|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
19778715|NCT04576455|42233842|FG000|Overall Study|Death|18|||
19778716|NCT04576455|42233843|FG001|Overall Study|Death|12|||
19607056|NCT00939692|42055823|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
19607057|NCT00939692|42055822|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
19607058|NCT00939692|42055823|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
19778717|NCT04576455|42233842|FG000|Overall Study|Lost to Follow-up|1|||
19778718|NCT04576455|42233843|FG001|Overall Study|Lost to Follow-up|0|||
19778719|NCT04576455|42233842|FG000|Overall Study|Withdrawal by Subject|10|||
19778720|NCT04576455|42233843|FG001|Overall Study|Withdrawal by Subject|5|||
19778721|NCT02807844|42233860|FG000|Overall Study|Physician Decision|0|||
19778722|NCT02807844|42233861|FG001|Overall Study|Physician Decision|0|||
19778723|NCT02807844|42233862|FG002|Overall Study|Physician Decision|0|||
19778724|NCT02807844|42233863|FG003|Overall Study|Physician Decision|0|||
19778725|NCT02807844|42233864|FG004|Overall Study|Physician Decision|0|||
19778726|NCT02807844|42233865|FG005|Overall Study|Physician Decision|0|||
19778727|NCT02807844|42233866|FG006|Overall Study|Physician Decision|3|||
19778728|NCT02807844|42233867|FG007|Overall Study|Physician Decision|0|||
19778729|NCT02807844|42233868|FG008|Overall Study|Physician Decision|1|||
19778730|NCT02807844|42233869|FG009|Overall Study|Physician Decision|2|||
19778731|NCT02807844|42233860|FG000|Overall Study|Death|0|||
19778732|NCT02807844|42233861|FG001|Overall Study|Death|0|||
19778733|NCT02807844|42233862|FG002|Overall Study|Death|2|||
19778734|NCT02807844|42233863|FG003|Overall Study|Death|4|||
19778735|NCT02807844|42233864|FG004|Overall Study|Death|1|||
19778736|NCT02807844|42233865|FG005|Overall Study|Death|2|||
19778737|NCT02807844|42233866|FG006|Overall Study|Death|1|||
19778738|NCT02807844|42233867|FG007|Overall Study|Death|2|||
19778739|NCT02807844|42233868|FG008|Overall Study|Death|0|||
19778740|NCT02807844|42233869|FG009|Overall Study|Death|1|||
19778741|NCT02807844|42233860|FG000|Overall Study|Withdrawal by Subject|0|||
19778742|NCT02807844|42233861|FG001|Overall Study|Withdrawal by Subject|0|||
19778743|NCT02807844|42233862|FG002|Overall Study|Withdrawal by Subject|2|||
19778744|NCT02807844|42233863|FG003|Overall Study|Withdrawal by Subject|1|||
19778745|NCT02807844|42233864|FG004|Overall Study|Withdrawal by Subject|1|||
19778746|NCT02807844|42233865|FG005|Overall Study|Withdrawal by Subject|0|||
19778747|NCT02807844|42233866|FG006|Overall Study|Withdrawal by Subject|1|||
19778748|NCT02807844|42233867|FG007|Overall Study|Withdrawal by Subject|0|||
19778749|NCT02807844|42233868|FG008|Overall Study|Withdrawal by Subject|0|||
19778750|NCT02807844|42233869|FG009|Overall Study|Withdrawal by Subject|0|||
19778751|NCT02807844|42233860|FG000|Overall Study|Progressive disease|5|||
19778752|NCT02807844|42233861|FG001|Overall Study|Progressive disease|12|||
19778753|NCT02807844|42233862|FG002|Overall Study|Progressive disease|8|||
19778754|NCT02807844|42233863|FG003|Overall Study|Progressive disease|8|||
19778755|NCT02807844|42233864|FG004|Overall Study|Progressive disease|3|||
19778756|NCT02807844|42233865|FG005|Overall Study|Progressive disease|8|||
19778757|NCT02807844|42233866|FG006|Overall Study|Progressive disease|14|||
19778758|NCT02807844|42233867|FG007|Overall Study|Progressive disease|17|||
19778759|NCT02807844|42233868|FG008|Overall Study|Progressive disease|19|||
19778760|NCT02807844|42233869|FG009|Overall Study|Progressive disease|15|||
19778761|NCT02807844|42233860|FG000|Overall Study|Adverse Event|1|||
19778762|NCT02807844|42233861|FG001|Overall Study|Adverse Event|0|||
19778763|NCT02807844|42233862|FG002|Overall Study|Adverse Event|0|||
19778764|NCT02807844|42233863|FG003|Overall Study|Adverse Event|0|||
19778765|NCT02807844|42233864|FG004|Overall Study|Adverse Event|1|||
19778766|NCT02807844|42233865|FG005|Overall Study|Adverse Event|1|||
19778767|NCT02807844|42233866|FG006|Overall Study|Adverse Event|1|||
19778768|NCT02807844|42233867|FG007|Overall Study|Adverse Event|1|||
19778769|NCT02807844|42233868|FG008|Overall Study|Adverse Event|1|||
19778770|NCT02807844|42233869|FG009|Overall Study|Adverse Event|2|||
19778771|NCT02763566|42233899|FG000|Overall Study|Lost to Follow-up|1|||
19778772|NCT02763566|42233900|FG001|Overall Study|Lost to Follow-up|4|||
19778773|NCT02763566|42233901|FG002|Overall Study|Lost to Follow-up|0|||
19778774|NCT02763566|42233902|FG003|Overall Study|Lost to Follow-up|1|||
19367256|NCT02435992|41607418|FG003|Overall Study|Other Reason|0|||
19607059|NCT04672252|42055831|FG000|Overall Study|Protocol Violation|1|||
19778775|NCT02763566|42233899|FG000|Overall Study|On study treatment at study conclusion|114|||
19778776|NCT02763566|42233900|FG001|Overall Study|On study treatment at study conclusion|34|||
19778777|NCT02763566|42233901|FG002|Overall Study|On study treatment at study conclusion|54|||
19778778|NCT02763566|42233902|FG003|Overall Study|On study treatment at study conclusion|13|||
19778779|NCT02763566|42233899|FG000|Overall Study|Withdrawal by Subject|3|||
19778780|NCT02763566|42233900|FG001|Overall Study|Withdrawal by Subject|1|||
19778781|NCT02763566|42233901|FG002|Overall Study|Withdrawal by Subject|0|||
19778782|NCT02763566|42233902|FG003|Overall Study|Withdrawal by Subject|0|||
19778783|NCT02763254|42233916|FG000|Overall Study|Adverse Event|1|||
19778784|NCT02805972|42233922|FG000|Washout Period|Lost to Follow-up|3|||
19778785|NCT02805972|42233923|FG001|Washout Period|Lost to Follow-up|0|||
19778786|NCT03032523|42233941|FG000|Overall Study|Withdrawal by Subject|2|||
19778787|NCT03032523|42233942|FG001|Overall Study|Withdrawal by Subject|2|||
19778788|NCT03032523|42233941|FG000|Overall Study|Physician Decision|1|||
19778789|NCT03032523|42233942|FG001|Overall Study|Physician Decision|0|||
19778790|NCT03031899|42233949|FG000|Overall Study|Protocol Violation|1|||
19778791|NCT03031899|42233949|FG000|Overall Study|lesion disappeared after stopping habit|1|||
19778792|NCT03086369|42233962|FG000|Overall Study|Lost to Follow-up|1|||
19778793|NCT03086369|42233963|FG001|Overall Study|Lost to Follow-up|0|||
19778794|NCT03086369|42233964|FG002|Overall Study|Lost to Follow-up|0|||
19693542|NCT00356408|42139156|FG000|Overall Study|Adverse Event|9|||
19693543|NCT00356408|42139156|FG000|Overall Study|Lack of Efficacy|36|||
19693544|NCT00356408|42139156|FG000|Overall Study|Lost to Follow-up|2|||
19693545|NCT00356408|42139156|FG000|Overall Study|Withdrawal by Subject|6|||
19693546|NCT00356408|42139156|FG000|Overall Study|Other: Principal investigator discretion|3|||
19693547|NCT00356408|42139156|FG000|Overall Study|Other: Sponsor request|1|||
19693548|NCT00356408|42139156|FG000|Overall Study|Other: Azathioprine stopped|1|||
19693549|NCT00356408|42139156|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
19693550|NCT00356408|42139156|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
19693551|NCT00509795|42139171|FG000|Overall Study|Adverse Event|4|||
19693552|NCT00509795|42139172|FG001|Overall Study|Adverse Event|3|||
19693553|NCT00509795|42139173|FG002|Overall Study|Adverse Event|5|||
19693554|NCT00509795|42139174|FG003|Overall Study|Adverse Event|4|||
19693555|NCT00509795|42139171|FG000|Overall Study|Death|3|||
19693556|NCT00509795|42139172|FG001|Overall Study|Death|1|||
19693557|NCT00509795|42139173|FG002|Overall Study|Death|2|||
19693558|NCT00509795|42139174|FG003|Overall Study|Death|7|||
19693559|NCT00509795|42139171|FG000|Overall Study|Lack of Efficacy|0|||
19693560|NCT00509795|42139172|FG001|Overall Study|Lack of Efficacy|0|||
19693561|NCT00509795|42139173|FG002|Overall Study|Lack of Efficacy|2|||
19778795|NCT03086369|42233965|FG003|Overall Study|Lost to Follow-up|2|||
19778796|NCT03086369|42233966|FG004|Overall Study|Lost to Follow-up|1|||
19778797|NCT03086369|42233962|FG000|Overall Study|Physician Decision|0|||
19778798|NCT03086369|42233963|FG001|Overall Study|Physician Decision|0|||
19778799|NCT03086369|42233964|FG002|Overall Study|Physician Decision|0|||
19778800|NCT03086369|42233965|FG003|Overall Study|Physician Decision|1|||
19778801|NCT03086369|42233966|FG004|Overall Study|Physician Decision|2|||
19778802|NCT03086369|42233962|FG000|Overall Study|Withdrawal by Subject|0|||
19778803|NCT03086369|42233963|FG001|Overall Study|Withdrawal by Subject|0|||
19778804|NCT03086369|42233964|FG002|Overall Study|Withdrawal by Subject|0|||
19778805|NCT03086369|42233965|FG003|Overall Study|Withdrawal by Subject|5|||
19778806|NCT03086369|42233966|FG004|Overall Study|Withdrawal by Subject|3|||
19778807|NCT03086369|42233962|FG000|Overall Study|Progressive Disease|0|||
19778808|NCT03086369|42233963|FG001|Overall Study|Progressive Disease|0|||
19778809|NCT03086369|42233964|FG002|Overall Study|Progressive Disease|0|||
19778810|NCT03086369|42233965|FG003|Overall Study|Progressive Disease|1|||
19778811|NCT03086369|42233966|FG004|Overall Study|Progressive Disease|1|||
19778812|NCT00101582|42233982|FG000|Overall Study|Ineligibility determined|0|||
19778813|NCT00101582|42233983|FG001|Overall Study|Ineligibility determined|1|||
19778814|NCT00101582|42233982|FG000|Overall Study|Adverse Event|1|||
19778815|NCT00101582|42233983|FG001|Overall Study|Adverse Event|4|||
19778816|NCT00101582|42233982|FG000|Overall Study|Withdrawal by Subject|6|||
19778817|NCT00101582|42233983|FG001|Overall Study|Withdrawal by Subject|4|||
19778818|NCT00101582|42233982|FG000|Overall Study|Physician Decision|1|||
19778819|NCT00101582|42233983|FG001|Overall Study|Physician Decision|0|||
19778820|NCT00101582|42233982|FG000|Overall Study|Death|3|||
19778821|NCT00101582|42233983|FG001|Overall Study|Death|5|||
19778822|NCT00101582|42233982|FG000|Overall Study|Other|0|||
19778823|NCT00101582|42233983|FG001|Overall Study|Other|1|||
19778824|NCT03086135|42233989|FG000|Overall Study|Adverse Event|1|||
19778825|NCT03086135|42233989|FG000|Overall Study|Lost to Follow-up|2|||
19778826|NCT02762708|42234006|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
19778827|NCT02762708|42234007|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
19778828|NCT02762708|42234008|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
19778829|NCT02762708|42234009|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
19778830|NCT02760602|42234021|FG000|Overall Study|Withdrawal by Subject|1|||
19778831|NCT02760602|42234022|FG001|Overall Study|Withdrawal by Subject|0|||
19778832|NCT02760602|42234021|FG000|Overall Study|Terminated by sponsor|12|||
19778833|NCT02760602|42234022|FG001|Overall Study|Terminated by sponsor|13|||
19778834|NCT03852719|42234031|FG000|Overall Study|Still on study|50|||
19778835|NCT03852719|42234032|FG001|Overall Study|Still on study|48|||
19778836|NCT03852719|42234033|FG002|Overall Study|Still on study|47|||
19778837|NCT03852719|42234031|FG000|Overall Study|Withdrawal of consent|0|||
19778838|NCT03852719|42234032|FG001|Overall Study|Withdrawal of consent|1|||
19778839|NCT03852719|42234033|FG002|Overall Study|Withdrawal of consent|2|||
19778840|NCT03852719|42234031|FG000|Overall Study|Physician Decision|0|||
19778841|NCT03852719|42234032|FG001|Overall Study|Physician Decision|0|||
19693562|NCT00509795|42139174|FG003|Overall Study|Lack of Efficacy|2|||
19693563|NCT00509795|42139171|FG000|Overall Study|Lost to Follow-up|1|||
19693564|NCT00509795|42139172|FG001|Overall Study|Lost to Follow-up|2|||
19778842|NCT03852719|42234033|FG002|Overall Study|Physician Decision|1|||
19778843|NCT03852719|42234031|FG000|Overall Study|Pregnancy|1|||
19778844|NCT03852719|42234032|FG001|Overall Study|Pregnancy|0|||
19778845|NCT03852719|42234033|FG002|Overall Study|Pregnancy|0|||
19778846|NCT00210249|42234041|FG000|Overall Study|Lost to Follow-up|5|||
19778847|NCT00210249|42234041|FG000|Overall Study|Protocol Violation|11|||
19778848|NCT03086057|42234049|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
19778849|NCT03086057|42234050|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
19778850|NCT03086057|42234051|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
19778851|NCT03086057|42234052|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
19778852|NCT03086057|42234049|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
19778853|NCT03086057|42234050|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
19693565|NCT00509795|42139173|FG002|Overall Study|Lost to Follow-up|4|||
19693566|NCT00509795|42139174|FG003|Overall Study|Lost to Follow-up|4|||
19693567|NCT00509795|42139171|FG000|Overall Study|OTHER|1|||
19693568|NCT00509795|42139172|FG001|Overall Study|OTHER|0|||
19693569|NCT00509795|42139173|FG002|Overall Study|OTHER|4|||
19693570|NCT00509795|42139174|FG003|Overall Study|OTHER|1|||
19693571|NCT00509795|42139171|FG000|Overall Study|Protocol Violation|3|||
19693572|NCT00509795|42139172|FG001|Overall Study|Protocol Violation|0|||
19693573|NCT00509795|42139173|FG002|Overall Study|Protocol Violation|3|||
19693574|NCT00509795|42139174|FG003|Overall Study|Protocol Violation|1|||
19778854|NCT03086057|42234051|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
19778855|NCT03086057|42234052|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
19778856|NCT03086057|42234049|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
19778857|NCT03086057|42234050|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
19778858|NCT03086057|42234051|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
19778859|NCT03086057|42234052|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
19778860|NCT03086057|42234049|FG000|Stage 1: PrEP Uptake|Death|1|||
19778861|NCT03086057|42234050|FG001|Stage 1: PrEP Uptake|Death|0|||
19778862|NCT03086057|42234051|FG002|Stage 1: PrEP Uptake|Death|0|||
19778863|NCT03086057|42234052|FG003|Stage 1: PrEP Uptake|Death|0|||
19778864|NCT03086057|42234049|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
19778865|NCT03086057|42234050|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
19778866|NCT03086057|42234051|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
19778867|NCT03086057|42234052|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
19778868|NCT03086057|42234049|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
19778869|NCT03086057|42234050|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
19778870|NCT03086057|42234051|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
19778871|NCT03086057|42234052|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
19778872|NCT03086057|42234049|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
19778873|NCT03086057|42234050|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
19778874|NCT03086057|42234051|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
19778875|NCT03086057|42234052|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
19778876|NCT02759120|42234064|FG000|Overall Study|Death|34|||
19778877|NCT02759120|42234065|FG001|Overall Study|Death|36|||
19778878|NCT02759120|42234064|FG000|Overall Study|Lost to Follow-up|4|||
19778879|NCT02759120|42234065|FG001|Overall Study|Lost to Follow-up|7|||
19778880|NCT02759120|42234064|FG000|Overall Study|Physician Decision|3|||
19778881|NCT02759120|42234065|FG001|Overall Study|Physician Decision|0|||
19778882|NCT02759120|42234064|FG000|Overall Study|Withdrawal by Subject|28|||
19778883|NCT02759120|42234065|FG001|Overall Study|Withdrawal by Subject|15|||
19778884|NCT02759120|42234064|FG000|Overall Study|Moved out of area|3|||
19778885|NCT02759120|42234065|FG001|Overall Study|Moved out of area|4|||
19778886|NCT02759120|42234064|FG000|Overall Study|Lung transplant|3|||
19778887|NCT02759120|42234065|FG001|Overall Study|Lung transplant|5|||
19778888|NCT02759120|42234064|FG000|Overall Study|Other reason not completed|10|||
19778889|NCT02759120|42234065|FG001|Overall Study|Other reason not completed|12|||
19778890|NCT00101192|42234071|FG000|Overall Study|Ineligible|6|||
19778891|NCT00101192|42234071|FG000|Overall Study|Inevaluable|1|||
19778892|NCT03031431|42234075|FG000|Overall Study|Infant removed by maternal request|1|||
19607060|NCT04672252|42055832|FG001|Overall Study|Protocol Violation|0|||
19607061|NCT00584740|42055840|FG000|Overall Study|Adverse Event|1|||
19607062|NCT00584740|42055841|FG001|Overall Study|Adverse Event|1|||
19607063|NCT00584740|42055840|FG000|Overall Study|Lack of Efficacy|8|||
19607064|NCT00584740|42055841|FG001|Overall Study|Lack of Efficacy|2|||
19607065|NCT00584740|42055840|FG000|Overall Study|Withdrawal by Subject|3|||
19607066|NCT00584740|42055841|FG001|Overall Study|Withdrawal by Subject|2|||
19607067|NCT00584740|42055840|FG000|Overall Study|Lost to Follow-up|0|||
19607068|NCT00584740|42055841|FG001|Overall Study|Lost to Follow-up|1|||
19607069|NCT00942968|42055847|FG000|Overall Study|Adverse Event|60|||
19607070|NCT00942968|42055847|FG000|Overall Study|Death|76|||
19607071|NCT00942968|42055847|FG000|Overall Study|Protocol Violation|9|||
19607072|NCT00942968|42055847|FG000|Overall Study|Lost to Follow-up|4|||
19607073|NCT00942968|42055847|FG000|Overall Study|Withdrawal by Subject|44|||
19778893|NCT03029247|42234081|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
19607074|NCT00942968|42055847|FG000|Overall Study|Sponsor request|5|||
19693575|NCT00509795|42139171|FG000|Overall Study|Withdrawal by Subject|10|||
19693576|NCT00509795|42139172|FG001|Overall Study|Withdrawal by Subject|5|||
19607075|NCT00942968|42055847|FG000|Overall Study|Physician Decision|11|||
19693577|NCT00509795|42139173|FG002|Overall Study|Withdrawal by Subject|7|||
19693578|NCT00509795|42139174|FG003|Overall Study|Withdrawal by Subject|8|||
19693579|NCT00165789|42139189|FG000|Overall Study|Adverse Event|0|||
19693580|NCT00165789|42139190|FG001|Overall Study|Adverse Event|3|||
19693581|NCT00165789|42139191|FG002|Overall Study|Adverse Event|0|||
19693582|NCT00165789|42139192|FG003|Overall Study|Adverse Event|12|||
19693583|NCT00165789|42139189|FG000|Overall Study|Withdrawal by Subject|0|||
19693584|NCT00165789|42139190|FG001|Overall Study|Withdrawal by Subject|1|||
19693585|NCT00165789|42139191|FG002|Overall Study|Withdrawal by Subject|1|||
19693586|NCT00165789|42139192|FG003|Overall Study|Withdrawal by Subject|2|||
19693587|NCT00504257|42139202|FG000|Overall Study|Withdrawal by Subject|2|||
19693588|NCT00504257|42139202|FG000|Overall Study|ineligible histology|2|||
19693589|NCT00509093|42139206|FG000|Overall Study|Adverse Event|10|||
19778894|NCT03029247|42234082|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
19778895|NCT03029247|42234081|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
19778896|NCT03029247|42234082|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
19778897|NCT03029247|42234081|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
19778898|NCT03029247|42234082|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
19778899|NCT03029247|42234081|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
19778900|NCT03029247|42234082|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
19778901|NCT04313283|42234088|FG000|Overall Study|did not complete intervention|4|||
19778902|NCT02760368|42234095|FG000|Overall Study|Withdrawal by Subject|12|||
19778903|NCT02760368|42234096|FG001|Overall Study|Withdrawal by Subject|8|||
19778904|NCT02760368|42234097|FG002|Overall Study|Withdrawal by Subject|9|||
19778905|NCT02760368|42234095|FG000|Overall Study|Screen Failure|0|||
19778906|NCT02760368|42234096|FG001|Overall Study|Screen Failure|0|||
19778907|NCT02760368|42234097|FG002|Overall Study|Screen Failure|1|||
19778908|NCT02760368|42234095|FG000|Overall Study|Death|1|||
19778909|NCT02760368|42234096|FG001|Overall Study|Death|0|||
19778910|NCT02760368|42234097|FG002|Overall Study|Death|0|||
19778911|NCT02760368|42234095|FG000|Overall Study|Withdrawal by Sponsor|0|||
19778912|NCT02760368|42234096|FG001|Overall Study|Withdrawal by Sponsor|0|||
19778913|NCT02760368|42234097|FG002|Overall Study|Withdrawal by Sponsor|1|||
19778914|NCT03026283|42234105|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
19778915|NCT03026283|42234106|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
19778916|NCT03026283|42234107|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
19778917|NCT03026283|42234108|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
19778918|NCT03026283|42234109|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
19778919|NCT03026283|42234110|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
19778920|NCT03026283|42234111|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
19778921|NCT03026283|42234112|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
19778922|NCT03026283|42234105|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
19778923|NCT03026283|42234106|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
19778924|NCT03026283|42234107|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
19778925|NCT03026283|42234108|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
19778926|NCT03026283|42234109|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
19778927|NCT03026283|42234110|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
19778928|NCT03026283|42234111|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
19778929|NCT03026283|42234112|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
19778930|NCT03026283|42234105|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778931|NCT03026283|42234106|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
19778932|NCT03026283|42234107|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778933|NCT03026283|42234108|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778934|NCT03026283|42234109|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778935|NCT03026283|42234110|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778936|NCT03026283|42234111|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778937|NCT03026283|42234112|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
19778938|NCT03026283|42234105|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778939|NCT03026283|42234106|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778940|NCT03026283|42234107|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
19778941|NCT03026283|42234108|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778942|NCT03026283|42234109|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778943|NCT03026283|42234110|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778944|NCT03026283|42234111|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778945|NCT03026283|42234112|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
19778946|NCT03026283|42234105|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19389165|NCT01625182|41632779|FG000|Overall Study|Withdrawal by Subject|5|||
19389166|NCT01625182|41632780|FG001|Overall Study|Withdrawal by Subject|1|||
19693590|NCT00509093|42139206|FG000|Overall Study|Disease Progression|9|||
19693591|NCT00509093|42139206|FG000|Overall Study|Transformed into MDS|1|||
19693592|NCT00509093|42139206|FG000|Overall Study|Withdrawal by Subject|3|||
19693593|NCT00509093|42139206|FG000|Overall Study|Physician Decision|1|||
19778947|NCT03026283|42234106|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19778948|NCT03026283|42234107|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19778949|NCT03026283|42234108|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
19778950|NCT03026283|42234109|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
19778951|NCT03026283|42234110|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19778952|NCT03026283|42234111|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19778953|NCT03026283|42234112|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
19778954|NCT03026283|42234105|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
19778955|NCT03026283|42234106|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
19778956|NCT03026283|42234107|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
19778957|NCT03026283|42234108|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
19778958|NCT03026283|42234109|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
19778959|NCT03026283|42234110|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
19778960|NCT03026283|42234111|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
19778961|NCT03026283|42234112|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
19778962|NCT03026283|42234105|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778963|NCT03026283|42234106|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778964|NCT03026283|42234107|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778965|NCT03026283|42234108|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
19778966|NCT03026283|42234109|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778967|NCT03026283|42234110|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
19778968|NCT03026283|42234111|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778969|NCT03026283|42234112|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
19778970|NCT03026283|42234105|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778971|NCT03026283|42234106|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778972|NCT03026283|42234107|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778973|NCT03026283|42234108|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
19778974|NCT03026283|42234109|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778975|NCT03026283|42234110|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778976|NCT03026283|42234111|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778977|NCT03026283|42234112|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
19778978|NCT03026283|42234105|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778979|NCT03026283|42234106|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778980|NCT03026283|42234107|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778981|NCT03026283|42234108|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778982|NCT03026283|42234109|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
19778983|NCT03026283|42234110|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
19778984|NCT03026283|42234111|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778985|NCT03026283|42234112|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
19778986|NCT02754440|42234129|FG000|Overall Study|Protocol Violation|3|||
19778987|NCT02754440|42234130|FG001|Overall Study|Protocol Violation|2|||
19778988|NCT02754440|42234131|FG002|Overall Study|Protocol Violation|2|||
19778989|NCT02754440|42234132|FG003|Overall Study|Protocol Violation|6|||
19778990|NCT02754440|42234129|FG000|Overall Study|Adverse Event|3|||
19778991|NCT02754440|42234130|FG001|Overall Study|Adverse Event|1|||
19778992|NCT02754440|42234131|FG002|Overall Study|Adverse Event|0|||
19778993|NCT02754440|42234132|FG003|Overall Study|Adverse Event|9|||
19778994|NCT02754440|42234129|FG000|Overall Study|Withdrawal by Subject|0|||
19778995|NCT02754440|42234130|FG001|Overall Study|Withdrawal by Subject|0|||
19778996|NCT02754440|42234131|FG002|Overall Study|Withdrawal by Subject|0|||
19693594|NCT00160641|42139210|FG000|Overall Study|Adverse Event|102|||
19693595|NCT00160641|42139210|FG000|Overall Study|Withdrawal by Subject|87|||
19693596|NCT00160641|42139210|FG000|Overall Study|Lost to Follow-up|8|||
19693597|NCT00160641|42139210|FG000|Overall Study|Lack of Efficacy|12|||
19693598|NCT00160641|42139210|FG000|Overall Study|Protocol Violation|3|||
19693599|NCT00160641|42139210|FG000|Overall Study|Other|9|||
19693600|NCT00493025|42139214|FG000|Overall Study|Physician Decision|19|||
19693601|NCT00160563|42139222|FG000|Overall Study|Adverse Event|1|||
19693602|NCT00160563|42139223|FG001|Overall Study|Adverse Event|1|||
19693603|NCT00160563|42139224|FG002|Overall Study|Adverse Event|1|||
19693604|NCT00160563|42139222|FG000|Overall Study|Lost to Follow-up|1|||
19693605|NCT00160563|42139223|FG001|Overall Study|Lost to Follow-up|1|||
19693606|NCT00160563|42139224|FG002|Overall Study|Lost to Follow-up|2|||
19693607|NCT00160563|42139222|FG000|Overall Study|Protocol Violation|0|||
19693608|NCT00160563|42139223|FG001|Overall Study|Protocol Violation|0|||
19693609|NCT00160563|42139224|FG002|Overall Study|Protocol Violation|3|||
19693610|NCT00160563|42139222|FG000|Overall Study|Withdrawal by Subject|1|||
19693611|NCT00160563|42139223|FG001|Overall Study|Withdrawal by Subject|2|||
19693612|NCT00160563|42139224|FG002|Overall Study|Withdrawal by Subject|3|||
19778997|NCT02754440|42234132|FG003|Overall Study|Withdrawal by Subject|1|||
19778998|NCT02754440|42234129|FG000|Overall Study|Equipment failure|0|||
19778999|NCT02754440|42234130|FG001|Overall Study|Equipment failure|5|||
19779000|NCT02754440|42234131|FG002|Overall Study|Equipment failure|5|||
19779001|NCT02754440|42234132|FG003|Overall Study|Equipment failure|7|||
19779002|NCT02754440|42234129|FG000|Overall Study|Subject issues not resulting in AE|0|||
19779003|NCT02754440|42234130|FG001|Overall Study|Subject issues not resulting in AE|0|||
19779004|NCT02754440|42234131|FG002|Overall Study|Subject issues not resulting in AE|0|||
19779005|NCT02754440|42234132|FG003|Overall Study|Subject issues not resulting in AE|12|||
19779006|NCT02753816|42234144|FG000|Overall Study|Protocol Violation|0|||
19779007|NCT02753816|42234145|FG001|Overall Study|Protocol Violation|1|||
19779008|NCT02753816|42234146|FG002|Overall Study|Protocol Violation|0|||
19779009|NCT02752802|42234154|FG000|Overall Study|Contrast Volume Not Collected|1|||
19779010|NCT02752802|42234155|FG001|Overall Study|Contrast Volume Not Collected|0|||
19779011|NCT02756078|42234163|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
19779012|NCT02756078|42234164|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
19779013|NCT02756078|42234163|FG000|Period 1|Lost to Follow-up|0|||
19779014|NCT02756078|42234164|FG001|Period 1|Lost to Follow-up|2|||
19779015|NCT02756078|42234163|FG000|Period 1|Protocol Violation|0|||
19779016|NCT02756078|42234164|FG001|Period 1|Protocol Violation|1|||
19779017|NCT02756078|42234163|FG000|Period 1|Adverse Event|1|||
19779018|NCT02756078|42234164|FG001|Period 1|Adverse Event|10|||
19367257|NCT02435992|41607419|FG004|Overall Study|Other Reason|0|||
19367258|NCT02435992|41607415|FG000|Overall Study|Physician Decision|0|||
19693613|NCT00160563|42139222|FG000|Overall Study|Other (listed in the study report)|48|||
19693614|NCT00160563|42139223|FG001|Overall Study|Other (listed in the study report)|40|||
19693615|NCT00160563|42139224|FG002|Overall Study|Other (listed in the study report)|81|||
19693616|NCT00160563|42139222|FG000|Overall Study|Missing reason|0|||
19693617|NCT00160563|42139223|FG001|Overall Study|Missing reason|1|||
19693618|NCT00160563|42139224|FG002|Overall Study|Missing reason|0|||
19693619|NCT00380744|42139240|FG000|Overall Study|Death|0|||
19693620|NCT00380744|42139241|FG001|Overall Study|Death|0|||
19693621|NCT00380744|42139242|FG002|Overall Study|Death|0|||
19693622|NCT00380744|42139243|FG003|Overall Study|Death|0|||
19693623|NCT00380744|42139244|FG004|Overall Study|Death|0|||
19693624|NCT00380744|42139245|FG005|Overall Study|Death|0|||
19693625|NCT00380744|42139246|FG006|Overall Study|Death|1|||
19693626|NCT00380744|42139240|FG000|Overall Study|Withdrawal by Subject|1|||
19693627|NCT00380744|42139241|FG001|Overall Study|Withdrawal by Subject|0|||
19693628|NCT00380744|42139242|FG002|Overall Study|Withdrawal by Subject|0|||
19693629|NCT00380744|42139243|FG003|Overall Study|Withdrawal by Subject|0|||
19693630|NCT00380744|42139244|FG004|Overall Study|Withdrawal by Subject|0|||
19693631|NCT00380744|42139245|FG005|Overall Study|Withdrawal by Subject|0|||
19693632|NCT00380744|42139246|FG006|Overall Study|Withdrawal by Subject|0|||
19693633|NCT00380588|42139265|FG000|Overall Study|Unequivocal Disease Progression|25|||
19693634|NCT00380588|42139266|FG001|Overall Study|Unequivocal Disease Progression|34|||
19693635|NCT00380588|42139265|FG000|Overall Study|Next Cycle Not Started|4|||
19693636|NCT00380588|42139266|FG001|Overall Study|Next Cycle Not Started|0|||
19693637|NCT00380588|42139265|FG000|Overall Study|Adverse Event|7|||
19693638|NCT00380588|42139266|FG001|Overall Study|Adverse Event|3|||
19693639|NCT00380588|42139265|FG000|Overall Study|Withdrawal by Subject|1|||
19693640|NCT00380588|42139266|FG001|Overall Study|Withdrawal by Subject|3|||
19693641|NCT00380588|42139265|FG000|Overall Study|Physician Decision|2|||
19693642|NCT00380588|42139266|FG001|Overall Study|Physician Decision|0|||
19693643|NCT00379808|42139272|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
19693644|NCT00379808|42139273|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
19693645|NCT00355784|42139282|FG000|Overall Study|Withdrawal by Subject|0|||
19693646|NCT00355784|42139283|FG001|Overall Study|Withdrawal by Subject|0|||
19693647|NCT00355784|42139284|FG002|Overall Study|Withdrawal by Subject|2|||
19693648|NCT00355472|42139293|FG000|Overall Study|Physician Decision|1|||
19693649|NCT00492557|42139307|FG000|Overall Study|Subject request|12|||
19693650|NCT00492557|42139308|FG001|Overall Study|Subject request|11|||
19693651|NCT00492557|42139307|FG000|Overall Study|Protocol Violation|7|||
19693652|NCT00492557|42139308|FG001|Overall Study|Protocol Violation|8|||
19693653|NCT00492557|42139307|FG000|Overall Study|Other|2|||
19693654|NCT00492557|42139308|FG001|Overall Study|Other|2|||
19693655|NCT00492557|42139307|FG000|Overall Study|Death|1|||
19693656|NCT00492557|42139308|FG001|Overall Study|Death|1|||
19693657|NCT00492557|42139307|FG000|Overall Study|Adverse Event|1|||
19693658|NCT00492557|42139308|FG001|Overall Study|Adverse Event|0|||
19693659|NCT00492557|42139307|FG000|Overall Study|Failed to return|1|||
19693660|NCT00492557|42139308|FG001|Overall Study|Failed to return|0|||
19693661|NCT00492557|42139307|FG000|Overall Study|Lost to Follow-up|0|||
19693662|NCT00492557|42139308|FG001|Overall Study|Lost to Follow-up|1|||
19693663|NCT00508391|42139319|FG000|First Treatment|Withdrawal by Subject|6|||
19693664|NCT00508391|42139320|FG001|First Treatment|Withdrawal by Subject|3|||
19779019|NCT02756078|42234163|FG000|Period 1|Withdrawal by Subject|6|||
19779020|NCT02756078|42234164|FG001|Period 1|Withdrawal by Subject|6|||
19779021|NCT02756078|42234163|FG000|Period 1|Lens Discomfort|2|||
19779022|NCT02756078|42234164|FG001|Period 1|Lens Discomfort|2|||
19779023|NCT02756078|42234163|FG000|Period 2|Adverse Event|3|||
19779024|NCT02756078|42234164|FG001|Period 2|Adverse Event|5|||
19779025|NCT02756078|42234163|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
19779026|NCT02756078|42234164|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
19779027|NCT02756078|42234163|FG000|Period 2|Withdrawal by Subject|3|||
19779028|NCT02756078|42234164|FG001|Period 2|Withdrawal by Subject|1|||
19779029|NCT03813147|42234172|FG000|Overall Study|Lack of Efficacy|4|||
19779030|NCT03813147|42234173|FG001|Overall Study|Lack of Efficacy|4|||
19779031|NCT03813147|42234172|FG000|Overall Study|Physician Decision|2|||
19779032|NCT03813147|42234173|FG001|Overall Study|Physician Decision|1|||
19779033|NCT02752958|42234179|FG000|Overall Study|Adverse Event|3|||
19779034|NCT02752958|42234179|FG000|Overall Study|Lost to Follow-up|1|||
19779035|NCT02752958|42234179|FG000|Overall Study|Protocol Violation|1|||
19779036|NCT02752958|42234179|FG000|Overall Study|Withdrawal by Subject|2|||
19779037|NCT02752958|42234179|FG000|Overall Study|Other (Reason not specified)|2|||
19779038|NCT02805660|42234192|FG000|Overall Study|Death|5|||
19779039|NCT02805660|42234193|FG001|Overall Study|Death|2|||
19779040|NCT02805660|42234194|FG002|Overall Study|Death|9|||
19779041|NCT02805660|42234195|FG003|Overall Study|Death|5|||
19779042|NCT02805660|42234196|FG004|Overall Study|Death|0|||
19779043|NCT02805660|42234197|FG005|Overall Study|Death|14|||
19779044|NCT02805660|42234198|FG006|Overall Study|Death|12|||
19779045|NCT02805660|42234192|FG000|Overall Study|Lost to Follow-up|0|||
19779046|NCT02805660|42234193|FG001|Overall Study|Lost to Follow-up|1|||
19779047|NCT02805660|42234194|FG002|Overall Study|Lost to Follow-up|1|||
19779048|NCT02805660|42234195|FG003|Overall Study|Lost to Follow-up|2|||
19779049|NCT02805660|42234196|FG004|Overall Study|Lost to Follow-up|0|||
19779050|NCT02805660|42234197|FG005|Overall Study|Lost to Follow-up|0|||
19779051|NCT02805660|42234198|FG006|Overall Study|Lost to Follow-up|0|||
19779052|NCT02805660|42234192|FG000|Overall Study|Withdrawal by Subject|0|||
19779053|NCT02805660|42234193|FG001|Overall Study|Withdrawal by Subject|0|||
19779054|NCT02805660|42234194|FG002|Overall Study|Withdrawal by Subject|0|||
19779055|NCT02805660|42234195|FG003|Overall Study|Withdrawal by Subject|3|||
19779056|NCT02805660|42234196|FG004|Overall Study|Withdrawal by Subject|1|||
19779057|NCT02805660|42234197|FG005|Overall Study|Withdrawal by Subject|0|||
19779058|NCT02805660|42234198|FG006|Overall Study|Withdrawal by Subject|2|||
19779059|NCT02805660|42234192|FG000|Overall Study|Study terminated by Sponsor|0|||
19779060|NCT02805660|42234193|FG001|Overall Study|Study terminated by Sponsor|0|||
19779061|NCT02805660|42234194|FG002|Overall Study|Study terminated by Sponsor|1|||
19779062|NCT02805660|42234195|FG003|Overall Study|Study terminated by Sponsor|4|||
19779063|NCT02805660|42234196|FG004|Overall Study|Study terminated by Sponsor|2|||
19779064|NCT02805660|42234197|FG005|Overall Study|Study terminated by Sponsor|3|||
19779065|NCT02805660|42234198|FG006|Overall Study|Study terminated by Sponsor|1|||
19779066|NCT02805660|42234192|FG000|Overall Study|Miscellaneous|0|||
19779067|NCT02805660|42234193|FG001|Overall Study|Miscellaneous|1|||
19779068|NCT02805660|42234194|FG002|Overall Study|Miscellaneous|0|||
19779069|NCT02805660|42234195|FG003|Overall Study|Miscellaneous|4|||
19779070|NCT02805660|42234196|FG004|Overall Study|Miscellaneous|0|||
19779071|NCT02805660|42234197|FG005|Overall Study|Miscellaneous|6|||
19779072|NCT02805660|42234198|FG006|Overall Study|Miscellaneous|4|||
19779073|NCT02807376|42234229|FG000|Overall Study|Intra-operative exclusion criteria|3|||
19779074|NCT02807376|42234230|FG001|Overall Study|Intra-operative exclusion criteria|0|||
19779075|NCT02807376|42234229|FG000|Overall Study|Lost to Follow-up|0|||
19779076|NCT02807376|42234230|FG001|Overall Study|Lost to Follow-up|1|||
19779077|NCT02804178|42234236|FG000|Overall Study|Adverse Event|1|||
19779078|NCT02917941|42234240|FG000|Treatment Period|Adverse Event|11|||
19779079|NCT02917941|42234240|FG000|Treatment Period|Progressive Disease|11|||
19779080|NCT02917941|42234240|FG000|Treatment Period|Reason not Specified|2|||
19607076|NCT00942968|42055847|FG000|Overall Study|Progression of disease|12|||
19607077|NCT00942968|42055847|FG000|Overall Study|Inferior vena cava filter placement|4|||
19607078|NCT00942968|42055847|FG000|Overall Study|Pulmonary embolism (PE)|1|||
19779081|NCT02917941|42234240|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
19779082|NCT02917941|42234240|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
19779083|NCT01333956|42234248|FG000|Overall Study|Lost to Follow-up|1|||
19779084|NCT01333956|42234249|FG001|Overall Study|Lost to Follow-up|2|||
19779085|NCT01333956|42234250|FG002|Overall Study|Lost to Follow-up|0|||
19779086|NCT01333956|42234251|FG003|Overall Study|Lost to Follow-up|1|||
19779087|NCT01333956|42234248|FG000|Overall Study|Unable to complete study procedure|1|||
19779088|NCT01333956|42234249|FG001|Overall Study|Unable to complete study procedure|0|||
19779089|NCT01333956|42234250|FG002|Overall Study|Unable to complete study procedure|0|||
19779090|NCT01333956|42234251|FG003|Overall Study|Unable to complete study procedure|1|||
19779091|NCT01333956|42234248|FG000|Overall Study|Withdrawal by Subject|0|||
19779092|NCT01333956|42234249|FG001|Overall Study|Withdrawal by Subject|2|||
19779093|NCT01333956|42234250|FG002|Overall Study|Withdrawal by Subject|1|||
19779094|NCT01333956|42234251|FG003|Overall Study|Withdrawal by Subject|0|||
19779095|NCT01333722|42234264|FG000|Overall Study|Lack of Efficacy|0|||
19779096|NCT01333722|42234265|FG001|Overall Study|Lack of Efficacy|2|||
19779097|NCT01333722|42234264|FG000|Overall Study|Withdrawal by Subject|0|||
19779098|NCT01333722|42234265|FG001|Overall Study|Withdrawal by Subject|1|||
19779099|NCT01370694|42234273|FG000|Overall Study|Switched to rituximab|4|||
19779100|NCT01370694|42234273|FG000|Overall Study|Progressive disease|2|||
19779101|NCT03315143|42234279|FG000|Overall Study|Death|240|||
19779102|NCT03315143|42234280|FG001|Overall Study|Death|246|||
19779103|NCT03315143|42234279|FG000|Overall Study|Withdrawal by Subject|57|||
19779104|NCT03315143|42234280|FG001|Overall Study|Withdrawal by Subject|68|||
19779105|NCT03315143|42234279|FG000|Overall Study|Site Terminated by Sponsor|256|||
19779106|NCT03315143|42234280|FG001|Overall Study|Site Terminated by Sponsor|282|||
19779107|NCT03315143|42234279|FG000|Overall Study|Study Terminated by Sponsor|4723|||
19779108|NCT03315143|42234280|FG001|Overall Study|Study Terminated by Sponsor|4664|||
19779109|NCT03315143|42234279|FG000|Overall Study|Reason not Specified|16|||
19779110|NCT03315143|42234280|FG001|Overall Study|Reason not Specified|32|||
19779111|NCT02797080|42234286|FG000|Overall Study|Lost to Follow-up|1|||
19779112|NCT02797080|42234286|FG000|Overall Study|Withdrawal by Subject|1|||
19779113|NCT02915835|42234292|FG000|Overall Study|Physician Decision|1|||
19779114|NCT02915835|42234293|FG001|Overall Study|Physician Decision|0|||
19779115|NCT02915835|42234292|FG000|Overall Study|Withdrawal by Subject|0|||
19779116|NCT02915835|42234293|FG001|Overall Study|Withdrawal by Subject|1|||
19779117|NCT01370616|42234301|FG000|Overall Study|Adverse Event|11|||
19779118|NCT01370616|42234302|FG001|Overall Study|Adverse Event|16|||
19779119|NCT01370616|42234301|FG000|Overall Study|Death|1|||
19779120|NCT01370616|42234302|FG001|Overall Study|Death|0|||
19779121|NCT01370616|42234301|FG000|Overall Study|Lack of Efficacy|6|||
19779122|NCT01370616|42234302|FG001|Overall Study|Lack of Efficacy|2|||
19779123|NCT01370616|42234301|FG000|Overall Study|Lost to Follow-up|0|||
19779124|NCT01370616|42234302|FG001|Overall Study|Lost to Follow-up|3|||
19779125|NCT01370616|42234301|FG000|Overall Study|Physician Decision|6|||
19779126|NCT01370616|42234302|FG001|Overall Study|Physician Decision|6|||
19779127|NCT01370616|42234301|FG000|Overall Study|Progressive Disease|0|||
19779128|NCT01370616|42234302|FG001|Overall Study|Progressive Disease|1|||
19779129|NCT01370616|42234301|FG000|Overall Study|Recovery|1|||
19779130|NCT01370616|42234302|FG001|Overall Study|Recovery|0|||
19779131|NCT01370616|42234301|FG000|Overall Study|Technical Problems|3|||
19779132|NCT01370616|42234302|FG001|Overall Study|Technical Problems|5|||
19779133|NCT01370616|42234301|FG000|Overall Study|Withdrawal by Subject|34|||
19779134|NCT01370616|42234302|FG001|Overall Study|Withdrawal by Subject|34|||
19779135|NCT02916927|42234315|FG000|Overall Study|Discharged prior to study drug receipt|0|||
19693665|NCT00508391|42139319|FG000|Second Treatment|Withdrawal by Subject|2|||
19693666|NCT00508391|42139320|FG001|Second Treatment|Withdrawal by Subject|0|||
19693667|NCT00508157|42139330|FG000|Overall Study|Adverse Event|0|||
19693668|NCT00508157|42139331|FG001|Overall Study|Adverse Event|1|||
19693669|NCT00508157|42139330|FG000|Overall Study|Subject Withdrew Consent|1|||
19693670|NCT00508157|42139331|FG001|Overall Study|Subject Withdrew Consent|0|||
19693671|NCT00508157|42139330|FG000|Overall Study|Lost to Follow-up|1|||
19693672|NCT00508157|42139331|FG001|Overall Study|Lost to Follow-up|0|||
19693673|NCT00508157|42139330|FG000|Overall Study|Subject no longer met study criteria|0|||
19693674|NCT00508157|42139331|FG001|Overall Study|Subject no longer met study criteria|1|||
19693675|NCT00508157|42139330|FG000|Overall Study|Other known cause|0|||
19693676|NCT00508157|42139331|FG001|Overall Study|Other known cause|1|||
19693677|NCT00378560|42139339|FG000|Overall Study|Adverse Event|1|||
19693678|NCT00378560|42139340|FG001|Overall Study|Adverse Event|0|||
19693679|NCT00378560|42139339|FG000|Overall Study|Lost to Follow-up|24|||
19693680|NCT00378560|42139340|FG001|Overall Study|Lost to Follow-up|29|||
19693681|NCT00378560|42139339|FG000|Overall Study|Protocol Violation|2|||
19693682|NCT00378560|42139340|FG001|Overall Study|Protocol Violation|0|||
19693683|NCT00378560|42139339|FG000|Overall Study|Withdrawal by Subject|17|||
19693684|NCT00378560|42139340|FG001|Overall Study|Withdrawal by Subject|21|||
19693685|NCT00378560|42139339|FG000|Overall Study|Moved|4|||
19779136|NCT02916927|42234316|FG001|Overall Study|Discharged prior to study drug receipt|2|||
19779137|NCT02916927|42234315|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
19779138|NCT02916927|42234316|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
19779139|NCT02916927|42234315|FG000|Overall Study|Withdrawal before first time point|1|||
19779140|NCT02916927|42234316|FG001|Overall Study|Withdrawal before first time point|0|||
19779141|NCT02916693|42234322|FG000|Overall Study|Lost to Follow-up|7|||
19779142|NCT02574455|42234332|FG000|Overall Study|Death|197|||
19779143|NCT02574455|42234333|FG001|Overall Study|Death|210|||
19779144|NCT02574455|42234332|FG000|Overall Study|Withdrawal of Consent|11|||
19779145|NCT02574455|42234333|FG001|Overall Study|Withdrawal of Consent|28|||
19693686|NCT00378560|42139340|FG001|Overall Study|Moved|3|||
19693687|NCT00378560|42139339|FG000|Overall Study|Pregnancy|7|||
19693688|NCT00378560|42139340|FG001|Overall Study|Pregnancy|5|||
19693689|NCT00378560|42139339|FG000|Overall Study|Laboratory test values abnormal|1|||
19693690|NCT00378560|42139340|FG001|Overall Study|Laboratory test values abnormal|0|||
19779146|NCT02574455|42234332|FG000|Overall Study|Lost to Follow-up|4|||
19779147|NCT02574455|42234333|FG001|Overall Study|Lost to Follow-up|4|||
19779148|NCT02574455|42234332|FG000|Overall Study|Sponsor's Decision|55|||
19779149|NCT02574455|42234333|FG001|Overall Study|Sponsor's Decision|20|||
19779150|NCT02795832|42234345|FG000|Overall Study|Adverse Event|0|||
19779151|NCT02795832|42234346|FG001|Overall Study|Adverse Event|0|||
19779152|NCT02795832|42234347|FG002|Overall Study|Adverse Event|0|||
19779153|NCT02795832|42234348|FG003|Overall Study|Adverse Event|0|||
19779154|NCT02795832|42234349|FG004|Overall Study|Adverse Event|0|||
19779155|NCT02795832|42234350|FG005|Overall Study|Adverse Event|3|||
19779156|NCT02794974|42234374|FG000|Overall Study|Physician Decision|0|||
19779157|NCT02794974|42234375|FG001|Overall Study|Physician Decision|1|||
19779158|NCT02419417|42234392|FG000|Overall Study|Disease progression|5|||
19779159|NCT02419417|42234393|FG001|Overall Study|Disease progression|4|||
19779160|NCT02419417|42234394|FG002|Overall Study|Disease progression|13|||
19693691|NCT00508001|42139349|FG000|Overall Study|Adverse Event|2|||
19779161|NCT02419417|42234395|FG003|Overall Study|Disease progression|10|||
19779162|NCT02419417|42234396|FG004|Overall Study|Disease progression|10|||
19779163|NCT02419417|42234397|FG005|Overall Study|Disease progression|3|||
19779164|NCT02419417|42234398|FG006|Overall Study|Disease progression|4|||
19779165|NCT02419417|42234399|FG007|Overall Study|Disease progression|5|||
19779166|NCT02419417|42234400|FG008|Overall Study|Disease progression|13|||
19693692|NCT00508001|42139350|FG001|Overall Study|Adverse Event|0|||
19693693|NCT00508001|42139351|FG002|Overall Study|Adverse Event|4|||
19693694|NCT00508001|42139349|FG000|Overall Study|condition under investigation worsened|13|||
19693695|NCT00508001|42139350|FG001|Overall Study|condition under investigation worsened|7|||
19693696|NCT00508001|42139351|FG002|Overall Study|condition under investigation worsened|1|||
19693697|NCT00508001|42139349|FG000|Overall Study|Death|0|||
19693698|NCT00508001|42139350|FG001|Overall Study|Death|1|||
19693699|NCT00508001|42139351|FG002|Overall Study|Death|1|||
19779167|NCT02419417|42234401|FG009|Overall Study|Disease progression|9|||
19693700|NCT00508001|42139349|FG000|Overall Study|Withdrawal by Subject|4|||
19693701|NCT00508001|42139350|FG001|Overall Study|Withdrawal by Subject|4|||
19693702|NCT00508001|42139351|FG002|Overall Study|Withdrawal by Subject|1|||
19693703|NCT00507689|42139362|FG000|Pre-Randomization Period|Adverse Event|1|||
19693704|NCT00507689|42139363|FG001|Pre-Randomization Period|Adverse Event|0|||
19693705|NCT00507689|42139362|FG000|Pre-Randomization Period|Physician Decision|1|||
19693706|NCT00507689|42139363|FG001|Pre-Randomization Period|Physician Decision|0|||
19693707|NCT00507689|42139362|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
19693708|NCT00507689|42139363|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
19693709|NCT00507689|42139362|FG000|Randomized Period|Adverse Event|1|||
19693710|NCT00507689|42139363|FG001|Randomized Period|Adverse Event|1|||
19693711|NCT00507689|42139362|FG000|Randomized Period|Withdrawal by Subject|0|||
19693712|NCT00507689|42139363|FG001|Randomized Period|Withdrawal by Subject|1|||
19693713|NCT00491387|42139370|FG000|Overall Study|study terminated|20|||
19693714|NCT00491075|42139374|FG000|Overall Study|Withdrawal by Subject|1|||
19693715|NCT00491075|42139374|FG000|Overall Study|Physician Decision|1|||
19693716|NCT00507455|42139381|FG000|Overall Study|Adverse Event|3|||
19693717|NCT00507455|42139382|FG001|Overall Study|Adverse Event|3|||
19693718|NCT00507455|42139383|FG002|Overall Study|Adverse Event|6|||
19693719|NCT00507455|42139381|FG000|Overall Study|Withdrawal by Subject|2|||
19693720|NCT00507455|42139382|FG001|Overall Study|Withdrawal by Subject|1|||
19693721|NCT00507455|42139383|FG002|Overall Study|Withdrawal by Subject|2|||
19693722|NCT00507455|42139381|FG000|Overall Study|Protocol Violation|4|||
19693723|NCT00507455|42139382|FG001|Overall Study|Protocol Violation|1|||
19693724|NCT00507455|42139383|FG002|Overall Study|Protocol Violation|1|||
19693725|NCT00507455|42139381|FG000|Overall Study|Lost to Follow-up|2|||
19693726|NCT00507455|42139382|FG001|Overall Study|Lost to Follow-up|0|||
19693727|NCT00507455|42139383|FG002|Overall Study|Lost to Follow-up|2|||
19693728|NCT00507455|42139381|FG000|Overall Study|Lack of Efficacy|0|||
19693729|NCT00507455|42139382|FG001|Overall Study|Lack of Efficacy|1|||
19693730|NCT00507455|42139383|FG002|Overall Study|Lack of Efficacy|0|||
19693731|NCT00507455|42139381|FG000|Overall Study|Other - miscellaneous reason|1|||
19693732|NCT00507455|42139382|FG001|Overall Study|Other - miscellaneous reason|0|||
19779168|NCT02419417|42234402|FG010|Overall Study|Disease progression|0|||
19779169|NCT02419417|42234392|FG000|Overall Study|Study drug toxicity|0|||
19779170|NCT02419417|42234393|FG001|Overall Study|Study drug toxicity|0|||
19779171|NCT02419417|42234394|FG002|Overall Study|Study drug toxicity|0|||
19779172|NCT02419417|42234395|FG003|Overall Study|Study drug toxicity|0|||
19779173|NCT02419417|42234396|FG004|Overall Study|Study drug toxicity|1|||
19779174|NCT02419417|42234397|FG005|Overall Study|Study drug toxicity|0|||
19779175|NCT02419417|42234398|FG006|Overall Study|Study drug toxicity|0|||
19367259|NCT02435992|41607416|FG001|Overall Study|Physician Decision|0|||
19693733|NCT00507455|42139383|FG002|Overall Study|Other - miscellaneous reason|1|||
19693734|NCT00506831|42139391|FG000|Overall Study|Death|1|||
19693735|NCT00506831|42139391|FG000|Overall Study|Withdrawal by Subject|1|||
19693736|NCT00506753|42139397|FG000|Overall Study|Lost to Follow-up|21|||
19693737|NCT00506753|42139398|FG001|Overall Study|Lost to Follow-up|15|||
19693738|NCT00490919|42139406|FG000|Open-label Run-in Period|Adverse Event|239|||
19693739|NCT00490919|42139407|FG001|Open-label Run-in Period|Adverse Event|0|||
19779176|NCT02419417|42234399|FG007|Overall Study|Study drug toxicity|0|||
19779177|NCT02419417|42234400|FG008|Overall Study|Study drug toxicity|0|||
19779178|NCT02419417|42234401|FG009|Overall Study|Study drug toxicity|0|||
19779179|NCT02419417|42234402|FG010|Overall Study|Study drug toxicity|0|||
19779180|NCT02419417|42234392|FG000|Overall Study|Adverse event unrelated to study drug|0|||
19779181|NCT02419417|42234393|FG001|Overall Study|Adverse event unrelated to study drug|0|||
19779182|NCT02419417|42234394|FG002|Overall Study|Adverse event unrelated to study drug|0|||
19779183|NCT02419417|42234395|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19779184|NCT02419417|42234396|FG004|Overall Study|Adverse event unrelated to study drug|2|||
19779185|NCT02419417|42234397|FG005|Overall Study|Adverse event unrelated to study drug|1|||
19779186|NCT02419417|42234398|FG006|Overall Study|Adverse event unrelated to study drug|0|||
19779187|NCT02419417|42234399|FG007|Overall Study|Adverse event unrelated to study drug|1|||
19779188|NCT02419417|42234400|FG008|Overall Study|Adverse event unrelated to study drug|0|||
19779189|NCT02419417|42234401|FG009|Overall Study|Adverse event unrelated to study drug|0|||
19779190|NCT02419417|42234402|FG010|Overall Study|Adverse event unrelated to study drug|0|||
19779191|NCT02419417|42234392|FG000|Overall Study|Participant request to discontinue|0|||
19779192|NCT02419417|42234393|FG001|Overall Study|Participant request to discontinue|0|||
19779193|NCT02419417|42234394|FG002|Overall Study|Participant request to discontinue|0|||
19779194|NCT02419417|42234395|FG003|Overall Study|Participant request to discontinue|0|||
19779195|NCT02419417|42234396|FG004|Overall Study|Participant request to discontinue|0|||
19779196|NCT02419417|42234397|FG005|Overall Study|Participant request to discontinue|0|||
19779197|NCT02419417|42234398|FG006|Overall Study|Participant request to discontinue|0|||
19779198|NCT02419417|42234399|FG007|Overall Study|Participant request to discontinue|0|||
19779199|NCT02419417|42234400|FG008|Overall Study|Participant request to discontinue|0|||
19779200|NCT02419417|42234401|FG009|Overall Study|Participant request to discontinue|1|||
19779201|NCT02419417|42234402|FG010|Overall Study|Participant request to discontinue|0|||
19779202|NCT02419417|42234392|FG000|Overall Study|Withdrawal by Subject|0|||
19779203|NCT02419417|42234393|FG001|Overall Study|Withdrawal by Subject|0|||
19779204|NCT02419417|42234394|FG002|Overall Study|Withdrawal by Subject|0|||
19779205|NCT02419417|42234395|FG003|Overall Study|Withdrawal by Subject|0|||
19779206|NCT02419417|42234396|FG004|Overall Study|Withdrawal by Subject|0|||
19779207|NCT02419417|42234397|FG005|Overall Study|Withdrawal by Subject|0|||
19779208|NCT02419417|42234398|FG006|Overall Study|Withdrawal by Subject|0|||
19779209|NCT02419417|42234399|FG007|Overall Study|Withdrawal by Subject|0|||
19779210|NCT02419417|42234400|FG008|Overall Study|Withdrawal by Subject|0|||
19779211|NCT02419417|42234401|FG009|Overall Study|Withdrawal by Subject|0|||
19693740|NCT00490919|42139408|FG002|Open-label Run-in Period|Adverse Event|0|||
19693741|NCT00490919|42139406|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
19693742|NCT00490919|42139407|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
19693743|NCT00490919|42139408|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
19693744|NCT00490919|42139406|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
19693745|NCT00490919|42139407|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
19693746|NCT00490919|42139408|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
19693747|NCT00490919|42139406|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
19693748|NCT00490919|42139407|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
19693749|NCT00490919|42139408|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
19693750|NCT00490919|42139406|FG000|Open-label Run-in Period|Administrative|40|||
19693751|NCT00490919|42139407|FG001|Open-label Run-in Period|Administrative|0|||
19693752|NCT00490919|42139408|FG002|Open-label Run-in Period|Administrative|0|||
19693753|NCT00490919|42139406|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
19693754|NCT00490919|42139407|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
19693755|NCT00490919|42139408|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
19693756|NCT00490919|42139406|FG000|Double-blind Phase|Adverse Event|0|||
19693757|NCT00490919|42139407|FG001|Double-blind Phase|Adverse Event|40|||
19693758|NCT00490919|42139408|FG002|Double-blind Phase|Adverse Event|20|||
19693759|NCT00490919|42139406|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19693760|NCT00490919|42139407|FG001|Double-blind Phase|Withdrawal by Subject|10|||
19693761|NCT00490919|42139408|FG002|Double-blind Phase|Withdrawal by Subject|11|||
19693762|NCT00490919|42139406|FG000|Double-blind Phase|Lost to Follow-up|0|||
19693763|NCT00490919|42139407|FG001|Double-blind Phase|Lost to Follow-up|8|||
19693764|NCT00490919|42139408|FG002|Double-blind Phase|Lost to Follow-up|11|||
19693765|NCT00490919|42139406|FG000|Double-blind Phase|Lack of Efficacy|0|||
19693766|NCT00490919|42139407|FG001|Double-blind Phase|Lack of Efficacy|22|||
19693767|NCT00490919|42139408|FG002|Double-blind Phase|Lack of Efficacy|36|||
19693768|NCT00490919|42139406|FG000|Double-blind Phase|Administrative|0|||
19693769|NCT00490919|42139407|FG001|Double-blind Phase|Administrative|6|||
19693770|NCT00490919|42139408|FG002|Double-blind Phase|Administrative|6|||
19693771|NCT00503867|42139415|FG000|Overall Study|Lost to Follow-up|1|||
19693772|NCT00503867|42139415|FG000|Overall Study|Adverse Event|1|||
19693773|NCT00503399|42139421|FG000|Overall Study|Death|2|||
19693774|NCT00503399|42139422|FG001|Overall Study|Death|1|||
19779212|NCT02419417|42234402|FG010|Overall Study|Withdrawal by Subject|1|||
19779213|NCT00777491|42234443|FG000|Overall Study|Protocol Violation|0|||
19779214|NCT00777491|42234444|FG001|Overall Study|Protocol Violation|2|||
19779215|NCT00777491|42234443|FG000|Overall Study|Did not receive any protocol treatment|2|||
19779216|NCT00777491|42234444|FG001|Overall Study|Did not receive any protocol treatment|0|||
19779217|NCT03077711|42234456|FG000|Overall Study|Lost to Follow-up|2|||
19779218|NCT03077711|42234457|FG001|Overall Study|Lost to Follow-up|2|||
19779219|NCT03077711|42234456|FG000|Overall Study|noncompliant taking medication|2|||
19779220|NCT03077711|42234457|FG001|Overall Study|noncompliant taking medication|0|||
19779221|NCT04311463|42234484|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
19779222|NCT04311463|42234485|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
19779223|NCT04311463|42234484|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
19779224|NCT04311463|42234485|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
19779225|NCT04311463|42234484|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
19779226|NCT04311463|42234485|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
19779227|NCT01370538|42234498|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
19779228|NCT01370538|42234499|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
19779229|NCT01370538|42234498|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19779230|NCT01370538|42234499|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19779231|NCT01370538|42234498|FG000|Overall Study|Adverse Event|1|||
19779232|NCT01370538|42234499|FG001|Overall Study|Adverse Event|0|||
19779233|NCT01370538|42234498|FG000|Overall Study|Protocol Violation|8|||
19779234|NCT01370538|42234499|FG001|Overall Study|Protocol Violation|5|||
19779235|NCT01370538|42234498|FG000|Overall Study|Development of study specific withdrawal|1|||
19779236|NCT01370538|42234499|FG001|Overall Study|Development of study specific withdrawal|1|||
19779237|NCT01370538|42234498|FG000|Overall Study|Lost to follow up|6|||
19779238|NCT01370538|42234499|FG001|Overall Study|Lost to follow up|10|||
19779239|NCT03402841|42234518|FG000|Overall Study|Withdrawal by Subject|3|||
19779240|NCT03402841|42234518|FG000|Overall Study|Lost to Follow-up|2|||
19779241|NCT03402841|42234518|FG000|Overall Study|Death|146|||
19779242|NCT02881957|42234533|FG000|Overall Study|Comfort care|0|||
19779243|NCT02881957|42234534|FG001|Overall Study|Comfort care|1|||
19779244|NCT02881957|42234533|FG000|Overall Study|Concurrent trial enrollment|0|||
19779245|NCT02881957|42234534|FG001|Overall Study|Concurrent trial enrollment|1|||
19779246|NCT02881957|42234533|FG000|Overall Study|Discharged within 48 hours|0|||
19779247|NCT02881957|42234534|FG001|Overall Study|Discharged within 48 hours|1|||
19779248|NCT02881957|42234533|FG000|Overall Study|Withdrawal by Subject|2|||
19779249|NCT02881957|42234534|FG001|Overall Study|Withdrawal by Subject|1|||
19779250|NCT02881957|42234533|FG000|Overall Study|Protocol Violation|1|||
19779251|NCT02881957|42234534|FG001|Overall Study|Protocol Violation|0|||
19779252|NCT03022461|42234540|FG000|Overall Study|Death|3|||
19779253|NCT02750930|42234545|FG000|Overall Study|Study closed/terminated|8|||
19779254|NCT03078907|42234551|FG000|Overall Study|Adverse Event|2|||
19779255|NCT03078907|42234552|FG001|Overall Study|Adverse Event|0|||
19779256|NCT03078907|42234551|FG000|Overall Study|Other|1|||
19779257|NCT03078907|42234552|FG001|Overall Study|Other|0|||
19779258|NCT03078907|42234551|FG000|Overall Study|Protocol Violation|0|||
19779259|NCT03078907|42234552|FG001|Overall Study|Protocol Violation|1|||
19779260|NCT03249714|42234560|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
19779261|NCT03249714|42234561|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
19779262|NCT03249714|42234560|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
19779263|NCT03249714|42234561|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
19779264|NCT03249714|42234560|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
19779265|NCT03249714|42234561|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
19779266|NCT03249714|42234560|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
19779267|NCT03249714|42234561|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
19779268|NCT02925117|42234587|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
19779269|NCT02925117|42234588|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
19779270|NCT02925117|42234589|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
19779271|NCT02925117|42234590|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
19779272|NCT02925117|42234591|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779273|NCT02925117|42234592|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779274|NCT02925117|42234593|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779275|NCT02925117|42234594|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779276|NCT02925117|42234595|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19607079|NCT00942968|42055847|FG000|Overall Study|Participant required pancreatic biopsy|1|||
19779277|NCT02925117|42234596|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779278|NCT02925117|42234597|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779279|NCT02925117|42234598|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
19779280|NCT02925117|42234587|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
19779281|NCT02925117|42234588|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
19779282|NCT02925117|42234589|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
19779283|NCT02925117|42234590|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779284|NCT02925117|42234591|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779285|NCT02925117|42234592|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779286|NCT02925117|42234593|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779287|NCT02925117|42234594|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779288|NCT02925117|42234595|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779289|NCT02925117|42234596|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779290|NCT02925117|42234597|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779291|NCT02925117|42234598|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
19779292|NCT02925117|42234587|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
19779293|NCT02925117|42234588|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
19779294|NCT02925117|42234589|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779295|NCT02925117|42234590|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779296|NCT02925117|42234591|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779297|NCT02925117|42234592|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779298|NCT02925117|42234593|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779299|NCT02925117|42234594|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779300|NCT02925117|42234595|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779301|NCT02925117|42234596|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779302|NCT02925117|42234597|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779303|NCT02925117|42234598|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
19779304|NCT02925117|42234587|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
19779305|NCT02925117|42234588|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
19779306|NCT02925117|42234589|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
19779307|NCT02925117|42234590|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
19779308|NCT02925117|42234591|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
19779309|NCT02925117|42234592|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
19779310|NCT02925117|42234593|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
19779311|NCT02925117|42234594|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
19779312|NCT02925117|42234595|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
19779313|NCT02925117|42234596|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
19779314|NCT02925117|42234597|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
19779315|NCT02925117|42234598|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
19779316|NCT02925117|42234587|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779317|NCT02925117|42234588|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779318|NCT02925117|42234589|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779319|NCT02925117|42234590|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779320|NCT02925117|42234591|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779321|NCT02925117|42234592|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
19779322|NCT02925117|42234593|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779323|NCT02925117|42234594|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779324|NCT02925117|42234595|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19693775|NCT00503399|42139421|FG000|Overall Study|Protocol Violation|1|||
19693776|NCT00503399|42139422|FG001|Overall Study|Protocol Violation|0|||
19779325|NCT02925117|42234596|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
19779326|NCT02925117|42234597|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
19779327|NCT02925117|42234598|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
19779328|NCT02925117|42234587|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
19779329|NCT02925117|42234588|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
19779330|NCT02925117|42234589|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
19779331|NCT02925117|42234590|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
19779332|NCT02925117|42234591|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
19779333|NCT02925117|42234592|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
19779334|NCT02925117|42234593|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
19779335|NCT02925117|42234594|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
19779336|NCT02925117|42234595|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
19779337|NCT02925117|42234596|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
19779338|NCT02925117|42234597|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
19779339|NCT02925117|42234598|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
19779340|NCT02925117|42234587|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779341|NCT02925117|42234588|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779342|NCT02925117|42234589|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779343|NCT02925117|42234590|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779344|NCT02925117|42234591|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
19693777|NCT00503399|42139421|FG000|Overall Study|Withdrawal by Subject|4|||
19693778|NCT00503399|42139422|FG001|Overall Study|Withdrawal by Subject|2|||
19693779|NCT00503399|42139421|FG000|Overall Study|Adverse Event|0|||
19693780|NCT00503399|42139422|FG001|Overall Study|Adverse Event|3|||
19693781|NCT00503399|42139421|FG000|Overall Study|Lost to Follow-up|0|||
19693782|NCT00503399|42139422|FG001|Overall Study|Lost to Follow-up|2|||
19693783|NCT00506519|42139431|FG000|Overall Study|Death|4|||
19693784|NCT00506519|42139432|FG001|Overall Study|Death|6|||
19693785|NCT00506519|42139433|FG002|Overall Study|Death|0|||
19693786|NCT00506519|42139431|FG000|Overall Study|Adverse Event|1|||
19693787|NCT00506519|42139432|FG001|Overall Study|Adverse Event|0|||
19693788|NCT00506519|42139433|FG002|Overall Study|Adverse Event|0|||
19693789|NCT00503009|42139447|FG000|Overall Study|Protocol Violation|1|||
19693790|NCT00503009|42139448|FG001|Overall Study|Protocol Violation|0|||
19779345|NCT02925117|42234592|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
19779346|NCT02925117|42234593|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
19693791|NCT00503009|42139449|FG002|Overall Study|Protocol Violation|1|||
19693792|NCT00503009|42139447|FG000|Overall Study|Withdrawal by Subject|0|||
19693793|NCT00503009|42139448|FG001|Overall Study|Withdrawal by Subject|1|||
19693794|NCT00503009|42139449|FG002|Overall Study|Withdrawal by Subject|1|||
19693795|NCT00503009|42139447|FG000|Overall Study|Physician Decision|0|||
19693796|NCT00503009|42139448|FG001|Overall Study|Physician Decision|1|||
19693797|NCT00503009|42139449|FG002|Overall Study|Physician Decision|1|||
19693798|NCT00160251|42139463|FG000|Prior to Amendment 2|Adverse Event|2|||
19693799|NCT00160251|42139464|FG001|Prior to Amendment 2|Adverse Event|1|||
19693800|NCT00160251|42139465|FG002|Prior to Amendment 2|Adverse Event|3|||
19693801|NCT00160251|42139466|FG003|Prior to Amendment 2|Adverse Event|1|||
19693802|NCT00160251|42139467|FG004|Prior to Amendment 2|Adverse Event|1|||
19693803|NCT00160251|42139468|FG005|Prior to Amendment 2|Adverse Event|1|||
19693804|NCT00160251|42139469|FG006|Prior to Amendment 2|Adverse Event|1|||
19779347|NCT02925117|42234594|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
19779348|NCT02925117|42234595|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
19779349|NCT02925117|42234596|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779350|NCT02925117|42234597|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
19779351|NCT02925117|42234598|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
19779352|NCT02925117|42234587|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
19779353|NCT02925117|42234588|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
19779354|NCT02925117|42234589|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
19779355|NCT02925117|42234590|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
19779356|NCT02925117|42234591|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
19779357|NCT02925117|42234592|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
19779358|NCT02925117|42234593|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
19779359|NCT02925117|42234594|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
19779360|NCT02925117|42234595|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
19779361|NCT02925117|42234596|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
19779362|NCT02925117|42234597|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
19779363|NCT02925117|42234598|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
19779364|NCT03075163|42234622|FG000|Overall Study|not eligible for treatment limb|138|||
19779365|NCT03075163|42234623|FG001|Overall Study|not eligible for treatment limb|138|||
19779366|NCT03078751|42234631|FG000|Overall Study|Adverse Event|4|||
19779367|NCT03078751|42234632|FG001|Overall Study|Adverse Event|0|||
19779368|NCT03078751|42234631|FG000|Overall Study|Physician Decision|1|||
19779369|NCT03078751|42234632|FG001|Overall Study|Physician Decision|0|||
19779370|NCT03078751|42234631|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
19779371|NCT03078751|42234632|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
19779372|NCT03078751|42234631|FG000|Overall Study|Subject/guardian decision|8|||
19779373|NCT03078751|42234632|FG001|Overall Study|Subject/guardian decision|1|||
19779374|NCT03078751|42234631|FG000|Overall Study|Untreated|0|||
19779375|NCT03078751|42234632|FG001|Overall Study|Untreated|4|||
19779376|NCT02924883|42234640|FG000|Overall Study|Death|39|||
19779377|NCT02924883|42234641|FG001|Overall Study|Death|20|||
19779378|NCT02924883|42234640|FG000|Overall Study|Lost to Follow-up|1|||
19779379|NCT02924883|42234641|FG001|Overall Study|Lost to Follow-up|0|||
19779380|NCT02924883|42234640|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
19779381|NCT02924883|42234641|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
19779382|NCT02924883|42234640|FG000|Overall Study|Protocol Violation|1|||
19779383|NCT02924883|42234641|FG001|Overall Study|Protocol Violation|0|||
19779384|NCT02924883|42234640|FG000|Overall Study|Withdrawal by Subject|22|||
19779385|NCT02924883|42234641|FG001|Overall Study|Withdrawal by Subject|16|||
19779386|NCT02924883|42234640|FG000|Overall Study|Progressive Disease|1|||
19779387|NCT02924883|42234641|FG001|Overall Study|Progressive Disease|0|||
19779388|NCT02924883|42234640|FG000|Overall Study|Study Terminated by Sponsor|69|||
19779389|NCT02924883|42234641|FG001|Overall Study|Study Terminated by Sponsor|32|||
19779390|NCT01369680|42234664|FG000|Overall Study|Lost to Follow-up|0|||
19779391|NCT01369680|42234665|FG001|Overall Study|Lost to Follow-up|0|||
19779392|NCT01369680|42234666|FG002|Overall Study|Lost to Follow-up|1|||
19779393|NCT01369680|42234667|FG003|Overall Study|Lost to Follow-up|2|||
19779394|NCT03074149|42234699|FG000|Overall Study|Reason unknown|22|||
19779395|NCT03074149|42234700|FG001|Overall Study|Reason unknown|35|||
19779396|NCT03074149|42234699|FG000|Overall Study|Death|10|||
19779397|NCT03074149|42234700|FG001|Overall Study|Death|45|||
19693805|NCT00160251|42139470|FG007|Prior to Amendment 2|Adverse Event|0|||
19779398|NCT02751320|42234708|FG000|Overall Study|Adverse Event|2|||
19779399|NCT02751320|42234708|FG000|Overall Study|Withdrawal by Subject|1|||
19779400|NCT02206035|42234736|FG000|Overall Study|Physician Decision|10|||
19779401|NCT02206035|42234737|FG001|Overall Study|Physician Decision|0|||
19367260|NCT02435992|41607417|FG002|Overall Study|Physician Decision|1|||
19693806|NCT00160251|42139463|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
19779402|NCT02206035|42234738|FG002|Overall Study|Physician Decision|175|||
19779403|NCT02746471|42234745|FG000|Overall Study|Death|43|||
19779404|NCT02746471|42234745|FG000|Overall Study|Exited before 36 months|1119|||
19779405|NCT02591953|42234752|FG000|Overall Study|Lost to Follow-up|6|||
19693807|NCT00160251|42139464|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
19779406|NCT02591953|42234753|FG001|Overall Study|Lost to Follow-up|6|||
19779407|NCT03073213|42234761|FG000|Multiple Dose Period|Protocol Violation|0|||
19779408|NCT03073213|42234762|FG001|Multiple Dose Period|Protocol Violation|0|||
19779409|NCT03073213|42234763|FG002|Multiple Dose Period|Protocol Violation|1|||
19779410|NCT03070483|42234772|FG000|Overall Study|Lost to Follow-up|2|||
19779411|NCT01757535|42234779|FG000|Overall Study|Disease Relapse|143|||
19779412|NCT01757535|42234780|FG001|Overall Study|Disease Relapse|180|||
19779413|NCT01757535|42234779|FG000|Overall Study|Adverse Event|29|||
19779414|NCT01757535|42234780|FG001|Overall Study|Adverse Event|11|||
19779415|NCT01757535|42234779|FG000|Overall Study|Withdrawal by Subject|9|||
19779416|NCT01757535|42234780|FG001|Overall Study|Withdrawal by Subject|13|||
19779417|NCT01757535|42234779|FG000|Overall Study|Miscellaneous|5|||
19779418|NCT01757535|42234780|FG001|Overall Study|Miscellaneous|2|||
19779419|NCT01757535|42234779|FG000|Overall Study|Physician Decision|6|||
19779420|NCT01757535|42234780|FG001|Overall Study|Physician Decision|0|||
19779421|NCT01757535|42234779|FG000|Overall Study|Death|1|||
19779422|NCT01757535|42234780|FG001|Overall Study|Death|2|||
19779423|NCT02231762|42234786|FG000|Combination Phase|Adverse Event|10|||
19779424|NCT02231762|42234787|FG001|Combination Phase|Adverse Event|0|||
19779425|NCT02231762|42234788|FG002|Combination Phase|Adverse Event|0|||
19779426|NCT02231762|42234789|FG003|Combination Phase|Adverse Event|0|||
19693808|NCT00160251|42139465|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
19693809|NCT00160251|42139466|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
19693810|NCT00160251|42139467|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
19693811|NCT00160251|42139468|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
19693812|NCT00160251|42139469|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
19693813|NCT00160251|42139470|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
19693814|NCT00160251|42139463|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
19779427|NCT02231762|42234786|FG000|Combination Phase|Withdrawal by Subject|2|||
19779428|NCT02231762|42234787|FG001|Combination Phase|Withdrawal by Subject|0|||
19779429|NCT02231762|42234788|FG002|Combination Phase|Withdrawal by Subject|0|||
19779430|NCT02231762|42234789|FG003|Combination Phase|Withdrawal by Subject|0|||
19779431|NCT02231762|42234786|FG000|Combination Phase|Disease Progression|6|||
19779432|NCT02231762|42234787|FG001|Combination Phase|Disease Progression|0|||
19779433|NCT02231762|42234788|FG002|Combination Phase|Disease Progression|0|||
19779434|NCT02231762|42234789|FG003|Combination Phase|Disease Progression|0|||
19779435|NCT02231762|42234786|FG000|Combination Phase|Did not meet inclusion criteria|1|||
19779436|NCT02231762|42234787|FG001|Combination Phase|Did not meet inclusion criteria|0|||
19779437|NCT02231762|42234788|FG002|Combination Phase|Did not meet inclusion criteria|0|||
19779438|NCT02231762|42234789|FG003|Combination Phase|Did not meet inclusion criteria|0|||
19779439|NCT02231762|42234786|FG000|Combination Phase|Protocol Violation|1|||
19779440|NCT02231762|42234787|FG001|Combination Phase|Protocol Violation|0|||
19779441|NCT02231762|42234788|FG002|Combination Phase|Protocol Violation|0|||
19779442|NCT02231762|42234789|FG003|Combination Phase|Protocol Violation|0|||
19779443|NCT02231762|42234786|FG000|Maintenance Phase|Disease progression|0|||
19779444|NCT02231762|42234787|FG001|Maintenance Phase|Disease progression|3|||
19779445|NCT02231762|42234788|FG002|Maintenance Phase|Disease progression|4|||
19779446|NCT02231762|42234789|FG003|Maintenance Phase|Disease progression|3|||
19693815|NCT00160251|42139464|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
19693816|NCT00160251|42139465|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
19693817|NCT00160251|42139466|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
19693818|NCT00160251|42139467|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
19693819|NCT00160251|42139468|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
19693820|NCT00160251|42139469|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
19693821|NCT00160251|42139470|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
19693822|NCT00160251|42139463|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
19693823|NCT00160251|42139464|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
19779447|NCT02231762|42234786|FG000|Maintenance Phase|Adverse Event|0|||
19779448|NCT02231762|42234787|FG001|Maintenance Phase|Adverse Event|0|||
19779449|NCT02231762|42234788|FG002|Maintenance Phase|Adverse Event|1|||
19779450|NCT02231762|42234789|FG003|Maintenance Phase|Adverse Event|2|||
19779451|NCT03023397|42234806|FG000|Run-In|Failed screening allergen challenge|1|||
19779452|NCT03023397|42234807|FG001|Run-In|Failed screening allergen challenge|0|||
19779453|NCT03023397|42234808|FG002|Run-In|Failed screening allergen challenge|0|||
19779454|NCT03023397|42234806|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
19779455|NCT03023397|42234807|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
19779456|NCT03023397|42234808|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
19779457|NCT04325906|42234819|FG000|Overall Study|Withdrawal by Subject|2|||
19779458|NCT04325906|42234820|FG001|Overall Study|Withdrawal by Subject|0|||
19779459|NCT03068455|42234828|FG000|Pre-treatment Period|Disease progression|0|||
19779460|NCT03068455|42234829|FG001|Pre-treatment Period|Disease progression|1|||
19779461|NCT03068455|42234828|FG000|Pre-treatment Period|Participant withdrew consent|1|||
19693824|NCT00160251|42139465|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
19779462|NCT03068455|42234829|FG001|Pre-treatment Period|Participant withdrew consent|1|||
19693825|NCT00160251|42139466|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
19779463|NCT03068455|42234828|FG000|Pre-treatment Period|Poor/non-compliance|0|||
19779464|NCT03068455|42234829|FG001|Pre-treatment Period|Poor/non-compliance|1|||
19779465|NCT03068455|42234828|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
19779466|NCT03068455|42234829|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
19693826|NCT00160251|42139467|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
19693827|NCT00160251|42139468|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
19693828|NCT00160251|42139469|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
19693829|NCT00160251|42139470|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
19693830|NCT00160251|42139463|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
19693831|NCT00160251|42139464|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
19693832|NCT00160251|42139465|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
19693833|NCT00160251|42139466|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
19693834|NCT00160251|42139467|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
19693835|NCT00160251|42139468|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
19693836|NCT00160251|42139469|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
19693837|NCT00160251|42139470|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
19693838|NCT00160251|42139463|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
19693839|NCT00160251|42139464|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
19693840|NCT00160251|42139465|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
19693841|NCT00160251|42139466|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
19693842|NCT00160251|42139467|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
19693843|NCT00160251|42139468|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
19693844|NCT00160251|42139469|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
19693845|NCT00160251|42139470|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
19693846|NCT00160251|42139463|FG000|Post-amendment 2|Adverse Event|0|||
19693847|NCT00160251|42139464|FG001|Post-amendment 2|Adverse Event|0|||
19693848|NCT00160251|42139465|FG002|Post-amendment 2|Adverse Event|0|||
19693849|NCT00160251|42139466|FG003|Post-amendment 2|Adverse Event|0|||
19693850|NCT00160251|42139467|FG004|Post-amendment 2|Adverse Event|0|||
19693851|NCT00160251|42139468|FG005|Post-amendment 2|Adverse Event|0|||
19693852|NCT00160251|42139469|FG006|Post-amendment 2|Adverse Event|0|||
19693853|NCT00160251|42139470|FG007|Post-amendment 2|Adverse Event|20|||
19693854|NCT00160251|42139463|FG000|Post-amendment 2|Lack of Efficacy|0|||
19693855|NCT00160251|42139464|FG001|Post-amendment 2|Lack of Efficacy|0|||
19693856|NCT00160251|42139465|FG002|Post-amendment 2|Lack of Efficacy|0|||
19693857|NCT00160251|42139466|FG003|Post-amendment 2|Lack of Efficacy|0|||
19693858|NCT00160251|42139467|FG004|Post-amendment 2|Lack of Efficacy|0|||
19693859|NCT00160251|42139468|FG005|Post-amendment 2|Lack of Efficacy|0|||
19693860|NCT00160251|42139469|FG006|Post-amendment 2|Lack of Efficacy|0|||
19693861|NCT00160251|42139470|FG007|Post-amendment 2|Lack of Efficacy|24|||
19693862|NCT00160251|42139463|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693863|NCT00160251|42139464|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693864|NCT00160251|42139465|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693865|NCT00160251|42139466|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693866|NCT00160251|42139467|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693867|NCT00160251|42139468|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693868|NCT00160251|42139469|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
19693869|NCT00160251|42139470|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
19693870|NCT00506441|42139527|FG000|Period 1; Open-label Period|Adverse Event|21|||
19693871|NCT00506441|42139528|FG001|Period 1; Open-label Period|Adverse Event|0|||
19693872|NCT00506441|42139527|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
19693873|NCT00506441|42139528|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
19693874|NCT00506441|42139527|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
19693875|NCT00506441|42139528|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
19693876|NCT00506441|42139527|FG000|Period 1; Open-label Period|Physician Decision|5|||
19693877|NCT00506441|42139528|FG001|Period 1; Open-label Period|Physician Decision|0|||
19693878|NCT00506441|42139527|FG000|Period 1; Open-label Period|Protocol Violation|9|||
19693879|NCT00506441|42139528|FG001|Period 1; Open-label Period|Protocol Violation|0|||
19693880|NCT00506441|42139527|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
19693881|NCT00506441|42139528|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
19693882|NCT00506441|42139527|FG000|Period 1; Open-label Period|Other Reasons|13|||
19693883|NCT00506441|42139528|FG001|Period 1; Open-label Period|Other Reasons|0|||
19779467|NCT03068455|42234828|FG000|Pre-treatment Period|Not reported|2|||
19779468|NCT03068455|42234829|FG001|Pre-treatment Period|Not reported|1|||
19779469|NCT03068455|42234828|FG000|Treatment Period|Disease progression|166|||
19693884|NCT00506441|42139527|FG000|Period 2; Double-blind Period|Adverse Event|0|||
19693885|NCT00506441|42139528|FG001|Period 2; Double-blind Period|Adverse Event|1|||
19693886|NCT00506441|42139527|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
19693887|NCT00506441|42139528|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
19693888|NCT00506441|42139527|FG000|Period 2; Double-blind Period|Physician Decision|1|||
19693889|NCT00506441|42139528|FG001|Period 2; Double-blind Period|Physician Decision|1|||
19693890|NCT00506441|42139527|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
19693891|NCT00506441|42139528|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
19693892|NCT00506441|42139527|FG000|Period 2; Double-blind Period|Other Reason|1|||
19693893|NCT00506441|42139528|FG001|Period 2; Double-blind Period|Other Reason|1|||
19693894|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
19693895|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
19693896|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Graft loss|1|||
19693897|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Graft loss|2|||
19693898|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Death|5|||
19693899|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Death|3|||
19693900|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
19693901|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
19693902|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
19693903|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
19693904|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
19693905|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
19693906|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
19693907|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
19693908|NCT00378014|42139555|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
19693909|NCT00378014|42139556|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
19693910|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
19693911|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
19693912|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Death|1|||
19693913|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Death|2|||
19693914|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
19693915|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
19693916|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
19693917|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
19693918|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
19693919|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
19693920|NCT00378014|42139555|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
19693921|NCT00378014|42139556|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
19693922|NCT00485303|42139564|FG000|Overall Study|Adverse Event|5|||
19693923|NCT00485303|42139564|FG000|Overall Study|Progressive Disease|44|||
19693924|NCT00485303|42139564|FG000|Overall Study|Other|3|||
19693925|NCT00485303|42139564|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
19693926|NCT00485303|42139564|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
19693927|NCT00490841|42139568|FG000|Overall Study|Death|5|||
19693928|NCT00490841|42139568|FG000|Overall Study|Withdrawal by Subject|4|||
19693929|NCT00490841|42139568|FG000|Overall Study|Lost to Follow-up|1|||
19693930|NCT00490841|42139568|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
19693931|NCT00377858|42139575|FG000|Overall Study|Withdrawal by Subject|12|||
19693932|NCT00377858|42139576|FG001|Overall Study|Withdrawal by Subject|11|||
19693933|NCT00377858|42139575|FG000|Overall Study|Lost to Follow-up|6|||
19693934|NCT00377858|42139576|FG001|Overall Study|Lost to Follow-up|1|||
19693935|NCT00377858|42139575|FG000|Overall Study|Physician Decision|5|||
19693936|NCT00377858|42139576|FG001|Overall Study|Physician Decision|5|||
19693937|NCT00377858|42139575|FG000|Overall Study|Protocol Violation|3|||
19693938|NCT00377858|42139576|FG001|Overall Study|Protocol Violation|4|||
19693939|NCT00377858|42139575|FG000|Overall Study|Adverse Event|2|||
19693940|NCT00377858|42139576|FG001|Overall Study|Adverse Event|1|||
19693941|NCT00377858|42139575|FG000|Overall Study|Entry Criteria Not Met|2|||
19693942|NCT00377858|42139576|FG001|Overall Study|Entry Criteria Not Met|0|||
19693943|NCT00377858|42139575|FG000|Overall Study|Sponsor Decision|1|||
19693944|NCT00377858|42139576|FG001|Overall Study|Sponsor Decision|2|||
19693945|NCT00377858|42139575|FG000|Overall Study|Death|0|||
19693946|NCT00377858|42139576|FG001|Overall Study|Death|3|||
19693947|NCT00502775|42139585|FG000|Overall Study|Adverse Event|1|||
19693948|NCT00502775|42139586|FG001|Overall Study|Adverse Event|2|||
19693949|NCT00502775|42139587|FG002|Overall Study|Adverse Event|1|||
19693950|NCT00502775|42139585|FG000|Overall Study|Protocol Violation|1|||
19693951|NCT00502775|42139586|FG001|Overall Study|Protocol Violation|5|||
19693952|NCT00502775|42139587|FG002|Overall Study|Protocol Violation|2|||
19693953|NCT00502775|42139585|FG000|Overall Study|Withdrawal by Subject|1|||
19693954|NCT00502775|42139586|FG001|Overall Study|Withdrawal by Subject|1|||
19693955|NCT00502775|42139587|FG002|Overall Study|Withdrawal by Subject|2|||
19693956|NCT00502775|42139585|FG000|Overall Study|Sponsor Terminated Study|1|||
19693957|NCT00502775|42139586|FG001|Overall Study|Sponsor Terminated Study|0|||
19693958|NCT00502775|42139587|FG002|Overall Study|Sponsor Terminated Study|1|||
19367261|NCT02435992|41607418|FG003|Overall Study|Physician Decision|0|||
19693959|NCT00502775|42139585|FG000|Overall Study|Non-compliance with eDiary|4|||
19693960|NCT00502775|42139586|FG001|Overall Study|Non-compliance with eDiary|1|||
19693961|NCT00502775|42139587|FG002|Overall Study|Non-compliance with eDiary|1|||
19693962|NCT00502775|42139585|FG000|Overall Study|Subject unable to swallow capsule|1|||
19693963|NCT00502775|42139586|FG001|Overall Study|Subject unable to swallow capsule|0|||
19693964|NCT00502775|42139587|FG002|Overall Study|Subject unable to swallow capsule|1|||
19693965|NCT00502775|42139585|FG000|Overall Study|Logpad compliance <80%|1|||
19693966|NCT00502775|42139586|FG001|Overall Study|Logpad compliance <80%|0|||
19693967|NCT00502775|42139587|FG002|Overall Study|Logpad compliance <80%|0|||
19693968|NCT00502775|42139585|FG000|Overall Study|Randomized in error|0|||
19693969|NCT00502775|42139586|FG001|Overall Study|Randomized in error|1|||
19693970|NCT00502775|42139587|FG002|Overall Study|Randomized in error|1|||
19693971|NCT00502775|42139585|FG000|Overall Study|Non-compliance|0|||
19693972|NCT00502775|42139586|FG001|Overall Study|Non-compliance|2|||
19693973|NCT00502775|42139587|FG002|Overall Study|Non-compliance|2|||
19693974|NCT00502775|42139585|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
19693975|NCT00502775|42139586|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
19693976|NCT00502775|42139587|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
19693977|NCT00502775|42139585|FG000|Overall Study|Declining pollen counts|0|||
19693978|NCT00502775|42139586|FG001|Overall Study|Declining pollen counts|1|||
19693979|NCT00502775|42139587|FG002|Overall Study|Declining pollen counts|1|||
19693980|NCT00502775|42139585|FG000|Overall Study|Subject in jail|0|||
19693981|NCT00502775|42139586|FG001|Overall Study|Subject in jail|1|||
19693982|NCT00502775|42139587|FG002|Overall Study|Subject in jail|0|||
19693983|NCT00502775|42139585|FG000|Overall Study|Subject took disallowed drug|0|||
19693984|NCT00502775|42139586|FG001|Overall Study|Subject took disallowed drug|0|||
19693985|NCT00502775|42139587|FG002|Overall Study|Subject took disallowed drug|1|||
19693986|NCT00502697|42139597|FG000|Overall Study|Withdrawal by Subject|3|||
19693987|NCT00502697|42139598|FG001|Overall Study|Withdrawal by Subject|1|||
19693988|NCT00502697|42139597|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
19693989|NCT00502697|42139598|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
19693990|NCT00502697|42139597|FG000|Overall Study|found not to meet eligibility criteria|3|||
19693991|NCT00502697|42139598|FG001|Overall Study|found not to meet eligibility criteria|4|||
19693992|NCT00502697|42139597|FG000|Overall Study|did not meet assignment criteria|4|||
19693993|NCT00502697|42139598|FG001|Overall Study|did not meet assignment criteria|2|||
19693994|NCT00485069|42139606|FG000|Overall Study|Adverse Event|10|||
19693995|NCT00485069|42139607|FG001|Overall Study|Adverse Event|4|||
19693996|NCT00485069|42139606|FG000|Overall Study|Lack of Efficacy|2|||
19693997|NCT00485069|42139607|FG001|Overall Study|Lack of Efficacy|1|||
19693998|NCT00485069|42139606|FG000|Overall Study|Protocol Violation|0|||
19693999|NCT00485069|42139607|FG001|Overall Study|Protocol Violation|1|||
19694000|NCT00485069|42139606|FG000|Overall Study|Withdrawal by Subject|6|||
19694001|NCT00485069|42139607|FG001|Overall Study|Withdrawal by Subject|6|||
19694002|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
19694003|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
19694004|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
19694005|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
19694006|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
19694007|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
19694008|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
19694009|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
19694010|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
19694011|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
19694012|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
19694013|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
19694014|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
19694015|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
19694016|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
19694017|NCT00355082|42139622|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
19694018|NCT00355082|42139623|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
19694019|NCT00355082|42139624|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
19694020|NCT00355082|42139622|FG000|Continuation Phase|Adverse Event|2|||
19694021|NCT00355082|42139623|FG001|Continuation Phase|Adverse Event|0|||
19694022|NCT00355082|42139624|FG002|Continuation Phase|Adverse Event|1|||
19694023|NCT00355082|42139622|FG000|Continuation Phase|Lost to Follow-up|2|||
19694024|NCT00355082|42139623|FG001|Continuation Phase|Lost to Follow-up|0|||
19694025|NCT00355082|42139624|FG002|Continuation Phase|Lost to Follow-up|1|||
19694026|NCT00355082|42139622|FG000|Continuation Phase|Protocol Violation|1|||
19694027|NCT00355082|42139623|FG001|Continuation Phase|Protocol Violation|0|||
19694028|NCT00355082|42139624|FG002|Continuation Phase|Protocol Violation|1|||
19694029|NCT00355082|42139622|FG000|Continuation Phase|Withdrawal by Subject|4|||
19694030|NCT00355082|42139623|FG001|Continuation Phase|Withdrawal by Subject|0|||
19694031|NCT00355082|42139624|FG002|Continuation Phase|Withdrawal by Subject|0|||
19694032|NCT00355082|42139622|FG000|Continuation Phase|Lack of Efficacy|5|||
19694033|NCT00355082|42139623|FG001|Continuation Phase|Lack of Efficacy|0|||
19694034|NCT00355082|42139624|FG002|Continuation Phase|Lack of Efficacy|0|||
19694035|NCT00355082|42139622|FG000|Continuation Phase|Site Closed by Sponsor|8|||
19694036|NCT00355082|42139623|FG001|Continuation Phase|Site Closed by Sponsor|0|||
19694037|NCT00355082|42139624|FG002|Continuation Phase|Site Closed by Sponsor|0|||
19694038|NCT00355082|42139622|FG000|Continuation Phase|Scheduling Error|1|||
19694039|NCT00355082|42139623|FG001|Continuation Phase|Scheduling Error|0|||
19694040|NCT00355082|42139624|FG002|Continuation Phase|Scheduling Error|0|||
19694041|NCT00355082|42139622|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
19694042|NCT00355082|42139623|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
19694043|NCT00355082|42139624|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
19694044|NCT00502307|42139635|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
19694045|NCT00502307|42139636|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
19694046|NCT00502307|42139637|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
19694047|NCT00502307|42139635|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
19694048|NCT00502307|42139636|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
19694049|NCT00502307|42139637|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
19694050|NCT00502307|42139635|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
19694051|NCT00502307|42139636|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
19694052|NCT00502307|42139637|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
19694053|NCT00502307|42139635|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
19694054|NCT00502307|42139636|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
19694055|NCT00502307|42139637|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
19694056|NCT00502307|42139635|FG000|Maintenance Period|Progressive disease|80|||
19694057|NCT00502307|42139636|FG001|Maintenance Period|Progressive disease|0|||
19694058|NCT00502307|42139637|FG002|Maintenance Period|Progressive disease|0|||
19694059|NCT00502307|42139635|FG000|Maintenance Period|Discontinued due to other reasons|68|||
19694060|NCT00502307|42139636|FG001|Maintenance Period|Discontinued due to other reasons|0|||
19694061|NCT00502307|42139637|FG002|Maintenance Period|Discontinued due to other reasons|0|||
19694062|NCT00484679|42139654|FG000|Overall Study|Withdrawal by Subject|3|||
19694063|NCT00377312|42139660|FG000|Overall Study|Adverse Event|1|||
19694064|NCT00377312|42139661|FG001|Overall Study|Adverse Event|1|||
19694065|NCT00377234|42139669|FG000|Overall Study|Adverse Event|14|||
19694066|NCT00377234|42139670|FG001|Overall Study|Adverse Event|17|||
19694067|NCT00377234|42139669|FG000|Overall Study|Withdrawal by Subject|11|||
19694068|NCT00377234|42139670|FG001|Overall Study|Withdrawal by Subject|9|||
19694069|NCT00377234|42139669|FG000|Overall Study|Lost to Follow-up|4|||
19694070|NCT00377234|42139670|FG001|Overall Study|Lost to Follow-up|2|||
19694071|NCT00377234|42139669|FG000|Overall Study|Administrative|2|||
19694072|NCT00377234|42139670|FG001|Overall Study|Administrative|1|||
19694073|NCT00377234|42139669|FG000|Overall Study|Not assigned|3|||
19694074|NCT00377234|42139670|FG001|Overall Study|Not assigned|2|||
19694075|NCT00377156|42139684|FG000|Overall Study|Death|23|||
19694076|NCT00377156|42139685|FG001|Overall Study|Death|19|||
19694077|NCT00377156|42139684|FG000|Overall Study|Withdrawal by Subject|16|||
19694078|NCT00377156|42139685|FG001|Overall Study|Withdrawal by Subject|24|||
19694079|NCT00377156|42139684|FG000|Overall Study|Had follow-up <90 d|3|||
19694080|NCT00377156|42139685|FG001|Overall Study|Had follow-up <90 d|6|||
19694081|NCT00377156|42139684|FG000|Overall Study|Cancellation|1|||
19694082|NCT00377156|42139685|FG001|Overall Study|Cancellation|0|||
19694083|NCT00377156|42139684|FG000|Overall Study|Refused testing|0|||
19694084|NCT00377156|42139685|FG001|Overall Study|Refused testing|1|||
19694085|NCT00377156|42139684|FG000|Overall Study|Ineligible|0|||
19694086|NCT00377156|42139685|FG001|Overall Study|Ineligible|1|||
19694087|NCT00377156|42139684|FG000|Overall Study|Disability or language problem|0|||
19694088|NCT00377156|42139685|FG001|Overall Study|Disability or language problem|1|||
19694089|NCT00377156|42139684|FG000|Overall Study|Other|5|||
19694090|NCT00377156|42139685|FG001|Overall Study|Other|2|||
19694091|NCT00376688|42139693|FG000|Overall Study|Adverse Event|3|||
19694092|NCT00376688|42139693|FG000|Overall Study|Death|1|||
19694093|NCT00376532|42139699|FG000|Overall Study|Lack sufficient blood sample|6|||
19694094|NCT00376532|42139700|FG001|Overall Study|Lack sufficient blood sample|6|||
19694095|NCT00376220|42139708|FG000|Overall Study|Lost to Follow-up|7|||
19694096|NCT00376220|42139709|FG001|Overall Study|Lost to Follow-up|10|||
19694097|NCT00376220|42139708|FG000|Overall Study|Withdrawal by Subject|3|||
19694098|NCT00376220|42139709|FG001|Overall Study|Withdrawal by Subject|2|||
19694099|NCT00375752|42139717|FG000|Overall Study|Lack of Efficacy|4|||
19694100|NCT00375752|42139718|FG001|Overall Study|Lack of Efficacy|4|||
19694101|NCT00375752|42139717|FG000|Overall Study|Adverse Event|1|||
19694102|NCT00375752|42139718|FG001|Overall Study|Adverse Event|6|||
19694103|NCT00375752|42139717|FG000|Overall Study|Withdrawal by Subject|6|||
19694104|NCT00375752|42139718|FG001|Overall Study|Withdrawal by Subject|1|||
19694105|NCT00375752|42139717|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
19694106|NCT00375752|42139718|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
19694107|NCT00375752|42139717|FG000|Overall Study|Protocol Violation|0|||
19694108|NCT00375752|42139718|FG001|Overall Study|Protocol Violation|2|||
19694109|NCT00375752|42139717|FG000|Overall Study|Administrative Problems|0|||
19694110|NCT00375752|42139718|FG001|Overall Study|Administrative Problems|1|||
19694111|NCT00484289|42139727|FG000|Long Term Phase|Adverse Event|1|||
19694112|NCT00484289|42139728|FG001|Long Term Phase|Adverse Event|17|||
19694113|NCT00484289|42139729|FG002|Long Term Phase|Adverse Event|5|||
19694114|NCT00484289|42139727|FG000|Long Term Phase|Withdrawal by Subject|0|||
19694115|NCT00484289|42139728|FG001|Long Term Phase|Withdrawal by Subject|7|||
19694116|NCT00484289|42139729|FG002|Long Term Phase|Withdrawal by Subject|6|||
19694117|NCT00484289|42139727|FG000|Long Term Phase|Inadequate response|2|||
19694118|NCT00484289|42139728|FG001|Long Term Phase|Inadequate response|7|||
19694119|NCT00484289|42139729|FG002|Long Term Phase|Inadequate response|4|||
19694120|NCT00484289|42139727|FG000|Long Term Phase|Other Reason|0|||
19694121|NCT00484289|42139728|FG001|Long Term Phase|Other Reason|5|||
19694122|NCT00484289|42139729|FG002|Long Term Phase|Other Reason|1|||
19694123|NCT00484289|42139727|FG000|Post Marketing Phase|Adverse Event|0|||
19694124|NCT00484289|42139728|FG001|Post Marketing Phase|Adverse Event|1|||
19694125|NCT00484289|42139729|FG002|Post Marketing Phase|Adverse Event|0|||
19694126|NCT00490529|42139738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
19694127|NCT00490529|42139738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
19694128|NCT00490529|42139738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
19694129|NCT00490529|42139738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
19694130|NCT00490529|42139738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
19694131|NCT00490529|42139738|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
19694132|NCT00333840|42139744|FG000|First-line Treatment Period|Adverse Event|38|||
19694133|NCT00333840|42139745|FG001|First-line Treatment Period|Adverse Event|37|||
19694134|NCT00333840|42139746|FG002|First-line Treatment Period|Adverse Event|0|||
19694135|NCT00333840|42139747|FG003|First-line Treatment Period|Adverse Event|0|||
19694136|NCT00333840|42139744|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
19694137|NCT00333840|42139745|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
19694138|NCT00333840|42139746|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
19694139|NCT00333840|42139747|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
19694140|NCT00333840|42139744|FG000|First-line Treatment Period|Abnormal procedure|2|||
19694141|NCT00333840|42139745|FG001|First-line Treatment Period|Abnormal procedure|0|||
19694142|NCT00333840|42139746|FG002|First-line Treatment Period|Abnormal procedure|0|||
19694143|NCT00333840|42139747|FG003|First-line Treatment Period|Abnormal procedure|0|||
19694144|NCT00333840|42139744|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
19694145|NCT00333840|42139745|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
19694146|NCT00333840|42139746|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
19694147|NCT00333840|42139747|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
19694148|NCT00333840|42139744|FG000|First-line Treatment Period|No longer required study drug|21|||
19694149|NCT00333840|42139745|FG001|First-line Treatment Period|No longer required study drug|8|||
19694150|NCT00333840|42139746|FG002|First-line Treatment Period|No longer required study drug|0|||
19694151|NCT00333840|42139747|FG003|First-line Treatment Period|No longer required study drug|0|||
19694152|NCT00333840|42139744|FG000|First-line Treatment Period|Protocol Violation|17|||
19694153|NCT00333840|42139745|FG001|First-line Treatment Period|Protocol Violation|17|||
19694154|NCT00333840|42139746|FG002|First-line Treatment Period|Protocol Violation|0|||
19694155|NCT00333840|42139747|FG003|First-line Treatment Period|Protocol Violation|0|||
19694156|NCT00333840|42139744|FG000|First-line Treatment Period|Subject withdrew consent|57|||
19694157|NCT00333840|42139745|FG001|First-line Treatment Period|Subject withdrew consent|77|||
19694158|NCT00333840|42139746|FG002|First-line Treatment Period|Subject withdrew consent|0|||
19694159|NCT00333840|42139747|FG003|First-line Treatment Period|Subject withdrew consent|0|||
19694160|NCT00333840|42139744|FG000|First-line Treatment Period|Lost to Follow-up|15|||
19694161|NCT00333840|42139745|FG001|First-line Treatment Period|Lost to Follow-up|6|||
19694162|NCT00333840|42139746|FG002|First-line Treatment Period|Lost to Follow-up|0|||
19694163|NCT00333840|42139747|FG003|First-line Treatment Period|Lost to Follow-up|0|||
19694164|NCT00333840|42139744|FG000|First-line Treatment Period|Administrative problems|12|||
19694165|NCT00333840|42139745|FG001|First-line Treatment Period|Administrative problems|6|||
19694166|NCT00333840|42139746|FG002|First-line Treatment Period|Administrative problems|0|||
19694167|NCT00333840|42139747|FG003|First-line Treatment Period|Administrative problems|0|||
19694168|NCT00333840|42139744|FG000|First-line Treatment Period|Death|19|||
19694169|NCT00333840|42139745|FG001|First-line Treatment Period|Death|2|||
19694170|NCT00333840|42139746|FG002|First-line Treatment Period|Death|0|||
19694171|NCT00333840|42139747|FG003|First-line Treatment Period|Death|0|||
19694172|NCT00333840|42139744|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
19694173|NCT00333840|42139745|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
19694174|NCT00333840|42139746|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
19694175|NCT00333840|42139747|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
19694176|NCT00333840|42139744|FG000|Second-line Treatment Period|Adverse Event|0|||
19694177|NCT00333840|42139745|FG001|Second-line Treatment Period|Adverse Event|0|||
19694178|NCT00333840|42139746|FG002|Second-line Treatment Period|Adverse Event|3|||
19694179|NCT00333840|42139747|FG003|Second-line Treatment Period|Adverse Event|34|||
19694180|NCT00333840|42139744|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
19694181|NCT00333840|42139745|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
19694182|NCT00333840|42139746|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
19694183|NCT00333840|42139747|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
19694184|NCT00333840|42139744|FG000|Second-line Treatment Period|Abnormal procedure|0|||
19694185|NCT00333840|42139745|FG001|Second-line Treatment Period|Abnormal procedure|0|||
19694186|NCT00333840|42139746|FG002|Second-line Treatment Period|Abnormal procedure|0|||
19694187|NCT00333840|42139747|FG003|Second-line Treatment Period|Abnormal procedure|1|||
19694188|NCT00333840|42139744|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
19694189|NCT00333840|42139745|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
19694190|NCT00333840|42139746|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
19694191|NCT00333840|42139747|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
19694192|NCT00333840|42139744|FG000|Second-line Treatment Period|No longer required study drug|0|||
19694193|NCT00333840|42139745|FG001|Second-line Treatment Period|No longer required study drug|0|||
19694194|NCT00333840|42139746|FG002|Second-line Treatment Period|No longer required study drug|1|||
19694195|NCT00333840|42139747|FG003|Second-line Treatment Period|No longer required study drug|14|||
19694196|NCT00333840|42139744|FG000|Second-line Treatment Period|Protocol Violation|0|||
19694197|NCT00333840|42139745|FG001|Second-line Treatment Period|Protocol Violation|0|||
19694198|NCT00333840|42139746|FG002|Second-line Treatment Period|Protocol Violation|1|||
19694199|NCT00333840|42139747|FG003|Second-line Treatment Period|Protocol Violation|10|||
19694200|NCT00333840|42139744|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
19694201|NCT00333840|42139745|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
19694202|NCT00333840|42139746|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
19694203|NCT00333840|42139747|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
19694204|NCT00333840|42139744|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
19694205|NCT00333840|42139745|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
19694206|NCT00333840|42139746|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
19694207|NCT00333840|42139747|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
19694208|NCT00333840|42139744|FG000|Second-line Treatment Period|Administrative problems|0|||
19694209|NCT00333840|42139745|FG001|Second-line Treatment Period|Administrative problems|0|||
19694210|NCT00333840|42139746|FG002|Second-line Treatment Period|Administrative problems|0|||
19694211|NCT00333840|42139747|FG003|Second-line Treatment Period|Administrative problems|7|||
19694212|NCT00333840|42139744|FG000|Second-line Treatment Period|Death|0|||
19694213|NCT00333840|42139745|FG001|Second-line Treatment Period|Death|0|||
19694214|NCT00333840|42139746|FG002|Second-line Treatment Period|Death|0|||
19694215|NCT00333840|42139747|FG003|Second-line Treatment Period|Death|9|||
19694216|NCT00490451|42139763|FG000|Overall Study|Adverse Event|3|||
19694217|NCT00490451|42139764|FG001|Overall Study|Adverse Event|3|||
19694218|NCT00490451|42139763|FG000|Overall Study|Death|3|||
19694219|NCT00490451|42139764|FG001|Overall Study|Death|1|||
19694220|NCT00490451|42139763|FG000|Overall Study|Withdrawal by Subject|2|||
19694221|NCT00490451|42139764|FG001|Overall Study|Withdrawal by Subject|0|||
19694222|NCT00490451|42139763|FG000|Overall Study|Investigator Decision|1|||
19694223|NCT00490451|42139764|FG001|Overall Study|Investigator Decision|0|||
19694224|NCT00490451|42139763|FG000|Overall Study|Protocol Violation|1|||
19694225|NCT00490451|42139764|FG001|Overall Study|Protocol Violation|0|||
19694226|NCT00490451|42139763|FG000|Overall Study|Progressive Disease|53|||
19694227|NCT00490451|42139764|FG001|Overall Study|Progressive Disease|34|||
19694228|NCT00321906|42139772|FG000|Overall Study|Adverse Event|36|||
19694229|NCT00321906|42139773|FG001|Overall Study|Adverse Event|44|||
19694230|NCT00321906|42139772|FG000|Overall Study|Death|9|||
19694231|NCT00321906|42139773|FG001|Overall Study|Death|6|||
19694232|NCT00321906|42139772|FG000|Overall Study|Lost to Follow-up|1|||
19694233|NCT00321906|42139773|FG001|Overall Study|Lost to Follow-up|2|||
19694234|NCT00321906|42139772|FG000|Overall Study|Withdrawal by Subject|0|||
19694235|NCT00321906|42139773|FG001|Overall Study|Withdrawal by Subject|4|||
19694236|NCT00339144|42139782|FG000|Overall Study|Disease progression|5|||
19694237|NCT00339144|42139783|FG001|Overall Study|Disease progression|2|||
19694238|NCT00339144|42139784|FG002|Overall Study|Disease progression|2|||
19694239|NCT00339144|42139782|FG000|Overall Study|Study drug toxicity|3|||
19694240|NCT00339144|42139783|FG001|Overall Study|Study drug toxicity|1|||
19694241|NCT00339144|42139784|FG002|Overall Study|Study drug toxicity|1|||
19694242|NCT00339144|42139782|FG000|Overall Study|Participant's request to discontinuation|1|||
19694243|NCT00339144|42139783|FG001|Overall Study|Participant's request to discontinuation|0|||
19694244|NCT00339144|42139784|FG002|Overall Study|Participant's request to discontinuation|1|||
19367262|NCT02435992|41607419|FG004|Overall Study|Physician Decision|0|||
19367263|NCT02788513|41607436|FG000|Overall Study|Withdrawal by Subject|3|||
19694245|NCT00321828|42139793|FG000|Overall Study|Ineligible|3|||
19694246|NCT00321828|42139793|FG000|Overall Study|No follow up data|1|||
19694247|NCT00333138|42139800|FG000|Core Study (6 Months)|Adverse Event|4|||
19694248|NCT00333138|42139801|FG001|Core Study (6 Months)|Adverse Event|5|||
19694249|NCT00333138|42139802|FG002|Core Study (6 Months)|Adverse Event|8|||
19367264|NCT02788513|41607437|FG001|Overall Study|Withdrawal by Subject|0|||
19694250|NCT00333138|42139800|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
19694251|NCT00333138|42139801|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
19694252|NCT00333138|42139802|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
19694253|NCT00333138|42139800|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
19694254|NCT00333138|42139801|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
19694255|NCT00333138|42139802|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
19694256|NCT00333138|42139800|FG000|Core Study (6 Months)|Protocol Violation|1|||
19694257|NCT00333138|42139801|FG001|Core Study (6 Months)|Protocol Violation|0|||
19694258|NCT00333138|42139802|FG002|Core Study (6 Months)|Protocol Violation|1|||
19694259|NCT00333138|42139800|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
19694260|NCT00333138|42139801|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
19694261|NCT00333138|42139802|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
19694262|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
19694263|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
19694264|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
19694265|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
19694266|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
19694267|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
19694268|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
19694269|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
19694270|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
19694271|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
19694272|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
19694273|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
19694274|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
19694275|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
19694276|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
19694277|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
19694278|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
19694279|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
19694280|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
19694281|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
19694282|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
19694283|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
19694284|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
19694285|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
19694286|NCT00333138|42139800|FG000|Extension Study (Month6 to End of Study)|Death|0|||
19694287|NCT00333138|42139801|FG001|Extension Study (Month6 to End of Study)|Death|1|||
19694288|NCT00333138|42139802|FG002|Extension Study (Month6 to End of Study)|Death|0|||
19694289|NCT00332202|42139814|FG000|Overall Study|Adverse Event|72|||
19694290|NCT00332202|42139815|FG001|Overall Study|Adverse Event|28|||
19694291|NCT00332202|42139814|FG000|Overall Study|Lost to Follow-up|2|||
19694292|NCT00332202|42139815|FG001|Overall Study|Lost to Follow-up|1|||
19694293|NCT00332202|42139814|FG000|Overall Study|Physician Decision|6|||
19694294|NCT00332202|42139815|FG001|Overall Study|Physician Decision|8|||
19694295|NCT00332202|42139814|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
19694296|NCT00332202|42139815|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
19694297|NCT00332202|42139814|FG000|Overall Study|Protocol Violation|7|||
19694298|NCT00332202|42139815|FG001|Overall Study|Protocol Violation|2|||
19694299|NCT00332202|42139814|FG000|Overall Study|Sponsor Decision|1|||
19694300|NCT00332202|42139815|FG001|Overall Study|Sponsor Decision|2|||
19694301|NCT00332202|42139814|FG000|Overall Study|Withdrawal by Subject|36|||
19694302|NCT00332202|42139815|FG001|Overall Study|Withdrawal by Subject|17|||
19694303|NCT00332202|42139814|FG000|Overall Study|Progressive Disease|106|||
19694304|NCT00332202|42139815|FG001|Overall Study|Progressive Disease|60|||
19694305|NCT00332202|42139814|FG000|Overall Study|Death|5|||
19694306|NCT00332202|42139815|FG001|Overall Study|Death|2|||
19694307|NCT00331422|42139830|FG000|Overall Study|Did not receive entire study regimen|5|||
19694308|NCT00331344|42139835|FG000|Phase I|Adverse Event|0|||
19694309|NCT00331344|42139836|FG001|Phase I|Adverse Event|0|||
19694310|NCT00331344|42139837|FG002|Phase I|Adverse Event|0|||
19694311|NCT00331344|42139838|FG003|Phase I|Adverse Event|1|||
19694312|NCT00331344|42139839|FG004|Phase I|Adverse Event|2|||
19694313|NCT00331344|42139840|FG005|Phase I|Adverse Event|2|||
19694314|NCT00331344|42139841|FG006|Phase I|Adverse Event|0|||
19694315|NCT00331344|42139842|FG007|Phase I|Adverse Event|1|||
19694316|NCT00331344|42139843|FG008|Phase I|Adverse Event|0|||
19694317|NCT00331344|42139835|FG000|Phase II|Death|0|||
19694318|NCT00331344|42139836|FG001|Phase II|Death|0|||
19694319|NCT00331344|42139837|FG002|Phase II|Death|0|||
19694320|NCT00331344|42139838|FG003|Phase II|Death|0|||
19694321|NCT00331344|42139839|FG004|Phase II|Death|0|||
19694322|NCT00331344|42139840|FG005|Phase II|Death|0|||
19694323|NCT00331344|42139841|FG006|Phase II|Death|0|||
19694324|NCT00331344|42139842|FG007|Phase II|Death|0|||
19694325|NCT00331344|42139843|FG008|Phase II|Death|4|||
19694326|NCT00321672|42139860|FG000|Overall Study|Withdrawal by Subject|5|||
19694327|NCT00321672|42139861|FG001|Overall Study|Withdrawal by Subject|1|||
19694328|NCT00321672|42139862|FG002|Overall Study|Withdrawal by Subject|2|||
19694329|NCT00321672|42139863|FG003|Overall Study|Withdrawal by Subject|0|||
19694330|NCT00321672|42139860|FG000|Overall Study|Noncompliance|1|||
19694331|NCT00321672|42139861|FG001|Overall Study|Noncompliance|2|||
19694332|NCT00321672|42139862|FG002|Overall Study|Noncompliance|1|||
19694333|NCT00321672|42139863|FG003|Overall Study|Noncompliance|0|||
19694334|NCT00321672|42139860|FG000|Overall Study|Adverse Event|1|||
19694335|NCT00321672|42139861|FG001|Overall Study|Adverse Event|1|||
19694336|NCT00321672|42139862|FG002|Overall Study|Adverse Event|0|||
19694337|NCT00321672|42139863|FG003|Overall Study|Adverse Event|0|||
19694338|NCT00321672|42139860|FG000|Overall Study|Lack of Efficacy|1|||
19694339|NCT00321672|42139861|FG001|Overall Study|Lack of Efficacy|1|||
19694340|NCT00321672|42139862|FG002|Overall Study|Lack of Efficacy|0|||
19694341|NCT00321672|42139863|FG003|Overall Study|Lack of Efficacy|0|||
19694342|NCT00321672|42139860|FG000|Overall Study|Lost to Follow-up|2|||
19694343|NCT00321672|42139861|FG001|Overall Study|Lost to Follow-up|0|||
19694344|NCT00321672|42139862|FG002|Overall Study|Lost to Follow-up|4|||
19694345|NCT00321672|42139863|FG003|Overall Study|Lost to Follow-up|2|||
19694346|NCT00321672|42139860|FG000|Overall Study|Death|1|||
19694347|NCT00321672|42139861|FG001|Overall Study|Death|0|||
19694348|NCT00321672|42139862|FG002|Overall Study|Death|0|||
19694349|NCT00321672|42139863|FG003|Overall Study|Death|0|||
19694350|NCT00321672|42139860|FG000|Overall Study|Too far to travel for visits|1|||
19694351|NCT00321672|42139861|FG001|Overall Study|Too far to travel for visits|0|||
19694352|NCT00321672|42139862|FG002|Overall Study|Too far to travel for visits|0|||
19694353|NCT00321672|42139863|FG003|Overall Study|Too far to travel for visits|0|||
19694354|NCT00321672|42139860|FG000|Overall Study|Incarcerated|0|||
19694355|NCT00321672|42139861|FG001|Overall Study|Incarcerated|0|||
19694356|NCT00321672|42139862|FG002|Overall Study|Incarcerated|2|||
19694357|NCT00321672|42139863|FG003|Overall Study|Incarcerated|0|||
19694358|NCT00321672|42139860|FG000|Overall Study|Moved out of state|0|||
19694359|NCT00321672|42139861|FG001|Overall Study|Moved out of state|1|||
19694360|NCT00321672|42139862|FG002|Overall Study|Moved out of state|1|||
19694361|NCT00321672|42139863|FG003|Overall Study|Moved out of state|0|||
19694362|NCT00321672|42139860|FG000|Overall Study|Protocol Violation|0|||
19694363|NCT00321672|42139861|FG001|Overall Study|Protocol Violation|0|||
19779470|NCT03068455|42234829|FG001|Treatment Period|Disease progression|208|||
19779471|NCT03068455|42234828|FG000|Treatment Period|Study drug toxicity|317|||
19779472|NCT03068455|42234829|FG001|Treatment Period|Study drug toxicity|104|||
19779473|NCT03068455|42234828|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
19779474|NCT03068455|42234829|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
19779475|NCT03068455|42234828|FG000|Treatment Period|Participant request to stop therapy|33|||
19779476|NCT03068455|42234829|FG001|Treatment Period|Participant request to stop therapy|20|||
19779477|NCT03068455|42234828|FG000|Treatment Period|Participant withdrew consent|5|||
19779478|NCT03068455|42234829|FG001|Treatment Period|Participant withdrew consent|10|||
19779479|NCT03068455|42234828|FG000|Treatment Period|Poor/non-compliance|3|||
19779480|NCT03068455|42234829|FG001|Treatment Period|Poor/non-compliance|0|||
19779481|NCT03068455|42234828|FG000|Treatment Period|Participant no longer meets study criteria|1|||
19779482|NCT03068455|42234829|FG001|Treatment Period|Participant no longer meets study criteria|3|||
19779483|NCT03068455|42234828|FG000|Treatment Period|Other reasons|12|||
19779484|NCT03068455|42234829|FG001|Treatment Period|Other reasons|4|||
19779485|NCT03067987|42234837|FG000|Overall Study|Lost to Follow-up|7|||
19779486|NCT03067987|42234838|FG001|Overall Study|Lost to Follow-up|10|||
19779487|NCT03067987|42234837|FG000|Overall Study|Protocol Violation|1|||
19779488|NCT03067987|42234838|FG001|Overall Study|Protocol Violation|2|||
19779489|NCT03067987|42234837|FG000|Overall Study|Withdrawal by Subject|2|||
19779490|NCT03067987|42234838|FG001|Overall Study|Withdrawal by Subject|1|||
19779491|NCT04889222|42234844|FG000|Overall Study|Did not meet eligibility criteria|8|||
19779492|NCT04889222|42234844|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
19779493|NCT04889222|42234844|FG000|Overall Study|Did not proceed due to time constraints|5|||
19779494|NCT03067441|42234850|FG000|Overall Study|Withdrawal by Subject|16|||
19779495|NCT03067441|42234851|FG001|Overall Study|Withdrawal by Subject|34|||
19779496|NCT03067441|42234850|FG000|Overall Study|Lost to Follow-up|7|||
19779497|NCT03067441|42234851|FG001|Overall Study|Lost to Follow-up|5|||
19694364|NCT00321672|42139862|FG002|Overall Study|Protocol Violation|1|||
19694365|NCT00321672|42139863|FG003|Overall Study|Protocol Violation|0|||
19694366|NCT00321672|42139860|FG000|Overall Study|Diagnosis of testicular cancer|0|||
19694367|NCT00321672|42139861|FG001|Overall Study|Diagnosis of testicular cancer|1|||
19694368|NCT00321672|42139862|FG002|Overall Study|Diagnosis of testicular cancer|0|||
19694369|NCT00321672|42139863|FG003|Overall Study|Diagnosis of testicular cancer|0|||
19694370|NCT00321672|42139860|FG000|Overall Study|Extensive travel required for new job|0|||
19779498|NCT03067441|42234850|FG000|Overall Study|Adverse Event|7|||
19779499|NCT03067441|42234851|FG001|Overall Study|Adverse Event|14|||
19779500|NCT03067441|42234850|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
19779501|NCT03067441|42234851|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
19779502|NCT03067441|42234850|FG000|Overall Study|Physician Decision|1|||
19779503|NCT03067441|42234851|FG001|Overall Study|Physician Decision|3|||
19779504|NCT03067441|42234850|FG000|Overall Study|Other|1|||
19779505|NCT03067441|42234851|FG001|Overall Study|Other|1|||
19779506|NCT02600923|42234860|FG000|Overall Study|Death|10|||
19779507|NCT02600923|42234860|FG000|Overall Study|Adverse Event|3|||
19779508|NCT02600923|42234860|FG000|Overall Study|Global deterioration of health status|2|||
19779509|NCT02600923|42234860|FG000|Overall Study|Insufficient clinical response|6|||
19779510|NCT02600923|42234860|FG000|Overall Study|Lost to Follow-up|1|||
19779511|NCT02600923|42234860|FG000|Overall Study|Withdrawal by Subject|5|||
19779512|NCT02600923|42234860|FG000|Overall Study|Objective progression or relapse|50|||
19779513|NCT02600923|42234860|FG000|Overall Study|Study terminated by Sponsor|53|||
19779514|NCT02600923|42234860|FG000|Overall Study|Not treated|1|||
19779515|NCT03070171|42234866|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
19779516|NCT03070171|42234867|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
19607080|NCT00942968|42055847|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
19694371|NCT00321672|42139861|FG001|Overall Study|Extensive travel required for new job|1|||
19694372|NCT00321672|42139862|FG002|Overall Study|Extensive travel required for new job|0|||
19694373|NCT00321672|42139863|FG003|Overall Study|Extensive travel required for new job|0|||
19694374|NCT00321048|42139879|FG000|Overall Study|Withdrawal by Subject|6|||
19694375|NCT00321048|42139880|FG001|Overall Study|Withdrawal by Subject|8|||
19694376|NCT00330174|42139888|FG000|Overall Study|Withdrawal by Subject|7|||
19694377|NCT00330174|42139889|FG001|Overall Study|Withdrawal by Subject|7|||
19694378|NCT00330174|42139888|FG000|Overall Study|Lost to Follow-up|4|||
19694379|NCT00330174|42139889|FG001|Overall Study|Lost to Follow-up|1|||
19694380|NCT00330174|42139888|FG000|Overall Study|Clinical deterioration|1|||
19694381|NCT00330174|42139889|FG001|Overall Study|Clinical deterioration|2|||
19694382|NCT00330174|42139888|FG000|Overall Study|Excessive missed visits|3|||
19694383|NCT00330174|42139889|FG001|Overall Study|Excessive missed visits|8|||
19694384|NCT00330174|42139888|FG000|Overall Study|Miscellaneous reasons|7|||
19694385|NCT00330174|42139889|FG001|Overall Study|Miscellaneous reasons|1|||
19694386|NCT00320424|42139895|FG000|Overall Study|Adverse Event|3|||
19694387|NCT00320424|42139895|FG000|Overall Study|Other|3|||
19694388|NCT00338286|42139901|FG000|Overall Study|Withdrawal by Subject|50|||
19694389|NCT00338286|42139902|FG001|Overall Study|Withdrawal by Subject|54|||
19694390|NCT00338286|42139901|FG000|Overall Study|Lost to Follow-up|80|||
19694391|NCT00338286|42139902|FG001|Overall Study|Lost to Follow-up|66|||
19694392|NCT00338286|42139901|FG000|Overall Study|Other|103|||
19694393|NCT00338286|42139902|FG001|Overall Study|Other|93|||
19694394|NCT00329784|42139912|FG000|Overall Study|Lost to Follow-up|0|||
19694395|NCT00329784|42139913|FG001|Overall Study|Lost to Follow-up|1|||
19694396|NCT00329784|42139914|FG002|Overall Study|Lost to Follow-up|0|||
19694397|NCT00329784|42139915|FG003|Overall Study|Lost to Follow-up|0|||
19694398|NCT00329784|42139912|FG000|Overall Study|Withdrawal by Subject|4|||
19694399|NCT00329784|42139913|FG001|Overall Study|Withdrawal by Subject|2|||
19694400|NCT00329784|42139914|FG002|Overall Study|Withdrawal by Subject|0|||
19694401|NCT00329784|42139915|FG003|Overall Study|Withdrawal by Subject|0|||
19694402|NCT00329784|42139912|FG000|Overall Study|Other|1|||
19694403|NCT00329784|42139913|FG001|Overall Study|Other|2|||
19694404|NCT00329784|42139914|FG002|Overall Study|Other|0|||
19694405|NCT00329784|42139915|FG003|Overall Study|Other|0|||
19694406|NCT00337818|42139930|FG000|Overall Study|Lost to Follow-up|289|||
19694407|NCT00337818|42139931|FG001|Overall Study|Lost to Follow-up|91|||
19694408|NCT00337818|42139932|FG002|Overall Study|Lost to Follow-up|107|||
19694409|NCT00329550|42139943|FG000|Overall Study|Adverse Event|3|||
19694410|NCT00329550|42139944|FG001|Overall Study|Adverse Event|4|||
19694411|NCT00329550|42139945|FG002|Overall Study|Adverse Event|2|||
19694412|NCT00329550|42139943|FG000|Overall Study|Withdrawal of Consent|1|||
19694413|NCT00329550|42139944|FG001|Overall Study|Withdrawal of Consent|0|||
19694414|NCT00329550|42139945|FG002|Overall Study|Withdrawal of Consent|1|||
19694415|NCT00329550|42139943|FG000|Overall Study|Due to Relocation|0|||
19694416|NCT00329550|42139944|FG001|Overall Study|Due to Relocation|0|||
19694417|NCT00329550|42139945|FG002|Overall Study|Due to Relocation|1|||
19607081|NCT00942734|42055851|FG000|Overall Study|Adverse Event|2|||
19607082|NCT00942734|42055851|FG000|Overall Study|Protocol Violation|3|||
19607083|NCT00942734|42055851|FG000|Overall Study|Disease Progression|2|||
19607084|NCT00942734|42055851|FG000|Overall Study|Physician Decision|1|||
19607085|NCT00584194|42055855|FG000|Overall Study|Other|135|||
19607086|NCT00942422|42055859|FG000|Overall Study|Withdrawal by Subject|1|||
19607087|NCT00942422|42055859|FG000|Overall Study|Death|1|||
19607088|NCT00942422|42055859|FG000|Overall Study|Progressive diease|1|||
19607089|NCT00677833|42055867|FG000|Overall Study|Withdrawal by Subject|4|||
19607090|NCT00677833|42055868|FG001|Overall Study|Withdrawal by Subject|0|||
19694418|NCT00375674|42139957|FG000|Overall Study|Other|26|||
19694419|NCT00375674|42139958|FG001|Overall Study|Other|18|||
19694420|NCT00375674|42139957|FG000|Overall Study|Death|67|||
19694421|NCT00375674|42139958|FG001|Overall Study|Death|76|||
19694422|NCT00375674|42139957|FG000|Overall Study|Participants refused further follow-up|31|||
19694423|NCT00375674|42139958|FG001|Overall Study|Participants refused further follow-up|30|||
19694424|NCT00375674|42139957|FG000|Overall Study|Lost to Follow-up|17|||
19694425|NCT00375674|42139958|FG001|Overall Study|Lost to Follow-up|15|||
19694426|NCT00375674|42139957|FG000|Overall Study|Enrolled but not treated|3|||
19694427|NCT00375674|42139958|FG001|Overall Study|Enrolled but not treated|2|||
19694428|NCT00350402|42139966|FG000|Overall Study|Lost to Follow-up|1|||
19694429|NCT00350402|42139967|FG001|Overall Study|Lost to Follow-up|1|||
19694430|NCT00320190|42139981|FG000|First 12 Months|Completed but did not enter extension|5|||
19694431|NCT00320190|42139982|FG001|First 12 Months|Completed but did not enter extension|3|||
19694432|NCT00320190|42139981|FG000|First 12 Months|Sponsor terminated study|2|||
19694433|NCT00320190|42139982|FG001|First 12 Months|Sponsor terminated study|2|||
19694434|NCT00320190|42139981|FG000|First 12 Months|Lost to Follow-up|0|||
19694435|NCT00320190|42139982|FG001|First 12 Months|Lost to Follow-up|1|||
19694436|NCT00320190|42139981|FG000|First 12 Months|Enrollment failure|0|||
19694437|NCT00320190|42139982|FG001|First 12 Months|Enrollment failure|1|||
19694438|NCT00320190|42139981|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
19694439|NCT00320190|42139982|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
19694440|NCT00320190|42139981|FG000|First 12 Months|Investigator request|0|||
19694441|NCT00320190|42139982|FG001|First 12 Months|Investigator request|1|||
19694442|NCT00320190|42139981|FG000|First 12 Months|Study drug toxicity|0|||
19694443|NCT00320190|42139982|FG001|First 12 Months|Study drug toxicity|1|||
19694444|NCT00320190|42139981|FG000|First 12 Months|Withdrawal by Subject|0|||
19694445|NCT00320190|42139982|FG001|First 12 Months|Withdrawal by Subject|1|||
19694446|NCT00320190|42139981|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
19694447|NCT00320190|42139982|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
19694448|NCT00320190|42139981|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
19694449|NCT00320190|42139982|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
19694450|NCT00320190|42139981|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
19694451|NCT00320190|42139982|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
19694452|NCT00320112|42139990|FG000|Overall Study|Lost to Follow-up|3|||
19694453|NCT00320112|42139991|FG001|Overall Study|Lost to Follow-up|4|||
19694454|NCT00320112|42139990|FG000|Overall Study|Withdrawal by Subject|3|||
19694455|NCT00320112|42139991|FG001|Overall Study|Withdrawal by Subject|0|||
19694456|NCT00320112|42139990|FG000|Overall Study|Death|2|||
19694457|NCT00320112|42139991|FG001|Overall Study|Death|1|||
19694458|NCT00319956|42140005|FG000|Overall Study|Death|20|||
19694459|NCT00319956|42140006|FG001|Overall Study|Death|24|||
19694460|NCT00349622|42140014|FG000|Overall Study|Death|168|||
19694461|NCT00349622|42140015|FG001|Overall Study|Death|86|||
19694462|NCT00349622|42140014|FG000|Overall Study|Lost to Follow-up|5|||
19694463|NCT00349622|42140015|FG001|Overall Study|Lost to Follow-up|1|||
19694464|NCT00349622|42140014|FG000|Overall Study|Withdrawal by Subject|5|||
19694465|NCT00349622|42140015|FG001|Overall Study|Withdrawal by Subject|9|||
19779517|NCT03070171|42234866|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
19779518|NCT03070171|42234867|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
19779519|NCT01084252|42234887|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
19779520|NCT01084252|42234888|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
19779521|NCT01084252|42234889|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
19779522|NCT01084252|42234890|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
19779523|NCT01084252|42234891|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
19779524|NCT01084252|42234892|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
19779525|NCT01084252|42234893|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
19779526|NCT01084252|42234894|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
19779527|NCT01084252|42234895|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
19779528|NCT01084252|42234896|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
19779529|NCT01084252|42234897|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
19779530|NCT01084252|42234898|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
19779531|NCT01084252|42234899|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
19779532|NCT01084252|42234900|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
19779533|NCT01084252|42234887|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
19779534|NCT01084252|42234888|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
19779535|NCT01084252|42234889|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
19779536|NCT01084252|42234890|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
19779537|NCT01084252|42234891|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
19779538|NCT01084252|42234892|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
19779539|NCT01084252|42234893|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
19779540|NCT01084252|42234894|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
19779541|NCT01084252|42234895|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
19779542|NCT01084252|42234896|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
19779543|NCT01084252|42234897|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
19779544|NCT01084252|42234898|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
19779545|NCT01084252|42234899|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
19779546|NCT01084252|42234900|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
19779547|NCT01084252|42234887|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
19779548|NCT01084252|42234888|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
19779549|NCT01084252|42234889|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
19779550|NCT01084252|42234890|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
19779551|NCT01084252|42234891|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
19779552|NCT01084252|42234892|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
19779553|NCT01084252|42234893|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
19779554|NCT01084252|42234894|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
19779555|NCT01084252|42234895|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
19779556|NCT01084252|42234896|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
19367265|NCT02788513|41607438|FG002|Overall Study|Withdrawal by Subject|2|||
19367266|NCT02788513|41607439|FG003|Overall Study|Withdrawal by Subject|3|||
19367267|NCT02788513|41607440|FG004|Overall Study|Withdrawal by Subject|1|||
19779557|NCT01084252|42234897|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
19779558|NCT01084252|42234898|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
19779559|NCT01084252|42234899|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
19779560|NCT01084252|42234900|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
19779561|NCT01084252|42234887|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779562|NCT01084252|42234888|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779563|NCT01084252|42234889|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779564|NCT01084252|42234890|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779565|NCT01084252|42234891|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779566|NCT01084252|42234892|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779567|NCT01084252|42234893|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779568|NCT01084252|42234894|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779569|NCT01084252|42234895|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779570|NCT01084252|42234896|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
19779571|NCT01084252|42234897|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
19779572|NCT01084252|42234898|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
19779573|NCT01084252|42234899|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19367268|NCT02788513|41607436|FG000|Overall Study|Lost to Follow-up|1|||
19367269|NCT02788513|41607437|FG001|Overall Study|Lost to Follow-up|0|||
19367270|NCT02788513|41607438|FG002|Overall Study|Lost to Follow-up|0|||
19367271|NCT02788513|41607439|FG003|Overall Study|Lost to Follow-up|0|||
19367272|NCT02788513|41607440|FG004|Overall Study|Lost to Follow-up|1|||
19367273|NCT02788513|41607436|FG000|Overall Study|Adverse Event|5|||
19367274|NCT02788513|41607437|FG001|Overall Study|Adverse Event|8|||
19367275|NCT02788513|41607438|FG002|Overall Study|Adverse Event|4|||
19367276|NCT02788513|41607439|FG003|Overall Study|Adverse Event|2|||
19367277|NCT02788513|41607440|FG004|Overall Study|Adverse Event|2|||
19367278|NCT02788513|41607436|FG000|Overall Study|Protocol Violation|0|||
19367279|NCT02788513|41607437|FG001|Overall Study|Protocol Violation|0|||
19367280|NCT02788513|41607438|FG002|Overall Study|Protocol Violation|1|||
19367281|NCT02788513|41607439|FG003|Overall Study|Protocol Violation|1|||
19367282|NCT02788513|41607440|FG004|Overall Study|Protocol Violation|0|||
19367283|NCT02788513|41607436|FG000|Overall Study|Subject decided to stop taking treatment|0|||
19367284|NCT02788513|41607437|FG001|Overall Study|Subject decided to stop taking treatment|0|||
19367285|NCT02788513|41607438|FG002|Overall Study|Subject decided to stop taking treatment|1|||
19367286|NCT02788513|41607439|FG003|Overall Study|Subject decided to stop taking treatment|0|||
19367287|NCT02788513|41607440|FG004|Overall Study|Subject decided to stop taking treatment|0|||
19367288|NCT02788513|41607436|FG000|Overall Study|Decision by the study team|0|||
19367289|NCT02788513|41607437|FG001|Overall Study|Decision by the study team|0|||
19367290|NCT02788513|41607438|FG002|Overall Study|Decision by the study team|0|||
19367291|NCT02788513|41607439|FG003|Overall Study|Decision by the study team|0|||
19607091|NCT00677833|42055869|FG002|Overall Study|Withdrawal by Subject|1|||
19779574|NCT01084252|42234900|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
19779575|NCT01084252|42234887|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779576|NCT01084252|42234888|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779577|NCT01084252|42234889|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779578|NCT01084252|42234890|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779579|NCT01084252|42234891|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779580|NCT01084252|42234892|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779581|NCT01084252|42234893|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779582|NCT01084252|42234894|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779583|NCT01084252|42234895|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
19779584|NCT01084252|42234896|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
19367292|NCT02788513|41607440|FG004|Overall Study|Decision by the study team|1|||
19367293|NCT02401672|41607454|FG000|Overall Study|Withdrawal by Subject|1|||
19779585|NCT01084252|42234897|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
19779586|NCT01084252|42234898|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
19779587|NCT01084252|42234899|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779588|NCT01084252|42234900|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
19779589|NCT01084252|42234887|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779590|NCT01084252|42234888|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779591|NCT01084252|42234889|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779592|NCT01084252|42234890|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779593|NCT01084252|42234891|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779594|NCT01084252|42234892|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779595|NCT01084252|42234893|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779596|NCT01084252|42234894|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779597|NCT01084252|42234895|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
19779598|NCT01084252|42234896|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779599|NCT01084252|42234897|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
19779600|NCT01084252|42234898|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
19779601|NCT01084252|42234899|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779602|NCT01084252|42234900|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
19779603|NCT01084252|42234887|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779604|NCT01084252|42234888|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779605|NCT01084252|42234889|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779606|NCT01084252|42234890|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779607|NCT01084252|42234891|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779608|NCT01084252|42234892|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779609|NCT01084252|42234893|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779610|NCT01084252|42234894|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779611|NCT01084252|42234895|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
19779612|NCT01084252|42234896|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
19779613|NCT01084252|42234897|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
19779614|NCT01084252|42234898|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
19779615|NCT01084252|42234899|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779616|NCT01084252|42234900|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
19779617|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779618|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779619|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779620|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779621|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779622|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779623|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779624|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19694466|NCT00354614|42140021|FG000|Overall Study|Lack of Efficacy|28|||
19694467|NCT00360308|42140028|FG000|Overall Study|Adverse Event|15|||
19694468|NCT00360308|42140029|FG001|Overall Study|Adverse Event|14|||
19694469|NCT00360308|42140030|FG002|Overall Study|Adverse Event|25|||
19694470|NCT00360308|42140028|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
19694471|NCT00360308|42140029|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
19694472|NCT00360308|42140030|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
19694473|NCT00360308|42140028|FG000|Overall Study|Protocol Violation|2|||
19694474|NCT00360308|42140029|FG001|Overall Study|Protocol Violation|1|||
19694475|NCT00360308|42140030|FG002|Overall Study|Protocol Violation|2|||
19694476|NCT00360308|42140028|FG000|Overall Study|Withdrawal by Subject|11|||
19694477|NCT00360308|42140029|FG001|Overall Study|Withdrawal by Subject|7|||
19694478|NCT00360308|42140030|FG002|Overall Study|Withdrawal by Subject|14|||
19607092|NCT00677833|42055870|FG003|Overall Study|Withdrawal by Subject|3|||
19607093|NCT00677833|42055867|FG000|Overall Study|Lost to Follow-up|0|||
19607094|NCT00677833|42055868|FG001|Overall Study|Lost to Follow-up|0|||
19607095|NCT00677833|42055869|FG002|Overall Study|Lost to Follow-up|1|||
19607096|NCT00677833|42055870|FG003|Overall Study|Lost to Follow-up|0|||
19607097|NCT00942266|42055880|FG000|Overall Study|Withdrawal by Subject|1|||
19607098|NCT00942266|42055881|FG001|Overall Study|Withdrawal by Subject|0|||
19607099|NCT00942266|42055880|FG000|Overall Study|Adverse Event|2|||
19607100|NCT00942266|42055881|FG001|Overall Study|Adverse Event|1|||
19607101|NCT00942266|42055880|FG000|Overall Study|Disease Progression|38|||
19607102|NCT00942266|42055881|FG001|Overall Study|Disease Progression|11|||
19607103|NCT00942266|42055880|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
19694479|NCT00360308|42140028|FG000|Overall Study|Lack of Efficacy|3|||
19607104|NCT00942266|42055881|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
19779625|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779626|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779627|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779628|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
19779629|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
19779630|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
19779631|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779632|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779633|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779634|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779635|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779636|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779637|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779638|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779639|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779640|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779641|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779642|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
19779643|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
19779644|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
19779645|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779646|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779647|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779648|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19694480|NCT00360308|42140029|FG001|Overall Study|Lack of Efficacy|0|||
19694481|NCT00360308|42140030|FG002|Overall Study|Lack of Efficacy|2|||
19694482|NCT00360308|42140028|FG000|Overall Study|Other|2|||
19694483|NCT00360308|42140029|FG001|Overall Study|Other|1|||
19779649|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779650|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779651|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779652|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779653|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779654|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779655|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779656|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779657|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
19779658|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
19779659|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779660|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19694484|NCT00360308|42140030|FG002|Overall Study|Other|1|||
19694485|NCT00360308|42140028|FG000|Overall Study|Study termination by sponsor|43|||
19694486|NCT00360308|42140029|FG001|Overall Study|Study termination by sponsor|55|||
19694487|NCT00360308|42140030|FG002|Overall Study|Study termination by sponsor|44|||
19779661|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779662|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779663|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779664|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779665|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779666|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779667|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779668|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779669|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779670|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
19779671|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
19779672|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
19779673|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779674|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779675|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779676|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779677|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779678|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779679|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779680|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779681|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779682|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779683|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19694488|NCT00348686|42140042|FG000|Overall Study|Withdrawal by Subject|45|||
19694489|NCT00348686|42140042|FG000|Overall Study|Adverse Event|5|||
19694490|NCT00348686|42140042|FG000|Overall Study|Protocol Violation|6|||
19779684|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
19779685|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
19779686|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
19779687|NCT01084252|42234887|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779688|NCT01084252|42234888|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779689|NCT01084252|42234889|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779690|NCT01084252|42234890|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779691|NCT01084252|42234891|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779692|NCT01084252|42234892|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779693|NCT01084252|42234893|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779694|NCT01084252|42234894|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779695|NCT01084252|42234895|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779696|NCT01084252|42234896|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779697|NCT01084252|42234897|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779698|NCT01084252|42234898|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779699|NCT01084252|42234899|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
19779700|NCT01084252|42234900|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
19779701|NCT03644017|42234964|FG000|Overall Study|Access Abandonment|5|||
19779702|NCT03644017|42234964|FG000|Overall Study|Kidney Transplant|2|||
19779703|NCT00158054|42234970|FG000|Overall Study|Refused to continue|3|||
19779704|NCT00158054|42234971|FG001|Overall Study|Refused to continue|0|||
19779705|NCT00158054|42234970|FG000|Overall Study|Unavailable for follow up|7|||
19779706|NCT00158054|42234971|FG001|Overall Study|Unavailable for follow up|3|||
19779707|NCT01337960|42234980|FG000|Overall Study|Lost to Follow-up|1|||
19779708|NCT01337960|42234981|FG001|Overall Study|Lost to Follow-up|0|||
19779709|NCT01337960|42234982|FG002|Overall Study|Lost to Follow-up|0|||
19779710|NCT01337960|42234980|FG000|Overall Study|Withdrawal by Subject|1|||
19779711|NCT01337960|42234981|FG001|Overall Study|Withdrawal by Subject|0|||
19779712|NCT01337960|42234982|FG002|Overall Study|Withdrawal by Subject|0|||
19779713|NCT04016714|42235001|FG000|Overall Study|Death|1|||
19779714|NCT04016714|42235002|FG001|Overall Study|Death|0|||
19779715|NCT04016714|42235001|FG000|Overall Study|Lost to Follow-up|3|||
19779716|NCT04016714|42235002|FG001|Overall Study|Lost to Follow-up|1|||
19779717|NCT04016714|42235001|FG000|Overall Study|Physician Decision|3|||
19779718|NCT04016714|42235002|FG001|Overall Study|Physician Decision|3|||
19694491|NCT00348686|42140042|FG000|Overall Study|Lost to Follow-up|2|||
19694492|NCT00348686|42140042|FG000|Overall Study|Multiple Reasons|8|||
19694493|NCT00360230|42140053|FG000|Overall Study|Withdrawal by Subject|1|||
19694494|NCT00360230|42140054|FG001|Overall Study|Withdrawal by Subject|1|||
19694495|NCT00360230|42140055|FG002|Overall Study|Withdrawal by Subject|0|||
19694496|NCT00360230|42140056|FG003|Overall Study|Withdrawal by Subject|1|||
19694497|NCT00360230|42140057|FG004|Overall Study|Withdrawal by Subject|1|||
19694498|NCT00360230|42140058|FG005|Overall Study|Withdrawal by Subject|1|||
19694499|NCT00360230|42140059|FG006|Overall Study|Withdrawal by Subject|0|||
19694500|NCT00360230|42140053|FG000|Overall Study|Migrated|4|||
19694501|NCT00360230|42140054|FG001|Overall Study|Migrated|1|||
19694502|NCT00360230|42140055|FG002|Overall Study|Migrated|3|||
19694503|NCT00360230|42140056|FG003|Overall Study|Migrated|1|||
19779719|NCT04016714|42235001|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
19779720|NCT04016714|42235002|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
19779721|NCT02750306|42235010|FG000|Overall Study|Withdrawal by Subject|5|||
19779722|NCT02750306|42235011|FG001|Overall Study|Withdrawal by Subject|2|||
19779723|NCT02750306|42235010|FG000|Overall Study|Protocol Violation|1|||
19779724|NCT02750306|42235011|FG001|Overall Study|Protocol Violation|0|||
19779725|NCT01816165|42235019|FG000|Overall Study|Adverse Event|1|||
19779726|NCT01816165|42235020|FG001|Overall Study|Adverse Event|0|||
19779727|NCT01816165|42235021|FG002|Overall Study|Adverse Event|0|||
19779728|NCT01816165|42235022|FG003|Overall Study|Adverse Event|0|||
19779729|NCT01677988|42235051|FG000|Overall Study|Lack of Efficacy|2|||
19779730|NCT02926573|42235058|FG000|Overall Study|Nausea|1|||
19779731|NCT02926573|42235059|FG001|Overall Study|Nausea|0|||
19779732|NCT02926573|42235058|FG000|Overall Study|Remain intubated|2|||
19779733|NCT02926573|42235059|FG001|Overall Study|Remain intubated|2|||
19779734|NCT02926573|42235058|FG000|Overall Study|Change in surgery plan|3|||
19779735|NCT02926573|42235059|FG001|Overall Study|Change in surgery plan|1|||
19779736|NCT02926573|42235058|FG000|Overall Study|Change to outpatient status|5|||
19779737|NCT02926573|42235059|FG001|Overall Study|Change to outpatient status|1|||
19779738|NCT02926573|42235058|FG000|Overall Study|Withdrawal by Subject|0|||
19779739|NCT02926573|42235059|FG001|Overall Study|Withdrawal by Subject|2|||
19779740|NCT02926573|42235058|FG000|Overall Study|Return to operating room|0|||
19779741|NCT02926573|42235059|FG001|Overall Study|Return to operating room|2|||
19389167|NCT01625182|41632779|FG000|Overall Study|Lack of Efficacy|12|||
19694504|NCT00360230|42140057|FG004|Overall Study|Migrated|4|||
19694505|NCT00360230|42140058|FG005|Overall Study|Migrated|1|||
19694506|NCT00360230|42140059|FG006|Overall Study|Migrated|1|||
19694507|NCT00360230|42140053|FG000|Overall Study|Other|1|||
19779742|NCT02926573|42235058|FG000|Overall Study|Delirium|0|||
19779743|NCT02926573|42235059|FG001|Overall Study|Delirium|1|||
19779744|NCT00158860|42235067|FG000|Overall Study|Adverse Event|3|||
19779745|NCT00158860|42235068|FG001|Overall Study|Adverse Event|6|||
19779746|NCT00158860|42235067|FG000|Overall Study|Lost to Follow-up|11|||
19779747|NCT00158860|42235068|FG001|Overall Study|Lost to Follow-up|17|||
19779748|NCT00158860|42235067|FG000|Overall Study|Protocol Violation|8|||
19779749|NCT00158860|42235068|FG001|Overall Study|Protocol Violation|23|||
19779750|NCT00158860|42235067|FG000|Overall Study|Withdrawal by Subject|7|||
19779751|NCT00158860|42235068|FG001|Overall Study|Withdrawal by Subject|17|||
19779752|NCT00158860|42235067|FG000|Overall Study|MOVING OUT OF STATE|1|||
19779753|NCT00158860|42235068|FG001|Overall Study|MOVING OUT OF STATE|0|||
19779754|NCT00158860|42235067|FG000|Overall Study|Pregnancy|3|||
19779755|NCT00158860|42235068|FG001|Overall Study|Pregnancy|3|||
19779756|NCT00158860|42235067|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
19779757|NCT00158860|42235068|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
19779758|NCT00158860|42235067|FG000|Overall Study|SPONSOR REQUEST|0|||
19694508|NCT00360230|42140054|FG001|Overall Study|Other|0|||
19694509|NCT00360230|42140055|FG002|Overall Study|Other|0|||
19694510|NCT00360230|42140056|FG003|Overall Study|Other|0|||
19694511|NCT00360230|42140057|FG004|Overall Study|Other|0|||
19694512|NCT00360230|42140058|FG005|Overall Study|Other|0|||
19694513|NCT00360230|42140059|FG006|Overall Study|Other|0|||
19694514|NCT00360230|42140053|FG000|Overall Study|Protocol Violation|0|||
19694515|NCT00360230|42140054|FG001|Overall Study|Protocol Violation|0|||
19694516|NCT00360230|42140055|FG002|Overall Study|Protocol Violation|0|||
19694517|NCT00360230|42140056|FG003|Overall Study|Protocol Violation|0|||
19694518|NCT00360230|42140057|FG004|Overall Study|Protocol Violation|0|||
19694519|NCT00360230|42140058|FG005|Overall Study|Protocol Violation|1|||
19694520|NCT00360230|42140059|FG006|Overall Study|Protocol Violation|0|||
19694521|NCT00360230|42140053|FG000|Overall Study|Death|0|||
19694522|NCT00360230|42140054|FG001|Overall Study|Death|1|||
19694523|NCT00360230|42140055|FG002|Overall Study|Death|0|||
19694524|NCT00360230|42140056|FG003|Overall Study|Death|0|||
19694525|NCT00360230|42140057|FG004|Overall Study|Death|0|||
19694526|NCT00360230|42140058|FG005|Overall Study|Death|1|||
19694527|NCT00360230|42140059|FG006|Overall Study|Death|1|||
19694528|NCT00348374|42140079|FG000|Overall Study|Adverse Event|1|||
19694529|NCT00348374|42140080|FG001|Overall Study|Adverse Event|4|||
19694530|NCT00348374|42140079|FG000|Overall Study|Lost to Follow-up|1|||
19694531|NCT00348374|42140080|FG001|Overall Study|Lost to Follow-up|3|||
19694532|NCT00348374|42140079|FG000|Overall Study|Withdrawal by Subject|5|||
19694533|NCT00348374|42140080|FG001|Overall Study|Withdrawal by Subject|5|||
19694534|NCT00348374|42140079|FG000|Overall Study|Other|11|||
19694535|NCT00348374|42140080|FG001|Overall Study|Other|12|||
19694536|NCT00348374|42140079|FG000|Overall Study|ongoing at date of cutoff|1|||
19694537|NCT00348374|42140080|FG001|Overall Study|ongoing at date of cutoff|1|||
19694538|NCT00348374|42140079|FG000|Overall Study|randomized but did not receive treatment|0|||
19694539|NCT00348374|42140080|FG001|Overall Study|randomized but did not receive treatment|7|||
19694540|NCT00353366|42140087|FG000|Overall Study|Adverse Event|8|||
19694541|NCT00353366|42140087|FG000|Overall Study|Protocol Violation|12|||
19694542|NCT00353366|42140087|FG000|Overall Study|Withdrawal by Subject|12|||
19694543|NCT00353366|42140087|FG000|Overall Study|Lost to Follow-up|92|||
19694544|NCT00353366|42140087|FG000|Overall Study|Other|19|||
19694545|NCT00352664|42140093|FG000|Overall Study|Withdrawal by Subject|7|||
19694546|NCT00352664|42140094|FG001|Overall Study|Withdrawal by Subject|0|||
19694547|NCT00490139|42140104|FG000|Overall Study|Death|106|||
19694548|NCT00490139|42140105|FG001|Overall Study|Death|119|||
19694549|NCT00490139|42140106|FG002|Overall Study|Death|168|||
19779759|NCT00158860|42235068|FG001|Overall Study|SPONSOR REQUEST|1|||
19694550|NCT00490139|42140107|FG003|Overall Study|Death|135|||
19694551|NCT00490139|42140104|FG000|Overall Study|Lost to Follow-up|56|||
19694552|NCT00490139|42140105|FG001|Overall Study|Lost to Follow-up|46|||
19694553|NCT00490139|42140106|FG002|Overall Study|Lost to Follow-up|58|||
19694554|NCT00490139|42140107|FG003|Overall Study|Lost to Follow-up|56|||
19694555|NCT00490139|42140104|FG000|Overall Study|Participant Withdrew Consent|146|||
19779760|NCT00158860|42235067|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
19779761|NCT00158860|42235068|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
19779762|NCT00158860|42235067|FG000|Overall Study|Closed per sponsor|0|||
19779763|NCT00158860|42235068|FG001|Overall Study|Closed per sponsor|1|||
19779764|NCT03067129|42235079|FG000|Overall Study|Ongoing|45|||
19779765|NCT03067129|42235080|FG001|Overall Study|Ongoing|28|||
19779766|NCT03067129|42235081|FG002|Overall Study|Ongoing|27|||
19779767|NCT03067129|42235082|FG003|Overall Study|Ongoing|23|||
19367294|NCT02401672|41607455|FG001|Overall Study|Withdrawal by Subject|3|||
19694556|NCT00490139|42140105|FG001|Overall Study|Participant Withdrew Consent|110|||
19694557|NCT00490139|42140106|FG002|Overall Study|Participant Withdrew Consent|208|||
19694558|NCT00490139|42140107|FG003|Overall Study|Participant Withdrew Consent|116|||
19779768|NCT03067129|42235079|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0|||
19694559|NCT00348140|42140122|FG000|Overall Study|Adverse Event|46|||
19779769|NCT03067129|42235080|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0|||
19779770|NCT03067129|42235081|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0|||
19694560|NCT00348140|42140123|FG001|Overall Study|Adverse Event|49|||
19694561|NCT00348140|42140124|FG002|Overall Study|Adverse Event|78|||
19694562|NCT00348140|42140122|FG000|Overall Study|Lost to Follow-up|4|||
19779771|NCT03067129|42235082|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1|||
19779772|NCT01679236|42235102|FG000|Overall Study|Lost to Follow-up|15|||
19779773|NCT01679236|42235103|FG001|Overall Study|Lost to Follow-up|15|||
19779774|NCT01679002|42235112|FG000|Overall Study|Adverse Event|1|||
19779775|NCT01679002|42235113|FG001|Overall Study|Adverse Event|1|||
19779776|NCT01679002|42235114|FG002|Overall Study|Adverse Event|0|||
19779777|NCT04409509|42235124|FG000|Overall Study|Failure to meet randomization requirement|1|||
19779778|NCT04409509|42235125|FG001|Overall Study|Failure to meet randomization requirement|0|||
19779779|NCT04409509|42235124|FG000|Overall Study|Adverse Event|0|||
19779780|NCT04409509|42235125|FG001|Overall Study|Adverse Event|1|||
19779781|NCT04409509|42235124|FG000|Overall Study|Death|11|||
19779782|NCT04409509|42235125|FG001|Overall Study|Death|10|||
19779783|NCT04409509|42235124|FG000|Overall Study|Non-compliance with study drug|0|||
19779784|NCT04409509|42235125|FG001|Overall Study|Non-compliance with study drug|1|||
19779785|NCT04409509|42235124|FG000|Overall Study|Lost to Follow-up|0|||
19779786|NCT04409509|42235125|FG001|Overall Study|Lost to Follow-up|3|||
19779787|NCT04409509|42235124|FG000|Overall Study|Withdrawal by Subject|0|||
19779788|NCT04409509|42235125|FG001|Overall Study|Withdrawal by Subject|3|||
19779789|NCT04409509|42235124|FG000|Overall Study|Randomized by mistake|0|||
19779790|NCT04409509|42235125|FG001|Overall Study|Randomized by mistake|1|||
19779791|NCT04409509|42235124|FG000|Overall Study|Other|1|||
19779792|NCT04409509|42235125|FG001|Overall Study|Other|1|||
19779793|NCT01678924|42235136|FG000|Overall Study|Adverse Event|1|||
19779794|NCT01678924|42235137|FG001|Overall Study|Adverse Event|1|||
19779795|NCT01678924|42235138|FG002|Overall Study|Adverse Event|0|||
19779796|NCT01678924|42235139|FG003|Overall Study|Adverse Event|1|||
19779797|NCT01678924|42235136|FG000|Overall Study|Lack of Efficacy|7|||
19779798|NCT01678924|42235137|FG001|Overall Study|Lack of Efficacy|2|||
19779799|NCT01678924|42235138|FG002|Overall Study|Lack of Efficacy|0|||
19779800|NCT01678924|42235139|FG003|Overall Study|Lack of Efficacy|5|||
19779801|NCT01678924|42235136|FG000|Overall Study|Lost to Follow-up|0|||
19779802|NCT01678924|42235137|FG001|Overall Study|Lost to Follow-up|4|||
19779803|NCT01678924|42235138|FG002|Overall Study|Lost to Follow-up|0|||
19779804|NCT01678924|42235139|FG003|Overall Study|Lost to Follow-up|2|||
19779805|NCT01678924|42235136|FG000|Overall Study|Personal Reasons|2|||
19779806|NCT01678924|42235137|FG001|Overall Study|Personal Reasons|2|||
19779807|NCT01678924|42235138|FG002|Overall Study|Personal Reasons|2|||
19779808|NCT01678924|42235139|FG003|Overall Study|Personal Reasons|7|||
19779809|NCT01678924|42235136|FG000|Overall Study|Withdrawal by Subject|0|||
19779810|NCT01678924|42235137|FG001|Overall Study|Withdrawal by Subject|3|||
19779811|NCT01678924|42235138|FG002|Overall Study|Withdrawal by Subject|0|||
19779812|NCT01678924|42235139|FG003|Overall Study|Withdrawal by Subject|2|||
19779813|NCT01678924|42235136|FG000|Overall Study|Unable to attend scheduled visits|0|||
19779814|NCT01678924|42235137|FG001|Overall Study|Unable to attend scheduled visits|0|||
19779815|NCT01678924|42235138|FG002|Overall Study|Unable to attend scheduled visits|0|||
19779816|NCT01678924|42235139|FG003|Overall Study|Unable to attend scheduled visits|1|||
19779817|NCT02925793|42235153|FG000|Overall Study|Adverse Event|3|||
19779818|NCT02925793|42235154|FG001|Overall Study|Adverse Event|3|||
19779819|NCT02925793|42235155|FG002|Overall Study|Adverse Event|6|||
19779820|NCT02925793|42235153|FG000|Overall Study|Withdrawal by Subject|16|||
19779821|NCT02925793|42235154|FG001|Overall Study|Withdrawal by Subject|15|||
19779822|NCT02925793|42235155|FG002|Overall Study|Withdrawal by Subject|13|||
19779823|NCT02925793|42235153|FG000|Overall Study|Investigator Discretion|0|||
19779824|NCT02925793|42235154|FG001|Overall Study|Investigator Discretion|1|||
19779825|NCT02925793|42235155|FG002|Overall Study|Investigator Discretion|1|||
19779826|NCT02925793|42235153|FG000|Overall Study|Lost to Follow-up|2|||
19779827|NCT02925793|42235154|FG001|Overall Study|Lost to Follow-up|3|||
19779828|NCT02925793|42235155|FG002|Overall Study|Lost to Follow-up|1|||
19779829|NCT02925793|42235153|FG000|Overall Study|Lack of Efficacy|2|||
19779830|NCT02925793|42235154|FG001|Overall Study|Lack of Efficacy|6|||
19779831|NCT02925793|42235155|FG002|Overall Study|Lack of Efficacy|4|||
19779832|NCT02925793|42235153|FG000|Overall Study|Other:|2|||
19779833|NCT02925793|42235154|FG001|Overall Study|Other:|1|||
19779834|NCT02925793|42235155|FG002|Overall Study|Other:|3|||
19694563|NCT00348140|42140123|FG001|Overall Study|Lost to Follow-up|4|||
19694564|NCT00348140|42140124|FG002|Overall Study|Lost to Follow-up|4|||
19694565|NCT00348140|42140122|FG000|Overall Study|Protocol Violation|12|||
19694566|NCT00348140|42140123|FG001|Overall Study|Protocol Violation|13|||
19694567|NCT00348140|42140124|FG002|Overall Study|Protocol Violation|14|||
19694568|NCT00348140|42140122|FG000|Overall Study|Withdrawal by Subject|32|||
19694569|NCT00348140|42140123|FG001|Overall Study|Withdrawal by Subject|40|||
19694570|NCT00348140|42140124|FG002|Overall Study|Withdrawal by Subject|40|||
19779835|NCT03071263|42235165|FG000|Overall Study|Adverse Event|1|||
19779836|NCT03071263|42235166|FG001|Overall Study|Adverse Event|3|||
19779837|NCT03071263|42235165|FG000|Overall Study|Withdrawal by Subject|1|||
19779838|NCT03071263|42235166|FG001|Overall Study|Withdrawal by Subject|3|||
19779839|NCT03071263|42235165|FG000|Overall Study|Physician Decision|1|||
19779840|NCT03071263|42235166|FG001|Overall Study|Physician Decision|0|||
19779841|NCT03071263|42235165|FG000|Overall Study|Participant moved to another city|0|||
19779842|NCT03071263|42235166|FG001|Overall Study|Participant moved to another city|1|||
19779843|NCT00157196|42235178|FG000|Overall Study|Ongoing at data cut-off|9|||
19779844|NCT03066193|42235182|FG000|Overall Study|Withdrawal by Subject|1|||
19779845|NCT03922321|42235186|FG000|Overall Study|Participant Moved|1|||
19779846|NCT03922321|42235186|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
19779847|NCT01677910|42235193|FG000|Double-Blind Treatment Period|Adverse Event|6|||
19779848|NCT01677910|42235194|FG001|Double-Blind Treatment Period|Adverse Event|2|||
19779849|NCT01677910|42235195|FG002|Double-Blind Treatment Period|Adverse Event|3|||
19779850|NCT01677910|42235196|FG003|Double-Blind Treatment Period|Adverse Event|0|||
19779851|NCT01677910|42235193|FG000|Double-Blind Treatment Period|Physician Decision|0|||
19779852|NCT01677910|42235194|FG001|Double-Blind Treatment Period|Physician Decision|0|||
19779853|NCT01677910|42235195|FG002|Double-Blind Treatment Period|Physician Decision|1|||
19779854|NCT01677910|42235196|FG003|Double-Blind Treatment Period|Physician Decision|0|||
19779855|NCT01677910|42235193|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
19779856|NCT01677910|42235194|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
19779857|NCT01677910|42235195|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
19779858|NCT01677910|42235196|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
19779859|NCT01677910|42235193|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
19779860|NCT01677910|42235194|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
19779861|NCT01677910|42235195|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
19779862|NCT01677910|42235196|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
19779863|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
19779864|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
19779865|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
19779866|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
19779867|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19779868|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19779869|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19779870|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
19779871|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19779872|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19779873|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19779874|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
19779875|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19779876|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19779877|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19779878|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
19779879|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
19779880|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
19779881|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
19694571|NCT00348140|42140122|FG000|Overall Study|Non-compliance|8|||
19694572|NCT00348140|42140123|FG001|Overall Study|Non-compliance|13|||
19694573|NCT00348140|42140124|FG002|Overall Study|Non-compliance|5|||
19694574|NCT00348140|42140122|FG000|Overall Study|Participant at risk due to study drug|2|||
19694575|NCT00348140|42140123|FG001|Overall Study|Participant at risk due to study drug|0|||
19694576|NCT00348140|42140124|FG002|Overall Study|Participant at risk due to study drug|0|||
19694577|NCT00348140|42140122|FG000|Overall Study|Conditional medication increased dose|1|||
19694578|NCT00348140|42140123|FG001|Overall Study|Conditional medication increased dose|0|||
19694579|NCT00348140|42140124|FG002|Overall Study|Conditional medication increased dose|0|||
19694580|NCT00348140|42140122|FG000|Overall Study|Caregiver related|4|||
19694581|NCT00348140|42140123|FG001|Overall Study|Caregiver related|7|||
19694582|NCT00348140|42140124|FG002|Overall Study|Caregiver related|3|||
19694583|NCT00348140|42140122|FG000|Overall Study|Participant hospitalised|3|||
19694584|NCT00348140|42140123|FG001|Overall Study|Participant hospitalised|0|||
19694585|NCT00348140|42140124|FG002|Overall Study|Participant hospitalised|0|||
19694586|NCT00348140|42140122|FG000|Overall Study|Efficacy related|1|||
19694587|NCT00348140|42140123|FG001|Overall Study|Efficacy related|1|||
19694588|NCT00348140|42140124|FG002|Overall Study|Efficacy related|0|||
19694589|NCT00348140|42140122|FG000|Overall Study|Administration related|3|||
19694590|NCT00348140|42140123|FG001|Overall Study|Administration related|1|||
19694591|NCT00348140|42140124|FG002|Overall Study|Administration related|1|||
19694592|NCT00348140|42140122|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
19694593|NCT00348140|42140123|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
19389168|NCT01625182|41632780|FG001|Overall Study|Lack of Efficacy|8|||
19694594|NCT00348140|42140124|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
19694595|NCT00348140|42140122|FG000|Overall Study|Participant unwell|1|||
19779882|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
19779883|NCT01677910|42235193|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
19779884|NCT01677910|42235194|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
19779885|NCT01677910|42235195|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
19779886|NCT01677910|42235196|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
19779887|NCT03911713|42235211|FG000|Overall Study|Lost to Follow-up|0|||
19779888|NCT03911713|42235212|FG001|Overall Study|Lost to Follow-up|2|||
19779889|NCT03911713|42235213|FG002|Overall Study|Lost to Follow-up|0|||
19779890|NCT03911713|42235214|FG003|Overall Study|Lost to Follow-up|0|||
19779891|NCT03911713|42235215|FG004|Overall Study|Lost to Follow-up|0|||
19694596|NCT00348140|42140123|FG001|Overall Study|Participant unwell|0|||
19694597|NCT00348140|42140124|FG002|Overall Study|Participant unwell|0|||
19694598|NCT00348140|42140122|FG000|Overall Study|Screen failure|1|||
19694599|NCT00348140|42140123|FG001|Overall Study|Screen failure|0|||
19694600|NCT00348140|42140124|FG002|Overall Study|Screen failure|0|||
19694601|NCT00348140|42140122|FG000|Overall Study|Investigator decided to discontinue|4|||
19694602|NCT00348140|42140123|FG001|Overall Study|Investigator decided to discontinue|1|||
19694603|NCT00348140|42140124|FG002|Overall Study|Investigator decided to discontinue|4|||
19694604|NCT00348140|42140122|FG000|Overall Study|Decided to discontinue on their own|1|||
19694605|NCT00348140|42140123|FG001|Overall Study|Decided to discontinue on their own|4|||
19694606|NCT00348140|42140124|FG002|Overall Study|Decided to discontinue on their own|1|||
19694607|NCT00348140|42140122|FG000|Overall Study|Use of prohibited drug|1|||
19694608|NCT00348140|42140123|FG001|Overall Study|Use of prohibited drug|0|||
19694609|NCT00348140|42140124|FG002|Overall Study|Use of prohibited drug|2|||
19694610|NCT00348140|42140122|FG000|Overall Study|Disease progression|1|||
19694611|NCT00348140|42140123|FG001|Overall Study|Disease progression|2|||
19694612|NCT00348140|42140124|FG002|Overall Study|Disease progression|5|||
19694613|NCT00348140|42140122|FG000|Overall Study|Increased risk of cardiac infarction|0|||
19694614|NCT00348140|42140123|FG001|Overall Study|Increased risk of cardiac infarction|1|||
19694615|NCT00348140|42140124|FG002|Overall Study|Increased risk of cardiac infarction|0|||
19694616|NCT00348140|42140122|FG000|Overall Study|Serious adverse event|0|||
19694617|NCT00348140|42140123|FG001|Overall Study|Serious adverse event|1|||
19694618|NCT00348140|42140124|FG002|Overall Study|Serious adverse event|0|||
19694619|NCT00348140|42140122|FG000|Overall Study|Abnormal ECG|0|||
19694620|NCT00348140|42140123|FG001|Overall Study|Abnormal ECG|1|||
19694621|NCT00348140|42140124|FG002|Overall Study|Abnormal ECG|3|||
19694622|NCT00348140|42140122|FG000|Overall Study|Participant died|0|||
19694623|NCT00348140|42140123|FG001|Overall Study|Participant died|1|||
19694624|NCT00348140|42140124|FG002|Overall Study|Participant died|0|||
19694625|NCT00348140|42140122|FG000|Overall Study|Exclusion criteria met|0|||
19694626|NCT00348140|42140123|FG001|Overall Study|Exclusion criteria met|0|||
19694627|NCT00348140|42140124|FG002|Overall Study|Exclusion criteria met|1|||
19694628|NCT00348140|42140122|FG000|Overall Study|Memory declined|0|||
19694629|NCT00348140|42140123|FG001|Overall Study|Memory declined|0|||
19694630|NCT00348140|42140124|FG002|Overall Study|Memory declined|1|||
19694631|NCT00490061|42140133|FG000|Overall Study|Physician Decision|1|||
19694632|NCT00483119|42140139|FG000|Overall Study|Adverse Event|0|||
19694633|NCT00483119|42140140|FG001|Overall Study|Adverse Event|1|||
19694634|NCT00483119|42140139|FG000|Overall Study|Physician Decision|1|||
19694635|NCT00483119|42140140|FG001|Overall Study|Physician Decision|0|||
19694636|NCT00483041|42140148|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
19694637|NCT00483041|42140149|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
19694638|NCT00501293|42140157|FG000|Optimization Period|Enrolled in error|1|||
19694639|NCT00501293|42140158|FG001|Optimization Period|Enrolled in error|0|||
19694640|NCT00501293|42140157|FG000|Maintenance Period|Withdrawal by Subject|14|||
19694641|NCT00501293|42140158|FG001|Maintenance Period|Withdrawal by Subject|13|||
19694642|NCT00501293|42140157|FG000|Maintenance Period|Lost to Follow-up|12|||
19694643|NCT00501293|42140158|FG001|Maintenance Period|Lost to Follow-up|7|||
19694644|NCT00501293|42140157|FG000|Maintenance Period|Adverse Event|6|||
19694645|NCT00501293|42140158|FG001|Maintenance Period|Adverse Event|6|||
19694646|NCT00501293|42140157|FG000|Maintenance Period|Protocol Violation|2|||
19694647|NCT00501293|42140158|FG001|Maintenance Period|Protocol Violation|1|||
19694648|NCT00501293|42140157|FG000|Maintenance Period|Lack of Efficacy|4|||
19694649|NCT00501293|42140158|FG001|Maintenance Period|Lack of Efficacy|1|||
19694650|NCT00501293|42140157|FG000|Maintenance Period|Noncompliant with study medication|5|||
19694651|NCT00501293|42140158|FG001|Maintenance Period|Noncompliant with study medication|0|||
19694652|NCT00501293|42140157|FG000|Maintenance Period|Went into rehabilitation|1|||
19694653|NCT00501293|42140158|FG001|Maintenance Period|Went into rehabilitation|0|||
19694654|NCT00501293|42140157|FG000|Maintenance Period|Would not wear patch|1|||
19694655|NCT00501293|42140158|FG001|Maintenance Period|Would not wear patch|0|||
19694656|NCT00501293|42140157|FG000|Maintenance Period|Application site reaction|1|||
19694657|NCT00501293|42140158|FG001|Maintenance Period|Application site reaction|0|||
19779892|NCT03911713|42235211|FG000|Overall Study|Other|0|||
19779893|NCT03911713|42235212|FG001|Overall Study|Other|0|||
19779894|NCT03911713|42235213|FG002|Overall Study|Other|0|||
19779895|NCT03911713|42235214|FG003|Overall Study|Other|1|||
19779896|NCT03911713|42235215|FG004|Overall Study|Other|0|||
19779897|NCT03911713|42235211|FG000|Overall Study|Randomized, Never Dosed|1|||
19779898|NCT03911713|42235212|FG001|Overall Study|Randomized, Never Dosed|0|||
19779899|NCT03911713|42235213|FG002|Overall Study|Randomized, Never Dosed|0|||
19779900|NCT03911713|42235214|FG003|Overall Study|Randomized, Never Dosed|1|||
19779901|NCT03911713|42235215|FG004|Overall Study|Randomized, Never Dosed|0|||
19779902|NCT03065023|42235233|FG000|Overall Study|Progressive Disease|0|||
19779903|NCT03065023|42235234|FG001|Overall Study|Progressive Disease|1|||
19779904|NCT03065023|42235235|FG002|Overall Study|Progressive Disease|0|||
19779905|NCT03065023|42235236|FG003|Overall Study|Progressive Disease|0|||
19779906|NCT03065023|42235237|FG004|Overall Study|Progressive Disease|0|||
19779907|NCT03065023|42235233|FG000|Overall Study|Death|2|||
19779908|NCT03065023|42235234|FG001|Overall Study|Death|0|||
19779909|NCT03065023|42235235|FG002|Overall Study|Death|1|||
19779910|NCT03065023|42235236|FG003|Overall Study|Death|1|||
19779911|NCT03065023|42235237|FG004|Overall Study|Death|0|||
19779912|NCT03065023|42235233|FG000|Overall Study|Lost to Follow-up|0|||
19779913|NCT03065023|42235234|FG001|Overall Study|Lost to Follow-up|1|||
19779914|NCT03065023|42235235|FG002|Overall Study|Lost to Follow-up|0|||
19779915|NCT03065023|42235236|FG003|Overall Study|Lost to Follow-up|0|||
19779916|NCT03065023|42235237|FG004|Overall Study|Lost to Follow-up|0|||
19779917|NCT03065023|42235233|FG000|Overall Study|Participant Decision|0|||
19779918|NCT03065023|42235234|FG001|Overall Study|Participant Decision|0|||
19779919|NCT03065023|42235235|FG002|Overall Study|Participant Decision|0|||
19779920|NCT03065023|42235236|FG003|Overall Study|Participant Decision|1|||
19779921|NCT03065023|42235237|FG004|Overall Study|Participant Decision|0|||
19779922|NCT03065023|42235233|FG000|Overall Study|Withdrawal by Subject|0|||
19779923|NCT03065023|42235234|FG001|Overall Study|Withdrawal by Subject|0|||
19779924|NCT03065023|42235235|FG002|Overall Study|Withdrawal by Subject|0|||
19779925|NCT03065023|42235236|FG003|Overall Study|Withdrawal by Subject|1|||
19779926|NCT03065023|42235237|FG004|Overall Study|Withdrawal by Subject|0|||
19779927|NCT03614923|42235250|FG000|Overall Study|Withdrawal by Subject|2|||
19779928|NCT03614923|42235251|FG001|Overall Study|Withdrawal by Subject|1|||
19779929|NCT03614923|42235252|FG002|Overall Study|Withdrawal by Subject|1|||
19779930|NCT03614923|42235250|FG000|Overall Study|Adverse Event|0|||
19779931|NCT03614923|42235251|FG001|Overall Study|Adverse Event|2|||
19779932|NCT03614923|42235252|FG002|Overall Study|Adverse Event|1|||
19779933|NCT03614923|42235250|FG000|Overall Study|Lost to Follow-up|1|||
19779934|NCT03614923|42235251|FG001|Overall Study|Lost to Follow-up|0|||
19779935|NCT03614923|42235252|FG002|Overall Study|Lost to Follow-up|1|||
19779936|NCT03614923|42235250|FG000|Overall Study|Lack of Efficacy|2|||
19779937|NCT03614923|42235251|FG001|Overall Study|Lack of Efficacy|0|||
19779938|NCT03614923|42235252|FG002|Overall Study|Lack of Efficacy|1|||
19779939|NCT03614923|42235250|FG000|Overall Study|Non-compliance|0|||
19779940|NCT03614923|42235251|FG001|Overall Study|Non-compliance|1|||
19779941|NCT03614923|42235252|FG002|Overall Study|Non-compliance|0|||
19779942|NCT03614923|42235250|FG000|Overall Study|Other|0|||
19779943|NCT03614923|42235251|FG001|Overall Study|Other|1|||
19779944|NCT03614923|42235252|FG002|Overall Study|Other|1|||
19779945|NCT02915016|42235268|FG000|Overall Study|Lost to Follow-up|4|||
19779946|NCT02915016|42235269|FG001|Overall Study|Lost to Follow-up|2|||
19779947|NCT02915016|42235270|FG002|Overall Study|Lost to Follow-up|5|||
19779948|NCT02915016|42235271|FG003|Overall Study|Lost to Follow-up|3|||
19779949|NCT02915016|42235272|FG004|Overall Study|Lost to Follow-up|5|||
19779950|NCT02915016|42235273|FG005|Overall Study|Lost to Follow-up|2|||
19779951|NCT02915016|42235274|FG006|Overall Study|Lost to Follow-up|8|||
19779952|NCT02915016|42235275|FG007|Overall Study|Lost to Follow-up|2|||
19779953|NCT02915016|42235268|FG000|Overall Study|Physician Decision|0|||
19779954|NCT02915016|42235269|FG001|Overall Study|Physician Decision|0|||
19779955|NCT02915016|42235270|FG002|Overall Study|Physician Decision|1|||
19779956|NCT02915016|42235271|FG003|Overall Study|Physician Decision|0|||
19779957|NCT02915016|42235272|FG004|Overall Study|Physician Decision|0|||
19779958|NCT02915016|42235273|FG005|Overall Study|Physician Decision|1|||
19779959|NCT02915016|42235274|FG006|Overall Study|Physician Decision|2|||
19779960|NCT02915016|42235275|FG007|Overall Study|Physician Decision|0|||
19779961|NCT02915016|42235268|FG000|Overall Study|Withdrawal by Subject|2|||
19779962|NCT02915016|42235269|FG001|Overall Study|Withdrawal by Subject|0|||
19779963|NCT02915016|42235270|FG002|Overall Study|Withdrawal by Subject|1|||
19779964|NCT02915016|42235271|FG003|Overall Study|Withdrawal by Subject|0|||
19779965|NCT02915016|42235272|FG004|Overall Study|Withdrawal by Subject|1|||
19779966|NCT02915016|42235273|FG005|Overall Study|Withdrawal by Subject|3|||
19779967|NCT02915016|42235274|FG006|Overall Study|Withdrawal by Subject|1|||
19779968|NCT02915016|42235275|FG007|Overall Study|Withdrawal by Subject|1|||
19779969|NCT02915016|42235268|FG000|Overall Study|Elected not to continue|0|||
19779970|NCT02915016|42235269|FG001|Overall Study|Elected not to continue|0|||
19779971|NCT02915016|42235270|FG002|Overall Study|Elected not to continue|0|||
19779972|NCT02915016|42235271|FG003|Overall Study|Elected not to continue|1|||
19779973|NCT02915016|42235272|FG004|Overall Study|Elected not to continue|0|||
19779974|NCT02915016|42235273|FG005|Overall Study|Elected not to continue|0|||
19779975|NCT02915016|42235274|FG006|Overall Study|Elected not to continue|1|||
19779976|NCT02915016|42235275|FG007|Overall Study|Elected not to continue|0|||
19779977|NCT02915016|42235268|FG000|Overall Study|HIV infection|1|||
19779978|NCT02915016|42235269|FG001|Overall Study|HIV infection|1|||
19779979|NCT02915016|42235270|FG002|Overall Study|HIV infection|1|||
19779980|NCT02915016|42235271|FG003|Overall Study|HIV infection|0|||
19779981|NCT02915016|42235272|FG004|Overall Study|HIV infection|1|||
19779982|NCT02915016|42235273|FG005|Overall Study|HIV infection|0|||
19779983|NCT02915016|42235274|FG006|Overall Study|HIV infection|0|||
19779984|NCT02915016|42235275|FG007|Overall Study|HIV infection|0|||
19779985|NCT02915016|42235268|FG000|Overall Study|Participant unable to adhere|0|||
19779986|NCT02915016|42235269|FG001|Overall Study|Participant unable to adhere|0|||
19779987|NCT02915016|42235270|FG002|Overall Study|Participant unable to adhere|0|||
19779988|NCT02915016|42235271|FG003|Overall Study|Participant unable to adhere|0|||
19779989|NCT02915016|42235272|FG004|Overall Study|Participant unable to adhere|0|||
19779990|NCT02915016|42235273|FG005|Overall Study|Participant unable to adhere|0|||
19779991|NCT02915016|42235274|FG006|Overall Study|Participant unable to adhere|0|||
19779992|NCT02915016|42235275|FG007|Overall Study|Participant unable to adhere|1|||
19779993|NCT03323749|42235295|FG000|Double-blind Period|Lost to Follow-up|4|||
19779994|NCT03323749|42235296|FG001|Double-blind Period|Lost to Follow-up|5|||
19779995|NCT03323749|42235295|FG000|Double-blind Period|Adverse Event|3|||
19779996|NCT03323749|42235296|FG001|Double-blind Period|Adverse Event|1|||
19779997|NCT03323749|42235295|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
19779998|NCT03323749|42235296|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
19779999|NCT03323749|42235295|FG000|Open-Label Period|Adverse Event|3|||
19780000|NCT03323749|42235296|FG001|Open-Label Period|Adverse Event|10|||
19780001|NCT03323749|42235295|FG000|Open-Label Period|Withdrawal by Subject|7|||
19780002|NCT03323749|42235296|FG001|Open-Label Period|Withdrawal by Subject|5|||
19780003|NCT02208024|42235315|FG000|Overall Study|Withdrawal by Subject|1|||
19780004|NCT02660086|42235321|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
19780005|NCT02660086|42235322|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
19780006|NCT02660086|42235321|FG000|Overall Study- 12-month|Left full-time employment|12|||
19780007|NCT02660086|42235322|FG001|Overall Study- 12-month|Left full-time employment|20|||
19780008|NCT02660086|42235321|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
19780009|NCT02660086|42235322|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
19780010|NCT02660086|42235321|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
19780011|NCT02660086|42235322|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
19780012|NCT02660086|42235321|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
19780013|NCT02660086|42235322|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
19694658|NCT00482729|42140167|FG000|Overall Study|Adverse Event|29|||
19694659|NCT00482729|42140168|FG001|Overall Study|Adverse Event|33|||
19694660|NCT00482729|42140167|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
19694661|NCT00482729|42140168|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
19694662|NCT00482729|42140167|FG000|Overall Study|Hyperglycemia Criteria|7|||
19694663|NCT00482729|42140168|FG001|Overall Study|Hyperglycemia Criteria|5|||
19694664|NCT00482729|42140167|FG000|Overall Study|Lack of Efficacy|4|||
19694665|NCT00482729|42140168|FG001|Overall Study|Lack of Efficacy|16|||
19694666|NCT00482729|42140167|FG000|Overall Study|Lost to Follow-up|86|||
19694667|NCT00482729|42140168|FG001|Overall Study|Lost to Follow-up|66|||
19694668|NCT00482729|42140167|FG000|Overall Study|Physician Decision|10|||
19694669|NCT00482729|42140168|FG001|Overall Study|Physician Decision|7|||
19694670|NCT00482729|42140167|FG000|Overall Study|Pregnancy|4|||
19780014|NCT02660086|42235321|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
19780015|NCT02660086|42235322|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
19780016|NCT01678144|42235328|FG000|Stage 1: MAR Classic|Adverse Event|1|||
19780017|NCT00153920|42235332|FG000|Overall Study|Adverse Event|9|||
19780018|NCT00153920|42235332|FG000|Overall Study|Progressive Disease|9|||
19780019|NCT00153920|42235332|FG000|Overall Study|Physician Decision|3|||
19780020|NCT00153920|42235332|FG000|Overall Study|Lack of Response|3|||
19780021|NCT00153920|42235332|FG000|Overall Study|Death|2|||
19780022|NCT00153920|42235332|FG000|Overall Study|Withdrawal by Subject|1|||
19780023|NCT00153920|42235332|FG000|Overall Study|Non-Protocol Therapy|1|||
19780024|NCT00153920|42235332|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
19780025|NCT00153920|42235332|FG000|Overall Study|Progressive Disease before Trt|1|||
19367295|NCT02435914|41607465|FG000|Overall Study|Ocular Adverse Event|1|||
19780026|NCT02660242|42235336|FG000|Glucose Tabs|Lost to Follow-up|1|||
19780027|NCT02660242|42235336|FG000|Glucagon Injection|Lost to Follow-up|1|||
19780028|NCT03072043|42235352|FG000|Overall Study|Death|0|||
19780029|NCT03072043|42235353|FG001|Overall Study|Death|0|||
19780030|NCT03072043|42235354|FG002|Overall Study|Death|3|||
19780031|NCT03072043|42235352|FG000|Overall Study|Adverse Event|0|||
19367296|NCT02435914|41607466|FG001|Overall Study|Ocular Adverse Event|0|||
19780032|NCT03072043|42235353|FG001|Overall Study|Adverse Event|0|||
19780033|NCT03072043|42235354|FG002|Overall Study|Adverse Event|2|||
19780034|NCT03072043|42235352|FG000|Overall Study|Withdrawal by Subject|0|||
19780035|NCT03072043|42235353|FG001|Overall Study|Withdrawal by Subject|0|||
19780036|NCT03072043|42235354|FG002|Overall Study|Withdrawal by Subject|4|||
19780037|NCT03069313|42235366|FG000|Overall Study|Adverse Event|5|||
19780038|NCT03068767|42235372|FG000|Overall Study|Lost to Follow-up|7|||
19780039|NCT03068767|42235373|FG001|Overall Study|Lost to Follow-up|3|||
19780040|NCT03068767|42235372|FG000|Overall Study|Protocol Violation|3|||
19780041|NCT03068767|42235373|FG001|Overall Study|Protocol Violation|0|||
19780042|NCT03020745|42235387|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
19694671|NCT00482729|42140168|FG001|Overall Study|Pregnancy|2|||
19694672|NCT00482729|42140167|FG000|Overall Study|Protocol Violation|10|||
19694673|NCT00482729|42140168|FG001|Overall Study|Protocol Violation|18|||
19694674|NCT00482729|42140167|FG000|Overall Study|Withdrawal by Subject|67|||
19694675|NCT00482729|42140168|FG001|Overall Study|Withdrawal by Subject|69|||
19694676|NCT00359762|42140176|FG000|Period II|Adverse Event|17|||
19694677|NCT00359762|42140177|FG001|Period II|Adverse Event|0|||
19694678|NCT00359762|42140178|FG002|Period II|Adverse Event|0|||
19694679|NCT00359762|42140179|FG003|Period II|Adverse Event|0|||
19694680|NCT00359762|42140180|FG004|Period II|Adverse Event|49|||
19780043|NCT03020745|42235388|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780044|NCT03020745|42235389|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780045|NCT03020745|42235390|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780046|NCT03020745|42235391|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780047|NCT03020745|42235392|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780048|NCT03020745|42235393|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780049|NCT03020745|42235394|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780050|NCT03020745|42235395|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
19780051|NCT03020745|42235396|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
19780052|NCT03020745|42235387|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780053|NCT03020745|42235388|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780054|NCT03020745|42235389|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780055|NCT03020745|42235390|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780056|NCT03020745|42235391|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780057|NCT03020745|42235392|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780058|NCT03020745|42235393|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780059|NCT03020745|42235394|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
19780060|NCT03020745|42235395|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780061|NCT03020745|42235396|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
19780062|NCT03020745|42235387|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780063|NCT03020745|42235388|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780064|NCT03020745|42235389|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780065|NCT03020745|42235390|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780066|NCT03020745|42235391|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780067|NCT03020745|42235392|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
19780068|NCT03020745|42235393|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780069|NCT03020745|42235394|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780070|NCT03020745|42235395|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
19780071|NCT03020745|42235396|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
19780072|NCT03020745|42235387|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780073|NCT03020745|42235388|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19694681|NCT00359762|42140176|FG000|Period II|Protocol Violation|18|||
19694682|NCT00359762|42140177|FG001|Period II|Protocol Violation|0|||
19694683|NCT00359762|42140178|FG002|Period II|Protocol Violation|0|||
19780074|NCT03020745|42235389|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780075|NCT03020745|42235390|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780076|NCT03020745|42235391|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780077|NCT03020745|42235392|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780078|NCT03020745|42235393|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780079|NCT03020745|42235394|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780080|NCT03020745|42235395|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
19477738|NCT01507831|41757003|FG000|Overall Study|Randomized but not treated|0|||
19477739|NCT01507831|41757004|FG001|Overall Study|Randomized but not treated|3|||
19694684|NCT00359762|42140179|FG003|Period II|Protocol Violation|0|||
19694685|NCT00359762|42140180|FG004|Period II|Protocol Violation|11|||
19694686|NCT00359762|42140176|FG000|Period II|Physician Decision|17|||
19694687|NCT00359762|42140177|FG001|Period II|Physician Decision|0|||
19780081|NCT03020745|42235396|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
19780082|NCT03019965|42235431|FG000|Overall Study|Withdrawal by Subject|1|||
19780083|NCT03019965|42235432|FG001|Overall Study|Withdrawal by Subject|0|||
19780084|NCT03019965|42235431|FG000|Overall Study|Protocol Violation|1|||
19780085|NCT03019965|42235432|FG001|Overall Study|Protocol Violation|3|||
19780086|NCT03019965|42235431|FG000|Overall Study|viral or fungal infection|3|||
19780087|NCT03019965|42235432|FG001|Overall Study|viral or fungal infection|4|||
19780088|NCT03019965|42235431|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
19780089|NCT03019965|42235432|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
19780090|NCT03019965|42235431|FG000|Overall Study|Physician Decision|1|||
19780091|NCT03019965|42235432|FG001|Overall Study|Physician Decision|1|||
19780092|NCT01675882|42235451|FG000|Overall Study|Adverse Event|0|||
19780093|NCT01675882|42235452|FG001|Overall Study|Adverse Event|2|||
19780094|NCT01675882|42235453|FG002|Overall Study|Adverse Event|1|||
19780095|NCT01675882|42235454|FG003|Overall Study|Adverse Event|0|||
19780096|NCT01675882|42235451|FG000|Overall Study|Participant unwilling to continue|2|||
19780097|NCT01675882|42235452|FG001|Overall Study|Participant unwilling to continue|4|||
19780098|NCT01675882|42235453|FG002|Overall Study|Participant unwilling to continue|2|||
19780099|NCT01675882|42235454|FG003|Overall Study|Participant unwilling to continue|1|||
19780100|NCT01675882|42235451|FG000|Overall Study|Lost to Follow-up|0|||
19780101|NCT01675882|42235452|FG001|Overall Study|Lost to Follow-up|1|||
19780102|NCT01675882|42235453|FG002|Overall Study|Lost to Follow-up|0|||
19780103|NCT01675882|42235454|FG003|Overall Study|Lost to Follow-up|0|||
19780104|NCT01675882|42235451|FG000|Overall Study|Non-compliance|0|||
19780105|NCT01675882|42235452|FG001|Overall Study|Non-compliance|0|||
19780106|NCT01675882|42235453|FG002|Overall Study|Non-compliance|0|||
19780107|NCT01675882|42235454|FG003|Overall Study|Non-compliance|1|||
19780108|NCT03018249|42235466|FG000|Overall Study|Withdrawal by Subject|2|||
19780109|NCT03018249|42235467|FG001|Overall Study|Withdrawal by Subject|2|||
19694688|NCT00359762|42140178|FG002|Period II|Physician Decision|0|||
19780110|NCT02923245|42235485|FG000|Overall Study|ultrasound order was cancelled|2|||
19780111|NCT02923245|42235486|FG001|Overall Study|ultrasound order was cancelled|1|||
19780112|NCT00905606|42235502|FG000|Period 1|Adverse Event|0|||
19780113|NCT00905606|42235503|FG001|Period 1|Adverse Event|1|||
19780114|NCT00905606|42235502|FG000|Washout|Withdrawal by Subject|1|||
19780115|NCT00905606|42235503|FG001|Washout|Withdrawal by Subject|0|||
19780116|NCT01676896|42235510|FG000|Overall Study|Withdrawal by Subject|12|||
19780117|NCT01676896|42235511|FG001|Overall Study|Withdrawal by Subject|7|||
19780118|NCT01676896|42235512|FG002|Overall Study|Withdrawal by Subject|19|||
19780119|NCT03017235|42235522|FG000|Overall Study|Withdrawal by Subject|4|||
19780120|NCT03017235|42235523|FG001|Overall Study|Withdrawal by Subject|3|||
19780121|NCT03017235|42235522|FG000|Overall Study|Lost to Follow-up|2|||
19780122|NCT03017235|42235523|FG001|Overall Study|Lost to Follow-up|7|||
19694689|NCT00359762|42140179|FG003|Period II|Physician Decision|0|||
19694690|NCT00359762|42140180|FG004|Period II|Physician Decision|23|||
19694691|NCT00359762|42140176|FG000|Period II|Death|2|||
19694692|NCT00359762|42140177|FG001|Period II|Death|0|||
19694693|NCT00359762|42140178|FG002|Period II|Death|0|||
19694694|NCT00359762|42140179|FG003|Period II|Death|0|||
19694695|NCT00359762|42140180|FG004|Period II|Death|4|||
19694696|NCT00359762|42140176|FG000|Period II|Lack of Efficacy|11|||
19694697|NCT00359762|42140177|FG001|Period II|Lack of Efficacy|0|||
19694698|NCT00359762|42140178|FG002|Period II|Lack of Efficacy|0|||
19694699|NCT00359762|42140179|FG003|Period II|Lack of Efficacy|0|||
19694700|NCT00359762|42140180|FG004|Period II|Lack of Efficacy|8|||
19694701|NCT00359762|42140176|FG000|Period II|Lost to follow up|5|||
19694702|NCT00359762|42140177|FG001|Period II|Lost to follow up|0|||
19694703|NCT00359762|42140178|FG002|Period II|Lost to follow up|0|||
19694704|NCT00359762|42140179|FG003|Period II|Lost to follow up|0|||
19694705|NCT00359762|42140180|FG004|Period II|Lost to follow up|5|||
19694706|NCT00359762|42140176|FG000|Period II|Entry Criteria Not Met|8|||
19694707|NCT00359762|42140177|FG001|Period II|Entry Criteria Not Met|0|||
19694708|NCT00359762|42140178|FG002|Period II|Entry Criteria Not Met|0|||
19694709|NCT00359762|42140179|FG003|Period II|Entry Criteria Not Met|0|||
19694710|NCT00359762|42140180|FG004|Period II|Entry Criteria Not Met|4|||
19694711|NCT00359762|42140176|FG000|Period II|Subject Decision|50|||
19694712|NCT00359762|42140177|FG001|Period II|Subject Decision|0|||
19694713|NCT00359762|42140178|FG002|Period II|Subject Decision|0|||
19694714|NCT00359762|42140179|FG003|Period II|Subject Decision|0|||
19694715|NCT00359762|42140180|FG004|Period II|Subject Decision|70|||
19694716|NCT00359762|42140176|FG000|Period III|Protocol Violation|0|||
19694717|NCT00359762|42140177|FG001|Period III|Protocol Violation|5|||
19694718|NCT00359762|42140178|FG002|Period III|Protocol Violation|3|||
19694719|NCT00359762|42140179|FG003|Period III|Protocol Violation|8|||
19780123|NCT03017235|42235522|FG000|Overall Study|Adverse Event|0|||
19780124|NCT03017235|42235523|FG001|Overall Study|Adverse Event|1|||
19780125|NCT03017235|42235522|FG000|Overall Study|Protocol Violation|2|||
19694720|NCT00359762|42140180|FG004|Period III|Protocol Violation|0|||
19694721|NCT00359762|42140176|FG000|Period III|Adverse Event|0|||
19694722|NCT00359762|42140177|FG001|Period III|Adverse Event|3|||
19694723|NCT00359762|42140178|FG002|Period III|Adverse Event|4|||
19694724|NCT00359762|42140179|FG003|Period III|Adverse Event|10|||
19694725|NCT00359762|42140180|FG004|Period III|Adverse Event|0|||
19694726|NCT00359762|42140176|FG000|Period III|Physician Decision|0|||
19694727|NCT00359762|42140177|FG001|Period III|Physician Decision|5|||
19694728|NCT00359762|42140178|FG002|Period III|Physician Decision|9|||
19694729|NCT00359762|42140179|FG003|Period III|Physician Decision|15|||
19694730|NCT00359762|42140180|FG004|Period III|Physician Decision|0|||
19694731|NCT00359762|42140176|FG000|Period III|Lack of Efficacy|0|||
19694732|NCT00359762|42140177|FG001|Period III|Lack of Efficacy|7|||
19694733|NCT00359762|42140178|FG002|Period III|Lack of Efficacy|5|||
19694734|NCT00359762|42140179|FG003|Period III|Lack of Efficacy|9|||
19694735|NCT00359762|42140180|FG004|Period III|Lack of Efficacy|0|||
19694736|NCT00359762|42140176|FG000|Period III|Lost to follow up|0|||
19694737|NCT00359762|42140177|FG001|Period III|Lost to follow up|1|||
19694738|NCT00359762|42140178|FG002|Period III|Lost to follow up|1|||
19694739|NCT00359762|42140179|FG003|Period III|Lost to follow up|2|||
19694740|NCT00359762|42140180|FG004|Period III|Lost to follow up|0|||
19694741|NCT00359762|42140176|FG000|Period III|Entry Criteria Not Met|0|||
19694742|NCT00359762|42140177|FG001|Period III|Entry Criteria Not Met|1|||
19694743|NCT00359762|42140178|FG002|Period III|Entry Criteria Not Met|0|||
19694744|NCT00359762|42140179|FG003|Period III|Entry Criteria Not Met|1|||
19694745|NCT00359762|42140180|FG004|Period III|Entry Criteria Not Met|0|||
19780126|NCT03017235|42235523|FG001|Overall Study|Protocol Violation|1|||
19780127|NCT03017235|42235522|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
19780128|NCT03017235|42235523|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
19780129|NCT03017079|42235531|FG000|Overall Study|Physician Decision|1|||
19780130|NCT03017079|42235532|FG001|Overall Study|Physician Decision|1|||
19780131|NCT03017079|42235531|FG000|Overall Study|Death|3|||
19780132|NCT03017079|42235532|FG001|Overall Study|Death|2|||
19780133|NCT03017079|42235531|FG000|Overall Study|Lack of Efficacy|2|||
19780134|NCT03017079|42235532|FG001|Overall Study|Lack of Efficacy|2|||
19780135|NCT03017079|42235531|FG000|Overall Study|Protocol Violation|0|||
19780136|NCT03017079|42235532|FG001|Overall Study|Protocol Violation|1|||
19780137|NCT03015363|42235545|FG000|Overall Study|Physician Decision|14|||
19780138|NCT03015363|42235545|FG000|Overall Study|Withdrawal by Subject|3|||
19780139|NCT02880371|42235557|FG000|Phase 1b|Lost to Follow-up|1|||
19780140|NCT02880371|42235558|FG001|Phase 1b|Lost to Follow-up|0|||
19780141|NCT02880371|42235559|FG002|Phase 1b|Lost to Follow-up|0|||
19780142|NCT02880371|42235560|FG003|Phase 1b|Lost to Follow-up|0|||
19694746|NCT00359762|42140176|FG000|Period III|Subject Decision|0|||
19694747|NCT00359762|42140177|FG001|Period III|Subject Decision|7|||
19694748|NCT00359762|42140178|FG002|Period III|Subject Decision|8|||
19694749|NCT00359762|42140179|FG003|Period III|Subject Decision|20|||
19694750|NCT00359762|42140180|FG004|Period III|Subject Decision|0|||
19694751|NCT00347438|42140194|FG000|Overall Study|Withdrawal by Subject|1|||
19694752|NCT00347438|42140194|FG000|Overall Study|Physician Decision|1|||
19694753|NCT00329238|42140200|FG000|Overall Study|Adverse Event|147|||
19694754|NCT00329238|42140201|FG001|Overall Study|Adverse Event|129|||
19694755|NCT00329238|42140200|FG000|Overall Study|Protocol Violation|23|||
19694756|NCT00329238|42140201|FG001|Overall Study|Protocol Violation|34|||
19694757|NCT00329238|42140200|FG000|Overall Study|Lost to Follow-up|2|||
19694758|NCT00329238|42140201|FG001|Overall Study|Lost to Follow-up|6|||
19694759|NCT00329238|42140200|FG000|Overall Study|Withdrawal by Subject|64|||
19694760|NCT00329238|42140201|FG001|Overall Study|Withdrawal by Subject|58|||
19694761|NCT00329238|42140200|FG000|Overall Study|Other reason (not specified)|40|||
19694762|NCT00329238|42140201|FG001|Overall Study|Other reason (not specified)|54|||
19694763|NCT00329160|42140209|FG000|Overall Study|Adverse Event|27|||
19780143|NCT02880371|42235561|FG004|Phase 1b|Lost to Follow-up|0|||
19780144|NCT02880371|42235562|FG005|Phase 1b|Lost to Follow-up|0|||
19780145|NCT02880371|42235563|FG006|Phase 1b|Lost to Follow-up|0|||
19780146|NCT02880371|42235564|FG007|Phase 1b|Lost to Follow-up|0|||
19780147|NCT02880371|42235557|FG000|Phase 1b|Participants terminated by Sponsor|1|||
19780148|NCT02880371|42235558|FG001|Phase 1b|Participants terminated by Sponsor|0|||
19780149|NCT02880371|42235559|FG002|Phase 1b|Participants terminated by Sponsor|0|||
19780150|NCT02880371|42235560|FG003|Phase 1b|Participants terminated by Sponsor|0|||
19780151|NCT02880371|42235561|FG004|Phase 1b|Participants terminated by Sponsor|0|||
19780152|NCT02880371|42235562|FG005|Phase 1b|Participants terminated by Sponsor|0|||
19780153|NCT02880371|42235563|FG006|Phase 1b|Participants terminated by Sponsor|0|||
19780154|NCT02880371|42235564|FG007|Phase 1b|Participants terminated by Sponsor|0|||
19780155|NCT02880371|42235557|FG000|Phase 1b|Withdrawal by Subject|0|||
19780156|NCT02880371|42235558|FG001|Phase 1b|Withdrawal by Subject|0|||
19780157|NCT02880371|42235559|FG002|Phase 1b|Withdrawal by Subject|1|||
19694764|NCT00329160|42140209|FG000|Overall Study|Withdrawal by Subject|13|||
19694765|NCT00329160|42140209|FG000|Overall Study|Protocol Violation|2|||
19780158|NCT02880371|42235560|FG003|Phase 1b|Withdrawal by Subject|0|||
19780159|NCT02880371|42235561|FG004|Phase 1b|Withdrawal by Subject|0|||
19780160|NCT02880371|42235562|FG005|Phase 1b|Withdrawal by Subject|0|||
19780161|NCT02880371|42235563|FG006|Phase 1b|Withdrawal by Subject|0|||
19780162|NCT02880371|42235564|FG007|Phase 1b|Withdrawal by Subject|0|||
19694766|NCT00329160|42140209|FG000|Overall Study|Did not Receive Study Drug|1|||
19694767|NCT00329160|42140209|FG000|Overall Study|Incomplete IVUS|45|||
19694768|NCT00328926|42140216|FG000|Overall Study|Pregnancy|2|||
19780163|NCT02880371|42235557|FG000|Phase 1b|Death|4|||
19694769|NCT00328926|42140217|FG001|Overall Study|Pregnancy|1|||
19780164|NCT02880371|42235558|FG001|Phase 1b|Death|6|||
19780165|NCT02880371|42235559|FG002|Phase 1b|Death|5|||
19780166|NCT02880371|42235560|FG003|Phase 1b|Death|1|||
19780167|NCT02880371|42235561|FG004|Phase 1b|Death|0|||
19780168|NCT02880371|42235562|FG005|Phase 1b|Death|0|||
19780169|NCT02880371|42235563|FG006|Phase 1b|Death|0|||
19780170|NCT02880371|42235564|FG007|Phase 1b|Death|0|||
19780171|NCT02880371|42235557|FG000|Phase 1b|Enrolled but not Treated|0|||
19780172|NCT02880371|42235558|FG001|Phase 1b|Enrolled but not Treated|1|||
19780173|NCT02880371|42235559|FG002|Phase 1b|Enrolled but not Treated|0|||
19780174|NCT02880371|42235560|FG003|Phase 1b|Enrolled but not Treated|0|||
19780175|NCT02880371|42235561|FG004|Phase 1b|Enrolled but not Treated|0|||
19780176|NCT02880371|42235562|FG005|Phase 1b|Enrolled but not Treated|0|||
19780177|NCT02880371|42235563|FG006|Phase 1b|Enrolled but not Treated|0|||
19780178|NCT02880371|42235564|FG007|Phase 1b|Enrolled but not Treated|0|||
19780179|NCT02880371|42235557|FG000|Phase 2|Enrolled but not Treated|0|||
19780180|NCT02880371|42235558|FG001|Phase 2|Enrolled but not Treated|0|||
19780181|NCT02880371|42235559|FG002|Phase 2|Enrolled but not Treated|0|||
19780182|NCT02880371|42235560|FG003|Phase 2|Enrolled but not Treated|0|||
19780183|NCT02880371|42235561|FG004|Phase 2|Enrolled but not Treated|0|||
19780184|NCT02880371|42235562|FG005|Phase 2|Enrolled but not Treated|1|||
19780185|NCT02880371|42235563|FG006|Phase 2|Enrolled but not Treated|1|||
19780186|NCT02880371|42235564|FG007|Phase 2|Enrolled but not Treated|0|||
19780187|NCT02880371|42235557|FG000|Phase 2|Other|0|||
19780188|NCT02880371|42235558|FG001|Phase 2|Other|0|||
19780189|NCT02880371|42235559|FG002|Phase 2|Other|0|||
19780190|NCT02880371|42235560|FG003|Phase 2|Other|0|||
19780191|NCT02880371|42235561|FG004|Phase 2|Other|0|||
19780192|NCT02880371|42235562|FG005|Phase 2|Other|1|||
19780193|NCT02880371|42235563|FG006|Phase 2|Other|2|||
19780194|NCT02880371|42235564|FG007|Phase 2|Other|1|||
19780195|NCT02880371|42235557|FG000|Phase 2|Participants terminated by Sponsor|0|||
19780196|NCT02880371|42235558|FG001|Phase 2|Participants terminated by Sponsor|0|||
19780197|NCT02880371|42235559|FG002|Phase 2|Participants terminated by Sponsor|0|||
19780198|NCT02880371|42235560|FG003|Phase 2|Participants terminated by Sponsor|0|||
19780199|NCT02880371|42235561|FG004|Phase 2|Participants terminated by Sponsor|1|||
19780200|NCT02880371|42235562|FG005|Phase 2|Participants terminated by Sponsor|6|||
19780201|NCT02880371|42235563|FG006|Phase 2|Participants terminated by Sponsor|1|||
19780202|NCT02880371|42235564|FG007|Phase 2|Participants terminated by Sponsor|5|||
19780203|NCT02880371|42235557|FG000|Phase 2|Death|0|||
19780204|NCT02880371|42235558|FG001|Phase 2|Death|0|||
19780205|NCT02880371|42235559|FG002|Phase 2|Death|0|||
19780206|NCT02880371|42235560|FG003|Phase 2|Death|0|||
19780207|NCT02880371|42235561|FG004|Phase 2|Death|1|||
19780208|NCT02880371|42235562|FG005|Phase 2|Death|10|||
19780209|NCT02880371|42235563|FG006|Phase 2|Death|20|||
19780210|NCT02880371|42235564|FG007|Phase 2|Death|5|||
19780211|NCT02880371|42235557|FG000|Phase 2|Lost to Follow-up|0|||
19780212|NCT02880371|42235558|FG001|Phase 2|Lost to Follow-up|0|||
19780213|NCT02880371|42235559|FG002|Phase 2|Lost to Follow-up|0|||
19780214|NCT02880371|42235560|FG003|Phase 2|Lost to Follow-up|0|||
19780215|NCT02880371|42235561|FG004|Phase 2|Lost to Follow-up|0|||
19780216|NCT02880371|42235562|FG005|Phase 2|Lost to Follow-up|0|||
19780217|NCT02880371|42235563|FG006|Phase 2|Lost to Follow-up|3|||
19780218|NCT02880371|42235564|FG007|Phase 2|Lost to Follow-up|0|||
19780219|NCT02880371|42235557|FG000|Phase 2|Withdrawal by Subject|0|||
19780220|NCT02880371|42235558|FG001|Phase 2|Withdrawal by Subject|0|||
19780221|NCT02880371|42235559|FG002|Phase 2|Withdrawal by Subject|0|||
19780222|NCT02880371|42235560|FG003|Phase 2|Withdrawal by Subject|0|||
19780223|NCT02880371|42235561|FG004|Phase 2|Withdrawal by Subject|0|||
19780224|NCT02880371|42235562|FG005|Phase 2|Withdrawal by Subject|1|||
19780225|NCT02880371|42235563|FG006|Phase 2|Withdrawal by Subject|1|||
19780226|NCT02880371|42235564|FG007|Phase 2|Withdrawal by Subject|0|||
19780227|NCT02880371|42235557|FG000|Phase 2|End of Study page not completed by error|0|||
19780228|NCT02880371|42235558|FG001|Phase 2|End of Study page not completed by error|0|||
19780229|NCT02880371|42235559|FG002|Phase 2|End of Study page not completed by error|0|||
19780230|NCT02880371|42235560|FG003|Phase 2|End of Study page not completed by error|0|||
19780231|NCT02880371|42235561|FG004|Phase 2|End of Study page not completed by error|0|||
19780232|NCT02880371|42235562|FG005|Phase 2|End of Study page not completed by error|1|||
19389169|NCT02661815|41632791|FG000|Overall Study|Withdrawal by Subject|1|||
19780233|NCT02880371|42235563|FG006|Phase 2|End of Study page not completed by error|0|||
19780234|NCT02880371|42235564|FG007|Phase 2|End of Study page not completed by error|0|||
19780235|NCT02837029|42235587|FG000|Screening|Failed to meet screening requirements.|7|||
19780236|NCT02837029|42235588|FG001|Screening|Failed to meet screening requirements.|3|||
19780237|NCT02837029|42235589|FG002|Screening|Failed to meet screening requirements.|0|||
19780238|NCT02837029|42235587|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
19477740|NCT01507831|41757003|FG000|Overall Study|Adverse Event|48|||
19780239|NCT02837029|42235588|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
19780240|NCT02837029|42235589|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
19780241|NCT02837029|42235587|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
19780242|NCT02837029|42235588|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
19780243|NCT02837029|42235589|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
19780244|NCT02837029|42235587|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
19780245|NCT02837029|42235588|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
19780246|NCT02837029|42235589|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
19780247|NCT02837029|42235587|FG000|Cycle 2 and Beyond|Adverse Event|1|||
19780248|NCT02837029|42235588|FG001|Cycle 2 and Beyond|Adverse Event|0|||
19780249|NCT02837029|42235589|FG002|Cycle 2 and Beyond|Adverse Event|0|||
19367297|NCT02435914|41607467|FG002|Overall Study|Ocular Adverse Event|0|||
19367298|NCT02435914|41607468|FG003|Overall Study|Ocular Adverse Event|0|||
19367299|NCT02435914|41607465|FG000|Overall Study|Withdrawal by Subject|0|||
19367300|NCT02435914|41607466|FG001|Overall Study|Withdrawal by Subject|1|||
19367301|NCT02435914|41607467|FG002|Overall Study|Withdrawal by Subject|0|||
19367302|NCT02435914|41607468|FG003|Overall Study|Withdrawal by Subject|0|||
19367303|NCT02435914|41607465|FG000|Overall Study|Other Miscellaneous Reason|0|||
19367304|NCT02435914|41607466|FG001|Overall Study|Other Miscellaneous Reason|0|||
19367305|NCT02435914|41607467|FG002|Overall Study|Other Miscellaneous Reason|1|||
19607105|NCT00942266|42055880|FG000|Overall Study|Intercurrent illness|0|||
19607106|NCT00942266|42055881|FG001|Overall Study|Intercurrent illness|1|||
19607107|NCT00942266|42055880|FG000|Overall Study|Physician Decision|2|||
19607108|NCT00942266|42055881|FG001|Overall Study|Physician Decision|0|||
19607109|NCT00942266|42055880|FG000|Overall Study|medical deterioration (pneumonia)|0|||
19607110|NCT00942266|42055881|FG001|Overall Study|medical deterioration (pneumonia)|1|||
19607111|NCT00942188|42055891|FG000|Overall Study|Adverse Event|0|||
19607112|NCT00942188|42055892|FG001|Overall Study|Adverse Event|3|||
19607113|NCT00942188|42055893|FG002|Overall Study|Adverse Event|2|||
19607114|NCT00942188|42055894|FG003|Overall Study|Adverse Event|0|||
19607115|NCT00942188|42055891|FG000|Overall Study|Lack of Efficacy|0|||
19607116|NCT00942188|42055892|FG001|Overall Study|Lack of Efficacy|0|||
19607117|NCT00942188|42055893|FG002|Overall Study|Lack of Efficacy|0|||
19607118|NCT00942188|42055894|FG003|Overall Study|Lack of Efficacy|1|||
19607119|NCT00942188|42055891|FG000|Overall Study|Protocol Violation|1|||
19607120|NCT00942188|42055892|FG001|Overall Study|Protocol Violation|1|||
19607121|NCT00942188|42055893|FG002|Overall Study|Protocol Violation|0|||
19607122|NCT00942188|42055894|FG003|Overall Study|Protocol Violation|0|||
19607123|NCT00942188|42055891|FG000|Overall Study|Lost to Follow-up|2|||
19607124|NCT00942188|42055892|FG001|Overall Study|Lost to Follow-up|1|||
19607125|NCT00942188|42055893|FG002|Overall Study|Lost to Follow-up|2|||
19607126|NCT00942188|42055894|FG003|Overall Study|Lost to Follow-up|0|||
19607127|NCT00942188|42055891|FG000|Overall Study|Withdrawal by Subject|1|||
19607128|NCT00942188|42055892|FG001|Overall Study|Withdrawal by Subject|3|||
19607129|NCT00942188|42055893|FG002|Overall Study|Withdrawal by Subject|4|||
19607130|NCT00942188|42055894|FG003|Overall Study|Withdrawal by Subject|2|||
19607131|NCT00942188|42055891|FG000|Overall Study|Physician Decision|0|||
19607132|NCT00942188|42055892|FG001|Overall Study|Physician Decision|0|||
19607133|NCT00942188|42055893|FG002|Overall Study|Physician Decision|1|||
19607134|NCT00942188|42055894|FG003|Overall Study|Physician Decision|0|||
19607135|NCT00942188|42055891|FG000|Overall Study|Sponsor Decision|0|||
19780250|NCT02837029|42235587|FG000|2 Year Follow-up|Death|6|||
19780251|NCT02837029|42235588|FG001|2 Year Follow-up|Death|7|||
19780252|NCT02837029|42235589|FG002|2 Year Follow-up|Death|0|||
19780253|NCT02642965|42235598|FG000|Overall Study|Lack of Efficacy|4|||
19780254|NCT02642965|42235598|FG000|Overall Study|Physician Decision|9|||
19780255|NCT03010527|42235605|FG000|Overall Study|Death|0|||
19780256|NCT03010527|42235606|FG001|Overall Study|Death|0|||
19780257|NCT03010527|42235607|FG002|Overall Study|Death|1|||
19780258|NCT03010527|42235605|FG000|Overall Study|Adverse Event|0|||
19780259|NCT03010527|42235606|FG001|Overall Study|Adverse Event|4|||
19780260|NCT03010527|42235607|FG002|Overall Study|Adverse Event|2|||
19780261|NCT03010527|42235605|FG000|Overall Study|Protocol Violation|0|||
19780262|NCT03010527|42235606|FG001|Overall Study|Protocol Violation|1|||
19780263|NCT03010527|42235607|FG002|Overall Study|Protocol Violation|0|||
19780264|NCT03010527|42235605|FG000|Overall Study|Lost to Follow-up|0|||
19780265|NCT03010527|42235606|FG001|Overall Study|Lost to Follow-up|2|||
19780266|NCT03010527|42235607|FG002|Overall Study|Lost to Follow-up|1|||
19780267|NCT03010527|42235605|FG000|Overall Study|Withdrawal by Subject|0|||
19780268|NCT03010527|42235606|FG001|Overall Study|Withdrawal by Subject|3|||
19780269|NCT03010527|42235607|FG002|Overall Study|Withdrawal by Subject|4|||
19389170|NCT02661815|41632792|FG001|Overall Study|Withdrawal by Subject|0|||
19780270|NCT03010527|42235605|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
19780271|NCT03010527|42235606|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
19477741|NCT01507831|41757004|FG001|Overall Study|Adverse Event|113|||
19607136|NCT00942188|42055892|FG001|Overall Study|Sponsor Decision|2|||
19607137|NCT00942188|42055893|FG002|Overall Study|Sponsor Decision|0|||
19607138|NCT00942188|42055894|FG003|Overall Study|Sponsor Decision|1|||
19607139|NCT00673231|42055908|FG000|Overall Study|Withdrawal by Subject|14|||
19780272|NCT03010527|42235607|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
19780273|NCT03010527|42235605|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
19780274|NCT03010527|42235606|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
19780275|NCT03010527|42235607|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
19780276|NCT03010527|42235605|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
19780277|NCT03010527|42235606|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
19780278|NCT03010527|42235607|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
19780279|NCT00794924|42235640|FG000|Overall Study|Lost to Follow-up|6|||
19780280|NCT00794924|42235641|FG001|Overall Study|Lost to Follow-up|8|||
19780281|NCT00794924|42235640|FG000|Overall Study|Withdrawal by Subject|48|||
19780282|NCT00794924|42235641|FG001|Overall Study|Withdrawal by Subject|60|||
19780283|NCT00794924|42235640|FG000|Overall Study|Adverse Event|6|||
19780284|NCT00794924|42235641|FG001|Overall Study|Adverse Event|2|||
19367306|NCT02435914|41607468|FG003|Overall Study|Other Miscellaneous Reason|0|||
19367307|NCT02786953|41607480|FG000|Overall Study|Withdrawal by Subject|3|||
19367308|NCT02786953|41607481|FG001|Overall Study|Withdrawal by Subject|0|||
19367309|NCT02786953|41607480|FG000|Overall Study|Physician Decision|0|||
19367310|NCT02786953|41607481|FG001|Overall Study|Physician Decision|1|||
19367311|NCT02435836|41607487|FG000|Overall Study|Lost to Follow-up|21|||
19367312|NCT02435836|41607487|FG000|Overall Study|Lack of Efficacy|1|||
19367313|NCT02435836|41607487|FG000|Overall Study|Withdrawal by Subject|236|||
19367314|NCT02435836|41607487|FG000|Overall Study|Insufficient Clinical Response|26|||
19367315|NCT02435836|41607487|FG000|Overall Study|Adverse Event|44|||
19367316|NCT02435836|41607487|FG000|Overall Study|Sponsor discontinued trial|167|||
19780285|NCT02914275|42235647|FG000|Overall Study|Lost to Follow-up|84|||
19780286|NCT02914275|42235648|FG001|Overall Study|Lost to Follow-up|29|||
19780287|NCT02914275|42235647|FG000|Overall Study|Withdrawal by Subject|26|||
19780288|NCT02914275|42235648|FG001|Overall Study|Withdrawal by Subject|10|||
19780289|NCT02914275|42235647|FG000|Overall Study|Protocol Violation|1|||
19780290|NCT02914275|42235648|FG001|Overall Study|Protocol Violation|1|||
19780291|NCT02914275|42235647|FG000|Overall Study|Physician Decision|3|||
19780292|NCT02914275|42235648|FG001|Overall Study|Physician Decision|1|||
19780293|NCT02914275|42235647|FG000|Overall Study|Other|4|||
19780294|NCT02914275|42235648|FG001|Overall Study|Other|1|||
19780295|NCT02914275|42235647|FG000|Overall Study|Excluded due to invalid informed consent|3|||
19780296|NCT02914275|42235648|FG001|Overall Study|Excluded due to invalid informed consent|0|||
19780297|NCT00792116|42235660|FG000|Overall Study|Lost to Follow-up|0|||
19780298|NCT00792116|42235661|FG001|Overall Study|Lost to Follow-up|1|||
19780299|NCT00792116|42235660|FG000|Overall Study|Discontnued intervention|1|||
19780300|NCT00792116|42235661|FG001|Overall Study|Discontnued intervention|0|||
19780301|NCT00489827|42235676|FG000|Overall Study|Intraoperative exclusion criteria|1|||
19780302|NCT00489827|42235677|FG001|Overall Study|Intraoperative exclusion criteria|1|||
19780303|NCT00489827|42235676|FG000|Overall Study|Intraoperative exclusion criteria|1|||
19780304|NCT00489827|42235677|FG001|Overall Study|Intraoperative exclusion criteria|1|||
19780305|NCT03007953|42235685|FG000|Overall Study|Withdrawal by Subject|5|||
19780306|NCT03007953|42235686|FG001|Overall Study|Withdrawal by Subject|2|||
19780307|NCT03007953|42235685|FG000|Overall Study|Death|5|||
19780308|NCT03007953|42235686|FG001|Overall Study|Death|7|||
19780309|NCT03007953|42235685|FG000|Overall Study|Lost to Follow-up|3|||
19780310|NCT03007953|42235686|FG001|Overall Study|Lost to Follow-up|2|||
19780311|NCT03007953|42235685|FG000|Overall Study|Enrolled in Hospice|3|||
19780312|NCT03007953|42235686|FG001|Overall Study|Enrolled in Hospice|2|||
19780313|NCT02604433|42235694|FG000|Overall Study|Withdrawal by Subject|37|||
19780314|NCT02604433|42235695|FG001|Overall Study|Withdrawal by Subject|16|||
19780315|NCT02604433|42235694|FG000|Overall Study|Adverse Event|4|||
19389171|NCT02661815|41632793|FG002|Overall Study|Withdrawal by Subject|0|||
19694770|NCT00328926|42140218|FG002|Overall Study|Pregnancy|0|||
19694771|NCT00328926|42140216|FG000|Overall Study|Lost to Follow-up|0|||
19694772|NCT00328926|42140217|FG001|Overall Study|Lost to Follow-up|1|||
19694773|NCT00328926|42140218|FG002|Overall Study|Lost to Follow-up|0|||
19694774|NCT00328926|42140216|FG000|Overall Study|Death|0|||
19694775|NCT00328926|42140217|FG001|Overall Study|Death|0|||
19694776|NCT00328926|42140218|FG002|Overall Study|Death|1|||
19694777|NCT00328926|42140216|FG000|Overall Study|In vitro fertilization treatment|0|||
19694778|NCT00328926|42140217|FG001|Overall Study|In vitro fertilization treatment|0|||
19694779|NCT00328926|42140218|FG002|Overall Study|In vitro fertilization treatment|1|||
19694780|NCT00328926|42140216|FG000|Overall Study|Lack of ovarian response|0|||
19694781|NCT00328926|42140217|FG001|Overall Study|Lack of ovarian response|1|||
19694782|NCT00328926|42140218|FG002|Overall Study|Lack of ovarian response|0|||
19780316|NCT02604433|42235695|FG001|Overall Study|Adverse Event|0|||
19780317|NCT02604433|42235694|FG000|Overall Study|Other reasons|3|||
19780318|NCT02604433|42235695|FG001|Overall Study|Other reasons|5|||
19780319|NCT02604433|42235694|FG000|Overall Study|Death|4|||
19780320|NCT02604433|42235695|FG001|Overall Study|Death|1|||
19780321|NCT02604433|42235694|FG000|Overall Study|Transition to Rollover Protocol|169|||
19780322|NCT02604433|42235695|FG001|Overall Study|Transition to Rollover Protocol|82|||
19780323|NCT02604433|42235694|FG000|Overall Study|Physician Decision|1|||
19367317|NCT02435836|41607487|FG000|Overall Study|Noncompliance|27|||
19367318|NCT02435836|41607487|FG000|Overall Study|Protocol Violation|6|||
19477742|NCT01507831|41757003|FG000|Overall Study|Death|6|||
19780324|NCT02604433|42235695|FG001|Overall Study|Physician Decision|1|||
19780325|NCT02604433|42235694|FG000|Overall Study|Lack of Efficacy|0|||
19780326|NCT02604433|42235695|FG001|Overall Study|Lack of Efficacy|1|||
19780327|NCT02659150|42235701|FG000|Subject Enrollment|Physician Decision|3|||
19780328|NCT02659150|42235701|FG000|Subject Enrollment|Withdrawal by Subject|2|||
19780329|NCT02659150|42235701|FG000|Baseline Imaging|Withdrawal by Subject|1|||
19780330|NCT02659150|42235701|FG000|Baseline Imaging|Physician Decision|1|||
19780331|NCT02659150|42235701|FG000|Study Drug Dosing|Adverse Event|1|||
19780332|NCT03006393|42235708|FG000|Overall Study|Withdrawal by Subject|1|||
19780333|NCT03006393|42235709|FG001|Overall Study|Withdrawal by Subject|1|||
19780334|NCT03006393|42235708|FG000|Overall Study|Pregnancy|0|||
19780335|NCT03006393|42235709|FG001|Overall Study|Pregnancy|1|||
19780336|NCT03006393|42235708|FG000|Overall Study|Lost to Follow-up|0|||
19780337|NCT03006393|42235709|FG001|Overall Study|Lost to Follow-up|1|||
19780338|NCT00882440|42235726|FG000|Overall Study|Adverse Event|2|||
19780339|NCT00882440|42235727|FG001|Overall Study|Adverse Event|2|||
19780340|NCT00882440|42235728|FG002|Overall Study|Adverse Event|2|||
19780341|NCT00882440|42235729|FG003|Overall Study|Adverse Event|1|||
19780342|NCT00882440|42235730|FG004|Overall Study|Adverse Event|1|||
19780343|NCT00882440|42235731|FG005|Overall Study|Adverse Event|4|||
19780344|NCT00882440|42235732|FG006|Overall Study|Adverse Event|2|||
19780345|NCT00882440|42235726|FG000|Overall Study|Lack of Efficacy|3|||
19780346|NCT00882440|42235727|FG001|Overall Study|Lack of Efficacy|5|||
19780347|NCT00882440|42235728|FG002|Overall Study|Lack of Efficacy|2|||
19780348|NCT00882440|42235729|FG003|Overall Study|Lack of Efficacy|0|||
19780349|NCT00882440|42235730|FG004|Overall Study|Lack of Efficacy|0|||
19780350|NCT00882440|42235731|FG005|Overall Study|Lack of Efficacy|3|||
19780351|NCT00882440|42235732|FG006|Overall Study|Lack of Efficacy|0|||
19780352|NCT00882440|42235726|FG000|Overall Study|Lost to Follow-up|2|||
19780353|NCT00882440|42235727|FG001|Overall Study|Lost to Follow-up|0|||
19780354|NCT00882440|42235728|FG002|Overall Study|Lost to Follow-up|1|||
19780355|NCT00882440|42235729|FG003|Overall Study|Lost to Follow-up|1|||
19780356|NCT00882440|42235730|FG004|Overall Study|Lost to Follow-up|1|||
19780357|NCT00882440|42235731|FG005|Overall Study|Lost to Follow-up|0|||
19780358|NCT00882440|42235732|FG006|Overall Study|Lost to Follow-up|1|||
19780359|NCT00882440|42235726|FG000|Overall Study|Protocol Violation|0|||
19780360|NCT00882440|42235727|FG001|Overall Study|Protocol Violation|0|||
19780361|NCT00882440|42235728|FG002|Overall Study|Protocol Violation|1|||
19780362|NCT00882440|42235729|FG003|Overall Study|Protocol Violation|1|||
19780363|NCT00882440|42235730|FG004|Overall Study|Protocol Violation|1|||
19780364|NCT00882440|42235731|FG005|Overall Study|Protocol Violation|0|||
19780365|NCT00882440|42235732|FG006|Overall Study|Protocol Violation|0|||
19780366|NCT00882440|42235726|FG000|Overall Study|Withdrawal by Subject|2|||
19780367|NCT00882440|42235727|FG001|Overall Study|Withdrawal by Subject|1|||
19694783|NCT00319254|42140226|FG000|Overall Study|Withdrawal by Subject|4|||
19780368|NCT00882440|42235728|FG002|Overall Study|Withdrawal by Subject|1|||
19780369|NCT00882440|42235729|FG003|Overall Study|Withdrawal by Subject|0|||
19780370|NCT00882440|42235730|FG004|Overall Study|Withdrawal by Subject|6|||
19780371|NCT00882440|42235731|FG005|Overall Study|Withdrawal by Subject|0|||
19780372|NCT00882440|42235732|FG006|Overall Study|Withdrawal by Subject|1|||
19780373|NCT00882440|42235726|FG000|Overall Study|Patient Uncooperative|2|||
19780374|NCT00882440|42235727|FG001|Overall Study|Patient Uncooperative|0|||
19780375|NCT00882440|42235728|FG002|Overall Study|Patient Uncooperative|0|||
19780376|NCT00882440|42235729|FG003|Overall Study|Patient Uncooperative|0|||
19694784|NCT00319254|42140226|FG000|Overall Study|Death|46|||
19694785|NCT00319254|42140226|FG000|Overall Study|Lost to Follow-up|2|||
19694786|NCT00319254|42140226|FG000|Overall Study|Enrolled, Not Treated|2|||
19694787|NCT00319098|42140234|FG000|Overall Study|Serious adverse event|3|||
19694788|NCT00319098|42140235|FG001|Overall Study|Serious adverse event|0|||
19694789|NCT00319098|42140234|FG000|Overall Study|Adverse Event|20|||
19694790|NCT00319098|42140235|FG001|Overall Study|Adverse Event|1|||
19694791|NCT00319098|42140234|FG000|Overall Study|Withdrawal by Subject|37|||
19694792|NCT00319098|42140235|FG001|Overall Study|Withdrawal by Subject|8|||
19694793|NCT00319098|42140234|FG000|Overall Study|Migrated/moved from study area|2|||
19694794|NCT00319098|42140235|FG001|Overall Study|Migrated/moved from study area|1|||
19694795|NCT00319098|42140234|FG000|Overall Study|Lost to Follow-up|37|||
19694796|NCT00319098|42140235|FG001|Overall Study|Lost to Follow-up|13|||
19694797|NCT00319098|42140234|FG000|Overall Study|Others|33|||
19780377|NCT00882440|42235730|FG004|Overall Study|Patient Uncooperative|1|||
19780378|NCT00882440|42235731|FG005|Overall Study|Patient Uncooperative|0|||
19780379|NCT00882440|42235732|FG006|Overall Study|Patient Uncooperative|0|||
19780380|NCT03005067|42235743|FG000|Overall Study|Withdrawal by Subject|3|||
19694798|NCT00319098|42140235|FG001|Overall Study|Others|8|||
19780381|NCT03005067|42235744|FG001|Overall Study|Withdrawal by Subject|2|||
19780382|NCT03005067|42235743|FG000|Overall Study|Adverse Event|4|||
19780383|NCT03005067|42235744|FG001|Overall Study|Adverse Event|3|||
19780384|NCT03005067|42235743|FG000|Overall Study|Other (reason not specified)|3|||
19780385|NCT03005067|42235744|FG001|Overall Study|Other (reason not specified)|1|||
19780386|NCT03005067|42235743|FG000|Overall Study|Protocol Violation|0|||
19780387|NCT03005067|42235744|FG001|Overall Study|Protocol Violation|1|||
19780388|NCT02658448|42235750|FG000|Overall Study|Lost to Follow-up|1|||
19780389|NCT03075761|42235756|FG000|Overall Study|Lost to Follow-up|1|||
19780390|NCT03075761|42235757|FG001|Overall Study|Lost to Follow-up|6|||
19780391|NCT03000075|42235771|FG000|Part A|Adverse Event|4|||
19780392|NCT03000075|42235772|FG001|Part A|Adverse Event|0|||
19780393|NCT03000075|42235773|FG002|Part A|Adverse Event|0|||
19780394|NCT03000075|42235774|FG003|Part A|Adverse Event|0|||
19780395|NCT03000075|42235775|FG004|Part A|Adverse Event|0|||
19780396|NCT03000075|42235776|FG005|Part A|Adverse Event|0|||
19780397|NCT03000075|42235777|FG006|Part A|Adverse Event|0|||
19780398|NCT03000075|42235771|FG000|Part B|Not dosed due to AE|0|||
19780399|NCT03000075|42235772|FG001|Part B|Not dosed due to AE|0|||
19780400|NCT03000075|42235773|FG002|Part B|Not dosed due to AE|0|||
19780401|NCT03000075|42235774|FG003|Part B|Not dosed due to AE|0|||
19780402|NCT03000075|42235775|FG004|Part B|Not dosed due to AE|0|||
19780403|NCT03000075|42235776|FG005|Part B|Not dosed due to AE|2|||
19780404|NCT03000075|42235777|FG006|Part B|Not dosed due to AE|1|||
19780405|NCT03000075|42235771|FG000|Part B|Adverse Event|0|||
19780406|NCT03000075|42235772|FG001|Part B|Adverse Event|0|||
19780407|NCT03000075|42235773|FG002|Part B|Adverse Event|0|||
19780408|NCT03000075|42235774|FG003|Part B|Adverse Event|0|||
19780409|NCT03000075|42235775|FG004|Part B|Adverse Event|1|||
19780410|NCT03000075|42235776|FG005|Part B|Adverse Event|0|||
19780411|NCT03000075|42235777|FG006|Part B|Adverse Event|0|||
19780412|NCT03073109|42235795|FG000|Overall Study|Adverse Event|0|||
19780413|NCT03073109|42235796|FG001|Overall Study|Adverse Event|1|||
19780414|NCT03073109|42235795|FG000|Overall Study|Other|2|||
19780415|NCT03073109|42235796|FG001|Overall Study|Other|0|||
19780416|NCT03073109|42235795|FG000|Overall Study|Lost to Follow-up|8|||
19780417|NCT03073109|42235796|FG001|Overall Study|Lost to Follow-up|1|||
19780418|NCT02371889|42235818|FG000|Overall Study|Adverse medication effect|11|||
19780419|NCT02371889|42235819|FG001|Overall Study|Adverse medication effect|2|||
19780420|NCT02371889|42235818|FG000|Overall Study|Lost to Follow-up|6|||
19780421|NCT02371889|42235819|FG001|Overall Study|Lost to Follow-up|5|||
19780422|NCT02371889|42235818|FG000|Overall Study|Personal time constraints|2|||
19780423|NCT02371889|42235819|FG001|Overall Study|Personal time constraints|4|||
19780424|NCT02371889|42235818|FG000|Overall Study|Lack of Efficacy|0|||
19780425|NCT02371889|42235819|FG001|Overall Study|Lack of Efficacy|2|||
19780426|NCT02371889|42235818|FG000|Overall Study|Relapse|0|||
19780427|NCT02371889|42235819|FG001|Overall Study|Relapse|1|||
19780428|NCT03072875|42235829|FG000|Overall Study|Lost to Follow-up|1|||
19780429|NCT04250077|42235837|FG000|Overall Study|Withdrawal by Subject|0|||
19780430|NCT04250077|42235838|FG001|Overall Study|Withdrawal by Subject|1|||
19780431|NCT04250077|42235839|FG002|Overall Study|Withdrawal by Subject|0|||
19780432|NCT04250077|42235837|FG000|Overall Study|Lost to Follow-up|2|||
19780433|NCT04250077|42235838|FG001|Overall Study|Lost to Follow-up|3|||
19607140|NCT00673231|42055909|FG001|Overall Study|Withdrawal by Subject|10|||
19607141|NCT00673231|42055910|FG002|Overall Study|Withdrawal by Subject|8|||
19607142|NCT00673231|42055911|FG003|Overall Study|Withdrawal by Subject|6|||
19607143|NCT00673231|42055908|FG000|Overall Study|Adverse Event|6|||
19607144|NCT00673231|42055909|FG001|Overall Study|Adverse Event|5|||
19607145|NCT00673231|42055910|FG002|Overall Study|Adverse Event|9|||
19607146|NCT00673231|42055911|FG003|Overall Study|Adverse Event|6|||
19607147|NCT00673231|42055908|FG000|Overall Study|Lost to Follow-up|1|||
19607148|NCT00673231|42055909|FG001|Overall Study|Lost to Follow-up|2|||
19607149|NCT00673231|42055910|FG002|Overall Study|Lost to Follow-up|1|||
19607150|NCT00673231|42055911|FG003|Overall Study|Lost to Follow-up|2|||
19607151|NCT00673231|42055908|FG000|Overall Study|Death|0|||
19607152|NCT00673231|42055909|FG001|Overall Study|Death|0|||
19607153|NCT00673231|42055910|FG002|Overall Study|Death|1|||
19607154|NCT00673231|42055911|FG003|Overall Study|Death|0|||
19607155|NCT00673231|42055908|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
19607156|NCT00673231|42055909|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
19607157|NCT00673231|42055910|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
19607158|NCT00673231|42055911|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
19607159|NCT00672841|42055923|FG000|Overall Study|Comfort care|1|||
19607160|NCT00672841|42055924|FG001|Overall Study|Comfort care|4|||
19607161|NCT00672841|42055923|FG000|Overall Study|icteric specimens|0|||
19607162|NCT00672841|42055924|FG001|Overall Study|icteric specimens|3|||
19607163|NCT00672841|42055923|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
19607164|NCT00672841|42055924|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
19780434|NCT04250077|42235839|FG002|Overall Study|Lost to Follow-up|0|||
19780435|NCT00859430|42235851|FG000|First Intervention|Withdrawal by Subject|0|||
19780436|NCT00859430|42235852|FG001|First Intervention|Withdrawal by Subject|1|||
19780437|NCT02913105|42235869|FG000|Overall Study|Adverse Event|11|||
19780438|NCT02913105|42235870|FG001|Overall Study|Adverse Event|0|||
19607165|NCT00672841|42055923|FG000|Overall Study|Adverse Event|0|||
19607166|NCT00672841|42055924|FG001|Overall Study|Adverse Event|3|||
19607167|NCT00672841|42055923|FG000|Overall Study|Pregnancy|0|||
19780439|NCT02913105|42235871|FG002|Overall Study|Adverse Event|4|||
19780440|NCT02913105|42235869|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19780441|NCT02913105|42235870|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19780442|NCT02913105|42235871|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19780443|NCT02913105|42235869|FG000|Overall Study|Reason Not Specified|3|||
19780444|NCT02913105|42235870|FG001|Overall Study|Reason Not Specified|1|||
19780445|NCT02913105|42235871|FG002|Overall Study|Reason Not Specified|1|||
19780446|NCT02913105|42235869|FG000|Overall Study|Physician Decision|1|||
19780447|NCT02913105|42235870|FG001|Overall Study|Physician Decision|1|||
19780448|NCT02913105|42235871|FG002|Overall Study|Physician Decision|0|||
19780449|NCT02913105|42235869|FG000|Overall Study|Withdrawal by Subject|0|||
19780450|NCT02913105|42235870|FG001|Overall Study|Withdrawal by Subject|3|||
19780451|NCT02913105|42235871|FG002|Overall Study|Withdrawal by Subject|1|||
19780452|NCT00840632|42235889|FG000|First Intervention|Withdrawal by Subject|0|||
19780453|NCT00840632|42235890|FG001|First Intervention|Withdrawal by Subject|1|||
19780454|NCT00840632|42235889|FG000|Washout|Withdrawal by Subject|1|||
19780455|NCT00840632|42235890|FG001|Washout|Withdrawal by Subject|1|||
19780456|NCT01602562|42235907|FG000|Overall Study|Adverse Event|3|||
19780457|NCT01602562|42235908|FG001|Overall Study|Adverse Event|1|||
19780458|NCT01602562|42235907|FG000|Overall Study|Physician Decision|1|||
19780459|NCT01602562|42235908|FG001|Overall Study|Physician Decision|1|||
19780460|NCT01602562|42235907|FG000|Overall Study|Withdrawal by Subject|1|||
19780461|NCT01602562|42235908|FG001|Overall Study|Withdrawal by Subject|1|||
19780462|NCT01945775|42235917|FG000|Overall Study|Death|214|||
19780463|NCT01945775|42235918|FG001|Overall Study|Death|98|||
19780464|NCT01945775|42235917|FG000|Overall Study|Lost to Follow-up|12|||
19780465|NCT01945775|42235918|FG001|Overall Study|Lost to Follow-up|7|||
19780466|NCT01945775|42235917|FG000|Overall Study|Withdrawal by Subject|11|||
19780467|NCT01945775|42235918|FG001|Overall Study|Withdrawal by Subject|21|||
19780468|NCT01945775|42235917|FG000|Overall Study|Other|50|||
19780469|NCT01945775|42235918|FG001|Overall Study|Other|18|||
19694799|NCT00319098|42140234|FG000|Overall Study|Protocol Violation|3|||
19694800|NCT00319098|42140235|FG001|Overall Study|Protocol Violation|1|||
19694801|NCT00347360|42140260|FG000|Overall Study|Adverse Event|1|||
19694802|NCT00347360|42140261|FG001|Overall Study|Adverse Event|2|||
19694803|NCT00347360|42140262|FG002|Overall Study|Adverse Event|0|||
19694804|NCT00347360|42140263|FG003|Overall Study|Adverse Event|4|||
19694805|NCT00347360|42140264|FG004|Overall Study|Adverse Event|1|||
19694806|NCT00347360|42140265|FG005|Overall Study|Adverse Event|2|||
19694807|NCT00347360|42140266|FG006|Overall Study|Adverse Event|2|||
19694808|NCT00347360|42140267|FG007|Overall Study|Adverse Event|0|||
19694809|NCT00347360|42140268|FG008|Overall Study|Adverse Event|2|||
19694810|NCT00347360|42140269|FG009|Overall Study|Adverse Event|3|||
19694811|NCT00347360|42140270|FG010|Overall Study|Adverse Event|3|||
19694812|NCT00347360|42140271|FG011|Overall Study|Adverse Event|1|||
19694813|NCT00347360|42140272|FG012|Overall Study|Adverse Event|3|||
19694814|NCT00347360|42140273|FG013|Overall Study|Adverse Event|2|||
19694815|NCT00347360|42140274|FG014|Overall Study|Adverse Event|2|||
19694816|NCT00347360|42140260|FG000|Overall Study|Lost to Follow-up|0|||
19694817|NCT00347360|42140261|FG001|Overall Study|Lost to Follow-up|0|||
19694818|NCT00347360|42140262|FG002|Overall Study|Lost to Follow-up|0|||
19694819|NCT00347360|42140263|FG003|Overall Study|Lost to Follow-up|2|||
19694820|NCT00347360|42140264|FG004|Overall Study|Lost to Follow-up|1|||
19694821|NCT00347360|42140265|FG005|Overall Study|Lost to Follow-up|1|||
19694822|NCT00347360|42140266|FG006|Overall Study|Lost to Follow-up|0|||
19694823|NCT00347360|42140267|FG007|Overall Study|Lost to Follow-up|1|||
19694824|NCT00347360|42140268|FG008|Overall Study|Lost to Follow-up|1|||
19694825|NCT00347360|42140269|FG009|Overall Study|Lost to Follow-up|2|||
19694826|NCT00347360|42140270|FG010|Overall Study|Lost to Follow-up|0|||
19694827|NCT00347360|42140271|FG011|Overall Study|Lost to Follow-up|0|||
19694828|NCT00347360|42140272|FG012|Overall Study|Lost to Follow-up|1|||
19694829|NCT00347360|42140273|FG013|Overall Study|Lost to Follow-up|0|||
19694830|NCT00347360|42140274|FG014|Overall Study|Lost to Follow-up|0|||
19694831|NCT00347360|42140260|FG000|Overall Study|Protocol Violation|2|||
19694832|NCT00347360|42140261|FG001|Overall Study|Protocol Violation|3|||
19694833|NCT00347360|42140262|FG002|Overall Study|Protocol Violation|1|||
19694834|NCT00347360|42140263|FG003|Overall Study|Protocol Violation|2|||
19694835|NCT00347360|42140264|FG004|Overall Study|Protocol Violation|1|||
19694836|NCT00347360|42140265|FG005|Overall Study|Protocol Violation|2|||
19694837|NCT00347360|42140266|FG006|Overall Study|Protocol Violation|0|||
19694838|NCT00347360|42140267|FG007|Overall Study|Protocol Violation|0|||
19694839|NCT00347360|42140268|FG008|Overall Study|Protocol Violation|1|||
19694840|NCT00347360|42140269|FG009|Overall Study|Protocol Violation|2|||
19694841|NCT00347360|42140270|FG010|Overall Study|Protocol Violation|0|||
19694842|NCT00347360|42140271|FG011|Overall Study|Protocol Violation|0|||
19694843|NCT00347360|42140272|FG012|Overall Study|Protocol Violation|0|||
19694844|NCT00347360|42140273|FG013|Overall Study|Protocol Violation|1|||
19694845|NCT00347360|42140274|FG014|Overall Study|Protocol Violation|0|||
19694846|NCT00347360|42140260|FG000|Overall Study|Withdrawal by Subject|0|||
19694847|NCT00347360|42140261|FG001|Overall Study|Withdrawal by Subject|1|||
19694848|NCT00347360|42140262|FG002|Overall Study|Withdrawal by Subject|2|||
19780470|NCT03072719|42235946|FG000|Overall Study|Adverse Event|1|||
19780471|NCT03072719|42235947|FG001|Overall Study|Adverse Event|1|||
19780472|NCT00835796|42235955|FG000|First Intervention|Withdrawal by Subject|0|||
19780473|NCT00835796|42235956|FG001|First Intervention|Withdrawal by Subject|1|||
19780474|NCT00835640|42235962|FG000|Second Intervention|Protocol Violation|1|||
19780475|NCT00835640|42235963|FG001|Second Intervention|Protocol Violation|0|||
19780476|NCT02942017|42235969|FG000|Overall Study|Adverse Event|0|||
19780477|NCT02942017|42235970|FG001|Overall Study|Adverse Event|1|||
19780478|NCT02942017|42235969|FG000|Overall Study|Withdrawal by Subject|0|||
19780479|NCT02942017|42235970|FG001|Overall Study|Withdrawal by Subject|1|||
19780480|NCT02942017|42235969|FG000|Overall Study|Lost to Follow-up|1|||
19780481|NCT02942017|42235970|FG001|Overall Study|Lost to Follow-up|1|||
19780482|NCT02942017|42235969|FG000|Overall Study|Randomized but not dosed|1|||
19780483|NCT02942017|42235970|FG001|Overall Study|Randomized but not dosed|3|||
19780484|NCT00835406|42235985|FG000|Period: First Intervention|Adverse Event|0|||
19780485|NCT00835406|42235986|FG001|Period: First Intervention|Adverse Event|1|||
19780486|NCT00835406|42235985|FG000|Period: First Intervention|Withdrawal by Subject|2|||
19780487|NCT00835406|42235986|FG001|Period: First Intervention|Withdrawal by Subject|0|||
19780488|NCT00835406|42235985|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
19780489|NCT00835406|42235986|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
19780490|NCT00835172|42235992|FG000|Washout|Protocol Violation|0|||
19780491|NCT00835172|42235993|FG001|Washout|Protocol Violation|1|||
19780492|NCT01676116|42235999|FG000|Overall Study|Withdrawal criteria|2|||
19780493|NCT01676116|42236000|FG001|Overall Study|Withdrawal criteria|14|||
19780494|NCT01676116|42235999|FG000|Overall Study|Adverse Event|1|||
19780495|NCT01676116|42236000|FG001|Overall Study|Adverse Event|2|||
19780496|NCT01676116|42235999|FG000|Overall Study|Unclassified|4|||
19780497|NCT01676116|42236000|FG001|Overall Study|Unclassified|10|||
19780498|NCT01676116|42235999|FG000|Overall Study|Protocol Violation|9|||
19780499|NCT01676116|42236000|FG001|Overall Study|Protocol Violation|3|||
19780500|NCT00740480|42236006|FG000|Overall Study|Adverse Event|1|||
19780501|NCT00740480|42236006|FG000|Overall Study|Physician Decision|1|||
19780502|NCT02743520|42236009|FG000|Overall Study|Withdrawal by Subject|1|||
19780503|NCT03001557|42236028|FG000|Core Phase|Randomized but not treated|0|||
19780504|NCT03001557|42236029|FG001|Core Phase|Randomized but not treated|0|||
19780505|NCT03001557|42236030|FG002|Core Phase|Randomized but not treated|1|||
19780506|NCT03001557|42236031|FG003|Core Phase|Randomized but not treated|0|||
19780507|NCT03001557|42236032|FG004|Core Phase|Randomized but not treated|0|||
19780508|NCT03001557|42236033|FG005|Core Phase|Randomized but not treated|0|||
19780509|NCT03001557|42236034|FG006|Core Phase|Randomized but not treated|0|||
19780510|NCT03001557|42236035|FG007|Core Phase|Randomized but not treated|0|||
19780511|NCT03001557|42236028|FG000|Extension Phase|Adverse Event|0|||
19780512|NCT03001557|42236029|FG001|Extension Phase|Adverse Event|0|||
19780513|NCT03001557|42236030|FG002|Extension Phase|Adverse Event|0|||
19780514|NCT03001557|42236031|FG003|Extension Phase|Adverse Event|0|||
19367319|NCT02435836|41607487|FG000|Overall Study|Met Withdrawal Criteria|7|||
19694849|NCT00347360|42140263|FG003|Overall Study|Withdrawal by Subject|4|||
19694850|NCT00347360|42140264|FG004|Overall Study|Withdrawal by Subject|1|||
19694851|NCT00347360|42140265|FG005|Overall Study|Withdrawal by Subject|2|||
19694852|NCT00347360|42140266|FG006|Overall Study|Withdrawal by Subject|1|||
19694853|NCT00347360|42140267|FG007|Overall Study|Withdrawal by Subject|1|||
19694854|NCT00347360|42140268|FG008|Overall Study|Withdrawal by Subject|1|||
19694855|NCT00347360|42140269|FG009|Overall Study|Withdrawal by Subject|1|||
19694856|NCT00347360|42140270|FG010|Overall Study|Withdrawal by Subject|0|||
19694857|NCT00347360|42140271|FG011|Overall Study|Withdrawal by Subject|3|||
19694858|NCT00347360|42140272|FG012|Overall Study|Withdrawal by Subject|4|||
19694859|NCT00347360|42140273|FG013|Overall Study|Withdrawal by Subject|2|||
19694860|NCT00347360|42140274|FG014|Overall Study|Withdrawal by Subject|1|||
19694861|NCT00347360|42140260|FG000|Overall Study|Lack of Efficacy|1|||
19694862|NCT00347360|42140261|FG001|Overall Study|Lack of Efficacy|1|||
19694863|NCT00347360|42140262|FG002|Overall Study|Lack of Efficacy|3|||
19694864|NCT00347360|42140263|FG003|Overall Study|Lack of Efficacy|1|||
19694865|NCT00347360|42140264|FG004|Overall Study|Lack of Efficacy|0|||
19694866|NCT00347360|42140265|FG005|Overall Study|Lack of Efficacy|1|||
19694867|NCT00347360|42140266|FG006|Overall Study|Lack of Efficacy|0|||
19694868|NCT00347360|42140267|FG007|Overall Study|Lack of Efficacy|1|||
19694869|NCT00347360|42140268|FG008|Overall Study|Lack of Efficacy|1|||
19694870|NCT00347360|42140269|FG009|Overall Study|Lack of Efficacy|0|||
19694871|NCT00347360|42140270|FG010|Overall Study|Lack of Efficacy|0|||
19694872|NCT00347360|42140271|FG011|Overall Study|Lack of Efficacy|0|||
19780515|NCT03001557|42236032|FG004|Extension Phase|Adverse Event|0|||
19780516|NCT03001557|42236033|FG005|Extension Phase|Adverse Event|2|||
19780517|NCT03001557|42236034|FG006|Extension Phase|Adverse Event|0|||
19780518|NCT03001557|42236035|FG007|Extension Phase|Adverse Event|0|||
19694873|NCT00347360|42140272|FG012|Overall Study|Lack of Efficacy|0|||
19694874|NCT00347360|42140273|FG013|Overall Study|Lack of Efficacy|0|||
19694875|NCT00347360|42140274|FG014|Overall Study|Lack of Efficacy|0|||
19780519|NCT03001557|42236028|FG000|Extension Phase|Withdrawal by Subject|0|||
19780520|NCT03001557|42236029|FG001|Extension Phase|Withdrawal by Subject|0|||
19780521|NCT03001557|42236030|FG002|Extension Phase|Withdrawal by Subject|0|||
19780522|NCT03001557|42236031|FG003|Extension Phase|Withdrawal by Subject|0|||
19780523|NCT03001557|42236032|FG004|Extension Phase|Withdrawal by Subject|0|||
19780524|NCT03001557|42236033|FG005|Extension Phase|Withdrawal by Subject|1|||
19780525|NCT03001557|42236034|FG006|Extension Phase|Withdrawal by Subject|5|||
19780526|NCT03001557|42236035|FG007|Extension Phase|Withdrawal by Subject|2|||
19780527|NCT03001557|42236028|FG000|Extension Phase|Lost to Follow-up|0|||
19780528|NCT03001557|42236029|FG001|Extension Phase|Lost to Follow-up|0|||
19780529|NCT03001557|42236030|FG002|Extension Phase|Lost to Follow-up|0|||
19780530|NCT03001557|42236031|FG003|Extension Phase|Lost to Follow-up|0|||
19780531|NCT03001557|42236032|FG004|Extension Phase|Lost to Follow-up|0|||
19780532|NCT03001557|42236033|FG005|Extension Phase|Lost to Follow-up|0|||
19780533|NCT03001557|42236034|FG006|Extension Phase|Lost to Follow-up|2|||
19780534|NCT03001557|42236035|FG007|Extension Phase|Lost to Follow-up|1|||
19780535|NCT03001557|42236028|FG000|Extension Phase|Administrative Reason|0|||
19780536|NCT03001557|42236029|FG001|Extension Phase|Administrative Reason|0|||
19780537|NCT03001557|42236030|FG002|Extension Phase|Administrative Reason|0|||
19780538|NCT03001557|42236031|FG003|Extension Phase|Administrative Reason|0|||
19780539|NCT03001557|42236032|FG004|Extension Phase|Administrative Reason|0|||
19780540|NCT03001557|42236033|FG005|Extension Phase|Administrative Reason|1|||
19780541|NCT03001557|42236034|FG006|Extension Phase|Administrative Reason|3|||
19780542|NCT03001557|42236035|FG007|Extension Phase|Administrative Reason|3|||
19780543|NCT03001557|42236028|FG000|Extension Phase|Loss of caregiver|0|||
19780544|NCT03001557|42236029|FG001|Extension Phase|Loss of caregiver|0|||
19780545|NCT03001557|42236030|FG002|Extension Phase|Loss of caregiver|0|||
19780546|NCT03001557|42236031|FG003|Extension Phase|Loss of caregiver|0|||
19780547|NCT03001557|42236032|FG004|Extension Phase|Loss of caregiver|0|||
19780548|NCT03001557|42236033|FG005|Extension Phase|Loss of caregiver|0|||
19780549|NCT03001557|42236034|FG006|Extension Phase|Loss of caregiver|1|||
19780550|NCT03001557|42236035|FG007|Extension Phase|Loss of caregiver|0|||
19780551|NCT03001557|42236028|FG000|Extension Phase|Others|0|||
19780552|NCT03001557|42236029|FG001|Extension Phase|Others|0|||
19780553|NCT03001557|42236030|FG002|Extension Phase|Others|0|||
19780554|NCT03001557|42236031|FG003|Extension Phase|Others|0|||
19780555|NCT03001557|42236032|FG004|Extension Phase|Others|0|||
19780556|NCT03001557|42236033|FG005|Extension Phase|Others|1|||
19780557|NCT03001557|42236034|FG006|Extension Phase|Others|3|||
19780558|NCT03001557|42236035|FG007|Extension Phase|Others|0|||
19780559|NCT00830336|42236072|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
19780560|NCT00830336|42236073|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
19780561|NCT00830258|42236079|FG000|First Intervention|Adverse Event|1|||
19780562|NCT00830258|42236080|FG001|First Intervention|Adverse Event|0|||
19780563|NCT00830258|42236079|FG000|Washout: 7 Days|Protocol Violation|1|||
19780564|NCT00830258|42236080|FG001|Washout: 7 Days|Protocol Violation|0|||
19780565|NCT03349775|42236086|FG000|Overall Study|Side Effects|1|||
19780566|NCT03349775|42236087|FG001|Overall Study|Side Effects|2|||
19780567|NCT03349775|42236086|FG000|Overall Study|Withdrawal by Subject|1|||
19780568|NCT03349775|42236087|FG001|Overall Study|Withdrawal by Subject|1|||
19780569|NCT03349775|42236086|FG000|Overall Study|No primary outcome measurements|0|||
19780570|NCT03349775|42236087|FG001|Overall Study|No primary outcome measurements|1|||
19780571|NCT00830024|42236095|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19780572|NCT00830024|42236096|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
19780573|NCT00829868|42236102|FG000|Washout|Physician Decision|1|||
19780574|NCT00829868|42236103|FG001|Washout|Physician Decision|0|||
19780575|NCT00829790|42236109|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
19780576|NCT00829790|42236110|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
19780577|NCT03207815|42236116|FG000|Overall Study|Protocol Violation|3|||
19780578|NCT03207815|42236117|FG001|Overall Study|Protocol Violation|1|||
19780579|NCT03207815|42236116|FG000|Overall Study|Adverse Event|1|||
19780580|NCT03207815|42236117|FG001|Overall Study|Adverse Event|2|||
19780581|NCT03207815|42236116|FG000|Overall Study|Lost to Follow-up|1|||
19780582|NCT03207815|42236117|FG001|Overall Study|Lost to Follow-up|2|||
19780583|NCT03207815|42236116|FG000|Overall Study|Investigator's Discretion|1|||
19780584|NCT03207815|42236117|FG001|Overall Study|Investigator's Discretion|1|||
19780585|NCT03207815|42236116|FG000|Overall Study|Lack of Efficacy|0|||
19780586|NCT03207815|42236117|FG001|Overall Study|Lack of Efficacy|1|||
19780587|NCT03207815|42236116|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
19780588|NCT03207815|42236117|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
19780589|NCT03207815|42236116|FG000|Overall Study|Withdrew Consent|1|||
19780590|NCT03207815|42236117|FG001|Overall Study|Withdrew Consent|0|||
19780591|NCT02911935|42236125|FG000|Overall Study|Lost to Follow-up|5|||
19780592|NCT02911935|42236126|FG001|Overall Study|Lost to Follow-up|7|||
19780593|NCT00829712|42236134|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
19780594|NCT00829712|42236135|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
19780595|NCT03069989|42236150|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
19477743|NCT01507831|41757004|FG001|Overall Study|Death|2|||
19780596|NCT03069989|42236151|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
19780597|NCT02698163|42236178|FG000|Overall Study|Lost to Follow-up|0|||
19780598|NCT02698163|42236179|FG001|Overall Study|Lost to Follow-up|1|||
19780599|NCT03817190|42236187|FG000|Overall Study|Early Termination|13|||
19780600|NCT03817190|42236188|FG001|Overall Study|Early Termination|20|||
19780601|NCT03817190|42236187|FG000|Overall Study|Adverse Event|10|||
19780602|NCT03817190|42236188|FG001|Overall Study|Adverse Event|17|||
19780603|NCT03817190|42236187|FG000|Overall Study|Withdrawal by Subject|12|||
19780604|NCT03817190|42236188|FG001|Overall Study|Withdrawal by Subject|8|||
19780605|NCT03817190|42236187|FG000|Overall Study|Lost to Follow-up|11|||
19780606|NCT03817190|42236188|FG001|Overall Study|Lost to Follow-up|7|||
19780607|NCT03817190|42236187|FG000|Overall Study|Lack of Efficacy|7|||
19780608|NCT03817190|42236188|FG001|Overall Study|Lack of Efficacy|5|||
19780609|NCT03817190|42236187|FG000|Overall Study|Investigator Decision|5|||
19780610|NCT03817190|42236188|FG001|Overall Study|Investigator Decision|1|||
19780611|NCT03817190|42236187|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
19780612|NCT03817190|42236188|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
19780613|NCT03817190|42236187|FG000|Overall Study|Lack of Contact|1|||
19780614|NCT03817190|42236188|FG001|Overall Study|Lack of Contact|0|||
19780615|NCT03817190|42236187|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
19780616|NCT03817190|42236188|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
19780617|NCT03797222|42236207|FG000|Overall Study|Withdrawal by Subject|1|||
19780618|NCT02742818|42236217|FG000|Overall Study|Adverse Event|0|||
19780619|NCT02742818|42236218|FG001|Overall Study|Adverse Event|1|||
19780620|NCT02742818|42236217|FG000|Overall Study|Protocol Violation|0|||
19780621|NCT02742818|42236218|FG001|Overall Study|Protocol Violation|1|||
19780622|NCT03069365|42236226|FG000|Overall Study|Adverse Event|1|||
19780623|NCT03065933|42236230|FG000|Overall Study|study terminated|5|||
19780624|NCT04256629|42236240|FG000|Overall Study|Adverse Event|0|||
19780625|NCT04256629|42236241|FG001|Overall Study|Adverse Event|0|||
19780626|NCT04256629|42236242|FG002|Overall Study|Adverse Event|0|||
19780627|NCT04256629|42236243|FG003|Overall Study|Adverse Event|0|||
19780628|NCT04256629|42236244|FG004|Overall Study|Adverse Event|0|||
19780629|NCT04256629|42236245|FG005|Overall Study|Adverse Event|1|||
19780630|NCT04256629|42236240|FG000|Overall Study|Protocol Violation|0|||
19780631|NCT04256629|42236241|FG001|Overall Study|Protocol Violation|1|||
19780632|NCT04256629|42236242|FG002|Overall Study|Protocol Violation|0|||
19780633|NCT04256629|42236243|FG003|Overall Study|Protocol Violation|0|||
19780634|NCT04256629|42236244|FG004|Overall Study|Protocol Violation|0|||
19780635|NCT04256629|42236245|FG005|Overall Study|Protocol Violation|0|||
19780636|NCT01346293|42236255|FG000|Overall Study|Protocol Violation|30|||
19780637|NCT01346293|42236256|FG001|Overall Study|Protocol Violation|9|||
19780638|NCT01346293|42236255|FG000|Overall Study|Lost to Follow-up|21|||
19780639|NCT01346293|42236256|FG001|Overall Study|Lost to Follow-up|8|||
19780640|NCT01346293|42236255|FG000|Overall Study|Withdrawal by Subject|15|||
19694876|NCT00347360|42140260|FG000|Overall Study|Reason not listed/blank|1|||
19694877|NCT00347360|42140261|FG001|Overall Study|Reason not listed/blank|0|||
19694878|NCT00347360|42140262|FG002|Overall Study|Reason not listed/blank|0|||
19694879|NCT00347360|42140263|FG003|Overall Study|Reason not listed/blank|0|||
19694880|NCT00347360|42140264|FG004|Overall Study|Reason not listed/blank|0|||
19694881|NCT00347360|42140265|FG005|Overall Study|Reason not listed/blank|0|||
19694882|NCT00347360|42140266|FG006|Overall Study|Reason not listed/blank|1|||
19694883|NCT00347360|42140267|FG007|Overall Study|Reason not listed/blank|0|||
19694884|NCT00347360|42140268|FG008|Overall Study|Reason not listed/blank|0|||
19694885|NCT00347360|42140269|FG009|Overall Study|Reason not listed/blank|0|||
19694886|NCT00347360|42140270|FG010|Overall Study|Reason not listed/blank|0|||
19694887|NCT00347360|42140271|FG011|Overall Study|Reason not listed/blank|0|||
19694888|NCT00347360|42140272|FG012|Overall Study|Reason not listed/blank|0|||
19694889|NCT00347360|42140273|FG013|Overall Study|Reason not listed/blank|1|||
19780641|NCT01346293|42236256|FG001|Overall Study|Withdrawal by Subject|4|||
19780642|NCT01346293|42236255|FG000|Overall Study|Other|1|||
19780643|NCT01346293|42236256|FG001|Overall Study|Other|0|||
19780644|NCT03502187|42236267|FG000|Overall Study|Withdrawal by Subject|4|||
19780645|NCT03502187|42236268|FG001|Overall Study|Withdrawal by Subject|3|||
19780646|NCT03502187|42236269|FG002|Overall Study|Withdrawal by Subject|3|||
19780647|NCT03502187|42236267|FG000|Overall Study|Lost to Follow-up|5|||
19780648|NCT03502187|42236268|FG001|Overall Study|Lost to Follow-up|4|||
19780649|NCT03502187|42236269|FG002|Overall Study|Lost to Follow-up|5|||
19780650|NCT03058705|42236277|FG000|Overall Study|Withdrawal by Subject|2|||
19780651|NCT03058705|42236277|FG000|Overall Study|Physician Decision|2|||
19780652|NCT02998671|42236286|FG000|Period 1|Study Terminated By Sponsor|2|||
19780653|NCT02998671|42236287|FG001|Period 1|Study Terminated By Sponsor|1|||
19389172|NCT02661815|41632794|FG003|Overall Study|Withdrawal by Subject|0|||
19389173|NCT02053792|41632810|FG000|Overall Study|Physician Decision|0|||
19694890|NCT00347360|42140274|FG014|Overall Study|Reason not listed/blank|0|||
19780654|NCT02998671|42236288|FG002|Period 1|Study Terminated By Sponsor|0|||
19780655|NCT02998671|42236289|FG003|Period 1|Study Terminated By Sponsor|0|||
19780656|NCT02998671|42236290|FG004|Period 1|Study Terminated By Sponsor|1|||
19780657|NCT02998671|42236286|FG000|Period 1|Withdrawal by Subject|1|||
19780658|NCT02998671|42236287|FG001|Period 1|Withdrawal by Subject|2|||
19780659|NCT02998671|42236288|FG002|Period 1|Withdrawal by Subject|0|||
19780660|NCT02998671|42236289|FG003|Period 1|Withdrawal by Subject|0|||
19780661|NCT02998671|42236290|FG004|Period 1|Withdrawal by Subject|2|||
19780662|NCT02998671|42236286|FG000|Period 1|Pregnancy|1|||
19780663|NCT02998671|42236287|FG001|Period 1|Pregnancy|0|||
19780664|NCT02998671|42236288|FG002|Period 1|Pregnancy|0|||
19780665|NCT02998671|42236289|FG003|Period 1|Pregnancy|0|||
19780666|NCT02998671|42236290|FG004|Period 1|Pregnancy|0|||
19780667|NCT02998671|42236286|FG000|Period 1|Adverse Event|0|||
19780668|NCT02998671|42236287|FG001|Period 1|Adverse Event|0|||
19780669|NCT02998671|42236288|FG002|Period 1|Adverse Event|0|||
19780670|NCT02998671|42236289|FG003|Period 1|Adverse Event|0|||
19780671|NCT02998671|42236290|FG004|Period 1|Adverse Event|1|||
19780672|NCT02998671|42236286|FG000|Period 2|Adverse Event|0|||
19780673|NCT02998671|42236287|FG001|Period 2|Adverse Event|1|||
19780674|NCT02998671|42236288|FG002|Period 2|Adverse Event|0|||
19780675|NCT02998671|42236289|FG003|Period 2|Adverse Event|0|||
19780676|NCT02998671|42236290|FG004|Period 2|Adverse Event|0|||
19780677|NCT02998671|42236286|FG000|Period 2|Study Terminated By Sponsor|3|||
19780678|NCT02998671|42236287|FG001|Period 2|Study Terminated By Sponsor|5|||
19780679|NCT02998671|42236288|FG002|Period 2|Study Terminated By Sponsor|1|||
19780680|NCT02998671|42236289|FG003|Period 2|Study Terminated By Sponsor|3|||
19780681|NCT02998671|42236290|FG004|Period 2|Study Terminated By Sponsor|0|||
19780682|NCT02998671|42236286|FG000|Period 2|Withdrawal by Subject|0|||
19780683|NCT02998671|42236287|FG001|Period 2|Withdrawal by Subject|1|||
19780684|NCT02998671|42236288|FG002|Period 2|Withdrawal by Subject|0|||
19780685|NCT02998671|42236289|FG003|Period 2|Withdrawal by Subject|0|||
19780686|NCT02998671|42236290|FG004|Period 2|Withdrawal by Subject|0|||
19780687|NCT02998671|42236286|FG000|Period 2|Lost to Follow-up|0|||
19780688|NCT02998671|42236287|FG001|Period 2|Lost to Follow-up|0|||
19780689|NCT02998671|42236288|FG002|Period 2|Lost to Follow-up|0|||
19780690|NCT02998671|42236289|FG003|Period 2|Lost to Follow-up|1|||
19780691|NCT02998671|42236290|FG004|Period 2|Lost to Follow-up|0|||
19694891|NCT00347360|42140260|FG000|Overall Study|Per sponsors instruction|0|||
19694892|NCT00347360|42140261|FG001|Overall Study|Per sponsors instruction|1|||
19694893|NCT00347360|42140262|FG002|Overall Study|Per sponsors instruction|0|||
19694894|NCT00347360|42140263|FG003|Overall Study|Per sponsors instruction|0|||
19694895|NCT00347360|42140264|FG004|Overall Study|Per sponsors instruction|0|||
19694896|NCT00347360|42140265|FG005|Overall Study|Per sponsors instruction|0|||
19694897|NCT00347360|42140266|FG006|Overall Study|Per sponsors instruction|0|||
19694898|NCT00347360|42140267|FG007|Overall Study|Per sponsors instruction|0|||
19694899|NCT00347360|42140268|FG008|Overall Study|Per sponsors instruction|0|||
19694900|NCT00347360|42140269|FG009|Overall Study|Per sponsors instruction|0|||
19694901|NCT00347360|42140270|FG010|Overall Study|Per sponsors instruction|0|||
19694902|NCT00347360|42140271|FG011|Overall Study|Per sponsors instruction|0|||
19780692|NCT02660827|42236310|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
19780693|NCT02660827|42236310|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
19780694|NCT02660827|42236310|FG000|From Study to End of Continued Access|Adverse Event|3|||
19780695|NCT02660827|42236310|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
19780696|NCT02660827|42236310|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
19780697|NCT02660827|42236310|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
19780698|NCT02660827|42236310|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
19780699|NCT02660827|42236310|FG000|Period 2: Continued Access Period|Adverse Event|3|||
19780700|NCT01069419|42236331|FG000|Overall Study|Adverse Event|233|||
19780701|NCT01069419|42236331|FG000|Overall Study|Lack of Efficacy|332|||
19780702|NCT01069419|42236331|FG000|Overall Study|Lost to Follow-up|49|||
19780703|NCT01069419|42236331|FG000|Overall Study|Remission of disease|11|||
19780704|NCT01069419|42236331|FG000|Overall Study|Withdrawal by Subject|34|||
19780705|NCT01069419|42236331|FG000|Overall Study|Other Reason|43|||
19780706|NCT01069419|42236331|FG000|Overall Study|Missing termination information|13|||
19780707|NCT01069341|42236335|FG000|Overall Study|Lost to Follow-up|1|||
19780708|NCT02996097|42236339|FG000|Overall Study|Lost to Follow-up|11|||
19780709|NCT02996097|42236340|FG001|Overall Study|Lost to Follow-up|11|||
19780710|NCT02992899|42236347|FG000|Overall Study|Withdrawal by Subject|1|||
19780711|NCT02992899|42236348|FG001|Overall Study|Withdrawal by Subject|0|||
19780712|NCT02992899|42236347|FG000|Overall Study|Lost to Follow-up|1|||
19694903|NCT00347360|42140272|FG012|Overall Study|Per sponsors instruction|0|||
19694904|NCT00347360|42140273|FG013|Overall Study|Per sponsors instruction|0|||
19694905|NCT00347360|42140274|FG014|Overall Study|Per sponsors instruction|0|||
19780713|NCT02992899|42236348|FG001|Overall Study|Lost to Follow-up|3|||
19780714|NCT01602484|42236356|FG000|Overall Study|Airway issues unrelated to study|0|||
19780715|NCT01602484|42236357|FG001|Overall Study|Airway issues unrelated to study|1|||
19780716|NCT02989389|42236373|FG000|Period 1|Lost to Follow-up|0|||
19780717|NCT02989389|42236374|FG001|Period 1|Lost to Follow-up|1|||
19780718|NCT02989389|42236375|FG002|Period 1|Lost to Follow-up|0|||
19780719|NCT02989389|42236376|FG003|Period 1|Lost to Follow-up|0|||
19780720|NCT02989389|42236377|FG004|Period 1|Lost to Follow-up|0|||
19780721|NCT02989389|42236378|FG005|Period 1|Lost to Follow-up|0|||
19780722|NCT02989389|42236379|FG006|Period 1|Lost to Follow-up|0|||
19780723|NCT02989389|42236380|FG007|Period 1|Lost to Follow-up|0|||
19780724|NCT02989389|42236381|FG008|Period 1|Lost to Follow-up|0|||
19780725|NCT02989389|42236382|FG009|Period 1|Lost to Follow-up|0|||
19780726|NCT02989389|42236373|FG000|Period 1|Physician Decision|0|||
19780727|NCT02989389|42236374|FG001|Period 1|Physician Decision|0|||
19780728|NCT02989389|42236375|FG002|Period 1|Physician Decision|0|||
19780729|NCT02989389|42236376|FG003|Period 1|Physician Decision|0|||
19780730|NCT02989389|42236377|FG004|Period 1|Physician Decision|0|||
19780731|NCT02989389|42236378|FG005|Period 1|Physician Decision|0|||
19780732|NCT02989389|42236379|FG006|Period 1|Physician Decision|0|||
19780733|NCT02989389|42236380|FG007|Period 1|Physician Decision|0|||
19780734|NCT02989389|42236381|FG008|Period 1|Physician Decision|1|||
19780735|NCT02989389|42236382|FG009|Period 1|Physician Decision|0|||
19780736|NCT02653300|42236422|FG000|Overall Study|Withdrawal by Subject|2|||
19780737|NCT01757665|42236428|FG000|Overall Study|Still on Study - Visit Completed|240|||
19780738|NCT01757665|42236429|FG001|Overall Study|Still on Study - Visit Completed|30|||
19780739|NCT01757665|42236428|FG000|Overall Study|Still on Study - Visit Pending|398|||
19780740|NCT01757665|42236429|FG001|Overall Study|Still on Study - Visit Pending|40|||
19780741|NCT01757665|42236428|FG000|Overall Study|Still on Study - Missed Visit|14|||
19780742|NCT01757665|42236429|FG001|Overall Study|Still on Study - Missed Visit|1|||
19780743|NCT01757665|42236428|FG000|Overall Study|Death|25|||
19780744|NCT01757665|42236429|FG001|Overall Study|Death|8|||
19780745|NCT01757665|42236428|FG000|Overall Study|Explant|1|||
19780746|NCT01757665|42236429|FG001|Overall Study|Explant|2|||
19780747|NCT01757665|42236428|FG000|Overall Study|Withdrawal by Subject|10|||
19780748|NCT01757665|42236429|FG001|Overall Study|Withdrawal by Subject|0|||
19780749|NCT01757665|42236428|FG000|Overall Study|Lost to Follow-up|1|||
19780750|NCT01757665|42236429|FG001|Overall Study|Lost to Follow-up|1|||
19780751|NCT01757665|42236428|FG000|Overall Study|Not Implanted with Device|5|||
19780752|NCT01757665|42236429|FG001|Overall Study|Not Implanted with Device|1|||
19780753|NCT00430508|42236454|FG000|Overall Study|Adverse Event|2|||
19780754|NCT00430508|42236455|FG001|Overall Study|Adverse Event|3|||
19780755|NCT00430508|42236456|FG002|Overall Study|Adverse Event|5|||
19780756|NCT00430508|42236457|FG003|Overall Study|Adverse Event|3|||
19780757|NCT00430508|42236454|FG000|Overall Study|Withdrawal by Subject|0|||
19780758|NCT00430508|42236455|FG001|Overall Study|Withdrawal by Subject|1|||
19780759|NCT00430508|42236456|FG002|Overall Study|Withdrawal by Subject|1|||
19780760|NCT00430508|42236457|FG003|Overall Study|Withdrawal by Subject|1|||
19780761|NCT00430508|42236454|FG000|Overall Study|responder at visit 4|0|||
19780762|NCT00430508|42236455|FG001|Overall Study|responder at visit 4|0|||
19780763|NCT00430508|42236456|FG002|Overall Study|responder at visit 4|2|||
19780764|NCT00430508|42236457|FG003|Overall Study|responder at visit 4|0|||
19780765|NCT00430508|42236454|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
19780766|NCT00430508|42236455|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
19780767|NCT00430508|42236456|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
19780768|NCT00430508|42236457|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
19780769|NCT00430508|42236454|FG000|Overall Study|Other|1|||
19780770|NCT00430508|42236455|FG001|Overall Study|Other|1|||
19780771|NCT00430508|42236456|FG002|Overall Study|Other|3|||
19780772|NCT00430508|42236457|FG003|Overall Study|Other|0|||
19780773|NCT02988219|42236465|FG000|Overall Study|Lack of Efficacy|1|||
19780774|NCT02988219|42236466|FG001|Overall Study|Lack of Efficacy|1|||
19780775|NCT02988219|42236465|FG000|Overall Study|Withdrawal by Subject|0|||
19780776|NCT02988219|42236466|FG001|Overall Study|Withdrawal by Subject|2|||
19780777|NCT01346059|42236474|FG000|Overall Study|Withdrawal by Subject|1|||
19780778|NCT01346059|42236475|FG001|Overall Study|Withdrawal by Subject|0|||
19780779|NCT01318915|42236481|FG000|Overall Study|Lost to Follow-up|1|||
19780780|NCT02987205|42236487|FG000|Overall Study|Adverse Event|1|||
19780781|NCT02987205|42236487|FG000|Overall Study|Withdrawal by Subject|3|||
19780782|NCT02926937|42236509|FG000|Overall Study|Adverse Event|0|||
19780783|NCT02926937|42236510|FG001|Overall Study|Adverse Event|1|||
19780784|NCT02926937|42236511|FG002|Overall Study|Adverse Event|1|||
19780785|NCT02926937|42236509|FG000|Overall Study|Poor Compliance to Protocol|1|||
19780786|NCT02926937|42236510|FG001|Overall Study|Poor Compliance to Protocol|0|||
19780787|NCT02926937|42236511|FG002|Overall Study|Poor Compliance to Protocol|0|||
19780788|NCT02926937|42236509|FG000|Overall Study|Lost to Follow-up|4|||
19780789|NCT02926937|42236510|FG001|Overall Study|Lost to Follow-up|5|||
19780790|NCT02926937|42236511|FG002|Overall Study|Lost to Follow-up|0|||
19780791|NCT02926937|42236509|FG000|Overall Study|At the Participant's own Request|11|||
19780792|NCT02926937|42236510|FG001|Overall Study|At the Participant's own Request|5|||
19780793|NCT02926937|42236511|FG002|Overall Study|At the Participant's own Request|8|||
19780794|NCT02926937|42236509|FG000|Overall Study|Reason not Specified|3|||
19780795|NCT02926937|42236510|FG001|Overall Study|Reason not Specified|4|||
19780796|NCT02926937|42236511|FG002|Overall Study|Reason not Specified|2|||
19780797|NCT04189588|42236522|FG000|Overall Study|Death|0|||
19780798|NCT04189588|42236523|FG001|Overall Study|Death|1|||
19780799|NCT04189588|42236522|FG000|Overall Study|Lost to Follow-up|0|||
19780800|NCT04189588|42236523|FG001|Overall Study|Lost to Follow-up|1|||
19780801|NCT00151892|42236531|FG000|Overall Study|Lack of Efficacy|50|||
19780802|NCT00151892|42236532|FG001|Overall Study|Lack of Efficacy|57|||
19780803|NCT00151892|42236531|FG000|Overall Study|Patient request|10|||
19780804|NCT00151892|42236532|FG001|Overall Study|Patient request|7|||
19780805|NCT00151892|42236531|FG000|Overall Study|Lost to Follow-up|5|||
19780806|NCT00151892|42236532|FG001|Overall Study|Lost to Follow-up|10|||
19780807|NCT00151892|42236531|FG000|Overall Study|Adverse Event|6|||
19780808|NCT00151892|42236532|FG001|Overall Study|Adverse Event|3|||
19780809|NCT00151892|42236531|FG000|Overall Study|Protocol Violation|3|||
19780810|NCT00151892|42236532|FG001|Overall Study|Protocol Violation|3|||
19780811|NCT00151892|42236531|FG000|Overall Study|Non-compliance|0|||
19780812|NCT00151892|42236532|FG001|Overall Study|Non-compliance|1|||
19780813|NCT00151892|42236531|FG000|Overall Study|Pregnancy|0|||
19780814|NCT00151892|42236532|FG001|Overall Study|Pregnancy|1|||
19780815|NCT00151892|42236531|FG000|Overall Study|Did not return for a visit|1|||
19780816|NCT00151892|42236532|FG001|Overall Study|Did not return for a visit|0|||
19780817|NCT00151892|42236531|FG000|Overall Study|Used prohibited corticosteroids|1|||
19780818|NCT00151892|42236532|FG001|Overall Study|Used prohibited corticosteroids|0|||
19780819|NCT00151892|42236531|FG000|Overall Study|Lack of study medication at center|0|||
19780820|NCT00151892|42236532|FG001|Overall Study|Lack of study medication at center|1|||
19780821|NCT03055195|42236556|FG000|Overall Study|Lack of Efficacy|1|||
19780822|NCT03055195|42236557|FG001|Overall Study|Lack of Efficacy|0|||
19780823|NCT03055195|42236556|FG000|Overall Study|Withdrawal by Subject|6|||
19780824|NCT03055195|42236557|FG001|Overall Study|Withdrawal by Subject|7|||
19780825|NCT03055195|42236556|FG000|Overall Study|Study Terminated by Sponsor|2|||
19780826|NCT03055195|42236557|FG001|Overall Study|Study Terminated by Sponsor|6|||
19780827|NCT03055195|42236556|FG000|Overall Study|Protocol Violation|2|||
19780828|NCT03055195|42236557|FG001|Overall Study|Protocol Violation|1|||
19780829|NCT03055195|42236556|FG000|Overall Study|Physician Decision|1|||
19780830|NCT03055195|42236557|FG001|Overall Study|Physician Decision|0|||
19780831|NCT02921919|42236565|FG000|Overall Study|Other|5|||
19780832|NCT02921919|42236566|FG001|Overall Study|Other|6|||
19780833|NCT02921919|42236565|FG000|Overall Study|Lost to Follow-up|0|||
19780834|NCT02921919|42236566|FG001|Overall Study|Lost to Follow-up|1|||
19780835|NCT02921919|42236565|FG000|Overall Study|Withdrawal by Subject|5|||
19780836|NCT02921919|42236566|FG001|Overall Study|Withdrawal by Subject|1|||
19780837|NCT02921919|42236565|FG000|Overall Study|Disease Progression|47|||
19780838|NCT02921919|42236566|FG001|Overall Study|Disease Progression|38|||
19780839|NCT02921919|42236565|FG000|Overall Study|Physician Decision|3|||
19780840|NCT02921919|42236566|FG001|Overall Study|Physician Decision|2|||
19780841|NCT02921919|42236565|FG000|Overall Study|Adverse Event|6|||
19780842|NCT02921919|42236566|FG001|Overall Study|Adverse Event|4|||
19780843|NCT01586910|42236588|FG000|Overall Study|Death|4|||
19780844|NCT01586910|42236589|FG001|Overall Study|Death|4|||
19780845|NCT01586910|42236588|FG000|Overall Study|Withdrawal by Subject|6|||
19780846|NCT01586910|42236589|FG001|Overall Study|Withdrawal by Subject|43|||
19780847|NCT01586910|42236588|FG000|Overall Study|Physician withdrew Subject|5|||
19780848|NCT01586910|42236589|FG001|Overall Study|Physician withdrew Subject|24|||
19780849|NCT02910219|42236599|FG000|Overall Study|Withdrawal by Subject|1|||
19780850|NCT02910219|42236600|FG001|Overall Study|Withdrawal by Subject|1|||
19780851|NCT01068717|42236606|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
19780852|NCT01068717|42236607|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
19780853|NCT01068717|42236608|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
19780854|NCT01068717|42236609|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
19780855|NCT02921763|42236623|FG000|Overall Study|Adverse Event|4|||
19780856|NCT02921763|42236623|FG000|Overall Study|Lost to Follow-up|4|||
19780857|NCT02921763|42236623|FG000|Overall Study|Lack of Efficacy|3|||
19780858|NCT02921763|42236623|FG000|Overall Study|Protocol Violation|2|||
19607168|NCT00672841|42055924|FG001|Overall Study|Pregnancy|1|||
19780859|NCT02921763|42236623|FG000|Overall Study|Withdrawal by Subject|2|||
19780860|NCT02921763|42236623|FG000|Overall Study|Physician Decision|1|||
19780861|NCT02921763|42236623|FG000|Overall Study|No data obtained|2|||
19780862|NCT01318135|42236645|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
19780863|NCT01318135|42236646|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780864|NCT01318135|42236647|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780865|NCT01318135|42236648|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780866|NCT01318135|42236649|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780867|NCT01318135|42236650|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780868|NCT01318135|42236651|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780869|NCT01318135|42236652|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19780870|NCT01318135|42236645|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
19780871|NCT01318135|42236646|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780872|NCT01318135|42236647|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780873|NCT01318135|42236648|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780874|NCT01318135|42236649|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780875|NCT01318135|42236650|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780876|NCT01318135|42236651|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780877|NCT01318135|42236652|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
19780878|NCT01318135|42236645|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
19780879|NCT01318135|42236646|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
19780880|NCT01318135|42236647|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
19780881|NCT01318135|42236648|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
19780882|NCT01318135|42236649|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
19780883|NCT01318135|42236650|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
19780884|NCT01318135|42236651|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
19780885|NCT01318135|42236652|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
19780886|NCT01318135|42236645|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
19780887|NCT01318135|42236646|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
19780888|NCT01318135|42236647|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
19780889|NCT01318135|42236648|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
19780890|NCT01318135|42236649|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
19780891|NCT01318135|42236650|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
19780892|NCT01318135|42236651|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
19780893|NCT01318135|42236652|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
19780894|NCT01318135|42236645|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19780895|NCT01318135|42236646|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19780896|NCT01318135|42236647|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19780897|NCT01318135|42236648|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19780898|NCT01318135|42236649|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19780899|NCT01318135|42236650|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19780900|NCT01318135|42236651|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19780901|NCT01318135|42236652|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19780902|NCT01318135|42236645|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
19780903|NCT01318135|42236646|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
19780904|NCT01318135|42236647|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
19780905|NCT01318135|42236648|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
19780906|NCT01318135|42236649|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
19780907|NCT01318135|42236650|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
19780908|NCT01318135|42236651|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19780909|NCT01318135|42236652|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19780910|NCT01318135|42236645|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780911|NCT01318135|42236646|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780912|NCT01318135|42236647|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780913|NCT01318135|42236648|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780914|NCT01318135|42236649|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780915|NCT01318135|42236650|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19780916|NCT01318135|42236651|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
19607169|NCT00673465|42055933|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607170|NCT00673465|42055934|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607171|NCT00673465|42055935|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607172|NCT00673465|42055936|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607173|NCT00673465|42055937|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
19607174|NCT00673465|42055938|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
19607175|NCT00673465|42055939|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
19780917|NCT01318135|42236652|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
19780918|NCT02922153|42236664|FG000|Overall Study|Death|8|||
19780919|NCT02922153|42236665|FG001|Overall Study|Death|1|||
19780920|NCT02922153|42236664|FG000|Overall Study|Lost to Follow-up|1|||
19780921|NCT02922153|42236665|FG001|Overall Study|Lost to Follow-up|0|||
19780922|NCT02922153|42236664|FG000|Overall Study|Physician Decision|1|||
19780923|NCT02922153|42236665|FG001|Overall Study|Physician Decision|1|||
19780924|NCT02920983|42236671|FG000|Dispense 1|Unacceptable Lens Fit|0|||
19780925|NCT02920983|42236672|FG001|Dispense 1|Unacceptable Lens Fit|0|||
19780926|NCT02920983|42236673|FG002|Dispense 1|Unacceptable Lens Fit|0|||
19780927|NCT02920983|42236674|FG003|Dispense 1|Unacceptable Lens Fit|0|||
19780928|NCT02920983|42236675|FG004|Dispense 1|Unacceptable Lens Fit|1|||
19780929|NCT02920983|42236676|FG005|Dispense 1|Unacceptable Lens Fit|0|||
19780930|NCT02920983|42236671|FG000|Dispense 2|Unscceptable lens fit|1|||
19780931|NCT02920983|42236672|FG001|Dispense 2|Unscceptable lens fit|0|||
19780932|NCT02920983|42236673|FG002|Dispense 2|Unscceptable lens fit|0|||
19780933|NCT02920983|42236674|FG003|Dispense 2|Unscceptable lens fit|0|||
19780934|NCT02920983|42236675|FG004|Dispense 2|Unscceptable lens fit|1|||
19780935|NCT02920983|42236676|FG005|Dispense 2|Unscceptable lens fit|0|||
19780936|NCT02920983|42236671|FG000|Dispense 3|Unacceptable Lens Fit|1|||
19780937|NCT02920983|42236672|FG001|Dispense 3|Unacceptable Lens Fit|1|||
19780938|NCT02920983|42236673|FG002|Dispense 3|Unacceptable Lens Fit|0|||
19780939|NCT02920983|42236674|FG003|Dispense 3|Unacceptable Lens Fit|0|||
19780940|NCT02920983|42236675|FG004|Dispense 3|Unacceptable Lens Fit|1|||
19780941|NCT02920983|42236676|FG005|Dispense 3|Unacceptable Lens Fit|0|||
19780942|NCT02654002|42236693|FG000|Overall Study|Adverse Event|0|||
19780943|NCT02654002|42236694|FG001|Overall Study|Adverse Event|0|||
19780944|NCT02654002|42236695|FG002|Overall Study|Adverse Event|0|||
19780945|NCT02654002|42236696|FG003|Overall Study|Adverse Event|0|||
19780946|NCT02654002|42236697|FG004|Overall Study|Adverse Event|0|||
19780947|NCT02654002|42236698|FG005|Overall Study|Adverse Event|0|||
19780948|NCT02654002|42236699|FG006|Overall Study|Adverse Event|1|||
19780949|NCT02654002|42236700|FG007|Overall Study|Adverse Event|0|||
19780950|NCT02654002|42236701|FG008|Overall Study|Adverse Event|0|||
19780951|NCT02654002|42236693|FG000|Overall Study|Withdrew Consent|0|||
19780952|NCT02654002|42236694|FG001|Overall Study|Withdrew Consent|0|||
19780953|NCT02654002|42236695|FG002|Overall Study|Withdrew Consent|0|||
19780954|NCT02654002|42236696|FG003|Overall Study|Withdrew Consent|0|||
19780955|NCT02654002|42236697|FG004|Overall Study|Withdrew Consent|0|||
19780956|NCT02654002|42236698|FG005|Overall Study|Withdrew Consent|1|||
19780957|NCT02654002|42236699|FG006|Overall Study|Withdrew Consent|0|||
19780958|NCT02654002|42236700|FG007|Overall Study|Withdrew Consent|1|||
19780959|NCT02654002|42236701|FG008|Overall Study|Withdrew Consent|0|||
19780960|NCT01675492|42236736|FG000|Overall Study|study completed early - product approval|42|||
19780961|NCT03924622|42236747|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
19780962|NCT03924622|42236748|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
19780963|NCT03924622|42236749|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
19780964|NCT03924622|42236750|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
19780965|NCT03924622|42236751|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
19780966|NCT03924622|42236752|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
19780967|NCT04044664|42236769|FG000|Stage 1|Adverse Event|3|||
19780968|NCT04044664|42236770|FG001|Stage 1|Adverse Event|3|||
19780969|NCT04044664|42236771|FG002|Stage 1|Adverse Event|1|||
19780970|NCT04044664|42236769|FG000|Stage 1|Lost to Follow-up|3|||
19780971|NCT04044664|42236770|FG001|Stage 1|Lost to Follow-up|2|||
19780972|NCT04044664|42236771|FG002|Stage 1|Lost to Follow-up|2|||
19780973|NCT04044664|42236769|FG000|Stage 1|Withdrawal by Subject|9|||
19780974|NCT04044664|42236770|FG001|Stage 1|Withdrawal by Subject|1|||
19780975|NCT04044664|42236771|FG002|Stage 1|Withdrawal by Subject|0|||
19780976|NCT04044664|42236769|FG000|Stage 1|noncompliance, personal reason|2|||
19780977|NCT04044664|42236770|FG001|Stage 1|noncompliance, personal reason|0|||
19780978|NCT04044664|42236771|FG002|Stage 1|noncompliance, personal reason|0|||
19780979|NCT04044664|42236769|FG000|Stage 1|randomization error|0|||
19780980|NCT04044664|42236770|FG001|Stage 1|randomization error|1|||
19780981|NCT04044664|42236771|FG002|Stage 1|randomization error|0|||
19780982|NCT04044664|42236769|FG000|Stage 2|Adverse Event|2|||
19780983|NCT04044664|42236770|FG001|Stage 2|Adverse Event|0|||
19780984|NCT04044664|42236771|FG002|Stage 2|Adverse Event|0|||
19780985|NCT04044664|42236769|FG000|Stage 2|Lost to Follow-up|3|||
19780986|NCT04044664|42236770|FG001|Stage 2|Lost to Follow-up|2|||
19780987|NCT04044664|42236771|FG002|Stage 2|Lost to Follow-up|1|||
19780988|NCT04044664|42236769|FG000|Stage 2|Withdrawal by Subject|3|||
19780989|NCT04044664|42236770|FG001|Stage 2|Withdrawal by Subject|0|||
19780990|NCT04044664|42236771|FG002|Stage 2|Withdrawal by Subject|0|||
19780991|NCT04044664|42236769|FG000|Stage 2|protocol deviation|1|||
19780992|NCT04044664|42236770|FG001|Stage 2|protocol deviation|0|||
19780993|NCT04044664|42236771|FG002|Stage 2|protocol deviation|0|||
19780994|NCT00150176|42236781|FG000|Overall Study|Adverse Event|16|||
19780995|NCT00150176|42236782|FG001|Overall Study|Adverse Event|53|||
19780996|NCT00150176|42236781|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
19780997|NCT00150176|42236782|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
19780998|NCT00150176|42236781|FG000|Overall Study|Withdrawal by Subject|19|||
19780999|NCT00150176|42236782|FG001|Overall Study|Withdrawal by Subject|12|||
19781000|NCT00150176|42236781|FG000|Overall Study|Lost to Follow-up|3|||
19781001|NCT00150176|42236782|FG001|Overall Study|Lost to Follow-up|3|||
19781002|NCT00150176|42236781|FG000|Overall Study|OTHER|11|||
19781003|NCT00150176|42236782|FG001|Overall Study|OTHER|13|||
19781004|NCT02985879|42236792|FG000|Overall Study|Adverse Event|7|||
19781005|NCT02985879|42236793|FG001|Overall Study|Adverse Event|9|||
19781006|NCT02985879|42236794|FG002|Overall Study|Adverse Event|7|||
19781007|NCT02985879|42236792|FG000|Overall Study|Withdrew consent|6|||
19781008|NCT02985879|42236793|FG001|Overall Study|Withdrew consent|8|||
19781009|NCT02985879|42236794|FG002|Overall Study|Withdrew consent|10|||
19781010|NCT02985879|42236792|FG000|Overall Study|Lost to Follow-up|1|||
19781011|NCT02985879|42236793|FG001|Overall Study|Lost to Follow-up|0|||
19781012|NCT02985879|42236794|FG002|Overall Study|Lost to Follow-up|2|||
19781013|NCT02985879|42236792|FG000|Overall Study|Other, not specified|62|||
19781014|NCT02985879|42236793|FG001|Overall Study|Other, not specified|58|||
19781015|NCT02985879|42236794|FG002|Overall Study|Other, not specified|58|||
19781016|NCT01067469|42236810|FG000|Overall Study|Withdrawal by Subject|0|||
19781017|NCT01067469|42236811|FG001|Overall Study|Withdrawal by Subject|1|||
19781018|NCT01067469|42236810|FG000|Overall Study|Disease Progression|0|||
19781019|NCT01067469|42236811|FG001|Overall Study|Disease Progression|1|||
19781020|NCT02985021|42236817|FG000|Overall Study|Inability to comply with study procedures|1|||
19781021|NCT01066923|42236825|FG000|Overall Study|Withdrawal by Subject|3|||
19781022|NCT01066923|42236826|FG001|Overall Study|Withdrawal by Subject|3|||
19781023|NCT01066923|42236827|FG002|Overall Study|Withdrawal by Subject|8|||
19781024|NCT01066923|42236828|FG003|Overall Study|Withdrawal by Subject|8|||
19781025|NCT02919267|42236853|FG000|Overall Study|Protocol Violation|0|||
19781026|NCT02919267|42236854|FG001|Overall Study|Protocol Violation|3|||
19781027|NCT02919267|42236855|FG002|Overall Study|Protocol Violation|3|||
19781028|NCT02919267|42236856|FG003|Overall Study|Protocol Violation|4|||
19781029|NCT01368900|42236866|FG000|Overall Study|Lost to Follow-up|7|||
19781030|NCT02910063|42236872|FG000|Phase 2|Withdrawal by Subject|3|||
19781031|NCT02910063|42236873|FG001|Phase 2|Withdrawal by Subject|0|||
19781032|NCT02910063|42236874|FG002|Phase 2|Withdrawal by Subject|0|||
19781033|NCT02910063|42236872|FG000|Phase 2|Lost to Follow-up|1|||
19781034|NCT02910063|42236873|FG001|Phase 2|Lost to Follow-up|0|||
19781035|NCT02910063|42236874|FG002|Phase 2|Lost to Follow-up|0|||
19781036|NCT02910063|42236872|FG000|Phase 2|Death|24|||
19781037|NCT02910063|42236873|FG001|Phase 2|Death|0|||
19781038|NCT02910063|42236874|FG002|Phase 2|Death|0|||
19781039|NCT02909907|42236885|FG000|Overall Study|Withdrawal by Subject|0|||
19781040|NCT02909907|42236886|FG001|Overall Study|Withdrawal by Subject|1|||
19781041|NCT02651194|42236892|FG000|Overall Study|Lost to Follow-up|3|||
19781042|NCT02651194|42236892|FG000|Overall Study|Other|2|||
19781043|NCT02907177|42236898|FG000|Overall Study|Death|0|||
19781044|NCT02907177|42236899|FG001|Overall Study|Death|1|||
19781045|NCT02907177|42236898|FG000|Overall Study|Physician Decision|3|||
19781046|NCT02907177|42236899|FG001|Overall Study|Physician Decision|3|||
19781047|NCT02907177|42236898|FG000|Overall Study|Withdrawal by Subject|15|||
19781048|NCT02907177|42236899|FG001|Overall Study|Withdrawal by Subject|7|||
19781049|NCT02907177|42236898|FG000|Overall Study|Sponsor's Decision|50|||
19781050|NCT02907177|42236899|FG001|Overall Study|Sponsor's Decision|57|||
19781051|NCT02652442|42236905|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
19781052|NCT02906709|42236919|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
19781053|NCT02906709|42236920|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
19781054|NCT02906709|42236919|FG000|Phase A (Week 0 to Week 16)|Death|0|||
19781055|NCT02906709|42236920|FG001|Phase A (Week 0 to Week 16)|Death|1|||
19781056|NCT02906709|42236919|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
19781057|NCT02906709|42236920|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
19781058|NCT02906709|42236919|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
19781059|NCT02906709|42236920|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
19781060|NCT00318656|42236934|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
19781061|NCT00318656|42236935|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
19781062|NCT00318656|42236934|FG000|Overall Study|Did not receive any treatment|0|||
19781063|NCT00318656|42236935|FG001|Overall Study|Did not receive any treatment|1|||
19781064|NCT02908347|42236941|FG000|Overall Study|Adverse Event|0|||
19781065|NCT02908347|42236942|FG001|Overall Study|Adverse Event|1|||
19694906|NCT00347360|42140260|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
19694907|NCT00347360|42140261|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
19781066|NCT02908347|42236941|FG000|Overall Study|Lost to Follow-up|1|||
19367320|NCT02435836|41607487|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
19367321|NCT02788201|41607497|FG000|Overall Study|Death|1|||
19367322|NCT02788201|41607498|FG001|Overall Study|Death|1|||
19367323|NCT02788201|41607499|FG002|Overall Study|Death|1|||
19367324|NCT02788201|41607500|FG003|Overall Study|Death|1|||
19367325|NCT02788201|41607501|FG004|Overall Study|Death|0|||
19367326|NCT02788201|41607502|FG005|Overall Study|Death|1|||
19367327|NCT02788201|41607497|FG000|Overall Study|Ineligible|0|||
19607176|NCT00673465|42055940|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607177|NCT00673465|42055941|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607178|NCT00673465|42055942|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607179|NCT00673465|42055943|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
19607180|NCT00673465|42055944|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
19694908|NCT00347360|42140262|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
19694909|NCT00347360|42140263|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
19694910|NCT00347360|42140264|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
19694911|NCT00347360|42140265|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
19694912|NCT00347360|42140266|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
19781067|NCT02908347|42236942|FG001|Overall Study|Lost to Follow-up|0|||
19607181|NCT00673465|42055933|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607182|NCT00673465|42055934|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607183|NCT00673465|42055935|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607184|NCT00673465|42055936|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607185|NCT00673465|42055937|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
19607186|NCT00673465|42055938|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607187|NCT00673465|42055939|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
19694913|NCT00347360|42140267|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
19694914|NCT00347360|42140268|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
19781068|NCT02983305|42236964|FG000|Overall Study|incomplete data|2|||
19781069|NCT02983305|42236965|FG001|Overall Study|incomplete data|0|||
19781070|NCT03663166|42236971|FG000|Overall Study|Withdrawal by Subject|1|||
19781071|NCT02983227|42236978|FG000|Overall Study|Adverse Event|21|||
19781072|NCT02983227|42236979|FG001|Overall Study|Adverse Event|3|||
19781073|NCT02983227|42236978|FG000|Overall Study|Death|3|||
19781074|NCT02983227|42236979|FG001|Overall Study|Death|0|||
19781075|NCT02983227|42236978|FG000|Overall Study|Lack of Efficacy|8|||
19781076|NCT02983227|42236979|FG001|Overall Study|Lack of Efficacy|1|||
19781077|NCT02983227|42236978|FG000|Overall Study|Lost to Follow-up|3|||
19781078|NCT02983227|42236979|FG001|Overall Study|Lost to Follow-up|0|||
19781079|NCT02983227|42236978|FG000|Overall Study|Multiple Reasons|2|||
19781080|NCT02983227|42236979|FG001|Overall Study|Multiple Reasons|1|||
19781081|NCT02983227|42236978|FG000|Overall Study|Physician Decision|3|||
19781082|NCT02983227|42236979|FG001|Overall Study|Physician Decision|1|||
19781083|NCT02983227|42236978|FG000|Overall Study|Withdrawal by Subject|19|||
19781084|NCT02983227|42236979|FG001|Overall Study|Withdrawal by Subject|8|||
19781085|NCT00301262|42236987|FG000|Double Blind Phase (DB)|Adverse Event|1|||
19781086|NCT00301262|42236988|FG001|Double Blind Phase (DB)|Adverse Event|0|||
19781087|NCT00301262|42236987|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
19781088|NCT00301262|42236988|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
19781089|NCT00301262|42236987|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
19781090|NCT00301262|42236988|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
19781091|NCT00301262|42236987|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
19781092|NCT00301262|42236988|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
19781093|NCT00301262|42236987|FG000|Double Blind Phase (DB)|Other|1|||
19781094|NCT00301262|42236988|FG001|Double Blind Phase (DB)|Other|4|||
19781095|NCT00301262|42236987|FG000|Open Label Phase (OL)|Adverse Event|1|||
19781096|NCT00301262|42236988|FG001|Open Label Phase (OL)|Adverse Event|0|||
19781097|NCT00301262|42236987|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
19781098|NCT00301262|42236988|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
19781099|NCT00301262|42236987|FG000|Open Label Phase (OL)|Other|2|||
19781100|NCT00301262|42236988|FG001|Open Label Phase (OL)|Other|0|||
19781101|NCT02905149|42237015|FG000|Overall Study|Lost to Follow-up|2|||
19781102|NCT02905149|42237016|FG001|Overall Study|Lost to Follow-up|0|||
19781103|NCT02790606|42237022|FG000|Overall Study|Death|27|||
19781104|NCT02790606|42237022|FG000|Overall Study|Lost to Follow-up|4|||
19781105|NCT02790606|42237022|FG000|Overall Study|Physician Decision|3|||
19781106|NCT02790606|42237022|FG000|Overall Study|Withdrawal by Subject|1|||
19781107|NCT03077620|42237030|FG000|Overall Study|Unable to place lumbar catheter|1|||
19781108|NCT03077620|42237031|FG001|Overall Study|Unable to place lumbar catheter|0|||
19781109|NCT03077620|42237032|FG002|Overall Study|Unable to place lumbar catheter|1|||
19781110|NCT03077620|42237033|FG003|Overall Study|Unable to place lumbar catheter|0|||
19781111|NCT03077620|42237030|FG000|Overall Study|Withdrawal by Subject|0|||
19781112|NCT03077620|42237031|FG001|Overall Study|Withdrawal by Subject|1|||
19781113|NCT03077620|42237032|FG002|Overall Study|Withdrawal by Subject|0|||
19781114|NCT03077620|42237033|FG003|Overall Study|Withdrawal by Subject|0|||
19781115|NCT03077620|42237030|FG000|Overall Study|Physician Decision|0|||
19781116|NCT03077620|42237031|FG001|Overall Study|Physician Decision|0|||
19781117|NCT03077620|42237032|FG002|Overall Study|Physician Decision|1|||
19781118|NCT03077620|42237033|FG003|Overall Study|Physician Decision|0|||
19781119|NCT02982213|42237054|FG000|Overall Study|Did not complete follow up questionnaire|5|||
19781120|NCT02982213|42237055|FG001|Overall Study|Did not complete follow up questionnaire|1|||
19694915|NCT00347360|42140269|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
19694916|NCT00347360|42140270|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
19694917|NCT00347360|42140271|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
19694918|NCT00347360|42140272|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
19694919|NCT00347360|42140273|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
19694920|NCT00347360|42140274|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
19694921|NCT00347360|42140260|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
19694922|NCT00347360|42140261|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
19694923|NCT00347360|42140262|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
19781121|NCT02649634|42237063|FG000|Overall Study|Withdrawal by Subject|3|||
19781122|NCT02649634|42237064|FG001|Overall Study|Withdrawal by Subject|5|||
19781123|NCT02649634|42237063|FG000|Overall Study|Lost to Follow-up|0|||
19781124|NCT02649634|42237064|FG001|Overall Study|Lost to Follow-up|1|||
19781125|NCT01066143|42237070|FG000|Overall Study|ineligible for the study|8|||
19781126|NCT02980107|42237076|FG000|Overall Study|Withdrawal by Subject|51|||
19781127|NCT02980107|42237077|FG001|Overall Study|Withdrawal by Subject|62|||
19781128|NCT02652130|42237083|FG000|Overall Study|Death|1|||
19781129|NCT02979639|42237087|FG000|Overall Study|Withdrawal based on medical judgement|1|||
19781130|NCT02979639|42237087|FG000|Overall Study|Lost to Follow-up|8|||
19781131|NCT02979639|42237087|FG000|Overall Study|Withdrawal by Subject|3|||
19781132|NCT02979639|42237087|FG000|Overall Study|Adverse Event|2|||
19781133|NCT01674634|42237091|FG000|Overall Study|Withdrawal by Subject|3|||
19781134|NCT01674634|42237091|FG000|Overall Study|Lost to Follow-up|3|||
19781135|NCT02979249|42237099|FG000|Overall Study|Lost to Follow-up|2|||
19781136|NCT02979249|42237099|FG000|Overall Study|Withdrawal by Subject|4|||
19781137|NCT02976519|42237110|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781138|NCT02976519|42237111|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
19781139|NCT02976519|42237112|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781140|NCT02976519|42237113|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781141|NCT02976519|42237114|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781142|NCT02976519|42237115|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781143|NCT02976519|42237116|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
19781144|NCT02976519|42237110|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781145|NCT02976519|42237111|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781146|NCT02976519|42237112|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781147|NCT02976519|42237113|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
19781148|NCT02976519|42237114|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781149|NCT02976519|42237115|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781150|NCT02976519|42237116|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
19781151|NCT02976519|42237110|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781152|NCT02976519|42237111|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781153|NCT02976519|42237112|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781154|NCT02976519|42237113|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781155|NCT02976519|42237114|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781156|NCT02976519|42237115|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
19781157|NCT02976519|42237116|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
19781158|NCT02976519|42237110|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781159|NCT02976519|42237111|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781160|NCT02976519|42237112|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781161|NCT02976519|42237113|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781162|NCT02976519|42237114|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781163|NCT02976519|42237115|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
19781164|NCT02976519|42237116|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
19781165|NCT02976519|42237110|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781166|NCT02976519|42237111|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781167|NCT02976519|42237112|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781168|NCT02976519|42237113|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781169|NCT02976519|42237114|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781170|NCT02976519|42237115|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
19781171|NCT02976519|42237116|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
19781172|NCT02975973|42237221|FG000|Overall Study|Adverse Event|1|||
19781173|NCT02975973|42237222|FG001|Overall Study|Adverse Event|1|||
19781174|NCT02975973|42237223|FG002|Overall Study|Adverse Event|1|||
19781175|NCT02975973|42237224|FG003|Overall Study|Adverse Event|0|||
19781176|NCT01362322|42237236|FG000|Overall Study|Withdrawal by Subject|3|||
19781177|NCT01362322|42237237|FG001|Overall Study|Withdrawal by Subject|1|||
19781178|NCT01362322|42237236|FG000|Overall Study|Lost to Follow-up|2|||
19781179|NCT01362322|42237237|FG001|Overall Study|Lost to Follow-up|6|||
19781180|NCT02975349|42237248|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19781181|NCT02975349|42237249|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19781182|NCT02975349|42237250|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
19781183|NCT02975349|42237251|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
19781184|NCT02975349|42237252|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19781185|NCT02975349|42237253|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19781186|NCT02975349|42237248|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
19781187|NCT02975349|42237249|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19781188|NCT02975349|42237250|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19781189|NCT02975349|42237251|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19781190|NCT02975349|42237252|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19781191|NCT02975349|42237253|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19781192|NCT02975349|42237248|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
19781193|NCT02975349|42237249|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
19781194|NCT02975349|42237250|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
19781195|NCT02975349|42237251|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
19781196|NCT02975349|42237252|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
19781197|NCT02975349|42237253|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
19781198|NCT02975349|42237248|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
19781199|NCT02975349|42237249|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
19781200|NCT02975349|42237250|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
19781201|NCT02975349|42237251|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
19781202|NCT02975349|42237252|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
19781203|NCT02975349|42237253|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
19781204|NCT02975349|42237248|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
19781205|NCT02975349|42237249|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
19781206|NCT02975349|42237250|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
19781207|NCT02975349|42237251|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
19781208|NCT02975349|42237252|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
19781209|NCT02975349|42237253|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
19781210|NCT02975349|42237248|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
19781211|NCT02975349|42237249|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
19781212|NCT02975349|42237250|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
19781213|NCT02975349|42237251|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
19781214|NCT02975349|42237252|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
19781215|NCT02975349|42237253|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
19781216|NCT02975349|42237248|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
19781217|NCT02975349|42237249|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
19781218|NCT02975349|42237250|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
19781219|NCT02975349|42237251|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
19781220|NCT02975349|42237252|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
19781221|NCT02975349|42237253|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
19781222|NCT02975349|42237248|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
19781223|NCT02975349|42237249|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
19781224|NCT02975349|42237250|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
19781225|NCT02975349|42237251|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
19781226|NCT02975349|42237252|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
19781227|NCT02975349|42237253|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
19781228|NCT02975349|42237248|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
19781229|NCT02975349|42237249|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
19781230|NCT02975349|42237250|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
19781231|NCT02975349|42237251|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
19781232|NCT02975349|42237252|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
19781233|NCT02975349|42237253|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
19781234|NCT02918877|42237274|FG000|Overall Study|Withdrawal by Subject|2|||
19781235|NCT02918877|42237275|FG001|Overall Study|Withdrawal by Subject|2|||
19781236|NCT02918877|42237274|FG000|Overall Study|Surgery cancelled|1|||
19781237|NCT02918877|42237275|FG001|Overall Study|Surgery cancelled|0|||
19781238|NCT02918877|42237274|FG000|Overall Study|Physician Decision|1|||
19781239|NCT02918877|42237275|FG001|Overall Study|Physician Decision|0|||
19781240|NCT02918877|42237274|FG000|Overall Study|Received intraoperative steroids|1|||
19781241|NCT02918877|42237275|FG001|Overall Study|Received intraoperative steroids|0|||
19781242|NCT02918877|42237274|FG000|Overall Study|Unable to obtain lab samples|1|||
19781243|NCT02918877|42237275|FG001|Overall Study|Unable to obtain lab samples|0|||
19781244|NCT02918877|42237274|FG000|Overall Study|Unsafe to perform BAL|0|||
19781245|NCT02918877|42237275|FG001|Overall Study|Unsafe to perform BAL|1|||
19781246|NCT01674712|42237286|FG000|Overall Study|Adverse Event|5|||
19781247|NCT01674712|42237287|FG001|Overall Study|Adverse Event|6|||
19781248|NCT01674712|42237288|FG002|Overall Study|Adverse Event|3|||
19781249|NCT01674712|42237289|FG003|Overall Study|Adverse Event|4|||
19781250|NCT01674712|42237290|FG004|Overall Study|Adverse Event|6|||
19781251|NCT01674712|42237286|FG000|Overall Study|Lost to Follow-up|1|||
19781252|NCT01674712|42237287|FG001|Overall Study|Lost to Follow-up|0|||
19781253|NCT01674712|42237288|FG002|Overall Study|Lost to Follow-up|0|||
19781254|NCT01674712|42237289|FG003|Overall Study|Lost to Follow-up|0|||
19781255|NCT01674712|42237290|FG004|Overall Study|Lost to Follow-up|0|||
19781256|NCT01674712|42237286|FG000|Overall Study|Protocol Violation|2|||
19781257|NCT01674712|42237287|FG001|Overall Study|Protocol Violation|0|||
19781258|NCT01674712|42237288|FG002|Overall Study|Protocol Violation|0|||
19781259|NCT01674712|42237289|FG003|Overall Study|Protocol Violation|0|||
19781260|NCT01674712|42237290|FG004|Overall Study|Protocol Violation|0|||
19781261|NCT01674712|42237286|FG000|Overall Study|Withdrawal by Subject|2|||
19607188|NCT00673465|42055940|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607189|NCT00673465|42055941|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
19367328|NCT02788201|41607498|FG001|Overall Study|Ineligible|0|||
19781262|NCT01674712|42237287|FG001|Overall Study|Withdrawal by Subject|2|||
19781263|NCT01674712|42237288|FG002|Overall Study|Withdrawal by Subject|5|||
19781264|NCT01674712|42237289|FG003|Overall Study|Withdrawal by Subject|4|||
19781265|NCT01674712|42237290|FG004|Overall Study|Withdrawal by Subject|3|||
19781266|NCT01674712|42237286|FG000|Overall Study|Administrative|0|||
19781267|NCT01674712|42237287|FG001|Overall Study|Administrative|1|||
19781268|NCT01674712|42237288|FG002|Overall Study|Administrative|0|||
19781269|NCT01674712|42237289|FG003|Overall Study|Administrative|0|||
19781270|NCT01674712|42237290|FG004|Overall Study|Administrative|1|||
19781271|NCT01674712|42237286|FG000|Overall Study|Lack of Efficacy|0|||
19781272|NCT01674712|42237287|FG001|Overall Study|Lack of Efficacy|0|||
19781273|NCT01674712|42237288|FG002|Overall Study|Lack of Efficacy|1|||
19781274|NCT01674712|42237289|FG003|Overall Study|Lack of Efficacy|0|||
19781275|NCT01674712|42237290|FG004|Overall Study|Lack of Efficacy|1|||
19781276|NCT01368432|42237304|FG000|Overall Study|Lost to Follow-up|0|||
19781277|NCT01368432|42237305|FG001|Overall Study|Lost to Follow-up|1|||
19781278|NCT01063881|42237328|FG000|Overall Study|Adverse Event|12|||
19781279|NCT01063881|42237329|FG001|Overall Study|Adverse Event|2|||
19781280|NCT01063881|42237330|FG002|Overall Study|Adverse Event|0|||
19781281|NCT01063881|42237328|FG000|Overall Study|Lost to Follow-up|13|||
19781282|NCT01063881|42237329|FG001|Overall Study|Lost to Follow-up|7|||
19781283|NCT01063881|42237330|FG002|Overall Study|Lost to Follow-up|1|||
19781284|NCT01063881|42237328|FG000|Overall Study|Withdrawal by Subject|25|||
19781285|NCT01063881|42237329|FG001|Overall Study|Withdrawal by Subject|1|||
19781286|NCT01063881|42237330|FG002|Overall Study|Withdrawal by Subject|0|||
19781287|NCT01063881|42237328|FG000|Overall Study|Reason for not completed not specified|5|||
19781288|NCT01063881|42237329|FG001|Overall Study|Reason for not completed not specified|1|||
19781289|NCT01063881|42237330|FG002|Overall Study|Reason for not completed not specified|0|||
19781290|NCT01065597|42237345|FG000|Overall Study|Adverse Event|1|||
19781291|NCT01062555|42237351|FG000|Phase 1|Death|10|||
19781292|NCT01062555|42237352|FG001|Phase 1|Death|17|||
19781293|NCT01062555|42237353|FG002|Phase 1|Death|0|||
19781294|NCT01062555|42237354|FG003|Phase 1|Death|0|||
19781295|NCT01062555|42237351|FG000|Phase 1|Graft Failure|12|||
19781296|NCT01062555|42237352|FG001|Phase 1|Graft Failure|8|||
19781297|NCT01062555|42237353|FG002|Phase 1|Graft Failure|0|||
19781298|NCT01062555|42237354|FG003|Phase 1|Graft Failure|0|||
19781299|NCT01062555|42237351|FG000|Phase 1|Withdrawal by Subject|1|||
19781300|NCT01062555|42237352|FG001|Phase 1|Withdrawal by Subject|1|||
19477744|NCT01507831|41757003|FG000|Overall Study|Poor compliance to protocol|38|||
19477745|NCT01507831|41757004|FG001|Overall Study|Poor compliance to protocol|60|||
19477746|NCT01507831|41757003|FG000|Overall Study|Physician Decision|0|||
19477747|NCT01507831|41757004|FG001|Overall Study|Physician Decision|4|||
19477748|NCT01507831|41757003|FG000|Overall Study|Participant moved|5|||
19477749|NCT01507831|41757004|FG001|Overall Study|Participant moved|19|||
19477750|NCT01507831|41757003|FG000|Overall Study|Consent withdrawn by participant|34|||
19477751|NCT01507831|41757004|FG001|Overall Study|Consent withdrawn by participant|72|||
19477752|NCT01507831|41757003|FG000|Overall Study|Related to study drug administration|5|||
19477753|NCT01507831|41757004|FG001|Overall Study|Related to study drug administration|14|||
19477754|NCT01507831|41757003|FG000|Overall Study|Last visit outside protocol visit window|51|||
19477755|NCT01507831|41757004|FG001|Overall Study|Last visit outside protocol visit window|143|||
19477756|NCT01507831|41757003|FG000|Overall Study|Selection criteria finally not met|0|||
19477757|NCT01507831|41757004|FG001|Overall Study|Selection criteria finally not met|1|||
19477758|NCT01507831|41757003|FG000|Overall Study|Site closure|0|||
19477759|NCT01507831|41757004|FG001|Overall Study|Site closure|3|||
19477760|NCT01507831|41757003|FG000|Overall Study|Potential lost to follow-up|3|||
19477761|NCT01507831|41757004|FG001|Overall Study|Potential lost to follow-up|0|||
19477762|NCT01507831|41757003|FG000|Overall Study|Other|3|||
19477763|NCT01507831|41757004|FG001|Overall Study|Other|6|||
19477764|NCT01479595|41757012|FG000|Overall Study|Protocol deviation|0|||
19477765|NCT01479595|41757013|FG001|Overall Study|Protocol deviation|1|||
19477766|NCT01479595|41757012|FG000|Overall Study|Adverse Event|2|||
19477767|NCT01479595|41757013|FG001|Overall Study|Adverse Event|1|||
19477768|NCT01462357|41757022|FG000|Overall Study|Death|0|||
19477769|NCT01462357|41757023|FG001|Overall Study|Death|0|||
19477770|NCT01462357|41757024|FG002|Overall Study|Death|1|||
19477771|NCT01462357|41757022|FG000|Overall Study|Withdrawal by Subject|3|||
19477772|NCT01462357|41757023|FG001|Overall Study|Withdrawal by Subject|11|||
19477773|NCT01462357|41757024|FG002|Overall Study|Withdrawal by Subject|3|||
19477774|NCT01462357|41757022|FG000|Overall Study|Migrated/moved from study area|2|||
19477775|NCT01462357|41757023|FG001|Overall Study|Migrated/moved from study area|3|||
19477776|NCT01462357|41757024|FG002|Overall Study|Migrated/moved from study area|1|||
19477777|NCT01462357|41757022|FG000|Overall Study|Lost to Follow-up|3|||
19477778|NCT01462357|41757023|FG001|Overall Study|Lost to Follow-up|5|||
19781301|NCT01062555|42237353|FG002|Phase 1|Withdrawal by Subject|0|||
19781302|NCT01062555|42237354|FG003|Phase 1|Withdrawal by Subject|0|||
19781303|NCT01062555|42237351|FG000|Phase 2|Death|0|||
19781304|NCT01062555|42237352|FG001|Phase 2|Death|0|||
19781305|NCT01062555|42237353|FG002|Phase 2|Death|8|||
19694924|NCT00347360|42140263|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
19694925|NCT00347360|42140264|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
19694926|NCT00347360|42140265|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
19694927|NCT00347360|42140266|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
19781306|NCT01062555|42237354|FG003|Phase 2|Death|3|||
19781307|NCT01062555|42237351|FG000|Phase 2|Graft failure|0|||
19781308|NCT01062555|42237352|FG001|Phase 2|Graft failure|0|||
19781309|NCT01062555|42237353|FG002|Phase 2|Graft failure|7|||
19781310|NCT01062555|42237354|FG003|Phase 2|Graft failure|4|||
19694928|NCT00347360|42140267|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
19694929|NCT00347360|42140268|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
19694930|NCT00347360|42140269|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
19781311|NCT01062555|42237351|FG000|Phase 2|Withdrawal by Subject|0|||
19781312|NCT01062555|42237352|FG001|Phase 2|Withdrawal by Subject|0|||
19781313|NCT01062555|42237353|FG002|Phase 2|Withdrawal by Subject|0|||
19781314|NCT01062555|42237354|FG003|Phase 2|Withdrawal by Subject|7|||
19781315|NCT01062555|42237351|FG000|Phase 2|Protocol Violation|0|||
19781316|NCT01062555|42237352|FG001|Phase 2|Protocol Violation|0|||
19781317|NCT01062555|42237353|FG002|Phase 2|Protocol Violation|0|||
19781318|NCT01062555|42237354|FG003|Phase 2|Protocol Violation|3|||
19781319|NCT01062555|42237351|FG000|Phase 2|Physician Decision|0|||
19781320|NCT01062555|42237352|FG001|Phase 2|Physician Decision|0|||
19781321|NCT01062555|42237353|FG002|Phase 2|Physician Decision|0|||
19781322|NCT01062555|42237354|FG003|Phase 2|Physician Decision|17|||
19781323|NCT01064817|42237366|FG000|Study Completion|Physician Decision|1|||
19781324|NCT01064817|42237367|FG001|Study Completion|Physician Decision|0|||
19781325|NCT01064817|42237366|FG000|Study Completion|Withdrawal by Subject|1|||
19781326|NCT01064817|42237367|FG001|Study Completion|Withdrawal by Subject|0|||
19781327|NCT01368276|42237375|FG000|Overall Study|Death|1|||
19781328|NCT01368276|42237376|FG001|Overall Study|Death|10|||
19781329|NCT01064739|42237382|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
19781330|NCT02741570|42237394|FG000|Pre-Treatment Period|Other reasons|0|||
19781331|NCT02741570|42237395|FG001|Pre-Treatment Period|Other reasons|3|||
19781332|NCT02741570|42237394|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
19781333|NCT02741570|42237395|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
19781334|NCT02741570|42237394|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
19781335|NCT02741570|42237395|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
19781336|NCT02741570|42237394|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
19781337|NCT02741570|42237395|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
19781338|NCT02741570|42237394|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
19781339|NCT02741570|42237395|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
19781340|NCT02741570|42237394|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
19781341|NCT02741570|42237395|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
19781342|NCT02741570|42237394|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
19781343|NCT02741570|42237395|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19694931|NCT00347360|42140270|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
19694932|NCT00347360|42140271|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
19694933|NCT00347360|42140272|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
19694934|NCT00347360|42140273|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
19781344|NCT02741570|42237394|FG000|Pre-Treatment Period|Death|0|||
19781345|NCT02741570|42237395|FG001|Pre-Treatment Period|Death|1|||
19781346|NCT02741570|42237394|FG000|Pre-Treatment Period|Disease progression|0|||
19781347|NCT02741570|42237395|FG001|Pre-Treatment Period|Disease progression|1|||
19781348|NCT02741570|42237394|FG000|Treatment Period|Other reasons|47|||
19694935|NCT00347360|42140274|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
19694936|NCT00347360|42140260|FG000|Overall Study|Abnormal lab values|0|||
19694937|NCT00347360|42140261|FG001|Overall Study|Abnormal lab values|0|||
19694938|NCT00347360|42140262|FG002|Overall Study|Abnormal lab values|0|||
19694939|NCT00347360|42140263|FG003|Overall Study|Abnormal lab values|0|||
19694940|NCT00347360|42140264|FG004|Overall Study|Abnormal lab values|0|||
19694941|NCT00347360|42140265|FG005|Overall Study|Abnormal lab values|0|||
19781349|NCT02741570|42237395|FG001|Treatment Period|Other reasons|8|||
19781350|NCT02741570|42237394|FG000|Treatment Period|Poor/non-compliance|0|||
19781351|NCT02741570|42237395|FG001|Treatment Period|Poor/non-compliance|1|||
19781352|NCT02741570|42237394|FG000|Treatment Period|Maximum clinical benefit|3|||
19781353|NCT02741570|42237395|FG001|Treatment Period|Maximum clinical benefit|5|||
19781354|NCT02741570|42237394|FG000|Treatment Period|Lost to Follow-up|1|||
19781355|NCT02741570|42237395|FG001|Treatment Period|Lost to Follow-up|3|||
19781356|NCT02741570|42237394|FG000|Treatment Period|Participant withdrew consent|9|||
19389174|NCT02053792|41632811|FG001|Overall Study|Physician Decision|1|||
19389175|NCT02053792|41632810|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
19389176|NCT02053792|41632811|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
19389177|NCT02053792|41632810|FG000|Overall Study|Lack of Efficacy|1|||
19477779|NCT01462357|41757024|FG002|Overall Study|Lost to Follow-up|7|||
19781357|NCT02741570|42237395|FG001|Treatment Period|Participant withdrew consent|13|||
19781358|NCT02741570|42237394|FG000|Treatment Period|Participant request to discontinue treatment|8|||
19781359|NCT02741570|42237395|FG001|Treatment Period|Participant request to discontinue treatment|23|||
19781360|NCT02741570|42237394|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
19781361|NCT02741570|42237395|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
19781362|NCT02741570|42237394|FG000|Treatment Period|Death|9|||
19781363|NCT02741570|42237395|FG001|Treatment Period|Death|7|||
19781364|NCT02741570|42237394|FG000|Treatment Period|Study drug toxicity|55|||
19781365|NCT02741570|42237395|FG001|Treatment Period|Study drug toxicity|45|||
19781366|NCT02741570|42237394|FG000|Treatment Period|Disease progression|295|||
19781367|NCT02741570|42237395|FG001|Treatment Period|Disease progression|304|||
19781368|NCT01061775|42237401|FG000|Overall Study|Physician Decision|2|||
19781369|NCT01061775|42237401|FG000|Overall Study|Lost to Follow-up|1|||
19781370|NCT02651116|42237408|FG000|Overall Study|Adverse Event|0|||
19781371|NCT02651116|42237409|FG001|Overall Study|Adverse Event|1|||
19781372|NCT02651116|42237408|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
19781373|NCT02651116|42237409|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
19781374|NCT01061385|42237417|FG000|Overall Study|Lost to Follow-up|1|||
19781375|NCT01061385|42237418|FG001|Overall Study|Lost to Follow-up|0|||
19781376|NCT01061385|42237417|FG000|Overall Study|subject decision not related to AE|0|||
19781377|NCT01061385|42237418|FG001|Overall Study|subject decision not related to AE|1|||
19781378|NCT02973477|42237427|FG000|First Intervention|Lost to Follow-up|0|||
19781379|NCT02973477|42237428|FG001|First Intervention|Lost to Follow-up|2|||
19781380|NCT02973477|42237427|FG000|Washout|Withdrawal by Subject|1|||
19781381|NCT02973477|42237428|FG001|Washout|Withdrawal by Subject|0|||
19781382|NCT02973477|42237427|FG000|Second Intervention|Lost to Follow-up|1|||
19781383|NCT02973477|42237428|FG001|Second Intervention|Lost to Follow-up|0|||
19781384|NCT02788656|42237442|FG000|Overall Study|Withdrawal by Subject|1|||
19781385|NCT02788656|42237443|FG001|Overall Study|Withdrawal by Subject|0|||
19781386|NCT00283868|42237451|FG000|Overall Study|Lost to Follow-up|7|||
19781387|NCT00283868|42237452|FG001|Overall Study|Lost to Follow-up|8|||
19781388|NCT02973087|42237458|FG000|Overall Study|Withdrawal by Subject|2|||
19781389|NCT02973087|42237459|FG001|Overall Study|Withdrawal by Subject|1|||
19781390|NCT02973087|42237458|FG000|Overall Study|Adverse Event|1|||
19781391|NCT02973087|42237459|FG001|Overall Study|Adverse Event|0|||
19781392|NCT02973087|42237458|FG000|Overall Study|other|1|||
19781393|NCT02973087|42237459|FG001|Overall Study|other|1|||
19781394|NCT00271544|42237479|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
19781395|NCT00271544|42237479|FG000|Overall Study|Model 4196 lead not attempted|9|||
19781396|NCT00271544|42237479|FG000|Overall Study|Implant not attempted|4|||
19781397|NCT05342532|42237502|FG000|Overall Study|Adverse Event|5|||
19781398|NCT05342532|42237503|FG001|Overall Study|Adverse Event|20|||
19781399|NCT05342532|42237502|FG000|Overall Study|Lost to Follow-up|10|||
19781400|NCT05342532|42237503|FG001|Overall Study|Lost to Follow-up|15|||
19781401|NCT02971683|42237511|FG000|Overall Study|Other reasons|0|||
19781402|NCT02971683|42237512|FG001|Overall Study|Other reasons|1|||
19781403|NCT02971683|42237511|FG000|Overall Study|Poor/Non-Compliance|0|||
19781404|NCT02971683|42237512|FG001|Overall Study|Poor/Non-Compliance|1|||
19781405|NCT02971683|42237511|FG000|Overall Study|Lost to Follow-up|1|||
19781406|NCT02971683|42237512|FG001|Overall Study|Lost to Follow-up|0|||
19781407|NCT02971683|42237511|FG000|Overall Study|Participant withdrew consent|1|||
19781408|NCT02971683|42237512|FG001|Overall Study|Participant withdrew consent|1|||
19781409|NCT02971683|42237511|FG000|Overall Study|Participant request to discontinue study treatment|1|||
19781410|NCT02971683|42237512|FG001|Overall Study|Participant request to discontinue study treatment|1|||
19781411|NCT02971683|42237511|FG000|Overall Study|Adverse Event|1|||
19781412|NCT02971683|42237512|FG001|Overall Study|Adverse Event|2|||
19781413|NCT02971683|42237511|FG000|Overall Study|Lack of Efficacy|2|||
19781414|NCT02971683|42237512|FG001|Overall Study|Lack of Efficacy|2|||
19781415|NCT02984943|42237518|FG000|Overall Study|Withdrawal by Subject|3|||
19781416|NCT02984943|42237518|FG000|Overall Study|Physician Decision|1|||
19781417|NCT02787408|42237522|FG000|Overall Study|Death|16|||
19781418|NCT02787408|42237522|FG000|Overall Study|Withdrawal by Subject|1|||
19389178|NCT02053792|41632811|FG001|Overall Study|Lack of Efficacy|0|||
19607190|NCT00673465|42055942|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
19781419|NCT02787408|42237522|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
19781420|NCT02971605|42237526|FG000|Overall Study|Withdrawal by Subject|1|||
19781421|NCT03054337|42237538|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
19781422|NCT03054337|42237539|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
19781423|NCT03054337|42237540|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
19781424|NCT03054337|42237541|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
19781425|NCT03054337|42237542|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
19781426|NCT03054337|42237543|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
19781427|NCT01060059|42237576|FG000|Overall Study|Adverse Event|1|||
19781428|NCT01060059|42237577|FG001|Overall Study|Adverse Event|1|||
19781429|NCT01060059|42237576|FG000|Overall Study|Death|2|||
19781430|NCT01060059|42237577|FG001|Overall Study|Death|3|||
19781431|NCT01060059|42237576|FG000|Overall Study|Lost to Follow-up|18|||
19781432|NCT01060059|42237577|FG001|Overall Study|Lost to Follow-up|34|||
19781433|NCT01060059|42237576|FG000|Overall Study|entry criteria not met|4|||
19781434|NCT01060059|42237577|FG001|Overall Study|entry criteria not met|3|||
19781435|NCT01060059|42237576|FG000|Overall Study|Withdrawal by Subject|35|||
19781436|NCT01060059|42237577|FG001|Overall Study|Withdrawal by Subject|23|||
19781437|NCT01060059|42237576|FG000|Overall Study|lack of glycemic control|2|||
19781438|NCT01060059|42237577|FG001|Overall Study|lack of glycemic control|1|||
19781439|NCT01060059|42237576|FG000|Overall Study|lack of compliance|5|||
19781440|NCT01060059|42237577|FG001|Overall Study|lack of compliance|2|||
19781441|NCT02648932|42237591|FG000|Overall Study|No transplant|3|||
19781442|NCT02648932|42237592|FG001|Overall Study|No transplant|1|||
19781443|NCT02903511|42237600|FG000|Overall Study|Withdrawal by Subject|1|||
19781444|NCT02903511|42237601|FG001|Overall Study|Withdrawal by Subject|0|||
19781445|NCT02903511|42237600|FG000|Overall Study|Lost to Follow-up|3|||
19781446|NCT02903511|42237601|FG001|Overall Study|Lost to Follow-up|2|||
19781447|NCT01368042|42237618|FG000|Overall Study|Death|14|||
19781448|NCT01368042|42237618|FG000|Overall Study|Protocol Violation|11|||
19781449|NCT01368042|42237618|FG000|Overall Study|Lost to Follow-up|4|||
19781450|NCT01368042|42237618|FG000|Overall Study|Transplanted|1|||
19781451|NCT00126776|42237624|FG000|Overall Study|follow up complete on all patients|0|||
19781452|NCT00126776|42237625|FG001|Overall Study|follow up complete on all patients|0|||
19781453|NCT01674010|42237629|FG000|Open Treatment Phase 1|Adverse Event|10|||
19781454|NCT01674010|42237630|FG001|Open Treatment Phase 1|Adverse Event|0|||
19781455|NCT01674010|42237631|FG002|Open Treatment Phase 1|Adverse Event|0|||
19781456|NCT01674010|42237629|FG000|Open Treatment Phase 1|Death|1|||
19781457|NCT01674010|42237630|FG001|Open Treatment Phase 1|Death|0|||
19781458|NCT01674010|42237631|FG002|Open Treatment Phase 1|Death|0|||
19781459|NCT01674010|42237629|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
19781460|NCT01674010|42237630|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
19781461|NCT01674010|42237631|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
19781462|NCT01674010|42237629|FG000|Open Treatment Phase 1|Physician Decision|9|||
19781463|NCT01674010|42237630|FG001|Open Treatment Phase 1|Physician Decision|0|||
19781464|NCT01674010|42237631|FG002|Open Treatment Phase 1|Physician Decision|0|||
19781465|NCT01674010|42237629|FG000|Open Treatment Phase 1|Protocol Violation|7|||
19781466|NCT01674010|42237630|FG001|Open Treatment Phase 1|Protocol Violation|0|||
19781467|NCT01674010|42237631|FG002|Open Treatment Phase 1|Protocol Violation|0|||
19781468|NCT01674010|42237629|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
19477780|NCT01479439|41757035|FG000|Overall Study|Adverse Event|1|||
19694942|NCT00347360|42140266|FG006|Overall Study|Abnormal lab values|1|||
19694943|NCT00347360|42140267|FG007|Overall Study|Abnormal lab values|0|||
19694944|NCT00347360|42140268|FG008|Overall Study|Abnormal lab values|0|||
19694945|NCT00347360|42140269|FG009|Overall Study|Abnormal lab values|0|||
19694946|NCT00347360|42140270|FG010|Overall Study|Abnormal lab values|0|||
19694947|NCT00347360|42140271|FG011|Overall Study|Abnormal lab values|0|||
19694948|NCT00347360|42140272|FG012|Overall Study|Abnormal lab values|0|||
19694949|NCT00347360|42140273|FG013|Overall Study|Abnormal lab values|0|||
19694950|NCT00347360|42140274|FG014|Overall Study|Abnormal lab values|0|||
19694951|NCT00347360|42140260|FG000|Overall Study|PI recommended early withdrawal|0|||
19694952|NCT00347360|42140261|FG001|Overall Study|PI recommended early withdrawal|0|||
19694953|NCT00347360|42140262|FG002|Overall Study|PI recommended early withdrawal|0|||
19694954|NCT00347360|42140263|FG003|Overall Study|PI recommended early withdrawal|0|||
19694955|NCT00347360|42140264|FG004|Overall Study|PI recommended early withdrawal|0|||
19694956|NCT00347360|42140265|FG005|Overall Study|PI recommended early withdrawal|0|||
19694957|NCT00347360|42140266|FG006|Overall Study|PI recommended early withdrawal|0|||
19694958|NCT00347360|42140267|FG007|Overall Study|PI recommended early withdrawal|0|||
19694959|NCT00347360|42140268|FG008|Overall Study|PI recommended early withdrawal|0|||
19694960|NCT00347360|42140269|FG009|Overall Study|PI recommended early withdrawal|1|||
19694961|NCT00347360|42140270|FG010|Overall Study|PI recommended early withdrawal|0|||
19694962|NCT00347360|42140271|FG011|Overall Study|PI recommended early withdrawal|0|||
19694963|NCT00347360|42140272|FG012|Overall Study|PI recommended early withdrawal|0|||
19694964|NCT00347360|42140273|FG013|Overall Study|PI recommended early withdrawal|0|||
19694965|NCT00347360|42140274|FG014|Overall Study|PI recommended early withdrawal|0|||
19694966|NCT00347360|42140260|FG000|Overall Study|Did not meet criteria before ABPM|0|||
19781469|NCT01674010|42237630|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
19781470|NCT01674010|42237631|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
19781471|NCT01674010|42237629|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
19781472|NCT01674010|42237630|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
19781473|NCT01674010|42237631|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
19781474|NCT01674010|42237629|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
19781475|NCT01674010|42237630|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
19781476|NCT01674010|42237631|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
19781477|NCT01674010|42237629|FG000|Randomization Phase 2|Adverse Event|0|||
19781478|NCT01674010|42237630|FG001|Randomization Phase 2|Adverse Event|1|||
19781479|NCT01674010|42237631|FG002|Randomization Phase 2|Adverse Event|1|||
19781480|NCT01674010|42237629|FG000|Randomization Phase 2|Lost to Follow-up|0|||
19781481|NCT01674010|42237630|FG001|Randomization Phase 2|Lost to Follow-up|1|||
19781482|NCT01674010|42237631|FG002|Randomization Phase 2|Lost to Follow-up|2|||
19781483|NCT01674010|42237629|FG000|Randomization Phase 2|Mood episode recurrence|0|||
19781484|NCT01674010|42237630|FG001|Randomization Phase 2|Mood episode recurrence|8|||
19781485|NCT01674010|42237631|FG002|Randomization Phase 2|Mood episode recurrence|2|||
19781486|NCT01674010|42237629|FG000|Randomization Phase 2|Physician Decision|0|||
19781487|NCT01674010|42237630|FG001|Randomization Phase 2|Physician Decision|0|||
19781488|NCT01674010|42237631|FG002|Randomization Phase 2|Physician Decision|2|||
19781489|NCT01674010|42237629|FG000|Randomization Phase 2|Pregnancy|0|||
19781490|NCT01674010|42237630|FG001|Randomization Phase 2|Pregnancy|1|||
19781491|NCT01674010|42237631|FG002|Randomization Phase 2|Pregnancy|1|||
19781492|NCT01674010|42237629|FG000|Randomization Phase 2|Protocol Violation|0|||
19781493|NCT01674010|42237630|FG001|Randomization Phase 2|Protocol Violation|1|||
19781494|NCT01674010|42237631|FG002|Randomization Phase 2|Protocol Violation|1|||
19781495|NCT01674010|42237629|FG000|Randomization Phase 2|Sponsor Decision|0|||
19781496|NCT01674010|42237630|FG001|Randomization Phase 2|Sponsor Decision|42|||
19781497|NCT01674010|42237631|FG002|Randomization Phase 2|Sponsor Decision|45|||
19781498|NCT01674010|42237629|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
19781499|NCT01674010|42237630|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
19781500|NCT01674010|42237631|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
19781501|NCT01345669|42237641|FG000|Overall Study|Primary tumour recurrence|53|||
19781502|NCT01345669|42237642|FG001|Overall Study|Primary tumour recurrence|32|||
19781503|NCT01345669|42237641|FG000|Overall Study|Second primary tumour|4|||
19781504|NCT01345669|42237642|FG001|Overall Study|Second primary tumour|3|||
19781505|NCT01345669|42237641|FG000|Overall Study|Adverse Event|63|||
19781506|NCT01345669|42237642|FG001|Overall Study|Adverse Event|9|||
19781507|NCT01345669|42237641|FG000|Overall Study|Protocol Violation|3|||
19781508|NCT01345669|42237642|FG001|Overall Study|Protocol Violation|1|||
19694967|NCT00347360|42140261|FG001|Overall Study|Did not meet criteria before ABPM|0|||
19694968|NCT00347360|42140262|FG002|Overall Study|Did not meet criteria before ABPM|0|||
19694969|NCT00347360|42140263|FG003|Overall Study|Did not meet criteria before ABPM|0|||
19694970|NCT00347360|42140264|FG004|Overall Study|Did not meet criteria before ABPM|0|||
19694971|NCT00347360|42140265|FG005|Overall Study|Did not meet criteria before ABPM|0|||
19694972|NCT00347360|42140266|FG006|Overall Study|Did not meet criteria before ABPM|0|||
19694973|NCT00347360|42140267|FG007|Overall Study|Did not meet criteria before ABPM|0|||
19781509|NCT01345669|42237641|FG000|Overall Study|Lost to Follow-up|1|||
19781510|NCT01345669|42237642|FG001|Overall Study|Lost to Follow-up|1|||
19781511|NCT01345669|42237641|FG000|Overall Study|Withdrawal by Subject|52|||
19781512|NCT01345669|42237642|FG001|Overall Study|Withdrawal by Subject|13|||
19781513|NCT01345669|42237641|FG000|Overall Study|Other Reasons|111|||
19781514|NCT01345669|42237642|FG001|Overall Study|Other Reasons|60|||
19781515|NCT05334212|42237648|FG000|Overall Study|Study terminated prematurely|7|||
19781516|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
19781517|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
19781518|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
19781519|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
19781520|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
19781521|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
19781522|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
19781523|NCT01673854|42237652|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
19781524|NCT01673854|42237652|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
19781525|NCT01673854|42237652|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
19781526|NCT01673854|42237652|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
19781527|NCT01673854|42237652|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
19781528|NCT01343407|42237656|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
19781529|NCT01343407|42237657|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
19781530|NCT01343407|42237658|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
19781531|NCT01343407|42237659|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
19781532|NCT01343407|42237660|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
19781533|NCT01343407|42237661|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
19781534|NCT01343407|42237656|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
19781535|NCT01343407|42237657|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
19781536|NCT01343407|42237658|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
19781537|NCT01343407|42237659|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
19781538|NCT01343407|42237660|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
19781539|NCT01343407|42237661|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
19781540|NCT01367886|42237669|FG000|Overall Study|Lost to Follow-up|4|||
19781541|NCT01367886|42237669|FG000|Overall Study|Lack of Efficacy|2|||
19781542|NCT01367886|42237669|FG000|Overall Study|Death|1|||
19781543|NCT01673698|42237676|FG000|Overall Study|Lost to Follow-up|51|||
19781544|NCT01673698|42237677|FG001|Overall Study|Lost to Follow-up|13|||
19781545|NCT02786004|42237686|FG000|Overall Study|Withdrawal by Subject|0|||
19781546|NCT02786004|42237687|FG001|Overall Study|Withdrawal by Subject|1|||
19781547|NCT03051607|42237695|FG000|Overall Study|Adverse Event|66|||
19781548|NCT01062399|42237704|FG000|Overall Study|Protocol Violation|0|||
19781549|NCT01062399|42237705|FG001|Overall Study|Protocol Violation|1|||
19781550|NCT01062399|42237706|FG002|Overall Study|Protocol Violation|0|||
19781551|NCT01062399|42237707|FG003|Overall Study|Protocol Violation|6|||
19781552|NCT01062399|42237708|FG004|Overall Study|Protocol Violation|4|||
19781553|NCT01317277|42237722|FG000|Overall Study|Lost to Follow-up|3|||
19781554|NCT01317277|42237723|FG001|Overall Study|Lost to Follow-up|1|||
19781555|NCT01317277|42237722|FG000|Overall Study|Lost MEMS|1|||
19781556|NCT01317277|42237723|FG001|Overall Study|Lost MEMS|1|||
19781557|NCT01317277|42237722|FG000|Overall Study|Unable to comply with intervention|1|||
19781558|NCT01317277|42237723|FG001|Overall Study|Unable to comply with intervention|0|||
19781559|NCT01317277|42237722|FG000|Overall Study|Withdrawal by Subject|1|||
19781560|NCT01317277|42237723|FG001|Overall Study|Withdrawal by Subject|0|||
19781561|NCT01317277|42237722|FG000|Overall Study|Adverse Event|1|||
19781562|NCT01317277|42237723|FG001|Overall Study|Adverse Event|0|||
19781563|NCT02740478|42237729|FG000|Overall Study|Withdrawal by Subject|1|||
19781564|NCT02969655|42237735|FG000|Overall Study|Withdrawal by Subject|3|||
19781565|NCT02969655|42237736|FG001|Overall Study|Withdrawal by Subject|2|||
19781566|NCT02969655|42237735|FG000|Overall Study|Physician Decision|4|||
19781567|NCT02969655|42237736|FG001|Overall Study|Physician Decision|3|||
19781568|NCT02969655|42237735|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
19781569|NCT02969655|42237736|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
19781570|NCT02969655|42237735|FG000|Overall Study|Adverse Event|10|||
19781571|NCT02969655|42237736|FG001|Overall Study|Adverse Event|8|||
19781572|NCT01317199|42237747|FG000|Dose-escalation Phase 1|Physician Decision|5|||
19781573|NCT01317199|42237748|FG001|Dose-escalation Phase 1|Physician Decision|0|||
19781574|NCT01317199|42237749|FG002|Dose-escalation Phase 1|Physician Decision|0|||
19781575|NCT01317199|42237750|FG003|Dose-escalation Phase 1|Physician Decision|0|||
19781576|NCT01317199|42237747|FG000|Dose-escalation Phase 1|Disease progression|1|||
19781577|NCT01317199|42237748|FG001|Dose-escalation Phase 1|Disease progression|0|||
19781578|NCT01317199|42237749|FG002|Dose-escalation Phase 1|Disease progression|0|||
19781579|NCT01317199|42237750|FG003|Dose-escalation Phase 1|Disease progression|0|||
19781580|NCT01317199|42237747|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
19781581|NCT01317199|42237748|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
19781582|NCT01317199|42237749|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
19781583|NCT01317199|42237750|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
19781584|NCT01317199|42237747|FG000|Randomized Phase 2|Disease progression|0|||
19781585|NCT01317199|42237748|FG001|Randomized Phase 2|Disease progression|3|||
19781586|NCT01317199|42237749|FG002|Randomized Phase 2|Disease progression|7|||
19781587|NCT01317199|42237750|FG003|Randomized Phase 2|Disease progression|5|||
19781588|NCT01317199|42237747|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
19694974|NCT00347360|42140268|FG008|Overall Study|Did not meet criteria before ABPM|0|||
19694975|NCT00347360|42140269|FG009|Overall Study|Did not meet criteria before ABPM|0|||
19781589|NCT01317199|42237748|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
19781590|NCT01317199|42237749|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
19781591|NCT01317199|42237750|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
19781592|NCT01317199|42237747|FG000|Randomized Phase 2|Adverse Event|0|||
19781593|NCT01317199|42237748|FG001|Randomized Phase 2|Adverse Event|0|||
19694976|NCT00347360|42140270|FG010|Overall Study|Did not meet criteria before ABPM|1|||
19694977|NCT00347360|42140271|FG011|Overall Study|Did not meet criteria before ABPM|0|||
19694978|NCT00347360|42140272|FG012|Overall Study|Did not meet criteria before ABPM|0|||
19694979|NCT00347360|42140273|FG013|Overall Study|Did not meet criteria before ABPM|0|||
19694980|NCT00347360|42140274|FG014|Overall Study|Did not meet criteria before ABPM|0|||
19694981|NCT00347360|42140260|FG000|Overall Study|Randomized in error|0|||
19694982|NCT00347360|42140261|FG001|Overall Study|Randomized in error|0|||
19694983|NCT00347360|42140262|FG002|Overall Study|Randomized in error|0|||
19694984|NCT00347360|42140263|FG003|Overall Study|Randomized in error|0|||
19694985|NCT00347360|42140264|FG004|Overall Study|Randomized in error|0|||
19694986|NCT00347360|42140265|FG005|Overall Study|Randomized in error|0|||
19694987|NCT00347360|42140266|FG006|Overall Study|Randomized in error|0|||
19694988|NCT00347360|42140267|FG007|Overall Study|Randomized in error|0|||
19694989|NCT00347360|42140268|FG008|Overall Study|Randomized in error|0|||
19694990|NCT00347360|42140269|FG009|Overall Study|Randomized in error|0|||
19694991|NCT00347360|42140270|FG010|Overall Study|Randomized in error|0|||
19694992|NCT00347360|42140271|FG011|Overall Study|Randomized in error|1|||
19694993|NCT00347360|42140272|FG012|Overall Study|Randomized in error|0|||
19694994|NCT00347360|42140273|FG013|Overall Study|Randomized in error|0|||
19694995|NCT00347360|42140274|FG014|Overall Study|Randomized in error|0|||
19694996|NCT00347360|42140260|FG000|Overall Study|Failed inclusion criteria #4|0|||
19694997|NCT00347360|42140261|FG001|Overall Study|Failed inclusion criteria #4|0|||
19781594|NCT01317199|42237749|FG002|Randomized Phase 2|Adverse Event|0|||
19781595|NCT01317199|42237750|FG003|Randomized Phase 2|Adverse Event|1|||
19781596|NCT01317199|42237747|FG000|Randomized Phase 2|Comorbidities|0|||
19781597|NCT01317199|42237748|FG001|Randomized Phase 2|Comorbidities|2|||
19781598|NCT01317199|42237749|FG002|Randomized Phase 2|Comorbidities|2|||
19781599|NCT01317199|42237750|FG003|Randomized Phase 2|Comorbidities|2|||
19781600|NCT01317199|42237747|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
19781601|NCT01317199|42237748|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
19781602|NCT01317199|42237749|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
19781603|NCT01317199|42237750|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
19781604|NCT01317199|42237747|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
19781605|NCT01317199|42237748|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
19781606|NCT01317199|42237749|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
19781607|NCT01317199|42237750|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
19781608|NCT01317199|42237747|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
19781609|NCT01317199|42237748|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
19781610|NCT01317199|42237749|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
19781611|NCT01317199|42237750|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
19781612|NCT01317199|42237747|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
19781613|NCT01317199|42237748|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
19781614|NCT01317199|42237749|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
19781615|NCT01317199|42237750|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
19781616|NCT02648698|42237769|FG000|Overall Study|Protocol Violation|1|||
19781617|NCT02648698|42237770|FG001|Overall Study|Protocol Violation|5|||
19781618|NCT02970669|42237778|FG000|Double-blind Period|Adverse Event|4|||
19781619|NCT02970669|42237779|FG001|Double-blind Period|Adverse Event|0|||
19781620|NCT02970669|42237778|FG000|Double-blind Period|Death|1|||
19781621|NCT02970669|42237779|FG001|Double-blind Period|Death|0|||
19781622|NCT02970669|42237778|FG000|Double-blind Period|Study terminated by sponsor|1|||
19781623|NCT02970669|42237779|FG001|Double-blind Period|Study terminated by sponsor|2|||
19781624|NCT02970669|42237778|FG000|Double-blind Period|Physician Decision|0|||
19781625|NCT02970669|42237779|FG001|Double-blind Period|Physician Decision|2|||
19781626|NCT02970669|42237778|FG000|Double-blind Period|Withdrawal by Subject|2|||
19781627|NCT02970669|42237779|FG001|Double-blind Period|Withdrawal by Subject|2|||
19781628|NCT02970669|42237778|FG000|Open-label Period|Withdrawal by Subject|2|||
19781629|NCT02970669|42237779|FG001|Open-label Period|Withdrawal by Subject|2|||
19781630|NCT02970669|42237778|FG000|Open-label Period|Adverse Event|1|||
19781631|NCT02970669|42237779|FG001|Open-label Period|Adverse Event|0|||
19781632|NCT02970669|42237778|FG000|Open-label Period|Physician Decision|1|||
19781633|NCT02970669|42237779|FG001|Open-label Period|Physician Decision|0|||
19781634|NCT02902965|42237787|FG000|Overall Study|Withdrawal by Subject|10|||
19781635|NCT02642042|42237792|FG000|Overall Study|Adverse Event|22|||
19781636|NCT02642042|42237792|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
19781637|NCT02642042|42237792|FG000|Overall Study|Progression/Relapse|28|||
19781638|NCT02642042|42237792|FG000|Overall Study|Death|1|||
19781639|NCT02642042|42237792|FG000|Overall Study|Not Protocol Specified|2|||
19781640|NCT02902809|42237796|FG000|Overall Study|Discontinuation of asthma program|28|||
19781641|NCT01362244|42237802|FG000|Overall Study|Adverse Event|3|||
19781642|NCT01362244|42237803|FG001|Overall Study|Adverse Event|5|||
19781643|NCT01362244|42237802|FG000|Overall Study|Lack of Efficacy|5|||
19781644|NCT01362244|42237803|FG001|Overall Study|Lack of Efficacy|11|||
19781645|NCT01362244|42237802|FG000|Overall Study|Lost to Follow-up|0|||
19781646|NCT01362244|42237803|FG001|Overall Study|Lost to Follow-up|2|||
19781647|NCT01362244|42237802|FG000|Overall Study|Protocol Violation|5|||
19781648|NCT01362244|42237803|FG001|Overall Study|Protocol Violation|1|||
19781649|NCT01362244|42237802|FG000|Overall Study|Withdrawal by Subject|2|||
19781650|NCT01362244|42237803|FG001|Overall Study|Withdrawal by Subject|1|||
19781651|NCT01362244|42237802|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
19781652|NCT01362244|42237803|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
19781653|NCT01362244|42237802|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
19781654|NCT01362244|42237803|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
19781655|NCT02969187|42237811|FG000|Overall Study|Physician Decision|12|||
19781656|NCT02969187|42237812|FG001|Overall Study|Physician Decision|13|||
19781657|NCT03050359|42237822|FG000|Overall Study|Randomized But Not Treated|2|||
19781658|NCT03050359|42237823|FG001|Overall Study|Randomized But Not Treated|0|||
19781659|NCT03050359|42237822|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
19781660|NCT03050359|42237823|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
19781661|NCT03050359|42237822|FG000|Overall Study|Significant Protocol Deviation|2|||
19781662|NCT03050359|42237823|FG001|Overall Study|Significant Protocol Deviation|3|||
19781663|NCT03050359|42237822|FG000|Overall Study|Lost to Follow-up|2|||
19781664|NCT03050359|42237823|FG001|Overall Study|Lost to Follow-up|1|||
19781665|NCT03050359|42237822|FG000|Overall Study|Voluntary Withdrawal|4|||
19781666|NCT03050359|42237823|FG001|Overall Study|Voluntary Withdrawal|6|||
19781667|NCT03050359|42237822|FG000|Overall Study|Pregnancy|1|||
19781668|NCT03050359|42237823|FG001|Overall Study|Pregnancy|0|||
19781669|NCT03050359|42237822|FG000|Overall Study|Reason Not Specified|1|||
19781670|NCT03050359|42237823|FG001|Overall Study|Reason Not Specified|0|||
19781671|NCT02785770|42237831|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
19781672|NCT02785770|42237832|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
19781673|NCT02785770|42237833|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
19781674|NCT02785770|42237834|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
19781675|NCT02785770|42237831|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
19781676|NCT02785770|42237832|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
19781677|NCT02785770|42237833|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
19781678|NCT02785770|42237834|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
19781679|NCT02785770|42237831|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
19781680|NCT02785770|42237832|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
19781681|NCT02785770|42237833|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
19781682|NCT02785770|42237834|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
19781683|NCT02965833|42237847|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
19781684|NCT02965833|42237848|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
19781685|NCT02965833|42237847|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
19781686|NCT02965833|42237848|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
19781687|NCT02965833|42237847|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
19781688|NCT02965833|42237848|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
19781689|NCT02965833|42237847|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
19781690|NCT02965833|42237848|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
19781691|NCT02965833|42237847|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
19781692|NCT02965833|42237848|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
19781693|NCT02968173|42237854|FG000|Overall Study|Withdrawal by Subject|1|||
19781694|NCT02785458|42237861|FG000|1 Month|Withdrawal by Subject|2|||
19781695|NCT02785458|42237862|FG001|1 Month|Withdrawal by Subject|1|||
19781696|NCT02785458|42237861|FG000|1 Month|Lost to Follow-up|38|||
19781697|NCT02785458|42237862|FG001|1 Month|Lost to Follow-up|31|||
19781698|NCT02785458|42237861|FG000|1 Month|Deemed Ineligible|1|||
19781699|NCT02785458|42237862|FG001|1 Month|Deemed Ineligible|0|||
19781700|NCT02785458|42237861|FG000|1 Month|Completed Evaluation by Baseline|42|||
19781701|NCT02785458|42237862|FG001|1 Month|Completed Evaluation by Baseline|39|||
19781702|NCT02785458|42237861|FG000|1 Month|Partial Interview|0|||
19781703|NCT02785458|42237862|FG001|1 Month|Partial Interview|4|||
19781704|NCT02785458|42237861|FG000|3 Months|Withdrawal by Subject|3|||
19781705|NCT02785458|42237862|FG001|3 Months|Withdrawal by Subject|1|||
19781706|NCT02785458|42237861|FG000|3 Months|Lost to Follow-up|25|||
19781707|NCT02785458|42237862|FG001|3 Months|Lost to Follow-up|21|||
19781708|NCT02785458|42237861|FG000|3 Months|Completed Evaluation at 1 Month|100|||
19781709|NCT02785458|42237862|FG001|3 Months|Completed Evaluation at 1 Month|89|||
19781710|NCT02784834|42237868|FG000|Overall Study|Lack of Efficacy|1|||
19781711|NCT02966223|42237885|FG000|Overall Study|Physician Decision|3|||
19781712|NCT02966223|42237885|FG000|Overall Study|Withdrawal by Subject|11|||
19781713|NCT02966223|42237885|FG000|Overall Study|Lost to Follow-up|1|||
19781714|NCT03049735|42237892|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
19781715|NCT03049735|42237893|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
19781716|NCT03049735|42237894|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
19781717|NCT03049735|42237892|FG000|Overall Study|Other|5|||
19781718|NCT03049735|42237893|FG001|Overall Study|Other|3|||
19781719|NCT03049735|42237894|FG002|Overall Study|Other|1|||
19781720|NCT03049735|42237892|FG000|Overall Study|Lack of Efficacy|4|||
19781721|NCT03049735|42237893|FG001|Overall Study|Lack of Efficacy|0|||
19781722|NCT03049735|42237894|FG002|Overall Study|Lack of Efficacy|3|||
19781723|NCT03049735|42237892|FG000|Overall Study|Protocol deviation|1|||
19694998|NCT00347360|42140262|FG002|Overall Study|Failed inclusion criteria #4|0|||
19694999|NCT00347360|42140263|FG003|Overall Study|Failed inclusion criteria #4|0|||
19695000|NCT00347360|42140264|FG004|Overall Study|Failed inclusion criteria #4|0|||
19695001|NCT00347360|42140265|FG005|Overall Study|Failed inclusion criteria #4|0|||
19695002|NCT00347360|42140266|FG006|Overall Study|Failed inclusion criteria #4|0|||
19695003|NCT00347360|42140267|FG007|Overall Study|Failed inclusion criteria #4|0|||
19695004|NCT00347360|42140268|FG008|Overall Study|Failed inclusion criteria #4|0|||
19695005|NCT00347360|42140269|FG009|Overall Study|Failed inclusion criteria #4|0|||
19695006|NCT00347360|42140270|FG010|Overall Study|Failed inclusion criteria #4|0|||
19695007|NCT00347360|42140271|FG011|Overall Study|Failed inclusion criteria #4|1|||
19781724|NCT03049735|42237893|FG001|Overall Study|Protocol deviation|0|||
19781725|NCT03049735|42237894|FG002|Overall Study|Protocol deviation|0|||
19781726|NCT03049735|42237892|FG000|Overall Study|Pregnancy|0|||
19781727|NCT03049735|42237893|FG001|Overall Study|Pregnancy|0|||
19781728|NCT03049735|42237894|FG002|Overall Study|Pregnancy|1|||
19781729|NCT03049735|42237892|FG000|Overall Study|Adverse Event|7|||
19781730|NCT03049735|42237893|FG001|Overall Study|Adverse Event|18|||
19781731|NCT03049735|42237894|FG002|Overall Study|Adverse Event|5|||
19781732|NCT03049735|42237892|FG000|Overall Study|Withdrawal by Subject|10|||
19781733|NCT03049735|42237893|FG001|Overall Study|Withdrawal by Subject|3|||
19781734|NCT03049735|42237894|FG002|Overall Study|Withdrawal by Subject|7|||
19781735|NCT03049735|42237892|FG000|Overall Study|Lost to Follow-up|1|||
19781736|NCT03049735|42237893|FG001|Overall Study|Lost to Follow-up|5|||
19781737|NCT03049735|42237894|FG002|Overall Study|Lost to Follow-up|5|||
19781738|NCT01295944|42237902|FG000|Overall Study|Switched to alternative treatment|1|||
19781739|NCT01295944|42237902|FG000|Overall Study|Ineligible|9|||
19781740|NCT01295944|42237902|FG000|Overall Study|Withdrawal by Subject|4|||
19781741|NCT01295944|42237902|FG000|Overall Study|Participant chose to be treated in Peru|1|||
19781742|NCT01295944|42237902|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
19781743|NCT01295944|42237902|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
19781744|NCT01295944|42237902|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
19781745|NCT02965599|42237908|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
19781746|NCT02965599|42237909|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
19781747|NCT02898597|42237918|FG000|Overall Study|Protocol Violation|4|||
19781748|NCT02898597|42237919|FG001|Overall Study|Protocol Violation|2|||
19781749|NCT02898597|42237918|FG000|Overall Study|Lost to Follow-up|0|||
19781750|NCT02898597|42237919|FG001|Overall Study|Lost to Follow-up|9|||
19781751|NCT02898597|42237918|FG000|Overall Study|Death|0|||
19781752|NCT02898597|42237919|FG001|Overall Study|Death|1|||
19781753|NCT02899377|42237927|FG000|Overall Study|Adverse Event|1|||
19781754|NCT02899377|42237928|FG001|Overall Study|Adverse Event|0|||
19781755|NCT01316887|42237939|FG000|Overall Study|Adverse Event|13|||
19781756|NCT01316887|42237940|FG001|Overall Study|Adverse Event|21|||
19781757|NCT01316887|42237941|FG002|Overall Study|Adverse Event|17|||
19781758|NCT01316887|42237939|FG000|Overall Study|Lack of Efficacy|9|||
19781759|NCT01316887|42237940|FG001|Overall Study|Lack of Efficacy|3|||
19781760|NCT01316887|42237941|FG002|Overall Study|Lack of Efficacy|1|||
19781761|NCT01316887|42237939|FG000|Overall Study|Protocol Violation|2|||
19781762|NCT01316887|42237940|FG001|Overall Study|Protocol Violation|6|||
19781763|NCT01316887|42237941|FG002|Overall Study|Protocol Violation|6|||
19695008|NCT00347360|42140272|FG012|Overall Study|Failed inclusion criteria #4|0|||
19695009|NCT00347360|42140273|FG013|Overall Study|Failed inclusion criteria #4|0|||
19781764|NCT01316887|42237939|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
19781765|NCT01316887|42237940|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
19781766|NCT01316887|42237941|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
19781767|NCT01316887|42237939|FG000|Overall Study|Study Closed/Terminated|2|||
19781768|NCT01316887|42237940|FG001|Overall Study|Study Closed/Terminated|4|||
19781769|NCT01316887|42237941|FG002|Overall Study|Study Closed/Terminated|3|||
19781770|NCT01316887|42237939|FG000|Overall Study|Lost to Follow-up|1|||
19781771|NCT01316887|42237940|FG001|Overall Study|Lost to Follow-up|7|||
19781772|NCT01316887|42237941|FG002|Overall Study|Lost to Follow-up|5|||
19781773|NCT01316887|42237939|FG000|Overall Study|Withdrawal by Subject|8|||
19781774|NCT01316887|42237940|FG001|Overall Study|Withdrawal by Subject|16|||
19781775|NCT01316887|42237941|FG002|Overall Study|Withdrawal by Subject|15|||
19781776|NCT02897349|42237952|FG000|Overall Study|Lost to Follow-up|2|||
19781777|NCT02897349|42237953|FG001|Overall Study|Lost to Follow-up|2|||
19781778|NCT02897349|42237952|FG000|Overall Study|Adverse Event|3|||
19781779|NCT02897349|42237953|FG001|Overall Study|Adverse Event|3|||
19781780|NCT02897349|42237952|FG000|Overall Study|Other than listed above|0|||
19781781|NCT02897349|42237953|FG001|Overall Study|Other than listed above|1|||
19781782|NCT03047551|42237961|FG000|Overall Study|Did not receive TAS|1|||
19781783|NCT03047551|42237962|FG001|Overall Study|Did not receive TAS|0|||
19781784|NCT03047551|42237961|FG000|Overall Study|Physician Decision|1|||
19781785|NCT03047551|42237962|FG001|Overall Study|Physician Decision|0|||
19781786|NCT03047551|42237961|FG000|Overall Study|Withdrawal by Subject|0|||
19781787|NCT03047551|42237962|FG001|Overall Study|Withdrawal by Subject|1|||
19781788|NCT03047551|42237961|FG000|Overall Study|Probe malfunction|0|||
19781789|NCT03047551|42237962|FG001|Overall Study|Probe malfunction|1|||
19781790|NCT03047551|42237961|FG000|Overall Study|Ineligible|0|||
19781791|NCT03047551|42237962|FG001|Overall Study|Ineligible|1|||
19781792|NCT02964741|42237971|FG000|Overall Study|Protocol Violation|1|||
19367329|NCT02788201|41607499|FG002|Overall Study|Ineligible|0|||
19695010|NCT00347360|42140274|FG014|Overall Study|Failed inclusion criteria #4|0|||
19695011|NCT00347360|42140260|FG000|Overall Study|Prolonged duration between visits|0|||
19695012|NCT00347360|42140261|FG001|Overall Study|Prolonged duration between visits|0|||
19695013|NCT00347360|42140262|FG002|Overall Study|Prolonged duration between visits|0|||
19695014|NCT00347360|42140263|FG003|Overall Study|Prolonged duration between visits|0|||
19695015|NCT00347360|42140264|FG004|Overall Study|Prolonged duration between visits|0|||
19781793|NCT02964741|42237972|FG001|Overall Study|Protocol Violation|0|||
19781794|NCT02964741|42237973|FG002|Overall Study|Protocol Violation|0|||
19367330|NCT02788201|41607500|FG003|Overall Study|Ineligible|0|||
19781795|NCT02964741|42237971|FG000|Overall Study|Withdrawal by Subject|0|||
19781796|NCT02964741|42237972|FG001|Overall Study|Withdrawal by Subject|1|||
19781797|NCT02964741|42237973|FG002|Overall Study|Withdrawal by Subject|0|||
19781798|NCT02964741|42237971|FG000|Overall Study|claustrophobia|1|||
19781799|NCT02964741|42237972|FG001|Overall Study|claustrophobia|0|||
19781800|NCT02964741|42237973|FG002|Overall Study|claustrophobia|0|||
19781801|NCT01316419|42237979|FG000|Overall Study|Not treated|103|||
19781802|NCT01316419|42237979|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
19781803|NCT01316419|42237979|FG000|Overall Study|Lost to Follow-up|19|||
19781804|NCT02964039|42237986|FG000|Overall Study|Medical reason unrelated to study participation|1|||
19781805|NCT02964039|42237987|FG001|Overall Study|Medical reason unrelated to study participation|0|||
19781806|NCT02964039|42237988|FG002|Overall Study|Medical reason unrelated to study participation|3|||
19781807|NCT02964039|42237986|FG000|Overall Study|Research shutdown due to pandemic|2|||
19781808|NCT02964039|42237987|FG001|Overall Study|Research shutdown due to pandemic|0|||
19781809|NCT02964039|42237988|FG002|Overall Study|Research shutdown due to pandemic|1|||
19781810|NCT02964039|42237986|FG000|Overall Study|Withdrawal by Subject|0|||
19781811|NCT02964039|42237987|FG001|Overall Study|Withdrawal by Subject|1|||
19781812|NCT02964039|42237988|FG002|Overall Study|Withdrawal by Subject|0|||
19781813|NCT02964039|42237986|FG000|Overall Study|Lost to Follow-up|1|||
19781814|NCT02964039|42237987|FG001|Overall Study|Lost to Follow-up|0|||
19781815|NCT02964039|42237988|FG002|Overall Study|Lost to Follow-up|1|||
19781816|NCT02897115|42237998|FG000|Overall Study|Early termination of study by sponsor|11|||
19781817|NCT02897115|42237999|FG001|Overall Study|Early termination of study by sponsor|8|||
19781818|NCT02896569|42238007|FG000|Overall Study|Lost to Follow-up|2|||
19781819|NCT02896569|42238008|FG001|Overall Study|Lost to Follow-up|1|||
19781820|NCT02896569|42238007|FG000|Overall Study|Physician Decision|1|||
19781821|NCT02896569|42238008|FG001|Overall Study|Physician Decision|3|||
19781822|NCT02896569|42238007|FG000|Overall Study|Adverse Event|0|||
19781823|NCT02896569|42238008|FG001|Overall Study|Adverse Event|1|||
19781824|NCT02896569|42238007|FG000|Overall Study|Withdrawal by Subject|1|||
19781825|NCT02896569|42238008|FG001|Overall Study|Withdrawal by Subject|0|||
19781826|NCT04030195|42238017|FG000|Overall Study|Withdrawal by Subject|2|||
19781827|NCT04030195|42238018|FG001|Overall Study|Withdrawal by Subject|0|||
19781828|NCT04030195|42238019|FG002|Overall Study|Withdrawal by Subject|0|||
19781829|NCT01673620|42238030|FG000|Overall Study|Adverse Event|1|||
19781830|NCT01673620|42238031|FG001|Overall Study|Adverse Event|0|||
19781831|NCT03044197|42238045|FG000|Overall Study|Withdrawal by Subject|3|||
19781832|NCT03044197|42238046|FG001|Overall Study|Withdrawal by Subject|1|||
19781833|NCT03575325|42238065|FG000|Overall Study|Death|1|||
19781834|NCT03043651|42238080|FG000|Overall Study|Death|1|||
19781835|NCT03043651|42238080|FG000|Overall Study|Progressive Disease|2|||
19781836|NCT03043651|42238080|FG000|Overall Study|Adverse Event|2|||
19781837|NCT03043651|42238080|FG000|Overall Study|Withdrawal by Subject|4|||
19781838|NCT03043651|42238080|FG000|Overall Study|Study Terminated by Sponsor|39|||
19781839|NCT03536143|42238084|FG000|Overall Study|Early termination, Sponsor decision|1|||
19781840|NCT01344759|42238094|FG000|Overall Study|Patients failed to reach sedation level|0|||
19781841|NCT01344759|42238095|FG001|Overall Study|Patients failed to reach sedation level|2|||
19781842|NCT02988661|42238124|FG000|Overall Study|Death|2|||
19781843|NCT02988661|42238125|FG001|Overall Study|Death|18|||
19781844|NCT02988661|42238124|FG000|Overall Study|Lost to Follow-up|0|||
19781845|NCT02988661|42238125|FG001|Overall Study|Lost to Follow-up|33|||
19695016|NCT00347360|42140265|FG005|Overall Study|Prolonged duration between visits|0|||
19695017|NCT00347360|42140266|FG006|Overall Study|Prolonged duration between visits|0|||
19695018|NCT00347360|42140267|FG007|Overall Study|Prolonged duration between visits|0|||
19695019|NCT00347360|42140268|FG008|Overall Study|Prolonged duration between visits|0|||
19695020|NCT00347360|42140269|FG009|Overall Study|Prolonged duration between visits|0|||
19695021|NCT00347360|42140270|FG010|Overall Study|Prolonged duration between visits|0|||
19695022|NCT00347360|42140271|FG011|Overall Study|Prolonged duration between visits|0|||
19695023|NCT00347360|42140272|FG012|Overall Study|Prolonged duration between visits|1|||
19695024|NCT00347360|42140273|FG013|Overall Study|Prolonged duration between visits|0|||
19695025|NCT00347360|42140274|FG014|Overall Study|Prolonged duration between visits|0|||
19695026|NCT00347360|42140260|FG000|Overall Study|Subject left town, ran out of study drug|0|||
19695027|NCT00347360|42140261|FG001|Overall Study|Subject left town, ran out of study drug|0|||
19695028|NCT00347360|42140262|FG002|Overall Study|Subject left town, ran out of study drug|0|||
19695029|NCT00347360|42140263|FG003|Overall Study|Subject left town, ran out of study drug|0|||
19695030|NCT00347360|42140264|FG004|Overall Study|Subject left town, ran out of study drug|0|||
19695031|NCT00347360|42140265|FG005|Overall Study|Subject left town, ran out of study drug|0|||
19695032|NCT00347360|42140266|FG006|Overall Study|Subject left town, ran out of study drug|0|||
19695033|NCT00347360|42140267|FG007|Overall Study|Subject left town, ran out of study drug|0|||
19695034|NCT00347360|42140268|FG008|Overall Study|Subject left town, ran out of study drug|0|||
19695035|NCT00347360|42140269|FG009|Overall Study|Subject left town, ran out of study drug|0|||
19695036|NCT00347360|42140270|FG010|Overall Study|Subject left town, ran out of study drug|0|||
19781846|NCT02988661|42238124|FG000|Overall Study|Withdrawal by Subject|0|||
19781847|NCT02988661|42238125|FG001|Overall Study|Withdrawal by Subject|6|||
19781848|NCT02988661|42238124|FG000|Overall Study|Unable to complete the 18-month survey|1|||
19781849|NCT02988661|42238125|FG001|Overall Study|Unable to complete the 18-month survey|27|||
19781850|NCT03738397|42238133|FG000|Overall Study|Adverse Event|3|||
19781851|NCT03738397|42238134|FG001|Overall Study|Adverse Event|7|||
19607191|NCT00673465|42055943|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
19781852|NCT03738397|42238133|FG000|Overall Study|Withdrawal by Subject|8|||
19781853|NCT03738397|42238134|FG001|Overall Study|Withdrawal by Subject|11|||
19781854|NCT03738397|42238133|FG000|Overall Study|Lost to Follow-up|8|||
19781855|NCT03738397|42238134|FG001|Overall Study|Lost to Follow-up|5|||
19781856|NCT03738397|42238133|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
19781857|NCT03738397|42238134|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
19781858|NCT03738397|42238133|FG000|Overall Study|Other|4|||
19781859|NCT03738397|42238134|FG001|Overall Study|Other|6|||
19781860|NCT02960217|42238142|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
19695037|NCT00347360|42140271|FG011|Overall Study|Subject left town, ran out of study drug|0|||
19695038|NCT00347360|42140272|FG012|Overall Study|Subject left town, ran out of study drug|0|||
19695039|NCT00347360|42140273|FG013|Overall Study|Subject left town, ran out of study drug|1|||
19695040|NCT00347360|42140274|FG014|Overall Study|Subject left town, ran out of study drug|0|||
19695041|NCT00347360|42140260|FG000|Overall Study|Subject refuse to sign updated consent|0|||
19695042|NCT00347360|42140261|FG001|Overall Study|Subject refuse to sign updated consent|0|||
19695043|NCT00347360|42140262|FG002|Overall Study|Subject refuse to sign updated consent|0|||
19695044|NCT00347360|42140263|FG003|Overall Study|Subject refuse to sign updated consent|0|||
19695045|NCT00347360|42140264|FG004|Overall Study|Subject refuse to sign updated consent|0|||
19695046|NCT00347360|42140265|FG005|Overall Study|Subject refuse to sign updated consent|0|||
19781861|NCT02960217|42238143|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
19781862|NCT02960217|42238142|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
19781863|NCT02960217|42238143|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
19781864|NCT02960217|42238142|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
19781865|NCT02960217|42238143|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
19781866|NCT02960217|42238142|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
19781867|NCT02960217|42238143|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
19781868|NCT02960217|42238142|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
19781869|NCT02960217|42238143|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
19781870|NCT02960217|42238142|FG000|Open-Label Extension Phase|Adverse Event|1|||
19781871|NCT02960217|42238143|FG001|Open-Label Extension Phase|Adverse Event|0|||
19781872|NCT02960217|42238142|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
19781873|NCT02960217|42238143|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
19781874|NCT02960217|42238142|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
19781875|NCT02960217|42238143|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
19781876|NCT02960217|42238142|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
19781877|NCT02960217|42238143|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
19781878|NCT02959983|42238155|FG000|Overall Study|Protocol Violation|0|||
19781879|NCT02959983|42238156|FG001|Overall Study|Protocol Violation|1|||
19781880|NCT02959983|42238155|FG000|Overall Study|Lack of Efficacy|0|||
19781881|NCT02959983|42238156|FG001|Overall Study|Lack of Efficacy|1|||
19781882|NCT02959983|42238155|FG000|Overall Study|Lost to Follow-up|12|||
19781883|NCT02959983|42238156|FG001|Overall Study|Lost to Follow-up|9|||
19781884|NCT02959983|42238155|FG000|Overall Study|Other|1|||
19695047|NCT00347360|42140266|FG006|Overall Study|Subject refuse to sign updated consent|0|||
19695048|NCT00347360|42140267|FG007|Overall Study|Subject refuse to sign updated consent|0|||
19695049|NCT00347360|42140268|FG008|Overall Study|Subject refuse to sign updated consent|0|||
19695050|NCT00347360|42140269|FG009|Overall Study|Subject refuse to sign updated consent|0|||
19695051|NCT00347360|42140270|FG010|Overall Study|Subject refuse to sign updated consent|0|||
19695052|NCT00347360|42140271|FG011|Overall Study|Subject refuse to sign updated consent|0|||
19695053|NCT00347360|42140272|FG012|Overall Study|Subject refuse to sign updated consent|0|||
19695054|NCT00347360|42140273|FG013|Overall Study|Subject refuse to sign updated consent|0|||
19695055|NCT00347360|42140274|FG014|Overall Study|Subject refuse to sign updated consent|1|||
19695056|NCT00347360|42140260|FG000|Overall Study|Visits conflicted with new job|0|||
19695057|NCT00347360|42140261|FG001|Overall Study|Visits conflicted with new job|0|||
19695058|NCT00347360|42140262|FG002|Overall Study|Visits conflicted with new job|0|||
19695059|NCT00347360|42140263|FG003|Overall Study|Visits conflicted with new job|0|||
19695060|NCT00347360|42140264|FG004|Overall Study|Visits conflicted with new job|0|||
19695061|NCT00347360|42140265|FG005|Overall Study|Visits conflicted with new job|0|||
19695062|NCT00347360|42140266|FG006|Overall Study|Visits conflicted with new job|1|||
19695063|NCT00347360|42140267|FG007|Overall Study|Visits conflicted with new job|0|||
19695064|NCT00347360|42140268|FG008|Overall Study|Visits conflicted with new job|0|||
19695065|NCT00347360|42140269|FG009|Overall Study|Visits conflicted with new job|0|||
19695066|NCT00347360|42140270|FG010|Overall Study|Visits conflicted with new job|0|||
19695067|NCT00347360|42140271|FG011|Overall Study|Visits conflicted with new job|0|||
19695068|NCT00347360|42140272|FG012|Overall Study|Visits conflicted with new job|0|||
19781885|NCT02959983|42238156|FG001|Overall Study|Other|1|||
19781886|NCT02959983|42238155|FG000|Overall Study|Physician Decision|1|||
19781887|NCT02959983|42238156|FG001|Overall Study|Physician Decision|0|||
19781888|NCT02959983|42238155|FG000|Overall Study|Adverse Event|5|||
19781889|NCT02959983|42238156|FG001|Overall Study|Adverse Event|1|||
19781890|NCT02959983|42238155|FG000|Overall Study|Withdrawal by Subject|7|||
19781891|NCT02959983|42238156|FG001|Overall Study|Withdrawal by Subject|12|||
19781892|NCT01344447|42238162|FG000|Overall Study|Adverse Event|1|||
19781893|NCT01344447|42238162|FG000|Overall Study|Protocol Violation|1|||
19781894|NCT01344447|42238162|FG000|Overall Study|Withdrawal by Subject|1|||
19781895|NCT01344447|42238162|FG000|Overall Study|The contrast was not seen|1|||
19781896|NCT01344447|42238162|FG000|Overall Study|Physician Decision|1|||
19781897|NCT01344447|42238162|FG000|Overall Study|MRA unsuccessful|1|||
19781898|NCT01344447|42238162|FG000|Overall Study|Bolus tracking failed|1|||
19781899|NCT01344447|42238162|FG000|Overall Study|Error of power injector|1|||
19781900|NCT03513068|42238172|FG000|Overall Study|Death|1|||
19781901|NCT03513068|42238173|FG001|Overall Study|Death|0|||
19781902|NCT03513068|42238172|FG000|Overall Study|Withdrawal by Subject|4|||
19781903|NCT03513068|42238173|FG001|Overall Study|Withdrawal by Subject|6|||
19781904|NCT01348425|42238181|FG000|Overall Study|Imaging was not taken.|1|||
19781905|NCT01348425|42238182|FG001|Overall Study|Imaging was not taken.|1|||
19781906|NCT03041701|42238190|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
19781907|NCT03041701|42238191|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
19781908|NCT03041701|42238192|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
19781909|NCT03041701|42238190|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
19781910|NCT03041701|42238191|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
19781911|NCT03041701|42238192|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
19781912|NCT02956629|42238209|FG000|Overall Study|Adverse Event|0|||
19781913|NCT02956629|42238210|FG001|Overall Study|Adverse Event|0|||
19781914|NCT02956629|42238211|FG002|Overall Study|Adverse Event|1|||
19781915|NCT02956629|42238212|FG003|Overall Study|Adverse Event|0|||
19781916|NCT02956629|42238213|FG004|Overall Study|Adverse Event|0|||
19781917|NCT02956629|42238214|FG005|Overall Study|Adverse Event|0|||
19781918|NCT02956629|42238209|FG000|Overall Study|Lost to Follow-up|2|||
19781919|NCT02956629|42238210|FG001|Overall Study|Lost to Follow-up|5|||
19781920|NCT02956629|42238211|FG002|Overall Study|Lost to Follow-up|3|||
19781921|NCT02956629|42238212|FG003|Overall Study|Lost to Follow-up|1|||
19781922|NCT02956629|42238213|FG004|Overall Study|Lost to Follow-up|0|||
19781923|NCT02956629|42238214|FG005|Overall Study|Lost to Follow-up|1|||
19781924|NCT02956629|42238209|FG000|Overall Study|Withdrawal by Subject|3|||
19781925|NCT02956629|42238210|FG001|Overall Study|Withdrawal by Subject|1|||
19781926|NCT02956629|42238211|FG002|Overall Study|Withdrawal by Subject|0|||
19781927|NCT02956629|42238212|FG003|Overall Study|Withdrawal by Subject|0|||
19781928|NCT02956629|42238213|FG004|Overall Study|Withdrawal by Subject|0|||
19781929|NCT02956629|42238214|FG005|Overall Study|Withdrawal by Subject|0|||
19781930|NCT01348347|42238231|FG000|Overall Study|Withdrawal by Subject|1|||
19781931|NCT01348347|42238232|FG001|Overall Study|Withdrawal by Subject|1|||
19781932|NCT01348347|42238233|FG002|Overall Study|Withdrawal by Subject|1|||
19781933|NCT01348347|42238231|FG000|Overall Study|Progressive disease|2|||
19781934|NCT01348347|42238232|FG001|Overall Study|Progressive disease|5|||
19781935|NCT01348347|42238233|FG002|Overall Study|Progressive disease|5|||
19781936|NCT02959671|42238242|FG000|Overall Study|Adverse Event|2|||
19781937|NCT02959671|42238242|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
19781938|NCT01597258|42238246|FG000|Overall Study|No Drug Administration|1|||
19781939|NCT02958267|42238252|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
19781940|NCT02958267|42238253|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
19781941|NCT02958267|42238252|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
19781942|NCT02958267|42238253|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
19781943|NCT02958267|42238252|FG000|Follow-up Visits|Additional treatment pursued|2|||
19781944|NCT02958267|42238253|FG001|Follow-up Visits|Additional treatment pursued|1|||
19781945|NCT01952574|42238263|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
19781946|NCT01952574|42238264|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
19781947|NCT01952574|42238265|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
19781948|NCT01952574|42238266|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
19781949|NCT01952574|42238267|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19781950|NCT01952574|42238268|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19781951|NCT01952574|42238269|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19781952|NCT01952574|42238263|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
19781953|NCT01952574|42238264|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
19781954|NCT01952574|42238265|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
19781955|NCT01952574|42238266|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
19781956|NCT01952574|42238267|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
19781957|NCT01952574|42238268|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
19781958|NCT01952574|42238269|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
19781959|NCT01952574|42238263|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
19781960|NCT01952574|42238264|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
19781961|NCT01952574|42238265|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
19781962|NCT01952574|42238266|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
19781963|NCT01952574|42238267|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
19781964|NCT01952574|42238268|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
19781965|NCT01952574|42238269|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
19781966|NCT01952574|42238263|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781967|NCT01952574|42238264|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781968|NCT01952574|42238265|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781969|NCT01952574|42238266|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781970|NCT01952574|42238267|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
19781971|NCT01952574|42238268|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781972|NCT01952574|42238269|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
19781973|NCT01952574|42238263|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
19781974|NCT01952574|42238264|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
19781975|NCT01952574|42238265|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
19781976|NCT01952574|42238266|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
19781977|NCT01952574|42238267|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
19781978|NCT01952574|42238268|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
19781979|NCT01952574|42238269|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
19781980|NCT01952574|42238263|FG000|Open-label Treatment Phase|Missing|0|||
19781981|NCT01952574|42238264|FG001|Open-label Treatment Phase|Missing|0|||
19781982|NCT01952574|42238265|FG002|Open-label Treatment Phase|Missing|0|||
19781983|NCT01952574|42238266|FG003|Open-label Treatment Phase|Missing|0|||
19781984|NCT01952574|42238267|FG004|Open-label Treatment Phase|Missing|4|||
19781985|NCT01952574|42238268|FG005|Open-label Treatment Phase|Missing|0|||
19781986|NCT01952574|42238269|FG006|Open-label Treatment Phase|Missing|0|||
19781987|NCT01952574|42238263|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
19781988|NCT01952574|42238264|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
19781989|NCT01952574|42238265|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
19781990|NCT01952574|42238266|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
19781991|NCT01952574|42238267|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
19781992|NCT01952574|42238268|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
19781993|NCT01952574|42238269|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
19781994|NCT01952574|42238263|FG000|Open-label Treatment Phase|Death|0|||
19781995|NCT01952574|42238264|FG001|Open-label Treatment Phase|Death|0|||
19781996|NCT01952574|42238265|FG002|Open-label Treatment Phase|Death|0|||
19781997|NCT01952574|42238266|FG003|Open-label Treatment Phase|Death|0|||
19781998|NCT01952574|42238267|FG004|Open-label Treatment Phase|Death|1|||
19781999|NCT01952574|42238268|FG005|Open-label Treatment Phase|Death|0|||
19782000|NCT01952574|42238269|FG006|Open-label Treatment Phase|Death|0|||
19782001|NCT01952574|42238263|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782002|NCT01952574|42238264|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782003|NCT01952574|42238265|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782004|NCT01952574|42238266|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782005|NCT01952574|42238267|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782006|NCT01952574|42238268|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
19782007|NCT01952574|42238269|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
19782008|NCT01952574|42238263|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
19782009|NCT01952574|42238264|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
19782010|NCT01952574|42238265|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
19782011|NCT01952574|42238266|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
19782012|NCT01952574|42238267|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
19782013|NCT01952574|42238268|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
19782014|NCT01952574|42238269|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
19782015|NCT02959437|42238298|FG000|Overall Study|Death|33|||
19782016|NCT02959437|42238299|FG001|Overall Study|Death|3|||
19782017|NCT02959437|42238300|FG002|Overall Study|Death|0|||
19782018|NCT02959437|42238301|FG003|Overall Study|Death|0|||
19782019|NCT02959437|42238298|FG000|Overall Study|Lost to Follow-up|3|||
19782020|NCT02959437|42238299|FG001|Overall Study|Lost to Follow-up|1|||
19782021|NCT02959437|42238300|FG002|Overall Study|Lost to Follow-up|0|||
19782022|NCT02959437|42238301|FG003|Overall Study|Lost to Follow-up|0|||
19782023|NCT02959437|42238298|FG000|Overall Study|Withdrawal by Subject|11|||
19782024|NCT02959437|42238299|FG001|Overall Study|Withdrawal by Subject|3|||
19782025|NCT02959437|42238300|FG002|Overall Study|Withdrawal by Subject|0|||
19782026|NCT02959437|42238301|FG003|Overall Study|Withdrawal by Subject|0|||
19782027|NCT02959437|42238298|FG000|Overall Study|Progressive Disease|9|||
19782028|NCT02959437|42238299|FG001|Overall Study|Progressive Disease|1|||
19782029|NCT02959437|42238300|FG002|Overall Study|Progressive Disease|0|||
19782030|NCT02959437|42238301|FG003|Overall Study|Progressive Disease|0|||
19782031|NCT02959437|42238298|FG000|Overall Study|Study Terminated by Sponsor|4|||
19782032|NCT02959437|42238299|FG001|Overall Study|Study Terminated by Sponsor|0|||
19782033|NCT02959437|42238300|FG002|Overall Study|Study Terminated by Sponsor|0|||
19782034|NCT02959437|42238301|FG003|Overall Study|Study Terminated by Sponsor|0|||
19782035|NCT02959437|42238298|FG000|Overall Study|Other Unspecified|2|||
19782036|NCT02959437|42238299|FG001|Overall Study|Other Unspecified|0|||
19782037|NCT02959437|42238300|FG002|Overall Study|Other Unspecified|0|||
19782038|NCT02959437|42238301|FG003|Overall Study|Other Unspecified|0|||
19782039|NCT02957331|42238314|FG000|Overall Study|Protocol Violation|1|||
19782040|NCT02957331|42238315|FG001|Overall Study|Protocol Violation|0|||
19782041|NCT02646124|42238323|FG000|Overall Study|Lost to Follow-up|0|||
19782042|NCT02646124|42238324|FG001|Overall Study|Lost to Follow-up|2|||
19782043|NCT03041467|42238332|FG000|Overall Study|Death|36|||
19782044|NCT03041467|42238333|FG001|Overall Study|Death|32|||
19782045|NCT03041467|42238332|FG000|Overall Study|Withdrawal by Subject|26|||
19782046|NCT03041467|42238333|FG001|Overall Study|Withdrawal by Subject|28|||
19782047|NCT03041467|42238332|FG000|Overall Study|Lost to Follow-up|6|||
19782048|NCT03041467|42238333|FG001|Overall Study|Lost to Follow-up|7|||
19782049|NCT03041467|42238332|FG000|Overall Study|Declined consent for study extension|21|||
19782050|NCT03041467|42238333|FG001|Overall Study|Declined consent for study extension|33|||
19782051|NCT03041467|42238332|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
19782052|NCT03041467|42238333|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
19782053|NCT03041467|42238332|FG000|Overall Study|36 Month visit not completed|2|||
19782054|NCT03041467|42238333|FG001|Overall Study|36 Month visit not completed|0|||
19782055|NCT01597492|42238343|FG000|Overall Study|Withdrawal by Subject|1|||
19782056|NCT01597492|42238344|FG001|Overall Study|Withdrawal by Subject|2|||
19782057|NCT01597492|42238343|FG000|Overall Study|Adverse Event|3|||
19782058|NCT01597492|42238344|FG001|Overall Study|Adverse Event|0|||
19782059|NCT01597492|42238343|FG000|Overall Study|Lost to Follow-up|0|||
19782060|NCT01597492|42238344|FG001|Overall Study|Lost to Follow-up|2|||
19782061|NCT01597492|42238343|FG000|Overall Study|Other Reason|2|||
19782062|NCT01597492|42238344|FG001|Overall Study|Other Reason|0|||
19782063|NCT03423602|42238350|FG000|Overall Study|Death|1|||
19782064|NCT03423602|42238350|FG000|Overall Study|Lost to Follow-up|6|||
19782065|NCT03423602|42238350|FG000|Overall Study|Protocol Violation|1|||
19782066|NCT03423602|42238350|FG000|Overall Study|Withdrawal by Subject|4|||
19782067|NCT00109590|42238357|FG000|Overall Study|Lost to Follow-up|1|||
19782068|NCT00109590|42238358|FG001|Overall Study|Lost to Follow-up|0|||
19782069|NCT00109590|42238359|FG002|Overall Study|Lost to Follow-up|1|||
19782070|NCT00109590|42238357|FG000|Overall Study|Never Started Treatment|1|||
19782071|NCT00109590|42238358|FG001|Overall Study|Never Started Treatment|2|||
19782072|NCT00109590|42238359|FG002|Overall Study|Never Started Treatment|3|||
19782073|NCT02781558|42238383|FG000|Overall Study|Lost to Follow-up|2|||
19782074|NCT02781558|42238384|FG001|Overall Study|Lost to Follow-up|2|||
19782075|NCT02781558|42238383|FG000|Overall Study|Adverse Event|1|||
19782076|NCT02781558|42238384|FG001|Overall Study|Adverse Event|0|||
19782077|NCT03041311|42238393|FG000|Overall Study|Death|39|||
19782078|NCT03041311|42238394|FG001|Overall Study|Death|42|||
19782079|NCT03041311|42238393|FG000|Overall Study|Lost to Follow-up|0|||
19782080|NCT03041311|42238394|FG001|Overall Study|Lost to Follow-up|1|||
19782081|NCT03041311|42238393|FG000|Overall Study|Withdrawal by Subject|8|||
19782082|NCT03041311|42238394|FG001|Overall Study|Withdrawal by Subject|5|||
19782083|NCT03041311|42238393|FG000|Overall Study|Sponsor Terminated Study|2|||
19782084|NCT03041311|42238394|FG001|Overall Study|Sponsor Terminated Study|4|||
19782085|NCT03041311|42238393|FG000|Overall Study|Disease Progression|3|||
19782086|NCT03041311|42238394|FG001|Overall Study|Disease Progression|1|||
19782087|NCT03041311|42238393|FG000|Overall Study|Randomized in error, did not receive drug|2|||
19782088|NCT03041311|42238394|FG001|Overall Study|Randomized in error, did not receive drug|0|||
19782089|NCT02644096|42238410|FG000|Overall Study|Withdrawal by Subject|28|||
19782090|NCT02644096|42238411|FG001|Overall Study|Withdrawal by Subject|25|||
19782091|NCT02643628|42238419|FG000|Overall Study|Lost to Follow-up|1|||
19782092|NCT02643628|42238420|FG001|Overall Study|Lost to Follow-up|4|||
19782093|NCT02643628|42238419|FG000|Overall Study|Withdrawal by Subject|0|||
19782094|NCT02643628|42238420|FG001|Overall Study|Withdrawal by Subject|1|||
19782095|NCT02643628|42238419|FG000|Overall Study|Relocated out of state|0|||
19782096|NCT02643628|42238420|FG001|Overall Study|Relocated out of state|1|||
19782097|NCT02643472|42238430|FG000|Overall Study|Death|2|||
19782098|NCT02643472|42238431|FG001|Overall Study|Death|5|||
19782099|NCT02643472|42238430|FG000|Overall Study|Withdrawal by Subject|3|||
19782100|NCT02643472|42238431|FG001|Overall Study|Withdrawal by Subject|2|||
19782101|NCT02643472|42238430|FG000|Overall Study|Protocol Violation|0|||
19782102|NCT02643472|42238431|FG001|Overall Study|Protocol Violation|1|||
19782103|NCT02643472|42238430|FG000|Overall Study|Lost to Follow-up|22|||
19782104|NCT02643472|42238431|FG001|Overall Study|Lost to Follow-up|26|||
19782105|NCT02738840|42238439|FG000|Overall Study|MRI Scan not Performed|5|||
19782106|NCT02738840|42238439|FG000|Overall Study|Lost to Follow-up|1|||
19782107|NCT02738840|42238439|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
19782108|NCT02738840|42238439|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
19782109|NCT03569293|42238449|FG000|Overall Study|Adverse Event|4|||
19782110|NCT03569293|42238450|FG001|Overall Study|Adverse Event|1|||
19782111|NCT03569293|42238451|FG002|Overall Study|Adverse Event|5|||
19782112|NCT03569293|42238452|FG003|Overall Study|Adverse Event|1|||
19782113|NCT03569293|42238453|FG004|Overall Study|Adverse Event|0|||
19782114|NCT03569293|42238454|FG005|Overall Study|Adverse Event|0|||
19782115|NCT03569293|42238449|FG000|Overall Study|Withdrawal by Subject|16|||
19782116|NCT03569293|42238450|FG001|Overall Study|Withdrawal by Subject|2|||
19782117|NCT03569293|42238451|FG002|Overall Study|Withdrawal by Subject|4|||
19782118|NCT03569293|42238452|FG003|Overall Study|Withdrawal by Subject|1|||
19782119|NCT03569293|42238453|FG004|Overall Study|Withdrawal by Subject|0|||
19782120|NCT03569293|42238454|FG005|Overall Study|Withdrawal by Subject|0|||
19782121|NCT03569293|42238449|FG000|Overall Study|Lost to Follow-up|1|||
19782122|NCT03569293|42238450|FG001|Overall Study|Lost to Follow-up|3|||
19782123|NCT03569293|42238451|FG002|Overall Study|Lost to Follow-up|1|||
19782124|NCT03569293|42238452|FG003|Overall Study|Lost to Follow-up|1|||
19782125|NCT03569293|42238453|FG004|Overall Study|Lost to Follow-up|0|||
19782126|NCT03569293|42238454|FG005|Overall Study|Lost to Follow-up|0|||
19782127|NCT03569293|42238449|FG000|Overall Study|Other|8|||
19782128|NCT03569293|42238450|FG001|Overall Study|Other|2|||
19782129|NCT03569293|42238451|FG002|Overall Study|Other|1|||
19782130|NCT03569293|42238452|FG003|Overall Study|Other|1|||
19782131|NCT03569293|42238453|FG004|Overall Study|Other|0|||
19782132|NCT03569293|42238454|FG005|Overall Study|Other|0|||
19782133|NCT03569293|42238449|FG000|Overall Study|Ongoing at Time of Analysis|8|||
19782134|NCT03569293|42238450|FG001|Overall Study|Ongoing at Time of Analysis|1|||
19782135|NCT03569293|42238451|FG002|Overall Study|Ongoing at Time of Analysis|3|||
19782136|NCT03569293|42238452|FG003|Overall Study|Ongoing at Time of Analysis|0|||
19782137|NCT03569293|42238453|FG004|Overall Study|Ongoing at Time of Analysis|0|||
19782138|NCT03569293|42238454|FG005|Overall Study|Ongoing at Time of Analysis|0|||
19782139|NCT02643394|42238470|FG000|Overall Study|Protocol Violation|4|||
19782140|NCT02643394|42238471|FG001|Overall Study|Protocol Violation|5|||
19782141|NCT03538158|42238479|FG000|Overall Study|Lost to Follow-up|13|||
19782142|NCT03538158|42238480|FG001|Overall Study|Lost to Follow-up|7|||
19782143|NCT03538158|42238479|FG000|Overall Study|Withdrawal by Subject|2|||
19782144|NCT03538158|42238480|FG001|Overall Study|Withdrawal by Subject|1|||
19782145|NCT02643082|42238486|FG000|Period 1|Adverse Event|1|||
19782146|NCT02643082|42238487|FG001|Period 1|Adverse Event|0|||
19782147|NCT00353496|42238496|FG000|Overall Study|Adverse Event|1|||
19782148|NCT00353496|42238497|FG001|Overall Study|Adverse Event|0|||
19782149|NCT00353496|42238496|FG000|Overall Study|Protocol Violation|2|||
19782150|NCT00353496|42238497|FG001|Overall Study|Protocol Violation|2|||
19782151|NCT00353496|42238496|FG000|Overall Study|Withdrawal by Subject|3|||
19782152|NCT00353496|42238497|FG001|Overall Study|Withdrawal by Subject|4|||
19782153|NCT00353496|42238496|FG000|Overall Study|Physician Decision|6|||
19782154|NCT00353496|42238497|FG001|Overall Study|Physician Decision|9|||
19782155|NCT00353496|42238496|FG000|Overall Study|Not otherwise specified|4|||
19782156|NCT00353496|42238497|FG001|Overall Study|Not otherwise specified|2|||
19782157|NCT01361464|42238513|FG000|Overall Study|Death|1|||
19782158|NCT01361464|42238513|FG000|Overall Study|Withdrawal by Subject|2|||
19782159|NCT03486912|42238521|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
19782160|NCT03486912|42238522|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
19782161|NCT03486912|42238523|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
19782162|NCT03486912|42238524|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
19782163|NCT03486912|42238521|FG000|Treatment Period|Withdrawal by Subject|3|||
19782164|NCT03486912|42238522|FG001|Treatment Period|Withdrawal by Subject|3|||
19782165|NCT03486912|42238523|FG002|Treatment Period|Withdrawal by Subject|3|||
19782166|NCT03486912|42238524|FG003|Treatment Period|Withdrawal by Subject|2|||
19782167|NCT03486912|42238521|FG000|Treatment Period|Other Reasons|0|||
19782168|NCT03486912|42238522|FG001|Treatment Period|Other Reasons|2|||
19782169|NCT03486912|42238523|FG002|Treatment Period|Other Reasons|1|||
19782170|NCT03486912|42238524|FG003|Treatment Period|Other Reasons|1|||
19782171|NCT03486912|42238521|FG000|Treatment Period|Adverse Event|0|||
19782172|NCT03486912|42238522|FG001|Treatment Period|Adverse Event|1|||
19782173|NCT03486912|42238523|FG002|Treatment Period|Adverse Event|1|||
19782174|NCT03486912|42238524|FG003|Treatment Period|Adverse Event|0|||
19782175|NCT03486912|42238521|FG000|Treatment Period|Lost to Follow-up|1|||
19782176|NCT03486912|42238522|FG001|Treatment Period|Lost to Follow-up|0|||
19782177|NCT03486912|42238523|FG002|Treatment Period|Lost to Follow-up|0|||
19782178|NCT03486912|42238524|FG003|Treatment Period|Lost to Follow-up|2|||
19782179|NCT03345342|42238534|FG000|Open-Label Phase|Adverse Event|30|||
19782180|NCT03345342|42238535|FG001|Open-Label Phase|Adverse Event|0|||
19782181|NCT03345342|42238536|FG002|Open-Label Phase|Adverse Event|0|||
19782182|NCT03345342|42238537|FG003|Open-Label Phase|Adverse Event|0|||
19782183|NCT03345342|42238538|FG004|Open-Label Phase|Adverse Event|0|||
19782184|NCT03345342|42238534|FG000|Open-Label Phase|Death|1|||
19782185|NCT03345342|42238535|FG001|Open-Label Phase|Death|0|||
19782186|NCT03345342|42238536|FG002|Open-Label Phase|Death|0|||
19782187|NCT03345342|42238537|FG003|Open-Label Phase|Death|0|||
19782188|NCT03345342|42238538|FG004|Open-Label Phase|Death|0|||
19782189|NCT03345342|42238534|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
19782190|NCT03345342|42238535|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
19782191|NCT03345342|42238536|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
19782192|NCT03345342|42238537|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
19782193|NCT03345342|42238538|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
19782194|NCT03345342|42238534|FG000|Open-Label Phase|Lack of Efficacy|6|||
19782195|NCT03345342|42238535|FG001|Open-Label Phase|Lack of Efficacy|0|||
19782196|NCT03345342|42238536|FG002|Open-Label Phase|Lack of Efficacy|0|||
19782197|NCT03345342|42238537|FG003|Open-Label Phase|Lack of Efficacy|0|||
19782198|NCT03345342|42238538|FG004|Open-Label Phase|Lack of Efficacy|0|||
19782199|NCT03345342|42238534|FG000|Open-Label Phase|Lost to Follow-up|9|||
19782200|NCT03345342|42238535|FG001|Open-Label Phase|Lost to Follow-up|0|||
19782201|NCT03345342|42238536|FG002|Open-Label Phase|Lost to Follow-up|0|||
19782202|NCT03345342|42238537|FG003|Open-Label Phase|Lost to Follow-up|0|||
19782203|NCT03345342|42238538|FG004|Open-Label Phase|Lost to Follow-up|0|||
19782204|NCT03345342|42238534|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
19782205|NCT03345342|42238535|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
19782206|NCT03345342|42238536|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
19782207|NCT03345342|42238537|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
19782208|NCT03345342|42238538|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
19782209|NCT03345342|42238534|FG000|Open-Label Phase|Physician Decision|4|||
19782210|NCT03345342|42238535|FG001|Open-Label Phase|Physician Decision|0|||
19782211|NCT03345342|42238536|FG002|Open-Label Phase|Physician Decision|0|||
19782212|NCT03345342|42238537|FG003|Open-Label Phase|Physician Decision|0|||
19782213|NCT03345342|42238538|FG004|Open-Label Phase|Physician Decision|0|||
19782214|NCT03345342|42238534|FG000|Open-Label Phase|Protocol Violation|8|||
19782215|NCT03345342|42238535|FG001|Open-Label Phase|Protocol Violation|0|||
19782216|NCT03345342|42238536|FG002|Open-Label Phase|Protocol Violation|0|||
19782217|NCT03345342|42238537|FG003|Open-Label Phase|Protocol Violation|0|||
19782218|NCT03345342|42238538|FG004|Open-Label Phase|Protocol Violation|0|||
19782219|NCT03345342|42238534|FG000|Open-Label Phase|Withdrawal by Subject|57|||
19782220|NCT03345342|42238535|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19782221|NCT03345342|42238536|FG002|Open-Label Phase|Withdrawal by Subject|0|||
19782222|NCT03345342|42238537|FG003|Open-Label Phase|Withdrawal by Subject|0|||
19782223|NCT03345342|42238538|FG004|Open-Label Phase|Withdrawal by Subject|0|||
19782224|NCT03345342|42238534|FG000|Open-Label Phase|Other|15|||
19782225|NCT03345342|42238535|FG001|Open-Label Phase|Other|0|||
19782226|NCT03345342|42238536|FG002|Open-Label Phase|Other|0|||
19782227|NCT03345342|42238537|FG003|Open-Label Phase|Other|0|||
19782228|NCT03345342|42238538|FG004|Open-Label Phase|Other|0|||
19782229|NCT03345342|42238534|FG000|Double-Blind Phase|Adverse Event|0|||
19782230|NCT03345342|42238535|FG001|Double-Blind Phase|Adverse Event|1|||
19782231|NCT03345342|42238536|FG002|Double-Blind Phase|Adverse Event|6|||
19782232|NCT03345342|42238537|FG003|Double-Blind Phase|Adverse Event|0|||
19782233|NCT03345342|42238538|FG004|Double-Blind Phase|Adverse Event|0|||
19782234|NCT03345342|42238534|FG000|Double-Blind Phase|Death|0|||
19782235|NCT03345342|42238535|FG001|Double-Blind Phase|Death|2|||
19782236|NCT03345342|42238536|FG002|Double-Blind Phase|Death|1|||
19782237|NCT03345342|42238537|FG003|Double-Blind Phase|Death|0|||
19782238|NCT03345342|42238538|FG004|Double-Blind Phase|Death|0|||
19782239|NCT03345342|42238534|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
19782240|NCT03345342|42238535|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
19782241|NCT03345342|42238536|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
19695069|NCT00347360|42140273|FG013|Overall Study|Visits conflicted with new job|0|||
19695070|NCT00347360|42140274|FG014|Overall Study|Visits conflicted with new job|0|||
19695071|NCT00319020|42140308|FG000|Overall Study|Death|2|||
19695072|NCT00319020|42140309|FG001|Overall Study|Death|2|||
19695073|NCT00319020|42140308|FG000|Overall Study|Withdrawal by Subject|4|||
19695074|NCT00319020|42140309|FG001|Overall Study|Withdrawal by Subject|1|||
19695075|NCT00319020|42140308|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
19782242|NCT03345342|42238537|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
19782243|NCT03345342|42238538|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
19782244|NCT03345342|42238534|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19782245|NCT03345342|42238535|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19782246|NCT03345342|42238536|FG002|Double-Blind Phase|Lost to Follow-up|7|||
19782247|NCT03345342|42238537|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19782248|NCT03345342|42238538|FG004|Double-Blind Phase|Lost to Follow-up|0|||
19782249|NCT03345342|42238534|FG000|Double-Blind Phase|Physician Decision|0|||
19782250|NCT03345342|42238535|FG001|Double-Blind Phase|Physician Decision|1|||
19695076|NCT00319020|42140309|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
19695077|NCT00319020|42140308|FG000|Overall Study|Administrative reason|0|||
19695078|NCT00319020|42140309|FG001|Overall Study|Administrative reason|5|||
19695079|NCT00319020|42140308|FG000|Overall Study|Disease progression|0|||
19782251|NCT03345342|42238536|FG002|Double-Blind Phase|Physician Decision|4|||
19782252|NCT03345342|42238537|FG003|Double-Blind Phase|Physician Decision|0|||
19782253|NCT03345342|42238538|FG004|Double-Blind Phase|Physician Decision|0|||
19782254|NCT03345342|42238534|FG000|Double-Blind Phase|Protocol Violation|0|||
19782255|NCT03345342|42238535|FG001|Double-Blind Phase|Protocol Violation|0|||
19782256|NCT03345342|42238536|FG002|Double-Blind Phase|Protocol Violation|1|||
19782257|NCT03345342|42238537|FG003|Double-Blind Phase|Protocol Violation|0|||
19782258|NCT03345342|42238538|FG004|Double-Blind Phase|Protocol Violation|0|||
19782259|NCT03345342|42238534|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19782260|NCT03345342|42238535|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
19782261|NCT03345342|42238536|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
19782262|NCT03345342|42238537|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19782263|NCT03345342|42238538|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
19782264|NCT03345342|42238534|FG000|Double-Blind Phase|Other|0|||
19782265|NCT03345342|42238535|FG001|Double-Blind Phase|Other|1|||
19782266|NCT03345342|42238536|FG002|Double-Blind Phase|Other|3|||
19782267|NCT03345342|42238537|FG003|Double-Blind Phase|Other|0|||
19782268|NCT03345342|42238538|FG004|Double-Blind Phase|Other|0|||
19782269|NCT03345342|42238534|FG000|Follow-Up Phase|Adverse Event|0|||
19782270|NCT03345342|42238535|FG001|Follow-Up Phase|Adverse Event|0|||
19782271|NCT03345342|42238536|FG002|Follow-Up Phase|Adverse Event|0|||
19782272|NCT03345342|42238537|FG003|Follow-Up Phase|Adverse Event|0|||
19782273|NCT03345342|42238538|FG004|Follow-Up Phase|Adverse Event|4|||
19782274|NCT03345342|42238534|FG000|Follow-Up Phase|Lost to Follow-up|0|||
19782275|NCT03345342|42238535|FG001|Follow-Up Phase|Lost to Follow-up|0|||
19782276|NCT03345342|42238536|FG002|Follow-Up Phase|Lost to Follow-up|0|||
19782277|NCT03345342|42238537|FG003|Follow-Up Phase|Lost to Follow-up|0|||
19782278|NCT03345342|42238538|FG004|Follow-Up Phase|Lost to Follow-up|6|||
19782279|NCT03345342|42238534|FG000|Follow-Up Phase|Physician Decision|0|||
19782280|NCT03345342|42238535|FG001|Follow-Up Phase|Physician Decision|0|||
19782281|NCT03345342|42238536|FG002|Follow-Up Phase|Physician Decision|0|||
19607192|NCT00673465|42055944|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
19607193|NCT00941798|42055954|FG000|Overall Study|Withdrawal by Subject|72|||
19607194|NCT00941798|42055955|FG001|Overall Study|Withdrawal by Subject|74|||
19607195|NCT00941798|42055954|FG000|Overall Study|Adverse Event|43|||
19607196|NCT00941798|42055955|FG001|Overall Study|Adverse Event|23|||
19607197|NCT00941798|42055954|FG000|Overall Study|Lost to Follow-up|29|||
19607198|NCT00941798|42055955|FG001|Overall Study|Lost to Follow-up|23|||
19607199|NCT00941798|42055954|FG000|Overall Study|Protocol Violation|17|||
19607200|NCT00941798|42055955|FG001|Overall Study|Protocol Violation|20|||
19607201|NCT00941798|42055954|FG000|Overall Study|Administrative problems|13|||
19607202|NCT00941798|42055955|FG001|Overall Study|Administrative problems|23|||
19607203|NCT00941798|42055954|FG000|Overall Study|Lack of Efficacy|10|||
19607204|NCT00941798|42055955|FG001|Overall Study|Lack of Efficacy|17|||
19607205|NCT00941798|42055954|FG000|Overall Study|Patient's inability to use device|6|||
19607206|NCT00941798|42055955|FG001|Overall Study|Patient's inability to use device|1|||
19607207|NCT00941798|42055954|FG000|Overall Study|Abnormal test procedure results|3|||
19607208|NCT00941798|42055955|FG001|Overall Study|Abnormal test procedure results|1|||
19607209|NCT00941798|42055954|FG000|Overall Study|Abnormal laboratory values|1|||
19607210|NCT00941798|42055955|FG001|Overall Study|Abnormal laboratory values|2|||
19607211|NCT00941798|42055954|FG000|Overall Study|Death|0|||
19607212|NCT00941798|42055955|FG001|Overall Study|Death|1|||
19607213|NCT00583102|42055961|FG000|Overall Study|Adverse Event|3|||
19607214|NCT00941720|42055965|FG000|Overall Study|Withdrawal by Subject|1|||
19607215|NCT00941720|42055965|FG000|Overall Study|Insurance denied participation|11|||
19607216|NCT00941720|42055965|FG000|Overall Study|ineligible|2|||
19607217|NCT00933686|42055971|FG000|Overall Study|Protocol Violation|0|||
19607218|NCT00933686|42055972|FG001|Overall Study|Protocol Violation|1|||
19607219|NCT00933686|42055971|FG000|Overall Study|Lost to Follow-up|2|||
19607220|NCT00933686|42055972|FG001|Overall Study|Lost to Follow-up|2|||
19607221|NCT00933686|42055971|FG000|Overall Study|Withdrawal by Subject|6|||
19607222|NCT00933686|42055972|FG001|Overall Study|Withdrawal by Subject|5|||
19607223|NCT00933686|42055971|FG000|Overall Study|Adverse Event|1|||
19607224|NCT00933686|42055972|FG001|Overall Study|Adverse Event|1|||
19607225|NCT00933686|42055971|FG000|Overall Study|Physician Decision|1|||
19607226|NCT00933686|42055972|FG001|Overall Study|Physician Decision|0|||
19607227|NCT00933686|42055971|FG000|Overall Study|Failure to show up at endpoint visits|0|||
19607228|NCT00933686|42055972|FG001|Overall Study|Failure to show up at endpoint visits|2|||
19607229|NCT00937040|42055980|FG000|Overall Study|Adverse Event|5|||
19607230|NCT00937040|42055981|FG001|Overall Study|Adverse Event|8|||
19607231|NCT00937040|42055980|FG000|Overall Study|Lost to Follow-up|12|||
19607232|NCT00937040|42055981|FG001|Overall Study|Lost to Follow-up|12|||
19607233|NCT00937040|42055980|FG000|Overall Study|Protocol Violation|3|||
19607234|NCT00937040|42055981|FG001|Overall Study|Protocol Violation|0|||
19607235|NCT00937040|42055980|FG000|Overall Study|Withdrawal by Subject|13|||
19607236|NCT00937040|42055981|FG001|Overall Study|Withdrawal by Subject|7|||
19782282|NCT03345342|42238537|FG003|Follow-Up Phase|Physician Decision|0|||
19782283|NCT03345342|42238538|FG004|Follow-Up Phase|Physician Decision|5|||
19782284|NCT03345342|42238534|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
19607237|NCT00937040|42055980|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
19607238|NCT00937040|42055981|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
19607239|NCT00937040|42055980|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
19607240|NCT00937040|42055981|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
19782285|NCT03345342|42238535|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
19695080|NCT00319020|42140309|FG001|Overall Study|Disease progression|2|||
19695081|NCT00319020|42140308|FG000|Overall Study|Transplant|0|||
19695082|NCT00319020|42140309|FG001|Overall Study|Transplant|1|||
19695083|NCT00319020|42140308|FG000|Overall Study|Treatment failure|0|||
19695084|NCT00319020|42140309|FG001|Overall Study|Treatment failure|1|||
19367331|NCT02788201|41607501|FG004|Overall Study|Ineligible|0|||
19695085|NCT00319020|42140308|FG000|Overall Study|Adverse Event|0|||
19695086|NCT00319020|42140309|FG001|Overall Study|Adverse Event|1|||
19695087|NCT00352118|42140317|FG000|Overall Study|Physician Decision|4|||
19695088|NCT00318474|42140323|FG000|Overall Study|Adverse Event|1|||
19695089|NCT00318474|42140324|FG001|Overall Study|Adverse Event|1|||
19695090|NCT00318474|42140323|FG000|Overall Study|Lost to Follow-up|0|||
19695091|NCT00318474|42140324|FG001|Overall Study|Lost to Follow-up|1|||
19695092|NCT00318474|42140323|FG000|Overall Study|Pregnancy|0|||
19695093|NCT00318474|42140324|FG001|Overall Study|Pregnancy|2|||
19367332|NCT02788201|41607502|FG005|Overall Study|Ineligible|1|||
19367333|NCT02788201|41607497|FG000|Overall Study|Withdrawal by Subject|0|||
19367334|NCT02788201|41607498|FG001|Overall Study|Withdrawal by Subject|0|||
19367335|NCT02788201|41607499|FG002|Overall Study|Withdrawal by Subject|0|||
19367336|NCT02788201|41607500|FG003|Overall Study|Withdrawal by Subject|0|||
19367337|NCT02788201|41607501|FG004|Overall Study|Withdrawal by Subject|0|||
19367338|NCT02788201|41607502|FG005|Overall Study|Withdrawal by Subject|1|||
19367339|NCT02456740|41607521|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
19367340|NCT02456740|41607522|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
19367341|NCT02456740|41607523|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
19389179|NCT02053792|41632810|FG000|Overall Study|Adverse Event|1|||
19607241|NCT00673387|42055995|FG000|Overall Study|Withdrawal by Subject|15|||
19782286|NCT03345342|42238536|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
19782287|NCT03345342|42238537|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
19782288|NCT03345342|42238538|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
19782289|NCT03345342|42238534|FG000|Follow-Up Phase|Other|0|||
19782290|NCT03345342|42238535|FG001|Follow-Up Phase|Other|0|||
19782291|NCT03345342|42238536|FG002|Follow-Up Phase|Other|0|||
19782292|NCT03345342|42238537|FG003|Follow-Up Phase|Other|3|||
19782293|NCT03345342|42238538|FG004|Follow-Up Phase|Other|1|||
19782294|NCT02642614|42238554|FG000|Overall Study|Adverse Event|1|||
19782295|NCT02642614|42238555|FG001|Overall Study|Adverse Event|1|||
19782296|NCT02642614|42238556|FG002|Overall Study|Adverse Event|2|||
19782297|NCT02642614|42238557|FG003|Overall Study|Adverse Event|2|||
19782298|NCT02642614|42238554|FG000|Overall Study|Lost to Follow-up|1|||
19782299|NCT02642614|42238555|FG001|Overall Study|Lost to Follow-up|0|||
19782300|NCT02642614|42238556|FG002|Overall Study|Lost to Follow-up|0|||
19782301|NCT02642614|42238557|FG003|Overall Study|Lost to Follow-up|0|||
19695094|NCT00318474|42140323|FG000|Overall Study|Protocol Violation|1|||
19695095|NCT00318474|42140324|FG001|Overall Study|Protocol Violation|0|||
19695096|NCT00318474|42140323|FG000|Overall Study|Withdrawal by Subject|3|||
19695097|NCT00318474|42140324|FG001|Overall Study|Withdrawal by Subject|2|||
19695098|NCT00318474|42140323|FG000|Overall Study|Fall in GFR|3|||
19695099|NCT00318474|42140324|FG001|Overall Study|Fall in GFR|3|||
19695100|NCT00318474|42140323|FG000|Overall Study|Post-therapy hyperflycemia|0|||
19695101|NCT00318474|42140324|FG001|Overall Study|Post-therapy hyperflycemia|1|||
19695102|NCT00318474|42140323|FG000|Overall Study|Trial terminated|10|||
19695103|NCT00318474|42140324|FG001|Overall Study|Trial terminated|7|||
19695104|NCT00350870|42140334|FG000|Overall Study|Withdrawal by Subject|21|||
19695105|NCT00350870|42140335|FG001|Overall Study|Withdrawal by Subject|17|||
19607242|NCT00673387|42055996|FG001|Overall Study|Withdrawal by Subject|16|||
19607243|NCT00673387|42055997|FG002|Overall Study|Withdrawal by Subject|20|||
19695106|NCT00350870|42140336|FG002|Overall Study|Withdrawal by Subject|15|||
19695107|NCT00350870|42140337|FG003|Overall Study|Withdrawal by Subject|14|||
19607244|NCT00673387|42055998|FG003|Overall Study|Withdrawal by Subject|16|||
19607245|NCT00673387|42055999|FG004|Overall Study|Withdrawal by Subject|18|||
19607246|NCT00673387|42056000|FG005|Overall Study|Withdrawal by Subject|21|||
19607247|NCT00673387|42056001|FG006|Overall Study|Withdrawal by Subject|15|||
19607248|NCT00673387|42056002|FG007|Overall Study|Withdrawal by Subject|21|||
19607249|NCT00673387|42055995|FG000|Overall Study|Adverse Event|3|||
19607250|NCT00673387|42055996|FG001|Overall Study|Adverse Event|1|||
19607251|NCT00673387|42055997|FG002|Overall Study|Adverse Event|5|||
19607252|NCT00673387|42055998|FG003|Overall Study|Adverse Event|2|||
19607253|NCT00673387|42055999|FG004|Overall Study|Adverse Event|6|||
19607254|NCT00673387|42056000|FG005|Overall Study|Adverse Event|2|||
19607255|NCT00673387|42056001|FG006|Overall Study|Adverse Event|5|||
19695108|NCT00350870|42140334|FG000|Overall Study|Physician Decision|1|||
19695109|NCT00350870|42140335|FG001|Overall Study|Physician Decision|0|||
19695110|NCT00350870|42140336|FG002|Overall Study|Physician Decision|1|||
19695111|NCT00350870|42140337|FG003|Overall Study|Physician Decision|1|||
19695112|NCT00350792|42140347|FG000|Overall Study|Adverse Event|11|||
19695113|NCT00350792|42140347|FG000|Overall Study|Death from Study Disease|1|||
19782302|NCT02642614|42238554|FG000|Overall Study|Withdrawal by Subject|1|||
19782303|NCT02642614|42238555|FG001|Overall Study|Withdrawal by Subject|1|||
19695114|NCT00350792|42140347|FG000|Overall Study|Death from Study Drug Toxicity|1|||
19695115|NCT00350792|42140347|FG000|Overall Study|Death Not Study Drug Related|2|||
19695116|NCT00350792|42140347|FG000|Overall Study|Protocol Violation|1|||
19695117|NCT00350792|42140347|FG000|Overall Study|Withdrawal by Subject|4|||
19695118|NCT00350792|42140347|FG000|Overall Study|Physician Decision|2|||
19695119|NCT00350792|42140347|FG000|Overall Study|Lack of Efficacy|11|||
19695120|NCT00317772|42140355|FG000|Overall Study|Adverse Event|0|||
19695121|NCT00317772|42140356|FG001|Overall Study|Adverse Event|0|||
19695122|NCT00317772|42140357|FG002|Overall Study|Adverse Event|0|||
19695123|NCT00317772|42140358|FG003|Overall Study|Adverse Event|2|||
19695124|NCT00317772|42140355|FG000|Overall Study|Disease Progression|2|||
19695125|NCT00317772|42140356|FG001|Overall Study|Disease Progression|2|||
19695126|NCT00317772|42140357|FG002|Overall Study|Disease Progression|1|||
19695127|NCT00317772|42140358|FG003|Overall Study|Disease Progression|7|||
19695128|NCT00350636|42140371|FG000|Overall Study|Adverse Event|19|||
19695129|NCT00350636|42140372|FG001|Overall Study|Adverse Event|13|||
19695130|NCT00350636|42140371|FG000|Overall Study|Protocol Violation|1|||
19367342|NCT02456740|41607524|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367343|NCT02456740|41607525|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367344|NCT02456740|41607526|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367345|NCT02456740|41607527|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367346|NCT02456740|41607528|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367347|NCT02456740|41607529|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
19367348|NCT02456740|41607521|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
19367349|NCT02456740|41607522|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
19367350|NCT02456740|41607523|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
19367351|NCT02456740|41607524|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19607256|NCT00673387|42056002|FG007|Overall Study|Adverse Event|5|||
19607257|NCT00673387|42055995|FG000|Overall Study|Physician Decision|0|||
19695131|NCT00350636|42140372|FG001|Overall Study|Protocol Violation|3|||
19695132|NCT00350636|42140371|FG000|Overall Study|Withdrawal by Subject|13|||
19695133|NCT00350636|42140372|FG001|Overall Study|Withdrawal by Subject|17|||
19695134|NCT00350636|42140371|FG000|Overall Study|Lost to Follow-up|9|||
19695135|NCT00350636|42140372|FG001|Overall Study|Lost to Follow-up|8|||
19695136|NCT00350636|42140371|FG000|Overall Study|Physician Decision|0|||
19695137|NCT00350636|42140372|FG001|Overall Study|Physician Decision|2|||
19782304|NCT02642614|42238556|FG002|Overall Study|Withdrawal by Subject|0|||
19782305|NCT02642614|42238557|FG003|Overall Study|Withdrawal by Subject|0|||
19782306|NCT02781324|42238572|FG000|Overall Study|Withdrawal by Subject|1|||
19782307|NCT02781324|42238573|FG001|Overall Study|Withdrawal by Subject|0|||
19782308|NCT02781324|42238572|FG000|Overall Study|Physician Decision|1|||
19782309|NCT02781324|42238573|FG001|Overall Study|Physician Decision|2|||
19782310|NCT03292146|42238583|FG000|Baseline to 12 Months|Relocation|1|||
19782311|NCT03292146|42238584|FG001|Baseline to 12 Months|Relocation|0|||
19782312|NCT03292146|42238583|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
19782313|NCT03292146|42238584|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
19782314|NCT03292146|42238583|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
19782315|NCT03292146|42238584|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
19782316|NCT03292146|42238583|FG000|12 Months to 24 Months|Planning pregnancy|2|||
19782317|NCT03292146|42238584|FG001|12 Months to 24 Months|Planning pregnancy|2|||
19782318|NCT03292146|42238583|FG000|12 Months to 24 Months|Personal reasons|1|||
19782319|NCT03292146|42238584|FG001|12 Months to 24 Months|Personal reasons|0|||
19782320|NCT03292146|42238583|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
19367352|NCT02456740|41607525|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19607258|NCT00673387|42055996|FG001|Overall Study|Physician Decision|0|||
19607259|NCT00673387|42055997|FG002|Overall Study|Physician Decision|0|||
19607260|NCT00673387|42055998|FG003|Overall Study|Physician Decision|0|||
19607261|NCT00673387|42055999|FG004|Overall Study|Physician Decision|0|||
19607262|NCT00673387|42056000|FG005|Overall Study|Physician Decision|5|||
19607263|NCT00673387|42056001|FG006|Overall Study|Physician Decision|1|||
19607264|NCT00673387|42056002|FG007|Overall Study|Physician Decision|1|||
19607265|NCT00673387|42055995|FG000|Overall Study|Protocol Violation|3|||
19607266|NCT00673387|42055996|FG001|Overall Study|Protocol Violation|0|||
19607267|NCT00673387|42055997|FG002|Overall Study|Protocol Violation|1|||
19607268|NCT00673387|42055998|FG003|Overall Study|Protocol Violation|2|||
19607269|NCT00673387|42055999|FG004|Overall Study|Protocol Violation|0|||
19607270|NCT00673387|42056000|FG005|Overall Study|Protocol Violation|1|||
19607271|NCT00673387|42056001|FG006|Overall Study|Protocol Violation|1|||
19695138|NCT00350636|42140371|FG000|Overall Study|Other|1|||
19695139|NCT00350636|42140372|FG001|Overall Study|Other|2|||
19695140|NCT00346268|42140380|FG000|Overall Study|Adverse Event|1|||
19695141|NCT00346268|42140381|FG001|Overall Study|Adverse Event|0|||
19695142|NCT00346268|42140380|FG000|Overall Study|Protocol Violation|1|||
19607272|NCT00673387|42056002|FG007|Overall Study|Protocol Violation|3|||
19695143|NCT00346268|42140381|FG001|Overall Study|Protocol Violation|0|||
19782321|NCT03292146|42238584|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
19782322|NCT01360996|42238593|FG000|Overall Study|Withdrawal by Subject|4|||
19782323|NCT01360996|42238594|FG001|Overall Study|Withdrawal by Subject|3|||
19782324|NCT01360996|42238595|FG002|Overall Study|Withdrawal by Subject|2|||
19782325|NCT01360996|42238593|FG000|Overall Study|Noncompliant|2|||
19782326|NCT01360996|42238594|FG001|Overall Study|Noncompliant|0|||
19782327|NCT01360996|42238595|FG002|Overall Study|Noncompliant|0|||
19782328|NCT01951885|42238604|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
19782329|NCT01951885|42238605|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
19782330|NCT01951885|42238604|FG000|Overall Study|Adverse Event|1|||
19782331|NCT01951885|42238605|FG001|Overall Study|Adverse Event|0|||
19782332|NCT01951885|42238604|FG000|Overall Study|Withdrawal by Subject|0|||
19782333|NCT01951885|42238605|FG001|Overall Study|Withdrawal by Subject|1|||
19782334|NCT01951885|42238604|FG000|Overall Study|ineligible due to a change in donor|0|||
19782335|NCT01951885|42238605|FG001|Overall Study|ineligible due to a change in donor|1|||
19782336|NCT01951885|42238604|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
19782337|NCT01951885|42238605|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
19782338|NCT02639338|42238613|FG000|Overall Study|Lost to Follow-up|2|||
19782339|NCT02639338|42238614|FG001|Overall Study|Lost to Follow-up|2|||
19782340|NCT02639338|42238613|FG000|Overall Study|Withdrew Consent|1|||
19782341|NCT02639338|42238614|FG001|Overall Study|Withdrew Consent|2|||
19782342|NCT02639338|42238613|FG000|Overall Study|Death|1|||
19782343|NCT02639338|42238614|FG001|Overall Study|Death|0|||
19782344|NCT02639338|42238613|FG000|Overall Study|Randomized but Not Treated|0|||
19782345|NCT02639338|42238614|FG001|Overall Study|Randomized but Not Treated|1|||
19782346|NCT02900352|42238622|FG000|Overall Study|Lost to Follow-up|28|||
19782347|NCT02900352|42238623|FG001|Overall Study|Lost to Follow-up|17|||
19782348|NCT03040687|42238632|FG000|Overall Study|Withdrawal by Subject|1|||
19782349|NCT03040687|42238633|FG001|Overall Study|Withdrawal by Subject|0|||
19782350|NCT03040687|42238634|FG002|Overall Study|Withdrawal by Subject|0|||
19782351|NCT03042559|42238644|FG000|Overall Study|drop out|1|||
19782352|NCT03042559|42238645|FG001|Overall Study|drop out|1|||
19782353|NCT02780856|42238651|FG000|Overall Study|Lost to Follow-up|1|||
19782354|NCT00108732|42238680|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
19782355|NCT00108732|42238680|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
19695144|NCT00346268|42140380|FG000|Overall Study|Participant refused|0|||
19695145|NCT00346268|42140381|FG001|Overall Study|Participant refused|3|||
19695146|NCT00327444|42140389|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
19695147|NCT00327444|42140390|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
19695148|NCT00327444|42140389|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
19695149|NCT00327444|42140390|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
19695150|NCT00327444|42140389|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
19695151|NCT00327444|42140390|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
19695152|NCT00327444|42140389|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
19695153|NCT00327444|42140390|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
19695154|NCT00327444|42140389|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
19695155|NCT00327444|42140390|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
19695156|NCT00327444|42140389|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
19695157|NCT00327444|42140390|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
19695158|NCT00327444|42140389|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
19695159|NCT00327444|42140390|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
19695160|NCT00327444|42140389|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
19782356|NCT00108732|42238680|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
19782357|NCT00108732|42238680|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
19782358|NCT00108732|42238680|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
19782359|NCT00108732|42238680|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
19782360|NCT00108732|42238680|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
19782361|NCT00107952|42238686|FG000|Overall Study|Death|75|||
19782362|NCT00107952|42238687|FG001|Overall Study|Death|61|||
19782363|NCT00107952|42238686|FG000|Overall Study|Lost to Follow-up|0|||
19782364|NCT00107952|42238687|FG001|Overall Study|Lost to Follow-up|3|||
19782365|NCT00107952|42238686|FG000|Overall Study|Withdrawal by Subject|9|||
19782366|NCT00107952|42238687|FG001|Overall Study|Withdrawal by Subject|6|||
19782367|NCT00107952|42238686|FG000|Overall Study|Other|2|||
19782368|NCT00107952|42238687|FG001|Overall Study|Other|5|||
19782369|NCT00107952|42238686|FG000|Overall Study|Never received study treatment|9|||
19782370|NCT00107952|42238687|FG001|Overall Study|Never received study treatment|6|||
19782371|NCT01366638|42238705|FG000|Overall Study|Withdrawal by Subject|0|||
19782372|NCT01366638|42238706|FG001|Overall Study|Withdrawal by Subject|0|||
19782373|NCT01366638|42238707|FG002|Overall Study|Withdrawal by Subject|6|||
19782374|NCT01366638|42238705|FG000|Overall Study|Other|1|||
19782375|NCT01366638|42238706|FG001|Overall Study|Other|0|||
19782376|NCT01366638|42238707|FG002|Overall Study|Other|0|||
19782377|NCT02780700|42238715|FG000|Overall Study|Progressive disease|1|||
19782378|NCT04230122|42238753|FG000|Overall Study|Lost to Follow-up|1|||
19782379|NCT04230122|42238754|FG001|Overall Study|Lost to Follow-up|0|||
19782380|NCT02780388|42238765|FG000|Overall Study|Lost to Follow-up|0|||
19782381|NCT02780388|42238766|FG001|Overall Study|Lost to Follow-up|1|||
19782382|NCT02780388|42238767|FG002|Overall Study|Lost to Follow-up|0|||
19782383|NCT02780388|42238768|FG003|Overall Study|Lost to Follow-up|0|||
19782384|NCT02780388|42238769|FG004|Overall Study|Lost to Follow-up|0|||
19782385|NCT02780388|42238765|FG000|Overall Study|Withdrawal by Subject|1|||
19782386|NCT02780388|42238766|FG001|Overall Study|Withdrawal by Subject|1|||
19782387|NCT02780388|42238767|FG002|Overall Study|Withdrawal by Subject|0|||
19782388|NCT02780388|42238768|FG003|Overall Study|Withdrawal by Subject|0|||
19782389|NCT02780388|42238769|FG004|Overall Study|Withdrawal by Subject|0|||
19782390|NCT02224573|42238787|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
19782391|NCT02224573|42238788|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
19782392|NCT02224573|42238787|FG000|Treatment Phase|Started on Other IMP|1|||
19782393|NCT02224573|42238788|FG001|Treatment Phase|Started on Other IMP|0|||
19782394|NCT02224573|42238787|FG000|Treatment Phase|Participant Discontinued IMP|0|||
19782395|NCT02224573|42238788|FG001|Treatment Phase|Participant Discontinued IMP|1|||
19782396|NCT02224573|42238787|FG000|Treatment Phase|Lack of Efficacy|15|||
19782397|NCT02224573|42238788|FG001|Treatment Phase|Lack of Efficacy|8|||
19782398|NCT02224573|42238787|FG000|Treatment Phase|Began Commercial Product|1|||
19782399|NCT02224573|42238788|FG001|Treatment Phase|Began Commercial Product|0|||
19782400|NCT02224573|42238787|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
19782401|NCT02224573|42238788|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
19782402|NCT02224573|42238787|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
19782403|NCT02224573|42238788|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
19782404|NCT02224573|42238787|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
19782405|NCT02224573|42238788|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
19782406|NCT02224573|42238787|FG000|Treatment Phase|Continued Compassionate Use|1|||
19782407|NCT02224573|42238788|FG001|Treatment Phase|Continued Compassionate Use|0|||
19782408|NCT02224573|42238787|FG000|Treatment Phase|Lack of Efficiency|2|||
19782409|NCT02224573|42238788|FG001|Treatment Phase|Lack of Efficiency|1|||
19782410|NCT02224573|42238787|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
19782411|NCT02224573|42238788|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
19782412|NCT02224573|42238787|FG000|Treatment Phase|Participant Moved|2|||
19782413|NCT02224573|42238788|FG001|Treatment Phase|Participant Moved|0|||
19782414|NCT02224573|42238787|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
19782415|NCT02224573|42238788|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
19782416|NCT02224573|42238787|FG000|Treatment Phase|Refused Medication|1|||
19782417|NCT02224573|42238788|FG001|Treatment Phase|Refused Medication|1|||
19782418|NCT02224573|42238787|FG000|Treatment Phase|Adverse Event|26|||
19782419|NCT02224573|42238788|FG001|Treatment Phase|Adverse Event|38|||
19782420|NCT02224573|42238787|FG000|Treatment Phase|Placed in Group Home|0|||
19782421|NCT02224573|42238788|FG001|Treatment Phase|Placed in Group Home|1|||
19782422|NCT02224573|42238787|FG000|Treatment Phase|Pursued Other Trials|1|||
19782423|NCT02224573|42238788|FG001|Treatment Phase|Pursued Other Trials|0|||
19782424|NCT02224573|42238787|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
19782425|NCT02224573|42238788|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
19782426|NCT02224573|42238787|FG000|Treatment Phase|Lost to Follow-up|2|||
19782427|NCT02224573|42238788|FG001|Treatment Phase|Lost to Follow-up|1|||
19782428|NCT02224573|42238787|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
19782429|NCT02224573|42238788|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
19782430|NCT02224573|42238787|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
19782431|NCT02224573|42238788|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
19782432|NCT02224573|42238787|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
19782433|NCT02224573|42238788|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
19782434|NCT02224573|42238787|FG000|Taper Phase|Adverse Event|1|||
19782435|NCT02224573|42238788|FG001|Taper Phase|Adverse Event|1|||
19782436|NCT01360840|42238798|FG000|Overall Study|Ongoing at data cut-off|10|||
19782437|NCT01360840|42238799|FG001|Overall Study|Ongoing at data cut-off|10|||
19782438|NCT01360840|42238800|FG002|Overall Study|Ongoing at data cut-off|9|||
19782439|NCT03350984|42238812|FG000|Overall Study|Death|1|||
19782440|NCT03350984|42238813|FG001|Overall Study|Death|0|||
19782441|NCT03350984|42238812|FG000|Overall Study|Lost to Follow-up|5|||
19782442|NCT03350984|42238813|FG001|Overall Study|Lost to Follow-up|6|||
19782443|NCT03350984|42238812|FG000|Overall Study|Protocol Violation|1|||
19782444|NCT03350984|42238813|FG001|Overall Study|Protocol Violation|2|||
19782445|NCT03350984|42238812|FG000|Overall Study|Physician Decision|1|||
19782446|NCT03350984|42238813|FG001|Overall Study|Physician Decision|0|||
19782447|NCT05176717|42238831|FG000|Overall Study|Sponsor Decision|1|||
19782448|NCT05176717|42238832|FG001|Overall Study|Sponsor Decision|2|||
19782449|NCT05176717|42238833|FG002|Overall Study|Sponsor Decision|2|||
19782450|NCT02770248|42238843|FG000|Overall Study|Adverse Event|0|||
19782451|NCT02770248|42238844|FG001|Overall Study|Adverse Event|1|||
19782452|NCT02770248|42238843|FG000|Overall Study|Randomized in error, prior to treatment|0|||
19782453|NCT02770248|42238844|FG001|Overall Study|Randomized in error, prior to treatment|1|||
19782454|NCT01344369|42238852|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
19782455|NCT01344369|42238853|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
19782456|NCT01344369|42238852|FG000|Washout of 28 Days|Physician Decision|0|||
19782457|NCT01344369|42238853|FG001|Washout of 28 Days|Physician Decision|1|||
19782458|NCT01344369|42238852|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
19782459|NCT01344369|42238853|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
19782460|NCT03179462|42238862|FG000|Overall Study|screening failure|1|||
19782461|NCT03179462|42238863|FG001|Overall Study|screening failure|2|||
19782462|NCT03179462|42238864|FG002|Overall Study|screening failure|0|||
19782463|NCT01314703|42238872|FG000|Overall Study|screen failure and closed enrollment|8|||
19782464|NCT01360762|42238877|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
19782465|NCT01360762|42238877|FG000|Main Study Period (12-month Treatment)|Death|5|||
19782466|NCT01360762|42238877|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
19782467|NCT01360762|42238877|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
19782468|NCT01360762|42238877|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
19782469|NCT01360762|42238877|FG000|Whole Study Period|Lost to Follow-up|10|||
19782470|NCT01360762|42238877|FG000|Whole Study Period|Death|7|||
19782471|NCT01360762|42238877|FG000|Whole Study Period|Patient relapsed|18|||
19782472|NCT01360762|42238877|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
19782473|NCT04382924|42238884|FG000|Overall Study|Death|2|||
19782474|NCT04382924|42238885|FG001|Overall Study|Death|5|||
19782475|NCT04382924|42238886|FG002|Overall Study|Death|4|||
19782476|NCT04382924|42238884|FG000|Overall Study|Protocol Violation|0|||
19782477|NCT04382924|42238885|FG001|Overall Study|Protocol Violation|1|||
19782478|NCT04382924|42238886|FG002|Overall Study|Protocol Violation|1|||
19782479|NCT04382924|42238884|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
19782480|NCT04382924|42238885|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
19782481|NCT04382924|42238886|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
19782482|NCT04382924|42238884|FG000|Overall Study|Withdrawal by Subject|6|||
19782483|NCT04382924|42238885|FG001|Overall Study|Withdrawal by Subject|3|||
19782484|NCT04382924|42238886|FG002|Overall Study|Withdrawal by Subject|6|||
19782485|NCT03044431|42238900|FG000|Overall Study|Lost to Follow-up|59|||
19782486|NCT02770170|42238908|FG000|Overall Study|Withdrawal by Subject|0|||
19782487|NCT02770170|42238909|FG001|Overall Study|Withdrawal by Subject|0|||
19695161|NCT00327444|42140390|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
19695162|NCT00337610|42140400|FG000|Overall Study|Adverse Event|2|||
19782488|NCT02770170|42238910|FG002|Overall Study|Withdrawal by Subject|0|||
19782489|NCT02770170|42238911|FG003|Overall Study|Withdrawal by Subject|2|||
19782490|NCT02770170|42238908|FG000|Overall Study|due to pregnancy|1|||
19782491|NCT02770170|42238909|FG001|Overall Study|due to pregnancy|0|||
19782492|NCT02770170|42238910|FG002|Overall Study|due to pregnancy|0|||
19782493|NCT02770170|42238911|FG003|Overall Study|due to pregnancy|0|||
19782494|NCT02770170|42238908|FG000|Overall Study|Lack of Efficacy|2|||
19782495|NCT02770170|42238909|FG001|Overall Study|Lack of Efficacy|0|||
19782496|NCT02770170|42238910|FG002|Overall Study|Lack of Efficacy|0|||
19782497|NCT02770170|42238911|FG003|Overall Study|Lack of Efficacy|1|||
19782498|NCT02770170|42238908|FG000|Overall Study|Adverse Event|4|||
19782499|NCT02770170|42238909|FG001|Overall Study|Adverse Event|3|||
19782500|NCT02770170|42238910|FG002|Overall Study|Adverse Event|5|||
19782501|NCT02770170|42238911|FG003|Overall Study|Adverse Event|3|||
19782502|NCT02770170|42238908|FG000|Overall Study|due to disease worsening|0|||
19782503|NCT02770170|42238909|FG001|Overall Study|due to disease worsening|0|||
19607273|NCT00673387|42055995|FG000|Overall Study|Lost to Follow-up|8|||
19695163|NCT00337610|42140401|FG001|Overall Study|Adverse Event|2|||
19695164|NCT00337610|42140400|FG000|Overall Study|Death|0|||
19695165|NCT00337610|42140401|FG001|Overall Study|Death|1|||
19695166|NCT00337610|42140400|FG000|Overall Study|Lack of Efficacy|6|||
19695167|NCT00337610|42140401|FG001|Overall Study|Lack of Efficacy|3|||
19695168|NCT00337610|42140400|FG000|Overall Study|Lost to Follow-up|3|||
19695169|NCT00337610|42140401|FG001|Overall Study|Lost to Follow-up|3|||
19695170|NCT00337610|42140400|FG000|Overall Study|Withdrawal by Subject|6|||
19695171|NCT00337610|42140401|FG001|Overall Study|Withdrawal by Subject|5|||
19695172|NCT00316914|42140409|FG000|Overall Study|Withdrawal by Subject|5|||
19695173|NCT00316914|42140410|FG001|Overall Study|Withdrawal by Subject|3|||
19695174|NCT00316914|42140409|FG000|Overall Study|Adverse Event|8|||
19695175|NCT00316914|42140410|FG001|Overall Study|Adverse Event|7|||
19695176|NCT00316914|42140409|FG000|Overall Study|Other Problems|6|||
19695177|NCT00316914|42140410|FG001|Overall Study|Other Problems|11|||
19695178|NCT00316914|42140409|FG000|Overall Study|Missing end of treatment documentation|14|||
19695179|NCT00316914|42140410|FG001|Overall Study|Missing end of treatment documentation|15|||
19695180|NCT00336284|42140418|FG000|Overall Study|Death|52|||
19695181|NCT00336284|42140419|FG001|Overall Study|Death|26|||
19782504|NCT02770170|42238910|FG002|Overall Study|due to disease worsening|0|||
19782505|NCT02770170|42238911|FG003|Overall Study|due to disease worsening|1|||
19782506|NCT02769858|42238921|FG000|Overall Study|Withdrawal by Subject|2|||
19782507|NCT02769624|42238925|FG000|Overall Study|Lost to Follow-up|0|||
19782508|NCT02769624|42238926|FG001|Overall Study|Lost to Follow-up|1|||
19782509|NCT03446768|42238934|FG000|Overall Study|Withdrawal by Subject|0|||
19782510|NCT03446768|42238935|FG001|Overall Study|Withdrawal by Subject|1|||
19782511|NCT02676284|42238941|FG000|Overall Study|Withdrawal by Subject|1|||
19782512|NCT02769312|42238947|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
19782513|NCT02769312|42238948|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
19782514|NCT02769312|42238947|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
19782515|NCT02769312|42238948|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
19782516|NCT02769312|42238947|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
19782517|NCT02769312|42238948|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
19782518|NCT02769312|42238947|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
19782519|NCT02769312|42238948|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
19782520|NCT02769312|42238947|FG000|Follow-up|Lost to Follow-up|1|||
19782521|NCT02769312|42238948|FG001|Follow-up|Lost to Follow-up|1|||
19782522|NCT01673386|42238955|FG000|Overall Study|Study terminated by sponsor|16|||
19782523|NCT01673386|42238956|FG001|Overall Study|Study terminated by sponsor|22|||
19782524|NCT01673386|42238955|FG000|Overall Study|Adverse Event|5|||
19782525|NCT01673386|42238956|FG001|Overall Study|Adverse Event|2|||
19782526|NCT01673386|42238955|FG000|Overall Study|Progressive disease|4|||
19782527|NCT01673386|42238956|FG001|Overall Study|Progressive disease|1|||
19782528|NCT01673386|42238955|FG000|Overall Study|Withdrawal by Subject|0|||
19782529|NCT01673386|42238956|FG001|Overall Study|Withdrawal by Subject|2|||
19782530|NCT00103740|42238964|FG000|Period 1 - Core|Adverse Event|1|||
19782531|NCT00103740|42238965|FG001|Period 1 - Core|Adverse Event|0|||
19782532|NCT00103740|42238964|FG000|Period 1 - Core|Protocol Violation|3|||
19782533|NCT00103740|42238965|FG001|Period 1 - Core|Protocol Violation|2|||
19782534|NCT00103740|42238964|FG000|Period 1 - Core|Patient withdrew consent|3|||
19782535|NCT00103740|42238965|FG001|Period 1 - Core|Patient withdrew consent|2|||
19782536|NCT00103740|42238964|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
19782537|NCT00103740|42238965|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
19782538|NCT00103740|42238964|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
19782539|NCT00103740|42238965|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
19782540|NCT00103740|42238964|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
19782541|NCT00103740|42238965|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
19782542|NCT00103740|42238964|FG000|Period 2 - Extended Observation Period|Death|6|||
19782543|NCT00103740|42238965|FG001|Period 2 - Extended Observation Period|Death|2|||
19782544|NCT00103740|42238964|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
19782545|NCT00103740|42238965|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
19782546|NCT01281644|42238971|FG000|Overall Study|Lost to Follow-up|3|||
19782547|NCT01281644|42238971|FG000|Overall Study|Withdrawal by Subject|2|||
19782548|NCT02869893|42238977|FG000|Overall Study|participant aversion to IV|5|||
19782549|NCT02869893|42238977|FG000|Overall Study|participant fear of MRI scanner|2|||
19782550|NCT02872935|42239007|FG000|Overall Study|Other|0|||
19782551|NCT02872935|42239008|FG001|Overall Study|Other|1|||
19782552|NCT02872311|42239023|FG000|Overall Study|Death|2|||
19782553|NCT02872311|42239024|FG001|Overall Study|Death|0|||
19782554|NCT02872311|42239025|FG002|Overall Study|Death|0|||
19782555|NCT02872311|42239026|FG003|Overall Study|Death|0|||
19782556|NCT02872311|42239027|FG004|Overall Study|Death|0|||
19782557|NCT02872311|42239023|FG000|Overall Study|Lost to Follow-up|2|||
19782558|NCT02872311|42239024|FG001|Overall Study|Lost to Follow-up|0|||
19782559|NCT02872311|42239025|FG002|Overall Study|Lost to Follow-up|0|||
19782560|NCT02872311|42239026|FG003|Overall Study|Lost to Follow-up|0|||
19782561|NCT02872311|42239027|FG004|Overall Study|Lost to Follow-up|0|||
19782562|NCT02872311|42239023|FG000|Overall Study|Protocol Violation|0|||
19782563|NCT02872311|42239024|FG001|Overall Study|Protocol Violation|2|||
19782564|NCT02872311|42239025|FG002|Overall Study|Protocol Violation|1|||
19782565|NCT02872311|42239026|FG003|Overall Study|Protocol Violation|0|||
19782566|NCT02872311|42239027|FG004|Overall Study|Protocol Violation|0|||
19782567|NCT02871375|42239055|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
19782568|NCT02871375|42239056|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
19782569|NCT02867709|42239067|FG000|Treatment Period|Adverse Event|1|||
19782570|NCT02867709|42239068|FG001|Treatment Period|Adverse Event|1|||
19782571|NCT02867709|42239069|FG002|Treatment Period|Adverse Event|2|||
19782572|NCT02867709|42239067|FG000|Treatment Period|Withdrawal of Consent|7|||
19782573|NCT02867709|42239068|FG001|Treatment Period|Withdrawal of Consent|9|||
19782574|NCT02867709|42239069|FG002|Treatment Period|Withdrawal of Consent|8|||
19782575|NCT02867709|42239067|FG000|Treatment Period|Lost to Follow-up|17|||
19782576|NCT02867709|42239068|FG001|Treatment Period|Lost to Follow-up|20|||
19782577|NCT02867709|42239069|FG002|Treatment Period|Lost to Follow-up|20|||
19782578|NCT02867709|42239067|FG000|Treatment Period|Lack of Qualifying Event|42|||
19782579|NCT02867709|42239068|FG001|Treatment Period|Lack of Qualifying Event|55|||
19782580|NCT02867709|42239069|FG002|Treatment Period|Lack of Qualifying Event|42|||
19782581|NCT02867709|42239067|FG000|Treatment Period|Protocol Violation|3|||
19782582|NCT02867709|42239068|FG001|Treatment Period|Protocol Violation|2|||
19782583|NCT02867709|42239069|FG002|Treatment Period|Protocol Violation|3|||
19782584|NCT02867709|42239067|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
19782585|NCT02867709|42239068|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
19782586|NCT02867709|42239069|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
19782587|NCT02867709|42239067|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
19782588|NCT02867709|42239068|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
19782589|NCT02867709|42239069|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
19782590|NCT02867709|42239067|FG000|Safety Follow-up Period|Pregnancy|0|||
19782591|NCT02867709|42239068|FG001|Safety Follow-up Period|Pregnancy|1|||
19782592|NCT02867709|42239069|FG002|Safety Follow-up Period|Pregnancy|0|||
19782593|NCT02867709|42239067|FG000|Safety Follow-up Period|Protocol Violation|0|||
19782594|NCT02867709|42239068|FG001|Safety Follow-up Period|Protocol Violation|1|||
19782595|NCT02867709|42239069|FG002|Safety Follow-up Period|Protocol Violation|1|||
19782596|NCT03044353|42239080|FG000|Overall Study|Adverse Event|0|||
19782597|NCT03044353|42239081|FG001|Overall Study|Adverse Event|1|||
19782598|NCT03044353|42239082|FG002|Overall Study|Adverse Event|0|||
19782599|NCT01361308|42239091|FG000|Overall Study|Withdrawal by Subject|9|||
19782600|NCT01361308|42239092|FG001|Overall Study|Withdrawal by Subject|13|||
19782601|NCT01361308|42239091|FG000|Overall Study|Physician Decision|3|||
19782602|NCT01361308|42239092|FG001|Overall Study|Physician Decision|3|||
19782603|NCT01361308|42239091|FG000|Overall Study|Lack of Efficacy|2|||
19782604|NCT01361308|42239092|FG001|Overall Study|Lack of Efficacy|0|||
19782605|NCT01361308|42239091|FG000|Overall Study|Protocol Violation|1|||
19782606|NCT01361308|42239092|FG001|Overall Study|Protocol Violation|0|||
19782607|NCT01361308|42239091|FG000|Overall Study|Lost to Follow-up|5|||
19782608|NCT01361308|42239092|FG001|Overall Study|Lost to Follow-up|4|||
19782609|NCT01361308|42239091|FG000|Overall Study|Adverse Event|8|||
19782610|NCT01361308|42239092|FG001|Overall Study|Adverse Event|4|||
19695182|NCT00336284|42140418|FG000|Overall Study|Lost to Follow-up|82|||
19695183|NCT00336284|42140419|FG001|Overall Study|Lost to Follow-up|61|||
19695184|NCT00336284|42140418|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
19695185|NCT00336284|42140419|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
19695186|NCT00316602|42140427|FG000|Overall Study|Withdrawal by Subject|3|||
19695187|NCT00316602|42140428|FG001|Overall Study|Withdrawal by Subject|2|||
19695188|NCT00316602|42140427|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
19695189|NCT00316602|42140428|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
19695190|NCT00316602|42140427|FG000|Overall Study|Adverse Event|1|||
19695191|NCT00316602|42140428|FG001|Overall Study|Adverse Event|0|||
19695192|NCT00316602|42140427|FG000|Overall Study|Other|3|||
19695193|NCT00316602|42140428|FG001|Overall Study|Other|6|||
19695194|NCT00335972|42140436|FG000|Overall Study|not given treatments|0|||
19695195|NCT00335972|42140437|FG001|Overall Study|not given treatments|3|||
19695196|NCT00346034|42140443|FG000|Overall Study|Adverse Event|34|||
19695197|NCT00346034|42140443|FG000|Overall Study|Lack of Efficacy|8|||
19695198|NCT00346034|42140443|FG000|Overall Study|Withdrawal by Subject|13|||
19695199|NCT00346034|42140443|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
19695200|NCT00346034|42140443|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
19695201|NCT00345878|42140449|FG000|Overall Study|Adverse Event|1|||
19695202|NCT00345878|42140450|FG001|Overall Study|Adverse Event|0|||
19695203|NCT00345878|42140449|FG000|Overall Study|Lost to Follow-up|2|||
19695204|NCT00345878|42140450|FG001|Overall Study|Lost to Follow-up|1|||
19695205|NCT00345878|42140449|FG000|Overall Study|Other|1|||
19695206|NCT00345878|42140450|FG001|Overall Study|Other|0|||
19695207|NCT00335738|42140458|FG000|Overall Study|Physician Decision|6|||
19695208|NCT00335738|42140459|FG001|Overall Study|Physician Decision|0|||
19695209|NCT00335738|42140458|FG000|Overall Study|Withdrawal by Subject|2|||
19695210|NCT00335738|42140459|FG001|Overall Study|Withdrawal by Subject|0|||
19695211|NCT00335738|42140458|FG000|Overall Study|Ineligible|3|||
19695212|NCT00335738|42140459|FG001|Overall Study|Ineligible|4|||
19695213|NCT00334958|42140477|FG000|Overall Study|Medication Noncompliance|0|||
19695214|NCT00334958|42140478|FG001|Overall Study|Medication Noncompliance|3|||
19695215|NCT00334958|42140477|FG000|Overall Study|Protocol Violation|2|||
19695216|NCT00334958|42140478|FG001|Overall Study|Protocol Violation|2|||
19695217|NCT00334958|42140477|FG000|Overall Study|Request of the investigator or sponsor|0|||
19695218|NCT00334958|42140478|FG001|Overall Study|Request of the investigator or sponsor|1|||
19695219|NCT00334958|42140477|FG000|Overall Study|Withdrawal by Subject|7|||
19695220|NCT00334958|42140478|FG001|Overall Study|Withdrawal by Subject|4|||
19695221|NCT00334958|42140477|FG000|Overall Study|Adverse Event|27|||
19695222|NCT00334958|42140478|FG001|Overall Study|Adverse Event|12|||
19695223|NCT00334958|42140477|FG000|Overall Study|Other|1|||
19695224|NCT00334958|42140478|FG001|Overall Study|Other|2|||
19782611|NCT01361308|42239091|FG000|Overall Study|Eligibility Criteria Not Met|2|||
19695225|NCT00326898|42140487|FG000|Overall Study|Disease progression|52|||
19695226|NCT00326898|42140488|FG001|Overall Study|Disease progression|54|||
19782612|NCT01361308|42239092|FG001|Overall Study|Eligibility Criteria Not Met|3|||
19782613|NCT01361308|42239091|FG000|Overall Study|Failed C-SSRS|5|||
19782614|NCT01361308|42239092|FG001|Overall Study|Failed C-SSRS|2|||
19782615|NCT01361308|42239091|FG000|Overall Study|Other|0|||
19782616|NCT01361308|42239092|FG001|Overall Study|Other|1|||
19782617|NCT00103662|42239104|FG000|Overall Study|Entered Rescue Procedure|0|||
19782618|NCT00103662|42239105|FG001|Overall Study|Entered Rescue Procedure|7|||
19782619|NCT00103662|42239104|FG000|Overall Study|Death|7|||
19782620|NCT00103662|42239105|FG001|Overall Study|Death|7|||
19782621|NCT00103662|42239104|FG000|Overall Study|Elective Withdrawal|5|||
19782622|NCT00103662|42239105|FG001|Overall Study|Elective Withdrawal|5|||
19782623|NCT00103662|42239104|FG000|Overall Study|Lost to Follow-up|0|||
19782624|NCT00103662|42239105|FG001|Overall Study|Lost to Follow-up|1|||
19782625|NCT00103662|42239104|FG000|Overall Study|Other|6|||
19782626|NCT00103662|42239105|FG001|Overall Study|Other|9|||
19782627|NCT00103662|42239104|FG000|Overall Study|Failed mobilization|0|||
19782628|NCT00103662|42239105|FG001|Overall Study|Failed mobilization|4|||
19782629|NCT00103662|42239104|FG000|Overall Study|Intercurrent illness|1|||
19782630|NCT00103662|42239105|FG001|Overall Study|Intercurrent illness|0|||
19695227|NCT00326898|42140489|FG002|Overall Study|Disease progression|102|||
19695228|NCT00326898|42140487|FG000|Overall Study|Adverse Event|124|||
19695229|NCT00326898|42140488|FG001|Overall Study|Adverse Event|128|||
19695230|NCT00326898|42140489|FG002|Overall Study|Adverse Event|33|||
19695231|NCT00326898|42140487|FG000|Overall Study|Death|2|||
19782631|NCT02865915|42239113|FG000|Overall Study|Pregnancy|1|||
19782632|NCT02865915|42239114|FG001|Overall Study|Pregnancy|0|||
19782633|NCT02865915|42239113|FG000|Overall Study|Withdrawal by Subject|1|||
19782634|NCT02865915|42239114|FG001|Overall Study|Withdrawal by Subject|1|||
19782635|NCT02865915|42239113|FG000|Overall Study|Adverse Event|0|||
19782636|NCT02865915|42239114|FG001|Overall Study|Adverse Event|4|||
19782637|NCT02865915|42239113|FG000|Overall Study|Lost to Follow-up|0|||
19782638|NCT02865915|42239114|FG001|Overall Study|Lost to Follow-up|1|||
19782639|NCT02865915|42239113|FG000|Overall Study|Protocol Violation|0|||
19782640|NCT02865915|42239114|FG001|Overall Study|Protocol Violation|1|||
19782641|NCT02865915|42239113|FG000|Overall Study|Study terminated by sponsor|23|||
19782642|NCT02865915|42239114|FG001|Overall Study|Study terminated by sponsor|18|||
19782643|NCT02865915|42239113|FG000|Overall Study|Dosing group discontinued|0|||
19782644|NCT02865915|42239114|FG001|Overall Study|Dosing group discontinued|5|||
19782645|NCT00104676|42239122|FG000|Overall Study|Death|3|||
19782646|NCT00104676|42239123|FG001|Overall Study|Death|2|||
19782647|NCT00104676|42239122|FG000|Overall Study|Withdrawal by Subject|0|||
19782648|NCT00104676|42239123|FG001|Overall Study|Withdrawal by Subject|2|||
19782649|NCT00104676|42239122|FG000|Overall Study|treatment interruption|4|||
19782650|NCT00104676|42239123|FG001|Overall Study|treatment interruption|10|||
19782651|NCT00354835|42239131|FG000|Overall Study|Death|1|||
19782652|NCT00354835|42239132|FG001|Overall Study|Death|1|||
19782653|NCT00354835|42239131|FG000|Overall Study|Physician Decision|8|||
19782654|NCT00354835|42239132|FG001|Overall Study|Physician Decision|13|||
19782655|NCT00354835|42239131|FG000|Overall Study|Withdrawal by Subject|2|||
19782656|NCT00354835|42239132|FG001|Overall Study|Withdrawal by Subject|1|||
19782657|NCT00354835|42239131|FG000|Overall Study|Ineligible|17|||
19782658|NCT00354835|42239132|FG001|Overall Study|Ineligible|16|||
19782659|NCT00354835|42239131|FG000|Overall Study|Disease progression or relapse|15|||
19782660|NCT00354835|42239132|FG001|Overall Study|Disease progression or relapse|22|||
19782661|NCT00354835|42239131|FG000|Overall Study|Adverse Event|6|||
19782662|NCT00354835|42239132|FG001|Overall Study|Adverse Event|0|||
19782663|NCT00354835|42239131|FG000|Overall Study|Refusal of further therapy|3|||
19782664|NCT00354835|42239132|FG001|Overall Study|Refusal of further therapy|8|||
19782665|NCT02768298|42239155|FG000|Overall Study|Adverse Event|1|||
19782666|NCT02768298|42239156|FG001|Overall Study|Adverse Event|4|||
19782667|NCT02768298|42239155|FG000|Overall Study|Death|2|||
19782668|NCT02768298|42239156|FG001|Overall Study|Death|1|||
19782669|NCT02768298|42239155|FG000|Overall Study|Non-compliance with study treatment|0|||
19782670|NCT02768298|42239156|FG001|Overall Study|Non-compliance with study treatment|1|||
19782671|NCT02768298|42239155|FG000|Overall Study|Subject/guardian decision|1|||
19782672|NCT02768298|42239156|FG001|Overall Study|Subject/guardian decision|0|||
19695232|NCT00326898|42140488|FG001|Overall Study|Death|0|||
19695233|NCT00326898|42140489|FG002|Overall Study|Death|0|||
19695234|NCT00326898|42140487|FG000|Overall Study|Withdrawal by Subject|134|||
19695235|NCT00326898|42140488|FG001|Overall Study|Withdrawal by Subject|128|||
19695236|NCT00326898|42140489|FG002|Overall Study|Withdrawal by Subject|32|||
19695237|NCT00326898|42140487|FG000|Overall Study|Alternative therapy|1|||
19695238|NCT00326898|42140488|FG001|Overall Study|Alternative therapy|0|||
19782673|NCT02768298|42239155|FG000|Overall Study|Withdrawal of informed consent|0|||
19782674|NCT02768298|42239156|FG001|Overall Study|Withdrawal of informed consent|1|||
19782675|NCT02775864|42239166|FG000|Overall Study|Data ended end of 2010|1764|||
19782676|NCT02775864|42239167|FG001|Overall Study|Data ended end of 2010|2880|||
19782677|NCT02775864|42239168|FG002|Overall Study|Data ended end of 2010|1140|||
19695239|NCT00326898|42140489|FG002|Overall Study|Alternative therapy|0|||
19782678|NCT02775864|42239169|FG003|Overall Study|Data ended end of 2010|1194|||
19782679|NCT02775864|42239166|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
19782680|NCT02775864|42239167|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
19782681|NCT02775864|42239168|FG002|Overall Study|Medicaid eligibility discontinued|720|||
19782682|NCT02775864|42239169|FG003|Overall Study|Medicaid eligibility discontinued|890|||
19782683|NCT02964273|42239182|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
19782684|NCT02964273|42239183|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
19782685|NCT02964273|42239184|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
19782686|NCT02964273|42239185|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
19782687|NCT02964273|42239182|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
19782688|NCT02964273|42239183|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
19782689|NCT02964273|42239184|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
19782690|NCT02964273|42239185|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
19782691|NCT02964273|42239182|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
19782692|NCT02964273|42239183|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
19782693|NCT02964273|42239184|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
19782694|NCT02964273|42239185|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
19782695|NCT02964273|42239182|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
19782696|NCT02964273|42239183|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
19782697|NCT02964273|42239184|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
19782698|NCT02964273|42239185|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
19782699|NCT02964273|42239182|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
19782700|NCT02964273|42239183|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
19782701|NCT02964273|42239184|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
19782702|NCT02964273|42239185|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
19782703|NCT02964273|42239182|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
19782704|NCT02964273|42239183|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
19782705|NCT02964273|42239184|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
19782706|NCT02964273|42239185|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
19782707|NCT02773446|42239204|FG000|First Admission|Withdrawal by Subject|0|||
19782708|NCT02773446|42239205|FG001|First Admission|Withdrawal by Subject|0|||
19782709|NCT02773446|42239206|FG002|First Admission|Withdrawal by Subject|0|||
19782710|NCT02773446|42239207|FG003|First Admission|Withdrawal by Subject|1|||
19782711|NCT02773446|42239208|FG004|First Admission|Withdrawal by Subject|0|||
19782712|NCT02773446|42239209|FG005|First Admission|Withdrawal by Subject|0|||
19782713|NCT02773446|42239204|FG000|First Admission|Lost to Follow-up|1|||
19782714|NCT02773446|42239205|FG001|First Admission|Lost to Follow-up|0|||
19782715|NCT02773446|42239206|FG002|First Admission|Lost to Follow-up|0|||
19782716|NCT02773446|42239207|FG003|First Admission|Lost to Follow-up|0|||
19782717|NCT02773446|42239208|FG004|First Admission|Lost to Follow-up|0|||
19782718|NCT02773446|42239209|FG005|First Admission|Lost to Follow-up|0|||
19782719|NCT02773368|42239228|FG000|Overall Study|Lost to Follow-up|4|||
19782720|NCT02773368|42239229|FG001|Overall Study|Lost to Follow-up|1|||
19782721|NCT02773368|42239228|FG000|Overall Study|Withdrawal by Subject|5|||
19782722|NCT02773368|42239229|FG001|Overall Study|Withdrawal by Subject|1|||
19782723|NCT02773368|42239228|FG000|Overall Study|Unclassified|1|||
19782724|NCT02773368|42239229|FG001|Overall Study|Unclassified|1|||
19782725|NCT02773368|42239228|FG000|Overall Study|Missing|0|||
19782726|NCT02773368|42239229|FG001|Overall Study|Missing|1|||
19782727|NCT01336647|42239238|FG000|Overall Study|Lost to Follow-up|4|||
19782728|NCT01336647|42239239|FG001|Overall Study|Lost to Follow-up|1|||
19782729|NCT01336647|42239240|FG002|Overall Study|Lost to Follow-up|3|||
19782730|NCT01336569|42239250|FG000|Overall Study|Lost to Follow-up|4|||
19782731|NCT02772978|42239254|FG000|Overall Study|Withdrawal by Subject|1|||
19782732|NCT02772978|42239255|FG001|Overall Study|Withdrawal by Subject|1|||
19782733|NCT00104052|42239260|FG000|Overall Study|Adverse Event|1|||
19782734|NCT00104052|42239260|FG000|Overall Study|Lack of Efficacy|26|||
19782735|NCT00104052|42239260|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
19782736|NCT02777970|42239267|FG000|Overall Study|Lost to Follow-up|0|||
19782737|NCT02777970|42239268|FG001|Overall Study|Lost to Follow-up|1|||
19782738|NCT02777970|42239269|FG002|Overall Study|Lost to Follow-up|0|||
19782739|NCT02777970|42239267|FG000|Overall Study|Protocol Violation|1|||
19782740|NCT02777970|42239268|FG001|Overall Study|Protocol Violation|0|||
19782741|NCT02777970|42239269|FG002|Overall Study|Protocol Violation|0|||
19782742|NCT03037489|42239281|FG000|Overall Study|Adverse Event|4|||
19782743|NCT03037489|42239282|FG001|Overall Study|Adverse Event|0|||
19782744|NCT03037489|42239281|FG000|Overall Study|Withdrawal by Subject|3|||
19782745|NCT03037489|42239282|FG001|Overall Study|Withdrawal by Subject|0|||
19389180|NCT02053792|41632811|FG001|Overall Study|Adverse Event|0|||
19477781|NCT01479439|41757036|FG001|Overall Study|Adverse Event|0|||
19477782|NCT01479439|41757037|FG002|Overall Study|Adverse Event|0|||
19782746|NCT01336023|42239291|FG000|Week 0 to Week 26|Adverse Event|8|||
19782747|NCT01336023|42239292|FG001|Week 0 to Week 26|Adverse Event|10|||
19782748|NCT01336023|42239293|FG002|Week 0 to Week 26|Adverse Event|24|||
19782749|NCT01336023|42239291|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
19782750|NCT01336023|42239292|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
19782751|NCT01336023|42239293|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
19782752|NCT01336023|42239291|FG000|Week 0 to Week 26|Protocol Violation|1|||
19782753|NCT01336023|42239292|FG001|Week 0 to Week 26|Protocol Violation|2|||
19782754|NCT01336023|42239293|FG002|Week 0 to Week 26|Protocol Violation|0|||
19782755|NCT01336023|42239291|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
19782756|NCT01336023|42239292|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
19782757|NCT01336023|42239293|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
19782758|NCT01336023|42239291|FG000|Week 0 to Week 26|Unclassified|5|||
19782759|NCT01336023|42239292|FG001|Week 0 to Week 26|Unclassified|16|||
19782760|NCT01336023|42239293|FG002|Week 0 to Week 26|Unclassified|9|||
19782761|NCT01336023|42239291|FG000|Week 27 to 52|Adverse Event|1|||
19782762|NCT01336023|42239292|FG001|Week 27 to 52|Adverse Event|5|||
19782763|NCT01336023|42239293|FG002|Week 27 to 52|Adverse Event|2|||
19782764|NCT01336023|42239291|FG000|Week 27 to 52|Protocol Violation|0|||
19782765|NCT01336023|42239292|FG001|Week 27 to 52|Protocol Violation|2|||
19695240|NCT00326898|42140487|FG000|Overall Study|Other complicating disease|5|||
19695241|NCT00326898|42140488|FG001|Overall Study|Other complicating disease|5|||
19695242|NCT00326898|42140489|FG002|Overall Study|Other complicating disease|4|||
19695243|NCT00326898|42140487|FG000|Overall Study|Other/Missing/Unknown|33|||
19695244|NCT00326898|42140488|FG001|Overall Study|Other/Missing/Unknown|28|||
19695245|NCT00326898|42140489|FG002|Overall Study|Other/Missing/Unknown|32|||
19695246|NCT00326118|42140499|FG000|Active Phase|Withdrawal by Subject|4|||
19695247|NCT00326118|42140500|FG001|Active Phase|Withdrawal by Subject|1|||
19695248|NCT00334802|42140509|FG000|Overall Study|Progressive Disease|2|||
19695249|NCT00334802|42140510|FG001|Overall Study|Progressive Disease|24|||
19695250|NCT00334802|42140509|FG000|Overall Study|Toxicity|1|||
19695251|NCT00334802|42140510|FG001|Overall Study|Toxicity|5|||
19695252|NCT00334802|42140509|FG000|Overall Study|Lack of Efficacy|1|||
19695253|NCT00334802|42140510|FG001|Overall Study|Lack of Efficacy|3|||
19695254|NCT00334802|42140509|FG000|Overall Study|Patient Condition Aggrevated|1|||
19695255|NCT00334802|42140510|FG001|Overall Study|Patient Condition Aggrevated|0|||
19695256|NCT00334802|42140509|FG000|Overall Study|Physician Decision|1|||
19695257|NCT00334802|42140510|FG001|Overall Study|Physician Decision|0|||
19695258|NCT00334802|42140509|FG000|Overall Study|Withdrawal by Subject|0|||
19695259|NCT00334802|42140510|FG001|Overall Study|Withdrawal by Subject|4|||
19695260|NCT00334802|42140509|FG000|Overall Study|Adverse Event|0|||
19695261|NCT00334802|42140510|FG001|Overall Study|Adverse Event|3|||
19695262|NCT00334802|42140509|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
19695263|NCT00334802|42140510|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
19695264|NCT00307164|42140521|FG000|Overall Study|Death|1|||
19695265|NCT00307164|42140522|FG001|Overall Study|Death|0|||
19695266|NCT00307164|42140521|FG000|Overall Study|Severe debilitation, unable to continue|1|||
19695267|NCT00307164|42140522|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19695268|NCT00307164|42140521|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
19695269|NCT00307164|42140522|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
19695270|NCT00307164|42140521|FG000|Overall Study|Withdrawal by Subject|1|||
19695271|NCT00307164|42140522|FG001|Overall Study|Withdrawal by Subject|8|||
19695272|NCT00307164|42140521|FG000|Overall Study|Not compliant with requirements|4|||
19695273|NCT00307164|42140522|FG001|Overall Study|Not compliant with requirements|4|||
19695274|NCT00307164|42140521|FG000|Overall Study|Lost to Follow-up|6|||
19695275|NCT00307164|42140522|FG001|Overall Study|Lost to Follow-up|1|||
19695276|NCT03827564|42140530|FG000|Overall Study|Discontinued due to Study Termination|1|||
19695277|NCT03827564|42140531|FG001|Overall Study|Discontinued due to Study Termination|0|||
19695278|NCT00307086|42140537|FG000|Overall Study|ineligible|5|||
19695279|NCT00325416|42140543|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
19695280|NCT00325416|42140544|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
19695281|NCT00325416|42140543|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
19695282|NCT00325416|42140544|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
19695283|NCT00325416|42140543|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
19695284|NCT00325416|42140544|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
19695285|NCT00325416|42140543|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
19695286|NCT00325416|42140544|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
19695287|NCT00325416|42140543|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
19695288|NCT00325416|42140544|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
19782766|NCT01336023|42239293|FG002|Week 27 to 52|Protocol Violation|1|||
19782767|NCT01336023|42239291|FG000|Week 27 to 52|Withdrawal Criteria|14|||
19782768|NCT01336023|42239292|FG001|Week 27 to 52|Withdrawal Criteria|19|||
19782769|NCT01336023|42239293|FG002|Week 27 to 52|Withdrawal Criteria|16|||
19782770|NCT01336023|42239291|FG000|Week 27 to 52|Unclassified|13|||
19782771|NCT01336023|42239292|FG001|Week 27 to 52|Unclassified|18|||
19782772|NCT01336023|42239293|FG002|Week 27 to 52|Unclassified|9|||
19695289|NCT00325416|42140543|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
19695290|NCT00325416|42140544|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
19695291|NCT00314808|42140550|FG000|Overall Study|Disease Progression without AE|4|||
19695292|NCT00314808|42140550|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
19695293|NCT00314574|42140556|FG000|Overall Study|Death|3|||
19695294|NCT00314574|42140557|FG001|Overall Study|Death|0|||
19695295|NCT00314574|42140556|FG000|Overall Study|Adverse Event|11|||
19695296|NCT00314574|42140557|FG001|Overall Study|Adverse Event|16|||
19695297|NCT00314574|42140556|FG000|Overall Study|Lost to Follow-up|19|||
19695298|NCT00314574|42140557|FG001|Overall Study|Lost to Follow-up|25|||
19695299|NCT00314574|42140556|FG000|Overall Study|Withdrawal by Subject|33|||
19695300|NCT00314574|42140557|FG001|Overall Study|Withdrawal by Subject|22|||
19695301|NCT00314574|42140556|FG000|Overall Study|Physician Decision|22|||
19695302|NCT00314574|42140557|FG001|Overall Study|Physician Decision|15|||
19695303|NCT00314574|42140556|FG000|Overall Study|Pregnancy|6|||
19695304|NCT00314574|42140557|FG001|Overall Study|Pregnancy|4|||
19695305|NCT00314574|42140556|FG000|Overall Study|Data unknown at database lock|0|||
19695306|NCT00314574|42140557|FG001|Overall Study|Data unknown at database lock|1|||
19695307|NCT00314340|42140563|FG000|Overall Study|lost interest|1|||
19695308|NCT00306852|42140571|FG000|Overall Study|Death|14|||
19782773|NCT03039283|42239301|FG000|Overall Study|Protocol Violation|2|||
19782774|NCT02863575|42239323|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
19782775|NCT02863575|42239324|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
19782776|NCT02863575|42239325|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
19782777|NCT02863575|42239323|FG000|Overall Study|Withdrawal by Subject|0|||
19782778|NCT02863575|42239324|FG001|Overall Study|Withdrawal by Subject|1|||
19782779|NCT02863575|42239325|FG002|Overall Study|Withdrawal by Subject|1|||
19782780|NCT02863575|42239323|FG000|Overall Study|Adverse Event|0|||
19782781|NCT02863575|42239324|FG001|Overall Study|Adverse Event|1|||
19782782|NCT02863575|42239325|FG002|Overall Study|Adverse Event|0|||
19782783|NCT01227187|42239337|FG000|Overall Study|Physician Decision|0|||
19782784|NCT01227187|42239338|FG001|Overall Study|Physician Decision|0|||
19782785|NCT01227187|42239339|FG002|Overall Study|Physician Decision|0|||
19782786|NCT01227187|42239340|FG003|Overall Study|Physician Decision|1|||
19782787|NCT02638012|42239361|FG000|Overall Study|Lost to Follow-up|1|||
19782788|NCT00103506|42239367|FG000|Overall Study|Study closed by sponsor|34|||
19782789|NCT00103506|42239368|FG001|Overall Study|Study closed by sponsor|37|||
19782790|NCT00103506|42239367|FG000|Overall Study|Death|257|||
19782791|NCT00103506|42239368|FG001|Overall Study|Death|253|||
19782792|NCT00103506|42239367|FG000|Overall Study|Lost to Follow-up|13|||
19782793|NCT00103506|42239368|FG001|Overall Study|Lost to Follow-up|13|||
19695309|NCT00306852|42140572|FG001|Overall Study|Death|14|||
19695310|NCT00306852|42140571|FG000|Overall Study|Lost to Follow-up|15|||
19695311|NCT00306852|42140572|FG001|Overall Study|Lost to Follow-up|24|||
19782794|NCT00103506|42239367|FG000|Overall Study|Withdrawal by Subject|18|||
19782795|NCT00103506|42239368|FG001|Overall Study|Withdrawal by Subject|21|||
19782796|NCT02765490|42239376|FG000|Overall Study|Lost to Follow-up|1|||
19782797|NCT02765490|42239377|FG001|Overall Study|Lost to Follow-up|1|||
19782798|NCT02765490|42239376|FG000|Overall Study|Other|0|||
19782799|NCT02765490|42239377|FG001|Overall Study|Other|1|||
19782800|NCT02765490|42239376|FG000|Overall Study|Death|0|||
19782801|NCT02765490|42239377|FG001|Overall Study|Death|1|||
19782802|NCT02762370|42239385|FG000|Overall Study|Protocol Violation|1|||
19782803|NCT02762370|42239386|FG001|Overall Study|Protocol Violation|0|||
19782804|NCT02639182|42239396|FG000|Overall Study|Disease Progression|50|||
19782805|NCT02639182|42239397|FG001|Overall Study|Disease Progression|49|||
19782806|NCT02639182|42239396|FG000|Overall Study|Adverse Event|7|||
19782807|NCT02639182|42239397|FG001|Overall Study|Adverse Event|5|||
19782808|NCT02639182|42239396|FG000|Overall Study|Physician Decision|3|||
19782809|NCT02639182|42239397|FG001|Overall Study|Physician Decision|3|||
19782810|NCT02639182|42239396|FG000|Overall Study|Withdrew Consent|5|||
19782811|NCT02639182|42239397|FG001|Overall Study|Withdrew Consent|4|||
19782812|NCT02639182|42239396|FG000|Overall Study|Lost to Follow-up|0|||
19782813|NCT02639182|42239397|FG001|Overall Study|Lost to Follow-up|1|||
19782814|NCT02639182|42239396|FG000|Overall Study|Study Closure|1|||
19782815|NCT02639182|42239397|FG001|Overall Study|Study Closure|2|||
19782816|NCT02639182|42239396|FG000|Overall Study|Sponsor Ended Study|0|||
19782817|NCT02639182|42239397|FG001|Overall Study|Sponsor Ended Study|1|||
19782818|NCT02639182|42239396|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
19782819|NCT02639182|42239397|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
19782820|NCT02863419|42239406|FG000|Overall Study|Lost to Follow-up|0|||
19782821|NCT02863419|42239407|FG001|Overall Study|Lost to Follow-up|1|||
19782822|NCT02863419|42239408|FG002|Overall Study|Lost to Follow-up|4|||
19782823|NCT02863419|42239406|FG000|Overall Study|Withdrawal by Subject|5|||
19782824|NCT02863419|42239407|FG001|Overall Study|Withdrawal by Subject|5|||
19782825|NCT02863419|42239408|FG002|Overall Study|Withdrawal by Subject|3|||
19782826|NCT02863419|42239406|FG000|Overall Study|Died|3|||
19695312|NCT00314262|42140578|FG000|Overall Study|Adverse Event|2|||
19782827|NCT02863419|42239407|FG001|Overall Study|Died|4|||
19782828|NCT02863419|42239408|FG002|Overall Study|Died|1|||
19782829|NCT02765100|42239418|FG000|Overall Study|subject found ineligible after baseline|1|||
19782830|NCT02765100|42239419|FG001|Overall Study|subject found ineligible after baseline|1|||
19782831|NCT02765100|42239418|FG000|Overall Study|Lost to Follow-up|0|||
19782832|NCT02765100|42239419|FG001|Overall Study|Lost to Follow-up|1|||
19782833|NCT02761980|42239429|FG000|Overall Study|Adverse Event|4|||
19782834|NCT02761980|42239430|FG001|Overall Study|Adverse Event|6|||
19782835|NCT02761980|42239431|FG002|Overall Study|Adverse Event|5|||
19782836|NCT02761980|42239432|FG003|Overall Study|Adverse Event|6|||
19782837|NCT02761980|42239429|FG000|Overall Study|Withdrawal by Subject|0|||
19782838|NCT02761980|42239430|FG001|Overall Study|Withdrawal by Subject|1|||
19782839|NCT02761980|42239431|FG002|Overall Study|Withdrawal by Subject|0|||
19695313|NCT00314262|42140578|FG000|Overall Study|Withdrawal by Subject|2|||
19695314|NCT00314262|42140578|FG000|Overall Study|Physician Decision|1|||
19695315|NCT00333866|42140586|FG000|Overall Study|Adverse Event|23|||
19695316|NCT00333866|42140587|FG001|Overall Study|Adverse Event|37|||
19695317|NCT00333866|42140588|FG002|Overall Study|Adverse Event|38|||
19695318|NCT00333866|42140589|FG003|Overall Study|Adverse Event|47|||
19695319|NCT00333866|42140586|FG000|Overall Study|Other|3|||
19695320|NCT00333866|42140587|FG001|Overall Study|Other|2|||
19695321|NCT00333866|42140588|FG002|Overall Study|Other|2|||
19695322|NCT00333866|42140589|FG003|Overall Study|Other|2|||
19695323|NCT00333866|42140586|FG000|Overall Study|Lack of Efficacy|8|||
19695324|NCT00333866|42140587|FG001|Overall Study|Lack of Efficacy|6|||
19695325|NCT00333866|42140588|FG002|Overall Study|Lack of Efficacy|3|||
19695326|NCT00333866|42140589|FG003|Overall Study|Lack of Efficacy|5|||
19695327|NCT00333866|42140586|FG000|Overall Study|Lost to Follow-up|1|||
19695328|NCT00333866|42140587|FG001|Overall Study|Lost to Follow-up|2|||
19695329|NCT00333866|42140588|FG002|Overall Study|Lost to Follow-up|2|||
19695330|NCT00333866|42140589|FG003|Overall Study|Lost to Follow-up|2|||
19695331|NCT00333866|42140586|FG000|Overall Study|Withdrawal by Subject|8|||
19695332|NCT00333866|42140587|FG001|Overall Study|Withdrawal by Subject|14|||
19695333|NCT00333866|42140588|FG002|Overall Study|Withdrawal by Subject|4|||
19695334|NCT00333866|42140589|FG003|Overall Study|Withdrawal by Subject|9|||
19695335|NCT00333866|42140586|FG000|Overall Study|Randomized but not Treated|5|||
19695336|NCT00333866|42140587|FG001|Overall Study|Randomized but not Treated|3|||
19695337|NCT00333866|42140588|FG002|Overall Study|Randomized but not Treated|2|||
19695338|NCT00333866|42140589|FG003|Overall Study|Randomized but not Treated|1|||
19695339|NCT00324740|42140599|FG000|Overall Study|Withdrawal by Subject|1|||
19782840|NCT02761980|42239432|FG003|Overall Study|Withdrawal by Subject|0|||
19782841|NCT02761980|42239429|FG000|Overall Study|Other|0|||
19782842|NCT02761980|42239430|FG001|Overall Study|Other|0|||
19782843|NCT02761980|42239431|FG002|Overall Study|Other|1|||
19782844|NCT02761980|42239432|FG003|Overall Study|Other|0|||
19782845|NCT02862171|42239451|FG000|Overall Study|Death|1|||
19782846|NCT02862171|42239451|FG000|Overall Study|Lost to Follow-up|13|||
19782847|NCT02862171|42239451|FG000|Overall Study|Withdrawal by Subject|57|||
19782848|NCT02862171|42239451|FG000|Overall Study|Non-compliance|4|||
19782849|NCT02862171|42239451|FG000|Overall Study|HIV-1 seroconversion|18|||
19782850|NCT02638948|42239459|FG000|Overall Study|Withdrawal by Subject|4|||
19782851|NCT02638948|42239460|FG001|Overall Study|Withdrawal by Subject|5|||
19782852|NCT02638948|42239461|FG002|Overall Study|Withdrawal by Subject|3|||
19782853|NCT02638948|42239462|FG003|Overall Study|Withdrawal by Subject|1|||
19782854|NCT02638948|42239459|FG000|Overall Study|Administrative Reason by Sponsor|0|||
19782855|NCT02638948|42239460|FG001|Overall Study|Administrative Reason by Sponsor|1|||
19782856|NCT02638948|42239461|FG002|Overall Study|Administrative Reason by Sponsor|0|||
19782857|NCT02638948|42239462|FG003|Overall Study|Administrative Reason by Sponsor|4|||
19782858|NCT02638948|42239459|FG000|Overall Study|Adverse Event|0|||
19782859|NCT02638948|42239460|FG001|Overall Study|Adverse Event|0|||
19782860|NCT02638948|42239461|FG002|Overall Study|Adverse Event|1|||
19782861|NCT02638948|42239462|FG003|Overall Study|Adverse Event|1|||
19782862|NCT02638948|42239459|FG000|Overall Study|Lack of Efficacy|1|||
19782863|NCT02638948|42239460|FG001|Overall Study|Lack of Efficacy|1|||
19782864|NCT02638948|42239461|FG002|Overall Study|Lack of Efficacy|0|||
19782865|NCT02638948|42239462|FG003|Overall Study|Lack of Efficacy|0|||
19695340|NCT00324740|42140600|FG001|Overall Study|Withdrawal by Subject|0|||
19695341|NCT00324740|42140601|FG002|Overall Study|Withdrawal by Subject|1|||
19695342|NCT00333788|42140608|FG000|Overall Study|Adverse Event|44|||
19695343|NCT00333788|42140608|FG000|Overall Study|Lack of Efficacy|80|||
19695344|NCT00333788|42140608|FG000|Overall Study|Lost to Follow-up|2|||
19695345|NCT00333788|42140608|FG000|Overall Study|Withdrawal by Subject|24|||
19695346|NCT00333788|42140608|FG000|Overall Study|Other: Non-compliance|2|||
19695347|NCT00333788|42140608|FG000|Overall Study|Other: Moved|2|||
19782866|NCT02638948|42239459|FG000|Overall Study|Lost to Follow-up|0|||
19782867|NCT02638948|42239460|FG001|Overall Study|Lost to Follow-up|0|||
19782868|NCT02638948|42239461|FG002|Overall Study|Lost to Follow-up|1|||
19782869|NCT02638948|42239462|FG003|Overall Study|Lost to Follow-up|1|||
19782870|NCT02638948|42239459|FG000|Overall Study|Poor/Non-Compliance|0|||
19782871|NCT02638948|42239460|FG001|Overall Study|Poor/Non-Compliance|2|||
19782872|NCT02638948|42239461|FG002|Overall Study|Poor/Non-Compliance|1|||
19782873|NCT02638948|42239462|FG003|Overall Study|Poor/Non-Compliance|0|||
19782874|NCT02638948|42239459|FG000|Overall Study|Participant no longer met study criteria|0|||
19782875|NCT02638948|42239460|FG001|Overall Study|Participant no longer met study criteria|1|||
19782876|NCT02638948|42239461|FG002|Overall Study|Participant no longer met study criteria|0|||
19782877|NCT02638948|42239462|FG003|Overall Study|Participant no longer met study criteria|0|||
19782878|NCT02638948|42239459|FG000|Overall Study|Other than specified above|4|||
19782879|NCT02638948|42239460|FG001|Overall Study|Other than specified above|1|||
19782880|NCT02638948|42239461|FG002|Overall Study|Other than specified above|1|||
19782881|NCT02638948|42239462|FG003|Overall Study|Other than specified above|1|||
19782882|NCT00102960|42239478|FG000|Overall Study|Death|23|||
19782883|NCT00102960|42239479|FG001|Overall Study|Death|11|||
19782884|NCT00102960|42239480|FG002|Overall Study|Death|11|||
19782885|NCT00102960|42239478|FG000|Overall Study|Lost to Follow-up|6|||
19782886|NCT00102960|42239479|FG001|Overall Study|Lost to Follow-up|12|||
19782887|NCT00102960|42239480|FG002|Overall Study|Lost to Follow-up|16|||
19782888|NCT00102960|42239478|FG000|Overall Study|Withdrawal by Subject|1|||
19782889|NCT00102960|42239479|FG001|Overall Study|Withdrawal by Subject|0|||
19782890|NCT00102960|42239480|FG002|Overall Study|Withdrawal by Subject|1|||
19782891|NCT02858895|42239492|FG000|Overall Study|Disease progression|31|||
19782892|NCT02858895|42239492|FG000|Overall Study|Death|2|||
19782893|NCT02858895|42239492|FG000|Overall Study|Adverse Event|1|||
19782894|NCT02858895|42239492|FG000|Overall Study|Withdrawal by Subject|3|||
19782895|NCT02858895|42239492|FG000|Overall Study|hospice,|1|||
19782896|NCT02858895|42239492|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
19782897|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
19782898|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
19782899|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
19782900|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
19782901|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
19782902|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
19782903|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
19782904|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
19782905|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
19782906|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
19782907|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
19695348|NCT00333788|42140608|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
19695349|NCT00333788|42140608|FG000|Overall Study|Other: Investigator decision|1|||
19695350|NCT00333788|42140608|FG000|Overall Study|Other: Quality of life concern|1|||
19695351|NCT00333788|42140608|FG000|Overall Study|Other: Sponsor decision|1|||
19695352|NCT00333788|42140608|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
19695353|NCT00333788|42140608|FG000|Overall Study|Other: Medical monitor decision|1|||
19695354|NCT00333788|42140608|FG000|Overall Study|Other: Physician decision|1|||
19695355|NCT00333788|42140608|FG000|Overall Study|Other: Signed consent for another study|1|||
19695356|NCT00324116|42140612|FG000|Overall Study|Adverse Event|5|||
19695357|NCT00324116|42140612|FG000|Overall Study|Lack of Efficacy|17|||
19695358|NCT00324116|42140612|FG000|Overall Study|Withdrawal by Subject|5|||
19695359|NCT00324116|42140612|FG000|Overall Study|Other|5|||
19695360|NCT00332696|42140618|FG000|Overall Study|Death|24|||
19695361|NCT00332696|42140619|FG001|Overall Study|Death|14|||
19695362|NCT00332696|42140618|FG000|Overall Study|Insufficient therapeutic effect|4|||
19695363|NCT00332696|42140619|FG001|Overall Study|Insufficient therapeutic effect|11|||
19695364|NCT00332696|42140618|FG000|Overall Study|Adverse Event|1|||
19695365|NCT00332696|42140619|FG001|Overall Study|Adverse Event|2|||
19695366|NCT00332696|42140618|FG000|Overall Study|Condition does not justify treatment|0|||
19695367|NCT00332696|42140619|FG001|Overall Study|Condition does not justify treatment|2|||
19695368|NCT00332696|42140618|FG000|Overall Study|Lost to Follow-up|0|||
19695369|NCT00332696|42140619|FG001|Overall Study|Lost to Follow-up|1|||
19695370|NCT00332696|42140618|FG000|Overall Study|Withdrawal by Subject|1|||
19695371|NCT00332696|42140619|FG001|Overall Study|Withdrawal by Subject|0|||
19695372|NCT00313716|42140631|FG000|Overall Study|Death|3|||
19695373|NCT00313716|42140632|FG001|Overall Study|Death|2|||
19695374|NCT00313716|42140633|FG002|Overall Study|Death|9|||
19695375|NCT00313716|42140634|FG003|Overall Study|Death|3|||
19695376|NCT00313716|42140635|FG004|Overall Study|Death|5|||
19695377|NCT00313716|42140636|FG005|Overall Study|Death|9|||
19695378|NCT00313716|42140631|FG000|Overall Study|Lost to Follow-up|2|||
19695379|NCT00313716|42140632|FG001|Overall Study|Lost to Follow-up|5|||
19782908|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
19782909|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
19782910|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
19782911|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
19782912|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
19782913|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
19695380|NCT00313716|42140633|FG002|Overall Study|Lost to Follow-up|2|||
19695381|NCT00313716|42140634|FG003|Overall Study|Lost to Follow-up|1|||
19695382|NCT00313716|42140635|FG004|Overall Study|Lost to Follow-up|0|||
19695383|NCT00313716|42140636|FG005|Overall Study|Lost to Follow-up|4|||
19695384|NCT00313716|42140631|FG000|Overall Study|Withdrawal by Subject|0|||
19695385|NCT00313716|42140632|FG001|Overall Study|Withdrawal by Subject|1|||
19695386|NCT00313716|42140633|FG002|Overall Study|Withdrawal by Subject|1|||
19695387|NCT00313716|42140634|FG003|Overall Study|Withdrawal by Subject|0|||
19695388|NCT00313716|42140635|FG004|Overall Study|Withdrawal by Subject|1|||
19695389|NCT00313716|42140636|FG005|Overall Study|Withdrawal by Subject|0|||
19695390|NCT00313170|42140657|FG000|Overall Study|Death|2|||
19695391|NCT00313170|42140658|FG001|Overall Study|Death|4|||
19695392|NCT00313170|42140659|FG002|Overall Study|Death|2|||
19695393|NCT00313170|42140657|FG000|Overall Study|Adverse Event|1|||
19695394|NCT00313170|42140658|FG001|Overall Study|Adverse Event|2|||
19695395|NCT00313170|42140659|FG002|Overall Study|Adverse Event|0|||
19695396|NCT00313170|42140657|FG000|Overall Study|Disease progression|31|||
19695397|NCT00313170|42140658|FG001|Overall Study|Disease progression|26|||
19695398|NCT00313170|42140659|FG002|Overall Study|Disease progression|27|||
19695399|NCT00313170|42140657|FG000|Overall Study|Withdrawal by Subject|1|||
19695400|NCT00313170|42140658|FG001|Overall Study|Withdrawal by Subject|0|||
19695401|NCT00313170|42140659|FG002|Overall Study|Withdrawal by Subject|1|||
19695402|NCT00313170|42140657|FG000|Overall Study|Incorrect enrollment|0|||
19695403|NCT00313170|42140658|FG001|Overall Study|Incorrect enrollment|2|||
19695404|NCT00313170|42140659|FG002|Overall Study|Incorrect enrollment|1|||
19695405|NCT00313170|42140657|FG000|Overall Study|Lost to Follow-up|0|||
19695406|NCT00313170|42140658|FG001|Overall Study|Lost to Follow-up|0|||
19695407|NCT00313170|42140659|FG002|Overall Study|Lost to Follow-up|1|||
19695408|NCT00313170|42140657|FG000|Overall Study|Progression (investigators opinion)|1|||
19695409|NCT00313170|42140658|FG001|Overall Study|Progression (investigators opinion)|0|||
19695410|NCT00313170|42140659|FG002|Overall Study|Progression (investigators opinion)|0|||
19695411|NCT00332462|42140668|FG000|Overall Study|Adverse Event|5|||
19695412|NCT00332462|42140668|FG000|Overall Study|Abnormal Lab Value|1|||
19695413|NCT00332462|42140668|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19695414|NCT00332462|42140668|FG000|Overall Study|no longer requires study drug|1|||
19695415|NCT00332462|42140668|FG000|Overall Study|Death|3|||
19695416|NCT00332462|42140668|FG000|Overall Study|Graft Loss|2|||
19695417|NCT00324038|42140677|FG000|Overall Study|Adverse Event|38|||
19695418|NCT00324038|42140678|FG001|Overall Study|Adverse Event|23|||
19695419|NCT00324038|42140677|FG000|Overall Study|Lack of Efficacy|5|||
19695420|NCT00324038|42140678|FG001|Overall Study|Lack of Efficacy|13|||
19695421|NCT00324038|42140677|FG000|Overall Study|Lost to Follow-up|0|||
19695422|NCT00324038|42140678|FG001|Overall Study|Lost to Follow-up|2|||
19695423|NCT00324038|42140677|FG000|Overall Study|Other|6|||
19695424|NCT00324038|42140678|FG001|Overall Study|Other|13|||
19695425|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Death|3|||
19695426|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Death|0|||
19695427|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Adverse Event|12|||
19695428|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Adverse Event|6|||
19695429|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
19695430|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
19695431|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
19695432|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
19695433|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
19695434|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
19695435|NCT00159861|42140686|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
19695436|NCT00159861|42140687|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
19695437|NCT00159861|42140686|FG000|Extension Study - up to 3 Years|Death|24|||
19695438|NCT00159861|42140687|FG001|Extension Study - up to 3 Years|Death|28|||
19695439|NCT00159861|42140686|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
19695440|NCT00159861|42140687|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
19695441|NCT00159861|42140686|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
19367353|NCT02456740|41607526|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19695442|NCT00159861|42140687|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
19695443|NCT00159861|42140686|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
19695444|NCT00159861|42140687|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
19695445|NCT00159861|42140686|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
19695446|NCT00159861|42140687|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
19695447|NCT00331760|42140700|FG000|Overall Study|Ineligible / no protocol treatment|15|||
19695448|NCT00331760|42140701|FG001|Overall Study|Ineligible / no protocol treatment|8|||
19695449|NCT00225147|42140712|FG000|Open-label Phase|Lost to Follow-up|0|||
19695450|NCT00225147|42140713|FG001|Open-label Phase|Lost to Follow-up|0|||
19695451|NCT00225147|42140714|FG002|Open-label Phase|Lost to Follow-up|0|||
19695452|NCT00225147|42140715|FG003|Open-label Phase|Lost to Follow-up|4|||
19695453|NCT00225147|42140712|FG000|Open-label Phase|Withdrawal by Subject|0|||
19695454|NCT00225147|42140713|FG001|Open-label Phase|Withdrawal by Subject|0|||
19367354|NCT02456740|41607527|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19367355|NCT02456740|41607528|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19367356|NCT02456740|41607529|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
19367357|NCT02456740|41607521|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
19367358|NCT02456740|41607522|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
19367359|NCT02456740|41607523|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
19367360|NCT02456740|41607524|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19367361|NCT02456740|41607525|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19367362|NCT02456740|41607526|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19695455|NCT00225147|42140714|FG002|Open-label Phase|Withdrawal by Subject|0|||
19695456|NCT00225147|42140715|FG003|Open-label Phase|Withdrawal by Subject|6|||
19695457|NCT00313014|42140730|FG000|Overall Study|Withdrawal by Subject|11|||
19695458|NCT00313014|42140731|FG001|Overall Study|Withdrawal by Subject|7|||
19695459|NCT00313014|42140732|FG002|Overall Study|Withdrawal by Subject|5|||
19695460|NCT00313014|42140730|FG000|Overall Study|Adverse Event|14|||
19695461|NCT00313014|42140731|FG001|Overall Study|Adverse Event|29|||
19695462|NCT00313014|42140732|FG002|Overall Study|Adverse Event|16|||
19695463|NCT00313014|42140730|FG000|Overall Study|Lost to Follow-up|7|||
19695464|NCT00313014|42140731|FG001|Overall Study|Lost to Follow-up|6|||
19695465|NCT00313014|42140732|FG002|Overall Study|Lost to Follow-up|10|||
19695466|NCT00313014|42140730|FG000|Overall Study|Administrative|9|||
19695467|NCT00313014|42140731|FG001|Overall Study|Administrative|6|||
19695468|NCT00313014|42140732|FG002|Overall Study|Administrative|14|||
19695469|NCT00313014|42140730|FG000|Overall Study|Lack of Efficacy|52|||
19695470|NCT00313014|42140731|FG001|Overall Study|Lack of Efficacy|25|||
19695471|NCT00313014|42140732|FG002|Overall Study|Lack of Efficacy|16|||
19695472|NCT00157209|42140743|FG000|Overall Study|Ongoing at data cut-off|10|||
19695473|NCT00157209|42140744|FG001|Overall Study|Ongoing at data cut-off|0|||
19695474|NCT00312858|42140752|FG000|Overall Study|Adverse Event|0|||
19695475|NCT00312858|42140753|FG001|Overall Study|Adverse Event|1|||
19695476|NCT00312858|42140752|FG000|Overall Study|Lost to Follow-up|25|||
19695477|NCT00312858|42140753|FG001|Overall Study|Lost to Follow-up|42|||
19695478|NCT00312858|42140752|FG000|Overall Study|Protocol Violation|3|||
19695479|NCT00312858|42140753|FG001|Overall Study|Protocol Violation|8|||
19695480|NCT00312858|42140752|FG000|Overall Study|Withdraw by Participant|20|||
19695481|NCT00312858|42140753|FG001|Overall Study|Withdraw by Participant|20|||
19695482|NCT00312858|42140752|FG000|Overall Study|Participant Moved|11|||
19782914|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
19782915|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
19782916|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
19782917|NCT02637856|42239503|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
19782918|NCT02637856|42239504|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
19782919|NCT02637856|42239503|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
19782920|NCT02637856|42239504|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
19782921|NCT02637856|42239503|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
19782922|NCT02637856|42239504|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
19782923|NCT02858037|42239510|FG000|Overall Study|Death|1|||
19782924|NCT02858037|42239510|FG000|Overall Study|Withdrawal by Subject|18|||
19695483|NCT00312858|42140753|FG001|Overall Study|Participant Moved|10|||
19695484|NCT00312858|42140752|FG000|Overall Study|Other|9|||
19695485|NCT00312858|42140753|FG001|Overall Study|Other|12|||
19695486|NCT00312702|42140762|FG000|Immunization Phase|Lost to Follow-up|0|||
19695487|NCT00312702|42140763|FG001|Immunization Phase|Lost to Follow-up|1|||
19695488|NCT00312702|42140764|FG002|Immunization Phase|Lost to Follow-up|0|||
19782925|NCT02858037|42239510|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
19782926|NCT02858037|42239510|FG000|Overall Study|Lost to Follow-up|3|||
19782927|NCT02858037|42239510|FG000|Overall Study|Other|4|||
19782928|NCT02065869|42239514|FG000|Overall Study|Death|7|||
19782929|NCT02065869|42239514|FG000|Overall Study|Disease relapse|16|||
19782930|NCT02065869|42239514|FG000|Overall Study|Lost to Follow-up|4|||
19782931|NCT02065869|42239514|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
19782932|NCT02065869|42239514|FG000|Overall Study|Withdrawal by Subject|1|||
19782933|NCT02856555|42239522|FG000|Overall Study|Adverse Event|1|||
19782934|NCT02856555|42239523|FG001|Overall Study|Adverse Event|0|||
19782935|NCT02856555|42239524|FG002|Overall Study|Adverse Event|0|||
19477783|NCT01479439|41757035|FG000|Overall Study|Lost to Follow-up|0|||
19477784|NCT01479439|41757036|FG001|Overall Study|Lost to Follow-up|1|||
19695489|NCT00156819|42140775|FG000|Overall Study|Lost to Follow-up|1|||
19695490|NCT00156819|42140776|FG001|Overall Study|Lost to Follow-up|1|||
19695491|NCT00156819|42140777|FG002|Overall Study|Lost to Follow-up|3|||
19695492|NCT03825042|42140787|FG000|Overall Study|Adverse Event|1|||
19695493|NCT03825042|42140788|FG001|Overall Study|Adverse Event|0|||
19695494|NCT03825042|42140787|FG000|Overall Study|Withdrawal by Subject|1|||
19695495|NCT03825042|42140788|FG001|Overall Study|Withdrawal by Subject|0|||
19782936|NCT02856555|42239522|FG000|Overall Study|Lost to Follow-up|1|||
19782937|NCT02856555|42239523|FG001|Overall Study|Lost to Follow-up|3|||
19782938|NCT02856555|42239524|FG002|Overall Study|Lost to Follow-up|0|||
19782939|NCT02856555|42239522|FG000|Overall Study|Withdrawal by Subject|3|||
19782940|NCT02856555|42239523|FG001|Overall Study|Withdrawal by Subject|0|||
19782941|NCT02856555|42239524|FG002|Overall Study|Withdrawal by Subject|0|||
19782942|NCT02856555|42239522|FG000|Overall Study|Randomized but Never Treated|0|||
19782943|NCT02856555|42239523|FG001|Overall Study|Randomized but Never Treated|1|||
19782944|NCT02856555|42239524|FG002|Overall Study|Randomized but Never Treated|0|||
19782945|NCT02637232|42239562|FG000|Overall Study|Lost to Follow-up|42|||
19782946|NCT02637232|42239562|FG000|Overall Study|Adverse Event|11|||
19782947|NCT02637232|42239562|FG000|Overall Study|patient 's decision|2|||
19782948|NCT02855541|42239566|FG000|Overall Study|Change in health status|2|||
19782949|NCT02855541|42239566|FG000|Overall Study|Withdrawal by Subject|2|||
19782950|NCT02635984|42239572|FG000|Overall Study|Lost to Follow-up|2|||
19782951|NCT02635984|42239573|FG001|Overall Study|Lost to Follow-up|4|||
19782952|NCT02635984|42239572|FG000|Overall Study|Study Arm Closed|1|||
19782953|NCT02635984|42239573|FG001|Overall Study|Study Arm Closed|0|||
19782954|NCT01147653|42239581|FG000|Year 2|Withdrawal by Subject|2|||
19782955|NCT01147653|42239582|FG001|Year 2|Withdrawal by Subject|3|||
19782956|NCT02747043|42239603|FG000|Overall Study|Other|1|||
19782957|NCT02747043|42239604|FG001|Overall Study|Other|1|||
19782958|NCT02747043|42239603|FG000|Overall Study|Adverse Event|3|||
19782959|NCT02747043|42239604|FG001|Overall Study|Adverse Event|1|||
19782960|NCT02747043|42239603|FG000|Overall Study|Withdrawal by Subject|1|||
19782961|NCT02747043|42239604|FG001|Overall Study|Withdrawal by Subject|1|||
19367363|NCT02456740|41607527|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19367364|NCT02456740|41607528|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19367365|NCT02456740|41607529|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
19367366|NCT02456740|41607521|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19367367|NCT02456740|41607522|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19607274|NCT00673387|42055996|FG001|Overall Study|Lost to Follow-up|6|||
19607275|NCT00673387|42055997|FG002|Overall Study|Lost to Follow-up|5|||
19607276|NCT00673387|42055998|FG003|Overall Study|Lost to Follow-up|6|||
19695496|NCT00129987|42140796|FG000|1st Educational Session|Withdrawal by Subject|141|||
19782962|NCT02747043|42239603|FG000|Overall Study|Physician Decision|1|||
19782963|NCT02747043|42239604|FG001|Overall Study|Physician Decision|1|||
19782964|NCT02747043|42239603|FG000|Overall Study|Protocol Violation|0|||
19782965|NCT02747043|42239604|FG001|Overall Study|Protocol Violation|1|||
19782966|NCT02747043|42239603|FG000|Overall Study|Disease progression|4|||
19782967|NCT02747043|42239604|FG001|Overall Study|Disease progression|0|||
19782968|NCT02637076|42239612|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
19782969|NCT02637076|42239613|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
19782970|NCT02637076|42239612|FG000|Overall Study|Withdrawal by Subject|0|||
19607277|NCT00673387|42055999|FG004|Overall Study|Lost to Follow-up|6|||
19695497|NCT00129987|42140797|FG001|1st Educational Session|Withdrawal by Subject|109|||
19695498|NCT00129987|42140796|FG000|1 Year|Withdrawal by Subject|32|||
19695499|NCT00129987|42140797|FG001|1 Year|Withdrawal by Subject|21|||
19607278|NCT00673387|42056000|FG005|Overall Study|Lost to Follow-up|5|||
19607279|NCT00673387|42056001|FG006|Overall Study|Lost to Follow-up|8|||
19695500|NCT00224133|42140803|FG000|Overall Study|Adverse Event|93|||
19695501|NCT00224133|42140803|FG000|Overall Study|Protocol Violation|6|||
19695502|NCT00224133|42140803|FG000|Overall Study|Withdrawal by Subject|33|||
19695503|NCT00224133|42140803|FG000|Overall Study|Lack of Efficacy|58|||
19695504|NCT00224133|42140803|FG000|Overall Study|Lost to Follow-up|21|||
19695505|NCT00224133|42140803|FG000|Overall Study|Physician Decision|1|||
19695506|NCT00224133|42140803|FG000|Overall Study|Other|14|||
19695507|NCT00224055|42140809|FG000|Overall Study|Adverse Event|9|||
19695508|NCT00224055|42140810|FG001|Overall Study|Adverse Event|3|||
19695509|NCT00224055|42140809|FG000|Overall Study|Lost to Follow-up|1|||
19695510|NCT00224055|42140810|FG001|Overall Study|Lost to Follow-up|2|||
19695511|NCT00224055|42140809|FG000|Overall Study|Protocol Violation|1|||
19695512|NCT00224055|42140810|FG001|Overall Study|Protocol Violation|1|||
19695513|NCT00224055|42140809|FG000|Overall Study|Inclusion Violation|3|||
19695514|NCT00224055|42140810|FG001|Overall Study|Inclusion Violation|6|||
19695515|NCT00224055|42140809|FG000|Overall Study|Withdrawal by Subject|0|||
19695516|NCT00224055|42140810|FG001|Overall Study|Withdrawal by Subject|2|||
19695517|NCT00224055|42140809|FG000|Overall Study|Other|1|||
19695518|NCT00224055|42140810|FG001|Overall Study|Other|0|||
19695519|NCT00150969|42140818|FG000|24 Month Main Study|Adverse Event|3|||
19607280|NCT00673387|42056002|FG007|Overall Study|Lost to Follow-up|5|||
19607281|NCT00933608|42056032|FG000|Overall Study|Adverse Event|4|||
19607282|NCT00933608|42056033|FG001|Overall Study|Adverse Event|2|||
19695520|NCT00150969|42140819|FG001|24 Month Main Study|Adverse Event|4|||
19695521|NCT00150969|42140818|FG000|24 Month Main Study|Death|1|||
19695522|NCT00150969|42140819|FG001|24 Month Main Study|Death|1|||
19695523|NCT00150969|42140818|FG000|24 Month Main Study|Lack of Efficacy|1|||
19695524|NCT00150969|42140819|FG001|24 Month Main Study|Lack of Efficacy|8|||
19695525|NCT00150969|42140818|FG000|24 Month Main Study|Lost to Follow-up|3|||
19695526|NCT00150969|42140819|FG001|24 Month Main Study|Lost to Follow-up|2|||
19695527|NCT00150969|42140818|FG000|24 Month Main Study|Protocol Violation|4|||
19695528|NCT00150969|42140819|FG001|24 Month Main Study|Protocol Violation|2|||
19695529|NCT00150969|42140818|FG000|24 Month Main Study|Withdrawal by Subject|7|||
19782971|NCT02637076|42239613|FG001|Overall Study|Withdrawal by Subject|4|||
19782972|NCT02854605|42239622|FG000|Overall Study|Adverse Event|1|||
19782973|NCT02854605|42239623|FG001|Overall Study|Adverse Event|5|||
19782974|NCT02854605|42239624|FG002|Overall Study|Adverse Event|2|||
19695530|NCT00150969|42140819|FG001|24 Month Main Study|Withdrawal by Subject|4|||
19695531|NCT00150969|42140818|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
19695532|NCT00150969|42140819|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
19695533|NCT00150969|42140818|FG000|24-48 Month Extension|Lack of Efficacy|0|||
19695534|NCT00150969|42140819|FG001|24-48 Month Extension|Lack of Efficacy|1|||
19695535|NCT00150969|42140818|FG000|24-48 Month Extension|Adverse Event|1|||
19695536|NCT00150969|42140819|FG001|24-48 Month Extension|Adverse Event|3|||
19695537|NCT00150969|42140818|FG000|24-48 Month Extension|Other Reason|81|||
19695538|NCT00150969|42140819|FG001|24-48 Month Extension|Other Reason|91|||
19695539|NCT00150345|42140828|FG000|Overall Study|Death|5|||
19695540|NCT00150345|42140829|FG001|Overall Study|Death|2|||
19695541|NCT00150345|42140828|FG000|Overall Study|Adverse Event|8|||
19695542|NCT00150345|42140829|FG001|Overall Study|Adverse Event|6|||
19695543|NCT00150345|42140828|FG000|Overall Study|Lack of Efficacy|5|||
19695544|NCT00150345|42140829|FG001|Overall Study|Lack of Efficacy|4|||
19695545|NCT00150345|42140828|FG000|Overall Study|Withdrawal by Subject|3|||
19695546|NCT00150345|42140829|FG001|Overall Study|Withdrawal by Subject|4|||
19695547|NCT00150345|42140828|FG000|Overall Study|Laboratory abnormality|1|||
19695548|NCT00150345|42140829|FG001|Overall Study|Laboratory abnormality|2|||
19695549|NCT00150345|42140828|FG000|Overall Study|Other|12|||
19695550|NCT00150345|42140829|FG001|Overall Study|Other|14|||
19695551|NCT00223977|42140839|FG000|Overall Study|Adverse Event|7|||
19695552|NCT00223977|42140840|FG001|Overall Study|Adverse Event|10|||
19695553|NCT00223977|42140841|FG002|Overall Study|Adverse Event|0|||
19695554|NCT00223977|42140839|FG000|Overall Study|Protocol Violation|0|||
19695555|NCT00223977|42140840|FG001|Overall Study|Protocol Violation|0|||
19695556|NCT00223977|42140841|FG002|Overall Study|Protocol Violation|1|||
19695557|NCT00223977|42140839|FG000|Overall Study|Withdrawal by Subject|1|||
19695558|NCT00223977|42140840|FG001|Overall Study|Withdrawal by Subject|1|||
19695559|NCT00223977|42140841|FG002|Overall Study|Withdrawal by Subject|2|||
19695560|NCT00223977|42140839|FG000|Overall Study|Other|1|||
19695561|NCT00223977|42140840|FG001|Overall Study|Other|0|||
19695562|NCT00223977|42140841|FG002|Overall Study|Other|0|||
19695563|NCT00148941|42140853|FG000|Overall Study|Lost to Follow-up|17|||
19695564|NCT00148941|42140854|FG001|Overall Study|Lost to Follow-up|24|||
19782975|NCT02854605|42239622|FG000|Overall Study|Lost to Follow-up|0|||
19782976|NCT02854605|42239623|FG001|Overall Study|Lost to Follow-up|2|||
19782977|NCT02854605|42239624|FG002|Overall Study|Lost to Follow-up|0|||
19782978|NCT02854605|42239622|FG000|Overall Study|Withdrew Consent|1|||
19782979|NCT02854605|42239623|FG001|Overall Study|Withdrew Consent|0|||
19782980|NCT02854605|42239624|FG002|Overall Study|Withdrew Consent|1|||
19782981|NCT02854605|42239622|FG000|Overall Study|Investigator's Discretion|1|||
19782982|NCT02854605|42239623|FG001|Overall Study|Investigator's Discretion|0|||
19782983|NCT02854605|42239624|FG002|Overall Study|Investigator's Discretion|0|||
19782984|NCT02854605|42239622|FG000|Overall Study|Protocol Violation|0|||
19782985|NCT02854605|42239623|FG001|Overall Study|Protocol Violation|0|||
19782986|NCT02854605|42239624|FG002|Overall Study|Protocol Violation|1|||
19695565|NCT00148941|42140855|FG002|Overall Study|Lost to Follow-up|18|||
19695566|NCT00148941|42140856|FG003|Overall Study|Lost to Follow-up|22|||
19782987|NCT02854527|42239642|FG000|Overall Study|Adverse Event|0|||
19782988|NCT02854527|42239643|FG001|Overall Study|Adverse Event|0|||
19782989|NCT02854527|42239644|FG002|Overall Study|Adverse Event|0|||
19782990|NCT02854527|42239645|FG003|Overall Study|Adverse Event|0|||
19782991|NCT02854527|42239646|FG004|Overall Study|Adverse Event|1|||
19782992|NCT02854527|42239647|FG005|Overall Study|Adverse Event|0|||
19782993|NCT02854527|42239648|FG006|Overall Study|Adverse Event|0|||
19782994|NCT02854527|42239649|FG007|Overall Study|Adverse Event|0|||
19782995|NCT02854527|42239650|FG008|Overall Study|Adverse Event|0|||
19782996|NCT02854527|42239651|FG009|Overall Study|Adverse Event|0|||
19477785|NCT01479439|41757037|FG002|Overall Study|Lost to Follow-up|0|||
19695567|NCT00148941|42140853|FG000|Overall Study|Withdrawal by Subject|1|||
19695568|NCT00148941|42140854|FG001|Overall Study|Withdrawal by Subject|0|||
19782997|NCT02854527|42239642|FG000|Overall Study|Lost to Follow-up|0|||
19782998|NCT02854527|42239643|FG001|Overall Study|Lost to Follow-up|0|||
19782999|NCT02854527|42239644|FG002|Overall Study|Lost to Follow-up|0|||
19695569|NCT00148941|42140855|FG002|Overall Study|Withdrawal by Subject|1|||
19695570|NCT00148941|42140856|FG003|Overall Study|Withdrawal by Subject|0|||
19695571|NCT00148941|42140853|FG000|Overall Study|Other|0|||
19695572|NCT00148941|42140854|FG001|Overall Study|Other|0|||
19783000|NCT02854527|42239645|FG003|Overall Study|Lost to Follow-up|1|||
19607283|NCT00933608|42056032|FG000|Overall Study|Physician Decision|1|||
19607284|NCT00933608|42056033|FG001|Overall Study|Physician Decision|0|||
19607285|NCT00574951|42056039|FG000|Overall Study|Ineligible - improper prior treatment|1|||
19695573|NCT00148941|42140855|FG002|Overall Study|Other|1|||
19695574|NCT00148941|42140856|FG003|Overall Study|Other|2|||
19695575|NCT00148317|42140866|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
19695576|NCT00148317|42140866|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
19695577|NCT00148317|42140866|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
19695578|NCT00323882|42140878|FG000|Overall Study|Adverse Event|2|||
19695579|NCT00323882|42140879|FG001|Overall Study|Adverse Event|1|||
19695580|NCT00323882|42140880|FG002|Overall Study|Adverse Event|1|||
19695581|NCT00323882|42140881|FG003|Overall Study|Adverse Event|1|||
19695582|NCT00323882|42140882|FG004|Overall Study|Adverse Event|3|||
19695583|NCT00323882|42140878|FG000|Overall Study|Disease Progression|6|||
19695584|NCT00323882|42140879|FG001|Overall Study|Disease Progression|4|||
19695585|NCT00323882|42140880|FG002|Overall Study|Disease Progression|10|||
19695586|NCT00323882|42140881|FG003|Overall Study|Disease Progression|5|||
19695587|NCT00323882|42140882|FG004|Overall Study|Disease Progression|22|||
19695588|NCT00323882|42140878|FG000|Overall Study|Death|0|||
19695589|NCT00323882|42140879|FG001|Overall Study|Death|1|||
19695590|NCT00323882|42140880|FG002|Overall Study|Death|1|||
19695591|NCT00323882|42140881|FG003|Overall Study|Death|0|||
19695592|NCT00323882|42140882|FG004|Overall Study|Death|5|||
19695593|NCT00323882|42140878|FG000|Overall Study|Lost to Follow-up|0|||
19695594|NCT00323882|42140879|FG001|Overall Study|Lost to Follow-up|0|||
19695595|NCT00323882|42140880|FG002|Overall Study|Lost to Follow-up|1|||
19695596|NCT00323882|42140881|FG003|Overall Study|Lost to Follow-up|0|||
19695597|NCT00323882|42140882|FG004|Overall Study|Lost to Follow-up|1|||
19695598|NCT00323882|42140878|FG000|Overall Study|Other|0|||
19695599|NCT00323882|42140879|FG001|Overall Study|Other|0|||
19695600|NCT00323882|42140880|FG002|Overall Study|Other|0|||
19695601|NCT00323882|42140881|FG003|Overall Study|Other|1|||
19695602|NCT00323882|42140882|FG004|Overall Study|Other|1|||
19695603|NCT00331682|42140903|FG000|Overall Study|Adverse Event|1|||
19695604|NCT00323492|42140909|FG000|Study Phase 1|Adverse Event|2|||
19695605|NCT00323492|42140910|FG001|Study Phase 1|Adverse Event|0|||
19695606|NCT00323492|42140911|FG002|Study Phase 1|Adverse Event|0|||
19695607|NCT00323492|42140909|FG000|Study Phase 2|Adverse Event|1|||
19695608|NCT00323492|42140910|FG001|Study Phase 2|Adverse Event|0|||
19695609|NCT00323492|42140911|FG002|Study Phase 2|Adverse Event|0|||
19695610|NCT00323492|42140909|FG000|Study Phase 2|Physician Decision|1|||
19695611|NCT00323492|42140910|FG001|Study Phase 2|Physician Decision|0|||
19695612|NCT00323492|42140911|FG002|Study Phase 2|Physician Decision|0|||
19695613|NCT00323492|42140909|FG000|Study Phase 2|Lost to Follow-up|1|||
19695614|NCT00323492|42140910|FG001|Study Phase 2|Lost to Follow-up|0|||
19695615|NCT00323492|42140911|FG002|Study Phase 2|Lost to Follow-up|0|||
19695616|NCT00323492|42140909|FG000|Study Phase 2|Withdrawal by Subject|0|||
19695617|NCT00323492|42140910|FG001|Study Phase 2|Withdrawal by Subject|1|||
19695618|NCT00323492|42140911|FG002|Study Phase 2|Withdrawal by Subject|0|||
19695619|NCT00323492|42140909|FG000|Study Phase 2|Noncompliance with study schedule|0|||
19695620|NCT00323492|42140910|FG001|Study Phase 2|Noncompliance with study schedule|0|||
19695621|NCT00323492|42140911|FG002|Study Phase 2|Noncompliance with study schedule|1|||
19695622|NCT00323492|42140909|FG000|Study Phase 2|Protocol Violation|1|||
19695623|NCT00323492|42140910|FG001|Study Phase 2|Protocol Violation|0|||
19695624|NCT00323492|42140911|FG002|Study Phase 2|Protocol Violation|0|||
19695625|NCT00331136|42140922|FG000|Overall Study|Adverse Event|3|||
19695626|NCT00331136|42140923|FG001|Overall Study|Adverse Event|5|||
19695627|NCT00331136|42140924|FG002|Overall Study|Adverse Event|0|||
19695628|NCT00331136|42140925|FG003|Overall Study|Adverse Event|1|||
19695629|NCT00331136|42140922|FG000|Overall Study|Withdrawal by Subject|0|||
19695630|NCT00331136|42140923|FG001|Overall Study|Withdrawal by Subject|1|||
19695631|NCT00331136|42140924|FG002|Overall Study|Withdrawal by Subject|0|||
19477786|NCT01479439|41757035|FG000|Overall Study|Protocol Violation|0|||
19695632|NCT00331136|42140925|FG003|Overall Study|Withdrawal by Subject|0|||
19695633|NCT00331136|42140922|FG000|Overall Study|Lost to Follow-up|0|||
19695634|NCT00331136|42140923|FG001|Overall Study|Lost to Follow-up|1|||
19695635|NCT00331136|42140924|FG002|Overall Study|Lost to Follow-up|0|||
19695636|NCT00331136|42140925|FG003|Overall Study|Lost to Follow-up|0|||
19695637|NCT00331136|42140922|FG000|Overall Study|Protocol Violation|1|||
19695638|NCT00331136|42140923|FG001|Overall Study|Protocol Violation|0|||
19695639|NCT00331136|42140924|FG002|Overall Study|Protocol Violation|0|||
19695640|NCT00331136|42140925|FG003|Overall Study|Protocol Violation|0|||
19695641|NCT00331136|42140922|FG000|Overall Study|Not treated|1|||
19695642|NCT00331136|42140923|FG001|Overall Study|Not treated|0|||
19695643|NCT00331136|42140924|FG002|Overall Study|Not treated|0|||
19695644|NCT00331136|42140925|FG003|Overall Study|Not treated|0|||
19695645|NCT00323414|42140937|FG000|Overall Study|Withdrawal by Subject|0|||
19695646|NCT00323414|42140938|FG001|Overall Study|Withdrawal by Subject|1|||
19695647|NCT00330668|42140944|FG000|BID Dosing Period|Adverse Event|1|||
19695648|NCT00330668|42140944|FG000|BID Dosing Period|Lost to Follow-up|7|||
19695649|NCT00330668|42140944|FG000|BID Dosing Period|Non-Compliance|5|||
19695650|NCT00330668|42140944|FG000|BID Dosing Period|Withdrawal by Subject|19|||
19783001|NCT02854527|42239646|FG004|Overall Study|Lost to Follow-up|0|||
19783002|NCT02854527|42239647|FG005|Overall Study|Lost to Follow-up|0|||
19783003|NCT02854527|42239648|FG006|Overall Study|Lost to Follow-up|0|||
19783004|NCT02854527|42239649|FG007|Overall Study|Lost to Follow-up|0|||
19783005|NCT02854527|42239650|FG008|Overall Study|Lost to Follow-up|0|||
19783006|NCT02854527|42239651|FG009|Overall Study|Lost to Follow-up|0|||
19783007|NCT02853435|42239678|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
19783008|NCT02853435|42239679|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
19783009|NCT02853435|42239680|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
19783010|NCT02853435|42239681|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
19783011|NCT02853435|42239682|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
19783012|NCT02853435|42239683|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
19783013|NCT02635204|42239715|FG000|Overall Study|Adverse Event|1|||
19783014|NCT02635204|42239716|FG001|Overall Study|Adverse Event|0|||
19783015|NCT02635204|42239715|FG000|Overall Study|Lost to Follow-up|1|||
19783016|NCT02635204|42239716|FG001|Overall Study|Lost to Follow-up|1|||
19783017|NCT00102804|42239724|FG000|Overall Study|Progressive Disease (PD)|307|||
19783018|NCT00102804|42239725|FG001|Overall Study|Progressive Disease (PD)|196|||
19783019|NCT00102804|42239724|FG000|Overall Study|Withdrawal by Subject|46|||
19783020|NCT00102804|42239725|FG001|Overall Study|Withdrawal by Subject|7|||
19783021|NCT00102804|42239724|FG000|Overall Study|Adverse Event|37|||
19783022|NCT00102804|42239725|FG001|Overall Study|Adverse Event|3|||
19783023|NCT00102804|42239724|FG000|Overall Study|Physician Decision|24|||
19783024|NCT00102804|42239725|FG001|Overall Study|Physician Decision|6|||
19783025|NCT00102804|42239724|FG000|Overall Study|Death|5|||
19783026|NCT00102804|42239725|FG001|Overall Study|Death|6|||
19783027|NCT00102804|42239724|FG000|Overall Study|Enrollment Criteria Not Met|6|||
19783028|NCT00102804|42239725|FG001|Overall Study|Enrollment Criteria Not Met|0|||
19783029|NCT00102804|42239724|FG000|Overall Study|Lost to Follow-up|4|||
19783030|NCT00102804|42239725|FG001|Overall Study|Lost to Follow-up|1|||
19695651|NCT00330668|42140944|FG000|BID Dosing Period|Sponsor's decision|1|||
19695652|NCT00330668|42140944|FG000|BID Dosing Period|Other|3|||
19695653|NCT00330668|42140944|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
19695654|NCT00330668|42140944|FG000|QD Dosing Period|Other|1|||
19695655|NCT00330668|42140944|FG000|QD Dosing Period|Withdrawal by Subject|1|||
19695656|NCT00330668|42140944|FG000|QD Dosing Period|Lost to Follow-up|2|||
19695657|NCT00306384|42140951|FG000|Overall Study|Adverse Event|103|||
19695658|NCT00306384|42140952|FG001|Overall Study|Adverse Event|87|||
19695659|NCT00306384|42140953|FG002|Overall Study|Adverse Event|40|||
19695660|NCT00306384|42140951|FG000|Overall Study|Major protocol deviation|43|||
19695661|NCT00306384|42140952|FG001|Overall Study|Major protocol deviation|51|||
19695662|NCT00306384|42140953|FG002|Overall Study|Major protocol deviation|18|||
19695663|NCT00306384|42140951|FG000|Overall Study|Lost to Follow-up|57|||
19695664|NCT00306384|42140952|FG001|Overall Study|Lost to Follow-up|41|||
19695665|NCT00306384|42140953|FG002|Overall Study|Lost to Follow-up|35|||
19695666|NCT00306384|42140951|FG000|Overall Study|Voluntary withdrawal|199|||
19695667|NCT00306384|42140952|FG001|Overall Study|Voluntary withdrawal|187|||
19695668|NCT00306384|42140953|FG002|Overall Study|Voluntary withdrawal|91|||
19783031|NCT00102804|42239724|FG000|Overall Study|Protocol Violation|2|||
19783032|NCT00102804|42239725|FG001|Overall Study|Protocol Violation|1|||
19783033|NCT00102804|42239724|FG000|Overall Study|Satisfactory Response|2|||
19783034|NCT00102804|42239725|FG001|Overall Study|Satisfactory Response|0|||
19783035|NCT00102804|42239724|FG000|Overall Study|Sponsor Decision|1|||
19783036|NCT00102804|42239725|FG001|Overall Study|Sponsor Decision|0|||
19783037|NCT00102804|42239724|FG000|Overall Study|Alive, Receiving Treatment|7|||
19783038|NCT00102804|42239725|FG001|Overall Study|Alive, Receiving Treatment|2|||
19783039|NCT01814072|42239763|FG000|Overall Study|Lost to Follow-up|2|||
19783040|NCT01814072|42239764|FG001|Overall Study|Lost to Follow-up|2|||
19783041|NCT01814072|42239765|FG002|Overall Study|Lost to Follow-up|2|||
19783042|NCT01814072|42239766|FG003|Overall Study|Lost to Follow-up|0|||
19783043|NCT01814072|42239767|FG004|Overall Study|Lost to Follow-up|2|||
19783044|NCT01814072|42239768|FG005|Overall Study|Lost to Follow-up|3|||
19783045|NCT01814072|42239769|FG006|Overall Study|Lost to Follow-up|3|||
19783046|NCT01814072|42239770|FG007|Overall Study|Lost to Follow-up|1|||
19783047|NCT01814072|42239771|FG008|Overall Study|Lost to Follow-up|2|||
19783048|NCT01814072|42239772|FG009|Overall Study|Lost to Follow-up|3|||
19783049|NCT01814072|42239773|FG010|Overall Study|Lost to Follow-up|1|||
19783050|NCT01814072|42239774|FG011|Overall Study|Lost to Follow-up|2|||
19783051|NCT01814072|42239775|FG012|Overall Study|Lost to Follow-up|2|||
19783052|NCT01814072|42239776|FG013|Overall Study|Lost to Follow-up|1|||
19783053|NCT01814072|42239777|FG014|Overall Study|Lost to Follow-up|2|||
19783054|NCT01814072|42239778|FG015|Overall Study|Lost to Follow-up|1|||
19695669|NCT00306384|42140951|FG000|Overall Study|Study termination|1|||
19695670|NCT00306384|42140952|FG001|Overall Study|Study termination|0|||
19695671|NCT00306384|42140953|FG002|Overall Study|Study termination|1|||
19695672|NCT00306384|42140951|FG000|Overall Study|Pregnancy|3|||
19783055|NCT01814072|42239779|FG016|Overall Study|Lost to Follow-up|3|||
19783056|NCT01814072|42239780|FG017|Overall Study|Lost to Follow-up|1|||
19783057|NCT01814072|42239781|FG018|Overall Study|Lost to Follow-up|3|||
19783058|NCT01814072|42239782|FG019|Overall Study|Lost to Follow-up|3|||
19783059|NCT01814072|42239783|FG020|Overall Study|Lost to Follow-up|2|||
19783060|NCT01814072|42239784|FG021|Overall Study|Lost to Follow-up|1|||
19783061|NCT01814072|42239785|FG022|Overall Study|Lost to Follow-up|3|||
19783062|NCT01814072|42239786|FG023|Overall Study|Lost to Follow-up|1|||
19783063|NCT01814072|42239787|FG024|Overall Study|Lost to Follow-up|4|||
19783064|NCT01814072|42239788|FG025|Overall Study|Lost to Follow-up|1|||
19783065|NCT01814072|42239789|FG026|Overall Study|Lost to Follow-up|1|||
19783066|NCT01814072|42239790|FG027|Overall Study|Lost to Follow-up|2|||
19783067|NCT01814072|42239791|FG028|Overall Study|Lost to Follow-up|3|||
19783068|NCT01814072|42239792|FG029|Overall Study|Lost to Follow-up|3|||
19783069|NCT01814072|42239793|FG030|Overall Study|Lost to Follow-up|2|||
19783070|NCT01814072|42239794|FG031|Overall Study|Lost to Follow-up|0|||
19783071|NCT01814072|42239763|FG000|Overall Study|Withdrawal by Subject|2|||
19783072|NCT01814072|42239764|FG001|Overall Study|Withdrawal by Subject|0|||
19783073|NCT01814072|42239765|FG002|Overall Study|Withdrawal by Subject|1|||
19783074|NCT01814072|42239766|FG003|Overall Study|Withdrawal by Subject|0|||
19783075|NCT01814072|42239767|FG004|Overall Study|Withdrawal by Subject|2|||
19783076|NCT01814072|42239768|FG005|Overall Study|Withdrawal by Subject|3|||
19783077|NCT01814072|42239769|FG006|Overall Study|Withdrawal by Subject|1|||
19783078|NCT01814072|42239770|FG007|Overall Study|Withdrawal by Subject|0|||
19783079|NCT01814072|42239771|FG008|Overall Study|Withdrawal by Subject|1|||
19783080|NCT01814072|42239772|FG009|Overall Study|Withdrawal by Subject|2|||
19783081|NCT01814072|42239773|FG010|Overall Study|Withdrawal by Subject|0|||
19783082|NCT01814072|42239774|FG011|Overall Study|Withdrawal by Subject|0|||
19783083|NCT01814072|42239775|FG012|Overall Study|Withdrawal by Subject|1|||
19783084|NCT01814072|42239776|FG013|Overall Study|Withdrawal by Subject|1|||
19783085|NCT01814072|42239777|FG014|Overall Study|Withdrawal by Subject|1|||
19783086|NCT01814072|42239778|FG015|Overall Study|Withdrawal by Subject|1|||
19783087|NCT01814072|42239779|FG016|Overall Study|Withdrawal by Subject|0|||
19783088|NCT01814072|42239780|FG017|Overall Study|Withdrawal by Subject|0|||
19783089|NCT01814072|42239781|FG018|Overall Study|Withdrawal by Subject|0|||
19783090|NCT01814072|42239782|FG019|Overall Study|Withdrawal by Subject|2|||
19783091|NCT01814072|42239783|FG020|Overall Study|Withdrawal by Subject|0|||
19783092|NCT01814072|42239784|FG021|Overall Study|Withdrawal by Subject|0|||
19783093|NCT01814072|42239785|FG022|Overall Study|Withdrawal by Subject|1|||
19783094|NCT01814072|42239786|FG023|Overall Study|Withdrawal by Subject|0|||
19783095|NCT01814072|42239787|FG024|Overall Study|Withdrawal by Subject|2|||
19783096|NCT01814072|42239788|FG025|Overall Study|Withdrawal by Subject|1|||
19783097|NCT01814072|42239789|FG026|Overall Study|Withdrawal by Subject|1|||
19783098|NCT01814072|42239790|FG027|Overall Study|Withdrawal by Subject|2|||
19783099|NCT01814072|42239791|FG028|Overall Study|Withdrawal by Subject|1|||
19783100|NCT01814072|42239792|FG029|Overall Study|Withdrawal by Subject|0|||
19783101|NCT01814072|42239793|FG030|Overall Study|Withdrawal by Subject|0|||
19783102|NCT01814072|42239794|FG031|Overall Study|Withdrawal by Subject|0|||
19783103|NCT03038113|42239849|FG000|Overall Study|Withdrawal by Subject|0|||
19783104|NCT03038113|42239850|FG001|Overall Study|Withdrawal by Subject|0|||
19695673|NCT00306384|42140952|FG001|Overall Study|Pregnancy|1|||
19695674|NCT00306384|42140953|FG002|Overall Study|Pregnancy|1|||
19695675|NCT00306384|42140951|FG000|Overall Study|Lack of Efficacy|26|||
19695676|NCT00306384|42140952|FG001|Overall Study|Lack of Efficacy|40|||
19695677|NCT00306384|42140953|FG002|Overall Study|Lack of Efficacy|38|||
19695678|NCT00306384|42140951|FG000|Overall Study|Investigator discretion|28|||
19695679|NCT00306384|42140952|FG001|Overall Study|Investigator discretion|31|||
19695680|NCT00306384|42140953|FG002|Overall Study|Investigator discretion|21|||
19695681|NCT00306384|42140951|FG000|Overall Study|Other|80|||
19695682|NCT00306384|42140952|FG001|Overall Study|Other|70|||
19695683|NCT00306384|42140953|FG002|Overall Study|Other|32|||
19695684|NCT00306384|42140951|FG000|Overall Study|Site closure|2|||
19695685|NCT00306384|42140952|FG001|Overall Study|Site closure|0|||
19695686|NCT00306384|42140953|FG002|Overall Study|Site closure|0|||
19695687|NCT00305604|42140963|FG000|Overall Study|Adverse Event|6|||
19695688|NCT00305604|42140964|FG001|Overall Study|Adverse Event|3|||
19695689|NCT00305604|42140963|FG000|Overall Study|Lack of Efficacy|11|||
19695690|NCT00305604|42140964|FG001|Overall Study|Lack of Efficacy|18|||
19695691|NCT00305604|42140963|FG000|Overall Study|Lost to Follow-up|0|||
19695692|NCT00305604|42140964|FG001|Overall Study|Lost to Follow-up|4|||
19695693|NCT00305604|42140963|FG000|Overall Study|Protocol Violation|2|||
19783105|NCT03038113|42239851|FG002|Overall Study|Withdrawal by Subject|1|||
19783106|NCT03038113|42239852|FG003|Overall Study|Withdrawal by Subject|0|||
19695694|NCT00305604|42140964|FG001|Overall Study|Protocol Violation|1|||
19783107|NCT03038113|42239853|FG004|Overall Study|Withdrawal by Subject|0|||
19783108|NCT03038113|42239854|FG005|Overall Study|Withdrawal by Subject|0|||
19695695|NCT00305604|42140963|FG000|Overall Study|Withdrawal by Subject|12|||
19783109|NCT03038113|42239855|FG006|Overall Study|Withdrawal by Subject|0|||
19695696|NCT00305604|42140964|FG001|Overall Study|Withdrawal by Subject|21|||
19695697|NCT00305604|42140963|FG000|Overall Study|Patient moved|1|||
19695698|NCT00305604|42140964|FG001|Overall Study|Patient moved|0|||
19695699|NCT00501059|42140972|FG000|Overall Study|Protocol Violation|80|||
19695700|NCT00501059|42140973|FG001|Overall Study|Protocol Violation|69|||
19695701|NCT00501059|42140972|FG000|Overall Study|Death|140|||
19695702|NCT00501059|42140973|FG001|Overall Study|Death|137|||
19695703|NCT00501059|42140972|FG000|Overall Study|Other|236|||
19783110|NCT03038113|42239856|FG007|Overall Study|Withdrawal by Subject|0|||
19783111|NCT03038113|42239857|FG008|Overall Study|Withdrawal by Subject|0|||
19783112|NCT03038113|42239858|FG009|Overall Study|Withdrawal by Subject|0|||
19783113|NCT03038113|42239859|FG010|Overall Study|Withdrawal by Subject|0|||
19783114|NCT03038113|42239860|FG011|Overall Study|Withdrawal by Subject|0|||
19783115|NCT03038113|42239861|FG012|Overall Study|Withdrawal by Subject|0|||
19783116|NCT03038113|42239862|FG013|Overall Study|Withdrawal by Subject|1|||
19783117|NCT03038113|42239849|FG000|Overall Study|Lost to Follow-up|0|||
19783118|NCT03038113|42239850|FG001|Overall Study|Lost to Follow-up|0|||
19783119|NCT03038113|42239851|FG002|Overall Study|Lost to Follow-up|0|||
19783120|NCT03038113|42239852|FG003|Overall Study|Lost to Follow-up|0|||
19783121|NCT03038113|42239853|FG004|Overall Study|Lost to Follow-up|0|||
19783122|NCT03038113|42239854|FG005|Overall Study|Lost to Follow-up|0|||
19783123|NCT03038113|42239855|FG006|Overall Study|Lost to Follow-up|1|||
19783124|NCT03038113|42239856|FG007|Overall Study|Lost to Follow-up|0|||
19783125|NCT03038113|42239857|FG008|Overall Study|Lost to Follow-up|0|||
19783126|NCT03038113|42239858|FG009|Overall Study|Lost to Follow-up|0|||
19783127|NCT03038113|42239859|FG010|Overall Study|Lost to Follow-up|0|||
19783128|NCT03038113|42239860|FG011|Overall Study|Lost to Follow-up|0|||
19783129|NCT03038113|42239861|FG012|Overall Study|Lost to Follow-up|0|||
19783130|NCT03038113|42239862|FG013|Overall Study|Lost to Follow-up|0|||
19783131|NCT00968149|42239911|FG000|Overall Study|Adverse Event|5|||
19783132|NCT00968149|42239912|FG001|Overall Study|Adverse Event|1|||
19783133|NCT00968149|42239911|FG000|Overall Study|Lack of Efficacy|0|||
19783134|NCT00968149|42239912|FG001|Overall Study|Lack of Efficacy|4|||
19783135|NCT00968149|42239911|FG000|Overall Study|Lost to Follow-up|0|||
19783136|NCT00968149|42239912|FG001|Overall Study|Lost to Follow-up|1|||
19783137|NCT00968149|42239911|FG000|Overall Study|Protocol Violation|4|||
19783138|NCT00968149|42239912|FG001|Overall Study|Protocol Violation|0|||
19783139|NCT00968149|42239911|FG000|Overall Study|Withdrawal by Subject|2|||
19783140|NCT00968149|42239912|FG001|Overall Study|Withdrawal by Subject|0|||
19783141|NCT00963469|42239921|FG000|Overall Study|Adverse Event|15|||
19783142|NCT00963469|42239922|FG001|Overall Study|Adverse Event|11|||
19783143|NCT00963469|42239923|FG002|Overall Study|Adverse Event|1|||
19783144|NCT00963469|42239921|FG000|Overall Study|Lack of Efficacy|10|||
19783145|NCT00963469|42239922|FG001|Overall Study|Lack of Efficacy|7|||
19783146|NCT00963469|42239923|FG002|Overall Study|Lack of Efficacy|2|||
19783147|NCT00963469|42239921|FG000|Overall Study|Lost to Follow-up|1|||
19783148|NCT00963469|42239922|FG001|Overall Study|Lost to Follow-up|1|||
19783149|NCT00963469|42239923|FG002|Overall Study|Lost to Follow-up|0|||
19783150|NCT00963469|42239921|FG000|Overall Study|Protocol Violation|5|||
19783151|NCT00963469|42239922|FG001|Overall Study|Protocol Violation|5|||
19783152|NCT00963469|42239923|FG002|Overall Study|Protocol Violation|3|||
19783153|NCT00963469|42239921|FG000|Overall Study|Withdrawal by Subject|4|||
19783154|NCT00963469|42239922|FG001|Overall Study|Withdrawal by Subject|1|||
19783155|NCT00963469|42239923|FG002|Overall Study|Withdrawal by Subject|1|||
19783156|NCT00963469|42239921|FG000|Overall Study|Pre-randomization Adverse Event|1|||
19783157|NCT00963469|42239922|FG001|Overall Study|Pre-randomization Adverse Event|2|||
19783158|NCT00963469|42239923|FG002|Overall Study|Pre-randomization Adverse Event|0|||
19783159|NCT00963469|42239921|FG000|Overall Study|Moved|1|||
19783160|NCT00963469|42239922|FG001|Overall Study|Moved|0|||
19783161|NCT00963469|42239923|FG002|Overall Study|Moved|0|||
19783162|NCT00963469|42239921|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
19783163|NCT00963469|42239922|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
19783164|NCT00963469|42239923|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
19783165|NCT00897949|42239934|FG000|Overall Study|Adverse Event|1|||
19783166|NCT00897949|42239935|FG001|Overall Study|Adverse Event|1|||
19783167|NCT00897949|42239936|FG002|Overall Study|Adverse Event|0|||
19783168|NCT00897949|42239934|FG000|Overall Study|Lost to Follow-up|0|||
19783169|NCT00897949|42239935|FG001|Overall Study|Lost to Follow-up|2|||
19783170|NCT00897949|42239936|FG002|Overall Study|Lost to Follow-up|1|||
19783171|NCT00897949|42239934|FG000|Overall Study|Protocol Violation|6|||
19783172|NCT00897949|42239935|FG001|Overall Study|Protocol Violation|3|||
19783173|NCT00897949|42239936|FG002|Overall Study|Protocol Violation|1|||
19695704|NCT00501059|42140973|FG001|Overall Study|Other|239|||
19783174|NCT00897949|42239934|FG000|Overall Study|Withdrawal by Subject|1|||
19783175|NCT00897949|42239935|FG001|Overall Study|Withdrawal by Subject|2|||
19783176|NCT00897949|42239936|FG002|Overall Study|Withdrawal by Subject|0|||
19783177|NCT00897949|42239934|FG000|Overall Study|Patient Uncoorperative|0|||
19695705|NCT00501059|42140972|FG000|Overall Study|Missing end-of-study page|91|||
19783178|NCT00897949|42239935|FG001|Overall Study|Patient Uncoorperative|2|||
19783179|NCT00897949|42239936|FG002|Overall Study|Patient Uncoorperative|1|||
19783180|NCT00897949|42239934|FG000|Overall Study|Lost to Follow-up|30|||
19783181|NCT00897949|42239935|FG001|Overall Study|Lost to Follow-up|23|||
19783182|NCT00897949|42239936|FG002|Overall Study|Lost to Follow-up|17|||
19783183|NCT00897949|42239934|FG000|Overall Study|Withdrawal by Subject|24|||
19783184|NCT00897949|42239935|FG001|Overall Study|Withdrawal by Subject|31|||
19783185|NCT00897949|42239936|FG002|Overall Study|Withdrawal by Subject|17|||
19783186|NCT00897949|42239934|FG000|Overall Study|Abnormal Prestudy Labs|2|||
19783187|NCT00897949|42239935|FG001|Overall Study|Abnormal Prestudy Labs|3|||
19783188|NCT00897949|42239936|FG002|Overall Study|Abnormal Prestudy Labs|4|||
19783189|NCT00897949|42239934|FG000|Overall Study|Abnormal Baseline ECG|2|||
19783190|NCT00897949|42239935|FG001|Overall Study|Abnormal Baseline ECG|2|||
19783191|NCT00897949|42239936|FG002|Overall Study|Abnormal Baseline ECG|4|||
19783192|NCT00897949|42239934|FG000|Overall Study|Need for Concom. Med.|0|||
19783193|NCT00897949|42239935|FG001|Overall Study|Need for Concom. Med.|1|||
19783194|NCT00897949|42239936|FG002|Overall Study|Need for Concom. Med.|1|||
19783195|NCT00897949|42239934|FG000|Overall Study|Lack of Migraine Attack|29|||
19783196|NCT00897949|42239935|FG001|Overall Study|Lack of Migraine Attack|30|||
19783197|NCT00897949|42239936|FG002|Overall Study|Lack of Migraine Attack|19|||
19783198|NCT00897949|42239934|FG000|Overall Study|Did not take study drug|9|||
19783199|NCT00897949|42239935|FG001|Overall Study|Did not take study drug|3|||
19783200|NCT00897949|42239936|FG002|Overall Study|Did not take study drug|4|||
19783201|NCT02760810|42239950|FG000|Overall Study|Protocol Violation|1|||
19783202|NCT02760654|42239956|FG000|Overall Study|Lost to Follow-up|3|||
19783203|NCT02760654|42239957|FG001|Overall Study|Lost to Follow-up|3|||
19783204|NCT02760654|42239956|FG000|Overall Study|Withdrawal by Subject|4|||
19783205|NCT02760654|42239957|FG001|Overall Study|Withdrawal by Subject|3|||
19783206|NCT00725491|42239965|FG000|Overall Study|Adverse Event|3|||
19783207|NCT00725491|42239966|FG001|Overall Study|Adverse Event|2|||
19783208|NCT00725491|42239965|FG000|Overall Study|Pregnancy|0|||
19783209|NCT00725491|42239966|FG001|Overall Study|Pregnancy|3|||
19783210|NCT00725491|42239965|FG000|Overall Study|Risk for hyperstimulation|2|||
19783211|NCT00725491|42239966|FG001|Overall Study|Risk for hyperstimulation|9|||
19783212|NCT00725491|42239965|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
19783213|NCT00725491|42239966|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
19783214|NCT00725491|42239965|FG000|Overall Study|Fertilization failure|0|||
19783215|NCT00725491|42239966|FG001|Overall Study|Fertilization failure|1|||
19783216|NCT00725491|42239965|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
19783217|NCT00725491|42239966|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
19783218|NCT02634580|42239976|FG000|Double-blind Treatment Period|Subject Request|1|||
19783219|NCT02634580|42239977|FG001|Double-blind Treatment Period|Subject Request|0|||
19783220|NCT02634580|42239978|FG002|Double-blind Treatment Period|Subject Request|1|||
19783221|NCT02634580|42239979|FG003|Double-blind Treatment Period|Subject Request|1|||
19783222|NCT02634580|42239976|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
19783223|NCT02634580|42239977|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
19783224|NCT02634580|42239978|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
19783225|NCT02634580|42239979|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
19783226|NCT02225366|42239990|FG000|Overall Study|Lack of Efficacy|1|||
19783227|NCT02225366|42239991|FG001|Overall Study|Lack of Efficacy|0|||
19783228|NCT00697255|42239999|FG000|Stage 1a|Insufficient ovarian response|1|||
19783229|NCT00697255|42240000|FG001|Stage 1a|Insufficient ovarian response|0|||
19783230|NCT00697255|42239999|FG000|Stage 1a|Multifollicular growth|1|||
19783231|NCT00697255|42240000|FG001|Stage 1a|Multifollicular growth|0|||
19783232|NCT00697255|42239999|FG000|Stage 1a|Not growing of dominant follicle|1|||
19783233|NCT00697255|42240000|FG001|Stage 1a|Not growing of dominant follicle|0|||
19783234|NCT00697255|42239999|FG000|Stage 1b|Not growing of dominant follicle|0|||
19783235|NCT00697255|42240000|FG001|Stage 1b|Not growing of dominant follicle|1|||
19783236|NCT00697255|42239999|FG000|Stage 1b|Insufficient ovarian response|0|||
19783237|NCT00697255|42240000|FG001|Stage 1b|Insufficient ovarian response|1|||
19783238|NCT02764320|42240008|FG000|Overall Study|Withdrawal by Subject|35|||
19783239|NCT02764320|42240009|FG001|Overall Study|Withdrawal by Subject|38|||
19783240|NCT02764320|42240008|FG000|Overall Study|Protocol Violation|11|||
19783241|NCT02764320|42240009|FG001|Overall Study|Protocol Violation|6|||
19783242|NCT02764320|42240008|FG000|Overall Study|Adverse Event|2|||
19783243|NCT02764320|42240009|FG001|Overall Study|Adverse Event|0|||
19783244|NCT02764320|42240008|FG000|Overall Study|Health Issues unable to continue|2|||
19783245|NCT02764320|42240009|FG001|Overall Study|Health Issues unable to continue|0|||
19783246|NCT02764320|42240008|FG000|Overall Study|Did not meet inclusion criteria|1|||
19783247|NCT02764320|42240009|FG001|Overall Study|Did not meet inclusion criteria|0|||
19783248|NCT02764320|42240008|FG000|Overall Study|Subject moved|0|||
19783249|NCT02764320|42240009|FG001|Overall Study|Subject moved|2|||
19783250|NCT02764320|42240008|FG000|Overall Study|Overused medication unavailable|0|||
19783251|NCT02764320|42240009|FG001|Overall Study|Overused medication unavailable|1|||
19783252|NCT02764320|42240008|FG000|Overall Study|Seeking care outside site|0|||
19783253|NCT02764320|42240009|FG001|Overall Study|Seeking care outside site|1|||
19783254|NCT02764320|42240008|FG000|Overall Study|Technology barriers|0|||
19783255|NCT02764320|42240009|FG001|Overall Study|Technology barriers|1|||
19783256|NCT02851407|42240017|FG000|Overall Study|Withdrawal by parent/guardian|2|||
19783257|NCT02851407|42240018|FG001|Overall Study|Withdrawal by parent/guardian|7|||
19783258|NCT02851407|42240017|FG000|Overall Study|Protocol deviation|0|||
19783259|NCT02851407|42240018|FG001|Overall Study|Protocol deviation|1|||
19783260|NCT02851407|42240017|FG000|Overall Study|Transferred to another hospital to continue|1|||
19783261|NCT02851407|42240018|FG001|Overall Study|Transferred to another hospital to continue|0|||
19783262|NCT02851407|42240017|FG000|Overall Study|Other Death|30|||
19783263|NCT02851407|42240018|FG001|Overall Study|Other Death|20|||
19783264|NCT02851407|42240017|FG000|Overall Study|Adverse event, serious fatal|6|||
19783265|NCT02851407|42240018|FG001|Overall Study|Adverse event, serious fatal|8|||
19783266|NCT02851407|42240017|FG000|Overall Study|Consent withdrawn by participant|5|||
19783267|NCT02851407|42240018|FG001|Overall Study|Consent withdrawn by participant|3|||
19695706|NCT00501059|42140973|FG001|Overall Study|Missing end-of-study page|92|||
19695707|NCT00501059|42140972|FG000|Overall Study|Clinical endpoint reached|110|||
19695708|NCT00501059|42140973|FG001|Overall Study|Clinical endpoint reached|123|||
19695709|NCT00501059|42140972|FG000|Overall Study|Insufficient therapeutic effect|4|||
19695710|NCT00501059|42140973|FG001|Overall Study|Insufficient therapeutic effect|5|||
19695711|NCT00501059|42140972|FG000|Overall Study|Consent withdrawn by subject|817|||
19695712|NCT00501059|42140973|FG001|Overall Study|Consent withdrawn by subject|873|||
19695713|NCT00501059|42140972|FG000|Overall Study|Non-compliant with study treatment|23|||
19783268|NCT02851407|42240017|FG000|Overall Study|Screen failure|2|||
19783269|NCT02851407|42240018|FG001|Overall Study|Screen failure|1|||
19783270|NCT02851407|42240017|FG000|Overall Study|Disease relapse|9|||
19783271|NCT02851407|42240018|FG001|Overall Study|Disease relapse|6|||
19783272|NCT02851407|42240017|FG000|Overall Study|Physician Decision|7|||
19783273|NCT02851407|42240018|FG001|Overall Study|Physician Decision|6|||
19783274|NCT02851407|42240017|FG000|Overall Study|Transferred to hospital closer to home|0|||
19783275|NCT02851407|42240018|FG001|Overall Study|Transferred to hospital closer to home|1|||
19783276|NCT02851407|42240017|FG000|Overall Study|Enrolled in an investigational study|0|||
19783277|NCT02851407|42240018|FG001|Overall Study|Enrolled in an investigational study|1|||
19783278|NCT02851407|42240017|FG000|Overall Study|Early recovery|1|||
19783279|NCT02851407|42240018|FG001|Overall Study|Early recovery|0|||
19783280|NCT02851407|42240017|FG000|Overall Study|Adverse event, non-fatal|7|||
19783281|NCT02851407|42240018|FG001|Overall Study|Adverse event, non-fatal|5|||
19783282|NCT02851407|42240017|FG000|Overall Study|Lost to Follow-up|0|||
19695714|NCT00501059|42140973|FG001|Overall Study|Non-compliant with study treatment|16|||
19695715|NCT00501059|42140972|FG000|Overall Study|Reason not given|3|||
19695716|NCT00501059|42140973|FG001|Overall Study|Reason not given|1|||
19695717|NCT00501059|42140972|FG000|Overall Study|Adverse Event|129|||
19695718|NCT00501059|42140973|FG001|Overall Study|Adverse Event|122|||
19695719|NCT00501059|42140972|FG000|Overall Study|Lost to Follow-up|210|||
19695720|NCT00501059|42140973|FG001|Overall Study|Lost to Follow-up|198|||
19695721|NCT00501059|42140972|FG000|Overall Study|Not treated|25|||
19695722|NCT00501059|42140973|FG001|Overall Study|Not treated|17|||
19695723|NCT00344318|42140985|FG000|Overall Study|Adverse Event|0|||
19695724|NCT00344318|42140986|FG001|Overall Study|Adverse Event|3|||
19695725|NCT00344318|42140987|FG002|Overall Study|Adverse Event|0|||
19695726|NCT00344318|42140988|FG003|Overall Study|Adverse Event|1|||
19695727|NCT00344318|42140985|FG000|Overall Study|Withdrawal by Subject|2|||
19695728|NCT00344318|42140986|FG001|Overall Study|Withdrawal by Subject|2|||
19695729|NCT00344318|42140987|FG002|Overall Study|Withdrawal by Subject|0|||
19695730|NCT00344318|42140988|FG003|Overall Study|Withdrawal by Subject|2|||
19695731|NCT00344318|42140985|FG000|Overall Study|Lost to Follow-up|2|||
19477787|NCT01479439|41757036|FG001|Overall Study|Protocol Violation|0|||
19695732|NCT00344318|42140986|FG001|Overall Study|Lost to Follow-up|0|||
19695733|NCT00344318|42140987|FG002|Overall Study|Lost to Follow-up|1|||
19695734|NCT00344318|42140988|FG003|Overall Study|Lost to Follow-up|0|||
19695735|NCT00323258|42141002|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
19695736|NCT00323258|42141003|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
19695737|NCT00323258|42141002|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
19695738|NCT00323258|42141003|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
19695739|NCT00323258|42141002|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
19695740|NCT00323258|42141003|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
19695741|NCT00323258|42141002|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
19783283|NCT02851407|42240018|FG001|Overall Study|Lost to Follow-up|2|||
19695742|NCT00323258|42141003|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
19695743|NCT00323258|42141002|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
19695744|NCT00323258|42141003|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
19695745|NCT00323258|42141002|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
19695746|NCT00323258|42141003|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
19695747|NCT00323258|42141002|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
19783284|NCT02636608|42240024|FG000|Overall Study|Failure to Return|4|||
19695748|NCT00323258|42141003|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
19695749|NCT00322868|42141009|FG000|Overall Study|disease progression|1|||
19695750|NCT00322712|42141014|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
19695751|NCT00343382|42141021|FG000|Overall Study|Adverse Event|2|||
19695752|NCT00343382|42141022|FG001|Overall Study|Adverse Event|10|||
19695753|NCT00343382|42141023|FG002|Overall Study|Adverse Event|7|||
19695754|NCT00343382|42141021|FG000|Overall Study|Withdrawal by Subject|1|||
19695755|NCT00343382|42141022|FG001|Overall Study|Withdrawal by Subject|2|||
19367368|NCT02456740|41607523|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19367369|NCT02456740|41607524|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
19367370|NCT02456740|41607525|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
19367371|NCT02456740|41607526|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19367372|NCT02456740|41607527|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19367373|NCT02456740|41607528|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
19367374|NCT02456740|41607529|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
19367375|NCT02456740|41607521|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19367376|NCT02456740|41607522|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19367377|NCT02456740|41607523|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19607286|NCT00936884|42056045|FG000|Double-blind|Withdrawal by Subject|6|||
19607287|NCT00936884|42056046|FG001|Double-blind|Withdrawal by Subject|4|||
19607288|NCT00936884|42056047|FG002|Double-blind|Withdrawal by Subject|0|||
19607289|NCT00936884|42056045|FG000|Double-blind|Death|2|||
19607290|NCT00936884|42056046|FG001|Double-blind|Death|1|||
19607291|NCT00936884|42056047|FG002|Double-blind|Death|0|||
19607292|NCT00936884|42056045|FG000|Double-blind|Lack of Efficacy|1|||
19695756|NCT00343382|42141023|FG002|Overall Study|Withdrawal by Subject|6|||
19695757|NCT00343382|42141021|FG000|Overall Study|Other Reason Not Specified|1|||
19695758|NCT00343382|42141022|FG001|Overall Study|Other Reason Not Specified|2|||
19695759|NCT00343382|42141023|FG002|Overall Study|Other Reason Not Specified|4|||
19695760|NCT00481871|42141036|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
19695761|NCT00481871|42141037|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
19695762|NCT00481871|42141038|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
19783285|NCT02636608|42240024|FG000|Overall Study|Insufficient Virological Response|1|||
19783286|NCT02636608|42240024|FG000|Overall Study|Death|3|||
19783287|NCT02636608|42240024|FG000|Overall Study|Other|2|||
19783288|NCT02636608|42240024|FG000|Overall Study|Did Not Receive Treatment|1|||
19783289|NCT02759562|42240033|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
19783290|NCT02759562|42240034|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
19783291|NCT02759562|42240033|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
19783292|NCT02759562|42240034|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
19783293|NCT02746575|42240041|FG000|Overall Study|Surgery cancelled or time chaned|13|||
19783294|NCT02746575|42240041|FG000|Overall Study|Received epidural|10|||
19695763|NCT00481871|42141039|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
19695764|NCT00481871|42141040|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
19695765|NCT00329420|42141051|FG000|Re-induction Phase|Lack of Efficacy|0|||
19783295|NCT02746575|42240041|FG000|Overall Study|Withdrawal by Subject|3|||
19783296|NCT02746575|42240041|FG000|Overall Study|Bradycardia/hypotension|9|||
19783297|NCT02746575|42240041|FG000|Overall Study|Study paused|8|||
19783298|NCT02746575|42240041|FG000|Overall Study|put on beta-blocker|3|||
19783299|NCT02746575|42240041|FG000|Overall Study|type of surgery|1|||
19783300|NCT02746575|42240041|FG000|Overall Study|typ of surgery|1|||
19783301|NCT02746575|42240041|FG000|Overall Study|PI unavailable|1|||
19783302|NCT02746575|42240041|FG000|Overall Study|Unknown history of CVA|1|||
19783303|NCT03625466|42240047|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
19783304|NCT03625466|42240048|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
19783305|NCT03625466|42240049|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
19607293|NCT00936884|42056046|FG001|Double-blind|Lack of Efficacy|1|||
19695766|NCT00329420|42141052|FG001|Re-induction Phase|Lack of Efficacy|1|||
19695767|NCT00329420|42141053|FG002|Re-induction Phase|Lack of Efficacy|0|||
19695768|NCT00329420|42141051|FG000|Re-induction Phase|Withdrawal of Consent|0|||
19783306|NCT03625466|42240047|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
19783307|NCT03625466|42240048|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
19783308|NCT03625466|42240049|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
19783309|NCT03625466|42240047|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
19607294|NCT00936884|42056047|FG002|Double-blind|Lack of Efficacy|0|||
19607295|NCT00936884|42056045|FG000|Double-blind|Adverse Event|1|||
19607296|NCT00936884|42056046|FG001|Double-blind|Adverse Event|0|||
19607297|NCT00936884|42056047|FG002|Double-blind|Adverse Event|0|||
19607298|NCT00936884|42056045|FG000|Double-blind|Physician Decision|1|||
19695769|NCT00329420|42141052|FG001|Re-induction Phase|Withdrawal of Consent|0|||
19695770|NCT00329420|42141053|FG002|Re-induction Phase|Withdrawal of Consent|1|||
19783310|NCT03625466|42240048|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
19783311|NCT03625466|42240049|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
19783312|NCT02853123|42240056|FG000|Treatment Period 1|Adverse Event|0|||
19783313|NCT02853123|42240057|FG001|Treatment Period 1|Adverse Event|3|||
19783314|NCT02853123|42240056|FG000|Washout Period|Worsening of COPD|0|||
19783315|NCT02853123|42240057|FG001|Washout Period|Worsening of COPD|3|||
19783316|NCT02853123|42240056|FG000|Washout Period|Adverse Event|1|||
19783317|NCT02853123|42240057|FG001|Washout Period|Adverse Event|0|||
19783318|NCT02634346|42240067|FG000|Overall Study|Withdrawal by Subject|8|||
19783319|NCT02634346|42240068|FG001|Overall Study|Withdrawal by Subject|9|||
19783320|NCT02634346|42240069|FG002|Overall Study|Withdrawal by Subject|8|||
19783321|NCT02634346|42240067|FG000|Overall Study|Adverse Event|2|||
19783322|NCT02634346|42240068|FG001|Overall Study|Adverse Event|2|||
19783323|NCT02634346|42240069|FG002|Overall Study|Adverse Event|7|||
19783324|NCT02634346|42240067|FG000|Overall Study|Lack of Efficacy|1|||
19783325|NCT02634346|42240068|FG001|Overall Study|Lack of Efficacy|2|||
19783326|NCT02634346|42240069|FG002|Overall Study|Lack of Efficacy|8|||
19783327|NCT02634346|42240067|FG000|Overall Study|Lost to Follow-up|1|||
19783328|NCT02634346|42240068|FG001|Overall Study|Lost to Follow-up|0|||
19783329|NCT02634346|42240069|FG002|Overall Study|Lost to Follow-up|0|||
19783330|NCT02634346|42240067|FG000|Overall Study|Protocol Violation|0|||
19783331|NCT02634346|42240068|FG001|Overall Study|Protocol Violation|1|||
19783332|NCT02634346|42240069|FG002|Overall Study|Protocol Violation|0|||
19783333|NCT00849147|42240077|FG000|Overall Study|Withdrawal by Subject|1|||
19783334|NCT00849147|42240077|FG000|Overall Study|Protocol Violation|2|||
19783335|NCT00849147|42240077|FG000|Overall Study|Disease Relapse/Progression|2|||
19783336|NCT00101166|42240081|FG000|Overall Study|progressive disease|10|||
19783337|NCT02759016|42240087|FG000|Overall Study|Not treated with BI 836826|1|||
19783338|NCT02759016|42240088|FG001|Overall Study|Not treated with BI 836826|0|||
19783339|NCT02759016|42240087|FG000|Overall Study|Progressive disease|1|||
19783340|NCT02759016|42240088|FG001|Overall Study|Progressive disease|0|||
19783341|NCT02759016|42240087|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
19783342|NCT02759016|42240088|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
19783343|NCT02759016|42240087|FG000|Overall Study|Other not defined above|2|||
19783344|NCT02759016|42240088|FG001|Overall Study|Other not defined above|1|||
19783345|NCT02852967|42240100|FG000|Overall Study|Adverse Event|3|||
19783346|NCT02852967|42240101|FG001|Overall Study|Adverse Event|1|||
19783347|NCT02852967|42240102|FG002|Overall Study|Adverse Event|0|||
19783348|NCT02852967|42240103|FG003|Overall Study|Adverse Event|1|||
19783349|NCT02852967|42240104|FG004|Overall Study|Adverse Event|0|||
19783350|NCT02852967|42240100|FG000|Overall Study|Death|1|||
19783351|NCT02852967|42240101|FG001|Overall Study|Death|0|||
19783352|NCT02852967|42240102|FG002|Overall Study|Death|0|||
19783353|NCT02852967|42240103|FG003|Overall Study|Death|0|||
19783354|NCT02852967|42240104|FG004|Overall Study|Death|0|||
19783355|NCT02852967|42240100|FG000|Overall Study|Lost to Follow-up|1|||
19783356|NCT02852967|42240101|FG001|Overall Study|Lost to Follow-up|2|||
19783357|NCT02852967|42240102|FG002|Overall Study|Lost to Follow-up|3|||
19783358|NCT02852967|42240103|FG003|Overall Study|Lost to Follow-up|4|||
19783359|NCT02852967|42240104|FG004|Overall Study|Lost to Follow-up|4|||
19783360|NCT02852967|42240100|FG000|Overall Study|Withdrawal by Subject|6|||
19783361|NCT02852967|42240101|FG001|Overall Study|Withdrawal by Subject|12|||
19783362|NCT02852967|42240102|FG002|Overall Study|Withdrawal by Subject|7|||
19783363|NCT02852967|42240103|FG003|Overall Study|Withdrawal by Subject|10|||
19783364|NCT02852967|42240104|FG004|Overall Study|Withdrawal by Subject|10|||
19783365|NCT02852967|42240100|FG000|Overall Study|SAE|0|||
19783366|NCT02852967|42240101|FG001|Overall Study|SAE|0|||
19783367|NCT02852967|42240102|FG002|Overall Study|SAE|0|||
19783368|NCT02852967|42240103|FG003|Overall Study|SAE|3|||
19783369|NCT02852967|42240104|FG004|Overall Study|SAE|0|||
19783370|NCT02852967|42240100|FG000|Overall Study|Elevated Liver Enzymes|2|||
19783371|NCT02852967|42240101|FG001|Overall Study|Elevated Liver Enzymes|0|||
19783372|NCT02852967|42240102|FG002|Overall Study|Elevated Liver Enzymes|0|||
19783373|NCT02852967|42240103|FG003|Overall Study|Elevated Liver Enzymes|2|||
19783374|NCT02852967|42240104|FG004|Overall Study|Elevated Liver Enzymes|2|||
19783375|NCT02852967|42240100|FG000|Overall Study|Physician Decision|0|||
19783376|NCT02852967|42240101|FG001|Overall Study|Physician Decision|0|||
19783377|NCT02852967|42240102|FG002|Overall Study|Physician Decision|0|||
19783378|NCT02852967|42240103|FG003|Overall Study|Physician Decision|1|||
19783379|NCT02852967|42240104|FG004|Overall Study|Physician Decision|0|||
19783380|NCT02852967|42240100|FG000|Overall Study|Lack of Efficacy|0|||
19783381|NCT02852967|42240101|FG001|Overall Study|Lack of Efficacy|1|||
19783382|NCT02852967|42240102|FG002|Overall Study|Lack of Efficacy|0|||
19783383|NCT02852967|42240103|FG003|Overall Study|Lack of Efficacy|0|||
19783384|NCT02852967|42240104|FG004|Overall Study|Lack of Efficacy|0|||
19783385|NCT02852967|42240100|FG000|Overall Study|Non-compliance|0|||
19783386|NCT02852967|42240101|FG001|Overall Study|Non-compliance|0|||
19783387|NCT02852967|42240102|FG002|Overall Study|Non-compliance|1|||
19783388|NCT02852967|42240103|FG003|Overall Study|Non-compliance|1|||
19783389|NCT02852967|42240104|FG004|Overall Study|Non-compliance|0|||
19783390|NCT02852967|42240100|FG000|Overall Study|Dispensing Drug Violation|0|||
19783391|NCT02852967|42240101|FG001|Overall Study|Dispensing Drug Violation|0|||
19783392|NCT02852967|42240102|FG002|Overall Study|Dispensing Drug Violation|1|||
19783393|NCT02852967|42240103|FG003|Overall Study|Dispensing Drug Violation|0|||
19783394|NCT02852967|42240104|FG004|Overall Study|Dispensing Drug Violation|0|||
19783395|NCT02852967|42240100|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
19783396|NCT02852967|42240101|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
19783397|NCT02852967|42240102|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
19783398|NCT02852967|42240103|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
19783399|NCT02852967|42240104|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
19783400|NCT02762994|42240132|FG000|Overall Study|Withdrawal by Subject|0|||
19783401|NCT02762994|42240133|FG001|Overall Study|Withdrawal by Subject|1|||
19783402|NCT02762994|42240134|FG002|Overall Study|Withdrawal by Subject|2|||
19783403|NCT02762994|42240135|FG003|Overall Study|Withdrawal by Subject|0|||
19783404|NCT02762994|42240132|FG000|Overall Study|Protocol Violation|1|||
19783405|NCT02762994|42240133|FG001|Overall Study|Protocol Violation|0|||
19783406|NCT02762994|42240134|FG002|Overall Study|Protocol Violation|0|||
19783407|NCT02762994|42240135|FG003|Overall Study|Protocol Violation|2|||
19783408|NCT02852265|42240151|FG000|3-month Follow-up|Lost to Follow-up|1|||
19783409|NCT02852265|42240152|FG001|3-month Follow-up|Lost to Follow-up|1|||
19783410|NCT02633800|42240164|FG000|Overall Study|Death|3|||
19783411|NCT02633800|42240165|FG001|Overall Study|Death|3|||
19783412|NCT02633800|42240164|FG000|Overall Study|Reason not provided|1|||
19695771|NCT00329420|42141051|FG000|Re-induction Phase|Did not respond to re-induction|6|||
19695772|NCT00329420|42141052|FG001|Re-induction Phase|Did not respond to re-induction|5|||
19695773|NCT00329420|42141053|FG002|Re-induction Phase|Did not respond to re-induction|7|||
19695774|NCT00329420|42141051|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
19695775|NCT00329420|42141052|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
19695776|NCT00329420|42141053|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
19695777|NCT00329420|42141051|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
19695778|NCT00329420|42141052|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
19695779|NCT00329420|42141053|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
19695780|NCT00329420|42141051|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
19695781|NCT00329420|42141052|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
19695782|NCT00329420|42141053|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
19695783|NCT00329108|42141065|FG000|Overall Study|Adverse Event|2|||
19695784|NCT00329108|42141066|FG001|Overall Study|Adverse Event|2|||
19695785|NCT00329108|42141065|FG000|Overall Study|Lack of Efficacy|3|||
19695786|NCT00329108|42141066|FG001|Overall Study|Lack of Efficacy|3|||
19695787|NCT00329108|42141065|FG000|Overall Study|Withdrawal by Subject|0|||
19695788|NCT00329108|42141066|FG001|Overall Study|Withdrawal by Subject|2|||
19695789|NCT00329108|42141065|FG000|Overall Study|symptomatic deterioration|1|||
19695790|NCT00329108|42141066|FG001|Overall Study|symptomatic deterioration|1|||
19695791|NCT00329108|42141065|FG000|Overall Study|Subject no longer willing to participate|2|||
19695792|NCT00329108|42141066|FG001|Overall Study|Subject no longer willing to participate|2|||
19695793|NCT00329108|42141065|FG000|Overall Study|study terminated by sponsor|1|||
19695794|NCT00329108|42141066|FG001|Overall Study|study terminated by sponsor|0|||
19695795|NCT00329108|42141065|FG000|Overall Study|withdrew patient after SAE resolved|1|||
19695796|NCT00329108|42141066|FG001|Overall Study|withdrew patient after SAE resolved|0|||
19695797|NCT00329108|42141065|FG000|Overall Study|Protocol Violation|0|||
19695798|NCT00329108|42141066|FG001|Overall Study|Protocol Violation|2|||
19695799|NCT00329030|42141074|FG000|Overall Study|Withdrawal by Subject|1|||
19695800|NCT00329030|42141075|FG001|Overall Study|Withdrawal by Subject|3|||
19695801|NCT00329030|42141074|FG000|Overall Study|Progressive Disease|6|||
19695802|NCT00329030|42141075|FG001|Overall Study|Progressive Disease|2|||
19695803|NCT00329030|42141074|FG000|Overall Study|Ineligible Pathology|1|||
19695804|NCT00329030|42141075|FG001|Overall Study|Ineligible Pathology|1|||
19695805|NCT00328562|42141081|FG000|Overall Study|Disease progression|1|||
19695806|NCT00328172|42141090|FG000|Overall Study|Adverse Event|3|||
19695807|NCT00328172|42141091|FG001|Overall Study|Adverse Event|2|||
19695808|NCT00328172|42141092|FG002|Overall Study|Adverse Event|1|||
19695809|NCT00328172|42141093|FG003|Overall Study|Adverse Event|2|||
19695810|NCT00328172|42141094|FG004|Overall Study|Adverse Event|1|||
19695811|NCT00328172|42141090|FG000|Overall Study|Protocol Violation|0|||
19695812|NCT00328172|42141091|FG001|Overall Study|Protocol Violation|1|||
19695813|NCT00328172|42141092|FG002|Overall Study|Protocol Violation|1|||
19695814|NCT00328172|42141093|FG003|Overall Study|Protocol Violation|0|||
19695815|NCT00328172|42141094|FG004|Overall Study|Protocol Violation|0|||
19783413|NCT02633800|42240165|FG001|Overall Study|Reason not provided|0|||
19783414|NCT02633800|42240164|FG000|Overall Study|Radiologic(al) progression|23|||
19783415|NCT02633800|42240165|FG001|Overall Study|Radiologic(al) progression|23|||
19783416|NCT02633800|42240164|FG000|Overall Study|Clinical progression|3|||
19783417|NCT02633800|42240165|FG001|Overall Study|Clinical progression|6|||
19783418|NCT02633800|42240164|FG000|Overall Study|Study terminated by sponsor|6|||
19783419|NCT02633800|42240165|FG001|Overall Study|Study terminated by sponsor|5|||
19783420|NCT02633800|42240164|FG000|Overall Study|Adverse event, non-fatal|7|||
19783421|NCT02633800|42240165|FG001|Overall Study|Adverse event, non-fatal|2|||
19783422|NCT02633800|42240164|FG000|Overall Study|Withdrawal by Subject|0|||
19783423|NCT02633800|42240165|FG001|Overall Study|Withdrawal by Subject|3|||
19783424|NCT02633800|42240164|FG000|Overall Study|Patient Request|1|||
19783425|NCT02633800|42240165|FG001|Overall Study|Patient Request|1|||
19783426|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
19783427|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
19783428|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
19783429|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
19783430|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
19783431|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
19783432|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
19783433|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
19783434|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
19783435|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
19783436|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
19783437|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
19783438|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
19783439|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
19783440|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
19783441|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
19783442|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
19783443|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
19783444|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
19783445|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
19783446|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
19783447|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
19783448|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
19783449|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
19783450|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
19783451|NCT03829657|42240174|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
19695816|NCT00328172|42141090|FG000|Overall Study|Lost to Follow-up|1|||
19695817|NCT00328172|42141091|FG001|Overall Study|Lost to Follow-up|1|||
19695818|NCT00328172|42141092|FG002|Overall Study|Lost to Follow-up|2|||
19695819|NCT00328172|42141093|FG003|Overall Study|Lost to Follow-up|1|||
19695820|NCT00328172|42141094|FG004|Overall Study|Lost to Follow-up|1|||
19695821|NCT00328172|42141090|FG000|Overall Study|Withdrawal by Subject|1|||
19695822|NCT00328172|42141091|FG001|Overall Study|Withdrawal by Subject|1|||
19695823|NCT00328172|42141092|FG002|Overall Study|Withdrawal by Subject|1|||
19695824|NCT00328172|42141093|FG003|Overall Study|Withdrawal by Subject|6|||
19695825|NCT00328172|42141094|FG004|Overall Study|Withdrawal by Subject|0|||
19783452|NCT03829657|42240175|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
19783453|NCT03829657|42240176|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
19783454|NCT03829657|42240177|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
19783455|NCT03829657|42240178|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
19783456|NCT03829657|42240174|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
19783457|NCT03829657|42240175|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
19783458|NCT03829657|42240176|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
19783459|NCT03829657|42240177|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
19783460|NCT03829657|42240178|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
19783461|NCT03829657|42240174|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
19783462|NCT03829657|42240175|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
19783463|NCT03829657|42240176|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
19695826|NCT00328172|42141090|FG000|Overall Study|Lack of Efficacy|14|||
19695827|NCT00328172|42141091|FG001|Overall Study|Lack of Efficacy|9|||
19695828|NCT00328172|42141092|FG002|Overall Study|Lack of Efficacy|4|||
19695829|NCT00328172|42141093|FG003|Overall Study|Lack of Efficacy|4|||
19695830|NCT00328172|42141094|FG004|Overall Study|Lack of Efficacy|3|||
19695831|NCT00328172|42141090|FG000|Overall Study|Other reason (not specified)|3|||
19695832|NCT00328172|42141091|FG001|Overall Study|Other reason (not specified)|0|||
19695833|NCT00328172|42141092|FG002|Overall Study|Other reason (not specified)|1|||
19695834|NCT00328172|42141093|FG003|Overall Study|Other reason (not specified)|0|||
19695835|NCT00328172|42141094|FG004|Overall Study|Other reason (not specified)|0|||
19695836|NCT00328094|42141108|FG000|Overall Study|Physician Decision|3|||
19783464|NCT03829657|42240177|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
19783465|NCT03829657|42240178|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
19783466|NCT03829657|42240174|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
19783467|NCT03829657|42240175|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
19607299|NCT00936884|42056046|FG001|Double-blind|Physician Decision|0|||
19695837|NCT00328094|42141109|FG001|Overall Study|Physician Decision|3|||
19695838|NCT00500903|42141118|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
19695839|NCT00500903|42141119|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
19695840|NCT00500903|42141120|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
19695841|NCT00500903|42141118|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
19695842|NCT00500903|42141119|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
19695843|NCT00500903|42141120|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
19695844|NCT00500903|42141118|FG000|Overall Study|Progressive Disease|41|||
19695845|NCT00500903|42141119|FG001|Overall Study|Progressive Disease|2|||
19695846|NCT00500903|42141120|FG002|Overall Study|Progressive Disease|15|||
19695847|NCT00500903|42141118|FG000|Overall Study|Patient Declined Further Treatment|0|||
19695848|NCT00500903|42141119|FG001|Overall Study|Patient Declined Further Treatment|0|||
19695849|NCT00500903|42141120|FG002|Overall Study|Patient Declined Further Treatment|3|||
19695850|NCT00500903|42141118|FG000|Overall Study|Symptomatic Deterioration|2|||
19695851|NCT00500903|42141119|FG001|Overall Study|Symptomatic Deterioration|0|||
19695852|NCT00500903|42141120|FG002|Overall Study|Symptomatic Deterioration|0|||
19695853|NCT00500903|42141118|FG000|Overall Study|Reason Not Specified|10|||
19695854|NCT00500903|42141119|FG001|Overall Study|Reason Not Specified|0|||
19695855|NCT00500903|42141120|FG002|Overall Study|Reason Not Specified|2|||
19695856|NCT00295932|42141169|FG000|Overall Study|Not Treated|0|||
19695857|NCT00295932|42141170|FG001|Overall Study|Not Treated|0|||
19695858|NCT00295932|42141171|FG002|Overall Study|Not Treated|0|||
19695859|NCT00295932|42141172|FG003|Overall Study|Not Treated|0|||
19695860|NCT00295932|42141173|FG004|Overall Study|Not Treated|0|||
19695861|NCT00295932|42141174|FG005|Overall Study|Not Treated|0|||
19695862|NCT00295932|42141175|FG006|Overall Study|Not Treated|0|||
19695863|NCT00295932|42141176|FG007|Overall Study|Not Treated|0|||
19695864|NCT00295932|42141177|FG008|Overall Study|Not Treated|0|||
19695865|NCT00295932|42141178|FG009|Overall Study|Not Treated|0|||
19695866|NCT00295932|42141179|FG010|Overall Study|Not Treated|1|||
19695867|NCT00305448|42141208|FG000|Overall Study|Protocol Violation|0|||
19695868|NCT00305448|42141209|FG001|Overall Study|Protocol Violation|1|||
19695869|NCT00305448|42141210|FG002|Overall Study|Protocol Violation|0|||
19695870|NCT00305448|42141208|FG000|Overall Study|Withdrawal by Subject|2|||
19695871|NCT00305448|42141209|FG001|Overall Study|Withdrawal by Subject|0|||
19695872|NCT00305448|42141210|FG002|Overall Study|Withdrawal by Subject|1|||
19695873|NCT00305448|42141208|FG000|Overall Study|Adverse Event|1|||
19695874|NCT00305448|42141209|FG001|Overall Study|Adverse Event|0|||
19695875|NCT00305448|42141210|FG002|Overall Study|Adverse Event|1|||
19695876|NCT00305448|42141208|FG000|Overall Study|Disease Progression|27|||
19695877|NCT00305448|42141209|FG001|Overall Study|Disease Progression|31|||
19695878|NCT00305448|42141210|FG002|Overall Study|Disease Progression|28|||
19695879|NCT00305448|42141208|FG000|Overall Study|Subjective Disease Progression|1|||
19695880|NCT00305448|42141209|FG001|Overall Study|Subjective Disease Progression|2|||
19695881|NCT00305448|42141210|FG002|Overall Study|Subjective Disease Progression|2|||
19695882|NCT00305448|42141208|FG000|Overall Study|Tumor Marker Elevation|0|||
19695883|NCT00305448|42141209|FG001|Overall Study|Tumor Marker Elevation|0|||
19695884|NCT00305448|42141210|FG002|Overall Study|Tumor Marker Elevation|1|||
19695885|NCT00305058|42141221|FG000|Overall Study|Participant too young|1|||
19695886|NCT00305058|42141222|FG001|Overall Study|Participant too young|0|||
19695887|NCT00305058|42141221|FG000|Overall Study|Missing data collection instrument|3|||
19695888|NCT00305058|42141222|FG001|Overall Study|Missing data collection instrument|2|||
19695889|NCT00305058|42141221|FG000|Overall Study|Missing outcome data|3|||
19695890|NCT00305058|42141222|FG001|Overall Study|Missing outcome data|2|||
19695891|NCT00295854|42141231|FG000|Overall Study|Adverse Event|7|||
19695892|NCT00295854|42141232|FG001|Overall Study|Adverse Event|7|||
19695893|NCT00295854|42141233|FG002|Overall Study|Adverse Event|6|||
19695894|NCT00295854|42141231|FG000|Overall Study|Protocol Violation|1|||
19695895|NCT00295854|42141232|FG001|Overall Study|Protocol Violation|1|||
19695896|NCT00295854|42141233|FG002|Overall Study|Protocol Violation|1|||
19695897|NCT00295854|42141231|FG000|Overall Study|Lost to Follow-up|2|||
19695898|NCT00295854|42141232|FG001|Overall Study|Lost to Follow-up|0|||
19695899|NCT00295854|42141233|FG002|Overall Study|Lost to Follow-up|1|||
19695900|NCT00295854|42141231|FG000|Overall Study|Withdrawal by Subject|3|||
19695901|NCT00295854|42141232|FG001|Overall Study|Withdrawal by Subject|7|||
19695902|NCT00295854|42141233|FG002|Overall Study|Withdrawal by Subject|4|||
19695903|NCT00295854|42141231|FG000|Overall Study|did not continue to meet criteria|1|||
19695904|NCT00295854|42141232|FG001|Overall Study|did not continue to meet criteria|1|||
19695905|NCT00295854|42141233|FG002|Overall Study|did not continue to meet criteria|2|||
19695906|NCT00295854|42141231|FG000|Overall Study|required a prohibited medication|1|||
19695907|NCT00295854|42141232|FG001|Overall Study|required a prohibited medication|0|||
19783468|NCT03829657|42240176|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
19783469|NCT03829657|42240177|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
19783470|NCT03829657|42240178|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
19783471|NCT03829657|42240174|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
19783472|NCT03829657|42240175|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
19783473|NCT03829657|42240176|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
19783474|NCT03829657|42240177|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
19783475|NCT03829657|42240178|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
19783476|NCT03035227|42240189|FG000|Overall Study|study stopped due to PI leaving institut|1|||
19783477|NCT03035227|42240190|FG001|Overall Study|study stopped due to PI leaving institut|1|||
19783478|NCT00100932|42240200|FG000|Overall Study|Adverse Event|11|||
19783479|NCT00100932|42240201|FG001|Overall Study|Adverse Event|2|||
19783480|NCT00100932|42240200|FG000|Overall Study|Withdrawal by Subject|6|||
19783481|NCT00100932|42240201|FG001|Overall Study|Withdrawal by Subject|0|||
19783482|NCT00100932|42240200|FG000|Overall Study|Progressive Disease|44|||
19783483|NCT00100932|42240201|FG001|Overall Study|Progressive Disease|18|||
19783484|NCT00100932|42240200|FG000|Overall Study|Physician Decision|7|||
19783485|NCT00100932|42240201|FG001|Overall Study|Physician Decision|5|||
19783486|NCT00100932|42240200|FG000|Overall Study|Other|5|||
19783487|NCT00100932|42240201|FG001|Overall Study|Other|2|||
19783488|NCT03180307|42240209|FG000|Overall Study|Lost to Follow-up|2|||
19783489|NCT03180307|42240210|FG001|Overall Study|Lost to Follow-up|0|||
19783490|NCT03180307|42240209|FG000|Overall Study|Death|1|||
19783491|NCT03180307|42240210|FG001|Overall Study|Death|0|||
19783492|NCT03180307|42240209|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
19783493|NCT03180307|42240210|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
19783494|NCT02848833|42240214|FG000|Overall Study|subject who are duplicated|1|||
19783495|NCT02848833|42240214|FG000|Overall Study|have not taken the study drug|11|||
19783496|NCT02848833|42240214|FG000|Overall Study|follow-up failure|6|||
19783497|NCT02848833|42240214|FG000|Overall Study|Protocol Violation|119|||
19783498|NCT03361189|42240220|FG000|Overall Study|Received heart transplant|1|||
19783499|NCT03361189|42240221|FG001|Overall Study|Received heart transplant|0|||
19783500|NCT03361189|42240220|FG000|Overall Study|Pacemake replacement|0|||
19783501|NCT03361189|42240221|FG001|Overall Study|Pacemake replacement|1|||
19783502|NCT00092131|42240229|FG000|Treatment Period I|Adverse Event|1|||
19783503|NCT00092131|42240230|FG001|Treatment Period I|Adverse Event|0|||
19695908|NCT00295854|42141233|FG002|Overall Study|required a prohibited medication|0|||
19695909|NCT00295854|42141231|FG000|Overall Study|Other|3|||
19695910|NCT00295854|42141232|FG001|Overall Study|Other|5|||
19695911|NCT00295854|42141233|FG002|Overall Study|Other|1|||
19695912|NCT00327470|42141243|FG000|Overall Study|Randomized, but not treated|0|||
19695913|NCT00327470|42141244|FG001|Overall Study|Randomized, but not treated|2|||
19695914|NCT00327470|42141243|FG000|Overall Study|Adverse Event|9|||
19783504|NCT00092131|42240229|FG000|Treatment Period II|Adverse Event|0|||
19783505|NCT00092131|42240230|FG001|Treatment Period II|Adverse Event|1|||
19783506|NCT02668783|42240238|FG000|Overall Study|Pregnancy|0|||
19783507|NCT02668783|42240239|FG001|Overall Study|Pregnancy|1|||
19783508|NCT02668783|42240238|FG000|Overall Study|Protocol Violation|2|||
19783509|NCT02668783|42240239|FG001|Overall Study|Protocol Violation|1|||
19783510|NCT02668783|42240238|FG000|Overall Study|Study terminated by sponsor|9|||
19783511|NCT02668783|42240239|FG001|Overall Study|Study terminated by sponsor|10|||
19783512|NCT02668783|42240238|FG000|Overall Study|Subject moved|1|||
19783513|NCT02668783|42240239|FG001|Overall Study|Subject moved|0|||
19783514|NCT02668783|42240238|FG000|Overall Study|Withdrawal by Subject|1|||
19783515|NCT02668783|42240239|FG001|Overall Study|Withdrawal by Subject|0|||
19783516|NCT00101010|42240245|FG000|Overall Study|Physician Decision|1|||
19783517|NCT02848599|42240251|FG000|Overall Study|Protocol Violation|7|||
19783518|NCT02848599|42240252|FG001|Overall Study|Protocol Violation|9|||
19783519|NCT00778999|42240283|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
19783520|NCT00778999|42240284|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
19783521|NCT00778999|42240283|FG000|Overall Study|Did not receive recFSH|14|||
19783522|NCT00778999|42240284|FG001|Overall Study|Did not receive recFSH|20|||
19783523|NCT02631850|42240294|FG000|Treatment Period|Lost to Follow-up|0|||
19783524|NCT02631850|42240295|FG001|Treatment Period|Lost to Follow-up|1|||
19783525|NCT02631850|42240296|FG002|Treatment Period|Lost to Follow-up|0|||
19783526|NCT02631850|42240297|FG003|Treatment Period|Lost to Follow-up|0|||
19783527|NCT02631850|42240294|FG000|Treatment Period|Protocol Violation|1|||
19783528|NCT02631850|42240295|FG001|Treatment Period|Protocol Violation|0|||
19783529|NCT02631850|42240296|FG002|Treatment Period|Protocol Violation|0|||
19783530|NCT02631850|42240297|FG003|Treatment Period|Protocol Violation|0|||
19783531|NCT02631850|42240294|FG000|Treatment Period|Withdrawal by Subject|0|||
19783532|NCT02631850|42240295|FG001|Treatment Period|Withdrawal by Subject|5|||
19783533|NCT02631850|42240296|FG002|Treatment Period|Withdrawal by Subject|2|||
19783534|NCT02631850|42240297|FG003|Treatment Period|Withdrawal by Subject|2|||
19783535|NCT02631850|42240294|FG000|Treatment Period|Adverse Event|1|||
19783536|NCT02631850|42240295|FG001|Treatment Period|Adverse Event|0|||
19783537|NCT02631850|42240296|FG002|Treatment Period|Adverse Event|2|||
19783538|NCT02631850|42240297|FG003|Treatment Period|Adverse Event|3|||
19783539|NCT02631850|42240294|FG000|Treatment Period|Family medical issue|1|||
19783540|NCT02631850|42240295|FG001|Treatment Period|Family medical issue|0|||
19783541|NCT02631850|42240296|FG002|Treatment Period|Family medical issue|0|||
19783542|NCT02631850|42240297|FG003|Treatment Period|Family medical issue|0|||
19783543|NCT02631850|42240294|FG000|6 Month Follow up|Lost to Follow-up|5|||
19783544|NCT02631850|42240295|FG001|6 Month Follow up|Lost to Follow-up|8|||
19783545|NCT02631850|42240296|FG002|6 Month Follow up|Lost to Follow-up|3|||
19695915|NCT00327470|42141244|FG001|Overall Study|Adverse Event|14|||
19695916|NCT00327470|42141243|FG000|Overall Study|Lack of Efficacy|7|||
19695917|NCT00327470|42141244|FG001|Overall Study|Lack of Efficacy|19|||
19783546|NCT02631850|42240297|FG003|6 Month Follow up|Lost to Follow-up|5|||
19783547|NCT02631850|42240294|FG000|6 Month Follow up|Withdrawal by Subject|1|||
19783548|NCT02631850|42240295|FG001|6 Month Follow up|Withdrawal by Subject|0|||
19783549|NCT02631850|42240296|FG002|6 Month Follow up|Withdrawal by Subject|0|||
19783550|NCT02631850|42240297|FG003|6 Month Follow up|Withdrawal by Subject|2|||
19783551|NCT02631850|42240294|FG000|6 Month Follow up|Adverse Event|1|||
19783552|NCT02631850|42240295|FG001|6 Month Follow up|Adverse Event|4|||
19783553|NCT02631850|42240296|FG002|6 Month Follow up|Adverse Event|1|||
19783554|NCT02631850|42240297|FG003|6 Month Follow up|Adverse Event|3|||
19783555|NCT02631850|42240294|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
19783556|NCT02631850|42240295|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
19783557|NCT02631850|42240296|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
19783558|NCT02631850|42240297|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
19783559|NCT00103038|42240308|FG000|Overall Study|Withdrawal by Subject|8|||
19783560|NCT00103038|42240308|FG000|Overall Study|Screen failure|3|||
19783561|NCT00103038|42240308|FG000|Overall Study|Death|1|||
19783562|NCT00103038|42240308|FG000|Overall Study|Physician Decision|1|||
19783563|NCT00620035|42240315|FG000|Overall Study|Adverse Event|106|||
19783564|NCT00620035|42240315|FG000|Overall Study|Withdrawal of Informed Consent|1|||
19783565|NCT00620035|42240315|FG000|Overall Study|Other Reason|38|||
19783566|NCT02763579|42240321|FG000|Overall Study|Death|101|||
19783567|NCT02763579|42240322|FG001|Overall Study|Death|132|||
19783568|NCT02763579|42240321|FG000|Overall Study|Lost to Follow-up|3|||
19783569|NCT02763579|42240322|FG001|Overall Study|Lost to Follow-up|1|||
19783570|NCT02763579|42240321|FG000|Overall Study|Withdrawal by Subject|18|||
19783571|NCT02763579|42240322|FG001|Overall Study|Withdrawal by Subject|9|||
19783572|NCT02763579|42240321|FG000|Overall Study|Physician Decision|2|||
19783573|NCT02763579|42240322|FG001|Overall Study|Physician Decision|0|||
19783574|NCT02763579|42240321|FG000|Overall Study|On-going in study|77|||
19783575|NCT02763579|42240322|FG001|Overall Study|On-going in study|60|||
19783576|NCT03034057|42240328|FG000|Overall Study|Withdrawal by Subject|10|||
19783577|NCT03034057|42240328|FG000|Overall Study|Protocol Violation|1|||
19783578|NCT03034057|42240328|FG000|Overall Study|Not defined|2|||
19783579|NCT03034057|42240328|FG000|Overall Study|Lost to Follow-up|19|||
19783580|NCT03034057|42240328|FG000|Overall Study|Adverse Event|22|||
19783581|NCT03034057|42240328|FG000|Overall Study|Medication error without associated AE|1|||
19783582|NCT02757768|42240334|FG000|Overall Study|Randomized Never Received Study Drug|3|||
19783583|NCT02757768|42240335|FG001|Overall Study|Randomized Never Received Study Drug|4|||
19783584|NCT02757768|42240334|FG000|Overall Study|Adverse Event|5|||
19783585|NCT02757768|42240335|FG001|Overall Study|Adverse Event|3|||
19783586|NCT02757768|42240334|FG000|Overall Study|Lack of Efficacy|2|||
19783587|NCT02757768|42240335|FG001|Overall Study|Lack of Efficacy|1|||
19783588|NCT02757768|42240334|FG000|Overall Study|Lost to Follow-up|1|||
19783589|NCT02757768|42240335|FG001|Overall Study|Lost to Follow-up|0|||
19783590|NCT02757768|42240334|FG000|Overall Study|Protocol Deviation|2|||
19783591|NCT02757768|42240335|FG001|Overall Study|Protocol Deviation|9|||
19783592|NCT02757768|42240334|FG000|Overall Study|Withdrawal by Subject|16|||
19783593|NCT02757768|42240335|FG001|Overall Study|Withdrawal by Subject|9|||
19783594|NCT02757768|42240334|FG000|Overall Study|Miscellaneous|4|||
19607300|NCT00936884|42056047|FG002|Double-blind|Physician Decision|0|||
19695918|NCT00327470|42141243|FG000|Overall Study|Other|5|||
19695919|NCT00327470|42141244|FG001|Overall Study|Other|9|||
19695920|NCT00327470|42141243|FG000|Overall Study|Lost to Follow-up|1|||
19695921|NCT00327470|42141244|FG001|Overall Study|Lost to Follow-up|3|||
19695922|NCT00327470|42141243|FG000|Overall Study|Withdrawal by Subject|6|||
19695923|NCT00327470|42141244|FG001|Overall Study|Withdrawal by Subject|12|||
19695924|NCT00327470|42141243|FG000|Overall Study|Death|1|||
19695925|NCT00327470|42141244|FG001|Overall Study|Death|4|||
19695926|NCT00322556|42141250|FG000|Overall Study|Adverse Event|1|||
19695927|NCT00322556|42141250|FG000|Overall Study|Withdrawal by Subject|1|||
19783595|NCT02757768|42240335|FG001|Overall Study|Miscellaneous|2|||
19783596|NCT02753946|42240345|FG000|Overall Study|Adverse Event|7|||
19783597|NCT02753946|42240346|FG001|Overall Study|Adverse Event|6|||
19783598|NCT02753946|42240345|FG000|Overall Study|Withdrawal by Subject|6|||
19695928|NCT00322556|42141250|FG000|Overall Study|Lost to Follow-up|3|||
19783599|NCT02753946|42240346|FG001|Overall Study|Withdrawal by Subject|1|||
19783600|NCT02753946|42240345|FG000|Overall Study|Lack of Efficacy|1|||
19783601|NCT02753946|42240346|FG001|Overall Study|Lack of Efficacy|0|||
19783602|NCT02753946|42240345|FG000|Overall Study|Physician Decision|0|||
19783603|NCT02753946|42240346|FG001|Overall Study|Physician Decision|2|||
19783604|NCT02756832|42240352|FG000|Overall Study|Lost for Observation after Baseline|6|||
19783605|NCT02756832|42240352|FG000|Overall Study|Lost for Observation|13|||
19783606|NCT02756832|42240352|FG000|Overall Study|Patient's Unwillingness|12|||
19783607|NCT02756832|42240352|FG000|Overall Study|Insufficient Efficacy|2|||
19783608|NCT02756832|42240352|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
19783609|NCT02756832|42240352|FG000|Overall Study|Reason not Specified|9|||
19783610|NCT02756832|42240352|FG000|Overall Study|Protocol Deviation|10|||
19783611|NCT00106080|42240358|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
19783612|NCT00106080|42240359|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
19783613|NCT02633020|42240367|FG000|Overall Study|Adverse Event|1|||
19783614|NCT02633020|42240368|FG001|Overall Study|Adverse Event|0|||
19783615|NCT00106626|42240378|FG000|Overall Study|Adverse Event|5|||
19783616|NCT00106626|42240379|FG001|Overall Study|Adverse Event|4|||
19695929|NCT00322556|42141250|FG000|Overall Study|Other Reason|7|||
19695930|NCT00321932|42141259|FG000|Overall Study|Death|3|||
19695931|NCT00321932|42141260|FG001|Overall Study|Death|6|||
19695932|NCT00321932|42141259|FG000|Overall Study|Withdrawal by Subject|3|||
19695933|NCT00321932|42141260|FG001|Overall Study|Withdrawal by Subject|6|||
19695934|NCT00321932|42141259|FG000|Overall Study|Early relapse|2|||
19695935|NCT00321932|42141260|FG001|Overall Study|Early relapse|8|||
19695936|NCT00321932|42141259|FG000|Overall Study|Missing data|2|||
19695937|NCT00321932|42141260|FG001|Overall Study|Missing data|1|||
19695938|NCT00326612|42141269|FG000|Overall Study|They did not have a seizure requiring tx|129|||
19783617|NCT00106626|42240380|FG002|Overall Study|Adverse Event|3|||
19783618|NCT00106626|42240381|FG003|Overall Study|Adverse Event|3|||
19783619|NCT00106626|42240378|FG000|Overall Study|Progressive Disease|4|||
19783620|NCT00106626|42240379|FG001|Overall Study|Progressive Disease|1|||
19783621|NCT00106626|42240380|FG002|Overall Study|Progressive Disease|9|||
19783622|NCT00106626|42240381|FG003|Overall Study|Progressive Disease|10|||
19783623|NCT00106626|42240378|FG000|Overall Study|Received radiation on new therapy|1|||
19783624|NCT00106626|42240379|FG001|Overall Study|Received radiation on new therapy|0|||
19783625|NCT00106626|42240380|FG002|Overall Study|Received radiation on new therapy|0|||
19783626|NCT00106626|42240381|FG003|Overall Study|Received radiation on new therapy|0|||
19783627|NCT00106626|42240378|FG000|Overall Study|> 14 day delay in therapy start|0|||
19783628|NCT00106626|42240379|FG001|Overall Study|> 14 day delay in therapy start|1|||
19783629|NCT00106626|42240380|FG002|Overall Study|> 14 day delay in therapy start|0|||
19783630|NCT00106626|42240381|FG003|Overall Study|> 14 day delay in therapy start|0|||
19783631|NCT02632786|42240398|FG000|Overall Study|Adverse Event|2|||
19783632|NCT02632786|42240399|FG001|Overall Study|Adverse Event|1|||
19783633|NCT02632786|42240398|FG000|Overall Study|Death|3|||
19783634|NCT02632786|42240399|FG001|Overall Study|Death|2|||
19783635|NCT02632786|42240398|FG000|Overall Study|Physician Decision|5|||
19783636|NCT02632786|42240399|FG001|Overall Study|Physician Decision|4|||
19783637|NCT02632786|42240398|FG000|Overall Study|Withdrawal by Subject|1|||
19783638|NCT02632786|42240399|FG001|Overall Study|Withdrawal by Subject|0|||
19783639|NCT02755818|42240410|FG000|Overall Study|Withdrawal by Subject|0|||
19783640|NCT02755818|42240411|FG001|Overall Study|Withdrawal by Subject|0|||
19783641|NCT02755818|42240412|FG002|Overall Study|Withdrawal by Subject|0|||
19783642|NCT02755818|42240413|FG003|Overall Study|Withdrawal by Subject|2|||
19783643|NCT02755818|42240410|FG000|Overall Study|withdrawal by PI|0|||
19783644|NCT02755818|42240411|FG001|Overall Study|withdrawal by PI|0|||
19783645|NCT02755818|42240412|FG002|Overall Study|withdrawal by PI|1|||
19783646|NCT02755818|42240413|FG003|Overall Study|withdrawal by PI|1|||
19783647|NCT03033745|42240428|FG000|Overall Study|Protocol Violation|0|||
19783648|NCT03033745|42240429|FG001|Overall Study|Protocol Violation|0|||
19783649|NCT03033745|42240430|FG002|Overall Study|Protocol Violation|1|||
19783650|NCT03033745|42240428|FG000|Overall Study|Adverse Event|1|||
19783651|NCT03033745|42240429|FG001|Overall Study|Adverse Event|0|||
19783652|NCT03033745|42240430|FG002|Overall Study|Adverse Event|1|||
19783653|NCT03033745|42240428|FG000|Overall Study|Withdrawal by Subject|0|||
19783654|NCT03033745|42240429|FG001|Overall Study|Withdrawal by Subject|1|||
19783655|NCT03033745|42240430|FG002|Overall Study|Withdrawal by Subject|0|||
19783656|NCT01672294|42240449|FG000|Overall Study|Withdrawal by Subject|4|||
19783657|NCT01672294|42240450|FG001|Overall Study|Withdrawal by Subject|4|||
19783658|NCT01672294|42240451|FG002|Overall Study|Withdrawal by Subject|4|||
19783659|NCT01672294|42240452|FG003|Overall Study|Withdrawal by Subject|4|||
19783660|NCT01672294|42240449|FG000|Overall Study|Excluded by study|1|||
19783661|NCT01672294|42240450|FG001|Overall Study|Excluded by study|1|||
19783662|NCT01672294|42240451|FG002|Overall Study|Excluded by study|0|||
19783663|NCT01672294|42240452|FG003|Overall Study|Excluded by study|0|||
19783664|NCT01672294|42240449|FG000|Overall Study|Lost to Follow-up|1|||
19695939|NCT00326612|42141270|FG001|Overall Study|They did not have a seizure requiring tx|137|||
19783665|NCT01672294|42240450|FG001|Overall Study|Lost to Follow-up|16|||
19783666|NCT01672294|42240451|FG002|Overall Study|Lost to Follow-up|7|||
19783667|NCT01672294|42240452|FG003|Overall Study|Lost to Follow-up|9|||
19783668|NCT02755116|42240464|FG000|Overall Study|surgery converted to open, pt admitted|3|||
19783669|NCT02755116|42240465|FG001|Overall Study|surgery converted to open, pt admitted|1|||
19783670|NCT02754492|42240475|FG000|Overall Study|Protocol Violation|2|||
19783671|NCT02754492|42240476|FG001|Overall Study|Protocol Violation|2|||
19783672|NCT02754492|42240477|FG002|Overall Study|Protocol Violation|0|||
19783673|NCT02754492|42240478|FG003|Overall Study|Protocol Violation|1|||
19783674|NCT02754492|42240475|FG000|Overall Study|Withdrawal by Subject|2|||
19783675|NCT02754492|42240476|FG001|Overall Study|Withdrawal by Subject|0|||
19783676|NCT02754492|42240477|FG002|Overall Study|Withdrawal by Subject|0|||
19783677|NCT02754492|42240478|FG003|Overall Study|Withdrawal by Subject|0|||
19783678|NCT02754492|42240475|FG000|Overall Study|Equipment malfuntion|0|||
19783679|NCT02754492|42240476|FG001|Overall Study|Equipment malfuntion|0|||
19783680|NCT02754492|42240477|FG002|Overall Study|Equipment malfuntion|2|||
19783681|NCT02754492|42240478|FG003|Overall Study|Equipment malfuntion|5|||
19783682|NCT02754492|42240475|FG000|Overall Study|Adverse Event|0|||
19783683|NCT02754492|42240476|FG001|Overall Study|Adverse Event|0|||
19783684|NCT02754492|42240477|FG002|Overall Study|Adverse Event|0|||
19783685|NCT02754492|42240478|FG003|Overall Study|Adverse Event|13|||
19783686|NCT02754492|42240475|FG000|Overall Study|Venous access issues not resulting in AE|0|||
19783687|NCT02754492|42240476|FG001|Overall Study|Venous access issues not resulting in AE|0|||
19695940|NCT00325754|42141282|FG000|Overall Study|Adverse Event|4|||
19695941|NCT00325754|42141283|FG001|Overall Study|Adverse Event|1|||
19783688|NCT02754492|42240477|FG002|Overall Study|Venous access issues not resulting in AE|0|||
19783689|NCT02754492|42240478|FG003|Overall Study|Venous access issues not resulting in AE|4|||
19783690|NCT04068688|42240497|FG000|Overall Study|Lost to Follow-up|1|||
19783691|NCT04068688|42240498|FG001|Overall Study|Lost to Follow-up|1|||
19783692|NCT04068688|42240499|FG002|Overall Study|Lost to Follow-up|0|||
19783693|NCT04068688|42240500|FG003|Overall Study|Lost to Follow-up|0|||
19783694|NCT04068688|42240501|FG004|Overall Study|Lost to Follow-up|5|||
19783695|NCT04068688|42240502|FG005|Overall Study|Lost to Follow-up|5|||
19783696|NCT04068688|42240503|FG006|Overall Study|Lost to Follow-up|0|||
19783697|NCT04068688|42240504|FG007|Overall Study|Lost to Follow-up|0|||
19783698|NCT04068688|42240505|FG008|Overall Study|Lost to Follow-up|1|||
19783699|NCT04068688|42240506|FG009|Overall Study|Lost to Follow-up|0|||
19783700|NCT04068688|42240497|FG000|Overall Study|Withdrawal by Subject|1|||
19783701|NCT04068688|42240498|FG001|Overall Study|Withdrawal by Subject|1|||
19783702|NCT04068688|42240499|FG002|Overall Study|Withdrawal by Subject|0|||
19783703|NCT04068688|42240500|FG003|Overall Study|Withdrawal by Subject|0|||
19783704|NCT04068688|42240501|FG004|Overall Study|Withdrawal by Subject|0|||
19783705|NCT04068688|42240502|FG005|Overall Study|Withdrawal by Subject|0|||
19783706|NCT04068688|42240503|FG006|Overall Study|Withdrawal by Subject|0|||
19783707|NCT04068688|42240504|FG007|Overall Study|Withdrawal by Subject|0|||
19783708|NCT04068688|42240505|FG008|Overall Study|Withdrawal by Subject|0|||
19783709|NCT04068688|42240506|FG009|Overall Study|Withdrawal by Subject|0|||
19783710|NCT04068688|42240497|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
19783711|NCT04068688|42240498|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
19783712|NCT04068688|42240499|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783713|NCT04068688|42240500|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783714|NCT04068688|42240501|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783715|NCT04068688|42240502|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783716|NCT04068688|42240503|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783717|NCT04068688|42240504|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19695942|NCT00325130|42141291|FG000|Overall Study|Lost to Follow-up|6|||
19695943|NCT00325130|42141292|FG001|Overall Study|Lost to Follow-up|14|||
19695944|NCT00325130|42141291|FG000|Overall Study|Withdrawal by Subject|12|||
19695945|NCT00325130|42141292|FG001|Overall Study|Withdrawal by Subject|14|||
19695946|NCT00325130|42141291|FG000|Overall Study|Protocol Deviation|0|||
19695947|NCT00325130|42141292|FG001|Overall Study|Protocol Deviation|1|||
19695948|NCT00325130|42141291|FG000|Overall Study|Moved|0|||
19695949|NCT00325130|42141292|FG001|Overall Study|Moved|1|||
19695950|NCT00325130|42141291|FG000|Overall Study|Patient Discontinued for Other|1|||
19695951|NCT00325130|42141292|FG001|Overall Study|Patient Discontinued for Other|0|||
19783718|NCT04068688|42240505|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783719|NCT04068688|42240506|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
19783720|NCT01671748|42240534|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
19783721|NCT01671748|42240535|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
19695952|NCT00321854|42141300|FG000|Overall Study|Adverse Event|41|||
19695953|NCT00321854|42141301|FG001|Overall Study|Adverse Event|43|||
19695954|NCT00321854|42141300|FG000|Overall Study|Lack of Efficacy|9|||
19695955|NCT00321854|42141301|FG001|Overall Study|Lack of Efficacy|14|||
19783722|NCT01671748|42240534|FG000|4 Week run-in Phase|Adverse Event|1|||
19783723|NCT01671748|42240535|FG001|4 Week run-in Phase|Adverse Event|0|||
19783724|NCT01671748|42240534|FG000|4 Week run-in Phase|Not eligible|9|||
19783725|NCT01671748|42240535|FG001|4 Week run-in Phase|Not eligible|0|||
19783726|NCT02657889|42240545|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
19783727|NCT02657889|42240546|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
19783728|NCT02657889|42240547|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
19783729|NCT02657889|42240548|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
19783730|NCT02657889|42240545|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
19783731|NCT02657889|42240546|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
19783732|NCT02657889|42240547|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
19783733|NCT02657889|42240548|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
19783734|NCT02657889|42240545|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
19783735|NCT02657889|42240546|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
19783736|NCT02657889|42240547|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
19783737|NCT02657889|42240548|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
19783738|NCT02657889|42240545|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
19783739|NCT02657889|42240546|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
19783740|NCT02657889|42240547|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
19783741|NCT02657889|42240548|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
19783742|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
19783743|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
19783744|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
19783745|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
19783746|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
19783747|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
19783748|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
19783749|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
19783750|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
19783751|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
19783752|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
19783753|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
19783754|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
19783755|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
19783756|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
19783757|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
19783758|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
19783759|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
19783760|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
19783761|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
19783762|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
19783763|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
19783764|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
19783765|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
19783766|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
19783767|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
19783768|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
19783769|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
19695956|NCT00321854|42141300|FG000|Overall Study|Protocol Violation|6|||
19695957|NCT00321854|42141301|FG001|Overall Study|Protocol Violation|5|||
19695958|NCT00321854|42141300|FG000|Overall Study|Lost to Follow-up|0|||
19695959|NCT00321854|42141301|FG001|Overall Study|Lost to Follow-up|2|||
19695960|NCT00321854|42141300|FG000|Overall Study|Withdrawal by Subject|6|||
19695961|NCT00321854|42141301|FG001|Overall Study|Withdrawal by Subject|17|||
19695962|NCT00321854|42141300|FG000|Overall Study|Other|1|||
19695963|NCT00321854|42141301|FG001|Overall Study|Other|1|||
19695964|NCT00310388|42141309|FG000|Primary Reporting Phase|Adverse Event|101|||
19695965|NCT00310388|42141310|FG001|Primary Reporting Phase|Adverse Event|0|||
19695966|NCT00310388|42141309|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
19695967|NCT00310388|42141310|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
19695968|NCT00310388|42141309|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
19695969|NCT00310388|42141310|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
19695970|NCT00310388|42141309|FG000|Primary Reporting Phase|Protocol Violation|10|||
19695971|NCT00310388|42141310|FG001|Primary Reporting Phase|Protocol Violation|0|||
19695972|NCT00310388|42141309|FG000|Primary Reporting Phase|Pregnancy|3|||
19695973|NCT00310388|42141310|FG001|Primary Reporting Phase|Pregnancy|0|||
19695974|NCT00310388|42141309|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
19783770|NCT02657889|42240545|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
19783771|NCT02657889|42240546|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
19783772|NCT02657889|42240547|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
19783773|NCT02657889|42240548|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
19783774|NCT03034915|42240563|FG000|Overall Study|Adverse Event|29|||
19783775|NCT03034915|42240564|FG001|Overall Study|Adverse Event|32|||
19783776|NCT03034915|42240565|FG002|Overall Study|Adverse Event|22|||
19783777|NCT03034915|42240563|FG000|Overall Study|Lost to Follow-up|5|||
19783778|NCT03034915|42240564|FG001|Overall Study|Lost to Follow-up|13|||
19783779|NCT03034915|42240565|FG002|Overall Study|Lost to Follow-up|3|||
19783780|NCT03034915|42240563|FG000|Overall Study|Withdrawal by Subject|29|||
19783781|NCT03034915|42240564|FG001|Overall Study|Withdrawal by Subject|46|||
19783782|NCT03034915|42240565|FG002|Overall Study|Withdrawal by Subject|41|||
19783783|NCT03034915|42240563|FG000|Overall Study|Protocol Deviation|2|||
19783784|NCT03034915|42240564|FG001|Overall Study|Protocol Deviation|14|||
19695975|NCT00310388|42141310|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
19695976|NCT00310388|42141309|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
19695977|NCT00310388|42141310|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
19695978|NCT00310388|42141309|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
19695979|NCT00310388|42141310|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
19695980|NCT00310388|42141309|FG000|Primary Reporting Phase|Physician Decision|2|||
19695981|NCT00310388|42141310|FG001|Primary Reporting Phase|Physician Decision|0|||
19695982|NCT00310388|42141309|FG000|Primary Reporting Phase|Request of the sponsor|19|||
19695983|NCT00310388|42141310|FG001|Primary Reporting Phase|Request of the sponsor|0|||
19695984|NCT00310388|42141309|FG000|Primary Reporting Phase|Failed to return|8|||
19695985|NCT00310388|42141310|FG001|Primary Reporting Phase|Failed to return|0|||
19695986|NCT00310388|42141309|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
19695987|NCT00310388|42141310|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
19695988|NCT00310388|42141309|FG000|Primary Reporting Phase|Participant request|2|||
19695989|NCT00310388|42141310|FG001|Primary Reporting Phase|Participant request|0|||
19695990|NCT00310388|42141309|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
19695991|NCT00310388|42141310|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
19783785|NCT03034915|42240565|FG002|Overall Study|Protocol Deviation|7|||
19783786|NCT03034915|42240563|FG000|Overall Study|Lack of Efficacy|8|||
19783787|NCT03034915|42240564|FG001|Overall Study|Lack of Efficacy|16|||
19783788|NCT03034915|42240565|FG002|Overall Study|Lack of Efficacy|18|||
19783789|NCT03034915|42240563|FG000|Overall Study|Site closed|2|||
19783790|NCT03034915|42240564|FG001|Overall Study|Site closed|2|||
19783791|NCT03034915|42240565|FG002|Overall Study|Site closed|4|||
19783792|NCT03034915|42240563|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
19783793|NCT03034915|42240564|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
19783794|NCT03034915|42240565|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
19783795|NCT03034915|42240563|FG000|Overall Study|Physician Decision|1|||
19783796|NCT03034915|42240564|FG001|Overall Study|Physician Decision|5|||
19783797|NCT03034915|42240565|FG002|Overall Study|Physician Decision|2|||
19783798|NCT02631538|42240577|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
19783799|NCT02631538|42240578|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
19783800|NCT02631538|42240579|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
19783801|NCT02631538|42240580|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
19783802|NCT02631538|42240577|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
19783803|NCT02631538|42240578|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
19783804|NCT02631538|42240579|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
19783805|NCT02631538|42240580|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
19783806|NCT02631538|42240577|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
19783807|NCT02631538|42240578|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
19783808|NCT02631538|42240579|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
19783809|NCT02631538|42240580|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
19783810|NCT02631538|42240577|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
19783811|NCT02631538|42240578|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
19783812|NCT02631538|42240579|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
19783813|NCT02631538|42240580|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
19783814|NCT02631538|42240577|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
19783815|NCT02631538|42240578|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
19783816|NCT02631538|42240579|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
19783817|NCT02631538|42240580|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
19783818|NCT02631538|42240577|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
19367378|NCT02456740|41607524|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
19367379|NCT02456740|41607525|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
19477788|NCT01479439|41757037|FG002|Overall Study|Protocol Violation|2|||
19783819|NCT02631538|42240578|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
19783820|NCT02631538|42240579|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
19783821|NCT02631538|42240580|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
19783822|NCT02631148|42240603|FG000|Overall Study|8 were ineligible|8|||
19783823|NCT02631148|42240604|FG001|Overall Study|8 were ineligible|0|||
19783824|NCT02631148|42240603|FG000|Overall Study|Withdrawal by Subject|1|||
19783825|NCT02631148|42240604|FG001|Overall Study|Withdrawal by Subject|0|||
19783826|NCT02631148|42240603|FG000|Overall Study|PAH not available to study participant|1|||
19783827|NCT02631148|42240604|FG001|Overall Study|PAH not available to study participant|0|||
19783828|NCT02753400|42240612|FG000|Overall Study|Adverse Event|3|||
19783829|NCT02753400|42240613|FG001|Overall Study|Adverse Event|0|||
19783830|NCT02753400|42240612|FG000|Overall Study|Withdrawal by Subject|2|||
19783831|NCT02753400|42240613|FG001|Overall Study|Withdrawal by Subject|1|||
19783832|NCT03943147|42240630|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
19783833|NCT03943147|42240631|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
19783834|NCT03943147|42240630|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
19783835|NCT03943147|42240631|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
19783836|NCT03943147|42240630|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
19783837|NCT03943147|42240631|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
19783838|NCT03943147|42240630|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
19783839|NCT03943147|42240631|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
19783840|NCT03943147|42240630|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
19783841|NCT03943147|42240631|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
19783842|NCT03943147|42240630|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
19783843|NCT03943147|42240631|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
19695992|NCT00310388|42141309|FG000|Primary Reporting Phase|Discontinuation of study|1|||
19695993|NCT00310388|42141310|FG001|Primary Reporting Phase|Discontinuation of study|0|||
19695994|NCT00310388|42141309|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
19695995|NCT00310388|42141310|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
19695996|NCT00310388|42141309|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
19695997|NCT00310388|42141310|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
19695998|NCT00310388|42141309|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
19695999|NCT00310388|42141310|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
19696000|NCT00310388|42141309|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
19696001|NCT00310388|42141310|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
19696002|NCT00310388|42141309|FG000|Primary Reporting Phase|Participant passed away|1|||
19696003|NCT00310388|42141310|FG001|Primary Reporting Phase|Participant passed away|0|||
19607301|NCT00936884|42056045|FG000|Double-blind|No post baseline diary entry|1|||
19696004|NCT00310388|42141309|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
19696005|NCT00310388|42141310|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
19696006|NCT00310388|42141309|FG000|Primary Reporting Phase|Missing|1|||
19696007|NCT00310388|42141310|FG001|Primary Reporting Phase|Missing|0|||
19607302|NCT00936884|42056046|FG001|Double-blind|No post baseline diary entry|0|||
19607303|NCT00936884|42056047|FG002|Double-blind|No post baseline diary entry|0|||
19607304|NCT00936884|42056045|FG000|Double-blind|Did not receive study drug|0|||
19607305|NCT00936884|42056046|FG001|Double-blind|Did not receive study drug|1|||
19607306|NCT00936884|42056047|FG002|Double-blind|Did not receive study drug|0|||
19607307|NCT00668863|42056063|FG000|Overall Study|Objective Progression or Relapse|42|||
19607308|NCT00668863|42056063|FG000|Overall Study|Adverse Event|13|||
19607309|NCT00668863|42056063|FG000|Overall Study|Study Terminated by Sponsor|8|||
19607310|NCT00668863|42056063|FG000|Overall Study|Global Deterioration of Health Status|4|||
19607311|NCT00668863|42056063|FG000|Overall Study|Withdrawal by Subject|1|||
19607312|NCT00668863|42056063|FG000|Overall Study|Surgery|1|||
19607313|NCT00668863|42056063|FG000|Overall Study|Subject's work scheduling problem|1|||
19607314|NCT00668863|42056063|FG000|Overall Study|Physician Decision|1|||
19607315|NCT00935012|42056067|FG000|Overall Study|Death|19|||
19607316|NCT00935012|42056067|FG000|Overall Study|Withdrawal by Subject|3|||
19607317|NCT00935012|42056067|FG000|Overall Study|Other|5|||
19607318|NCT00935012|42056067|FG000|Overall Study|Adverse Event|2|||
19607319|NCT00932360|42056071|FG000|Washout (One Week)|Withdrawal by Subject|0|||
19607320|NCT00932360|42056072|FG001|Washout (One Week)|Withdrawal by Subject|0|||
19607321|NCT00932360|42056073|FG002|Washout (One Week)|Withdrawal by Subject|0|||
19607322|NCT00932360|42056074|FG003|Washout (One Week)|Withdrawal by Subject|0|||
19607323|NCT00932360|42056075|FG004|Washout (One Week)|Withdrawal by Subject|2|||
19607324|NCT00932360|42056076|FG005|Washout (One Week)|Withdrawal by Subject|0|||
19607325|NCT00668707|42056092|FG000|Overall Study|Cancer Recurrence|58|||
19607326|NCT00668707|42056093|FG001|Overall Study|Cancer Recurrence|58|||
19607327|NCT00668707|42056092|FG000|Overall Study|Withdrawal by Subject|117|||
19607328|NCT00668707|42056093|FG001|Overall Study|Withdrawal by Subject|100|||
19607329|NCT00668707|42056092|FG000|Overall Study|Lost to Follow-up|3|||
19607330|NCT00668707|42056093|FG001|Overall Study|Lost to Follow-up|6|||
19783844|NCT03730987|42240649|FG000|Overall Study|Lost to Follow-up|2|||
19783845|NCT03730987|42240650|FG001|Overall Study|Lost to Follow-up|0|||
19783846|NCT03730987|42240651|FG002|Overall Study|Lost to Follow-up|2|||
19783847|NCT03730987|42240652|FG003|Overall Study|Lost to Follow-up|0|||
19783848|NCT03556891|42240663|FG000|Overall Study|Adverse Event|4|||
19696008|NCT00310388|42141309|FG000|Primary Reporting Phase|Other|1|||
19696009|NCT00310388|42141310|FG001|Primary Reporting Phase|Other|0|||
19696010|NCT00310388|42141309|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
19696011|NCT00310388|42141310|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
19783849|NCT03556891|42240663|FG000|Overall Study|MRI Need|3|||
19783850|NCT03556891|42240663|FG000|Overall Study|Device Failure|1|||
19783851|NCT03556891|42240663|FG000|Overall Study|Death|1|||
19783852|NCT03556891|42240663|FG000|Overall Study|Lost to Follow-up|1|||
19783853|NCT03556891|42240663|FG000|Overall Study|Missing at random|1|||
19783854|NCT03556891|42240663|FG000|Overall Study|Missing due to COVID|1|||
19783855|NCT03556891|42240663|FG000|Overall Study|Protocol Violation|1|||
19783856|NCT02844543|42240667|FG000|Overall Study|Withdrawal by Subject|4|||
19783857|NCT02844543|42240667|FG000|Overall Study|Did not meet eligibility criteria|1|||
19783858|NCT03034135|42240671|FG000|Overall Study|Withdrawal by Subject|2|||
19783859|NCT01671280|42240675|FG000|Overall Study|Withdrawal by Subject|2|||
19783860|NCT01405963|42240681|FG000|Overall Study|Moved Away|2|||
19783861|NCT01405963|42240682|FG001|Overall Study|Moved Away|0|||
19783862|NCT01405963|42240681|FG000|Overall Study|Adverse Event|0|||
19783863|NCT01405963|42240682|FG001|Overall Study|Adverse Event|1|||
19783864|NCT01405963|42240681|FG000|Overall Study|Lost to Follow-up|0|||
19783865|NCT01405963|42240682|FG001|Overall Study|Lost to Follow-up|1|||
19783866|NCT02846415|42240691|FG000|Overall Study|Lost to Follow-up|2|||
19783867|NCT02846415|42240692|FG001|Overall Study|Lost to Follow-up|0|||
19783868|NCT02846415|42240691|FG000|Overall Study|Withdrawal by Subject|1|||
19783869|NCT02846415|42240692|FG001|Overall Study|Withdrawal by Subject|1|||
19783870|NCT02628418|42240711|FG000|Overall Study|Lost to Follow-up|1|||
19783871|NCT02628418|42240712|FG001|Overall Study|Lost to Follow-up|2|||
19783872|NCT02752776|42240740|FG000|Overall Study|Adverse Event|15|||
19783873|NCT02752776|42240741|FG001|Overall Study|Adverse Event|23|||
19783874|NCT02752776|42240742|FG002|Overall Study|Adverse Event|11|||
19783875|NCT02752776|42240740|FG000|Overall Study|Lack of Efficacy|2|||
19783876|NCT02752776|42240741|FG001|Overall Study|Lack of Efficacy|6|||
19783877|NCT02752776|42240742|FG002|Overall Study|Lack of Efficacy|14|||
19783878|NCT02752776|42240740|FG000|Overall Study|Lost to Follow-up|11|||
19783879|NCT02752776|42240741|FG001|Overall Study|Lost to Follow-up|12|||
19783880|NCT02752776|42240742|FG002|Overall Study|Lost to Follow-up|4|||
19783881|NCT02752776|42240740|FG000|Overall Study|Non-compliance with study treatment|0|||
19783882|NCT02752776|42240741|FG001|Overall Study|Non-compliance with study treatment|0|||
19783883|NCT02752776|42240742|FG002|Overall Study|Non-compliance with study treatment|1|||
19783884|NCT02752776|42240740|FG000|Overall Study|Physician Decision|2|||
19783885|NCT02752776|42240741|FG001|Overall Study|Physician Decision|6|||
19783886|NCT02752776|42240742|FG002|Overall Study|Physician Decision|2|||
19783887|NCT02752776|42240740|FG000|Overall Study|Pregnancy|1|||
19783888|NCT02752776|42240741|FG001|Overall Study|Pregnancy|6|||
19783889|NCT02752776|42240742|FG002|Overall Study|Pregnancy|3|||
19783890|NCT02752776|42240740|FG000|Overall Study|Protocol Violation|10|||
19783891|NCT02752776|42240741|FG001|Overall Study|Protocol Violation|13|||
19783892|NCT02752776|42240742|FG002|Overall Study|Protocol Violation|6|||
19783893|NCT02752776|42240740|FG000|Overall Study|Subject/guardian decision|8|||
19783894|NCT02752776|42240741|FG001|Overall Study|Subject/guardian decision|6|||
19783895|NCT02752776|42240742|FG002|Overall Study|Subject/guardian decision|4|||
19783896|NCT02752776|42240740|FG000|Overall Study|Death|0|||
19783897|NCT02752776|42240741|FG001|Overall Study|Death|0|||
19783898|NCT02752776|42240742|FG002|Overall Study|Death|1|||
19783899|NCT02752776|42240740|FG000|Overall Study|Withdrawal by Subject|3|||
19783900|NCT02752776|42240741|FG001|Overall Study|Withdrawal by Subject|4|||
19783901|NCT02752776|42240742|FG002|Overall Study|Withdrawal by Subject|2|||
19696012|NCT00310388|42141309|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
19696013|NCT00310388|42141310|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
19696014|NCT00310388|42141309|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
19696015|NCT00310388|42141310|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
19696016|NCT00310388|42141309|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
19696017|NCT00310388|42141310|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
19783902|NCT01342965|42240754|FG000|Overall Study|Death|58|||
19783903|NCT01342965|42240755|FG001|Overall Study|Death|57|||
19783904|NCT01342965|42240754|FG000|Overall Study|Lost to Follow-up|5|||
19696018|NCT00500357|42141315|FG000|Overall Study|Death|1|||
19696019|NCT00309842|42141330|FG000|Overall Study|Lost to Follow-up|1|||
19783905|NCT01342965|42240755|FG001|Overall Study|Lost to Follow-up|3|||
19783906|NCT01342965|42240754|FG000|Overall Study|Other Reasons- Unspecified|44|||
19783907|NCT01342965|42240755|FG001|Overall Study|Other Reasons- Unspecified|38|||
19783908|NCT01342965|42240754|FG000|Overall Study|Withdrawal by Subject|2|||
19783909|NCT01342965|42240755|FG001|Overall Study|Withdrawal by Subject|9|||
19783910|NCT02629822|42240761|FG000|Base Study|Lost to Follow-up|2|||
19783911|NCT02629822|42240761|FG000|Base Study|Non-Compliance With Study Drug|1|||
19783912|NCT02629822|42240761|FG000|Extension Study|Adverse Event|1|||
19783913|NCT02629822|42240761|FG000|Extension Study|Lost to Follow-up|1|||
19783914|NCT02840721|42240766|FG000|Treatment Period|Adverse Event|1|||
19783915|NCT02840721|42240766|FG000|Follow-Up|Lack of Efficacy|1|||
19783916|NCT02840721|42240766|FG000|Follow-Up|Withdrawal by Subject|4|||
19783917|NCT02840721|42240766|FG000|Follow-Up|Withdrawal of Consent|2|||
19783918|NCT03462706|42240774|FG000|Overall Study|Polyp was pedunculated|1|||
19783919|NCT03462706|42240775|FG001|Overall Study|Polyp was pedunculated|0|||
19783920|NCT03462706|42240776|FG002|Overall Study|Polyp was pedunculated|1|||
19783921|NCT03462706|42240777|FG003|Overall Study|Polyp was pedunculated|0|||
19696020|NCT00499889|42141334|FG000|Overall Study|Infection prior to treatment|1|||
19696021|NCT00309608|42141343|FG000|Overall Study|Adverse Event|1|||
19696022|NCT00309608|42141344|FG001|Overall Study|Adverse Event|5|||
19696023|NCT00309608|42141345|FG002|Overall Study|Adverse Event|3|||
19783922|NCT03462706|42240774|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
19783923|NCT03462706|42240775|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
19783924|NCT03462706|42240776|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
19783925|NCT03462706|42240777|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
19783926|NCT02840253|42240787|FG000|Overall Study|Unsuccessful block|4|||
19783927|NCT02752074|42240793|FG000|Overall Study|Lost to Follow-up|1|||
19783928|NCT02752074|42240794|FG001|Overall Study|Lost to Follow-up|4|||
19783929|NCT02752074|42240793|FG000|Overall Study|Death|146|||
19783930|NCT02752074|42240794|FG001|Overall Study|Death|129|||
19783931|NCT02752074|42240793|FG000|Overall Study|Withdrawal by Subject|9|||
19783932|NCT02752074|42240794|FG001|Overall Study|Withdrawal by Subject|10|||
19783933|NCT02835495|42240802|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
19783934|NCT02835495|42240803|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
19783935|NCT02835495|42240802|FG000|Overall Study|Declined in-person follow-up visit|4|||
19783936|NCT02835495|42240803|FG001|Overall Study|Declined in-person follow-up visit|2|||
19783937|NCT02835339|42240813|FG000|Overall Study|Did not receive allocated intervention|13|||
19783938|NCT02835339|42240814|FG001|Overall Study|Did not receive allocated intervention|16|||
19783939|NCT02832063|42240822|FG000|Overall Study|Adverse Event|2|||
19783940|NCT02832063|42240823|FG001|Overall Study|Adverse Event|1|||
19783941|NCT02832063|42240822|FG000|Overall Study|Physician Decision|5|||
19783942|NCT02832063|42240823|FG001|Overall Study|Physician Decision|7|||
19783943|NCT02832063|42240822|FG000|Overall Study|Lost to Follow-up|15|||
19783944|NCT02832063|42240823|FG001|Overall Study|Lost to Follow-up|8|||
19783945|NCT02832063|42240822|FG000|Overall Study|Withdrawal by Subject|10|||
19783946|NCT02832063|42240823|FG001|Overall Study|Withdrawal by Subject|21|||
19783947|NCT02832063|42240822|FG000|Overall Study|Other|2|||
19783948|NCT02832063|42240823|FG001|Overall Study|Other|1|||
19783949|NCT03125902|42240831|FG000|Overall Study|Death|52|||
19783950|NCT03125902|42240832|FG001|Overall Study|Death|123|||
19696024|NCT00309608|42141346|FG003|Overall Study|Adverse Event|2|||
19696025|NCT00309608|42141347|FG004|Overall Study|Adverse Event|3|||
19696026|NCT00309608|42141343|FG000|Overall Study|Protocol Violation|2|||
19696027|NCT00309608|42141344|FG001|Overall Study|Protocol Violation|0|||
19696028|NCT00309608|42141345|FG002|Overall Study|Protocol Violation|0|||
19696029|NCT00309608|42141346|FG003|Overall Study|Protocol Violation|0|||
19696030|NCT00309608|42141347|FG004|Overall Study|Protocol Violation|0|||
19696031|NCT00309608|42141343|FG000|Overall Study|Lost to Follow-up|0|||
19696032|NCT00309608|42141344|FG001|Overall Study|Lost to Follow-up|0|||
19783951|NCT03125902|42240831|FG000|Overall Study|Lost to Follow-up|1|||
19367380|NCT02456740|41607526|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
19367381|NCT02456740|41607527|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
19783952|NCT03125902|42240832|FG001|Overall Study|Lost to Follow-up|0|||
19783953|NCT03125902|42240831|FG000|Overall Study|Mastectomy|0|||
19367382|NCT02456740|41607528|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
19367383|NCT02456740|41607529|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
19367384|NCT02456740|41607521|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19607331|NCT00668707|42056092|FG000|Overall Study|Protocol Violation|10|||
19607332|NCT00668707|42056093|FG001|Overall Study|Protocol Violation|12|||
19607333|NCT00668707|42056092|FG000|Overall Study|Death|11|||
19607334|NCT00668707|42056093|FG001|Overall Study|Death|4|||
19607335|NCT00668395|42056107|FG000|Overall Study|Withdrawal by Subject|4|||
19607336|NCT00668395|42056108|FG001|Overall Study|Withdrawal by Subject|4|||
19607337|NCT00668395|42056109|FG002|Overall Study|Withdrawal by Subject|1|||
19607338|NCT00668395|42056107|FG000|Overall Study|Adverse Event|1|||
19607339|NCT00668395|42056108|FG001|Overall Study|Adverse Event|1|||
19696033|NCT00309608|42141345|FG002|Overall Study|Lost to Follow-up|2|||
19696034|NCT00309608|42141346|FG003|Overall Study|Lost to Follow-up|0|||
19783954|NCT03125902|42240832|FG001|Overall Study|Mastectomy|1|||
19783955|NCT03125902|42240831|FG000|Overall Study|Physician Decision|1|||
19783956|NCT03125902|42240832|FG001|Overall Study|Physician Decision|0|||
19607340|NCT00668395|42056109|FG002|Overall Study|Adverse Event|0|||
19783957|NCT03125902|42240831|FG000|Overall Study|Withdrawal by Subject|13|||
19783958|NCT03125902|42240832|FG001|Overall Study|Withdrawal by Subject|25|||
19783959|NCT03125902|42240831|FG000|Overall Study|Study is ongoing|153|||
19783960|NCT03125902|42240832|FG001|Overall Study|Study is ongoing|282|||
19783961|NCT04412707|42240841|FG000|Cycle 1|Death|0|||
19783962|NCT04412707|42240842|FG001|Cycle 1|Death|3|||
19783963|NCT04412707|42240841|FG000|Cycle 1|Disease progression|1|||
19783964|NCT04412707|42240842|FG001|Cycle 1|Disease progression|2|||
19783965|NCT04412707|42240841|FG000|Cycle 2|Death|0|||
19783966|NCT04412707|42240842|FG001|Cycle 2|Death|1|||
19783967|NCT04412707|42240841|FG000|Cycle 2|Disease progression|3|||
19783968|NCT04412707|42240842|FG001|Cycle 2|Disease progression|0|||
19783969|NCT04412707|42240841|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
19783970|NCT04412707|42240842|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
19783971|NCT04412707|42240841|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
19783972|NCT04412707|42240842|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
19783973|NCT04412707|42240841|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
19783974|NCT04412707|42240842|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
19783975|NCT04412707|42240841|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
19783976|NCT04412707|42240842|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
19783977|NCT01358721|42240861|FG000|Overall Study|Withdrawal by Subject|0|||
19783978|NCT01358721|42240862|FG001|Overall Study|Withdrawal by Subject|0|||
19783979|NCT01358721|42240863|FG002|Overall Study|Withdrawal by Subject|0|||
19783980|NCT01358721|42240864|FG003|Overall Study|Withdrawal by Subject|1|||
19783981|NCT01358721|42240861|FG000|Overall Study|Death|0|||
19783982|NCT01358721|42240862|FG001|Overall Study|Death|2|||
19783983|NCT01358721|42240863|FG002|Overall Study|Death|0|||
19783984|NCT01358721|42240864|FG003|Overall Study|Death|0|||
19783985|NCT01358721|42240861|FG000|Overall Study|Study Drug Toxicity|1|||
19783986|NCT01358721|42240862|FG001|Overall Study|Study Drug Toxicity|3|||
19783987|NCT01358721|42240863|FG002|Overall Study|Study Drug Toxicity|4|||
19783988|NCT01358721|42240864|FG003|Overall Study|Study Drug Toxicity|5|||
19783989|NCT01358721|42240861|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
19783990|NCT01358721|42240862|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
19783991|NCT01358721|42240863|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
19783992|NCT01358721|42240864|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
19783993|NCT01358721|42240861|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
19783994|NCT01358721|42240862|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
19783995|NCT01358721|42240863|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
19783996|NCT01358721|42240864|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
19783997|NCT01358721|42240861|FG000|Overall Study|Adverse Event related to study drug|1|||
19367385|NCT02456740|41607522|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19367386|NCT02456740|41607523|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19367387|NCT02456740|41607524|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19696035|NCT00309608|42141347|FG004|Overall Study|Lost to Follow-up|1|||
19696036|NCT00309608|42141343|FG000|Overall Study|Withdrawal by Subject|1|||
19696037|NCT00309608|42141344|FG001|Overall Study|Withdrawal by Subject|4|||
19696038|NCT00309608|42141345|FG002|Overall Study|Withdrawal by Subject|2|||
19696039|NCT00309608|42141346|FG003|Overall Study|Withdrawal by Subject|0|||
19696040|NCT00309608|42141347|FG004|Overall Study|Withdrawal by Subject|0|||
19696041|NCT00309608|42141343|FG000|Overall Study|Other incl. Lack of efficacy|10|||
19696042|NCT00309608|42141344|FG001|Overall Study|Other incl. Lack of efficacy|4|||
19696043|NCT00309608|42141345|FG002|Overall Study|Other incl. Lack of efficacy|3|||
19696044|NCT00309608|42141346|FG003|Overall Study|Other incl. Lack of efficacy|4|||
19696045|NCT00309608|42141347|FG004|Overall Study|Other incl. Lack of efficacy|0|||
19696046|NCT00309452|42141361|FG000|Overall Study|Withdrawal by Subject|3|||
19696047|NCT00309452|42141362|FG001|Overall Study|Withdrawal by Subject|0|||
19696048|NCT00308750|42141371|FG000|Overall Study|Adverse Event|9|||
19696049|NCT00308750|42141372|FG001|Overall Study|Adverse Event|9|||
19696050|NCT00308750|42141373|FG002|Overall Study|Adverse Event|13|||
19696051|NCT00308750|42141371|FG000|Overall Study|Withdrawal by Subject|6|||
19696052|NCT00308750|42141372|FG001|Overall Study|Withdrawal by Subject|2|||
19696053|NCT00308750|42141373|FG002|Overall Study|Withdrawal by Subject|3|||
19696054|NCT00308750|42141371|FG000|Overall Study|Physician Decision|3|||
19696055|NCT00308750|42141372|FG001|Overall Study|Physician Decision|4|||
19696056|NCT00308750|42141373|FG002|Overall Study|Physician Decision|3|||
19696057|NCT00308750|42141371|FG000|Overall Study|Sponsor Decision|1|||
19367388|NCT02456740|41607525|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19696058|NCT00308750|42141372|FG001|Overall Study|Sponsor Decision|0|||
19696059|NCT00308750|42141373|FG002|Overall Study|Sponsor Decision|0|||
19696060|NCT00308750|42141371|FG000|Overall Study|Disease Progression|47|||
19696061|NCT00308750|42141372|FG001|Overall Study|Disease Progression|24|||
19696062|NCT00308750|42141373|FG002|Overall Study|Disease Progression|28|||
19783998|NCT01358721|42240862|FG001|Overall Study|Adverse Event related to study drug|0|||
19783999|NCT01358721|42240863|FG002|Overall Study|Adverse Event related to study drug|0|||
19696063|NCT00308750|42141371|FG000|Overall Study|Unrelated Complication|3|||
19696064|NCT00308750|42141372|FG001|Overall Study|Unrelated Complication|0|||
19696065|NCT00308750|42141373|FG002|Overall Study|Unrelated Complication|1|||
19696066|NCT00308750|42141371|FG000|Overall Study|Death|1|||
19696067|NCT00308750|42141372|FG001|Overall Study|Death|0|||
19696068|NCT00308750|42141373|FG002|Overall Study|Death|1|||
19696069|NCT00308750|42141371|FG000|Overall Study|Protocol Violation|1|||
19696070|NCT00308750|42141372|FG001|Overall Study|Protocol Violation|0|||
19696071|NCT00308750|42141373|FG002|Overall Study|Protocol Violation|0|||
19696072|NCT00308750|42141371|FG000|Overall Study|New Primary Disease Identified|1|||
19696073|NCT00308750|42141372|FG001|Overall Study|New Primary Disease Identified|1|||
19696074|NCT00308750|42141373|FG002|Overall Study|New Primary Disease Identified|0|||
19696075|NCT00489359|42141384|FG000|Overall Study|Death|0|||
19696076|NCT00489359|42141385|FG001|Overall Study|Death|2|||
19696077|NCT00489359|42141384|FG000|Overall Study|Progressive Disease|5|||
19696078|NCT00489359|42141385|FG001|Overall Study|Progressive Disease|6|||
19367389|NCT02456740|41607526|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19367390|NCT02456740|41607527|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19696079|NCT00489359|42141384|FG000|Overall Study|Lost to Follow-up|1|||
19696080|NCT00489359|42141385|FG001|Overall Study|Lost to Follow-up|0|||
19696081|NCT00489359|42141384|FG000|Overall Study|Withdrawal by Subject|1|||
19696082|NCT00489359|42141385|FG001|Overall Study|Withdrawal by Subject|5|||
19696083|NCT00489359|42141384|FG000|Overall Study|Adverse Event|0|||
19696084|NCT00489359|42141385|FG001|Overall Study|Adverse Event|16|||
19696085|NCT00481247|42141398|FG000|Overall Study|Death|0|||
19696086|NCT00481247|42141399|FG001|Overall Study|Death|1|||
19696087|NCT00481247|42141398|FG000|Overall Study|Disease progression|18|||
19696088|NCT00481247|42141399|FG001|Overall Study|Disease progression|22|||
19696089|NCT00481247|42141398|FG000|Overall Study|Intolerance|42|||
19696090|NCT00481247|42141399|FG001|Overall Study|Intolerance|17|||
19696091|NCT00481247|42141398|FG000|Overall Study|Treatment failure|10|||
19696092|NCT00481247|42141399|FG001|Overall Study|Treatment failure|14|||
19696093|NCT00481247|42141398|FG000|Overall Study|AE unrelated to study drug|13|||
19696094|NCT00481247|42141399|FG001|Overall Study|AE unrelated to study drug|4|||
19696095|NCT00481247|42141398|FG000|Overall Study|Withdrawal by Subject|8|||
19696096|NCT00481247|42141399|FG001|Overall Study|Withdrawal by Subject|13|||
19696097|NCT00481247|42141398|FG000|Overall Study|Pregnancy|2|||
19696098|NCT00481247|42141399|FG001|Overall Study|Pregnancy|1|||
19696099|NCT00481247|42141398|FG000|Overall Study|Lost to Follow-up|1|||
19696100|NCT00481247|42141399|FG001|Overall Study|Lost to Follow-up|2|||
19696101|NCT00481247|42141398|FG000|Overall Study|Poor compliance/noncompliance|1|||
19696102|NCT00481247|42141399|FG001|Overall Study|Poor compliance/noncompliance|7|||
19696103|NCT00481247|42141398|FG000|Overall Study|Administrative reason by sponsor|157|||
19696104|NCT00481247|42141399|FG001|Overall Study|Administrative reason by sponsor|162|||
19696105|NCT00481247|42141398|FG000|Overall Study|Varied|6|||
19696106|NCT00481247|42141399|FG001|Overall Study|Varied|15|||
19696107|NCT00481247|42141398|FG000|Overall Study|Did not receive treatment|1|||
19696108|NCT00481247|42141399|FG001|Overall Study|Did not receive treatment|2|||
19696109|NCT00480857|42141405|FG000|Overall Study|Lack of Efficacy|2|||
19696110|NCT00480779|42141411|FG000|Overall Study|Other|2|||
19696111|NCT00480779|42141412|FG001|Overall Study|Other|0|||
19696112|NCT00480779|42141411|FG000|Overall Study|Job and Health-related|0|||
19696113|NCT00480779|42141412|FG001|Overall Study|Job and Health-related|3|||
19696114|NCT00499031|42141418|FG000|Overall Study|Improper pre-protocol treatment|1|||
19696115|NCT00499031|42141418|FG000|Overall Study|Required test not done|1|||
19696116|NCT00499031|42141418|FG000|Overall Study|Never treated|1|||
19696117|NCT00498797|42141424|FG000|Overall Study|Withdrawal by Subject|4|||
19696118|NCT00498797|42141425|FG001|Overall Study|Withdrawal by Subject|2|||
19696119|NCT00498797|42141424|FG000|Overall Study|Adverse Event|12|||
19696120|NCT00498797|42141425|FG001|Overall Study|Adverse Event|5|||
19696121|NCT00498797|42141424|FG000|Overall Study|Condition under investigation worsened|19|||
19696122|NCT00498797|42141425|FG001|Overall Study|Condition under investigation worsened|21|||
19696123|NCT00498797|42141424|FG000|Overall Study|Other|3|||
19696124|NCT00498797|42141425|FG001|Overall Study|Other|1|||
19696125|NCT00498485|42141433|FG000|Overall Study|Adverse Event|1|||
19696126|NCT00498485|42141434|FG001|Overall Study|Adverse Event|5|||
19696127|NCT00480077|42141444|FG000|Overall Study|Death|19|||
19696128|NCT00480077|42141445|FG001|Overall Study|Death|15|||
19696129|NCT00480077|42141444|FG000|Overall Study|early exit|12|||
19696130|NCT00480077|42141445|FG001|Overall Study|early exit|11|||
19696131|NCT00498173|42141453|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
19696132|NCT00498173|42141454|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
19696133|NCT00498173|42141455|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
19696134|NCT00295620|42141465|FG000|Overall Study|Lost to Follow-up|9|||
19696135|NCT00295620|42141466|FG001|Overall Study|Lost to Follow-up|5|||
19696136|NCT00295620|42141465|FG000|Overall Study|Withdrawal by Subject|37|||
19696137|NCT00295620|42141466|FG001|Overall Study|Withdrawal by Subject|50|||
19367391|NCT02456740|41607528|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
19696138|NCT00295620|42141465|FG000|Overall Study|Death|206|||
19696139|NCT00295620|42141466|FG001|Overall Study|Death|207|||
19696140|NCT00295620|42141465|FG000|Overall Study|Other reasons|10|||
19696141|NCT00295620|42141466|FG001|Overall Study|Other reasons|9|||
19696142|NCT00295620|42141465|FG000|Overall Study|Discontinuation by sponsor|580|||
19696143|NCT00295620|42141466|FG001|Overall Study|Discontinuation by sponsor|593|||
19696144|NCT00295620|42141465|FG000|Overall Study|Protocol Violation|30|||
19696145|NCT00295620|42141466|FG001|Overall Study|Protocol Violation|32|||
19696146|NCT00310440|42141474|FG000|Overall Study|Lost to Follow-up|17|||
19696147|NCT00310440|42141475|FG001|Overall Study|Lost to Follow-up|8|||
19696148|NCT00310440|42141474|FG000|Overall Study|Withdrawal by Subject|2|||
19696149|NCT00310440|42141475|FG001|Overall Study|Withdrawal by Subject|1|||
19696150|NCT00310440|42141474|FG000|Overall Study|Missed 12 Month Visit|7|||
19696151|NCT00310440|42141475|FG001|Overall Study|Missed 12 Month Visit|4|||
19696152|NCT00304356|42141481|FG000|Nitazoxanide|Physician Decision|5|||
19696153|NCT00304356|42141481|FG000|Nitazoxanide|Physician Decision|1|||
19696154|NCT00304356|42141481|FG000|Nitazoxanide|number is 0|1|||
19696155|NCT00304356|42141481|FG000|Nitazoxanide|Physician Decision|1|||
19696156|NCT00304356|42141481|FG000|Nitazoxanide|Physician Decision|1|||
19696157|NCT00304356|42141481|FG000|Nitazoxanide|Physician Decision|1|||
19696158|NCT00321620|42141487|FG000|Overall Study|Death|269|||
19696159|NCT00321620|42141488|FG001|Overall Study|Death|294|||
19696160|NCT00321620|42141487|FG000|Overall Study|Withdrawal by Subject|164|||
19696161|NCT00321620|42141488|FG001|Overall Study|Withdrawal by Subject|147|||
19696162|NCT00321620|42141487|FG000|Overall Study|Disease progression|113|||
19696163|NCT00321620|42141488|FG001|Overall Study|Disease progression|117|||
19696164|NCT00321620|42141487|FG000|Overall Study|Adverse Event|43|||
19696165|NCT00321620|42141488|FG001|Overall Study|Adverse Event|56|||
19696166|NCT00321620|42141487|FG000|Overall Study|Lost to Follow-up|13|||
19696167|NCT00321620|42141488|FG001|Overall Study|Lost to Follow-up|9|||
19696168|NCT00321620|42141487|FG000|Overall Study|Physician Decision|4|||
19696169|NCT00321620|42141488|FG001|Overall Study|Physician Decision|1|||
19696170|NCT00321620|42141487|FG000|Overall Study|Noncompliance|14|||
19696171|NCT00321620|42141488|FG001|Overall Study|Noncompliance|7|||
19696172|NCT00321620|42141487|FG000|Overall Study|Protocol deviation|4|||
19696173|NCT00321620|42141488|FG001|Overall Study|Protocol deviation|3|||
19696174|NCT00321620|42141487|FG000|Overall Study|Ineligibility determined|2|||
19696175|NCT00321620|42141488|FG001|Overall Study|Ineligibility determined|3|||
19696176|NCT00321620|42141487|FG000|Overall Study|Participant request|75|||
19696177|NCT00321620|42141488|FG001|Overall Study|Participant request|52|||
19696178|NCT00321620|42141487|FG000|Overall Study|Other|42|||
19696179|NCT00321620|42141488|FG001|Overall Study|Other|33|||
19696180|NCT00304278|42141494|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
19696181|NCT00304278|42141494|FG000|Overall Study|PT had medical condition preventing TX|1|||
19696182|NCT00291018|42141501|FG000|Overall Study|Not Consented or Declined PAS|12|||
19696183|NCT00291018|42141502|FG001|Overall Study|Not Consented or Declined PAS|15|||
19696184|NCT00291018|42141503|FG002|Overall Study|Not Consented or Declined PAS|15|||
19696185|NCT00291018|42141501|FG000|Overall Study|Death|3|||
19696186|NCT00291018|42141502|FG001|Overall Study|Death|3|||
19696187|NCT00291018|42141503|FG002|Overall Study|Death|4|||
19696188|NCT00291018|42141501|FG000|Overall Study|Withdrawal by Subject|2|||
19696189|NCT00291018|42141502|FG001|Overall Study|Withdrawal by Subject|8|||
19696190|NCT00291018|42141503|FG002|Overall Study|Withdrawal by Subject|1|||
19696191|NCT00291018|42141501|FG000|Overall Study|Failures|5|||
19696192|NCT00291018|42141502|FG001|Overall Study|Failures|12|||
19696193|NCT00291018|42141503|FG002|Overall Study|Failures|5|||
19696194|NCT00291018|42141501|FG000|Overall Study|Lost to Follow-up|3|||
19696195|NCT00291018|42141502|FG001|Overall Study|Lost to Follow-up|4|||
19696196|NCT00291018|42141503|FG002|Overall Study|Lost to Follow-up|18|||
19696197|NCT00320606|42141514|FG000|Overall Study|Adverse Event|1|||
19696198|NCT00320606|42141514|FG000|Overall Study|Protocol Violation|1|||
19784000|NCT01358721|42240864|FG003|Overall Study|Adverse Event related to study drug|1|||
19784001|NCT01358721|42240861|FG000|Overall Study|Disease Progression|19|||
19784002|NCT01358721|42240862|FG001|Overall Study|Disease Progression|15|||
19784003|NCT01358721|42240863|FG002|Overall Study|Disease Progression|17|||
19784004|NCT01358721|42240864|FG003|Overall Study|Disease Progression|15|||
19784005|NCT01358721|42240861|FG000|Overall Study|Out of State/Unmet Criteria|0|||
19784006|NCT01358721|42240862|FG001|Overall Study|Out of State/Unmet Criteria|0|||
19784007|NCT01358721|42240863|FG002|Overall Study|Out of State/Unmet Criteria|1|||
19784008|NCT01358721|42240864|FG003|Overall Study|Out of State/Unmet Criteria|0|||
19784009|NCT01341639|42240876|FG000|Infant Series|Protocol Violation|1|||
19696199|NCT00320606|42141514|FG000|Overall Study|Withdrawal by Subject|1|||
19696200|NCT00307736|42141519|FG000|Overall Study|Adverse Event|0|||
19696201|NCT00307736|42141520|FG001|Overall Study|Adverse Event|0|||
19696202|NCT00307736|42141521|FG002|Overall Study|Adverse Event|1|||
19696203|NCT00307736|42141522|FG003|Overall Study|Adverse Event|3|||
19696204|NCT00307736|42141519|FG000|Overall Study|Withdrawal by Subject|0|||
19696205|NCT00307736|42141520|FG001|Overall Study|Withdrawal by Subject|0|||
19784010|NCT01341639|42240877|FG001|Infant Series|Protocol Violation|0|||
19784011|NCT01341639|42240876|FG000|Infant Series|Not Vaccinated|0|||
19784012|NCT01341639|42240877|FG001|Infant Series|Not Vaccinated|1|||
19784013|NCT01341639|42240876|FG000|Infant Series|Adverse Event|0|||
19784014|NCT01341639|42240877|FG001|Infant Series|Adverse Event|5|||
19696206|NCT00307736|42141521|FG002|Overall Study|Withdrawal by Subject|2|||
19696207|NCT00307736|42141522|FG003|Overall Study|Withdrawal by Subject|0|||
19696208|NCT00320528|42141536|FG000|Study Period II|Adverse Event|3|||
19696209|NCT00320528|42141537|FG001|Study Period II|Adverse Event|4|||
19696210|NCT00320528|42141538|FG002|Study Period II|Adverse Event|8|||
19696211|NCT00320528|42141536|FG000|Study Period II|Parent/Caregiver Decision|8|||
19696212|NCT00320528|42141537|FG001|Study Period II|Parent/Caregiver Decision|3|||
19696213|NCT00320528|42141538|FG002|Study Period II|Parent/Caregiver Decision|11|||
19696214|NCT00320528|42141536|FG000|Study Period II|Withdrawal by Subject|0|||
19696215|NCT00320528|42141537|FG001|Study Period II|Withdrawal by Subject|1|||
19696216|NCT00320528|42141538|FG002|Study Period II|Withdrawal by Subject|1|||
19696217|NCT00320528|42141536|FG000|Study Period II|Entry Criteria Exclusion|0|||
19696218|NCT00320528|42141537|FG001|Study Period II|Entry Criteria Exclusion|2|||
19696219|NCT00320528|42141538|FG002|Study Period II|Entry Criteria Exclusion|2|||
19696220|NCT00320528|42141536|FG000|Study Period III|Adverse Event|1|||
19696221|NCT00320528|42141537|FG001|Study Period III|Adverse Event|0|||
19696222|NCT00320528|42141538|FG002|Study Period III|Adverse Event|0|||
19696223|NCT00320528|42141536|FG000|Study Period III|Lost to Follow-up|1|||
19696224|NCT00320528|42141537|FG001|Study Period III|Lost to Follow-up|0|||
19696225|NCT00320528|42141538|FG002|Study Period III|Lost to Follow-up|0|||
19696226|NCT00320528|42141536|FG000|Study Period III|Withdrawal by Subject|1|||
19696227|NCT00320528|42141537|FG001|Study Period III|Withdrawal by Subject|1|||
19696228|NCT00320528|42141538|FG002|Study Period III|Withdrawal by Subject|2|||
19696229|NCT00320528|42141536|FG000|Study Period III|Lack of Efficacy|2|||
19696230|NCT00320528|42141537|FG001|Study Period III|Lack of Efficacy|0|||
19696231|NCT00320528|42141538|FG002|Study Period III|Lack of Efficacy|0|||
19696232|NCT00320528|42141536|FG000|Study Period III|Parent/Caregiver Decision|14|||
19696233|NCT00320528|42141537|FG001|Study Period III|Parent/Caregiver Decision|3|||
19696234|NCT00320528|42141538|FG002|Study Period III|Parent/Caregiver Decision|11|||
19696235|NCT00320528|42141536|FG000|Study Period III|Protocol Violation|0|||
19696236|NCT00320528|42141537|FG001|Study Period III|Protocol Violation|1|||
19696237|NCT00320528|42141538|FG002|Study Period III|Protocol Violation|0|||
19696238|NCT00320528|42141536|FG000|Study Period III|Physician Decision|0|||
19696239|NCT00320528|42141537|FG001|Study Period III|Physician Decision|1|||
19696240|NCT00320528|42141538|FG002|Study Period III|Physician Decision|2|||
19696241|NCT00320528|42141536|FG000|Study Period III|Sponsor Decision|0|||
19696242|NCT00320528|42141537|FG001|Study Period III|Sponsor Decision|0|||
19696243|NCT00320528|42141538|FG002|Study Period III|Sponsor Decision|1|||
19696244|NCT00320528|42141536|FG000|Study Period III|Atomoxetine Commercially Available|68|||
19696245|NCT00320528|42141537|FG001|Study Period III|Atomoxetine Commercially Available|25|||
19696246|NCT00320528|42141538|FG002|Study Period III|Atomoxetine Commercially Available|90|||
19696247|NCT00320372|42141549|FG000|Overall Study|Physician Decision|4|||
19696248|NCT00320372|42141550|FG001|Overall Study|Physician Decision|7|||
19696249|NCT00320372|42141549|FG000|Overall Study|Death|7|||
19696250|NCT00320372|42141550|FG001|Overall Study|Death|8|||
19696251|NCT00320372|42141549|FG000|Overall Study|Withdrawal by Subject|55|||
19696252|NCT00320372|42141550|FG001|Overall Study|Withdrawal by Subject|37|||
19696253|NCT00320372|42141549|FG000|Overall Study|Non-Compliance|40|||
19696254|NCT00320372|42141550|FG001|Overall Study|Non-Compliance|39|||
19696255|NCT00320372|42141549|FG000|Overall Study|Did not Meet (I/E)|3|||
19696256|NCT00320372|42141550|FG001|Overall Study|Did not Meet (I/E)|1|||
19696257|NCT00320372|42141549|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
19696258|NCT00320372|42141550|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
19696259|NCT00294762|42141566|FG000|Overall Study|Did not receive study treatment|3|||
19696260|NCT00294762|42141567|FG001|Overall Study|Did not receive study treatment|3|||
19696261|NCT00294684|42141575|FG000|Overall Study|Lost to Follow-up|5|||
19696262|NCT00294684|42141576|FG001|Overall Study|Lost to Follow-up|8|||
19696263|NCT00307034|42141584|FG000|Overall Study|Adverse Event|1|||
19696264|NCT00307034|42141585|FG001|Overall Study|Adverse Event|2|||
19696265|NCT00307034|42141584|FG000|Overall Study|Withdrawal by Subject|1|||
19696266|NCT00307034|42141585|FG001|Overall Study|Withdrawal by Subject|2|||
19696267|NCT00307034|42141584|FG000|Overall Study|Lost to Follow-up|0|||
19696268|NCT00307034|42141585|FG001|Overall Study|Lost to Follow-up|3|||
19696269|NCT00320216|42141596|FG000|Overall Study|Adverse Event|0|||
19696270|NCT00320216|42141597|FG001|Overall Study|Adverse Event|6|||
19696271|NCT00320216|42141598|FG002|Overall Study|Adverse Event|0|||
19696272|NCT00320216|42141599|FG003|Overall Study|Adverse Event|2|||
19696273|NCT00320216|42141600|FG004|Overall Study|Adverse Event|2|||
19696274|NCT00320216|42141596|FG000|Overall Study|Lack of Efficacy|6|||
19696275|NCT00320216|42141597|FG001|Overall Study|Lack of Efficacy|2|||
19696276|NCT00320216|42141598|FG002|Overall Study|Lack of Efficacy|1|||
19696277|NCT00320216|42141599|FG003|Overall Study|Lack of Efficacy|0|||
19696278|NCT00320216|42141600|FG004|Overall Study|Lack of Efficacy|1|||
19784015|NCT01341639|42240876|FG000|Infant Series|Withdrawal by Subject|11|||
19696279|NCT00320216|42141596|FG000|Overall Study|Lost to Follow-up|3|||
19696280|NCT00320216|42141597|FG001|Overall Study|Lost to Follow-up|0|||
19784016|NCT01341639|42240877|FG001|Infant Series|Withdrawal by Subject|8|||
19784017|NCT01341639|42240876|FG000|Infant Series|Lost to Follow-up|0|||
19784018|NCT01341639|42240877|FG001|Infant Series|Lost to Follow-up|2|||
19784019|NCT01341639|42240876|FG000|Infant Series|Site 0048 Participants|17|||
19784020|NCT01341639|42240877|FG001|Infant Series|Site 0048 Participants|16|||
19784021|NCT01341639|42240876|FG000|Interim Period|Withdrawal by Subject|6|||
19784022|NCT01341639|42240877|FG001|Interim Period|Withdrawal by Subject|7|||
19784023|NCT01341639|42240876|FG000|Interim Period|Lost to Follow-up|2|||
19784024|NCT01341639|42240877|FG001|Interim Period|Lost to Follow-up|0|||
19784025|NCT01341639|42240876|FG000|Interim Period|Physician Decision|0|||
19784026|NCT01341639|42240877|FG001|Interim Period|Physician Decision|1|||
19784027|NCT01341639|42240876|FG000|Interim Period|Protocol Violation|0|||
19784028|NCT01341639|42240877|FG001|Interim Period|Protocol Violation|1|||
19784029|NCT01341639|42240876|FG000|Post-Treatment|Withdrawal by Subject|0|||
19784030|NCT01341639|42240877|FG001|Post-Treatment|Withdrawal by Subject|1|||
19784031|NCT01341639|42240876|FG000|Post-Treatment|Adverse Event|0|||
19784032|NCT01341639|42240877|FG001|Post-Treatment|Adverse Event|2|||
19784033|NCT02628028|42240891|FG000|Dosing Period|Withdrawal by Subject|0|||
19784034|NCT02628028|42240892|FG001|Dosing Period|Withdrawal by Subject|0|||
19784035|NCT02628028|42240893|FG002|Dosing Period|Withdrawal by Subject|1|||
19784036|NCT02628028|42240894|FG003|Dosing Period|Withdrawal by Subject|0|||
19784037|NCT02628028|42240895|FG004|Dosing Period|Withdrawal by Subject|2|||
19696281|NCT00320216|42141598|FG002|Overall Study|Lost to Follow-up|0|||
19696282|NCT00320216|42141599|FG003|Overall Study|Lost to Follow-up|0|||
19696283|NCT00320216|42141600|FG004|Overall Study|Lost to Follow-up|0|||
19696284|NCT00320216|42141596|FG000|Overall Study|Other|7|||
19696285|NCT00320216|42141597|FG001|Overall Study|Other|2|||
19696286|NCT00320216|42141598|FG002|Overall Study|Other|5|||
19696287|NCT00320216|42141599|FG003|Overall Study|Other|1|||
19696288|NCT00320216|42141600|FG004|Overall Study|Other|3|||
19696289|NCT00290706|42141621|FG000|Overall Study|Withdrawal by Subject|2|||
19696290|NCT00290706|42141622|FG001|Overall Study|Withdrawal by Subject|0|||
19696291|NCT00290706|42141623|FG002|Overall Study|Withdrawal by Subject|0|||
19696292|NCT00290706|42141624|FG003|Overall Study|Withdrawal by Subject|0|||
19696293|NCT00290706|42141621|FG000|Overall Study|Progressive Disease|3|||
19696294|NCT00290706|42141622|FG001|Overall Study|Progressive Disease|5|||
19696295|NCT00290706|42141623|FG002|Overall Study|Progressive Disease|4|||
19696296|NCT00290706|42141624|FG003|Overall Study|Progressive Disease|10|||
19696297|NCT00290706|42141621|FG000|Overall Study|Adverse Event|0|||
19696298|NCT00290706|42141622|FG001|Overall Study|Adverse Event|1|||
19696299|NCT00290706|42141623|FG002|Overall Study|Adverse Event|2|||
19696300|NCT00290706|42141624|FG003|Overall Study|Adverse Event|0|||
19784038|NCT02628028|42240896|FG005|Dosing Period|Withdrawal by Subject|4|||
19784039|NCT02628028|42240897|FG006|Dosing Period|Withdrawal by Subject|1|||
19784040|NCT02628028|42240898|FG007|Dosing Period|Withdrawal by Subject|1|||
19784041|NCT02628028|42240891|FG000|Dosing Period|Adverse Event|0|||
19784042|NCT02628028|42240892|FG001|Dosing Period|Adverse Event|0|||
19784043|NCT02628028|42240893|FG002|Dosing Period|Adverse Event|0|||
19784044|NCT02628028|42240894|FG003|Dosing Period|Adverse Event|0|||
19784045|NCT02628028|42240895|FG004|Dosing Period|Adverse Event|2|||
19784046|NCT02628028|42240896|FG005|Dosing Period|Adverse Event|1|||
19696301|NCT00290706|42141621|FG000|Overall Study|Receive auto transplant or radiation|0|||
19696302|NCT00290706|42141622|FG001|Overall Study|Receive auto transplant or radiation|0|||
19696303|NCT00290706|42141623|FG002|Overall Study|Receive auto transplant or radiation|0|||
19696304|NCT00290706|42141624|FG003|Overall Study|Receive auto transplant or radiation|1|||
19784047|NCT02628028|42240897|FG006|Dosing Period|Adverse Event|3|||
19784048|NCT02628028|42240898|FG007|Dosing Period|Adverse Event|2|||
19784049|NCT02628028|42240891|FG000|Dosing Period|Death|0|||
19784050|NCT02628028|42240892|FG001|Dosing Period|Death|0|||
19784051|NCT02628028|42240893|FG002|Dosing Period|Death|0|||
19784052|NCT02628028|42240894|FG003|Dosing Period|Death|0|||
19784053|NCT02628028|42240895|FG004|Dosing Period|Death|0|||
19784054|NCT02628028|42240896|FG005|Dosing Period|Death|0|||
19784055|NCT02628028|42240897|FG006|Dosing Period|Death|0|||
19607341|NCT00668395|42056107|FG000|Overall Study|Physician Decision|1|||
19696305|NCT00290706|42141621|FG000|Overall Study|Physician Decision|0|||
19696306|NCT00290706|42141622|FG001|Overall Study|Physician Decision|0|||
19696307|NCT00290706|42141623|FG002|Overall Study|Physician Decision|0|||
19784056|NCT02628028|42240898|FG007|Dosing Period|Death|1|||
19784057|NCT02628028|42240891|FG000|Dosing Period|Lack of Efficacy|0|||
19784058|NCT02628028|42240892|FG001|Dosing Period|Lack of Efficacy|0|||
19784059|NCT02628028|42240893|FG002|Dosing Period|Lack of Efficacy|0|||
19784060|NCT02628028|42240894|FG003|Dosing Period|Lack of Efficacy|0|||
19784061|NCT02628028|42240895|FG004|Dosing Period|Lack of Efficacy|3|||
19784062|NCT02628028|42240896|FG005|Dosing Period|Lack of Efficacy|0|||
19784063|NCT02628028|42240897|FG006|Dosing Period|Lack of Efficacy|1|||
19784064|NCT02628028|42240898|FG007|Dosing Period|Lack of Efficacy|0|||
19784065|NCT02628028|42240891|FG000|Dosing Period|Study Terminated by Sponsor|0|||
19784066|NCT02628028|42240892|FG001|Dosing Period|Study Terminated by Sponsor|0|||
19784067|NCT02628028|42240893|FG002|Dosing Period|Study Terminated by Sponsor|0|||
19784068|NCT02628028|42240894|FG003|Dosing Period|Study Terminated by Sponsor|0|||
19784069|NCT02628028|42240895|FG004|Dosing Period|Study Terminated by Sponsor|7|||
19784070|NCT02628028|42240896|FG005|Dosing Period|Study Terminated by Sponsor|6|||
19784071|NCT02628028|42240897|FG006|Dosing Period|Study Terminated by Sponsor|7|||
19784072|NCT02628028|42240898|FG007|Dosing Period|Study Terminated by Sponsor|7|||
19784073|NCT02628028|42240891|FG000|Dosing Period|Physician Decision|0|||
19784074|NCT02628028|42240892|FG001|Dosing Period|Physician Decision|0|||
19784075|NCT02628028|42240893|FG002|Dosing Period|Physician Decision|0|||
19784076|NCT02628028|42240894|FG003|Dosing Period|Physician Decision|0|||
19784077|NCT02628028|42240895|FG004|Dosing Period|Physician Decision|0|||
19784078|NCT02628028|42240896|FG005|Dosing Period|Physician Decision|1|||
19784079|NCT02628028|42240897|FG006|Dosing Period|Physician Decision|0|||
19784080|NCT02628028|42240898|FG007|Dosing Period|Physician Decision|0|||
19784081|NCT02628028|42240891|FG000|Dosing Period|Site Terminated by Sponsor|0|||
19784082|NCT02628028|42240892|FG001|Dosing Period|Site Terminated by Sponsor|0|||
19784083|NCT02628028|42240893|FG002|Dosing Period|Site Terminated by Sponsor|0|||
19784084|NCT02628028|42240894|FG003|Dosing Period|Site Terminated by Sponsor|0|||
19784085|NCT02628028|42240895|FG004|Dosing Period|Site Terminated by Sponsor|0|||
19784086|NCT02628028|42240896|FG005|Dosing Period|Site Terminated by Sponsor|1|||
19784087|NCT02628028|42240897|FG006|Dosing Period|Site Terminated by Sponsor|1|||
19784088|NCT02628028|42240898|FG007|Dosing Period|Site Terminated by Sponsor|0|||
19784089|NCT02628028|42240891|FG000|Dosing Period|Lost to Follow-up|0|||
19784090|NCT02628028|42240892|FG001|Dosing Period|Lost to Follow-up|0|||
19784091|NCT02628028|42240893|FG002|Dosing Period|Lost to Follow-up|0|||
19784092|NCT02628028|42240894|FG003|Dosing Period|Lost to Follow-up|0|||
19784093|NCT02628028|42240895|FG004|Dosing Period|Lost to Follow-up|0|||
19784094|NCT02628028|42240896|FG005|Dosing Period|Lost to Follow-up|0|||
19784095|NCT02628028|42240897|FG006|Dosing Period|Lost to Follow-up|1|||
19784096|NCT02628028|42240898|FG007|Dosing Period|Lost to Follow-up|0|||
19784097|NCT02628028|42240891|FG000|Dosing Period|Other|0|||
19784098|NCT02628028|42240892|FG001|Dosing Period|Other|0|||
19784099|NCT02628028|42240893|FG002|Dosing Period|Other|0|||
19784100|NCT02628028|42240894|FG003|Dosing Period|Other|0|||
19784101|NCT02628028|42240895|FG004|Dosing Period|Other|2|||
19784102|NCT02628028|42240896|FG005|Dosing Period|Other|1|||
19696308|NCT00290706|42141624|FG003|Overall Study|Physician Decision|1|||
19696309|NCT00303186|42141635|FG000|Overall Study|Other|52|||
19696310|NCT00294060|42141639|FG000|Overall Study|Death|225|||
19696311|NCT00294060|42141639|FG000|Overall Study|Other|59|||
19696312|NCT00294060|42141639|FG000|Overall Study|Lost to Follow-up|55|||
19696313|NCT00294060|42141639|FG000|Overall Study|Withdrawal by Subject|11|||
19696314|NCT00294060|42141639|FG000|Overall Study|Physician Decision|797|||
19696315|NCT00294060|42141639|FG000|Overall Study|Medical condition|3|||
19696316|NCT00294060|42141639|FG000|Overall Study|Device explanted/not replaced|23|||
19696317|NCT00303108|42141646|FG000|Overall Study|Adverse Event|5|||
19696318|NCT00303108|42141647|FG001|Overall Study|Adverse Event|6|||
19696319|NCT00303108|42141648|FG002|Overall Study|Adverse Event|7|||
19784103|NCT02628028|42240897|FG006|Dosing Period|Other|2|||
19784104|NCT02628028|42240898|FG007|Dosing Period|Other|4|||
19784105|NCT02628028|42240891|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
19784106|NCT02628028|42240892|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
19784107|NCT02628028|42240893|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
19784108|NCT02628028|42240894|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
19784109|NCT02628028|42240895|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
19784110|NCT02628028|42240896|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
19784111|NCT02628028|42240897|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
19784112|NCT02628028|42240898|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
19784113|NCT02628028|42240891|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784114|NCT02628028|42240892|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784115|NCT02628028|42240893|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784116|NCT02628028|42240894|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784117|NCT02628028|42240895|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784118|NCT02628028|42240896|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
19784119|NCT02628028|42240897|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
19784120|NCT02628028|42240898|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
19784121|NCT02628028|42240891|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
19784122|NCT02628028|42240892|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
19784123|NCT02628028|42240893|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
19784124|NCT02628028|42240894|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
19696320|NCT00303108|42141646|FG000|Overall Study|Patient Request|4|||
19696321|NCT00303108|42141647|FG001|Overall Study|Patient Request|2|||
19696322|NCT00303108|42141648|FG002|Overall Study|Patient Request|8|||
19784125|NCT02628028|42240895|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
19696323|NCT00303108|42141646|FG000|Overall Study|Failed Entry|1|||
19696324|NCT00303108|42141647|FG001|Overall Study|Failed Entry|0|||
19696325|NCT00303108|42141648|FG002|Overall Study|Failed Entry|1|||
19696326|NCT00303108|42141646|FG000|Overall Study|ineligible|2|||
19696327|NCT00303108|42141647|FG001|Overall Study|ineligible|1|||
19696328|NCT00303108|42141648|FG002|Overall Study|ineligible|0|||
19696329|NCT00302952|42141657|FG000|Overall Study|Physician Decision|1|||
19696330|NCT00302952|42141658|FG001|Overall Study|Physician Decision|1|||
19696331|NCT00302952|42141657|FG000|Overall Study|Withdrawal by Subject|2|||
19696332|NCT00302952|42141658|FG001|Overall Study|Withdrawal by Subject|3|||
19696333|NCT00302952|42141657|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
19696334|NCT00302952|42141658|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
19696335|NCT00302718|42141668|FG000|Overall Study|Participant left the hospital|1|||
19784126|NCT02628028|42240896|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
19784127|NCT02628028|42240897|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
19784128|NCT02628028|42240898|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
19784129|NCT02628028|42240891|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
19784130|NCT02628028|42240892|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
19784131|NCT02628028|42240893|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
19696336|NCT00302718|42141669|FG001|Overall Study|Participant left the hospital|0|||
19696337|NCT00302718|42141670|FG002|Overall Study|Participant left the hospital|0|||
19784132|NCT02628028|42240894|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
19784133|NCT02628028|42240895|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
19784134|NCT02628028|42240896|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
19784135|NCT02628028|42240897|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
19784136|NCT02628028|42240898|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
19784137|NCT02628028|42240891|FG000|Long-term Extension (LTE) Period|Other|0|||
19784138|NCT02628028|42240892|FG001|Long-term Extension (LTE) Period|Other|0|||
19784139|NCT02628028|42240893|FG002|Long-term Extension (LTE) Period|Other|0|||
19784140|NCT02628028|42240894|FG003|Long-term Extension (LTE) Period|Other|0|||
19784141|NCT02628028|42240895|FG004|Long-term Extension (LTE) Period|Other|0|||
19784142|NCT02628028|42240896|FG005|Long-term Extension (LTE) Period|Other|3|||
19784143|NCT02628028|42240897|FG006|Long-term Extension (LTE) Period|Other|4|||
19784144|NCT02628028|42240898|FG007|Long-term Extension (LTE) Period|Other|3|||
19784145|NCT03977701|42240930|FG000|Overall Study|COVID-19 pandemic|0|||
19784146|NCT03977701|42240931|FG001|Overall Study|COVID-19 pandemic|0|||
19784147|NCT03977701|42240932|FG002|Overall Study|COVID-19 pandemic|0|||
19784148|NCT03977701|42240933|FG003|Overall Study|COVID-19 pandemic|0|||
19784149|NCT03977701|42240934|FG004|Overall Study|COVID-19 pandemic|0|||
19784150|NCT03977701|42240935|FG005|Overall Study|COVID-19 pandemic|1|||
19784151|NCT03977701|42240936|FG006|Overall Study|COVID-19 pandemic|0|||
19784152|NCT03977701|42240937|FG007|Overall Study|COVID-19 pandemic|1|||
19784153|NCT03977701|42240938|FG008|Overall Study|COVID-19 pandemic|0|||
19784154|NCT03977701|42240939|FG009|Overall Study|COVID-19 pandemic|0|||
19784155|NCT02814526|42240978|FG000|Overall Study|Adverse Event|4|||
19784156|NCT02814526|42240979|FG001|Overall Study|Adverse Event|3|||
19784157|NCT02814526|42240978|FG000|Overall Study|Death|1|||
19784158|NCT02814526|42240979|FG001|Overall Study|Death|1|||
19784159|NCT02814526|42240978|FG000|Overall Study|Lost to Follow-up|3|||
19784160|NCT02814526|42240979|FG001|Overall Study|Lost to Follow-up|4|||
19784161|NCT02814526|42240978|FG000|Overall Study|non site physician decision|1|||
19784162|NCT02814526|42240979|FG001|Overall Study|non site physician decision|0|||
19784163|NCT02814526|42240978|FG000|Overall Study|participant noncompliance|1|||
19784164|NCT02814526|42240979|FG001|Overall Study|participant noncompliance|1|||
19784165|NCT02814526|42240978|FG000|Overall Study|Withdrawal by Subject|20|||
19784166|NCT02814526|42240979|FG001|Overall Study|Withdrawal by Subject|14|||
19784167|NCT02814526|42240978|FG000|Overall Study|safety risk|2|||
19784168|NCT02814526|42240979|FG001|Overall Study|safety risk|1|||
19784169|NCT02814526|42240978|FG000|Overall Study|early termination-study terminated|1|||
19784170|NCT02814526|42240979|FG001|Overall Study|early termination-study terminated|2|||
19784171|NCT02814526|42240978|FG000|Overall Study|Other|0|||
19784172|NCT02814526|42240979|FG001|Overall Study|Other|4|||
19784173|NCT02329834|42240987|FG000|Overall Study|Physician Decision|1|||
19784174|NCT02329834|42240988|FG001|Overall Study|Physician Decision|0|||
19784175|NCT01340937|42240999|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
19784176|NCT01340937|42241000|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
19784177|NCT01340937|42241001|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
19784178|NCT01340937|42241002|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
19696338|NCT00302718|42141671|FG003|Overall Study|Participant left the hospital|1|||
19784179|NCT01340937|42240999|FG000|Period 1: Infant Series|Adverse Event|0|||
19784180|NCT01340937|42241000|FG001|Period 1: Infant Series|Adverse Event|1|||
19784181|NCT01340937|42241001|FG002|Period 1: Infant Series|Adverse Event|4|||
19784182|NCT01340937|42241002|FG003|Period 1: Infant Series|Adverse Event|0|||
19784183|NCT01340937|42240999|FG000|Period 1: Infant Series|Death|2|||
19784184|NCT01340937|42241000|FG001|Period 1: Infant Series|Death|0|||
19784185|NCT01340937|42241001|FG002|Period 1: Infant Series|Death|2|||
19784186|NCT01340937|42241002|FG003|Period 1: Infant Series|Death|0|||
19784187|NCT01340937|42240999|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
19784188|NCT01340937|42241000|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
19784189|NCT01340937|42241001|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
19784190|NCT01340937|42241002|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
19784191|NCT01340937|42240999|FG000|Period 1: Infant Series|Physician Decision|2|||
19784192|NCT01340937|42241000|FG001|Period 1: Infant Series|Physician Decision|3|||
19784193|NCT01340937|42241001|FG002|Period 1: Infant Series|Physician Decision|1|||
19784194|NCT01340937|42241002|FG003|Period 1: Infant Series|Physician Decision|0|||
19784195|NCT01340937|42240999|FG000|Period 1: Infant Series|Protocol Violation|1|||
19784196|NCT01340937|42241000|FG001|Period 1: Infant Series|Protocol Violation|4|||
19784197|NCT01340937|42241001|FG002|Period 1: Infant Series|Protocol Violation|4|||
19784198|NCT01340937|42241002|FG003|Period 1: Infant Series|Protocol Violation|3|||
19784199|NCT01340937|42240999|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
19784200|NCT01340937|42241000|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
19784201|NCT01340937|42241001|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
19784202|NCT01340937|42241002|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
19784203|NCT01340937|42240999|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
19784204|NCT01340937|42241000|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
19784205|NCT01340937|42241001|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
19784206|NCT01340937|42241002|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
19784207|NCT01340937|42240999|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
19784208|NCT01340937|42241000|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
19784209|NCT01340937|42241001|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
19784210|NCT01340937|42241002|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
19784211|NCT01340937|42240999|FG000|Period 2: Interim Period|Adverse Event|1|||
19784212|NCT01340937|42241000|FG001|Period 2: Interim Period|Adverse Event|0|||
19784213|NCT01340937|42241001|FG002|Period 2: Interim Period|Adverse Event|1|||
19784214|NCT01340937|42241002|FG003|Period 2: Interim Period|Adverse Event|0|||
19784215|NCT01340937|42240999|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
19784216|NCT01340937|42241000|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
19784217|NCT01340937|42241001|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
19784218|NCT01340937|42241002|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
19784219|NCT01340937|42240999|FG000|Period 2: Interim Period|Physician Decision|0|||
19784220|NCT01340937|42241000|FG001|Period 2: Interim Period|Physician Decision|1|||
19784221|NCT01340937|42241001|FG002|Period 2: Interim Period|Physician Decision|1|||
19784222|NCT01340937|42241002|FG003|Period 2: Interim Period|Physician Decision|0|||
19784223|NCT01340937|42240999|FG000|Period 2: Interim Period|Protocol Violation|5|||
19784224|NCT01340937|42241000|FG001|Period 2: Interim Period|Protocol Violation|3|||
19784225|NCT01340937|42241001|FG002|Period 2: Interim Period|Protocol Violation|6|||
19784226|NCT01340937|42241002|FG003|Period 2: Interim Period|Protocol Violation|3|||
19784227|NCT01340937|42240999|FG000|Period 2: Interim Period|Technical problems|4|||
19784228|NCT01340937|42241000|FG001|Period 2: Interim Period|Technical problems|4|||
19784229|NCT01340937|42241001|FG002|Period 2: Interim Period|Technical problems|6|||
19784230|NCT01340937|42241002|FG003|Period 2: Interim Period|Technical problems|3|||
19784231|NCT01340937|42240999|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
19784232|NCT01340937|42241000|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
19784233|NCT01340937|42241001|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
19784234|NCT01340937|42241002|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
19784235|NCT01340937|42240999|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
19784236|NCT01340937|42241000|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
19607342|NCT00668395|42056108|FG001|Overall Study|Physician Decision|1|||
19607343|NCT00668395|42056109|FG002|Overall Study|Physician Decision|0|||
19607344|NCT00668317|42056117|FG000|Overall Study|Adverse Event|2|||
19607345|NCT00670111|42056138|FG000|Enrollment to One Month|Testing Failure|0|||
19696339|NCT00302718|42141668|FG000|Overall Study|Withdrawal by Subject|0|||
19696340|NCT00302718|42141669|FG001|Overall Study|Withdrawal by Subject|1|||
19696341|NCT00302718|42141670|FG002|Overall Study|Withdrawal by Subject|0|||
19696342|NCT00302718|42141671|FG003|Overall Study|Withdrawal by Subject|0|||
19696343|NCT00302718|42141668|FG000|Overall Study|Participant left primary care setting|0|||
19696344|NCT00302718|42141669|FG001|Overall Study|Participant left primary care setting|0|||
19696345|NCT00302718|42141670|FG002|Overall Study|Participant left primary care setting|2|||
19696346|NCT00302718|42141671|FG003|Overall Study|Participant left primary care setting|1|||
19784237|NCT01340937|42241001|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
19784238|NCT01340937|42241002|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
19784239|NCT01340937|42240999|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
19784240|NCT01340937|42241000|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
19784241|NCT01340937|42241001|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
19784242|NCT01340937|42241002|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
19784243|NCT01340937|42240999|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
19784244|NCT01340937|42241000|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
19784245|NCT01340937|42241001|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
19784246|NCT01340937|42241002|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
19784247|NCT03029143|42241018|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
19784248|NCT03029143|42241019|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
19784249|NCT03029143|42241020|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
19784250|NCT03029143|42241018|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
19784251|NCT03029143|42241019|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
19784252|NCT03029143|42241020|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
19784253|NCT03029143|42241018|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
19784254|NCT03029143|42241019|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
19784255|NCT03029143|42241020|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
19784256|NCT03029143|42241018|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
19784257|NCT03029143|42241019|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
19784258|NCT03029143|42241020|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
19784259|NCT03029143|42241018|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
19784260|NCT03029143|42241019|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
19784261|NCT03029143|42241020|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
19784262|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
19784263|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
19784264|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
19784265|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
19784266|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
19784267|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
19784268|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
19696347|NCT00302328|42141689|FG000|Overall Study|Physician Decision|0|||
19696348|NCT00302328|42141690|FG001|Overall Study|Physician Decision|1|||
19696349|NCT00302328|42141691|FG002|Overall Study|Physician Decision|0|||
19696350|NCT00301080|42141702|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
19696351|NCT00301080|42141703|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
19696352|NCT00301080|42141704|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
19696353|NCT00301080|42141705|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
19696354|NCT00301080|42141706|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
19696355|NCT00290238|42141717|FG000|Overall Study|Study terminated|27|||
19696356|NCT00290238|42141718|FG001|Overall Study|Study terminated|27|||
19696357|NCT00290238|42141717|FG000|Overall Study|Lost to Follow-up|0|||
19696358|NCT00290238|42141718|FG001|Overall Study|Lost to Follow-up|1|||
19696359|NCT00290238|42141717|FG000|Overall Study|Withdrawal by Subject|15|||
19696360|NCT00290238|42141718|FG001|Overall Study|Withdrawal by Subject|13|||
19696361|NCT00289848|42141726|FG000|Overall Study|Adverse Event|6|||
19696362|NCT00289848|42141727|FG001|Overall Study|Adverse Event|4|||
19696363|NCT00289848|42141726|FG000|Overall Study|Death|1|||
19696364|NCT00289848|42141727|FG001|Overall Study|Death|0|||
19696365|NCT00289848|42141726|FG000|Overall Study|Lack of Efficacy|20|||
19696366|NCT00289848|42141727|FG001|Overall Study|Lack of Efficacy|24|||
19696367|NCT00289848|42141726|FG000|Overall Study|Lost to Follow-up|3|||
19696368|NCT00289848|42141727|FG001|Overall Study|Lost to Follow-up|1|||
19696369|NCT00289848|42141726|FG000|Overall Study|Protocol Violation|5|||
19696370|NCT00289848|42141727|FG001|Overall Study|Protocol Violation|2|||
19696371|NCT00289848|42141726|FG000|Overall Study|Withdrawal by Subject|5|||
19696372|NCT00289848|42141727|FG001|Overall Study|Withdrawal by Subject|11|||
19696373|NCT00289848|42141726|FG000|Overall Study|Patient Moved|6|||
19696374|NCT00289848|42141727|FG001|Overall Study|Patient Moved|2|||
19696375|NCT00289848|42141726|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
19696376|NCT00289848|42141727|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
19696377|NCT00289770|42141733|FG000|Year 15|Withdrawal by Subject|1|||
19696378|NCT00289536|42141737|FG000|Period 3|Lost to Follow-up|0|||
19696379|NCT00289536|42141738|FG001|Period 3|Lost to Follow-up|0|||
19696380|NCT00289536|42141739|FG002|Period 3|Lost to Follow-up|1|||
19784269|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
19784270|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
19784271|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
19784272|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
19784273|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
19784274|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
19784275|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
19784276|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
19696381|NCT00289458|42141748|FG000|Overall Study|Death|1|||
19696382|NCT00289458|42141749|FG001|Overall Study|Death|0|||
19696383|NCT00289458|42141750|FG002|Overall Study|Death|0|||
19696384|NCT00289458|42141748|FG000|Overall Study|Physician Decision|3|||
19784277|NCT03029143|42241018|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
19696385|NCT00289458|42141749|FG001|Overall Study|Physician Decision|4|||
19696386|NCT00289458|42141750|FG002|Overall Study|Physician Decision|2|||
19696387|NCT00289458|42141748|FG000|Overall Study|Withdrawal by Subject|2|||
19696388|NCT00289458|42141749|FG001|Overall Study|Withdrawal by Subject|2|||
19696389|NCT00289458|42141750|FG002|Overall Study|Withdrawal by Subject|4|||
19784278|NCT03029143|42241019|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
19784279|NCT03029143|42241020|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
19784280|NCT03028129|42241031|FG000|Overall Study|Adverse Event|13|||
19784281|NCT03028129|42241032|FG001|Overall Study|Adverse Event|2|||
19784282|NCT03028129|42241031|FG000|Overall Study|Lost to Follow-up|50|||
19784283|NCT03028129|42241032|FG001|Overall Study|Lost to Follow-up|38|||
19784284|NCT03028129|42241031|FG000|Overall Study|Physician Decision|0|||
19784285|NCT03028129|42241032|FG001|Overall Study|Physician Decision|1|||
19784286|NCT03028129|42241031|FG000|Overall Study|Protocol Violation|1|||
19784287|NCT03028129|42241032|FG001|Overall Study|Protocol Violation|1|||
19784288|NCT03028129|42241031|FG000|Overall Study|Withdrawal by Subject|62|||
19784289|NCT03028129|42241032|FG001|Overall Study|Withdrawal by Subject|45|||
19784290|NCT01309672|42241047|FG000|Overall Study|Lack of Efficacy|20|||
19696390|NCT00288912|42141761|FG000|Overall Study|Developed exclusion criterion|4|||
19696391|NCT00288912|42141762|FG001|Overall Study|Developed exclusion criterion|6|||
19696392|NCT00288912|42141763|FG002|Overall Study|Developed exclusion criterion|7|||
19696393|NCT00288912|42141761|FG000|Overall Study|Lost to Follow-up|9|||
19696394|NCT00288912|42141762|FG001|Overall Study|Lost to Follow-up|6|||
19696395|NCT00288912|42141763|FG002|Overall Study|Lost to Follow-up|9|||
19696396|NCT00288912|42141761|FG000|Overall Study|Withdrawal by Subject|4|||
19784291|NCT01309672|42241047|FG000|Overall Study|Other|9|||
19784292|NCT01309672|42241047|FG000|Overall Study|Adverse Event|5|||
19784293|NCT01309672|42241047|FG000|Overall Study|Withdrawal by Subject|3|||
19784294|NCT03026257|42241058|FG000|Overall Study|Adverse Event|3|||
19784295|NCT03026257|42241059|FG001|Overall Study|Adverse Event|0|||
19784296|NCT03026257|42241060|FG002|Overall Study|Adverse Event|0|||
19784297|NCT03026257|42241061|FG003|Overall Study|Adverse Event|0|||
19784298|NCT03026257|42241062|FG004|Overall Study|Adverse Event|0|||
19784299|NCT03026257|42241063|FG005|Overall Study|Adverse Event|0|||
19784300|NCT03026257|42241058|FG000|Overall Study|Lost to Follow-up|1|||
19784301|NCT03026257|42241059|FG001|Overall Study|Lost to Follow-up|0|||
19784302|NCT03026257|42241060|FG002|Overall Study|Lost to Follow-up|0|||
19784303|NCT03026257|42241061|FG003|Overall Study|Lost to Follow-up|0|||
19784304|NCT03026257|42241062|FG004|Overall Study|Lost to Follow-up|0|||
19607346|NCT00670111|42056139|FG001|Enrollment to One Month|Testing Failure|0|||
19607347|NCT00670111|42056140|FG002|Enrollment to One Month|Testing Failure|13|||
19696397|NCT00288912|42141762|FG001|Overall Study|Withdrawal by Subject|5|||
19696398|NCT00288912|42141763|FG002|Overall Study|Withdrawal by Subject|12|||
19696399|NCT00305864|42141775|FG000|Overall Study|Ineligible / No protocol treatment|0|||
19696400|NCT00305864|42141776|FG001|Overall Study|Ineligible / No protocol treatment|1|||
19696401|NCT00305864|42141777|FG002|Overall Study|Ineligible / No protocol treatment|1|||
19696402|NCT00305864|42141778|FG003|Overall Study|Ineligible / No protocol treatment|13|||
19696403|NCT00295880|42141788|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
19696404|NCT00295880|42141788|FG000|Overall Study|Unit randomization did not occur|1|||
19696405|NCT00319982|42141794|FG000|Overall Study|Withdrawal by Subject|1|||
19696406|NCT00319982|42141795|FG001|Overall Study|Withdrawal by Subject|0|||
19696407|NCT00319592|42141803|FG000|Overall Study|Protocol Violation|1|||
19696408|NCT00319592|42141804|FG001|Overall Study|Protocol Violation|0|||
19696409|NCT00319592|42141803|FG000|Overall Study|Physician Decision|0|||
19696410|NCT00319592|42141804|FG001|Overall Study|Physician Decision|1|||
19696411|NCT00295490|42141814|FG000|Overall Study|Protocol Violation|0|||
19696412|NCT00295490|42141815|FG001|Overall Study|Protocol Violation|0|||
19696413|NCT00295490|42141816|FG002|Overall Study|Protocol Violation|3|||
19696414|NCT00295490|42141817|FG003|Overall Study|Protocol Violation|3|||
19607348|NCT00670111|42056138|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
19607349|NCT00670111|42056139|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
19607350|NCT00670111|42056140|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
19607351|NCT00670111|42056138|FG000|Enrollment to One Month|Physician Decision|1|||
19607352|NCT00670111|42056139|FG001|Enrollment to One Month|Physician Decision|0|||
19607353|NCT00670111|42056140|FG002|Enrollment to One Month|Physician Decision|0|||
19607354|NCT00672139|42056150|FG000|Overall Study|Death|14|||
19607355|NCT00672139|42056151|FG001|Overall Study|Death|23|||
19696415|NCT00295490|42141814|FG000|Overall Study|Withdrawal by Subject|0|||
19696416|NCT00295490|42141815|FG001|Overall Study|Withdrawal by Subject|2|||
19784305|NCT03026257|42241063|FG005|Overall Study|Lost to Follow-up|0|||
19784306|NCT03026257|42241058|FG000|Overall Study|Protocol Violation|1|||
19784307|NCT03026257|42241059|FG001|Overall Study|Protocol Violation|0|||
19784308|NCT03026257|42241060|FG002|Overall Study|Protocol Violation|0|||
19784309|NCT03026257|42241061|FG003|Overall Study|Protocol Violation|1|||
19784310|NCT03026257|42241062|FG004|Overall Study|Protocol Violation|1|||
19784311|NCT03026257|42241063|FG005|Overall Study|Protocol Violation|0|||
19784312|NCT03026257|42241058|FG000|Overall Study|Withdrawal by Subject|1|||
19784313|NCT03026257|42241059|FG001|Overall Study|Withdrawal by Subject|1|||
19784314|NCT03026257|42241060|FG002|Overall Study|Withdrawal by Subject|0|||
19784315|NCT03026257|42241061|FG003|Overall Study|Withdrawal by Subject|0|||
19784316|NCT03026257|42241062|FG004|Overall Study|Withdrawal by Subject|0|||
19784317|NCT03026257|42241063|FG005|Overall Study|Withdrawal by Subject|0|||
19784318|NCT01670188|42241079|FG000|Overall Study|Death|0|||
19784319|NCT01670188|42241080|FG001|Overall Study|Death|1|||
19784320|NCT01933048|42241088|FG000|Overall Study|Lost to Follow-up|15|||
19784321|NCT01933048|42241089|FG001|Overall Study|Lost to Follow-up|18|||
19784322|NCT01933048|42241088|FG000|Overall Study|personal reasons|1|||
19784323|NCT01933048|42241089|FG001|Overall Study|personal reasons|1|||
19784324|NCT01933048|42241088|FG000|Overall Study|Protocol Violation|7|||
19784325|NCT01933048|42241089|FG001|Overall Study|Protocol Violation|8|||
19784326|NCT01933048|42241088|FG000|Overall Study|Physician Decision|1|||
19784327|NCT01933048|42241089|FG001|Overall Study|Physician Decision|0|||
19784328|NCT01933048|42241088|FG000|Overall Study|unknown reasons|1|||
19784329|NCT01933048|42241089|FG001|Overall Study|unknown reasons|1|||
19784330|NCT02751450|42241100|FG000|Overall Study|Adverse Event|1|||
19784331|NCT02751450|42241101|FG001|Overall Study|Adverse Event|0|||
19784332|NCT01515748|42241111|FG000|Overall Study|Withdrawal by Subject|32|||
19784333|NCT01515748|42241112|FG001|Overall Study|Withdrawal by Subject|41|||
19784334|NCT01515748|42241111|FG000|Overall Study|Lost to Follow-up|2|||
19784335|NCT01515748|42241112|FG001|Overall Study|Lost to Follow-up|4|||
19784336|NCT01515748|42241111|FG000|Overall Study|Ongoing|86|||
19784337|NCT01515748|42241112|FG001|Overall Study|Ongoing|90|||
19784338|NCT01358175|42241122|FG000|Overall Study|Death|1|||
19784339|NCT01358175|42241123|FG001|Overall Study|Death|0|||
19784340|NCT01358175|42241124|FG002|Overall Study|Death|1|||
19784341|NCT01358175|42241122|FG000|Overall Study|Withdrawal by Subject|9|||
19784342|NCT01358175|42241123|FG001|Overall Study|Withdrawal by Subject|5|||
19784343|NCT01358175|42241124|FG002|Overall Study|Withdrawal by Subject|10|||
19784344|NCT01358175|42241122|FG000|Overall Study|Technical issues|0|||
19784345|NCT01358175|42241123|FG001|Overall Study|Technical issues|1|||
19696417|NCT00295490|42141816|FG002|Overall Study|Withdrawal by Subject|0|||
19696418|NCT00295490|42141817|FG003|Overall Study|Withdrawal by Subject|1|||
19696419|NCT00295490|42141814|FG000|Overall Study|Lost to Follow-up|0|||
19696420|NCT00295490|42141815|FG001|Overall Study|Lost to Follow-up|0|||
19696421|NCT00295490|42141816|FG002|Overall Study|Lost to Follow-up|1|||
19696422|NCT00295490|42141817|FG003|Overall Study|Lost to Follow-up|0|||
19696423|NCT00295490|42141814|FG000|Overall Study|Adverse Event|1|||
19696424|NCT00295490|42141815|FG001|Overall Study|Adverse Event|0|||
19696425|NCT00295490|42141816|FG002|Overall Study|Adverse Event|0|||
19696426|NCT00295490|42141817|FG003|Overall Study|Adverse Event|0|||
19696427|NCT00295490|42141814|FG000|Overall Study|Other|0|||
19696428|NCT00295490|42141815|FG001|Overall Study|Other|2|||
19696429|NCT00295490|42141816|FG002|Overall Study|Other|0|||
19696430|NCT00295490|42141817|FG003|Overall Study|Other|1|||
19696431|NCT00305006|42141829|FG000|Overall Study|Withdrawal by Subject|1|||
19696432|NCT00305006|42141830|FG001|Overall Study|Withdrawal by Subject|0|||
19696433|NCT00305006|42141829|FG000|Overall Study|Failure to complete pretest|0|||
19696434|NCT00305006|42141830|FG001|Overall Study|Failure to complete pretest|1|||
19696435|NCT00319436|42141838|FG000|Overall Study|Withdrawal by Subject|6|||
19696436|NCT00319436|42141839|FG001|Overall Study|Withdrawal by Subject|7|||
19696437|NCT00319046|42141845|FG000|Overall Study|withdrawal of subject's consent|7|||
19696438|NCT00319046|42141845|FG000|Overall Study|administrative reason|1|||
19696439|NCT00303602|42141851|FG000|Overall Study|Adverse Event|2|||
19696440|NCT00303602|42141852|FG001|Overall Study|Adverse Event|2|||
19696441|NCT00303602|42141851|FG000|Overall Study|Withdrawal by Subject|5|||
19696442|NCT00303602|42141852|FG001|Overall Study|Withdrawal by Subject|6|||
19696443|NCT00303602|42141851|FG000|Overall Study|Lost to Follow-up|5|||
19696444|NCT00303602|42141852|FG001|Overall Study|Lost to Follow-up|2|||
19696445|NCT00303602|42141851|FG000|Overall Study|Protocol entry criteria not met|2|||
19696446|NCT00303602|42141852|FG001|Overall Study|Protocol entry criteria not met|2|||
19696447|NCT00303602|42141851|FG000|Overall Study|Physician Decision|2|||
19696448|NCT00303602|42141852|FG001|Overall Study|Physician Decision|1|||
19696449|NCT00303602|42141851|FG000|Overall Study|Noncompliance|2|||
19696450|NCT00303602|42141852|FG001|Overall Study|Noncompliance|2|||
19696451|NCT00303602|42141851|FG000|Overall Study|Protocol Violation|1|||
19696452|NCT00303602|42141852|FG001|Overall Study|Protocol Violation|0|||
19696453|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
19696454|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
19696455|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
19696456|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Death|1|||
19784346|NCT01358175|42241124|FG002|Overall Study|Technical issues|0|||
19784347|NCT01358175|42241122|FG000|Overall Study|Pregnancy|0|||
19784348|NCT01358175|42241123|FG001|Overall Study|Pregnancy|1|||
19784349|NCT01358175|42241124|FG002|Overall Study|Pregnancy|0|||
19784350|NCT01358175|42241122|FG000|Overall Study|Physician Decision|1|||
19784351|NCT01358175|42241123|FG001|Overall Study|Physician Decision|0|||
19784352|NCT01358175|42241124|FG002|Overall Study|Physician Decision|0|||
19696457|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Death|3|||
19696458|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Death|1|||
19696459|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
19784353|NCT01358175|42241122|FG000|Overall Study|Non Compliance with Study Treatment|0|||
19784354|NCT01358175|42241123|FG001|Overall Study|Non Compliance with Study Treatment|1|||
19784355|NCT01358175|42241124|FG002|Overall Study|Non Compliance with Study Treatment|1|||
19784356|NCT01358175|42241122|FG000|Overall Study|Lost to Follow-up|1|||
19784357|NCT01358175|42241123|FG001|Overall Study|Lost to Follow-up|1|||
19784358|NCT01358175|42241124|FG002|Overall Study|Lost to Follow-up|3|||
19784359|NCT01358175|42241122|FG000|Overall Study|Lack of Efficacy|3|||
19784360|NCT01358175|42241123|FG001|Overall Study|Lack of Efficacy|8|||
19784361|NCT01358175|42241124|FG002|Overall Study|Lack of Efficacy|6|||
19784362|NCT01358175|42241122|FG000|Overall Study|Adverse Event|6|||
19784363|NCT01358175|42241123|FG001|Overall Study|Adverse Event|11|||
19784364|NCT01358175|42241124|FG002|Overall Study|Adverse Event|11|||
19784365|NCT04116229|42241138|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
19784366|NCT04116229|42241139|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
19784367|NCT04116229|42241138|FG000|Overall Study|Scheduling not possible.|0|||
19784368|NCT04116229|42241139|FG001|Overall Study|Scheduling not possible.|1|||
19784369|NCT02833077|42241147|FG000|Overall Study|Adverse Event|1|||
19784370|NCT02833077|42241148|FG001|Overall Study|Adverse Event|2|||
19784371|NCT02833077|42241147|FG000|Overall Study|Lost to Follow-up|10|||
19607356|NCT00672139|42056150|FG000|Overall Study|Withdrawal by Subject|2|||
19607357|NCT00672139|42056151|FG001|Overall Study|Withdrawal by Subject|11|||
19607358|NCT00672139|42056150|FG000|Overall Study|Adverse Event|4|||
19607359|NCT00672139|42056151|FG001|Overall Study|Adverse Event|7|||
19607360|NCT00672139|42056150|FG000|Overall Study|Physician Decision|2|||
19607361|NCT00672139|42056151|FG001|Overall Study|Physician Decision|0|||
19607362|NCT00672139|42056150|FG000|Overall Study|Lack of Efficacy|4|||
19696460|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
19696461|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
19696462|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
19696463|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
19696464|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
19696465|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
19696466|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
19696467|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
19696468|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
19696469|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
19696470|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
19696471|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
19696472|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
19696473|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
19696474|NCT00299130|42141861|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
19696475|NCT00299130|42141862|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
19696476|NCT00299130|42141863|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
19696477|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
19696478|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
19696479|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
19696480|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
19784372|NCT02833077|42241148|FG001|Overall Study|Lost to Follow-up|1|||
19784373|NCT02833077|42241147|FG000|Overall Study|Personal Reasons|6|||
19784374|NCT02833077|42241148|FG001|Overall Study|Personal Reasons|4|||
19784375|NCT02833077|42241147|FG000|Overall Study|Protocol Deviation|0|||
19784376|NCT02833077|42241148|FG001|Overall Study|Protocol Deviation|1|||
19784377|NCT01355679|42241155|FG000|Overall Study|benign tumor types found at biopsy|2|||
19784378|NCT02832375|42241162|FG000|Overall Study|Lost to Follow-up|1|||
19784379|NCT02832375|42241163|FG001|Overall Study|Lost to Follow-up|0|||
19784380|NCT02832375|42241162|FG000|Overall Study|Withdrawal of Consent|1|||
19784381|NCT02832375|42241163|FG001|Overall Study|Withdrawal of Consent|0|||
19784382|NCT02925403|42241172|FG000|Overall Study|Lost to Follow-up|0|||
19784383|NCT02925403|42241173|FG001|Overall Study|Lost to Follow-up|1|||
19784384|NCT02626780|42241179|FG000|Overall Study|Withdrawal by Subject|3|||
19784385|NCT02831673|42241194|FG000|Overall Study|Adverse Event|6|||
19784386|NCT02831673|42241195|FG001|Overall Study|Adverse Event|4|||
19784387|NCT02831673|42241194|FG000|Overall Study|Lack of Efficacy|3|||
19784388|NCT02831673|42241195|FG001|Overall Study|Lack of Efficacy|1|||
19607363|NCT00672139|42056151|FG001|Overall Study|Lack of Efficacy|1|||
19784389|NCT02831673|42241194|FG000|Overall Study|Protocol Violation|5|||
19784390|NCT02831673|42241195|FG001|Overall Study|Protocol Violation|4|||
19784391|NCT02831673|42241194|FG000|Overall Study|Protocol Withdrawal Criterion Met|1|||
19784392|NCT02831673|42241195|FG001|Overall Study|Protocol Withdrawal Criterion Met|6|||
19607364|NCT00672139|42056150|FG000|Overall Study|Protocol Violation|1|||
19784393|NCT02831673|42241194|FG000|Overall Study|Lost to Follow-up|9|||
19784394|NCT02831673|42241195|FG001|Overall Study|Lost to Follow-up|6|||
19784395|NCT02831673|42241194|FG000|Overall Study|Physician Decision|6|||
19784396|NCT02831673|42241195|FG001|Overall Study|Physician Decision|3|||
19784397|NCT02831673|42241194|FG000|Overall Study|Withdrawal by Subject|6|||
19784398|NCT02831673|42241195|FG001|Overall Study|Withdrawal by Subject|4|||
19784399|NCT02831673|42241194|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320|||
19784400|NCT02831673|42241195|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330|||
19784401|NCT02830893|42241203|FG000|Overall Study|Relocation to out of the country|1|||
19784402|NCT02830893|42241204|FG001|Overall Study|Relocation to out of the country|0|||
19784403|NCT02830893|42241203|FG000|Overall Study|Lost to Follow-up|0|||
19784404|NCT02830893|42241204|FG001|Overall Study|Lost to Follow-up|2|||
19784405|NCT02830893|42241203|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
19784406|NCT02830893|42241204|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
19784407|NCT02625922|42241212|FG000|Overall Study|Non-availability of IMP|1|||
19784408|NCT02625922|42241213|FG001|Overall Study|Non-availability of IMP|1|||
19784409|NCT02625922|42241212|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
19784410|NCT02625922|42241213|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
19784411|NCT03350035|42241225|FG000|Overall Study|Lack of Efficacy|2|||
19784412|NCT03350035|42241226|FG001|Overall Study|Lack of Efficacy|0|||
19784413|NCT03350035|42241227|FG002|Overall Study|Lack of Efficacy|0|||
19784414|NCT03350035|42241225|FG000|Overall Study|Subject discharged to hospice|0|||
19784415|NCT03350035|42241226|FG001|Overall Study|Subject discharged to hospice|0|||
19784416|NCT03350035|42241227|FG002|Overall Study|Subject discharged to hospice|1|||
19784417|NCT01358331|42241261|FG000|Overall Study|Lost to Follow-up|0|||
19784418|NCT01358331|42241262|FG001|Overall Study|Lost to Follow-up|0|||
19784419|NCT01358331|42241263|FG002|Overall Study|Lost to Follow-up|0|||
19784420|NCT01358331|42241264|FG003|Overall Study|Lost to Follow-up|1|||
19784421|NCT01358331|42241265|FG004|Overall Study|Lost to Follow-up|0|||
19784422|NCT01358331|42241266|FG005|Overall Study|Lost to Follow-up|0|||
19784423|NCT01358331|42241261|FG000|Overall Study|Withdrawal by Subject|0|||
19784424|NCT01358331|42241262|FG001|Overall Study|Withdrawal by Subject|0|||
19784425|NCT01358331|42241263|FG002|Overall Study|Withdrawal by Subject|0|||
19784426|NCT01358331|42241264|FG003|Overall Study|Withdrawal by Subject|1|||
19784427|NCT01358331|42241265|FG004|Overall Study|Withdrawal by Subject|1|||
19784428|NCT01358331|42241266|FG005|Overall Study|Withdrawal by Subject|1|||
19784429|NCT01358331|42241261|FG000|Overall Study|Adverse Events|1|||
19784430|NCT01358331|42241262|FG001|Overall Study|Adverse Events|1|||
19784431|NCT01358331|42241263|FG002|Overall Study|Adverse Events|1|||
19784432|NCT01358331|42241264|FG003|Overall Study|Adverse Events|0|||
19784433|NCT01358331|42241265|FG004|Overall Study|Adverse Events|1|||
19784434|NCT01358331|42241266|FG005|Overall Study|Adverse Events|5|||
19784435|NCT01358331|42241261|FG000|Overall Study|Symptomatic Deterioration|0|||
19784436|NCT01358331|42241262|FG001|Overall Study|Symptomatic Deterioration|0|||
19784437|NCT01358331|42241263|FG002|Overall Study|Symptomatic Deterioration|0|||
19784438|NCT01358331|42241264|FG003|Overall Study|Symptomatic Deterioration|0|||
19784439|NCT01358331|42241265|FG004|Overall Study|Symptomatic Deterioration|1|||
19784440|NCT01358331|42241266|FG005|Overall Study|Symptomatic Deterioration|0|||
19784441|NCT01358331|42241261|FG000|Overall Study|Participants did not wish to continue|0|||
19784442|NCT01358331|42241262|FG001|Overall Study|Participants did not wish to continue|0|||
19784443|NCT01358331|42241263|FG002|Overall Study|Participants did not wish to continue|0|||
19784444|NCT01358331|42241264|FG003|Overall Study|Participants did not wish to continue|0|||
19784445|NCT01358331|42241265|FG004|Overall Study|Participants did not wish to continue|1|||
19784446|NCT01358331|42241266|FG005|Overall Study|Participants did not wish to continue|0|||
19784447|NCT01358331|42241261|FG000|Overall Study|Progress of disease under investigation|1|||
19784448|NCT01358331|42241262|FG001|Overall Study|Progress of disease under investigation|2|||
19784449|NCT01358331|42241263|FG002|Overall Study|Progress of disease under investigation|3|||
19784450|NCT01358331|42241264|FG003|Overall Study|Progress of disease under investigation|1|||
19784451|NCT01358331|42241265|FG004|Overall Study|Progress of disease under investigation|3|||
19784452|NCT01358331|42241266|FG005|Overall Study|Progress of disease under investigation|0|||
19784453|NCT02828241|42241282|FG000|Overall Study|Adverse Event|7|||
19784454|NCT02828241|42241283|FG001|Overall Study|Adverse Event|2|||
19784455|NCT02828241|42241282|FG000|Overall Study|Protocol Violation|1|||
19389181|NCT02053792|41632810|FG000|Overall Study|Withdrawal by Subject|2|||
19784456|NCT02828241|42241283|FG001|Overall Study|Protocol Violation|0|||
19784457|NCT01355523|42241292|FG000|Overall Study|Withdrawal by Subject|1|||
19784458|NCT01355523|42241293|FG001|Overall Study|Withdrawal by Subject|4|||
19784459|NCT01355523|42241292|FG000|Overall Study|Lost to Follow-up|0|||
19784460|NCT01355523|42241293|FG001|Overall Study|Lost to Follow-up|2|||
19784461|NCT01355523|42241292|FG000|Overall Study|Protocol Violation|0|||
19784462|NCT01355523|42241293|FG001|Overall Study|Protocol Violation|2|||
19784463|NCT01355523|42241292|FG000|Overall Study|Adverse Event|0|||
19784464|NCT01355523|42241293|FG001|Overall Study|Adverse Event|2|||
19784465|NCT02625220|42241299|FG000|Overall Study|Adverse Event|2|||
19784466|NCT02625220|42241299|FG000|Overall Study|Lost to Follow-up|2|||
19784467|NCT02625220|42241299|FG000|Overall Study|Protocol Violation|1|||
19784468|NCT02625220|42241299|FG000|Overall Study|Study discontinued at site|2|||
19784469|NCT02826603|42241305|FG000|Overall Study|Adverse Event|17|||
19784470|NCT02826603|42241306|FG001|Overall Study|Adverse Event|9|||
19784471|NCT02826603|42241305|FG000|Overall Study|Lack of Efficacy|4|||
19784472|NCT02826603|42241306|FG001|Overall Study|Lack of Efficacy|9|||
19784473|NCT02826603|42241305|FG000|Overall Study|Lost to Follow-up|13|||
19696481|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
19696482|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
19696483|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
19696484|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
19696485|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
19696486|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
19696487|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
19696488|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
19696489|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
19696490|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
19696491|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
19696492|NCT00299130|42141861|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
19696493|NCT00299130|42141862|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
19696494|NCT00299130|42141863|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
19696495|NCT00299130|42141861|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
19696496|NCT00299130|42141862|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
19784474|NCT02826603|42241306|FG001|Overall Study|Lost to Follow-up|12|||
19784475|NCT02826603|42241305|FG000|Overall Study|Noncompliance with treatment|0|||
19784476|NCT02826603|42241306|FG001|Overall Study|Noncompliance with treatment|2|||
19784477|NCT02826603|42241305|FG000|Overall Study|Physician Decision|1|||
19784478|NCT02826603|42241306|FG001|Overall Study|Physician Decision|7|||
19784479|NCT02826603|42241305|FG000|Overall Study|Pregnancy|1|||
19784480|NCT02826603|42241306|FG001|Overall Study|Pregnancy|2|||
19784481|NCT02826603|42241305|FG000|Overall Study|Protocol Violation|3|||
19784482|NCT02826603|42241306|FG001|Overall Study|Protocol Violation|3|||
19784483|NCT02826603|42241305|FG000|Overall Study|Withdrawal by Subject|20|||
19784484|NCT02826603|42241306|FG001|Overall Study|Withdrawal by Subject|19|||
19784485|NCT02826603|42241305|FG000|Overall Study|Death|2|||
19696497|NCT00299130|42141863|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
19696498|NCT00299130|42141861|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
19696499|NCT00299130|42141862|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
19696500|NCT00299130|42141863|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
19696501|NCT00299130|42141861|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
19696502|NCT00299130|42141862|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
19784486|NCT02826603|42241306|FG001|Overall Study|Death|0|||
19784487|NCT02826603|42241305|FG000|Overall Study|New therapy for study indication|0|||
19784488|NCT02826603|42241306|FG001|Overall Study|New therapy for study indication|1|||
19784489|NCT01329900|42241313|FG000|Overall Study|Elevated creatinine/renal function|1|||
19784490|NCT02825043|42241317|FG000|Overall Study|Lost to Follow-up|4|||
19784491|NCT02744391|42241321|FG000|Overall Study|Lost to Follow-up|9|||
19784492|NCT02744391|42241321|FG000|Overall Study|Physician Decision|2|||
19784493|NCT02744391|42241321|FG000|Overall Study|Withdrawal by Subject|3|||
19784494|NCT02750592|42241336|FG000|Overall Study|Adverse Event|3|||
19784495|NCT02750592|42241336|FG000|Overall Study|Lack of Efficacy|2|||
19784496|NCT02624986|42241348|FG000|Overall Study|Death|0|||
19784497|NCT02624986|42241349|FG001|Overall Study|Death|1|||
19784498|NCT02624986|42241350|FG002|Overall Study|Death|2|||
19784499|NCT02624986|42241351|FG003|Overall Study|Death|2|||
19784500|NCT02624986|42241352|FG004|Overall Study|Death|2|||
19784501|NCT02624986|42241353|FG005|Overall Study|Death|0|||
19784502|NCT02624986|42241354|FG006|Overall Study|Death|0|||
19784503|NCT02624986|42241355|FG007|Overall Study|Death|1|||
19784504|NCT02624986|42241348|FG000|Overall Study|Study Terminated by Sponsor|1|||
19784505|NCT02624986|42241349|FG001|Overall Study|Study Terminated by Sponsor|1|||
19784506|NCT02624986|42241350|FG002|Overall Study|Study Terminated by Sponsor|0|||
19784507|NCT02624986|42241351|FG003|Overall Study|Study Terminated by Sponsor|1|||
19784508|NCT02624986|42241352|FG004|Overall Study|Study Terminated by Sponsor|2|||
19784509|NCT02624986|42241353|FG005|Overall Study|Study Terminated by Sponsor|2|||
19784510|NCT02624986|42241354|FG006|Overall Study|Study Terminated by Sponsor|4|||
19784511|NCT02624986|42241355|FG007|Overall Study|Study Terminated by Sponsor|3|||
19784512|NCT02624986|42241348|FG000|Overall Study|Progressive Disease|0|||
19784513|NCT02624986|42241349|FG001|Overall Study|Progressive Disease|1|||
19784514|NCT02624986|42241350|FG002|Overall Study|Progressive Disease|0|||
19784515|NCT02624986|42241351|FG003|Overall Study|Progressive Disease|0|||
19784516|NCT02624986|42241352|FG004|Overall Study|Progressive Disease|0|||
19784517|NCT02624986|42241353|FG005|Overall Study|Progressive Disease|0|||
19784518|NCT02624986|42241354|FG006|Overall Study|Progressive Disease|0|||
19784519|NCT02624986|42241355|FG007|Overall Study|Progressive Disease|0|||
19784520|NCT02624986|42241348|FG000|Overall Study|Protocol Violation|1|||
19784521|NCT02624986|42241349|FG001|Overall Study|Protocol Violation|0|||
19784522|NCT02624986|42241350|FG002|Overall Study|Protocol Violation|0|||
19784523|NCT02624986|42241351|FG003|Overall Study|Protocol Violation|0|||
19784524|NCT02624986|42241352|FG004|Overall Study|Protocol Violation|0|||
19784525|NCT02624986|42241353|FG005|Overall Study|Protocol Violation|0|||
19784526|NCT02624986|42241354|FG006|Overall Study|Protocol Violation|0|||
19784527|NCT02624986|42241355|FG007|Overall Study|Protocol Violation|0|||
19784528|NCT02624986|42241348|FG000|Overall Study|Withdrawal by Subject|0|||
19784529|NCT02624986|42241349|FG001|Overall Study|Withdrawal by Subject|0|||
19784530|NCT02624986|42241350|FG002|Overall Study|Withdrawal by Subject|0|||
19784531|NCT02624986|42241351|FG003|Overall Study|Withdrawal by Subject|0|||
19784532|NCT02624986|42241352|FG004|Overall Study|Withdrawal by Subject|0|||
19784533|NCT02624986|42241353|FG005|Overall Study|Withdrawal by Subject|0|||
19784534|NCT02624986|42241354|FG006|Overall Study|Withdrawal by Subject|0|||
19784535|NCT02624986|42241355|FG007|Overall Study|Withdrawal by Subject|1|||
19784536|NCT02587598|42241388|FG000|Overall Study|Death|4|||
19784537|NCT02587598|42241389|FG001|Overall Study|Death|8|||
19784538|NCT02587598|42241390|FG002|Overall Study|Death|4|||
19784539|NCT02587598|42241391|FG003|Overall Study|Death|16|||
19784540|NCT02587598|42241392|FG004|Overall Study|Death|9|||
19784541|NCT02587598|42241393|FG005|Overall Study|Death|4|||
19784542|NCT02587598|42241394|FG006|Overall Study|Death|6|||
19784543|NCT02587598|42241395|FG007|Overall Study|Death|7|||
19784544|NCT02587598|42241396|FG008|Overall Study|Death|9|||
19784545|NCT02587598|42241397|FG009|Overall Study|Death|1|||
19784546|NCT02587598|42241398|FG010|Overall Study|Death|3|||
19784547|NCT02587598|42241388|FG000|Overall Study|Study Terminated by the Sponsor|0|||
19784548|NCT02587598|42241389|FG001|Overall Study|Study Terminated by the Sponsor|1|||
19784549|NCT02587598|42241390|FG002|Overall Study|Study Terminated by the Sponsor|0|||
19784550|NCT02587598|42241391|FG003|Overall Study|Study Terminated by the Sponsor|3|||
19784551|NCT02587598|42241392|FG004|Overall Study|Study Terminated by the Sponsor|0|||
19784552|NCT02587598|42241393|FG005|Overall Study|Study Terminated by the Sponsor|1|||
19784553|NCT02587598|42241394|FG006|Overall Study|Study Terminated by the Sponsor|0|||
19784554|NCT02587598|42241395|FG007|Overall Study|Study Terminated by the Sponsor|0|||
19784555|NCT02587598|42241396|FG008|Overall Study|Study Terminated by the Sponsor|0|||
19784556|NCT02587598|42241397|FG009|Overall Study|Study Terminated by the Sponsor|1|||
19784557|NCT02587598|42241398|FG010|Overall Study|Study Terminated by the Sponsor|6|||
19784558|NCT02587598|42241388|FG000|Overall Study|Reason for study withdrawal not specified|0|||
19784559|NCT02587598|42241389|FG001|Overall Study|Reason for study withdrawal not specified|1|||
19784560|NCT02587598|42241390|FG002|Overall Study|Reason for study withdrawal not specified|0|||
19784561|NCT02587598|42241391|FG003|Overall Study|Reason for study withdrawal not specified|0|||
19784562|NCT02587598|42241392|FG004|Overall Study|Reason for study withdrawal not specified|0|||
19784563|NCT02587598|42241393|FG005|Overall Study|Reason for study withdrawal not specified|0|||
19784564|NCT02587598|42241394|FG006|Overall Study|Reason for study withdrawal not specified|0|||
19784565|NCT02587598|42241395|FG007|Overall Study|Reason for study withdrawal not specified|0|||
19784566|NCT02587598|42241396|FG008|Overall Study|Reason for study withdrawal not specified|0|||
19784567|NCT02587598|42241397|FG009|Overall Study|Reason for study withdrawal not specified|0|||
19784568|NCT02587598|42241398|FG010|Overall Study|Reason for study withdrawal not specified|0|||
19784569|NCT02587598|42241388|FG000|Overall Study|Withdrawal by Subject|0|||
19696503|NCT00299130|42141863|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
19696504|NCT00288054|42141878|FG000|Overall Study|Protocol Violation|2|||
19696505|NCT00288054|42141878|FG000|Overall Study|Lack of Efficacy|16|||
19696506|NCT00288054|42141878|FG000|Overall Study|Adverse Event|3|||
19696507|NCT00288054|42141878|FG000|Overall Study|Withdrawal by Subject|1|||
19696508|NCT00288054|42141878|FG000|Overall Study|Not protocol specified|2|||
19696509|NCT00287586|42141886|FG000|Overall Study|Withdrew Consent|19|||
19696510|NCT00287586|42141887|FG001|Overall Study|Withdrew Consent|30|||
19696511|NCT00287586|42141886|FG000|Overall Study|Lost to Follow-up|5|||
19696512|NCT00287586|42141887|FG001|Overall Study|Lost to Follow-up|4|||
19696513|NCT00287586|42141886|FG000|Overall Study|Death|2|||
19696514|NCT00287586|42141887|FG001|Overall Study|Death|3|||
19696515|NCT00287586|42141886|FG000|Overall Study|Elevated Hematocrit|3|||
19696516|NCT00287586|42141887|FG001|Overall Study|Elevated Hematocrit|0|||
19696517|NCT00287586|42141886|FG000|Overall Study|Rash|3|||
19696518|NCT00287586|42141887|FG001|Overall Study|Rash|0|||
19784570|NCT02587598|42241389|FG001|Overall Study|Withdrawal by Subject|1|||
19784571|NCT02587598|42241390|FG002|Overall Study|Withdrawal by Subject|0|||
19784572|NCT02587598|42241391|FG003|Overall Study|Withdrawal by Subject|2|||
19784573|NCT02587598|42241392|FG004|Overall Study|Withdrawal by Subject|3|||
19784574|NCT02587598|42241393|FG005|Overall Study|Withdrawal by Subject|1|||
19784575|NCT02587598|42241394|FG006|Overall Study|Withdrawal by Subject|0|||
19784576|NCT02587598|42241395|FG007|Overall Study|Withdrawal by Subject|0|||
19784577|NCT02587598|42241396|FG008|Overall Study|Withdrawal by Subject|0|||
19784578|NCT02587598|42241397|FG009|Overall Study|Withdrawal by Subject|1|||
19784579|NCT02587598|42241398|FG010|Overall Study|Withdrawal by Subject|2|||
19696519|NCT00287586|42141886|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
19696520|NCT00287586|42141887|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
19696521|NCT00287586|42141886|FG000|Overall Study|Stroke|2|||
19696522|NCT00287586|42141887|FG001|Overall Study|Stroke|0|||
19696523|NCT00287586|42141886|FG000|Overall Study|Myocardial Infarction|1|||
19696524|NCT00287586|42141887|FG001|Overall Study|Myocardial Infarction|0|||
19696525|NCT00287586|42141886|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
19696526|NCT00287586|42141887|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
19696527|NCT00287586|42141886|FG000|Overall Study|Cognitive Impairment|1|||
19784580|NCT02587598|42241388|FG000|Overall Study|Physician Decision|0|||
19784581|NCT02587598|42241389|FG001|Overall Study|Physician Decision|0|||
19784582|NCT02587598|42241390|FG002|Overall Study|Physician Decision|0|||
19784583|NCT02587598|42241391|FG003|Overall Study|Physician Decision|0|||
19696528|NCT00287586|42141887|FG001|Overall Study|Cognitive Impairment|0|||
19696529|NCT00287586|42141886|FG000|Overall Study|Pancreatic Cancer|1|||
19696530|NCT00287586|42141887|FG001|Overall Study|Pancreatic Cancer|3|||
19696531|NCT00287586|42141886|FG000|Overall Study|Sleep Apnea|1|||
19784584|NCT02587598|42241392|FG004|Overall Study|Physician Decision|0|||
19784585|NCT02587598|42241393|FG005|Overall Study|Physician Decision|0|||
19784586|NCT02587598|42241394|FG006|Overall Study|Physician Decision|0|||
19784587|NCT02587598|42241395|FG007|Overall Study|Physician Decision|0|||
19784588|NCT02587598|42241396|FG008|Overall Study|Physician Decision|0|||
19607365|NCT00672139|42056151|FG001|Overall Study|Protocol Violation|1|||
19607366|NCT00672139|42056150|FG000|Overall Study|hospice discharge, caregiver requests|3|||
19607367|NCT00672139|42056151|FG001|Overall Study|hospice discharge, caregiver requests|2|||
19607368|NCT00570739|42056161|FG000|Overall Study|Adverse Event|8|||
19607369|NCT00570739|42056162|FG001|Overall Study|Adverse Event|6|||
19607370|NCT00570739|42056163|FG002|Overall Study|Adverse Event|2|||
19607371|NCT00570739|42056164|FG003|Overall Study|Adverse Event|2|||
19607372|NCT00570739|42056161|FG000|Overall Study|Lost to Follow-up|4|||
19607373|NCT00570739|42056162|FG001|Overall Study|Lost to Follow-up|5|||
19607374|NCT00570739|42056163|FG002|Overall Study|Lost to Follow-up|4|||
19607375|NCT00570739|42056164|FG003|Overall Study|Lost to Follow-up|1|||
19607376|NCT00570739|42056161|FG000|Overall Study|Physician Decision|1|||
19607377|NCT00570739|42056162|FG001|Overall Study|Physician Decision|1|||
19607378|NCT00570739|42056163|FG002|Overall Study|Physician Decision|0|||
19607379|NCT00570739|42056164|FG003|Overall Study|Physician Decision|0|||
19607380|NCT00570739|42056161|FG000|Overall Study|Withdrawal by Subject|7|||
19607381|NCT00570739|42056162|FG001|Overall Study|Withdrawal by Subject|7|||
19607382|NCT00570739|42056163|FG002|Overall Study|Withdrawal by Subject|3|||
19607383|NCT00570739|42056164|FG003|Overall Study|Withdrawal by Subject|5|||
19607384|NCT00570739|42056161|FG000|Overall Study|Required restricted medication|0|||
19607385|NCT00570739|42056162|FG001|Overall Study|Required restricted medication|0|||
19607386|NCT00570739|42056163|FG002|Overall Study|Required restricted medication|1|||
19607387|NCT00570739|42056164|FG003|Overall Study|Required restricted medication|0|||
19607388|NCT00570739|42056161|FG000|Overall Study|Met discontinuation criteria|1|||
19607389|NCT00570739|42056162|FG001|Overall Study|Met discontinuation criteria|0|||
19607390|NCT00570739|42056163|FG002|Overall Study|Met discontinuation criteria|1|||
19607391|NCT00570739|42056164|FG003|Overall Study|Met discontinuation criteria|1|||
19607392|NCT00570739|42056161|FG000|Overall Study|Other|0|||
19607393|NCT00570739|42056162|FG001|Overall Study|Other|2|||
19607394|NCT00570739|42056163|FG002|Overall Study|Other|5|||
19607395|NCT00570739|42056164|FG003|Overall Study|Other|3|||
19607396|NCT03689530|42056196|FG000|Overall Study|Withdrawal by Subject|53|||
19607397|NCT03689530|42056197|FG001|Overall Study|Withdrawal by Subject|16|||
19607398|NCT04188106|42056203|FG000|Overall Study|Lost to Follow-up|5|||
19607399|NCT04188106|42056203|FG000|Overall Study|Non-Compliance|1|||
19607400|NCT00669955|42056211|FG000|Overall Study|Adverse Event|3|||
19607401|NCT00669955|42056212|FG001|Overall Study|Adverse Event|5|||
19607402|NCT00669955|42056211|FG000|Overall Study|Death|0|||
19607403|NCT00669955|42056212|FG001|Overall Study|Death|1|||
19607404|NCT00669955|42056211|FG000|Overall Study|Withdrawal by Subject|2|||
19607405|NCT00669955|42056212|FG001|Overall Study|Withdrawal by Subject|3|||
19607406|NCT00669955|42056211|FG000|Overall Study|Lost to Follow-up|5|||
19607407|NCT00669955|42056212|FG001|Overall Study|Lost to Follow-up|7|||
19607408|NCT00669955|42056211|FG000|Overall Study|Protocol Violation|2|||
19696532|NCT00287586|42141887|FG001|Overall Study|Sleep Apnea|0|||
19696533|NCT00287586|42141886|FG000|Overall Study|Shoulder Pain|1|||
19696534|NCT00287586|42141887|FG001|Overall Study|Shoulder Pain|0|||
19696535|NCT00287586|42141886|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
19696536|NCT00287586|42141887|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
19696537|NCT00287586|42141886|FG000|Overall Study|Nonadherence|1|||
19696538|NCT00287586|42141887|FG001|Overall Study|Nonadherence|1|||
19696539|NCT00287586|42141886|FG000|Overall Study|Enrolled in Another Study|1|||
19607409|NCT00669955|42056212|FG001|Overall Study|Protocol Violation|7|||
19607410|NCT00669955|42056211|FG000|Overall Study|Investigator Sponsor Judgement|0|||
19696540|NCT00287586|42141887|FG001|Overall Study|Enrolled in Another Study|0|||
19784589|NCT02587598|42241397|FG009|Overall Study|Physician Decision|0|||
19784590|NCT02587598|42241398|FG010|Overall Study|Physician Decision|3|||
19784591|NCT02485574|42241434|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
19784592|NCT02624284|42241446|FG000|Overall Study|Withdrawal by Subject|3|||
19784593|NCT02624284|42241447|FG001|Overall Study|Withdrawal by Subject|6|||
19784594|NCT02624284|42241448|FG002|Overall Study|Withdrawal by Subject|3|||
19784595|NCT02624284|42241446|FG000|Overall Study|Protocol Violation|9|||
19784596|NCT02624284|42241447|FG001|Overall Study|Protocol Violation|10|||
19784597|NCT02624284|42241448|FG002|Overall Study|Protocol Violation|7|||
19784598|NCT02624284|42241446|FG000|Overall Study|Revealed exclusionary condition|2|||
19784599|NCT02624284|42241447|FG001|Overall Study|Revealed exclusionary condition|2|||
19784600|NCT02624284|42241448|FG002|Overall Study|Revealed exclusionary condition|0|||
19784601|NCT02624284|42241446|FG000|Overall Study|Adverse Event|0|||
19784602|NCT02624284|42241447|FG001|Overall Study|Adverse Event|0|||
19784603|NCT02624284|42241448|FG002|Overall Study|Adverse Event|1|||
19784604|NCT02738450|42241460|FG000|Overall Study|Withdrawal by Subject|0|||
19784605|NCT02738450|42241461|FG001|Overall Study|Withdrawal by Subject|2|||
19784606|NCT02738450|42241462|FG002|Overall Study|Withdrawal by Subject|0|||
19784607|NCT02624050|42241473|FG000|Overall Study|Physician Decision|4|||
19784608|NCT02624050|42241474|FG001|Overall Study|Physician Decision|0|||
19784609|NCT02624050|42241473|FG000|Overall Study|Protocol Violation|2|||
19784610|NCT02624050|42241474|FG001|Overall Study|Protocol Violation|0|||
19784611|NCT01338987|42241490|FG000|Overall Study|enrolled on new protocol|0|||
19784612|NCT01338987|42241491|FG001|Overall Study|enrolled on new protocol|0|||
19784613|NCT01338987|42241492|FG002|Overall Study|enrolled on new protocol|1|||
19784614|NCT01338987|42241493|FG003|Overall Study|enrolled on new protocol|0|||
19784615|NCT01338987|42241494|FG004|Overall Study|enrolled on new protocol|0|||
19784616|NCT01338987|42241490|FG000|Overall Study|Disease progression on study|2|||
19784617|NCT01338987|42241491|FG001|Overall Study|Disease progression on study|1|||
19784618|NCT01338987|42241492|FG002|Overall Study|Disease progression on study|1|||
19784619|NCT01338987|42241493|FG003|Overall Study|Disease progression on study|0|||
19784620|NCT01338987|42241494|FG004|Overall Study|Disease progression on study|0|||
19784621|NCT02738138|42241526|FG000|Overall Study|Adverse Event|0|||
19784622|NCT02738138|42241527|FG001|Overall Study|Adverse Event|1|||
19784623|NCT02738138|42241526|FG000|Overall Study|Lost to Follow-up|2|||
19784624|NCT02738138|42241527|FG001|Overall Study|Lost to Follow-up|0|||
19784625|NCT02738138|42241526|FG000|Overall Study|Other - not further specified|1|||
19784626|NCT02738138|42241527|FG001|Overall Study|Other - not further specified|0|||
19784627|NCT01355289|42241536|FG000|Core Study|Adverse Event, Non-Fatal|1|||
19784628|NCT01355289|42241537|FG001|Core Study|Adverse Event, Non-Fatal|0|||
19784629|NCT01355289|42241538|FG002|Core Study|Adverse Event, Non-Fatal|0|||
19784630|NCT01355289|42241539|FG003|Core Study|Adverse Event, Non-Fatal|0|||
19784631|NCT01355289|42241540|FG004|Core Study|Adverse Event, Non-Fatal|0|||
19784632|NCT01355289|42241536|FG000|Core Study|Inadequate Therapeutic Effect|0|||
19784633|NCT01355289|42241537|FG001|Core Study|Inadequate Therapeutic Effect|0|||
19784634|NCT01355289|42241538|FG002|Core Study|Inadequate Therapeutic Effect|0|||
19784635|NCT01355289|42241539|FG003|Core Study|Inadequate Therapeutic Effect|1|||
19784636|NCT01355289|42241540|FG004|Core Study|Inadequate Therapeutic Effect|0|||
19784637|NCT01355289|42241536|FG000|Core Study|Other|0|||
19784638|NCT01355289|42241537|FG001|Core Study|Other|0|||
19784639|NCT01355289|42241538|FG002|Core Study|Other|0|||
19784640|NCT01355289|42241539|FG003|Core Study|Other|1|||
19784641|NCT01355289|42241540|FG004|Core Study|Other|0|||
19784642|NCT01355289|42241536|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
19784643|NCT01355289|42241537|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
19784644|NCT01355289|42241538|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
19784645|NCT01355289|42241539|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
19784646|NCT01355289|42241540|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
19784647|NCT01355289|42241536|FG000|Open Label Extension|Lost to Follow-up|0|||
19784648|NCT01355289|42241537|FG001|Open Label Extension|Lost to Follow-up|0|||
19784649|NCT01355289|42241538|FG002|Open Label Extension|Lost to Follow-up|0|||
19784650|NCT01355289|42241539|FG003|Open Label Extension|Lost to Follow-up|0|||
19784651|NCT01355289|42241540|FG004|Open Label Extension|Lost to Follow-up|1|||
19784652|NCT01355289|42241536|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
19367392|NCT02456740|41607529|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
19367393|NCT02456740|41607521|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19784653|NCT01355289|42241537|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
19784654|NCT01355289|42241538|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
19784655|NCT01355289|42241539|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
19784656|NCT01355289|42241540|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
19784657|NCT01355289|42241536|FG000|Open Label Extension|Other|0|||
19784658|NCT01355289|42241537|FG001|Open Label Extension|Other|0|||
19784659|NCT01355289|42241538|FG002|Open Label Extension|Other|0|||
19784660|NCT01355289|42241539|FG003|Open Label Extension|Other|0|||
19784661|NCT01355289|42241540|FG004|Open Label Extension|Other|3|||
19784662|NCT02737592|42241553|FG000|Overall Study|Withdrawal by Subject|1|||
19784663|NCT02737358|42241580|FG000|Overall Study|Withdrawal by Subject|7|||
19784664|NCT02737358|42241581|FG001|Overall Study|Withdrawal by Subject|12|||
19784665|NCT02737358|42241580|FG000|Overall Study|Lost to Follow-up|2|||
19784666|NCT02737358|42241581|FG001|Overall Study|Lost to Follow-up|3|||
19784667|NCT01354431|42241590|FG000|Pre-Treatment Period|Not reported|1|||
19784668|NCT01354431|42241591|FG001|Pre-Treatment Period|Not reported|0|||
19784669|NCT01354431|42241592|FG002|Pre-Treatment Period|Not reported|0|||
19784670|NCT01354431|42241590|FG000|Treatment Period|Disease Progression|50|||
19784671|NCT01354431|42241591|FG001|Treatment Period|Disease Progression|40|||
19784672|NCT01354431|42241592|FG002|Treatment Period|Disease Progression|44|||
19784673|NCT01354431|42241590|FG000|Treatment Period|Study Drug Toxicity|5|||
19784674|NCT01354431|42241591|FG001|Treatment Period|Study Drug Toxicity|8|||
19784675|NCT01354431|42241592|FG002|Treatment Period|Study Drug Toxicity|4|||
19784676|NCT01354431|42241590|FG000|Treatment Period|Death|0|||
19784677|NCT01354431|42241591|FG001|Treatment Period|Death|1|||
19696541|NCT00287586|42141886|FG000|Overall Study|Major Depression|0|||
19696542|NCT00287586|42141887|FG001|Overall Study|Major Depression|2|||
19696543|NCT00287586|42141886|FG000|Overall Study|Lung Cancer|0|||
19696544|NCT00287586|42141887|FG001|Overall Study|Lung Cancer|2|||
19696545|NCT00287586|42141886|FG000|Overall Study|Elevated IPSS Score|0|||
19696546|NCT00287586|42141887|FG001|Overall Study|Elevated IPSS Score|1|||
19696547|NCT00287586|42141886|FG000|Overall Study|Retroperitoneal Cancer|0|||
19696548|NCT00287586|42141887|FG001|Overall Study|Retroperitoneal Cancer|1|||
19696549|NCT00287586|42141886|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
19696550|NCT00287586|42141887|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
19696551|NCT00287586|42141886|FG000|Overall Study|Mood Swings and Irritability|0|||
19696552|NCT00287586|42141887|FG001|Overall Study|Mood Swings and Irritability|1|||
19784678|NCT01354431|42241592|FG002|Treatment Period|Death|0|||
19784679|NCT01354431|42241590|FG000|Treatment Period|AE unrelated to study drug|1|||
19784680|NCT01354431|42241591|FG001|Treatment Period|AE unrelated to study drug|2|||
19784681|NCT01354431|42241592|FG002|Treatment Period|AE unrelated to study drug|5|||
19784682|NCT01354431|42241590|FG000|Treatment Period|Participant request to discontinue|2|||
19784683|NCT01354431|42241591|FG001|Treatment Period|Participant request to discontinue|2|||
19784684|NCT01354431|42241592|FG002|Treatment Period|Participant request to discontinue|1|||
19784685|NCT01354431|42241590|FG000|Treatment Period|Participant withdrew consent|0|||
19784686|NCT01354431|42241591|FG001|Treatment Period|Participant withdrew consent|1|||
19784687|NCT01354431|42241592|FG002|Treatment Period|Participant withdrew consent|0|||
19784688|NCT01354431|42241590|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
19784689|NCT01354431|42241591|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
19784690|NCT01354431|42241592|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
19784691|NCT02736578|42241602|FG000|Overall Study|Adverse Event|1|||
19784692|NCT02736578|42241603|FG001|Overall Study|Adverse Event|0|||
19784693|NCT02622724|42241615|FG000|Overall Study|Death|51|||
19784694|NCT02622724|42241616|FG001|Overall Study|Death|53|||
19784695|NCT02622724|42241615|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
19784696|NCT02622724|42241616|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
19784697|NCT02622724|42241615|FG000|Overall Study|Early termination of study|38|||
19784698|NCT02622724|42241616|FG001|Overall Study|Early termination of study|43|||
19784699|NCT01354353|42241634|FG000|Overall Study|Adverse Event|1|||
19784700|NCT01354353|42241635|FG001|Overall Study|Adverse Event|0|||
19784701|NCT01354353|42241636|FG002|Overall Study|Adverse Event|0|||
19784702|NCT01354353|42241637|FG003|Overall Study|Adverse Event|4|||
19784703|NCT01354353|42241638|FG004|Overall Study|Adverse Event|0|||
19784704|NCT01354353|42241639|FG005|Overall Study|Adverse Event|5|||
19784705|NCT01354353|42241634|FG000|Overall Study|Entry Criteria Not Met|0|||
19784706|NCT01354353|42241635|FG001|Overall Study|Entry Criteria Not Met|0|||
19784707|NCT01354353|42241636|FG002|Overall Study|Entry Criteria Not Met|0|||
19784708|NCT01354353|42241637|FG003|Overall Study|Entry Criteria Not Met|1|||
19784709|NCT01354353|42241638|FG004|Overall Study|Entry Criteria Not Met|1|||
19784710|NCT01354353|42241639|FG005|Overall Study|Entry Criteria Not Met|0|||
19784711|NCT01354353|42241634|FG000|Overall Study|Physician Decision|0|||
19784712|NCT01354353|42241635|FG001|Overall Study|Physician Decision|1|||
19784713|NCT01354353|42241636|FG002|Overall Study|Physician Decision|1|||
19784714|NCT01354353|42241637|FG003|Overall Study|Physician Decision|0|||
19784715|NCT01354353|42241638|FG004|Overall Study|Physician Decision|0|||
19696553|NCT00287586|42141886|FG000|Overall Study|Bradycardia|0|||
19784716|NCT01354353|42241639|FG005|Overall Study|Physician Decision|0|||
19784717|NCT01354353|42241634|FG000|Overall Study|Withdrawal by Subject|2|||
19784718|NCT01354353|42241635|FG001|Overall Study|Withdrawal by Subject|0|||
19784719|NCT01354353|42241636|FG002|Overall Study|Withdrawal by Subject|1|||
19784720|NCT01354353|42241637|FG003|Overall Study|Withdrawal by Subject|0|||
19784721|NCT01354353|42241638|FG004|Overall Study|Withdrawal by Subject|0|||
19784722|NCT01354353|42241639|FG005|Overall Study|Withdrawal by Subject|1|||
19784723|NCT02622568|42241662|FG000|Overall Study|Lost to Follow-up|5|||
19696554|NCT00287586|42141887|FG001|Overall Study|Bradycardia|1|||
19696555|NCT00287586|42141886|FG000|Overall Study|Itchy Swollen Eyes|0|||
19784724|NCT02622568|42241663|FG001|Overall Study|Lost to Follow-up|5|||
19784725|NCT01354899|42241669|FG000|Overall Study|discharge from the hospital|2|||
19784726|NCT01354899|42241669|FG000|Overall Study|Protocol Violation|1|||
19784727|NCT01353963|42241673|FG000|Overall Study|Adverse Event|2|||
19784728|NCT02820597|42241682|FG000|Overall Study|Lost to Follow-up|12|||
19784729|NCT02822235|42241688|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
19784730|NCT02822235|42241689|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
19784731|NCT02822235|42241688|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
19784732|NCT02822235|42241689|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
19784733|NCT02822235|42241688|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
19784734|NCT02822235|42241689|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
19784735|NCT02822235|42241688|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
19784736|NCT02822235|42241689|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
19784737|NCT02822235|42241688|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
19784738|NCT02822235|42241689|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
19784739|NCT02822235|42241688|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
19784740|NCT02822235|42241689|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
19784741|NCT02817555|42241704|FG000|Overall Study|Death|1|||
19784742|NCT02817555|42241705|FG001|Overall Study|Death|3|||
19784743|NCT02817555|42241704|FG000|Overall Study|moved away|1|||
19784744|NCT02817555|42241705|FG001|Overall Study|moved away|0|||
19784745|NCT02817555|42241704|FG000|Overall Study|transplant|1|||
19784746|NCT02817555|42241705|FG001|Overall Study|transplant|1|||
19784747|NCT02817555|42241704|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
19784748|NCT02817555|42241705|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
19784749|NCT02817087|42241713|FG000|Overall Study|Withdrawal by Subject|2|||
19784750|NCT02817087|42241714|FG001|Overall Study|Withdrawal by Subject|0|||
19784751|NCT02813577|42241720|FG000|Overall Study|Study terminated|4|||
19784752|NCT02815293|42241727|FG000|Overall Study|Study termination by sponsor|10|||
19784753|NCT02815293|42241728|FG001|Overall Study|Study termination by sponsor|7|||
19784754|NCT02815293|42241729|FG002|Overall Study|Study termination by sponsor|0|||
19784755|NCT02815293|42241727|FG000|Overall Study|Participants not randomized|0|||
19784756|NCT02815293|42241728|FG001|Overall Study|Participants not randomized|0|||
19784757|NCT02815293|42241729|FG002|Overall Study|Participants not randomized|18|||
19784758|NCT02815293|42241727|FG000|Overall Study|Adverse Event|0|||
19784759|NCT02815293|42241728|FG001|Overall Study|Adverse Event|1|||
19784760|NCT02815293|42241729|FG002|Overall Study|Adverse Event|0|||
19784761|NCT02813421|42241737|FG000|Overall Study|Withdrawal by Subject|1|||
19784762|NCT02813421|42241738|FG001|Overall Study|Withdrawal by Subject|2|||
19784763|NCT02813421|42241737|FG000|Overall Study|Lost to Follow-up|1|||
19784764|NCT02813421|42241738|FG001|Overall Study|Lost to Follow-up|1|||
19784765|NCT03672188|42241759|FG000|Overall Study|Withdrawal by Subject|0|||
19784766|NCT03672188|42241760|FG001|Overall Study|Withdrawal by Subject|0|||
19784767|NCT03672188|42241761|FG002|Overall Study|Withdrawal by Subject|0|||
19784768|NCT03672188|42241762|FG003|Overall Study|Withdrawal by Subject|3|||
19784769|NCT03672188|42241763|FG004|Overall Study|Withdrawal by Subject|0|||
19784770|NCT03672188|42241764|FG005|Overall Study|Withdrawal by Subject|0|||
19784771|NCT03672188|42241765|FG006|Overall Study|Withdrawal by Subject|0|||
19784772|NCT03672188|42241766|FG007|Overall Study|Withdrawal by Subject|0|||
19784773|NCT03672188|42241767|FG008|Overall Study|Withdrawal by Subject|0|||
19784774|NCT03672188|42241768|FG009|Overall Study|Withdrawal by Subject|0|||
19784775|NCT03672188|42241769|FG010|Overall Study|Withdrawal by Subject|0|||
19784776|NCT03672188|42241770|FG011|Overall Study|Withdrawal by Subject|0|||
19784777|NCT03672188|42241771|FG012|Overall Study|Withdrawal by Subject|0|||
19784778|NCT03672188|42241772|FG013|Overall Study|Withdrawal by Subject|0|||
19784779|NCT03672188|42241773|FG014|Overall Study|Withdrawal by Subject|0|||
19784780|NCT03672188|42241759|FG000|Overall Study|Death|0|||
19784781|NCT03672188|42241760|FG001|Overall Study|Death|0|||
19784782|NCT03672188|42241761|FG002|Overall Study|Death|0|||
19784783|NCT03672188|42241762|FG003|Overall Study|Death|0|||
19784784|NCT03672188|42241763|FG004|Overall Study|Death|0|||
19784785|NCT03672188|42241764|FG005|Overall Study|Death|0|||
19784786|NCT03672188|42241765|FG006|Overall Study|Death|0|||
19784787|NCT03672188|42241766|FG007|Overall Study|Death|0|||
19784788|NCT03672188|42241767|FG008|Overall Study|Death|0|||
19784789|NCT03672188|42241768|FG009|Overall Study|Death|0|||
19607411|NCT00669955|42056212|FG001|Overall Study|Investigator Sponsor Judgement|1|||
19784790|NCT03672188|42241769|FG010|Overall Study|Death|0|||
19784791|NCT03672188|42241770|FG011|Overall Study|Death|0|||
19784792|NCT03672188|42241771|FG012|Overall Study|Death|1|||
19784793|NCT03672188|42241772|FG013|Overall Study|Death|0|||
19784794|NCT03672188|42241773|FG014|Overall Study|Death|0|||
19784795|NCT03672188|42241759|FG000|Overall Study|Lost to Follow-up|0|||
19784796|NCT03672188|42241760|FG001|Overall Study|Lost to Follow-up|0|||
19784797|NCT03672188|42241761|FG002|Overall Study|Lost to Follow-up|1|||
19784798|NCT03672188|42241762|FG003|Overall Study|Lost to Follow-up|0|||
19784799|NCT03672188|42241763|FG004|Overall Study|Lost to Follow-up|0|||
19784800|NCT03672188|42241764|FG005|Overall Study|Lost to Follow-up|0|||
19784801|NCT03672188|42241765|FG006|Overall Study|Lost to Follow-up|0|||
19784802|NCT03672188|42241766|FG007|Overall Study|Lost to Follow-up|0|||
19784803|NCT03672188|42241767|FG008|Overall Study|Lost to Follow-up|0|||
19696556|NCT00287586|42141887|FG001|Overall Study|Itchy Swollen Eyes|1|||
19696557|NCT00287586|42141886|FG000|Overall Study|Recurrent Melanoma|0|||
19696558|NCT00287586|42141887|FG001|Overall Study|Recurrent Melanoma|1|||
19696559|NCT00287118|42141893|FG000|Overall Study|Adverse Event|30|||
19696560|NCT00287118|42141893|FG000|Overall Study|Death|1|||
19696561|NCT00287118|42141893|FG000|Overall Study|Lack of Efficacy|11|||
19696562|NCT00287118|42141893|FG000|Overall Study|Lost to Follow-up|1|||
19696563|NCT00287118|42141893|FG000|Overall Study|Protocol Violation|2|||
19784804|NCT03672188|42241768|FG009|Overall Study|Lost to Follow-up|0|||
19784805|NCT03672188|42241769|FG010|Overall Study|Lost to Follow-up|0|||
19784806|NCT03672188|42241770|FG011|Overall Study|Lost to Follow-up|0|||
19784807|NCT03672188|42241771|FG012|Overall Study|Lost to Follow-up|0|||
19784808|NCT03672188|42241772|FG013|Overall Study|Lost to Follow-up|0|||
19784809|NCT03672188|42241773|FG014|Overall Study|Lost to Follow-up|0|||
19696564|NCT00287118|42141893|FG000|Overall Study|Other|7|||
19696565|NCT00293202|42141899|FG000|Overall Study|Withdrawal by Subject|1|||
19696566|NCT00293202|42141900|FG001|Overall Study|Withdrawal by Subject|2|||
19784810|NCT02620384|42241841|FG000|Overall Study|Adverse Event|2|||
19784811|NCT02620384|42241842|FG001|Overall Study|Adverse Event|1|||
19784812|NCT02620384|42241841|FG000|Overall Study|Discharged prior to 2nd dose|2|||
19784813|NCT02620384|42241842|FG001|Overall Study|Discharged prior to 2nd dose|5|||
19784814|NCT02620384|42241841|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
19696567|NCT00293202|42141899|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
19696568|NCT00293202|42141900|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
19696569|NCT00293202|42141899|FG000|Overall Study|on-hold due to fistula maturation time|1|||
19696570|NCT00293202|42141900|FG001|Overall Study|on-hold due to fistula maturation time|0|||
19696571|NCT00298896|42141910|FG000|Overall Study|Death|3|||
19696572|NCT00298896|42141910|FG000|Overall Study|Physician Decision|2|||
19696573|NCT00298896|42141910|FG000|Overall Study|Intercurrent Illness|1|||
19696574|NCT00298896|42141910|FG000|Overall Study|Disease Progression|41|||
19696575|NCT00298896|42141910|FG000|Overall Study|Withdrawal by Subject|2|||
19696576|NCT00298896|42141910|FG000|Overall Study|Assigned to treatment in error|1|||
19696577|NCT00286494|42141917|FG000|Overall Study|Hyperglycemic rescue|12|||
19696578|NCT00286494|42141918|FG001|Overall Study|Hyperglycemic rescue|19|||
19696579|NCT00286494|42141919|FG002|Overall Study|Hyperglycemic rescue|18|||
19696580|NCT00286494|42141917|FG000|Overall Study|Withdrawal by Subject|2|||
19696581|NCT00286494|42141918|FG001|Overall Study|Withdrawal by Subject|10|||
19696582|NCT00286494|42141919|FG002|Overall Study|Withdrawal by Subject|9|||
19696583|NCT00286494|42141917|FG000|Overall Study|Adverse Event|3|||
19784815|NCT02620384|42241842|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
19784816|NCT03915860|42241848|FG000|Overall Study|Adverse Event|3|||
19784817|NCT03915860|42241848|FG000|Overall Study|Withdrawal by Subject|6|||
19784818|NCT03915860|42241848|FG000|Overall Study|Lost to Follow-up|2|||
19784819|NCT03915860|42241848|FG000|Overall Study|Other than specified|3|||
19784820|NCT03786380|42241857|FG000|Overall Study|Adverse Event|1|||
19784821|NCT03786380|42241858|FG001|Overall Study|Adverse Event|0|||
19784822|NCT03786380|42241859|FG002|Overall Study|Adverse Event|0|||
19784823|NCT03786380|42241860|FG003|Overall Study|Adverse Event|3|||
19784824|NCT03786380|42241861|FG004|Overall Study|Adverse Event|1|||
19784825|NCT03786380|42241857|FG000|Overall Study|Lack of Efficacy|0|||
19784826|NCT03786380|42241858|FG001|Overall Study|Lack of Efficacy|0|||
19784827|NCT03786380|42241859|FG002|Overall Study|Lack of Efficacy|0|||
19784828|NCT03786380|42241860|FG003|Overall Study|Lack of Efficacy|0|||
19784829|NCT03786380|42241861|FG004|Overall Study|Lack of Efficacy|1|||
19784830|NCT03786380|42241857|FG000|Overall Study|Withdrawal by Subject|1|||
19784831|NCT03786380|42241858|FG001|Overall Study|Withdrawal by Subject|2|||
19784832|NCT03786380|42241859|FG002|Overall Study|Withdrawal by Subject|2|||
19784833|NCT03786380|42241860|FG003|Overall Study|Withdrawal by Subject|1|||
19784834|NCT03786380|42241861|FG004|Overall Study|Withdrawal by Subject|2|||
19784835|NCT03786380|42241857|FG000|Overall Study|Lost to Follow-up|3|||
19784836|NCT03786380|42241858|FG001|Overall Study|Lost to Follow-up|0|||
19784837|NCT03786380|42241859|FG002|Overall Study|Lost to Follow-up|1|||
19784838|NCT03786380|42241860|FG003|Overall Study|Lost to Follow-up|2|||
19784839|NCT03786380|42241861|FG004|Overall Study|Lost to Follow-up|0|||
19784840|NCT03786380|42241857|FG000|Overall Study|Physician Decision|0|||
19784841|NCT03786380|42241858|FG001|Overall Study|Physician Decision|0|||
19784842|NCT03786380|42241859|FG002|Overall Study|Physician Decision|1|||
19784843|NCT03786380|42241860|FG003|Overall Study|Physician Decision|0|||
19784844|NCT03786380|42241861|FG004|Overall Study|Physician Decision|0|||
19784845|NCT03786380|42241857|FG000|Overall Study|Study Terminated by the Sponsor|30|||
19696584|NCT00286494|42141918|FG001|Overall Study|Adverse Event|8|||
19696585|NCT00286494|42141919|FG002|Overall Study|Adverse Event|6|||
19696586|NCT00286494|42141917|FG000|Overall Study|Physician Decision|5|||
19696587|NCT00286494|42141918|FG001|Overall Study|Physician Decision|5|||
19784846|NCT03786380|42241858|FG001|Overall Study|Study Terminated by the Sponsor|20|||
19784847|NCT03786380|42241859|FG002|Overall Study|Study Terminated by the Sponsor|50|||
19784848|NCT03786380|42241860|FG003|Overall Study|Study Terminated by the Sponsor|57|||
19784849|NCT03786380|42241861|FG004|Overall Study|Study Terminated by the Sponsor|23|||
19784850|NCT03786380|42241857|FG000|Overall Study|Reason Not Specified|0|||
19784851|NCT03786380|42241858|FG001|Overall Study|Reason Not Specified|0|||
19784852|NCT03786380|42241859|FG002|Overall Study|Reason Not Specified|0|||
19784853|NCT03786380|42241860|FG003|Overall Study|Reason Not Specified|0|||
19784854|NCT03786380|42241861|FG004|Overall Study|Reason Not Specified|1|||
19784855|NCT02626000|42241873|FG000|Overall Study|Decision by Sponsor|1|||
19784856|NCT02626000|42241873|FG000|Overall Study|Death|29|||
19784857|NCT02736890|42241889|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
19784858|NCT02736890|42241890|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
19784859|NCT02736890|42241889|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
19784860|NCT02736890|42241890|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
19784861|NCT02779556|42241898|FG000|Baseline|Partial baseline interview completed|1|||
19784862|NCT02779556|42241899|FG001|Baseline|Partial baseline interview completed|0|||
19784863|NCT02779556|42241898|FG000|3 Months|Lost to Follow-up|40|||
19784864|NCT02779556|42241899|FG001|3 Months|Lost to Follow-up|29|||
19784865|NCT02779556|42241898|FG000|3 Months|Missed 3 month clinic visit|27|||
19784866|NCT02779556|42241899|FG001|3 Months|Missed 3 month clinic visit|19|||
19784867|NCT02779556|42241898|FG000|6 Month|Lost to Follow-up|33|||
19784868|NCT02779556|42241899|FG001|6 Month|Lost to Follow-up|39|||
19784869|NCT02779556|42241898|FG000|6 Month HbA1c|No value collected during window|69|||
19784870|NCT02779556|42241899|FG001|6 Month HbA1c|No value collected during window|50|||
19784871|NCT02779556|42241898|FG000|12 Month HbA1c|No value collected during window|138|||
19784872|NCT02779556|42241899|FG001|12 Month HbA1c|No value collected during window|102|||
19784873|NCT01669798|42241905|FG000|Overall Study|Physician Decision|5|||
19784874|NCT02334722|42241911|FG000|Overall Study|Lost to Follow-up|4|||
19784875|NCT02334722|42241912|FG001|Overall Study|Lost to Follow-up|0|||
19784876|NCT02334722|42241911|FG000|Overall Study|6 week questionnaire not completed|2|||
19784877|NCT02334722|42241912|FG001|Overall Study|6 week questionnaire not completed|0|||
19784878|NCT02334722|42241911|FG000|Overall Study|Unable to obtain medication|1|||
19784879|NCT02334722|42241912|FG001|Overall Study|Unable to obtain medication|1|||
19784880|NCT02334722|42241911|FG000|Overall Study|Withdrawal by Subject|0|||
19784881|NCT02334722|42241912|FG001|Overall Study|Withdrawal by Subject|3|||
19784882|NCT02334722|42241911|FG000|Overall Study|Adverse Event|0|||
19784883|NCT02334722|42241912|FG001|Overall Study|Adverse Event|2|||
19784884|NCT02334722|42241911|FG000|Overall Study|Physician Decision|0|||
19784885|NCT02334722|42241912|FG001|Overall Study|Physician Decision|1|||
19696588|NCT00286494|42141919|FG002|Overall Study|Physician Decision|1|||
19696589|NCT00286494|42141917|FG000|Overall Study|Lost to Follow-up|3|||
19784886|NCT00812708|42241927|FG000|Overall Study|Device could not be implanted|2|||
19784887|NCT00812708|42241927|FG000|Overall Study|Lack of medical insurance|1|||
19784888|NCT00812708|42241927|FG000|Overall Study|Switched to another study|1|||
19696590|NCT00286494|42141918|FG001|Overall Study|Lost to Follow-up|1|||
19696591|NCT00286494|42141919|FG002|Overall Study|Lost to Follow-up|3|||
19696592|NCT00286494|42141917|FG000|Overall Study|Protocol Violation|1|||
19784889|NCT00812708|42241927|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
19784890|NCT00812708|42241927|FG000|Overall Study|Signed consent but later withdrew|3|||
19784891|NCT03761810|42241943|FG000|Overall Study|Adverse Event|12|||
19784892|NCT03761810|42241944|FG001|Overall Study|Adverse Event|0|||
19784893|NCT03761810|42241943|FG000|Overall Study|Lost to Follow-up|15|||
19784894|NCT03761810|42241944|FG001|Overall Study|Lost to Follow-up|7|||
19784895|NCT03761810|42241943|FG000|Overall Study|Pregnancy|1|||
19784896|NCT03761810|42241944|FG001|Overall Study|Pregnancy|0|||
19784897|NCT03761810|42241943|FG000|Overall Study|Withdrawal by Subject|14|||
19784898|NCT03761810|42241944|FG001|Overall Study|Withdrawal by Subject|5|||
19784899|NCT03761810|42241943|FG000|Overall Study|Physician Decision|1|||
19784900|NCT03761810|42241944|FG001|Overall Study|Physician Decision|0|||
19784901|NCT03761810|42241943|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
19784902|NCT03761810|42241944|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19784903|NCT03761810|42241943|FG000|Overall Study|Other Than Specified|1|||
19784904|NCT03761810|42241944|FG001|Overall Study|Other Than Specified|0|||
19784905|NCT02811861|42241958|FG000|Overall Study|Radiological Disease Progression|123|||
19696593|NCT00286494|42141918|FG001|Overall Study|Protocol Violation|1|||
19696594|NCT00286494|42141919|FG002|Overall Study|Protocol Violation|2|||
19696595|NCT00298740|42141927|FG000|Overall Study|Lack of Efficacy|6|||
19696596|NCT00298740|42141927|FG000|Overall Study|Withdrawal by Subject|3|||
19696597|NCT00285012|42141933|FG000|Assigned to Study Treatment (Tx)|Other|2|||
19696598|NCT00285012|42141934|FG001|Assigned to Study Treatment (Tx)|Other|3|||
19784906|NCT02811861|42241959|FG001|Overall Study|Radiological Disease Progression|97|||
19784907|NCT02811861|42241960|FG002|Overall Study|Radiological Disease Progression|174|||
19784908|NCT02811861|42241958|FG000|Overall Study|Clinical Disease Progression|20|||
19696599|NCT00285012|42141933|FG000|Received Study Tx|Death|2|||
19696600|NCT00285012|42141934|FG001|Received Study Tx|Death|1|||
19696601|NCT00285012|42141933|FG000|Received Study Tx|Adverse Event|5|||
19696602|NCT00285012|42141934|FG001|Received Study Tx|Adverse Event|11|||
19696603|NCT00285012|42141933|FG000|Received Study Tx|Lack of Efficacy|0|||
19696604|NCT00285012|42141934|FG001|Received Study Tx|Lack of Efficacy|3|||
19696605|NCT00285012|42141933|FG000|Received Study Tx|Lost to Follow-up|29|||
19696606|NCT00285012|42141934|FG001|Received Study Tx|Lost to Follow-up|31|||
19696607|NCT00285012|42141933|FG000|Received Study Tx|Withdrawal by Subject|31|||
19696608|NCT00285012|42141934|FG001|Received Study Tx|Withdrawal by Subject|43|||
19696609|NCT00285012|42141933|FG000|Received Study Tx|Other|5|||
19696610|NCT00285012|42141934|FG001|Received Study Tx|Other|5|||
19696611|NCT00284934|42141942|FG000|Overall Study|Adverse Event|1|||
19696612|NCT00284934|42141943|FG001|Overall Study|Adverse Event|2|||
19696613|NCT00284934|42141942|FG000|Overall Study|Other reasons|3|||
19696614|NCT00284934|42141943|FG001|Overall Study|Other reasons|1|||
19696615|NCT00284856|42141952|FG000|Overall Study|Adverse Event|3|||
19696616|NCT00284856|42141953|FG001|Overall Study|Adverse Event|3|||
19696617|NCT00284856|42141954|FG002|Overall Study|Adverse Event|3|||
19696618|NCT00284856|42141952|FG000|Overall Study|Lack of Efficacy|2|||
19696619|NCT00284856|42141953|FG001|Overall Study|Lack of Efficacy|1|||
19696620|NCT00284856|42141954|FG002|Overall Study|Lack of Efficacy|8|||
19696621|NCT00284856|42141952|FG000|Overall Study|Lost to Follow-up|25|||
19696622|NCT00284856|42141953|FG001|Overall Study|Lost to Follow-up|21|||
19696623|NCT00284856|42141954|FG002|Overall Study|Lost to Follow-up|22|||
19696624|NCT00284856|42141952|FG000|Overall Study|Protocol Violation|5|||
19696625|NCT00284856|42141953|FG001|Overall Study|Protocol Violation|4|||
19696626|NCT00284856|42141954|FG002|Overall Study|Protocol Violation|5|||
19696627|NCT00284856|42141952|FG000|Overall Study|Withdrawal by Subject|12|||
19696628|NCT00284856|42141953|FG001|Overall Study|Withdrawal by Subject|16|||
19696629|NCT00284856|42141954|FG002|Overall Study|Withdrawal by Subject|18|||
19696630|NCT00284856|42141952|FG000|Overall Study|Other|4|||
19696631|NCT00284856|42141953|FG001|Overall Study|Other|5|||
19696632|NCT00284856|42141954|FG002|Overall Study|Other|4|||
19784909|NCT02811861|42241959|FG001|Overall Study|Clinical Disease Progression|19|||
19784910|NCT02811861|42241960|FG002|Overall Study|Clinical Disease Progression|22|||
19784911|NCT02811861|42241958|FG000|Overall Study|Adverse Event|63|||
19784912|NCT02811861|42241959|FG001|Overall Study|Adverse Event|60|||
19784913|NCT02811861|42241960|FG002|Overall Study|Adverse Event|41|||
19784914|NCT02811861|42241958|FG000|Overall Study|Lost to Follow-up|0|||
19784915|NCT02811861|42241959|FG001|Overall Study|Lost to Follow-up|0|||
19784916|NCT02811861|42241960|FG002|Overall Study|Lost to Follow-up|1|||
19784917|NCT02811861|42241958|FG000|Overall Study|Subject Choice|29|||
19784918|NCT02811861|42241959|FG001|Overall Study|Subject Choice|17|||
19784919|NCT02811861|42241960|FG002|Overall Study|Subject Choice|23|||
19784920|NCT02811861|42241958|FG000|Overall Study|Withdrawal by Subject|4|||
19784921|NCT02811861|42241959|FG001|Overall Study|Withdrawal by Subject|4|||
19784922|NCT02811861|42241960|FG002|Overall Study|Withdrawal by Subject|9|||
19784923|NCT02811861|42241958|FG000|Overall Study|Other|4|||
19784924|NCT02811861|42241959|FG001|Overall Study|Other|13|||
19784925|NCT02811861|42241960|FG002|Overall Study|Other|3|||
19784926|NCT02811861|42241958|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
19784927|NCT02811861|42241959|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
19784928|NCT02811861|42241960|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
19784929|NCT02811861|42241958|FG000|Overall Study|Randomized but not treated|2|||
19784930|NCT02811861|42241959|FG001|Overall Study|Randomized but not treated|3|||
19784931|NCT02811861|42241960|FG002|Overall Study|Randomized but not treated|17|||
19784932|NCT02811159|42241968|FG000|Treatment Course 1|Lost to Follow-up|1|||
19784933|NCT01889186|42241974|FG000|Overall Study|Adverse event- not related to progression|18|||
19784934|NCT01889186|42241975|FG001|Overall Study|Adverse event- not related to progression|5|||
19784935|NCT01889186|42241974|FG000|Overall Study|Adverse event- related to progression|7|||
19784936|NCT01889186|42241975|FG001|Overall Study|Adverse event- related to progression|2|||
19784937|NCT01889186|42241974|FG000|Overall Study|COVID-19 logistical restrictions|1|||
19784938|NCT01889186|42241975|FG001|Overall Study|COVID-19 logistical restrictions|0|||
19784939|NCT01889186|42241974|FG000|Overall Study|Investigator request|1|||
19784940|NCT01889186|42241975|FG001|Overall Study|Investigator request|1|||
19784941|NCT01889186|42241974|FG000|Overall Study|Progressive disease- Richter's|12|||
19784942|NCT01889186|42241975|FG001|Overall Study|Progressive disease- Richter's|7|||
19784943|NCT01889186|42241974|FG000|Overall Study|Progressive disease per protocol|46|||
19784944|NCT01889186|42241975|FG001|Overall Study|Progressive disease per protocol|17|||
19784945|NCT01889186|42241974|FG000|Overall Study|Stem cell transplant|2|||
19696633|NCT00298272|42141964|FG000|Double-blind Phase|Adverse Event|2|||
19696634|NCT00298272|42141965|FG001|Double-blind Phase|Adverse Event|0|||
19696635|NCT00298272|42141964|FG000|Double-blind Phase|Failure to Return|2|||
19696636|NCT00298272|42141965|FG001|Double-blind Phase|Failure to Return|0|||
19696637|NCT00298272|42141964|FG000|Double-blind Phase|Protocol Violation|2|||
19696638|NCT00298272|42141965|FG001|Double-blind Phase|Protocol Violation|0|||
19696639|NCT00298272|42141964|FG000|Double-blind Phase|Withdrawal by Subject|2|||
19784946|NCT01889186|42241975|FG001|Overall Study|Stem cell transplant|1|||
19784947|NCT01889186|42241974|FG000|Overall Study|Withdrew consent|2|||
19784948|NCT01889186|42241975|FG001|Overall Study|Withdrew consent|3|||
19784949|NCT01889186|42241974|FG000|Overall Study|Other, not specified|18|||
19784950|NCT01889186|42241975|FG001|Overall Study|Other, not specified|15|||
19784951|NCT01510184|42241985|FG000|Overall Study|Sponsor discretion|28|||
19784952|NCT01510184|42241986|FG001|Overall Study|Sponsor discretion|28|||
19784953|NCT01510184|42241985|FG000|Overall Study|Death|1|||
19784954|NCT01510184|42241986|FG001|Overall Study|Death|2|||
19784955|NCT01510184|42241985|FG000|Overall Study|Withdrawal by Subject|1|||
19784956|NCT01510184|42241986|FG001|Overall Study|Withdrawal by Subject|4|||
19784957|NCT01510184|42241985|FG000|Overall Study|Other|0|||
19784958|NCT01510184|42241986|FG001|Overall Study|Other|1|||
19784959|NCT02809833|42242011|FG000|Overall Study|Death|3|||
19784960|NCT02809833|42242011|FG000|Overall Study|Intolerance|54|||
19784961|NCT02809833|42242011|FG000|Overall Study|Lack of Efficacy|89|||
19784962|NCT02809833|42242011|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
19784963|NCT02809833|42242011|FG000|Overall Study|Noncompliance|1|||
19784964|NCT02809833|42242011|FG000|Overall Study|Withdrawal by Subject|34|||
19784965|NCT02809833|42242011|FG000|Overall Study|Lost to Follow-up|35|||
19784966|NCT02809833|42242011|FG000|Overall Study|Adverse Event (AE)|24|||
19784967|NCT02809833|42242011|FG000|Overall Study|Other|5|||
19784968|NCT02809833|42242011|FG000|Overall Study|Missing Information|52|||
19784969|NCT02797262|42242017|FG000|Overall Study|Withdrawal by Subject|5|||
19784970|NCT02797262|42242018|FG001|Overall Study|Withdrawal by Subject|1|||
19784971|NCT02797262|42242017|FG000|Overall Study|Lost to Follow-up|10|||
19784972|NCT02797262|42242018|FG001|Overall Study|Lost to Follow-up|7|||
19784973|NCT02797262|42242017|FG000|Overall Study|Death|1|||
19784974|NCT02797262|42242018|FG001|Overall Study|Death|2|||
19784975|NCT02797262|42242017|FG000|Overall Study|Adverse Event|1|||
19784976|NCT02797262|42242018|FG001|Overall Study|Adverse Event|0|||
19784977|NCT02797262|42242017|FG000|Overall Study|COVID-19|2|||
19784978|NCT02797262|42242018|FG001|Overall Study|COVID-19|1|||
19784979|NCT02797262|42242017|FG000|Overall Study|Out-of-country|1|||
19784980|NCT02797262|42242018|FG001|Overall Study|Out-of-country|0|||
19784981|NCT02809053|42242026|FG000|Overall Study|Death|0|||
19784982|NCT02809053|42242027|FG001|Overall Study|Death|1|||
19784983|NCT02809053|42242026|FG000|Overall Study|Lost to Follow-up|3|||
19784984|NCT02809053|42242027|FG001|Overall Study|Lost to Follow-up|1|||
19784985|NCT02809053|42242026|FG000|Overall Study|Withdrawal by Subject|2|||
19784986|NCT02809053|42242027|FG001|Overall Study|Withdrawal by Subject|3|||
19784987|NCT02809053|42242026|FG000|Overall Study|Disease Progression|2|||
19784988|NCT02809053|42242027|FG001|Overall Study|Disease Progression|1|||
19784989|NCT02808975|42242035|FG000|Overall Study|Adverse Event|3|||
19784990|NCT02808975|42242036|FG001|Overall Study|Adverse Event|4|||
19784991|NCT02808975|42242035|FG000|Overall Study|Withdrew consent|9|||
19784992|NCT02808975|42242036|FG001|Overall Study|Withdrew consent|8|||
19784993|NCT02808975|42242035|FG000|Overall Study|Lost to Follow-up|4|||
19784994|NCT02808975|42242036|FG001|Overall Study|Lost to Follow-up|6|||
19784995|NCT02808975|42242035|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
19784996|NCT02808975|42242036|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
19784997|NCT02808975|42242035|FG000|Overall Study|Other, not specified|5|||
19784998|NCT02808975|42242036|FG001|Overall Study|Other, not specified|1|||
19784999|NCT02976038|42242042|FG000|Overall Study|Physician Decision|22|||
19785000|NCT02976038|42242042|FG000|Overall Study|Withdrawal by Subject|3|||
19785001|NCT02976038|42242042|FG000|Overall Study|Lost to Follow-up|2|||
19785002|NCT02976038|42242042|FG000|Overall Study|Adverse Event|1|||
19785003|NCT02808819|42242067|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
19785004|NCT02808819|42242068|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
19785005|NCT02808819|42242067|FG000|Overall Study|Withdrawal by Subject|10|||
19785006|NCT02808819|42242068|FG001|Overall Study|Withdrawal by Subject|13|||
19785007|NCT02808819|42242067|FG000|Overall Study|Site terminated by sponsor|2|||
19785008|NCT02808819|42242068|FG001|Overall Study|Site terminated by sponsor|0|||
19785009|NCT02808819|42242067|FG000|Overall Study|Pregnancy|1|||
19785010|NCT02808819|42242068|FG001|Overall Study|Pregnancy|0|||
19785011|NCT02808819|42242067|FG000|Overall Study|Lost to Follow-up|1|||
19785012|NCT02808819|42242068|FG001|Overall Study|Lost to Follow-up|6|||
19785013|NCT02808819|42242067|FG000|Overall Study|Protocol Violation|0|||
19785014|NCT02808819|42242068|FG001|Overall Study|Protocol Violation|1|||
19477789|NCT01478971|41757048|FG000|Standard of Care Period|Adverse Event|1|||
19785015|NCT02808819|42242067|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
19785016|NCT02808819|42242068|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
19785017|NCT02808819|42242067|FG000|Overall Study|Death|1|||
19785018|NCT02808819|42242068|FG001|Overall Study|Death|0|||
19785019|NCT02808819|42242067|FG000|Overall Study|Adverse Event|3|||
19785020|NCT02808819|42242068|FG001|Overall Study|Adverse Event|4|||
19785021|NCT02808429|42242078|FG000|Overall Study|Lost to Follow-up|1|||
19785022|NCT02808429|42242079|FG001|Overall Study|Lost to Follow-up|0|||
19785023|NCT02808429|42242080|FG002|Overall Study|Lost to Follow-up|0|||
19785024|NCT02808429|42242078|FG000|Overall Study|Protocol Violation|0|||
19785025|NCT02808429|42242079|FG001|Overall Study|Protocol Violation|1|||
19785026|NCT02808429|42242080|FG002|Overall Study|Protocol Violation|0|||
19785027|NCT02808429|42242078|FG000|Overall Study|Premature study termination by sponsor|2|||
19785028|NCT02808429|42242079|FG001|Overall Study|Premature study termination by sponsor|0|||
19785029|NCT02808429|42242080|FG002|Overall Study|Premature study termination by sponsor|1|||
19696640|NCT00298272|42141965|FG001|Double-blind Phase|Withdrawal by Subject|0|||
19696641|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Adverse Event|1|||
19696642|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Adverse Event|2|||
19696643|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
19696644|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
19696645|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Failure to Return|1|||
19696646|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Failure to Return|0|||
19696647|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
19696648|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
19696649|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
19696650|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
19696651|NCT00298272|42141964|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
19696652|NCT00298272|42141965|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
19696653|NCT00298272|42141964|FG000|Safety Follow-up Phase|Failure to Return|1|||
19696654|NCT00298272|42141965|FG001|Safety Follow-up Phase|Failure to Return|1|||
19696655|NCT00298272|42141964|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
19696656|NCT00298272|42141965|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
19696657|NCT00298272|42141964|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
19696658|NCT00298272|42141965|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
19696659|NCT00283842|42141979|FG000|Overall Study|Adverse Event|8|||
19696660|NCT00283842|42141980|FG001|Overall Study|Adverse Event|7|||
19696661|NCT00283842|42141981|FG002|Overall Study|Adverse Event|21|||
19696662|NCT00283842|42141982|FG003|Overall Study|Adverse Event|21|||
19696663|NCT00283842|42141983|FG004|Overall Study|Adverse Event|5|||
19696664|NCT00283842|42141979|FG000|Overall Study|Protocol Violation|1|||
19696665|NCT00283842|42141980|FG001|Overall Study|Protocol Violation|5|||
19696666|NCT00283842|42141981|FG002|Overall Study|Protocol Violation|4|||
19696667|NCT00283842|42141982|FG003|Overall Study|Protocol Violation|0|||
19696668|NCT00283842|42141983|FG004|Overall Study|Protocol Violation|0|||
19696669|NCT00283842|42141979|FG000|Overall Study|Protocol deviation|0|||
19696670|NCT00283842|42141980|FG001|Overall Study|Protocol deviation|0|||
19696671|NCT00283842|42141981|FG002|Overall Study|Protocol deviation|0|||
19785030|NCT02808429|42242078|FG000|Overall Study|Relocation|0|||
19785031|NCT02808429|42242079|FG001|Overall Study|Relocation|0|||
19785032|NCT02808429|42242080|FG002|Overall Study|Relocation|1|||
19785033|NCT01594762|42242090|FG000|Overall Study|Withdrawal by Subject|1|||
19785034|NCT01594762|42242091|FG001|Overall Study|Withdrawal by Subject|0|||
19785035|NCT01594762|42242090|FG000|Overall Study|Lost to Follow-up|10|||
19785036|NCT01594762|42242091|FG001|Overall Study|Lost to Follow-up|10|||
19785037|NCT02615470|42242099|FG000|Overall Study|Lost to Follow-up|21|||
19785038|NCT02615470|42242100|FG001|Overall Study|Lost to Follow-up|32|||
19785039|NCT02806947|42242108|FG000|Overall Study|Withdrawal by Subject|5|||
19785040|NCT02806947|42242109|FG001|Overall Study|Withdrawal by Subject|1|||
19785041|NCT02806713|42242117|FG000|Overall Study|Urethral injury during procedure|1|||
19785042|NCT02806713|42242118|FG001|Overall Study|Urethral injury during procedure|0|||
19785043|NCT02806713|42242117|FG000|Overall Study|cancelled surgery|1|||
19785044|NCT02806713|42242118|FG001|Overall Study|cancelled surgery|2|||
19785045|NCT02807493|42242126|FG000|Overall Study|Adverse Event|5|||
19785046|NCT02807493|42242127|FG001|Overall Study|Adverse Event|2|||
19785047|NCT02807493|42242126|FG000|Overall Study|Lost to Follow-up|6|||
19785048|NCT02807493|42242127|FG001|Overall Study|Lost to Follow-up|0|||
19785049|NCT02807493|42242126|FG000|Overall Study|Physician Decision|4|||
19785050|NCT02807493|42242127|FG001|Overall Study|Physician Decision|1|||
19785051|NCT02807493|42242126|FG000|Overall Study|Protocol Violation|7|||
19785052|NCT02807493|42242127|FG001|Overall Study|Protocol Violation|0|||
19785053|NCT02807493|42242126|FG000|Overall Study|Withdrawal by Subject|17|||
19785054|NCT02807493|42242127|FG001|Overall Study|Withdrawal by Subject|10|||
19785055|NCT02807493|42242126|FG000|Overall Study|Other withdrawal|17|||
19785056|NCT02807493|42242127|FG001|Overall Study|Other withdrawal|0|||
19785057|NCT02807493|42242126|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
19696672|NCT00283842|42141982|FG003|Overall Study|Protocol deviation|0|||
19696673|NCT00283842|42141983|FG004|Overall Study|Protocol deviation|2|||
19696674|NCT00283842|42141979|FG000|Overall Study|Withdrawal by Subject|2|||
19696675|NCT00283842|42141980|FG001|Overall Study|Withdrawal by Subject|1|||
19696676|NCT00283842|42141981|FG002|Overall Study|Withdrawal by Subject|1|||
19696677|NCT00283842|42141982|FG003|Overall Study|Withdrawal by Subject|5|||
19785058|NCT02807493|42242127|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
19785059|NCT02807259|42242135|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
19785060|NCT02807259|42242136|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
19785061|NCT02807259|42242135|FG000|Midline (3 Months)|migration, refusal, not available|30|||
19785062|NCT02807259|42242136|FG001|Midline (3 Months)|migration, refusal, not available|34|||
19785063|NCT02807259|42242135|FG000|Endline (3 Months)|migration, refusal, not available|35|||
19785064|NCT02807259|42242136|FG001|Endline (3 Months)|migration, refusal, not available|87|||
19785065|NCT02802345|42242146|FG000|Overall Study|Not Treated|0|||
19785066|NCT02802345|42242147|FG001|Overall Study|Not Treated|1|||
19785067|NCT02802345|42242146|FG000|Overall Study|Adverse Event|28|||
19785068|NCT02802345|42242147|FG001|Overall Study|Adverse Event|20|||
19785069|NCT02802345|42242146|FG000|Overall Study|Withdrawal by Subject|3|||
19785070|NCT02802345|42242147|FG001|Overall Study|Withdrawal by Subject|3|||
19785071|NCT02802345|42242146|FG000|Overall Study|Protocol Violation|0|||
19785072|NCT02802345|42242147|FG001|Overall Study|Protocol Violation|1|||
19785073|NCT02802345|42242146|FG000|Overall Study|Other than listed|1|||
19785074|NCT02802345|42242147|FG001|Overall Study|Other than listed|5|||
19785075|NCT02801877|42242157|FG000|Overall Study|Lost to Follow-up|1|||
19785076|NCT02801877|42242158|FG001|Overall Study|Lost to Follow-up|1|||
19785077|NCT02801877|42242159|FG002|Overall Study|Lost to Follow-up|2|||
19785078|NCT02801877|42242160|FG003|Overall Study|Lost to Follow-up|0|||
19785079|NCT02801877|42242157|FG000|Overall Study|Never Started Treatment|2|||
19785080|NCT02801877|42242158|FG001|Overall Study|Never Started Treatment|0|||
19785081|NCT02801877|42242159|FG002|Overall Study|Never Started Treatment|4|||
19785082|NCT02801877|42242160|FG003|Overall Study|Never Started Treatment|0|||
19785083|NCT02805309|42242173|FG000|Overall Study|Lost to Follow-up|2|||
19785084|NCT02805309|42242174|FG001|Overall Study|Lost to Follow-up|2|||
19785085|NCT02805309|42242175|FG002|Overall Study|Lost to Follow-up|2|||
19785086|NCT02805309|42242173|FG000|Overall Study|Post-Randomization Exclusion|0|||
19785087|NCT02805309|42242174|FG001|Overall Study|Post-Randomization Exclusion|2|||
19785088|NCT02805309|42242175|FG002|Overall Study|Post-Randomization Exclusion|1|||
19785089|NCT02804763|42242187|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
19785090|NCT02804763|42242188|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
19785091|NCT02804763|42242189|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
19785092|NCT02804763|42242190|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
19785093|NCT02804763|42242187|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
19785094|NCT02804763|42242188|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
19785095|NCT02804763|42242189|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
19785096|NCT02804763|42242190|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
19785097|NCT02804763|42242187|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
19785098|NCT02804763|42242188|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
19785099|NCT02804763|42242189|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
19785100|NCT02804763|42242190|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
19785101|NCT02804763|42242187|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
19785102|NCT02804763|42242188|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
19785103|NCT02804763|42242189|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
19785104|NCT02804763|42242190|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
19785105|NCT02804763|42242187|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
19785106|NCT02804763|42242188|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
19785107|NCT02804763|42242189|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
19785108|NCT02804763|42242190|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
19785109|NCT02804763|42242187|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
19785110|NCT02804763|42242188|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
19785111|NCT02804763|42242189|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
19785112|NCT02804763|42242190|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
19785113|NCT02748057|42242206|FG000|Overall Study|Adverse Event|1|||
19785114|NCT02748057|42242207|FG001|Overall Study|Adverse Event|0|||
19785115|NCT02748057|42242206|FG000|Overall Study|Physician Decision|0|||
19785116|NCT02748057|42242207|FG001|Overall Study|Physician Decision|1|||
19785117|NCT02748057|42242206|FG000|Overall Study|Protocol Violation|2|||
19785118|NCT02748057|42242207|FG001|Overall Study|Protocol Violation|1|||
19785119|NCT02748057|42242206|FG000|Overall Study|Participant Moved|1|||
19785120|NCT02748057|42242207|FG001|Overall Study|Participant Moved|0|||
19785121|NCT02748057|42242206|FG000|Overall Study|Withdrawal by Subject|1|||
19785122|NCT02748057|42242207|FG001|Overall Study|Withdrawal by Subject|0|||
19785123|NCT02748213|42242215|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
19785124|NCT02748213|42242216|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
19785125|NCT02748213|42242215|FG000|Overall Study|Abnormal Laboratory Test|1|||
19785126|NCT02748213|42242216|FG001|Overall Study|Abnormal Laboratory Test|0|||
19785127|NCT02748213|42242215|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
19785128|NCT02748213|42242216|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
19785129|NCT02748213|42242215|FG000|Overall Study|Death|5|||
19785130|NCT02748213|42242216|FG001|Overall Study|Death|3|||
19785131|NCT02748213|42242215|FG000|Overall Study|Insufficient Therapeutic Response|56|||
19785132|NCT02748213|42242216|FG001|Overall Study|Insufficient Therapeutic Response|57|||
19785133|NCT02748213|42242215|FG000|Overall Study|Violation of Selection Criteria|2|||
19785134|NCT02748213|42242216|FG001|Overall Study|Violation of Selection Criteria|0|||
19785135|NCT02748213|42242215|FG000|Overall Study|Protocol Violation|6|||
19785136|NCT02748213|42242216|FG001|Overall Study|Protocol Violation|4|||
19785137|NCT02748213|42242215|FG000|Overall Study|Refused Treatment*|6|||
19785138|NCT02748213|42242216|FG001|Overall Study|Refused Treatment*|6|||
19477790|NCT01478971|41757048|FG000|Standard of Care Period|Withdrawal by Subject|3|||
19477791|NCT01478971|41757048|FG000|Standard of Care Period|Death|8|||
19477792|NCT01478971|41757048|FG000|Standard of Care Period|Lost to Follow-up|9|||
19477793|NCT01478971|41757048|FG000|Standard of Care Period|Other|4|||
19477794|NCT01478971|41757048|FG000|Peginesatide Treatment Period|Adverse Event|1|||
19477795|NCT01478971|41757048|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
19477796|NCT01478971|41757048|FG000|Peginesatide Treatment Period|Death|4|||
19477797|NCT01478971|41757048|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
19477798|NCT01478971|41757048|FG000|Peginesatide Treatment Period|Other|4|||
19477799|NCT01507051|41757060|FG000|Overall Study|Withdrawal by Subject|1|||
19477800|NCT01507051|41757061|FG001|Overall Study|Withdrawal by Subject|3|||
19696678|NCT00283842|42141983|FG004|Overall Study|Withdrawal by Subject|4|||
19696679|NCT00283842|42141979|FG000|Overall Study|Lack of Efficacy|1|||
19696680|NCT00283842|42141980|FG001|Overall Study|Lack of Efficacy|3|||
19696681|NCT00283842|42141981|FG002|Overall Study|Lack of Efficacy|1|||
19696682|NCT00283842|42141982|FG003|Overall Study|Lack of Efficacy|0|||
19696683|NCT00283842|42141983|FG004|Overall Study|Lack of Efficacy|3|||
19696684|NCT00283842|42141979|FG000|Overall Study|Lost to Follow-up|0|||
19696685|NCT00283842|42141980|FG001|Overall Study|Lost to Follow-up|2|||
19696686|NCT00283842|42141981|FG002|Overall Study|Lost to Follow-up|4|||
19696687|NCT00283842|42141982|FG003|Overall Study|Lost to Follow-up|1|||
19696688|NCT00283842|42141983|FG004|Overall Study|Lost to Follow-up|1|||
19696689|NCT00298038|42141997|FG000|Overall Study|Lost to Follow-up|0|||
19696690|NCT00298038|42141998|FG001|Overall Study|Lost to Follow-up|1|||
19696691|NCT00298038|42141997|FG000|Overall Study|Liver Transplant|0|||
19696692|NCT00298038|42141998|FG001|Overall Study|Liver Transplant|1|||
19696693|NCT00298038|42141997|FG000|Overall Study|Protocol Violation|1|||
19477801|NCT01507051|41757062|FG002|Overall Study|Withdrawal by Subject|1|||
19477802|NCT01507051|41757063|FG003|Overall Study|Withdrawal by Subject|6|||
19477803|NCT01507051|41757060|FG000|Overall Study|Physician Decision|0|||
19477804|NCT01507051|41757061|FG001|Overall Study|Physician Decision|0|||
19477805|NCT01507051|41757062|FG002|Overall Study|Physician Decision|0|||
19477806|NCT01507051|41757063|FG003|Overall Study|Physician Decision|1|||
19477807|NCT01507051|41757060|FG000|Overall Study|Adverse Event|1|||
19477808|NCT01507051|41757061|FG001|Overall Study|Adverse Event|0|||
19477809|NCT01507051|41757062|FG002|Overall Study|Adverse Event|0|||
19477810|NCT01507051|41757063|FG003|Overall Study|Adverse Event|0|||
19477811|NCT01478347|41757073|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
19477812|NCT01478347|41757073|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
19477813|NCT01478347|41757073|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
19477814|NCT01478113|41757079|FG000|Overall Study|Withdrawal by Subject|0|||
19477815|NCT01478113|41757080|FG001|Overall Study|Withdrawal by Subject|1|||
19477816|NCT01478113|41757079|FG000|Overall Study|Physician Decision|1|||
19477817|NCT01478113|41757080|FG001|Overall Study|Physician Decision|0|||
19477818|NCT01506271|41757091|FG000|Overall Study|Progressive disease|0|||
19477819|NCT01506271|41757092|FG001|Overall Study|Progressive disease|1|||
19477820|NCT01506271|41757093|FG002|Overall Study|Progressive disease|0|||
19477821|NCT01506271|41757091|FG000|Overall Study|Protocol Violation|3|||
19477822|NCT01506271|41757092|FG001|Overall Study|Protocol Violation|1|||
19477823|NCT01506271|41757093|FG002|Overall Study|Protocol Violation|0|||
19477824|NCT01506271|41757091|FG000|Overall Study|Death|0|||
19477825|NCT01506271|41757092|FG001|Overall Study|Death|1|||
19477826|NCT01506271|41757093|FG002|Overall Study|Death|0|||
19477827|NCT01506271|41757091|FG000|Overall Study|Adverse Event|0|||
19477828|NCT01506271|41757092|FG001|Overall Study|Adverse Event|2|||
19477829|NCT01506271|41757093|FG002|Overall Study|Adverse Event|0|||
19477830|NCT01506271|41757091|FG000|Overall Study|Insufficient supply of study drug|1|||
19477831|NCT01506271|41757092|FG001|Overall Study|Insufficient supply of study drug|0|||
19477832|NCT01506271|41757093|FG002|Overall Study|Insufficient supply of study drug|0|||
19477833|NCT01506271|41757091|FG000|Overall Study|Withdrawal by Subject|0|||
19477834|NCT01506271|41757092|FG001|Overall Study|Withdrawal by Subject|1|||
19696694|NCT00298038|42141998|FG001|Overall Study|Protocol Violation|3|||
19696695|NCT00298038|42141997|FG000|Overall Study|Death|6|||
19696696|NCT00298038|42141998|FG001|Overall Study|Death|3|||
19785139|NCT02748213|42242215|FG000|Overall Study|Failure to Return|1|||
19785140|NCT02748213|42242216|FG001|Overall Study|Failure to Return|0|||
19785141|NCT02748213|42242215|FG000|Overall Study|Other|30|||
19696697|NCT00298038|42141997|FG000|Overall Study|Withdrawal by Subject|6|||
19785142|NCT02748213|42242216|FG001|Overall Study|Other|29|||
19785143|NCT02613910|42242222|FG000|Overall Study|Termination of study|1|||
19785144|NCT02802735|42242229|FG000|Overall Study|Withdrawal by Subject|0|||
19785145|NCT02802735|42242230|FG001|Overall Study|Withdrawal by Subject|1|||
19785146|NCT02802735|42242231|FG002|Overall Study|Withdrawal by Subject|0|||
19785147|NCT02802735|42242232|FG003|Overall Study|Withdrawal by Subject|0|||
19785148|NCT02802735|42242233|FG004|Overall Study|Withdrawal by Subject|0|||
19785149|NCT02799381|42242263|FG000|Overall Study|Withdrew consent|3|||
19785150|NCT02799381|42242264|FG001|Overall Study|Withdrew consent|2|||
19785151|NCT02799381|42242263|FG000|Overall Study|Adverse Event|0|||
19785152|NCT02799381|42242264|FG001|Overall Study|Adverse Event|1|||
19785153|NCT02799381|42242263|FG000|Overall Study|Participant did not take any study drug|1|||
19785154|NCT02799381|42242264|FG001|Overall Study|Participant did not take any study drug|0|||
19785155|NCT01333059|42242272|FG000|Overall Study|Physician Decision|3|||
19785156|NCT01333059|42242273|FG001|Overall Study|Physician Decision|3|||
19785157|NCT01333059|42242272|FG000|Overall Study|Protocol Violation|3|||
19785158|NCT01333059|42242273|FG001|Overall Study|Protocol Violation|0|||
19785159|NCT01370733|42242283|FG000|Overall Study|Withdrawal by Subject|8|||
19696698|NCT00298038|42141998|FG001|Overall Study|Withdrawal by Subject|9|||
19696699|NCT00298038|42141997|FG000|Overall Study|Adverse Event|8|||
19696700|NCT00298038|42141998|FG001|Overall Study|Adverse Event|7|||
19696701|NCT00298038|42141997|FG000|Overall Study|Breakthrough overt HE episode|28|||
19696702|NCT00298038|42141998|FG001|Overall Study|Breakthrough overt HE episode|69|||
19696703|NCT00298038|42141997|FG000|Overall Study|Noncompliance|1|||
19785160|NCT01370733|42242284|FG001|Overall Study|Withdrawal by Subject|8|||
19785161|NCT01370733|42242283|FG000|Overall Study|Lost to Follow-up|3|||
19785162|NCT01370733|42242284|FG001|Overall Study|Lost to Follow-up|0|||
19785163|NCT01370733|42242283|FG000|Overall Study|Adverse Event|2|||
19696704|NCT00298038|42141998|FG001|Overall Study|Noncompliance|0|||
19696705|NCT00298038|42141997|FG000|Overall Study|Cocaine Abuse|1|||
19696706|NCT00298038|42141998|FG001|Overall Study|Cocaine Abuse|0|||
19696707|NCT00298038|42141997|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
19696708|NCT00298038|42141998|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
19696709|NCT00283686|42142008|FG000|Overall Study|Death|1|||
19696710|NCT00283686|42142009|FG001|Overall Study|Death|1|||
19696711|NCT00283686|42142010|FG002|Overall Study|Death|1|||
19696712|NCT00283686|42142011|FG003|Overall Study|Death|0|||
19696713|NCT00283686|42142008|FG000|Overall Study|Lost to Follow-up|21|||
19696714|NCT00283686|42142009|FG001|Overall Study|Lost to Follow-up|31|||
19696715|NCT00283686|42142010|FG002|Overall Study|Lost to Follow-up|26|||
19696716|NCT00283686|42142011|FG003|Overall Study|Lost to Follow-up|20|||
19696717|NCT00283686|42142008|FG000|Overall Study|Less than full participation|7|||
19696718|NCT00283686|42142009|FG001|Overall Study|Less than full participation|9|||
19696719|NCT00283686|42142010|FG002|Overall Study|Less than full participation|6|||
19696720|NCT00283686|42142011|FG003|Overall Study|Less than full participation|12|||
19696721|NCT00297882|42142023|FG000|Day 14|Lack of Efficacy|12|||
19696722|NCT00297882|42142024|FG001|Day 14|Lack of Efficacy|49|||
19696723|NCT00297882|42142023|FG000|Day 28|Lost to Follow-up|13|||
19696724|NCT00297882|42142024|FG001|Day 28|Lost to Follow-up|23|||
19696725|NCT00297882|42142023|FG000|Day 28|Lack of Efficacy|3|||
19696726|NCT00297882|42142024|FG001|Day 28|Lack of Efficacy|0|||
19696727|NCT00297648|42142032|FG000|Overall Study|Adverse Event|13|||
19696728|NCT00297648|42142032|FG000|Overall Study|Lack of Efficacy|18|||
19696729|NCT00297648|42142032|FG000|Overall Study|Lost to Follow-up|1|||
19696730|NCT00297648|42142032|FG000|Overall Study|Withdrawal by Subject|3|||
19696731|NCT00297648|42142032|FG000|Overall Study|Other: Incompliance|1|||
19696732|NCT00283296|42142036|FG000|Overall Study|in-home trial not completed|5|||
19696733|NCT00297492|42142044|FG000|Set Quit Date|Lost to Follow-up|7|||
19696734|NCT00297492|42142045|FG001|Set Quit Date|Lost to Follow-up|13|||
19696735|NCT00297492|42142046|FG002|Set Quit Date|Lost to Follow-up|5|||
19696736|NCT00297492|42142044|FG000|6 Month Follow-up|Lost to Follow-up|63|||
19696737|NCT00297492|42142045|FG001|6 Month Follow-up|Lost to Follow-up|49|||
19696738|NCT00297492|42142046|FG002|6 Month Follow-up|Lost to Follow-up|27|||
19696739|NCT00297258|42142054|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
19696740|NCT00297258|42142054|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
19696741|NCT00297258|42142054|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
19696742|NCT00297258|42142054|FG000|Overall Study|Intercurrent Illness|3|||
19696743|NCT00297258|42142054|FG000|Overall Study|Intercurrent Death|2|||
19696744|NCT00297258|42142054|FG000|Overall Study|Deteriorization of General Condition|1|||
19696745|NCT00297258|42142054|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
19696746|NCT00297258|42142054|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
19696747|NCT00297258|42142054|FG000|Overall Study|Switch to Commercial Treatment|1|||
19696748|NCT00297258|42142054|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
19696749|NCT00496769|42142063|FG000|Double Blind|>=1 reason assigned per patient|558|||
19696750|NCT00496769|42142064|FG001|Double Blind|>=1 reason assigned per patient|649|||
19696751|NCT00496769|42142065|FG002|Double Blind|>=1 reason assigned per patient|0|||
19696752|NCT00496769|42142063|FG000|Open Label|>=1 reason assigned per patient|0|||
19696753|NCT00496769|42142064|FG001|Open Label|>=1 reason assigned per patient|0|||
19696754|NCT00496769|42142065|FG002|Open Label|>=1 reason assigned per patient|1011|||
19696755|NCT00478673|42142074|FG000|30-Days Post-Procedure|Death|2|||
19785164|NCT01370733|42242284|FG001|Overall Study|Adverse Event|4|||
19785165|NCT01370733|42242283|FG000|Overall Study|Lack of Efficacy|3|||
19785166|NCT01370733|42242284|FG001|Overall Study|Lack of Efficacy|5|||
19785167|NCT01370733|42242283|FG000|Overall Study|Physician Decision|0|||
19785168|NCT01370733|42242284|FG001|Overall Study|Physician Decision|2|||
19785169|NCT01370733|42242283|FG000|Overall Study|Protocol Violation|1|||
19785170|NCT01370733|42242284|FG001|Overall Study|Protocol Violation|3|||
19785171|NCT02613364|42242293|FG000|Overall Study|Other|19|||
19785172|NCT02613364|42242294|FG001|Overall Study|Other|29|||
19785173|NCT02613364|42242295|FG002|Overall Study|Other|17|||
19785174|NCT02613364|42242293|FG000|Overall Study|Too time consuming|21|||
19785175|NCT02613364|42242294|FG001|Overall Study|Too time consuming|26|||
19785176|NCT02613364|42242295|FG002|Overall Study|Too time consuming|26|||
19785177|NCT02613364|42242293|FG000|Overall Study|Withdrawal by Subject|13|||
19785178|NCT02613364|42242294|FG001|Overall Study|Withdrawal by Subject|18|||
19785179|NCT02613364|42242295|FG002|Overall Study|Withdrawal by Subject|17|||
19785180|NCT02613364|42242293|FG000|Overall Study|Medical|12|||
19785181|NCT02613364|42242294|FG001|Overall Study|Medical|13|||
19785182|NCT02613364|42242295|FG002|Overall Study|Medical|9|||
19785183|NCT02613364|42242293|FG000|Overall Study|Disliked Study Procedure|1|||
19785184|NCT02613364|42242294|FG001|Overall Study|Disliked Study Procedure|1|||
19785185|NCT02613364|42242295|FG002|Overall Study|Disliked Study Procedure|4|||
19785186|NCT02613364|42242293|FG000|Overall Study|Disliked Intervention|0|||
19785187|NCT02613364|42242294|FG001|Overall Study|Disliked Intervention|3|||
19785188|NCT02613364|42242295|FG002|Overall Study|Disliked Intervention|3|||
19785189|NCT01370655|42242315|FG000|Period 1|Adverse Event|2|||
19785190|NCT01370655|42242316|FG001|Period 1|Adverse Event|0|||
19785191|NCT01370655|42242317|FG002|Period 1|Adverse Event|0|||
19785192|NCT01370655|42242318|FG003|Period 1|Adverse Event|0|||
19785193|NCT01370655|42242319|FG004|Period 1|Adverse Event|0|||
19785194|NCT01370655|42242320|FG005|Period 1|Adverse Event|0|||
19785195|NCT01370655|42242321|FG006|Period 1|Adverse Event|1|||
19785196|NCT01370655|42242322|FG007|Period 1|Adverse Event|0|||
19785197|NCT01370655|42242323|FG008|Period 1|Adverse Event|0|||
19785198|NCT01370655|42242324|FG009|Period 1|Adverse Event|0|||
19785199|NCT01370655|42242325|FG010|Period 1|Adverse Event|0|||
19785200|NCT01370655|42242326|FG011|Period 1|Adverse Event|0|||
19785201|NCT01370655|42242315|FG000|Period 2|Adverse Event|0|||
19785202|NCT01370655|42242316|FG001|Period 2|Adverse Event|0|||
19785203|NCT01370655|42242317|FG002|Period 2|Adverse Event|1|||
19785204|NCT01370655|42242318|FG003|Period 2|Adverse Event|0|||
19785205|NCT01370655|42242319|FG004|Period 2|Adverse Event|1|||
19785206|NCT01370655|42242320|FG005|Period 2|Adverse Event|0|||
19785207|NCT01370655|42242321|FG006|Period 2|Adverse Event|0|||
19785208|NCT01370655|42242322|FG007|Period 2|Adverse Event|1|||
19785209|NCT01370655|42242323|FG008|Period 2|Adverse Event|0|||
19785210|NCT01370655|42242324|FG009|Period 2|Adverse Event|0|||
19785211|NCT01370655|42242325|FG010|Period 2|Adverse Event|0|||
19785212|NCT01370655|42242326|FG011|Period 2|Adverse Event|0|||
19785213|NCT01370655|42242315|FG000|Period 2|met protocol specified stopping criteria|0|||
19785214|NCT01370655|42242316|FG001|Period 2|met protocol specified stopping criteria|0|||
19785215|NCT01370655|42242317|FG002|Period 2|met protocol specified stopping criteria|1|||
19785216|NCT01370655|42242318|FG003|Period 2|met protocol specified stopping criteria|0|||
19785217|NCT01370655|42242319|FG004|Period 2|met protocol specified stopping criteria|0|||
19785218|NCT01370655|42242320|FG005|Period 2|met protocol specified stopping criteria|0|||
19785219|NCT01370655|42242321|FG006|Period 2|met protocol specified stopping criteria|1|||
19785220|NCT01370655|42242322|FG007|Period 2|met protocol specified stopping criteria|0|||
19785221|NCT01370655|42242323|FG008|Period 2|met protocol specified stopping criteria|1|||
19785222|NCT01370655|42242324|FG009|Period 2|met protocol specified stopping criteria|0|||
19785223|NCT01370655|42242325|FG010|Period 2|met protocol specified stopping criteria|1|||
19785224|NCT01370655|42242326|FG011|Period 2|met protocol specified stopping criteria|0|||
19785225|NCT01370655|42242315|FG000|Period 2|Withdrawal by Subject|0|||
19785226|NCT01370655|42242316|FG001|Period 2|Withdrawal by Subject|0|||
19785227|NCT01370655|42242317|FG002|Period 2|Withdrawal by Subject|0|||
19785228|NCT01370655|42242318|FG003|Period 2|Withdrawal by Subject|0|||
19785229|NCT01370655|42242319|FG004|Period 2|Withdrawal by Subject|0|||
19785230|NCT01370655|42242320|FG005|Period 2|Withdrawal by Subject|0|||
19785231|NCT01370655|42242321|FG006|Period 2|Withdrawal by Subject|0|||
19785232|NCT01370655|42242322|FG007|Period 2|Withdrawal by Subject|0|||
19785233|NCT01370655|42242323|FG008|Period 2|Withdrawal by Subject|1|||
19785234|NCT01370655|42242324|FG009|Period 2|Withdrawal by Subject|0|||
19785235|NCT01370655|42242325|FG010|Period 2|Withdrawal by Subject|0|||
19785236|NCT01370655|42242326|FG011|Period 2|Withdrawal by Subject|0|||
19477835|NCT01506271|41757093|FG002|Overall Study|Withdrawal by Subject|1|||
19785237|NCT02612194|42242339|FG000|Overall Study|Death|5|||
19785238|NCT02612194|42242340|FG001|Overall Study|Death|0|||
19785239|NCT02612194|42242341|FG002|Overall Study|Death|2|||
19785240|NCT02612194|42242339|FG000|Overall Study|Early Study Termination|1|||
19785241|NCT02612194|42242340|FG001|Overall Study|Early Study Termination|0|||
19785242|NCT02612194|42242341|FG002|Overall Study|Early Study Termination|0|||
19785243|NCT02798211|42242351|FG000|Period 1|Adverse Event|1|||
19785244|NCT02798211|42242352|FG001|Period 1|Adverse Event|1|||
19785245|NCT02798211|42242353|FG002|Period 1|Adverse Event|0|||
19785246|NCT02798211|42242354|FG003|Period 1|Adverse Event|0|||
19785247|NCT02798211|42242355|FG004|Period 1|Adverse Event|0|||
19785248|NCT02798211|42242356|FG005|Period 1|Adverse Event|0|||
19785249|NCT02798211|42242351|FG000|Period 1|Lost to Follow-up|2|||
19785250|NCT02798211|42242352|FG001|Period 1|Lost to Follow-up|1|||
19785251|NCT02798211|42242353|FG002|Period 1|Lost to Follow-up|0|||
19785252|NCT02798211|42242354|FG003|Period 1|Lost to Follow-up|0|||
19785253|NCT02798211|42242355|FG004|Period 1|Lost to Follow-up|0|||
19785254|NCT02798211|42242356|FG005|Period 1|Lost to Follow-up|0|||
19785255|NCT02798211|42242351|FG000|Period 1|Protocol Violation|0|||
19785256|NCT02798211|42242352|FG001|Period 1|Protocol Violation|0|||
19785257|NCT02798211|42242353|FG002|Period 1|Protocol Violation|2|||
19785258|NCT02798211|42242354|FG003|Period 1|Protocol Violation|0|||
19785259|NCT02798211|42242355|FG004|Period 1|Protocol Violation|0|||
19785260|NCT02798211|42242356|FG005|Period 1|Protocol Violation|0|||
19785261|NCT02798211|42242351|FG000|Period 1|Withdrawal by Subject|1|||
19785262|NCT02798211|42242352|FG001|Period 1|Withdrawal by Subject|1|||
19785263|NCT02798211|42242353|FG002|Period 1|Withdrawal by Subject|0|||
19785264|NCT02798211|42242354|FG003|Period 1|Withdrawal by Subject|0|||
19785265|NCT02798211|42242355|FG004|Period 1|Withdrawal by Subject|0|||
19785266|NCT02798211|42242356|FG005|Period 1|Withdrawal by Subject|0|||
19785267|NCT02798211|42242351|FG000|Period 1|Death|0|||
19785268|NCT02798211|42242352|FG001|Period 1|Death|0|||
19785269|NCT02798211|42242353|FG002|Period 1|Death|1|||
19785270|NCT02798211|42242354|FG003|Period 1|Death|0|||
19785271|NCT02798211|42242355|FG004|Period 1|Death|0|||
19785272|NCT02798211|42242356|FG005|Period 1|Death|0|||
19785273|NCT02798211|42242351|FG000|Period 1|Withdrawal of Informed Consent|2|||
19785274|NCT02798211|42242352|FG001|Period 1|Withdrawal of Informed Consent|7|||
19785275|NCT02798211|42242353|FG002|Period 1|Withdrawal of Informed Consent|3|||
19785276|NCT02798211|42242354|FG003|Period 1|Withdrawal of Informed Consent|0|||
19785277|NCT02798211|42242355|FG004|Period 1|Withdrawal of Informed Consent|0|||
19785278|NCT02798211|42242356|FG005|Period 1|Withdrawal of Informed Consent|0|||
19785279|NCT02798211|42242351|FG000|Period 2|Withdrawal by Subject|2|||
19785280|NCT02798211|42242352|FG001|Period 2|Withdrawal by Subject|0|||
19785281|NCT02798211|42242353|FG002|Period 2|Withdrawal by Subject|0|||
19785282|NCT02798211|42242354|FG003|Period 2|Withdrawal by Subject|0|||
19785283|NCT02798211|42242355|FG004|Period 2|Withdrawal by Subject|2|||
19785284|NCT02798211|42242356|FG005|Period 2|Withdrawal by Subject|2|||
19785285|NCT02798211|42242351|FG000|Period 2|Adverse Event|5|||
19785286|NCT02798211|42242352|FG001|Period 2|Adverse Event|0|||
19785287|NCT02798211|42242353|FG002|Period 2|Adverse Event|0|||
19785288|NCT02798211|42242354|FG003|Period 2|Adverse Event|0|||
19785289|NCT02798211|42242355|FG004|Period 2|Adverse Event|1|||
19785290|NCT02798211|42242356|FG005|Period 2|Adverse Event|0|||
19785291|NCT02798211|42242351|FG000|Period 2|Lack of Efficacy|1|||
19785292|NCT02798211|42242352|FG001|Period 2|Lack of Efficacy|0|||
19785293|NCT02798211|42242353|FG002|Period 2|Lack of Efficacy|0|||
19785294|NCT02798211|42242354|FG003|Period 2|Lack of Efficacy|1|||
19785295|NCT02798211|42242355|FG004|Period 2|Lack of Efficacy|0|||
19785296|NCT02798211|42242356|FG005|Period 2|Lack of Efficacy|1|||
19785297|NCT02798211|42242351|FG000|Period 2|Lost to Follow-up|3|||
19785298|NCT02798211|42242352|FG001|Period 2|Lost to Follow-up|0|||
19696756|NCT00478673|42142074|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
19696757|NCT00478673|42142074|FG000|30-Days Post-Procedure|Missed Visit|7|||
19696758|NCT00478673|42142074|FG000|12-Months Post-Procedure|Death|23|||
19696759|NCT00478673|42142074|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
19696760|NCT00478673|42142074|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
19696761|NCT00478673|42142074|FG000|12-Months Post-Procedure|Missed Visit|25|||
19696762|NCT00478673|42142074|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
19696763|NCT00488345|42142081|FG000|Overall Study|Adverse Event|0|||
19696764|NCT00488345|42142082|FG001|Overall Study|Adverse Event|1|||
19696765|NCT00488345|42142083|FG002|Overall Study|Adverse Event|1|||
19696766|NCT00488345|42142081|FG000|Overall Study|Unable to administer antibiotics at home|0|||
19696767|NCT00488345|42142082|FG001|Overall Study|Unable to administer antibiotics at home|1|||
19696768|NCT00488345|42142083|FG002|Overall Study|Unable to administer antibiotics at home|0|||
19785299|NCT02798211|42242353|FG002|Period 2|Lost to Follow-up|0|||
19785300|NCT02798211|42242354|FG003|Period 2|Lost to Follow-up|0|||
19785301|NCT02798211|42242355|FG004|Period 2|Lost to Follow-up|2|||
19785302|NCT02798211|42242356|FG005|Period 2|Lost to Follow-up|0|||
19785303|NCT02798211|42242351|FG000|Period 2|Physician Decision|1|||
19785304|NCT02798211|42242352|FG001|Period 2|Physician Decision|0|||
19785305|NCT02798211|42242353|FG002|Period 2|Physician Decision|0|||
19785306|NCT02798211|42242354|FG003|Period 2|Physician Decision|1|||
19785307|NCT02798211|42242355|FG004|Period 2|Physician Decision|1|||
19785308|NCT02798211|42242356|FG005|Period 2|Physician Decision|0|||
19785309|NCT02798211|42242351|FG000|Period 2|Pregnancy|0|||
19785310|NCT02798211|42242352|FG001|Period 2|Pregnancy|0|||
19785311|NCT02798211|42242353|FG002|Period 2|Pregnancy|0|||
19785312|NCT02798211|42242354|FG003|Period 2|Pregnancy|2|||
19785313|NCT02798211|42242355|FG004|Period 2|Pregnancy|0|||
19785314|NCT02798211|42242356|FG005|Period 2|Pregnancy|0|||
19696769|NCT00488345|42142081|FG000|Overall Study|Institutional Review Board review|0|||
19696770|NCT00488345|42142082|FG001|Overall Study|Institutional Review Board review|0|||
19696771|NCT00488345|42142083|FG002|Overall Study|Institutional Review Board review|1|||
19696772|NCT00488345|42142081|FG000|Overall Study|Surgical team recommendation|0|||
19696773|NCT00488345|42142082|FG001|Overall Study|Surgical team recommendation|1|||
19696774|NCT00488345|42142083|FG002|Overall Study|Surgical team recommendation|0|||
19696775|NCT00488345|42142081|FG000|Overall Study|Parent/legal guardian request|0|||
19696776|NCT00488345|42142082|FG001|Overall Study|Parent/legal guardian request|1|||
19696777|NCT00488345|42142083|FG002|Overall Study|Parent/legal guardian request|1|||
19696778|NCT00283062|42142096|FG000|Overall Study|Did not receive any study medication|5|||
19696779|NCT00283062|42142097|FG001|Overall Study|Did not receive any study medication|4|||
19696780|NCT00283062|42142098|FG002|Overall Study|Did not receive any study medication|36|||
19785315|NCT02798211|42242351|FG000|Period 2|Technical problems|1|||
19785316|NCT02798211|42242352|FG001|Period 2|Technical problems|0|||
19785317|NCT02798211|42242353|FG002|Period 2|Technical problems|0|||
19785318|NCT02798211|42242354|FG003|Period 2|Technical problems|1|||
19785319|NCT02798211|42242355|FG004|Period 2|Technical problems|0|||
19785320|NCT02798211|42242356|FG005|Period 2|Technical problems|0|||
19785321|NCT02798211|42242351|FG000|Period 2|Withdrawal of Informed Consent|1|||
19785322|NCT02798211|42242352|FG001|Period 2|Withdrawal of Informed Consent|0|||
19785323|NCT02798211|42242353|FG002|Period 2|Withdrawal of Informed Consent|0|||
19785324|NCT02798211|42242354|FG003|Period 2|Withdrawal of Informed Consent|2|||
19785325|NCT02798211|42242355|FG004|Period 2|Withdrawal of Informed Consent|2|||
19785326|NCT02798211|42242356|FG005|Period 2|Withdrawal of Informed Consent|3|||
19785327|NCT02799069|42242371|FG000|Overall Study|Adverse Event|0|||
19785328|NCT02799069|42242372|FG001|Overall Study|Adverse Event|2|||
19785329|NCT02799069|42242373|FG002|Overall Study|Adverse Event|2|||
19785330|NCT02799069|42242371|FG000|Overall Study|Lack of Efficacy|2|||
19785331|NCT02799069|42242372|FG001|Overall Study|Lack of Efficacy|0|||
19785332|NCT02799069|42242373|FG002|Overall Study|Lack of Efficacy|0|||
19785333|NCT02799069|42242371|FG000|Overall Study|Lost to Follow-up|1|||
19785334|NCT02799069|42242372|FG001|Overall Study|Lost to Follow-up|1|||
19785335|NCT02799069|42242373|FG002|Overall Study|Lost to Follow-up|0|||
19785336|NCT02799069|42242371|FG000|Overall Study|Withdrawal by Subject|4|||
19785337|NCT02799069|42242372|FG001|Overall Study|Withdrawal by Subject|4|||
19785338|NCT02799069|42242373|FG002|Overall Study|Withdrawal by Subject|3|||
19785339|NCT02799069|42242371|FG000|Overall Study|Protocol Violation|1|||
19785340|NCT02799069|42242372|FG001|Overall Study|Protocol Violation|0|||
19785341|NCT02799069|42242373|FG002|Overall Study|Protocol Violation|2|||
19785342|NCT01669174|42242383|FG000|Overall Study|Subject withdrew consent|2|||
19785343|NCT01669174|42242384|FG001|Overall Study|Subject withdrew consent|2|||
19785344|NCT01669174|42242383|FG000|Overall Study|Lost to Follow-up|1|||
19785345|NCT01669174|42242384|FG001|Overall Study|Lost to Follow-up|0|||
19785346|NCT01669174|42242383|FG000|Overall Study|Adverse Event|2|||
19785347|NCT01669174|42242384|FG001|Overall Study|Adverse Event|2|||
19785348|NCT01669174|42242383|FG000|Overall Study|Administrative problems|1|||
19785349|NCT01669174|42242384|FG001|Overall Study|Administrative problems|2|||
19785350|NCT02798835|42242393|FG000|Overall Study|Protocol Violation|0|||
19785351|NCT02798835|42242394|FG001|Overall Study|Protocol Violation|0|||
19785352|NCT02798835|42242395|FG002|Overall Study|Protocol Violation|3|||
19785353|NCT02611882|42242406|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
19785354|NCT02611882|42242407|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
19785355|NCT02611882|42242408|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
19785356|NCT02796963|42242419|FG000|Overall Study|Lost to Follow-up|89|||
19785357|NCT02796963|42242420|FG001|Overall Study|Lost to Follow-up|76|||
19785358|NCT02796963|42242421|FG002|Overall Study|Lost to Follow-up|69|||
19785359|NCT02796963|42242422|FG003|Overall Study|Lost to Follow-up|72|||
19785360|NCT02796651|42242432|FG000|Overall Study|Adverse Event|6|||
19785361|NCT02796651|42242432|FG000|Overall Study|Lost to Follow-up|1|||
19785362|NCT02796651|42242432|FG000|Overall Study|Withdrawal by Subject|4|||
19785363|NCT02796651|42242432|FG000|Overall Study|Protocol Violation|4|||
19785364|NCT02796651|42242432|FG000|Overall Study|Lack of Efficacy|1|||
19696781|NCT00283062|42142099|FG003|Overall Study|Did not receive any study medication|45|||
19696782|NCT00283062|42142096|FG000|Overall Study|Adverse Event|2|||
19785365|NCT02796651|42242432|FG000|Overall Study|Other|10|||
19785366|NCT02613208|42242447|FG000|Overall Study|Withdrawal by Subject|1|||
19785367|NCT02613208|42242447|FG000|Overall Study|Change of address|2|||
19785368|NCT02613208|42242447|FG000|Overall Study|Physician Decision|2|||
19477836|NCT01506271|41757091|FG000|Overall Study|Lost to Follow-up|0|||
19696783|NCT00283062|42142097|FG001|Overall Study|Adverse Event|0|||
19696784|NCT00283062|42142098|FG002|Overall Study|Adverse Event|1|||
19785369|NCT02613208|42242447|FG000|Overall Study|Lost to Follow-up|5|||
19785370|NCT02613208|42242447|FG000|Overall Study|Death|37|||
19785371|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
19785372|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
19785373|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
19785374|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
19785375|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
19785376|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
19785377|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
19785378|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
19785379|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
19785380|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
19785381|NCT01668784|42242453|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
19785382|NCT01668784|42242454|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
19785383|NCT01668784|42242453|FG000|Treatment Period|Disease Progression|316|||
19785384|NCT01668784|42242454|FG001|Treatment Period|Disease Progression|293|||
19785385|NCT01668784|42242453|FG000|Treatment Period|Study Drug Toxicity|46|||
19785386|NCT01668784|42242454|FG001|Treatment Period|Study Drug Toxicity|53|||
19785387|NCT01668784|42242453|FG000|Treatment Period|Death|1|||
19785388|NCT01668784|42242454|FG001|Treatment Period|Death|1|||
19785389|NCT01668784|42242453|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
19785390|NCT01668784|42242454|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
19785391|NCT01668784|42242453|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
19785392|NCT01668784|42242454|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
19785393|NCT01668784|42242453|FG000|Treatment Period|Withdrawal by Subject|5|||
19785394|NCT01668784|42242454|FG001|Treatment Period|Withdrawal by Subject|3|||
19785395|NCT01668784|42242453|FG000|Treatment Period|Maximal Clinical Benefit|3|||
19785396|NCT01668784|42242454|FG001|Treatment Period|Maximal Clinical Benefit|3|||
19785397|NCT01668784|42242453|FG000|Treatment Period|Other|2|||
19785398|NCT01668784|42242454|FG001|Treatment Period|Other|8|||
19785399|NCT01668784|42242453|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
19785400|NCT01668784|42242454|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
19785401|NCT02750514|42242465|FG000|Track 1|Disease progression|20|||
19785402|NCT02750514|42242466|FG001|Track 1|Disease progression|1|||
19785403|NCT02750514|42242467|FG002|Track 1|Disease progression|0|||
19785404|NCT02750514|42242468|FG003|Track 1|Disease progression|1|||
19785405|NCT02750514|42242469|FG004|Track 1|Disease progression|0|||
19785406|NCT02750514|42242465|FG000|Track 1|Adverse event unrelated to study drug|1|||
19785407|NCT02750514|42242466|FG001|Track 1|Adverse event unrelated to study drug|0|||
19785408|NCT02750514|42242467|FG002|Track 1|Adverse event unrelated to study drug|0|||
19785409|NCT02750514|42242468|FG003|Track 1|Adverse event unrelated to study drug|0|||
19785410|NCT02750514|42242469|FG004|Track 1|Adverse event unrelated to study drug|0|||
19785411|NCT02750514|42242465|FG000|Track 1|Study drug toxicity|4|||
19785412|NCT02750514|42242466|FG001|Track 1|Study drug toxicity|1|||
19785413|NCT02750514|42242467|FG002|Track 1|Study drug toxicity|0|||
19785414|NCT02750514|42242468|FG003|Track 1|Study drug toxicity|1|||
19785415|NCT02750514|42242469|FG004|Track 1|Study drug toxicity|0|||
19785416|NCT02750514|42242465|FG000|Track 1|Participant request to discontinue|1|||
19785417|NCT02750514|42242466|FG001|Track 1|Participant request to discontinue|0|||
19785418|NCT02750514|42242467|FG002|Track 1|Participant request to discontinue|0|||
19785419|NCT02750514|42242468|FG003|Track 1|Participant request to discontinue|0|||
19785420|NCT02750514|42242469|FG004|Track 1|Participant request to discontinue|0|||
19785421|NCT02750514|42242465|FG000|Track 1|Other reasons|1|||
19785422|NCT02750514|42242466|FG001|Track 1|Other reasons|0|||
19785423|NCT02750514|42242467|FG002|Track 1|Other reasons|0|||
19785424|NCT02750514|42242468|FG003|Track 1|Other reasons|0|||
19785425|NCT02750514|42242469|FG004|Track 1|Other reasons|0|||
19785426|NCT02750514|42242465|FG000|Track 2|Disease progression|4|||
19785427|NCT02750514|42242466|FG001|Track 2|Disease progression|5|||
19785428|NCT02750514|42242467|FG002|Track 2|Disease progression|2|||
19785429|NCT02750514|42242468|FG003|Track 2|Disease progression|5|||
19785430|NCT02750514|42242469|FG004|Track 2|Disease progression|0|||
19785431|NCT02750514|42242465|FG000|Track 2|Adverse event unrelated to study drug|1|||
19785432|NCT02750514|42242466|FG001|Track 2|Adverse event unrelated to study drug|0|||
19785433|NCT02750514|42242467|FG002|Track 2|Adverse event unrelated to study drug|0|||
19785434|NCT02750514|42242468|FG003|Track 2|Adverse event unrelated to study drug|0|||
19785435|NCT02750514|42242469|FG004|Track 2|Adverse event unrelated to study drug|0|||
19785436|NCT02750514|42242465|FG000|Track 2|Study drug toxicity|1|||
19785437|NCT02750514|42242466|FG001|Track 2|Study drug toxicity|2|||
19785438|NCT02750514|42242467|FG002|Track 2|Study drug toxicity|0|||
19785439|NCT02750514|42242468|FG003|Track 2|Study drug toxicity|2|||
19785440|NCT02750514|42242469|FG004|Track 2|Study drug toxicity|0|||
19785441|NCT02750514|42242465|FG000|Track 2|Participant withdrew consent|0|||
19785442|NCT02750514|42242466|FG001|Track 2|Participant withdrew consent|1|||
19785443|NCT02750514|42242467|FG002|Track 2|Participant withdrew consent|0|||
19785444|NCT02750514|42242468|FG003|Track 2|Participant withdrew consent|0|||
19785445|NCT02750514|42242469|FG004|Track 2|Participant withdrew consent|0|||
19477837|NCT01506271|41757092|FG001|Overall Study|Lost to Follow-up|1|||
19785446|NCT02750514|42242465|FG000|Track 3|Disease progression|0|||
19785447|NCT02750514|42242466|FG001|Track 3|Disease progression|24|||
19696785|NCT00283062|42142099|FG003|Overall Study|Adverse Event|0|||
19696786|NCT00283062|42142096|FG000|Overall Study|Lost to Follow-up|1|||
19696787|NCT00283062|42142097|FG001|Overall Study|Lost to Follow-up|0|||
19696788|NCT00283062|42142098|FG002|Overall Study|Lost to Follow-up|1|||
19785448|NCT02750514|42242467|FG002|Track 3|Disease progression|13|||
19785449|NCT02750514|42242468|FG003|Track 3|Disease progression|14|||
19785450|NCT02750514|42242469|FG004|Track 3|Disease progression|0|||
19785451|NCT02750514|42242465|FG000|Track 3|Adverse event unrelated to study drug|0|||
19785452|NCT02750514|42242466|FG001|Track 3|Adverse event unrelated to study drug|1|||
19785453|NCT02750514|42242467|FG002|Track 3|Adverse event unrelated to study drug|1|||
19785454|NCT02750514|42242468|FG003|Track 3|Adverse event unrelated to study drug|1|||
19785455|NCT02750514|42242469|FG004|Track 3|Adverse event unrelated to study drug|0|||
19696789|NCT00283062|42142099|FG003|Overall Study|Lost to Follow-up|0|||
19696790|NCT00283062|42142096|FG000|Overall Study|Progressive disease|0|||
19696791|NCT00283062|42142097|FG001|Overall Study|Progressive disease|0|||
19785456|NCT02750514|42242465|FG000|Track 3|Study drug toxicity|0|||
19785457|NCT02750514|42242466|FG001|Track 3|Study drug toxicity|3|||
19607412|NCT00669955|42056211|FG000|Overall Study|not compliant with study drug/visit|2|||
19607413|NCT00669955|42056212|FG001|Overall Study|not compliant with study drug/visit|3|||
19607414|NCT00671749|42056218|FG000|Overall Study|Adverse Event|2|||
19607415|NCT00671749|42056218|FG000|Overall Study|Withdrawal by Subject|4|||
19607416|NCT00671749|42056218|FG000|Overall Study|Protocol Violation|1|||
19607417|NCT00671749|42056218|FG000|Overall Study|Lost to Follow-up|1|||
19696792|NCT00283062|42142098|FG002|Overall Study|Progressive disease|1|||
19696793|NCT00283062|42142099|FG003|Overall Study|Progressive disease|0|||
19696794|NCT00283062|42142096|FG000|Overall Study|Participant did not wish to continue|3|||
19696795|NCT00283062|42142097|FG001|Overall Study|Participant did not wish to continue|2|||
19696796|NCT00283062|42142098|FG002|Overall Study|Participant did not wish to continue|1|||
19696797|NCT00283062|42142099|FG003|Overall Study|Participant did not wish to continue|0|||
19696798|NCT00283062|42142096|FG000|Overall Study|Undefined|0|||
19696799|NCT00283062|42142097|FG001|Overall Study|Undefined|1|||
19696800|NCT00283062|42142098|FG002|Overall Study|Undefined|1|||
19607418|NCT00669877|42056222|FG000|Overall Study|Disease Progression/Death|4|||
19607419|NCT00882999|42056233|FG000|Overall Study|Adverse Event|0|||
19607420|NCT00882999|42056234|FG001|Overall Study|Adverse Event|0|||
19607421|NCT00882999|42056235|FG002|Overall Study|Adverse Event|0|||
19607422|NCT00882999|42056236|FG003|Overall Study|Adverse Event|0|||
19607423|NCT00882999|42056237|FG004|Overall Study|Adverse Event|1|||
19607424|NCT00882999|42056238|FG005|Overall Study|Adverse Event|0|||
19607425|NCT00882999|42056239|FG006|Overall Study|Adverse Event|0|||
19607426|NCT00882999|42056233|FG000|Overall Study|Death|0|||
19607427|NCT00882999|42056234|FG001|Overall Study|Death|1|||
19607428|NCT00882999|42056235|FG002|Overall Study|Death|0|||
19607429|NCT00882999|42056236|FG003|Overall Study|Death|0|||
19607430|NCT00882999|42056237|FG004|Overall Study|Death|0|||
19607431|NCT00882999|42056238|FG005|Overall Study|Death|0|||
19607432|NCT00882999|42056239|FG006|Overall Study|Death|0|||
19607433|NCT00882999|42056233|FG000|Overall Study|Withdrawal by Subject|7|||
19607434|NCT00882999|42056234|FG001|Overall Study|Withdrawal by Subject|6|||
19607435|NCT00882999|42056235|FG002|Overall Study|Withdrawal by Subject|3|||
19607436|NCT00882999|42056236|FG003|Overall Study|Withdrawal by Subject|3|||
19607437|NCT00882999|42056237|FG004|Overall Study|Withdrawal by Subject|6|||
19607438|NCT00882999|42056238|FG005|Overall Study|Withdrawal by Subject|5|||
19785458|NCT02750514|42242467|FG002|Track 3|Study drug toxicity|0|||
19785459|NCT02750514|42242468|FG003|Track 3|Study drug toxicity|1|||
19785460|NCT02750514|42242469|FG004|Track 3|Study drug toxicity|0|||
19785461|NCT02750514|42242465|FG000|Track 3|Participant request to discontinue|0|||
19785462|NCT02750514|42242466|FG001|Track 3|Participant request to discontinue|2|||
19785463|NCT02750514|42242467|FG002|Track 3|Participant request to discontinue|0|||
19696801|NCT00283062|42142099|FG003|Overall Study|Undefined|4|||
19696802|NCT00283062|42142096|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
19696803|NCT00283062|42142097|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
19696804|NCT00283062|42142098|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
19696805|NCT00283062|42142099|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
19696806|NCT00282984|42142111|FG000|Overall Study|Death|2|||
19696807|NCT00282984|42142112|FG001|Overall Study|Death|5|||
19696808|NCT00282984|42142111|FG000|Overall Study|Adverse Event|8|||
19696809|NCT00282984|42142112|FG001|Overall Study|Adverse Event|5|||
19785464|NCT02750514|42242468|FG003|Track 3|Participant request to discontinue|0|||
19785465|NCT02750514|42242469|FG004|Track 3|Participant request to discontinue|0|||
19607439|NCT00882999|42056239|FG006|Overall Study|Withdrawal by Subject|5|||
19607440|NCT00882999|42056233|FG000|Overall Study|Lost to Follow-up|0|||
19607441|NCT00882999|42056234|FG001|Overall Study|Lost to Follow-up|1|||
19607442|NCT00882999|42056235|FG002|Overall Study|Lost to Follow-up|1|||
19607443|NCT00882999|42056236|FG003|Overall Study|Lost to Follow-up|2|||
19696810|NCT00282984|42142111|FG000|Overall Study|Lack of Efficacy|0|||
19696811|NCT00282984|42142112|FG001|Overall Study|Lack of Efficacy|2|||
19785466|NCT02750514|42242465|FG000|Track 3|Participant withdrew consent|0|||
19785467|NCT02750514|42242466|FG001|Track 3|Participant withdrew consent|3|||
19785468|NCT02750514|42242467|FG002|Track 3|Participant withdrew consent|1|||
19785469|NCT02750514|42242468|FG003|Track 3|Participant withdrew consent|0|||
19785470|NCT02750514|42242469|FG004|Track 3|Participant withdrew consent|0|||
19785471|NCT02750514|42242465|FG000|Track 3|Other reasons|0|||
19785472|NCT02750514|42242466|FG001|Track 3|Other reasons|3|||
19785473|NCT02750514|42242467|FG002|Track 3|Other reasons|0|||
19785474|NCT02750514|42242468|FG003|Track 3|Other reasons|0|||
19785475|NCT02750514|42242469|FG004|Track 3|Other reasons|0|||
19785476|NCT02750514|42242465|FG000|Track 4|Study drug toxicity|0|||
19785477|NCT02750514|42242466|FG001|Track 4|Study drug toxicity|6|||
19785478|NCT02750514|42242467|FG002|Track 4|Study drug toxicity|0|||
19785479|NCT02750514|42242468|FG003|Track 4|Study drug toxicity|5|||
19785480|NCT02750514|42242469|FG004|Track 4|Study drug toxicity|0|||
19785481|NCT02750514|42242465|FG000|Track 4|Participant request to discontinue|0|||
19785482|NCT02750514|42242466|FG001|Track 4|Participant request to discontinue|1|||
19785483|NCT02750514|42242467|FG002|Track 4|Participant request to discontinue|0|||
19785484|NCT02750514|42242468|FG003|Track 4|Participant request to discontinue|1|||
19785485|NCT02750514|42242469|FG004|Track 4|Participant request to discontinue|0|||
19696812|NCT00282984|42142111|FG000|Overall Study|Lost to Follow-up|14|||
19696813|NCT00282984|42142112|FG001|Overall Study|Lost to Follow-up|10|||
19696814|NCT00282984|42142111|FG000|Overall Study|Withdrawal by Participant|22|||
19696815|NCT00282984|42142112|FG001|Overall Study|Withdrawal by Participant|34|||
19696816|NCT00282984|42142111|FG000|Overall Study|Participant stopped study medication|2|||
19696817|NCT00282984|42142112|FG001|Overall Study|Participant stopped study medication|2|||
19696818|NCT00282984|42142111|FG000|Overall Study|Participant only allowed phone follow-up|0|||
19696819|NCT00282984|42142112|FG001|Overall Study|Participant only allowed phone follow-up|1|||
19696820|NCT00282984|42142111|FG000|Overall Study|Participant used antipsychosis meds|0|||
19696821|NCT00282984|42142112|FG001|Overall Study|Participant used antipsychosis meds|1|||
19696822|NCT00282984|42142111|FG000|Overall Study|lack of motivation|1|||
19696823|NCT00282984|42142112|FG001|Overall Study|lack of motivation|0|||
19696824|NCT00282984|42142111|FG000|Overall Study|in prison|0|||
19696825|NCT00282984|42142112|FG001|Overall Study|in prison|1|||
19696826|NCT00282984|42142111|FG000|Overall Study|Protocol Violation|2|||
19696827|NCT00282984|42142112|FG001|Overall Study|Protocol Violation|0|||
19696828|NCT00282438|42142120|FG000|Overall Study|Lack of Efficacy|1|||
19696829|NCT00282438|42142121|FG001|Overall Study|Lack of Efficacy|0|||
19696830|NCT00282438|42142120|FG000|Overall Study|Death|0|||
19696831|NCT00282438|42142121|FG001|Overall Study|Death|1|||
19696832|NCT00296400|42142130|FG000|Overall Study|Adverse Event|7|||
19696833|NCT00296400|42142131|FG001|Overall Study|Adverse Event|7|||
19696834|NCT00296400|42142132|FG002|Overall Study|Adverse Event|7|||
19696835|NCT00296400|42142130|FG000|Overall Study|Withdrawal by Subject|5|||
19696836|NCT00296400|42142131|FG001|Overall Study|Withdrawal by Subject|6|||
19696837|NCT00296400|42142132|FG002|Overall Study|Withdrawal by Subject|2|||
19696838|NCT00296400|42142130|FG000|Overall Study|Incorrect enrollment|2|||
19696839|NCT00296400|42142131|FG001|Overall Study|Incorrect enrollment|0|||
19696840|NCT00296400|42142132|FG002|Overall Study|Incorrect enrollment|0|||
19696841|NCT00296400|42142130|FG000|Overall Study|Protocol Violation|1|||
19696842|NCT00296400|42142131|FG001|Overall Study|Protocol Violation|1|||
19696843|NCT00296400|42142132|FG002|Overall Study|Protocol Violation|1|||
19696844|NCT00296400|42142130|FG000|Overall Study|Lost to Follow-up|1|||
19696845|NCT00296400|42142131|FG001|Overall Study|Lost to Follow-up|1|||
19696846|NCT00296400|42142132|FG002|Overall Study|Lost to Follow-up|2|||
19696847|NCT00296400|42142130|FG000|Overall Study|Study specific discontinuation criteria|0|||
19696848|NCT00296400|42142131|FG001|Overall Study|Study specific discontinuation criteria|0|||
19696849|NCT00296400|42142132|FG002|Overall Study|Study specific discontinuation criteria|1|||
19696850|NCT00296400|42142130|FG000|Overall Study|Visit 10 was performed earlier|0|||
19696851|NCT00296400|42142131|FG001|Overall Study|Visit 10 was performed earlier|1|||
19696852|NCT00296400|42142132|FG002|Overall Study|Visit 10 was performed earlier|0|||
19696853|NCT00296400|42142130|FG000|Overall Study|Pregnancy|1|||
19696854|NCT00296400|42142131|FG001|Overall Study|Pregnancy|2|||
19696855|NCT00296400|42142132|FG002|Overall Study|Pregnancy|0|||
19696856|NCT00296244|42142145|FG000|Overall Study|Underwent retransplant|0|||
19785486|NCT02750514|42242465|FG000|Track 4|Participant withdrew consent|0|||
19696857|NCT00296244|42142146|FG001|Overall Study|Underwent retransplant|1|||
19696858|NCT00274716|42142163|FG000|Phase A|Other non-reported reason|4|||
19696859|NCT00274716|42142164|FG001|Phase A|Other non-reported reason|2|||
19696860|NCT00274716|42142165|FG002|Phase A|Other non-reported reason|1|||
19696861|NCT00274716|42142166|FG003|Phase A|Other non-reported reason|2|||
19696862|NCT00274716|42142167|FG004|Phase A|Other non-reported reason|0|||
19696863|NCT00274716|42142168|FG005|Phase A|Other non-reported reason|1|||
19696864|NCT00274716|42142163|FG000|Phase A|Participant moved|0|||
19696865|NCT00274716|42142164|FG001|Phase A|Participant moved|0|||
19696866|NCT00274716|42142165|FG002|Phase A|Participant moved|1|||
19696867|NCT00274716|42142166|FG003|Phase A|Participant moved|0|||
19696868|NCT00274716|42142167|FG004|Phase A|Participant moved|0|||
19696869|NCT00274716|42142168|FG005|Phase A|Participant moved|1|||
19696870|NCT00274716|42142163|FG000|Phase A|Site Terminated|0|||
19696871|NCT00274716|42142164|FG001|Phase A|Site Terminated|0|||
19696872|NCT00274716|42142165|FG002|Phase A|Site Terminated|0|||
19696873|NCT00274716|42142166|FG003|Phase A|Site Terminated|1|||
19696874|NCT00274716|42142167|FG004|Phase A|Site Terminated|0|||
19696875|NCT00274716|42142168|FG005|Phase A|Site Terminated|0|||
19696876|NCT00274716|42142163|FG000|Phase A|Protocol Violation|1|||
19696877|NCT00274716|42142164|FG001|Phase A|Protocol Violation|0|||
19696878|NCT00274716|42142165|FG002|Phase A|Protocol Violation|0|||
19696879|NCT00274716|42142166|FG003|Phase A|Protocol Violation|1|||
19696880|NCT00274716|42142167|FG004|Phase A|Protocol Violation|0|||
19696881|NCT00274716|42142168|FG005|Phase A|Protocol Violation|0|||
19696882|NCT00274716|42142163|FG000|Phase A|Met criteria for discontinuation|1|||
19785487|NCT02750514|42242466|FG001|Track 4|Participant withdrew consent|1|||
19785488|NCT02750514|42242467|FG002|Track 4|Participant withdrew consent|0|||
19785489|NCT02750514|42242468|FG003|Track 4|Participant withdrew consent|0|||
19785490|NCT02750514|42242469|FG004|Track 4|Participant withdrew consent|0|||
19785491|NCT02750514|42242465|FG000|Track 4|Other reasons|0|||
19785492|NCT02750514|42242466|FG001|Track 4|Other reasons|5|||
19785493|NCT02750514|42242467|FG002|Track 4|Other reasons|0|||
19785494|NCT02750514|42242468|FG003|Track 4|Other reasons|3|||
19785495|NCT02750514|42242469|FG004|Track 4|Other reasons|0|||
19785496|NCT02750514|42242465|FG000|Track 4|Disease progression|0|||
19785497|NCT02750514|42242466|FG001|Track 4|Disease progression|33|||
19785498|NCT02750514|42242467|FG002|Track 4|Disease progression|0|||
19785499|NCT02750514|42242468|FG003|Track 4|Disease progression|32|||
19785500|NCT02750514|42242469|FG004|Track 4|Disease progression|0|||
19785501|NCT02750514|42242465|FG000|Track 4|Adverse event unrelated to study drug|0|||
19785502|NCT02750514|42242466|FG001|Track 4|Adverse event unrelated to study drug|5|||
19785503|NCT02750514|42242467|FG002|Track 4|Adverse event unrelated to study drug|0|||
19785504|NCT02750514|42242468|FG003|Track 4|Adverse event unrelated to study drug|0|||
19785505|NCT02750514|42242469|FG004|Track 4|Adverse event unrelated to study drug|0|||
19785506|NCT02750514|42242465|FG000|Track 4|Death|0|||
19785507|NCT02750514|42242466|FG001|Track 4|Death|0|||
19785508|NCT02750514|42242467|FG002|Track 4|Death|0|||
19785509|NCT02750514|42242468|FG003|Track 4|Death|1|||
19785510|NCT02750514|42242469|FG004|Track 4|Death|0|||
19785511|NCT02750514|42242465|FG000|Track 5|Disease progression|0|||
19785512|NCT02750514|42242466|FG001|Track 5|Disease progression|0|||
19785513|NCT02750514|42242467|FG002|Track 5|Disease progression|0|||
19785514|NCT02750514|42242468|FG003|Track 5|Disease progression|0|||
19785515|NCT02750514|42242469|FG004|Track 5|Disease progression|34|||
19785516|NCT02750514|42242465|FG000|Track 5|Adverse event unrelated to study drug|0|||
19785517|NCT02750514|42242466|FG001|Track 5|Adverse event unrelated to study drug|0|||
19785518|NCT02750514|42242467|FG002|Track 5|Adverse event unrelated to study drug|0|||
19785519|NCT02750514|42242468|FG003|Track 5|Adverse event unrelated to study drug|0|||
19785520|NCT02750514|42242469|FG004|Track 5|Adverse event unrelated to study drug|2|||
19785521|NCT02750514|42242465|FG000|Track 5|Study drug toxicity|0|||
19785522|NCT02750514|42242466|FG001|Track 5|Study drug toxicity|0|||
19785523|NCT02750514|42242467|FG002|Track 5|Study drug toxicity|0|||
19785524|NCT02750514|42242468|FG003|Track 5|Study drug toxicity|0|||
19785525|NCT02750514|42242469|FG004|Track 5|Study drug toxicity|2|||
19785526|NCT02750514|42242465|FG000|Track 5|Participant request to discontinue|0|||
19785527|NCT02750514|42242466|FG001|Track 5|Participant request to discontinue|0|||
19785528|NCT02750514|42242467|FG002|Track 5|Participant request to discontinue|0|||
19785529|NCT02750514|42242468|FG003|Track 5|Participant request to discontinue|0|||
19785530|NCT02750514|42242469|FG004|Track 5|Participant request to discontinue|3|||
19785531|NCT02750514|42242465|FG000|Track 5|Other reasons|0|||
19785532|NCT02750514|42242466|FG001|Track 5|Other reasons|0|||
19785533|NCT02750514|42242467|FG002|Track 5|Other reasons|0|||
19785534|NCT02750514|42242468|FG003|Track 5|Other reasons|0|||
19785535|NCT02750514|42242469|FG004|Track 5|Other reasons|2|||
19785536|NCT02612428|42242491|FG000|VTL-308|Death|14|||
19785537|NCT02612428|42242492|FG001|VTL-308|Death|16|||
19785538|NCT02612428|42242491|FG000|VTL-308|Withdrawal by Subject|0|||
19785539|NCT02612428|42242492|FG001|VTL-308|Withdrawal by Subject|1|||
19785540|NCT02612428|42242491|FG000|VTL-308E|Death|9|||
19785541|NCT02612428|42242492|FG001|VTL-308E|Death|7|||
19785542|NCT02612428|42242491|FG000|VTL-308E|Lost to Follow-up|2|||
19785543|NCT02612428|42242492|FG001|VTL-308E|Lost to Follow-up|0|||
19785544|NCT03679884|42242503|FG000|Overall Study|Other|12|||
19785545|NCT03679884|42242504|FG001|Overall Study|Other|12|||
19785546|NCT03679884|42242505|FG002|Overall Study|Other|12|||
19785547|NCT03679884|42242506|FG003|Overall Study|Other|7|||
19785548|NCT03679884|42242507|FG004|Overall Study|Other|8|||
19696883|NCT00274716|42142164|FG001|Phase A|Met criteria for discontinuation|1|||
19696884|NCT00274716|42142165|FG002|Phase A|Met criteria for discontinuation|0|||
19696885|NCT00274716|42142166|FG003|Phase A|Met criteria for discontinuation|0|||
19785549|NCT03679884|42242503|FG000|Overall Study|Lack of Efficacy|15|||
19785550|NCT03679884|42242504|FG001|Overall Study|Lack of Efficacy|29|||
19785551|NCT03679884|42242505|FG002|Overall Study|Lack of Efficacy|13|||
19785552|NCT03679884|42242506|FG003|Overall Study|Lack of Efficacy|29|||
19785553|NCT03679884|42242507|FG004|Overall Study|Lack of Efficacy|10|||
19785554|NCT03679884|42242503|FG000|Overall Study|Death|1|||
19785555|NCT03679884|42242504|FG001|Overall Study|Death|0|||
19785556|NCT03679884|42242505|FG002|Overall Study|Death|0|||
19785557|NCT03679884|42242506|FG003|Overall Study|Death|0|||
19785558|NCT03679884|42242507|FG004|Overall Study|Death|0|||
19785559|NCT03679884|42242503|FG000|Overall Study|Adverse Event|2|||
19785560|NCT03679884|42242504|FG001|Overall Study|Adverse Event|10|||
19785561|NCT03679884|42242505|FG002|Overall Study|Adverse Event|9|||
19696886|NCT00274716|42142167|FG004|Phase A|Met criteria for discontinuation|0|||
19696887|NCT00274716|42142168|FG005|Phase A|Met criteria for discontinuation|0|||
19696888|NCT00274716|42142163|FG000|Phase A|Withdrawal by Subject|2|||
19696889|NCT00274716|42142164|FG001|Phase A|Withdrawal by Subject|2|||
19696890|NCT00274716|42142165|FG002|Phase A|Withdrawal by Subject|1|||
19785562|NCT03679884|42242506|FG003|Overall Study|Adverse Event|6|||
19785563|NCT03679884|42242507|FG004|Overall Study|Adverse Event|6|||
19785564|NCT03679884|42242503|FG000|Overall Study|Withdrawal by Subject|12|||
19785565|NCT03679884|42242504|FG001|Overall Study|Withdrawal by Subject|23|||
19785566|NCT03679884|42242505|FG002|Overall Study|Withdrawal by Subject|8|||
19785567|NCT03679884|42242506|FG003|Overall Study|Withdrawal by Subject|8|||
19785568|NCT03679884|42242507|FG004|Overall Study|Withdrawal by Subject|9|||
19785569|NCT03679884|42242503|FG000|Overall Study|Lost to Follow-up|1|||
19785570|NCT03679884|42242504|FG001|Overall Study|Lost to Follow-up|4|||
19785571|NCT03679884|42242505|FG002|Overall Study|Lost to Follow-up|2|||
19785572|NCT03679884|42242506|FG003|Overall Study|Lost to Follow-up|0|||
19785573|NCT03679884|42242507|FG004|Overall Study|Lost to Follow-up|3|||
19785574|NCT01329978|42242522|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
19785575|NCT01329978|42242523|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
19785576|NCT01329978|42242524|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
19785577|NCT01329978|42242525|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
19785578|NCT01329978|42242526|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
19785579|NCT01329978|42242522|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
19785580|NCT01329978|42242523|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
19785581|NCT01329978|42242524|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
19785582|NCT01329978|42242525|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
19785583|NCT01329978|42242526|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
19785584|NCT01329978|42242522|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
19785585|NCT01329978|42242523|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
19785586|NCT01329978|42242524|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
19785587|NCT01329978|42242525|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
19785588|NCT01329978|42242526|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
19785589|NCT01329978|42242522|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
19785590|NCT01329978|42242523|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
19785591|NCT01329978|42242524|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
19785592|NCT01329978|42242525|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
19785593|NCT01329978|42242526|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
19785594|NCT01329978|42242522|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
19785595|NCT01329978|42242523|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
19785596|NCT01329978|42242524|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
19785597|NCT01329978|42242525|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
19785598|NCT01329978|42242526|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
19785599|NCT01329978|42242522|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
19785600|NCT01329978|42242523|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
19785601|NCT01329978|42242524|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
19785602|NCT01329978|42242525|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
19785603|NCT01329978|42242526|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
19785604|NCT01329978|42242522|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
19785605|NCT01329978|42242523|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
19785606|NCT01329978|42242524|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
19785607|NCT01329978|42242525|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
19785608|NCT01329978|42242526|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
19785609|NCT01338012|42242538|FG000|Overall Study|Death|4|||
19785610|NCT01338012|42242538|FG000|Overall Study|Study terminated|4|||
19696891|NCT00274716|42142166|FG003|Phase A|Withdrawal by Subject|3|||
19696892|NCT00274716|42142167|FG004|Phase A|Withdrawal by Subject|0|||
19696893|NCT00274716|42142168|FG005|Phase A|Withdrawal by Subject|1|||
19696894|NCT00274716|42142163|FG000|Phase A|Adverse Event|2|||
19785611|NCT04905498|42242544|FG000|Overall Study|Lost to Follow-up|0|||
19477838|NCT01506271|41757093|FG002|Overall Study|Lost to Follow-up|2|||
19696895|NCT00274716|42142164|FG001|Phase A|Adverse Event|3|||
19696896|NCT00274716|42142165|FG002|Phase A|Adverse Event|3|||
19785612|NCT04905498|42242545|FG001|Overall Study|Lost to Follow-up|2|||
19785613|NCT04905498|42242544|FG000|Overall Study|COVID lockdown|1|||
19785614|NCT04905498|42242545|FG001|Overall Study|COVID lockdown|0|||
19785615|NCT02607280|42242553|FG000|Overall Study|Adverse Event|4|||
19785616|NCT02607280|42242554|FG001|Overall Study|Adverse Event|0|||
19785617|NCT02607280|42242553|FG000|Overall Study|Decrease in CrCl <15|0|||
19785618|NCT02607280|42242554|FG001|Overall Study|Decrease in CrCl <15|1|||
19785619|NCT02202434|42242564|FG000|Overall Study|Death|70|||
19785620|NCT02202434|42242565|FG001|Overall Study|Death|39|||
19785621|NCT02202434|42242566|FG002|Overall Study|Death|13|||
19785622|NCT02202434|42242567|FG003|Overall Study|Death|27|||
19785623|NCT02202434|42242564|FG000|Overall Study|Lost to Follow-up|1|||
19785624|NCT02202434|42242565|FG001|Overall Study|Lost to Follow-up|1|||
19785625|NCT02202434|42242566|FG002|Overall Study|Lost to Follow-up|1|||
19785626|NCT02202434|42242567|FG003|Overall Study|Lost to Follow-up|0|||
19785627|NCT02202434|42242564|FG000|Overall Study|Physician Decision|2|||
19785628|NCT02202434|42242565|FG001|Overall Study|Physician Decision|3|||
19785629|NCT02202434|42242566|FG002|Overall Study|Physician Decision|0|||
19785630|NCT02202434|42242567|FG003|Overall Study|Physician Decision|0|||
19785631|NCT02202434|42242564|FG000|Overall Study|Withdrawal by Subject|13|||
19785632|NCT02202434|42242565|FG001|Overall Study|Withdrawal by Subject|14|||
19785633|NCT02202434|42242566|FG002|Overall Study|Withdrawal by Subject|1|||
19785634|NCT02202434|42242567|FG003|Overall Study|Withdrawal by Subject|4|||
19785635|NCT02202434|42242564|FG000|Overall Study|Completed Study|1|||
19785636|NCT02202434|42242565|FG001|Overall Study|Completed Study|0|||
19785637|NCT02202434|42242566|FG002|Overall Study|Completed Study|0|||
19785638|NCT02202434|42242567|FG003|Overall Study|Completed Study|0|||
19785639|NCT02202434|42242564|FG000|Overall Study|Visit Missed|21|||
19785640|NCT02202434|42242565|FG001|Overall Study|Visit Missed|12|||
19785641|NCT02202434|42242566|FG002|Overall Study|Visit Missed|0|||
19785642|NCT02202434|42242567|FG003|Overall Study|Visit Missed|5|||
19785643|NCT02202434|42242564|FG000|Overall Study|Other|1|||
19785644|NCT02202434|42242565|FG001|Overall Study|Other|0|||
19785645|NCT02202434|42242566|FG002|Overall Study|Other|0|||
19367394|NCT02456740|41607522|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19367395|NCT02456740|41607523|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19367396|NCT02456740|41607524|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
19367397|NCT02456740|41607525|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
19367398|NCT02456740|41607526|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
19367399|NCT02456740|41607527|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
19367400|NCT02456740|41607528|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
19367401|NCT02456740|41607529|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
19367402|NCT02400580|41607541|FG000|Overall Study|Withdrawal by Subject|1|||
19367403|NCT02400580|41607542|FG001|Overall Study|Withdrawal by Subject|1|||
19696897|NCT00274716|42142166|FG003|Phase A|Adverse Event|0|||
19696898|NCT00274716|42142167|FG004|Phase A|Adverse Event|2|||
19696899|NCT00274716|42142168|FG005|Phase A|Adverse Event|0|||
19696900|NCT00274716|42142163|FG000|Phase A|Completed but did not enter Phase B|1|||
19696901|NCT00274716|42142164|FG001|Phase A|Completed but did not enter Phase B|2|||
19696902|NCT00274716|42142165|FG002|Phase A|Completed but did not enter Phase B|2|||
19696903|NCT00274716|42142166|FG003|Phase A|Completed but did not enter Phase B|2|||
19696904|NCT00274716|42142167|FG004|Phase A|Completed but did not enter Phase B|1|||
19696905|NCT00274716|42142168|FG005|Phase A|Completed but did not enter Phase B|1|||
19696906|NCT00274716|42142163|FG000|Phase B|Adverse Event|0|||
19696907|NCT00274716|42142164|FG001|Phase B|Adverse Event|0|||
19696908|NCT00274716|42142165|FG002|Phase B|Adverse Event|2|||
19696909|NCT00274716|42142166|FG003|Phase B|Adverse Event|0|||
19696910|NCT00274716|42142167|FG004|Phase B|Adverse Event|0|||
19696911|NCT00274716|42142168|FG005|Phase B|Adverse Event|1|||
19696912|NCT00274716|42142163|FG000|Phase B|Protocol Violation|0|||
19696913|NCT00274716|42142164|FG001|Phase B|Protocol Violation|2|||
19696914|NCT00274716|42142165|FG002|Phase B|Protocol Violation|0|||
19696915|NCT00274716|42142166|FG003|Phase B|Protocol Violation|0|||
19696916|NCT00274716|42142167|FG004|Phase B|Protocol Violation|0|||
19696917|NCT00274716|42142168|FG005|Phase B|Protocol Violation|0|||
19696918|NCT00274716|42142163|FG000|Phase B|Withdrawal by Subject|0|||
19696919|NCT00274716|42142164|FG001|Phase B|Withdrawal by Subject|1|||
19696920|NCT00274716|42142165|FG002|Phase B|Withdrawal by Subject|0|||
19696921|NCT00274716|42142166|FG003|Phase B|Withdrawal by Subject|0|||
19696922|NCT00274716|42142167|FG004|Phase B|Withdrawal by Subject|0|||
19696923|NCT00274716|42142168|FG005|Phase B|Withdrawal by Subject|0|||
19696924|NCT00274716|42142163|FG000|Phase B|Participant moved|1|||
19785646|NCT02202434|42242567|FG003|Overall Study|Other|1|||
19785647|NCT01230242|42242577|FG000|Overall Study|Physician Decision|2|||
19785648|NCT01230242|42242577|FG000|Overall Study|Withdrawal by Subject|1|||
19785649|NCT02608450|42242583|FG000|Overall Study|Lost to Follow-up|39|||
19785650|NCT02608450|42242584|FG001|Overall Study|Lost to Follow-up|32|||
19785651|NCT02608450|42242583|FG000|Overall Study|Withdrawal by Subject|21|||
19785652|NCT02608450|42242584|FG001|Overall Study|Withdrawal by Subject|15|||
19696925|NCT00274716|42142164|FG001|Phase B|Participant moved|0|||
19785653|NCT02608450|42242583|FG000|Overall Study|Adverse Event|3|||
19785654|NCT02608450|42242584|FG001|Overall Study|Adverse Event|6|||
19785655|NCT02608450|42242583|FG000|Overall Study|Withdrawal by parent|2|||
19785656|NCT02608450|42242584|FG001|Overall Study|Withdrawal by parent|3|||
19785657|NCT02608450|42242583|FG000|Overall Study|Lack of Efficacy|0|||
19785658|NCT02608450|42242584|FG001|Overall Study|Lack of Efficacy|3|||
19785659|NCT02608450|42242583|FG000|Overall Study|Noncompliance with study drug|0|||
19785660|NCT02608450|42242584|FG001|Overall Study|Noncompliance with study drug|2|||
19785661|NCT02608450|42242583|FG000|Overall Study|Physician Decision|0|||
19785662|NCT02608450|42242584|FG001|Overall Study|Physician Decision|1|||
19785663|NCT02608450|42242583|FG000|Overall Study|Pregnancy|0|||
19785664|NCT02608450|42242584|FG001|Overall Study|Pregnancy|1|||
19785665|NCT02608450|42242583|FG000|Overall Study|Progressive disease|1|||
19785666|NCT02608450|42242584|FG001|Overall Study|Progressive disease|0|||
19785667|NCT02608450|42242583|FG000|Overall Study|Multiple reasons|0|||
19785668|NCT02608450|42242584|FG001|Overall Study|Multiple reasons|2|||
19785669|NCT01668004|42242590|FG000|Overall Study|Adverse Event|7|||
19785670|NCT01668004|42242590|FG000|Overall Study|Withdrawal by Subject|2|||
19785671|NCT01668004|42242590|FG000|Overall Study|Lost to Follow-up|5|||
19785672|NCT01668004|42242590|FG000|Overall Study|Lack of Efficacy|9|||
19785673|NCT01668004|42242590|FG000|Overall Study|Non-compliance with treatment|2|||
19785674|NCT01667926|42242598|FG000|Overall Study|Withdrawal by Subject|1|||
19785675|NCT01667926|42242599|FG001|Overall Study|Withdrawal by Subject|2|||
19785676|NCT01667926|42242600|FG002|Overall Study|Withdrawal by Subject|2|||
19785677|NCT01667926|42242598|FG000|Overall Study|Physician Decision|0|||
19785678|NCT01667926|42242599|FG001|Overall Study|Physician Decision|0|||
19785679|NCT01667926|42242600|FG002|Overall Study|Physician Decision|1|||
19785680|NCT01667926|42242598|FG000|Overall Study|Time committment|0|||
19785681|NCT01667926|42242599|FG001|Overall Study|Time committment|0|||
19785682|NCT01667926|42242600|FG002|Overall Study|Time committment|2|||
19785683|NCT01667926|42242598|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
19785684|NCT01667926|42242599|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
19785685|NCT01667926|42242600|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
19785686|NCT01667926|42242598|FG000|Overall Study|Lost to Follow-up|1|||
19785687|NCT01667926|42242599|FG001|Overall Study|Lost to Follow-up|2|||
19785688|NCT01667926|42242600|FG002|Overall Study|Lost to Follow-up|1|||
19785689|NCT01667926|42242598|FG000|Overall Study|Side effects|3|||
19785690|NCT01667926|42242599|FG001|Overall Study|Side effects|0|||
19785691|NCT01667926|42242600|FG002|Overall Study|Side effects|0|||
19785692|NCT02604160|42242608|FG000|Overall Study|Protocol Violation|0|||
19785693|NCT02604160|42242609|FG001|Overall Study|Protocol Violation|1|||
19785694|NCT02604160|42242608|FG000|Overall Study|Physician Decision|0|||
19785695|NCT02604160|42242609|FG001|Overall Study|Physician Decision|1|||
19785696|NCT01359904|42242619|FG000|Overall Study|Withdrawal by Subject|1|||
19785697|NCT01359904|42242620|FG001|Overall Study|Withdrawal by Subject|0|||
19785698|NCT02328014|42242630|FG000|Overall Study|Adverse Event|1|||
19785699|NCT02328014|42242631|FG001|Overall Study|Adverse Event|0|||
19785700|NCT02328014|42242632|FG002|Overall Study|Adverse Event|0|||
19785701|NCT02328014|42242633|FG003|Overall Study|Adverse Event|1|||
19785702|NCT02328014|42242630|FG000|Overall Study|Death|0|||
19785703|NCT02328014|42242631|FG001|Overall Study|Death|0|||
19785704|NCT02328014|42242632|FG002|Overall Study|Death|0|||
19785705|NCT02328014|42242633|FG003|Overall Study|Death|4|||
19785706|NCT02328014|42242630|FG000|Overall Study|Physician Decision|0|||
19785707|NCT02328014|42242631|FG001|Overall Study|Physician Decision|0|||
19785708|NCT02328014|42242632|FG002|Overall Study|Physician Decision|0|||
19785709|NCT02328014|42242633|FG003|Overall Study|Physician Decision|1|||
19785710|NCT02328014|42242630|FG000|Overall Study|Disease Progression|1|||
19785711|NCT02328014|42242631|FG001|Overall Study|Disease Progression|0|||
19785712|NCT02328014|42242632|FG002|Overall Study|Disease Progression|1|||
19785713|NCT02328014|42242633|FG003|Overall Study|Disease Progression|3|||
19367404|NCT02400580|41607541|FG000|Overall Study|Adverse Event|1|||
19367405|NCT02400580|41607542|FG001|Overall Study|Adverse Event|0|||
19696926|NCT00274716|42142165|FG002|Phase B|Participant moved|0|||
19696927|NCT00274716|42142166|FG003|Phase B|Participant moved|0|||
19696928|NCT00274716|42142167|FG004|Phase B|Participant moved|0|||
19696929|NCT00274716|42142168|FG005|Phase B|Participant moved|0|||
19696930|NCT00274716|42142163|FG000|Phase B|Other non-reported reason|0|||
19785714|NCT02328014|42242630|FG000|Overall Study|Study Terminated by Sponsor|4|||
19785715|NCT02328014|42242631|FG001|Overall Study|Study Terminated by Sponsor|1|||
19785716|NCT02328014|42242632|FG002|Overall Study|Study Terminated by Sponsor|1|||
19785717|NCT02328014|42242633|FG003|Overall Study|Study Terminated by Sponsor|0|||
19785718|NCT02328014|42242630|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
19785719|NCT02328014|42242631|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
19785720|NCT02328014|42242632|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
19785721|NCT02328014|42242633|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
19696931|NCT00274716|42142164|FG001|Phase B|Other non-reported reason|0|||
19696932|NCT00274716|42142165|FG002|Phase B|Other non-reported reason|1|||
19696933|NCT00274716|42142166|FG003|Phase B|Other non-reported reason|1|||
19696934|NCT00274716|42142167|FG004|Phase B|Other non-reported reason|0|||
19696935|NCT00274716|42142168|FG005|Phase B|Other non-reported reason|0|||
19785722|NCT02328014|42242630|FG000|Overall Study|Withdrawal by Subject|0|||
19785723|NCT02328014|42242631|FG001|Overall Study|Withdrawal by Subject|0|||
19785724|NCT02328014|42242632|FG002|Overall Study|Withdrawal by Subject|0|||
19785725|NCT02328014|42242633|FG003|Overall Study|Withdrawal by Subject|1|||
19785726|NCT00157248|42242666|FG000|Overall Study|Adverse Event|36|||
19785727|NCT00157248|42242667|FG001|Overall Study|Adverse Event|25|||
19785728|NCT00157248|42242668|FG002|Overall Study|Adverse Event|13|||
19785729|NCT00157248|42242669|FG003|Overall Study|Adverse Event|33|||
19785730|NCT00157248|42242666|FG000|Overall Study|Protocol Violation|4|||
19785731|NCT00157248|42242667|FG001|Overall Study|Protocol Violation|0|||
19785732|NCT00157248|42242668|FG002|Overall Study|Protocol Violation|2|||
19785733|NCT00157248|42242669|FG003|Overall Study|Protocol Violation|2|||
19785734|NCT00157248|42242666|FG000|Overall Study|Lost to Follow-up|0|||
19785735|NCT00157248|42242667|FG001|Overall Study|Lost to Follow-up|1|||
19785736|NCT00157248|42242668|FG002|Overall Study|Lost to Follow-up|0|||
19785737|NCT00157248|42242669|FG003|Overall Study|Lost to Follow-up|0|||
19785738|NCT00157248|42242666|FG000|Overall Study|Withdrawal by Subject|1|||
19785739|NCT00157248|42242667|FG001|Overall Study|Withdrawal by Subject|4|||
19785740|NCT00157248|42242668|FG002|Overall Study|Withdrawal by Subject|3|||
19785741|NCT00157248|42242669|FG003|Overall Study|Withdrawal by Subject|3|||
19785742|NCT00157248|42242666|FG000|Overall Study|site closures, subject moving|7|||
19785743|NCT00157248|42242667|FG001|Overall Study|site closures, subject moving|7|||
19785744|NCT00157248|42242668|FG002|Overall Study|site closures, subject moving|3|||
19785745|NCT00157248|42242669|FG003|Overall Study|site closures, subject moving|9|||
19785746|NCT03019406|42242687|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
19785747|NCT03019406|42242688|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
19785748|NCT03019406|42242689|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
19785749|NCT03019406|42242690|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
19785750|NCT01328756|42242703|FG000|Overall Study|Protocol Violation|4|||
19785751|NCT01328756|42242703|FG000|Overall Study|Adverse Event|39|||
19785752|NCT01328756|42242703|FG000|Overall Study|Lack of Efficacy|5|||
19785753|NCT01328756|42242703|FG000|Overall Study|Withdrawal by Subject|41|||
19785754|NCT01328756|42242703|FG000|Overall Study|Lost to Follow-up|5|||
19785755|NCT01328756|42242703|FG000|Overall Study|Other|29|||
19785756|NCT03922308|42242710|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
19785757|NCT03922308|42242711|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
19785758|NCT03922308|42242712|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
19785759|NCT03922308|42242710|FG000|Overall Study|Lost to Follow-up|1|||
19785760|NCT03922308|42242711|FG001|Overall Study|Lost to Follow-up|0|||
19785761|NCT03922308|42242712|FG002|Overall Study|Lost to Follow-up|0|||
19785762|NCT03922308|42242710|FG000|Overall Study|Reason not Specified|0|||
19785763|NCT03922308|42242711|FG001|Overall Study|Reason not Specified|2|||
19785764|NCT03922308|42242712|FG002|Overall Study|Reason not Specified|1|||
19785765|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
19785766|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
19785767|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
19785768|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
19785769|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
19477839|NCT01506193|41757104|FG000|Overall Study|Protocol Violation|1|||
19696936|NCT00274716|42142163|FG000|Phase B|Lost to Follow-up|0|||
19696937|NCT00274716|42142164|FG001|Phase B|Lost to Follow-up|1|||
19696938|NCT00274716|42142165|FG002|Phase B|Lost to Follow-up|0|||
19696939|NCT00274716|42142166|FG003|Phase B|Lost to Follow-up|0|||
19696940|NCT00274716|42142167|FG004|Phase B|Lost to Follow-up|0|||
19696941|NCT00274716|42142168|FG005|Phase B|Lost to Follow-up|0|||
19696942|NCT00282048|42142186|FG000|Overall Study|Lack of Efficacy|30|||
19696943|NCT00282048|42142186|FG000|Overall Study|Adverse Event|22|||
19696944|NCT00282048|42142186|FG000|Overall Study|Withdrawal by Subject|1|||
19696945|NCT00282048|42142186|FG000|Overall Study|Other|8|||
19696946|NCT00282048|42142186|FG000|Overall Study|Ongoing|1|||
19696947|NCT00474539|42142192|FG000|Infant Series|Withdrawal by Subject|3|||
19696948|NCT00474539|42142193|FG001|Infant Series|Withdrawal by Subject|4|||
19696949|NCT00474539|42142192|FG000|Infant Series|Randomization error|5|||
19696950|NCT00474539|42142193|FG001|Infant Series|Randomization error|0|||
19785770|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
19785771|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
19785772|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
19785773|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
19785774|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
19785775|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
19785776|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
19785777|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
19696951|NCT00474539|42142192|FG000|Infant Series|Lost to Follow-up|2|||
19785778|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
19785779|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
19785780|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
19785781|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
19785782|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
19785783|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
19785784|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
19785785|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
19785786|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
19785787|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
19785788|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
19785789|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Death|2|||
19785790|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Death|1|||
19785791|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Death|0|||
19785792|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Death|0|||
19785793|NCT02607930|42242729|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
19785794|NCT02607930|42242730|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
19785795|NCT02607930|42242731|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
19785796|NCT02607930|42242732|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
19785797|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
19785798|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
19785799|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
19785800|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
19785801|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
19785802|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
19785803|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
19785804|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
19785805|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
19785806|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
19785807|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
19785808|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
19785809|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
19785810|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
19785811|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
19785812|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
19785813|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
19785814|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
19785815|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
19785816|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
19785817|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
19785818|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
19785819|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
19785820|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
19785821|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
19785822|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
19785823|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
19785824|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
19785825|NCT02607930|42242729|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
19785826|NCT02607930|42242730|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
19785827|NCT02607930|42242731|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
19785828|NCT02607930|42242732|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
19785829|NCT02101034|42242747|FG000|Overall Study|Enrolled but did not start treatment|0|||
19785830|NCT02101034|42242748|FG001|Overall Study|Enrolled but did not start treatment|0|||
19785831|NCT02101034|42242749|FG002|Overall Study|Enrolled but did not start treatment|1|||
19785832|NCT02101034|42242750|FG003|Overall Study|Enrolled but did not start treatment|0|||
19785833|NCT02101034|42242751|FG004|Overall Study|Enrolled but did not start treatment|0|||
19696952|NCT00474539|42142193|FG001|Infant Series|Lost to Follow-up|1|||
19696953|NCT00474539|42142192|FG000|Infant Series|Protocol Violation|0|||
19785834|NCT02736188|42242786|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
19696954|NCT00474539|42142193|FG001|Infant Series|Protocol Violation|1|||
19696955|NCT00474539|42142192|FG000|After Infant Series|Lost to Follow-up|3|||
19696956|NCT00474539|42142193|FG001|After Infant Series|Lost to Follow-up|0|||
19696957|NCT00474539|42142192|FG000|After Infant Series|Withdrawal by Subject|1|||
19696958|NCT00474539|42142193|FG001|After Infant Series|Withdrawal by Subject|0|||
19696959|NCT00474539|42142192|FG000|Toddler Dose|Protocol Violation|1|||
19696960|NCT00474539|42142193|FG001|Toddler Dose|Protocol Violation|0|||
19696961|NCT00281580|42142240|FG000|Overall Study|Adverse Event|2|||
19696962|NCT00281580|42142241|FG001|Overall Study|Adverse Event|0|||
19785835|NCT02736188|42242786|FG000|Overall Study|Adverse Event|1|||
19785836|NCT02736188|42242786|FG000|Overall Study|Withdrawal by Subject|1|||
19785837|NCT02736188|42242786|FG000|Overall Study|Other|6|||
19785838|NCT00154284|42242794|FG000|Overall Study|Adverse Event|6|||
19785839|NCT00154284|42242795|FG001|Overall Study|Adverse Event|9|||
19785840|NCT00154284|42242794|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19785841|NCT00154284|42242795|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19785842|NCT00154284|42242794|FG000|Overall Study|Lack of Efficacy|1|||
19785843|NCT00154284|42242795|FG001|Overall Study|Lack of Efficacy|2|||
19785844|NCT00154284|42242794|FG000|Overall Study|Protocol Violation|0|||
19785845|NCT00154284|42242795|FG001|Overall Study|Protocol Violation|1|||
19785846|NCT02735096|42242803|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
19785847|NCT00905346|42242816|FG000|Period 1|Withdrawal by Subject|1|||
19785848|NCT00905346|42242817|FG001|Period 1|Withdrawal by Subject|0|||
19785849|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
19785850|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
19785851|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
19785852|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
19785853|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
19785854|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
19785855|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
19785856|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
19785857|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
19785858|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
19367406|NCT01367119|41607550|FG000|Overall Study|Adverse Event|1|||
19367407|NCT01367119|41607551|FG001|Overall Study|Adverse Event|0|||
19367408|NCT01367119|41607550|FG000|Overall Study|Withdrawal by Subject|1|||
19367409|NCT01367119|41607551|FG001|Overall Study|Withdrawal by Subject|1|||
19696963|NCT00281580|42142242|FG002|Overall Study|Adverse Event|2|||
19785859|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
19785860|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
19785861|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
19785862|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
19785863|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
19785864|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
19785865|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
19785866|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
19785867|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
19785868|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
19785869|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
19785870|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
19785871|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
19696964|NCT00281580|42142243|FG003|Overall Study|Adverse Event|4|||
19696965|NCT00281580|42142244|FG004|Overall Study|Adverse Event|1|||
19696966|NCT00281580|42142245|FG005|Overall Study|Adverse Event|0|||
19696967|NCT00281580|42142246|FG006|Overall Study|Adverse Event|1|||
19696968|NCT00281580|42142247|FG007|Overall Study|Adverse Event|0|||
19696969|NCT00281580|42142248|FG008|Overall Study|Adverse Event|1|||
19696970|NCT00281580|42142249|FG009|Overall Study|Adverse Event|6|||
19696971|NCT00281580|42142250|FG010|Overall Study|Adverse Event|0|||
19785872|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
19785873|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
19785874|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19785875|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19785876|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19785877|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19785878|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19785879|NCT01328444|42242830|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19785880|NCT01328444|42242831|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
19785881|NCT01328444|42242832|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
19785882|NCT01328444|42242833|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
19785883|NCT01328444|42242834|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
19785884|NCT01328444|42242835|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19785885|NCT01328444|42242830|FG000|Washout Period (14 Days)|Adverse Event|1|||
19785886|NCT01328444|42242831|FG001|Washout Period (14 Days)|Adverse Event|1|||
19785887|NCT01328444|42242832|FG002|Washout Period (14 Days)|Adverse Event|0|||
19785888|NCT01328444|42242833|FG003|Washout Period (14 Days)|Adverse Event|1|||
19696972|NCT00281580|42142251|FG011|Overall Study|Adverse Event|5|||
19785889|NCT01328444|42242834|FG004|Washout Period (14 Days)|Adverse Event|1|||
19785890|NCT01328444|42242835|FG005|Washout Period (14 Days)|Adverse Event|2|||
19367410|NCT02635724|41607560|FG000|Overall Study|Withdrawal by Subject|0|||
19696973|NCT00281580|42142252|FG012|Overall Study|Adverse Event|8|||
19785891|NCT01328444|42242830|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
19785892|NCT01328444|42242831|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
19785893|NCT01328444|42242832|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
19785894|NCT01328444|42242833|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
19785895|NCT01328444|42242834|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
19785896|NCT01328444|42242835|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
19785897|NCT01328444|42242830|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
19785898|NCT01328444|42242831|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
19785899|NCT01328444|42242832|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
19785900|NCT01328444|42242833|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
19785901|NCT01328444|42242834|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
19785902|NCT01328444|42242835|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
19785903|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
19785904|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19785905|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19785906|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19785907|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
19785908|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19785909|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
19696974|NCT00281580|42142253|FG013|Overall Study|Adverse Event|2|||
19696975|NCT00281580|42142254|FG014|Overall Study|Adverse Event|3|||
19696976|NCT00281580|42142255|FG015|Overall Study|Adverse Event|3|||
19696977|NCT00281580|42142240|FG000|Overall Study|Protocol Violation|0|||
19696978|NCT00281580|42142241|FG001|Overall Study|Protocol Violation|0|||
19696979|NCT00281580|42142242|FG002|Overall Study|Protocol Violation|1|||
19785910|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
19785911|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
19785912|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
19785913|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
19785914|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
19785915|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
19785916|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
19785917|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
19785918|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
19785919|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
19785920|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
19785921|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
19785922|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
19785923|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
19785924|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
19785925|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
19785926|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
19785927|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19785928|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
19785929|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
19785930|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
19785931|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
19785932|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
19785933|NCT01328444|42242830|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19785934|NCT01328444|42242831|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19785935|NCT01328444|42242832|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19785936|NCT01328444|42242833|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19785937|NCT01328444|42242834|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19785938|NCT01328444|42242835|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19785939|NCT00887250|42242852|FG000|Overall Study|Adverse Event|3|||
19785940|NCT00887250|42242853|FG001|Overall Study|Adverse Event|0|||
19785941|NCT00887250|42242854|FG002|Overall Study|Adverse Event|7|||
19785942|NCT00887250|42242852|FG000|Overall Study|Lack of Efficacy|9|||
19785943|NCT00887250|42242853|FG001|Overall Study|Lack of Efficacy|6|||
19785944|NCT00887250|42242854|FG002|Overall Study|Lack of Efficacy|1|||
19785945|NCT00887250|42242852|FG000|Overall Study|Lost to Follow-up|2|||
19785946|NCT00887250|42242853|FG001|Overall Study|Lost to Follow-up|3|||
19785947|NCT00887250|42242854|FG002|Overall Study|Lost to Follow-up|1|||
19785948|NCT00887250|42242852|FG000|Overall Study|Protocol Violation|2|||
19785949|NCT00887250|42242853|FG001|Overall Study|Protocol Violation|2|||
19785950|NCT00887250|42242854|FG002|Overall Study|Protocol Violation|1|||
19785951|NCT00887250|42242852|FG000|Overall Study|Withdrawal by Subject|2|||
19785952|NCT00887250|42242853|FG001|Overall Study|Withdrawal by Subject|1|||
19785953|NCT00887250|42242854|FG002|Overall Study|Withdrawal by Subject|2|||
19785954|NCT00887250|42242852|FG000|Overall Study|Patient uncooperative|0|||
19696980|NCT00281580|42142243|FG003|Overall Study|Protocol Violation|1|||
19785955|NCT00887250|42242853|FG001|Overall Study|Patient uncooperative|0|||
19785956|NCT00887250|42242854|FG002|Overall Study|Patient uncooperative|1|||
19785957|NCT02599402|42242859|FG000|Overall Study|Disease progression|153|||
19785958|NCT02599402|42242859|FG000|Overall Study|Study drug toxicity|201|||
19785959|NCT02599402|42242859|FG000|Overall Study|Death|26|||
19785960|NCT02599402|42242859|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
19785961|NCT02599402|42242859|FG000|Overall Study|Participant request to discontinue study treatment|13|||
19785962|NCT02599402|42242859|FG000|Overall Study|Participant withdrew consent|5|||
19785963|NCT02599402|42242859|FG000|Overall Study|Lost to Follow-up|1|||
19785964|NCT02599402|42242859|FG000|Overall Study|Maximum Clinical Benefit|7|||
19785965|NCT02599402|42242859|FG000|Overall Study|Poor/non-compliance|1|||
19785966|NCT02599402|42242859|FG000|Overall Study|Pregnancy|1|||
19785967|NCT02599402|42242859|FG000|Overall Study|Participant no longer met study criteria|7|||
19785968|NCT02599402|42242859|FG000|Overall Study|Other Reasons|95|||
19785969|NCT02734862|42242899|FG000|Part A|Death|3|||
19785970|NCT02734862|42242900|FG001|Part A|Death|4|||
19785971|NCT02734862|42242901|FG002|Part A|Death|6|||
19785972|NCT02734862|42242899|FG000|Part A|Lost to Follow-up|2|||
19785973|NCT02734862|42242900|FG001|Part A|Lost to Follow-up|1|||
19785974|NCT02734862|42242901|FG002|Part A|Lost to Follow-up|1|||
19785975|NCT02734862|42242899|FG000|Part A|Withdrawal by Subject|1|||
19785976|NCT02734862|42242900|FG001|Part A|Withdrawal by Subject|1|||
19785977|NCT02734862|42242901|FG002|Part A|Withdrawal by Subject|2|||
19785978|NCT02734862|42242899|FG000|Part A|Physician Decision|2|||
19785979|NCT02734862|42242900|FG001|Part A|Physician Decision|0|||
19785980|NCT02734862|42242901|FG002|Part A|Physician Decision|1|||
19785981|NCT02734862|42242899|FG000|Part A|Adverse Event|2|||
19785982|NCT02734862|42242900|FG001|Part A|Adverse Event|0|||
19785983|NCT02734862|42242901|FG002|Part A|Adverse Event|1|||
19785984|NCT02734862|42242899|FG000|Part A|Noncompliance|1|||
19785985|NCT02734862|42242900|FG001|Part A|Noncompliance|1|||
19785986|NCT02734862|42242901|FG002|Part A|Noncompliance|0|||
19785987|NCT02734862|42242899|FG000|Part A|Other|1|||
19785988|NCT02734862|42242900|FG001|Part A|Other|1|||
19785989|NCT02734862|42242901|FG002|Part A|Other|3|||
19785990|NCT02734862|42242899|FG000|Part B|Death|8|||
19785991|NCT02734862|42242900|FG001|Part B|Death|3|||
19785992|NCT02734862|42242901|FG002|Part B|Death|5|||
19785993|NCT02734862|42242899|FG000|Part B|Lost to Follow-up|2|||
19785994|NCT02734862|42242900|FG001|Part B|Lost to Follow-up|2|||
19785995|NCT02734862|42242901|FG002|Part B|Lost to Follow-up|0|||
19785996|NCT02734862|42242899|FG000|Part B|Withdrawal by Subject|3|||
19785997|NCT02734862|42242900|FG001|Part B|Withdrawal by Subject|1|||
19785998|NCT02734862|42242901|FG002|Part B|Withdrawal by Subject|0|||
19785999|NCT02734862|42242899|FG000|Part B|Other|0|||
19786000|NCT02734862|42242900|FG001|Part B|Other|1|||
19786001|NCT02734862|42242901|FG002|Part B|Other|0|||
19786002|NCT00858702|42242912|FG000|Overall Study|Lack of Efficacy|1|||
19786003|NCT00858702|42242913|FG001|Overall Study|Lack of Efficacy|0|||
19786004|NCT00858702|42242912|FG000|Overall Study|Protocol Violation|1|||
19786005|NCT00858702|42242913|FG001|Overall Study|Protocol Violation|1|||
19786006|NCT00858702|42242912|FG000|Overall Study|Other|2|||
19786007|NCT00858702|42242913|FG001|Overall Study|Other|1|||
19786008|NCT00858702|42242912|FG000|Overall Study|Withdrawal by Subject|1|||
19786009|NCT00858702|42242913|FG001|Overall Study|Withdrawal by Subject|0|||
19786010|NCT02598934|42242921|FG000|Overall Study|Adverse Event|11|||
19786011|NCT02598934|42242922|FG001|Overall Study|Adverse Event|13|||
19786012|NCT02598934|42242921|FG000|Overall Study|Failure to Return|3|||
19786013|NCT02598934|42242922|FG001|Overall Study|Failure to Return|3|||
19786014|NCT02598934|42242921|FG000|Overall Study|Withdrawal by Subject|2|||
19786015|NCT02598934|42242922|FG001|Overall Study|Withdrawal by Subject|3|||
19696981|NCT00281580|42142244|FG004|Overall Study|Protocol Violation|0|||
19786016|NCT02598934|42242921|FG000|Overall Study|Administrative|2|||
19786017|NCT02598934|42242922|FG001|Overall Study|Administrative|1|||
19786018|NCT02598934|42242921|FG000|Overall Study|Protocol Violation|1|||
19786019|NCT02598934|42242922|FG001|Overall Study|Protocol Violation|2|||
19786020|NCT02598622|42242930|FG000|Overall Study|Withdrawal by Subject|3|||
19786021|NCT02598622|42242931|FG001|Overall Study|Withdrawal by Subject|0|||
19786022|NCT02598622|42242930|FG000|Overall Study|Physician Decision|3|||
19786023|NCT02598622|42242931|FG001|Overall Study|Physician Decision|0|||
19786024|NCT00841698|42242939|FG000|First Intervention|Withdrawal by Subject|1|||
19786025|NCT00841698|42242940|FG001|First Intervention|Withdrawal by Subject|0|||
19786026|NCT00841542|42242946|FG000|Period 1|Adverse Event|1|||
19786027|NCT00841542|42242947|FG001|Period 1|Adverse Event|0|||
19786028|NCT00840216|42242969|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19786029|NCT00840216|42242970|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
19786030|NCT00836706|42242980|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
19786031|NCT00836706|42242981|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
19786032|NCT00836472|42242987|FG000|Washout|Adverse Event|1|||
19786033|NCT00836472|42242988|FG001|Washout|Adverse Event|2|||
19786034|NCT00836472|42242987|FG000|Washout|Withdrawal by Subject|1|||
19786035|NCT00836472|42242988|FG001|Washout|Withdrawal by Subject|1|||
19786036|NCT02598388|42243004|FG000|Overall Study|Lost to Follow-up|1|||
19786037|NCT02598388|42243005|FG001|Overall Study|Lost to Follow-up|0|||
19786038|NCT02598388|42243006|FG002|Overall Study|Lost to Follow-up|1|||
19786039|NCT02598388|42243007|FG003|Overall Study|Lost to Follow-up|0|||
19786040|NCT02598388|42243008|FG004|Overall Study|Lost to Follow-up|5|||
19786041|NCT02598388|42243009|FG005|Overall Study|Lost to Follow-up|1|||
19786042|NCT02598388|42243010|FG006|Overall Study|Lost to Follow-up|2|||
19786043|NCT02598388|42243011|FG007|Overall Study|Lost to Follow-up|1|||
19786044|NCT02598388|42243012|FG008|Overall Study|Lost to Follow-up|0|||
19786045|NCT02598388|42243013|FG009|Overall Study|Lost to Follow-up|0|||
19786046|NCT02598388|42243014|FG010|Overall Study|Lost to Follow-up|1|||
19786047|NCT02598388|42243015|FG011|Overall Study|Lost to Follow-up|0|||
19786048|NCT02598388|42243004|FG000|Overall Study|Withdrawal by Subject|0|||
19786049|NCT02598388|42243005|FG001|Overall Study|Withdrawal by Subject|0|||
19786050|NCT02598388|42243006|FG002|Overall Study|Withdrawal by Subject|0|||
19786051|NCT02598388|42243007|FG003|Overall Study|Withdrawal by Subject|0|||
19786052|NCT02598388|42243008|FG004|Overall Study|Withdrawal by Subject|2|||
19786053|NCT02598388|42243009|FG005|Overall Study|Withdrawal by Subject|0|||
19786054|NCT02598388|42243010|FG006|Overall Study|Withdrawal by Subject|2|||
19786055|NCT02598388|42243011|FG007|Overall Study|Withdrawal by Subject|0|||
19786056|NCT02598388|42243012|FG008|Overall Study|Withdrawal by Subject|0|||
19786057|NCT02598388|42243013|FG009|Overall Study|Withdrawal by Subject|1|||
19786058|NCT02598388|42243014|FG010|Overall Study|Withdrawal by Subject|0|||
19786059|NCT02598388|42243015|FG011|Overall Study|Withdrawal by Subject|0|||
19367411|NCT02635724|41607561|FG001|Overall Study|Withdrawal by Subject|1|||
19367412|NCT02635724|41607562|FG002|Overall Study|Withdrawal by Subject|0|||
19696982|NCT00281580|42142245|FG005|Overall Study|Protocol Violation|0|||
19696983|NCT00281580|42142246|FG006|Overall Study|Protocol Violation|1|||
19696984|NCT00281580|42142247|FG007|Overall Study|Protocol Violation|0|||
19696985|NCT00281580|42142248|FG008|Overall Study|Protocol Violation|2|||
19696986|NCT00281580|42142249|FG009|Overall Study|Protocol Violation|0|||
19696987|NCT00281580|42142250|FG010|Overall Study|Protocol Violation|1|||
19696988|NCT00281580|42142251|FG011|Overall Study|Protocol Violation|2|||
19696989|NCT00281580|42142252|FG012|Overall Study|Protocol Violation|0|||
19696990|NCT00281580|42142253|FG013|Overall Study|Protocol Violation|1|||
19696991|NCT00281580|42142254|FG014|Overall Study|Protocol Violation|1|||
19696992|NCT00281580|42142255|FG015|Overall Study|Protocol Violation|3|||
19696993|NCT00281580|42142240|FG000|Overall Study|Withdrawal by Subject|3|||
19696994|NCT00281580|42142241|FG001|Overall Study|Withdrawal by Subject|0|||
19696995|NCT00281580|42142242|FG002|Overall Study|Withdrawal by Subject|1|||
19696996|NCT00281580|42142243|FG003|Overall Study|Withdrawal by Subject|1|||
19696997|NCT00281580|42142244|FG004|Overall Study|Withdrawal by Subject|1|||
19696998|NCT00281580|42142245|FG005|Overall Study|Withdrawal by Subject|2|||
19696999|NCT00281580|42142246|FG006|Overall Study|Withdrawal by Subject|2|||
19697000|NCT00281580|42142247|FG007|Overall Study|Withdrawal by Subject|0|||
19697001|NCT00281580|42142248|FG008|Overall Study|Withdrawal by Subject|1|||
19697002|NCT00281580|42142249|FG009|Overall Study|Withdrawal by Subject|4|||
19697003|NCT00281580|42142250|FG010|Overall Study|Withdrawal by Subject|1|||
19697004|NCT00281580|42142251|FG011|Overall Study|Withdrawal by Subject|1|||
19697005|NCT00281580|42142252|FG012|Overall Study|Withdrawal by Subject|2|||
19697006|NCT00281580|42142253|FG013|Overall Study|Withdrawal by Subject|2|||
19697007|NCT00281580|42142254|FG014|Overall Study|Withdrawal by Subject|1|||
19697008|NCT00281580|42142255|FG015|Overall Study|Withdrawal by Subject|5|||
19697009|NCT00281580|42142240|FG000|Overall Study|Lack of Efficacy|2|||
19697010|NCT00281580|42142241|FG001|Overall Study|Lack of Efficacy|1|||
19697011|NCT00281580|42142242|FG002|Overall Study|Lack of Efficacy|1|||
19697012|NCT00281580|42142243|FG003|Overall Study|Lack of Efficacy|6|||
19697013|NCT00281580|42142244|FG004|Overall Study|Lack of Efficacy|2|||
19697014|NCT00281580|42142245|FG005|Overall Study|Lack of Efficacy|0|||
19697015|NCT00281580|42142246|FG006|Overall Study|Lack of Efficacy|0|||
19697016|NCT00281580|42142247|FG007|Overall Study|Lack of Efficacy|0|||
19697017|NCT00281580|42142248|FG008|Overall Study|Lack of Efficacy|0|||
19697018|NCT00281580|42142249|FG009|Overall Study|Lack of Efficacy|0|||
19697019|NCT00281580|42142250|FG010|Overall Study|Lack of Efficacy|0|||
19697020|NCT00281580|42142251|FG011|Overall Study|Lack of Efficacy|1|||
19697021|NCT00281580|42142252|FG012|Overall Study|Lack of Efficacy|0|||
19697022|NCT00281580|42142253|FG013|Overall Study|Lack of Efficacy|2|||
19697023|NCT00281580|42142254|FG014|Overall Study|Lack of Efficacy|1|||
19697024|NCT00281580|42142255|FG015|Overall Study|Lack of Efficacy|0|||
19697025|NCT00281580|42142240|FG000|Overall Study|Lost to Follow-up|0|||
19697026|NCT00281580|42142241|FG001|Overall Study|Lost to Follow-up|0|||
19786060|NCT02598388|42243004|FG000|Overall Study|Other|0|||
19786061|NCT02598388|42243005|FG001|Overall Study|Other|0|||
19786062|NCT02598388|42243006|FG002|Overall Study|Other|1|||
19786063|NCT02598388|42243007|FG003|Overall Study|Other|0|||
19786064|NCT02598388|42243008|FG004|Overall Study|Other|3|||
19786065|NCT02598388|42243009|FG005|Overall Study|Other|0|||
19786066|NCT02598388|42243010|FG006|Overall Study|Other|1|||
19786067|NCT02598388|42243011|FG007|Overall Study|Other|0|||
19697027|NCT00281580|42142242|FG002|Overall Study|Lost to Follow-up|0|||
19786068|NCT02598388|42243012|FG008|Overall Study|Other|0|||
19786069|NCT02598388|42243013|FG009|Overall Study|Other|0|||
19786070|NCT02598388|42243014|FG010|Overall Study|Other|0|||
19786071|NCT02598388|42243015|FG011|Overall Study|Other|0|||
19786072|NCT00835692|42243055|FG000|First Intervention|Withdrawal by Subject|1|||
19786073|NCT00835692|42243056|FG001|First Intervention|Withdrawal by Subject|0|||
19786074|NCT00835536|42243069|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
19786075|NCT00835536|42243070|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
19786076|NCT03865316|42243074|FG000|Overall Study|Procedure Cancelled|4|||
19786077|NCT03865316|42243074|FG000|Overall Study|Equipment failure|4|||
19786078|NCT02598076|42243080|FG000|Overall Study|Lost to Follow-up|2|||
19786079|NCT02598076|42243081|FG001|Overall Study|Lost to Follow-up|3|||
19786080|NCT02602288|42243089|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
19786081|NCT02602288|42243090|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
19786082|NCT02602288|42243089|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
19786083|NCT02602288|42243090|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
19786084|NCT02602288|42243089|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
19786085|NCT02602288|42243090|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
19786086|NCT02602288|42243089|FG000|12 Month Follow-up|Lost to Follow-up|0|||
19786087|NCT02602288|42243090|FG001|12 Month Follow-up|Lost to Follow-up|4|||
19786088|NCT02602288|42243089|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
19786089|NCT02602288|42243090|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
19786090|NCT02601820|42243096|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
19786091|NCT02601820|42243096|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
19786092|NCT02601820|42243096|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
19786093|NCT02601820|42243096|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
19786094|NCT02807454|42243115|FG000|Overall Study|Adverse Event|1|||
19786095|NCT02807454|42243116|FG001|Overall Study|Adverse Event|0|||
19786096|NCT02807454|42243115|FG000|Overall Study|Withdrawal by Subject|0|||
19786097|NCT02807454|42243116|FG001|Overall Study|Withdrawal by Subject|1|||
19786098|NCT02807454|42243115|FG000|Overall Study|Progressive Disease|30|||
19786099|NCT02807454|42243116|FG001|Overall Study|Progressive Disease|3|||
19786100|NCT02807454|42243115|FG000|Overall Study|Other Reasons|1|||
19786101|NCT02807454|42243116|FG001|Overall Study|Other Reasons|1|||
19786102|NCT02597920|42243131|FG000|Overall Study|Worsening of other pre-existing disease|0|||
19786103|NCT02597920|42243132|FG001|Overall Study|Worsening of other pre-existing disease|1|||
19786104|NCT02597920|42243133|FG002|Overall Study|Worsening of other pre-existing disease|0|||
19786105|NCT02597920|42243131|FG000|Overall Study|Other adverse event|20|||
19786106|NCT02597920|42243132|FG001|Overall Study|Other adverse event|30|||
19786107|NCT02597920|42243133|FG002|Overall Study|Other adverse event|0|||
19786108|NCT02597920|42243131|FG000|Overall Study|Lost to Follow-up|7|||
19786109|NCT02597920|42243132|FG001|Overall Study|Lost to Follow-up|9|||
19786110|NCT02597920|42243133|FG002|Overall Study|Lost to Follow-up|0|||
19786111|NCT02597920|42243131|FG000|Overall Study|Refuse to continue in the study|3|||
19786112|NCT02597920|42243132|FG001|Overall Study|Refuse to continue in the study|13|||
19786113|NCT02597920|42243133|FG002|Overall Study|Refuse to continue in the study|1|||
19786114|NCT02597920|42243131|FG000|Overall Study|Other than specified|10|||
19786115|NCT02597920|42243132|FG001|Overall Study|Other than specified|31|||
19786116|NCT02597920|42243133|FG002|Overall Study|Other than specified|5|||
19786117|NCT02597920|42243131|FG000|Overall Study|Other|1|||
19786118|NCT02597920|42243132|FG001|Overall Study|Other|0|||
19786119|NCT02597920|42243133|FG002|Overall Study|Other|0|||
19786120|NCT01235234|42243153|FG000|Overall Study|Adverse Event|2|||
19786121|NCT01235234|42243154|FG001|Overall Study|Adverse Event|2|||
19786122|NCT01235234|42243155|FG002|Overall Study|Adverse Event|1|||
19786123|NCT02597452|42243170|FG000|Overall Study|testing incomplete|30|||
19786124|NCT02597062|42243174|FG000|Overall Study|Ineligible|1|||
19786125|NCT00834756|42243180|FG000|First Intervention|Adverse Event|1|||
19786126|NCT00834756|42243181|FG001|First Intervention|Adverse Event|0|||
19367413|NCT02635646|41607572|FG000|Overall Study|Lost to Follow-up|24|||
19367414|NCT02635646|41607573|FG001|Overall Study|Lost to Follow-up|25|||
19786127|NCT00834756|42243180|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
19786128|NCT00834756|42243181|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
19786129|NCT00828854|42243185|FG000|Overall Study|Disease Progression|17|||
19786130|NCT00828854|42243185|FG000|Overall Study|Adverse Event|9|||
19786131|NCT00828854|42243185|FG000|Overall Study|Reason not Specified|1|||
19786132|NCT00834522|42243191|FG000|Washout|Adverse Event|1|||
19786133|NCT00834522|42243192|FG001|Washout|Adverse Event|0|||
19786134|NCT00834522|42243191|FG000|Washout|Withdrawal by Subject|2|||
19786135|NCT00834522|42243192|FG001|Washout|Withdrawal by Subject|1|||
19786136|NCT00834444|42243198|FG000|First Intervention|Adverse Event|1|||
19786137|NCT00834444|42243199|FG001|First Intervention|Adverse Event|0|||
19786138|NCT00834444|42243198|FG000|First Intervention|Intolerance to Venopuncture|0|||
19786139|NCT00834444|42243199|FG001|First Intervention|Intolerance to Venopuncture|1|||
19786140|NCT00834444|42243198|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
19786141|NCT00834444|42243199|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
19786142|NCT00834444|42243198|FG000|Second Intervention|Adverse Event|1|||
19786143|NCT00834444|42243199|FG001|Second Intervention|Adverse Event|0|||
19786144|NCT02605954|42243226|FG000|Overall Study|Adverse Event|5|||
19786145|NCT02605954|42243227|FG001|Overall Study|Adverse Event|1|||
19786146|NCT02605954|42243226|FG000|Overall Study|Investigator's Discretion|1|||
19786147|NCT02605954|42243227|FG001|Overall Study|Investigator's Discretion|0|||
19786148|NCT02605954|42243226|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19786149|NCT02605954|42243227|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19786150|NCT02605954|42243226|FG000|Overall Study|Withdrew Consent|2|||
19786151|NCT02605954|42243227|FG001|Overall Study|Withdrew Consent|2|||
19786152|NCT02605954|42243226|FG000|Overall Study|Lost to Follow-up|3|||
19786153|NCT02605954|42243227|FG001|Overall Study|Lost to Follow-up|0|||
19786154|NCT02605954|42243226|FG000|Overall Study|Randomized but not treated|0|||
19786155|NCT02605954|42243227|FG001|Overall Study|Randomized but not treated|1|||
19786156|NCT00724698|42243236|FG000|Overall Study|Adverse Event|9|||
19786157|NCT00724698|42243236|FG000|Overall Study|Failure of Therapy|4|||
19786158|NCT00724698|42243236|FG000|Overall Study|Poor Compliance|16|||
19786159|NCT00724698|42243236|FG000|Overall Study|Lost to Follow-up|36|||
19786160|NCT00724698|42243236|FG000|Overall Study|No Info|25|||
19786161|NCT00829998|42243241|FG000|Washout|Adverse Event|0|||
19786162|NCT00829998|42243242|FG001|Washout|Adverse Event|1|||
19786163|NCT00829764|42243253|FG000|First Intervention|Adverse Event|1|||
19786164|NCT00829764|42243254|FG001|First Intervention|Adverse Event|0|||
19786165|NCT00829764|42243253|FG000|First Intervention|Withdrawal by Subject|1|||
19786166|NCT00829764|42243254|FG001|First Intervention|Withdrawal by Subject|1|||
19786167|NCT00829530|42243276|FG000|First Intervention|Adverse Event|0|||
19786168|NCT00829530|42243277|FG001|First Intervention|Adverse Event|1|||
19786169|NCT00829530|42243276|FG000|First Intervention|Intolerance to Venopuncture|0|||
19786170|NCT00829530|42243277|FG001|First Intervention|Intolerance to Venopuncture|1|||
19786171|NCT00829530|42243276|FG000|Second Intervention|Intolerance to Venopuncture|1|||
19786172|NCT00829530|42243277|FG001|Second Intervention|Intolerance to Venopuncture|0|||
19786173|NCT01377194|42243284|FG000|Overall Study|Adverse Event|3|||
19786174|NCT01377194|42243285|FG001|Overall Study|Adverse Event|12|||
19786175|NCT01377194|42243286|FG002|Overall Study|Adverse Event|19|||
19786176|NCT01377194|42243284|FG000|Overall Study|Lack of Efficacy|3|||
19786177|NCT01377194|42243285|FG001|Overall Study|Lack of Efficacy|3|||
19786178|NCT01377194|42243286|FG002|Overall Study|Lack of Efficacy|3|||
19786179|NCT01377194|42243284|FG000|Overall Study|Protocol Violation|4|||
19786180|NCT01377194|42243285|FG001|Overall Study|Protocol Violation|10|||
19786181|NCT01377194|42243286|FG002|Overall Study|Protocol Violation|6|||
19786182|NCT01377194|42243284|FG000|Overall Study|Withdrawal by Subject|8|||
19786183|NCT01377194|42243285|FG001|Overall Study|Withdrawal by Subject|10|||
19786184|NCT01377194|42243286|FG002|Overall Study|Withdrawal by Subject|7|||
19786185|NCT01377194|42243284|FG000|Overall Study|Lost to Follow-up|14|||
19786186|NCT01377194|42243285|FG001|Overall Study|Lost to Follow-up|8|||
19786187|NCT01377194|42243286|FG002|Overall Study|Lost to Follow-up|11|||
19786188|NCT00829452|42243299|FG000|First Intervention|Withdrawal by Subject|0|||
19786189|NCT00829452|42243300|FG001|First Intervention|Withdrawal by Subject|1|||
19786190|NCT00829452|42243299|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
19786191|NCT00829452|42243300|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
19786192|NCT00829452|42243299|FG000|Second Intervention|Physician Decision|0|||
19786193|NCT00829452|42243300|FG001|Second Intervention|Physician Decision|1|||
19786194|NCT04600076|42243304|FG000|Overall Study|Lost to Follow-up|3|||
19786195|NCT02064387|42243320|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19697028|NCT00281580|42142243|FG003|Overall Study|Lost to Follow-up|3|||
19697029|NCT00281580|42142244|FG004|Overall Study|Lost to Follow-up|0|||
19697030|NCT00281580|42142245|FG005|Overall Study|Lost to Follow-up|1|||
19697031|NCT00281580|42142246|FG006|Overall Study|Lost to Follow-up|0|||
19697032|NCT00281580|42142247|FG007|Overall Study|Lost to Follow-up|1|||
19697033|NCT00281580|42142248|FG008|Overall Study|Lost to Follow-up|2|||
19697034|NCT00281580|42142249|FG009|Overall Study|Lost to Follow-up|1|||
19697035|NCT00281580|42142250|FG010|Overall Study|Lost to Follow-up|1|||
19697036|NCT00281580|42142251|FG011|Overall Study|Lost to Follow-up|0|||
19697037|NCT00281580|42142252|FG012|Overall Study|Lost to Follow-up|1|||
19697038|NCT00281580|42142253|FG013|Overall Study|Lost to Follow-up|0|||
19786196|NCT02064387|42243321|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786197|NCT02064387|42243322|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786198|NCT02064387|42243323|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786199|NCT02064387|42243324|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786200|NCT02064387|42243325|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786201|NCT02064387|42243326|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786202|NCT02064387|42243327|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
19786203|NCT02064387|42243328|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786204|NCT02064387|42243329|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
19786205|NCT02064387|42243330|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786206|NCT02064387|42243331|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
19786207|NCT02064387|42243320|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786208|NCT02064387|42243321|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19697039|NCT00281580|42142254|FG014|Overall Study|Lost to Follow-up|0|||
19697040|NCT00281580|42142255|FG015|Overall Study|Lost to Follow-up|0|||
19697041|NCT00281580|42142240|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
19697042|NCT00281580|42142241|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
19697043|NCT00281580|42142242|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
19697044|NCT00281580|42142243|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
19697045|NCT00281580|42142244|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
19697046|NCT00281580|42142245|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
19697047|NCT00281580|42142246|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
19697048|NCT00281580|42142247|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
19697049|NCT00281580|42142248|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
19697050|NCT00281580|42142249|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
19697051|NCT00281580|42142250|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
19697052|NCT00281580|42142251|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
19697053|NCT00281580|42142252|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
19697054|NCT00281580|42142253|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
19697055|NCT00281580|42142254|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
19697056|NCT00281580|42142255|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
19697057|NCT00495755|42142324|FG000|Overall Study|Adverse Event|3|||
19697058|NCT00495677|42142336|FG000|Stage 1 (25 Days)|Adverse Event|0|||
19697059|NCT00495677|42142337|FG001|Stage 1 (25 Days)|Adverse Event|0|||
19697060|NCT00495677|42142338|FG002|Stage 1 (25 Days)|Adverse Event|1|||
19697061|NCT00495677|42142339|FG003|Stage 1 (25 Days)|Adverse Event|0|||
19697062|NCT00495677|42142340|FG004|Stage 1 (25 Days)|Adverse Event|0|||
19697063|NCT00495677|42142341|FG005|Stage 1 (25 Days)|Adverse Event|0|||
19697064|NCT00495677|42142342|FG006|Stage 1 (25 Days)|Adverse Event|0|||
19697065|NCT00495521|42142360|FG000|Overall Study|Physician Decision|0|||
19697066|NCT00495521|42142361|FG001|Overall Study|Physician Decision|1|||
19697067|NCT00273858|42142367|FG000|Overall Study|Not completed 24 month observation time|334|||
19697068|NCT00273858|42142367|FG000|Overall Study|Lost to Follow-up|101|||
19697069|NCT00273858|42142367|FG000|Overall Study|Withdrawal by Subject|21|||
19697070|NCT00273858|42142367|FG000|Overall Study|Adverse Event|81|||
19697071|NCT00494507|42142375|FG000|Double-Blind Phase|Adverse Event|2|||
19697072|NCT00494507|42142376|FG001|Double-Blind Phase|Adverse Event|0|||
19697073|NCT00494507|42142377|FG002|Double-Blind Phase|Adverse Event|1|||
19697074|NCT00494507|42142378|FG003|Double-Blind Phase|Adverse Event|0|||
19697075|NCT00494507|42142375|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
19697076|NCT00494507|42142376|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
19697077|NCT00494507|42142377|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19697078|NCT00494507|42142378|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19697079|NCT00494507|42142375|FG000|Double-Blind Phase|Subject Non-compliance|0|||
19697080|NCT00494507|42142376|FG001|Double-Blind Phase|Subject Non-compliance|0|||
19697081|NCT00494507|42142377|FG002|Double-Blind Phase|Subject Non-compliance|1|||
19697082|NCT00494507|42142378|FG003|Double-Blind Phase|Subject Non-compliance|0|||
19697083|NCT00494507|42142375|FG000|Double-Blind Phase|Negative DNA test|0|||
19697084|NCT00494507|42142376|FG001|Double-Blind Phase|Negative DNA test|0|||
19697085|NCT00494507|42142377|FG002|Double-Blind Phase|Negative DNA test|0|||
19697086|NCT00494507|42142378|FG003|Double-Blind Phase|Negative DNA test|1|||
19697087|NCT00494507|42142375|FG000|Open-Label Phase|Adverse Event|0|||
19697088|NCT00494507|42142376|FG001|Open-Label Phase|Adverse Event|1|||
19697089|NCT00494507|42142377|FG002|Open-Label Phase|Adverse Event|5|||
19697090|NCT00494507|42142378|FG003|Open-Label Phase|Adverse Event|3|||
19697091|NCT00494507|42142375|FG000|Open-Label Phase|Worsening Disease|0|||
19697092|NCT00494507|42142376|FG001|Open-Label Phase|Worsening Disease|0|||
19697093|NCT00494507|42142377|FG002|Open-Label Phase|Worsening Disease|0|||
19697094|NCT00494507|42142378|FG003|Open-Label Phase|Worsening Disease|2|||
19697095|NCT00292188|42142400|FG000|Single-Blind|Adverse Event|14|||
19697096|NCT00292188|42142401|FG001|Single-Blind|Adverse Event|0|||
19697097|NCT00292188|42142402|FG002|Single-Blind|Adverse Event|0|||
19697098|NCT00292188|42142400|FG000|Single-Blind|Lack of Efficacy|2|||
19697099|NCT00292188|42142401|FG001|Single-Blind|Lack of Efficacy|0|||
19697100|NCT00292188|42142402|FG002|Single-Blind|Lack of Efficacy|0|||
19697101|NCT00292188|42142400|FG000|Single-Blind|Laboratory Abnormality|5|||
19697102|NCT00292188|42142401|FG001|Single-Blind|Laboratory Abnormality|0|||
19697103|NCT00292188|42142402|FG002|Single-Blind|Laboratory Abnormality|0|||
19697104|NCT00292188|42142400|FG000|Single-Blind|Lost to Follow-up|3|||
19697105|NCT00292188|42142401|FG001|Single-Blind|Lost to Follow-up|0|||
19697106|NCT00292188|42142402|FG002|Single-Blind|Lost to Follow-up|0|||
19697107|NCT00292188|42142400|FG000|Single-Blind|Other|77|||
19697108|NCT00292188|42142401|FG001|Single-Blind|Other|0|||
19697109|NCT00292188|42142402|FG002|Single-Blind|Other|0|||
19697110|NCT00292188|42142400|FG000|Single-Blind|Withdrawal by Subject|12|||
19697111|NCT00292188|42142401|FG001|Single-Blind|Withdrawal by Subject|0|||
19697112|NCT00292188|42142402|FG002|Single-Blind|Withdrawal by Subject|0|||
19697113|NCT00292188|42142400|FG000|Single-Blind|Did not receive treatment|1|||
19697114|NCT00292188|42142401|FG001|Single-Blind|Did not receive treatment|0|||
19697115|NCT00292188|42142402|FG002|Single-Blind|Did not receive treatment|0|||
19697116|NCT00292188|42142400|FG000|Double-Blind|Adverse Event|0|||
19697117|NCT00292188|42142401|FG001|Double-Blind|Adverse Event|25|||
19697118|NCT00292188|42142402|FG002|Double-Blind|Adverse Event|9|||
19697119|NCT00292188|42142400|FG000|Double-Blind|Lack of Efficacy|0|||
19697120|NCT00292188|42142401|FG001|Double-Blind|Lack of Efficacy|2|||
19697121|NCT00292188|42142402|FG002|Double-Blind|Lack of Efficacy|12|||
19697122|NCT00292188|42142400|FG000|Double-Blind|Lost to Follow-up|0|||
19697123|NCT00292188|42142401|FG001|Double-Blind|Lost to Follow-up|1|||
19697124|NCT00292188|42142402|FG002|Double-Blind|Lost to Follow-up|0|||
19697125|NCT00292188|42142400|FG000|Double-Blind|Other|0|||
19697126|NCT00292188|42142401|FG001|Double-Blind|Other|3|||
19697127|NCT00292188|42142402|FG002|Double-Blind|Other|4|||
19697128|NCT00292188|42142400|FG000|Double-Blind|Withdrawal by Subject|0|||
19697129|NCT00292188|42142401|FG001|Double-Blind|Withdrawal by Subject|0|||
19697130|NCT00292188|42142402|FG002|Double-Blind|Withdrawal by Subject|3|||
19697131|NCT00292188|42142400|FG000|Double-Blind|Laboratory Abnormality|0|||
19697132|NCT00292188|42142401|FG001|Double-Blind|Laboratory Abnormality|0|||
19697133|NCT00292188|42142402|FG002|Double-Blind|Laboratory Abnormality|1|||
19697134|NCT00272844|42142409|FG000|Overall Study|Withdrawal by Subject|5|||
19697135|NCT00271596|42142415|FG000|Overall Study|Protocol Violation|1|||
19697136|NCT00271596|42142416|FG001|Overall Study|Protocol Violation|0|||
19697137|NCT00271596|42142415|FG000|Overall Study|Withdrawal by Subject|0|||
19697138|NCT00271596|42142416|FG001|Overall Study|Withdrawal by Subject|1|||
19697139|NCT00291642|42142427|FG000|Overall Study|Adverse Event|1|||
19697140|NCT00291642|42142428|FG001|Overall Study|Adverse Event|0|||
19697141|NCT00291642|42142429|FG002|Overall Study|Adverse Event|1|||
19697142|NCT00291642|42142430|FG003|Overall Study|Adverse Event|0|||
19697143|NCT00291642|42142431|FG004|Overall Study|Adverse Event|1|||
19697144|NCT00291642|42142427|FG000|Overall Study|Patient missed visit|0|||
19697145|NCT00291642|42142428|FG001|Overall Study|Patient missed visit|0|||
19697146|NCT00291642|42142429|FG002|Overall Study|Patient missed visit|1|||
19697147|NCT00291642|42142430|FG003|Overall Study|Patient missed visit|0|||
19697148|NCT00291642|42142431|FG004|Overall Study|Patient missed visit|0|||
19697149|NCT00291642|42142427|FG000|Overall Study|Intake of prohibited medication|1|||
19697150|NCT00291642|42142428|FG001|Overall Study|Intake of prohibited medication|0|||
19697151|NCT00291642|42142429|FG002|Overall Study|Intake of prohibited medication|0|||
19697152|NCT00291642|42142430|FG003|Overall Study|Intake of prohibited medication|0|||
19697153|NCT00291642|42142431|FG004|Overall Study|Intake of prohibited medication|0|||
19697154|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
19697155|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
19697156|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
19697157|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
19697158|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
19697159|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
19697160|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
19697161|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
19697162|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
19697163|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
19697164|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
19697165|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
19697166|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
19697167|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
19697168|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
19697169|NCT00280566|42142445|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
19697170|NCT00280566|42142446|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
19697171|NCT00280566|42142447|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
19697172|NCT00280566|42142445|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
19697173|NCT00280566|42142446|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
19697174|NCT00280566|42142447|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
19697175|NCT00280566|42142445|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
19697176|NCT00280566|42142446|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
19697177|NCT00280566|42142447|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
19697178|NCT00280566|42142445|FG000|Period 2 Double Blind|Adverse Event|0|||
19697179|NCT00280566|42142446|FG001|Period 2 Double Blind|Adverse Event|11|||
19697180|NCT00280566|42142447|FG002|Period 2 Double Blind|Adverse Event|15|||
19697181|NCT00280566|42142445|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
19697182|NCT00280566|42142446|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
19697183|NCT00280566|42142447|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
19697184|NCT00280566|42142445|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
19697185|NCT00280566|42142446|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
19697186|NCT00280566|42142447|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
19697187|NCT00280566|42142445|FG000|Period 2 Double Blind|miscellaneous|0|||
19697188|NCT00280566|42142446|FG001|Period 2 Double Blind|miscellaneous|10|||
19697189|NCT00280566|42142447|FG002|Period 2 Double Blind|miscellaneous|5|||
19697190|NCT00270894|42142454|FG000|Overall Study|Adverse Event|1|||
19697191|NCT00270894|42142454|FG000|Overall Study|Withdrawal by Subject|1|||
19697192|NCT00317642|42142460|FG000|Overall Study|Not Received Either Study Drug|1|||
19786209|NCT02064387|42243322|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786210|NCT02064387|42243323|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786211|NCT02064387|42243324|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786212|NCT02064387|42243325|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786213|NCT02064387|42243326|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786214|NCT02064387|42243327|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
19786215|NCT02064387|42243328|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786216|NCT02064387|42243329|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786217|NCT02064387|42243330|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786218|NCT02064387|42243331|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
19786219|NCT02064387|42243320|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786220|NCT02064387|42243321|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786221|NCT02064387|42243322|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786222|NCT02064387|42243323|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786223|NCT02064387|42243324|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786224|NCT02064387|42243325|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786225|NCT02064387|42243326|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786226|NCT02064387|42243327|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786227|NCT02064387|42243328|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
19786228|NCT02064387|42243329|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786229|NCT02064387|42243330|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786230|NCT02064387|42243331|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
19786231|NCT02064387|42243320|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
19786232|NCT02064387|42243321|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
19786233|NCT02064387|42243322|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
19786234|NCT02064387|42243323|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
19786235|NCT02064387|42243324|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
19786236|NCT02064387|42243325|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
19786237|NCT02064387|42243326|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
19786238|NCT02064387|42243327|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
19786239|NCT02064387|42243328|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
19786240|NCT02064387|42243329|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
19786241|NCT02064387|42243330|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
19786242|NCT02064387|42243331|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
19786243|NCT02064387|42243320|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786244|NCT02064387|42243321|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786245|NCT02064387|42243322|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786246|NCT02064387|42243323|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786247|NCT02064387|42243324|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786248|NCT02064387|42243325|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786249|NCT02064387|42243326|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786250|NCT02064387|42243327|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786251|NCT02064387|42243328|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786252|NCT02064387|42243329|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786253|NCT02064387|42243330|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
19786254|NCT02064387|42243331|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
19786255|NCT01328366|42243370|FG000|Overall Study|Death|1|||
19786256|NCT01328366|42243370|FG000|Overall Study|Withdrawal by Subject|2|||
19786257|NCT01328366|42243370|FG000|Overall Study|Lost to Follow-up|7|||
19786258|NCT03256344|42243376|FG000|Overall Study|Death|6|||
19607444|NCT00882999|42056237|FG004|Overall Study|Lost to Follow-up|1|||
19607445|NCT00882999|42056238|FG005|Overall Study|Lost to Follow-up|1|||
19607446|NCT00882999|42056239|FG006|Overall Study|Lost to Follow-up|2|||
19607447|NCT00882999|42056233|FG000|Overall Study|Physician Decision|1|||
19697193|NCT00317642|42142461|FG001|Overall Study|Not Received Either Study Drug|3|||
19697194|NCT00317642|42142460|FG000|Overall Study|Physician Decision|15|||
19697195|NCT00317642|42142461|FG001|Overall Study|Physician Decision|7|||
19697196|NCT00317642|42142460|FG000|Overall Study|Participant declined treatment|14|||
19697197|NCT00317642|42142461|FG001|Overall Study|Participant declined treatment|3|||
19607448|NCT00882999|42056234|FG001|Overall Study|Physician Decision|0|||
19697198|NCT00317642|42142460|FG000|Overall Study|Adverse Event|17|||
19697199|NCT00317642|42142461|FG001|Overall Study|Adverse Event|5|||
19607449|NCT00882999|42056235|FG002|Overall Study|Physician Decision|0|||
19786259|NCT03256344|42243377|FG001|Overall Study|Death|22|||
19786260|NCT03256344|42243376|FG000|Overall Study|Withdrawal by Subject|3|||
19786261|NCT03256344|42243377|FG001|Overall Study|Withdrawal by Subject|3|||
19786262|NCT03256344|42243376|FG000|Overall Study|Sponsor Decision|1|||
19786263|NCT03256344|42243377|FG001|Overall Study|Sponsor Decision|0|||
19786264|NCT01370499|42243385|FG000|Overall Study|Adverse Event|38|||
19786265|NCT01370499|42243386|FG001|Overall Study|Adverse Event|12|||
19786266|NCT01370499|42243385|FG000|Overall Study|Lack of Efficacy|4|||
19786267|NCT01370499|42243386|FG001|Overall Study|Lack of Efficacy|2|||
19786268|NCT01370499|42243385|FG000|Overall Study|Lost to Follow-up|2|||
19786269|NCT01370499|42243386|FG001|Overall Study|Lost to Follow-up|1|||
19786270|NCT01370499|42243385|FG000|Overall Study|Physician Decision|3|||
19786271|NCT01370499|42243386|FG001|Overall Study|Physician Decision|3|||
19786272|NCT01370499|42243385|FG000|Overall Study|Protocol Violation|5|||
19786273|NCT01370499|42243386|FG001|Overall Study|Protocol Violation|4|||
19786274|NCT01370499|42243385|FG000|Overall Study|Withdrawal by Subject|18|||
19786275|NCT01370499|42243386|FG001|Overall Study|Withdrawal by Subject|7|||
19786276|NCT01370499|42243385|FG000|Overall Study|Sponsor Decision|41|||
19786277|NCT01370499|42243386|FG001|Overall Study|Sponsor Decision|15|||
19786278|NCT01370265|42243394|FG000|First Intervention|Adverse Event|1|||
19786279|NCT01370265|42243395|FG001|First Intervention|Adverse Event|1|||
19786280|NCT01359592|42243408|FG000|Initial Registration|Adverse Event|1|||
19786281|NCT01359592|42243409|FG001|Initial Registration|Adverse Event|0|||
19786282|NCT01359592|42243410|FG002|Initial Registration|Adverse Event|0|||
19786283|NCT01359592|42243411|FG003|Initial Registration|Adverse Event|0|||
19786284|NCT01359592|42243408|FG000|Initial Registration|Death|1|||
19786285|NCT01359592|42243409|FG001|Initial Registration|Death|0|||
19786286|NCT01359592|42243410|FG002|Initial Registration|Death|0|||
19786287|NCT01359592|42243411|FG003|Initial Registration|Death|0|||
19786288|NCT01359592|42243408|FG000|Initial Registration|Other reason not protocol specified|1|||
19786289|NCT01359592|42243409|FG001|Initial Registration|Other reason not protocol specified|0|||
19786290|NCT01359592|42243410|FG002|Initial Registration|Other reason not protocol specified|0|||
19786291|NCT01359592|42243411|FG003|Initial Registration|Other reason not protocol specified|0|||
19786292|NCT01359592|42243408|FG000|Initial Registration|Ineligible|26|||
19786293|NCT01359592|42243409|FG001|Initial Registration|Ineligible|0|||
19786294|NCT01359592|42243410|FG002|Initial Registration|Ineligible|0|||
19786295|NCT01359592|42243411|FG003|Initial Registration|Ineligible|0|||
19786296|NCT01359592|42243408|FG000|PET-Directed Therapy|Adverse Event|0|||
19786297|NCT01359592|42243409|FG001|PET-Directed Therapy|Adverse Event|0|||
19786298|NCT01359592|42243410|FG002|PET-Directed Therapy|Adverse Event|1|||
19786299|NCT01359592|42243411|FG003|PET-Directed Therapy|Adverse Event|0|||
19786300|NCT01359592|42243408|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
19786301|NCT01359592|42243409|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
19786302|NCT01359592|42243410|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
19786303|NCT01359592|42243411|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
19786304|NCT01359592|42243408|FG000|PET-Directed Therapy|Ineligible|0|||
19786305|NCT01359592|42243409|FG001|PET-Directed Therapy|Ineligible|0|||
19786306|NCT01359592|42243410|FG002|PET-Directed Therapy|Ineligible|24|||
19786307|NCT01359592|42243411|FG003|PET-Directed Therapy|Ineligible|0|||
19786308|NCT02792829|42243434|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786309|NCT02792829|42243435|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
19786310|NCT02792829|42243436|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786311|NCT02792829|42243437|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786312|NCT02792829|42243438|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786313|NCT02792829|42243439|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786314|NCT02792829|42243440|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786315|NCT02792829|42243441|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
19786316|NCT02792829|42243434|FG000|Treatment Period 2|Adverse Event|0|||
19786317|NCT02792829|42243435|FG001|Treatment Period 2|Adverse Event|0|||
19786318|NCT02792829|42243436|FG002|Treatment Period 2|Adverse Event|0|||
19786319|NCT02792829|42243437|FG003|Treatment Period 2|Adverse Event|0|||
19786320|NCT02792829|42243438|FG004|Treatment Period 2|Adverse Event|1|||
19786321|NCT02792829|42243439|FG005|Treatment Period 2|Adverse Event|0|||
19786322|NCT02792829|42243440|FG006|Treatment Period 2|Adverse Event|1|||
19786323|NCT02792829|42243441|FG007|Treatment Period 2|Adverse Event|1|||
19786324|NCT02792829|42243434|FG000|Treatment Period 2|Use of proscribed medications|0|||
19786325|NCT02792829|42243435|FG001|Treatment Period 2|Use of proscribed medications|0|||
19786326|NCT02792829|42243436|FG002|Treatment Period 2|Use of proscribed medications|0|||
19786327|NCT02792829|42243437|FG003|Treatment Period 2|Use of proscribed medications|0|||
19786328|NCT02792829|42243438|FG004|Treatment Period 2|Use of proscribed medications|0|||
19786329|NCT02792829|42243439|FG005|Treatment Period 2|Use of proscribed medications|0|||
19786330|NCT02792829|42243440|FG006|Treatment Period 2|Use of proscribed medications|0|||
19786331|NCT02792829|42243441|FG007|Treatment Period 2|Use of proscribed medications|1|||
19786332|NCT02867592|42243473|FG000|Overall Study|Adverse Event|3|||
19786333|NCT02867592|42243474|FG001|Overall Study|Adverse Event|0|||
19786334|NCT02867592|42243475|FG002|Overall Study|Adverse Event|2|||
19786335|NCT02867592|42243476|FG003|Overall Study|Adverse Event|1|||
19786336|NCT02867592|42243477|FG004|Overall Study|Adverse Event|1|||
19786337|NCT02867592|42243478|FG005|Overall Study|Adverse Event|5|||
19786338|NCT02867592|42243473|FG000|Overall Study|Death|0|||
19786339|NCT02867592|42243474|FG001|Overall Study|Death|0|||
19786340|NCT02867592|42243475|FG002|Overall Study|Death|0|||
19786341|NCT02867592|42243476|FG003|Overall Study|Death|1|||
19786342|NCT02867592|42243477|FG004|Overall Study|Death|0|||
19786343|NCT02867592|42243478|FG005|Overall Study|Death|1|||
19786344|NCT02867592|42243473|FG000|Overall Study|Lack of Efficacy|8|||
19477840|NCT01506193|41757105|FG001|Overall Study|Protocol Violation|0|||
19477841|NCT01506193|41757106|FG002|Overall Study|Protocol Violation|1|||
19477842|NCT01506193|41757104|FG000|Overall Study|Migrated/moved from study area|0|||
19607450|NCT00882999|42056236|FG003|Overall Study|Physician Decision|0|||
19786345|NCT02867592|42243474|FG001|Overall Study|Lack of Efficacy|10|||
19786346|NCT02867592|42243475|FG002|Overall Study|Lack of Efficacy|8|||
19786347|NCT02867592|42243476|FG003|Overall Study|Lack of Efficacy|8|||
19786348|NCT02867592|42243477|FG004|Overall Study|Lack of Efficacy|12|||
19786349|NCT02867592|42243478|FG005|Overall Study|Lack of Efficacy|17|||
19786350|NCT02867592|42243473|FG000|Overall Study|Physician Decision|1|||
19786351|NCT02867592|42243474|FG001|Overall Study|Physician Decision|2|||
19786352|NCT02867592|42243475|FG002|Overall Study|Physician Decision|2|||
19786353|NCT02867592|42243476|FG003|Overall Study|Physician Decision|0|||
19786354|NCT02867592|42243477|FG004|Overall Study|Physician Decision|5|||
19786355|NCT02867592|42243478|FG005|Overall Study|Physician Decision|1|||
19786356|NCT02867592|42243473|FG000|Overall Study|Protocol Violation|0|||
19786357|NCT02867592|42243474|FG001|Overall Study|Protocol Violation|0|||
19786358|NCT02867592|42243475|FG002|Overall Study|Protocol Violation|0|||
19786359|NCT02867592|42243476|FG003|Overall Study|Protocol Violation|0|||
19786360|NCT02867592|42243477|FG004|Overall Study|Protocol Violation|1|||
19786361|NCT02867592|42243478|FG005|Overall Study|Protocol Violation|1|||
19786362|NCT02867592|42243473|FG000|Overall Study|Withdrawal by Subject|0|||
19786363|NCT02867592|42243474|FG001|Overall Study|Withdrawal by Subject|1|||
19786364|NCT02867592|42243475|FG002|Overall Study|Withdrawal by Subject|0|||
19786365|NCT02867592|42243476|FG003|Overall Study|Withdrawal by Subject|1|||
19786366|NCT02867592|42243477|FG004|Overall Study|Withdrawal by Subject|3|||
19786367|NCT02867592|42243478|FG005|Overall Study|Withdrawal by Subject|3|||
19786368|NCT02867592|42243473|FG000|Overall Study|Ineligible|1|||
19786369|NCT02867592|42243474|FG001|Overall Study|Ineligible|1|||
19786370|NCT02867592|42243475|FG002|Overall Study|Ineligible|0|||
19786371|NCT02867592|42243476|FG003|Overall Study|Ineligible|0|||
19786372|NCT02867592|42243477|FG004|Overall Study|Ineligible|2|||
19786373|NCT02867592|42243478|FG005|Overall Study|Ineligible|0|||
19786374|NCT02867592|42243473|FG000|Overall Study|No Treatment|1|||
19786375|NCT02867592|42243474|FG001|Overall Study|No Treatment|0|||
19786376|NCT02867592|42243475|FG002|Overall Study|No Treatment|0|||
19786377|NCT02867592|42243476|FG003|Overall Study|No Treatment|0|||
19786378|NCT02867592|42243477|FG004|Overall Study|No Treatment|0|||
19786379|NCT02867592|42243478|FG005|Overall Study|No Treatment|0|||
19786380|NCT02867592|42243473|FG000|Overall Study|Still on Therapy|0|||
19786381|NCT02867592|42243474|FG001|Overall Study|Still on Therapy|0|||
19786382|NCT02867592|42243475|FG002|Overall Study|Still on Therapy|0|||
19786383|NCT02867592|42243476|FG003|Overall Study|Still on Therapy|0|||
19786384|NCT02867592|42243477|FG004|Overall Study|Still on Therapy|1|||
19786385|NCT02867592|42243478|FG005|Overall Study|Still on Therapy|0|||
19786386|NCT02867592|42243473|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
19786387|NCT02867592|42243474|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
19786388|NCT02867592|42243475|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
19786389|NCT02867592|42243476|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
19786390|NCT02867592|42243477|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
19786391|NCT02867592|42243478|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
19786392|NCT02867592|42243473|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
19786393|NCT02867592|42243474|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
19786394|NCT02867592|42243475|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
19786395|NCT02867592|42243476|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
19786396|NCT02867592|42243477|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
19786397|NCT02867592|42243478|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
19607451|NCT00882999|42056237|FG004|Overall Study|Physician Decision|0|||
19697200|NCT00317642|42142460|FG000|Overall Study|Treatment Failure|56|||
19786398|NCT00676494|42243494|FG000|Overall Study|Missed Visit|8|||
19786399|NCT00676494|42243494|FG000|Overall Study|Withdrawal by Subject|6|||
19786400|NCT02605642|42243499|FG000|Overall Study|Other|11|||
19786401|NCT02605642|42243500|FG001|Overall Study|Other|1|||
19786402|NCT02605642|42243499|FG000|Overall Study|Participant non-compliance|2|||
19786403|NCT02605642|42243500|FG001|Overall Study|Participant non-compliance|4|||
19786404|NCT02605642|42243499|FG000|Overall Study|Physician Decision|10|||
19786405|NCT02605642|42243500|FG001|Overall Study|Physician Decision|0|||
19786406|NCT02605642|42243499|FG000|Overall Study|Lost to Follow-up|12|||
19786407|NCT02605642|42243500|FG001|Overall Study|Lost to Follow-up|1|||
19786408|NCT02605642|42243499|FG000|Overall Study|Adverse Event|14|||
19786409|NCT02605642|42243500|FG001|Overall Study|Adverse Event|2|||
19786410|NCT02605642|42243499|FG000|Overall Study|Withdrawal by Subject|23|||
19786411|NCT02605642|42243500|FG001|Overall Study|Withdrawal by Subject|2|||
19786412|NCT02605642|42243499|FG000|Overall Study|Lack of response|24|||
19786413|NCT02605642|42243500|FG001|Overall Study|Lack of response|11|||
19786414|NCT02253810|42243508|FG000|Overall Study|Withdrawal by Subject|2|||
19786415|NCT02253810|42243509|FG001|Overall Study|Withdrawal by Subject|1|||
19786416|NCT02253810|42243508|FG000|Overall Study|Unknown concomitant procedure|3|||
19786417|NCT02253810|42243509|FG001|Overall Study|Unknown concomitant procedure|2|||
19786418|NCT03915470|42243530|FG000|Overall Study|Death|3|||
19786419|NCT03915470|42243531|FG001|Overall Study|Death|1|||
19786420|NCT03915470|42243530|FG000|Overall Study|Adverse Event|1|||
19786421|NCT03915470|42243531|FG001|Overall Study|Adverse Event|0|||
19786422|NCT03915470|42243530|FG000|Overall Study|Physician Decision|1|||
19786423|NCT03915470|42243531|FG001|Overall Study|Physician Decision|0|||
19786424|NCT03915470|42243530|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
19786425|NCT03915470|42243531|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
19786426|NCT02732912|42243542|FG000|Overall Study|Discharged before night|2|||
19786427|NCT02732912|42243543|FG001|Overall Study|Discharged before night|6|||
19786428|NCT02732912|42243542|FG000|Overall Study|Incomplete completion of questionnaire|2|||
19786429|NCT02732912|42243543|FG001|Overall Study|Incomplete completion of questionnaire|3|||
19786430|NCT02732912|42243542|FG000|Overall Study|No outcome; discharged or refused|6|||
19786431|NCT02732912|42243543|FG001|Overall Study|No outcome; discharged or refused|9|||
19786432|NCT02792517|42243549|FG000|Overall Study|Withdrawal by Subject|10|||
19786433|NCT02792517|42243549|FG000|Overall Study|Decision by Sponsor|7|||
19786434|NCT02792517|42243549|FG000|Overall Study|Lost to Follow-up|3|||
19786435|NCT03126435|42243555|FG000|Overall Study|Death|90|||
19786436|NCT03126435|42243556|FG001|Overall Study|Death|84|||
19786437|NCT03126435|42243555|FG000|Overall Study|Lost to Follow-up|4|||
19786438|NCT03126435|42243556|FG001|Overall Study|Lost to Follow-up|3|||
19786439|NCT03126435|42243555|FG000|Overall Study|Physician Decision|0|||
19786440|NCT03126435|42243556|FG001|Overall Study|Physician Decision|1|||
19786441|NCT03126435|42243555|FG000|Overall Study|Withdrawal by Subject|6|||
19786442|NCT03126435|42243556|FG001|Overall Study|Withdrawal by Subject|12|||
19786443|NCT03126435|42243555|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
19786444|NCT03126435|42243556|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
19786445|NCT01369485|42243595|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
19786446|NCT01369485|42243596|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
19786447|NCT01369485|42243595|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
19786448|NCT01369485|42243596|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
19786449|NCT01369485|42243595|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
19786450|NCT01369485|42243596|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
19786451|NCT01369485|42243595|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
19786452|NCT01369485|42243596|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
19786453|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
19786454|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
19786455|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
19786456|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
19786457|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
19786458|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
19786459|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
19786460|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
19786461|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
19786462|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
19786463|NCT01369485|42243595|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
19786464|NCT01369485|42243596|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
19786465|NCT02886572|42243623|FG000|Overall Study|Death|8|||
19786466|NCT02741700|42243636|FG000|Overall Study|Lost to Follow-up|17|||
19367415|NCT02635646|41607572|FG000|Overall Study|Pregnancy|1|||
19786467|NCT02741700|42243637|FG001|Overall Study|Lost to Follow-up|8|||
19786468|NCT02741700|42243636|FG000|Overall Study|Withdrawal by Subject|2|||
19786469|NCT02741700|42243637|FG001|Overall Study|Withdrawal by Subject|5|||
19786470|NCT02741700|42243636|FG000|Overall Study|Physician Decision|3|||
19786471|NCT02741700|42243637|FG001|Overall Study|Physician Decision|0|||
19786472|NCT02741700|42243636|FG000|Overall Study|Moved out of State|0|||
19367416|NCT02635646|41607573|FG001|Overall Study|Pregnancy|1|||
19786473|NCT02741700|42243637|FG001|Overall Study|Moved out of State|1|||
19786474|NCT02741700|42243636|FG000|Overall Study|Death|4|||
19786475|NCT02741700|42243637|FG001|Overall Study|Death|5|||
19786476|NCT00430950|42243645|FG000|Overall Study|Adverse Event|7|||
19786477|NCT00430950|42243646|FG001|Overall Study|Adverse Event|6|||
19786478|NCT00430950|42243645|FG000|Overall Study|Withdrawal by Subject|1|||
19786479|NCT00430950|42243646|FG001|Overall Study|Withdrawal by Subject|0|||
19786480|NCT00430950|42243645|FG000|Overall Study|concomitant medication,etc.|5|||
19786481|NCT00430950|42243646|FG001|Overall Study|concomitant medication,etc.|7|||
19786482|NCT02081391|42243654|FG000|12-hour Treatment|Withdrawal by Subject|3|||
19786483|NCT02081391|42243655|FG001|12-hour Treatment|Withdrawal by Subject|2|||
19786484|NCT02081391|42243656|FG002|12-hour Treatment|Withdrawal by Subject|0|||
19786485|NCT02081391|42243657|FG003|12-hour Treatment|Withdrawal by Subject|0|||
19786486|NCT02081391|42243654|FG000|12-hour Treatment|Physician Decision|4|||
19786487|NCT02081391|42243655|FG001|12-hour Treatment|Physician Decision|1|||
19786488|NCT02081391|42243656|FG002|12-hour Treatment|Physician Decision|0|||
19786489|NCT02081391|42243657|FG003|12-hour Treatment|Physician Decision|0|||
19786490|NCT02081391|42243654|FG000|12-hour Treatment|Lack of Efficacy|3|||
19786491|NCT02081391|42243655|FG001|12-hour Treatment|Lack of Efficacy|0|||
19786492|NCT02081391|42243656|FG002|12-hour Treatment|Lack of Efficacy|0|||
19786493|NCT02081391|42243657|FG003|12-hour Treatment|Lack of Efficacy|0|||
19786494|NCT02081391|42243654|FG000|12-hour Treatment|Adverse Event|4|||
19786495|NCT02081391|42243655|FG001|12-hour Treatment|Adverse Event|2|||
19786496|NCT02081391|42243656|FG002|12-hour Treatment|Adverse Event|0|||
19786497|NCT02081391|42243657|FG003|12-hour Treatment|Adverse Event|0|||
19786498|NCT02081391|42243654|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
19786499|NCT02081391|42243655|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
19786500|NCT02081391|42243656|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
19786501|NCT02081391|42243657|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
19786502|NCT02081391|42243654|FG000|12-hour Treatment|Further reasons|2|||
19786503|NCT02081391|42243655|FG001|12-hour Treatment|Further reasons|1|||
19786504|NCT02081391|42243656|FG002|12-hour Treatment|Further reasons|0|||
19786505|NCT02081391|42243657|FG003|12-hour Treatment|Further reasons|0|||
19786506|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
19786507|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
19786508|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
19786509|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
19786510|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
19786511|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
19786512|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
19786513|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
19786514|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
19786515|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
19786516|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
19786517|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
19786518|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
19786519|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
19786520|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
19786521|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
19786522|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
19786523|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
19786524|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
19786525|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
19786526|NCT02081391|42243654|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
19786527|NCT02081391|42243655|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
19786528|NCT02081391|42243656|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
19786529|NCT02081391|42243657|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
19786530|NCT00430092|42243680|FG000|Overall Study|Adverse Event|0|||
19786531|NCT00430092|42243681|FG001|Overall Study|Adverse Event|0|||
19786532|NCT00430092|42243682|FG002|Overall Study|Adverse Event|1|||
19786533|NCT00430092|42243680|FG000|Overall Study|Lack of Efficacy|5|||
19786534|NCT00430092|42243681|FG001|Overall Study|Lack of Efficacy|2|||
19786535|NCT00430092|42243682|FG002|Overall Study|Lack of Efficacy|54|||
19786536|NCT00430092|42243680|FG000|Overall Study|Lost to Follow-up|1|||
19786537|NCT00430092|42243681|FG001|Overall Study|Lost to Follow-up|0|||
19786538|NCT00430092|42243682|FG002|Overall Study|Lost to Follow-up|0|||
19786539|NCT00430092|42243680|FG000|Overall Study|Protocol Violation|0|||
19786540|NCT00430092|42243681|FG001|Overall Study|Protocol Violation|1|||
19786541|NCT00430092|42243682|FG002|Overall Study|Protocol Violation|1|||
19786542|NCT00430092|42243680|FG000|Overall Study|Withdrawal by Subject|0|||
19786543|NCT00430092|42243681|FG001|Overall Study|Withdrawal by Subject|1|||
19786544|NCT00430092|42243682|FG002|Overall Study|Withdrawal by Subject|1|||
19786545|NCT00425100|42243687|FG000|Overall Study|Adverse Event|36|||
19786546|NCT00425100|42243687|FG000|Overall Study|Lack of Efficacy|4|||
19786547|NCT00425100|42243687|FG000|Overall Study|Lost to Follow-up|2|||
19786548|NCT00425100|42243687|FG000|Overall Study|Protocol Violation|4|||
19786549|NCT00425100|42243687|FG000|Overall Study|Withdrawal by Subject|7|||
19786550|NCT00412932|42243692|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
19786551|NCT00412932|42243692|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
19786552|NCT00412932|42243692|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
19786553|NCT00412932|42243692|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
19786554|NCT00412932|42243692|FG000|Olmesartan (Olm) 20 mg|Other|1|||
19786555|NCT00412932|42243692|FG000|Olmesartan 40 mg|Adverse Event|4|||
19786556|NCT00412932|42243692|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
19786557|NCT00412932|42243692|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
19786558|NCT00412932|42243692|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
19786559|NCT00412932|42243692|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
19786560|NCT00412932|42243692|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
19786561|NCT00412932|42243692|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
19786562|NCT02696031|42243698|FG000|Up to Week 24|Adverse Event|2|||
19786563|NCT02696031|42243699|FG001|Up to Week 24|Adverse Event|4|||
19786564|NCT02696031|42243700|FG002|Up to Week 24|Adverse Event|2|||
19786565|NCT02696031|42243701|FG003|Up to Week 24|Adverse Event|0|||
19786566|NCT02696031|42243702|FG004|Up to Week 24|Adverse Event|0|||
19786567|NCT02696031|42243703|FG005|Up to Week 24|Adverse Event|0|||
19786568|NCT02696031|42243698|FG000|Up to Week 24|Lack of Efficacy|2|||
19786569|NCT02696031|42243699|FG001|Up to Week 24|Lack of Efficacy|1|||
19786570|NCT02696031|42243700|FG002|Up to Week 24|Lack of Efficacy|2|||
19786571|NCT02696031|42243701|FG003|Up to Week 24|Lack of Efficacy|0|||
19786572|NCT02696031|42243702|FG004|Up to Week 24|Lack of Efficacy|0|||
19786573|NCT02696031|42243703|FG005|Up to Week 24|Lack of Efficacy|0|||
19786574|NCT02696031|42243698|FG000|Up to Week 24|Lost to Follow-up|0|||
19786575|NCT02696031|42243699|FG001|Up to Week 24|Lost to Follow-up|1|||
19786576|NCT02696031|42243700|FG002|Up to Week 24|Lost to Follow-up|1|||
19786577|NCT02696031|42243701|FG003|Up to Week 24|Lost to Follow-up|0|||
19786578|NCT02696031|42243702|FG004|Up to Week 24|Lost to Follow-up|0|||
19786579|NCT02696031|42243703|FG005|Up to Week 24|Lost to Follow-up|0|||
19786580|NCT02696031|42243698|FG000|Up to Week 24|Physician Decision|1|||
19786581|NCT02696031|42243699|FG001|Up to Week 24|Physician Decision|0|||
19786582|NCT02696031|42243700|FG002|Up to Week 24|Physician Decision|1|||
19786583|NCT02696031|42243701|FG003|Up to Week 24|Physician Decision|0|||
19786584|NCT02696031|42243702|FG004|Up to Week 24|Physician Decision|0|||
19786585|NCT02696031|42243703|FG005|Up to Week 24|Physician Decision|0|||
19786586|NCT02696031|42243698|FG000|Up to Week 24|Protocol Violation|1|||
19786587|NCT02696031|42243699|FG001|Up to Week 24|Protocol Violation|0|||
19786588|NCT02696031|42243700|FG002|Up to Week 24|Protocol Violation|0|||
19786589|NCT02696031|42243701|FG003|Up to Week 24|Protocol Violation|0|||
19786590|NCT02696031|42243702|FG004|Up to Week 24|Protocol Violation|0|||
19786591|NCT02696031|42243703|FG005|Up to Week 24|Protocol Violation|0|||
19786592|NCT02696031|42243698|FG000|Up to Week 24|Withdrawal by Subject|4|||
19786593|NCT02696031|42243699|FG001|Up to Week 24|Withdrawal by Subject|1|||
19786594|NCT02696031|42243700|FG002|Up to Week 24|Withdrawal by Subject|5|||
19786595|NCT02696031|42243701|FG003|Up to Week 24|Withdrawal by Subject|0|||
19786596|NCT02696031|42243702|FG004|Up to Week 24|Withdrawal by Subject|0|||
19786597|NCT02696031|42243703|FG005|Up to Week 24|Withdrawal by Subject|0|||
19786598|NCT02696031|42243698|FG000|Up to Week 52|Adverse Event|4|||
19786599|NCT02696031|42243699|FG001|Up to Week 52|Adverse Event|5|||
19786600|NCT02696031|42243700|FG002|Up to Week 52|Adverse Event|3|||
19786601|NCT02696031|42243701|FG003|Up to Week 52|Adverse Event|0|||
19786602|NCT02696031|42243702|FG004|Up to Week 52|Adverse Event|0|||
19786603|NCT02696031|42243703|FG005|Up to Week 52|Adverse Event|0|||
19786604|NCT02696031|42243698|FG000|Up to Week 52|Lack of Efficacy|10|||
19786605|NCT02696031|42243699|FG001|Up to Week 52|Lack of Efficacy|7|||
19786606|NCT02696031|42243700|FG002|Up to Week 52|Lack of Efficacy|11|||
19786607|NCT02696031|42243701|FG003|Up to Week 52|Lack of Efficacy|0|||
19786608|NCT02696031|42243702|FG004|Up to Week 52|Lack of Efficacy|0|||
19786609|NCT02696031|42243703|FG005|Up to Week 52|Lack of Efficacy|0|||
19786610|NCT02696031|42243698|FG000|Up to Week 52|Lost to Follow-up|1|||
19786611|NCT02696031|42243699|FG001|Up to Week 52|Lost to Follow-up|1|||
19786612|NCT02696031|42243700|FG002|Up to Week 52|Lost to Follow-up|1|||
19786613|NCT02696031|42243701|FG003|Up to Week 52|Lost to Follow-up|0|||
19786614|NCT02696031|42243702|FG004|Up to Week 52|Lost to Follow-up|0|||
19786615|NCT02696031|42243703|FG005|Up to Week 52|Lost to Follow-up|0|||
19786616|NCT02696031|42243698|FG000|Up to Week 52|Physician Decision|1|||
19786617|NCT02696031|42243699|FG001|Up to Week 52|Physician Decision|1|||
19786618|NCT02696031|42243700|FG002|Up to Week 52|Physician Decision|2|||
19786619|NCT02696031|42243701|FG003|Up to Week 52|Physician Decision|0|||
19786620|NCT02696031|42243702|FG004|Up to Week 52|Physician Decision|0|||
19786621|NCT02696031|42243703|FG005|Up to Week 52|Physician Decision|0|||
19786622|NCT02696031|42243698|FG000|Up to Week 52|Pregnancy|0|||
19786623|NCT02696031|42243699|FG001|Up to Week 52|Pregnancy|2|||
19786624|NCT02696031|42243700|FG002|Up to Week 52|Pregnancy|0|||
19786625|NCT02696031|42243701|FG003|Up to Week 52|Pregnancy|0|||
19786626|NCT02696031|42243702|FG004|Up to Week 52|Pregnancy|0|||
19786627|NCT02696031|42243703|FG005|Up to Week 52|Pregnancy|0|||
19786628|NCT02696031|42243698|FG000|Up to Week 52|Protocol Violation|1|||
19786629|NCT02696031|42243699|FG001|Up to Week 52|Protocol Violation|0|||
19786630|NCT02696031|42243700|FG002|Up to Week 52|Protocol Violation|0|||
19786631|NCT02696031|42243701|FG003|Up to Week 52|Protocol Violation|0|||
19786632|NCT02696031|42243702|FG004|Up to Week 52|Protocol Violation|0|||
19786633|NCT02696031|42243703|FG005|Up to Week 52|Protocol Violation|0|||
19786634|NCT02696031|42243698|FG000|Up to Week 52|Withdrawal by Subject|12|||
19786635|NCT02696031|42243699|FG001|Up to Week 52|Withdrawal by Subject|3|||
19786636|NCT02696031|42243700|FG002|Up to Week 52|Withdrawal by Subject|9|||
19786637|NCT02696031|42243701|FG003|Up to Week 52|Withdrawal by Subject|0|||
19786638|NCT02696031|42243702|FG004|Up to Week 52|Withdrawal by Subject|0|||
19786639|NCT02696031|42243703|FG005|Up to Week 52|Withdrawal by Subject|0|||
19786640|NCT02696031|42243698|FG000|Up to Week 104|Pregnancy|0|||
19786641|NCT02696031|42243699|FG001|Up to Week 104|Pregnancy|2|||
19786642|NCT02696031|42243700|FG002|Up to Week 104|Pregnancy|1|||
19786643|NCT02696031|42243701|FG003|Up to Week 104|Pregnancy|0|||
19786644|NCT02696031|42243702|FG004|Up to Week 104|Pregnancy|0|||
19786645|NCT02696031|42243703|FG005|Up to Week 104|Pregnancy|0|||
19786646|NCT02696031|42243698|FG000|Up to Week 104|Withdrawal by Subject|15|||
19786647|NCT02696031|42243699|FG001|Up to Week 104|Withdrawal by Subject|10|||
19786648|NCT02696031|42243700|FG002|Up to Week 104|Withdrawal by Subject|16|||
19786649|NCT02696031|42243701|FG003|Up to Week 104|Withdrawal by Subject|0|||
19786650|NCT02696031|42243702|FG004|Up to Week 104|Withdrawal by Subject|0|||
19786651|NCT02696031|42243703|FG005|Up to Week 104|Withdrawal by Subject|0|||
19786652|NCT02696031|42243698|FG000|Up to Week 104|Protocol Violation|1|||
19786653|NCT02696031|42243699|FG001|Up to Week 104|Protocol Violation|0|||
19786654|NCT02696031|42243700|FG002|Up to Week 104|Protocol Violation|0|||
19786655|NCT02696031|42243701|FG003|Up to Week 104|Protocol Violation|0|||
19786656|NCT02696031|42243702|FG004|Up to Week 104|Protocol Violation|0|||
19786657|NCT02696031|42243703|FG005|Up to Week 104|Protocol Violation|0|||
19786658|NCT02696031|42243698|FG000|Up to Week 104|Physician Decision|1|||
19786659|NCT02696031|42243699|FG001|Up to Week 104|Physician Decision|2|||
19786660|NCT02696031|42243700|FG002|Up to Week 104|Physician Decision|3|||
19786661|NCT02696031|42243701|FG003|Up to Week 104|Physician Decision|0|||
19786662|NCT02696031|42243702|FG004|Up to Week 104|Physician Decision|0|||
19786663|NCT02696031|42243703|FG005|Up to Week 104|Physician Decision|0|||
19786664|NCT02696031|42243698|FG000|Up to Week 104|Lost to Follow-up|2|||
19786665|NCT02696031|42243699|FG001|Up to Week 104|Lost to Follow-up|3|||
19786666|NCT02696031|42243700|FG002|Up to Week 104|Lost to Follow-up|1|||
19786667|NCT02696031|42243701|FG003|Up to Week 104|Lost to Follow-up|0|||
19786668|NCT02696031|42243702|FG004|Up to Week 104|Lost to Follow-up|0|||
19786669|NCT02696031|42243703|FG005|Up to Week 104|Lost to Follow-up|0|||
19786670|NCT02696031|42243698|FG000|Up to Week 104|Lack of Efficacy|13|||
19786671|NCT02696031|42243699|FG001|Up to Week 104|Lack of Efficacy|12|||
19786672|NCT02696031|42243700|FG002|Up to Week 104|Lack of Efficacy|11|||
19786673|NCT02696031|42243701|FG003|Up to Week 104|Lack of Efficacy|0|||
19786674|NCT02696031|42243702|FG004|Up to Week 104|Lack of Efficacy|0|||
19786675|NCT02696031|42243703|FG005|Up to Week 104|Lack of Efficacy|0|||
19786676|NCT02696031|42243698|FG000|Up to Week 104|Adverse Event|7|||
19786677|NCT02696031|42243699|FG001|Up to Week 104|Adverse Event|11|||
19786678|NCT02696031|42243700|FG002|Up to Week 104|Adverse Event|5|||
19786679|NCT02696031|42243701|FG003|Up to Week 104|Adverse Event|0|||
19786680|NCT02696031|42243702|FG004|Up to Week 104|Adverse Event|0|||
19786681|NCT02696031|42243703|FG005|Up to Week 104|Adverse Event|0|||
19697201|NCT00317642|42142461|FG001|Overall Study|Treatment Failure|102|||
19697202|NCT00317642|42142460|FG000|Overall Study|Disease Recurrence|1|||
19697203|NCT00317642|42142461|FG001|Overall Study|Disease Recurrence|2|||
19697204|NCT00317642|42142460|FG000|Overall Study|Death|14|||
19697205|NCT00317642|42142461|FG001|Overall Study|Death|7|||
19697206|NCT00317642|42142460|FG000|Overall Study|Not Continue to Consolidation|2|||
19697207|NCT00317642|42142461|FG001|Overall Study|Not Continue to Consolidation|0|||
19697208|NCT00317642|42142460|FG000|Overall Study|Withdrawal by Subject|0|||
19786682|NCT02696031|42243698|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
19786683|NCT02696031|42243699|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
19786684|NCT02696031|42243700|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
19786685|NCT02696031|42243701|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
19786686|NCT02696031|42243702|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
19786687|NCT02696031|42243703|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
19786688|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
19786689|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
19786690|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
19786691|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
19786692|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
19697209|NCT00317642|42142461|FG001|Overall Study|Withdrawal by Subject|1|||
19786693|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
19786694|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
19786695|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
19786696|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
19786697|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
19786698|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
19786699|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
19786700|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
19786701|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
19786702|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
19786703|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
19786704|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
19786705|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
19786706|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
19786707|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
19786708|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
19786709|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
19786710|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
19786711|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
19786712|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
19786713|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
19786714|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
19786715|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
19786716|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
19786717|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
19786718|NCT02696031|42243698|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
19786719|NCT02696031|42243699|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
19786720|NCT02696031|42243700|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
19786721|NCT02696031|42243701|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
19786722|NCT02696031|42243702|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
19786723|NCT02696031|42243703|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
19786724|NCT00397254|42243712|FG000|Overall Study|Lost to Follow-up|2|||
19786725|NCT00397254|42243713|FG001|Overall Study|Lost to Follow-up|2|||
19786726|NCT01369641|42243717|FG000|Overall Study|Withdrawal by Subject|1|||
19786727|NCT00529152|42243721|FG000|Overall Study|Adverse Event|2|||
19786728|NCT00529152|42243721|FG000|Overall Study|Withdrawal by Subject|2|||
19786729|NCT00529152|42243721|FG000|Overall Study|Lost to Follow-up|1|||
19786730|NCT02605174|42243728|FG000|Overall Study|Adverse Event|0|||
19786731|NCT02605174|42243729|FG001|Overall Study|Adverse Event|0|||
19786732|NCT02605174|42243730|FG002|Overall Study|Adverse Event|1|||
19786733|NCT02605174|42243731|FG003|Overall Study|Adverse Event|0|||
19786734|NCT02605174|42243732|FG004|Overall Study|Adverse Event|4|||
19786735|NCT02605174|42243733|FG005|Overall Study|Adverse Event|0|||
19786736|NCT02605174|42243734|FG006|Overall Study|Adverse Event|0|||
19786737|NCT02605174|42243728|FG000|Overall Study|Lost to Follow-up|20|||
19786738|NCT02605174|42243729|FG001|Overall Study|Lost to Follow-up|7|||
19786739|NCT02605174|42243730|FG002|Overall Study|Lost to Follow-up|27|||
19786740|NCT02605174|42243731|FG003|Overall Study|Lost to Follow-up|10|||
19786741|NCT02605174|42243732|FG004|Overall Study|Lost to Follow-up|20|||
19786742|NCT02605174|42243733|FG005|Overall Study|Lost to Follow-up|10|||
19786743|NCT02605174|42243734|FG006|Overall Study|Lost to Follow-up|29|||
19697210|NCT00317642|42142460|FG000|Overall Study|Referred For Transplantation|1|||
19697211|NCT00317642|42142461|FG001|Overall Study|Referred For Transplantation|0|||
19697212|NCT00317642|42142460|FG000|Overall Study|AML Not Centrally Confirmed|1|||
19697213|NCT00317642|42142461|FG001|Overall Study|AML Not Centrally Confirmed|5|||
19697214|NCT00295022|42142477|FG000|Overall Study|Adverse Event|1|||
19697215|NCT00295022|42142478|FG001|Overall Study|Adverse Event|1|||
19697216|NCT00295022|42142479|FG002|Overall Study|Adverse Event|2|||
19697217|NCT00295022|42142477|FG000|Overall Study|Lost to Follow-up|0|||
19697218|NCT00295022|42142478|FG001|Overall Study|Lost to Follow-up|0|||
19697219|NCT00295022|42142479|FG002|Overall Study|Lost to Follow-up|1|||
19697220|NCT00295022|42142477|FG000|Overall Study|Withdrawal by Subject|0|||
19786744|NCT02605174|42243728|FG000|Overall Study|Protocol Violation|10|||
19786745|NCT02605174|42243729|FG001|Overall Study|Protocol Violation|4|||
19786746|NCT02605174|42243730|FG002|Overall Study|Protocol Violation|14|||
19786747|NCT02605174|42243731|FG003|Overall Study|Protocol Violation|6|||
19786748|NCT02605174|42243732|FG004|Overall Study|Protocol Violation|7|||
19786749|NCT02605174|42243733|FG005|Overall Study|Protocol Violation|7|||
19786750|NCT02605174|42243734|FG006|Overall Study|Protocol Violation|12|||
19786751|NCT02605174|42243728|FG000|Overall Study|Pregnancy|1|||
19786752|NCT02605174|42243729|FG001|Overall Study|Pregnancy|0|||
19697221|NCT00295022|42142478|FG001|Overall Study|Withdrawal by Subject|0|||
19786753|NCT02605174|42243730|FG002|Overall Study|Pregnancy|0|||
19786754|NCT02605174|42243731|FG003|Overall Study|Pregnancy|2|||
19786755|NCT02605174|42243732|FG004|Overall Study|Pregnancy|0|||
19786756|NCT02605174|42243733|FG005|Overall Study|Pregnancy|0|||
19786757|NCT02605174|42243734|FG006|Overall Study|Pregnancy|0|||
19786758|NCT02605174|42243728|FG000|Overall Study|Withdrawal by Subject|9|||
19786759|NCT02605174|42243729|FG001|Overall Study|Withdrawal by Subject|6|||
19786760|NCT02605174|42243730|FG002|Overall Study|Withdrawal by Subject|14|||
19786761|NCT02605174|42243731|FG003|Overall Study|Withdrawal by Subject|11|||
19786762|NCT02605174|42243732|FG004|Overall Study|Withdrawal by Subject|6|||
19786763|NCT02605174|42243733|FG005|Overall Study|Withdrawal by Subject|4|||
19786764|NCT02605174|42243734|FG006|Overall Study|Withdrawal by Subject|15|||
19786765|NCT02605174|42243728|FG000|Overall Study|Physician Decision|2|||
19786766|NCT02605174|42243729|FG001|Overall Study|Physician Decision|0|||
19786767|NCT02605174|42243730|FG002|Overall Study|Physician Decision|0|||
19786768|NCT02605174|42243731|FG003|Overall Study|Physician Decision|0|||
19786769|NCT02605174|42243732|FG004|Overall Study|Physician Decision|0|||
19786770|NCT02605174|42243733|FG005|Overall Study|Physician Decision|0|||
19786771|NCT02605174|42243734|FG006|Overall Study|Physician Decision|3|||
19786772|NCT02605174|42243728|FG000|Overall Study|Randomization Failure|22|||
19786773|NCT02605174|42243729|FG001|Overall Study|Randomization Failure|6|||
19786774|NCT02605174|42243730|FG002|Overall Study|Randomization Failure|20|||
19786775|NCT02605174|42243731|FG003|Overall Study|Randomization Failure|7|||
19786776|NCT02605174|42243732|FG004|Overall Study|Randomization Failure|16|||
19786777|NCT02605174|42243733|FG005|Overall Study|Randomization Failure|11|||
19786778|NCT02605174|42243734|FG006|Overall Study|Randomization Failure|30|||
19786779|NCT02604550|42243762|FG000|Overall Study|Lost to Follow-up|7|||
19786780|NCT02604550|42243763|FG001|Overall Study|Lost to Follow-up|6|||
19786781|NCT02604550|42243762|FG000|Overall Study|Withdrawal by Subject|0|||
19786782|NCT02604550|42243763|FG001|Overall Study|Withdrawal by Subject|1|||
19786783|NCT02604550|42243762|FG000|Overall Study|Incomplete data using paper journal|18|||
19786784|NCT02604550|42243763|FG001|Overall Study|Incomplete data using paper journal|19|||
19786785|NCT02591290|42243769|FG000|Overall Study|Withdrawal by Subject|2|||
19786786|NCT02791893|42243775|FG000|Blinded Phase|Lost to Follow-up|2|||
19786787|NCT02791893|42243776|FG001|Blinded Phase|Lost to Follow-up|2|||
19786788|NCT02791893|42243775|FG000|Blinded Phase|Withdrawal by Subject|1|||
19786789|NCT02791893|42243776|FG001|Blinded Phase|Withdrawal by Subject|2|||
19786790|NCT02791893|42243775|FG000|Open Label Phase|Lost to Follow-up|3|||
19786791|NCT02791893|42243776|FG001|Open Label Phase|Lost to Follow-up|0|||
19786792|NCT02791893|42243775|FG000|Open Label Phase|Withdrawal by Subject|0|||
19786793|NCT02791893|42243776|FG001|Open Label Phase|Withdrawal by Subject|2|||
19786794|NCT00120042|42243785|FG000|Overall Study|all completed protocl|0|||
19786795|NCT00120042|42243786|FG001|Overall Study|all completed protocl|0|||
19786796|NCT00120042|42243787|FG002|Overall Study|all completed protocl|0|||
19786797|NCT02476851|42243794|FG000|Overall Study|Protocol Violation|1|||
19786798|NCT02476851|42243795|FG001|Overall Study|Protocol Violation|1|||
19786799|NCT02595970|42243801|FG000|Overall Study|Withdrawal by Subject|2|||
19786800|NCT02595970|42243801|FG000|Overall Study|Physician Decision|2|||
19607452|NCT00882999|42056238|FG005|Overall Study|Physician Decision|1|||
19607453|NCT00882999|42056239|FG006|Overall Study|Physician Decision|1|||
19607454|NCT00671437|42056262|FG000|Overall Study|Progressive disease before C1 week 8|8|||
19607455|NCT00671437|42056262|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
19607456|NCT00671437|42056262|FG000|Overall Study|Adverse Event|3|||
19786801|NCT02595970|42243801|FG000|Overall Study|Protocol Violation|4|||
19607457|NCT00671437|42056262|FG000|Overall Study|Ineligible post-hoc|1|||
19697222|NCT00295022|42142479|FG002|Overall Study|Withdrawal by Subject|2|||
19697223|NCT00303446|42142491|FG000|Overall Study|Withdrawal by Subject|2|||
19697224|NCT00303446|42142492|FG001|Overall Study|Withdrawal by Subject|2|||
19697225|NCT00303446|42142491|FG000|Overall Study|Death|0|||
19697226|NCT00303446|42142492|FG001|Overall Study|Death|1|||
19697227|NCT00303446|42142491|FG000|Overall Study|Physician Decision|0|||
19697228|NCT00303446|42142492|FG001|Overall Study|Physician Decision|1|||
19697229|NCT00316706|42142500|FG000|Overall Study|Lost to Follow-up|38|||
19697230|NCT00316706|42142501|FG001|Overall Study|Lost to Follow-up|48|||
19697231|NCT00291486|42142512|FG000|Overall Study|Adverse Event|0|||
19786802|NCT02595970|42243801|FG000|Overall Study|Adverse Event|5|||
19786803|NCT02595970|42243801|FG000|Overall Study|Lack of Efficacy|7|||
19786804|NCT01866111|42243809|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
19786805|NCT01866111|42243810|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
19786806|NCT01866111|42243811|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
19786807|NCT01866111|42243812|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
19786808|NCT01866111|42243809|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
19786809|NCT01866111|42243810|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
19697232|NCT00291486|42142513|FG001|Overall Study|Adverse Event|3|||
19697233|NCT00291486|42142514|FG002|Overall Study|Adverse Event|0|||
19697234|NCT00291486|42142515|FG003|Overall Study|Adverse Event|1|||
19697235|NCT00291486|42142516|FG004|Overall Study|Adverse Event|0|||
19697236|NCT00291486|42142512|FG000|Overall Study|Withdrawal by Subject|0|||
19697237|NCT00291486|42142513|FG001|Overall Study|Withdrawal by Subject|0|||
19697238|NCT00291486|42142514|FG002|Overall Study|Withdrawal by Subject|0|||
19697239|NCT00291486|42142515|FG003|Overall Study|Withdrawal by Subject|0|||
19697240|NCT00291486|42142516|FG004|Overall Study|Withdrawal by Subject|1|||
19786810|NCT01866111|42243811|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
19786811|NCT01866111|42243812|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
19786812|NCT02595502|42243822|FG000|Period 1|Adverse Event|0|||
19786813|NCT02595502|42243823|FG001|Period 1|Adverse Event|1|||
19697241|NCT00291486|42142512|FG000|Overall Study|Disease progression|1|||
19697242|NCT00291486|42142513|FG001|Overall Study|Disease progression|0|||
19697243|NCT00291486|42142514|FG002|Overall Study|Disease progression|1|||
19697244|NCT00291486|42142515|FG003|Overall Study|Disease progression|0|||
19697245|NCT00291486|42142516|FG004|Overall Study|Disease progression|0|||
19697246|NCT00301964|42142537|FG000|Overall Study|Second primary|2|||
19697247|NCT00301964|42142537|FG000|Overall Study|Wrong primary|1|||
19786814|NCT02595502|42243822|FG000|Period 1|Withdrawal by Subject|1|||
19786815|NCT02595502|42243823|FG001|Period 1|Withdrawal by Subject|0|||
19786816|NCT02595502|42243822|FG000|Period 1|Lost to Follow-up|0|||
19786817|NCT02595502|42243823|FG001|Period 1|Lost to Follow-up|1|||
19786818|NCT02595502|42243822|FG000|Period 2|Adverse Event|1|||
19786819|NCT02595502|42243823|FG001|Period 2|Adverse Event|1|||
19786820|NCT02595502|42243822|FG000|Period 2|Received incorrect lens at Period 1|0|||
19786821|NCT02595502|42243823|FG001|Period 2|Received incorrect lens at Period 1|1|||
19786822|NCT02595502|42243822|FG000|Period 3|Protocol Violation|0|||
19786823|NCT02595502|42243823|FG001|Period 3|Protocol Violation|1|||
19786824|NCT02595502|42243822|FG000|Period 3|Lost to Follow-up|1|||
19786825|NCT02595502|42243823|FG001|Period 3|Lost to Follow-up|0|||
19786826|NCT02595502|42243822|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
19786827|NCT02595502|42243823|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
19786828|NCT01369329|42243832|FG000|Overall Study|Withdrawal by Subject|8|||
19786829|NCT01369329|42243833|FG001|Overall Study|Withdrawal by Subject|6|||
19786830|NCT01369329|42243834|FG002|Overall Study|Withdrawal by Subject|10|||
19786831|NCT01369329|42243832|FG000|Overall Study|Lost to Follow-up|2|||
19786832|NCT01369329|42243833|FG001|Overall Study|Lost to Follow-up|2|||
19786833|NCT01369329|42243834|FG002|Overall Study|Lost to Follow-up|2|||
19786834|NCT01369329|42243832|FG000|Overall Study|Other|2|||
19786835|NCT01369329|42243833|FG001|Overall Study|Other|3|||
19786836|NCT01369329|42243834|FG002|Overall Study|Other|2|||
19786837|NCT02791659|42243844|FG000|Overall Study|Protocol Violation|0|||
19786838|NCT02791659|42243845|FG001|Overall Study|Protocol Violation|1|||
19786839|NCT02594098|42243853|FG000|Overall Study|Lack of Efficacy|17|||
19786840|NCT02594098|42243854|FG001|Overall Study|Lack of Efficacy|6|||
19786841|NCT02594098|42243853|FG000|Overall Study|Withdrawal by Subject|1|||
19786842|NCT02594098|42243854|FG001|Overall Study|Withdrawal by Subject|3|||
19786843|NCT02594098|42243853|FG000|Overall Study|Terminated participation|6|||
19786844|NCT02594098|42243854|FG001|Overall Study|Terminated participation|2|||
19786845|NCT02594098|42243853|FG000|Overall Study|Seek alternative treatment|2|||
19786846|NCT02594098|42243854|FG001|Overall Study|Seek alternative treatment|1|||
19786847|NCT02594098|42243853|FG000|Overall Study|Other|0|||
19786848|NCT02594098|42243854|FG001|Overall Study|Other|1|||
19786849|NCT02593864|42243862|FG000|Overall Study|Withdrawal by Subject|3|||
19786850|NCT02593864|42243862|FG000|Overall Study|Lost to Follow-up|3|||
19786851|NCT02590588|42243866|FG000|Overall Study|Adverse Event|1|||
19786852|NCT01434602|42243875|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
19786853|NCT01434602|42243876|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
19786854|NCT01434602|42243877|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
19786855|NCT01434602|42243878|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
19786856|NCT01434602|42243879|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
19607458|NCT00882921|42056274|FG000|Overall Study|Death|2|||
19697248|NCT00301964|42142537|FG000|Overall Study|Inadequate pathology|1|||
19697249|NCT00301808|42142547|FG000|Overall Study|Adverse Event|5|||
19697250|NCT00301808|42142547|FG000|Overall Study|Death|3|||
19786857|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
19786858|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
19786859|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
19786860|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
19786861|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
19607459|NCT00882921|42056274|FG000|Overall Study|Other|3|||
19697251|NCT00301808|42142547|FG000|Overall Study|Lack of Efficacy|4|||
19367417|NCT02634788|41607589|FG000|Overall Study|Adverse Event|0|||
19367418|NCT02634788|41607590|FG001|Overall Study|Adverse Event|8|||
19367419|NCT02634788|41607591|FG002|Overall Study|Adverse Event|3|||
19477843|NCT01506193|41757105|FG001|Overall Study|Migrated/moved from study area|0|||
19786862|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
19786863|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
19786864|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
19786865|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
19786866|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
19786867|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
19786868|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
19786869|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
19786870|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
19786871|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
19786872|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
19786873|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
19786874|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
19786875|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
19697252|NCT00268242|42142551|FG000|Overall Study|Death|1|||
19697253|NCT00294554|42142557|FG000|Overall Study|Lack of Efficacy|0|||
19697254|NCT00294554|42142558|FG001|Overall Study|Lack of Efficacy|1|||
19697255|NCT00294554|42142557|FG000|Overall Study|Physician Decision|0|||
19697256|NCT00294554|42142558|FG001|Overall Study|Physician Decision|1|||
19697257|NCT00294398|42142566|FG000|Overall Study|Lost to Follow-up|21|||
19697258|NCT00294398|42142567|FG001|Overall Study|Lost to Follow-up|26|||
19697259|NCT00279708|42142575|FG000|Overall Study|Withdrawal by Subject|2|||
19697260|NCT00279708|42142576|FG001|Overall Study|Withdrawal by Subject|3|||
19697261|NCT00279708|42142575|FG000|Overall Study|Adverse Event|1|||
19697262|NCT00279708|42142576|FG001|Overall Study|Adverse Event|1|||
19697263|NCT00299702|42142584|FG000|Overall Study|Death|1|||
19697264|NCT00299702|42142585|FG001|Overall Study|Death|0|||
19697265|NCT00299702|42142584|FG000|Overall Study|Adverse Event|0|||
19697266|NCT00299702|42142585|FG001|Overall Study|Adverse Event|4|||
19697267|NCT00299702|42142584|FG000|Overall Study|Lost to Follow-up|18|||
19697268|NCT00299702|42142585|FG001|Overall Study|Lost to Follow-up|10|||
19697269|NCT00299702|42142584|FG000|Overall Study|Withdrawal by Subject|25|||
19697270|NCT00299702|42142585|FG001|Overall Study|Withdrawal by Subject|23|||
19697271|NCT00299702|42142584|FG000|Overall Study|Pregnancy|0|||
19697272|NCT00299702|42142585|FG001|Overall Study|Pregnancy|1|||
19786876|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
19786877|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
19697273|NCT00299702|42142584|FG000|Overall Study|Insufficient Response|4|||
19477844|NCT01506193|41757106|FG002|Overall Study|Migrated/moved from study area|1|||
19477845|NCT01506193|41757104|FG000|Overall Study|Adverse event, non-fatal|0|||
19477846|NCT01506193|41757105|FG001|Overall Study|Adverse event, non-fatal|0|||
19477847|NCT01506193|41757106|FG002|Overall Study|Adverse event, non-fatal|1|||
19477848|NCT01506193|41757104|FG000|Overall Study|Withdrawal by Subject|5|||
19477849|NCT01506193|41757105|FG001|Overall Study|Withdrawal by Subject|1|||
19477850|NCT01506193|41757106|FG002|Overall Study|Withdrawal by Subject|8|||
19477851|NCT01506193|41757104|FG000|Overall Study|Lost to Follow-up|8|||
19477852|NCT01506193|41757105|FG001|Overall Study|Lost to Follow-up|3|||
19477853|NCT01506193|41757106|FG002|Overall Study|Lost to Follow-up|3|||
19477854|NCT01505881|41757117|FG000|Overall Study|Adverse Event|0|||
19477855|NCT01505881|41757118|FG001|Overall Study|Adverse Event|1|||
19477856|NCT01505881|41757117|FG000|Overall Study|Lost to Follow-up|2|||
19477857|NCT01505881|41757118|FG001|Overall Study|Lost to Follow-up|0|||
19477858|NCT01505881|41757117|FG000|Overall Study|Withdrawal by Subject|2|||
19477859|NCT01505881|41757118|FG001|Overall Study|Withdrawal by Subject|0|||
19477860|NCT01462045|41757128|FG000|Overall Study|Family matter|0|||
19697274|NCT00299702|42142585|FG001|Overall Study|Insufficient Response|3|||
19697275|NCT00299702|42142584|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
19697276|NCT00299702|42142585|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
19697277|NCT00291330|42142593|FG000|Overall Study|Adverse Event|47|||
19697278|NCT00291330|42142594|FG001|Overall Study|Adverse Event|40|||
19697279|NCT00291330|42142593|FG000|Overall Study|Protocol Violation|13|||
19477861|NCT01462045|41757129|FG001|Overall Study|Family matter|1|||
19697280|NCT00291330|42142594|FG001|Overall Study|Protocol Violation|20|||
19697281|NCT00291330|42142593|FG000|Overall Study|Lost to Follow-up|16|||
19697282|NCT00291330|42142594|FG001|Overall Study|Lost to Follow-up|11|||
19697283|NCT00291330|42142593|FG000|Overall Study|Withdrawal by Subject|22|||
19697284|NCT00291330|42142594|FG001|Overall Study|Withdrawal by Subject|25|||
19697285|NCT00291330|42142593|FG000|Overall Study|Other|3|||
19697286|NCT00291330|42142594|FG001|Overall Study|Other|1|||
19697287|NCT00267150|42142600|FG000|Overall Study|Adverse Event|1|||
19697288|NCT00278148|42142604|FG000|Phase II - Expansion Phase|Disease progression|0|||
19697289|NCT00278148|42142605|FG001|Phase II - Expansion Phase|Disease progression|0|||
19786878|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
19786879|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
19786880|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
19786881|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
19786882|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
19786883|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
19786884|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
19786885|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
19786886|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
19786887|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
19786888|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
19786889|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
19786890|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
19786891|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
19786892|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
19786893|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
19786894|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
19786895|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
19786896|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
19786897|NCT01434602|42243875|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
19786898|NCT01434602|42243876|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
19786899|NCT01434602|42243877|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
19786900|NCT01434602|42243878|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
19786901|NCT01434602|42243879|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
19697290|NCT00278148|42142606|FG002|Phase II - Expansion Phase|Disease progression|4|||
19697291|NCT00278148|42142604|FG000|Phase II - Expansion Phase|Adverse Event|0|||
19697292|NCT00278148|42142605|FG001|Phase II - Expansion Phase|Adverse Event|0|||
19786902|NCT01767129|42243901|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
19786903|NCT01767129|42243902|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
19786904|NCT02791269|42243911|FG000|Overall Study|Lost to Follow-up|0|||
19786905|NCT02791269|42243912|FG001|Overall Study|Lost to Follow-up|1|||
19786906|NCT02696564|42243922|FG000|Overall Study|Death|1|||
19786907|NCT02696564|42243923|FG001|Overall Study|Death|2|||
19786908|NCT02696564|42243922|FG000|Overall Study|Withdrawal by Subject|3|||
19786909|NCT02696564|42243923|FG001|Overall Study|Withdrawal by Subject|2|||
19786910|NCT02696564|42243922|FG000|Overall Study|Lost to Follow-up|3|||
19786911|NCT02696564|42243923|FG001|Overall Study|Lost to Follow-up|3|||
19786912|NCT02696564|42243922|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
19786913|NCT02696564|42243923|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
19786914|NCT02696564|42243922|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
19786915|NCT02696564|42243923|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
19786916|NCT02696564|42243922|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
19786917|NCT02696564|42243923|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
19697293|NCT00278148|42142606|FG002|Phase II - Expansion Phase|Adverse Event|2|||
19786918|NCT02696564|42243922|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
19786919|NCT02696564|42243923|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
19786920|NCT02696564|42243922|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
19786921|NCT02696564|42243923|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
19786922|NCT02640950|42243929|FG000|Overall Study|Adverse Event|1|||
19786923|NCT02640950|42243929|FG000|Overall Study|Withdrawal by Subject|1|||
19786924|NCT02593786|42243937|FG000|Overall Study|Disease progression|12|||
19786925|NCT02593786|42243938|FG001|Overall Study|Disease progression|16|||
19786926|NCT02593786|42243939|FG002|Overall Study|Disease progression|10|||
19786927|NCT02593786|42243940|FG003|Overall Study|Disease progression|7|||
19786928|NCT02593786|42243937|FG000|Overall Study|Study drug toxicity|1|||
19786929|NCT02593786|42243938|FG001|Overall Study|Study drug toxicity|0|||
19786930|NCT02593786|42243939|FG002|Overall Study|Study drug toxicity|0|||
19786931|NCT02593786|42243940|FG003|Overall Study|Study drug toxicity|0|||
19786932|NCT02593786|42243937|FG000|Overall Study|Adverse event unrelated to study drug|1|||
19786933|NCT02593786|42243938|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19697294|NCT00299546|42142616|FG000|Overall Study|Death|3|||
19697295|NCT00299546|42142617|FG001|Overall Study|Death|2|||
19786934|NCT02593786|42243939|FG002|Overall Study|Adverse event unrelated to study drug|1|||
19697296|NCT00299546|42142618|FG002|Overall Study|Death|0|||
19697297|NCT00299546|42142616|FG000|Overall Study|Lost to Follow-up|2|||
19697298|NCT00299546|42142617|FG001|Overall Study|Lost to Follow-up|2|||
19697299|NCT00299546|42142618|FG002|Overall Study|Lost to Follow-up|5|||
19786935|NCT02593786|42243940|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19786936|NCT02593786|42243937|FG000|Overall Study|Participant request to discontinue study therapy|0|||
19786937|NCT02593786|42243938|FG001|Overall Study|Participant request to discontinue study therapy|2|||
19786938|NCT02593786|42243939|FG002|Overall Study|Participant request to discontinue study therapy|0|||
19786939|NCT02593786|42243940|FG003|Overall Study|Participant request to discontinue study therapy|0|||
19786940|NCT02593786|42243937|FG000|Overall Study|Other reasons|1|||
19786941|NCT02593786|42243938|FG001|Overall Study|Other reasons|1|||
19786942|NCT02593786|42243939|FG002|Overall Study|Other reasons|0|||
19786943|NCT02593786|42243940|FG003|Overall Study|Other reasons|5|||
19786944|NCT04829331|42243979|FG000|Overall Study|Lost to Follow-up|1|||
19697300|NCT00299546|42142616|FG000|Overall Study|Adverse Event|37|||
19697301|NCT00299546|42142617|FG001|Overall Study|Adverse Event|22|||
19697302|NCT00299546|42142618|FG002|Overall Study|Adverse Event|27|||
19697303|NCT00299546|42142616|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
19697304|NCT00299546|42142617|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
19697305|NCT00299546|42142618|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
19697306|NCT00299546|42142616|FG000|Overall Study|Other|24|||
19697307|NCT00299546|42142617|FG001|Overall Study|Other|26|||
19697308|NCT00299546|42142618|FG002|Overall Study|Other|19|||
19697309|NCT00299546|42142616|FG000|Overall Study|Not treated|0|||
19697310|NCT00299546|42142617|FG001|Overall Study|Not treated|1|||
19697311|NCT00299546|42142618|FG002|Overall Study|Not treated|1|||
19697312|NCT00299156|42142630|FG000|Period 2 (Randomized)|Screen Failure|0|||
19697313|NCT00299156|42142631|FG001|Period 2 (Randomized)|Screen Failure|1|||
19697314|NCT00299156|42142632|FG002|Period 2 (Randomized)|Screen Failure|0|||
19697315|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
19697316|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
19697317|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
19697318|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
19697319|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
19697320|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
19697321|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
19697322|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
19697323|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
19697324|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
19697325|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
19697326|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
19697327|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
19697328|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
19697329|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
19697330|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
19697331|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
19697332|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
19697333|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
19697334|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
19697335|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
19697336|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
19697337|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
19697338|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
19697339|NCT00277212|42142640|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
19697340|NCT00277212|42142641|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
19697341|NCT00277212|42142642|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
19697342|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
19697343|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
19697344|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
19697345|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
19697346|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
19697347|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
19697348|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
19697349|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
19786945|NCT04829331|42243980|FG001|Overall Study|Lost to Follow-up|0|||
19786946|NCT04602546|42243995|FG000|Overall Study|Training|2|||
19786947|NCT04602546|42243996|FG001|Overall Study|Training|2|||
19786948|NCT04602546|42243997|FG002|Overall Study|Training|1|||
19697350|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
19697351|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
19697352|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
19697353|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
19697354|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
19697355|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
19697356|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
19697357|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
19697358|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
19697359|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
19697360|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
19697361|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
19697362|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
19697363|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
19697364|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
19697365|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
19697366|NCT00277212|42142640|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
19697367|NCT00277212|42142641|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
19697368|NCT00277212|42142642|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
19697369|NCT00276744|42142650|FG000|PART A|Reason unknown|98|||
19697370|NCT00251316|42142656|FG000|Overall Study|Physician Decision|2|||
19697371|NCT00251316|42142657|FG001|Overall Study|Physician Decision|3|||
19697372|NCT00293462|42142666|FG000|Overall Study|Withdrawal by Subject|4|||
19697373|NCT00293462|42142667|FG001|Overall Study|Withdrawal by Subject|3|||
19697374|NCT00293462|42142668|FG002|Overall Study|Withdrawal by Subject|8|||
19697375|NCT00293462|42142666|FG000|Overall Study|Death|1|||
19697376|NCT00293462|42142667|FG001|Overall Study|Death|0|||
19697377|NCT00293462|42142668|FG002|Overall Study|Death|0|||
19697378|NCT00293462|42142666|FG000|Overall Study|Lost to Follow-up|0|||
19697379|NCT00293462|42142667|FG001|Overall Study|Lost to Follow-up|1|||
19697380|NCT00293462|42142668|FG002|Overall Study|Lost to Follow-up|0|||
19697381|NCT00293462|42142666|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
19697382|NCT00293462|42142667|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
19697383|NCT00293462|42142668|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
19697384|NCT00293462|42142666|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
19697385|NCT00293462|42142667|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
19697386|NCT00293462|42142668|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
19697387|NCT00293462|42142666|FG000|Overall Study|Refuse Radiation Treatment|1|||
19697388|NCT00293462|42142667|FG001|Overall Study|Refuse Radiation Treatment|0|||
19697389|NCT00293462|42142668|FG002|Overall Study|Refuse Radiation Treatment|0|||
19697390|NCT00293462|42142666|FG000|Overall Study|No Show|0|||
19697391|NCT00293462|42142667|FG001|Overall Study|No Show|0|||
19697392|NCT00293462|42142668|FG002|Overall Study|No Show|1|||
19786949|NCT04602546|42243998|FG003|Overall Study|Training|2|||
19786950|NCT04602546|42243999|FG004|Overall Study|Training|0|||
19786951|NCT04602546|42243995|FG000|Overall Study|Randomized with disqualified data|2|||
19786952|NCT04602546|42243996|FG001|Overall Study|Randomized with disqualified data|0|||
19786953|NCT04602546|42243997|FG002|Overall Study|Randomized with disqualified data|2|||
19786954|NCT04602546|42243998|FG003|Overall Study|Randomized with disqualified data|5|||
19786955|NCT04602546|42243999|FG004|Overall Study|Randomized with disqualified data|3|||
19786956|NCT04102189|42244029|FG000|Overall Study|Withdrawal by Subject|1|||
19786957|NCT04102189|42244030|FG001|Overall Study|Withdrawal by Subject|2|||
19786958|NCT04102189|42244029|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19786959|NCT04102189|42244030|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19786960|NCT04102189|42244029|FG000|Overall Study|Lost to Follow-up|1|||
19786961|NCT04102189|42244030|FG001|Overall Study|Lost to Follow-up|0|||
19786962|NCT04004988|42244045|FG000|Period 1|Physician Decision|2|||
19786963|NCT04004988|42244046|FG001|Period 1|Physician Decision|0|||
19786964|NCT04004988|42244045|FG000|Period 1|Withdrawal by Subject|0|||
19786965|NCT04004988|42244046|FG001|Period 1|Withdrawal by Subject|1|||
19786966|NCT04004988|42244045|FG000|Period 1|Adverse Event|1|||
19786967|NCT04004988|42244046|FG001|Period 1|Adverse Event|2|||
19786968|NCT03898700|42244053|FG000|Overall Study|Withdrawal by Subject|2|||
19786969|NCT03693300|42244059|FG000|Overall Study|Patients ongoing study|43|||
19786970|NCT03693300|42244060|FG001|Overall Study|Patients ongoing study|1|||
19786971|NCT03602586|42244077|FG000|Overall Study|Withdrawal by Subject|3|||
19786972|NCT03586973|42244083|FG000|Overall Study|Death|15|||
19786973|NCT03586973|42244084|FG001|Overall Study|Death|8|||
19786974|NCT03586973|42244083|FG000|Overall Study|Site Terminated by Sponsor|3|||
19786975|NCT03586973|42244084|FG001|Overall Study|Site Terminated by Sponsor|6|||
19786976|NCT03586973|42244083|FG000|Overall Study|Withdrawal by Subject|1|||
19786977|NCT03586973|42244084|FG001|Overall Study|Withdrawal by Subject|0|||
19786978|NCT03586973|42244083|FG000|Overall Study|Lost to Follow-up|1|||
19786979|NCT03586973|42244084|FG001|Overall Study|Lost to Follow-up|0|||
19786980|NCT03383692|42244092|FG000|Overall Study|Progressive disease as per RECIST|3|||
19786981|NCT03383692|42244093|FG001|Overall Study|Progressive disease as per RECIST|3|||
19786982|NCT03383692|42244092|FG000|Overall Study|Clinical progression|0|||
19786983|NCT03383692|42244093|FG001|Overall Study|Clinical progression|1|||
19786984|NCT03383692|42244092|FG000|Overall Study|Adverse Event|3|||
19786985|NCT03383692|42244093|FG001|Overall Study|Adverse Event|0|||
19786986|NCT03334435|42244106|FG000|Overall Study|Ongoing as of Week 52|70|||
19786987|NCT03334435|42244107|FG001|Overall Study|Ongoing as of Week 52|32|||
19786988|NCT03334435|42244108|FG002|Overall Study|Ongoing as of Week 52|379|||
19786989|NCT03334435|42244109|FG003|Overall Study|Ongoing as of Week 52|519|||
19786990|NCT03334435|42244110|FG004|Overall Study|Ongoing as of Week 52|146|||
19786991|NCT03334435|42244106|FG000|Overall Study|Lack of Efficacy|3|||
19786992|NCT03334435|42244107|FG001|Overall Study|Lack of Efficacy|5|||
19786993|NCT03334435|42244108|FG002|Overall Study|Lack of Efficacy|76|||
19786994|NCT03334435|42244109|FG003|Overall Study|Lack of Efficacy|140|||
19786995|NCT03334435|42244110|FG004|Overall Study|Lack of Efficacy|61|||
19786996|NCT03334435|42244106|FG000|Overall Study|Adverse Event|2|||
19786997|NCT03334435|42244107|FG001|Overall Study|Adverse Event|1|||
19786998|NCT03334435|42244108|FG002|Overall Study|Adverse Event|9|||
19786999|NCT03334435|42244109|FG003|Overall Study|Adverse Event|23|||
19787000|NCT03334435|42244110|FG004|Overall Study|Adverse Event|13|||
19787001|NCT03334435|42244106|FG000|Overall Study|Withdrawal by Subject|11|||
19787002|NCT03334435|42244107|FG001|Overall Study|Withdrawal by Subject|4|||
19787003|NCT03334435|42244108|FG002|Overall Study|Withdrawal by Subject|38|||
19787004|NCT03334435|42244109|FG003|Overall Study|Withdrawal by Subject|42|||
19787005|NCT03334435|42244110|FG004|Overall Study|Withdrawal by Subject|20|||
19787006|NCT03334435|42244106|FG000|Overall Study|Lost to Follow-up|3|||
19787007|NCT03334435|42244107|FG001|Overall Study|Lost to Follow-up|0|||
19787008|NCT03334435|42244108|FG002|Overall Study|Lost to Follow-up|2|||
19787009|NCT03334435|42244109|FG003|Overall Study|Lost to Follow-up|1|||
19787010|NCT03334435|42244110|FG004|Overall Study|Lost to Follow-up|1|||
19787011|NCT03334435|42244106|FG000|Overall Study|Death|0|||
19787012|NCT03334435|42244107|FG001|Overall Study|Death|0|||
19787013|NCT03334435|42244108|FG002|Overall Study|Death|0|||
19787014|NCT03334435|42244109|FG003|Overall Study|Death|1|||
19787015|NCT03334435|42244110|FG004|Overall Study|Death|0|||
19787016|NCT03334435|42244106|FG000|Overall Study|Other|0|||
19787017|NCT03334435|42244107|FG001|Overall Study|Other|1|||
19787018|NCT03334435|42244108|FG002|Overall Study|Other|3|||
19787019|NCT03334435|42244109|FG003|Overall Study|Other|2|||
19787020|NCT03334435|42244110|FG004|Overall Study|Other|1|||
19787021|NCT03043313|42244143|FG000|Overall Study|Withdrawal by Subject|4|||
19787022|NCT03043313|42244144|FG001|Overall Study|Withdrawal by Subject|1|||
19787023|NCT03043313|42244145|FG002|Overall Study|Withdrawal by Subject|1|||
19787024|NCT03043313|42244143|FG000|Overall Study|Lost to Follow-up|1|||
19787025|NCT03043313|42244144|FG001|Overall Study|Lost to Follow-up|0|||
19787026|NCT03043313|42244145|FG002|Overall Study|Lost to Follow-up|0|||
19787027|NCT03043313|42244143|FG000|Overall Study|Death|26|||
19787028|NCT03043313|42244144|FG001|Overall Study|Death|13|||
19787029|NCT03043313|42244145|FG002|Overall Study|Death|8|||
19787030|NCT03043313|42244143|FG000|Overall Study|On Treatment|7|||
19787031|NCT03043313|42244144|FG001|Overall Study|On Treatment|12|||
19787032|NCT03043313|42244145|FG002|Overall Study|On Treatment|11|||
19787033|NCT03043313|42244143|FG000|Overall Study|In follow up|7|||
19787034|NCT03043313|42244144|FG001|Overall Study|In follow up|15|||
19787035|NCT03043313|42244145|FG002|Overall Study|In follow up|11|||
19787036|NCT02968849|42244154|FG000|Overall Study|Death|8|||
19787037|NCT02968849|42244155|FG001|Overall Study|Death|10|||
19787038|NCT02968849|42244154|FG000|Overall Study|Lost to Follow-up|31|||
19787039|NCT02968849|42244155|FG001|Overall Study|Lost to Follow-up|29|||
19787040|NCT02968849|42244154|FG000|Overall Study|Withdrawal by Subject|73|||
19787041|NCT02968849|42244155|FG001|Overall Study|Withdrawal by Subject|64|||
19787042|NCT02968849|42244154|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
19787043|NCT02968849|42244155|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
19787044|NCT02968849|42244154|FG000|Overall Study|Physician Decision|6|||
19787045|NCT02968849|42244155|FG001|Overall Study|Physician Decision|9|||
19787046|NCT02968849|42244154|FG000|Overall Study|Other|16|||
19787047|NCT02968849|42244155|FG001|Overall Study|Other|10|||
19787048|NCT02872116|42244167|FG000|Pre-Treatment|Disease Progression|0|||
19787049|NCT02872116|42244168|FG001|Pre-Treatment|Disease Progression|1|||
19607460|NCT00882921|42056274|FG000|Overall Study|Lost to Follow-up|2|||
19787050|NCT02872116|42244169|FG002|Pre-Treatment|Disease Progression|0|||
19787051|NCT02872116|42244167|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
19787052|NCT02872116|42244168|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
19787053|NCT02872116|42244169|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
19787054|NCT02872116|42244167|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
19787055|NCT02872116|42244168|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
19787056|NCT02872116|42244169|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
19787057|NCT02872116|42244167|FG000|Pre-Treatment|Participant withdrew consent|2|||
19787058|NCT02872116|42244168|FG001|Pre-Treatment|Participant withdrew consent|20|||
19787059|NCT02872116|42244169|FG002|Pre-Treatment|Participant withdrew consent|3|||
19787060|NCT02872116|42244167|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
19787061|NCT02872116|42244168|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
19787062|NCT02872116|42244169|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
19787063|NCT02872116|42244167|FG000|Pre-Treatment|Other reasons|1|||
19787064|NCT02872116|42244168|FG001|Pre-Treatment|Other reasons|2|||
19787065|NCT02872116|42244169|FG002|Pre-Treatment|Other reasons|2|||
19787066|NCT02872116|42244167|FG000|Treatment|Death|122|||
19787067|NCT02872116|42244168|FG001|Treatment|Death|94|||
19787068|NCT02872116|42244169|FG002|Treatment|Death|68|||
19787069|NCT02872116|42244167|FG000|Treatment|Lost to Follow-up|5|||
19787070|NCT02872116|42244168|FG001|Treatment|Lost to Follow-up|7|||
19787071|NCT02872116|42244169|FG002|Treatment|Lost to Follow-up|3|||
19787072|NCT02872116|42244167|FG000|Treatment|Participant withdrew consent|20|||
19787073|NCT02872116|42244168|FG001|Treatment|Participant withdrew consent|40|||
19787074|NCT02872116|42244169|FG002|Treatment|Participant withdrew consent|8|||
19787075|NCT02872116|42244167|FG000|Treatment|Other reasons|12|||
19787076|NCT02872116|42244168|FG001|Treatment|Other reasons|12|||
19787077|NCT02872116|42244169|FG002|Treatment|Other reasons|5|||
19787078|NCT02669212|42244195|FG000|Overall Study|Lost to Follow-up|1|||
19787079|NCT02669212|42244196|FG001|Overall Study|Lost to Follow-up|0|||
19787080|NCT02669212|42244195|FG000|Overall Study|Medical Condition|3|||
19787081|NCT02669212|42244196|FG001|Overall Study|Medical Condition|4|||
19787082|NCT02669212|42244195|FG000|Overall Study|Withdrawal by Subject|0|||
19787083|NCT02669212|42244196|FG001|Overall Study|Withdrawal by Subject|2|||
19787084|NCT02669212|42244195|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
19787085|NCT02669212|42244196|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
19787086|NCT02667587|42244207|FG000|Pre-Treatment|Not reported|1|||
19787087|NCT02667587|42244208|FG001|Pre-Treatment|Not reported|0|||
19787088|NCT02667587|42244207|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
19787089|NCT02667587|42244208|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
19787090|NCT02667587|42244207|FG000|Pre-Treatment|Participant withdrew consent|0|||
19787091|NCT02667587|42244208|FG001|Pre-Treatment|Participant withdrew consent|1|||
19787092|NCT02667587|42244207|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
19787093|NCT02667587|42244208|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
19787094|NCT02667587|42244207|FG000|End of Treatment|Other reasons|11|||
19787095|NCT02667587|42244208|FG001|End of Treatment|Other reasons|8|||
19787096|NCT02667587|42244207|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
19787097|NCT02667587|42244208|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
19787098|NCT02667587|42244207|FG000|End of Treatment|Poor/Non-Compliance|0|||
19787099|NCT02667587|42244208|FG001|End of Treatment|Poor/Non-Compliance|1|||
19389182|NCT02053792|41632811|FG001|Overall Study|Withdrawal by Subject|2|||
19697393|NCT00293462|42142666|FG000|Overall Study|Went back to his home country|0|||
19697394|NCT00293462|42142667|FG001|Overall Study|Went back to his home country|0|||
19697395|NCT00293462|42142668|FG002|Overall Study|Went back to his home country|1|||
19697396|NCT00293462|42142666|FG000|Overall Study|Blood clot after chemotherapy|0|||
19697397|NCT00293462|42142667|FG001|Overall Study|Blood clot after chemotherapy|0|||
19697398|NCT00293462|42142668|FG002|Overall Study|Blood clot after chemotherapy|1|||
19697399|NCT00293462|42142666|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
19697400|NCT00293462|42142667|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
19697401|NCT00293462|42142668|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
19697402|NCT00293462|42142666|FG000|Overall Study|Possible Tracheostomy leakage|0|||
19697403|NCT00293462|42142667|FG001|Overall Study|Possible Tracheostomy leakage|1|||
19697404|NCT00293462|42142668|FG002|Overall Study|Possible Tracheostomy leakage|0|||
19697405|NCT00293462|42142666|FG000|Overall Study|Low radiation dose in oral cavity|0|||
19697406|NCT00293462|42142667|FG001|Overall Study|Low radiation dose in oral cavity|1|||
19697407|NCT00293462|42142668|FG002|Overall Study|Low radiation dose in oral cavity|0|||
19697408|NCT00293462|42142666|FG000|Overall Study|Physician Decision|0|||
19697409|NCT00293462|42142667|FG001|Overall Study|Physician Decision|1|||
19697410|NCT00293462|42142668|FG002|Overall Study|Physician Decision|0|||
19697411|NCT00316082|42142681|FG000|Overall Study|Lack of Efficacy|2|||
19697412|NCT00316082|42142682|FG001|Overall Study|Lack of Efficacy|3|||
19787100|NCT02667587|42244207|FG000|End of Treatment|Maximum Clinical Benefit|3|||
19787101|NCT02667587|42244208|FG001|End of Treatment|Maximum Clinical Benefit|3|||
19787102|NCT02667587|42244207|FG000|End of Treatment|Participant Withdrew Consent|5|||
19787103|NCT02667587|42244208|FG001|End of Treatment|Participant Withdrew Consent|6|||
19787104|NCT02667587|42244207|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
19787105|NCT02667587|42244208|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
19787106|NCT02667587|42244207|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
19787107|NCT02667587|42244208|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
19787108|NCT02667587|42244207|FG000|End of Treatment|Death|2|||
19477862|NCT01462045|41757130|FG002|Overall Study|Family matter|0|||
19697413|NCT00316082|42142683|FG002|Overall Study|Lack of Efficacy|3|||
19697414|NCT00316082|42142684|FG003|Overall Study|Lack of Efficacy|4|||
19787109|NCT02667587|42244208|FG001|End of Treatment|Death|1|||
19787110|NCT02667587|42244207|FG000|End of Treatment|Study Drug Toxicity|74|||
19787111|NCT02667587|42244208|FG001|End of Treatment|Study Drug Toxicity|18|||
19787112|NCT02667587|42244207|FG000|End of Treatment|Disease progression|177|||
19787113|NCT02667587|42244208|FG001|End of Treatment|Disease progression|222|||
19787114|NCT02667587|42244207|FG000|End of Treatment|Lost to Follow-up|1|||
19697415|NCT00316082|42142685|FG004|Overall Study|Lack of Efficacy|6|||
19697416|NCT00316082|42142681|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
19697417|NCT00316082|42142682|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
19697418|NCT00316082|42142683|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
19697419|NCT00316082|42142684|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
19697420|NCT00316082|42142685|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
19697421|NCT00316082|42142681|FG000|Overall Study|Lost to Follow-up|7|||
19697422|NCT00316082|42142682|FG001|Overall Study|Lost to Follow-up|6|||
19697423|NCT00316082|42142683|FG002|Overall Study|Lost to Follow-up|7|||
19697424|NCT00316082|42142684|FG003|Overall Study|Lost to Follow-up|8|||
19697425|NCT00316082|42142685|FG004|Overall Study|Lost to Follow-up|6|||
19697426|NCT00316082|42142681|FG000|Overall Study|Poor/noncompliance|6|||
19697427|NCT00316082|42142682|FG001|Overall Study|Poor/noncompliance|1|||
19697428|NCT00316082|42142683|FG002|Overall Study|Poor/noncompliance|4|||
19697429|NCT00316082|42142684|FG003|Overall Study|Poor/noncompliance|1|||
19697430|NCT00316082|42142685|FG004|Overall Study|Poor/noncompliance|4|||
19697431|NCT00316082|42142681|FG000|Overall Study|Adverse Event|4|||
19697432|NCT00316082|42142682|FG001|Overall Study|Adverse Event|2|||
19697433|NCT00316082|42142683|FG002|Overall Study|Adverse Event|5|||
19697434|NCT00316082|42142684|FG003|Overall Study|Adverse Event|1|||
19697435|NCT00316082|42142685|FG004|Overall Study|Adverse Event|3|||
19697436|NCT00316082|42142681|FG000|Overall Study|Subject no longer meets study criteria|3|||
19697437|NCT00316082|42142682|FG001|Overall Study|Subject no longer meets study criteria|1|||
19697438|NCT00316082|42142683|FG002|Overall Study|Subject no longer meets study criteria|2|||
19697439|NCT00316082|42142684|FG003|Overall Study|Subject no longer meets study criteria|2|||
19697440|NCT00316082|42142685|FG004|Overall Study|Subject no longer meets study criteria|1|||
19697441|NCT00316082|42142681|FG000|Overall Study|Physician Decision|1|||
19697442|NCT00316082|42142682|FG001|Overall Study|Physician Decision|1|||
19697443|NCT00316082|42142683|FG002|Overall Study|Physician Decision|2|||
19787115|NCT02667587|42244208|FG001|End of Treatment|Lost to Follow-up|3|||
19607461|NCT00882921|42056274|FG000|Overall Study|Termination By Investigator|3|||
19607462|NCT00882921|42056274|FG000|Overall Study|Withdrawal Of Consent|1|||
19787116|NCT02536664|42244227|FG000|Overall Study|Inadequate completion of documentation|2|||
19787117|NCT02536664|42244228|FG001|Overall Study|Inadequate completion of documentation|4|||
19607463|NCT00582712|42056279|FG000|Overall Study|Adverse Event|1|||
19607464|NCT00582712|42056279|FG000|Overall Study|Lack of Efficacy|1|||
19787118|NCT02536664|42244227|FG000|Overall Study|Progression|13|||
19607465|NCT00582712|42056279|FG000|Overall Study|Withdrawal by Subject|1|||
19607466|NCT00582712|42056279|FG000|Overall Study|Complicating disease requiring treatment|1|||
19607467|NCT00667459|42056285|FG000|Overall Study|Death|0|||
19607468|NCT00667459|42056286|FG001|Overall Study|Death|2|||
19607469|NCT00667459|42056285|FG000|Overall Study|Lost to Follow-up|8|||
19607470|NCT00667459|42056286|FG001|Overall Study|Lost to Follow-up|43|||
19787119|NCT02536664|42244228|FG001|Overall Study|Progression|18|||
19787120|NCT02536664|42244227|FG000|Overall Study|Death due to lymphoma|2|||
19787121|NCT02536664|42244228|FG001|Overall Study|Death due to lymphoma|1|||
19787122|NCT02536664|42244227|FG000|Overall Study|Death due to other reason|3|||
19787123|NCT02536664|42244228|FG001|Overall Study|Death due to other reason|2|||
19787124|NCT02536664|42244227|FG000|Overall Study|Intolerability|8|||
19787125|NCT02536664|42244228|FG001|Overall Study|Intolerability|6|||
19787126|NCT02536664|42244227|FG000|Overall Study|Withdrawal by Subject|8|||
19787127|NCT02536664|42244228|FG001|Overall Study|Withdrawal by Subject|5|||
19787128|NCT02536664|42244227|FG000|Overall Study|Other|18|||
19787129|NCT02536664|42244228|FG001|Overall Study|Other|24|||
19787130|NCT02536664|42244227|FG000|Overall Study|Missing|53|||
19787131|NCT02536664|42244228|FG001|Overall Study|Missing|20|||
19787132|NCT02426892|42244234|FG000|Overall Study|Adverse Event|2|||
19787133|NCT02426892|42244234|FG000|Overall Study|Lack of Efficacy|17|||
19787134|NCT02426892|42244234|FG000|Overall Study|Withdrawal by Subject|1|||
19787135|NCT02312687|42244238|FG000|Overall Study|Other, Not Specified|1|||
19607471|NCT00582790|42056292|FG000|Overall Study|Rapid progression of disease|1|||
19607472|NCT00881751|42056299|FG000|Overall Study|Physician Decision|0|||
19607473|NCT00881751|42056300|FG001|Overall Study|Physician Decision|1|||
19607474|NCT00881751|42056299|FG000|Overall Study|Adverse Event|0|||
19607475|NCT00881751|42056300|FG001|Overall Study|Adverse Event|2|||
19787136|NCT02304367|42244242|FG000|Overall Study|Lack of Response to Bruosumab|1|||
19787137|NCT02304367|42244242|FG000|Overall Study|Sponsor Decision|3|||
19787138|NCT02304367|42244242|FG000|Overall Study|Death|2|||
19787139|NCT02304367|42244242|FG000|Overall Study|Physician Decision|1|||
19787140|NCT02304367|42244242|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
19787141|NCT02246621|42244255|FG000|Overall Study|Withdrawal by Subject|28|||
19787142|NCT02246621|42244256|FG001|Overall Study|Withdrawal by Subject|16|||
19607476|NCT00881751|42056299|FG000|Overall Study|Withdrawal by Subject|0|||
19607477|NCT00881751|42056300|FG001|Overall Study|Withdrawal by Subject|2|||
19607478|NCT00934856|42056312|FG000|Feasibility Part|Progressive disease|4|||
19607479|NCT00934856|42056313|FG001|Feasibility Part|Progressive disease|4|||
19607480|NCT00934856|42056314|FG002|Feasibility Part|Progressive disease|2|||
19697444|NCT00316082|42142684|FG003|Overall Study|Physician Decision|1|||
19787143|NCT02246621|42244255|FG000|Overall Study|Lost to Follow-up|1|||
19787144|NCT02246621|42244256|FG001|Overall Study|Lost to Follow-up|0|||
19697445|NCT00316082|42142685|FG004|Overall Study|Physician Decision|1|||
19697446|NCT00316082|42142681|FG000|Overall Study|Death|0|||
19697447|NCT00316082|42142682|FG001|Overall Study|Death|0|||
19697448|NCT00316082|42142683|FG002|Overall Study|Death|1|||
19697449|NCT00316082|42142684|FG003|Overall Study|Death|0|||
19697450|NCT00316082|42142685|FG004|Overall Study|Death|0|||
19697451|NCT00316082|42142681|FG000|Overall Study|Administrative reason by sponsor|0|||
19697452|NCT00316082|42142682|FG001|Overall Study|Administrative reason by sponsor|0|||
19697453|NCT00316082|42142683|FG002|Overall Study|Administrative reason by sponsor|1|||
19697454|NCT00316082|42142684|FG003|Overall Study|Administrative reason by sponsor|0|||
19697455|NCT00316082|42142685|FG004|Overall Study|Administrative reason by sponsor|0|||
19787145|NCT02246621|42244255|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
19787146|NCT02246621|42244256|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
19787147|NCT02107703|42244264|FG000|Overall Study|Withdrawal by Subject|36|||
19787148|NCT02107703|42244265|FG001|Overall Study|Withdrawal by Subject|19|||
19787149|NCT02107703|42244264|FG000|Overall Study|Lost to Follow-up|6|||
19787150|NCT02107703|42244265|FG001|Overall Study|Lost to Follow-up|4|||
19787151|NCT02107703|42244264|FG000|Overall Study|On study treatment/follow up|319|||
19787152|NCT02107703|42244265|FG001|Overall Study|On study treatment/follow up|152|||
19787153|NCT02054520|42244280|FG000|Overall Study|Adverse Event|1|||
19787154|NCT02054520|42244281|FG001|Overall Study|Adverse Event|4|||
19787155|NCT02054520|42244282|FG002|Overall Study|Adverse Event|2|||
19787156|NCT02054520|42244283|FG003|Overall Study|Adverse Event|1|||
19787157|NCT02054520|42244284|FG004|Overall Study|Adverse Event|1|||
19787158|NCT02054520|42244285|FG005|Overall Study|Adverse Event|0|||
19787159|NCT02054520|42244280|FG000|Overall Study|Lack of Efficacy|7|||
19787160|NCT02054520|42244281|FG001|Overall Study|Lack of Efficacy|0|||
19787161|NCT02054520|42244282|FG002|Overall Study|Lack of Efficacy|2|||
19787162|NCT02054520|42244283|FG003|Overall Study|Lack of Efficacy|1|||
19787163|NCT02054520|42244284|FG004|Overall Study|Lack of Efficacy|3|||
19787164|NCT02054520|42244285|FG005|Overall Study|Lack of Efficacy|2|||
19787165|NCT02054520|42244280|FG000|Overall Study|Withdrawal by Subject|1|||
19787166|NCT02054520|42244281|FG001|Overall Study|Withdrawal by Subject|0|||
19787167|NCT02054520|42244282|FG002|Overall Study|Withdrawal by Subject|0|||
19787168|NCT02054520|42244283|FG003|Overall Study|Withdrawal by Subject|2|||
19787169|NCT02054520|42244284|FG004|Overall Study|Withdrawal by Subject|1|||
19787170|NCT02054520|42244285|FG005|Overall Study|Withdrawal by Subject|0|||
19787171|NCT02054520|42244280|FG000|Overall Study|Physician Decision|0|||
19787172|NCT02054520|42244281|FG001|Overall Study|Physician Decision|1|||
19787173|NCT02054520|42244282|FG002|Overall Study|Physician Decision|0|||
19787174|NCT02054520|42244283|FG003|Overall Study|Physician Decision|1|||
19787175|NCT02054520|42244284|FG004|Overall Study|Physician Decision|0|||
19787176|NCT02054520|42244285|FG005|Overall Study|Physician Decision|1|||
19787177|NCT02054520|42244280|FG000|Overall Study|Study terminated by Sponsor|0|||
19787178|NCT02054520|42244281|FG001|Overall Study|Study terminated by Sponsor|0|||
19787179|NCT02054520|42244282|FG002|Overall Study|Study terminated by Sponsor|2|||
19787180|NCT02054520|42244283|FG003|Overall Study|Study terminated by Sponsor|1|||
19787181|NCT02054520|42244284|FG004|Overall Study|Study terminated by Sponsor|0|||
19787182|NCT02054520|42244285|FG005|Overall Study|Study terminated by Sponsor|0|||
19787183|NCT01546987|42244314|FG000|Overall Study|Protocol Violation|3|||
19787184|NCT01546987|42244315|FG001|Overall Study|Protocol Violation|4|||
19787185|NCT01367002|42244323|FG000|Overall Study|Withdrawal by Subject|1|||
19787186|NCT01367002|42244324|FG001|Overall Study|Withdrawal by Subject|0|||
19787187|NCT01367002|42244323|FG000|Overall Study|Physician Decision|0|||
19787188|NCT01367002|42244324|FG001|Overall Study|Physician Decision|2|||
19787189|NCT00676715|42244349|FG000|Overall Study|Withdrawal by Subject|7|||
19787190|NCT00676715|42244350|FG001|Overall Study|Withdrawal by Subject|9|||
19787191|NCT00676715|42244351|FG002|Overall Study|Withdrawal by Subject|10|||
19787192|NCT00676715|42244352|FG003|Overall Study|Withdrawal by Subject|10|||
19787193|NCT00676715|42244349|FG000|Overall Study|Other|2|||
19787194|NCT00676715|42244350|FG001|Overall Study|Other|6|||
19787195|NCT00676715|42244351|FG002|Overall Study|Other|4|||
19787196|NCT00676715|42244352|FG003|Overall Study|Other|3|||
19787197|NCT00676715|42244349|FG000|Overall Study|Lost to Follow-up|1|||
19787198|NCT00676715|42244350|FG001|Overall Study|Lost to Follow-up|1|||
19787199|NCT00676715|42244351|FG002|Overall Study|Lost to Follow-up|7|||
19787200|NCT00676715|42244352|FG003|Overall Study|Lost to Follow-up|3|||
19787201|NCT00676715|42244349|FG000|Overall Study|Death|1|||
19787202|NCT00676715|42244350|FG001|Overall Study|Death|1|||
19787203|NCT00676715|42244351|FG002|Overall Study|Death|1|||
19787204|NCT00676715|42244352|FG003|Overall Study|Death|0|||
19787205|NCT00676715|42244349|FG000|Overall Study|Adverse Event|0|||
19787206|NCT00676715|42244350|FG001|Overall Study|Adverse Event|1|||
19787207|NCT00676715|42244351|FG002|Overall Study|Adverse Event|2|||
19787208|NCT00676715|42244352|FG003|Overall Study|Adverse Event|0|||
19787209|NCT00676715|42244349|FG000|Overall Study|Participants Ongoing|29|||
19787210|NCT00676715|42244350|FG001|Overall Study|Participants Ongoing|29|||
19697456|NCT00316004|42142704|FG000|Overall Study|Subject was not given study fluid.|14|||
19787211|NCT00676715|42244351|FG002|Overall Study|Participants Ongoing|17|||
19787212|NCT00676715|42244352|FG003|Overall Study|Participants Ongoing|24|||
19787213|NCT00304070|42244365|FG000|Overall Study|Death|0|||
19787214|NCT00304070|42244366|FG001|Overall Study|Death|0|||
19787215|NCT00304070|42244367|FG002|Overall Study|Death|3|||
19787216|NCT00304070|42244365|FG000|Overall Study|Lost to Follow-up|0|||
19787217|NCT00304070|42244366|FG001|Overall Study|Lost to Follow-up|0|||
19787218|NCT00304070|42244367|FG002|Overall Study|Lost to Follow-up|1|||
19787219|NCT00304070|42244365|FG000|Overall Study|Physician Decision|0|||
19787220|NCT00304070|42244366|FG001|Overall Study|Physician Decision|0|||
19787221|NCT00304070|42244367|FG002|Overall Study|Physician Decision|3|||
19787222|NCT00304070|42244365|FG000|Overall Study|Withdrawal by Subject|0|||
19787223|NCT00304070|42244366|FG001|Overall Study|Withdrawal by Subject|0|||
19787224|NCT00304070|42244367|FG002|Overall Study|Withdrawal by Subject|1|||
19787225|NCT00304070|42244365|FG000|Overall Study|Progressive Disease|3|||
19787226|NCT00304070|42244366|FG001|Overall Study|Progressive Disease|7|||
19787227|NCT00304070|42244367|FG002|Overall Study|Progressive Disease|4|||
19787228|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
19787229|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
19787230|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
19787231|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
19787232|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
19787233|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
19787234|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
19787235|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
19787236|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
19787237|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
19787238|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
19787239|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
19697457|NCT00316004|42142705|FG001|Overall Study|Subject was not given study fluid.|14|||
19697458|NCT00316004|42142706|FG002|Overall Study|Subject was not given study fluid.|21|||
19697459|NCT00298766|42142714|FG000|Overall Study|Adverse Event|18|||
19697460|NCT00298766|42142714|FG000|Overall Study|Death|2|||
19697461|NCT00298766|42142714|FG000|Overall Study|Withdrawal by Subject|9|||
19697462|NCT00298766|42142714|FG000|Overall Study|Treatment ongoing|4|||
19697463|NCT00298766|42142714|FG000|Overall Study|Progression of amyloid markers|4|||
19697464|NCT00298766|42142714|FG000|Overall Study|Deterioration in KPS and organ function|1|||
19697465|NCT00298766|42142714|FG000|Overall Study|Subjects overall condition deterioration|4|||
19697466|NCT00298766|42142714|FG000|Overall Study|Other|4|||
19697467|NCT00315458|42142720|FG000|Overall Study|Administrative|0|||
19697468|NCT00315458|42142721|FG001|Overall Study|Administrative|3|||
19697469|NCT00315458|42142722|FG002|Overall Study|Administrative|8|||
19697470|NCT00315458|42142723|FG003|Overall Study|Administrative|21|||
19697471|NCT00315458|42142720|FG000|Overall Study|Adverse Event|2|||
19697472|NCT00315458|42142721|FG001|Overall Study|Adverse Event|4|||
19697473|NCT00315458|42142722|FG002|Overall Study|Adverse Event|23|||
19697474|NCT00315458|42142723|FG003|Overall Study|Adverse Event|3|||
19697475|NCT00315458|42142720|FG000|Overall Study|Lost to Follow-up|1|||
19697476|NCT00315458|42142721|FG001|Overall Study|Lost to Follow-up|2|||
19697477|NCT00315458|42142722|FG002|Overall Study|Lost to Follow-up|0|||
19697478|NCT00315458|42142723|FG003|Overall Study|Lost to Follow-up|2|||
19697479|NCT00315458|42142720|FG000|Overall Study|Withdrawal by Subject|0|||
19697480|NCT00315458|42142721|FG001|Overall Study|Withdrawal by Subject|3|||
19697481|NCT00315458|42142722|FG002|Overall Study|Withdrawal by Subject|0|||
19697482|NCT00315458|42142723|FG003|Overall Study|Withdrawal by Subject|2|||
19697483|NCT00315458|42142720|FG000|Overall Study|Lack of Efficacy|0|||
19697484|NCT00315458|42142721|FG001|Overall Study|Lack of Efficacy|0|||
19697485|NCT00315458|42142722|FG002|Overall Study|Lack of Efficacy|20|||
19697486|NCT00315458|42142723|FG003|Overall Study|Lack of Efficacy|1|||
19697487|NCT00315458|42142720|FG000|Overall Study|Did not qualify|0|||
19697488|NCT00315458|42142721|FG001|Overall Study|Did not qualify|0|||
19697489|NCT00315458|42142722|FG002|Overall Study|Did not qualify|1|||
19697490|NCT00315458|42142723|FG003|Overall Study|Did not qualify|0|||
19697491|NCT00293384|42142733|FG000|Overall Study|Non-compliance|2|||
19697492|NCT00293384|42142733|FG000|Overall Study|Missed dosage/study drug|1|||
19697493|NCT00293384|42142733|FG000|Overall Study|Ineligible|2|||
19697494|NCT00297830|42142740|FG000|6 Month Visit|Death|1|||
19697495|NCT00297830|42142741|FG001|6 Month Visit|Death|0|||
19697496|NCT00297830|42142742|FG002|6 Month Visit|Death|2|||
19697497|NCT00297830|42142740|FG000|6 Month Visit|Withdrawal by Subject|2|||
19697498|NCT00297830|42142741|FG001|6 Month Visit|Withdrawal by Subject|1|||
19697499|NCT00297830|42142742|FG002|6 Month Visit|Withdrawal by Subject|1|||
19697500|NCT00297830|42142740|FG000|6 Month Visit|Adverse Event|0|||
19697501|NCT00297830|42142741|FG001|6 Month Visit|Adverse Event|1|||
19697502|NCT00297830|42142742|FG002|6 Month Visit|Adverse Event|0|||
19697503|NCT00297830|42142740|FG000|12 Month Visit|Lost to Follow-up|1|||
19697504|NCT00297830|42142741|FG001|12 Month Visit|Lost to Follow-up|0|||
19697505|NCT00297830|42142742|FG002|12 Month Visit|Lost to Follow-up|0|||
19787240|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
19787241|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
19787242|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
19787243|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
19787244|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
19787245|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
19787246|NCT00261443|42244381|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
19787247|NCT00261443|42244382|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
19697506|NCT00297830|42142740|FG000|12 Month Visit|Adverse Event|0|||
19697507|NCT00297830|42142741|FG001|12 Month Visit|Adverse Event|3|||
19697508|NCT00297830|42142742|FG002|12 Month Visit|Adverse Event|0|||
19697509|NCT00297830|42142740|FG000|12 Month Visit|Withdrawal by Subject|0|||
19697510|NCT00297830|42142741|FG001|12 Month Visit|Withdrawal by Subject|3|||
19697511|NCT00297830|42142742|FG002|12 Month Visit|Withdrawal by Subject|0|||
19697512|NCT00314366|42142752|FG000|Overall Study|not treated due to patient medical condi|1|||
19697513|NCT00314366|42142753|FG001|Overall Study|not treated due to patient medical condi|0|||
19697514|NCT00296816|42142764|FG000|Overall Study|Disease Progression|37|||
19697515|NCT00296816|42142764|FG000|Overall Study|Adverse Event|18|||
19697516|NCT00296816|42142764|FG000|Overall Study|Investigator/Participant request|5|||
19697517|NCT00296816|42142764|FG000|Overall Study|Non-compliance|1|||
19697518|NCT00296816|42142764|FG000|Overall Study|Missing for end of treatment|4|||
19697519|NCT00296816|42142764|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
19697520|NCT00296816|42142764|FG000|Overall Study|Poor performance status|1|||
19697521|NCT00296816|42142764|FG000|Overall Study|Relocation to Florida|1|||
19697522|NCT00296816|42142764|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
19697523|NCT00296816|42142764|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
19697524|NCT00296816|42142764|FG000|Overall Study|Neuropathy/patient preference|1|||
19697525|NCT00296816|42142764|FG000|Overall Study|Proteinuria|1|||
19367420|NCT02634788|41607592|FG003|Overall Study|Adverse Event|1|||
19367421|NCT02634788|41607589|FG000|Overall Study|Lack of Efficacy|4|||
19367422|NCT02634788|41607590|FG001|Overall Study|Lack of Efficacy|0|||
19367423|NCT02634788|41607591|FG002|Overall Study|Lack of Efficacy|1|||
19697526|NCT00296816|42142764|FG000|Overall Study|ineligibility due to radiation treatment|1|||
19697527|NCT00314132|42142770|FG000|Overall Study|Lost to Follow-up|3|||
19697528|NCT00314132|42142771|FG001|Overall Study|Lost to Follow-up|13|||
19697529|NCT00314132|42142770|FG000|Overall Study|Withdrawal by Subject|3|||
19787248|NCT00261443|42244383|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
19787249|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
19787250|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
19787251|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
19787252|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
19787253|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
19787254|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
19787255|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
19787256|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
19787257|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
19787258|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
19787259|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
19787260|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
19787261|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
19787262|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
19787263|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
19367424|NCT02634788|41607592|FG003|Overall Study|Lack of Efficacy|4|||
19367425|NCT02634788|41607589|FG000|Overall Study|Lost to Follow-up|0|||
19367426|NCT02634788|41607590|FG001|Overall Study|Lost to Follow-up|1|||
19367427|NCT02634788|41607591|FG002|Overall Study|Lost to Follow-up|0|||
19367428|NCT02634788|41607592|FG003|Overall Study|Lost to Follow-up|0|||
19697530|NCT00314132|42142771|FG001|Overall Study|Withdrawal by Subject|5|||
19697531|NCT00314132|42142770|FG000|Overall Study|Adverse Event|1|||
19697532|NCT00314132|42142771|FG001|Overall Study|Adverse Event|0|||
19697533|NCT00314132|42142770|FG000|Overall Study|Physician Decision|1|||
19697534|NCT00314132|42142771|FG001|Overall Study|Physician Decision|0|||
19787264|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
19787265|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
19787266|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
19787267|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
19787268|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
19787269|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
19787270|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
19787271|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
19787272|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
19787273|NCT00261443|42244381|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
19787274|NCT00261443|42244382|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
19787275|NCT00261443|42244383|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
19697535|NCT00097786|42142783|FG000|Overall Study|lost to follow-up for all-cause death|296|||
19697536|NCT00097786|42142784|FG001|Overall Study|lost to follow-up for all-cause death|292|||
19697537|NCT00097786|42142785|FG002|Overall Study|lost to follow-up for all-cause death|313|||
19697538|NCT00097786|42142786|FG003|Overall Study|lost to follow-up for all-cause death|310|||
19697539|NCT00117988|42142796|FG000|Overall Study|Death|3|||
19697540|NCT00117988|42142796|FG000|Overall Study|Adverse Event|1|||
19697541|NCT00117676|42142802|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
19697542|NCT00117676|42142803|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
19697543|NCT00117676|42142802|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
19697544|NCT00117676|42142803|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
19697545|NCT00117676|42142802|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
19697546|NCT00117676|42142803|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
19697547|NCT00117676|42142802|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
19697548|NCT00117676|42142803|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
19697549|NCT00117676|42142802|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
19697550|NCT00117676|42142803|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
19697551|NCT00117676|42142802|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
19697552|NCT00117676|42142803|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
19697553|NCT00117676|42142802|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
19697554|NCT00117676|42142803|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
19697555|NCT00117676|42142802|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
19697556|NCT00117676|42142803|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
19697557|NCT00117676|42142802|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
19697558|NCT00117676|42142803|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
19697559|NCT00117676|42142802|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
19697560|NCT00117676|42142803|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
19697561|NCT00117676|42142802|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
19697562|NCT00117676|42142803|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
19787276|NCT00261443|42244381|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
19787277|NCT00261443|42244382|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
19787278|NCT00261443|42244383|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
19787279|NCT00261443|42244381|FG000|3: Assessment of Relapse|Adverse Event|0|||
19787280|NCT00261443|42244382|FG001|3: Assessment of Relapse|Adverse Event|15|||
19787281|NCT00261443|42244383|FG002|3: Assessment of Relapse|Adverse Event|19|||
19787282|NCT00261443|42244381|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
19787283|NCT00261443|42244382|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
19787284|NCT00261443|42244383|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
19787285|NCT00261443|42244381|FG000|3: Assessment of Relapse|Death|0|||
19787286|NCT00261443|42244382|FG001|3: Assessment of Relapse|Death|0|||
19787287|NCT00261443|42244383|FG002|3: Assessment of Relapse|Death|1|||
19787288|NCT00261443|42244381|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
19787289|NCT00261443|42244382|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
19787290|NCT00261443|42244383|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
19787291|NCT00261443|42244381|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
19787292|NCT00261443|42244382|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
19787293|NCT00261443|42244383|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
19787294|NCT00261443|42244381|FG000|3: Assessment of Relapse|Pregnancy|0|||
19787295|NCT00261443|42244382|FG001|3: Assessment of Relapse|Pregnancy|2|||
19697563|NCT00117676|42142802|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
19697564|NCT00117676|42142803|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
19697565|NCT00117676|42142802|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
19697566|NCT00117676|42142803|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
19697567|NCT00117676|42142802|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
19697568|NCT00117676|42142803|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
19697569|NCT00117676|42142802|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
19697570|NCT00117676|42142803|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
19697571|NCT00117676|42142802|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
19697572|NCT00117676|42142803|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
19697573|NCT00117676|42142802|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
19697574|NCT00117676|42142803|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
19697575|NCT00117676|42142802|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
19697576|NCT00117676|42142803|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
19697577|NCT00117676|42142802|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
19697578|NCT00117676|42142803|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
19697579|NCT00117676|42142802|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
19697580|NCT00117676|42142803|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
19697581|NCT00117676|42142802|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
19697582|NCT00117676|42142803|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
19697583|NCT00117676|42142802|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
19697584|NCT00117676|42142803|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
19697585|NCT00117676|42142802|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
19697586|NCT00117676|42142803|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
19697587|NCT00117676|42142802|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
19697588|NCT00117676|42142803|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
19697589|NCT00117676|42142802|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
19697590|NCT00117676|42142803|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
19697591|NCT00117676|42142802|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
19697592|NCT00117676|42142803|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
19697593|NCT00117676|42142802|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
19697594|NCT00117676|42142803|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
19697595|NCT00117676|42142802|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
19697596|NCT00117676|42142803|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
19697597|NCT00117676|42142802|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
19697598|NCT00117676|42142803|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
19697599|NCT00117676|42142802|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
19697600|NCT00117676|42142803|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
19697601|NCT00117676|42142802|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
19697602|NCT00117676|42142803|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
19697603|NCT00117676|42142802|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
19697604|NCT00117676|42142803|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
19697605|NCT00117676|42142802|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
19697606|NCT00117676|42142803|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
19697607|NCT00117676|42142802|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
19697608|NCT00117676|42142803|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
19697609|NCT00117676|42142802|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
19697610|NCT00117676|42142803|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
19697611|NCT00251004|42142817|FG000|Overall Study|Withdrawal by Subject|23|||
19697612|NCT00251004|42142818|FG001|Overall Study|Withdrawal by Subject|16|||
19697613|NCT00251004|42142819|FG002|Overall Study|Withdrawal by Subject|14|||
19697614|NCT00251004|42142817|FG000|Overall Study|Death|9|||
19697615|NCT00251004|42142818|FG001|Overall Study|Death|10|||
19697616|NCT00251004|42142819|FG002|Overall Study|Death|8|||
19697617|NCT00251004|42142817|FG000|Overall Study|Lost to Follow-up|1|||
19697618|NCT00251004|42142818|FG001|Overall Study|Lost to Follow-up|2|||
19697619|NCT00251004|42142819|FG002|Overall Study|Lost to Follow-up|1|||
19697620|NCT00251004|42142817|FG000|Overall Study|Graft Loss|12|||
19697621|NCT00251004|42142818|FG001|Overall Study|Graft Loss|13|||
19697622|NCT00251004|42142819|FG002|Overall Study|Graft Loss|8|||
19697623|NCT00275340|42142829|FG000|Overall Study|Lost to Follow-up|2|||
19697624|NCT00275340|42142830|FG001|Overall Study|Lost to Follow-up|4|||
19697625|NCT00275262|42142836|FG000|Overall Study|Adverse Event|2|||
19697626|NCT00275262|42142837|FG001|Overall Study|Adverse Event|0|||
19697627|NCT00275262|42142836|FG000|Overall Study|Disease progression|2|||
19697628|NCT00275262|42142837|FG001|Overall Study|Disease progression|5|||
19697629|NCT00275262|42142836|FG000|Overall Study|Lost to Follow-up|0|||
19697630|NCT00275262|42142837|FG001|Overall Study|Lost to Follow-up|2|||
19697631|NCT00275262|42142836|FG000|Overall Study|Protocol Violation|0|||
19697632|NCT00275262|42142837|FG001|Overall Study|Protocol Violation|2|||
19697633|NCT00275262|42142836|FG000|Overall Study|Death|1|||
19697634|NCT00275262|42142837|FG001|Overall Study|Death|0|||
19697635|NCT00275262|42142836|FG000|Overall Study|Started Chemotherapy|1|||
19697636|NCT00275262|42142837|FG001|Overall Study|Started Chemotherapy|0|||
19697637|NCT00275028|42142843|FG000|Overall Study|Withdrew consent before treatment began|1|||
19697638|NCT00275028|42142843|FG000|Overall Study|Withdrawal by Subject|5|||
19697639|NCT00275028|42142843|FG000|Overall Study|Adverse Event|9|||
19697640|NCT00275028|42142843|FG000|Overall Study|Progressive Disease|30|||
19697641|NCT00275028|42142843|FG000|Overall Study|Physician Decision|2|||
19697642|NCT00471497|42142850|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
19697643|NCT00471497|42142851|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
19697644|NCT00471497|42142852|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
19697645|NCT00471497|42142850|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
19697646|NCT00471497|42142851|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
19697647|NCT00471497|42142852|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
19697648|NCT00471497|42142850|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
19697649|NCT00471497|42142851|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
19787296|NCT00261443|42244383|FG002|3: Assessment of Relapse|Pregnancy|1|||
19787297|NCT00261443|42244381|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
19787298|NCT00261443|42244382|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
19787299|NCT00261443|42244383|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
19787300|NCT00261443|42244381|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
19787301|NCT00261443|42244382|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
19787302|NCT00261443|42244383|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
19787303|NCT00261443|42244381|FG000|3: Assessment of Relapse|Other Reasons|0|||
19787304|NCT00261443|42244382|FG001|3: Assessment of Relapse|Other Reasons|4|||
19787305|NCT00261443|42244383|FG002|3: Assessment of Relapse|Other Reasons|3|||
19787306|NCT00261443|42244381|FG000|4: Extension Phase|Adverse Event|0|||
19787307|NCT00261443|42244382|FG001|4: Extension Phase|Adverse Event|1|||
19787308|NCT00261443|42244383|FG002|4: Extension Phase|Adverse Event|0|||
19787309|NCT00261443|42244381|FG000|4: Extension Phase|Withdrawal by Subject|0|||
19787310|NCT00261443|42244382|FG001|4: Extension Phase|Withdrawal by Subject|1|||
19787311|NCT00261443|42244383|FG002|4: Extension Phase|Withdrawal by Subject|2|||
19697650|NCT00471497|42142852|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
19697651|NCT00471497|42142850|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
19697652|NCT00471497|42142851|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
19697653|NCT00471497|42142852|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
19697654|NCT00471497|42142850|FG000|Core Treatment Phase|Lost to Follow-up|6|||
19697655|NCT00471497|42142851|FG001|Core Treatment Phase|Lost to Follow-up|6|||
19697656|NCT00471497|42142852|FG002|Core Treatment Phase|Lost to Follow-up|3|||
19697657|NCT00471497|42142850|FG000|Core Treatment Phase|Death|3|||
19697658|NCT00471497|42142851|FG001|Core Treatment Phase|Death|9|||
19697659|NCT00471497|42142852|FG002|Core Treatment Phase|Death|3|||
19697660|NCT00471497|42142850|FG000|Core Treatment Phase|Disease Progression|10|||
19697661|NCT00471497|42142851|FG001|Core Treatment Phase|Disease Progression|2|||
19697662|NCT00471497|42142852|FG002|Core Treatment Phase|Disease Progression|4|||
19697663|NCT00471497|42142850|FG000|Core Treatment Phase|Protocol Violation|6|||
19697664|NCT00471497|42142851|FG001|Core Treatment Phase|Protocol Violation|15|||
19697665|NCT00471497|42142852|FG002|Core Treatment Phase|Protocol Violation|11|||
19697666|NCT00471497|42142850|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
19697667|NCT00471497|42142851|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
19697668|NCT00471497|42142852|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
19697669|NCT00471497|42142850|FG000|Core Treatment Phase|Administrative problems|14|||
19697670|NCT00471497|42142851|FG001|Core Treatment Phase|Administrative problems|14|||
19697671|NCT00471497|42142852|FG002|Core Treatment Phase|Administrative problems|12|||
19697672|NCT00471497|42142850|FG000|Core Treatment Phase|Adverse Event|43|||
19697673|NCT00471497|42142851|FG001|Core Treatment Phase|Adverse Event|53|||
19697674|NCT00471497|42142852|FG002|Core Treatment Phase|Adverse Event|89|||
19697675|NCT00471497|42142850|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
19697676|NCT00471497|42142851|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
19697677|NCT00471497|42142852|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
19697678|NCT00471497|42142850|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
19697679|NCT00471497|42142851|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
19697680|NCT00471497|42142852|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
19697681|NCT00471497|42142850|FG000|Extension Phase|Adverse Event|9|||
19697682|NCT00471497|42142851|FG001|Extension Phase|Adverse Event|5|||
19697683|NCT00471497|42142852|FG002|Extension Phase|Adverse Event|1|||
19697684|NCT00471497|42142850|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
19697685|NCT00471497|42142851|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
19389183|NCT02053792|41632810|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
19697686|NCT00471497|42142852|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
19697687|NCT00471497|42142850|FG000|Extension Phase|Withdrawal by Subject|3|||
19697688|NCT00471497|42142851|FG001|Extension Phase|Withdrawal by Subject|1|||
19697689|NCT00471497|42142852|FG002|Extension Phase|Withdrawal by Subject|0|||
19697690|NCT00471497|42142850|FG000|Extension Phase|Lost to Follow-up|2|||
19787312|NCT00261443|42244381|FG000|4: Extension Phase|Lost to Follow-up|0|||
19787313|NCT00261443|42244382|FG001|4: Extension Phase|Lost to Follow-up|1|||
19787314|NCT00261443|42244383|FG002|4: Extension Phase|Lost to Follow-up|0|||
19787315|NCT02593318|42244400|FG000|Overall Study|Withdrawal by Subject|1|||
19787316|NCT02593318|42244401|FG001|Overall Study|Withdrawal by Subject|1|||
19787317|NCT02343302|42244415|FG000|Overall Study|Physician Decision|1|||
19787318|NCT02343302|42244416|FG001|Overall Study|Physician Decision|1|||
19787319|NCT02590432|42244424|FG000|Open-label Treatment Period|Adverse Event|97|||
19787320|NCT02590432|42244425|FG001|Open-label Treatment Period|Adverse Event|79|||
19787321|NCT02590432|42244426|FG002|Open-label Treatment Period|Adverse Event|0|||
19787322|NCT02590432|42244427|FG003|Open-label Treatment Period|Adverse Event|0|||
19787323|NCT02590432|42244428|FG004|Open-label Treatment Period|Adverse Event|0|||
19787324|NCT02590432|42244429|FG005|Open-label Treatment Period|Adverse Event|0|||
19787325|NCT02590432|42244430|FG006|Open-label Treatment Period|Adverse Event|0|||
19787326|NCT02590432|42244431|FG007|Open-label Treatment Period|Adverse Event|0|||
19787327|NCT02590432|42244432|FG008|Open-label Treatment Period|Adverse Event|0|||
19787328|NCT02590432|42244424|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
19787329|NCT02590432|42244425|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
19787330|NCT02590432|42244426|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
19787331|NCT02590432|42244427|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
19787332|NCT02590432|42244428|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
19787333|NCT02590432|42244429|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
19787334|NCT02590432|42244430|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
19787335|NCT02590432|42244431|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
19787336|NCT02590432|42244432|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
19787337|NCT02590432|42244424|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
19787338|NCT02590432|42244425|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
19787339|NCT02590432|42244426|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
19787340|NCT02590432|42244427|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
19787341|NCT02590432|42244428|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
19787342|NCT02590432|42244429|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
19787343|NCT02590432|42244430|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
19787344|NCT02590432|42244431|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
19787345|NCT02590432|42244432|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
19787346|NCT02590432|42244424|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
19787347|NCT02590432|42244425|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
19787348|NCT02590432|42244426|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
19787349|NCT02590432|42244427|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
19787350|NCT02590432|42244428|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
19787351|NCT02590432|42244429|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
19787352|NCT02590432|42244430|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
19787353|NCT02590432|42244431|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
19787354|NCT02590432|42244432|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
19787355|NCT02590432|42244424|FG000|Open-label Treatment Period|Protocol Violation|10|||
19787356|NCT02590432|42244425|FG001|Open-label Treatment Period|Protocol Violation|4|||
19787357|NCT02590432|42244426|FG002|Open-label Treatment Period|Protocol Violation|0|||
19787358|NCT02590432|42244427|FG003|Open-label Treatment Period|Protocol Violation|0|||
19787359|NCT02590432|42244428|FG004|Open-label Treatment Period|Protocol Violation|0|||
19787360|NCT02590432|42244429|FG005|Open-label Treatment Period|Protocol Violation|0|||
19787361|NCT02590432|42244430|FG006|Open-label Treatment Period|Protocol Violation|0|||
19787362|NCT02590432|42244431|FG007|Open-label Treatment Period|Protocol Violation|0|||
19607481|NCT00934856|42056315|FG003|Feasibility Part|Progressive disease|3|||
19607482|NCT00934856|42056316|FG004|Feasibility Part|Progressive disease|0|||
19697691|NCT00471497|42142851|FG001|Extension Phase|Lost to Follow-up|0|||
19697692|NCT00471497|42142852|FG002|Extension Phase|Lost to Follow-up|0|||
19697693|NCT00471497|42142850|FG000|Extension Phase|Death|1|||
19697694|NCT00471497|42142851|FG001|Extension Phase|Death|0|||
19697695|NCT00471497|42142852|FG002|Extension Phase|Death|0|||
19697696|NCT00471497|42142850|FG000|Extension Phase|Disease progression|2|||
19697697|NCT00471497|42142851|FG001|Extension Phase|Disease progression|0|||
19697698|NCT00471497|42142852|FG002|Extension Phase|Disease progression|0|||
19697699|NCT00471497|42142850|FG000|Extension Phase|Protocol Violation|2|||
19697700|NCT00471497|42142851|FG001|Extension Phase|Protocol Violation|2|||
19697701|NCT00471497|42142852|FG002|Extension Phase|Protocol Violation|0|||
19697702|NCT00493649|42142863|FG000|Overall Study|Adverse Event|44|||
19787363|NCT02590432|42244432|FG008|Open-label Treatment Period|Protocol Violation|0|||
19787364|NCT02590432|42244424|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
19787365|NCT02590432|42244425|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
19787366|NCT02590432|42244426|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787367|NCT02590432|42244427|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19697703|NCT00493649|42142863|FG000|Overall Study|Patient Request|21|||
19697704|NCT00493649|42142863|FG000|Overall Study|Investigator Request|2|||
19787368|NCT02590432|42244428|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787369|NCT02590432|42244429|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787370|NCT02590432|42244430|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787371|NCT02590432|42244431|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787372|NCT02590432|42244432|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
19787373|NCT02590432|42244424|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
19787374|NCT02590432|42244425|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
19787375|NCT02590432|42244426|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787376|NCT02590432|42244427|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787377|NCT02590432|42244428|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787378|NCT02590432|42244429|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787379|NCT02590432|42244430|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787380|NCT02590432|42244431|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787381|NCT02590432|42244432|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
19787382|NCT02590432|42244424|FG000|Double-blind Treatment Period|Adverse Event|0|||
19787383|NCT02590432|42244425|FG001|Double-blind Treatment Period|Adverse Event|0|||
19787384|NCT02590432|42244426|FG002|Double-blind Treatment Period|Adverse Event|14|||
19787385|NCT02590432|42244427|FG003|Double-blind Treatment Period|Adverse Event|12|||
19787386|NCT02590432|42244428|FG004|Double-blind Treatment Period|Adverse Event|6|||
19787387|NCT02590432|42244429|FG005|Double-blind Treatment Period|Adverse Event|22|||
19787388|NCT02590432|42244430|FG006|Double-blind Treatment Period|Adverse Event|20|||
19787389|NCT02590432|42244431|FG007|Double-blind Treatment Period|Adverse Event|0|||
19787390|NCT02590432|42244432|FG008|Double-blind Treatment Period|Adverse Event|0|||
19787391|NCT02590432|42244424|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
19787392|NCT02590432|42244425|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
19787393|NCT02590432|42244426|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
19787394|NCT02590432|42244427|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
19787395|NCT02590432|42244428|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
19787396|NCT02590432|42244429|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
19787397|NCT02590432|42244430|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
19787398|NCT02590432|42244431|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
19787399|NCT02590432|42244432|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
19787400|NCT02590432|42244424|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
19787401|NCT02590432|42244425|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
19787402|NCT02590432|42244426|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
19787403|NCT02590432|42244427|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
19787404|NCT02590432|42244428|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
19787405|NCT02590432|42244429|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
19787406|NCT02590432|42244430|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
19787407|NCT02590432|42244431|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
19787408|NCT02590432|42244432|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
19787409|NCT02590432|42244424|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19787410|NCT02590432|42244425|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
19787411|NCT02590432|42244426|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
19787412|NCT02590432|42244427|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
19787413|NCT02590432|42244428|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
19787414|NCT02590432|42244429|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
19787415|NCT02590432|42244430|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
19787416|NCT02590432|42244431|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
19787417|NCT02590432|42244432|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
19787418|NCT02590432|42244424|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787419|NCT02590432|42244425|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787420|NCT02590432|42244426|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787421|NCT02590432|42244427|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787422|NCT02590432|42244428|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787423|NCT02590432|42244429|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
19787424|NCT02590432|42244430|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787425|NCT02590432|42244431|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787426|NCT02590432|42244432|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
19787427|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787428|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787429|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787430|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19367429|NCT02634788|41607589|FG000|Overall Study|Withdrawal by Subject|0|||
19367430|NCT02634788|41607590|FG001|Overall Study|Withdrawal by Subject|1|||
19367431|NCT02634788|41607591|FG002|Overall Study|Withdrawal by Subject|1|||
19787431|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787432|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787433|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
19787434|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
19787435|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
19787436|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787437|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787438|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787439|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787440|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787441|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19607483|NCT00934856|42056317|FG005|Feasibility Part|Progressive disease|0|||
19607484|NCT00934856|42056312|FG000|Feasibility Part|Physician Decision|0|||
19607485|NCT00934856|42056313|FG001|Feasibility Part|Physician Decision|0|||
19607486|NCT00934856|42056314|FG002|Feasibility Part|Physician Decision|1|||
19607487|NCT00934856|42056315|FG003|Feasibility Part|Physician Decision|0|||
19607488|NCT00934856|42056316|FG004|Feasibility Part|Physician Decision|0|||
19607489|NCT00934856|42056317|FG005|Feasibility Part|Physician Decision|0|||
19607490|NCT00934856|42056312|FG000|Feasibility Part|Adverse Event|1|||
19607491|NCT00934856|42056313|FG001|Feasibility Part|Adverse Event|1|||
19607492|NCT00934856|42056314|FG002|Feasibility Part|Adverse Event|0|||
19607493|NCT00934856|42056315|FG003|Feasibility Part|Adverse Event|1|||
19607494|NCT00934856|42056316|FG004|Feasibility Part|Adverse Event|0|||
19787442|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787443|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
19787444|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
19787445|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787446|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787447|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787448|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787449|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787450|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787451|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
19787452|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
19787453|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
19787454|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787455|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787456|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787457|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787458|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787459|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787460|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787461|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
19787462|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
19787463|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787464|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787465|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787466|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787467|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787468|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787469|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787470|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
19787471|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
19787472|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787473|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787474|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787475|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787476|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787477|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787478|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787479|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
19367432|NCT02634788|41607592|FG003|Overall Study|Withdrawal by Subject|0|||
19607495|NCT00934856|42056317|FG005|Feasibility Part|Adverse Event|2|||
19607496|NCT00934856|42056312|FG000|Feasibility Part|Withdrawal by Subject|0|||
19367433|NCT02785939|41607604|FG000|Overall Study|Progression|25|||
19787480|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
19787481|NCT02590432|42244424|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787482|NCT02590432|42244425|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787483|NCT02590432|42244426|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787484|NCT02590432|42244427|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787485|NCT02590432|42244428|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787486|NCT02590432|42244429|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787487|NCT02590432|42244430|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787488|NCT02590432|42244431|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
19787489|NCT02590432|42244432|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
19787490|NCT02590354|42244444|FG000|Phase 1|Active hepatitis B or C infection|1|||
19787491|NCT02590354|42244444|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
19787492|NCT02590354|42244444|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
19787493|NCT02590354|42244444|FG000|Phase 1|Subject does not want to participate|20|||
19787494|NCT02590354|42244444|FG000|Phase 1|Lost to Follow-up|1|||
19787495|NCT02590354|42244444|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
19787496|NCT01667224|42244451|FG000|Overall Study|Withdrawal by Subject|3|||
19787497|NCT01667224|42244452|FG001|Overall Study|Withdrawal by Subject|1|||
19787498|NCT01667224|42244451|FG000|Overall Study|Protocol Violation|1|||
19787499|NCT01667224|42244452|FG001|Overall Study|Protocol Violation|1|||
19787500|NCT03923738|42244460|FG000|Period 1|Adverse Event|1|||
19787501|NCT03923738|42244460|FG000|Period 1|Withdrawal by Subject|1|||
19787502|NCT02588248|42244468|FG000|Overall Study|Physician Decision|4|||
19787503|NCT02588248|42244469|FG001|Overall Study|Physician Decision|3|||
19787504|NCT01328054|42244480|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
19787505|NCT01328054|42244481|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
19787506|NCT01328054|42244480|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
19787507|NCT01328054|42244481|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
19787508|NCT01328054|42244480|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
19787509|NCT01328054|42244481|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
19787510|NCT01849250|42244504|FG000|Overall Study|Withdrawal by Subject|1|||
19787511|NCT01849250|42244505|FG001|Overall Study|Withdrawal by Subject|0|||
19787512|NCT01849250|42244504|FG000|Overall Study|Not Evaluable|5|||
19787513|NCT01849250|42244505|FG001|Overall Study|Not Evaluable|3|||
19787514|NCT01849250|42244504|FG000|Overall Study|Screen Failure|1|||
19787515|NCT01849250|42244505|FG001|Overall Study|Screen Failure|0|||
19787516|NCT02791191|42244515|FG000|Overall Study|Adverse Event|2|||
19787517|NCT02791191|42244516|FG001|Overall Study|Adverse Event|4|||
19787518|NCT02791191|42244517|FG002|Overall Study|Adverse Event|5|||
19787519|NCT02791191|42244515|FG000|Overall Study|Lack of Efficacy|0|||
19787520|NCT02791191|42244516|FG001|Overall Study|Lack of Efficacy|1|||
19787521|NCT02791191|42244517|FG002|Overall Study|Lack of Efficacy|0|||
19787522|NCT02791191|42244515|FG000|Overall Study|Study Drug Non-Compliance|0|||
19787523|NCT02791191|42244516|FG001|Overall Study|Study Drug Non-Compliance|2|||
19787524|NCT02791191|42244517|FG002|Overall Study|Study Drug Non-Compliance|0|||
19787525|NCT02791191|42244515|FG000|Overall Study|Site Closed by Sponsor|1|||
19787526|NCT02791191|42244516|FG001|Overall Study|Site Closed by Sponsor|1|||
19787527|NCT02791191|42244517|FG002|Overall Study|Site Closed by Sponsor|3|||
19787528|NCT02791191|42244515|FG000|Overall Study|Progressive Disease|1|||
19787529|NCT02791191|42244516|FG001|Overall Study|Progressive Disease|0|||
19787530|NCT02791191|42244517|FG002|Overall Study|Progressive Disease|0|||
19787531|NCT02791191|42244515|FG000|Overall Study|Study Terminated by Sponsor|29|||
19787532|NCT02791191|42244516|FG001|Overall Study|Study Terminated by Sponsor|101|||
19787533|NCT02791191|42244517|FG002|Overall Study|Study Terminated by Sponsor|109|||
19787534|NCT02791191|42244515|FG000|Overall Study|Withdrawal by Subject|3|||
19787535|NCT02791191|42244516|FG001|Overall Study|Withdrawal by Subject|1|||
19787536|NCT02791191|42244517|FG002|Overall Study|Withdrawal by Subject|3|||
19787537|NCT02791191|42244515|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
19787538|NCT02791191|42244516|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
19787539|NCT02791191|42244517|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
19787540|NCT02114697|42244540|FG000|Overall Study|Study terminated|5|||
19787541|NCT02114697|42244541|FG001|Overall Study|Study terminated|4|||
19787542|NCT01330017|42244552|FG000|Overall Study|Adverse Event|0|||
19787543|NCT01330017|42244553|FG001|Overall Study|Adverse Event|1|||
19787544|NCT01330017|42244554|FG002|Overall Study|Adverse Event|1|||
19787545|NCT01330017|42244555|FG003|Overall Study|Adverse Event|4|||
19787546|NCT01330017|42244556|FG004|Overall Study|Adverse Event|0|||
19787547|NCT01330017|42244552|FG000|Overall Study|Withdrawal by Subject|0|||
19787548|NCT01330017|42244553|FG001|Overall Study|Withdrawal by Subject|0|||
19367434|NCT02785939|41607605|FG001|Overall Study|Progression|8|||
19697705|NCT00493649|42142863|FG000|Overall Study|Disease Progression|1|||
19367435|NCT02785939|41607604|FG000|Overall Study|Adverse Event|3|||
19787549|NCT01330017|42244554|FG002|Overall Study|Withdrawal by Subject|1|||
19787550|NCT01330017|42244555|FG003|Overall Study|Withdrawal by Subject|0|||
19787551|NCT01330017|42244556|FG004|Overall Study|Withdrawal by Subject|1|||
19787552|NCT01330017|42244552|FG000|Overall Study|Lost to Follow-up|0|||
19787553|NCT01330017|42244553|FG001|Overall Study|Lost to Follow-up|0|||
19787554|NCT01330017|42244554|FG002|Overall Study|Lost to Follow-up|1|||
19787555|NCT01330017|42244555|FG003|Overall Study|Lost to Follow-up|0|||
19787556|NCT01330017|42244556|FG004|Overall Study|Lost to Follow-up|0|||
19787557|NCT01330017|42244552|FG000|Overall Study|Protocol Violation|0|||
19787558|NCT01330017|42244553|FG001|Overall Study|Protocol Violation|0|||
19787559|NCT01330017|42244554|FG002|Overall Study|Protocol Violation|0|||
19787560|NCT01330017|42244555|FG003|Overall Study|Protocol Violation|1|||
19787561|NCT01330017|42244556|FG004|Overall Study|Protocol Violation|0|||
19787562|NCT01330017|42244552|FG000|Overall Study|Unknown Reason|5|||
19787563|NCT01330017|42244553|FG001|Overall Study|Unknown Reason|3|||
19787564|NCT01330017|42244554|FG002|Overall Study|Unknown Reason|5|||
19787565|NCT01330017|42244555|FG003|Overall Study|Unknown Reason|7|||
19787566|NCT01330017|42244556|FG004|Overall Study|Unknown Reason|2|||
19787567|NCT00150462|42244579|FG000|Overall Study|Disease Progression or Relapse|3|||
19787568|NCT00150462|42244580|FG001|Overall Study|Disease Progression or Relapse|1|||
19787569|NCT00150462|42244581|FG002|Overall Study|Disease Progression or Relapse|2|||
19787570|NCT00150462|42244582|FG003|Overall Study|Disease Progression or Relapse|1|||
19787571|NCT00150462|42244583|FG004|Overall Study|Disease Progression or Relapse|2|||
19787572|NCT00150462|42244584|FG005|Overall Study|Disease Progression or Relapse|2|||
19787573|NCT00150462|42244585|FG006|Overall Study|Disease Progression or Relapse|3|||
19787574|NCT00150462|42244586|FG007|Overall Study|Disease Progression or Relapse|5|||
19787575|NCT00150462|42244587|FG008|Overall Study|Disease Progression or Relapse|5|||
19787576|NCT00150462|42244588|FG009|Overall Study|Disease Progression or Relapse|3|||
19787577|NCT00150462|42244589|FG010|Overall Study|Disease Progression or Relapse|2|||
19787578|NCT00150462|42244579|FG000|Overall Study|Withdrawal by Subject|0|||
19787579|NCT00150462|42244580|FG001|Overall Study|Withdrawal by Subject|1|||
19787580|NCT00150462|42244581|FG002|Overall Study|Withdrawal by Subject|1|||
19787581|NCT00150462|42244582|FG003|Overall Study|Withdrawal by Subject|0|||
19787582|NCT00150462|42244583|FG004|Overall Study|Withdrawal by Subject|1|||
19787583|NCT00150462|42244584|FG005|Overall Study|Withdrawal by Subject|2|||
19787584|NCT00150462|42244585|FG006|Overall Study|Withdrawal by Subject|0|||
19787585|NCT00150462|42244586|FG007|Overall Study|Withdrawal by Subject|1|||
19787586|NCT00150462|42244587|FG008|Overall Study|Withdrawal by Subject|0|||
19787587|NCT00150462|42244588|FG009|Overall Study|Withdrawal by Subject|1|||
19787588|NCT00150462|42244589|FG010|Overall Study|Withdrawal by Subject|0|||
19787589|NCT00150462|42244579|FG000|Overall Study|Death|0|||
19787590|NCT00150462|42244580|FG001|Overall Study|Death|1|||
19787591|NCT00150462|42244581|FG002|Overall Study|Death|0|||
19787592|NCT00150462|42244582|FG003|Overall Study|Death|0|||
19787593|NCT00150462|42244583|FG004|Overall Study|Death|0|||
19787594|NCT00150462|42244584|FG005|Overall Study|Death|0|||
19787595|NCT00150462|42244585|FG006|Overall Study|Death|0|||
19787596|NCT00150462|42244586|FG007|Overall Study|Death|0|||
19787597|NCT00150462|42244587|FG008|Overall Study|Death|1|||
19787598|NCT00150462|42244588|FG009|Overall Study|Death|0|||
19787599|NCT00150462|42244589|FG010|Overall Study|Death|0|||
19787600|NCT00150462|42244579|FG000|Overall Study|Adverse Event|0|||
19787601|NCT00150462|42244580|FG001|Overall Study|Adverse Event|0|||
19787602|NCT00150462|42244581|FG002|Overall Study|Adverse Event|0|||
19787603|NCT00150462|42244582|FG003|Overall Study|Adverse Event|1|||
19787604|NCT00150462|42244583|FG004|Overall Study|Adverse Event|0|||
19787605|NCT00150462|42244584|FG005|Overall Study|Adverse Event|0|||
19787606|NCT00150462|42244585|FG006|Overall Study|Adverse Event|0|||
19787607|NCT00150462|42244586|FG007|Overall Study|Adverse Event|2|||
19787608|NCT00150462|42244587|FG008|Overall Study|Adverse Event|0|||
19787609|NCT00150462|42244588|FG009|Overall Study|Adverse Event|1|||
19787610|NCT00150462|42244589|FG010|Overall Study|Adverse Event|0|||
19787611|NCT00150462|42244579|FG000|Overall Study|Physician Decision|0|||
19787612|NCT00150462|42244580|FG001|Overall Study|Physician Decision|0|||
19787613|NCT00150462|42244581|FG002|Overall Study|Physician Decision|1|||
19787614|NCT00150462|42244582|FG003|Overall Study|Physician Decision|1|||
19787615|NCT00150462|42244583|FG004|Overall Study|Physician Decision|0|||
19787616|NCT00150462|42244584|FG005|Overall Study|Physician Decision|0|||
19787617|NCT00150462|42244585|FG006|Overall Study|Physician Decision|0|||
19787618|NCT00150462|42244586|FG007|Overall Study|Physician Decision|0|||
19787619|NCT00150462|42244587|FG008|Overall Study|Physician Decision|0|||
19787620|NCT00150462|42244588|FG009|Overall Study|Physician Decision|0|||
19787621|NCT00150462|42244589|FG010|Overall Study|Physician Decision|0|||
19787622|NCT00150462|42244579|FG000|Overall Study|Other|0|||
19787623|NCT00150462|42244580|FG001|Overall Study|Other|0|||
19787624|NCT00150462|42244581|FG002|Overall Study|Other|0|||
19787625|NCT00150462|42244582|FG003|Overall Study|Other|0|||
19787626|NCT00150462|42244583|FG004|Overall Study|Other|0|||
19787627|NCT00150462|42244584|FG005|Overall Study|Other|0|||
19787628|NCT00150462|42244585|FG006|Overall Study|Other|0|||
19697706|NCT00493649|42142863|FG000|Overall Study|Lost to Follow-up|1|||
19697707|NCT00493649|42142863|FG000|Overall Study|Other|13|||
19697708|NCT00471107|42142873|FG000|Overall Study|Technical problems/data loss|3|||
19697709|NCT00471107|42142874|FG001|Overall Study|Technical problems/data loss|1|||
19697710|NCT00471107|42142875|FG002|Overall Study|Technical problems/data loss|3|||
19697711|NCT00488033|42142885|FG000|Overall Study|Withdrawal by Subject|1|||
19697712|NCT00488033|42142886|FG001|Overall Study|Withdrawal by Subject|0|||
19697713|NCT00117598|42142895|FG000|Prior to Treatment Cross Over|Death|40|||
19697714|NCT00117598|42142896|FG001|Prior to Treatment Cross Over|Death|41|||
19697715|NCT00117598|42142897|FG002|Prior to Treatment Cross Over|Death|37|||
19697716|NCT00117598|42142898|FG003|Prior to Treatment Cross Over|Death|0|||
19697717|NCT00117598|42142899|FG004|Prior to Treatment Cross Over|Death|0|||
19697718|NCT00117598|42142895|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
19697719|NCT00117598|42142896|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
19697720|NCT00117598|42142897|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
19697721|NCT00117598|42142898|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
19697722|NCT00117598|42142899|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
19697723|NCT00117598|42142895|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
19697724|NCT00117598|42142896|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
19697725|NCT00117598|42142897|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
19697726|NCT00117598|42142898|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
19697727|NCT00117598|42142899|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
19697728|NCT00117598|42142895|FG000|Prior to Treatment Cross Over|Other|15|||
19697729|NCT00117598|42142896|FG001|Prior to Treatment Cross Over|Other|9|||
19697730|NCT00117598|42142897|FG002|Prior to Treatment Cross Over|Other|9|||
19697731|NCT00117598|42142898|FG003|Prior to Treatment Cross Over|Other|0|||
19697732|NCT00117598|42142899|FG004|Prior to Treatment Cross Over|Other|0|||
19697733|NCT00117598|42142895|FG000|After Treament Cross Over|Death|0|||
19697734|NCT00117598|42142896|FG001|After Treament Cross Over|Death|0|||
19697735|NCT00117598|42142897|FG002|After Treament Cross Over|Death|0|||
19697736|NCT00117598|42142898|FG003|After Treament Cross Over|Death|1|||
19697737|NCT00117598|42142899|FG004|After Treament Cross Over|Death|2|||
19697738|NCT00117598|42142895|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
19697739|NCT00117598|42142896|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
19697740|NCT00117598|42142897|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
19697741|NCT00117598|42142898|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
19697742|NCT00117598|42142899|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
19697743|NCT00117598|42142895|FG000|After Treament Cross Over|Other|0|||
19697744|NCT00117598|42142896|FG001|After Treament Cross Over|Other|0|||
19697745|NCT00117598|42142897|FG002|After Treament Cross Over|Other|0|||
19697746|NCT00117598|42142898|FG003|After Treament Cross Over|Other|1|||
19697747|NCT00117598|42142899|FG004|After Treament Cross Over|Other|2|||
19697748|NCT00469859|42142911|FG000|Overall Study|Inevaluable|0|||
19697749|NCT00469859|42142912|FG001|Overall Study|Inevaluable|2|||
19697750|NCT00093808|42142918|FG000|Overall Study|Cancel participation before receiving tx|1|||
19697751|NCT00093808|42142918|FG000|Overall Study|Protocol Violation|1|||
19697752|NCT00469079|42142925|FG000|Overall Study|Lack of Efficacy|3|||
19697753|NCT00469079|42142926|FG001|Overall Study|Lack of Efficacy|8|||
19697754|NCT00469079|42142927|FG002|Overall Study|Lack of Efficacy|5|||
19697755|NCT00469079|42142925|FG000|Overall Study|Adverse Event|1|||
19697756|NCT00469079|42142926|FG001|Overall Study|Adverse Event|3|||
19697757|NCT00469079|42142927|FG002|Overall Study|Adverse Event|2|||
19697758|NCT00469079|42142925|FG000|Overall Study|Lost to Follow-up|4|||
19697759|NCT00469079|42142926|FG001|Overall Study|Lost to Follow-up|8|||
19697760|NCT00469079|42142927|FG002|Overall Study|Lost to Follow-up|10|||
19697761|NCT00469079|42142925|FG000|Overall Study|Withdrawal by Subject|1|||
19697762|NCT00469079|42142926|FG001|Overall Study|Withdrawal by Subject|2|||
19697763|NCT00469079|42142927|FG002|Overall Study|Withdrawal by Subject|2|||
19697764|NCT00469079|42142925|FG000|Overall Study|Ineligible|0|||
19697765|NCT00469079|42142926|FG001|Overall Study|Ineligible|1|||
19697766|NCT00469079|42142927|FG002|Overall Study|Ineligible|0|||
19697767|NCT00093496|42142943|FG000|Overall Study|Protocol Violation|1|||
19697768|NCT00093496|42142944|FG001|Overall Study|Protocol Violation|3|||
19697769|NCT00117286|42142951|FG000|Overall Study|Adverse Event|12|||
19697770|NCT00117286|42142952|FG001|Overall Study|Adverse Event|6|||
19697771|NCT00117286|42142951|FG000|Overall Study|Lost to Follow-up|2|||
19697772|NCT00117286|42142952|FG001|Overall Study|Lost to Follow-up|0|||
19697773|NCT00117286|42142951|FG000|Overall Study|Protocol Violation|3|||
19697774|NCT00117286|42142952|FG001|Overall Study|Protocol Violation|3|||
19697775|NCT00117286|42142951|FG000|Overall Study|Withdrawal by Subject|6|||
19697776|NCT00117286|42142952|FG001|Overall Study|Withdrawal by Subject|2|||
19697777|NCT00117286|42142951|FG000|Overall Study|Physician Decision|3|||
19697778|NCT00117286|42142952|FG001|Overall Study|Physician Decision|7|||
19697779|NCT00117286|42142951|FG000|Overall Study|Lack of Efficacy|2|||
19697780|NCT00117286|42142952|FG001|Overall Study|Lack of Efficacy|1|||
19697781|NCT00117286|42142951|FG000|Overall Study|Research site closing|0|||
19697782|NCT00117286|42142952|FG001|Overall Study|Research site closing|2|||
19787629|NCT00150462|42244586|FG007|Overall Study|Other|0|||
19787630|NCT00150462|42244587|FG008|Overall Study|Other|0|||
19787631|NCT00150462|42244588|FG009|Overall Study|Other|1|||
19787632|NCT00150462|42244589|FG010|Overall Study|Other|1|||
19787633|NCT01368081|42244629|FG000|Overall Study|Adverse Event|4|||
19787634|NCT01368081|42244630|FG001|Overall Study|Adverse Event|4|||
19787635|NCT01368081|42244631|FG002|Overall Study|Adverse Event|3|||
19787636|NCT01368081|42244632|FG003|Overall Study|Adverse Event|2|||
19787637|NCT01368081|42244633|FG004|Overall Study|Adverse Event|2|||
19787638|NCT01368081|42244634|FG005|Overall Study|Adverse Event|5|||
19787639|NCT01368081|42244635|FG006|Overall Study|Adverse Event|6|||
19787640|NCT01368081|42244636|FG007|Overall Study|Adverse Event|2|||
19787641|NCT01368081|42244637|FG008|Overall Study|Adverse Event|3|||
19787642|NCT01368081|42244638|FG009|Overall Study|Adverse Event|5|||
19787643|NCT01368081|42244639|FG010|Overall Study|Adverse Event|6|||
19787644|NCT01368081|42244640|FG011|Overall Study|Adverse Event|1|||
19787645|NCT01368081|42244641|FG012|Overall Study|Adverse Event|3|||
19787646|NCT01368081|42244629|FG000|Overall Study|Lack of Efficacy|0|||
19787647|NCT01368081|42244630|FG001|Overall Study|Lack of Efficacy|1|||
19787648|NCT01368081|42244631|FG002|Overall Study|Lack of Efficacy|0|||
19787649|NCT01368081|42244632|FG003|Overall Study|Lack of Efficacy|1|||
19787650|NCT01368081|42244633|FG004|Overall Study|Lack of Efficacy|0|||
19787651|NCT01368081|42244634|FG005|Overall Study|Lack of Efficacy|0|||
19787652|NCT01368081|42244635|FG006|Overall Study|Lack of Efficacy|0|||
19787653|NCT01368081|42244636|FG007|Overall Study|Lack of Efficacy|2|||
19787654|NCT01368081|42244637|FG008|Overall Study|Lack of Efficacy|0|||
19787655|NCT01368081|42244638|FG009|Overall Study|Lack of Efficacy|0|||
19787656|NCT01368081|42244639|FG010|Overall Study|Lack of Efficacy|0|||
19787657|NCT01368081|42244640|FG011|Overall Study|Lack of Efficacy|0|||
19787658|NCT01368081|42244641|FG012|Overall Study|Lack of Efficacy|0|||
19787659|NCT01368081|42244629|FG000|Overall Study|Protocol Violation|0|||
19787660|NCT01368081|42244630|FG001|Overall Study|Protocol Violation|0|||
19787661|NCT01368081|42244631|FG002|Overall Study|Protocol Violation|0|||
19787662|NCT01368081|42244632|FG003|Overall Study|Protocol Violation|0|||
19787663|NCT01368081|42244633|FG004|Overall Study|Protocol Violation|0|||
19787664|NCT01368081|42244634|FG005|Overall Study|Protocol Violation|1|||
19787665|NCT01368081|42244635|FG006|Overall Study|Protocol Violation|0|||
19787666|NCT01368081|42244636|FG007|Overall Study|Protocol Violation|1|||
19787667|NCT01368081|42244637|FG008|Overall Study|Protocol Violation|0|||
19787668|NCT01368081|42244638|FG009|Overall Study|Protocol Violation|0|||
19787669|NCT01368081|42244639|FG010|Overall Study|Protocol Violation|0|||
19787670|NCT01368081|42244640|FG011|Overall Study|Protocol Violation|0|||
19787671|NCT01368081|42244641|FG012|Overall Study|Protocol Violation|0|||
19787672|NCT01368081|42244629|FG000|Overall Study|Lost to Follow-up|0|||
19787673|NCT01368081|42244630|FG001|Overall Study|Lost to Follow-up|0|||
19787674|NCT01368081|42244631|FG002|Overall Study|Lost to Follow-up|0|||
19787675|NCT01368081|42244632|FG003|Overall Study|Lost to Follow-up|0|||
19787676|NCT01368081|42244633|FG004|Overall Study|Lost to Follow-up|0|||
19787677|NCT01368081|42244634|FG005|Overall Study|Lost to Follow-up|0|||
19787678|NCT01368081|42244635|FG006|Overall Study|Lost to Follow-up|0|||
19787679|NCT01368081|42244636|FG007|Overall Study|Lost to Follow-up|0|||
19787680|NCT01368081|42244637|FG008|Overall Study|Lost to Follow-up|0|||
19787681|NCT01368081|42244638|FG009|Overall Study|Lost to Follow-up|0|||
19787682|NCT01368081|42244639|FG010|Overall Study|Lost to Follow-up|0|||
19787683|NCT01368081|42244640|FG011|Overall Study|Lost to Follow-up|0|||
19787684|NCT01368081|42244641|FG012|Overall Study|Lost to Follow-up|1|||
19787685|NCT01368081|42244629|FG000|Overall Study|Withdrawal by Subject|4|||
19787686|NCT01368081|42244630|FG001|Overall Study|Withdrawal by Subject|4|||
19787687|NCT01368081|42244631|FG002|Overall Study|Withdrawal by Subject|1|||
19787688|NCT01368081|42244632|FG003|Overall Study|Withdrawal by Subject|1|||
19787689|NCT01368081|42244633|FG004|Overall Study|Withdrawal by Subject|0|||
19787690|NCT01368081|42244634|FG005|Overall Study|Withdrawal by Subject|3|||
19787691|NCT01368081|42244635|FG006|Overall Study|Withdrawal by Subject|4|||
19787692|NCT01368081|42244636|FG007|Overall Study|Withdrawal by Subject|2|||
19787693|NCT01368081|42244637|FG008|Overall Study|Withdrawal by Subject|5|||
19787694|NCT01368081|42244638|FG009|Overall Study|Withdrawal by Subject|4|||
19787695|NCT01368081|42244639|FG010|Overall Study|Withdrawal by Subject|3|||
19787696|NCT01368081|42244640|FG011|Overall Study|Withdrawal by Subject|2|||
19787697|NCT01368081|42244641|FG012|Overall Study|Withdrawal by Subject|0|||
19787698|NCT01368081|42244629|FG000|Overall Study|Other reason not defined above|2|||
19787699|NCT01368081|42244630|FG001|Overall Study|Other reason not defined above|0|||
19787700|NCT01368081|42244631|FG002|Overall Study|Other reason not defined above|0|||
19787701|NCT01368081|42244632|FG003|Overall Study|Other reason not defined above|1|||
19787702|NCT01368081|42244633|FG004|Overall Study|Other reason not defined above|0|||
19787703|NCT01368081|42244634|FG005|Overall Study|Other reason not defined above|1|||
19787704|NCT01368081|42244635|FG006|Overall Study|Other reason not defined above|2|||
19787705|NCT01368081|42244636|FG007|Overall Study|Other reason not defined above|0|||
19787706|NCT01368081|42244637|FG008|Overall Study|Other reason not defined above|0|||
19787707|NCT01368081|42244638|FG009|Overall Study|Other reason not defined above|1|||
19787708|NCT01368081|42244639|FG010|Overall Study|Other reason not defined above|0|||
19787709|NCT01368081|42244640|FG011|Overall Study|Other reason not defined above|0|||
19787710|NCT01368081|42244641|FG012|Overall Study|Other reason not defined above|3|||
19787711|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
19787712|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
19787713|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
19787714|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
19787715|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
19787716|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
19787717|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
19787718|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
19787719|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Other|4|||
19787720|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Other|1|||
19787721|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
19787722|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
19787723|NCT00303498|42244671|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
19787724|NCT00303498|42244672|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
19787725|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
19787726|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
19787727|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Death|1|||
19787728|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Death|0|||
19787729|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
19787730|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
19787731|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
19787732|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
19787733|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
19787734|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
19787735|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
19787736|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
19787737|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Other|1|||
19787738|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Other|0|||
19787739|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
19787740|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
19787741|NCT00303498|42244671|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
19787742|NCT00303498|42244672|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
19787743|NCT02588092|42244688|FG000|Overall Study|Death|4|||
19787744|NCT02588092|42244689|FG001|Overall Study|Death|3|||
19787745|NCT02588092|42244690|FG002|Overall Study|Death|3|||
19787746|NCT02588092|42244691|FG003|Overall Study|Death|3|||
19787747|NCT02588092|42244692|FG004|Overall Study|Death|2|||
19787748|NCT02588092|42244693|FG005|Overall Study|Death|2|||
19787749|NCT02588092|42244694|FG006|Overall Study|Death|2|||
19787750|NCT02588092|42244695|FG007|Overall Study|Death|1|||
19787751|NCT02588092|42244696|FG008|Overall Study|Death|5|||
19787752|NCT02588092|42244697|FG009|Overall Study|Death|2|||
19787753|NCT02588092|42244688|FG000|Overall Study|Withdrawal by Subject|0|||
19787754|NCT02588092|42244689|FG001|Overall Study|Withdrawal by Subject|0|||
19787755|NCT02588092|42244690|FG002|Overall Study|Withdrawal by Subject|0|||
19787756|NCT02588092|42244691|FG003|Overall Study|Withdrawal by Subject|0|||
19787757|NCT02588092|42244692|FG004|Overall Study|Withdrawal by Subject|0|||
19787758|NCT02588092|42244693|FG005|Overall Study|Withdrawal by Subject|1|||
19787759|NCT02588092|42244694|FG006|Overall Study|Withdrawal by Subject|1|||
19787760|NCT02588092|42244695|FG007|Overall Study|Withdrawal by Subject|2|||
19787761|NCT02588092|42244696|FG008|Overall Study|Withdrawal by Subject|0|||
19787762|NCT02588092|42244697|FG009|Overall Study|Withdrawal by Subject|0|||
19787763|NCT02588092|42244688|FG000|Overall Study|Started Another Treatment|0|||
19787764|NCT02588092|42244689|FG001|Overall Study|Started Another Treatment|0|||
19787765|NCT02588092|42244690|FG002|Overall Study|Started Another Treatment|0|||
19787766|NCT02588092|42244691|FG003|Overall Study|Started Another Treatment|0|||
19787767|NCT02588092|42244692|FG004|Overall Study|Started Another Treatment|1|||
19787768|NCT02588092|42244693|FG005|Overall Study|Started Another Treatment|0|||
19787769|NCT02588092|42244694|FG006|Overall Study|Started Another Treatment|0|||
19787770|NCT02588092|42244695|FG007|Overall Study|Started Another Treatment|1|||
19787771|NCT02588092|42244696|FG008|Overall Study|Started Another Treatment|0|||
19787772|NCT02588092|42244697|FG009|Overall Study|Started Another Treatment|0|||
19787773|NCT02588092|42244688|FG000|Overall Study|Sponsor Decision|0|||
19787774|NCT02588092|42244689|FG001|Overall Study|Sponsor Decision|0|||
19787775|NCT02588092|42244690|FG002|Overall Study|Sponsor Decision|0|||
19607497|NCT00934856|42056313|FG001|Feasibility Part|Withdrawal by Subject|0|||
19607498|NCT00934856|42056314|FG002|Feasibility Part|Withdrawal by Subject|0|||
19787776|NCT02588092|42244691|FG003|Overall Study|Sponsor Decision|0|||
19787777|NCT02588092|42244692|FG004|Overall Study|Sponsor Decision|0|||
19787778|NCT02588092|42244693|FG005|Overall Study|Sponsor Decision|0|||
19787779|NCT02588092|42244694|FG006|Overall Study|Sponsor Decision|0|||
19787780|NCT02588092|42244695|FG007|Overall Study|Sponsor Decision|0|||
19787781|NCT02588092|42244696|FG008|Overall Study|Sponsor Decision|1|||
19787782|NCT02588092|42244697|FG009|Overall Study|Sponsor Decision|1|||
19787783|NCT01367847|42244725|FG000|Overall Study|Withdrawal by Subject|2|||
19787784|NCT01367847|42244726|FG001|Overall Study|Withdrawal by Subject|2|||
19787785|NCT00150618|42244738|FG000|Overall Study|Adverse Event|2|||
19787786|NCT00150618|42244739|FG001|Overall Study|Adverse Event|2|||
19787787|NCT00150618|42244740|FG002|Overall Study|Adverse Event|6|||
19787788|NCT00150618|42244741|FG003|Overall Study|Adverse Event|9|||
19787789|NCT00150618|42244742|FG004|Overall Study|Adverse Event|5|||
19787790|NCT00150618|42244738|FG000|Overall Study|Withdrawal by Subject|6|||
19787791|NCT00150618|42244739|FG001|Overall Study|Withdrawal by Subject|8|||
19787792|NCT00150618|42244740|FG002|Overall Study|Withdrawal by Subject|8|||
19787793|NCT00150618|42244741|FG003|Overall Study|Withdrawal by Subject|4|||
19787794|NCT00150618|42244742|FG004|Overall Study|Withdrawal by Subject|5|||
19787795|NCT00150618|42244738|FG000|Overall Study|Lost to Follow-up|4|||
19787796|NCT00150618|42244739|FG001|Overall Study|Lost to Follow-up|1|||
19787797|NCT00150618|42244740|FG002|Overall Study|Lost to Follow-up|5|||
19787798|NCT00150618|42244741|FG003|Overall Study|Lost to Follow-up|8|||
19787799|NCT00150618|42244742|FG004|Overall Study|Lost to Follow-up|4|||
19787800|NCT00150618|42244738|FG000|Overall Study|Protocol Violation|1|||
19787801|NCT00150618|42244739|FG001|Overall Study|Protocol Violation|0|||
19787802|NCT00150618|42244740|FG002|Overall Study|Protocol Violation|0|||
19787803|NCT00150618|42244741|FG003|Overall Study|Protocol Violation|0|||
19787804|NCT00150618|42244742|FG004|Overall Study|Protocol Violation|1|||
19787805|NCT00150618|42244738|FG000|Overall Study|Lack of Efficacy|1|||
19787806|NCT00150618|42244739|FG001|Overall Study|Lack of Efficacy|4|||
19787807|NCT00150618|42244740|FG002|Overall Study|Lack of Efficacy|7|||
19787808|NCT00150618|42244741|FG003|Overall Study|Lack of Efficacy|4|||
19787809|NCT00150618|42244742|FG004|Overall Study|Lack of Efficacy|6|||
19787810|NCT00150618|42244738|FG000|Overall Study|No study meds|0|||
19787811|NCT00150618|42244739|FG001|Overall Study|No study meds|0|||
19787812|NCT00150618|42244740|FG002|Overall Study|No study meds|0|||
19787813|NCT00150618|42244741|FG003|Overall Study|No study meds|0|||
19787814|NCT00150618|42244742|FG004|Overall Study|No study meds|2|||
19787815|NCT00150618|42244738|FG000|Overall Study|Physician Decision|0|||
19787816|NCT00150618|42244739|FG001|Overall Study|Physician Decision|2|||
19787817|NCT00150618|42244740|FG002|Overall Study|Physician Decision|0|||
19787818|NCT00150618|42244741|FG003|Overall Study|Physician Decision|0|||
19787819|NCT00150618|42244742|FG004|Overall Study|Physician Decision|1|||
19787820|NCT00150618|42244738|FG000|Overall Study|Lack of compliance|2|||
19787821|NCT00150618|42244739|FG001|Overall Study|Lack of compliance|1|||
19787822|NCT00150618|42244740|FG002|Overall Study|Lack of compliance|1|||
19787823|NCT00150618|42244741|FG003|Overall Study|Lack of compliance|0|||
19787824|NCT00150618|42244742|FG004|Overall Study|Lack of compliance|1|||
19787825|NCT00150618|42244738|FG000|Overall Study|Abnormal ECG|1|||
19787826|NCT00150618|42244739|FG001|Overall Study|Abnormal ECG|0|||
19787827|NCT00150618|42244740|FG002|Overall Study|Abnormal ECG|0|||
19787828|NCT00150618|42244741|FG003|Overall Study|Abnormal ECG|0|||
19787829|NCT00150618|42244742|FG004|Overall Study|Abnormal ECG|0|||
19787830|NCT00150618|42244738|FG000|Overall Study|Sponsor's decision|0|||
19787831|NCT00150618|42244739|FG001|Overall Study|Sponsor's decision|0|||
19787832|NCT00150618|42244740|FG002|Overall Study|Sponsor's decision|0|||
19787833|NCT00150618|42244741|FG003|Overall Study|Sponsor's decision|1|||
19787834|NCT00150618|42244742|FG004|Overall Study|Sponsor's decision|0|||
19787835|NCT02587234|42244756|FG000|Overall Study|Withdrawal by Subject|1|||
19787836|NCT02587234|42244757|FG001|Overall Study|Withdrawal by Subject|1|||
19787837|NCT02587234|42244756|FG000|Overall Study|Lost to Follow-up|0|||
19787838|NCT02587234|42244757|FG001|Overall Study|Lost to Follow-up|2|||
19787839|NCT01359046|42244765|FG000|Overall Study|Did not receive allocated intervention|6|||
19787840|NCT01359046|42244766|FG001|Overall Study|Did not receive allocated intervention|6|||
19787841|NCT01359046|42244765|FG000|Overall Study|Physician Decision|1|||
19787842|NCT01359046|42244766|FG001|Overall Study|Physician Decision|11|||
19787843|NCT02741310|42244774|FG000|Overall Study|Sponsor Decision|2|||
19787844|NCT02741310|42244775|FG001|Overall Study|Sponsor Decision|2|||
19787845|NCT01367457|42244792|FG000|Overall Study|Death|2|||
19787846|NCT01367457|42244793|FG001|Overall Study|Death|0|||
19787847|NCT01367457|42244794|FG002|Overall Study|Death|0|||
19787848|NCT01367457|42244792|FG000|Overall Study|Investigator's decision|2|||
19787849|NCT01367457|42244793|FG001|Overall Study|Investigator's decision|0|||
19787850|NCT01367457|42244794|FG002|Overall Study|Investigator's decision|0|||
19787851|NCT01367457|42244792|FG000|Overall Study|Clinical decline (CD)|2|||
19787852|NCT01367457|42244793|FG001|Overall Study|Clinical decline (CD)|0|||
19787853|NCT01367457|42244794|FG002|Overall Study|Clinical decline (CD)|0|||
19787854|NCT01367457|42244792|FG000|Overall Study|Progression and death|8|||
19787855|NCT01367457|42244793|FG001|Overall Study|Progression and death|0|||
19787856|NCT01367457|42244794|FG002|Overall Study|Progression and death|0|||
19787857|NCT01367457|42244792|FG000|Overall Study|Toxicity|16|||
19787858|NCT01367457|42244793|FG001|Overall Study|Toxicity|0|||
19787859|NCT01367457|42244794|FG002|Overall Study|Toxicity|0|||
19787860|NCT01367457|42244792|FG000|Overall Study|Progression|137|||
19787861|NCT01367457|42244793|FG001|Overall Study|Progression|0|||
19787862|NCT01367457|42244794|FG002|Overall Study|Progression|0|||
19787863|NCT01367457|42244792|FG000|Overall Study|Patient asks for rest + slow progression|1|||
19787864|NCT01367457|42244793|FG001|Overall Study|Patient asks for rest + slow progression|0|||
19787865|NCT01367457|42244794|FG002|Overall Study|Patient asks for rest + slow progression|0|||
19787866|NCT01367457|42244792|FG000|Overall Study|Investigator's opinion, stable disease|1|||
19787867|NCT01367457|42244793|FG001|Overall Study|Investigator's opinion, stable disease|0|||
19787868|NCT01367457|42244794|FG002|Overall Study|Investigator's opinion, stable disease|0|||
19787869|NCT01367457|42244792|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
19787870|NCT01367457|42244793|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
19787871|NCT01367457|42244794|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
19787872|NCT01367457|42244792|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
19787873|NCT01367457|42244793|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
19787874|NCT01367457|42244794|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
19787875|NCT01367457|42244792|FG000|Overall Study|low grade toxicities + stable disease|1|||
19787876|NCT01367457|42244793|FG001|Overall Study|low grade toxicities + stable disease|0|||
19787877|NCT01367457|42244794|FG002|Overall Study|low grade toxicities + stable disease|0|||
19787878|NCT01367457|42244792|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
19787879|NCT01367457|42244793|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
19787880|NCT01367457|42244794|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
19787881|NCT01367457|42244792|FG000|Overall Study|Withdrawal by Subject|1|||
19787882|NCT01367457|42244793|FG001|Overall Study|Withdrawal by Subject|0|||
19787883|NCT01367457|42244794|FG002|Overall Study|Withdrawal by Subject|0|||
19787884|NCT01367457|42244792|FG000|Overall Study|CD, associated leukaemia|1|||
19787885|NCT01367457|42244793|FG001|Overall Study|CD, associated leukaemia|0|||
19787886|NCT01367457|42244794|FG002|Overall Study|CD, associated leukaemia|0|||
19787887|NCT01367457|42244792|FG000|Overall Study|Uncontrolled pain|1|||
19787888|NCT01367457|42244793|FG001|Overall Study|Uncontrolled pain|0|||
19787889|NCT01367457|42244794|FG002|Overall Study|Uncontrolled pain|0|||
19787890|NCT01367457|42244792|FG000|Overall Study|Overall status worsens to grade 4|1|||
19787891|NCT01367457|42244793|FG001|Overall Study|Overall status worsens to grade 4|0|||
19787892|NCT01367457|42244794|FG002|Overall Study|Overall status worsens to grade 4|0|||
19787893|NCT01367457|42244792|FG000|Overall Study|Stabilisation + frequent infections|1|||
19787894|NCT01367457|42244793|FG001|Overall Study|Stabilisation + frequent infections|0|||
19787895|NCT01367457|42244794|FG002|Overall Study|Stabilisation + frequent infections|0|||
19787896|NCT01367457|42244792|FG000|Overall Study|No clinical benefit|1|||
19787897|NCT01367457|42244793|FG001|Overall Study|No clinical benefit|0|||
19787898|NCT01367457|42244794|FG002|Overall Study|No clinical benefit|0|||
19787899|NCT01367457|42244792|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
19787900|NCT01367457|42244793|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
19787901|NCT01367457|42244794|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
19787902|NCT01367457|42244792|FG000|Overall Study|Overall decline|1|||
19787903|NCT01367457|42244793|FG001|Overall Study|Overall decline|0|||
19787904|NCT01367457|42244794|FG002|Overall Study|Overall decline|0|||
19787905|NCT01367457|42244792|FG000|Overall Study|Rejection of treatment|1|||
19787906|NCT01367457|42244793|FG001|Overall Study|Rejection of treatment|0|||
19787907|NCT01367457|42244794|FG002|Overall Study|Rejection of treatment|0|||
19787908|NCT01367457|42244792|FG000|Overall Study|Lost to Follow-up|1|||
19787909|NCT01367457|42244793|FG001|Overall Study|Lost to Follow-up|0|||
19787910|NCT01367457|42244794|FG002|Overall Study|Lost to Follow-up|0|||
19787911|NCT01367457|42244792|FG000|Overall Study|Death from septic shock|1|||
19787912|NCT01367457|42244793|FG001|Overall Study|Death from septic shock|0|||
19787913|NCT01367457|42244794|FG002|Overall Study|Death from septic shock|0|||
19787914|NCT01367457|42244792|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
19787915|NCT01367457|42244793|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
19787916|NCT01367457|42244794|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
19787917|NCT01367457|42244792|FG000|Overall Study|Patient's Wish|1|||
19787918|NCT01367457|42244793|FG001|Overall Study|Patient's Wish|0|||
19787919|NCT01367457|42244794|FG002|Overall Study|Patient's Wish|0|||
19787920|NCT01367457|42244792|FG000|Overall Study|Palliative. Overall decline|1|||
19787921|NCT01367457|42244793|FG001|Overall Study|Palliative. Overall decline|0|||
19787922|NCT01367457|42244794|FG002|Overall Study|Palliative. Overall decline|0|||
19787923|NCT01367457|42244792|FG000|Overall Study|Suspected DP/suspected active infection|1|||
19787924|NCT01367457|42244793|FG001|Overall Study|Suspected DP/suspected active infection|0|||
19787925|NCT01367457|42244794|FG002|Overall Study|Suspected DP/suspected active infection|0|||
19787926|NCT00235326|42244804|FG000|Overall Study|Lost to Follow-up|746|||
19787927|NCT00235326|42244805|FG001|Overall Study|Lost to Follow-up|1400|||
19787928|NCT00162942|42244815|FG000|Overall Study|Adverse Event|10|||
19787929|NCT00162942|42244816|FG001|Overall Study|Adverse Event|6|||
19787930|NCT00162942|42244815|FG000|Overall Study|Death|1|||
19787931|NCT00162942|42244816|FG001|Overall Study|Death|0|||
19787932|NCT00162942|42244815|FG000|Overall Study|Withdrawal by Subject|3|||
19787933|NCT00162942|42244816|FG001|Overall Study|Withdrawal by Subject|6|||
19787934|NCT00162942|42244815|FG000|Overall Study|Physician Decision|1|||
19787935|NCT00162942|42244816|FG001|Overall Study|Physician Decision|0|||
19787936|NCT00162942|42244815|FG000|Overall Study|Enter Open-Label Study|76|||
19787937|NCT00162942|42244816|FG001|Overall Study|Enter Open-Label Study|35|||
19787938|NCT00162942|42244815|FG000|Overall Study|Alternate Therapy|6|||
19787939|NCT00162942|42244816|FG001|Overall Study|Alternate Therapy|2|||
19787940|NCT00162942|42244815|FG000|Overall Study|Lack of Efficacy|1|||
19787941|NCT00162942|42244816|FG001|Overall Study|Lack of Efficacy|0|||
19787942|NCT00162942|42244815|FG000|Overall Study|Flare During Active Treatment|7|||
19787943|NCT00162942|42244816|FG001|Overall Study|Flare During Active Treatment|3|||
19787944|NCT00162942|42244815|FG000|Overall Study|2 or more consecutive treatments missed|1|||
19787945|NCT00162942|42244816|FG001|Overall Study|2 or more consecutive treatments missed|0|||
19787946|NCT02786901|42244846|FG000|Overall Study|Adverse Event|1|||
19787947|NCT02786901|42244847|FG001|Overall Study|Adverse Event|1|||
19787948|NCT02786901|42244848|FG002|Overall Study|Adverse Event|2|||
19787949|NCT02786901|42244846|FG000|Overall Study|Physician Decision|1|||
19787950|NCT02786901|42244847|FG001|Overall Study|Physician Decision|0|||
19787951|NCT02786901|42244848|FG002|Overall Study|Physician Decision|0|||
19787952|NCT02786901|42244846|FG000|Overall Study|Rescue Therapy Use|71|||
19787953|NCT02786901|42244847|FG001|Overall Study|Rescue Therapy Use|49|||
19787954|NCT02786901|42244848|FG002|Overall Study|Rescue Therapy Use|33|||
19787955|NCT02786901|42244846|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
19787956|NCT02786901|42244847|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
19787957|NCT02786901|42244848|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
19787958|NCT02786901|42244846|FG000|Overall Study|Disallowed medication|1|||
19787959|NCT02786901|42244847|FG001|Overall Study|Disallowed medication|1|||
19787960|NCT02786901|42244848|FG002|Overall Study|Disallowed medication|0|||
19787961|NCT02786901|42244846|FG000|Overall Study|Randomized in error|2|||
19787962|NCT02786901|42244847|FG001|Overall Study|Randomized in error|0|||
19787963|NCT02786901|42244848|FG002|Overall Study|Randomized in error|1|||
19787964|NCT02137239|42244858|FG000|Overall Study|Discontinued Study Treatment|0|||
19787965|NCT02137239|42244859|FG001|Overall Study|Discontinued Study Treatment|3|||
19787966|NCT02137239|42244858|FG000|Overall Study|Withdrew Consent|1|||
19787967|NCT02137239|42244859|FG001|Overall Study|Withdrew Consent|1|||
19787968|NCT02137239|42244858|FG000|Overall Study|Adverse Event|2|||
19787969|NCT02137239|42244859|FG001|Overall Study|Adverse Event|2|||
19787970|NCT02741076|42244878|FG000|Overall Study|Adverse Event|0|||
19787971|NCT02741076|42244879|FG001|Overall Study|Adverse Event|1|||
19787972|NCT02741076|42244880|FG002|Overall Study|Adverse Event|1|||
19787973|NCT02741076|42244881|FG003|Overall Study|Adverse Event|0|||
19787974|NCT02741076|42244878|FG000|Overall Study|Lack of Efficacy|1|||
19787975|NCT02741076|42244879|FG001|Overall Study|Lack of Efficacy|0|||
19787976|NCT02741076|42244880|FG002|Overall Study|Lack of Efficacy|0|||
19787977|NCT02741076|42244881|FG003|Overall Study|Lack of Efficacy|0|||
19787978|NCT02741076|42244878|FG000|Overall Study|Withdrawal by Subject|0|||
19787979|NCT02741076|42244879|FG001|Overall Study|Withdrawal by Subject|1|||
19787980|NCT02741076|42244880|FG002|Overall Study|Withdrawal by Subject|0|||
19787981|NCT02741076|42244881|FG003|Overall Study|Withdrawal by Subject|0|||
19787982|NCT02741076|42244878|FG000|Overall Study|Sponsor Request|2|||
19787983|NCT02741076|42244879|FG001|Overall Study|Sponsor Request|3|||
19787984|NCT02741076|42244880|FG002|Overall Study|Sponsor Request|0|||
19787985|NCT02741076|42244881|FG003|Overall Study|Sponsor Request|1|||
19787986|NCT02741076|42244878|FG000|Overall Study|No additional information available|0|||
19787987|NCT02741076|42244879|FG001|Overall Study|No additional information available|0|||
19787988|NCT02741076|42244880|FG002|Overall Study|No additional information available|1|||
19787989|NCT02741076|42244881|FG003|Overall Study|No additional information available|1|||
19787990|NCT01666444|42244894|FG000|Overall Study|Did not initiate treatment|2|||
19787991|NCT01666444|42244895|FG001|Overall Study|Did not initiate treatment|1|||
19787992|NCT05159622|42244903|FG000|Overall Study|Lost to Follow-up|4|||
19787993|NCT05159622|42244904|FG001|Overall Study|Lost to Follow-up|5|||
19787994|NCT01665430|42244916|FG000|Overall Study|Adverse Event|1|||
19787995|NCT01665430|42244916|FG000|Overall Study|Withdrawal by Subject|6|||
19787996|NCT01665430|42244916|FG000|Overall Study|Other Unspecified|2|||
19787997|NCT02739594|42244922|FG000|Overall Study|Undesired Event|3|||
19787998|NCT02739594|42244923|FG001|Overall Study|Undesired Event|4|||
19787999|NCT02739594|42244922|FG000|Overall Study|Violation of Eligibility Criteria|1|||
19788000|NCT02739594|42244923|FG001|Overall Study|Violation of Eligibility Criteria|2|||
19788001|NCT02739594|42244922|FG000|Overall Study|Protocol Violation|5|||
19788002|NCT02739594|42244923|FG001|Overall Study|Protocol Violation|6|||
19788003|NCT02739594|42244922|FG000|Overall Study|Death|4|||
19788004|NCT02739594|42244923|FG001|Overall Study|Death|2|||
19788005|NCT02739594|42244922|FG000|Overall Study|Renal Insufficiency|4|||
19788006|NCT02739594|42244923|FG001|Overall Study|Renal Insufficiency|6|||
19788007|NCT02739594|42244922|FG000|Overall Study|Administrative Reasons|1|||
19788008|NCT02739594|42244923|FG001|Overall Study|Administrative Reasons|3|||
19788009|NCT02739594|42244922|FG000|Overall Study|Withdrawal by Subject|1|||
19788010|NCT02739594|42244923|FG001|Overall Study|Withdrawal by Subject|1|||
19788011|NCT02739594|42244922|FG000|Overall Study|Lost to Follow-up|0|||
19788012|NCT02739594|42244923|FG001|Overall Study|Lost to Follow-up|1|||
19788013|NCT02739594|42244922|FG000|Overall Study|Elevated Serum Creatinine|0|||
19788014|NCT02739594|42244923|FG001|Overall Study|Elevated Serum Creatinine|1|||
19788015|NCT02739594|42244922|FG000|Overall Study|Other|6|||
19788016|NCT02739594|42244923|FG001|Overall Study|Other|2|||
19788017|NCT03989232|42244932|FG000|Overall Study|Lost to Follow-up|3|||
19788018|NCT03989232|42244933|FG001|Overall Study|Lost to Follow-up|10|||
19788019|NCT03989232|42244932|FG000|Overall Study|Withdrawal by Subject|6|||
19788020|NCT03989232|42244933|FG001|Overall Study|Withdrawal by Subject|6|||
19788021|NCT03989232|42244932|FG000|Overall Study|Death|1|||
19788022|NCT03989232|42244933|FG001|Overall Study|Death|2|||
19788023|NCT02585830|42244939|FG000|Overall Study|Withdrawal by Subject|3|||
19788024|NCT02584504|42244946|FG000|Double-blind Treatment|Participant withdrew consent|0|||
19788025|NCT02584504|42244947|FG001|Double-blind Treatment|Participant withdrew consent|0|||
19788026|NCT02584504|42244948|FG002|Double-blind Treatment|Participant withdrew consent|1|||
19788027|NCT02584504|42244946|FG000|Double-blind Treatment|Adverse Event|0|||
19788028|NCT02584504|42244947|FG001|Double-blind Treatment|Adverse Event|1|||
19788029|NCT02584504|42244948|FG002|Double-blind Treatment|Adverse Event|0|||
19788030|NCT02584504|42244946|FG000|Double-blind Treatment|Family Matter|0|||
19788031|NCT02584504|42244947|FG001|Double-blind Treatment|Family Matter|1|||
19788032|NCT02584504|42244948|FG002|Double-blind Treatment|Family Matter|0|||
19788033|NCT02584504|42244946|FG000|Open-label Treatment|Participant withdrew consent|0|||
19788034|NCT02584504|42244947|FG001|Open-label Treatment|Participant withdrew consent|0|||
19788035|NCT02584504|42244948|FG002|Open-label Treatment|Participant withdrew consent|4|||
19788036|NCT02584504|42244946|FG000|Open-label Treatment|Adverse Event|2|||
19788037|NCT02584504|42244947|FG001|Open-label Treatment|Adverse Event|2|||
19788038|NCT02584504|42244948|FG002|Open-label Treatment|Adverse Event|3|||
19788039|NCT02584504|42244946|FG000|Open-label Treatment|Physician Decision|0|||
19788040|NCT02584504|42244947|FG001|Open-label Treatment|Physician Decision|1|||
19788041|NCT02584504|42244948|FG002|Open-label Treatment|Physician Decision|0|||
19788042|NCT02584504|42244946|FG000|Open-label Treatment|Entered but not treated|0|||
19788043|NCT02584504|42244947|FG001|Open-label Treatment|Entered but not treated|1|||
19788044|NCT02584504|42244948|FG002|Open-label Treatment|Entered but not treated|1|||
19788045|NCT04354155|42244973|FG000|Overall Study|Withdrawal by Subject|1|||
19788046|NCT04354155|42244973|FG000|Overall Study|Did not meet criteria for study intervention|1|||
19788047|NCT02586064|42244979|FG000|Overall Study|Other Obligations|6|||
19788048|NCT02586064|42244980|FG001|Overall Study|Other Obligations|6|||
19788049|NCT02586064|42244979|FG000|Overall Study|Other|3|||
19788050|NCT02586064|42244980|FG001|Overall Study|Other|7|||
19788051|NCT02586064|42244979|FG000|Overall Study|Never Started|3|||
19788052|NCT02586064|42244980|FG001|Overall Study|Never Started|3|||
19788053|NCT02586064|42244979|FG000|Overall Study|Lost Interest|1|||
19788054|NCT02586064|42244980|FG001|Overall Study|Lost Interest|4|||
19788055|NCT02586064|42244979|FG000|Overall Study|Miscellaneous Life Issues|0|||
19788056|NCT02586064|42244980|FG001|Overall Study|Miscellaneous Life Issues|5|||
19788057|NCT02586064|42244979|FG000|Overall Study|Infrequent Attendance|2|||
19788058|NCT02586064|42244980|FG001|Overall Study|Infrequent Attendance|1|||
19788059|NCT02586064|42244979|FG000|Overall Study|Timed Out|2|||
19788060|NCT02586064|42244980|FG001|Overall Study|Timed Out|0|||
19788061|NCT02586064|42244979|FG000|Overall Study|AUD relapse|0|||
19788062|NCT02586064|42244980|FG001|Overall Study|AUD relapse|2|||
19788063|NCT02586064|42244979|FG000|Overall Study|Legal Issue|1|||
19788064|NCT02586064|42244980|FG001|Overall Study|Legal Issue|0|||
19788065|NCT03810495|42244989|FG000|Overall Study|Lost to Follow-up|2|||
19788066|NCT03810495|42244989|FG000|Overall Study|Withdrawal by Subject|1|||
19788067|NCT02782923|42244993|FG000|Overall Study|Lost to Follow-up|15|||
19788068|NCT03760458|42245002|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
19788069|NCT03760458|42245003|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
19788070|NCT03760458|42245004|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
19788071|NCT03760458|42245005|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
19788072|NCT03760458|42245006|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
19788073|NCT02066415|42245021|FG000|Overall Study|Decision by Sponsor|5|||
19788074|NCT02066415|42245022|FG001|Overall Study|Decision by Sponsor|4|||
19788075|NCT02066415|42245023|FG002|Overall Study|Decision by Sponsor|2|||
19788076|NCT02066415|42245021|FG000|Overall Study|Withdrawal by Subject|9|||
19788077|NCT02066415|42245022|FG001|Overall Study|Withdrawal by Subject|1|||
19788078|NCT02066415|42245023|FG002|Overall Study|Withdrawal by Subject|4|||
19788079|NCT02066415|42245021|FG000|Overall Study|Lost to Follow-up|7|||
19788080|NCT02066415|42245022|FG001|Overall Study|Lost to Follow-up|2|||
19788081|NCT02066415|42245023|FG002|Overall Study|Lost to Follow-up|2|||
19788082|NCT02583256|42245035|FG000|Overall Study|Withdrawal by Subject|0|||
19788083|NCT02583256|42245036|FG001|Overall Study|Withdrawal by Subject|1|||
19788084|NCT02583256|42245037|FG002|Overall Study|Withdrawal by Subject|1|||
19788085|NCT02583256|42245038|FG003|Overall Study|Withdrawal by Subject|0|||
19788086|NCT02583256|42245035|FG000|Overall Study|Lost to Follow-up|1|||
19788087|NCT02583256|42245036|FG001|Overall Study|Lost to Follow-up|1|||
19788088|NCT02583256|42245037|FG002|Overall Study|Lost to Follow-up|0|||
19788089|NCT02583256|42245038|FG003|Overall Study|Lost to Follow-up|1|||
19788090|NCT02583256|42245035|FG000|Overall Study|Administrative/Other|2|||
19788091|NCT02583256|42245036|FG001|Overall Study|Administrative/Other|0|||
19788092|NCT02583256|42245037|FG002|Overall Study|Administrative/Other|1|||
19788093|NCT02583256|42245038|FG003|Overall Study|Administrative/Other|2|||
19788094|NCT02582866|42245059|FG000|Overall Study|Death|1|||
19788095|NCT02582866|42245059|FG000|Overall Study|Lack of Efficacy|2|||
19788096|NCT02582866|42245059|FG000|Overall Study|Lost to Follow-up|2|||
19788097|NCT02582866|42245059|FG000|Overall Study|Withdrawal by Subject|7|||
19788098|NCT02582866|42245059|FG000|Overall Study|Investigator decision|5|||
19788099|NCT02582866|42245059|FG000|Overall Study|Participant wants to get pregnant|1|||
19788100|NCT02582866|42245059|FG000|Overall Study|Pregnancy|2|||
19788101|NCT02582866|42245059|FG000|Overall Study|Sponsor decision|1|||
19788102|NCT02582866|42245059|FG000|Overall Study|Withdrawal due to personal reasons|1|||
19788103|NCT01981551|42245063|FG000|Overall Study|Refused further treatment|8|||
19788104|NCT01981551|42245063|FG000|Overall Study|Adverse Event|1|||
19788105|NCT02584660|42245069|FG000|Overall Study|Adverse Event|4|||
19788106|NCT02584660|42245070|FG001|Overall Study|Adverse Event|0|||
19788107|NCT02584660|42245069|FG000|Overall Study|Lost to Follow-up|3|||
19788108|NCT02584660|42245070|FG001|Overall Study|Lost to Follow-up|4|||
19788109|NCT02584660|42245069|FG000|Overall Study|Protocol Violation|0|||
19788110|NCT02584660|42245070|FG001|Overall Study|Protocol Violation|1|||
19788111|NCT02584660|42245069|FG000|Overall Study|Withdrawal by Subject|0|||
19788112|NCT02584660|42245070|FG001|Overall Study|Withdrawal by Subject|2|||
19788113|NCT02584660|42245069|FG000|Overall Study|Other|0|||
19788114|NCT02584660|42245070|FG001|Overall Study|Other|1|||
19788115|NCT02582632|42245101|FG000|Overall Study|Other|1|||
19788116|NCT02178722|42245110|FG000|Overall Study|Withdrawal by Subject|0|||
19788117|NCT02178722|42245111|FG001|Overall Study|Withdrawal by Subject|0|||
19788118|NCT02178722|42245112|FG002|Overall Study|Withdrawal by Subject|0|||
19788119|NCT02178722|42245113|FG003|Overall Study|Withdrawal by Subject|2|||
19788120|NCT02178722|42245114|FG004|Overall Study|Withdrawal by Subject|33|||
19788121|NCT02178722|42245110|FG000|Overall Study|Death|2|||
19788122|NCT02178722|42245111|FG001|Overall Study|Death|13|||
19788123|NCT02178722|42245112|FG002|Overall Study|Death|12|||
19788124|NCT02178722|42245113|FG003|Overall Study|Death|12|||
19788125|NCT02178722|42245114|FG004|Overall Study|Death|205|||
19788126|NCT02178722|42245110|FG000|Overall Study|Lost to Follow-up|0|||
19788127|NCT02178722|42245111|FG001|Overall Study|Lost to Follow-up|0|||
19788128|NCT02178722|42245112|FG002|Overall Study|Lost to Follow-up|0|||
19788129|NCT02178722|42245113|FG003|Overall Study|Lost to Follow-up|2|||
19788130|NCT02178722|42245114|FG004|Overall Study|Lost to Follow-up|11|||
19788131|NCT02178722|42245110|FG000|Overall Study|Study terminated by Sponsor|2|||
19788132|NCT02178722|42245111|FG001|Overall Study|Study terminated by Sponsor|7|||
19788133|NCT02178722|42245112|FG002|Overall Study|Study terminated by Sponsor|6|||
19788134|NCT02178722|42245113|FG003|Overall Study|Study terminated by Sponsor|4|||
19788135|NCT02178722|42245114|FG004|Overall Study|Study terminated by Sponsor|128|||
19788136|NCT02178722|42245110|FG000|Overall Study|Physician Decision|0|||
19788137|NCT02178722|42245111|FG001|Overall Study|Physician Decision|0|||
19788138|NCT02178722|42245112|FG002|Overall Study|Physician Decision|0|||
19788139|NCT02178722|42245113|FG003|Overall Study|Physician Decision|0|||
19788140|NCT02178722|42245114|FG004|Overall Study|Physician Decision|3|||
19788141|NCT02178722|42245110|FG000|Overall Study|Other|0|||
19788142|NCT02178722|42245111|FG001|Overall Study|Other|0|||
19788143|NCT02178722|42245112|FG002|Overall Study|Other|0|||
19788144|NCT02178722|42245113|FG003|Overall Study|Other|0|||
19788145|NCT02178722|42245114|FG004|Overall Study|Other|2|||
19788146|NCT00972309|42245131|FG000|Overall Study|Switched to alternative treatment|0|||
19788147|NCT00972309|42245132|FG001|Overall Study|Switched to alternative treatment|2|||
19788148|NCT00972309|42245131|FG000|Overall Study|Refused further treatment|0|||
19788149|NCT00972309|42245132|FG001|Overall Study|Refused further treatment|1|||
19788150|NCT00972309|42245131|FG000|Overall Study|Late determination of ineligibility|0|||
19788151|NCT00972309|42245132|FG001|Overall Study|Late determination of ineligibility|1|||
19788152|NCT00972309|42245131|FG000|Overall Study|Second malignancy|1|||
19788153|NCT00972309|42245132|FG001|Overall Study|Second malignancy|1|||
19788154|NCT00972309|42245131|FG000|Overall Study|Visa issues|0|||
19788155|NCT00972309|42245132|FG001|Overall Study|Visa issues|1|||
19788156|NCT00972309|42245131|FG000|Overall Study|Secondary cancer (SCC)|0|||
19788157|NCT00972309|42245132|FG001|Overall Study|Secondary cancer (SCC)|1|||
19788158|NCT00972309|42245131|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
19788159|NCT00972309|42245132|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
19788160|NCT00972309|42245131|FG000|Overall Study|Lost to Follow-up|1|||
19788161|NCT00972309|42245132|FG001|Overall Study|Lost to Follow-up|1|||
19788162|NCT00972309|42245131|FG000|Overall Study|Disease progression on study|10|||
19788163|NCT00972309|42245132|FG001|Overall Study|Disease progression on study|4|||
19788164|NCT02582242|42245151|FG000|Overall Study|Adverse Event|4|||
19788165|NCT02582242|42245152|FG001|Overall Study|Adverse Event|3|||
19788166|NCT02582242|42245151|FG000|Overall Study|Protocol Violation|3|||
19788167|NCT02582242|42245152|FG001|Overall Study|Protocol Violation|1|||
19788168|NCT02582242|42245151|FG000|Overall Study|Lost to Follow-up|0|||
19788169|NCT02582242|42245152|FG001|Overall Study|Lost to Follow-up|1|||
19788170|NCT02582242|42245151|FG000|Overall Study|Withdrawal by Subject|11|||
19788171|NCT02582242|42245152|FG001|Overall Study|Withdrawal by Subject|11|||
19788172|NCT02582242|42245151|FG000|Overall Study|Unclassified|2|||
19788173|NCT02582242|42245152|FG001|Overall Study|Unclassified|1|||
19788174|NCT00663351|42245160|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
19788175|NCT00663351|42245161|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
19788176|NCT00663351|42245160|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
19788177|NCT00663351|42245161|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
19788178|NCT00663351|42245160|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
19788179|NCT00663351|42245161|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
19788180|NCT00663351|42245160|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
19788181|NCT00663351|42245161|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
19788182|NCT00663351|42245160|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
19788183|NCT00663351|42245161|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
19788184|NCT00663351|42245160|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
19788185|NCT00663351|42245161|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
19788186|NCT00616941|42245170|FG000|Overall Study|Progressive Disease|1|||
19788187|NCT00616941|42245171|FG001|Overall Study|Progressive Disease|2|||
19788188|NCT00616941|42245172|FG002|Overall Study|Progressive Disease|1|||
19788189|NCT00616941|42245170|FG000|Overall Study|Adverse Event|0|||
19788190|NCT00616941|42245171|FG001|Overall Study|Adverse Event|1|||
19788191|NCT00616941|42245172|FG002|Overall Study|Adverse Event|1|||
19788192|NCT00616941|42245170|FG000|Overall Study|Subject Non-compliance|0|||
19788193|NCT00616941|42245171|FG001|Overall Study|Subject Non-compliance|0|||
19788194|NCT00616941|42245172|FG002|Overall Study|Subject Non-compliance|1|||
19788195|NCT00616941|42245170|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
19788196|NCT00616941|42245171|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
19788197|NCT00616941|42245172|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
19788198|NCT00616941|42245170|FG000|Overall Study|Vaccination Suspended|0|||
19788199|NCT00616941|42245171|FG001|Overall Study|Vaccination Suspended|0|||
19788200|NCT00616941|42245172|FG002|Overall Study|Vaccination Suspended|3|||
19788201|NCT02581930|42245180|FG000|Overall Study|Withdrawal by Subject|1|||
19788202|NCT02581930|42245180|FG000|Overall Study|patient declined further treatment|1|||
19788203|NCT00105560|42245184|FG000|Overall Study|Lost to Follow-up|1|||
19788204|NCT02577718|42245197|FG000|Overall Study|Death|6|||
19788205|NCT02577718|42245197|FG000|Overall Study|Withdrawal by Subject|2|||
19788206|NCT00520533|42245203|FG000|Overall Study|Death|1|||
19788207|NCT00520533|42245203|FG000|Overall Study|Suspension of the study for safety reasons|1|||
19788208|NCT00520533|42245203|FG000|Overall Study|Withdrawal by Subject|1|||
19788209|NCT00520533|42245203|FG000|Overall Study|Physician Decision|1|||
19788210|NCT01664104|42245212|FG000|Overall Study|Adverse Event|6|||
19788211|NCT01664104|42245212|FG000|Overall Study|Lack of Efficacy|2|||
19788212|NCT01664104|42245212|FG000|Overall Study|Withdrawal by Subject|1|||
19788213|NCT01664104|42245212|FG000|Overall Study|Lost to Follow-up|4|||
19788214|NCT01664104|42245212|FG000|Overall Study|Other|1|||
19788215|NCT01664104|42245212|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
19788216|NCT02739984|42245220|FG000|Overall Study|Sponsor Decision|1|||
19788217|NCT02739984|42245221|FG001|Overall Study|Sponsor Decision|0|||
19788218|NCT02739984|42245220|FG000|Overall Study|Withdrawal by Subject|1|||
19788219|NCT02739984|42245221|FG001|Overall Study|Withdrawal by Subject|1|||
19788220|NCT02739984|42245220|FG000|Overall Study|Death|0|||
19788221|NCT02739984|42245221|FG001|Overall Study|Death|1|||
19788222|NCT02739984|42245220|FG000|Overall Study|Lost to Follow-up|3|||
19788223|NCT02739984|42245221|FG001|Overall Study|Lost to Follow-up|0|||
19788224|NCT00496730|42245229|FG000|Overall Study|Lost to Follow-up|4|||
19788225|NCT00496730|42245230|FG001|Overall Study|Lost to Follow-up|3|||
19788226|NCT00496730|42245229|FG000|Overall Study|Withdrawal by Subject|2|||
19788227|NCT00496730|42245230|FG001|Overall Study|Withdrawal by Subject|2|||
19788228|NCT02739828|42245236|FG000|Overall Study|Adverse Event|1|||
19788229|NCT02739828|42245236|FG000|Overall Study|Lost to Follow-up|4|||
19788230|NCT04435808|42245242|FG000|Overall Study|Study stopped by DSMB|0|||
19788231|NCT04435808|42245243|FG001|Overall Study|Study stopped by DSMB|1|||
19788232|NCT01664494|42245266|FG000|Overall Study|Withdrawal by Subject|27|||
19788233|NCT01664494|42245266|FG000|Overall Study|Death|18|||
19788234|NCT01664494|42245266|FG000|Overall Study|Other|49|||
19788235|NCT01664494|42245266|FG000|Overall Study|Lost to Follow-up|99|||
19788236|NCT02577016|42245272|FG000|Overall Study|Adverse Event|2|||
19788237|NCT02577016|42245273|FG001|Overall Study|Adverse Event|1|||
19788238|NCT02577016|42245272|FG000|Overall Study|Physician Decision|0|||
19788239|NCT02577016|42245273|FG001|Overall Study|Physician Decision|1|||
19788240|NCT05101252|42245281|FG000|Overall Study|Unsatisfactory Test Article|1|||
19788241|NCT05101252|42245282|FG001|Overall Study|Unsatisfactory Test Article|0|||
19788242|NCT05101252|42245281|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
19788243|NCT05101252|42245282|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
19788244|NCT05101252|42245281|FG000|Overall Study|Withdrew Consent during study|0|||
19788245|NCT05101252|42245282|FG001|Overall Study|Withdrew Consent during study|1|||
19788246|NCT05101252|42245281|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
19788247|NCT05101252|42245282|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
19788248|NCT03316586|42245288|FG000|Overall Study|Adverse Event|2|||
19788249|NCT03316586|42245288|FG000|Overall Study|Physician Decision|3|||
19788250|NCT03316586|42245288|FG000|Overall Study|Lack of Efficacy|10|||
19788251|NCT03316586|42245288|FG000|Overall Study|still on treatment|1|||
19788252|NCT03316586|42245288|FG000|Overall Study|Patient needed radiation therapy|1|||
19788253|NCT03316586|42245288|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
19788254|NCT02994927|42245294|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19788255|NCT02994927|42245295|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19788256|NCT02994927|42245294|FG000|Overall Study|Did not meet eligibility criteria|0|||
19788257|NCT02994927|42245295|FG001|Overall Study|Did not meet eligibility criteria|1|||
19788258|NCT02994927|42245294|FG000|Overall Study|Physician Decision|4|||
19788259|NCT02994927|42245295|FG001|Overall Study|Physician Decision|3|||
19788260|NCT02994927|42245294|FG000|Overall Study|Death|4|||
19788261|NCT02994927|42245295|FG001|Overall Study|Death|2|||
19788262|NCT02994927|42245294|FG000|Overall Study|Adverse Event|2|||
19788263|NCT02994927|42245295|FG001|Overall Study|Adverse Event|1|||
19788264|NCT02994927|42245294|FG000|Overall Study|Withdrawal by Subject|3|||
19788265|NCT02994927|42245295|FG001|Overall Study|Withdrawal by Subject|6|||
19788266|NCT02994927|42245294|FG000|Overall Study|Lost to Follow-up|2|||
19788267|NCT02994927|42245295|FG001|Overall Study|Lost to Follow-up|1|||
19788268|NCT00107991|42245301|FG000|Eligibility Assessment|Disease not severe enough|7|||
19788269|NCT00107991|42245301|FG000|Eligibility Assessment|Unwilling to participate|7|||
19788270|NCT00107991|42245301|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
19788271|NCT00107991|42245301|FG000|Eligibility Assessment|Abnormal labs|2|||
19788272|NCT00107991|42245301|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
19788273|NCT00107991|42245301|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
19788274|NCT00107991|42245301|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
19788275|NCT00107991|42245301|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
19788276|NCT00107991|42245301|FG000|12 Week Treatment Period|Adverse Event|1|||
19788277|NCT00107991|42245301|FG000|12 Week Treatment Period|Protocol Violation|1|||
19788278|NCT00107991|42245301|FG000|12 Week Treatment Period|Incarcerated|1|||
19788279|NCT00107991|42245301|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
19788280|NCT03142334|42245307|FG000|Overall Study|Death|18|||
19788281|NCT03142334|42245308|FG001|Overall Study|Death|33|||
19788282|NCT03142334|42245307|FG000|Overall Study|Withdrawal by Subject|15|||
19788283|NCT03142334|42245308|FG001|Overall Study|Withdrawal by Subject|11|||
19788284|NCT03142334|42245307|FG000|Overall Study|Ongoing on trial follow up|463|||
19788285|NCT03142334|42245308|FG001|Overall Study|Ongoing on trial follow up|454|||
19788286|NCT00492856|42245314|FG000|Induction|Adverse Event|2|||
19788287|NCT00492856|42245315|FG001|Induction|Adverse Event|0|||
19788288|NCT00492856|42245316|FG002|Induction|Adverse Event|0|||
19788289|NCT00492856|42245317|FG003|Induction|Adverse Event|0|||
19788290|NCT00492856|42245314|FG000|Induction|Withdrawal by Subject|1|||
19788291|NCT00492856|42245315|FG001|Induction|Withdrawal by Subject|0|||
19788292|NCT00492856|42245316|FG002|Induction|Withdrawal by Subject|0|||
19788293|NCT00492856|42245317|FG003|Induction|Withdrawal by Subject|0|||
19788294|NCT00492856|42245314|FG000|Induction|Death|3|||
19788295|NCT00492856|42245315|FG001|Induction|Death|0|||
19788296|NCT00492856|42245316|FG002|Induction|Death|0|||
19788297|NCT00492856|42245317|FG003|Induction|Death|0|||
19788298|NCT00492856|42245314|FG000|Consolidation|Adverse Event|6|||
19788299|NCT00492856|42245315|FG001|Consolidation|Adverse Event|0|||
19788300|NCT00492856|42245316|FG002|Consolidation|Adverse Event|0|||
19788301|NCT00492856|42245317|FG003|Consolidation|Adverse Event|0|||
19788302|NCT00492856|42245314|FG000|Consolidation|Not protocol specified|2|||
19788303|NCT00492856|42245315|FG001|Consolidation|Not protocol specified|0|||
19788304|NCT00492856|42245316|FG002|Consolidation|Not protocol specified|0|||
19788305|NCT00492856|42245317|FG003|Consolidation|Not protocol specified|0|||
19788306|NCT00492856|42245314|FG000|Consolidation|Lost to Follow-up|1|||
19788307|NCT00492856|42245315|FG001|Consolidation|Lost to Follow-up|0|||
19788308|NCT00492856|42245316|FG002|Consolidation|Lost to Follow-up|0|||
19788309|NCT00492856|42245317|FG003|Consolidation|Lost to Follow-up|0|||
19788310|NCT00492856|42245314|FG000|Post-consolidation|Adverse Event|0|||
19788311|NCT00492856|42245315|FG001|Post-consolidation|Adverse Event|4|||
19788312|NCT00492856|42245316|FG002|Post-consolidation|Adverse Event|0|||
19788313|NCT00492856|42245317|FG003|Post-consolidation|Adverse Event|1|||
19788314|NCT00492856|42245314|FG000|Post-consolidation|Withdrawal by Subject|0|||
19788315|NCT00492856|42245315|FG001|Post-consolidation|Withdrawal by Subject|4|||
19788316|NCT00492856|42245316|FG002|Post-consolidation|Withdrawal by Subject|0|||
19788317|NCT00492856|42245317|FG003|Post-consolidation|Withdrawal by Subject|0|||
19788318|NCT00492856|42245314|FG000|Post-consolidation|Death|0|||
19788319|NCT00492856|42245315|FG001|Post-consolidation|Death|1|||
19788320|NCT00492856|42245316|FG002|Post-consolidation|Death|0|||
19788321|NCT00492856|42245317|FG003|Post-consolidation|Death|0|||
19788322|NCT00492856|42245314|FG000|Post-consolidation|Not protocol specified|0|||
19788323|NCT00492856|42245315|FG001|Post-consolidation|Not protocol specified|1|||
19788324|NCT00492856|42245316|FG002|Post-consolidation|Not protocol specified|0|||
19788325|NCT00492856|42245317|FG003|Post-consolidation|Not protocol specified|0|||
19788326|NCT00492856|42245314|FG000|Post-consolidation|Lost to Follow-up|0|||
19788327|NCT00492856|42245315|FG001|Post-consolidation|Lost to Follow-up|2|||
19788328|NCT00492856|42245316|FG002|Post-consolidation|Lost to Follow-up|0|||
19788329|NCT00492856|42245317|FG003|Post-consolidation|Lost to Follow-up|0|||
19788330|NCT00492856|42245314|FG000|Post-consolidation|Observation Arm|0|||
19788331|NCT00492856|42245315|FG001|Post-consolidation|Observation Arm|0|||
19788332|NCT00492856|42245316|FG002|Post-consolidation|Observation Arm|27|||
19788333|NCT00492856|42245317|FG003|Post-consolidation|Observation Arm|0|||
19788334|NCT02782377|42245329|FG000|Overall Study|Physician Decision|5|||
19788335|NCT02410629|42245336|FG000|Overall Study|Family cannot commit to the study|2|||
19788336|NCT02410629|42245337|FG001|Overall Study|Family cannot commit to the study|1|||
19788337|NCT02410629|42245336|FG000|Overall Study|Subject returned to work|1|||
19788338|NCT02410629|42245337|FG001|Overall Study|Subject returned to work|0|||
19788339|NCT02410629|42245336|FG000|Overall Study|Subject moved back to home country|0|||
19788340|NCT02410629|42245337|FG001|Overall Study|Subject moved back to home country|1|||
19788341|NCT02410629|42245336|FG000|Overall Study|Subject underwent heart surgery|0|||
19788342|NCT02410629|42245337|FG001|Overall Study|Subject underwent heart surgery|1|||
19788343|NCT02252211|42245345|FG000|Overall Study|Adverse Event|0|||
19788344|NCT02252211|42245346|FG001|Overall Study|Adverse Event|1|||
19788345|NCT02252211|42245347|FG002|Overall Study|Adverse Event|0|||
19788346|NCT02252211|42245345|FG000|Overall Study|Progressive disease|3|||
19788347|NCT02252211|42245346|FG001|Overall Study|Progressive disease|2|||
19788348|NCT02252211|42245347|FG002|Overall Study|Progressive disease|0|||
19788349|NCT02252211|42245345|FG000|Overall Study|Withdrawal by Subject|1|||
19788350|NCT02252211|42245346|FG001|Overall Study|Withdrawal by Subject|0|||
19788351|NCT02252211|42245347|FG002|Overall Study|Withdrawal by Subject|0|||
19788352|NCT02252211|42245345|FG000|Overall Study|Serious Adverse Event During Screening|1|||
19788353|NCT02252211|42245346|FG001|Overall Study|Serious Adverse Event During Screening|0|||
19788354|NCT02252211|42245347|FG002|Overall Study|Serious Adverse Event During Screening|1|||
19788355|NCT02776683|42245354|FG000|Pre-switch Period|Protocol Violation|1|||
19788356|NCT02776683|42245355|FG001|Pre-switch Period|Protocol Violation|0|||
19788357|NCT02776683|42245354|FG000|Pre-switch Period|Adverse Event|21|||
19788358|NCT02776683|42245355|FG001|Pre-switch Period|Adverse Event|0|||
19788359|NCT02776683|42245354|FG000|Pre-switch Period|Withdrawal by Subject|9|||
19788360|NCT02776683|42245355|FG001|Pre-switch Period|Withdrawal by Subject|0|||
19788361|NCT02776683|42245354|FG000|Pre-switch Period|Physician Decision|7|||
19788362|NCT02776683|42245355|FG001|Pre-switch Period|Physician Decision|0|||
19788363|NCT02776683|42245354|FG000|Pre-switch Period|Progressive disease|39|||
19788364|NCT02776683|42245355|FG001|Pre-switch Period|Progressive disease|0|||
19788365|NCT02776683|42245354|FG000|Pre-switch Period|Other than listed|3|||
19788366|NCT02776683|42245355|FG001|Pre-switch Period|Other than listed|0|||
19788367|NCT02776683|42245354|FG000|Post-switch Period|Adverse Event|0|||
19788368|NCT02776683|42245355|FG001|Post-switch Period|Adverse Event|3|||
19788369|NCT02776683|42245354|FG000|Post-switch Period|Withdrawal by Subject|0|||
19788370|NCT02776683|42245355|FG001|Post-switch Period|Withdrawal by Subject|2|||
19788371|NCT02776683|42245354|FG000|Post-switch Period|Physician Decision|0|||
19788372|NCT02776683|42245355|FG001|Post-switch Period|Physician Decision|3|||
19788373|NCT02776683|42245354|FG000|Post-switch Period|Progressive disease|0|||
19788374|NCT02776683|42245355|FG001|Post-switch Period|Progressive disease|20|||
19788375|NCT02776683|42245354|FG000|Post-switch Period|Other than listed|0|||
19788376|NCT02776683|42245355|FG001|Post-switch Period|Other than listed|15|||
19788377|NCT02731742|42245363|FG000|Overall Study|Death|1|||
19788378|NCT02731742|42245364|FG001|Overall Study|Death|2|||
19788379|NCT02731742|42245365|FG002|Overall Study|Death|5|||
19788380|NCT02731742|42245366|FG003|Overall Study|Death|0|||
19788381|NCT02731742|42245363|FG000|Overall Study|Physician Decision|0|||
19788382|NCT02731742|42245364|FG001|Overall Study|Physician Decision|0|||
19788383|NCT02731742|42245365|FG002|Overall Study|Physician Decision|0|||
19788384|NCT02731742|42245366|FG003|Overall Study|Physician Decision|1|||
19788385|NCT02731742|42245363|FG000|Overall Study|Study Terminated by Sponsor|2|||
19788386|NCT02731742|42245364|FG001|Overall Study|Study Terminated by Sponsor|1|||
19788387|NCT02731742|42245365|FG002|Overall Study|Study Terminated by Sponsor|1|||
19788388|NCT02731742|42245366|FG003|Overall Study|Study Terminated by Sponsor|1|||
19788389|NCT00104871|42245389|FG000|Overall Study|Not evaluable|1|||
19697783|NCT00265122|42142964|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
19788390|NCT03487796|42245397|FG000|Overall Study|Lost to Follow-up|18|||
19788391|NCT03487796|42245398|FG001|Overall Study|Lost to Follow-up|6|||
19788392|NCT03446612|42245412|FG000|Overall Study|Protocol defined stopping criteria|0|||
19788393|NCT03446612|42245413|FG001|Overall Study|Protocol defined stopping criteria|1|||
19788394|NCT02730728|42245424|FG000|Overall Study|Withdrawal by Subject|0|||
19788395|NCT02730728|42245425|FG001|Overall Study|Withdrawal by Subject|1|||
19788396|NCT02730728|42245426|FG002|Overall Study|Withdrawal by Subject|0|||
19788397|NCT02730728|42245424|FG000|Overall Study|Lack of Efficacy|0|||
19788398|NCT02730728|42245425|FG001|Overall Study|Lack of Efficacy|1|||
19788399|NCT02730728|42245426|FG002|Overall Study|Lack of Efficacy|1|||
19788400|NCT02580058|42245437|FG000|Overall Study|Lost to Follow-up|4|||
19788401|NCT02580058|42245438|FG001|Overall Study|Lost to Follow-up|5|||
19788402|NCT02580058|42245439|FG002|Overall Study|Lost to Follow-up|4|||
19788403|NCT02580058|42245437|FG000|Overall Study|Ongoing|51|||
19788404|NCT02580058|42245438|FG001|Overall Study|Ongoing|55|||
19788405|NCT02580058|42245439|FG002|Overall Study|Ongoing|46|||
19788406|NCT02580058|42245437|FG000|Overall Study|Withdrawal by Subject|24|||
19788407|NCT02580058|42245438|FG001|Overall Study|Withdrawal by Subject|26|||
19788408|NCT02580058|42245439|FG002|Overall Study|Withdrawal by Subject|36|||
19788409|NCT00104637|42245447|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
19788410|NCT00104637|42245448|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
19788411|NCT02768103|42245457|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
19788412|NCT02767323|42245466|FG000|Overall Study|Withdrawal by Subject|17|||
19788413|NCT02767323|42245467|FG001|Overall Study|Withdrawal by Subject|5|||
19788414|NCT02767323|42245468|FG002|Overall Study|Withdrawal by Subject|13|||
19788415|NCT02767323|42245469|FG003|Overall Study|Withdrawal by Subject|0|||
19788416|NCT02767323|42245466|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
19788417|NCT02767323|42245467|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
19788418|NCT02767323|42245468|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
19788419|NCT02767323|42245469|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
19788420|NCT02780115|42245487|FG000|Overall Study|Withdrawal by Subject|0|||
19788421|NCT02780115|42245488|FG001|Overall Study|Withdrawal by Subject|1|||
19788422|NCT02780115|42245489|FG002|Overall Study|Withdrawal by Subject|1|||
19788423|NCT02780115|42245490|FG003|Overall Study|Withdrawal by Subject|0|||
19788424|NCT02780115|42245491|FG004|Overall Study|Withdrawal by Subject|0|||
19788425|NCT02780115|42245487|FG000|Overall Study|Adverse Event|0|||
19788426|NCT02780115|42245488|FG001|Overall Study|Adverse Event|0|||
19788427|NCT02780115|42245489|FG002|Overall Study|Adverse Event|0|||
19788428|NCT02780115|42245490|FG003|Overall Study|Adverse Event|1|||
19788429|NCT02780115|42245491|FG004|Overall Study|Adverse Event|1|||
19788430|NCT02766777|42245503|FG000|Overall Study|Adverse Event|12|||
19788431|NCT02766777|42245503|FG000|Overall Study|Lost to Follow-up|16|||
19788432|NCT02766777|42245503|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19788433|NCT02766777|42245503|FG000|Overall Study|Protocol Violation|1|||
19788434|NCT02766777|42245503|FG000|Overall Study|Withdrawal by Subject|4|||
19788435|NCT00157014|42245511|FG000|Overall Study|Death|4|||
19788436|NCT00157014|42245512|FG001|Overall Study|Death|2|||
19788437|NCT00157014|42245513|FG002|Overall Study|Death|1|||
19788438|NCT00157014|42245514|FG003|Overall Study|Death|1|||
19788439|NCT00157014|42245511|FG000|Overall Study|Physician Decision|0|||
19788440|NCT00157014|42245512|FG001|Overall Study|Physician Decision|1|||
19788441|NCT00157014|42245513|FG002|Overall Study|Physician Decision|0|||
19788442|NCT00157014|42245514|FG003|Overall Study|Physician Decision|0|||
19788443|NCT00157014|42245511|FG000|Overall Study|Medications withdrawn on family request|0|||
19788444|NCT00157014|42245512|FG001|Overall Study|Medications withdrawn on family request|1|||
19788445|NCT00157014|42245513|FG002|Overall Study|Medications withdrawn on family request|0|||
19788446|NCT00157014|42245514|FG003|Overall Study|Medications withdrawn on family request|0|||
19788447|NCT00157014|42245511|FG000|Overall Study|Patient withdrawn by investigator|1|||
19788448|NCT00157014|42245512|FG001|Overall Study|Patient withdrawn by investigator|0|||
19788449|NCT00157014|42245513|FG002|Overall Study|Patient withdrawn by investigator|0|||
19788450|NCT00157014|42245514|FG003|Overall Study|Patient withdrawn by investigator|0|||
19788451|NCT00157014|42245511|FG000|Overall Study|Patient unable to return in nursing home|1|||
19788452|NCT00157014|42245512|FG001|Overall Study|Patient unable to return in nursing home|0|||
19788453|NCT00157014|42245513|FG002|Overall Study|Patient unable to return in nursing home|0|||
19788454|NCT00157014|42245514|FG003|Overall Study|Patient unable to return in nursing home|0|||
19788455|NCT00157014|42245511|FG000|Overall Study|Patient would not receive transplant|0|||
19788456|NCT00157014|42245512|FG001|Overall Study|Patient would not receive transplant|1|||
19788457|NCT00157014|42245513|FG002|Overall Study|Patient would not receive transplant|0|||
19788458|NCT00157014|42245514|FG003|Overall Study|Patient would not receive transplant|0|||
19788459|NCT00157014|42245511|FG000|Overall Study|Withdrawal by Subject|1|||
19788460|NCT00157014|42245512|FG001|Overall Study|Withdrawal by Subject|0|||
19788461|NCT00157014|42245513|FG002|Overall Study|Withdrawal by Subject|0|||
19788462|NCT00157014|42245514|FG003|Overall Study|Withdrawal by Subject|0|||
19788463|NCT02778867|42245526|FG000|Phase 1|Withdrawal by Subject|2|||
19788464|NCT02778867|42245527|FG001|Phase 1|Withdrawal by Subject|3|||
19788465|NCT02778867|42245528|FG002|Phase 1|Withdrawal by Subject|0|||
19788466|NCT02778867|42245529|FG003|Phase 1|Withdrawal by Subject|0|||
19788467|NCT02778867|42245526|FG000|Phase 2|Withdrawal by Subject|0|||
19788468|NCT02778867|42245527|FG001|Phase 2|Withdrawal by Subject|0|||
19788469|NCT02778867|42245528|FG002|Phase 2|Withdrawal by Subject|1|||
19788470|NCT02778867|42245529|FG003|Phase 2|Withdrawal by Subject|0|||
19788471|NCT02778867|42245526|FG000|Phase 2|Physician Decision|0|||
19788472|NCT02778867|42245527|FG001|Phase 2|Physician Decision|0|||
19788473|NCT02778867|42245528|FG002|Phase 2|Physician Decision|0|||
19788474|NCT02778867|42245529|FG003|Phase 2|Physician Decision|1|||
19788475|NCT02778867|42245526|FG000|Phase 2|Adverse Event|0|||
19788476|NCT02778867|42245527|FG001|Phase 2|Adverse Event|0|||
19788477|NCT02778867|42245528|FG002|Phase 2|Adverse Event|0|||
19788478|NCT02778867|42245529|FG003|Phase 2|Adverse Event|1|||
19788479|NCT02778555|42245542|FG000|Overall Study|Withdrawal by Subject|55|||
19788480|NCT02778555|42245543|FG001|Overall Study|Withdrawal by Subject|32|||
19788481|NCT02778555|42245544|FG002|Overall Study|Withdrawal by Subject|107|||
19788482|NCT02778399|42245558|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
19788483|NCT02778399|42245559|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
19788484|NCT02778399|42245560|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
19788485|NCT02778399|42245561|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
19788486|NCT02778399|42245562|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
19788487|NCT02778399|42245563|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
19788488|NCT02778399|42245558|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
19788489|NCT02778399|42245559|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
19788490|NCT02778399|42245560|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
19788491|NCT02778399|42245561|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
19788492|NCT02778399|42245562|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
19788493|NCT02778399|42245563|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
19788494|NCT02778399|42245558|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
19788495|NCT02778399|42245559|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
19788496|NCT02778399|42245560|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
19788497|NCT02778399|42245561|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
19788498|NCT02778399|42245562|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
19788499|NCT02778399|42245563|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
19788500|NCT02778399|42245558|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
19788501|NCT02778399|42245559|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
19788502|NCT02778399|42245560|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
19788503|NCT02778399|42245561|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
19788504|NCT02778399|42245562|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
19788505|NCT02778399|42245563|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
19788506|NCT02778399|42245558|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
19788507|NCT02778399|42245559|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
19788508|NCT02778399|42245560|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
19788509|NCT02778399|42245561|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
19788510|NCT02778399|42245562|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
19788511|NCT02778399|42245563|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
19788512|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
19788513|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
19788514|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
19788515|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
19788516|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
19788517|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
19788518|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
19788519|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
19788520|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
19788521|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
19788522|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
19788523|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
19788524|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
19788525|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
19788526|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
19788527|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
19788528|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
19788529|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
19788530|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
19788531|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
19788532|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
19788533|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
19788534|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
19788535|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
19788536|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
19788537|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
19788538|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
19788539|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
19788540|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
19788541|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
19788542|NCT02778399|42245558|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
19788543|NCT02778399|42245559|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
19788544|NCT02778399|42245560|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
19788545|NCT02778399|42245561|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
19788546|NCT02778399|42245562|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
19788547|NCT02778399|42245563|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
19788548|NCT03656744|42245612|FG000|Overall Study|Adverse Event|1|||
19788549|NCT03656744|42245613|FG001|Overall Study|Adverse Event|4|||
19788550|NCT03656744|42245614|FG002|Overall Study|Adverse Event|1|||
19788551|NCT03656744|42245612|FG000|Overall Study|Protocol Violation|1|||
19788552|NCT03656744|42245613|FG001|Overall Study|Protocol Violation|0|||
19788553|NCT03656744|42245614|FG002|Overall Study|Protocol Violation|0|||
19788554|NCT03656744|42245612|FG000|Overall Study|Lost to Follow-up|2|||
19788555|NCT03656744|42245613|FG001|Overall Study|Lost to Follow-up|2|||
19788556|NCT03656744|42245614|FG002|Overall Study|Lost to Follow-up|0|||
19788557|NCT03656744|42245612|FG000|Overall Study|Withdrawal by Subject|0|||
19788558|NCT03656744|42245613|FG001|Overall Study|Withdrawal by Subject|1|||
19788559|NCT03656744|42245614|FG002|Overall Study|Withdrawal by Subject|0|||
19788560|NCT03656744|42245612|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
19788561|NCT03656744|42245613|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
19788562|NCT03656744|42245614|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
19788563|NCT02739360|42245622|FG000|Overall Study|Adverse Event|1|||
19788564|NCT02739360|42245622|FG000|Overall Study|Study terminated by Sponsor|2|||
19788565|NCT01822522|42245632|FG000|Overall Study|Adverse Event|1|||
19788566|NCT01822522|42245633|FG001|Overall Study|Adverse Event|1|||
19788567|NCT01822522|42245634|FG002|Overall Study|Adverse Event|1|||
19788568|NCT01822522|42245635|FG003|Overall Study|Adverse Event|0|||
19788569|NCT01822522|42245636|FG004|Overall Study|Adverse Event|0|||
19788570|NCT01822522|42245637|FG005|Overall Study|Adverse Event|1|||
19788571|NCT01822522|42245632|FG000|Overall Study|Death|3|||
19788572|NCT01822522|42245633|FG001|Overall Study|Death|0|||
19788573|NCT01822522|42245634|FG002|Overall Study|Death|2|||
19788574|NCT01822522|42245635|FG003|Overall Study|Death|0|||
19788575|NCT01822522|42245636|FG004|Overall Study|Death|0|||
19788576|NCT01822522|42245637|FG005|Overall Study|Death|0|||
19788577|NCT01822522|42245632|FG000|Overall Study|Lost to Follow-up|0|||
19788578|NCT01822522|42245633|FG001|Overall Study|Lost to Follow-up|0|||
19788579|NCT01822522|42245634|FG002|Overall Study|Lost to Follow-up|1|||
19788580|NCT01822522|42245635|FG003|Overall Study|Lost to Follow-up|1|||
19788581|NCT01822522|42245636|FG004|Overall Study|Lost to Follow-up|0|||
19788582|NCT01822522|42245637|FG005|Overall Study|Lost to Follow-up|1|||
19788583|NCT01822522|42245632|FG000|Overall Study|Withdrawal by Subject|0|||
19788584|NCT01822522|42245633|FG001|Overall Study|Withdrawal by Subject|0|||
19788585|NCT01822522|42245634|FG002|Overall Study|Withdrawal by Subject|0|||
19788586|NCT01822522|42245635|FG003|Overall Study|Withdrawal by Subject|1|||
19788587|NCT01822522|42245636|FG004|Overall Study|Withdrawal by Subject|0|||
19788588|NCT01822522|42245637|FG005|Overall Study|Withdrawal by Subject|0|||
19788589|NCT01822522|42245632|FG000|Overall Study|Lack of Efficacy|0|||
19788590|NCT01822522|42245633|FG001|Overall Study|Lack of Efficacy|0|||
19788591|NCT01822522|42245634|FG002|Overall Study|Lack of Efficacy|0|||
19788592|NCT01822522|42245635|FG003|Overall Study|Lack of Efficacy|0|||
19788593|NCT01822522|42245636|FG004|Overall Study|Lack of Efficacy|0|||
19788594|NCT01822522|42245637|FG005|Overall Study|Lack of Efficacy|2|||
19788595|NCT00102687|42245681|FG000|Initial Period|Withdrawal by Subject|6|||
19788596|NCT00102687|42245682|FG001|Initial Period|Withdrawal by Subject|3|||
19788597|NCT00102687|42245683|FG002|Initial Period|Withdrawal by Subject|5|||
19788598|NCT00102687|42245684|FG003|Initial Period|Withdrawal by Subject|0|||
19788599|NCT00102687|42245685|FG004|Initial Period|Withdrawal by Subject|0|||
19788600|NCT00102687|42245681|FG000|Initial Period|Adverse Event|4|||
19788601|NCT00102687|42245682|FG001|Initial Period|Adverse Event|7|||
19788602|NCT00102687|42245683|FG002|Initial Period|Adverse Event|9|||
19788603|NCT00102687|42245684|FG003|Initial Period|Adverse Event|0|||
19788604|NCT00102687|42245685|FG004|Initial Period|Adverse Event|0|||
19788605|NCT00102687|42245681|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
19788606|NCT00102687|42245682|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
19788607|NCT00102687|42245683|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
19788608|NCT00102687|42245684|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
19788609|NCT00102687|42245685|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
19788610|NCT00102687|42245681|FG000|Initial Period|Protocol Violation|0|||
19788611|NCT00102687|42245682|FG001|Initial Period|Protocol Violation|0|||
19788612|NCT00102687|42245683|FG002|Initial Period|Protocol Violation|2|||
19788613|NCT00102687|42245684|FG003|Initial Period|Protocol Violation|0|||
19788614|NCT00102687|42245685|FG004|Initial Period|Protocol Violation|0|||
19788615|NCT00102687|42245681|FG000|Initial Period|Physician Decision|2|||
19788616|NCT00102687|42245682|FG001|Initial Period|Physician Decision|9|||
19788617|NCT00102687|42245683|FG002|Initial Period|Physician Decision|6|||
19788618|NCT00102687|42245684|FG003|Initial Period|Physician Decision|0|||
19788619|NCT00102687|42245685|FG004|Initial Period|Physician Decision|0|||
19788620|NCT00102687|42245681|FG000|Initial Period|Sponsor's decision|0|||
19788621|NCT00102687|42245682|FG001|Initial Period|Sponsor's decision|1|||
19788622|NCT00102687|42245683|FG002|Initial Period|Sponsor's decision|1|||
19788623|NCT00102687|42245684|FG003|Initial Period|Sponsor's decision|0|||
19788624|NCT00102687|42245685|FG004|Initial Period|Sponsor's decision|0|||
19788625|NCT00102687|42245681|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
19788626|NCT00102687|42245682|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
19788627|NCT00102687|42245683|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
19788628|NCT00102687|42245684|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
19788629|NCT00102687|42245685|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
19788630|NCT00102687|42245681|FG000|Initial Period|Death|1|||
19788631|NCT00102687|42245682|FG001|Initial Period|Death|1|||
19788632|NCT00102687|42245683|FG002|Initial Period|Death|1|||
19788633|NCT00102687|42245684|FG003|Initial Period|Death|0|||
19788634|NCT00102687|42245685|FG004|Initial Period|Death|0|||
19788635|NCT00102687|42245681|FG000|Maintenance Period|Withdrawal by Subject|4|||
19788636|NCT00102687|42245682|FG001|Maintenance Period|Withdrawal by Subject|0|||
19788637|NCT00102687|42245683|FG002|Maintenance Period|Withdrawal by Subject|2|||
19788638|NCT00102687|42245684|FG003|Maintenance Period|Withdrawal by Subject|3|||
19788639|NCT00102687|42245685|FG004|Maintenance Period|Withdrawal by Subject|1|||
19788640|NCT00102687|42245681|FG000|Maintenance Period|Adverse Event|1|||
19788641|NCT00102687|42245682|FG001|Maintenance Period|Adverse Event|0|||
19367436|NCT02785939|41607605|FG001|Overall Study|Adverse Event|1|||
19367437|NCT02785939|41607604|FG000|Overall Study|Death|1|||
19367438|NCT02785939|41607605|FG001|Overall Study|Death|0|||
19367439|NCT02785939|41607604|FG000|Overall Study|Refusal|1|||
19788642|NCT00102687|42245683|FG002|Maintenance Period|Adverse Event|0|||
19788643|NCT00102687|42245684|FG003|Maintenance Period|Adverse Event|1|||
19788644|NCT00102687|42245685|FG004|Maintenance Period|Adverse Event|3|||
19367440|NCT02785939|41607605|FG001|Overall Study|Refusal|0|||
19367441|NCT02785939|41607604|FG000|Overall Study|Deteriorating health|1|||
19367442|NCT02785939|41607605|FG001|Overall Study|Deteriorating health|0|||
19367443|NCT02785939|41607604|FG000|Overall Study|Not protocol specified|0|||
19367444|NCT02785939|41607605|FG001|Overall Study|Not protocol specified|1|||
19367445|NCT02634320|41607619|FG000|Overall Study|Adverse Event|2|||
19367446|NCT02634320|41607619|FG000|Overall Study|Lost to Follow-up|3|||
19788645|NCT00102687|42245681|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
19788646|NCT00102687|42245682|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
19788647|NCT00102687|42245683|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
19788648|NCT00102687|42245684|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
19788649|NCT00102687|42245685|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
19788650|NCT00102687|42245681|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
19788651|NCT00102687|42245682|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
19788652|NCT00102687|42245683|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
19788653|NCT00102687|42245684|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
19788654|NCT00102687|42245685|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
19788655|NCT00102687|42245681|FG000|Maintenance Period|Death|0|||
19788656|NCT00102687|42245682|FG001|Maintenance Period|Death|0|||
19788657|NCT00102687|42245683|FG002|Maintenance Period|Death|0|||
19788658|NCT00102687|42245684|FG003|Maintenance Period|Death|1|||
19788659|NCT00102687|42245685|FG004|Maintenance Period|Death|1|||
19788660|NCT00102687|42245681|FG000|Maintenance Period|Physician Decision|1|||
19788661|NCT00102687|42245682|FG001|Maintenance Period|Physician Decision|2|||
19788662|NCT00102687|42245683|FG002|Maintenance Period|Physician Decision|3|||
19788663|NCT00102687|42245684|FG003|Maintenance Period|Physician Decision|0|||
19788664|NCT00102687|42245685|FG004|Maintenance Period|Physician Decision|4|||
19788665|NCT00102531|42245703|FG000|Overall Study|Adverse Event|0|||
19367447|NCT02634320|41607619|FG000|Overall Study|Moved out of area|2|||
19788666|NCT00102531|42245704|FG001|Overall Study|Adverse Event|1|||
19788667|NCT00102531|42245703|FG000|Overall Study|Disease Progression|5|||
19788668|NCT00102531|42245704|FG001|Overall Study|Disease Progression|9|||
19788669|NCT00102531|42245703|FG000|Overall Study|Physician Decision|0|||
19788670|NCT00102531|42245704|FG001|Overall Study|Physician Decision|1|||
19788671|NCT02771145|42245710|FG000|Overall Study|Adverse Event|3|||
19367448|NCT02634320|41607619|FG000|Overall Study|Out of window for study visits|1|||
19788672|NCT02771145|42245710|FG000|Overall Study|Lost to Follow-up|1|||
19367449|NCT02634320|41607619|FG000|Overall Study|Protocol Violation|1|||
19788673|NCT02578186|42245730|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
19788674|NCT02578186|42245731|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
19788675|NCT02578186|42245730|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
19788676|NCT02578186|42245731|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
19788677|NCT00103311|42245739|FG000|Overall Study|Lost to Follow-up|1|||
19788678|NCT00103311|42245740|FG001|Overall Study|Lost to Follow-up|0|||
19788679|NCT00103311|42245739|FG000|Overall Study|Withdrawal by Subject|2|||
19788680|NCT00103311|42245740|FG001|Overall Study|Withdrawal by Subject|1|||
19788681|NCT00103311|42245739|FG000|Overall Study|Adverse Event|1|||
19788682|NCT00103311|42245740|FG001|Overall Study|Adverse Event|0|||
19788683|NCT02576938|42245753|FG000|Overall Study|Adverse Event|5|||
19788684|NCT02576938|42245754|FG001|Overall Study|Adverse Event|3|||
19788685|NCT02576938|42245755|FG002|Overall Study|Adverse Event|6|||
19788686|NCT02576938|42245753|FG000|Overall Study|Protocol Violation|1|||
19788687|NCT02576938|42245754|FG001|Overall Study|Protocol Violation|1|||
19788688|NCT02576938|42245755|FG002|Overall Study|Protocol Violation|1|||
19788689|NCT02576938|42245753|FG000|Overall Study|Withdrawal by Subject|3|||
19788690|NCT02576938|42245754|FG001|Overall Study|Withdrawal by Subject|2|||
19788691|NCT02576938|42245755|FG002|Overall Study|Withdrawal by Subject|4|||
19788692|NCT02576938|42245753|FG000|Overall Study|Lack of Efficacy|9|||
19788693|NCT02576938|42245754|FG001|Overall Study|Lack of Efficacy|4|||
19788694|NCT02576938|42245755|FG002|Overall Study|Lack of Efficacy|0|||
19788695|NCT02576938|42245753|FG000|Overall Study|Lost to Follow-up|2|||
19788696|NCT02576938|42245754|FG001|Overall Study|Lost to Follow-up|0|||
19788697|NCT02576938|42245755|FG002|Overall Study|Lost to Follow-up|1|||
19788698|NCT02576938|42245753|FG000|Overall Study|Physician Decision|0|||
19788699|NCT02576938|42245754|FG001|Overall Study|Physician Decision|1|||
19788700|NCT02576938|42245755|FG002|Overall Study|Physician Decision|0|||
19788701|NCT02576938|42245753|FG000|Overall Study|Met Exclusion Criteria|0|||
19788702|NCT02576938|42245754|FG001|Overall Study|Met Exclusion Criteria|1|||
19788703|NCT02576938|42245755|FG002|Overall Study|Met Exclusion Criteria|0|||
19788704|NCT02576860|42245767|FG000|Overall Study|Adverse Event|6|||
19788705|NCT02576860|42245768|FG001|Overall Study|Adverse Event|6|||
19788706|NCT02576860|42245767|FG000|Overall Study|Lost to Follow-up|5|||
19788707|NCT02576860|42245768|FG001|Overall Study|Lost to Follow-up|7|||
19788708|NCT02576860|42245767|FG000|Overall Study|Physician Decision|0|||
19788709|NCT02576860|42245768|FG001|Overall Study|Physician Decision|1|||
19788710|NCT02576860|42245767|FG000|Overall Study|Protocol Violation|0|||
19788711|NCT02576860|42245768|FG001|Overall Study|Protocol Violation|2|||
19788712|NCT02576860|42245767|FG000|Overall Study|Withdrawal by Subject|13|||
19788713|NCT02576860|42245768|FG001|Overall Study|Withdrawal by Subject|8|||
19788714|NCT02576860|42245767|FG000|Overall Study|Disallowed medication|1|||
19788715|NCT02576860|42245768|FG001|Overall Study|Disallowed medication|0|||
19788716|NCT02572570|42245775|FG000|Overall Study|Study Terminated|27|||
19788717|NCT00709202|42245784|FG000|Overall Study|Withdrawal by Subject|6|||
19788718|NCT00709202|42245785|FG001|Overall Study|Withdrawal by Subject|6|||
19367450|NCT02634320|41607619|FG000|Overall Study|Withdrawal by Subject|5|||
19697784|NCT00265122|42142965|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
19697785|NCT00265122|42142966|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
19697786|NCT00265122|42142967|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
19697787|NCT00265122|42142968|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
19697788|NCT00265122|42142969|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
19697789|NCT00265122|42142964|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
19697790|NCT00265122|42142965|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
19697791|NCT00265122|42142966|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
19697792|NCT00265122|42142967|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
19697793|NCT00265122|42142968|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
19697794|NCT00265122|42142969|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
19697795|NCT00265122|42142964|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
19697796|NCT00265122|42142965|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
19697797|NCT00265122|42142966|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
19697798|NCT00265122|42142967|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
19697799|NCT00265122|42142968|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
19697800|NCT00265122|42142969|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
19697801|NCT00265122|42142964|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
19697802|NCT00265122|42142965|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
19697803|NCT00265122|42142966|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
19697804|NCT00265122|42142967|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
19697805|NCT00265122|42142968|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
19788719|NCT00709124|42245794|FG000|Overall Study|Death|3|||
19788720|NCT00709124|42245795|FG001|Overall Study|Death|1|||
19788721|NCT00709124|42245794|FG000|Overall Study|encephalopathy; can't do assessment|1|||
19788722|NCT00709124|42245795|FG001|Overall Study|encephalopathy; can't do assessment|0|||
19697806|NCT00265122|42142969|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
19697807|NCT00265122|42142964|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
19697808|NCT00265122|42142965|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
19697809|NCT00265122|42142966|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
19697810|NCT00265122|42142967|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
19697811|NCT00265122|42142968|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
19697812|NCT00265122|42142969|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
19697813|NCT00265122|42142964|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
19788723|NCT02738580|42245807|FG000|Overall Study|Adverse Event|1|||
19788724|NCT02738580|42245808|FG001|Overall Study|Adverse Event|0|||
19788725|NCT02738580|42245807|FG000|Overall Study|Lack of Efficacy|3|||
19788726|NCT02738580|42245808|FG001|Overall Study|Lack of Efficacy|2|||
19788727|NCT02738580|42245807|FG000|Overall Study|Withdrawal by Subject|0|||
19788728|NCT02738580|42245808|FG001|Overall Study|Withdrawal by Subject|1|||
19788729|NCT02738580|42245807|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
19788730|NCT02738580|42245808|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
19788731|NCT02571244|42245816|FG000|Overall Study|Lost to Follow-up|0|||
19788732|NCT02571244|42245817|FG001|Overall Study|Lost to Follow-up|1|||
19788733|NCT02571244|42245816|FG000|Overall Study|Unable to reach out post discharge|3|||
19788734|NCT02571244|42245817|FG001|Overall Study|Unable to reach out post discharge|0|||
19788735|NCT02573350|42245828|FG000|Overall Study|Lost to Follow-up|2|||
19788736|NCT02573350|42245829|FG001|Overall Study|Lost to Follow-up|1|||
19788737|NCT02573350|42245828|FG000|Overall Study|Adverse Event|3|||
19788738|NCT02573350|42245829|FG001|Overall Study|Adverse Event|4|||
19788739|NCT02573350|42245828|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
19788740|NCT02573350|42245829|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
19788741|NCT02573350|42245828|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
19788742|NCT02573350|42245829|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
19788743|NCT02573350|42245828|FG000|Overall Study|Subject withdrew consent to participate|6|||
19788744|NCT02573350|42245829|FG001|Overall Study|Subject withdrew consent to participate|1|||
19788745|NCT02573350|42245828|FG000|Overall Study|Protocol Deviation|1|||
19788746|NCT02573350|42245829|FG001|Overall Study|Protocol Deviation|1|||
19788747|NCT01376804|42245838|FG000|Treatment Period|Withdrawal by Subject|1|||
19788748|NCT01376804|42245838|FG000|Treatment Period|Adverse Event|6|||
19788749|NCT01376804|42245838|FG000|Treatment Period|Patient did not receive study drug|1|||
19788750|NCT02574520|42245846|FG000|Overall Study|Not dosed|2|||
19788751|NCT02574520|42245847|FG001|Overall Study|Not dosed|0|||
19788752|NCT02574520|42245848|FG002|Overall Study|Not dosed|5|||
19788753|NCT02574520|42245849|FG003|Overall Study|Not dosed|4|||
19788754|NCT02574520|42245846|FG000|Overall Study|Adverse Event|0|||
19788755|NCT02574520|42245847|FG001|Overall Study|Adverse Event|0|||
19788756|NCT02574520|42245848|FG002|Overall Study|Adverse Event|0|||
19788757|NCT02574520|42245849|FG003|Overall Study|Adverse Event|1|||
19788758|NCT02574520|42245846|FG000|Overall Study|Withdrawal by Subject|0|||
19788759|NCT02574520|42245847|FG001|Overall Study|Withdrawal by Subject|0|||
19788760|NCT02574520|42245848|FG002|Overall Study|Withdrawal by Subject|0|||
19697814|NCT00265122|42142965|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
19697815|NCT00265122|42142966|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
19697816|NCT00265122|42142967|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
19697817|NCT00265122|42142968|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
19697818|NCT00265122|42142969|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
19697819|NCT00116584|42142990|FG000|Overall Study|Withdrawal by Subject|1|||
19697820|NCT00116584|42142991|FG001|Overall Study|Withdrawal by Subject|0|||
19697821|NCT00116584|42142990|FG000|Overall Study|Protocol Violation|1|||
19788761|NCT02574520|42245849|FG003|Overall Study|Withdrawal by Subject|1|||
19788762|NCT02574520|42245846|FG000|Overall Study|Other|0|||
19788763|NCT02574520|42245847|FG001|Overall Study|Other|0|||
19788764|NCT02574520|42245848|FG002|Overall Study|Other|0|||
19788765|NCT02574520|42245849|FG003|Overall Study|Other|2|||
19788766|NCT00709592|42245861|FG000|Overall Study|Unable to proceed to transplant|0|||
19788767|NCT00709592|42245862|FG001|Overall Study|Unable to proceed to transplant|1|||
19788768|NCT02570152|42245868|FG000|Overall Study|Protocol Violation|2|||
19788769|NCT02570152|42245868|FG000|Overall Study|Migrated/moved from study area|13|||
19788770|NCT02570074|42245874|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
19788771|NCT02570074|42245875|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
19788772|NCT02569996|42245893|FG000|Overall Study|Adverse Event|6|||
19788773|NCT02569996|42245893|FG000|Overall Study|Physician Decision|3|||
19788774|NCT02569996|42245893|FG000|Overall Study|Progression of the disease|18|||
19788775|NCT02569996|42245893|FG000|Overall Study|New anti-lymphoma treatment|1|||
19697822|NCT00116584|42142991|FG001|Overall Study|Protocol Violation|1|||
19697823|NCT00096538|42142997|FG000|Overall Study|Withdrawal by Subject|1|||
19788776|NCT02569996|42245893|FG000|Overall Study|Non-compliance|9|||
19788777|NCT02569996|42245893|FG000|Overall Study|Withdrawal by Subject|5|||
19788778|NCT02569996|42245893|FG000|Overall Study|Lost to Follow-up|5|||
19788779|NCT02569996|42245893|FG000|Overall Study|Complete remission|7|||
19788780|NCT02569996|42245893|FG000|Overall Study|Unknown reason|1|||
19788781|NCT02572882|42245897|FG000|Overall Study|Withdrawal by Subject|1|||
19788782|NCT02572882|42245897|FG000|Overall Study|Participant received kidney transplant|1|||
19788783|NCT00708500|42245927|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
19788784|NCT00708500|42245928|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
19788785|NCT00708500|42245929|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
19788786|NCT00708500|42245927|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
19788787|NCT00708500|42245928|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
19788788|NCT00708500|42245929|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
19788789|NCT00708500|42245927|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
19788790|NCT00708500|42245928|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
19788791|NCT00708500|42245929|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
19788792|NCT00708500|42245927|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
19788793|NCT00708500|42245928|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
19788794|NCT00708500|42245929|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
19788795|NCT00708500|42245927|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
19788796|NCT00708500|42245928|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
19788797|NCT00708500|42245929|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
19788798|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
19788799|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
19788800|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
19788801|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
19788802|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
19788803|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
19788804|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
19788805|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
19788806|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
19788807|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
19788808|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
19788809|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
19788810|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
19788811|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
19788812|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
19788813|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
19788814|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
19788815|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
19788816|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
19788817|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
19788818|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
19788819|NCT00708500|42245927|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
19788820|NCT00708500|42245928|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
19788821|NCT00708500|42245929|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
19788822|NCT00708500|42245927|FG000|FOLLOWUP|Adverse Event|0|||
19788823|NCT00708500|42245928|FG001|FOLLOWUP|Adverse Event|1|||
19788824|NCT00708500|42245929|FG002|FOLLOWUP|Adverse Event|0|||
19788825|NCT00708500|42245927|FG000|FOLLOWUP|Lost to Follow-up|1|||
19788826|NCT00708500|42245928|FG001|FOLLOWUP|Lost to Follow-up|6|||
19788827|NCT00708500|42245929|FG002|FOLLOWUP|Lost to Follow-up|4|||
19788828|NCT00708500|42245927|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
19788829|NCT00708500|42245928|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
19788830|NCT00708500|42245929|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
19788831|NCT00708500|42245927|FG000|FOLLOWUP|Subject withdrew consent|31|||
19788832|NCT00708500|42245928|FG001|FOLLOWUP|Subject withdrew consent|4|||
19788833|NCT00708500|42245929|FG002|FOLLOWUP|Subject withdrew consent|5|||
19788834|NCT00708500|42245927|FG000|FOLLOWUP|Non-compliance with protocol|5|||
19788835|NCT00708500|42245928|FG001|FOLLOWUP|Non-compliance with protocol|0|||
19788836|NCT00708500|42245929|FG002|FOLLOWUP|Non-compliance with protocol|1|||
19788837|NCT00708734|42245946|FG000|Overall Study|scheduling conflict|2|||
19788838|NCT00708734|42245946|FG000|Overall Study|moved|1|||
19788839|NCT00708734|42245946|FG000|Overall Study|leg injury|1|||
19788840|NCT00708734|42245946|FG000|Overall Study|knee replacement|1|||
19788841|NCT00708734|42245946|FG000|Overall Study|vertigo|1|||
19788842|NCT00708734|42245946|FG000|Overall Study|leg fracture|1|||
19788843|NCT04834362|42245952|FG000|Overall Study|Death|1|||
19788844|NCT04834362|42245953|FG001|Overall Study|Death|2|||
19788845|NCT00101907|42245982|FG000|Overall Study|Adverse Event|1|||
19788846|NCT00101907|42245983|FG001|Overall Study|Adverse Event|0|||
19367451|NCT02634320|41607619|FG000|Overall Study|Lack of Efficacy|2|||
19788847|NCT00101907|42245984|FG002|Overall Study|Adverse Event|0|||
19788848|NCT00101907|42245985|FG003|Overall Study|Adverse Event|0|||
19788849|NCT00101907|42245986|FG004|Overall Study|Adverse Event|0|||
19788850|NCT00101907|42245987|FG005|Overall Study|Adverse Event|0|||
19788851|NCT00101907|42245982|FG000|Overall Study|Death|0|||
19788852|NCT00101907|42245983|FG001|Overall Study|Death|1|||
19788853|NCT00101907|42245984|FG002|Overall Study|Death|0|||
19788854|NCT00101907|42245985|FG003|Overall Study|Death|0|||
19788855|NCT00101907|42245986|FG004|Overall Study|Death|3|||
19788856|NCT00101907|42245987|FG005|Overall Study|Death|0|||
19788857|NCT00101907|42245982|FG000|Overall Study|Physician Decision|0|||
19788858|NCT00101907|42245983|FG001|Overall Study|Physician Decision|0|||
19788859|NCT00101907|42245984|FG002|Overall Study|Physician Decision|0|||
19788860|NCT00101907|42245985|FG003|Overall Study|Physician Decision|1|||
19788861|NCT00101907|42245986|FG004|Overall Study|Physician Decision|1|||
19788862|NCT00101907|42245987|FG005|Overall Study|Physician Decision|0|||
19788863|NCT00101907|42245982|FG000|Overall Study|Withdrawal by Subject|1|||
19788864|NCT00101907|42245983|FG001|Overall Study|Withdrawal by Subject|0|||
19788865|NCT00101907|42245984|FG002|Overall Study|Withdrawal by Subject|1|||
19788866|NCT00101907|42245985|FG003|Overall Study|Withdrawal by Subject|0|||
19788867|NCT00101907|42245986|FG004|Overall Study|Withdrawal by Subject|1|||
19788868|NCT00101907|42245987|FG005|Overall Study|Withdrawal by Subject|0|||
19788869|NCT02565784|42246008|FG000|First Treatment|Adverse Event|1|||
19788870|NCT02565784|42246008|FG000|First Treatment|Withdrawal by Subject|1|||
19788871|NCT02565784|42246008|FG000|Second Treatment|Withdrawal by Subject|2|||
19788872|NCT02761629|42246042|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
19788873|NCT02761629|42246043|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
19788874|NCT02761629|42246042|FG000|Overall Study|Insufficient Therapeutic Response|2|||
19788875|NCT02761629|42246043|FG001|Overall Study|Insufficient Therapeutic Response|7|||
19788876|NCT02761629|42246042|FG000|Overall Study|Failure to Return|2|||
19788877|NCT02761629|42246043|FG001|Overall Study|Failure to Return|4|||
19788878|NCT02761629|42246042|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
19788879|NCT02761629|42246043|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
19788880|NCT02761629|42246042|FG000|Overall Study|Protocol Violation|2|||
19788881|NCT02761629|42246043|FG001|Overall Study|Protocol Violation|2|||
19788882|NCT02761629|42246042|FG000|Overall Study|Withdrawal by Subject|0|||
19788883|NCT02761629|42246043|FG001|Overall Study|Withdrawal by Subject|3|||
19788884|NCT02761629|42246042|FG000|Overall Study|Other|0|||
19788885|NCT02761629|42246043|FG001|Overall Study|Other|2|||
19788886|NCT02761629|42246042|FG000|Overall Study|Lost to Follow-up|4|||
19788887|NCT02761629|42246043|FG001|Overall Study|Lost to Follow-up|1|||
19788888|NCT02761629|42246042|FG000|Overall Study|Randomized But Not Treated|8|||
19788889|NCT02761629|42246043|FG001|Overall Study|Randomized But Not Treated|4|||
19788890|NCT02760927|42246049|FG000|Overall Study|Tube Slippage from Device|1|||
19788891|NCT00101439|42246055|FG000|Period 2|Withdrawal by Subject|0|||
19788892|NCT00101439|42246056|FG001|Period 2|Withdrawal by Subject|2|||
19788893|NCT04033068|42246066|FG000|Overall Study|Withdrawal by Subject|0|||
19788894|NCT04033068|42246067|FG001|Overall Study|Withdrawal by Subject|0|||
19788895|NCT04033068|42246068|FG002|Overall Study|Withdrawal by Subject|1|||
19788896|NCT04033068|42246069|FG003|Overall Study|Withdrawal by Subject|0|||
19788897|NCT04033068|42246066|FG000|Overall Study|Lost to Follow-up|0|||
19788898|NCT04033068|42246067|FG001|Overall Study|Lost to Follow-up|1|||
19788899|NCT04033068|42246068|FG002|Overall Study|Lost to Follow-up|0|||
19788900|NCT04033068|42246069|FG003|Overall Study|Lost to Follow-up|0|||
19788901|NCT04033068|42246066|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
19788902|NCT04033068|42246067|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
19788903|NCT04033068|42246068|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
19788904|NCT04033068|42246069|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
19788905|NCT00101283|42246081|FG000|Overall Study|Withdrawal by Subject|0|||
19788906|NCT00101283|42246082|FG001|Overall Study|Withdrawal by Subject|1|||
19788907|NCT00101283|42246081|FG000|Overall Study|Insurance Refusal|0|||
19788908|NCT00101283|42246082|FG001|Overall Study|Insurance Refusal|1|||
19788909|NCT00101283|42246081|FG000|Overall Study|Prostate Cancer Recurrence|0|||
19788910|NCT00101283|42246082|FG001|Overall Study|Prostate Cancer Recurrence|1|||
19788911|NCT02762565|42246088|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
19788912|NCT02757963|42246101|FG000|Overall Study|Adverse Event|3|||
19788913|NCT02757963|42246101|FG000|Overall Study|Reached Stopping Criteria|1054|||
19788914|NCT02757963|42246101|FG000|Overall Study|Lost to Follow-up|5|||
19788915|NCT02757963|42246101|FG000|Overall Study|Physician Decision|1|||
19788916|NCT02757963|42246101|FG000|Overall Study|Withdrawal by Subject|34|||
19788917|NCT03111732|42246116|FG000|Overall Study|Enrolled in different study|1|||
19788918|NCT03111732|42246116|FG000|Overall Study|Progressive disease|3|||
19788919|NCT03111732|42246116|FG000|Overall Study|Withdrawal by Subject|1|||
19788920|NCT01663714|42246125|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
19788921|NCT01663714|42246125|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
19788922|NCT01663714|42246125|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
19788923|NCT01663714|42246125|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
19788924|NCT01663714|42246125|FG000|Long-Term Follow-Up|Death|4|||
19788925|NCT01663714|42246125|FG000|Long-Term Follow-Up|Non-compliance|1|||
19788926|NCT01663636|42246147|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
19788927|NCT01663636|42246148|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
19788928|NCT03065244|42246156|FG000|Overall Study|Lost to Follow-up|1|||
19788929|NCT03065244|42246157|FG001|Overall Study|Lost to Follow-up|1|||
19788930|NCT03065244|42246156|FG000|Overall Study|Diagnosed with a different disease|1|||
19788931|NCT03065244|42246157|FG001|Overall Study|Diagnosed with a different disease|1|||
19788932|NCT03065244|42246156|FG000|Overall Study|Protocol Violation|0|||
19788933|NCT03065244|42246157|FG001|Overall Study|Protocol Violation|1|||
19788934|NCT03065244|42246156|FG000|Overall Study|Withdrawal by Subject|1|||
19788935|NCT03065244|42246157|FG001|Overall Study|Withdrawal by Subject|1|||
19788936|NCT00100815|42246163|FG000|Overall Study|Progression|24|||
19788937|NCT00100815|42246163|FG000|Overall Study|Adverse Event|18|||
19788938|NCT00100815|42246163|FG000|Overall Study|Death|4|||
19788939|NCT00100815|42246163|FG000|Overall Study|Other|3|||
19788940|NCT00708422|42246169|FG000|Overall Study|Adverse Event|3|||
19788941|NCT00708422|42246170|FG001|Overall Study|Adverse Event|1|||
19788942|NCT00708422|42246169|FG000|Overall Study|Withdrawal by Subject|1|||
19788943|NCT00708422|42246170|FG001|Overall Study|Withdrawal by Subject|0|||
19697824|NCT00239928|42143001|FG000|Overall Study|Lack of Efficacy|1|||
19697825|NCT00239928|42143001|FG000|Overall Study|Adverse Event|4|||
19697826|NCT00239928|42143001|FG000|Overall Study|Not need to continue study|3|||
19697827|NCT00239928|42143001|FG000|Overall Study|Withdrawal by Subject|2|||
19697828|NCT00116428|42143007|FG000|Overall Study|Withdrawal by Subject|2|||
19697829|NCT00116428|42143008|FG001|Overall Study|Withdrawal by Subject|5|||
19697830|NCT00116428|42143007|FG000|Overall Study|Did not meet inclusion criteria|1|||
19697831|NCT00116428|42143008|FG001|Overall Study|Did not meet inclusion criteria|0|||
19788944|NCT02760069|42246179|FG000|Overall Study|Withdrawal by Subject|0|||
19788945|NCT02760069|42246180|FG001|Overall Study|Withdrawal by Subject|1|||
19788946|NCT02760069|42246181|FG002|Overall Study|Withdrawal by Subject|1|||
19788947|NCT00707486|42246189|FG000|Overall Study|Withdrawal by Subject|1|||
19788948|NCT02759055|42246197|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
19788949|NCT02759055|42246198|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
19788950|NCT04634253|42246207|FG000|Overall Study|Adverse Event|1|||
19788951|NCT04634253|42246208|FG001|Overall Study|Adverse Event|1|||
19788952|NCT04634253|42246209|FG002|Overall Study|Adverse Event|0|||
19788953|NCT04634253|42246207|FG000|Overall Study|Physician Decision|0|||
19788954|NCT04634253|42246208|FG001|Overall Study|Physician Decision|1|||
19788955|NCT04634253|42246209|FG002|Overall Study|Physician Decision|0|||
19788956|NCT04634253|42246207|FG000|Overall Study|Withdrawal by Subject|1|||
19788957|NCT04634253|42246208|FG001|Overall Study|Withdrawal by Subject|0|||
19788958|NCT04634253|42246209|FG002|Overall Study|Withdrawal by Subject|3|||
19788959|NCT02756637|42246221|FG000|Overall Study|Not eligible for initial SWOG study|10|||
19788960|NCT02756637|42246222|FG001|Overall Study|Not eligible for initial SWOG study|10|||
19788961|NCT02756637|42246221|FG000|Overall Study|No available NLR value|44|||
19788962|NCT02756637|42246222|FG001|Overall Study|No available NLR value|44|||
19788963|NCT02756637|42246221|FG000|Overall Study|Did not complete curative therapy|33|||
19788964|NCT02756637|42246222|FG001|Overall Study|Did not complete curative therapy|0|||
19788965|NCT00708032|42246230|FG000|Overall Study|Adverse Event|0|||
19788966|NCT00708032|42246231|FG001|Overall Study|Adverse Event|2|||
19788967|NCT00708032|42246230|FG000|Overall Study|Lost to Follow-up|1|||
19788968|NCT00708032|42246231|FG001|Overall Study|Lost to Follow-up|2|||
19788969|NCT00708032|42246230|FG000|Overall Study|Pregnancy|0|||
19788970|NCT00708032|42246231|FG001|Overall Study|Pregnancy|1|||
19788971|NCT00708032|42246230|FG000|Overall Study|Poor vision|0|||
19788972|NCT00708032|42246231|FG001|Overall Study|Poor vision|6|||
19788973|NCT00708032|42246230|FG000|Overall Study|Visit out of range at month 12|4|||
19788974|NCT00708032|42246231|FG001|Overall Study|Visit out of range at month 12|1|||
19788975|NCT00708032|42246230|FG000|Overall Study|Did not meet protocol criteria|1|||
19788976|NCT00708032|42246231|FG001|Overall Study|Did not meet protocol criteria|2|||
19788977|NCT00708032|42246230|FG000|Overall Study|Protocol Violation|4|||
19788978|NCT00708032|42246231|FG001|Overall Study|Protocol Violation|1|||
19788979|NCT00708032|42246230|FG000|Overall Study|Withdrawal by Subject|0|||
19788980|NCT00708032|42246231|FG001|Overall Study|Withdrawal by Subject|1|||
19788981|NCT00707174|42246239|FG000|Overall Study|Adverse Event|1|||
19367452|NCT02435680|41607626|FG000|Overall Study|Physician Decision|3|||
19697832|NCT00468845|42143020|FG000|Overall Study|Adverse Event|9|||
19697833|NCT00468845|42143021|FG001|Overall Study|Adverse Event|14|||
19788982|NCT00707174|42246240|FG001|Overall Study|Adverse Event|6|||
19788983|NCT00707174|42246239|FG000|Overall Study|Withdrawal by Subject|4|||
19788984|NCT00707174|42246240|FG001|Overall Study|Withdrawal by Subject|1|||
19788985|NCT02756403|42246250|FG000|Overall Study|Unable to swallow medication|0|||
19367453|NCT02435680|41607627|FG001|Overall Study|Physician Decision|0|||
19697834|NCT00468845|42143022|FG002|Overall Study|Adverse Event|11|||
19788986|NCT02756403|42246251|FG001|Overall Study|Unable to swallow medication|1|||
19788987|NCT02756403|42246252|FG002|Overall Study|Unable to swallow medication|1|||
19788988|NCT02756403|42246253|FG003|Overall Study|Unable to swallow medication|1|||
19788989|NCT02756403|42246250|FG000|Overall Study|Did not complete Procedure|0|||
19788990|NCT02756403|42246251|FG001|Overall Study|Did not complete Procedure|1|||
19788991|NCT02756403|42246252|FG002|Overall Study|Did not complete Procedure|0|||
19788992|NCT02756403|42246253|FG003|Overall Study|Did not complete Procedure|0|||
19788993|NCT02756403|42246250|FG000|Overall Study|Changed Mind About Procedure|0|||
19788994|NCT02756403|42246251|FG001|Overall Study|Changed Mind About Procedure|0|||
19788995|NCT02756403|42246252|FG002|Overall Study|Changed Mind About Procedure|1|||
19788996|NCT02756403|42246253|FG003|Overall Study|Changed Mind About Procedure|0|||
19788997|NCT02756403|42246250|FG000|Overall Study|Protocol Violation|0|||
19788998|NCT02756403|42246251|FG001|Overall Study|Protocol Violation|1|||
19788999|NCT02756403|42246252|FG002|Overall Study|Protocol Violation|0|||
19789000|NCT02756403|42246253|FG003|Overall Study|Protocol Violation|1|||
19789001|NCT02753595|42246265|FG000|Overall Study|Sponsor termination|2|||
19789002|NCT02753595|42246266|FG001|Overall Study|Sponsor termination|2|||
19789003|NCT00707954|42246289|FG000|Overall Study|Physician Decision|0|||
19789004|NCT00707954|42246290|FG001|Overall Study|Physician Decision|0|||
19789005|NCT00707954|42246291|FG002|Overall Study|Physician Decision|0|||
19789006|NCT00707954|42246292|FG003|Overall Study|Physician Decision|0|||
19789007|NCT00707954|42246293|FG004|Overall Study|Physician Decision|1|||
19789008|NCT02561962|42246314|FG000|Overall Study|Ongoing in study|1|||
19789009|NCT02561962|42246315|FG001|Overall Study|Ongoing in study|0|||
19789010|NCT02561962|42246316|FG002|Overall Study|Ongoing in study|0|||
19789011|NCT02561962|42246317|FG003|Overall Study|Ongoing in study|1|||
19789012|NCT02561962|42246318|FG004|Overall Study|Ongoing in study|0|||
19789013|NCT02561962|42246319|FG005|Overall Study|Ongoing in study|1|||
19789014|NCT02561962|42246320|FG006|Overall Study|Ongoing in study|0|||
19789015|NCT02561962|42246321|FG007|Overall Study|Ongoing in study|4|||
19789016|NCT02561962|42246322|FG008|Overall Study|Ongoing in study|1|||
19789017|NCT02561962|42246314|FG000|Overall Study|Withdrawal by Subject|1|||
19789018|NCT02561962|42246315|FG001|Overall Study|Withdrawal by Subject|0|||
19789019|NCT02561962|42246316|FG002|Overall Study|Withdrawal by Subject|0|||
19789020|NCT02561962|42246317|FG003|Overall Study|Withdrawal by Subject|0|||
19697835|NCT00468845|42143020|FG000|Overall Study|Lost to Follow-up|2|||
19697836|NCT00468845|42143021|FG001|Overall Study|Lost to Follow-up|1|||
19789021|NCT02561962|42246318|FG004|Overall Study|Withdrawal by Subject|1|||
19789022|NCT02561962|42246319|FG005|Overall Study|Withdrawal by Subject|1|||
19789023|NCT02561962|42246320|FG006|Overall Study|Withdrawal by Subject|2|||
19789024|NCT02561962|42246321|FG007|Overall Study|Withdrawal by Subject|1|||
19477863|NCT01505647|41757140|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
19697837|NCT00468845|42143022|FG002|Overall Study|Lost to Follow-up|2|||
19697838|NCT00468845|42143020|FG000|Overall Study|Other|4|||
19697839|NCT00468845|42143021|FG001|Overall Study|Other|9|||
19697840|NCT00468845|42143022|FG002|Overall Study|Other|5|||
19697841|NCT00468845|42143020|FG000|Overall Study|No longer willing to participate|5|||
19697842|NCT00468845|42143021|FG001|Overall Study|No longer willing to participate|6|||
19697843|NCT00468845|42143022|FG002|Overall Study|No longer willing to participate|10|||
19697844|NCT00468845|42143020|FG000|Overall Study|Randomized, not treated|1|||
19697845|NCT00468845|42143021|FG001|Overall Study|Randomized, not treated|4|||
19697846|NCT00468845|42143022|FG002|Overall Study|Randomized, not treated|2|||
19697847|NCT00468299|42143032|FG000|Overall Study|Withdrawal by Subject|0|||
19697848|NCT00468299|42143033|FG001|Overall Study|Withdrawal by Subject|1|||
19697849|NCT00468143|42143041|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
19697850|NCT00468143|42143042|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
19697851|NCT00468143|42143041|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
19697852|NCT00468143|42143042|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
19697853|NCT00467831|42143048|FG000|Overall Study|Death|2|||
19697854|NCT00467831|42143048|FG000|Overall Study|Withdrawal by Subject|1|||
19697855|NCT00467753|42143054|FG000|Overall Study|Lost to Follow-up|1|||
19697856|NCT00467753|42143055|FG001|Overall Study|Lost to Follow-up|2|||
19697857|NCT00467753|42143054|FG000|Overall Study|Adverse Event|2|||
19697858|NCT00467753|42143055|FG001|Overall Study|Adverse Event|0|||
19477864|NCT01505647|41757141|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
19697859|NCT00116272|42143067|FG000|Overall Study|Lost to Follow-up|11|||
19697860|NCT00116272|42143068|FG001|Overall Study|Lost to Follow-up|6|||
19697861|NCT00467597|42143080|FG000|Overall Study|Withdrawal by Subject|2|||
19697862|NCT00467597|42143081|FG001|Overall Study|Withdrawal by Subject|0|||
19697863|NCT00115804|42143091|FG000|Overall Study|Adverse Event|2|||
19789025|NCT02561962|42246322|FG008|Overall Study|Withdrawal by Subject|0|||
19789026|NCT02561962|42246314|FG000|Overall Study|Decision by sponsor|0|||
19789027|NCT02561962|42246315|FG001|Overall Study|Decision by sponsor|0|||
19789028|NCT02561962|42246316|FG002|Overall Study|Decision by sponsor|0|||
19789029|NCT02561962|42246317|FG003|Overall Study|Decision by sponsor|0|||
19789030|NCT02561962|42246318|FG004|Overall Study|Decision by sponsor|1|||
19789031|NCT02561962|42246319|FG005|Overall Study|Decision by sponsor|1|||
19789032|NCT02561962|42246320|FG006|Overall Study|Decision by sponsor|0|||
19789033|NCT02561962|42246321|FG007|Overall Study|Decision by sponsor|3|||
19789034|NCT02561962|42246322|FG008|Overall Study|Decision by sponsor|0|||
19789035|NCT02561962|42246314|FG000|Overall Study|Lost to Follow-up|0|||
19789036|NCT02561962|42246315|FG001|Overall Study|Lost to Follow-up|0|||
19789037|NCT02561962|42246316|FG002|Overall Study|Lost to Follow-up|0|||
19789038|NCT02561962|42246317|FG003|Overall Study|Lost to Follow-up|0|||
19789039|NCT02561962|42246318|FG004|Overall Study|Lost to Follow-up|0|||
19789040|NCT02561962|42246319|FG005|Overall Study|Lost to Follow-up|1|||
19789041|NCT02561962|42246320|FG006|Overall Study|Lost to Follow-up|0|||
19789042|NCT02561962|42246321|FG007|Overall Study|Lost to Follow-up|0|||
19789043|NCT02561962|42246322|FG008|Overall Study|Lost to Follow-up|0|||
19789044|NCT02565706|42246346|FG000|Overall Study|Withdrawal by Subject|5|||
19789045|NCT02565706|42246347|FG001|Overall Study|Withdrawal by Subject|7|||
19789046|NCT02565706|42246348|FG002|Overall Study|Withdrawal by Subject|7|||
19789047|NCT02565706|42246349|FG003|Overall Study|Withdrawal by Subject|11|||
19789048|NCT02565706|42246346|FG000|Overall Study|Lost to Follow-up|72|||
19789049|NCT02565706|42246347|FG001|Overall Study|Lost to Follow-up|75|||
19789050|NCT02565706|42246348|FG002|Overall Study|Lost to Follow-up|82|||
19789051|NCT02565706|42246349|FG003|Overall Study|Lost to Follow-up|74|||
19789052|NCT00706628|42246368|FG000|Overall Study|Other Adverse Event|16|||
19789053|NCT00706628|42246369|FG001|Overall Study|Other Adverse Event|5|||
19789054|NCT00706628|42246370|FG002|Overall Study|Other Adverse Event|5|||
19789055|NCT00706628|42246371|FG003|Overall Study|Other Adverse Event|2|||
19789056|NCT00706628|42246368|FG000|Overall Study|Non compliant with protocol|0|||
19789057|NCT00706628|42246369|FG001|Overall Study|Non compliant with protocol|1|||
19789058|NCT00706628|42246370|FG002|Overall Study|Non compliant with protocol|0|||
19789059|NCT00706628|42246371|FG003|Overall Study|Non compliant with protocol|0|||
19789060|NCT00706628|42246368|FG000|Overall Study|Consent withdrawn|6|||
19789061|NCT00706628|42246369|FG001|Overall Study|Consent withdrawn|1|||
19789062|NCT00706628|42246370|FG002|Overall Study|Consent withdrawn|3|||
19789063|NCT00706628|42246371|FG003|Overall Study|Consent withdrawn|0|||
19789064|NCT00706628|42246368|FG000|Overall Study|Progressive disease|20|||
19789065|NCT00706628|42246369|FG001|Overall Study|Progressive disease|13|||
19789066|NCT00706628|42246370|FG002|Overall Study|Progressive disease|8|||
19789067|NCT00706628|42246371|FG003|Overall Study|Progressive disease|1|||
19789068|NCT00706628|42246368|FG000|Overall Study|Other than those stated above|4|||
19789069|NCT00706628|42246369|FG001|Overall Study|Other than those stated above|0|||
19789070|NCT00706628|42246370|FG002|Overall Study|Other than those stated above|0|||
19789071|NCT00706628|42246371|FG003|Overall Study|Other than those stated above|0|||
19789072|NCT00706628|42246368|FG000|Overall Study|Not treated|1|||
19789073|NCT00706628|42246369|FG001|Overall Study|Not treated|1|||
19789074|NCT00706628|42246370|FG002|Overall Study|Not treated|0|||
19789075|NCT00706628|42246371|FG003|Overall Study|Not treated|0|||
19789076|NCT02561806|42246386|FG000|Induction Period|Adverse Event|0|||
19789077|NCT02561806|42246387|FG001|Induction Period|Adverse Event|2|||
19789078|NCT02561806|42246386|FG000|Induction Period|Lack of Efficacy|1|||
19789079|NCT02561806|42246387|FG001|Induction Period|Lack of Efficacy|0|||
19789080|NCT02561806|42246386|FG000|Induction Period|Withdrawal by Subject|0|||
19789081|NCT02561806|42246387|FG001|Induction Period|Withdrawal by Subject|2|||
19789082|NCT02561806|42246386|FG000|Induction Period|Site staff became unblinded|1|||
19789083|NCT02561806|42246387|FG001|Induction Period|Site staff became unblinded|0|||
19789084|NCT02561806|42246386|FG000|Induction Period|Randomized but not treated|0|||
19789085|NCT02561806|42246387|FG001|Induction Period|Randomized but not treated|1|||
19789086|NCT02561806|42246386|FG000|Maintenance Period|Adverse Event|2|||
19789087|NCT02561806|42246387|FG001|Maintenance Period|Adverse Event|1|||
19789088|NCT02561806|42246386|FG000|Maintenance Period|Lack of Efficacy|3|||
19789089|NCT02561806|42246387|FG001|Maintenance Period|Lack of Efficacy|1|||
19789090|NCT02561806|42246386|FG000|Maintenance Period|Lost to Follow-up|2|||
19789091|NCT02561806|42246387|FG001|Maintenance Period|Lost to Follow-up|2|||
19789092|NCT02561806|42246386|FG000|Maintenance Period|Protocol Violation|1|||
19789093|NCT02561806|42246387|FG001|Maintenance Period|Protocol Violation|0|||
19789094|NCT02561806|42246386|FG000|Maintenance Period|Withdrawal by Subject|5|||
19789095|NCT02561806|42246387|FG001|Maintenance Period|Withdrawal by Subject|3|||
19789096|NCT02561806|42246386|FG000|Maintenance Period|Site staff became unblinded|0|||
19789097|NCT02561806|42246387|FG001|Maintenance Period|Site staff became unblinded|1|||
19789098|NCT02561806|42246386|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
19789099|NCT02561806|42246387|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
19789100|NCT02561806|42246386|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
19789101|NCT02561806|42246387|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
19789102|NCT02561572|42246410|FG000|Overall Study|Inadequate time before surgery|2|||
19789103|NCT02561572|42246411|FG001|Overall Study|Inadequate time before surgery|1|||
19789104|NCT02561572|42246410|FG000|Overall Study|Protocol Violation|0|||
19789105|NCT02561572|42246411|FG001|Overall Study|Protocol Violation|1|||
19789106|NCT02180217|42246420|FG000|Overall Study|Adverse Event|3|||
19789107|NCT02180217|42246421|FG001|Overall Study|Adverse Event|2|||
19789108|NCT02180217|42246422|FG002|Overall Study|Adverse Event|22|||
19789109|NCT02180217|42246420|FG000|Overall Study|Death|1|||
19789110|NCT02180217|42246421|FG001|Overall Study|Death|1|||
19789111|NCT02180217|42246422|FG002|Overall Study|Death|0|||
19789112|NCT02180217|42246420|FG000|Overall Study|Withdrawal by Subject|1|||
19789113|NCT02180217|42246421|FG001|Overall Study|Withdrawal by Subject|1|||
19789114|NCT02180217|42246422|FG002|Overall Study|Withdrawal by Subject|4|||
19789115|NCT02180217|42246420|FG000|Overall Study|Subject/Guardian decision|5|||
19789116|NCT02180217|42246421|FG001|Overall Study|Subject/Guardian decision|3|||
19789117|NCT02180217|42246422|FG002|Overall Study|Subject/Guardian decision|6|||
19789118|NCT02180217|42246420|FG000|Overall Study|Physician Decision|1|||
19789119|NCT02180217|42246421|FG001|Overall Study|Physician Decision|1|||
19789120|NCT02180217|42246422|FG002|Overall Study|Physician Decision|6|||
19789121|NCT02180217|42246420|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19789122|NCT02180217|42246421|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19789123|NCT02180217|42246422|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19789124|NCT02560558|42246439|FG000|Overall Study|Adverse Event|1|||
19789125|NCT02560558|42246440|FG001|Overall Study|Adverse Event|0|||
19789126|NCT02560558|42246439|FG000|Overall Study|Death|0|||
19789127|NCT02560558|42246440|FG001|Overall Study|Death|2|||
19789128|NCT02560558|42246439|FG000|Overall Study|Lost to Follow-up|0|||
19789129|NCT02560558|42246440|FG001|Overall Study|Lost to Follow-up|4|||
19789130|NCT02560558|42246439|FG000|Overall Study|Protocol Violation|3|||
19789131|NCT02560558|42246440|FG001|Overall Study|Protocol Violation|0|||
19789132|NCT02560558|42246439|FG000|Overall Study|Withdrawal by Subject|3|||
19789133|NCT02560558|42246440|FG001|Overall Study|Withdrawal by Subject|0|||
19789134|NCT02568046|42246448|FG000|Overall Study|Adverse Event|0|||
19789135|NCT02568046|42246449|FG001|Overall Study|Adverse Event|1|||
19789136|NCT02568046|42246448|FG000|Overall Study|Death|2|||
19789137|NCT02568046|42246449|FG001|Overall Study|Death|0|||
19789138|NCT02568046|42246448|FG000|Overall Study|Progressive Disease|1|||
19789139|NCT02568046|42246449|FG001|Overall Study|Progressive Disease|0|||
19789140|NCT02568046|42246448|FG000|Overall Study|Withdrawal by Subject|2|||
19789141|NCT02568046|42246449|FG001|Overall Study|Withdrawal by Subject|1|||
19789142|NCT02568046|42246448|FG000|Overall Study|Other Events|0|||
19789143|NCT02568046|42246449|FG001|Overall Study|Other Events|1|||
19789144|NCT02567656|42246461|FG000|Overall Study|Premature discontinuation due to PD|1|||
19789145|NCT02567656|42246462|FG001|Overall Study|Premature discontinuation due to PD|1|||
19789146|NCT02567656|42246463|FG002|Overall Study|Premature discontinuation due to PD|2|||
19789147|NCT02567656|42246464|FG003|Overall Study|Premature discontinuation due to PD|0|||
19789148|NCT02567656|42246465|FG004|Overall Study|Premature discontinuation due to PD|0|||
19789149|NCT02567656|42246466|FG005|Overall Study|Premature discontinuation due to PD|0|||
19789150|NCT02560012|42246480|FG000|Overall Study|Study Terminated|2|||
19789151|NCT02567266|42246487|FG000|Overall Study|Withdrawal by Subject|10|||
19789152|NCT02567266|42246488|FG001|Overall Study|Withdrawal by Subject|7|||
19789153|NCT02567266|42246489|FG002|Overall Study|Withdrawal by Subject|6|||
19789154|NCT02567266|42246487|FG000|Overall Study|Lost to Follow-up|13|||
19789155|NCT02567266|42246488|FG001|Overall Study|Lost to Follow-up|8|||
19789156|NCT02567266|42246489|FG002|Overall Study|Lost to Follow-up|10|||
19789157|NCT02567188|42246497|FG000|Overall Study|Death|10|||
19789158|NCT02567188|42246497|FG000|Overall Study|Terminated Mircera Treatment|9|||
19789159|NCT02567188|42246497|FG000|Overall Study|Lost to Follow-up|5|||
19789160|NCT02567188|42246497|FG000|Overall Study|Adverse Event|1|||
19789161|NCT02567188|42246497|FG000|Overall Study|Withdrawal by Subject|1|||
19789162|NCT02567188|42246497|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
19789163|NCT02567188|42246497|FG000|Overall Study|Moved and Changed Clinic|1|||
19789164|NCT02567188|42246497|FG000|Overall Study|Started Hemodialysis|2|||
19789165|NCT02567188|42246497|FG000|Overall Study|Protocol Violation|5|||
19789166|NCT00706238|42246502|FG000|Overall Study|Disease progression|4|||
19789167|NCT00706238|42246502|FG000|Overall Study|Other|1|||
19789168|NCT04649164|42246509|FG000|Overall Study|Withdrawal by Subject|1|||
19789169|NCT04649164|42246510|FG001|Overall Study|Withdrawal by Subject|1|||
19789170|NCT04649164|42246511|FG002|Overall Study|Withdrawal by Subject|2|||
19789171|NCT04649164|42246509|FG000|Overall Study|Participant's care recipient expired|0|||
19789172|NCT04649164|42246510|FG001|Overall Study|Participant's care recipient expired|0|||
19789173|NCT04649164|42246511|FG002|Overall Study|Participant's care recipient expired|2|||
19789174|NCT02753127|42246521|FG000|Overall Study|Lost to Follow-up|13|||
19789175|NCT02753127|42246522|FG001|Overall Study|Lost to Follow-up|11|||
19789176|NCT02753127|42246521|FG000|Overall Study|Withdrawal by Subject|37|||
19789177|NCT02753127|42246522|FG001|Overall Study|Withdrawal by Subject|47|||
19789178|NCT02753127|42246521|FG000|Overall Study|Other|3|||
19789179|NCT02753127|42246522|FG001|Overall Study|Other|8|||
19789180|NCT02753127|42246521|FG000|Overall Study|Hospice|0|||
19367454|NCT02435680|41607628|FG002|Overall Study|Physician Decision|0|||
19789181|NCT02753127|42246522|FG001|Overall Study|Hospice|2|||
19789182|NCT00706004|42246554|FG000|Overall Study|Did not meet eligibility criteria|2|||
19789183|NCT02724644|42246561|FG000|Overall Study|Adverse Event|7|||
19789184|NCT02724644|42246562|FG001|Overall Study|Adverse Event|1|||
19789185|NCT02724644|42246561|FG000|Overall Study|Lost to Follow-up|6|||
19789186|NCT02724644|42246562|FG001|Overall Study|Lost to Follow-up|2|||
19789187|NCT02724644|42246561|FG000|Overall Study|Withdrawal by Subject|7|||
19789188|NCT02724644|42246562|FG001|Overall Study|Withdrawal by Subject|1|||
19789189|NCT02724644|42246561|FG000|Overall Study|Administrative|1|||
19789190|NCT02724644|42246562|FG001|Overall Study|Administrative|0|||
19789191|NCT02725268|42246572|FG000|Overall Study|Death|58|||
19789192|NCT02725268|42246573|FG001|Overall Study|Death|59|||
19789193|NCT02725268|42246574|FG002|Overall Study|Death|30|||
19789194|NCT02725268|42246575|FG003|Overall Study|Death|16|||
19789195|NCT02725268|42246572|FG000|Overall Study|Lost to Follow-up|4|||
19789196|NCT02725268|42246573|FG001|Overall Study|Lost to Follow-up|3|||
19789197|NCT02725268|42246574|FG002|Overall Study|Lost to Follow-up|0|||
19789198|NCT02725268|42246575|FG003|Overall Study|Lost to Follow-up|1|||
19789199|NCT02725268|42246572|FG000|Overall Study|Site Terminated by Sponsor|0|||
19789200|NCT02725268|42246573|FG001|Overall Study|Site Terminated by Sponsor|1|||
19789201|NCT02725268|42246574|FG002|Overall Study|Site Terminated by Sponsor|0|||
19789202|NCT02725268|42246575|FG003|Overall Study|Site Terminated by Sponsor|0|||
19789203|NCT02725268|42246572|FG000|Overall Study|Withdrawal by Subject|8|||
19789204|NCT02725268|42246573|FG001|Overall Study|Withdrawal by Subject|6|||
19789205|NCT02725268|42246574|FG002|Overall Study|Withdrawal by Subject|8|||
19789206|NCT02725268|42246575|FG003|Overall Study|Withdrawal by Subject|1|||
19789207|NCT02725268|42246572|FG000|Overall Study|Reason not Specified|2|||
19789208|NCT02725268|42246573|FG001|Overall Study|Reason not Specified|1|||
19789209|NCT02725268|42246574|FG002|Overall Study|Reason not Specified|0|||
19789210|NCT02725268|42246575|FG003|Overall Study|Reason not Specified|0|||
19789211|NCT02724956|42246587|FG000|Overall Study|Physician Decision|1|||
19789212|NCT02724956|42246588|FG001|Overall Study|Physician Decision|0|||
19789213|NCT02724956|42246587|FG000|Overall Study|Lack of Efficacy|0|||
19789214|NCT02724956|42246588|FG001|Overall Study|Lack of Efficacy|1|||
19789215|NCT02724956|42246587|FG000|Overall Study|Withdrawal by Subject|0|||
19789216|NCT02724956|42246588|FG001|Overall Study|Withdrawal by Subject|1|||
19789217|NCT00705536|42246596|FG000|Start Period 1|Withdrawal by Subject|0|||
19789218|NCT00705536|42246597|FG001|Start Period 1|Withdrawal by Subject|0|||
19789219|NCT00705536|42246598|FG002|Start Period 1|Withdrawal by Subject|0|||
19789220|NCT00705536|42246599|FG003|Start Period 1|Withdrawal by Subject|1|||
19789221|NCT02724878|42246618|FG000|Overall Study|Still on Active Therapy|15|||
19789222|NCT02724878|42246618|FG000|Overall Study|Disease Progression|31|||
19789223|NCT02724878|42246618|FG000|Overall Study|Toxicity|5|||
19789224|NCT02724878|42246618|FG000|Overall Study|Death|1|||
19789225|NCT02724878|42246618|FG000|Overall Study|Withdrawal by Subject|4|||
19789226|NCT02724878|42246618|FG000|Overall Study|Lost to Follow-up|2|||
19789227|NCT02724878|42246618|FG000|Overall Study|Protocol Violation|1|||
19789228|NCT02724878|42246618|FG000|Overall Study|Ineligible for Study Drug|5|||
19789229|NCT02724878|42246618|FG000|Overall Study|not started|1|||
19789230|NCT02660034|42246636|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
19789231|NCT02660034|42246637|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
19789232|NCT02660034|42246638|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
19789233|NCT02660034|42246639|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
19789234|NCT02660034|42246640|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
19789235|NCT02660034|42246641|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
19789236|NCT02660034|42246642|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
19789237|NCT02660034|42246643|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
19789238|NCT02660034|42246644|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
19789239|NCT02660034|42246645|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
19789240|NCT02660034|42246646|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
19789241|NCT02660034|42246647|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
19789242|NCT02660034|42246648|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
19789243|NCT02660034|42246649|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
19789244|NCT02660034|42246636|FG000|Overall Study|Progressive Disease (Clinical)|7|||
19789245|NCT02660034|42246637|FG001|Overall Study|Progressive Disease (Clinical)|8|||
19789246|NCT02660034|42246638|FG002|Overall Study|Progressive Disease (Clinical)|3|||
19789247|NCT02660034|42246639|FG003|Overall Study|Progressive Disease (Clinical)|9|||
19789248|NCT02660034|42246640|FG004|Overall Study|Progressive Disease (Clinical)|3|||
19789249|NCT02660034|42246641|FG005|Overall Study|Progressive Disease (Clinical)|0|||
19789250|NCT02660034|42246642|FG006|Overall Study|Progressive Disease (Clinical)|0|||
19789251|NCT02660034|42246643|FG007|Overall Study|Progressive Disease (Clinical)|0|||
19789252|NCT02660034|42246644|FG008|Overall Study|Progressive Disease (Clinical)|0|||
19789253|NCT02660034|42246645|FG009|Overall Study|Progressive Disease (Clinical)|0|||
19789254|NCT02660034|42246646|FG010|Overall Study|Progressive Disease (Clinical)|0|||
19789255|NCT02660034|42246647|FG011|Overall Study|Progressive Disease (Clinical)|0|||
19789256|NCT02660034|42246648|FG012|Overall Study|Progressive Disease (Clinical)|0|||
19789257|NCT02660034|42246649|FG013|Overall Study|Progressive Disease (Clinical)|0|||
19789258|NCT02660034|42246636|FG000|Overall Study|Lost to Follow-up|0|||
19789259|NCT02660034|42246637|FG001|Overall Study|Lost to Follow-up|0|||
19789260|NCT02660034|42246638|FG002|Overall Study|Lost to Follow-up|1|||
19789261|NCT02660034|42246639|FG003|Overall Study|Lost to Follow-up|1|||
19789262|NCT02660034|42246640|FG004|Overall Study|Lost to Follow-up|0|||
19789263|NCT02660034|42246641|FG005|Overall Study|Lost to Follow-up|0|||
19789264|NCT02660034|42246642|FG006|Overall Study|Lost to Follow-up|0|||
19789265|NCT02660034|42246643|FG007|Overall Study|Lost to Follow-up|0|||
19789266|NCT02660034|42246644|FG008|Overall Study|Lost to Follow-up|0|||
19789267|NCT02660034|42246645|FG009|Overall Study|Lost to Follow-up|1|||
19789268|NCT02660034|42246646|FG010|Overall Study|Lost to Follow-up|1|||
19789269|NCT02660034|42246647|FG011|Overall Study|Lost to Follow-up|1|||
19789270|NCT02660034|42246648|FG012|Overall Study|Lost to Follow-up|0|||
19789271|NCT02660034|42246649|FG013|Overall Study|Lost to Follow-up|0|||
19789272|NCT02660034|42246636|FG000|Overall Study|Participant moved into special access scheme|1|||
19789273|NCT02660034|42246637|FG001|Overall Study|Participant moved into special access scheme|2|||
19789274|NCT02660034|42246638|FG002|Overall Study|Participant moved into special access scheme|0|||
19789275|NCT02660034|42246639|FG003|Overall Study|Participant moved into special access scheme|0|||
19789276|NCT02660034|42246640|FG004|Overall Study|Participant moved into special access scheme|0|||
19789277|NCT02660034|42246641|FG005|Overall Study|Participant moved into special access scheme|0|||
19789278|NCT02660034|42246642|FG006|Overall Study|Participant moved into special access scheme|0|||
19789279|NCT02660034|42246643|FG007|Overall Study|Participant moved into special access scheme|0|||
19789280|NCT02660034|42246644|FG008|Overall Study|Participant moved into special access scheme|0|||
19789281|NCT02660034|42246645|FG009|Overall Study|Participant moved into special access scheme|0|||
19789282|NCT02660034|42246646|FG010|Overall Study|Participant moved into special access scheme|0|||
19789283|NCT02660034|42246647|FG011|Overall Study|Participant moved into special access scheme|0|||
19789284|NCT02660034|42246648|FG012|Overall Study|Participant moved into special access scheme|0|||
19789285|NCT02660034|42246649|FG013|Overall Study|Participant moved into special access scheme|0|||
19789286|NCT02660034|42246636|FG000|Overall Study|Adverse Event|1|||
19789287|NCT02660034|42246637|FG001|Overall Study|Adverse Event|0|||
19789288|NCT02660034|42246638|FG002|Overall Study|Adverse Event|0|||
19789289|NCT02660034|42246639|FG003|Overall Study|Adverse Event|0|||
19789290|NCT02660034|42246640|FG004|Overall Study|Adverse Event|0|||
19789291|NCT02660034|42246641|FG005|Overall Study|Adverse Event|0|||
19789292|NCT02660034|42246642|FG006|Overall Study|Adverse Event|0|||
19789293|NCT02660034|42246643|FG007|Overall Study|Adverse Event|0|||
19789294|NCT02660034|42246644|FG008|Overall Study|Adverse Event|0|||
19789295|NCT02660034|42246645|FG009|Overall Study|Adverse Event|0|||
19789296|NCT02660034|42246646|FG010|Overall Study|Adverse Event|0|||
19789297|NCT02660034|42246647|FG011|Overall Study|Adverse Event|0|||
19789298|NCT02660034|42246648|FG012|Overall Study|Adverse Event|0|||
19789299|NCT02660034|42246649|FG013|Overall Study|Adverse Event|0|||
19789300|NCT02660034|42246636|FG000|Overall Study|Sponsor Decision|0|||
19789301|NCT02660034|42246637|FG001|Overall Study|Sponsor Decision|1|||
19789302|NCT02660034|42246638|FG002|Overall Study|Sponsor Decision|2|||
19789303|NCT02660034|42246639|FG003|Overall Study|Sponsor Decision|2|||
19789304|NCT02660034|42246640|FG004|Overall Study|Sponsor Decision|3|||
19789305|NCT02660034|42246641|FG005|Overall Study|Sponsor Decision|0|||
19789306|NCT02660034|42246642|FG006|Overall Study|Sponsor Decision|0|||
19789307|NCT02660034|42246643|FG007|Overall Study|Sponsor Decision|0|||
19789308|NCT02660034|42246644|FG008|Overall Study|Sponsor Decision|0|||
19789309|NCT02660034|42246645|FG009|Overall Study|Sponsor Decision|0|||
19789310|NCT02660034|42246646|FG010|Overall Study|Sponsor Decision|0|||
19789311|NCT02660034|42246647|FG011|Overall Study|Sponsor Decision|0|||
19789312|NCT02660034|42246648|FG012|Overall Study|Sponsor Decision|0|||
19789313|NCT02660034|42246649|FG013|Overall Study|Sponsor Decision|1|||
19789314|NCT02660034|42246636|FG000|Overall Study|Withdrawal by Subject|0|||
19789315|NCT02660034|42246637|FG001|Overall Study|Withdrawal by Subject|0|||
19789316|NCT02660034|42246638|FG002|Overall Study|Withdrawal by Subject|0|||
19789317|NCT02660034|42246639|FG003|Overall Study|Withdrawal by Subject|0|||
19789318|NCT02660034|42246640|FG004|Overall Study|Withdrawal by Subject|0|||
19789319|NCT02660034|42246641|FG005|Overall Study|Withdrawal by Subject|0|||
19789320|NCT02660034|42246642|FG006|Overall Study|Withdrawal by Subject|1|||
19789321|NCT02660034|42246643|FG007|Overall Study|Withdrawal by Subject|1|||
19789322|NCT02660034|42246644|FG008|Overall Study|Withdrawal by Subject|1|||
19789323|NCT02660034|42246645|FG009|Overall Study|Withdrawal by Subject|0|||
19789324|NCT02660034|42246646|FG010|Overall Study|Withdrawal by Subject|0|||
19789325|NCT02660034|42246647|FG011|Overall Study|Withdrawal by Subject|1|||
19789326|NCT02660034|42246648|FG012|Overall Study|Withdrawal by Subject|2|||
19789327|NCT02660034|42246649|FG013|Overall Study|Withdrawal by Subject|0|||
19789328|NCT02660034|42246636|FG000|Overall Study|Death|0|||
19789329|NCT02660034|42246637|FG001|Overall Study|Death|0|||
19789330|NCT02660034|42246638|FG002|Overall Study|Death|0|||
19789331|NCT02660034|42246639|FG003|Overall Study|Death|0|||
19789332|NCT02660034|42246640|FG004|Overall Study|Death|0|||
19789333|NCT02660034|42246641|FG005|Overall Study|Death|13|||
19789334|NCT02660034|42246642|FG006|Overall Study|Death|14|||
19789335|NCT02660034|42246643|FG007|Overall Study|Death|10|||
19789336|NCT02660034|42246644|FG008|Overall Study|Death|9|||
19789337|NCT02660034|42246645|FG009|Overall Study|Death|21|||
19789338|NCT02660034|42246646|FG010|Overall Study|Death|17|||
19789339|NCT02660034|42246647|FG011|Overall Study|Death|15|||
19789340|NCT02660034|42246648|FG012|Overall Study|Death|18|||
19789341|NCT02660034|42246649|FG013|Overall Study|Death|7|||
19789342|NCT02660034|42246636|FG000|Overall Study|Physician Decision|0|||
19789343|NCT02660034|42246637|FG001|Overall Study|Physician Decision|0|||
19789344|NCT02660034|42246638|FG002|Overall Study|Physician Decision|0|||
19789345|NCT02660034|42246639|FG003|Overall Study|Physician Decision|0|||
19789346|NCT02660034|42246640|FG004|Overall Study|Physician Decision|0|||
19789347|NCT02660034|42246641|FG005|Overall Study|Physician Decision|0|||
19789348|NCT02660034|42246642|FG006|Overall Study|Physician Decision|0|||
19789349|NCT02660034|42246643|FG007|Overall Study|Physician Decision|0|||
19789350|NCT02660034|42246644|FG008|Overall Study|Physician Decision|0|||
19789351|NCT02660034|42246645|FG009|Overall Study|Physician Decision|0|||
19789352|NCT02660034|42246646|FG010|Overall Study|Physician Decision|0|||
19789353|NCT02660034|42246647|FG011|Overall Study|Physician Decision|0|||
19789354|NCT02660034|42246648|FG012|Overall Study|Physician Decision|0|||
19789355|NCT02660034|42246649|FG013|Overall Study|Physician Decision|1|||
19789356|NCT02660034|42246636|FG000|Overall Study|Participants transferred to LTE|0|||
19789357|NCT02660034|42246637|FG001|Overall Study|Participants transferred to LTE|0|||
19789358|NCT02660034|42246638|FG002|Overall Study|Participants transferred to LTE|0|||
19789359|NCT02660034|42246639|FG003|Overall Study|Participants transferred to LTE|0|||
19789360|NCT02660034|42246640|FG004|Overall Study|Participants transferred to LTE|0|||
19789361|NCT02660034|42246641|FG005|Overall Study|Participants transferred to LTE|10|||
19789362|NCT02660034|42246642|FG006|Overall Study|Participants transferred to LTE|8|||
19789363|NCT02660034|42246643|FG007|Overall Study|Participants transferred to LTE|8|||
19789364|NCT02660034|42246644|FG008|Overall Study|Participants transferred to LTE|10|||
19789365|NCT02660034|42246645|FG009|Overall Study|Participants transferred to LTE|1|||
19789366|NCT02660034|42246646|FG010|Overall Study|Participants transferred to LTE|2|||
19789367|NCT02660034|42246647|FG011|Overall Study|Participants transferred to LTE|4|||
19789368|NCT02660034|42246648|FG012|Overall Study|Participants transferred to LTE|1|||
19789369|NCT02660034|42246649|FG013|Overall Study|Participants transferred to LTE|1|||
19789370|NCT02724020|42246686|FG000|Overall Study|Death|16|||
19789371|NCT02724020|42246687|FG001|Overall Study|Death|18|||
19789372|NCT02724020|42246688|FG002|Overall Study|Death|19|||
19789373|NCT02724020|42246686|FG000|Overall Study|Lost to Follow-up|0|||
19789374|NCT02724020|42246687|FG001|Overall Study|Lost to Follow-up|3|||
19789375|NCT02724020|42246688|FG002|Overall Study|Lost to Follow-up|0|||
19789376|NCT02724020|42246686|FG000|Overall Study|Site Terminated by Sponsor|15|||
19789377|NCT02724020|42246687|FG001|Overall Study|Site Terminated by Sponsor|8|||
19789378|NCT02724020|42246688|FG002|Overall Study|Site Terminated by Sponsor|8|||
19789379|NCT02724020|42246686|FG000|Overall Study|Withdrawal by Subject|1|||
19789380|NCT02724020|42246687|FG001|Overall Study|Withdrawal by Subject|3|||
19789381|NCT02724020|42246688|FG002|Overall Study|Withdrawal by Subject|5|||
19789382|NCT02193867|42246705|FG000|Overall Study|Death|2|||
19789383|NCT02193867|42246705|FG000|Overall Study|Sponsor Study Termination|2|||
19789384|NCT02200770|42246733|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
19789385|NCT02200770|42246734|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
19789386|NCT02200770|42246733|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
19789387|NCT02200770|42246734|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
19789388|NCT02200770|42246733|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
19789389|NCT02200770|42246734|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
19789390|NCT02200770|42246733|FG000|Randomized-controlled Period (RCP)|Other|1|||
19789391|NCT02200770|42246734|FG001|Randomized-controlled Period (RCP)|Other|2|||
19789392|NCT02200770|42246733|FG000|Open-label Period (OLP)|Adverse Event|1|||
19789393|NCT02200770|42246734|FG001|Open-label Period (OLP)|Adverse Event|2|||
19789394|NCT02200770|42246733|FG000|Open-label Period (OLP)|Death|1|||
19789395|NCT02200770|42246734|FG001|Open-label Period (OLP)|Death|2|||
19789396|NCT02200770|42246733|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
19789397|NCT02200770|42246734|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
19789398|NCT02200770|42246733|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
19789399|NCT02200770|42246734|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
19789400|NCT02200770|42246733|FG000|Open-label Period (OLP)|Other|6|||
19789401|NCT02200770|42246734|FG001|Open-label Period (OLP)|Other|15|||
19789402|NCT01186848|42246742|FG000|Overall Study|Lost to Follow-up|4|||
19789403|NCT01186848|42246742|FG000|Overall Study|Withdrawal by Subject|2|||
19789404|NCT01186848|42246742|FG000|Overall Study|Adverse Event|2|||
19789405|NCT01024608|42246750|FG000|Overall Study|Adverse Event|1|||
19789406|NCT01024608|42246751|FG001|Overall Study|Adverse Event|0|||
19789407|NCT01024608|42246750|FG000|Overall Study|Withdrawal by Subject|1|||
19789408|NCT01024608|42246751|FG001|Overall Study|Withdrawal by Subject|0|||
19789409|NCT01024608|42246750|FG000|Overall Study|Lost to Follow-up|0|||
19789410|NCT01024608|42246751|FG001|Overall Study|Lost to Follow-up|1|||
19789411|NCT01024608|42246750|FG000|Overall Study|Protocol Violation|0|||
19789412|NCT01024608|42246751|FG001|Overall Study|Protocol Violation|3|||
19789413|NCT01024608|42246750|FG000|Overall Study|Never received study treatment|2|||
19789414|NCT01024608|42246751|FG001|Overall Study|Never received study treatment|0|||
19789415|NCT00910650|42246757|FG000|Overall Study|Death|2|||
19789416|NCT03996876|42246792|FG000|Overall Study|Incomplete Data|2|||
19789417|NCT03996876|42246793|FG001|Overall Study|Incomplete Data|4|||
19789418|NCT01460160|42246800|FG000|Treatment Phase|Lack of Efficacy|3|||
19789419|NCT01460160|42246800|FG000|Treatment Phase|Study Drug Toxicity|2|||
19789420|NCT01460160|42246800|FG000|Treatment Phase|Adverse Event|8|||
19789421|NCT01460160|42246800|FG000|Treatment Phase|Withdrawal by Subject|4|||
19789422|NCT01460160|42246800|FG000|Treatment Phase|Death|2|||
19789423|NCT01460160|42246800|FG000|Treatment Phase|Other reasons|9|||
19789424|NCT01460160|42246800|FG000|Follow-up Phase|Withdrawal by Subject|4|||
19789425|NCT01460160|42246800|FG000|Follow-up Phase|Death|14|||
19789426|NCT01460160|42246800|FG000|Follow-up Phase|Lost to Follow-up|7|||
19789427|NCT01460160|42246800|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
19789428|NCT01460160|42246800|FG000|Follow-up Phase|Other and not reported reasons|5|||
19789429|NCT01170702|42246808|FG000|Overall Study|Exclusion criteria met after consent|1|||
19789430|NCT01170702|42246809|FG001|Overall Study|Exclusion criteria met after consent|2|||
19789431|NCT01170702|42246810|FG002|Overall Study|Exclusion criteria met after consent|0|||
19789432|NCT01170702|42246811|FG003|Overall Study|Exclusion criteria met after consent|2|||
19789433|NCT02723864|42246850|FG000|Overall Study|Refused further treatment|1|||
19789434|NCT02723864|42246851|FG001|Overall Study|Refused further treatment|0|||
19789435|NCT02723864|42246852|FG002|Overall Study|Refused further treatment|0|||
19789436|NCT02723864|42246853|FG003|Overall Study|Refused further treatment|0|||
19789437|NCT02723864|42246854|FG004|Overall Study|Refused further treatment|1|||
19789438|NCT02723864|42246855|FG005|Overall Study|Refused further treatment|2|||
19789439|NCT02723864|42246856|FG006|Overall Study|Refused further treatment|0|||
19789440|NCT02723864|42246850|FG000|Overall Study|Exceed treatment hold time|0|||
19789441|NCT02723864|42246851|FG001|Overall Study|Exceed treatment hold time|1|||
19789442|NCT02723864|42246852|FG002|Overall Study|Exceed treatment hold time|0|||
19789443|NCT02723864|42246853|FG003|Overall Study|Exceed treatment hold time|0|||
19789444|NCT02723864|42246854|FG004|Overall Study|Exceed treatment hold time|0|||
19789445|NCT02723864|42246855|FG005|Overall Study|Exceed treatment hold time|0|||
19789446|NCT02723864|42246856|FG006|Overall Study|Exceed treatment hold time|0|||
19789447|NCT02723864|42246850|FG000|Overall Study|Clinical progression|0|||
19789448|NCT02723864|42246851|FG001|Overall Study|Clinical progression|0|||
19789449|NCT02723864|42246852|FG002|Overall Study|Clinical progression|1|||
19789450|NCT02723864|42246853|FG003|Overall Study|Clinical progression|0|||
19789451|NCT02723864|42246854|FG004|Overall Study|Clinical progression|0|||
19789452|NCT02723864|42246855|FG005|Overall Study|Clinical progression|3|||
19789453|NCT02723864|42246856|FG006|Overall Study|Clinical progression|1|||
19789454|NCT02723864|42246850|FG000|Overall Study|Physician Decision|0|||
19789455|NCT02723864|42246851|FG001|Overall Study|Physician Decision|0|||
19789456|NCT02723864|42246852|FG002|Overall Study|Physician Decision|0|||
19789457|NCT02723864|42246853|FG003|Overall Study|Physician Decision|0|||
19789458|NCT02723864|42246854|FG004|Overall Study|Physician Decision|0|||
19789459|NCT02723864|42246855|FG005|Overall Study|Physician Decision|0|||
19789460|NCT02723864|42246856|FG006|Overall Study|Physician Decision|1|||
19789461|NCT02723864|42246850|FG000|Overall Study|Changes in patient condition|0|||
19789462|NCT02723864|42246851|FG001|Overall Study|Changes in patient condition|0|||
19789463|NCT02723864|42246852|FG002|Overall Study|Changes in patient condition|0|||
19789464|NCT02723864|42246853|FG003|Overall Study|Changes in patient condition|0|||
19789465|NCT02723864|42246854|FG004|Overall Study|Changes in patient condition|0|||
19789466|NCT02723864|42246855|FG005|Overall Study|Changes in patient condition|1|||
19789467|NCT02723864|42246856|FG006|Overall Study|Changes in patient condition|0|||
19789468|NCT02723864|42246850|FG000|Overall Study|Patient choice|0|||
19789469|NCT02723864|42246851|FG001|Overall Study|Patient choice|0|||
19789470|NCT02723864|42246852|FG002|Overall Study|Patient choice|0|||
19789471|NCT02723864|42246853|FG003|Overall Study|Patient choice|0|||
19789472|NCT02723864|42246854|FG004|Overall Study|Patient choice|0|||
19789473|NCT02723864|42246855|FG005|Overall Study|Patient choice|1|||
19789474|NCT02723864|42246856|FG006|Overall Study|Patient choice|0|||
19789475|NCT02723864|42246850|FG000|Overall Study|Adverse Event|0|||
19789476|NCT02723864|42246851|FG001|Overall Study|Adverse Event|0|||
19789477|NCT02723864|42246852|FG002|Overall Study|Adverse Event|0|||
19789478|NCT02723864|42246853|FG003|Overall Study|Adverse Event|0|||
19789479|NCT02723864|42246854|FG004|Overall Study|Adverse Event|0|||
19789480|NCT02723864|42246855|FG005|Overall Study|Adverse Event|1|||
19367455|NCT02435680|41607626|FG000|Overall Study|subject / guardian decision|0|||
19367456|NCT02435680|41607627|FG001|Overall Study|subject / guardian decision|3|||
19789481|NCT02723864|42246856|FG006|Overall Study|Adverse Event|0|||
19789482|NCT02723864|42246850|FG000|Overall Study|Started new treatment|0|||
19789483|NCT02723864|42246851|FG001|Overall Study|Started new treatment|0|||
19789484|NCT02723864|42246852|FG002|Overall Study|Started new treatment|0|||
19789485|NCT02723864|42246853|FG003|Overall Study|Started new treatment|0|||
19789486|NCT02723864|42246854|FG004|Overall Study|Started new treatment|0|||
19789487|NCT02723864|42246855|FG005|Overall Study|Started new treatment|1|||
19789488|NCT02723864|42246856|FG006|Overall Study|Started new treatment|0|||
19789489|NCT02723864|42246850|FG000|Overall Study|Switched to alternative treatment|0|||
19789490|NCT02723864|42246851|FG001|Overall Study|Switched to alternative treatment|0|||
19789491|NCT02723864|42246852|FG002|Overall Study|Switched to alternative treatment|0|||
19789492|NCT02723864|42246853|FG003|Overall Study|Switched to alternative treatment|0|||
19789493|NCT02723864|42246854|FG004|Overall Study|Switched to alternative treatment|0|||
19789494|NCT02723864|42246855|FG005|Overall Study|Switched to alternative treatment|1|||
19789495|NCT02723864|42246856|FG006|Overall Study|Switched to alternative treatment|0|||
19789496|NCT02723864|42246850|FG000|Overall Study|Late determination of ineligibility|0|||
19789497|NCT02723864|42246851|FG001|Overall Study|Late determination of ineligibility|0|||
19789498|NCT02723864|42246852|FG002|Overall Study|Late determination of ineligibility|0|||
19789499|NCT02723864|42246853|FG003|Overall Study|Late determination of ineligibility|0|||
19789500|NCT02723864|42246854|FG004|Overall Study|Late determination of ineligibility|0|||
19789501|NCT02723864|42246855|FG005|Overall Study|Late determination of ineligibility|1|||
19789502|NCT02723864|42246856|FG006|Overall Study|Late determination of ineligibility|0|||
19789503|NCT00705146|42246895|FG000|Overall Study|Lost to Follow-up|1|||
19789504|NCT00705146|42246896|FG001|Overall Study|Lost to Follow-up|1|||
19789505|NCT03203642|42246904|FG000|Overall Study|Adverse Event|3|||
19789506|NCT03203642|42246905|FG001|Overall Study|Adverse Event|1|||
19789507|NCT03203642|42246904|FG000|Overall Study|Withdrawal by Subject|6|||
19789508|NCT03203642|42246905|FG001|Overall Study|Withdrawal by Subject|6|||
19789509|NCT03203642|42246904|FG000|Overall Study|Lost to Follow-up|2|||
19789510|NCT03203642|42246905|FG001|Overall Study|Lost to Follow-up|1|||
19789511|NCT03203642|42246904|FG000|Overall Study|Termination of the study by sponsor|1|||
19789512|NCT03203642|42246905|FG001|Overall Study|Termination of the study by sponsor|1|||
19789513|NCT03203642|42246904|FG000|Overall Study|Participant moved|0|||
19789514|NCT03203642|42246905|FG001|Overall Study|Participant moved|1|||
19789515|NCT03203642|42246904|FG000|Overall Study|Investigator's decision|3|||
19789516|NCT03203642|42246905|FG001|Overall Study|Investigator's decision|0|||
19789517|NCT03203642|42246904|FG000|Overall Study|Other than above specified|0|||
19789518|NCT03203642|42246905|FG001|Overall Study|Other than above specified|1|||
19789519|NCT02737722|42246915|FG000|Overall Study|Physician Decision|0|||
19789520|NCT02737722|42246916|FG001|Overall Study|Physician Decision|0|||
19789521|NCT02737722|42246917|FG002|Overall Study|Physician Decision|1|||
19789522|NCT02737722|42246918|FG003|Overall Study|Physician Decision|0|||
19789523|NCT03792750|42246928|FG000|Overall Study|Death|3|||
19789524|NCT02750709|42246933|FG000|Treatment Period 1|Adverse Event|0|||
19789525|NCT02750709|42246934|FG001|Treatment Period 1|Adverse Event|0|||
19789526|NCT02750709|42246935|FG002|Treatment Period 1|Adverse Event|0|||
19789527|NCT02750709|42246936|FG003|Treatment Period 1|Adverse Event|0|||
19789528|NCT02750709|42246937|FG004|Treatment Period 1|Adverse Event|0|||
19789529|NCT02750709|42246938|FG005|Treatment Period 1|Adverse Event|1|||
19789530|NCT02723786|42246946|FG000|Overall Study|Lost to Follow-up|1|||
19789531|NCT02723084|42246965|FG000|Overall Study|Withdrawal by Subject|1|||
19789532|NCT02723084|42246966|FG001|Overall Study|Withdrawal by Subject|1|||
19789533|NCT02723084|42246965|FG000|Overall Study|Lost to Follow-up|3|||
19789534|NCT02723084|42246966|FG001|Overall Study|Lost to Follow-up|0|||
19789535|NCT02750943|42246974|FG000|Overall Study|Lost to Follow-up|1|||
19789536|NCT02750943|42246975|FG001|Overall Study|Lost to Follow-up|2|||
19789537|NCT02750943|42246974|FG000|Overall Study|Withdrawal by Subject|5|||
19789538|NCT02750943|42246975|FG001|Overall Study|Withdrawal by Subject|7|||
19789539|NCT04730349|42246992|FG000|Overall Study|Participant withdrew consent|1|||
19789540|NCT04730349|42246993|FG001|Overall Study|Participant withdrew consent|0|||
19789541|NCT04730349|42246992|FG000|Overall Study|Disease progression|6|||
19789542|NCT04730349|42246993|FG001|Overall Study|Disease progression|4|||
19789543|NCT04730349|42246992|FG000|Overall Study|Study drug toxicity|0|||
19789544|NCT04730349|42246993|FG001|Overall Study|Study drug toxicity|1|||
19789545|NCT04307394|42247012|FG000|Overall Study|Lost to Follow-up|3|||
19789546|NCT04307394|42247012|FG000|Overall Study|Withdrawal by Subject|2|||
19789547|NCT04050670|42247056|FG000|Period 3|Physician Decision|0|||
19789548|NCT04050670|42247057|FG001|Period 3|Physician Decision|1|||
19789549|NCT04050670|42247058|FG002|Period 3|Physician Decision|0|||
19789550|NCT03940742|42247070|FG000|Overall Study|Lost to Follow-up|0|||
19789551|NCT03940742|42247071|FG001|Overall Study|Lost to Follow-up|0|||
19789552|NCT03940742|42247072|FG002|Overall Study|Lost to Follow-up|0|||
19789553|NCT03940742|42247073|FG003|Overall Study|Lost to Follow-up|1|||
19789554|NCT03917654|42247095|FG000|Year 1|Withdrawal by Subject|1|||
19789555|NCT03917654|42247096|FG001|Year 1|Withdrawal by Subject|0|||
19789556|NCT03917654|42247097|FG002|Year 1|Withdrawal by Subject|0|||
19789557|NCT03917654|42247098|FG003|Year 1|Withdrawal by Subject|0|||
19789558|NCT03917654|42247099|FG004|Year 1|Withdrawal by Subject|0|||
19789559|NCT03917654|42247100|FG005|Year 1|Withdrawal by Subject|1|||
19789560|NCT03917654|42247101|FG006|Year 1|Withdrawal by Subject|6|||
19789561|NCT03917654|42247102|FG007|Year 1|Withdrawal by Subject|2|||
19789562|NCT03917654|42247103|FG008|Year 1|Withdrawal by Subject|5|||
19789563|NCT03917654|42247104|FG009|Year 1|Withdrawal by Subject|3|||
19789564|NCT03917654|42247105|FG010|Year 1|Withdrawal by Subject|1|||
19789565|NCT03917654|42247106|FG011|Year 1|Withdrawal by Subject|0|||
19789566|NCT03917654|42247095|FG000|Year 1|Travel|0|||
19789567|NCT03917654|42247096|FG001|Year 1|Travel|1|||
19789568|NCT03917654|42247097|FG002|Year 1|Travel|1|||
19789569|NCT03917654|42247098|FG003|Year 1|Travel|0|||
19789570|NCT03917654|42247099|FG004|Year 1|Travel|4|||
19789571|NCT03917654|42247100|FG005|Year 1|Travel|4|||
19789572|NCT03917654|42247101|FG006|Year 1|Travel|10|||
19789573|NCT03917654|42247102|FG007|Year 1|Travel|8|||
19789574|NCT03917654|42247103|FG008|Year 1|Travel|2|||
19789575|NCT03917654|42247104|FG009|Year 1|Travel|5|||
19789576|NCT03917654|42247105|FG010|Year 1|Travel|3|||
19789577|NCT03917654|42247106|FG011|Year 1|Travel|3|||
19789578|NCT03917654|42247095|FG000|Year 1|Subject moved away from site|0|||
19789579|NCT03917654|42247096|FG001|Year 1|Subject moved away from site|1|||
19789580|NCT03917654|42247097|FG002|Year 1|Subject moved away from site|0|||
19789581|NCT03917654|42247098|FG003|Year 1|Subject moved away from site|0|||
19789582|NCT03917654|42247099|FG004|Year 1|Subject moved away from site|0|||
19789583|NCT03917654|42247100|FG005|Year 1|Subject moved away from site|0|||
19789584|NCT03917654|42247101|FG006|Year 1|Subject moved away from site|1|||
19789585|NCT03917654|42247102|FG007|Year 1|Subject moved away from site|2|||
19789586|NCT03917654|42247103|FG008|Year 1|Subject moved away from site|1|||
19789587|NCT03917654|42247104|FG009|Year 1|Subject moved away from site|0|||
19789588|NCT03917654|42247105|FG010|Year 1|Subject moved away from site|0|||
19789589|NCT03917654|42247106|FG011|Year 1|Subject moved away from site|3|||
19789590|NCT03917654|42247095|FG000|Year 1|Spouse/Family member request|0|||
19789591|NCT03917654|42247096|FG001|Year 1|Spouse/Family member request|0|||
19789592|NCT03917654|42247097|FG002|Year 1|Spouse/Family member request|1|||
19789593|NCT03917654|42247098|FG003|Year 1|Spouse/Family member request|0|||
19789594|NCT03917654|42247099|FG004|Year 1|Spouse/Family member request|1|||
19789595|NCT03917654|42247100|FG005|Year 1|Spouse/Family member request|0|||
19789596|NCT03917654|42247101|FG006|Year 1|Spouse/Family member request|0|||
19789597|NCT03917654|42247102|FG007|Year 1|Spouse/Family member request|2|||
19789598|NCT03917654|42247103|FG008|Year 1|Spouse/Family member request|0|||
19789599|NCT03917654|42247104|FG009|Year 1|Spouse/Family member request|0|||
19789600|NCT03917654|42247105|FG010|Year 1|Spouse/Family member request|0|||
19789601|NCT03917654|42247106|FG011|Year 1|Spouse/Family member request|1|||
19789602|NCT03917654|42247095|FG000|Year 1|Death|0|||
19789603|NCT03917654|42247096|FG001|Year 1|Death|0|||
19789604|NCT03917654|42247097|FG002|Year 1|Death|0|||
19789605|NCT03917654|42247098|FG003|Year 1|Death|0|||
19789606|NCT03917654|42247099|FG004|Year 1|Death|0|||
19789607|NCT03917654|42247100|FG005|Year 1|Death|0|||
19789608|NCT03917654|42247101|FG006|Year 1|Death|0|||
19789609|NCT03917654|42247102|FG007|Year 1|Death|0|||
19789610|NCT03917654|42247103|FG008|Year 1|Death|1|||
19789611|NCT03917654|42247104|FG009|Year 1|Death|1|||
19789612|NCT03917654|42247105|FG010|Year 1|Death|0|||
19789613|NCT03917654|42247106|FG011|Year 1|Death|0|||
19789614|NCT03917654|42247095|FG000|Year 1|Lost to Follow-up|0|||
19789615|NCT03917654|42247096|FG001|Year 1|Lost to Follow-up|0|||
19789616|NCT03917654|42247097|FG002|Year 1|Lost to Follow-up|0|||
19789617|NCT03917654|42247098|FG003|Year 1|Lost to Follow-up|0|||
19789618|NCT03917654|42247099|FG004|Year 1|Lost to Follow-up|0|||
19789619|NCT03917654|42247100|FG005|Year 1|Lost to Follow-up|0|||
19789620|NCT03917654|42247101|FG006|Year 1|Lost to Follow-up|2|||
19789621|NCT03917654|42247102|FG007|Year 1|Lost to Follow-up|0|||
19789622|NCT03917654|42247103|FG008|Year 1|Lost to Follow-up|0|||
19789623|NCT03917654|42247104|FG009|Year 1|Lost to Follow-up|0|||
19789624|NCT03917654|42247105|FG010|Year 1|Lost to Follow-up|0|||
19789625|NCT03917654|42247106|FG011|Year 1|Lost to Follow-up|0|||
19789626|NCT03917654|42247095|FG000|Year 1|Missed visits|0|||
19789627|NCT03917654|42247096|FG001|Year 1|Missed visits|0|||
19789628|NCT03917654|42247097|FG002|Year 1|Missed visits|0|||
19789629|NCT03917654|42247098|FG003|Year 1|Missed visits|0|||
19789630|NCT03917654|42247099|FG004|Year 1|Missed visits|0|||
19789631|NCT03917654|42247100|FG005|Year 1|Missed visits|0|||
19789632|NCT03917654|42247101|FG006|Year 1|Missed visits|0|||
19789633|NCT03917654|42247102|FG007|Year 1|Missed visits|0|||
19367457|NCT02435680|41607628|FG002|Overall Study|subject / guardian decision|2|||
19367458|NCT02435680|41607626|FG000|Overall Study|Adverse Event|8|||
19367459|NCT02435680|41607627|FG001|Overall Study|Adverse Event|3|||
19789634|NCT03917654|42247103|FG008|Year 1|Missed visits|0|||
19789635|NCT03917654|42247104|FG009|Year 1|Missed visits|0|||
19789636|NCT03917654|42247105|FG010|Year 1|Missed visits|1|||
19789637|NCT03917654|42247106|FG011|Year 1|Missed visits|1|||
19789638|NCT03917654|42247095|FG000|Year 1|Pregnancy|0|||
19789639|NCT03917654|42247096|FG001|Year 1|Pregnancy|0|||
19789640|NCT03917654|42247097|FG002|Year 1|Pregnancy|0|||
19789641|NCT03917654|42247098|FG003|Year 1|Pregnancy|0|||
19789642|NCT03917654|42247099|FG004|Year 1|Pregnancy|0|||
19789643|NCT03917654|42247100|FG005|Year 1|Pregnancy|0|||
19789644|NCT03917654|42247101|FG006|Year 1|Pregnancy|0|||
19789645|NCT03917654|42247102|FG007|Year 1|Pregnancy|1|||
19789646|NCT03917654|42247103|FG008|Year 1|Pregnancy|0|||
19789647|NCT03917654|42247104|FG009|Year 1|Pregnancy|1|||
19789648|NCT03917654|42247105|FG010|Year 1|Pregnancy|0|||
19789649|NCT03917654|42247106|FG011|Year 1|Pregnancy|0|||
19789650|NCT03917654|42247095|FG000|Year 2|Travel|1|||
19789651|NCT03917654|42247096|FG001|Year 2|Travel|0|||
19789652|NCT03917654|42247097|FG002|Year 2|Travel|0|||
19789653|NCT03917654|42247098|FG003|Year 2|Travel|0|||
19789654|NCT03917654|42247099|FG004|Year 2|Travel|1|||
19789655|NCT03917654|42247100|FG005|Year 2|Travel|1|||
19789656|NCT03917654|42247101|FG006|Year 2|Travel|2|||
19789657|NCT03917654|42247102|FG007|Year 2|Travel|1|||
19789658|NCT03917654|42247103|FG008|Year 2|Travel|0|||
19789659|NCT03917654|42247104|FG009|Year 2|Travel|1|||
19789660|NCT03917654|42247105|FG010|Year 2|Travel|0|||
19789661|NCT03917654|42247106|FG011|Year 2|Travel|1|||
19789662|NCT03917654|42247095|FG000|Year 2|Married|1|||
19789663|NCT03917654|42247096|FG001|Year 2|Married|0|||
19789664|NCT03917654|42247097|FG002|Year 2|Married|0|||
19789665|NCT03917654|42247098|FG003|Year 2|Married|0|||
19789666|NCT03917654|42247099|FG004|Year 2|Married|0|||
19789667|NCT03917654|42247100|FG005|Year 2|Married|0|||
19789668|NCT03917654|42247101|FG006|Year 2|Married|1|||
19789669|NCT03917654|42247102|FG007|Year 2|Married|1|||
19789670|NCT03917654|42247103|FG008|Year 2|Married|0|||
19789671|NCT03917654|42247104|FG009|Year 2|Married|0|||
19789672|NCT03917654|42247105|FG010|Year 2|Married|0|||
19789673|NCT03917654|42247106|FG011|Year 2|Married|0|||
19789674|NCT03917654|42247095|FG000|Year 2|Subject moved away from site|1|||
19789675|NCT03917654|42247096|FG001|Year 2|Subject moved away from site|0|||
19789676|NCT03917654|42247097|FG002|Year 2|Subject moved away from site|0|||
19789677|NCT03917654|42247098|FG003|Year 2|Subject moved away from site|0|||
19789678|NCT03917654|42247099|FG004|Year 2|Subject moved away from site|1|||
19789679|NCT03917654|42247100|FG005|Year 2|Subject moved away from site|0|||
19789680|NCT03917654|42247101|FG006|Year 2|Subject moved away from site|2|||
19789681|NCT03917654|42247102|FG007|Year 2|Subject moved away from site|3|||
19789682|NCT03917654|42247103|FG008|Year 2|Subject moved away from site|0|||
19789683|NCT03917654|42247104|FG009|Year 2|Subject moved away from site|2|||
19789684|NCT03917654|42247105|FG010|Year 2|Subject moved away from site|0|||
19789685|NCT03917654|42247106|FG011|Year 2|Subject moved away from site|1|||
19789686|NCT03917654|42247095|FG000|Year 2|Year 2 Screening failure|0|||
19789687|NCT03917654|42247096|FG001|Year 2|Year 2 Screening failure|1|||
19789688|NCT03917654|42247097|FG002|Year 2|Year 2 Screening failure|0|||
19789689|NCT03917654|42247098|FG003|Year 2|Year 2 Screening failure|0|||
19789690|NCT03917654|42247099|FG004|Year 2|Year 2 Screening failure|2|||
19789691|NCT03917654|42247100|FG005|Year 2|Year 2 Screening failure|0|||
19789692|NCT03917654|42247101|FG006|Year 2|Year 2 Screening failure|4|||
19789693|NCT03917654|42247102|FG007|Year 2|Year 2 Screening failure|3|||
19789694|NCT03917654|42247103|FG008|Year 2|Year 2 Screening failure|10|||
19789695|NCT03917654|42247104|FG009|Year 2|Year 2 Screening failure|2|||
19789696|NCT03917654|42247105|FG010|Year 2|Year 2 Screening failure|1|||
19789697|NCT03917654|42247106|FG011|Year 2|Year 2 Screening failure|1|||
19789698|NCT03917654|42247095|FG000|Year 2|Death|0|||
19789699|NCT03917654|42247096|FG001|Year 2|Death|0|||
19789700|NCT03917654|42247097|FG002|Year 2|Death|0|||
19789701|NCT03917654|42247098|FG003|Year 2|Death|0|||
19789702|NCT03917654|42247099|FG004|Year 2|Death|0|||
19789703|NCT03917654|42247100|FG005|Year 2|Death|1|||
19789704|NCT03917654|42247101|FG006|Year 2|Death|0|||
19789705|NCT03917654|42247102|FG007|Year 2|Death|0|||
19789706|NCT03917654|42247103|FG008|Year 2|Death|1|||
19789707|NCT03917654|42247104|FG009|Year 2|Death|1|||
19789708|NCT03917654|42247105|FG010|Year 2|Death|0|||
19789709|NCT03917654|42247106|FG011|Year 2|Death|0|||
19789710|NCT03917654|42247095|FG000|Year 2|Withdrawal by Subject|0|||
19789711|NCT03917654|42247096|FG001|Year 2|Withdrawal by Subject|0|||
19789712|NCT03917654|42247097|FG002|Year 2|Withdrawal by Subject|0|||
19789713|NCT03917654|42247098|FG003|Year 2|Withdrawal by Subject|0|||
19789714|NCT03917654|42247099|FG004|Year 2|Withdrawal by Subject|0|||
19789715|NCT03917654|42247100|FG005|Year 2|Withdrawal by Subject|0|||
19789716|NCT03917654|42247101|FG006|Year 2|Withdrawal by Subject|3|||
19789717|NCT03917654|42247102|FG007|Year 2|Withdrawal by Subject|0|||
19789718|NCT03917654|42247103|FG008|Year 2|Withdrawal by Subject|2|||
19789719|NCT03917654|42247104|FG009|Year 2|Withdrawal by Subject|5|||
19789720|NCT03917654|42247105|FG010|Year 2|Withdrawal by Subject|0|||
19789721|NCT03917654|42247106|FG011|Year 2|Withdrawal by Subject|0|||
19789722|NCT03917654|42247095|FG000|Year 2|Spouse/family member request|0|||
19789723|NCT03917654|42247096|FG001|Year 2|Spouse/family member request|0|||
19789724|NCT03917654|42247097|FG002|Year 2|Spouse/family member request|0|||
19789725|NCT03917654|42247098|FG003|Year 2|Spouse/family member request|0|||
19789726|NCT03917654|42247099|FG004|Year 2|Spouse/family member request|0|||
19789727|NCT03917654|42247100|FG005|Year 2|Spouse/family member request|0|||
19789728|NCT03917654|42247101|FG006|Year 2|Spouse/family member request|1|||
19789729|NCT03917654|42247102|FG007|Year 2|Spouse/family member request|0|||
19789730|NCT03917654|42247103|FG008|Year 2|Spouse/family member request|0|||
19789731|NCT03917654|42247104|FG009|Year 2|Spouse/family member request|0|||
19789732|NCT03917654|42247105|FG010|Year 2|Spouse/family member request|0|||
19789733|NCT03917654|42247106|FG011|Year 2|Spouse/family member request|0|||
19789734|NCT03917654|42247095|FG000|Year 2|Lost to Follow-up|0|||
19789735|NCT03917654|42247096|FG001|Year 2|Lost to Follow-up|0|||
19789736|NCT03917654|42247097|FG002|Year 2|Lost to Follow-up|0|||
19789737|NCT03917654|42247098|FG003|Year 2|Lost to Follow-up|0|||
19789738|NCT03917654|42247099|FG004|Year 2|Lost to Follow-up|0|||
19789739|NCT03917654|42247100|FG005|Year 2|Lost to Follow-up|0|||
19789740|NCT03917654|42247101|FG006|Year 2|Lost to Follow-up|1|||
19789741|NCT03917654|42247102|FG007|Year 2|Lost to Follow-up|0|||
19789742|NCT03917654|42247103|FG008|Year 2|Lost to Follow-up|1|||
19789743|NCT03917654|42247104|FG009|Year 2|Lost to Follow-up|0|||
19789744|NCT03917654|42247105|FG010|Year 2|Lost to Follow-up|0|||
19789745|NCT03917654|42247106|FG011|Year 2|Lost to Follow-up|1|||
19789746|NCT03917654|42247095|FG000|Year 2|Adverse Event|0|||
19789747|NCT03917654|42247096|FG001|Year 2|Adverse Event|0|||
19789748|NCT03917654|42247097|FG002|Year 2|Adverse Event|0|||
19789749|NCT03917654|42247098|FG003|Year 2|Adverse Event|0|||
19789750|NCT03917654|42247099|FG004|Year 2|Adverse Event|0|||
19789751|NCT03917654|42247100|FG005|Year 2|Adverse Event|0|||
19789752|NCT03917654|42247101|FG006|Year 2|Adverse Event|0|||
19789753|NCT03917654|42247102|FG007|Year 2|Adverse Event|0|||
19789754|NCT03917654|42247103|FG008|Year 2|Adverse Event|0|||
19789755|NCT03917654|42247104|FG009|Year 2|Adverse Event|1|||
19789756|NCT03917654|42247105|FG010|Year 2|Adverse Event|0|||
19789757|NCT03917654|42247106|FG011|Year 2|Adverse Event|0|||
19789758|NCT03060577|42247152|FG000|Overall Study|Withdrawal by Subject|25|||
19789759|NCT03060577|42247153|FG001|Overall Study|Withdrawal by Subject|5|||
19789760|NCT03060577|42247152|FG000|Overall Study|Physician Decision|4|||
19789761|NCT03060577|42247153|FG001|Overall Study|Physician Decision|3|||
19789762|NCT03060577|42247152|FG000|Overall Study|Lost to Follow-up|3|||
19789763|NCT03060577|42247153|FG001|Overall Study|Lost to Follow-up|0|||
19789764|NCT03060577|42247152|FG000|Overall Study|Death|7|||
19789765|NCT03060577|42247153|FG001|Overall Study|Death|1|||
19789766|NCT03060577|42247152|FG000|Overall Study|Adverse Event|9|||
19789767|NCT03060577|42247153|FG001|Overall Study|Adverse Event|1|||
19789768|NCT03060577|42247152|FG000|Overall Study|Inclusion/Exclusion|1|||
19789769|NCT03060577|42247153|FG001|Overall Study|Inclusion/Exclusion|0|||
19789770|NCT03060577|42247152|FG000|Overall Study|Other|8|||
19789771|NCT03060577|42247153|FG001|Overall Study|Other|2|||
19789772|NCT02872714|42247164|FG000|Overall Study|Progressive Disease|1|||
19789773|NCT02872714|42247165|FG001|Overall Study|Progressive Disease|2|||
19789774|NCT02872714|42247166|FG002|Overall Study|Progressive Disease|0|||
19789775|NCT02872714|42247167|FG003|Overall Study|Progressive Disease|0|||
19789776|NCT02872714|42247168|FG004|Overall Study|Progressive Disease|0|||
19789777|NCT02872714|42247164|FG000|Overall Study|Death|87|||
19789778|NCT02872714|42247165|FG001|Overall Study|Death|36|||
19789779|NCT02872714|42247166|FG002|Overall Study|Death|8|||
19789780|NCT02872714|42247167|FG003|Overall Study|Death|81|||
19789781|NCT02872714|42247168|FG004|Overall Study|Death|2|||
19789782|NCT02872714|42247164|FG000|Overall Study|Lost to Follow-up|2|||
19789783|NCT02872714|42247165|FG001|Overall Study|Lost to Follow-up|1|||
19789784|NCT02872714|42247166|FG002|Overall Study|Lost to Follow-up|0|||
19789785|NCT02872714|42247167|FG003|Overall Study|Lost to Follow-up|3|||
19789786|NCT02872714|42247168|FG004|Overall Study|Lost to Follow-up|0|||
19789787|NCT02872714|42247164|FG000|Overall Study|Physician Decision|0|||
19789788|NCT02872714|42247165|FG001|Overall Study|Physician Decision|0|||
19789789|NCT02872714|42247166|FG002|Overall Study|Physician Decision|0|||
19789790|NCT02872714|42247167|FG003|Overall Study|Physician Decision|1|||
19789791|NCT02872714|42247168|FG004|Overall Study|Physician Decision|0|||
19789792|NCT02872714|42247164|FG000|Overall Study|Withdrawal by Subject|1|||
19789793|NCT02872714|42247165|FG001|Overall Study|Withdrawal by Subject|3|||
19789794|NCT02872714|42247166|FG002|Overall Study|Withdrawal by Subject|0|||
19789795|NCT02872714|42247167|FG003|Overall Study|Withdrawal by Subject|2|||
19789796|NCT02872714|42247168|FG004|Overall Study|Withdrawal by Subject|0|||
19789797|NCT02872714|42247164|FG000|Overall Study|Captured as Other|2|||
19789798|NCT02872714|42247165|FG001|Overall Study|Captured as Other|0|||
19789799|NCT02872714|42247166|FG002|Overall Study|Captured as Other|0|||
19789800|NCT02872714|42247167|FG003|Overall Study|Captured as Other|1|||
19367460|NCT02435680|41607628|FG002|Overall Study|Adverse Event|2|||
19367461|NCT02435680|41607626|FG000|Overall Study|progressive disease|10|||
19367462|NCT02435680|41607627|FG001|Overall Study|progressive disease|7|||
19477865|NCT01505647|41757140|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
19477866|NCT01505647|41757141|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
19477867|NCT01505647|41757140|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
19477868|NCT01505647|41757141|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
19477869|NCT01505647|41757140|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
19789801|NCT02872714|42247168|FG004|Overall Study|Captured as Other|0|||
19789802|NCT02787005|42247188|FG000|Overall Study|Adverse Event|24|||
19789803|NCT02787005|42247189|FG001|Overall Study|Adverse Event|9|||
19789804|NCT02787005|42247190|FG002|Overall Study|Adverse Event|9|||
19789805|NCT02787005|42247191|FG003|Overall Study|Adverse Event|7|||
19789806|NCT02787005|42247192|FG004|Overall Study|Adverse Event|2|||
19789807|NCT02787005|42247188|FG000|Overall Study|Death|100|||
19789808|NCT02787005|42247189|FG001|Overall Study|Death|53|||
19477870|NCT01505647|41757141|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
19477871|NCT01505647|41757140|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
19477872|NCT01505647|41757141|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
19477873|NCT01477333|41757147|FG000|Overall Study|Adverse Event|1|||
19697864|NCT00467519|42143099|FG000|Overall Study|Protocol Violation|8|||
19697865|NCT00467519|42143100|FG001|Overall Study|Protocol Violation|4|||
19789809|NCT02787005|42247190|FG002|Overall Study|Death|48|||
19789810|NCT02787005|42247191|FG003|Overall Study|Death|69|||
19789811|NCT02787005|42247192|FG004|Overall Study|Death|38|||
19789812|NCT02787005|42247188|FG000|Overall Study|Sponsor Decision|7|||
19789813|NCT02787005|42247189|FG001|Overall Study|Sponsor Decision|4|||
19789814|NCT02787005|42247190|FG002|Overall Study|Sponsor Decision|0|||
19789815|NCT02787005|42247191|FG003|Overall Study|Sponsor Decision|4|||
19789816|NCT02787005|42247192|FG004|Overall Study|Sponsor Decision|5|||
19789817|NCT02787005|42247188|FG000|Overall Study|Withdrawal by Subject|2|||
19789818|NCT02787005|42247189|FG001|Overall Study|Withdrawal by Subject|1|||
19789819|NCT02787005|42247190|FG002|Overall Study|Withdrawal by Subject|1|||
19789820|NCT02787005|42247191|FG003|Overall Study|Withdrawal by Subject|0|||
19789821|NCT02787005|42247192|FG004|Overall Study|Withdrawal by Subject|1|||
19789822|NCT02787005|42247188|FG000|Overall Study|Screen Failure|0|||
19789823|NCT02787005|42247189|FG001|Overall Study|Screen Failure|2|||
19789824|NCT02787005|42247190|FG002|Overall Study|Screen Failure|0|||
19789825|NCT02787005|42247191|FG003|Overall Study|Screen Failure|0|||
19789826|NCT02787005|42247192|FG004|Overall Study|Screen Failure|1|||
19789827|NCT02787005|42247188|FG000|Overall Study|Lost to Follow-up|0|||
19789828|NCT02787005|42247189|FG001|Overall Study|Lost to Follow-up|0|||
19789829|NCT02787005|42247190|FG002|Overall Study|Lost to Follow-up|0|||
19789830|NCT02787005|42247191|FG003|Overall Study|Lost to Follow-up|1|||
19789831|NCT02787005|42247192|FG004|Overall Study|Lost to Follow-up|0|||
19789832|NCT02601313|42247226|FG000|Overall Study|Death|2|||
19789833|NCT02601313|42247227|FG001|Overall Study|Death|16|||
19789834|NCT02601313|42247228|FG002|Overall Study|Death|4|||
19789835|NCT02601313|42247226|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
19789836|NCT02601313|42247227|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
19789837|NCT02601313|42247228|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
19789838|NCT02601313|42247226|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
19789839|NCT02601313|42247227|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
19789840|NCT02601313|42247228|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
19789841|NCT02601313|42247226|FG000|Overall Study|Still on study|0|||
19789842|NCT02601313|42247227|FG001|Overall Study|Still on study|52|||
19789843|NCT02601313|42247228|FG002|Overall Study|Still on study|10|||
19789844|NCT02601313|42247226|FG000|Overall Study|Enrolled, did not initiate AC|4|||
19789845|NCT02601313|42247227|FG001|Overall Study|Enrolled, did not initiate AC|0|||
19789846|NCT02601313|42247228|FG002|Overall Study|Enrolled, did not initiate AC|0|||
19789847|NCT02514083|42247236|FG000|Overall Study|Adverse Event|1|||
19789848|NCT02453282|42247243|FG000|Overall Study|Death|275|||
19789849|NCT02453282|42247244|FG001|Overall Study|Death|277|||
19789850|NCT02453282|42247245|FG002|Overall Study|Death|296|||
19789851|NCT02453282|42247243|FG000|Overall Study|Lost to Follow-up|1|||
19789852|NCT02453282|42247244|FG001|Overall Study|Lost to Follow-up|0|||
19789853|NCT02453282|42247245|FG002|Overall Study|Lost to Follow-up|2|||
19789854|NCT02453282|42247243|FG000|Overall Study|Withdrawal by Subject|12|||
19789855|NCT02453282|42247244|FG001|Overall Study|Withdrawal by Subject|10|||
19789856|NCT02453282|42247245|FG002|Overall Study|Withdrawal by Subject|11|||
19789857|NCT02453282|42247243|FG000|Overall Study|Participants ongoing at data cut-off|85|||
19789858|NCT02453282|42247244|FG001|Overall Study|Participants ongoing at data cut-off|84|||
19789859|NCT02453282|42247245|FG002|Overall Study|Participants ongoing at data cut-off|62|||
19789860|NCT02453282|42247243|FG000|Overall Study|Other|1|||
19789861|NCT02453282|42247244|FG001|Overall Study|Other|1|||
19789862|NCT02453282|42247245|FG002|Overall Study|Other|1|||
19789863|NCT02395848|42247255|FG000|Overall Study|Lost to Follow-up|2|||
19789864|NCT02061761|42247272|FG000|Overall Study|Disease progression|2|||
19697866|NCT00467519|42143099|FG000|Overall Study|Lost to Follow-up|2|||
19697867|NCT00467519|42143100|FG001|Overall Study|Lost to Follow-up|9|||
19697868|NCT00467519|42143099|FG000|Overall Study|Withdrawal by Subject|4|||
19697869|NCT00467519|42143100|FG001|Overall Study|Withdrawal by Subject|10|||
19697870|NCT00264810|42143108|FG000|Baseline|Withdrawal by Subject|10|||
19697871|NCT00264810|42143109|FG001|Baseline|Withdrawal by Subject|10|||
19789865|NCT02061761|42247273|FG001|Overall Study|Disease progression|8|||
19789866|NCT02061761|42247274|FG002|Overall Study|Disease progression|4|||
19789867|NCT02061761|42247275|FG003|Overall Study|Disease progression|5|||
19789868|NCT02061761|42247276|FG004|Overall Study|Disease progression|9|||
19789869|NCT02061761|42247277|FG005|Overall Study|Disease progression|3|||
19789870|NCT02061761|42247278|FG006|Overall Study|Disease progression|1|||
19477874|NCT01477333|41757147|FG000|Overall Study|Withdrawal by Subject|1|||
19789871|NCT02061761|42247279|FG007|Overall Study|Disease progression|2|||
19789872|NCT02061761|42247280|FG008|Overall Study|Disease progression|28|||
19789873|NCT02061761|42247272|FG000|Overall Study|Study Drug toxicity|0|||
19789874|NCT02061761|42247273|FG001|Overall Study|Study Drug toxicity|0|||
19789875|NCT02061761|42247274|FG002|Overall Study|Study Drug toxicity|0|||
19789876|NCT02061761|42247275|FG003|Overall Study|Study Drug toxicity|0|||
19789877|NCT02061761|42247276|FG004|Overall Study|Study Drug toxicity|0|||
19789878|NCT02061761|42247277|FG005|Overall Study|Study Drug toxicity|1|||
19789879|NCT02061761|42247278|FG006|Overall Study|Study Drug toxicity|0|||
19789880|NCT02061761|42247279|FG007|Overall Study|Study Drug toxicity|2|||
19789881|NCT02061761|42247280|FG008|Overall Study|Study Drug toxicity|6|||
19789882|NCT02061761|42247272|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
19789883|NCT02061761|42247273|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
19789884|NCT02061761|42247274|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
19789885|NCT02061761|42247275|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
19789886|NCT02061761|42247276|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
19789887|NCT02061761|42247277|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
19789888|NCT02061761|42247278|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
19789889|NCT02061761|42247279|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
19789890|NCT02061761|42247280|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
19789891|NCT02061761|42247272|FG000|Overall Study|Participant request to discontinue study treatment|0|||
19789892|NCT02061761|42247273|FG001|Overall Study|Participant request to discontinue study treatment|0|||
19789893|NCT02061761|42247274|FG002|Overall Study|Participant request to discontinue study treatment|2|||
19789894|NCT02061761|42247275|FG003|Overall Study|Participant request to discontinue study treatment|2|||
19789895|NCT02061761|42247276|FG004|Overall Study|Participant request to discontinue study treatment|0|||
19789896|NCT02061761|42247277|FG005|Overall Study|Participant request to discontinue study treatment|1|||
19789897|NCT02061761|42247278|FG006|Overall Study|Participant request to discontinue study treatment|0|||
19789898|NCT02061761|42247279|FG007|Overall Study|Participant request to discontinue study treatment|0|||
19789899|NCT02061761|42247280|FG008|Overall Study|Participant request to discontinue study treatment|2|||
19789900|NCT02061761|42247272|FG000|Overall Study|Withdrawal by Subject|0|||
19789901|NCT02061761|42247273|FG001|Overall Study|Withdrawal by Subject|0|||
19789902|NCT02061761|42247274|FG002|Overall Study|Withdrawal by Subject|0|||
19789903|NCT02061761|42247275|FG003|Overall Study|Withdrawal by Subject|0|||
19789904|NCT02061761|42247276|FG004|Overall Study|Withdrawal by Subject|0|||
19789905|NCT02061761|42247277|FG005|Overall Study|Withdrawal by Subject|0|||
19789906|NCT02061761|42247278|FG006|Overall Study|Withdrawal by Subject|0|||
19789907|NCT02061761|42247279|FG007|Overall Study|Withdrawal by Subject|0|||
19789908|NCT02061761|42247280|FG008|Overall Study|Withdrawal by Subject|2|||
19789909|NCT02061761|42247272|FG000|Overall Study|Maximum clinical benefit|0|||
19789910|NCT02061761|42247273|FG001|Overall Study|Maximum clinical benefit|0|||
19789911|NCT02061761|42247274|FG002|Overall Study|Maximum clinical benefit|0|||
19789912|NCT02061761|42247275|FG003|Overall Study|Maximum clinical benefit|1|||
19789913|NCT02061761|42247276|FG004|Overall Study|Maximum clinical benefit|0|||
19789914|NCT02061761|42247277|FG005|Overall Study|Maximum clinical benefit|0|||
19789915|NCT02061761|42247278|FG006|Overall Study|Maximum clinical benefit|0|||
19789916|NCT02061761|42247279|FG007|Overall Study|Maximum clinical benefit|0|||
19789917|NCT02061761|42247280|FG008|Overall Study|Maximum clinical benefit|6|||
19789918|NCT02061761|42247272|FG000|Overall Study|Participant no longer meets study criteria|0|||
19789919|NCT02061761|42247273|FG001|Overall Study|Participant no longer meets study criteria|0|||
19789920|NCT02061761|42247274|FG002|Overall Study|Participant no longer meets study criteria|0|||
19789921|NCT02061761|42247275|FG003|Overall Study|Participant no longer meets study criteria|0|||
19789922|NCT02061761|42247276|FG004|Overall Study|Participant no longer meets study criteria|0|||
19789923|NCT02061761|42247277|FG005|Overall Study|Participant no longer meets study criteria|0|||
19789924|NCT02061761|42247278|FG006|Overall Study|Participant no longer meets study criteria|0|||
19789925|NCT02061761|42247279|FG007|Overall Study|Participant no longer meets study criteria|0|||
19789926|NCT02061761|42247280|FG008|Overall Study|Participant no longer meets study criteria|1|||
19789927|NCT02061761|42247272|FG000|Overall Study|Other reasons|0|||
19789928|NCT02061761|42247273|FG001|Overall Study|Other reasons|0|||
19789929|NCT02061761|42247274|FG002|Overall Study|Other reasons|0|||
19789930|NCT02061761|42247275|FG003|Overall Study|Other reasons|0|||
19789931|NCT02061761|42247276|FG004|Overall Study|Other reasons|2|||
19789932|NCT02061761|42247277|FG005|Overall Study|Other reasons|0|||
19697872|NCT00264810|42143108|FG000|Baseline|Physician Decision|7|||
19697873|NCT00264810|42143109|FG001|Baseline|Physician Decision|8|||
19697874|NCT00264810|42143108|FG000|Baseline|Subject Compliance Failure|3|||
19697875|NCT00264810|42143109|FG001|Baseline|Subject Compliance Failure|3|||
19697876|NCT00264810|42143108|FG000|Baseline|Insufficient Seizure Frequency|2|||
19697877|NCT00264810|42143109|FG001|Baseline|Insufficient Seizure Frequency|2|||
19697878|NCT00264810|42143108|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
19697879|NCT00264810|42143109|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
19697880|NCT00264810|42143108|FG000|Baseline|Other|0|||
19697881|NCT00264810|42143109|FG001|Baseline|Other|1|||
19697882|NCT00264810|42143108|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
19697883|NCT00264810|42143109|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
19697884|NCT00264810|42143108|FG000|Stimulation Optimization Period|Death|0|||
19789933|NCT02061761|42247278|FG006|Overall Study|Other reasons|0|||
19789934|NCT02061761|42247279|FG007|Overall Study|Other reasons|0|||
19789935|NCT02061761|42247280|FG008|Overall Study|Other reasons|6|||
19789936|NCT01927068|42247308|FG000|Overall Study|Death|37|||
19789937|NCT01927068|42247309|FG001|Overall Study|Death|3|||
19789938|NCT01927068|42247308|FG000|Overall Study|Withdrawal by Subject|50|||
19789939|NCT01927068|42247309|FG001|Overall Study|Withdrawal by Subject|3|||
19789940|NCT01927068|42247308|FG000|Overall Study|Lost to Follow-up|10|||
19789941|NCT01927068|42247309|FG001|Overall Study|Lost to Follow-up|2|||
19789942|NCT01927068|42247308|FG000|Overall Study|Physician Decision|9|||
19789943|NCT01927068|42247309|FG001|Overall Study|Physician Decision|0|||
19789944|NCT01927068|42247308|FG000|Overall Study|Missed last follow-up visit|2|||
19789945|NCT01927068|42247309|FG001|Overall Study|Missed last follow-up visit|0|||
19789946|NCT01309230|42247318|FG000|Overall Study|Withdrawal by Subject|0|||
19789947|NCT01309230|42247319|FG001|Overall Study|Withdrawal by Subject|2|||
19789948|NCT01309230|42247318|FG000|Overall Study|Observation arm closed|0|||
19789949|NCT01309230|42247319|FG001|Overall Study|Observation arm closed|2|||
19789950|NCT00819832|42247331|FG000|Overall Study|Sponsor Termination of Study|3|||
19697885|NCT00264810|42143109|FG001|Stimulation Optimization Period|Death|1|||
19697886|NCT00264810|42143108|FG000|Blinded Evaluation Period|Explant due to infection|1|||
19697887|NCT00264810|42143109|FG001|Blinded Evaluation Period|Explant due to infection|1|||
19697888|NCT00264810|42143108|FG000|Open Label Evaluation Period|Explant due to infection|1|||
19697889|NCT00264810|42143109|FG001|Open Label Evaluation Period|Explant due to infection|1|||
19697890|NCT00264810|42143108|FG000|Open Label Evaluation Period|Death|3|||
19697891|NCT00264810|42143109|FG001|Open Label Evaluation Period|Death|2|||
19697892|NCT00264810|42143108|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
19697893|NCT00264810|42143109|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
19697894|NCT00467363|42143119|FG000|Overall Study|Lost to Follow-up|80|||
19697895|NCT00467363|42143120|FG001|Overall Study|Lost to Follow-up|70|||
19697896|NCT00091390|42143126|FG000|Overall Study|Protocol Violation|1|||
19697897|NCT00091390|42143126|FG000|Overall Study|No protocol treatment|3|||
19697898|NCT00239226|42143134|FG000|Overall Study|permAF during stabilization period|0|||
19697899|NCT00239226|42143135|FG001|Overall Study|permAF during stabilization period|0|||
19697900|NCT00239226|42143136|FG002|Overall Study|permAF during stabilization period|0|||
19697901|NCT00239226|42143137|FG003|Overall Study|permAF during stabilization period|3|||
19697902|NCT00239226|42143134|FG000|Overall Study|Lost to Follow-up|1|||
19697903|NCT00239226|42143135|FG001|Overall Study|Lost to Follow-up|0|||
19697904|NCT00239226|42143136|FG002|Overall Study|Lost to Follow-up|1|||
19697905|NCT00239226|42143137|FG003|Overall Study|Lost to Follow-up|0|||
19697906|NCT00467285|42143149|FG000|Overall Study|Lost to Follow-up|4|||
19697907|NCT00467285|42143150|FG001|Overall Study|Lost to Follow-up|4|||
19697908|NCT00264576|42143160|FG000|Overall Study|Lost to Follow-up|1|||
19697909|NCT00264576|42143161|FG001|Overall Study|Lost to Follow-up|1|||
19697910|NCT00466505|42143168|FG000|Overall Study|disease progression|13|||
19697911|NCT00466505|42143168|FG000|Overall Study|Adverse Event|4|||
19697912|NCT00467051|42143172|FG000|Overall Study|Adverse Event|2|||
19697913|NCT00264498|42143179|FG000|Randomized Treatment|Death|0|||
19697914|NCT00264498|42143180|FG001|Randomized Treatment|Death|3|||
19697915|NCT00264498|42143179|FG000|Randomized Treatment|Withdrawal by Subject|0|||
19697916|NCT00264498|42143180|FG001|Randomized Treatment|Withdrawal by Subject|1|||
19697917|NCT00264498|42143179|FG000|Randomized Treatment|Objective disease Progression|13|||
19697918|NCT00264498|42143180|FG001|Randomized Treatment|Objective disease Progression|14|||
19697919|NCT00264498|42143179|FG000|Randomized Treatment|Physician Decision|1|||
19697920|NCT00264498|42143180|FG001|Randomized Treatment|Physician Decision|0|||
19697921|NCT00264498|42143179|FG000|Randomized Treatment|Incorrectly randomized|1|||
19697922|NCT00264498|42143180|FG001|Randomized Treatment|Incorrectly randomized|0|||
19697923|NCT00264498|42143179|FG000|Randomized Treatment|Study Closure|1|||
19697924|NCT00264498|42143180|FG001|Randomized Treatment|Study Closure|0|||
19697925|NCT00264498|42143179|FG000|Randomized Treatment|Protocol Violation|1|||
19789951|NCT00819832|42247332|FG001|Overall Study|Sponsor Termination of Study|0|||
19789952|NCT00819832|42247333|FG002|Overall Study|Sponsor Termination of Study|0|||
19789953|NCT00819832|42247334|FG003|Overall Study|Sponsor Termination of Study|0|||
19789954|NCT00819832|42247335|FG004|Overall Study|Sponsor Termination of Study|0|||
19789955|NCT00819832|42247336|FG005|Overall Study|Sponsor Termination of Study|0|||
19789956|NCT00704522|42247352|FG000|Overall Study|Lack of Efficacy|65|||
19789957|NCT00704522|42247353|FG001|Overall Study|Lack of Efficacy|17|||
19789958|NCT00704522|42247352|FG000|Overall Study|Failure to appear again at hospital|56|||
19789959|NCT00704522|42247353|FG001|Overall Study|Failure to appear again at hospital|10|||
19789960|NCT00704522|42247352|FG000|Overall Study|Withdrawal by Subject|17|||
19697926|NCT00264498|42143180|FG001|Randomized Treatment|Protocol Violation|0|||
19697927|NCT00264498|42143179|FG000|Crossover Treatment|Death|1|||
19789961|NCT00704522|42247353|FG001|Overall Study|Withdrawal by Subject|8|||
19789962|NCT00704522|42247352|FG000|Overall Study|Adverse Event|9|||
19789963|NCT00704522|42247353|FG001|Overall Study|Adverse Event|1|||
19789964|NCT00704522|42247352|FG000|Overall Study|Undefined causes|9|||
19789965|NCT00704522|42247353|FG001|Overall Study|Undefined causes|7|||
19789966|NCT00704522|42247352|FG000|Overall Study|No information on therapy end|27|||
19789967|NCT00704522|42247353|FG001|Overall Study|No information on therapy end|2|||
19789968|NCT02723630|42247364|FG000|Intervention Period 1|Adverse Event|1|||
19789969|NCT02723630|42247365|FG001|Intervention Period 1|Adverse Event|0|||
19789970|NCT02723630|42247366|FG002|Intervention Period 1|Adverse Event|0|||
19789971|NCT02723630|42247367|FG003|Intervention Period 1|Adverse Event|0|||
19789972|NCT02723630|42247368|FG004|Intervention Period 1|Adverse Event|0|||
19789973|NCT02723630|42247369|FG005|Intervention Period 1|Adverse Event|0|||
19789974|NCT02723630|42247364|FG000|Intervention Period 3|consumption of restricted item|0|||
19789975|NCT02723630|42247365|FG001|Intervention Period 3|consumption of restricted item|1|||
19789976|NCT02723630|42247366|FG002|Intervention Period 3|consumption of restricted item|0|||
19789977|NCT02723630|42247367|FG003|Intervention Period 3|consumption of restricted item|0|||
19789978|NCT02723630|42247368|FG004|Intervention Period 3|consumption of restricted item|0|||
19789979|NCT02723630|42247369|FG005|Intervention Period 3|consumption of restricted item|0|||
19789980|NCT01876784|42247408|FG000|Overall Study|Withdrawal by Subject|17|||
19789981|NCT01876784|42247409|FG001|Overall Study|Withdrawal by Subject|2|||
19789982|NCT01876784|42247408|FG000|Overall Study|Adverse Event|15|||
19789983|NCT01876784|42247409|FG001|Overall Study|Adverse Event|2|||
19789984|NCT01876784|42247408|FG000|Overall Study|Protocol Violation|1|||
19789985|NCT01876784|42247409|FG001|Overall Study|Protocol Violation|0|||
19789986|NCT01876784|42247408|FG000|Overall Study|Disease progression|37|||
19789987|NCT01876784|42247409|FG001|Overall Study|Disease progression|67|||
19789988|NCT01876784|42247408|FG000|Overall Study|Lost to Follow-up|0|||
19789989|NCT01876784|42247409|FG001|Overall Study|Lost to Follow-up|1|||
19789990|NCT01876784|42247408|FG000|Overall Study|Death|1|||
19789991|NCT01876784|42247409|FG001|Overall Study|Death|0|||
19789992|NCT01876784|42247408|FG000|Overall Study|Randomized but not treated|2|||
19789993|NCT01876784|42247409|FG001|Overall Study|Randomized but not treated|1|||
19789994|NCT01876784|42247408|FG000|Overall Study|Other than specified above|5|||
19789995|NCT01876784|42247409|FG001|Overall Study|Other than specified above|6|||
19789996|NCT01876784|42247408|FG000|Overall Study|Ongoing|41|||
19789997|NCT01876784|42247409|FG001|Overall Study|Ongoing|40|||
19789998|NCT04205162|42247417|FG000|Overall Study|Lost to Follow-up|1|||
19789999|NCT04205162|42247418|FG001|Overall Study|Lost to Follow-up|0|||
19790000|NCT04205162|42247417|FG000|Overall Study|Withdrawal by Subject|2|||
19790001|NCT04205162|42247418|FG001|Overall Study|Withdrawal by Subject|0|||
19790002|NCT04205162|42247417|FG000|Overall Study|University closure due to COVID-19|1|||
19790003|NCT04205162|42247418|FG001|Overall Study|University closure due to COVID-19|0|||
19790004|NCT01329939|42247429|FG000|Overall Study|Lost to Follow-up|3|||
19790005|NCT01329939|42247430|FG001|Overall Study|Lost to Follow-up|0|||
19790006|NCT01329939|42247431|FG002|Overall Study|Lost to Follow-up|1|||
19790007|NCT01329939|42247432|FG003|Overall Study|Lost to Follow-up|2|||
19790008|NCT01329939|42247429|FG000|Overall Study|Withdrawal by Subject|0|||
19790009|NCT01329939|42247430|FG001|Overall Study|Withdrawal by Subject|1|||
19790010|NCT01329939|42247431|FG002|Overall Study|Withdrawal by Subject|0|||
19790011|NCT01329939|42247432|FG003|Overall Study|Withdrawal by Subject|0|||
19790012|NCT01329939|42247429|FG000|Overall Study|Adverse Event|0|||
19790013|NCT01329939|42247430|FG001|Overall Study|Adverse Event|0|||
19790014|NCT01329939|42247431|FG002|Overall Study|Adverse Event|0|||
19790015|NCT01329939|42247432|FG003|Overall Study|Adverse Event|3|||
19790016|NCT02499900|42247444|FG000|Core Study Period|Other|1|||
19790017|NCT02499900|42247445|FG001|Core Study Period|Other|4|||
19790018|NCT02499900|42247444|FG000|Core Study Period|Lost to Follow-up|1|||
19790019|NCT02499900|42247445|FG001|Core Study Period|Lost to Follow-up|2|||
19790020|NCT02499900|42247444|FG000|Core Study Period|Per sponsor request|0|||
19790021|NCT02499900|42247445|FG001|Core Study Period|Per sponsor request|1|||
19790022|NCT02499900|42247444|FG000|Core Study Period|Pregnancy|1|||
19790023|NCT02499900|42247445|FG001|Core Study Period|Pregnancy|0|||
19790024|NCT02499900|42247444|FG000|Core Study Period|Protocol Violation|3|||
19790025|NCT02499900|42247445|FG001|Core Study Period|Protocol Violation|0|||
19790026|NCT02499900|42247444|FG000|Core Study Period|Withdrawal by Subject|11|||
19790027|NCT02499900|42247445|FG001|Core Study Period|Withdrawal by Subject|10|||
19790028|NCT02499900|42247444|FG000|Core Study Period|Adverse Event|18|||
19790029|NCT02499900|42247445|FG001|Core Study Period|Adverse Event|14|||
19790030|NCT02499900|42247444|FG000|Core Study Period|Death|0|||
19790031|NCT02499900|42247445|FG001|Core Study Period|Death|1|||
19790032|NCT02499900|42247444|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
19790033|NCT02499900|42247445|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
19790034|NCT02499900|42247444|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
19790035|NCT02499900|42247445|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
19790036|NCT02499900|42247444|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
19790037|NCT02499900|42247445|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
19790038|NCT02499900|42247444|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
19790039|NCT02499900|42247445|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
19790040|NCT02499900|42247444|FG000|Extension Study Period|Adverse Event|2|||
19790041|NCT02499900|42247445|FG001|Extension Study Period|Adverse Event|4|||
19790042|NCT02499900|42247444|FG000|Extension Study Period|Withdrawal by Subject|5|||
19790043|NCT02499900|42247445|FG001|Extension Study Period|Withdrawal by Subject|2|||
19790044|NCT02499900|42247444|FG000|Extension Study Period|Physician Decision|2|||
19790045|NCT02499900|42247445|FG001|Extension Study Period|Physician Decision|5|||
19790046|NCT02499900|42247444|FG000|Extension Study Period|Pregnancy|1|||
19790047|NCT02499900|42247445|FG001|Extension Study Period|Pregnancy|2|||
19790048|NCT02499900|42247444|FG000|Extension Study Period|Lost to Follow-up|2|||
19790049|NCT02499900|42247445|FG001|Extension Study Period|Lost to Follow-up|5|||
19790050|NCT02499900|42247444|FG000|Extension Study Period|Other|0|||
19790051|NCT02499900|42247445|FG001|Extension Study Period|Other|2|||
19790052|NCT03505749|42247459|FG000|Overall Study|Lost to Follow-up|7|||
19790053|NCT03505749|42247460|FG001|Overall Study|Lost to Follow-up|11|||
19790054|NCT03505749|42247459|FG000|Overall Study|Withdrawal by Subject|6|||
19790055|NCT03505749|42247460|FG001|Overall Study|Withdrawal by Subject|0|||
19790056|NCT03505749|42247459|FG000|Overall Study|Discharged from treatment|3|||
19790057|NCT03505749|42247460|FG001|Overall Study|Discharged from treatment|6|||
19790058|NCT03710642|42247484|FG000|Overall Study|Adverse Event|5|||
19790059|NCT03710642|42247485|FG001|Overall Study|Adverse Event|1|||
19790060|NCT03710642|42247484|FG000|Overall Study|non-site physician recommendation|1|||
19790061|NCT03710642|42247485|FG001|Overall Study|non-site physician recommendation|0|||
19790062|NCT03710642|42247484|FG000|Overall Study|Participant unwilling or unable to participate|1|||
19790063|NCT03710642|42247485|FG001|Overall Study|Participant unwilling or unable to participate|1|||
19790064|NCT03710642|42247484|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
19790065|NCT03710642|42247485|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
19790066|NCT03710642|42247484|FG000|Overall Study|NA-no code provided|1|||
19790067|NCT03710642|42247485|FG001|Overall Study|NA-no code provided|0|||
19790068|NCT03710642|42247484|FG000|Overall Study|Withdrawal by Subject|1|||
19790069|NCT03710642|42247485|FG001|Overall Study|Withdrawal by Subject|0|||
19790070|NCT00705224|42247491|FG000|Overall Study|Adverse Event|1|||
19790071|NCT00705224|42247491|FG000|Overall Study|Lack of Efficacy|2|||
19790072|NCT00705224|42247491|FG000|Overall Study|Withdrawal by Subject|3|||
19790073|NCT00705224|42247491|FG000|Overall Study|Lost to Follow-up|5|||
19790074|NCT02722148|42247498|FG000|Overall Study|Lost to Follow-up|2|||
19790075|NCT02722148|42247498|FG000|Overall Study|Non compliant with treatment regimen|3|||
19790076|NCT00704132|42247504|FG000|Overall Study|Clinical Adverse Experience|1|||
19790077|NCT00704132|42247505|FG001|Overall Study|Clinical Adverse Experience|0|||
19790078|NCT00704132|42247504|FG000|Overall Study|Lack of Efficacy|0|||
19790079|NCT00704132|42247505|FG001|Overall Study|Lack of Efficacy|1|||
19790080|NCT00704132|42247504|FG000|Overall Study|Withdrawal by Subject|0|||
19790081|NCT00704132|42247505|FG001|Overall Study|Withdrawal by Subject|1|||
19790082|NCT01329549|42247520|FG000|Overall Study|Withdrawal by Subject|1|||
19790083|NCT01329549|42247520|FG000|Overall Study|Adverse Event|1|||
19790084|NCT02736474|42247526|FG000|Overall Study|Lost to Follow-up|0|||
19790085|NCT02736474|42247527|FG001|Overall Study|Lost to Follow-up|1|||
19790086|NCT00702650|42247549|FG000|Overall Study|Withdrawal by Subject|9|||
19790087|NCT00702650|42247549|FG000|Overall Study|Non-Compliance of Study Drug|3|||
19790088|NCT00702650|42247549|FG000|Overall Study|Lost to Follow-up|2|||
19790089|NCT00702650|42247549|FG000|Overall Study|Non-Compliance with Site Directives|1|||
19790090|NCT00702650|42247549|FG000|Overall Study|Sponsor Request|1|||
19790091|NCT00702650|42247549|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
19790092|NCT00702650|42247549|FG000|Overall Study|Adverse Event|3|||
19790093|NCT03230916|42247564|FG000|Overall Study|Withdrawal by Subject|0|||
19790094|NCT03230916|42247565|FG001|Overall Study|Withdrawal by Subject|0|||
19790095|NCT03230916|42247566|FG002|Overall Study|Withdrawal by Subject|0|||
19790096|NCT03230916|42247567|FG003|Overall Study|Withdrawal by Subject|0|||
19790097|NCT03230916|42247568|FG004|Overall Study|Withdrawal by Subject|0|||
19790098|NCT03230916|42247569|FG005|Overall Study|Withdrawal by Subject|1|||
19790099|NCT03230916|42247570|FG006|Overall Study|Withdrawal by Subject|0|||
19790100|NCT03230916|42247571|FG007|Overall Study|Withdrawal by Subject|0|||
19790101|NCT03230916|42247572|FG008|Overall Study|Withdrawal by Subject|0|||
19790102|NCT03230916|42247573|FG009|Overall Study|Withdrawal by Subject|0|||
19790103|NCT03230916|42247574|FG010|Overall Study|Withdrawal by Subject|0|||
19790104|NCT01337115|42247617|FG000|Overall Study|Protocol Violation|2|||
19790105|NCT01337115|42247618|FG001|Overall Study|Protocol Violation|0|||
19790106|NCT03761784|42247628|FG000|Overall Study|Adverse Event|4|||
19790107|NCT03761784|42247629|FG001|Overall Study|Adverse Event|0|||
19790108|NCT03761784|42247628|FG000|Overall Study|Lost to Follow-up|10|||
19790109|NCT03761784|42247629|FG001|Overall Study|Lost to Follow-up|7|||
19790110|NCT03761784|42247628|FG000|Overall Study|Pregnancy|1|||
19790111|NCT03761784|42247629|FG001|Overall Study|Pregnancy|0|||
19790112|NCT03761784|42247628|FG000|Overall Study|Protocol Violation|2|||
19790113|NCT03761784|42247629|FG001|Overall Study|Protocol Violation|0|||
19790114|NCT03761784|42247628|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
19790115|NCT03761784|42247629|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
19790116|NCT03761784|42247628|FG000|Overall Study|Withdrawal by Subject|9|||
19790117|NCT03761784|42247629|FG001|Overall Study|Withdrawal by Subject|4|||
19790118|NCT03761784|42247628|FG000|Overall Study|Physician Decision|1|||
19790119|NCT03761784|42247629|FG001|Overall Study|Physician Decision|0|||
19790120|NCT03761784|42247628|FG000|Overall Study|Other Than Specified|1|||
19790121|NCT03761784|42247629|FG001|Overall Study|Other Than Specified|0|||
19790122|NCT03195894|42247637|FG000|Overall Study|"An example is Started other treatment."|4|||
19790123|NCT03195894|42247638|FG001|Overall Study|"An example is Started other treatment."|5|||
19790124|NCT03195894|42247637|FG000|Overall Study|Withdrawal by Subject|15|||
19790125|NCT03195894|42247638|FG001|Overall Study|Withdrawal by Subject|4|||
19790126|NCT03195894|42247637|FG000|Overall Study|Lost to Follow-up|14|||
19790127|NCT03195894|42247638|FG001|Overall Study|Lost to Follow-up|19|||
19790128|NCT01337973|42247650|FG000|Overall Study|Lost to Follow-up|2|||
19790129|NCT01337973|42247651|FG001|Overall Study|Lost to Follow-up|4|||
19790130|NCT01337973|42247652|FG002|Overall Study|Lost to Follow-up|3|||
19790131|NCT01337973|42247650|FG000|Overall Study|Death|1|||
19790132|NCT01337973|42247651|FG001|Overall Study|Death|2|||
19790133|NCT01337973|42247652|FG002|Overall Study|Death|1|||
19790134|NCT01337973|42247650|FG000|Overall Study|Withdrawal by Subject|10|||
19790135|NCT01337973|42247651|FG001|Overall Study|Withdrawal by Subject|8|||
19790136|NCT01337973|42247652|FG002|Overall Study|Withdrawal by Subject|4|||
19790137|NCT01337973|42247650|FG000|Overall Study|missing data on primary outcome|3|||
19790138|NCT01337973|42247651|FG001|Overall Study|missing data on primary outcome|1|||
19790139|NCT01337973|42247652|FG002|Overall Study|missing data on primary outcome|3|||
19790140|NCT02929056|42247662|FG000|Overall Study|Lost to Follow-up|0|||
19790141|NCT02929056|42247663|FG001|Overall Study|Lost to Follow-up|1|||
19790142|NCT00157755|42247682|FG000|Overall Study|Death|2|||
19790143|NCT00157755|42247683|FG001|Overall Study|Death|3|||
19790144|NCT00157755|42247684|FG002|Overall Study|Death|3|||
19790145|NCT00157755|42247685|FG003|Overall Study|Death|2|||
19790146|NCT00157755|42247686|FG004|Overall Study|Death|0|||
19790147|NCT00157755|42247687|FG005|Overall Study|Death|0|||
19790148|NCT00157755|42247682|FG000|Overall Study|Lost to Follow-up|0|||
19790149|NCT00157755|42247683|FG001|Overall Study|Lost to Follow-up|0|||
19790150|NCT00157755|42247684|FG002|Overall Study|Lost to Follow-up|1|||
19790151|NCT00157755|42247685|FG003|Overall Study|Lost to Follow-up|0|||
19790152|NCT00157755|42247686|FG004|Overall Study|Lost to Follow-up|0|||
19790153|NCT00157755|42247687|FG005|Overall Study|Lost to Follow-up|0|||
19790154|NCT00157755|42247682|FG000|Overall Study|Withdrawal by Subject|0|||
19790155|NCT00157755|42247683|FG001|Overall Study|Withdrawal by Subject|0|||
19790156|NCT00157755|42247684|FG002|Overall Study|Withdrawal by Subject|1|||
19790157|NCT00157755|42247685|FG003|Overall Study|Withdrawal by Subject|1|||
19790158|NCT00157755|42247686|FG004|Overall Study|Withdrawal by Subject|1|||
19790159|NCT00157755|42247687|FG005|Overall Study|Withdrawal by Subject|2|||
19790160|NCT00157755|42247682|FG000|Overall Study|Explant due to infection|0|||
19790161|NCT00157755|42247683|FG001|Overall Study|Explant due to infection|0|||
19790162|NCT00157755|42247684|FG002|Overall Study|Explant due to infection|1|||
19790163|NCT00157755|42247685|FG003|Overall Study|Explant due to infection|0|||
19790164|NCT00157755|42247686|FG004|Overall Study|Explant due to infection|0|||
19790165|NCT00157755|42247687|FG005|Overall Study|Explant due to infection|0|||
19790166|NCT00157755|42247682|FG000|Overall Study|Medical reason|0|||
19790167|NCT00157755|42247683|FG001|Overall Study|Medical reason|0|||
19790168|NCT00157755|42247684|FG002|Overall Study|Medical reason|1|||
19790169|NCT00157755|42247685|FG003|Overall Study|Medical reason|1|||
19790170|NCT00157755|42247686|FG004|Overall Study|Medical reason|0|||
19790171|NCT00157755|42247687|FG005|Overall Study|Medical reason|0|||
19790172|NCT00157755|42247682|FG000|Overall Study|Study site closure|0|||
19790173|NCT00157755|42247683|FG001|Overall Study|Study site closure|1|||
19790174|NCT00157755|42247684|FG002|Overall Study|Study site closure|0|||
19790175|NCT00157755|42247685|FG003|Overall Study|Study site closure|0|||
19790176|NCT00157755|42247686|FG004|Overall Study|Study site closure|0|||
19790177|NCT00157755|42247687|FG005|Overall Study|Study site closure|0|||
19790178|NCT00157755|42247682|FG000|Overall Study|Subject non-compliance|0|||
19367463|NCT02435680|41607628|FG002|Overall Study|progressive disease|11|||
19790179|NCT00157755|42247683|FG001|Overall Study|Subject non-compliance|0|||
19790180|NCT00157755|42247684|FG002|Overall Study|Subject non-compliance|0|||
19790181|NCT00157755|42247685|FG003|Overall Study|Subject non-compliance|0|||
19790182|NCT00157755|42247686|FG004|Overall Study|Subject non-compliance|0|||
19790183|NCT00157755|42247687|FG005|Overall Study|Subject non-compliance|1|||
19790184|NCT00157755|42247682|FG000|Overall Study|Study completion|0|||
19790185|NCT00157755|42247683|FG001|Overall Study|Study completion|0|||
19790186|NCT00157755|42247684|FG002|Overall Study|Study completion|0|||
19790187|NCT00157755|42247685|FG003|Overall Study|Study completion|0|||
19790188|NCT00157755|42247686|FG004|Overall Study|Study completion|1|||
19790189|NCT00157755|42247687|FG005|Overall Study|Study completion|2|||
19790190|NCT02723006|42247696|FG000|Overall Study|Withdrawal by Subject|0|||
19790191|NCT02723006|42247697|FG001|Overall Study|Withdrawal by Subject|1|||
19790192|NCT02723006|42247698|FG002|Overall Study|Withdrawal by Subject|1|||
19790193|NCT02723006|42247696|FG000|Overall Study|Study Terminated by Sponsor|1|||
19790194|NCT02723006|42247697|FG001|Overall Study|Study Terminated by Sponsor|6|||
19790195|NCT02723006|42247698|FG002|Overall Study|Study Terminated by Sponsor|6|||
19790196|NCT04003389|42247709|FG000|Overall Study|Adverse Event|27|||
19790197|NCT04003389|42247710|FG001|Overall Study|Adverse Event|34|||
19790198|NCT04003389|42247711|FG002|Overall Study|Adverse Event|28|||
19790199|NCT04003389|42247709|FG000|Overall Study|Lost to Follow-up|39|||
19790200|NCT04003389|42247710|FG001|Overall Study|Lost to Follow-up|30|||
19790201|NCT04003389|42247711|FG002|Overall Study|Lost to Follow-up|33|||
19790202|NCT04003389|42247709|FG000|Overall Study|Protocol Violation|1|||
19790203|NCT04003389|42247710|FG001|Overall Study|Protocol Violation|6|||
19790204|NCT04003389|42247711|FG002|Overall Study|Protocol Violation|5|||
19790205|NCT04003389|42247709|FG000|Overall Study|Withdrawal by Subject|119|||
19790206|NCT04003389|42247710|FG001|Overall Study|Withdrawal by Subject|79|||
19790207|NCT04003389|42247711|FG002|Overall Study|Withdrawal by Subject|85|||
19790208|NCT04003389|42247709|FG000|Overall Study|Miscellaneous|14|||
19790209|NCT04003389|42247710|FG001|Overall Study|Miscellaneous|11|||
19790210|NCT04003389|42247711|FG002|Overall Study|Miscellaneous|14|||
19790211|NCT04003389|42247709|FG000|Overall Study|Participant did not receive study drug|1|||
19790212|NCT04003389|42247710|FG001|Overall Study|Participant did not receive study drug|0|||
19790213|NCT04003389|42247711|FG002|Overall Study|Participant did not receive study drug|0|||
19790214|NCT00702962|42247721|FG000|Overall Study|Progressive disease|0|||
19790215|NCT00702962|42247722|FG001|Overall Study|Progressive disease|1|||
19790216|NCT00702962|42247721|FG000|Overall Study|Hospitalized for other health disorder|1|||
19790217|NCT00702962|42247722|FG001|Overall Study|Hospitalized for other health disorder|0|||
19790218|NCT01379508|42247734|FG000|Treatment to Week 104|Adverse Event|2|||
19790219|NCT01379508|42247735|FG001|Treatment to Week 104|Adverse Event|0|||
19790220|NCT01379508|42247736|FG002|Treatment to Week 104|Adverse Event|5|||
19790221|NCT01379508|42247737|FG003|Treatment to Week 104|Adverse Event|0|||
19790222|NCT01379508|42247734|FG000|Treatment to Week 104|Abnormal lab value|1|||
19790223|NCT01379508|42247735|FG001|Treatment to Week 104|Abnormal lab value|0|||
19790224|NCT01379508|42247736|FG002|Treatment to Week 104|Abnormal lab value|0|||
19790225|NCT01379508|42247737|FG003|Treatment to Week 104|Abnormal lab value|0|||
19790226|NCT01379508|42247734|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
19790227|NCT01379508|42247735|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
19790228|NCT01379508|42247736|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
19790229|NCT01379508|42247737|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
19790230|NCT01379508|42247734|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
19790231|NCT01379508|42247735|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
19790232|NCT01379508|42247736|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
19790233|NCT01379508|42247737|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
19790234|NCT01379508|42247734|FG000|Treatment to Week 104|Lost to Follow-up|5|||
19790235|NCT01379508|42247735|FG001|Treatment to Week 104|Lost to Follow-up|0|||
19790236|NCT01379508|42247736|FG002|Treatment to Week 104|Lost to Follow-up|3|||
19790237|NCT01379508|42247737|FG003|Treatment to Week 104|Lost to Follow-up|0|||
19790238|NCT01379508|42247734|FG000|Treatment to Week 104|Administrative problems|3|||
19790239|NCT01379508|42247735|FG001|Treatment to Week 104|Administrative problems|1|||
19790240|NCT01379508|42247736|FG002|Treatment to Week 104|Administrative problems|0|||
19790241|NCT01379508|42247737|FG003|Treatment to Week 104|Administrative problems|0|||
19790242|NCT01379508|42247734|FG000|Treatment to Week 104|Protocol Violation|1|||
19790243|NCT01379508|42247735|FG001|Treatment to Week 104|Protocol Violation|1|||
19790244|NCT01379508|42247736|FG002|Treatment to Week 104|Protocol Violation|1|||
19790245|NCT01379508|42247737|FG003|Treatment to Week 104|Protocol Violation|0|||
19790246|NCT01379508|42247734|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
19790247|NCT01379508|42247735|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
19790248|NCT01379508|42247736|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
19790249|NCT01379508|42247737|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
19790250|NCT01379508|42247734|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
19790251|NCT01379508|42247735|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
19790252|NCT01379508|42247736|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
19790253|NCT01379508|42247737|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
19790254|NCT01379508|42247734|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
19790255|NCT01379508|42247735|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
19790256|NCT01379508|42247736|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
19790257|NCT01379508|42247737|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
19790258|NCT01379508|42247734|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
19790259|NCT01379508|42247735|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
19790260|NCT01379508|42247736|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
19790261|NCT01379508|42247737|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
19790262|NCT02722928|42247753|FG000|Overall Study|Standard CT was not as required per prot|5|||
19790263|NCT02722928|42247754|FG001|Overall Study|Standard CT was not as required per prot|13|||
19790264|NCT02722928|42247753|FG000|Overall Study|Required Intraoperative MRI|5|||
19790265|NCT02722928|42247754|FG001|Overall Study|Required Intraoperative MRI|7|||
19790266|NCT02519439|42247764|FG000|Overall Study|Study Termination|19|||
19790267|NCT02519439|42247764|FG000|Overall Study|Withdrawal by Subject|1|||
19790268|NCT02519439|42247764|FG000|Overall Study|Adverse Event|1|||
19790269|NCT02722304|42247773|FG000|Overall Study|Study Terminated by Sponsor|1|||
19790270|NCT02722304|42247774|FG001|Overall Study|Study Terminated by Sponsor|0|||
19790271|NCT02722304|42247775|FG002|Overall Study|Study Terminated by Sponsor|2|||
19790272|NCT02722304|42247776|FG003|Overall Study|Study Terminated by Sponsor|1|||
19790273|NCT02722304|42247777|FG004|Overall Study|Study Terminated by Sponsor|1|||
19790274|NCT02722304|42247773|FG000|Overall Study|Other|0|||
19790275|NCT02722304|42247774|FG001|Overall Study|Other|0|||
19790276|NCT02722304|42247775|FG002|Overall Study|Other|0|||
19790277|NCT02722304|42247776|FG003|Overall Study|Other|1|||
19790278|NCT02722304|42247777|FG004|Overall Study|Other|1|||
19790279|NCT00709956|42247793|FG000|Overall Study|Withdrawal by Subject|1|||
19790280|NCT00709956|42247794|FG001|Overall Study|Withdrawal by Subject|1|||
19790281|NCT00709956|42247793|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
19790282|NCT00709956|42247794|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
19790283|NCT02719028|42247824|FG000|Overall Study|Adverse Event|2|||
19790284|NCT02719028|42247825|FG001|Overall Study|Adverse Event|1|||
19790285|NCT02719028|42247826|FG002|Overall Study|Adverse Event|4|||
19790286|NCT02719028|42247827|FG003|Overall Study|Adverse Event|8|||
19790287|NCT02719028|42247824|FG000|Overall Study|Physician Decision|0|||
19790288|NCT02719028|42247825|FG001|Overall Study|Physician Decision|1|||
19790289|NCT02719028|42247826|FG002|Overall Study|Physician Decision|1|||
19790290|NCT02719028|42247827|FG003|Overall Study|Physician Decision|1|||
19790291|NCT02719028|42247824|FG000|Overall Study|Use of prohibited medication|0|||
19790292|NCT02719028|42247825|FG001|Overall Study|Use of prohibited medication|0|||
19790293|NCT02719028|42247826|FG002|Overall Study|Use of prohibited medication|1|||
19790294|NCT02719028|42247827|FG003|Overall Study|Use of prohibited medication|0|||
19790295|NCT02719028|42247824|FG000|Overall Study|Protocol Violation|0|||
19790296|NCT02719028|42247825|FG001|Overall Study|Protocol Violation|0|||
19790297|NCT02719028|42247826|FG002|Overall Study|Protocol Violation|0|||
19790298|NCT02719028|42247827|FG003|Overall Study|Protocol Violation|1|||
19790299|NCT02720510|42247839|FG000|Overall Study|Study Terminated by the sponsor|2|||
19790300|NCT02720510|42247840|FG001|Overall Study|Study Terminated by the sponsor|0|||
19790301|NCT02720510|42247839|FG000|Overall Study|Adverse Event|0|||
19790302|NCT02720510|42247840|FG001|Overall Study|Adverse Event|1|||
19790303|NCT02720510|42247839|FG000|Overall Study|Physician Decision|1|||
19790304|NCT02720510|42247840|FG001|Overall Study|Physician Decision|2|||
19790305|NCT02720198|42247848|FG000|Overall Study|Withdrawal by Subject|0|||
19790306|NCT02720198|42247849|FG001|Overall Study|Withdrawal by Subject|1|||
19790307|NCT00703118|42247871|FG000|Overall Study|Adverse Event|1|||
19790308|NCT00703118|42247872|FG001|Overall Study|Adverse Event|2|||
19790309|NCT00703118|42247873|FG002|Overall Study|Adverse Event|2|||
19790310|NCT00703118|42247871|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
19790311|NCT00703118|42247872|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
19790312|NCT00703118|42247873|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
19790313|NCT00703118|42247871|FG000|Overall Study|Lost to Follow-up|6|||
19790314|NCT00703118|42247872|FG001|Overall Study|Lost to Follow-up|4|||
19790315|NCT00703118|42247873|FG002|Overall Study|Lost to Follow-up|4|||
19790316|NCT00703118|42247871|FG000|Overall Study|Withdrawal by Subject|8|||
19790317|NCT00703118|42247872|FG001|Overall Study|Withdrawal by Subject|7|||
19790318|NCT00703118|42247873|FG002|Overall Study|Withdrawal by Subject|13|||
19790319|NCT00703118|42247871|FG000|Overall Study|Other|0|||
19790320|NCT00703118|42247872|FG001|Overall Study|Other|0|||
19790321|NCT00703118|42247873|FG002|Overall Study|Other|1|||
19790322|NCT00909753|42247895|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
19790323|NCT00909753|42247896|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
19790324|NCT00909753|42247895|FG000|Period: Second Intervention|Protocol Violation|1|||
19790325|NCT00909753|42247896|FG001|Period: Second Intervention|Protocol Violation|0|||
19790326|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
19790327|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
19790328|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
19790329|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19790330|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19790331|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19790332|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
19790333|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
19790334|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790335|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790336|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790337|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790338|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790339|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19790340|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
19790341|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
19790342|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
19790343|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19790344|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19790345|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19790346|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19790347|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
19790348|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
19790349|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19790350|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19790351|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19790352|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19790353|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
19790354|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
19790355|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790356|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790357|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790358|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790359|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790360|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
19790361|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790362|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
19790363|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790364|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790365|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790366|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790367|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
19790368|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
19790369|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
19790370|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
19790371|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19790372|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19790373|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19790374|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19790375|NCT03745638|42247903|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
19790376|NCT03745638|42247904|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
19790377|NCT03745638|42247905|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
19790378|NCT03745638|42247906|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
19790379|NCT03745638|42247907|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
19790380|NCT03745638|42247908|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
19790381|NCT03745638|42247909|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
19790382|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19790383|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19790384|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19790385|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19790386|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
19790387|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
19790388|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
19790389|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19790390|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19790391|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19790392|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
19790393|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
19790394|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
19790395|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
19790396|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19790397|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19790398|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
19790399|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
19790400|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
19790401|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
19790402|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
19790403|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19790404|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19790405|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19790406|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19790407|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
19790408|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
19790409|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
19790410|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790411|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790412|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790413|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790414|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790415|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
19790416|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
19790417|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19790418|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19790419|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
19790420|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
19790421|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
19790422|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
19790423|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
19790424|NCT03745638|42247903|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
19790425|NCT03745638|42247904|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
19790426|NCT03745638|42247905|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
19790427|NCT03745638|42247906|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
19790428|NCT03745638|42247907|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
19790429|NCT03745638|42247908|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
19790430|NCT03745638|42247909|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
19790431|NCT03715764|42247928|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
19790432|NCT03715764|42247929|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
19790433|NCT03715764|42247928|FG000|3 Month Follow-up|Lost to Follow-up|2|||
19790434|NCT03715764|42247929|FG001|3 Month Follow-up|Lost to Follow-up|2|||
19790435|NCT03715764|42247928|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
19790436|NCT03715764|42247929|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
19790437|NCT03715764|42247928|FG000|6 Month Follow-up|Lost to Follow-up|3|||
19790438|NCT03715764|42247929|FG001|6 Month Follow-up|Lost to Follow-up|0|||
19790439|NCT03715764|42247928|FG000|12 Month Follow-up|Lost to Follow-up|2|||
19790440|NCT03715764|42247929|FG001|12 Month Follow-up|Lost to Follow-up|3|||
19790441|NCT03715764|42247928|FG000|12 Month Follow-up|Pregnancy|0|||
19790442|NCT03715764|42247929|FG001|12 Month Follow-up|Pregnancy|1|||
19790443|NCT03715764|42247928|FG000|12 Month Follow-up|Surgery|2|||
19790444|NCT03715764|42247929|FG001|12 Month Follow-up|Surgery|0|||
19790445|NCT03715764|42247928|FG000|12 Month Follow-up|Wrong address|1|||
19790446|NCT03715764|42247929|FG001|12 Month Follow-up|Wrong address|0|||
19790447|NCT03715764|42247928|FG000|12 Month Follow-up|No symptoms|1|||
19790448|NCT03715764|42247929|FG001|12 Month Follow-up|No symptoms|0|||
19790449|NCT03715764|42247928|FG000|12 Month Follow-up|Changed primary care centre|0|||
19790450|NCT03715764|42247929|FG001|12 Month Follow-up|Changed primary care centre|1|||
19790451|NCT02718326|42247938|FG000|Overall Study|Adverse Event|4|||
19790452|NCT02718326|42247939|FG001|Overall Study|Adverse Event|9|||
19790453|NCT02718326|42247940|FG002|Overall Study|Adverse Event|0|||
19790454|NCT02718326|42247938|FG000|Overall Study|Death|8|||
19790455|NCT02718326|42247939|FG001|Overall Study|Death|1|||
19790456|NCT02718326|42247940|FG002|Overall Study|Death|2|||
19790457|NCT02718326|42247938|FG000|Overall Study|Withdrawal by Subject|4|||
19790458|NCT02718326|42247939|FG001|Overall Study|Withdrawal by Subject|9|||
19790459|NCT02718326|42247940|FG002|Overall Study|Withdrawal by Subject|6|||
19790460|NCT02718326|42247938|FG000|Overall Study|Lost to Follow-up|18|||
19790461|NCT02718326|42247939|FG001|Overall Study|Lost to Follow-up|5|||
19790462|NCT02718326|42247940|FG002|Overall Study|Lost to Follow-up|14|||
19790463|NCT02718326|42247938|FG000|Overall Study|Protocol Deviation|1|||
19790464|NCT02718326|42247939|FG001|Overall Study|Protocol Deviation|0|||
19790465|NCT02718326|42247940|FG002|Overall Study|Protocol Deviation|0|||
19790466|NCT02718326|42247938|FG000|Overall Study|Pregnancy|1|||
19790467|NCT02718326|42247939|FG001|Overall Study|Pregnancy|0|||
19790468|NCT02718326|42247940|FG002|Overall Study|Pregnancy|0|||
19790469|NCT03600714|42247950|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
19790470|NCT02720042|42247989|FG000|Overall Study|Death|3|||
19790471|NCT02720042|42247989|FG000|Overall Study|Lost to Follow-up|4|||
19790472|NCT02720042|42247989|FG000|Overall Study|Withdrawal by Subject|1|||
19790473|NCT02720042|42247989|FG000|Overall Study|Physician Decision|3|||
19790474|NCT02720042|42247989|FG000|Overall Study|Phasix Mesh explanted|1|||
19790475|NCT02720042|42247989|FG000|Overall Study|unable due to non-study-related illness|3|||
19790476|NCT01352793|42247995|FG000|Overall Study|Lost to Follow-up|289|||
19790477|NCT01352793|42247996|FG001|Overall Study|Lost to Follow-up|125|||
19790478|NCT01352793|42247995|FG000|Overall Study|Withdrawal by Subject|120|||
19790479|NCT01352793|42247996|FG001|Overall Study|Withdrawal by Subject|55|||
19790480|NCT01352793|42247995|FG000|Overall Study|Protocol Violation|44|||
19790481|NCT01352793|42247996|FG001|Overall Study|Protocol Violation|23|||
19790482|NCT01352793|42247995|FG000|Overall Study|Adverse Event|44|||
19790483|NCT01352793|42247996|FG001|Overall Study|Adverse Event|10|||
19790484|NCT01352793|42247995|FG000|Overall Study|Physician Decision|1|||
19790485|NCT01352793|42247996|FG001|Overall Study|Physician Decision|0|||
19790486|NCT01352793|42247995|FG000|Overall Study|Pregnancy|26|||
19790487|NCT01352793|42247996|FG001|Overall Study|Pregnancy|8|||
19790488|NCT01352793|42247995|FG000|Overall Study|Other|25|||
19790489|NCT01352793|42247996|FG001|Overall Study|Other|7|||
19790490|NCT01352793|42247995|FG000|Overall Study|Medication error|2|||
19790491|NCT01352793|42247996|FG001|Overall Study|Medication error|2|||
19790492|NCT01352793|42247995|FG000|Overall Study|Death|1|||
19790493|NCT01352793|42247996|FG001|Overall Study|Death|0|||
19790494|NCT01352793|42247995|FG000|Overall Study|Randomized but not vaccinated|8|||
19790495|NCT01352793|42247996|FG001|Overall Study|Randomized but not vaccinated|0|||
19790496|NCT01352793|42247995|FG000|Overall Study|No longer meets eligibility criteria|25|||
19790497|NCT01352793|42247996|FG001|Overall Study|No longer meets eligibility criteria|15|||
19790498|NCT02717546|42248002|FG000|Overall Study|Lost to Follow-up|12|||
19790499|NCT01378962|42248006|FG000|Overall Study|Death|14|||
19790500|NCT01378962|42248006|FG000|Overall Study|Lost to Follow-up|1|||
19790501|NCT01378962|42248006|FG000|Overall Study|Other|2|||
19790502|NCT00890409|42248012|FG000|Overall Study|Lost to Follow-up|20|||
19790503|NCT00890409|42248013|FG001|Overall Study|Lost to Follow-up|21|||
19790504|NCT04495478|42248024|FG000|Overall Study|Withdrawal by Subject|0|||
19790505|NCT04495478|42248025|FG001|Overall Study|Withdrawal by Subject|0|||
19790506|NCT04495478|42248026|FG002|Overall Study|Withdrawal by Subject|0|||
19790507|NCT04495478|42248027|FG003|Overall Study|Withdrawal by Subject|1|||
19790508|NCT04495478|42248028|FG004|Overall Study|Withdrawal by Subject|0|||
19790509|NCT04495478|42248029|FG005|Overall Study|Withdrawal by Subject|0|||
19790510|NCT04495478|42248030|FG006|Overall Study|Withdrawal by Subject|0|||
19790511|NCT04495478|42248024|FG000|Overall Study|Physician Decision|0|||
19790512|NCT04495478|42248025|FG001|Overall Study|Physician Decision|1|||
19790513|NCT04495478|42248026|FG002|Overall Study|Physician Decision|0|||
19790514|NCT04495478|42248027|FG003|Overall Study|Physician Decision|0|||
19790515|NCT04495478|42248028|FG004|Overall Study|Physician Decision|1|||
19790516|NCT04495478|42248029|FG005|Overall Study|Physician Decision|0|||
19790517|NCT04495478|42248030|FG006|Overall Study|Physician Decision|0|||
19790518|NCT00152763|42248056|FG000|Overall Study|Death|4|||
19790519|NCT00152763|42248057|FG001|Overall Study|Death|1|||
19790520|NCT00152763|42248058|FG002|Overall Study|Death|2|||
19790521|NCT00152763|42248059|FG003|Overall Study|Death|1|||
19790522|NCT00152763|42248056|FG000|Overall Study|Lost to Follow-up|6|||
19790523|NCT00152763|42248057|FG001|Overall Study|Lost to Follow-up|4|||
19790524|NCT00152763|42248058|FG002|Overall Study|Lost to Follow-up|2|||
19790525|NCT00152763|42248059|FG003|Overall Study|Lost to Follow-up|13|||
19790526|NCT03181542|42248073|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
19790527|NCT03181542|42248074|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
19790528|NCT00806403|42248082|FG000|Overall Study|Death|4|||
19790529|NCT00806403|42248083|FG001|Overall Study|Death|3|||
19790530|NCT00701558|42248100|FG000|Overall Study|Death|7|||
19790531|NCT00701558|42248100|FG000|Overall Study|Lost to Follow-up|8|||
19790532|NCT01663402|42248106|FG000|Overall Study|Randomized but not treated|19|||
19790533|NCT01663402|42248107|FG001|Overall Study|Randomized but not treated|11|||
19790534|NCT01663402|42248106|FG000|Overall Study|Adverse Event|347|||
19790535|NCT01663402|42248107|FG001|Overall Study|Adverse Event|362|||
19790536|NCT01663402|42248106|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
19790537|NCT01663402|42248107|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
19790538|NCT01663402|42248106|FG000|Overall Study|Poor compliance to protocol|529|||
19790539|NCT01663402|42248107|FG001|Overall Study|Poor compliance to protocol|454|||
19790540|NCT01663402|42248106|FG000|Overall Study|Physician Decision|77|||
19790541|NCT01663402|42248107|FG001|Overall Study|Physician Decision|62|||
19790542|NCT01663402|42248106|FG000|Overall Study|Site terminated by sponsor|1|||
19790543|NCT01663402|42248107|FG001|Overall Study|Site terminated by sponsor|3|||
19790544|NCT01663402|42248106|FG000|Overall Study|Participant moved|139|||
19790545|NCT01663402|42248107|FG001|Overall Study|Participant moved|104|||
19790546|NCT01663402|42248106|FG000|Overall Study|Withdrawal by Subject|118|||
19790547|NCT01663402|42248107|FG001|Overall Study|Withdrawal by Subject|91|||
19790548|NCT01663402|42248106|FG000|Overall Study|Related to study drug administration|96|||
19790549|NCT01663402|42248107|FG001|Overall Study|Related to study drug administration|105|||
19790550|NCT01663402|42248106|FG000|Overall Study|Lost to Follow-up|17|||
19790551|NCT01663402|42248107|FG001|Overall Study|Lost to Follow-up|15|||
19790552|NCT01663402|42248106|FG000|Overall Study|Other than specified above|172|||
19790553|NCT01663402|42248107|FG001|Overall Study|Other than specified above|147|||
19790554|NCT00859521|42248124|FG000|Washout|Withdrawal by Subject|0|||
19790555|NCT00859521|42248125|FG001|Washout|Withdrawal by Subject|1|||
19790556|NCT00841815|42248140|FG000|Washout|Withdrawal by Subject|0|||
19790557|NCT00841815|42248141|FG001|Washout|Withdrawal by Subject|1|||
19790558|NCT00841659|42248148|FG000|Washout: 2 Weeks|Protocol Violation|1|||
19790559|NCT00841659|42248149|FG001|Washout: 2 Weeks|Protocol Violation|0|||
19790560|NCT02716298|42248153|FG000|First Intervention (1 Month)|Lens discomfort|1|||
19790561|NCT02716298|42248154|FG001|First Intervention (1 Month)|Lens discomfort|1|||
19790562|NCT00840879|42248167|FG000|Second Intervention|Withdrawal by Subject|1|||
19790563|NCT00840879|42248168|FG001|Second Intervention|Withdrawal by Subject|0|||
19790564|NCT00840411|42248183|FG000|First Intervention|Adverse Event|1|||
19790565|NCT00840411|42248184|FG001|First Intervention|Adverse Event|0|||
19790566|NCT00840411|42248183|FG000|Washout|Withdrawal by Subject|1|||
19790567|NCT00840411|42248184|FG001|Washout|Withdrawal by Subject|0|||
19790568|NCT00836901|42248197|FG000|First Intervention|Withdrawal by Subject|1|||
19790569|NCT00836901|42248198|FG001|First Intervention|Withdrawal by Subject|0|||
19790570|NCT04466384|42248202|FG000|First Phase|Protocol Violation|1|||
19790571|NCT04466384|42248203|FG001|First Phase|Protocol Violation|0|||
19790572|NCT04466384|42248202|FG000|First Phase|Missing data|1|||
19790573|NCT04466384|42248203|FG001|First Phase|Missing data|0|||
19790574|NCT04466384|42248202|FG000|Cross Over Phase|Physician Decision|1|||
19790575|NCT04466384|42248203|FG001|Cross Over Phase|Physician Decision|0|||
19790576|NCT04466384|42248202|FG000|Cross Over Phase|Withdrawal by Subject|0|||
19790577|NCT04466384|42248203|FG001|Cross Over Phase|Withdrawal by Subject|1|||
19790578|NCT03050814|42248214|FG000|Overall Study|Screen failures|0|||
19790579|NCT03050814|42248215|FG001|Overall Study|Screen failures|0|||
19790580|NCT03050814|42248216|FG002|Overall Study|Screen failures|4|||
19790581|NCT00835575|42248224|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
19790582|NCT00835575|42248225|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
19790583|NCT04601194|42248229|FG000|Overall Study|Lost to Follow-up|7|||
19790584|NCT00835263|42248242|FG000|Second Intervention|Adverse Event|1|||
19790585|NCT00835263|42248243|FG001|Second Intervention|Adverse Event|0|||
19790586|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
19790587|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
19790588|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
19790589|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
19790590|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
19790591|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
19790592|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
19607499|NCT00934856|42056315|FG003|Feasibility Part|Withdrawal by Subject|1|||
19607500|NCT00934856|42056316|FG004|Feasibility Part|Withdrawal by Subject|0|||
19607501|NCT00934856|42056317|FG005|Feasibility Part|Withdrawal by Subject|1|||
19607502|NCT00934856|42056312|FG000|Extension Part|Adverse Event|0|||
19607503|NCT00934856|42056313|FG001|Extension Part|Adverse Event|0|||
19607504|NCT00934856|42056314|FG002|Extension Part|Adverse Event|0|||
19607505|NCT00934856|42056315|FG003|Extension Part|Adverse Event|1|||
19607506|NCT00934856|42056316|FG004|Extension Part|Adverse Event|4|||
19607507|NCT00934856|42056317|FG005|Extension Part|Adverse Event|4|||
19607508|NCT00934856|42056312|FG000|Extension Part|Progressive disease|0|||
19607509|NCT00934856|42056313|FG001|Extension Part|Progressive disease|0|||
19607510|NCT00934856|42056314|FG002|Extension Part|Progressive disease|0|||
19607511|NCT00934856|42056315|FG003|Extension Part|Progressive disease|1|||
19607512|NCT00934856|42056316|FG004|Extension Part|Progressive disease|0|||
19607513|NCT00934856|42056317|FG005|Extension Part|Progressive disease|0|||
19607514|NCT00934856|42056312|FG000|Extension Part|Non-compliance with drug|0|||
19607515|NCT00934856|42056313|FG001|Extension Part|Non-compliance with drug|0|||
19607516|NCT00934856|42056314|FG002|Extension Part|Non-compliance with drug|0|||
19607517|NCT00934856|42056315|FG003|Extension Part|Non-compliance with drug|0|||
19607518|NCT00934856|42056316|FG004|Extension Part|Non-compliance with drug|0|||
19607519|NCT00934856|42056317|FG005|Extension Part|Non-compliance with drug|1|||
19790593|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
19790594|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
19790595|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
19790596|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
19607520|NCT00934700|42056351|FG000|Overall Study|missing scan|5|||
19607521|NCT00934700|42056352|FG001|Overall Study|missing scan|9|||
19607522|NCT00934700|42056351|FG000|Overall Study|Death|8|||
19607523|NCT00934700|42056352|FG001|Overall Study|Death|3|||
19607524|NCT00930176|42056359|FG000|Overall Study|Death|1|||
19790597|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
19790598|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
19790599|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
19790600|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
19790601|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
19790602|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
19790603|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
19790604|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
19790605|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
19790606|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
19790607|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
19790608|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
19790609|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
19790610|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
19790611|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
19790612|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
19790613|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
19790614|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
19790615|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
19790616|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
19790617|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
19790618|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
19790619|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
19790620|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
19790621|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
19790622|NCT01963208|42248281|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
19790623|NCT01963208|42248282|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
19790624|NCT01963208|42248283|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
19790625|NCT01963208|42248284|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
19790626|NCT01963208|42248285|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
19790627|NCT01963208|42248286|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
19790628|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
19790629|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
19790630|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
19790631|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
19790632|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
19790633|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
19790634|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
19790635|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
19790636|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
19790637|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
19790638|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
19790639|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
19790640|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
19790641|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
19790642|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
19790643|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
19790644|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
19790645|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
19790646|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
19790647|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
19790648|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
19790649|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
19790650|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
19790651|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
19790652|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
19790653|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
19790654|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
19790655|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
19790656|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
19790657|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
19790658|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
19790659|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
19790660|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
19790661|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
19790662|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
19790663|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
19790664|NCT01963208|42248281|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
19790665|NCT01963208|42248282|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
19790666|NCT01963208|42248283|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
19367464|NCT02435680|41607626|FG000|Overall Study|not treated|0|||
19790667|NCT01963208|42248284|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
19367465|NCT02435680|41607627|FG001|Overall Study|not treated|0|||
19790668|NCT01963208|42248285|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
19790669|NCT01963208|42248286|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
19790670|NCT00834873|42248298|FG000|First Intervention|Adverse Event|0|||
19790671|NCT00834873|42248299|FG001|First Intervention|Adverse Event|1|||
19790672|NCT01377480|42248307|FG000|Overall Study|Protocol Violation|0|||
19790673|NCT01377480|42248308|FG001|Overall Study|Protocol Violation|0|||
19790674|NCT01377480|42248309|FG002|Overall Study|Protocol Violation|0|||
19790675|NCT01377480|42248310|FG003|Overall Study|Protocol Violation|4|||
19790676|NCT01377480|42248307|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
19790677|NCT01377480|42248308|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
19790678|NCT01377480|42248309|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
19790679|NCT01377480|42248310|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
19790680|NCT01377480|42248307|FG000|Overall Study|Withdrawal by Subject|0|||
19790681|NCT01377480|42248308|FG001|Overall Study|Withdrawal by Subject|0|||
19790682|NCT01377480|42248309|FG002|Overall Study|Withdrawal by Subject|1|||
19790683|NCT01377480|42248310|FG003|Overall Study|Withdrawal by Subject|0|||
19790684|NCT01377480|42248307|FG000|Overall Study|Serious adverse event|0|||
19790685|NCT01377480|42248308|FG001|Overall Study|Serious adverse event|0|||
19790686|NCT01377480|42248309|FG002|Overall Study|Serious adverse event|1|||
19790687|NCT01377480|42248310|FG003|Overall Study|Serious adverse event|1|||
19790688|NCT01377480|42248307|FG000|Overall Study|Other|0|||
19790689|NCT01377480|42248308|FG001|Overall Study|Other|0|||
19790690|NCT01377480|42248309|FG002|Overall Study|Other|7|||
19790691|NCT01377480|42248310|FG003|Overall Study|Other|6|||
19790692|NCT00834795|42248322|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
19790693|NCT00834795|42248323|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
19790694|NCT00834795|42248322|FG000|Second Intervention|Adverse Event|1|||
19790695|NCT00834795|42248323|FG001|Second Intervention|Adverse Event|0|||
19790696|NCT00834717|42248329|FG000|First Intervention|Adverse Event|1|||
19790697|NCT00834717|42248330|FG001|First Intervention|Adverse Event|0|||
19790698|NCT00834717|42248329|FG000|First Intervention|Withdrawal by Subject|0|||
19790699|NCT00834717|42248330|FG001|First Intervention|Withdrawal by Subject|1|||
19790700|NCT00834639|42248336|FG000|Second Intervention|Physician Decision|0|||
19790701|NCT00834639|42248337|FG001|Second Intervention|Physician Decision|2|||
19790702|NCT00834249|42248357|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19790703|NCT00834249|42248358|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
19790704|NCT00834249|42248357|FG000|Second Intervention|Adverse Event|1|||
19790705|NCT00834249|42248358|FG001|Second Intervention|Adverse Event|0|||
19790706|NCT00833937|42248364|FG000|Washout|Withdrawal by Subject|1|||
19790707|NCT00833937|42248365|FG001|Washout|Withdrawal by Subject|0|||
19790708|NCT00924170|42248371|FG000|Overall Study|Refused further treatment|0|||
19790709|NCT00924170|42248372|FG001|Overall Study|Refused further treatment|1|||
19790710|NCT00924170|42248371|FG000|Overall Study|Physician Decision|0|||
19790711|NCT00924170|42248372|FG001|Overall Study|Physician Decision|1|||
19790712|NCT00924170|42248371|FG000|Overall Study|Progressive disease|3|||
19790713|NCT00924170|42248372|FG001|Overall Study|Progressive disease|6|||
19790714|NCT00924170|42248371|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
19790715|NCT00924170|42248372|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
19790716|NCT00924170|42248371|FG000|Overall Study|Death|1|||
19790717|NCT00924170|42248372|FG001|Overall Study|Death|0|||
19790718|NCT00828321|42248386|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
19790719|NCT00828321|42248387|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
19790720|NCT00828321|42248386|FG000|Second Intervention|Protocol Violation|0|||
19790721|NCT00828321|42248387|FG001|Second Intervention|Protocol Violation|1|||
19790722|NCT01352715|42248393|FG000|Overall Study|Death|3|||
19790723|NCT01352715|42248394|FG001|Overall Study|Death|3|||
19790724|NCT01352715|42248393|FG000|Overall Study|Lost to Follow-up|5|||
19790725|NCT01352715|42248394|FG001|Overall Study|Lost to Follow-up|7|||
19790726|NCT01352715|42248393|FG000|Overall Study|Withdrawal by Subject|4|||
19790727|NCT01352715|42248394|FG001|Overall Study|Withdrawal by Subject|8|||
19790728|NCT01352715|42248393|FG000|Overall Study|site closure|16|||
19790729|NCT01352715|42248394|FG001|Overall Study|site closure|15|||
19790730|NCT01352715|42248393|FG000|Overall Study|no final visit in closeout period|15|||
19790731|NCT01352715|42248394|FG001|Overall Study|no final visit in closeout period|12|||
19790732|NCT01352715|42248393|FG000|Overall Study|major ineligibility|2|||
19790733|NCT01352715|42248394|FG001|Overall Study|major ineligibility|1|||
19790734|NCT00919893|42248405|FG000|Overall Study|Protocol Violation|19|||
19790735|NCT00919893|42248406|FG001|Overall Study|Protocol Violation|9|||
19790736|NCT02559622|42248414|FG000|Overall Study|Progressive disease|0|||
19790737|NCT02559622|42248415|FG001|Overall Study|Progressive disease|1|||
19790738|NCT02559622|42248416|FG002|Overall Study|Progressive disease|0|||
19790739|NCT02559622|42248417|FG003|Overall Study|Progressive disease|0|||
19790740|NCT02559622|42248414|FG000|Overall Study|Adverse Event|0|||
19790741|NCT02559622|42248415|FG001|Overall Study|Adverse Event|2|||
19790742|NCT02559622|42248416|FG002|Overall Study|Adverse Event|2|||
19790743|NCT02559622|42248417|FG003|Overall Study|Adverse Event|2|||
19790744|NCT02559622|42248414|FG000|Overall Study|Patient/guardian decision|1|||
19790745|NCT02559622|42248415|FG001|Overall Study|Patient/guardian decision|2|||
19790746|NCT02559622|42248416|FG002|Overall Study|Patient/guardian decision|0|||
19790747|NCT02559622|42248417|FG003|Overall Study|Patient/guardian decision|1|||
19790748|NCT02559310|42248433|FG000|Overall Study|Death|4|||
19790749|NCT02559310|42248434|FG001|Overall Study|Death|3|||
19790750|NCT02559310|42248433|FG000|Overall Study|Lost to Follow-up|5|||
19790751|NCT02559310|42248434|FG001|Overall Study|Lost to Follow-up|3|||
19790752|NCT02559310|42248433|FG000|Overall Study|Physician Decision|2|||
19790753|NCT02559310|42248434|FG001|Overall Study|Physician Decision|1|||
19790754|NCT02559310|42248433|FG000|Overall Study|Withdrawal by Subject|13|||
19790755|NCT02559310|42248434|FG001|Overall Study|Withdrawal by Subject|9|||
19790756|NCT02559310|42248433|FG000|Overall Study|Sponsor Decision|0|||
19790757|NCT02559310|42248434|FG001|Overall Study|Sponsor Decision|1|||
19790758|NCT02559310|42248433|FG000|Overall Study|Randomized but not treated|3|||
19790759|NCT02559310|42248434|FG001|Overall Study|Randomized but not treated|2|||
19790760|NCT03517449|42248442|FG000|Overall Study|Death|184|||
19790761|NCT03517449|42248443|FG001|Overall Study|Death|236|||
19790762|NCT03517449|42248442|FG000|Overall Study|Lost to Follow-up|0|||
19790763|NCT03517449|42248443|FG001|Overall Study|Lost to Follow-up|2|||
19790764|NCT03517449|42248442|FG000|Overall Study|Withdrawal by Subject|7|||
19790765|NCT03517449|42248443|FG001|Overall Study|Withdrawal by Subject|26|||
19790766|NCT03517449|42248442|FG000|Overall Study|Participants Ongoing|220|||
19790767|NCT03517449|42248443|FG001|Overall Study|Participants Ongoing|152|||
19790768|NCT02555878|42248475|FG000|Overall Study|Lost to Follow-up|2|||
19790769|NCT02555878|42248476|FG001|Overall Study|Lost to Follow-up|3|||
19790770|NCT02555878|42248475|FG000|Overall Study|Withdrawal by Subject|48|||
19790771|NCT02555878|42248476|FG001|Overall Study|Withdrawal by Subject|48|||
19790772|NCT02555878|42248475|FG000|Overall Study|Adverse Event|12|||
19790773|NCT02555878|42248476|FG001|Overall Study|Adverse Event|8|||
19790774|NCT02555878|42248475|FG000|Overall Study|Death|74|||
19790775|NCT02555878|42248476|FG001|Overall Study|Death|59|||
19790776|NCT02555878|42248475|FG000|Overall Study|Protocol Violation|1|||
19790777|NCT02555878|42248476|FG001|Overall Study|Protocol Violation|2|||
19790778|NCT02555878|42248475|FG000|Overall Study|Physician Decision|12|||
19790779|NCT02555878|42248476|FG001|Overall Study|Physician Decision|13|||
19790780|NCT02555878|42248475|FG000|Overall Study|Other|17|||
19790781|NCT02555878|42248476|FG001|Overall Study|Other|17|||
19790782|NCT02555722|42248484|FG000|Week 2|Adverse Event|0|||
19790783|NCT02555722|42248485|FG001|Week 2|Adverse Event|1|||
19790784|NCT02555722|42248484|FG000|Week 2|Withdrawal by Subject|1|||
19790785|NCT02555722|42248485|FG001|Week 2|Withdrawal by Subject|0|||
19790786|NCT02555722|42248484|FG000|Month 1|Lens Discomfort|1|||
19790787|NCT02555722|42248485|FG001|Month 1|Lens Discomfort|0|||
19790788|NCT02555722|42248484|FG000|Month 2|Withdrawal by Subject|3|||
19790789|NCT02555722|42248485|FG001|Month 2|Withdrawal by Subject|0|||
19790790|NCT02555722|42248484|FG000|Month 2|Lost to Follow-up|1|||
19790791|NCT02555722|42248485|FG001|Month 2|Lost to Follow-up|0|||
19790792|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Adverse Event|9|||
19790793|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Adverse Event|3|||
19790794|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Death|7|||
19790795|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Death|7|||
19790796|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
19790797|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
19790798|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Physician Decision|1|||
19790799|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Physician Decision|0|||
19790800|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
19790801|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
19790802|NCT02558296|42248539|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
19790803|NCT02558296|42248540|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
19790804|NCT02558296|42248539|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
19790805|NCT02558296|42248540|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
19790806|NCT02558296|42248539|FG000|Completed the Study|Adverse Event|14|||
19790807|NCT02558296|42248540|FG001|Completed the Study|Adverse Event|5|||
19790808|NCT02558296|42248539|FG000|Completed the Study|Death|39|||
19790809|NCT02558296|42248540|FG001|Completed the Study|Death|25|||
19790810|NCT02558296|42248539|FG000|Completed the Study|Lost to Follow-up|31|||
19790811|NCT02558296|42248540|FG001|Completed the Study|Lost to Follow-up|23|||
19790812|NCT02558296|42248539|FG000|Completed the Study|Physician Decision|6|||
19790813|NCT02558296|42248540|FG001|Completed the Study|Physician Decision|0|||
19790814|NCT02558296|42248539|FG000|Completed the Study|Protocol Violation|2|||
19790815|NCT02558296|42248540|FG001|Completed the Study|Protocol Violation|1|||
19790816|NCT02558296|42248539|FG000|Completed the Study|Withdrawal by Subject|53|||
19790817|NCT02558296|42248540|FG001|Completed the Study|Withdrawal by Subject|31|||
19790818|NCT02558296|42248539|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
19790819|NCT02558296|42248540|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
19790820|NCT02737475|42248577|FG000|Overall Study|Other reasons|0|||
19790821|NCT02737475|42248578|FG001|Overall Study|Other reasons|0|||
19790822|NCT02737475|42248579|FG002|Overall Study|Other reasons|0|||
19790823|NCT02737475|42248580|FG003|Overall Study|Other reasons|0|||
19790824|NCT02737475|42248581|FG004|Overall Study|Other reasons|1|||
19790825|NCT02737475|42248582|FG005|Overall Study|Other reasons|1|||
19790826|NCT02737475|42248583|FG006|Overall Study|Other reasons|0|||
19790827|NCT02737475|42248584|FG007|Overall Study|Other reasons|0|||
19790828|NCT02737475|42248585|FG008|Overall Study|Other reasons|1|||
19790829|NCT02737475|42248586|FG009|Overall Study|Other reasons|0|||
19790830|NCT02737475|42248587|FG010|Overall Study|Other reasons|1|||
19790831|NCT02737475|42248588|FG011|Overall Study|Other reasons|0|||
19790832|NCT02737475|42248589|FG012|Overall Study|Other reasons|0|||
19790833|NCT02737475|42248590|FG013|Overall Study|Other reasons|0|||
19790834|NCT02737475|42248591|FG014|Overall Study|Other reasons|0|||
19790835|NCT02737475|42248592|FG015|Overall Study|Other reasons|0|||
19790836|NCT02737475|42248593|FG016|Overall Study|Other reasons|0|||
19790837|NCT02737475|42248594|FG017|Overall Study|Other reasons|0|||
19790838|NCT02737475|42248595|FG018|Overall Study|Other reasons|0|||
19790839|NCT02737475|42248596|FG019|Overall Study|Other reasons|0|||
19790840|NCT02737475|42248597|FG020|Overall Study|Other reasons|0|||
19790841|NCT02737475|42248598|FG021|Overall Study|Other reasons|1|||
19790842|NCT02737475|42248599|FG022|Overall Study|Other reasons|0|||
19790843|NCT02737475|42248600|FG023|Overall Study|Other reasons|1|||
19790844|NCT02737475|42248601|FG024|Overall Study|Other reasons|1|||
19790845|NCT02737475|42248602|FG025|Overall Study|Other reasons|1|||
19790846|NCT02737475|42248603|FG026|Overall Study|Other reasons|0|||
19790847|NCT02737475|42248577|FG000|Overall Study|Death|1|||
19790848|NCT02737475|42248578|FG001|Overall Study|Death|0|||
19790849|NCT02737475|42248579|FG002|Overall Study|Death|0|||
19790850|NCT02737475|42248580|FG003|Overall Study|Death|1|||
19790851|NCT02737475|42248581|FG004|Overall Study|Death|0|||
19790852|NCT02737475|42248582|FG005|Overall Study|Death|0|||
19790853|NCT02737475|42248583|FG006|Overall Study|Death|0|||
19790854|NCT02737475|42248584|FG007|Overall Study|Death|2|||
19790855|NCT02737475|42248585|FG008|Overall Study|Death|0|||
19790856|NCT02737475|42248586|FG009|Overall Study|Death|0|||
19790857|NCT02737475|42248587|FG010|Overall Study|Death|0|||
19790858|NCT02737475|42248588|FG011|Overall Study|Death|4|||
19790859|NCT02737475|42248589|FG012|Overall Study|Death|2|||
19790860|NCT02737475|42248590|FG013|Overall Study|Death|2|||
19790861|NCT02737475|42248591|FG014|Overall Study|Death|0|||
19790862|NCT02737475|42248592|FG015|Overall Study|Death|2|||
19790863|NCT02737475|42248593|FG016|Overall Study|Death|2|||
19790864|NCT02737475|42248594|FG017|Overall Study|Death|2|||
19790865|NCT02737475|42248595|FG018|Overall Study|Death|1|||
19790866|NCT02737475|42248596|FG019|Overall Study|Death|0|||
19790867|NCT02737475|42248597|FG020|Overall Study|Death|0|||
19790868|NCT02737475|42248598|FG021|Overall Study|Death|0|||
19790869|NCT02737475|42248599|FG022|Overall Study|Death|0|||
19790870|NCT02737475|42248600|FG023|Overall Study|Death|0|||
19790871|NCT02737475|42248601|FG024|Overall Study|Death|0|||
19790872|NCT02737475|42248602|FG025|Overall Study|Death|0|||
19790873|NCT02737475|42248603|FG026|Overall Study|Death|0|||
19790874|NCT02737475|42248577|FG000|Overall Study|Participant withdrew consent|0|||
19790875|NCT02737475|42248578|FG001|Overall Study|Participant withdrew consent|0|||
19790876|NCT02737475|42248579|FG002|Overall Study|Participant withdrew consent|0|||
19790877|NCT02737475|42248580|FG003|Overall Study|Participant withdrew consent|0|||
19790878|NCT02737475|42248581|FG004|Overall Study|Participant withdrew consent|0|||
19790879|NCT02737475|42248582|FG005|Overall Study|Participant withdrew consent|2|||
19790880|NCT02737475|42248583|FG006|Overall Study|Participant withdrew consent|0|||
19790881|NCT02737475|42248584|FG007|Overall Study|Participant withdrew consent|0|||
19790882|NCT02737475|42248585|FG008|Overall Study|Participant withdrew consent|0|||
19790883|NCT02737475|42248586|FG009|Overall Study|Participant withdrew consent|0|||
19790884|NCT02737475|42248587|FG010|Overall Study|Participant withdrew consent|0|||
19790885|NCT02737475|42248588|FG011|Overall Study|Participant withdrew consent|0|||
19790886|NCT02737475|42248589|FG012|Overall Study|Participant withdrew consent|0|||
19790887|NCT02737475|42248590|FG013|Overall Study|Participant withdrew consent|0|||
19790888|NCT02737475|42248591|FG014|Overall Study|Participant withdrew consent|1|||
19790889|NCT02737475|42248592|FG015|Overall Study|Participant withdrew consent|0|||
19790890|NCT02737475|42248593|FG016|Overall Study|Participant withdrew consent|0|||
19790891|NCT02737475|42248594|FG017|Overall Study|Participant withdrew consent|2|||
19790892|NCT02737475|42248595|FG018|Overall Study|Participant withdrew consent|1|||
19790893|NCT02737475|42248596|FG019|Overall Study|Participant withdrew consent|0|||
19790894|NCT02737475|42248597|FG020|Overall Study|Participant withdrew consent|2|||
19790895|NCT02737475|42248598|FG021|Overall Study|Participant withdrew consent|0|||
19790896|NCT02737475|42248599|FG022|Overall Study|Participant withdrew consent|0|||
19790897|NCT02737475|42248600|FG023|Overall Study|Participant withdrew consent|0|||
19790898|NCT02737475|42248601|FG024|Overall Study|Participant withdrew consent|0|||
19790899|NCT02737475|42248602|FG025|Overall Study|Participant withdrew consent|0|||
19790900|NCT02737475|42248603|FG026|Overall Study|Participant withdrew consent|0|||
19790901|NCT02737475|42248577|FG000|Overall Study|Lost to Follow-up|0|||
19790902|NCT02737475|42248578|FG001|Overall Study|Lost to Follow-up|0|||
19790903|NCT02737475|42248579|FG002|Overall Study|Lost to Follow-up|0|||
19790904|NCT02737475|42248580|FG003|Overall Study|Lost to Follow-up|0|||
19790905|NCT02737475|42248581|FG004|Overall Study|Lost to Follow-up|0|||
19790906|NCT02737475|42248582|FG005|Overall Study|Lost to Follow-up|0|||
19790907|NCT02737475|42248583|FG006|Overall Study|Lost to Follow-up|0|||
19790908|NCT02737475|42248584|FG007|Overall Study|Lost to Follow-up|0|||
19790909|NCT02737475|42248585|FG008|Overall Study|Lost to Follow-up|0|||
19790910|NCT02737475|42248586|FG009|Overall Study|Lost to Follow-up|0|||
19790911|NCT02737475|42248587|FG010|Overall Study|Lost to Follow-up|0|||
19607525|NCT00669409|42056369|FG000|Part 2|Withdrawal by Subject|0|||
19607526|NCT00669409|42056370|FG001|Part 2|Withdrawal by Subject|0|||
19607527|NCT00669409|42056371|FG002|Part 2|Withdrawal by Subject|0|||
19607528|NCT00669409|42056372|FG003|Part 2|Withdrawal by Subject|0|||
19607529|NCT00669409|42056373|FG004|Part 2|Withdrawal by Subject|0|||
19607530|NCT00669409|42056374|FG005|Part 2|Withdrawal by Subject|0|||
19607531|NCT00669409|42056375|FG006|Part 2|Withdrawal by Subject|0|||
19607532|NCT00669409|42056376|FG007|Part 2|Withdrawal by Subject|0|||
19607533|NCT00669409|42056377|FG008|Part 2|Withdrawal by Subject|0|||
19607534|NCT00669409|42056378|FG009|Part 2|Withdrawal by Subject|1|||
19607535|NCT00669409|42056379|FG010|Part 2|Withdrawal by Subject|0|||
19607536|NCT00669331|42056408|FG000|Randomisation to First Dose|Adverse Event|1|||
19607537|NCT00669331|42056409|FG001|Randomisation to First Dose|Adverse Event|0|||
19607538|NCT00669331|42056408|FG000|Randomisation to First Dose|Protocol Violation|1|||
19607539|NCT00669331|42056409|FG001|Randomisation to First Dose|Protocol Violation|0|||
19607540|NCT00669331|42056408|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
19607541|NCT00669331|42056409|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
19607542|NCT00669331|42056408|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
19607543|NCT00669331|42056409|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
19607544|NCT00669331|42056408|FG000|Randomisation to First Dose|Death|1|||
19607545|NCT00669331|42056409|FG001|Randomisation to First Dose|Death|0|||
19607546|NCT00669331|42056408|FG000|Randomisation to First Dose|Sponsor decision|0|||
19607547|NCT00669331|42056409|FG001|Randomisation to First Dose|Sponsor decision|1|||
19607548|NCT00669331|42056408|FG000|Randomisation to First Dose|Randomised in error|3|||
19607549|NCT00669331|42056409|FG001|Randomisation to First Dose|Randomised in error|10|||
19607550|NCT00669331|42056408|FG000|Blinded Treatment Period|Adverse Event|16|||
19607551|NCT00669331|42056409|FG001|Blinded Treatment Period|Adverse Event|10|||
19607552|NCT00669331|42056408|FG000|Blinded Treatment Period|Protocol Violation|1|||
19607553|NCT00669331|42056409|FG001|Blinded Treatment Period|Protocol Violation|1|||
19607554|NCT00669331|42056408|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
19607555|NCT00669331|42056409|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
19607556|NCT00669331|42056408|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
19607557|NCT00669331|42056409|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
19607558|NCT00669331|42056408|FG000|Blinded Treatment Period|Death|0|||
19607559|NCT00669331|42056409|FG001|Blinded Treatment Period|Death|2|||
19607560|NCT00669331|42056408|FG000|Blinded Treatment Period|Physician Decision|3|||
19607561|NCT00669331|42056409|FG001|Blinded Treatment Period|Physician Decision|3|||
19607562|NCT00669331|42056408|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
19607563|NCT00669331|42056409|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
19607564|NCT00932126|42056417|FG000|Overall Study|Adverse Event|0|||
19607565|NCT00932126|42056418|FG001|Overall Study|Adverse Event|0|||
19607566|NCT00932126|42056419|FG002|Overall Study|Adverse Event|0|||
19607567|NCT00932126|42056420|FG003|Overall Study|Adverse Event|0|||
19607568|NCT00932126|42056421|FG004|Overall Study|Adverse Event|0|||
19607569|NCT00932126|42056422|FG005|Overall Study|Adverse Event|0|||
19607570|NCT00932126|42056423|FG006|Overall Study|Adverse Event|1|||
19607571|NCT00932126|42056424|FG007|Overall Study|Adverse Event|2|||
19607572|NCT00932126|42056417|FG000|Overall Study|Protocol Violation|0|||
19607573|NCT00932126|42056418|FG001|Overall Study|Protocol Violation|0|||
19607574|NCT00932126|42056419|FG002|Overall Study|Protocol Violation|0|||
19607575|NCT00932126|42056420|FG003|Overall Study|Protocol Violation|0|||
19607576|NCT00932126|42056421|FG004|Overall Study|Protocol Violation|1|||
19607577|NCT00932126|42056422|FG005|Overall Study|Protocol Violation|0|||
19790912|NCT02737475|42248588|FG011|Overall Study|Lost to Follow-up|0|||
19607578|NCT00932126|42056423|FG006|Overall Study|Protocol Violation|0|||
19607579|NCT00932126|42056424|FG007|Overall Study|Protocol Violation|0|||
19607580|NCT00932126|42056417|FG000|Overall Study|Withdrawal by Subject|0|||
19607581|NCT00932126|42056418|FG001|Overall Study|Withdrawal by Subject|0|||
19607582|NCT00932126|42056419|FG002|Overall Study|Withdrawal by Subject|1|||
19607583|NCT00932126|42056420|FG003|Overall Study|Withdrawal by Subject|0|||
19607584|NCT00932126|42056421|FG004|Overall Study|Withdrawal by Subject|0|||
19607585|NCT00932126|42056422|FG005|Overall Study|Withdrawal by Subject|0|||
19790913|NCT02737475|42248589|FG012|Overall Study|Lost to Follow-up|0|||
19790914|NCT02737475|42248590|FG013|Overall Study|Lost to Follow-up|0|||
19607586|NCT00932126|42056423|FG006|Overall Study|Withdrawal by Subject|0|||
19790915|NCT02737475|42248591|FG014|Overall Study|Lost to Follow-up|0|||
19790916|NCT02737475|42248592|FG015|Overall Study|Lost to Follow-up|1|||
19790917|NCT02737475|42248593|FG016|Overall Study|Lost to Follow-up|0|||
19790918|NCT02737475|42248594|FG017|Overall Study|Lost to Follow-up|0|||
19790919|NCT02737475|42248595|FG018|Overall Study|Lost to Follow-up|0|||
19790920|NCT02737475|42248596|FG019|Overall Study|Lost to Follow-up|0|||
19790921|NCT02737475|42248597|FG020|Overall Study|Lost to Follow-up|0|||
19790922|NCT02737475|42248598|FG021|Overall Study|Lost to Follow-up|0|||
19790923|NCT02737475|42248599|FG022|Overall Study|Lost to Follow-up|0|||
19790924|NCT02737475|42248600|FG023|Overall Study|Lost to Follow-up|0|||
19790925|NCT02737475|42248601|FG024|Overall Study|Lost to Follow-up|0|||
19790926|NCT02737475|42248602|FG025|Overall Study|Lost to Follow-up|0|||
19790927|NCT02737475|42248603|FG026|Overall Study|Lost to Follow-up|0|||
19790928|NCT02737475|42248577|FG000|Overall Study|Disease Progression|0|||
19790929|NCT02737475|42248578|FG001|Overall Study|Disease Progression|0|||
19790930|NCT02737475|42248579|FG002|Overall Study|Disease Progression|0|||
19790931|NCT02737475|42248580|FG003|Overall Study|Disease Progression|0|||
19790932|NCT02737475|42248581|FG004|Overall Study|Disease Progression|0|||
19790933|NCT02737475|42248582|FG005|Overall Study|Disease Progression|0|||
19790934|NCT02737475|42248583|FG006|Overall Study|Disease Progression|0|||
19790935|NCT02737475|42248584|FG007|Overall Study|Disease Progression|0|||
19790936|NCT02737475|42248585|FG008|Overall Study|Disease Progression|0|||
19790937|NCT02737475|42248586|FG009|Overall Study|Disease Progression|0|||
19790938|NCT02737475|42248587|FG010|Overall Study|Disease Progression|0|||
19790939|NCT02737475|42248588|FG011|Overall Study|Disease Progression|0|||
19790940|NCT02737475|42248589|FG012|Overall Study|Disease Progression|0|||
19790941|NCT02737475|42248590|FG013|Overall Study|Disease Progression|0|||
19790942|NCT02737475|42248591|FG014|Overall Study|Disease Progression|0|||
19790943|NCT02737475|42248592|FG015|Overall Study|Disease Progression|0|||
19790944|NCT02737475|42248593|FG016|Overall Study|Disease Progression|0|||
19790945|NCT02737475|42248594|FG017|Overall Study|Disease Progression|0|||
19790946|NCT02737475|42248595|FG018|Overall Study|Disease Progression|0|||
19790947|NCT02737475|42248596|FG019|Overall Study|Disease Progression|0|||
19790948|NCT02737475|42248597|FG020|Overall Study|Disease Progression|0|||
19790949|NCT02737475|42248598|FG021|Overall Study|Disease Progression|0|||
19790950|NCT02737475|42248599|FG022|Overall Study|Disease Progression|0|||
19790951|NCT02737475|42248600|FG023|Overall Study|Disease Progression|0|||
19790952|NCT02737475|42248601|FG024|Overall Study|Disease Progression|0|||
19790953|NCT02737475|42248602|FG025|Overall Study|Disease Progression|0|||
19790954|NCT02737475|42248603|FG026|Overall Study|Disease Progression|1|||
19790955|NCT02557672|42248693|FG000|Overall Study|Withdrawal by Subject|4|||
19790956|NCT02557672|42248694|FG001|Overall Study|Withdrawal by Subject|2|||
19790957|NCT02714426|42248706|FG000|Overall Study|Withdrawal by Subject|2|||
19607587|NCT00932126|42056424|FG007|Overall Study|Withdrawal by Subject|1|||
19607588|NCT00932126|42056417|FG000|Overall Study|Objective progression or relapse|3|||
19607589|NCT00932126|42056418|FG001|Overall Study|Objective progression or relapse|3|||
19607590|NCT00932126|42056419|FG002|Overall Study|Objective progression or relapse|2|||
19607591|NCT00932126|42056420|FG003|Overall Study|Objective progression or relapse|3|||
19607592|NCT00932126|42056421|FG004|Overall Study|Objective progression or relapse|3|||
19607593|NCT00932126|42056422|FG005|Overall Study|Objective progression or relapse|3|||
19607594|NCT00932126|42056423|FG006|Overall Study|Objective progression or relapse|3|||
19607595|NCT00932126|42056424|FG007|Overall Study|Objective progression or relapse|5|||
19607596|NCT00932126|42056417|FG000|Overall Study|Other|0|||
19790958|NCT02714426|42248707|FG001|Overall Study|Withdrawal by Subject|2|||
19790959|NCT02925923|42248720|FG000|Overall Study|blood samples hemolyzed|0|||
19790960|NCT02925923|42248721|FG001|Overall Study|blood samples hemolyzed|2|||
19790961|NCT02410343|42248729|FG000|Core Period (24 Weeks)|Adverse Event|1|||
19790962|NCT02410343|42248730|FG001|Core Period (24 Weeks)|Adverse Event|0|||
19790963|NCT02410343|42248729|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
19790964|NCT02410343|42248730|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
19790965|NCT02410343|42248729|FG000|Extension Period (12 Months)|Adverse Event|1|||
19790966|NCT02410343|42248730|FG001|Extension Period (12 Months)|Adverse Event|0|||
19790967|NCT02410343|42248729|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
19790968|NCT02410343|42248730|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
19790969|NCT03064841|42248737|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
19790970|NCT03064841|42248737|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
19607597|NCT00932126|42056418|FG001|Overall Study|Other|0|||
19607598|NCT00932126|42056419|FG002|Overall Study|Other|0|||
19607599|NCT00932126|42056420|FG003|Overall Study|Other|0|||
19607600|NCT00932126|42056421|FG004|Overall Study|Other|1|||
19607601|NCT00932126|42056422|FG005|Overall Study|Other|0|||
19607602|NCT00932126|42056423|FG006|Overall Study|Other|1|||
19607603|NCT00932126|42056424|FG007|Overall Study|Other|2|||
19607604|NCT00667225|42056446|FG000|Overall Study|Subject had no more lesions to treat.|1|||
19607605|NCT00667225|42056447|FG001|Overall Study|Subject had no more lesions to treat.|0|||
19607606|NCT00667225|42056446|FG000|Overall Study|Lost to Follow-up|0|||
19607607|NCT00667225|42056447|FG001|Overall Study|Lost to Follow-up|1|||
19607608|NCT00929864|42056455|FG000|Overall Study|Death|1|||
19790971|NCT03064841|42248737|FG000|Overall Study|Screen failure|2|||
19790972|NCT02045303|42248743|FG000|Overall Study|Protocol Violation|2|||
19790973|NCT02045303|42248744|FG001|Overall Study|Protocol Violation|1|||
19790974|NCT02045303|42248745|FG002|Overall Study|Protocol Violation|0|||
19790975|NCT02045303|42248743|FG000|Overall Study|Withdrawal by Subject|0|||
19790976|NCT02045303|42248744|FG001|Overall Study|Withdrawal by Subject|2|||
19790977|NCT02045303|42248745|FG002|Overall Study|Withdrawal by Subject|0|||
19790978|NCT03434379|42248756|FG000|Global Period|Lost to Follow-up|3|||
19790979|NCT03434379|42248757|FG001|Global Period|Lost to Follow-up|1|||
19790980|NCT03434379|42248758|FG002|Global Period|Lost to Follow-up|0|||
19790981|NCT03434379|42248759|FG003|Global Period|Lost to Follow-up|0|||
19790982|NCT03434379|42248756|FG000|Global Period|Death|99|||
19790983|NCT03434379|42248757|FG001|Global Period|Death|179|||
19790984|NCT03434379|42248758|FG002|Global Period|Death|0|||
19790985|NCT03434379|42248759|FG003|Global Period|Death|0|||
19790986|NCT03434379|42248756|FG000|Global Period|Withdrawal by Subject|20|||
19790987|NCT03434379|42248757|FG001|Global Period|Withdrawal by Subject|20|||
19790988|NCT03434379|42248758|FG002|Global Period|Withdrawal by Subject|0|||
19790989|NCT03434379|42248759|FG003|Global Period|Withdrawal by Subject|0|||
19790990|NCT03434379|42248756|FG000|Global Period|On Study|43|||
19790991|NCT03434379|42248757|FG001|Global Period|On Study|136|||
19790992|NCT03434379|42248758|FG002|Global Period|On Study|0|||
19790993|NCT03434379|42248759|FG003|Global Period|On Study|0|||
19790994|NCT03434379|42248756|FG000|China Extension Period|Lost to Follow-up|0|||
19790995|NCT03434379|42248757|FG001|China Extension Period|Lost to Follow-up|0|||
19790996|NCT03434379|42248758|FG002|China Extension Period|Lost to Follow-up|1|||
19790997|NCT03434379|42248759|FG003|China Extension Period|Lost to Follow-up|0|||
19790998|NCT03434379|42248756|FG000|China Extension Period|Death|0|||
19790999|NCT03434379|42248757|FG001|China Extension Period|Death|0|||
19791000|NCT03434379|42248758|FG002|China Extension Period|Death|38|||
19791001|NCT03434379|42248759|FG003|China Extension Period|Death|61|||
19791002|NCT03434379|42248756|FG000|China Extension Period|Withdrawal by Subject|0|||
19791003|NCT03434379|42248757|FG001|China Extension Period|Withdrawal by Subject|0|||
19791004|NCT03434379|42248758|FG002|China Extension Period|Withdrawal by Subject|7|||
19791005|NCT03434379|42248759|FG003|China Extension Period|Withdrawal by Subject|6|||
19791006|NCT03434379|42248756|FG000|China Extension Period|On Study|0|||
19791007|NCT03434379|42248757|FG001|China Extension Period|On Study|0|||
19791008|NCT03434379|42248758|FG002|China Extension Period|On Study|15|||
19791009|NCT03434379|42248759|FG003|China Extension Period|On Study|66|||
19791010|NCT03064451|42248775|FG000|Overall Study|Lost to Follow-up|1|||
19791011|NCT03064451|42248775|FG000|Overall Study|Mapping Failure|4|||
19791012|NCT03064451|42248775|FG000|Overall Study|Exited prior to procedure|8|||
19791013|NCT03064451|42248775|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
19607609|NCT00929864|42056456|FG001|Overall Study|Death|1|||
19607610|NCT00929864|42056455|FG000|Overall Study|Adverse Event|11|||
19607611|NCT00929864|42056456|FG001|Overall Study|Adverse Event|30|||
19607612|NCT00929864|42056455|FG000|Overall Study|Lack of Efficacy|19|||
19607613|NCT00929864|42056456|FG001|Overall Study|Lack of Efficacy|16|||
19607614|NCT00929864|42056455|FG000|Overall Study|Lost to Follow-up|7|||
19607615|NCT00929864|42056456|FG001|Overall Study|Lost to Follow-up|12|||
19607616|NCT00929864|42056455|FG000|Overall Study|Withdrawal by Subject|20|||
19607617|NCT00929864|42056456|FG001|Overall Study|Withdrawal by Subject|9|||
19607618|NCT00929864|42056455|FG000|Overall Study|No longer met criteria|2|||
19607619|NCT00929864|42056456|FG001|Overall Study|No longer met criteria|1|||
19607620|NCT00929864|42056455|FG000|Overall Study|Poor or non-compliance|3|||
19607621|NCT00929864|42056456|FG001|Overall Study|Poor or non-compliance|3|||
19607622|NCT00929864|42056455|FG000|Overall Study|Pregnancy|0|||
19607623|NCT00929864|42056456|FG001|Overall Study|Pregnancy|3|||
19607624|NCT00929864|42056455|FG000|Overall Study|Administrative reason by Sponsor|1|||
19607625|NCT00929864|42056456|FG001|Overall Study|Administrative reason by Sponsor|1|||
19607626|NCT00929864|42056455|FG000|Overall Study|Non-specified|2|||
19607627|NCT00929864|42056456|FG001|Overall Study|Non-specified|7|||
19607628|NCT00597753|42056464|FG000|Overall Study|Adverse Event|6|||
19607629|NCT00597753|42056465|FG001|Overall Study|Adverse Event|2|||
19607630|NCT00597753|42056464|FG000|Overall Study|Death|55|||
19791014|NCT03058679|42248781|FG000|Baseline to Week 6|Lost to Follow-up|3|||
19791015|NCT03058679|42248782|FG001|Baseline to Week 6|Lost to Follow-up|2|||
19791016|NCT03058679|42248781|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
19791017|NCT03058679|42248782|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
19791018|NCT03058679|42248781|FG000|Baseline to Week 6|Adverse Event|6|||
19607631|NCT00597753|42056465|FG001|Overall Study|Death|29|||
19607632|NCT00597753|42056464|FG000|Overall Study|Lack of Efficacy|2|||
19607633|NCT00597753|42056465|FG001|Overall Study|Lack of Efficacy|0|||
19607634|NCT00597753|42056464|FG000|Overall Study|Lost to Follow-up|10|||
19791019|NCT03058679|42248782|FG001|Baseline to Week 6|Adverse Event|6|||
19791020|NCT03058679|42248781|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
19607635|NCT00597753|42056465|FG001|Overall Study|Lost to Follow-up|3|||
19607636|NCT00597753|42056464|FG000|Overall Study|Physician Decision|5|||
19607637|NCT00597753|42056465|FG001|Overall Study|Physician Decision|1|||
19791021|NCT03058679|42248782|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
19791022|NCT03058679|42248781|FG000|Baseline to Week 6|Difficulty following the diet|0|||
19791023|NCT03058679|42248782|FG001|Baseline to Week 6|Difficulty following the diet|2|||
19791024|NCT03058679|42248781|FG000|Baseline to Week 6|Physician Decision|1|||
19791025|NCT03058679|42248782|FG001|Baseline to Week 6|Physician Decision|0|||
19791026|NCT03058679|42248781|FG000|Week 6 to Week 12|Change in medication|5|||
19791027|NCT03058679|42248782|FG001|Week 6 to Week 12|Change in medication|7|||
19791028|NCT03058679|42248781|FG000|Week 6 to Week 12|Adverse Event|4|||
19791029|NCT03058679|42248782|FG001|Week 6 to Week 12|Adverse Event|3|||
19791030|NCT03058679|42248781|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
19791031|NCT03058679|42248782|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
19791032|NCT03058679|42248781|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
19791033|NCT03058679|42248782|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
19791034|NCT03382821|42248790|FG000|Overall Study|Did not receive allocated intervention.|0|||
19791035|NCT03382821|42248791|FG001|Overall Study|Did not receive allocated intervention.|3|||
19791036|NCT02557516|42248802|FG000|Overall Study|Adverse Event|1|||
19791037|NCT02557516|42248803|FG001|Overall Study|Adverse Event|0|||
19791038|NCT02557516|42248804|FG002|Overall Study|Adverse Event|2|||
19791039|NCT02557516|42248805|FG003|Overall Study|Adverse Event|1|||
19791040|NCT02557516|42248802|FG000|Overall Study|Disease progression|0|||
19791041|NCT02557516|42248803|FG001|Overall Study|Disease progression|2|||
19791042|NCT02557516|42248804|FG002|Overall Study|Disease progression|0|||
19791043|NCT02557516|42248805|FG003|Overall Study|Disease progression|0|||
19791044|NCT02557516|42248802|FG000|Overall Study|Physician Decision|0|||
19791045|NCT02557516|42248803|FG001|Overall Study|Physician Decision|2|||
19791046|NCT02557516|42248804|FG002|Overall Study|Physician Decision|0|||
19791047|NCT02557516|42248805|FG003|Overall Study|Physician Decision|0|||
19791048|NCT02557516|42248802|FG000|Overall Study|Sponsor decision|0|||
19791049|NCT02557516|42248803|FG001|Overall Study|Sponsor decision|1|||
19791050|NCT02557516|42248804|FG002|Overall Study|Sponsor decision|2|||
19791051|NCT02557516|42248805|FG003|Overall Study|Sponsor decision|8|||
19791052|NCT00711555|42248824|FG000|Overall Study|Adverse Event|3|||
19791053|NCT02713490|42248829|FG000|Overall Study|Withdrawal by Subject|2|||
19791054|NCT02713490|42248830|FG001|Overall Study|Withdrawal by Subject|1|||
19791055|NCT02713490|42248829|FG000|Overall Study|Did not receive study drug|1|||
19791056|NCT02713490|42248830|FG001|Overall Study|Did not receive study drug|0|||
19791057|NCT02713490|42248829|FG000|Overall Study|Met exclusion criteria|0|||
19791058|NCT02713490|42248830|FG001|Overall Study|Met exclusion criteria|1|||
19791059|NCT03772574|42248839|FG000|Overall Study|Protocol Violation|2|||
19791060|NCT03772574|42248840|FG001|Overall Study|Protocol Violation|0|||
19791061|NCT03772574|42248841|FG002|Overall Study|Protocol Violation|0|||
19791062|NCT03772574|42248839|FG000|Overall Study|Discomfort|0|||
19791063|NCT03772574|42248840|FG001|Overall Study|Discomfort|5|||
19791064|NCT03772574|42248841|FG002|Overall Study|Discomfort|4|||
19791065|NCT02743221|42248851|FG000|Overall Study|Progressive disease|29|||
19791066|NCT02743221|42248852|FG001|Overall Study|Progressive disease|38|||
19791067|NCT02743221|42248851|FG000|Overall Study|Adverse Event|17|||
19791068|NCT02743221|42248852|FG001|Overall Study|Adverse Event|14|||
19791069|NCT02743221|42248851|FG000|Overall Study|non medical reason|8|||
19791070|NCT02743221|42248852|FG001|Overall Study|non medical reason|2|||
19791071|NCT02743221|42248851|FG000|Overall Study|Physician Decision|2|||
19791072|NCT02743221|42248852|FG001|Overall Study|Physician Decision|5|||
19791073|NCT02743221|42248851|FG000|Overall Study|Patient not eligible, not treated|0|||
19791074|NCT02743221|42248852|FG001|Overall Study|Patient not eligible, not treated|1|||
19791075|NCT03836625|42248860|FG000|Overall Study|Lost to Follow-up|9|||
19791076|NCT03836625|42248861|FG001|Overall Study|Lost to Follow-up|9|||
19791077|NCT03836625|42248860|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
19791078|NCT03836625|42248861|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
19791079|NCT03836625|42248860|FG000|Overall Study|Death|0|||
19791080|NCT03836625|42248861|FG001|Overall Study|Death|1|||
19791081|NCT03836625|42248860|FG000|Overall Study|Refused follow-up|0|||
19791082|NCT03836625|42248861|FG001|Overall Study|Refused follow-up|1|||
19791083|NCT01358968|42248867|FG000|Period 2|Adverse Event|0|||
19791084|NCT01358968|42248868|FG001|Period 2|Adverse Event|1|||
19791085|NCT01358968|42248869|FG002|Period 2|Adverse Event|0|||
19791086|NCT01358968|42248870|FG003|Period 2|Adverse Event|0|||
19791087|NCT01358968|42248867|FG000|Continued Access Phase|Progression of Disease|0|||
19791088|NCT01358968|42248868|FG001|Continued Access Phase|Progression of Disease|0|||
19791089|NCT01358968|42248869|FG002|Continued Access Phase|Progression of Disease|8|||
19791090|NCT01358968|42248870|FG003|Continued Access Phase|Progression of Disease|4|||
19791091|NCT01358968|42248867|FG000|Continued Access Phase|Protocol Violation|0|||
19791092|NCT01358968|42248868|FG001|Continued Access Phase|Protocol Violation|0|||
19791093|NCT01358968|42248869|FG002|Continued Access Phase|Protocol Violation|0|||
19791094|NCT01358968|42248870|FG003|Continued Access Phase|Protocol Violation|2|||
19791095|NCT01358968|42248867|FG000|Continued Access Phase|Withdrawal by Subject|0|||
19791096|NCT01358968|42248868|FG001|Continued Access Phase|Withdrawal by Subject|0|||
19791097|NCT01358968|42248869|FG002|Continued Access Phase|Withdrawal by Subject|3|||
19791098|NCT01358968|42248870|FG003|Continued Access Phase|Withdrawal by Subject|0|||
19791099|NCT01358968|42248867|FG000|Continued Access Phase|Death|0|||
19791100|NCT01358968|42248868|FG001|Continued Access Phase|Death|0|||
19791101|NCT01358968|42248869|FG002|Continued Access Phase|Death|1|||
19791102|NCT01358968|42248870|FG003|Continued Access Phase|Death|1|||
19791103|NCT00701090|42248882|FG000|Overall Study|Adverse Event|11|||
19791104|NCT00701090|42248883|FG001|Overall Study|Adverse Event|2|||
19791105|NCT00701090|42248882|FG000|Overall Study|Death|0|||
19791106|NCT00701090|42248883|FG001|Overall Study|Death|1|||
19791107|NCT00701090|42248882|FG000|Overall Study|Lack of Efficacy|5|||
19791108|NCT00701090|42248883|FG001|Overall Study|Lack of Efficacy|4|||
19791109|NCT00701090|42248882|FG000|Overall Study|Lost to Follow-up|9|||
19791110|NCT00701090|42248883|FG001|Overall Study|Lost to Follow-up|9|||
19791111|NCT00701090|42248882|FG000|Overall Study|Physician Decision|3|||
19791112|NCT00701090|42248883|FG001|Overall Study|Physician Decision|4|||
19791113|NCT00701090|42248882|FG000|Overall Study|Protocol Violation|2|||
19791114|NCT00701090|42248883|FG001|Overall Study|Protocol Violation|3|||
19791115|NCT00701090|42248882|FG000|Overall Study|Withdrawal by Subject|11|||
19791116|NCT00701090|42248883|FG001|Overall Study|Withdrawal by Subject|16|||
19791117|NCT00701090|42248882|FG000|Overall Study|Other|7|||
19791118|NCT00701090|42248883|FG001|Overall Study|Other|12|||
19791119|NCT03950674|42248891|FG000|Overall Study|Death|3|||
19791120|NCT03950674|42248892|FG001|Overall Study|Death|7|||
19791121|NCT03950674|42248891|FG000|Overall Study|Ongoing in Study|22|||
19791122|NCT03950674|42248892|FG001|Overall Study|Ongoing in Study|8|||
19791123|NCT03057977|42248901|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
19791124|NCT03057977|42248902|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
19791125|NCT03057977|42248901|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
19791126|NCT03057977|42248902|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
19791127|NCT03057977|42248901|FG000|Discontinuation From Treatment|Protocol Violation|6|||
19791128|NCT03057977|42248902|FG001|Discontinuation From Treatment|Protocol Violation|5|||
19791129|NCT03057977|42248901|FG000|Discontinuation From Treatment|Not treated|4|||
19791130|NCT03057977|42248902|FG001|Discontinuation From Treatment|Not treated|0|||
19791131|NCT03057977|42248901|FG000|Discontinuation From Treatment|Adverse Event|343|||
19791132|NCT03057977|42248902|FG001|Discontinuation From Treatment|Adverse Event|337|||
19791133|NCT03057977|42248901|FG000|Discontinuation From Treatment|Reason Unknown|0|||
19791134|NCT03057977|42248902|FG001|Discontinuation From Treatment|Reason Unknown|1|||
19791135|NCT03057977|42248901|FG000|Discontinuation From Treatment|Personal Reasons|1|||
19791136|NCT03057977|42248902|FG001|Discontinuation From Treatment|Personal Reasons|1|||
19791137|NCT03057977|42248901|FG000|Discontinuation From Treatment|Unblinded medication|1|||
19791138|NCT03057977|42248902|FG001|Discontinuation From Treatment|Unblinded medication|0|||
19791139|NCT03057977|42248901|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
19791140|NCT03057977|42248902|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
19791141|NCT03057977|42248901|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
19791142|NCT03057977|42248902|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
19791143|NCT03057977|42248901|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
19791144|NCT03057977|42248902|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
19791145|NCT03057977|42248901|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
19791146|NCT03057977|42248902|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
19791147|NCT03057977|42248901|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
19791148|NCT03057977|42248902|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
19791149|NCT03057977|42248901|FG000|Discontinuation From Treatment|Not attending study visit|3|||
19791150|NCT03057977|42248902|FG001|Discontinuation From Treatment|Not attending study visit|10|||
19791151|NCT03057977|42248901|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
19791152|NCT03057977|42248902|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
19791153|NCT03057977|42248901|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
19791154|NCT03057977|42248902|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
19791155|NCT03057977|42248901|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
19791156|NCT03057977|42248902|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
19791157|NCT03057977|42248901|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
19791158|NCT03057977|42248902|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
19791159|NCT03057977|42248901|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
19791160|NCT03057977|42248902|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
19791161|NCT03062891|42248914|FG000|Overall Study|Withdrawal by Subject|2|||
19791162|NCT03062891|42248915|FG001|Overall Study|Withdrawal by Subject|0|||
19791163|NCT03062891|42248914|FG000|Overall Study|Lost to Follow-up|50|||
19791164|NCT03062891|42248915|FG001|Overall Study|Lost to Follow-up|38|||
19791165|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
19791166|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
19367466|NCT02435680|41607628|FG002|Overall Study|not treated|1|||
19791167|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
19791168|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
19791169|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
19791170|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
19791171|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
19791172|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
19791173|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
19791174|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
19791175|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
19791176|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
19791177|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
19791178|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
19791179|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
19791180|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
19791181|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
19791182|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
19791183|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
19791184|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
19791185|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
19791186|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
19791187|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
19791188|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
19791189|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
19791190|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
19791191|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
19791192|NCT02552212|42248924|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
19791193|NCT02552212|42248925|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
19791194|NCT02552212|42248926|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
19791195|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
19791196|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
19791197|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
19791198|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
19791199|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
19791200|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
19791201|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
19791202|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
19791203|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
19791204|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
19791205|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
19791206|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
19791207|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
19791208|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
19791209|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
19791210|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
19791211|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
19791212|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
19791213|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
19791214|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
19791215|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
19791216|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
19791217|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
19791218|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
19791219|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
19791220|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
19791221|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
19791222|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
19791223|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
19791224|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
19791225|NCT02552212|42248924|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
19791226|NCT02552212|42248925|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
19791227|NCT02552212|42248926|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
19791228|NCT00685919|42248946|FG000|Overall Study|Withdrawal by Subject|0|||
19791229|NCT00685919|42248947|FG001|Overall Study|Withdrawal by Subject|0|||
19791230|NCT00685919|42248948|FG002|Overall Study|Withdrawal by Subject|1|||
19791231|NCT00685919|42248949|FG003|Overall Study|Withdrawal by Subject|0|||
19791232|NCT00685919|42248946|FG000|Overall Study|Physician Decision|1|||
19791233|NCT00685919|42248947|FG001|Overall Study|Physician Decision|0|||
19791234|NCT00685919|42248948|FG002|Overall Study|Physician Decision|0|||
19791235|NCT00685919|42248949|FG003|Overall Study|Physician Decision|0|||
19791236|NCT03061331|42248961|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
19791237|NCT03061331|42248962|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
19791238|NCT00700778|42248968|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
19791239|NCT03908476|42248974|FG000|Overall Study|Death|3|||
19791240|NCT03908476|42248975|FG001|Overall Study|Death|0|||
19791241|NCT03908476|42248974|FG000|Overall Study|Lost to Follow-up|3|||
19791242|NCT03908476|42248975|FG001|Overall Study|Lost to Follow-up|1|||
19791243|NCT03908476|42248974|FG000|Overall Study|Withdrawal by Subject|7|||
19791244|NCT03908476|42248975|FG001|Overall Study|Withdrawal by Subject|1|||
19791245|NCT03908476|42248974|FG000|Overall Study|Physician Decision|2|||
19791246|NCT03908476|42248975|FG001|Overall Study|Physician Decision|0|||
19791247|NCT03908476|42248974|FG000|Overall Study|System Explanted and not Replaced|4|||
19791248|NCT03908476|42248975|FG001|Overall Study|System Explanted and not Replaced|0|||
19791249|NCT03908476|42248974|FG000|Overall Study|Intrathecal Pump|1|||
19791250|NCT03908476|42248975|FG001|Overall Study|Intrathecal Pump|0|||
19791251|NCT03908476|42248974|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
19791252|NCT03908476|42248975|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
19791253|NCT02551666|42248983|FG000|Overall Study|Withdrawal by Subject|1|||
19791254|NCT02551666|42248984|FG001|Overall Study|Withdrawal by Subject|3|||
19791255|NCT03061175|42248996|FG000|Baseline|Participant was deemed ineligible|1|||
19791256|NCT03061175|42248997|FG001|Baseline|Participant was deemed ineligible|0|||
19791257|NCT03061175|42248996|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
19791258|NCT03061175|42248997|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
19791259|NCT03061175|42248996|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
19791260|NCT03061175|42248997|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
19791261|NCT03061175|42248996|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
19791262|NCT03061175|42248997|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
19791263|NCT02554474|42249014|FG000|Overall Study|Protocol Violation|1|||
19791264|NCT02554474|42249015|FG001|Overall Study|Protocol Violation|1|||
19791265|NCT02554474|42249014|FG000|Overall Study|Health issue not related to the study|1|||
19791266|NCT02554474|42249015|FG001|Overall Study|Health issue not related to the study|0|||
19791267|NCT02554474|42249014|FG000|Overall Study|Withdrawal by Subject|1|||
19791268|NCT02554474|42249015|FG001|Overall Study|Withdrawal by Subject|1|||
19791269|NCT03061097|42249023|FG000|Overall Study|Withdrawal by Subject|0|||
19791270|NCT03061097|42249024|FG001|Overall Study|Withdrawal by Subject|3|||
19697928|NCT00264498|42143180|FG001|Crossover Treatment|Death|3|||
19697929|NCT00264498|42143179|FG000|Crossover Treatment|Objective disease progression|4|||
19697930|NCT00264498|42143180|FG001|Crossover Treatment|Objective disease progression|5|||
19697931|NCT00264498|42143179|FG000|Crossover Treatment|Study closure|0|||
19697932|NCT00264498|42143180|FG001|Crossover Treatment|Study closure|1|||
19697933|NCT00264498|42143179|FG000|Crossover Treatment|Withdrawal by Subject|1|||
19697934|NCT00264498|42143180|FG001|Crossover Treatment|Withdrawal by Subject|0|||
19697935|NCT00466193|42143188|FG000|Overall Study|Adverse Event|0|||
19697936|NCT00466193|42143189|FG001|Overall Study|Adverse Event|1|||
19697937|NCT00466193|42143188|FG000|Overall Study|Lost to Follow-up|2|||
19697938|NCT00466193|42143189|FG001|Overall Study|Lost to Follow-up|4|||
19697939|NCT00466193|42143188|FG000|Overall Study|Physician Decision|1|||
19697940|NCT00466193|42143189|FG001|Overall Study|Physician Decision|0|||
19697941|NCT00466193|42143188|FG000|Overall Study|Protocol Violation|1|||
19697942|NCT00466193|42143189|FG001|Overall Study|Protocol Violation|1|||
19697943|NCT00466193|42143188|FG000|Overall Study|Withdrawal by Subject|7|||
19697944|NCT00466193|42143189|FG001|Overall Study|Withdrawal by Subject|2|||
19697945|NCT00466193|42143188|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
19697946|NCT00466193|42143189|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
19697947|NCT00263562|42143197|FG000|Overall Study|Protocol Violation|3|||
19697948|NCT00263562|42143198|FG001|Overall Study|Protocol Violation|0|||
19697949|NCT00454181|42143208|FG000|Overall Study|Adverse Event|1|||
19697950|NCT00454181|42143209|FG001|Overall Study|Adverse Event|1|||
19697951|NCT00454181|42143208|FG000|Overall Study|Lost to Follow-up|11|||
19697952|NCT00454181|42143209|FG001|Overall Study|Lost to Follow-up|1|||
19697953|NCT00454181|42143208|FG000|Overall Study|Protocol Violation|1|||
19697954|NCT00454181|42143209|FG001|Overall Study|Protocol Violation|1|||
19697955|NCT00454181|42143208|FG000|Overall Study|Withdrawal by Subject|2|||
19697956|NCT00454181|42143209|FG001|Overall Study|Withdrawal by Subject|0|||
19697957|NCT00237744|42143218|FG000|Overall Study|Withdrawal by Subject|3|||
19697958|NCT00237744|42143219|FG001|Overall Study|Withdrawal by Subject|1|||
19697959|NCT00237744|42143220|FG002|Overall Study|Withdrawal by Subject|0|||
19791271|NCT02554318|42249032|FG000|Overall Study|Withdrawal by Subject|10|||
19791272|NCT02554318|42249033|FG001|Overall Study|Withdrawal by Subject|8|||
19791273|NCT02550106|42249039|FG000|Overall Study|Adverse Event|1|||
19791274|NCT02550106|42249039|FG000|Overall Study|Lack of Efficacy|3|||
19791275|NCT02550106|42249039|FG000|Overall Study|Protocol Violation|6|||
19697960|NCT00237042|42143234|FG000|Treatment|Became ineligible post-randomization|0|||
19791276|NCT02550106|42249039|FG000|Overall Study|Withdrawal by Subject|2|||
19791277|NCT03060551|42249045|FG000|Overall Study|Withdrawal by Subject|1|||
19791278|NCT03060551|42249045|FG000|Overall Study|Adverse Event|1|||
19791279|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
19791280|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
19791281|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
19791282|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
19791283|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
19791284|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
19791285|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
19791286|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
19791287|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
19791288|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
19791289|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
19791290|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
19791291|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
19791292|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
19791293|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
19791294|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
19791295|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
19791296|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
19791297|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
19791298|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
19791299|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
19791300|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
19791301|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
19791302|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
19791303|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
19791304|NCT01662310|42249049|FG000|Run-In or Stabilization Phase|Other|1|||
19791305|NCT01662310|42249050|FG001|Run-In or Stabilization Phase|Other|0|||
19791306|NCT01662310|42249051|FG002|Run-In or Stabilization Phase|Other|0|||
19791307|NCT01662310|42249052|FG003|Run-In or Stabilization Phase|Other|0|||
19791308|NCT01662310|42249053|FG004|Run-In or Stabilization Phase|Other|0|||
19791309|NCT01662310|42249049|FG000|Double-Blind Phase|Adverse Event|0|||
19791310|NCT01662310|42249050|FG001|Double-Blind Phase|Adverse Event|0|||
19791311|NCT01662310|42249051|FG002|Double-Blind Phase|Adverse Event|1|||
19791312|NCT01662310|42249052|FG003|Double-Blind Phase|Adverse Event|0|||
19791313|NCT01662310|42249053|FG004|Double-Blind Phase|Adverse Event|0|||
19791314|NCT01662310|42249049|FG000|Double-Blind Phase|Lost to Follow-up|0|||
19791315|NCT01662310|42249050|FG001|Double-Blind Phase|Lost to Follow-up|3|||
19791316|NCT01662310|42249051|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19791317|NCT01662310|42249052|FG003|Double-Blind Phase|Lost to Follow-up|0|||
19791318|NCT01662310|42249053|FG004|Double-Blind Phase|Lost to Follow-up|0|||
19791319|NCT01662310|42249049|FG000|Double-Blind Phase|Pregnancy|0|||
19791320|NCT01662310|42249050|FG001|Double-Blind Phase|Pregnancy|2|||
19791321|NCT01662310|42249051|FG002|Double-Blind Phase|Pregnancy|0|||
19791322|NCT01662310|42249052|FG003|Double-Blind Phase|Pregnancy|0|||
19791323|NCT01662310|42249053|FG004|Double-Blind Phase|Pregnancy|0|||
19791324|NCT01662310|42249049|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19791325|NCT01662310|42249050|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
19791326|NCT01662310|42249051|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
19791327|NCT01662310|42249052|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19791328|NCT01662310|42249053|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
19791329|NCT01662310|42249049|FG000|Double-Blind Phase|Other|0|||
19791330|NCT01662310|42249050|FG001|Double-Blind Phase|Other|0|||
19791331|NCT01662310|42249051|FG002|Double-Blind Phase|Other|1|||
19791332|NCT01662310|42249052|FG003|Double-Blind Phase|Other|0|||
19791333|NCT01662310|42249053|FG004|Double-Blind Phase|Other|0|||
19791334|NCT01662310|42249049|FG000|Double-Blind Phase|Randomized but not treated|0|||
19791335|NCT01662310|42249050|FG001|Double-Blind Phase|Randomized but not treated|1|||
19791336|NCT01662310|42249051|FG002|Double-Blind Phase|Randomized but not treated|0|||
19791337|NCT01662310|42249052|FG003|Double-Blind Phase|Randomized but not treated|0|||
19791338|NCT01662310|42249053|FG004|Double-Blind Phase|Randomized but not treated|0|||
19791339|NCT01662310|42249049|FG000|Open-Label Extension Phase|Adverse Event|0|||
19791340|NCT01662310|42249050|FG001|Open-Label Extension Phase|Adverse Event|0|||
19791341|NCT01662310|42249051|FG002|Open-Label Extension Phase|Adverse Event|0|||
19791342|NCT01662310|42249052|FG003|Open-Label Extension Phase|Adverse Event|3|||
19791343|NCT01662310|42249053|FG004|Open-Label Extension Phase|Adverse Event|0|||
19791344|NCT01662310|42249049|FG000|Open-Label Extension Phase|Death|0|||
19791345|NCT01662310|42249050|FG001|Open-Label Extension Phase|Death|0|||
19791346|NCT01662310|42249051|FG002|Open-Label Extension Phase|Death|0|||
19791347|NCT01662310|42249052|FG003|Open-Label Extension Phase|Death|1|||
19791348|NCT01662310|42249053|FG004|Open-Label Extension Phase|Death|0|||
19791349|NCT01662310|42249049|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
19791350|NCT01662310|42249050|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
19791351|NCT01662310|42249051|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
19791352|NCT01662310|42249052|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
19791353|NCT01662310|42249053|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
19791354|NCT01662310|42249049|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
19791355|NCT01662310|42249050|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
19791356|NCT01662310|42249051|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
19791357|NCT01662310|42249052|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
19791358|NCT01662310|42249053|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
19791359|NCT01662310|42249049|FG000|Open-Label Extension Phase|Pregnancy|0|||
19791360|NCT01662310|42249050|FG001|Open-Label Extension Phase|Pregnancy|0|||
19791361|NCT01662310|42249051|FG002|Open-Label Extension Phase|Pregnancy|0|||
19791362|NCT01662310|42249052|FG003|Open-Label Extension Phase|Pregnancy|1|||
19791363|NCT01662310|42249053|FG004|Open-Label Extension Phase|Pregnancy|0|||
19791364|NCT01662310|42249049|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
19791365|NCT01662310|42249050|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
19791366|NCT01662310|42249051|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
19791367|NCT01662310|42249052|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
19791368|NCT01662310|42249053|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
19791369|NCT00700622|42249067|FG000|Overall Study|Adverse Event|4|||
19791370|NCT00700622|42249068|FG001|Overall Study|Adverse Event|0|||
19791371|NCT00700622|42249067|FG000|Overall Study|Lost to Follow-up|0|||
19791372|NCT00700622|42249068|FG001|Overall Study|Lost to Follow-up|1|||
19791373|NCT00700622|42249067|FG000|Overall Study|Physician Decision|2|||
19791374|NCT00700622|42249068|FG001|Overall Study|Physician Decision|1|||
19791375|NCT00700622|42249067|FG000|Overall Study|Protocol Violation|0|||
19791376|NCT00700622|42249068|FG001|Overall Study|Protocol Violation|1|||
19791377|NCT00700622|42249067|FG000|Overall Study|Withdrawal by Subject|4|||
19791378|NCT00700622|42249068|FG001|Overall Study|Withdrawal by Subject|1|||
19791379|NCT00700622|42249067|FG000|Overall Study|Other|3|||
19791380|NCT00700622|42249068|FG001|Overall Study|Other|1|||
19791381|NCT02553928|42249076|FG000|Overall Study|Adverse Event|2|||
19791382|NCT02553928|42249077|FG001|Overall Study|Adverse Event|1|||
19791383|NCT02553928|42249076|FG000|Overall Study|Lost to Follow-up|0|||
19791384|NCT02553928|42249077|FG001|Overall Study|Lost to Follow-up|1|||
19791385|NCT02553928|42249076|FG000|Overall Study|Administrative reason(s)|0|||
19791386|NCT02553928|42249077|FG001|Overall Study|Administrative reason(s)|1|||
19791387|NCT03076775|42249086|FG000|Overall Study|Lost to Follow-up|1|||
19791388|NCT03076775|42249087|FG001|Overall Study|Lost to Follow-up|0|||
19791389|NCT03058991|42249104|FG000|Overall Study|Lost to Follow-up|17|||
19791390|NCT03058991|42249105|FG001|Overall Study|Lost to Follow-up|12|||
19791391|NCT03058991|42249106|FG002|Overall Study|Lost to Follow-up|12|||
19791392|NCT03058991|42249104|FG000|Overall Study|Withdrawal by Subject|1|||
19791393|NCT03058991|42249105|FG001|Overall Study|Withdrawal by Subject|0|||
19791394|NCT03058991|42249106|FG002|Overall Study|Withdrawal by Subject|0|||
19791395|NCT00700310|42249118|FG000|Overall Study|Adverse Event|6|||
19791396|NCT00700310|42249119|FG001|Overall Study|Adverse Event|10|||
19791397|NCT00700310|42249120|FG002|Overall Study|Adverse Event|5|||
19791398|NCT00700310|42249121|FG003|Overall Study|Adverse Event|11|||
19791399|NCT00700310|42249118|FG000|Overall Study|Lost to Follow-up|4|||
19791400|NCT00700310|42249119|FG001|Overall Study|Lost to Follow-up|1|||
19791401|NCT00700310|42249120|FG002|Overall Study|Lost to Follow-up|0|||
19791402|NCT00700310|42249121|FG003|Overall Study|Lost to Follow-up|1|||
19791403|NCT00700310|42249118|FG000|Overall Study|Withdrawal by Subject|8|||
19791404|NCT00700310|42249119|FG001|Overall Study|Withdrawal by Subject|9|||
19791405|NCT00700310|42249120|FG002|Overall Study|Withdrawal by Subject|8|||
19791406|NCT00700310|42249121|FG003|Overall Study|Withdrawal by Subject|8|||
19791407|NCT00700310|42249118|FG000|Overall Study|Lack of Efficacy|0|||
19791408|NCT00700310|42249119|FG001|Overall Study|Lack of Efficacy|3|||
19791409|NCT00700310|42249120|FG002|Overall Study|Lack of Efficacy|0|||
19791410|NCT00700310|42249121|FG003|Overall Study|Lack of Efficacy|1|||
19791411|NCT00700310|42249118|FG000|Overall Study|Administrative/Other|1|||
19791412|NCT00700310|42249119|FG001|Overall Study|Administrative/Other|3|||
19791413|NCT00700310|42249120|FG002|Overall Study|Administrative/Other|1|||
19791414|NCT00700310|42249121|FG003|Overall Study|Administrative/Other|3|||
19791415|NCT00700310|42249118|FG000|Overall Study|Randomized, Not Treated|2|||
19791416|NCT00700310|42249119|FG001|Overall Study|Randomized, Not Treated|0|||
19367467|NCT03371732|41607642|FG000|Overall Study|Withdrawal by Subject|9|||
19607638|NCT00597753|42056464|FG000|Overall Study|Pregnancy|1|||
19791417|NCT00700310|42249120|FG002|Overall Study|Randomized, Not Treated|2|||
19791418|NCT00700310|42249121|FG003|Overall Study|Randomized, Not Treated|2|||
19791419|NCT01575548|42249151|FG000|Overall Study|Adverse Event|15|||
19791420|NCT01575548|42249152|FG001|Overall Study|Adverse Event|2|||
19791421|NCT01575548|42249151|FG000|Overall Study|Disease progression|12|||
19791422|NCT01575548|42249152|FG001|Overall Study|Disease progression|25|||
19791423|NCT01575548|42249151|FG000|Overall Study|Death|1|||
19791424|NCT01575548|42249152|FG001|Overall Study|Death|0|||
19791425|NCT01575548|42249151|FG000|Overall Study|Other complicating disease|1|||
19791426|NCT01575548|42249152|FG001|Overall Study|Other complicating disease|0|||
19791427|NCT01575548|42249151|FG000|Overall Study|Withdrawal by Subject|7|||
19791428|NCT01575548|42249152|FG001|Overall Study|Withdrawal by Subject|3|||
19791429|NCT01575548|42249151|FG000|Overall Study|Noncompliance|1|||
19791430|NCT01575548|42249152|FG001|Overall Study|Noncompliance|0|||
19791431|NCT01575548|42249151|FG000|Overall Study|Anticipated surgery|0|||
19791432|NCT01575548|42249152|FG001|Overall Study|Anticipated surgery|1|||
19791433|NCT01575548|42249151|FG000|Overall Study|Never started protocol therapy|3|||
19791434|NCT01575548|42249152|FG001|Overall Study|Never started protocol therapy|2|||
19791435|NCT01750281|42249161|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
19791436|NCT01750281|42249162|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
19791437|NCT01750281|42249163|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
19791438|NCT01750281|42249161|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
19791439|NCT01750281|42249162|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
19791440|NCT01750281|42249163|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
19791441|NCT01750281|42249161|FG000|Overall Study|Did not receive treatment|0|||
19791442|NCT01750281|42249162|FG001|Overall Study|Did not receive treatment|1|||
19791443|NCT01750281|42249163|FG002|Overall Study|Did not receive treatment|0|||
19791444|NCT03000569|42249190|FG000|Overall Study|Withdrawal by Subject|1|||
19791445|NCT03000569|42249191|FG001|Overall Study|Withdrawal by Subject|0|||
19791446|NCT02554786|42249210|FG000|Overall Study|Subject/guardian decision|29|||
19791447|NCT02554786|42249211|FG001|Overall Study|Subject/guardian decision|17|||
19791448|NCT02554786|42249212|FG002|Overall Study|Subject/guardian decision|18|||
19791449|NCT02554786|42249213|FG003|Overall Study|Subject/guardian decision|30|||
19791450|NCT02554786|42249214|FG004|Overall Study|Subject/guardian decision|20|||
19791451|NCT02554786|42249210|FG000|Overall Study|Lost to Follow-up|4|||
19791452|NCT02554786|42249211|FG001|Overall Study|Lost to Follow-up|3|||
19791453|NCT02554786|42249212|FG002|Overall Study|Lost to Follow-up|4|||
19791454|NCT02554786|42249213|FG003|Overall Study|Lost to Follow-up|2|||
19791455|NCT02554786|42249214|FG004|Overall Study|Lost to Follow-up|2|||
19791456|NCT02554786|42249210|FG000|Overall Study|Protocol deviation|1|||
19791457|NCT02554786|42249211|FG001|Overall Study|Protocol deviation|3|||
19791458|NCT02554786|42249212|FG002|Overall Study|Protocol deviation|3|||
19791459|NCT02554786|42249213|FG003|Overall Study|Protocol deviation|4|||
19791460|NCT02554786|42249214|FG004|Overall Study|Protocol deviation|2|||
19791461|NCT02554786|42249210|FG000|Overall Study|Technical problems|1|||
19791462|NCT02554786|42249211|FG001|Overall Study|Technical problems|1|||
19791463|NCT02554786|42249212|FG002|Overall Study|Technical problems|0|||
19791464|NCT02554786|42249213|FG003|Overall Study|Technical problems|2|||
19791465|NCT02554786|42249214|FG004|Overall Study|Technical problems|1|||
19791466|NCT02554786|42249210|FG000|Overall Study|Adverse Event|0|||
19791467|NCT02554786|42249211|FG001|Overall Study|Adverse Event|0|||
19791468|NCT02554786|42249212|FG002|Overall Study|Adverse Event|0|||
19791469|NCT02554786|42249213|FG003|Overall Study|Adverse Event|0|||
19791470|NCT02554786|42249214|FG004|Overall Study|Adverse Event|2|||
19791471|NCT02554786|42249210|FG000|Overall Study|Death|0|||
19791472|NCT02554786|42249211|FG001|Overall Study|Death|0|||
19791473|NCT02554786|42249212|FG002|Overall Study|Death|0|||
19791474|NCT02554786|42249213|FG003|Overall Study|Death|1|||
19791475|NCT02554786|42249214|FG004|Overall Study|Death|0|||
19791476|NCT02554786|42249210|FG000|Overall Study|Non-compliance with study treatment|0|||
19791477|NCT02554786|42249211|FG001|Overall Study|Non-compliance with study treatment|1|||
19791478|NCT02554786|42249212|FG002|Overall Study|Non-compliance with study treatment|1|||
19791479|NCT02554786|42249213|FG003|Overall Study|Non-compliance with study treatment|0|||
19791480|NCT02554786|42249214|FG004|Overall Study|Non-compliance with study treatment|1|||
19791481|NCT02554786|42249210|FG000|Overall Study|Physician Decision|0|||
19791482|NCT02554786|42249211|FG001|Overall Study|Physician Decision|1|||
19791483|NCT02554786|42249212|FG002|Overall Study|Physician Decision|4|||
19791484|NCT02554786|42249213|FG003|Overall Study|Physician Decision|1|||
19791485|NCT02554786|42249214|FG004|Overall Study|Physician Decision|1|||
19791486|NCT02554786|42249210|FG000|Overall Study|Pregnancy|0|||
19791487|NCT02554786|42249211|FG001|Overall Study|Pregnancy|0|||
19791488|NCT02554786|42249212|FG002|Overall Study|Pregnancy|0|||
19791489|NCT02554786|42249213|FG003|Overall Study|Pregnancy|1|||
19791490|NCT02554786|42249214|FG004|Overall Study|Pregnancy|1|||
19791491|NCT02893930|42249230|FG000|Overall Study|Adverse Event|3|||
19791492|NCT02893930|42249230|FG000|Overall Study|Death|1|||
19791493|NCT02893930|42249230|FG000|Overall Study|Disease progression|5|||
19791494|NCT02893930|42249230|FG000|Overall Study|Withdrawal by Subject|2|||
19791495|NCT02893930|42249230|FG000|Overall Study|Physician Decision|1|||
19791496|NCT02893930|42249230|FG000|Overall Study|Ineligible|1|||
19791497|NCT01347645|42249239|FG000|Overall Study|Death|1|||
19791498|NCT01347645|42249240|FG001|Overall Study|Death|5|||
19791499|NCT01347645|42249241|FG002|Overall Study|Death|2|||
19791500|NCT01347645|42249242|FG003|Overall Study|Death|7|||
19791501|NCT01347645|42249243|FG004|Overall Study|Death|7|||
19791502|NCT01347645|42249239|FG000|Overall Study|Lost to Follow-up|1|||
19791503|NCT01347645|42249240|FG001|Overall Study|Lost to Follow-up|1|||
19791504|NCT01347645|42249241|FG002|Overall Study|Lost to Follow-up|0|||
19791505|NCT01347645|42249242|FG003|Overall Study|Lost to Follow-up|1|||
19791506|NCT01347645|42249243|FG004|Overall Study|Lost to Follow-up|1|||
19791507|NCT01347645|42249239|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
19791508|NCT01347645|42249240|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
19791509|NCT01347645|42249241|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
19791510|NCT01347645|42249242|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
19791511|NCT01347645|42249243|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
19791512|NCT01347645|42249239|FG000|Overall Study|Other|1|||
19791513|NCT01347645|42249240|FG001|Overall Study|Other|0|||
19791514|NCT01347645|42249241|FG002|Overall Study|Other|0|||
19791515|NCT01347645|42249242|FG003|Overall Study|Other|0|||
19791516|NCT01347645|42249243|FG004|Overall Study|Other|1|||
19791517|NCT01347645|42249239|FG000|Overall Study|Withdrawal by Subject|0|||
19791518|NCT01347645|42249240|FG001|Overall Study|Withdrawal by Subject|0|||
19791519|NCT01347645|42249241|FG002|Overall Study|Withdrawal by Subject|0|||
19791520|NCT01347645|42249242|FG003|Overall Study|Withdrawal by Subject|3|||
19791521|NCT01347645|42249243|FG004|Overall Study|Withdrawal by Subject|3|||
19791522|NCT01347645|42249239|FG000|Overall Study|Physician Decision|0|||
19791523|NCT01347645|42249240|FG001|Overall Study|Physician Decision|0|||
19791524|NCT01347645|42249241|FG002|Overall Study|Physician Decision|0|||
19791525|NCT01347645|42249242|FG003|Overall Study|Physician Decision|0|||
19791526|NCT01347645|42249243|FG004|Overall Study|Physician Decision|1|||
19791527|NCT01347645|42249239|FG000|Overall Study|Adverse Event|0|||
19791528|NCT01347645|42249240|FG001|Overall Study|Adverse Event|0|||
19791529|NCT01347645|42249241|FG002|Overall Study|Adverse Event|0|||
19791530|NCT01347645|42249242|FG003|Overall Study|Adverse Event|1|||
19791531|NCT01347645|42249243|FG004|Overall Study|Adverse Event|1|||
19791532|NCT00484419|42249281|FG000|Overall Study|Adverse Event|3|||
19791533|NCT00484419|42249282|FG001|Overall Study|Adverse Event|0|||
19791534|NCT00484419|42249283|FG002|Overall Study|Adverse Event|0|||
19791535|NCT00484419|42249281|FG000|Overall Study|Lost to Follow-up|1|||
19791536|NCT00484419|42249282|FG001|Overall Study|Lost to Follow-up|0|||
19791537|NCT00484419|42249283|FG002|Overall Study|Lost to Follow-up|2|||
19791538|NCT00484419|42249281|FG000|Overall Study|Withdrawal by Subject|3|||
19791539|NCT00484419|42249282|FG001|Overall Study|Withdrawal by Subject|1|||
19791540|NCT00484419|42249283|FG002|Overall Study|Withdrawal by Subject|1|||
19791541|NCT00484419|42249281|FG000|Overall Study|subject met discontinuation criteria|2|||
19791542|NCT00484419|42249282|FG001|Overall Study|subject met discontinuation criteria|2|||
19791543|NCT00484419|42249283|FG002|Overall Study|subject met discontinuation criteria|4|||
19791544|NCT00484419|42249281|FG000|Overall Study|required restricted medication|1|||
19791545|NCT00484419|42249282|FG001|Overall Study|required restricted medication|0|||
19791546|NCT00484419|42249283|FG002|Overall Study|required restricted medication|1|||
19791547|NCT00484419|42249281|FG000|Overall Study|Physician Decision|1|||
19791548|NCT00484419|42249282|FG001|Overall Study|Physician Decision|1|||
19791549|NCT00484419|42249283|FG002|Overall Study|Physician Decision|1|||
19791550|NCT00484419|42249281|FG000|Overall Study|subject unable to receive medication|1|||
19791551|NCT00484419|42249282|FG001|Overall Study|subject unable to receive medication|0|||
19791552|NCT00484419|42249283|FG002|Overall Study|subject unable to receive medication|0|||
19791553|NCT00484419|42249281|FG000|Overall Study|subject relocated|0|||
19791554|NCT00484419|42249282|FG001|Overall Study|subject relocated|1|||
19791555|NCT00484419|42249283|FG002|Overall Study|subject relocated|0|||
19791556|NCT00484419|42249281|FG000|Overall Study|sponsor decision, randomized in error|0|||
19791557|NCT00484419|42249282|FG001|Overall Study|sponsor decision, randomized in error|0|||
19791558|NCT00484419|42249283|FG002|Overall Study|sponsor decision, randomized in error|2|||
19791559|NCT03220724|42249292|FG000|Overall Study|Lost to Follow-up|2|||
19791560|NCT03220724|42249293|FG001|Overall Study|Lost to Follow-up|1|||
19791561|NCT03220724|42249294|FG002|Overall Study|Lost to Follow-up|0|||
19791562|NCT03220724|42249295|FG003|Overall Study|Lost to Follow-up|3|||
19791563|NCT03220724|42249292|FG000|Overall Study|Withdrawal by Subject|1|||
19791564|NCT03220724|42249293|FG001|Overall Study|Withdrawal by Subject|1|||
19791565|NCT03220724|42249294|FG002|Overall Study|Withdrawal by Subject|1|||
19791566|NCT03220724|42249295|FG003|Overall Study|Withdrawal by Subject|0|||
19791567|NCT02549092|42249307|FG000|Treatment Period|Adverse Event|2|||
19791568|NCT02549092|42249308|FG001|Treatment Period|Adverse Event|2|||
19791569|NCT02549092|42249307|FG000|Treatment Period|Withdrawal by Subject|1|||
19791570|NCT02549092|42249308|FG001|Treatment Period|Withdrawal by Subject|3|||
19791571|NCT02549092|42249307|FG000|Treatment Period|Lack of Efficacy|0|||
19791572|NCT02549092|42249308|FG001|Treatment Period|Lack of Efficacy|2|||
19791573|NCT02549092|42249307|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
19791574|NCT02549092|42249308|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
19791575|NCT02549092|42249307|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
19791576|NCT02549092|42249308|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
19791577|NCT03056573|42249319|FG000|Overall Study|Death|2|||
19791578|NCT03056573|42249320|FG001|Overall Study|Death|4|||
19791579|NCT03056573|42249319|FG000|Overall Study|Withdrawal by Subject|2|||
19791580|NCT03056573|42249320|FG001|Overall Study|Withdrawal by Subject|0|||
19791581|NCT03056573|42249319|FG000|Overall Study|Lost to Follow-up|1|||
19791582|NCT03056573|42249320|FG001|Overall Study|Lost to Follow-up|1|||
19791583|NCT02553772|42249328|FG000|Overall Study|Adverse Event|2|||
19791584|NCT02553772|42249329|FG001|Overall Study|Adverse Event|3|||
19791585|NCT02553772|42249328|FG000|Overall Study|Lost to Follow-up|2|||
19791586|NCT02553772|42249329|FG001|Overall Study|Lost to Follow-up|1|||
19791587|NCT02553772|42249328|FG000|Overall Study|Withdrawal of Consent|1|||
19791588|NCT02553772|42249329|FG001|Overall Study|Withdrawal of Consent|1|||
19791589|NCT02553772|42249328|FG000|Overall Study|Lack of Efficacy|1|||
19791590|NCT02553772|42249329|FG001|Overall Study|Lack of Efficacy|0|||
19791591|NCT02553772|42249328|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19791592|NCT02553772|42249329|FG001|Overall Study|Other Miscellaneous Reasons|1|||
19791593|NCT02553538|42249337|FG000|Overall Study|Could Not Reach by Telephone|133|||
19791594|NCT02553538|42249338|FG001|Overall Study|Could Not Reach by Telephone|0|||
19791595|NCT02553538|42249337|FG000|Overall Study|Died or Left Network|54|||
19791596|NCT02553538|42249338|FG001|Overall Study|Died or Left Network|56|||
19791597|NCT02548156|42249344|FG000|Washout Period 1|Lost to Follow-up|0|||
19791598|NCT02548156|42249345|FG001|Washout Period 1|Lost to Follow-up|0|||
19791599|NCT02548156|42249346|FG002|Washout Period 1|Lost to Follow-up|0|||
19791600|NCT02548156|42249347|FG003|Washout Period 1|Lost to Follow-up|0|||
19791601|NCT02548156|42249348|FG004|Washout Period 1|Lost to Follow-up|1|||
19791602|NCT02548156|42249349|FG005|Washout Period 1|Lost to Follow-up|0|||
19791603|NCT01503515|42249359|FG000|Overall Study|Adverse Event|4|||
19791604|NCT01503515|42249360|FG001|Overall Study|Adverse Event|5|||
19791605|NCT01503515|42249359|FG000|Overall Study|Death|0|||
19791606|NCT01503515|42249360|FG001|Overall Study|Death|1|||
19791607|NCT01503515|42249359|FG000|Overall Study|Physician Decision|14|||
19791608|NCT01503515|42249360|FG001|Overall Study|Physician Decision|23|||
19791609|NCT01503515|42249359|FG000|Overall Study|Withdrawal by Subject|0|||
19791610|NCT01503515|42249360|FG001|Overall Study|Withdrawal by Subject|1|||
19791611|NCT01503515|42249359|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
19791612|NCT01503515|42249360|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
19791613|NCT01503515|42249359|FG000|Overall Study|Ineligible|1|||
19791614|NCT01503515|42249360|FG001|Overall Study|Ineligible|1|||
19791615|NCT02742519|42249368|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
19791616|NCT02742519|42249369|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
19791617|NCT02742519|42249370|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
19791618|NCT02742519|42249368|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
19791619|NCT02742519|42249369|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
19791620|NCT02742519|42249370|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
19791621|NCT02742519|42249368|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
19791622|NCT02742519|42249369|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
19791623|NCT02742519|42249370|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
19791624|NCT01375010|42249380|FG000|Overall Study|Lost to Follow-up|8|||
19791625|NCT01375010|42249381|FG001|Overall Study|Lost to Follow-up|2|||
19791626|NCT01375010|42249380|FG000|Overall Study|Withdrawal by Subject|4|||
19791627|NCT01375010|42249381|FG001|Overall Study|Withdrawal by Subject|2|||
19791628|NCT00659061|42249405|FG000|Overall Study|Migration due to political unrest|21|||
19791629|NCT00659061|42249406|FG001|Overall Study|Migration due to political unrest|15|||
19791630|NCT02548078|42249423|FG000|Overall Study|Serious adverse event/Adverse event|1|||
19791631|NCT02548078|42249424|FG001|Overall Study|Serious adverse event/Adverse event|0|||
19791632|NCT02548078|42249423|FG000|Overall Study|Moved from study area|3|||
19791633|NCT02548078|42249424|FG001|Overall Study|Moved from study area|3|||
19791634|NCT02548078|42249423|FG000|Overall Study|Lost to Follow-up|1|||
19791635|NCT02548078|42249424|FG001|Overall Study|Lost to Follow-up|3|||
19791636|NCT02671435|42249452|FG000|Overall Study|Death|1|||
19791637|NCT02671435|42249453|FG001|Overall Study|Death|3|||
19791638|NCT02671435|42249454|FG002|Overall Study|Death|0|||
19791639|NCT02671435|42249455|FG003|Overall Study|Death|16|||
19791640|NCT02671435|42249456|FG004|Overall Study|Death|14|||
19791641|NCT02671435|42249457|FG005|Overall Study|Death|29|||
19791642|NCT02671435|42249458|FG006|Overall Study|Death|34|||
19791643|NCT02671435|42249459|FG007|Overall Study|Death|28|||
19791644|NCT02671435|42249460|FG008|Overall Study|Death|19|||
19791645|NCT02671435|42249461|FG009|Overall Study|Death|10|||
19791646|NCT02671435|42249462|FG010|Overall Study|Death|8|||
19791647|NCT02671435|42249463|FG011|Overall Study|Death|29|||
19791648|NCT02671435|42249464|FG012|Overall Study|Death|29|||
19791649|NCT02671435|42249465|FG013|Overall Study|Death|29|||
19791650|NCT02671435|42249466|FG014|Overall Study|Death|27|||
19791651|NCT02671435|42249452|FG000|Overall Study|Lost to Follow-up|0|||
19791652|NCT02671435|42249453|FG001|Overall Study|Lost to Follow-up|0|||
19791653|NCT02671435|42249454|FG002|Overall Study|Lost to Follow-up|1|||
19791654|NCT02671435|42249455|FG003|Overall Study|Lost to Follow-up|0|||
19791655|NCT02671435|42249456|FG004|Overall Study|Lost to Follow-up|1|||
19791656|NCT02671435|42249457|FG005|Overall Study|Lost to Follow-up|1|||
19791657|NCT02671435|42249458|FG006|Overall Study|Lost to Follow-up|2|||
19791658|NCT02671435|42249459|FG007|Overall Study|Lost to Follow-up|2|||
19791659|NCT02671435|42249460|FG008|Overall Study|Lost to Follow-up|0|||
19791660|NCT02671435|42249461|FG009|Overall Study|Lost to Follow-up|2|||
19791661|NCT02671435|42249462|FG010|Overall Study|Lost to Follow-up|0|||
19791662|NCT02671435|42249463|FG011|Overall Study|Lost to Follow-up|3|||
19791663|NCT02671435|42249464|FG012|Overall Study|Lost to Follow-up|3|||
19791664|NCT02671435|42249465|FG013|Overall Study|Lost to Follow-up|2|||
19791665|NCT02671435|42249466|FG014|Overall Study|Lost to Follow-up|0|||
19791666|NCT02671435|42249452|FG000|Overall Study|Withdrawal by Subject|2|||
19791667|NCT02671435|42249453|FG001|Overall Study|Withdrawal by Subject|0|||
19791668|NCT02671435|42249454|FG002|Overall Study|Withdrawal by Subject|2|||
19791669|NCT02671435|42249455|FG003|Overall Study|Withdrawal by Subject|2|||
19791670|NCT02671435|42249456|FG004|Overall Study|Withdrawal by Subject|2|||
19791671|NCT02671435|42249457|FG005|Overall Study|Withdrawal by Subject|7|||
19791672|NCT02671435|42249458|FG006|Overall Study|Withdrawal by Subject|2|||
19791673|NCT02671435|42249459|FG007|Overall Study|Withdrawal by Subject|7|||
19791674|NCT02671435|42249460|FG008|Overall Study|Withdrawal by Subject|1|||
19791675|NCT02671435|42249461|FG009|Overall Study|Withdrawal by Subject|1|||
19791676|NCT02671435|42249462|FG010|Overall Study|Withdrawal by Subject|2|||
19791677|NCT02671435|42249463|FG011|Overall Study|Withdrawal by Subject|4|||
19791678|NCT02671435|42249464|FG012|Overall Study|Withdrawal by Subject|4|||
19791679|NCT02671435|42249465|FG013|Overall Study|Withdrawal by Subject|4|||
19791680|NCT02671435|42249466|FG014|Overall Study|Withdrawal by Subject|2|||
19791681|NCT02671435|42249452|FG000|Overall Study|Un-specified|0|||
19791682|NCT02671435|42249453|FG001|Overall Study|Un-specified|0|||
19791683|NCT02671435|42249454|FG002|Overall Study|Un-specified|0|||
19791684|NCT02671435|42249455|FG003|Overall Study|Un-specified|0|||
19791685|NCT02671435|42249456|FG004|Overall Study|Un-specified|1|||
19791686|NCT02671435|42249457|FG005|Overall Study|Un-specified|3|||
19791687|NCT02671435|42249458|FG006|Overall Study|Un-specified|2|||
19791688|NCT02671435|42249459|FG007|Overall Study|Un-specified|3|||
19791689|NCT02671435|42249460|FG008|Overall Study|Un-specified|0|||
19791690|NCT02671435|42249461|FG009|Overall Study|Un-specified|5|||
19791691|NCT02671435|42249462|FG010|Overall Study|Un-specified|8|||
19791692|NCT02671435|42249463|FG011|Overall Study|Un-specified|4|||
19791693|NCT02671435|42249464|FG012|Overall Study|Un-specified|5|||
19791694|NCT02671435|42249465|FG013|Overall Study|Un-specified|9|||
19791695|NCT02671435|42249466|FG014|Overall Study|Un-specified|8|||
19791696|NCT02916433|42249521|FG000|Overall Study|Withdrawal by Subject|1|||
19791697|NCT02916433|42249522|FG001|Overall Study|Withdrawal by Subject|0|||
19791698|NCT02916433|42249521|FG000|Overall Study|Physician Decision|1|||
19791699|NCT02916433|42249522|FG001|Overall Study|Physician Decision|0|||
19791700|NCT00526227|42249531|FG000|Overall Study|Device not implanted|1|||
19791701|NCT00526227|42249531|FG000|Overall Study|Death|1|||
19791702|NCT02547922|42249539|FG000|Overall Study|Withdrawal by Subject|9|||
19791703|NCT02547922|42249540|FG001|Overall Study|Withdrawal by Subject|6|||
19791704|NCT02547922|42249541|FG002|Overall Study|Withdrawal by Subject|10|||
19791705|NCT02547922|42249539|FG000|Overall Study|Adverse Event|3|||
19791706|NCT02547922|42249540|FG001|Overall Study|Adverse Event|1|||
19791707|NCT02547922|42249541|FG002|Overall Study|Adverse Event|2|||
19791708|NCT02547922|42249539|FG000|Overall Study|Lost to Follow-up|1|||
19791709|NCT02547922|42249540|FG001|Overall Study|Lost to Follow-up|0|||
19791710|NCT02547922|42249541|FG002|Overall Study|Lost to Follow-up|0|||
19791711|NCT02547922|42249539|FG000|Overall Study|Lack of Efficacy|5|||
19791712|NCT02547922|42249540|FG001|Overall Study|Lack of Efficacy|7|||
19791713|NCT02547922|42249541|FG002|Overall Study|Lack of Efficacy|4|||
19791714|NCT02547922|42249539|FG000|Overall Study|Death|1|||
19791715|NCT02547922|42249540|FG001|Overall Study|Death|0|||
19791716|NCT02547922|42249541|FG002|Overall Study|Death|0|||
19791717|NCT02547922|42249539|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
19791718|NCT02547922|42249540|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
19791719|NCT02547922|42249541|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
19791720|NCT02547922|42249539|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
19791721|NCT02547922|42249540|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
19791722|NCT02547922|42249541|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
19791723|NCT02547922|42249539|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
19791724|NCT02547922|42249540|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
19367468|NCT03371732|41607643|FG001|Overall Study|Withdrawal by Subject|3|||
19791725|NCT02547922|42249541|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
19791726|NCT02547922|42249539|FG000|Overall Study|Physician Decision|2|||
19791727|NCT02547922|42249540|FG001|Overall Study|Physician Decision|1|||
19791728|NCT02547922|42249541|FG002|Overall Study|Physician Decision|2|||
19791729|NCT02547922|42249539|FG000|Overall Study|Patients did not receive IP|1|||
19791730|NCT02547922|42249540|FG001|Overall Study|Patients did not receive IP|1|||
19791731|NCT02547922|42249541|FG002|Overall Study|Patients did not receive IP|0|||
19791732|NCT02547766|42249555|FG000|Overall Study|Withdrawal by Subject|1|||
19791733|NCT02547454|42249559|FG000|Overall Study|Due to hemodialysis|53|||
19791734|NCT02547454|42249559|FG000|Overall Study|Due to transplantation|1|||
19791735|NCT02547454|42249559|FG000|Overall Study|Due to no further need to treat|4|||
19791736|NCT02547454|42249559|FG000|Overall Study|Death|38|||
19791737|NCT02547454|42249559|FG000|Overall Study|Lost to Follow-up|26|||
19791738|NCT02547454|42249559|FG000|Overall Study|Other|39|||
19791739|NCT02547454|42249559|FG000|Overall Study|No data|11|||
19791740|NCT02742441|42249572|FG000|Overall Study|Lost to Follow-up|4|||
19791741|NCT02742441|42249573|FG001|Overall Study|Lost to Follow-up|4|||
19791742|NCT02742441|42249572|FG000|Overall Study|Withdrawal by Subject|2|||
19791743|NCT02742441|42249573|FG001|Overall Study|Withdrawal by Subject|2|||
19791744|NCT02742441|42249572|FG000|Overall Study|Adverse Event|0|||
19791745|NCT02742441|42249573|FG001|Overall Study|Adverse Event|2|||
19791746|NCT02547220|42249590|FG000|Overall Study|Withdrawal by Subject|1|||
19791747|NCT02547220|42249591|FG001|Overall Study|Withdrawal by Subject|0|||
19791748|NCT02547220|42249590|FG000|Overall Study|Study terminated by sponsor|18|||
19791749|NCT02547220|42249591|FG001|Overall Study|Study terminated by sponsor|20|||
19791750|NCT02542072|42249599|FG000|First Intervention (1 Month)|Adverse Event|1|||
19791751|NCT02542072|42249600|FG001|First Intervention (1 Month)|Adverse Event|1|||
19791752|NCT02542072|42249599|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
19791753|NCT02542072|42249600|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
19791754|NCT02542072|42249599|FG000|First Intervention (1 Month)|Lens discomfort|1|||
19791755|NCT02542072|42249600|FG001|First Intervention (1 Month)|Lens discomfort|2|||
19791756|NCT02542072|42249599|FG000|First Intervention (1 Month)|Protocol Violation|1|||
19791757|NCT02542072|42249600|FG001|First Intervention (1 Month)|Protocol Violation|0|||
19791758|NCT02542072|42249599|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
19791759|NCT02542072|42249600|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
19791760|NCT02542072|42249599|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
19791761|NCT02542072|42249600|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
19791762|NCT00415623|42249653|FG000|Overall Study|Adverse Event|3|||
19791763|NCT00415623|42249654|FG001|Overall Study|Adverse Event|4|||
19791764|NCT00415623|42249653|FG000|Overall Study|Death|1|||
19791765|NCT00415623|42249654|FG001|Overall Study|Death|0|||
19791766|NCT00415623|42249653|FG000|Overall Study|Withdrawal by Subject|1|||
19367469|NCT03371732|41607642|FG000|Overall Study|Refusal to continue|3|||
19367470|NCT03371732|41607643|FG001|Overall Study|Refusal to continue|4|||
19607639|NCT00597753|42056465|FG001|Overall Study|Pregnancy|0|||
19607640|NCT00597753|42056464|FG000|Overall Study|Withdrawal by Subject|35|||
19607641|NCT00597753|42056465|FG001|Overall Study|Withdrawal by Subject|12|||
19607642|NCT00597753|42056464|FG000|Overall Study|Discontinued Dialysis|0|||
19607643|NCT00597753|42056465|FG001|Overall Study|Discontinued Dialysis|1|||
19607644|NCT00597753|42056464|FG000|Overall Study|Never dosed|2|||
19607645|NCT00597753|42056465|FG001|Overall Study|Never dosed|0|||
19607646|NCT00597753|42056464|FG000|Overall Study|Noncompliance|2|||
19607647|NCT00597753|42056465|FG001|Overall Study|Noncompliance|1|||
19607648|NCT00597753|42056464|FG000|Overall Study|Relocation|17|||
19607649|NCT00597753|42056465|FG001|Overall Study|Relocation|6|||
19607650|NCT00597753|42056464|FG000|Overall Study|Renal transplant|10|||
19607651|NCT00597753|42056465|FG001|Overall Study|Renal transplant|3|||
19607652|NCT00597753|42056464|FG000|Overall Study|Site closed by sponsor|19|||
19697961|NCT00237042|42143235|FG001|Treatment|Became ineligible post-randomization|1|||
19697962|NCT00237042|42143236|FG002|Treatment|Became ineligible post-randomization|16|||
19697963|NCT00237042|42143234|FG000|Treatment|Moved out of state|1|||
19697964|NCT00237042|42143235|FG001|Treatment|Moved out of state|1|||
19697965|NCT00237042|42143236|FG002|Treatment|Moved out of state|1|||
19697966|NCT00237042|42143234|FG000|Treatment|Completed no treatment|5|||
19697967|NCT00237042|42143235|FG001|Treatment|Completed no treatment|5|||
19697968|NCT00237042|42143236|FG002|Treatment|Completed no treatment|21|||
19697969|NCT00237042|42143234|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
19697970|NCT00237042|42143235|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
19697971|NCT00237042|42143236|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
19697972|NCT00237042|42143234|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
19697973|NCT00237042|42143235|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
19697974|NCT00237042|42143236|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
19697975|NCT00465647|42143248|FG000|Overall Study|Administrative|2|||
19697976|NCT00465647|42143249|FG001|Overall Study|Administrative|2|||
19697977|NCT00465647|42143250|FG002|Overall Study|Administrative|3|||
19697978|NCT00465647|42143251|FG003|Overall Study|Administrative|2|||
19791767|NCT00415623|42249654|FG001|Overall Study|Withdrawal by Subject|1|||
19791768|NCT01969409|42249663|FG000|Overall Study|Death|2|||
19791769|NCT01969409|42249664|FG001|Overall Study|Death|2|||
19791770|NCT01969409|42249663|FG000|Overall Study|Transplant|1|||
19791771|NCT01969409|42249664|FG001|Overall Study|Transplant|1|||
19697979|NCT00465647|42143248|FG000|Overall Study|Adverse Event|2|||
19791772|NCT01969409|42249663|FG000|Overall Study|Withdrawal by Subject|0|||
19791773|NCT01969409|42249664|FG001|Overall Study|Withdrawal by Subject|1|||
19791774|NCT00150813|42249670|FG000|Overall Study|Adverse Event|1|||
19791775|NCT00150813|42249670|FG000|Overall Study|Lack of Efficacy|1|||
19791776|NCT00150813|42249670|FG000|Overall Study|Lost to Follow-up|5|||
19791777|NCT00150813|42249670|FG000|Overall Study|Withdrawal by Subject|5|||
19791778|NCT00150813|42249670|FG000|Overall Study|Remission|3|||
19791779|NCT00150813|42249670|FG000|Overall Study|Planned pregancy|1|||
19791780|NCT00150813|42249670|FG000|Overall Study|Switch to commercially available LEV|2|||
19791781|NCT02712788|42249676|FG000|Overall Study|Physician Decision|1|||
19791782|NCT02712788|42249677|FG001|Overall Study|Physician Decision|0|||
19791783|NCT02712788|42249676|FG000|Overall Study|Protocol Violation|1|||
19791784|NCT02712788|42249677|FG001|Overall Study|Protocol Violation|0|||
19791785|NCT02308111|42249685|FG000|Overall Study|Adverse Event|31|||
19791786|NCT02308111|42249686|FG001|Overall Study|Adverse Event|19|||
19791787|NCT02308111|42249685|FG000|Overall Study|Death|9|||
19791788|NCT02308111|42249686|FG001|Overall Study|Death|6|||
19791789|NCT02308111|42249685|FG000|Overall Study|Lost to Follow-up|2|||
19791790|NCT02308111|42249686|FG001|Overall Study|Lost to Follow-up|7|||
19791791|NCT02308111|42249685|FG000|Overall Study|Physician Decision|6|||
19791792|NCT02308111|42249686|FG001|Overall Study|Physician Decision|17|||
19791793|NCT02308111|42249685|FG000|Overall Study|Protocol Violation|0|||
19791794|NCT02308111|42249686|FG001|Overall Study|Protocol Violation|1|||
19791795|NCT02308111|42249685|FG000|Overall Study|Withdrawal by Subject|28|||
19791796|NCT02308111|42249686|FG001|Overall Study|Withdrawal by Subject|38|||
19791797|NCT02308111|42249685|FG000|Overall Study|Study Terminated by Sponsor|72|||
19791798|NCT02308111|42249686|FG001|Overall Study|Study Terminated by Sponsor|61|||
19791799|NCT02308111|42249685|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
19791800|NCT02308111|42249686|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
19791801|NCT02308111|42249685|FG000|Overall Study|Site Closure|3|||
19791802|NCT02308111|42249686|FG001|Overall Study|Site Closure|3|||
19791803|NCT02308111|42249685|FG000|Overall Study|Non-compliance with Study Drug|3|||
19791804|NCT02308111|42249686|FG001|Overall Study|Non-compliance with Study Drug|1|||
19791805|NCT02308111|42249685|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
19791806|NCT02308111|42249686|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
19791807|NCT02308111|42249685|FG000|Overall Study|Liver Transplant|3|||
19791808|NCT02308111|42249686|FG001|Overall Study|Liver Transplant|3|||
19791809|NCT02308111|42249685|FG000|Overall Study|Liver Transplant Waitlist|2|||
19791810|NCT02308111|42249686|FG001|Overall Study|Liver Transplant Waitlist|2|||
19791811|NCT02308111|42249685|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
19791812|NCT02308111|42249686|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
19791813|NCT01346189|42249697|FG000|Overall Study|Withdrawal by Subject|7|||
19791814|NCT01346189|42249698|FG001|Overall Study|Withdrawal by Subject|5|||
19791815|NCT01346189|42249699|FG002|Overall Study|Withdrawal by Subject|3|||
19791816|NCT01346189|42249700|FG003|Overall Study|Withdrawal by Subject|5|||
19791817|NCT01346189|42249697|FG000|Overall Study|Physician Decision|4|||
19791818|NCT01346189|42249698|FG001|Overall Study|Physician Decision|0|||
19791819|NCT01346189|42249699|FG002|Overall Study|Physician Decision|0|||
19791820|NCT01346189|42249700|FG003|Overall Study|Physician Decision|0|||
19791821|NCT01346189|42249697|FG000|Overall Study|Moved|3|||
19791822|NCT01346189|42249698|FG001|Overall Study|Moved|0|||
19791823|NCT01346189|42249699|FG002|Overall Study|Moved|4|||
19791824|NCT01346189|42249700|FG003|Overall Study|Moved|0|||
19791825|NCT01346189|42249697|FG000|Overall Study|Other|2|||
19791826|NCT01346189|42249698|FG001|Overall Study|Other|4|||
19791827|NCT01346189|42249699|FG002|Overall Study|Other|7|||
19791828|NCT01346189|42249700|FG003|Overall Study|Other|3|||
19791829|NCT01346189|42249697|FG000|Overall Study|Death|0|||
19791830|NCT01346189|42249698|FG001|Overall Study|Death|3|||
19791831|NCT01346189|42249699|FG002|Overall Study|Death|0|||
19791832|NCT01346189|42249700|FG003|Overall Study|Death|0|||
19791833|NCT01346189|42249697|FG000|Overall Study|Non-health system primary care physician|0|||
19791834|NCT01346189|42249698|FG001|Overall Study|Non-health system primary care physician|5|||
19791835|NCT01346189|42249699|FG002|Overall Study|Non-health system primary care physician|0|||
19791836|NCT01346189|42249700|FG003|Overall Study|Non-health system primary care physician|0|||
19791837|NCT01346189|42249697|FG000|Overall Study|Travel|0|||
19791838|NCT01346189|42249698|FG001|Overall Study|Travel|0|||
19791839|NCT01346189|42249699|FG002|Overall Study|Travel|0|||
19791840|NCT01346189|42249700|FG003|Overall Study|Travel|3|||
19791841|NCT00369317|42249710|FG000|Overall Study|Adverse Event|3|||
19791842|NCT00369317|42249710|FG000|Overall Study|Death|1|||
19791843|NCT00369317|42249710|FG000|Overall Study|Lack of Efficacy|5|||
19791844|NCT00369317|42249710|FG000|Overall Study|Physician Decision|2|||
19791845|NCT00369317|42249710|FG000|Overall Study|Withdrawal by Subject|8|||
19791846|NCT00369317|42249710|FG000|Overall Study|Ineligible|1|||
19791847|NCT03193021|42249717|FG000|Overall Study|Lost to Follow-up|1|||
19791848|NCT03193021|42249718|FG001|Overall Study|Lost to Follow-up|1|||
19791849|NCT03913091|42249726|FG000|Overall Study|Lost to Follow-up|18|||
19791850|NCT03913091|42249727|FG001|Overall Study|Lost to Follow-up|11|||
19791851|NCT03913091|42249726|FG000|Overall Study|Required additional meds/surgery|1|||
19791852|NCT03913091|42249727|FG001|Overall Study|Required additional meds/surgery|2|||
19791853|NCT03913091|42249726|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
19791854|NCT03913091|42249727|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
19791855|NCT01318499|42249751|FG000|Overall Study|Adverse Event|16|||
19791856|NCT01318499|42249752|FG001|Overall Study|Adverse Event|11|||
19791857|NCT01318499|42249753|FG002|Overall Study|Adverse Event|6|||
19791858|NCT01318499|42249751|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
19791859|NCT01318499|42249752|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
19791860|NCT01318499|42249753|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
19791861|NCT01318499|42249751|FG000|Overall Study|Noncompliance|2|||
19791862|NCT01318499|42249752|FG001|Overall Study|Noncompliance|3|||
19791863|NCT01318499|42249753|FG002|Overall Study|Noncompliance|0|||
19791864|NCT01318499|42249751|FG000|Overall Study|Treatment Failure|19|||
19791865|NCT01318499|42249752|FG001|Overall Study|Treatment Failure|19|||
19791866|NCT01318499|42249753|FG002|Overall Study|Treatment Failure|101|||
19791867|NCT01318499|42249751|FG000|Overall Study|Protocol Violation|2|||
19791868|NCT01318499|42249752|FG001|Overall Study|Protocol Violation|4|||
19791869|NCT01318499|42249753|FG002|Overall Study|Protocol Violation|2|||
19791870|NCT01318499|42249751|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
19791871|NCT01318499|42249752|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
19791872|NCT01318499|42249753|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
19791873|NCT01318499|42249751|FG000|Overall Study|Other|7|||
19607653|NCT00597753|42056465|FG001|Overall Study|Site closed by sponsor|7|||
19607654|NCT00597753|42056464|FG000|Overall Study|Site elected to close|2|||
19607655|NCT00597753|42056465|FG001|Overall Study|Site elected to close|4|||
19607656|NCT00665431|42056474|FG000|Overall Study|Adverse Event|16|||
19607657|NCT00665431|42056475|FG001|Overall Study|Adverse Event|22|||
19607658|NCT00665431|42056476|FG002|Overall Study|Adverse Event|6|||
19607659|NCT00665431|42056474|FG000|Overall Study|Withdrawal by Subject|17|||
19607660|NCT00665431|42056475|FG001|Overall Study|Withdrawal by Subject|25|||
19607661|NCT00665431|42056476|FG002|Overall Study|Withdrawal by Subject|15|||
19607662|NCT00665431|42056474|FG000|Overall Study|Lost to Follow-up|3|||
19607663|NCT00665431|42056475|FG001|Overall Study|Lost to Follow-up|3|||
19607664|NCT00665431|42056476|FG002|Overall Study|Lost to Follow-up|1|||
19607665|NCT00665431|42056474|FG000|Overall Study|Other|4|||
19607666|NCT00665431|42056475|FG001|Overall Study|Other|7|||
19607667|NCT00665431|42056476|FG002|Overall Study|Other|2|||
19607668|NCT00934622|42056484|FG000|Overall Study|Lost to Follow-up|7|||
19607669|NCT00934622|42056484|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
19607670|NCT00881361|42056490|FG000|Overall Study|Terminated prior to surgery|27|||
19607671|NCT00881361|42056491|FG001|Overall Study|Terminated prior to surgery|7|||
19607672|NCT00881361|42056492|FG002|Overall Study|Terminated prior to surgery|0|||
19697980|NCT00465647|42143249|FG001|Overall Study|Adverse Event|0|||
19697981|NCT00465647|42143250|FG002|Overall Study|Adverse Event|3|||
19697982|NCT00465647|42143251|FG003|Overall Study|Adverse Event|2|||
19697983|NCT00465647|42143248|FG000|Overall Study|Withdrawal by Subject|1|||
19697984|NCT00465647|42143249|FG001|Overall Study|Withdrawal by Subject|2|||
19697985|NCT00465647|42143250|FG002|Overall Study|Withdrawal by Subject|2|||
19697986|NCT00465647|42143251|FG003|Overall Study|Withdrawal by Subject|7|||
19697987|NCT00465647|42143248|FG000|Overall Study|"The other reasons included loss of IV"|8|||
19697988|NCT00465647|42143249|FG001|Overall Study|"The other reasons included loss of IV"|4|||
19697989|NCT00465647|42143250|FG002|Overall Study|"The other reasons included loss of IV"|3|||
19697990|NCT00465647|42143251|FG003|Overall Study|"The other reasons included loss of IV"|2|||
19697991|NCT00465569|42143273|FG000|Overall Study|persistent eczema during dose escalation|1|||
19697992|NCT00465569|42143274|FG001|Overall Study|persistent eczema during dose escalation|0|||
19697993|NCT00090766|42143283|FG000|Overall Study|Nephrectomy Planned|0|||
19697994|NCT00090766|42143284|FG001|Overall Study|Nephrectomy Planned|0|||
19697995|NCT00090766|42143285|FG002|Overall Study|Nephrectomy Planned|1|||
19697996|NCT00090766|42143283|FG000|Overall Study|Death|1|||
19791874|NCT01318499|42249752|FG001|Overall Study|Other|10|||
19791875|NCT01318499|42249753|FG002|Overall Study|Other|22|||
19607673|NCT00881361|42056490|FG000|Overall Study|Ineligible|17|||
19607674|NCT00881361|42056491|FG001|Overall Study|Ineligible|2|||
19607675|NCT00881361|42056492|FG002|Overall Study|Ineligible|2|||
19697997|NCT00090766|42143284|FG001|Overall Study|Death|0|||
19697998|NCT00090766|42143285|FG002|Overall Study|Death|0|||
19791876|NCT02285595|42249787|FG000|Overall Study|Lost to Follow-up|14|||
19791877|NCT02285595|42249787|FG000|Overall Study|Withdrawal by Subject|1|||
19791878|NCT02712398|42249810|FG000|Overall Study|Withdrawal by Subject|6|||
19607676|NCT01000727|42056503|FG000|Overall Study|Lost to Follow-up|41|||
19607677|NCT01000727|42056504|FG001|Overall Study|Lost to Follow-up|43|||
19791879|NCT02712398|42249810|FG000|Overall Study|Lost to Follow-up|6|||
19697999|NCT00090766|42143283|FG000|Overall Study|Admin|0|||
19698000|NCT00090766|42143284|FG001|Overall Study|Admin|2|||
19607678|NCT01000727|42056503|FG000|Overall Study|Withdrawal by Subject|111|||
19791880|NCT02712398|42249810|FG000|Overall Study|Sponsor Decision|1|||
19791881|NCT02712398|42249810|FG000|Overall Study|Physician Decision|1|||
19791882|NCT02712398|42249810|FG000|Overall Study|Death|2|||
19791883|NCT02712398|42249810|FG000|Overall Study|Re-operation|21|||
19791884|NCT00282867|42249817|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
19791885|NCT00282867|42249818|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
19791886|NCT00282867|42249819|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
19791887|NCT00151281|42249824|FG000|Overall Study|Not evaluable|3|||
19791888|NCT01318109|42249839|FG000|Overall Study|Adverse Event|0|||
19791889|NCT01318109|42249840|FG001|Overall Study|Adverse Event|2|||
19791890|NCT01318109|42249841|FG002|Overall Study|Adverse Event|0|||
19791891|NCT01318109|42249839|FG000|Overall Study|Withdrawal by Subject|1|||
19791892|NCT01318109|42249840|FG001|Overall Study|Withdrawal by Subject|0|||
19791893|NCT01318109|42249841|FG002|Overall Study|Withdrawal by Subject|0|||
19791894|NCT01318109|42249839|FG000|Overall Study|Schedule Conflict|0|||
19791895|NCT01318109|42249840|FG001|Overall Study|Schedule Conflict|1|||
19791896|NCT01318109|42249841|FG002|Overall Study|Schedule Conflict|0|||
19791897|NCT02712554|42249851|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
19791898|NCT02712554|42249852|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
19791899|NCT02712554|42249851|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
19791900|NCT02712554|42249852|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
19791901|NCT02712554|42249851|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
19791902|NCT02712554|42249852|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
19791903|NCT02712554|42249851|FG000|Part B: Qualification Phase|Adverse Event|0|||
19791904|NCT02712554|42249852|FG001|Part B: Qualification Phase|Adverse Event|1|||
19791905|NCT02712554|42249851|FG000|Part B: Treatment Phase|Adverse Event|0|||
19791906|NCT02712554|42249852|FG001|Part B: Treatment Phase|Adverse Event|1|||
19791907|NCT02712554|42249851|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
19791908|NCT02712554|42249852|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
19791909|NCT02712554|42249851|FG000|Part B: Treatment Phase|Other|0|||
19791910|NCT02712554|42249852|FG001|Part B: Treatment Phase|Other|1|||
19791911|NCT02712320|42249875|FG000|Overall Study|Lost to Follow-up|1|||
19791912|NCT02712320|42249875|FG000|Overall Study|Withdrawal by Subject|1|||
19791913|NCT02712320|42249875|FG000|Overall Study|Transferred to another facility|1|||
19791914|NCT02712320|42249875|FG000|Overall Study|Treating with the prohibited medications|2|||
19791915|NCT03052751|42249881|FG000|Dosing Period 1|Adverse Event|0|||
19791916|NCT03052751|42249882|FG001|Dosing Period 1|Adverse Event|1|||
19791917|NCT03052751|42249883|FG002|Dosing Period 1|Adverse Event|0|||
19791918|NCT03052751|42249884|FG003|Dosing Period 1|Adverse Event|0|||
19791919|NCT03052751|42249885|FG004|Dosing Period 1|Adverse Event|0|||
19791920|NCT03052751|42249886|FG005|Dosing Period 1|Adverse Event|0|||
19791921|NCT03052751|42249881|FG000|Dosing Period 2|Adverse Event|0|||
19791922|NCT03052751|42249882|FG001|Dosing Period 2|Adverse Event|0|||
19791923|NCT03052751|42249883|FG002|Dosing Period 2|Adverse Event|3|||
19791924|NCT03052751|42249884|FG003|Dosing Period 2|Adverse Event|0|||
19791925|NCT03052751|42249885|FG004|Dosing Period 2|Adverse Event|0|||
19791926|NCT03052751|42249886|FG005|Dosing Period 2|Adverse Event|0|||
19791927|NCT03052751|42249881|FG000|Observation Period|Adverse Event|0|||
19791928|NCT03052751|42249882|FG001|Observation Period|Adverse Event|0|||
19791929|NCT03052751|42249883|FG002|Observation Period|Adverse Event|0|||
19791930|NCT03052751|42249884|FG003|Observation Period|Adverse Event|0|||
19791931|NCT03052751|42249885|FG004|Observation Period|Adverse Event|1|||
19791932|NCT03052751|42249886|FG005|Observation Period|Adverse Event|0|||
19791933|NCT01317797|42249899|FG000|Overall Study|Other|0|||
19367471|NCT02745119|41607655|FG000|Overall Study|Adverse Event|1|||
19698001|NCT00090766|42143285|FG002|Overall Study|Admin|0|||
19698002|NCT00090766|42143283|FG000|Overall Study|Lost to Follow-up|2|||
19698003|NCT00090766|42143284|FG001|Overall Study|Lost to Follow-up|0|||
19698004|NCT00090766|42143285|FG002|Overall Study|Lost to Follow-up|2|||
19698005|NCT00465179|42143295|FG000|Overall Study|Adverse Event|4|||
19698006|NCT00465179|42143295|FG000|Overall Study|Withdrawal by Subject|2|||
19698007|NCT00465179|42143295|FG000|Overall Study|Progression of Disease|47|||
19698008|NCT00465101|42143299|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
19698009|NCT00465101|42143299|FG000|Overall Study|Change in health precluded follow up|4|||
19791934|NCT01317797|42249900|FG001|Overall Study|Other|1|||
19791935|NCT01317797|42249901|FG002|Overall Study|Other|0|||
19791936|NCT01317797|42249899|FG000|Overall Study|Withdrawal of Patient|0|||
19791937|NCT01317797|42249900|FG001|Overall Study|Withdrawal of Patient|0|||
19791938|NCT01317797|42249901|FG002|Overall Study|Withdrawal of Patient|1|||
19791939|NCT01343693|42249909|FG000|Overall Study|Lost to Follow-up|9|||
19791940|NCT02712008|42249916|FG000|Baseline (Day 1) up to Week 12|Death|3|||
19791941|NCT02712008|42249917|FG001|Baseline (Day 1) up to Week 12|Death|0|||
19791942|NCT02712008|42249918|FG002|Baseline (Day 1) up to Week 12|Death|0|||
19367472|NCT02745119|41607656|FG001|Overall Study|Adverse Event|0|||
19698010|NCT00465101|42143299|FG000|Overall Study|Did not meet study criteria|4|||
19791943|NCT02712008|42249919|FG003|Baseline (Day 1) up to Week 12|Death|0|||
19791944|NCT02712008|42249920|FG004|Baseline (Day 1) up to Week 12|Death|0|||
19791945|NCT02712008|42249921|FG005|Baseline (Day 1) up to Week 12|Death|0|||
19791946|NCT02712008|42249922|FG006|Baseline (Day 1) up to Week 12|Death|0|||
19791947|NCT02712008|42249923|FG007|Baseline (Day 1) up to Week 12|Death|0|||
19791948|NCT02712008|42249916|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791949|NCT02712008|42249917|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
19791950|NCT02712008|42249918|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
19791951|NCT02712008|42249919|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791952|NCT02712008|42249920|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791953|NCT02712008|42249921|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791954|NCT02712008|42249922|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791955|NCT02712008|42249923|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
19791956|NCT02712008|42249916|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
19791957|NCT02712008|42249917|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19791958|NCT02712008|42249918|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
19607679|NCT01000727|42056504|FG001|Overall Study|Withdrawal by Subject|109|||
19607680|NCT01000727|42056503|FG000|Overall Study|Study closed/terminated|23|||
19607681|NCT01000727|42056504|FG001|Overall Study|Study closed/terminated|24|||
19607682|NCT00881205|42056514|FG000|Overall Study|Adverse Event|8|||
19607683|NCT00881205|42056515|FG001|Overall Study|Adverse Event|3|||
19607684|NCT00881205|42056514|FG000|Overall Study|Withdrawal by Subject|1|||
19607685|NCT00881205|42056515|FG001|Overall Study|Withdrawal by Subject|2|||
19607686|NCT00881205|42056514|FG000|Overall Study|Lost to Follow-up|0|||
19607687|NCT00881205|42056515|FG001|Overall Study|Lost to Follow-up|1|||
19607688|NCT00881205|42056514|FG000|Overall Study|Administrative problems|1|||
19607689|NCT00881205|42056515|FG001|Overall Study|Administrative problems|1|||
19607690|NCT00881205|42056514|FG000|Overall Study|Condition no longer requires drug|1|||
19607691|NCT00881205|42056515|FG001|Overall Study|Condition no longer requires drug|0|||
19607692|NCT00879879|42056522|FG000|Overall Study|Death|1|||
19607693|NCT00879879|42056522|FG000|Overall Study|Withdrawal by Subject|1|||
19607694|NCT00879879|42056522|FG000|Overall Study|Physician Decision|1|||
19607695|NCT00661999|42056531|FG000|Overall Study|Adverse Event|11|||
19607696|NCT00661999|42056532|FG001|Overall Study|Adverse Event|5|||
19607697|NCT00661999|42056533|FG002|Overall Study|Adverse Event|8|||
19607698|NCT00661999|42056531|FG000|Overall Study|Death|8|||
19607699|NCT00661999|42056532|FG001|Overall Study|Death|6|||
19607700|NCT00661999|42056533|FG002|Overall Study|Death|3|||
19607701|NCT00661999|42056531|FG000|Overall Study|Other Reasons|5|||
19607702|NCT00661999|42056532|FG001|Overall Study|Other Reasons|12|||
19607703|NCT00661999|42056533|FG002|Overall Study|Other Reasons|23|||
19607704|NCT00661999|42056531|FG000|Overall Study|Withdrawal by Subject|30|||
19607705|NCT00661999|42056532|FG001|Overall Study|Withdrawal by Subject|23|||
19607706|NCT00661999|42056533|FG002|Overall Study|Withdrawal by Subject|14|||
19607707|NCT00661999|42056531|FG000|Overall Study|Alternative Treatment|1|||
19607708|NCT00661999|42056532|FG001|Overall Study|Alternative Treatment|0|||
19607709|NCT00661999|42056533|FG002|Overall Study|Alternative Treatment|0|||
19607710|NCT00661999|42056531|FG000|Overall Study|Other Medical Problems|4|||
19607711|NCT00661999|42056532|FG001|Overall Study|Other Medical Problems|4|||
19607712|NCT00661999|42056533|FG002|Overall Study|Other Medical Problems|9|||
19607713|NCT00665353|42056541|FG000|Study Step 1|Adverse Event|1|||
19607714|NCT00665353|42056541|FG000|Study Step 1|Withdrawal by Subject|2|||
19607715|NCT00665353|42056541|FG000|Study Step 2|Lost to Follow-up|2|||
19607716|NCT00665353|42056541|FG000|Study Step 2|Lack of Efficacy|12|||
19607717|NCT00597207|42056547|FG000|Overall Study|Lost to Follow-up|5|||
19607718|NCT00597207|42056548|FG001|Overall Study|Lost to Follow-up|7|||
19607719|NCT00879645|42056558|FG000|Overall Study|Adverse Event|1|||
19607720|NCT00879645|42056559|FG001|Overall Study|Adverse Event|0|||
19607721|NCT00879645|42056560|FG002|Overall Study|Adverse Event|0|||
19607722|NCT00879645|42056561|FG003|Overall Study|Adverse Event|0|||
19607723|NCT00664105|42056571|FG000|Overall Study|Death|3|||
19607724|NCT00664105|42056571|FG000|Overall Study|Withdrawal by Subject|5|||
19607725|NCT00664105|42056571|FG000|Overall Study|Adverse Event|9|||
19607726|NCT00664105|42056571|FG000|Overall Study|Disease progression|7|||
19607727|NCT00661687|42056576|FG000|Overall Study|Study related symptoms and complaints|5|||
19607728|NCT00661687|42056576|FG000|Overall Study|Positive slit lamp findings|4|||
19607729|NCT00661687|42056576|FG000|Overall Study|Inability to maintain wearing schedule|3|||
19607730|NCT00661687|42056576|FG000|Overall Study|Physician Decision|1|||
19607731|NCT00661687|42056576|FG000|Overall Study|Adverse Event|2|||
19607732|NCT00596817|42056585|FG000|Open-label Period|Adverse Event|0|||
19607733|NCT00596817|42056586|FG001|Open-label Period|Adverse Event|49|||
19607734|NCT00596817|42056585|FG000|Open-label Period|Lack of Efficacy|0|||
19607735|NCT00596817|42056586|FG001|Open-label Period|Lack of Efficacy|33|||
19607736|NCT00596817|42056585|FG000|Open-label Period|Other Reasons|0|||
19791959|NCT02712008|42249919|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19791960|NCT02712008|42249920|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19607737|NCT00596817|42056586|FG001|Open-label Period|Other Reasons|65|||
19607738|NCT00596817|42056585|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
19791961|NCT02712008|42249921|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19791962|NCT02712008|42249922|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19791963|NCT02712008|42249923|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
19791964|NCT02712008|42249916|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791965|NCT02712008|42249917|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791966|NCT02712008|42249918|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
19791967|NCT02712008|42249919|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791968|NCT02712008|42249920|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791969|NCT02712008|42249921|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791970|NCT02712008|42249922|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791971|NCT02712008|42249923|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
19791972|NCT02712008|42249916|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791973|NCT02712008|42249917|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
19791974|NCT02712008|42249918|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791975|NCT02712008|42249919|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791976|NCT02712008|42249920|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791977|NCT02712008|42249921|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791978|NCT02712008|42249922|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791979|NCT02712008|42249923|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
19791980|NCT02712008|42249916|FG000|From Week 12 up to Week 36|Adverse Event|0|||
19791981|NCT02712008|42249917|FG001|From Week 12 up to Week 36|Adverse Event|0|||
19791982|NCT02712008|42249918|FG002|From Week 12 up to Week 36|Adverse Event|0|||
19791983|NCT02712008|42249919|FG003|From Week 12 up to Week 36|Adverse Event|0|||
19791984|NCT02712008|42249920|FG004|From Week 12 up to Week 36|Adverse Event|1|||
19791985|NCT02712008|42249921|FG005|From Week 12 up to Week 36|Adverse Event|0|||
19791986|NCT02712008|42249922|FG006|From Week 12 up to Week 36|Adverse Event|0|||
19791987|NCT02712008|42249923|FG007|From Week 12 up to Week 36|Adverse Event|2|||
19791988|NCT02712008|42249916|FG000|From Week 12 up to Week 36|Death|1|||
19791989|NCT02712008|42249917|FG001|From Week 12 up to Week 36|Death|0|||
19791990|NCT02712008|42249918|FG002|From Week 12 up to Week 36|Death|0|||
19791991|NCT02712008|42249919|FG003|From Week 12 up to Week 36|Death|0|||
19791992|NCT02712008|42249920|FG004|From Week 12 up to Week 36|Death|0|||
19791993|NCT02712008|42249921|FG005|From Week 12 up to Week 36|Death|0|||
19791994|NCT02712008|42249922|FG006|From Week 12 up to Week 36|Death|1|||
19791995|NCT02712008|42249923|FG007|From Week 12 up to Week 36|Death|0|||
19791996|NCT02712008|42249916|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
19791997|NCT02712008|42249917|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
19791998|NCT02712008|42249918|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
19791999|NCT02712008|42249919|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
19792000|NCT02712008|42249920|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
19792001|NCT02712008|42249921|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
19792002|NCT02712008|42249922|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
19792003|NCT02712008|42249923|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
19792004|NCT02712008|42249916|FG000|From Week 12 up to Week 36|Physician Decision|0|||
19792005|NCT02712008|42249917|FG001|From Week 12 up to Week 36|Physician Decision|0|||
19607739|NCT00596817|42056586|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
19792006|NCT02712008|42249918|FG002|From Week 12 up to Week 36|Physician Decision|0|||
19792007|NCT02712008|42249919|FG003|From Week 12 up to Week 36|Physician Decision|1|||
19792008|NCT02712008|42249920|FG004|From Week 12 up to Week 36|Physician Decision|1|||
19792009|NCT02712008|42249921|FG005|From Week 12 up to Week 36|Physician Decision|0|||
19792010|NCT02712008|42249922|FG006|From Week 12 up to Week 36|Physician Decision|0|||
19792011|NCT02712008|42249923|FG007|From Week 12 up to Week 36|Physician Decision|0|||
19792012|NCT02712008|42249916|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19792013|NCT02712008|42249917|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19367473|NCT02745119|41607657|FG002|Overall Study|Adverse Event|1|||
19367474|NCT02745119|41607658|FG003|Overall Study|Adverse Event|3|||
19367475|NCT02745119|41607655|FG000|Overall Study|Death|3|||
19367476|NCT02745119|41607656|FG001|Overall Study|Death|3|||
19367477|NCT02745119|41607657|FG002|Overall Study|Death|0|||
19367478|NCT02745119|41607658|FG003|Overall Study|Death|4|||
19367479|NCT02745119|41607655|FG000|Overall Study|Lost to Follow-up|0|||
19367480|NCT02745119|41607656|FG001|Overall Study|Lost to Follow-up|0|||
19367481|NCT02745119|41607657|FG002|Overall Study|Lost to Follow-up|0|||
19367482|NCT02745119|41607658|FG003|Overall Study|Lost to Follow-up|1|||
19367483|NCT02745119|41607655|FG000|Overall Study|Protocol Deviation|0|||
19367484|NCT02745119|41607656|FG001|Overall Study|Protocol Deviation|0|||
19367485|NCT02745119|41607657|FG002|Overall Study|Protocol Deviation|0|||
19367486|NCT02745119|41607658|FG003|Overall Study|Protocol Deviation|1|||
19367487|NCT02745119|41607655|FG000|Overall Study|Withdrawal by Subject|7|||
19367488|NCT02745119|41607656|FG001|Overall Study|Withdrawal by Subject|15|||
19607740|NCT00596817|42056585|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
19698011|NCT00465101|42143299|FG000|Overall Study|Lost to Follow-up|5|||
19792014|NCT02712008|42249918|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19792015|NCT02712008|42249919|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19367489|NCT02745119|41607657|FG002|Overall Study|Withdrawal by Subject|8|||
19367490|NCT02745119|41607658|FG003|Overall Study|Withdrawal by Subject|14|||
19367491|NCT02745119|41607655|FG000|Overall Study|Study Terminated by Sponsor|134|||
19367492|NCT02745119|41607656|FG001|Overall Study|Study Terminated by Sponsor|252|||
19367493|NCT02745119|41607657|FG002|Overall Study|Study Terminated by Sponsor|135|||
19367494|NCT02745119|41607658|FG003|Overall Study|Study Terminated by Sponsor|251|||
19367495|NCT02745119|41607655|FG000|Overall Study|Physician Decision|0|||
19367496|NCT02745119|41607656|FG001|Overall Study|Physician Decision|2|||
19367497|NCT02745119|41607657|FG002|Overall Study|Physician Decision|2|||
19367498|NCT02745119|41607658|FG003|Overall Study|Physician Decision|2|||
19367499|NCT02745119|41607655|FG000|Overall Study|Reason Not Specified|0|||
19367500|NCT02745119|41607656|FG001|Overall Study|Reason Not Specified|2|||
19367501|NCT02745119|41607657|FG002|Overall Study|Reason Not Specified|0|||
19367502|NCT02745119|41607658|FG003|Overall Study|Reason Not Specified|1|||
19367503|NCT01367665|41607672|FG000|Overall Study|Death|102|||
19367504|NCT01367665|41607673|FG001|Overall Study|Death|19|||
19607741|NCT00596817|42056586|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
19607742|NCT00596817|42056585|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
19607743|NCT00596817|42056586|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
19792016|NCT02712008|42249920|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19792017|NCT02712008|42249921|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
19792018|NCT02712008|42249922|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
19607744|NCT00596817|42056585|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
19792019|NCT02712008|42249923|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
19792020|NCT04238481|42249941|FG000|Overall Study|Miscellaneous|0|||
19792021|NCT04238481|42249942|FG001|Overall Study|Miscellaneous|1|||
19792022|NCT04238481|42249943|FG002|Overall Study|Miscellaneous|0|||
19792023|NCT04238481|42249944|FG003|Overall Study|Miscellaneous|0|||
19792024|NCT02711306|42249960|FG000|Overall Study|Withdrawal by Subject|2|||
19607745|NCT00596817|42056586|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
19607746|NCT00596817|42056585|FG000|Double-blind Period|Adverse Event|5|||
19607747|NCT00596817|42056586|FG001|Double-blind Period|Adverse Event|16|||
19698012|NCT00465101|42143299|FG000|Overall Study|Other|6|||
19698013|NCT00465101|42143299|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
19698014|NCT00465101|42143299|FG000|Overall Study|Patient postponed procedure|1|||
19698015|NCT00465101|42143299|FG000|Overall Study|Site closed due to IRB expiration|1|||
19607748|NCT00596817|42056585|FG000|Double-blind Period|Lack of Efficacy|52|||
19698016|NCT00465101|42143299|FG000|Overall Study|Unable to obtain IRB approval|1|||
19698017|NCT00465101|42143299|FG000|Overall Study|Death|3|||
19698018|NCT00465101|42143299|FG000|Overall Study|Withdrawal by Subject|25|||
19698019|NCT00465101|42143299|FG000|Overall Study|Physician Decision|1|||
19698020|NCT00465101|42143299|FG000|Overall Study|Withdrew consent prior to procedure|3|||
19698021|NCT00084136|42143328|FG000|PI Comparison|Death|10|||
19698022|NCT00084136|42143329|FG001|PI Comparison|Death|9|||
19698023|NCT00084136|42143330|FG002|PI Comparison|Death|0|||
19698024|NCT00084136|42143328|FG000|PI Comparison|Lost to Follow-up|11|||
19698025|NCT00084136|42143329|FG001|PI Comparison|Lost to Follow-up|8|||
19698026|NCT00084136|42143330|FG002|PI Comparison|Lost to Follow-up|0|||
19698027|NCT00084136|42143328|FG000|PI Comparison|Withdrawal by Subject|33|||
19698028|NCT00084136|42143329|FG001|PI Comparison|Withdrawal by Subject|30|||
19698029|NCT00084136|42143330|FG002|PI Comparison|Withdrawal by Subject|0|||
19698030|NCT00084136|42143328|FG000|PI Comparison|Clinic site closed|1|||
19698031|NCT00084136|42143329|FG001|PI Comparison|Clinic site closed|0|||
19698032|NCT00084136|42143330|FG002|PI Comparison|Clinic site closed|0|||
19698033|NCT00084136|42143328|FG000|NRTI Comparison|Death|20|||
19698034|NCT00084136|42143329|FG001|NRTI Comparison|Death|0|||
19698035|NCT00084136|42143330|FG002|NRTI Comparison|Death|18|||
19698036|NCT00084136|42143328|FG000|NRTI Comparison|Lost to Follow-up|14|||
19698037|NCT00084136|42143329|FG001|NRTI Comparison|Lost to Follow-up|0|||
19698038|NCT00084136|42143330|FG002|NRTI Comparison|Lost to Follow-up|12|||
19698039|NCT00084136|42143328|FG000|NRTI Comparison|Withdrawal by Subject|54|||
19698040|NCT00084136|42143329|FG001|NRTI Comparison|Withdrawal by Subject|0|||
19698041|NCT00084136|42143330|FG002|NRTI Comparison|Withdrawal by Subject|38|||
19698042|NCT00084136|42143328|FG000|NRTI Comparison|Clinic site closed|12|||
19698043|NCT00084136|42143329|FG001|NRTI Comparison|Clinic site closed|0|||
19698044|NCT00084136|42143330|FG002|NRTI Comparison|Clinic site closed|14|||
19698045|NCT00084136|42143328|FG000|NRTI Comparison|Not reason above|1|||
19792025|NCT02711306|42249961|FG001|Overall Study|Withdrawal by Subject|2|||
19792026|NCT05012163|42249971|FG000|Overall Study|Protocol Violation|0|||
19367505|NCT01367665|41607672|FG000|Overall Study|Lost to Follow-up|222|||
19607749|NCT00596817|42056586|FG001|Double-blind Period|Lack of Efficacy|28|||
19607750|NCT00596817|42056585|FG000|Double-blind Period|Non-compliance With Study Product|3|||
19698046|NCT00084136|42143329|FG001|NRTI Comparison|Not reason above|0|||
19698047|NCT00084136|42143330|FG002|NRTI Comparison|Not reason above|0|||
19698048|NCT03812380|42143341|FG000|Overall Study|Protocol Violation|3|||
19698049|NCT03812380|42143342|FG001|Overall Study|Protocol Violation|3|||
19698050|NCT03812380|42143341|FG000|Overall Study|Withdrawal by Subject|5|||
19698051|NCT03812380|42143342|FG001|Overall Study|Withdrawal by Subject|4|||
19698052|NCT03812380|42143341|FG000|Overall Study|Early termination of study|14|||
19792027|NCT05012163|42249972|FG001|Overall Study|Protocol Violation|0|||
19792028|NCT05012163|42249973|FG002|Overall Study|Protocol Violation|1|||
19792029|NCT05012163|42249974|FG003|Overall Study|Protocol Violation|1|||
19792030|NCT02710292|42249984|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
19792031|NCT02710292|42249985|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
19792032|NCT02710292|42249984|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
19792033|NCT02710292|42249985|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
19792034|NCT02710214|42249994|FG000|Overall Study|Lost to Follow-up|1|||
19792035|NCT02710214|42249995|FG001|Overall Study|Lost to Follow-up|0|||
19792036|NCT02710214|42249994|FG000|Overall Study|Lack of Efficacy|0|||
19792037|NCT02710214|42249995|FG001|Overall Study|Lack of Efficacy|1|||
19792038|NCT02710214|42249994|FG000|Overall Study|Death|0|||
19792039|NCT02710214|42249995|FG001|Overall Study|Death|1|||
19792040|NCT03052517|42250004|FG000|Overall Study|Study Terminated By Sponsor|928|||
19792041|NCT03052517|42250005|FG001|Overall Study|Study Terminated By Sponsor|938|||
19792042|NCT03052517|42250006|FG002|Overall Study|Study Terminated By Sponsor|296|||
19792043|NCT03052517|42250004|FG000|Overall Study|Subject/Guardian Decision|50|||
19792044|NCT03052517|42250005|FG001|Overall Study|Subject/Guardian Decision|45|||
19792045|NCT03052517|42250006|FG002|Overall Study|Subject/Guardian Decision|22|||
19792046|NCT03052517|42250004|FG000|Overall Study|Lack of Efficacy|23|||
19792047|NCT03052517|42250005|FG001|Overall Study|Lack of Efficacy|14|||
19792048|NCT03052517|42250006|FG002|Overall Study|Lack of Efficacy|7|||
19792049|NCT03052517|42250004|FG000|Overall Study|Adverse Event|6|||
19792050|NCT03052517|42250005|FG001|Overall Study|Adverse Event|5|||
19792051|NCT03052517|42250006|FG002|Overall Study|Adverse Event|0|||
19792052|NCT03052517|42250004|FG000|Overall Study|Physician Decision|4|||
19792053|NCT03052517|42250005|FG001|Overall Study|Physician Decision|5|||
19792054|NCT03052517|42250006|FG002|Overall Study|Physician Decision|1|||
19792055|NCT03052517|42250004|FG000|Overall Study|Death|3|||
19792056|NCT03052517|42250005|FG001|Overall Study|Death|0|||
19792057|NCT03052517|42250006|FG002|Overall Study|Death|1|||
19792058|NCT03052517|42250004|FG000|Overall Study|Lost to Follow-up|2|||
19792059|NCT03052517|42250005|FG001|Overall Study|Lost to Follow-up|4|||
19792060|NCT03052517|42250006|FG002|Overall Study|Lost to Follow-up|0|||
19792061|NCT03052517|42250004|FG000|Overall Study|Pregnancy|1|||
19792062|NCT03052517|42250005|FG001|Overall Study|Pregnancy|0|||
19792063|NCT03052517|42250006|FG002|Overall Study|Pregnancy|1|||
19792064|NCT03052517|42250004|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
19792065|NCT03052517|42250005|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
19792066|NCT03052517|42250006|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
19792067|NCT03052517|42250004|FG000|Overall Study|Technical Problems|0|||
19792068|NCT03052517|42250005|FG001|Overall Study|Technical Problems|1|||
19792069|NCT03052517|42250006|FG002|Overall Study|Technical Problems|0|||
19792070|NCT02708498|42250022|FG000|Overall Study|Death|20|||
19792071|NCT02708498|42250023|FG001|Overall Study|Death|19|||
19792072|NCT02708498|42250024|FG002|Overall Study|Death|0|||
19792073|NCT02708498|42250025|FG003|Overall Study|Death|0|||
19792074|NCT02708498|42250026|FG004|Overall Study|Death|1|||
19792075|NCT02708498|42250027|FG005|Overall Study|Death|0|||
19792076|NCT02708498|42250028|FG006|Overall Study|Death|0|||
19792077|NCT02708498|42250029|FG007|Overall Study|Death|0|||
19792078|NCT02708498|42250022|FG000|Overall Study|Unknown reason, missing data|0|||
19792079|NCT02708498|42250023|FG001|Overall Study|Unknown reason, missing data|0|||
19792080|NCT02708498|42250024|FG002|Overall Study|Unknown reason, missing data|62|||
19792081|NCT02708498|42250025|FG003|Overall Study|Unknown reason, missing data|51|||
19792082|NCT02708498|42250026|FG004|Overall Study|Unknown reason, missing data|195|||
19792083|NCT02708498|42250027|FG005|Overall Study|Unknown reason, missing data|132|||
19792084|NCT02708498|42250028|FG006|Overall Study|Unknown reason, missing data|0|||
19792085|NCT02708498|42250029|FG007|Overall Study|Unknown reason, missing data|0|||
19792086|NCT02710136|42250047|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
19792087|NCT02710136|42250048|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
19792088|NCT03702231|42250058|FG000|Overall Study|Withdrawal by Subject|1|||
19792089|NCT03702231|42250059|FG001|Overall Study|Withdrawal by Subject|0|||
19792090|NCT03702231|42250060|FG002|Overall Study|Withdrawal by Subject|0|||
19367506|NCT01367665|41607673|FG001|Overall Study|Lost to Follow-up|22|||
19367507|NCT01367665|41607672|FG000|Overall Study|Not Done|118|||
19367508|NCT01367665|41607673|FG001|Overall Study|Not Done|14|||
19792091|NCT03702231|42250058|FG000|Overall Study|Protocol Violation|0|||
19792092|NCT03702231|42250059|FG001|Overall Study|Protocol Violation|0|||
19792093|NCT03702231|42250060|FG002|Overall Study|Protocol Violation|1|||
19792094|NCT03702231|42250058|FG000|Overall Study|COVID Pandemic|3|||
19792095|NCT03702231|42250059|FG001|Overall Study|COVID Pandemic|4|||
19792096|NCT03702231|42250060|FG002|Overall Study|COVID Pandemic|1|||
19792097|NCT02741271|42250070|FG000|Overall Study|Lost to Follow-up|2|||
19792098|NCT02741271|42250071|FG001|Overall Study|Lost to Follow-up|0|||
19792099|NCT02741271|42250070|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19792100|NCT02741271|42250071|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
19792101|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
19792102|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
19792103|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
19792104|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
19792105|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
19792106|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
19792107|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
19792108|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
19792109|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
19792110|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
19792111|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
19792112|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
19792113|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
19792114|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
19792115|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
19792116|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
19792117|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
19792118|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
19792119|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
19792120|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
19792121|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
19792122|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
19792123|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
19792124|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
19792125|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
19792126|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
19792127|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
19792128|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
19792129|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
19792130|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
19792131|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
19792132|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
19792133|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
19792134|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
19792135|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
19792136|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
19792137|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
19792138|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
19792139|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
19792140|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
19792141|NCT02709746|42250084|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
19792142|NCT02709746|42250085|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
19792143|NCT02709746|42250086|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
19792144|NCT02709746|42250087|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
19792145|NCT02709746|42250088|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
19792146|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
19792147|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
19792148|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
19792149|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
19792150|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
19792151|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
19792152|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
19792153|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
19792154|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
19792155|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
19792156|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
19792157|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
19792158|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
19792159|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
19792160|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
19792161|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
19792162|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
19792163|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
19792164|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
19792165|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
19792166|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
19792167|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
19792168|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
19792169|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
19792170|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
19792171|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
19792172|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
19792173|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
19792174|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
19792175|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
19792176|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
19792177|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
19792178|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
19792179|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
19792180|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
19792181|NCT02709746|42250084|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
19792182|NCT02709746|42250085|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
19792183|NCT02709746|42250086|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
19792184|NCT02709746|42250087|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
19792185|NCT02709746|42250088|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
19792186|NCT01317641|42250109|FG000|Overall Study|Not treated|0|||
19792187|NCT01317641|42250110|FG001|Overall Study|Not treated|0|||
19792188|NCT01317641|42250111|FG002|Overall Study|Not treated|0|||
19792189|NCT01317641|42250112|FG003|Overall Study|Not treated|0|||
19792190|NCT01317641|42250113|FG004|Overall Study|Not treated|0|||
19792191|NCT01317641|42250114|FG005|Overall Study|Not treated|0|||
19792192|NCT01317641|42250115|FG006|Overall Study|Not treated|0|||
19792193|NCT01317641|42250116|FG007|Overall Study|Not treated|1|||
19792194|NCT01317641|42250117|FG008|Overall Study|Not treated|1|||
19792195|NCT01317641|42250109|FG000|Overall Study|Adverse Event|0|||
19792196|NCT01317641|42250110|FG001|Overall Study|Adverse Event|1|||
19792197|NCT01317641|42250111|FG002|Overall Study|Adverse Event|0|||
19792198|NCT01317641|42250112|FG003|Overall Study|Adverse Event|1|||
19792199|NCT01317641|42250113|FG004|Overall Study|Adverse Event|0|||
19792200|NCT01317641|42250114|FG005|Overall Study|Adverse Event|0|||
19792201|NCT01317641|42250115|FG006|Overall Study|Adverse Event|2|||
19792202|NCT01317641|42250116|FG007|Overall Study|Adverse Event|1|||
19792203|NCT01317641|42250117|FG008|Overall Study|Adverse Event|0|||
19792204|NCT01317641|42250109|FG000|Overall Study|Protocol Violation|1|||
19792205|NCT01317641|42250110|FG001|Overall Study|Protocol Violation|0|||
19792206|NCT01317641|42250111|FG002|Overall Study|Protocol Violation|0|||
19792207|NCT01317641|42250112|FG003|Overall Study|Protocol Violation|0|||
19792208|NCT01317641|42250113|FG004|Overall Study|Protocol Violation|0|||
19792209|NCT01317641|42250114|FG005|Overall Study|Protocol Violation|0|||
19792210|NCT01317641|42250115|FG006|Overall Study|Protocol Violation|0|||
19792211|NCT01317641|42250116|FG007|Overall Study|Protocol Violation|0|||
19792212|NCT01317641|42250117|FG008|Overall Study|Protocol Violation|0|||
19792213|NCT01317641|42250109|FG000|Overall Study|Disease progression|0|||
19792214|NCT01317641|42250110|FG001|Overall Study|Disease progression|0|||
19792215|NCT01317641|42250111|FG002|Overall Study|Disease progression|0|||
19792216|NCT01317641|42250112|FG003|Overall Study|Disease progression|0|||
19792217|NCT01317641|42250113|FG004|Overall Study|Disease progression|0|||
19792218|NCT01317641|42250114|FG005|Overall Study|Disease progression|0|||
19792219|NCT01317641|42250115|FG006|Overall Study|Disease progression|0|||
19792220|NCT01317641|42250116|FG007|Overall Study|Disease progression|3|||
19792221|NCT01317641|42250117|FG008|Overall Study|Disease progression|4|||
19792222|NCT01317641|42250109|FG000|Overall Study|Withdrawal by Subject|0|||
19792223|NCT01317641|42250110|FG001|Overall Study|Withdrawal by Subject|0|||
19792224|NCT01317641|42250111|FG002|Overall Study|Withdrawal by Subject|0|||
19792225|NCT01317641|42250112|FG003|Overall Study|Withdrawal by Subject|0|||
19792226|NCT01317641|42250113|FG004|Overall Study|Withdrawal by Subject|0|||
19792227|NCT01317641|42250114|FG005|Overall Study|Withdrawal by Subject|0|||
19792228|NCT01317641|42250115|FG006|Overall Study|Withdrawal by Subject|1|||
19792229|NCT01317641|42250116|FG007|Overall Study|Withdrawal by Subject|0|||
19792230|NCT01317641|42250117|FG008|Overall Study|Withdrawal by Subject|0|||
19792231|NCT03186794|42250153|FG000|Overall Study|Physician Decision|2|||
19792232|NCT03186794|42250153|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
19792233|NCT02290431|42250158|FG000|Overall Study|Adverse Event|20|||
19792234|NCT02290431|42250158|FG000|Overall Study|Progressive disease|4|||
19792235|NCT02290431|42250158|FG000|Overall Study|Study terminated by Sponsor|1|||
19792236|NCT02290431|42250158|FG000|Overall Study|Physician Decision|2|||
19792237|NCT03051659|42250164|FG000|Treatment Period|Withdrawal by Subject|0|||
19792238|NCT03051659|42250165|FG001|Treatment Period|Withdrawal by Subject|2|||
19792239|NCT03051659|42250164|FG000|Survival Follow-up|Lost to Follow-up|23|||
19792240|NCT03051659|42250165|FG001|Survival Follow-up|Lost to Follow-up|22|||
19792241|NCT02707952|42250175|FG000|Overall Study|Adverse Event|1|||
19792242|NCT02707952|42250176|FG001|Overall Study|Adverse Event|0|||
19792243|NCT02707952|42250177|FG002|Overall Study|Adverse Event|0|||
19792244|NCT02707952|42250178|FG003|Overall Study|Adverse Event|0|||
19792245|NCT02707952|42250175|FG000|Overall Study|Lost to Follow-up|1|||
19792246|NCT02707952|42250176|FG001|Overall Study|Lost to Follow-up|0|||
19792247|NCT02707952|42250177|FG002|Overall Study|Lost to Follow-up|0|||
19792248|NCT02707952|42250178|FG003|Overall Study|Lost to Follow-up|0|||
19792249|NCT02707952|42250175|FG000|Overall Study|Withdrawal by Subject|0|||
19792250|NCT02707952|42250176|FG001|Overall Study|Withdrawal by Subject|1|||
19792251|NCT02707952|42250177|FG002|Overall Study|Withdrawal by Subject|2|||
19792252|NCT02707952|42250178|FG003|Overall Study|Withdrawal by Subject|0|||
19792253|NCT03050801|42250196|FG000|Experiment 1|Lost to Follow-up|0|||
19792254|NCT03050801|42250197|FG001|Experiment 1|Lost to Follow-up|1|||
19792255|NCT03050801|42250198|FG002|Experiment 1|Lost to Follow-up|0|||
19792256|NCT03050801|42250199|FG003|Experiment 1|Lost to Follow-up|0|||
19792257|NCT03050801|42250200|FG004|Experiment 1|Lost to Follow-up|0|||
19792258|NCT03050801|42250201|FG005|Experiment 1|Lost to Follow-up|0|||
19792259|NCT03050801|42250196|FG000|Experiment 1|Physician Decision|0|||
19792260|NCT03050801|42250197|FG001|Experiment 1|Physician Decision|3|||
19792261|NCT03050801|42250198|FG002|Experiment 1|Physician Decision|0|||
19792262|NCT03050801|42250199|FG003|Experiment 1|Physician Decision|0|||
19792263|NCT03050801|42250200|FG004|Experiment 1|Physician Decision|0|||
19792264|NCT03050801|42250201|FG005|Experiment 1|Physician Decision|0|||
19792265|NCT03050801|42250196|FG000|Experiment 1|Change of experimental design|0|||
19792266|NCT03050801|42250197|FG001|Experiment 1|Change of experimental design|3|||
19792267|NCT03050801|42250198|FG002|Experiment 1|Change of experimental design|0|||
19792268|NCT03050801|42250199|FG003|Experiment 1|Change of experimental design|0|||
19792269|NCT03050801|42250200|FG004|Experiment 1|Change of experimental design|0|||
19792270|NCT03050801|42250201|FG005|Experiment 1|Change of experimental design|0|||
19792271|NCT03050801|42250196|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
19792272|NCT03050801|42250197|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
19792273|NCT03050801|42250198|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
19792274|NCT03050801|42250199|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
19792275|NCT03050801|42250200|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
19792276|NCT03050801|42250201|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
19792277|NCT03050801|42250196|FG000|Experiment 2|Lost to Follow-up|0|||
19792278|NCT03050801|42250197|FG001|Experiment 2|Lost to Follow-up|0|||
19792279|NCT03050801|42250198|FG002|Experiment 2|Lost to Follow-up|0|||
19792280|NCT03050801|42250199|FG003|Experiment 2|Lost to Follow-up|1|||
19792281|NCT03050801|42250200|FG004|Experiment 2|Lost to Follow-up|1|||
19792282|NCT03050801|42250201|FG005|Experiment 2|Lost to Follow-up|0|||
19792283|NCT03050801|42250196|FG000|Experiment 2|Physician Decision|0|||
19792284|NCT03050801|42250197|FG001|Experiment 2|Physician Decision|0|||
19792285|NCT03050801|42250198|FG002|Experiment 2|Physician Decision|0|||
19792286|NCT03050801|42250199|FG003|Experiment 2|Physician Decision|0|||
19792287|NCT03050801|42250200|FG004|Experiment 2|Physician Decision|1|||
19792288|NCT03050801|42250201|FG005|Experiment 2|Physician Decision|0|||
19792289|NCT03050801|42250196|FG000|Experiment 2|Pregnancy|0|||
19792290|NCT03050801|42250197|FG001|Experiment 2|Pregnancy|0|||
19792291|NCT03050801|42250198|FG002|Experiment 2|Pregnancy|0|||
19792292|NCT03050801|42250199|FG003|Experiment 2|Pregnancy|0|||
19792293|NCT03050801|42250200|FG004|Experiment 2|Pregnancy|1|||
19792294|NCT03050801|42250201|FG005|Experiment 2|Pregnancy|0|||
19792295|NCT03050801|42250196|FG000|Experiment 2|Withdrawal by Subject|0|||
19792296|NCT03050801|42250197|FG001|Experiment 2|Withdrawal by Subject|0|||
19792297|NCT03050801|42250198|FG002|Experiment 2|Withdrawal by Subject|0|||
19792298|NCT03050801|42250199|FG003|Experiment 2|Withdrawal by Subject|1|||
19792299|NCT03050801|42250200|FG004|Experiment 2|Withdrawal by Subject|0|||
19792300|NCT03050801|42250201|FG005|Experiment 2|Withdrawal by Subject|0|||
19792301|NCT03050801|42250196|FG000|Experiment 2|Poor data quality|0|||
19792302|NCT03050801|42250197|FG001|Experiment 2|Poor data quality|0|||
19367509|NCT02576847|41607680|FG000|Overall Study|Adverse Event|27|||
19792303|NCT03050801|42250198|FG002|Experiment 2|Poor data quality|0|||
19792304|NCT03050801|42250199|FG003|Experiment 2|Poor data quality|4|||
19792305|NCT03050801|42250200|FG004|Experiment 2|Poor data quality|1|||
19792306|NCT03050801|42250201|FG005|Experiment 2|Poor data quality|0|||
19792307|NCT03050801|42250196|FG000|Experiment 2|Discomfort during stimulation|0|||
19792308|NCT03050801|42250197|FG001|Experiment 2|Discomfort during stimulation|0|||
19792309|NCT03050801|42250198|FG002|Experiment 2|Discomfort during stimulation|0|||
19792310|NCT03050801|42250199|FG003|Experiment 2|Discomfort during stimulation|0|||
19792311|NCT03050801|42250200|FG004|Experiment 2|Discomfort during stimulation|0|||
19792312|NCT03050801|42250201|FG005|Experiment 2|Discomfort during stimulation|2|||
19792313|NCT02707640|42250220|FG000|Overall Study|Adverse Event|4|||
19792314|NCT02707640|42250221|FG001|Overall Study|Adverse Event|2|||
19792315|NCT02707640|42250220|FG000|Overall Study|Death|1|||
19792316|NCT02707640|42250221|FG001|Overall Study|Death|2|||
19792317|NCT02707640|42250220|FG000|Overall Study|Physician Decision|2|||
19792318|NCT02707640|42250221|FG001|Overall Study|Physician Decision|0|||
19792319|NCT02707640|42250220|FG000|Overall Study|Withdrawal by Subject|0|||
19792320|NCT02707640|42250221|FG001|Overall Study|Withdrawal by Subject|1|||
19792321|NCT02707640|42250220|FG000|Overall Study|Participant's Personal Decision|1|||
19792322|NCT02707640|42250221|FG001|Overall Study|Participant's Personal Decision|2|||
19792323|NCT02707640|42250220|FG000|Overall Study|Sponsor Discretion|1|||
19792324|NCT02707640|42250221|FG001|Overall Study|Sponsor Discretion|0|||
19792325|NCT02708966|42250229|FG000|Overall Study|Lost to Follow-up|2|||
19792326|NCT02708966|42250230|FG001|Overall Study|Lost to Follow-up|2|||
19792327|NCT02706938|42250238|FG000|First Period, 6 Weeks|Adverse Event|8|||
19792328|NCT02706938|42250239|FG001|First Period, 6 Weeks|Adverse Event|0|||
19792329|NCT02706938|42250238|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
19792330|NCT02706938|42250239|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
19792331|NCT02706938|42250238|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
19792332|NCT02706938|42250239|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
19792333|NCT02706938|42250238|FG000|Second Period, 6 Weeks|Adverse Event|0|||
19792334|NCT02706938|42250239|FG001|Second Period, 6 Weeks|Adverse Event|7|||
19792335|NCT02706938|42250238|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
19792336|NCT02706938|42250239|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
19792337|NCT03053063|42250249|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
19792338|NCT03053063|42250250|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
19792339|NCT03053063|42250251|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
19792340|NCT03053063|42250252|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
19792341|NCT03053063|42250249|FG000|Randomized Phase|Withdrew consent|8|||
19792342|NCT03053063|42250250|FG001|Randomized Phase|Withdrew consent|11|||
19792343|NCT03053063|42250251|FG002|Randomized Phase|Withdrew consent|5|||
19792344|NCT03053063|42250252|FG003|Randomized Phase|Withdrew consent|0|||
19792345|NCT03053063|42250249|FG000|Randomized Phase|Investigator's Discretion|8|||
19792346|NCT03053063|42250250|FG001|Randomized Phase|Investigator's Discretion|6|||
19792347|NCT03053063|42250251|FG002|Randomized Phase|Investigator's Discretion|2|||
19792348|NCT03053063|42250252|FG003|Randomized Phase|Investigator's Discretion|0|||
19792349|NCT03053063|42250249|FG000|Randomized Phase|Lost to Follow-up|3|||
19792350|NCT03053063|42250250|FG001|Randomized Phase|Lost to Follow-up|5|||
19792351|NCT03053063|42250251|FG002|Randomized Phase|Lost to Follow-up|1|||
19792352|NCT03053063|42250252|FG003|Randomized Phase|Lost to Follow-up|0|||
19792353|NCT03053063|42250249|FG000|Randomized Phase|Adverse Event|0|||
19792354|NCT03053063|42250250|FG001|Randomized Phase|Adverse Event|1|||
19792355|NCT03053063|42250251|FG002|Randomized Phase|Adverse Event|0|||
19792356|NCT03053063|42250252|FG003|Randomized Phase|Adverse Event|0|||
19792357|NCT03053063|42250249|FG000|Randomized Phase|Randomized but Never Treated|1|||
19792358|NCT03053063|42250250|FG001|Randomized Phase|Randomized but Never Treated|3|||
19792359|NCT03053063|42250251|FG002|Randomized Phase|Randomized but Never Treated|2|||
19792360|NCT03053063|42250252|FG003|Randomized Phase|Randomized but Never Treated|0|||
19792361|NCT03053063|42250249|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
19792362|NCT03053063|42250250|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
19792363|NCT03053063|42250251|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
19792364|NCT03053063|42250252|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
19792365|NCT03053063|42250249|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
19792366|NCT03053063|42250250|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
19792367|NCT03053063|42250251|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
19792368|NCT03053063|42250252|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
19792369|NCT03053063|42250249|FG000|Open-Label Phase|Death|0|||
19792370|NCT03053063|42250250|FG001|Open-Label Phase|Death|0|||
19792371|NCT03053063|42250251|FG002|Open-Label Phase|Death|0|||
19792372|NCT03053063|42250252|FG003|Open-Label Phase|Death|2|||
19792373|NCT03053063|42250249|FG000|Open-Label Phase|Investigator's discretion|0|||
19792374|NCT03053063|42250250|FG001|Open-Label Phase|Investigator's discretion|0|||
19792375|NCT03053063|42250251|FG002|Open-Label Phase|Investigator's discretion|0|||
19792376|NCT03053063|42250252|FG003|Open-Label Phase|Investigator's discretion|2|||
19792377|NCT01316939|42250274|FG000|Overall Study|Study closed/terminated|26|||
19792378|NCT01316939|42250275|FG001|Overall Study|Study closed/terminated|25|||
19792379|NCT01316939|42250276|FG002|Overall Study|Study closed/terminated|23|||
19792380|NCT01316939|42250274|FG000|Overall Study|Lack of Efficacy|24|||
19792381|NCT01316939|42250275|FG001|Overall Study|Lack of Efficacy|25|||
19792382|NCT01316939|42250276|FG002|Overall Study|Lack of Efficacy|25|||
19792383|NCT01316939|42250274|FG000|Overall Study|Adverse Event|9|||
19792384|NCT01316939|42250275|FG001|Overall Study|Adverse Event|12|||
19792385|NCT01316939|42250276|FG002|Overall Study|Adverse Event|11|||
19792386|NCT01316939|42250274|FG000|Overall Study|Withdrawal by Subject|1|||
19792387|NCT01316939|42250275|FG001|Overall Study|Withdrawal by Subject|3|||
19792388|NCT01316939|42250276|FG002|Overall Study|Withdrawal by Subject|6|||
19792389|NCT01316939|42250274|FG000|Overall Study|Physician Decision|2|||
19792390|NCT01316939|42250275|FG001|Overall Study|Physician Decision|2|||
19792391|NCT01316939|42250276|FG002|Overall Study|Physician Decision|1|||
19792392|NCT01316939|42250274|FG000|Overall Study|Lost to Follow-up|0|||
19792393|NCT01316939|42250275|FG001|Overall Study|Lost to Follow-up|0|||
19792394|NCT01316939|42250276|FG002|Overall Study|Lost to Follow-up|2|||
19792395|NCT01316939|42250274|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
19792396|NCT01316939|42250275|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
19792397|NCT01316939|42250276|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
19792398|NCT01316939|42250274|FG000|Overall Study|Protocol Violation|0|||
19792399|NCT01316939|42250275|FG001|Overall Study|Protocol Violation|1|||
19792400|NCT01316939|42250276|FG002|Overall Study|Protocol Violation|0|||
19792401|NCT03044249|42250286|FG000|Overall Study|Adverse Event|4|||
19792402|NCT03044249|42250287|FG001|Overall Study|Adverse Event|9|||
19792403|NCT03044249|42250286|FG000|Overall Study|Lost to Follow-up|1|||
19792404|NCT03044249|42250287|FG001|Overall Study|Lost to Follow-up|0|||
19792405|NCT03044249|42250286|FG000|Overall Study|Non-compliance with Study Drug|1|||
19792406|NCT03044249|42250287|FG001|Overall Study|Non-compliance with Study Drug|0|||
19792407|NCT03044249|42250286|FG000|Overall Study|Study Terminated by Sponsor|2|||
19792408|NCT03044249|42250287|FG001|Overall Study|Study Terminated by Sponsor|0|||
19792409|NCT03044249|42250286|FG000|Overall Study|Withdrawal by Subject|2|||
19792410|NCT03044249|42250287|FG001|Overall Study|Withdrawal by Subject|5|||
19792411|NCT02704130|42250300|FG000|Overall Study|Physician Decision|5|||
19792412|NCT02704130|42250301|FG001|Overall Study|Physician Decision|3|||
19792413|NCT03740009|42250307|FG000|Overall Study|Physician Decision|9|||
19792414|NCT03740009|42250307|FG000|Overall Study|Lost to Follow-up|1|||
19792415|NCT03649217|42250311|FG000|Overall Study|subject had severe ataxia not initially found|1|||
19792416|NCT03649217|42250311|FG000|Overall Study|subject had cognitive issues not initially found|1|||
19792417|NCT03138889|42250340|FG000|Overall Study|Withdrawal by Subject|5|||
19792418|NCT03138889|42250341|FG001|Overall Study|Withdrawal by Subject|5|||
19698053|NCT03812380|42143342|FG001|Overall Study|Early termination of study|14|||
19698054|NCT00464945|42143350|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
19698055|NCT00464945|42143351|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
19698056|NCT00464945|42143350|FG000|Infant Series|Protocol Violation|1|||
19698057|NCT00464945|42143351|FG001|Infant Series|Protocol Violation|0|||
19698058|NCT00464945|42143350|FG000|Infant Series|Lost to Follow-up|1|||
19698059|NCT00464945|42143351|FG001|Infant Series|Lost to Follow-up|0|||
19698060|NCT00464945|42143350|FG000|After Infant Series|Withdrawal by Subject|0|||
19698061|NCT00464945|42143351|FG001|After Infant Series|Withdrawal by Subject|2|||
19698062|NCT00464945|42143350|FG000|Toddler Dose|Lost to Follow-up|0|||
19698063|NCT00464945|42143351|FG001|Toddler Dose|Lost to Follow-up|1|||
19698064|NCT00464087|42143376|FG000|Overall Study|No PCI per inclusion criteria|0|||
19698065|NCT00464087|42143377|FG001|Overall Study|No PCI per inclusion criteria|0|||
19698066|NCT00464087|42143378|FG002|Overall Study|No PCI per inclusion criteria|29|||
19698067|NCT00452699|42143388|FG000|Overall Study|Adverse Event|10|||
19698068|NCT00452699|42143389|FG001|Overall Study|Adverse Event|3|||
19698069|NCT00452699|42143388|FG000|Overall Study|Lack of Efficacy|6|||
19698070|NCT00452699|42143389|FG001|Overall Study|Lack of Efficacy|4|||
19698071|NCT00452699|42143388|FG000|Overall Study|Lost to Follow-up|6|||
19698072|NCT00452699|42143389|FG001|Overall Study|Lost to Follow-up|9|||
19698073|NCT00452699|42143388|FG000|Overall Study|Protocol Violation|21|||
19698074|NCT00452699|42143389|FG001|Overall Study|Protocol Violation|25|||
19698075|NCT00452699|42143388|FG000|Overall Study|Withdrawal by Subject|26|||
19698076|NCT00452699|42143389|FG001|Overall Study|Withdrawal by Subject|25|||
19698077|NCT00452699|42143388|FG000|Overall Study|Other|12|||
19698078|NCT00452699|42143389|FG001|Overall Study|Other|7|||
19698079|NCT00069784|42143397|FG000|Overall Study|Adverse Event|105|||
19698080|NCT00069784|42143398|FG001|Overall Study|Adverse Event|0|||
19698081|NCT00069784|42143397|FG000|Overall Study|Withdrawal by Subject|1090|||
19698082|NCT00069784|42143398|FG001|Overall Study|Withdrawal by Subject|0|||
19698083|NCT00069784|42143397|FG000|Overall Study|Other|17|||
19698084|NCT00069784|42143398|FG001|Overall Study|Other|0|||
19698085|NCT03811834|42143404|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
19698086|NCT00090610|42143419|FG000|Overall Study|Withdrawal by Subject|1|||
19698087|NCT00090610|42143420|FG001|Overall Study|Withdrawal by Subject|1|||
19698088|NCT00463385|42143430|FG000|Overall Study|Other|4|||
19698089|NCT00463385|42143431|FG001|Overall Study|Other|3|||
19698090|NCT00463385|42143432|FG002|Overall Study|Other|6|||
19698091|NCT00463385|42143433|FG003|Overall Study|Other|4|||
19698092|NCT00463385|42143430|FG000|Overall Study|Adverse Event|5|||
19698093|NCT00463385|42143431|FG001|Overall Study|Adverse Event|8|||
19698094|NCT00463385|42143432|FG002|Overall Study|Adverse Event|4|||
19792419|NCT03138889|42250342|FG002|Overall Study|Withdrawal by Subject|0|||
19367510|NCT02576847|41607680|FG000|Overall Study|Lost to Follow-up|22|||
19698095|NCT00463385|42143433|FG003|Overall Study|Adverse Event|2|||
19698096|NCT00463385|42143430|FG000|Overall Study|Lack of Efficacy|6|||
19792420|NCT03138889|42250343|FG003|Overall Study|Withdrawal by Subject|2|||
19792421|NCT03138889|42250344|FG004|Overall Study|Withdrawal by Subject|1|||
19792422|NCT03138889|42250345|FG005|Overall Study|Withdrawal by Subject|3|||
19792423|NCT03138889|42250346|FG006|Overall Study|Withdrawal by Subject|0|||
19792424|NCT03138889|42250347|FG007|Overall Study|Withdrawal by Subject|1|||
19792425|NCT02706392|42250399|FG000|Overall Study|Death|1|||
19792426|NCT02706392|42250400|FG001|Overall Study|Death|0|||
19792427|NCT02706392|42250401|FG002|Overall Study|Death|2|||
19792428|NCT02706392|42250402|FG003|Overall Study|Death|2|||
19792429|NCT02706392|42250403|FG004|Overall Study|Death|5|||
19792430|NCT02706392|42250404|FG005|Overall Study|Death|2|||
19792431|NCT02933489|42250420|FG000|Overall Study|Ineligible|3|||
19792432|NCT02933489|42250421|FG001|Overall Study|Ineligible|3|||
19792433|NCT02933489|42250420|FG000|Overall Study|Withdrawal by Subject|27|||
19792434|NCT02933489|42250421|FG001|Overall Study|Withdrawal by Subject|18|||
19792435|NCT02933489|42250420|FG000|Overall Study|Unable to complete exams (other)|14|||
19792436|NCT02933489|42250421|FG001|Overall Study|Unable to complete exams (other)|7|||
19792437|NCT03042767|42250434|FG000|Overall Study|Lost to Follow-up|1|||
19792438|NCT03042767|42250435|FG001|Overall Study|Lost to Follow-up|2|||
19792439|NCT00703820|42250443|FG000|Overall Study|Adverse Event|12|||
19792440|NCT00703820|42250444|FG001|Overall Study|Adverse Event|17|||
19792441|NCT00703820|42250443|FG000|Overall Study|Death|5|||
19792442|NCT00703820|42250444|FG001|Overall Study|Death|0|||
19792443|NCT00703820|42250443|FG000|Overall Study|Lack of Efficacy|11|||
19792444|NCT00703820|42250444|FG001|Overall Study|Lack of Efficacy|11|||
19792445|NCT00703820|42250443|FG000|Overall Study|Received non-protocol therapy|1|||
19792446|NCT00703820|42250444|FG001|Overall Study|Received non-protocol therapy|0|||
19792447|NCT00703820|42250443|FG000|Overall Study|Physician Decision|4|||
19792448|NCT00703820|42250444|FG001|Overall Study|Physician Decision|5|||
19792449|NCT00703820|42250443|FG000|Overall Study|Withdrawal by Subject|2|||
19792450|NCT00703820|42250444|FG001|Overall Study|Withdrawal by Subject|1|||
19792451|NCT03045887|42250462|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
19792452|NCT03045887|42250463|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792453|NCT03045887|42250464|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792454|NCT03045887|42250465|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792455|NCT03045887|42250466|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792456|NCT03045887|42250467|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792457|NCT03045887|42250468|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792458|NCT03045887|42250469|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792459|NCT03045887|42250470|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792460|NCT03045887|42250471|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
19792461|NCT03045887|42250462|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792462|NCT03045887|42250463|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792463|NCT03045887|42250464|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792464|NCT03045887|42250465|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
19792465|NCT03045887|42250466|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792466|NCT03045887|42250467|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792467|NCT03045887|42250468|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792468|NCT03045887|42250469|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792469|NCT03045887|42250470|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792470|NCT03045887|42250471|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
19792471|NCT03045887|42250462|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
19792472|NCT03045887|42250463|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792473|NCT03045887|42250464|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792474|NCT03045887|42250465|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792475|NCT03045887|42250466|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792476|NCT03045887|42250467|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792477|NCT03045887|42250468|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792478|NCT03045887|42250469|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792479|NCT03045887|42250470|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
19698097|NCT00463385|42143431|FG001|Overall Study|Lack of Efficacy|6|||
19698098|NCT00463385|42143432|FG002|Overall Study|Lack of Efficacy|7|||
19698099|NCT00463385|42143433|FG003|Overall Study|Lack of Efficacy|9|||
19698100|NCT00463385|42143430|FG000|Overall Study|Withdrawal by Subject|3|||
19698101|NCT00463385|42143431|FG001|Overall Study|Withdrawal by Subject|3|||
19698102|NCT00463385|42143432|FG002|Overall Study|Withdrawal by Subject|3|||
19698103|NCT00463385|42143433|FG003|Overall Study|Withdrawal by Subject|4|||
19698104|NCT00463385|42143430|FG000|Overall Study|Lost to Follow-up|0|||
19698105|NCT00463385|42143431|FG001|Overall Study|Lost to Follow-up|0|||
19698106|NCT00463385|42143432|FG002|Overall Study|Lost to Follow-up|0|||
19698107|NCT00463385|42143433|FG003|Overall Study|Lost to Follow-up|1|||
19792480|NCT03045887|42250471|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
19792481|NCT03045887|42250462|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792482|NCT03045887|42250463|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792483|NCT03045887|42250464|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
19792484|NCT03045887|42250465|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
19792485|NCT03045887|42250466|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792486|NCT03045887|42250467|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792487|NCT03045887|42250468|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792488|NCT03045887|42250469|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792489|NCT03045887|42250470|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792490|NCT03045887|42250471|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
19792491|NCT03045887|42250462|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792492|NCT03045887|42250463|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792493|NCT03045887|42250464|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792494|NCT03045887|42250465|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
19792495|NCT03045887|42250466|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792496|NCT03045887|42250467|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792497|NCT03045887|42250468|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792498|NCT03045887|42250469|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792499|NCT03045887|42250470|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792500|NCT03045887|42250471|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
19792501|NCT02583269|42250503|FG000|Overall Study|Patient hospitalized prior to start|1|||
19792502|NCT02583269|42250504|FG001|Overall Study|Patient hospitalized prior to start|0|||
19792503|NCT02583269|42250505|FG002|Overall Study|Patient hospitalized prior to start|0|||
19792504|NCT02583269|42250506|FG003|Overall Study|Patient hospitalized prior to start|0|||
19792505|NCT02583269|42250507|FG004|Overall Study|Patient hospitalized prior to start|0|||
19792506|NCT01564537|42250522|FG000|Overall Study|Site Terminated by Sponsor|1|||
19792507|NCT01564537|42250523|FG001|Overall Study|Site Terminated by Sponsor|0|||
19792508|NCT01564537|42250522|FG000|Overall Study|Withdrawal by Subject|12|||
19792509|NCT01564537|42250523|FG001|Overall Study|Withdrawal by Subject|14|||
19792510|NCT01564537|42250522|FG000|Overall Study|Lost to Follow-up|7|||
19792511|NCT01564537|42250523|FG001|Overall Study|Lost to Follow-up|3|||
19792512|NCT01564537|42250522|FG000|Overall Study|Reason not specified|81|||
19792513|NCT01564537|42250523|FG001|Overall Study|Reason not specified|82|||
19792514|NCT03042611|42250534|FG000|Core Phase|Withdrawal by Subject|13|||
19792515|NCT03042611|42250535|FG001|Core Phase|Withdrawal by Subject|4|||
19792516|NCT03042611|42250536|FG002|Core Phase|Withdrawal by Subject|0|||
19792517|NCT03042611|42250537|FG003|Core Phase|Withdrawal by Subject|0|||
19792518|NCT03042611|42250534|FG000|Core Phase|Death|232|||
19792519|NCT03042611|42250535|FG001|Core Phase|Death|110|||
19792520|NCT03042611|42250536|FG002|Core Phase|Death|0|||
19792521|NCT03042611|42250537|FG003|Core Phase|Death|0|||
19792522|NCT03042611|42250534|FG000|Core Phase|Lost to Follow-up|4|||
19792523|NCT03042611|42250535|FG001|Core Phase|Lost to Follow-up|7|||
19792524|NCT03042611|42250536|FG002|Core Phase|Lost to Follow-up|0|||
19792525|NCT03042611|42250537|FG003|Core Phase|Lost to Follow-up|0|||
19792526|NCT03042611|42250534|FG000|Core Phase|Physician Decision|7|||
19792527|NCT03042611|42250535|FG001|Core Phase|Physician Decision|2|||
19792528|NCT03042611|42250536|FG002|Core Phase|Physician Decision|0|||
19792529|NCT03042611|42250537|FG003|Core Phase|Physician Decision|0|||
19792530|NCT03042611|42250534|FG000|Core Phase|Study Closed|0|||
19792531|NCT03042611|42250535|FG001|Core Phase|Study Closed|1|||
19792532|NCT03042611|42250536|FG002|Core Phase|Study Closed|0|||
19792533|NCT03042611|42250537|FG003|Core Phase|Study Closed|0|||
19792534|NCT03042611|42250534|FG000|Extension Phase|Death|0|||
19792535|NCT03042611|42250535|FG001|Extension Phase|Death|0|||
19792536|NCT03042611|42250536|FG002|Extension Phase|Death|34|||
19792537|NCT03042611|42250537|FG003|Extension Phase|Death|16|||
19792538|NCT03042611|42250534|FG000|Extension Phase|Lost to Follow-up|0|||
19792539|NCT03042611|42250535|FG001|Extension Phase|Lost to Follow-up|0|||
19792540|NCT03042611|42250536|FG002|Extension Phase|Lost to Follow-up|1|||
19792541|NCT03042611|42250537|FG003|Extension Phase|Lost to Follow-up|1|||
19792542|NCT03042611|42250534|FG000|Extension Phase|Study Closed|0|||
19698108|NCT00463385|42143430|FG000|Overall Study|Death|2|||
19698109|NCT00463385|42143431|FG001|Overall Study|Death|1|||
19698110|NCT00463385|42143432|FG002|Overall Study|Death|2|||
19698111|NCT00463385|42143433|FG003|Overall Study|Death|0|||
19698112|NCT00463385|42143430|FG000|Overall Study|Missing|2|||
19698113|NCT00463385|42143431|FG001|Overall Study|Missing|0|||
19698114|NCT00463385|42143432|FG002|Overall Study|Missing|0|||
19698115|NCT00463385|42143433|FG003|Overall Study|Missing|2|||
19698116|NCT00463385|42143430|FG000|Overall Study|1 participant received commercial drug|0|||
19792543|NCT03042611|42250535|FG001|Extension Phase|Study Closed|0|||
19792544|NCT03042611|42250536|FG002|Extension Phase|Study Closed|17|||
19792545|NCT03042611|42250537|FG003|Extension Phase|Study Closed|11|||
19792546|NCT02701634|42250545|FG000|Overall Study|Adverse Event|2|||
19792547|NCT02701634|42250546|FG001|Overall Study|Adverse Event|3|||
19792548|NCT02701634|42250545|FG000|Overall Study|Death|1|||
19792549|NCT02701634|42250546|FG001|Overall Study|Death|0|||
19792550|NCT02701634|42250545|FG000|Overall Study|Investigator's Discretion|7|||
19792551|NCT02701634|42250546|FG001|Overall Study|Investigator's Discretion|4|||
19792552|NCT02701634|42250545|FG000|Overall Study|Study terminated by Sponsor|15|||
19792553|NCT02701634|42250546|FG001|Overall Study|Study terminated by Sponsor|17|||
19792554|NCT02701634|42250545|FG000|Overall Study|Withdrew Consent|6|||
19792555|NCT02701634|42250546|FG001|Overall Study|Withdrew Consent|7|||
19792556|NCT02701634|42250545|FG000|Overall Study|Randomized but not treated|1|||
19792557|NCT02701634|42250546|FG001|Overall Study|Randomized but not treated|0|||
19792558|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
19792559|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
19792560|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
19792561|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
19792562|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
19792563|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
19792564|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
19792565|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
19792566|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Death|0|||
19792567|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Death|0|||
19792568|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Death|0|||
19792569|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Death|1|||
19792570|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Death|1|||
19792571|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Death|0|||
19792572|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Death|2|||
19792573|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Death|0|||
19792574|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792575|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792576|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792577|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
19792578|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792579|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792580|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792581|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
19792582|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792583|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792584|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792585|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
19792586|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792587|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792588|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792589|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
19792590|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
19792591|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
19792592|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
19792593|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
19792594|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
19792595|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
19792596|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
19792597|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
19792598|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
19792599|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
19792600|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
19792601|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
19792602|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
19792603|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
19792604|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
19792605|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
19792606|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
19792607|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
19792608|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
19792609|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
19792610|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
19792611|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
19792612|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
19792613|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
19792614|NCT02442765|42250556|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792615|NCT02442765|42250557|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792616|NCT02442765|42250558|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792617|NCT02442765|42250559|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792618|NCT02442765|42250560|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
19698117|NCT00463385|42143431|FG001|Overall Study|1 participant received commercial drug|1|||
19792619|NCT02442765|42250561|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792620|NCT02442765|42250562|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
19792621|NCT02442765|42250563|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
19792622|NCT02180867|42250601|FG000|Overall Study|Adverse Event|3|||
19792623|NCT02180867|42250602|FG001|Overall Study|Adverse Event|4|||
19792624|NCT02180867|42250603|FG002|Overall Study|Adverse Event|1|||
19792625|NCT02180867|42250604|FG003|Overall Study|Adverse Event|5|||
19792626|NCT02180867|42250605|FG004|Overall Study|Adverse Event|0|||
19792627|NCT02180867|42250606|FG005|Overall Study|Adverse Event|0|||
19792628|NCT02180867|42250607|FG006|Overall Study|Adverse Event|0|||
19792629|NCT02180867|42250601|FG000|Overall Study|Death|0|||
19792630|NCT02180867|42250602|FG001|Overall Study|Death|0|||
19792631|NCT02180867|42250603|FG002|Overall Study|Death|0|||
19792632|NCT02180867|42250604|FG003|Overall Study|Death|0|||
19792633|NCT02180867|42250605|FG004|Overall Study|Death|1|||
19792634|NCT02180867|42250606|FG005|Overall Study|Death|0|||
19792635|NCT02180867|42250607|FG006|Overall Study|Death|0|||
19792636|NCT02180867|42250601|FG000|Overall Study|Lack of Efficacy|0|||
19792637|NCT02180867|42250602|FG001|Overall Study|Lack of Efficacy|2|||
19792638|NCT02180867|42250603|FG002|Overall Study|Lack of Efficacy|0|||
19792639|NCT02180867|42250604|FG003|Overall Study|Lack of Efficacy|1|||
19792640|NCT02180867|42250605|FG004|Overall Study|Lack of Efficacy|6|||
19792641|NCT02180867|42250606|FG005|Overall Study|Lack of Efficacy|0|||
19792642|NCT02180867|42250607|FG006|Overall Study|Lack of Efficacy|1|||
19792643|NCT02180867|42250601|FG000|Overall Study|Physician Decision|1|||
19792644|NCT02180867|42250602|FG001|Overall Study|Physician Decision|3|||
19792645|NCT02180867|42250603|FG002|Overall Study|Physician Decision|1|||
19792646|NCT02180867|42250604|FG003|Overall Study|Physician Decision|10|||
19792647|NCT02180867|42250605|FG004|Overall Study|Physician Decision|9|||
19792648|NCT02180867|42250606|FG005|Overall Study|Physician Decision|3|||
19792649|NCT02180867|42250607|FG006|Overall Study|Physician Decision|4|||
19792650|NCT02180867|42250601|FG000|Overall Study|Withdrawal by Subject|0|||
19792651|NCT02180867|42250602|FG001|Overall Study|Withdrawal by Subject|0|||
19792652|NCT02180867|42250603|FG002|Overall Study|Withdrawal by Subject|0|||
19792653|NCT02180867|42250604|FG003|Overall Study|Withdrawal by Subject|1|||
19792654|NCT02180867|42250605|FG004|Overall Study|Withdrawal by Subject|1|||
19792655|NCT02180867|42250606|FG005|Overall Study|Withdrawal by Subject|0|||
19792656|NCT02180867|42250607|FG006|Overall Study|Withdrawal by Subject|0|||
19792657|NCT02180867|42250601|FG000|Overall Study|Ineligible|1|||
19792658|NCT02180867|42250602|FG001|Overall Study|Ineligible|2|||
19792659|NCT02180867|42250603|FG002|Overall Study|Ineligible|0|||
19792660|NCT02180867|42250604|FG003|Overall Study|Ineligible|3|||
19792661|NCT02180867|42250605|FG004|Overall Study|Ineligible|5|||
19792662|NCT02180867|42250606|FG005|Overall Study|Ineligible|0|||
19792663|NCT02180867|42250607|FG006|Overall Study|Ineligible|0|||
19792664|NCT02180867|42250601|FG000|Overall Study|Repeat Eligibility Studies|0|||
19792665|NCT02180867|42250602|FG001|Overall Study|Repeat Eligibility Studies|0|||
19792666|NCT02180867|42250603|FG002|Overall Study|Repeat Eligibility Studies|0|||
19792667|NCT02180867|42250604|FG003|Overall Study|Repeat Eligibility Studies|0|||
19792668|NCT02180867|42250605|FG004|Overall Study|Repeat Eligibility Studies|1|||
19792669|NCT02180867|42250606|FG005|Overall Study|Repeat Eligibility Studies|0|||
19792670|NCT02180867|42250607|FG006|Overall Study|Repeat Eligibility Studies|0|||
19792671|NCT02180867|42250601|FG000|Overall Study|Refusal of further protocol therapy|1|||
19792672|NCT02180867|42250602|FG001|Overall Study|Refusal of further protocol therapy|0|||
19792673|NCT02180867|42250603|FG002|Overall Study|Refusal of further protocol therapy|2|||
19792674|NCT02180867|42250604|FG003|Overall Study|Refusal of further protocol therapy|6|||
19792675|NCT02180867|42250605|FG004|Overall Study|Refusal of further protocol therapy|4|||
19792676|NCT02180867|42250606|FG005|Overall Study|Refusal of further protocol therapy|0|||
19792677|NCT02180867|42250607|FG006|Overall Study|Refusal of further protocol therapy|0|||
19792678|NCT03520413|42250637|FG000|Overall Study|Lost to Follow-up|1|||
19792679|NCT03520413|42250638|FG001|Overall Study|Lost to Follow-up|1|||
19792680|NCT03520413|42250637|FG000|Overall Study|Withdrawal by Subject|1|||
19792681|NCT03520413|42250638|FG001|Overall Study|Withdrawal by Subject|2|||
19792682|NCT03520413|42250637|FG000|Overall Study|Death|0|||
19792683|NCT03520413|42250638|FG001|Overall Study|Death|1|||
19792684|NCT03520413|42250637|FG000|Overall Study|Physician Decision|3|||
19792685|NCT03520413|42250638|FG001|Overall Study|Physician Decision|3|||
19792686|NCT03520413|42250637|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
19792687|NCT03520413|42250638|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
19792688|NCT02699684|42250645|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
19792689|NCT02699684|42250646|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
19792690|NCT02700698|42250655|FG000|Overall Study|Withdrawal by Subject|1|||
19367511|NCT02576847|41607680|FG000|Overall Study|Physician Decision|1|||
19792691|NCT02700698|42250656|FG001|Overall Study|Withdrawal by Subject|0|||
19792692|NCT01774721|42250664|FG000|Overall Study|Death|76|||
19792693|NCT01774721|42250665|FG001|Overall Study|Death|91|||
19792694|NCT01774721|42250664|FG000|Overall Study|Withdrawal by Subject|14|||
19792695|NCT01774721|42250665|FG001|Overall Study|Withdrawal by Subject|10|||
19792696|NCT01774721|42250664|FG000|Overall Study|Lost to Follow-up|1|||
19792697|NCT01774721|42250665|FG001|Overall Study|Lost to Follow-up|1|||
19792698|NCT01774721|42250664|FG000|Overall Study|Did not meet eligibility criteria|0|||
19792699|NCT01774721|42250665|FG001|Overall Study|Did not meet eligibility criteria|3|||
19792700|NCT01774721|42250664|FG000|Overall Study|Ongoing in study|136|||
19792701|NCT01774721|42250665|FG001|Overall Study|Ongoing in study|120|||
19792702|NCT01275677|42250675|FG000|Overall Study|Not at risk for recurrence.|1|||
19792703|NCT01275677|42250676|FG001|Overall Study|Not at risk for recurrence.|1|||
19792704|NCT01275677|42250675|FG000|Overall Study|No follow-up|26|||
19792705|NCT01275677|42250676|FG001|Overall Study|No follow-up|37|||
19792706|NCT01275677|42250675|FG000|Overall Study|No clinical follow up.|1|||
19792707|NCT01275677|42250676|FG001|Overall Study|No clinical follow up.|4|||
19792708|NCT00937937|42250682|FG000|Overall Study|Adverse Event|6|||
19792709|NCT00937937|42250682|FG000|Overall Study|Withdrawal by Subject|2|||
19792710|NCT00937937|42250682|FG000|Overall Study|Progression/relapse|61|||
19792711|NCT00937937|42250682|FG000|Overall Study|Death|1|||
19792712|NCT00937937|42250682|FG000|Overall Study|Other|2|||
19792713|NCT02699450|42250690|FG000|Overall Study|Death|2|||
19792714|NCT02699450|42250691|FG001|Overall Study|Death|1|||
19792715|NCT02699450|42250692|FG002|Overall Study|Death|2|||
19792716|NCT02699450|42250690|FG000|Overall Study|Met Criteria for Study Exit|0|||
19792717|NCT02699450|42250691|FG001|Overall Study|Met Criteria for Study Exit|0|||
19792718|NCT02699450|42250692|FG002|Overall Study|Met Criteria for Study Exit|1|||
19792719|NCT02699450|42250690|FG000|Overall Study|Protocol Violation|4|||
19792720|NCT02699450|42250691|FG001|Overall Study|Protocol Violation|3|||
19792721|NCT02699450|42250692|FG002|Overall Study|Protocol Violation|5|||
19792722|NCT02699450|42250690|FG000|Overall Study|Lost to Follow-up|3|||
19792723|NCT02699450|42250691|FG001|Overall Study|Lost to Follow-up|0|||
19792724|NCT02699450|42250692|FG002|Overall Study|Lost to Follow-up|5|||
19792725|NCT02699450|42250690|FG000|Overall Study|Physician Decision|2|||
19792726|NCT02699450|42250691|FG001|Overall Study|Physician Decision|0|||
19792727|NCT02699450|42250692|FG002|Overall Study|Physician Decision|0|||
19792728|NCT02699450|42250690|FG000|Overall Study|Withdrawal by Subject|3|||
19792729|NCT02699450|42250691|FG001|Overall Study|Withdrawal by Subject|1|||
19792730|NCT02699450|42250692|FG002|Overall Study|Withdrawal by Subject|2|||
19792731|NCT02699450|42250690|FG000|Overall Study|Adverse Event|1|||
19792732|NCT02699450|42250691|FG001|Overall Study|Adverse Event|0|||
19792733|NCT02699450|42250692|FG002|Overall Study|Adverse Event|0|||
19792734|NCT02699996|42250703|FG000|Overall Study|Withdrawal by Subject|5|||
19792735|NCT02699996|42250704|FG001|Overall Study|Withdrawal by Subject|2|||
19792736|NCT02739321|42250713|FG000|Overall Study|Lack of Efficacy|1|||
19792737|NCT02739321|42250714|FG001|Overall Study|Lack of Efficacy|1|||
19792738|NCT02739321|42250713|FG000|Overall Study|Lost to Follow-up|1|||
19792739|NCT02739321|42250714|FG001|Overall Study|Lost to Follow-up|1|||
19792740|NCT02739321|42250713|FG000|Overall Study|Withdrawal by Subject|1|||
19792741|NCT02739321|42250714|FG001|Overall Study|Withdrawal by Subject|2|||
19792742|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
19792743|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
19792744|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
19792745|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Death|0|||
19792746|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Death|0|||
19792747|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Death|1|||
19792748|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
19792749|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
19792750|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
19792751|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
19792752|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
19792753|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
19792754|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
19792755|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
19792756|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
19792757|NCT02696798|42250732|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
19792758|NCT02696798|42250733|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
19792759|NCT02696798|42250734|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
19792760|NCT02696798|42250732|FG000|Extended Treatment Period|Adverse Event|1|||
19792761|NCT02696798|42250733|FG001|Extended Treatment Period|Adverse Event|4|||
19792762|NCT02696798|42250734|FG002|Extended Treatment Period|Adverse Event|5|||
19792763|NCT02696798|42250732|FG000|Extended Treatment Period|Lack of Efficacy|7|||
19792764|NCT02696798|42250733|FG001|Extended Treatment Period|Lack of Efficacy|2|||
19792765|NCT02696798|42250734|FG002|Extended Treatment Period|Lack of Efficacy|2|||
19792766|NCT02696798|42250732|FG000|Extended Treatment Period|Lost to Follow-up|1|||
19792767|NCT02696798|42250733|FG001|Extended Treatment Period|Lost to Follow-up|0|||
19792768|NCT02696798|42250734|FG002|Extended Treatment Period|Lost to Follow-up|0|||
19792769|NCT02696798|42250732|FG000|Extended Treatment Period|Physician Decision|0|||
19792770|NCT02696798|42250733|FG001|Extended Treatment Period|Physician Decision|1|||
19792771|NCT02696798|42250734|FG002|Extended Treatment Period|Physician Decision|0|||
19792772|NCT02696798|42250732|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
19792773|NCT02696798|42250733|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
19792774|NCT02696798|42250734|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
19792775|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
19792776|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
19792777|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
19792778|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
19792779|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
19792780|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
19792781|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
19792782|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
19792783|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
19792784|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
19792785|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
19792786|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
19792787|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
19792788|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
19792789|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
19792790|NCT02696798|42250732|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
19792791|NCT02696798|42250733|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
19792792|NCT02696798|42250734|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
19792793|NCT02698826|42250756|FG000|Overall Study|Death|13|||
19792794|NCT02698826|42250756|FG000|Overall Study|Adverse Event|1|||
19792795|NCT02541604|42250774|FG000|Overall Study|Death|6|||
19792796|NCT02541604|42250775|FG001|Overall Study|Death|5|||
19792797|NCT02541604|42250776|FG002|Overall Study|Death|7|||
19792798|NCT02541604|42250777|FG003|Overall Study|Death|2|||
19792799|NCT02541604|42250778|FG004|Overall Study|Death|9|||
19792800|NCT02541604|42250779|FG005|Overall Study|Death|8|||
19792801|NCT02541604|42250780|FG006|Overall Study|Death|9|||
19792802|NCT02541604|42250781|FG007|Overall Study|Death|9|||
19792803|NCT02541604|42250782|FG008|Overall Study|Death|3|||
19792804|NCT02541604|42250783|FG009|Overall Study|Death|4|||
19792805|NCT02541604|42250784|FG010|Overall Study|Death|2|||
19792806|NCT02541604|42250785|FG011|Overall Study|Death|3|||
19792807|NCT02541604|42250774|FG000|Overall Study|Lost to Follow-up|2|||
19792808|NCT02541604|42250775|FG001|Overall Study|Lost to Follow-up|0|||
19792809|NCT02541604|42250776|FG002|Overall Study|Lost to Follow-up|1|||
19792810|NCT02541604|42250777|FG003|Overall Study|Lost to Follow-up|0|||
19792811|NCT02541604|42250778|FG004|Overall Study|Lost to Follow-up|0|||
19792812|NCT02541604|42250779|FG005|Overall Study|Lost to Follow-up|1|||
19792813|NCT02541604|42250780|FG006|Overall Study|Lost to Follow-up|1|||
19792814|NCT02541604|42250781|FG007|Overall Study|Lost to Follow-up|0|||
19792815|NCT02541604|42250782|FG008|Overall Study|Lost to Follow-up|0|||
19792816|NCT02541604|42250783|FG009|Overall Study|Lost to Follow-up|0|||
19792817|NCT02541604|42250784|FG010|Overall Study|Lost to Follow-up|0|||
19792818|NCT02541604|42250785|FG011|Overall Study|Lost to Follow-up|0|||
19792819|NCT02541604|42250774|FG000|Overall Study|Withdrawal by Subject|2|||
19792820|NCT02541604|42250775|FG001|Overall Study|Withdrawal by Subject|0|||
19792821|NCT02541604|42250776|FG002|Overall Study|Withdrawal by Subject|1|||
19792822|NCT02541604|42250777|FG003|Overall Study|Withdrawal by Subject|0|||
19792823|NCT02541604|42250778|FG004|Overall Study|Withdrawal by Subject|1|||
19792824|NCT02541604|42250779|FG005|Overall Study|Withdrawal by Subject|1|||
19792825|NCT02541604|42250780|FG006|Overall Study|Withdrawal by Subject|0|||
19792826|NCT02541604|42250781|FG007|Overall Study|Withdrawal by Subject|0|||
19792827|NCT02541604|42250782|FG008|Overall Study|Withdrawal by Subject|1|||
19792828|NCT02541604|42250783|FG009|Overall Study|Withdrawal by Subject|0|||
19792829|NCT02541604|42250784|FG010|Overall Study|Withdrawal by Subject|0|||
19792830|NCT02541604|42250785|FG011|Overall Study|Withdrawal by Subject|0|||
19698118|NCT00463385|42143432|FG002|Overall Study|1 participant received commercial drug|0|||
19698119|NCT00463385|42143433|FG003|Overall Study|1 participant received commercial drug|0|||
19698120|NCT00463229|42143453|FG000|Overall Study|Lost to Follow-up|5|||
19698121|NCT00463229|42143454|FG001|Overall Study|Lost to Follow-up|7|||
19698122|NCT00463229|42143453|FG000|Overall Study|Death|4|||
19792831|NCT02541604|42250774|FG000|Overall Study|Study Terminated by Sponsor|1|||
19792832|NCT02541604|42250775|FG001|Overall Study|Study Terminated by Sponsor|4|||
19792833|NCT02541604|42250776|FG002|Overall Study|Study Terminated by Sponsor|2|||
19792834|NCT02541604|42250777|FG003|Overall Study|Study Terminated by Sponsor|1|||
19792835|NCT02541604|42250778|FG004|Overall Study|Study Terminated by Sponsor|0|||
19792836|NCT02541604|42250779|FG005|Overall Study|Study Terminated by Sponsor|0|||
19792837|NCT02541604|42250780|FG006|Overall Study|Study Terminated by Sponsor|0|||
19792838|NCT02541604|42250781|FG007|Overall Study|Study Terminated by Sponsor|0|||
19792839|NCT02541604|42250782|FG008|Overall Study|Study Terminated by Sponsor|0|||
19792840|NCT02541604|42250783|FG009|Overall Study|Study Terminated by Sponsor|0|||
19792841|NCT02541604|42250784|FG010|Overall Study|Study Terminated by Sponsor|0|||
19792842|NCT02541604|42250785|FG011|Overall Study|Study Terminated by Sponsor|0|||
19792843|NCT02541604|42250774|FG000|Overall Study|Medical condition may jeopardize safety|0|||
19792844|NCT02541604|42250775|FG001|Overall Study|Medical condition may jeopardize safety|0|||
19792845|NCT02541604|42250776|FG002|Overall Study|Medical condition may jeopardize safety|0|||
19792846|NCT02541604|42250777|FG003|Overall Study|Medical condition may jeopardize safety|0|||
19792847|NCT02541604|42250778|FG004|Overall Study|Medical condition may jeopardize safety|0|||
19792848|NCT02541604|42250779|FG005|Overall Study|Medical condition may jeopardize safety|0|||
19792849|NCT02541604|42250780|FG006|Overall Study|Medical condition may jeopardize safety|0|||
19792850|NCT02541604|42250781|FG007|Overall Study|Medical condition may jeopardize safety|1|||
19792851|NCT02541604|42250782|FG008|Overall Study|Medical condition may jeopardize safety|0|||
19792852|NCT02541604|42250783|FG009|Overall Study|Medical condition may jeopardize safety|0|||
19792853|NCT02541604|42250784|FG010|Overall Study|Medical condition may jeopardize safety|0|||
19792854|NCT02541604|42250785|FG011|Overall Study|Medical condition may jeopardize safety|0|||
19792855|NCT02546674|42250834|FG000|Overall Study|Adverse Event|19|||
19792856|NCT02546674|42250834|FG000|Overall Study|Death|1|||
19792857|NCT02546674|42250834|FG000|Overall Study|Lost to Follow-up|1|||
19792858|NCT02546674|42250834|FG000|Overall Study|Physician Decision|13|||
19792859|NCT02546674|42250834|FG000|Overall Study|Pregnancy|1|||
19792860|NCT02546674|42250834|FG000|Overall Study|Progressive Disease|2|||
19792861|NCT02546674|42250834|FG000|Overall Study|Protocol Deviation|2|||
19792862|NCT02546674|42250834|FG000|Overall Study|Subject/Guardian Decision|6|||
19792863|NCT02546674|42250834|FG000|Overall Study|Withdrawal of Informed Consent|3|||
19792864|NCT02546362|42250839|FG000|4-week Treatment Period|Lost to Follow-up|1|||
19792865|NCT02546362|42250839|FG000|4-week Treatment Period|Change in medication|2|||
19792866|NCT02546362|42250839|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
19792867|NCT02546362|42250839|FG000|12-week Treatment Period|Lost to Follow-up|2|||
19792868|NCT02546362|42250839|FG000|12-week Treatment Period|Change in medication|1|||
19792869|NCT02698436|42250845|FG000|Overall Study|Adverse Event|1|||
19792870|NCT02698436|42250846|FG001|Overall Study|Adverse Event|0|||
19792871|NCT02698436|42250845|FG000|Overall Study|Withdrawal by Subject|3|||
19792872|NCT02698436|42250846|FG001|Overall Study|Withdrawal by Subject|3|||
19792873|NCT02698436|42250845|FG000|Overall Study|Lost to Follow-up|2|||
19792874|NCT02698436|42250846|FG001|Overall Study|Lost to Follow-up|4|||
19792875|NCT02698436|42250845|FG000|Overall Study|Non-compliance with study regimen|1|||
19792876|NCT02698436|42250846|FG001|Overall Study|Non-compliance with study regimen|0|||
19792877|NCT02694536|42250852|FG000|Overall Study|Progressive Disease|40|||
19792878|NCT02694536|42250852|FG000|Overall Study|Lost to Follow-up|1|||
19792879|NCT02694536|42250852|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
19792880|NCT02694536|42250852|FG000|Overall Study|Withdrawal by Subject|8|||
19792881|NCT02694536|42250852|FG000|Overall Study|Death|8|||
19792882|NCT02694536|42250852|FG000|Overall Study|Other|22|||
19792883|NCT01661686|42250858|FG000|Overall Study|Lost to Follow-up|2|||
19792884|NCT01661686|42250859|FG001|Overall Study|Lost to Follow-up|1|||
19792885|NCT01661686|42250858|FG000|Overall Study|did not receive allocated intervention|0|||
19792886|NCT01661686|42250859|FG001|Overall Study|did not receive allocated intervention|1|||
19792887|NCT02696096|42250865|FG000|Overall Study|ruled out at screening|1|||
19792888|NCT02696096|42250865|FG000|Overall Study|did not attend second fMRI|1|||
19792889|NCT02695628|42250873|FG000|Overall Study|Withdrawal by Subject|1|||
19792890|NCT02693834|42250877|FG000|Baseline Measurement|Withdrawal by Subject|1|||
19792891|NCT02693834|42250878|FG001|Baseline Measurement|Withdrawal by Subject|0|||
19792892|NCT02693834|42250877|FG000|Baseline Measurement|Adverse Event|1|||
19792893|NCT02693834|42250878|FG001|Baseline Measurement|Adverse Event|0|||
19792894|NCT02693834|42250877|FG000|Week 2 Practice|Adverse Event|0|||
19792895|NCT02693834|42250878|FG001|Week 2 Practice|Adverse Event|1|||
19792896|NCT02545504|42250886|FG000|Overall Study|Death|174|||
19792897|NCT02545504|42250887|FG001|Overall Study|Death|168|||
19792898|NCT02545504|42250886|FG000|Overall Study|Unknown reason|30|||
19792899|NCT02545504|42250887|FG001|Overall Study|Unknown reason|32|||
19792900|NCT02545504|42250886|FG000|Overall Study|Withdrew consent|9|||
19792901|NCT02545504|42250887|FG001|Overall Study|Withdrew consent|11|||
19792902|NCT02545504|42250886|FG000|Overall Study|Investigator's discretion|3|||
19792903|NCT02545504|42250887|FG001|Overall Study|Investigator's discretion|1|||
19792904|NCT02545504|42250886|FG000|Overall Study|Lost to Follow-up|2|||
19792905|NCT02545504|42250887|FG001|Overall Study|Lost to Follow-up|2|||
19792906|NCT02545270|42250900|FG000|Overall Study|technical difficulties|0|||
19792907|NCT02545270|42250901|FG001|Overall Study|technical difficulties|1|||
19792908|NCT02545270|42250902|FG002|Overall Study|technical difficulties|0|||
19792909|NCT02545270|42250900|FG000|Overall Study|Videos being too similar to other|0|||
19792910|NCT02545270|42250901|FG001|Overall Study|Videos being too similar to other|0|||
19792911|NCT02545270|42250902|FG002|Overall Study|Videos being too similar to other|2|||
19792912|NCT02540668|42250911|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
19792913|NCT02540668|42250912|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
19792914|NCT02339740|42250921|FG000|Overall Study|Death|1|||
19792915|NCT02339740|42250922|FG001|Overall Study|Death|0|||
19792916|NCT02339740|42250921|FG000|Overall Study|Physician Decision|0|||
19792917|NCT02339740|42250922|FG001|Overall Study|Physician Decision|2|||
19792918|NCT02339740|42250921|FG000|Overall Study|Withdrawal by Subject|5|||
19792919|NCT02339740|42250922|FG001|Overall Study|Withdrawal by Subject|1|||
19792920|NCT02339740|42250921|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
19792921|NCT02339740|42250922|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
19792922|NCT00433511|42250948|FG000|Step 1|Adverse Event|50|||
19792923|NCT00433511|42250949|FG001|Step 1|Adverse Event|157|||
19792924|NCT00433511|42250950|FG002|Step 1|Adverse Event|153|||
19792925|NCT00433511|42250948|FG000|Step 1|Withdrawal by Subject|45|||
19792926|NCT00433511|42250949|FG001|Step 1|Withdrawal by Subject|143|||
19792927|NCT00433511|42250950|FG002|Step 1|Withdrawal by Subject|154|||
19792928|NCT00433511|42250948|FG000|Step 1|Death|3|||
19792929|NCT00433511|42250949|FG001|Step 1|Death|1|||
19792930|NCT00433511|42250950|FG002|Step 1|Death|1|||
19792931|NCT00433511|42250948|FG000|Step 1|Physician Decision|1|||
19792932|NCT00433511|42250949|FG001|Step 1|Physician Decision|4|||
19792933|NCT00433511|42250950|FG002|Step 1|Physician Decision|3|||
19792934|NCT00433511|42250948|FG000|Step 1|Never started protocol therapy|28|||
19792935|NCT00433511|42250949|FG001|Step 1|Never started protocol therapy|64|||
19792936|NCT00433511|42250950|FG002|Step 1|Never started protocol therapy|66|||
19792937|NCT00433511|42250948|FG000|Step 1|Alternative therapy|2|||
19792938|NCT00433511|42250949|FG001|Step 1|Alternative therapy|1|||
19792939|NCT00433511|42250950|FG002|Step 1|Alternative therapy|3|||
19792940|NCT00433511|42250948|FG000|Step 1|Disease progression, relapse|5|||
19792941|NCT00433511|42250949|FG001|Step 1|Disease progression, relapse|3|||
19792942|NCT00433511|42250950|FG002|Step 1|Disease progression, relapse|3|||
19792943|NCT00433511|42250948|FG000|Step 1|Other complicating disease|2|||
19792944|NCT00433511|42250949|FG001|Step 1|Other complicating disease|6|||
19792945|NCT00433511|42250950|FG002|Step 1|Other complicating disease|3|||
19792946|NCT00433511|42250948|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
19792947|NCT00433511|42250949|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
19792948|NCT00433511|42250950|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
19792949|NCT00433511|42250948|FG000|Step 1|Suspected recurrence|0|||
19792950|NCT00433511|42250949|FG001|Step 1|Suspected recurrence|1|||
19792951|NCT00433511|42250950|FG002|Step 1|Suspected recurrence|0|||
19792952|NCT00433511|42250948|FG000|Step 1|Insurance/drug distribution issues|0|||
19792953|NCT00433511|42250949|FG001|Step 1|Insurance/drug distribution issues|1|||
19792954|NCT00433511|42250950|FG002|Step 1|Insurance/drug distribution issues|2|||
19792955|NCT00433511|42250948|FG000|Step 1|Patient moved|0|||
19792956|NCT00433511|42250949|FG001|Step 1|Patient moved|0|||
19792957|NCT00433511|42250950|FG002|Step 1|Patient moved|1|||
19792958|NCT00433511|42250948|FG000|Step 2 (Arm D)|Adverse Event|0|||
19792959|NCT00433511|42250949|FG001|Step 2 (Arm D)|Adverse Event|0|||
19792960|NCT00433511|42250950|FG002|Step 2 (Arm D)|Adverse Event|135|||
19792961|NCT00433511|42250948|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
19792962|NCT00433511|42250949|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
19792963|NCT00433511|42250950|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
19792964|NCT00433511|42250948|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
19792965|NCT00433511|42250949|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
19792966|NCT00433511|42250950|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
19792967|NCT00433511|42250948|FG000|Step 2 (Arm D)|Physician Decision|0|||
19792968|NCT00433511|42250949|FG001|Step 2 (Arm D)|Physician Decision|0|||
19792969|NCT00433511|42250950|FG002|Step 2 (Arm D)|Physician Decision|9|||
19792970|NCT00433511|42250948|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
19792971|NCT00433511|42250949|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
19792972|NCT00433511|42250950|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
19792973|NCT00433511|42250948|FG000|Step 2 (Arm D)|Other complicating disease|0|||
19792974|NCT00433511|42250949|FG001|Step 2 (Arm D)|Other complicating disease|0|||
19792975|NCT00433511|42250950|FG002|Step 2 (Arm D)|Other complicating disease|3|||
19792976|NCT00433511|42250948|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
19792977|NCT00433511|42250949|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
19792978|NCT00433511|42250950|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
19792979|NCT00433511|42250948|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
19792980|NCT00433511|42250949|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
19792981|NCT00433511|42250950|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
19792982|NCT00433511|42250948|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
19792983|NCT00433511|42250949|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
19792984|NCT00433511|42250950|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
19792985|NCT00433511|42250948|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
19792986|NCT00433511|42250949|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
19792987|NCT00433511|42250950|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
19792988|NCT02535364|42250961|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
19792989|NCT02535364|42250961|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
19792990|NCT02535364|42250961|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
19792991|NCT02535364|42250961|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
19792992|NCT02535364|42250961|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
19792993|NCT02535364|42250961|FG000|Part B Screening|Death|2|||
19792994|NCT02535364|42250961|FG000|Part B Screening|Physician Decision|1|||
19792995|NCT02535364|42250961|FG000|Part B Screening|Withdrawal by Subject|1|||
19792996|NCT02535364|42250961|FG000|Part B Screening|Adverse Event|1|||
19792997|NCT02535364|42250961|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
19792998|NCT02535364|42250961|FG000|Study Treatment|Death|1|||
19792999|NCT02535364|42250961|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
19793000|NCT02535364|42250961|FG000|12-Month Follow-up Period|Disease progression|22|||
19793001|NCT02535364|42250961|FG000|12-Month Follow-up Period|Death|5|||
19793002|NCT02535364|42250961|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
19793003|NCT02535364|42250961|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
19793004|NCT02535364|42250961|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
19793005|NCT02540356|42250967|FG000|Overall Study|Terminated due to disease progression|1|||
19793006|NCT02540356|42250968|FG001|Overall Study|Terminated due to disease progression|0|||
19793007|NCT02534896|42250976|FG000|Overall Study|Adverse Event|2|||
19793008|NCT02534896|42250977|FG001|Overall Study|Adverse Event|1|||
19793009|NCT02534896|42250978|FG002|Overall Study|Adverse Event|1|||
19793010|NCT02534896|42250976|FG000|Overall Study|Insufficient therapeutic response|2|||
19793011|NCT02534896|42250977|FG001|Overall Study|Insufficient therapeutic response|0|||
19793012|NCT02534896|42250978|FG002|Overall Study|Insufficient therapeutic response|0|||
19793013|NCT02697734|42250988|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
19793014|NCT02697734|42250989|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
19793015|NCT02697734|42250988|FG000|Core Phase - up to Week 48|Adverse Event|1|||
19793016|NCT02697734|42250989|FG001|Core Phase - up to Week 48|Adverse Event|2|||
19793017|NCT02697734|42250988|FG000|Core Phase - up to Week 48|Physician Decision|1|||
19793018|NCT02697734|42250989|FG001|Core Phase - up to Week 48|Physician Decision|0|||
19793019|NCT02697734|42250988|FG000|Optional Extension Phase|Adverse Event|5|||
19793020|NCT02697734|42250989|FG001|Optional Extension Phase|Adverse Event|1|||
19793021|NCT02697734|42250988|FG000|Optional Extension Phase|Physician Decision|0|||
19793022|NCT02697734|42250989|FG001|Optional Extension Phase|Physician Decision|1|||
19793023|NCT02692586|42251003|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
19793024|NCT02692586|42251003|FG000|Overall Study|Received adjunctive thrombolytics|2|||
19793025|NCT02534350|42251009|FG000|Overall Study|Randomized But Not Treated|1|||
19793026|NCT02534350|42251010|FG001|Overall Study|Randomized But Not Treated|0|||
19793027|NCT02534350|42251009|FG000|Overall Study|Protocol Violation|1|||
19793028|NCT02534350|42251010|FG001|Overall Study|Protocol Violation|0|||
19793029|NCT02534350|42251009|FG000|Overall Study|Withdrew Consent|2|||
19793030|NCT02534350|42251010|FG001|Overall Study|Withdrew Consent|0|||
19793031|NCT02689076|42251019|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
19793032|NCT02689076|42251020|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
19793033|NCT02689076|42251021|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
19793034|NCT02689076|42251019|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
19793035|NCT02689076|42251020|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
19793036|NCT02689076|42251021|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
19793037|NCT02689076|42251019|FG000|Overall Study|Did not have an HIE match|2|||
19793038|NCT02689076|42251020|FG001|Overall Study|Did not have an HIE match|0|||
19793039|NCT02689076|42251021|FG002|Overall Study|Did not have an HIE match|0|||
19793040|NCT02689076|42251019|FG000|Overall Study|Death during non-VA encounter|2|||
19793041|NCT02689076|42251020|FG001|Overall Study|Death during non-VA encounter|5|||
19793042|NCT02689076|42251021|FG002|Overall Study|Death during non-VA encounter|0|||
19793043|NCT02689076|42251019|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
19793044|NCT02689076|42251020|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
19793045|NCT02689076|42251021|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
19793046|NCT02689076|42251019|FG000|Overall Study|Participant no longer active in VA system|1|||
19793047|NCT02689076|42251020|FG001|Overall Study|Participant no longer active in VA system|0|||
19793048|NCT02689076|42251021|FG002|Overall Study|Participant no longer active in VA system|0|||
19793049|NCT02689076|42251019|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
19793050|NCT02689076|42251020|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
19793051|NCT02689076|42251021|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
19607751|NCT00596817|42056586|FG001|Double-blind Period|Non-compliance With Study Product|4|||
19607752|NCT00596817|42056585|FG000|Double-blind Period|Protocol Violation|11|||
19607753|NCT00596817|42056586|FG001|Double-blind Period|Protocol Violation|8|||
19607754|NCT00596817|42056585|FG000|Double-blind Period|Withdrawal of Consent|7|||
19607755|NCT00596817|42056586|FG001|Double-blind Period|Withdrawal of Consent|3|||
19607756|NCT00596817|42056585|FG000|Double-blind Period|Lost to Follow-up|0|||
19607757|NCT00596817|42056586|FG001|Double-blind Period|Lost to Follow-up|2|||
19607758|NCT00596817|42056585|FG000|Double-blind Period|Other Reasons|10|||
19793052|NCT00070499|42251033|FG000|Overall Study|Adverse Event|6|||
19793053|NCT00070499|42251034|FG001|Overall Study|Adverse Event|6|||
19793054|NCT00070499|42251035|FG002|Overall Study|Adverse Event|19|||
19793055|NCT00070499|42251036|FG003|Overall Study|Adverse Event|15|||
19793056|NCT00070499|42251033|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
19793057|NCT00070499|42251034|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
19793058|NCT00070499|42251035|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
19793059|NCT00070499|42251036|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
19793060|NCT00070499|42251033|FG000|Overall Study|Progression/relapse|4|||
19793061|NCT00070499|42251034|FG001|Overall Study|Progression/relapse|2|||
19793062|NCT00070499|42251035|FG002|Overall Study|Progression/relapse|1|||
19793063|NCT00070499|42251036|FG003|Overall Study|Progression/relapse|4|||
19793064|NCT00070499|42251033|FG000|Overall Study|Death|1|||
19793065|NCT00070499|42251034|FG001|Overall Study|Death|1|||
19793066|NCT00070499|42251035|FG002|Overall Study|Death|1|||
19793067|NCT00070499|42251036|FG003|Overall Study|Death|2|||
19793068|NCT00070499|42251033|FG000|Overall Study|Other - not protocol specified|7|||
19793069|NCT00070499|42251034|FG001|Overall Study|Other - not protocol specified|3|||
19793070|NCT00070499|42251035|FG002|Overall Study|Other - not protocol specified|12|||
19793071|NCT00070499|42251036|FG003|Overall Study|Other - not protocol specified|20|||
19793072|NCT00070499|42251033|FG000|Overall Study|Still on protocol treatment|10|||
19793073|NCT00070499|42251034|FG001|Overall Study|Still on protocol treatment|4|||
19793074|NCT00070499|42251035|FG002|Overall Study|Still on protocol treatment|79|||
19793075|NCT00070499|42251036|FG003|Overall Study|Still on protocol treatment|57|||
19793076|NCT00070499|42251033|FG000|Overall Study|Did not start treatment|1|||
19793077|NCT00070499|42251034|FG001|Overall Study|Did not start treatment|0|||
19793078|NCT00070499|42251035|FG002|Overall Study|Did not start treatment|0|||
19793079|NCT00070499|42251036|FG003|Overall Study|Did not start treatment|2|||
19793080|NCT00070499|42251033|FG000|Overall Study|Not eligible|2|||
19793081|NCT00070499|42251034|FG001|Overall Study|Not eligible|5|||
19793082|NCT00070499|42251035|FG002|Overall Study|Not eligible|3|||
19793083|NCT00070499|42251036|FG003|Overall Study|Not eligible|2|||
19793084|NCT02688764|42251056|FG000|Overall Study|Adverse Event|3|||
19793085|NCT02688764|42251057|FG001|Overall Study|Adverse Event|3|||
19793086|NCT02688764|42251056|FG000|Overall Study|AE/Kidney transplant|1|||
19793087|NCT02688764|42251057|FG001|Overall Study|AE/Kidney transplant|0|||
19793088|NCT02688764|42251056|FG000|Overall Study|AE/Lack of efficacy|1|||
19367512|NCT02576847|41607680|FG000|Overall Study|Pregnancy|1|||
19367513|NCT02576847|41607680|FG000|Overall Study|Protocol Violation|3|||
19367514|NCT02576847|41607680|FG000|Overall Study|Withdrawal by Subject|78|||
19367515|NCT02576847|41607680|FG000|Overall Study|Other|5|||
19607759|NCT00596817|42056586|FG001|Double-blind Period|Other Reasons|18|||
19607760|NCT01000649|42056597|FG000|Overall Study|Adverse Event|5|||
19607761|NCT01000649|42056598|FG001|Overall Study|Adverse Event|1|||
19607762|NCT01000649|42056599|FG002|Overall Study|Adverse Event|2|||
19607763|NCT01000649|42056600|FG003|Overall Study|Adverse Event|4|||
19607764|NCT01000649|42056597|FG000|Overall Study|Lost to Follow-up|0|||
19607765|NCT01000649|42056598|FG001|Overall Study|Lost to Follow-up|2|||
19607766|NCT01000649|42056599|FG002|Overall Study|Lost to Follow-up|0|||
19607767|NCT01000649|42056600|FG003|Overall Study|Lost to Follow-up|2|||
19607768|NCT00666835|42056611|FG000|Overall Study|Withdrawal by Subject|5|||
19607769|NCT00666835|42056612|FG001|Overall Study|Withdrawal by Subject|2|||
19607770|NCT00666835|42056611|FG000|Overall Study|Lack of Efficacy|0|||
19607771|NCT00666835|42056612|FG001|Overall Study|Lack of Efficacy|1|||
19607772|NCT00666835|42056611|FG000|Overall Study|Incl./excl. not fulfilled|7|||
19607773|NCT00666835|42056612|FG001|Overall Study|Incl./excl. not fulfilled|2|||
19607774|NCT00666835|42056611|FG000|Overall Study|Adverse Event|7|||
19607775|NCT00666835|42056612|FG001|Overall Study|Adverse Event|6|||
19607776|NCT00666835|42056611|FG000|Overall Study|Protocol Violation|2|||
19793089|NCT02688764|42251057|FG001|Overall Study|AE/Lack of efficacy|0|||
19793090|NCT02688764|42251056|FG000|Overall Study|AE/Non-compl.|1|||
19793091|NCT02688764|42251057|FG001|Overall Study|AE/Non-compl.|0|||
19793092|NCT02688764|42251056|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
19367516|NCT02135029|41607696|FG000|Overall Study|Adverse Event|2|||
19367517|NCT02135029|41607697|FG001|Overall Study|Adverse Event|2|||
19367518|NCT02135029|41607698|FG002|Overall Study|Adverse Event|2|||
19367519|NCT02135029|41607696|FG000|Overall Study|Lost to Follow-up|0|||
19367520|NCT02135029|41607697|FG001|Overall Study|Lost to Follow-up|1|||
19367521|NCT02135029|41607698|FG002|Overall Study|Lost to Follow-up|0|||
19607777|NCT00666835|42056612|FG001|Overall Study|Protocol Violation|0|||
19607778|NCT00666835|42056611|FG000|Overall Study|Death|15|||
19607779|NCT00666835|42056612|FG001|Overall Study|Death|4|||
19607780|NCT00666835|42056611|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
19698123|NCT00463229|42143454|FG001|Overall Study|Death|3|||
19793093|NCT02688764|42251057|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
19793094|NCT02688764|42251056|FG000|Overall Study|AE/Other|0|||
19793095|NCT02688764|42251057|FG001|Overall Study|AE/Other|1|||
19793096|NCT02688764|42251056|FG000|Overall Study|AE/Physician decision|1|||
19793097|NCT02688764|42251057|FG001|Overall Study|AE/Physician decision|0|||
19793098|NCT02688764|42251056|FG000|Overall Study|AE/Withd. parent|3|||
19793099|NCT02688764|42251057|FG001|Overall Study|AE/Withd. parent|0|||
19793100|NCT02688764|42251056|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
19793101|NCT02688764|42251057|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
19793102|NCT02688764|42251056|FG000|Overall Study|AE/Withd. subject|1|||
19793103|NCT02688764|42251057|FG001|Overall Study|AE/Withd. subject|0|||
19793104|NCT02688764|42251056|FG000|Overall Study|Kidney transplant|10|||
19793105|NCT02688764|42251057|FG001|Overall Study|Kidney transplant|4|||
19793106|NCT02688764|42251056|FG000|Overall Study|Lack of Efficacy|3|||
19793107|NCT02688764|42251057|FG001|Overall Study|Lack of Efficacy|2|||
19793108|NCT02688764|42251056|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
19793109|NCT02688764|42251057|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
19793110|NCT02688764|42251056|FG000|Overall Study|Non-compliance with study drug|4|||
19793111|NCT02688764|42251057|FG001|Overall Study|Non-compliance with study drug|0|||
19793112|NCT02688764|42251056|FG000|Overall Study|Non-compl./Physician decision|2|||
19793113|NCT02688764|42251057|FG001|Overall Study|Non-compl./Physician decision|0|||
19793114|NCT02688764|42251056|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
19793115|NCT02688764|42251057|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
19793116|NCT02688764|42251056|FG000|Overall Study|Non-compl./Withd. subject|0|||
19793117|NCT02688764|42251057|FG001|Overall Study|Non-compl./Withd. subject|2|||
19793118|NCT02688764|42251056|FG000|Overall Study|Phosphorus level outside safe range|0|||
19793119|NCT02688764|42251057|FG001|Overall Study|Phosphorus level outside safe range|1|||
19793120|NCT02688764|42251056|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
19793121|NCT02688764|42251057|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
19793122|NCT02688764|42251056|FG000|Overall Study|Study drug taste/Withd. parent|1|||
19793123|NCT02688764|42251057|FG001|Overall Study|Study drug taste/Withd. parent|0|||
19793124|NCT02688764|42251056|FG000|Overall Study|Subject moving out|2|||
19793125|NCT02688764|42251057|FG001|Overall Study|Subject moving out|0|||
19793126|NCT02688764|42251056|FG000|Overall Study|Subject taken off dialysis|1|||
19793127|NCT02688764|42251057|FG001|Overall Study|Subject taken off dialysis|0|||
19793128|NCT02688764|42251056|FG000|Overall Study|Withdrawal by parent|3|||
19793129|NCT02688764|42251057|FG001|Overall Study|Withdrawal by parent|0|||
19793130|NCT02688608|42251066|FG000|Overall Study|Lost to Follow-up|1|||
19793131|NCT02688530|42251074|FG000|Overall Study|Withdrawal by Subject|0|||
19793132|NCT02688530|42251075|FG001|Overall Study|Withdrawal by Subject|1|||
19793133|NCT02688530|42251076|FG002|Overall Study|Withdrawal by Subject|0|||
19793134|NCT02688530|42251077|FG003|Overall Study|Withdrawal by Subject|0|||
19793135|NCT02688530|42251074|FG000|Overall Study|Lost to Follow-up|0|||
19793136|NCT02688530|42251075|FG001|Overall Study|Lost to Follow-up|0|||
19793137|NCT02688530|42251076|FG002|Overall Study|Lost to Follow-up|2|||
19793138|NCT02688530|42251077|FG003|Overall Study|Lost to Follow-up|0|||
19793139|NCT02467270|42251094|FG000|Overall Study|Participants Never Treated|0|||
19793140|NCT02467270|42251095|FG001|Overall Study|Participants Never Treated|1|||
19793141|NCT02467270|42251096|FG002|Overall Study|Participants Never Treated|0|||
19793142|NCT02467270|42251094|FG000|Overall Study|Ongoing|50|||
19793143|NCT02467270|42251095|FG001|Overall Study|Ongoing|41|||
19793144|NCT02467270|42251096|FG002|Overall Study|Ongoing|43|||
19793145|NCT02467270|42251094|FG000|Overall Study|Adverse Event|16|||
19793146|NCT02467270|42251095|FG001|Overall Study|Adverse Event|15|||
19793147|NCT02467270|42251096|FG002|Overall Study|Adverse Event|14|||
19793148|NCT02467270|42251094|FG000|Overall Study|Progressive Disease|7|||
19793149|NCT02467270|42251095|FG001|Overall Study|Progressive Disease|7|||
19793150|NCT02467270|42251096|FG002|Overall Study|Progressive Disease|4|||
19793151|NCT02467270|42251094|FG000|Overall Study|Death|2|||
19793152|NCT02467270|42251095|FG001|Overall Study|Death|0|||
19793153|NCT02467270|42251096|FG002|Overall Study|Death|2|||
19793154|NCT02467270|42251094|FG000|Overall Study|Lack of Efficacy|12|||
19793155|NCT02467270|42251095|FG001|Overall Study|Lack of Efficacy|18|||
19793156|NCT02467270|42251096|FG002|Overall Study|Lack of Efficacy|23|||
19793157|NCT02467270|42251094|FG000|Overall Study|Non-compliance With Study Drug|0|||
19793158|NCT02467270|42251095|FG001|Overall Study|Non-compliance With Study Drug|2|||
19793159|NCT02467270|42251096|FG002|Overall Study|Non-compliance With Study Drug|1|||
19793160|NCT02467270|42251094|FG000|Overall Study|Lost to Follow-up|2|||
19793161|NCT02467270|42251095|FG001|Overall Study|Lost to Follow-up|1|||
19793162|NCT02467270|42251096|FG002|Overall Study|Lost to Follow-up|0|||
19793163|NCT02467270|42251094|FG000|Overall Study|Pregnancy|0|||
19793164|NCT02467270|42251095|FG001|Overall Study|Pregnancy|1|||
19793165|NCT02467270|42251096|FG002|Overall Study|Pregnancy|0|||
19793166|NCT02467270|42251094|FG000|Overall Study|Physician Decision|0|||
19793167|NCT02467270|42251095|FG001|Overall Study|Physician Decision|4|||
19793168|NCT02467270|42251096|FG002|Overall Study|Physician Decision|1|||
19793169|NCT02467270|42251094|FG000|Overall Study|Withdrawal by Subject|4|||
19793170|NCT02467270|42251095|FG001|Overall Study|Withdrawal by Subject|3|||
19793171|NCT02467270|42251096|FG002|Overall Study|Withdrawal by Subject|5|||
19793172|NCT02467270|42251094|FG000|Overall Study|Reason not Specified|1|||
19793173|NCT02467270|42251095|FG001|Overall Study|Reason not Specified|2|||
19793174|NCT02467270|42251096|FG002|Overall Study|Reason not Specified|1|||
19793175|NCT05083559|42251106|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
19793176|NCT05083559|42251107|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
19793177|NCT05083559|42251106|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
19793178|NCT05083559|42251107|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
19793179|NCT05083559|42251106|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
19793180|NCT05083559|42251107|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
19793181|NCT03037307|42251113|FG000|Period 1|Did Not Meet Study Criteria|0|||
19793182|NCT03037307|42251114|FG001|Period 1|Did Not Meet Study Criteria|0|||
19793183|NCT03037307|42251115|FG002|Period 1|Did Not Meet Study Criteria|0|||
19793184|NCT03037307|42251116|FG003|Period 1|Did Not Meet Study Criteria|1|||
19793185|NCT03037307|42251117|FG004|Period 1|Did Not Meet Study Criteria|0|||
19793186|NCT03037307|42251118|FG005|Period 1|Did Not Meet Study Criteria|0|||
19793187|NCT02538094|42251127|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
19793188|NCT02538094|42251128|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
19793189|NCT02538094|42251127|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
19793190|NCT02538094|42251128|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
19793191|NCT02686034|42251136|FG000|Run-In Period 1|Eligibility|12|||
19793192|NCT02686034|42251137|FG001|Run-In Period 1|Eligibility|10|||
19793193|NCT02686034|42251136|FG000|Run-In Period 1|Withdrawal by Subject|4|||
19793194|NCT02686034|42251137|FG001|Run-In Period 1|Withdrawal by Subject|3|||
19793195|NCT02686034|42251136|FG000|Run-In Period 1|Lost to Follow-up|4|||
19793196|NCT02686034|42251137|FG001|Run-In Period 1|Lost to Follow-up|4|||
19793197|NCT02686034|42251136|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
19793198|NCT02686034|42251137|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
19793199|NCT02686034|42251136|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
19793200|NCT02686034|42251137|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
19793201|NCT02686034|42251136|FG000|Randomized Controlled Period 2|Adverse Event|0|||
19793202|NCT02686034|42251137|FG001|Randomized Controlled Period 2|Adverse Event|2|||
19793203|NCT02686034|42251136|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
19793204|NCT02686034|42251137|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
19793205|NCT02686034|42251136|FG000|Open Label Period 3|Lost to Follow-up|0|||
19793206|NCT02686034|42251137|FG001|Open Label Period 3|Lost to Follow-up|1|||
19793207|NCT02685488|42251145|FG000|Overall Study|Withdrawal by Subject|0|||
19793208|NCT02685488|42251146|FG001|Overall Study|Withdrawal by Subject|1|||
19793209|NCT02533570|42251155|FG000|Overall Study|Adverse Event|0|||
19793210|NCT02533570|42251156|FG001|Overall Study|Adverse Event|1|||
19793211|NCT02533570|42251157|FG002|Overall Study|Adverse Event|1|||
19793212|NCT03036839|42251168|FG000|Overall Study|Adverse Event|0|||
19793213|NCT03036839|42251169|FG001|Overall Study|Adverse Event|0|||
19793214|NCT03036839|42251170|FG002|Overall Study|Adverse Event|1|||
19793215|NCT03036839|42251168|FG000|Overall Study|Death|3|||
19793216|NCT03036839|42251169|FG001|Overall Study|Death|0|||
19793217|NCT03036839|42251170|FG002|Overall Study|Death|3|||
19793218|NCT03036839|42251168|FG000|Overall Study|Withdrew Consent|0|||
19793219|NCT03036839|42251169|FG001|Overall Study|Withdrew Consent|0|||
19793220|NCT03036839|42251170|FG002|Overall Study|Withdrew Consent|1|||
19793221|NCT01286207|42251181|FG000|Overall Study|Adverse Event|27|||
19793222|NCT01286207|42251182|FG001|Overall Study|Adverse Event|41|||
19793223|NCT01286207|42251183|FG002|Overall Study|Adverse Event|8|||
19793224|NCT01286207|42251181|FG000|Overall Study|Lost to Follow-up|49|||
19793225|NCT01286207|42251182|FG001|Overall Study|Lost to Follow-up|43|||
19793226|NCT01286207|42251183|FG002|Overall Study|Lost to Follow-up|20|||
19793227|NCT01286207|42251181|FG000|Overall Study|Withdrawal by Subject|93|||
19793228|NCT01286207|42251182|FG001|Overall Study|Withdrawal by Subject|79|||
19793229|NCT01286207|42251183|FG002|Overall Study|Withdrawal by Subject|41|||
19793230|NCT01286207|42251181|FG000|Overall Study|Lack of Response|92|||
19793231|NCT01286207|42251182|FG001|Overall Study|Lack of Response|38|||
19793232|NCT01286207|42251183|FG002|Overall Study|Lack of Response|8|||
19793233|NCT01286207|42251181|FG000|Overall Study|Other|37|||
19793234|NCT01286207|42251182|FG001|Overall Study|Other|47|||
19793235|NCT01286207|42251183|FG002|Overall Study|Other|13|||
19793236|NCT00968201|42251220|FG000|Base Study - (Period II)|Adverse Event|8|||
19793237|NCT00968201|42251221|FG001|Base Study - (Period II)|Adverse Event|0|||
19793238|NCT00968201|42251222|FG002|Base Study - (Period II)|Adverse Event|16|||
19367522|NCT02135029|41607696|FG000|Overall Study|Withdrawal by Subject|2|||
19793239|NCT00968201|42251220|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
19793240|NCT00968201|42251221|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
19793241|NCT00968201|42251222|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
19793242|NCT00968201|42251220|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
19793243|NCT00968201|42251221|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
19793244|NCT00968201|42251222|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
19793245|NCT00968201|42251220|FG000|Base Study - (Period II)|Protocol Violation|12|||
19793246|NCT00968201|42251221|FG001|Base Study - (Period II)|Protocol Violation|0|||
19367523|NCT02135029|41607697|FG001|Overall Study|Withdrawal by Subject|0|||
19793247|NCT00968201|42251222|FG002|Base Study - (Period II)|Protocol Violation|12|||
19793248|NCT00968201|42251220|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
19793249|NCT00968201|42251221|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
19793250|NCT00968201|42251222|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
19793251|NCT00968201|42251220|FG000|Base Study - (Period II)|Site Error|0|||
19793252|NCT00968201|42251221|FG001|Base Study - (Period II)|Site Error|0|||
19793253|NCT00968201|42251222|FG002|Base Study - (Period II)|Site Error|1|||
19793254|NCT00968201|42251220|FG000|Extension Study - (Period III)|Adverse Event|0|||
19793255|NCT00968201|42251221|FG001|Extension Study - (Period III)|Adverse Event|5|||
19793256|NCT00968201|42251222|FG002|Extension Study - (Period III)|Adverse Event|22|||
19793257|NCT00968201|42251220|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
19793258|NCT00968201|42251221|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
19793259|NCT00968201|42251222|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
19793260|NCT00968201|42251220|FG000|Extension Study - (Period III)|Protocol Violation|0|||
19793261|NCT00968201|42251221|FG001|Extension Study - (Period III)|Protocol Violation|17|||
19793262|NCT00968201|42251222|FG002|Extension Study - (Period III)|Protocol Violation|14|||
19793263|NCT00968201|42251220|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
19793264|NCT00968201|42251221|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
19793265|NCT00968201|42251222|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
19793266|NCT00968201|42251220|FG000|Extension Study - (Period III)|Patient Relocated|0|||
19793267|NCT00968201|42251221|FG001|Extension Study - (Period III)|Patient Relocated|1|||
19793268|NCT00968201|42251222|FG002|Extension Study - (Period III)|Patient Relocated|1|||
19793269|NCT00968201|42251220|FG000|Extension Study - (Period III)|Noncompliance|0|||
19793270|NCT00968201|42251221|FG001|Extension Study - (Period III)|Noncompliance|0|||
19793271|NCT00968201|42251222|FG002|Extension Study - (Period III)|Noncompliance|3|||
19793272|NCT00968201|42251220|FG000|Extension Study - (Period III)|Other|0|||
19793273|NCT00968201|42251221|FG001|Extension Study - (Period III)|Other|0|||
19793274|NCT00968201|42251222|FG002|Extension Study - (Period III)|Other|2|||
19793275|NCT00968201|42251220|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
19793276|NCT00968201|42251221|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
19793277|NCT00968201|42251222|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
19793278|NCT00943397|42251233|FG000|Overall Study|Adverse Event|0|||
19793279|NCT00943397|42251234|FG001|Overall Study|Adverse Event|6|||
19793280|NCT00943397|42251233|FG000|Overall Study|Lost to Follow-up|0|||
19793281|NCT00943397|42251234|FG001|Overall Study|Lost to Follow-up|4|||
19793282|NCT00943397|42251233|FG000|Overall Study|Protocol Violation|2|||
19793283|NCT00943397|42251234|FG001|Overall Study|Protocol Violation|5|||
19793284|NCT00943397|42251233|FG000|Overall Study|Withdrawal by Subject|1|||
19793285|NCT00943397|42251234|FG001|Overall Study|Withdrawal by Subject|1|||
19793286|NCT00943397|42251233|FG000|Overall Study|Site terminated and other|12|||
19793287|NCT00943397|42251234|FG001|Overall Study|Site terminated and other|56|||
19793288|NCT00702845|42251242|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
19793289|NCT00702845|42251243|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
19793290|NCT00702845|42251242|FG000|Overall Study|Too high ovarian response|5|||
19793291|NCT00702845|42251243|FG001|Overall Study|Too high ovarian response|1|||
19793292|NCT00702845|42251242|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
19793293|NCT00702845|42251243|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
19793294|NCT00702845|42251242|FG000|Overall Study|Insufficient ovarian response|1|||
19793295|NCT00702845|42251243|FG001|Overall Study|Insufficient ovarian response|0|||
19793296|NCT00702845|42251242|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
19793297|NCT00702845|42251243|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
19793298|NCT00702845|42251242|FG000|Overall Study|No or abnormal fertilization|4|||
19793299|NCT00702845|42251243|FG001|Overall Study|No or abnormal fertilization|2|||
19793300|NCT00702845|42251242|FG000|Overall Study|Patient's decision|2|||
19793301|NCT00702845|42251243|FG001|Overall Study|Patient's decision|1|||
19793302|NCT00702845|42251242|FG000|Overall Study|Not randomized|0|||
19793303|NCT00702845|42251243|FG001|Overall Study|Not randomized|1|||
19793304|NCT01302847|42251257|FG000|Overall Study|Ongoing|0|||
19793305|NCT01302847|42251258|FG001|Overall Study|Ongoing|0|||
19793306|NCT01302847|42251259|FG002|Overall Study|Ongoing|0|||
19793307|NCT01302847|42251260|FG003|Overall Study|Ongoing|0|||
19793308|NCT01302847|42251261|FG004|Overall Study|Ongoing|0|||
19793309|NCT01302847|42251262|FG005|Overall Study|Ongoing|27|||
19793310|NCT01302847|42251263|FG006|Overall Study|Ongoing|22|||
19793311|NCT01302847|42251264|FG007|Overall Study|Ongoing|17|||
19793312|NCT01302847|42251257|FG000|Overall Study|Death|0|||
19793313|NCT01302847|42251258|FG001|Overall Study|Death|1|||
19793314|NCT01302847|42251259|FG002|Overall Study|Death|0|||
19793315|NCT01302847|42251260|FG003|Overall Study|Death|0|||
19793316|NCT01302847|42251261|FG004|Overall Study|Death|0|||
19793317|NCT01302847|42251262|FG005|Overall Study|Death|1|||
19793318|NCT01302847|42251263|FG006|Overall Study|Death|1|||
19793319|NCT01302847|42251264|FG007|Overall Study|Death|0|||
19793320|NCT01302847|42251257|FG000|Overall Study|Pregnancy|2|||
19793321|NCT01302847|42251258|FG001|Overall Study|Pregnancy|0|||
19793322|NCT01302847|42251259|FG002|Overall Study|Pregnancy|0|||
19793323|NCT01302847|42251260|FG003|Overall Study|Pregnancy|0|||
19793324|NCT01302847|42251261|FG004|Overall Study|Pregnancy|0|||
19793325|NCT01302847|42251262|FG005|Overall Study|Pregnancy|0|||
19793326|NCT01302847|42251263|FG006|Overall Study|Pregnancy|0|||
19793327|NCT01302847|42251264|FG007|Overall Study|Pregnancy|0|||
19793328|NCT01302847|42251257|FG000|Overall Study|Virologic failure|0|||
19793329|NCT01302847|42251258|FG001|Overall Study|Virologic failure|2|||
19793330|NCT01302847|42251259|FG002|Overall Study|Virologic failure|2|||
19793331|NCT01302847|42251260|FG003|Overall Study|Virologic failure|0|||
19793332|NCT01302847|42251261|FG004|Overall Study|Virologic failure|1|||
19793333|NCT01302847|42251262|FG005|Overall Study|Virologic failure|1|||
19793334|NCT01302847|42251263|FG006|Overall Study|Virologic failure|0|||
19793335|NCT01302847|42251264|FG007|Overall Study|Virologic failure|2|||
19793336|NCT01302847|42251257|FG000|Overall Study|Severe debilitation, unable to continue|0|||
19793337|NCT01302847|42251258|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19793338|NCT01302847|42251259|FG002|Overall Study|Severe debilitation, unable to continue|0|||
19793339|NCT01302847|42251260|FG003|Overall Study|Severe debilitation, unable to continue|0|||
19793340|NCT01302847|42251261|FG004|Overall Study|Severe debilitation, unable to continue|0|||
19793341|NCT01302847|42251262|FG005|Overall Study|Severe debilitation, unable to continue|1|||
19793342|NCT01302847|42251263|FG006|Overall Study|Severe debilitation, unable to continue|1|||
19793343|NCT01302847|42251264|FG007|Overall Study|Severe debilitation, unable to continue|0|||
19793344|NCT01302847|42251257|FG000|Overall Study|Not able to get to clinic|1|||
19793345|NCT01302847|42251258|FG001|Overall Study|Not able to get to clinic|1|||
19607781|NCT00666835|42056612|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
19607782|NCT00666835|42056611|FG000|Overall Study|Hemoglobulin concentration|4|||
19793346|NCT01302847|42251259|FG002|Overall Study|Not able to get to clinic|0|||
19793347|NCT01302847|42251260|FG003|Overall Study|Not able to get to clinic|0|||
19793348|NCT01302847|42251261|FG004|Overall Study|Not able to get to clinic|0|||
19793349|NCT01302847|42251262|FG005|Overall Study|Not able to get to clinic|0|||
19793350|NCT01302847|42251263|FG006|Overall Study|Not able to get to clinic|0|||
19793351|NCT01302847|42251264|FG007|Overall Study|Not able to get to clinic|0|||
19793352|NCT01302847|42251257|FG000|Overall Study|Site closing|2|||
19793353|NCT01302847|42251258|FG001|Overall Study|Site closing|2|||
19793354|NCT01302847|42251259|FG002|Overall Study|Site closing|0|||
19793355|NCT01302847|42251260|FG003|Overall Study|Site closing|0|||
19793356|NCT01302847|42251261|FG004|Overall Study|Site closing|0|||
19793357|NCT01302847|42251262|FG005|Overall Study|Site closing|0|||
19793358|NCT01302847|42251263|FG006|Overall Study|Site closing|0|||
19793359|NCT01302847|42251264|FG007|Overall Study|Site closing|0|||
19793360|NCT01302847|42251257|FG000|Overall Study|Withdrawal by Subject|1|||
19793361|NCT01302847|42251258|FG001|Overall Study|Withdrawal by Subject|0|||
19793362|NCT01302847|42251259|FG002|Overall Study|Withdrawal by Subject|0|||
19793363|NCT01302847|42251260|FG003|Overall Study|Withdrawal by Subject|0|||
19793364|NCT01302847|42251261|FG004|Overall Study|Withdrawal by Subject|1|||
19793365|NCT01302847|42251262|FG005|Overall Study|Withdrawal by Subject|0|||
19793366|NCT01302847|42251263|FG006|Overall Study|Withdrawal by Subject|0|||
19793367|NCT01302847|42251264|FG007|Overall Study|Withdrawal by Subject|1|||
19793368|NCT01302847|42251257|FG000|Overall Study|Not willing to adhere to requirements|5|||
19793369|NCT01302847|42251258|FG001|Overall Study|Not willing to adhere to requirements|0|||
19793370|NCT01302847|42251259|FG002|Overall Study|Not willing to adhere to requirements|0|||
19793371|NCT01302847|42251260|FG003|Overall Study|Not willing to adhere to requirements|1|||
19793372|NCT01302847|42251261|FG004|Overall Study|Not willing to adhere to requirements|0|||
19793373|NCT01302847|42251262|FG005|Overall Study|Not willing to adhere to requirements|0|||
19793374|NCT01302847|42251263|FG006|Overall Study|Not willing to adhere to requirements|0|||
19793375|NCT01302847|42251264|FG007|Overall Study|Not willing to adhere to requirements|2|||
19793376|NCT01302847|42251257|FG000|Overall Study|Site unable to contact participant|2|||
19793377|NCT01302847|42251258|FG001|Overall Study|Site unable to contact participant|1|||
19793378|NCT01302847|42251259|FG002|Overall Study|Site unable to contact participant|0|||
19793379|NCT01302847|42251260|FG003|Overall Study|Site unable to contact participant|0|||
19793380|NCT01302847|42251261|FG004|Overall Study|Site unable to contact participant|0|||
19793381|NCT01302847|42251262|FG005|Overall Study|Site unable to contact participant|0|||
19793382|NCT01302847|42251263|FG006|Overall Study|Site unable to contact participant|2|||
19793383|NCT01302847|42251264|FG007|Overall Study|Site unable to contact participant|0|||
19793384|NCT03039569|42251293|FG000|Overall Study|Lost to Follow-up|5|||
19793385|NCT03039569|42251294|FG001|Overall Study|Lost to Follow-up|4|||
19793386|NCT02738775|42251307|FG000|Overall Study|Withdrawal by Subject|0|||
19793387|NCT02738775|42251308|FG001|Overall Study|Withdrawal by Subject|1|||
19793388|NCT02738775|42251309|FG002|Overall Study|Withdrawal by Subject|0|||
19793389|NCT02738775|42251310|FG003|Overall Study|Withdrawal by Subject|0|||
19793390|NCT02738775|42251311|FG004|Overall Study|Withdrawal by Subject|0|||
19793391|NCT02738775|42251312|FG005|Overall Study|Withdrawal by Subject|0|||
19793392|NCT02738775|42251307|FG000|Overall Study|Adverse Event|0|||
19607783|NCT00666835|42056612|FG001|Overall Study|Hemoglobulin concentration|3|||
19793393|NCT02738775|42251308|FG001|Overall Study|Adverse Event|0|||
19793394|NCT02738775|42251309|FG002|Overall Study|Adverse Event|0|||
19793395|NCT02738775|42251310|FG003|Overall Study|Adverse Event|1|||
19793396|NCT02738775|42251311|FG004|Overall Study|Adverse Event|0|||
19793397|NCT02738775|42251312|FG005|Overall Study|Adverse Event|0|||
19793398|NCT02738775|42251307|FG000|Overall Study|Pregnancy|0|||
19793399|NCT02738775|42251308|FG001|Overall Study|Pregnancy|1|||
19793400|NCT02738775|42251309|FG002|Overall Study|Pregnancy|0|||
19793401|NCT02738775|42251310|FG003|Overall Study|Pregnancy|0|||
19793402|NCT02738775|42251311|FG004|Overall Study|Pregnancy|0|||
19793403|NCT02738775|42251312|FG005|Overall Study|Pregnancy|0|||
19793404|NCT02738775|42251307|FG000|Overall Study|Missing|0|||
19793405|NCT02738775|42251308|FG001|Overall Study|Missing|0|||
19793406|NCT02738775|42251309|FG002|Overall Study|Missing|0|||
19793407|NCT02738775|42251310|FG003|Overall Study|Missing|0|||
19793408|NCT02738775|42251311|FG004|Overall Study|Missing|0|||
19793409|NCT02738775|42251312|FG005|Overall Study|Missing|1|||
19793410|NCT02314923|42251349|FG000|Overall Study|Death|0|||
19793411|NCT02314923|42251350|FG001|Overall Study|Death|0|||
19793412|NCT02314923|42251351|FG002|Overall Study|Death|0|||
19793413|NCT02314923|42251352|FG003|Overall Study|Death|1|||
19793414|NCT02314923|42251353|FG004|Overall Study|Death|0|||
19793415|NCT02314923|42251354|FG005|Overall Study|Death|0|||
19793416|NCT02314923|42251355|FG006|Overall Study|Death|0|||
19793417|NCT02314923|42251356|FG007|Overall Study|Death|0|||
19793418|NCT02314923|42251357|FG008|Overall Study|Death|0|||
19793419|NCT02314923|42251358|FG009|Overall Study|Death|0|||
19793420|NCT02314923|42251349|FG000|Overall Study|Lost to Follow-up|2|||
19793421|NCT02314923|42251350|FG001|Overall Study|Lost to Follow-up|3|||
19793422|NCT02314923|42251351|FG002|Overall Study|Lost to Follow-up|1|||
19793423|NCT02314923|42251352|FG003|Overall Study|Lost to Follow-up|0|||
19793424|NCT02314923|42251353|FG004|Overall Study|Lost to Follow-up|0|||
19793425|NCT02314923|42251354|FG005|Overall Study|Lost to Follow-up|0|||
19793426|NCT02314923|42251355|FG006|Overall Study|Lost to Follow-up|3|||
19793427|NCT02314923|42251356|FG007|Overall Study|Lost to Follow-up|4|||
19793428|NCT02314923|42251357|FG008|Overall Study|Lost to Follow-up|2|||
19793429|NCT02314923|42251358|FG009|Overall Study|Lost to Follow-up|0|||
19793430|NCT02314923|42251349|FG000|Overall Study|Withdrawal by Subject|0|||
19793431|NCT02314923|42251350|FG001|Overall Study|Withdrawal by Subject|0|||
19793432|NCT02314923|42251351|FG002|Overall Study|Withdrawal by Subject|1|||
19793433|NCT02314923|42251352|FG003|Overall Study|Withdrawal by Subject|0|||
19793434|NCT02314923|42251353|FG004|Overall Study|Withdrawal by Subject|1|||
19793435|NCT02314923|42251354|FG005|Overall Study|Withdrawal by Subject|0|||
19793436|NCT02314923|42251355|FG006|Overall Study|Withdrawal by Subject|1|||
19793437|NCT02314923|42251356|FG007|Overall Study|Withdrawal by Subject|0|||
19793438|NCT02314923|42251357|FG008|Overall Study|Withdrawal by Subject|0|||
19793439|NCT02314923|42251358|FG009|Overall Study|Withdrawal by Subject|0|||
19793440|NCT02314923|42251349|FG000|Overall Study|Physician Decision|0|||
19793441|NCT02314923|42251350|FG001|Overall Study|Physician Decision|1|||
19793442|NCT02314923|42251351|FG002|Overall Study|Physician Decision|0|||
19793443|NCT02314923|42251352|FG003|Overall Study|Physician Decision|0|||
19793444|NCT02314923|42251353|FG004|Overall Study|Physician Decision|0|||
19793445|NCT02314923|42251354|FG005|Overall Study|Physician Decision|0|||
19793446|NCT02314923|42251355|FG006|Overall Study|Physician Decision|0|||
19793447|NCT02314923|42251356|FG007|Overall Study|Physician Decision|0|||
19793448|NCT02314923|42251357|FG008|Overall Study|Physician Decision|0|||
19793449|NCT02314923|42251358|FG009|Overall Study|Physician Decision|0|||
19793450|NCT02314923|42251349|FG000|Overall Study|Participant unavailable|0|||
19793451|NCT02314923|42251350|FG001|Overall Study|Participant unavailable|0|||
19793452|NCT02314923|42251351|FG002|Overall Study|Participant unavailable|0|||
19793453|NCT02314923|42251352|FG003|Overall Study|Participant unavailable|0|||
19793454|NCT02314923|42251353|FG004|Overall Study|Participant unavailable|0|||
19793455|NCT02314923|42251354|FG005|Overall Study|Participant unavailable|1|||
19793456|NCT02314923|42251355|FG006|Overall Study|Participant unavailable|0|||
19793457|NCT02314923|42251356|FG007|Overall Study|Participant unavailable|0|||
19793458|NCT02314923|42251357|FG008|Overall Study|Participant unavailable|0|||
19793459|NCT02314923|42251358|FG009|Overall Study|Participant unavailable|0|||
19793460|NCT02314923|42251349|FG000|Overall Study|Screen failure|0|||
19793461|NCT02314923|42251350|FG001|Overall Study|Screen failure|0|||
19793462|NCT02314923|42251351|FG002|Overall Study|Screen failure|0|||
19793463|NCT02314923|42251352|FG003|Overall Study|Screen failure|0|||
19793464|NCT02314923|42251353|FG004|Overall Study|Screen failure|0|||
19793465|NCT02314923|42251354|FG005|Overall Study|Screen failure|0|||
19793466|NCT02314923|42251355|FG006|Overall Study|Screen failure|1|||
19793467|NCT02314923|42251356|FG007|Overall Study|Screen failure|0|||
19793468|NCT02314923|42251357|FG008|Overall Study|Screen failure|0|||
19793469|NCT02314923|42251358|FG009|Overall Study|Screen failure|0|||
19793470|NCT02314923|42251349|FG000|Overall Study|Participant relocation|1|||
19793471|NCT02314923|42251350|FG001|Overall Study|Participant relocation|0|||
19793472|NCT02314923|42251351|FG002|Overall Study|Participant relocation|0|||
19793473|NCT02314923|42251352|FG003|Overall Study|Participant relocation|0|||
19793474|NCT02314923|42251353|FG004|Overall Study|Participant relocation|0|||
19607784|NCT00666835|42056611|FG000|Overall Study|Planned operation|2|||
19607785|NCT00666835|42056612|FG001|Overall Study|Planned operation|0|||
19698124|NCT03839693|42143464|FG000|Overall Study|Lost to Follow-up|0|||
19698125|NCT03839693|42143465|FG001|Overall Study|Lost to Follow-up|2|||
19698126|NCT03839693|42143466|FG002|Overall Study|Lost to Follow-up|2|||
19698127|NCT03839693|42143464|FG000|Overall Study|Withdrawal by Subject|1|||
19698128|NCT03839693|42143465|FG001|Overall Study|Withdrawal by Subject|0|||
19698129|NCT03839693|42143466|FG002|Overall Study|Withdrawal by Subject|2|||
19698130|NCT03839693|42143464|FG000|Overall Study|subject moved out of the area|1|||
19698131|NCT03839693|42143465|FG001|Overall Study|subject moved out of the area|0|||
19698132|NCT03839693|42143466|FG002|Overall Study|subject moved out of the area|0|||
19698133|NCT00068692|42143479|FG000|Step 1: Registration|Disese progression/relapse|5|||
19607786|NCT00666835|42056611|FG000|Overall Study|Physician Decision|1|||
19607787|NCT00666835|42056612|FG001|Overall Study|Physician Decision|2|||
19607788|NCT00879411|42056619|FG000|Overall Study|lost to follow-up (non-AE)|162|||
19607789|NCT01000493|42056625|FG000|Overall Study|Adverse Event|3|||
19607790|NCT01000493|42056626|FG001|Overall Study|Adverse Event|6|||
19607791|NCT01000493|42056625|FG000|Overall Study|Lack of Efficacy|1|||
19607792|NCT01000493|42056626|FG001|Overall Study|Lack of Efficacy|1|||
19607793|NCT01000493|42056625|FG000|Overall Study|Protocol Violation|1|||
19607794|NCT01000493|42056626|FG001|Overall Study|Protocol Violation|8|||
19698134|NCT00068692|42143480|FG001|Step 1: Registration|Disese progression/relapse|0|||
19698135|NCT00068692|42143481|FG002|Step 1: Registration|Disese progression/relapse|0|||
19698136|NCT00068692|42143482|FG003|Step 1: Registration|Disese progression/relapse|0|||
19698137|NCT00068692|42143483|FG004|Step 1: Registration|Disese progression/relapse|0|||
19607795|NCT01000493|42056625|FG000|Overall Study|Study closed/terminated|25|||
19698138|NCT00068692|42143484|FG005|Step 1: Registration|Disese progression/relapse|0|||
19698139|NCT00068692|42143485|FG006|Step 1: Registration|Disese progression/relapse|0|||
19607796|NCT01000493|42056626|FG001|Overall Study|Study closed/terminated|23|||
19607797|NCT01000493|42056625|FG000|Overall Study|Lost to Follow-up|5|||
19607798|NCT01000493|42056626|FG001|Overall Study|Lost to Follow-up|9|||
19607799|NCT01000493|42056625|FG000|Overall Study|Physician Decision|1|||
19607800|NCT01000493|42056626|FG001|Overall Study|Physician Decision|1|||
19607801|NCT01000493|42056625|FG000|Overall Study|Withdrawal by Subject|3|||
19607802|NCT01000493|42056626|FG001|Overall Study|Withdrawal by Subject|7|||
19607803|NCT00666757|42056634|FG000|Overall Study|Lost to Follow-up|39|||
19698140|NCT00068692|42143486|FG007|Step 1: Registration|Disese progression/relapse|0|||
19698141|NCT00068692|42143479|FG000|Step 1: Registration|Adverse Event|7|||
19698142|NCT00068692|42143480|FG001|Step 1: Registration|Adverse Event|0|||
19698143|NCT00068692|42143481|FG002|Step 1: Registration|Adverse Event|0|||
19698144|NCT00068692|42143482|FG003|Step 1: Registration|Adverse Event|0|||
19698145|NCT00068692|42143483|FG004|Step 1: Registration|Adverse Event|0|||
19698146|NCT00068692|42143484|FG005|Step 1: Registration|Adverse Event|0|||
19698147|NCT00068692|42143485|FG006|Step 1: Registration|Adverse Event|0|||
19698148|NCT00068692|42143486|FG007|Step 1: Registration|Adverse Event|0|||
19698149|NCT00068692|42143479|FG000|Step 1: Registration|Death|1|||
19698150|NCT00068692|42143480|FG001|Step 1: Registration|Death|0|||
19607804|NCT00666757|42056635|FG001|Overall Study|Lost to Follow-up|35|||
19607805|NCT00666757|42056634|FG000|Overall Study|Protocol Violation|23|||
19607806|NCT00666757|42056635|FG001|Overall Study|Protocol Violation|24|||
19607807|NCT00666757|42056634|FG000|Overall Study|Adverse Event|22|||
19607808|NCT00666757|42056635|FG001|Overall Study|Adverse Event|12|||
19607809|NCT00666757|42056634|FG000|Overall Study|Withdrawal by Subject|13|||
19698151|NCT00068692|42143481|FG002|Step 1: Registration|Death|0|||
19698152|NCT00068692|42143482|FG003|Step 1: Registration|Death|0|||
19698153|NCT00068692|42143483|FG004|Step 1: Registration|Death|0|||
19698154|NCT00068692|42143484|FG005|Step 1: Registration|Death|0|||
19698155|NCT00068692|42143485|FG006|Step 1: Registration|Death|0|||
19698156|NCT00068692|42143486|FG007|Step 1: Registration|Death|0|||
19698157|NCT00068692|42143479|FG000|Step 1: Registration|Withdrawal by Subject|11|||
19698158|NCT00068692|42143480|FG001|Step 1: Registration|Withdrawal by Subject|0|||
19698159|NCT00068692|42143481|FG002|Step 1: Registration|Withdrawal by Subject|0|||
19698160|NCT00068692|42143482|FG003|Step 1: Registration|Withdrawal by Subject|0|||
19698161|NCT00068692|42143483|FG004|Step 1: Registration|Withdrawal by Subject|0|||
19698162|NCT00068692|42143484|FG005|Step 1: Registration|Withdrawal by Subject|0|||
19698163|NCT00068692|42143485|FG006|Step 1: Registration|Withdrawal by Subject|0|||
19698164|NCT00068692|42143486|FG007|Step 1: Registration|Withdrawal by Subject|0|||
19698165|NCT00068692|42143479|FG000|Step 1: Registration|Alternative therapy|2|||
19698166|NCT00068692|42143480|FG001|Step 1: Registration|Alternative therapy|0|||
19698167|NCT00068692|42143481|FG002|Step 1: Registration|Alternative therapy|0|||
19793475|NCT02314923|42251354|FG005|Overall Study|Participant relocation|0|||
19607810|NCT00666757|42056635|FG001|Overall Study|Withdrawal by Subject|17|||
19607811|NCT00666757|42056634|FG000|Overall Study|Lack of Efficacy|3|||
19607812|NCT00666757|42056635|FG001|Overall Study|Lack of Efficacy|6|||
19607813|NCT00666757|42056634|FG000|Overall Study|Physician Decision|0|||
19793476|NCT02314923|42251355|FG006|Overall Study|Participant relocation|0|||
19793477|NCT02314923|42251356|FG007|Overall Study|Participant relocation|1|||
19793478|NCT02314923|42251357|FG008|Overall Study|Participant relocation|0|||
19793479|NCT02314923|42251358|FG009|Overall Study|Participant relocation|0|||
19793480|NCT03023137|42251383|FG000|Overall Study|Multiple pregnancy|2|||
19793481|NCT03023137|42251384|FG001|Overall Study|Multiple pregnancy|4|||
19793482|NCT03023137|42251383|FG000|Overall Study|Lost to Follow-up|1|||
19793483|NCT03023137|42251384|FG001|Overall Study|Lost to Follow-up|1|||
19793484|NCT03023137|42251383|FG000|Overall Study|Protocol Violation|0|||
19793485|NCT03023137|42251384|FG001|Overall Study|Protocol Violation|4|||
19793486|NCT03023137|42251383|FG000|Overall Study|Lost the baby in a car accident|1|||
19793487|NCT03023137|42251384|FG001|Overall Study|Lost the baby in a car accident|0|||
19793488|NCT03049813|42251395|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
19793489|NCT03049813|42251396|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
19793490|NCT03049813|42251397|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
19793491|NCT03049813|42251398|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
19793492|NCT03049813|42251395|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
19793493|NCT03049813|42251396|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
19793494|NCT03049813|42251397|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
19793495|NCT03049813|42251398|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
19793496|NCT03049813|42251395|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
19793497|NCT03049813|42251396|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
19793498|NCT03049813|42251397|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
19793499|NCT03049813|42251398|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
19793500|NCT03049813|42251395|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
19793501|NCT03049813|42251396|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
19793502|NCT03049813|42251397|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
19793503|NCT03049813|42251398|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
19793504|NCT03022981|42251409|FG000|Overall Study|Adverse Event|0|||
19793505|NCT03022981|42251410|FG001|Overall Study|Adverse Event|1|||
19793506|NCT03022981|42251411|FG002|Overall Study|Adverse Event|0|||
19793507|NCT03022981|42251409|FG000|Overall Study|Investigator's Discretion|0|||
19793508|NCT03022981|42251410|FG001|Overall Study|Investigator's Discretion|1|||
19793509|NCT03022981|42251411|FG002|Overall Study|Investigator's Discretion|2|||
19793510|NCT03022981|42251409|FG000|Overall Study|Lost to Follow-up|6|||
19793511|NCT03022981|42251410|FG001|Overall Study|Lost to Follow-up|2|||
19793512|NCT03022981|42251411|FG002|Overall Study|Lost to Follow-up|1|||
19793513|NCT03022981|42251409|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19793514|NCT03022981|42251410|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19793515|NCT03022981|42251411|FG002|Overall Study|Non-Compliance With Study Drug|2|||
19793516|NCT03022981|42251409|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
19793517|NCT03022981|42251410|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
19793518|NCT03022981|42251411|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
19793519|NCT03377699|42251431|FG000|Overall Study|Withdrawal by Subject|2|||
19793520|NCT03377699|42251432|FG001|Overall Study|Withdrawal by Subject|9|||
19793521|NCT03377699|42251431|FG000|Overall Study|Lost to Follow-up|1|||
19793522|NCT03377699|42251432|FG001|Overall Study|Lost to Follow-up|1|||
19793523|NCT03377699|42251431|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
19793524|NCT03377699|42251432|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
19793525|NCT03377699|42251431|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
19793526|NCT03377699|42251432|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
19793527|NCT03377699|42251431|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
19793528|NCT03377699|42251432|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
19793529|NCT03377699|42251431|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
19793530|NCT03377699|42251432|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
19793531|NCT01314443|42251444|FG000|Overall Study|Withdrawal by Subject|2|||
19793532|NCT01314443|42251445|FG001|Overall Study|Withdrawal by Subject|1|||
19793533|NCT01314443|42251446|FG002|Overall Study|Withdrawal by Subject|1|||
19793534|NCT01314443|42251447|FG003|Overall Study|Withdrawal by Subject|1|||
19793535|NCT01314443|42251444|FG000|Overall Study|Protocol Violation|2|||
19793536|NCT01314443|42251445|FG001|Overall Study|Protocol Violation|2|||
19793537|NCT01314443|42251446|FG002|Overall Study|Protocol Violation|1|||
19793538|NCT01314443|42251447|FG003|Overall Study|Protocol Violation|1|||
19793539|NCT02923921|42251459|FG000|Overall Study|Sponsor Decision|39|||
19793540|NCT02923921|42251460|FG001|Overall Study|Sponsor Decision|38|||
19793541|NCT02923921|42251459|FG000|Overall Study|Lost to Follow-up|1|||
19793542|NCT02923921|42251460|FG001|Overall Study|Lost to Follow-up|0|||
19793543|NCT02923921|42251459|FG000|Overall Study|Withdrawal by Subject|6|||
19793544|NCT02923921|42251460|FG001|Overall Study|Withdrawal by Subject|13|||
19793545|NCT02923921|42251459|FG000|Overall Study|Unknown, Not Collected|7|||
19793546|NCT02923921|42251460|FG001|Overall Study|Unknown, Not Collected|6|||
19793547|NCT03039023|42251471|FG000|Overall Study|Withdrawal by Subject|1|||
19793548|NCT03039023|42251472|FG001|Overall Study|Withdrawal by Subject|0|||
19793549|NCT03039023|42251473|FG002|Overall Study|Withdrawal by Subject|1|||
19793550|NCT03039023|42251474|FG003|Overall Study|Withdrawal by Subject|1|||
19793551|NCT03039023|42251475|FG004|Overall Study|Withdrawal by Subject|0|||
19793552|NCT03039023|42251471|FG000|Overall Study|Physician Decision|0|||
19793553|NCT03039023|42251472|FG001|Overall Study|Physician Decision|0|||
19793554|NCT03039023|42251473|FG002|Overall Study|Physician Decision|0|||
19793555|NCT03039023|42251474|FG003|Overall Study|Physician Decision|1|||
19793556|NCT03039023|42251475|FG004|Overall Study|Physician Decision|0|||
19793557|NCT03022045|42251489|FG000|Overall Study|Adverse Event|0|||
19793558|NCT03022045|42251490|FG001|Overall Study|Adverse Event|1|||
19793559|NCT03022045|42251489|FG000|Overall Study|Withdrawal by Subject|1|||
19793560|NCT03022045|42251490|FG001|Overall Study|Withdrawal by Subject|1|||
19793561|NCT03037619|42251502|FG000|Overall Study|Lost to Follow-up|0|||
19793562|NCT03037619|42251503|FG001|Overall Study|Lost to Follow-up|1|||
19793563|NCT04771013|42251511|FG000|Overall Study|Withdrawal by Subject|2|||
19793564|NCT04771013|42251512|FG001|Overall Study|Withdrawal by Subject|0|||
19793565|NCT04771013|42251511|FG000|Overall Study|Death|0|||
19793566|NCT04771013|42251512|FG001|Overall Study|Death|5|||
19793567|NCT04771013|42251511|FG000|Overall Study|Referred to another hospital before day 20|0|||
19793568|NCT04771013|42251512|FG001|Overall Study|Referred to another hospital before day 20|1|||
19793569|NCT03021265|42251518|FG000|Overall Study|Adverse Event|29|||
19793570|NCT03021265|42251518|FG000|Overall Study|Lack of Efficacy|3|||
19793571|NCT03021265|42251518|FG000|Overall Study|Improved|17|||
19793572|NCT03021265|42251518|FG000|Overall Study|Lost to Follow-up|67|||
19793573|NCT03021265|42251518|FG000|Overall Study|No reason given|2|||
19793574|NCT03021265|42251518|FG000|Overall Study|No visit since the first visit|4|||
19793575|NCT04611789|42251525|FG000|Overall Study|Lost to Follow-up|1|||
19793576|NCT04611789|42251526|FG001|Overall Study|Lost to Follow-up|0|||
19793577|NCT04611789|42251527|FG002|Overall Study|Lost to Follow-up|0|||
19793578|NCT03561597|42251543|FG000|Overall Study|Lost to Follow-up|20|||
19793579|NCT03034967|42251566|FG000|Overall Study|Withdrawal by Subject|9|||
19793580|NCT03034967|42251567|FG001|Overall Study|Withdrawal by Subject|2|||
19793581|NCT03034967|42251568|FG002|Overall Study|Withdrawal by Subject|6|||
19793582|NCT03034967|42251569|FG003|Overall Study|Withdrawal by Subject|6|||
19793583|NCT03034967|42251570|FG004|Overall Study|Withdrawal by Subject|9|||
19793584|NCT03034967|42251571|FG005|Overall Study|Withdrawal by Subject|2|||
19793585|NCT03034967|42251566|FG000|Overall Study|Physician Decision|1|||
19793586|NCT03034967|42251567|FG001|Overall Study|Physician Decision|0|||
19793587|NCT03034967|42251568|FG002|Overall Study|Physician Decision|1|||
19793588|NCT03034967|42251569|FG003|Overall Study|Physician Decision|1|||
19793589|NCT03034967|42251570|FG004|Overall Study|Physician Decision|1|||
19793590|NCT03034967|42251571|FG005|Overall Study|Physician Decision|0|||
19793591|NCT03034967|42251566|FG000|Overall Study|Lost to Follow-up|0|||
19793592|NCT03034967|42251567|FG001|Overall Study|Lost to Follow-up|0|||
19793593|NCT03034967|42251568|FG002|Overall Study|Lost to Follow-up|0|||
19793594|NCT03034967|42251569|FG003|Overall Study|Lost to Follow-up|1|||
19793595|NCT03034967|42251570|FG004|Overall Study|Lost to Follow-up|0|||
19793596|NCT03034967|42251571|FG005|Overall Study|Lost to Follow-up|2|||
19698168|NCT00068692|42143482|FG003|Step 1: Registration|Alternative therapy|0|||
19698169|NCT00068692|42143483|FG004|Step 1: Registration|Alternative therapy|0|||
19698170|NCT00068692|42143484|FG005|Step 1: Registration|Alternative therapy|0|||
19698171|NCT00068692|42143485|FG006|Step 1: Registration|Alternative therapy|0|||
19698172|NCT00068692|42143486|FG007|Step 1: Registration|Alternative therapy|0|||
19698173|NCT00068692|42143479|FG000|Step 1: Registration|Complicating disease|2|||
19698174|NCT00068692|42143480|FG001|Step 1: Registration|Complicating disease|0|||
19698175|NCT00068692|42143481|FG002|Step 1: Registration|Complicating disease|0|||
19698176|NCT00068692|42143482|FG003|Step 1: Registration|Complicating disease|0|||
19698177|NCT00068692|42143483|FG004|Step 1: Registration|Complicating disease|0|||
19698178|NCT00068692|42143484|FG005|Step 1: Registration|Complicating disease|0|||
19793597|NCT03034967|42251566|FG000|Overall Study|Liver function test abnormality|0|||
19793598|NCT03034967|42251567|FG001|Overall Study|Liver function test abnormality|0|||
19793599|NCT03034967|42251568|FG002|Overall Study|Liver function test abnormality|1|||
19793600|NCT03034967|42251569|FG003|Overall Study|Liver function test abnormality|0|||
19793601|NCT03034967|42251570|FG004|Overall Study|Liver function test abnormality|0|||
19793602|NCT03034967|42251571|FG005|Overall Study|Liver function test abnormality|0|||
19793603|NCT03034967|42251566|FG000|Overall Study|Protocol Violation|1|||
19793604|NCT03034967|42251567|FG001|Overall Study|Protocol Violation|0|||
19793605|NCT03034967|42251568|FG002|Overall Study|Protocol Violation|0|||
19793606|NCT03034967|42251569|FG003|Overall Study|Protocol Violation|0|||
19793607|NCT03034967|42251570|FG004|Overall Study|Protocol Violation|0|||
19793608|NCT03034967|42251571|FG005|Overall Study|Protocol Violation|2|||
19793609|NCT03034967|42251566|FG000|Overall Study|Lack of Efficacy|0|||
19793610|NCT03034967|42251567|FG001|Overall Study|Lack of Efficacy|1|||
19793611|NCT03034967|42251568|FG002|Overall Study|Lack of Efficacy|2|||
19793612|NCT03034967|42251569|FG003|Overall Study|Lack of Efficacy|1|||
19793613|NCT03034967|42251570|FG004|Overall Study|Lack of Efficacy|1|||
19793614|NCT03034967|42251571|FG005|Overall Study|Lack of Efficacy|0|||
19793615|NCT03034967|42251566|FG000|Overall Study|Adverse Event, non-fatal|3|||
19793616|NCT03034967|42251567|FG001|Overall Study|Adverse Event, non-fatal|1|||
19793617|NCT03034967|42251568|FG002|Overall Study|Adverse Event, non-fatal|2|||
19793618|NCT03034967|42251569|FG003|Overall Study|Adverse Event, non-fatal|0|||
19793619|NCT03034967|42251570|FG004|Overall Study|Adverse Event, non-fatal|2|||
19793620|NCT03034967|42251571|FG005|Overall Study|Adverse Event, non-fatal|8|||
19793621|NCT03034967|42251566|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
19793622|NCT03034967|42251567|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
19793623|NCT03034967|42251568|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
19793624|NCT03034967|42251569|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
19793625|NCT03034967|42251570|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
19793626|NCT03034967|42251571|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
19793627|NCT03021187|42251594|FG000|Overall Study|Death|0|||
19793628|NCT03021187|42251595|FG001|Overall Study|Death|0|||
19793629|NCT03021187|42251596|FG002|Overall Study|Death|3|||
19793630|NCT03021187|42251597|FG003|Overall Study|Death|0|||
19793631|NCT03021187|42251594|FG000|Overall Study|Withdrawal by Subject|0|||
19793632|NCT03021187|42251595|FG001|Overall Study|Withdrawal by Subject|6|||
19793633|NCT03021187|42251596|FG002|Overall Study|Withdrawal by Subject|2|||
19793634|NCT03021187|42251597|FG003|Overall Study|Withdrawal by Subject|5|||
19793635|NCT03021187|42251594|FG000|Overall Study|Lost to Follow-up|10|||
19793636|NCT03021187|42251595|FG001|Overall Study|Lost to Follow-up|3|||
19793637|NCT03021187|42251596|FG002|Overall Study|Lost to Follow-up|1|||
19793638|NCT03021187|42251597|FG003|Overall Study|Lost to Follow-up|4|||
19793639|NCT02143414|42251609|FG000|Induction|Adverse Event|1|||
19793640|NCT02143414|42251610|FG001|Induction|Adverse Event|2|||
19793641|NCT02143414|42251609|FG000|Induction|Death|1|||
19793642|NCT02143414|42251610|FG001|Induction|Death|2|||
19793643|NCT02143414|42251609|FG000|Induction|Patient refusal|1|||
19793644|NCT02143414|42251610|FG001|Induction|Patient refusal|1|||
19793645|NCT02143414|42251609|FG000|Induction|Refractory|1|||
19793646|NCT02143414|42251610|FG001|Induction|Refractory|0|||
19793647|NCT02143414|42251609|FG000|Induction|Began alternative treatment|1|||
19793648|NCT02143414|42251610|FG001|Induction|Began alternative treatment|0|||
19793649|NCT02143414|42251609|FG000|Induction|Ineligible for postremission|5|||
19793650|NCT02143414|42251610|FG001|Induction|Ineligible for postremission|1|||
19793651|NCT02143414|42251609|FG000|Post-remission|Adverse Event|0|||
19793652|NCT02143414|42251610|FG001|Post-remission|Adverse Event|2|||
19793653|NCT02143414|42251609|FG000|Post-remission|Disease progression/relapse|5|||
19793654|NCT02143414|42251610|FG001|Post-remission|Disease progression/relapse|0|||
19793655|NCT02143414|42251609|FG000|Maintenance|Adverse Event|4|||
19793656|NCT02143414|42251610|FG001|Maintenance|Adverse Event|6|||
19793657|NCT02143414|42251609|FG000|Maintenance|Disease progression/relapse|3|||
19793658|NCT02143414|42251610|FG001|Maintenance|Disease progression/relapse|2|||
19793659|NCT02143414|42251609|FG000|Maintenance|Patient refusal|2|||
19793660|NCT02143414|42251610|FG001|Maintenance|Patient refusal|1|||
19793661|NCT02143414|42251609|FG000|Maintenance|Physician Decision|1|||
19793662|NCT02143414|42251610|FG001|Maintenance|Physician Decision|0|||
19793663|NCT02143414|42251609|FG000|Maintenance|Death|0|||
19793664|NCT02143414|42251610|FG001|Maintenance|Death|1|||
19793665|NCT02143414|42251609|FG000|Maintenance|On protocol treatment|0|||
19793666|NCT02143414|42251610|FG001|Maintenance|On protocol treatment|6|||
19793667|NCT03014479|42251629|FG000|Overall Study|Adverse Event|0|||
19793668|NCT03014479|42251630|FG001|Overall Study|Adverse Event|1|||
19793669|NCT03014479|42251629|FG000|Overall Study|Voluntary Withdrawal|0|||
19793670|NCT03014479|42251630|FG001|Overall Study|Voluntary Withdrawal|2|||
19793671|NCT03014479|42251629|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
19793672|NCT03014479|42251630|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
19793673|NCT04766333|42251638|FG000|Overall Study|Lost to Follow-up|40|||
19793674|NCT04766333|42251639|FG001|Overall Study|Lost to Follow-up|826|||
19793675|NCT03020641|42251647|FG000|Overall Study|Lost to Follow-up|0|||
19793676|NCT03020641|42251648|FG001|Overall Study|Lost to Follow-up|1|||
19793677|NCT03020641|42251647|FG000|Overall Study|Converted to open surgery|2|||
19793678|NCT03020641|42251648|FG001|Overall Study|Converted to open surgery|1|||
19793679|NCT03020641|42251647|FG000|Overall Study|for surgery not performed|0|||
19793680|NCT03020641|42251648|FG001|Overall Study|for surgery not performed|1|||
19793681|NCT03020407|42251659|FG000|Overall Study|Withdrawal by Subject|2|||
19793682|NCT03020407|42251660|FG001|Overall Study|Withdrawal by Subject|1|||
19793683|NCT03020407|42251659|FG000|Overall Study|Lost to Follow-up|2|||
19793684|NCT03020407|42251660|FG001|Overall Study|Lost to Follow-up|3|||
19793685|NCT03020407|42251659|FG000|Overall Study|Protocol Violation|0|||
19793686|NCT03020407|42251660|FG001|Overall Study|Protocol Violation|1|||
19793687|NCT02536846|42251666|FG000|Overall Study|Withdrawal by Subject|1|||
19793688|NCT03014011|42251671|FG000|First Intervention|Withdrawal by Subject|1|||
19793689|NCT03014011|42251672|FG001|First Intervention|Withdrawal by Subject|0|||
19793690|NCT03014011|42251671|FG000|Washout|Withdrawal by Subject|1|||
19793691|NCT03014011|42251672|FG001|Washout|Withdrawal by Subject|0|||
19793692|NCT03012841|42251687|FG000|Overall Study|Protocol Violation|0|||
19793693|NCT03012841|42251688|FG001|Overall Study|Protocol Violation|10|||
19793694|NCT03012841|42251687|FG000|Overall Study|Lost to Follow-up|6|||
19793695|NCT03012841|42251688|FG001|Overall Study|Lost to Follow-up|1|||
19793696|NCT03012841|42251687|FG000|Overall Study|Withdrawal by Subject|6|||
19793697|NCT03012841|42251688|FG001|Overall Study|Withdrawal by Subject|0|||
19793698|NCT03012841|42251687|FG000|Overall Study|Unable to complete 12 month visit|6|||
19793699|NCT03012841|42251688|FG001|Overall Study|Unable to complete 12 month visit|0|||
19793700|NCT03012841|42251687|FG000|Overall Study|Subject relocation|1|||
19793701|NCT03012841|42251688|FG001|Overall Study|Subject relocation|0|||
19793702|NCT03012841|42251687|FG000|Overall Study|Seasonal winter travel|1|||
19793703|NCT03012841|42251688|FG001|Overall Study|Seasonal winter travel|0|||
19793704|NCT03012841|42251687|FG000|Overall Study|Physician Decision|0|||
19793705|NCT03012841|42251688|FG001|Overall Study|Physician Decision|2|||
19793706|NCT03012841|42251687|FG000|Overall Study|No ablation performed|0|||
19793707|NCT03012841|42251688|FG001|Overall Study|No ablation performed|2|||
19793708|NCT03012841|42251687|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
19793709|NCT03012841|42251688|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
19793710|NCT03012841|42251687|FG000|Overall Study|Insurance change|0|||
19793711|NCT03012841|42251688|FG001|Overall Study|Insurance change|1|||
19793712|NCT02359864|42251695|FG000|Overall Study|Withdrawal by Subject|1|||
19793713|NCT02359864|42251696|FG001|Overall Study|Withdrawal by Subject|0|||
19793714|NCT02533258|42251702|FG000|Overall Study|Adverse Event|1|||
19793715|NCT02533258|42251702|FG000|Overall Study|Death|2|||
19793716|NCT02533258|42251702|FG000|Overall Study|Other|1|||
19793717|NCT02533258|42251702|FG000|Overall Study|Economic factor|1|||
19793718|NCT02533258|42251702|FG000|Overall Study|Progression of pleural effusion|1|||
19793719|NCT02533258|42251702|FG000|Overall Study|Lack of Efficacy|2|||
19793720|NCT03019627|42251721|FG000|Overall Study|Adverse Event|8|||
19793721|NCT03019627|42251722|FG001|Overall Study|Adverse Event|0|||
19793722|NCT03019627|42251721|FG000|Overall Study|Unrelated to adverse event|1|||
19793723|NCT03019627|42251722|FG001|Overall Study|Unrelated to adverse event|3|||
19793724|NCT03019627|42251721|FG000|Overall Study|Lost to Follow-up|2|||
19793725|NCT03019627|42251722|FG001|Overall Study|Lost to Follow-up|1|||
19793726|NCT03019627|42251721|FG000|Overall Study|not compliance|2|||
19793727|NCT03019627|42251722|FG001|Overall Study|not compliance|2|||
19793728|NCT03019627|42251721|FG000|Overall Study|Other|2|||
19793729|NCT03019627|42251722|FG001|Overall Study|Other|2|||
19793730|NCT01661140|42251728|FG000|Open-Label Period|Adverse Event|44|||
19793731|NCT01661140|42251729|FG001|Open-Label Period|Adverse Event|0|||
19793732|NCT01661140|42251730|FG002|Open-Label Period|Adverse Event|0|||
19793733|NCT01661140|42251728|FG000|Open-Label Period|Protocol Violation|3|||
19793734|NCT01661140|42251729|FG001|Open-Label Period|Protocol Violation|0|||
19793735|NCT01661140|42251730|FG002|Open-Label Period|Protocol Violation|0|||
19793736|NCT01661140|42251728|FG000|Open-Label Period|Withdrawal by Subject|5|||
19793737|NCT01661140|42251729|FG001|Open-Label Period|Withdrawal by Subject|0|||
19793738|NCT01661140|42251730|FG002|Open-Label Period|Withdrawal by Subject|0|||
19793739|NCT01661140|42251728|FG000|Open-Label Period|Investigator Decision|3|||
19793740|NCT01661140|42251729|FG001|Open-Label Period|Investigator Decision|0|||
19793741|NCT01661140|42251730|FG002|Open-Label Period|Investigator Decision|0|||
19793742|NCT01661140|42251728|FG000|Open-Label Period|Death|1|||
19793743|NCT01661140|42251729|FG001|Open-Label Period|Death|0|||
19793744|NCT01661140|42251730|FG002|Open-Label Period|Death|0|||
19793745|NCT01661140|42251728|FG000|Open-Label Period|Administrative/Other|1|||
19793746|NCT01661140|42251729|FG001|Open-Label Period|Administrative/Other|0|||
19793747|NCT01661140|42251730|FG002|Open-Label Period|Administrative/Other|0|||
19793748|NCT01661140|42251728|FG000|Open-Label Period|Sponsor termination|16|||
19793749|NCT01661140|42251729|FG001|Open-Label Period|Sponsor termination|0|||
19793750|NCT01661140|42251730|FG002|Open-Label Period|Sponsor termination|0|||
19793751|NCT01661140|42251728|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
19477875|NCT01477333|41757147|FG000|Overall Study|Clinical Deterioration|1|||
19477876|NCT01461811|41757157|FG000|Overall Study|Adverse Event|2|||
19477877|NCT01461811|41757158|FG001|Overall Study|Adverse Event|1|||
19477878|NCT01461811|41757157|FG000|Overall Study|Subject decision unrelated to an AE|1|||
19477879|NCT01461811|41757158|FG001|Overall Study|Subject decision unrelated to an AE|1|||
19793752|NCT01661140|42251729|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
19793753|NCT01661140|42251730|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
19793754|NCT01661140|42251728|FG000|Open-Label Period|Lost to Follow-up|2|||
19793755|NCT01661140|42251729|FG001|Open-Label Period|Lost to Follow-up|0|||
19793756|NCT01661140|42251730|FG002|Open-Label Period|Lost to Follow-up|0|||
19793757|NCT01661140|42251728|FG000|Double-Blind Period|Refused Treatment|0|||
19793758|NCT01661140|42251729|FG001|Double-Blind Period|Refused Treatment|0|||
19793759|NCT01661140|42251730|FG002|Double-Blind Period|Refused Treatment|1|||
19793760|NCT01661140|42251728|FG000|Double-Blind Period|Adverse Event|0|||
19477880|NCT01461811|41757157|FG000|Overall Study|Noncompliance|1|||
19793761|NCT01661140|42251729|FG001|Double-Blind Period|Adverse Event|16|||
19793762|NCT01661140|42251730|FG002|Double-Blind Period|Adverse Event|18|||
19793763|NCT01661140|42251728|FG000|Double-Blind Period|Protocol Violation|0|||
19793764|NCT01661140|42251729|FG001|Double-Blind Period|Protocol Violation|2|||
19793765|NCT01661140|42251730|FG002|Double-Blind Period|Protocol Violation|3|||
19793766|NCT01661140|42251728|FG000|Double-Blind Period|Withdrawal by Subject|0|||
19793767|NCT01661140|42251729|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19793768|NCT01661140|42251730|FG002|Double-Blind Period|Withdrawal by Subject|3|||
19793769|NCT01661140|42251728|FG000|Double-Blind Period|Investigator's Decision|0|||
19793770|NCT01661140|42251729|FG001|Double-Blind Period|Investigator's Decision|1|||
19793771|NCT01661140|42251730|FG002|Double-Blind Period|Investigator's Decision|2|||
19793772|NCT01661140|42251728|FG000|Double-Blind Period|Sponsor Termination|0|||
19793773|NCT01661140|42251729|FG001|Double-Blind Period|Sponsor Termination|14|||
19793774|NCT01661140|42251730|FG002|Double-Blind Period|Sponsor Termination|17|||
19793775|NCT01661140|42251728|FG000|Double-Blind Period|Administrative/Other|0|||
19793776|NCT01661140|42251729|FG001|Double-Blind Period|Administrative/Other|7|||
19793777|NCT01661140|42251730|FG002|Double-Blind Period|Administrative/Other|6|||
19793778|NCT03019549|42251738|FG000|Washout|DId not meet genotype criteria|11|||
19793779|NCT03019549|42251738|FG000|Period 2|Adverse Event|2|||
19793780|NCT03019549|42251738|FG000|Period 2|Physician Decision|2|||
19793781|NCT03019549|42251738|FG000|Period 2|Withdrawal by Subject|1|||
19793782|NCT01661062|42251747|FG000|Overall Study|Completed Treatment Off Study|3|||
19793783|NCT01661062|42251747|FG000|Overall Study|Withdrawal by Subject|2|||
19793784|NCT02536378|42251753|FG000|Overall Study|Physician Decision|0|||
19793785|NCT02536378|42251754|FG001|Overall Study|Physician Decision|2|||
19793786|NCT02536378|42251753|FG000|Overall Study|Withdrawal by Subject|0|||
19793787|NCT02536378|42251754|FG001|Overall Study|Withdrawal by Subject|1|||
19793788|NCT02536378|42251753|FG000|Overall Study|Death|1|||
19793789|NCT02536378|42251754|FG001|Overall Study|Death|2|||
19793790|NCT02536378|42251753|FG000|Overall Study|Patient refused further follow up|6|||
19793791|NCT02536378|42251754|FG001|Overall Study|Patient refused further follow up|2|||
19793792|NCT01373151|42251769|FG000|Period 1|Lack of Efficacy|3|||
19793793|NCT01373151|42251770|FG001|Period 1|Lack of Efficacy|0|||
19793794|NCT01373151|42251771|FG002|Period 1|Lack of Efficacy|0|||
19793795|NCT01373151|42251772|FG003|Period 1|Lack of Efficacy|0|||
19793796|NCT01373151|42251773|FG004|Period 1|Lack of Efficacy|1|||
19793797|NCT01373151|42251774|FG005|Period 1|Lack of Efficacy|0|||
19793798|NCT01373151|42251775|FG006|Period 1|Lack of Efficacy|0|||
19793799|NCT01373151|42251769|FG000|Period 1|Adverse Event|0|||
19793800|NCT01373151|42251770|FG001|Period 1|Adverse Event|0|||
19793801|NCT01373151|42251771|FG002|Period 1|Adverse Event|1|||
19793802|NCT01373151|42251772|FG003|Period 1|Adverse Event|0|||
19793803|NCT01373151|42251773|FG004|Period 1|Adverse Event|4|||
19793804|NCT01373151|42251774|FG005|Period 1|Adverse Event|3|||
19793805|NCT01373151|42251775|FG006|Period 1|Adverse Event|0|||
19793806|NCT01373151|42251769|FG000|Period 1|Withdrawal by Subject|2|||
19793807|NCT01373151|42251770|FG001|Period 1|Withdrawal by Subject|0|||
19793808|NCT01373151|42251771|FG002|Period 1|Withdrawal by Subject|3|||
19793809|NCT01373151|42251772|FG003|Period 1|Withdrawal by Subject|1|||
19793810|NCT01373151|42251773|FG004|Period 1|Withdrawal by Subject|0|||
19793811|NCT01373151|42251774|FG005|Period 1|Withdrawal by Subject|1|||
19793812|NCT01373151|42251775|FG006|Period 1|Withdrawal by Subject|0|||
19793813|NCT01373151|42251769|FG000|Period 2|Lack of Efficacy|9|||
19793814|NCT01373151|42251770|FG001|Period 2|Lack of Efficacy|0|||
19793815|NCT01373151|42251771|FG002|Period 2|Lack of Efficacy|0|||
19793816|NCT01373151|42251772|FG003|Period 2|Lack of Efficacy|1|||
19793817|NCT01373151|42251773|FG004|Period 2|Lack of Efficacy|2|||
19793818|NCT01373151|42251774|FG005|Period 2|Lack of Efficacy|0|||
19793819|NCT01373151|42251775|FG006|Period 2|Lack of Efficacy|3|||
19793820|NCT01373151|42251769|FG000|Period 2|Adverse Event|0|||
19793821|NCT01373151|42251770|FG001|Period 2|Adverse Event|0|||
19793822|NCT01373151|42251771|FG002|Period 2|Adverse Event|3|||
19793823|NCT01373151|42251772|FG003|Period 2|Adverse Event|3|||
19793824|NCT01373151|42251773|FG004|Period 2|Adverse Event|0|||
19793825|NCT01373151|42251774|FG005|Period 2|Adverse Event|0|||
19793826|NCT01373151|42251775|FG006|Period 2|Adverse Event|1|||
19793827|NCT01373151|42251769|FG000|Period 2|subject request to discontinue|0|||
19793828|NCT01373151|42251770|FG001|Period 2|subject request to discontinue|1|||
19793829|NCT01373151|42251771|FG002|Period 2|subject request to discontinue|0|||
19793830|NCT01373151|42251772|FG003|Period 2|subject request to discontinue|0|||
19793831|NCT01373151|42251773|FG004|Period 2|subject request to discontinue|0|||
19793832|NCT01373151|42251774|FG005|Period 2|subject request to discontinue|0|||
19793833|NCT01373151|42251775|FG006|Period 2|subject request to discontinue|0|||
19793834|NCT01373151|42251769|FG000|Period 2|Withdrawal by Subject|0|||
19793835|NCT01373151|42251770|FG001|Period 2|Withdrawal by Subject|0|||
19793836|NCT01373151|42251771|FG002|Period 2|Withdrawal by Subject|0|||
19793837|NCT01373151|42251772|FG003|Period 2|Withdrawal by Subject|1|||
19793838|NCT01373151|42251773|FG004|Period 2|Withdrawal by Subject|0|||
19793839|NCT01373151|42251774|FG005|Period 2|Withdrawal by Subject|0|||
19793840|NCT01373151|42251775|FG006|Period 2|Withdrawal by Subject|0|||
19793841|NCT01373151|42251769|FG000|Period 2|Other|0|||
19793842|NCT01373151|42251770|FG001|Period 2|Other|0|||
19793843|NCT01373151|42251771|FG002|Period 2|Other|1|||
19793844|NCT01373151|42251772|FG003|Period 2|Other|0|||
19793845|NCT01373151|42251773|FG004|Period 2|Other|0|||
19793846|NCT01373151|42251774|FG005|Period 2|Other|0|||
19793847|NCT01373151|42251775|FG006|Period 2|Other|1|||
19793848|NCT01660906|42251791|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
19793849|NCT03015181|42251811|FG000|Overall Study|Enrolled, but product never administered|1|||
19793850|NCT03015181|42251812|FG001|Overall Study|Enrolled, but product never administered|0|||
19793851|NCT03015181|42251813|FG002|Overall Study|Enrolled, but product never administered|0|||
19793852|NCT03015181|42251814|FG003|Overall Study|Enrolled, but product never administered|0|||
19793853|NCT03015181|42251815|FG004|Overall Study|Enrolled, but product never administered|0|||
19793854|NCT03015181|42251816|FG005|Overall Study|Enrolled, but product never administered|0|||
19793855|NCT03015181|42251817|FG006|Overall Study|Enrolled, but product never administered|0|||
19793856|NCT03015181|42251811|FG000|Overall Study|Withdrawal by Subject|0|||
19793857|NCT03015181|42251812|FG001|Overall Study|Withdrawal by Subject|0|||
19793858|NCT03015181|42251813|FG002|Overall Study|Withdrawal by Subject|0|||
19793859|NCT03015181|42251814|FG003|Overall Study|Withdrawal by Subject|0|||
19793860|NCT03015181|42251815|FG004|Overall Study|Withdrawal by Subject|0|||
19793861|NCT03015181|42251816|FG005|Overall Study|Withdrawal by Subject|1|||
19607814|NCT00666757|42056635|FG001|Overall Study|Physician Decision|2|||
19607815|NCT00666757|42056634|FG000|Overall Study|Sponsor decision|0|||
19698179|NCT00068692|42143485|FG006|Step 1: Registration|Complicating disease|0|||
19698180|NCT00068692|42143486|FG007|Step 1: Registration|Complicating disease|0|||
19698181|NCT00068692|42143479|FG000|Step 1: Registration|Protocol Violation|1|||
19698182|NCT00068692|42143480|FG001|Step 1: Registration|Protocol Violation|0|||
19698183|NCT00068692|42143481|FG002|Step 1: Registration|Protocol Violation|0|||
19698184|NCT00068692|42143482|FG003|Step 1: Registration|Protocol Violation|0|||
19698185|NCT00068692|42143483|FG004|Step 1: Registration|Protocol Violation|0|||
19698186|NCT00068692|42143484|FG005|Step 1: Registration|Protocol Violation|0|||
19698187|NCT00068692|42143485|FG006|Step 1: Registration|Protocol Violation|0|||
19698188|NCT00068692|42143486|FG007|Step 1: Registration|Protocol Violation|0|||
19698189|NCT00068692|42143479|FG000|Step 1: Registration|Not eligible|6|||
19698190|NCT00068692|42143480|FG001|Step 1: Registration|Not eligible|0|||
19698191|NCT00068692|42143481|FG002|Step 1: Registration|Not eligible|0|||
19698192|NCT00068692|42143482|FG003|Step 1: Registration|Not eligible|0|||
19698193|NCT00068692|42143483|FG004|Step 1: Registration|Not eligible|0|||
19698194|NCT00068692|42143484|FG005|Step 1: Registration|Not eligible|0|||
19698195|NCT00068692|42143485|FG006|Step 1: Registration|Not eligible|0|||
19698196|NCT00068692|42143486|FG007|Step 1: Registration|Not eligible|0|||
19607816|NCT00666757|42056635|FG001|Overall Study|Sponsor decision|1|||
19607817|NCT01000337|42056646|FG000|Overall Study|Lost to Follow-up|4|||
19607818|NCT01000337|42056647|FG001|Overall Study|Lost to Follow-up|3|||
19607819|NCT00666679|42056655|FG000|First Intervention|Lost to Follow-up|1|||
19607820|NCT00666679|42056656|FG001|First Intervention|Lost to Follow-up|0|||
19607821|NCT00666679|42056655|FG000|First Intervention|Protocol Violation|1|||
19607822|NCT00666679|42056656|FG001|First Intervention|Protocol Violation|0|||
19607823|NCT00666679|42056655|FG000|First Intervention|Withdrawal by Subject|1|||
19607824|NCT00666679|42056656|FG001|First Intervention|Withdrawal by Subject|0|||
19607825|NCT00666679|42056655|FG000|First Intervention|Randomized did not start treatment|1|||
19607826|NCT00666679|42056656|FG001|First Intervention|Randomized did not start treatment|1|||
19607827|NCT00666679|42056655|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
19607828|NCT00666679|42056656|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
19607829|NCT00666679|42056655|FG000|Washout Period of 1 Week|Protocol Violation|0|||
19607830|NCT00666679|42056656|FG001|Washout Period of 1 Week|Protocol Violation|1|||
19607831|NCT00666679|42056655|FG000|Second Intervention|Adverse Event|1|||
19607832|NCT00666679|42056656|FG001|Second Intervention|Adverse Event|0|||
19607833|NCT00666679|42056655|FG000|Second Intervention|Death|0|||
19607834|NCT00666679|42056656|FG001|Second Intervention|Death|1|||
19607835|NCT00595413|42056666|FG000|Overall Study|Adverse Event|0|||
19607836|NCT00595413|42056667|FG001|Overall Study|Adverse Event|2|||
19607837|NCT00595413|42056668|FG002|Overall Study|Adverse Event|1|||
19607838|NCT00595413|42056669|FG003|Overall Study|Adverse Event|1|||
19607839|NCT00595413|42056666|FG000|Overall Study|Lost to Follow-up|2|||
19607840|NCT00595413|42056667|FG001|Overall Study|Lost to Follow-up|2|||
19607841|NCT00595413|42056668|FG002|Overall Study|Lost to Follow-up|1|||
19607842|NCT00595413|42056669|FG003|Overall Study|Lost to Follow-up|3|||
19607843|NCT00595413|42056666|FG000|Overall Study|Death|0|||
19607844|NCT00595413|42056667|FG001|Overall Study|Death|0|||
19607845|NCT00595413|42056668|FG002|Overall Study|Death|1|||
19607846|NCT00595413|42056669|FG003|Overall Study|Death|0|||
19793862|NCT03015181|42251817|FG006|Overall Study|Withdrawal by Subject|0|||
19607847|NCT00595413|42056666|FG000|Overall Study|Other|5|||
19793863|NCT03015181|42251811|FG000|Overall Study|Physician Decision|0|||
19607848|NCT00595413|42056667|FG001|Overall Study|Other|1|||
19607849|NCT00595413|42056668|FG002|Overall Study|Other|5|||
19698197|NCT00068692|42143479|FG000|Step 1: Registration|Other|2|||
19698198|NCT00068692|42143480|FG001|Step 1: Registration|Other|0|||
19793864|NCT03015181|42251812|FG001|Overall Study|Physician Decision|0|||
19793865|NCT03015181|42251813|FG002|Overall Study|Physician Decision|0|||
19793866|NCT03015181|42251814|FG003|Overall Study|Physician Decision|0|||
19793867|NCT03015181|42251815|FG004|Overall Study|Physician Decision|0|||
19793868|NCT03015181|42251816|FG005|Overall Study|Physician Decision|0|||
19793869|NCT03015181|42251817|FG006|Overall Study|Physician Decision|1|||
19793870|NCT00960297|42251866|FG000|Overall Study|Physician Decision|1|||
19793871|NCT00960297|42251866|FG000|Overall Study|Venous port infection|1|||
19793872|NCT00960297|42251866|FG000|Overall Study|Disease progression|1|||
19793873|NCT03018691|42251873|FG000|Overall Study|Adverse Event|1|||
19793874|NCT03018691|42251874|FG001|Overall Study|Adverse Event|1|||
19793875|NCT03018691|42251875|FG002|Overall Study|Adverse Event|4|||
19793876|NCT03018691|42251873|FG000|Overall Study|Lack of Efficacy|0|||
19793877|NCT03018691|42251874|FG001|Overall Study|Lack of Efficacy|0|||
19793878|NCT03018691|42251875|FG002|Overall Study|Lack of Efficacy|1|||
19793879|NCT03018691|42251873|FG000|Overall Study|Withdrawal by Subject|0|||
19793880|NCT03018691|42251874|FG001|Overall Study|Withdrawal by Subject|0|||
19793881|NCT03018691|42251875|FG002|Overall Study|Withdrawal by Subject|1|||
19793882|NCT03018691|42251873|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19793883|NCT03018691|42251874|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19793884|NCT03018691|42251875|FG002|Overall Study|Withdrawal by parent/guardian|1|||
19793885|NCT03012061|42251888|FG000|Overall Study|Withdrawal by Subject|1|||
19793886|NCT03012061|42251889|FG001|Overall Study|Withdrawal by Subject|5|||
19793887|NCT03012061|42251890|FG002|Overall Study|Withdrawal by Subject|4|||
19793888|NCT03012061|42251888|FG000|Overall Study|Investigator Site Closed|1|||
19793889|NCT03012061|42251889|FG001|Overall Study|Investigator Site Closed|2|||
19793890|NCT03012061|42251890|FG002|Overall Study|Investigator Site Closed|0|||
19793891|NCT03012061|42251888|FG000|Overall Study|Lost to Follow-up|2|||
19793892|NCT03012061|42251889|FG001|Overall Study|Lost to Follow-up|1|||
19793893|NCT03012061|42251890|FG002|Overall Study|Lost to Follow-up|0|||
19793894|NCT03012061|42251888|FG000|Overall Study|Study closed/ Terminated|0|||
19793895|NCT03012061|42251889|FG001|Overall Study|Study closed/ Terminated|0|||
19793896|NCT03012061|42251890|FG002|Overall Study|Study closed/ Terminated|1|||
19793897|NCT03012061|42251888|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
19793898|NCT03012061|42251889|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
19793899|NCT03012061|42251890|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
19793900|NCT03012061|42251888|FG000|Overall Study|Protocol Violation|0|||
19793901|NCT03012061|42251889|FG001|Overall Study|Protocol Violation|0|||
19793902|NCT03012061|42251890|FG002|Overall Study|Protocol Violation|2|||
19793903|NCT03012061|42251888|FG000|Overall Study|Lack of Efficacy|0|||
19793904|NCT03012061|42251889|FG001|Overall Study|Lack of Efficacy|1|||
19793905|NCT03012061|42251890|FG002|Overall Study|Lack of Efficacy|0|||
19793906|NCT03012061|42251888|FG000|Overall Study|Adverse Event|2|||
19793907|NCT03012061|42251889|FG001|Overall Study|Adverse Event|0|||
19793908|NCT03012061|42251890|FG002|Overall Study|Adverse Event|0|||
19793909|NCT03010501|42251898|FG000|Study Week 1|Withdrawal by Subject|2|||
19793910|NCT03010501|42251899|FG001|Study Week 1|Withdrawal by Subject|1|||
19793911|NCT03010501|42251900|FG002|Study Week 1|Withdrawal by Subject|0|||
19793912|NCT03010501|42251901|FG003|Study Week 1|Withdrawal by Subject|2|||
19793913|NCT03010501|42251902|FG004|Study Week 1|Withdrawal by Subject|0|||
19793914|NCT03010501|42251903|FG005|Study Week 1|Withdrawal by Subject|0|||
19793915|NCT03010501|42251898|FG000|Study Week 3|Withdrawal by Subject|0|||
19793916|NCT03010501|42251899|FG001|Study Week 3|Withdrawal by Subject|0|||
19793917|NCT03010501|42251900|FG002|Study Week 3|Withdrawal by Subject|0|||
19793918|NCT03010501|42251901|FG003|Study Week 3|Withdrawal by Subject|1|||
19793919|NCT03010501|42251902|FG004|Study Week 3|Withdrawal by Subject|0|||
19793920|NCT03010501|42251903|FG005|Study Week 3|Withdrawal by Subject|0|||
19793921|NCT03002623|42251913|FG000|Overall Study|Lost to Follow-up|1|||
19793922|NCT03002623|42251914|FG001|Overall Study|Lost to Follow-up|0|||
19793923|NCT03002623|42251913|FG000|Overall Study|Physician Decision|1|||
19793924|NCT03002623|42251914|FG001|Overall Study|Physician Decision|1|||
19793925|NCT03010423|42251922|FG000|Overall Study|Study termination|8|||
19793926|NCT03002311|42251928|FG000|Overall Study|Lost to Follow-up|13|||
19793927|NCT03002311|42251929|FG001|Overall Study|Lost to Follow-up|26|||
19793928|NCT03002311|42251928|FG000|Overall Study|Referral provider called to schedule app|3|||
19793929|NCT03002311|42251929|FG001|Overall Study|Referral provider called to schedule app|3|||
19793930|NCT03002311|42251928|FG000|Overall Study|Physician Decision|3|||
19793931|NCT03002311|42251929|FG001|Overall Study|Physician Decision|1|||
19793932|NCT03002077|42251935|FG000|Overall Study|Non-compliance with Study Drug|4|||
19793933|NCT03002077|42251935|FG000|Overall Study|Non-compliance w/Background ADT|1|||
19793934|NCT03002077|42251935|FG000|Overall Study|Study Terminated by Sponsor|257|||
19793935|NCT03002077|42251935|FG000|Overall Study|Site Terminated by Sponsor|5|||
19793936|NCT03002077|42251935|FG000|Overall Study|Miscellaneous Reasons|10|||
19793937|NCT03002077|42251935|FG000|Overall Study|Adverse Event|23|||
19793938|NCT03002077|42251935|FG000|Overall Study|Lack of Efficacy|20|||
19793939|NCT03002077|42251935|FG000|Overall Study|Withdrawal by Subject|72|||
19793940|NCT03002077|42251935|FG000|Overall Study|Lost to Follow-up|21|||
19793941|NCT03002077|42251935|FG000|Overall Study|Pregnancy|4|||
19793942|NCT03002077|42251935|FG000|Overall Study|Protocol Violation|21|||
19793943|NCT03008005|42251942|FG000|Overall Study|Physician Decision|1|||
19793944|NCT03008005|42251943|FG001|Overall Study|Physician Decision|0|||
19793945|NCT03008005|42251944|FG002|Overall Study|Physician Decision|0|||
19793946|NCT03008005|42251942|FG000|Overall Study|Withdrawal by Subject|1|||
19793947|NCT03008005|42251943|FG001|Overall Study|Withdrawal by Subject|0|||
19793948|NCT03008005|42251944|FG002|Overall Study|Withdrawal by Subject|0|||
19793949|NCT03008005|42251942|FG000|Overall Study|Ineligible|0|||
19793950|NCT03008005|42251943|FG001|Overall Study|Ineligible|1|||
19793951|NCT03008005|42251944|FG002|Overall Study|Ineligible|0|||
19793952|NCT02440425|42251961|FG000|Overall Study|Death likely due to disease progression|1|||
19793953|NCT02440425|42251961|FG000|Overall Study|Withdrawal by Subject|2|||
19793954|NCT02440425|42251961|FG000|Overall Study|Adverse Event|1|||
19793955|NCT02440425|42251961|FG000|Overall Study|Adverse Event/Ineligible|1|||
19793956|NCT03001219|42251976|FG000|Proof of Concept|Study Termination by Sponsor|0|||
19793957|NCT03001219|42251977|FG001|Proof of Concept|Study Termination by Sponsor|1|||
19793958|NCT03001219|42251976|FG000|Proof of Concept|Withdrawal by Subject|0|||
19793959|NCT03001219|42251977|FG001|Proof of Concept|Withdrawal by Subject|4|||
19793960|NCT03001219|42251976|FG000|Proof of Concept|Protocol Deviation|0|||
19793961|NCT03001219|42251977|FG001|Proof of Concept|Protocol Deviation|1|||
19793962|NCT03001219|42251976|FG000|Proof of Concept|Adverse Event|1|||
19793963|NCT03001219|42251977|FG001|Proof of Concept|Adverse Event|1|||
19793964|NCT03001219|42251976|FG000|Proof of Concept|Physician Decision|1|||
19793965|NCT03001219|42251977|FG001|Proof of Concept|Physician Decision|0|||
19793966|NCT03001219|42251976|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
19793967|NCT03001219|42251977|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
19793968|NCT03001219|42251976|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
19793969|NCT03001219|42251977|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
19793970|NCT03001219|42251976|FG000|Extension Period Analysis|Physician Decision|0|||
19793971|NCT03001219|42251977|FG001|Extension Period Analysis|Physician Decision|1|||
19793972|NCT03001219|42251976|FG000|Extension Period Analysis|Adverse Event|1|||
19793973|NCT03001219|42251977|FG001|Extension Period Analysis|Adverse Event|1|||
19793974|NCT03001219|42251976|FG000|Extension Period Analysis|Protocol Deviation|0|||
19793975|NCT03001219|42251977|FG001|Extension Period Analysis|Protocol Deviation|1|||
19793976|NCT03001219|42251976|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
19793977|NCT03001219|42251977|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
19793978|NCT03000673|42251992|FG000|Overall Study|Withdrawal by Subject|1|||
19793979|NCT03000673|42251993|FG001|Overall Study|Withdrawal by Subject|0|||
19793980|NCT03000673|42251994|FG002|Overall Study|Withdrawal by Subject|0|||
19793981|NCT03000673|42251995|FG003|Overall Study|Withdrawal by Subject|0|||
19793982|NCT02912455|42252008|FG000|Overall Study|Withdrawal by Subject|0|||
19793983|NCT02912455|42252009|FG001|Overall Study|Withdrawal by Subject|1|||
19793984|NCT02912455|42252008|FG000|Overall Study|Lack of Efficacy|0|||
19793985|NCT02912455|42252009|FG001|Overall Study|Lack of Efficacy|1|||
19793986|NCT02912455|42252008|FG000|Overall Study|Lost to Follow-up|2|||
19793987|NCT02912455|42252009|FG001|Overall Study|Lost to Follow-up|1|||
19793988|NCT04524507|42252017|FG000|Overall Study|Lost to Follow-up|2|||
19793989|NCT04524507|42252018|FG001|Overall Study|Lost to Follow-up|4|||
19793990|NCT04524507|42252017|FG000|Overall Study|Withdrawal by Subject|2|||
19793991|NCT04524507|42252018|FG001|Overall Study|Withdrawal by Subject|9|||
19793992|NCT04524507|42252017|FG000|Overall Study|Death|2|||
19793993|NCT04524507|42252018|FG001|Overall Study|Death|10|||
19793994|NCT02999191|42252027|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
19793995|NCT02999191|42252028|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
19793996|NCT02999191|42252029|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
19793997|NCT02531698|42252039|FG000|Overall Study|Adverse Event|2|||
19793998|NCT02531698|42252040|FG001|Overall Study|Adverse Event|1|||
19793999|NCT02531698|42252039|FG000|Overall Study|Withdrawal by Subject|6|||
19794000|NCT02531698|42252040|FG001|Overall Study|Withdrawal by Subject|1|||
19794001|NCT02531698|42252039|FG000|Overall Study|Protocol Violation|2|||
19794002|NCT02531698|42252040|FG001|Overall Study|Protocol Violation|0|||
19794003|NCT02531698|42252039|FG000|Overall Study|Lost to Follow-up|1|||
19794004|NCT02531698|42252040|FG001|Overall Study|Lost to Follow-up|0|||
19794005|NCT02998021|42252057|FG000|Overall Study|Withdrawal by Subject|3|||
19794006|NCT02998021|42252058|FG001|Overall Study|Withdrawal by Subject|1|||
19794007|NCT02998021|42252057|FG000|Overall Study|unsafe home|0|||
19794008|NCT02998021|42252058|FG001|Overall Study|unsafe home|1|||
19794009|NCT01207492|42252070|FG000|Overall Study|Still on study|1|||
19794010|NCT01207492|42252070|FG000|Overall Study|Withdrawal by Subject|9|||
19794011|NCT01207492|42252070|FG000|Overall Study|Physician Decision|1|||
19389184|NCT02053792|41632811|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
19794012|NCT01207492|42252070|FG000|Overall Study|Progressive disease|3|||
19794013|NCT01207492|42252070|FG000|Overall Study|Toxicity|1|||
19794014|NCT03034577|42252076|FG000|Overall Study|Withdrawal by Subject|6|||
19794015|NCT03034577|42252077|FG001|Overall Study|Withdrawal by Subject|9|||
19794016|NCT03034577|42252076|FG000|Overall Study|Lost to Follow-up|25|||
19794017|NCT03034577|42252077|FG001|Overall Study|Lost to Follow-up|26|||
19794018|NCT01659736|42252087|FG000|Treatment Period|Adverse Event|1|||
19794019|NCT01659736|42252088|FG001|Treatment Period|Adverse Event|1|||
19794020|NCT01659736|42252087|FG000|Treatment Period|Protocol Violation|3|||
19794021|NCT01659736|42252088|FG001|Treatment Period|Protocol Violation|1|||
19794022|NCT01659736|42252087|FG000|Treatment Period|Withdrawal by Subject|1|||
19794023|NCT01659736|42252088|FG001|Treatment Period|Withdrawal by Subject|0|||
19794024|NCT01659736|42252087|FG000|3-month Follow-up|Lost to Follow-up|0|||
19794025|NCT01659736|42252088|FG001|3-month Follow-up|Lost to Follow-up|1|||
19794026|NCT02997163|42252100|FG000|Overall Study|Adverse Event|1|||
19794027|NCT02997163|42252101|FG001|Overall Study|Adverse Event|0|||
19794028|NCT02997163|42252102|FG002|Overall Study|Adverse Event|0|||
19794029|NCT02997163|42252103|FG003|Overall Study|Adverse Event|1|||
19794030|NCT00458536|42252113|FG000|Overall Study|Disease progression prior to treatment|7|||
19794031|NCT00458536|42252113|FG000|Overall Study|Unable to make vaccine|3|||
19794032|NCT00458536|42252113|FG000|Overall Study|No measurable disease after surgery|2|||
19794033|NCT00458536|42252113|FG000|Overall Study|Did not have renal cell carcinoma|2|||
19794034|NCT00458536|42252113|FG000|Overall Study|Patient did not have surgery|1|||
19794035|NCT00458536|42252113|FG000|Overall Study|Ineligible due to toxicity|1|||
19794036|NCT00458536|42252113|FG000|Overall Study|Withdrawal by Subject|1|||
19794037|NCT00458536|42252113|FG000|Overall Study|Progressive disease during treatment|2|||
19794038|NCT02526550|42252117|FG000|Overall Study|Lost to Follow-up|1|||
19794039|NCT03030989|42252132|FG000|Overall Study|Fever|2|||
19794040|NCT03030989|42252133|FG001|Overall Study|Fever|2|||
19794041|NCT03030989|42252132|FG000|Overall Study|Rash|2|||
19794042|NCT03030989|42252133|FG001|Overall Study|Rash|1|||
19794043|NCT03030989|42252132|FG000|Overall Study|Fatigue/Overwhelmed|1|||
19794044|NCT03030989|42252133|FG001|Overall Study|Fatigue/Overwhelmed|5|||
19794045|NCT03030989|42252132|FG000|Overall Study|Positive Blood Cultures|2|||
19794046|NCT03030989|42252133|FG001|Overall Study|Positive Blood Cultures|1|||
19794047|NCT03030989|42252132|FG000|Overall Study|Line Removed|0|||
19794048|NCT03030989|42252133|FG001|Overall Study|Line Removed|2|||
19794049|NCT03030989|42252132|FG000|Overall Study|No longer interested|5|||
19794050|NCT03030989|42252133|FG001|Overall Study|No longer interested|3|||
19794051|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
19794052|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
19794053|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
19794054|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Other|1|||
19794055|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Other|0|||
19794056|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Other|0|||
19794057|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Physician Decision|3|||
19794058|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Physician Decision|0|||
19794059|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Physician Decision|0|||
19794060|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
19794061|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
19794062|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
19794063|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
19794064|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
19794065|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
19794066|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Adverse Event|18|||
19794067|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Adverse Event|0|||
19794068|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Adverse Event|0|||
19794069|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
19794070|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
19794071|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
19794072|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
19794073|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
19794074|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
19794075|NCT03030599|42252139|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
19794076|NCT03030599|42252140|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
19794077|NCT03030599|42252141|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
19794078|NCT03030599|42252139|FG000|Stable Dose|Protocol deviation|3|||
19794079|NCT03030599|42252140|FG001|Stable Dose|Protocol deviation|0|||
19794080|NCT03030599|42252141|FG002|Stable Dose|Protocol deviation|0|||
19794081|NCT03030599|42252139|FG000|Stable Dose|Adverse Event|1|||
19794082|NCT03030599|42252140|FG001|Stable Dose|Adverse Event|0|||
19794083|NCT03030599|42252141|FG002|Stable Dose|Adverse Event|0|||
19794084|NCT03030599|42252139|FG000|Stable Dose|Lost to Follow-up|1|||
19794085|NCT03030599|42252140|FG001|Stable Dose|Lost to Follow-up|0|||
19794086|NCT03030599|42252141|FG002|Stable Dose|Lost to Follow-up|0|||
19794087|NCT03030599|42252139|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
19607850|NCT00595413|42056669|FG003|Overall Study|Other|0|||
19607851|NCT01000025|42056681|FG000|Overall Study|Adverse Event|43|||
19794088|NCT03030599|42252140|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
19794089|NCT03030599|42252141|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
19794090|NCT03030599|42252139|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
19794091|NCT03030599|42252140|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
19794092|NCT03030599|42252141|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
19794093|NCT03030599|42252139|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
19794094|NCT03030599|42252140|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
19794095|NCT03030599|42252141|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
19794096|NCT03030599|42252139|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
19794097|NCT03030599|42252140|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
19794098|NCT03030599|42252141|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
19794099|NCT03030599|42252139|FG000|Open-label Extension|Adverse Event|3|||
19794100|NCT03030599|42252140|FG001|Open-label Extension|Adverse Event|0|||
19794101|NCT03030599|42252141|FG002|Open-label Extension|Adverse Event|0|||
19794102|NCT03030599|42252139|FG000|Open-label Extension|Lost to Follow-up|2|||
19794103|NCT03030599|42252140|FG001|Open-label Extension|Lost to Follow-up|0|||
19794104|NCT03030599|42252141|FG002|Open-label Extension|Lost to Follow-up|0|||
19794105|NCT03030599|42252139|FG000|Open-label Extension|Lack of Efficacy|1|||
19794106|NCT03030599|42252140|FG001|Open-label Extension|Lack of Efficacy|0|||
19794107|NCT03030599|42252141|FG002|Open-label Extension|Lack of Efficacy|0|||
19794108|NCT03030599|42252139|FG000|Open-label Extension|Other Reason|1|||
19794109|NCT03030599|42252140|FG001|Open-label Extension|Other Reason|0|||
19794110|NCT03030599|42252141|FG002|Open-label Extension|Other Reason|0|||
19794111|NCT03031847|42252151|FG000|Overall Study|Death|1|||
19794112|NCT03031847|42252152|FG001|Overall Study|Death|1|||
19794113|NCT03031847|42252153|FG002|Overall Study|Death|2|||
19794114|NCT03031847|42252154|FG003|Overall Study|Death|3|||
19794115|NCT03031847|42252151|FG000|Overall Study|Lost to Follow-up|1|||
19794116|NCT03031847|42252152|FG001|Overall Study|Lost to Follow-up|1|||
19794117|NCT03031847|42252153|FG002|Overall Study|Lost to Follow-up|2|||
19794118|NCT03031847|42252154|FG003|Overall Study|Lost to Follow-up|3|||
19794119|NCT03028415|42252166|FG000|Overall Study|Lost to Follow-up|6|||
19794120|NCT03028415|42252167|FG001|Overall Study|Lost to Follow-up|3|||
19794121|NCT03028415|42252166|FG000|Overall Study|Withdrawal by Subject|1|||
19794122|NCT03028415|42252167|FG001|Overall Study|Withdrawal by Subject|0|||
19794123|NCT03028415|42252166|FG000|Overall Study|Discontinued due to COVID-19|1|||
19794124|NCT03028415|42252167|FG001|Overall Study|Discontinued due to COVID-19|0|||
19794125|NCT02692040|42252191|FG000|Overall Study|Protocol Violation|0|||
19794126|NCT02692040|42252192|FG001|Overall Study|Protocol Violation|0|||
19794127|NCT02692040|42252193|FG002|Overall Study|Protocol Violation|0|||
19794128|NCT02692040|42252194|FG003|Overall Study|Protocol Violation|0|||
19794129|NCT02692040|42252195|FG004|Overall Study|Protocol Violation|0|||
19794130|NCT02692040|42252196|FG005|Overall Study|Protocol Violation|0|||
19794131|NCT02692040|42252197|FG006|Overall Study|Protocol Violation|0|||
19794132|NCT02692040|42252198|FG007|Overall Study|Protocol Violation|0|||
19794133|NCT02692040|42252199|FG008|Overall Study|Protocol Violation|0|||
19794134|NCT02692040|42252200|FG009|Overall Study|Protocol Violation|0|||
19794135|NCT02692040|42252201|FG010|Overall Study|Protocol Violation|0|||
19794136|NCT02692040|42252202|FG011|Overall Study|Protocol Violation|0|||
19794137|NCT02692040|42252203|FG012|Overall Study|Protocol Violation|1|||
19794138|NCT02692040|42252204|FG013|Overall Study|Protocol Violation|0|||
19794139|NCT02692040|42252205|FG014|Overall Study|Protocol Violation|0|||
19794140|NCT02692040|42252206|FG015|Overall Study|Protocol Violation|0|||
19794141|NCT02692040|42252207|FG016|Overall Study|Protocol Violation|0|||
19794142|NCT02692040|42252191|FG000|Overall Study|Adverse Event|0|||
19794143|NCT02692040|42252192|FG001|Overall Study|Adverse Event|0|||
19794144|NCT02692040|42252193|FG002|Overall Study|Adverse Event|0|||
19794145|NCT02692040|42252194|FG003|Overall Study|Adverse Event|0|||
19794146|NCT02692040|42252195|FG004|Overall Study|Adverse Event|0|||
19794147|NCT02692040|42252196|FG005|Overall Study|Adverse Event|0|||
19794148|NCT02692040|42252197|FG006|Overall Study|Adverse Event|0|||
19794149|NCT02692040|42252198|FG007|Overall Study|Adverse Event|0|||
19794150|NCT02692040|42252199|FG008|Overall Study|Adverse Event|0|||
19794151|NCT02692040|42252200|FG009|Overall Study|Adverse Event|0|||
19794152|NCT02692040|42252201|FG010|Overall Study|Adverse Event|0|||
19794153|NCT02692040|42252202|FG011|Overall Study|Adverse Event|0|||
19794154|NCT02692040|42252203|FG012|Overall Study|Adverse Event|0|||
19794155|NCT02692040|42252204|FG013|Overall Study|Adverse Event|3|||
19794156|NCT02692040|42252205|FG014|Overall Study|Adverse Event|1|||
19794157|NCT02692040|42252206|FG015|Overall Study|Adverse Event|1|||
19794158|NCT02692040|42252207|FG016|Overall Study|Adverse Event|0|||
19794159|NCT03029819|42252286|FG000|Overall Study|Lost to Follow-up|3|||
19794160|NCT03029819|42252287|FG001|Overall Study|Lost to Follow-up|5|||
19794161|NCT03029819|42252286|FG000|Overall Study|Removed due to disruptive behavior|0|||
19607852|NCT01000025|42056682|FG001|Overall Study|Adverse Event|2|||
19794162|NCT03029819|42252287|FG001|Overall Study|Removed due to disruptive behavior|1|||
19794163|NCT02678390|42252298|FG000|AE (1 Day)|Withdrawal by Subject|0|||
19794164|NCT02678390|42252299|FG001|AE (1 Day)|Withdrawal by Subject|1|||
19794165|NCT03027557|42252308|FG000|Overall Study|Adverse Event|1|||
19794166|NCT03027557|42252309|FG001|Overall Study|Adverse Event|0|||
19794167|NCT03027557|42252310|FG002|Overall Study|Adverse Event|0|||
19794168|NCT03029585|42252320|FG000|Overall Study|Death|1|||
19794169|NCT03029585|42252321|FG001|Overall Study|Death|1|||
19794170|NCT03029585|42252320|FG000|Overall Study|Withdrawal by Subject|1|||
19794171|NCT03029585|42252321|FG001|Overall Study|Withdrawal by Subject|0|||
19794172|NCT02678000|42252332|FG000|PART 2|Adverse Event|0|||
19794173|NCT02678000|42252333|FG001|PART 2|Adverse Event|0|||
19794174|NCT02678000|42252334|FG002|PART 2|Adverse Event|2|||
19794175|NCT02678000|42252335|FG003|PART 2|Adverse Event|1|||
19794176|NCT02678000|42252336|FG004|PART 2|Adverse Event|0|||
19794177|NCT02678000|42252332|FG000|PART 2|Withdrawal by Subject|0|||
19794178|NCT02678000|42252333|FG001|PART 2|Withdrawal by Subject|0|||
19794179|NCT02678000|42252334|FG002|PART 2|Withdrawal by Subject|1|||
19794180|NCT02678000|42252335|FG003|PART 2|Withdrawal by Subject|0|||
19794181|NCT02678000|42252336|FG004|PART 2|Withdrawal by Subject|0|||
19794182|NCT02691572|42252363|FG000|Overall Study|Withdrawal by Subject|1|||
19794183|NCT02691572|42252364|FG001|Overall Study|Withdrawal by Subject|0|||
19794184|NCT02691572|42252363|FG000|Overall Study|Protocol Violation|0|||
19794185|NCT02691572|42252364|FG001|Overall Study|Protocol Violation|1|||
19794186|NCT02677844|42252372|FG000|Period 3|Withdrawal by Subject|0|||
19794187|NCT02677844|42252373|FG001|Period 3|Withdrawal by Subject|0|||
19794188|NCT02677844|42252374|FG002|Period 3|Withdrawal by Subject|0|||
19794189|NCT02677844|42252375|FG003|Period 3|Withdrawal by Subject|1|||
19794190|NCT02677844|42252376|FG004|Period 3|Withdrawal by Subject|0|||
19794191|NCT02677844|42252377|FG005|Period 3|Withdrawal by Subject|0|||
19794192|NCT02677844|42252378|FG006|Period 3|Withdrawal by Subject|0|||
19794193|NCT02691494|42252400|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
19794194|NCT02691494|42252401|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
19794195|NCT02691494|42252402|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
19794196|NCT02691494|42252400|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
19794197|NCT02691494|42252401|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
19794198|NCT02691494|42252402|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
19794199|NCT02691494|42252400|FG000|Post-Treatment Follow-Up Period|Other|2|||
19794200|NCT02691494|42252401|FG001|Post-Treatment Follow-Up Period|Other|1|||
19794201|NCT02691494|42252402|FG002|Post-Treatment Follow-Up Period|Other|1|||
19794202|NCT02691494|42252400|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
19794203|NCT02691494|42252401|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
19794204|NCT02691494|42252402|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
19794205|NCT02691494|42252400|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
19794206|NCT02691494|42252401|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
19794207|NCT02691494|42252402|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
19794208|NCT02677220|42252410|FG000|Overall Study|Adverse Event|1|||
19794209|NCT02682602|42252417|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
19794210|NCT02682602|42252418|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
19794211|NCT02682602|42252417|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
19794212|NCT02682602|42252418|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
19794213|NCT02681510|42252428|FG000|Overall Study|Withdrawal by Subject|1|||
19794214|NCT02681510|42252428|FG000|Overall Study|Lost to Follow-up|9|||
19794215|NCT02690714|42252432|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
19794216|NCT02690714|42252432|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
19794217|NCT01898793|42252447|FG000|Overall Study|Death|2|||
19794218|NCT01898793|42252448|FG001|Overall Study|Death|1|||
19794219|NCT01898793|42252449|FG002|Overall Study|Death|4|||
19794220|NCT01898793|42252450|FG003|Overall Study|Death|0|||
19794221|NCT01898793|42252451|FG004|Overall Study|Death|0|||
19794222|NCT01898793|42252452|FG005|Overall Study|Death|0|||
19794223|NCT01898793|42252453|FG006|Overall Study|Death|0|||
19794224|NCT01791543|42252472|FG000|Overall Study|Lost to Follow-up|1|||
19794225|NCT01791543|42252472|FG000|Overall Study|Adverse Event|1|||
19794226|NCT02925455|42252479|FG000|Overall Study|Withdrawal by Subject|2|||
19794227|NCT02925455|42252480|FG001|Overall Study|Withdrawal by Subject|0|||
19607853|NCT01000025|42056681|FG000|Overall Study|Withdrawal by Subject|13|||
19698199|NCT00068692|42143481|FG002|Step 1: Registration|Other|0|||
19698200|NCT00068692|42143482|FG003|Step 1: Registration|Other|0|||
19698201|NCT00068692|42143483|FG004|Step 1: Registration|Other|0|||
19698202|NCT00068692|42143484|FG005|Step 1: Registration|Other|0|||
19698203|NCT00068692|42143485|FG006|Step 1: Registration|Other|0|||
19698204|NCT00068692|42143486|FG007|Step 1: Registration|Other|0|||
19698205|NCT00068692|42143479|FG000|Step 1: Registration|Not start protocol therapy|3|||
19698206|NCT00068692|42143480|FG001|Step 1: Registration|Not start protocol therapy|0|||
19698207|NCT00068692|42143481|FG002|Step 1: Registration|Not start protocol therapy|0|||
19698208|NCT00068692|42143482|FG003|Step 1: Registration|Not start protocol therapy|0|||
19794228|NCT03033069|42252490|FG000|Overall Study|Adverse Event|6|||
19794229|NCT03033069|42252491|FG001|Overall Study|Adverse Event|7|||
19794230|NCT03033069|42252492|FG002|Overall Study|Adverse Event|4|||
19794231|NCT03033069|42252493|FG003|Overall Study|Adverse Event|6|||
19794232|NCT03033069|42252490|FG000|Overall Study|Lack of Efficacy|0|||
19794233|NCT03033069|42252491|FG001|Overall Study|Lack of Efficacy|0|||
19794234|NCT03033069|42252492|FG002|Overall Study|Lack of Efficacy|1|||
19794235|NCT03033069|42252493|FG003|Overall Study|Lack of Efficacy|0|||
19794236|NCT03033069|42252490|FG000|Overall Study|Lost to Follow-up|6|||
19794237|NCT03033069|42252491|FG001|Overall Study|Lost to Follow-up|5|||
19794238|NCT03033069|42252492|FG002|Overall Study|Lost to Follow-up|5|||
19794239|NCT03033069|42252493|FG003|Overall Study|Lost to Follow-up|6|||
19794240|NCT03033069|42252490|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19794241|NCT03033069|42252491|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19794242|NCT03033069|42252492|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19794243|NCT03033069|42252493|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19794244|NCT03033069|42252490|FG000|Overall Study|Protocol Deviation|0|||
19794245|NCT03033069|42252491|FG001|Overall Study|Protocol Deviation|1|||
19794246|NCT03033069|42252492|FG002|Overall Study|Protocol Deviation|0|||
19794247|NCT03033069|42252493|FG003|Overall Study|Protocol Deviation|0|||
19794248|NCT03033069|42252490|FG000|Overall Study|Withdrawal by Subject|10|||
19794249|NCT03033069|42252491|FG001|Overall Study|Withdrawal by Subject|10|||
19794250|NCT03033069|42252492|FG002|Overall Study|Withdrawal by Subject|11|||
19794251|NCT03033069|42252493|FG003|Overall Study|Withdrawal by Subject|6|||
19794252|NCT03033069|42252490|FG000|Overall Study|Withdrawal By Caregiver|1|||
19794253|NCT03033069|42252491|FG001|Overall Study|Withdrawal By Caregiver|0|||
19794254|NCT03033069|42252492|FG002|Overall Study|Withdrawal By Caregiver|0|||
19794255|NCT03033069|42252493|FG003|Overall Study|Withdrawal By Caregiver|0|||
19794256|NCT03033069|42252490|FG000|Overall Study|Reason not Specified|0|||
19794257|NCT03033069|42252491|FG001|Overall Study|Reason not Specified|1|||
19794258|NCT03033069|42252492|FG002|Overall Study|Reason not Specified|0|||
19794259|NCT03033069|42252493|FG003|Overall Study|Reason not Specified|1|||
19794260|NCT02917265|42252505|FG000|Overall Study|Physician Decision|1|||
19794261|NCT02917265|42252506|FG001|Overall Study|Physician Decision|0|||
19794262|NCT02917265|42252505|FG000|Overall Study|Withdrawal by Subject|1|||
19794263|NCT02917265|42252506|FG001|Overall Study|Withdrawal by Subject|0|||
19794264|NCT02136069|42252516|FG000|Overall Study|UC flare-up|1|||
19794265|NCT02136069|42252517|FG001|Overall Study|UC flare-up|0|||
19794266|NCT02136069|42252516|FG000|Overall Study|Adverse Event|6|||
19794267|NCT02136069|42252517|FG001|Overall Study|Adverse Event|8|||
19794268|NCT02136069|42252516|FG000|Overall Study|Death|0|||
19794269|NCT02136069|42252517|FG001|Overall Study|Death|1|||
19794270|NCT02136069|42252516|FG000|Overall Study|Lack of Efficacy|10|||
19794271|NCT02136069|42252517|FG001|Overall Study|Lack of Efficacy|4|||
19794272|NCT02136069|42252516|FG000|Overall Study|Lost to Follow-up|1|||
19794273|NCT02136069|42252517|FG001|Overall Study|Lost to Follow-up|0|||
19794274|NCT02136069|42252516|FG000|Overall Study|Non-Compliance|1|||
19794275|NCT02136069|42252517|FG001|Overall Study|Non-Compliance|0|||
19794276|NCT02136069|42252516|FG000|Overall Study|Physician Decision|5|||
19794277|NCT02136069|42252517|FG001|Overall Study|Physician Decision|4|||
19794278|NCT02136069|42252516|FG000|Overall Study|Withdrawal by Subject|10|||
19794279|NCT02136069|42252517|FG001|Overall Study|Withdrawal by Subject|11|||
19794280|NCT02917031|42252526|FG000|Overall Study|Reason not specified|7|||
19794281|NCT02917031|42252527|FG001|Overall Study|Reason not specified|5|||
19794282|NCT02917031|42252528|FG002|Overall Study|Reason not specified|6|||
19794283|NCT02917031|42252526|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
19794284|NCT02917031|42252527|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
19794285|NCT02917031|42252528|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
19794286|NCT02917031|42252526|FG000|Overall Study|Withdrawal by Subject|3|||
19794287|NCT02917031|42252527|FG001|Overall Study|Withdrawal by Subject|3|||
19794288|NCT02917031|42252528|FG002|Overall Study|Withdrawal by Subject|0|||
19794289|NCT02917031|42252526|FG000|Overall Study|Physician Decision|1|||
19794290|NCT02917031|42252527|FG001|Overall Study|Physician Decision|0|||
19794291|NCT02917031|42252528|FG002|Overall Study|Physician Decision|0|||
19794292|NCT02917031|42252526|FG000|Overall Study|Adverse Event|4|||
19794293|NCT02917031|42252527|FG001|Overall Study|Adverse Event|1|||
19794294|NCT02917031|42252528|FG002|Overall Study|Adverse Event|5|||
19794295|NCT02917031|42252526|FG000|Overall Study|Death|2|||
19794296|NCT02917031|42252527|FG001|Overall Study|Death|3|||
19794297|NCT02917031|42252528|FG002|Overall Study|Death|4|||
19794298|NCT01018563|42252537|FG000|Overall Study|Termination of the study by Sponsor|2|||
19794299|NCT01018563|42252538|FG001|Overall Study|Termination of the study by Sponsor|1|||
19794300|NCT02528188|42252551|FG000|Overall Study|Adverse Event|23|||
19794301|NCT02528188|42252552|FG001|Overall Study|Adverse Event|22|||
19794302|NCT02528188|42252553|FG002|Overall Study|Adverse Event|8|||
19794303|NCT02528188|42252551|FG000|Overall Study|Protocol Violation|4|||
19794304|NCT02528188|42252552|FG001|Overall Study|Protocol Violation|6|||
19794305|NCT02528188|42252553|FG002|Overall Study|Protocol Violation|4|||
19794306|NCT02528188|42252551|FG000|Overall Study|Lack of Efficacy|19|||
19794307|NCT02528188|42252552|FG001|Overall Study|Lack of Efficacy|21|||
19794308|NCT02528188|42252553|FG002|Overall Study|Lack of Efficacy|22|||
19794309|NCT02528188|42252551|FG000|Overall Study|Withdrawal by Subject|97|||
19794310|NCT02528188|42252552|FG001|Overall Study|Withdrawal by Subject|104|||
19794311|NCT02528188|42252553|FG002|Overall Study|Withdrawal by Subject|100|||
19794312|NCT02528188|42252551|FG000|Overall Study|Lost to Follow-up|25|||
19794313|NCT02528188|42252552|FG001|Overall Study|Lost to Follow-up|21|||
19794314|NCT02528188|42252553|FG002|Overall Study|Lost to Follow-up|31|||
19794315|NCT02528188|42252551|FG000|Overall Study|Death|4|||
19794316|NCT02528188|42252552|FG001|Overall Study|Death|4|||
19794317|NCT02528188|42252553|FG002|Overall Study|Death|0|||
19794318|NCT02528188|42252551|FG000|Overall Study|Other|89|||
19794319|NCT02528188|42252552|FG001|Overall Study|Other|91|||
19794320|NCT02528188|42252553|FG002|Overall Study|Other|74|||
19794321|NCT02528188|42252551|FG000|Overall Study|Randomized but not treated|6|||
19794322|NCT02528188|42252552|FG001|Overall Study|Randomized but not treated|7|||
19794323|NCT02528188|42252553|FG002|Overall Study|Randomized but not treated|12|||
19794324|NCT03896165|42252561|FG000|Overall Study|Withdrawal by Subject|2|||
19794325|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
19794326|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
19794327|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
19794328|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
19794329|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
19794330|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
19794331|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
19794332|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
19794333|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
19794334|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
19794335|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
19794336|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
19794337|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
19794338|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
19794339|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
19794340|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
19794341|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
19794342|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
19794343|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
19794344|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
19794345|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
19794346|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
19794347|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
19794348|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
19794349|NCT02269917|42252587|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
19794350|NCT02269917|42252588|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
19794351|NCT02269917|42252589|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
19794352|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
19794353|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
19794354|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
19794355|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
19794356|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
19794357|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
19794358|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
19794359|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
19794360|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
19794361|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
19794362|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
19794363|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
19794364|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
19794365|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
19794366|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
19794367|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
19794368|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
19794369|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
19794370|NCT02269917|42252587|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
19794371|NCT02269917|42252588|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
19794372|NCT02269917|42252589|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
19794373|NCT02522494|42252600|FG000|Overall Study|Lost to Follow-up|6|||
19794374|NCT02522494|42252601|FG001|Overall Study|Lost to Follow-up|2|||
19794375|NCT02522494|42252600|FG000|Overall Study|Withdrawal by Subject|1|||
19794376|NCT02522494|42252601|FG001|Overall Study|Withdrawal by Subject|0|||
19477881|NCT01461811|41757158|FG001|Overall Study|Noncompliance|1|||
19794377|NCT02522494|42252600|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
19794378|NCT02522494|42252601|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
19794379|NCT02522494|42252600|FG000|Overall Study|Participant did not watch the video|1|||
19794380|NCT02522494|42252601|FG001|Overall Study|Participant did not watch the video|0|||
19794381|NCT02522494|42252600|FG000|Overall Study|Death|0|||
19794382|NCT02522494|42252601|FG001|Overall Study|Death|1|||
19794383|NCT01658020|42252609|FG000|Overall Study|Adverse Event|3|||
19794384|NCT01658020|42252610|FG001|Overall Study|Adverse Event|3|||
19794385|NCT01658020|42252609|FG000|Overall Study|Lost to Follow-up|1|||
19794386|NCT01658020|42252610|FG001|Overall Study|Lost to Follow-up|0|||
19794387|NCT01658020|42252609|FG000|Overall Study|Withdrawal by Subject|4|||
19794388|NCT01658020|42252610|FG001|Overall Study|Withdrawal by Subject|5|||
19794389|NCT01658020|42252609|FG000|Overall Study|Protocol Violation|0|||
19794390|NCT01658020|42252610|FG001|Overall Study|Protocol Violation|1|||
19794391|NCT03389477|42252628|FG000|Step 1|Withdrawal by Subject|1|||
19794392|NCT03389477|42252629|FG001|Step 1|Withdrawal by Subject|0|||
19794393|NCT03389477|42252628|FG000|Step 2|Withdrawal by Subject|1|||
19794394|NCT03389477|42252629|FG001|Step 2|Withdrawal by Subject|2|||
19794395|NCT03389477|42252628|FG000|Step 2|Disease progression|1|||
19794396|NCT03389477|42252629|FG001|Step 2|Disease progression|0|||
19794397|NCT03389477|42252628|FG000|Step 2|Death|0|||
19794398|NCT03389477|42252629|FG001|Step 2|Death|1|||
19794399|NCT03389477|42252628|FG000|Step 2|Poor performance status and nutrition|0|||
19794400|NCT03389477|42252629|FG001|Step 2|Poor performance status and nutrition|1|||
19794401|NCT03389477|42252628|FG000|Step 3|Withdrawal after 3 cycles|0|||
19794402|NCT03389477|42252629|FG001|Step 3|Withdrawal after 3 cycles|1|||
19794403|NCT03389477|42252628|FG000|Step 3|Still receiving active treatment|4|||
19794404|NCT03389477|42252629|FG001|Step 3|Still receiving active treatment|0|||
19794405|NCT03389477|42252628|FG000|Step 3|Progressive disease after 2 cycles|1|||
19794406|NCT03389477|42252629|FG001|Step 3|Progressive disease after 2 cycles|0|||
19794407|NCT02680574|42252639|FG000|Overall Study|Death|137|||
19794408|NCT02680574|42252640|FG001|Overall Study|Death|137|||
19794409|NCT02680574|42252639|FG000|Overall Study|Withdrawal by Subject|17|||
19794410|NCT02680574|42252640|FG001|Overall Study|Withdrawal by Subject|9|||
19794411|NCT02680574|42252639|FG000|Overall Study|Lost to Follow-up|4|||
19794412|NCT02680574|42252640|FG001|Overall Study|Lost to Follow-up|6|||
19794413|NCT02522884|42252646|FG000|Overall Study|Withdrawal by Subject|6|||
19794414|NCT02522884|42252646|FG000|Overall Study|Death|3|||
19794415|NCT02522884|42252646|FG000|Overall Study|Missed 12-month Follow-up|9|||
19794416|NCT02674568|42252663|FG000|Overall Study|Withdrawal by Subject|5|||
19794417|NCT02674568|42252663|FG000|Overall Study|Death|303|||
19794418|NCT02674568|42252663|FG000|Overall Study|Physician Decision|2|||
19794419|NCT02674568|42252663|FG000|Overall Study|Lost to Follow-up|9|||
19794420|NCT02674568|42252663|FG000|Overall Study|Other, Not Specified|20|||
19794421|NCT03022799|42252685|FG000|Overall Study|Adverse Event|0|||
19794422|NCT03022799|42252686|FG001|Overall Study|Adverse Event|0|||
19794423|NCT03022799|42252687|FG002|Overall Study|Adverse Event|0|||
19794424|NCT03022799|42252688|FG003|Overall Study|Adverse Event|0|||
19794425|NCT03022799|42252689|FG004|Overall Study|Adverse Event|0|||
19794426|NCT03022799|42252690|FG005|Overall Study|Adverse Event|0|||
19794427|NCT03022799|42252691|FG006|Overall Study|Adverse Event|0|||
19794428|NCT03022799|42252692|FG007|Overall Study|Adverse Event|0|||
19794429|NCT03022799|42252693|FG008|Overall Study|Adverse Event|0|||
19794430|NCT03022799|42252694|FG009|Overall Study|Adverse Event|1|||
19794431|NCT03022799|42252695|FG010|Overall Study|Adverse Event|1|||
19794432|NCT03022799|42252696|FG011|Overall Study|Adverse Event|0|||
19794433|NCT03022799|42252697|FG012|Overall Study|Adverse Event|0|||
19794434|NCT02674334|42252744|FG000|Overall Study|Lost to Follow-up|5|||
19794435|NCT02674334|42252745|FG001|Overall Study|Lost to Follow-up|3|||
19794436|NCT02674334|42252744|FG000|Overall Study|participant difficulty breathing|1|||
19794437|NCT02674334|42252745|FG001|Overall Study|participant difficulty breathing|0|||
19794438|NCT02674334|42252744|FG000|Overall Study|NIRS not recording|1|||
19794439|NCT02674334|42252745|FG001|Overall Study|NIRS not recording|0|||
19794440|NCT03026075|42252751|FG000|Overall Study|Physician Decision|1|||
19794441|NCT01373918|42252757|FG000|Overall Study|Physician Decision|0|||
19794442|NCT01373918|42252758|FG001|Overall Study|Physician Decision|1|||
19477882|NCT01505491|41757167|FG000|Overall Study|Other reason not listed|1|||
19794443|NCT02667626|42252766|FG000|Overall Study|Withdrawal by Subject|0|||
19794444|NCT02667626|42252767|FG001|Overall Study|Withdrawal by Subject|1|||
19794445|NCT02522728|42252778|FG000|Overall Study|Withdrawal by Subject|6|||
19794446|NCT02522728|42252779|FG001|Overall Study|Withdrawal by Subject|6|||
19794447|NCT02522728|42252778|FG000|Overall Study|Death|4|||
19794448|NCT02522728|42252779|FG001|Overall Study|Death|3|||
19794449|NCT02522728|42252778|FG000|Overall Study|Adverse Event|2|||
19794450|NCT02522728|42252779|FG001|Overall Study|Adverse Event|1|||
19794451|NCT02522728|42252778|FG000|Overall Study|Did not receive randomized study device|0|||
19794452|NCT02522728|42252779|FG001|Overall Study|Did not receive randomized study device|1|||
19794453|NCT02827877|42252785|FG000|Overall Study|Withdrawal by Subject|1|||
19794454|NCT03025217|42252798|FG000|Overall Study|Pregnancy|1|||
19794455|NCT03025217|42252798|FG000|Overall Study|Lost to Follow-up|1|||
19794456|NCT03025217|42252798|FG000|Overall Study|Not eligible, poor English|2|||
19794457|NCT03023813|42252805|FG000|Overall Study|Lost to Follow-up|1|||
19794458|NCT03023813|42252806|FG001|Overall Study|Lost to Follow-up|2|||
19794459|NCT03023813|42252807|FG002|Overall Study|Lost to Follow-up|0|||
19794460|NCT01365130|42252816|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
19794461|NCT01657162|42252822|FG000|Overall Study|Adverse Event|26|||
19794462|NCT01657162|42252823|FG001|Overall Study|Adverse Event|36|||
19794463|NCT01657162|42252822|FG000|Overall Study|Withdrawal by Subject|13|||
19794464|NCT01657162|42252823|FG001|Overall Study|Withdrawal by Subject|13|||
19794465|NCT01657162|42252822|FG000|Overall Study|Continuing Significant Deterioration|9|||
19794466|NCT01657162|42252823|FG001|Overall Study|Continuing Significant Deterioration|3|||
19794467|NCT01657162|42252822|FG000|Overall Study|Refusal of Treatment|4|||
19794468|NCT01657162|42252823|FG001|Overall Study|Refusal of Treatment|6|||
19794469|NCT01657162|42252822|FG000|Overall Study|Lost to Follow-up|3|||
19794470|NCT01657162|42252823|FG001|Overall Study|Lost to Follow-up|4|||
19794471|NCT01657162|42252822|FG000|Overall Study|Death|2|||
19794472|NCT01657162|42252823|FG001|Overall Study|Death|3|||
19794473|NCT01657162|42252822|FG000|Overall Study|Inability to Complete Study Procedures|1|||
19794474|NCT01657162|42252823|FG001|Overall Study|Inability to Complete Study Procedures|7|||
19794475|NCT01657162|42252822|FG000|Overall Study|Protocol Violation|1|||
19794476|NCT01657162|42252823|FG001|Overall Study|Protocol Violation|0|||
19794477|NCT01657162|42252822|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
19794478|NCT01657162|42252823|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
19794479|NCT01657162|42252822|FG000|Overall Study|Other than Specified|0|||
19794480|NCT01657162|42252823|FG001|Overall Study|Other than Specified|2|||
19794481|NCT01373294|42252857|FG000|Overall Study|Adverse Event|1|||
19794482|NCT01373294|42252858|FG001|Overall Study|Adverse Event|0|||
19607854|NCT01000025|42056682|FG001|Overall Study|Withdrawal by Subject|8|||
19607855|NCT01000025|42056681|FG000|Overall Study|Death|23|||
19607856|NCT01000025|42056682|FG001|Overall Study|Death|13|||
19607857|NCT01000025|42056681|FG000|Overall Study|Lack of Efficacy|363|||
19607858|NCT01000025|42056682|FG001|Overall Study|Lack of Efficacy|208|||
19607859|NCT01000025|42056681|FG000|Overall Study|Intercurrent Illness|26|||
19607860|NCT01000025|42056682|FG001|Overall Study|Intercurrent Illness|7|||
19698209|NCT00068692|42143483|FG004|Step 1: Registration|Not start protocol therapy|0|||
19698210|NCT00068692|42143484|FG005|Step 1: Registration|Not start protocol therapy|0|||
19698211|NCT00068692|42143485|FG006|Step 1: Registration|Not start protocol therapy|0|||
19698212|NCT00068692|42143486|FG007|Step 1: Registration|Not start protocol therapy|0|||
19698213|NCT00068692|42143479|FG000|Step 1: Registration|Registered but not randomized|0|||
19698214|NCT00068692|42143480|FG001|Step 1: Registration|Registered but not randomized|1|||
19698215|NCT00068692|42143481|FG002|Step 1: Registration|Registered but not randomized|0|||
19698216|NCT00068692|42143482|FG003|Step 1: Registration|Registered but not randomized|0|||
19698217|NCT00068692|42143483|FG004|Step 1: Registration|Registered but not randomized|0|||
19698218|NCT00068692|42143484|FG005|Step 1: Registration|Registered but not randomized|0|||
19698219|NCT00068692|42143485|FG006|Step 1: Registration|Registered but not randomized|0|||
19698220|NCT00068692|42143486|FG007|Step 1: Registration|Registered but not randomized|0|||
19698221|NCT00068692|42143479|FG000|Step 2: Randomization|Disesae progression/replase|0|||
19698222|NCT00068692|42143480|FG001|Step 2: Randomization|Disesae progression/replase|0|||
19698223|NCT00068692|42143481|FG002|Step 2: Randomization|Disesae progression/replase|1|||
19698224|NCT00068692|42143482|FG003|Step 2: Randomization|Disesae progression/replase|1|||
19698225|NCT00068692|42143483|FG004|Step 2: Randomization|Disesae progression/replase|0|||
19698226|NCT00068692|42143484|FG005|Step 2: Randomization|Disesae progression/replase|0|||
19698227|NCT00068692|42143485|FG006|Step 2: Randomization|Disesae progression/replase|0|||
19698228|NCT00068692|42143486|FG007|Step 2: Randomization|Disesae progression/replase|0|||
19698229|NCT00068692|42143479|FG000|Step 2: Randomization|Adverse Event|0|||
19698230|NCT00068692|42143480|FG001|Step 2: Randomization|Adverse Event|0|||
19698231|NCT00068692|42143481|FG002|Step 2: Randomization|Adverse Event|4|||
19794483|NCT01656304|42252864|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
19794484|NCT03023423|42252871|FG000|Overall Study|Death|5|||
19607861|NCT00595335|42056690|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
19607862|NCT00595335|42056691|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
19607863|NCT00595335|42056690|FG000|Baseline to Six Months|Disease Progression|1|||
19607864|NCT00595335|42056691|FG001|Baseline to Six Months|Disease Progression|1|||
19607865|NCT00595335|42056690|FG000|Baseline to Six Months|Adverse Event|1|||
19607866|NCT00595335|42056691|FG001|Baseline to Six Months|Adverse Event|0|||
19607867|NCT00595335|42056690|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
19607868|NCT00595335|42056691|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
19794485|NCT03023423|42252872|FG001|Overall Study|Death|12|||
19794486|NCT03023423|42252873|FG002|Overall Study|Death|20|||
19794487|NCT03023423|42252871|FG000|Overall Study|Other|0|||
19794488|NCT03023423|42252872|FG001|Overall Study|Other|2|||
19607869|NCT00595335|42056690|FG000|Six Months to Twelve Months|Disease Progression|1|||
19698232|NCT00068692|42143482|FG003|Step 2: Randomization|Adverse Event|2|||
19607870|NCT00595335|42056691|FG001|Six Months to Twelve Months|Disease Progression|0|||
19607871|NCT00661609|42056701|FG000|Overall Study|Adverse Event|4|||
19607872|NCT00661609|42056701|FG000|Overall Study|Death|20|||
19607873|NCT00661609|42056701|FG000|Overall Study|Withdrawal by Subject|2|||
19607874|NCT00661609|42056701|FG000|Overall Study|PI Decision|1|||
19607875|NCT00661609|42056701|FG000|Overall Study|Survival follow up stage discontinued|11|||
19607876|NCT00661609|42056701|FG000|Overall Study|Disease progression|3|||
19607877|NCT00661531|42056705|FG000|Overall Study|Withdrawal by Subject|3|||
19607878|NCT00998309|42056709|FG000|Overall Study|Protocol Violation|4|||
19698233|NCT00068692|42143483|FG004|Step 2: Randomization|Adverse Event|2|||
19698234|NCT00068692|42143484|FG005|Step 2: Randomization|Adverse Event|3|||
19698235|NCT00068692|42143485|FG006|Step 2: Randomization|Adverse Event|4|||
19698236|NCT00068692|42143486|FG007|Step 2: Randomization|Adverse Event|4|||
19698237|NCT00068692|42143479|FG000|Step 2: Randomization|Death|0|||
19698238|NCT00068692|42143480|FG001|Step 2: Randomization|Death|0|||
19698239|NCT00068692|42143481|FG002|Step 2: Randomization|Death|0|||
19698240|NCT00068692|42143482|FG003|Step 2: Randomization|Death|0|||
19698241|NCT00068692|42143483|FG004|Step 2: Randomization|Death|1|||
19698242|NCT00068692|42143484|FG005|Step 2: Randomization|Death|0|||
19698243|NCT00068692|42143485|FG006|Step 2: Randomization|Death|0|||
19698244|NCT00068692|42143486|FG007|Step 2: Randomization|Death|1|||
19698245|NCT00068692|42143479|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
19698246|NCT00068692|42143480|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
19698247|NCT00068692|42143481|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
19698248|NCT00068692|42143482|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
19698249|NCT00068692|42143483|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
19698250|NCT00068692|42143484|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
19698251|NCT00068692|42143485|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
19698252|NCT00068692|42143486|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
19698253|NCT00068692|42143479|FG000|Step 2: Randomization|alternative therapy|0|||
19698254|NCT00068692|42143480|FG001|Step 2: Randomization|alternative therapy|0|||
19698255|NCT00068692|42143481|FG002|Step 2: Randomization|alternative therapy|0|||
19698256|NCT00068692|42143482|FG003|Step 2: Randomization|alternative therapy|1|||
19698257|NCT00068692|42143483|FG004|Step 2: Randomization|alternative therapy|1|||
19698258|NCT00068692|42143484|FG005|Step 2: Randomization|alternative therapy|0|||
19698259|NCT00068692|42143485|FG006|Step 2: Randomization|alternative therapy|0|||
19698260|NCT00068692|42143486|FG007|Step 2: Randomization|alternative therapy|0|||
19607879|NCT00999713|42056763|FG000|Overall Study|Physician Decision|2|||
19607880|NCT00999713|42056764|FG001|Overall Study|Physician Decision|0|||
19607881|NCT00997373|42056772|FG000|Overall Study|Withdrawal by Subject|5|||
19607882|NCT00997373|42056773|FG001|Overall Study|Withdrawal by Subject|0|||
19607883|NCT00997373|42056772|FG000|Overall Study|wrong tumor type|4|||
19607884|NCT00997373|42056773|FG001|Overall Study|wrong tumor type|0|||
19607885|NCT00997373|42056772|FG000|Overall Study|could not have hysterectomy|6|||
19607886|NCT00997373|42056773|FG001|Overall Study|could not have hysterectomy|0|||
19607887|NCT00663871|42056781|FG000|Overall Study|Lost to Follow-up|5|||
19607888|NCT00663871|42056782|FG001|Overall Study|Lost to Follow-up|5|||
19607889|NCT00663871|42056781|FG000|Overall Study|Withdrawal by Subject|5|||
19607890|NCT00663871|42056782|FG001|Overall Study|Withdrawal by Subject|2|||
19607891|NCT04152447|42056792|FG000|Overall Study|Lost to Follow-up|1|||
19607892|NCT04152447|42056793|FG001|Overall Study|Lost to Follow-up|0|||
19607893|NCT04152447|42056792|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
19607894|NCT04152447|42056793|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
19607895|NCT04152447|42056792|FG000|Overall Study|Withdrawal by Subject|0|||
19607896|NCT04152447|42056793|FG001|Overall Study|Withdrawal by Subject|1|||
19607897|NCT04152447|42056792|FG000|Overall Study|Found ineligible after enrolling|1|||
19698261|NCT00068692|42143479|FG000|Step 2: Randomization|Physician Decision|0|||
19698262|NCT00068692|42143480|FG001|Step 2: Randomization|Physician Decision|0|||
19698263|NCT00068692|42143481|FG002|Step 2: Randomization|Physician Decision|0|||
19698264|NCT00068692|42143482|FG003|Step 2: Randomization|Physician Decision|1|||
19698265|NCT00068692|42143483|FG004|Step 2: Randomization|Physician Decision|1|||
19698266|NCT00068692|42143484|FG005|Step 2: Randomization|Physician Decision|0|||
19607898|NCT04152447|42056793|FG001|Overall Study|Found ineligible after enrolling|1|||
19607899|NCT04152447|42056792|FG000|Overall Study|Did not receive VR headset in time.|0|||
19607900|NCT04152447|42056793|FG001|Overall Study|Did not receive VR headset in time.|2|||
19607901|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
19607902|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
19607903|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
19698267|NCT00068692|42143485|FG006|Step 2: Randomization|Physician Decision|0|||
19698268|NCT00068692|42143486|FG007|Step 2: Randomization|Physician Decision|0|||
19698269|NCT00068692|42143479|FG000|Step 2: Randomization|Other|0|||
19698270|NCT00068692|42143480|FG001|Step 2: Randomization|Other|0|||
19698271|NCT00068692|42143481|FG002|Step 2: Randomization|Other|0|||
19698272|NCT00068692|42143482|FG003|Step 2: Randomization|Other|1|||
19698273|NCT00068692|42143483|FG004|Step 2: Randomization|Other|0|||
19794489|NCT03023423|42252873|FG002|Overall Study|Other|2|||
19794490|NCT03023423|42252871|FG000|Overall Study|Ongoing|2|||
19794491|NCT03023423|42252872|FG001|Overall Study|Ongoing|32|||
19794492|NCT03023423|42252873|FG002|Overall Study|Ongoing|24|||
19794493|NCT03185741|42252888|FG000|Baseline|Withdrawal by Subject|1|||
19794494|NCT03185741|42252889|FG001|Baseline|Withdrawal by Subject|3|||
19794495|NCT03185741|42252890|FG002|Baseline|Withdrawal by Subject|2|||
19794496|NCT03185741|42252888|FG000|Baseline|Lost to Follow-up|1|||
19794497|NCT03185741|42252889|FG001|Baseline|Lost to Follow-up|2|||
19794498|NCT03185741|42252890|FG002|Baseline|Lost to Follow-up|3|||
19794499|NCT03185741|42252888|FG000|3Month|Death|1|||
19794500|NCT03185741|42252889|FG001|3Month|Death|1|||
19794501|NCT03185741|42252890|FG002|3Month|Death|2|||
19794502|NCT03185741|42252888|FG000|3Month|Withdrawal by Subject|1|||
19794503|NCT03185741|42252889|FG001|3Month|Withdrawal by Subject|5|||
19794504|NCT03185741|42252890|FG002|3Month|Withdrawal by Subject|1|||
19794505|NCT03185741|42252888|FG000|3Month|Lost to Follow-up|7|||
19794506|NCT03185741|42252889|FG001|3Month|Lost to Follow-up|9|||
19794507|NCT03185741|42252890|FG002|3Month|Lost to Follow-up|8|||
19794508|NCT03185741|42252888|FG000|3Month|Unavailable for 3Month|11|||
19794509|NCT03185741|42252889|FG001|3Month|Unavailable for 3Month|10|||
19794510|NCT03185741|42252890|FG002|3Month|Unavailable for 3Month|11|||
19794511|NCT03185741|42252888|FG000|3Month|Protocol Violation|0|||
19794512|NCT03185741|42252889|FG001|3Month|Protocol Violation|0|||
19794513|NCT03185741|42252890|FG002|3Month|Protocol Violation|3|||
19794514|NCT03185741|42252888|FG000|6Month|Death|1|||
19794515|NCT03185741|42252889|FG001|6Month|Death|1|||
19794516|NCT03185741|42252890|FG002|6Month|Death|2|||
19794517|NCT03185741|42252888|FG000|6Month|Withdrawal by Subject|2|||
19794518|NCT03185741|42252889|FG001|6Month|Withdrawal by Subject|3|||
19794519|NCT03185741|42252890|FG002|6Month|Withdrawal by Subject|1|||
19794520|NCT03185741|42252888|FG000|6Month|Lost to Follow-up|16|||
19794521|NCT03185741|42252889|FG001|6Month|Lost to Follow-up|15|||
19794522|NCT03185741|42252890|FG002|6Month|Lost to Follow-up|16|||
19794523|NCT02672852|42252900|FG000|Part A1|Disease Worsening|1|||
19794524|NCT02672852|42252901|FG001|Part A1|Disease Worsening|0|||
19794525|NCT02672852|42252902|FG002|Part A1|Disease Worsening|0|||
19794526|NCT02672852|42252903|FG003|Part A1|Disease Worsening|0|||
19794527|NCT02672852|42252904|FG004|Part A1|Disease Worsening|0|||
19794528|NCT02672852|42252905|FG005|Part A1|Disease Worsening|0|||
19794529|NCT02672852|42252906|FG006|Part A1|Disease Worsening|0|||
19794530|NCT02672852|42252900|FG000|Part A1|Adverse Event|0|||
19794531|NCT02672852|42252901|FG001|Part A1|Adverse Event|1|||
19794532|NCT02672852|42252902|FG002|Part A1|Adverse Event|0|||
19794533|NCT02672852|42252903|FG003|Part A1|Adverse Event|0|||
19794534|NCT02672852|42252904|FG004|Part A1|Adverse Event|0|||
19794535|NCT02672852|42252905|FG005|Part A1|Adverse Event|0|||
19794536|NCT02672852|42252906|FG006|Part A1|Adverse Event|0|||
19794537|NCT02672852|42252900|FG000|Part A1|Lost to Follow-up|1|||
19794538|NCT02672852|42252901|FG001|Part A1|Lost to Follow-up|2|||
19794539|NCT02672852|42252902|FG002|Part A1|Lost to Follow-up|0|||
19794540|NCT02672852|42252903|FG003|Part A1|Lost to Follow-up|0|||
19794541|NCT02672852|42252904|FG004|Part A1|Lost to Follow-up|0|||
19794542|NCT02672852|42252905|FG005|Part A1|Lost to Follow-up|0|||
19794543|NCT02672852|42252906|FG006|Part A1|Lost to Follow-up|0|||
19794544|NCT02672852|42252900|FG000|Part A1|Withdrawal by Subject|1|||
19794545|NCT02672852|42252901|FG001|Part A1|Withdrawal by Subject|1|||
19794546|NCT02672852|42252902|FG002|Part A1|Withdrawal by Subject|0|||
19794547|NCT02672852|42252903|FG003|Part A1|Withdrawal by Subject|0|||
19794548|NCT02672852|42252904|FG004|Part A1|Withdrawal by Subject|0|||
19794549|NCT02672852|42252905|FG005|Part A1|Withdrawal by Subject|0|||
19794550|NCT02672852|42252906|FG006|Part A1|Withdrawal by Subject|0|||
19794551|NCT02672852|42252900|FG000|Part A2|Disease worsening|0|||
19794552|NCT02672852|42252901|FG001|Part A2|Disease worsening|0|||
19794553|NCT02672852|42252902|FG002|Part A2|Disease worsening|1|||
19794554|NCT02672852|42252903|FG003|Part A2|Disease worsening|0|||
19794555|NCT02672852|42252904|FG004|Part A2|Disease worsening|0|||
19794556|NCT02672852|42252905|FG005|Part A2|Disease worsening|0|||
19794557|NCT02672852|42252906|FG006|Part A2|Disease worsening|0|||
19794558|NCT02672852|42252900|FG000|Part A2|Adverse Event|0|||
19794559|NCT02672852|42252901|FG001|Part A2|Adverse Event|0|||
19794560|NCT02672852|42252902|FG002|Part A2|Adverse Event|3|||
19794561|NCT02672852|42252903|FG003|Part A2|Adverse Event|0|||
19794562|NCT02672852|42252904|FG004|Part A2|Adverse Event|0|||
19794563|NCT02672852|42252905|FG005|Part A2|Adverse Event|0|||
19794564|NCT02672852|42252906|FG006|Part A2|Adverse Event|0|||
19794565|NCT02672852|42252900|FG000|Part A2|Lost to Follow-up|0|||
19794566|NCT02672852|42252901|FG001|Part A2|Lost to Follow-up|0|||
19794567|NCT02672852|42252902|FG002|Part A2|Lost to Follow-up|2|||
19794568|NCT02672852|42252903|FG003|Part A2|Lost to Follow-up|0|||
19794569|NCT02672852|42252904|FG004|Part A2|Lost to Follow-up|0|||
19794570|NCT02672852|42252905|FG005|Part A2|Lost to Follow-up|0|||
19794571|NCT02672852|42252906|FG006|Part A2|Lost to Follow-up|0|||
19794572|NCT02672852|42252900|FG000|Part A2|Withdrawal by Subject|0|||
19794573|NCT02672852|42252901|FG001|Part A2|Withdrawal by Subject|0|||
19794574|NCT02672852|42252902|FG002|Part A2|Withdrawal by Subject|1|||
19794575|NCT02672852|42252903|FG003|Part A2|Withdrawal by Subject|0|||
19794576|NCT02672852|42252904|FG004|Part A2|Withdrawal by Subject|0|||
19794577|NCT02672852|42252905|FG005|Part A2|Withdrawal by Subject|0|||
19794578|NCT02672852|42252906|FG006|Part A2|Withdrawal by Subject|0|||
19794579|NCT02672852|42252900|FG000|Part A2|Other|0|||
19794580|NCT02672852|42252901|FG001|Part A2|Other|0|||
19794581|NCT02672852|42252902|FG002|Part A2|Other|3|||
19794582|NCT02672852|42252903|FG003|Part A2|Other|0|||
19794583|NCT02672852|42252904|FG004|Part A2|Other|0|||
19794584|NCT02672852|42252905|FG005|Part A2|Other|0|||
19794585|NCT02672852|42252906|FG006|Part A2|Other|0|||
19794586|NCT02672852|42252900|FG000|Part A2|Not entered in Part B|0|||
19794587|NCT02672852|42252901|FG001|Part A2|Not entered in Part B|0|||
19794588|NCT02672852|42252902|FG002|Part A2|Not entered in Part B|0|||
19794589|NCT02672852|42252903|FG003|Part A2|Not entered in Part B|4|||
19477883|NCT01505491|41757168|FG001|Overall Study|Other reason not listed|0|||
19698274|NCT00068692|42143484|FG005|Step 2: Randomization|Other|1|||
19794590|NCT02672852|42252904|FG004|Part A2|Not entered in Part B|0|||
19794591|NCT02672852|42252905|FG005|Part A2|Not entered in Part B|0|||
19794592|NCT02672852|42252906|FG006|Part A2|Not entered in Part B|0|||
19794593|NCT02672852|42252900|FG000|Part B|Disease worsening|0|||
19794594|NCT02672852|42252901|FG001|Part B|Disease worsening|0|||
19794595|NCT02672852|42252902|FG002|Part B|Disease worsening|0|||
19794596|NCT02672852|42252903|FG003|Part B|Disease worsening|0|||
19794597|NCT02672852|42252904|FG004|Part B|Disease worsening|1|||
19794598|NCT02672852|42252905|FG005|Part B|Disease worsening|0|||
19794599|NCT02672852|42252906|FG006|Part B|Disease worsening|1|||
19794600|NCT02672852|42252900|FG000|Part B|Worsening pre-existing condition|0|||
19794601|NCT02672852|42252901|FG001|Part B|Worsening pre-existing condition|0|||
19794602|NCT02672852|42252902|FG002|Part B|Worsening pre-existing condition|0|||
19794603|NCT02672852|42252903|FG003|Part B|Worsening pre-existing condition|0|||
19794604|NCT02672852|42252904|FG004|Part B|Worsening pre-existing condition|0|||
19794605|NCT02672852|42252905|FG005|Part B|Worsening pre-existing condition|1|||
19698275|NCT00068692|42143485|FG006|Step 2: Randomization|Other|0|||
19698276|NCT00068692|42143486|FG007|Step 2: Randomization|Other|0|||
19698277|NCT00068692|42143479|FG000|Step 2: Randomization|never start protocol therapy|0|||
19698278|NCT00068692|42143480|FG001|Step 2: Randomization|never start protocol therapy|0|||
19698279|NCT00068692|42143481|FG002|Step 2: Randomization|never start protocol therapy|1|||
19698280|NCT00068692|42143482|FG003|Step 2: Randomization|never start protocol therapy|0|||
19698281|NCT00068692|42143483|FG004|Step 2: Randomization|never start protocol therapy|1|||
19698282|NCT00068692|42143484|FG005|Step 2: Randomization|never start protocol therapy|0|||
19698283|NCT00068692|42143485|FG006|Step 2: Randomization|never start protocol therapy|0|||
19698284|NCT00068692|42143486|FG007|Step 2: Randomization|never start protocol therapy|0|||
19698285|NCT00463151|42143503|FG000|Overall Study|Adverse Event|0|||
19698286|NCT00463151|42143504|FG001|Overall Study|Adverse Event|0|||
19698287|NCT00463151|42143505|FG002|Overall Study|Adverse Event|1|||
19698288|NCT00463151|42143506|FG003|Overall Study|Adverse Event|0|||
19698289|NCT00463151|42143503|FG000|Overall Study|Lack of Efficacy|2|||
19698290|NCT00463151|42143504|FG001|Overall Study|Lack of Efficacy|5|||
19698291|NCT00463151|42143505|FG002|Overall Study|Lack of Efficacy|2|||
19698292|NCT00463151|42143506|FG003|Overall Study|Lack of Efficacy|5|||
19698293|NCT00463151|42143503|FG000|Overall Study|Protocol Violation|0|||
19698294|NCT00463151|42143504|FG001|Overall Study|Protocol Violation|0|||
19698295|NCT00463151|42143505|FG002|Overall Study|Protocol Violation|0|||
19698296|NCT00463151|42143506|FG003|Overall Study|Protocol Violation|1|||
19698297|NCT00463151|42143503|FG000|Overall Study|Withdrawal by Subject|0|||
19698298|NCT00463151|42143504|FG001|Overall Study|Withdrawal by Subject|0|||
19698299|NCT00463151|42143505|FG002|Overall Study|Withdrawal by Subject|0|||
19698300|NCT00463151|42143506|FG003|Overall Study|Withdrawal by Subject|1|||
19698301|NCT00068380|42143516|FG000|Overall Study|Withdrawal by Subject|3|||
19698302|NCT00068380|42143516|FG000|Overall Study|Adverse Event|2|||
19698303|NCT00067990|42143522|FG000|Overall Study|Death|5|||
19698304|NCT00067990|42143523|FG001|Overall Study|Death|7|||
19698305|NCT00067990|42143522|FG000|Overall Study|ESRD, Non IF/TA|1|||
19698306|NCT00067990|42143523|FG001|Overall Study|ESRD, Non IF/TA|3|||
19698307|NCT00067990|42143522|FG000|Overall Study|Withdrawal by Subject|4|||
19698308|NCT00067990|42143523|FG001|Overall Study|Withdrawal by Subject|12|||
19698309|NCT00090220|42143531|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
19794606|NCT02672852|42252906|FG006|Part B|Worsening pre-existing condition|0|||
19794607|NCT02672852|42252900|FG000|Part B|Other adverse event|0|||
19794608|NCT02672852|42252901|FG001|Part B|Other adverse event|0|||
19794609|NCT02672852|42252902|FG002|Part B|Other adverse event|0|||
19794610|NCT02672852|42252903|FG003|Part B|Other adverse event|0|||
19794611|NCT02672852|42252904|FG004|Part B|Other adverse event|3|||
19794612|NCT02672852|42252905|FG005|Part B|Other adverse event|5|||
19794613|NCT02672852|42252906|FG006|Part B|Other adverse event|1|||
19794614|NCT02672852|42252900|FG000|Part B|Lost to Follow-up|0|||
19794615|NCT02672852|42252901|FG001|Part B|Lost to Follow-up|0|||
19794616|NCT02672852|42252902|FG002|Part B|Lost to Follow-up|0|||
19794617|NCT02672852|42252903|FG003|Part B|Lost to Follow-up|0|||
19794618|NCT02672852|42252904|FG004|Part B|Lost to Follow-up|3|||
19794619|NCT02672852|42252905|FG005|Part B|Lost to Follow-up|4|||
19794620|NCT02672852|42252906|FG006|Part B|Lost to Follow-up|1|||
19794621|NCT02672852|42252900|FG000|Part B|Withdrawal by Subject|0|||
19794622|NCT02672852|42252901|FG001|Part B|Withdrawal by Subject|0|||
19794623|NCT02672852|42252902|FG002|Part B|Withdrawal by Subject|0|||
19794624|NCT02672852|42252903|FG003|Part B|Withdrawal by Subject|0|||
19794625|NCT02672852|42252904|FG004|Part B|Withdrawal by Subject|5|||
19794626|NCT02672852|42252905|FG005|Part B|Withdrawal by Subject|0|||
19794627|NCT02672852|42252906|FG006|Part B|Withdrawal by Subject|7|||
19794628|NCT02672852|42252900|FG000|Part B|Other|0|||
19794629|NCT02672852|42252901|FG001|Part B|Other|0|||
19794630|NCT02672852|42252902|FG002|Part B|Other|0|||
19794631|NCT02672852|42252903|FG003|Part B|Other|0|||
19794632|NCT02672852|42252904|FG004|Part B|Other|4|||
19794633|NCT02672852|42252905|FG005|Part B|Other|1|||
19794634|NCT02672852|42252906|FG006|Part B|Other|2|||
19794635|NCT02671760|42252917|FG000|Overall Study|Lost to Follow-up|0|||
19794636|NCT02671760|42252918|FG001|Overall Study|Lost to Follow-up|1|||
19794637|NCT02671760|42252919|FG002|Overall Study|Lost to Follow-up|0|||
19794638|NCT02667236|42252929|FG000|Overall Study|Adverse Event|1|||
19794639|NCT02667236|42252930|FG001|Overall Study|Adverse Event|1|||
19794640|NCT02667236|42252929|FG000|Overall Study|Withdrawal by Subject|2|||
19794641|NCT02667236|42252930|FG001|Overall Study|Withdrawal by Subject|0|||
19794642|NCT01126749|42252940|FG000|Phase 1b|Other|0|||
19794643|NCT01126749|42252941|FG001|Phase 1b|Other|1|||
19794644|NCT01126749|42252942|FG002|Phase 1b|Other|0|||
19794645|NCT01126749|42252943|FG003|Phase 1b|Other|0|||
19794646|NCT01126749|42252940|FG000|Phase 1b|Withdrawal by Subject|0|||
19794647|NCT01126749|42252941|FG001|Phase 1b|Withdrawal by Subject|1|||
19794648|NCT01126749|42252942|FG002|Phase 1b|Withdrawal by Subject|0|||
19794649|NCT01126749|42252943|FG003|Phase 1b|Withdrawal by Subject|0|||
19794650|NCT01126749|42252940|FG000|Phase 1b|Death|3|||
19794651|NCT01126749|42252941|FG001|Phase 1b|Death|4|||
19794652|NCT01126749|42252942|FG002|Phase 1b|Death|0|||
19794653|NCT01126749|42252943|FG003|Phase 1b|Death|0|||
19794654|NCT01126749|42252940|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
19794655|NCT01126749|42252941|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
19794656|NCT01126749|42252942|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
19794657|NCT01126749|42252943|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
19794658|NCT01126749|42252940|FG000|Phase 2|Study Termination by Sponsor|0|||
19794659|NCT01126749|42252941|FG001|Phase 2|Study Termination by Sponsor|0|||
19794660|NCT01126749|42252942|FG002|Phase 2|Study Termination by Sponsor|12|||
19794661|NCT01126749|42252943|FG003|Phase 2|Study Termination by Sponsor|6|||
19794662|NCT01126749|42252940|FG000|Phase 2|Other|0|||
19794663|NCT01126749|42252941|FG001|Phase 2|Other|0|||
19794664|NCT01126749|42252942|FG002|Phase 2|Other|4|||
19794665|NCT01126749|42252943|FG003|Phase 2|Other|2|||
19794666|NCT01126749|42252940|FG000|Phase 2|Withdrawal by Subject|0|||
19794667|NCT01126749|42252941|FG001|Phase 2|Withdrawal by Subject|0|||
19794668|NCT01126749|42252942|FG002|Phase 2|Withdrawal by Subject|0|||
19794669|NCT01126749|42252943|FG003|Phase 2|Withdrawal by Subject|2|||
19794670|NCT01126749|42252940|FG000|Phase 2|Lost to Follow-up|0|||
19794671|NCT01126749|42252941|FG001|Phase 2|Lost to Follow-up|0|||
19794672|NCT01126749|42252942|FG002|Phase 2|Lost to Follow-up|0|||
19794673|NCT01126749|42252943|FG003|Phase 2|Lost to Follow-up|1|||
19794674|NCT01126749|42252940|FG000|Phase 2|Death|0|||
19794675|NCT01126749|42252941|FG001|Phase 2|Death|0|||
19794676|NCT01126749|42252942|FG002|Phase 2|Death|22|||
19794677|NCT01126749|42252943|FG003|Phase 2|Death|22|||
19794678|NCT01126749|42252940|FG000|Phase 2|Adverse Event|0|||
19477884|NCT01505491|41757169|FG002|Overall Study|Other reason not listed|0|||
19477885|NCT01505491|41757167|FG000|Overall Study|Withdrawal by Subject|1|||
19794679|NCT01126749|42252941|FG001|Phase 2|Adverse Event|0|||
19794680|NCT01126749|42252942|FG002|Phase 2|Adverse Event|0|||
19794681|NCT01126749|42252943|FG003|Phase 2|Adverse Event|1|||
19794682|NCT02521948|42252953|FG000|Overall Study|Adverse Event|2|||
19794683|NCT02521948|42252953|FG000|Overall Study|Death|4|||
19794684|NCT02521948|42252953|FG000|Overall Study|Lost to Follow-up|1|||
19794685|NCT02521948|42252953|FG000|Overall Study|Did not attend one or both follow-ups|6|||
19794686|NCT04446429|42252962|FG000|Overall Study|Lost to Follow-up|6|||
19794687|NCT04446429|42252963|FG001|Overall Study|Lost to Follow-up|0|||
19794688|NCT02832687|42252971|FG000|Overall Study|Adverse Event|0|||
19794689|NCT02832687|42252972|FG001|Overall Study|Adverse Event|2|||
19794690|NCT01656850|42252997|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
19794691|NCT01656850|42252998|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
19794692|NCT03116685|42253010|FG000|Overall Study|Physician Decision|0|||
19794693|NCT03116685|42253011|FG001|Overall Study|Physician Decision|1|||
19794694|NCT02666222|42253031|FG000|Overall Study|Death|2|||
19794695|NCT00739401|42253035|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
19794696|NCT00739401|42253035|FG000|Overall Study|Death|3|||
19794697|NCT00739401|42253035|FG000|Overall Study|Withdrawal by Subject|4|||
19794698|NCT01365052|42253041|FG000|Overall Study|Adverse Event|4|||
19794699|NCT01365052|42253042|FG001|Overall Study|Adverse Event|4|||
19794700|NCT01372748|42253050|FG000|Overall Study|Lost to Follow-up|16|||
19794701|NCT01372748|42253051|FG001|Overall Study|Lost to Follow-up|34|||
19794702|NCT01372748|42253050|FG000|Overall Study|Withdrawal by Subject|7|||
19794703|NCT01372748|42253051|FG001|Overall Study|Withdrawal by Subject|5|||
19794704|NCT02268851|42253063|FG000|Overall Study|Death|0|||
19794705|NCT02268851|42253064|FG001|Overall Study|Death|0|||
19794706|NCT02268851|42253065|FG002|Overall Study|Death|0|||
19794707|NCT02268851|42253066|FG003|Overall Study|Death|1|||
19794708|NCT02268851|42253067|FG004|Overall Study|Death|2|||
19794709|NCT02268851|42253068|FG005|Overall Study|Death|1|||
19794710|NCT02268851|42253063|FG000|Overall Study|Adverse Event|0|||
19794711|NCT02268851|42253064|FG001|Overall Study|Adverse Event|0|||
19794712|NCT02268851|42253065|FG002|Overall Study|Adverse Event|0|||
19794713|NCT02268851|42253066|FG003|Overall Study|Adverse Event|0|||
19794714|NCT02268851|42253067|FG004|Overall Study|Adverse Event|2|||
19698310|NCT00090220|42143532|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
19698311|NCT00090220|42143533|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19698312|NCT00090220|42143534|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19698313|NCT00090220|42143535|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19698314|NCT00090220|42143536|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19698315|NCT00090220|42143531|FG000|Base Study Vaccination Period|Adverse Event|6|||
19698316|NCT00090220|42143532|FG001|Base Study Vaccination Period|Adverse Event|1|||
19698317|NCT00090220|42143533|FG002|Base Study Vaccination Period|Adverse Event|0|||
19698318|NCT00090220|42143534|FG003|Base Study Vaccination Period|Adverse Event|0|||
19698319|NCT00090220|42143535|FG004|Base Study Vaccination Period|Adverse Event|0|||
19698320|NCT00090220|42143536|FG005|Base Study Vaccination Period|Adverse Event|0|||
19698321|NCT00090220|42143531|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
19698322|NCT00090220|42143532|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
19698323|NCT00090220|42143533|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
19698324|NCT00090220|42143534|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
19698325|NCT00090220|42143535|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
19698326|NCT00090220|42143536|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
19698327|NCT00090220|42143531|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
19698328|NCT00090220|42143532|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
19698329|NCT00090220|42143533|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
19698330|NCT00090220|42143534|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
19698331|NCT00090220|42143535|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
19698332|NCT00090220|42143536|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
19698333|NCT00090220|42143531|FG000|Base Study Vaccination Period|Patient Moved|6|||
19698334|NCT00090220|42143532|FG001|Base Study Vaccination Period|Patient Moved|2|||
19698335|NCT00090220|42143533|FG002|Base Study Vaccination Period|Patient Moved|0|||
19698336|NCT00090220|42143534|FG003|Base Study Vaccination Period|Patient Moved|0|||
19698337|NCT00090220|42143535|FG004|Base Study Vaccination Period|Patient Moved|0|||
19698338|NCT00090220|42143536|FG005|Base Study Vaccination Period|Patient Moved|0|||
19698339|NCT00090220|42143531|FG000|Base Study Vaccination Period|Other|4|||
19698340|NCT00090220|42143532|FG001|Base Study Vaccination Period|Other|4|||
19698341|NCT00090220|42143533|FG002|Base Study Vaccination Period|Other|0|||
19698342|NCT00090220|42143534|FG003|Base Study Vaccination Period|Other|0|||
19698343|NCT00090220|42143535|FG004|Base Study Vaccination Period|Other|0|||
19698344|NCT00090220|42143536|FG005|Base Study Vaccination Period|Other|0|||
19698345|NCT00090220|42143531|FG000|Base Study Follow-up Period|Adverse Event|6|||
19698346|NCT00090220|42143532|FG001|Base Study Follow-up Period|Adverse Event|1|||
19698347|NCT00090220|42143533|FG002|Base Study Follow-up Period|Adverse Event|0|||
19698348|NCT00090220|42143534|FG003|Base Study Follow-up Period|Adverse Event|0|||
19698349|NCT00090220|42143535|FG004|Base Study Follow-up Period|Adverse Event|0|||
19698350|NCT00090220|42143536|FG005|Base Study Follow-up Period|Adverse Event|0|||
19698351|NCT00090220|42143531|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
19698352|NCT00090220|42143532|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
19698353|NCT00090220|42143533|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
19698354|NCT00090220|42143534|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
19698355|NCT00090220|42143535|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
19698356|NCT00090220|42143536|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
19698357|NCT00090220|42143531|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
19698358|NCT00090220|42143532|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
19698359|NCT00090220|42143533|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
19698360|NCT00090220|42143534|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
19698361|NCT00090220|42143535|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
19698362|NCT00090220|42143536|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
19698363|NCT00090220|42143531|FG000|Base Study Follow-up Period|Patient Moved|20|||
19794715|NCT02268851|42253068|FG005|Overall Study|Adverse Event|2|||
19794716|NCT02268851|42253063|FG000|Overall Study|Withdrawal by Subject|0|||
19794717|NCT02268851|42253064|FG001|Overall Study|Withdrawal by Subject|0|||
19794718|NCT02268851|42253065|FG002|Overall Study|Withdrawal by Subject|0|||
19794719|NCT02268851|42253066|FG003|Overall Study|Withdrawal by Subject|2|||
19367524|NCT02135029|41607698|FG002|Overall Study|Withdrawal by Subject|1|||
19367525|NCT02135029|41607696|FG000|Overall Study|Other|0|||
19367526|NCT02135029|41607697|FG001|Overall Study|Other|1|||
19367527|NCT02135029|41607698|FG002|Overall Study|Other|0|||
19367528|NCT02135029|41607696|FG000|Overall Study|Death|0|||
19794720|NCT02268851|42253067|FG004|Overall Study|Withdrawal by Subject|0|||
19794721|NCT02268851|42253068|FG005|Overall Study|Withdrawal by Subject|1|||
19794722|NCT02268851|42253063|FG000|Overall Study|Progressive Disease|1|||
19794723|NCT02268851|42253064|FG001|Overall Study|Progressive Disease|3|||
19794724|NCT02268851|42253065|FG002|Overall Study|Progressive Disease|0|||
19794725|NCT02268851|42253066|FG003|Overall Study|Progressive Disease|0|||
19794726|NCT02268851|42253067|FG004|Overall Study|Progressive Disease|1|||
19794727|NCT02268851|42253068|FG005|Overall Study|Progressive Disease|4|||
19794728|NCT02268851|42253063|FG000|Overall Study|Physician Decision|0|||
19794729|NCT02268851|42253064|FG001|Overall Study|Physician Decision|0|||
19794730|NCT02268851|42253065|FG002|Overall Study|Physician Decision|1|||
19794731|NCT02268851|42253066|FG003|Overall Study|Physician Decision|0|||
19794732|NCT02268851|42253067|FG004|Overall Study|Physician Decision|0|||
19794733|NCT02268851|42253068|FG005|Overall Study|Physician Decision|1|||
19794734|NCT02268851|42253063|FG000|Overall Study|Patient Compliance|0|||
19794735|NCT02268851|42253064|FG001|Overall Study|Patient Compliance|0|||
19794736|NCT02268851|42253065|FG002|Overall Study|Patient Compliance|0|||
19794737|NCT02268851|42253066|FG003|Overall Study|Patient Compliance|0|||
19794738|NCT02268851|42253067|FG004|Overall Study|Patient Compliance|1|||
19794739|NCT02268851|42253068|FG005|Overall Study|Patient Compliance|1|||
19794740|NCT02268851|42253063|FG000|Overall Study|Co-Morbid Condition|0|||
19794741|NCT02268851|42253064|FG001|Overall Study|Co-Morbid Condition|0|||
19794742|NCT02268851|42253065|FG002|Overall Study|Co-Morbid Condition|0|||
19794743|NCT02268851|42253066|FG003|Overall Study|Co-Morbid Condition|0|||
19794744|NCT02268851|42253067|FG004|Overall Study|Co-Morbid Condition|1|||
19794745|NCT02268851|42253068|FG005|Overall Study|Co-Morbid Condition|1|||
19794746|NCT02736825|42253084|FG000|Overall Study|Lost to Follow-up|10|||
19794747|NCT02736825|42253085|FG001|Overall Study|Lost to Follow-up|11|||
19794748|NCT02736825|42253084|FG000|Overall Study|Early Termination|0|||
19794749|NCT02736825|42253085|FG001|Overall Study|Early Termination|1|||
19794750|NCT02670122|42253092|FG000|Overall Study|Lost to Follow-up|4|||
19794751|NCT03283371|42253105|FG000|Placebo-controlled|Adverse Event|1|||
19794752|NCT03283371|42253106|FG001|Placebo-controlled|Adverse Event|1|||
19794753|NCT03283371|42253107|FG002|Placebo-controlled|Adverse Event|0|||
19794754|NCT03283371|42253108|FG003|Placebo-controlled|Adverse Event|0|||
19794755|NCT03283371|42253105|FG000|Placebo-controlled|Lack of Efficacy|1|||
19794756|NCT03283371|42253106|FG001|Placebo-controlled|Lack of Efficacy|0|||
19794757|NCT03283371|42253107|FG002|Placebo-controlled|Lack of Efficacy|0|||
19794758|NCT03283371|42253108|FG003|Placebo-controlled|Lack of Efficacy|0|||
19794759|NCT03283371|42253105|FG000|Placebo-controlled|Withdrawal by Subject|1|||
19794760|NCT03283371|42253106|FG001|Placebo-controlled|Withdrawal by Subject|1|||
19794761|NCT03283371|42253107|FG002|Placebo-controlled|Withdrawal by Subject|0|||
19794762|NCT03283371|42253108|FG003|Placebo-controlled|Withdrawal by Subject|0|||
19794763|NCT03283371|42253105|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
19794764|NCT03283371|42253106|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
19794765|NCT03283371|42253107|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
19794766|NCT03283371|42253108|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
19794767|NCT03283371|42253105|FG000|Open-label Phase|Adverse Event|0|||
19794768|NCT03283371|42253106|FG001|Open-label Phase|Adverse Event|0|||
19794769|NCT03283371|42253107|FG002|Open-label Phase|Adverse Event|2|||
19794770|NCT03283371|42253108|FG003|Open-label Phase|Adverse Event|0|||
19794771|NCT03283371|42253105|FG000|Open-label Phase|Withdrawal by Subject|0|||
19794772|NCT03283371|42253106|FG001|Open-label Phase|Withdrawal by Subject|0|||
19794773|NCT03283371|42253107|FG002|Open-label Phase|Withdrawal by Subject|1|||
19794774|NCT03283371|42253108|FG003|Open-label Phase|Withdrawal by Subject|0|||
19794775|NCT03283371|42253105|FG000|Open-label Phase|Other|0|||
19794776|NCT03283371|42253106|FG001|Open-label Phase|Other|0|||
19794777|NCT03283371|42253107|FG002|Open-label Phase|Other|1|||
19794778|NCT03283371|42253108|FG003|Open-label Phase|Other|1|||
19794779|NCT03069417|42253120|FG000|Overall Study|Lost to Follow-up|2|||
19794780|NCT03069417|42253121|FG001|Overall Study|Lost to Follow-up|0|||
19794781|NCT03069417|42253120|FG000|Overall Study|Reason Unknown|4|||
19794782|NCT03069417|42253121|FG001|Overall Study|Reason Unknown|7|||
19794783|NCT04930263|42253130|FG000|Overall Study|Withdrawal by Subject|3|||
19794784|NCT04930263|42253131|FG001|Overall Study|Withdrawal by Subject|5|||
19794785|NCT02665286|42253140|FG000|Overall Study|Lost to Follow-up|3|||
19367529|NCT02135029|41607697|FG001|Overall Study|Death|1|||
19794786|NCT02665286|42253141|FG001|Overall Study|Lost to Follow-up|2|||
19794787|NCT02665286|42253142|FG002|Overall Study|Lost to Follow-up|1|||
19794788|NCT02134925|42253152|FG000|Overall Study|Withdrawal by Subject|1|||
19794789|NCT02134925|42253153|FG001|Overall Study|Withdrawal by Subject|0|||
19794790|NCT02134925|42253152|FG000|Overall Study|Cancel|1|||
19794791|NCT02134925|42253153|FG001|Overall Study|Cancel|6|||
19794792|NCT02911519|42253161|FG000|Overall Study|Lost to Follow-up|2|||
19794793|NCT02911519|42253162|FG001|Overall Study|Lost to Follow-up|2|||
19794794|NCT02911519|42253161|FG000|Overall Study|Death|0|||
19794795|NCT02911519|42253162|FG001|Overall Study|Death|2|||
19794796|NCT02911285|42253170|FG000|Overall Study|Lost to Follow-up|8|||
19794797|NCT02911285|42253171|FG001|Overall Study|Lost to Follow-up|5|||
19794798|NCT02911285|42253170|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
19794799|NCT02911285|42253171|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
19794800|NCT02910739|42253183|FG000|Overall Study|Adverse Event|1|||
19794801|NCT02910739|42253184|FG001|Overall Study|Adverse Event|0|||
19794802|NCT02910739|42253185|FG002|Overall Study|Adverse Event|0|||
19794803|NCT02910739|42253186|FG003|Overall Study|Adverse Event|0|||
19794804|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
19794805|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
19794806|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
19794807|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
19794808|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
19794809|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
19794810|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
19794811|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
19794812|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
19794813|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
19794814|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
19794815|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
19794816|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
19794817|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
19794818|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
19794819|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
19794820|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
19794821|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
19794822|NCT01069939|42253194|FG000|Randomised and Included in the Analyses|Removal|1|||
19794823|NCT01069939|42253195|FG001|Randomised and Included in the Analyses|Removal|0|||
19794824|NCT01069705|42253201|FG000|Overall Study|Adverse Event|1|||
19794825|NCT01069705|42253201|FG000|Overall Study|Withdrawal by Subject|2|||
19794826|NCT01069627|42253205|FG000|Overall Study|Disease progression|7|||
19794827|NCT01069627|42253205|FG000|Overall Study|Adverse Event|12|||
19794828|NCT01069627|42253205|FG000|Overall Study|Protocol Violation|1|||
19794829|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
19794830|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
19794831|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
19794832|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
19794833|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
19794834|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
19794835|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
19794836|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
19794837|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
19794838|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
19794839|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
19794840|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
19794841|NCT02422797|42253211|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
19794842|NCT02422797|42253212|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
19794843|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
19794844|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
19794845|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
19794846|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
19794847|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
19794848|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
19794849|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
19794850|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
19698364|NCT00090220|42143532|FG001|Base Study Follow-up Period|Patient Moved|28|||
19698365|NCT00090220|42143533|FG002|Base Study Follow-up Period|Patient Moved|0|||
19698366|NCT00090220|42143534|FG003|Base Study Follow-up Period|Patient Moved|0|||
19698367|NCT00090220|42143535|FG004|Base Study Follow-up Period|Patient Moved|0|||
19698368|NCT00090220|42143536|FG005|Base Study Follow-up Period|Patient Moved|0|||
19698369|NCT00090220|42143531|FG000|Base Study Follow-up Period|Other|19|||
19698370|NCT00090220|42143532|FG001|Base Study Follow-up Period|Other|21|||
19698371|NCT00090220|42143533|FG002|Base Study Follow-up Period|Other|0|||
19698372|NCT00090220|42143534|FG003|Base Study Follow-up Period|Other|0|||
19794851|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
19794852|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
19794853|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
19794854|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
19794855|NCT02422797|42253211|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
19794856|NCT02422797|42253212|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
19794857|NCT03021551|42253228|FG000|Overall Study|Equipment Issues|2|||
19794858|NCT03021551|42253228|FG000|Overall Study|Protocol Violation|1|||
19794859|NCT01585025|42253235|FG000|Overall Study|Withdrawal by Subject|0|||
19794860|NCT01585025|42253236|FG001|Overall Study|Withdrawal by Subject|3|||
19794861|NCT01585025|42253237|FG002|Overall Study|Withdrawal by Subject|4|||
19794862|NCT01068769|42253245|FG000|Overall Study|Ineligible|1|||
19794863|NCT05114564|42253264|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
19794864|NCT05114564|42253265|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
19794865|NCT05114564|42253264|FG000|First Intervention|Adverse Event|0|||
19794866|NCT05114564|42253265|FG001|First Intervention|Adverse Event|1|||
19794867|NCT04706416|42253273|FG000|Overall Study|Lost to Follow-up|2|||
19794868|NCT04706416|42253274|FG001|Overall Study|Lost to Follow-up|0|||
19794869|NCT04683926|42253287|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
19794870|NCT04683926|42253288|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
19794871|NCT04683926|42253289|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
19794872|NCT04683926|42253290|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
19794873|NCT04285346|42253302|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
19794874|NCT04285346|42253303|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
19794875|NCT04285346|42253302|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
19794876|NCT04285346|42253303|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
19794877|NCT04285346|42253302|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
19794878|NCT04285346|42253303|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
19794879|NCT04148287|42253318|FG000|Overall Study|Death|2|||
19794880|NCT03772613|42253350|FG000|Overall Study|Lost to Follow-up|0|||
19794881|NCT03772613|42253351|FG001|Overall Study|Lost to Follow-up|1|||
19794882|NCT03772613|42253352|FG002|Overall Study|Lost to Follow-up|1|||
19794883|NCT03739437|42253362|FG000|Overall Study|Lost to Follow-up|2|||
19794884|NCT03739437|42253363|FG001|Overall Study|Lost to Follow-up|5|||
19794885|NCT03730194|42253371|FG000|First Stage Treatment|Withdrawal by Subject|1|||
19794886|NCT03730194|42253372|FG001|First Stage Treatment|Withdrawal by Subject|1|||
19794887|NCT03730194|42253373|FG002|First Stage Treatment|Withdrawal by Subject|0|||
19794888|NCT03730194|42253374|FG003|First Stage Treatment|Withdrawal by Subject|0|||
19794889|NCT03730194|42253375|FG004|First Stage Treatment|Withdrawal by Subject|0|||
19794890|NCT03730194|42253376|FG005|First Stage Treatment|Withdrawal by Subject|0|||
19794891|NCT03730194|42253371|FG000|First Stage Treatment|Protocol Violation|3|||
19794892|NCT03730194|42253372|FG001|First Stage Treatment|Protocol Violation|3|||
19794893|NCT03730194|42253373|FG002|First Stage Treatment|Protocol Violation|0|||
19794894|NCT03730194|42253374|FG003|First Stage Treatment|Protocol Violation|0|||
19794895|NCT03730194|42253375|FG004|First Stage Treatment|Protocol Violation|0|||
19794896|NCT03730194|42253376|FG005|First Stage Treatment|Protocol Violation|0|||
19794897|NCT03701555|42253419|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
19794898|NCT03701555|42253420|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
19794899|NCT03701555|42253421|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
19794900|NCT03701555|42253422|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
19794901|NCT03701555|42253423|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
19794902|NCT03701555|42253424|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
19794903|NCT03701555|42253425|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
19794904|NCT03701555|42253426|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
19794905|NCT03701555|42253427|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
19794906|NCT03701555|42253428|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
19794907|NCT03701555|42253429|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
19794908|NCT03701555|42253430|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
19794909|NCT03701555|42253431|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
19794910|NCT03701555|42253432|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
19794911|NCT03701555|42253433|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
19794912|NCT03701555|42253434|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
19794913|NCT03701555|42253435|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
19794914|NCT03701555|42253436|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
19794915|NCT03701555|42253437|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
19794916|NCT03701555|42253438|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
19794917|NCT03701555|42253439|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
19367530|NCT02135029|41607698|FG002|Overall Study|Death|0|||
19367531|NCT02842151|41607707|FG000|Overall Study|Adverse Event|1|||
19794918|NCT03701555|42253440|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
19794919|NCT03701555|42253441|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
19794920|NCT03701555|42253442|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
19794921|NCT03701555|42253443|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
19794922|NCT03701555|42253444|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
19794923|NCT03701555|42253445|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
19794924|NCT03701555|42253446|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
19794925|NCT03701555|42253447|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
19794926|NCT03701555|42253448|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
19794927|NCT03701555|42253449|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
19794928|NCT03701555|42253450|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
19794929|NCT03701555|42253451|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
19794930|NCT03701555|42253452|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
19794931|NCT03701555|42253453|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
19794932|NCT03701555|42253454|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
19794933|NCT03701555|42253419|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
19794934|NCT03701555|42253420|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
19794935|NCT03701555|42253421|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
19794936|NCT03701555|42253422|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
19794937|NCT03701555|42253423|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
19794938|NCT03701555|42253424|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
19794939|NCT03701555|42253425|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
19794940|NCT03701555|42253426|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
19794941|NCT03701555|42253427|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
19794942|NCT03701555|42253428|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
19794943|NCT03701555|42253429|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
19794944|NCT03701555|42253430|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
19794945|NCT03701555|42253431|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
19794946|NCT03701555|42253432|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
19794947|NCT03701555|42253433|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
19794948|NCT03701555|42253434|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
19794949|NCT03701555|42253435|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
19794950|NCT03701555|42253436|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
19794951|NCT03701555|42253437|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
19794952|NCT03701555|42253438|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
19794953|NCT03701555|42253439|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
19794954|NCT03701555|42253440|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
19794955|NCT03701555|42253441|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
19794956|NCT03701555|42253442|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
19794957|NCT03701555|42253443|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
19794958|NCT03701555|42253444|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
19794959|NCT03701555|42253445|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
19794960|NCT03701555|42253446|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
19794961|NCT03701555|42253447|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
19794962|NCT03701555|42253448|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
19794963|NCT03701555|42253449|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
19794964|NCT03701555|42253450|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
19794965|NCT03701555|42253451|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
19794966|NCT03701555|42253452|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
19794967|NCT03701555|42253453|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
19794968|NCT03701555|42253454|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
19794969|NCT03701555|42253419|FG000|Part 2 (Day 1)|Other|0|||
19794970|NCT03701555|42253420|FG001|Part 2 (Day 1)|Other|0|||
19794971|NCT03701555|42253421|FG002|Part 2 (Day 1)|Other|0|||
19794972|NCT03701555|42253422|FG003|Part 2 (Day 1)|Other|0|||
19794973|NCT03701555|42253423|FG004|Part 2 (Day 1)|Other|0|||
19794974|NCT03701555|42253424|FG005|Part 2 (Day 1)|Other|0|||
19794975|NCT03701555|42253425|FG006|Part 2 (Day 1)|Other|0|||
19794976|NCT03701555|42253426|FG007|Part 2 (Day 1)|Other|0|||
19794977|NCT03701555|42253427|FG008|Part 2 (Day 1)|Other|0|||
19794978|NCT03701555|42253428|FG009|Part 2 (Day 1)|Other|0|||
19794979|NCT03701555|42253429|FG010|Part 2 (Day 1)|Other|3|||
19794980|NCT03701555|42253430|FG011|Part 2 (Day 1)|Other|1|||
19794981|NCT03701555|42253431|FG012|Part 2 (Day 1)|Other|0|||
19794982|NCT03701555|42253432|FG013|Part 2 (Day 1)|Other|1|||
19794983|NCT03701555|42253433|FG014|Part 2 (Day 1)|Other|0|||
19794984|NCT03701555|42253434|FG015|Part 2 (Day 1)|Other|2|||
19794985|NCT03701555|42253435|FG016|Part 2 (Day 1)|Other|2|||
19794986|NCT03701555|42253436|FG017|Part 2 (Day 1)|Other|0|||
19794987|NCT03701555|42253437|FG018|Part 2 (Day 1)|Other|0|||
19794988|NCT03701555|42253438|FG019|Part 2 (Day 1)|Other|0|||
19794989|NCT03701555|42253439|FG020|Part 2 (Day 1)|Other|0|||
19794990|NCT03701555|42253440|FG021|Part 2 (Day 1)|Other|0|||
19794991|NCT03701555|42253441|FG022|Part 2 (Day 1)|Other|0|||
19794992|NCT03701555|42253442|FG023|Part 2 (Day 1)|Other|0|||
19794993|NCT03701555|42253443|FG024|Part 2 (Day 1)|Other|0|||
19794994|NCT03701555|42253444|FG025|Part 2 (Day 1)|Other|0|||
19794995|NCT03701555|42253445|FG026|Part 2 (Day 1)|Other|0|||
19794996|NCT03701555|42253446|FG027|Part 2 (Day 1)|Other|0|||
19794997|NCT03701555|42253447|FG028|Part 2 (Day 1)|Other|0|||
19794998|NCT03701555|42253448|FG029|Part 2 (Day 1)|Other|0|||
19794999|NCT03701555|42253449|FG030|Part 2 (Day 1)|Other|0|||
19795000|NCT03701555|42253450|FG031|Part 2 (Day 1)|Other|0|||
19795001|NCT03701555|42253451|FG032|Part 2 (Day 1)|Other|0|||
19795002|NCT03701555|42253452|FG033|Part 2 (Day 1)|Other|0|||
19795003|NCT03701555|42253453|FG034|Part 2 (Day 1)|Other|0|||
19795004|NCT03701555|42253454|FG035|Part 2 (Day 1)|Other|0|||
19795005|NCT03701555|42253419|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
19795006|NCT03701555|42253420|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
19795007|NCT03701555|42253421|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
19795008|NCT03701555|42253422|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
19795009|NCT03701555|42253423|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
19795010|NCT03701555|42253424|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
19795011|NCT03701555|42253425|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
19795012|NCT03701555|42253426|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
19795013|NCT03701555|42253427|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
19795014|NCT03701555|42253428|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
19795015|NCT03701555|42253429|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
19795016|NCT03701555|42253430|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
19795017|NCT03701555|42253431|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
19795018|NCT03701555|42253432|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
19795019|NCT03701555|42253433|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
19795020|NCT03701555|42253434|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
19795021|NCT03701555|42253435|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
19795022|NCT03701555|42253436|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
19795023|NCT03701555|42253437|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
19795024|NCT03701555|42253438|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
19795025|NCT03701555|42253439|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
19795026|NCT03701555|42253440|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
19795027|NCT03701555|42253441|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
19795028|NCT03701555|42253442|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
19795029|NCT03701555|42253443|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
19795030|NCT03701555|42253444|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
19795031|NCT03701555|42253445|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
19795032|NCT03701555|42253446|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
19795033|NCT03701555|42253447|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
19795034|NCT03701555|42253448|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
19795035|NCT03701555|42253449|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
19795036|NCT03701555|42253450|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
19795037|NCT03701555|42253451|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
19795038|NCT03701555|42253452|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
19795039|NCT03701555|42253453|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
19795040|NCT03701555|42253454|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
19795041|NCT03701555|42253419|FG000|Part 3 (Day 1)|Subject Decision|0|||
19795042|NCT03701555|42253420|FG001|Part 3 (Day 1)|Subject Decision|0|||
19795043|NCT03701555|42253421|FG002|Part 3 (Day 1)|Subject Decision|0|||
19795044|NCT03701555|42253422|FG003|Part 3 (Day 1)|Subject Decision|0|||
19795045|NCT03701555|42253423|FG004|Part 3 (Day 1)|Subject Decision|0|||
19795046|NCT03701555|42253424|FG005|Part 3 (Day 1)|Subject Decision|0|||
19795047|NCT03701555|42253425|FG006|Part 3 (Day 1)|Subject Decision|0|||
19795048|NCT03701555|42253426|FG007|Part 3 (Day 1)|Subject Decision|0|||
19795049|NCT03701555|42253427|FG008|Part 3 (Day 1)|Subject Decision|0|||
19795050|NCT03701555|42253428|FG009|Part 3 (Day 1)|Subject Decision|0|||
19795051|NCT03701555|42253429|FG010|Part 3 (Day 1)|Subject Decision|0|||
19795052|NCT03701555|42253430|FG011|Part 3 (Day 1)|Subject Decision|0|||
19795053|NCT03701555|42253431|FG012|Part 3 (Day 1)|Subject Decision|0|||
19795054|NCT03701555|42253432|FG013|Part 3 (Day 1)|Subject Decision|0|||
19795055|NCT03701555|42253433|FG014|Part 3 (Day 1)|Subject Decision|0|||
19795056|NCT03701555|42253434|FG015|Part 3 (Day 1)|Subject Decision|0|||
19795057|NCT03701555|42253435|FG016|Part 3 (Day 1)|Subject Decision|0|||
19795058|NCT03701555|42253436|FG017|Part 3 (Day 1)|Subject Decision|0|||
19795059|NCT03701555|42253437|FG018|Part 3 (Day 1)|Subject Decision|0|||
19795060|NCT03701555|42253438|FG019|Part 3 (Day 1)|Subject Decision|0|||
19795061|NCT03701555|42253439|FG020|Part 3 (Day 1)|Subject Decision|0|||
19795062|NCT03701555|42253440|FG021|Part 3 (Day 1)|Subject Decision|0|||
19795063|NCT03701555|42253441|FG022|Part 3 (Day 1)|Subject Decision|0|||
19795064|NCT03701555|42253442|FG023|Part 3 (Day 1)|Subject Decision|0|||
19795065|NCT03701555|42253443|FG024|Part 3 (Day 1)|Subject Decision|0|||
19795066|NCT03701555|42253444|FG025|Part 3 (Day 1)|Subject Decision|0|||
19795067|NCT03701555|42253445|FG026|Part 3 (Day 1)|Subject Decision|1|||
19795068|NCT03701555|42253446|FG027|Part 3 (Day 1)|Subject Decision|0|||
19795069|NCT03701555|42253447|FG028|Part 3 (Day 1)|Subject Decision|0|||
19795070|NCT03701555|42253448|FG029|Part 3 (Day 1)|Subject Decision|0|||
19795071|NCT03701555|42253449|FG030|Part 3 (Day 1)|Subject Decision|0|||
19795072|NCT03701555|42253450|FG031|Part 3 (Day 1)|Subject Decision|2|||
19367532|NCT02842151|41607707|FG000|Overall Study|Subject moved too far away|1|||
19795073|NCT03701555|42253451|FG032|Part 3 (Day 1)|Subject Decision|1|||
19795074|NCT03701555|42253452|FG033|Part 3 (Day 1)|Subject Decision|1|||
19795075|NCT03701555|42253453|FG034|Part 3 (Day 1)|Subject Decision|0|||
19795076|NCT03701555|42253454|FG035|Part 3 (Day 1)|Subject Decision|0|||
19795077|NCT03701555|42253419|FG000|Part 3 (Day 1)|Other|0|||
19795078|NCT03701555|42253420|FG001|Part 3 (Day 1)|Other|0|||
19795079|NCT03701555|42253421|FG002|Part 3 (Day 1)|Other|0|||
19795080|NCT03701555|42253422|FG003|Part 3 (Day 1)|Other|0|||
19795081|NCT03701555|42253423|FG004|Part 3 (Day 1)|Other|0|||
19795082|NCT03701555|42253424|FG005|Part 3 (Day 1)|Other|0|||
19795083|NCT03701555|42253425|FG006|Part 3 (Day 1)|Other|0|||
19795084|NCT03701555|42253426|FG007|Part 3 (Day 1)|Other|0|||
19795085|NCT03701555|42253427|FG008|Part 3 (Day 1)|Other|0|||
19795086|NCT03701555|42253428|FG009|Part 3 (Day 1)|Other|0|||
19795087|NCT03701555|42253429|FG010|Part 3 (Day 1)|Other|0|||
19795088|NCT03701555|42253430|FG011|Part 3 (Day 1)|Other|0|||
19795089|NCT03701555|42253431|FG012|Part 3 (Day 1)|Other|0|||
19795090|NCT03701555|42253432|FG013|Part 3 (Day 1)|Other|0|||
19795091|NCT03701555|42253433|FG014|Part 3 (Day 1)|Other|0|||
19795092|NCT03701555|42253434|FG015|Part 3 (Day 1)|Other|0|||
19795093|NCT03701555|42253435|FG016|Part 3 (Day 1)|Other|0|||
19795094|NCT03701555|42253436|FG017|Part 3 (Day 1)|Other|0|||
19795095|NCT03701555|42253437|FG018|Part 3 (Day 1)|Other|0|||
19795096|NCT03701555|42253438|FG019|Part 3 (Day 1)|Other|0|||
19795097|NCT03701555|42253439|FG020|Part 3 (Day 1)|Other|0|||
19795098|NCT03701555|42253440|FG021|Part 3 (Day 1)|Other|0|||
19795099|NCT03701555|42253441|FG022|Part 3 (Day 1)|Other|0|||
19795100|NCT03701555|42253442|FG023|Part 3 (Day 1)|Other|0|||
19795101|NCT03701555|42253443|FG024|Part 3 (Day 1)|Other|1|||
19795102|NCT03701555|42253444|FG025|Part 3 (Day 1)|Other|1|||
19795103|NCT03701555|42253445|FG026|Part 3 (Day 1)|Other|0|||
19795104|NCT03701555|42253446|FG027|Part 3 (Day 1)|Other|0|||
19795105|NCT03701555|42253447|FG028|Part 3 (Day 1)|Other|0|||
19795106|NCT03701555|42253448|FG029|Part 3 (Day 1)|Other|1|||
19795107|NCT03701555|42253449|FG030|Part 3 (Day 1)|Other|1|||
19795108|NCT03701555|42253450|FG031|Part 3 (Day 1)|Other|0|||
19795109|NCT03701555|42253451|FG032|Part 3 (Day 1)|Other|1|||
19795110|NCT03701555|42253452|FG033|Part 3 (Day 1)|Other|1|||
19795111|NCT03701555|42253453|FG034|Part 3 (Day 1)|Other|0|||
19795112|NCT03701555|42253454|FG035|Part 3 (Day 1)|Other|0|||
19795113|NCT03699007|42253569|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
19795114|NCT03699007|42253570|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
19795115|NCT03699007|42253569|FG000|6-month Follow Up|Lost to Follow-up|2|||
19795116|NCT03699007|42253570|FG001|6-month Follow Up|Lost to Follow-up|3|||
19795117|NCT02577406|42253601|FG000|Randomized Period|Death|1|||
19795118|NCT02577406|42253602|FG001|Randomized Period|Death|0|||
19795119|NCT02577406|42253601|FG000|Randomized Period|Other reasons|0|||
19795120|NCT02577406|42253602|FG001|Randomized Period|Other reasons|20|||
19607904|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
19607905|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
19607906|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
19607907|NCT00996593|42056799|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
19607908|NCT00996593|42056799|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
19607909|NCT00996593|42056799|FG000|Long-Term Follow-Up|Site Closed|1|||
19607910|NCT00570661|42056803|FG000|Overall Study|Disease worsening|5|||
19607911|NCT00570661|42056803|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
19607912|NCT00570661|42056803|FG000|Overall Study|Adverse Event|1|||
19607913|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
19607914|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
19607915|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
19607916|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
19607917|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
19607918|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
19607919|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
19607920|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
19607921|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
19607922|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
19607923|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
19607924|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
19607925|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
19607926|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
19607927|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
19795121|NCT02577406|42253601|FG000|Treatment Period|Transition to commercially available treatment|1|||
19795122|NCT02577406|42253602|FG001|Treatment Period|Transition to commercially available treatment|0|||
19795123|NCT02577406|42253601|FG000|Treatment Period|Progressive disease|47|||
19795124|NCT02577406|42253602|FG001|Treatment Period|Progressive disease|36|||
19795125|NCT02577406|42253601|FG000|Treatment Period|Death|36|||
19795126|NCT02577406|42253602|FG001|Treatment Period|Death|23|||
19795127|NCT02577406|42253601|FG000|Treatment Period|Other reasons|3|||
19795128|NCT02577406|42253602|FG001|Treatment Period|Other reasons|37|||
19795129|NCT02577406|42253601|FG000|Treatment Period|Withdrawal by Subject|10|||
19795130|NCT02577406|42253602|FG001|Treatment Period|Withdrawal by Subject|24|||
19795131|NCT02577406|42253601|FG000|Treatment Period|Adverse Event|17|||
19795132|NCT02577406|42253602|FG001|Treatment Period|Adverse Event|12|||
19795133|NCT02577406|42253601|FG000|Treatment Period|Disease relapse|27|||
19795134|NCT02577406|42253602|FG001|Treatment Period|Disease relapse|1|||
19795135|NCT02577406|42253601|FG000|Treatment Period|HSCT|6|||
19795136|NCT02577406|42253602|FG001|Treatment Period|HSCT|2|||
19795137|NCT02577406|42253601|FG000|Treatment Period|Lost to Follow-up|0|||
19795138|NCT02577406|42253602|FG001|Treatment Period|Lost to Follow-up|1|||
19795139|NCT02577406|42253601|FG000|Treatment Period|Protocol Violation|0|||
19795140|NCT02577406|42253602|FG001|Treatment Period|Protocol Violation|1|||
19795141|NCT02484443|42253612|FG000|Overall Study|Lack of Efficacy|28|||
19795142|NCT02484443|42253612|FG000|Overall Study|Physician Decision|2|||
19795143|NCT02484443|42253612|FG000|Overall Study|Ineligible|2|||
19795144|NCT02306161|42253618|FG000|Overall Study|Death|1|||
19795145|NCT02306161|42253619|FG001|Overall Study|Death|3|||
19795146|NCT02306161|42253618|FG000|Overall Study|Lack of Efficacy|20|||
19795147|NCT02306161|42253619|FG001|Overall Study|Lack of Efficacy|43|||
19795148|NCT02306161|42253618|FG000|Overall Study|Physician Decision|30|||
19795149|NCT02306161|42253619|FG001|Overall Study|Physician Decision|18|||
19795150|NCT02306161|42253618|FG000|Overall Study|Withdrawal by Subject|4|||
19795151|NCT02306161|42253619|FG001|Overall Study|Withdrawal by Subject|0|||
19795152|NCT02306161|42253618|FG000|Overall Study|Ineligible|9|||
19795153|NCT02306161|42253619|FG001|Overall Study|Ineligible|5|||
19795154|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
19795155|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
19795156|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
19795157|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
19795158|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
19795159|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
19795160|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
19795161|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
19795162|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
19795163|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
19795164|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
19795165|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
19795166|NCT02288247|42253625|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
19795167|NCT02288247|42253626|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
19795168|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
19795169|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
19795170|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
19795171|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
19795172|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
19795173|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
19795174|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
19795175|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
19795176|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
19795177|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
19795178|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
19795179|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
19607928|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
19607929|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
19607930|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
19607931|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
19607932|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
19607933|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
19795180|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
19795181|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
19795182|NCT02288247|42253625|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
19795183|NCT02288247|42253626|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
19795184|NCT02254278|42253636|FG000|Overall Study|Protocol Violation|1|||
19795185|NCT02254278|42253637|FG001|Overall Study|Protocol Violation|1|||
19795186|NCT02253316|42253646|FG000|Consolidation|Progression|4|||
19607934|NCT00934544|42056810|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
19607935|NCT00934544|42056811|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
19607936|NCT00934544|42056812|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
19607937|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
19607938|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
19607939|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
19607940|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
19607941|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
19607942|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
19607943|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
19607944|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
19795187|NCT02253316|42253647|FG001|Consolidation|Progression|0|||
19795188|NCT02253316|42253648|FG002|Consolidation|Progression|0|||
19795189|NCT02253316|42253646|FG000|Consolidation|Non-Compliance|1|||
19795190|NCT02253316|42253647|FG001|Consolidation|Non-Compliance|0|||
19795191|NCT02253316|42253648|FG002|Consolidation|Non-Compliance|0|||
19795192|NCT02253316|42253646|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
19795193|NCT02253316|42253647|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
19795194|NCT02253316|42253648|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
19795195|NCT02253316|42253646|FG000|Consolidation|Secondary Malignancy|2|||
19795196|NCT02253316|42253647|FG001|Consolidation|Secondary Malignancy|0|||
19795197|NCT02253316|42253648|FG002|Consolidation|Secondary Malignancy|0|||
19795198|NCT02253316|42253646|FG000|Consolidation|Adverse Event|7|||
19795199|NCT02253316|42253647|FG001|Consolidation|Adverse Event|0|||
19795200|NCT02253316|42253648|FG002|Consolidation|Adverse Event|0|||
19795201|NCT02253316|42253646|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
19795202|NCT02253316|42253647|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
19795203|NCT02253316|42253648|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
19795204|NCT02253316|42253646|FG000|Maintenance|Physician Decision|0|||
19698373|NCT00090220|42143535|FG004|Base Study Follow-up Period|Other|0|||
19698374|NCT00090220|42143536|FG005|Base Study Follow-up Period|Other|0|||
19698375|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Adverse Event|0|||
19698376|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Adverse Event|0|||
19698377|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Adverse Event|4|||
19698378|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Adverse Event|0|||
19698379|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Adverse Event|0|||
19698380|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Adverse Event|0|||
19698381|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
19698382|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
19698383|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
19698384|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
19698385|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
19698386|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
19795205|NCT02253316|42253647|FG001|Maintenance|Physician Decision|5|||
19795206|NCT02253316|42253648|FG002|Maintenance|Physician Decision|16|||
19795207|NCT02253316|42253646|FG000|Maintenance|Non-Compliance|0|||
19795208|NCT02253316|42253647|FG001|Maintenance|Non-Compliance|1|||
19795209|NCT02253316|42253648|FG002|Maintenance|Non-Compliance|0|||
19795210|NCT02253316|42253646|FG000|Maintenance|Secondary Malignancy|0|||
19795211|NCT02253316|42253647|FG001|Maintenance|Secondary Malignancy|1|||
19795212|NCT02253316|42253648|FG002|Maintenance|Secondary Malignancy|5|||
19795213|NCT02253316|42253646|FG000|Maintenance|Adverse Event|0|||
19795214|NCT02253316|42253647|FG001|Maintenance|Adverse Event|8|||
19795215|NCT02253316|42253648|FG002|Maintenance|Adverse Event|12|||
19795216|NCT02253316|42253646|FG000|Maintenance|Still receiving active treatment|0|||
19795217|NCT02253316|42253647|FG001|Maintenance|Still receiving active treatment|23|||
19795218|NCT02253316|42253648|FG002|Maintenance|Still receiving active treatment|26|||
19795219|NCT02178098|42253658|FG000|Overall Study|Withdrawal by Subject|0|||
19795220|NCT02178098|42253659|FG001|Overall Study|Withdrawal by Subject|6|||
19795221|NCT02178098|42253658|FG000|Overall Study|Adverse Event|1|||
19795222|NCT02178098|42253659|FG001|Overall Study|Adverse Event|2|||
19795223|NCT02178098|42253658|FG000|Overall Study|Protocol Violation|1|||
19795224|NCT02178098|42253659|FG001|Overall Study|Protocol Violation|1|||
19795225|NCT02178098|42253658|FG000|Overall Study|Lost to Follow-up|0|||
19795226|NCT02178098|42253659|FG001|Overall Study|Lost to Follow-up|1|||
19795227|NCT02178098|42253658|FG000|Overall Study|Sponsor Request|1|||
19795228|NCT02178098|42253659|FG001|Overall Study|Sponsor Request|0|||
19795229|NCT02178098|42253658|FG000|Overall Study|Other|2|||
19795230|NCT02178098|42253659|FG001|Overall Study|Other|2|||
19795231|NCT02101853|42253667|FG000|Block 1 Induction|Adverse Event|11|||
19795232|NCT02101853|42253668|FG001|Block 1 Induction|Adverse Event|0|||
19795233|NCT02101853|42253669|FG002|Block 1 Induction|Adverse Event|0|||
19607945|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
19607946|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
19607947|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
19607948|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
19607949|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
19607950|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
19607951|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
19607952|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
19607953|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
19698387|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Moved|0|||
19698388|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Moved|0|||
19698389|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Moved|2|||
19698390|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Moved|1|||
19698391|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Moved|0|||
19698392|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Moved|0|||
19607954|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
19607955|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
19607956|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
19607957|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
19607958|NCT00934544|42056810|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
19607959|NCT00934544|42056811|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
19607960|NCT00934544|42056812|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
19607961|NCT00999167|42056831|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
19607962|NCT00999167|42056832|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
19607963|NCT00999167|42056833|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
19795234|NCT02101853|42253670|FG003|Block 1 Induction|Adverse Event|0|||
19795235|NCT02101853|42253671|FG004|Block 1 Induction|Adverse Event|0|||
19795236|NCT02101853|42253672|FG005|Block 1 Induction|Adverse Event|0|||
19795237|NCT02101853|42253667|FG000|Block 1 Induction|Death|20|||
19795238|NCT02101853|42253668|FG001|Block 1 Induction|Death|0|||
19795239|NCT02101853|42253669|FG002|Block 1 Induction|Death|0|||
19607964|NCT00999167|42056831|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
19607965|NCT00999167|42056832|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
19607966|NCT00999167|42056833|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
19607967|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
19607968|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
19607969|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
19607970|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
19607971|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
19607972|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
19607973|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
19607974|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
19607975|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
19607976|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
19607977|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
19607978|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
19607979|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
19607980|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
19607981|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
19607982|NCT00999167|42056831|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
19607983|NCT00999167|42056832|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
19607984|NCT00999167|42056833|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
19607985|NCT00570505|42056843|FG000|Overall Study|Adverse Event|7|||
19607986|NCT00570505|42056843|FG000|Overall Study|Withdrawal by Subject|7|||
19607987|NCT00570505|42056843|FG000|Overall Study|Lost to Follow-up|23|||
19607988|NCT00570505|42056843|FG000|Overall Study|Other loss to follow-up|4|||
19607989|NCT00931892|42056849|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
19607990|NCT00931892|42056850|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
19607991|NCT00666211|42056898|FG000|Overall Study|Withdrawal by Subject|10|||
19607992|NCT00666211|42056899|FG001|Overall Study|Withdrawal by Subject|13|||
19607993|NCT00666211|42056898|FG000|Overall Study|went off medication, no more pain|1|||
19607994|NCT00666211|42056899|FG001|Overall Study|went off medication, no more pain|0|||
19607995|NCT00666211|42056898|FG000|Overall Study|patient non-compliant|6|||
19607996|NCT00666211|42056899|FG001|Overall Study|patient non-compliant|6|||
19607997|NCT00666211|42056898|FG000|Overall Study|disease progression|1|||
19607998|NCT00666211|42056899|FG001|Overall Study|disease progression|8|||
19607999|NCT00666211|42056898|FG000|Overall Study|Lost to Follow-up|2|||
19608000|NCT00666211|42056899|FG001|Overall Study|Lost to Follow-up|0|||
19608001|NCT00666211|42056898|FG000|Overall Study|toxicity|0|||
19608002|NCT00666211|42056899|FG001|Overall Study|toxicity|2|||
19608003|NCT00666211|42056898|FG000|Overall Study|hospital admission|0|||
19608004|NCT00666211|42056899|FG001|Overall Study|hospital admission|5|||
19608005|NCT00666211|42056898|FG000|Overall Study|Death|0|||
19608006|NCT00666211|42056899|FG001|Overall Study|Death|2|||
19608007|NCT00666211|42056898|FG000|Overall Study|off tx for other complicating disease|0|||
19608008|NCT00666211|42056899|FG001|Overall Study|off tx for other complicating disease|1|||
19608009|NCT00666211|42056898|FG000|Overall Study|Physician Decision|0|||
19608010|NCT00666211|42056899|FG001|Overall Study|Physician Decision|1|||
19608011|NCT00878709|42056907|FG000|Overall Study|Withdrawal by Subject|197|||
19608012|NCT00878709|42056908|FG001|Overall Study|Withdrawal by Subject|120|||
19608013|NCT00878709|42056907|FG000|Overall Study|Lost to Follow-up|35|||
19608014|NCT00878709|42056908|FG001|Overall Study|Lost to Follow-up|33|||
19608015|NCT00878709|42056907|FG000|Overall Study|Other Reasons|93|||
19608016|NCT00878709|42056908|FG001|Overall Study|Other Reasons|84|||
19795240|NCT02101853|42253670|FG003|Block 1 Induction|Death|0|||
19608017|NCT00927758|42056915|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
19608018|NCT00927758|42056916|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
19608019|NCT00927758|42056917|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
19608020|NCT00927758|42056918|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
19608021|NCT00927758|42056919|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
19608022|NCT00927758|42056920|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
19608023|NCT00927758|42056915|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
19608024|NCT00927758|42056916|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
19608025|NCT00927758|42056917|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
19608026|NCT00927758|42056918|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
19608027|NCT00927758|42056919|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
19608028|NCT00927758|42056920|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
19608029|NCT00927368|42056931|FG000|Overall Study|enrollment in another study|1|||
19608030|NCT00927368|42056932|FG001|Overall Study|enrollment in another study|1|||
19608031|NCT00927368|42056933|FG002|Overall Study|enrollment in another study|2|||
19608032|NCT00927368|42056931|FG000|Overall Study|Lost to Follow-up|4|||
19608033|NCT00927368|42056932|FG001|Overall Study|Lost to Follow-up|0|||
19608034|NCT00927368|42056933|FG002|Overall Study|Lost to Follow-up|0|||
19608035|NCT00927368|42056931|FG000|Overall Study|equipment failure|1|||
19608036|NCT00927368|42056932|FG001|Overall Study|equipment failure|0|||
19608037|NCT00927368|42056933|FG002|Overall Study|equipment failure|0|||
19608038|NCT00927368|42056931|FG000|Overall Study|ineligible post randomization|0|||
19608039|NCT00927368|42056932|FG001|Overall Study|ineligible post randomization|3|||
19608040|NCT00927368|42056933|FG002|Overall Study|ineligible post randomization|1|||
19608041|NCT00927368|42056931|FG000|Overall Study|cancellation of surgery|0|||
19608042|NCT00927368|42056932|FG001|Overall Study|cancellation of surgery|1|||
19608043|NCT00927368|42056933|FG002|Overall Study|cancellation of surgery|2|||
19608044|NCT00662857|42056941|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
19608045|NCT00662857|42056942|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
19608046|NCT00662857|42056941|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
19608047|NCT00662857|42056942|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
19608048|NCT00662857|42056941|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
19698393|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
19698394|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
19698395|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
19698396|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
19698397|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
19698398|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
19698399|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
19698400|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
19698401|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
19698402|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
19698403|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
19698404|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
19698405|NCT00090220|42143531|FG000|Extension 1 (EXT1)|Other reason|0|||
19698406|NCT00090220|42143532|FG001|Extension 1 (EXT1)|Other reason|0|||
19698407|NCT00090220|42143533|FG002|Extension 1 (EXT1)|Other reason|2|||
19795241|NCT02101853|42253671|FG004|Block 1 Induction|Death|0|||
19795242|NCT02101853|42253672|FG005|Block 1 Induction|Death|0|||
19795243|NCT02101853|42253667|FG000|Block 1 Induction|Lack of Efficacy|6|||
19608049|NCT00662857|42056942|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
19608050|NCT00878553|42056955|FG000|Sleep Study|Withdrawal by Subject|2|||
19608051|NCT00878553|42056956|FG001|Sleep Study|Withdrawal by Subject|0|||
19795244|NCT02101853|42253668|FG001|Block 1 Induction|Lack of Efficacy|0|||
19795245|NCT02101853|42253669|FG002|Block 1 Induction|Lack of Efficacy|0|||
19795246|NCT02101853|42253670|FG003|Block 1 Induction|Lack of Efficacy|0|||
19795247|NCT02101853|42253671|FG004|Block 1 Induction|Lack of Efficacy|0|||
19795248|NCT02101853|42253672|FG005|Block 1 Induction|Lack of Efficacy|0|||
19795249|NCT02101853|42253667|FG000|Block 1 Induction|Physician Decision|61|||
19795250|NCT02101853|42253668|FG001|Block 1 Induction|Physician Decision|0|||
19795251|NCT02101853|42253669|FG002|Block 1 Induction|Physician Decision|0|||
19795252|NCT02101853|42253670|FG003|Block 1 Induction|Physician Decision|0|||
19367533|NCT02842073|41607713|FG000|Overall Study|Withdrawal by Subject|1|||
19795253|NCT02101853|42253671|FG004|Block 1 Induction|Physician Decision|0|||
19795254|NCT02101853|42253672|FG005|Block 1 Induction|Physician Decision|0|||
19795255|NCT02101853|42253667|FG000|Block 1 Induction|Protocol Violation|2|||
19795256|NCT02101853|42253668|FG001|Block 1 Induction|Protocol Violation|0|||
19795257|NCT02101853|42253669|FG002|Block 1 Induction|Protocol Violation|0|||
19608052|NCT00878553|42056957|FG002|Sleep Study|Withdrawal by Subject|0|||
19608053|NCT00878553|42056958|FG003|Sleep Study|Withdrawal by Subject|0|||
19608054|NCT00878553|42056959|FG004|Sleep Study|Withdrawal by Subject|0|||
19698408|NCT00090220|42143534|FG003|Extension 1 (EXT1)|Other reason|0|||
19698409|NCT00090220|42143535|FG004|Extension 1 (EXT1)|Other reason|0|||
19698410|NCT00090220|42143536|FG005|Extension 1 (EXT1)|Other reason|0|||
19795258|NCT02101853|42253670|FG003|Block 1 Induction|Protocol Violation|0|||
19795259|NCT02101853|42253671|FG004|Block 1 Induction|Protocol Violation|0|||
19795260|NCT02101853|42253672|FG005|Block 1 Induction|Protocol Violation|0|||
19795261|NCT02101853|42253667|FG000|Block 1 Induction|Withdrawal by Subject|65|||
19795262|NCT02101853|42253668|FG001|Block 1 Induction|Withdrawal by Subject|0|||
19795263|NCT02101853|42253669|FG002|Block 1 Induction|Withdrawal by Subject|0|||
19795264|NCT02101853|42253670|FG003|Block 1 Induction|Withdrawal by Subject|0|||
19795265|NCT02101853|42253671|FG004|Block 1 Induction|Withdrawal by Subject|0|||
19795266|NCT02101853|42253672|FG005|Block 1 Induction|Withdrawal by Subject|0|||
19795267|NCT02101853|42253667|FG000|Block 1 Induction|Ineligible|8|||
19795268|NCT02101853|42253668|FG001|Block 1 Induction|Ineligible|0|||
19795269|NCT02101853|42253669|FG002|Block 1 Induction|Ineligible|0|||
19795270|NCT02101853|42253670|FG003|Block 1 Induction|Ineligible|0|||
19795271|NCT02101853|42253671|FG004|Block 1 Induction|Ineligible|0|||
19795272|NCT02101853|42253672|FG005|Block 1 Induction|Ineligible|0|||
19795273|NCT02101853|42253667|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
19795274|NCT02101853|42253668|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
19795275|NCT02101853|42253669|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
19795276|NCT02101853|42253670|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
19795277|NCT02101853|42253671|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
19795278|NCT02101853|42253672|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
19795279|NCT02101853|42253667|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
19795280|NCT02101853|42253668|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795281|NCT02101853|42253669|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795282|NCT02101853|42253670|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795283|NCT02101853|42253671|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795284|NCT02101853|42253672|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795285|NCT02101853|42253667|FG000|Post Induction Randomization|Adverse Event|0|||
19795286|NCT02101853|42253668|FG001|Post Induction Randomization|Adverse Event|3|||
19795287|NCT02101853|42253669|FG002|Post Induction Randomization|Adverse Event|8|||
19795288|NCT02101853|42253670|FG003|Post Induction Randomization|Adverse Event|4|||
19795289|NCT02101853|42253671|FG004|Post Induction Randomization|Adverse Event|4|||
19795290|NCT02101853|42253672|FG005|Post Induction Randomization|Adverse Event|0|||
19795291|NCT02101853|42253667|FG000|Post Induction Randomization|Death|0|||
19795292|NCT02101853|42253668|FG001|Post Induction Randomization|Death|9|||
19795293|NCT02101853|42253669|FG002|Post Induction Randomization|Death|2|||
19795294|NCT02101853|42253670|FG003|Post Induction Randomization|Death|2|||
19795295|NCT02101853|42253671|FG004|Post Induction Randomization|Death|0|||
19795296|NCT02101853|42253672|FG005|Post Induction Randomization|Death|0|||
19795297|NCT02101853|42253667|FG000|Post Induction Randomization|Lack of Efficacy|0|||
19795298|NCT02101853|42253668|FG001|Post Induction Randomization|Lack of Efficacy|14|||
19795299|NCT02101853|42253669|FG002|Post Induction Randomization|Lack of Efficacy|23|||
19795300|NCT02101853|42253670|FG003|Post Induction Randomization|Lack of Efficacy|18|||
19795301|NCT02101853|42253671|FG004|Post Induction Randomization|Lack of Efficacy|21|||
19795302|NCT02101853|42253672|FG005|Post Induction Randomization|Lack of Efficacy|0|||
19795303|NCT02101853|42253667|FG000|Post Induction Randomization|Physician Decision|0|||
19795304|NCT02101853|42253668|FG001|Post Induction Randomization|Physician Decision|43|||
19795305|NCT02101853|42253669|FG002|Post Induction Randomization|Physician Decision|23|||
19795306|NCT02101853|42253670|FG003|Post Induction Randomization|Physician Decision|14|||
19795307|NCT02101853|42253671|FG004|Post Induction Randomization|Physician Decision|14|||
19795308|NCT02101853|42253672|FG005|Post Induction Randomization|Physician Decision|0|||
19795309|NCT02101853|42253667|FG000|Post Induction Randomization|Protocol Violation|0|||
19795310|NCT02101853|42253668|FG001|Post Induction Randomization|Protocol Violation|3|||
19795311|NCT02101853|42253669|FG002|Post Induction Randomization|Protocol Violation|0|||
19795312|NCT02101853|42253670|FG003|Post Induction Randomization|Protocol Violation|0|||
19795313|NCT02101853|42253671|FG004|Post Induction Randomization|Protocol Violation|0|||
19795314|NCT02101853|42253672|FG005|Post Induction Randomization|Protocol Violation|0|||
19795315|NCT02101853|42253667|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
19795316|NCT02101853|42253668|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
19795317|NCT02101853|42253669|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
19795318|NCT02101853|42253670|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
19795319|NCT02101853|42253671|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
19795320|NCT02101853|42253672|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
19795321|NCT02101853|42253667|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795322|NCT02101853|42253668|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795323|NCT02101853|42253669|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795324|NCT02101853|42253670|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
19795325|NCT02101853|42253671|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795326|NCT02101853|42253672|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
19795327|NCT02101853|42253667|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
19795328|NCT02101853|42253668|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
19795329|NCT02101853|42253669|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
19795330|NCT02101853|42253670|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
19795331|NCT02101853|42253671|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
19795332|NCT02101853|42253672|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
19795333|NCT02101853|42253667|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
19795334|NCT02101853|42253668|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
19795335|NCT02101853|42253669|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
19795336|NCT02101853|42253670|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
19795337|NCT02101853|42253671|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
19795338|NCT02101853|42253672|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
19795339|NCT02101853|42253667|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
19795340|NCT02101853|42253668|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
19795341|NCT02101853|42253669|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
19795342|NCT02101853|42253670|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
19795343|NCT02101853|42253671|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
19795344|NCT02101853|42253672|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
19795345|NCT02101853|42253667|FG000|Blinatumomab Salvage Therapy|Death|0|||
19795346|NCT02101853|42253668|FG001|Blinatumomab Salvage Therapy|Death|0|||
19795347|NCT02101853|42253669|FG002|Blinatumomab Salvage Therapy|Death|0|||
19795348|NCT02101853|42253670|FG003|Blinatumomab Salvage Therapy|Death|0|||
19795349|NCT02101853|42253671|FG004|Blinatumomab Salvage Therapy|Death|0|||
19795350|NCT02101853|42253672|FG005|Blinatumomab Salvage Therapy|Death|2|||
19795351|NCT02101853|42253667|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
19795352|NCT02101853|42253668|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
19795353|NCT02101853|42253669|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
19477886|NCT01505491|41757168|FG001|Overall Study|Withdrawal by Subject|1|||
19477887|NCT01505491|41757169|FG002|Overall Study|Withdrawal by Subject|4|||
19477888|NCT01505491|41757167|FG000|Overall Study|Lost to Follow-up|0|||
19477889|NCT01505491|41757168|FG001|Overall Study|Lost to Follow-up|0|||
19477890|NCT01505491|41757169|FG002|Overall Study|Lost to Follow-up|1|||
19477891|NCT01504867|41757179|FG000|Overall Study|Inclusion criteria not met|2|||
19477892|NCT01504867|41757180|FG001|Overall Study|Inclusion criteria not met|2|||
19477893|NCT01504867|41757179|FG000|Overall Study|Consent revoked|5|||
19477894|NCT01504867|41757180|FG001|Overall Study|Consent revoked|1|||
19477895|NCT01476475|41757188|FG000|Overall Study|Adverse Event|6|||
19477896|NCT01476475|41757189|FG001|Overall Study|Adverse Event|0|||
19477897|NCT01476475|41757188|FG000|Overall Study|Poor compliance to protocol|1|||
19477898|NCT01476475|41757189|FG001|Overall Study|Poor compliance to protocol|1|||
19477899|NCT01476475|41757188|FG000|Overall Study|Other reasons|4|||
19477900|NCT01476475|41757189|FG001|Overall Study|Other reasons|2|||
19477901|NCT01475851|41757198|FG000|Overall Study|Protocol defined stopping criteria|1|||
19477902|NCT01475851|41757199|FG001|Overall Study|Protocol defined stopping criteria|0|||
19477903|NCT01460719|41757205|FG000|Overall Study|Adverse Event|1|||
19477904|NCT01460719|41757205|FG000|Overall Study|Withdrawal by Subject|1|||
19477905|NCT01468181|41757275|FG000|Overall Study|Adverse Event|8|||
19477906|NCT01468181|41757276|FG001|Overall Study|Adverse Event|1|||
19477907|NCT01468181|41757277|FG002|Overall Study|Adverse Event|6|||
19477908|NCT01468181|41757278|FG003|Overall Study|Adverse Event|2|||
19477909|NCT01468181|41757279|FG004|Overall Study|Adverse Event|2|||
19477910|NCT01468181|41757275|FG000|Overall Study|Protocol Violation|2|||
19477911|NCT01468181|41757276|FG001|Overall Study|Protocol Violation|0|||
19477912|NCT01468181|41757277|FG002|Overall Study|Protocol Violation|1|||
19477913|NCT01468181|41757278|FG003|Overall Study|Protocol Violation|0|||
19477914|NCT01468181|41757279|FG004|Overall Study|Protocol Violation|1|||
19477915|NCT01468181|41757275|FG000|Overall Study|Physician Decision|0|||
19477916|NCT01468181|41757276|FG001|Overall Study|Physician Decision|0|||
19477917|NCT01468181|41757277|FG002|Overall Study|Physician Decision|0|||
19795354|NCT02101853|42253670|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
19795355|NCT02101853|42253671|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
19795356|NCT02101853|42253672|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
19367534|NCT02784535|41607717|FG000|Overall Study|Adverse Event|1|||
19367535|NCT02784535|41607718|FG001|Overall Study|Adverse Event|0|||
19477918|NCT01468181|41757278|FG003|Overall Study|Physician Decision|1|||
19795357|NCT02101853|42253667|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
19795358|NCT02101853|42253668|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
19795359|NCT02101853|42253669|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
19795360|NCT02101853|42253670|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
19795361|NCT02101853|42253671|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
19795362|NCT02101853|42253672|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
19795363|NCT02101853|42253667|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
19795364|NCT02101853|42253668|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
19795365|NCT02101853|42253669|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
19795366|NCT02101853|42253670|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
19795367|NCT02101853|42253671|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
19795368|NCT02101853|42253672|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
19795369|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795370|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795371|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795372|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
19795373|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
19795374|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795375|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795376|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795377|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795378|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
19795379|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795380|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795381|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
19795382|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
19795383|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
19795384|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
19795385|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
19795386|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
19795387|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
19795388|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
19795389|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
19795390|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795391|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795392|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
19795393|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
19795394|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795395|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
19795396|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795397|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
19795398|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795399|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795400|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
19795401|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
19795402|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
19795403|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
19795404|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
19795405|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
19795406|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
19795407|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
19795408|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
19795409|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
19795410|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
19795411|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
19795412|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
19795413|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
19795414|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
19795415|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
19795416|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
19795417|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
19795418|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
19795419|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
19477919|NCT01468181|41757279|FG004|Overall Study|Physician Decision|1|||
19795420|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
19698411|NCT00090220|42143531|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19698412|NCT00090220|42143532|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19698413|NCT00090220|42143533|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19698414|NCT00090220|42143534|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
19698415|NCT00090220|42143535|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
19698416|NCT00090220|42143536|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
19698417|NCT00090220|42143531|FG000|Long-term Follow-up (EXT2)|Death|0|||
19698418|NCT00090220|42143532|FG001|Long-term Follow-up (EXT2)|Death|0|||
19698419|NCT00090220|42143533|FG002|Long-term Follow-up (EXT2)|Death|0|||
19698420|NCT00090220|42143534|FG003|Long-term Follow-up (EXT2)|Death|0|||
19698421|NCT00090220|42143535|FG004|Long-term Follow-up (EXT2)|Death|1|||
19698422|NCT00090220|42143536|FG005|Long-term Follow-up (EXT2)|Death|1|||
19698423|NCT00090220|42143531|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19698424|NCT00090220|42143532|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19698425|NCT00090220|42143533|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19698426|NCT00090220|42143534|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
19698427|NCT00090220|42143535|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
19698428|NCT00090220|42143536|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
19698429|NCT00090220|42143531|FG000|Long-term Follow-up (EXT2)|Other|0|||
19698430|NCT00090220|42143532|FG001|Long-term Follow-up (EXT2)|Other|0|||
19698431|NCT00090220|42143533|FG002|Long-term Follow-up (EXT2)|Other|0|||
19698432|NCT00090220|42143534|FG003|Long-term Follow-up (EXT2)|Other|0|||
19698433|NCT00090220|42143535|FG004|Long-term Follow-up (EXT2)|Other|1|||
19698434|NCT00090220|42143536|FG005|Long-term Follow-up (EXT2)|Other|0|||
19698435|NCT00263328|42143556|FG000|Overall Study|Death|0|||
19698436|NCT00263328|42143557|FG001|Overall Study|Death|0|||
19698437|NCT00263328|42143558|FG002|Overall Study|Death|1|||
19698438|NCT00263328|42143556|FG000|Overall Study|Lost to Follow-up|1|||
19698439|NCT00263328|42143557|FG001|Overall Study|Lost to Follow-up|1|||
19698440|NCT00263328|42143558|FG002|Overall Study|Lost to Follow-up|0|||
19698441|NCT00263328|42143556|FG000|Overall Study|Withdrawal by Subject|3|||
19698442|NCT00263328|42143557|FG001|Overall Study|Withdrawal by Subject|0|||
19698443|NCT00263328|42143558|FG002|Overall Study|Withdrawal by Subject|1|||
19698444|NCT00263328|42143556|FG000|Overall Study|Other|3|||
19698445|NCT00263328|42143557|FG001|Overall Study|Other|0|||
19698446|NCT00263328|42143558|FG002|Overall Study|Other|1|||
19698447|NCT00263328|42143556|FG000|Overall Study|Adverse Event|1|||
19698448|NCT00263328|42143557|FG001|Overall Study|Adverse Event|1|||
19698449|NCT00263328|42143558|FG002|Overall Study|Adverse Event|4|||
19698450|NCT00262860|42143568|FG000|Overall Study|Adverse Event|2|||
19698451|NCT00236184|42143574|FG000|Overall Study|Adverse Event|5|||
19698452|NCT00236184|42143575|FG001|Overall Study|Adverse Event|2|||
19698453|NCT00236184|42143574|FG000|Overall Study|Lack of Efficacy|0|||
19698454|NCT00236184|42143575|FG001|Overall Study|Lack of Efficacy|1|||
19698455|NCT00236184|42143574|FG000|Overall Study|Lost to Follow-up|3|||
19698456|NCT00236184|42143575|FG001|Overall Study|Lost to Follow-up|4|||
19698457|NCT00236184|42143574|FG000|Overall Study|Physician Decision|1|||
19698458|NCT00236184|42143575|FG001|Overall Study|Physician Decision|1|||
19698459|NCT00236184|42143574|FG000|Overall Study|Withdrawal by Subject|3|||
19698460|NCT00236184|42143575|FG001|Overall Study|Withdrawal by Subject|0|||
19698461|NCT00236184|42143574|FG000|Overall Study|Protocol Violation|3|||
19698462|NCT00236184|42143575|FG001|Overall Study|Protocol Violation|0|||
19698463|NCT00236184|42143574|FG000|Overall Study|non-compliance with study drug|2|||
19698464|NCT00236184|42143575|FG001|Overall Study|non-compliance with study drug|1|||
19698465|NCT00236184|42143574|FG000|Overall Study|other|1|||
19698466|NCT00236184|42143575|FG001|Overall Study|other|2|||
19698467|NCT00296504|42143589|FG000|Interim Analysis|Withdrawal by Subject|8|||
19698468|NCT00296504|42143590|FG001|Interim Analysis|Withdrawal by Subject|0|||
19698469|NCT00296504|42143591|FG002|Interim Analysis|Withdrawal by Subject|12|||
19698470|NCT00296504|42143592|FG003|Interim Analysis|Withdrawal by Subject|0|||
19698471|NCT00296504|42143593|FG004|Interim Analysis|Withdrawal by Subject|5|||
19698472|NCT00296504|42143594|FG005|Interim Analysis|Withdrawal by Subject|5|||
19795421|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
19795422|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
19698473|NCT00296504|42143595|FG006|Interim Analysis|Withdrawal by Subject|9|||
19698474|NCT00296504|42143596|FG007|Interim Analysis|Withdrawal by Subject|3|||
19698475|NCT00296504|42143597|FG008|Interim Analysis|Withdrawal by Subject|0|||
19698476|NCT00296504|42143589|FG000|Interim Analysis|Lost to Follow-up|13|||
19698477|NCT00296504|42143590|FG001|Interim Analysis|Lost to Follow-up|3|||
19698478|NCT00296504|42143591|FG002|Interim Analysis|Lost to Follow-up|26|||
19698479|NCT00296504|42143592|FG003|Interim Analysis|Lost to Follow-up|8|||
19698480|NCT00296504|42143593|FG004|Interim Analysis|Lost to Follow-up|14|||
19698481|NCT00296504|42143594|FG005|Interim Analysis|Lost to Follow-up|4|||
19698482|NCT00296504|42143595|FG006|Interim Analysis|Lost to Follow-up|11|||
19698483|NCT00296504|42143596|FG007|Interim Analysis|Lost to Follow-up|4|||
19698484|NCT00296504|42143597|FG008|Interim Analysis|Lost to Follow-up|0|||
19795423|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
19795424|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
19795425|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
19795426|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795427|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795428|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795429|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795430|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795431|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795432|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795433|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795434|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795435|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795436|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
19795437|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795438|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795439|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795440|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795441|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795442|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795443|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795444|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
19795445|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
19795446|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795447|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795448|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795449|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795450|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
19795451|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795452|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795453|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795454|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795455|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
19795456|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795457|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795458|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
19795459|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
19795460|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
19795461|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
19795462|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
19795463|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
19795464|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795465|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795466|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795467|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795468|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
19795469|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795470|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795471|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795472|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795473|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
19795474|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795475|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795476|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795477|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795478|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795479|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795480|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795481|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795482|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
19795483|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795484|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795485|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
19795486|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795487|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795488|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795489|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795490|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795491|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795492|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795493|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795494|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795495|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795496|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795497|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795498|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
19795499|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
19795500|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
19795501|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
19795502|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
19795503|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
19795504|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795505|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
19795506|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795507|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795508|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
19795509|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795510|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795511|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795512|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
19795513|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795514|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
19795515|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
19795516|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
19795517|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
19795518|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
19795519|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
19795520|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
19795521|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795522|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795523|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795524|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795525|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795526|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795527|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795528|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795529|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795530|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795531|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
19795532|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795533|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795534|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
19795535|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795536|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795537|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
19795538|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
19795539|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
19795540|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
19795541|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795542|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795543|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795544|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795545|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
19795546|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795547|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795548|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795549|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795550|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795551|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795552|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795553|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795554|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
19795555|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795556|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795557|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
19795558|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
19795559|NCT01915498|42253702|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795560|NCT01915498|42253703|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795561|NCT01915498|42253704|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795562|NCT01915498|42253705|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795563|NCT01915498|42253706|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795564|NCT01915498|42253707|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
19795565|NCT01915498|42253708|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795566|NCT01915498|42253709|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795567|NCT01915498|42253710|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795568|NCT01915498|42253711|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
19795569|NCT01915498|42253712|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795570|NCT01915498|42253713|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795571|NCT01915498|42253714|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795572|NCT01915498|42253715|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
19795573|NCT01915498|42253716|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
19795574|NCT01915498|42253717|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
19795575|NCT01915498|42253718|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
19795576|NCT01915498|42253719|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
19795577|NCT01915498|42253720|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
19795578|NCT01915498|42253702|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795579|NCT01915498|42253703|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795580|NCT01915498|42253704|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795581|NCT01915498|42253705|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795582|NCT01915498|42253706|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795583|NCT01915498|42253707|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795584|NCT01915498|42253708|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795585|NCT01915498|42253709|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795586|NCT01915498|42253710|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795587|NCT01915498|42253711|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795588|NCT01915498|42253712|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795589|NCT01915498|42253713|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795590|NCT01915498|42253714|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795591|NCT01915498|42253715|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795592|NCT01915498|42253716|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795593|NCT01915498|42253717|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795594|NCT01915498|42253718|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795595|NCT01915498|42253719|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
19795596|NCT01915498|42253720|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
19795597|NCT01798004|42253812|FG000|Overall Study|Death|2|||
19795598|NCT01798004|42253812|FG000|Overall Study|Lack of Efficacy|8|||
19795599|NCT01798004|42253812|FG000|Overall Study|Physician Decision|25|||
19795600|NCT01798004|42253812|FG000|Overall Study|Withdrawal by Subject|4|||
19795601|NCT01798004|42253812|FG000|Overall Study|Ineligible|4|||
19795602|NCT01798004|42253812|FG000|Overall Study|Patient/parent refusal|7|||
19795603|NCT01798004|42253812|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
19795604|NCT01798004|42253812|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
19795605|NCT01711541|42253821|FG000|Overall Study|Cancel prior to treatment|0|||
19795606|NCT01711541|42253822|FG001|Overall Study|Cancel prior to treatment|0|||
19795607|NCT01711541|42253823|FG002|Overall Study|Cancel prior to treatment|0|||
19795608|NCT01711541|42253824|FG003|Overall Study|Cancel prior to treatment|1|||
19795609|NCT01711541|42253825|FG004|Overall Study|Cancel prior to treatment|0|||
19795610|NCT01711541|42253821|FG000|Overall Study|Ineligible|0|||
19795611|NCT01711541|42253822|FG001|Overall Study|Ineligible|1|||
19795612|NCT01711541|42253823|FG002|Overall Study|Ineligible|0|||
19795613|NCT01711541|42253824|FG003|Overall Study|Ineligible|0|||
19795614|NCT01711541|42253825|FG004|Overall Study|Ineligible|0|||
19795615|NCT01630434|42253844|FG000|Overall Study|Donor lungs turned down|1|||
19795616|NCT01630434|42253845|FG001|Overall Study|Donor lungs turned down|0|||
19795617|NCT01630434|42253844|FG000|Overall Study|Protocol Violation|9|||
19795618|NCT01630434|42253845|FG001|Overall Study|Protocol Violation|4|||
19795619|NCT01630434|42253844|FG000|Overall Study|Death|20|||
19795620|NCT01630434|42253845|FG001|Overall Study|Death|26|||
19795621|NCT01256398|42253855|FG000|Overall Study|Withdrawal by Subject|1|||
19795622|NCT01196390|42253863|FG000|Overall Study|Protocol Violation|4|||
19795623|NCT01196390|42253864|FG001|Overall Study|Protocol Violation|5|||
19795624|NCT01175356|42253872|FG000|Overall Study|Death|1|||
19795625|NCT01175356|42253872|FG000|Overall Study|Lack of Efficacy|12|||
19795626|NCT01175356|42253872|FG000|Overall Study|Lost to Follow-up|1|||
19795627|NCT01175356|42253872|FG000|Overall Study|Physician Decision|23|||
19795628|NCT01175356|42253872|FG000|Overall Study|Ineligible|1|||
19795629|NCT01175356|42253872|FG000|Overall Study|Treatment Slot Not Available|18|||
19795630|NCT01175356|42253872|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
19795631|NCT01175356|42253872|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
19795632|NCT01175356|42253872|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
19795633|NCT01175356|42253872|FG000|Overall Study|Inadequate stem cell for transplant|1|||
19795634|NCT01175356|42253872|FG000|Overall Study|Initiation other tx prior to completion|9|||
19795635|NCT01151423|42253887|FG000|Overall Study|Study terminated by Sponsor|9|||
19795636|NCT01151423|42253888|FG001|Overall Study|Study terminated by Sponsor|10|||
19795637|NCT01151423|42253887|FG000|Overall Study|Protocol Violation|0|||
19795638|NCT01151423|42253888|FG001|Overall Study|Protocol Violation|1|||
19795639|NCT01151423|42253887|FG000|Overall Study|Physician Decision|1|||
19795640|NCT01151423|42253888|FG001|Overall Study|Physician Decision|1|||
19795641|NCT01151423|42253887|FG000|Overall Study|Pregnancy|0|||
19795642|NCT01151423|42253888|FG001|Overall Study|Pregnancy|1|||
19795643|NCT01151423|42253887|FG000|Overall Study|Death|0|||
19795644|NCT01151423|42253888|FG001|Overall Study|Death|1|||
19795645|NCT01151423|42253887|FG000|Overall Study|Adverse Event|3|||
19795646|NCT01151423|42253888|FG001|Overall Study|Adverse Event|0|||
19795647|NCT01151423|42253887|FG000|Overall Study|Withdrawal by Subject|1|||
19795648|NCT01151423|42253888|FG001|Overall Study|Withdrawal by Subject|3|||
19795649|NCT01151423|42253887|FG000|Overall Study|Lost to Follow-up|1|||
19795650|NCT01151423|42253888|FG001|Overall Study|Lost to Follow-up|0|||
19795651|NCT01151423|42253887|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
19795652|NCT01151423|42253888|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
19795653|NCT01151423|42253887|FG000|Overall Study|Participated in other clinical trial|1|||
19795654|NCT01151423|42253888|FG001|Overall Study|Participated in other clinical trial|0|||
19795655|NCT00977574|42253914|FG000|Overall Study|Never Treated|4|||
19795656|NCT00977574|42253915|FG001|Overall Study|Never Treated|2|||
19795657|NCT00977574|42253916|FG002|Overall Study|Never Treated|4|||
19795658|NCT00569127|42253935|FG000|Overall Study|Adverse Event|57|||
19795659|NCT00569127|42253936|FG001|Overall Study|Adverse Event|47|||
19795660|NCT00569127|42253935|FG000|Overall Study|Withdrawal by Subject|13|||
19795661|NCT00569127|42253936|FG001|Overall Study|Withdrawal by Subject|27|||
19795662|NCT00569127|42253935|FG000|Overall Study|Progression|99|||
19795663|NCT00569127|42253936|FG001|Overall Study|Progression|100|||
19795664|NCT00569127|42253935|FG000|Overall Study|Death|4|||
19795665|NCT00569127|42253936|FG001|Overall Study|Death|3|||
19795666|NCT00569127|42253935|FG000|Overall Study|Other|20|||
19795667|NCT00569127|42253936|FG001|Overall Study|Other|19|||
19795668|NCT00569127|42253935|FG000|Overall Study|Lost to Follow-up|0|||
19795669|NCT00569127|42253936|FG001|Overall Study|Lost to Follow-up|3|||
19795670|NCT00569127|42253935|FG000|Overall Study|Not Eligible|14|||
19795671|NCT00569127|42253936|FG001|Overall Study|Not Eligible|11|||
19795672|NCT00569127|42253935|FG000|Overall Study|Still on Treatment|7|||
19795673|NCT00569127|42253936|FG001|Overall Study|Still on Treatment|3|||
19795674|NCT00565617|42253942|FG000|Overall Study|Withdrawal by Subject|1|||
19795675|NCT00453154|42253949|FG000|Double BIind Maintenance|Adverse Event|0|||
19795676|NCT00453154|42253950|FG001|Double BIind Maintenance|Adverse Event|0|||
19795677|NCT00453154|42253951|FG002|Double BIind Maintenance|Adverse Event|3|||
19795678|NCT00453154|42253952|FG003|Double BIind Maintenance|Adverse Event|12|||
19795679|NCT00453154|42253949|FG000|Double BIind Maintenance|Death|0|||
19795680|NCT00453154|42253950|FG001|Double BIind Maintenance|Death|0|||
19795681|NCT00453154|42253951|FG002|Double BIind Maintenance|Death|2|||
19795682|NCT00453154|42253952|FG003|Double BIind Maintenance|Death|1|||
19795683|NCT00453154|42253949|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
19795684|NCT00453154|42253950|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
19795685|NCT00453154|42253951|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
19795686|NCT00453154|42253952|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
19795687|NCT00453154|42253949|FG000|Double BIind Maintenance|Progression|0|||
19795688|NCT00453154|42253950|FG001|Double BIind Maintenance|Progression|0|||
19795689|NCT00453154|42253951|FG002|Double BIind Maintenance|Progression|29|||
19795690|NCT00453154|42253952|FG003|Double BIind Maintenance|Progression|26|||
19795691|NCT00453154|42253949|FG000|Double BIind Maintenance|Medical Issues|0|||
19795692|NCT00453154|42253950|FG001|Double BIind Maintenance|Medical Issues|0|||
19795693|NCT00453154|42253951|FG002|Double BIind Maintenance|Medical Issues|3|||
19795694|NCT00453154|42253952|FG003|Double BIind Maintenance|Medical Issues|1|||
19795695|NCT00453154|42253949|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
19795696|NCT00453154|42253950|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
19795697|NCT00453154|42253951|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
19795698|NCT00453154|42253952|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
19795699|NCT00408005|42253963|FG000|Induction|Adverse Event|19|||
19795700|NCT00408005|42253964|FG001|Induction|Adverse Event|3|||
19795701|NCT00408005|42253965|FG002|Induction|Adverse Event|0|||
19795702|NCT00408005|42253966|FG003|Induction|Adverse Event|0|||
19795703|NCT00408005|42253967|FG004|Induction|Adverse Event|0|||
19795704|NCT00408005|42253968|FG005|Induction|Adverse Event|0|||
19795705|NCT00408005|42253969|FG006|Induction|Adverse Event|0|||
19795706|NCT00408005|42253970|FG007|Induction|Adverse Event|0|||
19795707|NCT00408005|42253963|FG000|Induction|Death|6|||
19795708|NCT00408005|42253964|FG001|Induction|Death|0|||
19795709|NCT00408005|42253965|FG002|Induction|Death|0|||
19795710|NCT00408005|42253966|FG003|Induction|Death|0|||
19795711|NCT00408005|42253967|FG004|Induction|Death|0|||
19795712|NCT00408005|42253968|FG005|Induction|Death|0|||
19795713|NCT00408005|42253969|FG006|Induction|Death|0|||
19795714|NCT00408005|42253970|FG007|Induction|Death|0|||
19795715|NCT00408005|42253963|FG000|Induction|Physician Decision|83|||
19795716|NCT00408005|42253964|FG001|Induction|Physician Decision|9|||
19795717|NCT00408005|42253965|FG002|Induction|Physician Decision|0|||
19795718|NCT00408005|42253966|FG003|Induction|Physician Decision|0|||
19795719|NCT00408005|42253967|FG004|Induction|Physician Decision|0|||
19795720|NCT00408005|42253968|FG005|Induction|Physician Decision|0|||
19795721|NCT00408005|42253969|FG006|Induction|Physician Decision|0|||
19795722|NCT00408005|42253970|FG007|Induction|Physician Decision|0|||
19795723|NCT00408005|42253963|FG000|Induction|Withdrawal by Subject|2|||
19795724|NCT00408005|42253964|FG001|Induction|Withdrawal by Subject|4|||
19795725|NCT00408005|42253965|FG002|Induction|Withdrawal by Subject|0|||
19795726|NCT00408005|42253966|FG003|Induction|Withdrawal by Subject|0|||
19795727|NCT00408005|42253967|FG004|Induction|Withdrawal by Subject|0|||
19795728|NCT00408005|42253968|FG005|Induction|Withdrawal by Subject|0|||
19795729|NCT00408005|42253969|FG006|Induction|Withdrawal by Subject|0|||
19795730|NCT00408005|42253970|FG007|Induction|Withdrawal by Subject|0|||
19795731|NCT00408005|42253963|FG000|Induction|Ineligible|33|||
19795732|NCT00408005|42253964|FG001|Induction|Ineligible|14|||
19795733|NCT00408005|42253965|FG002|Induction|Ineligible|0|||
19795734|NCT00408005|42253966|FG003|Induction|Ineligible|0|||
19795735|NCT00408005|42253967|FG004|Induction|Ineligible|0|||
19795736|NCT00408005|42253968|FG005|Induction|Ineligible|0|||
19795737|NCT00408005|42253969|FG006|Induction|Ineligible|0|||
19795738|NCT00408005|42253970|FG007|Induction|Ineligible|0|||
19795739|NCT00408005|42253963|FG000|Induction|Refusal of Further Protocol Therapy|225|||
19795740|NCT00408005|42253964|FG001|Induction|Refusal of Further Protocol Therapy|44|||
19795741|NCT00408005|42253965|FG002|Induction|Refusal of Further Protocol Therapy|0|||
19795742|NCT00408005|42253966|FG003|Induction|Refusal of Further Protocol Therapy|0|||
19795743|NCT00408005|42253967|FG004|Induction|Refusal of Further Protocol Therapy|0|||
19795744|NCT00408005|42253968|FG005|Induction|Refusal of Further Protocol Therapy|0|||
19795745|NCT00408005|42253969|FG006|Induction|Refusal of Further Protocol Therapy|0|||
19795746|NCT00408005|42253970|FG007|Induction|Refusal of Further Protocol Therapy|0|||
19795747|NCT00408005|42253963|FG000|Induction|Entered another COG therapeutic protocol|4|||
19795748|NCT00408005|42253964|FG001|Induction|Entered another COG therapeutic protocol|0|||
19795749|NCT00408005|42253965|FG002|Induction|Entered another COG therapeutic protocol|0|||
19795750|NCT00408005|42253966|FG003|Induction|Entered another COG therapeutic protocol|0|||
19795751|NCT00408005|42253967|FG004|Induction|Entered another COG therapeutic protocol|0|||
19795752|NCT00408005|42253968|FG005|Induction|Entered another COG therapeutic protocol|0|||
19795753|NCT00408005|42253969|FG006|Induction|Entered another COG therapeutic protocol|0|||
19795754|NCT00408005|42253970|FG007|Induction|Entered another COG therapeutic protocol|0|||
19795755|NCT00408005|42253963|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
19795756|NCT00408005|42253964|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
19795757|NCT00408005|42253965|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
19795758|NCT00408005|42253966|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
19795759|NCT00408005|42253967|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
19795760|NCT00408005|42253968|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
19795761|NCT00408005|42253969|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
19795762|NCT00408005|42253970|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
19795763|NCT00408005|42253963|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
19795764|NCT00408005|42253964|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
19795765|NCT00408005|42253965|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
19795766|NCT00408005|42253966|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
19795767|NCT00408005|42253967|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
19795768|NCT00408005|42253968|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
19795769|NCT00408005|42253969|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
19795770|NCT00408005|42253970|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
19795771|NCT00408005|42253963|FG000|Induction|Progressive Disease|0|||
19795772|NCT00408005|42253964|FG001|Induction|Progressive Disease|1|||
19795773|NCT00408005|42253965|FG002|Induction|Progressive Disease|0|||
19795774|NCT00408005|42253966|FG003|Induction|Progressive Disease|0|||
19795775|NCT00408005|42253967|FG004|Induction|Progressive Disease|0|||
19795776|NCT00408005|42253968|FG005|Induction|Progressive Disease|0|||
19795777|NCT00408005|42253969|FG006|Induction|Progressive Disease|0|||
19795778|NCT00408005|42253970|FG007|Induction|Progressive Disease|0|||
19795779|NCT00408005|42253963|FG000|Induction|Inevaluable|18|||
19795780|NCT00408005|42253964|FG001|Induction|Inevaluable|14|||
19795781|NCT00408005|42253965|FG002|Induction|Inevaluable|0|||
19795782|NCT00408005|42253966|FG003|Induction|Inevaluable|0|||
19795783|NCT00408005|42253967|FG004|Induction|Inevaluable|0|||
19795784|NCT00408005|42253968|FG005|Induction|Inevaluable|0|||
19795785|NCT00408005|42253969|FG006|Induction|Inevaluable|0|||
19795786|NCT00408005|42253970|FG007|Induction|Inevaluable|0|||
19795787|NCT00408005|42253963|FG000|Induction|Failed to Complete Randomization|3|||
19795788|NCT00408005|42253964|FG001|Induction|Failed to Complete Randomization|2|||
19795789|NCT00408005|42253965|FG002|Induction|Failed to Complete Randomization|0|||
19795790|NCT00408005|42253966|FG003|Induction|Failed to Complete Randomization|0|||
19795791|NCT00408005|42253967|FG004|Induction|Failed to Complete Randomization|0|||
19795792|NCT00408005|42253968|FG005|Induction|Failed to Complete Randomization|0|||
19795793|NCT00408005|42253969|FG006|Induction|Failed to Complete Randomization|0|||
19795794|NCT00408005|42253970|FG007|Induction|Failed to Complete Randomization|0|||
19795795|NCT00408005|42253963|FG000|Induction|Protocol Deviation|3|||
19795796|NCT00408005|42253964|FG001|Induction|Protocol Deviation|1|||
19795797|NCT00408005|42253965|FG002|Induction|Protocol Deviation|0|||
19795798|NCT00408005|42253966|FG003|Induction|Protocol Deviation|0|||
19795799|NCT00408005|42253967|FG004|Induction|Protocol Deviation|0|||
19795800|NCT00408005|42253968|FG005|Induction|Protocol Deviation|0|||
19795801|NCT00408005|42253969|FG006|Induction|Protocol Deviation|0|||
19795802|NCT00408005|42253970|FG007|Induction|Protocol Deviation|0|||
19795803|NCT00408005|42253963|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
19795804|NCT00408005|42253964|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795805|NCT00408005|42253965|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795806|NCT00408005|42253966|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795807|NCT00408005|42253967|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795808|NCT00408005|42253968|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795809|NCT00408005|42253969|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795810|NCT00408005|42253970|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
19795811|NCT00408005|42253963|FG000|Induction|Recurrent leukemia|1|||
19795812|NCT00408005|42253964|FG001|Induction|Recurrent leukemia|0|||
19795813|NCT00408005|42253965|FG002|Induction|Recurrent leukemia|0|||
19795814|NCT00408005|42253966|FG003|Induction|Recurrent leukemia|0|||
19795815|NCT00408005|42253967|FG004|Induction|Recurrent leukemia|0|||
19795816|NCT00408005|42253968|FG005|Induction|Recurrent leukemia|0|||
19795817|NCT00408005|42253969|FG006|Induction|Recurrent leukemia|0|||
19795818|NCT00408005|42253970|FG007|Induction|Recurrent leukemia|0|||
19795819|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
19795820|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
19795821|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
19795822|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
19795823|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
19795824|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
19795825|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
19795826|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
19795827|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
19795828|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
19795829|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
19795830|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
19795831|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
19795832|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
19795833|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
19795834|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
19795835|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795836|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795837|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
19795838|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795839|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
19795840|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795841|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795842|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
19795843|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
19795844|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
19795845|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
19795846|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
19795847|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
19795848|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
19795849|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
19795850|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
19795851|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
19795852|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
19795853|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
19795854|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
19795855|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
19795856|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
19795857|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
19795858|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
19795859|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
19795860|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
19795861|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
19795862|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
19795863|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
19795864|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
19795865|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
19795866|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
19795867|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795868|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795869|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795870|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795871|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
19795872|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795873|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795874|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
19795875|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
19795876|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
19795877|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
19795878|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
19795879|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
19795880|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
19795881|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
19795882|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
19795883|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
19795884|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
19795885|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
19795886|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
19795887|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
19795888|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
19795889|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
19795890|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
19795891|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795892|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795893|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795894|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795895|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795896|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
19795897|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795898|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
19795899|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
19795900|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
19795901|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
19795902|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
19795903|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
19795904|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
19795905|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
19795906|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
19795907|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795908|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795909|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795910|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795911|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
19795912|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
19795913|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795914|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
19795915|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
19795916|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
19795917|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
19795918|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
19795919|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
19795920|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
19795921|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
19795922|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
19795923|NCT00408005|42253963|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
19795924|NCT00408005|42253964|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
19795925|NCT00408005|42253965|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
19795926|NCT00408005|42253966|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
19795927|NCT00408005|42253967|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
19795928|NCT00408005|42253968|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
19795929|NCT00408005|42253969|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
19795930|NCT00408005|42253970|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
19795931|NCT00334815|42253992|FG000|Overall Study|Adverse Event|3|||
19795932|NCT00334815|42253993|FG001|Overall Study|Adverse Event|2|||
19795933|NCT00334815|42253992|FG000|Overall Study|Death|0|||
19795934|NCT00334815|42253993|FG001|Overall Study|Death|2|||
19795935|NCT00334815|42253992|FG000|Overall Study|Progression|1|||
19795936|NCT00334815|42253993|FG001|Overall Study|Progression|0|||
19795937|NCT00334815|42253992|FG000|Overall Study|ineligible|1|||
19795938|NCT00334815|42253993|FG001|Overall Study|ineligible|1|||
19795939|NCT00334815|42253992|FG000|Overall Study|patient refused treatment|0|||
19795940|NCT00334815|42253993|FG001|Overall Study|patient refused treatment|1|||
19795941|NCT00334815|42253992|FG000|Overall Study|Physician Decision|2|||
19795942|NCT00334815|42253993|FG001|Overall Study|Physician Decision|4|||
19795943|NCT00258960|42254001|FG000|Overall Study|Death|2|||
19795944|NCT00258960|42254001|FG000|Overall Study|Disease Progression|7|||
19795945|NCT00258960|42254001|FG000|Overall Study|Adverse Event|4|||
19795946|NCT00258960|42254001|FG000|Overall Study|Physician Decision|1|||
19795947|NCT00258960|42254001|FG000|Overall Study|Withdrawal by Subject|1|||
19795948|NCT00258960|42254001|FG000|Overall Study|Mistake|2|||
19795949|NCT00121992|42254007|FG000|Overall Study|Treatment not received|2|||
19795950|NCT00121992|42254008|FG001|Overall Study|Treatment not received|11|||
19795951|NCT00070564|42254020|FG000|Overall Study|Progression|2|||
19795952|NCT00070564|42254021|FG001|Overall Study|Progression|4|||
19795953|NCT00070564|42254022|FG002|Overall Study|Progression|7|||
19795954|NCT00070564|42254023|FG003|Overall Study|Progression|7|||
19795955|NCT00070564|42254024|FG004|Overall Study|Progression|1|||
19795956|NCT00070564|42254025|FG005|Overall Study|Progression|0|||
19795957|NCT00070564|42254020|FG000|Overall Study|Delinquent|1|||
19795958|NCT00070564|42254021|FG001|Overall Study|Delinquent|4|||
19795959|NCT00070564|42254022|FG002|Overall Study|Delinquent|2|||
19795960|NCT00070564|42254023|FG003|Overall Study|Delinquent|0|||
19795961|NCT00070564|42254024|FG004|Overall Study|Delinquent|0|||
19795962|NCT00070564|42254025|FG005|Overall Study|Delinquent|0|||
19795963|NCT00070564|42254020|FG000|Overall Study|Adverse Event|150|||
19795964|NCT00070564|42254021|FG001|Overall Study|Adverse Event|142|||
19795965|NCT00070564|42254022|FG002|Overall Study|Adverse Event|120|||
19795966|NCT00070564|42254023|FG003|Overall Study|Adverse Event|108|||
19795967|NCT00070564|42254024|FG004|Overall Study|Adverse Event|63|||
19795968|NCT00070564|42254025|FG005|Overall Study|Adverse Event|36|||
19795969|NCT00070564|42254020|FG000|Overall Study|Death|4|||
19795970|NCT00070564|42254021|FG001|Overall Study|Death|1|||
19795971|NCT00070564|42254022|FG002|Overall Study|Death|5|||
19795972|NCT00070564|42254023|FG003|Overall Study|Death|3|||
19795973|NCT00070564|42254024|FG004|Overall Study|Death|0|||
19795974|NCT00070564|42254025|FG005|Overall Study|Death|1|||
19795975|NCT00070564|42254020|FG000|Overall Study|Other, not protocol specified|17|||
19795976|NCT00070564|42254021|FG001|Overall Study|Other, not protocol specified|15|||
19795977|NCT00070564|42254022|FG002|Overall Study|Other, not protocol specified|14|||
19795978|NCT00070564|42254023|FG003|Overall Study|Other, not protocol specified|19|||
19795979|NCT00070564|42254024|FG004|Overall Study|Other, not protocol specified|6|||
19795980|NCT00070564|42254025|FG005|Overall Study|Other, not protocol specified|7|||
19795981|NCT00070564|42254020|FG000|Overall Study|Withdrawal by Subject|26|||
19795982|NCT00070564|42254021|FG001|Overall Study|Withdrawal by Subject|37|||
19795983|NCT00070564|42254022|FG002|Overall Study|Withdrawal by Subject|23|||
19795984|NCT00070564|42254023|FG003|Overall Study|Withdrawal by Subject|30|||
19795985|NCT00070564|42254024|FG004|Overall Study|Withdrawal by Subject|8|||
19795986|NCT00070564|42254025|FG005|Overall Study|Withdrawal by Subject|8|||
19795987|NCT00070564|42254020|FG000|Overall Study|Not reported|0|||
19795988|NCT00070564|42254021|FG001|Overall Study|Not reported|0|||
19795989|NCT00070564|42254022|FG002|Overall Study|Not reported|0|||
19795990|NCT00070564|42254023|FG003|Overall Study|Not reported|0|||
19795991|NCT00070564|42254024|FG004|Overall Study|Not reported|1|||
19795992|NCT00070564|42254025|FG005|Overall Study|Not reported|0|||
19795993|NCT02738151|42254051|FG000|Overall Study|Randomized but not treated|4|||
19795994|NCT02738151|42254052|FG001|Overall Study|Randomized but not treated|1|||
19795995|NCT02738151|42254051|FG000|Overall Study|Adverse Event|4|||
19795996|NCT02738151|42254052|FG001|Overall Study|Adverse Event|5|||
19795997|NCT02738151|42254051|FG000|Overall Study|Hypoglycemia|0|||
19795998|NCT02738151|42254052|FG001|Overall Study|Hypoglycemia|1|||
19795999|NCT02738151|42254051|FG000|Overall Study|Poor Compliance to Protocol|4|||
19796000|NCT02738151|42254052|FG001|Overall Study|Poor Compliance to Protocol|3|||
19796001|NCT02738151|42254051|FG000|Overall Study|Other than specified above|11|||
19796002|NCT02738151|42254052|FG001|Overall Study|Other than specified above|21|||
19796003|NCT02993731|42254060|FG000|Overall Study|Study Termination|101|||
19796004|NCT02993731|42254061|FG001|Overall Study|Study Termination|105|||
19796005|NCT02915159|42254079|FG000|Overall Study|Participant no longer meets criteria|2|||
19796006|NCT02915159|42254080|FG001|Overall Study|Participant no longer meets criteria|0|||
19796007|NCT02915159|42254079|FG000|Overall Study|poor/non-compliance|1|||
19796008|NCT02915159|42254080|FG001|Overall Study|poor/non-compliance|0|||
19796009|NCT02915159|42254079|FG000|Overall Study|Participant withdrew consent|5|||
19796010|NCT02915159|42254080|FG001|Overall Study|Participant withdrew consent|1|||
19796011|NCT02915159|42254079|FG000|Overall Study|Request to discontinue treatment|1|||
19796012|NCT02915159|42254080|FG001|Overall Study|Request to discontinue treatment|2|||
19796013|NCT02915159|42254079|FG000|Overall Study|Adverse Event|2|||
19796014|NCT02915159|42254080|FG001|Overall Study|Adverse Event|2|||
19796015|NCT02915159|42254079|FG000|Overall Study|Lack of Efficacy|0|||
19796016|NCT02915159|42254080|FG001|Overall Study|Lack of Efficacy|3|||
19796017|NCT02924051|42254092|FG000|Overall Study|Withdrawal by Subject|1|||
19796018|NCT02924051|42254093|FG001|Overall Study|Withdrawal by Subject|9|||
19796019|NCT02923427|42254103|FG000|Overall Study|convert to laparatomy|2|||
19796020|NCT02923427|42254104|FG001|Overall Study|convert to laparatomy|2|||
19796021|NCT02923427|42254103|FG000|Overall Study|destaturation|1|||
19796022|NCT02923427|42254104|FG001|Overall Study|destaturation|0|||
19796023|NCT02923427|42254103|FG000|Overall Study|can not replace LMA|1|||
19796024|NCT02923427|42254104|FG001|Overall Study|can not replace LMA|0|||
19796025|NCT02669264|42254117|FG000|Overall Study|Death|5|||
19796026|NCT02669264|42254118|FG001|Overall Study|Death|5|||
19796027|NCT02669264|42254119|FG002|Overall Study|Death|3|||
19796028|NCT02669264|42254120|FG003|Overall Study|Death|3|||
19796029|NCT02669264|42254121|FG004|Overall Study|Death|3|||
19796030|NCT02669264|42254122|FG005|Overall Study|Death|6|||
19796031|NCT02669264|42254123|FG006|Overall Study|Death|3|||
19796032|NCT02669264|42254117|FG000|Overall Study|Withdrawal by Subject|0|||
19796033|NCT02669264|42254118|FG001|Overall Study|Withdrawal by Subject|1|||
19796034|NCT02669264|42254119|FG002|Overall Study|Withdrawal by Subject|0|||
19796035|NCT02669264|42254120|FG003|Overall Study|Withdrawal by Subject|0|||
19796036|NCT02669264|42254121|FG004|Overall Study|Withdrawal by Subject|1|||
19796037|NCT02669264|42254122|FG005|Overall Study|Withdrawal by Subject|0|||
19796038|NCT02669264|42254123|FG006|Overall Study|Withdrawal by Subject|0|||
19796039|NCT02669264|42254117|FG000|Overall Study|Lost to Follow-up|0|||
19796040|NCT02669264|42254118|FG001|Overall Study|Lost to Follow-up|0|||
19796041|NCT02669264|42254119|FG002|Overall Study|Lost to Follow-up|0|||
19796042|NCT02669264|42254120|FG003|Overall Study|Lost to Follow-up|0|||
19796043|NCT02669264|42254121|FG004|Overall Study|Lost to Follow-up|1|||
19796044|NCT02669264|42254122|FG005|Overall Study|Lost to Follow-up|0|||
19796045|NCT02669264|42254123|FG006|Overall Study|Lost to Follow-up|0|||
19796046|NCT02669264|42254117|FG000|Overall Study|Miscellaneous|0|||
19796047|NCT02669264|42254118|FG001|Overall Study|Miscellaneous|0|||
19796048|NCT02669264|42254119|FG002|Overall Study|Miscellaneous|0|||
19796049|NCT02669264|42254120|FG003|Overall Study|Miscellaneous|0|||
19796050|NCT02669264|42254121|FG004|Overall Study|Miscellaneous|0|||
19796051|NCT02669264|42254122|FG005|Overall Study|Miscellaneous|0|||
19796052|NCT02669264|42254123|FG006|Overall Study|Miscellaneous|2|||
19796053|NCT02521870|42254149|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796054|NCT02521870|42254150|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
19796055|NCT02521870|42254151|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796056|NCT02521870|42254152|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796057|NCT02521870|42254153|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796058|NCT02521870|42254154|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796059|NCT02521870|42254155|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796060|NCT02521870|42254156|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796061|NCT02521870|42254157|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796062|NCT02521870|42254158|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796063|NCT02521870|42254159|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796064|NCT02521870|42254160|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
19796065|NCT02521870|42254149|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
19796066|NCT02521870|42254150|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
19796067|NCT02521870|42254151|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
19796068|NCT02521870|42254152|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
19796069|NCT02521870|42254153|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
19796070|NCT02521870|42254154|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
19796071|NCT02521870|42254155|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
19796072|NCT02521870|42254156|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
19796073|NCT02521870|42254157|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
19796074|NCT02521870|42254158|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
19796075|NCT02521870|42254159|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
19796076|NCT02521870|42254160|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
19796077|NCT02521870|42254149|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
19796078|NCT02521870|42254150|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
19796079|NCT02521870|42254151|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
19796080|NCT02521870|42254152|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
19796081|NCT02521870|42254153|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
19796082|NCT02521870|42254154|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
19796083|NCT02521870|42254155|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
19796084|NCT02521870|42254156|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
19796085|NCT02521870|42254157|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
19796086|NCT02521870|42254158|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
19796087|NCT02521870|42254159|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
19796088|NCT02521870|42254160|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
19796089|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796090|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796091|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796092|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796093|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
19796094|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
19796095|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
19796096|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796097|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
19796098|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
19796099|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
19796100|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
19796101|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
19796102|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
19796103|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
19796104|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
19796105|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
19796106|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
19796107|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
19796108|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
19796109|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
19796110|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
19796111|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
19796112|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
19796113|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
19796114|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
19796115|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
19796116|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
19796117|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
19796118|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
19796119|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
19796120|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
19796121|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
19477920|NCT01468181|41757275|FG000|Overall Study|Lost to Follow-up|0|||
19796122|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
19796123|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
19796124|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
19796125|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Death|0|||
19796126|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Death|0|||
19796127|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Death|0|||
19796128|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Death|0|||
19796129|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Death|1|||
19796130|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Death|1|||
19796131|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Death|3|||
19796132|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Death|1|||
19796133|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Death|1|||
19796134|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Death|5|||
19796135|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Death|2|||
19796136|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Death|2|||
19796137|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Other|0|||
19796138|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Other|0|||
19796139|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Other|0|||
19796140|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Other|0|||
19796141|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Other|10|||
19796142|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Other|3|||
19796143|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Other|2|||
19796144|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Other|0|||
19796145|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Other|10|||
19796146|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Other|5|||
19796147|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Other|1|||
19796148|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Other|7|||
19796149|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796150|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796151|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796152|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796153|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
19796154|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796155|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796156|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796157|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796158|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796159|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796160|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
19796161|NCT02521870|42254149|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796162|NCT02521870|42254150|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796163|NCT02521870|42254151|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796164|NCT02521870|42254152|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796165|NCT02521870|42254153|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
19796166|NCT02521870|42254154|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796167|NCT02521870|42254155|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796168|NCT02521870|42254156|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796169|NCT02521870|42254157|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796170|NCT02521870|42254158|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796171|NCT02521870|42254159|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796172|NCT02521870|42254160|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
19796173|NCT02923349|42254197|FG000|Overall Study|Other|1|||
19796174|NCT02923349|42254198|FG001|Overall Study|Other|2|||
19796175|NCT02923349|42254199|FG002|Overall Study|Other|4|||
19796176|NCT02923349|42254200|FG003|Overall Study|Other|1|||
19796177|NCT02923349|42254201|FG004|Overall Study|Other|3|||
19796178|NCT02923349|42254202|FG005|Overall Study|Other|0|||
19796179|NCT02923349|42254203|FG006|Overall Study|Other|1|||
19796180|NCT02923349|42254197|FG000|Overall Study|Withdrawal by Subject|2|||
19796181|NCT02923349|42254198|FG001|Overall Study|Withdrawal by Subject|2|||
19796182|NCT02923349|42254199|FG002|Overall Study|Withdrawal by Subject|8|||
19796183|NCT02923349|42254200|FG003|Overall Study|Withdrawal by Subject|10|||
19796184|NCT02923349|42254201|FG004|Overall Study|Withdrawal by Subject|12|||
19796185|NCT02923349|42254202|FG005|Overall Study|Withdrawal by Subject|3|||
19796186|NCT02923349|42254203|FG006|Overall Study|Withdrawal by Subject|0|||
19796187|NCT02923349|42254197|FG000|Overall Study|Physician Decision|0|||
19796188|NCT02923349|42254198|FG001|Overall Study|Physician Decision|0|||
19477921|NCT01468181|41757276|FG001|Overall Study|Lost to Follow-up|0|||
19477922|NCT01468181|41757277|FG002|Overall Study|Lost to Follow-up|1|||
19796189|NCT02923349|42254199|FG002|Overall Study|Physician Decision|0|||
19796190|NCT02923349|42254200|FG003|Overall Study|Physician Decision|1|||
19796191|NCT02923349|42254201|FG004|Overall Study|Physician Decision|1|||
19796192|NCT02923349|42254202|FG005|Overall Study|Physician Decision|0|||
19796193|NCT02923349|42254203|FG006|Overall Study|Physician Decision|2|||
19796194|NCT02923349|42254197|FG000|Overall Study|Lost to Follow-up|0|||
19796195|NCT02923349|42254198|FG001|Overall Study|Lost to Follow-up|0|||
19796196|NCT02923349|42254199|FG002|Overall Study|Lost to Follow-up|3|||
19796197|NCT02923349|42254200|FG003|Overall Study|Lost to Follow-up|0|||
19796198|NCT02923349|42254201|FG004|Overall Study|Lost to Follow-up|1|||
19796199|NCT02923349|42254202|FG005|Overall Study|Lost to Follow-up|1|||
19796200|NCT02923349|42254203|FG006|Overall Study|Lost to Follow-up|0|||
19796201|NCT02923349|42254197|FG000|Overall Study|Death|1|||
19796202|NCT02923349|42254198|FG001|Overall Study|Death|0|||
19796203|NCT02923349|42254199|FG002|Overall Study|Death|2|||
19796204|NCT02923349|42254200|FG003|Overall Study|Death|4|||
19796205|NCT02923349|42254201|FG004|Overall Study|Death|2|||
19796206|NCT02923349|42254202|FG005|Overall Study|Death|3|||
19796207|NCT02923349|42254203|FG006|Overall Study|Death|0|||
19796208|NCT02521792|42254219|FG000|Overall Study|Study Terminated|6|||
19796209|NCT03020615|42254226|FG000|Overall Study|Physician Decision|3|||
19796210|NCT03020615|42254227|FG001|Overall Study|Physician Decision|1|||
19796211|NCT03020615|42254228|FG002|Overall Study|Physician Decision|2|||
19796212|NCT03020615|42254226|FG000|Overall Study|Parent/guardian/patient choice|3|||
19796213|NCT03020615|42254227|FG001|Overall Study|Parent/guardian/patient choice|0|||
19796214|NCT03020615|42254228|FG002|Overall Study|Parent/guardian/patient choice|4|||
19796215|NCT03020615|42254226|FG000|Overall Study|Screen failure|0|||
19796216|NCT03020615|42254227|FG001|Overall Study|Screen failure|0|||
19796217|NCT03020615|42254228|FG002|Overall Study|Screen failure|1|||
19796218|NCT03020615|42254226|FG000|Overall Study|Death|1|||
19796219|NCT03020615|42254227|FG001|Overall Study|Death|0|||
19796220|NCT03020615|42254228|FG002|Overall Study|Death|0|||
19796221|NCT03020615|42254226|FG000|Overall Study|Lost to Follow-up|0|||
19796222|NCT03020615|42254227|FG001|Overall Study|Lost to Follow-up|1|||
19796223|NCT03020615|42254228|FG002|Overall Study|Lost to Follow-up|0|||
19796224|NCT03020069|42254241|FG000|Overall Study|Lost to Follow-up|0|||
19796225|NCT03020069|42254242|FG001|Overall Study|Lost to Follow-up|1|||
19796226|NCT03693170|42254248|FG000|Overall Study|Disease Progression|48|||
19796227|NCT03693170|42254248|FG000|Overall Study|Adverse Event|16|||
19796228|NCT03693170|42254248|FG000|Overall Study|Physician Decision|6|||
19796229|NCT03693170|42254248|FG000|Overall Study|Protocol Violation|2|||
19796230|NCT03693170|42254248|FG000|Overall Study|Death|1|||
19796231|NCT03693170|42254248|FG000|Overall Study|Non compliance with study drug|1|||
19796232|NCT03693170|42254248|FG000|Overall Study|Withdrawal by Subject|1|||
19796233|NCT03021005|42254255|FG000|Overall Study|Lost to Follow-up|39|||
19796234|NCT03021005|42254256|FG001|Overall Study|Lost to Follow-up|26|||
19796235|NCT02914457|42254262|FG000|Overall Study|Withdrawal by Subject|1|||
19796236|NCT02914457|42254262|FG000|Overall Study|Physician Decision|1|||
19796237|NCT02914457|42254262|FG000|Overall Study|No veins available for lead placement|1|||
19796238|NCT02914457|42254262|FG000|Overall Study|Electrical instability of patient|1|||
19796239|NCT02914457|42254262|FG000|Overall Study|ECG acquisition error due to sweating|1|||
19796240|NCT02914457|42254262|FG000|Overall Study|Protocol Violation|1|||
19796241|NCT02665052|42254270|FG000|Overall Study|Lost to Follow-up|1|||
19796242|NCT02665052|42254271|FG001|Overall Study|Lost to Follow-up|0|||
19796243|NCT02665052|42254272|FG002|Overall Study|Lost to Follow-up|0|||
19796244|NCT02665052|42254273|FG003|Overall Study|Lost to Follow-up|0|||
19796245|NCT02665052|42254270|FG000|Overall Study|Withdrawal by Subject|1|||
19796246|NCT02665052|42254271|FG001|Overall Study|Withdrawal by Subject|1|||
19796247|NCT02665052|42254272|FG002|Overall Study|Withdrawal by Subject|0|||
19796248|NCT02665052|42254273|FG003|Overall Study|Withdrawal by Subject|5|||
19796249|NCT02665052|42254270|FG000|Overall Study|Adverse Event|1|||
19796250|NCT02665052|42254271|FG001|Overall Study|Adverse Event|1|||
19796251|NCT02665052|42254272|FG002|Overall Study|Adverse Event|0|||
19796252|NCT02665052|42254273|FG003|Overall Study|Adverse Event|0|||
19796253|NCT03019289|42254293|FG000|Overall Study|Adverse Event|1|||
19796254|NCT03019289|42254294|FG001|Overall Study|Adverse Event|0|||
19796255|NCT03019289|42254295|FG002|Overall Study|Adverse Event|0|||
19796256|NCT03019289|42254296|FG003|Overall Study|Adverse Event|0|||
19796257|NCT03019289|42254297|FG004|Overall Study|Adverse Event|0|||
19796258|NCT03019289|42254298|FG005|Overall Study|Adverse Event|0|||
19796259|NCT03019289|42254299|FG006|Overall Study|Adverse Event|0|||
19796260|NCT03019289|42254300|FG007|Overall Study|Adverse Event|0|||
19796261|NCT03019289|42254301|FG008|Overall Study|Adverse Event|1|||
19796262|NCT03019289|42254293|FG000|Overall Study|Other|1|||
19796263|NCT03019289|42254294|FG001|Overall Study|Other|0|||
19796264|NCT03019289|42254295|FG002|Overall Study|Other|0|||
19796265|NCT03019289|42254296|FG003|Overall Study|Other|0|||
19796266|NCT03019289|42254297|FG004|Overall Study|Other|0|||
19796267|NCT03019289|42254298|FG005|Overall Study|Other|0|||
19796268|NCT03019289|42254299|FG006|Overall Study|Other|0|||
19796269|NCT03019289|42254300|FG007|Overall Study|Other|0|||
19796270|NCT03019289|42254301|FG008|Overall Study|Other|0|||
19796271|NCT02520388|42254324|FG000|Overall Study|Physician Decision|1|||
19796272|NCT02520388|42254325|FG001|Overall Study|Physician Decision|0|||
19796273|NCT02520388|42254324|FG000|Overall Study|Subject or parent/guardian request|0|||
19796274|NCT02520388|42254325|FG001|Overall Study|Subject or parent/guardian request|6|||
19796275|NCT02520388|42254324|FG000|Overall Study|Adverse Event|1|||
19796276|NCT02520388|42254325|FG001|Overall Study|Adverse Event|4|||
19796277|NCT02520388|42254324|FG000|Overall Study|Lost to Follow-up|3|||
19796278|NCT02520388|42254325|FG001|Overall Study|Lost to Follow-up|2|||
19796279|NCT02520388|42254324|FG000|Overall Study|Other (reason not defined)|4|||
19796280|NCT02520388|42254325|FG001|Overall Study|Other (reason not defined)|4|||
19796281|NCT02924129|42254333|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
19796282|NCT02924129|42254334|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
19796283|NCT02924129|42254333|FG000|Overall Study|Withdrawal by Subject|2|||
19796284|NCT02924129|42254334|FG001|Overall Study|Withdrawal by Subject|2|||
19796285|NCT02924129|42254333|FG000|Overall Study|Physician Decision|1|||
19796286|NCT02924129|42254334|FG001|Overall Study|Physician Decision|0|||
19796287|NCT02924129|42254333|FG000|Overall Study|Missed Visit|0|||
19796288|NCT02924129|42254334|FG001|Overall Study|Missed Visit|1|||
19796289|NCT02668640|42254340|FG000|Overall Study|Lost to Follow-up|13|||
19796290|NCT02668640|42254340|FG000|Overall Study|Other, not specified|1|||
19796291|NCT03014453|42254344|FG000|Overall Study|Lost to Follow-up|12|||
19796292|NCT03014453|42254344|FG000|Overall Study|Discontinued GER|3|||
19796293|NCT03014453|42254344|FG000|Overall Study|Excluded|19|||
19796294|NCT03014453|42254344|FG000|Overall Study|Refused to take part in|37|||
19796295|NCT02664272|42254348|FG000|Overall Study|Fluoroscopic images not made available|2|||
19796296|NCT02663882|42254354|FG000|Overall Study|Lost to Follow-up|4|||
19796297|NCT02663882|42254355|FG001|Overall Study|Lost to Follow-up|2|||
19796298|NCT03011333|42254368|FG000|Overall Study|Lost to Follow-up|0|||
19796299|NCT03011333|42254369|FG001|Overall Study|Lost to Follow-up|1|||
19796300|NCT03011333|42254370|FG002|Overall Study|Lost to Follow-up|0|||
19796301|NCT03011333|42254371|FG003|Overall Study|Lost to Follow-up|1|||
19796302|NCT03011333|42254372|FG004|Overall Study|Lost to Follow-up|4|||
19796303|NCT03011333|42254373|FG005|Overall Study|Lost to Follow-up|4|||
19796304|NCT03011333|42254374|FG006|Overall Study|Lost to Follow-up|5|||
19796305|NCT03011099|42254392|FG000|Overall Study|Withdrawal by Subject|0|||
19796306|NCT03011099|42254393|FG001|Overall Study|Withdrawal by Subject|2|||
19796307|NCT03013985|42254403|FG000|Overall Study|Protocol Violation|2|||
19796308|NCT03013985|42254404|FG001|Overall Study|Protocol Violation|2|||
19796309|NCT03013985|42254403|FG000|Overall Study|Withdrawal by Subject|14|||
19796310|NCT03013985|42254404|FG001|Overall Study|Withdrawal by Subject|17|||
19796311|NCT03016403|42254414|FG000|Baseline|Death|5|||
19796312|NCT03016403|42254415|FG001|Baseline|Death|8|||
19796313|NCT03016403|42254416|FG002|Baseline|Death|1|||
19796314|NCT03016403|42254417|FG003|Baseline|Death|0|||
19796315|NCT03016403|42254414|FG000|Baseline|Withdrawal by Subject|2|||
19796316|NCT03016403|42254415|FG001|Baseline|Withdrawal by Subject|8|||
19796317|NCT03016403|42254416|FG002|Baseline|Withdrawal by Subject|4|||
19796318|NCT03016403|42254417|FG003|Baseline|Withdrawal by Subject|10|||
19796319|NCT03016403|42254414|FG000|Baseline|Lost to Follow-up|9|||
19698485|NCT00296504|42143589|FG000|Interim Analysis|Clinical Progression|1|||
19698486|NCT00296504|42143590|FG001|Interim Analysis|Clinical Progression|0|||
19698487|NCT00296504|42143591|FG002|Interim Analysis|Clinical Progression|1|||
19698488|NCT00296504|42143592|FG003|Interim Analysis|Clinical Progression|1|||
19698489|NCT00296504|42143593|FG004|Interim Analysis|Clinical Progression|0|||
19698490|NCT00296504|42143594|FG005|Interim Analysis|Clinical Progression|2|||
19698491|NCT00296504|42143595|FG006|Interim Analysis|Clinical Progression|1|||
19698492|NCT00296504|42143596|FG007|Interim Analysis|Clinical Progression|2|||
19698493|NCT00296504|42143597|FG008|Interim Analysis|Clinical Progression|0|||
19698494|NCT00296504|42143589|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
19698495|NCT00296504|42143590|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
19698496|NCT00296504|42143591|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
19698497|NCT00296504|42143592|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
19698498|NCT00296504|42143593|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
19698499|NCT00296504|42143594|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
19698500|NCT00296504|42143595|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
19698501|NCT00296504|42143596|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
19698502|NCT00296504|42143597|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
19698503|NCT00296504|42143589|FG000|Interim Analysis|Adverse Event|0|||
19698504|NCT00296504|42143590|FG001|Interim Analysis|Adverse Event|0|||
19698505|NCT00296504|42143591|FG002|Interim Analysis|Adverse Event|13|||
19698506|NCT00296504|42143592|FG003|Interim Analysis|Adverse Event|4|||
19698507|NCT00296504|42143593|FG004|Interim Analysis|Adverse Event|6|||
19698508|NCT00296504|42143594|FG005|Interim Analysis|Adverse Event|3|||
19698509|NCT00296504|42143595|FG006|Interim Analysis|Adverse Event|4|||
19796320|NCT03016403|42254415|FG001|Baseline|Lost to Follow-up|11|||
19796321|NCT03016403|42254416|FG002|Baseline|Lost to Follow-up|6|||
19698510|NCT00296504|42143596|FG007|Interim Analysis|Adverse Event|5|||
19698511|NCT00296504|42143597|FG008|Interim Analysis|Adverse Event|0|||
19698512|NCT00296504|42143589|FG000|Interim Analysis|Protocol Violation|0|||
19698513|NCT00296504|42143590|FG001|Interim Analysis|Protocol Violation|0|||
19796322|NCT03016403|42254417|FG003|Baseline|Lost to Follow-up|24|||
19796323|NCT03016403|42254414|FG000|6-week Follow-up|Death|1|||
19796324|NCT03016403|42254415|FG001|6-week Follow-up|Death|4|||
19796325|NCT03016403|42254416|FG002|6-week Follow-up|Death|0|||
19796326|NCT03016403|42254417|FG003|6-week Follow-up|Death|0|||
19796327|NCT03016403|42254414|FG000|6-week Follow-up|Lost to Follow-up|2|||
19796328|NCT03016403|42254415|FG001|6-week Follow-up|Lost to Follow-up|7|||
19796329|NCT03016403|42254416|FG002|6-week Follow-up|Lost to Follow-up|4|||
19796330|NCT03016403|42254417|FG003|6-week Follow-up|Lost to Follow-up|8|||
19796331|NCT03016403|42254414|FG000|6-week Follow-up|Withdrawal by Subject|0|||
19796332|NCT03016403|42254415|FG001|6-week Follow-up|Withdrawal by Subject|2|||
19796333|NCT03016403|42254416|FG002|6-week Follow-up|Withdrawal by Subject|0|||
19796334|NCT03016403|42254417|FG003|6-week Follow-up|Withdrawal by Subject|1|||
19796335|NCT03016403|42254414|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
19796336|NCT03016403|42254415|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
19796337|NCT03016403|42254416|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
19796338|NCT03016403|42254417|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
19796339|NCT03016403|42254414|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
19796340|NCT03016403|42254415|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
19796341|NCT03016403|42254416|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
19796342|NCT03016403|42254417|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
19796343|NCT03016403|42254414|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
19796344|NCT03016403|42254415|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
19796345|NCT03016403|42254416|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
19796346|NCT03016403|42254417|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
19796347|NCT02520310|42254429|FG000|At 6 Months Clinical Follow-up|Death|1|||
19796348|NCT02520310|42254429|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
19796349|NCT02520310|42254429|FG000|AT 3 Year Clinical Follow-up|Death|2|||
19796350|NCT02520310|42254429|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
19796351|NCT02520310|42254429|FG000|AT 4 Year Clinical Follow-up|Death|1|||
19796352|NCT02520310|42254429|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
19796353|NCT02662556|42254435|FG000|Overall Study|Adverse Event|4|||
19796354|NCT02662556|42254435|FG000|Overall Study|Lack of Efficacy|4|||
19796355|NCT02516098|42254442|FG000|Period 1|Protocol Violation|1|||
19796356|NCT02516098|42254443|FG001|Period 1|Protocol Violation|0|||
19796357|NCT02516098|42254442|FG000|Washout After Period 1|Adverse Event|0|||
19796358|NCT02516098|42254443|FG001|Washout After Period 1|Adverse Event|1|||
19796359|NCT02516098|42254442|FG000|Period 2|Withdrawal by Subject|0|||
19796360|NCT02516098|42254443|FG001|Period 2|Withdrawal by Subject|1|||
19796361|NCT01364428|42254451|FG000|Overall Study|Adverse Event|1|||
19796362|NCT01364428|42254452|FG001|Overall Study|Adverse Event|2|||
19796363|NCT01364428|42254451|FG000|Overall Study|Protocol Violation|2|||
19796364|NCT01364428|42254452|FG001|Overall Study|Protocol Violation|0|||
19796365|NCT01364428|42254451|FG000|Overall Study|Withdrawal Criteria|14|||
19796366|NCT01364428|42254452|FG001|Overall Study|Withdrawal Criteria|10|||
19796367|NCT01364428|42254451|FG000|Overall Study|Other|3|||
19796368|NCT01364428|42254452|FG001|Overall Study|Other|3|||
19796369|NCT02515942|42254461|FG000|Overall Study|Adverse Event|5|||
19796370|NCT02515942|42254462|FG001|Overall Study|Adverse Event|0|||
19796371|NCT02515942|42254463|FG002|Overall Study|Adverse Event|0|||
19796372|NCT02515942|42254461|FG000|Overall Study|Death|0|||
19796373|NCT02515942|42254462|FG001|Overall Study|Death|0|||
19796374|NCT02515942|42254463|FG002|Overall Study|Death|1|||
19796375|NCT02515942|42254461|FG000|Overall Study|Lack of Efficacy|0|||
19796376|NCT02515942|42254462|FG001|Overall Study|Lack of Efficacy|0|||
19796377|NCT02515942|42254463|FG002|Overall Study|Lack of Efficacy|1|||
19796378|NCT02515942|42254461|FG000|Overall Study|Lost to Follow-up|2|||
19796379|NCT02515942|42254462|FG001|Overall Study|Lost to Follow-up|0|||
19796380|NCT02515942|42254463|FG002|Overall Study|Lost to Follow-up|0|||
19796381|NCT02515942|42254461|FG000|Overall Study|Withdrawal by Subject|0|||
19796382|NCT02515942|42254462|FG001|Overall Study|Withdrawal by Subject|3|||
19796383|NCT02515942|42254463|FG002|Overall Study|Withdrawal by Subject|2|||
19796384|NCT02991859|42254490|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796385|NCT02991859|42254491|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
19796386|NCT02991859|42254492|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796387|NCT02991859|42254493|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796388|NCT02991859|42254494|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
19796389|NCT02991859|42254495|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796390|NCT02991859|42254496|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796391|NCT02991859|42254497|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796392|NCT02991859|42254498|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796393|NCT02991859|42254499|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796394|NCT02991859|42254500|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796395|NCT02991859|42254501|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796396|NCT02991859|42254502|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796397|NCT02991859|42254503|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796398|NCT02991859|42254504|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796399|NCT02991859|42254505|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796400|NCT02991859|42254506|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
19796401|NCT02991859|42254490|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796402|NCT02991859|42254491|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796403|NCT02991859|42254492|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796404|NCT02991859|42254493|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796405|NCT02991859|42254494|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796406|NCT02991859|42254495|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796407|NCT02991859|42254496|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796408|NCT02991859|42254497|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796409|NCT02991859|42254498|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796410|NCT02991859|42254499|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796411|NCT02991859|42254500|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796412|NCT02991859|42254501|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796413|NCT02991859|42254502|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
19796414|NCT02991859|42254503|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
19796415|NCT02991859|42254504|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796416|NCT02991859|42254505|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796417|NCT02991859|42254506|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
19796418|NCT02991859|42254490|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796419|NCT02991859|42254491|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796420|NCT02991859|42254492|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796421|NCT02991859|42254493|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796422|NCT02991859|42254494|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796423|NCT02991859|42254495|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
19796424|NCT02991859|42254496|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796425|NCT02991859|42254497|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796426|NCT02991859|42254498|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796427|NCT02991859|42254499|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796428|NCT02991859|42254500|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796429|NCT02991859|42254501|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796430|NCT02991859|42254502|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796431|NCT02991859|42254503|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796432|NCT02991859|42254504|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796433|NCT02991859|42254505|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796434|NCT02991859|42254506|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
19796435|NCT02991859|42254490|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796436|NCT02991859|42254491|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796437|NCT02991859|42254492|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796438|NCT02991859|42254493|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796439|NCT02991859|42254494|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796440|NCT02991859|42254495|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796441|NCT02991859|42254496|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796442|NCT02991859|42254497|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796443|NCT02991859|42254498|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796444|NCT02991859|42254499|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
19796445|NCT02991859|42254500|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796446|NCT02991859|42254501|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796447|NCT02991859|42254502|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796448|NCT02991859|42254503|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796449|NCT02991859|42254504|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796450|NCT02991859|42254505|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796451|NCT02991859|42254506|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
19796452|NCT02991859|42254490|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796453|NCT02991859|42254491|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796454|NCT02991859|42254492|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796455|NCT02991859|42254493|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796456|NCT02991859|42254494|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796457|NCT02991859|42254495|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796458|NCT02991859|42254496|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796459|NCT02991859|42254497|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796460|NCT02991859|42254498|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
19796461|NCT02991859|42254499|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796462|NCT02991859|42254500|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796463|NCT02991859|42254501|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796464|NCT02991859|42254502|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796465|NCT02991859|42254503|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796466|NCT02991859|42254504|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796467|NCT02991859|42254505|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796468|NCT02991859|42254506|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
19796469|NCT03016325|42254589|FG000|Treatment Period|Participant withdrew consent|0|||
19796470|NCT03016325|42254590|FG001|Treatment Period|Participant withdrew consent|1|||
19796471|NCT03016325|42254591|FG002|Treatment Period|Participant withdrew consent|0|||
19796472|NCT03016325|42254592|FG003|Treatment Period|Participant withdrew consent|0|||
19796473|NCT03016325|42254593|FG004|Treatment Period|Participant withdrew consent|0|||
19796474|NCT03016325|42254594|FG005|Treatment Period|Participant withdrew consent|0|||
19796475|NCT03016325|42254595|FG006|Treatment Period|Participant withdrew consent|0|||
19796476|NCT03016325|42254596|FG007|Treatment Period|Participant withdrew consent|0|||
19796477|NCT03016325|42254589|FG000|Treatment Period|Death|0|||
19796478|NCT03016325|42254590|FG001|Treatment Period|Death|0|||
19796479|NCT03016325|42254591|FG002|Treatment Period|Death|0|||
19796480|NCT03016325|42254592|FG003|Treatment Period|Death|0|||
19796481|NCT03016325|42254593|FG004|Treatment Period|Death|2|||
19796482|NCT03016325|42254594|FG005|Treatment Period|Death|0|||
19796483|NCT03016325|42254595|FG006|Treatment Period|Death|0|||
19796484|NCT03016325|42254596|FG007|Treatment Period|Death|0|||
19796485|NCT03016325|42254589|FG000|Treatment Period|Participant refuses assessments|0|||
19796486|NCT03016325|42254590|FG001|Treatment Period|Participant refuses assessments|0|||
19796487|NCT03016325|42254591|FG002|Treatment Period|Participant refuses assessments|1|||
19796488|NCT03016325|42254592|FG003|Treatment Period|Participant refuses assessments|0|||
19796489|NCT03016325|42254593|FG004|Treatment Period|Participant refuses assessments|0|||
19796490|NCT03016325|42254594|FG005|Treatment Period|Participant refuses assessments|0|||
19796491|NCT03016325|42254595|FG006|Treatment Period|Participant refuses assessments|0|||
19796492|NCT03016325|42254596|FG007|Treatment Period|Participant refuses assessments|0|||
19796493|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Death|2|||
19796494|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Death|0|||
19796495|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Death|5|||
19796496|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Death|6|||
19796497|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Death|3|||
19796498|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Death|0|||
19796499|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Death|0|||
19796500|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Death|0|||
19796501|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
19796502|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
19796503|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
19796504|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
19796505|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
19796506|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
19796507|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
19796508|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
19796509|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
19796510|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
19796511|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
19796512|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
19796513|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
19796514|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
19796515|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
19796516|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
19796517|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
19796518|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
19796519|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
19796520|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
19796521|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
19796522|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
19796523|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
19367536|NCT02784535|41607717|FG000|Overall Study|Withdrawal by Subject|0|||
19367537|NCT02784535|41607718|FG001|Overall Study|Withdrawal by Subject|1|||
19367538|NCT02784535|41607717|FG000|Overall Study|Physician Decision|0|||
19477923|NCT01468181|41757278|FG003|Overall Study|Lost to Follow-up|0|||
19608055|NCT00878553|42056955|FG000|Sleep Study|Lost to Follow-up|1|||
19608056|NCT00878553|42056956|FG001|Sleep Study|Lost to Follow-up|0|||
19608057|NCT00878553|42056957|FG002|Sleep Study|Lost to Follow-up|0|||
19608058|NCT00878553|42056958|FG003|Sleep Study|Lost to Follow-up|0|||
19608059|NCT00878553|42056959|FG004|Sleep Study|Lost to Follow-up|0|||
19608060|NCT00878553|42056955|FG000|Sleep Study|car accident|1|||
19608061|NCT00878553|42056956|FG001|Sleep Study|car accident|0|||
19608062|NCT00878553|42056957|FG002|Sleep Study|car accident|0|||
19608063|NCT00878553|42056958|FG003|Sleep Study|car accident|0|||
19608064|NCT00878553|42056959|FG004|Sleep Study|car accident|0|||
19608065|NCT00878553|42056955|FG000|Sleep Study|family emergency|1|||
19608066|NCT00878553|42056956|FG001|Sleep Study|family emergency|0|||
19608067|NCT00878553|42056957|FG002|Sleep Study|family emergency|0|||
19796524|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
19796525|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796526|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796527|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796528|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796529|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
19796530|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796531|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
19796532|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
19796533|NCT03016325|42254589|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796534|NCT03016325|42254590|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796535|NCT03016325|42254591|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
19796536|NCT03016325|42254592|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796537|NCT03016325|42254593|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796538|NCT03016325|42254594|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796539|NCT03016325|42254595|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796540|NCT03016325|42254596|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
19796541|NCT03016325|42254589|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796542|NCT03016325|42254590|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
19796543|NCT03016325|42254591|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796544|NCT03016325|42254592|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796545|NCT03016325|42254593|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796546|NCT03016325|42254594|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796547|NCT03016325|42254595|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796548|NCT03016325|42254596|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
19796549|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Death|3|||
19796550|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Death|3|||
19796551|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Death|11|||
19796552|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Death|12|||
19796553|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Death|9|||
19796554|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Death|0|||
19796555|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Death|0|||
19796556|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Death|1|||
19796557|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
19796558|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796559|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796560|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796561|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796562|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796563|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796564|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
19796565|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796566|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796567|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796568|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796569|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
19796570|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796571|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
19796572|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
19796573|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19796574|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19698514|NCT00296504|42143591|FG002|Interim Analysis|Protocol Violation|2|||
19698515|NCT00296504|42143592|FG003|Interim Analysis|Protocol Violation|0|||
19698516|NCT00296504|42143593|FG004|Interim Analysis|Protocol Violation|1|||
19698517|NCT00296504|42143594|FG005|Interim Analysis|Protocol Violation|0|||
19698518|NCT00296504|42143595|FG006|Interim Analysis|Protocol Violation|0|||
19698519|NCT00296504|42143596|FG007|Interim Analysis|Protocol Violation|1|||
19698520|NCT00296504|42143597|FG008|Interim Analysis|Protocol Violation|0|||
19698521|NCT00296504|42143589|FG000|Interim Analysis|Insufficient CD4 Response|0|||
19698522|NCT00296504|42143590|FG001|Interim Analysis|Insufficient CD4 Response|0|||
19698523|NCT00296504|42143591|FG002|Interim Analysis|Insufficient CD4 Response|0|||
19796575|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19796576|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19367539|NCT02784535|41607718|FG001|Overall Study|Physician Decision|1|||
19367540|NCT01367275|41607727|FG000|Overall Study|Ineligible|1|||
19698524|NCT00296504|42143592|FG003|Interim Analysis|Insufficient CD4 Response|0|||
19698525|NCT00296504|42143593|FG004|Interim Analysis|Insufficient CD4 Response|1|||
19698526|NCT00296504|42143594|FG005|Interim Analysis|Insufficient CD4 Response|1|||
19796577|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
19796578|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19796579|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19796580|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
19796581|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796582|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796583|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796584|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796585|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
19796586|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796587|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796588|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
19796589|NCT03016325|42254589|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796590|NCT03016325|42254590|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796591|NCT03016325|42254591|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796592|NCT03016325|42254592|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
19796593|NCT03016325|42254593|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796594|NCT03016325|42254594|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796595|NCT03016325|42254595|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796596|NCT03016325|42254596|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
19796597|NCT03016325|42254589|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796598|NCT03016325|42254590|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
19796599|NCT03016325|42254591|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796600|NCT03016325|42254592|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796601|NCT03016325|42254593|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796602|NCT03016325|42254594|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796603|NCT03016325|42254595|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796604|NCT03016325|42254596|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
19796605|NCT03016325|42254589|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
19796606|NCT03016325|42254590|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
19796607|NCT03016325|42254591|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
19796608|NCT03016325|42254592|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
19796609|NCT03016325|42254593|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
19796610|NCT03016325|42254594|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
19796611|NCT03016325|42254595|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
19796612|NCT03016325|42254596|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
19796613|NCT02988115|42254619|FG000|Overall Study|Adverse Event|6|||
19796614|NCT02988115|42254620|FG001|Overall Study|Adverse Event|1|||
19796615|NCT02988115|42254619|FG000|Overall Study|Sponsor Decision|5|||
19796616|NCT02988115|42254620|FG001|Overall Study|Sponsor Decision|2|||
19796617|NCT02988115|42254619|FG000|Overall Study|Withdrawal by Subject|1|||
19796618|NCT02988115|42254620|FG001|Overall Study|Withdrawal by Subject|1|||
19796619|NCT02988115|42254619|FG000|Overall Study|Withdrawn by Mistake|1|||
19796620|NCT02988115|42254620|FG001|Overall Study|Withdrawn by Mistake|0|||
19796621|NCT02988115|42254619|FG000|Overall Study|Lost to Follow-up|1|||
19796622|NCT02988115|42254620|FG001|Overall Study|Lost to Follow-up|0|||
19796623|NCT02921425|42254626|FG000|Overall Study|Protocol Violation|9|||
19796624|NCT03008915|42254630|FG000|Treatment 1|Withdrawal by Subject|0|||
19796625|NCT03008915|42254631|FG001|Treatment 1|Withdrawal by Subject|1|||
19796626|NCT02515630|42254644|FG000|Overall Study|Withdrawal by Subject|5|||
19796627|NCT02515630|42254644|FG000|Overall Study|Adverse Event|4|||
19796628|NCT02515630|42254644|FG000|Overall Study|Physician Decision|4|||
19796629|NCT02515630|42254644|FG000|Overall Study|Death|2|||
19796630|NCT02515630|42254644|FG000|Overall Study|Disease Progression|1|||
19796631|NCT02920957|42254651|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
19796632|NCT02920957|42254652|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
19796633|NCT02920957|42254651|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
19796634|NCT02920957|42254652|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
19796635|NCT02920957|42254651|FG000|First Intervention : 1 Month|Adverse Event|1|||
19796636|NCT02920957|42254652|FG001|First Intervention : 1 Month|Adverse Event|0|||
19796637|NCT02920957|42254651|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
19796638|NCT02920957|42254652|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
19796639|NCT03006887|42254669|FG000|Overall Study|Adverse Event|1|||
19796640|NCT02514772|42254675|FG000|Overall Study|Adverse Event|1|||
19608068|NCT00878553|42056958|FG003|Sleep Study|family emergency|0|||
19608069|NCT00878553|42056959|FG004|Sleep Study|family emergency|0|||
19796641|NCT02514772|42254676|FG001|Overall Study|Adverse Event|0|||
19796642|NCT02514772|42254675|FG000|Overall Study|Death|0|||
19796643|NCT02514772|42254676|FG001|Overall Study|Death|1|||
19796644|NCT02514772|42254675|FG000|Overall Study|Withdrawal by Subject|2|||
19608070|NCT00878553|42056955|FG000|PK Study|Withdrawal by Subject|0|||
19608071|NCT00878553|42056956|FG001|PK Study|Withdrawal by Subject|0|||
19608072|NCT00878553|42056957|FG002|PK Study|Withdrawal by Subject|0|||
19608073|NCT00878553|42056958|FG003|PK Study|Withdrawal by Subject|1|||
19698527|NCT00296504|42143595|FG006|Interim Analysis|Insufficient CD4 Response|0|||
19796645|NCT02514772|42254676|FG001|Overall Study|Withdrawal by Subject|1|||
19796646|NCT03000179|42254684|FG000|Overall Study|Lost to Follow-up|2|||
19796647|NCT02920177|42254690|FG000|Overall Study|Withdrawal by Subject|1|||
19796648|NCT02920177|42254691|FG001|Overall Study|Withdrawal by Subject|1|||
19796649|NCT02920177|42254690|FG000|Overall Study|Physician Decision|1|||
19796650|NCT02920177|42254691|FG001|Overall Study|Physician Decision|0|||
19796651|NCT02920177|42254690|FG000|Overall Study|Lost to Follow-up|0|||
19796652|NCT02920177|42254691|FG001|Overall Study|Lost to Follow-up|1|||
19796653|NCT03006341|42254701|FG000|Overall Study|Not linked in the EMR|25069|||
19796654|NCT03006341|42254702|FG001|Overall Study|Not linked in the EMR|67505|||
19796655|NCT03006341|42254703|FG002|Overall Study|Not linked in the EMR|30993|||
19796656|NCT03006341|42254704|FG003|Overall Study|Not linked in the EMR|10685|||
19796657|NCT03935594|42254712|FG000|Overall Study|Physician Decision|3|||
19796658|NCT02512042|42254720|FG000|Overall Study|Adverse Event|0|||
19796659|NCT02512042|42254721|FG001|Overall Study|Adverse Event|4|||
19796660|NCT02512042|42254720|FG000|Overall Study|Withdrawal by Subject|6|||
19796661|NCT02512042|42254721|FG001|Overall Study|Withdrawal by Subject|6|||
19796662|NCT02512042|42254720|FG000|Overall Study|Non-compliance with study drug|1|||
19796663|NCT02512042|42254721|FG001|Overall Study|Non-compliance with study drug|2|||
19796664|NCT02512042|42254720|FG000|Overall Study|Lost to Follow-up|5|||
19796665|NCT02512042|42254721|FG001|Overall Study|Lost to Follow-up|2|||
19796666|NCT02512042|42254720|FG000|Overall Study|Other|11|||
19796667|NCT02512042|42254721|FG001|Overall Study|Other|11|||
19796668|NCT02911025|42254727|FG000|Overall Study|Lost to Follow-up|3|||
19796669|NCT02919475|42254736|FG000|Overall Study|Adverse Event|3|||
19796670|NCT02919475|42254737|FG001|Overall Study|Adverse Event|3|||
19796671|NCT02919475|42254738|FG002|Overall Study|Adverse Event|3|||
19796672|NCT02919475|42254739|FG003|Overall Study|Adverse Event|9|||
19796673|NCT02919475|42254740|FG004|Overall Study|Adverse Event|2|||
19796674|NCT02919475|42254736|FG000|Overall Study|Death|0|||
19796675|NCT02919475|42254737|FG001|Overall Study|Death|1|||
19796676|NCT02919475|42254738|FG002|Overall Study|Death|0|||
19796677|NCT02919475|42254739|FG003|Overall Study|Death|0|||
19796678|NCT02919475|42254740|FG004|Overall Study|Death|0|||
19796679|NCT02919475|42254736|FG000|Overall Study|Lost to Follow-up|0|||
19796680|NCT02919475|42254737|FG001|Overall Study|Lost to Follow-up|0|||
19796681|NCT02919475|42254738|FG002|Overall Study|Lost to Follow-up|0|||
19367541|NCT01367275|41607727|FG000|Overall Study|Disease Progression|2|||
19698528|NCT00296504|42143596|FG007|Interim Analysis|Insufficient CD4 Response|0|||
19698529|NCT00296504|42143597|FG008|Interim Analysis|Insufficient CD4 Response|0|||
19698530|NCT00296504|42143589|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
19698531|NCT00296504|42143590|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
19698532|NCT00296504|42143591|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
19698533|NCT00296504|42143592|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
19698534|NCT00296504|42143593|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
19698535|NCT00296504|42143594|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
19698536|NCT00296504|42143595|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
19698537|NCT00296504|42143596|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
19698538|NCT00296504|42143597|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
19698539|NCT00296504|42143589|FG000|Interim Analysis|Pregnancy|4|||
19698540|NCT00296504|42143590|FG001|Interim Analysis|Pregnancy|1|||
19698541|NCT00296504|42143591|FG002|Interim Analysis|Pregnancy|4|||
19698542|NCT00296504|42143592|FG003|Interim Analysis|Pregnancy|2|||
19698543|NCT00296504|42143593|FG004|Interim Analysis|Pregnancy|0|||
19698544|NCT00296504|42143594|FG005|Interim Analysis|Pregnancy|1|||
19698545|NCT00296504|42143595|FG006|Interim Analysis|Pregnancy|1|||
19698546|NCT00296504|42143596|FG007|Interim Analysis|Pregnancy|1|||
19698547|NCT00296504|42143597|FG008|Interim Analysis|Pregnancy|0|||
19698548|NCT00296504|42143589|FG000|Interim Analysis|Death|1|||
19698549|NCT00296504|42143590|FG001|Interim Analysis|Death|0|||
19796682|NCT02919475|42254739|FG003|Overall Study|Lost to Follow-up|1|||
19796683|NCT02919475|42254740|FG004|Overall Study|Lost to Follow-up|0|||
19796684|NCT02919475|42254736|FG000|Overall Study|Withdrawal by Subject|2|||
19796685|NCT02919475|42254737|FG001|Overall Study|Withdrawal by Subject|3|||
19796686|NCT02919475|42254738|FG002|Overall Study|Withdrawal by Subject|1|||
19608074|NCT00878553|42056959|FG004|PK Study|Withdrawal by Subject|0|||
19698550|NCT00296504|42143591|FG002|Interim Analysis|Death|3|||
19698551|NCT00296504|42143592|FG003|Interim Analysis|Death|0|||
19698552|NCT00296504|42143593|FG004|Interim Analysis|Death|0|||
19698553|NCT00296504|42143594|FG005|Interim Analysis|Death|0|||
19698554|NCT00296504|42143595|FG006|Interim Analysis|Death|0|||
19796687|NCT02919475|42254739|FG003|Overall Study|Withdrawal by Subject|2|||
19796688|NCT02919475|42254740|FG004|Overall Study|Withdrawal by Subject|2|||
19796689|NCT02919475|42254736|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19796690|NCT02919475|42254737|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19796691|NCT02919475|42254738|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19796692|NCT02919475|42254739|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19796693|NCT02919475|42254740|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19796694|NCT01066897|42254754|FG000|Overall Study|Withdrawal by Subject|1|||
19796695|NCT01066897|42254755|FG001|Overall Study|Withdrawal by Subject|0|||
19796696|NCT01066897|42254754|FG000|Overall Study|stopped study after developing the flu.|1|||
19796697|NCT01066897|42254755|FG001|Overall Study|stopped study after developing the flu.|0|||
19796698|NCT02985541|42254762|FG000|Overall Study|Withdrawal by Subject|33|||
19796699|NCT02985541|42254762|FG000|Overall Study|Lost to Follow-up|26|||
19796700|NCT02985541|42254762|FG000|Overall Study|Adverse Event|27|||
19796701|NCT02985541|42254762|FG000|Overall Study|Physician Decision|2|||
19796702|NCT02985541|42254762|FG000|Overall Study|Pregnancy|2|||
19796703|NCT02985541|42254762|FG000|Overall Study|Wish for pregnancy|44|||
19796704|NCT02985541|42254762|FG000|Overall Study|Other reason|5|||
19796705|NCT02985541|42254762|FG000|Overall Study|Not valid for analysis|2|||
19796706|NCT02910037|42254775|FG000|Overall Study|Withdrawal by Subject|4|||
19796707|NCT02910037|42254775|FG000|Overall Study|Lost to Follow-up|6|||
19796708|NCT02511184|42254810|FG000|Overall Study|Death|1|||
19796709|NCT02511184|42254811|FG001|Overall Study|Death|0|||
19796710|NCT02511184|42254810|FG000|Overall Study|Lost to Follow-up|0|||
19796711|NCT02511184|42254811|FG001|Overall Study|Lost to Follow-up|1|||
19796712|NCT02511184|42254810|FG000|Overall Study|Study terminated by sponsor|1|||
19796713|NCT02511184|42254811|FG001|Overall Study|Study terminated by sponsor|5|||
19796714|NCT02511184|42254810|FG000|Overall Study|Withdrawal by Subject|0|||
19796715|NCT02511184|42254811|FG001|Overall Study|Withdrawal by Subject|1|||
19796716|NCT02984995|42254824|FG000|Overall Study|Required stem cell transplant|13|||
19796717|NCT02984995|42254825|FG001|Overall Study|Required stem cell transplant|2|||
19796718|NCT02984995|42254824|FG000|Overall Study|Progressive disease|11|||
19796719|NCT02984995|42254825|FG001|Overall Study|Progressive disease|1|||
19796720|NCT02984995|42254824|FG000|Overall Study|Adverse Event|1|||
19796721|NCT02984995|42254825|FG001|Overall Study|Adverse Event|0|||
19796722|NCT02984683|42254849|FG000|Overall Study|Adverse Event|3|||
19796723|NCT02984683|42254850|FG001|Overall Study|Adverse Event|3|||
19796724|NCT02984683|42254849|FG000|Overall Study|Withdrawal by Subject|1|||
19796725|NCT02984683|42254850|FG001|Overall Study|Withdrawal by Subject|0|||
19796726|NCT02984683|42254849|FG000|Overall Study|Disease progression|7|||
19796727|NCT02984683|42254850|FG001|Overall Study|Disease progression|9|||
19796728|NCT02909101|42254858|FG000|Overall Study|Lost to Follow-up|1|||
19796729|NCT02909101|42254859|FG001|Overall Study|Lost to Follow-up|1|||
19796730|NCT03004469|42254868|FG000|Overall Study|Adverse Event|6|||
19796731|NCT03004469|42254869|FG001|Overall Study|Adverse Event|4|||
19796732|NCT03004469|42254870|FG002|Overall Study|Adverse Event|6|||
19796733|NCT03004469|42254868|FG000|Overall Study|Lack of Efficacy|1|||
19796734|NCT03004469|42254869|FG001|Overall Study|Lack of Efficacy|0|||
19796735|NCT03004469|42254870|FG002|Overall Study|Lack of Efficacy|1|||
19796736|NCT03004469|42254868|FG000|Overall Study|Lost to Follow-up|23|||
19796737|NCT03004469|42254869|FG001|Overall Study|Lost to Follow-up|14|||
19796738|NCT03004469|42254870|FG002|Overall Study|Lost to Follow-up|6|||
19796739|NCT03004469|42254868|FG000|Overall Study|Non-Compliance with Study Drug|2|||
19796740|NCT03004469|42254869|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19796741|NCT03004469|42254870|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19796742|NCT03004469|42254868|FG000|Overall Study|Protocol Violation|0|||
19796743|NCT03004469|42254869|FG001|Overall Study|Protocol Violation|0|||
19796744|NCT03004469|42254870|FG002|Overall Study|Protocol Violation|1|||
19796745|NCT03004469|42254868|FG000|Overall Study|Withdrawal by Subject|29|||
19796746|NCT03004469|42254869|FG001|Overall Study|Withdrawal by Subject|27|||
19796747|NCT03004469|42254870|FG002|Overall Study|Withdrawal by Subject|10|||
19796748|NCT03004469|42254868|FG000|Overall Study|Other unspecified reason|0|||
19796749|NCT03004469|42254869|FG001|Overall Study|Other unspecified reason|4|||
19796750|NCT03004469|42254870|FG002|Overall Study|Other unspecified reason|1|||
19796751|NCT02910713|42254879|FG000|Overall Study|Protocol Violation|2|||
19796752|NCT02910713|42254879|FG000|Overall Study|Subject Choice|4|||
19796753|NCT02910713|42254879|FG000|Overall Study|Received One Application|10|||
19796754|NCT02910713|42254879|FG000|Overall Study|Received Neither Application|18|||
19796755|NCT02910713|42254879|FG000|Overall Study|Enrollment cap|7|||
19796756|NCT02910713|42254879|FG000|Overall Study|Investigator Discretion|1|||
19796757|NCT02998541|42254887|FG000|Overall Study|Adverse Event|4|||
19796758|NCT02998541|42254888|FG001|Overall Study|Adverse Event|5|||
19796759|NCT02998541|42254889|FG002|Overall Study|Adverse Event|1|||
19796760|NCT02998541|42254887|FG000|Overall Study|Protocol Violation|1|||
19796761|NCT02998541|42254888|FG001|Overall Study|Protocol Violation|0|||
19796762|NCT02998541|42254889|FG002|Overall Study|Protocol Violation|0|||
19796763|NCT02998541|42254887|FG000|Overall Study|Withdrawal by Subject|3|||
19796764|NCT02998541|42254888|FG001|Overall Study|Withdrawal by Subject|1|||
19796765|NCT02998541|42254889|FG002|Overall Study|Withdrawal by Subject|0|||
19796766|NCT02998541|42254887|FG000|Overall Study|Lost to Follow-up|0|||
19796767|NCT02998541|42254888|FG001|Overall Study|Lost to Follow-up|3|||
19796768|NCT02998541|42254889|FG002|Overall Study|Lost to Follow-up|1|||
19796769|NCT02998541|42254887|FG000|Overall Study|Physician Decision|0|||
19796770|NCT02998541|42254888|FG001|Overall Study|Physician Decision|0|||
19796771|NCT02998541|42254889|FG002|Overall Study|Physician Decision|3|||
19796772|NCT02998541|42254887|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19796773|NCT02998541|42254888|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19796774|NCT02998541|42254889|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
19796775|NCT02998151|42254897|FG000|Overall Study|Withdrawal by Subject|3|||
19796776|NCT02998151|42254897|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
19796777|NCT02998151|42254897|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
19796778|NCT01066819|42254928|FG000|Overall Study|Adverse Event|18|||
19796779|NCT01066819|42254929|FG001|Overall Study|Adverse Event|1|||
19796780|NCT01066819|42254930|FG002|Overall Study|Adverse Event|6|||
19796781|NCT01066819|42254931|FG003|Overall Study|Adverse Event|0|||
19796782|NCT01066819|42254932|FG004|Overall Study|Adverse Event|0|||
19796783|NCT01066819|42254933|FG005|Overall Study|Adverse Event|0|||
19796784|NCT01066819|42254928|FG000|Overall Study|Death|5|||
19796785|NCT01066819|42254929|FG001|Overall Study|Death|0|||
19796786|NCT01066819|42254930|FG002|Overall Study|Death|1|||
19796787|NCT01066819|42254931|FG003|Overall Study|Death|0|||
19796788|NCT01066819|42254932|FG004|Overall Study|Death|0|||
19796789|NCT01066819|42254933|FG005|Overall Study|Death|0|||
19796790|NCT01066819|42254928|FG000|Overall Study|Lack of Efficacy|22|||
19796791|NCT01066819|42254929|FG001|Overall Study|Lack of Efficacy|1|||
19796792|NCT01066819|42254930|FG002|Overall Study|Lack of Efficacy|2|||
19796793|NCT01066819|42254931|FG003|Overall Study|Lack of Efficacy|1|||
19796794|NCT01066819|42254932|FG004|Overall Study|Lack of Efficacy|0|||
19796795|NCT01066819|42254933|FG005|Overall Study|Lack of Efficacy|0|||
19796796|NCT01066819|42254928|FG000|Overall Study|Physician Decision|6|||
19796797|NCT01066819|42254929|FG001|Overall Study|Physician Decision|2|||
19796798|NCT01066819|42254930|FG002|Overall Study|Physician Decision|3|||
19367542|NCT02842853|41607735|FG000|Overall Study|Non-compliance with the protocol|3|||
19608075|NCT00996437|42056978|FG000|Overall Study|Death|1|||
19608076|NCT00996437|42056979|FG001|Overall Study|Death|0|||
19698555|NCT00296504|42143596|FG007|Interim Analysis|Death|0|||
19698556|NCT00296504|42143597|FG008|Interim Analysis|Death|0|||
19698557|NCT00296504|42143589|FG000|Interim Analysis|Participant Non-compliant|0|||
19698558|NCT00296504|42143590|FG001|Interim Analysis|Participant Non-compliant|1|||
19698559|NCT00296504|42143591|FG002|Interim Analysis|Participant Non-compliant|2|||
19698560|NCT00296504|42143592|FG003|Interim Analysis|Participant Non-compliant|1|||
19698561|NCT00296504|42143593|FG004|Interim Analysis|Participant Non-compliant|1|||
19698562|NCT00296504|42143594|FG005|Interim Analysis|Participant Non-compliant|3|||
19698563|NCT00296504|42143595|FG006|Interim Analysis|Participant Non-compliant|6|||
19698564|NCT00296504|42143596|FG007|Interim Analysis|Participant Non-compliant|2|||
19698565|NCT00296504|42143597|FG008|Interim Analysis|Participant Non-compliant|0|||
19608077|NCT00996437|42056978|FG000|Overall Study|Dropped|2|||
19608078|NCT00996437|42056979|FG001|Overall Study|Dropped|2|||
19608079|NCT00996437|42056978|FG000|Overall Study|Missed|2|||
19608080|NCT00996437|42056979|FG001|Overall Study|Missed|5|||
19608081|NCT00662311|42056988|FG000|Overall Study|Respiratory Infection|1|||
19608082|NCT00662311|42056989|FG001|Overall Study|Respiratory Infection|0|||
19608083|NCT00662311|42056990|FG002|Overall Study|Respiratory Infection|0|||
19608084|NCT00929708|42057003|FG000|Overall Study|Protocol Violation|2|||
19608085|NCT00929708|42057004|FG001|Overall Study|Protocol Violation|1|||
19608086|NCT00929708|42057005|FG002|Overall Study|Protocol Violation|1|||
19608087|NCT00929708|42057006|FG003|Overall Study|Protocol Violation|1|||
19608088|NCT00929708|42057007|FG004|Overall Study|Protocol Violation|1|||
19608089|NCT00929708|42057003|FG000|Overall Study|Withdrawal by Subject|2|||
19608090|NCT00929708|42057004|FG001|Overall Study|Withdrawal by Subject|0|||
19608091|NCT00929708|42057005|FG002|Overall Study|Withdrawal by Subject|0|||
19608092|NCT00929708|42057006|FG003|Overall Study|Withdrawal by Subject|2|||
19608093|NCT00929708|42057007|FG004|Overall Study|Withdrawal by Subject|1|||
19608094|NCT00929708|42057003|FG000|Overall Study|Adverse Event|0|||
19608095|NCT00929708|42057004|FG001|Overall Study|Adverse Event|0|||
19608096|NCT00929708|42057005|FG002|Overall Study|Adverse Event|0|||
19608097|NCT00929708|42057006|FG003|Overall Study|Adverse Event|0|||
19608098|NCT00929708|42057007|FG004|Overall Study|Adverse Event|3|||
19608099|NCT00929708|42057003|FG000|Overall Study|Physician Decision|0|||
19608100|NCT00929708|42057004|FG001|Overall Study|Physician Decision|2|||
19608101|NCT00929708|42057005|FG002|Overall Study|Physician Decision|2|||
19608102|NCT00929708|42057006|FG003|Overall Study|Physician Decision|2|||
19608103|NCT00929708|42057007|FG004|Overall Study|Physician Decision|1|||
19796799|NCT01066819|42254931|FG003|Overall Study|Physician Decision|0|||
19796800|NCT01066819|42254932|FG004|Overall Study|Physician Decision|0|||
19796801|NCT01066819|42254933|FG005|Overall Study|Physician Decision|0|||
19796802|NCT01066819|42254928|FG000|Overall Study|Protocol Violation|12|||
19796803|NCT01066819|42254929|FG001|Overall Study|Protocol Violation|6|||
19796804|NCT01066819|42254930|FG002|Overall Study|Protocol Violation|0|||
19796805|NCT01066819|42254931|FG003|Overall Study|Protocol Violation|0|||
19796806|NCT01066819|42254932|FG004|Overall Study|Protocol Violation|0|||
19796807|NCT01066819|42254933|FG005|Overall Study|Protocol Violation|0|||
19796808|NCT01066819|42254928|FG000|Overall Study|Withdrawal by Subject|29|||
19796809|NCT01066819|42254929|FG001|Overall Study|Withdrawal by Subject|11|||
19796810|NCT01066819|42254930|FG002|Overall Study|Withdrawal by Subject|6|||
19796811|NCT01066819|42254931|FG003|Overall Study|Withdrawal by Subject|0|||
19796812|NCT01066819|42254932|FG004|Overall Study|Withdrawal by Subject|0|||
19796813|NCT01066819|42254933|FG005|Overall Study|Withdrawal by Subject|0|||
19796814|NCT01066819|42254928|FG000|Overall Study|Administrative|6|||
19796815|NCT01066819|42254929|FG001|Overall Study|Administrative|4|||
19796816|NCT01066819|42254930|FG002|Overall Study|Administrative|2|||
19796817|NCT01066819|42254931|FG003|Overall Study|Administrative|0|||
19796818|NCT01066819|42254932|FG004|Overall Study|Administrative|0|||
19796819|NCT01066819|42254933|FG005|Overall Study|Administrative|0|||
19796820|NCT01066819|42254928|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
19796821|NCT01066819|42254929|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
19796822|NCT01066819|42254930|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
19796823|NCT01066819|42254931|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
19796824|NCT01066819|42254932|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
19796825|NCT01066819|42254933|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
19796826|NCT01066819|42254928|FG000|Overall Study|Early termination|2|||
19796827|NCT01066819|42254929|FG001|Overall Study|Early termination|0|||
19796828|NCT01066819|42254930|FG002|Overall Study|Early termination|0|||
19796829|NCT01066819|42254931|FG003|Overall Study|Early termination|0|||
19796830|NCT01066819|42254932|FG004|Overall Study|Early termination|0|||
19796831|NCT01066819|42254933|FG005|Overall Study|Early termination|0|||
19796832|NCT01066819|42254928|FG000|Overall Study|Failed to return|298|||
19796833|NCT01066819|42254929|FG001|Overall Study|Failed to return|107|||
19796834|NCT01066819|42254930|FG002|Overall Study|Failed to return|68|||
19698566|NCT00296504|42143589|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698567|NCT00296504|42143590|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698568|NCT00296504|42143591|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
19698569|NCT00296504|42143592|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19796835|NCT01066819|42254931|FG003|Overall Study|Failed to return|7|||
19796836|NCT01066819|42254932|FG004|Overall Study|Failed to return|2|||
19796837|NCT01066819|42254933|FG005|Overall Study|Failed to return|3|||
19796838|NCT01066819|42254928|FG000|Overall Study|Lab test not done|9|||
19796839|NCT01066819|42254929|FG001|Overall Study|Lab test not done|0|||
19796840|NCT01066819|42254930|FG002|Overall Study|Lab test not done|2|||
19796841|NCT01066819|42254931|FG003|Overall Study|Lab test not done|1|||
19796842|NCT01066819|42254932|FG004|Overall Study|Lab test not done|0|||
19796843|NCT01066819|42254933|FG005|Overall Study|Lab test not done|0|||
19796844|NCT01066819|42254928|FG000|Overall Study|Miscellaneous|28|||
19796845|NCT01066819|42254929|FG001|Overall Study|Miscellaneous|10|||
19796846|NCT01066819|42254930|FG002|Overall Study|Miscellaneous|18|||
19796847|NCT01066819|42254931|FG003|Overall Study|Miscellaneous|1|||
19796848|NCT01066819|42254932|FG004|Overall Study|Miscellaneous|0|||
19796849|NCT01066819|42254933|FG005|Overall Study|Miscellaneous|0|||
19796850|NCT01066819|42254928|FG000|Overall Study|Non responders|123|||
19796851|NCT01066819|42254929|FG001|Overall Study|Non responders|2|||
19796852|NCT01066819|42254930|FG002|Overall Study|Non responders|7|||
19796853|NCT01066819|42254931|FG003|Overall Study|Non responders|2|||
19796854|NCT01066819|42254932|FG004|Overall Study|Non responders|0|||
19796855|NCT01066819|42254933|FG005|Overall Study|Non responders|1|||
19796856|NCT01066819|42254928|FG000|Overall Study|Not categorised|9|||
19796857|NCT01066819|42254929|FG001|Overall Study|Not categorised|2|||
19796858|NCT01066819|42254930|FG002|Overall Study|Not categorised|6|||
19796859|NCT01066819|42254931|FG003|Overall Study|Not categorised|1|||
19796860|NCT01066819|42254932|FG004|Overall Study|Not categorised|0|||
19796861|NCT01066819|42254933|FG005|Overall Study|Not categorised|0|||
19796862|NCT01066819|42254928|FG000|Overall Study|Relapse|16|||
19796863|NCT01066819|42254929|FG001|Overall Study|Relapse|4|||
19367543|NCT02842853|41607736|FG001|Overall Study|Non-compliance with the protocol|7|||
19796864|NCT01066819|42254930|FG002|Overall Study|Relapse|3|||
19796865|NCT01066819|42254931|FG003|Overall Study|Relapse|0|||
19796866|NCT01066819|42254932|FG004|Overall Study|Relapse|0|||
19796867|NCT01066819|42254933|FG005|Overall Study|Relapse|0|||
19796868|NCT01066819|42254928|FG000|Overall Study|Results not available|1|||
19796869|NCT01066819|42254929|FG001|Overall Study|Results not available|0|||
19796870|NCT01066819|42254930|FG002|Overall Study|Results not available|0|||
19796871|NCT01066819|42254931|FG003|Overall Study|Results not available|0|||
19796872|NCT01066819|42254932|FG004|Overall Study|Results not available|0|||
19796873|NCT01066819|42254933|FG005|Overall Study|Results not available|0|||
19796874|NCT01066819|42254928|FG000|Overall Study|Screen failure|1|||
19796875|NCT01066819|42254929|FG001|Overall Study|Screen failure|0|||
19796876|NCT01066819|42254930|FG002|Overall Study|Screen failure|0|||
19796877|NCT01066819|42254931|FG003|Overall Study|Screen failure|0|||
19796878|NCT01066819|42254932|FG004|Overall Study|Screen failure|0|||
19796879|NCT01066819|42254933|FG005|Overall Study|Screen failure|0|||
19796880|NCT01066819|42254928|FG000|Overall Study|Spontaneous cure|1|||
19796881|NCT01066819|42254929|FG001|Overall Study|Spontaneous cure|0|||
19796882|NCT01066819|42254930|FG002|Overall Study|Spontaneous cure|0|||
19796883|NCT01066819|42254931|FG003|Overall Study|Spontaneous cure|0|||
19796884|NCT01066819|42254932|FG004|Overall Study|Spontaneous cure|0|||
19796885|NCT01066819|42254933|FG005|Overall Study|Spontaneous cure|0|||
19796886|NCT01066819|42254928|FG000|Overall Study|Treatment never started|85|||
19796887|NCT01066819|42254929|FG001|Overall Study|Treatment never started|19|||
19796888|NCT01066819|42254930|FG002|Overall Study|Treatment never started|19|||
19796889|NCT01066819|42254931|FG003|Overall Study|Treatment never started|3|||
19796890|NCT01066819|42254932|FG004|Overall Study|Treatment never started|2|||
19796891|NCT01066819|42254933|FG005|Overall Study|Treatment never started|2|||
19796892|NCT01066819|42254928|FG000|Overall Study|Treatment stopped|12|||
19796893|NCT01066819|42254929|FG001|Overall Study|Treatment stopped|1|||
19796894|NCT01066819|42254930|FG002|Overall Study|Treatment stopped|2|||
19796895|NCT01066819|42254931|FG003|Overall Study|Treatment stopped|1|||
19796896|NCT01066819|42254932|FG004|Overall Study|Treatment stopped|0|||
19796897|NCT01066819|42254933|FG005|Overall Study|Treatment stopped|0|||
19796898|NCT01066819|42254928|FG000|Overall Study|Other|5|||
19796899|NCT01066819|42254929|FG001|Overall Study|Other|1|||
19796900|NCT01066819|42254930|FG002|Overall Study|Other|1|||
19796901|NCT01066819|42254931|FG003|Overall Study|Other|0|||
19796902|NCT01066819|42254932|FG004|Overall Study|Other|0|||
19796903|NCT01066819|42254933|FG005|Overall Study|Other|0|||
19796904|NCT04056299|42254947|FG000|Overall Study|Sponsor discontinued study|3|||
19796905|NCT04056299|42254948|FG001|Overall Study|Sponsor discontinued study|3|||
19796906|NCT04057937|42254956|FG000|Placebo-controlled Phase|Adverse Event|3|||
19796907|NCT04057937|42254957|FG001|Placebo-controlled Phase|Adverse Event|0|||
19796908|NCT04057937|42254956|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
19796909|NCT04057937|42254957|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
19796910|NCT04057937|42254956|FG000|Active-treatment Phase|Pregnancy|0|||
19796911|NCT04057937|42254957|FG001|Active-treatment Phase|Pregnancy|1|||
19796912|NCT04057937|42254956|FG000|Active-treatment Phase|Physician Decision|0|||
19796913|NCT04057937|42254957|FG001|Active-treatment Phase|Physician Decision|1|||
19796914|NCT01069523|42254966|FG000|Overall Study|Withdrawal by Subject|4|||
19796915|NCT01069523|42254967|FG001|Overall Study|Withdrawal by Subject|7|||
19796916|NCT01069289|42254977|FG000|Overall Study|Withdrawal by Subject|15|||
19796917|NCT01069289|42254978|FG001|Overall Study|Withdrawal by Subject|26|||
19796918|NCT01069289|42254977|FG000|Overall Study|Adverse Event|21|||
19796919|NCT01069289|42254978|FG001|Overall Study|Adverse Event|28|||
19796920|NCT01069289|42254977|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19796921|NCT01069289|42254978|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19796922|NCT01069289|42254977|FG000|Overall Study|Severe non-compliance to protocol|3|||
19796923|NCT01069289|42254978|FG001|Overall Study|Severe non-compliance to protocol|2|||
19796924|NCT01069289|42254977|FG000|Overall Study|Due to deteriorating health condition|1|||
19796925|NCT01069289|42254978|FG001|Overall Study|Due to deteriorating health condition|0|||
19796926|NCT02510794|42254997|FG000|Overall Study|Adverse Event|0|||
19796927|NCT02510794|42254998|FG001|Overall Study|Adverse Event|1|||
19796928|NCT02510794|42254999|FG002|Overall Study|Adverse Event|0|||
19796929|NCT02510794|42255000|FG003|Overall Study|Adverse Event|0|||
19796930|NCT02510794|42254997|FG000|Overall Study|Death|1|||
19796931|NCT02510794|42254998|FG001|Overall Study|Death|2|||
19796932|NCT02510794|42254999|FG002|Overall Study|Death|1|||
19796933|NCT02510794|42255000|FG003|Overall Study|Death|1|||
19796934|NCT02510794|42254997|FG000|Overall Study|Lack of Efficacy|3|||
19796935|NCT02510794|42254998|FG001|Overall Study|Lack of Efficacy|1|||
19796936|NCT02510794|42254999|FG002|Overall Study|Lack of Efficacy|1|||
19796937|NCT02510794|42255000|FG003|Overall Study|Lack of Efficacy|0|||
19796938|NCT02510794|42254997|FG000|Overall Study|Participant moved out of the area|0|||
19796939|NCT02510794|42254998|FG001|Overall Study|Participant moved out of the area|0|||
19796940|NCT02510794|42254999|FG002|Overall Study|Participant moved out of the area|0|||
19477924|NCT01468181|41757279|FG004|Overall Study|Lost to Follow-up|1|||
19608104|NCT00929708|42057003|FG000|Overall Study|Lost to Follow-up|0|||
19796941|NCT02510794|42255000|FG003|Overall Study|Participant moved out of the area|1|||
19796942|NCT02510794|42254997|FG000|Overall Study|Physician Decision|3|||
19796943|NCT02510794|42254998|FG001|Overall Study|Physician Decision|0|||
19796944|NCT02510794|42254999|FG002|Overall Study|Physician Decision|0|||
19796945|NCT02510794|42255000|FG003|Overall Study|Physician Decision|0|||
19796946|NCT02510794|42254997|FG000|Overall Study|Protocol Violation|0|||
19796947|NCT02510794|42254998|FG001|Overall Study|Protocol Violation|0|||
19796948|NCT02510794|42254999|FG002|Overall Study|Protocol Violation|1|||
19796949|NCT02510794|42255000|FG003|Overall Study|Protocol Violation|0|||
19796950|NCT02510794|42254997|FG000|Overall Study|Withdrawal by Subject|1|||
19796951|NCT02510794|42254998|FG001|Overall Study|Withdrawal by Subject|2|||
19796952|NCT02510794|42254999|FG002|Overall Study|Withdrawal by Subject|4|||
19796953|NCT02510794|42255000|FG003|Overall Study|Withdrawal by Subject|3|||
19796954|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
19796955|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
19796956|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
19796957|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
19796958|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
19796959|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
19796960|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
19796961|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
19796962|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
19796963|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
19796964|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
19796965|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
19796966|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
19796967|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
19796968|NCT02510014|42255025|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
19796969|NCT02510014|42255026|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
19796970|NCT02510014|42255025|FG000|Treatment Period|Adverse Event|11|||
19796971|NCT02510014|42255026|FG001|Treatment Period|Adverse Event|4|||
19796972|NCT02510014|42255025|FG000|Treatment Period|Withdrawal symptoms|3|||
19796973|NCT02510014|42255026|FG001|Treatment Period|Withdrawal symptoms|0|||
19796974|NCT02510014|42255025|FG000|Treatment Period|Lost to Follow-up|80|||
19796975|NCT02510014|42255026|FG001|Treatment Period|Lost to Follow-up|19|||
19796976|NCT02510014|42255025|FG000|Treatment Period|Physician Decision|5|||
19796977|NCT02510014|42255026|FG001|Treatment Period|Physician Decision|0|||
19796978|NCT02510014|42255025|FG000|Treatment Period|Withdrawal by Subject|67|||
19796979|NCT02510014|42255026|FG001|Treatment Period|Withdrawal by Subject|24|||
19796980|NCT02510014|42255025|FG000|Treatment Period|Withdrawn by the investigator|7|||
19796981|NCT02510014|42255026|FG001|Treatment Period|Withdrawn by the investigator|1|||
19796982|NCT02510014|42255025|FG000|Treatment Period|Protocol Violation|4|||
19796983|NCT02510014|42255026|FG001|Treatment Period|Protocol Violation|4|||
19796984|NCT02510014|42255025|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
19796985|NCT02510014|42255026|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
19796986|NCT02509312|42255034|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
19796987|NCT02509312|42255035|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
19796988|NCT02509312|42255034|FG000|Overall Study|Obstetrician refusal|0|||
19796989|NCT02509312|42255035|FG001|Overall Study|Obstetrician refusal|1|||
19796990|NCT02509312|42255034|FG000|Overall Study|Patient elected for TOLAC|1|||
19796991|NCT02509312|42255035|FG001|Overall Study|Patient elected for TOLAC|0|||
19796992|NCT02509312|42255034|FG000|Overall Study|Cesarean deemed stat|1|||
19796993|NCT02509312|42255035|FG001|Overall Study|Cesarean deemed stat|0|||
19796994|NCT02509312|42255034|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
19796995|NCT02509312|42255035|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
19796996|NCT02509156|42255045|FG000|Randomized Phase|Death|1|||
19796997|NCT02509156|42255046|FG001|Randomized Phase|Death|0|||
19796998|NCT02509156|42255045|FG000|Randomized Phase|Withdrawal by Subject|1|||
19796999|NCT02509156|42255046|FG001|Randomized Phase|Withdrawal by Subject|1|||
19797000|NCT01654666|42255055|FG000|Overall Study|Protocol Violation|7|||
19797001|NCT01654666|42255056|FG001|Overall Study|Protocol Violation|4|||
19797002|NCT01654666|42255057|FG002|Overall Study|Protocol Violation|8|||
19797003|NCT01654666|42255055|FG000|Overall Study|Lost to Follow-up|4|||
19797004|NCT01654666|42255056|FG001|Overall Study|Lost to Follow-up|5|||
19797005|NCT01654666|42255057|FG002|Overall Study|Lost to Follow-up|5|||
19797006|NCT01654666|42255055|FG000|Overall Study|Withdrawal by Subject|4|||
19797007|NCT01654666|42255056|FG001|Overall Study|Withdrawal by Subject|4|||
19797008|NCT01654666|42255057|FG002|Overall Study|Withdrawal by Subject|1|||
19797009|NCT02519842|42255067|FG000|Base Study: Cycle 1|Screening Failure|1|||
19797010|NCT02519842|42255068|FG001|Base Study: Cycle 1|Screening Failure|1|||
19797011|NCT02519842|42255069|FG002|Base Study: Cycle 1|Screening Failure|0|||
19797012|NCT02519842|42255067|FG000|Base Study: Cycle 1|Adverse Event|1|||
19797013|NCT02519842|42255068|FG001|Base Study: Cycle 1|Adverse Event|0|||
19797014|NCT02519842|42255069|FG002|Base Study: Cycle 1|Adverse Event|0|||
19797015|NCT02519842|42255067|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
19797016|NCT02519842|42255068|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
19797017|NCT02519842|42255069|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
19797018|NCT02519842|42255067|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
19797019|NCT02519842|42255068|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
19797020|NCT02519842|42255069|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
19797021|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
19797022|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
19797023|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
19797024|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
19797025|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
19797026|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
19797027|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19797028|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
19797029|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
19797030|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
19797031|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
19797032|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
19797033|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Death|0|||
19797034|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Death|0|||
19797035|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Death|1|||
19797036|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
19797037|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
19797038|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
19797039|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
19797040|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
19797041|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
19797042|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
19797043|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
19797044|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
19797045|NCT02519842|42255067|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
19797046|NCT02519842|42255068|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
19797047|NCT02519842|42255069|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
19797048|NCT02509078|42255079|FG000|Overall Study|Protocol Violation|1|||
19797049|NCT02509078|42255080|FG001|Overall Study|Protocol Violation|1|||
19797050|NCT02993783|42255090|FG000|Overall Study|Reason not Specified|6|||
19797051|NCT02993783|42255091|FG001|Overall Study|Reason not Specified|9|||
19797052|NCT02993471|42255097|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
19797053|NCT02993471|42255097|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
19797054|NCT02988713|42255119|FG000|Overall Study|Withdrawal by Subject|1|||
19797055|NCT02988713|42255119|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
19797056|NCT01068743|42255123|FG000|Period 3|Adverse Event|0|||
19797057|NCT01068743|42255124|FG001|Period 3|Adverse Event|1|||
19797058|NCT01068743|42255125|FG002|Period 3|Adverse Event|0|||
19797059|NCT01068743|42255126|FG003|Period 3|Adverse Event|0|||
19797060|NCT02992691|42255139|FG000|Overall Study|Adverse Event|2|||
19797061|NCT02992691|42255139|FG000|Overall Study|Withdrawal by Subject|1|||
19797062|NCT02921087|42255156|FG000|Overall Study|Withdrawal by Subject|0|||
19797063|NCT02921087|42255157|FG001|Overall Study|Withdrawal by Subject|1|||
19797064|NCT02907619|42255176|FG000|Overall Study|Study terminated by sponsor|18|||
19797065|NCT02907619|42255177|FG001|Overall Study|Study terminated by sponsor|18|||
19797066|NCT02907619|42255178|FG002|Overall Study|Study terminated by sponsor|19|||
19797067|NCT02907619|42255176|FG000|Overall Study|Death|0|||
19797068|NCT02907619|42255177|FG001|Overall Study|Death|0|||
19797069|NCT02907619|42255178|FG002|Overall Study|Death|1|||
19797070|NCT02907619|42255176|FG000|Overall Study|Withdrawal by Subject|1|||
19797071|NCT02907619|42255177|FG001|Overall Study|Withdrawal by Subject|1|||
19797072|NCT02907619|42255178|FG002|Overall Study|Withdrawal by Subject|0|||
19797073|NCT02907619|42255176|FG000|Overall Study|Other|0|||
19797074|NCT02907619|42255177|FG001|Overall Study|Other|1|||
19797075|NCT02907619|42255178|FG002|Overall Study|Other|0|||
19797076|NCT02986373|42255188|FG000|Overall Study|Adverse Event|4|||
19797077|NCT02986373|42255188|FG000|Overall Study|Lost to Follow-up|1|||
19797078|NCT02986373|42255188|FG000|Overall Study|Withdrawal by Subject|10|||
19797079|NCT02986373|42255188|FG000|Overall Study|Other|24|||
19797080|NCT02986139|42255194|FG000|Overall Study|Sponsor Decision|1|||
19797081|NCT02986139|42255195|FG001|Overall Study|Sponsor Decision|2|||
19797082|NCT02986139|42255194|FG000|Overall Study|Withdrawal by Subject|0|||
19797083|NCT02986139|42255195|FG001|Overall Study|Withdrawal by Subject|1|||
19797084|NCT02986139|42255194|FG000|Overall Study|Lost to Follow-up|0|||
19797085|NCT02986139|42255195|FG001|Overall Study|Lost to Follow-up|1|||
19797086|NCT02989805|42255207|FG000|Overall Study|invalid consent|6|||
19797087|NCT02989805|42255208|FG001|Overall Study|invalid consent|4|||
19797088|NCT02907463|42255214|FG000|Overall Study|Lost to Follow-up|17|||
19797089|NCT02907463|42255214|FG000|Overall Study|Death|10|||
19797090|NCT02907463|42255214|FG000|Overall Study|Withdrawal by Subject|4|||
19797091|NCT02907463|42255214|FG000|Overall Study|MIS Approach was not used|2|||
19797092|NCT02907463|42255214|FG000|Overall Study|Not Implanted with Study Device|2|||
19797093|NCT02907463|42255214|FG000|Overall Study|Device Explanted|1|||
19797094|NCT02907463|42255214|FG000|Overall Study|Missing Exit Form|1|||
19797095|NCT02906917|42255228|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
19797096|NCT02906917|42255229|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
19797097|NCT02906917|42255228|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
19797098|NCT02906917|42255229|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
19797099|NCT02906917|42255228|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
19797100|NCT02906917|42255229|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
19797101|NCT02906917|42255228|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
19797102|NCT02906917|42255229|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
19797103|NCT02906917|42255228|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
19797104|NCT02906917|42255229|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
19797105|NCT02906917|42255228|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
19797106|NCT02906917|42255229|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
19797107|NCT02906917|42255228|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
19797108|NCT02906917|42255229|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
19797109|NCT02906917|42255228|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
19797110|NCT02906917|42255229|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
19797111|NCT02982187|42255237|FG000|Overall Study|Withdrawal by Subject|0|||
19797112|NCT02982187|42255238|FG001|Overall Study|Withdrawal by Subject|0|||
19797113|NCT02982187|42255239|FG002|Overall Study|Withdrawal by Subject|0|||
19797114|NCT02982187|42255240|FG003|Overall Study|Withdrawal by Subject|0|||
19797115|NCT02982187|42255241|FG004|Overall Study|Withdrawal by Subject|0|||
19797116|NCT02982187|42255242|FG005|Overall Study|Withdrawal by Subject|0|||
19797117|NCT02982187|42255243|FG006|Overall Study|Withdrawal by Subject|1|||
19797118|NCT02982187|42255244|FG007|Overall Study|Withdrawal by Subject|0|||
19797119|NCT02981953|42255254|FG000|Overall Study|Death|9|||
19797120|NCT02981953|42255254|FG000|Overall Study|Withdrawal by Subject|1|||
19797121|NCT02981953|42255254|FG000|Overall Study|Withdrawal to non-compliance|1|||
19797122|NCT01066585|42255270|FG000|Overall Study|Protocol Violation|1|||
19797123|NCT01066585|42255271|FG001|Overall Study|Protocol Violation|0|||
19797124|NCT01066585|42255270|FG000|Overall Study|Withdrawal by Subject|0|||
19797125|NCT01066585|42255271|FG001|Overall Study|Withdrawal by Subject|3|||
19797126|NCT02980783|42255277|FG000|Overall Study|Lost to Follow-up|1|||
19797127|NCT02980705|42255283|FG000|Overall Study|Adverse Event|0|||
19797128|NCT02980705|42255284|FG001|Overall Study|Adverse Event|1|||
19797129|NCT02980705|42255283|FG000|Overall Study|Withdrawal by Subject|6|||
19797130|NCT02980705|42255284|FG001|Overall Study|Withdrawal by Subject|9|||
19797131|NCT02980705|42255283|FG000|Overall Study|withdrew participation|0|||
19797132|NCT02980705|42255284|FG001|Overall Study|withdrew participation|1|||
19797133|NCT02980705|42255283|FG000|Overall Study|Lost to Follow-up|2|||
19797134|NCT02980705|42255284|FG001|Overall Study|Lost to Follow-up|0|||
19797135|NCT02989649|42255291|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
19797136|NCT02989649|42255291|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
19797137|NCT02989649|42255291|FG000|Overall Study|Lost For Observation During Study|3|||
19797138|NCT02989649|42255291|FG000|Overall Study|Reason Not Specified|13|||
19797139|NCT02905435|42255295|FG000|Overall Study|Death|2|||
19797140|NCT02905435|42255295|FG000|Overall Study|Physician Decision|1|||
19797141|NCT02905435|42255295|FG000|Overall Study|Lost to Follow-up|4|||
19797142|NCT02978833|42255302|FG000|Overall Study|Study terminated|1|||
19797143|NCT02978833|42255303|FG001|Overall Study|Study terminated|1|||
19797144|NCT01067339|42255312|FG000|Overall Study|Withdrawal by Subject|6|||
19797145|NCT01067339|42255313|FG001|Overall Study|Withdrawal by Subject|5|||
19797146|NCT02573259|42255326|FG000|Overall Study|Death|1|||
19797147|NCT02573259|42255327|FG001|Overall Study|Death|6|||
19797148|NCT02573259|42255328|FG002|Overall Study|Death|5|||
19797149|NCT02573259|42255329|FG003|Overall Study|Death|6|||
19797150|NCT02573259|42255330|FG004|Overall Study|Death|9|||
19797151|NCT02573259|42255331|FG005|Overall Study|Death|32|||
19797152|NCT02573259|42255332|FG006|Overall Study|Death|21|||
19797153|NCT02573259|42255326|FG000|Overall Study|Lost to Follow-up|0|||
19797154|NCT02573259|42255327|FG001|Overall Study|Lost to Follow-up|0|||
19797155|NCT02573259|42255328|FG002|Overall Study|Lost to Follow-up|0|||
19797156|NCT02573259|42255329|FG003|Overall Study|Lost to Follow-up|0|||
19797157|NCT02573259|42255330|FG004|Overall Study|Lost to Follow-up|0|||
19797158|NCT02573259|42255331|FG005|Overall Study|Lost to Follow-up|2|||
19797159|NCT02573259|42255332|FG006|Overall Study|Lost to Follow-up|1|||
19797160|NCT02573259|42255326|FG000|Overall Study|Participant refused further follow-up|0|||
19797161|NCT02573259|42255327|FG001|Overall Study|Participant refused further follow-up|2|||
19797162|NCT02573259|42255328|FG002|Overall Study|Participant refused further follow-up|1|||
19797163|NCT02573259|42255329|FG003|Overall Study|Participant refused further follow-up|0|||
19797164|NCT02573259|42255330|FG004|Overall Study|Participant refused further follow-up|3|||
19797165|NCT02573259|42255331|FG005|Overall Study|Participant refused further follow-up|20|||
19797166|NCT02573259|42255332|FG006|Overall Study|Participant refused further follow-up|7|||
19797167|NCT02573259|42255326|FG000|Overall Study|Other|0|||
19797168|NCT02573259|42255327|FG001|Overall Study|Other|0|||
19797169|NCT02573259|42255328|FG002|Overall Study|Other|0|||
19797170|NCT02573259|42255329|FG003|Overall Study|Other|0|||
19797171|NCT02573259|42255330|FG004|Overall Study|Other|1|||
19797172|NCT02573259|42255331|FG005|Overall Study|Other|4|||
19797173|NCT02573259|42255332|FG006|Overall Study|Other|5|||
19797174|NCT02977507|42255369|FG000|Overall Study|Protocol Deviation|1|||
19797175|NCT02977507|42255370|FG001|Overall Study|Protocol Deviation|0|||
19797176|NCT02977507|42255369|FG000|Overall Study|Lost to Follow-up|1|||
19797177|NCT02977507|42255370|FG001|Overall Study|Lost to Follow-up|0|||
19797178|NCT02976103|42255379|FG000|Overall Study|Withdrawal by Subject|1|||
19797179|NCT02976103|42255380|FG001|Overall Study|Withdrawal by Subject|0|||
19797180|NCT02976103|42255379|FG000|Overall Study|Lost to Follow-up|12|||
19797181|NCT02976103|42255380|FG001|Overall Study|Lost to Follow-up|8|||
19797182|NCT01066039|42255387|FG000|Overall Study|Adverse Event|6|||
19797183|NCT01066039|42255387|FG000|Overall Study|Withdrawal by Subject|17|||
19797184|NCT01066039|42255387|FG000|Overall Study|Protocol Violation|2|||
19797185|NCT01066039|42255387|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
19797186|NCT01066039|42255387|FG000|Overall Study|Investigator's Request|1|||
19797187|NCT01066039|42255387|FG000|Overall Study|Dropout due to Insulin Administration|1|||
19797188|NCT01066039|42255387|FG000|Overall Study|Additional Antihypertensive Required|4|||
19797189|NCT01066039|42255387|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
19797190|NCT01066039|42255387|FG000|Overall Study|Failure to Control Blood Pressure|1|||
19797191|NCT01066039|42255387|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
19797192|NCT02919995|42255397|FG000|Overall Study|Adverse Event|0|||
19797193|NCT02919995|42255398|FG001|Overall Study|Adverse Event|0|||
19797194|NCT02919995|42255399|FG002|Overall Study|Adverse Event|0|||
19797195|NCT02919995|42255400|FG003|Overall Study|Adverse Event|0|||
19797196|NCT02919995|42255401|FG004|Overall Study|Adverse Event|0|||
19797197|NCT02919995|42255402|FG005|Overall Study|Adverse Event|1|||
19797198|NCT02919761|42255410|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
19797199|NCT02919761|42255411|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
19797200|NCT02919761|42255412|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
19797201|NCT02919761|42255410|FG000|Part 1: Open Label|Adverse Event|1|||
19797202|NCT02919761|42255411|FG001|Part 1: Open Label|Adverse Event|0|||
19797203|NCT02919761|42255412|FG002|Part 1: Open Label|Adverse Event|0|||
19797204|NCT02919761|42255410|FG000|Part 1: Open Label|Lost to Follow-up|1|||
19797205|NCT02919761|42255411|FG001|Part 1: Open Label|Lost to Follow-up|0|||
19797206|NCT02919761|42255412|FG002|Part 1: Open Label|Lost to Follow-up|0|||
19797207|NCT02919761|42255410|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
19797208|NCT02919761|42255411|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
19797209|NCT02919761|42255412|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
19797210|NCT02919761|42255410|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
19797211|NCT02919761|42255411|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
19797212|NCT02919761|42255412|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
19797213|NCT02919761|42255410|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
19797214|NCT02919761|42255411|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
19797215|NCT02919761|42255412|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
19797216|NCT02919761|42255410|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
19797217|NCT02919761|42255411|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
19797218|NCT02919761|42255412|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
19797219|NCT02919761|42255410|FG000|Part 1: Open Label|Termination by Sponsor|1|||
19797220|NCT02919761|42255411|FG001|Part 1: Open Label|Termination by Sponsor|0|||
19797221|NCT02919761|42255412|FG002|Part 1: Open Label|Termination by Sponsor|0|||
19797222|NCT02919761|42255410|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
19797223|NCT02919761|42255411|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
19797224|NCT02919761|42255412|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
19797225|NCT02919761|42255410|FG000|Part 2: Double-blind|Adverse Event|0|||
19797226|NCT02919761|42255411|FG001|Part 2: Double-blind|Adverse Event|1|||
19797227|NCT02919761|42255412|FG002|Part 2: Double-blind|Adverse Event|0|||
19797228|NCT02919761|42255410|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
19797229|NCT02919761|42255411|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
19797230|NCT02919761|42255412|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
19797231|NCT02919761|42255410|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
19797232|NCT02919761|42255411|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
19797233|NCT02919761|42255412|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
19797234|NCT02919761|42255410|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
19797235|NCT02919761|42255411|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
19797236|NCT02919761|42255412|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
19797237|NCT02919761|42255410|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
19797238|NCT02919761|42255411|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
19797239|NCT02919761|42255412|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
19797240|NCT02919761|42255410|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
19797241|NCT02919761|42255411|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
19797242|NCT02919761|42255412|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
19797243|NCT02919761|42255410|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
19797244|NCT02919761|42255411|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
19797245|NCT02919761|42255412|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
19797246|NCT02910167|42255423|FG000|Overall Study|Adverse Event|1|||
19797247|NCT02910167|42255423|FG000|Overall Study|Lost to Follow-up|18|||
19797248|NCT01067105|42255427|FG000|Overall Study|Adverse Event|14|||
19797249|NCT01067105|42255427|FG000|Overall Study|Protocol Violation|48|||
19797250|NCT01067105|42255427|FG000|Overall Study|Withdrawal by Subject|36|||
19797251|NCT01067105|42255427|FG000|Overall Study|Lost to Follow-up|6|||
19797252|NCT01067105|42255427|FG000|Overall Study|Physician Decision|6|||
19797253|NCT01067105|42255427|FG000|Overall Study|Other|31|||
19797254|NCT02910089|42255437|FG000|Overall Study|Lost insurance eligibility|22|||
19797255|NCT02910089|42255438|FG001|Overall Study|Lost insurance eligibility|16|||
19797256|NCT02985515|42255446|FG000|Olfaction Testing|Lost to Follow-up|0|||
19797257|NCT02985515|42255447|FG001|Olfaction Testing|Lost to Follow-up|5|||
19797258|NCT02985515|42255446|FG000|Olfaction Testing|Protocol Violation|0|||
19797259|NCT02985515|42255447|FG001|Olfaction Testing|Protocol Violation|3|||
19797260|NCT02910011|42255460|FG000|Overall Study|Physician Decision|2|||
19797261|NCT02908841|42255468|FG000|Overall Study|Physician Decision|4|||
19797262|NCT02908841|42255469|FG001|Overall Study|Physician Decision|0|||
19797263|NCT02909153|42255480|FG000|Overall Study|Withdrawal by Subject|0|||
19797264|NCT02909153|42255481|FG001|Overall Study|Withdrawal by Subject|1|||
19797265|NCT02909153|42255482|FG002|Overall Study|Withdrawal by Subject|0|||
19797266|NCT02909153|42255483|FG003|Overall Study|Withdrawal by Subject|0|||
19797267|NCT02909153|42255484|FG004|Overall Study|Withdrawal by Subject|0|||
19797268|NCT02908529|42255496|FG000|Overall Study|Lost to Follow-up|0|||
19797269|NCT02908529|42255497|FG001|Overall Study|Lost to Follow-up|2|||
19797270|NCT02984267|42255507|FG000|Overall Study|Protocol Violation|1|||
19797271|NCT02984267|42255508|FG001|Overall Study|Protocol Violation|0|||
19797272|NCT02984267|42255507|FG000|Overall Study|Withdrawal by Subject|0|||
19797273|NCT02984267|42255508|FG001|Overall Study|Withdrawal by Subject|1|||
19797274|NCT02675751|42255514|FG000|Overall Study|Lost to Follow-up|16|||
19797275|NCT02974855|42255531|FG000|Overall Study|Adverse Event|0|||
19797276|NCT02974855|42255532|FG001|Overall Study|Adverse Event|1|||
19797277|NCT02974855|42255533|FG002|Overall Study|Adverse Event|0|||
19797278|NCT02974855|42255534|FG003|Overall Study|Adverse Event|1|||
19797279|NCT00455403|42255559|FG000|Overall Study|Lost to Follow-up|2|||
19797280|NCT00455403|42255560|FG001|Overall Study|Lost to Follow-up|1|||
19797281|NCT00455403|42255559|FG000|Overall Study|Withdrawal by Subject|1|||
19797282|NCT00455403|42255560|FG001|Overall Study|Withdrawal by Subject|3|||
19797283|NCT00455403|42255559|FG000|Overall Study|Protocol Violation|0|||
19797284|NCT00455403|42255560|FG001|Overall Study|Protocol Violation|2|||
19797285|NCT02979613|42255568|FG000|Double-Blind Phase|Withdrew Consent|2|||
19797286|NCT02979613|42255569|FG001|Double-Blind Phase|Withdrew Consent|4|||
19797287|NCT02979613|42255568|FG000|Double-Blind Phase|Pregnancy|2|||
19797288|NCT02979613|42255569|FG001|Double-Blind Phase|Pregnancy|2|||
19797289|NCT02979613|42255568|FG000|Double-Blind Phase|Adverse Event|2|||
19797290|NCT02979613|42255569|FG001|Double-Blind Phase|Adverse Event|0|||
19797291|NCT02979613|42255568|FG000|Double-Blind Phase|Lost to Follow-up|1|||
19797292|NCT02979613|42255569|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19797293|NCT02979613|42255568|FG000|Double-Blind Phase|Protocol Violation|1|||
19797294|NCT02979613|42255569|FG001|Double-Blind Phase|Protocol Violation|1|||
19797295|NCT02979613|42255568|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
19797296|NCT02979613|42255569|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
19797297|NCT02979613|42255568|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
19797298|NCT02979613|42255569|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
19797299|NCT02979613|42255568|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
19797300|NCT02979613|42255569|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
19797301|NCT02979613|42255568|FG000|Open-Label Extension (OLE) Phase|Death|0|||
19797302|NCT02979613|42255569|FG001|Open-Label Extension (OLE) Phase|Death|1|||
19797303|NCT02979613|42255568|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
19797304|NCT02979613|42255569|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
19797305|NCT01064167|42255579|FG000|Overall Study|Protocol Violation|14|||
19797306|NCT01064167|42255580|FG001|Overall Study|Protocol Violation|15|||
19797307|NCT02974543|42255588|FG000|Overall Study|Withdrawal by Subject|1|||
19797308|NCT02974543|42255589|FG001|Overall Study|Withdrawal by Subject|0|||
19797309|NCT01064947|42255603|FG000|Overall Study|negative culture|41|||
19797310|NCT02974153|42255614|FG000|Overall Study|Adverse Event|6|||
19797311|NCT02974153|42255615|FG001|Overall Study|Adverse Event|0|||
19797312|NCT02974153|42255616|FG002|Overall Study|Adverse Event|1|||
19797313|NCT02974153|42255614|FG000|Overall Study|Lack of Efficacy|6|||
19797314|NCT02974153|42255615|FG001|Overall Study|Lack of Efficacy|5|||
19797315|NCT02974153|42255616|FG002|Overall Study|Lack of Efficacy|10|||
19797316|NCT02974153|42255614|FG000|Overall Study|Lost to Follow-up|9|||
19797317|NCT02974153|42255615|FG001|Overall Study|Lost to Follow-up|10|||
19797318|NCT02974153|42255616|FG002|Overall Study|Lost to Follow-up|17|||
19797319|NCT02974153|42255614|FG000|Overall Study|Physician Decision|0|||
19797320|NCT02974153|42255615|FG001|Overall Study|Physician Decision|2|||
19797321|NCT02974153|42255616|FG002|Overall Study|Physician Decision|1|||
19797322|NCT02974153|42255614|FG000|Overall Study|Withdrawal by Subject|9|||
19797323|NCT02974153|42255615|FG001|Overall Study|Withdrawal by Subject|16|||
19797324|NCT02974153|42255616|FG002|Overall Study|Withdrawal by Subject|11|||
19797325|NCT02974153|42255614|FG000|Overall Study|Study Burden|8|||
19797326|NCT02974153|42255615|FG001|Overall Study|Study Burden|7|||
19797327|NCT02974153|42255616|FG002|Overall Study|Study Burden|3|||
19797328|NCT02974153|42255614|FG000|Overall Study|Other|14|||
19797329|NCT02974153|42255615|FG001|Overall Study|Other|8|||
19797330|NCT02974153|42255616|FG002|Overall Study|Other|7|||
19797331|NCT02508532|42255631|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797332|NCT02508532|42255632|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797333|NCT02508532|42255633|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797334|NCT02508532|42255634|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797335|NCT02508532|42255635|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797336|NCT02508532|42255636|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797337|NCT02508532|42255637|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
19797338|NCT02508532|42255638|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797339|NCT02508532|42255639|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
19797340|NCT02508532|42255631|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797341|NCT02508532|42255632|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797342|NCT02508532|42255633|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797343|NCT02508532|42255634|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797344|NCT02508532|42255635|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797345|NCT02508532|42255636|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797346|NCT02508532|42255637|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797347|NCT02508532|42255638|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
19797348|NCT02508532|42255639|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
19797349|NCT02508532|42255631|FG000|Part 2 - Treatment|Disease Progression|0|||
19797350|NCT02508532|42255632|FG001|Part 2 - Treatment|Disease Progression|0|||
19797351|NCT02508532|42255633|FG002|Part 2 - Treatment|Disease Progression|0|||
19797352|NCT02508532|42255634|FG003|Part 2 - Treatment|Disease Progression|0|||
19797353|NCT02508532|42255635|FG004|Part 2 - Treatment|Disease Progression|0|||
19797354|NCT02508532|42255636|FG005|Part 2 - Treatment|Disease Progression|0|||
19797355|NCT02508532|42255637|FG006|Part 2 - Treatment|Disease Progression|0|||
19797356|NCT02508532|42255638|FG007|Part 2 - Treatment|Disease Progression|0|||
19797357|NCT02508532|42255639|FG008|Part 2 - Treatment|Disease Progression|118|||
19797358|NCT02508532|42255631|FG000|Part 2 - Treatment|Adverse Event|0|||
19797359|NCT02508532|42255632|FG001|Part 2 - Treatment|Adverse Event|0|||
19797360|NCT02508532|42255633|FG002|Part 2 - Treatment|Adverse Event|0|||
19797361|NCT02508532|42255634|FG003|Part 2 - Treatment|Adverse Event|0|||
19797362|NCT02508532|42255635|FG004|Part 2 - Treatment|Adverse Event|0|||
19797363|NCT02508532|42255636|FG005|Part 2 - Treatment|Adverse Event|0|||
19797364|NCT02508532|42255637|FG006|Part 2 - Treatment|Adverse Event|0|||
19797365|NCT02508532|42255638|FG007|Part 2 - Treatment|Adverse Event|0|||
19797366|NCT02508532|42255639|FG008|Part 2 - Treatment|Adverse Event|49|||
19797367|NCT02508532|42255631|FG000|Part 2 - Treatment|Physician Decision|0|||
19797368|NCT02508532|42255632|FG001|Part 2 - Treatment|Physician Decision|0|||
19797369|NCT02508532|42255633|FG002|Part 2 - Treatment|Physician Decision|0|||
19797370|NCT02508532|42255634|FG003|Part 2 - Treatment|Physician Decision|0|||
19797371|NCT02508532|42255635|FG004|Part 2 - Treatment|Physician Decision|0|||
19797372|NCT02508532|42255636|FG005|Part 2 - Treatment|Physician Decision|0|||
19797373|NCT02508532|42255637|FG006|Part 2 - Treatment|Physician Decision|0|||
19797374|NCT02508532|42255638|FG007|Part 2 - Treatment|Physician Decision|0|||
19797375|NCT02508532|42255639|FG008|Part 2 - Treatment|Physician Decision|12|||
19797376|NCT02508532|42255631|FG000|Part 2 - Treatment|Administrative|0|||
19797377|NCT02508532|42255632|FG001|Part 2 - Treatment|Administrative|0|||
19797378|NCT02508532|42255633|FG002|Part 2 - Treatment|Administrative|0|||
19797379|NCT02508532|42255634|FG003|Part 2 - Treatment|Administrative|0|||
19797380|NCT02508532|42255635|FG004|Part 2 - Treatment|Administrative|0|||
19797381|NCT02508532|42255636|FG005|Part 2 - Treatment|Administrative|0|||
19797382|NCT02508532|42255637|FG006|Part 2 - Treatment|Administrative|0|||
19797383|NCT02508532|42255638|FG007|Part 2 - Treatment|Administrative|0|||
19797384|NCT02508532|42255639|FG008|Part 2 - Treatment|Administrative|3|||
19797385|NCT02508532|42255631|FG000|Part 2 - Treatment|Sponsor Decision|0|||
19797386|NCT02508532|42255632|FG001|Part 2 - Treatment|Sponsor Decision|0|||
19797387|NCT02508532|42255633|FG002|Part 2 - Treatment|Sponsor Decision|0|||
19797388|NCT02508532|42255634|FG003|Part 2 - Treatment|Sponsor Decision|0|||
19797389|NCT02508532|42255635|FG004|Part 2 - Treatment|Sponsor Decision|0|||
19797390|NCT02508532|42255636|FG005|Part 2 - Treatment|Sponsor Decision|0|||
19797391|NCT02508532|42255637|FG006|Part 2 - Treatment|Sponsor Decision|0|||
19797392|NCT02508532|42255638|FG007|Part 2 - Treatment|Sponsor Decision|0|||
19797393|NCT02508532|42255639|FG008|Part 2 - Treatment|Sponsor Decision|28|||
19797394|NCT02508532|42255631|FG000|Part 2 - Treatment|Death|0|||
19797395|NCT02508532|42255632|FG001|Part 2 - Treatment|Death|0|||
19797396|NCT02508532|42255633|FG002|Part 2 - Treatment|Death|0|||
19797397|NCT02508532|42255634|FG003|Part 2 - Treatment|Death|0|||
19797398|NCT02508532|42255635|FG004|Part 2 - Treatment|Death|0|||
19797399|NCT02508532|42255636|FG005|Part 2 - Treatment|Death|0|||
19797400|NCT02508532|42255637|FG006|Part 2 - Treatment|Death|0|||
19797401|NCT02508532|42255638|FG007|Part 2 - Treatment|Death|0|||
19797402|NCT02508532|42255639|FG008|Part 2 - Treatment|Death|1|||
19797403|NCT02508532|42255631|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
19797404|NCT02508532|42255632|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
19797405|NCT02508532|42255633|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
19797406|NCT02508532|42255634|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
19797407|NCT02508532|42255635|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
19797408|NCT02508532|42255636|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
19797409|NCT02508532|42255637|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
19797410|NCT02508532|42255638|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
19797411|NCT02508532|42255639|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
19797412|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
19797413|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797414|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797415|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797416|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797417|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797418|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
19797419|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
19797420|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
19797421|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
19797422|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797423|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
19797424|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797425|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797426|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797427|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797428|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
19797429|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
19797430|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Death|0|||
19797431|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Death|4|||
19797432|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Death|2|||
19797433|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Death|4|||
19797434|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Death|3|||
19797435|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Death|0|||
19797436|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Death|0|||
19797437|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Death|1|||
19797438|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Death|111|||
19797439|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
19797440|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
19797441|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
19797442|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
19797443|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
19797444|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
19797445|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
19797446|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
19797447|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
19797448|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797449|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797450|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797451|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797452|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797453|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797454|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797455|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
19797456|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
19797457|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797458|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797459|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
19797460|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797461|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
19797462|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797463|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797464|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
19797465|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
19797466|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797467|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797468|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797469|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797470|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797471|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797472|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797473|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
19797474|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
19797475|NCT02508532|42255631|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
19797476|NCT02508532|42255632|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
19797477|NCT02508532|42255633|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
19797478|NCT02508532|42255634|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
19797479|NCT02508532|42255635|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
19797480|NCT02508532|42255636|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
19797481|NCT02508532|42255637|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
19797482|NCT02508532|42255638|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
19797483|NCT02508532|42255639|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
19797484|NCT02918071|42255668|FG000|Overall Study|Withdrawal by Subject|2|||
19797485|NCT02918071|42255668|FG000|Overall Study|Lost to Follow-up|1|||
19797486|NCT02507752|42255672|FG000|Overall Study|Adverse Event|1|||
19797487|NCT02507752|42255672|FG000|Overall Study|Protocol Violation|6|||
19797488|NCT02507752|42255672|FG000|Overall Study|Lost to Follow-up|7|||
19797489|NCT02507752|42255672|FG000|Overall Study|Infusion reaction at first infusion|1|||
19797490|NCT02507752|42255672|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
19797491|NCT02507752|42255672|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
19797492|NCT02506816|42255676|FG000|Overall Study|Adverse Event|3|||
19797493|NCT02506036|42255682|FG000|First Intervention (4-6 Weeks)|Death|1|||
19797494|NCT02506036|42255683|FG001|First Intervention (4-6 Weeks)|Death|0|||
19797495|NCT02506036|42255682|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
19797496|NCT02506036|42255683|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
19797497|NCT02506036|42255682|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
19797498|NCT02506036|42255683|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
19797499|NCT01063855|42255691|FG000|Overall Study|Adverse Event|4|||
19797500|NCT01063855|42255692|FG001|Overall Study|Adverse Event|4|||
19797501|NCT01063855|42255691|FG000|Overall Study|Death|0|||
19797502|NCT01063855|42255692|FG001|Overall Study|Death|1|||
19797503|NCT01063855|42255691|FG000|Overall Study|Lost to Follow-up|8|||
19797504|NCT01063855|42255692|FG001|Overall Study|Lost to Follow-up|4|||
19797505|NCT01063855|42255691|FG000|Overall Study|Pregnancy|1|||
19797506|NCT01063855|42255692|FG001|Overall Study|Pregnancy|0|||
19797507|NCT01063855|42255691|FG000|Overall Study|Lack of Efficacy|0|||
19797508|NCT01063855|42255692|FG001|Overall Study|Lack of Efficacy|1|||
19797509|NCT01063855|42255691|FG000|Overall Study|Withdrawal by Subject|11|||
19797510|NCT01063855|42255692|FG001|Overall Study|Withdrawal by Subject|8|||
19797511|NCT01063855|42255691|FG000|Overall Study|Reason not specified|13|||
19797512|NCT01063855|42255692|FG001|Overall Study|Reason not specified|11|||
19797513|NCT01063153|42255704|FG000|Overall Study|Found Ineligible During Screening|2|||
19797514|NCT01063153|42255705|FG001|Overall Study|Found Ineligible During Screening|0|||
19797515|NCT01063153|42255704|FG000|Overall Study|Lost to Follow-up|0|||
19797516|NCT01063153|42255705|FG001|Overall Study|Lost to Follow-up|7|||
19797517|NCT01063153|42255704|FG000|Overall Study|Withdrawal by Subject|0|||
19797518|NCT01063153|42255705|FG001|Overall Study|Withdrawal by Subject|1|||
19797519|NCT01063153|42255704|FG000|Overall Study|Physician Decision|0|||
19797520|NCT01063153|42255705|FG001|Overall Study|Physician Decision|4|||
19797521|NCT01062841|42255717|FG000|Overall Study|Indwelling Device Removed|41|||
19797522|NCT01062841|42255718|FG001|Overall Study|Indwelling Device Removed|48|||
19797523|NCT01062841|42255717|FG000|Overall Study|Death|3|||
19797524|NCT01062841|42255718|FG001|Overall Study|Death|5|||
19797525|NCT01062841|42255717|FG000|Overall Study|Withdrawal by Subject|2|||
19797526|NCT01062841|42255718|FG001|Overall Study|Withdrawal by Subject|0|||
19797527|NCT01062841|42255717|FG000|Overall Study|Withdrawal by Study|3|||
19797528|NCT01062841|42255718|FG001|Overall Study|Withdrawal by Study|0|||
19797529|NCT02505334|42255726|FG000|Main Treatment Period|Adverse Event|3|||
19797530|NCT02505334|42255727|FG001|Main Treatment Period|Adverse Event|3|||
19797531|NCT02505334|42255726|FG000|Main Treatment Period|Lack of Efficacy|7|||
19797532|NCT02505334|42255727|FG001|Main Treatment Period|Lack of Efficacy|17|||
19797533|NCT02505334|42255726|FG000|Main Treatment Period|Protocol Violation|0|||
19797534|NCT02505334|42255727|FG001|Main Treatment Period|Protocol Violation|1|||
19797535|NCT02505334|42255726|FG000|Main Treatment Period|Withdrawal by Subject|1|||
19797536|NCT02505334|42255727|FG001|Main Treatment Period|Withdrawal by Subject|8|||
19797537|NCT02505334|42255726|FG000|Main Treatment Period|Unclassified|4|||
19797538|NCT02505334|42255727|FG001|Main Treatment Period|Unclassified|10|||
19797539|NCT02505334|42255726|FG000|Extension Treatment Period|Adverse Event|5|||
19797540|NCT02505334|42255727|FG001|Extension Treatment Period|Adverse Event|0|||
19797541|NCT02505334|42255726|FG000|Extension Treatment Period|Lack of Efficacy|4|||
19797542|NCT02505334|42255727|FG001|Extension Treatment Period|Lack of Efficacy|0|||
19797543|NCT02505334|42255726|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
19797544|NCT02505334|42255727|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
19797545|NCT02505334|42255726|FG000|Extension Treatment Period|Unclassified|3|||
19797546|NCT02505334|42255727|FG001|Extension Treatment Period|Unclassified|0|||
19797547|NCT01062061|42255733|FG000|Overall Study|Enrolled more than once|2|||
19797548|NCT01062061|42255733|FG000|Overall Study|Investigated before study start|13|||
19797549|NCT01062061|42255733|FG000|Overall Study|Outside chief indications|10|||
19797550|NCT01062061|42255733|FG000|Overall Study|Failed to meet inclusion criteria|2|||
19797551|NCT02504320|42255745|FG000|Treatment Period 1|Positive Drug Screen|0|||
19797552|NCT02504320|42255746|FG001|Treatment Period 1|Positive Drug Screen|0|||
19797553|NCT02504320|42255747|FG002|Treatment Period 1|Positive Drug Screen|1|||
19797554|NCT02504320|42255748|FG003|Treatment Period 1|Positive Drug Screen|0|||
19797555|NCT02504320|42255745|FG000|Treatment Period 2|Positive Drug Screen|0|||
19797556|NCT02504320|42255746|FG001|Treatment Period 2|Positive Drug Screen|1|||
19797557|NCT02504320|42255747|FG002|Treatment Period 2|Positive Drug Screen|0|||
19797558|NCT02504320|42255748|FG003|Treatment Period 2|Positive Drug Screen|0|||
19797559|NCT02504320|42255745|FG000|Treatment Period 3|Positive Drug Screen|0|||
19797560|NCT02504320|42255746|FG001|Treatment Period 3|Positive Drug Screen|0|||
19797561|NCT02504320|42255747|FG002|Treatment Period 3|Positive Drug Screen|0|||
19797562|NCT02504320|42255748|FG003|Treatment Period 3|Positive Drug Screen|1|||
19797563|NCT02504320|42255745|FG000|Treatment Period 3|Adverse Event|0|||
19797564|NCT02504320|42255746|FG001|Treatment Period 3|Adverse Event|0|||
19797565|NCT02504320|42255747|FG002|Treatment Period 3|Adverse Event|1|||
19797566|NCT02504320|42255748|FG003|Treatment Period 3|Adverse Event|0|||
19797567|NCT01061671|42255760|FG000|Overall Study|Withdrawal by Subject|16|||
19797568|NCT01061671|42255761|FG001|Overall Study|Withdrawal by Subject|20|||
19797569|NCT01061671|42255760|FG000|Overall Study|Lost to Follow-up|3|||
19797570|NCT01061671|42255761|FG001|Overall Study|Lost to Follow-up|5|||
19797571|NCT01061671|42255760|FG000|Overall Study|Death|28|||
19797572|NCT01061671|42255761|FG001|Overall Study|Death|30|||
19797573|NCT00709995|42255769|FG000|Overall Study|Adverse Event|4|||
19797574|NCT00709995|42255770|FG001|Overall Study|Adverse Event|2|||
19797575|NCT00709995|42255769|FG000|Overall Study|Withdrawal by Subject|1|||
19797576|NCT00709995|42255770|FG001|Overall Study|Withdrawal by Subject|3|||
19797577|NCT02503540|42255779|FG000|Overall Study|Death|2|||
19797578|NCT02503540|42255779|FG000|Overall Study|Withdrawal by Subject|1|||
19797579|NCT02502526|42255786|FG000|Overall Study|Lost to Follow-up|2|||
19797580|NCT02502526|42255787|FG001|Overall Study|Lost to Follow-up|2|||
19797581|NCT02502526|42255788|FG002|Overall Study|Lost to Follow-up|3|||
19797582|NCT02502526|42255786|FG000|Overall Study|Withdrawal by Subject|0|||
19797583|NCT02502526|42255787|FG001|Overall Study|Withdrawal by Subject|1|||
19797584|NCT02502526|42255788|FG002|Overall Study|Withdrawal by Subject|1|||
19797585|NCT02502526|42255786|FG000|Overall Study|Disqualified due to cataract grading|0|||
19797586|NCT02502526|42255787|FG001|Overall Study|Disqualified due to cataract grading|0|||
19797587|NCT02502526|42255788|FG002|Overall Study|Disqualified due to cataract grading|1|||
19797588|NCT02502526|42255786|FG000|Overall Study|Enrollment suspension|4|||
19797589|NCT02502526|42255787|FG001|Overall Study|Enrollment suspension|1|||
19797590|NCT02502526|42255788|FG002|Overall Study|Enrollment suspension|1|||
19797591|NCT02972515|42255797|FG000|Overall Study|Lost to Follow-up|78|||
19797592|NCT02972359|42255801|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
19797593|NCT02972359|42255801|FG000|Overall Study|Lack of Efficacy|1|||
19797594|NCT02972359|42255801|FG000|Overall Study|Adverse Event|4|||
19797595|NCT02972359|42255801|FG000|Overall Study|Death|1|||
19797596|NCT02972359|42255801|FG000|Overall Study|Withdrawal by Subject|30|||
19797597|NCT02972359|42255801|FG000|Overall Study|Protocol Violation|1|||
19797598|NCT02972359|42255801|FG000|Overall Study|Lost to Follow-up|26|||
19797599|NCT02972359|42255801|FG000|Overall Study|Other reasons|5|||
19797600|NCT02972359|42255801|FG000|Overall Study|Missing|1|||
19797601|NCT01060111|42255808|FG000|Overall Study|Adverse Event|9|||
19797602|NCT01060111|42255809|FG001|Overall Study|Adverse Event|5|||
19797603|NCT01060111|42255810|FG002|Overall Study|Adverse Event|18|||
19797604|NCT01060111|42255808|FG000|Overall Study|Lack of Efficacy|2|||
19797605|NCT01060111|42255809|FG001|Overall Study|Lack of Efficacy|1|||
19797606|NCT01060111|42255810|FG002|Overall Study|Lack of Efficacy|0|||
19797607|NCT01060111|42255808|FG000|Overall Study|Inappropriate participant|5|||
19367544|NCT02842853|41607737|FG002|Overall Study|Non-compliance with the protocol|2|||
19608105|NCT00929708|42057004|FG001|Overall Study|Lost to Follow-up|0|||
19797608|NCT01060111|42255809|FG001|Overall Study|Inappropriate participant|4|||
19797609|NCT01060111|42255810|FG002|Overall Study|Inappropriate participant|5|||
19797610|NCT01060111|42255808|FG000|Overall Study|Participants' evasion for hospital visit|0|||
19797611|NCT01060111|42255809|FG001|Overall Study|Participants' evasion for hospital visit|3|||
19797612|NCT01060111|42255810|FG002|Overall Study|Participants' evasion for hospital visit|2|||
19797613|NCT01060111|42255808|FG000|Overall Study|Participants' non-cooperation|8|||
19797614|NCT01060111|42255809|FG001|Overall Study|Participants' non-cooperation|6|||
19797615|NCT01060111|42255810|FG002|Overall Study|Participants' non-cooperation|6|||
19797616|NCT01060111|42255808|FG000|Overall Study|Adverse event and insufficient effect|0|||
19797617|NCT01060111|42255809|FG001|Overall Study|Adverse event and insufficient effect|1|||
19797618|NCT01060111|42255810|FG002|Overall Study|Adverse event and insufficient effect|0|||
19797619|NCT01060111|42255808|FG000|Overall Study|Participants' non-cooperation|1|||
19797620|NCT01060111|42255809|FG001|Overall Study|Participants' non-cooperation|0|||
19797621|NCT01060111|42255810|FG002|Overall Study|Participants' non-cooperation|0|||
19797622|NCT01060111|42255808|FG000|Overall Study|Other|2|||
19797623|NCT01060111|42255809|FG001|Overall Study|Other|3|||
19797624|NCT01060111|42255810|FG002|Overall Study|Other|4|||
19797625|NCT02969863|42255821|FG000|Overall Study|Physician Decision|1|||
19797626|NCT02969863|42255822|FG001|Overall Study|Physician Decision|0|||
19797627|NCT02969863|42255823|FG002|Overall Study|Physician Decision|0|||
19797628|NCT02969863|42255824|FG003|Overall Study|Physician Decision|0|||
19797629|NCT02969863|42255825|FG004|Overall Study|Physician Decision|0|||
19608106|NCT00929708|42057005|FG002|Overall Study|Lost to Follow-up|0|||
19608107|NCT00929708|42057006|FG003|Overall Study|Lost to Follow-up|1|||
19608108|NCT00929708|42057007|FG004|Overall Study|Lost to Follow-up|0|||
19608109|NCT00996281|42057021|FG000|Overall Study|Adverse Event|75|||
19608110|NCT00996281|42057022|FG001|Overall Study|Adverse Event|37|||
19608111|NCT00996281|42057021|FG000|Overall Study|Major Protocol Deviation|6|||
19608112|NCT00996281|42057022|FG001|Overall Study|Major Protocol Deviation|7|||
19608113|NCT00996281|42057021|FG000|Overall Study|Lost to Follow-up|14|||
19608114|NCT00996281|42057022|FG001|Overall Study|Lost to Follow-up|16|||
19608115|NCT00996281|42057021|FG000|Overall Study|Withdrawal by Subject|31|||
19608116|NCT00996281|42057022|FG001|Overall Study|Withdrawal by Subject|20|||
19608117|NCT00996281|42057021|FG000|Overall Study|Lack of Efficacy|0|||
19608118|NCT00996281|42057022|FG001|Overall Study|Lack of Efficacy|2|||
19608119|NCT00996281|42057021|FG000|Overall Study|Other|5|||
19608120|NCT00996281|42057022|FG001|Overall Study|Other|7|||
19608121|NCT00996203|42057028|FG000|Overall Study|Adverse Event|3|||
19608122|NCT00996203|42057028|FG000|Overall Study|Lost to Follow-up|1|||
19608123|NCT00996203|42057028|FG000|Overall Study|Lack of Efficacy|1|||
19608124|NCT00996203|42057028|FG000|Overall Study|Protocol Violation|2|||
19608125|NCT00877929|42057035|FG000|Overall Study|Adverse Event|11|||
19608126|NCT00877929|42057036|FG001|Overall Study|Adverse Event|20|||
19608127|NCT00877929|42057035|FG000|Overall Study|Protocol Violation|3|||
19608128|NCT00877929|42057036|FG001|Overall Study|Protocol Violation|3|||
19608129|NCT00877929|42057035|FG000|Overall Study|Lost to Follow-up|0|||
19608130|NCT00877929|42057036|FG001|Overall Study|Lost to Follow-up|1|||
19608131|NCT00877929|42057035|FG000|Overall Study|Withdrawal by Subject|4|||
19608132|NCT00877929|42057036|FG001|Overall Study|Withdrawal by Subject|4|||
19608133|NCT00877929|42057035|FG000|Overall Study|Lack of Efficacy|0|||
19608134|NCT00877929|42057036|FG001|Overall Study|Lack of Efficacy|1|||
19608135|NCT00877929|42057035|FG000|Overall Study|Other reason (not specified)|2|||
19608136|NCT00877929|42057036|FG001|Overall Study|Other reason (not specified)|6|||
19608137|NCT00931268|42057046|FG000|Overall Study|Lost to Follow-up|6|||
19608138|NCT00996125|42057052|FG000|Overall Study|Adverse Event|0|||
19608139|NCT00996125|42057053|FG001|Overall Study|Adverse Event|2|||
19608140|NCT00996125|42057052|FG000|Overall Study|Lost to Follow-up|1|||
19608141|NCT00996125|42057053|FG001|Overall Study|Lost to Follow-up|6|||
19608142|NCT00996125|42057052|FG000|Overall Study|Withdrawal by Subject|4|||
19608143|NCT00996125|42057053|FG001|Overall Study|Withdrawal by Subject|3|||
19608144|NCT04211363|42057061|FG000|Overall Study|Adverse Event|5|||
19608145|NCT04211363|42057062|FG001|Overall Study|Adverse Event|2|||
19608146|NCT04211363|42057061|FG000|Overall Study|Physician Decision|0|||
19608147|NCT04211363|42057062|FG001|Overall Study|Physician Decision|1|||
19608148|NCT04211363|42057061|FG000|Overall Study|Protocol Violation|1|||
19608149|NCT04211363|42057062|FG001|Overall Study|Protocol Violation|0|||
19608150|NCT04211363|42057061|FG000|Overall Study|Pregnancy|1|||
19608151|NCT04211363|42057062|FG001|Overall Study|Pregnancy|0|||
19608152|NCT04211363|42057061|FG000|Overall Study|Lost to Follow-up|12|||
19608153|NCT04211363|42057062|FG001|Overall Study|Lost to Follow-up|4|||
19608154|NCT04211363|42057061|FG000|Overall Study|Withdrawal by Subject|11|||
19608155|NCT04211363|42057062|FG001|Overall Study|Withdrawal by Subject|11|||
19608156|NCT04211363|42057061|FG000|Overall Study|Other|1|||
19608157|NCT04211363|42057062|FG001|Overall Study|Other|2|||
19608158|NCT00995345|42057073|FG000|Overall Study|Withdrawal by Subject|4|||
19608159|NCT00995345|42057074|FG001|Overall Study|Withdrawal by Subject|2|||
19608160|NCT00995345|42057075|FG002|Overall Study|Withdrawal by Subject|1|||
19608161|NCT00995345|42057076|FG003|Overall Study|Withdrawal by Subject|3|||
19608162|NCT00995345|42057077|FG004|Overall Study|Withdrawal by Subject|1|||
19608163|NCT00995345|42057073|FG000|Overall Study|Adverse Event|3|||
19608164|NCT00995345|42057074|FG001|Overall Study|Adverse Event|1|||
19608165|NCT00995345|42057075|FG002|Overall Study|Adverse Event|2|||
19608166|NCT00995345|42057076|FG003|Overall Study|Adverse Event|0|||
19797630|NCT02969863|42255826|FG005|Overall Study|Physician Decision|0|||
19797631|NCT02969707|42255842|FG000|Overall Study|Adverse Event|1|||
19797632|NCT02969707|42255843|FG001|Overall Study|Adverse Event|2|||
19797633|NCT02969707|42255842|FG000|Overall Study|Lost to Follow-up|3|||
19797634|NCT02969707|42255843|FG001|Overall Study|Lost to Follow-up|0|||
19797635|NCT02969707|42255842|FG000|Overall Study|Physician Decision|0|||
19797636|NCT02969707|42255843|FG001|Overall Study|Physician Decision|1|||
19797637|NCT02969707|42255842|FG000|Overall Study|Protocol Violation|1|||
19797638|NCT02969707|42255843|FG001|Overall Study|Protocol Violation|1|||
19797639|NCT02969707|42255842|FG000|Overall Study|Withdrawal by Subject|3|||
19797640|NCT02969707|42255843|FG001|Overall Study|Withdrawal by Subject|4|||
19797641|NCT02967055|42255854|FG000|Overall Study|Excluded|40|||
19797642|NCT02967055|42255854|FG000|Overall Study|Screen fail|3|||
19797643|NCT02967055|42255854|FG000|Overall Study|Lost to Follow-up|2|||
19797644|NCT02967055|42255854|FG000|Overall Study|Stopped due to side effects|3|||
19797645|NCT02967055|42255854|FG000|Overall Study|Stopped due to drug cost|1|||
19797646|NCT02904265|42255860|FG000|Overall Study|Physician Decision|1|||
19797647|NCT02904265|42255861|FG001|Overall Study|Physician Decision|2|||
19797648|NCT03461211|42255869|FG000|Overall Study|Adverse Event|1|||
19797649|NCT03461211|42255870|FG001|Overall Study|Adverse Event|1|||
19797650|NCT03461211|42255869|FG000|Overall Study|Lack of Efficacy|0|||
19797651|NCT03461211|42255870|FG001|Overall Study|Lack of Efficacy|1|||
19797652|NCT02967679|42255878|FG000|Overall Study|Adverse Event|1|||
19797653|NCT02966509|42255888|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
19797654|NCT02966509|42255889|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
19797655|NCT02966509|42255888|FG000|Baseline Satisfaction Survey|Death|0|||
19797656|NCT02966509|42255889|FG001|Baseline Satisfaction Survey|Death|1|||
19797657|NCT02966509|42255888|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
19797658|NCT02966509|42255889|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
19797659|NCT02966509|42255888|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
19797660|NCT02966509|42255889|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
19797661|NCT02966509|42255888|FG000|6 Month Satisfaction Decision Survey|Death|22|||
19797662|NCT02966509|42255889|FG001|6 Month Satisfaction Decision Survey|Death|25|||
19797663|NCT02966509|42255888|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
19797664|NCT02966509|42255889|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
19797665|NCT02966509|42255888|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
19797666|NCT02966509|42255889|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
19797667|NCT02966509|42255888|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
19797668|NCT02966509|42255889|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
19797669|NCT02966509|42255888|FG000|6 Month Satisfaction Survey|Death|36|||
19797670|NCT02966509|42255889|FG001|6 Month Satisfaction Survey|Death|33|||
19797671|NCT02966509|42255888|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
19797672|NCT02966509|42255889|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
19797673|NCT02966509|42255888|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
19797674|NCT02966509|42255889|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
19797675|NCT02966509|42255888|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
19797676|NCT02966509|42255889|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
19797677|NCT02966509|42255888|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
19797678|NCT02966509|42255889|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
19797679|NCT02966509|42255888|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
19797680|NCT02966509|42255889|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
19797681|NCT02966353|42255895|FG000|Overall Study|Withdrawal by Subject|7|||
19797682|NCT02966353|42255895|FG000|Overall Study|Adverse Event|4|||
19797683|NCT02966353|42255895|FG000|Overall Study|Death|4|||
19797684|NCT02966353|42255895|FG000|Overall Study|Physician Decision|3|||
19797685|NCT02966353|42255895|FG000|Overall Study|Progressive disease|2|||
19797686|NCT02966353|42255895|FG000|Overall Study|Protocol deviation|2|||
19797687|NCT02965573|42255928|FG000|Overall Study|Lack of Efficacy|1|||
19797688|NCT02965573|42255929|FG001|Overall Study|Lack of Efficacy|0|||
19797689|NCT02964325|42255937|FG000|Overall Study|Lost to Follow-up|3|||
19797690|NCT02964325|42255938|FG001|Overall Study|Lost to Follow-up|3|||
19797691|NCT02964325|42255937|FG000|Overall Study|Physician Decision|5|||
19797692|NCT02964325|42255938|FG001|Overall Study|Physician Decision|4|||
19797693|NCT02964325|42255937|FG000|Overall Study|Death|1|||
19797694|NCT02964325|42255938|FG001|Overall Study|Death|3|||
19797695|NCT02964325|42255937|FG000|Overall Study|Withdrawal by Subject|2|||
19797696|NCT02964325|42255938|FG001|Overall Study|Withdrawal by Subject|1|||
19797697|NCT02964325|42255937|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
19797698|NCT02964325|42255938|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
19797699|NCT02964247|42255946|FG000|Overall Study|Lost to Follow-up|2|||
19797700|NCT02964247|42255947|FG001|Overall Study|Lost to Follow-up|0|||
19797701|NCT02964247|42255946|FG000|Overall Study|Withdrawal by Subject|1|||
19797702|NCT02964247|42255947|FG001|Overall Study|Withdrawal by Subject|2|||
19797703|NCT03654729|42255956|FG000|Overall Study|Death|9|||
19797704|NCT03654729|42255957|FG001|Overall Study|Death|9|||
19797705|NCT03654729|42255958|FG002|Overall Study|Death|16|||
19797706|NCT03654729|42255956|FG000|Overall Study|Withdrawal by Subject|8|||
19797707|NCT03654729|42255957|FG001|Overall Study|Withdrawal by Subject|6|||
19797708|NCT03654729|42255958|FG002|Overall Study|Withdrawal by Subject|4|||
19797709|NCT03654729|42255956|FG000|Overall Study|Study terminated by Sponsor|3|||
19797710|NCT03654729|42255957|FG001|Overall Study|Study terminated by Sponsor|5|||
19797711|NCT03654729|42255958|FG002|Overall Study|Study terminated by Sponsor|4|||
19797712|NCT03654729|42255956|FG000|Overall Study|Not reported|2|||
19797713|NCT03654729|42255957|FG001|Overall Study|Not reported|4|||
19797714|NCT03654729|42255958|FG002|Overall Study|Not reported|5|||
19797715|NCT03654729|42255956|FG000|Overall Study|Progressive disease|3|||
19797716|NCT03654729|42255957|FG001|Overall Study|Progressive disease|0|||
19797717|NCT03654729|42255958|FG002|Overall Study|Progressive disease|0|||
19797718|NCT03654729|42255956|FG000|Overall Study|Lost to Follow-up|2|||
19797719|NCT03654729|42255957|FG001|Overall Study|Lost to Follow-up|0|||
19797720|NCT03654729|42255958|FG002|Overall Study|Lost to Follow-up|0|||
19797721|NCT03654729|42255956|FG000|Overall Study|Physician Decision|2|||
19797722|NCT03654729|42255957|FG001|Overall Study|Physician Decision|0|||
19797723|NCT03654729|42255958|FG002|Overall Study|Physician Decision|0|||
19797724|NCT03654729|42255956|FG000|Overall Study|Protocol Violation|1|||
19797725|NCT03654729|42255957|FG001|Overall Study|Protocol Violation|1|||
19797726|NCT03654729|42255958|FG002|Overall Study|Protocol Violation|0|||
19797727|NCT03654729|42255956|FG000|Overall Study|Non-compliance with study drug|0|||
19797728|NCT03654729|42255957|FG001|Overall Study|Non-compliance with study drug|1|||
19797729|NCT03654729|42255958|FG002|Overall Study|Non-compliance with study drug|0|||
19797730|NCT03654729|42255956|FG000|Overall Study|Site terminated by Sponsor|1|||
19797731|NCT03654729|42255957|FG001|Overall Study|Site terminated by Sponsor|0|||
19797732|NCT03654729|42255958|FG002|Overall Study|Site terminated by Sponsor|0|||
19797733|NCT01377987|42255966|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
19797734|NCT01377987|42255967|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
19797735|NCT02898259|42255978|FG000|Overall Study|Adverse Event|0|||
19797736|NCT02898259|42255979|FG001|Overall Study|Adverse Event|0|||
19797737|NCT02898259|42255980|FG002|Overall Study|Adverse Event|1|||
19797738|NCT02898259|42255981|FG003|Overall Study|Adverse Event|0|||
19797739|NCT02898259|42255982|FG004|Overall Study|Adverse Event|0|||
19797740|NCT02898259|42255978|FG000|Overall Study|Lack of Efficacy|1|||
19477925|NCT01468181|41757275|FG000|Overall Study|Withdrawal by Subject|0|||
19477926|NCT01468181|41757276|FG001|Overall Study|Withdrawal by Subject|1|||
19797741|NCT02898259|42255979|FG001|Overall Study|Lack of Efficacy|1|||
19797742|NCT02898259|42255980|FG002|Overall Study|Lack of Efficacy|3|||
19797743|NCT02898259|42255981|FG003|Overall Study|Lack of Efficacy|0|||
19797744|NCT02898259|42255982|FG004|Overall Study|Lack of Efficacy|0|||
19797745|NCT02898259|42255978|FG000|Overall Study|Lost to Follow-up|0|||
19797746|NCT02898259|42255979|FG001|Overall Study|Lost to Follow-up|0|||
19797747|NCT02898259|42255980|FG002|Overall Study|Lost to Follow-up|1|||
19797748|NCT02898259|42255981|FG003|Overall Study|Lost to Follow-up|0|||
19797749|NCT02898259|42255982|FG004|Overall Study|Lost to Follow-up|0|||
19797750|NCT02898259|42255978|FG000|Overall Study|Transformation before study began|0|||
19797751|NCT02898259|42255979|FG001|Overall Study|Transformation before study began|0|||
19797752|NCT02898259|42255980|FG002|Overall Study|Transformation before study began|0|||
19797753|NCT02898259|42255981|FG003|Overall Study|Transformation before study began|1|||
19797754|NCT02898259|42255982|FG004|Overall Study|Transformation before study began|0|||
19797755|NCT02963935|42255997|FG000|Overall Study|Adverse Event|12|||
19797756|NCT02963935|42255998|FG001|Overall Study|Adverse Event|6|||
19797757|NCT02963935|42255997|FG000|Overall Study|Protocol Violation|2|||
19797758|NCT02963935|42255998|FG001|Overall Study|Protocol Violation|1|||
19797759|NCT02963935|42255997|FG000|Overall Study|Lack of Efficacy|0|||
19797760|NCT02963935|42255998|FG001|Overall Study|Lack of Efficacy|2|||
19797761|NCT02963935|42255997|FG000|Overall Study|Lost to Follow-up|1|||
19797762|NCT02963935|42255998|FG001|Overall Study|Lost to Follow-up|6|||
19797763|NCT02963935|42255997|FG000|Overall Study|Unclassified|13|||
19797764|NCT02963935|42255998|FG001|Overall Study|Unclassified|22|||
19797765|NCT02899195|42256004|FG000|Concurrent Durvalumab|Adverse Event|4|||
19797766|NCT02899195|42256004|FG000|Concurrent Durvalumab|Physician Decision|1|||
19797767|NCT02899195|42256004|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
19797768|NCT02899195|42256004|FG000|Concurrent Durvalumab|Progressive Disease|5|||
19797769|NCT02899195|42256004|FG000|Maintenance Durvalumab|Adverse Event|1|||
19797770|NCT02899195|42256004|FG000|Maintenance Durvalumab|Physician Decision|1|||
19797771|NCT02899195|42256004|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
19797772|NCT02899195|42256004|FG000|Maintenance Durvalumab|Progressive Disease|31|||
19797773|NCT02963701|42256010|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
19797774|NCT02963701|42256011|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
19797775|NCT01345591|42256017|FG000|Overall Study|Lost to Follow-up|1|||
19797776|NCT02961751|42256026|FG000|Overall Study|Lost to Follow-up|11|||
19797777|NCT02961751|42256026|FG000|Overall Study|Physician Decision|2|||
19797778|NCT02961751|42256026|FG000|Overall Study|Not Eligible at Enrollment|1|||
19797779|NCT02961751|42256026|FG000|Overall Study|Protocol Violation|1|||
19797780|NCT02963311|42256030|FG000|Overall Study|Withdrawal by Subject|1|||
19797781|NCT02963311|42256030|FG000|Overall Study|Screen Failure|4|||
19797782|NCT02962765|42256034|FG000|Overall Study|Protocol Violation|9|||
19797783|NCT02962765|42256034|FG000|Overall Study|Withdrawal by Subject|3|||
19797784|NCT02962765|42256034|FG000|Overall Study|Lost to Follow-up|1|||
19797785|NCT02962765|42256034|FG000|Overall Study|Death|1|||
19797786|NCT02962765|42256034|FG000|Overall Study|Limited access to study medication|3|||
19797787|NCT02362035|42256045|FG000|Overall Study|Death|67|||
19797788|NCT02362035|42256045|FG000|Overall Study|Lost to Follow-up|3|||
19797789|NCT02362035|42256045|FG000|Overall Study|Adverse Event|1|||
19797790|NCT02362035|42256045|FG000|Overall Study|Physician Decision|1|||
19797791|NCT02362035|42256045|FG000|Overall Study|Subject started another cancer therapy|10|||
19797792|NCT02362035|42256045|FG000|Overall Study|Study terminated by sponsor|45|||
19797793|NCT02362035|42256045|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
19797794|NCT02362035|42256045|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
19797795|NCT02362035|42256045|FG000|Overall Study|Disease progression|11|||
19797796|NCT02362035|42256045|FG000|Overall Study|Withdrawal by Subject|20|||
19799458|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
19799459|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
19799460|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
19799461|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
19799462|NCT01345253|42257529|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
19799463|NCT01345253|42257530|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
19799464|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
19799465|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
19799466|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
19799467|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
19799468|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
19799469|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
19799470|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
19799471|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
19799472|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
19799473|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
19799474|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
19799475|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
19799476|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
19799477|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
19799478|NCT01345253|42257529|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
19799479|NCT01345253|42257530|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
19608167|NCT00995345|42057077|FG004|Overall Study|Adverse Event|1|||
19608168|NCT00995345|42057073|FG000|Overall Study|Lost to Follow-up|2|||
19608169|NCT00995345|42057074|FG001|Overall Study|Lost to Follow-up|2|||
19608170|NCT00995345|42057075|FG002|Overall Study|Lost to Follow-up|2|||
19608171|NCT00995345|42057076|FG003|Overall Study|Lost to Follow-up|1|||
19608172|NCT00995345|42057077|FG004|Overall Study|Lost to Follow-up|0|||
19608173|NCT00995345|42057073|FG000|Overall Study|all other reasons combined|2|||
19608174|NCT00995345|42057074|FG001|Overall Study|all other reasons combined|2|||
19608175|NCT00995345|42057075|FG002|Overall Study|all other reasons combined|2|||
19608176|NCT00995345|42057076|FG003|Overall Study|all other reasons combined|1|||
19608177|NCT00995345|42057077|FG004|Overall Study|all other reasons combined|3|||
19608178|NCT00660907|42057091|FG000|Overall Study|Incorrect Enrollment|1|||
19608179|NCT00660907|42057092|FG001|Overall Study|Incorrect Enrollment|1|||
19608180|NCT00660907|42057091|FG000|Overall Study|Adverse Event|33|||
19608181|NCT00660907|42057092|FG001|Overall Study|Adverse Event|19|||
19608182|NCT00660907|42057091|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
19608183|NCT00660907|42057092|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
19608184|NCT00660907|42057091|FG000|Overall Study|Withdrawal by Subject|23|||
19608185|NCT00660907|42057092|FG001|Overall Study|Withdrawal by Subject|32|||
19608186|NCT00660907|42057091|FG000|Overall Study|Lost to Follow-up|3|||
19608187|NCT00660907|42057092|FG001|Overall Study|Lost to Follow-up|3|||
19608188|NCT00660907|42057091|FG000|Overall Study|Poor/Non-Compliance|5|||
19608189|NCT00660907|42057092|FG001|Overall Study|Poor/Non-Compliance|1|||
19608190|NCT00660907|42057091|FG000|Overall Study|Safety|1|||
19608191|NCT00660907|42057092|FG001|Overall Study|Safety|0|||
19608192|NCT00660907|42057091|FG000|Overall Study|Death|1|||
19608193|NCT00660907|42057092|FG001|Overall Study|Death|3|||
19608194|NCT00660907|42057091|FG000|Overall Study|Various|11|||
19608195|NCT00660907|42057092|FG001|Overall Study|Various|8|||
19608196|NCT00877773|42057098|FG000|Overall Study|Disease Progression|44|||
19608197|NCT00659815|42057104|FG000|Overall Study|Study related symptoms and complaints|2|||
19608198|NCT00659815|42057105|FG001|Overall Study|Study related symptoms and complaints|1|||
19608199|NCT00659815|42057104|FG000|Overall Study|Inability to maintain wearing schedule|1|||
19608200|NCT00659815|42057105|FG001|Overall Study|Inability to maintain wearing schedule|2|||
19608201|NCT00659815|42057104|FG000|Overall Study|Withdrawal by Subject|1|||
19608202|NCT00659815|42057105|FG001|Overall Study|Withdrawal by Subject|1|||
19608203|NCT00994643|42057111|FG000|Overall Study|Withdrawal by Subject|1|||
19799480|NCT02958527|42257538|FG000|Overall Study|Not collected CRFs|12|||
19797797|NCT00965757|42256051|FG000|Double-blind Phase|Progression of concomitant disease|1|||
19797798|NCT00965757|42256052|FG001|Double-blind Phase|Progression of concomitant disease|2|||
19797799|NCT00965757|42256053|FG002|Double-blind Phase|Progression of concomitant disease|0|||
19797800|NCT00965757|42256054|FG003|Double-blind Phase|Progression of concomitant disease|0|||
19797801|NCT00965757|42256051|FG000|Double-blind Phase|Adverse drug reaction|2|||
19797802|NCT00965757|42256052|FG001|Double-blind Phase|Adverse drug reaction|1|||
19367545|NCT02842853|41607738|FG003|Overall Study|Non-compliance with the protocol|5|||
19797803|NCT00965757|42256053|FG002|Double-blind Phase|Adverse drug reaction|0|||
19797804|NCT00965757|42256054|FG003|Double-blind Phase|Adverse drug reaction|0|||
19797805|NCT00965757|42256051|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
19797806|NCT00965757|42256052|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
19797807|NCT00965757|42256053|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
19797808|NCT00965757|42256054|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
19797809|NCT00965757|42256051|FG000|Double-blind Phase|Lack of Efficacy|7|||
19797810|NCT00965757|42256052|FG001|Double-blind Phase|Lack of Efficacy|11|||
19797811|NCT00965757|42256053|FG002|Double-blind Phase|Lack of Efficacy|0|||
19797812|NCT00965757|42256054|FG003|Double-blind Phase|Lack of Efficacy|0|||
19797813|NCT00965757|42256051|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
19797814|NCT00965757|42256052|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
19797815|NCT00965757|42256053|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
19797816|NCT00965757|42256054|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
19797817|NCT00965757|42256051|FG000|Double-blind Phase|Lost to Follow-up|0|||
19797818|NCT00965757|42256052|FG001|Double-blind Phase|Lost to Follow-up|1|||
19797819|NCT00965757|42256053|FG002|Double-blind Phase|Lost to Follow-up|0|||
19797820|NCT00965757|42256054|FG003|Double-blind Phase|Lost to Follow-up|0|||
19797821|NCT00965757|42256051|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
19797822|NCT00965757|42256052|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
19367546|NCT02842853|41607735|FG000|Overall Study|Subject met exclusion criteria|0|||
19367547|NCT02842853|41607736|FG001|Overall Study|Subject met exclusion criteria|1|||
19367548|NCT02842853|41607737|FG002|Overall Study|Subject met exclusion criteria|0|||
19367549|NCT02842853|41607738|FG003|Overall Study|Subject met exclusion criteria|0|||
19367550|NCT02842853|41607735|FG000|Overall Study|Withdrawal by Subject|11|||
19367551|NCT02842853|41607736|FG001|Overall Study|Withdrawal by Subject|13|||
19367552|NCT02842853|41607737|FG002|Overall Study|Withdrawal by Subject|9|||
19367553|NCT02842853|41607738|FG003|Overall Study|Withdrawal by Subject|8|||
19367554|NCT02842853|41607735|FG000|Overall Study|Lost to Follow-up|9|||
19367555|NCT02842853|41607736|FG001|Overall Study|Lost to Follow-up|13|||
19367556|NCT02842853|41607737|FG002|Overall Study|Lost to Follow-up|10|||
19367557|NCT02842853|41607738|FG003|Overall Study|Lost to Follow-up|11|||
19367558|NCT02433340|41607754|FG000|Overall Study|Adverse Event|0|||
19367559|NCT02433340|41607755|FG001|Overall Study|Adverse Event|0|||
19367560|NCT02433340|41607756|FG002|Overall Study|Adverse Event|1|||
19797823|NCT00965757|42256053|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
19797824|NCT00965757|42256054|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
19797825|NCT00965757|42256051|FG000|Double-blind Phase|Other|1|||
19797826|NCT00965757|42256052|FG001|Double-blind Phase|Other|0|||
19608204|NCT00660829|42057117|FG000|Overall Study|Adverse Event|3|||
19608205|NCT00660829|42057118|FG001|Overall Study|Adverse Event|4|||
19608206|NCT00660829|42057117|FG000|Overall Study|Lack of Efficacy|2|||
19608207|NCT00660829|42057118|FG001|Overall Study|Lack of Efficacy|3|||
19608208|NCT00660829|42057117|FG000|Overall Study|Non-Compliance|0|||
19608209|NCT00660829|42057118|FG001|Overall Study|Non-Compliance|4|||
19608210|NCT00660829|42057117|FG000|Overall Study|Withdrawal by Subject|1|||
19608211|NCT00660829|42057118|FG001|Overall Study|Withdrawal by Subject|2|||
19608212|NCT00660829|42057117|FG000|Overall Study|Lost to Follow-up|3|||
19608213|NCT00660829|42057118|FG001|Overall Study|Lost to Follow-up|2|||
19608214|NCT00660829|42057117|FG000|Overall Study|Other|9|||
19608215|NCT00660829|42057118|FG001|Overall Study|Other|4|||
19608216|NCT00877383|42057126|FG000|Overall Study|Adverse Event|13|||
19608217|NCT00877383|42057127|FG001|Overall Study|Adverse Event|14|||
19608218|NCT00877383|42057126|FG000|Overall Study|Lost to Follow-up|5|||
19608219|NCT00877383|42057127|FG001|Overall Study|Lost to Follow-up|3|||
19608220|NCT00877383|42057126|FG000|Overall Study|Subject withdrew consent|3|||
19608221|NCT00877383|42057127|FG001|Overall Study|Subject withdrew consent|12|||
19608222|NCT00877383|42057126|FG000|Overall Study|Subject no longer requires study drug|2|||
19608223|NCT00877383|42057127|FG001|Overall Study|Subject no longer requires study drug|0|||
19608224|NCT00877383|42057126|FG000|Overall Study|Administrative problems|2|||
19608225|NCT00877383|42057127|FG001|Overall Study|Administrative problems|0|||
19797827|NCT00965757|42256053|FG002|Double-blind Phase|Other|0|||
19367561|NCT02433340|41607757|FG003|Overall Study|Adverse Event|0|||
19367562|NCT02433340|41607754|FG000|Overall Study|Withdrawal by Subject|1|||
19367563|NCT02433340|41607755|FG001|Overall Study|Withdrawal by Subject|0|||
19608226|NCT00877383|42057126|FG000|Overall Study|Protocol deviation|2|||
19608227|NCT00877383|42057127|FG001|Overall Study|Protocol deviation|6|||
19797828|NCT00965757|42256054|FG003|Double-blind Phase|Other|0|||
19797829|NCT00965757|42256051|FG000|Extension Phase|Progression of concomitant disease|0|||
19797830|NCT00965757|42256052|FG001|Extension Phase|Progression of concomitant disease|0|||
19797831|NCT00965757|42256053|FG002|Extension Phase|Progression of concomitant disease|4|||
19797832|NCT00965757|42256054|FG003|Extension Phase|Progression of concomitant disease|2|||
19797833|NCT00965757|42256051|FG000|Extension Phase|Adverse drug reaction|0|||
19797834|NCT00965757|42256052|FG001|Extension Phase|Adverse drug reaction|0|||
19797835|NCT00965757|42256053|FG002|Extension Phase|Adverse drug reaction|6|||
19797836|NCT00965757|42256054|FG003|Extension Phase|Adverse drug reaction|3|||
19797837|NCT00965757|42256051|FG000|Extension Phase|Abnormal Laboratory Value|0|||
19797838|NCT00965757|42256052|FG001|Extension Phase|Abnormal Laboratory Value|0|||
19797839|NCT00965757|42256053|FG002|Extension Phase|Abnormal Laboratory Value|6|||
19797840|NCT00965757|42256054|FG003|Extension Phase|Abnormal Laboratory Value|1|||
19797841|NCT00965757|42256051|FG000|Extension Phase|Lack of Efficacy|0|||
19797842|NCT00965757|42256052|FG001|Extension Phase|Lack of Efficacy|0|||
19797843|NCT00965757|42256053|FG002|Extension Phase|Lack of Efficacy|8|||
19797844|NCT00965757|42256054|FG003|Extension Phase|Lack of Efficacy|12|||
19797845|NCT00965757|42256051|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
19797846|NCT00965757|42256052|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
19797847|NCT00965757|42256053|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
19797848|NCT00965757|42256054|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
19797849|NCT00965757|42256051|FG000|Extension Phase|Lost to Follow-up|0|||
19797850|NCT00965757|42256052|FG001|Extension Phase|Lost to Follow-up|0|||
19797851|NCT00965757|42256053|FG002|Extension Phase|Lost to Follow-up|0|||
19797852|NCT00965757|42256054|FG003|Extension Phase|Lost to Follow-up|1|||
19797853|NCT00965757|42256051|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
19797854|NCT00965757|42256052|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
19797855|NCT00965757|42256053|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
19797856|NCT00965757|42256054|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
19797857|NCT00965757|42256051|FG000|Extension Phase|Protocol Violation|0|||
19797858|NCT00965757|42256052|FG001|Extension Phase|Protocol Violation|0|||
19797859|NCT00965757|42256053|FG002|Extension Phase|Protocol Violation|0|||
19797860|NCT00965757|42256054|FG003|Extension Phase|Protocol Violation|1|||
19797861|NCT00965757|42256051|FG000|Extension Phase|Other|0|||
19797862|NCT00965757|42256052|FG001|Extension Phase|Other|0|||
19797863|NCT00965757|42256053|FG002|Extension Phase|Other|2|||
19797864|NCT00965757|42256054|FG003|Extension Phase|Other|1|||
19797865|NCT03072459|42256062|FG000|Overall Study|Device revised/removed|1|||
19797866|NCT03072459|42256062|FG000|Overall Study|Subject not able to return|1|||
19797867|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
19797868|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
19797869|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
19797870|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
19797871|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
19797872|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
19797873|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
19797874|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
19797875|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
19797876|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
19797877|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
19797878|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
19797879|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
19797880|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
19797881|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
19797882|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
19797883|NCT01067521|42256068|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
19797884|NCT01067521|42256069|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
19797885|NCT01067521|42256068|FG000|Open-Label Period|Death|3|||
19797886|NCT01067521|42256069|FG001|Open-Label Period|Death|1|||
19797887|NCT01067521|42256068|FG000|Open-Label Period|Adverse Event|30|||
19797888|NCT01067521|42256069|FG001|Open-Label Period|Adverse Event|28|||
19797889|NCT01067521|42256068|FG000|Open-Label Period|Withdrawal by Subject|160|||
19797890|NCT01067521|42256069|FG001|Open-Label Period|Withdrawal by Subject|88|||
19608228|NCT00877383|42057126|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19608229|NCT00877383|42057127|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19797891|NCT01067521|42256068|FG000|Open-Label Period|Physician Decision|13|||
19797892|NCT01067521|42256069|FG001|Open-Label Period|Physician Decision|11|||
19797893|NCT01067521|42256068|FG000|Open-Label Period|Non-compliance with study drug|5|||
19797894|NCT01067521|42256069|FG001|Open-Label Period|Non-compliance with study drug|0|||
19797895|NCT01067521|42256068|FG000|Open-Label Period|Protocol Violation|3|||
19797896|NCT01067521|42256069|FG001|Open-Label Period|Protocol Violation|0|||
19797897|NCT01067521|42256068|FG000|Open-Label Period|Pregnancy|14|||
19797898|NCT01067521|42256069|FG001|Open-Label Period|Pregnancy|8|||
19797899|NCT01067521|42256068|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
19797900|NCT01067521|42256069|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
19797901|NCT01067521|42256068|FG000|Open-Label Period|Lost to Follow-up|21|||
19797902|NCT01067521|42256069|FG001|Open-Label Period|Lost to Follow-up|20|||
19797903|NCT02735577|42256080|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
19797904|NCT02735577|42256080|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
19797905|NCT01345123|42256087|FG000|Overall Study|participants no longer with health plan|79|||
19797906|NCT01345123|42256088|FG001|Overall Study|participants no longer with health plan|85|||
19797907|NCT01345123|42256089|FG002|Overall Study|participants no longer with health plan|88|||
19797908|NCT02735421|42256098|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
19797909|NCT02735421|42256098|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
19797910|NCT02735421|42256098|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
19797911|NCT02735421|42256098|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
19797912|NCT02735421|42256098|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
19797913|NCT02735421|42256098|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
19797914|NCT02735421|42256098|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
19797915|NCT02983799|42256115|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
19797916|NCT02983799|42256116|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
19797917|NCT02983799|42256117|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
19797918|NCT02983799|42256118|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
19797919|NCT02983799|42256119|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
19797920|NCT02983799|42256115|FG000|Overall Study|Death|20|||
19797921|NCT02983799|42256116|FG001|Overall Study|Death|5|||
19797922|NCT02983799|42256117|FG002|Overall Study|Death|23|||
19797923|NCT02983799|42256118|FG003|Overall Study|Death|47|||
19797924|NCT02983799|42256119|FG004|Overall Study|Death|7|||
19797925|NCT02983799|42256115|FG000|Overall Study|Withdrawal by Subject|1|||
19797926|NCT02983799|42256116|FG001|Overall Study|Withdrawal by Subject|0|||
19797927|NCT02983799|42256117|FG002|Overall Study|Withdrawal by Subject|3|||
19797928|NCT02983799|42256118|FG003|Overall Study|Withdrawal by Subject|4|||
19797929|NCT02983799|42256119|FG004|Overall Study|Withdrawal by Subject|1|||
19797930|NCT02983799|42256115|FG000|Overall Study|Protocol Violation|0|||
19797931|NCT02983799|42256116|FG001|Overall Study|Protocol Violation|1|||
19797932|NCT02983799|42256117|FG002|Overall Study|Protocol Violation|0|||
19797933|NCT02983799|42256118|FG003|Overall Study|Protocol Violation|0|||
19797934|NCT02983799|42256119|FG004|Overall Study|Protocol Violation|1|||
19797935|NCT02983799|42256115|FG000|Overall Study|Lost to Follow-up|1|||
19797936|NCT02983799|42256116|FG001|Overall Study|Lost to Follow-up|0|||
19797937|NCT02983799|42256117|FG002|Overall Study|Lost to Follow-up|1|||
19797938|NCT02983799|42256118|FG003|Overall Study|Lost to Follow-up|0|||
19797939|NCT02983799|42256119|FG004|Overall Study|Lost to Follow-up|0|||
19797940|NCT02186847|42256137|FG000|Overall Study|Protocol Violation|3|||
19797941|NCT02186847|42256138|FG001|Overall Study|Protocol Violation|0|||
19797942|NCT01066871|42256148|FG000|Overall Study|Lost to Follow-up|0|||
19797943|NCT01066871|42256149|FG001|Overall Study|Lost to Follow-up|2|||
19797944|NCT01066871|42256150|FG002|Overall Study|Lost to Follow-up|2|||
19797945|NCT01066871|42256151|FG003|Overall Study|Lost to Follow-up|0|||
19797946|NCT01066871|42256148|FG000|Overall Study|Protocol Violation|1|||
19797947|NCT01066871|42256149|FG001|Overall Study|Protocol Violation|0|||
19797948|NCT01066871|42256150|FG002|Overall Study|Protocol Violation|3|||
19797949|NCT01066871|42256151|FG003|Overall Study|Protocol Violation|2|||
19797950|NCT01066871|42256148|FG000|Overall Study|Lack of Efficacy|0|||
19797951|NCT01066871|42256149|FG001|Overall Study|Lack of Efficacy|0|||
19797952|NCT01066871|42256150|FG002|Overall Study|Lack of Efficacy|0|||
19797953|NCT01066871|42256151|FG003|Overall Study|Lack of Efficacy|1|||
19797954|NCT01066871|42256148|FG000|Overall Study|Withdrawal by Subject|3|||
19797955|NCT01066871|42256149|FG001|Overall Study|Withdrawal by Subject|1|||
19797956|NCT01066871|42256150|FG002|Overall Study|Withdrawal by Subject|0|||
19797957|NCT01066871|42256151|FG003|Overall Study|Withdrawal by Subject|0|||
19797958|NCT01066871|42256148|FG000|Overall Study|Other|0|||
19797959|NCT01066871|42256149|FG001|Overall Study|Other|2|||
19797960|NCT01066871|42256150|FG002|Overall Study|Other|1|||
19797961|NCT01066871|42256151|FG003|Overall Study|Other|2|||
19797962|NCT02982863|42256171|FG000|Overall Study|Not eligible patients|809|||
19797963|NCT02982863|42256172|FG001|Overall Study|Not eligible patients|4261|||
19797964|NCT02982863|42256173|FG002|Overall Study|Not eligible patients|1852|||
19797965|NCT02982863|42256174|FG003|Overall Study|Not eligible patients|1400|||
19797966|NCT02982863|42256175|FG004|Overall Study|Not eligible patients|492|||
19797967|NCT04343651|42256218|FG000|Overall Study|Physician Decision|2|||
19797968|NCT04343651|42256219|FG001|Overall Study|Physician Decision|1|||
19797969|NCT04343651|42256218|FG000|Overall Study|Lost to Follow-up|2|||
19797970|NCT04343651|42256219|FG001|Overall Study|Lost to Follow-up|1|||
19797971|NCT04343651|42256218|FG000|Overall Study|Protocol Violation|4|||
19797972|NCT04343651|42256219|FG001|Overall Study|Protocol Violation|6|||
19797973|NCT04343651|42256218|FG000|Overall Study|Missing|3|||
19797974|NCT04343651|42256219|FG001|Overall Study|Missing|9|||
19797975|NCT04343651|42256218|FG000|Overall Study|Withdrawal by Subject|0|||
19797976|NCT04343651|42256219|FG001|Overall Study|Withdrawal by Subject|4|||
19797977|NCT04343651|42256218|FG000|Overall Study|Death|0|||
19797978|NCT04343651|42256219|FG001|Overall Study|Death|1|||
19797979|NCT04343651|42256218|FG000|Overall Study|Did not start treatment|1|||
19797980|NCT04343651|42256219|FG001|Overall Study|Did not start treatment|1|||
19797981|NCT04343651|42256218|FG000|Overall Study|Patient did not complete visits 3-6|0|||
19797982|NCT04343651|42256219|FG001|Overall Study|Patient did not complete visits 3-6|1|||
19797983|NCT02906579|42256227|FG000|Overall Study|Adverse Event|1|||
19797984|NCT02906579|42256227|FG000|Overall Study|Physician Decision|1|||
19797985|NCT01328535|42256247|FG000|Overall Study|Ineligible|1|||
19797986|NCT02905331|42256255|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
19797987|NCT02905331|42256256|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
19797988|NCT02905331|42256257|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
19797989|NCT02905331|42256255|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
19797990|NCT02905331|42256256|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
19797991|NCT02905331|42256257|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
19797992|NCT02905331|42256255|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
19797993|NCT02905331|42256256|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
19797994|NCT02905331|42256257|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
19797995|NCT02905331|42256255|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
19797996|NCT02905331|42256256|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
19797997|NCT02905331|42256257|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
19797998|NCT02905331|42256255|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
19797999|NCT02905331|42256256|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
19798000|NCT02905331|42256257|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
19798001|NCT02979197|42256268|FG000|Overall Study|Adverse Event|4|||
19798002|NCT02979197|42256269|FG001|Overall Study|Adverse Event|2|||
19798003|NCT02979197|42256270|FG002|Overall Study|Adverse Event|0|||
19798004|NCT02979197|42256268|FG000|Overall Study|Protocol Violation|0|||
19798005|NCT02979197|42256269|FG001|Overall Study|Protocol Violation|1|||
19798006|NCT02979197|42256270|FG002|Overall Study|Protocol Violation|0|||
19798007|NCT02979197|42256268|FG000|Overall Study|Subject unable to commit to study dates|0|||
19798008|NCT02979197|42256269|FG001|Overall Study|Subject unable to commit to study dates|1|||
19798009|NCT02979197|42256270|FG002|Overall Study|Subject unable to commit to study dates|0|||
19798010|NCT02982239|42256280|FG000|Overall Study|Lost to Follow-up|3|||
19798011|NCT02982239|42256281|FG001|Overall Study|Lost to Follow-up|2|||
19798012|NCT01066793|42256294|FG000|Overall Study|Death|4|||
19798013|NCT01066793|42256295|FG001|Overall Study|Death|1|||
19798014|NCT01066793|42256296|FG002|Overall Study|Death|1|||
19798015|NCT01066793|42256297|FG003|Overall Study|Death|0|||
19798016|NCT01066793|42256298|FG004|Overall Study|Death|0|||
19798017|NCT01066793|42256299|FG005|Overall Study|Death|0|||
19798018|NCT01066793|42256294|FG000|Overall Study|Lack of Efficacy|2|||
19798019|NCT01066793|42256295|FG001|Overall Study|Lack of Efficacy|1|||
19798020|NCT01066793|42256296|FG002|Overall Study|Lack of Efficacy|0|||
19798021|NCT01066793|42256297|FG003|Overall Study|Lack of Efficacy|0|||
19798022|NCT01066793|42256298|FG004|Overall Study|Lack of Efficacy|0|||
19798023|NCT01066793|42256299|FG005|Overall Study|Lack of Efficacy|0|||
19798024|NCT01066793|42256294|FG000|Overall Study|Lost to Follow-up|180|||
19798025|NCT01066793|42256295|FG001|Overall Study|Lost to Follow-up|39|||
19798026|NCT01066793|42256296|FG002|Overall Study|Lost to Follow-up|82|||
19798027|NCT01066793|42256297|FG003|Overall Study|Lost to Follow-up|16|||
19798028|NCT01066793|42256298|FG004|Overall Study|Lost to Follow-up|0|||
19798029|NCT01066793|42256299|FG005|Overall Study|Lost to Follow-up|1|||
19798030|NCT01066793|42256294|FG000|Overall Study|Physician Decision|3|||
19798031|NCT01066793|42256295|FG001|Overall Study|Physician Decision|0|||
19798032|NCT01066793|42256296|FG002|Overall Study|Physician Decision|0|||
19798033|NCT01066793|42256297|FG003|Overall Study|Physician Decision|0|||
19798034|NCT01066793|42256298|FG004|Overall Study|Physician Decision|0|||
19798035|NCT01066793|42256299|FG005|Overall Study|Physician Decision|0|||
19798036|NCT01066793|42256294|FG000|Overall Study|Protocol Violation|3|||
19798037|NCT01066793|42256295|FG001|Overall Study|Protocol Violation|2|||
19798038|NCT01066793|42256296|FG002|Overall Study|Protocol Violation|2|||
19798039|NCT01066793|42256297|FG003|Overall Study|Protocol Violation|0|||
19798040|NCT01066793|42256298|FG004|Overall Study|Protocol Violation|0|||
19798041|NCT01066793|42256299|FG005|Overall Study|Protocol Violation|0|||
19798042|NCT01066793|42256294|FG000|Overall Study|Withdrawal by Subject|7|||
19798043|NCT01066793|42256295|FG001|Overall Study|Withdrawal by Subject|4|||
19798044|NCT01066793|42256296|FG002|Overall Study|Withdrawal by Subject|1|||
19798045|NCT01066793|42256297|FG003|Overall Study|Withdrawal by Subject|0|||
19798046|NCT01066793|42256298|FG004|Overall Study|Withdrawal by Subject|0|||
19798047|NCT01066793|42256299|FG005|Overall Study|Withdrawal by Subject|0|||
19798048|NCT01066793|42256294|FG000|Overall Study|Early Termination|3|||
19798049|NCT01066793|42256295|FG001|Overall Study|Early Termination|0|||
19798050|NCT01066793|42256296|FG002|Overall Study|Early Termination|0|||
19798051|NCT01066793|42256297|FG003|Overall Study|Early Termination|0|||
19798052|NCT01066793|42256298|FG004|Overall Study|Early Termination|0|||
19798053|NCT01066793|42256299|FG005|Overall Study|Early Termination|0|||
19798054|NCT01066793|42256294|FG000|Overall Study|Lab test not done|7|||
19798055|NCT01066793|42256295|FG001|Overall Study|Lab test not done|0|||
19798056|NCT01066793|42256296|FG002|Overall Study|Lab test not done|0|||
19798057|NCT01066793|42256297|FG003|Overall Study|Lab test not done|1|||
19798058|NCT01066793|42256298|FG004|Overall Study|Lab test not done|0|||
19798059|NCT01066793|42256299|FG005|Overall Study|Lab test not done|0|||
19798060|NCT01066793|42256294|FG000|Overall Study|Miscellaneous|4|||
19798061|NCT01066793|42256295|FG001|Overall Study|Miscellaneous|5|||
19798062|NCT01066793|42256296|FG002|Overall Study|Miscellaneous|6|||
19798063|NCT01066793|42256297|FG003|Overall Study|Miscellaneous|0|||
19798064|NCT01066793|42256298|FG004|Overall Study|Miscellaneous|0|||
19798065|NCT01066793|42256299|FG005|Overall Study|Miscellaneous|0|||
19798066|NCT01066793|42256294|FG000|Overall Study|Non-responders|104|||
19798067|NCT01066793|42256295|FG001|Overall Study|Non-responders|5|||
19798068|NCT01066793|42256296|FG002|Overall Study|Non-responders|11|||
19798069|NCT01066793|42256297|FG003|Overall Study|Non-responders|25|||
19798070|NCT01066793|42256298|FG004|Overall Study|Non-responders|0|||
19798071|NCT01066793|42256299|FG005|Overall Study|Non-responders|0|||
19798072|NCT01066793|42256294|FG000|Overall Study|Other|15|||
19798073|NCT01066793|42256295|FG001|Overall Study|Other|5|||
19798074|NCT01066793|42256296|FG002|Overall Study|Other|6|||
19798075|NCT01066793|42256297|FG003|Overall Study|Other|2|||
19798076|NCT01066793|42256298|FG004|Overall Study|Other|0|||
19798077|NCT01066793|42256299|FG005|Overall Study|Other|0|||
19798078|NCT01066793|42256294|FG000|Overall Study|Relapse|20|||
19798079|NCT01066793|42256295|FG001|Overall Study|Relapse|8|||
19798080|NCT01066793|42256296|FG002|Overall Study|Relapse|2|||
19798081|NCT01066793|42256297|FG003|Overall Study|Relapse|3|||
19798082|NCT01066793|42256298|FG004|Overall Study|Relapse|0|||
19698570|NCT00296504|42143593|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698571|NCT00296504|42143594|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
19698572|NCT00296504|42143595|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698573|NCT00296504|42143596|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698574|NCT00296504|42143597|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
19698575|NCT00296504|42143589|FG000|Interim Analysis|To Simplify Treatment|0|||
19698576|NCT00296504|42143590|FG001|Interim Analysis|To Simplify Treatment|0|||
19698577|NCT00296504|42143591|FG002|Interim Analysis|To Simplify Treatment|1|||
19698578|NCT00296504|42143592|FG003|Interim Analysis|To Simplify Treatment|0|||
19698579|NCT00296504|42143593|FG004|Interim Analysis|To Simplify Treatment|0|||
19698580|NCT00296504|42143594|FG005|Interim Analysis|To Simplify Treatment|0|||
19698581|NCT00296504|42143595|FG006|Interim Analysis|To Simplify Treatment|2|||
19698582|NCT00296504|42143596|FG007|Interim Analysis|To Simplify Treatment|0|||
19798083|NCT01066793|42256299|FG005|Overall Study|Relapse|0|||
19798084|NCT01066793|42256294|FG000|Overall Study|Result Not Available|1|||
19798085|NCT01066793|42256295|FG001|Overall Study|Result Not Available|0|||
19798086|NCT01066793|42256296|FG002|Overall Study|Result Not Available|0|||
19798087|NCT01066793|42256297|FG003|Overall Study|Result Not Available|0|||
19798088|NCT01066793|42256298|FG004|Overall Study|Result Not Available|0|||
19698583|NCT00296504|42143597|FG008|Interim Analysis|To Simplify Treatment|0|||
19698584|NCT00296504|42143589|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
19798089|NCT01066793|42256299|FG005|Overall Study|Result Not Available|0|||
19798090|NCT01066793|42256294|FG000|Overall Study|Treatment Interrupted|1|||
19798091|NCT01066793|42256295|FG001|Overall Study|Treatment Interrupted|1|||
19798092|NCT01066793|42256296|FG002|Overall Study|Treatment Interrupted|0|||
19798093|NCT01066793|42256297|FG003|Overall Study|Treatment Interrupted|0|||
19798094|NCT01066793|42256298|FG004|Overall Study|Treatment Interrupted|0|||
19798095|NCT01066793|42256299|FG005|Overall Study|Treatment Interrupted|0|||
19798096|NCT01066793|42256294|FG000|Overall Study|Treatment Never Started|18|||
19798097|NCT01066793|42256295|FG001|Overall Study|Treatment Never Started|5|||
19798098|NCT01066793|42256296|FG002|Overall Study|Treatment Never Started|4|||
19798099|NCT01066793|42256297|FG003|Overall Study|Treatment Never Started|1|||
19798100|NCT01066793|42256298|FG004|Overall Study|Treatment Never Started|0|||
19798101|NCT01066793|42256299|FG005|Overall Study|Treatment Never Started|0|||
19608230|NCT00877383|42057126|FG000|Overall Study|Death|1|||
19608231|NCT00877383|42057127|FG001|Overall Study|Death|2|||
19798102|NCT01066793|42256294|FG000|Overall Study|Treatment Stopped|2|||
19798103|NCT01066793|42256295|FG001|Overall Study|Treatment Stopped|1|||
19698585|NCT00296504|42143590|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
19798104|NCT01066793|42256296|FG002|Overall Study|Treatment Stopped|0|||
19798105|NCT01066793|42256297|FG003|Overall Study|Treatment Stopped|1|||
19798106|NCT01066793|42256298|FG004|Overall Study|Treatment Stopped|0|||
19798107|NCT01066793|42256299|FG005|Overall Study|Treatment Stopped|0|||
19798108|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
19798109|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
19798110|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
19798111|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
19798112|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
19798113|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
19798114|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
19798115|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
19798116|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
19798117|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
19798118|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
19798119|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
19798120|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
19798121|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
19798122|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
19798123|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
19798124|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
19798125|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
19798126|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
19798127|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
19798128|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
19798129|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
19798130|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
19798131|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
19798132|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
19798133|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
19798134|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
19798135|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
19798136|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
19798137|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
19798138|NCT03985293|42256320|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
19798139|NCT03985293|42256321|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
19798140|NCT03985293|42256322|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
19798141|NCT03985293|42256323|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
19798142|NCT03985293|42256324|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
19798143|NCT03985293|42256325|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
19798144|NCT03985293|42256320|FG000|FOLLOW-UP|Lost to Follow-up|0|||
19798145|NCT03985293|42256321|FG001|FOLLOW-UP|Lost to Follow-up|0|||
19798146|NCT03985293|42256322|FG002|FOLLOW-UP|Lost to Follow-up|1|||
19798147|NCT03985293|42256323|FG003|FOLLOW-UP|Lost to Follow-up|0|||
19798148|NCT03985293|42256324|FG004|FOLLOW-UP|Lost to Follow-up|0|||
19798149|NCT03985293|42256325|FG005|FOLLOW-UP|Lost to Follow-up|0|||
19798150|NCT02980601|42256341|FG000|Overall Study|Lost to Follow-up|2|||
19798151|NCT02980601|42256342|FG001|Overall Study|Lost to Follow-up|2|||
19798152|NCT02980601|42256341|FG000|Overall Study|Death|0|||
19798153|NCT02980601|42256342|FG001|Overall Study|Death|1|||
19798154|NCT02980601|42256341|FG000|Overall Study|Graft loss|1|||
19798155|NCT02980601|42256342|FG001|Overall Study|Graft loss|0|||
19798156|NCT02980601|42256341|FG000|Overall Study|Failed to sign consent|2|||
19798157|NCT02980601|42256342|FG001|Overall Study|Failed to sign consent|0|||
19798158|NCT02980523|42256353|FG000|Overall Study|Lost to Follow-up|1|||
19798159|NCT02980523|42256354|FG001|Overall Study|Lost to Follow-up|4|||
19798160|NCT02980523|42256355|FG002|Overall Study|Lost to Follow-up|1|||
19798161|NCT02980523|42256356|FG003|Overall Study|Lost to Follow-up|2|||
19798162|NCT02980523|42256357|FG004|Overall Study|Lost to Follow-up|1|||
19798163|NCT02980523|42256353|FG000|Overall Study|Excluded from analysis|1|||
19798164|NCT02980523|42256354|FG001|Overall Study|Excluded from analysis|3|||
19798165|NCT02980523|42256355|FG002|Overall Study|Excluded from analysis|1|||
19798166|NCT02980523|42256356|FG003|Overall Study|Excluded from analysis|1|||
19798167|NCT02980523|42256357|FG004|Overall Study|Excluded from analysis|1|||
19798168|NCT02980523|42256353|FG000|Overall Study|Lack of Efficacy|1|||
19798169|NCT02980523|42256354|FG001|Overall Study|Lack of Efficacy|4|||
19798170|NCT02980523|42256355|FG002|Overall Study|Lack of Efficacy|4|||
19798171|NCT02980523|42256356|FG003|Overall Study|Lack of Efficacy|5|||
19798172|NCT02980523|42256357|FG004|Overall Study|Lack of Efficacy|8|||
19798173|NCT02980523|42256353|FG000|Overall Study|Did not receive intervention|0|||
19798174|NCT02980523|42256354|FG001|Overall Study|Did not receive intervention|0|||
19798175|NCT02980523|42256355|FG002|Overall Study|Did not receive intervention|0|||
19798176|NCT02980523|42256356|FG003|Overall Study|Did not receive intervention|1|||
19798177|NCT02980523|42256357|FG004|Overall Study|Did not receive intervention|0|||
19798178|NCT02980133|42256376|FG000|Overall Study|Other than specified|1|||
19798179|NCT02980133|42256377|FG001|Overall Study|Other than specified|1|||
19798180|NCT02980133|42256378|FG002|Overall Study|Other than specified|2|||
19798181|NCT02980133|42256379|FG003|Overall Study|Other than specified|2|||
19798182|NCT02980133|42256376|FG000|Overall Study|Lost to Follow-up|0|||
19798183|NCT02980133|42256377|FG001|Overall Study|Lost to Follow-up|0|||
19798184|NCT02980133|42256378|FG002|Overall Study|Lost to Follow-up|1|||
19798185|NCT02980133|42256379|FG003|Overall Study|Lost to Follow-up|3|||
19798186|NCT02980133|42256376|FG000|Overall Study|Protocol Violation|0|||
19798187|NCT02980133|42256377|FG001|Overall Study|Protocol Violation|1|||
19798188|NCT02980133|42256378|FG002|Overall Study|Protocol Violation|0|||
19798189|NCT02980133|42256379|FG003|Overall Study|Protocol Violation|0|||
19798190|NCT02980133|42256376|FG000|Overall Study|Withdrawal by parent/guardian|6|||
19798191|NCT02980133|42256377|FG001|Overall Study|Withdrawal by parent/guardian|3|||
19798192|NCT02980133|42256378|FG002|Overall Study|Withdrawal by parent/guardian|3|||
19798193|NCT02980133|42256379|FG003|Overall Study|Withdrawal by parent/guardian|1|||
19798194|NCT02980133|42256376|FG000|Overall Study|Withdrawal by Subject|0|||
19798195|NCT02980133|42256377|FG001|Overall Study|Withdrawal by Subject|0|||
19798196|NCT02980133|42256378|FG002|Overall Study|Withdrawal by Subject|1|||
19798197|NCT02980133|42256379|FG003|Overall Study|Withdrawal by Subject|0|||
19798198|NCT02979431|42256396|FG000|Overall Study|Parent/guardian withdrew consent|2|||
19798199|NCT02979431|42256397|FG001|Overall Study|Parent/guardian withdrew consent|1|||
19798200|NCT02979431|42256398|FG002|Overall Study|Parent/guardian withdrew consent|1|||
19798201|NCT02979431|42256399|FG003|Overall Study|Parent/guardian withdrew consent|1|||
19798202|NCT02979431|42256396|FG000|Overall Study|Randomized but received no study drug|1|||
19798203|NCT02979431|42256397|FG001|Overall Study|Randomized but received no study drug|1|||
19798204|NCT02979431|42256398|FG002|Overall Study|Randomized but received no study drug|0|||
19798205|NCT02979431|42256399|FG003|Overall Study|Randomized but received no study drug|0|||
19798206|NCT02979431|42256396|FG000|Overall Study|Adverse Event|0|||
19798207|NCT02979431|42256397|FG001|Overall Study|Adverse Event|0|||
19798208|NCT02979431|42256398|FG002|Overall Study|Adverse Event|1|||
19798209|NCT02979431|42256399|FG003|Overall Study|Adverse Event|0|||
19798210|NCT02979431|42256396|FG000|Overall Study|Subject left country after Day14|1|||
19798211|NCT02979431|42256397|FG001|Overall Study|Subject left country after Day14|0|||
19798212|NCT02979431|42256398|FG002|Overall Study|Subject left country after Day14|0|||
19798213|NCT02979431|42256399|FG003|Overall Study|Subject left country after Day14|0|||
19798214|NCT02978417|42256411|FG000|Overall Study|Lost to Follow-up|2|||
19798215|NCT02978417|42256412|FG001|Overall Study|Lost to Follow-up|2|||
19798216|NCT04368429|42256420|FG000|Overall Study|Adverse Event|1|||
19798217|NCT04368429|42256421|FG001|Overall Study|Adverse Event|0|||
19798218|NCT02733627|42256431|FG000|Overall Study|Adverse Event|0|||
19798219|NCT02733627|42256432|FG001|Overall Study|Adverse Event|1|||
19798220|NCT02733627|42256433|FG002|Overall Study|Adverse Event|1|||
19798221|NCT02733627|42256434|FG003|Overall Study|Adverse Event|0|||
19798222|NCT02733627|42256431|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
19798223|NCT02733627|42256432|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
19798224|NCT02733627|42256433|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
19798225|NCT02733627|42256434|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
19798226|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798227|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
19798228|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798229|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
19798230|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
19798231|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
19798232|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
19798233|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798234|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798235|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798236|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798237|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798238|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798239|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798240|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798241|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
19798242|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
19798243|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
19698586|NCT00296504|42143591|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
19698587|NCT00296504|42143592|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
19698588|NCT00296504|42143593|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
19698589|NCT00296504|42143594|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
19698590|NCT00296504|42143595|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
19698591|NCT00296504|42143596|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
19798244|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
19798245|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
19798246|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
19798247|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
19798248|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
19798249|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
19798250|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
19798251|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
19798252|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
19798253|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
19798254|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
19798255|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
19798256|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
19798257|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
19798258|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
19798259|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
19798260|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798261|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798262|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798263|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798264|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798265|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798266|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798267|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798268|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798269|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798270|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798271|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798272|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798273|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
19798274|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
19798275|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798276|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
19798277|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
19798278|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
19798279|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
19798280|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
19798281|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798282|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798283|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798284|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798285|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798286|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798287|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798288|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798289|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
19798290|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798291|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798292|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798293|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
19798294|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798295|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798296|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
19798297|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798298|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798299|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798300|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798301|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798302|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798303|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798304|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798305|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
19798306|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798307|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798308|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
19798309|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798310|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798311|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798312|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798313|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798314|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798315|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798316|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798317|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798318|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798319|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798320|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798321|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
19798322|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
19798323|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
19798324|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
19798325|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798326|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798327|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798328|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798329|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798330|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798331|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798332|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798333|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798334|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798335|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798336|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798337|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
19798338|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
19798339|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
19798340|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
19798341|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
19798342|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
19798343|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
19798344|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
19798345|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
19798346|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
19798347|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
19798348|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
19798349|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
19798350|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
19798351|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
19798352|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
19798353|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
19798354|NCT02958865|42256451|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798355|NCT02958865|42256452|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798356|NCT02958865|42256453|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798357|NCT02958865|42256454|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798358|NCT02958865|42256455|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
19798359|NCT02958865|42256456|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798360|NCT02958865|42256457|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798361|NCT02958865|42256458|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798362|NCT02958865|42256459|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798363|NCT02958865|42256460|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798364|NCT02958865|42256461|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798365|NCT02958865|42256462|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798366|NCT02958865|42256463|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798367|NCT02958865|42256464|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798368|NCT02958865|42256465|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798369|NCT02958865|42256466|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
19798370|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798371|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798372|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798373|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798374|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798375|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798376|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798377|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
19798378|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
19798379|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
19798380|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
19798381|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
19798382|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
19798383|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
19798384|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
19798385|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
19798386|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798387|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798388|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798389|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798390|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798391|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798392|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798393|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798394|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
19798395|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
19798396|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798397|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
19798398|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798399|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
19798400|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
19798401|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
19798402|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798403|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798404|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798405|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798406|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798407|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798408|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798409|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798410|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798411|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
19798412|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798413|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798414|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798415|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798416|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
19798417|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
19798418|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798419|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798420|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798421|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798422|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798423|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798424|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798425|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798426|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798427|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798428|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
19798429|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
19798430|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
19798431|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
19798432|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
19798433|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
19798434|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
19798435|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
19798436|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
19798437|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
19798438|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
19798439|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
19798440|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
19798441|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
19798442|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
19798443|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
19798444|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
19798445|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
19798446|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
19798447|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
19798448|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
19798449|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
19798450|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19367564|NCT02433340|41607756|FG002|Overall Study|Withdrawal by Subject|1|||
19798451|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798452|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798453|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798454|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798455|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798456|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798457|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798458|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798459|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798460|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798461|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798462|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798463|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
19798464|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798465|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
19798466|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798467|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798468|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798469|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798470|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798471|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798472|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798473|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798474|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798475|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798476|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798477|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798478|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798479|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
19798480|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798481|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
19798482|NCT02958865|42256451|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798483|NCT02958865|42256452|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798484|NCT02958865|42256453|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798485|NCT02958865|42256454|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798486|NCT02958865|42256455|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798487|NCT02958865|42256456|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798488|NCT02958865|42256457|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798489|NCT02958865|42256458|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798490|NCT02958865|42256459|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798491|NCT02958865|42256460|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
19798492|NCT02958865|42256461|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798493|NCT02958865|42256462|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798494|NCT02958865|42256463|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798495|NCT02958865|42256464|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798496|NCT02958865|42256465|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798497|NCT02958865|42256466|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
19798498|NCT02958553|42256518|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
19798499|NCT02958553|42256518|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
19798500|NCT02501902|42256531|FG000|Overall Study|Subject Refused Further Follow-up|0|||
19798501|NCT02501902|42256532|FG001|Overall Study|Subject Refused Further Follow-up|0|||
19798502|NCT02501902|42256533|FG002|Overall Study|Subject Refused Further Follow-up|0|||
19798503|NCT02501902|42256534|FG003|Overall Study|Subject Refused Further Follow-up|0|||
19798504|NCT02501902|42256535|FG004|Overall Study|Subject Refused Further Follow-up|0|||
19798505|NCT02501902|42256536|FG005|Overall Study|Subject Refused Further Follow-up|0|||
19798506|NCT02501902|42256537|FG006|Overall Study|Subject Refused Further Follow-up|0|||
19798507|NCT02501902|42256538|FG007|Overall Study|Subject Refused Further Follow-up|1|||
19798508|NCT02501902|42256531|FG000|Overall Study|Study Terminated by Sponsor|0|||
19798509|NCT02501902|42256532|FG001|Overall Study|Study Terminated by Sponsor|3|||
19798510|NCT02501902|42256533|FG002|Overall Study|Study Terminated by Sponsor|0|||
19798511|NCT02501902|42256534|FG003|Overall Study|Study Terminated by Sponsor|1|||
19798512|NCT02501902|42256535|FG004|Overall Study|Study Terminated by Sponsor|1|||
19389185|NCT02053792|41632810|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
19798513|NCT02501902|42256536|FG005|Overall Study|Study Terminated by Sponsor|0|||
19798514|NCT02501902|42256537|FG006|Overall Study|Study Terminated by Sponsor|2|||
19798515|NCT02501902|42256538|FG007|Overall Study|Study Terminated by Sponsor|4|||
19798516|NCT02501902|42256531|FG000|Overall Study|Death|3|||
19798517|NCT02501902|42256532|FG001|Overall Study|Death|4|||
19798518|NCT02501902|42256533|FG002|Overall Study|Death|4|||
19798519|NCT02501902|42256534|FG003|Overall Study|Death|10|||
19798520|NCT02501902|42256535|FG004|Overall Study|Death|10|||
19798521|NCT02501902|42256536|FG005|Overall Study|Death|11|||
19798522|NCT02501902|42256537|FG006|Overall Study|Death|7|||
19798523|NCT02501902|42256538|FG007|Overall Study|Death|15|||
19798524|NCT01955109|42256563|FG000|Overall Study|Adverse Event|2|||
19798525|NCT01955109|42256564|FG001|Overall Study|Adverse Event|0|||
19798526|NCT01955109|42256563|FG000|Overall Study|Participant unwilling to continue|35|||
19798527|NCT01955109|42256564|FG001|Overall Study|Participant unwilling to continue|7|||
19798528|NCT01955109|42256563|FG000|Overall Study|Physician Decision|2|||
19798529|NCT01955109|42256564|FG001|Overall Study|Physician Decision|0|||
19798530|NCT01955109|42256563|FG000|Overall Study|Lost to Follow-up|3|||
19798531|NCT01955109|42256564|FG001|Overall Study|Lost to Follow-up|1|||
19798532|NCT01955109|42256563|FG000|Overall Study|Non-compliance|3|||
19798533|NCT01955109|42256564|FG001|Overall Study|Non-compliance|1|||
19798534|NCT02500732|42256572|FG000|Overall Study|Physician Decision|0|||
19798535|NCT02500732|42256573|FG001|Overall Study|Physician Decision|1|||
19798536|NCT02518048|42256579|FG000|Overall Study|Withdrawal by Subject|1|||
19798537|NCT02499952|42256584|FG000|Overall Study|Lost to Follow-up|1|||
19798538|NCT02499952|42256584|FG000|Overall Study|Death|9|||
19798539|NCT02499406|42256588|FG000|Overall Study|missed 3 treatment sessions|4|||
19798540|NCT02499172|42256596|FG000|Overall Study|Financial reason|0|||
19798541|NCT02499172|42256597|FG001|Overall Study|Financial reason|0|||
19798542|NCT02499172|42256598|FG002|Overall Study|Financial reason|523|||
19798543|NCT02499172|42256599|FG003|Overall Study|Financial reason|436|||
19798544|NCT02499172|42256596|FG000|Overall Study|Lost to Follow-up|65|||
19798545|NCT02499172|42256597|FG001|Overall Study|Lost to Follow-up|64|||
19798546|NCT02499172|42256598|FG002|Overall Study|Lost to Follow-up|0|||
19798547|NCT02499172|42256599|FG003|Overall Study|Lost to Follow-up|0|||
19798548|NCT02498392|42256611|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
19798549|NCT02498392|42256612|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
19798550|NCT02498392|42256611|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
19798551|NCT02498392|42256612|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
19798552|NCT02498392|42256611|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
19798553|NCT02498392|42256612|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
19798554|NCT02498392|42256611|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
19798555|NCT02498392|42256612|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
19798556|NCT02498392|42256611|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
19798557|NCT02498392|42256612|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
19798558|NCT02498392|42256611|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
19798559|NCT02498392|42256612|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
19798560|NCT03205605|42256620|FG000|Overall Study|Withdrawal by Subject|1|||
19798561|NCT02498236|42256638|FG000|Overall Study|Did not show for testing|1|||
19798562|NCT02498236|42256639|FG001|Overall Study|Did not show for testing|0|||
19798563|NCT02498236|42256640|FG002|Overall Study|Did not show for testing|0|||
19798564|NCT02498236|42256641|FG003|Overall Study|Did not show for testing|0|||
19798565|NCT02498236|42256642|FG004|Overall Study|Did not show for testing|0|||
19798566|NCT02498236|42256643|FG005|Overall Study|Did not show for testing|0|||
19798567|NCT02498236|42256644|FG006|Overall Study|Did not show for testing|0|||
19798568|NCT02498236|42256645|FG007|Overall Study|Did not show for testing|1|||
19798569|NCT02498236|42256638|FG000|Overall Study|Equipment failure|0|||
19798570|NCT02498236|42256639|FG001|Overall Study|Equipment failure|0|||
19798571|NCT02498236|42256640|FG002|Overall Study|Equipment failure|0|||
19798572|NCT02498236|42256641|FG003|Overall Study|Equipment failure|0|||
19798573|NCT02498236|42256642|FG004|Overall Study|Equipment failure|0|||
19798574|NCT02498236|42256643|FG005|Overall Study|Equipment failure|0|||
19798575|NCT02498236|42256644|FG006|Overall Study|Equipment failure|1|||
19798576|NCT02498236|42256645|FG007|Overall Study|Equipment failure|0|||
19798577|NCT02498236|42256638|FG000|Overall Study|Withdrawal by Subject|0|||
19798578|NCT02498236|42256639|FG001|Overall Study|Withdrawal by Subject|0|||
19608232|NCT00993473|42057135|FG000|Overall Study|Adverse Event|0|||
19798579|NCT02498236|42256640|FG002|Overall Study|Withdrawal by Subject|0|||
19798580|NCT02498236|42256641|FG003|Overall Study|Withdrawal by Subject|0|||
19798581|NCT02498236|42256642|FG004|Overall Study|Withdrawal by Subject|1|||
19798582|NCT02498236|42256643|FG005|Overall Study|Withdrawal by Subject|0|||
19798583|NCT02498236|42256644|FG006|Overall Study|Withdrawal by Subject|0|||
19798584|NCT02498236|42256645|FG007|Overall Study|Withdrawal by Subject|0|||
19798585|NCT02496676|42256668|FG000|Phase 1 - Period 1|Adverse Event|0|||
19798586|NCT02496676|42256669|FG001|Phase 1 - Period 1|Adverse Event|1|||
19798587|NCT02496676|42256668|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
19798588|NCT02496676|42256669|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
19798589|NCT02517268|42256685|FG000|Overall Study|Withdrawal by Subject|1|||
19798590|NCT02517268|42256686|FG001|Overall Study|Withdrawal by Subject|0|||
19798591|NCT01160211|42256695|FG000|Overall Study|ongoing|90|||
19798592|NCT01160211|42256696|FG001|Overall Study|ongoing|75|||
19798593|NCT01160211|42256697|FG002|Overall Study|ongoing|79|||
19798594|NCT01160211|42256695|FG000|Overall Study|Withdrawal by Subject|3|||
19798595|NCT01160211|42256696|FG001|Overall Study|Withdrawal by Subject|5|||
19798596|NCT01160211|42256697|FG002|Overall Study|Withdrawal by Subject|3|||
19798597|NCT01160211|42256695|FG000|Overall Study|Physician Decision|2|||
19798598|NCT01160211|42256696|FG001|Overall Study|Physician Decision|0|||
19798599|NCT01160211|42256697|FG002|Overall Study|Physician Decision|0|||
19798600|NCT01160211|42256695|FG000|Overall Study|Lost to Follow-up|4|||
19798601|NCT01160211|42256696|FG001|Overall Study|Lost to Follow-up|7|||
19798602|NCT01160211|42256697|FG002|Overall Study|Lost to Follow-up|5|||
19798603|NCT01064687|42256710|FG000|Overall Study|Adverse Event|9|||
19798604|NCT01064687|42256711|FG001|Overall Study|Adverse Event|4|||
19798605|NCT01064687|42256712|FG002|Overall Study|Adverse Event|10|||
19798606|NCT01064687|42256713|FG003|Overall Study|Adverse Event|3|||
19798607|NCT01064687|42256710|FG000|Overall Study|Death|1|||
19798608|NCT01064687|42256711|FG001|Overall Study|Death|1|||
19798609|NCT01064687|42256712|FG002|Overall Study|Death|0|||
19798610|NCT01064687|42256713|FG003|Overall Study|Death|0|||
19798611|NCT01064687|42256710|FG000|Overall Study|Entry Criteria Not Met|3|||
19798612|NCT01064687|42256711|FG001|Overall Study|Entry Criteria Not Met|0|||
19798613|NCT01064687|42256712|FG002|Overall Study|Entry Criteria Not Met|0|||
19798614|NCT01064687|42256713|FG003|Overall Study|Entry Criteria Not Met|0|||
19798615|NCT01064687|42256710|FG000|Overall Study|Lack of Efficacy|1|||
19798616|NCT01064687|42256711|FG001|Overall Study|Lack of Efficacy|0|||
19798617|NCT01064687|42256712|FG002|Overall Study|Lack of Efficacy|2|||
19798618|NCT01064687|42256713|FG003|Overall Study|Lack of Efficacy|3|||
19798619|NCT01064687|42256710|FG000|Overall Study|Lost to Follow-up|7|||
19798620|NCT01064687|42256711|FG001|Overall Study|Lost to Follow-up|10|||
19798621|NCT01064687|42256712|FG002|Overall Study|Lost to Follow-up|13|||
19798622|NCT01064687|42256713|FG003|Overall Study|Lost to Follow-up|5|||
19798623|NCT01064687|42256710|FG000|Overall Study|Physician Decision|2|||
19798624|NCT01064687|42256711|FG001|Overall Study|Physician Decision|2|||
19798625|NCT01064687|42256712|FG002|Overall Study|Physician Decision|0|||
19798626|NCT01064687|42256713|FG003|Overall Study|Physician Decision|0|||
19798627|NCT01064687|42256710|FG000|Overall Study|Protocol Violation|1|||
19798628|NCT01064687|42256711|FG001|Overall Study|Protocol Violation|1|||
19798629|NCT01064687|42256712|FG002|Overall Study|Protocol Violation|0|||
19798630|NCT01064687|42256713|FG003|Overall Study|Protocol Violation|1|||
19798631|NCT01064687|42256710|FG000|Overall Study|Sponsor Decision|0|||
19798632|NCT01064687|42256711|FG001|Overall Study|Sponsor Decision|0|||
19798633|NCT01064687|42256712|FG002|Overall Study|Sponsor Decision|3|||
19798634|NCT01064687|42256713|FG003|Overall Study|Sponsor Decision|0|||
19798635|NCT01064687|42256710|FG000|Overall Study|Withdrawal by Subject|9|||
19798636|NCT01064687|42256711|FG001|Overall Study|Withdrawal by Subject|7|||
19798637|NCT01064687|42256712|FG002|Overall Study|Withdrawal by Subject|12|||
19798638|NCT01064687|42256713|FG003|Overall Study|Withdrawal by Subject|5|||
19798639|NCT01064687|42256710|FG000|Overall Study|Treatment Noncompliance|1|||
19798640|NCT01064687|42256711|FG001|Overall Study|Treatment Noncompliance|1|||
19798641|NCT01064687|42256712|FG002|Overall Study|Treatment Noncompliance|1|||
19798642|NCT01064687|42256713|FG003|Overall Study|Treatment Noncompliance|0|||
19798643|NCT02493946|42256737|FG000|DB Period|Withdrawal by Subject|8|||
19798644|NCT02493946|42256738|FG001|DB Period|Withdrawal by Subject|5|||
19798645|NCT02493946|42256739|FG002|DB Period|Withdrawal by Subject|0|||
19798646|NCT02493946|42256737|FG000|Open Label Period|Withdrawal by Subject|0|||
19798647|NCT02493946|42256738|FG001|Open Label Period|Withdrawal by Subject|0|||
19798648|NCT02493946|42256739|FG002|Open Label Period|Withdrawal by Subject|74|||
19798649|NCT02493946|42256737|FG000|Open Label Period|Adverse Event|0|||
19798650|NCT02493946|42256738|FG001|Open Label Period|Adverse Event|0|||
19798651|NCT02493946|42256739|FG002|Open Label Period|Adverse Event|4|||
19798652|NCT02493946|42256737|FG000|Open Label Period|Lost to Follow-up|0|||
19798653|NCT02493946|42256738|FG001|Open Label Period|Lost to Follow-up|0|||
19798654|NCT02493946|42256739|FG002|Open Label Period|Lost to Follow-up|1|||
19798655|NCT02493946|42256737|FG000|Open Label Period|Investigator decision, non-compliance|0|||
19798656|NCT02493946|42256738|FG001|Open Label Period|Investigator decision, non-compliance|0|||
19389186|NCT02053792|41632811|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
19798657|NCT02493946|42256739|FG002|Open Label Period|Investigator decision, non-compliance|2|||
19798658|NCT02493946|42256737|FG000|Open Label Period|Investigator decision, non-availability|0|||
19798659|NCT02493946|42256738|FG001|Open Label Period|Investigator decision, non-availability|0|||
19798660|NCT02493946|42256739|FG002|Open Label Period|Investigator decision, non-availability|1|||
19798661|NCT02493946|42256737|FG000|Open Label Period|Pregnancy|0|||
19798662|NCT02493946|42256738|FG001|Open Label Period|Pregnancy|0|||
19798663|NCT02493946|42256739|FG002|Open Label Period|Pregnancy|3|||
19798664|NCT02493946|42256737|FG000|Open Label Period|Site error|0|||
19798665|NCT02493946|42256738|FG001|Open Label Period|Site error|0|||
19798666|NCT02493946|42256739|FG002|Open Label Period|Site error|1|||
19798667|NCT01064531|42256749|FG000|Overall Study|Lost to Follow-up|0|||
19798668|NCT01064531|42256750|FG001|Overall Study|Lost to Follow-up|2|||
19798669|NCT01064531|42256749|FG000|Overall Study|Physician Decision|0|||
19798670|NCT01064531|42256750|FG001|Overall Study|Physician Decision|1|||
19798671|NCT01064531|42256749|FG000|Overall Study|Withdrawal by Subject|2|||
19798672|NCT01064531|42256750|FG001|Overall Study|Withdrawal by Subject|2|||
19798673|NCT01064531|42256749|FG000|Overall Study|Revision due to femoral stem loosening|1|||
19798674|NCT01064531|42256750|FG001|Overall Study|Revision due to femoral stem loosening|0|||
19798675|NCT01064531|42256749|FG000|Overall Study|Revision due to dislocation|0|||
19798676|NCT01064531|42256750|FG001|Overall Study|Revision due to dislocation|1|||
19798677|NCT01064531|42256749|FG000|Overall Study|Death|0|||
19798678|NCT01064531|42256750|FG001|Overall Study|Death|1|||
19798679|NCT02220855|42256756|FG000|Overall Study|Adverse Event|8|||
19798680|NCT02220855|42256756|FG000|Overall Study|Disease Progression|5|||
19798681|NCT02220855|42256756|FG000|Overall Study|Withdrawal by Subject|1|||
19798682|NCT02918279|42256762|FG000|Overall Study|Lost to Follow-up|3|||
19798683|NCT02918279|42256763|FG001|Overall Study|Lost to Follow-up|6|||
19798684|NCT02918279|42256762|FG000|Overall Study|Withdrawal by Subject|5|||
19798685|NCT02918279|42256763|FG001|Overall Study|Withdrawal by Subject|15|||
19798686|NCT02918279|42256762|FG000|Overall Study|Withdrawal by parent/guardian|2|||
19798687|NCT02918279|42256763|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19798688|NCT02918279|42256762|FG000|Overall Study|Other|3|||
19798689|NCT02918279|42256763|FG001|Overall Study|Other|1|||
19798690|NCT02956837|42256773|FG000|Overall Study|Serious Adverse Events|0|||
19798691|NCT02956837|42256774|FG001|Overall Study|Serious Adverse Events|1|||
19798692|NCT02956837|42256775|FG002|Overall Study|Serious Adverse Events|0|||
19798693|NCT02956837|42256776|FG003|Overall Study|Serious Adverse Events|0|||
19798694|NCT02956837|42256773|FG000|Overall Study|Withdrawal by Subject|0|||
19798695|NCT02956837|42256774|FG001|Overall Study|Withdrawal by Subject|1|||
19798696|NCT02956837|42256775|FG002|Overall Study|Withdrawal by Subject|0|||
19798697|NCT02956837|42256776|FG003|Overall Study|Withdrawal by Subject|3|||
19798698|NCT02956837|42256773|FG000|Overall Study|Lost to Follow-up|0|||
19798699|NCT02956837|42256774|FG001|Overall Study|Lost to Follow-up|1|||
19798700|NCT02956837|42256775|FG002|Overall Study|Lost to Follow-up|2|||
19798701|NCT02956837|42256776|FG003|Overall Study|Lost to Follow-up|0|||
19798702|NCT01063595|42256789|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
19798703|NCT01063595|42256790|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
19798704|NCT01063595|42256789|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
19798705|NCT01063595|42256790|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
19798706|NCT01063595|42256789|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
19798707|NCT01063595|42256790|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
19798708|NCT01063595|42256789|FG000|First Intervention|Adverse Event|1|||
19798709|NCT01063595|42256790|FG001|First Intervention|Adverse Event|4|||
19798710|NCT01063595|42256789|FG000|First Intervention|Withdrawal by Subject|1|||
19798711|NCT01063595|42256790|FG001|First Intervention|Withdrawal by Subject|0|||
19798712|NCT01063595|42256789|FG000|First Intervention|Reason not Specified|0|||
19798713|NCT01063595|42256790|FG001|First Intervention|Reason not Specified|1|||
19798714|NCT01063283|42256798|FG000|Cycle 1|Adverse Event|2|||
19798715|NCT01063283|42256799|FG001|Cycle 1|Adverse Event|0|||
19798716|NCT01063283|42256800|FG002|Cycle 1|Adverse Event|0|||
19798717|NCT01063283|42256798|FG000|Cycle 1|Technical failure in data collection|1|||
19798718|NCT01063283|42256799|FG001|Cycle 1|Technical failure in data collection|0|||
19798719|NCT01063283|42256800|FG002|Cycle 1|Technical failure in data collection|0|||
19798720|NCT01062971|42256808|FG000|Overall Study|Protocol Violation|1|||
19798721|NCT01062971|42256809|FG001|Overall Study|Protocol Violation|3|||
19798722|NCT01062971|42256808|FG000|Overall Study|Lost to Follow-up|3|||
19798723|NCT01062971|42256809|FG001|Overall Study|Lost to Follow-up|4|||
19798724|NCT01348165|42256822|FG000|Overall Study|Adverse Event|0|||
19798725|NCT01348165|42256823|FG001|Overall Study|Adverse Event|0|||
19477927|NCT01468181|41757277|FG002|Overall Study|Withdrawal by Subject|0|||
19798726|NCT01348165|42256824|FG002|Overall Study|Adverse Event|0|||
19798727|NCT01348165|42256825|FG003|Overall Study|Adverse Event|0|||
19798728|NCT01348165|42256826|FG004|Overall Study|Adverse Event|0|||
19798729|NCT01348165|42256827|FG005|Overall Study|Adverse Event|0|||
19798730|NCT01348165|42256828|FG006|Overall Study|Adverse Event|1|||
19798731|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Adverse Event|22|||
19798732|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Adverse Event|0|||
19798733|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
19798734|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
19798735|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
19798736|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
19798737|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
19798738|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
19798739|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
19798740|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
19798741|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
19798742|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
19798743|NCT02493868|42256848|FG000|Induction Phase: DE Participants|Other|8|||
19798744|NCT02493868|42256849|FG001|Induction Phase: DE Participants|Other|0|||
19798745|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
19798746|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
19798747|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
19798748|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
19798749|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
19798750|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
19798751|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
19798752|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
19798753|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
19798754|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
19798755|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
19608233|NCT00993473|42057136|FG001|Overall Study|Adverse Event|2|||
19608234|NCT00993473|42057135|FG000|Overall Study|Protocol Violation|1|||
19608235|NCT00993473|42057136|FG001|Overall Study|Protocol Violation|2|||
19608236|NCT00993473|42057135|FG000|Overall Study|Lost to Follow-up|1|||
19608237|NCT00993473|42057136|FG001|Overall Study|Lost to Follow-up|0|||
19608238|NCT00993473|42057135|FG000|Overall Study|Withdrawal by Subject|1|||
19608239|NCT00993473|42057136|FG001|Overall Study|Withdrawal by Subject|5|||
19608240|NCT00993473|42057135|FG000|Overall Study|Technical problem with CGM device|0|||
19608241|NCT00993473|42057136|FG001|Overall Study|Technical problem with CGM device|1|||
19608242|NCT00993473|42057135|FG000|Overall Study|Family event|1|||
19608243|NCT00993473|42057136|FG001|Overall Study|Family event|0|||
19608244|NCT00660595|42057144|FG000|Overall Study|Lost to Follow-up|0|||
19608245|NCT00660595|42057145|FG001|Overall Study|Lost to Follow-up|1|||
19608246|NCT00660595|42057144|FG000|Overall Study|Did not consent to participate in study|12|||
19608247|NCT00660595|42057145|FG001|Overall Study|Did not consent to participate in study|8|||
19608248|NCT00660595|42057144|FG000|Overall Study|Participant left hospital|1|||
19608249|NCT00660595|42057145|FG001|Overall Study|Participant left hospital|0|||
19608250|NCT00660595|42057144|FG000|Overall Study|Non Specified reasons|5|||
19798756|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
19798757|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
19798758|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
19798759|NCT02493868|42256848|FG000|Optimization Phase: DE+TE Participants|Other|10|||
19798760|NCT02493868|42256849|FG001|Optimization Phase: DE+TE Participants|Other|2|||
19798761|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
19798762|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
19798763|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
19798764|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
19798765|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
19798766|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
19798767|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
19798768|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
19798769|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
19798770|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
19798771|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
19798772|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
19798773|NCT02493868|42256848|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
19798774|NCT02493868|42256849|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
19798775|NCT02493868|42256848|FG000|Follow-up Phase|Lost to Follow-up|1|||
19608251|NCT00660595|42057145|FG001|Overall Study|Non Specified reasons|0|||
19608252|NCT00929240|42057151|FG000|Initial Treatment Phase|Adverse Event|31|||
19608253|NCT00929240|42057152|FG001|Initial Treatment Phase|Adverse Event|0|||
19608254|NCT00929240|42057153|FG002|Initial Treatment Phase|Adverse Event|0|||
19698592|NCT00296504|42143597|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
19698593|NCT00296504|42143589|FG000|Interim Analysis|Participant Moved|1|||
19698594|NCT00296504|42143590|FG001|Interim Analysis|Participant Moved|0|||
19698595|NCT00296504|42143591|FG002|Interim Analysis|Participant Moved|1|||
19698596|NCT00296504|42143592|FG003|Interim Analysis|Participant Moved|0|||
19698597|NCT00296504|42143593|FG004|Interim Analysis|Participant Moved|0|||
19698598|NCT00296504|42143594|FG005|Interim Analysis|Participant Moved|1|||
19698599|NCT00296504|42143595|FG006|Interim Analysis|Participant Moved|1|||
19698600|NCT00296504|42143596|FG007|Interim Analysis|Participant Moved|0|||
19698601|NCT00296504|42143597|FG008|Interim Analysis|Participant Moved|0|||
19698602|NCT00296504|42143589|FG000|Interim Analysis|Participant Was Incarcerated|2|||
19798776|NCT02493868|42256849|FG001|Follow-up Phase|Lost to Follow-up|0|||
19798777|NCT02493868|42256848|FG000|Follow-up Phase|Withdrawal by Subject|3|||
19798778|NCT02493868|42256849|FG001|Follow-up Phase|Withdrawal by Subject|0|||
19798779|NCT02493868|42256848|FG000|Follow-up Phase|Investigator Decision|5|||
19798780|NCT02493868|42256849|FG001|Follow-up Phase|Investigator Decision|1|||
19798781|NCT02493868|42256848|FG000|Follow-up Phase|Other|2|||
19798782|NCT02493868|42256849|FG001|Follow-up Phase|Other|1|||
19798783|NCT02516410|42256863|FG000|Overall Study|Adverse Event|0|||
19798784|NCT02516410|42256864|FG001|Overall Study|Adverse Event|1|||
19798785|NCT02516410|42256863|FG000|Overall Study|Withdrawal by Subject|0|||
19798786|NCT02516410|42256864|FG001|Overall Study|Withdrawal by Subject|1|||
19798787|NCT02493712|42256874|FG000|Overall Study|Withdrawal by Subject|1|||
19798788|NCT02493712|42256875|FG001|Overall Study|Withdrawal by Subject|0|||
19798789|NCT02493712|42256876|FG002|Overall Study|Withdrawal by Subject|2|||
19798790|NCT02493712|42256874|FG000|Overall Study|Protocol Violation|0|||
19798791|NCT02493712|42256875|FG001|Overall Study|Protocol Violation|0|||
19798792|NCT02493712|42256876|FG002|Overall Study|Protocol Violation|1|||
19798793|NCT02493712|42256874|FG000|Overall Study|Lost to Follow-up|1|||
19798794|NCT02493712|42256875|FG001|Overall Study|Lost to Follow-up|0|||
19798795|NCT02493712|42256876|FG002|Overall Study|Lost to Follow-up|0|||
19798796|NCT02493712|42256874|FG000|Overall Study|Physician Decision|0|||
19798797|NCT02493712|42256875|FG001|Overall Study|Physician Decision|1|||
19798798|NCT02493712|42256876|FG002|Overall Study|Physician Decision|0|||
19798799|NCT02493712|42256874|FG000|Overall Study|Lack of Efficacy|0|||
19798800|NCT02493712|42256875|FG001|Overall Study|Lack of Efficacy|5|||
19798801|NCT02493712|42256876|FG002|Overall Study|Lack of Efficacy|3|||
19798802|NCT02516332|42256887|FG000|Overall Study|Withdrawal by Subject|2|||
19798803|NCT02516332|42256888|FG001|Overall Study|Withdrawal by Subject|1|||
19798804|NCT02516332|42256889|FG002|Overall Study|Withdrawal by Subject|2|||
19798805|NCT02483572|42256899|FG000|Overall Study|Withdrawal by Subject|1|||
19798806|NCT02483572|42256900|FG001|Overall Study|Withdrawal by Subject|0|||
19798807|NCT02483572|42256899|FG000|Overall Study|Lost to Follow-up|1|||
19798808|NCT02483572|42256900|FG001|Overall Study|Lost to Follow-up|0|||
19798809|NCT02483572|42256899|FG000|Overall Study|Physician Decision|0|||
19798810|NCT02483572|42256900|FG001|Overall Study|Physician Decision|1|||
19798811|NCT01062425|42256908|FG000|Overall Study|Protocol Violation|3|||
19798812|NCT01062425|42256909|FG001|Overall Study|Protocol Violation|6|||
19798813|NCT01060553|42256915|FG000|Overall Study|Lost to Follow-up|3|||
19798814|NCT01060553|42256916|FG001|Overall Study|Lost to Follow-up|5|||
19798815|NCT01060553|42256915|FG000|Overall Study|Withdrawal by Subject|5|||
19798816|NCT01060553|42256916|FG001|Overall Study|Withdrawal by Subject|5|||
19798817|NCT01060553|42256915|FG000|Overall Study|Lack of Efficacy|1|||
19798818|NCT01060553|42256916|FG001|Overall Study|Lack of Efficacy|0|||
19798819|NCT02491684|42256923|FG000|Treatment Phase|Adverse Event|2|||
19798820|NCT02491684|42256924|FG001|Treatment Phase|Adverse Event|2|||
19798821|NCT02491684|42256923|FG000|Treatment Phase|Incorrect randomisation|1|||
19798822|NCT02491684|42256924|FG001|Treatment Phase|Incorrect randomisation|0|||
19798823|NCT02491684|42256923|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
19798824|NCT02491684|42256924|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
19798825|NCT01061723|42256936|FG000|Overall Study|Adverse Event|0|||
19798826|NCT01061723|42256937|FG001|Overall Study|Adverse Event|2|||
19798827|NCT01061723|42256938|FG002|Overall Study|Adverse Event|5|||
19798828|NCT01061723|42256939|FG003|Overall Study|Adverse Event|5|||
19798829|NCT01061723|42256940|FG004|Overall Study|Adverse Event|2|||
19798830|NCT01061723|42256941|FG005|Overall Study|Adverse Event|6|||
19798831|NCT01061723|42256936|FG000|Overall Study|Lack of Efficacy|2|||
19698603|NCT00296504|42143590|FG001|Interim Analysis|Participant Was Incarcerated|0|||
19698604|NCT00296504|42143591|FG002|Interim Analysis|Participant Was Incarcerated|1|||
19698605|NCT00296504|42143592|FG003|Interim Analysis|Participant Was Incarcerated|0|||
19698606|NCT00296504|42143593|FG004|Interim Analysis|Participant Was Incarcerated|0|||
19698607|NCT00296504|42143594|FG005|Interim Analysis|Participant Was Incarcerated|0|||
19798832|NCT01061723|42256937|FG001|Overall Study|Lack of Efficacy|3|||
19798833|NCT01061723|42256938|FG002|Overall Study|Lack of Efficacy|4|||
19798834|NCT01061723|42256939|FG003|Overall Study|Lack of Efficacy|2|||
19798835|NCT01061723|42256940|FG004|Overall Study|Lack of Efficacy|1|||
19798836|NCT01061723|42256941|FG005|Overall Study|Lack of Efficacy|1|||
19798837|NCT01061723|42256936|FG000|Overall Study|Randomized but not treated|0|||
19798838|NCT01061723|42256937|FG001|Overall Study|Randomized but not treated|0|||
19798839|NCT01061723|42256938|FG002|Overall Study|Randomized but not treated|0|||
19798840|NCT01061723|42256939|FG003|Overall Study|Randomized but not treated|0|||
19798841|NCT01061723|42256940|FG004|Overall Study|Randomized but not treated|0|||
19798842|NCT01061723|42256941|FG005|Overall Study|Randomized but not treated|1|||
19698608|NCT00296504|42143595|FG006|Interim Analysis|Participant Was Incarcerated|0|||
19798843|NCT01061723|42256936|FG000|Overall Study|Other than specified above|2|||
19798844|NCT01061723|42256937|FG001|Overall Study|Other than specified above|1|||
19798845|NCT01061723|42256938|FG002|Overall Study|Other than specified above|1|||
19798846|NCT01061723|42256939|FG003|Overall Study|Other than specified above|1|||
19798847|NCT01061723|42256940|FG004|Overall Study|Other than specified above|0|||
19798848|NCT01061723|42256941|FG005|Overall Study|Other than specified above|1|||
19798849|NCT01061567|42256960|FG000|Overall Study|Adverse Event|32|||
19798850|NCT01061567|42256960|FG000|Overall Study|Death|2|||
19798851|NCT01061567|42256960|FG000|Overall Study|Lack of Efficacy|3|||
19798852|NCT01061567|42256960|FG000|Overall Study|Lost to Follow-up|24|||
19798853|NCT01061567|42256960|FG000|Overall Study|Protocol Violation|1|||
19798854|NCT01061567|42256960|FG000|Overall Study|Withdrawal by Subject|11|||
19798855|NCT01061567|42256960|FG000|Overall Study|Other reason than stated above|3|||
19798856|NCT01061333|42256964|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
19798857|NCT01061333|42256965|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
19798858|NCT02489968|42256978|FG000|Open-label Treatment Period|Adverse Event|14|||
19798859|NCT02489968|42256979|FG001|Open-label Treatment Period|Adverse Event|7|||
19798860|NCT02489968|42256980|FG002|Open-label Treatment Period|Adverse Event|0|||
19798861|NCT02489968|42256981|FG003|Open-label Treatment Period|Adverse Event|0|||
19798862|NCT02489968|42256982|FG004|Open-label Treatment Period|Adverse Event|0|||
19798863|NCT02489968|42256983|FG005|Open-label Treatment Period|Adverse Event|0|||
19798864|NCT02489968|42256978|FG000|Open-label Treatment Period|Protocol Violation|2|||
19798865|NCT02489968|42256979|FG001|Open-label Treatment Period|Protocol Violation|2|||
19798866|NCT02489968|42256980|FG002|Open-label Treatment Period|Protocol Violation|0|||
19798867|NCT02489968|42256981|FG003|Open-label Treatment Period|Protocol Violation|0|||
19798868|NCT02489968|42256982|FG004|Open-label Treatment Period|Protocol Violation|0|||
19798869|NCT02489968|42256983|FG005|Open-label Treatment Period|Protocol Violation|0|||
19798870|NCT02489968|42256978|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
19798871|NCT02489968|42256979|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
19798872|NCT02489968|42256980|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
19798873|NCT02489968|42256981|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
19798874|NCT02489968|42256982|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
19798875|NCT02489968|42256983|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
19798876|NCT02489968|42256978|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
19798877|NCT02489968|42256979|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
19798878|NCT02489968|42256980|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
19798879|NCT02489968|42256981|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
19798880|NCT02489968|42256982|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
19798881|NCT02489968|42256983|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
19798882|NCT02489968|42256978|FG000|Open-label Treatment Period|Other than specified above|204|||
19798883|NCT02489968|42256979|FG001|Open-label Treatment Period|Other than specified above|189|||
19798884|NCT02489968|42256980|FG002|Open-label Treatment Period|Other than specified above|0|||
19798885|NCT02489968|42256981|FG003|Open-label Treatment Period|Other than specified above|0|||
19798886|NCT02489968|42256982|FG004|Open-label Treatment Period|Other than specified above|0|||
19798887|NCT02489968|42256983|FG005|Open-label Treatment Period|Other than specified above|0|||
19798888|NCT02489968|42256978|FG000|Double-blind Treatment Period|Adverse Event|0|||
19798889|NCT02489968|42256979|FG001|Double-blind Treatment Period|Adverse Event|0|||
19798890|NCT02489968|42256980|FG002|Double-blind Treatment Period|Adverse Event|2|||
19798891|NCT02489968|42256981|FG003|Double-blind Treatment Period|Adverse Event|6|||
19798892|NCT02489968|42256982|FG004|Double-blind Treatment Period|Adverse Event|4|||
19798893|NCT02489968|42256983|FG005|Double-blind Treatment Period|Adverse Event|5|||
19798894|NCT02489968|42256978|FG000|Double-blind Treatment Period|Protocol Violation|0|||
19798895|NCT02489968|42256979|FG001|Double-blind Treatment Period|Protocol Violation|0|||
19798896|NCT02489968|42256980|FG002|Double-blind Treatment Period|Protocol Violation|0|||
19798897|NCT02489968|42256981|FG003|Double-blind Treatment Period|Protocol Violation|0|||
19798898|NCT02489968|42256982|FG004|Double-blind Treatment Period|Protocol Violation|1|||
19798899|NCT02489968|42256983|FG005|Double-blind Treatment Period|Protocol Violation|1|||
19798900|NCT02489968|42256978|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
19798901|NCT02489968|42256979|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
19798902|NCT02489968|42256980|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19798903|NCT02489968|42256981|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
19798904|NCT02489968|42256982|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
19798905|NCT02489968|42256983|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
19798906|NCT02489968|42256978|FG000|Double-blind Treatment Period|Other than specified above|0|||
19798907|NCT02489968|42256979|FG001|Double-blind Treatment Period|Other than specified above|0|||
19798908|NCT02489968|42256980|FG002|Double-blind Treatment Period|Other than specified above|0|||
19798909|NCT02489968|42256981|FG003|Double-blind Treatment Period|Other than specified above|0|||
19798910|NCT02489968|42256982|FG004|Double-blind Treatment Period|Other than specified above|1|||
19798911|NCT02489968|42256983|FG005|Double-blind Treatment Period|Other than specified above|0|||
19798912|NCT02483416|42256997|FG000|Overall Study|Other reason|0|||
19798913|NCT02483416|42256998|FG001|Overall Study|Other reason|1|||
19798914|NCT02483416|42256997|FG000|Overall Study|Treatment stop|3|||
19798915|NCT02483416|42256998|FG001|Overall Study|Treatment stop|0|||
19798916|NCT01061177|42257005|FG000|Overall Study|Adverse Event|117|||
19477928|NCT01468181|41757278|FG003|Overall Study|Withdrawal by Subject|0|||
19798917|NCT01061177|42257005|FG000|Overall Study|Withdrawal by Subject|27|||
19798918|NCT01061177|42257005|FG000|Overall Study|Disease progression|17|||
19798919|NCT01061177|42257005|FG000|Overall Study|Protocol Violation|11|||
19798920|NCT01061177|42257005|FG000|Overall Study|Lost to Follow-up|9|||
19798921|NCT01061177|42257005|FG000|Overall Study|New cancer therapy|9|||
19798922|NCT01061177|42257005|FG000|Overall Study|Abnormal laboratory values|6|||
19798923|NCT01061177|42257005|FG000|Overall Study|Abnormal test procedure results|4|||
19798924|NCT01061177|42257005|FG000|Overall Study|Administratie problems|4|||
19798925|NCT01061177|42257005|FG000|Overall Study|Death|4|||
19798926|NCT02481934|42257009|FG000|Overall Study|Death|2|||
19798927|NCT02973425|42257015|FG000|Overall Study|Lost to Follow-up|49|||
19798928|NCT02973425|42257016|FG001|Overall Study|Lost to Follow-up|53|||
19798929|NCT02489500|42257025|FG000|Overall Study|Death|1|||
19798930|NCT02489500|42257026|FG001|Overall Study|Death|1|||
19798931|NCT02732847|42257034|FG000|Overall Study|some filled early|42|||
19798932|NCT02732847|42257035|FG001|Overall Study|some filled early|42|||
19798933|NCT02489344|42257041|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
19798934|NCT02489344|42257041|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
19798935|NCT02489344|42257041|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
19798936|NCT02489344|42257041|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
19798937|NCT02488330|42257045|FG000|Overall Study|Adverse Event|1|||
19798938|NCT02488330|42257045|FG000|Overall Study|Physician Decision|2|||
19798939|NCT02488330|42257045|FG000|Overall Study|Death|2|||
19798940|NCT02488330|42257045|FG000|Overall Study|Disease Progression|3|||
19798941|NCT02488330|42257045|FG000|Overall Study|Study Termination by Sponsor|4|||
19798942|NCT02481310|42257052|FG000|Follow up|Still in follow up|0|||
19798943|NCT02481310|42257053|FG001|Follow up|Still in follow up|3|||
19798944|NCT02481310|42257054|FG002|Follow up|Still in follow up|0|||
19798945|NCT02480764|42257061|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
19798946|NCT02480764|42257062|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
19798947|NCT02480764|42257063|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
19798948|NCT02480764|42257061|FG000|Overall Study|Major Protocol Deviation|1|||
19798949|NCT02480764|42257062|FG001|Overall Study|Major Protocol Deviation|4|||
19798950|NCT02480764|42257063|FG002|Overall Study|Major Protocol Deviation|3|||
19798951|NCT02480764|42257061|FG000|Overall Study|Lost to Follow-up|0|||
19798952|NCT02480764|42257062|FG001|Overall Study|Lost to Follow-up|1|||
19798953|NCT02480764|42257063|FG002|Overall Study|Lost to Follow-up|2|||
19798954|NCT02480764|42257061|FG000|Overall Study|Voluntary Withdrawal|6|||
19798955|NCT02480764|42257062|FG001|Overall Study|Voluntary Withdrawal|5|||
19798956|NCT02480764|42257063|FG002|Overall Study|Voluntary Withdrawal|10|||
19798957|NCT02480764|42257061|FG000|Overall Study|Lack of Efficacy|0|||
19798958|NCT02480764|42257062|FG001|Overall Study|Lack of Efficacy|3|||
19798959|NCT02480764|42257063|FG002|Overall Study|Lack of Efficacy|3|||
19798960|NCT02480764|42257061|FG000|Overall Study|Reason not Specified|0|||
19798961|NCT02480764|42257062|FG001|Overall Study|Reason not Specified|1|||
19798962|NCT02480764|42257063|FG002|Overall Study|Reason not Specified|0|||
19798963|NCT02487472|42257071|FG000|Overall Study|Did not complete telephonic interviews|9|||
19798964|NCT02487472|42257071|FG000|Overall Study|Other|2|||
19798965|NCT02451670|42257079|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
19798966|NCT02451670|42257080|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
19798967|NCT02486692|42257088|FG000|Overall Study|did not login for randomization|4|||
19798968|NCT02486692|42257089|FG001|Overall Study|did not login for randomization|7|||
19798969|NCT01060007|42257106|FG000|Overall Study|Withdrawal by Subject|1|||
19798970|NCT01060007|42257106|FG000|Overall Study|Inevaluable for response at surgery|3|||
19367565|NCT02433340|41607757|FG003|Overall Study|Withdrawal by Subject|2|||
19367566|NCT02433340|41607754|FG000|Overall Study|Lost to Follow-up|0|||
19367567|NCT02433340|41607755|FG001|Overall Study|Lost to Follow-up|1|||
19367568|NCT02433340|41607756|FG002|Overall Study|Lost to Follow-up|0|||
19367569|NCT02433340|41607757|FG003|Overall Study|Lost to Follow-up|0|||
19698609|NCT00296504|42143596|FG007|Interim Analysis|Participant Was Incarcerated|0|||
19698610|NCT00296504|42143597|FG008|Interim Analysis|Participant Was Incarcerated|0|||
19698611|NCT00296504|42143589|FG000|Interim Analysis|Resistance to FPV|0|||
19698612|NCT00296504|42143590|FG001|Interim Analysis|Resistance to FPV|0|||
19698613|NCT00296504|42143591|FG002|Interim Analysis|Resistance to FPV|1|||
19698614|NCT00296504|42143592|FG003|Interim Analysis|Resistance to FPV|0|||
19698615|NCT00296504|42143593|FG004|Interim Analysis|Resistance to FPV|0|||
19698616|NCT00296504|42143594|FG005|Interim Analysis|Resistance to FPV|0|||
19698617|NCT00296504|42143595|FG006|Interim Analysis|Resistance to FPV|0|||
19698618|NCT00296504|42143596|FG007|Interim Analysis|Resistance to FPV|0|||
19698619|NCT00296504|42143597|FG008|Interim Analysis|Resistance to FPV|0|||
19698620|NCT00296504|42143589|FG000|Interim Analysis|Physician Decision|0|||
19698621|NCT00296504|42143590|FG001|Interim Analysis|Physician Decision|0|||
19698622|NCT00296504|42143591|FG002|Interim Analysis|Physician Decision|1|||
19798971|NCT02971163|42257115|FG000|Overall Study|Lost to Follow-up|4|||
19367570|NCT02433340|41607754|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
19698623|NCT00296504|42143592|FG003|Interim Analysis|Physician Decision|0|||
19698624|NCT00296504|42143593|FG004|Interim Analysis|Physician Decision|0|||
19798972|NCT02971163|42257116|FG001|Overall Study|Lost to Follow-up|2|||
19798973|NCT02971007|42257125|FG000|Overall Study|Adverse Event|1|||
19798974|NCT02971007|42257126|FG001|Overall Study|Adverse Event|0|||
19798975|NCT02971007|42257127|FG002|Overall Study|Adverse Event|0|||
19798976|NCT02971007|42257125|FG000|Overall Study|Lost to Follow-up|0|||
19798977|NCT02971007|42257126|FG001|Overall Study|Lost to Follow-up|1|||
19798978|NCT02971007|42257127|FG002|Overall Study|Lost to Follow-up|1|||
19798979|NCT02971007|42257125|FG000|Overall Study|Withdrawal by Subject|0|||
19798980|NCT02971007|42257126|FG001|Overall Study|Withdrawal by Subject|1|||
19798981|NCT02971007|42257127|FG002|Overall Study|Withdrawal by Subject|0|||
19798982|NCT02971007|42257125|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
19798983|NCT02971007|42257126|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
19798984|NCT02971007|42257127|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
19798985|NCT02971007|42257125|FG000|Overall Study|Patient discontinued study drug|0|||
19798986|NCT02971007|42257126|FG001|Overall Study|Patient discontinued study drug|1|||
19798987|NCT02971007|42257127|FG002|Overall Study|Patient discontinued study drug|0|||
19798988|NCT03881553|42257138|FG000|Overall Study|Discharged prior to participation|1|||
19798989|NCT03881553|42257139|FG001|Overall Study|Discharged prior to participation|1|||
19798990|NCT03881553|42257140|FG002|Overall Study|Discharged prior to participation|0|||
19798991|NCT03881553|42257138|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
19798992|NCT03881553|42257139|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
19798993|NCT03881553|42257140|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
19798994|NCT02970929|42257148|FG000|Overall Study|Adverse Event|18|||
19798995|NCT02970929|42257148|FG000|Overall Study|Lack of Efficacy|8|||
19798996|NCT02970929|42257148|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
19798997|NCT02970929|42257148|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
19798998|NCT02970929|42257148|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
19798999|NCT02970929|42257148|FG000|Overall Study|LOST TO FOLLOWUP|6|||
19799000|NCT02970929|42257148|FG000|Overall Study|MOVED OUT OF STATE|1|||
19799001|NCT02970929|42257148|FG000|Overall Study|Withdrawal by Subject|16|||
19799002|NCT02970305|42257165|FG000|Overall Study|Adverse Event|10|||
19799003|NCT02970305|42257166|FG001|Overall Study|Adverse Event|6|||
19799004|NCT02970305|42257165|FG000|Overall Study|Lack of Efficacy|1|||
19799005|NCT02970305|42257166|FG001|Overall Study|Lack of Efficacy|1|||
19799006|NCT02970305|42257165|FG000|Overall Study|Noncompliance with study drug|2|||
19799007|NCT02970305|42257166|FG001|Overall Study|Noncompliance with study drug|4|||
19799008|NCT02970305|42257165|FG000|Overall Study|Protocol Violation|2|||
19799009|NCT02970305|42257166|FG001|Overall Study|Protocol Violation|2|||
19799010|NCT02970305|42257165|FG000|Overall Study|Withdrawal by Subject|12|||
19799011|NCT02970305|42257166|FG001|Overall Study|Withdrawal by Subject|11|||
19799012|NCT02970305|42257165|FG000|Overall Study|Not further specified|1|||
19799013|NCT02970305|42257166|FG001|Overall Study|Not further specified|2|||
19799014|NCT02970305|42257165|FG000|Overall Study|Lost to Follow-up|1|||
19799015|NCT02970305|42257166|FG001|Overall Study|Lost to Follow-up|2|||
19799016|NCT03654651|42257183|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
19799017|NCT03654651|42257184|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
19799018|NCT02022033|42257195|FG000|Overall Study|Physician Decision|1|||
19799019|NCT03505671|42257201|FG000|Overall Study|Withdrawal by Subject|2|||
19799020|NCT03505671|42257202|FG001|Overall Study|Withdrawal by Subject|1|||
19799021|NCT03505671|42257201|FG000|Overall Study|Lost to Follow-up|1|||
19799022|NCT03505671|42257202|FG001|Overall Study|Lost to Follow-up|0|||
19799023|NCT01103349|42257223|FG000|Overall Study|Adverse Event|8|||
19799024|NCT01103349|42257224|FG001|Overall Study|Adverse Event|5|||
19799025|NCT01103349|42257225|FG002|Overall Study|Adverse Event|3|||
19799026|NCT01103349|42257223|FG000|Overall Study|Consent withdrawn|1|||
19799027|NCT01103349|42257224|FG001|Overall Study|Consent withdrawn|0|||
19799028|NCT01103349|42257225|FG002|Overall Study|Consent withdrawn|0|||
19799029|NCT01103349|42257223|FG000|Overall Study|Incorrectly included in the trial|1|||
19799030|NCT01103349|42257224|FG001|Overall Study|Incorrectly included in the trial|0|||
19799031|NCT01103349|42257225|FG002|Overall Study|Incorrectly included in the trial|0|||
19799032|NCT01103349|42257223|FG000|Overall Study|Withdrawal by Subject|1|||
19799033|NCT01103349|42257224|FG001|Overall Study|Withdrawal by Subject|1|||
19799034|NCT01103349|42257225|FG002|Overall Study|Withdrawal by Subject|0|||
19799035|NCT01103349|42257223|FG000|Overall Study|did not want to take trial medication|0|||
19799036|NCT01103349|42257224|FG001|Overall Study|did not want to take trial medication|1|||
19799037|NCT01103349|42257225|FG002|Overall Study|did not want to take trial medication|0|||
19799038|NCT01103349|42257223|FG000|Overall Study|forgot to take medication|0|||
19799039|NCT01103349|42257224|FG001|Overall Study|forgot to take medication|0|||
19799040|NCT01103349|42257225|FG002|Overall Study|forgot to take medication|1|||
19799041|NCT02959177|42257236|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
19799042|NCT02959177|42257237|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
19799043|NCT02959177|42257238|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
19799044|NCT02959177|42257236|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
19799045|NCT02959177|42257237|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
19799046|NCT02959177|42257238|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
19799047|NCT02959177|42257236|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
19799048|NCT02959177|42257237|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
19799049|NCT02959177|42257238|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
19799050|NCT02959177|42257236|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
19799051|NCT02959177|42257237|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19799052|NCT02959177|42257238|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
19799053|NCT02959177|42257236|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
19799054|NCT02959177|42257237|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
19799055|NCT02959177|42257238|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
19799056|NCT02959177|42257236|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
19608255|NCT00929240|42057151|FG000|Initial Treatment Phase|Disease progression|41|||
19608256|NCT00929240|42057152|FG001|Initial Treatment Phase|Disease progression|0|||
19608257|NCT00929240|42057153|FG002|Initial Treatment Phase|Disease progression|0|||
19608258|NCT00929240|42057151|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
19698625|NCT00296504|42143594|FG005|Interim Analysis|Physician Decision|0|||
19698626|NCT00296504|42143595|FG006|Interim Analysis|Physician Decision|0|||
19698627|NCT00296504|42143596|FG007|Interim Analysis|Physician Decision|0|||
19698628|NCT00296504|42143597|FG008|Interim Analysis|Physician Decision|0|||
19608259|NCT00929240|42057152|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
19608260|NCT00929240|42057153|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
19608261|NCT00929240|42057151|FG000|Initial Treatment Phase|Protocol Violation|5|||
19608262|NCT00929240|42057152|FG001|Initial Treatment Phase|Protocol Violation|0|||
19608263|NCT00929240|42057153|FG002|Initial Treatment Phase|Protocol Violation|0|||
19608264|NCT00929240|42057151|FG000|Initial Treatment Phase|Death|2|||
19608265|NCT00929240|42057152|FG001|Initial Treatment Phase|Death|0|||
19608266|NCT00929240|42057153|FG002|Initial Treatment Phase|Death|0|||
19608267|NCT00929240|42057151|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
19608268|NCT00929240|42057152|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
19608269|NCT00929240|42057153|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
19608270|NCT00929240|42057151|FG000|Initial Treatment Phase|Physician Decision|4|||
19608271|NCT00929240|42057152|FG001|Initial Treatment Phase|Physician Decision|0|||
19608272|NCT00929240|42057153|FG002|Initial Treatment Phase|Physician Decision|0|||
19608273|NCT00929240|42057151|FG000|Maintenance Phase|Disease progression|0|||
19608274|NCT00929240|42057152|FG001|Maintenance Phase|Disease progression|73|||
19608275|NCT00929240|42057153|FG002|Maintenance Phase|Disease progression|60|||
19608276|NCT00929240|42057151|FG000|Maintenance Phase|Adverse Event|0|||
19608277|NCT00929240|42057152|FG001|Maintenance Phase|Adverse Event|9|||
19608278|NCT00929240|42057153|FG002|Maintenance Phase|Adverse Event|12|||
19608279|NCT00929240|42057151|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19608280|NCT00929240|42057152|FG001|Maintenance Phase|Withdrawal by Subject|2|||
19698629|NCT00296504|42143589|FG000|Interim Analysis|Principle Investigator Discretion|2|||
19698630|NCT00296504|42143590|FG001|Interim Analysis|Principle Investigator Discretion|0|||
19698631|NCT00296504|42143591|FG002|Interim Analysis|Principle Investigator Discretion|1|||
19698632|NCT00296504|42143592|FG003|Interim Analysis|Principle Investigator Discretion|1|||
19698633|NCT00296504|42143593|FG004|Interim Analysis|Principle Investigator Discretion|0|||
19698634|NCT00296504|42143594|FG005|Interim Analysis|Principle Investigator Discretion|0|||
19698635|NCT00296504|42143595|FG006|Interim Analysis|Principle Investigator Discretion|0|||
19698636|NCT00296504|42143596|FG007|Interim Analysis|Principle Investigator Discretion|0|||
19698637|NCT00296504|42143597|FG008|Interim Analysis|Principle Investigator Discretion|0|||
19799057|NCT02959177|42257237|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
19608281|NCT00929240|42057153|FG002|Maintenance Phase|Withdrawal by Subject|6|||
19608282|NCT00929240|42057151|FG000|Maintenance Phase|Protocol Violation|0|||
19608283|NCT00929240|42057152|FG001|Maintenance Phase|Protocol Violation|1|||
19608284|NCT00929240|42057153|FG002|Maintenance Phase|Protocol Violation|0|||
19608285|NCT00929240|42057151|FG000|Maintenance Phase|Health authority/Study termination|0|||
19799058|NCT02959177|42257238|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
19608286|NCT00929240|42057152|FG001|Maintenance Phase|Health authority/Study termination|1|||
19608287|NCT00929240|42057153|FG002|Maintenance Phase|Health authority/Study termination|2|||
19608288|NCT00929240|42057151|FG000|Maintenance Phase|Physician Decision|0|||
19608289|NCT00929240|42057152|FG001|Maintenance Phase|Physician Decision|2|||
19608290|NCT00929240|42057153|FG002|Maintenance Phase|Physician Decision|1|||
19608291|NCT00929240|42057151|FG000|Maintenance Phase|Change of treatment|0|||
19608292|NCT00929240|42057152|FG001|Maintenance Phase|Change of treatment|4|||
19608293|NCT00929240|42057153|FG002|Maintenance Phase|Change of treatment|0|||
19608294|NCT00929240|42057151|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
19698638|NCT00296504|42143589|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
19698639|NCT00296504|42143590|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
19799059|NCT02959177|42257236|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
19799060|NCT02959177|42257237|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
19799061|NCT02959177|42257238|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
19799062|NCT04706403|42257255|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
19799063|NCT04706403|42257256|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
19799064|NCT04706403|42257257|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
19799065|NCT04706403|42257258|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
19799066|NCT04706403|42257259|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
19799067|NCT02983617|42257273|FG000|Overall Study|Adverse Event|0|||
19799068|NCT02983617|42257274|FG001|Overall Study|Adverse Event|7|||
19799069|NCT02983617|42257273|FG000|Overall Study|Death|0|||
19799070|NCT02983617|42257274|FG001|Overall Study|Death|1|||
19799071|NCT02983617|42257273|FG000|Overall Study|Investigator's Discretion|0|||
19799072|NCT02983617|42257274|FG001|Overall Study|Investigator's Discretion|1|||
19799073|NCT02873689|42257282|FG000|Overall Study|Lack of Efficacy|1|||
19799074|NCT02873689|42257283|FG001|Overall Study|Lack of Efficacy|0|||
19799075|NCT02873689|42257282|FG000|Overall Study|Withdrawal by Subject|2|||
19799076|NCT02873689|42257283|FG001|Overall Study|Withdrawal by Subject|2|||
19799077|NCT02873689|42257282|FG000|Overall Study|Protocol Violation|1|||
19799078|NCT02873689|42257283|FG001|Overall Study|Protocol Violation|0|||
19799079|NCT02873689|42257282|FG000|Overall Study|Adverse Event|2|||
19799080|NCT02873689|42257283|FG001|Overall Study|Adverse Event|2|||
19799081|NCT02873689|42257282|FG000|Overall Study|Randomized but not Treated|1|||
19799082|NCT02873689|42257283|FG001|Overall Study|Randomized but not Treated|1|||
19799083|NCT02901431|42257297|FG000|PK Part|Adverse Event|0|||
19799084|NCT02901431|42257298|FG001|PK Part|Adverse Event|1|||
19799085|NCT02901431|42257299|FG002|PK Part|Adverse Event|0|||
19799086|NCT02901431|42257300|FG003|PK Part|Adverse Event|0|||
19799087|NCT02901431|42257301|FG004|PK Part|Adverse Event|0|||
19799088|NCT02901431|42257302|FG005|PK Part|Adverse Event|0|||
19799089|NCT02901431|42257303|FG006|PK Part|Adverse Event|0|||
19799090|NCT02901431|42257304|FG007|PK Part|Adverse Event|0|||
19799091|NCT02901431|42257305|FG008|PK Part|Adverse Event|0|||
19799092|NCT02901431|42257306|FG009|PK Part|Adverse Event|0|||
19799093|NCT02901431|42257307|FG010|PK Part|Adverse Event|0|||
19799094|NCT02901431|42257308|FG011|PK Part|Adverse Event|0|||
19799095|NCT02901431|42257309|FG012|PK Part|Adverse Event|0|||
19799096|NCT02901431|42257297|FG000|PK Part|Lost to Follow-up|0|||
19799097|NCT02901431|42257298|FG001|PK Part|Lost to Follow-up|0|||
19799098|NCT02901431|42257299|FG002|PK Part|Lost to Follow-up|1|||
19799099|NCT02901431|42257300|FG003|PK Part|Lost to Follow-up|0|||
19799100|NCT02901431|42257301|FG004|PK Part|Lost to Follow-up|0|||
19799101|NCT02901431|42257302|FG005|PK Part|Lost to Follow-up|0|||
19799102|NCT02901431|42257303|FG006|PK Part|Lost to Follow-up|0|||
19799103|NCT02901431|42257304|FG007|PK Part|Lost to Follow-up|0|||
19799104|NCT02901431|42257305|FG008|PK Part|Lost to Follow-up|0|||
19799105|NCT02901431|42257306|FG009|PK Part|Lost to Follow-up|0|||
19799106|NCT02901431|42257307|FG010|PK Part|Lost to Follow-up|0|||
19799107|NCT02901431|42257308|FG011|PK Part|Lost to Follow-up|0|||
19799108|NCT02901431|42257309|FG012|PK Part|Lost to Follow-up|0|||
19799109|NCT02901431|42257297|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
19367571|NCT02433340|41607755|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
19367572|NCT02433340|41607756|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
19367573|NCT02433340|41607757|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
19367574|NCT02433340|41607754|FG000|Overall Study|Other|0|||
19367575|NCT02433340|41607755|FG001|Overall Study|Other|1|||
19367576|NCT02433340|41607756|FG002|Overall Study|Other|0|||
19367577|NCT02433340|41607757|FG003|Overall Study|Other|0|||
19367578|NCT02400346|41607769|FG000|Overall Study|Adverse Event|24|||
19367579|NCT02400346|41607769|FG000|Overall Study|Lack of Efficacy|9|||
19367580|NCT02400346|41607769|FG000|Overall Study|Non-compliance with IMP|1|||
19367581|NCT02400346|41607769|FG000|Overall Study|Withdrawal by Subject|7|||
19367582|NCT02400346|41607769|FG000|Overall Study|Administrative or other reason(s)|2|||
19367583|NCT02400346|41607769|FG000|Overall Study|Lost to Follow-up|1|||
19367584|NCT02399254|41607773|FG000|Overall Study|Physician Decision|2|||
19367585|NCT02456662|41607780|FG000|Overall Study|Lost to Follow-up|2|||
19799110|NCT02901431|42257298|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799111|NCT02901431|42257299|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799112|NCT02901431|42257300|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799113|NCT02901431|42257301|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799114|NCT02901431|42257302|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799115|NCT02901431|42257303|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799116|NCT02901431|42257304|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19367586|NCT02456662|41607781|FG001|Overall Study|Lost to Follow-up|1|||
19367587|NCT01653262|41607787|FG000|Overall Study|Lack of Efficacy|1|||
19367588|NCT01653262|41607787|FG000|Overall Study|SAE, non-fatal|1|||
19367589|NCT01653262|41607787|FG000|Overall Study|AE, non-serious non-fatal|1|||
19367590|NCT02455336|41607793|FG000|Overall Study|Withdrawal by Subject|0|||
19367591|NCT02455336|41607794|FG001|Overall Study|Withdrawal by Subject|2|||
19367592|NCT02455336|41607793|FG000|Overall Study|Adverse Event|3|||
19367593|NCT02455336|41607794|FG001|Overall Study|Adverse Event|0|||
19367594|NCT02455336|41607793|FG000|Overall Study|Non-responder to treatment|2|||
19367595|NCT02455336|41607794|FG001|Overall Study|Non-responder to treatment|0|||
19367596|NCT02397694|41607802|FG000|Double-Blinded Phase|Adverse Event|1|||
19367597|NCT02397694|41607803|FG001|Double-Blinded Phase|Adverse Event|0|||
19367598|NCT02397694|41607802|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
19367599|NCT02397694|41607803|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
19367600|NCT02397694|41607802|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
19367601|NCT02397694|41607803|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
19367602|NCT02397694|41607802|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
19367603|NCT02397694|41607803|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
19367604|NCT02397694|41607802|FG000|Open Label Extension Phase|Protocol Violation|1|||
19367605|NCT02397694|41607803|FG001|Open Label Extension Phase|Protocol Violation|0|||
19367606|NCT02397694|41607802|FG000|Open Label Extension Phase|Withdrew Consent|3|||
19367607|NCT02397694|41607803|FG001|Open Label Extension Phase|Withdrew Consent|1|||
19367608|NCT02397694|41607802|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
19367609|NCT02397694|41607803|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
19367610|NCT02783599|41607813|FG000|Overall Study|Progressive disease|23|||
19367611|NCT02783599|41607813|FG000|Overall Study|Surgical Resection|10|||
19367612|NCT02783599|41607813|FG000|Overall Study|Adverse Event|4|||
19367613|NCT02783599|41607813|FG000|Overall Study|Physician Decision|2|||
19367614|NCT02783599|41607813|FG000|Overall Study|Death|1|||
19367615|NCT02838017|41607826|FG000|Overall Study|Lost to Follow-up|14|||
19367616|NCT02838017|41607827|FG001|Overall Study|Lost to Follow-up|11|||
19367617|NCT03188666|41607835|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
19367618|NCT03188666|41607836|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
19367619|NCT03188666|41607837|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
19367620|NCT03188666|41607838|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
19367621|NCT03188666|41607835|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
19367622|NCT03188666|41607836|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
19367623|NCT03188666|41607837|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
19367624|NCT03188666|41607838|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
19367625|NCT03188666|41607835|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
19367626|NCT03188666|41607836|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
19367627|NCT03188666|41607837|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
19367628|NCT03188666|41607838|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
19367629|NCT03188666|41607835|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
19367630|NCT03188666|41607836|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
19367631|NCT03188666|41607837|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
19367632|NCT03188666|41607838|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
19367633|NCT02836769|41607852|FG000|Overall Study|Lost to Follow-up|10|||
19367634|NCT02836769|41607852|FG000|Overall Study|Medical withdrawal|2|||
19367635|NCT02836769|41607852|FG000|Overall Study|Withdrawal by Subject|3|||
19367636|NCT02836613|41607858|FG000|Overall Study|Accidental drowning|1|||
19367637|NCT02836613|41607859|FG001|Overall Study|Accidental drowning|0|||
19367638|NCT02836613|41607858|FG000|Overall Study|Lost to Follow-up|0|||
19367639|NCT02836613|41607859|FG001|Overall Study|Lost to Follow-up|1|||
19367640|NCT02836613|41607858|FG000|Overall Study|Withdrawal by Subject|0|||
19367641|NCT02836613|41607859|FG001|Overall Study|Withdrawal by Subject|2|||
19367642|NCT02397460|41607873|FG000|Treatment Period 2|Adverse Event|0|||
19367643|NCT02397460|41607874|FG001|Treatment Period 2|Adverse Event|0|||
19367644|NCT02397460|41607875|FG002|Treatment Period 2|Adverse Event|0|||
19367645|NCT02397460|41607876|FG003|Treatment Period 2|Adverse Event|0|||
19367646|NCT02397460|41607877|FG004|Treatment Period 2|Adverse Event|0|||
19367647|NCT02397460|41607878|FG005|Treatment Period 2|Adverse Event|0|||
19367648|NCT02397460|41607879|FG006|Treatment Period 2|Adverse Event|0|||
19367649|NCT02397460|41607880|FG007|Treatment Period 2|Adverse Event|1|||
19367650|NCT02397460|41607873|FG000|Treatment Period 4|Adverse Event|0|||
19367651|NCT02397460|41607874|FG001|Treatment Period 4|Adverse Event|1|||
19367652|NCT02397460|41607875|FG002|Treatment Period 4|Adverse Event|0|||
19367653|NCT02397460|41607876|FG003|Treatment Period 4|Adverse Event|0|||
19367654|NCT02397460|41607877|FG004|Treatment Period 4|Adverse Event|0|||
19367655|NCT02397460|41607878|FG005|Treatment Period 4|Adverse Event|0|||
19367656|NCT02397460|41607879|FG006|Treatment Period 4|Adverse Event|0|||
19367657|NCT02397460|41607880|FG007|Treatment Period 4|Adverse Event|0|||
19367658|NCT02397460|41607873|FG000|Treatment Period 4|Physician Decision|0|||
19367659|NCT02397460|41607874|FG001|Treatment Period 4|Physician Decision|0|||
19367660|NCT02397460|41607875|FG002|Treatment Period 4|Physician Decision|0|||
19367661|NCT02397460|41607876|FG003|Treatment Period 4|Physician Decision|0|||
19367662|NCT02397460|41607877|FG004|Treatment Period 4|Physician Decision|1|||
19367663|NCT02397460|41607878|FG005|Treatment Period 4|Physician Decision|0|||
19367664|NCT02397460|41607879|FG006|Treatment Period 4|Physician Decision|0|||
19367665|NCT02397460|41607880|FG007|Treatment Period 4|Physician Decision|0|||
19367666|NCT02834819|41607956|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
19367667|NCT02834819|41607957|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
19367668|NCT02454478|41607963|FG000|Overall Study|Incomplete DLT Evaluation|1|||
19367669|NCT01341587|41607969|FG000|Overall Study|Lost to Follow-up|2|||
19367670|NCT01341587|41607970|FG001|Overall Study|Lost to Follow-up|0|||
19367671|NCT01341587|41607969|FG000|Overall Study|stopped using the meters|2|||
19367672|NCT01341587|41607970|FG001|Overall Study|stopped using the meters|10|||
19367673|NCT01358825|41607978|FG000|Overall Study|Blood sample not drawn|0|||
19367674|NCT01358825|41607979|FG001|Overall Study|Blood sample not drawn|1|||
19367675|NCT02453386|41607988|FG000|Overall Study|Adverse Event|22|||
19367676|NCT02453386|41607989|FG001|Overall Study|Adverse Event|30|||
19367677|NCT02453386|41607990|FG002|Overall Study|Adverse Event|15|||
19367678|NCT02453386|41607988|FG000|Overall Study|Protocol Violation|1|||
19367679|NCT02453386|41607989|FG001|Overall Study|Protocol Violation|0|||
19367680|NCT02453386|41607990|FG002|Overall Study|Protocol Violation|1|||
19367681|NCT02453386|41607988|FG000|Overall Study|Withdrawal by Subject|10|||
19367682|NCT02453386|41607989|FG001|Overall Study|Withdrawal by Subject|9|||
19367683|NCT02453386|41607990|FG002|Overall Study|Withdrawal by Subject|9|||
19367684|NCT02453386|41607988|FG000|Overall Study|Sponsor Terminated Study|14|||
19367685|NCT02453386|41607989|FG001|Overall Study|Sponsor Terminated Study|8|||
19367686|NCT02453386|41607990|FG002|Overall Study|Sponsor Terminated Study|11|||
19367687|NCT02453386|41607988|FG000|Overall Study|Subject Terminated by Sponsor|1|||
19367688|NCT02453386|41607989|FG001|Overall Study|Subject Terminated by Sponsor|1|||
19367689|NCT02453386|41607990|FG002|Overall Study|Subject Terminated by Sponsor|1|||
19367690|NCT02453386|41607988|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
19367691|NCT02453386|41607989|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
19367692|NCT02453386|41607990|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
19367693|NCT02453386|41607988|FG000|Overall Study|Lost to Follow-up|0|||
19367694|NCT02453386|41607989|FG001|Overall Study|Lost to Follow-up|0|||
19367695|NCT02453386|41607990|FG002|Overall Study|Lost to Follow-up|1|||
19367696|NCT02453386|41607988|FG000|Overall Study|Other|1|||
19367697|NCT02453386|41607989|FG001|Overall Study|Other|0|||
19367698|NCT02453386|41607990|FG002|Overall Study|Other|1|||
19367699|NCT02431468|41608008|FG000|Overall Study|Adverse Event|2|||
19367700|NCT02431468|41608009|FG001|Overall Study|Adverse Event|4|||
19367701|NCT02431468|41608010|FG002|Overall Study|Adverse Event|5|||
19367702|NCT02431468|41608008|FG000|Overall Study|Withdrawal by Subject|4|||
19367703|NCT02431468|41608009|FG001|Overall Study|Withdrawal by Subject|12|||
19367704|NCT02431468|41608010|FG002|Overall Study|Withdrawal by Subject|2|||
19367705|NCT02431468|41608008|FG000|Overall Study|noncompliance, investigator termination,|2|||
19367706|NCT02431468|41608009|FG001|Overall Study|noncompliance, investigator termination,|2|||
19367707|NCT02431468|41608010|FG002|Overall Study|noncompliance, investigator termination,|2|||
19367708|NCT02452762|41608026|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
19367709|NCT02452762|41608027|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
19367710|NCT02452762|41608026|FG000|Overall Study|Withdrawal by Subject|1|||
19367711|NCT02452762|41608027|FG001|Overall Study|Withdrawal by Subject|0|||
19367712|NCT02631746|41608034|FG000|Overall Study|Lack of Efficacy|3|||
19367713|NCT02633306|41608038|FG000|Overall Study|Withdrawal by Subject|3|||
19367714|NCT02396758|41608047|FG000|Overall Study|Withdrawal by Subject|2|||
19367715|NCT02396758|41608048|FG001|Overall Study|Withdrawal by Subject|0|||
19367716|NCT02396758|41608049|FG002|Overall Study|Withdrawal by Subject|0|||
19367717|NCT02396758|41608050|FG003|Overall Study|Withdrawal by Subject|1|||
19367718|NCT02396758|41608047|FG000|Overall Study|Lost to Follow-up|8|||
19367719|NCT02396758|41608048|FG001|Overall Study|Lost to Follow-up|5|||
19367720|NCT02396758|41608049|FG002|Overall Study|Lost to Follow-up|3|||
19367721|NCT02396758|41608050|FG003|Overall Study|Lost to Follow-up|3|||
19367722|NCT02396758|41608047|FG000|Overall Study|Death|1|||
19367723|NCT02396758|41608048|FG001|Overall Study|Death|1|||
19367724|NCT02396758|41608049|FG002|Overall Study|Death|0|||
19367725|NCT02396758|41608050|FG003|Overall Study|Death|1|||
19367726|NCT02396758|41608047|FG000|Overall Study|Randomized but not treated|1|||
19367727|NCT02396758|41608048|FG001|Overall Study|Randomized but not treated|0|||
19367728|NCT02396758|41608049|FG002|Overall Study|Randomized but not treated|1|||
19367729|NCT02396758|41608050|FG003|Overall Study|Randomized but not treated|0|||
19367730|NCT02632838|41608062|FG000|Overall Study|Withdrawal by Subject|3|||
19367731|NCT02632838|41608063|FG001|Overall Study|Withdrawal by Subject|0|||
19367732|NCT02632838|41608062|FG000|Overall Study|Lost to Follow-up|0|||
19367733|NCT02632838|41608063|FG001|Overall Study|Lost to Follow-up|2|||
19367734|NCT02396212|41608073|FG000|Overall Study|Adverse Event|1|||
19367735|NCT02396212|41608073|FG000|Overall Study|Lack of Efficacy|2|||
19367736|NCT02395822|41608077|FG000|Overall Study|Withdrawal by Subject|1|||
19367737|NCT02395822|41608077|FG000|Overall Study|Death|1|||
19367738|NCT01651936|41608083|FG000|Base Study|Adverse Event|3|||
19367739|NCT01651936|41608084|FG001|Base Study|Adverse Event|0|||
19367740|NCT01651936|41608085|FG002|Base Study|Adverse Event|0|||
19367741|NCT01651936|41608083|FG000|Base Study|Withdrawal by Subject|1|||
19367742|NCT01651936|41608084|FG001|Base Study|Withdrawal by Subject|1|||
19367743|NCT01651936|41608085|FG002|Base Study|Withdrawal by Subject|0|||
19367744|NCT01651936|41608083|FG000|Base Study|Early Escape|2|||
19367745|NCT01651936|41608084|FG001|Base Study|Early Escape|8|||
19367746|NCT01651936|41608085|FG002|Base Study|Early Escape|0|||
19367747|NCT01651936|41608083|FG000|Base Study|Study terminated by sponsor|21|||
19367748|NCT01651936|41608084|FG001|Base Study|Study terminated by sponsor|16|||
19367749|NCT01651936|41608085|FG002|Base Study|Study terminated by sponsor|0|||
19367750|NCT01651936|41608083|FG000|Extension Study|Lack of Efficacy|0|||
19367751|NCT01651936|41608084|FG001|Extension Study|Lack of Efficacy|0|||
19367752|NCT01651936|41608085|FG002|Extension Study|Lack of Efficacy|1|||
19367753|NCT01651936|41608083|FG000|Extension Study|Study terminated by sponsor|0|||
19367754|NCT01651936|41608084|FG001|Extension Study|Study terminated by sponsor|0|||
19367755|NCT01651936|41608085|FG002|Extension Study|Study terminated by sponsor|13|||
19367756|NCT02395042|41608095|FG000|Treatment 1 Period|Adverse Event|1|||
19367757|NCT02395042|41608096|FG001|Treatment 1 Period|Adverse Event|3|||
19367758|NCT02395042|41608097|FG002|Treatment 1 Period|Adverse Event|1|||
19367759|NCT02395042|41608095|FG000|Treatment 1 Period|Lack of Efficacy|1|||
19367760|NCT02395042|41608096|FG001|Treatment 1 Period|Lack of Efficacy|1|||
19367761|NCT02395042|41608097|FG002|Treatment 1 Period|Lack of Efficacy|0|||
19367762|NCT02395042|41608095|FG000|Treatment 1 Period|Lost to Follow-up|1|||
19367763|NCT02395042|41608096|FG001|Treatment 1 Period|Lost to Follow-up|0|||
19367764|NCT02395042|41608097|FG002|Treatment 1 Period|Lost to Follow-up|0|||
19367765|NCT02395042|41608095|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
19367766|NCT02395042|41608096|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
19367767|NCT02395042|41608097|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
19367768|NCT02395042|41608095|FG000|Treatment 2 Period|Lack of Efficacy|1|||
19367769|NCT02395042|41608096|FG001|Treatment 2 Period|Lack of Efficacy|1|||
19367770|NCT02395042|41608097|FG002|Treatment 2 Period|Lack of Efficacy|0|||
19367771|NCT02394808|41608108|FG000|Period 1|Unsatisfactory lens fitting|0|||
19367772|NCT02394808|41608109|FG001|Period 1|Unsatisfactory lens fitting|1|||
19367773|NCT02394808|41608108|FG000|Period 2|Lost to Follow-up|1|||
19367774|NCT02394808|41608109|FG001|Period 2|Lost to Follow-up|0|||
19367775|NCT02630966|41608117|FG000|Overall Study|Adverse Event|1|||
19367776|NCT02630966|41608118|FG001|Overall Study|Adverse Event|3|||
19367777|NCT02630966|41608117|FG000|Overall Study|Significant Protocol Deviation|0|||
19367778|NCT02630966|41608118|FG001|Overall Study|Significant Protocol Deviation|2|||
19367779|NCT02630966|41608117|FG000|Overall Study|Voluntary Withdrawal|1|||
19367780|NCT02630966|41608118|FG001|Overall Study|Voluntary Withdrawal|1|||
19367781|NCT02630966|41608117|FG000|Overall Study|Lack of Efficacy|0|||
19367782|NCT02630966|41608118|FG001|Overall Study|Lack of Efficacy|2|||
19367783|NCT01651780|41608126|FG000|Overall Study|Physician decision: No 30-day visit|2|||
19367784|NCT01651780|41608127|FG001|Overall Study|Physician decision: No 30-day visit|1|||
19367785|NCT01651780|41608126|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
19367786|NCT01651780|41608127|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
19367787|NCT01651780|41608126|FG000|Overall Study|Withdrawal by Subject|2|||
19367788|NCT01651780|41608127|FG001|Overall Study|Withdrawal by Subject|0|||
19367789|NCT01651780|41608126|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
19367790|NCT01651780|41608127|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19367791|NCT01651780|41608126|FG000|Overall Study|Lost to Follow-up|1|||
19367792|NCT01651780|41608127|FG001|Overall Study|Lost to Follow-up|2|||
19367793|NCT01651780|41608126|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
19367794|NCT01651780|41608127|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
19367795|NCT02394730|41608139|FG000|Overall Study|Lost to Follow-up|1|||
19367796|NCT02394730|41608140|FG001|Overall Study|Lost to Follow-up|0|||
19367797|NCT02394730|41608139|FG000|Overall Study|Withdrawal by Subject|0|||
19367798|NCT02394730|41608140|FG001|Overall Study|Withdrawal by Subject|1|||
19367799|NCT02430532|41608148|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
19367800|NCT02430532|41608149|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
19367801|NCT02430532|41608148|FG000|Overall Study|Consent Withdrawn|0|||
19367802|NCT02430532|41608149|FG001|Overall Study|Consent Withdrawn|2|||
19367803|NCT02430532|41608148|FG000|Overall Study|Adverse Event|0|||
19367804|NCT02430532|41608149|FG001|Overall Study|Adverse Event|1|||
19367805|NCT02394340|41608157|FG000|Overall Study|Failed drug screen test|1|||
19367806|NCT02394340|41608157|FG000|Overall Study|Adverse Event|1|||
19367807|NCT01672736|41608161|FG000|Overall Study|Available drug expired on 31 May 16|3|||
19367808|NCT01560637|41608165|FG000|Overall Study|Adverse Event|63|||
19367809|NCT01560637|41608165|FG000|Overall Study|Death|69|||
19367810|NCT01560637|41608165|FG000|Overall Study|Lost to Follow-up|8|||
19367811|NCT01560637|41608165|FG000|Overall Study|Protocol Violation|8|||
19367812|NCT01560637|41608165|FG000|Overall Study|Withdrawal by Subject|24|||
19367813|NCT01560637|41608165|FG000|Overall Study|Progressive Disease|20|||
19367814|NCT01560637|41608165|FG000|Overall Study|Other Reason Not Specified|6|||
19367815|NCT01353911|41608177|FG000|Overall Study|Lost to Follow-up|2|||
19367816|NCT01353911|41608178|FG001|Overall Study|Lost to Follow-up|6|||
19367817|NCT01353911|41608179|FG002|Overall Study|Lost to Follow-up|4|||
19367818|NCT01353911|41608180|FG003|Overall Study|Lost to Follow-up|0|||
19367819|NCT01353911|41608181|FG004|Overall Study|Lost to Follow-up|4|||
19367820|NCT01353911|41608182|FG005|Overall Study|Lost to Follow-up|4|||
19367821|NCT01353911|41608183|FG006|Overall Study|Lost to Follow-up|3|||
19367822|NCT01353911|41608184|FG007|Overall Study|Lost to Follow-up|6|||
19367823|NCT01353911|41608177|FG000|Overall Study|Withdrawal by Subject|2|||
19367824|NCT01353911|41608178|FG001|Overall Study|Withdrawal by Subject|3|||
19367825|NCT01353911|41608179|FG002|Overall Study|Withdrawal by Subject|4|||
19367826|NCT01353911|41608180|FG003|Overall Study|Withdrawal by Subject|2|||
19367827|NCT01353911|41608181|FG004|Overall Study|Withdrawal by Subject|2|||
19367828|NCT01353911|41608182|FG005|Overall Study|Withdrawal by Subject|3|||
19367829|NCT01353911|41608183|FG006|Overall Study|Withdrawal by Subject|3|||
19367830|NCT01353911|41608184|FG007|Overall Study|Withdrawal by Subject|9|||
19367831|NCT01353911|41608177|FG000|Overall Study|Status Not Recorded|4|||
19367832|NCT01353911|41608178|FG001|Overall Study|Status Not Recorded|0|||
19367833|NCT01353911|41608179|FG002|Overall Study|Status Not Recorded|1|||
19367834|NCT01353911|41608180|FG003|Overall Study|Status Not Recorded|0|||
19367835|NCT01353911|41608181|FG004|Overall Study|Status Not Recorded|0|||
19367836|NCT01353911|41608182|FG005|Overall Study|Status Not Recorded|0|||
19367837|NCT01353911|41608183|FG006|Overall Study|Status Not Recorded|0|||
19367838|NCT01353911|41608184|FG007|Overall Study|Status Not Recorded|0|||
19367839|NCT01671488|41608202|FG000|Overall Study|Withdrawal by Subject|1|||
19367840|NCT02783911|41608208|FG000|Overall Study|Lost to Follow-up|3|||
19367841|NCT02783911|41608209|FG001|Overall Study|Lost to Follow-up|32|||
19367842|NCT01358357|41608217|FG000|Open Label Phase|Adverse Event|0|||
19367843|NCT01358357|41608218|FG001|Open Label Phase|Adverse Event|0|||
19367844|NCT01358357|41608219|FG002|Open Label Phase|Adverse Event|59|||
19367845|NCT01358357|41608217|FG000|Open Label Phase|Lack of Efficacy|0|||
19367846|NCT01358357|41608218|FG001|Open Label Phase|Lack of Efficacy|0|||
19367847|NCT01358357|41608219|FG002|Open Label Phase|Lack of Efficacy|107|||
19367848|NCT01358357|41608217|FG000|Open Label Phase|Lost to Follow-up|0|||
19367849|NCT01358357|41608218|FG001|Open Label Phase|Lost to Follow-up|0|||
19367850|NCT01358357|41608219|FG002|Open Label Phase|Lost to Follow-up|76|||
19367851|NCT01358357|41608217|FG000|Open Label Phase|Protocol Violation|0|||
19367852|NCT01358357|41608218|FG001|Open Label Phase|Protocol Violation|0|||
19367853|NCT01358357|41608219|FG002|Open Label Phase|Protocol Violation|45|||
19367854|NCT01358357|41608217|FG000|Open Label Phase|Withdrawal by Subject|0|||
19367855|NCT01358357|41608218|FG001|Open Label Phase|Withdrawal by Subject|0|||
19367856|NCT01358357|41608219|FG002|Open Label Phase|Withdrawal by Subject|112|||
19367857|NCT01358357|41608217|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
19367858|NCT01358357|41608218|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
19367859|NCT01358357|41608219|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
19367860|NCT01358357|41608217|FG000|Open Label Phase|Terminated at study completion|0|||
19367861|NCT01358357|41608218|FG001|Open Label Phase|Terminated at study completion|0|||
19367862|NCT01358357|41608219|FG002|Open Label Phase|Terminated at study completion|5|||
19367863|NCT01358357|41608217|FG000|Open Label Phase|Mood episode|0|||
19367864|NCT01358357|41608218|FG001|Open Label Phase|Mood episode|0|||
19367865|NCT01358357|41608219|FG002|Open Label Phase|Mood episode|42|||
19367866|NCT01358357|41608217|FG000|Double-Blind Phase|Adverse Event|8|||
19367867|NCT01358357|41608218|FG001|Double-Blind Phase|Adverse Event|5|||
19367868|NCT01358357|41608219|FG002|Double-Blind Phase|Adverse Event|0|||
19367869|NCT01358357|41608217|FG000|Double-Blind Phase|Lost to Follow-up|5|||
19367870|NCT01358357|41608218|FG001|Double-Blind Phase|Lost to Follow-up|7|||
19367871|NCT01358357|41608219|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19367872|NCT01358357|41608217|FG000|Double-Blind Phase|Protocol Violation|1|||
19367873|NCT01358357|41608218|FG001|Double-Blind Phase|Protocol Violation|11|||
19367874|NCT01358357|41608219|FG002|Double-Blind Phase|Protocol Violation|0|||
19367875|NCT01358357|41608217|FG000|Double-Blind Phase|Protocol Violation|16|||
19367876|NCT01358357|41608218|FG001|Double-Blind Phase|Protocol Violation|12|||
19367877|NCT01358357|41608219|FG002|Double-Blind Phase|Protocol Violation|0|||
19367878|NCT01358357|41608217|FG000|Double-Blind Phase|Terminated at study completion|2|||
19367879|NCT01358357|41608218|FG001|Double-Blind Phase|Terminated at study completion|0|||
19367880|NCT01358357|41608219|FG002|Double-Blind Phase|Terminated at study completion|0|||
19367881|NCT01358357|41608217|FG000|Double-Blind Phase|Recurrence of mood event|48|||
19367882|NCT01358357|41608218|FG001|Double-Blind Phase|Recurrence of mood event|64|||
19367883|NCT01358357|41608219|FG002|Double-Blind Phase|Recurrence of mood event|0|||
19367884|NCT01358357|41608217|FG000|Double-Blind Phase|Administrative|0|||
19367885|NCT01358357|41608218|FG001|Double-Blind Phase|Administrative|1|||
19367886|NCT01358357|41608219|FG002|Double-Blind Phase|Administrative|0|||
19367887|NCT02831387|41608228|FG000|Overall Study|Withdrawal by Subject|1|||
19367888|NCT02831387|41608229|FG001|Overall Study|Withdrawal by Subject|1|||
19367889|NCT02831387|41608228|FG000|Overall Study|Discontinued due to stock recovery|0|||
19367890|NCT02831387|41608229|FG001|Overall Study|Discontinued due to stock recovery|1|||
19367891|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
19367892|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
19367893|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
19367894|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
19367895|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
19367896|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
19367897|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
19367898|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
19367899|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
19367900|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
19367901|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
19367902|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
19367903|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
19367904|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
19367905|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
19367906|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
19367907|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
19367908|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
19367909|NCT02831855|41608235|FG000|Open Label Phase (24 Weeks)|Other|4|||
19367910|NCT02831855|41608236|FG001|Open Label Phase (24 Weeks)|Other|0|||
19367911|NCT02831855|41608237|FG002|Open Label Phase (24 Weeks)|Other|0|||
19367912|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
19367913|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
19367914|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
19367915|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Death|0|||
19367916|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Death|0|||
19367917|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Death|2|||
19367918|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
19367919|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
19367920|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
19367921|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
19367922|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
19367923|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
19367924|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
19367925|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
19367926|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
19367927|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Other|0|||
19367928|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Other|2|||
19367929|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Other|5|||
19367930|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
19367931|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
19367932|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
19367933|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
19367934|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
19367935|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
19367936|NCT02831855|41608235|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
19367937|NCT02831855|41608236|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
19367938|NCT02831855|41608237|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
19367939|NCT02628938|41608250|FG000|Overall Study|Did not attend the follow up recall|2|||
19367940|NCT02628938|41608251|FG001|Overall Study|Did not attend the follow up recall|2|||
19367941|NCT02628938|41608252|FG002|Overall Study|Did not attend the follow up recall|1|||
19367942|NCT02628938|41608250|FG000|Overall Study|Failure to comply with the instructions|3|||
19367943|NCT02628938|41608251|FG001|Overall Study|Failure to comply with the instructions|0|||
19367944|NCT02628938|41608252|FG002|Overall Study|Failure to comply with the instructions|3|||
19367945|NCT01356407|41608266|FG000|Overall Study|Lost to Follow-up|2|||
19367946|NCT01356407|41608267|FG001|Overall Study|Lost to Follow-up|0|||
19367947|NCT01356407|41608266|FG000|Overall Study|Patient Withdrew Consent|2|||
19367948|NCT01356407|41608267|FG001|Overall Study|Patient Withdrew Consent|1|||
19367949|NCT01356407|41608266|FG000|Overall Study|Could not afford IMP administration|0|||
19367950|NCT01356407|41608267|FG001|Overall Study|Could not afford IMP administration|1|||
19367951|NCT01356407|41608266|FG000|Overall Study|Not complete Endoscopy|2|||
19367952|NCT01356407|41608267|FG001|Overall Study|Not complete Endoscopy|2|||
19367953|NCT00109837|41608273|FG000|Overall Study|Adverse Event|2|||
19367954|NCT00109837|41608273|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
19367955|NCT00109837|41608273|FG000|Overall Study|Death|1|||
19367956|NCT00109837|41608273|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
19367957|NCT00109837|41608273|FG000|Overall Study|Not treated|1|||
19367958|NCT00109837|41608273|FG000|Overall Study|Ineligible|1|||
19367959|NCT02828111|41608286|FG000|Overall Study|Withdrawal by Subject|0|||
19367960|NCT02828111|41608287|FG001|Overall Study|Withdrawal by Subject|0|||
19367961|NCT02828111|41608288|FG002|Overall Study|Withdrawal by Subject|2|||
19367962|NCT02828111|41608289|FG003|Overall Study|Withdrawal by Subject|0|||
19367963|NCT02828111|41608290|FG004|Overall Study|Withdrawal by Subject|0|||
19367964|NCT02828111|41608286|FG000|Overall Study|Lost to Follow-up|0|||
19367965|NCT02828111|41608287|FG001|Overall Study|Lost to Follow-up|0|||
19367966|NCT02828111|41608288|FG002|Overall Study|Lost to Follow-up|0|||
19367967|NCT02828111|41608289|FG003|Overall Study|Lost to Follow-up|1|||
19367968|NCT02828111|41608290|FG004|Overall Study|Lost to Follow-up|1|||
19367969|NCT01671332|41608313|FG000|Overall Study|Withdrawal by Subject|1|||
19367970|NCT01671332|41608314|FG001|Overall Study|Withdrawal by Subject|1|||
19367971|NCT01355627|41608322|FG000|Overall Study|Request By the Patient to Discontinue|5|||
19367972|NCT01355627|41608323|FG001|Overall Study|Request By the Patient to Discontinue|7|||
19367973|NCT01355627|41608322|FG000|Overall Study|Lost to Follow-up|8|||
19367974|NCT01355627|41608323|FG001|Overall Study|Lost to Follow-up|7|||
19367975|NCT01355627|41608322|FG000|Overall Study|Fatal Adverse Event|19|||
19367976|NCT01355627|41608323|FG001|Overall Study|Fatal Adverse Event|23|||
19367977|NCT01355627|41608322|FG000|Overall Study|Other|1|||
19367978|NCT01355627|41608323|FG001|Overall Study|Other|1|||
19367979|NCT00100802|41608329|FG000|Overall Study|Adverse Event|9|||
19367980|NCT00100802|41608329|FG000|Overall Study|Death|1|||
19367981|NCT00100802|41608329|FG000|Overall Study|Lack of Efficacy|47|||
19367982|NCT00100802|41608329|FG000|Overall Study|Physician Decision|5|||
19367983|NCT00100802|41608329|FG000|Overall Study|Protocol Violation|1|||
19367984|NCT00100802|41608329|FG000|Overall Study|Withdrawal by Subject|5|||
19367985|NCT00100802|41608329|FG000|Overall Study|Ineligible|12|||
19367986|NCT01355159|41608335|FG000|Overall Study|Withdrew consent|39|||
19367987|NCT01355159|41608336|FG001|Overall Study|Withdrew consent|47|||
19367988|NCT01355159|41608335|FG000|Overall Study|No primary outcome data|17|||
19367989|NCT01355159|41608336|FG001|Overall Study|No primary outcome data|11|||
19367990|NCT01355159|41608335|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
19367991|NCT01355159|41608336|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
19367992|NCT01355159|41608335|FG000|Overall Study|Early intrauterine fetal death|6|||
19367993|NCT01355159|41608336|FG001|Overall Study|Early intrauterine fetal death|6|||
19367994|NCT02630186|41608342|FG000|Overall Study|Withdrawal by Subject|1|||
19367995|NCT01669928|41608348|FG000|First Intervention|Withdrawal by Subject|3|||
19367996|NCT01669928|41608349|FG001|First Intervention|Withdrawal by Subject|5|||
19367997|NCT01355081|41608360|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
19367998|NCT01355081|41608361|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
19367999|NCT01355081|41608362|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
19368000|NCT01355081|41608360|FG000|Overall Study|Major Protocol Deviation|0|||
19368001|NCT01355081|41608361|FG001|Overall Study|Major Protocol Deviation|1|||
19368002|NCT01355081|41608362|FG002|Overall Study|Major Protocol Deviation|0|||
19368003|NCT01355081|41608360|FG000|Overall Study|Lost to Follow-up|0|||
19368004|NCT01355081|41608361|FG001|Overall Study|Lost to Follow-up|0|||
19368005|NCT01355081|41608362|FG002|Overall Study|Lost to Follow-up|1|||
19368006|NCT01355081|41608360|FG000|Overall Study|Withdrawal of Consent|2|||
19368007|NCT01355081|41608361|FG001|Overall Study|Withdrawal of Consent|3|||
19368008|NCT01355081|41608362|FG002|Overall Study|Withdrawal of Consent|3|||
19368009|NCT01355081|41608360|FG000|Overall Study|Lack of Efficacy|2|||
19368010|NCT01355081|41608361|FG001|Overall Study|Lack of Efficacy|1|||
19368011|NCT01355081|41608362|FG002|Overall Study|Lack of Efficacy|1|||
19368012|NCT01355081|41608360|FG000|Overall Study|Non Compliance with Study Medication|0|||
19368013|NCT01355081|41608361|FG001|Overall Study|Non Compliance with Study Medication|1|||
19368014|NCT01355081|41608362|FG002|Overall Study|Non Compliance with Study Medication|0|||
19368015|NCT01354223|41608372|FG000|Overall Study|Withdrawal by Subject|3|||
19368016|NCT01354223|41608373|FG001|Overall Study|Withdrawal by Subject|1|||
19368017|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
19368018|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
19368019|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
19368020|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
19698640|NCT00296504|42143591|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
19698641|NCT00296504|42143592|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
19698642|NCT00296504|42143593|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
19698643|NCT00296504|42143594|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
19698644|NCT00296504|42143595|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
19698645|NCT00296504|42143596|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
19698646|NCT00296504|42143597|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
19698647|NCT00296504|42143589|FG000|Interim Analysis|Non-adherence|2|||
19698648|NCT00296504|42143590|FG001|Interim Analysis|Non-adherence|0|||
19698649|NCT00296504|42143591|FG002|Interim Analysis|Non-adherence|0|||
19698650|NCT00296504|42143592|FG003|Interim Analysis|Non-adherence|0|||
19698651|NCT00296504|42143593|FG004|Interim Analysis|Non-adherence|1|||
19698652|NCT00296504|42143594|FG005|Interim Analysis|Non-adherence|0|||
19698653|NCT00296504|42143595|FG006|Interim Analysis|Non-adherence|0|||
19698654|NCT00296504|42143596|FG007|Interim Analysis|Non-adherence|1|||
19698655|NCT00296504|42143597|FG008|Interim Analysis|Non-adherence|0|||
19698656|NCT00296504|42143589|FG000|Interim Analysis|Site Closing|1|||
19698657|NCT00296504|42143590|FG001|Interim Analysis|Site Closing|0|||
19698658|NCT00296504|42143591|FG002|Interim Analysis|Site Closing|0|||
19698659|NCT00296504|42143592|FG003|Interim Analysis|Site Closing|0|||
19368021|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
19368022|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
19368023|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
19368024|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
19368025|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
19368026|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
19368027|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
19368028|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
19368029|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
19368030|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
19368031|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
19368032|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
19368033|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
19368034|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
19368035|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
19368036|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
19368037|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
19368038|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
19368039|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
19368040|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
19368041|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
19368042|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
19368043|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
19368044|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
19368045|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
19368046|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
19368047|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
19368048|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
19368049|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
19368050|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
19368051|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
19368052|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
19368053|NCT04043455|41608383|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
19368054|NCT04043455|41608384|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
19368055|NCT04043455|41608385|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
19368056|NCT04043455|41608386|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
19368057|NCT04043455|41608387|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
19368058|NCT04043455|41608388|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
19368059|NCT04043455|41608383|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
19368060|NCT04043455|41608384|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
19368061|NCT04043455|41608385|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
19368062|NCT04043455|41608386|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
19368063|NCT04043455|41608387|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
19368064|NCT04043455|41608388|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
19368065|NCT04043455|41608383|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
19368066|NCT04043455|41608384|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
19368067|NCT04043455|41608385|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
19368068|NCT04043455|41608386|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
19368069|NCT04043455|41608387|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
19368070|NCT04043455|41608388|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
19368071|NCT04043455|41608383|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
19368072|NCT04043455|41608384|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
19368073|NCT04043455|41608385|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
19368074|NCT04043455|41608386|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
19368075|NCT04043455|41608387|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
19368076|NCT04043455|41608388|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
19368077|NCT04043455|41608383|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
19368078|NCT04043455|41608384|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
19368079|NCT04043455|41608385|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
19368080|NCT04043455|41608386|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
19368081|NCT04043455|41608387|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
19368082|NCT04043455|41608388|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
19368083|NCT02627144|41608406|FG000|Overall Study|Serious adverse event|32|||
19368084|NCT02627144|41608406|FG000|Overall Study|Cancer progression|171|||
19368085|NCT02627144|41608406|FG000|Overall Study|Death from cancer|20|||
19368086|NCT02627144|41608406|FG000|Overall Study|Death from other cause|8|||
19368087|NCT02627144|41608406|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
19368088|NCT02627144|41608406|FG000|Overall Study|Administrative reasons|65|||
19368089|NCT02627144|41608406|FG000|Overall Study|Lost to Follow-up|8|||
19368090|NCT02627144|41608406|FG000|Overall Study|Enrolled, not treated|6|||
19368091|NCT02627144|41608406|FG000|Overall Study|Other|17|||
19368092|NCT02626520|41608412|FG000|Overall Study|Physician Decision|1|||
19368093|NCT02626520|41608413|FG001|Overall Study|Physician Decision|1|||
19368094|NCT02626520|41608412|FG000|Overall Study|Adverse Event|0|||
19368095|NCT02626520|41608413|FG001|Overall Study|Adverse Event|4|||
19368096|NCT02626520|41608412|FG000|Overall Study|Lack of Efficacy|0|||
19368097|NCT02626520|41608413|FG001|Overall Study|Lack of Efficacy|2|||
19368098|NCT02626520|41608412|FG000|Overall Study|Did not start protocol therapy|0|||
19368099|NCT02626520|41608413|FG001|Overall Study|Did not start protocol therapy|2|||
19368100|NCT02626520|41608412|FG000|Overall Study|Study terminated|0|||
19368101|NCT02626520|41608413|FG001|Overall Study|Study terminated|1|||
19368102|NCT04522141|41608421|FG000|Overall Study|Withdrawal by Subject|1|||
19368103|NCT04522141|41608422|FG001|Overall Study|Withdrawal by Subject|0|||
19368104|NCT01329029|41608445|FG000|Overall Study|Withdrawal by Subject|117|||
19368105|NCT01329029|41608446|FG001|Overall Study|Withdrawal by Subject|87|||
19368106|NCT01329029|41608445|FG000|Overall Study|Adverse Event|82|||
19368107|NCT01329029|41608446|FG001|Overall Study|Adverse Event|29|||
19368108|NCT01329029|41608445|FG000|Overall Study|Death|16|||
19368109|NCT01329029|41608446|FG001|Overall Study|Death|19|||
19368110|NCT01329029|41608445|FG000|Overall Study|Other|14|||
19368111|NCT01329029|41608446|FG001|Overall Study|Other|20|||
19368112|NCT01329029|41608445|FG000|Overall Study|COPD Exacerbation|11|||
19368113|NCT01329029|41608446|FG001|Overall Study|COPD Exacerbation|18|||
19368114|NCT01329029|41608445|FG000|Overall Study|Physician Decision|16|||
19368115|NCT01329029|41608446|FG001|Overall Study|Physician Decision|13|||
19368116|NCT01329029|41608445|FG000|Overall Study|Lost to Follow-up|8|||
19368117|NCT01329029|41608446|FG001|Overall Study|Lost to Follow-up|5|||
19368118|NCT01329029|41608445|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
19368119|NCT01329029|41608446|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
19368120|NCT01372085|41608462|FG000|Washout Period 2|Physician Decision|0|||
19368121|NCT01372085|41608463|FG001|Washout Period 2|Physician Decision|0|||
19368122|NCT01372085|41608464|FG002|Washout Period 2|Physician Decision|0|||
19368123|NCT01372085|41608465|FG003|Washout Period 2|Physician Decision|0|||
19368124|NCT01372085|41608466|FG004|Washout Period 2|Physician Decision|1|||
19368125|NCT01372085|41608467|FG005|Washout Period 2|Physician Decision|0|||
19368126|NCT01372085|41608468|FG006|Washout Period 2|Physician Decision|0|||
19368127|NCT01372085|41608469|FG007|Washout Period 2|Physician Decision|0|||
19368128|NCT01372085|41608470|FG008|Washout Period 2|Physician Decision|0|||
19368129|NCT01372085|41608471|FG009|Washout Period 2|Physician Decision|0|||
19368130|NCT01372085|41608462|FG000|Washout Period 3|Withdrawal by Subject|0|||
19368131|NCT01372085|41608463|FG001|Washout Period 3|Withdrawal by Subject|0|||
19368132|NCT01372085|41608464|FG002|Washout Period 3|Withdrawal by Subject|0|||
19368133|NCT01372085|41608465|FG003|Washout Period 3|Withdrawal by Subject|0|||
19368134|NCT01372085|41608466|FG004|Washout Period 3|Withdrawal by Subject|0|||
19368135|NCT01372085|41608467|FG005|Washout Period 3|Withdrawal by Subject|2|||
19368136|NCT01372085|41608468|FG006|Washout Period 3|Withdrawal by Subject|0|||
19368137|NCT01372085|41608469|FG007|Washout Period 3|Withdrawal by Subject|0|||
19368138|NCT01372085|41608470|FG008|Washout Period 3|Withdrawal by Subject|0|||
19368139|NCT01372085|41608471|FG009|Washout Period 3|Withdrawal by Subject|0|||
19368140|NCT04012853|41608497|FG000|Overall Study|Withdrawal by Subject|1|||
19368141|NCT04012853|41608498|FG001|Overall Study|Withdrawal by Subject|1|||
19368142|NCT04012853|41608497|FG000|Overall Study|Protocol Violation|1|||
19368143|NCT04012853|41608498|FG001|Overall Study|Protocol Violation|0|||
19368144|NCT04012853|41608497|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
19368145|NCT04012853|41608498|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
19368146|NCT02941549|41608507|FG000|Overall Study|Adverse Event|1|||
19368147|NCT02941549|41608508|FG001|Overall Study|Adverse Event|0|||
19368148|NCT02941549|41608509|FG002|Overall Study|Adverse Event|0|||
19368149|NCT02941549|41608507|FG000|Overall Study|Withdrawal by Subject|2|||
19368150|NCT02941549|41608508|FG001|Overall Study|Withdrawal by Subject|1|||
19368151|NCT02941549|41608509|FG002|Overall Study|Withdrawal by Subject|2|||
19368152|NCT02394028|41608531|FG000|Induction Phase|Adverse Event|2|||
19368153|NCT02394028|41608532|FG001|Induction Phase|Adverse Event|4|||
19368154|NCT02394028|41608533|FG002|Induction Phase|Adverse Event|1|||
19368155|NCT02394028|41608534|FG003|Induction Phase|Adverse Event|2|||
19368156|NCT02394028|41608535|FG004|Induction Phase|Adverse Event|5|||
19368157|NCT02394028|41608536|FG005|Induction Phase|Adverse Event|2|||
19368158|NCT02394028|41608537|FG006|Induction Phase|Adverse Event|0|||
19368159|NCT02394028|41608538|FG007|Induction Phase|Adverse Event|0|||
19368160|NCT02394028|41608539|FG008|Induction Phase|Adverse Event|0|||
19368161|NCT02394028|41608540|FG009|Induction Phase|Adverse Event|0|||
19368162|NCT02394028|41608541|FG010|Induction Phase|Adverse Event|0|||
19368163|NCT02394028|41608531|FG000|Induction Phase|Lack of Efficacy|3|||
19368164|NCT02394028|41608532|FG001|Induction Phase|Lack of Efficacy|6|||
19368165|NCT02394028|41608533|FG002|Induction Phase|Lack of Efficacy|2|||
19368166|NCT02394028|41608534|FG003|Induction Phase|Lack of Efficacy|17|||
19368167|NCT02394028|41608535|FG004|Induction Phase|Lack of Efficacy|14|||
19368168|NCT02394028|41608536|FG005|Induction Phase|Lack of Efficacy|8|||
19368169|NCT02394028|41608537|FG006|Induction Phase|Lack of Efficacy|17|||
19368170|NCT02394028|41608538|FG007|Induction Phase|Lack of Efficacy|23|||
19368171|NCT02394028|41608539|FG008|Induction Phase|Lack of Efficacy|0|||
19368172|NCT02394028|41608540|FG009|Induction Phase|Lack of Efficacy|0|||
19368173|NCT02394028|41608541|FG010|Induction Phase|Lack of Efficacy|0|||
19368174|NCT02394028|41608531|FG000|Induction Phase|Lost to Follow-up|1|||
19368175|NCT02394028|41608532|FG001|Induction Phase|Lost to Follow-up|0|||
19368176|NCT02394028|41608533|FG002|Induction Phase|Lost to Follow-up|0|||
19368177|NCT02394028|41608534|FG003|Induction Phase|Lost to Follow-up|1|||
19368178|NCT02394028|41608535|FG004|Induction Phase|Lost to Follow-up|0|||
19368179|NCT02394028|41608536|FG005|Induction Phase|Lost to Follow-up|0|||
19368180|NCT02394028|41608537|FG006|Induction Phase|Lost to Follow-up|1|||
19368181|NCT02394028|41608538|FG007|Induction Phase|Lost to Follow-up|0|||
19368182|NCT02394028|41608539|FG008|Induction Phase|Lost to Follow-up|0|||
19368183|NCT02394028|41608540|FG009|Induction Phase|Lost to Follow-up|0|||
19368184|NCT02394028|41608541|FG010|Induction Phase|Lost to Follow-up|0|||
19368185|NCT02394028|41608531|FG000|Induction Phase|Non-compliance|0|||
19368186|NCT02394028|41608532|FG001|Induction Phase|Non-compliance|1|||
19368187|NCT02394028|41608533|FG002|Induction Phase|Non-compliance|3|||
19368188|NCT02394028|41608534|FG003|Induction Phase|Non-compliance|1|||
19368189|NCT02394028|41608535|FG004|Induction Phase|Non-compliance|3|||
19368190|NCT02394028|41608536|FG005|Induction Phase|Non-compliance|0|||
19368191|NCT02394028|41608537|FG006|Induction Phase|Non-compliance|1|||
19368192|NCT02394028|41608538|FG007|Induction Phase|Non-compliance|1|||
19368193|NCT02394028|41608539|FG008|Induction Phase|Non-compliance|0|||
19368194|NCT02394028|41608540|FG009|Induction Phase|Non-compliance|0|||
19368195|NCT02394028|41608541|FG010|Induction Phase|Non-compliance|0|||
19368196|NCT02394028|41608531|FG000|Induction Phase|Physician Decision|0|||
19368197|NCT02394028|41608532|FG001|Induction Phase|Physician Decision|0|||
19368198|NCT02394028|41608533|FG002|Induction Phase|Physician Decision|1|||
19368199|NCT02394028|41608534|FG003|Induction Phase|Physician Decision|4|||
19368200|NCT02394028|41608535|FG004|Induction Phase|Physician Decision|0|||
19368201|NCT02394028|41608536|FG005|Induction Phase|Physician Decision|2|||
19368202|NCT02394028|41608537|FG006|Induction Phase|Physician Decision|1|||
19368203|NCT02394028|41608538|FG007|Induction Phase|Physician Decision|0|||
19368204|NCT02394028|41608539|FG008|Induction Phase|Physician Decision|0|||
19368205|NCT02394028|41608540|FG009|Induction Phase|Physician Decision|0|||
19368206|NCT02394028|41608541|FG010|Induction Phase|Physician Decision|0|||
19368207|NCT02394028|41608531|FG000|Induction Phase|Protocol Violation|0|||
19368208|NCT02394028|41608532|FG001|Induction Phase|Protocol Violation|2|||
19368209|NCT02394028|41608533|FG002|Induction Phase|Protocol Violation|0|||
19368210|NCT02394028|41608534|FG003|Induction Phase|Protocol Violation|3|||
19368211|NCT02394028|41608535|FG004|Induction Phase|Protocol Violation|0|||
19368212|NCT02394028|41608536|FG005|Induction Phase|Protocol Violation|1|||
19368213|NCT02394028|41608537|FG006|Induction Phase|Protocol Violation|1|||
19368214|NCT02394028|41608538|FG007|Induction Phase|Protocol Violation|0|||
19368215|NCT02394028|41608539|FG008|Induction Phase|Protocol Violation|0|||
19368216|NCT02394028|41608540|FG009|Induction Phase|Protocol Violation|0|||
19368217|NCT02394028|41608541|FG010|Induction Phase|Protocol Violation|0|||
19368218|NCT02394028|41608531|FG000|Induction Phase|Withdrawal by Subject|1|||
19368219|NCT02394028|41608532|FG001|Induction Phase|Withdrawal by Subject|2|||
19368220|NCT02394028|41608533|FG002|Induction Phase|Withdrawal by Subject|4|||
19368221|NCT02394028|41608534|FG003|Induction Phase|Withdrawal by Subject|6|||
19368222|NCT02394028|41608535|FG004|Induction Phase|Withdrawal by Subject|7|||
19368223|NCT02394028|41608536|FG005|Induction Phase|Withdrawal by Subject|4|||
19368224|NCT02394028|41608537|FG006|Induction Phase|Withdrawal by Subject|3|||
19368225|NCT02394028|41608538|FG007|Induction Phase|Withdrawal by Subject|6|||
19368226|NCT02394028|41608539|FG008|Induction Phase|Withdrawal by Subject|0|||
19368227|NCT02394028|41608540|FG009|Induction Phase|Withdrawal by Subject|0|||
19368228|NCT02394028|41608541|FG010|Induction Phase|Withdrawal by Subject|0|||
19368229|NCT02394028|41608531|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368230|NCT02394028|41608532|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368231|NCT02394028|41608533|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368232|NCT02394028|41608534|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368233|NCT02394028|41608535|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368234|NCT02394028|41608536|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368235|NCT02394028|41608537|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
19368236|NCT02394028|41608538|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368237|NCT02394028|41608539|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368238|NCT02394028|41608540|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368239|NCT02394028|41608541|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
19368240|NCT02394028|41608531|FG000|Induction Phase|Sponsor decision|0|||
19368241|NCT02394028|41608532|FG001|Induction Phase|Sponsor decision|1|||
19368242|NCT02394028|41608533|FG002|Induction Phase|Sponsor decision|2|||
19368243|NCT02394028|41608534|FG003|Induction Phase|Sponsor decision|0|||
19368244|NCT02394028|41608535|FG004|Induction Phase|Sponsor decision|0|||
19368245|NCT02394028|41608536|FG005|Induction Phase|Sponsor decision|0|||
19368246|NCT02394028|41608537|FG006|Induction Phase|Sponsor decision|0|||
19368247|NCT02394028|41608538|FG007|Induction Phase|Sponsor decision|0|||
19368248|NCT02394028|41608539|FG008|Induction Phase|Sponsor decision|0|||
19368249|NCT02394028|41608540|FG009|Induction Phase|Sponsor decision|0|||
19368250|NCT02394028|41608541|FG010|Induction Phase|Sponsor decision|0|||
19368251|NCT02394028|41608531|FG000|Induction Phase|Technical reason|0|||
19368252|NCT02394028|41608532|FG001|Induction Phase|Technical reason|0|||
19368253|NCT02394028|41608533|FG002|Induction Phase|Technical reason|0|||
19368254|NCT02394028|41608534|FG003|Induction Phase|Technical reason|1|||
19368255|NCT02394028|41608535|FG004|Induction Phase|Technical reason|0|||
19368256|NCT02394028|41608536|FG005|Induction Phase|Technical reason|0|||
19368257|NCT02394028|41608537|FG006|Induction Phase|Technical reason|0|||
19368258|NCT02394028|41608538|FG007|Induction Phase|Technical reason|0|||
19368259|NCT02394028|41608539|FG008|Induction Phase|Technical reason|0|||
19368260|NCT02394028|41608540|FG009|Induction Phase|Technical reason|0|||
19368261|NCT02394028|41608541|FG010|Induction Phase|Technical reason|0|||
19368262|NCT02394028|41608531|FG000|Induction Phase|:ack of calculation|0|||
19368263|NCT02394028|41608532|FG001|Induction Phase|:ack of calculation|0|||
19368264|NCT02394028|41608533|FG002|Induction Phase|:ack of calculation|0|||
19368265|NCT02394028|41608534|FG003|Induction Phase|:ack of calculation|0|||
19368266|NCT02394028|41608535|FG004|Induction Phase|:ack of calculation|0|||
19368267|NCT02394028|41608536|FG005|Induction Phase|:ack of calculation|0|||
19368268|NCT02394028|41608537|FG006|Induction Phase|:ack of calculation|0|||
19368269|NCT02394028|41608538|FG007|Induction Phase|:ack of calculation|1|||
19368270|NCT02394028|41608539|FG008|Induction Phase|:ack of calculation|0|||
19368271|NCT02394028|41608540|FG009|Induction Phase|:ack of calculation|0|||
19368272|NCT02394028|41608541|FG010|Induction Phase|:ack of calculation|0|||
19368273|NCT02394028|41608531|FG000|Maintenance Phase|Protocol Violation|0|||
19368274|NCT02394028|41608532|FG001|Maintenance Phase|Protocol Violation|0|||
19698660|NCT00296504|42143593|FG004|Interim Analysis|Site Closing|0|||
19698661|NCT00296504|42143594|FG005|Interim Analysis|Site Closing|1|||
19698662|NCT00296504|42143595|FG006|Interim Analysis|Site Closing|2|||
19698663|NCT00296504|42143596|FG007|Interim Analysis|Site Closing|0|||
19698664|NCT00296504|42143597|FG008|Interim Analysis|Site Closing|0|||
19698665|NCT00296504|42143589|FG000|Interim Analysis|Lack of Personnel at Site|1|||
19698666|NCT00296504|42143590|FG001|Interim Analysis|Lack of Personnel at Site|0|||
19698667|NCT00296504|42143591|FG002|Interim Analysis|Lack of Personnel at Site|0|||
19698668|NCT00296504|42143592|FG003|Interim Analysis|Lack of Personnel at Site|0|||
19698669|NCT00296504|42143593|FG004|Interim Analysis|Lack of Personnel at Site|0|||
19698670|NCT00296504|42143594|FG005|Interim Analysis|Lack of Personnel at Site|0|||
19698671|NCT00296504|42143595|FG006|Interim Analysis|Lack of Personnel at Site|0|||
19698672|NCT00296504|42143596|FG007|Interim Analysis|Lack of Personnel at Site|0|||
19698673|NCT00296504|42143597|FG008|Interim Analysis|Lack of Personnel at Site|0|||
19698674|NCT00296504|42143589|FG000|Interim Analysis|Missed Schedule Date|1|||
19698675|NCT00296504|42143590|FG001|Interim Analysis|Missed Schedule Date|0|||
19698676|NCT00296504|42143591|FG002|Interim Analysis|Missed Schedule Date|0|||
19698677|NCT00296504|42143592|FG003|Interim Analysis|Missed Schedule Date|0|||
19698678|NCT00296504|42143593|FG004|Interim Analysis|Missed Schedule Date|0|||
19698679|NCT00296504|42143594|FG005|Interim Analysis|Missed Schedule Date|0|||
19698680|NCT00296504|42143595|FG006|Interim Analysis|Missed Schedule Date|0|||
19698681|NCT00296504|42143596|FG007|Interim Analysis|Missed Schedule Date|0|||
19698682|NCT00296504|42143597|FG008|Interim Analysis|Missed Schedule Date|0|||
19698683|NCT00296504|42143589|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
19698684|NCT00296504|42143590|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
19698685|NCT00296504|42143591|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
19368275|NCT02394028|41608533|FG002|Maintenance Phase|Protocol Violation|0|||
19368276|NCT02394028|41608534|FG003|Maintenance Phase|Protocol Violation|0|||
19368277|NCT02394028|41608535|FG004|Maintenance Phase|Protocol Violation|0|||
19698686|NCT00296504|42143592|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
19698687|NCT00296504|42143593|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
19698688|NCT00296504|42143594|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
19698689|NCT00296504|42143595|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
19698690|NCT00296504|42143596|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
19698691|NCT00296504|42143597|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
19368278|NCT02394028|41608536|FG005|Maintenance Phase|Protocol Violation|0|||
19368279|NCT02394028|41608537|FG006|Maintenance Phase|Protocol Violation|0|||
19368280|NCT02394028|41608538|FG007|Maintenance Phase|Protocol Violation|0|||
19368281|NCT02394028|41608539|FG008|Maintenance Phase|Protocol Violation|0|||
19368282|NCT02394028|41608540|FG009|Maintenance Phase|Protocol Violation|0|||
19368283|NCT02394028|41608541|FG010|Maintenance Phase|Protocol Violation|1|||
19368284|NCT02394028|41608531|FG000|Maintenance Phase|Physician Decision|0|||
19368285|NCT02394028|41608532|FG001|Maintenance Phase|Physician Decision|0|||
19368286|NCT02394028|41608533|FG002|Maintenance Phase|Physician Decision|0|||
19368287|NCT02394028|41608534|FG003|Maintenance Phase|Physician Decision|0|||
19368288|NCT02394028|41608535|FG004|Maintenance Phase|Physician Decision|0|||
19368289|NCT02394028|41608536|FG005|Maintenance Phase|Physician Decision|0|||
19368290|NCT02394028|41608537|FG006|Maintenance Phase|Physician Decision|0|||
19368291|NCT02394028|41608538|FG007|Maintenance Phase|Physician Decision|0|||
19368292|NCT02394028|41608539|FG008|Maintenance Phase|Physician Decision|1|||
19368293|NCT02394028|41608540|FG009|Maintenance Phase|Physician Decision|3|||
19368294|NCT02394028|41608541|FG010|Maintenance Phase|Physician Decision|2|||
19368295|NCT02394028|41608531|FG000|Maintenance Phase|Lack of Efficacy|0|||
19368296|NCT02394028|41608532|FG001|Maintenance Phase|Lack of Efficacy|0|||
19368297|NCT02394028|41608533|FG002|Maintenance Phase|Lack of Efficacy|0|||
19368298|NCT02394028|41608534|FG003|Maintenance Phase|Lack of Efficacy|0|||
19368299|NCT02394028|41608535|FG004|Maintenance Phase|Lack of Efficacy|0|||
19368300|NCT02394028|41608536|FG005|Maintenance Phase|Lack of Efficacy|0|||
19368301|NCT02394028|41608537|FG006|Maintenance Phase|Lack of Efficacy|0|||
19368302|NCT02394028|41608538|FG007|Maintenance Phase|Lack of Efficacy|0|||
19368303|NCT02394028|41608539|FG008|Maintenance Phase|Lack of Efficacy|7|||
19368304|NCT02394028|41608540|FG009|Maintenance Phase|Lack of Efficacy|25|||
19368305|NCT02394028|41608541|FG010|Maintenance Phase|Lack of Efficacy|33|||
19368306|NCT02394028|41608531|FG000|Maintenance Phase|Death|0|||
19368307|NCT02394028|41608532|FG001|Maintenance Phase|Death|0|||
19368308|NCT02394028|41608533|FG002|Maintenance Phase|Death|0|||
19368309|NCT02394028|41608534|FG003|Maintenance Phase|Death|0|||
19368310|NCT02394028|41608535|FG004|Maintenance Phase|Death|0|||
19368311|NCT02394028|41608536|FG005|Maintenance Phase|Death|0|||
19368312|NCT02394028|41608537|FG006|Maintenance Phase|Death|0|||
19368313|NCT02394028|41608538|FG007|Maintenance Phase|Death|0|||
19368314|NCT02394028|41608539|FG008|Maintenance Phase|Death|0|||
19368315|NCT02394028|41608540|FG009|Maintenance Phase|Death|0|||
19368316|NCT02394028|41608541|FG010|Maintenance Phase|Death|1|||
19368317|NCT02394028|41608531|FG000|Maintenance Phase|Adverse Event|0|||
19368318|NCT02394028|41608532|FG001|Maintenance Phase|Adverse Event|0|||
19368319|NCT02394028|41608533|FG002|Maintenance Phase|Adverse Event|0|||
19368320|NCT02394028|41608534|FG003|Maintenance Phase|Adverse Event|0|||
19368321|NCT02394028|41608535|FG004|Maintenance Phase|Adverse Event|0|||
19368322|NCT02394028|41608536|FG005|Maintenance Phase|Adverse Event|0|||
19368323|NCT02394028|41608537|FG006|Maintenance Phase|Adverse Event|0|||
19368324|NCT02394028|41608538|FG007|Maintenance Phase|Adverse Event|0|||
19368325|NCT02394028|41608539|FG008|Maintenance Phase|Adverse Event|1|||
19368326|NCT02394028|41608540|FG009|Maintenance Phase|Adverse Event|1|||
19368327|NCT02394028|41608541|FG010|Maintenance Phase|Adverse Event|3|||
19368328|NCT02394028|41608531|FG000|Maintenance Phase|Site closure|0|||
19368329|NCT02394028|41608532|FG001|Maintenance Phase|Site closure|0|||
19368330|NCT02394028|41608533|FG002|Maintenance Phase|Site closure|0|||
19368331|NCT02394028|41608534|FG003|Maintenance Phase|Site closure|0|||
19368332|NCT02394028|41608535|FG004|Maintenance Phase|Site closure|0|||
19368333|NCT02394028|41608536|FG005|Maintenance Phase|Site closure|0|||
19368334|NCT02394028|41608537|FG006|Maintenance Phase|Site closure|0|||
19368335|NCT02394028|41608538|FG007|Maintenance Phase|Site closure|0|||
19368336|NCT02394028|41608539|FG008|Maintenance Phase|Site closure|0|||
19368337|NCT02394028|41608540|FG009|Maintenance Phase|Site closure|1|||
19368338|NCT02394028|41608541|FG010|Maintenance Phase|Site closure|0|||
19368339|NCT02394028|41608531|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19368340|NCT02394028|41608532|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19368341|NCT02394028|41608533|FG002|Maintenance Phase|Withdrawal by Subject|0|||
19477929|NCT01468181|41757279|FG004|Overall Study|Withdrawal by Subject|0|||
19368342|NCT02394028|41608534|FG003|Maintenance Phase|Withdrawal by Subject|0|||
19368343|NCT02394028|41608535|FG004|Maintenance Phase|Withdrawal by Subject|0|||
19368344|NCT02394028|41608536|FG005|Maintenance Phase|Withdrawal by Subject|0|||
19368345|NCT02394028|41608537|FG006|Maintenance Phase|Withdrawal by Subject|0|||
19368346|NCT02394028|41608538|FG007|Maintenance Phase|Withdrawal by Subject|0|||
19368347|NCT02394028|41608539|FG008|Maintenance Phase|Withdrawal by Subject|3|||
19368348|NCT02394028|41608540|FG009|Maintenance Phase|Withdrawal by Subject|12|||
19368349|NCT02394028|41608541|FG010|Maintenance Phase|Withdrawal by Subject|12|||
19368350|NCT01371539|41608595|FG000|Period One: One Week|Lost to Follow-up|0|||
19368351|NCT01371539|41608596|FG001|Period One: One Week|Lost to Follow-up|1|||
19368352|NCT01371539|41608595|FG000|Period Two: One Week|Lost to Follow-up|0|||
19368353|NCT01371539|41608596|FG001|Period Two: One Week|Lost to Follow-up|1|||
19368354|NCT01371539|41608595|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
19368355|NCT01371539|41608596|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
19368356|NCT01371539|41608595|FG000|Period Two: One Week|Time/job conflict|0|||
19368357|NCT01371539|41608596|FG001|Period Two: One Week|Time/job conflict|1|||
19368358|NCT03320330|41608605|FG000|Overall Study|Lack of Efficacy|5|||
19368359|NCT03320330|41608606|FG001|Overall Study|Lack of Efficacy|5|||
19368360|NCT03320330|41608607|FG002|Overall Study|Lack of Efficacy|14|||
19368361|NCT03320330|41608605|FG000|Overall Study|Physician Decision|1|||
19368362|NCT03320330|41608606|FG001|Overall Study|Physician Decision|0|||
19368363|NCT03320330|41608607|FG002|Overall Study|Physician Decision|0|||
19368364|NCT02819297|41608618|FG000|Overall Study|Withdrawal by Subject|25|||
19368365|NCT02819297|41608619|FG001|Overall Study|Withdrawal by Subject|13|||
19368366|NCT02819297|41608618|FG000|Overall Study|Lost to Follow-up|12|||
19368367|NCT02819297|41608619|FG001|Overall Study|Lost to Follow-up|14|||
19368368|NCT02819297|41608618|FG000|Overall Study|Adverse Event|12|||
19368369|NCT02819297|41608619|FG001|Overall Study|Adverse Event|10|||
19368370|NCT02819297|41608618|FG000|Overall Study|Physician Decision|5|||
19368371|NCT02819297|41608619|FG001|Overall Study|Physician Decision|5|||
19368372|NCT02819297|41608618|FG000|Overall Study|Lack of Efficacy|5|||
19368373|NCT02819297|41608619|FG001|Overall Study|Lack of Efficacy|8|||
19368374|NCT02819297|41608618|FG000|Overall Study|Protocol Violation|1|||
19368375|NCT02819297|41608619|FG001|Overall Study|Protocol Violation|2|||
19368376|NCT02429830|41608625|FG000|Overall Study|Lost to Follow-up|1|||
19368377|NCT02429830|41608625|FG000|Overall Study|Device Explant|2|||
19368378|NCT02821715|41608629|FG000|Overall Study|Protocol Violation|1|||
19368379|NCT02821715|41608630|FG001|Overall Study|Protocol Violation|0|||
19368380|NCT02821715|41608631|FG002|Overall Study|Protocol Violation|0|||
19368381|NCT02821715|41608632|FG003|Overall Study|Protocol Violation|0|||
19368382|NCT02821715|41608633|FG004|Overall Study|Protocol Violation|0|||
19368383|NCT02821715|41608634|FG005|Overall Study|Protocol Violation|0|||
19368384|NCT02813681|41608645|FG000|Overall Study|Physician Decision|5|||
19368385|NCT02813681|41608646|FG001|Overall Study|Physician Decision|5|||
19368386|NCT02813681|41608647|FG002|Overall Study|Physician Decision|0|||
19368387|NCT02813681|41608645|FG000|Overall Study|Lost to Follow-up|0|||
19368388|NCT02813681|41608646|FG001|Overall Study|Lost to Follow-up|1|||
19368389|NCT02813681|41608647|FG002|Overall Study|Lost to Follow-up|0|||
19368390|NCT02393950|41608659|FG000|Overall Study|Adverse Event|1|||
19368391|NCT02393950|41608660|FG001|Overall Study|Adverse Event|0|||
19368392|NCT02393950|41608659|FG000|Overall Study|Withdrawal by Subject|0|||
19368393|NCT02393950|41608660|FG001|Overall Study|Withdrawal by Subject|1|||
19368394|NCT02815397|41608695|FG000|Overall Study|Physician Decision|2|||
19368395|NCT02427958|41608699|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
19368396|NCT02427958|41608699|FG000|Overall Study|Lost to Follow-up|6|||
19368397|NCT02427958|41608699|FG000|Overall Study|Withdrawal by Subject|14|||
19368398|NCT02427958|41608699|FG000|Overall Study|Lack of Efficacy|1|||
19368399|NCT02392624|41608706|FG000|Overall Study|Withdrawal by Subject|15|||
19368400|NCT02392624|41608707|FG001|Overall Study|Withdrawal by Subject|12|||
19368401|NCT02392624|41608708|FG002|Overall Study|Withdrawal by Subject|9|||
19368402|NCT02392624|41608706|FG000|Overall Study|Adverse Event|4|||
19368403|NCT02392624|41608707|FG001|Overall Study|Adverse Event|1|||
19368404|NCT02392624|41608708|FG002|Overall Study|Adverse Event|2|||
19368405|NCT02392624|41608706|FG000|Overall Study|Pregnancy|1|||
19368406|NCT02392624|41608707|FG001|Overall Study|Pregnancy|0|||
19368407|NCT02392624|41608708|FG002|Overall Study|Pregnancy|0|||
19368408|NCT02392624|41608706|FG000|Overall Study|Protocol Violation|0|||
19368409|NCT02392624|41608707|FG001|Overall Study|Protocol Violation|0|||
19368410|NCT02392624|41608708|FG002|Overall Study|Protocol Violation|1|||
19368411|NCT02392624|41608706|FG000|Overall Study|Sponsor/Investigator Decision|2|||
19368412|NCT02392624|41608707|FG001|Overall Study|Sponsor/Investigator Decision|1|||
19368413|NCT02392624|41608708|FG002|Overall Study|Sponsor/Investigator Decision|0|||
19368414|NCT02392624|41608706|FG000|Overall Study|Other|49|||
19368415|NCT02392624|41608707|FG001|Overall Study|Other|1|||
19368416|NCT02392624|41608708|FG002|Overall Study|Other|1|||
19799117|NCT02901431|42257305|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19368418|NCT02387164|41608722|FG000|Overall Study|Lost to Follow-up|2|||
19368419|NCT02387164|41608723|FG001|Overall Study|Lost to Follow-up|0|||
19368420|NCT02387164|41608722|FG000|Overall Study|Diagnosed|1|||
19368421|NCT02387164|41608723|FG001|Overall Study|Diagnosed|2|||
19368422|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
19368423|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
19368424|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
19368425|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
19368426|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
19368427|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
19368428|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
19368429|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
19368430|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
19368431|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
19368432|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
19368433|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
19368434|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19368435|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19368436|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19368437|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19368438|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19368439|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
19368440|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
19368441|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
19368442|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
19368443|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
19368444|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
19368445|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
19368446|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
19368447|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
19368448|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
19368449|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
19368450|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
19368451|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
19368452|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
19368453|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
19368454|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
19368455|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
19368456|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
19368457|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
19368458|NCT02392234|41608741|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
19368459|NCT02392234|41608742|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
19368460|NCT02392234|41608743|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
19368461|NCT02392234|41608744|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
19368462|NCT02392234|41608745|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
19368463|NCT02392234|41608746|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
19368464|NCT02392234|41608741|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
19368465|NCT02392234|41608742|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
19368466|NCT02392234|41608743|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
19368467|NCT02392234|41608744|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
19368468|NCT02392234|41608745|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
19368469|NCT02392234|41608746|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
19368470|NCT02963090|41608760|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
19368471|NCT02963090|41608761|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
19368472|NCT02427802|41608773|FG000|Overall Study|Adverse Event|11|||
19368473|NCT02427802|41608774|FG001|Overall Study|Adverse Event|3|||
19368474|NCT02427802|41608775|FG002|Overall Study|Adverse Event|7|||
19368475|NCT02427802|41608773|FG000|Overall Study|Death|0|||
19368476|NCT02427802|41608774|FG001|Overall Study|Death|4|||
19368477|NCT02427802|41608775|FG002|Overall Study|Death|1|||
19368478|NCT02427802|41608773|FG000|Overall Study|Lost to Follow-up|13|||
19368479|NCT02427802|41608774|FG001|Overall Study|Lost to Follow-up|8|||
19368480|NCT02427802|41608775|FG002|Overall Study|Lost to Follow-up|8|||
19368481|NCT02427802|41608773|FG000|Overall Study|Physician Decision|4|||
19368482|NCT02427802|41608774|FG001|Overall Study|Physician Decision|2|||
19368483|NCT02427802|41608775|FG002|Overall Study|Physician Decision|4|||
19368484|NCT02427802|41608773|FG000|Overall Study|Withdrawal by Subject|10|||
19368485|NCT02427802|41608774|FG001|Overall Study|Withdrawal by Subject|5|||
19368486|NCT02427802|41608775|FG002|Overall Study|Withdrawal by Subject|11|||
19368487|NCT02427802|41608773|FG000|Overall Study|Protocol Violation|3|||
19368488|NCT02427802|41608774|FG001|Overall Study|Protocol Violation|1|||
19368489|NCT02427802|41608775|FG002|Overall Study|Protocol Violation|1|||
19368490|NCT02427802|41608773|FG000|Overall Study|protocol specific treatment unrelated|18|||
19368491|NCT02427802|41608774|FG001|Overall Study|protocol specific treatment unrelated|11|||
19368492|NCT02427802|41608775|FG002|Overall Study|protocol specific treatment unrelated|11|||
19368493|NCT02392000|41608783|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
19368494|NCT02392000|41608783|FG000|Overall Study|Withdrawal by Subject|1|||
19368495|NCT02392000|41608783|FG000|Overall Study|Lost to Follow-up|8|||
19368496|NCT02427646|41608790|FG000|Overall Study|Lack of Efficacy|2|||
19368497|NCT02427646|41608791|FG001|Overall Study|Lack of Efficacy|3|||
19368498|NCT02427646|41608790|FG000|Overall Study|Physician Decision|1|||
19368499|NCT02427646|41608791|FG001|Overall Study|Physician Decision|4|||
19698692|NCT00296504|42143589|FG000|Interim Analysis|Participant Stopped|0|||
19368500|NCT02427646|41608790|FG000|Overall Study|Protocol Violation|3|||
19368501|NCT02427646|41608791|FG001|Overall Study|Protocol Violation|3|||
19368502|NCT02427646|41608790|FG000|Overall Study|Bothersome hand weakness|2|||
19368503|NCT02427646|41608791|FG001|Overall Study|Bothersome hand weakness|4|||
19368504|NCT02385526|41608802|FG000|Overall Study|Withdrawal by Subject|0|||
19368505|NCT02385526|41608803|FG001|Overall Study|Withdrawal by Subject|2|||
19368506|NCT02385526|41608804|FG002|Overall Study|Withdrawal by Subject|0|||
19368507|NCT02385526|41608802|FG000|Overall Study|Lost to Follow-up|0|||
19368508|NCT02385526|41608803|FG001|Overall Study|Lost to Follow-up|1|||
19368509|NCT02385526|41608804|FG002|Overall Study|Lost to Follow-up|0|||
19368510|NCT02385526|41608802|FG000|Overall Study|Physician Decision|1|||
19368511|NCT02385526|41608803|FG001|Overall Study|Physician Decision|0|||
19368512|NCT02385526|41608804|FG002|Overall Study|Physician Decision|0|||
19368513|NCT02385526|41608802|FG000|Overall Study|Protocol Violation|1|||
19368514|NCT02385526|41608803|FG001|Overall Study|Protocol Violation|0|||
19368515|NCT02385526|41608804|FG002|Overall Study|Protocol Violation|0|||
19368516|NCT02808143|41608814|FG000|Maintenance Phase|Disease recurrence|1|||
19368517|NCT02808143|41608815|FG001|Maintenance Phase|Disease recurrence|3|||
19368518|NCT02808143|41608814|FG000|Maintenance Phase|Disease progression|1|||
19368519|NCT02808143|41608815|FG001|Maintenance Phase|Disease progression|2|||
19368520|NCT02808143|41608814|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
19368521|NCT02808143|41608815|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
19368522|NCT02808143|41608814|FG000|Survival Follow-Up|Disease recurrence|0|||
19368523|NCT02808143|41608815|FG001|Survival Follow-Up|Disease recurrence|2|||
19368524|NCT02808143|41608814|FG000|Survival Follow-Up|Adverse Event|0|||
19368525|NCT02808143|41608815|FG001|Survival Follow-Up|Adverse Event|1|||
19368526|NCT02808143|41608814|FG000|Survival Follow-Up|Death|1|||
19368527|NCT02808143|41608815|FG001|Survival Follow-Up|Death|0|||
19368528|NCT02427100|41608825|FG000|Overall Study|Lost to Follow-up|0|||
19368529|NCT02427100|41608826|FG001|Overall Study|Lost to Follow-up|2|||
19368530|NCT02806973|41608832|FG000|Period 1|Withdrawal by Subject|0|||
19368531|NCT02806973|41608833|FG001|Period 1|Withdrawal by Subject|2|||
19368532|NCT02806973|41608834|FG002|Period 1|Withdrawal by Subject|1|||
19368533|NCT02806973|41608835|FG003|Period 1|Withdrawal by Subject|1|||
19368534|NCT02806973|41608832|FG000|Period 1|Adverse Event|0|||
19368535|NCT02806973|41608833|FG001|Period 1|Adverse Event|0|||
19368536|NCT02806973|41608834|FG002|Period 1|Adverse Event|0|||
19368537|NCT02806973|41608835|FG003|Period 1|Adverse Event|1|||
19368538|NCT02806973|41608832|FG000|Period 3|Withdrawal by Subject|0|||
19368539|NCT02806973|41608833|FG001|Period 3|Withdrawal by Subject|0|||
19368540|NCT02806973|41608834|FG002|Period 3|Withdrawal by Subject|0|||
19368541|NCT02806973|41608835|FG003|Period 3|Withdrawal by Subject|3|||
19368542|NCT02806973|41608832|FG000|Period 3|Adverse Event|0|||
19368543|NCT02806973|41608833|FG001|Period 3|Adverse Event|0|||
19368544|NCT02806973|41608834|FG002|Period 3|Adverse Event|1|||
19368545|NCT02806973|41608835|FG003|Period 3|Adverse Event|0|||
19368546|NCT02806505|41608847|FG000|Overall Study|Adverse event/intercurrent illness|1|||
19368547|NCT02806505|41608848|FG001|Overall Study|Adverse event/intercurrent illness|3|||
19368548|NCT02806505|41608847|FG000|Overall Study|Death|4|||
19368549|NCT02806505|41608848|FG001|Overall Study|Death|0|||
19368550|NCT02806505|41608847|FG000|Overall Study|Did not cooperate/refused treatment|3|||
19368551|NCT02806505|41608848|FG001|Overall Study|Did not cooperate/refused treatment|3|||
19368552|NCT02806505|41608847|FG000|Overall Study|Failure to return|0|||
19368553|NCT02806505|41608848|FG001|Overall Study|Failure to return|1|||
19368554|NCT02806505|41608847|FG000|Overall Study|Insufficient therapeutic response|2|||
19368555|NCT02806505|41608848|FG001|Overall Study|Insufficient therapeutic response|4|||
19368556|NCT02807363|41608858|FG000|Dosing Period|Adverse Event|0|||
19368557|NCT02807363|41608859|FG001|Dosing Period|Adverse Event|1|||
19368558|NCT02807363|41608860|FG002|Dosing Period|Adverse Event|0|||
19368559|NCT02807363|41608861|FG003|Dosing Period|Adverse Event|0|||
19368560|NCT02426086|41608875|FG000|Overall Study|Death|33|||
19368561|NCT02426086|41608876|FG001|Overall Study|Death|36|||
19368562|NCT02426086|41608875|FG000|Overall Study|Lost to Follow-up|2|||
19368563|NCT02426086|41608876|FG001|Overall Study|Lost to Follow-up|0|||
19368564|NCT02426086|41608875|FG000|Overall Study|Study Terminated by Sponsor|5|||
19368565|NCT02426086|41608876|FG001|Overall Study|Study Terminated by Sponsor|14|||
19368566|NCT02426086|41608875|FG000|Overall Study|Withdrawal by Subject|8|||
19368567|NCT02426086|41608876|FG001|Overall Study|Withdrawal by Subject|9|||
19368568|NCT02383966|41608889|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
19368569|NCT02383966|41608890|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
19368570|NCT02383966|41608889|FG000|Overall Study|Randomized, but not treated|1|||
19368571|NCT02383966|41608890|FG001|Overall Study|Randomized, but not treated|3|||
19368572|NCT02383576|41608898|FG000|Overall Study|Death|53|||
19368573|NCT02383576|41608899|FG001|Overall Study|Death|33|||
19368574|NCT02383576|41608898|FG000|Overall Study|Lost to Follow-up|7|||
19368575|NCT02383576|41608899|FG001|Overall Study|Lost to Follow-up|1|||
19368576|NCT02383576|41608898|FG000|Overall Study|Withdrew Consent|1|||
19368577|NCT02383576|41608899|FG001|Overall Study|Withdrew Consent|6|||
19368578|NCT02383576|41608898|FG000|Overall Study|Investigator's Decision|0|||
19368579|NCT02383576|41608899|FG001|Overall Study|Investigator's Decision|1|||
19368580|NCT02383576|41608898|FG000|Overall Study|Administrative/Other|2|||
19368581|NCT02383576|41608899|FG001|Overall Study|Administrative/Other|4|||
19368582|NCT02748317|41608905|FG000|Overall Study|Withdrawal by Subject|14|||
19368583|NCT02748317|41608905|FG000|Overall Study|Lost to Follow-up|8|||
19368584|NCT02748317|41608905|FG000|Overall Study|Death|1|||
19368585|NCT02422264|41608911|FG000|Overall Study|Serious Adverse Event|1|||
19368586|NCT02422264|41608912|FG001|Overall Study|Serious Adverse Event|0|||
19368587|NCT02422264|41608911|FG000|Overall Study|Withdrawal by Subject|1|||
19368588|NCT02422264|41608912|FG001|Overall Study|Withdrawal by Subject|2|||
19368589|NCT02422264|41608911|FG000|Overall Study|Migrated/moved from study area|3|||
19368590|NCT02422264|41608912|FG001|Overall Study|Migrated/moved from study area|1|||
19368591|NCT02422264|41608911|FG000|Overall Study|Subject vaccinated outside of the study|0|||
19368592|NCT02422264|41608912|FG001|Overall Study|Subject vaccinated outside of the study|1|||
19368593|NCT02390362|41608920|FG000|Overall Study|Withdrawal by Subject|0|||
19368594|NCT02390362|41608921|FG001|Overall Study|Withdrawal by Subject|1|||
19368595|NCT02389894|41608930|FG000|Overall Study|Death|4|||
19368596|NCT02389894|41608931|FG001|Overall Study|Death|5|||
19368597|NCT02389894|41608932|FG002|Overall Study|Death|3|||
19368598|NCT02389894|41608930|FG000|Overall Study|Withdrawal by Subject|2|||
19368599|NCT02389894|41608931|FG001|Overall Study|Withdrawal by Subject|4|||
19368600|NCT02389894|41608932|FG002|Overall Study|Withdrawal by Subject|5|||
19368601|NCT02389894|41608930|FG000|Overall Study|Lost to Follow-up|2|||
19368602|NCT02389894|41608931|FG001|Overall Study|Lost to Follow-up|1|||
19368603|NCT02389894|41608932|FG002|Overall Study|Lost to Follow-up|1|||
19368604|NCT02389816|41608943|FG000|Overall Study|Randomized but Not Treated|1|||
19368605|NCT02389816|41608944|FG001|Overall Study|Randomized but Not Treated|0|||
19368606|NCT02389816|41608945|FG002|Overall Study|Randomized but Not Treated|0|||
19368607|NCT02389816|41608943|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
19368608|NCT02389816|41608944|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
19368609|NCT02389816|41608945|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
19368610|NCT02389816|41608943|FG000|Overall Study|Major Protocol Deviation|1|||
19608295|NCT00929240|42057152|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
19608296|NCT00929240|42057153|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
19608297|NCT00929240|42057151|FG000|Maintenance Phase|Participant not treated|0|||
19608298|NCT00929240|42057152|FG001|Maintenance Phase|Participant not treated|2|||
19799118|NCT02901431|42257306|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799119|NCT02901431|42257307|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799120|NCT02901431|42257308|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799121|NCT02901431|42257309|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
19799122|NCT02901431|42257297|FG000|PK Part|Pending dose confirmation|0|||
19799123|NCT02901431|42257298|FG001|PK Part|Pending dose confirmation|1|||
19799124|NCT02901431|42257299|FG002|PK Part|Pending dose confirmation|0|||
19799125|NCT02901431|42257300|FG003|PK Part|Pending dose confirmation|0|||
19799126|NCT02901431|42257301|FG004|PK Part|Pending dose confirmation|0|||
19799127|NCT02901431|42257302|FG005|PK Part|Pending dose confirmation|0|||
19799128|NCT02901431|42257303|FG006|PK Part|Pending dose confirmation|0|||
19799129|NCT02901431|42257304|FG007|PK Part|Pending dose confirmation|0|||
19799130|NCT02901431|42257305|FG008|PK Part|Pending dose confirmation|0|||
19799131|NCT02901431|42257306|FG009|PK Part|Pending dose confirmation|0|||
19799132|NCT02901431|42257307|FG010|PK Part|Pending dose confirmation|0|||
19799133|NCT02901431|42257308|FG011|PK Part|Pending dose confirmation|0|||
19799134|NCT02901431|42257309|FG012|PK Part|Pending dose confirmation|0|||
19799135|NCT02901431|42257297|FG000|PK Part|8 weeks of treatment ran out|2|||
19799136|NCT02901431|42257298|FG001|PK Part|8 weeks of treatment ran out|0|||
19799137|NCT02901431|42257299|FG002|PK Part|8 weeks of treatment ran out|0|||
19799138|NCT02901431|42257300|FG003|PK Part|8 weeks of treatment ran out|0|||
19799139|NCT02901431|42257301|FG004|PK Part|8 weeks of treatment ran out|0|||
19799140|NCT02901431|42257302|FG005|PK Part|8 weeks of treatment ran out|0|||
19799141|NCT02901431|42257303|FG006|PK Part|8 weeks of treatment ran out|0|||
19698693|NCT00296504|42143590|FG001|Interim Analysis|Participant Stopped|0|||
19698694|NCT00296504|42143591|FG002|Interim Analysis|Participant Stopped|0|||
19698695|NCT00296504|42143592|FG003|Interim Analysis|Participant Stopped|0|||
19698696|NCT00296504|42143593|FG004|Interim Analysis|Participant Stopped|1|||
19698697|NCT00296504|42143594|FG005|Interim Analysis|Participant Stopped|0|||
19698698|NCT00296504|42143595|FG006|Interim Analysis|Participant Stopped|0|||
19608299|NCT00929240|42057153|FG002|Maintenance Phase|Participant not treated|0|||
19608300|NCT00993317|42057164|FG000|Overall Study|Adverse Event|2|||
19698699|NCT00296504|42143596|FG007|Interim Analysis|Participant Stopped|0|||
19799142|NCT02901431|42257304|FG007|PK Part|8 weeks of treatment ran out|0|||
19799143|NCT02901431|42257305|FG008|PK Part|8 weeks of treatment ran out|0|||
19799144|NCT02901431|42257306|FG009|PK Part|8 weeks of treatment ran out|0|||
19799145|NCT02901431|42257307|FG010|PK Part|8 weeks of treatment ran out|0|||
19799146|NCT02901431|42257308|FG011|PK Part|8 weeks of treatment ran out|0|||
19799147|NCT02901431|42257309|FG012|PK Part|8 weeks of treatment ran out|0|||
19799148|NCT02901431|42257297|FG000|PK Part|Stopped treatment after 8 weeks|1|||
19368611|NCT02389816|41608944|FG001|Overall Study|Major Protocol Deviation|0|||
19368612|NCT02389816|41608945|FG002|Overall Study|Major Protocol Deviation|0|||
19368613|NCT02389816|41608943|FG000|Overall Study|Lost to Follow-up|1|||
19368614|NCT02389816|41608944|FG001|Overall Study|Lost to Follow-up|0|||
19368615|NCT02389816|41608945|FG002|Overall Study|Lost to Follow-up|0|||
19368616|NCT02389816|41608943|FG000|Overall Study|Withdrawal of Consent|6|||
19368617|NCT02389816|41608944|FG001|Overall Study|Withdrawal of Consent|4|||
19368618|NCT02389816|41608945|FG002|Overall Study|Withdrawal of Consent|4|||
19368619|NCT02389816|41608943|FG000|Overall Study|Lack of Efficacy|1|||
19368620|NCT02389816|41608944|FG001|Overall Study|Lack of Efficacy|0|||
19368621|NCT02389816|41608945|FG002|Overall Study|Lack of Efficacy|0|||
19368622|NCT02389816|41608943|FG000|Overall Study|Non Compliance with Study Drug|1|||
19368623|NCT02389816|41608944|FG001|Overall Study|Non Compliance with Study Drug|1|||
19368624|NCT02389816|41608945|FG002|Overall Study|Non Compliance with Study Drug|1|||
19368625|NCT02389816|41608943|FG000|Overall Study|Reason not Specified|0|||
19368626|NCT02389816|41608944|FG001|Overall Study|Reason not Specified|2|||
19368627|NCT02389816|41608945|FG002|Overall Study|Reason not Specified|0|||
19368628|NCT02388724|41608955|FG000|Overall Study|Reason not Specified|0|||
19368629|NCT02388724|41608956|FG001|Overall Study|Reason not Specified|1|||
19368630|NCT02388724|41608955|FG000|Overall Study|Major Protocol Deviation|3|||
19368631|NCT02388724|41608956|FG001|Overall Study|Major Protocol Deviation|3|||
19368632|NCT02388724|41608955|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
19368633|NCT02388724|41608956|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
19368634|NCT02388724|41608955|FG000|Overall Study|Voluntary Withdrawal|6|||
19368635|NCT02388724|41608956|FG001|Overall Study|Voluntary Withdrawal|5|||
19368636|NCT02388724|41608955|FG000|Overall Study|Randomized but not Treated|0|||
19368637|NCT02388724|41608956|FG001|Overall Study|Randomized but not Treated|2|||
19368638|NCT02382796|41608962|FG000|Overall Study|Global deterioration of health status|1|||
19368639|NCT02382796|41608962|FG000|Overall Study|Objective progression or relapse|3|||
19368640|NCT02382796|41608962|FG000|Overall Study|Commercial dacomitinib became available|3|||
19368641|NCT02382640|41608970|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
19368642|NCT02382640|41608971|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
19368643|NCT02382640|41608972|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
19368644|NCT02382640|41608973|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
19368645|NCT02801669|41608985|FG000|Overall Study|Death|66|||
19368646|NCT02801669|41608986|FG001|Overall Study|Death|69|||
19368647|NCT02801669|41608985|FG000|Overall Study|Withdrawal by Subject|81|||
19368648|NCT02801669|41608986|FG001|Overall Study|Withdrawal by Subject|77|||
19368649|NCT02801669|41608985|FG000|Overall Study|Other|4|||
19368650|NCT02801669|41608986|FG001|Overall Study|Other|6|||
19368651|NCT02804399|41608992|FG000|Period 2|Adverse Event|0|||
19368652|NCT02804399|41608993|FG001|Period 2|Adverse Event|1|||
19368653|NCT01333943|41609004|FG000|Overall Study|Known neuropathy|1|||
19368654|NCT01333943|41609005|FG001|Overall Study|Known neuropathy|0|||
19368655|NCT01333865|41609011|FG000|Overall Study|Adverse Event|2|||
19368656|NCT01333475|41609017|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
19368657|NCT01333475|41609018|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
19368658|NCT01333475|41609017|FG000|Overall Study|Toxicity|1|||
19368659|NCT01333475|41609018|FG001|Overall Study|Toxicity|3|||
19368660|NCT01333397|41609030|FG000|Overall Study|Lost to Follow-up|1|||
19368661|NCT01333397|41609031|FG001|Overall Study|Lost to Follow-up|0|||
19368662|NCT01333397|41609032|FG002|Overall Study|Lost to Follow-up|0|||
19368663|NCT01333397|41609033|FG003|Overall Study|Lost to Follow-up|1|||
19368664|NCT01333397|41609034|FG004|Overall Study|Lost to Follow-up|0|||
19368665|NCT02798861|41609055|FG000|Overall Study|Lost to Follow-up|22|||
19368666|NCT02798861|41609055|FG000|Overall Study|Withdrawal by Subject|1|||
19368667|NCT02798315|41609059|FG000|Overall Study|Failure to return|1|||
19368668|NCT02796755|41609065|FG000|Overall Study|Adverse Event|2|||
19368669|NCT02796755|41609066|FG001|Overall Study|Adverse Event|0|||
19368670|NCT02382016|41609074|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
19368671|NCT02382016|41609075|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
19368672|NCT02382016|41609074|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
19368673|NCT02382016|41609075|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
19368674|NCT02382016|41609074|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
19368675|NCT02382016|41609075|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
19368676|NCT02382016|41609074|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
19368677|NCT02382016|41609075|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
19368678|NCT02382016|41609074|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
19368679|NCT02382016|41609075|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
19368680|NCT02382016|41609074|FG000|Open-label (OL) Treatment Period|Death|4|||
19368681|NCT02382016|41609075|FG001|Open-label (OL) Treatment Period|Death|0|||
19608301|NCT00993317|42057165|FG001|Overall Study|Adverse Event|4|||
19608302|NCT00993317|42057164|FG000|Overall Study|Lack of Efficacy|18|||
19368682|NCT02382016|41609074|FG000|OL Extension Period|Physician Decision|3|||
19368683|NCT02382016|41609075|FG001|OL Extension Period|Physician Decision|0|||
19368684|NCT02382016|41609074|FG000|OL Extension Period|Death|2|||
19368685|NCT02382016|41609075|FG001|OL Extension Period|Death|0|||
19368686|NCT02382016|41609074|FG000|OL Extension Period|Withdrawal by Subject|1|||
19368687|NCT02382016|41609075|FG001|OL Extension Period|Withdrawal by Subject|0|||
19608303|NCT00993317|42057165|FG001|Overall Study|Lack of Efficacy|18|||
19368688|NCT02380690|41609085|FG000|Overall Study|Lost to Follow-up|14|||
19368689|NCT02380690|41609086|FG001|Overall Study|Lost to Follow-up|4|||
19368690|NCT02380690|41609085|FG000|Overall Study|Withdrawal by Subject|20|||
19368691|NCT02380690|41609086|FG001|Overall Study|Withdrawal by Subject|8|||
19368692|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
19368693|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
19368694|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
19368695|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
19368696|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
19368697|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
19368698|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
19368699|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
19368700|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
19368701|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
19368702|NCT02422186|41609094|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
19368703|NCT02422186|41609095|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
19368704|NCT02422186|41609094|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
19368705|NCT02422186|41609095|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
19368706|NCT02422186|41609094|FG000|Follow-up Phase (2 Weeks)|Other|3|||
19368707|NCT02422186|41609095|FG001|Follow-up Phase (2 Weeks)|Other|0|||
19368708|NCT02421952|41609103|FG000|Overall Study|Diary Not Returned|93|||
19368709|NCT02421952|41609103|FG000|Overall Study|Failed seriation task|13|||
19368710|NCT02421952|41609103|FG000|Overall Study|Subject uncooperative for baseline test|2|||
19368711|NCT02421952|41609103|FG000|Overall Study|Surgery cancelled|1|||
19368712|NCT02796677|41609114|FG000|Overall Study|Adverse Event|11|||
19368713|NCT02796677|41609115|FG001|Overall Study|Adverse Event|22|||
19368714|NCT02796677|41609116|FG002|Overall Study|Adverse Event|14|||
19368715|NCT02796677|41609117|FG003|Overall Study|Adverse Event|14|||
19368716|NCT02796677|41609114|FG000|Overall Study|Protocol Violation|7|||
19368717|NCT02796677|41609115|FG001|Overall Study|Protocol Violation|5|||
19368718|NCT02796677|41609116|FG002|Overall Study|Protocol Violation|4|||
19368719|NCT02796677|41609117|FG003|Overall Study|Protocol Violation|8|||
19368720|NCT02796677|41609114|FG000|Overall Study|Lost to Follow-up|1|||
19368721|NCT02796677|41609115|FG001|Overall Study|Lost to Follow-up|5|||
19368722|NCT02796677|41609116|FG002|Overall Study|Lost to Follow-up|2|||
19368723|NCT02796677|41609117|FG003|Overall Study|Lost to Follow-up|2|||
19368724|NCT02796677|41609114|FG000|Overall Study|Lack of Efficacy|7|||
19368725|NCT02796677|41609115|FG001|Overall Study|Lack of Efficacy|9|||
19368726|NCT02796677|41609116|FG002|Overall Study|Lack of Efficacy|14|||
19368727|NCT02796677|41609117|FG003|Overall Study|Lack of Efficacy|20|||
19368728|NCT02796677|41609114|FG000|Overall Study|Withdrawal by Subject|4|||
19368729|NCT02796677|41609115|FG001|Overall Study|Withdrawal by Subject|14|||
19368730|NCT02796677|41609116|FG002|Overall Study|Withdrawal by Subject|6|||
19368731|NCT02796677|41609117|FG003|Overall Study|Withdrawal by Subject|7|||
19368732|NCT02796677|41609114|FG000|Overall Study|Progressive disease|6|||
19368733|NCT02796677|41609115|FG001|Overall Study|Progressive disease|15|||
19368734|NCT02796677|41609116|FG002|Overall Study|Progressive disease|13|||
19368735|NCT02796677|41609117|FG003|Overall Study|Progressive disease|18|||
19368736|NCT02796677|41609114|FG000|Overall Study|Reason not mentioned|2|||
19368737|NCT02796677|41609115|FG001|Overall Study|Reason not mentioned|3|||
19368738|NCT02796677|41609116|FG002|Overall Study|Reason not mentioned|0|||
19368739|NCT02796677|41609117|FG003|Overall Study|Reason not mentioned|5|||
19698700|NCT00296504|42143597|FG008|Interim Analysis|Participant Stopped|0|||
19698701|NCT00296504|42143589|FG000|Interim Analysis|Physician and Participant Decision|0|||
19698702|NCT00296504|42143590|FG001|Interim Analysis|Physician and Participant Decision|0|||
19698703|NCT00296504|42143591|FG002|Interim Analysis|Physician and Participant Decision|0|||
19698704|NCT00296504|42143592|FG003|Interim Analysis|Physician and Participant Decision|0|||
19698705|NCT00296504|42143593|FG004|Interim Analysis|Physician and Participant Decision|0|||
19698706|NCT00296504|42143594|FG005|Interim Analysis|Physician and Participant Decision|1|||
19698707|NCT00296504|42143595|FG006|Interim Analysis|Physician and Participant Decision|0|||
19698708|NCT00296504|42143596|FG007|Interim Analysis|Physician and Participant Decision|0|||
19698709|NCT00296504|42143597|FG008|Interim Analysis|Physician and Participant Decision|0|||
19698710|NCT00296504|42143589|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
19698711|NCT00296504|42143590|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
19698712|NCT00296504|42143591|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
19698713|NCT00296504|42143592|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
19698714|NCT00296504|42143593|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
19608304|NCT00993317|42057164|FG000|Overall Study|Withdrawal by Subject|0|||
19608305|NCT00993317|42057165|FG001|Overall Study|Withdrawal by Subject|2|||
19698715|NCT00296504|42143594|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
19698716|NCT00296504|42143595|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
19608306|NCT00993317|42057164|FG000|Overall Study|Investigator's opinion|0|||
19698717|NCT00296504|42143596|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
19698718|NCT00296504|42143597|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
19698719|NCT00296504|42143589|FG000|Interim Analysis|Study Ended|0|||
19698720|NCT00296504|42143590|FG001|Interim Analysis|Study Ended|0|||
19698721|NCT00296504|42143591|FG002|Interim Analysis|Study Ended|0|||
19698722|NCT00296504|42143592|FG003|Interim Analysis|Study Ended|0|||
19698723|NCT00296504|42143593|FG004|Interim Analysis|Study Ended|0|||
19698724|NCT00296504|42143594|FG005|Interim Analysis|Study Ended|0|||
19698725|NCT00296504|42143595|FG006|Interim Analysis|Study Ended|1|||
19698726|NCT00296504|42143596|FG007|Interim Analysis|Study Ended|0|||
19698727|NCT00296504|42143597|FG008|Interim Analysis|Study Ended|0|||
19698728|NCT00296504|42143589|FG000|Interim Analysis|Participant Needed Interferon|0|||
19698729|NCT00296504|42143590|FG001|Interim Analysis|Participant Needed Interferon|0|||
19698730|NCT00296504|42143591|FG002|Interim Analysis|Participant Needed Interferon|0|||
19698731|NCT00296504|42143592|FG003|Interim Analysis|Participant Needed Interferon|0|||
19698732|NCT00296504|42143593|FG004|Interim Analysis|Participant Needed Interferon|0|||
19698733|NCT00296504|42143594|FG005|Interim Analysis|Participant Needed Interferon|0|||
19698734|NCT00296504|42143595|FG006|Interim Analysis|Participant Needed Interferon|0|||
19698735|NCT00296504|42143596|FG007|Interim Analysis|Participant Needed Interferon|1|||
19698736|NCT00296504|42143597|FG008|Interim Analysis|Participant Needed Interferon|0|||
19698737|NCT00296504|42143589|FG000|Interim Analysis|Ongoing|32|||
19698738|NCT00296504|42143590|FG001|Interim Analysis|Ongoing|12|||
19698739|NCT00296504|42143591|FG002|Interim Analysis|Ongoing|16|||
19698740|NCT00296504|42143592|FG003|Interim Analysis|Ongoing|22|||
19698741|NCT00296504|42143593|FG004|Interim Analysis|Ongoing|0|||
19368784|NCT02421172|41609151|FG000|Period 1|Adverse Event|1|||
19368785|NCT02421172|41609152|FG001|Period 1|Adverse Event|0|||
19368786|NCT02421172|41609153|FG002|Period 1|Adverse Event|0|||
19368787|NCT02421172|41609154|FG003|Period 1|Adverse Event|0|||
19368788|NCT02421172|41609155|FG004|Period 1|Adverse Event|0|||
19368789|NCT02421172|41609151|FG000|Period 1|Lost to Follow-up|3|||
19368790|NCT02421172|41609152|FG001|Period 1|Lost to Follow-up|1|||
19368791|NCT02421172|41609153|FG002|Period 1|Lost to Follow-up|0|||
19368792|NCT02421172|41609154|FG003|Period 1|Lost to Follow-up|0|||
19368793|NCT02421172|41609155|FG004|Period 1|Lost to Follow-up|0|||
19368794|NCT02421172|41609151|FG000|Period 1|Patient/guardian decision|0|||
19368795|NCT02421172|41609152|FG001|Period 1|Patient/guardian decision|1|||
19368796|NCT02421172|41609153|FG002|Period 1|Patient/guardian decision|0|||
19368797|NCT02421172|41609154|FG003|Period 1|Patient/guardian decision|0|||
19368798|NCT02421172|41609155|FG004|Period 1|Patient/guardian decision|0|||
19368799|NCT02421172|41609151|FG000|Period 2|Adverse Event|0|||
19368800|NCT02421172|41609152|FG001|Period 2|Adverse Event|0|||
19368801|NCT02421172|41609153|FG002|Period 2|Adverse Event|4|||
19368802|NCT02421172|41609154|FG003|Period 2|Adverse Event|0|||
19368803|NCT02421172|41609155|FG004|Period 2|Adverse Event|0|||
19368804|NCT02421172|41609151|FG000|Period 2|Lost to Follow-up|0|||
19368805|NCT02421172|41609152|FG001|Period 2|Lost to Follow-up|0|||
19368806|NCT02421172|41609153|FG002|Period 2|Lost to Follow-up|0|||
19368807|NCT02421172|41609154|FG003|Period 2|Lost to Follow-up|1|||
19368808|NCT02421172|41609155|FG004|Period 2|Lost to Follow-up|0|||
19368809|NCT02421172|41609151|FG000|Period 2|Patient/guardian decision|0|||
19368810|NCT02421172|41609152|FG001|Period 2|Patient/guardian decision|0|||
19368811|NCT02421172|41609153|FG002|Period 2|Patient/guardian decision|3|||
19368812|NCT02421172|41609154|FG003|Period 2|Patient/guardian decision|2|||
19368813|NCT02421172|41609155|FG004|Period 2|Patient/guardian decision|1|||
19368814|NCT02379052|41609168|FG000|Overall Study|Protocol Violation|0|||
19368815|NCT02379052|41609169|FG001|Overall Study|Protocol Violation|1|||
19368816|NCT02379052|41609168|FG000|Overall Study|Adverse Event|0|||
19368817|NCT02379052|41609169|FG001|Overall Study|Adverse Event|1|||
19368818|NCT02379052|41609168|FG000|Overall Study|Physician Decision|1|||
19368819|NCT02379052|41609169|FG001|Overall Study|Physician Decision|1|||
19368820|NCT02379052|41609168|FG000|Overall Study|Withdrawal by Subject|2|||
19368821|NCT02379052|41609169|FG001|Overall Study|Withdrawal by Subject|0|||
19368822|NCT02379052|41609168|FG000|Overall Study|Lost to Follow-up|2|||
19368823|NCT02379052|41609169|FG001|Overall Study|Lost to Follow-up|1|||
19368824|NCT02379052|41609168|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
19368825|NCT02379052|41609169|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
19368826|NCT02379052|41609168|FG000|Overall Study|Subject was Incarcerated|0|||
19368827|NCT02379052|41609169|FG001|Overall Study|Subject was Incarcerated|1|||
19368828|NCT02378662|41609177|FG000|Overall Study|Early Discontinuation|2|||
19368829|NCT02378662|41609178|FG001|Overall Study|Early Discontinuation|0|||
19368830|NCT02378506|41609184|FG000|Overall Study|Lack of Efficacy|3|||
19368831|NCT02378506|41609184|FG000|Overall Study|Withdrawal by Subject|4|||
19368832|NCT02378506|41609184|FG000|Overall Study|Protocol Violation|2|||
19368833|NCT02378506|41609184|FG000|Overall Study|Death|1|||
19368834|NCT02378506|41609184|FG000|Overall Study|Adverse Event|14|||
19698742|NCT00296504|42143594|FG005|Interim Analysis|Ongoing|0|||
19698743|NCT00296504|42143595|FG006|Interim Analysis|Ongoing|30|||
19698744|NCT00296504|42143596|FG007|Interim Analysis|Ongoing|1|||
19368835|NCT02378506|41609184|FG000|Overall Study|Randomized But Not Treated|1|||
19368836|NCT02347774|41609191|FG000|Study Participation|Lost to Follow-up|3|||
19368837|NCT02347774|41609192|FG001|Study Participation|Lost to Follow-up|6|||
19368838|NCT02347774|41609193|FG002|Study Participation|Lost to Follow-up|2|||
19368839|NCT02347774|41609191|FG000|Study Participation|Withdrawal by Subject|8|||
19368840|NCT02347774|41609192|FG001|Study Participation|Withdrawal by Subject|9|||
19368841|NCT02347774|41609193|FG002|Study Participation|Withdrawal by Subject|15|||
19368842|NCT02347774|41609191|FG000|Study Participation|Adverse Event|1|||
19368843|NCT02347774|41609192|FG001|Study Participation|Adverse Event|4|||
19368844|NCT02347774|41609193|FG002|Study Participation|Adverse Event|6|||
19368845|NCT02347774|41609191|FG000|Study Participation|withdrew consent|1|||
19368846|NCT02347774|41609192|FG001|Study Participation|withdrew consent|1|||
19368847|NCT02347774|41609193|FG002|Study Participation|withdrew consent|1|||
19368848|NCT02347774|41609191|FG000|Study Participation|Met Prolonged QT criteria|1|||
19368849|NCT02347774|41609192|FG001|Study Participation|Met Prolonged QT criteria|0|||
19368850|NCT02347774|41609193|FG002|Study Participation|Met Prolonged QT criteria|0|||
19368851|NCT02347774|41609191|FG000|Study Participation|non-compliance with study drug|0|||
19368852|NCT02347774|41609192|FG001|Study Participation|non-compliance with study drug|1|||
19368853|NCT02347774|41609193|FG002|Study Participation|non-compliance with study drug|0|||
19368854|NCT02347774|41609191|FG000|Study Participation|incarceration|1|||
19368855|NCT02347774|41609192|FG001|Study Participation|incarceration|0|||
19368856|NCT02347774|41609193|FG002|Study Participation|incarceration|0|||
19368857|NCT02347774|41609191|FG000|Study Participation|randomized in error|0|||
19368858|NCT02347774|41609192|FG001|Study Participation|randomized in error|0|||
19368859|NCT02347774|41609193|FG002|Study Participation|randomized in error|1|||
19368860|NCT02347774|41609191|FG000|On Study Treatment|Adverse Event|9|||
19368861|NCT02347774|41609192|FG001|On Study Treatment|Adverse Event|15|||
19368862|NCT02347774|41609193|FG002|On Study Treatment|Adverse Event|19|||
19368863|NCT02347774|41609191|FG000|On Study Treatment|Lack of Efficacy|3|||
19368864|NCT02347774|41609192|FG001|On Study Treatment|Lack of Efficacy|0|||
19368865|NCT02347774|41609193|FG002|On Study Treatment|Lack of Efficacy|2|||
19368866|NCT02347774|41609191|FG000|On Study Treatment|non-complicance with study medication|0|||
19368867|NCT02347774|41609192|FG001|On Study Treatment|non-complicance with study medication|2|||
19368868|NCT02347774|41609193|FG002|On Study Treatment|non-complicance with study medication|0|||
19368869|NCT02347774|41609191|FG000|On Study Treatment|Protocol Violation|0|||
19368870|NCT02347774|41609192|FG001|On Study Treatment|Protocol Violation|0|||
19368871|NCT02347774|41609193|FG002|On Study Treatment|Protocol Violation|1|||
19368872|NCT02347774|41609191|FG000|On Study Treatment|withdrew consent|9|||
19368873|NCT02347774|41609192|FG001|On Study Treatment|withdrew consent|8|||
19368874|NCT02347774|41609193|FG002|On Study Treatment|withdrew consent|12|||
19368875|NCT02347774|41609191|FG000|On Study Treatment|Lost to Follow-up|2|||
19368876|NCT02347774|41609192|FG001|On Study Treatment|Lost to Follow-up|6|||
19368877|NCT02347774|41609193|FG002|On Study Treatment|Lost to Follow-up|1|||
19368878|NCT02347774|41609191|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
19368879|NCT02347774|41609192|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
19368880|NCT02347774|41609193|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
19368881|NCT02347774|41609191|FG000|On Study Treatment|ranomized in error|0|||
19368882|NCT02347774|41609192|FG001|On Study Treatment|ranomized in error|0|||
19368883|NCT02347774|41609193|FG002|On Study Treatment|ranomized in error|1|||
19368884|NCT02794883|41609204|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
19368885|NCT02794883|41609205|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
19368886|NCT02794883|41609206|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
19368887|NCT02794883|41609204|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
19368888|NCT02794883|41609205|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
19368889|NCT02794883|41609206|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
19368890|NCT02794883|41609204|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
19368891|NCT02794883|41609205|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
19368892|NCT02794883|41609206|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
19368893|NCT02794883|41609204|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
19368894|NCT02794883|41609205|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
19368895|NCT02794883|41609206|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
19368896|NCT02794883|41609204|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
19368897|NCT02794883|41609205|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
19368898|NCT02794883|41609206|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
19368899|NCT02794883|41609204|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
19368900|NCT02794883|41609205|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
19368901|NCT02794883|41609206|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
19368902|NCT02794883|41609204|FG000|Follow-up Period (up to 2 Years)|Death|12|||
19368903|NCT02794883|41609205|FG001|Follow-up Period (up to 2 Years)|Death|10|||
19368904|NCT02794883|41609206|FG002|Follow-up Period (up to 2 Years)|Death|10|||
19368905|NCT01370603|41609216|FG000|Period 1|Adverse Event|5|||
19368906|NCT01370603|41609217|FG001|Period 1|Adverse Event|3|||
19368907|NCT01370603|41609216|FG000|Period 1|Lost to Follow-up|2|||
19368908|NCT01370603|41609217|FG001|Period 1|Lost to Follow-up|0|||
19368909|NCT01370603|41609216|FG000|Period 1|Protocol Violation|2|||
19368910|NCT01370603|41609217|FG001|Period 1|Protocol Violation|2|||
19368911|NCT01370603|41609216|FG000|Period 1|Withdrawal by Subject|5|||
19368912|NCT01370603|41609217|FG001|Period 1|Withdrawal by Subject|5|||
19608307|NCT00993317|42057165|FG001|Overall Study|Investigator's opinion|1|||
19608308|NCT00993317|42057164|FG000|Overall Study|Early study termination at the site|1|||
19799149|NCT02901431|42257298|FG001|PK Part|Stopped treatment after 8 weeks|0|||
19799150|NCT02901431|42257299|FG002|PK Part|Stopped treatment after 8 weeks|1|||
19799151|NCT02901431|42257300|FG003|PK Part|Stopped treatment after 8 weeks|0|||
19799152|NCT02901431|42257301|FG004|PK Part|Stopped treatment after 8 weeks|0|||
19799153|NCT02901431|42257302|FG005|PK Part|Stopped treatment after 8 weeks|0|||
19799154|NCT02901431|42257303|FG006|PK Part|Stopped treatment after 8 weeks|0|||
19799155|NCT02901431|42257304|FG007|PK Part|Stopped treatment after 8 weeks|0|||
19799156|NCT02901431|42257305|FG008|PK Part|Stopped treatment after 8 weeks|0|||
19799157|NCT02901431|42257306|FG009|PK Part|Stopped treatment after 8 weeks|0|||
19799158|NCT02901431|42257307|FG010|PK Part|Stopped treatment after 8 weeks|0|||
19799159|NCT02901431|42257308|FG011|PK Part|Stopped treatment after 8 weeks|0|||
19799160|NCT02901431|42257309|FG012|PK Part|Stopped treatment after 8 weeks|0|||
19368913|NCT01370603|41609216|FG000|Crossover Washout|Adverse Event|2|||
19368914|NCT01370603|41609217|FG001|Crossover Washout|Adverse Event|1|||
19608309|NCT00993317|42057165|FG001|Overall Study|Early study termination at the site|0|||
19608310|NCT01030133|42057173|FG000|Overall Study|failed to experience pain at level 7/10|2|||
19608311|NCT01030133|42057174|FG001|Overall Study|failed to experience pain at level 7/10|2|||
19608312|NCT00877071|42057184|FG000|Overall Study|disease progression|2|||
19608313|NCT00987389|42057190|FG000|Overall Study|Ineligible|0|||
19608314|NCT00987389|42057191|FG001|Overall Study|Ineligible|3|||
19608315|NCT00987389|42057192|FG002|Overall Study|Ineligible|0|||
19608316|NCT00987389|42057193|FG003|Overall Study|Ineligible|0|||
19608317|NCT00987389|42057190|FG000|Overall Study|Lost to Follow-up|4|||
19608318|NCT00987389|42057191|FG001|Overall Study|Lost to Follow-up|1|||
19608319|NCT00987389|42057192|FG002|Overall Study|Lost to Follow-up|3|||
19608320|NCT00987389|42057193|FG003|Overall Study|Lost to Follow-up|1|||
19608321|NCT00987389|42057190|FG000|Overall Study|Withdrawal by Subject|4|||
19608322|NCT00987389|42057191|FG001|Overall Study|Withdrawal by Subject|3|||
19608323|NCT00987389|42057192|FG002|Overall Study|Withdrawal by Subject|2|||
19608324|NCT00987389|42057193|FG003|Overall Study|Withdrawal by Subject|1|||
19608325|NCT00987389|42057190|FG000|Overall Study|Withdrawn from Treatment|0|||
19608326|NCT00987389|42057191|FG001|Overall Study|Withdrawn from Treatment|1|||
19608327|NCT00987389|42057192|FG002|Overall Study|Withdrawn from Treatment|0|||
19608328|NCT00987389|42057193|FG003|Overall Study|Withdrawn from Treatment|0|||
19608329|NCT00987389|42057190|FG000|Overall Study|Multiple different reasons|1|||
19608330|NCT00987389|42057191|FG001|Overall Study|Multiple different reasons|0|||
19608331|NCT00987389|42057192|FG002|Overall Study|Multiple different reasons|3|||
19608332|NCT00987389|42057193|FG003|Overall Study|Multiple different reasons|1|||
19608333|NCT00929162|42057203|FG000|Overall Study|Adverse Event|8|||
19608334|NCT00929162|42057204|FG001|Overall Study|Adverse Event|5|||
19608335|NCT00929162|42057203|FG000|Overall Study|Withdrawal by Subject|3|||
19608336|NCT00929162|42057204|FG001|Overall Study|Withdrawal by Subject|1|||
19608337|NCT00929162|42057203|FG000|Overall Study|Protocol Violation|32|||
19608338|NCT00929162|42057204|FG001|Overall Study|Protocol Violation|30|||
19608339|NCT00929162|42057203|FG000|Overall Study|Other termination reason|5|||
19608340|NCT00929162|42057204|FG001|Overall Study|Other termination reason|6|||
19608341|NCT00992459|42057212|FG000|Overall Study|Withdrawal by Subject|0|||
19608342|NCT00992459|42057213|FG001|Overall Study|Withdrawal by Subject|1|||
19608343|NCT00992459|42057212|FG000|Overall Study|Adverse Event|1|||
19608344|NCT00992459|42057213|FG001|Overall Study|Adverse Event|0|||
19608345|NCT00930722|42057219|FG000|Overall Study|Lost to Follow-up|16|||
19608346|NCT00930722|42057219|FG000|Overall Study|No longer willing to participate|9|||
19608347|NCT00930722|42057219|FG000|Overall Study|Study terminated by sponsor|2|||
19608348|NCT00992225|42057223|FG000|Overall Study|Entry Criteria Not Met|8|||
19608349|NCT00992225|42057223|FG000|Overall Study|Adverse Event|2|||
19608350|NCT00659581|42057227|FG000|Overall Study|Adverse Event|1006|||
19608351|NCT00659581|42057227|FG000|Overall Study|Lack of Efficacy|1183|||
19608352|NCT00659581|42057227|FG000|Overall Study|Other|6393|||
19799161|NCT02901431|42257297|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
19799162|NCT02901431|42257298|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19368915|NCT01370603|41609216|FG000|Crossover Washout|Lost to Follow-up|2|||
19608353|NCT00991289|42057231|FG000|Overall Study|Adverse Event|1|||
19608354|NCT00991289|42057231|FG000|Overall Study|Physician Decision|2|||
19608355|NCT00991289|42057231|FG000|Overall Study|Withdrawal by Subject|3|||
19608356|NCT00991289|42057231|FG000|Overall Study|Lost to Follow-up|4|||
19608357|NCT00991289|42057231|FG000|Overall Study|Protocol Violation|2|||
19608358|NCT00930644|42057235|FG000|Overall Study|Withdrawal by Subject|4|||
19608359|NCT00930644|42057235|FG000|Overall Study|Physician Decision|2|||
19608360|NCT00930644|42057235|FG000|Overall Study|Death|1|||
19608361|NCT00930644|42057235|FG000|Overall Study|Adverse Event|16|||
19368916|NCT01370603|41609217|FG001|Crossover Washout|Lost to Follow-up|0|||
19368917|NCT01370603|41609216|FG000|Crossover Washout|Protocol Violation|1|||
19368918|NCT01370603|41609217|FG001|Crossover Washout|Protocol Violation|0|||
19368919|NCT01370603|41609216|FG000|Crossover Washout|Withdrawal by Subject|4|||
19368920|NCT01370603|41609217|FG001|Crossover Washout|Withdrawal by Subject|1|||
19368921|NCT01370603|41609216|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
19368922|NCT01370603|41609217|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
19368923|NCT01370603|41609216|FG000|Period 2|Adverse Event|1|||
19698745|NCT00296504|42143597|FG008|Interim Analysis|Ongoing|0|||
19698746|NCT00296504|42143589|FG000|Final Analysis|Withdrawal by Subject|0|||
19698747|NCT00296504|42143590|FG001|Final Analysis|Withdrawal by Subject|0|||
19698748|NCT00296504|42143591|FG002|Final Analysis|Withdrawal by Subject|0|||
19698749|NCT00296504|42143592|FG003|Final Analysis|Withdrawal by Subject|0|||
19698750|NCT00296504|42143593|FG004|Final Analysis|Withdrawal by Subject|0|||
19698751|NCT00296504|42143594|FG005|Final Analysis|Withdrawal by Subject|0|||
19698752|NCT00296504|42143595|FG006|Final Analysis|Withdrawal by Subject|0|||
19698753|NCT00296504|42143596|FG007|Final Analysis|Withdrawal by Subject|0|||
19698754|NCT00296504|42143597|FG008|Final Analysis|Withdrawal by Subject|1|||
19698755|NCT00296504|42143589|FG000|Final Analysis|Lost to Follow-up|0|||
19698756|NCT00296504|42143590|FG001|Final Analysis|Lost to Follow-up|0|||
19698757|NCT00296504|42143591|FG002|Final Analysis|Lost to Follow-up|0|||
19698758|NCT00296504|42143592|FG003|Final Analysis|Lost to Follow-up|0|||
19698759|NCT00296504|42143593|FG004|Final Analysis|Lost to Follow-up|0|||
19698760|NCT00296504|42143594|FG005|Final Analysis|Lost to Follow-up|0|||
19698761|NCT00296504|42143595|FG006|Final Analysis|Lost to Follow-up|0|||
19698762|NCT00296504|42143596|FG007|Final Analysis|Lost to Follow-up|0|||
19698763|NCT00296504|42143597|FG008|Final Analysis|Lost to Follow-up|5|||
19698764|NCT00296504|42143589|FG000|Final Analysis|Insufficient Viral Load Response|0|||
19698765|NCT00296504|42143590|FG001|Final Analysis|Insufficient Viral Load Response|0|||
19698766|NCT00296504|42143591|FG002|Final Analysis|Insufficient Viral Load Response|0|||
19368924|NCT01370603|41609217|FG001|Period 2|Adverse Event|4|||
19368925|NCT01370603|41609216|FG000|Period 2|Lost to Follow-up|1|||
19368926|NCT01370603|41609217|FG001|Period 2|Lost to Follow-up|0|||
19368927|NCT01370603|41609216|FG000|Period 2|Withdrawal by Subject|1|||
19368928|NCT01370603|41609217|FG001|Period 2|Withdrawal by Subject|0|||
19368929|NCT02312206|41609225|FG000|Overall Study|Adverse Event|3|||
19368930|NCT02312206|41609226|FG001|Overall Study|Adverse Event|6|||
19368931|NCT02312206|41609225|FG000|Overall Study|Withdrawal by Subject|7|||
19368932|NCT02312206|41609226|FG001|Overall Study|Withdrawal by Subject|6|||
19368933|NCT02312206|41609225|FG000|Overall Study|Physician Decision|7|||
19368934|NCT02312206|41609226|FG001|Overall Study|Physician Decision|6|||
19368935|NCT02312206|41609225|FG000|Overall Study|Death|30|||
19368936|NCT02312206|41609226|FG001|Overall Study|Death|36|||
19368937|NCT02312206|41609225|FG000|Overall Study|Study Terminated by Sponsor|81|||
19368938|NCT02312206|41609226|FG001|Overall Study|Study Terminated by Sponsor|74|||
19368939|NCT02312206|41609225|FG000|Overall Study|Disease Progression|1|||
19368940|NCT02312206|41609226|FG001|Overall Study|Disease Progression|0|||
19368941|NCT02312206|41609225|FG000|Overall Study|Patient progression and new therapy|1|||
19368942|NCT02312206|41609226|FG001|Overall Study|Patient progression and new therapy|0|||
19368943|NCT02312206|41609225|FG000|Overall Study|Patient transferred to hospice|0|||
19608362|NCT00990821|42057256|FG000|Overall Study|Withdrawal by Subject|0|||
19608363|NCT00990821|42057257|FG001|Overall Study|Withdrawal by Subject|2|||
19608364|NCT00990821|42057258|FG002|Overall Study|Withdrawal by Subject|0|||
19608365|NCT00990821|42057259|FG003|Overall Study|Withdrawal by Subject|0|||
19608366|NCT00990821|42057260|FG004|Overall Study|Withdrawal by Subject|3|||
19608367|NCT00990821|42057261|FG005|Overall Study|Withdrawal by Subject|3|||
19608368|NCT00990821|42057262|FG006|Overall Study|Withdrawal by Subject|1|||
19698767|NCT00296504|42143592|FG003|Final Analysis|Insufficient Viral Load Response|0|||
19368944|NCT02312206|41609226|FG001|Overall Study|Patient transferred to hospice|1|||
19608369|NCT00990821|42057263|FG007|Overall Study|Withdrawal by Subject|0|||
19608370|NCT00990821|42057264|FG008|Overall Study|Withdrawal by Subject|0|||
19608371|NCT00990821|42057265|FG009|Overall Study|Withdrawal by Subject|1|||
19608372|NCT00990821|42057266|FG010|Overall Study|Withdrawal by Subject|3|||
19608373|NCT00990821|42057267|FG011|Overall Study|Withdrawal by Subject|5|||
19608374|NCT00990821|42057268|FG012|Overall Study|Withdrawal by Subject|2|||
19608375|NCT00990821|42057269|FG013|Overall Study|Withdrawal by Subject|1|||
19608376|NCT00990665|42057286|FG000|Overall Study|Unsuccessful Implant|8|||
19608377|NCT00990665|42057286|FG000|Overall Study|Death|29|||
19368945|NCT02312206|41609225|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
19608378|NCT00990665|42057286|FG000|Overall Study|Heart Transplant|1|||
19608379|NCT00990665|42057286|FG000|Overall Study|Withdrawal by Subject|6|||
19608380|NCT00990665|42057286|FG000|Overall Study|Lost to Follow-up|1|||
19608381|NCT00990665|42057286|FG000|Overall Study|System Explant|3|||
19368946|NCT02312206|41609226|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
19608382|NCT00658567|42057295|FG000|Overall Study|Adverse Event|5|||
19698768|NCT00296504|42143593|FG004|Final Analysis|Insufficient Viral Load Response|0|||
19698769|NCT00296504|42143594|FG005|Final Analysis|Insufficient Viral Load Response|0|||
19368947|NCT02347072|41609232|FG000|Overall Study|Adverse Event|2|||
19368948|NCT02347072|41609232|FG000|Overall Study|Withdrawal by Subject|6|||
19368949|NCT02347072|41609232|FG000|Overall Study|Physician Decision|1|||
19368950|NCT02347072|41609232|FG000|Overall Study|Lost to Follow-up|2|||
19368951|NCT02347072|41609232|FG000|Overall Study|Protocol Violation|1|||
19368952|NCT02347072|41609232|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
19368953|NCT02794103|41609240|FG000|Overall Study|Loss to follow up due to high sedation|3|||
19368954|NCT02346370|41609247|FG000|Overall Study|Not treated|1|||
19368955|NCT02346370|41609248|FG001|Overall Study|Not treated|0|||
19368956|NCT02346370|41609249|FG002|Overall Study|Not treated|0|||
19368957|NCT02346370|41609247|FG000|Overall Study|Withdrawal of consent|1|||
19368958|NCT02346370|41609248|FG001|Overall Study|Withdrawal of consent|0|||
19368959|NCT02346370|41609249|FG002|Overall Study|Withdrawal of consent|0|||
19368960|NCT02346370|41609247|FG000|Overall Study|Death|1|||
19368961|NCT02346370|41609248|FG001|Overall Study|Death|3|||
19368962|NCT02346370|41609249|FG002|Overall Study|Death|1|||
19368963|NCT02346370|41609247|FG000|Overall Study|Sponsor discontinued study|5|||
19368964|NCT02346370|41609248|FG001|Overall Study|Sponsor discontinued study|0|||
19368965|NCT02346370|41609249|FG002|Overall Study|Sponsor discontinued study|2|||
19368966|NCT02346370|41609247|FG000|Overall Study|Radiologic progression|0|||
19368967|NCT02346370|41609248|FG001|Overall Study|Radiologic progression|0|||
19368968|NCT02346370|41609249|FG002|Overall Study|Radiologic progression|1|||
19368969|NCT02346370|41609247|FG000|Overall Study|Physician Decision|0|||
19368970|NCT02346370|41609248|FG001|Overall Study|Physician Decision|1|||
19368971|NCT02346370|41609249|FG002|Overall Study|Physician Decision|0|||
19368972|NCT02346136|41609261|FG000|Overall Study|Withdrawal by Subject|7|||
19368973|NCT02346136|41609262|FG001|Overall Study|Withdrawal by Subject|5|||
19368974|NCT02346136|41609261|FG000|Overall Study|Death|1|||
19368975|NCT02346136|41609262|FG001|Overall Study|Death|0|||
19368976|NCT02346136|41609261|FG000|Overall Study|Study termination|14|||
19368977|NCT02346136|41609262|FG001|Overall Study|Study termination|18|||
19368978|NCT02793947|41609270|FG000|Overall Study|Death|1|||
19368979|NCT02793947|41609271|FG001|Overall Study|Death|0|||
19368980|NCT02793947|41609270|FG000|Overall Study|Physician Decision|1|||
19368981|NCT02793947|41609271|FG001|Overall Study|Physician Decision|5|||
19368982|NCT02345512|41609277|FG000|Overall Study|Adverse Event|1|||
19368983|NCT02345512|41609277|FG000|Overall Study|Withdrawal by Subject|1|||
19368984|NCT02345434|41609288|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
19368985|NCT02345434|41609289|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
19368986|NCT01370213|41609298|FG000|Overall Study|Early Death|1|||
19368987|NCT01370213|41609299|FG001|Overall Study|Early Death|0|||
19368988|NCT01370213|41609300|FG002|Overall Study|Early Death|0|||
19368989|NCT01370213|41609298|FG000|Overall Study|Not evaluable|0|||
19368990|NCT01370213|41609299|FG001|Overall Study|Not evaluable|2|||
19368991|NCT01370213|41609300|FG002|Overall Study|Not evaluable|0|||
19368992|NCT01370525|41609309|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
19368993|NCT01370525|41609310|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
19368994|NCT01370525|41609309|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19368995|NCT01370525|41609310|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19368996|NCT01370525|41609309|FG000|Overall Study|Adverse Event|0|||
19368997|NCT01370525|41609310|FG001|Overall Study|Adverse Event|1|||
19368998|NCT01370525|41609309|FG000|Overall Study|Protocol Violation|2|||
19368999|NCT01370525|41609310|FG001|Overall Study|Protocol Violation|1|||
19369000|NCT01370525|41609309|FG000|Overall Study|Lost to follow up|2|||
19369001|NCT01370525|41609310|FG001|Overall Study|Lost to follow up|6|||
19369002|NCT02792777|41609318|FG000|Overall Study|Withdrawal by Subject|2|||
19369003|NCT02792777|41609319|FG001|Overall Study|Withdrawal by Subject|0|||
19369004|NCT02792777|41609318|FG000|Overall Study|Recording malfunction|2|||
19369005|NCT02792777|41609319|FG001|Overall Study|Recording malfunction|0|||
19369006|NCT02792777|41609318|FG000|Overall Study|Later determined to be ineligible|2|||
19369007|NCT02792777|41609319|FG001|Overall Study|Later determined to be ineligible|0|||
19369008|NCT02792777|41609318|FG000|Overall Study|Participant interviewed twice|1|||
19369009|NCT02792777|41609319|FG001|Overall Study|Participant interviewed twice|0|||
19369010|NCT02625974|41609328|FG000|Overall Study|Adverse Event|12|||
19369011|NCT02625974|41609329|FG001|Overall Study|Adverse Event|2|||
19369012|NCT02625974|41609328|FG000|Overall Study|Withdrawal by Subject|3|||
19369013|NCT02625974|41609329|FG001|Overall Study|Withdrawal by Subject|1|||
19369014|NCT02625974|41609328|FG000|Overall Study|positive parasitemia|1|||
19369015|NCT02625974|41609329|FG001|Overall Study|positive parasitemia|0|||
19369016|NCT02625974|41609328|FG000|Overall Study|non-compliance with study drug|0|||
19369017|NCT02625974|41609329|FG001|Overall Study|non-compliance with study drug|2|||
19608383|NCT00658567|42057296|FG001|Overall Study|Adverse Event|2|||
19608384|NCT00658567|42057297|FG002|Overall Study|Adverse Event|3|||
19369018|NCT02625974|41609328|FG000|Overall Study|Protocol Violation|0|||
19369019|NCT02625974|41609329|FG001|Overall Study|Protocol Violation|1|||
19369020|NCT02792699|41609374|FG000|Overall Study|Adverse Event|1|||
19369021|NCT02792699|41609375|FG001|Overall Study|Adverse Event|2|||
19608385|NCT00658567|42057295|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
19369022|NCT02792699|41609376|FG002|Overall Study|Adverse Event|4|||
19369023|NCT02792699|41609374|FG000|Overall Study|Withdrawal by Subject|4|||
19369024|NCT02792699|41609375|FG001|Overall Study|Withdrawal by Subject|4|||
19369025|NCT02792699|41609376|FG002|Overall Study|Withdrawal by Subject|3|||
19369026|NCT02792699|41609374|FG000|Overall Study|Lost to Follow-up|0|||
19369027|NCT02792699|41609375|FG001|Overall Study|Lost to Follow-up|1|||
19369028|NCT02792699|41609376|FG002|Overall Study|Lost to Follow-up|2|||
19369029|NCT02792699|41609374|FG000|Overall Study|Physician Decision|2|||
19369030|NCT02792699|41609375|FG001|Overall Study|Physician Decision|0|||
19369031|NCT02792699|41609376|FG002|Overall Study|Physician Decision|0|||
19608386|NCT00658567|42057296|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
19608387|NCT00658567|42057297|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
19698770|NCT00296504|42143595|FG006|Final Analysis|Insufficient Viral Load Response|0|||
19698771|NCT00296504|42143596|FG007|Final Analysis|Insufficient Viral Load Response|0|||
19608388|NCT00658567|42057295|FG000|Overall Study|Physician Decision|0|||
19608389|NCT00658567|42057296|FG001|Overall Study|Physician Decision|1|||
19608390|NCT00658567|42057297|FG002|Overall Study|Physician Decision|0|||
19608391|NCT00658567|42057295|FG000|Overall Study|At Discretion of Sponsor|1|||
19698772|NCT00296504|42143597|FG008|Final Analysis|Insufficient Viral Load Response|6|||
19698773|NCT00296504|42143589|FG000|Final Analysis|Adverse Event|0|||
19698774|NCT00296504|42143590|FG001|Final Analysis|Adverse Event|0|||
19698775|NCT00296504|42143591|FG002|Final Analysis|Adverse Event|0|||
19698776|NCT00296504|42143592|FG003|Final Analysis|Adverse Event|0|||
19698777|NCT00296504|42143593|FG004|Final Analysis|Adverse Event|0|||
19698778|NCT00296504|42143594|FG005|Final Analysis|Adverse Event|0|||
19698779|NCT00296504|42143595|FG006|Final Analysis|Adverse Event|0|||
19608392|NCT00658567|42057296|FG001|Overall Study|At Discretion of Sponsor|1|||
19608393|NCT00658567|42057297|FG002|Overall Study|At Discretion of Sponsor|1|||
19608394|NCT00875433|42057305|FG000|Overall Study|Progressive disease|41|||
19608395|NCT00875433|42057305|FG000|Overall Study|Other Adverse Event|14|||
19698780|NCT00296504|42143596|FG007|Final Analysis|Adverse Event|0|||
19698781|NCT00296504|42143597|FG008|Final Analysis|Adverse Event|2|||
19698782|NCT00296504|42143589|FG000|Final Analysis|Pregnancy|0|||
19698783|NCT00296504|42143590|FG001|Final Analysis|Pregnancy|0|||
19698784|NCT00296504|42143591|FG002|Final Analysis|Pregnancy|0|||
19799163|NCT02901431|42257299|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
19799164|NCT02901431|42257300|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799165|NCT02901431|42257301|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799166|NCT02901431|42257302|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799167|NCT02901431|42257303|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799168|NCT02901431|42257304|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799169|NCT02901431|42257305|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799170|NCT02901431|42257306|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799171|NCT02901431|42257307|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799172|NCT02901431|42257308|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799173|NCT02901431|42257309|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
19799174|NCT02901431|42257297|FG000|PK Part|Discontinued per Sponsor|0|||
19799175|NCT02901431|42257298|FG001|PK Part|Discontinued per Sponsor|3|||
19799176|NCT02901431|42257299|FG002|PK Part|Discontinued per Sponsor|0|||
19799177|NCT02901431|42257300|FG003|PK Part|Discontinued per Sponsor|0|||
19799178|NCT02901431|42257301|FG004|PK Part|Discontinued per Sponsor|0|||
19799179|NCT02901431|42257302|FG005|PK Part|Discontinued per Sponsor|0|||
19799180|NCT02901431|42257303|FG006|PK Part|Discontinued per Sponsor|0|||
19799181|NCT02901431|42257304|FG007|PK Part|Discontinued per Sponsor|0|||
19799182|NCT02901431|42257305|FG008|PK Part|Discontinued per Sponsor|0|||
19799183|NCT02901431|42257306|FG009|PK Part|Discontinued per Sponsor|0|||
19799184|NCT02901431|42257307|FG010|PK Part|Discontinued per Sponsor|0|||
19799185|NCT02901431|42257308|FG011|PK Part|Discontinued per Sponsor|0|||
19799186|NCT02901431|42257309|FG012|PK Part|Discontinued per Sponsor|0|||
19799187|NCT02901431|42257297|FG000|PK Part|Withdrawal by Subject|1|||
19799188|NCT02901431|42257298|FG001|PK Part|Withdrawal by Subject|1|||
19799189|NCT02901431|42257299|FG002|PK Part|Withdrawal by Subject|3|||
19799190|NCT02901431|42257300|FG003|PK Part|Withdrawal by Subject|0|||
19799191|NCT02901431|42257301|FG004|PK Part|Withdrawal by Subject|0|||
19799192|NCT02901431|42257302|FG005|PK Part|Withdrawal by Subject|0|||
19799193|NCT02901431|42257303|FG006|PK Part|Withdrawal by Subject|0|||
19799194|NCT02901431|42257304|FG007|PK Part|Withdrawal by Subject|0|||
19799195|NCT02901431|42257305|FG008|PK Part|Withdrawal by Subject|0|||
19799196|NCT02901431|42257306|FG009|PK Part|Withdrawal by Subject|0|||
19369032|NCT02792699|41609374|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
19369033|NCT02792699|41609375|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
19608396|NCT00875433|42057305|FG000|Overall Study|Withdrawal by Subject|2|||
19698785|NCT00296504|42143592|FG003|Final Analysis|Pregnancy|0|||
19698786|NCT00296504|42143593|FG004|Final Analysis|Pregnancy|0|||
19698787|NCT00296504|42143594|FG005|Final Analysis|Pregnancy|0|||
19698788|NCT00296504|42143595|FG006|Final Analysis|Pregnancy|0|||
19369034|NCT02792699|41609376|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
19369035|NCT02792699|41609374|FG000|Overall Study|Other|1|||
19369036|NCT02792699|41609375|FG001|Overall Study|Other|0|||
19369037|NCT02792699|41609376|FG002|Overall Study|Other|0|||
19369038|NCT03010319|41609393|FG000|Overall Study|Adverse Event|15|||
19369039|NCT03010319|41609394|FG001|Overall Study|Adverse Event|9|||
19369040|NCT03010319|41609393|FG000|Overall Study|Withdrawal by Subject|1|||
19369041|NCT03010319|41609394|FG001|Overall Study|Withdrawal by Subject|6|||
19369042|NCT03010319|41609393|FG000|Overall Study|Physician Decision|2|||
19369043|NCT03010319|41609394|FG001|Overall Study|Physician Decision|4|||
19369044|NCT03010319|41609393|FG000|Overall Study|Sponsor requested withdrawal|2|||
19369045|NCT03010319|41609394|FG001|Overall Study|Sponsor requested withdrawal|2|||
19369046|NCT03010319|41609393|FG000|Overall Study|Death|1|||
19369047|NCT03010319|41609394|FG001|Overall Study|Death|0|||
19369048|NCT03010319|41609393|FG000|Overall Study|Lost to Follow-up|0|||
19369049|NCT03010319|41609394|FG001|Overall Study|Lost to Follow-up|1|||
19369050|NCT03010319|41609393|FG000|Overall Study|Other Reason|5|||
19369051|NCT03010319|41609394|FG001|Overall Study|Other Reason|7|||
19369052|NCT01369511|41609404|FG000|Overall Study|Adverse Event|1|||
19369053|NCT01369511|41609405|FG001|Overall Study|Adverse Event|1|||
19369054|NCT01369511|41609406|FG002|Overall Study|Adverse Event|5|||
19369055|NCT01369511|41609407|FG003|Overall Study|Adverse Event|0|||
19369056|NCT01369511|41609404|FG000|Overall Study|Entry criteria not met|2|||
19369057|NCT01369511|41609405|FG001|Overall Study|Entry criteria not met|0|||
19369058|NCT01369511|41609406|FG002|Overall Study|Entry criteria not met|0|||
19369059|NCT01369511|41609407|FG003|Overall Study|Entry criteria not met|1|||
19369060|NCT01369511|41609404|FG000|Overall Study|Lost to Follow-up|0|||
19369061|NCT01369511|41609405|FG001|Overall Study|Lost to Follow-up|1|||
19369062|NCT01369511|41609406|FG002|Overall Study|Lost to Follow-up|1|||
19369063|NCT01369511|41609407|FG003|Overall Study|Lost to Follow-up|2|||
19369064|NCT01369511|41609404|FG000|Overall Study|Protocol Violation|0|||
19369065|NCT01369511|41609405|FG001|Overall Study|Protocol Violation|1|||
19369066|NCT01369511|41609406|FG002|Overall Study|Protocol Violation|0|||
19369067|NCT01369511|41609407|FG003|Overall Study|Protocol Violation|2|||
19369068|NCT01369511|41609404|FG000|Overall Study|Physician Decision|3|||
19369069|NCT01369511|41609405|FG001|Overall Study|Physician Decision|4|||
19369070|NCT01369511|41609406|FG002|Overall Study|Physician Decision|0|||
19369071|NCT01369511|41609407|FG003|Overall Study|Physician Decision|0|||
19369072|NCT01369511|41609404|FG000|Overall Study|Sponsor decision|2|||
19369073|NCT01369511|41609405|FG001|Overall Study|Sponsor decision|0|||
19369074|NCT01369511|41609406|FG002|Overall Study|Sponsor decision|1|||
19369075|NCT01369511|41609407|FG003|Overall Study|Sponsor decision|0|||
19369076|NCT01369511|41609404|FG000|Overall Study|Withdrawal by Subject|5|||
19369077|NCT01369511|41609405|FG001|Overall Study|Withdrawal by Subject|6|||
19369078|NCT01369511|41609406|FG002|Overall Study|Withdrawal by Subject|4|||
19369079|NCT01369511|41609407|FG003|Overall Study|Withdrawal by Subject|6|||
19369080|NCT01369433|41609419|FG000|Overall Study|Adverse Event|31|||
19369081|NCT01369433|41609420|FG001|Overall Study|Adverse Event|1|||
19369082|NCT01369433|41609419|FG000|Overall Study|Required significant surgical procedure|1|||
19369083|NCT01369433|41609420|FG001|Overall Study|Required significant surgical procedure|0|||
19369084|NCT01369433|41609419|FG000|Overall Study|Non-compliance|1|||
19369085|NCT01369433|41609420|FG001|Overall Study|Non-compliance|0|||
19369086|NCT01369433|41609419|FG000|Overall Study|Withdrawal by Subject|5|||
19369087|NCT01369433|41609420|FG001|Overall Study|Withdrawal by Subject|2|||
19369088|NCT01369433|41609419|FG000|Overall Study|Study terminated by Sponsor|67|||
19369089|NCT01369433|41609420|FG001|Overall Study|Study terminated by Sponsor|0|||
19369090|NCT01369433|41609419|FG000|Overall Study|Lost to Follow-up|1|||
19369091|NCT01369433|41609420|FG001|Overall Study|Lost to Follow-up|0|||
19369092|NCT01369433|41609419|FG000|Overall Study|Death|5|||
19369093|NCT01369433|41609420|FG001|Overall Study|Death|0|||
19369094|NCT01369433|41609419|FG000|Overall Study|Investigator discretion|6|||
19369095|NCT01369433|41609420|FG001|Overall Study|Investigator discretion|1|||
19369096|NCT01369433|41609419|FG000|Overall Study|Progressive Disease|92|||
19369097|NCT01369433|41609420|FG001|Overall Study|Progressive Disease|12|||
19369098|NCT02624492|41609429|FG000|Overall Study|Adverse Event|2|||
19369099|NCT02624492|41609430|FG001|Overall Study|Adverse Event|2|||
19369100|NCT02624492|41609431|FG002|Overall Study|Adverse Event|2|||
19369101|NCT02624492|41609429|FG000|Overall Study|Progressive disease|0|||
19369102|NCT02624492|41609430|FG001|Overall Study|Progressive disease|2|||
19369103|NCT02624492|41609431|FG002|Overall Study|Progressive disease|3|||
19369104|NCT01975831|41609448|FG000|Overall Study|Adverse Event|1|||
19369105|NCT01975831|41609449|FG001|Overall Study|Adverse Event|2|||
19369106|NCT01975831|41609450|FG002|Overall Study|Adverse Event|2|||
19369107|NCT01975831|41609451|FG003|Overall Study|Adverse Event|0|||
19369108|NCT01975831|41609452|FG004|Overall Study|Adverse Event|1|||
19369109|NCT01975831|41609453|FG005|Overall Study|Adverse Event|1|||
19369110|NCT01975831|41609454|FG006|Overall Study|Adverse Event|3|||
19369111|NCT01975831|41609455|FG007|Overall Study|Adverse Event|4|||
19369112|NCT01975831|41609456|FG008|Overall Study|Adverse Event|1|||
19369113|NCT01975831|41609448|FG000|Overall Study|Death|1|||
19369114|NCT01975831|41609449|FG001|Overall Study|Death|1|||
19369115|NCT01975831|41609450|FG002|Overall Study|Death|0|||
19369116|NCT01975831|41609451|FG003|Overall Study|Death|0|||
19369117|NCT01975831|41609452|FG004|Overall Study|Death|1|||
19369118|NCT01975831|41609453|FG005|Overall Study|Death|0|||
19369119|NCT01975831|41609454|FG006|Overall Study|Death|1|||
19369120|NCT01975831|41609455|FG007|Overall Study|Death|0|||
19369121|NCT01975831|41609456|FG008|Overall Study|Death|0|||
19369122|NCT01975831|41609448|FG000|Overall Study|Progressive Disease|1|||
19369123|NCT01975831|41609449|FG001|Overall Study|Progressive Disease|3|||
19369124|NCT01975831|41609450|FG002|Overall Study|Progressive Disease|2|||
19369125|NCT01975831|41609451|FG003|Overall Study|Progressive Disease|4|||
19369126|NCT01975831|41609452|FG004|Overall Study|Progressive Disease|13|||
19369127|NCT01975831|41609453|FG005|Overall Study|Progressive Disease|9|||
19369128|NCT01975831|41609454|FG006|Overall Study|Progressive Disease|10|||
19369129|NCT01975831|41609455|FG007|Overall Study|Progressive Disease|8|||
19369130|NCT01975831|41609456|FG008|Overall Study|Progressive Disease|10|||
19369131|NCT01975831|41609448|FG000|Overall Study|Withdrawal by Subject|0|||
19369132|NCT01975831|41609449|FG001|Overall Study|Withdrawal by Subject|3|||
19369133|NCT01975831|41609450|FG002|Overall Study|Withdrawal by Subject|0|||
19369134|NCT01975831|41609451|FG003|Overall Study|Withdrawal by Subject|0|||
19369135|NCT01975831|41609452|FG004|Overall Study|Withdrawal by Subject|3|||
19369136|NCT01975831|41609453|FG005|Overall Study|Withdrawal by Subject|1|||
19369137|NCT01975831|41609454|FG006|Overall Study|Withdrawal by Subject|1|||
19369138|NCT01975831|41609455|FG007|Overall Study|Withdrawal by Subject|0|||
19369139|NCT01975831|41609456|FG008|Overall Study|Withdrawal by Subject|0|||
19369140|NCT01975831|41609448|FG000|Overall Study|Physician Decision|0|||
19369141|NCT01975831|41609449|FG001|Overall Study|Physician Decision|0|||
19369142|NCT01975831|41609450|FG002|Overall Study|Physician Decision|0|||
19369143|NCT01975831|41609451|FG003|Overall Study|Physician Decision|0|||
19369144|NCT01975831|41609452|FG004|Overall Study|Physician Decision|0|||
19369145|NCT01975831|41609453|FG005|Overall Study|Physician Decision|1|||
19369146|NCT01975831|41609454|FG006|Overall Study|Physician Decision|0|||
19369147|NCT01975831|41609455|FG007|Overall Study|Physician Decision|1|||
19369148|NCT01975831|41609456|FG008|Overall Study|Physician Decision|0|||
19369149|NCT01975831|41609448|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
19369150|NCT01975831|41609449|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
19369151|NCT01975831|41609450|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
19369152|NCT01975831|41609451|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
19369153|NCT01975831|41609452|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
19369154|NCT01975831|41609453|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
19369155|NCT01975831|41609454|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
19369156|NCT01975831|41609455|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
19369157|NCT01975831|41609456|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
19369158|NCT01975831|41609448|FG000|Overall Study|Entered Hospice|0|||
19369159|NCT01975831|41609449|FG001|Overall Study|Entered Hospice|0|||
19369160|NCT01975831|41609450|FG002|Overall Study|Entered Hospice|0|||
19369161|NCT01975831|41609451|FG003|Overall Study|Entered Hospice|0|||
19369162|NCT01975831|41609452|FG004|Overall Study|Entered Hospice|0|||
19369163|NCT01975831|41609453|FG005|Overall Study|Entered Hospice|1|||
19608397|NCT00875433|42057305|FG000|Overall Study|Other|3|||
19608398|NCT00985985|42057313|FG000|Overall Study|Adverse Event|4|||
19608399|NCT00985985|42057314|FG001|Overall Study|Adverse Event|2|||
19608400|NCT00985985|42057315|FG002|Overall Study|Adverse Event|2|||
19608401|NCT00985985|42057316|FG003|Overall Study|Adverse Event|2|||
19608402|NCT00985985|42057313|FG000|Overall Study|Lost to Follow-up|4|||
19608403|NCT00985985|42057314|FG001|Overall Study|Lost to Follow-up|11|||
19608404|NCT00985985|42057315|FG002|Overall Study|Lost to Follow-up|2|||
19608405|NCT00985985|42057316|FG003|Overall Study|Lost to Follow-up|3|||
19608406|NCT00985985|42057313|FG000|Overall Study|Protocol Violation|1|||
19608407|NCT00985985|42057314|FG001|Overall Study|Protocol Violation|2|||
19608408|NCT00985985|42057315|FG002|Overall Study|Protocol Violation|0|||
19608409|NCT00985985|42057316|FG003|Overall Study|Protocol Violation|1|||
19608410|NCT00985985|42057313|FG000|Overall Study|Lack of Efficacy|5|||
19608411|NCT00985985|42057314|FG001|Overall Study|Lack of Efficacy|6|||
19608412|NCT00985985|42057315|FG002|Overall Study|Lack of Efficacy|1|||
19608413|NCT00985985|42057316|FG003|Overall Study|Lack of Efficacy|3|||
19608414|NCT00985985|42057313|FG000|Overall Study|Withdrawal by Subject|4|||
19698789|NCT00296504|42143596|FG007|Final Analysis|Pregnancy|0|||
19799197|NCT02901431|42257307|FG010|PK Part|Withdrawal by Subject|0|||
19608415|NCT00985985|42057314|FG001|Overall Study|Withdrawal by Subject|2|||
19369164|NCT01975831|41609454|FG006|Overall Study|Entered Hospice|0|||
19369165|NCT01975831|41609455|FG007|Overall Study|Entered Hospice|0|||
19369166|NCT01975831|41609456|FG008|Overall Study|Entered Hospice|0|||
19369167|NCT01975831|41609448|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369168|NCT01975831|41609449|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369169|NCT01975831|41609450|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
19389187|NCT02082340|41632819|FG000|Overall Study|Lost to Follow-up|1|||
19369170|NCT01975831|41609451|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369171|NCT01975831|41609452|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369172|NCT01975831|41609453|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369173|NCT01975831|41609454|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
19369174|NCT01975831|41609455|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
19369175|NCT01975831|41609456|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
19369176|NCT00700713|41609479|FG000|Overall Study|Protocol Violation|1|||
19369177|NCT00700713|41609480|FG001|Overall Study|Protocol Violation|0|||
19369178|NCT00700713|41609481|FG002|Overall Study|Protocol Violation|1|||
19369179|NCT00700713|41609479|FG000|Overall Study|Withdrawal by Subject|0|||
19369180|NCT00700713|41609480|FG001|Overall Study|Withdrawal by Subject|0|||
19369181|NCT00700713|41609481|FG002|Overall Study|Withdrawal by Subject|1|||
19369182|NCT02622386|41609489|FG000|First Assignment|Withdrawal by Subject|3|||
19369183|NCT02622386|41609490|FG001|First Assignment|Withdrawal by Subject|2|||
19369184|NCT02622386|41609489|FG000|Washout|Withdrawal by Subject|4|||
19369185|NCT02622386|41609490|FG001|Washout|Withdrawal by Subject|4|||
19369186|NCT02622386|41609489|FG000|Second Assignment|Withdrawal by Subject|0|||
19369187|NCT02622386|41609490|FG001|Second Assignment|Withdrawal by Subject|2|||
19369188|NCT02792231|41609498|FG000|Overall Study|Patient/guardian decision|32|||
19369189|NCT02792231|41609499|FG001|Overall Study|Patient/guardian decision|42|||
19369190|NCT02792231|41609498|FG000|Overall Study|Adverse Event|15|||
19369191|NCT02792231|41609499|FG001|Overall Study|Adverse Event|11|||
19369192|NCT02792231|41609498|FG000|Overall Study|Physician Decision|14|||
19369193|NCT02792231|41609499|FG001|Overall Study|Physician Decision|12|||
19369194|NCT02792231|41609498|FG000|Overall Study|Lack of Efficacy|7|||
19369195|NCT02792231|41609499|FG001|Overall Study|Lack of Efficacy|9|||
19369196|NCT02792231|41609498|FG000|Overall Study|Lost to Follow-up|9|||
19369197|NCT02792231|41609499|FG001|Overall Study|Lost to Follow-up|5|||
19369198|NCT02792231|41609498|FG000|Overall Study|Pregnancy|1|||
19369199|NCT02792231|41609499|FG001|Overall Study|Pregnancy|3|||
19369200|NCT02792231|41609498|FG000|Overall Study|Non-compliance with study treatment|2|||
19369201|NCT02792231|41609499|FG001|Overall Study|Non-compliance with study treatment|1|||
19369202|NCT02792231|41609498|FG000|Overall Study|Protocol deviation|2|||
19369203|NCT02792231|41609499|FG001|Overall Study|Protocol deviation|0|||
19369204|NCT02792231|41609498|FG000|Overall Study|Technical problems|0|||
19369205|NCT02792231|41609499|FG001|Overall Study|Technical problems|1|||
19369206|NCT00700401|41609505|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
19369207|NCT00700401|41609505|FG000|Overall Study|Adverse Event|5|||
19369208|NCT00700401|41609505|FG000|Overall Study|Refused Treatment|2|||
19369209|NCT00700401|41609505|FG000|Overall Study|Lost to Follow-up|1|||
19369210|NCT00700401|41609505|FG000|Overall Study|Treatment never started|1|||
19369211|NCT00700401|41609505|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
19369212|NCT00700401|41609505|FG000|Overall Study|Withdrawal by Subject|2|||
19369213|NCT02621606|41609512|FG000|Overall Study|Withdrawal by Subject|0|||
19369214|NCT02621606|41609513|FG001|Overall Study|Withdrawal by Subject|1|||
19369215|NCT02621606|41609514|FG002|Overall Study|Withdrawal by Subject|0|||
19369216|NCT02871401|41609524|FG000|Overall Study|Adverse Event|1|||
19369217|NCT02871401|41609525|FG001|Overall Study|Adverse Event|0|||
19369218|NCT02576509|41609533|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
19369219|NCT02576509|41609534|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
19369220|NCT02576509|41609533|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
19369221|NCT02576509|41609534|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
19369222|NCT02576509|41609533|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
19369223|NCT02576509|41609534|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
19369224|NCT02576509|41609533|FG000|Treatment Period|Disease progression|245|||
19608416|NCT00985985|42057315|FG002|Overall Study|Withdrawal by Subject|2|||
19369225|NCT02576509|41609534|FG001|Treatment Period|Disease progression|240|||
19369226|NCT02576509|41609533|FG000|Treatment Period|Study drug toxicity|32|||
19369227|NCT02576509|41609534|FG001|Treatment Period|Study drug toxicity|41|||
19369228|NCT02576509|41609533|FG000|Treatment Period|Death|1|||
19369229|NCT02576509|41609534|FG001|Treatment Period|Death|1|||
19369230|NCT02576509|41609533|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
19369231|NCT02576509|41609534|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
19369232|NCT02576509|41609533|FG000|Treatment Period|Participant request to stop treatment|8|||
19369233|NCT02576509|41609534|FG001|Treatment Period|Participant request to stop treatment|17|||
19369234|NCT02576509|41609533|FG000|Treatment Period|Participant withdrew consent|2|||
19369235|NCT02576509|41609534|FG001|Treatment Period|Participant withdrew consent|7|||
19389188|NCT02082340|41632820|FG001|Overall Study|Lost to Follow-up|1|||
19608417|NCT00985985|42057316|FG003|Overall Study|Withdrawal by Subject|2|||
19608418|NCT00985985|42057313|FG000|Overall Study|Other Reason|6|||
19369236|NCT02576509|41609533|FG000|Treatment Period|Lost to Follow-up|0|||
19369237|NCT02576509|41609534|FG001|Treatment Period|Lost to Follow-up|1|||
19369238|NCT02576509|41609533|FG000|Treatment Period|Maximum clinical benefit|1|||
19369239|NCT02576509|41609534|FG001|Treatment Period|Maximum clinical benefit|0|||
19389189|NCT02053246|41632826|FG000|Overall Study|Withdrawal by Subject|3|||
19369240|NCT02576509|41609533|FG000|Treatment Period|Poor/non-compliance|0|||
19369241|NCT02576509|41609534|FG001|Treatment Period|Poor/non-compliance|1|||
19369242|NCT02576509|41609533|FG000|Treatment Period|Participant no longer meets criteria|1|||
19369243|NCT02576509|41609534|FG001|Treatment Period|Participant no longer meets criteria|0|||
19369244|NCT02576509|41609533|FG000|Treatment Period|Other reason|2|||
19369245|NCT02576509|41609534|FG001|Treatment Period|Other reason|7|||
19369246|NCT02576509|41609533|FG000|Follow-up Period|Death|41|||
19369247|NCT02576509|41609534|FG001|Follow-up Period|Death|35|||
19369248|NCT02576509|41609533|FG000|Follow-up Period|Participant withdrew consent|7|||
19369249|NCT02576509|41609534|FG001|Follow-up Period|Participant withdrew consent|14|||
19369250|NCT02576509|41609533|FG000|Follow-up Period|Lost to Follow-up|0|||
19369251|NCT02576509|41609534|FG001|Follow-up Period|Lost to Follow-up|1|||
19369252|NCT02576509|41609533|FG000|Follow-up Period|Other reason|1|||
19369253|NCT02576509|41609534|FG001|Follow-up Period|Other reason|2|||
19369254|NCT02619812|41609544|FG000|Overall Study|Withdrawal by Subject|0|||
19369255|NCT02619812|41609545|FG001|Overall Study|Withdrawal by Subject|0|||
19369256|NCT02619812|41609546|FG002|Overall Study|Withdrawal by Subject|1|||
19369257|NCT02619812|41609547|FG003|Overall Study|Withdrawal by Subject|2|||
19369258|NCT02623322|41609560|FG000|Overall Study|Lost to Follow-up|2|||
19369259|NCT02623322|41609561|FG001|Overall Study|Lost to Follow-up|1|||
19369260|NCT02623322|41609562|FG002|Overall Study|Lost to Follow-up|0|||
19369261|NCT00105157|41609576|FG000|Double-Blind (DB)|Never Treated|1|||
19369262|NCT00105157|41609577|FG001|Double-Blind (DB)|Never Treated|0|||
19369263|NCT00105157|41609578|FG002|Double-Blind (DB)|Never Treated|0|||
19369264|NCT00105157|41609579|FG003|Double-Blind (DB)|Never Treated|0|||
19369265|NCT00105157|41609576|FG000|Double-Blind (DB)|Adverse Event|2|||
19369266|NCT00105157|41609577|FG001|Double-Blind (DB)|Adverse Event|0|||
19369267|NCT00105157|41609578|FG002|Double-Blind (DB)|Adverse Event|1|||
19369268|NCT00105157|41609579|FG003|Double-Blind (DB)|Adverse Event|1|||
19369269|NCT00105157|41609576|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
19369270|NCT00105157|41609577|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
19369271|NCT00105157|41609578|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
19369272|NCT00105157|41609579|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
19369273|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Adverse Event|3|||
19369274|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Adverse Event|1|||
19369275|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Adverse Event|0|||
19369276|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Adverse Event|0|||
19369277|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
19369278|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
19369279|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
19369280|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
19369281|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
19369282|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
19369283|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
19369284|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
19369285|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
19369286|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
19369287|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
19369288|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
19369289|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
19369290|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
19369291|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
19369292|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
19369293|NCT00105157|41609576|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
19369294|NCT00105157|41609577|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
19369295|NCT00105157|41609578|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
19369296|NCT00105157|41609579|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
19369297|NCT00105157|41609576|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
19369298|NCT00105157|41609577|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
19369299|NCT00105157|41609578|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
19369300|NCT00105157|41609579|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
19369301|NCT00105157|41609576|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
19369302|NCT00105157|41609577|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
19369303|NCT00105157|41609578|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
19369304|NCT00105157|41609579|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
19369305|NCT00105157|41609576|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
19369306|NCT00105157|41609577|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
19369307|NCT00105157|41609578|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
19369308|NCT00105157|41609579|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
19369309|NCT00105157|41609576|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
19369310|NCT00105157|41609577|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
19369311|NCT00105157|41609578|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
19369312|NCT00105157|41609579|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
19369313|NCT00105157|41609576|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
19369314|NCT00105157|41609577|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
19369315|NCT00105157|41609578|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
19369316|NCT00105157|41609579|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
19369317|NCT02148133|41609600|FG000|Overall Study|Investigator discretion|1|||
19369318|NCT02148133|41609600|FG000|Overall Study|Lack of Efficacy|1|||
19369319|NCT02148133|41609600|FG000|Overall Study|Protocol deviation|1|||
19369320|NCT02148133|41609600|FG000|Overall Study|Protocol-defined stopping criteria|2|||
19369321|NCT00803569|41609604|FG000|Overall Study|Progressive Disease|3|||
19369322|NCT00803569|41609604|FG000|Overall Study|Noncompliance|1|||
19369323|NCT00112957|41609608|FG000|Overall Study|Progressive disease|18|||
19369324|NCT00112957|41609608|FG000|Overall Study|Physician Decision|1|||
19369325|NCT02376790|41609615|FG000|Overall Study|Withdrawal by Subject|43|||
19369326|NCT02376790|41609616|FG001|Overall Study|Withdrawal by Subject|36|||
19369327|NCT02376790|41609617|FG002|Overall Study|Withdrawal by Subject|37|||
19369328|NCT02376790|41609615|FG000|Overall Study|Decision by Sponsor|2|||
19369329|NCT02376790|41609616|FG001|Overall Study|Decision by Sponsor|1|||
19369330|NCT02376790|41609617|FG002|Overall Study|Decision by Sponsor|4|||
19369331|NCT02376790|41609615|FG000|Overall Study|Lost to Follow-up|15|||
19369332|NCT02376790|41609616|FG001|Overall Study|Lost to Follow-up|10|||
19369333|NCT02376790|41609617|FG002|Overall Study|Lost to Follow-up|12|||
19369334|NCT02376166|41609625|FG000|Overall Study|Adverse Event|1|||
19369335|NCT02376166|41609625|FG000|Overall Study|Discontinued metformin early|2|||
19369336|NCT02311894|41609629|FG000|Overall Study|Discontinued in error|1|||
19369337|NCT02311894|41609629|FG000|Overall Study|Lost to Follow-up|1|||
19369338|NCT02311894|41609629|FG000|Overall Study|Adverse Event|1|||
19369339|NCT02311894|41609629|FG000|Overall Study|Withdrawal by Subject|1|||
19369340|NCT02310646|41609635|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
19369341|NCT02310646|41609636|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
19369342|NCT02310646|41609635|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
19369343|NCT02310646|41609636|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
19369344|NCT02375698|41609660|FG000|Overall Study|Withdrawal by Subject|0|||
19369345|NCT02375698|41609661|FG001|Overall Study|Withdrawal by Subject|2|||
19369346|NCT02375698|41609660|FG000|Overall Study|Physician Decision|2|||
19369347|NCT02375698|41609661|FG001|Overall Study|Physician Decision|0|||
19369348|NCT02374918|41609671|FG000|Overall Study|Protocol Violation|2|||
19369349|NCT02374918|41609672|FG001|Overall Study|Protocol Violation|0|||
19369350|NCT02374918|41609673|FG002|Overall Study|Protocol Violation|2|||
19369351|NCT02374918|41609674|FG003|Overall Study|Protocol Violation|1|||
19369352|NCT02374918|41609671|FG000|Overall Study|Withdrawal by Subject|1|||
19369353|NCT02374918|41609672|FG001|Overall Study|Withdrawal by Subject|1|||
19369354|NCT02374918|41609673|FG002|Overall Study|Withdrawal by Subject|1|||
19369355|NCT02374918|41609674|FG003|Overall Study|Withdrawal by Subject|0|||
19369356|NCT02374918|41609671|FG000|Overall Study|Lack of Efficacy|0|||
19369357|NCT02374918|41609672|FG001|Overall Study|Lack of Efficacy|0|||
19369358|NCT02374918|41609673|FG002|Overall Study|Lack of Efficacy|1|||
19369359|NCT02374918|41609674|FG003|Overall Study|Lack of Efficacy|1|||
19369360|NCT02344576|41609686|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
19369361|NCT02344576|41609687|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
19369362|NCT02344576|41609688|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
19369363|NCT02344576|41609689|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
19369364|NCT02344576|41609686|FG000|1-Month Follow-Up|Death|13|||
19369365|NCT02344576|41609687|FG001|1-Month Follow-Up|Death|8|||
19369366|NCT02344576|41609688|FG002|1-Month Follow-Up|Death|0|||
19369367|NCT02344576|41609689|FG003|1-Month Follow-Up|Death|0|||
19369368|NCT02344576|41609686|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
19369369|NCT02344576|41609687|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
19369370|NCT02344576|41609688|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
19369371|NCT02344576|41609689|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
19369372|NCT02344576|41609686|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
19369373|NCT02344576|41609687|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
19369374|NCT02344576|41609688|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
19369375|NCT02344576|41609689|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
19369376|NCT02344576|41609686|FG000|6-Month Follow-Up|Death|14|||
19369377|NCT02344576|41609687|FG001|6-Month Follow-Up|Death|14|||
19369378|NCT02344576|41609688|FG002|6-Month Follow-Up|Death|0|||
19369379|NCT02344576|41609689|FG003|6-Month Follow-Up|Death|0|||
19369380|NCT02344576|41609686|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
19369381|NCT02344576|41609687|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
19369382|NCT02344576|41609688|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
19369383|NCT02344576|41609689|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
19369384|NCT02344576|41609686|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
19369385|NCT02344576|41609687|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
19369386|NCT02344576|41609688|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
19369387|NCT02344576|41609689|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
19369388|NCT02344342|41609705|FG000|Overall Study|Industry partner dropped out|11|||
19369389|NCT02344342|41609706|FG001|Overall Study|Industry partner dropped out|9|||
19369390|NCT02344342|41609707|FG002|Overall Study|Industry partner dropped out|14|||
19369391|NCT02344342|41609708|FG003|Overall Study|Industry partner dropped out|10|||
19369392|NCT02343952|41609722|FG000|Study Treatment|Disease Progression|23|||
19369393|NCT02343952|41609722|FG000|Study Treatment|Death|3|||
19369394|NCT02343952|41609722|FG000|Study Treatment|Adverse Event|19|||
19369395|NCT02343952|41609722|FG000|Study Treatment|Withdrawal by Subject|7|||
19369396|NCT02343952|41609722|FG000|Study Treatment|other complicating Diseases|1|||
19369397|NCT02343952|41609722|FG000|Follow up|Withdrawal by Subject|3|||
19369398|NCT02343952|41609722|FG000|Follow up|Death|33|||
19369399|NCT02343952|41609722|FG000|Follow up|Patient does not meet eligibility for study.|1|||
19369400|NCT02343952|41609722|FG000|Follow up|Research department closed by the practice.|5|||
19369401|NCT02343952|41609722|FG000|Follow up|Patient went home to Russia|1|||
19369402|NCT02343952|41609722|FG000|Follow up|Disease Progression|1|||
19369403|NCT02343952|41609722|FG000|Follow up|study terminated|1|||
19369404|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
19369405|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
19369406|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
19369407|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
19369408|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
19369409|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
19369410|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
19369411|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
19369412|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
19369413|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
19369414|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|Other|1|||
19369415|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|Other|1|||
19369416|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|Other|0|||
19369417|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|Other|0|||
19369418|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|Other|0|||
19369419|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
19369420|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
19369421|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
19369422|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
19369423|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
19369424|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
19369425|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
19369426|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
19369427|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
19369428|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
19369429|NCT02310568|41609731|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
19369430|NCT02310568|41609732|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
19369431|NCT02310568|41609733|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
19369432|NCT02310568|41609734|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
19369433|NCT02310568|41609735|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
19369434|NCT02310568|41609731|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
19369435|NCT02310568|41609732|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
19369436|NCT02310568|41609733|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
19369437|NCT02310568|41609734|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
19369438|NCT02310568|41609735|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
19369439|NCT02310568|41609731|FG000|Stage 2 (4 Weeks)|Other|0|||
19369440|NCT02310568|41609732|FG001|Stage 2 (4 Weeks)|Other|1|||
19369441|NCT02310568|41609733|FG002|Stage 2 (4 Weeks)|Other|1|||
19369442|NCT02310568|41609734|FG003|Stage 2 (4 Weeks)|Other|0|||
19369443|NCT02310568|41609735|FG004|Stage 2 (4 Weeks)|Other|0|||
19369444|NCT02310568|41609731|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
19369445|NCT02310568|41609732|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
19369446|NCT02310568|41609733|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
19369447|NCT02310568|41609734|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
19369448|NCT02310568|41609735|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
19369449|NCT02310568|41609731|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
19369450|NCT02310568|41609732|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
19369451|NCT02310568|41609733|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
19369452|NCT02310568|41609734|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
19369453|NCT02310568|41609735|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
19369454|NCT02310568|41609731|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
19369455|NCT02310568|41609732|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
19369456|NCT02310568|41609733|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
19369457|NCT02310568|41609734|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
19369458|NCT02310568|41609735|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
19369459|NCT02310100|41609753|FG000|Overall Study|Physician Decision|3|||
19369460|NCT02310100|41609753|FG000|Overall Study|Withdrawal by Subject|10|||
19369461|NCT02310100|41609753|FG000|Overall Study|Enrollment closure|1|||
19369462|NCT02310100|41609753|FG000|Overall Study|Unapproved ablation operator|1|||
19369463|NCT02310100|41609753|FG000|Overall Study|Visit compliance|1|||
19369464|NCT02310100|41609753|FG000|Overall Study|Lost to Follow-up|2|||
19369465|NCT02780167|41609763|FG000|Overall Study|Adverse Event|9|||
19369466|NCT02780167|41609764|FG001|Overall Study|Adverse Event|8|||
19369467|NCT02780167|41609765|FG002|Overall Study|Adverse Event|8|||
19369468|NCT02780167|41609766|FG003|Overall Study|Adverse Event|12|||
19369469|NCT02780167|41609767|FG004|Overall Study|Adverse Event|8|||
19369470|NCT02780167|41609763|FG000|Overall Study|Lack of Efficacy|6|||
19369471|NCT02780167|41609764|FG001|Overall Study|Lack of Efficacy|5|||
19369472|NCT02780167|41609765|FG002|Overall Study|Lack of Efficacy|6|||
19369473|NCT02780167|41609766|FG003|Overall Study|Lack of Efficacy|1|||
19369474|NCT02780167|41609767|FG004|Overall Study|Lack of Efficacy|0|||
19369475|NCT02780167|41609763|FG000|Overall Study|Lost to Follow-up|2|||
19369476|NCT02780167|41609764|FG001|Overall Study|Lost to Follow-up|0|||
19369477|NCT02780167|41609765|FG002|Overall Study|Lost to Follow-up|1|||
19369478|NCT02780167|41609766|FG003|Overall Study|Lost to Follow-up|0|||
19369479|NCT02780167|41609767|FG004|Overall Study|Lost to Follow-up|0|||
19369480|NCT02780167|41609763|FG000|Overall Study|Does not meet entrance criteria|0|||
19369481|NCT02780167|41609764|FG001|Overall Study|Does not meet entrance criteria|0|||
19369482|NCT02780167|41609765|FG002|Overall Study|Does not meet entrance criteria|1|||
19369483|NCT02780167|41609766|FG003|Overall Study|Does not meet entrance criteria|0|||
19369484|NCT02780167|41609767|FG004|Overall Study|Does not meet entrance criteria|0|||
19369485|NCT02780167|41609763|FG000|Overall Study|No longer meets eligibility criteria|0|||
19369486|NCT02780167|41609764|FG001|Overall Study|No longer meets eligibility criteria|0|||
19369487|NCT02780167|41609765|FG002|Overall Study|No longer meets eligibility criteria|0|||
19369488|NCT02780167|41609766|FG003|Overall Study|No longer meets eligibility criteria|1|||
19369489|NCT02780167|41609767|FG004|Overall Study|No longer meets eligibility criteria|1|||
19369490|NCT02780167|41609763|FG000|Overall Study|Protocol Violation|5|||
19369491|NCT02780167|41609764|FG001|Overall Study|Protocol Violation|5|||
19369492|NCT02780167|41609765|FG002|Overall Study|Protocol Violation|1|||
19369493|NCT02780167|41609766|FG003|Overall Study|Protocol Violation|1|||
19369494|NCT02780167|41609767|FG004|Overall Study|Protocol Violation|2|||
19369495|NCT02780167|41609763|FG000|Overall Study|Withdrawal by Subject|6|||
19369496|NCT02780167|41609764|FG001|Overall Study|Withdrawal by Subject|4|||
19369497|NCT02780167|41609765|FG002|Overall Study|Withdrawal by Subject|4|||
19369498|NCT02780167|41609766|FG003|Overall Study|Withdrawal by Subject|3|||
19369499|NCT02780167|41609767|FG004|Overall Study|Withdrawal by Subject|4|||
19369500|NCT02780167|41609763|FG000|Overall Study|Other|0|||
19369501|NCT02780167|41609764|FG001|Overall Study|Other|0|||
19369502|NCT02780167|41609765|FG002|Overall Study|Other|3|||
19369503|NCT02780167|41609766|FG003|Overall Study|Other|1|||
19369504|NCT02780167|41609767|FG004|Overall Study|Other|2|||
19369505|NCT02779075|41609779|FG000|Overall Study|Withdrawal by Subject|1|||
19369506|NCT02779075|41609780|FG001|Overall Study|Withdrawal by Subject|3|||
19369507|NCT02779075|41609779|FG000|Overall Study|IV lost during 2nd study|1|||
19369508|NCT02779075|41609780|FG001|Overall Study|IV lost during 2nd study|0|||
19389190|NCT02053246|41632826|FG000|Overall Study|Physician Decision|1|||
19389191|NCT02053168|41632830|FG000|Overall Study|Withdrawal by Subject|1|||
19389192|NCT02053168|41632830|FG000|Overall Study|Physician Decision|1|||
19389193|NCT02053168|41632830|FG000|Overall Study|Lost to Follow-up|1|||
19389194|NCT02052466|41632834|FG000|Overall Study|Withdrawal by Subject|1|||
19389195|NCT02052466|41632834|FG000|Overall Study|Acromial fracture|1|||
19389196|NCT02032888|41632841|FG000|Treatment Period|Poor compliance/noncompliance|1|||
19389197|NCT02032888|41632842|FG001|Treatment Period|Poor compliance/noncompliance|1|||
19389198|NCT02032888|41632843|FG002|Treatment Period|Poor compliance/noncompliance|0|||
19389199|NCT02032888|41632841|FG000|Treatment Period|Other|1|||
19389200|NCT02032888|41632842|FG001|Treatment Period|Other|1|||
19389201|NCT02032888|41632843|FG002|Treatment Period|Other|0|||
19389202|NCT02032888|41632841|FG000|Follow-up Period|Lost to Follow-up|1|||
19389203|NCT02032888|41632842|FG001|Follow-up Period|Lost to Follow-up|1|||
19389204|NCT02032888|41632843|FG002|Follow-up Period|Lost to Follow-up|0|||
19389205|NCT02032888|41632841|FG000|Follow-up Period|Death|1|||
19389206|NCT02032888|41632842|FG001|Follow-up Period|Death|1|||
19389207|NCT02032888|41632843|FG002|Follow-up Period|Death|0|||
19389208|NCT02032888|41632841|FG000|Follow-up Period|Other|1|||
19369509|NCT00105079|41609792|FG000|Overall Study|Adverse Event|5|||
19369510|NCT00105079|41609793|FG001|Overall Study|Adverse Event|12|||
19369511|NCT00105079|41609792|FG000|Overall Study|Death|3|||
19369512|NCT00105079|41609793|FG001|Overall Study|Death|1|||
19369513|NCT00105079|41609792|FG000|Overall Study|Lost to Follow-up|12|||
19369514|NCT00105079|41609793|FG001|Overall Study|Lost to Follow-up|12|||
19369515|NCT00105079|41609792|FG000|Overall Study|Lack of Efficacy|9|||
19389209|NCT02032888|41632842|FG001|Follow-up Period|Other|0|||
19389210|NCT02032888|41632843|FG002|Follow-up Period|Other|0|||
19389211|NCT02082262|41632860|FG000|Overall Study|Withdrawal by Subject|3|||
19389212|NCT02082262|41632860|FG000|Overall Study|Adverse Event|48|||
19608419|NCT00985985|42057314|FG001|Overall Study|Other Reason|1|||
19389213|NCT04697069|41632866|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
19389214|NCT04697069|41632867|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
19389215|NCT04697069|41632866|FG000|Overall Study|Study termination|2|||
19389216|NCT04697069|41632867|FG001|Overall Study|Study termination|1|||
19389217|NCT02082184|41632875|FG000|Overall Study|Adverse Event|1|||
19389218|NCT02082184|41632876|FG001|Overall Study|Adverse Event|0|||
19389219|NCT02082184|41632875|FG000|Overall Study|Medical diagnosis|1|||
19389220|NCT02082184|41632876|FG001|Overall Study|Medical diagnosis|2|||
19389221|NCT02082184|41632875|FG000|Overall Study|Device associated symptoms|5|||
19389222|NCT02082184|41632876|FG001|Overall Study|Device associated symptoms|0|||
19389223|NCT02082184|41632875|FG000|Overall Study|Withdrawal by Subject|3|||
19389224|NCT02082184|41632876|FG001|Overall Study|Withdrawal by Subject|2|||
19389225|NCT02082184|41632875|FG000|Overall Study|Protocol Violation|0|||
19389226|NCT02082184|41632876|FG001|Overall Study|Protocol Violation|6|||
19389227|NCT02082184|41632875|FG000|Overall Study|Lost to Follow-up|0|||
19389228|NCT02082184|41632876|FG001|Overall Study|Lost to Follow-up|2|||
19389229|NCT02082184|41632875|FG000|Overall Study|Subject non-compliance|0|||
19389230|NCT02082184|41632876|FG001|Overall Study|Subject non-compliance|1|||
19389231|NCT01624870|41632882|FG000|Overall Study|Death|19|||
19389232|NCT01624870|41632882|FG000|Overall Study|Withdrawal by Subject|1|||
19389233|NCT01624870|41632882|FG000|Overall Study|CoreValve not implanted|6|||
19389234|NCT01624870|41632882|FG000|Overall Study|Lost to follow up|1|||
19389235|NCT02031640|41632893|FG000|Screening Period|Adverse Event|1|||
19389236|NCT02031640|41632894|FG001|Screening Period|Adverse Event|0|||
19389237|NCT02031640|41632895|FG002|Screening Period|Adverse Event|0|||
19389238|NCT02031640|41632896|FG003|Screening Period|Adverse Event|0|||
19389239|NCT02031640|41632897|FG004|Screening Period|Adverse Event|0|||
19389240|NCT02031640|41632898|FG005|Screening Period|Adverse Event|0|||
19389241|NCT02031640|41632893|FG000|Screening Period|Withdrawal by Subject|29|||
19369516|NCT00105079|41609793|FG001|Overall Study|Lack of Efficacy|3|||
19369517|NCT00105079|41609792|FG000|Overall Study|Refused treatment|6|||
19369518|NCT00105079|41609793|FG001|Overall Study|Refused treatment|4|||
19369519|NCT00105079|41609792|FG000|Overall Study|Violation of selection criteria at entry|0|||
19369520|NCT00105079|41609793|FG001|Overall Study|Violation of selection criteria at entry|2|||
19369521|NCT00105079|41609792|FG000|Overall Study|Protocol Violation|1|||
19369522|NCT00105079|41609793|FG001|Overall Study|Protocol Violation|0|||
19369523|NCT00105079|41609792|FG000|Overall Study|Other|3|||
19369524|NCT00105079|41609793|FG001|Overall Study|Other|1|||
19369525|NCT02777827|41609799|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
19369526|NCT02777827|41609800|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
19369527|NCT02777827|41609801|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
19369528|NCT02777827|41609802|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
19369529|NCT02777827|41609803|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
19369530|NCT02777827|41609804|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
19369531|NCT02712333|41609820|FG000|First Period|Withdrawal by Subject|3|||
19369532|NCT02712333|41609821|FG001|First Period|Withdrawal by Subject|2|||
19369533|NCT02343406|41609837|FG000|Overall Study|Progressive disease|72|||
19369534|NCT02343406|41609838|FG001|Overall Study|Progressive disease|70|||
19369535|NCT02343406|41609839|FG002|Overall Study|Progressive disease|43|||
19369536|NCT02343406|41609840|FG003|Overall Study|Progressive disease|15|||
19389242|NCT02031640|41632894|FG001|Screening Period|Withdrawal by Subject|0|||
19389243|NCT02031640|41632895|FG002|Screening Period|Withdrawal by Subject|0|||
19389244|NCT02031640|41632896|FG003|Screening Period|Withdrawal by Subject|0|||
19389245|NCT02031640|41632897|FG004|Screening Period|Withdrawal by Subject|0|||
19389246|NCT02031640|41632898|FG005|Screening Period|Withdrawal by Subject|0|||
19389247|NCT02031640|41632893|FG000|Screening Period|Inclusion criteria not met|312|||
19389248|NCT02031640|41632894|FG001|Screening Period|Inclusion criteria not met|0|||
19389249|NCT02031640|41632895|FG002|Screening Period|Inclusion criteria not met|0|||
19369537|NCT02343406|41609841|FG004|Overall Study|Progressive disease|5|||
19369538|NCT02343406|41609837|FG000|Overall Study|Adverse Event|6|||
19369539|NCT02343406|41609838|FG001|Overall Study|Adverse Event|8|||
19369540|NCT02343406|41609839|FG002|Overall Study|Adverse Event|6|||
19369541|NCT02343406|41609840|FG003|Overall Study|Adverse Event|3|||
19369542|NCT02343406|41609841|FG004|Overall Study|Adverse Event|0|||
19369543|NCT02343406|41609837|FG000|Overall Study|Withdrawal by Subject|6|||
19369544|NCT02343406|41609838|FG001|Overall Study|Withdrawal by Subject|4|||
19369545|NCT02343406|41609839|FG002|Overall Study|Withdrawal by Subject|8|||
19389250|NCT02031640|41632896|FG003|Screening Period|Inclusion criteria not met|0|||
19389251|NCT02031640|41632897|FG004|Screening Period|Inclusion criteria not met|0|||
19369546|NCT02343406|41609840|FG003|Overall Study|Withdrawal by Subject|3|||
19369547|NCT02343406|41609841|FG004|Overall Study|Withdrawal by Subject|0|||
19369548|NCT02343406|41609837|FG000|Overall Study|Death|2|||
19369549|NCT02343406|41609838|FG001|Overall Study|Death|1|||
19369550|NCT02343406|41609839|FG002|Overall Study|Death|0|||
19389252|NCT02031640|41632898|FG005|Screening Period|Inclusion criteria not met|0|||
19369551|NCT02343406|41609840|FG003|Overall Study|Death|0|||
19369552|NCT02343406|41609841|FG004|Overall Study|Death|0|||
19369553|NCT02343406|41609837|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
19389253|NCT02031640|41632893|FG000|Screening Period|Exclusion criteria met|30|||
19389254|NCT02031640|41632894|FG001|Screening Period|Exclusion criteria met|0|||
19389255|NCT02031640|41632895|FG002|Screening Period|Exclusion criteria met|0|||
19389256|NCT02031640|41632896|FG003|Screening Period|Exclusion criteria met|0|||
19389257|NCT02031640|41632897|FG004|Screening Period|Exclusion criteria met|0|||
19389258|NCT02031640|41632898|FG005|Screening Period|Exclusion criteria met|0|||
19389259|NCT02031640|41632893|FG000|Screening Period|Lost to Follow-up|14|||
19389260|NCT02031640|41632894|FG001|Screening Period|Lost to Follow-up|0|||
19389261|NCT02031640|41632895|FG002|Screening Period|Lost to Follow-up|0|||
19389262|NCT02031640|41632896|FG003|Screening Period|Lost to Follow-up|0|||
19389263|NCT02031640|41632897|FG004|Screening Period|Lost to Follow-up|0|||
19389264|NCT02031640|41632898|FG005|Screening Period|Lost to Follow-up|0|||
19389265|NCT02031640|41632893|FG000|Screening Period|Enrollment closed|26|||
19389266|NCT02031640|41632894|FG001|Screening Period|Enrollment closed|0|||
19389267|NCT02031640|41632895|FG002|Screening Period|Enrollment closed|0|||
19389268|NCT02031640|41632896|FG003|Screening Period|Enrollment closed|0|||
19389269|NCT02031640|41632897|FG004|Screening Period|Enrollment closed|0|||
19389270|NCT02031640|41632898|FG005|Screening Period|Enrollment closed|0|||
19389271|NCT02031640|41632893|FG000|Run-In Period|Adverse Event|4|||
19389272|NCT02031640|41632894|FG001|Run-In Period|Adverse Event|0|||
19389273|NCT02031640|41632895|FG002|Run-In Period|Adverse Event|0|||
19389274|NCT02031640|41632896|FG003|Run-In Period|Adverse Event|0|||
19389275|NCT02031640|41632897|FG004|Run-In Period|Adverse Event|0|||
19389276|NCT02031640|41632898|FG005|Run-In Period|Adverse Event|0|||
19389277|NCT02031640|41632893|FG000|Run-In Period|Withdrawal by Subject|17|||
19389278|NCT02031640|41632894|FG001|Run-In Period|Withdrawal by Subject|0|||
19389279|NCT02031640|41632895|FG002|Run-In Period|Withdrawal by Subject|0|||
19389280|NCT02031640|41632896|FG003|Run-In Period|Withdrawal by Subject|0|||
19389281|NCT02031640|41632897|FG004|Run-In Period|Withdrawal by Subject|0|||
19389282|NCT02031640|41632898|FG005|Run-In Period|Withdrawal by Subject|0|||
19389283|NCT02031640|41632893|FG000|Run-In Period|Inclusion criteria not met|38|||
19389284|NCT02031640|41632894|FG001|Run-In Period|Inclusion criteria not met|0|||
19389285|NCT02031640|41632895|FG002|Run-In Period|Inclusion criteria not met|0|||
19389286|NCT02031640|41632896|FG003|Run-In Period|Inclusion criteria not met|0|||
19389287|NCT02031640|41632897|FG004|Run-In Period|Inclusion criteria not met|0|||
19389288|NCT02031640|41632898|FG005|Run-In Period|Inclusion criteria not met|0|||
19389289|NCT02031640|41632893|FG000|Run-In Period|Exclusion criteria met|8|||
19369554|NCT02343406|41609838|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
19369555|NCT02343406|41609839|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
19369556|NCT02343406|41609840|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
19369557|NCT02343406|41609841|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
19369558|NCT02343406|41609837|FG000|Overall Study|Other primary malignancy|0|||
19369559|NCT02343406|41609838|FG001|Overall Study|Other primary malignancy|1|||
19369560|NCT02343406|41609839|FG002|Overall Study|Other primary malignancy|0|||
19369561|NCT02343406|41609840|FG003|Overall Study|Other primary malignancy|0|||
19369562|NCT02343406|41609841|FG004|Overall Study|Other primary malignancy|0|||
19389290|NCT02031640|41632894|FG001|Run-In Period|Exclusion criteria met|0|||
19389291|NCT02031640|41632895|FG002|Run-In Period|Exclusion criteria met|0|||
19389292|NCT02031640|41632896|FG003|Run-In Period|Exclusion criteria met|0|||
19389293|NCT02031640|41632897|FG004|Run-In Period|Exclusion criteria met|0|||
19389294|NCT02031640|41632898|FG005|Run-In Period|Exclusion criteria met|0|||
19389295|NCT02031640|41632893|FG000|Run-In Period|Randomization criteria not met|85|||
19389296|NCT02031640|41632894|FG001|Run-In Period|Randomization criteria not met|0|||
19389297|NCT02031640|41632895|FG002|Run-In Period|Randomization criteria not met|0|||
19389298|NCT02031640|41632896|FG003|Run-In Period|Randomization criteria not met|0|||
19389299|NCT02031640|41632897|FG004|Run-In Period|Randomization criteria not met|0|||
19389300|NCT02031640|41632898|FG005|Run-In Period|Randomization criteria not met|0|||
19389301|NCT02031640|41632893|FG000|Run-In Period|Various administrative reasons|17|||
19389302|NCT02031640|41632894|FG001|Run-In Period|Various administrative reasons|0|||
19389303|NCT02031640|41632895|FG002|Run-In Period|Various administrative reasons|0|||
19389304|NCT02031640|41632896|FG003|Run-In Period|Various administrative reasons|0|||
19389305|NCT02031640|41632897|FG004|Run-In Period|Various administrative reasons|0|||
19389306|NCT02031640|41632898|FG005|Run-In Period|Various administrative reasons|0|||
19389307|NCT02031640|41632893|FG000|Double-blind Treatment Period|Protocol deviation|0|||
19389308|NCT02031640|41632894|FG001|Double-blind Treatment Period|Protocol deviation|2|||
19389309|NCT02031640|41632895|FG002|Double-blind Treatment Period|Protocol deviation|0|||
19389310|NCT02031640|41632896|FG003|Double-blind Treatment Period|Protocol deviation|1|||
19389311|NCT02031640|41632897|FG004|Double-blind Treatment Period|Protocol deviation|3|||
19389312|NCT02031640|41632898|FG005|Double-blind Treatment Period|Protocol deviation|1|||
19389313|NCT02031640|41632893|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
19608420|NCT00985985|42057315|FG002|Overall Study|Other Reason|4|||
19608421|NCT00985985|42057316|FG003|Overall Study|Other Reason|2|||
19389314|NCT02031640|41632894|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
19389315|NCT02031640|41632895|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
19369563|NCT02343406|41609837|FG000|Overall Study|Other, not specified|2|||
19369564|NCT02343406|41609838|FG001|Overall Study|Other, not specified|1|||
19369565|NCT02343406|41609839|FG002|Overall Study|Other, not specified|1|||
19369566|NCT02343406|41609840|FG003|Overall Study|Other, not specified|4|||
19369567|NCT02343406|41609841|FG004|Overall Study|Other, not specified|0|||
19369568|NCT02710071|41609854|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
19369569|NCT02710071|41609855|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
19369570|NCT02710071|41609854|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
19369571|NCT02710071|41609855|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
19389316|NCT02031640|41632896|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
19389317|NCT02031640|41632897|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
19389318|NCT02031640|41632898|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
19389319|NCT02031640|41632893|FG000|Double-blind Treatment Period|Non-compliance|0|||
19389320|NCT02031640|41632894|FG001|Double-blind Treatment Period|Non-compliance|1|||
19389321|NCT02031640|41632895|FG002|Double-blind Treatment Period|Non-compliance|0|||
19389322|NCT02031640|41632896|FG003|Double-blind Treatment Period|Non-compliance|1|||
19389323|NCT02031640|41632897|FG004|Double-blind Treatment Period|Non-compliance|1|||
19389324|NCT02031640|41632898|FG005|Double-blind Treatment Period|Non-compliance|0|||
19389325|NCT02031640|41632893|FG000|Double-blind Treatment Period|Adverse Event|0|||
19389326|NCT02031640|41632894|FG001|Double-blind Treatment Period|Adverse Event|0|||
19389327|NCT02031640|41632895|FG002|Double-blind Treatment Period|Adverse Event|0|||
19389328|NCT02031640|41632896|FG003|Double-blind Treatment Period|Adverse Event|2|||
19389329|NCT02031640|41632897|FG004|Double-blind Treatment Period|Adverse Event|0|||
19389330|NCT02031640|41632898|FG005|Double-blind Treatment Period|Adverse Event|0|||
19389331|NCT02031640|41632893|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
19389332|NCT02031640|41632894|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
19389333|NCT02031640|41632895|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
19389334|NCT02031640|41632896|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
19389335|NCT02031640|41632897|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
19389336|NCT02031640|41632898|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
19389337|NCT02031640|41632893|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19389338|NCT02031640|41632894|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
19389339|NCT02031640|41632895|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
19389340|NCT02031640|41632896|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
19389341|NCT02031640|41632897|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
19389342|NCT02031640|41632898|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
19389343|NCT02660489|41632924|FG000|Overall Study|Lost to Follow-up|1|||
19389344|NCT02660489|41632925|FG001|Overall Study|Lost to Follow-up|1|||
19389345|NCT02660489|41632924|FG000|Overall Study|Adverse Event|1|||
19389346|NCT02660489|41632925|FG001|Overall Study|Adverse Event|3|||
19389347|NCT02660489|41632924|FG000|Overall Study|no rhinovirus infection|4|||
19389348|NCT02660489|41632925|FG001|Overall Study|no rhinovirus infection|4|||
19369572|NCT02373202|41609866|FG000|Overall Study|Adverse Event|2|||
19369573|NCT02373202|41609867|FG001|Overall Study|Adverse Event|5|||
19369574|NCT02373202|41609868|FG002|Overall Study|Adverse Event|2|||
19369575|NCT02373202|41609869|FG003|Overall Study|Adverse Event|1|||
19369576|NCT02373202|41609866|FG000|Overall Study|Lack of Efficacy|0|||
19369577|NCT02373202|41609867|FG001|Overall Study|Lack of Efficacy|0|||
19369578|NCT02373202|41609868|FG002|Overall Study|Lack of Efficacy|1|||
19369579|NCT02373202|41609869|FG003|Overall Study|Lack of Efficacy|0|||
19369580|NCT02373202|41609866|FG000|Overall Study|Other|0|||
19369581|NCT02373202|41609867|FG001|Overall Study|Other|1|||
19369582|NCT02373202|41609868|FG002|Overall Study|Other|0|||
19389349|NCT02052310|41632933|FG000|Overall Study|Death|64|||
19389350|NCT02052310|41632934|FG001|Overall Study|Death|54|||
19389351|NCT02052310|41632933|FG000|Overall Study|Withdrawal by Subject|37|||
19389352|NCT02052310|41632934|FG001|Overall Study|Withdrawal by Subject|49|||
19389353|NCT02052310|41632933|FG000|Overall Study|Other than specified|32|||
19389354|NCT02052310|41632934|FG001|Overall Study|Other than specified|29|||
19389355|NCT02052310|41632933|FG000|Overall Study|Adverse Event|29|||
19389356|NCT02052310|41632934|FG001|Overall Study|Adverse Event|22|||
19389357|NCT02052310|41632933|FG000|Overall Study|Kidney Transplant|23|||
19389358|NCT02052310|41632934|FG001|Overall Study|Kidney Transplant|29|||
19389359|NCT02052310|41632933|FG000|Overall Study|Physician Decision|14|||
19389360|NCT02052310|41632934|FG001|Overall Study|Physician Decision|7|||
19389361|NCT02052310|41632933|FG000|Overall Study|Lack of Efficacy|6|||
19389362|NCT02052310|41632934|FG001|Overall Study|Lack of Efficacy|1|||
19389363|NCT02052310|41632933|FG000|Overall Study|Site Terminated by Sponsor|5|||
19389364|NCT02052310|41632934|FG001|Overall Study|Site Terminated by Sponsor|13|||
19369583|NCT02373202|41609869|FG003|Overall Study|Other|0|||
19369584|NCT02622074|41609885|FG000|Overall Study|Death|4|||
19369585|NCT02622074|41609886|FG001|Overall Study|Death|0|||
19369586|NCT02622074|41609887|FG002|Overall Study|Death|0|||
19389365|NCT02052310|41632933|FG000|Overall Study|Lost to Follow-up|4|||
19389366|NCT02052310|41632934|FG001|Overall Study|Lost to Follow-up|2|||
19389367|NCT02052310|41632933|FG000|Overall Study|Protocol Violation|1|||
19369587|NCT02622074|41609888|FG003|Overall Study|Death|1|||
19369588|NCT02622074|41609889|FG004|Overall Study|Death|1|||
19369589|NCT02622074|41609890|FG005|Overall Study|Death|0|||
19369590|NCT02622074|41609885|FG000|Overall Study|Withdrawal by Subject|0|||
19369591|NCT02622074|41609886|FG001|Overall Study|Withdrawal by Subject|1|||
19369592|NCT02622074|41609887|FG002|Overall Study|Withdrawal by Subject|0|||
19369593|NCT02622074|41609888|FG003|Overall Study|Withdrawal by Subject|0|||
19369594|NCT02622074|41609889|FG004|Overall Study|Withdrawal by Subject|0|||
19369595|NCT02622074|41609890|FG005|Overall Study|Withdrawal by Subject|0|||
19389368|NCT02052310|41632934|FG001|Overall Study|Protocol Violation|6|||
19389369|NCT02051764|41632942|FG000|Overall Study|Study terminated by sponsor|0|||
19389370|NCT02051764|41632943|FG001|Overall Study|Study terminated by sponsor|7|||
19389371|NCT02051296|41632951|FG000|Overall Study|Lost to Follow-up|1|||
19389372|NCT02051296|41632952|FG001|Overall Study|Lost to Follow-up|2|||
19389373|NCT02051296|41632951|FG000|Overall Study|withdraw prior to treatment|7|||
19389374|NCT02051296|41632952|FG001|Overall Study|withdraw prior to treatment|7|||
19389375|NCT02050048|41632960|FG000|Overall Study|Lost to Follow-up|0|||
19389376|NCT02050048|41632961|FG001|Overall Study|Lost to Follow-up|1|||
19389377|NCT02050048|41632960|FG000|Overall Study|Death|1|||
19389378|NCT02050048|41632961|FG001|Overall Study|Death|0|||
19389379|NCT02050048|41632960|FG000|Overall Study|Ineligible after ERCP|4|||
19389380|NCT02050048|41632961|FG001|Overall Study|Ineligible after ERCP|1|||
19389381|NCT02049814|41632969|FG000|Overall Study|Reason not Specified|4|||
19389382|NCT02049814|41632970|FG001|Overall Study|Reason not Specified|3|||
19389383|NCT02049814|41632969|FG000|Overall Study|Pregnancy|1|||
19389384|NCT02049814|41632970|FG001|Overall Study|Pregnancy|0|||
19389385|NCT02049814|41632969|FG000|Overall Study|Lost to Follow-up|2|||
19389386|NCT02049814|41632970|FG001|Overall Study|Lost to Follow-up|3|||
19389387|NCT02049814|41632969|FG000|Overall Study|Serious Protocol Violation|5|||
19389388|NCT02049814|41632970|FG001|Overall Study|Serious Protocol Violation|7|||
19369596|NCT02308696|41609906|FG000|Overall Study|Lost to Follow-up|28|||
19369597|NCT02308696|41609907|FG001|Overall Study|Lost to Follow-up|21|||
19369598|NCT02308696|41609906|FG000|Overall Study|Death|8|||
19389389|NCT02049814|41632969|FG000|Overall Study|Study Termination|0|||
19389390|NCT02049814|41632970|FG001|Overall Study|Study Termination|1|||
19389391|NCT02049814|41632969|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
19389392|NCT02049814|41632970|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
19389393|NCT02049814|41632969|FG000|Overall Study|Voluntary withdrawal|9|||
19389394|NCT02049814|41632970|FG001|Overall Study|Voluntary withdrawal|8|||
19389395|NCT02079844|41632988|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
19389396|NCT02079844|41632989|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
19389397|NCT02079844|41632990|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
19389398|NCT02079844|41632988|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
19389399|NCT02079844|41632989|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
19389400|NCT02079844|41632990|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
19389401|NCT02048722|41633010|FG000|2 Cycles of Treatment|Adverse Event|2|||
19389402|NCT02048722|41633010|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
19389403|NCT02048722|41633010|FG000|2 Cycles of Treatment|Progressive Disease|2|||
19477930|NCT01693562|41757314|FG000|Escalation Phase|Withdrawal by Subject|0|||
19477931|NCT01693562|41757315|FG001|Escalation Phase|Withdrawal by Subject|1|||
19369599|NCT02308696|41609907|FG001|Overall Study|Death|4|||
19369600|NCT02308696|41609906|FG000|Overall Study|Moved to a Higher Level of Care|17|||
19369601|NCT02308696|41609907|FG001|Overall Study|Moved to a Higher Level of Care|6|||
19369602|NCT02342704|41609915|FG000|Overall Study|Physician Decision|0|||
19369603|NCT02342704|41609916|FG001|Overall Study|Physician Decision|3|||
19369604|NCT02342704|41609915|FG000|Overall Study|Sponsor Termination|49|||
19389404|NCT02048722|41633010|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
19477932|NCT01693562|41757316|FG002|Escalation Phase|Withdrawal by Subject|0|||
19477933|NCT01693562|41757317|FG003|Escalation Phase|Withdrawal by Subject|0|||
19477934|NCT01693562|41757318|FG004|Escalation Phase|Withdrawal by Subject|0|||
19477935|NCT01693562|41757319|FG005|Escalation Phase|Withdrawal by Subject|2|||
19477936|NCT01693562|41757320|FG006|Escalation Phase|Withdrawal by Subject|0|||
19477937|NCT01693562|41757321|FG007|Escalation Phase|Withdrawal by Subject|0|||
19477938|NCT01693562|41757322|FG008|Escalation Phase|Withdrawal by Subject|0|||
19477939|NCT01693562|41757323|FG009|Escalation Phase|Withdrawal by Subject|0|||
19369605|NCT02342704|41609916|FG001|Overall Study|Sponsor Termination|43|||
19389405|NCT02048722|41633010|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
19389406|NCT02048722|41633010|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
19389407|NCT02030002|41633014|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
19477940|NCT01693562|41757324|FG010|Escalation Phase|Withdrawal by Subject|0|||
19698790|NCT00296504|42143597|FG008|Final Analysis|Pregnancy|4|||
19369606|NCT02342704|41609915|FG000|Overall Study|Other|0|||
19369607|NCT02342704|41609916|FG001|Overall Study|Other|1|||
19369608|NCT02342704|41609915|FG000|Overall Study|Withdrawal by Subject|1|||
19369609|NCT02342704|41609916|FG001|Overall Study|Withdrawal by Subject|0|||
19369610|NCT02342704|41609915|FG000|Overall Study|Lost to Follow-up|2|||
19369611|NCT02342704|41609916|FG001|Overall Study|Lost to Follow-up|1|||
19369612|NCT02342704|41609915|FG000|Overall Study|Adverse Event|1|||
19369613|NCT02342704|41609916|FG001|Overall Study|Adverse Event|3|||
19369614|NCT02342548|41609925|FG000|Overall Study|Adverse Event|12|||
19369615|NCT02342548|41609926|FG001|Overall Study|Adverse Event|17|||
19369616|NCT02342548|41609927|FG002|Overall Study|Adverse Event|13|||
19369617|NCT02342548|41609925|FG000|Overall Study|Lost to Follow-up|0|||
19369618|NCT02342548|41609926|FG001|Overall Study|Lost to Follow-up|1|||
19369619|NCT02342548|41609927|FG002|Overall Study|Lost to Follow-up|0|||
19369620|NCT02342548|41609925|FG000|Overall Study|Study terminated by sponsor|20|||
19369621|NCT02342548|41609926|FG001|Overall Study|Study terminated by sponsor|39|||
19369622|NCT02342548|41609927|FG002|Overall Study|Study terminated by sponsor|25|||
19369623|NCT02342548|41609925|FG000|Overall Study|Protocol Violation|0|||
19369624|NCT02342548|41609926|FG001|Overall Study|Protocol Violation|1|||
19369625|NCT02342548|41609927|FG002|Overall Study|Protocol Violation|0|||
19369626|NCT02342548|41609925|FG000|Overall Study|Withdrawal by Subject|1|||
19369627|NCT02342548|41609926|FG001|Overall Study|Withdrawal by Subject|3|||
19369628|NCT02342548|41609927|FG002|Overall Study|Withdrawal by Subject|4|||
19369629|NCT02342548|41609925|FG000|Overall Study|Other|1|||
19369630|NCT02342548|41609926|FG001|Overall Study|Other|1|||
19369631|NCT02342548|41609927|FG002|Overall Study|Other|1|||
19369632|NCT02617628|41609937|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
19369633|NCT02617628|41609938|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
19369634|NCT02308540|41609954|FG000|Overall Study|Lost to Follow-up|0|||
19369635|NCT02308540|41609955|FG001|Overall Study|Lost to Follow-up|0|||
19369636|NCT02308540|41609956|FG002|Overall Study|Lost to Follow-up|0|||
19369637|NCT02308540|41609957|FG003|Overall Study|Lost to Follow-up|0|||
19369638|NCT02308540|41609958|FG004|Overall Study|Lost to Follow-up|0|||
19369639|NCT02308540|41609959|FG005|Overall Study|Lost to Follow-up|1|||
19369640|NCT02308228|41610010|FG000|Overall Study|Adverse Event|3|||
19369641|NCT02308228|41610011|FG001|Overall Study|Adverse Event|4|||
19369642|NCT02308228|41610010|FG000|Overall Study|Withdrawal by Subject|5|||
19369643|NCT02308228|41610011|FG001|Overall Study|Withdrawal by Subject|3|||
19369644|NCT02616614|41610029|FG000|Overall Study|Withdrawal by Subject|10|||
19369645|NCT02616614|41610030|FG001|Overall Study|Withdrawal by Subject|5|||
19369646|NCT02616614|41610031|FG002|Overall Study|Withdrawal by Subject|6|||
19369647|NCT02616614|41610029|FG000|Overall Study|Physician Decision|2|||
19369648|NCT02616614|41610030|FG001|Overall Study|Physician Decision|1|||
19369649|NCT02616614|41610031|FG002|Overall Study|Physician Decision|0|||
19369650|NCT02616614|41610029|FG000|Overall Study|Adverse Event|1|||
19369651|NCT02616614|41610030|FG001|Overall Study|Adverse Event|4|||
19369652|NCT02616614|41610031|FG002|Overall Study|Adverse Event|1|||
19369653|NCT02616614|41610029|FG000|Overall Study|Protocol Violation|0|||
19369654|NCT02616614|41610030|FG001|Overall Study|Protocol Violation|3|||
19369655|NCT02616614|41610031|FG002|Overall Study|Protocol Violation|1|||
19369656|NCT02616614|41610029|FG000|Overall Study|Prohibited Medication|12|||
19369657|NCT02616614|41610030|FG001|Overall Study|Prohibited Medication|9|||
19369658|NCT02616614|41610031|FG002|Overall Study|Prohibited Medication|5|||
19369659|NCT02616614|41610029|FG000|Overall Study|More than 3 applications missed|6|||
19369660|NCT02616614|41610030|FG001|Overall Study|More than 3 applications missed|8|||
19369661|NCT02616614|41610031|FG002|Overall Study|More than 3 applications missed|1|||
19369662|NCT02616614|41610029|FG000|Overall Study|Lost to Follow-up|31|||
19369663|NCT02616614|41610030|FG001|Overall Study|Lost to Follow-up|28|||
19369664|NCT02616614|41610031|FG002|Overall Study|Lost to Follow-up|13|||
19369665|NCT02616614|41610029|FG000|Overall Study|Pregnancy|2|||
19369666|NCT02616614|41610030|FG001|Overall Study|Pregnancy|0|||
19369667|NCT02616614|41610031|FG002|Overall Study|Pregnancy|1|||
19369668|NCT02616614|41610029|FG000|Overall Study|Other|1|||
19369669|NCT02616614|41610030|FG001|Overall Study|Other|2|||
19369670|NCT02616614|41610031|FG002|Overall Study|Other|1|||
19369671|NCT02616380|41610057|FG000|Overall Study|Lost to Follow-up|1|||
19369672|NCT02616380|41610057|FG000|Overall Study|Other|2|||
19369673|NCT01596062|41610068|FG000|Overall Study|Adverse Event|1|||
19369674|NCT01596062|41610069|FG001|Overall Study|Adverse Event|0|||
19369675|NCT01596062|41610070|FG002|Overall Study|Adverse Event|2|||
19369676|NCT01596062|41610068|FG000|Overall Study|Lack of Efficacy|0|||
19369677|NCT01596062|41610069|FG001|Overall Study|Lack of Efficacy|0|||
19369678|NCT01596062|41610070|FG002|Overall Study|Lack of Efficacy|1|||
19369679|NCT02614898|41610089|FG000|Overall Study|Participated until study termination|10|||
19369680|NCT02614898|41610090|FG001|Overall Study|Participated until study termination|26|||
19369681|NCT02614898|41610089|FG000|Overall Study|Lost to Follow-up|0|||
19369682|NCT02614898|41610090|FG001|Overall Study|Lost to Follow-up|2|||
19369683|NCT02614898|41610089|FG000|Overall Study|Physician Decision|1|||
19369684|NCT02614898|41610090|FG001|Overall Study|Physician Decision|8|||
19369685|NCT02614898|41610089|FG000|Overall Study|Study Terminated by Sponsor|3|||
19369686|NCT02614898|41610090|FG001|Overall Study|Study Terminated by Sponsor|0|||
19369687|NCT02614898|41610089|FG000|Overall Study|Withdrawal by Subject|0|||
19369688|NCT02614898|41610090|FG001|Overall Study|Withdrawal by Subject|2|||
19369689|NCT02614898|41610089|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19369690|NCT02614898|41610090|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19369691|NCT02614898|41610089|FG000|Overall Study|Other-Additional Information Unavailable|0|||
19369692|NCT02614898|41610090|FG001|Overall Study|Other-Additional Information Unavailable|11|||
19369693|NCT02614898|41610089|FG000|Overall Study|Missing|0|||
19369694|NCT02614898|41610090|FG001|Overall Study|Missing|1|||
19369695|NCT02777593|41610102|FG000|Overall Study|Still in study|66|||
19369696|NCT02777593|41610103|FG001|Overall Study|Still in study|105|||
19369697|NCT02777593|41610104|FG002|Overall Study|Still in study|10|||
19369698|NCT02777593|41610105|FG003|Overall Study|Still in study|8|||
19369699|NCT02777593|41610106|FG004|Overall Study|Still in study|6|||
19369700|NCT02777593|41610102|FG000|Overall Study|Death|11|||
19608422|NCT00923936|42057333|FG000|Overall Study|progressive disease on study|2|||
19608423|NCT00923936|42057334|FG001|Overall Study|progressive disease on study|1|||
19608424|NCT00923936|42057333|FG000|Overall Study|Adverse Event|2|||
19608425|NCT00923936|42057334|FG001|Overall Study|Adverse Event|1|||
19608426|NCT00923936|42057333|FG000|Overall Study|Lost to follow up|2|||
19608427|NCT00923936|42057334|FG001|Overall Study|Lost to follow up|0|||
19608428|NCT00923936|42057333|FG000|Overall Study|Continuing in follow up period|2|||
19608429|NCT00923936|42057334|FG001|Overall Study|Continuing in follow up period|1|||
19369701|NCT02777593|41610103|FG001|Overall Study|Death|19|||
19369702|NCT02777593|41610104|FG002|Overall Study|Death|0|||
19369703|NCT02777593|41610105|FG003|Overall Study|Death|4|||
19369704|NCT02777593|41610106|FG004|Overall Study|Death|0|||
19369705|NCT02777593|41610102|FG000|Overall Study|Withdrawal by Subject|5|||
19369706|NCT02777593|41610103|FG001|Overall Study|Withdrawal by Subject|1|||
19369707|NCT02777593|41610104|FG002|Overall Study|Withdrawal by Subject|0|||
19369708|NCT02777593|41610105|FG003|Overall Study|Withdrawal by Subject|1|||
19369709|NCT02777593|41610106|FG004|Overall Study|Withdrawal by Subject|0|||
19369710|NCT02777593|41610102|FG000|Overall Study|Lost to Follow-up|1|||
19369711|NCT02777593|41610103|FG001|Overall Study|Lost to Follow-up|6|||
19369712|NCT02777593|41610104|FG002|Overall Study|Lost to Follow-up|0|||
19369713|NCT02777593|41610105|FG003|Overall Study|Lost to Follow-up|0|||
19369714|NCT02777593|41610106|FG004|Overall Study|Lost to Follow-up|0|||
19369715|NCT02777593|41610102|FG000|Overall Study|Physician Decision|0|||
19369716|NCT02777593|41610103|FG001|Overall Study|Physician Decision|1|||
19369717|NCT02777593|41610104|FG002|Overall Study|Physician Decision|0|||
19369718|NCT02777593|41610105|FG003|Overall Study|Physician Decision|0|||
19369719|NCT02777593|41610106|FG004|Overall Study|Physician Decision|0|||
19369720|NCT02777593|41610102|FG000|Overall Study|Discontinued due to Other|2|||
19369721|NCT02777593|41610103|FG001|Overall Study|Discontinued due to Other|0|||
19369722|NCT02777593|41610104|FG002|Overall Study|Discontinued due to Other|0|||
19369723|NCT02777593|41610105|FG003|Overall Study|Discontinued due to Other|0|||
19369724|NCT02777593|41610106|FG004|Overall Study|Discontinued due to Other|0|||
19369725|NCT02776033|41610131|FG000|Overall Study|Withdrawal by Subject|0|||
19369726|NCT02776033|41610132|FG001|Overall Study|Withdrawal by Subject|0|||
19369727|NCT02776033|41610133|FG002|Overall Study|Withdrawal by Subject|2|||
19369728|NCT02776033|41610131|FG000|Overall Study|Physician Decision|2|||
19369729|NCT02776033|41610132|FG001|Overall Study|Physician Decision|0|||
19369730|NCT02776033|41610133|FG002|Overall Study|Physician Decision|0|||
19369731|NCT02776033|41610131|FG000|Overall Study|Lost to Follow-up|1|||
19369732|NCT02776033|41610132|FG001|Overall Study|Lost to Follow-up|0|||
19369733|NCT02776033|41610133|FG002|Overall Study|Lost to Follow-up|0|||
19369734|NCT02776033|41610131|FG000|Overall Study|Adverse Event|1|||
19369735|NCT02776033|41610132|FG001|Overall Study|Adverse Event|2|||
19369736|NCT02776033|41610133|FG002|Overall Study|Adverse Event|0|||
19369737|NCT02777125|41610149|FG000|Overall Study|Consent form violation|14|||
19369738|NCT02777125|41610150|FG001|Overall Study|Consent form violation|12|||
19369739|NCT02777125|41610149|FG000|Overall Study|Assent form violation|21|||
19369740|NCT02777125|41610150|FG001|Overall Study|Assent form violation|23|||
19369741|NCT02777125|41610149|FG000|Overall Study|Protocol Violation|8|||
19369742|NCT02777125|41610150|FG001|Overall Study|Protocol Violation|12|||
19390378|NCT01987960|41634110|FG000|Period 3|Administrative or other reason|0|||
19608430|NCT00924950|42057342|FG000|Overall Study|Lost to Follow-up|2|||
19608431|NCT00988637|42057351|FG000|Overall Study|Lost to Follow-up|2|||
19369743|NCT02769481|41610175|FG000|Overall Study|Protocol Violation|1|||
19369744|NCT02769481|41610176|FG001|Overall Study|Protocol Violation|0|||
19369745|NCT02769481|41610175|FG000|Overall Study|Adverse Event|3|||
19369746|NCT02769481|41610176|FG001|Overall Study|Adverse Event|6|||
19369747|NCT02769481|41610175|FG000|Overall Study|Entry Criteria Not Met|1|||
19369748|NCT02769481|41610176|FG001|Overall Study|Entry Criteria Not Met|2|||
19369749|NCT02769481|41610175|FG000|Overall Study|Withdrawal by Subject|14|||
19369750|NCT02769481|41610176|FG001|Overall Study|Withdrawal by Subject|16|||
19369751|NCT02769481|41610175|FG000|Overall Study|Lost to Follow-up|9|||
19369752|NCT02769481|41610176|FG001|Overall Study|Lost to Follow-up|9|||
19369753|NCT02769481|41610175|FG000|Overall Study|Physician Decision|0|||
19369754|NCT02769481|41610176|FG001|Overall Study|Physician Decision|1|||
19369755|NCT02769481|41610175|FG000|Overall Study|Terminated by Sponsor|1|||
19369756|NCT02769481|41610176|FG001|Overall Study|Terminated by Sponsor|0|||
19369757|NCT02769481|41610175|FG000|Overall Study|Death|0|||
19369758|NCT02769481|41610176|FG001|Overall Study|Death|1|||
19369759|NCT02769481|41610175|FG000|Overall Study|Undefined|4|||
19369760|NCT02769481|41610176|FG001|Overall Study|Undefined|1|||
19369761|NCT02769247|41610186|FG000|Overall Study|Withdrawal by Subject|1|||
19369762|NCT02769247|41610187|FG001|Overall Study|Withdrawal by Subject|0|||
19369763|NCT02769247|41610188|FG002|Overall Study|Withdrawal by Subject|0|||
19369764|NCT02769247|41610189|FG003|Overall Study|Withdrawal by Subject|1|||
19369765|NCT02769247|41610186|FG000|Overall Study|Protocol Violation|0|||
19369766|NCT02769247|41610187|FG001|Overall Study|Protocol Violation|0|||
19369767|NCT02769247|41610188|FG002|Overall Study|Protocol Violation|1|||
19369768|NCT02769247|41610189|FG003|Overall Study|Protocol Violation|0|||
19369769|NCT02769247|41610186|FG000|Overall Study|Physician Decision|1|||
19369770|NCT02769247|41610187|FG001|Overall Study|Physician Decision|0|||
19369771|NCT02769247|41610188|FG002|Overall Study|Physician Decision|0|||
19369772|NCT02769247|41610189|FG003|Overall Study|Physician Decision|0|||
19369773|NCT02773537|41610206|FG000|Overall Study|Lost to Follow-up|0|||
19369774|NCT02773537|41610207|FG001|Overall Study|Lost to Follow-up|1|||
19369775|NCT02773537|41610208|FG002|Overall Study|Lost to Follow-up|4|||
19369776|NCT02780713|41610216|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
19369777|NCT02780713|41610217|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
19369778|NCT02780713|41610218|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
19369779|NCT02780713|41610219|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
19369780|NCT02780713|41610220|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
19369781|NCT02767765|41610239|FG000|Overall Study|Adverse Event|4|||
19369782|NCT02767765|41610239|FG000|Overall Study|Death|1|||
19369783|NCT02767765|41610239|FG000|Overall Study|Insufficient response|1|||
19369784|NCT02767765|41610239|FG000|Overall Study|Lost to Follow-up|2|||
19369785|NCT02767765|41610239|FG000|Overall Study|Investigator decision|1|||
19369786|NCT02767765|41610239|FG000|Overall Study|Non-Compliance|1|||
19369787|NCT02767765|41610239|FG000|Overall Study|Withdrawal by Subject|1|||
19369788|NCT02772757|41610246|FG000|Overall Study|Withdrawal by Subject|1|||
19369789|NCT02772757|41610247|FG001|Overall Study|Withdrawal by Subject|0|||
19369790|NCT02772757|41610248|FG002|Overall Study|Withdrawal by Subject|1|||
19369791|NCT02772757|41610246|FG000|Overall Study|Protocol Violation|0|||
19369792|NCT02772757|41610247|FG001|Overall Study|Protocol Violation|0|||
19369793|NCT02772757|41610248|FG002|Overall Study|Protocol Violation|1|||
19369794|NCT02772757|41610246|FG000|Overall Study|Physician Decision|0|||
19369795|NCT02772757|41610247|FG001|Overall Study|Physician Decision|3|||
19369796|NCT02772757|41610248|FG002|Overall Study|Physician Decision|3|||
19369797|NCT00103207|41610257|FG000|Overall Study|Adverse Event|3|||
19369798|NCT00103207|41610257|FG000|Overall Study|Death|1|||
19369799|NCT00103207|41610257|FG000|Overall Study|Withdrawal by Subject|2|||
19369800|NCT00103207|41610257|FG000|Overall Study|Other complicating disease|1|||
19369801|NCT00103207|41610257|FG000|Overall Study|Ineligible|4|||
19369802|NCT00103207|41610257|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
19369803|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
19369804|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
19369805|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
19369806|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
19369807|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
19369808|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
19369809|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
19369810|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
19369811|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
19369812|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
19369813|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
19369814|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
19369815|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
19369816|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
19389408|NCT02030002|41633014|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
19369817|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
19369818|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
19369819|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
19369820|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
19369821|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369822|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
19369823|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
19369824|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369825|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369826|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
19369827|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369828|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369829|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
19369830|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
19369831|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
19369832|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
19369833|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
19369834|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
19369835|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
19369836|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
19369837|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
19369838|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
19369839|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
19369840|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
19369841|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
19369842|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
19369843|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
19369844|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
19369845|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
19369846|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
19369847|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
19369848|NCT01369355|41610269|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
19369849|NCT01369355|41610270|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
19369850|NCT01369355|41610271|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
19369851|NCT01369355|41610272|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
19369852|NCT01369355|41610273|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
19369853|NCT01369355|41610274|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
19369854|NCT01369355|41610275|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
19369855|NCT01369355|41610276|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
19369856|NCT01369355|41610277|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
19369857|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369858|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369859|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369860|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369861|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369862|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
19369863|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
19369864|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
19369865|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
19369866|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Death|0|||
19369867|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Death|0|||
19369868|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Death|0|||
19369869|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Death|0|||
19369870|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Death|0|||
19369871|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Death|0|||
19369872|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Death|0|||
19369873|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Death|1|||
19369874|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Death|3|||
19369875|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369876|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369877|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369878|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369879|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369880|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
19369881|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
19369882|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
19369883|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
19369884|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369885|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369886|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369887|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369888|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19698791|NCT00296504|42143589|FG000|Final Analysis|Tuberculosis|0|||
19698792|NCT00296504|42143590|FG001|Final Analysis|Tuberculosis|0|||
19698793|NCT00296504|42143591|FG002|Final Analysis|Tuberculosis|0|||
19698794|NCT00296504|42143592|FG003|Final Analysis|Tuberculosis|0|||
19698795|NCT00296504|42143593|FG004|Final Analysis|Tuberculosis|0|||
19369889|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369890|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
19369891|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
19369892|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
19698796|NCT00296504|42143594|FG005|Final Analysis|Tuberculosis|0|||
19369893|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369894|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369895|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369896|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369897|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369898|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
19369899|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
19369900|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
19369901|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
19369902|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369903|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369904|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369905|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369906|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369907|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
19369908|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
19608432|NCT00988637|42057352|FG001|Overall Study|Lost to Follow-up|1|||
19608433|NCT00988637|42057351|FG000|Overall Study|Withdrawal by Subject|1|||
19608434|NCT00988637|42057352|FG001|Overall Study|Withdrawal by Subject|1|||
19608435|NCT00988637|42057351|FG000|Overall Study|non-compliance with study drug|0|||
19608436|NCT00988637|42057352|FG001|Overall Study|non-compliance with study drug|1|||
19608437|NCT00923702|42057363|FG000|Overall Study|Ongoing enrollment|0|||
19608438|NCT00923702|42057364|FG001|Overall Study|Ongoing enrollment|0|||
19608439|NCT00923702|42057365|FG002|Overall Study|Ongoing enrollment|0|||
19608440|NCT00923702|42057366|FG003|Overall Study|Ongoing enrollment|0|||
19608441|NCT00923702|42057367|FG004|Overall Study|Ongoing enrollment|354|||
19608442|NCT00923156|42057382|FG000|Overall Study|Adverse Event|0|||
19608443|NCT00923156|42057383|FG001|Overall Study|Adverse Event|2|||
19608444|NCT00923156|42057384|FG002|Overall Study|Adverse Event|1|||
19608445|NCT00923156|42057382|FG000|Overall Study|Abnormal laboratory values|0|||
19608446|NCT00923156|42057383|FG001|Overall Study|Abnormal laboratory values|0|||
19608447|NCT00923156|42057384|FG002|Overall Study|Abnormal laboratory values|1|||
19608448|NCT00923156|42057382|FG000|Overall Study|Withdrawal by Subject|0|||
19608449|NCT00923156|42057383|FG001|Overall Study|Withdrawal by Subject|1|||
19608450|NCT00923156|42057384|FG002|Overall Study|Withdrawal by Subject|0|||
19698797|NCT00296504|42143595|FG006|Final Analysis|Tuberculosis|0|||
19698798|NCT00296504|42143596|FG007|Final Analysis|Tuberculosis|0|||
19698799|NCT00296504|42143597|FG008|Final Analysis|Tuberculosis|1|||
19698800|NCT00296504|42143589|FG000|Final Analysis|Participant Moved to Another Country|0|||
19698801|NCT00296504|42143590|FG001|Final Analysis|Participant Moved to Another Country|0|||
19698802|NCT00296504|42143591|FG002|Final Analysis|Participant Moved to Another Country|0|||
19698803|NCT00296504|42143592|FG003|Final Analysis|Participant Moved to Another Country|0|||
19698804|NCT00296504|42143593|FG004|Final Analysis|Participant Moved to Another Country|0|||
19698805|NCT00296504|42143594|FG005|Final Analysis|Participant Moved to Another Country|0|||
19698806|NCT00296504|42143595|FG006|Final Analysis|Participant Moved to Another Country|0|||
19698807|NCT00296504|42143596|FG007|Final Analysis|Participant Moved to Another Country|0|||
19799198|NCT02901431|42257308|FG011|PK Part|Withdrawal by Subject|0|||
19799199|NCT02901431|42257309|FG012|PK Part|Withdrawal by Subject|0|||
19799200|NCT02901431|42257297|FG000|Main Treatment Part|Adverse Event|0|||
19799201|NCT02901431|42257298|FG001|Main Treatment Part|Adverse Event|0|||
19799202|NCT02901431|42257299|FG002|Main Treatment Part|Adverse Event|0|||
19799203|NCT02901431|42257300|FG003|Main Treatment Part|Adverse Event|3|||
19799204|NCT02901431|42257301|FG004|Main Treatment Part|Adverse Event|3|||
19799205|NCT02901431|42257302|FG005|Main Treatment Part|Adverse Event|4|||
19369909|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
19369910|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
19369911|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19369912|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19369913|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19369914|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19369915|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19369916|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
19389409|NCT02030002|41633014|FG000|Follow-up|Lost to Follow-up|2|||
19608451|NCT00923156|42057382|FG000|Overall Study|Death|0|||
19608452|NCT00923156|42057383|FG001|Overall Study|Death|1|||
19608453|NCT00923156|42057384|FG002|Overall Study|Death|0|||
19608454|NCT00923156|42057382|FG000|Overall Study|Lack of Efficacy|0|||
19608455|NCT00923156|42057383|FG001|Overall Study|Lack of Efficacy|0|||
19608456|NCT00923156|42057384|FG002|Overall Study|Lack of Efficacy|1|||
19608457|NCT00874731|42057392|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
19698808|NCT00296504|42143597|FG008|Final Analysis|Participant Moved to Another Country|1|||
19799206|NCT02901431|42257303|FG006|Main Treatment Part|Adverse Event|1|||
19369917|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
19369918|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
19369919|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
19369920|NCT01369355|41610269|FG000|Long-term Extension (Week 44-272)|Other|0|||
19369921|NCT01369355|41610270|FG001|Long-term Extension (Week 44-272)|Other|0|||
19369922|NCT01369355|41610271|FG002|Long-term Extension (Week 44-272)|Other|0|||
19369923|NCT01369355|41610272|FG003|Long-term Extension (Week 44-272)|Other|0|||
19698809|NCT00296504|42143589|FG000|Final Analysis|Poor Adherence|0|||
19369924|NCT01369355|41610273|FG004|Long-term Extension (Week 44-272)|Other|0|||
19369925|NCT01369355|41610274|FG005|Long-term Extension (Week 44-272)|Other|0|||
19369926|NCT01369355|41610275|FG006|Long-term Extension (Week 44-272)|Other|110|||
19369927|NCT01369355|41610276|FG007|Long-term Extension (Week 44-272)|Other|9|||
19369928|NCT01369355|41610277|FG008|Long-term Extension (Week 44-272)|Other|17|||
19369929|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Adverse Event|8|||
19369930|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Adverse Event|5|||
19369931|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Adverse Event|9|||
19369932|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Adverse Event|0|||
19369933|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Adverse Event|0|||
19369934|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Adverse Event|0|||
19369935|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
19369936|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
19369937|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
19369938|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
19369939|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
19369940|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
19369941|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
19369942|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
19369943|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
19369944|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
19369945|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
19369946|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
19369947|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Physician Decision|4|||
19369948|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Physician Decision|0|||
19369949|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Physician Decision|2|||
19369950|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Physician Decision|0|||
19369951|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Physician Decision|0|||
19369952|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Physician Decision|0|||
19369953|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Pregnancy|1|||
19369954|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Pregnancy|2|||
19369955|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Pregnancy|0|||
19369956|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Pregnancy|0|||
19369957|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Pregnancy|0|||
19369958|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Pregnancy|0|||
19369959|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
19369960|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
19369961|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
19369962|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
19369963|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
19369964|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
19369965|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
19369966|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
19369967|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
19369968|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
19369969|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
19369970|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
19369971|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
19369972|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
19369973|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
19369974|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
19369975|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
19369976|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
19369977|NCT02614196|41610300|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
19369978|NCT02614196|41610301|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
19369979|NCT02614196|41610302|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
19369980|NCT02614196|41610303|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
19369981|NCT02614196|41610304|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
19369982|NCT02614196|41610305|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
19369983|NCT02614196|41610300|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
19369984|NCT02614196|41610301|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
19369985|NCT02614196|41610302|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
19369986|NCT02614196|41610303|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
19369987|NCT02614196|41610304|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
19369988|NCT02614196|41610305|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
19369989|NCT02614196|41610300|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
19369990|NCT02614196|41610301|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
19369991|NCT02614196|41610302|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
19369992|NCT02614196|41610303|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
19369993|NCT02614196|41610304|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
19369994|NCT02614196|41610305|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
19369995|NCT02614196|41610300|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
19369996|NCT02614196|41610301|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
19369997|NCT02614196|41610302|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
19369998|NCT02614196|41610303|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
19369999|NCT02614196|41610304|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
19370000|NCT02614196|41610305|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
19370001|NCT02614196|41610300|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
19370002|NCT02614196|41610301|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
19370003|NCT02614196|41610302|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
19370004|NCT02614196|41610303|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
19370005|NCT02614196|41610304|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
19370006|NCT02614196|41610305|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
19370007|NCT02765035|41610335|FG000|First Intervention (90 Days)|Adverse Event|1|||
19370008|NCT02765035|41610336|FG001|First Intervention (90 Days)|Adverse Event|1|||
19370009|NCT02765035|41610335|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
19370010|NCT02765035|41610336|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
19370011|NCT02307682|41610346|FG000|Overall Study|Adverse Event|9|||
19370012|NCT02307682|41610347|FG001|Overall Study|Adverse Event|8|||
19370013|NCT02307682|41610348|FG002|Overall Study|Adverse Event|12|||
19370014|NCT02307682|41610346|FG000|Overall Study|Lack of Efficacy|1|||
19370015|NCT02307682|41610347|FG001|Overall Study|Lack of Efficacy|0|||
19370016|NCT02307682|41610348|FG002|Overall Study|Lack of Efficacy|1|||
19370017|NCT02307682|41610346|FG000|Overall Study|Physician Decision|2|||
19370018|NCT02307682|41610347|FG001|Overall Study|Physician Decision|2|||
19370019|NCT02307682|41610348|FG002|Overall Study|Physician Decision|8|||
19370020|NCT02307682|41610346|FG000|Overall Study|Progressive Disease|1|||
19370021|NCT02307682|41610347|FG001|Overall Study|Progressive Disease|0|||
19370022|NCT02307682|41610348|FG002|Overall Study|Progressive Disease|0|||
19370023|NCT02307682|41610346|FG000|Overall Study|Withdrawal by Subject|26|||
19370024|NCT02307682|41610347|FG001|Overall Study|Withdrawal by Subject|34|||
19370025|NCT02307682|41610348|FG002|Overall Study|Withdrawal by Subject|23|||
19370026|NCT02307682|41610346|FG000|Overall Study|Death|9|||
19370027|NCT02307682|41610347|FG001|Overall Study|Death|7|||
19370028|NCT02307682|41610348|FG002|Overall Study|Death|12|||
19370029|NCT02307682|41610346|FG000|Overall Study|Lost to Follow-up|1|||
19370030|NCT02307682|41610347|FG001|Overall Study|Lost to Follow-up|5|||
19370031|NCT02307682|41610348|FG002|Overall Study|Lost to Follow-up|6|||
19370032|NCT02307682|41610346|FG000|Overall Study|Protocol Deviation|0|||
19370033|NCT02307682|41610347|FG001|Overall Study|Protocol Deviation|0|||
19370034|NCT02307682|41610348|FG002|Overall Study|Protocol Deviation|2|||
19370035|NCT02307682|41610346|FG000|Overall Study|Other|1|||
19370036|NCT02307682|41610347|FG001|Overall Study|Other|1|||
19370037|NCT02307682|41610348|FG002|Overall Study|Other|0|||
19370038|NCT02615990|41610358|FG000|Overall Study|study terminated|1|||
19370039|NCT02615990|41610359|FG001|Overall Study|study terminated|1|||
19370040|NCT02613884|41610365|FG000|Overall Study|Death|1|||
19370041|NCT02613884|41610365|FG000|Overall Study|Lost to Follow-up|1|||
19370042|NCT02791763|41610373|FG000|Overall Study|Protocol Violation|0|||
19370043|NCT02791763|41610374|FG001|Overall Study|Protocol Violation|0|||
19370044|NCT02791763|41610375|FG002|Overall Study|Protocol Violation|1|||
19370045|NCT02791763|41610373|FG000|Overall Study|Withdrawal by Subject|5|||
19370046|NCT02791763|41610374|FG001|Overall Study|Withdrawal by Subject|1|||
19370047|NCT02791763|41610375|FG002|Overall Study|Withdrawal by Subject|0|||
19370048|NCT02791763|41610373|FG000|Overall Study|Physician Decision|0|||
19370049|NCT02791763|41610374|FG001|Overall Study|Physician Decision|1|||
19370050|NCT02791763|41610375|FG002|Overall Study|Physician Decision|0|||
19370051|NCT02791763|41610373|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
19370052|NCT02791763|41610374|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
19370053|NCT02791763|41610375|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
19370054|NCT02791763|41610373|FG000|Overall Study|Cancer event|1|||
19370055|NCT02791763|41610374|FG001|Overall Study|Cancer event|3|||
19370056|NCT02791763|41610375|FG002|Overall Study|Cancer event|0|||
19370057|NCT02791763|41610373|FG000|Overall Study|Participant had renal transplant|3|||
19370058|NCT02791763|41610374|FG001|Overall Study|Participant had renal transplant|0|||
19370059|NCT02791763|41610375|FG002|Overall Study|Participant had renal transplant|0|||
19370060|NCT02791763|41610373|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
19370061|NCT02791763|41610374|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
19370062|NCT02791763|41610375|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
19370063|NCT02791763|41610373|FG000|Overall Study|Adverse Event|12|||
19370064|NCT02791763|41610374|FG001|Overall Study|Adverse Event|13|||
19370065|NCT02791763|41610375|FG002|Overall Study|Adverse Event|7|||
19370066|NCT02613572|41610395|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
19370067|NCT02613572|41610396|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
19370068|NCT02613572|41610397|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
19370069|NCT02613572|41610395|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
19370070|NCT02613572|41610396|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
19370071|NCT02613572|41610397|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
19370072|NCT02087189|41610409|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
19370073|NCT02341456|41610416|FG000|Overall Study|Disease progression|2|||
19370074|NCT02341456|41610417|FG001|Overall Study|Disease progression|3|||
19370075|NCT02341456|41610418|FG002|Overall Study|Disease progression|1|||
19370076|NCT02341456|41610416|FG000|Overall Study|Death|1|||
19370077|NCT02341456|41610417|FG001|Overall Study|Death|1|||
19370078|NCT02341456|41610418|FG002|Overall Study|Death|1|||
19370079|NCT02341456|41610416|FG000|Overall Study|Withdrawal by Subject|0|||
19370080|NCT02341456|41610417|FG001|Overall Study|Withdrawal by Subject|1|||
19370081|NCT02341456|41610418|FG002|Overall Study|Withdrawal by Subject|1|||
19370082|NCT02341456|41610416|FG000|Overall Study|Moved to local access programme.|0|||
19370083|NCT02341456|41610417|FG001|Overall Study|Moved to local access programme.|1|||
19370084|NCT02341456|41610418|FG002|Overall Study|Moved to local access programme.|1|||
19370085|NCT02341456|41610416|FG000|Overall Study|Physician Decision|1|||
19370086|NCT02341456|41610417|FG001|Overall Study|Physician Decision|0|||
19370087|NCT02341456|41610418|FG002|Overall Study|Physician Decision|0|||
19370088|NCT02370784|41610428|FG000|Overall Study|Patient started prohibited medication|0|||
19370089|NCT02370784|41610429|FG001|Overall Study|Patient started prohibited medication|1|||
19370090|NCT02307370|41610437|FG000|Overall Study|Death|5|||
19370091|NCT02307370|41610437|FG000|Overall Study|Lost to Follow-up|1|||
19370092|NCT02307370|41610437|FG000|Overall Study|Withdrawal by Subject|1|||
19370093|NCT02307370|41610437|FG000|Overall Study|Declined Addendum ICF|6|||
19370094|NCT02307370|41610437|FG000|Overall Study|No response during telephone contact|5|||
19370095|NCT02307370|41610437|FG000|Overall Study|Protocol Violation|1|||
19370096|NCT02370394|41610445|FG000|Overall Study|Lost to Follow-up|2|||
19370097|NCT02370394|41610446|FG001|Overall Study|Lost to Follow-up|1|||
19370098|NCT02370394|41610445|FG000|Overall Study|Withdrawal by Subject|0|||
19370099|NCT02370394|41610446|FG001|Overall Study|Withdrawal by Subject|1|||
19370100|NCT01595438|41610455|FG000|Overall Study|Lost to Follow-up|20|||
19370101|NCT01595438|41610456|FG001|Overall Study|Lost to Follow-up|20|||
19370102|NCT01595438|41610455|FG000|Overall Study|Withdrawal by Subject|12|||
19370103|NCT01595438|41610456|FG001|Overall Study|Withdrawal by Subject|12|||
19370104|NCT01595438|41610455|FG000|Overall Study|Other Eligibility criteria|11|||
19370105|NCT01595438|41610456|FG001|Overall Study|Other Eligibility criteria|9|||
19370106|NCT02340520|41610462|FG000|Overall Study|Lost to Follow-up|1|||
19370107|NCT02340520|41610462|FG000|Overall Study|Patient did not take drug as specified|1|||
19370108|NCT02340520|41610462|FG000|Overall Study|Withdrawal by Subject|1|||
19370109|NCT02339584|41610468|FG000|Overall Study|Adverse Event|11|||
19370110|NCT02339584|41610469|FG001|Overall Study|Adverse Event|7|||
19370111|NCT02339584|41610468|FG000|Overall Study|Lack of Efficacy|0|||
19370112|NCT02339584|41610469|FG001|Overall Study|Lack of Efficacy|1|||
19370113|NCT02339584|41610468|FG000|Overall Study|Physician Decision|1|||
19370114|NCT02339584|41610469|FG001|Overall Study|Physician Decision|2|||
19370115|NCT02339584|41610468|FG000|Overall Study|Protocol Violation|1|||
19370116|NCT02339584|41610469|FG001|Overall Study|Protocol Violation|1|||
19370117|NCT02339584|41610468|FG000|Overall Study|Withdrawal by Subject|2|||
19370118|NCT02339584|41610469|FG001|Overall Study|Withdrawal by Subject|4|||
19370119|NCT02339506|41610475|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
19370120|NCT02339506|41610476|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
19370121|NCT02339506|41610475|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
19370122|NCT02339506|41610476|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
19370123|NCT02305888|41610485|FG000|Overall Study|Lost to Follow-up|0|||
19370124|NCT02305888|41610486|FG001|Overall Study|Lost to Follow-up|0|||
19370125|NCT02305888|41610487|FG002|Overall Study|Lost to Follow-up|1|||
19370126|NCT02305888|41610485|FG000|Overall Study|Adverse Event|0|||
19370127|NCT02305888|41610486|FG001|Overall Study|Adverse Event|1|||
19370128|NCT02305888|41610487|FG002|Overall Study|Adverse Event|0|||
19370129|NCT02338882|41610497|FG000|Overall Study|Death|1|||
19370130|NCT02338882|41610498|FG001|Overall Study|Death|0|||
19370131|NCT02338882|41610497|FG000|Overall Study|Lost to Follow-up|6|||
19370132|NCT02338882|41610498|FG001|Overall Study|Lost to Follow-up|3|||
19370133|NCT01594970|41610510|FG000|Overall Study|Non-Adverse Event Related|4|||
19370134|NCT01594970|41610511|FG001|Overall Study|Non-Adverse Event Related|5|||
19370135|NCT01594970|41610512|FG002|Overall Study|Non-Adverse Event Related|6|||
19389410|NCT02079610|41633022|FG000|Overall Study|Withdrawal by Subject|1|||
19370136|NCT01594970|41610510|FG000|Overall Study|Adverse Event|17|||
19370137|NCT01594970|41610511|FG001|Overall Study|Adverse Event|23|||
19370138|NCT01594970|41610512|FG002|Overall Study|Adverse Event|23|||
19370139|NCT01594970|41610510|FG000|Overall Study|Lost to Follow-up|54|||
19370140|NCT01594970|41610511|FG001|Overall Study|Lost to Follow-up|54|||
19370141|NCT01594970|41610512|FG002|Overall Study|Lost to Follow-up|37|||
19370142|NCT02338492|41610520|FG000|Overall Study|Death|32|||
19370143|NCT02338492|41610520|FG000|Overall Study|Adverse Event|3|||
19370144|NCT02338492|41610520|FG000|Overall Study|Lost to Follow-up|4|||
19370145|NCT02338492|41610520|FG000|Overall Study|Reason not captured above|6|||
19370146|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
19370147|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
19370148|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
19370149|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
19370150|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
19370151|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
19370152|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
19370153|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
19370154|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
19370155|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
19370156|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
19370157|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
19370158|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
19370159|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
19370160|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
19370161|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
19370162|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
19370163|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
19370164|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
19370165|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
19370166|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
19370167|NCT02337946|41610524|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
19370168|NCT02337946|41610525|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
19370169|NCT02337946|41610526|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
19370170|NCT02337946|41610524|FG000|In-between Period|Without Informed Consent|1|||
19370171|NCT02337946|41610525|FG001|In-between Period|Without Informed Consent|0|||
19370172|NCT02337946|41610526|FG002|In-between Period|Without Informed Consent|0|||
19370173|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
19370174|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
19370175|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
19370176|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
19370177|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
19370178|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
19370179|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
19370180|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
19370181|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
19370182|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
19370183|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
19370184|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
19370185|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
19370186|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
19370187|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
19370188|NCT02337946|41610524|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
19370189|NCT02337946|41610525|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
19370190|NCT02337946|41610526|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
19370191|NCT01369199|41610532|FG000|Overall Study|Withdrawal by Subject|1|||
19370192|NCT01369199|41610532|FG000|Overall Study|Lost to Follow-up|2|||
19370193|NCT01368965|41610536|FG000|Overall Study|Lost to Follow-up|12|||
19370194|NCT02610140|41610544|FG000|Randomization and Treatment Period|Radiological progression|23|||
19370195|NCT02610140|41610545|FG001|Randomization and Treatment Period|Radiological progression|15|||
19370196|NCT02610140|41610544|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
19370197|NCT02610140|41610545|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
19370198|NCT02610140|41610544|FG000|Randomization and Treatment Period|Protocol Violation|1|||
19370199|NCT02610140|41610545|FG001|Randomization and Treatment Period|Protocol Violation|0|||
19370200|NCT02610140|41610544|FG000|Randomization and Treatment Period|Physician Decision|0|||
19370201|NCT02610140|41610545|FG001|Randomization and Treatment Period|Physician Decision|1|||
19370202|NCT02610140|41610544|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
19370203|NCT02610140|41610545|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
19608458|NCT00874731|42057393|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
19608459|NCT00874731|42057394|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
19370204|NCT02610140|41610544|FG000|Randomization and Treatment Period|Death|7|||
19370205|NCT02610140|41610545|FG001|Randomization and Treatment Period|Death|1|||
19370206|NCT02610140|41610544|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
19370207|NCT02610140|41610545|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
19370208|NCT02610140|41610544|FG000|Randomization and Treatment Period|Adverse Event|44|||
19370209|NCT02610140|41610545|FG001|Randomization and Treatment Period|Adverse Event|13|||
19370210|NCT02610140|41610544|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
19370211|NCT02610140|41610545|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
19370212|NCT02610140|41610544|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
19370213|NCT02610140|41610545|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
19370214|NCT02610140|41610544|FG000|Randomization and Treatment Period|Not treated|3|||
19370215|NCT02610140|41610545|FG001|Randomization and Treatment Period|Not treated|10|||
19370216|NCT02610140|41610544|FG000|Safety Follow-up|Other|0|||
19370217|NCT02610140|41610545|FG001|Safety Follow-up|Other|2|||
19370218|NCT02610140|41610544|FG000|Safety Follow-up|Lost to Follow-up|1|||
19370219|NCT02610140|41610545|FG001|Safety Follow-up|Lost to Follow-up|0|||
19370220|NCT02610140|41610544|FG000|Safety Follow-up|No follow-up|5|||
19370221|NCT02610140|41610545|FG001|Safety Follow-up|No follow-up|3|||
19370222|NCT02610140|41610544|FG000|Safety Follow-up|Death|12|||
19370223|NCT02610140|41610545|FG001|Safety Follow-up|Death|2|||
19370224|NCT02610140|41610544|FG000|Safety Follow-up|Deterioration of general conditions|15|||
19370225|NCT02610140|41610545|FG001|Safety Follow-up|Deterioration of general conditions|5|||
19370226|NCT02610140|41610544|FG000|Safety Follow-up|Withdrawal by Subject|12|||
19370227|NCT02610140|41610545|FG001|Safety Follow-up|Withdrawal by Subject|12|||
19370228|NCT02610140|41610544|FG000|Active Follow-up|Progressive disease - radiological|30|||
19370229|NCT02610140|41610545|FG001|Active Follow-up|Progressive disease - radiological|22|||
19370230|NCT02610140|41610544|FG000|Active Follow-up|Death|8|||
19370231|NCT02610140|41610545|FG001|Active Follow-up|Death|1|||
19370232|NCT02610140|41610544|FG000|Active Follow-up|Withdrawal by Subject|4|||
19370233|NCT02610140|41610545|FG001|Active Follow-up|Withdrawal by Subject|0|||
19370234|NCT02610140|41610544|FG000|Active Follow-up|Progressive disease - clinical|1|||
19370235|NCT02610140|41610545|FG001|Active Follow-up|Progressive disease - clinical|2|||
19370236|NCT02610140|41610544|FG000|Active Follow-up|Deterioration of general conditions|1|||
19370237|NCT02610140|41610545|FG001|Active Follow-up|Deterioration of general conditions|0|||
19370238|NCT02610140|41610544|FG000|Active Follow-up|Ongoing but not completed|4|||
19370239|NCT02610140|41610545|FG001|Active Follow-up|Ongoing but not completed|1|||
19370240|NCT02610140|41610544|FG000|Long-term Follow-up|Death|86|||
19370241|NCT02610140|41610545|FG001|Long-term Follow-up|Death|44|||
19370242|NCT02610140|41610544|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
19370243|NCT02610140|41610545|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
19370244|NCT02610140|41610544|FG000|Long-term Follow-up|Lost to Follow-up|1|||
19370245|NCT02610140|41610545|FG001|Long-term Follow-up|Lost to Follow-up|2|||
19370246|NCT02610140|41610544|FG000|Long-term Follow-up|Ongoing but not completed|30|||
19370247|NCT02610140|41610545|FG001|Long-term Follow-up|Ongoing but not completed|17|||
19370248|NCT02789657|41610555|FG000|Overall Study|Withdrawal by Subject|2|||
19370249|NCT02789657|41610556|FG001|Overall Study|Withdrawal by Subject|0|||
19370250|NCT02789657|41610557|FG002|Overall Study|Withdrawal by Subject|0|||
19370251|NCT02789657|41610558|FG003|Overall Study|Withdrawal by Subject|0|||
19370252|NCT02609984|41610569|FG000|Overall Study|Death|29|||
19370253|NCT02609984|41610570|FG001|Overall Study|Death|26|||
19370254|NCT02609984|41610569|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
19370255|NCT02609984|41610570|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
19370256|NCT02609984|41610569|FG000|Overall Study|Lost to Follow-up|1|||
19370257|NCT02609984|41610570|FG001|Overall Study|Lost to Follow-up|2|||
19370258|NCT02609984|41610569|FG000|Overall Study|Withdrawal by Subject|0|||
19370259|NCT02609984|41610570|FG001|Overall Study|Withdrawal by Subject|1|||
19370260|NCT02609984|41610569|FG000|Overall Study|Disease Progression|2|||
19370261|NCT02609984|41610570|FG001|Overall Study|Disease Progression|0|||
19370262|NCT02609672|41610578|FG000|Overall Study|Lost to Follow-up|3|||
19370263|NCT02609672|41610579|FG001|Overall Study|Lost to Follow-up|1|||
19370264|NCT02611778|41610587|FG000|Overall Study|Withdrawal by Subject|2|||
19370265|NCT02611778|41610588|FG001|Overall Study|Withdrawal by Subject|8|||
19370266|NCT02611778|41610587|FG000|Overall Study|Adverse Event|1|||
19370267|NCT02611778|41610588|FG001|Overall Study|Adverse Event|2|||
19370268|NCT02611778|41610587|FG000|Overall Study|Death|2|||
19370269|NCT02611778|41610588|FG001|Overall Study|Death|1|||
19370270|NCT02611778|41610587|FG000|Overall Study|Protocol Violation|1|||
19370271|NCT02611778|41610588|FG001|Overall Study|Protocol Violation|0|||
19370272|NCT02611778|41610587|FG000|Overall Study|Lost to Follow-up|3|||
19370273|NCT02611778|41610588|FG001|Overall Study|Lost to Follow-up|1|||
19370274|NCT02611778|41610587|FG000|Overall Study|Need for alternative treatment|1|||
19370275|NCT02611778|41610588|FG001|Overall Study|Need for alternative treatment|0|||
19370276|NCT02611778|41610587|FG000|Overall Study|Other Reason|2|||
19370277|NCT02611778|41610588|FG001|Overall Study|Other Reason|1|||
19370278|NCT02711553|41610599|FG000|Overall Study|Withdrawal by Subject|2|||
19370279|NCT02711553|41610600|FG001|Overall Study|Withdrawal by Subject|1|||
19370280|NCT02711553|41610601|FG002|Overall Study|Withdrawal by Subject|1|||
19370281|NCT02711553|41610602|FG003|Overall Study|Withdrawal by Subject|0|||
19370282|NCT02711553|41610599|FG000|Overall Study|Lost to Follow-up|3|||
19370283|NCT02711553|41610600|FG001|Overall Study|Lost to Follow-up|3|||
19370284|NCT02711553|41610601|FG002|Overall Study|Lost to Follow-up|6|||
19370285|NCT02711553|41610602|FG003|Overall Study|Lost to Follow-up|3|||
19370286|NCT02711553|41610599|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
19370287|NCT02711553|41610600|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
19370288|NCT02711553|41610601|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
19370289|NCT02711553|41610602|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
19370290|NCT02709369|41610614|FG000|Overall Study|Lost to Follow-up|15|||
19370291|NCT02709369|41610614|FG000|Overall Study|Withdrawal by Subject|10|||
19370292|NCT02709369|41610614|FG000|Overall Study|Did not received intervention|2|||
19370293|NCT02613182|41610618|FG000|Overall Study|Death|6|||
19370294|NCT02613182|41610618|FG000|Overall Study|Physician Decision|1|||
19370295|NCT02613182|41610618|FG000|Overall Study|Study Terminated by Sponsor|21|||
19370296|NCT02613182|41610618|FG000|Overall Study|Withdrawal by Subject|6|||
19370297|NCT02610842|41610622|FG000|Overall Study|Lost to Follow-up|5|||
19370298|NCT01648582|41610631|FG000|Overall Study|Adverse Event|6|||
19370299|NCT01648582|41610632|FG001|Overall Study|Adverse Event|11|||
19370300|NCT01648582|41610633|FG002|Overall Study|Adverse Event|2|||
19370301|NCT01648582|41610631|FG000|Overall Study|Lost to Follow-up|9|||
19370302|NCT01648582|41610632|FG001|Overall Study|Lost to Follow-up|6|||
19370303|NCT01648582|41610633|FG002|Overall Study|Lost to Follow-up|8|||
19370304|NCT01648582|41610631|FG000|Overall Study|Protocol Violation|1|||
19370305|NCT01648582|41610632|FG001|Overall Study|Protocol Violation|2|||
19370306|NCT01648582|41610633|FG002|Overall Study|Protocol Violation|1|||
19370307|NCT01648582|41610631|FG000|Overall Study|Withdrawal by Subject|15|||
19370308|NCT01648582|41610632|FG001|Overall Study|Withdrawal by Subject|17|||
19370309|NCT01648582|41610633|FG002|Overall Study|Withdrawal by Subject|17|||
19370310|NCT01648582|41610631|FG000|Overall Study|Physician Decision|0|||
19370311|NCT01648582|41610632|FG001|Overall Study|Physician Decision|1|||
19370312|NCT01648582|41610633|FG002|Overall Study|Physician Decision|3|||
19370313|NCT01648582|41610631|FG000|Overall Study|Death|1|||
19370314|NCT01648582|41610632|FG001|Overall Study|Death|0|||
19370315|NCT01648582|41610633|FG002|Overall Study|Death|0|||
19370316|NCT01648582|41610631|FG000|Overall Study|Sponsor Decision|0|||
19370317|NCT01648582|41610632|FG001|Overall Study|Sponsor Decision|1|||
19370318|NCT01648582|41610633|FG002|Overall Study|Sponsor Decision|1|||
19370319|NCT02607800|41610646|FG000|Overall Study|Lost to Follow-up|7|||
19370320|NCT02607800|41610647|FG001|Overall Study|Lost to Follow-up|10|||
19370321|NCT02607800|41610646|FG000|Overall Study|Withdrew Consent|2|||
19370322|NCT02607800|41610647|FG001|Overall Study|Withdrew Consent|0|||
19370323|NCT02607800|41610646|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
19370324|NCT02607800|41610647|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
19370325|NCT02304484|41610654|FG000|Overall Study|Death|9|||
19370326|NCT02304484|41610654|FG000|Overall Study|Withdrawal by Subject|14|||
19370327|NCT02304484|41610654|FG000|Overall Study|Lost to Follow-up|2|||
19370328|NCT02708355|41610661|FG000|Overall Study|Adverse Event|1|||
19370329|NCT02708355|41610662|FG001|Overall Study|Adverse Event|0|||
19370330|NCT02708355|41610663|FG002|Overall Study|Adverse Event|0|||
19370331|NCT02708277|41610673|FG000|Overall Study|Lost to Follow-up|7|||
19370332|NCT02708277|41610674|FG001|Overall Study|Lost to Follow-up|4|||
19370333|NCT02337478|41610680|FG000|Overall Study|Lack of Efficacy|5|||
19370334|NCT02303704|41610686|FG000|Overall Study|Protocol Violation|5|||
19370335|NCT02303704|41610687|FG001|Overall Study|Protocol Violation|9|||
19370336|NCT02608892|41610695|FG000|Overall Study|Lost to Follow-up|1|||
19370337|NCT02608892|41610696|FG001|Overall Study|Lost to Follow-up|0|||
19370338|NCT02706951|41610706|FG000|Overall Study|Adverse Event|1|||
19370339|NCT02706951|41610707|FG001|Overall Study|Adverse Event|5|||
19370340|NCT02706951|41610708|FG002|Overall Study|Adverse Event|3|||
19370341|NCT02706951|41610706|FG000|Overall Study|Withdrawal by Subject|11|||
19370342|NCT02706951|41610707|FG001|Overall Study|Withdrawal by Subject|6|||
19370343|NCT02706951|41610708|FG002|Overall Study|Withdrawal by Subject|6|||
19370344|NCT02706951|41610706|FG000|Overall Study|Lost to Follow-up|0|||
19370345|NCT02706951|41610707|FG001|Overall Study|Lost to Follow-up|4|||
19370346|NCT02706951|41610708|FG002|Overall Study|Lost to Follow-up|1|||
19370347|NCT02706951|41610706|FG000|Overall Study|Other|2|||
19370348|NCT02706951|41610707|FG001|Overall Study|Other|1|||
19370349|NCT02706951|41610708|FG002|Overall Study|Other|0|||
19370350|NCT02708121|41610718|FG000|Overall Study|Withdrawn by Study Team|1|||
19370351|NCT02708121|41610719|FG001|Overall Study|Withdrawn by Study Team|1|||
19370352|NCT02708121|41610718|FG000|Overall Study|Withdrawal by Subject|0|||
19370353|NCT02708121|41610719|FG001|Overall Study|Withdrawal by Subject|4|||
19370354|NCT02707965|41610734|FG000|Overall Study|Withdrawal by Subject|0|||
19370355|NCT02707965|41610735|FG001|Overall Study|Withdrawal by Subject|0|||
19370356|NCT02707965|41610736|FG002|Overall Study|Withdrawal by Subject|1|||
19370357|NCT02707965|41610737|FG003|Overall Study|Withdrawal by Subject|0|||
19370358|NCT02707965|41610738|FG004|Overall Study|Withdrawal by Subject|0|||
19370359|NCT02707965|41610739|FG005|Overall Study|Withdrawal by Subject|0|||
19370360|NCT02707965|41610740|FG006|Overall Study|Withdrawal by Subject|0|||
19370361|NCT02707965|41610741|FG007|Overall Study|Withdrawal by Subject|2|||
19370362|NCT02707965|41610742|FG008|Overall Study|Withdrawal by Subject|0|||
19370363|NCT02707965|41610743|FG009|Overall Study|Withdrawal by Subject|0|||
19370364|NCT02707965|41610744|FG010|Overall Study|Withdrawal by Subject|0|||
19370365|NCT02707965|41610745|FG011|Overall Study|Withdrawal by Subject|0|||
19370366|NCT02707965|41610746|FG012|Overall Study|Withdrawal by Subject|0|||
19370367|NCT02707965|41610747|FG013|Overall Study|Withdrawal by Subject|0|||
19370368|NCT02707965|41610748|FG014|Overall Study|Withdrawal by Subject|0|||
19370369|NCT02707965|41610749|FG015|Overall Study|Withdrawal by Subject|0|||
19370370|NCT02707965|41610734|FG000|Overall Study|PI decisions|0|||
19370371|NCT02707965|41610735|FG001|Overall Study|PI decisions|0|||
19370372|NCT02707965|41610736|FG002|Overall Study|PI decisions|0|||
19370373|NCT02707965|41610737|FG003|Overall Study|PI decisions|0|||
19370374|NCT02707965|41610738|FG004|Overall Study|PI decisions|0|||
19370375|NCT02707965|41610739|FG005|Overall Study|PI decisions|0|||
19370376|NCT02707965|41610740|FG006|Overall Study|PI decisions|0|||
19370377|NCT02707965|41610741|FG007|Overall Study|PI decisions|0|||
19370378|NCT02707965|41610742|FG008|Overall Study|PI decisions|0|||
19370379|NCT02707965|41610743|FG009|Overall Study|PI decisions|0|||
19370380|NCT02707965|41610744|FG010|Overall Study|PI decisions|0|||
19370381|NCT02707965|41610745|FG011|Overall Study|PI decisions|0|||
19370382|NCT02707965|41610746|FG012|Overall Study|PI decisions|0|||
19370383|NCT02707965|41610747|FG013|Overall Study|PI decisions|0|||
19370384|NCT02707965|41610748|FG014|Overall Study|PI decisions|2|||
19370385|NCT02707965|41610749|FG015|Overall Study|PI decisions|0|||
19370386|NCT02707965|41610734|FG000|Overall Study|Protocol deviation|1|||
19370387|NCT02707965|41610735|FG001|Overall Study|Protocol deviation|1|||
19370388|NCT02707965|41610736|FG002|Overall Study|Protocol deviation|0|||
19370389|NCT02707965|41610737|FG003|Overall Study|Protocol deviation|0|||
19370390|NCT02707965|41610738|FG004|Overall Study|Protocol deviation|0|||
19370391|NCT02707965|41610739|FG005|Overall Study|Protocol deviation|0|||
19370392|NCT02707965|41610740|FG006|Overall Study|Protocol deviation|0|||
19370393|NCT02707965|41610741|FG007|Overall Study|Protocol deviation|1|||
19370394|NCT02707965|41610742|FG008|Overall Study|Protocol deviation|0|||
19370395|NCT02707965|41610743|FG009|Overall Study|Protocol deviation|0|||
19370396|NCT02707965|41610744|FG010|Overall Study|Protocol deviation|0|||
19370397|NCT02707965|41610745|FG011|Overall Study|Protocol deviation|0|||
19370398|NCT02707965|41610746|FG012|Overall Study|Protocol deviation|0|||
19370399|NCT02707965|41610747|FG013|Overall Study|Protocol deviation|0|||
19370400|NCT02707965|41610748|FG014|Overall Study|Protocol deviation|0|||
19370401|NCT02707965|41610749|FG015|Overall Study|Protocol deviation|0|||
19370402|NCT01667900|41610787|FG000|Part B|Death|0|||
19370403|NCT01667900|41610788|FG001|Part B|Death|0|||
19370404|NCT01667900|41610789|FG002|Part B|Death|0|||
19370405|NCT01667900|41610790|FG003|Part B|Death|0|||
19370406|NCT01667900|41610791|FG004|Part B|Death|0|||
19370407|NCT01667900|41610792|FG005|Part B|Death|0|||
19370408|NCT01667900|41610793|FG006|Part B|Death|0|||
19370409|NCT01667900|41610794|FG007|Part B|Death|0|||
19370410|NCT01667900|41610795|FG008|Part B|Death|0|||
19370411|NCT01667900|41610796|FG009|Part B|Death|0|||
19370412|NCT01667900|41610797|FG010|Part B|Death|0|||
19370413|NCT01667900|41610798|FG011|Part B|Death|0|||
19370414|NCT01667900|41610799|FG012|Part B|Death|0|||
19370415|NCT01667900|41610800|FG013|Part B|Death|0|||
19370416|NCT01667900|41610801|FG014|Part B|Death|0|||
19370417|NCT01667900|41610802|FG015|Part B|Death|0|||
19370418|NCT01667900|41610803|FG016|Part B|Death|1|||
19370419|NCT01667900|41610804|FG017|Part B|Death|0|||
19370420|NCT01667900|41610805|FG018|Part B|Death|0|||
19370421|NCT01667900|41610806|FG019|Part B|Death|0|||
19370422|NCT02605928|41610835|FG000|Overall Study|Model tuning phase|28|||
19370423|NCT02605928|41610835|FG000|Overall Study|Lack of Efficacy|5|||
19370424|NCT02706717|41610841|FG000|Overall Study|Withdrawal by Subject|1|||
19370425|NCT02706717|41610842|FG001|Overall Study|Withdrawal by Subject|8|||
19389411|NCT02079610|41633023|FG001|Overall Study|Withdrawal by Subject|1|||
19389412|NCT02079532|41633029|FG000|Overall Study|Adverse Event|7|||
19370426|NCT02706717|41610841|FG000|Overall Study|Lost to Follow-up|0|||
19370427|NCT02706717|41610842|FG001|Overall Study|Lost to Follow-up|1|||
19370428|NCT02706717|41610841|FG000|Overall Study|Physician Decision|0|||
19370429|NCT02706717|41610842|FG001|Overall Study|Physician Decision|1|||
19370430|NCT02706717|41610841|FG000|Overall Study|Death|0|||
19370431|NCT02706717|41610842|FG001|Overall Study|Death|1|||
19370432|NCT01331837|41610850|FG000|Overall Study|Death|30|||
19370433|NCT01331837|41610851|FG001|Overall Study|Death|34|||
19370434|NCT01331837|41610850|FG000|Overall Study|Lost to Follow-up|3|||
19370435|NCT01331837|41610851|FG001|Overall Study|Lost to Follow-up|1|||
19370436|NCT01331837|41610850|FG000|Overall Study|Info not recorded|10|||
19370437|NCT01331837|41610851|FG001|Overall Study|Info not recorded|16|||
19370438|NCT01331837|41610850|FG000|Overall Study|Withdrawal by Subject|13|||
19370439|NCT01331837|41610851|FG001|Overall Study|Withdrawal by Subject|16|||
19370440|NCT02706483|41610857|FG000|Overall Study|Adverse Event|97|||
19370441|NCT02706483|41610857|FG000|Overall Study|Death|1|||
19370442|NCT02706483|41610857|FG000|Overall Study|Lack of Efficacy|39|||
19370443|NCT02706483|41610857|FG000|Overall Study|Lost to Follow-up|101|||
19370444|NCT02706483|41610857|FG000|Overall Study|Non-compliance with study drug|15|||
19370445|NCT02706483|41610857|FG000|Overall Study|Physician Decision|6|||
19370446|NCT02706483|41610857|FG000|Overall Study|Pregnancy|6|||
19370447|NCT02706483|41610857|FG000|Overall Study|Protocol Violation|18|||
19370448|NCT02706483|41610857|FG000|Overall Study|Withdrawal by Subject|136|||
19370449|NCT02706483|41610857|FG000|Overall Study|Non-compliance with visits|6|||
19370450|NCT02706483|41610857|FG000|Overall Study|Site closure|4|||
19370451|NCT02706483|41610857|FG000|Overall Study|Subject moved|1|||
19370452|NCT01648348|41610864|FG000|Overall Study|Cancel|1|||
19370453|NCT01648348|41610865|FG001|Overall Study|Cancel|0|||
19370454|NCT01648348|41610866|FG002|Overall Study|Cancel|0|||
19370455|NCT01648348|41610867|FG003|Overall Study|Cancel|0|||
19370456|NCT01648348|41610868|FG004|Overall Study|Cancel|3|||
19370457|NCT01648348|41610869|FG005|Overall Study|Cancel|6|||
19370458|NCT01648348|41610864|FG000|Overall Study|Replaced for MTD analysis|1|||
19370459|NCT01648348|41610865|FG001|Overall Study|Replaced for MTD analysis|0|||
19370460|NCT01648348|41610866|FG002|Overall Study|Replaced for MTD analysis|1|||
19370461|NCT01648348|41610867|FG003|Overall Study|Replaced for MTD analysis|0|||
19370462|NCT01648348|41610868|FG004|Overall Study|Replaced for MTD analysis|0|||
19370463|NCT01648348|41610869|FG005|Overall Study|Replaced for MTD analysis|0|||
19370464|NCT01648270|41610882|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
19370465|NCT02302846|41610892|FG000|Overall Study|Withdrawal by Subject|1|||
19370466|NCT02336230|41610896|FG000|Overall Study|Adverse Event|1|||
19370467|NCT02336230|41610896|FG000|Overall Study|Withdrawal of consent|1|||
19370468|NCT02336230|41610896|FG000|Overall Study|Death|9|||
19370469|NCT02336230|41610896|FG000|Overall Study|Dose not received due to shipping delay|1|||
19370470|NCT02336230|41610896|FG000|Overall Study|Discontinuation of MSC infusion|1|||
19370471|NCT02302222|41610902|FG000|Overall Study|Physician Decision|0|||
19370472|NCT02302222|41610903|FG001|Overall Study|Physician Decision|4|||
19370473|NCT02302222|41610902|FG000|Overall Study|Lost to Follow-up|1|||
19370474|NCT02302222|41610903|FG001|Overall Study|Lost to Follow-up|0|||
19370475|NCT02302222|41610902|FG000|Overall Study|Treatment discontinued before day 5|0|||
19370476|NCT02302222|41610903|FG001|Overall Study|Treatment discontinued before day 5|1|||
19370477|NCT02302222|41610902|FG000|Overall Study|Withdrawn prior to any treatment|0|||
19370478|NCT02302222|41610903|FG001|Overall Study|Withdrawn prior to any treatment|1|||
19370479|NCT02336074|41610911|FG000|Overall Study|Adverse Event|0|||
19370480|NCT02336074|41610912|FG001|Overall Study|Adverse Event|2|||
19370481|NCT02335450|41610923|FG000|Overall Study|Pregnancy|1|||
19370482|NCT02603432|41610935|FG000|Overall Study|Ongoing|184|||
19370483|NCT02603432|41610936|FG001|Overall Study|Ongoing|144|||
19370484|NCT02603432|41610935|FG000|Overall Study|Adverse Event|1|||
19370485|NCT02603432|41610936|FG001|Overall Study|Adverse Event|0|||
19370486|NCT02603432|41610935|FG000|Overall Study|Death|144|||
19370487|NCT02603432|41610936|FG001|Overall Study|Death|177|||
19370488|NCT02603432|41610935|FG000|Overall Study|Lost to Follow-up|4|||
19370489|NCT02603432|41610936|FG001|Overall Study|Lost to Follow-up|6|||
19370490|NCT02603432|41610935|FG000|Overall Study|Progressive Disease|5|||
19370491|NCT02603432|41610936|FG001|Overall Study|Progressive Disease|5|||
19370492|NCT02603432|41610935|FG000|Overall Study|Withdrawal by Subject|9|||
19370493|NCT02603432|41610936|FG001|Overall Study|Withdrawal by Subject|17|||
19370494|NCT02603432|41610935|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
19370495|NCT02603432|41610936|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19370496|NCT02603432|41610935|FG000|Overall Study|Other|0|||
19370497|NCT02603432|41610936|FG001|Overall Study|Other|1|||
19370498|NCT02302066|41610946|FG000|Overall Study|Adverse Event|1|||
19370499|NCT02302066|41610947|FG001|Overall Study|Adverse Event|1|||
19370500|NCT02302066|41610948|FG002|Overall Study|Adverse Event|3|||
19370501|NCT02302066|41610949|FG003|Overall Study|Adverse Event|0|||
19370502|NCT02302066|41610946|FG000|Overall Study|Lost to Follow-up|4|||
19370503|NCT02302066|41610947|FG001|Overall Study|Lost to Follow-up|5|||
19370504|NCT02302066|41610948|FG002|Overall Study|Lost to Follow-up|24|||
19370505|NCT02302066|41610949|FG003|Overall Study|Lost to Follow-up|7|||
19370506|NCT02302066|41610946|FG000|Overall Study|Withdrawal by Subject|25|||
19370507|NCT02302066|41610947|FG001|Overall Study|Withdrawal by Subject|58|||
19370508|NCT02302066|41610948|FG002|Overall Study|Withdrawal by Subject|124|||
19370509|NCT02302066|41610949|FG003|Overall Study|Withdrawal by Subject|33|||
19370510|NCT02302066|41610946|FG000|Overall Study|Pregnancy|2|||
19370511|NCT02302066|41610947|FG001|Overall Study|Pregnancy|10|||
19370512|NCT02302066|41610948|FG002|Overall Study|Pregnancy|12|||
19370513|NCT02302066|41610949|FG003|Overall Study|Pregnancy|0|||
19370514|NCT02302066|41610946|FG000|Overall Study|Reason Not Specified|1|||
19370515|NCT02302066|41610947|FG001|Overall Study|Reason Not Specified|1|||
19370516|NCT02302066|41610948|FG002|Overall Study|Reason Not Specified|9|||
19370517|NCT02302066|41610949|FG003|Overall Study|Reason Not Specified|1|||
19370518|NCT02790437|41610971|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
19370519|NCT02790437|41610972|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
19370520|NCT02790437|41610971|FG000|Overall Study|Adverse Event|1|||
19370521|NCT02790437|41610972|FG001|Overall Study|Adverse Event|0|||
19370522|NCT02790437|41610971|FG000|Overall Study|Withdrawal by Subject|1|||
19370523|NCT02790437|41610972|FG001|Overall Study|Withdrawal by Subject|0|||
19370524|NCT02301988|41610987|FG000|Overall Study|Withdrawal by Subject|2|||
19370525|NCT02301988|41610988|FG001|Overall Study|Withdrawal by Subject|1|||
19370526|NCT02301988|41610987|FG000|Overall Study|Physician Decision|2|||
19370527|NCT02301988|41610988|FG001|Overall Study|Physician Decision|2|||
19370528|NCT02301988|41610987|FG000|Overall Study|Unknown Reason|1|||
19370529|NCT02301988|41610988|FG001|Overall Study|Unknown Reason|3|||
19370530|NCT02301988|41610987|FG000|Overall Study|Lack of Efficacy|3|||
19370531|NCT02301988|41610988|FG001|Overall Study|Lack of Efficacy|2|||
19370532|NCT02301988|41610987|FG000|Overall Study|Death|1|||
19370533|NCT02301988|41610988|FG001|Overall Study|Death|0|||
19370534|NCT02301988|41610987|FG000|Overall Study|Adverse Event|1|||
19370535|NCT02301988|41610988|FG001|Overall Study|Adverse Event|1|||
19370536|NCT02334748|41611003|FG000|Overall Study|Adverse Event|1|||
19370537|NCT02334748|41611003|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
19370538|NCT02334748|41611003|FG000|Overall Study|Patient no longer required study drug|2|||
19370539|NCT02334748|41611003|FG000|Overall Study|Lack of Efficacy|4|||
19370540|NCT02332876|41611009|FG000|Overall Study|Lost to Follow-up|1|||
19370541|NCT02332876|41611010|FG001|Overall Study|Lost to Follow-up|1|||
19370542|NCT02332798|41611019|FG000|Overall Study|Unwilling to Participate in Study|0|||
19370543|NCT02332798|41611020|FG001|Overall Study|Unwilling to Participate in Study|1|||
19370544|NCT02332798|41611021|FG002|Overall Study|Unwilling to Participate in Study|1|||
19370545|NCT02332798|41611019|FG000|Overall Study|Positive Urine Drug Test|0|||
19370546|NCT02332798|41611020|FG001|Overall Study|Positive Urine Drug Test|1|||
19370547|NCT02332798|41611021|FG002|Overall Study|Positive Urine Drug Test|0|||
19370548|NCT02332798|41611019|FG000|Overall Study|Abnormal Laboratory Findings|1|||
19370549|NCT02332798|41611020|FG001|Overall Study|Abnormal Laboratory Findings|0|||
19370550|NCT02332798|41611021|FG002|Overall Study|Abnormal Laboratory Findings|0|||
19370551|NCT02604212|41611033|FG000|Overall Study|Study Terminated by Sponsor|2|||
19370552|NCT02604212|41611034|FG001|Overall Study|Study Terminated by Sponsor|1|||
19370553|NCT02604212|41611035|FG002|Overall Study|Study Terminated by Sponsor|3|||
19370554|NCT02604212|41611036|FG003|Overall Study|Study Terminated by Sponsor|3|||
19370555|NCT02604212|41611033|FG000|Overall Study|Withdrawal by Subject|0|||
19370556|NCT02604212|41611034|FG001|Overall Study|Withdrawal by Subject|0|||
19370557|NCT02604212|41611035|FG002|Overall Study|Withdrawal by Subject|1|||
19370558|NCT02604212|41611036|FG003|Overall Study|Withdrawal by Subject|0|||
19370559|NCT02789111|41611053|FG000|Overall Study|Withdrawal by Subject|1|||
19370560|NCT02789111|41611054|FG001|Overall Study|Withdrawal by Subject|4|||
19370561|NCT01359644|41611072|FG000|Treatment Period|Lack of Efficacy|0|||
19370562|NCT01359644|41611073|FG001|Treatment Period|Lack of Efficacy|1|||
19370563|NCT01359644|41611074|FG002|Treatment Period|Lack of Efficacy|0|||
19370564|NCT01359644|41611075|FG003|Treatment Period|Lack of Efficacy|0|||
19370565|NCT01359644|41611076|FG004|Treatment Period|Lack of Efficacy|0|||
19370566|NCT01359644|41611077|FG005|Treatment Period|Lack of Efficacy|0|||
19370567|NCT01359644|41611078|FG006|Treatment Period|Lack of Efficacy|0|||
19370568|NCT01359644|41611079|FG007|Treatment Period|Lack of Efficacy|0|||
19370569|NCT01359644|41611080|FG008|Treatment Period|Lack of Efficacy|0|||
19370570|NCT01359644|41611081|FG009|Treatment Period|Lack of Efficacy|0|||
19370571|NCT01359644|41611072|FG000|Treatment Period|Adverse Event|0|||
19370572|NCT01359644|41611073|FG001|Treatment Period|Adverse Event|0|||
19370573|NCT01359644|41611074|FG002|Treatment Period|Adverse Event|1|||
19370574|NCT01359644|41611075|FG003|Treatment Period|Adverse Event|0|||
19370575|NCT01359644|41611076|FG004|Treatment Period|Adverse Event|0|||
19370576|NCT01359644|41611077|FG005|Treatment Period|Adverse Event|1|||
19370577|NCT01359644|41611078|FG006|Treatment Period|Adverse Event|0|||
19370578|NCT01359644|41611079|FG007|Treatment Period|Adverse Event|0|||
19370579|NCT01359644|41611080|FG008|Treatment Period|Adverse Event|0|||
19370580|NCT01359644|41611081|FG009|Treatment Period|Adverse Event|0|||
19370581|NCT01359644|41611072|FG000|Treatment Period|Lost to Follow-up|0|||
19370582|NCT01359644|41611073|FG001|Treatment Period|Lost to Follow-up|0|||
19370583|NCT01359644|41611074|FG002|Treatment Period|Lost to Follow-up|0|||
19370584|NCT01359644|41611075|FG003|Treatment Period|Lost to Follow-up|0|||
19370585|NCT01359644|41611076|FG004|Treatment Period|Lost to Follow-up|0|||
19389413|NCT02079532|41633029|FG000|Overall Study|Additional or changed therapy|2|||
19370586|NCT01359644|41611077|FG005|Treatment Period|Lost to Follow-up|1|||
19389414|NCT02079532|41633029|FG000|Overall Study|Lack of Efficacy|9|||
19389415|NCT02079532|41633029|FG000|Overall Study|Protocol Violation|3|||
19370587|NCT01359644|41611078|FG006|Treatment Period|Lost to Follow-up|0|||
19370588|NCT01359644|41611079|FG007|Treatment Period|Lost to Follow-up|0|||
19370589|NCT01359644|41611080|FG008|Treatment Period|Lost to Follow-up|0|||
19370590|NCT01359644|41611081|FG009|Treatment Period|Lost to Follow-up|0|||
19370591|NCT01359644|41611072|FG000|Follow-up Period|Withdrawal by Subject|0|||
19370592|NCT01359644|41611073|FG001|Follow-up Period|Withdrawal by Subject|0|||
19370593|NCT01359644|41611074|FG002|Follow-up Period|Withdrawal by Subject|0|||
19370594|NCT01359644|41611075|FG003|Follow-up Period|Withdrawal by Subject|0|||
19370595|NCT01359644|41611076|FG004|Follow-up Period|Withdrawal by Subject|0|||
19370596|NCT01359644|41611077|FG005|Follow-up Period|Withdrawal by Subject|1|||
19370597|NCT01359644|41611078|FG006|Follow-up Period|Withdrawal by Subject|0|||
19370598|NCT01359644|41611079|FG007|Follow-up Period|Withdrawal by Subject|0|||
19370599|NCT01359644|41611080|FG008|Follow-up Period|Withdrawal by Subject|0|||
19370600|NCT01359644|41611081|FG009|Follow-up Period|Withdrawal by Subject|0|||
19370601|NCT01359644|41611072|FG000|Follow-up Period|Lost to Follow-up|0|||
19370602|NCT01359644|41611073|FG001|Follow-up Period|Lost to Follow-up|0|||
19370603|NCT01359644|41611074|FG002|Follow-up Period|Lost to Follow-up|0|||
19370604|NCT01359644|41611075|FG003|Follow-up Period|Lost to Follow-up|0|||
19370605|NCT01359644|41611076|FG004|Follow-up Period|Lost to Follow-up|0|||
19370606|NCT01359644|41611077|FG005|Follow-up Period|Lost to Follow-up|0|||
19370607|NCT01359644|41611078|FG006|Follow-up Period|Lost to Follow-up|1|||
19370608|NCT01359644|41611079|FG007|Follow-up Period|Lost to Follow-up|2|||
19370609|NCT01359644|41611080|FG008|Follow-up Period|Lost to Follow-up|0|||
19370610|NCT01359644|41611081|FG009|Follow-up Period|Lost to Follow-up|0|||
19370611|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
19370612|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
19370613|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
19370614|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
19370615|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
19370616|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
19370617|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Death|2|||
19370618|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Death|0|||
19370619|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
19370620|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
19370621|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
19370622|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
19370623|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
19370624|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
19370625|NCT02603120|41611116|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
19370626|NCT02603120|41611117|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
19370627|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
19370628|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
19370629|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
19370630|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
19370631|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
19370632|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
19370633|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
19370634|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
19370635|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
19370636|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
19370637|NCT02603120|41611116|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
19370638|NCT02603120|41611117|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
19370639|NCT02599688|41611125|FG000|Overall Study|Lack of Efficacy|1|||
19370640|NCT02599688|41611125|FG000|Overall Study|Withdrawal by Subject|1|||
19370641|NCT02599688|41611125|FG000|Overall Study|Termination by Sponsor|2|||
19370642|NCT01331681|41611132|FG000|Overall Study|Adverse Event|10|||
19370643|NCT01331681|41611133|FG001|Overall Study|Adverse Event|13|||
19370644|NCT01331681|41611134|FG002|Overall Study|Adverse Event|10|||
19370645|NCT01331681|41611132|FG000|Overall Study|Death|6|||
19370646|NCT01331681|41611133|FG001|Overall Study|Death|6|||
19370647|NCT01331681|41611134|FG002|Overall Study|Death|2|||
19370648|NCT01331681|41611132|FG000|Overall Study|Lack of Efficacy|0|||
19370649|NCT01331681|41611133|FG001|Overall Study|Lack of Efficacy|1|||
19370650|NCT01331681|41611134|FG002|Overall Study|Lack of Efficacy|0|||
19370651|NCT01331681|41611132|FG000|Overall Study|Withdrawal by Subject|12|||
19370652|NCT01331681|41611133|FG001|Overall Study|Withdrawal by Subject|8|||
19370653|NCT01331681|41611134|FG002|Overall Study|Withdrawal by Subject|15|||
19370654|NCT01331681|41611132|FG000|Overall Study|Protocol Violation|1|||
19370655|NCT01331681|41611133|FG001|Overall Study|Protocol Violation|1|||
19370656|NCT01331681|41611134|FG002|Overall Study|Protocol Violation|0|||
19370657|NCT01331681|41611132|FG000|Overall Study|Lost to Follow-up|2|||
19370658|NCT01331681|41611133|FG001|Overall Study|Lost to Follow-up|4|||
19370659|NCT01331681|41611134|FG002|Overall Study|Lost to Follow-up|1|||
19370660|NCT01331681|41611132|FG000|Overall Study|Physician Decision|2|||
19370661|NCT01331681|41611133|FG001|Overall Study|Physician Decision|0|||
19370662|NCT01331681|41611134|FG002|Overall Study|Physician Decision|4|||
19370663|NCT01331681|41611132|FG000|Overall Study|Therapeutic procedure required|1|||
19370664|NCT01331681|41611133|FG001|Overall Study|Therapeutic procedure required|0|||
19370665|NCT01331681|41611134|FG002|Overall Study|Therapeutic procedure required|0|||
19370666|NCT01331681|41611132|FG000|Overall Study|Sponsor decision|1|||
19370667|NCT01331681|41611133|FG001|Overall Study|Sponsor decision|1|||
19370668|NCT01331681|41611134|FG002|Overall Study|Sponsor decision|0|||
19370669|NCT01331681|41611132|FG000|Overall Study|Switching to other therapy|0|||
19370670|NCT01331681|41611133|FG001|Overall Study|Switching to other therapy|0|||
19370671|NCT01331681|41611134|FG002|Overall Study|Switching to other therapy|1|||
19370672|NCT01331681|41611132|FG000|Overall Study|Not Received Study Treatment|0|||
19370673|NCT01331681|41611133|FG001|Overall Study|Not Received Study Treatment|0|||
19370674|NCT01331681|41611134|FG002|Overall Study|Not Received Study Treatment|2|||
19370675|NCT01331291|41611144|FG000|Overall Study|Lack of Efficacy|2|||
19370676|NCT01331291|41611145|FG001|Overall Study|Lack of Efficacy|8|||
19370677|NCT01331291|41611144|FG000|Overall Study|Death|0|||
19370678|NCT01331291|41611145|FG001|Overall Study|Death|1|||
19370679|NCT02601560|41611158|FG000|Overall Study|Other|0|||
19370680|NCT02601560|41611159|FG001|Overall Study|Other|0|||
19370681|NCT02601560|41611160|FG002|Overall Study|Other|0|||
19370682|NCT02601560|41611161|FG003|Overall Study|Other|0|||
19370683|NCT02601560|41611162|FG004|Overall Study|Other|0|||
19370684|NCT02601560|41611163|FG005|Overall Study|Other|0|||
19370685|NCT02601560|41611164|FG006|Overall Study|Other|1|||
19370686|NCT02601560|41611165|FG007|Overall Study|Other|0|||
19370687|NCT02595398|41611196|FG000|Overall Study|Non-compliance|1|||
19370688|NCT02595398|41611197|FG001|Overall Study|Non-compliance|0|||
19370689|NCT02595398|41611196|FG000|Overall Study|Withdrawal by Subject|2|||
19370690|NCT02595398|41611197|FG001|Overall Study|Withdrawal by Subject|1|||
19370691|NCT02595398|41611196|FG000|Overall Study|Lost to Follow-up|1|||
19370692|NCT02595398|41611197|FG001|Overall Study|Lost to Follow-up|0|||
19370693|NCT01368497|41611203|FG000|Overall Study|Lost to Follow-up|2|||
19370694|NCT02595008|41611209|FG000|Overall Study|Enrolled In Error|1|||
19370695|NCT02595008|41611210|FG001|Overall Study|Enrolled In Error|0|||
19370696|NCT02598128|41611216|FG000|Period A: Days -7 to -1|Adverse Event|1|||
19370697|NCT02598128|41611217|FG001|Period A: Days -7 to -1|Adverse Event|0|||
19370698|NCT02598128|41611218|FG002|Period A: Days -7 to -1|Adverse Event|0|||
19370699|NCT02598128|41611219|FG003|Period A: Days -7 to -1|Adverse Event|0|||
19370700|NCT02788175|41611231|FG000|Overall Study|Protocol Violation|3|||
19370701|NCT02788175|41611231|FG000|Overall Study|Withdrawal by Subject|4|||
19370702|NCT02788175|41611231|FG000|Overall Study|Ineligible prior to study agent|6|||
19370703|NCT02787083|41611237|FG000|Overall Study|Adverse Event|1|||
19370704|NCT02787083|41611238|FG001|Overall Study|Adverse Event|0|||
19370705|NCT02787083|41611237|FG000|Overall Study|Withdrawal by Subject|2|||
19370706|NCT02787083|41611238|FG001|Overall Study|Withdrawal by Subject|2|||
19370707|NCT02787863|41611252|FG000|Overall Study|Death|1|||
19370708|NCT02787863|41611253|FG001|Overall Study|Death|0|||
19370709|NCT02787863|41611254|FG002|Overall Study|Death|1|||
19370710|NCT02787863|41611255|FG003|Overall Study|Death|0|||
19370711|NCT02787863|41611256|FG004|Overall Study|Death|0|||
19370712|NCT02787863|41611257|FG005|Overall Study|Death|0|||
19370713|NCT02787863|41611258|FG006|Overall Study|Death|0|||
19370714|NCT02787863|41611259|FG007|Overall Study|Death|0|||
19370715|NCT02787863|41611252|FG000|Overall Study|Withdrawal by Subject|0|||
19370716|NCT02787863|41611253|FG001|Overall Study|Withdrawal by Subject|1|||
19370717|NCT02787863|41611254|FG002|Overall Study|Withdrawal by Subject|1|||
19370718|NCT02787863|41611255|FG003|Overall Study|Withdrawal by Subject|0|||
19370719|NCT02787863|41611256|FG004|Overall Study|Withdrawal by Subject|0|||
19370720|NCT02787863|41611257|FG005|Overall Study|Withdrawal by Subject|0|||
19370721|NCT02787863|41611258|FG006|Overall Study|Withdrawal by Subject|0|||
19370722|NCT02787863|41611259|FG007|Overall Study|Withdrawal by Subject|0|||
19370723|NCT02596958|41611300|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
19370724|NCT02596958|41611300|FG000|Overall Study|Cancer Progression|441|||
19370725|NCT02596958|41611300|FG000|Overall Study|Death From Cancer|112|||
19370726|NCT02596958|41611300|FG000|Overall Study|Death From Other Cause|33|||
19370727|NCT02596958|41611300|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
19370728|NCT02596958|41611300|FG000|Overall Study|Administrative Reasons/Other|231|||
19370729|NCT02596958|41611300|FG000|Overall Study|Lost to Follow-up|33|||
19370730|NCT02596958|41611300|FG000|Overall Study|Missing|32|||
19370731|NCT02596958|41611300|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
19370732|NCT01367249|41611306|FG000|Overall Study|Withdrawal by Subject|6|||
19370733|NCT01367249|41611307|FG001|Overall Study|Withdrawal by Subject|6|||
19370734|NCT01367249|41611306|FG000|Overall Study|Other|3|||
19370735|NCT01367249|41611307|FG001|Overall Study|Other|10|||
19370736|NCT02786927|41611313|FG000|Overall Study|Adverse Event|1|||
19370737|NCT02786927|41611313|FG000|Overall Study|Protocol Violation|4|||
19370738|NCT02592434|41611318|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
19370739|NCT02592434|41611319|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
19370740|NCT02592434|41611320|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
19370741|NCT02592434|41611318|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
19370742|NCT02592434|41611319|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
19698810|NCT00296504|42143590|FG001|Final Analysis|Poor Adherence|0|||
19370743|NCT02592434|41611320|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
19370744|NCT02592434|41611318|FG000|Open-Label Phase (18 Weeks)|Other|3|||
19370745|NCT02592434|41611319|FG001|Open-Label Phase (18 Weeks)|Other|0|||
19370746|NCT02592434|41611320|FG002|Open-Label Phase (18 Weeks)|Other|0|||
19370747|NCT02592434|41611318|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
19370748|NCT02592434|41611319|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
19370749|NCT02592434|41611320|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
19370750|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
19370751|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
19370752|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
19370753|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
19370754|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
19370755|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
19370756|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Other|0|||
19370757|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Other|1|||
19370758|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Other|0|||
19370759|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
19370760|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
19370761|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
19370762|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
19370763|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
19370764|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
19370765|NCT02592434|41611318|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
19370766|NCT02592434|41611319|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
19370767|NCT02592434|41611320|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
19370768|NCT02785913|41611328|FG000|Overall Study|Adverse Event|5|||
19370769|NCT02785913|41611328|FG000|Overall Study|Death|2|||
19370770|NCT02785913|41611328|FG000|Overall Study|Progression|18|||
19370771|NCT02785913|41611328|FG000|Overall Study|Not protocol specified|1|||
19370772|NCT02590562|41611337|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
19370773|NCT02783729|41611364|FG000|Overall Study|Lack of Efficacy|1|||
19370774|NCT02783729|41611365|FG001|Overall Study|Lack of Efficacy|0|||
19370775|NCT02783729|41611366|FG002|Overall Study|Lack of Efficacy|0|||
19370776|NCT02783729|41611367|FG003|Overall Study|Lack of Efficacy|0|||
19370777|NCT02783729|41611364|FG000|Overall Study|Adverse Event|2|||
19370778|NCT02783729|41611365|FG001|Overall Study|Adverse Event|6|||
19370779|NCT02783729|41611366|FG002|Overall Study|Adverse Event|2|||
19370780|NCT02783729|41611367|FG003|Overall Study|Adverse Event|3|||
19370781|NCT02783729|41611364|FG000|Overall Study|Other|1|||
19370782|NCT02783729|41611365|FG001|Overall Study|Other|6|||
19370783|NCT02783729|41611366|FG002|Overall Study|Other|2|||
19370784|NCT02783729|41611367|FG003|Overall Study|Other|3|||
19370785|NCT02783729|41611364|FG000|Overall Study|Withdrawal by Subject|2|||
19370786|NCT02783729|41611365|FG001|Overall Study|Withdrawal by Subject|3|||
19370787|NCT02783729|41611366|FG002|Overall Study|Withdrawal by Subject|1|||
19370788|NCT02783729|41611367|FG003|Overall Study|Withdrawal by Subject|2|||
19370789|NCT02783729|41611364|FG000|Overall Study|Participant's choice|2|||
19370790|NCT02783729|41611365|FG001|Overall Study|Participant's choice|1|||
19370791|NCT02783729|41611366|FG002|Overall Study|Participant's choice|2|||
19370792|NCT02783729|41611367|FG003|Overall Study|Participant's choice|1|||
19370793|NCT02783729|41611364|FG000|Overall Study|Lost to Follow-up|2|||
19370794|NCT02783729|41611365|FG001|Overall Study|Lost to Follow-up|1|||
19370795|NCT02783729|41611366|FG002|Overall Study|Lost to Follow-up|1|||
19370796|NCT02783729|41611367|FG003|Overall Study|Lost to Follow-up|0|||
19370797|NCT02784431|41611389|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
19370798|NCT02784431|41611389|FG000|Overall Study|Early Study Termination|19|||
19370799|NCT02590406|41611395|FG000|Overall Study|Adverse Event|1|||
19370800|NCT02590406|41611396|FG001|Overall Study|Adverse Event|0|||
19370801|NCT02590406|41611395|FG000|Overall Study|Saturometer malfunction|0|||
19370802|NCT02590406|41611396|FG001|Overall Study|Saturometer malfunction|1|||
19370803|NCT01359254|41611404|FG000|Overall Study|Death|1|||
19370804|NCT01359254|41611405|FG001|Overall Study|Death|0|||
19370805|NCT01667432|41611411|FG000|Overall Study|Premature Study Termination|26|||
19370806|NCT01667432|41611411|FG000|Overall Study|Failure to Return|10|||
19370807|NCT01667432|41611411|FG000|Overall Study|Moved to Another Center|3|||
19370808|NCT01667432|41611411|FG000|Overall Study|Lost to Follow-up|3|||
19370809|NCT01667432|41611411|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
19370810|NCT01667432|41611411|FG000|Overall Study|Insufficient Therapeutic Response|4|||
19370811|NCT01667432|41611411|FG000|Overall Study|Adverse Event|1|||
19370812|NCT01667432|41611411|FG000|Overall Study|Protocol Deviation|2|||
19370813|NCT01667432|41611411|FG000|Overall Study|Principal Investigator Decision|1|||
19370814|NCT01667432|41611411|FG000|Overall Study|Reason Not Specified|2|||
19370815|NCT01667432|41611411|FG000|Overall Study|Missing Information|4|||
19370816|NCT01563107|41611419|FG000|Overall Study|Physician Decision|0|||
19370817|NCT01563107|41611420|FG001|Overall Study|Physician Decision|1|||
19370818|NCT01563107|41611421|FG002|Overall Study|Physician Decision|1|||
19370819|NCT01563107|41611422|FG003|Overall Study|Physician Decision|3|||
19370820|NCT01563107|41611419|FG000|Overall Study|Withdrawal by Subject|1|||
19370821|NCT01563107|41611420|FG001|Overall Study|Withdrawal by Subject|2|||
19370822|NCT01563107|41611421|FG002|Overall Study|Withdrawal by Subject|1|||
19370823|NCT01563107|41611422|FG003|Overall Study|Withdrawal by Subject|2|||
19370824|NCT02589626|41611484|FG000|Overall Study|Other than the reason specified|1|||
19370825|NCT02589626|41611485|FG001|Overall Study|Other than the reason specified|0|||
19370826|NCT02589626|41611484|FG000|Overall Study|Withdrawal by Subject|1|||
19370827|NCT02589626|41611485|FG001|Overall Study|Withdrawal by Subject|1|||
19370828|NCT02589626|41611484|FG000|Overall Study|Adverse Event|1|||
19370829|NCT02589626|41611485|FG001|Overall Study|Adverse Event|1|||
19370830|NCT01666730|41611500|FG000|Overall Study|Adverse Event|16|||
19370831|NCT01666730|41611500|FG000|Overall Study|Death|2|||
19370832|NCT01666730|41611500|FG000|Overall Study|Physician Decision|5|||
19370833|NCT01666730|41611500|FG000|Overall Study|Withdrawal by Subject|9|||
19370834|NCT01666730|41611500|FG000|Overall Study|Disease progression/relapse|18|||
19370835|NCT00103285|41611513|FG000|Induction|Adverse Event|14|||
19370836|NCT00103285|41611514|FG001|Induction|Adverse Event|0|||
19370837|NCT00103285|41611515|FG002|Induction|Adverse Event|0|||
19370838|NCT00103285|41611516|FG003|Induction|Adverse Event|0|||
19370839|NCT00103285|41611517|FG004|Induction|Adverse Event|0|||
19370840|NCT00103285|41611518|FG005|Induction|Adverse Event|0|||
19370841|NCT00103285|41611519|FG006|Induction|Adverse Event|0|||
19370842|NCT00103285|41611520|FG007|Induction|Adverse Event|0|||
19370843|NCT00103285|41611513|FG000|Induction|Death|24|||
19370844|NCT00103285|41611514|FG001|Induction|Death|0|||
19370845|NCT00103285|41611515|FG002|Induction|Death|0|||
19370846|NCT00103285|41611516|FG003|Induction|Death|0|||
19370847|NCT00103285|41611517|FG004|Induction|Death|0|||
19370848|NCT00103285|41611518|FG005|Induction|Death|0|||
19370849|NCT00103285|41611519|FG006|Induction|Death|0|||
19370850|NCT00103285|41611520|FG007|Induction|Death|0|||
19370851|NCT00103285|41611513|FG000|Induction|Physician Decision|103|||
19370852|NCT00103285|41611514|FG001|Induction|Physician Decision|0|||
19370853|NCT00103285|41611515|FG002|Induction|Physician Decision|0|||
19370854|NCT00103285|41611516|FG003|Induction|Physician Decision|0|||
19370855|NCT00103285|41611517|FG004|Induction|Physician Decision|0|||
19370856|NCT00103285|41611518|FG005|Induction|Physician Decision|0|||
19370857|NCT00103285|41611519|FG006|Induction|Physician Decision|0|||
19370858|NCT00103285|41611520|FG007|Induction|Physician Decision|0|||
19370859|NCT00103285|41611513|FG000|Induction|Withdrawal by Subject|1|||
19477941|NCT01693562|41757325|FG011|Escalation Phase|Withdrawal by Subject|0|||
19477942|NCT01693562|41757326|FG012|Escalation Phase|Withdrawal by Subject|0|||
19477943|NCT01693562|41757327|FG013|Escalation Phase|Withdrawal by Subject|0|||
19477944|NCT01693562|41757328|FG014|Escalation Phase|Withdrawal by Subject|0|||
19477945|NCT01693562|41757329|FG015|Escalation Phase|Withdrawal by Subject|0|||
19477946|NCT01693562|41757330|FG016|Escalation Phase|Withdrawal by Subject|0|||
19477947|NCT01693562|41757331|FG017|Escalation Phase|Withdrawal by Subject|0|||
19477948|NCT01693562|41757332|FG018|Escalation Phase|Withdrawal by Subject|0|||
19477949|NCT01693562|41757333|FG019|Escalation Phase|Withdrawal by Subject|0|||
19477950|NCT01693562|41757334|FG020|Escalation Phase|Withdrawal by Subject|0|||
19477951|NCT01693562|41757335|FG021|Escalation Phase|Withdrawal by Subject|0|||
19477952|NCT01693562|41757336|FG022|Escalation Phase|Withdrawal by Subject|0|||
19477953|NCT01693562|41757314|FG000|Escalation Phase|Death|4|||
19477954|NCT01693562|41757315|FG001|Escalation Phase|Death|2|||
19477955|NCT01693562|41757316|FG002|Escalation Phase|Death|0|||
19477956|NCT01693562|41757317|FG003|Escalation Phase|Death|3|||
19477957|NCT01693562|41757318|FG004|Escalation Phase|Death|6|||
19477958|NCT01693562|41757319|FG005|Escalation Phase|Death|4|||
19477959|NCT01693562|41757320|FG006|Escalation Phase|Death|0|||
19477960|NCT01693562|41757321|FG007|Escalation Phase|Death|0|||
19477961|NCT01693562|41757322|FG008|Escalation Phase|Death|0|||
19477962|NCT01693562|41757323|FG009|Escalation Phase|Death|0|||
19477963|NCT01693562|41757324|FG010|Escalation Phase|Death|0|||
19477964|NCT01693562|41757325|FG011|Escalation Phase|Death|0|||
19477965|NCT01693562|41757326|FG012|Escalation Phase|Death|0|||
19477966|NCT01693562|41757327|FG013|Escalation Phase|Death|0|||
19477967|NCT01693562|41757328|FG014|Escalation Phase|Death|0|||
19477968|NCT01693562|41757329|FG015|Escalation Phase|Death|0|||
19477969|NCT01693562|41757330|FG016|Escalation Phase|Death|0|||
19477970|NCT01693562|41757331|FG017|Escalation Phase|Death|0|||
19799207|NCT02901431|42257304|FG007|Main Treatment Part|Adverse Event|0|||
19477971|NCT01693562|41757332|FG018|Escalation Phase|Death|0|||
19370860|NCT00103285|41611514|FG001|Induction|Withdrawal by Subject|0|||
19370861|NCT00103285|41611515|FG002|Induction|Withdrawal by Subject|0|||
19370862|NCT00103285|41611516|FG003|Induction|Withdrawal by Subject|0|||
19477972|NCT01693562|41757333|FG019|Escalation Phase|Death|0|||
19477973|NCT01693562|41757334|FG020|Escalation Phase|Death|0|||
19477974|NCT01693562|41757335|FG021|Escalation Phase|Death|0|||
19477975|NCT01693562|41757336|FG022|Escalation Phase|Death|0|||
19477976|NCT01693562|41757314|FG000|Escalation Phase|Lost to Follow-up|0|||
19477977|NCT01693562|41757315|FG001|Escalation Phase|Lost to Follow-up|1|||
19477978|NCT01693562|41757316|FG002|Escalation Phase|Lost to Follow-up|1|||
19477979|NCT01693562|41757317|FG003|Escalation Phase|Lost to Follow-up|0|||
19477980|NCT01693562|41757318|FG004|Escalation Phase|Lost to Follow-up|0|||
19477981|NCT01693562|41757319|FG005|Escalation Phase|Lost to Follow-up|0|||
19477982|NCT01693562|41757320|FG006|Escalation Phase|Lost to Follow-up|0|||
19477983|NCT01693562|41757321|FG007|Escalation Phase|Lost to Follow-up|0|||
19477984|NCT01693562|41757322|FG008|Escalation Phase|Lost to Follow-up|0|||
19477985|NCT01693562|41757323|FG009|Escalation Phase|Lost to Follow-up|0|||
19477986|NCT01693562|41757324|FG010|Escalation Phase|Lost to Follow-up|0|||
19477987|NCT01693562|41757325|FG011|Escalation Phase|Lost to Follow-up|0|||
19477988|NCT01693562|41757326|FG012|Escalation Phase|Lost to Follow-up|0|||
19477989|NCT01693562|41757327|FG013|Escalation Phase|Lost to Follow-up|0|||
19477990|NCT01693562|41757328|FG014|Escalation Phase|Lost to Follow-up|0|||
19477991|NCT01693562|41757329|FG015|Escalation Phase|Lost to Follow-up|0|||
19477992|NCT01693562|41757330|FG016|Escalation Phase|Lost to Follow-up|0|||
19477993|NCT01693562|41757331|FG017|Escalation Phase|Lost to Follow-up|0|||
19477994|NCT01693562|41757332|FG018|Escalation Phase|Lost to Follow-up|0|||
19477995|NCT01693562|41757333|FG019|Escalation Phase|Lost to Follow-up|0|||
19477996|NCT01693562|41757334|FG020|Escalation Phase|Lost to Follow-up|0|||
19477997|NCT01693562|41757335|FG021|Escalation Phase|Lost to Follow-up|0|||
19477998|NCT01693562|41757336|FG022|Escalation Phase|Lost to Follow-up|0|||
19477999|NCT01693562|41757314|FG000|Escalation Phase|Other|0|||
19478000|NCT01693562|41757315|FG001|Escalation Phase|Other|0|||
19478001|NCT01693562|41757316|FG002|Escalation Phase|Other|2|||
19478002|NCT01693562|41757317|FG003|Escalation Phase|Other|0|||
19478003|NCT01693562|41757318|FG004|Escalation Phase|Other|0|||
19478004|NCT01693562|41757319|FG005|Escalation Phase|Other|1|||
19478005|NCT01693562|41757320|FG006|Escalation Phase|Other|0|||
19478006|NCT01693562|41757321|FG007|Escalation Phase|Other|0|||
19478007|NCT01693562|41757322|FG008|Escalation Phase|Other|0|||
19478008|NCT01693562|41757323|FG009|Escalation Phase|Other|0|||
19478009|NCT01693562|41757324|FG010|Escalation Phase|Other|0|||
19478010|NCT01693562|41757325|FG011|Escalation Phase|Other|0|||
19478011|NCT01693562|41757326|FG012|Escalation Phase|Other|0|||
19478012|NCT01693562|41757327|FG013|Escalation Phase|Other|0|||
19478013|NCT01693562|41757328|FG014|Escalation Phase|Other|0|||
19478014|NCT01693562|41757329|FG015|Escalation Phase|Other|0|||
19478015|NCT01693562|41757330|FG016|Escalation Phase|Other|0|||
19478016|NCT01693562|41757331|FG017|Escalation Phase|Other|0|||
19478017|NCT01693562|41757332|FG018|Escalation Phase|Other|0|||
19478018|NCT01693562|41757333|FG019|Escalation Phase|Other|0|||
19478019|NCT01693562|41757334|FG020|Escalation Phase|Other|0|||
19478020|NCT01693562|41757335|FG021|Escalation Phase|Other|0|||
19478021|NCT01693562|41757336|FG022|Escalation Phase|Other|0|||
19478022|NCT01693562|41757314|FG000|Exploration Phase|Withdrawal by Subject|0|||
19478023|NCT01693562|41757315|FG001|Exploration Phase|Withdrawal by Subject|0|||
19478024|NCT01693562|41757316|FG002|Exploration Phase|Withdrawal by Subject|0|||
19478025|NCT01693562|41757317|FG003|Exploration Phase|Withdrawal by Subject|0|||
19478026|NCT01693562|41757318|FG004|Exploration Phase|Withdrawal by Subject|0|||
19478027|NCT01693562|41757319|FG005|Exploration Phase|Withdrawal by Subject|0|||
19478028|NCT01693562|41757320|FG006|Exploration Phase|Withdrawal by Subject|2|||
19478029|NCT01693562|41757321|FG007|Exploration Phase|Withdrawal by Subject|0|||
19478030|NCT01693562|41757322|FG008|Exploration Phase|Withdrawal by Subject|0|||
19478031|NCT01693562|41757323|FG009|Exploration Phase|Withdrawal by Subject|0|||
19478032|NCT01693562|41757324|FG010|Exploration Phase|Withdrawal by Subject|0|||
19478033|NCT01693562|41757325|FG011|Exploration Phase|Withdrawal by Subject|0|||
19370863|NCT00103285|41611517|FG004|Induction|Withdrawal by Subject|0|||
19370864|NCT00103285|41611518|FG005|Induction|Withdrawal by Subject|0|||
19370865|NCT00103285|41611519|FG006|Induction|Withdrawal by Subject|0|||
19370866|NCT00103285|41611520|FG007|Induction|Withdrawal by Subject|0|||
19370867|NCT00103285|41611513|FG000|Induction|Ineligible|43|||
19370868|NCT00103285|41611514|FG001|Induction|Ineligible|0|||
19370869|NCT00103285|41611515|FG002|Induction|Ineligible|0|||
19370870|NCT00103285|41611516|FG003|Induction|Ineligible|0|||
19370871|NCT00103285|41611517|FG004|Induction|Ineligible|0|||
19370872|NCT00103285|41611518|FG005|Induction|Ineligible|0|||
19370873|NCT00103285|41611519|FG006|Induction|Ineligible|0|||
19370874|NCT00103285|41611520|FG007|Induction|Ineligible|0|||
19478034|NCT01693562|41757326|FG012|Exploration Phase|Withdrawal by Subject|0|||
19478035|NCT01693562|41757327|FG013|Exploration Phase|Withdrawal by Subject|0|||
19478036|NCT01693562|41757328|FG014|Exploration Phase|Withdrawal by Subject|0|||
19478037|NCT01693562|41757329|FG015|Exploration Phase|Withdrawal by Subject|0|||
19478038|NCT01693562|41757330|FG016|Exploration Phase|Withdrawal by Subject|0|||
19478039|NCT01693562|41757331|FG017|Exploration Phase|Withdrawal by Subject|0|||
19478040|NCT01693562|41757332|FG018|Exploration Phase|Withdrawal by Subject|0|||
19478041|NCT01693562|41757333|FG019|Exploration Phase|Withdrawal by Subject|0|||
19478042|NCT01693562|41757334|FG020|Exploration Phase|Withdrawal by Subject|0|||
19478043|NCT01693562|41757335|FG021|Exploration Phase|Withdrawal by Subject|0|||
19478044|NCT01693562|41757336|FG022|Exploration Phase|Withdrawal by Subject|0|||
19478045|NCT01693562|41757314|FG000|Exploration Phase|Death|0|||
19370875|NCT00103285|41611513|FG000|Induction|Refusal|906|||
19370876|NCT00103285|41611514|FG001|Induction|Refusal|0|||
19370877|NCT00103285|41611515|FG002|Induction|Refusal|0|||
19799208|NCT02901431|42257305|FG008|Main Treatment Part|Adverse Event|0|||
19799209|NCT02901431|42257306|FG009|Main Treatment Part|Adverse Event|0|||
19799210|NCT02901431|42257307|FG010|Main Treatment Part|Adverse Event|0|||
19799211|NCT02901431|42257308|FG011|Main Treatment Part|Adverse Event|0|||
19799212|NCT02901431|42257309|FG012|Main Treatment Part|Adverse Event|0|||
19608460|NCT00874731|42057392|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
19799213|NCT02901431|42257297|FG000|Main Treatment Part|Lack of Efficacy|0|||
19799214|NCT02901431|42257298|FG001|Main Treatment Part|Lack of Efficacy|0|||
19799215|NCT02901431|42257299|FG002|Main Treatment Part|Lack of Efficacy|0|||
19799216|NCT02901431|42257300|FG003|Main Treatment Part|Lack of Efficacy|1|||
19799217|NCT02901431|42257301|FG004|Main Treatment Part|Lack of Efficacy|0|||
19799218|NCT02901431|42257302|FG005|Main Treatment Part|Lack of Efficacy|0|||
19799219|NCT02901431|42257303|FG006|Main Treatment Part|Lack of Efficacy|0|||
19799220|NCT02901431|42257304|FG007|Main Treatment Part|Lack of Efficacy|0|||
19799221|NCT02901431|42257305|FG008|Main Treatment Part|Lack of Efficacy|0|||
19799222|NCT02901431|42257306|FG009|Main Treatment Part|Lack of Efficacy|0|||
19799223|NCT02901431|42257307|FG010|Main Treatment Part|Lack of Efficacy|0|||
19608461|NCT00874731|42057393|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
19698811|NCT00296504|42143591|FG002|Final Analysis|Poor Adherence|0|||
19698812|NCT00296504|42143592|FG003|Final Analysis|Poor Adherence|0|||
19698813|NCT00296504|42143593|FG004|Final Analysis|Poor Adherence|0|||
19698814|NCT00296504|42143594|FG005|Final Analysis|Poor Adherence|0|||
19698815|NCT00296504|42143595|FG006|Final Analysis|Poor Adherence|0|||
19698816|NCT00296504|42143596|FG007|Final Analysis|Poor Adherence|0|||
19698817|NCT00296504|42143597|FG008|Final Analysis|Poor Adherence|1|||
19698818|NCT00313820|42143624|FG000|Assigned to Treatment|Other|1|||
19698819|NCT00313820|42143625|FG001|Assigned to Treatment|Other|0|||
19698820|NCT00313820|42143624|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
19698821|NCT00313820|42143625|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
19698822|NCT00313820|42143624|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
19698823|NCT00313820|42143625|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
19698824|NCT00313820|42143624|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
19698825|NCT00313820|42143625|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
19698826|NCT00313820|42143624|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
19698827|NCT00313820|42143625|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
19698828|NCT00313820|42143624|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
19698829|NCT00313820|42143625|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
19698830|NCT00462761|42143631|FG000|Overall Study|Adverse Event|6|||
19698831|NCT00462761|42143631|FG000|Overall Study|Withdrawal by Subject|9|||
19698832|NCT00462761|42143631|FG000|Overall Study|Physician Decision|5|||
19698833|NCT00462761|42143631|FG000|Overall Study|Disease progression|43|||
19698834|NCT00462761|42143631|FG000|Overall Study|Death|12|||
19698835|NCT00462761|42143631|FG000|Overall Study|Other|1|||
19698836|NCT00235872|42143663|FG000|Overall Study|Adverse Event|34|||
19698837|NCT00235872|42143663|FG000|Overall Study|Death|1|||
19698838|NCT00235872|42143663|FG000|Overall Study|Lost to Follow-up|1|||
19698839|NCT00235872|42143663|FG000|Overall Study|Withdrawal by Subject|50|||
19698840|NCT00235872|42143663|FG000|Overall Study|Administrative reason|61|||
19698841|NCT00461981|42143669|FG000|Overall Study|Lost to Follow-up|9|||
19698842|NCT00461981|42143670|FG001|Overall Study|Lost to Follow-up|6|||
19799224|NCT02901431|42257308|FG011|Main Treatment Part|Lack of Efficacy|0|||
19608462|NCT00874731|42057394|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
19608463|NCT00874731|42057392|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
19608464|NCT00874731|42057393|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
19608465|NCT00874731|42057394|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
19608466|NCT00924638|42057404|FG000|Overall Study|Death|3|||
19608467|NCT00924638|42057405|FG001|Overall Study|Death|2|||
19608468|NCT00924638|42057404|FG000|Overall Study|Lost to Follow-up|1|||
19608469|NCT00924638|42057405|FG001|Overall Study|Lost to Follow-up|1|||
19608470|NCT00924638|42057404|FG000|Overall Study|Withdrawal by Subject|5|||
19608471|NCT00924638|42057405|FG001|Overall Study|Withdrawal by Subject|7|||
19608472|NCT00924638|42057404|FG000|Overall Study|Physician Decision|3|||
19608473|NCT00924638|42057405|FG001|Overall Study|Physician Decision|3|||
19608474|NCT00874497|42057413|FG000|Overall Study|Lost to Follow-up|2|||
19608475|NCT00874497|42057414|FG001|Overall Study|Lost to Follow-up|4|||
19608476|NCT00874497|42057413|FG000|Overall Study|Adverse Event|9|||
19608477|NCT00874497|42057414|FG001|Overall Study|Adverse Event|4|||
19608478|NCT00874497|42057413|FG000|Overall Study|Sponsor Discontinued Trial|7|||
19608479|NCT00874497|42057414|FG001|Overall Study|Sponsor Discontinued Trial|3|||
19698843|NCT00461981|42143669|FG000|Overall Study|Withdrawal by Subject|2|||
19799225|NCT02901431|42257309|FG012|Main Treatment Part|Lack of Efficacy|0|||
19608480|NCT00874497|42057413|FG000|Overall Study|Met Withdrawal Criteria|4|||
19608481|NCT00874497|42057414|FG001|Overall Study|Met Withdrawal Criteria|2|||
19370878|NCT00103285|41611516|FG003|Induction|Refusal|0|||
19370879|NCT00103285|41611517|FG004|Induction|Refusal|0|||
19370880|NCT00103285|41611518|FG005|Induction|Refusal|0|||
19370881|NCT00103285|41611519|FG006|Induction|Refusal|0|||
19370882|NCT00103285|41611520|FG007|Induction|Refusal|0|||
19370883|NCT00103285|41611513|FG000|Induction|Other|258|||
19370884|NCT00103285|41611514|FG001|Induction|Other|0|||
19370885|NCT00103285|41611515|FG002|Induction|Other|0|||
19370886|NCT00103285|41611516|FG003|Induction|Other|0|||
19370887|NCT00103285|41611517|FG004|Induction|Other|0|||
19370888|NCT00103285|41611518|FG005|Induction|Other|0|||
19370889|NCT00103285|41611519|FG006|Induction|Other|0|||
19370890|NCT00103285|41611520|FG007|Induction|Other|0|||
19370891|NCT00103285|41611513|FG000|Response Assignment|Adverse Event|0|||
19370892|NCT00103285|41611514|FG001|Response Assignment|Adverse Event|8|||
19370893|NCT00103285|41611515|FG002|Response Assignment|Adverse Event|3|||
19370894|NCT00103285|41611516|FG003|Response Assignment|Adverse Event|2|||
19370895|NCT00103285|41611517|FG004|Response Assignment|Adverse Event|3|||
19370896|NCT00103285|41611518|FG005|Response Assignment|Adverse Event|1|||
19370897|NCT00103285|41611519|FG006|Response Assignment|Adverse Event|1|||
19370898|NCT00103285|41611520|FG007|Response Assignment|Adverse Event|2|||
19370899|NCT00103285|41611513|FG000|Response Assignment|Death|0|||
19370900|NCT00103285|41611514|FG001|Response Assignment|Death|5|||
19370901|NCT00103285|41611515|FG002|Response Assignment|Death|2|||
19370902|NCT00103285|41611516|FG003|Response Assignment|Death|2|||
19370903|NCT00103285|41611517|FG004|Response Assignment|Death|3|||
19370904|NCT00103285|41611518|FG005|Response Assignment|Death|1|||
19370905|NCT00103285|41611519|FG006|Response Assignment|Death|0|||
19370906|NCT00103285|41611520|FG007|Response Assignment|Death|8|||
19370907|NCT00103285|41611513|FG000|Response Assignment|Lost to Follow-up|0|||
19370908|NCT00103285|41611514|FG001|Response Assignment|Lost to Follow-up|9|||
19370909|NCT00103285|41611515|FG002|Response Assignment|Lost to Follow-up|5|||
19370910|NCT00103285|41611516|FG003|Response Assignment|Lost to Follow-up|5|||
19370911|NCT00103285|41611517|FG004|Response Assignment|Lost to Follow-up|1|||
19370912|NCT00103285|41611518|FG005|Response Assignment|Lost to Follow-up|2|||
19370913|NCT00103285|41611519|FG006|Response Assignment|Lost to Follow-up|2|||
19370914|NCT00103285|41611520|FG007|Response Assignment|Lost to Follow-up|5|||
19370915|NCT00103285|41611513|FG000|Response Assignment|Physician Decision|0|||
19370916|NCT00103285|41611514|FG001|Response Assignment|Physician Decision|13|||
19370917|NCT00103285|41611515|FG002|Response Assignment|Physician Decision|14|||
19370918|NCT00103285|41611516|FG003|Response Assignment|Physician Decision|9|||
19370919|NCT00103285|41611517|FG004|Response Assignment|Physician Decision|13|||
19370920|NCT00103285|41611518|FG005|Response Assignment|Physician Decision|7|||
19370921|NCT00103285|41611519|FG006|Response Assignment|Physician Decision|4|||
19370922|NCT00103285|41611520|FG007|Response Assignment|Physician Decision|35|||
19370923|NCT00103285|41611513|FG000|Response Assignment|Protocol Violation|0|||
19370924|NCT00103285|41611514|FG001|Response Assignment|Protocol Violation|2|||
19370925|NCT00103285|41611515|FG002|Response Assignment|Protocol Violation|0|||
19370926|NCT00103285|41611516|FG003|Response Assignment|Protocol Violation|0|||
19370927|NCT00103285|41611517|FG004|Response Assignment|Protocol Violation|0|||
19370928|NCT00103285|41611518|FG005|Response Assignment|Protocol Violation|0|||
19370929|NCT00103285|41611519|FG006|Response Assignment|Protocol Violation|0|||
19370930|NCT00103285|41611520|FG007|Response Assignment|Protocol Violation|0|||
19370931|NCT00103285|41611513|FG000|Response Assignment|Withdrawal by Subject|0|||
19370932|NCT00103285|41611514|FG001|Response Assignment|Withdrawal by Subject|4|||
19370933|NCT00103285|41611515|FG002|Response Assignment|Withdrawal by Subject|1|||
19370934|NCT00103285|41611516|FG003|Response Assignment|Withdrawal by Subject|1|||
19370935|NCT00103285|41611517|FG004|Response Assignment|Withdrawal by Subject|2|||
19370936|NCT00103285|41611518|FG005|Response Assignment|Withdrawal by Subject|2|||
19370937|NCT00103285|41611519|FG006|Response Assignment|Withdrawal by Subject|0|||
19370938|NCT00103285|41611520|FG007|Response Assignment|Withdrawal by Subject|2|||
19370939|NCT00103285|41611513|FG000|Response Assignment|Ineligible|0|||
19370940|NCT00103285|41611514|FG001|Response Assignment|Ineligible|8|||
19370941|NCT00103285|41611515|FG002|Response Assignment|Ineligible|6|||
19370942|NCT00103285|41611516|FG003|Response Assignment|Ineligible|2|||
19370943|NCT00103285|41611517|FG004|Response Assignment|Ineligible|0|||
19370944|NCT00103285|41611518|FG005|Response Assignment|Ineligible|3|||
19370945|NCT00103285|41611519|FG006|Response Assignment|Ineligible|1|||
19370946|NCT00103285|41611520|FG007|Response Assignment|Ineligible|5|||
19370947|NCT00103285|41611513|FG000|Response Assignment|Refusal|0|||
19370948|NCT00103285|41611514|FG001|Response Assignment|Refusal|53|||
19370949|NCT00103285|41611515|FG002|Response Assignment|Refusal|5|||
19608482|NCT00874497|42057413|FG000|Overall Study|Physician Decision|1|||
19370950|NCT00103285|41611516|FG003|Response Assignment|Refusal|3|||
19370951|NCT00103285|41611517|FG004|Response Assignment|Refusal|25|||
19370952|NCT00103285|41611518|FG005|Response Assignment|Refusal|15|||
19370953|NCT00103285|41611519|FG006|Response Assignment|Refusal|30|||
19370954|NCT00103285|41611520|FG007|Response Assignment|Refusal|10|||
19370955|NCT00103285|41611513|FG000|Response Assignment|Other|0|||
19370956|NCT00103285|41611514|FG001|Response Assignment|Other|30|||
19370957|NCT00103285|41611515|FG002|Response Assignment|Other|48|||
19370958|NCT00103285|41611516|FG003|Response Assignment|Other|38|||
19608483|NCT00874497|42057414|FG001|Overall Study|Physician Decision|1|||
19370959|NCT00103285|41611517|FG004|Response Assignment|Other|37|||
19370960|NCT00103285|41611518|FG005|Response Assignment|Other|17|||
19370961|NCT00103285|41611519|FG006|Response Assignment|Other|11|||
19370962|NCT00103285|41611520|FG007|Response Assignment|Other|53|||
19370963|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
19370964|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
19370965|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
19370966|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Death|4|||
19370967|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Death|2|||
19370968|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Death|3|||
19370969|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
19370970|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
19370971|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
19370972|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
19370973|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
19370974|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
19370975|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
19370976|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
19370977|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
19370978|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
19370979|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
19370980|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
19370981|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
19370982|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
19370983|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
19370984|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
19370985|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
19370986|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
19370987|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
19370988|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
19370989|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
19370990|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
19370991|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
19370992|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
19370993|NCT02783573|41611548|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
19370994|NCT02783573|41611549|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
19370995|NCT02783573|41611550|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
19370996|NCT02783573|41611548|FG000|Delayed-Start Period|Sponsor Decision|0|||
19370997|NCT02783573|41611549|FG001|Delayed-Start Period|Sponsor Decision|17|||
19370998|NCT02783573|41611550|FG002|Delayed-Start Period|Sponsor Decision|12|||
19370999|NCT02766283|41611561|FG000|Overall Study|Lost to Follow-up|27|||
19371000|NCT01666652|41611574|FG000|Overall Study|Serious Adverse Event|0|||
19371001|NCT01666652|41611575|FG001|Overall Study|Serious Adverse Event|0|||
19371002|NCT01666652|41611576|FG002|Overall Study|Serious Adverse Event|0|||
19371003|NCT01666652|41611577|FG003|Overall Study|Serious Adverse Event|1|||
19371004|NCT01666652|41611578|FG004|Overall Study|Serious Adverse Event|0|||
19371005|NCT01666652|41611574|FG000|Overall Study|Withdrawal by Subject|0|||
19371006|NCT01666652|41611575|FG001|Overall Study|Withdrawal by Subject|0|||
19371007|NCT01666652|41611576|FG002|Overall Study|Withdrawal by Subject|0|||
19371008|NCT01666652|41611577|FG003|Overall Study|Withdrawal by Subject|0|||
19371009|NCT01666652|41611578|FG004|Overall Study|Withdrawal by Subject|1|||
19371010|NCT01666652|41611574|FG000|Overall Study|Moved from study area|1|||
19371011|NCT01666652|41611575|FG001|Overall Study|Moved from study area|0|||
19371012|NCT01666652|41611576|FG002|Overall Study|Moved from study area|0|||
19371013|NCT01666652|41611577|FG003|Overall Study|Moved from study area|2|||
19371014|NCT01666652|41611578|FG004|Overall Study|Moved from study area|0|||
19371015|NCT01666652|41611574|FG000|Overall Study|Lost to Follow-up|1|||
19389416|NCT02079532|41633029|FG000|Overall Study|Withdrawal by Subject|1|||
19389417|NCT02079532|41633029|FG000|Overall Study|Administrative problems|1|||
19371016|NCT01666652|41611575|FG001|Overall Study|Lost to Follow-up|1|||
19389418|NCT02079532|41633029|FG000|Overall Study|Inclusion into ReFIRST|3|||
19389419|NCT02079532|41633029|FG000|Overall Study|Other|3|||
19478046|NCT01693562|41757315|FG001|Exploration Phase|Death|0|||
19371017|NCT01666652|41611576|FG002|Overall Study|Lost to Follow-up|1|||
19371018|NCT01666652|41611577|FG003|Overall Study|Lost to Follow-up|1|||
19371019|NCT01666652|41611578|FG004|Overall Study|Lost to Follow-up|0|||
19371020|NCT00109733|41611592|FG000|Overall Study|Protocol Violation|0|||
19371021|NCT00109733|41611593|FG001|Overall Study|Protocol Violation|1|||
19371022|NCT00109733|41611592|FG000|Overall Study|Stopped taking study drug|1|||
19389420|NCT02709889|41633082|FG000|Overall Study|Withdrawal by Subject|11|||
19389421|NCT02709889|41633083|FG001|Overall Study|Withdrawal by Subject|10|||
19478047|NCT01693562|41757316|FG002|Exploration Phase|Death|0|||
19478048|NCT01693562|41757317|FG003|Exploration Phase|Death|0|||
19478049|NCT01693562|41757318|FG004|Exploration Phase|Death|0|||
19478050|NCT01693562|41757319|FG005|Exploration Phase|Death|0|||
19478051|NCT01693562|41757320|FG006|Exploration Phase|Death|17|||
19478052|NCT01693562|41757321|FG007|Exploration Phase|Death|0|||
19478053|NCT01693562|41757322|FG008|Exploration Phase|Death|0|||
19478054|NCT01693562|41757323|FG009|Exploration Phase|Death|0|||
19371023|NCT00109733|41611593|FG001|Overall Study|Stopped taking study drug|1|||
19371024|NCT00109733|41611592|FG000|Overall Study|Non-compliant|0|||
19371025|NCT00109733|41611593|FG001|Overall Study|Non-compliant|1|||
19371026|NCT00109733|41611592|FG000|Overall Study|Could not commit time for study|1|||
19371027|NCT00109733|41611593|FG001|Overall Study|Could not commit time for study|1|||
19371028|NCT02706405|41611607|FG000|Overall Study|Death|3|||
19371029|NCT02706405|41611608|FG001|Overall Study|Death|2|||
19371030|NCT02706405|41611609|FG002|Overall Study|Death|0|||
19371031|NCT02706405|41611610|FG003|Overall Study|Death|1|||
19371032|NCT02706405|41611611|FG004|Overall Study|Death|0|||
19371033|NCT02706405|41611612|FG005|Overall Study|Death|0|||
19371034|NCT02706405|41611613|FG006|Overall Study|Death|3|||
19371035|NCT02706405|41611614|FG007|Overall Study|Death|4|||
19371036|NCT02706405|41611607|FG000|Overall Study|Disease progression|0|||
19371037|NCT02706405|41611608|FG001|Overall Study|Disease progression|0|||
19371038|NCT02706405|41611609|FG002|Overall Study|Disease progression|0|||
19371039|NCT02706405|41611610|FG003|Overall Study|Disease progression|0|||
19371040|NCT02706405|41611611|FG004|Overall Study|Disease progression|0|||
19371041|NCT02706405|41611612|FG005|Overall Study|Disease progression|0|||
19371042|NCT02706405|41611613|FG006|Overall Study|Disease progression|0|||
19371043|NCT02706405|41611614|FG007|Overall Study|Disease progression|1|||
19371044|NCT02706405|41611607|FG000|Overall Study|Pt moved to new therapy|0|||
19371045|NCT02706405|41611608|FG001|Overall Study|Pt moved to new therapy|0|||
19371046|NCT02706405|41611609|FG002|Overall Study|Pt moved to new therapy|0|||
19371047|NCT02706405|41611610|FG003|Overall Study|Pt moved to new therapy|0|||
19371048|NCT02706405|41611611|FG004|Overall Study|Pt moved to new therapy|0|||
19371049|NCT02706405|41611612|FG005|Overall Study|Pt moved to new therapy|1|||
19371050|NCT02706405|41611613|FG006|Overall Study|Pt moved to new therapy|0|||
19371051|NCT02706405|41611614|FG007|Overall Study|Pt moved to new therapy|1|||
19371052|NCT02706405|41611607|FG000|Overall Study|Physician Decision|1|||
19371053|NCT02706405|41611608|FG001|Overall Study|Physician Decision|0|||
19371054|NCT02706405|41611609|FG002|Overall Study|Physician Decision|0|||
19371055|NCT02706405|41611610|FG003|Overall Study|Physician Decision|0|||
19371056|NCT02706405|41611611|FG004|Overall Study|Physician Decision|0|||
19371057|NCT02706405|41611612|FG005|Overall Study|Physician Decision|0|||
19371058|NCT02706405|41611613|FG006|Overall Study|Physician Decision|0|||
19371059|NCT02706405|41611614|FG007|Overall Study|Physician Decision|0|||
19371060|NCT02761993|41611643|FG000|Overall Study|Adverse Event|0|||
19371061|NCT02761993|41611644|FG001|Overall Study|Adverse Event|2|||
19371062|NCT02761993|41611645|FG002|Overall Study|Adverse Event|0|||
19371063|NCT02761993|41611643|FG000|Overall Study|Lost to Follow-up|1|||
19371064|NCT02761993|41611644|FG001|Overall Study|Lost to Follow-up|3|||
19371065|NCT02761993|41611645|FG002|Overall Study|Lost to Follow-up|2|||
19371066|NCT02761993|41611643|FG000|Overall Study|Withdrawal by Subject|1|||
19371067|NCT02761993|41611644|FG001|Overall Study|Withdrawal by Subject|1|||
19371068|NCT02761993|41611645|FG002|Overall Study|Withdrawal by Subject|2|||
19371069|NCT02761915|41611668|FG000|Overall Study|Death|3|||
19371070|NCT02761915|41611669|FG001|Overall Study|Death|1|||
19371071|NCT02761915|41611670|FG002|Overall Study|Death|1|||
19371072|NCT02761915|41611671|FG003|Overall Study|Death|1|||
19371073|NCT02761915|41611672|FG004|Overall Study|Death|0|||
19371074|NCT02761915|41611673|FG005|Overall Study|Death|1|||
19371075|NCT02761915|41611668|FG000|Overall Study|Withdrawal by Subject|1|||
19389422|NCT02709889|41633084|FG002|Overall Study|Withdrawal by Subject|2|||
19389423|NCT02709889|41633085|FG003|Overall Study|Withdrawal by Subject|12|||
19389424|NCT02709889|41633082|FG000|Overall Study|Death|25|||
19389425|NCT02709889|41633083|FG001|Overall Study|Death|38|||
19389426|NCT02709889|41633084|FG002|Overall Study|Death|4|||
19389427|NCT02709889|41633085|FG003|Overall Study|Death|44|||
19389428|NCT02709889|41633082|FG000|Overall Study|Physician Decision|1|||
19389429|NCT02709889|41633083|FG001|Overall Study|Physician Decision|2|||
19389430|NCT02709889|41633084|FG002|Overall Study|Physician Decision|3|||
19389431|NCT02709889|41633085|FG003|Overall Study|Physician Decision|5|||
19389432|NCT02709889|41633082|FG000|Overall Study|Lost to Follow-up|2|||
19389433|NCT02709889|41633083|FG001|Overall Study|Lost to Follow-up|0|||
19389434|NCT02709889|41633084|FG002|Overall Study|Lost to Follow-up|0|||
19371076|NCT02761915|41611669|FG001|Overall Study|Withdrawal by Subject|0|||
19371077|NCT02761915|41611670|FG002|Overall Study|Withdrawal by Subject|0|||
19371078|NCT02761915|41611671|FG003|Overall Study|Withdrawal by Subject|0|||
19371079|NCT02761915|41611672|FG004|Overall Study|Withdrawal by Subject|1|||
19389435|NCT02709889|41633085|FG003|Overall Study|Lost to Follow-up|4|||
19389436|NCT02709889|41633082|FG000|Overall Study|Study Terminated by Sponsor|4|||
19478055|NCT01693562|41757324|FG010|Exploration Phase|Death|0|||
19478056|NCT01693562|41757325|FG011|Exploration Phase|Death|0|||
19371080|NCT02761915|41611673|FG005|Overall Study|Withdrawal by Subject|2|||
19371081|NCT02761915|41611668|FG000|Overall Study|Disease Progression|0|||
19371082|NCT02761915|41611669|FG001|Overall Study|Disease Progression|0|||
19371083|NCT02761915|41611670|FG002|Overall Study|Disease Progression|0|||
19371084|NCT02761915|41611671|FG003|Overall Study|Disease Progression|2|||
19371085|NCT02761915|41611672|FG004|Overall Study|Disease Progression|2|||
19371086|NCT02761915|41611673|FG005|Overall Study|Disease Progression|2|||
19371087|NCT02706327|41611694|FG000|Overall Study|Lost to Follow-up|1|||
19371088|NCT02706327|41611695|FG001|Overall Study|Lost to Follow-up|1|||
19371089|NCT02706327|41611696|FG002|Overall Study|Lost to Follow-up|2|||
19371090|NCT02764333|41611704|FG000|Overall Study|Ineligible|1|||
19371091|NCT02705625|41611711|FG000|Overall Study|Protocol Violation|1|||
19371092|NCT02705625|41611712|FG001|Overall Study|Protocol Violation|0|||
19371093|NCT02705625|41611713|FG002|Overall Study|Protocol Violation|0|||
19371094|NCT02705625|41611711|FG000|Overall Study|Adverse Event|6|||
19371095|NCT02705625|41611712|FG001|Overall Study|Adverse Event|5|||
19371096|NCT02705625|41611713|FG002|Overall Study|Adverse Event|2|||
19371097|NCT02705625|41611711|FG000|Overall Study|Death|0|||
19371098|NCT02705625|41611712|FG001|Overall Study|Death|0|||
19371099|NCT02705625|41611713|FG002|Overall Study|Death|1|||
19371100|NCT02705625|41611711|FG000|Overall Study|Withdrawal by Subject|1|||
19371101|NCT02705625|41611712|FG001|Overall Study|Withdrawal by Subject|4|||
19371102|NCT02705625|41611713|FG002|Overall Study|Withdrawal by Subject|5|||
19371103|NCT02705625|41611711|FG000|Overall Study|Lost to Follow-up|0|||
19371104|NCT02705625|41611712|FG001|Overall Study|Lost to Follow-up|0|||
19371105|NCT02705625|41611713|FG002|Overall Study|Lost to Follow-up|1|||
19371106|NCT02705625|41611711|FG000|Overall Study|Non-compliance|0|||
19371107|NCT02705625|41611712|FG001|Overall Study|Non-compliance|1|||
19371108|NCT02705625|41611713|FG002|Overall Study|Non-compliance|1|||
19371109|NCT02705625|41611711|FG000|Overall Study|Overdosing|0|||
19371110|NCT02705625|41611712|FG001|Overall Study|Overdosing|0|||
19371111|NCT02705625|41611713|FG002|Overall Study|Overdosing|1|||
19371112|NCT02588612|41611721|FG000|Overall Study|Physician Decision|1|||
19371113|NCT02588612|41611721|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
19371114|NCT02588612|41611721|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
19371115|NCT02588612|41611721|FG000|Overall Study|Death prior to T-cell infusion|1|||
19371116|NCT02704689|41611738|FG000|Overall Study|Physician Decision|1|||
19371117|NCT02704689|41611738|FG000|Overall Study|Study device not implanted|2|||
19371118|NCT02704143|41611742|FG000|Overall Study|disease progression|10|||
19371119|NCT02586506|41611746|FG000|Overall Study|Protocol Violation|6|||
19371120|NCT02586506|41611746|FG000|Overall Study|Lost to Follow-up|1|||
19371121|NCT02586506|41611746|FG000|Overall Study|Other Reason|2|||
19371122|NCT00109031|41611754|FG000|Overall Study|Adverse Event|0|||
19371123|NCT00109031|41611755|FG001|Overall Study|Adverse Event|0|||
19371124|NCT00109031|41611756|FG002|Overall Study|Adverse Event|1|||
19371125|NCT00109031|41611757|FG003|Overall Study|Adverse Event|0|||
19371126|NCT00109031|41611754|FG000|Overall Study|Withdrawal by Subject|0|||
19371127|NCT00109031|41611755|FG001|Overall Study|Withdrawal by Subject|1|||
19371128|NCT00109031|41611756|FG002|Overall Study|Withdrawal by Subject|0|||
19371129|NCT00109031|41611757|FG003|Overall Study|Withdrawal by Subject|0|||
19371130|NCT00109031|41611754|FG000|Overall Study|Physician Decision|0|||
19371131|NCT00109031|41611755|FG001|Overall Study|Physician Decision|1|||
19371132|NCT00109031|41611756|FG002|Overall Study|Physician Decision|0|||
19371133|NCT00109031|41611757|FG003|Overall Study|Physician Decision|0|||
19371134|NCT00109031|41611754|FG000|Overall Study|Protocol Violation|0|||
19371135|NCT00109031|41611755|FG001|Overall Study|Protocol Violation|0|||
19371136|NCT00109031|41611756|FG002|Overall Study|Protocol Violation|1|||
19371137|NCT00109031|41611757|FG003|Overall Study|Protocol Violation|0|||
19371138|NCT01664624|41611771|FG000|Overall Study|Adverse Event|0|||
19371139|NCT01664624|41611772|FG001|Overall Study|Adverse Event|1|||
19371140|NCT01664624|41611773|FG002|Overall Study|Adverse Event|0|||
19371141|NCT01664624|41611774|FG003|Overall Study|Adverse Event|0|||
19371142|NCT02702193|41611786|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
19371143|NCT02702193|41611787|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
19371144|NCT02702193|41611786|FG000|4 Month Follow up|Withdrawal by Subject|1|||
19371145|NCT02702193|41611787|FG001|4 Month Follow up|Withdrawal by Subject|0|||
19371146|NCT02702193|41611786|FG000|4 Month Follow up|Lost to Follow-up|17|||
19371147|NCT02702193|41611787|FG001|4 Month Follow up|Lost to Follow-up|18|||
19371148|NCT02702193|41611786|FG000|8 Month Follow up|Withdrawal by Subject|1|||
19371149|NCT02702193|41611787|FG001|8 Month Follow up|Withdrawal by Subject|0|||
19371150|NCT02702193|41611786|FG000|8 Month Follow up|Lost to Follow-up|14|||
19371151|NCT02702193|41611787|FG001|8 Month Follow up|Lost to Follow-up|18|||
19371152|NCT02702193|41611786|FG000|12 Month Follow up|Withdrawal by Subject|1|||
19371153|NCT02702193|41611787|FG001|12 Month Follow up|Withdrawal by Subject|0|||
19371154|NCT02702193|41611786|FG000|12 Month Follow up|Lost to Follow-up|16|||
19371155|NCT02702193|41611787|FG001|12 Month Follow up|Lost to Follow-up|18|||
19371156|NCT02761057|41611797|FG000|Overall Study|Currently On Study Treatment|0|||
19371157|NCT02761057|41611798|FG001|Overall Study|Currently On Study Treatment|3|||
19478057|NCT01693562|41757326|FG012|Exploration Phase|Death|0|||
19371158|NCT02761057|41611799|FG002|Overall Study|Currently On Study Treatment|0|||
19371159|NCT02761057|41611800|FG003|Overall Study|Currently On Study Treatment|0|||
19371160|NCT02761057|41611797|FG000|Overall Study|Adverse Event|11|||
19371161|NCT02761057|41611798|FG001|Overall Study|Adverse Event|9|||
19371162|NCT02761057|41611799|FG002|Overall Study|Adverse Event|5|||
19371163|NCT02761057|41611800|FG003|Overall Study|Adverse Event|3|||
19371164|NCT02761057|41611797|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
19371165|NCT02761057|41611798|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
19371166|NCT02761057|41611799|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
19371167|NCT02761057|41611800|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
19371168|NCT02761057|41611797|FG000|Overall Study|Progression/Relapse|29|||
19371169|NCT02761057|41611798|FG001|Overall Study|Progression/Relapse|27|||
19371170|NCT02761057|41611799|FG002|Overall Study|Progression/Relapse|20|||
19371171|NCT02761057|41611800|FG003|Overall Study|Progression/Relapse|23|||
19371172|NCT02761057|41611797|FG000|Overall Study|Death|2|||
19371173|NCT02761057|41611798|FG001|Overall Study|Death|2|||
19371174|NCT02761057|41611799|FG002|Overall Study|Death|1|||
19371175|NCT02761057|41611800|FG003|Overall Study|Death|1|||
19371176|NCT02761057|41611797|FG000|Overall Study|Other - Not Protocol Specified|2|||
19371177|NCT02761057|41611798|FG001|Overall Study|Other - Not Protocol Specified|1|||
19371178|NCT02761057|41611799|FG002|Overall Study|Other - Not Protocol Specified|2|||
19371179|NCT02761057|41611800|FG003|Overall Study|Other - Not Protocol Specified|0|||
19371180|NCT02701413|41611812|FG000|Overall Study|Withdrawal by Subject|7|||
19371181|NCT02701413|41611813|FG001|Overall Study|Withdrawal by Subject|11|||
19371182|NCT02759185|41611823|FG000|Stage 1|Adverse Event|0|||
19371183|NCT02759185|41611824|FG001|Stage 1|Adverse Event|1|||
19371184|NCT02759185|41611825|FG002|Stage 1|Adverse Event|3|||
19371185|NCT02759185|41611826|FG003|Stage 1|Adverse Event|0|||
19371186|NCT02759185|41611827|FG004|Stage 1|Adverse Event|0|||
19371187|NCT02759185|41611828|FG005|Stage 1|Adverse Event|0|||
19371188|NCT02759185|41611829|FG006|Stage 1|Adverse Event|0|||
19371189|NCT02759185|41611823|FG000|Stage 1|Withdrawal by Subject|1|||
19371190|NCT02759185|41611824|FG001|Stage 1|Withdrawal by Subject|0|||
19371191|NCT02759185|41611825|FG002|Stage 1|Withdrawal by Subject|0|||
19371192|NCT02759185|41611826|FG003|Stage 1|Withdrawal by Subject|0|||
19371193|NCT02759185|41611827|FG004|Stage 1|Withdrawal by Subject|0|||
19371194|NCT02759185|41611828|FG005|Stage 1|Withdrawal by Subject|0|||
19371195|NCT02759185|41611829|FG006|Stage 1|Withdrawal by Subject|0|||
19371196|NCT02759185|41611823|FG000|Stage 2|Adverse Event|0|||
19371197|NCT02759185|41611824|FG001|Stage 2|Adverse Event|0|||
19371198|NCT02759185|41611825|FG002|Stage 2|Adverse Event|0|||
19371199|NCT02759185|41611826|FG003|Stage 2|Adverse Event|0|||
19371200|NCT02759185|41611827|FG004|Stage 2|Adverse Event|1|||
19371201|NCT02759185|41611828|FG005|Stage 2|Adverse Event|2|||
19371202|NCT02759185|41611829|FG006|Stage 2|Adverse Event|0|||
19371203|NCT02759185|41611823|FG000|Stage 2|Withdrawal by Subject|0|||
19371204|NCT02759185|41611824|FG001|Stage 2|Withdrawal by Subject|0|||
19371205|NCT02759185|41611825|FG002|Stage 2|Withdrawal by Subject|0|||
19371206|NCT02759185|41611826|FG003|Stage 2|Withdrawal by Subject|0|||
19371207|NCT02759185|41611827|FG004|Stage 2|Withdrawal by Subject|1|||
19371208|NCT02759185|41611828|FG005|Stage 2|Withdrawal by Subject|1|||
19371209|NCT02759185|41611829|FG006|Stage 2|Withdrawal by Subject|1|||
19371210|NCT02582684|41611851|FG000|Overall Study|Unable to contact subject/parent|4|||
19371211|NCT02582684|41611851|FG000|Overall Study|Subject not able to get to clinic|10|||
19371212|NCT02582684|41611851|FG000|Overall Study|Subject withdrew consent|1|||
19371213|NCT02582684|41611851|FG000|Overall Study|Found to be ineligible after enrollment|2|||
19371214|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Physician Decision|0|||
19371215|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Physician Decision|1|||
19371216|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Physician Decision|0|||
19371217|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
19478058|NCT01693562|41757327|FG013|Exploration Phase|Death|0|||
19698844|NCT00461981|42143670|FG001|Overall Study|Withdrawal by Subject|3|||
19698845|NCT00296036|42143678|FG000|Overall Study|Withdrawal by Subject|1|||
19698846|NCT00296036|42143679|FG001|Overall Study|Withdrawal by Subject|0|||
19799226|NCT02901431|42257297|FG000|Main Treatment Part|Lost to Follow-up|0|||
19799227|NCT02901431|42257298|FG001|Main Treatment Part|Lost to Follow-up|0|||
19799228|NCT02901431|42257299|FG002|Main Treatment Part|Lost to Follow-up|0|||
19799229|NCT02901431|42257300|FG003|Main Treatment Part|Lost to Follow-up|3|||
19799230|NCT02901431|42257301|FG004|Main Treatment Part|Lost to Follow-up|1|||
19371218|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
19371219|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
19371220|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
19371221|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
19371222|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
19371223|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Other|4|||
19371224|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Other|4|||
19371225|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Other|0|||
19478059|NCT01693562|41757328|FG014|Exploration Phase|Death|0|||
19698847|NCT00296036|42143680|FG002|Overall Study|Withdrawal by Subject|2|||
19698848|NCT00296036|42143681|FG003|Overall Study|Withdrawal by Subject|1|||
19698849|NCT00296036|42143682|FG004|Overall Study|Withdrawal by Subject|2|||
19371226|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
19371227|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
19371228|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
19371229|NCT02585960|41611858|FG000|PK/Safety Assessment Period|Screen Failure|0|||
19371230|NCT02585960|41611859|FG001|PK/Safety Assessment Period|Screen Failure|0|||
19371231|NCT02585960|41611860|FG002|PK/Safety Assessment Period|Screen Failure|1|||
19371232|NCT02585960|41611858|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
19371233|NCT02585960|41611859|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
19371234|NCT02585960|41611860|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
19371235|NCT02585960|41611858|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
19371236|NCT02585960|41611859|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
19371237|NCT02585960|41611860|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
19371238|NCT02760433|41611876|FG000|Overall Study|Lost to Follow-up|1|||
19371239|NCT02760433|41611877|FG001|Overall Study|Lost to Follow-up|0|||
19371240|NCT02760433|41611878|FG002|Overall Study|Lost to Follow-up|1|||
19371241|NCT02760433|41611879|FG003|Overall Study|Lost to Follow-up|0|||
19371242|NCT02760433|41611880|FG004|Overall Study|Lost to Follow-up|0|||
19371243|NCT02760433|41611876|FG000|Overall Study|Withdrawal by Subject|23|||
19371244|NCT02760433|41611877|FG001|Overall Study|Withdrawal by Subject|9|||
19371245|NCT02760433|41611878|FG002|Overall Study|Withdrawal by Subject|0|||
19371246|NCT02760433|41611879|FG003|Overall Study|Withdrawal by Subject|2|||
19371247|NCT02760433|41611880|FG004|Overall Study|Withdrawal by Subject|9|||
19371248|NCT02760433|41611876|FG000|Overall Study|Lack of Response At Week 14|0|||
19371249|NCT02760433|41611877|FG001|Overall Study|Lack of Response At Week 14|0|||
19371250|NCT02760433|41611878|FG002|Overall Study|Lack of Response At Week 14|0|||
19371251|NCT02760433|41611879|FG003|Overall Study|Lack of Response At Week 14|0|||
19371252|NCT02760433|41611880|FG004|Overall Study|Lack of Response At Week 14|1|||
19371253|NCT02760433|41611876|FG000|Overall Study|Subject refused to continue the study|1|||
19371254|NCT02760433|41611877|FG001|Overall Study|Subject refused to continue the study|0|||
19371255|NCT02760433|41611878|FG002|Overall Study|Subject refused to continue the study|0|||
19371256|NCT02760433|41611879|FG003|Overall Study|Subject refused to continue the study|0|||
19371257|NCT02760433|41611880|FG004|Overall Study|Subject refused to continue the study|0|||
19371258|NCT02760433|41611876|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
19371259|NCT02760433|41611877|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
19371260|NCT02760433|41611878|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
19371261|NCT02760433|41611879|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
19371262|NCT02760433|41611880|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
19371263|NCT02760433|41611876|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
19371264|NCT02760433|41611877|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
19371265|NCT02760433|41611878|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
19371266|NCT02760433|41611879|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
19371267|NCT02760433|41611880|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
19371268|NCT02699463|41611899|FG000|Overall Study|Lost to Follow-up|11|||
19371269|NCT02699463|41611900|FG001|Overall Study|Lost to Follow-up|8|||
19371270|NCT02699463|41611899|FG000|Overall Study|Withdrawal by Subject|4|||
19371271|NCT02699463|41611900|FG001|Overall Study|Withdrawal by Subject|1|||
19371272|NCT00100789|41611906|FG000|Overall Study|Adverse Event|10|||
19371273|NCT00100789|41611906|FG000|Overall Study|Withdrawal by Subject|1|||
19371274|NCT00100789|41611906|FG000|Overall Study|Progression/relapse|42|||
19371275|NCT00100789|41611906|FG000|Overall Study|Death|2|||
19371276|NCT00100789|41611906|FG000|Overall Study|Not protocol specified|5|||
19371277|NCT00100789|41611906|FG000|Overall Study|Ineligible|3|||
19698850|NCT00296036|42143683|FG005|Overall Study|Withdrawal by Subject|1|||
19698851|NCT00296036|42143678|FG000|Overall Study|Protocol Violation|0|||
19698852|NCT00296036|42143679|FG001|Overall Study|Protocol Violation|0|||
19698853|NCT00296036|42143680|FG002|Overall Study|Protocol Violation|0|||
19698854|NCT00296036|42143681|FG003|Overall Study|Protocol Violation|0|||
19698855|NCT00296036|42143682|FG004|Overall Study|Protocol Violation|0|||
19698856|NCT00296036|42143683|FG005|Overall Study|Protocol Violation|3|||
19698857|NCT00089674|42143702|FG000|Overall Study|Physician Decision|4|||
19698858|NCT00089674|42143703|FG001|Overall Study|Physician Decision|2|||
19698859|NCT00089674|42143702|FG000|Overall Study|Adverse Event|23|||
19698860|NCT00089674|42143703|FG001|Overall Study|Adverse Event|29|||
19698861|NCT00089674|42143702|FG000|Overall Study|Withdrawal by Subject|143|||
19698862|NCT00089674|42143703|FG001|Overall Study|Withdrawal by Subject|127|||
19698863|NCT00089674|42143702|FG000|Overall Study|Death|43|||
19371278|NCT00100789|41611906|FG000|Overall Study|Never received treatment|1|||
19371279|NCT00708123|41611911|FG000|Period 1|Protocol Violation|0|||
19371280|NCT00708123|41611912|FG001|Period 1|Protocol Violation|1|||
19371281|NCT00708123|41611913|FG002|Period 1|Protocol Violation|0|||
19371282|NCT00708123|41611914|FG003|Period 1|Protocol Violation|1|||
19371283|NCT00708123|41611915|FG004|Period 1|Protocol Violation|0|||
19371284|NCT00708123|41611911|FG000|Period 1|Adverse Event|0|||
19371285|NCT00708123|41611912|FG001|Period 1|Adverse Event|0|||
19371286|NCT00708123|41611913|FG002|Period 1|Adverse Event|1|||
19371287|NCT00708123|41611914|FG003|Period 1|Adverse Event|0|||
19371288|NCT00708123|41611915|FG004|Period 1|Adverse Event|0|||
19371289|NCT00708123|41611911|FG000|Period 2|Protocol Violation|0|||
19371290|NCT00708123|41611912|FG001|Period 2|Protocol Violation|0|||
19371291|NCT00708123|41611913|FG002|Period 2|Protocol Violation|0|||
19371292|NCT00708123|41611914|FG003|Period 2|Protocol Violation|1|||
19371293|NCT00708123|41611915|FG004|Period 2|Protocol Violation|0|||
19371294|NCT00708123|41611911|FG000|Period 2|Other Reason|1|||
19371295|NCT00708123|41611912|FG001|Period 2|Other Reason|0|||
19371296|NCT00708123|41611913|FG002|Period 2|Other Reason|0|||
19371297|NCT00708123|41611914|FG003|Period 2|Other Reason|0|||
19371298|NCT00708123|41611915|FG004|Period 2|Other Reason|0|||
19371299|NCT00708123|41611911|FG000|Period 3|Lost to Follow-up|0|||
19371300|NCT00708123|41611912|FG001|Period 3|Lost to Follow-up|0|||
19371301|NCT00708123|41611913|FG002|Period 3|Lost to Follow-up|1|||
19371302|NCT00708123|41611914|FG003|Period 3|Lost to Follow-up|1|||
19371303|NCT00708123|41611915|FG004|Period 3|Lost to Follow-up|0|||
19371304|NCT00708123|41611911|FG000|Period 4|Protocol Violation|0|||
19371305|NCT00708123|41611912|FG001|Period 4|Protocol Violation|1|||
19371306|NCT00708123|41611913|FG002|Period 4|Protocol Violation|0|||
19371307|NCT00708123|41611914|FG003|Period 4|Protocol Violation|0|||
19371308|NCT00708123|41611915|FG004|Period 4|Protocol Violation|0|||
19371309|NCT02165215|41611934|FG000|Induction Phase|Adverse Event|1|||
19371310|NCT02165215|41611935|FG001|Induction Phase|Adverse Event|0|||
19371311|NCT02165215|41611936|FG002|Induction Phase|Adverse Event|0|||
19371312|NCT02165215|41611934|FG000|Induction Phase|Withdrawal by Subject|10|||
19371313|NCT02165215|41611935|FG001|Induction Phase|Withdrawal by Subject|0|||
19371314|NCT02165215|41611936|FG002|Induction Phase|Withdrawal by Subject|0|||
19371315|NCT02165215|41611934|FG000|Induction Phase|Protocol Violation|1|||
19371316|NCT02165215|41611935|FG001|Induction Phase|Protocol Violation|0|||
19371317|NCT02165215|41611936|FG002|Induction Phase|Protocol Violation|0|||
19371318|NCT02165215|41611934|FG000|Induction Phase|Physician Decision|1|||
19371319|NCT02165215|41611935|FG001|Induction Phase|Physician Decision|0|||
19371320|NCT02165215|41611936|FG002|Induction Phase|Physician Decision|0|||
19371321|NCT02165215|41611934|FG000|Induction Phase|Lack of Efficacy|2|||
19371322|NCT02165215|41611935|FG001|Induction Phase|Lack of Efficacy|0|||
19371323|NCT02165215|41611936|FG002|Induction Phase|Lack of Efficacy|0|||
19371324|NCT02165215|41611934|FG000|Induction Phase|Non-Compliance|2|||
19371325|NCT02165215|41611935|FG001|Induction Phase|Non-Compliance|0|||
19371326|NCT02165215|41611936|FG002|Induction Phase|Non-Compliance|0|||
19371327|NCT02165215|41611934|FG000|Induction Phase|Lost to Follow-up|6|||
19371328|NCT02165215|41611935|FG001|Induction Phase|Lost to Follow-up|0|||
19371329|NCT02165215|41611936|FG002|Induction Phase|Lost to Follow-up|0|||
19371330|NCT02165215|41611934|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19371331|NCT02165215|41611935|FG001|Maintenance Phase|Withdrawal by Subject|7|||
19371332|NCT02165215|41611936|FG002|Maintenance Phase|Withdrawal by Subject|3|||
19371333|NCT02165215|41611934|FG000|Maintenance Phase|Multiple reasons|0|||
19371334|NCT02165215|41611935|FG001|Maintenance Phase|Multiple reasons|2|||
19371335|NCT02165215|41611936|FG002|Maintenance Phase|Multiple reasons|1|||
19371336|NCT02165215|41611934|FG000|Maintenance Phase|Lost to Follow-up|0|||
19371337|NCT02165215|41611935|FG001|Maintenance Phase|Lost to Follow-up|2|||
19371338|NCT02165215|41611936|FG002|Maintenance Phase|Lost to Follow-up|0|||
19371339|NCT02165215|41611934|FG000|Maintenance Phase|Adverse Event|0|||
19371340|NCT02165215|41611935|FG001|Maintenance Phase|Adverse Event|1|||
19371341|NCT02165215|41611936|FG002|Maintenance Phase|Adverse Event|1|||
19478060|NCT01693562|41757329|FG015|Exploration Phase|Death|0|||
19371342|NCT02757625|41611951|FG000|Overall Study|Investigator's discretion|0|||
19371343|NCT02757625|41611952|FG001|Overall Study|Investigator's discretion|0|||
19371344|NCT02757625|41611953|FG002|Overall Study|Investigator's discretion|1|||
19478061|NCT01693562|41757330|FG016|Exploration Phase|Death|0|||
19371345|NCT02757625|41611954|FG003|Overall Study|Investigator's discretion|0|||
19371346|NCT02757625|41611951|FG000|Overall Study|Adverse Event|0|||
19371347|NCT02757625|41611952|FG001|Overall Study|Adverse Event|0|||
19371348|NCT02757625|41611953|FG002|Overall Study|Adverse Event|1|||
19371349|NCT02757625|41611954|FG003|Overall Study|Adverse Event|0|||
19371350|NCT02581202|41611966|FG000|Overall Study|Lack of Efficacy|2|||
19371351|NCT02581202|41611966|FG000|Overall Study|Withdrawal by Subject|4|||
19371352|NCT02581202|41611966|FG000|Overall Study|Lost to Follow-up|5|||
19371353|NCT02581202|41611966|FG000|Overall Study|Pregnancy|3|||
19371354|NCT02758171|41611973|FG000|Wash-out|Withdrawal by Subject|1|||
19371355|NCT02758171|41611974|FG001|Wash-out|Withdrawal by Subject|0|||
19371356|NCT02758171|41611973|FG000|Wash-out|Other reason|1|||
19371357|NCT02758171|41611974|FG001|Wash-out|Other reason|0|||
19371358|NCT00101101|41611980|FG000|Overall Study|never received vaccine|20|||
19371359|NCT01664078|41612007|FG000|Overall Study|Death|9|||
19371360|NCT01664078|41612007|FG000|Overall Study|Withdrawal by Subject|4|||
19371361|NCT01664078|41612007|FG000|Overall Study|Lost to Follow-up|2|||
19371362|NCT01664078|41612007|FG000|Overall Study|missed 5 year visit|1|||
19371363|NCT01664078|41612007|FG000|Overall Study|Other|53|||
19371364|NCT03367403|41612060|FG000|Overall Study|Adverse Event|20|||
19371365|NCT03367403|41612061|FG001|Overall Study|Adverse Event|6|||
19371366|NCT03367403|41612062|FG002|Overall Study|Adverse Event|2|||
19371367|NCT03367403|41612060|FG000|Overall Study|Withdrawal by Subject|12|||
19371368|NCT03367403|41612061|FG001|Overall Study|Withdrawal by Subject|13|||
19371369|NCT03367403|41612062|FG002|Overall Study|Withdrawal by Subject|1|||
19371370|NCT03367403|41612060|FG000|Overall Study|Death|1|||
19371371|NCT03367403|41612061|FG001|Overall Study|Death|2|||
19371372|NCT03367403|41612062|FG002|Overall Study|Death|0|||
19371373|NCT03367403|41612060|FG000|Overall Study|Physician Decision|0|||
19371374|NCT03367403|41612061|FG001|Overall Study|Physician Decision|1|||
19371375|NCT03367403|41612062|FG002|Overall Study|Physician Decision|0|||
19371376|NCT03367403|41612060|FG000|Overall Study|Protocol Violation|1|||
19371377|NCT03367403|41612061|FG001|Overall Study|Protocol Violation|1|||
19371378|NCT03367403|41612062|FG002|Overall Study|Protocol Violation|0|||
19389437|NCT02709889|41633083|FG001|Overall Study|Study Terminated by Sponsor|6|||
19389438|NCT02709889|41633084|FG002|Overall Study|Study Terminated by Sponsor|2|||
19389439|NCT02709889|41633085|FG003|Overall Study|Study Terminated by Sponsor|17|||
19389440|NCT02709889|41633082|FG000|Overall Study|Other, Not Specified|0|||
19389441|NCT02709889|41633083|FG001|Overall Study|Other, Not Specified|1|||
19389442|NCT02709889|41633084|FG002|Overall Study|Other, Not Specified|1|||
19389443|NCT02709889|41633085|FG003|Overall Study|Other, Not Specified|6|||
19389444|NCT02711995|41633130|FG000|Washout (90 Days)|Conflicting medication|1|||
19389445|NCT02514239|41633168|FG000|Overall Study|Refused to continue trial medication|0|||
19389446|NCT02514239|41633169|FG001|Overall Study|Refused to continue trial medication|0|||
19389447|NCT02514239|41633170|FG002|Overall Study|Refused to continue trial medication|0|||
19389448|NCT02514239|41633171|FG003|Overall Study|Refused to continue trial medication|0|||
19389449|NCT02514239|41633172|FG004|Overall Study|Refused to continue trial medication|0|||
19389450|NCT02514239|41633173|FG005|Overall Study|Refused to continue trial medication|0|||
19389451|NCT02514239|41633174|FG006|Overall Study|Refused to continue trial medication|0|||
19389452|NCT02514239|41633175|FG007|Overall Study|Refused to continue trial medication|0|||
19389453|NCT02514239|41633176|FG008|Overall Study|Refused to continue trial medication|0|||
19389454|NCT02514239|41633177|FG009|Overall Study|Refused to continue trial medication|1|||
19389455|NCT02514239|41633168|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389456|NCT02514239|41633169|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389457|NCT02514239|41633170|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389458|NCT02514239|41633171|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389459|NCT02514239|41633172|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
19371379|NCT03367403|41612060|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
19371380|NCT03367403|41612061|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
19371381|NCT03367403|41612062|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
19371382|NCT03367403|41612060|FG000|Overall Study|COVID-19|3|||
19389460|NCT02514239|41633173|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389461|NCT02514239|41633174|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389462|NCT02514239|41633175|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
19389463|NCT02514239|41633176|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
19389464|NCT02514239|41633177|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
19389465|NCT02514239|41633168|FG000|Overall Study|Not treated|0|||
19389466|NCT02514239|41633169|FG001|Overall Study|Not treated|1|||
19478062|NCT01693562|41757331|FG017|Exploration Phase|Death|0|||
19371383|NCT03367403|41612061|FG001|Overall Study|COVID-19|6|||
19371384|NCT03367403|41612062|FG002|Overall Study|COVID-19|0|||
19371385|NCT03367403|41612060|FG000|Overall Study|Abuse of Alcohol Intake|0|||
19371386|NCT03367403|41612061|FG001|Overall Study|Abuse of Alcohol Intake|1|||
19371387|NCT03367403|41612062|FG002|Overall Study|Abuse of Alcohol Intake|0|||
19371388|NCT03367403|41612060|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
19371389|NCT03367403|41612061|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
19371390|NCT03367403|41612062|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
19371391|NCT02577146|41612070|FG000|Overall Study|Lost to Follow-up|8|||
19371392|NCT02577146|41612070|FG000|Overall Study|Physician Decision|3|||
19371393|NCT02577146|41612070|FG000|Overall Study|Screen Failure|17|||
19371394|NCT00109967|41612076|FG000|Overall Study|Cancel Prior to Treatment|2|||
19371395|NCT00109967|41612077|FG001|Overall Study|Cancel Prior to Treatment|0|||
19478063|NCT01693562|41757332|FG018|Exploration Phase|Death|0|||
19371396|NCT00109967|41612076|FG000|Overall Study|Adverse Event|12|||
19371397|NCT00109967|41612077|FG001|Overall Study|Adverse Event|1|||
19371398|NCT00109967|41612076|FG000|Overall Study|Withdrawal by Subject|5|||
19371399|NCT00109967|41612077|FG001|Overall Study|Withdrawal by Subject|0|||
19371400|NCT00109967|41612076|FG000|Overall Study|Physician Decision|1|||
19371401|NCT00109967|41612077|FG001|Overall Study|Physician Decision|3|||
19371402|NCT00109967|41612076|FG000|Overall Study|Death|0|||
19371403|NCT00109967|41612077|FG001|Overall Study|Death|2|||
19371404|NCT02579096|41612085|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
19371405|NCT02579096|41612086|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
19371406|NCT02579096|41612085|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
19371407|NCT02579096|41612086|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
19371408|NCT02579096|41612085|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
19371409|NCT02579096|41612086|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
19371410|NCT02579096|41612085|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
19371411|NCT02579096|41612086|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
19371412|NCT02579096|41612085|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
19371413|NCT02579096|41612086|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
19371414|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Death|2|||
19371415|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Death|4|||
19371416|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
19371417|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
19371418|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
19371419|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
19371420|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
19371421|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
19371422|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
19371423|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
19371424|NCT02579096|41612085|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
19371425|NCT02579096|41612086|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
19371426|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Death|3|||
19371427|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Death|2|||
19371428|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
19371429|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
19371430|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
19371431|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
19371432|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
19371433|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
19371434|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
19371435|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
19371436|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
19371437|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
19371438|NCT02579096|41612085|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
19371439|NCT02579096|41612086|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
19371440|NCT02578940|41612092|FG000|Overall Study|Screening failure|5|||
19371441|NCT02578940|41612092|FG000|Overall Study|Lost to Follow-up|1|||
19371442|NCT02578862|41612100|FG000|Overall Study|Withdrawal by Subject|0|||
19371443|NCT02578862|41612101|FG001|Overall Study|Withdrawal by Subject|1|||
19371444|NCT02578862|41612100|FG000|Overall Study|Unplanned unilateral procedure|0|||
19371445|NCT02578862|41612101|FG001|Overall Study|Unplanned unilateral procedure|1|||
19371446|NCT02578706|41612110|FG000|Overall Study|Withdrawal by Subject|1|||
19371447|NCT02578706|41612111|FG001|Overall Study|Withdrawal by Subject|0|||
19371448|NCT02578706|41612112|FG002|Overall Study|Withdrawal by Subject|0|||
19371449|NCT02578706|41612110|FG000|Overall Study|Lost to Follow-up|0|||
19371450|NCT02578706|41612111|FG001|Overall Study|Lost to Follow-up|4|||
19371451|NCT02578706|41612112|FG002|Overall Study|Lost to Follow-up|0|||
19371452|NCT02578706|41612110|FG000|Overall Study|Physician Decision|0|||
19371453|NCT02578706|41612111|FG001|Overall Study|Physician Decision|1|||
19371454|NCT02578706|41612112|FG002|Overall Study|Physician Decision|0|||
19371455|NCT00108953|41612122|FG000|Follow-up|Death|18|||
19371456|NCT00108953|41612123|FG001|Follow-up|Death|26|||
19371457|NCT00108953|41612122|FG000|Follow-up|Lost to Follow-up|1|||
19371458|NCT00108953|41612123|FG001|Follow-up|Lost to Follow-up|1|||
19371459|NCT00108953|41612122|FG000|Follow-up|Study terminated by sponsor|10|||
19371460|NCT00108953|41612123|FG001|Follow-up|Study terminated by sponsor|6|||
19478064|NCT01693562|41757333|FG019|Exploration Phase|Death|0|||
19698864|NCT00089674|42143703|FG001|Overall Study|Death|43|||
19371461|NCT02578316|41612131|FG000|Extension Phase|Progression of disease|6|||
19371462|NCT02576678|41612142|FG000|Overall Study|Adverse Event|0|||
19371463|NCT02576678|41612143|FG001|Overall Study|Adverse Event|0|||
19371464|NCT02576678|41612144|FG002|Overall Study|Adverse Event|2|||
19371465|NCT02576678|41612142|FG000|Overall Study|Withdrawal by Subject|3|||
19371466|NCT02576678|41612143|FG001|Overall Study|Withdrawal by Subject|1|||
19371467|NCT02576678|41612144|FG002|Overall Study|Withdrawal by Subject|2|||
19371468|NCT02576678|41612142|FG000|Overall Study|Lost to Follow-up|0|||
19371469|NCT02576678|41612143|FG001|Overall Study|Lost to Follow-up|0|||
19371470|NCT02576678|41612144|FG002|Overall Study|Lost to Follow-up|1|||
19371471|NCT02576678|41612142|FG000|Overall Study|Miscellaneous|2|||
19371472|NCT02576678|41612143|FG001|Overall Study|Miscellaneous|0|||
19371473|NCT02576678|41612144|FG002|Overall Study|Miscellaneous|0|||
19371474|NCT00108745|41612155|FG000|Overall Study|Withdrawal by Subject|19|||
19371475|NCT00108745|41612156|FG001|Overall Study|Withdrawal by Subject|12|||
19371476|NCT00108745|41612157|FG002|Overall Study|Withdrawal by Subject|12|||
19371477|NCT00108745|41612155|FG000|Overall Study|Never Treated|8|||
19371478|NCT00108745|41612156|FG001|Overall Study|Never Treated|10|||
19371479|NCT00108745|41612157|FG002|Overall Study|Never Treated|12|||
19371480|NCT00108745|41612155|FG000|Overall Study|Ineligible|7|||
19371481|NCT00108745|41612156|FG001|Overall Study|Ineligible|13|||
19371482|NCT00108745|41612157|FG002|Overall Study|Ineligible|13|||
19371483|NCT02581982|41612187|FG000|Overall Study|Lack of Efficacy|12|||
19371484|NCT02581982|41612187|FG000|Overall Study|Adverse Event|3|||
19371485|NCT02581982|41612187|FG000|Overall Study|Physician Decision|1|||
19371486|NCT02716805|41612191|FG000|Overall Study|Progressive disease|2|||
19371487|NCT02716805|41612192|FG001|Overall Study|Progressive disease|0|||
19371488|NCT02716805|41612193|FG002|Overall Study|Progressive disease|0|||
19371489|NCT02716805|41612194|FG003|Overall Study|Progressive disease|0|||
19371490|NCT02576990|41612200|FG000|Overall Study|Death|29|||
19371491|NCT02576990|41612201|FG001|Overall Study|Death|18|||
19371492|NCT02576990|41612200|FG000|Overall Study|Physician Decision|1|||
19371493|NCT02576990|41612201|FG001|Overall Study|Physician Decision|0|||
19371494|NCT02576990|41612200|FG000|Overall Study|Screen failure|2|||
19371495|NCT02576990|41612201|FG001|Overall Study|Screen failure|0|||
19371496|NCT02576990|41612200|FG000|Overall Study|Sponsor's decision|24|||
19371497|NCT02576990|41612201|FG001|Overall Study|Sponsor's decision|4|||
19371498|NCT02576990|41612200|FG000|Overall Study|Withdrawal by Subject|0|||
19371499|NCT02576990|41612201|FG001|Overall Study|Withdrawal by Subject|2|||
19371500|NCT04510285|41612207|FG000|Overall Study|Death|1|||
19371501|NCT02576054|41612211|FG000|Overall Study|Withdrawal by Subject|1|||
19371502|NCT01606202|41612219|FG000|Overall Study|Adverse Event|5|||
19371503|NCT01606202|41612220|FG001|Overall Study|Adverse Event|0|||
19371504|NCT01606202|41612219|FG000|Overall Study|Withdrawal by Subject|2|||
19371505|NCT01606202|41612220|FG001|Overall Study|Withdrawal by Subject|1|||
19371506|NCT01606202|41612219|FG000|Overall Study|Personal problems|0|||
19371507|NCT01606202|41612220|FG001|Overall Study|Personal problems|1|||
19371508|NCT01606202|41612219|FG000|Overall Study|Problems with administration|0|||
19371509|NCT01606202|41612220|FG001|Overall Study|Problems with administration|1|||
19371510|NCT01493960|41612228|FG000|Overall Study|Adverse Event|0|||
19371511|NCT01493960|41612229|FG001|Overall Study|Adverse Event|1|||
19371512|NCT01493960|41612228|FG000|Overall Study|Lack of Efficacy|15|||
19371513|NCT01493960|41612229|FG001|Overall Study|Lack of Efficacy|9|||
19371514|NCT01493960|41612228|FG000|Overall Study|Protocol Violation|3|||
19371515|NCT01493960|41612229|FG001|Overall Study|Protocol Violation|0|||
19371516|NCT01493960|41612228|FG000|Overall Study|Withdrawal by Subject|10|||
19371517|NCT01493960|41612229|FG001|Overall Study|Withdrawal by Subject|4|||
19371518|NCT01493960|41612228|FG000|Overall Study|Non-specified|4|||
19371519|NCT01493960|41612229|FG001|Overall Study|Non-specified|4|||
19371520|NCT02630459|41612239|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371521|NCT02630459|41612240|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
19371522|NCT02630459|41612241|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371523|NCT02630459|41612242|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
19371524|NCT02630459|41612243|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371525|NCT02630459|41612244|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371526|NCT02630459|41612245|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371527|NCT02630459|41612246|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
19371528|NCT02630459|41612239|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371529|NCT02630459|41612240|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371530|NCT02630459|41612241|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
19371531|NCT02630459|41612242|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371532|NCT02630459|41612243|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371533|NCT02630459|41612244|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371534|NCT02630459|41612245|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371535|NCT02630459|41612246|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
19371536|NCT02630459|41612239|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
19371537|NCT02630459|41612240|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
19371538|NCT02630459|41612241|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
19371539|NCT02630459|41612242|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
19371540|NCT02630459|41612243|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
19371541|NCT02630459|41612244|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
19371542|NCT02630459|41612245|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
19371543|NCT02630459|41612246|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
19371544|NCT02630459|41612239|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
19371545|NCT02630459|41612240|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371546|NCT02630459|41612241|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371547|NCT02630459|41612242|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371548|NCT02630459|41612243|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371549|NCT02630459|41612244|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371550|NCT02630459|41612245|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371551|NCT02630459|41612246|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
19371552|NCT02630459|41612239|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371553|NCT02630459|41612240|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371554|NCT02630459|41612241|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371555|NCT02630459|41612242|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371556|NCT02630459|41612243|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
19371557|NCT02630459|41612244|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
19371558|NCT02630459|41612245|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371559|NCT02630459|41612246|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
19371560|NCT02630459|41612239|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371561|NCT02630459|41612240|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371562|NCT02630459|41612241|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371563|NCT02630459|41612242|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371564|NCT02630459|41612243|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
19371565|NCT02630459|41612244|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
19371566|NCT02630459|41612245|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371567|NCT02630459|41612246|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
19371568|NCT02630459|41612239|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371569|NCT02630459|41612240|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371570|NCT02630459|41612241|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371571|NCT02630459|41612242|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371572|NCT02630459|41612243|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
19371573|NCT02630459|41612244|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371574|NCT02630459|41612245|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371575|NCT02630459|41612246|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
19371576|NCT02573948|41612271|FG000|Longitudinal Cohort|Death|9|||
19371577|NCT02573948|41612271|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
19371578|NCT02573948|41612271|FG000|Longitudinal Cohort|Incarcerated|25|||
19371579|NCT01464593|41612278|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
19371580|NCT01361711|41612282|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
19371581|NCT01361711|41612282|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
19371582|NCT01361711|41612282|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
19371583|NCT01361711|41612282|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
19371584|NCT01361711|41612282|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
19371585|NCT01361711|41612282|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
19371586|NCT01361711|41612282|FG000|Completed Week 18 of Treatment|Other|9|||
19371587|NCT01361711|41612282|FG000|10 Year Follow-up|Still in follow-up|22|||
19371588|NCT01361711|41612282|FG000|10 Year Follow-up|Death|7|||
19371589|NCT01361711|41612282|FG000|10 Year Follow-up|Developed new cancer|1|||
19371590|NCT01361711|41612282|FG000|10 Year Follow-up|Lost to Follow-up|2|||
19371591|NCT01361711|41612282|FG000|10 Year Follow-up|New treatment started|6|||
19371592|NCT01361711|41612282|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
19371593|NCT01361711|41612282|FG000|10 Year Follow-up|Progressive Disease|1|||
19371594|NCT02572388|41612290|FG000|Overall Study|Withdrawal by Subject|1|||
19371595|NCT02572388|41612291|FG001|Overall Study|Withdrawal by Subject|1|||
19371596|NCT02572388|41612292|FG002|Overall Study|Withdrawal by Subject|2|||
19371597|NCT02572388|41612293|FG003|Overall Study|Withdrawal by Subject|2|||
19371598|NCT02573870|41612305|FG000|Overall Study|Adverse Event|0|||
19371599|NCT02573870|41612306|FG001|Overall Study|Adverse Event|2|||
19371600|NCT02573870|41612305|FG000|Overall Study|Lack of Efficacy|0|||
19371601|NCT02573870|41612306|FG001|Overall Study|Lack of Efficacy|1|||
19371602|NCT02573870|41612305|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
19371603|NCT02573870|41612306|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
19371604|NCT02573870|41612305|FG000|Overall Study|Lost to Follow-up|0|||
19371605|NCT02573870|41612306|FG001|Overall Study|Lost to Follow-up|1|||
19371606|NCT02573870|41612305|FG000|Overall Study|Other: Fail to Meet Visit|0|||
19371607|NCT02573870|41612306|FG001|Overall Study|Other: Fail to Meet Visit|2|||
19371608|NCT02572076|41612312|FG000|Overall Study|Protocol Violation|1|||
19371609|NCT02571452|41612318|FG000|Overall Study Treatment|Protocol Violation|0|||
19371610|NCT02571452|41612319|FG001|Overall Study Treatment|Protocol Violation|1|||
19371611|NCT02571452|41612318|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
19371612|NCT02571452|41612319|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
19371613|NCT02571452|41612318|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
19371614|NCT02571452|41612319|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
19371615|NCT02574260|41612325|FG000|Overall Study|Disease Progression|1|||
19371616|NCT02570126|41612331|FG000|Overall Study|Lost to Follow-up|2|||
19371617|NCT02570126|41612332|FG001|Overall Study|Lost to Follow-up|0|||
19371618|NCT02570126|41612331|FG000|Overall Study|Unable To Arrange Visit 3|1|||
19371619|NCT02570126|41612332|FG001|Overall Study|Unable To Arrange Visit 3|0|||
19371620|NCT02570126|41612331|FG000|Overall Study|Violation Of Procedures GSK|0|||
19371621|NCT02570126|41612332|FG001|Overall Study|Violation Of Procedures GSK|1|||
19371622|NCT02570126|41612331|FG000|Overall Study|Protocol Violation|0|||
19371623|NCT02570126|41612332|FG001|Overall Study|Protocol Violation|1|||
19371624|NCT02570126|41612331|FG000|Overall Study|Withdrawal by Subject|3|||
19371625|NCT02570126|41612332|FG001|Overall Study|Withdrawal by Subject|7|||
19371626|NCT04424641|41612346|FG000|Overall Study|Death|1|||
19371627|NCT04424641|41612347|FG001|Overall Study|Death|2|||
19371628|NCT04424641|41612348|FG002|Overall Study|Death|3|||
19371629|NCT04424641|41612349|FG003|Overall Study|Death|0|||
19371630|NCT04424641|41612350|FG004|Overall Study|Death|3|||
19371631|NCT04424641|41612351|FG005|Overall Study|Death|0|||
19371632|NCT04424641|41612352|FG006|Overall Study|Death|1|||
19371633|NCT04424641|41612353|FG007|Overall Study|Death|2|||
19371634|NCT04424641|41612346|FG000|Overall Study|Sponsor decision|0|||
19371635|NCT04424641|41612347|FG001|Overall Study|Sponsor decision|2|||
19371636|NCT04424641|41612348|FG002|Overall Study|Sponsor decision|3|||
19371637|NCT04424641|41612349|FG003|Overall Study|Sponsor decision|7|||
19371638|NCT04424641|41612350|FG004|Overall Study|Sponsor decision|2|||
19371639|NCT04424641|41612351|FG005|Overall Study|Sponsor decision|2|||
19371640|NCT04424641|41612352|FG006|Overall Study|Sponsor decision|3|||
19371641|NCT04424641|41612353|FG007|Overall Study|Sponsor decision|4|||
19371642|NCT04424641|41612346|FG000|Overall Study|Withdrawal by Subject|0|||
19371643|NCT04424641|41612347|FG001|Overall Study|Withdrawal by Subject|0|||
19371644|NCT04424641|41612348|FG002|Overall Study|Withdrawal by Subject|0|||
19371645|NCT04424641|41612349|FG003|Overall Study|Withdrawal by Subject|0|||
19371646|NCT04424641|41612350|FG004|Overall Study|Withdrawal by Subject|1|||
19371647|NCT04424641|41612351|FG005|Overall Study|Withdrawal by Subject|0|||
19371648|NCT04424641|41612352|FG006|Overall Study|Withdrawal by Subject|0|||
19371649|NCT04424641|41612353|FG007|Overall Study|Withdrawal by Subject|0|||
19371650|NCT04424641|41612346|FG000|Overall Study|Other|0|||
19371651|NCT04424641|41612347|FG001|Overall Study|Other|0|||
19371652|NCT04424641|41612348|FG002|Overall Study|Other|1|||
19371653|NCT04424641|41612349|FG003|Overall Study|Other|0|||
19371654|NCT04424641|41612350|FG004|Overall Study|Other|0|||
19371655|NCT04424641|41612351|FG005|Overall Study|Other|0|||
19371656|NCT04424641|41612352|FG006|Overall Study|Other|0|||
19371657|NCT04424641|41612353|FG007|Overall Study|Other|0|||
19371658|NCT02755831|41612373|FG000|Overall Study|Lost to Follow-up|3|||
19371659|NCT02755831|41612374|FG001|Overall Study|Lost to Follow-up|3|||
19371660|NCT02573246|41612385|FG000|Overall Study|Lost to Follow-up|2|||
19371661|NCT02573246|41612386|FG001|Overall Study|Lost to Follow-up|0|||
19371662|NCT02573246|41612387|FG002|Overall Study|Lost to Follow-up|0|||
19371663|NCT02573246|41612388|FG003|Overall Study|Lost to Follow-up|0|||
19371664|NCT02573246|41612389|FG004|Overall Study|Lost to Follow-up|1|||
19371665|NCT02573246|41612385|FG000|Overall Study|Withdrawal by Subject|0|||
19371666|NCT02573246|41612386|FG001|Overall Study|Withdrawal by Subject|0|||
19371667|NCT02573246|41612387|FG002|Overall Study|Withdrawal by Subject|0|||
19371668|NCT02573246|41612388|FG003|Overall Study|Withdrawal by Subject|0|||
19371669|NCT02573246|41612389|FG004|Overall Study|Withdrawal by Subject|1|||
19371670|NCT02573246|41612385|FG000|Overall Study|Physician Decision|1|||
19371671|NCT02573246|41612386|FG001|Overall Study|Physician Decision|1|||
19371672|NCT02573246|41612387|FG002|Overall Study|Physician Decision|3|||
19371673|NCT02573246|41612388|FG003|Overall Study|Physician Decision|2|||
19371674|NCT02573246|41612389|FG004|Overall Study|Physician Decision|2|||
19371675|NCT02570750|41612408|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
19371676|NCT02570750|41612409|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
19371677|NCT02570750|41612408|FG000|Overall Study|Protocol deviation|4|||
19371678|NCT02570750|41612409|FG001|Overall Study|Protocol deviation|2|||
19371679|NCT02570750|41612408|FG000|Overall Study|Withdrawal by Subject|5|||
19371680|NCT02570750|41612409|FG001|Overall Study|Withdrawal by Subject|0|||
19371681|NCT02570750|41612408|FG000|Overall Study|Lost to Follow-up|2|||
19371682|NCT02570750|41612409|FG001|Overall Study|Lost to Follow-up|2|||
19371683|NCT02570750|41612408|FG000|Overall Study|Adverse Event|2|||
19371684|NCT02570750|41612409|FG001|Overall Study|Adverse Event|1|||
19371685|NCT02573012|41612417|FG000|Overall Study|Adverse Event|5|||
19371686|NCT02573012|41612418|FG001|Overall Study|Adverse Event|5|||
19371687|NCT02573012|41612417|FG000|Overall Study|Lack of Efficacy|5|||
19371688|NCT02573012|41612418|FG001|Overall Study|Lack of Efficacy|4|||
19371689|NCT02573012|41612417|FG000|Overall Study|Non-compliance|1|||
19371690|NCT02573012|41612418|FG001|Overall Study|Non-compliance|2|||
19371691|NCT02573012|41612417|FG000|Overall Study|Withdrawal by Subject|2|||
19371692|NCT02573012|41612418|FG001|Overall Study|Withdrawal by Subject|2|||
19371693|NCT02573012|41612417|FG000|Overall Study|Study Ended per Protocol|1|||
19371694|NCT02573012|41612418|FG001|Overall Study|Study Ended per Protocol|0|||
19371695|NCT02573012|41612417|FG000|Overall Study|Physician Decision|1|||
19371696|NCT02573012|41612418|FG001|Overall Study|Physician Decision|2|||
19371697|NCT02752633|41612424|FG000|Overall Study|Withdrawal by Subject|1|||
19371698|NCT02752087|41612428|FG000|Washout|Physician Decision|1|||
19371699|NCT02752087|41612429|FG001|Washout|Physician Decision|0|||
19371700|NCT02563028|41612435|FG000|Overall Study|Lack of equipment|1|||
19371701|NCT02563028|41612435|FG000|Overall Study|Unable to elicit VEP post induction|1|||
19371702|NCT02192827|41612441|FG000|Overall Study|Lost to Follow-up|25|||
19371703|NCT02192827|41612442|FG001|Overall Study|Lost to Follow-up|27|||
19371704|NCT02192827|41612441|FG000|Overall Study|Given additional steroids with admission|13|||
19371705|NCT02192827|41612442|FG001|Overall Study|Given additional steroids with admission|11|||
19371706|NCT02562716|41612450|FG000|Overall Study|Adverse Event|7|||
19371707|NCT02562716|41612451|FG001|Overall Study|Adverse Event|14|||
19371708|NCT02562716|41612450|FG000|Overall Study|Withdrawal unrelated to AE|7|||
19371709|NCT02562716|41612451|FG001|Overall Study|Withdrawal unrelated to AE|1|||
19371710|NCT02562716|41612450|FG000|Overall Study|Progression|8|||
19371711|NCT02562716|41612451|FG001|Overall Study|Progression|10|||
19371712|NCT02562716|41612450|FG000|Overall Study|Death|2|||
19371713|NCT02562716|41612451|FG001|Overall Study|Death|1|||
19371714|NCT02562716|41612450|FG000|Overall Study|Not protocol specified|4|||
19371715|NCT02562716|41612451|FG001|Overall Study|Not protocol specified|2|||
19371716|NCT02562482|41612461|FG000|Overall Study|Enrolled, but did not receive product|4|||
19371717|NCT02562482|41612462|FG001|Overall Study|Enrolled, but did not receive product|0|||
19371718|NCT02562482|41612461|FG000|Overall Study|Lost to Follow-up|9|||
19371719|NCT02562482|41612462|FG001|Overall Study|Lost to Follow-up|6|||
19371720|NCT02562482|41612461|FG000|Overall Study|Moved from area|2|||
19371721|NCT02562482|41612462|FG001|Overall Study|Moved from area|3|||
19371722|NCT02562482|41612461|FG000|Overall Study|Withdrawal by Subject|5|||
19371723|NCT02562482|41612462|FG001|Overall Study|Withdrawal by Subject|3|||
19371724|NCT02562482|41612461|FG000|Overall Study|Physician Decision|1|||
19371725|NCT02562482|41612462|FG001|Overall Study|Physician Decision|3|||
19371726|NCT02562482|41612461|FG000|Overall Study|Illness/Injury unrelated to product|0|||
19371727|NCT02562482|41612462|FG001|Overall Study|Illness/Injury unrelated to product|1|||
19371728|NCT02568254|41612477|FG000|Period 2|Adverse Event|0|||
19371729|NCT02568254|41612478|FG001|Period 2|Adverse Event|0|||
19371730|NCT02568254|41612479|FG002|Period 2|Adverse Event|1|||
19371731|NCT02568254|41612480|FG003|Period 2|Adverse Event|0|||
19371732|NCT02568254|41612481|FG004|Period 2|Adverse Event|0|||
19371733|NCT02568254|41612482|FG005|Period 2|Adverse Event|0|||
19371734|NCT02568254|41612477|FG000|Period 3|Unstatisfactory Lens fitting|0|||
19371735|NCT02568254|41612478|FG001|Period 3|Unstatisfactory Lens fitting|0|||
19371736|NCT02568254|41612479|FG002|Period 3|Unstatisfactory Lens fitting|0|||
19371737|NCT02568254|41612480|FG003|Period 3|Unstatisfactory Lens fitting|0|||
19371738|NCT02568254|41612481|FG004|Period 3|Unstatisfactory Lens fitting|1|||
19371739|NCT02568254|41612482|FG005|Period 3|Unstatisfactory Lens fitting|0|||
19371740|NCT02567708|41612490|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
19371741|NCT02567708|41612491|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
19371742|NCT02567708|41612490|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
19371743|NCT02567708|41612491|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
19371744|NCT02567708|41612490|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
19371745|NCT02567708|41612491|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
19371746|NCT02567708|41612490|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
19371747|NCT02567708|41612491|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
19371748|NCT02751931|41612500|FG000|Overall Study|Adverse Event|3|||
19371749|NCT02751931|41612501|FG001|Overall Study|Adverse Event|0|||
19371750|NCT02751931|41612500|FG000|Overall Study|Other: Miscelleneous|10|||
19371751|NCT02751931|41612501|FG001|Overall Study|Other: Miscelleneous|8|||
19371752|NCT02561156|41612526|FG000|Part 2|Adverse Event|0|||
19371753|NCT02561156|41612527|FG001|Part 2|Adverse Event|0|||
19371754|NCT02561156|41612528|FG002|Part 2|Adverse Event|0|||
19371755|NCT02561156|41612529|FG003|Part 2|Adverse Event|0|||
19371756|NCT02561156|41612530|FG004|Part 2|Adverse Event|0|||
19371757|NCT02561156|41612531|FG005|Part 2|Adverse Event|0|||
19371758|NCT02561156|41612532|FG006|Part 2|Adverse Event|0|||
19371759|NCT02561156|41612533|FG007|Part 2|Adverse Event|0|||
19371760|NCT02561156|41612534|FG008|Part 2|Adverse Event|0|||
19371761|NCT02561156|41612535|FG009|Part 2|Adverse Event|0|||
19371762|NCT02561156|41612536|FG010|Part 2|Adverse Event|0|||
19371763|NCT02561156|41612537|FG011|Part 2|Adverse Event|1|||
19371764|NCT02561156|41612538|FG012|Part 2|Adverse Event|0|||
19371765|NCT02561078|41612584|FG000|Overall Study|Adverse Event|5|||
19371766|NCT02561078|41612585|FG001|Overall Study|Adverse Event|2|||
19371767|NCT02561078|41612584|FG000|Overall Study|Death|2|||
19371768|NCT02561078|41612585|FG001|Overall Study|Death|1|||
19371769|NCT02561078|41612584|FG000|Overall Study|Lost to Follow-up|2|||
19371770|NCT02561078|41612585|FG001|Overall Study|Lost to Follow-up|6|||
19371771|NCT02561078|41612584|FG000|Overall Study|Non-Compliance with Study Drug|6|||
19371772|NCT02561078|41612585|FG001|Overall Study|Non-Compliance with Study Drug|3|||
19371773|NCT02561078|41612584|FG000|Overall Study|Physician Decision|2|||
19371774|NCT02561078|41612585|FG001|Overall Study|Physician Decision|3|||
19371775|NCT02561078|41612584|FG000|Overall Study|Withdrawal by Subject|13|||
19371776|NCT02561078|41612585|FG001|Overall Study|Withdrawal by Subject|10|||
19371777|NCT02567552|41612593|FG000|Overall Study|Adverse Event|0|||
19371778|NCT02567552|41612594|FG001|Overall Study|Adverse Event|1|||
19371779|NCT02561000|41612608|FG000|Overall Study|Withdrawal by Subject|2|||
19371780|NCT02561000|41612609|FG001|Overall Study|Withdrawal by Subject|3|||
19371781|NCT02561000|41612610|FG002|Overall Study|Withdrawal by Subject|0|||
19371782|NCT02561000|41612608|FG000|Overall Study|Adverse Event|0|||
19371783|NCT02561000|41612609|FG001|Overall Study|Adverse Event|1|||
19371784|NCT02561000|41612610|FG002|Overall Study|Adverse Event|0|||
19371785|NCT01663532|41612620|FG000|Overall Study|Lost to Follow-up|9|||
19371786|NCT01663532|41612621|FG001|Overall Study|Lost to Follow-up|10|||
19371787|NCT01663532|41612620|FG000|Overall Study|Adverse Event|7|||
19371788|NCT01663532|41612621|FG001|Overall Study|Adverse Event|13|||
19371789|NCT01663532|41612620|FG000|Overall Study|Met Withdrawal Criteria|7|||
19371790|NCT01663532|41612621|FG001|Overall Study|Met Withdrawal Criteria|6|||
19371791|NCT01663532|41612620|FG000|Overall Study|Physician Decision|1|||
19371792|NCT01663532|41612621|FG001|Overall Study|Physician Decision|1|||
19371793|NCT01663532|41612620|FG000|Overall Study|Withdrawal by Subject|35|||
19371794|NCT01663532|41612621|FG001|Overall Study|Withdrawal by Subject|17|||
19371795|NCT01663532|41612620|FG000|Overall Study|Lack of Efficacy|15|||
19371796|NCT01663532|41612621|FG001|Overall Study|Lack of Efficacy|60|||
19371797|NCT02525939|41612629|FG000|Overall Study|Lost to Follow-up|27|||
19371798|NCT02525939|41612630|FG001|Overall Study|Lost to Follow-up|24|||
19371799|NCT02525939|41612629|FG000|Overall Study|Physician Decision|0|||
19371800|NCT02525939|41612630|FG001|Overall Study|Physician Decision|1|||
19371801|NCT02525939|41612629|FG000|Overall Study|Withdrawal by Subject|24|||
19371802|NCT02525939|41612630|FG001|Overall Study|Withdrawal by Subject|39|||
19371803|NCT02525939|41612629|FG000|Overall Study|Death|180|||
19371804|NCT02525939|41612630|FG001|Overall Study|Death|179|||
19371805|NCT02697591|41612667|FG000|Overall Study|Lost to Follow-up|0|||
19371806|NCT02697591|41612668|FG001|Overall Study|Lost to Follow-up|0|||
19371807|NCT02697591|41612669|FG002|Overall Study|Lost to Follow-up|0|||
19371808|NCT02697591|41612670|FG003|Overall Study|Lost to Follow-up|0|||
19371809|NCT02697591|41612671|FG004|Overall Study|Lost to Follow-up|0|||
19371810|NCT02697591|41612672|FG005|Overall Study|Lost to Follow-up|1|||
19371811|NCT02697591|41612673|FG006|Overall Study|Lost to Follow-up|1|||
19371812|NCT02697591|41612674|FG007|Overall Study|Lost to Follow-up|0|||
19371813|NCT02697591|41612675|FG008|Overall Study|Lost to Follow-up|0|||
19371814|NCT02697591|41612676|FG009|Overall Study|Lost to Follow-up|1|||
19371815|NCT02697591|41612667|FG000|Overall Study|Withdrawal by Subject|1|||
19371816|NCT02697591|41612668|FG001|Overall Study|Withdrawal by Subject|1|||
19371817|NCT02697591|41612669|FG002|Overall Study|Withdrawal by Subject|2|||
19371818|NCT02697591|41612670|FG003|Overall Study|Withdrawal by Subject|1|||
19371819|NCT02697591|41612671|FG004|Overall Study|Withdrawal by Subject|7|||
19371820|NCT02697591|41612672|FG005|Overall Study|Withdrawal by Subject|6|||
19371821|NCT02697591|41612673|FG006|Overall Study|Withdrawal by Subject|9|||
19371822|NCT02697591|41612674|FG007|Overall Study|Withdrawal by Subject|1|||
19371823|NCT02697591|41612675|FG008|Overall Study|Withdrawal by Subject|6|||
19371824|NCT02697591|41612676|FG009|Overall Study|Withdrawal by Subject|10|||
19371825|NCT02697591|41612667|FG000|Overall Study|Physician Decision|1|||
19371826|NCT02697591|41612668|FG001|Overall Study|Physician Decision|0|||
19371827|NCT02697591|41612669|FG002|Overall Study|Physician Decision|0|||
19371828|NCT02697591|41612670|FG003|Overall Study|Physician Decision|0|||
19371829|NCT02697591|41612671|FG004|Overall Study|Physician Decision|1|||
19371830|NCT02697591|41612672|FG005|Overall Study|Physician Decision|2|||
19371831|NCT02697591|41612673|FG006|Overall Study|Physician Decision|0|||
19371832|NCT02697591|41612674|FG007|Overall Study|Physician Decision|0|||
19371833|NCT02697591|41612675|FG008|Overall Study|Physician Decision|1|||
19371834|NCT02697591|41612676|FG009|Overall Study|Physician Decision|1|||
19371835|NCT02697591|41612667|FG000|Overall Study|Death|2|||
19371836|NCT02697591|41612668|FG001|Overall Study|Death|3|||
19371837|NCT02697591|41612669|FG002|Overall Study|Death|1|||
19371838|NCT02697591|41612670|FG003|Overall Study|Death|1|||
19371839|NCT02697591|41612671|FG004|Overall Study|Death|4|||
19371840|NCT02697591|41612672|FG005|Overall Study|Death|5|||
19371841|NCT02697591|41612673|FG006|Overall Study|Death|3|||
19371842|NCT02697591|41612674|FG007|Overall Study|Death|1|||
19371843|NCT02697591|41612675|FG008|Overall Study|Death|1|||
19371844|NCT02697591|41612676|FG009|Overall Study|Death|5|||
19371845|NCT02697591|41612667|FG000|Overall Study|Reason not Specified|0|||
19371846|NCT02697591|41612668|FG001|Overall Study|Reason not Specified|0|||
19371847|NCT02697591|41612669|FG002|Overall Study|Reason not Specified|0|||
19371848|NCT02697591|41612670|FG003|Overall Study|Reason not Specified|1|||
19371849|NCT02697591|41612671|FG004|Overall Study|Reason not Specified|1|||
19371850|NCT02697591|41612672|FG005|Overall Study|Reason not Specified|2|||
19371851|NCT02697591|41612673|FG006|Overall Study|Reason not Specified|3|||
19371852|NCT02697591|41612674|FG007|Overall Study|Reason not Specified|1|||
19371853|NCT02697591|41612675|FG008|Overall Study|Reason not Specified|1|||
19371854|NCT02697591|41612676|FG009|Overall Study|Reason not Specified|3|||
19371855|NCT02697435|41612701|FG000|Overall Study|Withdrawal by Subject|1|||
19371856|NCT02697435|41612702|FG001|Overall Study|Withdrawal by Subject|0|||
19371857|NCT02697435|41612701|FG000|Overall Study|Physician Decision|0|||
19371858|NCT02697435|41612702|FG001|Overall Study|Physician Decision|4|||
19371859|NCT02174861|41612709|FG000|Overall Study|Decision by sponsor|8|||
19371860|NCT02174861|41612709|FG000|Overall Study|Withdrawal by Subject|124|||
19371861|NCT02174861|41612709|FG000|Overall Study|Lost to Follow-up|26|||
19371862|NCT00140855|41612715|FG000|Overall Study|Progressive disease|2|||
19371863|NCT00700635|41612722|FG000|Overall Study|Adverse Event|1|||
19371864|NCT00700635|41612723|FG001|Overall Study|Adverse Event|0|||
19371865|NCT00700635|41612724|FG002|Overall Study|Adverse Event|0|||
19371866|NCT00700635|41612722|FG000|Overall Study|Lost to Follow-up|1|||
19371867|NCT00700635|41612723|FG001|Overall Study|Lost to Follow-up|3|||
19371868|NCT00700635|41612724|FG002|Overall Study|Lost to Follow-up|0|||
19371869|NCT00700635|41612722|FG000|Overall Study|Protocol Violation|2|||
19371870|NCT00700635|41612723|FG001|Overall Study|Protocol Violation|2|||
19371871|NCT00700635|41612724|FG002|Overall Study|Protocol Violation|0|||
19371872|NCT00700635|41612722|FG000|Overall Study|Withdrawal by Subject|7|||
19371873|NCT00700635|41612723|FG001|Overall Study|Withdrawal by Subject|3|||
19371874|NCT00700635|41612724|FG002|Overall Study|Withdrawal by Subject|1|||
19371875|NCT02780687|41612734|FG000|Overall Study|Adverse Event|1|||
19371876|NCT02780687|41612735|FG001|Overall Study|Adverse Event|1|||
19371877|NCT02780687|41612734|FG000|Overall Study|Withdrawal by Subject|2|||
19371878|NCT02780687|41612735|FG001|Overall Study|Withdrawal by Subject|1|||
19371879|NCT02780687|41612734|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
19371880|NCT02780687|41612735|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
19371881|NCT02780687|41612734|FG000|Overall Study|progressive disease|29|||
19371882|NCT02780687|41612735|FG001|Overall Study|progressive disease|6|||
19371883|NCT02698371|41612740|FG000|All Participants Flow|Lost to Follow-up|3|||
19371884|NCT02698371|41612740|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
19371885|NCT02698371|41612740|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
19371886|NCT02698371|41612740|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
19371887|NCT02698371|41612740|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
19371888|NCT02698371|41612740|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
19371889|NCT02698371|41612740|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
19371890|NCT02781311|41612759|FG000|Overall Study|Adverse Event|2|||
19371891|NCT02781311|41612760|FG001|Overall Study|Adverse Event|6|||
19371892|NCT02781311|41612761|FG002|Overall Study|Adverse Event|1|||
19371893|NCT02781311|41612759|FG000|Overall Study|Withdrawal of Consent|11|||
19371894|NCT02781311|41612760|FG001|Overall Study|Withdrawal of Consent|12|||
19371895|NCT02781311|41612761|FG002|Overall Study|Withdrawal of Consent|2|||
19371896|NCT02781311|41612759|FG000|Overall Study|Lost to Follow-up|11|||
19371897|NCT02781311|41612760|FG001|Overall Study|Lost to Follow-up|8|||
19371898|NCT02781311|41612761|FG002|Overall Study|Lost to Follow-up|1|||
19371899|NCT02781311|41612759|FG000|Overall Study|Non-Compliance with Study Drug|2|||
19371900|NCT02781311|41612760|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19371901|NCT02781311|41612761|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19371902|NCT02564198|41612771|FG000|Overall Study|Withdrawal by Subject|2|||
19371903|NCT02564198|41612772|FG001|Overall Study|Withdrawal by Subject|4|||
19371904|NCT02564198|41612773|FG002|Overall Study|Withdrawal by Subject|0|||
19371905|NCT02564198|41612771|FG000|Overall Study|Adverse Event|0|||
19371906|NCT02564198|41612772|FG001|Overall Study|Adverse Event|1|||
19371907|NCT02564198|41612773|FG002|Overall Study|Adverse Event|0|||
19371908|NCT02564120|41612788|FG000|Overall Study|Did not return release forms|160|||
19371909|NCT02564120|41612788|FG000|Overall Study|Death|58|||
19371910|NCT02564120|41612788|FG000|Overall Study|Withdrawal by Subject|204|||
19371911|NCT02564120|41612788|FG000|Overall Study|Other medical condition|24|||
19371912|NCT00705783|41612804|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
19371913|NCT00705783|41612805|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
19371914|NCT00705783|41612806|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
19371915|NCT00705783|41612804|FG000|Conversion Phase|Lost to Follow-up|13|||
19371916|NCT00705783|41612805|FG001|Conversion Phase|Lost to Follow-up|0|||
19371917|NCT00705783|41612806|FG002|Conversion Phase|Lost to Follow-up|0|||
19371918|NCT00705783|41612804|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
19371919|NCT00705783|41612805|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
19371920|NCT00705783|41612806|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
19371921|NCT00705783|41612804|FG000|Conversion Phase|Withdrawn by Investigator|4|||
19371922|NCT00705783|41612805|FG001|Conversion Phase|Withdrawn by Investigator|0|||
19371923|NCT00705783|41612806|FG002|Conversion Phase|Withdrawn by Investigator|0|||
19371924|NCT00705783|41612804|FG000|Conversion Phase|Withdrew Consent|24|||
19371925|NCT00705783|41612805|FG001|Conversion Phase|Withdrew Consent|0|||
19371926|NCT00705783|41612806|FG002|Conversion Phase|Withdrew Consent|0|||
19371927|NCT00705783|41612804|FG000|Conversion Phase|Protocol Deviation|2|||
19371928|NCT00705783|41612805|FG001|Conversion Phase|Protocol Deviation|0|||
19371929|NCT00705783|41612806|FG002|Conversion Phase|Protocol Deviation|0|||
19371930|NCT00705783|41612804|FG000|Conversion Phase|Adverse Event|11|||
19371931|NCT00705783|41612805|FG001|Conversion Phase|Adverse Event|0|||
19371932|NCT00705783|41612806|FG002|Conversion Phase|Adverse Event|0|||
19371933|NCT00705783|41612804|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
19371934|NCT00705783|41612805|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
19371935|NCT00705783|41612806|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
19371936|NCT00705783|41612804|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
19371937|NCT00705783|41612805|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
19371938|NCT00705783|41612806|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
19371939|NCT00705783|41612804|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
19371940|NCT00705783|41612805|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
19371941|NCT00705783|41612806|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
19371942|NCT00705783|41612804|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
19371943|NCT00705783|41612805|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
19371944|NCT00705783|41612806|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
19371945|NCT00705783|41612804|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
19371946|NCT00705783|41612805|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
19371947|NCT00705783|41612806|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
19371948|NCT00705783|41612804|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
19371949|NCT00705783|41612805|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
19371950|NCT00705783|41612806|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
19371951|NCT00705783|41612804|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
19371952|NCT00705783|41612805|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
19371953|NCT00705783|41612806|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
19371954|NCT00705783|41612804|FG000|Oral Stabilization Phase|Adverse Event|14|||
19371955|NCT00705783|41612805|FG001|Oral Stabilization Phase|Adverse Event|0|||
19371956|NCT00705783|41612806|FG002|Oral Stabilization Phase|Adverse Event|0|||
19371957|NCT00705783|41612804|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
19371958|NCT00705783|41612805|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19371959|NCT00705783|41612806|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19371960|NCT00705783|41612804|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
19371961|NCT00705783|41612805|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19371962|NCT00705783|41612806|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19371963|NCT00705783|41612804|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
19371964|NCT00705783|41612805|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
19371965|NCT00705783|41612806|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
19371966|NCT00705783|41612804|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
19371967|NCT00705783|41612805|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
19371968|NCT00705783|41612806|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
19371969|NCT00705783|41612804|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
19371970|NCT00705783|41612805|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
19371971|NCT00705783|41612806|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
19371972|NCT00705783|41612804|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
19371973|NCT00705783|41612805|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
19371974|NCT00705783|41612806|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
19371975|NCT00705783|41612804|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
19371976|NCT00705783|41612805|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
19371977|NCT00705783|41612806|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
19371978|NCT00705783|41612804|FG000|Depot Stabilization Phase|Adverse Event|17|||
19371979|NCT00705783|41612805|FG001|Depot Stabilization Phase|Adverse Event|0|||
19371980|NCT00705783|41612806|FG002|Depot Stabilization Phase|Adverse Event|0|||
19371981|NCT00705783|41612804|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
19371982|NCT00705783|41612805|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19371983|NCT00705783|41612806|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
19371984|NCT00705783|41612804|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
19371985|NCT00705783|41612805|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19371986|NCT00705783|41612806|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
19371987|NCT00705783|41612804|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
19371988|NCT00705783|41612805|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
19799231|NCT02901431|42257302|FG005|Main Treatment Part|Lost to Follow-up|2|||
19799232|NCT02901431|42257303|FG006|Main Treatment Part|Lost to Follow-up|3|||
19799233|NCT02901431|42257304|FG007|Main Treatment Part|Lost to Follow-up|0|||
19799234|NCT02901431|42257305|FG008|Main Treatment Part|Lost to Follow-up|0|||
19799235|NCT02901431|42257306|FG009|Main Treatment Part|Lost to Follow-up|0|||
19799236|NCT02901431|42257307|FG010|Main Treatment Part|Lost to Follow-up|0|||
19799237|NCT02901431|42257308|FG011|Main Treatment Part|Lost to Follow-up|0|||
19371989|NCT00705783|41612806|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
19371990|NCT00705783|41612804|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
19371991|NCT00705783|41612805|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
19371992|NCT00705783|41612806|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
19371993|NCT00705783|41612804|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
19371994|NCT00705783|41612805|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
19371995|NCT00705783|41612806|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
19371996|NCT00705783|41612804|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
19371997|NCT00705783|41612805|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
19371998|NCT00705783|41612806|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
19371999|NCT00705783|41612804|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
19372000|NCT00705783|41612805|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
19372001|NCT00705783|41612806|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
19372002|NCT00705783|41612804|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
19372003|NCT00705783|41612805|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
19372004|NCT00705783|41612806|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
19372005|NCT00705783|41612804|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
19372006|NCT00705783|41612805|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
19372007|NCT00705783|41612806|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
19372008|NCT00705783|41612804|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
19372009|NCT00705783|41612805|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
19372010|NCT00705783|41612806|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
19372011|NCT00705783|41612804|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
19372012|NCT00705783|41612805|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
19372013|NCT00705783|41612806|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
19372014|NCT02694549|41612815|FG000|Overall Study|screen failures|2|||
19372015|NCT02782325|41612821|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
19372016|NCT02782325|41612822|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
19372017|NCT02782325|41612823|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
19372018|NCT02782325|41612821|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
19372019|NCT02782325|41612822|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
19372020|NCT02782325|41612823|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
19372021|NCT02693691|41612831|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
19372022|NCT02693691|41612831|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
19372023|NCT02693691|41612831|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
19372024|NCT02693691|41612831|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
19372025|NCT02693691|41612831|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
19372026|NCT02693691|41612831|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
19372027|NCT02693691|41612831|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
19372028|NCT04203667|41612835|FG000|Overall Study|Withdrawal by Subject|1|||
19372029|NCT04203667|41612835|FG000|Overall Study|Lost to Follow-up|1|||
19372030|NCT04203667|41612835|FG000|Overall Study|Death|1|||
19372031|NCT04203667|41612835|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
19372032|NCT02782169|41612842|FG000|Overall Study|Lost to Follow-up|1|||
19372033|NCT02782169|41612843|FG001|Overall Study|Lost to Follow-up|2|||
19372034|NCT02564042|41612855|FG000|Overall Study|Adverse Event|4|||
19372035|NCT02564042|41612856|FG001|Overall Study|Adverse Event|4|||
19372036|NCT02564042|41612857|FG002|Overall Study|Adverse Event|3|||
19372037|NCT02564042|41612858|FG003|Overall Study|Adverse Event|0|||
19372038|NCT02564042|41612859|FG004|Overall Study|Adverse Event|0|||
19372039|NCT02564042|41612860|FG005|Overall Study|Adverse Event|1|||
19372040|NCT02564042|41612855|FG000|Overall Study|Lost to Follow-up|1|||
19372041|NCT02564042|41612856|FG001|Overall Study|Lost to Follow-up|1|||
19372042|NCT02564042|41612857|FG002|Overall Study|Lost to Follow-up|1|||
19372043|NCT02564042|41612858|FG003|Overall Study|Lost to Follow-up|0|||
19372044|NCT02564042|41612859|FG004|Overall Study|Lost to Follow-up|1|||
19372045|NCT02564042|41612860|FG005|Overall Study|Lost to Follow-up|1|||
19372046|NCT02564042|41612855|FG000|Overall Study|Physician Decision|1|||
19372047|NCT02564042|41612856|FG001|Overall Study|Physician Decision|0|||
19372048|NCT02564042|41612857|FG002|Overall Study|Physician Decision|0|||
19372049|NCT02564042|41612858|FG003|Overall Study|Physician Decision|1|||
19372050|NCT02564042|41612859|FG004|Overall Study|Physician Decision|0|||
19372051|NCT02564042|41612860|FG005|Overall Study|Physician Decision|0|||
19372052|NCT02564042|41612855|FG000|Overall Study|Withdrawal by Subject|5|||
19372053|NCT02564042|41612856|FG001|Overall Study|Withdrawal by Subject|3|||
19372054|NCT02564042|41612857|FG002|Overall Study|Withdrawal by Subject|2|||
19372055|NCT02564042|41612858|FG003|Overall Study|Withdrawal by Subject|2|||
19372056|NCT02564042|41612859|FG004|Overall Study|Withdrawal by Subject|10|||
19372057|NCT02564042|41612860|FG005|Overall Study|Withdrawal by Subject|12|||
19372058|NCT02695719|41612893|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
19372059|NCT02695719|41612894|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
19372060|NCT02695719|41612893|FG000|Overall Study|Significant Protocol Deviation|0|||
19372061|NCT02695719|41612894|FG001|Overall Study|Significant Protocol Deviation|1|||
19372062|NCT02695719|41612893|FG000|Overall Study|Voluntary Withdrawal|1|||
19372063|NCT02695719|41612894|FG001|Overall Study|Voluntary Withdrawal|0|||
19372064|NCT02563106|41612911|FG000|Overall Study|Withdrawal by Subject|7|||
19372065|NCT02563106|41612912|FG001|Overall Study|Withdrawal by Subject|8|||
19372066|NCT02563106|41612911|FG000|Overall Study|Adverse Event|17|||
19372067|NCT02563106|41612912|FG001|Overall Study|Adverse Event|15|||
19372068|NCT02563106|41612911|FG000|Overall Study|Protocol Violation|1|||
19372069|NCT02563106|41612912|FG001|Overall Study|Protocol Violation|0|||
19372070|NCT02563106|41612911|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
19372071|NCT02563106|41612912|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
19372072|NCT02563106|41612911|FG000|Overall Study|Lost to Follow-up|3|||
19372073|NCT02563106|41612912|FG001|Overall Study|Lost to Follow-up|2|||
19372074|NCT02563106|41612911|FG000|Overall Study|Physician Decision|3|||
19372075|NCT02563106|41612912|FG001|Overall Study|Physician Decision|1|||
19372076|NCT02563106|41612911|FG000|Overall Study|Other reason - not specified|2|||
19372077|NCT02563106|41612912|FG001|Overall Study|Other reason - not specified|1|||
19372078|NCT02691741|41612920|FG000|Overall Study|Adverse Event|0|||
19372079|NCT02691741|41612921|FG001|Overall Study|Adverse Event|2|||
19372080|NCT02691741|41612920|FG000|Overall Study|Lost to Follow-up|1|||
19372081|NCT02691741|41612921|FG001|Overall Study|Lost to Follow-up|0|||
19372082|NCT02691741|41612920|FG000|Overall Study|Physician Decision|0|||
19372083|NCT02691741|41612921|FG001|Overall Study|Physician Decision|1|||
19372084|NCT02691741|41612920|FG000|Overall Study|Withdrawal by Subject|0|||
19372085|NCT02691741|41612921|FG001|Overall Study|Withdrawal by Subject|4|||
19372086|NCT02691507|41612934|FG000|Overall Study|Missed Visit 3|0|||
19372087|NCT02691507|41612935|FG001|Overall Study|Missed Visit 3|1|||
19372088|NCT04579393|41612943|FG000|Overall Study|Withdrawal by Subject|2|||
19372089|NCT04579393|41612944|FG001|Overall Study|Withdrawal by Subject|2|||
19372090|NCT04579393|41612943|FG000|Overall Study|Death|1|||
19372091|NCT04579393|41612944|FG001|Overall Study|Death|3|||
19372092|NCT02776553|41612953|FG000|Overall Study|Lost to Follow-up|1|||
19372093|NCT02776553|41612954|FG001|Overall Study|Lost to Follow-up|0|||
19372094|NCT02776553|41612953|FG000|Overall Study|got liver transplant|1|||
19372095|NCT02776553|41612954|FG001|Overall Study|got liver transplant|2|||
19372096|NCT02776553|41612953|FG000|Overall Study|had other surgery|1|||
19372097|NCT02776553|41612954|FG001|Overall Study|had other surgery|0|||
19372098|NCT02776553|41612953|FG000|Overall Study|Protocol Violation|0|||
19372099|NCT02776553|41612954|FG001|Overall Study|Protocol Violation|1|||
19372100|NCT02690727|41612960|FG000|Overall Study|Adverse Event|2|||
19372101|NCT02690727|41612961|FG001|Overall Study|Adverse Event|2|||
19372102|NCT02777333|41612971|FG000|Overall Study|Withdrawal by Subject|0|||
19372103|NCT02777333|41612972|FG001|Overall Study|Withdrawal by Subject|1|||
19372104|NCT02777333|41612971|FG000|Overall Study|Lost to Follow-up|0|||
19372105|NCT02777333|41612972|FG001|Overall Study|Lost to Follow-up|1|||
19372106|NCT02695329|41612980|FG000|Overall Study|Adverse Event|1|||
19372107|NCT02695329|41612981|FG001|Overall Study|Adverse Event|0|||
19372108|NCT02695329|41612980|FG000|Overall Study|Poor X-ray quality for measurement|4|||
19372109|NCT02695329|41612981|FG001|Overall Study|Poor X-ray quality for measurement|5|||
19372110|NCT02690649|41612989|FG000|Overall Study|Withdrawal by Subject|1|||
19372111|NCT02690649|41612990|FG001|Overall Study|Withdrawal by Subject|1|||
19372112|NCT02690649|41612989|FG000|Overall Study|Protocol Violation|0|||
19372113|NCT02690649|41612990|FG001|Overall Study|Protocol Violation|3|||
19372114|NCT01358864|41613006|FG000|Overall Study|Adverse Event|0|||
19372115|NCT01358864|41613007|FG001|Overall Study|Adverse Event|6|||
19372116|NCT01358864|41613008|FG002|Overall Study|Adverse Event|9|||
19372117|NCT01358864|41613009|FG003|Overall Study|Adverse Event|0|||
19372118|NCT01358864|41613010|FG004|Overall Study|Adverse Event|4|||
19372119|NCT01358864|41613011|FG005|Overall Study|Adverse Event|8|||
19372120|NCT01358864|41613012|FG006|Overall Study|Adverse Event|12|||
19372121|NCT01358864|41613013|FG007|Overall Study|Adverse Event|7|||
19372122|NCT01358864|41613006|FG000|Overall Study|Lack of Efficacy|26|||
19372123|NCT01358864|41613007|FG001|Overall Study|Lack of Efficacy|3|||
19372124|NCT01358864|41613008|FG002|Overall Study|Lack of Efficacy|4|||
19372125|NCT01358864|41613009|FG003|Overall Study|Lack of Efficacy|19|||
19389467|NCT02514239|41633170|FG002|Overall Study|Not treated|0|||
19698865|NCT00089674|42143702|FG000|Overall Study|Disease progression|21|||
19372126|NCT01358864|41613010|FG004|Overall Study|Lack of Efficacy|7|||
19372127|NCT01358864|41613011|FG005|Overall Study|Lack of Efficacy|4|||
19372128|NCT01358864|41613012|FG006|Overall Study|Lack of Efficacy|49|||
19372129|NCT01358864|41613013|FG007|Overall Study|Lack of Efficacy|44|||
19372130|NCT01358864|41613006|FG000|Overall Study|Lost to Follow-up|0|||
19372131|NCT01358864|41613007|FG001|Overall Study|Lost to Follow-up|0|||
19372132|NCT01358864|41613008|FG002|Overall Study|Lost to Follow-up|1|||
19372133|NCT01358864|41613009|FG003|Overall Study|Lost to Follow-up|0|||
19372134|NCT01358864|41613010|FG004|Overall Study|Lost to Follow-up|0|||
19372135|NCT01358864|41613011|FG005|Overall Study|Lost to Follow-up|0|||
19372136|NCT01358864|41613012|FG006|Overall Study|Lost to Follow-up|0|||
19372137|NCT01358864|41613013|FG007|Overall Study|Lost to Follow-up|1|||
19372138|NCT01358864|41613006|FG000|Overall Study|Withdrawal by Subject|3|||
19372139|NCT01358864|41613007|FG001|Overall Study|Withdrawal by Subject|4|||
19372140|NCT01358864|41613008|FG002|Overall Study|Withdrawal by Subject|2|||
19372141|NCT01358864|41613009|FG003|Overall Study|Withdrawal by Subject|0|||
19372142|NCT01358864|41613010|FG004|Overall Study|Withdrawal by Subject|0|||
19372143|NCT01358864|41613011|FG005|Overall Study|Withdrawal by Subject|1|||
19372144|NCT01358864|41613012|FG006|Overall Study|Withdrawal by Subject|1|||
19372145|NCT01358864|41613013|FG007|Overall Study|Withdrawal by Subject|3|||
19372146|NCT01358864|41613006|FG000|Overall Study|Other reason not defined above|2|||
19372147|NCT01358864|41613007|FG001|Overall Study|Other reason not defined above|0|||
19372148|NCT01358864|41613008|FG002|Overall Study|Other reason not defined above|0|||
19372149|NCT01358864|41613009|FG003|Overall Study|Other reason not defined above|0|||
19372150|NCT01358864|41613010|FG004|Overall Study|Other reason not defined above|0|||
19372151|NCT01358864|41613011|FG005|Overall Study|Other reason not defined above|0|||
19608484|NCT00874497|42057413|FG000|Overall Study|Withdrawal by Subject|5|||
19608485|NCT00874497|42057414|FG001|Overall Study|Withdrawal by Subject|4|||
19372152|NCT01358864|41613012|FG006|Overall Study|Other reason not defined above|2|||
19372153|NCT01358864|41613013|FG007|Overall Study|Other reason not defined above|0|||
19372154|NCT01358864|41613006|FG000|Overall Study|Not treated|0|||
19372155|NCT01358864|41613007|FG001|Overall Study|Not treated|0|||
19372156|NCT01358864|41613008|FG002|Overall Study|Not treated|0|||
19372157|NCT01358864|41613009|FG003|Overall Study|Not treated|0|||
19372158|NCT01358864|41613010|FG004|Overall Study|Not treated|0|||
19372159|NCT01358864|41613011|FG005|Overall Study|Not treated|0|||
19608486|NCT00924560|42057423|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
19608487|NCT00924560|42057424|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
19608488|NCT00924560|42057425|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
19608489|NCT00924560|42057423|FG000|Overall Study|Non Compliance with the Protocol|20|||
19608490|NCT00924560|42057424|FG001|Overall Study|Non Compliance with the Protocol|15|||
19608491|NCT00924560|42057425|FG002|Overall Study|Non Compliance with the Protocol|4|||
19608492|NCT00924560|42057423|FG000|Overall Study|Physician Decision|2|||
19608493|NCT00924560|42057424|FG001|Overall Study|Physician Decision|3|||
19608494|NCT00924560|42057425|FG002|Overall Study|Physician Decision|4|||
19608495|NCT00924560|42057423|FG000|Overall Study|Withdrawal by Subject|50|||
19608496|NCT00924560|42057424|FG001|Overall Study|Withdrawal by Subject|44|||
19608497|NCT00924560|42057425|FG002|Overall Study|Withdrawal by Subject|18|||
19608498|NCT00924560|42057423|FG000|Overall Study|Adverse Event|39|||
19608499|NCT00924560|42057424|FG001|Overall Study|Adverse Event|33|||
19608500|NCT00924560|42057425|FG002|Overall Study|Adverse Event|0|||
19608501|NCT00924560|42057423|FG000|Overall Study|Pregnancy|5|||
19608502|NCT00924560|42057424|FG001|Overall Study|Pregnancy|7|||
19608503|NCT00924560|42057425|FG002|Overall Study|Pregnancy|1|||
19608504|NCT00924560|42057423|FG000|Overall Study|Lost to Follow-up|78|||
19608505|NCT00924560|42057424|FG001|Overall Study|Lost to Follow-up|94|||
19608506|NCT00924560|42057425|FG002|Overall Study|Lost to Follow-up|45|||
19608507|NCT00924560|42057423|FG000|Overall Study|Miscellaneous Reasons|13|||
19608508|NCT00924560|42057424|FG001|Overall Study|Miscellaneous Reasons|10|||
19608509|NCT00924560|42057425|FG002|Overall Study|Miscellaneous Reasons|10|||
19608510|NCT00923078|42057438|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
19608511|NCT00923078|42057439|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
19608512|NCT00923078|42057440|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
19608513|NCT00923078|42057438|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
19608514|NCT00923078|42057439|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
19608515|NCT00923078|42057440|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
19608516|NCT00978731|42057451|FG000|Overall Study|Death|4|||
19608517|NCT00978731|42057452|FG001|Overall Study|Death|1|||
19608518|NCT00978731|42057453|FG002|Overall Study|Death|1|||
19608519|NCT00978731|42057454|FG003|Overall Study|Death|0|||
19372160|NCT01358864|41613012|FG006|Overall Study|Not treated|1|||
19372161|NCT01358864|41613013|FG007|Overall Study|Not treated|0|||
19372162|NCT02750761|41613039|FG000|Overall Study|Lost to Follow-up|0|||
19372163|NCT02750761|41613040|FG001|Overall Study|Lost to Follow-up|0|||
19372164|NCT02750761|41613041|FG002|Overall Study|Lost to Follow-up|1|||
19372165|NCT02750761|41613042|FG003|Overall Study|Lost to Follow-up|0|||
19372166|NCT02750761|41613043|FG004|Overall Study|Lost to Follow-up|0|||
19372167|NCT02750761|41613044|FG005|Overall Study|Lost to Follow-up|0|||
19372168|NCT02688933|41613087|FG000|Overall Study|Adverse Event|3|||
19372169|NCT02688933|41613088|FG001|Overall Study|Adverse Event|1|||
19372170|NCT02688933|41613087|FG000|Overall Study|Lack of Efficacy|2|||
19372171|NCT02688933|41613088|FG001|Overall Study|Lack of Efficacy|2|||
19608520|NCT00978731|42057451|FG000|Overall Study|Lost to Follow-up|0|||
19372172|NCT02688933|41613087|FG000|Overall Study|Poor compliance to protocol|7|||
19372173|NCT02688933|41613088|FG001|Overall Study|Poor compliance to protocol|4|||
19372174|NCT02688933|41613087|FG000|Overall Study|Hypoglycemia|2|||
19372175|NCT02688933|41613088|FG001|Overall Study|Hypoglycemia|0|||
19372176|NCT02688933|41613087|FG000|Overall Study|Other than Specified|14|||
19372177|NCT02688933|41613088|FG001|Overall Study|Other than Specified|25|||
19372178|NCT02688933|41613087|FG000|Overall Study|Lost to Follow-up|1|||
19372179|NCT02688933|41613088|FG001|Overall Study|Lost to Follow-up|5|||
19372180|NCT02688621|41613108|FG000|Overall Study|Pregnancy|1|||
19372181|NCT02688621|41613109|FG001|Overall Study|Pregnancy|3|||
19372182|NCT02688621|41613108|FG000|Overall Study|Lost to Follow-up|38|||
19372183|NCT02688621|41613109|FG001|Overall Study|Lost to Follow-up|15|||
19372184|NCT02688621|41613108|FG000|Overall Study|Withdrawal by Subject|1|||
19372185|NCT02688621|41613109|FG001|Overall Study|Withdrawal by Subject|0|||
19372186|NCT04227704|41613121|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
19372187|NCT04227704|41613122|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
19372188|NCT04227704|41613123|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
19372189|NCT04227704|41613121|FG000|Overall Study|due to C/S being cancelled|1|||
19372190|NCT04227704|41613122|FG001|Overall Study|due to C/S being cancelled|0|||
19372191|NCT04227704|41613123|FG002|Overall Study|due to C/S being cancelled|0|||
19372192|NCT03530293|41613133|FG000|Pre-randomization|Adverse Event|12|||
19372193|NCT03530293|41613134|FG001|Pre-randomization|Adverse Event|0|||
19372194|NCT03530293|41613135|FG002|Pre-randomization|Adverse Event|0|||
19372195|NCT03530293|41613133|FG000|Pre-randomization|Protocol Violation|2|||
19372196|NCT03530293|41613134|FG001|Pre-randomization|Protocol Violation|0|||
19372197|NCT03530293|41613135|FG002|Pre-randomization|Protocol Violation|0|||
19372198|NCT03530293|41613133|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
19372199|NCT03530293|41613134|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
19372200|NCT03530293|41613135|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
19372201|NCT03530293|41613133|FG000|Pre-randomization|Withdrawal by Subject|5|||
19372202|NCT03530293|41613134|FG001|Pre-randomization|Withdrawal by Subject|0|||
19372203|NCT03530293|41613135|FG002|Pre-randomization|Withdrawal by Subject|0|||
19372204|NCT03530293|41613133|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
19372205|NCT03530293|41613134|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
19372206|NCT03530293|41613135|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
19372207|NCT03530293|41613133|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
19372208|NCT03530293|41613134|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
19372209|NCT03530293|41613135|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
19372210|NCT03530293|41613133|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
19372211|NCT03530293|41613134|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
19372212|NCT03530293|41613135|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
19372213|NCT03530293|41613133|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
19372214|NCT03530293|41613134|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
19372215|NCT03530293|41613135|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
19372216|NCT03530293|41613133|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
19372217|NCT03530293|41613134|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
19372218|NCT03530293|41613135|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
19372219|NCT01662986|41613170|FG000|Overall Study|Adverse Event|5|||
19372220|NCT01662986|41613171|FG001|Overall Study|Adverse Event|4|||
19372221|NCT01662986|41613170|FG000|Overall Study|Protocol Violation|2|||
19372222|NCT01662986|41613171|FG001|Overall Study|Protocol Violation|3|||
19372223|NCT01662986|41613170|FG000|Overall Study|Lost to Follow-up|5|||
19372224|NCT01662986|41613171|FG001|Overall Study|Lost to Follow-up|4|||
19372225|NCT01662986|41613170|FG000|Overall Study|Withdrawal by Subject|2|||
19372226|NCT01662986|41613171|FG001|Overall Study|Withdrawal by Subject|2|||
19372227|NCT01662986|41613170|FG000|Overall Study|Not Treated|1|||
19372228|NCT01662986|41613171|FG001|Overall Study|Not Treated|0|||
19372229|NCT01662986|41613170|FG000|Overall Study|Other than stated above|3|||
19372230|NCT01662986|41613171|FG001|Overall Study|Other than stated above|0|||
19372231|NCT01337167|41613179|FG000|Infant Series|Adverse Event|1|||
19372232|NCT01337167|41613180|FG001|Infant Series|Adverse Event|1|||
19372233|NCT01337167|41613179|FG000|Infant Series|Death|1|||
19372234|NCT01337167|41613180|FG001|Infant Series|Death|1|||
19372235|NCT01337167|41613179|FG000|Infant Series|Lost to Follow-up|13|||
19372236|NCT01337167|41613180|FG001|Infant Series|Lost to Follow-up|7|||
19372237|NCT01337167|41613179|FG000|Infant Series|Non-compliance with study drug|2|||
19372238|NCT01337167|41613180|FG001|Infant Series|Non-compliance with study drug|1|||
19372239|NCT01337167|41613179|FG000|Infant Series|Physician Decision|3|||
19372240|NCT01337167|41613180|FG001|Infant Series|Physician Decision|1|||
19372241|NCT01337167|41613179|FG000|Infant Series|Protocol Violation|22|||
19372242|NCT01337167|41613180|FG001|Infant Series|Protocol Violation|9|||
19372243|NCT01337167|41613179|FG000|Infant Series|Withdrawal by Subject|15|||
19372244|NCT01337167|41613180|FG001|Infant Series|Withdrawal by Subject|4|||
19372245|NCT01337167|41613179|FG000|Infant Series|Randomized but not vaccinated|5|||
19372246|NCT01337167|41613180|FG001|Infant Series|Randomized but not vaccinated|3|||
19372247|NCT01337167|41613179|FG000|Interim Period|Lost to Follow-up|51|||
19372248|NCT01337167|41613180|FG001|Interim Period|Lost to Follow-up|23|||
19372249|NCT01337167|41613179|FG000|Interim Period|Non-compliance with study drug|1|||
19372250|NCT01337167|41613180|FG001|Interim Period|Non-compliance with study drug|0|||
19372251|NCT01337167|41613179|FG000|Interim Period|Physician Decision|6|||
19372252|NCT01337167|41613180|FG001|Interim Period|Physician Decision|3|||
19372253|NCT01337167|41613179|FG000|Interim Period|Protocol Violation|5|||
19372254|NCT01337167|41613180|FG001|Interim Period|Protocol Violation|3|||
19372255|NCT01337167|41613179|FG000|Interim Period|Withdrawal by Subject|18|||
19372256|NCT01337167|41613180|FG001|Interim Period|Withdrawal by Subject|10|||
19372257|NCT01337167|41613179|FG000|Interim Period|Other protocol criterion not met|0|||
19372258|NCT01337167|41613180|FG001|Interim Period|Other protocol criterion not met|1|||
19372259|NCT01337167|41613179|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
19372260|NCT01337167|41613180|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
19372261|NCT01337167|41613179|FG000|Toddler Vaccinations|Protocol Violation|0|||
19372262|NCT01337167|41613180|FG001|Toddler Vaccinations|Protocol Violation|1|||
19372263|NCT01337167|41613179|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
19372264|NCT01337167|41613180|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
19372265|NCT01338025|41613188|FG000|Overall Study|Unexpected closure of study|10|||
19372266|NCT01338025|41613189|FG001|Overall Study|Unexpected closure of study|9|||
19372267|NCT01338025|41613188|FG000|Overall Study|Withdrawal by Subject|0|||
19372268|NCT01338025|41613189|FG001|Overall Study|Withdrawal by Subject|2|||
19372269|NCT01338025|41613188|FG000|Overall Study|Found ineligible after starting|1|||
19372270|NCT01338025|41613189|FG001|Overall Study|Found ineligible after starting|0|||
19372271|NCT02559206|41613233|FG000|Overall Study|Adverse Event|0|||
19372272|NCT02559206|41613234|FG001|Overall Study|Adverse Event|4|||
19372273|NCT02559206|41613235|FG002|Overall Study|Adverse Event|1|||
19372274|NCT02559206|41613236|FG003|Overall Study|Adverse Event|5|||
19372275|NCT02559206|41613237|FG004|Overall Study|Adverse Event|3|||
19372276|NCT02559206|41613238|FG005|Overall Study|Adverse Event|0|||
19372277|NCT02559206|41613239|FG006|Overall Study|Adverse Event|1|||
19372278|NCT02559206|41613240|FG007|Overall Study|Adverse Event|0|||
19372279|NCT02559206|41613233|FG000|Overall Study|Protocol Violation|1|||
19372280|NCT02559206|41613234|FG001|Overall Study|Protocol Violation|0|||
19372281|NCT02559206|41613235|FG002|Overall Study|Protocol Violation|1|||
19372282|NCT02559206|41613236|FG003|Overall Study|Protocol Violation|0|||
19372283|NCT02559206|41613237|FG004|Overall Study|Protocol Violation|0|||
19372284|NCT02559206|41613238|FG005|Overall Study|Protocol Violation|2|||
19372285|NCT02559206|41613239|FG006|Overall Study|Protocol Violation|0|||
19372286|NCT02559206|41613240|FG007|Overall Study|Protocol Violation|0|||
19372287|NCT02559206|41613233|FG000|Overall Study|Withdrawal by Subject|3|||
19372288|NCT02559206|41613234|FG001|Overall Study|Withdrawal by Subject|3|||
19372289|NCT02559206|41613235|FG002|Overall Study|Withdrawal by Subject|1|||
19372290|NCT02559206|41613236|FG003|Overall Study|Withdrawal by Subject|3|||
19372291|NCT02559206|41613237|FG004|Overall Study|Withdrawal by Subject|5|||
19372292|NCT02559206|41613238|FG005|Overall Study|Withdrawal by Subject|4|||
19372293|NCT02559206|41613239|FG006|Overall Study|Withdrawal by Subject|1|||
19372294|NCT02559206|41613240|FG007|Overall Study|Withdrawal by Subject|2|||
19372295|NCT02559206|41613233|FG000|Overall Study|Lost to Follow-up|3|||
19372296|NCT02559206|41613234|FG001|Overall Study|Lost to Follow-up|5|||
19372297|NCT02559206|41613235|FG002|Overall Study|Lost to Follow-up|3|||
19372298|NCT02559206|41613236|FG003|Overall Study|Lost to Follow-up|3|||
19372299|NCT02559206|41613237|FG004|Overall Study|Lost to Follow-up|2|||
19372300|NCT02559206|41613238|FG005|Overall Study|Lost to Follow-up|5|||
19372301|NCT02559206|41613239|FG006|Overall Study|Lost to Follow-up|1|||
19372302|NCT02559206|41613240|FG007|Overall Study|Lost to Follow-up|4|||
19372303|NCT02559206|41613233|FG000|Overall Study|Lack of Efficacy|1|||
19372304|NCT02559206|41613234|FG001|Overall Study|Lack of Efficacy|0|||
19372305|NCT02559206|41613235|FG002|Overall Study|Lack of Efficacy|3|||
19372306|NCT02559206|41613236|FG003|Overall Study|Lack of Efficacy|2|||
19372307|NCT02559206|41613237|FG004|Overall Study|Lack of Efficacy|2|||
19372308|NCT02559206|41613238|FG005|Overall Study|Lack of Efficacy|3|||
19372309|NCT02559206|41613239|FG006|Overall Study|Lack of Efficacy|3|||
19372310|NCT02559206|41613240|FG007|Overall Study|Lack of Efficacy|3|||
19372311|NCT02559206|41613233|FG000|Overall Study|Other Not Specified|0|||
19372312|NCT02559206|41613234|FG001|Overall Study|Other Not Specified|0|||
19372313|NCT02559206|41613235|FG002|Overall Study|Other Not Specified|0|||
19372314|NCT02559206|41613236|FG003|Overall Study|Other Not Specified|1|||
19372315|NCT02559206|41613237|FG004|Overall Study|Other Not Specified|0|||
19372316|NCT02559206|41613238|FG005|Overall Study|Other Not Specified|0|||
19372317|NCT02559206|41613239|FG006|Overall Study|Other Not Specified|0|||
19372318|NCT02559206|41613240|FG007|Overall Study|Other Not Specified|0|||
19372319|NCT02558894|41613260|FG000|Overall Study|Death; any cause, entire study duration|28|||
19372320|NCT02558894|41613261|FG001|Overall Study|Death; any cause, entire study duration|31|||
19372321|NCT02558894|41613260|FG000|Overall Study|Withdrawal by Subject|2|||
19372322|NCT02558894|41613261|FG001|Overall Study|Withdrawal by Subject|1|||
19372323|NCT02558894|41613260|FG000|Overall Study|Closure of Part A|2|||
19372324|NCT02558894|41613261|FG001|Overall Study|Closure of Part A|1|||
19372325|NCT02688387|41613271|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372326|NCT02688387|41613272|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372327|NCT02688387|41613273|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
19372328|NCT02688387|41613274|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372329|NCT02688387|41613275|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372330|NCT02688387|41613276|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372331|NCT02688387|41613277|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372332|NCT02688387|41613278|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372333|NCT02688387|41613279|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372334|NCT02688387|41613280|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372335|NCT02688387|41613281|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372336|NCT02688387|41613282|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372337|NCT02688387|41613283|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372338|NCT02688387|41613284|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372339|NCT02688387|41613285|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372340|NCT02688387|41613286|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372341|NCT02688387|41613287|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372342|NCT02688387|41613288|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372343|NCT02688387|41613289|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372344|NCT02688387|41613290|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372345|NCT02688387|41613291|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372346|NCT02688387|41613292|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
19372347|NCT02688387|41613271|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372348|NCT02688387|41613272|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372349|NCT02688387|41613273|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372350|NCT02688387|41613274|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
19372351|NCT02688387|41613275|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372352|NCT02688387|41613276|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372353|NCT02688387|41613277|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372354|NCT02688387|41613278|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372355|NCT02688387|41613279|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372356|NCT02688387|41613280|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372357|NCT02688387|41613281|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372358|NCT02688387|41613282|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372359|NCT02688387|41613283|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372360|NCT02688387|41613284|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372361|NCT02688387|41613285|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372362|NCT02688387|41613286|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372363|NCT02688387|41613287|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372364|NCT02688387|41613288|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372365|NCT02688387|41613289|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372366|NCT02688387|41613290|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372367|NCT02688387|41613291|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372368|NCT02688387|41613292|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372369|NCT02688387|41613271|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372370|NCT02688387|41613272|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
19372371|NCT02688387|41613273|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372372|NCT02688387|41613274|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372373|NCT02688387|41613275|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372374|NCT02688387|41613276|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372375|NCT02688387|41613277|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372376|NCT02688387|41613278|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372377|NCT02688387|41613279|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372378|NCT02688387|41613280|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372379|NCT02688387|41613281|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372380|NCT02688387|41613282|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372381|NCT02688387|41613283|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372382|NCT02688387|41613284|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372383|NCT02688387|41613285|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372384|NCT02688387|41613286|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372385|NCT02688387|41613287|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372386|NCT02688387|41613288|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372387|NCT02688387|41613289|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372388|NCT02688387|41613290|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372389|NCT02688387|41613291|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372390|NCT02688387|41613292|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
19372391|NCT02688387|41613271|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19373629|NCT02760407|41614834|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
19372392|NCT02688387|41613272|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372393|NCT02688387|41613273|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
19372394|NCT02688387|41613274|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19608521|NCT00978731|42057452|FG001|Overall Study|Lost to Follow-up|0|||
19608522|NCT00978731|42057453|FG002|Overall Study|Lost to Follow-up|0|||
19608523|NCT00978731|42057454|FG003|Overall Study|Lost to Follow-up|1|||
19608524|NCT00978731|42057451|FG000|Overall Study|Adverse Event|5|||
19608525|NCT00978731|42057452|FG001|Overall Study|Adverse Event|2|||
19608526|NCT00978731|42057453|FG002|Overall Study|Adverse Event|0|||
19608527|NCT00978731|42057454|FG003|Overall Study|Adverse Event|0|||
19608528|NCT00978731|42057451|FG000|Overall Study|Participant's request|1|||
19608529|NCT00978731|42057452|FG001|Overall Study|Participant's request|0|||
19608530|NCT00978731|42057453|FG002|Overall Study|Participant's request|0|||
19608531|NCT00978731|42057454|FG003|Overall Study|Participant's request|0|||
19608532|NCT00978731|42057451|FG000|Overall Study|Administrative reason|3|||
19608533|NCT00978731|42057452|FG001|Overall Study|Administrative reason|3|||
19608534|NCT00978731|42057453|FG002|Overall Study|Administrative reason|1|||
19608535|NCT00978731|42057454|FG003|Overall Study|Administrative reason|0|||
19608536|NCT00978731|42057451|FG000|Overall Study|Deterioration without progression|0|||
19608537|NCT00978731|42057452|FG001|Overall Study|Deterioration without progression|1|||
19608538|NCT00978731|42057453|FG002|Overall Study|Deterioration without progression|0|||
19608539|NCT00978731|42057454|FG003|Overall Study|Deterioration without progression|0|||
19608540|NCT00978731|42057451|FG000|Overall Study|Disease progression/relapse|5|||
19608541|NCT00978731|42057452|FG001|Overall Study|Disease progression/relapse|4|||
19372395|NCT02688387|41613275|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
19372396|NCT02688387|41613276|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372397|NCT02688387|41613277|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372398|NCT02688387|41613278|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372399|NCT02688387|41613279|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372400|NCT02688387|41613280|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372401|NCT02688387|41613281|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372402|NCT02688387|41613282|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372403|NCT02688387|41613283|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372404|NCT02688387|41613284|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372405|NCT02688387|41613285|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372406|NCT02688387|41613286|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372407|NCT02688387|41613287|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372408|NCT02688387|41613288|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372409|NCT02688387|41613289|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372410|NCT02688387|41613290|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372411|NCT02688387|41613291|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372412|NCT02688387|41613292|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
19372413|NCT02688387|41613271|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
19372414|NCT02688387|41613272|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372415|NCT02688387|41613273|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372416|NCT02688387|41613274|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372417|NCT02688387|41613275|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372418|NCT02688387|41613276|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372419|NCT02688387|41613277|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372420|NCT02688387|41613278|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372421|NCT02688387|41613279|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372422|NCT02688387|41613280|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372423|NCT02688387|41613281|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372424|NCT02688387|41613282|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372425|NCT02688387|41613283|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372426|NCT02688387|41613284|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372427|NCT02688387|41613285|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372428|NCT02688387|41613286|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372429|NCT02688387|41613287|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372430|NCT02688387|41613288|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372431|NCT02688387|41613289|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372432|NCT02688387|41613290|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19389468|NCT02514239|41633171|FG003|Overall Study|Not treated|0|||
19389469|NCT02514239|41633172|FG004|Overall Study|Not treated|0|||
19608542|NCT00978731|42057453|FG002|Overall Study|Disease progression/relapse|2|||
19608543|NCT00978731|42057454|FG003|Overall Study|Disease progression/relapse|2|||
19608544|NCT00978731|42057451|FG000|Overall Study|Study closure|3|||
19372433|NCT02688387|41613291|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372434|NCT02688387|41613292|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
19372435|NCT02688387|41613271|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372436|NCT02688387|41613272|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372437|NCT02688387|41613273|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372438|NCT02688387|41613274|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372439|NCT02688387|41613275|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372440|NCT02688387|41613276|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372441|NCT02688387|41613277|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372442|NCT02688387|41613278|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372443|NCT02688387|41613279|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372444|NCT02688387|41613280|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372445|NCT02688387|41613281|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
19372446|NCT02688387|41613282|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372447|NCT02688387|41613283|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372448|NCT02688387|41613284|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372449|NCT02688387|41613285|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372450|NCT02688387|41613286|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372451|NCT02688387|41613287|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372452|NCT02688387|41613288|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372453|NCT02688387|41613289|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372454|NCT02688387|41613290|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372455|NCT02688387|41613291|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372456|NCT02688387|41613292|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
19372457|NCT02688387|41613271|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372458|NCT02688387|41613272|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372459|NCT02688387|41613273|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372460|NCT02688387|41613274|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372461|NCT02688387|41613275|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372462|NCT02688387|41613276|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372463|NCT02688387|41613277|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372464|NCT02688387|41613278|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372465|NCT02688387|41613279|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372466|NCT02688387|41613280|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372467|NCT02688387|41613281|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372468|NCT02688387|41613282|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372469|NCT02688387|41613283|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372470|NCT02688387|41613284|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372471|NCT02688387|41613285|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
19372472|NCT02688387|41613286|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372473|NCT02688387|41613287|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372474|NCT02688387|41613288|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372475|NCT02688387|41613289|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372476|NCT02688387|41613290|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372477|NCT02688387|41613291|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372478|NCT02688387|41613292|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
19372479|NCT02688387|41613271|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372480|NCT02688387|41613272|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372481|NCT02688387|41613273|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372482|NCT02688387|41613274|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372483|NCT02688387|41613275|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372484|NCT02688387|41613276|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372485|NCT02688387|41613277|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372486|NCT02688387|41613278|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372487|NCT02688387|41613279|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372488|NCT02688387|41613280|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372489|NCT02688387|41613281|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372490|NCT02688387|41613282|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372491|NCT02688387|41613283|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372492|NCT02688387|41613284|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372493|NCT02688387|41613285|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372494|NCT02688387|41613286|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372495|NCT02688387|41613287|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372496|NCT02688387|41613288|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372497|NCT02688387|41613289|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372498|NCT02688387|41613290|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19608545|NCT00978731|42057452|FG001|Overall Study|Study closure|4|||
19372499|NCT02688387|41613291|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
19372500|NCT02688387|41613292|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
19372501|NCT02688387|41613271|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372502|NCT02688387|41613272|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372503|NCT02688387|41613273|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372504|NCT02688387|41613274|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372505|NCT02688387|41613275|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372506|NCT02688387|41613276|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372507|NCT02688387|41613277|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372508|NCT02688387|41613278|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372509|NCT02688387|41613279|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372510|NCT02688387|41613280|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372511|NCT02688387|41613281|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372512|NCT02688387|41613282|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372513|NCT02688387|41613283|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372514|NCT02688387|41613284|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372515|NCT02688387|41613285|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372516|NCT02688387|41613286|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372517|NCT02688387|41613287|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372518|NCT02688387|41613288|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372519|NCT02688387|41613289|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
19372520|NCT02688387|41613290|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372521|NCT02688387|41613291|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
19372522|NCT02688387|41613292|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
19372523|NCT02688387|41613271|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372524|NCT02688387|41613272|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372525|NCT02688387|41613273|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372526|NCT02688387|41613274|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372527|NCT02688387|41613275|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372528|NCT02688387|41613276|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372529|NCT02688387|41613277|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372530|NCT02688387|41613278|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372531|NCT02688387|41613279|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372532|NCT02688387|41613280|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372533|NCT02688387|41613281|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372534|NCT02688387|41613282|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372535|NCT02688387|41613283|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372536|NCT02688387|41613284|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372537|NCT02688387|41613285|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372538|NCT02688387|41613286|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372539|NCT02688387|41613287|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372540|NCT02688387|41613288|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372541|NCT02688387|41613289|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372542|NCT02688387|41613290|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
19372543|NCT02688387|41613291|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372544|NCT02688387|41613292|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
19372545|NCT02476201|41613338|FG000|Overall Study|Unable to program MPP|9|||
19372546|NCT02476201|41613338|FG000|Overall Study|Study echo not performed|5|||
19372547|NCT02476201|41613338|FG000|Overall Study|Adverse Event|4|||
19372548|NCT02476201|41613338|FG000|Overall Study|Death|2|||
19372549|NCT02476201|41613338|FG000|Overall Study|Lost to Follow-up|2|||
19372550|NCT02476201|41613338|FG000|Overall Study|MPP programmed to OFF|2|||
19372551|NCT02476201|41613338|FG000|Overall Study|Withdrawal by Subject|1|||
19372552|NCT02476201|41613338|FG000|Overall Study|Unsuccessful implant|1|||
19372553|NCT04112173|41613343|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
19372554|NCT02688153|41613349|FG000|Overall Study|Death|7|||
19372555|NCT02688153|41613350|FG001|Overall Study|Death|5|||
19372556|NCT02688153|41613349|FG000|Overall Study|Withdrawal by Subject|4|||
19372557|NCT02688153|41613350|FG001|Overall Study|Withdrawal by Subject|2|||
19372558|NCT02688153|41613349|FG000|Overall Study|Valve Explant|1|||
19372559|NCT02688153|41613350|FG001|Overall Study|Valve Explant|0|||
19372560|NCT02688153|41613349|FG000|Overall Study|Conversion to Commercial Valve|3|||
19372561|NCT02688153|41613350|FG001|Overall Study|Conversion to Commercial Valve|0|||
19372562|NCT02687919|41613359|FG000|Overall Study|Withdrawal by Subject|6|||
19372563|NCT02687919|41613360|FG001|Overall Study|Withdrawal by Subject|6|||
19372564|NCT02687919|41613359|FG000|Overall Study|Protocol Violation|2|||
19372565|NCT02687919|41613360|FG001|Overall Study|Protocol Violation|0|||
19372566|NCT02687451|41613372|FG000|Overall Study|Withdrawal by Subject|1|||
19372567|NCT02687451|41613373|FG001|Overall Study|Withdrawal by Subject|0|||
19372568|NCT02687451|41613374|FG002|Overall Study|Withdrawal by Subject|0|||
19372569|NCT02687451|41613375|FG003|Overall Study|Withdrawal by Subject|0|||
19372570|NCT02687451|41613376|FG004|Overall Study|Withdrawal by Subject|0|||
19372571|NCT02687451|41613377|FG005|Overall Study|Withdrawal by Subject|1|||
19372572|NCT02557646|41613393|FG000|Overall Study|Adverse Event|40|||
19372573|NCT02557646|41613393|FG000|Overall Study|Death|1|||
19372574|NCT02557646|41613393|FG000|Overall Study|Lack of Efficacy|186|||
19372575|NCT02557646|41613393|FG000|Overall Study|Withdrawal by Subject|18|||
19372576|NCT02557646|41613393|FG000|Overall Study|Lost to Follow-up|17|||
19372577|NCT02557646|41613393|FG000|Overall Study|Other|14|||
19372578|NCT02679573|41613399|FG000|Overall Study|Adverse Event|13|||
19372579|NCT02679573|41613400|FG001|Overall Study|Adverse Event|6|||
19372580|NCT02679573|41613399|FG000|Overall Study|Lack of Efficacy|12|||
19372581|NCT02679573|41613400|FG001|Overall Study|Lack of Efficacy|15|||
19372582|NCT02679573|41613399|FG000|Overall Study|Could not complete required study visits|6|||
19372583|NCT02679573|41613400|FG001|Overall Study|Could not complete required study visits|2|||
19372584|NCT02679573|41613399|FG000|Overall Study|Withdrawal by Subject|2|||
19372585|NCT02679573|41613400|FG001|Overall Study|Withdrawal by Subject|9|||
19372586|NCT02679573|41613399|FG000|Overall Study|Death|2|||
19372587|NCT02679573|41613400|FG001|Overall Study|Death|0|||
19372588|NCT02679573|41613399|FG000|Overall Study|Physician Decision|2|||
19372589|NCT02679573|41613400|FG001|Overall Study|Physician Decision|4|||
19372590|NCT02679573|41613399|FG000|Overall Study|Lost to Follow-up|0|||
19372591|NCT02679573|41613400|FG001|Overall Study|Lost to Follow-up|3|||
19372592|NCT02685033|41613408|FG000|Overall Study|Withdrawal of Consent|0|||
19372593|NCT02685033|41613409|FG001|Overall Study|Withdrawal of Consent|1|||
19372594|NCT02685033|41613408|FG000|Overall Study|Lost to Follow-up|2|||
19372595|NCT02685033|41613409|FG001|Overall Study|Lost to Follow-up|1|||
19372596|NCT02685033|41613408|FG000|Overall Study|Adverse Event|1|||
19372597|NCT02685033|41613409|FG001|Overall Study|Adverse Event|0|||
19372598|NCT02684097|41613417|FG000|Overall Study|Lack of Efficacy|13|||
19372599|NCT02684097|41613418|FG001|Overall Study|Lack of Efficacy|6|||
19372600|NCT02555618|41613426|FG000|Overall Study|Sponsor's Circumstances|1|||
19372601|NCT02555618|41613427|FG001|Overall Study|Sponsor's Circumstances|0|||
19372602|NCT02557100|41613453|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
19372603|NCT02557100|41613454|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
19372604|NCT02557100|41613455|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
19372605|NCT02557100|41613453|FG000|Single Blind Treatment Period|Death|0|||
19372606|NCT02557100|41613454|FG001|Single Blind Treatment Period|Death|1|||
19372607|NCT02557100|41613455|FG002|Single Blind Treatment Period|Death|0|||
19372608|NCT02557100|41613453|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
19372609|NCT02557100|41613454|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
19372610|NCT02557100|41613455|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
19372611|NCT02557100|41613453|FG000|Single Blind Treatment Period|Adverse Event|0|||
19372612|NCT02557100|41613454|FG001|Single Blind Treatment Period|Adverse Event|1|||
19372613|NCT02557100|41613455|FG002|Single Blind Treatment Period|Adverse Event|0|||
19372614|NCT02557100|41613453|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
19372615|NCT02557100|41613454|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
19372616|NCT02557100|41613455|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
19372617|NCT02557100|41613453|FG000|Cumulative Abatacept Period|Other Reasons|0|||
19372618|NCT02557100|41613454|FG001|Cumulative Abatacept Period|Other Reasons|0|||
19372619|NCT02557100|41613455|FG002|Cumulative Abatacept Period|Other Reasons|1|||
19372620|NCT02557100|41613453|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
19372621|NCT02557100|41613454|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
19372622|NCT02557100|41613455|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
19389470|NCT02514239|41633173|FG005|Overall Study|Not treated|0|||
19389471|NCT02514239|41633174|FG006|Overall Study|Not treated|0|||
19389472|NCT02514239|41633175|FG007|Overall Study|Not treated|0|||
19389473|NCT02514239|41633176|FG008|Overall Study|Not treated|0|||
19389474|NCT02514239|41633177|FG009|Overall Study|Not treated|0|||
19389475|NCT02514239|41633168|FG000|Overall Study|Other Adverse Events|2|||
19389476|NCT02514239|41633169|FG001|Overall Study|Other Adverse Events|0|||
19389477|NCT02514239|41633170|FG002|Overall Study|Other Adverse Events|0|||
19389478|NCT02514239|41633171|FG003|Overall Study|Other Adverse Events|1|||
19389479|NCT02514239|41633172|FG004|Overall Study|Other Adverse Events|0|||
19389480|NCT02514239|41633173|FG005|Overall Study|Other Adverse Events|1|||
19372623|NCT02557100|41613453|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
19372624|NCT02557100|41613454|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
19372625|NCT02557100|41613455|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
19372626|NCT01337635|41613465|FG000|Overall Study|Lost to Follow-up|0|||
19372627|NCT01337635|41613466|FG001|Overall Study|Lost to Follow-up|1|||
19372628|NCT02556710|41613474|FG000|Overall Study|Surgical treatment|3|||
19372629|NCT02556710|41613475|FG001|Overall Study|Surgical treatment|0|||
19372630|NCT02556710|41613474|FG000|Overall Study|Required proscribed pain medication|2|||
19372631|NCT02556710|41613475|FG001|Overall Study|Required proscribed pain medication|1|||
19372632|NCT02556710|41613474|FG000|Overall Study|Lack of Efficacy|1|||
19389481|NCT02514239|41633174|FG006|Overall Study|Other Adverse Events|0|||
19478065|NCT01693562|41757334|FG020|Exploration Phase|Death|0|||
19372633|NCT02556710|41613475|FG001|Overall Study|Lack of Efficacy|0|||
19372634|NCT02556710|41613474|FG000|Overall Study|Worsening osteoarthritis|1|||
19372635|NCT02556710|41613475|FG001|Overall Study|Worsening osteoarthritis|0|||
19372636|NCT02556710|41613474|FG000|Overall Study|Moved out of state|1|||
19372637|NCT02556710|41613475|FG001|Overall Study|Moved out of state|0|||
19372638|NCT02556710|41613474|FG000|Overall Study|Missing reason|3|||
19372639|NCT02556710|41613475|FG001|Overall Study|Missing reason|1|||
19372640|NCT02556710|41613474|FG000|Overall Study|Pain as lack of efficacy|0|||
19372641|NCT02556710|41613475|FG001|Overall Study|Pain as lack of efficacy|4|||
19372642|NCT02556632|41613486|FG000|Overall Study|Lost to Follow-up|1|||
19372643|NCT02556632|41613487|FG001|Overall Study|Lost to Follow-up|0|||
19372644|NCT02556632|41613488|FG002|Overall Study|Lost to Follow-up|0|||
19372645|NCT02556632|41613486|FG000|Overall Study|Disliked Intervention|1|||
19372646|NCT02556632|41613487|FG001|Overall Study|Disliked Intervention|1|||
19372647|NCT02556632|41613488|FG002|Overall Study|Disliked Intervention|1|||
19372648|NCT02556632|41613486|FG000|Overall Study|No Reason|1|||
19372649|NCT02556632|41613487|FG001|Overall Study|No Reason|0|||
19372650|NCT02556632|41613488|FG002|Overall Study|No Reason|1|||
19372651|NCT02556632|41613486|FG000|Overall Study|Personal Issues|0|||
19372652|NCT02556632|41613487|FG001|Overall Study|Personal Issues|1|||
19372653|NCT02556632|41613488|FG002|Overall Study|Personal Issues|1|||
19372654|NCT02556632|41613486|FG000|Overall Study|Changed Mind|0|||
19372655|NCT02556632|41613487|FG001|Overall Study|Changed Mind|1|||
19372656|NCT02556632|41613488|FG002|Overall Study|Changed Mind|0|||
19372657|NCT02556632|41613486|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
19372658|NCT02556632|41613487|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
19372659|NCT02556632|41613488|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
19372660|NCT02556632|41613486|FG000|Overall Study|Unrelated Adverse Event|1|||
19372661|NCT02556632|41613487|FG001|Overall Study|Unrelated Adverse Event|0|||
19372662|NCT02556632|41613488|FG002|Overall Study|Unrelated Adverse Event|3|||
19372663|NCT02556632|41613486|FG000|Overall Study|Related Adverse Event|0|||
19372664|NCT02556632|41613487|FG001|Overall Study|Related Adverse Event|1|||
19372665|NCT02556632|41613488|FG002|Overall Study|Related Adverse Event|0|||
19372666|NCT02556632|41613486|FG000|Overall Study|Possibly Related Adverse Event|0|||
19372667|NCT02556632|41613487|FG001|Overall Study|Possibly Related Adverse Event|0|||
19372668|NCT02556632|41613488|FG002|Overall Study|Possibly Related Adverse Event|1|||
19372669|NCT02556632|41613486|FG000|Overall Study|Did Not Start RT|0|||
19372670|NCT02556632|41613487|FG001|Overall Study|Did Not Start RT|1|||
19372671|NCT02556632|41613488|FG002|Overall Study|Did Not Start RT|0|||
19372672|NCT02556632|41613486|FG000|Overall Study|Ineligible|0|||
19372673|NCT02556632|41613487|FG001|Overall Study|Ineligible|1|||
19372674|NCT02556632|41613488|FG002|Overall Study|Ineligible|0|||
19372675|NCT02556632|41613486|FG000|Overall Study|Disliked Study Procedures|0|||
19372676|NCT02556632|41613487|FG001|Overall Study|Disliked Study Procedures|0|||
19372677|NCT02556632|41613488|FG002|Overall Study|Disliked Study Procedures|1|||
19372678|NCT02556632|41613486|FG000|Overall Study|Treatment or Change Delay|0|||
19372679|NCT02556632|41613487|FG001|Overall Study|Treatment or Change Delay|0|||
19372680|NCT02556632|41613488|FG002|Overall Study|Treatment or Change Delay|1|||
19372681|NCT01662440|41613500|FG000|Overall Study|Adverse Event|1|||
19372682|NCT01662440|41613501|FG001|Overall Study|Adverse Event|0|||
19372683|NCT01662440|41613502|FG002|Overall Study|Adverse Event|0|||
19372684|NCT01662440|41613503|FG003|Overall Study|Adverse Event|1|||
19372685|NCT01662440|41613500|FG000|Overall Study|Death|0|||
19372686|NCT01662440|41613501|FG001|Overall Study|Death|1|||
19372687|NCT01662440|41613502|FG002|Overall Study|Death|0|||
19799238|NCT02901431|42257309|FG012|Main Treatment Part|Lost to Follow-up|0|||
19799239|NCT02901431|42257297|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
19799240|NCT02901431|42257298|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
19799241|NCT02901431|42257299|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
19799242|NCT02901431|42257300|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
19799243|NCT02901431|42257301|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
19799244|NCT02901431|42257302|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
19799245|NCT02901431|42257303|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
19799246|NCT02901431|42257304|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
19799247|NCT02901431|42257305|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
19799248|NCT02901431|42257306|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
19799249|NCT02901431|42257307|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
19372688|NCT01662440|41613503|FG003|Overall Study|Death|0|||
19372689|NCT01662440|41613500|FG000|Overall Study|Lost to Follow-up|2|||
19372690|NCT01662440|41613501|FG001|Overall Study|Lost to Follow-up|2|||
19372691|NCT01662440|41613502|FG002|Overall Study|Lost to Follow-up|4|||
19372692|NCT01662440|41613503|FG003|Overall Study|Lost to Follow-up|1|||
19372693|NCT01662440|41613500|FG000|Overall Study|Subject moved to another country.|0|||
19372694|NCT01662440|41613501|FG001|Overall Study|Subject moved to another country.|1|||
19372695|NCT01662440|41613502|FG002|Overall Study|Subject moved to another country.|0|||
19372696|NCT01662440|41613503|FG003|Overall Study|Subject moved to another country.|0|||
19372697|NCT01662440|41613500|FG000|Overall Study|Protocol Violation|1|||
19372698|NCT01662440|41613501|FG001|Overall Study|Protocol Violation|0|||
19372699|NCT01662440|41613502|FG002|Overall Study|Protocol Violation|0|||
19372700|NCT01662440|41613503|FG003|Overall Study|Protocol Violation|0|||
19372701|NCT01662440|41613500|FG000|Overall Study|Withdrawal by Subject|5|||
19372702|NCT01662440|41613501|FG001|Overall Study|Withdrawal by Subject|2|||
19372703|NCT01662440|41613502|FG002|Overall Study|Withdrawal by Subject|2|||
19372704|NCT01662440|41613503|FG003|Overall Study|Withdrawal by Subject|2|||
19372705|NCT01662362|41613523|FG000|Overall Study|Lost to Follow-up|38|||
19372706|NCT02554682|41613538|FG000|Overall Study|Lost to Follow-up|11|||
19372707|NCT02554682|41613539|FG001|Overall Study|Lost to Follow-up|9|||
19372708|NCT02554682|41613540|FG002|Overall Study|Lost to Follow-up|4|||
19372709|NCT02554682|41613541|FG003|Overall Study|Lost to Follow-up|3|||
19372710|NCT02554682|41613542|FG004|Overall Study|Lost to Follow-up|2|||
19372711|NCT02554682|41613543|FG005|Overall Study|Lost to Follow-up|1|||
19698866|NCT00089674|42143703|FG001|Overall Study|Disease progression|23|||
19698867|NCT00089674|42143702|FG000|Overall Study|Ineligibility determined|8|||
19698868|NCT00089674|42143703|FG001|Overall Study|Ineligibility determined|10|||
19698869|NCT00089674|42143702|FG000|Overall Study|Lost to Follow-up|21|||
19698870|NCT00089674|42143703|FG001|Overall Study|Lost to Follow-up|17|||
19698871|NCT00089674|42143702|FG000|Overall Study|Noncompliance|7|||
19698872|NCT00089674|42143703|FG001|Overall Study|Noncompliance|3|||
19698873|NCT00089674|42143702|FG000|Overall Study|Other|5|||
19372712|NCT02554682|41613544|FG006|Overall Study|Lost to Follow-up|6|||
19372713|NCT02554682|41613545|FG007|Overall Study|Lost to Follow-up|6|||
19372714|NCT02554682|41613546|FG008|Overall Study|Lost to Follow-up|2|||
19372715|NCT02554682|41613547|FG009|Overall Study|Lost to Follow-up|2|||
19372716|NCT02554682|41613538|FG000|Overall Study|Withdrawal by Subject|2|||
19372717|NCT02554682|41613539|FG001|Overall Study|Withdrawal by Subject|1|||
19372718|NCT02554682|41613540|FG002|Overall Study|Withdrawal by Subject|0|||
19372719|NCT02554682|41613541|FG003|Overall Study|Withdrawal by Subject|0|||
19372720|NCT02554682|41613542|FG004|Overall Study|Withdrawal by Subject|0|||
19372721|NCT02554682|41613543|FG005|Overall Study|Withdrawal by Subject|0|||
19372722|NCT02554682|41613544|FG006|Overall Study|Withdrawal by Subject|0|||
19372723|NCT02554682|41613545|FG007|Overall Study|Withdrawal by Subject|0|||
19372724|NCT02554682|41613546|FG008|Overall Study|Withdrawal by Subject|0|||
19372725|NCT02554682|41613547|FG009|Overall Study|Withdrawal by Subject|0|||
19372726|NCT02554682|41613538|FG000|Overall Study|Physician Decision|2|||
19372727|NCT02554682|41613539|FG001|Overall Study|Physician Decision|2|||
19372728|NCT02554682|41613540|FG002|Overall Study|Physician Decision|0|||
19372729|NCT02554682|41613541|FG003|Overall Study|Physician Decision|0|||
19372730|NCT02554682|41613542|FG004|Overall Study|Physician Decision|0|||
19372731|NCT02554682|41613543|FG005|Overall Study|Physician Decision|0|||
19372732|NCT02554682|41613544|FG006|Overall Study|Physician Decision|0|||
19372733|NCT02554682|41613545|FG007|Overall Study|Physician Decision|0|||
19372734|NCT02554682|41613546|FG008|Overall Study|Physician Decision|0|||
19372735|NCT02554682|41613547|FG009|Overall Study|Physician Decision|0|||
19372736|NCT00154063|41613583|FG000|Overall Study|Adverse Event|4|||
19372737|NCT00154063|41613584|FG001|Overall Study|Adverse Event|8|||
19372738|NCT00154063|41613583|FG000|Overall Study|Protocol Violation|1|||
19372739|NCT00154063|41613584|FG001|Overall Study|Protocol Violation|1|||
19372740|NCT00154063|41613583|FG000|Overall Study|Investigator or Sponsor Request|0|||
19372741|NCT00154063|41613584|FG001|Overall Study|Investigator or Sponsor Request|1|||
19372742|NCT00154063|41613583|FG000|Overall Study|Withdrawal by Subject|4|||
19372743|NCT00154063|41613584|FG001|Overall Study|Withdrawal by Subject|9|||
19372744|NCT00154063|41613583|FG000|Overall Study|Other|3|||
19372745|NCT00154063|41613584|FG001|Overall Study|Other|3|||
19372746|NCT02683941|41613596|FG000|Double-blind Phase|Adverse Event|0|||
19372747|NCT02683941|41613597|FG001|Double-blind Phase|Adverse Event|1|||
19372748|NCT02683941|41613596|FG000|Double-blind Phase|Withdrawal by Subject|4|||
19372749|NCT02683941|41613597|FG001|Double-blind Phase|Withdrawal by Subject|2|||
19372750|NCT02683941|41613596|FG000|Double-blind Phase|Lost to Follow-up|1|||
19372751|NCT02683941|41613597|FG001|Double-blind Phase|Lost to Follow-up|0|||
19372752|NCT02683941|41613596|FG000|Double-blind Phase|Disease Progression|5|||
19372753|NCT02683941|41613597|FG001|Double-blind Phase|Disease Progression|2|||
19372754|NCT02683941|41613596|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
19372755|NCT02683941|41613597|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
19698874|NCT00089674|42143703|FG001|Overall Study|Other|9|||
19698875|NCT00089674|42143702|FG000|Overall Study|Requirement for alternative therapy|14|||
19698876|NCT00089674|42143703|FG001|Overall Study|Requirement for alternative therapy|4|||
19698877|NCT00313586|42143713|FG000|Overall Study|Disease progression|14|||
19698878|NCT00313586|42143714|FG001|Overall Study|Disease progression|19|||
19698879|NCT00313586|42143715|FG002|Overall Study|Disease progression|10|||
19698880|NCT00313586|42143716|FG003|Overall Study|Disease progression|3|||
19698881|NCT00313586|42143713|FG000|Overall Study|Adverse Event|12|||
19698882|NCT00313586|42143714|FG001|Overall Study|Adverse Event|18|||
19698883|NCT00313586|42143715|FG002|Overall Study|Adverse Event|3|||
19478066|NCT01693562|41757335|FG021|Exploration Phase|Death|0|||
19698884|NCT00313586|42143716|FG003|Overall Study|Adverse Event|10|||
19372756|NCT02683941|41613596|FG000|Open-label Treatment Phase|Disease Progression|1|||
19372757|NCT02683941|41613597|FG001|Open-label Treatment Phase|Disease Progression|2|||
19372758|NCT02683941|41613596|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
19372759|NCT02683941|41613597|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
19372760|NCT02683941|41613596|FG000|Open-label Treatment Phase|Other|1|||
19372761|NCT02683941|41613597|FG001|Open-label Treatment Phase|Other|0|||
19372762|NCT02683941|41613596|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
19372763|NCT02683941|41613597|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
19372764|NCT02683941|41613596|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
19372765|NCT02683941|41613597|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
19372766|NCT02683941|41613596|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
19372767|NCT02683941|41613597|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
19372768|NCT02683941|41613596|FG000|Open-label Follow-up Phase|Other|8|||
19372769|NCT02683941|41613597|FG001|Open-label Follow-up Phase|Other|1|||
19372770|NCT02678247|41613609|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
19372771|NCT02678247|41613610|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
19372772|NCT02678247|41613609|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
19372773|NCT02678247|41613610|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
19372774|NCT02678247|41613609|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
19372775|NCT02678247|41613610|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
19372776|NCT02678247|41613609|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
19372777|NCT02678247|41613610|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
19372778|NCT02678247|41613609|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
19372779|NCT02678247|41613610|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
19372780|NCT02678247|41613609|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
19372781|NCT02678247|41613610|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
19372782|NCT02683785|41613623|FG000|Overall Study|Withdrawal by Subject|1|||
19372783|NCT02683785|41613624|FG001|Overall Study|Withdrawal by Subject|1|||
19372784|NCT02683785|41613623|FG000|Overall Study|Lost to Follow-up|0|||
19372785|NCT02683785|41613624|FG001|Overall Study|Lost to Follow-up|1|||
19372786|NCT02683785|41613623|FG000|Overall Study|Adverse Event|0|||
19372787|NCT02683785|41613624|FG001|Overall Study|Adverse Event|2|||
19608546|NCT00978731|42057453|FG002|Overall Study|Study closure|1|||
19608547|NCT00978731|42057454|FG003|Overall Study|Study closure|1|||
19608548|NCT00978731|42057451|FG000|Overall Study|No response|1|||
19608549|NCT00978731|42057452|FG001|Overall Study|No response|0|||
19608550|NCT00978731|42057453|FG002|Overall Study|No response|0|||
19608551|NCT00978731|42057454|FG003|Overall Study|No response|0|||
19372794|NCT02543294|41613647|FG000|Overall Study|Lost to Follow-up|3|||
19372795|NCT02543294|41613647|FG000|Overall Study|Physician Decision|2|||
19372796|NCT02543294|41613647|FG000|Overall Study|Withdrawal by Subject|7|||
19372797|NCT02728076|41613652|FG000|Overall Study|Physician Decision|4|||
19372798|NCT02551874|41613658|FG000|Overall Study|Lost to Follow-up|0|||
19372799|NCT02551874|41613659|FG001|Overall Study|Lost to Follow-up|2|||
19372800|NCT02551874|41613658|FG000|Overall Study|Pregnancy|0|||
19372801|NCT02551874|41613659|FG001|Overall Study|Pregnancy|1|||
19372802|NCT02551874|41613658|FG000|Overall Study|Reason not reported|10|||
19372803|NCT02551874|41613659|FG001|Overall Study|Reason not reported|4|||
19372804|NCT02551874|41613658|FG000|Overall Study|Did not receive randomized treatment|0|||
19372805|NCT02551874|41613659|FG001|Overall Study|Did not receive randomized treatment|7|||
19372806|NCT02551874|41613658|FG000|Overall Study|Did not enter long-term study|18|||
19372807|NCT02551874|41613659|FG001|Overall Study|Did not enter long-term study|25|||
19372808|NCT02682927|41613684|FG000|Overall Study|Adverse Event|0|||
19372809|NCT02682927|41613685|FG001|Overall Study|Adverse Event|0|||
19372810|NCT02682927|41613686|FG002|Overall Study|Adverse Event|5|||
19372811|NCT02682927|41613687|FG003|Overall Study|Adverse Event|1|||
19372812|NCT02682927|41613688|FG004|Overall Study|Adverse Event|0|||
19372813|NCT02682927|41613689|FG005|Overall Study|Adverse Event|2|||
19372814|NCT02682927|41613684|FG000|Overall Study|Death|0|||
19372815|NCT02682927|41613685|FG001|Overall Study|Death|0|||
19372816|NCT02682927|41613686|FG002|Overall Study|Death|0|||
19372817|NCT02682927|41613687|FG003|Overall Study|Death|1|||
19372818|NCT02682927|41613688|FG004|Overall Study|Death|0|||
19372819|NCT02682927|41613689|FG005|Overall Study|Death|0|||
19372820|NCT02682927|41613684|FG000|Overall Study|Lack of Efficacy|1|||
19372821|NCT02682927|41613685|FG001|Overall Study|Lack of Efficacy|0|||
19372822|NCT02682927|41613686|FG002|Overall Study|Lack of Efficacy|0|||
19372823|NCT02682927|41613687|FG003|Overall Study|Lack of Efficacy|1|||
19372824|NCT02682927|41613688|FG004|Overall Study|Lack of Efficacy|0|||
19372825|NCT02682927|41613689|FG005|Overall Study|Lack of Efficacy|0|||
19372826|NCT02682927|41613684|FG000|Overall Study|Other|0|||
19372827|NCT02682927|41613685|FG001|Overall Study|Other|0|||
19372828|NCT02682927|41613686|FG002|Overall Study|Other|0|||
19372829|NCT02682927|41613687|FG003|Overall Study|Other|2|||
19608552|NCT05056870|42057468|FG000|Period 1|Site COVID-19 Related|3|||
19372830|NCT02682927|41613688|FG004|Overall Study|Other|0|||
19372831|NCT02682927|41613689|FG005|Overall Study|Other|0|||
19372832|NCT02682927|41613684|FG000|Overall Study|Withdrawal by Subject|2|||
19372833|NCT02682927|41613685|FG001|Overall Study|Withdrawal by Subject|0|||
19372834|NCT02682927|41613686|FG002|Overall Study|Withdrawal by Subject|1|||
19372835|NCT02682927|41613687|FG003|Overall Study|Withdrawal by Subject|0|||
19372836|NCT02682927|41613688|FG004|Overall Study|Withdrawal by Subject|1|||
19372837|NCT02682927|41613689|FG005|Overall Study|Withdrawal by Subject|1|||
19372838|NCT02550938|41613713|FG000|Overall Study|Lost to Follow-up|8|||
19372839|NCT02550938|41613714|FG001|Overall Study|Lost to Follow-up|7|||
19372840|NCT02550938|41613715|FG002|Overall Study|Lost to Follow-up|12|||
19372841|NCT02550938|41613716|FG003|Overall Study|Lost to Follow-up|11|||
19372842|NCT02769065|41613756|FG000|Overall Study|Voluntary Withdrawal|1|||
19372843|NCT02769065|41613757|FG001|Overall Study|Voluntary Withdrawal|0|||
19372844|NCT02769065|41613758|FG002|Overall Study|Voluntary Withdrawal|0|||
19372845|NCT02769065|41613759|FG003|Overall Study|Voluntary Withdrawal|0|||
19372846|NCT02769065|41613760|FG004|Overall Study|Voluntary Withdrawal|0|||
19372847|NCT02769065|41613761|FG005|Overall Study|Voluntary Withdrawal|0|||
19372848|NCT02769065|41613762|FG006|Overall Study|Voluntary Withdrawal|0|||
19372849|NCT02769065|41613763|FG007|Overall Study|Voluntary Withdrawal|0|||
19372850|NCT02769065|41613764|FG008|Overall Study|Voluntary Withdrawal|0|||
19372851|NCT02769065|41613765|FG009|Overall Study|Voluntary Withdrawal|0|||
19372852|NCT02769065|41613766|FG010|Overall Study|Voluntary Withdrawal|0|||
19372853|NCT02769065|41613767|FG011|Overall Study|Voluntary Withdrawal|0|||
19372854|NCT02769065|41613768|FG012|Overall Study|Voluntary Withdrawal|0|||
19372855|NCT02769065|41613769|FG013|Overall Study|Voluntary Withdrawal|0|||
19372856|NCT02769065|41613770|FG014|Overall Study|Voluntary Withdrawal|0|||
19372857|NCT02769065|41613771|FG015|Overall Study|Voluntary Withdrawal|0|||
19372858|NCT02769065|41613772|FG016|Overall Study|Voluntary Withdrawal|0|||
19372859|NCT02769065|41613773|FG017|Overall Study|Voluntary Withdrawal|0|||
19372860|NCT02769065|41613774|FG018|Overall Study|Voluntary Withdrawal|0|||
19372861|NCT02769065|41613775|FG019|Overall Study|Voluntary Withdrawal|0|||
19372862|NCT02769065|41613776|FG020|Overall Study|Voluntary Withdrawal|0|||
19372863|NCT02769065|41613777|FG021|Overall Study|Voluntary Withdrawal|0|||
19372864|NCT02769065|41613778|FG022|Overall Study|Voluntary Withdrawal|0|||
19372865|NCT02769065|41613779|FG023|Overall Study|Voluntary Withdrawal|0|||
19372866|NCT02769065|41613780|FG024|Overall Study|Voluntary Withdrawal|0|||
19372867|NCT02769065|41613781|FG025|Overall Study|Voluntary Withdrawal|0|||
19372868|NCT02769065|41613782|FG026|Overall Study|Voluntary Withdrawal|0|||
19372869|NCT02769065|41613783|FG027|Overall Study|Voluntary Withdrawal|0|||
19372870|NCT02769065|41613784|FG028|Overall Study|Voluntary Withdrawal|0|||
19372871|NCT02769065|41613785|FG029|Overall Study|Voluntary Withdrawal|0|||
19372872|NCT02769065|41613756|FG000|Overall Study|Reason Not Specified|0|||
19372873|NCT02769065|41613757|FG001|Overall Study|Reason Not Specified|0|||
19372874|NCT02769065|41613758|FG002|Overall Study|Reason Not Specified|0|||
19372875|NCT02769065|41613759|FG003|Overall Study|Reason Not Specified|0|||
19372876|NCT02769065|41613760|FG004|Overall Study|Reason Not Specified|0|||
19372877|NCT02769065|41613761|FG005|Overall Study|Reason Not Specified|0|||
19372878|NCT02769065|41613762|FG006|Overall Study|Reason Not Specified|1|||
19372879|NCT02769065|41613763|FG007|Overall Study|Reason Not Specified|0|||
19372880|NCT02769065|41613764|FG008|Overall Study|Reason Not Specified|0|||
19372881|NCT02769065|41613765|FG009|Overall Study|Reason Not Specified|0|||
19372882|NCT02769065|41613766|FG010|Overall Study|Reason Not Specified|0|||
19372883|NCT02769065|41613767|FG011|Overall Study|Reason Not Specified|0|||
19372884|NCT02769065|41613768|FG012|Overall Study|Reason Not Specified|0|||
19372885|NCT02769065|41613769|FG013|Overall Study|Reason Not Specified|0|||
19372886|NCT02769065|41613770|FG014|Overall Study|Reason Not Specified|0|||
19372887|NCT02769065|41613771|FG015|Overall Study|Reason Not Specified|0|||
19372888|NCT02769065|41613772|FG016|Overall Study|Reason Not Specified|0|||
19372889|NCT02769065|41613773|FG017|Overall Study|Reason Not Specified|0|||
19372890|NCT02769065|41613774|FG018|Overall Study|Reason Not Specified|0|||
19372891|NCT02769065|41613775|FG019|Overall Study|Reason Not Specified|0|||
19372892|NCT02769065|41613776|FG020|Overall Study|Reason Not Specified|0|||
19372893|NCT02769065|41613777|FG021|Overall Study|Reason Not Specified|0|||
19372894|NCT02769065|41613778|FG022|Overall Study|Reason Not Specified|0|||
19372895|NCT02769065|41613779|FG023|Overall Study|Reason Not Specified|0|||
19372896|NCT02769065|41613780|FG024|Overall Study|Reason Not Specified|0|||
19372897|NCT02769065|41613781|FG025|Overall Study|Reason Not Specified|0|||
19372898|NCT02769065|41613782|FG026|Overall Study|Reason Not Specified|0|||
19372899|NCT02769065|41613783|FG027|Overall Study|Reason Not Specified|0|||
19372900|NCT02769065|41613784|FG028|Overall Study|Reason Not Specified|0|||
19372901|NCT02769065|41613785|FG029|Overall Study|Reason Not Specified|0|||
19372902|NCT02769065|41613756|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372903|NCT02769065|41613757|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372904|NCT02769065|41613758|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372905|NCT02769065|41613759|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372906|NCT02769065|41613760|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372907|NCT02769065|41613761|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372908|NCT02769065|41613762|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372909|NCT02769065|41613763|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372910|NCT02769065|41613764|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372911|NCT02769065|41613765|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372912|NCT02769065|41613766|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
19372913|NCT02769065|41613767|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372914|NCT02769065|41613768|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372915|NCT02769065|41613769|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372916|NCT02769065|41613770|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372917|NCT02769065|41613771|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372918|NCT02769065|41613772|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372919|NCT02769065|41613773|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372920|NCT02769065|41613774|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372921|NCT02769065|41613775|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372922|NCT02769065|41613776|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372923|NCT02769065|41613777|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372924|NCT02769065|41613778|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372925|NCT02769065|41613779|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372926|NCT02769065|41613780|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372927|NCT02769065|41613781|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372928|NCT02769065|41613782|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372929|NCT02769065|41613783|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372930|NCT02769065|41613784|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372931|NCT02769065|41613785|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
19372932|NCT02681523|41613878|FG000|Overall Study|Adverse Event|1|||
19372933|NCT02681523|41613878|FG000|Overall Study|Patient Non-compliance|1|||
19372934|NCT02540954|41613884|FG000|Overall Study|Physician Decision|3|||
19372935|NCT02540954|41613885|FG001|Overall Study|Physician Decision|1|||
19372936|NCT02540954|41613884|FG000|Overall Study|Withdrawal by Subject|6|||
19372937|NCT02540954|41613885|FG001|Overall Study|Withdrawal by Subject|5|||
19372938|NCT02540954|41613884|FG000|Overall Study|Lost to Follow-up|1|||
19372939|NCT02540954|41613885|FG001|Overall Study|Lost to Follow-up|1|||
19372940|NCT02540954|41613884|FG000|Overall Study|Adverse Event|4|||
19372941|NCT02540954|41613885|FG001|Overall Study|Adverse Event|2|||
19372942|NCT02540954|41613884|FG000|Overall Study|Death|0|||
19372943|NCT02540954|41613885|FG001|Overall Study|Death|3|||
19372944|NCT02540954|41613884|FG000|Overall Study|Treatment failure|1|||
19372945|NCT02540954|41613885|FG001|Overall Study|Treatment failure|0|||
19372946|NCT02540954|41613884|FG000|Overall Study|Other reason|4|||
19372947|NCT02540954|41613885|FG001|Overall Study|Other reason|2|||
19372948|NCT02658812|41613891|FG000|Overall Study|Disease Progression|7|||
19372949|NCT02658812|41613891|FG000|Overall Study|Unrelated to study treatment|1|||
19372950|NCT02658812|41613891|FG000|Overall Study|Adverse Event|1|||
19372951|NCT02680665|41613895|FG000|Overall Study|No visit after the first prescription|5|||
19372952|NCT00154375|41613901|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
19372953|NCT00154375|41613902|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
19372954|NCT00154375|41613901|FG000|Overall Study|Adverse Event|18|||
19372955|NCT00154375|41613902|FG001|Overall Study|Adverse Event|20|||
19372956|NCT00154375|41613901|FG000|Overall Study|Withdrawal by Subject|14|||
19372957|NCT00154375|41613902|FG001|Overall Study|Withdrawal by Subject|10|||
19372958|NCT00154375|41613901|FG000|Overall Study|Death|5|||
19372959|NCT00154375|41613902|FG001|Overall Study|Death|13|||
19372960|NCT00154375|41613901|FG000|Overall Study|Study drug no longer required|5|||
19372961|NCT00154375|41613902|FG001|Overall Study|Study drug no longer required|3|||
19372962|NCT00154375|41613901|FG000|Overall Study|Lost to Follow-up|2|||
19372963|NCT00154375|41613902|FG001|Overall Study|Lost to Follow-up|1|||
19372964|NCT00154375|41613901|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19372965|NCT00154375|41613902|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19372966|NCT00154375|41613901|FG000|Overall Study|Protocol Violation|0|||
19372967|NCT00154375|41613902|FG001|Overall Study|Protocol Violation|1|||
19372968|NCT00154375|41613901|FG000|Overall Study|Suspected progression of disease|44|||
19372969|NCT00154375|41613902|FG001|Overall Study|Suspected progression of disease|30|||
19372970|NCT02765399|41613911|FG000|Overall Study|Nausea|1|||
19372971|NCT02765399|41613912|FG001|Overall Study|Nausea|0|||
19372972|NCT02676765|41613920|FG000|Overall Study|Lost to Follow-up|0|||
19372973|NCT02676765|41613921|FG001|Overall Study|Lost to Follow-up|1|||
19372974|NCT02680041|41613927|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
19372975|NCT02680041|41613927|FG000|Overall Study|Lost to Follow-up|2|||
19372976|NCT02547974|41613936|FG000|Overall Study|Withdrawal by Subject|1|||
19372977|NCT02547974|41613937|FG001|Overall Study|Withdrawal by Subject|0|||
19372978|NCT02547974|41613938|FG002|Overall Study|Withdrawal by Subject|0|||
19372979|NCT02547974|41613939|FG003|Overall Study|Withdrawal by Subject|0|||
19372980|NCT00154297|41613954|FG000|Overall Study|Death|5|||
19372981|NCT00154297|41613955|FG001|Overall Study|Death|2|||
19372982|NCT00154297|41613954|FG000|Overall Study|Withdrawal by Subject|0|||
19372983|NCT00154297|41613955|FG001|Overall Study|Withdrawal by Subject|5|||
19372984|NCT00154297|41613954|FG000|Overall Study|Lost to Follow-up|3|||
19372985|NCT00154297|41613955|FG001|Overall Study|Lost to Follow-up|0|||
19372986|NCT02679729|41613970|FG000|Overall Study|Lost to Follow-up|0|||
19372987|NCT02679729|41613971|FG001|Overall Study|Lost to Follow-up|1|||
19372988|NCT02679729|41613972|FG002|Overall Study|Lost to Follow-up|0|||
19372989|NCT02679729|41613973|FG003|Overall Study|Lost to Follow-up|0|||
19372990|NCT02679729|41613974|FG004|Overall Study|Lost to Follow-up|1|||
19372991|NCT02679729|41613975|FG005|Overall Study|Lost to Follow-up|0|||
19372992|NCT02679729|41613976|FG006|Overall Study|Lost to Follow-up|0|||
19372993|NCT02679729|41613977|FG007|Overall Study|Lost to Follow-up|0|||
19372994|NCT02679729|41613978|FG008|Overall Study|Lost to Follow-up|0|||
19372995|NCT02679729|41613970|FG000|Overall Study|Participant decision|0|||
19372996|NCT02679729|41613971|FG001|Overall Study|Participant decision|1|||
19372997|NCT02679729|41613972|FG002|Overall Study|Participant decision|0|||
19372998|NCT02679729|41613973|FG003|Overall Study|Participant decision|0|||
19372999|NCT02679729|41613974|FG004|Overall Study|Participant decision|0|||
19373000|NCT02679729|41613975|FG005|Overall Study|Participant decision|0|||
19373001|NCT02679729|41613976|FG006|Overall Study|Participant decision|1|||
19373002|NCT02679729|41613977|FG007|Overall Study|Participant decision|0|||
19373003|NCT02679729|41613978|FG008|Overall Study|Participant decision|0|||
19373004|NCT02765165|41614017|FG000|Treatment Period|Progressive disease|3|||
19373005|NCT02765165|41614018|FG001|Treatment Period|Progressive disease|2|||
19373006|NCT02765165|41614019|FG002|Treatment Period|Progressive disease|3|||
19373007|NCT02765165|41614020|FG003|Treatment Period|Progressive disease|3|||
19373008|NCT02765165|41614021|FG004|Treatment Period|Progressive disease|4|||
19373009|NCT02765165|41614022|FG005|Treatment Period|Progressive disease|2|||
19373010|NCT02765165|41614023|FG006|Treatment Period|Progressive disease|2|||
19373011|NCT02765165|41614017|FG000|Treatment Period|Physician Decision|0|||
19373012|NCT02765165|41614018|FG001|Treatment Period|Physician Decision|1|||
19373013|NCT02765165|41614019|FG002|Treatment Period|Physician Decision|0|||
19373014|NCT02765165|41614020|FG003|Treatment Period|Physician Decision|0|||
19373015|NCT02765165|41614021|FG004|Treatment Period|Physician Decision|0|||
19373016|NCT02765165|41614022|FG005|Treatment Period|Physician Decision|0|||
19373017|NCT02765165|41614023|FG006|Treatment Period|Physician Decision|0|||
19373018|NCT02765165|41614017|FG000|Treatment Period|Adverse Event|0|||
19373019|NCT02765165|41614018|FG001|Treatment Period|Adverse Event|1|||
19373020|NCT02765165|41614019|FG002|Treatment Period|Adverse Event|0|||
19373021|NCT02765165|41614020|FG003|Treatment Period|Adverse Event|0|||
19373022|NCT02765165|41614021|FG004|Treatment Period|Adverse Event|0|||
19373023|NCT02765165|41614022|FG005|Treatment Period|Adverse Event|0|||
19373024|NCT02765165|41614023|FG006|Treatment Period|Adverse Event|0|||
19373025|NCT02765165|41614017|FG000|Treatment Period|Withdrawal by Subject|0|||
19373026|NCT02765165|41614018|FG001|Treatment Period|Withdrawal by Subject|0|||
19373027|NCT02765165|41614019|FG002|Treatment Period|Withdrawal by Subject|0|||
19373028|NCT02765165|41614020|FG003|Treatment Period|Withdrawal by Subject|0|||
19373029|NCT02765165|41614021|FG004|Treatment Period|Withdrawal by Subject|2|||
19373030|NCT02765165|41614022|FG005|Treatment Period|Withdrawal by Subject|0|||
19373031|NCT02765165|41614023|FG006|Treatment Period|Withdrawal by Subject|0|||
19373032|NCT02765165|41614017|FG000|Treatment Period|Study terminated|0|||
19373033|NCT02765165|41614018|FG001|Treatment Period|Study terminated|0|||
19373034|NCT02765165|41614019|FG002|Treatment Period|Study terminated|0|||
19373035|NCT02765165|41614020|FG003|Treatment Period|Study terminated|0|||
19373036|NCT02765165|41614021|FG004|Treatment Period|Study terminated|0|||
19373037|NCT02765165|41614022|FG005|Treatment Period|Study terminated|1|||
19373038|NCT02765165|41614023|FG006|Treatment Period|Study terminated|2|||
19373039|NCT02765165|41614017|FG000|Post-treatment Follow-up|Death|1|||
19389482|NCT02514239|41633175|FG007|Overall Study|Other Adverse Events|1|||
19389483|NCT02514239|41633176|FG008|Overall Study|Other Adverse Events|2|||
19389484|NCT02514239|41633177|FG009|Overall Study|Other Adverse Events|0|||
19389485|NCT02514239|41633168|FG000|Overall Study|Progressive disease|3|||
19389486|NCT02514239|41633169|FG001|Overall Study|Progressive disease|3|||
19389487|NCT02514239|41633170|FG002|Overall Study|Progressive disease|2|||
19389488|NCT02514239|41633171|FG003|Overall Study|Progressive disease|2|||
19389489|NCT02514239|41633172|FG004|Overall Study|Progressive disease|3|||
19389490|NCT02514239|41633173|FG005|Overall Study|Progressive disease|3|||
19389491|NCT02514239|41633174|FG006|Overall Study|Progressive disease|4|||
19389492|NCT02514239|41633175|FG007|Overall Study|Progressive disease|2|||
19389493|NCT02514239|41633176|FG008|Overall Study|Progressive disease|5|||
19389494|NCT02514239|41633177|FG009|Overall Study|Progressive disease|0|||
19389495|NCT02709109|41633221|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
19389496|NCT02709109|41633222|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
19373040|NCT02765165|41614018|FG001|Post-treatment Follow-up|Death|2|||
19373041|NCT02765165|41614019|FG002|Post-treatment Follow-up|Death|1|||
19373042|NCT02765165|41614020|FG003|Post-treatment Follow-up|Death|1|||
19373043|NCT02765165|41614021|FG004|Post-treatment Follow-up|Death|1|||
19389497|NCT02709109|41633223|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
19373044|NCT02765165|41614022|FG005|Post-treatment Follow-up|Death|1|||
19373045|NCT02765165|41614023|FG006|Post-treatment Follow-up|Death|0|||
19373046|NCT02765165|41614017|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
19373047|NCT02765165|41614018|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
19373048|NCT02765165|41614019|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
19373049|NCT02765165|41614020|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
19373050|NCT02765165|41614021|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
19373051|NCT02765165|41614022|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
19373052|NCT02765165|41614023|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
19373053|NCT02765165|41614017|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373054|NCT02765165|41614018|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373055|NCT02765165|41614019|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
19389498|NCT02709109|41633224|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
19389499|NCT02709109|41633221|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
19389500|NCT02709109|41633222|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
19698885|NCT00313586|42143713|FG000|Overall Study|Death|11|||
19698886|NCT00313586|42143714|FG001|Overall Study|Death|8|||
19389501|NCT02709109|41633223|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
19389502|NCT02709109|41633224|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
19389503|NCT02709109|41633221|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
19389504|NCT02709109|41633222|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
19389505|NCT02709109|41633223|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
19389506|NCT02709109|41633224|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
19389507|NCT02709109|41633221|FG000|Washout Period (28 Days)|Other|2|||
19389508|NCT02709109|41633222|FG001|Washout Period (28 Days)|Other|2|||
19389509|NCT02709109|41633223|FG002|Washout Period (28 Days)|Other|3|||
19389510|NCT02709109|41633224|FG003|Washout Period (28 Days)|Other|0|||
19389511|NCT02709109|41633221|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
19389512|NCT02709109|41633222|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
19389513|NCT02709109|41633223|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
19389514|NCT02709109|41633224|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
19389515|NCT02709109|41633221|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
19389516|NCT02709109|41633222|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
19389517|NCT02709109|41633223|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
19389518|NCT02709109|41633224|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
19389519|NCT02709109|41633221|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
19389520|NCT02709109|41633222|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
19389521|NCT02709109|41633223|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
19389522|NCT02709109|41633224|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
19389523|NCT02709109|41633221|FG000|Treatment Period 2 (28 Days)|Other|0|||
19389524|NCT02709109|41633222|FG001|Treatment Period 2 (28 Days)|Other|0|||
19389525|NCT02709109|41633223|FG002|Treatment Period 2 (28 Days)|Other|1|||
19389526|NCT02709109|41633224|FG003|Treatment Period 2 (28 Days)|Other|0|||
19389527|NCT04289051|41633239|FG000|Overall Study|Lost to Follow-up|0|||
19389528|NCT04289051|41633240|FG001|Overall Study|Lost to Follow-up|0|||
19389529|NCT04289051|41633241|FG002|Overall Study|Lost to Follow-up|2|||
19389530|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
19389531|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
19389532|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
19389533|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
19389534|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
19389535|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
19389536|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
19389537|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
19389538|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
19389539|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
19389540|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
19389541|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
19389542|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
19389543|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
19389544|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
19373056|NCT02765165|41614020|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373057|NCT02765165|41614021|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373058|NCT02765165|41614022|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373059|NCT02765165|41614023|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
19373060|NCT02765165|41614017|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
19373061|NCT02765165|41614018|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
19478067|NCT01693562|41757336|FG022|Exploration Phase|Death|0|||
19478068|NCT01693562|41757314|FG000|Exploration Phase|Other|0|||
19389545|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
19389546|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
19389547|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
19389548|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
19389549|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
19389550|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
19389551|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
19389552|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
19389553|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
19389554|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
19389555|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
19389556|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
19389557|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
19389558|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
19389559|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
19389560|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
19389561|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
19389562|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
19389563|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
19389564|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
19389565|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
19389566|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
19389567|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
19389568|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
19389569|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
19389570|NCT02709655|41633249|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
19389571|NCT02709655|41633250|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
19389572|NCT02709655|41633251|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
19389573|NCT02709655|41633252|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
19389574|NCT02709655|41633253|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
19389575|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
19389576|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
19389577|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
19389578|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
19389579|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
19389580|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
19389581|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
19389582|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
19389583|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
19389584|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
19389585|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
19389586|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
19389587|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
19389588|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
19389589|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
19389590|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
19389591|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
19389592|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
19389593|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
19389594|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
19389595|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
19389596|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
19389597|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
19389598|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
19389599|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
19389600|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
19389601|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
19389602|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
19389603|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
19389604|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
19389605|NCT02709655|41633249|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
19389606|NCT02709655|41633250|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
19389607|NCT02709655|41633251|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
19389608|NCT02709655|41633252|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
19389609|NCT02709655|41633253|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
19389610|NCT02708485|41633267|FG000|Overall Study|Withdrawal by Subject|3|||
19389611|NCT02708485|41633268|FG001|Overall Study|Withdrawal by Subject|2|||
19389612|NCT02709577|41633280|FG000|Overall Study|non-accommodating anatomy|0|||
19389613|NCT02709577|41633281|FG001|Overall Study|non-accommodating anatomy|1|||
19389614|NCT02709577|41633282|FG002|Overall Study|non-accommodating anatomy|0|||
19389615|NCT02709577|41633283|FG003|Overall Study|non-accommodating anatomy|0|||
19389616|NCT02709577|41633280|FG000|Overall Study|procedural complication|0|||
19389617|NCT02709577|41633281|FG001|Overall Study|procedural complication|1|||
19389618|NCT02709577|41633282|FG002|Overall Study|procedural complication|0|||
19389619|NCT02709577|41633283|FG003|Overall Study|procedural complication|0|||
19389620|NCT02709577|41633280|FG000|Overall Study|Withdrawal by Subject|2|||
19389621|NCT02709577|41633281|FG001|Overall Study|Withdrawal by Subject|3|||
19389622|NCT02709577|41633282|FG002|Overall Study|Withdrawal by Subject|2|||
19389623|NCT02709577|41633283|FG003|Overall Study|Withdrawal by Subject|0|||
19389624|NCT02078752|41633304|FG000|Overall Study|Death|0|||
19389625|NCT02078752|41633305|FG001|Overall Study|Death|3|||
19389626|NCT02078752|41633306|FG002|Overall Study|Death|0|||
19389627|NCT02078752|41633307|FG003|Overall Study|Death|0|||
19389628|NCT02078752|41633308|FG004|Overall Study|Death|0|||
19389629|NCT02078752|41633309|FG005|Overall Study|Death|1|||
19389630|NCT02078752|41633310|FG006|Overall Study|Death|0|||
19389631|NCT02078752|41633311|FG007|Overall Study|Death|1|||
19389632|NCT02078752|41633312|FG008|Overall Study|Death|0|||
19389633|NCT02078752|41633313|FG009|Overall Study|Death|4|||
19389634|NCT02078752|41633304|FG000|Overall Study|Lost to Follow-up|1|||
19389635|NCT02078752|41633305|FG001|Overall Study|Lost to Follow-up|0|||
19389636|NCT02078752|41633306|FG002|Overall Study|Lost to Follow-up|0|||
19389637|NCT02078752|41633307|FG003|Overall Study|Lost to Follow-up|1|||
19389638|NCT02078752|41633308|FG004|Overall Study|Lost to Follow-up|0|||
19389639|NCT02078752|41633309|FG005|Overall Study|Lost to Follow-up|0|||
19389640|NCT02078752|41633310|FG006|Overall Study|Lost to Follow-up|0|||
19389641|NCT02078752|41633311|FG007|Overall Study|Lost to Follow-up|0|||
19389642|NCT02078752|41633312|FG008|Overall Study|Lost to Follow-up|0|||
19389643|NCT02078752|41633313|FG009|Overall Study|Lost to Follow-up|0|||
19389644|NCT02078752|41633304|FG000|Overall Study|Withdrawal by Subject|1|||
19389645|NCT02078752|41633305|FG001|Overall Study|Withdrawal by Subject|1|||
19389646|NCT02078752|41633306|FG002|Overall Study|Withdrawal by Subject|1|||
19389647|NCT02078752|41633307|FG003|Overall Study|Withdrawal by Subject|1|||
19389648|NCT02078752|41633308|FG004|Overall Study|Withdrawal by Subject|0|||
19389649|NCT02078752|41633309|FG005|Overall Study|Withdrawal by Subject|3|||
19389650|NCT02078752|41633310|FG006|Overall Study|Withdrawal by Subject|2|||
19389651|NCT02078752|41633311|FG007|Overall Study|Withdrawal by Subject|1|||
19389652|NCT02078752|41633312|FG008|Overall Study|Withdrawal by Subject|0|||
19389653|NCT02078752|41633313|FG009|Overall Study|Withdrawal by Subject|1|||
19389654|NCT02078752|41633304|FG000|Overall Study|Other|0|||
19389655|NCT02078752|41633305|FG001|Overall Study|Other|3|||
19389656|NCT02078752|41633306|FG002|Overall Study|Other|0|||
19389657|NCT02078752|41633307|FG003|Overall Study|Other|0|||
19389658|NCT02078752|41633308|FG004|Overall Study|Other|1|||
19389659|NCT02078752|41633309|FG005|Overall Study|Other|0|||
19389660|NCT02078752|41633310|FG006|Overall Study|Other|0|||
19389661|NCT02078752|41633311|FG007|Overall Study|Other|1|||
19389662|NCT02078752|41633312|FG008|Overall Study|Other|0|||
19389663|NCT02078752|41633313|FG009|Overall Study|Other|0|||
19389664|NCT02078752|41633304|FG000|Overall Study|Study terminated by sponsor|0|||
19389665|NCT02078752|41633305|FG001|Overall Study|Study terminated by sponsor|0|||
19389666|NCT02078752|41633306|FG002|Overall Study|Study terminated by sponsor|0|||
19373062|NCT02765165|41614019|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
19373063|NCT02765165|41614020|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
19373064|NCT02765165|41614021|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
19373065|NCT02765165|41614022|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
19373066|NCT02765165|41614023|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
19373067|NCT02765165|41614017|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
19373068|NCT02765165|41614018|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
19373069|NCT02765165|41614019|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
19373070|NCT02765165|41614020|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
19389667|NCT02078752|41633307|FG003|Overall Study|Study terminated by sponsor|0|||
19389668|NCT02078752|41633308|FG004|Overall Study|Study terminated by sponsor|0|||
19389669|NCT02078752|41633309|FG005|Overall Study|Study terminated by sponsor|0|||
19389670|NCT02078752|41633310|FG006|Overall Study|Study terminated by sponsor|0|||
19389671|NCT02078752|41633311|FG007|Overall Study|Study terminated by sponsor|0|||
19389672|NCT02078752|41633312|FG008|Overall Study|Study terminated by sponsor|0|||
19389673|NCT02078752|41633313|FG009|Overall Study|Study terminated by sponsor|5|||
19389674|NCT02022748|41633346|FG000|Overall Study|Adverse Event|1|||
19389675|NCT02022748|41633347|FG001|Overall Study|Adverse Event|1|||
19389676|NCT02022748|41633348|FG002|Overall Study|Adverse Event|0|||
19389677|NCT02022748|41633346|FG000|Overall Study|Withdrawal by Subject|0|||
19389678|NCT02022748|41633347|FG001|Overall Study|Withdrawal by Subject|1|||
19389679|NCT02022748|41633348|FG002|Overall Study|Withdrawal by Subject|0|||
19389680|NCT02022670|41633359|FG000|Overall Study|Adverse Event|1|||
19389681|NCT02022670|41633360|FG001|Overall Study|Adverse Event|0|||
19389682|NCT02022670|41633361|FG002|Overall Study|Adverse Event|1|||
19389683|NCT02076334|41633374|FG000|Overall Study|Protocol Violation|1|||
19389684|NCT02076334|41633375|FG001|Overall Study|Protocol Violation|0|||
19389685|NCT02076334|41633376|FG002|Overall Study|Protocol Violation|0|||
19389686|NCT02076334|41633377|FG003|Overall Study|Protocol Violation|0|||
19389687|NCT02076334|41633374|FG000|Overall Study|Lost to Follow-up|0|||
19389688|NCT02076334|41633375|FG001|Overall Study|Lost to Follow-up|1|||
19389689|NCT02076334|41633376|FG002|Overall Study|Lost to Follow-up|1|||
19389690|NCT02076334|41633377|FG003|Overall Study|Lost to Follow-up|0|||
19389691|NCT02076334|41633374|FG000|Overall Study|muscle soreness|0|||
19389692|NCT02076334|41633375|FG001|Overall Study|muscle soreness|0|||
19389693|NCT02076334|41633376|FG002|Overall Study|muscle soreness|0|||
19389694|NCT02076334|41633377|FG003|Overall Study|muscle soreness|1|||
19389695|NCT02021812|41633387|FG000|Overall Study|Death|8|||
19389696|NCT02021812|41633387|FG000|Overall Study|Withdrawal by Subject|3|||
19389697|NCT02021812|41633387|FG000|Overall Study|Lost to Follow-up|2|||
19389698|NCT02021812|41633387|FG000|Overall Study|Refuse to return, COVD 19|2|||
19389699|NCT02021656|41633391|FG000|Overall Study|Adverse Event|1|||
19389700|NCT02021656|41633391|FG000|Overall Study|Lack of Efficacy|2|||
19389701|NCT02021656|41633391|FG000|Overall Study|Lost to Follow-up|1|||
19389702|NCT02021656|41633391|FG000|Overall Study|Withdrew Consent|2|||
19389703|NCT02076022|41633401|FG000|Overall Study|Withdrawal by Subject|2|||
19389704|NCT02076022|41633402|FG001|Overall Study|Withdrawal by Subject|0|||
19389705|NCT02075632|41633410|FG000|Overall Study|Adverse Event|1|||
19389706|NCT02075632|41633411|FG001|Overall Study|Adverse Event|1|||
19389707|NCT02075632|41633410|FG000|Overall Study|Lost to Follow-up|0|||
19389708|NCT02075632|41633411|FG001|Overall Study|Lost to Follow-up|3|||
19389709|NCT02075632|41633410|FG000|Overall Study|Withdrawal by Subject|0|||
19389710|NCT02075632|41633411|FG001|Overall Study|Withdrawal by Subject|1|||
19389711|NCT02075554|41633417|FG000|Overall Study|Lost to Follow-up|7|||
19389712|NCT02075554|41633417|FG000|Overall Study|Withdrawal by Subject|5|||
19389713|NCT02075554|41633417|FG000|Overall Study|Physician Decision|3|||
19389714|NCT02075476|41633423|FG000|Overall Study|Death|2|||
19389715|NCT02075476|41633424|FG001|Overall Study|Death|2|||
19389716|NCT02075476|41633423|FG000|Overall Study|Lost to Follow-up|1|||
19389717|NCT02075476|41633424|FG001|Overall Study|Lost to Follow-up|3|||
19389718|NCT02075320|41633430|FG000|Overall Study|Withdrawal by Subject|2|||
19389719|NCT02708095|41633437|FG000|Overall Study|Adverse Event|4|||
19389720|NCT02708095|41633438|FG001|Overall Study|Adverse Event|10|||
19389721|NCT02708095|41633439|FG002|Overall Study|Adverse Event|11|||
19389722|NCT02708095|41633437|FG000|Overall Study|Lack of Efficacy|9|||
19389723|NCT02708095|41633438|FG001|Overall Study|Lack of Efficacy|3|||
19389724|NCT02708095|41633439|FG002|Overall Study|Lack of Efficacy|0|||
19389725|NCT02708095|41633437|FG000|Overall Study|Lost to Follow-up|2|||
19389726|NCT02708095|41633438|FG001|Overall Study|Lost to Follow-up|0|||
19389727|NCT02708095|41633439|FG002|Overall Study|Lost to Follow-up|0|||
19389728|NCT02708095|41633437|FG000|Overall Study|Physician Decision|2|||
19389729|NCT02708095|41633438|FG001|Overall Study|Physician Decision|3|||
19389730|NCT02708095|41633439|FG002|Overall Study|Physician Decision|2|||
19389731|NCT02708095|41633437|FG000|Overall Study|Protocol Violation|0|||
19389732|NCT02708095|41633438|FG001|Overall Study|Protocol Violation|0|||
19389733|NCT02708095|41633439|FG002|Overall Study|Protocol Violation|1|||
19389734|NCT02708095|41633437|FG000|Overall Study|Withdrawal by Subject|5|||
19389735|NCT02708095|41633438|FG001|Overall Study|Withdrawal by Subject|3|||
19389736|NCT02708095|41633439|FG002|Overall Study|Withdrawal by Subject|4|||
19389737|NCT02707861|41633451|FG000|Overall Study|Went onto commercial drug|30|||
19389738|NCT02707861|41633452|FG001|Overall Study|Went onto commercial drug|23|||
19389739|NCT02707861|41633451|FG000|Overall Study|Adverse Event|2|||
19389740|NCT02707861|41633452|FG001|Overall Study|Adverse Event|3|||
19389741|NCT02707861|41633451|FG000|Overall Study|Death|5|||
19389742|NCT02707861|41633452|FG001|Overall Study|Death|2|||
19389743|NCT02707861|41633451|FG000|Overall Study|Lack of Efficacy|0|||
19389744|NCT02707861|41633452|FG001|Overall Study|Lack of Efficacy|2|||
19389745|NCT02707861|41633451|FG000|Overall Study|Physician Decision|1|||
19389746|NCT02707861|41633452|FG001|Overall Study|Physician Decision|4|||
19389747|NCT02707861|41633451|FG000|Overall Study|Withdrawal by Subject|2|||
19608553|NCT05056870|42057469|FG001|Period 1|Site COVID-19 Related|3|||
19698887|NCT00313586|42143715|FG002|Overall Study|Death|1|||
19389748|NCT02707861|41633452|FG001|Overall Study|Withdrawal by Subject|1|||
19389749|NCT02707861|41633451|FG000|Overall Study|Lost to Follow-up|1|||
19389750|NCT02707861|41633452|FG001|Overall Study|Lost to Follow-up|3|||
19389751|NCT02027428|41633460|FG000|Induction|Never treated|7|||
19389752|NCT02027428|41633461|FG001|Induction|Never treated|0|||
19389753|NCT02027428|41633462|FG002|Induction|Never treated|0|||
19389754|NCT02027428|41633460|FG000|Induction|Progressive disease|77|||
19389755|NCT02027428|41633461|FG001|Induction|Progressive disease|0|||
19389756|NCT02027428|41633462|FG002|Induction|Progressive disease|0|||
19389757|NCT02027428|41633460|FG000|Induction|Adverse Event|51|||
19389758|NCT02027428|41633461|FG001|Induction|Adverse Event|0|||
19389759|NCT02027428|41633462|FG002|Induction|Adverse Event|0|||
19389760|NCT02027428|41633460|FG000|Induction|Withdrawal by Subject|22|||
19389761|NCT02027428|41633461|FG001|Induction|Withdrawal by Subject|0|||
19389762|NCT02027428|41633462|FG002|Induction|Withdrawal by Subject|0|||
19389763|NCT02027428|41633460|FG000|Induction|Death|21|||
19389764|NCT02027428|41633461|FG001|Induction|Death|0|||
19389765|NCT02027428|41633462|FG002|Induction|Death|0|||
19389766|NCT02027428|41633460|FG000|Induction|Symptomatic deterioration|16|||
19389767|NCT02027428|41633461|FG001|Induction|Symptomatic deterioration|0|||
19389768|NCT02027428|41633462|FG002|Induction|Symptomatic deterioration|0|||
19389769|NCT02027428|41633460|FG000|Induction|Study terminated by sponsor|12|||
19389770|NCT02027428|41633461|FG001|Induction|Study terminated by sponsor|0|||
19389771|NCT02027428|41633462|FG002|Induction|Study terminated by sponsor|0|||
19389772|NCT02027428|41633460|FG000|Induction|Protocol Violation|1|||
19389773|NCT02027428|41633461|FG001|Induction|Protocol Violation|0|||
19373071|NCT02765165|41614021|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
19373072|NCT02765165|41614022|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
19373073|NCT02765165|41614023|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
19373074|NCT02765165|41614017|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
19373075|NCT02765165|41614018|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
19373076|NCT02765165|41614019|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
19373077|NCT02765165|41614020|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
19373078|NCT02765165|41614021|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
19373079|NCT02765165|41614022|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
19373080|NCT02765165|41614023|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
19373081|NCT02675907|41614045|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
19373082|NCT02675907|41614046|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
19373083|NCT02675907|41614045|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
19373084|NCT02675907|41614046|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
19373085|NCT02675907|41614045|FG000|Study Overall|Lack of Efficacy|1|||
19373086|NCT02675907|41614046|FG001|Study Overall|Lack of Efficacy|0|||
19373087|NCT02675907|41614045|FG000|Study Overall|Withdrawal by Subject|2|||
19373088|NCT02675907|41614046|FG001|Study Overall|Withdrawal by Subject|2|||
19373089|NCT02675907|41614045|FG000|Study Overall|Lost to Follow-up|0|||
19373090|NCT02675907|41614046|FG001|Study Overall|Lost to Follow-up|2|||
19373091|NCT02675517|41614052|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
19373092|NCT02675517|41614052|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
19373093|NCT02764775|41614056|FG000|Overall Study|Death|1|||
19373094|NCT02764775|41614056|FG000|Overall Study|Lost to Follow-up|2|||
19373095|NCT02764775|41614056|FG000|Overall Study|Withdrawal by Subject|3|||
19373096|NCT02774681|41614060|FG000|Treatment on Study|Progressive Disease|7|||
19373097|NCT02774681|41614060|FG000|Follow-Up for 3 Years|Death|11|||
19373098|NCT02774681|41614060|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
19373099|NCT02547428|41614066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
19373100|NCT02547428|41614067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
19373101|NCT02547428|41614066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
19373102|NCT02547428|41614067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
19373103|NCT02547428|41614066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
19373104|NCT02547428|41614067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
19389774|NCT02027428|41633462|FG002|Induction|Protocol Violation|0|||
19389775|NCT02027428|41633460|FG000|Induction|Miscellaneous|14|||
19389776|NCT02027428|41633461|FG001|Induction|Miscellaneous|0|||
19389777|NCT02027428|41633462|FG002|Induction|Miscellaneous|0|||
19389778|NCT02027428|41633460|FG000|Induction|Induction Treatment Ongoing|4|||
19389779|NCT02027428|41633461|FG001|Induction|Induction Treatment Ongoing|0|||
19389780|NCT02027428|41633462|FG002|Induction|Induction Treatment Ongoing|0|||
19389781|NCT02027428|41633460|FG000|Maintenance|Death|0|||
19389782|NCT02027428|41633461|FG001|Maintenance|Death|3|||
19389783|NCT02027428|41633462|FG002|Maintenance|Death|2|||
19389784|NCT02027428|41633460|FG000|Maintenance|Adverse Event|0|||
19389785|NCT02027428|41633461|FG001|Maintenance|Adverse Event|21|||
19389786|NCT02027428|41633462|FG002|Maintenance|Adverse Event|1|||
19389787|NCT02027428|41633460|FG000|Maintenance|Progressive disease|0|||
19389788|NCT02027428|41633461|FG001|Maintenance|Progressive disease|84|||
19389789|NCT02027428|41633462|FG002|Maintenance|Progressive disease|47|||
19389790|NCT02027428|41633460|FG000|Maintenance|Symptomatic deterioration|0|||
19373105|NCT02547428|41614066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
19389791|NCT02027428|41633461|FG001|Maintenance|Symptomatic deterioration|4|||
19389792|NCT02027428|41633462|FG002|Maintenance|Symptomatic deterioration|1|||
19389793|NCT02027428|41633460|FG000|Maintenance|Withdrawal by Subject|0|||
19389794|NCT02027428|41633461|FG001|Maintenance|Withdrawal by Subject|6|||
19389795|NCT02027428|41633462|FG002|Maintenance|Withdrawal by Subject|5|||
19389796|NCT02027428|41633460|FG000|Maintenance|Protocol Violation|0|||
19389797|NCT02027428|41633461|FG001|Maintenance|Protocol Violation|0|||
19389798|NCT02027428|41633462|FG002|Maintenance|Protocol Violation|1|||
19389799|NCT02027428|41633460|FG000|Maintenance|Other|0|||
19389800|NCT02027428|41633461|FG001|Maintenance|Other|6|||
19389801|NCT02027428|41633462|FG002|Maintenance|Other|3|||
19389802|NCT02027428|41633460|FG000|Survival Follow-up|Death|0|||
19389803|NCT02027428|41633461|FG001|Survival Follow-up|Death|78|||
19389804|NCT02027428|41633462|FG002|Survival Follow-up|Death|45|||
19389805|NCT02027428|41633460|FG000|Survival Follow-up|Lost to Follow-up|0|||
19389806|NCT02027428|41633461|FG001|Survival Follow-up|Lost to Follow-up|1|||
19389807|NCT02027428|41633462|FG002|Survival Follow-up|Lost to Follow-up|1|||
19389808|NCT01995136|41633485|FG000|Overall Study|Change in residence|1|||
19608554|NCT05056870|42057468|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
19608555|NCT05056870|42057469|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
19608556|NCT05056870|42057468|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
19608557|NCT05056870|42057469|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
19608558|NCT05056870|42057468|FG000|Period 2|COVID-19 Related|1|||
19608559|NCT05056870|42057469|FG001|Period 2|COVID-19 Related|0|||
19608560|NCT05056870|42057468|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
19608561|NCT05056870|42057469|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
19608562|NCT04488822|42057493|FG000|Overall Study|Adverse Event|8|||
19608563|NCT04488822|42057493|FG000|Overall Study|Withdrawal by Subject|1|||
19608564|NCT04396626|42057506|FG000|Overall Study|Premature termination of study|975|||
19608565|NCT04242186|42057510|FG000|Overall Study|Death|5|||
19608566|NCT03934216|42057517|FG000|Randomization|Randomized in Error|1|||
19608567|NCT03934216|42057518|FG001|Randomization|Randomized in Error|1|||
19608568|NCT03934216|42057517|FG000|Treatment Period|Adverse Event|10|||
19608569|NCT03934216|42057518|FG001|Treatment Period|Adverse Event|3|||
19608570|NCT03934216|42057517|FG000|Treatment Period|Withdrawal by Participant|6|||
19608571|NCT03934216|42057518|FG001|Treatment Period|Withdrawal by Participant|2|||
19608572|NCT03934216|42057517|FG000|Treatment Period|Other Reasons|2|||
19608573|NCT03934216|42057518|FG001|Treatment Period|Other Reasons|2|||
19608574|NCT03474107|42057555|FG000|Overall Study|Adverse Event|42|||
19608575|NCT03474107|42057556|FG001|Overall Study|Adverse Event|46|||
19608576|NCT03474107|42057555|FG000|Overall Study|Death|2|||
19608577|NCT03474107|42057556|FG001|Overall Study|Death|2|||
19608578|NCT03474107|42057555|FG000|Overall Study|Lost to Follow-up|0|||
19608579|NCT03474107|42057556|FG001|Overall Study|Lost to Follow-up|1|||
19608580|NCT03474107|42057555|FG000|Overall Study|Progressive Disease|177|||
19608581|NCT03474107|42057556|FG001|Overall Study|Progressive Disease|180|||
19608582|NCT03474107|42057555|FG000|Overall Study|Protocol Violation|1|||
19608583|NCT03474107|42057556|FG001|Overall Study|Protocol Violation|1|||
19608584|NCT03474107|42057555|FG000|Overall Study|Withdrawal by Subject|15|||
19608585|NCT03474107|42057556|FG001|Overall Study|Withdrawal by Subject|27|||
19608586|NCT03474107|42057555|FG000|Overall Study|Physician Decision|7|||
19608587|NCT03474107|42057556|FG001|Overall Study|Physician Decision|22|||
19608588|NCT03474107|42057555|FG000|Overall Study|Miscellaneous|1|||
19608589|NCT03474107|42057556|FG001|Overall Study|Miscellaneous|6|||
19799250|NCT02901431|42257308|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
19799251|NCT02901431|42257309|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
19799252|NCT02901431|42257297|FG000|Main Treatment Part|Physician Decision|0|||
19799253|NCT02901431|42257298|FG001|Main Treatment Part|Physician Decision|0|||
19608594|NCT03183128|42057577|FG000|Overall Study|Adverse Event|1|||
19608595|NCT03183128|42057578|FG001|Overall Study|Adverse Event|2|||
19608596|NCT03183128|42057577|FG000|Overall Study|Withdrawal by Subject|1|||
19608597|NCT03183128|42057578|FG001|Overall Study|Withdrawal by Subject|8|||
19608598|NCT03183128|42057577|FG000|Overall Study|Protocol Violation|2|||
19698888|NCT00313586|42143716|FG003|Overall Study|Death|7|||
19698889|NCT00313586|42143713|FG000|Overall Study|Withdrawal by Subject|13|||
19389809|NCT01994902|41633489|FG000|Test Period 1|Withdrawal by Subject|3|||
19608599|NCT03183128|42057578|FG001|Overall Study|Protocol Violation|0|||
19608600|NCT03183128|42057577|FG000|Overall Study|Lack of Efficacy|4|||
19608601|NCT03183128|42057578|FG001|Overall Study|Lack of Efficacy|27|||
19608602|NCT03183128|42057577|FG000|Overall Study|Lost to Follow-up|1|||
19608603|NCT03183128|42057578|FG001|Overall Study|Lost to Follow-up|0|||
19608604|NCT03183128|42057577|FG000|Overall Study|Death|2|||
19608605|NCT03183128|42057578|FG001|Overall Study|Death|0|||
19608606|NCT03183128|42057577|FG000|Overall Study|Physician Decision|1|||
19608607|NCT03183128|42057578|FG001|Overall Study|Physician Decision|0|||
19608608|NCT02308488|42057620|FG000|Overall Study|Withdrawal by Subject|2|||
19608609|NCT02159950|42057626|FG000|Overall Study|Adverse Event|0|||
19608610|NCT02159950|42057627|FG001|Overall Study|Adverse Event|1|||
19608611|NCT02159950|42057626|FG000|Overall Study|Progression|0|||
19608612|NCT02159950|42057627|FG001|Overall Study|Progression|1|||
19608613|NCT02152137|42057633|FG000|Overall Study|Withdrawal by Subject|1|||
19608614|NCT02152137|42057633|FG000|Overall Study|Originally assigned to Arm B|3|||
19608615|NCT02007512|42057641|FG000|Double Blind Treatment Period|Adverse Event|4|||
19608616|NCT02007512|42057642|FG001|Double Blind Treatment Period|Adverse Event|2|||
19608617|NCT02007512|42057643|FG002|Double Blind Treatment Period|Adverse Event|6|||
19608618|NCT02007512|42057644|FG003|Double Blind Treatment Period|Adverse Event|2|||
19608619|NCT02007512|42057641|FG000|Double Blind Treatment Period|Death|1|||
19608620|NCT02007512|42057642|FG001|Double Blind Treatment Period|Death|0|||
19389810|NCT01994902|41633490|FG001|Test Period 1|Withdrawal by Subject|0|||
19389811|NCT01994902|41633489|FG000|Test Period 1|device deficiency with adverse event|0|||
19389812|NCT01994902|41633490|FG001|Test Period 1|device deficiency with adverse event|1|||
19389813|NCT01994902|41633489|FG000|Test Period 1|Adverse Event|2|||
19389814|NCT01994902|41633490|FG001|Test Period 1|Adverse Event|1|||
19389815|NCT01994902|41633489|FG000|Test Period 1|Lack of Efficacy|0|||
19389816|NCT01994902|41633490|FG001|Test Period 1|Lack of Efficacy|1|||
19389817|NCT01994902|41633489|FG000|Test Period 1|bag too small|1|||
19389818|NCT01994902|41633490|FG001|Test Period 1|bag too small|0|||
19389819|NCT01994902|41633489|FG000|Test Period 2|Withdrawal by Subject|0|||
19389820|NCT01994902|41633490|FG001|Test Period 2|Withdrawal by Subject|2|||
19389821|NCT01994902|41633489|FG000|Test Period 2|Lack of Efficacy|0|||
19389822|NCT01994902|41633490|FG001|Test Period 2|Lack of Efficacy|1|||
19389823|NCT01994902|41633489|FG000|Test Period 2|Other|0|||
19389824|NCT01994902|41633490|FG001|Test Period 2|Other|3|||
19389825|NCT02026258|41633498|FG000|Randomized|Did not start treatment|2|||
19389826|NCT02026258|41633499|FG001|Randomized|Did not start treatment|1|||
19389827|NCT02026258|41633498|FG000|Randomized|Change in treatment plan|1|||
19389828|NCT02026258|41633499|FG001|Randomized|Change in treatment plan|0|||
19389829|NCT02026258|41633498|FG000|Randomized|Presence of periodontal disease|1|||
19389830|NCT02026258|41633499|FG001|Randomized|Presence of periodontal disease|1|||
19389831|NCT02026258|41633498|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
19389832|NCT02026258|41633499|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
19389833|NCT02026258|41633498|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
19389834|NCT02026258|41633499|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
19389835|NCT01994590|41633506|FG000|Overall Study|Adverse Event|1|||
19389836|NCT01994590|41633506|FG000|Overall Study|Trial Terminated|1|||
19389837|NCT02019550|41633512|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19389838|NCT02019550|41633513|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
19389839|NCT02019472|41633524|FG000|Overall Study|Adverse Event|14|||
19389840|NCT02019472|41633525|FG001|Overall Study|Adverse Event|23|||
19389841|NCT02019472|41633526|FG002|Overall Study|Adverse Event|17|||
19389842|NCT02019472|41633524|FG000|Overall Study|Death|0|||
19389843|NCT02019472|41633525|FG001|Overall Study|Death|1|||
19389844|NCT02019472|41633526|FG002|Overall Study|Death|1|||
19389845|NCT02019472|41633524|FG000|Overall Study|Lack of Efficacy|7|||
19389846|NCT02019472|41633525|FG001|Overall Study|Lack of Efficacy|4|||
19389847|NCT02019472|41633526|FG002|Overall Study|Lack of Efficacy|4|||
19389848|NCT02019472|41633524|FG000|Overall Study|Lost to Follow-up|0|||
19389849|NCT02019472|41633525|FG001|Overall Study|Lost to Follow-up|2|||
19389850|NCT02019472|41633526|FG002|Overall Study|Lost to Follow-up|1|||
19389851|NCT02019472|41633524|FG000|Overall Study|Physician Decision|1|||
19389852|NCT02019472|41633525|FG001|Overall Study|Physician Decision|2|||
19389853|NCT02019472|41633526|FG002|Overall Study|Physician Decision|0|||
19389854|NCT02019472|41633524|FG000|Overall Study|Pregnancy|1|||
19389855|NCT02019472|41633525|FG001|Overall Study|Pregnancy|2|||
19389856|NCT02019472|41633526|FG002|Overall Study|Pregnancy|2|||
19389857|NCT02019472|41633524|FG000|Overall Study|Withdrawal by Subject|11|||
19389858|NCT02019472|41633525|FG001|Overall Study|Withdrawal by Subject|10|||
19389859|NCT02019472|41633526|FG002|Overall Study|Withdrawal by Subject|11|||
19389860|NCT02019472|41633524|FG000|Overall Study|Other|3|||
19389861|NCT02019472|41633525|FG001|Overall Study|Other|8|||
19389862|NCT02019472|41633526|FG002|Overall Study|Other|6|||
19389863|NCT02705755|41633538|FG000|Part A (6 Days)|Adverse Event|1|||
19389864|NCT02705755|41633539|FG001|Part A (6 Days)|Adverse Event|0|||
19389865|NCT02705755|41633540|FG002|Part A (6 Days)|Adverse Event|0|||
19389866|NCT02705755|41633541|FG003|Part A (6 Days)|Adverse Event|0|||
19389867|NCT02705755|41633538|FG000|Part A (6 Days)|Physician Decision|3|||
19389868|NCT02705755|41633539|FG001|Part A (6 Days)|Physician Decision|0|||
19389869|NCT02705755|41633540|FG002|Part A (6 Days)|Physician Decision|0|||
19389870|NCT02705755|41633541|FG003|Part A (6 Days)|Physician Decision|0|||
19389871|NCT02705755|41633538|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
19389872|NCT02705755|41633539|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
19389873|NCT02705755|41633540|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
19389874|NCT02705755|41633541|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
19389875|NCT02705755|41633538|FG000|Part C (20 Weeks)|Physician Decision|0|||
19389876|NCT02705755|41633539|FG001|Part C (20 Weeks)|Physician Decision|0|||
19389877|NCT02705755|41633540|FG002|Part C (20 Weeks)|Physician Decision|0|||
19389878|NCT02705755|41633541|FG003|Part C (20 Weeks)|Physician Decision|2|||
19389879|NCT02705755|41633538|FG000|Part C (20 Weeks)|Adverse Event|0|||
19389880|NCT02705755|41633539|FG001|Part C (20 Weeks)|Adverse Event|0|||
19389881|NCT02705755|41633540|FG002|Part C (20 Weeks)|Adverse Event|0|||
19389882|NCT02705755|41633541|FG003|Part C (20 Weeks)|Adverse Event|6|||
19389883|NCT02705755|41633538|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
19389884|NCT02705755|41633539|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
19389885|NCT02705755|41633540|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
19389886|NCT02705755|41633541|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
19389887|NCT02024932|41633574|FG000|Overall Study|Adverse Event|2|||
19389888|NCT02024932|41633575|FG001|Overall Study|Adverse Event|3|||
19389889|NCT02024932|41633576|FG002|Overall Study|Adverse Event|0|||
19389890|NCT02024932|41633577|FG003|Overall Study|Adverse Event|0|||
19389891|NCT02024932|41633578|FG004|Overall Study|Adverse Event|2|||
19389892|NCT02024932|41633579|FG005|Overall Study|Adverse Event|0|||
19389893|NCT02024932|41633574|FG000|Overall Study|Abnormal laboratory value|0|||
19389894|NCT02024932|41633575|FG001|Overall Study|Abnormal laboratory value|0|||
19389895|NCT02024932|41633576|FG002|Overall Study|Abnormal laboratory value|0|||
19389896|NCT02024932|41633577|FG003|Overall Study|Abnormal laboratory value|2|||
19389897|NCT02024932|41633578|FG004|Overall Study|Abnormal laboratory value|0|||
19389898|NCT02024932|41633579|FG005|Overall Study|Abnormal laboratory value|0|||
19389899|NCT01993888|41633610|FG000|Overall Study|Death|1|||
19389900|NCT01993888|41633611|FG001|Overall Study|Death|1|||
19389901|NCT01993888|41633610|FG000|Overall Study|Lost to Follow-up|1|||
19389902|NCT01993888|41633611|FG001|Overall Study|Lost to Follow-up|1|||
19389903|NCT01993888|41633610|FG000|Overall Study|Withdrawal by Subject|0|||
19389904|NCT01993888|41633611|FG001|Overall Study|Withdrawal by Subject|1|||
19389905|NCT02024698|41633617|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
19389906|NCT02024698|41633618|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
19389907|NCT02018458|41633624|FG000|Overall Study|Death|4|||
19389908|NCT02017522|41633628|FG000|Overall Study|Withdrawal by Subject|1|||
19389909|NCT02017444|41633635|FG000|Overall Study|Physician Decision|1|||
19389910|NCT02017444|41633636|FG001|Overall Study|Physician Decision|0|||
19389911|NCT02017444|41633635|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
19799254|NCT02901431|42257299|FG002|Main Treatment Part|Physician Decision|0|||
19799255|NCT02901431|42257300|FG003|Main Treatment Part|Physician Decision|1|||
19799256|NCT02901431|42257301|FG004|Main Treatment Part|Physician Decision|0|||
19799257|NCT02901431|42257302|FG005|Main Treatment Part|Physician Decision|0|||
19799258|NCT02901431|42257303|FG006|Main Treatment Part|Physician Decision|1|||
19389912|NCT02017444|41633636|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
19389913|NCT01993186|41633644|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
19389914|NCT01993186|41633645|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
19389915|NCT01993186|41633644|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
19389916|NCT01993186|41633645|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
19389917|NCT01993186|41633644|FG000|Open-Label Extension Period|Other, Not Specified|0|||
19389918|NCT01993186|41633645|FG001|Open-Label Extension Period|Other, Not Specified|1|||
19389919|NCT01993186|41633644|FG000|Open-Label Extension Period|Adverse Event|1|||
19389920|NCT01993186|41633645|FG001|Open-Label Extension Period|Adverse Event|0|||
19389921|NCT01993186|41633644|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
19389922|NCT01993186|41633645|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
19389923|NCT01993186|41633644|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
19389924|NCT01993186|41633645|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
19389925|NCT01993186|41633644|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
19389926|NCT01993186|41633645|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
19389927|NCT02016898|41633654|FG000|Overall Study|Death|1|||
19389928|NCT02016898|41633655|FG001|Overall Study|Death|1|||
19389929|NCT02016898|41633654|FG000|Overall Study|Lost to Follow-up|4|||
19389930|NCT02016898|41633655|FG001|Overall Study|Lost to Follow-up|4|||
19389931|NCT01993030|41633663|FG000|Overall Study|Adverse Event|0|||
19389932|NCT01993030|41633664|FG001|Overall Study|Adverse Event|4|||
19389933|NCT01992094|41633673|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
19389934|NCT01992094|41633674|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
19389935|NCT01992094|41633675|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
19389936|NCT01992094|41633673|FG000|Overall Study|Adverse Event|1|||
19389937|NCT01992094|41633674|FG001|Overall Study|Adverse Event|0|||
19389938|NCT01992094|41633675|FG002|Overall Study|Adverse Event|0|||
19389939|NCT01992094|41633673|FG000|Overall Study|Death|5|||
19389940|NCT01992094|41633674|FG001|Overall Study|Death|5|||
19799259|NCT02901431|42257304|FG007|Main Treatment Part|Physician Decision|0|||
19799260|NCT02901431|42257305|FG008|Main Treatment Part|Physician Decision|0|||
19799261|NCT02901431|42257306|FG009|Main Treatment Part|Physician Decision|0|||
19799262|NCT02901431|42257307|FG010|Main Treatment Part|Physician Decision|0|||
19799263|NCT02901431|42257308|FG011|Main Treatment Part|Physician Decision|0|||
19799264|NCT02901431|42257309|FG012|Main Treatment Part|Physician Decision|0|||
19799265|NCT02901431|42257297|FG000|Main Treatment Part|Withdrawal by Subject|0|||
19799266|NCT02901431|42257298|FG001|Main Treatment Part|Withdrawal by Subject|0|||
19389941|NCT01992094|41633675|FG002|Overall Study|Death|2|||
19799267|NCT02901431|42257299|FG002|Main Treatment Part|Withdrawal by Subject|0|||
19799268|NCT02901431|42257300|FG003|Main Treatment Part|Withdrawal by Subject|18|||
19389942|NCT01992094|41633673|FG000|Overall Study|Lost to Follow-up|26|||
19389943|NCT01992094|41633674|FG001|Overall Study|Lost to Follow-up|9|||
19389944|NCT01992094|41633675|FG002|Overall Study|Lost to Follow-up|13|||
19389945|NCT01992094|41633673|FG000|Overall Study|OTHER|4|||
19799269|NCT02901431|42257301|FG004|Main Treatment Part|Withdrawal by Subject|3|||
19389946|NCT01992094|41633674|FG001|Overall Study|OTHER|0|||
19389947|NCT01992094|41633675|FG002|Overall Study|OTHER|0|||
19389948|NCT01992094|41633673|FG000|Overall Study|Protocol Violation|1|||
19389949|NCT01992094|41633674|FG001|Overall Study|Protocol Violation|0|||
19389950|NCT01992094|41633675|FG002|Overall Study|Protocol Violation|1|||
19389951|NCT01992094|41633673|FG000|Overall Study|Withdrawal by Subject|7|||
19389952|NCT01992094|41633674|FG001|Overall Study|Withdrawal by Subject|3|||
19389953|NCT01992094|41633675|FG002|Overall Study|Withdrawal by Subject|4|||
19389954|NCT02706691|41633699|FG000|Overall Study|Adverse Event|1|||
19389955|NCT01991470|41633704|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
19389956|NCT01991470|41633704|FG000|Enlite 1 Period|Adverse Event|1|||
19389957|NCT01991470|41633704|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
19389958|NCT01991470|41633704|FG000|Enlite 3 Period|Lost to Follow-up|1|||
19389959|NCT01991470|41633704|FG000|Enlite 3 Period|Physician Decision|2|||
19389960|NCT01991470|41633704|FG000|Enlite 3 Period|Physician Decision|8|||
19389961|NCT01991470|41633704|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
19389962|NCT01991314|41633718|FG000|Overall Study|Adverse Event|5|||
19389963|NCT01991314|41633719|FG001|Overall Study|Adverse Event|1|||
19389964|NCT01991314|41633718|FG000|Overall Study|Lost to Follow-up|6|||
19389965|NCT01991314|41633719|FG001|Overall Study|Lost to Follow-up|10|||
19389966|NCT01990768|41633728|FG000|Intervention Started|Found to be ineligible|14|||
19389967|NCT01990768|41633729|FG001|Intervention Started|Found to be ineligible|13|||
19389968|NCT01990768|41633730|FG002|Intervention Started|Found to be ineligible|11|||
19389969|NCT01990768|41633728|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
19389970|NCT01990768|41633729|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
19389971|NCT01990768|41633730|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
19389972|NCT01990768|41633728|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
19389973|NCT01990768|41633729|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
19389974|NCT01990768|41633730|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
19389975|NCT01990768|41633728|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
19389976|NCT01990768|41633729|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
19389977|NCT01990768|41633730|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
19389978|NCT01990768|41633728|FG000|Intervention Started|Patient care priority|1|||
19389979|NCT01990768|41633729|FG001|Intervention Started|Patient care priority|2|||
19389980|NCT01990768|41633730|FG002|Intervention Started|Patient care priority|3|||
19389981|NCT01990768|41633728|FG000|Intervention Started|IV lost|2|||
19389982|NCT01990768|41633729|FG001|Intervention Started|IV lost|2|||
19389983|NCT01990768|41633730|FG002|Intervention Started|IV lost|2|||
19389984|NCT01990768|41633728|FG000|Intervention Started|Required CPR|1|||
19389985|NCT01990768|41633729|FG001|Intervention Started|Required CPR|1|||
19389986|NCT01990768|41633730|FG002|Intervention Started|Required CPR|0|||
19389987|NCT01990768|41633728|FG000|Intervention Started|Seizure or hx of seizure|0|||
19389988|NCT01990768|41633729|FG001|Intervention Started|Seizure or hx of seizure|0|||
19389989|NCT01990768|41633730|FG002|Intervention Started|Seizure or hx of seizure|2|||
19389990|NCT01990768|41633728|FG000|Intervention Started|Discovered to be pregnant|0|||
19389991|NCT01990768|41633729|FG001|Intervention Started|Discovered to be pregnant|1|||
19389992|NCT01990768|41633730|FG002|Intervention Started|Discovered to be pregnant|0|||
19389993|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
19389994|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
19389995|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
19389996|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
19389997|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
19389998|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
19389999|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
19390000|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
19390001|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
19390002|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
19390003|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
19390004|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
19390005|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Death|3|||
19390006|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Death|1|||
19390007|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Death|1|||
19390008|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Discharged|2|||
19390009|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Discharged|1|||
19390010|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Discharged|0|||
19390011|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
19390012|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
19390013|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
19390014|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
19390015|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
19390016|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
19390017|NCT01990768|41633728|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
19799270|NCT02901431|42257302|FG005|Main Treatment Part|Withdrawal by Subject|5|||
19390018|NCT01990768|41633729|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
19390019|NCT01990768|41633730|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
19390020|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
19390021|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
19390022|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
19390023|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
19390024|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
19390025|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
19390026|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
19390027|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
19390028|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
19390029|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
19390030|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
19390031|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
19390032|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
19390033|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
19390034|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
19390035|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
19390036|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
19390037|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
19390038|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
19390039|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
19390040|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
19390041|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
19390042|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
19390043|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
19390044|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
19390045|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
19390046|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
19390047|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
19799271|NCT02901431|42257303|FG006|Main Treatment Part|Withdrawal by Subject|6|||
19799272|NCT02901431|42257304|FG007|Main Treatment Part|Withdrawal by Subject|0|||
19390048|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
19390049|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
19390050|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
19390051|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
19390052|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
19390053|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
19390054|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
19390055|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
19390056|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
19390057|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
19390058|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
19390059|NCT01990768|41633728|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
19390060|NCT01990768|41633729|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
19390061|NCT01990768|41633730|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
19390062|NCT01990768|41633728|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
19799273|NCT02901431|42257305|FG008|Main Treatment Part|Withdrawal by Subject|0|||
19799274|NCT02901431|42257306|FG009|Main Treatment Part|Withdrawal by Subject|0|||
19799275|NCT02901431|42257307|FG010|Main Treatment Part|Withdrawal by Subject|0|||
19390063|NCT01990768|41633729|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
19390064|NCT01990768|41633730|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
19390065|NCT01990768|41633728|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
19390066|NCT01990768|41633729|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
19390067|NCT01990768|41633730|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
19390068|NCT01990768|41633728|FG000|6-Month Follow-up|No contact information|5|||
19390069|NCT01990768|41633729|FG001|6-Month Follow-up|No contact information|6|||
19390070|NCT01990768|41633730|FG002|6-Month Follow-up|No contact information|5|||
19390071|NCT01990768|41633728|FG000|6-Month Follow-up|Homeless|4|||
19390072|NCT01990768|41633729|FG001|6-Month Follow-up|Homeless|3|||
19390073|NCT01990768|41633730|FG002|6-Month Follow-up|Homeless|6|||
19390074|NCT01990768|41633728|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
19390075|NCT01990768|41633729|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
19390076|NCT01990768|41633730|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
19390077|NCT01990768|41633728|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
19478069|NCT01693562|41757315|FG001|Exploration Phase|Other|0|||
19390078|NCT01990768|41633729|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
19390079|NCT01990768|41633730|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
19390080|NCT01990768|41633728|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
19390081|NCT01990768|41633729|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
19478070|NCT01693562|41757316|FG002|Exploration Phase|Other|0|||
19478071|NCT01693562|41757317|FG003|Exploration Phase|Other|0|||
19478072|NCT01693562|41757318|FG004|Exploration Phase|Other|0|||
19608621|NCT02007512|42057643|FG002|Double Blind Treatment Period|Death|0|||
19608622|NCT02007512|42057644|FG003|Double Blind Treatment Period|Death|0|||
19799276|NCT02901431|42257308|FG011|Main Treatment Part|Withdrawal by Subject|0|||
19799277|NCT02901431|42257309|FG012|Main Treatment Part|Withdrawal by Subject|0|||
19799278|NCT02901431|42257297|FG000|Open Label Part|Adverse Event|0|||
19799279|NCT02901431|42257298|FG001|Open Label Part|Adverse Event|0|||
19799280|NCT02901431|42257299|FG002|Open Label Part|Adverse Event|0|||
19799281|NCT02901431|42257300|FG003|Open Label Part|Adverse Event|0|||
19799282|NCT02901431|42257301|FG004|Open Label Part|Adverse Event|0|||
19799283|NCT02901431|42257302|FG005|Open Label Part|Adverse Event|0|||
19799284|NCT02901431|42257303|FG006|Open Label Part|Adverse Event|0|||
19799285|NCT02901431|42257304|FG007|Open Label Part|Adverse Event|0|||
19799286|NCT02901431|42257305|FG008|Open Label Part|Adverse Event|4|||
19799287|NCT02901431|42257306|FG009|Open Label Part|Adverse Event|4|||
19799288|NCT02901431|42257307|FG010|Open Label Part|Adverse Event|0|||
19390082|NCT01990768|41633730|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
19390083|NCT01990612|41633741|FG000|Overall Study|Lost to Follow-up|2|||
19390084|NCT01990612|41633742|FG001|Overall Study|Lost to Follow-up|1|||
19390085|NCT01990612|41633741|FG000|Overall Study|Withdrawal by Subject|5|||
19390086|NCT01990612|41633742|FG001|Overall Study|Withdrawal by Subject|2|||
19373106|NCT02547428|41614067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
19373107|NCT02547428|41614066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
19373108|NCT02547428|41614067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
19373109|NCT02547428|41614066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
19373110|NCT02547428|41614067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
19373111|NCT02547428|41614066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
19373112|NCT02547428|41614067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
19373113|NCT02547428|41614066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
19373114|NCT02547428|41614067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
19373115|NCT01374087|41614082|FG000|Overall Study|Adverse Event|1|||
19373116|NCT01374087|41614083|FG001|Overall Study|Adverse Event|0|||
19373117|NCT01374087|41614082|FG000|Overall Study|Disease progression|2|||
19373118|NCT01374087|41614083|FG001|Overall Study|Disease progression|2|||
19373119|NCT01374087|41614082|FG000|Overall Study|Study discontinued|13|||
19373120|NCT01374087|41614083|FG001|Overall Study|Study discontinued|13|||
19373121|NCT00152971|41614092|FG000|Overall Study|Adverse Event|12|||
19390087|NCT01990534|41633748|FG000|Overall Study|Death|22|||
19390088|NCT01990534|41633748|FG000|Overall Study|Progressive disease|3|||
19390089|NCT01990534|41633748|FG000|Overall Study|Protocol Violation|1|||
19390090|NCT01990534|41633748|FG000|Overall Study|Withdrawal of Informed Consent|2|||
19390091|NCT01990534|41633748|FG000|Overall Study|Symptomatic Deterioration|1|||
19390092|NCT01990534|41633748|FG000|Overall Study|Withdrawal by Subject|3|||
19390093|NCT01990534|41633748|FG000|Overall Study|Reason not Specified|2|||
19390094|NCT01990534|41633748|FG000|Overall Study|Lost to Follow-up|1|||
19390095|NCT01967134|41633755|FG000|Overall Study|Lost to Follow-up|0|||
19390096|NCT01967134|41633756|FG001|Overall Study|Lost to Follow-up|1|||
19390097|NCT01967134|41633757|FG002|Overall Study|Lost to Follow-up|0|||
19390098|NCT01990300|41633765|FG000|Overall Study|Case Report Forms Uncollected|89|||
19390099|NCT01990300|41633765|FG000|Overall Study|Protocol Deviation|53|||
19390100|NCT01966432|41633772|FG000|Overall Study|Lost to Follow-up|3|||
19390101|NCT01966432|41633773|FG001|Overall Study|Lost to Follow-up|2|||
19390102|NCT01966432|41633774|FG002|Overall Study|Lost to Follow-up|5|||
19390103|NCT01966432|41633772|FG000|Overall Study|Withdrawal by Subject|1|||
19390104|NCT01966432|41633773|FG001|Overall Study|Withdrawal by Subject|3|||
19390105|NCT01966432|41633774|FG002|Overall Study|Withdrawal by Subject|0|||
19390106|NCT01966432|41633772|FG000|Overall Study|Subject Incarcerated|0|||
19390107|NCT01966432|41633773|FG001|Overall Study|Subject Incarcerated|0|||
19390108|NCT01966432|41633774|FG002|Overall Study|Subject Incarcerated|1|||
19390109|NCT01966432|41633772|FG000|Overall Study|SBIRT program ended|1|||
19390110|NCT01966432|41633773|FG001|Overall Study|SBIRT program ended|8|||
19390111|NCT01966432|41633774|FG002|Overall Study|SBIRT program ended|20|||
19390112|NCT01966120|41633786|FG000|Overall Study|Withdrawal by Subject|0|||
19390113|NCT01966120|41633787|FG001|Overall Study|Withdrawal by Subject|5|||
19390114|NCT01966120|41633786|FG000|Overall Study|Lost to Follow-up|1|||
19390115|NCT01966120|41633787|FG001|Overall Study|Lost to Follow-up|1|||
19390116|NCT02702401|41633795|FG000|Overall Study|Death|242|||
19390117|NCT02702401|41633796|FG001|Overall Study|Death|125|||
19390118|NCT02702401|41633795|FG000|Overall Study|Withdrawal by Subject|15|||
19390119|NCT02702401|41633796|FG001|Overall Study|Withdrawal by Subject|5|||
19390120|NCT02702401|41633795|FG000|Overall Study|Sponsor Decision|19|||
19390121|NCT02702401|41633796|FG001|Overall Study|Sponsor Decision|3|||
19390122|NCT02702401|41633795|FG000|Overall Study|Physician Decision|1|||
19390123|NCT02702401|41633796|FG001|Overall Study|Physician Decision|2|||
19390124|NCT02702401|41633795|FG000|Overall Study|Lost to Follow-up|1|||
19390125|NCT02702401|41633796|FG001|Overall Study|Lost to Follow-up|0|||
19390126|NCT02703337|41633803|FG000|Period One (Part A)|Withdrawal by Subject|0|||
19390127|NCT02703337|41633804|FG001|Period One (Part A)|Withdrawal by Subject|0|||
19390128|NCT02703337|41633805|FG002|Period One (Part A)|Withdrawal by Subject|0|||
19390129|NCT02703337|41633806|FG003|Period One (Part A)|Withdrawal by Subject|0|||
19390130|NCT02703337|41633807|FG004|Period One (Part A)|Withdrawal by Subject|1|||
19390131|NCT02703337|41633808|FG005|Period One (Part A)|Withdrawal by Subject|0|||
19390132|NCT02703337|41633809|FG006|Period One (Part A)|Withdrawal by Subject|0|||
19390133|NCT02703337|41633810|FG007|Period One (Part A)|Withdrawal by Subject|0|||
19390134|NCT01680497|41633828|FG000|Overall Study|Lost to Follow-up|2|||
19373122|NCT00152971|41614093|FG001|Overall Study|Adverse Event|10|||
19373123|NCT00152971|41614094|FG002|Overall Study|Adverse Event|9|||
19373124|NCT00152971|41614092|FG000|Overall Study|Protocol Violation|10|||
19373125|NCT00152971|41614093|FG001|Overall Study|Protocol Violation|11|||
19373126|NCT00152971|41614094|FG002|Overall Study|Protocol Violation|8|||
19373127|NCT00152971|41614092|FG000|Overall Study|Lost to Follow-up|17|||
19373128|NCT00152971|41614093|FG001|Overall Study|Lost to Follow-up|14|||
19373129|NCT00152971|41614094|FG002|Overall Study|Lost to Follow-up|13|||
19373130|NCT00152971|41614092|FG000|Overall Study|Withdrawal by Subject|9|||
19373131|NCT00152971|41614093|FG001|Overall Study|Withdrawal by Subject|8|||
19373132|NCT00152971|41614094|FG002|Overall Study|Withdrawal by Subject|14|||
19373133|NCT00152971|41614092|FG000|Overall Study|Other|3|||
19373134|NCT00152971|41614093|FG001|Overall Study|Other|5|||
19373135|NCT00152971|41614094|FG002|Overall Study|Other|5|||
19373136|NCT00152971|41614092|FG000|Treatment|Adverse Event|49|||
19373137|NCT00152971|41614093|FG001|Treatment|Adverse Event|40|||
19373138|NCT00152971|41614094|FG002|Treatment|Adverse Event|54|||
19373139|NCT00152971|41614092|FG000|Treatment|Protocol Violation|8|||
19373140|NCT00152971|41614093|FG001|Treatment|Protocol Violation|6|||
19373141|NCT00152971|41614094|FG002|Treatment|Protocol Violation|10|||
19373142|NCT00152971|41614092|FG000|Treatment|Lost to Follow-up|1|||
19373143|NCT00152971|41614093|FG001|Treatment|Lost to Follow-up|2|||
19373144|NCT00152971|41614094|FG002|Treatment|Lost to Follow-up|1|||
19373145|NCT00152971|41614092|FG000|Treatment|Withdrawal by Subject|4|||
19373146|NCT00152971|41614093|FG001|Treatment|Withdrawal by Subject|4|||
19373147|NCT00152971|41614094|FG002|Treatment|Withdrawal by Subject|5|||
19373148|NCT00152971|41614092|FG000|Treatment|Other|9|||
19373149|NCT00152971|41614093|FG001|Treatment|Other|11|||
19373150|NCT00152971|41614094|FG002|Treatment|Other|10|||
19373151|NCT02538614|41614102|FG000|Overall Study|Progressive Disease|2|||
19373152|NCT04620135|41614110|FG000|Study Completion|Adverse Event|2|||
19373153|NCT04620135|41614111|FG001|Study Completion|Adverse Event|3|||
19390135|NCT01680341|41633834|FG000|Overall Study|Adverse Event|3|||
19390136|NCT01680341|41633835|FG001|Overall Study|Adverse Event|2|||
19390137|NCT01680341|41633834|FG000|Overall Study|Unclassified|18|||
19390138|NCT01680341|41633835|FG001|Overall Study|Unclassified|15|||
19390139|NCT01679405|41633843|FG000|Overall Study|Death|2|||
19390140|NCT01679405|41633844|FG001|Overall Study|Death|5|||
19390141|NCT01603355|41633850|FG000|Overall Study|Lack of Efficacy|2|||
19390142|NCT02703259|41633856|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
19390143|NCT02703259|41633857|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
19390144|NCT02703259|41633856|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
19390145|NCT02703259|41633857|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
19390146|NCT02703259|41633856|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
19390147|NCT02703259|41633857|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
19390148|NCT00701701|41633865|FG000|Overall Study|Withdrawal by Subject|0|||
19390149|NCT00701701|41633866|FG001|Overall Study|Withdrawal by Subject|1|||
19390150|NCT00701701|41633865|FG000|Overall Study|Adverse Event|0|||
19390151|NCT00701701|41633866|FG001|Overall Study|Adverse Event|1|||
19390152|NCT01989754|41633875|FG000|Overall Study|Withdrawal by Subject|10|||
19390153|NCT01989754|41633876|FG001|Overall Study|Withdrawal by Subject|14|||
19390154|NCT01989754|41633875|FG000|Overall Study|Lost to Follow-up|28|||
19390155|NCT01989754|41633876|FG001|Overall Study|Lost to Follow-up|20|||
19390156|NCT01989754|41633875|FG000|Overall Study|Closed Site|1|||
19390157|NCT01989754|41633876|FG001|Overall Study|Closed Site|1|||
19390158|NCT01619878|41633882|FG000|6 Week Follow-up Phase|Adverse Event|1|||
19390159|NCT01619878|41633882|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
19478073|NCT01693562|41757319|FG005|Exploration Phase|Other|0|||
19390160|NCT01619878|41633882|FG000|Follow-up at 12 Months of Age|Death|2|||
19390161|NCT02015104|41633888|FG000|Overall Study|Withdrew consent after first dose drug|1|||
19799289|NCT02901431|42257308|FG011|Open Label Part|Adverse Event|4|||
19373154|NCT04620135|41614110|FG000|Study Completion|Withdrawal by Subject|2|||
19373155|NCT04620135|41614111|FG001|Study Completion|Withdrawal by Subject|0|||
19373156|NCT02552966|41614117|FG000|Overall Study|Lost to Follow-up|2|||
19390162|NCT02015104|41633889|FG001|Overall Study|Withdrew consent after first dose drug|0|||
19390163|NCT02015104|41633888|FG000|Overall Study|Withdrew consent prior to treatment|0|||
19390164|NCT02015104|41633889|FG001|Overall Study|Withdrew consent prior to treatment|1|||
19390165|NCT01619800|41633900|FG000|Overall Study|study terminated|2|||
19390166|NCT01619800|41633901|FG001|Overall Study|study terminated|0|||
19390167|NCT01989208|41633909|FG000|200 mg (7 Days)|Protocol Violation|0|||
19390168|NCT01989208|41633910|FG001|200 mg (7 Days)|Protocol Violation|1|||
19390169|NCT01619410|41633930|FG000|Overall Study|Lost to Follow-up|7|||
19390170|NCT01619410|41633931|FG001|Overall Study|Lost to Follow-up|4|||
19390171|NCT01966042|41633937|FG000|Overall Study|Death|2|||
19390172|NCT02014480|41633941|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19390173|NCT02014480|41633942|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19390174|NCT02014480|41633943|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
19390175|NCT02014480|41633944|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19390176|NCT02014480|41633945|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19390177|NCT02014480|41633946|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19390178|NCT02014480|41633941|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19390179|NCT02014480|41633942|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19390180|NCT02014480|41633943|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19390181|NCT02014480|41633944|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
19390182|NCT02014480|41633945|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19390183|NCT02014480|41633946|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19373157|NCT02552966|41614117|FG000|Overall Study|Withdrawal by Subject|3|||
19373158|NCT02552888|41614123|FG000|Overall Study|Lost to Follow-up|1|||
19373159|NCT02552888|41614124|FG001|Overall Study|Lost to Follow-up|1|||
19373160|NCT01373931|41614143|FG000|Lead-in Period|Adverse Event|2|||
19373161|NCT01373931|41614144|FG001|Lead-in Period|Adverse Event|0|||
19373162|NCT01373931|41614143|FG000|Period 1|Adverse Event|2|||
19373163|NCT01373931|41614144|FG001|Period 1|Adverse Event|0|||
19373164|NCT01373931|41614143|FG000|Period 1|Withdrawal by Subject|0|||
19373165|NCT01373931|41614144|FG001|Period 1|Withdrawal by Subject|2|||
19373166|NCT02552732|41614151|FG000|Overall Study|Lost to Follow-up|2|||
19373167|NCT02552732|41614151|FG000|Overall Study|Physician Decision|1|||
19373168|NCT02552732|41614151|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
19373169|NCT02552732|41614151|FG000|Overall Study|Withdrawal by Subject|6|||
19373170|NCT02547038|41614158|FG000|Overall Study|Lost to Follow-up|3|||
19373171|NCT02547038|41614159|FG001|Overall Study|Lost to Follow-up|2|||
19373172|NCT02764697|41614165|FG000|Overall Study|Lack of Efficacy|3|||
19373173|NCT02673489|41614171|FG000|Treatment Period|Lost to Follow-up|3|||
19373174|NCT02673489|41614172|FG001|Treatment Period|Lost to Follow-up|0|||
19373175|NCT02673489|41614171|FG000|Treatment Period|Participant request to discontinue|1|||
19373176|NCT02673489|41614172|FG001|Treatment Period|Participant request to discontinue|1|||
19373177|NCT02673489|41614171|FG000|Treatment Period|Participant moved to another province|1|||
19390184|NCT02014480|41633941|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19390185|NCT02014480|41633942|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19390186|NCT02014480|41633943|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
19390187|NCT02014480|41633944|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19390188|NCT02014480|41633945|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19390189|NCT02014480|41633946|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19390190|NCT02014480|41633941|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
19390191|NCT02014480|41633942|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
19390192|NCT02014480|41633943|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
19390193|NCT02014480|41633944|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
19390194|NCT02014480|41633945|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19390195|NCT02014480|41633946|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19390196|NCT02014480|41633941|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19390197|NCT02014480|41633942|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
19390198|NCT02014480|41633943|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19390199|NCT02014480|41633944|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19390200|NCT02014480|41633945|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19390201|NCT02014480|41633946|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19390202|NCT02014480|41633941|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
19390203|NCT02014480|41633942|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
19390204|NCT02014480|41633943|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
19390205|NCT02014480|41633944|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
19390206|NCT02014480|41633945|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
19608623|NCT02007512|42057641|FG000|Double Blind Treatment Period|Disease progression|44|||
19608624|NCT02007512|42057642|FG001|Double Blind Treatment Period|Disease progression|49|||
19390207|NCT02014480|41633946|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
19390208|NCT02014480|41633941|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19390209|NCT02014480|41633942|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19373178|NCT02673489|41614172|FG001|Treatment Period|Participant moved to another province|0|||
19390210|NCT02014480|41633943|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19390211|NCT02014480|41633944|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19390212|NCT02014480|41633945|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19390213|NCT02014480|41633946|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
19390214|NCT01668719|41633957|FG000|Phase I|On treatment|1|||
19390215|NCT01668719|41633958|FG001|Phase I|On treatment|0|||
19390216|NCT01668719|41633959|FG002|Phase I|On treatment|0|||
19390217|NCT01668719|41633957|FG000|Phase I|Adverse Event|2|||
19390218|NCT01668719|41633958|FG001|Phase I|Adverse Event|0|||
19390219|NCT01668719|41633959|FG002|Phase I|Adverse Event|0|||
19390220|NCT01668719|41633957|FG000|Phase I|Progression/relapse|1|||
19390221|NCT01668719|41633958|FG001|Phase I|Progression/relapse|0|||
19390222|NCT01668719|41633959|FG002|Phase I|Progression/relapse|0|||
19390223|NCT01668719|41633957|FG000|Phase I|not protocol specified|2|||
19390224|NCT01668719|41633958|FG001|Phase I|not protocol specified|0|||
19390225|NCT01668719|41633959|FG002|Phase I|not protocol specified|0|||
19390226|NCT01668719|41633957|FG000|Phase II|On treatment|0|||
19390227|NCT01668719|41633958|FG001|Phase II|On treatment|4|||
19390228|NCT01668719|41633959|FG002|Phase II|On treatment|3|||
19390229|NCT01668719|41633957|FG000|Phase II|Adverse Event|0|||
19390230|NCT01668719|41633958|FG001|Phase II|Adverse Event|18|||
19390231|NCT01668719|41633959|FG002|Phase II|Adverse Event|18|||
19390232|NCT01668719|41633957|FG000|Phase II|Refusal unrelated to adverse event|0|||
19390233|NCT01668719|41633958|FG001|Phase II|Refusal unrelated to adverse event|4|||
19390234|NCT01668719|41633959|FG002|Phase II|Refusal unrelated to adverse event|1|||
19390235|NCT01668719|41633957|FG000|Phase II|Progression/relapse|0|||
19390236|NCT01668719|41633958|FG001|Phase II|Progression/relapse|13|||
19390237|NCT01668719|41633959|FG002|Phase II|Progression/relapse|17|||
19390238|NCT01668719|41633957|FG000|Phase II|Death|0|||
19390239|NCT01668719|41633958|FG001|Phase II|Death|0|||
19390240|NCT01668719|41633959|FG002|Phase II|Death|2|||
19390241|NCT01668719|41633957|FG000|Phase II|not protocol specified|0|||
19390242|NCT01668719|41633958|FG001|Phase II|not protocol specified|13|||
19390243|NCT01668719|41633959|FG002|Phase II|not protocol specified|7|||
19390244|NCT01261247|41633969|FG000|Overall Study|Ineligible|2|||
19390245|NCT01677767|41633973|FG000|Overall Study|Adverse Event|1|||
19608625|NCT02007512|42057643|FG002|Double Blind Treatment Period|Disease progression|45|||
19608626|NCT02007512|42057644|FG003|Double Blind Treatment Period|Disease progression|51|||
19608627|NCT02007512|42057641|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
19608628|NCT02007512|42057642|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
19608629|NCT02007512|42057643|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
19608630|NCT02007512|42057644|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
19608631|NCT02007512|42057641|FG000|Double Blind Treatment Period|Protocol Violation|0|||
19608632|NCT02007512|42057642|FG001|Double Blind Treatment Period|Protocol Violation|0|||
19608633|NCT02007512|42057643|FG002|Double Blind Treatment Period|Protocol Violation|0|||
19698890|NCT00313586|42143714|FG001|Overall Study|Withdrawal by Subject|6|||
19698891|NCT00313586|42143715|FG002|Overall Study|Withdrawal by Subject|6|||
19698892|NCT00313586|42143716|FG003|Overall Study|Withdrawal by Subject|2|||
19698893|NCT00313586|42143713|FG000|Overall Study|Alternative therapy|3|||
19698894|NCT00313586|42143714|FG001|Overall Study|Alternative therapy|6|||
19698895|NCT00313586|42143715|FG002|Overall Study|Alternative therapy|2|||
19698896|NCT00313586|42143716|FG003|Overall Study|Alternative therapy|0|||
19698897|NCT00313586|42143713|FG000|Overall Study|Other complicating disease|2|||
19698898|NCT00313586|42143714|FG001|Overall Study|Other complicating disease|2|||
19698899|NCT00313586|42143715|FG002|Overall Study|Other complicating disease|0|||
19698900|NCT00313586|42143716|FG003|Overall Study|Other complicating disease|0|||
19698901|NCT00313586|42143713|FG000|Overall Study|Did not achieve HI-major/better response|10|||
19698902|NCT00313586|42143714|FG001|Overall Study|Did not achieve HI-major/better response|7|||
19698903|NCT00313586|42143715|FG002|Overall Study|Did not achieve HI-major/better response|2|||
19698904|NCT00313586|42143716|FG003|Overall Study|Did not achieve HI-major/better response|1|||
19698905|NCT00313586|42143713|FG000|Overall Study|Physician Decision|2|||
19698906|NCT00313586|42143714|FG001|Overall Study|Physician Decision|1|||
19698907|NCT00313586|42143715|FG002|Overall Study|Physician Decision|0|||
19390246|NCT01677767|41633973|FG000|Overall Study|Death|4|||
19608634|NCT02007512|42057644|FG003|Double Blind Treatment Period|Protocol Violation|1|||
19608635|NCT02007512|42057641|FG000|Double Blind Treatment Period|Other|0|||
19608636|NCT02007512|42057642|FG001|Double Blind Treatment Period|Other|0|||
19608637|NCT02007512|42057643|FG002|Double Blind Treatment Period|Other|1|||
19608638|NCT02007512|42057644|FG003|Double Blind Treatment Period|Other|2|||
19608639|NCT02007512|42057641|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
19608640|NCT02007512|42057642|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
19608641|NCT02007512|42057643|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
19390247|NCT01677767|41633973|FG000|Overall Study|Protocol Violation|4|||
19390248|NCT01677767|41633973|FG000|Overall Study|Withdrawal by Subject|10|||
19390249|NCT01677767|41633973|FG000|Overall Study|Non-compliance by the participants|3|||
19390250|NCT01603277|41633994|FG000|Overall Study|Adverse Event|1|||
19390251|NCT01603277|41633995|FG001|Overall Study|Adverse Event|2|||
19390252|NCT01603277|41633994|FG000|Overall Study|Physician Decision|0|||
19390253|NCT01603277|41633995|FG001|Overall Study|Physician Decision|1|||
19390254|NCT01603277|41633994|FG000|Overall Study|Protocol Violation|6|||
19390255|NCT01603277|41633995|FG001|Overall Study|Protocol Violation|10|||
19390256|NCT01603277|41633994|FG000|Overall Study|Withdrawal by Subject|5|||
19390257|NCT01603277|41633995|FG001|Overall Study|Withdrawal by Subject|4|||
19390258|NCT01603277|41633994|FG000|Overall Study|Non-Compliance|2|||
19390259|NCT01603277|41633995|FG001|Overall Study|Non-Compliance|1|||
19390260|NCT01678313|41634003|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
19390261|NCT01678313|41634004|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
19390262|NCT01678313|41634003|FG000|Completed the 3-month Therapy|Physician Decision|3|||
19390263|NCT01678313|41634004|FG001|Completed the 3-month Therapy|Physician Decision|4|||
19390264|NCT01678313|41634003|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
19390265|NCT01678313|41634004|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
19390266|NCT01678313|41634003|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
19390267|NCT01678313|41634004|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
19390268|NCT01603121|41634010|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
19390269|NCT01603121|41634011|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
19390270|NCT01603043|41634019|FG000|Overall Study|Study Futility|7|||
19390271|NCT01603043|41634020|FG001|Overall Study|Study Futility|3|||
19390272|NCT02014402|41634030|FG000|Overall Study|Adverse Event|1|||
19390273|NCT02014402|41634031|FG001|Overall Study|Adverse Event|0|||
19390274|NCT02014402|41634032|FG002|Overall Study|Adverse Event|0|||
19390275|NCT02014402|41634033|FG003|Overall Study|Adverse Event|0|||
19390276|NCT02014402|41634030|FG000|Overall Study|Withdrawal by Subject|1|||
19390277|NCT02014402|41634031|FG001|Overall Study|Withdrawal by Subject|2|||
19390278|NCT02014402|41634032|FG002|Overall Study|Withdrawal by Subject|2|||
19390279|NCT02014402|41634033|FG003|Overall Study|Withdrawal by Subject|1|||
19390280|NCT02014402|41634030|FG000|Overall Study|Subject did not have transportation|0|||
19390281|NCT02014402|41634031|FG001|Overall Study|Subject did not have transportation|1|||
19390282|NCT02014402|41634032|FG002|Overall Study|Subject did not have transportation|0|||
19390283|NCT02014402|41634033|FG003|Overall Study|Subject did not have transportation|0|||
19390284|NCT02014402|41634030|FG000|Overall Study|Lost to Follow-up|0|||
19390285|NCT02014402|41634031|FG001|Overall Study|Lost to Follow-up|0|||
19390286|NCT02014402|41634032|FG002|Overall Study|Lost to Follow-up|1|||
19390287|NCT02014402|41634033|FG003|Overall Study|Lost to Follow-up|2|||
19390288|NCT01988662|41634052|FG000|Overall Study|Subject/guardian decision|1|||
19390289|NCT01988662|41634053|FG001|Overall Study|Subject/guardian decision|1|||
19390290|NCT01988662|41634052|FG000|Overall Study|Adverse Event|3|||
19373179|NCT02673489|41614171|FG000|Treatment Period|Participant was incarcerated|0|||
19373180|NCT02673489|41614172|FG001|Treatment Period|Participant was incarcerated|1|||
19373181|NCT02673489|41614171|FG000|Treatment Period|Adverse Event|0|||
19799290|NCT02901431|42257309|FG012|Open Label Part|Adverse Event|1|||
19799291|NCT02901431|42257297|FG000|Open Label Part|Lost to Follow-up|0|||
19799292|NCT02901431|42257298|FG001|Open Label Part|Lost to Follow-up|0|||
19799293|NCT02901431|42257299|FG002|Open Label Part|Lost to Follow-up|0|||
19799294|NCT02901431|42257300|FG003|Open Label Part|Lost to Follow-up|0|||
19799295|NCT02901431|42257301|FG004|Open Label Part|Lost to Follow-up|0|||
19799296|NCT02901431|42257302|FG005|Open Label Part|Lost to Follow-up|0|||
19390291|NCT01988662|41634053|FG001|Overall Study|Adverse Event|1|||
19390292|NCT02839343|41634062|FG000|Overall Study|Withdrawal by Subject|3|||
19390293|NCT02839343|41634063|FG001|Overall Study|Withdrawal by Subject|1|||
19390294|NCT02839343|41634062|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
19390295|NCT02839343|41634063|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
19390296|NCT02839343|41634062|FG000|Overall Study|Adverse Event|1|||
19390297|NCT02839343|41634063|FG001|Overall Study|Adverse Event|0|||
19390298|NCT01965652|41634092|FG000|Overall Study|Adverse Event|40|||
19390299|NCT01965652|41634093|FG001|Overall Study|Adverse Event|37|||
19390300|NCT01965652|41634092|FG000|Overall Study|Withdrawal by Subject|62|||
19799297|NCT02901431|42257303|FG006|Open Label Part|Lost to Follow-up|0|||
19799298|NCT02901431|42257304|FG007|Open Label Part|Lost to Follow-up|0|||
19373182|NCT02673489|41614172|FG001|Treatment Period|Adverse Event|1|||
19373183|NCT02673489|41614171|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
19373184|NCT02673489|41614172|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
19373185|NCT02673489|41614171|FG000|Follow Up Period|Unable to return for follow-up|0|||
19373186|NCT02673489|41614172|FG001|Follow Up Period|Unable to return for follow-up|1|||
19373187|NCT02772809|41614179|FG000|Overall Study|not completed some tasks|6|||
19373188|NCT02537678|41614190|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
19373189|NCT02537678|41614191|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
19390301|NCT01965652|41634093|FG001|Overall Study|Withdrawal by Subject|69|||
19390302|NCT01965652|41634092|FG000|Overall Study|Lost to Follow-up|53|||
19390303|NCT01965652|41634093|FG001|Overall Study|Lost to Follow-up|40|||
19390304|NCT01965652|41634092|FG000|Overall Study|Protocol Violation|34|||
19799299|NCT02901431|42257305|FG008|Open Label Part|Lost to Follow-up|2|||
19799300|NCT02901431|42257306|FG009|Open Label Part|Lost to Follow-up|2|||
19373190|NCT02537678|41614190|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
19373191|NCT02537678|41614191|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
19373192|NCT02537678|41614190|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
19373193|NCT02537678|41614191|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
19373194|NCT02537678|41614190|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
19373195|NCT02537678|41614191|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
19373196|NCT02537678|41614190|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
19373197|NCT02537678|41614191|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
19373198|NCT02537678|41614190|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
19373199|NCT02537678|41614191|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
19373200|NCT02537678|41614190|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
19373201|NCT02537678|41614191|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
19373202|NCT02766023|41614203|FG000|Overall Study|Lost to Follow-up|23|||
19373203|NCT02766023|41614204|FG001|Overall Study|Lost to Follow-up|11|||
19373204|NCT02766023|41614203|FG000|Overall Study|Pregnancy|1|||
19373205|NCT02766023|41614204|FG001|Overall Study|Pregnancy|0|||
19373206|NCT02766023|41614203|FG000|Overall Study|Adverse Event|1|||
19373207|NCT02766023|41614204|FG001|Overall Study|Adverse Event|0|||
19373208|NCT02766023|41614203|FG000|Overall Study|Withdrawal by Subject|4|||
19373209|NCT02766023|41614204|FG001|Overall Study|Withdrawal by Subject|5|||
19390305|NCT01965652|41634093|FG001|Overall Study|Protocol Violation|38|||
19390306|NCT01965652|41634092|FG000|Overall Study|Death|3|||
19390307|NCT01965652|41634093|FG001|Overall Study|Death|4|||
19390308|NCT01965652|41634092|FG000|Overall Study|Other - Miscellaneous|18|||
19390309|NCT01965652|41634093|FG001|Overall Study|Other - Miscellaneous|21|||
19390310|NCT01965652|41634092|FG000|Overall Study|Pregnancy|0|||
19390311|NCT01965652|41634093|FG001|Overall Study|Pregnancy|1|||
19390312|NCT01602965|41634101|FG000|Overall Study|Lost to Follow-up|4|||
19390313|NCT01602965|41634102|FG001|Overall Study|Lost to Follow-up|2|||
19608642|NCT02007512|42057644|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
19373210|NCT02766023|41614203|FG000|Overall Study|Physician Decision|1|||
19373211|NCT02766023|41614204|FG001|Overall Study|Physician Decision|0|||
19373212|NCT02766023|41614203|FG000|Overall Study|Not Eligible at Enrollment|0|||
19373213|NCT02766023|41614204|FG001|Overall Study|Not Eligible at Enrollment|1|||
19373214|NCT02764229|41614210|FG000|Overall Study|Withdrawal by Subject|15|||
19373215|NCT02764229|41614210|FG000|Overall Study|Adverse Event|9|||
19373216|NCT02764229|41614210|FG000|Overall Study|Physician Decision|5|||
19373217|NCT02764229|41614210|FG000|Overall Study|Lost to Follow-up|3|||
19373218|NCT02764229|41614210|FG000|Overall Study|Lack of Efficacy|1|||
19373219|NCT02764229|41614210|FG000|Overall Study|Study Stopped by Sponsor|69|||
19373220|NCT02537522|41614214|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
19373221|NCT02537522|41614215|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
19373222|NCT02537522|41614216|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
19373223|NCT02537522|41614217|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
19373224|NCT02537522|41614214|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
19373225|NCT02537522|41614215|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
19373226|NCT02537522|41614216|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
19373227|NCT02537522|41614217|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
19373228|NCT02537522|41614214|FG000|Phase I - Contralateral|incorrect randomization|0|||
19373229|NCT02537522|41614215|FG001|Phase I - Contralateral|incorrect randomization|1|||
19373230|NCT02537522|41614216|FG002|Phase I - Contralateral|incorrect randomization|0|||
19608643|NCT02007512|42057641|FG000|Open Label Treatment Period|Adverse Event|0|||
19799301|NCT02901431|42257307|FG010|Open Label Part|Lost to Follow-up|1|||
19799302|NCT02901431|42257308|FG011|Open Label Part|Lost to Follow-up|1|||
19799303|NCT02901431|42257309|FG012|Open Label Part|Lost to Follow-up|1|||
19799304|NCT02901431|42257297|FG000|Open Label Part|Physician Decision|0|||
19799305|NCT02901431|42257298|FG001|Open Label Part|Physician Decision|0|||
19799306|NCT02901431|42257299|FG002|Open Label Part|Physician Decision|0|||
19799307|NCT02901431|42257300|FG003|Open Label Part|Physician Decision|0|||
19799308|NCT02901431|42257301|FG004|Open Label Part|Physician Decision|0|||
19799309|NCT02901431|42257302|FG005|Open Label Part|Physician Decision|0|||
19799310|NCT02901431|42257303|FG006|Open Label Part|Physician Decision|0|||
19799311|NCT02901431|42257304|FG007|Open Label Part|Physician Decision|0|||
19799312|NCT02901431|42257305|FG008|Open Label Part|Physician Decision|1|||
19799313|NCT02901431|42257306|FG009|Open Label Part|Physician Decision|1|||
19799314|NCT02901431|42257307|FG010|Open Label Part|Physician Decision|0|||
19799315|NCT02901431|42257308|FG011|Open Label Part|Physician Decision|0|||
19799316|NCT02901431|42257309|FG012|Open Label Part|Physician Decision|0|||
19799317|NCT02901431|42257297|FG000|Open Label Part|Study Terminated By Sponsor|0|||
19799318|NCT02901431|42257298|FG001|Open Label Part|Study Terminated By Sponsor|0|||
19799319|NCT02901431|42257299|FG002|Open Label Part|Study Terminated By Sponsor|0|||
19390314|NCT01987960|41634110|FG000|Period 1|Adverse Event|24|||
19799481|NCT02477800|42257554|FG000|Placebo-Controlled Period|Adverse Event|16|||
19799482|NCT02477800|42257555|FG001|Placebo-Controlled Period|Adverse Event|25|||
19799483|NCT02477800|42257556|FG002|Placebo-Controlled Period|Adverse Event|28|||
19799484|NCT02477800|42257557|FG003|Placebo-Controlled Period|Adverse Event|0|||
19799485|NCT02477800|42257558|FG004|Placebo-Controlled Period|Adverse Event|0|||
19799486|NCT02477800|42257559|FG005|Placebo-Controlled Period|Adverse Event|0|||
19799487|NCT02477800|42257560|FG006|Placebo-Controlled Period|Adverse Event|0|||
19799488|NCT02477800|42257554|FG000|Placebo-Controlled Period|Change of Treatment|1|||
19699068|NCT00290186|42143874|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
19699069|NCT00290186|42143875|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
19699070|NCT00290186|42143874|FG000|Overall Study|Withdrawal by Subject|0|||
19699071|NCT00290186|42143875|FG001|Overall Study|Withdrawal by Subject|1|||
19699072|NCT00460655|42143885|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
19608777|NCT00928070|42057814|FG001|Overall Study|Randomized but not treated|2|||
19608778|NCT00928070|42057813|FG000|Overall Study|Other|5|||
19608779|NCT00928070|42057814|FG001|Overall Study|Other|5|||
19608780|NCT00924404|42057822|FG000|Overall Study|Lost to Follow-up|6|||
19608781|NCT00924404|42057823|FG001|Overall Study|Lost to Follow-up|4|||
19608782|NCT00976937|42057831|FG000|Overall Study|Adverse Event|4|||
19608783|NCT00976937|42057832|FG001|Overall Study|Adverse Event|5|||
19608784|NCT00976937|42057831|FG000|Overall Study|Lost to Follow-up|2|||
19608785|NCT00976937|42057832|FG001|Overall Study|Lost to Follow-up|1|||
19608786|NCT00976937|42057831|FG000|Overall Study|Withdrawal by Subject|5|||
19608787|NCT00976937|42057832|FG001|Overall Study|Withdrawal by Subject|3|||
19608788|NCT00976937|42057831|FG000|Overall Study|Poor compliance to protocol|3|||
19799489|NCT02477800|42257555|FG001|Placebo-Controlled Period|Change of Treatment|2|||
19799490|NCT02477800|42257556|FG002|Placebo-Controlled Period|Change of Treatment|1|||
19799491|NCT02477800|42257557|FG003|Placebo-Controlled Period|Change of Treatment|0|||
19799492|NCT02477800|42257558|FG004|Placebo-Controlled Period|Change of Treatment|0|||
19699073|NCT00460655|42143886|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19699074|NCT00460655|42143887|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19699075|NCT00460655|42143888|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
19699076|NCT00460655|42143885|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
19699077|NCT00460655|42143886|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19699078|NCT00460655|42143887|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19699079|NCT00460655|42143888|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
19699080|NCT00460655|42143885|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
19699081|NCT00460655|42143886|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
19699082|NCT00460655|42143887|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
19699083|NCT00460655|42143888|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
19699084|NCT00460655|42143885|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19699085|NCT00460655|42143886|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
19699086|NCT00460655|42143887|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
19699087|NCT00460655|42143888|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
19699088|NCT00460655|42143885|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19699089|NCT00460655|42143886|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
19699090|NCT00460655|42143887|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
19699091|NCT00460655|42143888|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
19699092|NCT00460655|42143885|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
19699093|NCT00460655|42143886|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
19699094|NCT00460655|42143887|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
19699095|NCT00460655|42143888|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
19699096|NCT00460577|42143900|FG000|Overall Study|Protocol Violation|2|||
19699097|NCT00460577|42143901|FG001|Overall Study|Protocol Violation|6|||
19699098|NCT00289016|42143907|FG000|Overall Study|Disease Progression|29|||
19699099|NCT00289016|42143907|FG000|Overall Study|Death|2|||
19699100|NCT00289016|42143907|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
19699101|NCT00289016|42143907|FG000|Overall Study|Withdrawal by Subject|2|||
19699102|NCT00289016|42143907|FG000|Overall Study|Adverse Event|1|||
19799493|NCT02477800|42257559|FG005|Placebo-Controlled Period|Change of Treatment|0|||
19799494|NCT02477800|42257560|FG006|Placebo-Controlled Period|Change of Treatment|0|||
19608789|NCT00976937|42057832|FG001|Overall Study|Poor compliance to protocol|0|||
19608790|NCT00976937|42057831|FG000|Overall Study|Personal and Familial Reason|2|||
19699103|NCT00289016|42143907|FG000|Overall Study|Other|1|||
19699104|NCT00288860|42143913|FG000|Overall Study|Did not complete intake|4|||
19608791|NCT00976937|42057832|FG001|Overall Study|Personal and Familial Reason|2|||
19608792|NCT00976703|42057840|FG000|Overall Study|Physician Decision|1|||
19799495|NCT02477800|42257554|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
19608793|NCT00976703|42057841|FG001|Overall Study|Physician Decision|1|||
19608794|NCT00976703|42057840|FG000|Overall Study|ineligible for study|2|||
19608795|NCT00976703|42057841|FG001|Overall Study|ineligible for study|2|||
19608796|NCT00975689|42057849|FG000|Overall Study|Adverse Event|0|||
19699105|NCT00288860|42143914|FG001|Overall Study|Did not complete intake|8|||
19699106|NCT00288860|42143913|FG000|Overall Study|Death|4|||
19699107|NCT00288860|42143914|FG001|Overall Study|Death|3|||
19608797|NCT00975689|42057850|FG001|Overall Study|Adverse Event|3|||
19608798|NCT00975689|42057849|FG000|Overall Study|Withdrawal by Subject|1|||
19699108|NCT00288860|42143913|FG000|Overall Study|Withdrawal by Subject|20|||
19699109|NCT00288860|42143914|FG001|Overall Study|Withdrawal by Subject|15|||
19699110|NCT00288860|42143913|FG000|Overall Study|Lost to Follow-up|74|||
19699111|NCT00288860|42143914|FG001|Overall Study|Lost to Follow-up|71|||
19608799|NCT00975689|42057850|FG001|Overall Study|Withdrawal by Subject|0|||
19608800|NCT00975689|42057849|FG000|Overall Study|Physician Decision|1|||
19608801|NCT00975689|42057850|FG001|Overall Study|Physician Decision|0|||
19608802|NCT00922766|42057856|FG000|Overall Study|Death|3|||
19608803|NCT00922766|42057856|FG000|Overall Study|Withdrawal by Subject|2|||
19608804|NCT00922766|42057856|FG000|Overall Study|Other|1|||
19608805|NCT00922766|42057856|FG000|Overall Study|Adverse Event|1|||
19608806|NCT00917852|42057860|FG000|Overall Study|Death|6|||
19699112|NCT00288704|42143926|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
19699113|NCT00288704|42143927|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
19699114|NCT00288704|42143928|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
19699115|NCT00288704|42143926|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
19699116|NCT00288704|42143927|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
19699117|NCT00288704|42143928|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
19699118|NCT00288704|42143926|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
19699119|NCT00288704|42143927|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
19699120|NCT00288704|42143928|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
19608807|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
19608808|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
19608809|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
19608810|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
19608811|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
19608812|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
19608813|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
19608814|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
19608815|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
19608816|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
19608817|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
19608818|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
19608819|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
19608820|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
19608821|NCT00976391|42057867|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
19799496|NCT02477800|42257555|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
19608822|NCT00976391|42057868|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
19608823|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
19608824|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
19608825|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
19699121|NCT00288704|42143926|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
19699122|NCT00288704|42143927|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
19699123|NCT00288704|42143928|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
19699124|NCT00288704|42143926|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
19699125|NCT00288704|42143927|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
19699126|NCT00288704|42143928|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
19699127|NCT00288704|42143926|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
19699128|NCT00288704|42143927|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
19699129|NCT00288704|42143928|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
19799497|NCT02477800|42257556|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
19799498|NCT02477800|42257557|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
19799499|NCT02477800|42257558|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
19390379|NCT01987960|41634111|FG001|Period 3|Administrative or other reason|0|||
19608826|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
19608827|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
19799500|NCT02477800|42257559|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
19799501|NCT02477800|42257560|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
19390380|NCT01987960|41634112|FG002|Period 3|Administrative or other reason|0|||
19390381|NCT01987960|41634113|FG003|Period 3|Administrative or other reason|43|||
19390382|NCT02013778|41634123|FG000|Overall Study|Death|4|||
19390383|NCT02013778|41634123|FG000|Overall Study|Withdrawal by Subject|1|||
19390384|NCT02013778|41634123|FG000|Overall Study|Physician Decision|1|||
19390385|NCT02013778|41634123|FG000|Overall Study|Adverse Event|1|||
19608828|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
19608829|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
19390386|NCT02013622|41634127|FG000|Overall Study|Lost to Follow-up|10|||
19608830|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
19699130|NCT00288704|42143926|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
19699131|NCT00288704|42143927|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
19699132|NCT00288704|42143928|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
19699133|NCT00288626|42143935|FG000|Overall Study|Death|3|||
19699134|NCT00288626|42143935|FG000|Overall Study|Withdrawal by Subject|4|||
19699135|NCT00087490|42143943|FG000|Overall Study|Death|6|||
19699136|NCT00087490|42143944|FG001|Overall Study|Death|4|||
19699137|NCT00087490|42143943|FG000|Overall Study|Adverse Event|3|||
19699138|NCT00087490|42143944|FG001|Overall Study|Adverse Event|8|||
19699139|NCT00087490|42143943|FG000|Overall Study|Lack of Efficacy|0|||
19699140|NCT00087490|42143944|FG001|Overall Study|Lack of Efficacy|2|||
19699141|NCT00087490|42143943|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
19699142|NCT00087490|42143944|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
19699143|NCT00087490|42143943|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
19699144|NCT00087490|42143944|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
19699145|NCT00087490|42143943|FG000|Overall Study|Randomized but not treated|7|||
19699146|NCT00087490|42143944|FG001|Overall Study|Randomized but not treated|18|||
19699147|NCT00087178|42143952|FG000|Overall Study|No follow up data|5|||
19699148|NCT00087178|42143953|FG001|Overall Study|No follow up data|15|||
19699149|NCT00087178|42143952|FG000|Overall Study|No clinical assessment|1|||
19699150|NCT00087178|42143953|FG001|Overall Study|No clinical assessment|2|||
19699151|NCT00087178|42143952|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
19699152|NCT00087178|42143953|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
19699153|NCT00288080|42143961|FG000|Overall Study|Withdrawal by Subject|1|||
19699154|NCT00288080|42143962|FG001|Overall Study|Withdrawal by Subject|3|||
19699155|NCT00288080|42143961|FG000|Overall Study|Protocol Violation|25|||
19699156|NCT00288080|42143962|FG001|Overall Study|Protocol Violation|20|||
19699157|NCT00287690|42143970|FG000|Overall Study|Protocol Violation|20|||
19699158|NCT00287690|42143971|FG001|Overall Study|Protocol Violation|26|||
19699159|NCT00286754|42143980|FG000|Overall Study|Adverse Event|2|||
19699160|NCT00286754|42143981|FG001|Overall Study|Adverse Event|2|||
19699161|NCT00286754|42143982|FG002|Overall Study|Adverse Event|3|||
19699162|NCT00286754|42143980|FG000|Overall Study|Withdrawal by Subject|6|||
19699163|NCT00286754|42143981|FG001|Overall Study|Withdrawal by Subject|2|||
19699164|NCT00286754|42143982|FG002|Overall Study|Withdrawal by Subject|0|||
19699165|NCT00286754|42143980|FG000|Overall Study|Lost to Follow-up|12|||
19699166|NCT00286754|42143981|FG001|Overall Study|Lost to Follow-up|14|||
19699167|NCT00286754|42143982|FG002|Overall Study|Lost to Follow-up|6|||
19699168|NCT00286754|42143980|FG000|Overall Study|Moved out of state|0|||
19699169|NCT00286754|42143981|FG001|Overall Study|Moved out of state|0|||
19699170|NCT00286754|42143982|FG002|Overall Study|Moved out of state|1|||
19699171|NCT00066742|42143996|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
19608831|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
19608832|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
19608833|NCT00976391|42057867|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
19699172|NCT00066742|42143996|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
19699173|NCT00066742|42143996|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
19699174|NCT00066742|42143996|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
19608834|NCT00976391|42057868|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
19608835|NCT00917462|42057874|FG000|Overall Study|Clinical Deterioration|1|||
19608836|NCT00979901|42057882|FG000|Overall Study|Adverse Event|1|||
19699175|NCT00066742|42143996|FG000|Induction Chemoradiotherapy|Ineligible|3|||
19699176|NCT00066742|42143996|FG000|Consolidation Chemotherapy|not protocol specified|1|||
19699177|NCT00066742|42143996|FG000|Consolidation Chemotherapy|Ineligible|2|||
19699178|NCT00460265|42144004|FG000|Overall Study|Lost to Follow-up|14|||
19699179|NCT00460265|42144005|FG001|Overall Study|Lost to Follow-up|15|||
19699180|NCT00460265|42144004|FG000|Overall Study|Physician Decision|1|||
19699181|NCT00460265|42144005|FG001|Overall Study|Physician Decision|2|||
19699182|NCT00460265|42144004|FG000|Overall Study|Withdrawal by Subject|10|||
19699183|NCT00460265|42144005|FG001|Overall Study|Withdrawal by Subject|25|||
19699184|NCT00460265|42144004|FG000|Overall Study|Ongoing|60|||
19390387|NCT02013622|41634127|FG000|Overall Study|Adverse Event|3|||
19699185|NCT00460265|42144005|FG001|Overall Study|Ongoing|47|||
19699186|NCT00460109|42144011|FG000|Overall Study|Death|1|||
19390388|NCT02013622|41634127|FG000|Overall Study|Met Withdrawal Criteria|3|||
19608837|NCT00979901|42057883|FG001|Overall Study|Adverse Event|3|||
19608838|NCT00979901|42057884|FG002|Overall Study|Adverse Event|9|||
19608839|NCT00979901|42057885|FG003|Overall Study|Adverse Event|2|||
19699187|NCT00065260|42144017|FG000|Overall Study|Death|0|||
19699188|NCT00065260|42144018|FG001|Overall Study|Death|1|||
19699189|NCT00460031|42144024|FG000|Overall Study|Adverse Event|5|||
19699190|NCT00460031|42144024|FG000|Overall Study|Withdrawal by Subject|5|||
19699191|NCT00460031|42144024|FG000|Overall Study|Death|1|||
19699192|NCT00451217|42144032|FG000|Overall Study|Lost to Follow-up|0|||
19699193|NCT00451217|42144033|FG001|Overall Study|Lost to Follow-up|1|||
19699194|NCT00451217|42144034|FG002|Overall Study|Lost to Follow-up|1|||
19699195|NCT00451217|42144035|FG003|Overall Study|Lost to Follow-up|1|||
19699196|NCT00451217|42144032|FG000|Overall Study|Withdrawal by Subject|1|||
19699197|NCT00451217|42144033|FG001|Overall Study|Withdrawal by Subject|0|||
19699198|NCT00451217|42144034|FG002|Overall Study|Withdrawal by Subject|0|||
19699199|NCT00451217|42144035|FG003|Overall Study|Withdrawal by Subject|0|||
19699200|NCT00451217|42144032|FG000|Overall Study|Not Treated|1|||
19699201|NCT00451217|42144033|FG001|Overall Study|Not Treated|1|||
19699202|NCT00451217|42144034|FG002|Overall Study|Not Treated|3|||
19699203|NCT00451217|42144035|FG003|Overall Study|Not Treated|4|||
19699204|NCT00459953|42144047|FG000|Overall Study|not analyzed-household member in study|1|||
19699205|NCT00459953|42144048|FG001|Overall Study|not analyzed-household member in study|1|||
19699206|NCT00459875|42144054|FG000|Overall Study|Ineligible participant|1|||
19699207|NCT00459875|42144054|FG000|Overall Study|Adverse Event|2|||
19699208|NCT00311402|42144060|FG000|Overall Study|Adverse Event|118|||
19699209|NCT00311402|42144061|FG001|Overall Study|Adverse Event|105|||
19699210|NCT00311402|42144060|FG000|Overall Study|Lost to Follow-up|0|||
19699211|NCT00311402|42144061|FG001|Overall Study|Lost to Follow-up|3|||
19699212|NCT00311402|42144060|FG000|Overall Study|Withdrawal by Subject|17|||
19699213|NCT00311402|42144061|FG001|Overall Study|Withdrawal by Subject|18|||
19699214|NCT00311402|42144060|FG000|Overall Study|Lack of Efficacy|58|||
19699215|NCT00311402|42144061|FG001|Overall Study|Lack of Efficacy|42|||
19699216|NCT00311402|42144060|FG000|Overall Study|Protocol Violation|7|||
19608840|NCT00979901|42057882|FG000|Overall Study|Lack of Efficacy|8|||
19608841|NCT00979901|42057883|FG001|Overall Study|Lack of Efficacy|4|||
19608842|NCT00979901|42057884|FG002|Overall Study|Lack of Efficacy|9|||
19699217|NCT00311402|42144061|FG001|Overall Study|Protocol Violation|6|||
19699218|NCT00311402|42144060|FG000|Overall Study|IRB's rejection etc.|10|||
19699219|NCT00311402|42144061|FG001|Overall Study|IRB's rejection etc.|3|||
19699220|NCT00450749|42144070|FG000|Overall Study|Withdrawal by Subject|0|||
19699221|NCT00450749|42144071|FG001|Overall Study|Withdrawal by Subject|0|||
19699222|NCT00450749|42144072|FG002|Overall Study|Withdrawal by Subject|2|||
19699223|NCT00450749|42144070|FG000|Overall Study|Noncompliant|0|||
19699224|NCT00450749|42144071|FG001|Overall Study|Noncompliant|1|||
19699225|NCT00450749|42144072|FG002|Overall Study|Noncompliant|0|||
19699226|NCT00292370|42144083|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
19699227|NCT00292370|42144084|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
19699228|NCT00292370|42144085|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
19699229|NCT00292370|42144083|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
19699230|NCT00292370|42144084|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
19699231|NCT00292370|42144085|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
19699232|NCT00292370|42144083|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
19699233|NCT00292370|42144084|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
19699234|NCT00292370|42144085|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
19699235|NCT00292370|42144083|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
19699236|NCT00292370|42144084|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
19699237|NCT00292370|42144085|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
19699238|NCT00292370|42144083|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
19699239|NCT00292370|42144084|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
19699240|NCT00292370|42144085|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
19699241|NCT00292370|42144083|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
19699242|NCT00292370|42144084|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
19699243|NCT00292370|42144085|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
19699244|NCT00065182|42144094|FG000|Overall Study|Adverse Event|24|||
19699245|NCT00065182|42144095|FG001|Overall Study|Adverse Event|17|||
19699246|NCT00065182|42144094|FG000|Overall Study|Lost to Follow-up|0|||
19699247|NCT00065182|42144095|FG001|Overall Study|Lost to Follow-up|4|||
19699248|NCT00065182|42144094|FG000|Overall Study|Protocol Violation|3|||
19699249|NCT00065182|42144095|FG001|Overall Study|Protocol Violation|4|||
19699250|NCT00065182|42144094|FG000|Overall Study|Serious adverse events (SAE)|1|||
19699251|NCT00065182|42144095|FG001|Overall Study|Serious adverse events (SAE)|0|||
19699252|NCT00065182|42144094|FG000|Overall Study|Sponsor Decision|11|||
19699253|NCT00065182|42144095|FG001|Overall Study|Sponsor Decision|7|||
19608843|NCT00979901|42057885|FG003|Overall Study|Lack of Efficacy|0|||
19608844|NCT00979901|42057882|FG000|Overall Study|Lost to Follow-up|1|||
19608845|NCT00979901|42057883|FG001|Overall Study|Lost to Follow-up|1|||
19608846|NCT00979901|42057884|FG002|Overall Study|Lost to Follow-up|2|||
19608847|NCT00979901|42057885|FG003|Overall Study|Lost to Follow-up|0|||
19608848|NCT00979901|42057882|FG000|Overall Study|Protocol Violation|2|||
19608849|NCT00979901|42057883|FG001|Overall Study|Protocol Violation|2|||
19699254|NCT00065182|42144094|FG000|Overall Study|Withdrawal by Subject|8|||
19608850|NCT00979901|42057884|FG002|Overall Study|Protocol Violation|7|||
19608851|NCT00979901|42057885|FG003|Overall Study|Protocol Violation|1|||
19699255|NCT00065182|42144095|FG001|Overall Study|Withdrawal by Subject|3|||
19699256|NCT00065182|42144094|FG000|Overall Study|No clinical benefit|1|||
19699257|NCT00065182|42144095|FG001|Overall Study|No clinical benefit|0|||
19699258|NCT00065182|42144094|FG000|Overall Study|Death|0|||
19699259|NCT00065182|42144095|FG001|Overall Study|Death|1|||
19699260|NCT00065182|42144094|FG000|Overall Study|Decline in Status|0|||
19699261|NCT00065182|42144095|FG001|Overall Study|Decline in Status|1|||
19699262|NCT00064792|42144103|FG000|Overall Study|Withdrawal by Subject|2|||
19699263|NCT00064792|42144104|FG001|Overall Study|Withdrawal by Subject|0|||
19699264|NCT00064792|42144103|FG000|Overall Study|Adverse Event|3|||
19699265|NCT00064792|42144104|FG001|Overall Study|Adverse Event|0|||
19699266|NCT00450437|42144112|FG000|Overall Study|Withdrawal by Subject|10|||
19699267|NCT00450437|42144113|FG001|Overall Study|Withdrawal by Subject|2|||
19699268|NCT00450437|42144114|FG002|Overall Study|Withdrawal by Subject|0|||
19699269|NCT00450437|42144115|FG003|Overall Study|Withdrawal by Subject|1|||
19699270|NCT00450437|42144112|FG000|Overall Study|Lost to Follow-up|31|||
19699271|NCT00450437|42144113|FG001|Overall Study|Lost to Follow-up|12|||
19699272|NCT00450437|42144114|FG002|Overall Study|Lost to Follow-up|19|||
19699273|NCT00450437|42144115|FG003|Overall Study|Lost to Follow-up|9|||
19699274|NCT00450437|42144112|FG000|Overall Study|Protocol Violation|0|||
19699275|NCT00450437|42144113|FG001|Overall Study|Protocol Violation|1|||
19699276|NCT00450437|42144114|FG002|Overall Study|Protocol Violation|0|||
19699277|NCT00450437|42144115|FG003|Overall Study|Protocol Violation|1|||
19699278|NCT00450437|42144112|FG000|Overall Study|Inappropriate enrollment|4|||
19699279|NCT00450437|42144113|FG001|Overall Study|Inappropriate enrollment|1|||
19699280|NCT00450437|42144114|FG002|Overall Study|Inappropriate enrollment|3|||
19699281|NCT00450437|42144115|FG003|Overall Study|Inappropriate enrollment|0|||
19699282|NCT00450437|42144112|FG000|Overall Study|Administrative reason|0|||
19699283|NCT00450437|42144113|FG001|Overall Study|Administrative reason|0|||
19699284|NCT00450437|42144114|FG002|Overall Study|Administrative reason|1|||
19699285|NCT00450437|42144115|FG003|Overall Study|Administrative reason|0|||
19699286|NCT00450437|42144112|FG000|Overall Study|Unable to Classify|1|||
19699287|NCT00450437|42144113|FG001|Overall Study|Unable to Classify|0|||
19699288|NCT00450437|42144114|FG002|Overall Study|Unable to Classify|1|||
19699289|NCT00450437|42144115|FG003|Overall Study|Unable to Classify|0|||
19699290|NCT00286442|42144132|FG000|Overall Study|Hyperglycemic Rescue|19|||
19608852|NCT00979901|42057882|FG000|Overall Study|Withdrawal by Subject|2|||
19608853|NCT00979901|42057883|FG001|Overall Study|Withdrawal by Subject|1|||
19608854|NCT00979901|42057884|FG002|Overall Study|Withdrawal by Subject|1|||
19608855|NCT00979901|42057885|FG003|Overall Study|Withdrawal by Subject|1|||
19608856|NCT00979901|42057882|FG000|Overall Study|Noncompliance|1|||
19608857|NCT00979901|42057883|FG001|Overall Study|Noncompliance|0|||
19608858|NCT00979901|42057884|FG002|Overall Study|Noncompliance|0|||
19608859|NCT00979901|42057885|FG003|Overall Study|Noncompliance|0|||
19608860|NCT00979901|42057882|FG000|Overall Study|out-of-state|1|||
19608861|NCT00979901|42057883|FG001|Overall Study|out-of-state|0|||
19608862|NCT00979901|42057884|FG002|Overall Study|out-of-state|0|||
19608863|NCT00979901|42057885|FG003|Overall Study|out-of-state|0|||
19699291|NCT00286442|42144133|FG001|Overall Study|Hyperglycemic Rescue|17|||
19699292|NCT00286442|42144134|FG002|Overall Study|Hyperglycemic Rescue|25|||
19699293|NCT00286442|42144132|FG000|Overall Study|Adverse Event|7|||
19699294|NCT00286442|42144133|FG001|Overall Study|Adverse Event|6|||
19799502|NCT02477800|42257554|FG000|Placebo-Controlled Period|Death|0|||
19799503|NCT02477800|42257555|FG001|Placebo-Controlled Period|Death|3|||
19799504|NCT02477800|42257556|FG002|Placebo-Controlled Period|Death|2|||
19799505|NCT02477800|42257557|FG003|Placebo-Controlled Period|Death|0|||
19799506|NCT02477800|42257558|FG004|Placebo-Controlled Period|Death|0|||
19608864|NCT00979901|42057882|FG000|Overall Study|vacation|1|||
19699295|NCT00286442|42144134|FG002|Overall Study|Adverse Event|1|||
19699296|NCT00286442|42144132|FG000|Overall Study|Protocol Violation|2|||
19699297|NCT00286442|42144133|FG001|Overall Study|Protocol Violation|4|||
19699298|NCT00286442|42144134|FG002|Overall Study|Protocol Violation|2|||
19699299|NCT00286442|42144132|FG000|Overall Study|Lost to Follow-up|5|||
19699300|NCT00286442|42144133|FG001|Overall Study|Lost to Follow-up|2|||
19699301|NCT00286442|42144134|FG002|Overall Study|Lost to Follow-up|1|||
19699302|NCT00286442|42144132|FG000|Overall Study|Physician Decision|1|||
19699303|NCT00286442|42144133|FG001|Overall Study|Physician Decision|1|||
19699304|NCT00286442|42144134|FG002|Overall Study|Physician Decision|1|||
19699305|NCT00286442|42144132|FG000|Overall Study|Administrative Error|1|||
19699306|NCT00286442|42144133|FG001|Overall Study|Administrative Error|1|||
19699307|NCT00286442|42144134|FG002|Overall Study|Administrative Error|0|||
19699308|NCT00286442|42144132|FG000|Overall Study|Withdrawal by Subject|2|||
19699309|NCT00286442|42144133|FG001|Overall Study|Withdrawal by Subject|14|||
19699310|NCT00286442|42144134|FG002|Overall Study|Withdrawal by Subject|2|||
19699311|NCT00063934|42144142|FG000|Overall Study|Ineligible|1|||
19799507|NCT02477800|42257559|FG005|Placebo-Controlled Period|Death|0|||
19608865|NCT00979901|42057883|FG001|Overall Study|vacation|0|||
19699312|NCT00458783|42144148|FG000|Overall Study|Protocol Violation|1228|||
19699313|NCT00458783|42144149|FG001|Overall Study|Protocol Violation|1220|||
19699314|NCT00063154|42144155|FG000|Overall Study|Disease progression|27|||
19699315|NCT00063154|42144155|FG000|Overall Study|Adverse Event|2|||
19699316|NCT00063154|42144155|FG000|Overall Study|Physician Decision|10|||
19699317|NCT00063154|42144155|FG000|Overall Study|Death|3|||
19699318|NCT00063154|42144155|FG000|Overall Study|Reason unspecified|1|||
19699319|NCT00063154|42144155|FG000|Overall Study|Did not receive treatment|8|||
19699320|NCT00311168|42144161|FG000|First Intervention|Withdrawal by Subject|2|||
19699321|NCT00311168|42144162|FG001|First Intervention|Withdrawal by Subject|2|||
19699322|NCT00311168|42144161|FG000|First Intervention|Lost to Follow-up|1|||
19699323|NCT00311168|42144162|FG001|First Intervention|Lost to Follow-up|1|||
19699324|NCT00311168|42144161|FG000|First Intervention|Protocol Violation|1|||
19699325|NCT00311168|42144162|FG001|First Intervention|Protocol Violation|1|||
19699326|NCT00311168|42144161|FG000|First Intervention|Adverse Event|1|||
19699327|NCT00311168|42144162|FG001|First Intervention|Adverse Event|0|||
19699328|NCT00311168|42144161|FG000|First Intervention|Other|2|||
19699329|NCT00311168|42144162|FG001|First Intervention|Other|2|||
19699330|NCT00311168|42144161|FG000|Second Intervention|Lost to Follow-up|9|||
19699331|NCT00311168|42144162|FG001|Second Intervention|Lost to Follow-up|2|||
19699332|NCT00311168|42144161|FG000|Second Intervention|Withdrawal by Subject|0|||
19699333|NCT00311168|42144162|FG001|Second Intervention|Withdrawal by Subject|1|||
19699334|NCT00311168|42144161|FG000|Second Intervention|Other|1|||
19699335|NCT00311168|42144162|FG001|Second Intervention|Other|1|||
19699336|NCT00458705|42144170|FG000|Overall Study|Adverse Event|4|||
19699337|NCT00458705|42144170|FG000|Overall Study|Not Treated|1|||
19699338|NCT00062374|42144174|FG000|Overall Study|Not treated|12|||
19699339|NCT00285818|42144180|FG000|Overall Study|Withdrawal by Subject|3|||
19699340|NCT00285818|42144181|FG001|Overall Study|Withdrawal by Subject|2|||
19699341|NCT00285818|42144180|FG000|Overall Study|Lost to Follow-up|1|||
19699342|NCT00285818|42144181|FG001|Overall Study|Lost to Follow-up|0|||
19699343|NCT00285584|42144189|FG000|Month 3|Lost to Follow-up|3|||
19699344|NCT00285584|42144190|FG001|Month 3|Lost to Follow-up|3|||
19699345|NCT00285584|42144189|FG000|Month 3|Withdrawal by Subject|1|||
19699346|NCT00285584|42144190|FG001|Month 3|Withdrawal by Subject|0|||
19699347|NCT00285584|42144189|FG000|Month 6|Lost to Follow-up|0|||
19699348|NCT00285584|42144190|FG001|Month 6|Lost to Follow-up|1|||
19699349|NCT03807700|42144202|FG000|Overall Study|Withdrawal by Subject|2|||
19699350|NCT03807700|42144203|FG001|Overall Study|Withdrawal by Subject|1|||
19699351|NCT00291668|42144213|FG000|Overall Study|Lack of Efficacy|1|||
19699352|NCT00291668|42144214|FG001|Overall Study|Lack of Efficacy|0|||
19699353|NCT00291668|42144215|FG002|Overall Study|Lack of Efficacy|0|||
19699354|NCT00291668|42144213|FG000|Overall Study|SAE, non-fatal|1|||
19699355|NCT00291668|42144214|FG001|Overall Study|SAE, non-fatal|1|||
19699356|NCT00291668|42144215|FG002|Overall Study|SAE, non-fatal|1|||
19699357|NCT00291668|42144213|FG000|Overall Study|AE, non-serious non-fatal|1|||
19699358|NCT00291668|42144214|FG001|Overall Study|AE, non-serious non-fatal|0|||
19699359|NCT00291668|42144215|FG002|Overall Study|AE, non-serious non-fatal|0|||
19699360|NCT00291668|42144213|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19699361|NCT00291668|42144214|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19699362|NCT00291668|42144215|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19699363|NCT00458393|42144225|FG000|Overall Study|Withdrawal by Subject|67|||
19699364|NCT00458393|42144226|FG001|Overall Study|Withdrawal by Subject|80|||
19699365|NCT00458393|42144225|FG000|Overall Study|Physician Decision|31|||
19699366|NCT00458393|42144226|FG001|Overall Study|Physician Decision|22|||
19699367|NCT00458393|42144225|FG000|Overall Study|Relocated|77|||
19699368|NCT00458393|42144226|FG001|Overall Study|Relocated|81|||
19699369|NCT00458393|42144225|FG000|Overall Study|Lost to Follow-up|115|||
19699370|NCT00458393|42144226|FG001|Overall Study|Lost to Follow-up|92|||
19699371|NCT00458393|42144225|FG000|Overall Study|Sites marked other on the form.|19|||
19699372|NCT00458393|42144226|FG001|Overall Study|Sites marked other on the form.|20|||
19699373|NCT00310856|42144237|FG000|Overall Study|Withdrawal by Subject|2|||
19699374|NCT00310856|42144238|FG001|Overall Study|Withdrawal by Subject|2|||
19699375|NCT00310856|42144239|FG002|Overall Study|Withdrawal by Subject|2|||
19699376|NCT00310856|42144237|FG000|Overall Study|Lost to Follow-up|1|||
19699377|NCT00310856|42144238|FG001|Overall Study|Lost to Follow-up|2|||
19478183|NCT01467713|41757433|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
19699378|NCT00310856|42144239|FG002|Overall Study|Lost to Follow-up|6|||
19699379|NCT00310856|42144237|FG000|Overall Study|Inappropriate enrollment|1|||
19699380|NCT00310856|42144238|FG001|Overall Study|Inappropriate enrollment|1|||
19699381|NCT00310856|42144239|FG002|Overall Study|Inappropriate enrollment|0|||
19699382|NCT00310856|42144237|FG000|Overall Study|Unable to classify|1|||
19699383|NCT00310856|42144238|FG001|Overall Study|Unable to classify|0|||
19478184|NCT01467713|41757434|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
19608866|NCT00979901|42057884|FG002|Overall Study|vacation|0|||
19699384|NCT00310856|42144239|FG002|Overall Study|Unable to classify|0|||
19699385|NCT00283712|42144250|FG000|Overall Study|Death|0|||
19699386|NCT00283712|42144251|FG001|Overall Study|Death|1|||
19699387|NCT00048724|42144259|FG000|Overall Study|Adverse Event|53|||
19699388|NCT00048724|42144260|FG001|Overall Study|Adverse Event|12|||
19699389|NCT00048724|42144259|FG000|Overall Study|Withdrawal by Subject|34|||
19699390|NCT00048724|42144260|FG001|Overall Study|Withdrawal by Subject|54|||
19699391|NCT00048724|42144259|FG000|Overall Study|Lost to Follow-up|5|||
19699392|NCT00048724|42144260|FG001|Overall Study|Lost to Follow-up|5|||
19699393|NCT00048724|42144259|FG000|Overall Study|Protocol-defined Clinical Event|17|||
19608867|NCT00979901|42057885|FG003|Overall Study|vacation|0|||
19608868|NCT00979901|42057882|FG000|Overall Study|elevated lab values pre-randomization|1|||
19608869|NCT00979901|42057883|FG001|Overall Study|elevated lab values pre-randomization|0|||
19608870|NCT00979901|42057884|FG002|Overall Study|elevated lab values pre-randomization|0|||
19608871|NCT00979901|42057885|FG003|Overall Study|elevated lab values pre-randomization|0|||
19608872|NCT00979901|42057882|FG000|Overall Study|Discontinued in Error|0|||
19799508|NCT02477800|42257560|FG006|Placebo-Controlled Period|Death|0|||
19799509|NCT02477800|42257554|FG000|Placebo-Controlled Period|Disease Progression|1|||
19699394|NCT00048724|42144260|FG001|Overall Study|Protocol-defined Clinical Event|32|||
19699395|NCT00048724|42144259|FG000|Overall Study|Noncompliance With Protocol|4|||
19699396|NCT00048724|42144260|FG001|Overall Study|Noncompliance With Protocol|12|||
19699397|NCT00048724|42144259|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
19699398|NCT00048724|42144260|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
19699399|NCT00048724|42144259|FG000|Overall Study|Administrative|1|||
19699400|NCT00048724|42144260|FG001|Overall Study|Administrative|1|||
19699401|NCT00449033|42144268|FG000|Treatment Period|Adverse Event|117|||
19608873|NCT00979901|42057883|FG001|Overall Study|Discontinued in Error|1|||
19608874|NCT00979901|42057884|FG002|Overall Study|Discontinued in Error|0|||
19608875|NCT00979901|42057885|FG003|Overall Study|Discontinued in Error|0|||
19608876|NCT00979901|42057882|FG000|Overall Study|Left Country|0|||
19608877|NCT00979901|42057883|FG001|Overall Study|Left Country|0|||
19608878|NCT00979901|42057884|FG002|Overall Study|Left Country|1|||
19608879|NCT00979901|42057885|FG003|Overall Study|Left Country|0|||
19608880|NCT00979901|42057882|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
19608881|NCT00979901|42057883|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
19608882|NCT00979901|42057884|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
19608883|NCT00979901|42057885|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
19608884|NCT00975611|42057894|FG000|Overall Study|Screen Fail|16|||
19608885|NCT00975611|42057894|FG000|Overall Study|Physician Decision|1|||
19608886|NCT00970307|42057901|FG000|Overall Study|Serious Adverse Event|1|||
19699402|NCT00449033|42144269|FG001|Treatment Period|Adverse Event|83|||
19699403|NCT00449033|42144268|FG000|Treatment Period|Death|21|||
19699404|NCT00449033|42144269|FG001|Treatment Period|Death|12|||
19699405|NCT00449033|42144268|FG000|Treatment Period|Lost to Follow-up|0|||
19699406|NCT00449033|42144269|FG001|Treatment Period|Lost to Follow-up|2|||
19699407|NCT00449033|42144268|FG000|Treatment Period|Physician Decision|4|||
19699408|NCT00449033|42144269|FG001|Treatment Period|Physician Decision|5|||
19699409|NCT00449033|42144268|FG000|Treatment Period|Protocol Violation|8|||
19699410|NCT00449033|42144269|FG001|Treatment Period|Protocol Violation|7|||
19699411|NCT00449033|42144268|FG000|Treatment Period|Disease Progression|231|||
19699412|NCT00449033|42144269|FG001|Treatment Period|Disease Progression|288|||
19699413|NCT00449033|42144268|FG000|Treatment Period|Consent Withdrawn|36|||
19699414|NCT00449033|42144269|FG001|Treatment Period|Consent Withdrawn|20|||
19699415|NCT00449033|42144268|FG000|Treatment Period|Amended Protocol Criteria|22|||
19699416|NCT00449033|42144269|FG001|Treatment Period|Amended Protocol Criteria|18|||
19699417|NCT00449033|42144268|FG000|Treatment Period|Non-compliance|7|||
19699418|NCT00449033|42144269|FG001|Treatment Period|Non-compliance|8|||
19699419|NCT00449033|42144268|FG000|Treatment Period|Second Malignancy|0|||
19699420|NCT00449033|42144269|FG001|Treatment Period|Second Malignancy|1|||
19699421|NCT00449033|42144268|FG000|Treatment Period|Reason Missing|0|||
19699422|NCT00449033|42144269|FG001|Treatment Period|Reason Missing|4|||
19699423|NCT00449033|42144268|FG000|Treatment Period|Treatment Ongoing|6|||
19699424|NCT00449033|42144269|FG001|Treatment Period|Treatment Ongoing|4|||
19699425|NCT00449033|42144268|FG000|Follow-up Period|Death|299|||
19699426|NCT00449033|42144269|FG001|Follow-up Period|Death|311|||
19699427|NCT00449033|42144268|FG000|Follow-up Period|Lost to Follow-up|6|||
19699428|NCT00449033|42144269|FG001|Follow-up Period|Lost to Follow-up|10|||
19699429|NCT00449033|42144268|FG000|Follow-up Period|Reason Missing|120|||
19699430|NCT00449033|42144269|FG001|Follow-up Period|Reason Missing|113|||
19699431|NCT00448019|42144275|FG000|Overall Study|Withdrawal by Subject|3|||
19699432|NCT00448019|42144275|FG000|Overall Study|Disease progression|1|||
19699433|NCT00448019|42144275|FG000|Overall Study|Death|2|||
19799510|NCT02477800|42257555|FG001|Placebo-Controlled Period|Disease Progression|0|||
19608887|NCT00970307|42057902|FG001|Overall Study|Serious Adverse Event|0|||
19699434|NCT00448019|42144275|FG000|Overall Study|Insurance Issues|1|||
19699435|NCT00457691|42144281|FG000|Overall Study|Adverse Event|4|||
19699436|NCT00457691|42144282|FG001|Overall Study|Adverse Event|1|||
19699437|NCT00457691|42144281|FG000|Overall Study|Death|163|||
19699438|NCT00457691|42144282|FG001|Overall Study|Death|148|||
19699439|NCT00457691|42144281|FG000|Overall Study|Protocol Violation|1|||
19699440|NCT00457691|42144282|FG001|Overall Study|Protocol Violation|3|||
19699441|NCT00457691|42144281|FG000|Overall Study|Lost to Follow-up|23|||
19699442|NCT00457691|42144282|FG001|Overall Study|Lost to Follow-up|14|||
19608888|NCT00970307|42057903|FG002|Overall Study|Serious Adverse Event|0|||
19608889|NCT00970307|42057901|FG000|Overall Study|Withdrawal by Subject|2|||
19699443|NCT00457691|42144281|FG000|Overall Study|Study terminated by Sponsor|1|||
19699444|NCT00457691|42144282|FG001|Overall Study|Study terminated by Sponsor|1|||
19699445|NCT00457691|42144281|FG000|Overall Study|Subject refused (reason other than AE)|14|||
19699446|NCT00457691|42144282|FG001|Overall Study|Subject refused (reason other than AE)|19|||
19699447|NCT00457691|42144281|FG000|Overall Study|Disease progression, study terminated|180|||
19699448|NCT00457691|42144282|FG001|Overall Study|Disease progression, study terminated|196|||
19699449|NCT00457301|42144290|FG000|Overall Study|Withdrawal by Subject|3|||
19699450|NCT00457301|42144291|FG001|Overall Study|Withdrawal by Subject|3|||
19699451|NCT00457301|42144290|FG000|Overall Study|Censored out of the study|15|||
19699452|NCT00457301|42144291|FG001|Overall Study|Censored out of the study|14|||
19699453|NCT00457301|42144290|FG000|Overall Study|Death|5|||
19699454|NCT00457301|42144291|FG001|Overall Study|Death|7|||
19699455|NCT00456755|42144299|FG000|Overall Study|Lost to Follow-up|2|||
19699456|NCT00456755|42144300|FG001|Overall Study|Lost to Follow-up|1|||
19699457|NCT00447005|42144306|FG000|Overall Study|Adverse Event|1|||
19699458|NCT00447005|42144306|FG000|Overall Study|Lack of Efficacy|11|||
19699459|NCT00446849|42144310|FG000|Acute Phase|Lack of Efficacy|64|||
19699460|NCT00446849|42144310|FG000|Acute Phase|Protocol Violation|10|||
19699461|NCT00446849|42144310|FG000|Acute Phase|Consent withdrawn|4|||
19699462|NCT00446849|42144310|FG000|Acute Phase|Lost to Follow-up|2|||
19699463|NCT00446849|42144310|FG000|Acute Phase|Physician Decision|1|||
19699464|NCT00446849|42144310|FG000|Acute Phase|noncompliance|1|||
19699465|NCT00446849|42144310|FG000|Maintenance Phase|Lack of Efficacy|40|||
19699466|NCT00446849|42144310|FG000|Maintenance Phase|Protocol Violation|7|||
19699467|NCT00446849|42144310|FG000|Maintenance Phase|Adverse Event|6|||
19699468|NCT00446849|42144310|FG000|Maintenance Phase|Consent withdrawn|5|||
19699469|NCT00446849|42144310|FG000|Maintenance Phase|Lost to Follow-up|3|||
19699470|NCT00446849|42144310|FG000|Maintenance Phase|Pregnancy|1|||
19699471|NCT00446849|42144310|FG000|Maintenance Phase|noncompliance|2|||
19699472|NCT00446849|42144310|FG000|Maintenance Phase|prohibited medication use|2|||
19699473|NCT00446849|42144310|FG000|Maintenance Phase|antibiotic use|1|||
19699474|NCT00446849|42144310|FG000|Maintenance Phase|study closure|1|||
19699475|NCT00446849|42144310|FG000|Maintenance Phase|hydrocodone use|1|||
19699476|NCT00446849|42144310|FG000|Maintenance Phase|concomitant medication use|1|||
19699477|NCT00446459|42144315|FG000|8 Months|Protocol Violation|12|||
19699478|NCT00446459|42144315|FG000|12 Months|Protocol Violation|4|||
19699479|NCT00446459|42144315|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
19699480|NCT00456599|42144319|FG000|Overall Study|Non-compliance|1|||
19699481|NCT00456599|42144319|FG000|Overall Study|Withdrawal by Subject|2|||
19699482|NCT00456521|42144325|FG000|Overall Study|Adverse Event|150|||
19699483|NCT00456521|42144326|FG001|Overall Study|Adverse Event|25|||
19699484|NCT00456521|42144325|FG000|Overall Study|Withdrawal by Subject|43|||
19699485|NCT00456521|42144326|FG001|Overall Study|Withdrawal by Subject|24|||
19699486|NCT00456521|42144325|FG000|Overall Study|Lost to Follow-up|22|||
19699487|NCT00456521|42144326|FG001|Overall Study|Lost to Follow-up|17|||
19699488|NCT00456521|42144325|FG000|Overall Study|Lack of Efficacy|3|||
19699489|NCT00456521|42144326|FG001|Overall Study|Lack of Efficacy|6|||
19699490|NCT00456521|42144325|FG000|Overall Study|Protocol Violation|4|||
19699491|NCT00456521|42144326|FG001|Overall Study|Protocol Violation|0|||
19699492|NCT00456521|42144325|FG000|Overall Study|Pregnancy|1|||
19699493|NCT00456521|42144326|FG001|Overall Study|Pregnancy|1|||
19699494|NCT00456521|42144325|FG000|Overall Study|Drug non-compliance, moved, other|26|||
19699495|NCT00456521|42144326|FG001|Overall Study|Drug non-compliance, moved, other|11|||
19699496|NCT00456365|42144335|FG000|Overall Study|Lost to Follow-up|1|||
19699497|NCT00456365|42144336|FG001|Overall Study|Lost to Follow-up|3|||
19699498|NCT00456365|42144335|FG000|Overall Study|Withdrawal by Subject|4|||
19390389|NCT02013622|41634127|FG000|Overall Study|Withdrawal by Subject|6|||
19390390|NCT02013622|41634127|FG000|Overall Study|Protocol Deviation|1|||
19390391|NCT02013622|41634127|FG000|Overall Study|Lack of Efficacy|1|||
19390392|NCT01987102|41634133|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
19390393|NCT01987102|41634134|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
19390394|NCT01987102|41634133|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
19390395|NCT01987102|41634134|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
19390396|NCT01987102|41634133|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
19699499|NCT00456365|42144336|FG001|Overall Study|Withdrawal by Subject|7|||
19699500|NCT00456365|42144335|FG000|Overall Study|Pregnancy|1|||
19699501|NCT00456365|42144336|FG001|Overall Study|Pregnancy|1|||
19699502|NCT00456365|42144335|FG000|Overall Study|oncologic diagnosis|1|||
19699503|NCT00456365|42144336|FG001|Overall Study|oncologic diagnosis|1|||
19699504|NCT00455741|42144346|FG000|Overall Study|Physician Decision|0|||
19699505|NCT00455741|42144347|FG001|Overall Study|Physician Decision|1|||
19699506|NCT00445679|42144367|FG000|Overall Study|Adverse Event|22|||
19699507|NCT00445679|42144368|FG001|Overall Study|Adverse Event|12|||
19699508|NCT00445679|42144369|FG002|Overall Study|Adverse Event|30|||
19699509|NCT00445679|42144370|FG003|Overall Study|Adverse Event|19|||
19699510|NCT00445679|42144367|FG000|Overall Study|Failed to return|1|||
19699511|NCT00445679|42144368|FG001|Overall Study|Failed to return|3|||
19699512|NCT00445679|42144369|FG002|Overall Study|Failed to return|2|||
19699513|NCT00445679|42144370|FG003|Overall Study|Failed to return|2|||
19699514|NCT00445679|42144367|FG000|Overall Study|Physician Decision|0|||
19699515|NCT00445679|42144368|FG001|Overall Study|Physician Decision|0|||
19699516|NCT00445679|42144369|FG002|Overall Study|Physician Decision|1|||
19699517|NCT00445679|42144370|FG003|Overall Study|Physician Decision|0|||
19699518|NCT00445679|42144367|FG000|Overall Study|Lost to Follow-up|10|||
19699519|NCT00445679|42144368|FG001|Overall Study|Lost to Follow-up|6|||
19699520|NCT00445679|42144369|FG002|Overall Study|Lost to Follow-up|6|||
19699521|NCT00445679|42144370|FG003|Overall Study|Lost to Follow-up|5|||
19699522|NCT00445679|42144367|FG000|Overall Study|Compliance|3|||
19699523|NCT00445679|42144368|FG001|Overall Study|Compliance|2|||
19699524|NCT00445679|42144369|FG002|Overall Study|Compliance|1|||
19699525|NCT00445679|42144370|FG003|Overall Study|Compliance|2|||
19699526|NCT00445679|42144367|FG000|Overall Study|Withdrawal of Informed Consent|0|||
19699527|NCT00445679|42144368|FG001|Overall Study|Withdrawal of Informed Consent|0|||
19699528|NCT00445679|42144369|FG002|Overall Study|Withdrawal of Informed Consent|1|||
19699529|NCT00445679|42144370|FG003|Overall Study|Withdrawal of Informed Consent|0|||
19699530|NCT00445679|42144367|FG000|Overall Study|Protocol Violation|2|||
19699531|NCT00445679|42144368|FG001|Overall Study|Protocol Violation|3|||
19699532|NCT00445679|42144369|FG002|Overall Study|Protocol Violation|3|||
19699533|NCT00445679|42144370|FG003|Overall Study|Protocol Violation|1|||
19699534|NCT00445679|42144367|FG000|Overall Study|Withdrawal by Subject|8|||
19699535|NCT00445679|42144368|FG001|Overall Study|Withdrawal by Subject|14|||
19699536|NCT00445679|42144369|FG002|Overall Study|Withdrawal by Subject|20|||
19699537|NCT00445679|42144370|FG003|Overall Study|Withdrawal by Subject|18|||
19699538|NCT00445679|42144367|FG000|Overall Study|Lack of Efficacy|2|||
19699539|NCT00445679|42144368|FG001|Overall Study|Lack of Efficacy|6|||
19699540|NCT00445679|42144369|FG002|Overall Study|Lack of Efficacy|2|||
19699541|NCT00445679|42144370|FG003|Overall Study|Lack of Efficacy|0|||
19699542|NCT00455429|42144384|FG000|Overall Study|Study Terminated by Sponsor|0|||
19699543|NCT00455429|42144385|FG001|Overall Study|Study Terminated by Sponsor|0|||
19699544|NCT00455429|42144386|FG002|Overall Study|Study Terminated by Sponsor|0|||
19699545|NCT00455429|42144387|FG003|Overall Study|Study Terminated by Sponsor|3|||
19699546|NCT00455429|42144384|FG000|Overall Study|Lost to Follow-up|1|||
19699547|NCT00455429|42144385|FG001|Overall Study|Lost to Follow-up|0|||
19699548|NCT00455429|42144386|FG002|Overall Study|Lost to Follow-up|0|||
19699549|NCT00455429|42144387|FG003|Overall Study|Lost to Follow-up|3|||
19699550|NCT00455429|42144384|FG000|Overall Study|Withdrawal by Subject|0|||
19699551|NCT00455429|42144385|FG001|Overall Study|Withdrawal by Subject|1|||
19699552|NCT00455429|42144386|FG002|Overall Study|Withdrawal by Subject|1|||
19699553|NCT00455429|42144387|FG003|Overall Study|Withdrawal by Subject|0|||
19699554|NCT00455429|42144384|FG000|Overall Study|Lack of Efficacy|0|||
19699555|NCT00455429|42144385|FG001|Overall Study|Lack of Efficacy|1|||
19699556|NCT00455429|42144386|FG002|Overall Study|Lack of Efficacy|0|||
19699557|NCT00455429|42144387|FG003|Overall Study|Lack of Efficacy|1|||
19699558|NCT00455429|42144384|FG000|Overall Study|Adverse Event|0|||
19699559|NCT00455429|42144385|FG001|Overall Study|Adverse Event|1|||
19699560|NCT00455429|42144386|FG002|Overall Study|Adverse Event|0|||
19699561|NCT00455429|42144387|FG003|Overall Study|Adverse Event|3|||
19699562|NCT00455429|42144384|FG000|Overall Study|Randomly assigned but not treated|0|||
19699563|NCT00455429|42144385|FG001|Overall Study|Randomly assigned but not treated|0|||
19699564|NCT00455429|42144386|FG002|Overall Study|Randomly assigned but not treated|0|||
19699565|NCT00455429|42144387|FG003|Overall Study|Randomly assigned but not treated|2|||
19699566|NCT00455429|42144384|FG000|Overall Study|Personal Reason|1|||
19699567|NCT00455429|42144385|FG001|Overall Study|Personal Reason|0|||
19699568|NCT00455429|42144386|FG002|Overall Study|Personal Reason|0|||
19699569|NCT00455429|42144387|FG003|Overall Study|Personal Reason|0|||
19699570|NCT00455429|42144384|FG000|Overall Study|Non-compliance|0|||
19699571|NCT00455429|42144385|FG001|Overall Study|Non-compliance|0|||
19699572|NCT00455429|42144386|FG002|Overall Study|Non-compliance|0|||
19699573|NCT00455429|42144387|FG003|Overall Study|Non-compliance|1|||
19699574|NCT00455429|42144384|FG000|Overall Study|Other|0|||
19699575|NCT00455429|42144385|FG001|Overall Study|Other|2|||
19699576|NCT00455429|42144386|FG002|Overall Study|Other|0|||
19699577|NCT00455429|42144387|FG003|Overall Study|Other|1|||
19699578|NCT00445601|42144402|FG000|Overall Study|Withdrawal by Subject|11|||
19699579|NCT00445601|42144403|FG001|Overall Study|Withdrawal by Subject|11|||
19699580|NCT00445601|42144402|FG000|Overall Study|TURBT Complication|12|||
19699581|NCT00445601|42144403|FG001|Overall Study|TURBT Complication|8|||
19699582|NCT00445601|42144402|FG000|Overall Study|Incorrect Disease Status|6|||
19699583|NCT00445601|42144403|FG001|Overall Study|Incorrect Disease Status|6|||
19699584|NCT00445601|42144402|FG000|Overall Study|Drug Delivery Issue|2|||
19699585|NCT00445601|42144403|FG001|Overall Study|Drug Delivery Issue|2|||
19699586|NCT00445601|42144402|FG000|Overall Study|Adverse Event|2|||
19699587|NCT00445601|42144403|FG001|Overall Study|Adverse Event|0|||
19699588|NCT00445601|42144402|FG000|Overall Study|Death prior to TURBT|0|||
19699589|NCT00445601|42144403|FG001|Overall Study|Death prior to TURBT|1|||
19699590|NCT00444587|42144415|FG000|Overall Study|Death|2|||
19699591|NCT00444587|42144416|FG001|Overall Study|Death|1|||
19699592|NCT00444587|42144415|FG000|Overall Study|Progression of the disease|73|||
19699593|NCT00444587|42144416|FG001|Overall Study|Progression of the disease|8|||
19699594|NCT00444587|42144415|FG000|Overall Study|Refused treatment/did not cooperate|4|||
19699595|NCT00444587|42144416|FG001|Overall Study|Refused treatment/did not cooperate|1|||
19699596|NCT00444587|42144415|FG000|Overall Study|Investigator decision|3|||
19699597|NCT00444587|42144416|FG001|Overall Study|Investigator decision|0|||
19699598|NCT00444587|42144415|FG000|Overall Study|Protocol Violation|1|||
19699599|NCT00444587|42144416|FG001|Overall Study|Protocol Violation|0|||
19699600|NCT00444587|42144415|FG000|Overall Study|Missing|0|||
19699601|NCT00444587|42144416|FG001|Overall Study|Missing|5|||
19699602|NCT03841331|42144426|FG000|Overall Study|Withdrawal by Subject|4|||
19699603|NCT03841331|42144427|FG001|Overall Study|Withdrawal by Subject|9|||
19699604|NCT03841331|42144426|FG000|Overall Study|Lost to Follow-up|5|||
19699605|NCT03841331|42144427|FG001|Overall Study|Lost to Follow-up|1|||
19699606|NCT00455195|42144435|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
19699607|NCT00455195|42144436|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
19699608|NCT00455195|42144435|FG000|Double-blind Study AGLU02704|Death|1|||
19699609|NCT00455195|42144436|FG001|Double-blind Study AGLU02704|Death|0|||
19699610|NCT00455195|42144435|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
19699611|NCT00455195|42144436|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
19699612|NCT00455195|42144435|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
19699613|NCT00455195|42144436|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
19699614|NCT00235716|42144446|FG000|Overall Study|Death|26|||
19699615|NCT00235716|42144447|FG001|Overall Study|Death|39|||
19699616|NCT00235716|42144448|FG002|Overall Study|Death|32|||
19699617|NCT00235716|42144449|FG003|Overall Study|Death|31|||
19699618|NCT00235716|42144446|FG000|Overall Study|Withdrawal by Subject|23|||
19699619|NCT00235716|42144447|FG001|Overall Study|Withdrawal by Subject|19|||
19699620|NCT00235716|42144448|FG002|Overall Study|Withdrawal by Subject|17|||
19699621|NCT00235716|42144449|FG003|Overall Study|Withdrawal by Subject|18|||
19699622|NCT00235716|42144446|FG000|Overall Study|Lost to Follow-up|12|||
19699623|NCT00235716|42144447|FG001|Overall Study|Lost to Follow-up|7|||
19699624|NCT00235716|42144448|FG002|Overall Study|Lost to Follow-up|14|||
19699625|NCT00235716|42144449|FG003|Overall Study|Lost to Follow-up|10|||
19699626|NCT00235716|42144446|FG000|Overall Study|Adverse Event|1|||
19699627|NCT00235716|42144447|FG001|Overall Study|Adverse Event|1|||
19699628|NCT00235716|42144448|FG002|Overall Study|Adverse Event|1|||
19699629|NCT00235716|42144449|FG003|Overall Study|Adverse Event|0|||
19699630|NCT00235716|42144446|FG000|Overall Study|Physician Decision|0|||
19699631|NCT00235716|42144447|FG001|Overall Study|Physician Decision|1|||
19699632|NCT00235716|42144448|FG002|Overall Study|Physician Decision|1|||
19699633|NCT00235716|42144449|FG003|Overall Study|Physician Decision|3|||
19699634|NCT00274742|42144465|FG000|Overall Study|Adverse Event|0|||
19699635|NCT00274742|42144466|FG001|Overall Study|Adverse Event|4|||
19699636|NCT00274742|42144467|FG002|Overall Study|Adverse Event|1|||
19608890|NCT00970307|42057902|FG001|Overall Study|Withdrawal by Subject|3|||
19608891|NCT00970307|42057903|FG002|Overall Study|Withdrawal by Subject|2|||
19608892|NCT00917384|42057913|FG000|Overall Study|Lost to Follow-up|4|||
19608893|NCT00917384|42057914|FG001|Overall Study|Lost to Follow-up|2|||
19608894|NCT00917384|42057913|FG000|Overall Study|Withdrawal by Subject|10|||
19608895|NCT00917384|42057914|FG001|Overall Study|Withdrawal by Subject|2|||
19608896|NCT00864513|42057920|FG000|Overall Study|Withdrawal by Subject|3|||
19608897|NCT00917150|42057928|FG000|Overall Study|Adverse Event|12|||
19608898|NCT00917150|42057929|FG001|Overall Study|Adverse Event|7|||
19608899|NCT00917150|42057930|FG002|Overall Study|Adverse Event|12|||
19608900|NCT00917150|42057931|FG003|Overall Study|Adverse Event|11|||
19608901|NCT00917150|42057928|FG000|Overall Study|Death|1|||
19608902|NCT00917150|42057929|FG001|Overall Study|Death|4|||
19608903|NCT00917150|42057930|FG002|Overall Study|Death|3|||
19608904|NCT00917150|42057931|FG003|Overall Study|Death|2|||
19608905|NCT00917150|42057928|FG000|Overall Study|Lost to Follow-up|1|||
19608906|NCT00917150|42057929|FG001|Overall Study|Lost to Follow-up|0|||
19608907|NCT00917150|42057930|FG002|Overall Study|Lost to Follow-up|4|||
19608908|NCT00917150|42057931|FG003|Overall Study|Lost to Follow-up|2|||
19608909|NCT00917150|42057928|FG000|Overall Study|Physician Decision|0|||
19699637|NCT00274742|42144468|FG003|Overall Study|Adverse Event|4|||
19699638|NCT00274742|42144469|FG004|Overall Study|Adverse Event|12|||
19699639|NCT00274742|42144470|FG005|Overall Study|Adverse Event|3|||
19699640|NCT00274742|42144465|FG000|Overall Study|Lost to Follow-up|0|||
19699641|NCT00274742|42144466|FG001|Overall Study|Lost to Follow-up|0|||
19699642|NCT00274742|42144467|FG002|Overall Study|Lost to Follow-up|0|||
19699643|NCT00274742|42144468|FG003|Overall Study|Lost to Follow-up|0|||
19699644|NCT00274742|42144469|FG004|Overall Study|Lost to Follow-up|1|||
19608910|NCT00917150|42057929|FG001|Overall Study|Physician Decision|2|||
19608911|NCT00917150|42057930|FG002|Overall Study|Physician Decision|0|||
19699645|NCT00274742|42144470|FG005|Overall Study|Lost to Follow-up|0|||
19608912|NCT00917150|42057931|FG003|Overall Study|Physician Decision|1|||
19608913|NCT00917150|42057928|FG000|Overall Study|Protocol Violation|5|||
19699646|NCT00274742|42144465|FG000|Overall Study|End of Study|0|||
19699647|NCT00274742|42144466|FG001|Overall Study|End of Study|0|||
19699648|NCT00274742|42144467|FG002|Overall Study|End of Study|0|||
19699649|NCT00274742|42144468|FG003|Overall Study|End of Study|1|||
19699650|NCT00274742|42144469|FG004|Overall Study|End of Study|0|||
19699651|NCT00274742|42144470|FG005|Overall Study|End of Study|0|||
19699652|NCT00274742|42144465|FG000|Overall Study|Disease Progression|0|||
19699653|NCT00274742|42144466|FG001|Overall Study|Disease Progression|1|||
19699654|NCT00274742|42144467|FG002|Overall Study|Disease Progression|1|||
19608914|NCT00917150|42057929|FG001|Overall Study|Protocol Violation|5|||
19608915|NCT00917150|42057930|FG002|Overall Study|Protocol Violation|3|||
19608916|NCT00917150|42057931|FG003|Overall Study|Protocol Violation|5|||
19608917|NCT00917150|42057928|FG000|Overall Study|Withdrawal by Subject|15|||
19608918|NCT00917150|42057929|FG001|Overall Study|Withdrawal by Subject|16|||
19608919|NCT00917150|42057930|FG002|Overall Study|Withdrawal by Subject|18|||
19608920|NCT00917150|42057931|FG003|Overall Study|Withdrawal by Subject|11|||
19608921|NCT00917150|42057928|FG000|Overall Study|Other than specified|3|||
19799511|NCT02477800|42257556|FG002|Placebo-Controlled Period|Disease Progression|1|||
19799512|NCT02477800|42257557|FG003|Placebo-Controlled Period|Disease Progression|0|||
19799513|NCT02477800|42257558|FG004|Placebo-Controlled Period|Disease Progression|0|||
19799514|NCT02477800|42257559|FG005|Placebo-Controlled Period|Disease Progression|0|||
19799515|NCT02477800|42257560|FG006|Placebo-Controlled Period|Disease Progression|0|||
19799516|NCT02477800|42257554|FG000|Placebo-Controlled Period|Investigator Decision|3|||
19799517|NCT02477800|42257555|FG001|Placebo-Controlled Period|Investigator Decision|2|||
19799518|NCT02477800|42257556|FG002|Placebo-Controlled Period|Investigator Decision|1|||
19799519|NCT02477800|42257557|FG003|Placebo-Controlled Period|Investigator Decision|0|||
19799520|NCT02477800|42257558|FG004|Placebo-Controlled Period|Investigator Decision|0|||
19799521|NCT02477800|42257559|FG005|Placebo-Controlled Period|Investigator Decision|0|||
19799522|NCT02477800|42257560|FG006|Placebo-Controlled Period|Investigator Decision|0|||
19799523|NCT02477800|42257554|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
19608922|NCT00917150|42057929|FG001|Overall Study|Other than specified|3|||
19608923|NCT00917150|42057930|FG002|Overall Study|Other than specified|2|||
19608924|NCT00917150|42057931|FG003|Overall Study|Other than specified|2|||
19608925|NCT00659425|42057951|FG000|Overall Study|Disease progression|1|||
19608926|NCT00659425|42057952|FG001|Overall Study|Disease progression|0|||
19608927|NCT00659425|42057953|FG002|Overall Study|Disease progression|0|||
19608928|NCT00659425|42057954|FG003|Overall Study|Disease progression|1|||
19608929|NCT00659425|42057955|FG004|Overall Study|Disease progression|0|||
19608930|NCT00659425|42057956|FG005|Overall Study|Disease progression|2|||
19608931|NCT00659425|42057957|FG006|Overall Study|Disease progression|4|||
19608932|NCT00659425|42057958|FG007|Overall Study|Disease progression|3|||
19608933|NCT00659425|42057959|FG008|Overall Study|Disease progression|5|||
19608934|NCT00659425|42057960|FG009|Overall Study|Disease progression|3|||
19608935|NCT00659425|42057951|FG000|Overall Study|Death|0|||
19608936|NCT00659425|42057952|FG001|Overall Study|Death|0|||
19608937|NCT00659425|42057953|FG002|Overall Study|Death|0|||
19608938|NCT00659425|42057954|FG003|Overall Study|Death|1|||
19608939|NCT00659425|42057955|FG004|Overall Study|Death|0|||
19608940|NCT00659425|42057956|FG005|Overall Study|Death|0|||
19608941|NCT00659425|42057957|FG006|Overall Study|Death|1|||
19608942|NCT00659425|42057958|FG007|Overall Study|Death|0|||
19699655|NCT00274742|42144468|FG003|Overall Study|Disease Progression|0|||
19699656|NCT00274742|42144469|FG004|Overall Study|Disease Progression|1|||
19699657|NCT00274742|42144470|FG005|Overall Study|Disease Progression|0|||
19699658|NCT00274742|42144465|FG000|Overall Study|Other|0|||
19699659|NCT00274742|42144466|FG001|Overall Study|Other|3|||
19699660|NCT00274742|42144467|FG002|Overall Study|Other|0|||
19699661|NCT00274742|42144468|FG003|Overall Study|Other|0|||
19699662|NCT00274742|42144469|FG004|Overall Study|Other|2|||
19699663|NCT00274742|42144470|FG005|Overall Study|Other|0|||
19699664|NCT00262314|42144490|FG000|Overall Study|Changing physicians|38|||
19699665|NCT00262314|42144490|FG000|Overall Study|Death|12|||
19699666|NCT00262314|42144490|FG000|Overall Study|Patient's decision|92|||
19699667|NCT00262314|42144490|FG000|Overall Study|Other|95|||
19699668|NCT00262314|42144490|FG000|Overall Study|Lost to Follow-up|70|||
19699669|NCT00262314|42144490|FG000|Overall Study|Administrative withdrawal|30|||
19699670|NCT00283400|42144498|FG000|Overall Study|Withdrawal by Subject|1|||
19699671|NCT00283400|42144499|FG001|Overall Study|Withdrawal by Subject|1|||
19699672|NCT00283400|42144500|FG002|Overall Study|Withdrawal by Subject|0|||
19608943|NCT00659425|42057959|FG008|Overall Study|Death|0|||
19608944|NCT00659425|42057960|FG009|Overall Study|Death|0|||
19608945|NCT00659425|42057951|FG000|Overall Study|Adverse Event|0|||
19699673|NCT00283400|42144501|FG003|Overall Study|Withdrawal by Subject|0|||
19799524|NCT02477800|42257555|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
19478185|NCT01467713|41757435|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
19608946|NCT00659425|42057952|FG001|Overall Study|Adverse Event|0|||
19608947|NCT00659425|42057953|FG002|Overall Study|Adverse Event|0|||
19608948|NCT00659425|42057954|FG003|Overall Study|Adverse Event|0|||
19699674|NCT00283400|42144498|FG000|Overall Study|Death|1|||
19699675|NCT00283400|42144499|FG001|Overall Study|Death|0|||
19699676|NCT00283400|42144500|FG002|Overall Study|Death|1|||
19699677|NCT00283400|42144501|FG003|Overall Study|Death|0|||
19699678|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
19699679|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
19699680|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
19699681|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
19699682|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
19699683|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
19699684|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
19699685|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
19699686|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
19699687|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
19699688|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Adverse Event|0|||
19699689|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Adverse Event|0|||
19699690|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Adverse Event|3|||
19699691|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Adverse Event|2|||
19699692|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Adverse Event|13|||
19699693|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
19699694|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
19699695|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
19699696|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
19699697|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
19699698|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Patient's wish|0|||
19699699|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Patient's wish|0|||
19699700|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Patient's wish|19|||
19699701|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Patient's wish|9|||
19699702|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Patient's wish|20|||
19699703|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
19699704|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
19699705|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
19699706|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
19699707|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
19699708|NCT00444275|42144514|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
19699709|NCT00444275|42144515|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
19699710|NCT00444275|42144516|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
19699711|NCT00444275|42144517|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
19699712|NCT00444275|42144518|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
19699713|NCT00454805|42144535|FG000|Overall Study|Withdrawal by Subject|9|||
19699714|NCT00454805|42144536|FG001|Overall Study|Withdrawal by Subject|2|||
19699715|NCT00454805|42144535|FG000|Overall Study|Death|0|||
19699716|NCT00454805|42144536|FG001|Overall Study|Death|2|||
19699717|NCT00454805|42144535|FG000|Overall Study|Disease progression|16|||
19699718|NCT00454805|42144536|FG001|Overall Study|Disease progression|19|||
19699719|NCT00454805|42144535|FG000|Overall Study|In order to begin radiotherapy|1|||
19699720|NCT00454805|42144536|FG001|Overall Study|In order to begin radiotherapy|0|||
19699721|NCT00283244|42144545|FG000|Overall Study|Adverse Event|0|||
19699722|NCT00283244|42144546|FG001|Overall Study|Adverse Event|8|||
19699723|NCT00283244|42144547|FG002|Overall Study|Adverse Event|11|||
19699724|NCT00283244|42144545|FG000|Overall Study|Death|4|||
19699725|NCT00283244|42144546|FG001|Overall Study|Death|3|||
19699726|NCT00283244|42144547|FG002|Overall Study|Death|2|||
19699727|NCT00283244|42144545|FG000|Overall Study|Lack of Efficacy|8|||
19699728|NCT00283244|42144546|FG001|Overall Study|Lack of Efficacy|32|||
19699729|NCT00283244|42144547|FG002|Overall Study|Lack of Efficacy|26|||
19699730|NCT00283244|42144545|FG000|Overall Study|Withdrawal by Subject|1|||
19699731|NCT00283244|42144546|FG001|Overall Study|Withdrawal by Subject|2|||
19699732|NCT00283244|42144547|FG002|Overall Study|Withdrawal by Subject|2|||
19699733|NCT00283244|42144545|FG000|Overall Study|Physician Decision|0|||
19699734|NCT00283244|42144546|FG001|Overall Study|Physician Decision|0|||
19699735|NCT00283244|42144547|FG002|Overall Study|Physician Decision|1|||
19699736|NCT00283244|42144545|FG000|Overall Study|Medical illness (other complicating dz)|4|||
19699737|NCT00283244|42144546|FG001|Overall Study|Medical illness (other complicating dz)|3|||
19699738|NCT00283244|42144547|FG002|Overall Study|Medical illness (other complicating dz)|6|||
19699739|NCT00283244|42144545|FG000|Overall Study|Clinical deterioration|1|||
19390397|NCT01987102|41634134|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
19699740|NCT00283244|42144546|FG001|Overall Study|Clinical deterioration|3|||
19699741|NCT00283244|42144547|FG002|Overall Study|Clinical deterioration|3|||
19699742|NCT00282464|42144558|FG000|Overall Study|Adverse Event|26|||
19699743|NCT00282464|42144559|FG001|Overall Study|Adverse Event|20|||
19699744|NCT00282464|42144558|FG000|Overall Study|Lack of Efficacy|8|||
19699745|NCT00282464|42144559|FG001|Overall Study|Lack of Efficacy|8|||
19699746|NCT00282464|42144558|FG000|Overall Study|Lost to Follow-up|10|||
19699747|NCT00282464|42144559|FG001|Overall Study|Lost to Follow-up|10|||
19390398|NCT01987102|41634133|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
19699748|NCT00282464|42144558|FG000|Overall Study|Withdrawal by Subject|24|||
19699749|NCT00282464|42144559|FG001|Overall Study|Withdrawal by Subject|10|||
19699750|NCT00282464|42144558|FG000|Overall Study|laboratory abnormality|1|||
19699751|NCT00282464|42144559|FG001|Overall Study|laboratory abnormality|2|||
19699752|NCT00282464|42144558|FG000|Overall Study|Protocol Violation|0|||
19699753|NCT00282464|42144559|FG001|Overall Study|Protocol Violation|7|||
19699754|NCT00282464|42144558|FG000|Overall Study|Patient moved|1|||
19699755|NCT00282464|42144559|FG001|Overall Study|Patient moved|0|||
19699756|NCT00282464|42144558|FG000|Overall Study|patient non-compliant|3|||
19699757|NCT00282464|42144559|FG001|Overall Study|patient non-compliant|0|||
19699758|NCT00282464|42144558|FG000|Overall Study|patient no show|0|||
19699759|NCT00282464|42144559|FG001|Overall Study|patient no show|1|||
19699760|NCT00282464|42144558|FG000|Overall Study|patient incarcerated|0|||
19699761|NCT00282464|42144559|FG001|Overall Study|patient incarcerated|1|||
19699762|NCT00282464|42144558|FG000|Overall Study|family crisis|0|||
19699763|NCT00282464|42144559|FG001|Overall Study|family crisis|1|||
19699764|NCT00282464|42144558|FG000|Overall Study|dispensed wrong kit|0|||
19699765|NCT00282464|42144559|FG001|Overall Study|dispensed wrong kit|1|||
19699766|NCT00282464|42144558|FG000|Overall Study|dropped due to missed visits|0|||
19699767|NCT00282464|42144559|FG001|Overall Study|dropped due to missed visits|1|||
19699768|NCT00273182|42144565|FG000|Overall Study|Death|450|||
19699769|NCT00273182|42144565|FG000|Overall Study|Lost to Follow-up|88|||
19699770|NCT00273182|42144565|FG000|Overall Study|Withdrawal by Subject|257|||
19699771|NCT00273182|42144565|FG000|Overall Study|Device/System Explant|154|||
19699772|NCT00273182|42144565|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
19699773|NCT00209274|42144572|FG000|Overall Study|Missed visit|3|||
19699774|NCT00209274|42144573|FG001|Overall Study|Missed visit|2|||
19699775|NCT00209274|42144572|FG000|Overall Study|Death|32|||
19699776|NCT00209274|42144573|FG001|Overall Study|Death|15|||
19699777|NCT00209274|42144572|FG000|Overall Study|Withdrawal by Subject|30|||
19699778|NCT00209274|42144573|FG001|Overall Study|Withdrawal by Subject|15|||
19699779|NCT00209274|42144572|FG000|Overall Study|Randomized not treated (RNT)|6|||
19390399|NCT01987102|41634134|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
19390400|NCT01987102|41634133|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
19390401|NCT01987102|41634134|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
19390402|NCT01987102|41634133|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
19390403|NCT01987102|41634134|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
19390404|NCT02013544|41634143|FG000|Overall Study|Adverse Event|5|||
19390405|NCT02013544|41634144|FG001|Overall Study|Adverse Event|5|||
19390406|NCT02013544|41634143|FG000|Overall Study|Lost to Follow-up|2|||
19390407|NCT02013544|41634144|FG001|Overall Study|Lost to Follow-up|3|||
19390408|NCT02013544|41634143|FG000|Overall Study|Withdrawal by Subject|2|||
19390409|NCT02013544|41634144|FG001|Overall Study|Withdrawal by Subject|8|||
19390410|NCT02013544|41634143|FG000|Overall Study|Physician Decision|0|||
19390411|NCT02013544|41634144|FG001|Overall Study|Physician Decision|1|||
19390412|NCT02013544|41634143|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
19390413|NCT02013544|41634144|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
19390414|NCT02013388|41634158|FG000|Overall Study|work emergency|1|||
19390415|NCT02013388|41634159|FG001|Overall Study|work emergency|0|||
19390416|NCT02013388|41634160|FG002|Overall Study|work emergency|0|||
19390417|NCT02013388|41634161|FG003|Overall Study|work emergency|0|||
19390418|NCT02013388|41634162|FG004|Overall Study|work emergency|1|||
19390419|NCT02013388|41634163|FG005|Overall Study|work emergency|0|||
19390420|NCT02013388|41634164|FG006|Overall Study|work emergency|0|||
19390421|NCT02013388|41634165|FG007|Overall Study|work emergency|0|||
19390422|NCT02012686|41634189|FG000|Overall Study|muscle contraction|0|||
19390423|NCT02012686|41634190|FG001|Overall Study|muscle contraction|1|||
19390424|NCT02012686|41634189|FG000|Overall Study|electrocardiography monitoring noise|0|||
19390425|NCT02012686|41634190|FG001|Overall Study|electrocardiography monitoring noise|1|||
19390426|NCT02012452|41634198|FG000|Overall Study|Lost to Follow-up|2|||
19390427|NCT02012452|41634199|FG001|Overall Study|Lost to Follow-up|1|||
19390428|NCT02012452|41634198|FG000|Overall Study|Withdrawal by Subject|4|||
19390429|NCT02012452|41634199|FG001|Overall Study|Withdrawal by Subject|0|||
19390430|NCT01676909|41634207|FG000|Overall Study|Withdrawal by Subject|3|||
19390431|NCT01676909|41634208|FG001|Overall Study|Withdrawal by Subject|5|||
19390432|NCT01676909|41634207|FG000|Overall Study|Lost to Follow-up|15|||
19699780|NCT00209274|42144573|FG001|Overall Study|Randomized not treated (RNT)|15|||
19390433|NCT01676909|41634208|FG001|Overall Study|Lost to Follow-up|9|||
19390434|NCT02012296|41634219|FG000|Overall Study|Lack of Efficacy|0|||
19390435|NCT02012296|41634220|FG001|Overall Study|Lack of Efficacy|0|||
19390436|NCT02012296|41634221|FG002|Overall Study|Lack of Efficacy|15|||
19390437|NCT02012296|41634219|FG000|Overall Study|Adverse Event|0|||
19390438|NCT02012296|41634220|FG001|Overall Study|Adverse Event|0|||
19390439|NCT02012296|41634221|FG002|Overall Study|Adverse Event|2|||
19699781|NCT00262080|42144582|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
19699782|NCT00262080|42144583|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
19699783|NCT00262080|42144584|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
19699784|NCT00262080|42144582|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
19699785|NCT00262080|42144583|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
19699786|NCT00262080|42144584|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
19699787|NCT00262080|42144582|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
19699788|NCT00262080|42144583|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
19699789|NCT00262080|42144584|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
19699790|NCT00262080|42144582|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
19699791|NCT00262080|42144583|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
19699792|NCT00262080|42144584|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
19699793|NCT00262080|42144582|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
19699794|NCT00262080|42144583|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
19699795|NCT00262080|42144584|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
19699796|NCT00262080|42144582|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
19699797|NCT00262080|42144583|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
19699798|NCT00262080|42144584|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
19699799|NCT00282308|42144594|FG000|Treatment Period|Lost to Follow-up|1|||
19699800|NCT00282308|42144595|FG001|Treatment Period|Lost to Follow-up|0|||
19699801|NCT00282308|42144596|FG002|Treatment Period|Lost to Follow-up|0|||
19699802|NCT00282308|42144594|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
19699803|NCT00282308|42144595|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
19699804|NCT00282308|42144596|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
19699805|NCT00282308|42144594|FG000|Treatment Period|Adverse Event|0|||
19699806|NCT00282308|42144595|FG001|Treatment Period|Adverse Event|2|||
19699807|NCT00282308|42144596|FG002|Treatment Period|Adverse Event|0|||
19699808|NCT00282308|42144594|FG000|Treatment Period|Not Treated with Study Drug|1|||
19699809|NCT00282308|42144595|FG001|Treatment Period|Not Treated with Study Drug|0|||
19699810|NCT00282308|42144596|FG002|Treatment Period|Not Treated with Study Drug|0|||
19699811|NCT00282308|42144594|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
19699812|NCT00282308|42144595|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
19699813|NCT00282308|42144596|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
19699814|NCT00282308|42144594|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
19699815|NCT00282308|42144595|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
19699816|NCT00282308|42144596|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
19699817|NCT00282308|42144594|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
19699818|NCT00282308|42144595|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
19699819|NCT00282308|42144596|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
19699820|NCT00282308|42144594|FG000|Safety Follow-up Period|Adverse Event|0|||
19699821|NCT00282308|42144595|FG001|Safety Follow-up Period|Adverse Event|0|||
19699822|NCT00282308|42144596|FG002|Safety Follow-up Period|Adverse Event|1|||
19699823|NCT00282308|42144594|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
19699824|NCT00282308|42144595|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
19699825|NCT00282308|42144596|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
19699826|NCT00282308|42144594|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
19699827|NCT00282308|42144595|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
19699828|NCT00282308|42144596|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
19699829|NCT00282308|42144594|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
19699830|NCT00282308|42144595|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
19699831|NCT00282308|42144596|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
19699832|NCT00282152|42144608|FG000|Overall Study|Withdrawal by Subject|1|||
19699833|NCT00282152|42144609|FG001|Overall Study|Withdrawal by Subject|0|||
19699834|NCT00281840|42144616|FG000|Overall Study|Adverse Event|12|||
19699835|NCT00281840|42144616|FG000|Overall Study|Physician Decision|6|||
19699836|NCT00281840|42144616|FG000|Overall Study|Withdrawal by Subject|3|||
19699837|NCT00281840|42144616|FG000|Overall Study|Disease Progression|2|||
19699838|NCT00281840|42144616|FG000|Overall Study|exceed maximum delay in treatment|1|||
19390440|NCT02012296|41634219|FG000|Overall Study|Early study closure|0|||
19390441|NCT02012296|41634220|FG001|Overall Study|Early study closure|0|||
19390442|NCT02012296|41634221|FG002|Overall Study|Early study closure|5|||
19390443|NCT02012296|41634219|FG000|Overall Study|Protocol Violation|0|||
19390444|NCT02012296|41634220|FG001|Overall Study|Protocol Violation|1|||
19390445|NCT02012296|41634221|FG002|Overall Study|Protocol Violation|0|||
19390446|NCT02012218|41634238|FG000|Overall Study|Withdrawal by Subject|1|||
19390447|NCT02012218|41634239|FG001|Overall Study|Withdrawal by Subject|0|||
19699839|NCT00281840|42144616|FG000|Overall Study|Complicating Disease|1|||
19699840|NCT00281684|42144625|FG000|Overall Study|Lost to Follow-up|0|||
19699841|NCT00281684|42144626|FG001|Overall Study|Lost to Follow-up|0|||
19390448|NCT02012218|41634240|FG002|Overall Study|Withdrawal by Subject|1|||
19699842|NCT00281684|42144627|FG002|Overall Study|Lost to Follow-up|1|||
19699843|NCT00281684|42144628|FG003|Overall Study|Lost to Follow-up|0|||
19390449|NCT02012218|41634241|FG003|Overall Study|Withdrawal by Subject|1|||
19608949|NCT00659425|42057955|FG004|Overall Study|Adverse Event|0|||
19608950|NCT00659425|42057956|FG005|Overall Study|Adverse Event|1|||
19608951|NCT00659425|42057957|FG006|Overall Study|Adverse Event|0|||
19608952|NCT00659425|42057958|FG007|Overall Study|Adverse Event|3|||
19608953|NCT00659425|42057959|FG008|Overall Study|Adverse Event|1|||
19608954|NCT00659425|42057960|FG009|Overall Study|Adverse Event|4|||
19608955|NCT00659425|42057951|FG000|Overall Study|Investigator Discretion|0|||
19608956|NCT00659425|42057952|FG001|Overall Study|Investigator Discretion|0|||
19390450|NCT02012218|41634242|FG004|Overall Study|Withdrawal by Subject|1|||
19390451|NCT02012218|41634238|FG000|Overall Study|Adverse Event|1|||
19390452|NCT02012218|41634239|FG001|Overall Study|Adverse Event|0|||
19390453|NCT02012218|41634240|FG002|Overall Study|Adverse Event|0|||
19390454|NCT02012218|41634241|FG003|Overall Study|Adverse Event|1|||
19390455|NCT02012218|41634242|FG004|Overall Study|Adverse Event|0|||
19390456|NCT02012218|41634238|FG000|Overall Study|Lost to Follow-up|0|||
19390457|NCT02012218|41634239|FG001|Overall Study|Lost to Follow-up|1|||
19390458|NCT02012218|41634240|FG002|Overall Study|Lost to Follow-up|1|||
19390459|NCT02012218|41634241|FG003|Overall Study|Lost to Follow-up|0|||
19390460|NCT02012218|41634242|FG004|Overall Study|Lost to Follow-up|0|||
19390461|NCT02012218|41634238|FG000|Overall Study|Protocol Specified|1|||
19390462|NCT02012218|41634239|FG001|Overall Study|Protocol Specified|0|||
19390463|NCT02012218|41634240|FG002|Overall Study|Protocol Specified|0|||
19390464|NCT02012218|41634241|FG003|Overall Study|Protocol Specified|0|||
19390465|NCT02012218|41634242|FG004|Overall Study|Protocol Specified|0|||
19390466|NCT02012218|41634238|FG000|Overall Study|Protocol Deviation|1|||
19390467|NCT02012218|41634239|FG001|Overall Study|Protocol Deviation|0|||
19390468|NCT02012218|41634240|FG002|Overall Study|Protocol Deviation|0|||
19390469|NCT02012218|41634241|FG003|Overall Study|Protocol Deviation|0|||
19390470|NCT02012218|41634242|FG004|Overall Study|Protocol Deviation|0|||
19390471|NCT01965262|41634254|FG000|Second Intervention (7 Days)|Discontinued|0|||
19390472|NCT01965262|41634255|FG001|Second Intervention (7 Days)|Discontinued|1|||
19390473|NCT01965262|41634254|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
19390474|NCT01965262|41634255|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
19390475|NCT01965262|41634254|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
19390476|NCT01965262|41634255|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
19390477|NCT01677377|41634264|FG000|Overall Study|Protocol Violation|1|||
19390478|NCT01677377|41634265|FG001|Overall Study|Protocol Violation|0|||
19390479|NCT01677377|41634266|FG002|Overall Study|Protocol Violation|0|||
19390480|NCT01677377|41634264|FG000|Overall Study|Lost to Follow-up|0|||
19390481|NCT01677377|41634265|FG001|Overall Study|Lost to Follow-up|1|||
19390482|NCT01677377|41634266|FG002|Overall Study|Lost to Follow-up|1|||
19390483|NCT01677377|41634264|FG000|Overall Study|Withdrawal by Subject|0|||
19390484|NCT01677377|41634265|FG001|Overall Study|Withdrawal by Subject|0|||
19390485|NCT01677377|41634266|FG002|Overall Study|Withdrawal by Subject|3|||
19390486|NCT01677377|41634264|FG000|Overall Study|Lack of Efficacy|0|||
19390487|NCT01677377|41634265|FG001|Overall Study|Lack of Efficacy|0|||
19390488|NCT01677377|41634266|FG002|Overall Study|Lack of Efficacy|1|||
19390489|NCT01677377|41634264|FG000|Overall Study|Pregnancy|0|||
19390490|NCT01677377|41634265|FG001|Overall Study|Pregnancy|0|||
19390491|NCT01677377|41634266|FG002|Overall Study|Pregnancy|1|||
19390492|NCT01964950|41634276|FG000|Overall Study|Protocol Violation|25|||
19390493|NCT01964716|41634285|FG000|Overall Study|Withdrawal by Subject|2|||
19390494|NCT01964716|41634286|FG001|Overall Study|Withdrawal by Subject|3|||
19390495|NCT01964716|41634285|FG000|Overall Study|Lost to Follow-up|1|||
19390496|NCT01964716|41634286|FG001|Overall Study|Lost to Follow-up|2|||
19390497|NCT01964716|41634285|FG000|Overall Study|No longer met eligibility criteria|1|||
19390498|NCT01964716|41634286|FG001|Overall Study|No longer met eligibility criteria|1|||
19390499|NCT01964716|41634285|FG000|Overall Study|Death|1|||
19390500|NCT01964716|41634286|FG001|Overall Study|Death|0|||
19390501|NCT01964560|41634300|FG000|Overall Study|Adverse Event|23|||
19390502|NCT01964560|41634300|FG000|Overall Study|Lack of Efficacy|46|||
19390503|NCT01964560|41634300|FG000|Overall Study|Protocol deviation|2|||
19390504|NCT01964560|41634300|FG000|Overall Study|Lost to Follow-up|4|||
19390505|NCT01964560|41634300|FG000|Overall Study|Withdrawal by Subject|64|||
19390506|NCT01964560|41634300|FG000|Overall Study|Surgery-hemispherotomy|1|||
19390507|NCT01964560|41634300|FG000|Overall Study|Surgery|1|||
19390508|NCT01964560|41634300|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
19390509|NCT01964560|41634300|FG000|Overall Study|Patient and Investigator choice|1|||
19390510|NCT01964560|41634300|FG000|Overall Study|Patient was prescribed CBD|1|||
19390511|NCT01964560|41634300|FG000|Overall Study|Participant moved to another country|1|||
19390512|NCT02659943|41634311|FG000|Overall Study|Switched to alternative treatment|1|||
19390513|NCT02659943|41634312|FG001|Overall Study|Switched to alternative treatment|1|||
19390514|NCT02659943|41634313|FG002|Overall Study|Switched to alternative treatment|0|||
19608957|NCT00659425|42057953|FG002|Overall Study|Investigator Discretion|0|||
19390515|NCT02659943|41634314|FG003|Overall Study|Switched to alternative treatment|2|||
19390516|NCT02659943|41634315|FG004|Overall Study|Switched to alternative treatment|1|||
19608958|NCT00659425|42057954|FG003|Overall Study|Investigator Discretion|0|||
19608959|NCT00659425|42057955|FG004|Overall Study|Investigator Discretion|0|||
19608960|NCT00659425|42057956|FG005|Overall Study|Investigator Discretion|1|||
19608961|NCT00659425|42057957|FG006|Overall Study|Investigator Discretion|0|||
19608962|NCT00659425|42057958|FG007|Overall Study|Investigator Discretion|3|||
19608963|NCT00659425|42057959|FG008|Overall Study|Investigator Discretion|0|||
19608964|NCT00659425|42057960|FG009|Overall Study|Investigator Discretion|0|||
19608965|NCT00659425|42057951|FG000|Overall Study|Other|0|||
19608966|NCT00659425|42057952|FG001|Overall Study|Other|1|||
19608967|NCT00659425|42057953|FG002|Overall Study|Other|1|||
19608968|NCT00659425|42057954|FG003|Overall Study|Other|2|||
19608969|NCT00659425|42057955|FG004|Overall Study|Other|4|||
19608970|NCT00659425|42057956|FG005|Overall Study|Other|0|||
19608971|NCT00659425|42057957|FG006|Overall Study|Other|3|||
19608972|NCT00659425|42057958|FG007|Overall Study|Other|2|||
19608973|NCT00659425|42057959|FG008|Overall Study|Other|0|||
19608974|NCT00659425|42057960|FG009|Overall Study|Other|6|||
19608975|NCT00656851|42057997|FG000|Overall Study|Withdrawal by Subject|0|||
19608976|NCT00656851|42057998|FG001|Overall Study|Withdrawal by Subject|4|||
19608977|NCT00656617|42058004|FG000|Overall Study|Adverse Event|1|||
19608978|NCT00656617|42058004|FG000|Overall Study|Death|2|||
19608979|NCT00656617|42058004|FG000|Overall Study|Insurance Issues|2|||
19608980|NCT00656617|42058004|FG000|Overall Study|Move to different clinical trial|2|||
19608981|NCT04797637|42058011|FG000|Overall Study|Lost to Follow-up|23|||
19608982|NCT04797637|42058012|FG001|Overall Study|Lost to Follow-up|32|||
19608983|NCT04797637|42058011|FG000|Overall Study|Withdrawal by Subject|0|||
19608984|NCT04797637|42058012|FG001|Overall Study|Withdrawal by Subject|1|||
19608985|NCT00659269|42058020|FG000|Overall Study|Physician Decision|1|||
19608986|NCT00659269|42058021|FG001|Overall Study|Physician Decision|1|||
19608987|NCT00658333|42058038|FG000|Overall Study|Adverse Event|2|||
19608988|NCT00658333|42058039|FG001|Overall Study|Adverse Event|1|||
19608989|NCT00658879|42058045|FG000|Overall Study|Protocol Violation|1|||
19608990|NCT00570037|42058051|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
19608991|NCT00570037|42058052|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
19608992|NCT00863655|42058060|FG000|Overall Study|Protocol Violation|4|||
19608993|NCT00863655|42058061|FG001|Overall Study|Protocol Violation|0|||
19608994|NCT00863655|42058060|FG000|Overall Study|Adverse Event|52|||
19608995|NCT00863655|42058061|FG001|Overall Study|Adverse Event|8|||
19608996|NCT00863655|42058060|FG000|Overall Study|Withdrawal by Subject|47|||
19608997|NCT00863655|42058061|FG001|Overall Study|Withdrawal by Subject|7|||
19608998|NCT00863655|42058060|FG000|Overall Study|Administrative problems|1|||
19608999|NCT00863655|42058061|FG001|Overall Study|Administrative problems|0|||
19609000|NCT00863655|42058060|FG000|Overall Study|Death|7|||
19609001|NCT00863655|42058061|FG001|Overall Study|Death|1|||
19609002|NCT00863655|42058060|FG000|Overall Study|New cancer therapy|5|||
19609003|NCT00863655|42058061|FG001|Overall Study|New cancer therapy|1|||
19609004|NCT00863655|42058060|FG000|Overall Study|Disease progression|364|||
19609005|NCT00863655|42058061|FG001|Overall Study|Disease progression|221|||
19609006|NCT00863655|42058060|FG000|Overall Study|Treatment completed as per protocol|5|||
19609007|NCT00863655|42058061|FG001|Overall Study|Treatment completed as per protocol|1|||
19609008|NCT00658723|42058069|FG000|Overall Study|Lost to Follow-up|0|||
19609009|NCT00658723|42058070|FG001|Overall Study|Lost to Follow-up|2|||
19609010|NCT00658723|42058071|FG002|Overall Study|Lost to Follow-up|2|||
19609011|NCT00658723|42058069|FG000|Overall Study|Death|2|||
19609012|NCT00658723|42058070|FG001|Overall Study|Death|1|||
19609013|NCT00658723|42058071|FG002|Overall Study|Death|4|||
19609014|NCT00658723|42058069|FG000|Overall Study|Scheduling Issue|1|||
19609015|NCT00658723|42058070|FG001|Overall Study|Scheduling Issue|1|||
19609016|NCT00658723|42058071|FG002|Overall Study|Scheduling Issue|0|||
19609017|NCT00658723|42058069|FG000|Overall Study|Withdrawal by Subject|1|||
19609018|NCT00658723|42058070|FG001|Overall Study|Withdrawal by Subject|0|||
19699844|NCT00281684|42144625|FG000|Overall Study|Withdrawal by Subject|1|||
19699845|NCT00281684|42144626|FG001|Overall Study|Withdrawal by Subject|0|||
19478186|NCT01467713|41757436|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
19478187|NCT01467713|41757433|FG000|Overall Study|Major Protocol Deviation|2|||
19609019|NCT00658723|42058071|FG002|Overall Study|Withdrawal by Subject|1|||
19609020|NCT00593385|42058082|FG000|Overall Study|Death|14|||
19699846|NCT00281684|42144627|FG002|Overall Study|Withdrawal by Subject|0|||
19699847|NCT00281684|42144628|FG003|Overall Study|Withdrawal by Subject|0|||
19609021|NCT00593385|42058082|FG000|Overall Study|Lost to Follow-up|17|||
19609022|NCT00593385|42058082|FG000|Overall Study|Withdrawal by Subject|9|||
19609023|NCT00658021|42058091|FG000|28-Week Treatment Period|Adverse Event|3|||
19609024|NCT00658021|42058092|FG001|28-Week Treatment Period|Adverse Event|1|||
19609025|NCT00658021|42058093|FG002|28-Week Treatment Period|Adverse Event|0|||
19609026|NCT00658021|42058091|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
19609027|NCT00658021|42058092|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
19609028|NCT00658021|42058093|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
19609029|NCT00658021|42058091|FG000|28-Week Treatment Period|Protocol Violation|0|||
19609030|NCT00658021|42058092|FG001|28-Week Treatment Period|Protocol Violation|2|||
19609031|NCT00658021|42058093|FG002|28-Week Treatment Period|Protocol Violation|1|||
19609032|NCT00658021|42058091|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
19609033|NCT00658021|42058092|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
19609034|NCT00658021|42058093|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
19609035|NCT00658021|42058091|FG000|28-Week Treatment Period|Physician Decision|1|||
19609036|NCT00658021|42058092|FG001|28-Week Treatment Period|Physician Decision|2|||
19609037|NCT00658021|42058093|FG002|28-Week Treatment Period|Physician Decision|1|||
19609038|NCT00658021|42058091|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
19609039|NCT00658021|42058092|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
19609040|NCT00658021|42058093|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
19609041|NCT00658021|42058091|FG000|28-Week Treatment Period|Loss of glucose control|1|||
19609042|NCT00658021|42058092|FG001|28-Week Treatment Period|Loss of glucose control|1|||
19609043|NCT00658021|42058093|FG002|28-Week Treatment Period|Loss of glucose control|10|||
19609044|NCT00658021|42058091|FG000|28-Week Treatment Period|Other|2|||
19609045|NCT00658021|42058092|FG001|28-Week Treatment Period|Other|3|||
19609046|NCT00658021|42058093|FG002|28-Week Treatment Period|Other|1|||
19609047|NCT00658021|42058091|FG000|28-Week Treatment Period|Did not receive treatment|2|||
19699848|NCT00272792|42144642|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
19699849|NCT00272792|42144643|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
19699850|NCT00272792|42144642|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
19390517|NCT02659943|41634316|FG005|Overall Study|Switched to alternative treatment|0|||
19390518|NCT02659943|41634317|FG006|Overall Study|Switched to alternative treatment|1|||
19390519|NCT02659943|41634311|FG000|Overall Study|Disease progression on study|0|||
19390520|NCT02659943|41634312|FG001|Overall Study|Disease progression on study|1|||
19390521|NCT02659943|41634313|FG002|Overall Study|Disease progression on study|1|||
19390522|NCT02659943|41634314|FG003|Overall Study|Disease progression on study|1|||
19390523|NCT02659943|41634315|FG004|Overall Study|Disease progression on study|1|||
19390524|NCT02659943|41634316|FG005|Overall Study|Disease progression on study|4|||
19390525|NCT02659943|41634317|FG006|Overall Study|Disease progression on study|0|||
19390526|NCT02659943|41634311|FG000|Overall Study|Patient's condition per principal investigator|0|||
19390527|NCT02659943|41634312|FG001|Overall Study|Patient's condition per principal investigator|0|||
19390528|NCT02659943|41634313|FG002|Overall Study|Patient's condition per principal investigator|0|||
19478188|NCT01467713|41757434|FG001|Overall Study|Major Protocol Deviation|4|||
19478189|NCT01467713|41757435|FG002|Overall Study|Major Protocol Deviation|4|||
19478190|NCT01467713|41757436|FG003|Overall Study|Major Protocol Deviation|1|||
19478191|NCT01467713|41757433|FG000|Overall Study|Lost to Follow-up|9|||
19478192|NCT01467713|41757434|FG001|Overall Study|Lost to Follow-up|12|||
19478193|NCT01467713|41757435|FG002|Overall Study|Lost to Follow-up|6|||
19478194|NCT01467713|41757436|FG003|Overall Study|Lost to Follow-up|9|||
19478195|NCT01467713|41757433|FG000|Overall Study|Voluntary Withdrawal|18|||
19478196|NCT01467713|41757434|FG001|Overall Study|Voluntary Withdrawal|14|||
19478197|NCT01467713|41757435|FG002|Overall Study|Voluntary Withdrawal|21|||
19478198|NCT01467713|41757436|FG003|Overall Study|Voluntary Withdrawal|20|||
19478199|NCT01467713|41757433|FG000|Overall Study|Study Termination|23|||
19478200|NCT01467713|41757434|FG001|Overall Study|Study Termination|33|||
19478201|NCT01467713|41757435|FG002|Overall Study|Study Termination|28|||
19478202|NCT01467713|41757436|FG003|Overall Study|Study Termination|29|||
19478203|NCT01467713|41757433|FG000|Overall Study|Pregnancy|0|||
19478204|NCT01467713|41757434|FG001|Overall Study|Pregnancy|1|||
19478205|NCT01467713|41757435|FG002|Overall Study|Pregnancy|1|||
19478206|NCT01467713|41757436|FG003|Overall Study|Pregnancy|3|||
19478207|NCT01467713|41757433|FG000|Overall Study|Relapse|35|||
19478208|NCT01467713|41757434|FG001|Overall Study|Relapse|25|||
19478209|NCT01467713|41757435|FG002|Overall Study|Relapse|28|||
19478210|NCT01467713|41757436|FG003|Overall Study|Relapse|35|||
19478211|NCT01467713|41757433|FG000|Overall Study|Reason not Specified|6|||
19478212|NCT01467713|41757434|FG001|Overall Study|Reason not Specified|11|||
19478213|NCT01467713|41757435|FG002|Overall Study|Reason not Specified|8|||
19478214|NCT01467713|41757436|FG003|Overall Study|Reason not Specified|7|||
19478215|NCT01693250|41757474|FG000|Overall Study|Lost to Follow-up|2|||
19478216|NCT01693250|41757475|FG001|Overall Study|Lost to Follow-up|2|||
19478217|NCT01590758|41757498|FG000|Overall Study|Withdrawal by Subject|0|||
19478218|NCT01590758|41757499|FG001|Overall Study|Withdrawal by Subject|3|||
19478219|NCT01590758|41757498|FG000|Overall Study|Physician Decision|1|||
19478220|NCT01590758|41757499|FG001|Overall Study|Physician Decision|2|||
19478221|NCT01590758|41757498|FG000|Overall Study|Lost to Follow-up|4|||
19478222|NCT01590758|41757499|FG001|Overall Study|Lost to Follow-up|2|||
19478223|NCT01590212|41757508|FG000|Overall Study|Withdrawal by Subject|2|||
19478224|NCT01590212|41757509|FG001|Overall Study|Withdrawal by Subject|2|||
19478225|NCT01590212|41757510|FG002|Overall Study|Withdrawal by Subject|2|||
19609048|NCT00658021|42058092|FG001|28-Week Treatment Period|Did not receive treatment|0|||
19609049|NCT00658021|42058093|FG002|28-Week Treatment Period|Did not receive treatment|0|||
19478226|NCT01590212|41757508|FG000|Overall Study|Lost to Follow-up|1|||
19478227|NCT01590212|41757509|FG001|Overall Study|Lost to Follow-up|2|||
19478228|NCT01590212|41757510|FG002|Overall Study|Lost to Follow-up|3|||
19609050|NCT00658021|42058091|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
19609051|NCT00658021|42058092|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
19609052|NCT00658021|42058093|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
19609053|NCT00658021|42058091|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
19609054|NCT00658021|42058092|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
19609055|NCT00658021|42058093|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
19609056|NCT00920816|42058107|FG000|Overall Study|Death|116|||
19609057|NCT00920816|42058108|FG001|Overall Study|Death|63|||
19609058|NCT00920816|42058109|FG002|Overall Study|Death|8|||
19609059|NCT00920816|42058110|FG003|Overall Study|Death|3|||
19609060|NCT00920816|42058107|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
19609061|NCT00920816|42058108|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
19609062|NCT00920816|42058109|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
19609063|NCT00920816|42058110|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
19609064|NCT00920816|42058107|FG000|Overall Study|Global deterioration of health status|2|||
19609065|NCT00920816|42058108|FG001|Overall Study|Global deterioration of health status|0|||
19609066|NCT00920816|42058109|FG002|Overall Study|Global deterioration of health status|0|||
19609067|NCT00920816|42058110|FG003|Overall Study|Global deterioration of health status|0|||
19609068|NCT00920816|42058107|FG000|Overall Study|Objective progression or relapse|6|||
19609069|NCT00920816|42058108|FG001|Overall Study|Objective progression or relapse|2|||
19609070|NCT00920816|42058109|FG002|Overall Study|Objective progression or relapse|0|||
19609071|NCT00920816|42058110|FG003|Overall Study|Objective progression or relapse|0|||
19609072|NCT00920816|42058107|FG000|Overall Study|Other|26|||
19609073|NCT00920816|42058108|FG001|Overall Study|Other|15|||
19609074|NCT00920816|42058109|FG002|Overall Study|Other|1|||
19609075|NCT00920816|42058110|FG003|Overall Study|Other|2|||
19609076|NCT00920816|42058107|FG000|Overall Study|Lost to Follow-up|11|||
19609077|NCT00920816|42058108|FG001|Overall Study|Lost to Follow-up|2|||
19609078|NCT00920816|42058109|FG002|Overall Study|Lost to Follow-up|0|||
19609079|NCT00920816|42058110|FG003|Overall Study|Lost to Follow-up|0|||
19609080|NCT00920816|42058107|FG000|Overall Study|Adverse Event|1|||
19609081|NCT00920816|42058108|FG001|Overall Study|Adverse Event|1|||
19609082|NCT00920816|42058109|FG002|Overall Study|Adverse Event|1|||
19609083|NCT00920816|42058110|FG003|Overall Study|Adverse Event|0|||
19609084|NCT00920816|42058107|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
19609085|NCT00920816|42058108|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
19609086|NCT00920816|42058109|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
19609087|NCT00920816|42058110|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
19609088|NCT00920816|42058107|FG000|Overall Study|Randomized but not treated|3|||
19609089|NCT00920816|42058108|FG001|Overall Study|Randomized but not treated|0|||
19609090|NCT00920816|42058109|FG002|Overall Study|Randomized but not treated|0|||
19609091|NCT00920816|42058110|FG003|Overall Study|Randomized but not treated|0|||
19609092|NCT00657709|42058125|FG000|Overall Study|AE or Death|7|||
19609093|NCT00657709|42058126|FG001|Overall Study|AE or Death|7|||
19609094|NCT00657709|42058127|FG002|Overall Study|AE or Death|6|||
19609095|NCT00657709|42058128|FG003|Overall Study|AE or Death|7|||
19609096|NCT00657709|42058129|FG004|Overall Study|AE or Death|1|||
19609097|NCT00657709|42058125|FG000|Overall Study|Withdrawal by Subject|7|||
19609098|NCT00657709|42058126|FG001|Overall Study|Withdrawal by Subject|15|||
19609099|NCT00657709|42058127|FG002|Overall Study|Withdrawal by Subject|15|||
19609100|NCT00657709|42058128|FG003|Overall Study|Withdrawal by Subject|5|||
19609101|NCT00657709|42058129|FG004|Overall Study|Withdrawal by Subject|9|||
19609102|NCT00657709|42058125|FG000|Overall Study|Lost to Follow-up|9|||
19609103|NCT00657709|42058126|FG001|Overall Study|Lost to Follow-up|9|||
19609104|NCT00657709|42058127|FG002|Overall Study|Lost to Follow-up|7|||
19609105|NCT00657709|42058128|FG003|Overall Study|Lost to Follow-up|1|||
19799525|NCT02477800|42257556|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
19799526|NCT02477800|42257557|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
19799527|NCT02477800|42257558|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
19799528|NCT02477800|42257559|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
19799529|NCT02477800|42257560|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
19799530|NCT02477800|42257554|FG000|Placebo-Controlled Period|Relocation|2|||
19799531|NCT02477800|42257555|FG001|Placebo-Controlled Period|Relocation|0|||
19799532|NCT02477800|42257556|FG002|Placebo-Controlled Period|Relocation|0|||
19799533|NCT02477800|42257557|FG003|Placebo-Controlled Period|Relocation|0|||
19799534|NCT02477800|42257558|FG004|Placebo-Controlled Period|Relocation|0|||
19478229|NCT01692938|41757521|FG000|Overall Study|Protocol Deviation|1|||
19609106|NCT00657709|42058129|FG004|Overall Study|Lost to Follow-up|21|||
19609107|NCT00657709|42058125|FG000|Overall Study|Protocol Violation|0|||
19609108|NCT00657709|42058126|FG001|Overall Study|Protocol Violation|2|||
19799535|NCT02477800|42257559|FG005|Placebo-Controlled Period|Relocation|0|||
19799536|NCT02477800|42257560|FG006|Placebo-Controlled Period|Relocation|0|||
19799537|NCT02477800|42257554|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
19609109|NCT00657709|42058127|FG002|Overall Study|Protocol Violation|0|||
19609110|NCT00657709|42058128|FG003|Overall Study|Protocol Violation|1|||
19609111|NCT00657709|42058129|FG004|Overall Study|Protocol Violation|2|||
19609112|NCT00915356|42058156|FG000|Overall Study|Withdrawal by Subject|1|||
19609113|NCT00915356|42058157|FG001|Overall Study|Withdrawal by Subject|0|||
19609114|NCT00915356|42058158|FG002|Overall Study|Withdrawal by Subject|0|||
19609115|NCT00915356|42058159|FG003|Overall Study|Withdrawal by Subject|0|||
19609116|NCT00915356|42058160|FG004|Overall Study|Withdrawal by Subject|0|||
19699851|NCT00272792|42144643|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
19699852|NCT00272792|42144642|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
19699853|NCT00272792|42144643|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
19478230|NCT01692938|41757522|FG001|Overall Study|Protocol Deviation|1|||
19478231|NCT01692938|41757521|FG000|Overall Study|Study completed prior to site completion|3|||
19478232|NCT01692938|41757522|FG001|Overall Study|Study completed prior to site completion|3|||
19478233|NCT01692782|41757535|FG000|Overall Study|Adverse Event|12|||
19478234|NCT01692782|41757536|FG001|Overall Study|Adverse Event|32|||
19478235|NCT01692782|41757537|FG002|Overall Study|Adverse Event|2|||
19478236|NCT01692782|41757535|FG000|Overall Study|Lack of Efficacy|1|||
19478237|NCT01692782|41757536|FG001|Overall Study|Lack of Efficacy|2|||
19478238|NCT01692782|41757537|FG002|Overall Study|Lack of Efficacy|0|||
19478239|NCT01692782|41757535|FG000|Overall Study|Lost to Follow-up|2|||
19478240|NCT01692782|41757536|FG001|Overall Study|Lost to Follow-up|7|||
19478241|NCT01692782|41757537|FG002|Overall Study|Lost to Follow-up|1|||
19478242|NCT01692782|41757535|FG000|Overall Study|Pregnancy|1|||
19478243|NCT01692782|41757536|FG001|Overall Study|Pregnancy|0|||
19478244|NCT01692782|41757537|FG002|Overall Study|Pregnancy|0|||
19478245|NCT01692782|41757535|FG000|Overall Study|Protocol Violation|1|||
19478246|NCT01692782|41757536|FG001|Overall Study|Protocol Violation|0|||
19478247|NCT01692782|41757537|FG002|Overall Study|Protocol Violation|2|||
19478248|NCT01692782|41757535|FG000|Overall Study|Non-complance with study drug|0|||
19478249|NCT01692782|41757536|FG001|Overall Study|Non-complance with study drug|4|||
19478250|NCT01692782|41757537|FG002|Overall Study|Non-complance with study drug|1|||
19478251|NCT01692782|41757535|FG000|Overall Study|Non-compliant with study visits|0|||
19478252|NCT01692782|41757536|FG001|Overall Study|Non-compliant with study visits|0|||
19478253|NCT01692782|41757537|FG002|Overall Study|Non-compliant with study visits|1|||
19478254|NCT01692782|41757535|FG000|Overall Study|SAE not related to study drug|0|||
19478255|NCT01692782|41757536|FG001|Overall Study|SAE not related to study drug|1|||
19478256|NCT01692782|41757537|FG002|Overall Study|SAE not related to study drug|0|||
19478257|NCT01692782|41757535|FG000|Overall Study|Withdrawal by Subject|3|||
19478258|NCT01692782|41757536|FG001|Overall Study|Withdrawal by Subject|10|||
19478259|NCT01692782|41757537|FG002|Overall Study|Withdrawal by Subject|3|||
19478260|NCT01692626|41757545|FG000|Overall Study|Death|0|||
19478261|NCT01692626|41757546|FG001|Overall Study|Death|1|||
19478262|NCT01692626|41757545|FG000|Overall Study|Adverse Event|2|||
19478263|NCT01692626|41757546|FG001|Overall Study|Adverse Event|3|||
19478264|NCT01692626|41757545|FG000|Overall Study|Protocol Violation|1|||
19478265|NCT01692626|41757546|FG001|Overall Study|Protocol Violation|2|||
19478266|NCT01692626|41757545|FG000|Overall Study|Withdrawal by Subject|1|||
19478267|NCT01692626|41757546|FG001|Overall Study|Withdrawal by Subject|0|||
19478268|NCT01475461|41757572|FG000|Run-in Period|Not meet eligibility criteria|16|||
19478269|NCT01475461|41757573|FG001|Run-in Period|Not meet eligibility criteria|0|||
19478270|NCT01475461|41757574|FG002|Run-in Period|Not meet eligibility criteria|0|||
19478271|NCT01475461|41757575|FG003|Run-in Period|Not meet eligibility criteria|0|||
19478272|NCT01475461|41757576|FG004|Run-in Period|Not meet eligibility criteria|0|||
19478273|NCT01475461|41757577|FG005|Run-in Period|Not meet eligibility criteria|0|||
19478274|NCT01475461|41757578|FG006|Run-in Period|Not meet eligibility criteria|0|||
19478275|NCT01475461|41757572|FG000|Run-in Period|Lost to Follow-up|7|||
19478276|NCT01475461|41757573|FG001|Run-in Period|Lost to Follow-up|0|||
19478277|NCT01475461|41757574|FG002|Run-in Period|Lost to Follow-up|0|||
19478278|NCT01475461|41757575|FG003|Run-in Period|Lost to Follow-up|0|||
19478279|NCT01475461|41757576|FG004|Run-in Period|Lost to Follow-up|0|||
19478280|NCT01475461|41757577|FG005|Run-in Period|Lost to Follow-up|0|||
19478281|NCT01475461|41757578|FG006|Run-in Period|Lost to Follow-up|0|||
19478282|NCT01475461|41757572|FG000|Run-in Period|Withdrawal by Subject|11|||
19699854|NCT00272792|42144642|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
19699855|NCT00272792|42144643|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
19699856|NCT00048568|42144651|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
19799538|NCT02477800|42257555|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
19478283|NCT01475461|41757573|FG001|Run-in Period|Withdrawal by Subject|0|||
19478284|NCT01475461|41757574|FG002|Run-in Period|Withdrawal by Subject|0|||
19478285|NCT01475461|41757575|FG003|Run-in Period|Withdrawal by Subject|0|||
19478286|NCT01475461|41757576|FG004|Run-in Period|Withdrawal by Subject|0|||
19478287|NCT01475461|41757577|FG005|Run-in Period|Withdrawal by Subject|0|||
19478288|NCT01475461|41757578|FG006|Run-in Period|Withdrawal by Subject|0|||
19609117|NCT00657553|42058174|FG000|Overall Study|low accrual, no analysis run|5|||
19478289|NCT01475461|41757572|FG000|Run-in Period|Other|3|||
19478290|NCT01475461|41757573|FG001|Run-in Period|Other|0|||
19478291|NCT01475461|41757574|FG002|Run-in Period|Other|0|||
19478292|NCT01475461|41757575|FG003|Run-in Period|Other|0|||
19478293|NCT01475461|41757576|FG004|Run-in Period|Other|0|||
19478294|NCT01475461|41757577|FG005|Run-in Period|Other|0|||
19478295|NCT01475461|41757578|FG006|Run-in Period|Other|0|||
19478296|NCT01475461|41757572|FG000|Run-in Period|Protocol Violation|4|||
19478297|NCT01475461|41757573|FG001|Run-in Period|Protocol Violation|0|||
19478298|NCT01475461|41757574|FG002|Run-in Period|Protocol Violation|0|||
19478299|NCT01475461|41757575|FG003|Run-in Period|Protocol Violation|0|||
19478300|NCT01475461|41757576|FG004|Run-in Period|Protocol Violation|0|||
19478301|NCT01475461|41757577|FG005|Run-in Period|Protocol Violation|0|||
19478302|NCT01475461|41757578|FG006|Run-in Period|Protocol Violation|0|||
19478303|NCT01475461|41757572|FG000|Treatment Period|Death|0|||
19478304|NCT01475461|41757573|FG001|Treatment Period|Death|0|||
19478305|NCT01475461|41757574|FG002|Treatment Period|Death|0|||
19478306|NCT01475461|41757575|FG003|Treatment Period|Death|1|||
19478307|NCT01475461|41757576|FG004|Treatment Period|Death|0|||
19478308|NCT01475461|41757577|FG005|Treatment Period|Death|0|||
19478309|NCT01475461|41757578|FG006|Treatment Period|Death|0|||
19478310|NCT01475461|41757572|FG000|Treatment Period|Lost to Follow-up|0|||
19478311|NCT01475461|41757573|FG001|Treatment Period|Lost to Follow-up|3|||
19478312|NCT01475461|41757574|FG002|Treatment Period|Lost to Follow-up|2|||
19478313|NCT01475461|41757575|FG003|Treatment Period|Lost to Follow-up|3|||
19478314|NCT01475461|41757576|FG004|Treatment Period|Lost to Follow-up|1|||
19478315|NCT01475461|41757577|FG005|Treatment Period|Lost to Follow-up|2|||
19478316|NCT01475461|41757578|FG006|Treatment Period|Lost to Follow-up|1|||
19478317|NCT01475461|41757572|FG000|Treatment Period|Withdrawal by Subject|0|||
19478318|NCT01475461|41757573|FG001|Treatment Period|Withdrawal by Subject|2|||
19478319|NCT01475461|41757574|FG002|Treatment Period|Withdrawal by Subject|2|||
19478320|NCT01475461|41757575|FG003|Treatment Period|Withdrawal by Subject|0|||
19478321|NCT01475461|41757576|FG004|Treatment Period|Withdrawal by Subject|2|||
19478322|NCT01475461|41757577|FG005|Treatment Period|Withdrawal by Subject|2|||
19478323|NCT01475461|41757578|FG006|Treatment Period|Withdrawal by Subject|0|||
19478324|NCT01475461|41757572|FG000|Treatment Period|Other|0|||
19478325|NCT01475461|41757573|FG001|Treatment Period|Other|1|||
19478326|NCT01475461|41757574|FG002|Treatment Period|Other|0|||
19478327|NCT01475461|41757575|FG003|Treatment Period|Other|0|||
19478328|NCT01475461|41757576|FG004|Treatment Period|Other|0|||
19478329|NCT01475461|41757577|FG005|Treatment Period|Other|0|||
19478330|NCT01475461|41757578|FG006|Treatment Period|Other|0|||
19478331|NCT01475461|41757572|FG000|Treatment Period|Protocol Violation|0|||
19478332|NCT01475461|41757573|FG001|Treatment Period|Protocol Violation|1|||
19478333|NCT01475461|41757574|FG002|Treatment Period|Protocol Violation|0|||
19478334|NCT01475461|41757575|FG003|Treatment Period|Protocol Violation|0|||
19478335|NCT01475461|41757576|FG004|Treatment Period|Protocol Violation|0|||
19478336|NCT01475461|41757577|FG005|Treatment Period|Protocol Violation|0|||
19478337|NCT01475461|41757578|FG006|Treatment Period|Protocol Violation|1|||
19478338|NCT01475461|41757572|FG000|Treatment Period|Lack of Efficacy|0|||
19478339|NCT01475461|41757573|FG001|Treatment Period|Lack of Efficacy|2|||
19478340|NCT01475461|41757574|FG002|Treatment Period|Lack of Efficacy|0|||
19478341|NCT01475461|41757575|FG003|Treatment Period|Lack of Efficacy|2|||
19478342|NCT01475461|41757576|FG004|Treatment Period|Lack of Efficacy|1|||
19478343|NCT01475461|41757577|FG005|Treatment Period|Lack of Efficacy|1|||
19478344|NCT01475461|41757578|FG006|Treatment Period|Lack of Efficacy|0|||
19478345|NCT01475461|41757572|FG000|Treatment Period|Medication Error|0|||
19478346|NCT01475461|41757573|FG001|Treatment Period|Medication Error|0|||
19478347|NCT01475461|41757574|FG002|Treatment Period|Medication Error|0|||
19478348|NCT01475461|41757575|FG003|Treatment Period|Medication Error|1|||
19478349|NCT01475461|41757576|FG004|Treatment Period|Medication Error|0|||
19478350|NCT01475461|41757577|FG005|Treatment Period|Medication Error|0|||
19478351|NCT01475461|41757578|FG006|Treatment Period|Medication Error|0|||
19478352|NCT01475461|41757572|FG000|Treatment Period|Adverse Event|0|||
19478353|NCT01475461|41757573|FG001|Treatment Period|Adverse Event|0|||
19478354|NCT01475461|41757574|FG002|Treatment Period|Adverse Event|0|||
19478355|NCT01475461|41757575|FG003|Treatment Period|Adverse Event|1|||
19478356|NCT01475461|41757576|FG004|Treatment Period|Adverse Event|0|||
19478357|NCT01475461|41757577|FG005|Treatment Period|Adverse Event|0|||
19478358|NCT01475461|41757578|FG006|Treatment Period|Adverse Event|0|||
19478359|NCT01589822|41757614|FG000|Overall Study|Withdrawal by Subject|1|||
19478360|NCT01589822|41757615|FG001|Overall Study|Withdrawal by Subject|2|||
19478361|NCT01589822|41757616|FG002|Overall Study|Withdrawal by Subject|0|||
19478362|NCT01589822|41757614|FG000|Overall Study|Death|1|||
19478363|NCT01589822|41757615|FG001|Overall Study|Death|0|||
19478364|NCT01589822|41757616|FG002|Overall Study|Death|0|||
19478365|NCT01589822|41757614|FG000|Overall Study|Missed 90 day visit|2|||
19478366|NCT01589822|41757615|FG001|Overall Study|Missed 90 day visit|1|||
19478367|NCT01589822|41757616|FG002|Overall Study|Missed 90 day visit|1|||
19478368|NCT01565642|41757628|FG000|Overall Study|Withdrawal by Subject|2|||
19478369|NCT01565642|41757629|FG001|Overall Study|Withdrawal by Subject|1|||
19478370|NCT01475071|41757635|FG000|Overall Study|Physician Decision|1|||
19478371|NCT01475071|41757635|FG000|Overall Study|Withdrawal by Subject|6|||
19478372|NCT01475071|41757635|FG000|Overall Study|Lost to Follow-up|1|||
19478373|NCT01474993|41757643|FG000|Overall Study|Lost to Follow-up|1|||
19478374|NCT01474993|41757644|FG001|Overall Study|Lost to Follow-up|2|||
19478375|NCT01474993|41757643|FG000|Overall Study|Adverse Event|0|||
19478376|NCT01474993|41757644|FG001|Overall Study|Adverse Event|1|||
19478377|NCT01691768|41757654|FG000|Overall Study|Death|0|||
19478378|NCT01691768|41757655|FG001|Overall Study|Death|2|||
19478379|NCT01691768|41757654|FG000|Overall Study|Lost to Follow-up|4|||
19478380|NCT01691768|41757655|FG001|Overall Study|Lost to Follow-up|3|||
19478381|NCT01691768|41757654|FG000|Overall Study|Withdrawal by Subject|10|||
19478382|NCT01691768|41757655|FG001|Overall Study|Withdrawal by Subject|9|||
19699857|NCT00048568|42144652|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
19699858|NCT00048568|42144653|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
19699859|NCT00048568|42144651|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
19699860|NCT00048568|42144652|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
19699861|NCT00048568|42144653|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
19699862|NCT00048568|42144651|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
19699863|NCT00048568|42144652|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
19699864|NCT00048568|42144653|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
19699865|NCT00048568|42144651|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
19699866|NCT00048568|42144652|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
19699867|NCT00048568|42144653|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
19699868|NCT00048568|42144651|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
19699869|NCT00048568|42144652|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
19699870|NCT00048568|42144653|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
19699871|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Death|1|||
19699872|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Death|1|||
19699873|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Death|0|||
19699874|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
19699875|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
19699876|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
19699877|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
19699878|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
19699879|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
19699880|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
19699881|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
19699882|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
19699883|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
19699884|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
19699885|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
19699886|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
19699887|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
19699888|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
19699889|NCT00048568|42144651|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
19699890|NCT00048568|42144652|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
19699891|NCT00048568|42144653|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
19699892|NCT00048568|42144651|FG000|Open-Label Period|Death|0|||
19699893|NCT00048568|42144652|FG001|Open-Label Period|Death|0|||
19699894|NCT00048568|42144653|FG002|Open-Label Period|Death|13|||
19699895|NCT00048568|42144651|FG000|Open-Label Period|Adverse Event|0|||
19699896|NCT00048568|42144652|FG001|Open-Label Period|Adverse Event|0|||
19699897|NCT00048568|42144653|FG002|Open-Label Period|Adverse Event|49|||
19699898|NCT00048568|42144651|FG000|Open-Label Period|Lack of Efficacy|0|||
19699899|NCT00048568|42144652|FG001|Open-Label Period|Lack of Efficacy|0|||
19699900|NCT00048568|42144653|FG002|Open-Label Period|Lack of Efficacy|32|||
19699901|NCT00048568|42144651|FG000|Open-Label Period|Withdrawal by Subject|0|||
19699902|NCT00048568|42144652|FG001|Open-Label Period|Withdrawal by Subject|0|||
19699903|NCT00048568|42144653|FG002|Open-Label Period|Withdrawal by Subject|26|||
19699904|NCT00048568|42144651|FG000|Open-Label Period|Pregnancy|0|||
19699905|NCT00048568|42144652|FG001|Open-Label Period|Pregnancy|0|||
19699906|NCT00048568|42144653|FG002|Open-Label Period|Pregnancy|5|||
19699907|NCT00048568|42144651|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
19699908|NCT00048568|42144652|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
19699909|NCT00048568|42144653|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
19699910|NCT00048568|42144651|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
19699911|NCT00048568|42144652|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
19699912|NCT00048568|42144653|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
19699913|NCT00048568|42144651|FG000|Open-Label Period|Unknown Reasons|0|||
19699914|NCT00048568|42144652|FG001|Open-Label Period|Unknown Reasons|0|||
19478383|NCT01691768|41757654|FG000|Overall Study|Relocated|0|||
19390529|NCT02659943|41634314|FG003|Overall Study|Patient's condition per principal investigator|0|||
19390530|NCT02659943|41634315|FG004|Overall Study|Patient's condition per principal investigator|0|||
19390531|NCT02659943|41634316|FG005|Overall Study|Patient's condition per principal investigator|1|||
19390532|NCT02659943|41634317|FG006|Overall Study|Patient's condition per principal investigator|0|||
19390533|NCT02659943|41634311|FG000|Overall Study|Ineligible|0|||
19390534|NCT02659943|41634312|FG001|Overall Study|Ineligible|0|||
19390535|NCT02659943|41634313|FG002|Overall Study|Ineligible|0|||
19390536|NCT02659943|41634314|FG003|Overall Study|Ineligible|0|||
19390537|NCT02659943|41634315|FG004|Overall Study|Ineligible|0|||
19390538|NCT02659943|41634316|FG005|Overall Study|Ineligible|0|||
19390539|NCT02659943|41634317|FG006|Overall Study|Ineligible|1|||
19390540|NCT02659943|41634311|FG000|Overall Study|No longer meets eligibility|0|||
19390541|NCT02659943|41634312|FG001|Overall Study|No longer meets eligibility|0|||
19390542|NCT02659943|41634313|FG002|Overall Study|No longer meets eligibility|0|||
19609118|NCT00657553|42058175|FG001|Overall Study|low accrual, no analysis run|5|||
19609119|NCT00862719|42058185|FG000|Overall Study|Disease Progression|5|||
19609120|NCT00862719|42058186|FG001|Overall Study|Disease Progression|0|||
19609121|NCT00862719|42058187|FG002|Overall Study|Disease Progression|1|||
19609122|NCT00862719|42058188|FG003|Overall Study|Disease Progression|0|||
19609123|NCT00862719|42058185|FG000|Overall Study|Death|5|||
19609124|NCT00862719|42058186|FG001|Overall Study|Death|6|||
19609125|NCT00862719|42058187|FG002|Overall Study|Death|1|||
19609126|NCT00862719|42058188|FG003|Overall Study|Death|1|||
19609127|NCT00862719|42058185|FG000|Overall Study|Engraftment failure|0|||
19609128|NCT00862719|42058186|FG001|Overall Study|Engraftment failure|0|||
19609129|NCT00862719|42058187|FG002|Overall Study|Engraftment failure|1|||
19699915|NCT00048568|42144653|FG002|Open-Label Period|Unknown Reasons|25|||
19699916|NCT00048568|42144651|FG000|Open-Label Period|Lost to Follow-up|0|||
19699917|NCT00048568|42144652|FG001|Open-Label Period|Lost to Follow-up|0|||
19699918|NCT00048568|42144653|FG002|Open-Label Period|Lost to Follow-up|7|||
19699919|NCT00262002|42144681|FG000|Overall Study|Adverse Event|2|||
19699920|NCT00262002|42144682|FG001|Overall Study|Adverse Event|1|||
19699921|NCT00262002|42144683|FG002|Overall Study|Adverse Event|0|||
19699922|NCT00262002|42144684|FG003|Overall Study|Adverse Event|0|||
19699923|NCT00262002|42144685|FG004|Overall Study|Adverse Event|0|||
19699924|NCT00262002|42144686|FG005|Overall Study|Adverse Event|1|||
19699925|NCT00262002|42144687|FG006|Overall Study|Adverse Event|0|||
19699926|NCT00262002|42144681|FG000|Overall Study|Withdrawal by Subject|4|||
19699927|NCT00262002|42144682|FG001|Overall Study|Withdrawal by Subject|2|||
19699928|NCT00262002|42144683|FG002|Overall Study|Withdrawal by Subject|0|||
19699929|NCT00262002|42144684|FG003|Overall Study|Withdrawal by Subject|1|||
19699930|NCT00262002|42144685|FG004|Overall Study|Withdrawal by Subject|2|||
19699931|NCT00262002|42144686|FG005|Overall Study|Withdrawal by Subject|2|||
19699932|NCT00262002|42144687|FG006|Overall Study|Withdrawal by Subject|2|||
19699933|NCT00262002|42144681|FG000|Overall Study|Lost to Follow-up|2|||
19699934|NCT00262002|42144682|FG001|Overall Study|Lost to Follow-up|0|||
19699935|NCT00262002|42144683|FG002|Overall Study|Lost to Follow-up|0|||
19699936|NCT00262002|42144684|FG003|Overall Study|Lost to Follow-up|2|||
19699937|NCT00262002|42144685|FG004|Overall Study|Lost to Follow-up|0|||
19699938|NCT00262002|42144686|FG005|Overall Study|Lost to Follow-up|1|||
19699939|NCT00262002|42144687|FG006|Overall Study|Lost to Follow-up|0|||
19699940|NCT00262002|42144681|FG000|Overall Study|Inapropriate enrollment|0|||
19699941|NCT00262002|42144682|FG001|Overall Study|Inapropriate enrollment|1|||
19699942|NCT00262002|42144683|FG002|Overall Study|Inapropriate enrollment|0|||
19699943|NCT00262002|42144684|FG003|Overall Study|Inapropriate enrollment|0|||
19699944|NCT00262002|42144685|FG004|Overall Study|Inapropriate enrollment|0|||
19699945|NCT00262002|42144686|FG005|Overall Study|Inapropriate enrollment|0|||
19699946|NCT00262002|42144687|FG006|Overall Study|Inapropriate enrollment|0|||
19699947|NCT00262002|42144681|FG000|Overall Study|Protocol Violation|3|||
19699948|NCT00262002|42144682|FG001|Overall Study|Protocol Violation|2|||
19699949|NCT00262002|42144683|FG002|Overall Study|Protocol Violation|0|||
19699950|NCT00262002|42144684|FG003|Overall Study|Protocol Violation|2|||
19699951|NCT00262002|42144685|FG004|Overall Study|Protocol Violation|5|||
19699952|NCT00262002|42144686|FG005|Overall Study|Protocol Violation|3|||
19699953|NCT00262002|42144687|FG006|Overall Study|Protocol Violation|2|||
19699954|NCT00262002|42144681|FG000|Overall Study|Unable to classify|0|||
19699955|NCT00262002|42144682|FG001|Overall Study|Unable to classify|0|||
19699956|NCT00262002|42144683|FG002|Overall Study|Unable to classify|0|||
19699957|NCT00262002|42144684|FG003|Overall Study|Unable to classify|0|||
19390543|NCT02659943|41634314|FG003|Overall Study|No longer meets eligibility|0|||
19699958|NCT00262002|42144685|FG004|Overall Study|Unable to classify|0|||
19699959|NCT00262002|42144686|FG005|Overall Study|Unable to classify|0|||
19699960|NCT00262002|42144687|FG006|Overall Study|Unable to classify|2|||
19699961|NCT00281528|42144755|FG000|Overall Study|Progressive Disease|28|||
19699962|NCT00281528|42144756|FG001|Overall Study|Progressive Disease|18|||
19390544|NCT02659943|41634315|FG004|Overall Study|No longer meets eligibility|0|||
19609130|NCT00862719|42058188|FG003|Overall Study|Engraftment failure|0|||
19699963|NCT00281528|42144757|FG002|Overall Study|Progressive Disease|27|||
19699964|NCT00281528|42144755|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
19799539|NCT02477800|42257556|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
19799540|NCT02477800|42257557|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
19799541|NCT02477800|42257558|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
19799542|NCT02477800|42257559|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
19799543|NCT02477800|42257560|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
19799544|NCT02477800|42257554|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
19799545|NCT02477800|42257555|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
19799546|NCT02477800|42257556|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
19799547|NCT02477800|42257557|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
19799548|NCT02477800|42257558|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
19799549|NCT02477800|42257559|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
19799550|NCT02477800|42257560|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
19799551|NCT02477800|42257554|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
19799552|NCT02477800|42257555|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
19799553|NCT02477800|42257556|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
19799554|NCT02477800|42257557|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
19799555|NCT02477800|42257558|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
19799556|NCT02477800|42257559|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
19799557|NCT02477800|42257560|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
19799558|NCT02477800|42257554|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
19799559|NCT02477800|42257555|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
19799560|NCT02477800|42257556|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
19799561|NCT02477800|42257557|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19799562|NCT02477800|42257558|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19799563|NCT02477800|42257559|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19799564|NCT02477800|42257560|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19799565|NCT02477800|42257554|FG000|Placebo-Controlled Period|Reason not Specified|161|||
19799566|NCT02477800|42257555|FG001|Placebo-Controlled Period|Reason not Specified|161|||
19799567|NCT02477800|42257556|FG002|Placebo-Controlled Period|Reason not Specified|189|||
19799568|NCT02477800|42257557|FG003|Placebo-Controlled Period|Reason not Specified|0|||
19799569|NCT02477800|42257558|FG004|Placebo-Controlled Period|Reason not Specified|0|||
19799570|NCT02477800|42257559|FG005|Placebo-Controlled Period|Reason not Specified|0|||
19799571|NCT02477800|42257560|FG006|Placebo-Controlled Period|Reason not Specified|0|||
19799572|NCT02477800|42257554|FG000|Long Term Extension Period|Adverse Event|0|||
19799573|NCT02477800|42257555|FG001|Long Term Extension Period|Adverse Event|0|||
19799574|NCT02477800|42257556|FG002|Long Term Extension Period|Adverse Event|0|||
19799575|NCT02477800|42257557|FG003|Long Term Extension Period|Adverse Event|6|||
19799576|NCT02477800|42257558|FG004|Long Term Extension Period|Adverse Event|2|||
19799577|NCT02477800|42257559|FG005|Long Term Extension Period|Adverse Event|4|||
19799578|NCT02477800|42257560|FG006|Long Term Extension Period|Adverse Event|3|||
19799579|NCT02477800|42257554|FG000|Long Term Extension Period|Death|0|||
19799580|NCT02477800|42257555|FG001|Long Term Extension Period|Death|0|||
19799581|NCT02477800|42257556|FG002|Long Term Extension Period|Death|0|||
19799582|NCT02477800|42257557|FG003|Long Term Extension Period|Death|1|||
19799583|NCT02477800|42257558|FG004|Long Term Extension Period|Death|1|||
19799584|NCT02477800|42257559|FG005|Long Term Extension Period|Death|1|||
19799585|NCT02477800|42257560|FG006|Long Term Extension Period|Death|2|||
19799586|NCT02477800|42257554|FG000|Long Term Extension Period|Consent Withdrawn|0|||
19799587|NCT02477800|42257555|FG001|Long Term Extension Period|Consent Withdrawn|0|||
19799588|NCT02477800|42257556|FG002|Long Term Extension Period|Consent Withdrawn|0|||
19799589|NCT02477800|42257557|FG003|Long Term Extension Period|Consent Withdrawn|10|||
19799590|NCT02477800|42257558|FG004|Long Term Extension Period|Consent Withdrawn|4|||
19799591|NCT02477800|42257559|FG005|Long Term Extension Period|Consent Withdrawn|13|||
19799592|NCT02477800|42257560|FG006|Long Term Extension Period|Consent Withdrawn|16|||
19799593|NCT02477800|42257554|FG000|Long Term Extension Period|Disease Progression|0|||
19799594|NCT02477800|42257555|FG001|Long Term Extension Period|Disease Progression|0|||
19799595|NCT02477800|42257556|FG002|Long Term Extension Period|Disease Progression|0|||
19799596|NCT02477800|42257557|FG003|Long Term Extension Period|Disease Progression|3|||
19799597|NCT02477800|42257558|FG004|Long Term Extension Period|Disease Progression|1|||
19799598|NCT02477800|42257559|FG005|Long Term Extension Period|Disease Progression|1|||
19799599|NCT02477800|42257560|FG006|Long Term Extension Period|Disease Progression|0|||
19799600|NCT02477800|42257554|FG000|Long Term Extension Period|Investigator Decision|0|||
19799601|NCT02477800|42257555|FG001|Long Term Extension Period|Investigator Decision|0|||
19799602|NCT02477800|42257556|FG002|Long Term Extension Period|Investigator Decision|0|||
19799603|NCT02477800|42257557|FG003|Long Term Extension Period|Investigator Decision|0|||
19799604|NCT02477800|42257558|FG004|Long Term Extension Period|Investigator Decision|0|||
19799605|NCT02477800|42257559|FG005|Long Term Extension Period|Investigator Decision|0|||
19799606|NCT02477800|42257560|FG006|Long Term Extension Period|Investigator Decision|2|||
19799607|NCT02477800|42257554|FG000|Long Term Extension Period|Lost to Follow-up|0|||
19799608|NCT02477800|42257555|FG001|Long Term Extension Period|Lost to Follow-up|0|||
19799609|NCT02477800|42257556|FG002|Long Term Extension Period|Lost to Follow-up|0|||
19799610|NCT02477800|42257557|FG003|Long Term Extension Period|Lost to Follow-up|0|||
19799611|NCT02477800|42257558|FG004|Long Term Extension Period|Lost to Follow-up|1|||
19799612|NCT02477800|42257559|FG005|Long Term Extension Period|Lost to Follow-up|3|||
19799613|NCT02477800|42257560|FG006|Long Term Extension Period|Lost to Follow-up|0|||
19799614|NCT02477800|42257554|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
19799615|NCT02477800|42257555|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
19799616|NCT02477800|42257556|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
19799617|NCT02477800|42257557|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
19799618|NCT02477800|42257558|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
19799619|NCT02477800|42257559|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
19799620|NCT02477800|42257560|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
19799621|NCT02477800|42257554|FG000|Long Term Extension Period|Study Visit Burden|0|||
19799622|NCT02477800|42257555|FG001|Long Term Extension Period|Study Visit Burden|0|||
19799623|NCT02477800|42257556|FG002|Long Term Extension Period|Study Visit Burden|0|||
19799624|NCT02477800|42257557|FG003|Long Term Extension Period|Study Visit Burden|3|||
19799625|NCT02477800|42257558|FG004|Long Term Extension Period|Study Visit Burden|0|||
19799626|NCT02477800|42257559|FG005|Long Term Extension Period|Study Visit Burden|2|||
19799627|NCT02477800|42257560|FG006|Long Term Extension Period|Study Visit Burden|2|||
19799628|NCT02477800|42257554|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
19799629|NCT02477800|42257555|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
19799630|NCT02477800|42257556|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
19799631|NCT02477800|42257557|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
19799632|NCT02477800|42257558|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
19799633|NCT02477800|42257559|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
19799634|NCT02477800|42257560|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
19799635|NCT02477800|42257554|FG000|Long Term Extension Period|Reason not Specified|0|||
19799636|NCT02477800|42257555|FG001|Long Term Extension Period|Reason not Specified|0|||
19799637|NCT02477800|42257556|FG002|Long Term Extension Period|Reason not Specified|0|||
19799638|NCT02477800|42257557|FG003|Long Term Extension Period|Reason not Specified|126|||
19799639|NCT02477800|42257558|FG004|Long Term Extension Period|Reason not Specified|140|||
19799640|NCT02477800|42257559|FG005|Long Term Extension Period|Reason not Specified|270|||
19799641|NCT02477800|42257560|FG006|Long Term Extension Period|Reason not Specified|224|||
19799642|NCT02957747|42257574|FG000|Overall Study|Withdrawal by Subject|0|||
19799643|NCT02957747|42257575|FG001|Overall Study|Withdrawal by Subject|3|||
19799644|NCT02957747|42257574|FG000|Overall Study|Lost to Follow-up|10|||
19799645|NCT02957747|42257575|FG001|Overall Study|Lost to Follow-up|5|||
19799646|NCT01344161|42257584|FG000|Overall Study|Lost to Follow-up|4|||
19799647|NCT01344161|42257585|FG001|Overall Study|Lost to Follow-up|1|||
19799648|NCT01344161|42257584|FG000|Overall Study|Pregnancy|0|||
19799649|NCT01344161|42257585|FG001|Overall Study|Pregnancy|1|||
19799650|NCT01344161|42257584|FG000|Overall Study|Protocol Violation|1|||
19799651|NCT01344161|42257585|FG001|Overall Study|Protocol Violation|1|||
19799652|NCT02451358|42257595|FG000|Overall Study|Withdrawal by Subject|1|||
19799653|NCT02451358|42257596|FG001|Overall Study|Withdrawal by Subject|1|||
19799654|NCT02451358|42257597|FG002|Overall Study|Withdrawal by Subject|0|||
19799655|NCT02451358|42257598|FG003|Overall Study|Withdrawal by Subject|0|||
19799656|NCT02451358|42257595|FG000|Overall Study|Protocol Violation|0|||
19799657|NCT02451358|42257596|FG001|Overall Study|Protocol Violation|1|||
19799658|NCT02451358|42257597|FG002|Overall Study|Protocol Violation|1|||
19799659|NCT02451358|42257598|FG003|Overall Study|Protocol Violation|0|||
19799660|NCT02749721|42257608|FG000|Screening|Withdrawal by Subject|1|||
19799661|NCT02749721|42257608|FG000|Screening|Lost to Follow-up|2|||
19799662|NCT02749721|42257608|FG000|Screening|Protocol Violation|3|||
19799663|NCT02749721|42257608|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
19799664|NCT02749721|42257608|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
19799665|NCT01348139|42257614|FG000|Period 1|Adverse Event|1|||
19799666|NCT01348139|42257615|FG001|Period 1|Adverse Event|0|||
19799667|NCT01348139|42257616|FG002|Period 1|Adverse Event|0|||
19799668|NCT01348139|42257617|FG003|Period 1|Adverse Event|0|||
19799669|NCT01348139|42257618|FG004|Period 1|Adverse Event|0|||
19799670|NCT01348139|42257619|FG005|Period 1|Adverse Event|0|||
19799671|NCT02868229|42257637|FG000|Overall Study|Adverse Event|1|||
19799672|NCT02868229|42257638|FG001|Overall Study|Adverse Event|0|||
19799673|NCT02868229|42257639|FG002|Overall Study|Adverse Event|0|||
19799674|NCT02868229|42257640|FG003|Overall Study|Adverse Event|1|||
19799675|NCT02868229|42257637|FG000|Overall Study|Death|0|||
19799676|NCT02868229|42257638|FG001|Overall Study|Death|0|||
19799677|NCT02868229|42257639|FG002|Overall Study|Death|1|||
19799678|NCT02868229|42257640|FG003|Overall Study|Death|1|||
19799679|NCT02868229|42257637|FG000|Overall Study|Missed dose|0|||
19799680|NCT02868229|42257638|FG001|Overall Study|Missed dose|0|||
19799681|NCT02868229|42257639|FG002|Overall Study|Missed dose|0|||
19390545|NCT02659943|41634316|FG005|Overall Study|No longer meets eligibility|0|||
19478384|NCT01691768|41757655|FG001|Overall Study|Relocated|1|||
19799682|NCT02868229|42257640|FG003|Overall Study|Missed dose|3|||
19799683|NCT02956967|42257655|FG000|Overall Study|Adverse Event|3|||
19799684|NCT02956967|42257655|FG000|Overall Study|Reason non-related to neutropenia|10|||
19799685|NCT02956967|42257655|FG000|Overall Study|Lost to Follow-up|5|||
19799686|NCT02956967|42257655|FG000|Overall Study|Missing|1|||
19699965|NCT00281528|42144756|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
19699966|NCT00281528|42144757|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
19699967|NCT00281528|42144755|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
19699968|NCT00281528|42144756|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
19699969|NCT00281528|42144757|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
19699970|NCT00281528|42144755|FG000|Overall Study|Physician Decision|11|||
19699971|NCT00281528|42144756|FG001|Overall Study|Physician Decision|4|||
19699972|NCT00281528|42144757|FG002|Overall Study|Physician Decision|5|||
19699973|NCT00281528|42144755|FG000|Overall Study|Protocol Violation|1|||
19699974|NCT00281528|42144756|FG001|Overall Study|Protocol Violation|0|||
19699975|NCT00281528|42144757|FG002|Overall Study|Protocol Violation|1|||
19699976|NCT00281528|42144755|FG000|Overall Study|Withdrawal by Subject|5|||
19699977|NCT00281528|42144756|FG001|Overall Study|Withdrawal by Subject|5|||
19699978|NCT00281528|42144757|FG002|Overall Study|Withdrawal by Subject|7|||
19699979|NCT00281528|42144755|FG000|Overall Study|Other|6|||
19699980|NCT00281528|42144756|FG001|Overall Study|Other|3|||
19699981|NCT00281528|42144757|FG002|Overall Study|Other|5|||
19699982|NCT00280748|42144765|FG000|Overall Study|Decline in performance|3|||
19699983|NCT00280748|42144765|FG000|Overall Study|Extra-cranial disease progression|1|||
19699984|NCT00271856|42144771|FG000|Overall Study|Withdrawal by Subject|1|||
19699985|NCT00271856|42144772|FG001|Overall Study|Withdrawal by Subject|7|||
19699986|NCT00271856|42144771|FG000|Overall Study|Lost to Follow-up|10|||
19699987|NCT00271856|42144772|FG001|Overall Study|Lost to Follow-up|11|||
19699988|NCT00061048|42144778|FG000|Overall Study|Adverse Event|2|||
19699989|NCT00061048|42144778|FG000|Overall Study|disease progression|20|||
19699990|NCT00270998|42144785|FG000|3 Month Follow-up|Adverse Event|1|||
19699991|NCT00270998|42144786|FG001|3 Month Follow-up|Adverse Event|0|||
19699992|NCT00270998|42144787|FG002|3 Month Follow-up|Adverse Event|0|||
19699993|NCT00270998|42144785|FG000|3 Month Follow-up|Lack of Efficacy|1|||
19699994|NCT00270998|42144786|FG001|3 Month Follow-up|Lack of Efficacy|2|||
19699995|NCT00270998|42144787|FG002|3 Month Follow-up|Lack of Efficacy|1|||
19699996|NCT00270998|42144785|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
19699997|NCT00270998|42144786|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
19699998|NCT00270998|42144787|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
19699999|NCT00270998|42144785|FG000|3 Month Follow-up|Pessary did not fit|12|||
19700000|NCT00270998|42144786|FG001|3 Month Follow-up|Pessary did not fit|0|||
19700001|NCT00270998|42144787|FG002|3 Month Follow-up|Pessary did not fit|0|||
19700002|NCT00270998|42144785|FG000|3 Month Follow-up|Personal/family health|1|||
19700003|NCT00270998|42144786|FG001|3 Month Follow-up|Personal/family health|1|||
19700004|NCT00270998|42144787|FG002|3 Month Follow-up|Personal/family health|0|||
19700005|NCT00270998|42144785|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
19700006|NCT00270998|42144786|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
19700007|NCT00270998|42144787|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
19700008|NCT00270998|42144785|FG000|12 Month Follow-up|Lack of Efficacy|5|||
19700009|NCT00270998|42144786|FG001|12 Month Follow-up|Lack of Efficacy|4|||
19700010|NCT00270998|42144787|FG002|12 Month Follow-up|Lack of Efficacy|3|||
19700011|NCT00270998|42144785|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
19700012|NCT00270998|42144786|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
19700013|NCT00270998|42144787|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
19700014|NCT00270998|42144785|FG000|12 Month Follow-up|Pessary did not fit|1|||
19700015|NCT00270998|42144786|FG001|12 Month Follow-up|Pessary did not fit|0|||
19700016|NCT00270998|42144787|FG002|12 Month Follow-up|Pessary did not fit|0|||
19700017|NCT00270998|42144785|FG000|12 Month Follow-up|Personal/family health|0|||
19700018|NCT00270998|42144786|FG001|12 Month Follow-up|Personal/family health|5|||
19700019|NCT00270998|42144787|FG002|12 Month Follow-up|Personal/family health|1|||
19700020|NCT00270998|42144785|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
19700021|NCT00270998|42144786|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
19700022|NCT00270998|42144787|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
19700023|NCT00279812|42144803|FG000|Overall Study|Protocol Violation|1|||
19700024|NCT00279812|42144804|FG001|Overall Study|Protocol Violation|1|||
19700025|NCT00279812|42144805|FG002|Overall Study|Protocol Violation|0|||
19700026|NCT00279812|42144806|FG003|Overall Study|Protocol Violation|0|||
19700027|NCT00279812|42144807|FG004|Overall Study|Protocol Violation|1|||
19700028|NCT00279812|42144808|FG005|Overall Study|Protocol Violation|0|||
19700029|NCT00279812|42144803|FG000|Overall Study|Withdrawal by Subject|0|||
19700030|NCT00279812|42144804|FG001|Overall Study|Withdrawal by Subject|4|||
19700031|NCT00279812|42144805|FG002|Overall Study|Withdrawal by Subject|2|||
19700032|NCT00279812|42144806|FG003|Overall Study|Withdrawal by Subject|0|||
19700033|NCT00279812|42144807|FG004|Overall Study|Withdrawal by Subject|0|||
19700034|NCT00279812|42144808|FG005|Overall Study|Withdrawal by Subject|0|||
19799687|NCT02956967|42257655|FG000|Overall Study|Termination of Nivestim administration|29|||
19799688|NCT02867995|42257679|FG000|Overall Study|Withdrawal by Subject|0|||
19799689|NCT02867995|42257680|FG001|Overall Study|Withdrawal by Subject|1|||
19799690|NCT02867995|42257679|FG000|Overall Study|Lost to Follow-up|0|||
19799691|NCT02867995|42257680|FG001|Overall Study|Lost to Follow-up|2|||
19799692|NCT03392883|42257693|FG000|Overall Study|Lost to Follow-up|122|||
19799693|NCT03392883|42257694|FG001|Overall Study|Lost to Follow-up|13|||
19799694|NCT03392883|42257695|FG002|Overall Study|Lost to Follow-up|9|||
19799695|NCT03392883|42257693|FG000|Overall Study|Death|4|||
19799696|NCT03392883|42257694|FG001|Overall Study|Death|0|||
19799697|NCT03392883|42257695|FG002|Overall Study|Death|0|||
19799698|NCT03392883|42257693|FG000|Overall Study|Lack of Efficacy|29|||
19799699|NCT03392883|42257694|FG001|Overall Study|Lack of Efficacy|0|||
19700035|NCT00279812|42144803|FG000|Overall Study|Adverse Event|0|||
19700036|NCT00279812|42144804|FG001|Overall Study|Adverse Event|1|||
19700037|NCT00279812|42144805|FG002|Overall Study|Adverse Event|1|||
19700038|NCT00279812|42144806|FG003|Overall Study|Adverse Event|0|||
19700039|NCT00279812|42144807|FG004|Overall Study|Adverse Event|2|||
19700040|NCT00279812|42144808|FG005|Overall Study|Adverse Event|1|||
19700041|NCT00207714|42144827|FG000|Overall Study|Adverse Event|6|||
19700042|NCT00207714|42144828|FG001|Overall Study|Adverse Event|2|||
19799700|NCT03392883|42257695|FG002|Overall Study|Lack of Efficacy|0|||
19799701|NCT03392883|42257693|FG000|Overall Study|Withdrawal by Subject|180|||
19478385|NCT01691768|41757654|FG000|Overall Study|Investigator decision|1|||
19478386|NCT01691768|41757655|FG001|Overall Study|Investigator decision|1|||
19609131|NCT00862719|42058185|FG000|Overall Study|Veno-Occlusive Disease|0|||
19609132|NCT00862719|42058186|FG001|Overall Study|Veno-Occlusive Disease|0|||
19609133|NCT00862719|42058187|FG002|Overall Study|Veno-Occlusive Disease|1|||
19609134|NCT00862719|42058188|FG003|Overall Study|Veno-Occlusive Disease|0|||
19609135|NCT00862641|42058202|FG000|Overall Study|Randomized, but drug not received|1|||
19609136|NCT00862641|42058203|FG001|Overall Study|Randomized, but drug not received|4|||
19609137|NCT00862641|42058204|FG002|Overall Study|Randomized, but drug not received|1|||
19609138|NCT00862641|42058205|FG003|Overall Study|Randomized, but drug not received|4|||
19609139|NCT00861471|42058215|FG000|Overall Study|Withdrawal by Subject|1|||
19609140|NCT00861471|42058215|FG000|Overall Study|Adverse Event|2|||
19609141|NCT00861471|42058215|FG000|Overall Study|Lack of Efficacy|3|||
19609142|NCT00861471|42058215|FG000|Overall Study|treatment for lumbar laminectomy|1|||
19609143|NCT00861471|42058215|FG000|Overall Study|Physician Decision|2|||
19609144|NCT00860067|42058222|FG000|Overall Study|Lost to Follow-up|46|||
19609145|NCT00860067|42058223|FG001|Overall Study|Lost to Follow-up|9|||
19609146|NCT00860067|42058224|FG002|Overall Study|Lost to Follow-up|9|||
19609147|NCT00860067|42058222|FG000|Overall Study|Withdrawal by Subject|4|||
19609148|NCT00860067|42058223|FG001|Overall Study|Withdrawal by Subject|0|||
19609149|NCT00860067|42058224|FG002|Overall Study|Withdrawal by Subject|0|||
19609150|NCT00860067|42058222|FG000|Overall Study|Pregnancy|1|||
19609151|NCT00860067|42058223|FG001|Overall Study|Pregnancy|0|||
19609152|NCT00860067|42058224|FG002|Overall Study|Pregnancy|0|||
19609153|NCT00858117|42058235|FG000|Treatment on Study|Adverse Event|2|||
19609154|NCT00858117|42058235|FG000|Follow up for 5 Years|Death|4|||
19609155|NCT00858117|42058235|FG000|Follow up for 5 Years|No further data collected for study|9|||
19609156|NCT00652951|42058242|FG000|Booster Phase|Adverse event, non-fatal|0|||
19609157|NCT00652951|42058243|FG001|Booster Phase|Adverse event, non-fatal|1|||
19609158|NCT00652951|42058244|FG002|Booster Phase|Adverse event, non-fatal|0|||
19609159|NCT00652951|42058242|FG000|Booster Phase|Other|1|||
19609160|NCT00652951|42058243|FG001|Booster Phase|Other|0|||
19609161|NCT00652951|42058244|FG002|Booster Phase|Other|0|||
19609162|NCT00848211|42058256|FG000|Overall Study|Protocol Violation|0|||
19609163|NCT00848211|42058257|FG001|Overall Study|Protocol Violation|1|||
19609164|NCT00848211|42058258|FG002|Overall Study|Protocol Violation|1|||
19609165|NCT00848211|42058259|FG003|Overall Study|Protocol Violation|0|||
19609166|NCT00848211|42058256|FG000|Overall Study|Adverse Event|0|||
19609167|NCT00848211|42058257|FG001|Overall Study|Adverse Event|0|||
19609168|NCT00848211|42058258|FG002|Overall Study|Adverse Event|0|||
19609169|NCT00848211|42058259|FG003|Overall Study|Adverse Event|0|||
19609170|NCT00592683|42058271|FG000|Overall Study|Found ineligible|0|||
19609171|NCT00592683|42058272|FG001|Overall Study|Found ineligible|1|||
19609172|NCT00592683|42058271|FG000|Overall Study|Withdrawal by Subject|1|||
19609173|NCT00592683|42058272|FG001|Overall Study|Withdrawal by Subject|0|||
19700043|NCT00207714|42144829|FG002|Overall Study|Adverse Event|4|||
19799702|NCT03392883|42257694|FG001|Overall Study|Withdrawal by Subject|0|||
19799703|NCT03392883|42257695|FG002|Overall Study|Withdrawal by Subject|0|||
19609174|NCT00592683|42058271|FG000|Overall Study|Adverse Event|0|||
19609175|NCT00592683|42058272|FG001|Overall Study|Adverse Event|2|||
19609176|NCT00592683|42058271|FG000|Overall Study|Protocol Violation|1|||
19609177|NCT00592683|42058272|FG001|Overall Study|Protocol Violation|0|||
19609178|NCT00592683|42058271|FG000|Overall Study|Study drug expired|1|||
19609179|NCT00592683|42058272|FG001|Overall Study|Study drug expired|0|||
19700044|NCT00207714|42144830|FG003|Overall Study|Adverse Event|3|||
19700045|NCT00207714|42144831|FG004|Overall Study|Adverse Event|1|||
19799704|NCT03392883|42257693|FG000|Overall Study|Adverse Event|1|||
19799705|NCT03392883|42257694|FG001|Overall Study|Adverse Event|0|||
19799706|NCT03392883|42257695|FG002|Overall Study|Adverse Event|0|||
19799707|NCT02748863|42257706|FG000|Treatment Period 1|Adverse Event|0|||
19799708|NCT02748863|42257707|FG001|Treatment Period 1|Adverse Event|1|||
19799709|NCT02748863|42257708|FG002|Treatment Period 1|Adverse Event|0|||
19799710|NCT02748863|42257709|FG003|Treatment Period 1|Adverse Event|0|||
19799711|NCT02748863|42257710|FG004|Treatment Period 1|Adverse Event|0|||
19799712|NCT02748863|42257706|FG000|Treatment Period 1|Lack of Efficacy|0|||
19799713|NCT02748863|42257707|FG001|Treatment Period 1|Lack of Efficacy|0|||
19799714|NCT02748863|42257708|FG002|Treatment Period 1|Lack of Efficacy|1|||
19799715|NCT02748863|42257709|FG003|Treatment Period 1|Lack of Efficacy|0|||
19799716|NCT02748863|42257710|FG004|Treatment Period 1|Lack of Efficacy|0|||
19799717|NCT02748863|42257706|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19799718|NCT02748863|42257707|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19799719|NCT02748863|42257708|FG002|Treatment Period 1|Withdrawal by Subject|1|||
19799720|NCT02748863|42257709|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19799721|NCT02748863|42257710|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19799722|NCT02748863|42257706|FG000|Treatment Period 2|Lost to Follow-up|2|||
19799723|NCT02748863|42257707|FG001|Treatment Period 2|Lost to Follow-up|0|||
19799724|NCT02748863|42257708|FG002|Treatment Period 2|Lost to Follow-up|0|||
19799725|NCT02748863|42257709|FG003|Treatment Period 2|Lost to Follow-up|0|||
19799726|NCT02748863|42257710|FG004|Treatment Period 2|Lost to Follow-up|0|||
19799727|NCT02748863|42257706|FG000|Treatment Period 2|Adverse Event|3|||
19799728|NCT02748863|42257707|FG001|Treatment Period 2|Adverse Event|2|||
19799729|NCT02748863|42257708|FG002|Treatment Period 2|Adverse Event|0|||
19799730|NCT02748863|42257709|FG003|Treatment Period 2|Adverse Event|2|||
19799731|NCT02748863|42257710|FG004|Treatment Period 2|Adverse Event|0|||
19799732|NCT02748863|42257706|FG000|Treatment Period 2|Lack of Efficacy|0|||
19799733|NCT02748863|42257707|FG001|Treatment Period 2|Lack of Efficacy|1|||
19799734|NCT02748863|42257708|FG002|Treatment Period 2|Lack of Efficacy|0|||
19799735|NCT02748863|42257709|FG003|Treatment Period 2|Lack of Efficacy|0|||
19799736|NCT02748863|42257710|FG004|Treatment Period 2|Lack of Efficacy|0|||
19799737|NCT02748863|42257706|FG000|Treatment Period 2|Pregnancy|0|||
19799738|NCT02748863|42257707|FG001|Treatment Period 2|Pregnancy|0|||
19799739|NCT02748863|42257708|FG002|Treatment Period 2|Pregnancy|0|||
19799740|NCT02748863|42257709|FG003|Treatment Period 2|Pregnancy|0|||
19799741|NCT02748863|42257710|FG004|Treatment Period 2|Pregnancy|1|||
19799742|NCT02865499|42257731|FG000|Baseline|Adverse Event|1|||
19799743|NCT02865499|42257731|FG000|Baseline|Withdrawal by Subject|1|||
19799744|NCT02870933|42257737|FG000|Overall Study|Death|2|||
19799745|NCT02870933|42257738|FG001|Overall Study|Death|1|||
19799746|NCT02870933|42257737|FG000|Overall Study|Withdrawal by Subject|0|||
19799747|NCT02870933|42257738|FG001|Overall Study|Withdrawal by Subject|1|||
19799748|NCT02864407|42257745|FG000|Overall Study|Protocol Violation|3|||
19799749|NCT02864407|42257745|FG000|Overall Study|Lost to Follow-up|115|||
19799750|NCT02864407|42257745|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
19799751|NCT02864407|42257745|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
19799752|NCT02864407|42257745|FG000|Overall Study|Consent prior to the contract date|1|||
19799753|NCT02873429|42257751|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
19799754|NCT02873429|42257752|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
19799755|NCT02873429|42257751|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
19799756|NCT02873429|42257752|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
19799757|NCT02873429|42257751|FG000|16 Weeks|Lost to Follow-up|3|||
19799758|NCT02873429|42257752|FG001|16 Weeks|Lost to Follow-up|0|||
19799759|NCT02486302|42257758|FG000|Overall Study|Discontinued prematurely|410|||
19799760|NCT02486302|42257758|FG000|Overall Study|Documentation not completed|255|||
19478387|NCT01503229|41757662|FG000|Overall Study|Withdrew consent|1|||
19609180|NCT00592683|42058271|FG000|Overall Study|Other|1|||
19609181|NCT00592683|42058272|FG001|Overall Study|Other|0|||
19700046|NCT00207714|42144827|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
19700047|NCT00207714|42144828|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19700048|NCT00207714|42144829|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
19700049|NCT00207714|42144830|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
19700050|NCT00207714|42144831|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
19700051|NCT00207714|42144827|FG000|Overall Study|Other|3|||
19700052|NCT00207714|42144828|FG001|Overall Study|Other|2|||
19700053|NCT00207714|42144829|FG002|Overall Study|Other|5|||
19700054|NCT00207714|42144830|FG003|Overall Study|Other|1|||
19700055|NCT00207714|42144831|FG004|Overall Study|Other|0|||
19700056|NCT00207090|42144850|FG000|Overall Study|Study drug toxicity|3|||
19700057|NCT00207090|42144850|FG000|Overall Study|Chest wall mass larger|1|||
19799761|NCT02486302|42257758|FG000|Overall Study|Excluded due to legal reasons|8|||
19799762|NCT02486302|42257758|FG000|Overall Study|Not treated|3|||
19799763|NCT02747875|42257773|FG000|Overall Study|Physician Decision|1|||
19799764|NCT02747875|42257774|FG001|Overall Study|Physician Decision|0|||
19700058|NCT00207090|42144850|FG000|Overall Study|Disease progression/relapse|2|||
19700059|NCT00207090|42144850|FG000|Overall Study|Physician Decision|1|||
19700060|NCT00059332|42144861|FG000|Overall Study|Withdrawal by Subject|2|||
19700061|NCT00059332|42144862|FG001|Overall Study|Withdrawal by Subject|1|||
19700062|NCT00059332|42144861|FG000|Overall Study|Lost to Follow-up|1|||
19700063|NCT00059332|42144862|FG001|Overall Study|Lost to Follow-up|1|||
19700064|NCT00233454|42144868|FG000|Overall Study|Death|6|||
19700065|NCT00047320|42144872|FG000|Overall Study|Lack of Efficacy|8|||
19700066|NCT00047320|42144872|FG000|Overall Study|Lost to Follow-up|1|||
19700067|NCT00047320|42144872|FG000|Overall Study|Physician Decision|8|||
19700068|NCT00047320|42144872|FG000|Overall Study|Withdrawal by Subject|9|||
19700069|NCT00047320|42144872|FG000|Overall Study|Ineligible|2|||
19700070|NCT00233064|42144878|FG000|Overall Study|Lost to Follow-up|7|||
19700071|NCT00233064|42144879|FG001|Overall Study|Lost to Follow-up|7|||
19700072|NCT00233064|42144878|FG000|Overall Study|Withdrawal by Subject|5|||
19700073|NCT00233064|42144879|FG001|Overall Study|Withdrawal by Subject|3|||
19700074|NCT00233064|42144878|FG000|Overall Study|Death|0|||
19700075|NCT00233064|42144879|FG001|Overall Study|Death|1|||
19700076|NCT00233064|42144878|FG000|Overall Study|Relocation|0|||
19700077|NCT00233064|42144879|FG001|Overall Study|Relocation|1|||
19700078|NCT00233064|42144878|FG000|Overall Study|Protocol Violation|1|||
19700079|NCT00233064|42144879|FG001|Overall Study|Protocol Violation|0|||
19700080|NCT00233064|42144878|FG000|Overall Study|Moved to Dom. Republic|1|||
19700081|NCT00233064|42144879|FG001|Overall Study|Moved to Dom. Republic|0|||
19700082|NCT00268892|42144889|FG000|Overall Study|Adverse Event|14|||
19700083|NCT00268892|42144890|FG001|Overall Study|Adverse Event|17|||
19700084|NCT00268892|42144891|FG002|Overall Study|Adverse Event|20|||
19700085|NCT00268892|42144889|FG000|Overall Study|Lack of Efficacy|1|||
19700086|NCT00268892|42144890|FG001|Overall Study|Lack of Efficacy|3|||
19700087|NCT00268892|42144891|FG002|Overall Study|Lack of Efficacy|0|||
19799765|NCT02747875|42257773|FG000|Overall Study|Adverse Event|0|||
19799766|NCT02747875|42257774|FG001|Overall Study|Adverse Event|1|||
19799767|NCT02451124|42257800|FG000|Overall Study|Withdrawal by Subject|1|||
19799768|NCT02450578|42257812|FG000|Overall Study|ECG abnormality so not treated|1|||
19700088|NCT00268892|42144889|FG000|Overall Study|Withdrawal by Subject|14|||
19700089|NCT00268892|42144890|FG001|Overall Study|Withdrawal by Subject|15|||
19700090|NCT00268892|42144891|FG002|Overall Study|Withdrawal by Subject|13|||
19700091|NCT00268892|42144889|FG000|Overall Study|Physician Decision|0|||
19700092|NCT00268892|42144890|FG001|Overall Study|Physician Decision|1|||
19700093|NCT00268892|42144891|FG002|Overall Study|Physician Decision|0|||
19700094|NCT00268892|42144889|FG000|Overall Study|Lost to Follow-up|5|||
19700095|NCT00268892|42144890|FG001|Overall Study|Lost to Follow-up|2|||
19700096|NCT00268892|42144891|FG002|Overall Study|Lost to Follow-up|4|||
19700097|NCT00268892|42144889|FG000|Overall Study|Protocol Violation|0|||
19700098|NCT00268892|42144890|FG001|Overall Study|Protocol Violation|1|||
19700099|NCT00268892|42144891|FG002|Overall Study|Protocol Violation|0|||
19700100|NCT00268892|42144889|FG000|Overall Study|Disease Progression|1|||
19700101|NCT00268892|42144890|FG001|Overall Study|Disease Progression|1|||
19700102|NCT00268892|42144891|FG002|Overall Study|Disease Progression|0|||
19700103|NCT00268892|42144889|FG000|Overall Study|Trial Site Closed|4|||
19700104|NCT00268892|42144890|FG001|Overall Study|Trial Site Closed|2|||
19700105|NCT00268892|42144891|FG002|Overall Study|Trial Site Closed|2|||
19700106|NCT00206076|42144901|FG000|Overall Study|Physician Decision|2|||
19799769|NCT02450578|42257813|FG001|Overall Study|ECG abnormality so not treated|0|||
19799770|NCT02450578|42257814|FG002|Overall Study|ECG abnormality so not treated|0|||
19799771|NCT02450578|42257815|FG003|Overall Study|ECG abnormality so not treated|0|||
19700107|NCT00206076|42144902|FG001|Overall Study|Physician Decision|0|||
19700108|NCT00206076|42144901|FG000|Overall Study|Withdrawal by Subject|1|||
19700109|NCT00206076|42144902|FG001|Overall Study|Withdrawal by Subject|1|||
19700110|NCT00278954|42144910|FG000|Overall Study|Adverse Event|3|||
19700111|NCT00278954|42144910|FG000|Overall Study|Lost to Follow-up|1|||
19700112|NCT00278954|42144910|FG000|Overall Study|Withdrawal by Subject|1|||
19700113|NCT00278564|42144914|FG000|Overall Study|Lack of Efficacy|4|||
19700114|NCT00268346|42144920|FG000|Overall Study|Adverse Event|0|||
19700115|NCT00268346|42144921|FG001|Overall Study|Adverse Event|1|||
19700116|NCT00268346|42144920|FG000|Overall Study|Death|0|||
19700117|NCT00268346|42144921|FG001|Overall Study|Death|1|||
19700118|NCT00268346|42144920|FG000|Overall Study|Withdrawal by Subject|0|||
19700119|NCT00268346|42144921|FG001|Overall Study|Withdrawal by Subject|1|||
19700120|NCT00203892|42144930|FG000|Overall Study|Physician Decision|1|||
19700121|NCT00203892|42144931|FG001|Overall Study|Physician Decision|2|||
19700122|NCT00203892|42144932|FG002|Overall Study|Physician Decision|0|||
19700123|NCT00203892|42144930|FG000|Overall Study|Death|1|||
19700124|NCT00203892|42144931|FG001|Overall Study|Death|0|||
19700125|NCT00203892|42144932|FG002|Overall Study|Death|0|||
19700126|NCT00250718|42144940|FG000|Overall Study|Death|1|||
19700127|NCT00250718|42144940|FG000|Overall Study|Adverse Event|1|||
19700128|NCT00250718|42144940|FG000|Overall Study|Withdrawal by Subject|1|||
19700129|NCT00276614|42144944|FG000|Overall Study|Progression of disease under study|3|||
19700130|NCT00276458|42144950|FG000|Overall Study|Adverse Event|0|||
19700131|NCT00276458|42144951|FG001|Overall Study|Adverse Event|2|||
19700132|NCT00276458|42144950|FG000|Overall Study|Lost to Follow-up|2|||
19799772|NCT02449018|42257842|FG000|Overall Study|Abnormal laboratory value|0|||
19799773|NCT02449018|42257843|FG001|Overall Study|Abnormal laboratory value|1|||
19799774|NCT02449018|42257842|FG000|Overall Study|Administrative problems|1|||
19799775|NCT02449018|42257843|FG001|Overall Study|Administrative problems|0|||
19799776|NCT02449018|42257842|FG000|Overall Study|Adverse Event|5|||
19799777|NCT02449018|42257843|FG001|Overall Study|Adverse Event|1|||
19799778|NCT02449018|42257842|FG000|Overall Study|Protocol deviation|4|||
19799779|NCT02449018|42257843|FG001|Overall Study|Protocol deviation|0|||
19799780|NCT02449018|42257842|FG000|Overall Study|Patient decision|2|||
19799781|NCT02449018|42257843|FG001|Overall Study|Patient decision|0|||
19799782|NCT02859415|42257851|FG000|Overall Study|Physician Decision|1|||
19799783|NCT02859415|42257852|FG001|Overall Study|Physician Decision|0|||
19799784|NCT02859415|42257851|FG000|Overall Study|Off treatment due to cardiac event|0|||
19799785|NCT02859415|42257852|FG001|Overall Study|Off treatment due to cardiac event|1|||
19799786|NCT02871791|42257862|FG000|Phase 1b|Death|0|||
19799787|NCT02871791|42257863|FG001|Phase 1b|Death|1|||
19799788|NCT02871791|42257862|FG000|Phase 1b|progressive disease|6|||
19799789|NCT02871791|42257863|FG001|Phase 1b|progressive disease|2|||
19799790|NCT02871791|42257862|FG000|Phase 2|Death|1|||
19799791|NCT02871791|42257863|FG001|Phase 2|Death|0|||
19799792|NCT02871791|42257862|FG000|Phase 2|Lost to Follow-up|2|||
19799793|NCT02871791|42257863|FG001|Phase 2|Lost to Follow-up|0|||
19799794|NCT02871635|42257871|FG000|Overall Study|Primary lack of efficacy|4|||
19799795|NCT02871635|42257872|FG001|Overall Study|Primary lack of efficacy|4|||
19799796|NCT02871635|42257871|FG000|Overall Study|Protocol Violation|3|||
19799797|NCT02871635|42257872|FG001|Overall Study|Protocol Violation|1|||
19799798|NCT02871635|42257871|FG000|Overall Study|Lost to Follow-up|1|||
19799799|NCT02871635|42257872|FG001|Overall Study|Lost to Follow-up|2|||
19799800|NCT02871635|42257871|FG000|Overall Study|Pregnancy|0|||
19799801|NCT02871635|42257872|FG001|Overall Study|Pregnancy|2|||
19799802|NCT02871635|42257871|FG000|Overall Study|Physician Decision|1|||
19799803|NCT02871635|42257872|FG001|Overall Study|Physician Decision|1|||
19799804|NCT02871635|42257871|FG000|Overall Study|Withdrawal by Subject|3|||
19799805|NCT02871635|42257872|FG001|Overall Study|Withdrawal by Subject|4|||
19609182|NCT00592683|42058271|FG000|Overall Study|Lost to Follow-up|0|||
19609183|NCT00592683|42058272|FG001|Overall Study|Lost to Follow-up|1|||
19700133|NCT00276458|42144951|FG001|Overall Study|Lost to Follow-up|2|||
19700134|NCT00276458|42144950|FG000|Overall Study|Protocol Violation|4|||
19700135|NCT00276458|42144951|FG001|Overall Study|Protocol Violation|3|||
19700136|NCT00276380|42144959|FG000|Overall Study|Adverse Event|5|||
19700137|NCT00276380|42144960|FG001|Overall Study|Adverse Event|3|||
19700138|NCT00276380|42144959|FG000|Overall Study|Lost to Follow-up|1|||
19700139|NCT00276380|42144960|FG001|Overall Study|Lost to Follow-up|1|||
19700140|NCT00276380|42144959|FG000|Overall Study|Withdrawal by Subject|3|||
19700141|NCT00276380|42144960|FG001|Overall Study|Withdrawal by Subject|6|||
19700142|NCT00276380|42144959|FG000|Overall Study|Death|5|||
19700143|NCT00276380|42144960|FG001|Overall Study|Death|3|||
19700144|NCT00276380|42144959|FG000|Overall Study|Abnormal aPPT Levels|0|||
19700145|NCT00276380|42144960|FG001|Overall Study|Abnormal aPPT Levels|1|||
19700146|NCT00267956|42144969|FG000|Controlled Period|Adverse Event|4|||
19700147|NCT00267956|42144970|FG001|Controlled Period|Adverse Event|1|||
19700148|NCT00267956|42144971|FG002|Controlled Period|Adverse Event|0|||
19700149|NCT00267956|42144972|FG003|Controlled Period|Adverse Event|0|||
19700150|NCT00267956|42144969|FG000|Controlled Period|Lack of Efficacy|4|||
19700151|NCT00267956|42144970|FG001|Controlled Period|Lack of Efficacy|2|||
19700152|NCT00267956|42144971|FG002|Controlled Period|Lack of Efficacy|0|||
19700153|NCT00267956|42144972|FG003|Controlled Period|Lack of Efficacy|0|||
19700154|NCT00267956|42144969|FG000|Controlled Period|Lost to Follow-up|2|||
19700155|NCT00267956|42144970|FG001|Controlled Period|Lost to Follow-up|0|||
19700156|NCT00267956|42144971|FG002|Controlled Period|Lost to Follow-up|0|||
19700157|NCT00267956|42144972|FG003|Controlled Period|Lost to Follow-up|0|||
19700158|NCT00267956|42144969|FG000|Controlled Period|Withdrew consent|3|||
19700159|NCT00267956|42144970|FG001|Controlled Period|Withdrew consent|1|||
19700160|NCT00267956|42144971|FG002|Controlled Period|Withdrew consent|0|||
19700161|NCT00267956|42144972|FG003|Controlled Period|Withdrew consent|0|||
19700162|NCT00267956|42144969|FG000|After Controlled Period|Adverse Event|0|||
19700163|NCT00267956|42144970|FG001|After Controlled Period|Adverse Event|0|||
19700164|NCT00267956|42144971|FG002|After Controlled Period|Adverse Event|2|||
19700165|NCT00267956|42144972|FG003|After Controlled Period|Adverse Event|1|||
19799806|NCT02871635|42257871|FG000|Overall Study|Adverse Event|4|||
19799807|NCT02871635|42257872|FG001|Overall Study|Adverse Event|4|||
19700166|NCT00267956|42144969|FG000|After Controlled Period|Lack of Efficacy|0|||
19700167|NCT00267956|42144970|FG001|After Controlled Period|Lack of Efficacy|0|||
19799808|NCT02871635|42257871|FG000|Overall Study|Secondary lack of efficacy|2|||
19799809|NCT02871635|42257872|FG001|Overall Study|Secondary lack of efficacy|1|||
19799810|NCT02477332|42257886|FG000|Overall Study|Adverse Event|0|||
19799811|NCT02477332|42257887|FG001|Overall Study|Adverse Event|1|||
19799812|NCT02477332|42257888|FG002|Overall Study|Adverse Event|1|||
19799813|NCT02477332|42257889|FG003|Overall Study|Adverse Event|2|||
19700168|NCT00267956|42144971|FG002|After Controlled Period|Lack of Efficacy|1|||
19700169|NCT00267956|42144972|FG003|After Controlled Period|Lack of Efficacy|1|||
19700170|NCT00267956|42144969|FG000|After Controlled Period|Lost to Follow-up|0|||
19700171|NCT00267956|42144970|FG001|After Controlled Period|Lost to Follow-up|0|||
19700172|NCT00267956|42144971|FG002|After Controlled Period|Lost to Follow-up|1|||
19700173|NCT00267956|42144972|FG003|After Controlled Period|Lost to Follow-up|0|||
19700174|NCT00267956|42144969|FG000|After Controlled Period|Withdrew consent|0|||
19700175|NCT00267956|42144970|FG001|After Controlled Period|Withdrew consent|0|||
19700176|NCT00267956|42144971|FG002|After Controlled Period|Withdrew consent|1|||
19700177|NCT00267956|42144972|FG003|After Controlled Period|Withdrew consent|0|||
19700178|NCT00267488|42144980|FG000|Overall Study|Sponsor Terminated Study|9|||
19700179|NCT00267488|42144980|FG000|Overall Study|Protocol Violation|1|||
19700180|NCT00267488|42144980|FG000|Overall Study|Other (Disease Progression)|1|||
19700181|NCT00046930|42144986|FG000|Overall Study|Ineligible|12|||
19700182|NCT00046930|42144987|FG001|Overall Study|Ineligible|4|||
19700183|NCT00058552|42144998|FG000|Overall Study|Died prior to receiving treatment|4|||
19700184|NCT00058552|42144999|FG001|Overall Study|Died prior to receiving treatment|2|||
19700185|NCT00058552|42144998|FG000|Overall Study|Disease progression|52|||
19700186|NCT00058552|42144999|FG001|Overall Study|Disease progression|44|||
19700187|NCT00058552|42144998|FG000|Overall Study|Adverse Event|4|||
19700188|NCT00058552|42144999|FG001|Overall Study|Adverse Event|2|||
19700189|NCT00058552|42144998|FG000|Overall Study|Withdrawal by Subject|3|||
19700190|NCT00058552|42144999|FG001|Overall Study|Withdrawal by Subject|5|||
19700191|NCT00058552|42144998|FG000|Overall Study|Physician Decision|2|||
19700192|NCT00058552|42144999|FG001|Overall Study|Physician Decision|5|||
19700193|NCT00058552|42144998|FG000|Overall Study|Clinical disease progression|0|||
19700194|NCT00058552|42144999|FG001|Overall Study|Clinical disease progression|4|||
19700195|NCT00044512|42145007|FG000|Follow Up|Lost to Follow-up|2|||
19700196|NCT03805438|42145011|FG000|Overall Study|Lack of Efficacy|1|||
19700197|NCT03805438|42145011|FG000|Overall Study|Protocol Violation|1|||
19700198|NCT00147537|42145019|FG000|Phase 1b|Death|0|||
19799814|NCT02477332|42257890|FG004|Overall Study|Adverse Event|1|||
19799815|NCT02477332|42257891|FG005|Overall Study|Adverse Event|2|||
19799816|NCT02477332|42257886|FG000|Overall Study|Lack of Efficacy|1|||
19799817|NCT02477332|42257887|FG001|Overall Study|Lack of Efficacy|2|||
19799818|NCT02477332|42257888|FG002|Overall Study|Lack of Efficacy|1|||
19799819|NCT02477332|42257889|FG003|Overall Study|Lack of Efficacy|2|||
19799820|NCT02477332|42257890|FG004|Overall Study|Lack of Efficacy|1|||
19799821|NCT02477332|42257891|FG005|Overall Study|Lack of Efficacy|1|||
19799822|NCT02477332|42257886|FG000|Overall Study|Non-compliance with study treatment|0|||
19700199|NCT00147537|42145020|FG001|Phase 1b|Death|1|||
19700200|NCT00147537|42145021|FG002|Phase 1b|Death|2|||
19700201|NCT00147537|42145022|FG003|Phase 1b|Death|1|||
19700202|NCT00147537|42145023|FG004|Phase 1b|Death|2|||
19700203|NCT00147537|42145024|FG005|Phase 1b|Death|2|||
19700204|NCT00147537|42145025|FG006|Phase 1b|Death|1|||
19700205|NCT00147537|42145026|FG007|Phase 1b|Death|3|||
19700206|NCT00147537|42145027|FG008|Phase 1b|Death|9|||
19700207|NCT00147537|42145028|FG009|Phase 1b|Death|0|||
19799823|NCT02477332|42257887|FG001|Overall Study|Non-compliance with study treatment|1|||
19799824|NCT02477332|42257888|FG002|Overall Study|Non-compliance with study treatment|2|||
19799825|NCT02477332|42257889|FG003|Overall Study|Non-compliance with study treatment|0|||
19799826|NCT02477332|42257890|FG004|Overall Study|Non-compliance with study treatment|0|||
19799827|NCT02477332|42257891|FG005|Overall Study|Non-compliance with study treatment|0|||
19799828|NCT02477332|42257886|FG000|Overall Study|Pregnancy|0|||
19609184|NCT00847665|42058280|FG000|Overall Study|Withdrawal by Subject|1|||
19609185|NCT00847665|42058281|FG001|Overall Study|Withdrawal by Subject|0|||
19609186|NCT00916370|42058289|FG000|Overall Study|Death|3|||
19609187|NCT00916370|42058290|FG001|Overall Study|Death|1|||
19609188|NCT00916370|42058289|FG000|Overall Study|Withdrawal by Subject|2|||
19609189|NCT00916370|42058290|FG001|Overall Study|Withdrawal by Subject|0|||
19609190|NCT00916370|42058289|FG000|Overall Study|Physician Decision|0|||
19609191|NCT00916370|42058290|FG001|Overall Study|Physician Decision|1|||
19609192|NCT00847197|42058299|FG000|Overall Study|Adverse Event|21|||
19609193|NCT00847197|42058300|FG001|Overall Study|Adverse Event|3|||
19609194|NCT00847197|42058299|FG000|Overall Study|Protocol Violation|0|||
19700208|NCT00147537|42145029|FG010|Phase 1b|Death|0|||
19700209|NCT00147537|42145019|FG000|Phase 1b|Lost to Follow-up|2|||
19700210|NCT00147537|42145020|FG001|Phase 1b|Lost to Follow-up|1|||
19700211|NCT00147537|42145021|FG002|Phase 1b|Lost to Follow-up|0|||
19700212|NCT00147537|42145022|FG003|Phase 1b|Lost to Follow-up|0|||
19700213|NCT00147537|42145023|FG004|Phase 1b|Lost to Follow-up|0|||
19799829|NCT02477332|42257887|FG001|Overall Study|Pregnancy|0|||
19799830|NCT02477332|42257888|FG002|Overall Study|Pregnancy|0|||
19609195|NCT00847197|42058300|FG001|Overall Study|Protocol Violation|1|||
19609196|NCT00847197|42058299|FG000|Overall Study|Withdrawal by Subject|3|||
19609197|NCT00847197|42058300|FG001|Overall Study|Withdrawal by Subject|1|||
19700214|NCT00147537|42145024|FG005|Phase 1b|Lost to Follow-up|0|||
19700215|NCT00147537|42145025|FG006|Phase 1b|Lost to Follow-up|2|||
19799831|NCT02477332|42257889|FG003|Overall Study|Pregnancy|1|||
19700216|NCT00147537|42145026|FG007|Phase 1b|Lost to Follow-up|0|||
19700217|NCT00147537|42145027|FG008|Phase 1b|Lost to Follow-up|1|||
19700218|NCT00147537|42145028|FG009|Phase 1b|Lost to Follow-up|0|||
19700219|NCT00147537|42145029|FG010|Phase 1b|Lost to Follow-up|0|||
19700220|NCT00147537|42145019|FG000|Phase 1b|Other|0|||
19700221|NCT00147537|42145020|FG001|Phase 1b|Other|0|||
19700222|NCT00147537|42145021|FG002|Phase 1b|Other|2|||
19700223|NCT00147537|42145022|FG003|Phase 1b|Other|1|||
19700224|NCT00147537|42145023|FG004|Phase 1b|Other|1|||
19700225|NCT00147537|42145024|FG005|Phase 1b|Other|1|||
19700226|NCT00147537|42145025|FG006|Phase 1b|Other|14|||
19700227|NCT00147537|42145026|FG007|Phase 1b|Other|4|||
19700228|NCT00147537|42145027|FG008|Phase 1b|Other|4|||
19700229|NCT00147537|42145028|FG009|Phase 1b|Other|0|||
19700230|NCT00147537|42145029|FG010|Phase 1b|Other|0|||
19700231|NCT00147537|42145019|FG000|Phase 1b|Withdrawal by Subject|0|||
19700232|NCT00147537|42145020|FG001|Phase 1b|Withdrawal by Subject|0|||
19700233|NCT00147537|42145021|FG002|Phase 1b|Withdrawal by Subject|0|||
19700234|NCT00147537|42145022|FG003|Phase 1b|Withdrawal by Subject|0|||
19700235|NCT00147537|42145023|FG004|Phase 1b|Withdrawal by Subject|0|||
19700236|NCT00147537|42145024|FG005|Phase 1b|Withdrawal by Subject|0|||
19700237|NCT00147537|42145025|FG006|Phase 1b|Withdrawal by Subject|0|||
19700238|NCT00147537|42145026|FG007|Phase 1b|Withdrawal by Subject|0|||
19700239|NCT00147537|42145027|FG008|Phase 1b|Withdrawal by Subject|2|||
19700240|NCT00147537|42145028|FG009|Phase 1b|Withdrawal by Subject|0|||
19609198|NCT00654901|42058310|FG000|Overall Study|Lost to Follow-up|1|||
19609199|NCT00654901|42058311|FG001|Overall Study|Lost to Follow-up|0|||
19609200|NCT00654901|42058312|FG002|Overall Study|Lost to Follow-up|1|||
19609201|NCT00654901|42058313|FG003|Overall Study|Lost to Follow-up|0|||
19609202|NCT00654901|42058310|FG000|Overall Study|Withdrawal by Subject|3|||
19609203|NCT00654901|42058311|FG001|Overall Study|Withdrawal by Subject|0|||
19609204|NCT00654901|42058312|FG002|Overall Study|Withdrawal by Subject|1|||
19609205|NCT00654901|42058313|FG003|Overall Study|Withdrawal by Subject|0|||
19609206|NCT00846807|42058323|FG000|Overall Study|Adverse Event|270|||
19609207|NCT00846807|42058323|FG000|Overall Study|Lost to Follow-up|94|||
19609208|NCT00846807|42058323|FG000|Overall Study|Withdrawal by Subject|56|||
19609209|NCT00846807|42058323|FG000|Overall Study|Non compliant with European label|7|||
19609210|NCT00846807|42058323|FG000|Overall Study|Switch to other anticoagulants|89|||
19609211|NCT00846807|42058323|FG000|Overall Study|No prescription after hospital discharge|56|||
19609212|NCT00846807|42058323|FG000|Overall Study|Other|60|||
19609213|NCT00846495|42058329|FG000|Overall Study|Lost to Follow-up|1|||
19609214|NCT00846495|42058330|FG001|Overall Study|Lost to Follow-up|0|||
19609215|NCT00846495|42058329|FG000|Overall Study|Adverse Event|5|||
19609216|NCT00846495|42058330|FG001|Overall Study|Adverse Event|1|||
19609217|NCT00846495|42058329|FG000|Overall Study|Lack of Efficacy|1|||
19609218|NCT00846495|42058330|FG001|Overall Study|Lack of Efficacy|2|||
19609219|NCT00846495|42058329|FG000|Overall Study|Physician Decision|1|||
19609220|NCT00846495|42058330|FG001|Overall Study|Physician Decision|0|||
19609221|NCT00654745|42058336|FG000|Overall Study|Adverse Event|12|||
19609222|NCT00654745|42058336|FG000|Overall Study|Lost to Follow-up|7|||
19609223|NCT00654745|42058336|FG000|Overall Study|Protocol Violation|11|||
19609224|NCT00654745|42058336|FG000|Overall Study|Withdrawal by Subject|10|||
19609225|NCT00654745|42058336|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
19609226|NCT00846027|42058346|FG000|Overall Study|Death|3|||
19609227|NCT00846027|42058346|FG000|Overall Study|Disease Progression|30|||
19609228|NCT00846027|42058346|FG000|Overall Study|Toxicity|12|||
19609229|NCT00846027|42058346|FG000|Overall Study|Patient Decision|7|||
19609230|NCT00846027|42058346|FG000|Overall Study|Investigator Discretion|29|||
19609231|NCT00846027|42058346|FG000|Overall Study|Protocol Violation|2|||
19609232|NCT00846027|42058346|FG000|Overall Study|Subject Not Treated|7|||
19609233|NCT00646399|42058352|FG000|Overall Study|Death|63|||
19609234|NCT00646399|42058353|FG001|Overall Study|Death|53|||
19609235|NCT00646399|42058352|FG000|Overall Study|Withdrawal by Subject|9|||
19609236|NCT00646399|42058353|FG001|Overall Study|Withdrawal by Subject|10|||
19609237|NCT00646399|42058352|FG000|Overall Study|Other Reason|11|||
19700241|NCT00147537|42145029|FG010|Phase 1b|Withdrawal by Subject|0|||
19700242|NCT00147537|42145019|FG000|Phase 1b|Randomized but not treated|0|||
19700243|NCT00147537|42145020|FG001|Phase 1b|Randomized but not treated|0|||
19700244|NCT00147537|42145021|FG002|Phase 1b|Randomized but not treated|0|||
19609238|NCT00646399|42058353|FG001|Overall Study|Other Reason|11|||
19609239|NCT00652327|42058361|FG000|Overall Study|Adverse Event|0|||
19609240|NCT00652327|42058362|FG001|Overall Study|Adverse Event|2|||
19609241|NCT00652327|42058361|FG000|Overall Study|Lost to Follow-up|0|||
19609242|NCT00652327|42058362|FG001|Overall Study|Lost to Follow-up|3|||
19609243|NCT00645853|42058370|FG000|Overall Study|Adverse Event|18|||
19609244|NCT00645853|42058371|FG001|Overall Study|Adverse Event|7|||
19609245|NCT00645853|42058370|FG000|Overall Study|AZ study closure in Hungary|60|||
19609246|NCT00645853|42058371|FG001|Overall Study|AZ study closure in Hungary|40|||
19609247|NCT00645853|42058370|FG000|Overall Study|Withdrawal by Subject|5|||
19700245|NCT00147537|42145022|FG003|Phase 1b|Randomized but not treated|0|||
19700246|NCT00147537|42145023|FG004|Phase 1b|Randomized but not treated|0|||
19799832|NCT02477332|42257890|FG004|Overall Study|Pregnancy|0|||
19799833|NCT02477332|42257891|FG005|Overall Study|Pregnancy|0|||
19799834|NCT02477332|42257886|FG000|Overall Study|Protocol Violation|2|||
19799835|NCT02477332|42257887|FG001|Overall Study|Protocol Violation|0|||
19799836|NCT02477332|42257888|FG002|Overall Study|Protocol Violation|3|||
19799837|NCT02477332|42257889|FG003|Overall Study|Protocol Violation|3|||
19799838|NCT02477332|42257890|FG004|Overall Study|Protocol Violation|1|||
19799839|NCT02477332|42257891|FG005|Overall Study|Protocol Violation|1|||
19799840|NCT02477332|42257886|FG000|Overall Study|Technical problems|0|||
19799841|NCT02477332|42257887|FG001|Overall Study|Technical problems|0|||
19799842|NCT02477332|42257888|FG002|Overall Study|Technical problems|1|||
19799843|NCT02477332|42257889|FG003|Overall Study|Technical problems|0|||
19799844|NCT02477332|42257890|FG004|Overall Study|Technical problems|0|||
19799845|NCT02477332|42257891|FG005|Overall Study|Technical problems|0|||
19799846|NCT02477332|42257886|FG000|Overall Study|Lost to Follow-up|0|||
19799847|NCT02477332|42257887|FG001|Overall Study|Lost to Follow-up|0|||
19799848|NCT02477332|42257888|FG002|Overall Study|Lost to Follow-up|2|||
19799849|NCT02477332|42257889|FG003|Overall Study|Lost to Follow-up|0|||
19799850|NCT02477332|42257890|FG004|Overall Study|Lost to Follow-up|0|||
19799851|NCT02477332|42257891|FG005|Overall Study|Lost to Follow-up|0|||
19799852|NCT02477332|42257886|FG000|Overall Study|Physician Decision|0|||
19799853|NCT02477332|42257887|FG001|Overall Study|Physician Decision|0|||
19799854|NCT02477332|42257888|FG002|Overall Study|Physician Decision|1|||
19799855|NCT02477332|42257889|FG003|Overall Study|Physician Decision|3|||
19799856|NCT02477332|42257890|FG004|Overall Study|Physician Decision|0|||
19799857|NCT02477332|42257891|FG005|Overall Study|Physician Decision|1|||
19799858|NCT02477332|42257886|FG000|Overall Study|Withdrawal by Subject|0|||
19799859|NCT02477332|42257887|FG001|Overall Study|Withdrawal by Subject|3|||
19799860|NCT02477332|42257888|FG002|Overall Study|Withdrawal by Subject|1|||
19799861|NCT02477332|42257889|FG003|Overall Study|Withdrawal by Subject|2|||
19799862|NCT02477332|42257890|FG004|Overall Study|Withdrawal by Subject|1|||
19799863|NCT02477332|42257891|FG005|Overall Study|Withdrawal by Subject|0|||
19799864|NCT02477020|42257909|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
19799865|NCT02477020|42257910|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
19799866|NCT02477020|42257909|FG000|Overall Study|Voluntary Withdrawal|7|||
19799867|NCT02477020|42257910|FG001|Overall Study|Voluntary Withdrawal|16|||
19799868|NCT02477020|42257909|FG000|Overall Study|Reason not Specified|3|||
19799869|NCT02477020|42257910|FG001|Overall Study|Reason not Specified|1|||
19799870|NCT02477020|42257909|FG000|Overall Study|Lack of Efficacy|14|||
19799871|NCT02477020|42257910|FG001|Overall Study|Lack of Efficacy|5|||
19799872|NCT02862535|42257920|FG000|Overall Study|Death|7|||
19799873|NCT02862535|42257921|FG001|Overall Study|Death|3|||
19799874|NCT02862535|42257922|FG002|Overall Study|Death|2|||
19799875|NCT02862535|42257923|FG003|Overall Study|Death|5|||
19799876|NCT02862535|42257920|FG000|Overall Study|Study Terminated by Sponsor|1|||
19799877|NCT02862535|42257921|FG001|Overall Study|Study Terminated by Sponsor|3|||
19799878|NCT02862535|42257922|FG002|Overall Study|Study Terminated by Sponsor|8|||
19799879|NCT02862535|42257923|FG003|Overall Study|Study Terminated by Sponsor|5|||
19799880|NCT02862535|42257920|FG000|Overall Study|Enrolled, not Treated|1|||
19799881|NCT02862535|42257921|FG001|Overall Study|Enrolled, not Treated|0|||
19799882|NCT02862535|42257922|FG002|Overall Study|Enrolled, not Treated|0|||
19799883|NCT02862535|42257923|FG003|Overall Study|Enrolled, not Treated|1|||
19799884|NCT02448706|42257933|FG000|Overall Study|Withdrawal by Subject|4|||
19799885|NCT02448706|42257934|FG001|Overall Study|Withdrawal by Subject|3|||
19700247|NCT00147537|42145024|FG005|Phase 1b|Randomized but not treated|0|||
19700248|NCT00147537|42145025|FG006|Phase 1b|Randomized but not treated|1|||
19700249|NCT00147537|42145026|FG007|Phase 1b|Randomized but not treated|0|||
19700250|NCT00147537|42145027|FG008|Phase 1b|Randomized but not treated|1|||
19700251|NCT00147537|42145028|FG009|Phase 1b|Randomized but not treated|0|||
19700252|NCT00147537|42145029|FG010|Phase 1b|Randomized but not treated|0|||
19700253|NCT00147537|42145019|FG000|Phase 2|Death|0|||
19700254|NCT00147537|42145020|FG001|Phase 2|Death|0|||
19700255|NCT00147537|42145021|FG002|Phase 2|Death|0|||
19700256|NCT00147537|42145022|FG003|Phase 2|Death|0|||
19799886|NCT02448706|42257933|FG000|Overall Study|Protocol Violation|1|||
19799887|NCT02448706|42257934|FG001|Overall Study|Protocol Violation|1|||
19799888|NCT02868281|42257944|FG000|Overall Study|Adverse Event|2|||
19799889|NCT02868281|42257945|FG001|Overall Study|Adverse Event|2|||
19799890|NCT02868281|42257944|FG000|Overall Study|Protocol Violation|13|||
19799891|NCT02868281|42257945|FG001|Overall Study|Protocol Violation|10|||
19799892|NCT02868281|42257944|FG000|Overall Study|Lost to Follow-up|3|||
19799893|NCT02868281|42257945|FG001|Overall Study|Lost to Follow-up|6|||
19799894|NCT02868281|42257944|FG000|Overall Study|Withdrawal by Subject|11|||
19799895|NCT02868281|42257945|FG001|Overall Study|Withdrawal by Subject|15|||
19799896|NCT02868281|42257944|FG000|Overall Study|Physician Decision|2|||
19799897|NCT02868281|42257945|FG001|Overall Study|Physician Decision|0|||
19799898|NCT02868281|42257944|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
19799899|NCT02868281|42257945|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
19799900|NCT02868281|42257944|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
19799901|NCT02868281|42257945|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
19799902|NCT02868281|42257944|FG000|Overall Study|Long journey/moving away|1|||
19700257|NCT00147537|42145023|FG004|Phase 2|Death|0|||
19700258|NCT00147537|42145024|FG005|Phase 2|Death|0|||
19700259|NCT00147537|42145025|FG006|Phase 2|Death|0|||
19700260|NCT00147537|42145026|FG007|Phase 2|Death|0|||
19700261|NCT00147537|42145027|FG008|Phase 2|Death|0|||
19700262|NCT00147537|42145028|FG009|Phase 2|Death|85|||
19700263|NCT00147537|42145029|FG010|Phase 2|Death|31|||
19700264|NCT00147537|42145019|FG000|Phase 2|Lost to Follow-up|0|||
19700265|NCT00147537|42145020|FG001|Phase 2|Lost to Follow-up|0|||
19700266|NCT00147537|42145021|FG002|Phase 2|Lost to Follow-up|0|||
19700267|NCT00147537|42145022|FG003|Phase 2|Lost to Follow-up|0|||
19700268|NCT00147537|42145023|FG004|Phase 2|Lost to Follow-up|0|||
19700269|NCT00147537|42145024|FG005|Phase 2|Lost to Follow-up|0|||
19700270|NCT00147537|42145025|FG006|Phase 2|Lost to Follow-up|0|||
19700271|NCT00147537|42145026|FG007|Phase 2|Lost to Follow-up|0|||
19700272|NCT00147537|42145027|FG008|Phase 2|Lost to Follow-up|0|||
19700273|NCT00147537|42145028|FG009|Phase 2|Lost to Follow-up|12|||
19700274|NCT00147537|42145029|FG010|Phase 2|Lost to Follow-up|4|||
19700275|NCT00147537|42145019|FG000|Phase 2|Other|0|||
19700276|NCT00147537|42145020|FG001|Phase 2|Other|0|||
19700277|NCT00147537|42145021|FG002|Phase 2|Other|0|||
19700278|NCT00147537|42145022|FG003|Phase 2|Other|0|||
19700279|NCT00147537|42145023|FG004|Phase 2|Other|0|||
19609248|NCT00645853|42058371|FG001|Overall Study|Withdrawal by Subject|2|||
19609249|NCT00645853|42058370|FG000|Overall Study|Protocol Violation|0|||
19609250|NCT00645853|42058371|FG001|Overall Study|Protocol Violation|2|||
19609251|NCT00645853|42058370|FG000|Overall Study|Discontinuation criteria|2|||
19609252|NCT00645853|42058371|FG001|Overall Study|Discontinuation criteria|2|||
19609253|NCT00645853|42058370|FG000|Overall Study|recall of ICF, planned operation, death|7|||
19609254|NCT00645853|42058371|FG001|Overall Study|recall of ICF, planned operation, death|4|||
19609255|NCT00652093|42058383|FG000|Overall Study|Withdrawal by Subject|0|||
19609256|NCT00652093|42058384|FG001|Overall Study|Withdrawal by Subject|0|||
19609257|NCT00652093|42058385|FG002|Overall Study|Withdrawal by Subject|1|||
19609258|NCT00652093|42058386|FG003|Overall Study|Withdrawal by Subject|0|||
19609259|NCT00652093|42058387|FG004|Overall Study|Withdrawal by Subject|1|||
19609260|NCT00652093|42058388|FG005|Overall Study|Withdrawal by Subject|0|||
19609261|NCT00652093|42058383|FG000|Overall Study|Physician Decision|0|||
19609262|NCT00652093|42058384|FG001|Overall Study|Physician Decision|0|||
19609263|NCT00652093|42058385|FG002|Overall Study|Physician Decision|0|||
19609264|NCT00652093|42058386|FG003|Overall Study|Physician Decision|0|||
19609265|NCT00652093|42058387|FG004|Overall Study|Physician Decision|1|||
19609266|NCT00652093|42058388|FG005|Overall Study|Physician Decision|0|||
19609267|NCT00651937|42058404|FG000|Overall Study|Withdrawal by Subject|4|||
19609268|NCT00651937|42058405|FG001|Overall Study|Withdrawal by Subject|1|||
19609269|NCT00654355|42058413|FG000|Overall Study|Lost to Follow-up|2|||
19609270|NCT00654355|42058414|FG001|Overall Study|Lost to Follow-up|2|||
19609271|NCT00651313|42058422|FG000|Overall Study|Adverse Event|0|||
19609272|NCT00651313|42058423|FG001|Overall Study|Adverse Event|1|||
19609273|NCT00651313|42058422|FG000|Overall Study|Withdrawal by Subject|3|||
19609274|NCT00651313|42058423|FG001|Overall Study|Withdrawal by Subject|1|||
19609275|NCT00651313|42058422|FG000|Overall Study|Lost to Follow-up|1|||
19609276|NCT00651313|42058423|FG001|Overall Study|Lost to Follow-up|1|||
19609277|NCT00651313|42058422|FG000|Overall Study|Adminstrative Discontinuation|2|||
19609278|NCT00651313|42058423|FG001|Overall Study|Adminstrative Discontinuation|3|||
19609279|NCT00969761|42058441|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
19700280|NCT00147537|42145024|FG005|Phase 2|Other|0|||
19700281|NCT00147537|42145025|FG006|Phase 2|Other|0|||
19700282|NCT00147537|42145026|FG007|Phase 2|Other|0|||
19700283|NCT00147537|42145027|FG008|Phase 2|Other|0|||
19700284|NCT00147537|42145028|FG009|Phase 2|Other|47|||
19700285|NCT00147537|42145029|FG010|Phase 2|Other|12|||
19700286|NCT00147537|42145019|FG000|Phase 2|Withdrawal by Subject|0|||
19700287|NCT00147537|42145020|FG001|Phase 2|Withdrawal by Subject|0|||
19700288|NCT00147537|42145021|FG002|Phase 2|Withdrawal by Subject|0|||
19700289|NCT00147537|42145022|FG003|Phase 2|Withdrawal by Subject|0|||
19700290|NCT00147537|42145023|FG004|Phase 2|Withdrawal by Subject|0|||
19700291|NCT00147537|42145024|FG005|Phase 2|Withdrawal by Subject|0|||
19478388|NCT01691612|41757666|FG000|Overall Study|deemed ineligible after 1st visit|6|||
19478389|NCT01691612|41757666|FG000|Overall Study|Adverse Event|1|||
19700292|NCT00147537|42145025|FG006|Phase 2|Withdrawal by Subject|0|||
19609280|NCT00969761|42058442|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609281|NCT00969761|42058443|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609282|NCT00969761|42058444|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
19609283|NCT00969761|42058445|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19700293|NCT00147537|42145026|FG007|Phase 2|Withdrawal by Subject|0|||
19700294|NCT00147537|42145027|FG008|Phase 2|Withdrawal by Subject|0|||
19700295|NCT00147537|42145028|FG009|Phase 2|Withdrawal by Subject|16|||
19700296|NCT00147537|42145029|FG010|Phase 2|Withdrawal by Subject|4|||
19700297|NCT00147537|42145019|FG000|Phase 2|Randomized but not treated|0|||
19609284|NCT00969761|42058446|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609285|NCT00969761|42058447|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609286|NCT00969761|42058448|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609287|NCT00969761|42058449|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
19609288|NCT00969761|42058450|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
19609289|NCT00969761|42058451|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19609290|NCT00969761|42058452|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
19700298|NCT00147537|42145020|FG001|Phase 2|Randomized but not treated|0|||
19700299|NCT00147537|42145021|FG002|Phase 2|Randomized but not treated|0|||
19700300|NCT00147537|42145022|FG003|Phase 2|Randomized but not treated|0|||
19700301|NCT00147537|42145023|FG004|Phase 2|Randomized but not treated|0|||
19700302|NCT00147537|42145024|FG005|Phase 2|Randomized but not treated|0|||
19700303|NCT00147537|42145025|FG006|Phase 2|Randomized but not treated|0|||
19700304|NCT00147537|42145026|FG007|Phase 2|Randomized but not treated|0|||
19700305|NCT00147537|42145027|FG008|Phase 2|Randomized but not treated|0|||
19700306|NCT00147537|42145028|FG009|Phase 2|Randomized but not treated|1|||
19700307|NCT00147537|42145029|FG010|Phase 2|Randomized but not treated|1|||
19700308|NCT00222729|42145074|FG000|Overall Study|Adverse Event|3|||
19700309|NCT00147225|42145084|FG000|Overall Study|Withdrawal by Subject|1|||
19700310|NCT00147225|42145085|FG001|Overall Study|Withdrawal by Subject|0|||
19700311|NCT00147225|42145086|FG002|Overall Study|Withdrawal by Subject|1|||
19478390|NCT01565564|41757672|FG000|Overall Study|Lost to Follow-up|5|||
19478391|NCT01565564|41757673|FG001|Overall Study|Lost to Follow-up|1|||
19478392|NCT01460407|41757679|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
19478393|NCT01460407|41757680|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
19478394|NCT01502371|41757692|FG000|Overall Study|Withdrawal by Subject|1|||
19478395|NCT01502371|41757693|FG001|Overall Study|Withdrawal by Subject|2|||
19478396|NCT01502371|41757694|FG002|Overall Study|Withdrawal by Subject|1|||
19478397|NCT01502371|41757695|FG003|Overall Study|Withdrawal by Subject|1|||
19478398|NCT01502371|41757696|FG004|Overall Study|Withdrawal by Subject|1|||
19478399|NCT01502371|41757692|FG000|Overall Study|Adverse Event|2|||
19478400|NCT01502371|41757693|FG001|Overall Study|Adverse Event|1|||
19478401|NCT01502371|41757694|FG002|Overall Study|Adverse Event|0|||
19700312|NCT00147225|42145087|FG003|Overall Study|Withdrawal by Subject|0|||
19700313|NCT00147225|42145088|FG004|Overall Study|Withdrawal by Subject|0|||
19700314|NCT00147225|42145089|FG005|Overall Study|Withdrawal by Subject|1|||
19700315|NCT00147225|42145084|FG000|Overall Study|Adverse Event|0|||
19700316|NCT00147225|42145085|FG001|Overall Study|Adverse Event|0|||
19700317|NCT00147225|42145086|FG002|Overall Study|Adverse Event|1|||
19700318|NCT00147225|42145087|FG003|Overall Study|Adverse Event|1|||
19700319|NCT00147225|42145088|FG004|Overall Study|Adverse Event|0|||
19700320|NCT00147225|42145089|FG005|Overall Study|Adverse Event|0|||
19700321|NCT00147225|42145084|FG000|Overall Study|Screen Failure|0|||
19700322|NCT00147225|42145085|FG001|Overall Study|Screen Failure|0|||
19700323|NCT00147225|42145086|FG002|Overall Study|Screen Failure|0|||
19700324|NCT00147225|42145087|FG003|Overall Study|Screen Failure|0|||
19700325|NCT00147225|42145088|FG004|Overall Study|Screen Failure|1|||
19700326|NCT00147225|42145089|FG005|Overall Study|Screen Failure|0|||
19700327|NCT00147225|42145084|FG000|Overall Study|Chemotherapy Changed|0|||
19700328|NCT00147225|42145085|FG001|Overall Study|Chemotherapy Changed|0|||
19700329|NCT00147225|42145086|FG002|Overall Study|Chemotherapy Changed|0|||
19700330|NCT00147225|42145087|FG003|Overall Study|Chemotherapy Changed|0|||
19700331|NCT00147225|42145088|FG004|Overall Study|Chemotherapy Changed|0|||
19700332|NCT00147225|42145089|FG005|Overall Study|Chemotherapy Changed|1|||
19700333|NCT00222105|42145103|FG000|Overall Study|Removed due to wrong diagnosis|1|||
19700334|NCT00222105|42145103|FG000|Overall Study|Withdrawal by Subject|1|||
19700335|NCT00222105|42145103|FG000|Overall Study|Adverse Event|8|||
19700336|NCT00222105|42145103|FG000|Overall Study|Treatment delays|2|||
19700337|NCT00222105|42145103|FG000|Overall Study|Death|2|||
19700338|NCT00146757|42145107|FG000|Overall Study|Death|1|||
19700339|NCT00146757|42145108|FG001|Overall Study|Death|0|||
19700340|NCT00146757|42145107|FG000|Overall Study|Adverse Event|1|||
19700341|NCT00146757|42145108|FG001|Overall Study|Adverse Event|0|||
19700342|NCT00267098|42145122|FG000|Overall Study|Death|0|||
19700343|NCT00267098|42145123|FG001|Overall Study|Death|0|||
19700344|NCT00267098|42145124|FG002|Overall Study|Death|57|||
19700345|NCT00267098|42145125|FG003|Overall Study|Death|66|||
19700346|NCT00267098|42145126|FG004|Overall Study|Death|14|||
19700347|NCT00267098|42145127|FG005|Overall Study|Death|23|||
19700348|NCT00267098|42145128|FG006|Overall Study|Death|28|||
19700349|NCT00267098|42145129|FG007|Overall Study|Death|9|||
19700350|NCT00267098|42145122|FG000|Overall Study|Lost to Follow-up|0|||
19700351|NCT00267098|42145123|FG001|Overall Study|Lost to Follow-up|0|||
19700352|NCT00267098|42145124|FG002|Overall Study|Lost to Follow-up|6|||
19799903|NCT02868281|42257945|FG001|Overall Study|Long journey/moving away|1|||
19700353|NCT00267098|42145125|FG003|Overall Study|Lost to Follow-up|5|||
19478402|NCT01502371|41757695|FG003|Overall Study|Adverse Event|4|||
19799904|NCT02476006|42257951|FG000|Overall Study|Death|4|||
19799905|NCT02476006|42257951|FG000|Overall Study|Lack of treatment efficacy|2|||
19799906|NCT02476006|42257951|FG000|Overall Study|Pregnancy|1|||
19799907|NCT02476006|42257951|FG000|Overall Study|Participant did not wish to continue|39|||
19799908|NCT02476006|42257951|FG000|Overall Study|Adverse Event|41|||
19799909|NCT02476006|42257951|FG000|Overall Study|Poor compliance to study protocol|3|||
19799910|NCT02476006|42257951|FG000|Overall Study|Sponsor decision|6|||
19799911|NCT02476006|42257951|FG000|Overall Study|Lost to Follow-up|5|||
19799912|NCT02476006|42257951|FG000|Overall Study|Physician Decision|5|||
19799913|NCT02476006|42257951|FG000|Overall Study|Study ended treatment not available|4|||
19799914|NCT02476006|42257951|FG000|Overall Study|Switched to commercial drug|4|||
19799915|NCT02476006|42257951|FG000|Overall Study|Excluded from study|1|||
19799916|NCT02476006|42257951|FG000|Overall Study|Protocol Violation|1|||
19799917|NCT02476006|42257951|FG000|Overall Study|Enrolled but not treated|4|||
19799918|NCT02475850|42257957|FG000|Overall Study|Death|155|||
19799919|NCT02475850|42257958|FG001|Overall Study|Death|141|||
19799920|NCT02475850|42257957|FG000|Overall Study|Lost to Follow-up|217|||
19799921|NCT02475850|42257958|FG001|Overall Study|Lost to Follow-up|188|||
19799922|NCT02475850|42257957|FG000|Overall Study|Withdrawal by Subject|221|||
19799923|NCT02475850|42257958|FG001|Overall Study|Withdrawal by Subject|155|||
19799924|NCT02419612|42257967|FG000|Short-term Treatment Period|Adverse Event|1|||
19799925|NCT02419612|42257968|FG001|Short-term Treatment Period|Adverse Event|1|||
19799926|NCT02419612|42257967|FG000|Short-term Treatment Period|Death|0|||
19799927|NCT02419612|42257968|FG001|Short-term Treatment Period|Death|2|||
19799928|NCT02419612|42257967|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
19799929|NCT02419612|42257968|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
19799930|NCT02419612|42257967|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
19799931|NCT02419612|42257968|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
19799932|NCT02419612|42257967|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
19799933|NCT02419612|42257968|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
19799934|NCT02419612|42257967|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
19799935|NCT02419612|42257968|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
19799936|NCT02419612|42257967|FG000|Short-term Treatment Period|Worsening of liver function|0|||
19799937|NCT02419612|42257968|FG001|Short-term Treatment Period|Worsening of liver function|1|||
19799938|NCT02419612|42257967|FG000|Short-term Treatment Period|Subject moved out of state|0|||
19799939|NCT02419612|42257968|FG001|Short-term Treatment Period|Subject moved out of state|1|||
19799940|NCT02419612|42257967|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
19799941|NCT02419612|42257968|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
19799942|NCT02419612|42257967|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
19799943|NCT02419612|42257968|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
19700354|NCT00267098|42145126|FG004|Overall Study|Lost to Follow-up|2|||
19700355|NCT00267098|42145127|FG005|Overall Study|Lost to Follow-up|3|||
19700356|NCT00267098|42145128|FG006|Overall Study|Lost to Follow-up|1|||
19700357|NCT00267098|42145129|FG007|Overall Study|Lost to Follow-up|1|||
19700358|NCT00267098|42145122|FG000|Overall Study|Withdrawal by Subject|8|||
19700359|NCT00267098|42145123|FG001|Overall Study|Withdrawal by Subject|0|||
19700360|NCT00267098|42145124|FG002|Overall Study|Withdrawal by Subject|24|||
19700361|NCT00267098|42145125|FG003|Overall Study|Withdrawal by Subject|21|||
19700362|NCT00267098|42145126|FG004|Overall Study|Withdrawal by Subject|12|||
19700363|NCT00267098|42145127|FG005|Overall Study|Withdrawal by Subject|9|||
19700364|NCT00267098|42145128|FG006|Overall Study|Withdrawal by Subject|12|||
19700365|NCT00267098|42145129|FG007|Overall Study|Withdrawal by Subject|5|||
19700366|NCT00267098|42145122|FG000|Overall Study|Physician Decision|5|||
19700367|NCT00267098|42145123|FG001|Overall Study|Physician Decision|0|||
19700368|NCT00267098|42145124|FG002|Overall Study|Physician Decision|7|||
19700369|NCT00267098|42145125|FG003|Overall Study|Physician Decision|11|||
19700370|NCT00267098|42145126|FG004|Overall Study|Physician Decision|5|||
19700371|NCT00267098|42145127|FG005|Overall Study|Physician Decision|4|||
19700372|NCT00267098|42145128|FG006|Overall Study|Physician Decision|3|||
19700373|NCT00267098|42145129|FG007|Overall Study|Physician Decision|0|||
19700374|NCT00267098|42145122|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
19799944|NCT02419612|42257967|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
19799945|NCT02419612|42257968|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
19799946|NCT02419612|42257967|FG000|Long-term Treatment Period|Death|0|||
19799947|NCT02419612|42257968|FG001|Long-term Treatment Period|Death|1|||
19799948|NCT02419612|42257967|FG000|Long-term Treatment Period|Adverse Event|0|||
19799949|NCT02419612|42257968|FG001|Long-term Treatment Period|Adverse Event|5|||
19799950|NCT02419612|42257967|FG000|Long-term Treatment Period|Other|4|||
19799951|NCT02419612|42257968|FG001|Long-term Treatment Period|Other|4|||
19799952|NCT02419612|42257967|FG000|Long-term Treatment Period|Subject Decision|2|||
19700375|NCT00267098|42145123|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700376|NCT00267098|42145124|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700377|NCT00267098|42145125|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700378|NCT00267098|42145126|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
19799953|NCT02419612|42257968|FG001|Long-term Treatment Period|Subject Decision|4|||
19799954|NCT02419612|42257967|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
19799955|NCT02419612|42257968|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
19799956|NCT02447848|42257974|FG000|Overall Study|Patient discharged|3|||
19799957|NCT02447848|42257974|FG000|Overall Study|Lack of Efficacy|4|||
19799958|NCT02447848|42257974|FG000|Overall Study|Withdrawal by Subject|4|||
19799959|NCT02418910|42257978|FG000|Overall Study|Lost to Follow-up|3|||
19799960|NCT02418910|42257978|FG000|Overall Study|Withdrawal by Subject|4|||
19799961|NCT02418754|42257994|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
19799962|NCT02418754|42257995|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
19799963|NCT02418754|42257996|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
19799964|NCT02418754|42257997|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
19799965|NCT02418754|42257998|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
19799966|NCT02418754|42257994|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
19799967|NCT02418754|42257995|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
19799968|NCT02418754|42257996|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
19390546|NCT02659943|41634317|FG006|Overall Study|No longer meets eligibility|1|||
19390547|NCT02659943|41634311|FG000|Overall Study|No treatment, per protocol|0|||
19390548|NCT02659943|41634312|FG001|Overall Study|No treatment, per protocol|0|||
19390549|NCT02659943|41634313|FG002|Overall Study|No treatment, per protocol|0|||
19390550|NCT02659943|41634314|FG003|Overall Study|No treatment, per protocol|0|||
19390551|NCT02659943|41634315|FG004|Overall Study|No treatment, per protocol|0|||
19390552|NCT02659943|41634316|FG005|Overall Study|No treatment, per protocol|0|||
19478403|NCT01502371|41757696|FG004|Overall Study|Adverse Event|3|||
19478404|NCT01502371|41757692|FG000|Overall Study|Treatment Failure|22|||
19799969|NCT02418754|42257997|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
19799970|NCT02418754|42257998|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
19799971|NCT02418754|42257994|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
19799972|NCT02418754|42257995|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
19799973|NCT02418754|42257996|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
19799974|NCT02418754|42257997|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
19799975|NCT02418754|42257998|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
19799976|NCT02418754|42257994|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
19799977|NCT02418754|42257995|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
19799978|NCT02418754|42257996|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
19799979|NCT02418754|42257997|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
19799980|NCT02418754|42257998|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
19799981|NCT02418754|42257994|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
19700379|NCT00267098|42145127|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700380|NCT00267098|42145128|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700381|NCT00267098|42145129|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19700382|NCT00267098|42145122|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700383|NCT00267098|42145123|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
19700384|NCT00267098|42145124|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700385|NCT00267098|42145125|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700386|NCT00267098|42145126|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700387|NCT00267098|42145127|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700388|NCT00267098|42145128|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700389|NCT00267098|42145129|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
19700390|NCT00267098|42145122|FG000|Overall Study|Site closure|0|||
19799982|NCT02418754|42257995|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
19799983|NCT02418754|42257996|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
19799984|NCT02418754|42257997|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
19799985|NCT02418754|42257998|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
19799986|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
19799987|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
19799988|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
19799989|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
19799990|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
19799991|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
19799992|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
19799993|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
19799994|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
19478405|NCT01502371|41757693|FG001|Overall Study|Treatment Failure|20|||
19478406|NCT01502371|41757694|FG002|Overall Study|Treatment Failure|12|||
19799995|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
19799996|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
19799997|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
19799998|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
19799999|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
19390553|NCT02659943|41634317|FG006|Overall Study|No treatment, per protocol|3|||
19800000|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
19800001|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
19800002|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
19609291|NCT00969761|42058441|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609292|NCT00969761|42058442|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609293|NCT00969761|42058443|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
19609294|NCT00969761|42058444|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609295|NCT00969761|42058445|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609296|NCT00969761|42058446|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609297|NCT00969761|42058447|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609298|NCT00969761|42058448|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609299|NCT00969761|42058449|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609300|NCT00969761|42058450|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609301|NCT00969761|42058451|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609302|NCT00969761|42058452|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
19609303|NCT00969761|42058441|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609304|NCT00969761|42058442|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609305|NCT00969761|42058443|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
19609306|NCT00969761|42058444|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19700391|NCT00267098|42145123|FG001|Overall Study|Site closure|0|||
19700392|NCT00267098|42145124|FG002|Overall Study|Site closure|0|||
19700393|NCT00267098|42145125|FG003|Overall Study|Site closure|1|||
19700394|NCT00267098|42145126|FG004|Overall Study|Site closure|0|||
19700395|NCT00267098|42145127|FG005|Overall Study|Site closure|1|||
19700396|NCT00267098|42145128|FG006|Overall Study|Site closure|1|||
19700397|NCT00267098|42145129|FG007|Overall Study|Site closure|0|||
19700398|NCT00267098|42145122|FG000|Overall Study|Explanted Medtronic device|0|||
19700399|NCT00267098|42145123|FG001|Overall Study|Explanted Medtronic device|0|||
19700400|NCT00267098|42145124|FG002|Overall Study|Explanted Medtronic device|0|||
19700401|NCT00267098|42145125|FG003|Overall Study|Explanted Medtronic device|1|||
19700402|NCT00267098|42145126|FG004|Overall Study|Explanted Medtronic device|0|||
19700403|NCT00267098|42145127|FG005|Overall Study|Explanted Medtronic device|0|||
19700404|NCT00267098|42145128|FG006|Overall Study|Explanted Medtronic device|0|||
19700405|NCT00267098|42145129|FG007|Overall Study|Explanted Medtronic device|0|||
19700406|NCT00267098|42145122|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700407|NCT00267098|42145123|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700408|NCT00267098|42145124|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700409|NCT00267098|42145125|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700410|NCT00267098|42145126|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
19700411|NCT00267098|42145127|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700412|NCT00267098|42145128|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700413|NCT00267098|42145129|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
19700414|NCT00267098|42145122|FG000|Overall Study|Subject listed for heart transplant|0|||
19700415|NCT00267098|42145123|FG001|Overall Study|Subject listed for heart transplant|0|||
19700416|NCT00267098|42145124|FG002|Overall Study|Subject listed for heart transplant|0|||
19700417|NCT00267098|42145125|FG003|Overall Study|Subject listed for heart transplant|0|||
19700418|NCT00267098|42145126|FG004|Overall Study|Subject listed for heart transplant|0|||
19800003|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
19800004|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
19800005|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
19800006|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
19800007|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
19800008|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
19800009|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
19800010|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
19800011|NCT02418754|42257994|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
19800012|NCT02418754|42257995|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
19800013|NCT02418754|42257996|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
19800014|NCT02418754|42257997|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
19800015|NCT02418754|42257998|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
19800016|NCT02447458|42258014|FG000|Overall Study|Other|0|||
19800017|NCT02447458|42258015|FG001|Overall Study|Other|0|||
19800018|NCT02447458|42258016|FG002|Overall Study|Other|1|||
19800019|NCT02447458|42258017|FG003|Overall Study|Other|0|||
19800020|NCT02447458|42258018|FG004|Overall Study|Other|0|||
19800021|NCT02447458|42258019|FG005|Overall Study|Other|0|||
19800022|NCT02862457|42258045|FG000|Overall Study|Death|1|||
19800023|NCT02862457|42258046|FG001|Overall Study|Death|3|||
19800024|NCT02862457|42258047|FG002|Overall Study|Death|2|||
19800025|NCT02862457|42258048|FG003|Overall Study|Death|3|||
19800026|NCT02862457|42258049|FG004|Overall Study|Death|0|||
19800027|NCT02862457|42258050|FG005|Overall Study|Death|2|||
19800028|NCT02862457|42258051|FG006|Overall Study|Death|1|||
19800029|NCT02862457|42258045|FG000|Overall Study|Lost to Follow-up|1|||
19800030|NCT02862457|42258046|FG001|Overall Study|Lost to Follow-up|0|||
19800031|NCT02862457|42258047|FG002|Overall Study|Lost to Follow-up|0|||
19800032|NCT02862457|42258048|FG003|Overall Study|Lost to Follow-up|1|||
19800033|NCT02862457|42258049|FG004|Overall Study|Lost to Follow-up|0|||
19800034|NCT02862457|42258050|FG005|Overall Study|Lost to Follow-up|0|||
19800035|NCT02862457|42258051|FG006|Overall Study|Lost to Follow-up|0|||
19800036|NCT02862457|42258045|FG000|Overall Study|Withdrawal by Subject|0|||
19800037|NCT02862457|42258046|FG001|Overall Study|Withdrawal by Subject|0|||
19800038|NCT02862457|42258047|FG002|Overall Study|Withdrawal by Subject|1|||
19800039|NCT02862457|42258048|FG003|Overall Study|Withdrawal by Subject|0|||
19800040|NCT02862457|42258049|FG004|Overall Study|Withdrawal by Subject|0|||
19800041|NCT02862457|42258050|FG005|Overall Study|Withdrawal by Subject|1|||
19800042|NCT02862457|42258051|FG006|Overall Study|Withdrawal by Subject|0|||
19800043|NCT02447302|42258078|FG000|Overall Study|Physician Decision|1|||
19800044|NCT02447302|42258079|FG001|Overall Study|Physician Decision|0|||
19800045|NCT02447302|42258080|FG002|Overall Study|Physician Decision|0|||
19800046|NCT02447302|42258078|FG000|Overall Study|Adverse Event|4|||
19800047|NCT02447302|42258079|FG001|Overall Study|Adverse Event|3|||
19800048|NCT02447302|42258080|FG002|Overall Study|Adverse Event|0|||
19800049|NCT02447302|42258078|FG000|Overall Study|Withdrawal by Subject|0|||
19800050|NCT02447302|42258079|FG001|Overall Study|Withdrawal by Subject|1|||
19800051|NCT02447302|42258080|FG002|Overall Study|Withdrawal by Subject|5|||
19800052|NCT02447302|42258078|FG000|Overall Study|Sponsor Decision|0|||
19800053|NCT02447302|42258079|FG001|Overall Study|Sponsor Decision|0|||
19800054|NCT02447302|42258080|FG002|Overall Study|Sponsor Decision|1|||
19800055|NCT02454517|42258090|FG000|Overall Study|Withdrawal by Subject|3|||
19800056|NCT02454517|42258091|FG001|Overall Study|Withdrawal by Subject|0|||
19800057|NCT02454517|42258090|FG000|Overall Study|Lost to Follow-up|4|||
19800058|NCT02454517|42258091|FG001|Overall Study|Lost to Follow-up|7|||
19800059|NCT02454517|42258090|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
19800060|NCT02454517|42258091|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
19800061|NCT03861039|42258102|FG000|Overall Study|Adverse Event|2|||
19800062|NCT03861039|42258103|FG001|Overall Study|Adverse Event|5|||
19800063|NCT03861039|42258104|FG002|Overall Study|Adverse Event|11|||
19800064|NCT03861039|42258102|FG000|Overall Study|Withdrawal by Subject|1|||
19390554|NCT01677299|41634342|FG000|Overall Study|Adverse Event|0|||
19390555|NCT01677299|41634343|FG001|Overall Study|Adverse Event|2|||
19700419|NCT00267098|42145127|FG005|Overall Study|Subject listed for heart transplant|0|||
19700420|NCT00267098|42145128|FG006|Overall Study|Subject listed for heart transplant|1|||
19700421|NCT00267098|42145129|FG007|Overall Study|Subject listed for heart transplant|0|||
19700422|NCT00267098|42145122|FG000|Overall Study|Sponsor withdrew subject|0|||
19700423|NCT00267098|42145123|FG001|Overall Study|Sponsor withdrew subject|0|||
19700424|NCT00267098|42145124|FG002|Overall Study|Sponsor withdrew subject|0|||
19700425|NCT00267098|42145125|FG003|Overall Study|Sponsor withdrew subject|1|||
19700426|NCT00267098|42145126|FG004|Overall Study|Sponsor withdrew subject|0|||
19700427|NCT00267098|42145127|FG005|Overall Study|Sponsor withdrew subject|0|||
19700428|NCT00267098|42145128|FG006|Overall Study|Sponsor withdrew subject|0|||
19700429|NCT00267098|42145129|FG007|Overall Study|Sponsor withdrew subject|0|||
19700430|NCT00247676|42145152|FG000|Overall Study|Death|5|||
19700431|NCT00247676|42145152|FG000|Overall Study|Adverse Event|11|||
19700432|NCT00247676|42145152|FG000|Overall Study|Lack of Efficacy|15|||
19700433|NCT00247676|42145152|FG000|Overall Study|Other|3|||
19700434|NCT00247676|42145152|FG000|Overall Study|Withdrawal by Subject|2|||
19700435|NCT00267020|42145158|FG000|Overall Study|Adverse Event|22|||
19700436|NCT00267020|42145159|FG001|Overall Study|Adverse Event|5|||
19700437|NCT00267020|42145158|FG000|Overall Study|Death|2|||
19700438|NCT00267020|42145159|FG001|Overall Study|Death|1|||
19700439|NCT00267020|42145158|FG000|Overall Study|Withdrawal by Subject|17|||
19700440|NCT00267020|42145159|FG001|Overall Study|Withdrawal by Subject|7|||
19700441|NCT00267020|42145158|FG000|Overall Study|Physician Decision|3|||
19700442|NCT00267020|42145159|FG001|Overall Study|Physician Decision|2|||
19700443|NCT00267020|42145158|FG000|Overall Study|Disease Progression|39|||
19700444|NCT00267020|42145159|FG001|Overall Study|Disease Progression|25|||
19700445|NCT00267020|42145158|FG000|Overall Study|Unrelated Complication|1|||
19700446|NCT00267020|42145159|FG001|Overall Study|Unrelated Complication|1|||
19700447|NCT00267020|42145158|FG000|Overall Study|Sponsor Request|1|||
19700448|NCT00267020|42145159|FG001|Overall Study|Sponsor Request|0|||
19700449|NCT00267020|42145158|FG000|Overall Study|Other|1|||
19700450|NCT00267020|42145159|FG001|Overall Study|Other|2|||
19800065|NCT03861039|42258103|FG001|Overall Study|Withdrawal by Subject|3|||
19800066|NCT03861039|42258104|FG002|Overall Study|Withdrawal by Subject|4|||
19800067|NCT02731755|42258114|FG000|First Intervention|Withdrawal by Subject|0|||
19700451|NCT00242216|42145167|FG000|Overall Study|Lost to Follow-up|12|||
19700452|NCT00242216|42145168|FG001|Overall Study|Lost to Follow-up|17|||
19700453|NCT00242216|42145167|FG000|Overall Study|Death|4|||
19700454|NCT00242216|42145168|FG001|Overall Study|Death|2|||
19700455|NCT00242216|42145167|FG000|Overall Study|Lack of Efficacy|1|||
19700456|NCT00242216|42145168|FG001|Overall Study|Lack of Efficacy|2|||
19700457|NCT00242216|42145167|FG000|Overall Study|no medicaiton dispensed|1|||
19700458|NCT00242216|42145168|FG001|Overall Study|no medicaiton dispensed|1|||
19700459|NCT00240110|42145176|FG000|Overall Study|Lost to Follow-up|6|||
19700460|NCT00240110|42145177|FG001|Overall Study|Lost to Follow-up|7|||
19700461|NCT00239720|42145187|FG000|Overall Study|Adverse Event|1|||
19700462|NCT00239720|42145188|FG001|Overall Study|Adverse Event|0|||
19700463|NCT00239720|42145187|FG000|Overall Study|Lost to Follow-up|0|||
19700464|NCT00239720|42145188|FG001|Overall Study|Lost to Follow-up|1|||
19700465|NCT00266864|42145196|FG000|Overall Study|Lost to Follow-up|4|||
19700466|NCT00266864|42145197|FG001|Overall Study|Lost to Follow-up|1|||
19700467|NCT00266864|42145196|FG000|Overall Study|Withdrawal by Subject|1|||
19700468|NCT00266864|42145197|FG001|Overall Study|Withdrawal by Subject|1|||
19700469|NCT00266708|42145205|FG000|Overall Study|No renal function|1|||
19700470|NCT00266708|42145206|FG001|Overall Study|No renal function|1|||
19700471|NCT00266708|42145205|FG000|Overall Study|Refused biopsy|3|||
19700472|NCT00266708|42145206|FG001|Overall Study|Refused biopsy|6|||
19700473|NCT00266708|42145205|FG000|Overall Study|Asthma|0|||
19700474|NCT00266708|42145206|FG001|Overall Study|Asthma|2|||
19700475|NCT00266630|42145214|FG000|Overall Study|Adverse Event|8|||
19700476|NCT00266630|42145215|FG001|Overall Study|Adverse Event|6|||
19700477|NCT00266630|42145214|FG000|Overall Study|Lack of Efficacy|1|||
19700478|NCT00266630|42145215|FG001|Overall Study|Lack of Efficacy|4|||
19700479|NCT00266630|42145214|FG000|Overall Study|Entry Criteria not met|1|||
19700480|NCT00266630|42145215|FG001|Overall Study|Entry Criteria not met|0|||
19700481|NCT00266630|42145214|FG000|Overall Study|Protocol Violation|1|||
19700482|NCT00266630|42145215|FG001|Overall Study|Protocol Violation|3|||
19700483|NCT00266630|42145214|FG000|Overall Study|Physician Decision|1|||
19700484|NCT00266630|42145215|FG001|Overall Study|Physician Decision|2|||
19700485|NCT00266630|42145214|FG000|Overall Study|Withdrawal by Subject|10|||
19700486|NCT00266630|42145215|FG001|Overall Study|Withdrawal by Subject|2|||
19700487|NCT00266630|42145214|FG000|Overall Study|Lost to Follow-up|1|||
19700488|NCT00266630|42145215|FG001|Overall Study|Lost to Follow-up|0|||
19700489|NCT00266630|42145214|FG000|Overall Study|Other|19|||
19700490|NCT00266630|42145215|FG001|Overall Study|Other|11|||
19700491|NCT00129129|42145226|FG000|Primary Phase|Adverse Event|2|||
19700492|NCT00129129|42145227|FG001|Primary Phase|Adverse Event|1|||
19700493|NCT00129129|42145228|FG002|Primary Phase|Adverse Event|0|||
19700494|NCT00129129|42145229|FG003|Primary Phase|Adverse Event|0|||
19700495|NCT00129129|42145230|FG004|Primary Phase|Adverse Event|0|||
19700496|NCT00129129|42145226|FG000|Primary Phase|Withdrawal by Subject|12|||
19700497|NCT00129129|42145227|FG001|Primary Phase|Withdrawal by Subject|10|||
19700498|NCT00129129|42145228|FG002|Primary Phase|Withdrawal by Subject|0|||
19700499|NCT00129129|42145229|FG003|Primary Phase|Withdrawal by Subject|0|||
19700500|NCT00129129|42145230|FG004|Primary Phase|Withdrawal by Subject|0|||
19700501|NCT00129129|42145226|FG000|Primary Phase|Migration from study area|1|||
19700502|NCT00129129|42145227|FG001|Primary Phase|Migration from study area|3|||
19700503|NCT00129129|42145228|FG002|Primary Phase|Migration from study area|0|||
19700504|NCT00129129|42145229|FG003|Primary Phase|Migration from study area|0|||
19700505|NCT00129129|42145230|FG004|Primary Phase|Migration from study area|0|||
19700506|NCT00129129|42145226|FG000|Primary Phase|Lost to Follow-up|8|||
19700507|NCT00129129|42145227|FG001|Primary Phase|Lost to Follow-up|6|||
19700508|NCT00129129|42145228|FG002|Primary Phase|Lost to Follow-up|0|||
19700509|NCT00129129|42145229|FG003|Primary Phase|Lost to Follow-up|0|||
19700510|NCT00129129|42145230|FG004|Primary Phase|Lost to Follow-up|0|||
19700511|NCT00129129|42145226|FG000|Primary Phase|Other|2|||
19700512|NCT00129129|42145227|FG001|Primary Phase|Other|5|||
19700513|NCT00129129|42145228|FG002|Primary Phase|Other|0|||
19700514|NCT00129129|42145229|FG003|Primary Phase|Other|0|||
19700515|NCT00129129|42145230|FG004|Primary Phase|Other|0|||
19700516|NCT00129129|42145226|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
19700517|NCT00129129|42145227|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
19700518|NCT00129129|42145228|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
19700519|NCT00129129|42145229|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
19700520|NCT00129129|42145230|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
19700521|NCT00129129|42145226|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
19700522|NCT00129129|42145227|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
19700523|NCT00129129|42145228|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
19700524|NCT00129129|42145229|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
19700525|NCT00129129|42145230|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
19700526|NCT00129129|42145226|FG000|Fourth Dose Phase|Migration from study area|0|||
19700527|NCT00129129|42145227|FG001|Fourth Dose Phase|Migration from study area|0|||
19700528|NCT00129129|42145228|FG002|Fourth Dose Phase|Migration from study area|0|||
19700529|NCT00129129|42145229|FG003|Fourth Dose Phase|Migration from study area|0|||
19800068|NCT02731755|42258115|FG001|First Intervention|Withdrawal by Subject|2|||
19800069|NCT02866175|42258144|FG000|Overall Study|Adverse Event|56|||
19800070|NCT02866175|42258145|FG001|Overall Study|Adverse Event|54|||
19800071|NCT02866175|42258144|FG000|Overall Study|Withdrawal by Subject|31|||
19800072|NCT02866175|42258145|FG001|Overall Study|Withdrawal by Subject|52|||
19800073|NCT02866175|42258144|FG000|Overall Study|Death|30|||
19800074|NCT02866175|42258145|FG001|Overall Study|Death|23|||
19800075|NCT02866175|42258144|FG000|Overall Study|Other|7|||
19800076|NCT02866175|42258145|FG001|Overall Study|Other|14|||
19800077|NCT02866175|42258144|FG000|Overall Study|Progressive disease|1|||
19800078|NCT02866175|42258145|FG001|Overall Study|Progressive disease|1|||
19800079|NCT02866175|42258144|FG000|Overall Study|Lost to Follow-up|2|||
19800080|NCT02866175|42258145|FG001|Overall Study|Lost to Follow-up|0|||
19800081|NCT02866175|42258144|FG000|Overall Study|Lack of Efficacy|0|||
19800082|NCT02866175|42258145|FG001|Overall Study|Lack of Efficacy|1|||
19800083|NCT02866175|42258144|FG000|Overall Study|Physician Decision|3|||
19800084|NCT02866175|42258145|FG001|Overall Study|Physician Decision|15|||
19800085|NCT02866175|42258144|FG000|Overall Study|Did not receive treatment|5|||
19800086|NCT02866175|42258145|FG001|Overall Study|Did not receive treatment|15|||
19800087|NCT03675308|42258158|FG000|Overall Study|Adverse Event|3|||
19800088|NCT03675308|42258159|FG001|Overall Study|Adverse Event|2|||
19800089|NCT03675308|42258158|FG000|Overall Study|Withdrawal by Subject|6|||
19800090|NCT03675308|42258159|FG001|Overall Study|Withdrawal by Subject|4|||
19800091|NCT03675308|42258158|FG000|Overall Study|Lost to Follow-up|3|||
19800092|NCT03675308|42258159|FG001|Overall Study|Lost to Follow-up|0|||
19800093|NCT03675308|42258158|FG000|Overall Study|Lack of Efficacy|1|||
19800094|NCT03675308|42258159|FG001|Overall Study|Lack of Efficacy|1|||
19800095|NCT03675308|42258158|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
19800096|NCT03675308|42258159|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
19800097|NCT03675308|42258158|FG000|Overall Study|Other|0|||
19800098|NCT03675308|42258159|FG001|Overall Study|Other|1|||
19800099|NCT01336205|42258167|FG000|Overall Study|Other|22|||
19800100|NCT01336205|42258168|FG001|Overall Study|Other|9|||
19800101|NCT01336205|42258167|FG000|Overall Study|Lost to Follow-up|40|||
19800102|NCT01336205|42258168|FG001|Overall Study|Lost to Follow-up|20|||
19800103|NCT01336205|42258167|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
19800104|NCT01336205|42258168|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
19800105|NCT01336205|42258167|FG000|Overall Study|Lack of Efficacy|4|||
19800106|NCT01336205|42258168|FG001|Overall Study|Lack of Efficacy|0|||
19700530|NCT00129129|42145230|FG004|Fourth Dose Phase|Migration from study area|2|||
19700531|NCT00129129|42145226|FG000|Fourth Dose Phase|Other|0|||
19700532|NCT00129129|42145227|FG001|Fourth Dose Phase|Other|0|||
19700533|NCT00129129|42145228|FG002|Fourth Dose Phase|Other|0|||
19700534|NCT00129129|42145229|FG003|Fourth Dose Phase|Other|1|||
19700535|NCT00129129|42145230|FG004|Fourth Dose Phase|Other|1|||
19700536|NCT00129129|42145226|FG000|Fourth Dose Phase|Protocol Violation|0|||
19700537|NCT00129129|42145227|FG001|Fourth Dose Phase|Protocol Violation|0|||
19700538|NCT00129129|42145228|FG002|Fourth Dose Phase|Protocol Violation|0|||
19700539|NCT00129129|42145229|FG003|Fourth Dose Phase|Protocol Violation|1|||
19700540|NCT00129129|42145230|FG004|Fourth Dose Phase|Protocol Violation|0|||
19700541|NCT00221403|42145253|FG000|Overall Study|Protocol Violation|1|||
19700542|NCT00221403|42145254|FG001|Overall Study|Protocol Violation|0|||
19700543|NCT00221403|42145255|FG002|Overall Study|Protocol Violation|0|||
19700544|NCT00221403|42145253|FG000|Overall Study|Physician Decision|1|||
19700545|NCT00221403|42145254|FG001|Overall Study|Physician Decision|0|||
19700546|NCT00221403|42145255|FG002|Overall Study|Physician Decision|0|||
19700547|NCT00221403|42145253|FG000|Overall Study|Withdrawal by Subject|0|||
19700548|NCT00221403|42145254|FG001|Overall Study|Withdrawal by Subject|3|||
19700549|NCT00221403|42145255|FG002|Overall Study|Withdrawal by Subject|0|||
19700550|NCT00221403|42145253|FG000|Overall Study|Lack of Efficacy|0|||
19700551|NCT00221403|42145254|FG001|Overall Study|Lack of Efficacy|1|||
19700552|NCT00221403|42145255|FG002|Overall Study|Lack of Efficacy|0|||
19700553|NCT00221403|42145253|FG000|Overall Study|Adverse Event|0|||
19700554|NCT00221403|42145254|FG001|Overall Study|Adverse Event|1|||
19700555|NCT00221403|42145255|FG002|Overall Study|Adverse Event|0|||
19700556|NCT00145977|42145265|FG000|Overall Study|Lack of Efficacy|0|||
19700557|NCT00145977|42145266|FG001|Overall Study|Lack of Efficacy|4|||
19700558|NCT00145977|42145265|FG000|Overall Study|Lost to Follow-up|1|||
19700559|NCT00145977|42145266|FG001|Overall Study|Lost to Follow-up|0|||
19700560|NCT00145977|42145265|FG000|Overall Study|Withdrawal by Subject|1|||
19700561|NCT00145977|42145266|FG001|Overall Study|Withdrawal by Subject|0|||
19700562|NCT00238238|42145275|FG000|Overall Study|Withdrawal by Subject|0|||
19700563|NCT00238238|42145276|FG001|Overall Study|Withdrawal by Subject|3|||
19700564|NCT00238238|42145277|FG002|Overall Study|Withdrawal by Subject|0|||
19800107|NCT01336205|42258167|FG000|Overall Study|Severe noncompliance with protocol|9|||
19800108|NCT01336205|42258168|FG001|Overall Study|Severe noncompliance with protocol|2|||
19800109|NCT01336205|42258167|FG000|Overall Study|Adverse Event|56|||
19800110|NCT01336205|42258168|FG001|Overall Study|Adverse Event|6|||
19800111|NCT01336205|42258167|FG000|Overall Study|Death|1|||
19700565|NCT00128661|42145287|FG000|Overall Study|Adverse Event|14|||
19700566|NCT00128661|42145288|FG001|Overall Study|Adverse Event|11|||
19700567|NCT00128661|42145287|FG000|Overall Study|Lost to Follow-up|10|||
19700568|NCT00128661|42145288|FG001|Overall Study|Lost to Follow-up|7|||
19700569|NCT00128661|42145287|FG000|Overall Study|Withdrawal by Subject|243|||
19700570|NCT00128661|42145288|FG001|Overall Study|Withdrawal by Subject|232|||
19700571|NCT00128661|42145287|FG000|Overall Study|Other|7|||
19700572|NCT00128661|42145288|FG001|Overall Study|Other|8|||
19700573|NCT00145509|42145296|FG000|Overall Study|Adverse Event|10|||
19700574|NCT00145509|42145297|FG001|Overall Study|Adverse Event|3|||
19700575|NCT00145509|42145296|FG000|Overall Study|Lack of Efficacy|3|||
19700576|NCT00145509|42145297|FG001|Overall Study|Lack of Efficacy|1|||
19700577|NCT00145509|42145296|FG000|Overall Study|Lost to Follow-up|5|||
19700578|NCT00145509|42145297|FG001|Overall Study|Lost to Follow-up|9|||
19700579|NCT00145509|42145296|FG000|Overall Study|Withdrew Consent|2|||
19700580|NCT00145509|42145297|FG001|Overall Study|Withdrew Consent|7|||
19700581|NCT00145509|42145296|FG000|Overall Study|Reason not provided|2|||
19700582|NCT00145509|42145297|FG001|Overall Study|Reason not provided|1|||
19700583|NCT00145119|42145303|FG000|Overall Study|Death|45|||
19700584|NCT00220779|42145310|FG000|Overall Study|Adverse Event|1|||
19700585|NCT00220779|42145311|FG001|Overall Study|Adverse Event|0|||
19700586|NCT00220779|42145312|FG002|Overall Study|Adverse Event|0|||
19700587|NCT00220779|42145310|FG000|Overall Study|Withdrawal by Subject|1|||
19700588|NCT00220779|42145311|FG001|Overall Study|Withdrawal by Subject|4|||
19700589|NCT00220779|42145312|FG002|Overall Study|Withdrawal by Subject|1|||
19700590|NCT00220779|42145310|FG000|Overall Study|Non-compliance|1|||
19700591|NCT00220779|42145311|FG001|Overall Study|Non-compliance|0|||
19800112|NCT01336205|42258168|FG001|Overall Study|Death|1|||
19800113|NCT01336205|42258167|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
19800114|NCT01336205|42258168|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
19800115|NCT01336205|42258167|FG000|Overall Study|Withdrawal by Subject|72|||
19800116|NCT01336205|42258168|FG001|Overall Study|Withdrawal by Subject|38|||
19800117|NCT01336205|42258167|FG000|Overall Study|Did not receive treatment|4|||
19700592|NCT00220779|42145312|FG002|Overall Study|Non-compliance|0|||
19700593|NCT00220779|42145310|FG000|Overall Study|Too time consuming|1|||
19700594|NCT00220779|42145311|FG001|Overall Study|Too time consuming|0|||
19700595|NCT00220779|42145312|FG002|Overall Study|Too time consuming|0|||
19800118|NCT01336205|42258168|FG001|Overall Study|Did not receive treatment|0|||
19800119|NCT02865395|42258177|FG000|Overall Study|Physician Decision|6|||
19800120|NCT02865395|42258178|FG001|Overall Study|Physician Decision|10|||
19800121|NCT02865395|42258179|FG002|Overall Study|Physician Decision|7|||
19800122|NCT01123707|42258191|FG000|Overall Study|Lost to Follow-up|3|||
19800123|NCT01123707|42258192|FG001|Overall Study|Lost to Follow-up|1|||
19800124|NCT01123707|42258193|FG002|Overall Study|Lost to Follow-up|3|||
19800125|NCT01123707|42258194|FG003|Overall Study|Lost to Follow-up|2|||
19800126|NCT01123707|42258191|FG000|Overall Study|Adverse Event|5|||
19800127|NCT01123707|42258192|FG001|Overall Study|Adverse Event|7|||
19800128|NCT01123707|42258193|FG002|Overall Study|Adverse Event|5|||
19390556|NCT01677299|41634344|FG002|Overall Study|Adverse Event|1|||
19700596|NCT00220779|42145310|FG000|Overall Study|Pregnancy|0|||
19700597|NCT00220779|42145311|FG001|Overall Study|Pregnancy|0|||
19700598|NCT00220779|42145312|FG002|Overall Study|Pregnancy|2|||
19700599|NCT00220779|42145310|FG000|Overall Study|Lack of Efficacy|3|||
19700600|NCT00220779|42145311|FG001|Overall Study|Lack of Efficacy|0|||
19700601|NCT00220779|42145312|FG002|Overall Study|Lack of Efficacy|1|||
19700602|NCT00207740|42145324|FG000|Overall Study|Adverse Event|4|||
19700603|NCT00207740|42145325|FG001|Overall Study|Adverse Event|14|||
19700604|NCT00207740|42145326|FG002|Overall Study|Adverse Event|14|||
19700605|NCT00207740|42145327|FG003|Overall Study|Adverse Event|11|||
19700606|NCT00207740|42145324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19700607|NCT00207740|42145325|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19700608|NCT00207740|42145326|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19700609|NCT00207740|42145327|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
19700610|NCT00207740|42145324|FG000|Overall Study|Lost to Follow-up|0|||
19700611|NCT00207740|42145325|FG001|Overall Study|Lost to Follow-up|2|||
19700612|NCT00207740|42145326|FG002|Overall Study|Lost to Follow-up|1|||
19700613|NCT00207740|42145327|FG003|Overall Study|Lost to Follow-up|1|||
19700614|NCT00207740|42145324|FG000|Overall Study|Death|0|||
19700615|NCT00207740|42145325|FG001|Overall Study|Death|0|||
19700616|NCT00207740|42145326|FG002|Overall Study|Death|0|||
19700617|NCT00207740|42145327|FG003|Overall Study|Death|1|||
19700618|NCT00207740|42145324|FG000|Overall Study|Sponsor Directive|22|||
19700619|NCT00207740|42145325|FG001|Overall Study|Sponsor Directive|15|||
19700620|NCT00207740|42145326|FG002|Overall Study|Sponsor Directive|16|||
19700621|NCT00207740|42145327|FG003|Overall Study|Sponsor Directive|21|||
19390557|NCT01677299|41634345|FG003|Overall Study|Adverse Event|0|||
19700622|NCT00207740|42145324|FG000|Overall Study|Other|2|||
19800129|NCT01123707|42258194|FG003|Overall Study|Adverse Event|3|||
19800130|NCT01123707|42258191|FG000|Overall Study|Sponsor Discontinued Study|30|||
19800131|NCT01123707|42258192|FG001|Overall Study|Sponsor Discontinued Study|24|||
19700623|NCT00207740|42145325|FG001|Overall Study|Other|10|||
19700624|NCT00207740|42145326|FG002|Overall Study|Other|7|||
19700625|NCT00207740|42145327|FG003|Overall Study|Other|5|||
19700626|NCT00265382|42145341|FG000|Overall Study|Adverse Event|21|||
19700627|NCT00265382|42145341|FG000|Overall Study|Laboratory Abnormality|1|||
19700628|NCT00265382|42145341|FG000|Overall Study|Lost to Follow-up|3|||
19700629|NCT00265382|42145341|FG000|Overall Study|Lack of Efficacy|6|||
19700630|NCT00265382|42145341|FG000|Overall Study|Miscellaneous|6|||
19700631|NCT00265382|42145341|FG000|Overall Study|Withdrawal by Subject|13|||
19700632|NCT00265382|42145341|FG000|Overall Study|Study terminated by sponsor|94|||
19700633|NCT00265382|42145341|FG000|Overall Study|Death|1|||
19800132|NCT01123707|42258193|FG002|Overall Study|Sponsor Discontinued Study|25|||
19800133|NCT01123707|42258194|FG003|Overall Study|Sponsor Discontinued Study|40|||
19700634|NCT00206726|42145345|FG000|Overall Study|Delayed recovery of blood counts|1|||
19700635|NCT00206726|42145345|FG000|Overall Study|Progressive disease or relapsed disease|18|||
19700636|NCT00206726|42145345|FG000|Overall Study|Placed on new protocol|1|||
19700637|NCT00206726|42145345|FG000|Overall Study|Bone marrow transplant|1|||
19700638|NCT00206726|42145345|FG000|Overall Study|Adverse Event|17|||
19700639|NCT00206726|42145345|FG000|Overall Study|Death|4|||
19700640|NCT00206726|42145345|FG000|Overall Study|Protocol Violation|1|||
19700641|NCT00206726|42145345|FG000|Overall Study|Withdrawal by Subject|8|||
19700642|NCT00237692|42145353|FG000|Overall Study|Lost to Follow-up|9|||
19700643|NCT00237692|42145354|FG001|Overall Study|Lost to Follow-up|3|||
19700644|NCT00237692|42145355|FG002|Overall Study|Lost to Follow-up|5|||
19700645|NCT00237692|42145356|FG003|Overall Study|Lost to Follow-up|3|||
19700646|NCT00237692|42145353|FG000|Overall Study|Death|1|||
19700647|NCT00237692|42145354|FG001|Overall Study|Death|2|||
19700648|NCT00237692|42145355|FG002|Overall Study|Death|2|||
19700649|NCT00237692|42145356|FG003|Overall Study|Death|3|||
19700650|NCT00237692|42145353|FG000|Overall Study|Excluded - did not meet criteria|4|||
19700651|NCT00237692|42145354|FG001|Overall Study|Excluded - did not meet criteria|3|||
19700652|NCT00237692|42145355|FG002|Overall Study|Excluded - did not meet criteria|5|||
19700653|NCT00237692|42145356|FG003|Overall Study|Excluded - did not meet criteria|9|||
19700654|NCT00237692|42145353|FG000|Overall Study|Withdrawal by Subject|4|||
19700655|NCT00237692|42145354|FG001|Overall Study|Withdrawal by Subject|6|||
19700656|NCT00237692|42145355|FG002|Overall Study|Withdrawal by Subject|10|||
19700657|NCT00237692|42145356|FG003|Overall Study|Withdrawal by Subject|4|||
19700658|NCT00237458|42145366|FG000|Overall Study|Lack of Efficacy|1|||
19700659|NCT00237458|42145366|FG000|Overall Study|Adverse Event|1|||
19700660|NCT00237458|42145366|FG000|Overall Study|Withdrawal by Subject|1|||
19700661|NCT00265148|42145372|FG000|Overall Study|Adverse Event|2|||
19700662|NCT00265148|42145373|FG001|Overall Study|Adverse Event|2|||
19700663|NCT00265148|42145372|FG000|Overall Study|Lack of Efficacy|0|||
19700664|NCT00265148|42145373|FG001|Overall Study|Lack of Efficacy|2|||
19700665|NCT00265148|42145372|FG000|Overall Study|Protocol Violation|3|||
19700666|NCT00265148|42145373|FG001|Overall Study|Protocol Violation|2|||
19700667|NCT00265148|42145372|FG000|Overall Study|Lost to Follow-up|0|||
19700668|NCT00265148|42145373|FG001|Overall Study|Lost to Follow-up|1|||
19700669|NCT00265148|42145372|FG000|Overall Study|Withdrawal by Subject|2|||
19700670|NCT00265148|42145373|FG001|Overall Study|Withdrawal by Subject|1|||
19700671|NCT00265148|42145372|FG000|Overall Study|Physician Decision|1|||
19700672|NCT00265148|42145373|FG001|Overall Study|Physician Decision|0|||
19700673|NCT00265148|42145372|FG000|Overall Study|Increasing frailty|0|||
19800134|NCT01123707|42258191|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
19800135|NCT01123707|42258192|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
19800136|NCT01123707|42258193|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
19800137|NCT01123707|42258194|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
19800138|NCT01123707|42258191|FG000|Overall Study|Investigator Withdrew Participant|0|||
19800139|NCT01123707|42258192|FG001|Overall Study|Investigator Withdrew Participant|1|||
19800140|NCT01123707|42258193|FG002|Overall Study|Investigator Withdrew Participant|1|||
19800141|NCT01123707|42258194|FG003|Overall Study|Investigator Withdrew Participant|1|||
19800142|NCT01123707|42258191|FG000|Overall Study|Subject Withdrew Consent|4|||
19800143|NCT01123707|42258192|FG001|Overall Study|Subject Withdrew Consent|5|||
19800144|NCT01123707|42258193|FG002|Overall Study|Subject Withdrew Consent|1|||
19800145|NCT01123707|42258194|FG003|Overall Study|Subject Withdrew Consent|2|||
19800146|NCT01123707|42258191|FG000|Overall Study|Lack of Efficacy|1|||
19800147|NCT01123707|42258192|FG001|Overall Study|Lack of Efficacy|2|||
19800148|NCT01123707|42258193|FG002|Overall Study|Lack of Efficacy|1|||
19800149|NCT01123707|42258194|FG003|Overall Study|Lack of Efficacy|0|||
19800150|NCT01123707|42258191|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
19800151|NCT01123707|42258192|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
19700674|NCT00265148|42145373|FG001|Overall Study|Increasing frailty|1|||
19700675|NCT00265148|42145372|FG000|Overall Study|Subject chose to change of the dose|1|||
19700676|NCT00265148|42145373|FG001|Overall Study|Subject chose to change of the dose|0|||
19700677|NCT00043186|42145389|FG000|Overall Study|Physician Decision|0|||
19800152|NCT01123707|42258193|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
19800153|NCT01123707|42258194|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
19800154|NCT02755103|42258206|FG000|Overall Study|Lost to Follow-up|17|||
19800155|NCT02755103|42258207|FG001|Overall Study|Lost to Follow-up|15|||
19800156|NCT02755103|42258206|FG000|Overall Study|Death|0|||
19800157|NCT02755103|42258207|FG001|Overall Study|Death|1|||
19800158|NCT02755103|42258206|FG000|Overall Study|Physician Decision|0|||
19800159|NCT02755103|42258207|FG001|Overall Study|Physician Decision|1|||
19800160|NCT02755103|42258206|FG000|Overall Study|Pregnancy|0|||
19800161|NCT02755103|42258207|FG001|Overall Study|Pregnancy|1|||
19800162|NCT02755103|42258206|FG000|Overall Study|Withdrawal by Subject|3|||
19800163|NCT02755103|42258207|FG001|Overall Study|Withdrawal by Subject|0|||
19800164|NCT01258803|42258217|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
19800165|NCT01258803|42258218|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
19800166|NCT01258803|42258219|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
19800167|NCT01258803|42258220|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
19800168|NCT01258803|42258221|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
19800169|NCT01258803|42258222|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
19800170|NCT01258803|42258217|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
19800171|NCT01258803|42258218|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
19800172|NCT01258803|42258219|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
19800173|NCT01258803|42258220|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
19800174|NCT01258803|42258221|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
19800175|NCT01258803|42258222|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
19800176|NCT01258803|42258217|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
19800177|NCT01258803|42258218|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
19800178|NCT01258803|42258219|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
19800179|NCT01258803|42258220|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
19800180|NCT01258803|42258221|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
19800181|NCT01258803|42258222|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
19800182|NCT02865083|42258238|FG000|Overall Study|Early Termination|3|||
19800183|NCT02865083|42258239|FG001|Overall Study|Early Termination|1|||
19800184|NCT00862251|42258248|FG000|Overall Study|Adverse Event|8|||
19800185|NCT00862251|42258249|FG001|Overall Study|Adverse Event|3|||
19700678|NCT00043186|42145390|FG001|Overall Study|Physician Decision|0|||
19700679|NCT00043186|42145391|FG002|Overall Study|Physician Decision|3|||
19700680|NCT00043186|42145392|FG003|Overall Study|Physician Decision|0|||
19700681|NCT00043186|42145393|FG004|Overall Study|Physician Decision|1|||
19700682|NCT00043186|42145394|FG005|Overall Study|Physician Decision|0|||
19700683|NCT00043186|42145395|FG006|Overall Study|Physician Decision|0|||
19700684|NCT00043186|42145396|FG007|Overall Study|Physician Decision|1|||
19700685|NCT00043186|42145397|FG008|Overall Study|Physician Decision|1|||
19700686|NCT00043186|42145389|FG000|Overall Study|Adverse Event|2|||
19700687|NCT00043186|42145390|FG001|Overall Study|Adverse Event|2|||
19700688|NCT00043186|42145391|FG002|Overall Study|Adverse Event|2|||
19700689|NCT00043186|42145392|FG003|Overall Study|Adverse Event|3|||
19700690|NCT00043186|42145393|FG004|Overall Study|Adverse Event|2|||
19700691|NCT00043186|42145394|FG005|Overall Study|Adverse Event|1|||
19700692|NCT00043186|42145395|FG006|Overall Study|Adverse Event|2|||
19700693|NCT00043186|42145396|FG007|Overall Study|Adverse Event|1|||
19700694|NCT00043186|42145397|FG008|Overall Study|Adverse Event|3|||
19700695|NCT00043186|42145389|FG000|Overall Study|Withdrawal by Subject|11|||
19700696|NCT00043186|42145390|FG001|Overall Study|Withdrawal by Subject|8|||
19700697|NCT00043186|42145391|FG002|Overall Study|Withdrawal by Subject|11|||
19700698|NCT00043186|42145392|FG003|Overall Study|Withdrawal by Subject|13|||
19700699|NCT00043186|42145393|FG004|Overall Study|Withdrawal by Subject|14|||
19700700|NCT00043186|42145394|FG005|Overall Study|Withdrawal by Subject|6|||
19800186|NCT00862251|42258250|FG002|Overall Study|Adverse Event|1|||
19800187|NCT00862251|42258248|FG000|Overall Study|Lost to Follow-up|0|||
19800188|NCT00862251|42258249|FG001|Overall Study|Lost to Follow-up|0|||
19800189|NCT00862251|42258250|FG002|Overall Study|Lost to Follow-up|1|||
19800190|NCT00862251|42258248|FG000|Overall Study|Protocol Violation|2|||
19800191|NCT00862251|42258249|FG001|Overall Study|Protocol Violation|0|||
19800192|NCT00862251|42258250|FG002|Overall Study|Protocol Violation|1|||
19800193|NCT00862251|42258248|FG000|Overall Study|Withdrawal by Subject|9|||
19800194|NCT00862251|42258249|FG001|Overall Study|Withdrawal by Subject|2|||
19478407|NCT01502371|41757695|FG003|Overall Study|Treatment Failure|19|||
19800195|NCT00862251|42258250|FG002|Overall Study|Withdrawal by Subject|6|||
19800196|NCT02864381|42258279|FG000|Overall Study|Death|58|||
19478408|NCT01502371|41757696|FG004|Overall Study|Treatment Failure|30|||
19700701|NCT00043186|42145395|FG006|Overall Study|Withdrawal by Subject|12|||
19700702|NCT00043186|42145396|FG007|Overall Study|Withdrawal by Subject|9|||
19700703|NCT00043186|42145397|FG008|Overall Study|Withdrawal by Subject|10|||
19800197|NCT02864381|42258280|FG001|Overall Study|Death|61|||
19800198|NCT02864381|42258279|FG000|Overall Study|Withdrew Consent|5|||
19800199|NCT02864381|42258280|FG001|Overall Study|Withdrew Consent|6|||
19800200|NCT02864381|42258279|FG000|Overall Study|Reason Unknown|7|||
19800201|NCT02864381|42258280|FG001|Overall Study|Reason Unknown|3|||
19800202|NCT02864381|42258279|FG000|Overall Study|Lost to Follow-up|1|||
19800203|NCT02864381|42258280|FG001|Overall Study|Lost to Follow-up|1|||
19700704|NCT00043186|42145389|FG000|Overall Study|Death|0|||
19700705|NCT00043186|42145390|FG001|Overall Study|Death|0|||
19700706|NCT00043186|42145391|FG002|Overall Study|Death|1|||
19700707|NCT00043186|42145392|FG003|Overall Study|Death|0|||
19700708|NCT00043186|42145393|FG004|Overall Study|Death|0|||
19700709|NCT00043186|42145394|FG005|Overall Study|Death|0|||
19700710|NCT00043186|42145395|FG006|Overall Study|Death|2|||
19700711|NCT00043186|42145396|FG007|Overall Study|Death|0|||
19700712|NCT00043186|42145397|FG008|Overall Study|Death|0|||
19700713|NCT00043186|42145389|FG000|Overall Study|Disease progression|1|||
19800204|NCT02864381|42258279|FG000|Overall Study|Investigator's Discretion|1|||
19800205|NCT02864381|42258280|FG001|Overall Study|Investigator's Discretion|0|||
19800206|NCT02864381|42258279|FG000|Overall Study|Protocol Violation|0|||
19800207|NCT02864381|42258280|FG001|Overall Study|Protocol Violation|1|||
19800208|NCT02860169|42258288|FG000|Part A|Withdrawal by Subject|1|||
19800209|NCT02860169|42258288|FG000|Part A|Other (Screening failure)|6|||
19800210|NCT02860169|42258288|FG000|Part A|Other (Survey not completed)|3|||
19800211|NCT02860169|42258288|FG000|Part A|Other (did not completed consent)|1|||
19800212|NCT02860169|42258288|FG000|Part B|Other (Screening failure)|10|||
19800213|NCT02860169|42258288|FG000|Part B|Withdrawal by Subject|1|||
19800214|NCT02860169|42258288|FG000|Part C|Other (Screening failure)|1|||
19800215|NCT00409773|42258299|FG000|Overall Study|Adverse Event|3|||
19800216|NCT00409773|42258300|FG001|Overall Study|Adverse Event|4|||
19800217|NCT00409773|42258301|FG002|Overall Study|Adverse Event|4|||
19800218|NCT00409773|42258302|FG003|Overall Study|Adverse Event|2|||
19800219|NCT00409773|42258303|FG004|Overall Study|Adverse Event|6|||
19800220|NCT00409773|42258299|FG000|Overall Study|Lost to Follow-up|6|||
19800221|NCT00409773|42258300|FG001|Overall Study|Lost to Follow-up|1|||
19800222|NCT00409773|42258301|FG002|Overall Study|Lost to Follow-up|2|||
19800223|NCT00409773|42258302|FG003|Overall Study|Lost to Follow-up|3|||
19800224|NCT00409773|42258303|FG004|Overall Study|Lost to Follow-up|1|||
19800225|NCT00409773|42258299|FG000|Overall Study|Physician Decision|0|||
19800226|NCT00409773|42258300|FG001|Overall Study|Physician Decision|0|||
19800227|NCT00409773|42258301|FG002|Overall Study|Physician Decision|0|||
19800228|NCT00409773|42258302|FG003|Overall Study|Physician Decision|2|||
19800229|NCT00409773|42258303|FG004|Overall Study|Physician Decision|0|||
19800230|NCT00409773|42258299|FG000|Overall Study|Protocol Violation|0|||
19800231|NCT00409773|42258300|FG001|Overall Study|Protocol Violation|2|||
19800232|NCT00409773|42258301|FG002|Overall Study|Protocol Violation|3|||
19800233|NCT00409773|42258302|FG003|Overall Study|Protocol Violation|3|||
19800234|NCT00409773|42258303|FG004|Overall Study|Protocol Violation|1|||
19800235|NCT00409773|42258299|FG000|Overall Study|Withdrawal by Subject|0|||
19800236|NCT00409773|42258300|FG001|Overall Study|Withdrawal by Subject|0|||
19800237|NCT00409773|42258301|FG002|Overall Study|Withdrawal by Subject|0|||
19800238|NCT00409773|42258302|FG003|Overall Study|Withdrawal by Subject|2|||
19800239|NCT00409773|42258303|FG004|Overall Study|Withdrawal by Subject|1|||
19800240|NCT00409773|42258299|FG000|Overall Study|Lack of Eligibility|0|||
19800241|NCT00409773|42258300|FG001|Overall Study|Lack of Eligibility|0|||
19700714|NCT00043186|42145390|FG001|Overall Study|Disease progression|0|||
19700715|NCT00043186|42145391|FG002|Overall Study|Disease progression|0|||
19700716|NCT00043186|42145392|FG003|Overall Study|Disease progression|3|||
19700717|NCT00043186|42145393|FG004|Overall Study|Disease progression|0|||
19700718|NCT00043186|42145394|FG005|Overall Study|Disease progression|0|||
19700719|NCT00043186|42145395|FG006|Overall Study|Disease progression|0|||
19700720|NCT00043186|42145396|FG007|Overall Study|Disease progression|4|||
19700721|NCT00043186|42145397|FG008|Overall Study|Disease progression|0|||
19700722|NCT00043186|42145389|FG000|Overall Study|Ineligibility determined|0|||
19700723|NCT00043186|42145390|FG001|Overall Study|Ineligibility determined|0|||
19700724|NCT00043186|42145391|FG002|Overall Study|Ineligibility determined|0|||
19700725|NCT00043186|42145392|FG003|Overall Study|Ineligibility determined|0|||
19700726|NCT00043186|42145393|FG004|Overall Study|Ineligibility determined|0|||
19700727|NCT00043186|42145394|FG005|Overall Study|Ineligibility determined|0|||
19700728|NCT00043186|42145395|FG006|Overall Study|Ineligibility determined|0|||
19700729|NCT00043186|42145396|FG007|Overall Study|Ineligibility determined|0|||
19700730|NCT00043186|42145397|FG008|Overall Study|Ineligibility determined|1|||
19700731|NCT00043186|42145389|FG000|Overall Study|Lost to Follow-up|3|||
19700732|NCT00043186|42145390|FG001|Overall Study|Lost to Follow-up|5|||
19700733|NCT00043186|42145391|FG002|Overall Study|Lost to Follow-up|1|||
19700734|NCT00043186|42145392|FG003|Overall Study|Lost to Follow-up|1|||
19800242|NCT00409773|42258301|FG002|Overall Study|Lack of Eligibility|0|||
19800243|NCT00409773|42258302|FG003|Overall Study|Lack of Eligibility|0|||
19800244|NCT00409773|42258303|FG004|Overall Study|Lack of Eligibility|1|||
19800245|NCT02861807|42258317|FG000|Overall Study|Lost to Follow-up|7|||
19800246|NCT02861807|42258318|FG001|Overall Study|Lost to Follow-up|6|||
19478409|NCT01502371|41757692|FG000|Overall Study|Lack of Efficacy|3|||
19700735|NCT00043186|42145393|FG004|Overall Study|Lost to Follow-up|1|||
19700736|NCT00043186|42145394|FG005|Overall Study|Lost to Follow-up|1|||
19700737|NCT00043186|42145395|FG006|Overall Study|Lost to Follow-up|1|||
19700738|NCT00043186|42145396|FG007|Overall Study|Lost to Follow-up|1|||
19700739|NCT00043186|42145397|FG008|Overall Study|Lost to Follow-up|2|||
19700740|NCT00043186|42145389|FG000|Overall Study|Noncompliance|0|||
19700741|NCT00043186|42145390|FG001|Overall Study|Noncompliance|0|||
19700742|NCT00043186|42145391|FG002|Overall Study|Noncompliance|1|||
19700743|NCT00043186|42145392|FG003|Overall Study|Noncompliance|1|||
19700744|NCT00043186|42145393|FG004|Overall Study|Noncompliance|0|||
19700745|NCT00043186|42145394|FG005|Overall Study|Noncompliance|0|||
19700746|NCT00043186|42145395|FG006|Overall Study|Noncompliance|0|||
19700747|NCT00043186|42145396|FG007|Overall Study|Noncompliance|0|||
19700748|NCT00043186|42145397|FG008|Overall Study|Noncompliance|0|||
19700749|NCT00043186|42145389|FG000|Overall Study|Other|0|||
19700750|NCT00043186|42145390|FG001|Overall Study|Other|0|||
19700751|NCT00043186|42145391|FG002|Overall Study|Other|1|||
19700752|NCT00043186|42145392|FG003|Overall Study|Other|1|||
19700753|NCT00043186|42145393|FG004|Overall Study|Other|0|||
19700754|NCT00043186|42145394|FG005|Overall Study|Other|0|||
19700755|NCT00043186|42145395|FG006|Overall Study|Other|0|||
19700756|NCT00043186|42145396|FG007|Overall Study|Other|0|||
19700757|NCT00043186|42145397|FG008|Overall Study|Other|0|||
19700758|NCT00041470|42145418|FG000|Overall Study|Loss of Funding|38|||
19700759|NCT00206102|42145424|FG000|Overall Study|Adverse Event|119|||
19700760|NCT00206102|42145425|FG001|Overall Study|Adverse Event|82|||
19700761|NCT00206102|42145424|FG000|Overall Study|Protocol Violation|0|||
19700762|NCT00206102|42145425|FG001|Overall Study|Protocol Violation|2|||
19700763|NCT00206102|42145424|FG000|Overall Study|Lack of therapeutic response|16|||
19700764|NCT00206102|42145425|FG001|Overall Study|Lack of therapeutic response|11|||
19700765|NCT00206102|42145424|FG000|Overall Study|Lost to Follow-up|95|||
19700766|NCT00206102|42145425|FG001|Overall Study|Lost to Follow-up|66|||
19700767|NCT00206102|42145424|FG000|Overall Study|Withdrawal by Subject|118|||
19700768|NCT00206102|42145425|FG001|Overall Study|Withdrawal by Subject|101|||
19700769|NCT00206102|42145424|FG000|Overall Study|Study-specific discontinuation criteria|18|||
19700770|NCT00206102|42145425|FG001|Overall Study|Study-specific discontinuation criteria|17|||
19700771|NCT00206102|42145424|FG000|Overall Study|None of those categories|42|||
19700772|NCT00206102|42145425|FG001|Overall Study|None of those categories|36|||
19700773|NCT00041080|42145433|FG000|Overall Study|Adverse Event|21|||
19700774|NCT00041080|42145434|FG001|Overall Study|Adverse Event|1|||
19700775|NCT00041080|42145433|FG000|Overall Study|Withdrawal by Subject|6|||
19700776|NCT00041080|42145434|FG001|Overall Study|Withdrawal by Subject|6|||
19700777|NCT00041080|42145433|FG000|Overall Study|Concommitant Illness/Other|1|||
19700778|NCT00041080|42145434|FG001|Overall Study|Concommitant Illness/Other|2|||
19700779|NCT00041080|42145433|FG000|Overall Study|Did not start therapy|1|||
19700780|NCT00041080|42145434|FG001|Overall Study|Did not start therapy|1|||
19700781|NCT00041080|42145433|FG000|Overall Study|Ineligible|1|||
19700782|NCT00041080|42145434|FG001|Overall Study|Ineligible|0|||
19700783|NCT00205712|42145442|FG000|Overall Study|Lost to Follow-up|0|||
19700784|NCT00205712|42145443|FG001|Overall Study|Lost to Follow-up|1|||
19700785|NCT00203294|42145453|FG000|Overall Study|Withdrawal by Subject|8|||
19700786|NCT00203294|42145454|FG001|Overall Study|Withdrawal by Subject|13|||
19700787|NCT00264290|42145462|FG000|Intervention (8 Weeks)|Adverse Event|1|||
19700788|NCT00264290|42145463|FG001|Intervention (8 Weeks)|Adverse Event|0|||
19700789|NCT00234494|42145473|FG000|Overall Study|Protocol Violation|2|||
19700790|NCT00234104|42145481|FG000|Overall Study|Adverse Event|4|||
19700791|NCT00234104|42145482|FG001|Overall Study|Adverse Event|0|||
19700792|NCT00234104|42145483|FG002|Overall Study|Adverse Event|3|||
19700793|NCT00234104|42145484|FG003|Overall Study|Adverse Event|5|||
19700794|NCT00234104|42145481|FG000|Overall Study|Protocol Violation|0|||
19700795|NCT00234104|42145482|FG001|Overall Study|Protocol Violation|0|||
19700796|NCT00234104|42145483|FG002|Overall Study|Protocol Violation|0|||
19700797|NCT00234104|42145484|FG003|Overall Study|Protocol Violation|1|||
19700798|NCT00234104|42145481|FG000|Overall Study|Physician Decision|0|||
19700799|NCT00234104|42145482|FG001|Overall Study|Physician Decision|1|||
19700800|NCT00234104|42145483|FG002|Overall Study|Physician Decision|2|||
19700801|NCT00234104|42145484|FG003|Overall Study|Physician Decision|2|||
19700802|NCT00263666|42145496|FG000|Overall Study|Adverse Event|6|||
19700803|NCT00263666|42145497|FG001|Overall Study|Adverse Event|8|||
19700804|NCT00263666|42145496|FG000|Overall Study|Lost to Follow-up|1|||
19700805|NCT00263666|42145497|FG001|Overall Study|Lost to Follow-up|2|||
19700806|NCT00263666|42145496|FG000|Overall Study|Withdrawal by Subject|0|||
19700807|NCT00263666|42145497|FG001|Overall Study|Withdrawal by Subject|1|||
19700808|NCT00195338|42145503|FG000|Overall Study|Lost to Follow-up|2|||
19700809|NCT00195338|42145503|FG000|Overall Study|Adverse Event|5|||
19700810|NCT00195338|42145503|FG000|Overall Study|Lack of Efficacy|1|||
19700811|NCT00195338|42145503|FG000|Overall Study|Early closure of the site|4|||
19700812|NCT00039130|42145507|FG000|Overall Study|Adverse Event|11|||
19700813|NCT00039130|42145507|FG000|Overall Study|Death|9|||
19700814|NCT00039130|42145507|FG000|Overall Study|Withdrawal by Subject|3|||
19700815|NCT00039130|42145507|FG000|Overall Study|Progression|2|||
19700816|NCT00039130|42145507|FG000|Overall Study|Subsequent treatment|2|||
19700817|NCT00039130|42145507|FG000|Overall Study|Physician Decision|3|||
19700818|NCT00035932|42145514|FG000|Overall Study|Adverse Event|10|||
19700819|NCT00035932|42145515|FG001|Overall Study|Adverse Event|9|||
19700820|NCT00035932|42145516|FG002|Overall Study|Adverse Event|9|||
19700821|NCT00035932|42145514|FG000|Overall Study|Death|0|||
19700822|NCT00035932|42145515|FG001|Overall Study|Death|0|||
19700823|NCT00035932|42145516|FG002|Overall Study|Death|1|||
19700824|NCT00035932|42145514|FG000|Overall Study|Disease Progression / Relapse|1|||
19700825|NCT00035932|42145515|FG001|Overall Study|Disease Progression / Relapse|1|||
19700826|NCT00035932|42145516|FG002|Overall Study|Disease Progression / Relapse|0|||
19700827|NCT00035932|42145514|FG000|Overall Study|Lost to Follow-up|4|||
19700828|NCT00035932|42145515|FG001|Overall Study|Lost to Follow-up|4|||
19700829|NCT00035932|42145516|FG002|Overall Study|Lost to Follow-up|3|||
19700830|NCT00035932|42145514|FG000|Overall Study|Noncompliance|6|||
19700831|NCT00035932|42145515|FG001|Overall Study|Noncompliance|7|||
19700832|NCT00035932|42145516|FG002|Overall Study|Noncompliance|6|||
19700833|NCT00035932|42145514|FG000|Overall Study|Protocol Violation While on Study|0|||
19700834|NCT00035932|42145515|FG001|Overall Study|Protocol Violation While on Study|1|||
19700835|NCT00035932|42145516|FG002|Overall Study|Protocol Violation While on Study|2|||
19700836|NCT00035932|42145514|FG000|Overall Study|Withdrawal by Subject|1|||
19700837|NCT00035932|42145515|FG001|Overall Study|Withdrawal by Subject|5|||
19700838|NCT00035932|42145516|FG002|Overall Study|Withdrawal by Subject|0|||
19700839|NCT00035932|42145514|FG000|Overall Study|Study Termination by Sponsor|1|||
19700840|NCT00035932|42145515|FG001|Overall Study|Study Termination by Sponsor|0|||
19700841|NCT00035932|42145516|FG002|Overall Study|Study Termination by Sponsor|0|||
19700842|NCT00035932|42145514|FG000|Overall Study|Lack of Efficacy|33|||
19700843|NCT00035932|42145515|FG001|Overall Study|Lack of Efficacy|33|||
19700844|NCT00035932|42145516|FG002|Overall Study|Lack of Efficacy|28|||
19700845|NCT00022516|42145531|FG000|Overall Study|Adverse Event|0|||
19700846|NCT00022516|42145532|FG001|Overall Study|Adverse Event|59|||
19700847|NCT00022516|42145531|FG000|Overall Study|Lack of Efficacy|0|||
19700848|NCT00022516|42145532|FG001|Overall Study|Lack of Efficacy|27|||
19700849|NCT00022516|42145531|FG000|Overall Study|Physician Decision|0|||
19700850|NCT00022516|42145532|FG001|Overall Study|Physician Decision|1|||
19700851|NCT00022516|42145531|FG000|Overall Study|Protocol Violation|1|||
19700852|NCT00022516|42145532|FG001|Overall Study|Protocol Violation|3|||
19700853|NCT00022516|42145531|FG000|Overall Study|Withdrawal by Subject|2|||
19700854|NCT00022516|42145532|FG001|Overall Study|Withdrawal by Subject|113|||
19700855|NCT00022516|42145531|FG000|Overall Study|Incomplete documentation|0|||
19700856|NCT00022516|42145532|FG001|Overall Study|Incomplete documentation|27|||
19700857|NCT00033514|42145540|FG000|Overall Study|Lost to Follow-up|1|||
19700858|NCT00033514|42145541|FG001|Overall Study|Lost to Follow-up|1|||
19700859|NCT00033514|42145540|FG000|Overall Study|Withdrawal by Subject|0|||
19700860|NCT00033514|42145541|FG001|Overall Study|Withdrawal by Subject|3|||
19700861|NCT00006916|42145548|FG000|Overall Study|Device not inserted|4|||
19700862|NCT00006916|42145548|FG000|Overall Study|Complication of device insertion|1|||
19700863|NCT00454649|42145562|FG000|Overall Study|Lack of Efficacy|2|||
19700864|NCT00454649|42145563|FG001|Overall Study|Lack of Efficacy|2|||
19700865|NCT00454649|42145564|FG002|Overall Study|Lack of Efficacy|10|||
19700866|NCT00454649|42145565|FG003|Overall Study|Lack of Efficacy|3|||
19700867|NCT00454649|42145566|FG004|Overall Study|Lack of Efficacy|0|||
19700868|NCT00454649|42145567|FG005|Overall Study|Lack of Efficacy|4|||
19700869|NCT00454649|42145568|FG006|Overall Study|Lack of Efficacy|5|||
19700870|NCT00454649|42145569|FG007|Overall Study|Lack of Efficacy|13|||
19700871|NCT00454649|42145570|FG008|Overall Study|Lack of Efficacy|10|||
19700872|NCT00454649|42145571|FG009|Overall Study|Lack of Efficacy|2|||
19700873|NCT00454649|42145562|FG000|Overall Study|Adverse Event|0|||
19700874|NCT00454649|42145563|FG001|Overall Study|Adverse Event|1|||
19700875|NCT00454649|42145564|FG002|Overall Study|Adverse Event|3|||
19700876|NCT00454649|42145565|FG003|Overall Study|Adverse Event|0|||
19700877|NCT00454649|42145566|FG004|Overall Study|Adverse Event|1|||
19700878|NCT00454649|42145567|FG005|Overall Study|Adverse Event|2|||
19700879|NCT00454649|42145568|FG006|Overall Study|Adverse Event|3|||
19700880|NCT00454649|42145569|FG007|Overall Study|Adverse Event|4|||
19700881|NCT00454649|42145570|FG008|Overall Study|Adverse Event|6|||
19700882|NCT00454649|42145571|FG009|Overall Study|Adverse Event|2|||
19700883|NCT00454649|42145562|FG000|Overall Study|Lost to Follow-up|0|||
19700884|NCT00454649|42145563|FG001|Overall Study|Lost to Follow-up|0|||
19700885|NCT00454649|42145564|FG002|Overall Study|Lost to Follow-up|1|||
19700886|NCT00454649|42145565|FG003|Overall Study|Lost to Follow-up|0|||
19700887|NCT00454649|42145566|FG004|Overall Study|Lost to Follow-up|0|||
19700888|NCT00454649|42145567|FG005|Overall Study|Lost to Follow-up|0|||
19700889|NCT00454649|42145568|FG006|Overall Study|Lost to Follow-up|1|||
19700890|NCT00454649|42145569|FG007|Overall Study|Lost to Follow-up|0|||
19700891|NCT00454649|42145570|FG008|Overall Study|Lost to Follow-up|0|||
19700892|NCT00454649|42145571|FG009|Overall Study|Lost to Follow-up|0|||
19700893|NCT00454649|42145562|FG000|Overall Study|Other|1|||
19700894|NCT00454649|42145563|FG001|Overall Study|Other|1|||
19700895|NCT00454649|42145564|FG002|Overall Study|Other|5|||
19700896|NCT00454649|42145565|FG003|Overall Study|Other|3|||
19700897|NCT00454649|42145566|FG004|Overall Study|Other|0|||
19700898|NCT00454649|42145567|FG005|Overall Study|Other|0|||
19700899|NCT00454649|42145568|FG006|Overall Study|Other|0|||
19700900|NCT00454649|42145569|FG007|Overall Study|Other|0|||
19700901|NCT00454649|42145570|FG008|Overall Study|Other|3|||
19700902|NCT00454649|42145571|FG009|Overall Study|Other|1|||
19700903|NCT00454649|42145562|FG000|Overall Study|Withdrawal by Subject|0|||
19700904|NCT00454649|42145563|FG001|Overall Study|Withdrawal by Subject|0|||
19700905|NCT00454649|42145564|FG002|Overall Study|Withdrawal by Subject|0|||
19700906|NCT00454649|42145565|FG003|Overall Study|Withdrawal by Subject|0|||
19700907|NCT00454649|42145566|FG004|Overall Study|Withdrawal by Subject|0|||
19700908|NCT00454649|42145567|FG005|Overall Study|Withdrawal by Subject|1|||
19700909|NCT00454649|42145568|FG006|Overall Study|Withdrawal by Subject|0|||
19700910|NCT00454649|42145569|FG007|Overall Study|Withdrawal by Subject|2|||
19700911|NCT00454649|42145570|FG008|Overall Study|Withdrawal by Subject|1|||
19700912|NCT00454649|42145571|FG009|Overall Study|Withdrawal by Subject|0|||
19700913|NCT00454571|42145614|FG000|Overall Study|Adverse Event|2|||
19700914|NCT00454571|42145615|FG001|Overall Study|Adverse Event|0|||
19700915|NCT00454571|42145614|FG000|Overall Study|Physician Decision|0|||
19700916|NCT00454571|42145615|FG001|Overall Study|Physician Decision|1|||
19700917|NCT00454571|42145614|FG000|Overall Study|Protocol Violation|1|||
19700918|NCT00454571|42145615|FG001|Overall Study|Protocol Violation|0|||
19700919|NCT00454571|42145614|FG000|Overall Study|Withdrawal by Subject|10|||
19700920|NCT00454571|42145615|FG001|Overall Study|Withdrawal by Subject|5|||
19700921|NCT03837743|42145621|FG000|Overall Study|Adverse Event|1|||
19700922|NCT03837743|42145621|FG000|Overall Study|Withdrawal by Subject|2|||
19700923|NCT03836729|42145629|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
19700924|NCT00443729|42145639|FG000|Overall Study|Never Treated|0|||
19700925|NCT00443729|42145640|FG001|Overall Study|Never Treated|1|||
19700926|NCT00443729|42145639|FG000|Overall Study|Lack of Efficacy|4|||
19700927|NCT00443729|42145640|FG001|Overall Study|Lack of Efficacy|2|||
19700928|NCT00443729|42145639|FG000|Overall Study|Lost to Follow-up|0|||
19700929|NCT00443729|42145640|FG001|Overall Study|Lost to Follow-up|1|||
19700930|NCT00443729|42145639|FG000|Overall Study|Physician Decision|2|||
19700931|NCT00443729|42145640|FG001|Overall Study|Physician Decision|1|||
19700932|NCT00443729|42145639|FG000|Overall Study|Protocol Violation|1|||
19700933|NCT00443729|42145640|FG001|Overall Study|Protocol Violation|1|||
19700934|NCT00443729|42145639|FG000|Overall Study|Withdrawal by Subject|3|||
19700935|NCT00443729|42145640|FG001|Overall Study|Withdrawal by Subject|1|||
19700936|NCT00443651|42145648|FG000|Overall Study|Death|1|||
19700937|NCT00443651|42145649|FG001|Overall Study|Death|5|||
19700938|NCT00443651|42145648|FG000|Overall Study|Adverse Event|5|||
19700939|NCT00443651|42145649|FG001|Overall Study|Adverse Event|6|||
19700940|NCT00443651|42145648|FG000|Overall Study|Lost to Follow-up|18|||
19700941|NCT00443651|42145649|FG001|Overall Study|Lost to Follow-up|12|||
19700942|NCT00443651|42145648|FG000|Overall Study|Patient's/Guardian's Decision|58|||
19700943|NCT00443651|42145649|FG001|Overall Study|Patient's/Guardian's Decision|30|||
19700944|NCT00443651|42145648|FG000|Overall Study|Physician Decision|13|||
19700945|NCT00443651|42145649|FG001|Overall Study|Physician Decision|4|||
19700946|NCT00443651|42145648|FG000|Overall Study|Pregnancy|0|||
19700947|NCT00443651|42145649|FG001|Overall Study|Pregnancy|1|||
19700948|NCT00443261|42145655|FG000|Overall Study|Death|1|||
19700949|NCT00439517|42145661|FG000|Overall Study|Subject on treatment|1|||
19700950|NCT00439517|42145662|FG001|Overall Study|Subject on treatment|0|||
19700951|NCT00439517|42145661|FG000|Overall Study|Subject in survival follow-up|1|||
19700952|NCT00439517|42145662|FG001|Overall Study|Subject in survival follow-up|0|||
19700953|NCT00438815|42145668|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
19700954|NCT00438815|42145668|FG000|Overall Study|3-month follow-up no longer required|12|||
19700955|NCT00438815|42145668|FG000|Overall Study|Noncompliance with protocol requirements|9|||
19700956|NCT00438815|42145668|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
19700957|NCT00438815|42145668|FG000|Overall Study|Lost to Follow-up|6|||
19700958|NCT00438815|42145668|FG000|Overall Study|Withdrawal by Subject|6|||
19700959|NCT00438815|42145668|FG000|Overall Study|Death|1|||
19700960|NCT00438659|42145674|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
19700961|NCT00438659|42145675|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
19700962|NCT00438659|42145674|FG000|Overall Study|Cancel|5|||
19700963|NCT00438659|42145675|FG001|Overall Study|Cancel|2|||
19700964|NCT00437645|42145684|FG000|Overall Study|Adverse Event|15|||
19700965|NCT00437645|42145685|FG001|Overall Study|Adverse Event|84|||
19700966|NCT00437645|42145684|FG000|Overall Study|Withdrawal by Subject|10|||
19700967|NCT00437645|42145685|FG001|Overall Study|Withdrawal by Subject|22|||
19700968|NCT00437645|42145684|FG000|Overall Study|Protocol Violation|3|||
19700969|NCT00437645|42145685|FG001|Overall Study|Protocol Violation|3|||
19700970|NCT00437645|42145684|FG000|Overall Study|Lost to Follow-up|2|||
19700971|NCT00437645|42145685|FG001|Overall Study|Lost to Follow-up|3|||
19700972|NCT00437645|42145684|FG000|Overall Study|Administrative problems|2|||
19700973|NCT00437645|42145685|FG001|Overall Study|Administrative problems|1|||
19700974|NCT00437645|42145684|FG000|Overall Study|Lack of Efficacy|2|||
19700975|NCT00437645|42145685|FG001|Overall Study|Lack of Efficacy|1|||
19700976|NCT00437645|42145684|FG000|Overall Study|Condition no longer requires study drug|1|||
19700977|NCT00437645|42145685|FG001|Overall Study|Condition no longer requires study drug|1|||
19700978|NCT00437489|42145693|FG000|Overall Study|Study terminated by sponsor|23|||
19700979|NCT00437489|42145694|FG001|Overall Study|Study terminated by sponsor|21|||
19700980|NCT00437489|42145693|FG000|Overall Study|Lost to Follow-up|0|||
19700981|NCT00437489|42145694|FG001|Overall Study|Lost to Follow-up|1|||
19700982|NCT00442559|42145702|FG000|Overall Study|Lost to Follow-up|32|||
19700983|NCT00442559|42145703|FG001|Overall Study|Lost to Follow-up|34|||
19700984|NCT00442559|42145702|FG000|Overall Study|Protocol Violation|1|||
19700985|NCT00442559|42145703|FG001|Overall Study|Protocol Violation|1|||
19700986|NCT00442559|42145702|FG000|Overall Study|Withdrawal by Subject|1|||
19700987|NCT00442559|42145703|FG001|Overall Study|Withdrawal by Subject|0|||
19700988|NCT00441701|42145725|FG000|Overall Study|Adverse Event|3|||
19700989|NCT00441701|42145726|FG001|Overall Study|Adverse Event|2|||
19700990|NCT00441701|42145727|FG002|Overall Study|Adverse Event|1|||
19700991|NCT00441701|42145728|FG003|Overall Study|Adverse Event|0|||
19700992|NCT00441701|42145729|FG004|Overall Study|Adverse Event|2|||
19700993|NCT00441701|42145730|FG005|Overall Study|Adverse Event|2|||
19700994|NCT00441701|42145731|FG006|Overall Study|Adverse Event|0|||
19700995|NCT00441701|42145732|FG007|Overall Study|Adverse Event|0|||
19700996|NCT00441701|42145733|FG008|Overall Study|Adverse Event|0|||
19700997|NCT00441701|42145734|FG009|Overall Study|Adverse Event|0|||
19700998|NCT00441701|42145725|FG000|Overall Study|Lack of Efficacy|2|||
19700999|NCT00441701|42145726|FG001|Overall Study|Lack of Efficacy|0|||
19701000|NCT00441701|42145727|FG002|Overall Study|Lack of Efficacy|2|||
19701001|NCT00441701|42145728|FG003|Overall Study|Lack of Efficacy|2|||
19701002|NCT00441701|42145729|FG004|Overall Study|Lack of Efficacy|0|||
19701003|NCT00441701|42145730|FG005|Overall Study|Lack of Efficacy|1|||
19701004|NCT00441701|42145731|FG006|Overall Study|Lack of Efficacy|0|||
19701005|NCT00441701|42145732|FG007|Overall Study|Lack of Efficacy|0|||
19701006|NCT00441701|42145733|FG008|Overall Study|Lack of Efficacy|0|||
19701007|NCT00441701|42145734|FG009|Overall Study|Lack of Efficacy|0|||
19701008|NCT00441701|42145725|FG000|Overall Study|Withdrawal by Subject|0|||
19701009|NCT00441701|42145726|FG001|Overall Study|Withdrawal by Subject|2|||
19701010|NCT00441701|42145727|FG002|Overall Study|Withdrawal by Subject|1|||
19701011|NCT00441701|42145728|FG003|Overall Study|Withdrawal by Subject|1|||
19701012|NCT00441701|42145729|FG004|Overall Study|Withdrawal by Subject|0|||
19701013|NCT00441701|42145730|FG005|Overall Study|Withdrawal by Subject|0|||
19701014|NCT00441701|42145731|FG006|Overall Study|Withdrawal by Subject|0|||
19701015|NCT00441701|42145732|FG007|Overall Study|Withdrawal by Subject|0|||
19701016|NCT00441701|42145733|FG008|Overall Study|Withdrawal by Subject|0|||
19701017|NCT00441701|42145734|FG009|Overall Study|Withdrawal by Subject|0|||
19701018|NCT00441545|42145752|FG000|First Intervention|Adverse Event|6|||
19609307|NCT00969761|42058445|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609308|NCT00969761|42058446|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19701019|NCT00441545|42145753|FG001|First Intervention|Adverse Event|5|||
19701020|NCT00441545|42145752|FG000|First Intervention|Protocol Violation|2|||
19701021|NCT00441545|42145753|FG001|First Intervention|Protocol Violation|2|||
19701022|NCT00441545|42145752|FG000|First Intervention|Withdrawal by Subject|3|||
19609309|NCT00969761|42058447|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609310|NCT00969761|42058448|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609311|NCT00969761|42058449|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609312|NCT00969761|42058450|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609313|NCT00969761|42058451|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609314|NCT00969761|42058452|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
19609315|NCT00969761|42058441|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609316|NCT00969761|42058442|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609317|NCT00969761|42058443|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19701023|NCT00441545|42145753|FG001|First Intervention|Withdrawal by Subject|3|||
19701024|NCT00441545|42145752|FG000|First Intervention|Kidney transplant|1|||
19701025|NCT00441545|42145753|FG001|First Intervention|Kidney transplant|1|||
19701026|NCT00441545|42145752|FG000|First Intervention|Lack of Efficacy|2|||
19701027|NCT00441545|42145753|FG001|First Intervention|Lack of Efficacy|0|||
19701028|NCT00441545|42145752|FG000|First Intervention|Subject exceeded safety criteria|0|||
19701029|NCT00441545|42145753|FG001|First Intervention|Subject exceeded safety criteria|1|||
19701030|NCT00441545|42145752|FG000|First Intervention|Subject met an exclusionary criteria|1|||
19701031|NCT00441545|42145753|FG001|First Intervention|Subject met an exclusionary criteria|0|||
19701032|NCT00441545|42145752|FG000|First Intervention|Extended hospitalization|1|||
19701033|NCT00441545|42145753|FG001|First Intervention|Extended hospitalization|0|||
19701034|NCT00441545|42145752|FG000|First Intervention|Site error|1|||
19701035|NCT00441545|42145753|FG001|First Intervention|Site error|0|||
19701036|NCT00441545|42145752|FG000|First Intervention|Sponsor's request|1|||
19701037|NCT00441545|42145753|FG001|First Intervention|Sponsor's request|0|||
19701038|NCT00441545|42145752|FG000|Second Intervention|Adverse Event|5|||
19800247|NCT02861807|42258317|FG000|Overall Study|Withdrawal by Subject|5|||
19478410|NCT01502371|41757693|FG001|Overall Study|Lack of Efficacy|3|||
19701039|NCT00441545|42145753|FG001|Second Intervention|Adverse Event|2|||
19701040|NCT00441545|42145752|FG000|Second Intervention|Protocol Violation|4|||
19701041|NCT00441545|42145753|FG001|Second Intervention|Protocol Violation|1|||
19701042|NCT00441545|42145752|FG000|Second Intervention|Withdrawal by Subject|1|||
19701043|NCT00441545|42145753|FG001|Second Intervention|Withdrawal by Subject|1|||
19701044|NCT00441545|42145752|FG000|Second Intervention|Kidney Transplant|1|||
19701045|NCT00441545|42145753|FG001|Second Intervention|Kidney Transplant|1|||
19701046|NCT00441545|42145752|FG000|Second Intervention|Lack of Efficacy|0|||
19701047|NCT00441545|42145753|FG001|Second Intervention|Lack of Efficacy|1|||
19701048|NCT00441545|42145752|FG000|Second Intervention|Subject exceeded safety criteria|1|||
19701049|NCT00441545|42145753|FG001|Second Intervention|Subject exceeded safety criteria|0|||
19701050|NCT00441545|42145752|FG000|Second Intervention|Subject moved|0|||
19701051|NCT00441545|42145753|FG001|Second Intervention|Subject moved|1|||
19701052|NCT00436553|42145762|FG000|Overall Study|Adverse Event|4|||
19701053|NCT00436553|42145763|FG001|Overall Study|Adverse Event|3|||
19701054|NCT00436553|42145764|FG002|Overall Study|Adverse Event|4|||
19701055|NCT00436553|42145762|FG000|Overall Study|Death|3|||
19701056|NCT00436553|42145763|FG001|Overall Study|Death|1|||
19701057|NCT00436553|42145764|FG002|Overall Study|Death|3|||
19701058|NCT00436553|42145762|FG000|Overall Study|Lost to Follow-up|0|||
19701059|NCT00436553|42145763|FG001|Overall Study|Lost to Follow-up|2|||
19701060|NCT00436553|42145764|FG002|Overall Study|Lost to Follow-up|0|||
19609318|NCT00969761|42058444|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609319|NCT00969761|42058445|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609320|NCT00969761|42058446|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609321|NCT00969761|42058447|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609322|NCT00969761|42058448|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609323|NCT00969761|42058449|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
19609324|NCT00969761|42058450|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609325|NCT00969761|42058451|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19609326|NCT00969761|42058452|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
19701061|NCT00436553|42145762|FG000|Overall Study|Protocol Violation|1|||
19609327|NCT00969761|42058441|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
19609328|NCT00969761|42058442|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609329|NCT00969761|42058443|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
19609330|NCT00969761|42058444|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609331|NCT00969761|42058445|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
19701062|NCT00436553|42145763|FG001|Overall Study|Protocol Violation|0|||
19701063|NCT00436553|42145764|FG002|Overall Study|Protocol Violation|0|||
19701064|NCT00436553|42145762|FG000|Overall Study|Withdrawal by Subject|5|||
19701065|NCT00436553|42145763|FG001|Overall Study|Withdrawal by Subject|6|||
19701066|NCT00436553|42145764|FG002|Overall Study|Withdrawal by Subject|3|||
19701067|NCT00441467|42145772|FG000|Overall Study|Adverse Event|6|||
19701068|NCT00441467|42145772|FG000|Overall Study|Withdrawal by Subject|3|||
19701069|NCT00441467|42145772|FG000|Overall Study|Progressive disease|9|||
19701070|NCT00436163|42145776|FG000|Overall Study|Lost to Follow-up|2|||
19701071|NCT00436163|42145776|FG000|Overall Study|Adverse Event|1|||
19701072|NCT00006604|42145788|FG000|Overall Study|Met study objective - no further FU|1|||
19701073|NCT00006604|42145789|FG001|Overall Study|Met study objective - no further FU|0|||
19701074|NCT00006604|42145790|FG002|Overall Study|Met study objective - no further FU|0|||
19701075|NCT00006604|42145791|FG003|Overall Study|Met study objective - no further FU|0|||
19701076|NCT00006604|42145792|FG004|Overall Study|Met study objective - no further FU|0|||
19701077|NCT00006604|42145793|FG005|Overall Study|Met study objective - no further FU|0|||
19701078|NCT00006604|42145794|FG006|Overall Study|Met study objective - no further FU|0|||
19701079|NCT00006604|42145795|FG007|Overall Study|Met study objective - no further FU|0|||
19701080|NCT00006604|42145796|FG008|Overall Study|Met study objective - no further FU|0|||
19701081|NCT00006604|42145797|FG009|Overall Study|Met study objective - no further FU|0|||
19701082|NCT00006604|42145798|FG010|Overall Study|Met study objective - no further FU|0|||
19701083|NCT00006604|42145799|FG011|Overall Study|Met study objective - no further FU|0|||
19701084|NCT00006604|42145800|FG012|Overall Study|Met study objective - no further FU|0|||
19701085|NCT00006604|42145801|FG013|Overall Study|Met study objective - no further FU|0|||
19701086|NCT00006604|42145802|FG014|Overall Study|Met study objective - no further FU|1|||
19701087|NCT00006604|42145803|FG015|Overall Study|Met study objective - no further FU|1|||
19701088|NCT00006604|42145804|FG016|Overall Study|Met study objective - no further FU|0|||
19701089|NCT00006604|42145788|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
19701090|NCT00006604|42145789|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
19701091|NCT00006604|42145790|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
19701092|NCT00006604|42145791|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
19701093|NCT00006604|42145792|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
19701094|NCT00006604|42145793|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
19701095|NCT00006604|42145794|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
19701096|NCT00006604|42145795|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
19701097|NCT00006604|42145796|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
19701098|NCT00006604|42145797|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
19701099|NCT00006604|42145798|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
19701100|NCT00006604|42145799|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
19701101|NCT00006604|42145800|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
19701102|NCT00006604|42145801|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
19701103|NCT00006604|42145802|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
19701104|NCT00006604|42145803|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
19609332|NCT00969761|42058446|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609333|NCT00969761|42058447|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609334|NCT00969761|42058448|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
19609335|NCT00969761|42058449|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
19701105|NCT00006604|42145804|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
19701106|NCT00006604|42145788|FG000|Overall Study|Death|0|||
19701107|NCT00006604|42145789|FG001|Overall Study|Death|0|||
19701108|NCT00006604|42145790|FG002|Overall Study|Death|0|||
19701109|NCT00006604|42145791|FG003|Overall Study|Death|0|||
19701110|NCT00006604|42145792|FG004|Overall Study|Death|0|||
19701111|NCT00006604|42145793|FG005|Overall Study|Death|0|||
19701112|NCT00006604|42145794|FG006|Overall Study|Death|0|||
19701113|NCT00006604|42145795|FG007|Overall Study|Death|0|||
19701114|NCT00006604|42145796|FG008|Overall Study|Death|0|||
19701115|NCT00006604|42145797|FG009|Overall Study|Death|1|||
19701116|NCT00006604|42145798|FG010|Overall Study|Death|1|||
19609336|NCT00969761|42058450|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
19609337|NCT00969761|42058451|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609338|NCT00969761|42058452|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
19609339|NCT00969761|42058441|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609340|NCT00969761|42058442|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609341|NCT00969761|42058443|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609342|NCT00969761|42058444|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
19609343|NCT00969761|42058445|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
19609344|NCT00969761|42058446|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609345|NCT00969761|42058447|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609346|NCT00969761|42058448|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609347|NCT00969761|42058449|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
19609348|NCT00969761|42058450|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609349|NCT00969761|42058451|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609350|NCT00969761|42058452|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
19609351|NCT00845871|42058478|FG000|Assessment Period|Adverse Event|2|||
19609352|NCT00845871|42058478|FG000|Assessment Period|Abnormal laboratory values|1|||
19609353|NCT00845871|42058478|FG000|Assessment Period|Abnormal test procedure results|1|||
19609354|NCT00845871|42058478|FG000|Assessment Period|Patient withdrew consent|3|||
19609355|NCT00915278|42058508|FG000|Overall Study|Death|1|||
19609356|NCT00915278|42058509|FG001|Overall Study|Death|0|||
19609357|NCT00915278|42058510|FG002|Overall Study|Death|0|||
19609358|NCT00915278|42058511|FG003|Overall Study|Death|0|||
19609359|NCT00915278|42058512|FG004|Overall Study|Death|0|||
19609360|NCT00915278|42058513|FG005|Overall Study|Death|0|||
19609361|NCT00915278|42058508|FG000|Overall Study|Lost to Follow-up|0|||
19609362|NCT00915278|42058509|FG001|Overall Study|Lost to Follow-up|1|||
19609363|NCT00915278|42058510|FG002|Overall Study|Lost to Follow-up|0|||
19609364|NCT00915278|42058511|FG003|Overall Study|Lost to Follow-up|0|||
19609365|NCT00915278|42058512|FG004|Overall Study|Lost to Follow-up|0|||
19609366|NCT00915278|42058513|FG005|Overall Study|Lost to Follow-up|0|||
19609367|NCT00915278|42058508|FG000|Overall Study|Withdrawal by Subject|0|||
19609368|NCT00915278|42058509|FG001|Overall Study|Withdrawal by Subject|1|||
19609369|NCT00915278|42058510|FG002|Overall Study|Withdrawal by Subject|0|||
19609370|NCT00915278|42058511|FG003|Overall Study|Withdrawal by Subject|0|||
19609371|NCT00915278|42058512|FG004|Overall Study|Withdrawal by Subject|1|||
19609372|NCT00915278|42058513|FG005|Overall Study|Withdrawal by Subject|4|||
19609373|NCT00915278|42058508|FG000|Overall Study|Adverse Event|4|||
19609374|NCT00915278|42058509|FG001|Overall Study|Adverse Event|1|||
19609375|NCT00915278|42058510|FG002|Overall Study|Adverse Event|0|||
19609376|NCT00915278|42058511|FG003|Overall Study|Adverse Event|0|||
19609377|NCT00915278|42058512|FG004|Overall Study|Adverse Event|0|||
19701117|NCT00006604|42145799|FG011|Overall Study|Death|1|||
19609378|NCT00915278|42058513|FG005|Overall Study|Adverse Event|0|||
19609379|NCT00915278|42058508|FG000|Overall Study|Progressive disease/clinical progression|0|||
19609380|NCT00915278|42058509|FG001|Overall Study|Progressive disease/clinical progression|0|||
19609381|NCT00915278|42058510|FG002|Overall Study|Progressive disease/clinical progression|0|||
19609382|NCT00915278|42058511|FG003|Overall Study|Progressive disease/clinical progression|3|||
19701118|NCT00006604|42145800|FG012|Overall Study|Death|0|||
19609383|NCT00915278|42058512|FG004|Overall Study|Progressive disease/clinical progression|1|||
19609384|NCT00915278|42058513|FG005|Overall Study|Progressive disease/clinical progression|2|||
19609385|NCT00915278|42058508|FG000|Overall Study|Infusion related AEs|0|||
19609386|NCT00915278|42058509|FG001|Overall Study|Infusion related AEs|0|||
19609387|NCT00915278|42058510|FG002|Overall Study|Infusion related AEs|0|||
19609388|NCT00915278|42058511|FG003|Overall Study|Infusion related AEs|0|||
19609389|NCT00915278|42058512|FG004|Overall Study|Infusion related AEs|0|||
19609390|NCT00915278|42058513|FG005|Overall Study|Infusion related AEs|2|||
19609391|NCT00915278|42058508|FG000|Overall Study|Admission to hospice|0|||
19609392|NCT00915278|42058509|FG001|Overall Study|Admission to hospice|0|||
19609393|NCT00915278|42058510|FG002|Overall Study|Admission to hospice|1|||
19609394|NCT00915278|42058511|FG003|Overall Study|Admission to hospice|0|||
19609395|NCT00915278|42058512|FG004|Overall Study|Admission to hospice|0|||
19609396|NCT00915278|42058513|FG005|Overall Study|Admission to hospice|0|||
19609397|NCT00844857|42058529|FG000|Overall Study|Adverse Event|24|||
19609398|NCT00844857|42058530|FG001|Overall Study|Adverse Event|5|||
19609399|NCT00844857|42058529|FG000|Overall Study|Sponsor Decision|1|||
19609400|NCT00844857|42058530|FG001|Overall Study|Sponsor Decision|1|||
19609401|NCT00844857|42058529|FG000|Overall Study|Physician Decision|2|||
19609402|NCT00844857|42058530|FG001|Overall Study|Physician Decision|0|||
19609403|NCT00844857|42058529|FG000|Overall Study|Parent/Caregiver Decision|6|||
19609404|NCT00844857|42058530|FG001|Overall Study|Parent/Caregiver Decision|2|||
19701119|NCT00006604|42145801|FG013|Overall Study|Death|0|||
19701120|NCT00006604|42145802|FG014|Overall Study|Death|0|||
19701121|NCT00006604|42145803|FG015|Overall Study|Death|0|||
19701122|NCT00006604|42145804|FG016|Overall Study|Death|0|||
19701123|NCT00006604|42145788|FG000|Overall Study|Severe debilitation, unable to continue|0|||
19701124|NCT00006604|42145789|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19701125|NCT00006604|42145790|FG002|Overall Study|Severe debilitation, unable to continue|0|||
19701126|NCT00006604|42145791|FG003|Overall Study|Severe debilitation, unable to continue|0|||
19701127|NCT00006604|42145792|FG004|Overall Study|Severe debilitation, unable to continue|0|||
19701128|NCT00006604|42145793|FG005|Overall Study|Severe debilitation, unable to continue|0|||
19701129|NCT00006604|42145794|FG006|Overall Study|Severe debilitation, unable to continue|3|||
19701130|NCT00006604|42145795|FG007|Overall Study|Severe debilitation, unable to continue|0|||
19701131|NCT00006604|42145796|FG008|Overall Study|Severe debilitation, unable to continue|0|||
19701132|NCT00006604|42145797|FG009|Overall Study|Severe debilitation, unable to continue|5|||
19609405|NCT00844857|42058529|FG000|Overall Study|Withdrawal by Subject|8|||
19609406|NCT00844857|42058530|FG001|Overall Study|Withdrawal by Subject|7|||
19609407|NCT00844857|42058529|FG000|Overall Study|Protocol Violation|6|||
19609408|NCT00844857|42058530|FG001|Overall Study|Protocol Violation|0|||
19609409|NCT00844857|42058529|FG000|Overall Study|Lack of Efficacy|5|||
19609410|NCT00844857|42058530|FG001|Overall Study|Lack of Efficacy|5|||
19609411|NCT00844857|42058529|FG000|Overall Study|Clinical Relapse|0|||
19701133|NCT00006604|42145798|FG010|Overall Study|Severe debilitation, unable to continue|0|||
19701134|NCT00006604|42145799|FG011|Overall Study|Severe debilitation, unable to continue|2|||
19701135|NCT00006604|42145800|FG012|Overall Study|Severe debilitation, unable to continue|1|||
19701136|NCT00006604|42145801|FG013|Overall Study|Severe debilitation, unable to continue|0|||
19701137|NCT00006604|42145802|FG014|Overall Study|Severe debilitation, unable to continue|2|||
19701138|NCT00006604|42145803|FG015|Overall Study|Severe debilitation, unable to continue|0|||
19701139|NCT00006604|42145804|FG016|Overall Study|Severe debilitation, unable to continue|0|||
19701140|NCT00006604|42145788|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
19701141|NCT00006604|42145789|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
19701142|NCT00006604|42145790|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
19701143|NCT00006604|42145791|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
19701144|NCT00006604|42145792|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
19701145|NCT00006604|42145793|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
19701146|NCT00006604|42145794|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
19701147|NCT00006604|42145795|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
19701148|NCT00006604|42145796|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
19701149|NCT00006604|42145797|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
19701150|NCT00006604|42145798|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
19701151|NCT00006604|42145799|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
19701152|NCT00006604|42145800|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
19478411|NCT01502371|41757694|FG002|Overall Study|Lack of Efficacy|2|||
19609412|NCT00844857|42058530|FG001|Overall Study|Clinical Relapse|1|||
19609413|NCT00844857|42058529|FG000|Overall Study|Entry Criteria Not Met|0|||
19609414|NCT00844857|42058530|FG001|Overall Study|Entry Criteria Not Met|1|||
19609415|NCT00844857|42058529|FG000|Overall Study|Lost to Follow-up|2|||
19609416|NCT00844857|42058530|FG001|Overall Study|Lost to Follow-up|3|||
19609417|NCT00844857|42058529|FG000|Overall Study|Did Not Take Study Drug|3|||
19609418|NCT00844857|42058530|FG001|Overall Study|Did Not Take Study Drug|1|||
19609419|NCT00844857|42058529|FG000|Overall Study|Good Clinical Practice Violations|21|||
19609420|NCT00844857|42058530|FG001|Overall Study|Good Clinical Practice Violations|11|||
19609421|NCT00569803|42058547|FG000|Overall Study|Lost to Follow-up|1|||
19609422|NCT00569803|42058548|FG001|Overall Study|Lost to Follow-up|0|||
19609423|NCT00569803|42058549|FG002|Overall Study|Lost to Follow-up|0|||
19609424|NCT00569803|42058550|FG003|Overall Study|Lost to Follow-up|0|||
19609425|NCT00569803|42058551|FG004|Overall Study|Lost to Follow-up|0|||
19609426|NCT00569803|42058552|FG005|Overall Study|Lost to Follow-up|0|||
19609427|NCT00569803|42058553|FG006|Overall Study|Lost to Follow-up|0|||
19609428|NCT00569803|42058554|FG007|Overall Study|Lost to Follow-up|0|||
19609429|NCT00569803|42058547|FG000|Overall Study|injection syringe leaked during dosing|0|||
19609430|NCT00569803|42058548|FG001|Overall Study|injection syringe leaked during dosing|0|||
19609431|NCT00569803|42058549|FG002|Overall Study|injection syringe leaked during dosing|0|||
19609432|NCT00569803|42058550|FG003|Overall Study|injection syringe leaked during dosing|1|||
19609433|NCT00569803|42058551|FG004|Overall Study|injection syringe leaked during dosing|0|||
19701153|NCT00006604|42145801|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
19701154|NCT00006604|42145802|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
19701155|NCT00006604|42145803|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
19701156|NCT00006604|42145804|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
19701157|NCT00006604|42145788|FG000|Overall Study|Site closing|0|||
19701158|NCT00006604|42145789|FG001|Overall Study|Site closing|0|||
19701159|NCT00006604|42145790|FG002|Overall Study|Site closing|1|||
19701160|NCT00006604|42145791|FG003|Overall Study|Site closing|1|||
19701161|NCT00006604|42145792|FG004|Overall Study|Site closing|0|||
19390558|NCT01677299|41634342|FG000|Overall Study|Withdrawal by Subject|0|||
19390559|NCT01677299|41634343|FG001|Overall Study|Withdrawal by Subject|1|||
19609434|NCT00569803|42058552|FG005|Overall Study|injection syringe leaked during dosing|0|||
19609435|NCT00569803|42058553|FG006|Overall Study|injection syringe leaked during dosing|0|||
19390560|NCT01677299|41634344|FG002|Overall Study|Withdrawal by Subject|0|||
19390561|NCT01677299|41634345|FG003|Overall Study|Withdrawal by Subject|1|||
19390562|NCT01964326|41634359|FG000|Overall Study|Adverse Event|48|||
19390563|NCT01964326|41634359|FG000|Overall Study|Death|2|||
19390564|NCT01964326|41634359|FG000|Overall Study|Protocol Violation|4|||
19390565|NCT01964326|41634359|FG000|Overall Study|Lost to Follow-up|88|||
19390566|NCT01964326|41634359|FG000|Overall Study|Withdrawal by Subject|87|||
19390567|NCT01964326|41634359|FG000|Overall Study|Pregnancy|1|||
19390568|NCT01964326|41634359|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
19390569|NCT01964326|41634359|FG000|Overall Study|Physician Decision|55|||
19390570|NCT01964326|41634359|FG000|Overall Study|Investigator Discretion|1|||
19390571|NCT01964326|41634359|FG000|Overall Study|Other|9|||
19390572|NCT01964326|41634359|FG000|Overall Study|Did not meet eligibility criteria|1|||
19390573|NCT02699749|41634377|FG000|Overall Study|Other|0|||
19390574|NCT02699749|41634378|FG001|Overall Study|Other|0|||
19390575|NCT02699749|41634379|FG002|Overall Study|Other|2|||
19390576|NCT02699749|41634380|FG003|Overall Study|Other|0|||
19390577|NCT02699749|41634381|FG004|Overall Study|Other|0|||
19390578|NCT02699749|41634382|FG005|Overall Study|Other|1|||
19390579|NCT02699749|41634383|FG006|Overall Study|Other|1|||
19390580|NCT02699749|41634384|FG007|Overall Study|Other|0|||
19390581|NCT02699749|41634385|FG008|Overall Study|Other|0|||
19390582|NCT02699749|41634386|FG009|Overall Study|Other|0|||
19390583|NCT02699749|41634387|FG010|Overall Study|Other|1|||
19390584|NCT02699749|41634388|FG011|Overall Study|Other|0|||
19390585|NCT02699749|41634389|FG012|Overall Study|Other|0|||
19390586|NCT02699749|41634390|FG013|Overall Study|Other|0|||
19390587|NCT02699749|41634377|FG000|Overall Study|Progressive Disease|3|||
19390588|NCT02699749|41634378|FG001|Overall Study|Progressive Disease|3|||
19390589|NCT02699749|41634379|FG002|Overall Study|Progressive Disease|14|||
19390590|NCT02699749|41634380|FG003|Overall Study|Progressive Disease|3|||
19390591|NCT02699749|41634381|FG004|Overall Study|Progressive Disease|3|||
19390592|NCT02699749|41634382|FG005|Overall Study|Progressive Disease|7|||
19390593|NCT02699749|41634383|FG006|Overall Study|Progressive Disease|5|||
19390594|NCT02699749|41634384|FG007|Overall Study|Progressive Disease|5|||
19390595|NCT02699749|41634385|FG008|Overall Study|Progressive Disease|6|||
19390596|NCT02699749|41634386|FG009|Overall Study|Progressive Disease|6|||
19390597|NCT02699749|41634387|FG010|Overall Study|Progressive Disease|5|||
19390598|NCT02699749|41634388|FG011|Overall Study|Progressive Disease|4|||
19390599|NCT02699749|41634389|FG012|Overall Study|Progressive Disease|3|||
19390600|NCT02699749|41634390|FG013|Overall Study|Progressive Disease|5|||
19390601|NCT02699749|41634377|FG000|Overall Study|Death|0|||
19390602|NCT02699749|41634378|FG001|Overall Study|Death|0|||
19390603|NCT02699749|41634379|FG002|Overall Study|Death|0|||
19390604|NCT02699749|41634380|FG003|Overall Study|Death|0|||
19390605|NCT02699749|41634381|FG004|Overall Study|Death|0|||
19390606|NCT02699749|41634382|FG005|Overall Study|Death|0|||
19390607|NCT02699749|41634383|FG006|Overall Study|Death|0|||
19390608|NCT02699749|41634384|FG007|Overall Study|Death|0|||
19390609|NCT02699749|41634385|FG008|Overall Study|Death|0|||
19390610|NCT02699749|41634386|FG009|Overall Study|Death|0|||
19701162|NCT00006604|42145793|FG005|Overall Study|Site closing|0|||
19609436|NCT00569803|42058554|FG007|Overall Study|injection syringe leaked during dosing|0|||
19609437|NCT00569803|42058547|FG000|Overall Study|Withdrawal by Subject|0|||
19609438|NCT00569803|42058548|FG001|Overall Study|Withdrawal by Subject|0|||
19609439|NCT00569803|42058549|FG002|Overall Study|Withdrawal by Subject|0|||
19609440|NCT00569803|42058550|FG003|Overall Study|Withdrawal by Subject|0|||
19609441|NCT00569803|42058551|FG004|Overall Study|Withdrawal by Subject|0|||
19609442|NCT00569803|42058552|FG005|Overall Study|Withdrawal by Subject|0|||
19609443|NCT00569803|42058553|FG006|Overall Study|Withdrawal by Subject|0|||
19609444|NCT00569803|42058554|FG007|Overall Study|Withdrawal by Subject|1|||
19609445|NCT00920426|42058579|FG000|ITZ111451|Adverse Event|1|||
19609446|NCT00920426|42058580|FG001|ITZ111451|Adverse Event|0|||
19609447|NCT00920426|42058581|FG002|ITZ111451|Adverse Event|0|||
19609448|NCT00920426|42058582|FG003|ITZ111451|Adverse Event|0|||
19609449|NCT00644995|42058596|FG000|Overall Study|Lost to Follow-up|1|||
19609450|NCT00644995|42058597|FG001|Overall Study|Lost to Follow-up|4|||
19609451|NCT00644995|42058596|FG000|Overall Study|Refused|1|||
19609452|NCT00644995|42058597|FG001|Overall Study|Refused|0|||
19609453|NCT00914966|42058605|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
19609454|NCT00914966|42058605|FG000|Step 1: 1500 Units|Physician Decision|1|||
19609455|NCT00914966|42058605|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
19609456|NCT00914810|42058616|FG000|Overall Study|Withdrawal by Subject|1|||
19609457|NCT00914810|42058617|FG001|Overall Study|Withdrawal by Subject|0|||
19609458|NCT00914810|42058616|FG000|Overall Study|Relocated out of state|1|||
19609459|NCT00914810|42058617|FG001|Overall Study|Relocated out of state|0|||
19609460|NCT00914810|42058616|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
19609461|NCT00914810|42058617|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
19609462|NCT00644917|42058623|FG000|Overall Study|Withdrawal by Subject|2|||
19609463|NCT00914732|42058634|FG000|Overall Study|Lost to Follow-up|6|||
19609464|NCT00914732|42058635|FG001|Overall Study|Lost to Follow-up|7|||
19701163|NCT00006604|42145794|FG006|Overall Study|Site closing|0|||
19701164|NCT00006604|42145795|FG007|Overall Study|Site closing|1|||
19609465|NCT00914732|42058636|FG002|Overall Study|Lost to Follow-up|9|||
19609466|NCT00914732|42058634|FG000|Overall Study|Withdrawal by Subject|3|||
19701165|NCT00006604|42145796|FG008|Overall Study|Site closing|0|||
19701166|NCT00006604|42145797|FG009|Overall Study|Site closing|0|||
19701167|NCT00006604|42145798|FG010|Overall Study|Site closing|0|||
19701168|NCT00006604|42145799|FG011|Overall Study|Site closing|1|||
19609467|NCT00914732|42058635|FG001|Overall Study|Withdrawal by Subject|0|||
19701169|NCT00006604|42145800|FG012|Overall Study|Site closing|1|||
19701170|NCT00006604|42145801|FG013|Overall Study|Site closing|1|||
19701171|NCT00006604|42145802|FG014|Overall Study|Site closing|0|||
19701172|NCT00006604|42145803|FG015|Overall Study|Site closing|0|||
19701173|NCT00006604|42145804|FG016|Overall Study|Site closing|1|||
19701174|NCT00006604|42145788|FG000|Overall Study|Withdrawal by Subject|1|||
19701175|NCT00006604|42145789|FG001|Overall Study|Withdrawal by Subject|0|||
19701176|NCT00006604|42145790|FG002|Overall Study|Withdrawal by Subject|2|||
19701177|NCT00006604|42145791|FG003|Overall Study|Withdrawal by Subject|0|||
19701178|NCT00006604|42145792|FG004|Overall Study|Withdrawal by Subject|1|||
19701179|NCT00006604|42145793|FG005|Overall Study|Withdrawal by Subject|2|||
19701180|NCT00006604|42145794|FG006|Overall Study|Withdrawal by Subject|2|||
19701181|NCT00006604|42145795|FG007|Overall Study|Withdrawal by Subject|0|||
19701182|NCT00006604|42145796|FG008|Overall Study|Withdrawal by Subject|1|||
19701183|NCT00006604|42145797|FG009|Overall Study|Withdrawal by Subject|3|||
19701184|NCT00006604|42145798|FG010|Overall Study|Withdrawal by Subject|2|||
19701185|NCT00006604|42145799|FG011|Overall Study|Withdrawal by Subject|0|||
19701186|NCT00006604|42145800|FG012|Overall Study|Withdrawal by Subject|1|||
19701187|NCT00006604|42145801|FG013|Overall Study|Withdrawal by Subject|2|||
19701188|NCT00006604|42145802|FG014|Overall Study|Withdrawal by Subject|1|||
19701189|NCT00006604|42145803|FG015|Overall Study|Withdrawal by Subject|0|||
19701190|NCT00006604|42145804|FG016|Overall Study|Withdrawal by Subject|1|||
19701191|NCT00006604|42145788|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
19701192|NCT00006604|42145789|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
19701193|NCT00006604|42145790|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
19701194|NCT00006604|42145791|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
19701195|NCT00006604|42145792|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
19701196|NCT00006604|42145793|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
19701197|NCT00006604|42145794|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
19701198|NCT00006604|42145795|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
19701199|NCT00006604|42145796|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
19701200|NCT00006604|42145797|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
19701201|NCT00006604|42145798|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
19701202|NCT00006604|42145799|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
19609468|NCT00914732|42058636|FG002|Overall Study|Withdrawal by Subject|2|||
19609469|NCT00914732|42058634|FG000|Overall Study|Adverse Event|1|||
19609470|NCT00914732|42058635|FG001|Overall Study|Adverse Event|0|||
19701203|NCT00006604|42145800|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
19609471|NCT00914732|42058636|FG002|Overall Study|Adverse Event|0|||
19609472|NCT00844545|42058645|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
19609473|NCT00844545|42058645|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
19609474|NCT00844545|42058645|FG000|Extension Treatment Period|Adverse Event|2|||
19701204|NCT00006604|42145801|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
19701205|NCT00006604|42145802|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
19701206|NCT00006604|42145803|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
19701207|NCT00006604|42145804|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
19701208|NCT00006604|42145788|FG000|Overall Study|Lost to Follow-up|0|||
19701209|NCT00006604|42145789|FG001|Overall Study|Lost to Follow-up|0|||
19701210|NCT00006604|42145790|FG002|Overall Study|Lost to Follow-up|0|||
19701211|NCT00006604|42145791|FG003|Overall Study|Lost to Follow-up|0|||
19701212|NCT00006604|42145792|FG004|Overall Study|Lost to Follow-up|0|||
19701213|NCT00006604|42145793|FG005|Overall Study|Lost to Follow-up|0|||
19701214|NCT00006604|42145794|FG006|Overall Study|Lost to Follow-up|0|||
19701215|NCT00006604|42145795|FG007|Overall Study|Lost to Follow-up|1|||
19609475|NCT00844545|42058645|FG000|Post Treatment Period|Withdrawal by Subject|1|||
19609476|NCT00651157|42058650|FG000|Overall Study|Death|1|||
19609477|NCT00651157|42058650|FG000|Overall Study|Protocol Violation|1|||
19609478|NCT00843843|42058656|FG000|Overall Study|Physician Decision|1|||
19609479|NCT00843843|42058657|FG001|Overall Study|Physician Decision|1|||
19609480|NCT00843843|42058656|FG000|Overall Study|Protocol Violation|1|||
19609481|NCT00843843|42058657|FG001|Overall Study|Protocol Violation|1|||
19609482|NCT00650845|42058665|FG000|Overall Study|Withdrawal by Subject|5|||
19609483|NCT00650845|42058666|FG001|Overall Study|Withdrawal by Subject|0|||
19609484|NCT00650845|42058665|FG000|Overall Study|Protocol Violation|0|||
19609485|NCT00650845|42058666|FG001|Overall Study|Protocol Violation|13|||
19609486|NCT00842985|42058673|FG000|Screening|Did not meet entrance requirements|27|||
19701216|NCT00006604|42145796|FG008|Overall Study|Lost to Follow-up|0|||
19701217|NCT00006604|42145797|FG009|Overall Study|Lost to Follow-up|2|||
19390611|NCT02699749|41634387|FG010|Overall Study|Death|0|||
19390612|NCT02699749|41634388|FG011|Overall Study|Death|0|||
19390613|NCT02699749|41634389|FG012|Overall Study|Death|0|||
19390614|NCT02699749|41634390|FG013|Overall Study|Death|1|||
19609487|NCT00842985|42058673|FG000|First Intervention|Withdrawal by Subject|3|||
19609488|NCT00842985|42058673|FG000|First Intervention|Protocol Violation|3|||
19609489|NCT00842985|42058673|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
19609490|NCT00842985|42058673|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
19390615|NCT02699749|41634377|FG000|Overall Study|Lost to Follow-up|0|||
19390616|NCT02699749|41634378|FG001|Overall Study|Lost to Follow-up|0|||
19390617|NCT02699749|41634379|FG002|Overall Study|Lost to Follow-up|0|||
19390618|NCT02699749|41634380|FG003|Overall Study|Lost to Follow-up|0|||
19390619|NCT02699749|41634381|FG004|Overall Study|Lost to Follow-up|0|||
19390620|NCT02699749|41634382|FG005|Overall Study|Lost to Follow-up|1|||
19390621|NCT02699749|41634383|FG006|Overall Study|Lost to Follow-up|0|||
19390622|NCT02699749|41634384|FG007|Overall Study|Lost to Follow-up|1|||
19390623|NCT02699749|41634385|FG008|Overall Study|Lost to Follow-up|0|||
19390624|NCT02699749|41634386|FG009|Overall Study|Lost to Follow-up|0|||
19390625|NCT02699749|41634387|FG010|Overall Study|Lost to Follow-up|0|||
19390626|NCT02699749|41634388|FG011|Overall Study|Lost to Follow-up|0|||
19390627|NCT02699749|41634389|FG012|Overall Study|Lost to Follow-up|0|||
19390628|NCT02699749|41634390|FG013|Overall Study|Lost to Follow-up|0|||
19390629|NCT02699593|41634420|FG000|Period 1|Unsatisfactory Visual Response|0|||
19390630|NCT02699593|41634421|FG001|Period 1|Unsatisfactory Visual Response|1|||
19390631|NCT02699593|41634420|FG000|Period 1|Torn Contact Len|4|||
19390632|NCT02699593|41634421|FG001|Period 1|Torn Contact Len|3|||
19390633|NCT02699593|41634420|FG000|Period 1|Protocol Violation|0|||
19390634|NCT02699593|41634421|FG001|Period 1|Protocol Violation|1|||
19390635|NCT02699593|41634420|FG000|Period 1|Withdrawal by Subject|0|||
19390636|NCT02699593|41634421|FG001|Period 1|Withdrawal by Subject|1|||
19390637|NCT02699593|41634420|FG000|Period 1|Adverse Event|1|||
19390638|NCT02699593|41634421|FG001|Period 1|Adverse Event|1|||
19390639|NCT02699593|41634420|FG000|Period 2|Adverse Event|1|||
19390640|NCT02699593|41634421|FG001|Period 2|Adverse Event|1|||
19390641|NCT02699593|41634420|FG000|Period 2|Lost Contact Lens|0|||
19390642|NCT02699593|41634421|FG001|Period 2|Lost Contact Lens|1|||
19390643|NCT02699593|41634420|FG000|Period 2|Torn Contact Lens|1|||
19390644|NCT02699593|41634421|FG001|Period 2|Torn Contact Lens|0|||
19390645|NCT00708097|41634427|FG000|Period 1|Protocol Violation|0|||
19609491|NCT00842829|42058682|FG000|Dose Titration Period|Adverse Event|11|||
19609492|NCT00842829|42058683|FG001|Dose Titration Period|Adverse Event|10|||
19609493|NCT00842829|42058684|FG002|Dose Titration Period|Adverse Event|0|||
19701218|NCT00006604|42145798|FG010|Overall Study|Lost to Follow-up|0|||
19701219|NCT00006604|42145799|FG011|Overall Study|Lost to Follow-up|0|||
19701220|NCT00006604|42145800|FG012|Overall Study|Lost to Follow-up|0|||
19701221|NCT00006604|42145801|FG013|Overall Study|Lost to Follow-up|0|||
19701222|NCT00006604|42145802|FG014|Overall Study|Lost to Follow-up|0|||
19390646|NCT00708097|41634428|FG001|Period 1|Protocol Violation|1|||
19609494|NCT00842829|42058682|FG000|Dose Titration Period|Lack of Efficacy|4|||
19609495|NCT00842829|42058683|FG001|Dose Titration Period|Lack of Efficacy|1|||
19609496|NCT00842829|42058684|FG002|Dose Titration Period|Lack of Efficacy|0|||
19609497|NCT00842829|42058682|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
19609498|NCT00842829|42058683|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
19609499|NCT00842829|42058684|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
19609500|NCT00842829|42058682|FG000|Dose Titration Period|Withdrawal by Subject|2|||
19609501|NCT00842829|42058683|FG001|Dose Titration Period|Withdrawal by Subject|6|||
19609502|NCT00842829|42058684|FG002|Dose Titration Period|Withdrawal by Subject|0|||
19609503|NCT00842829|42058682|FG000|Dose Titration Period|Other|5|||
19609504|NCT00842829|42058683|FG001|Dose Titration Period|Other|4|||
19609505|NCT00842829|42058684|FG002|Dose Titration Period|Other|0|||
19609506|NCT00842829|42058682|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
19609507|NCT00842829|42058683|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
19609508|NCT00842829|42058684|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
19609509|NCT00842829|42058682|FG000|Dose Titration Period|Non-compliance to study drug|2|||
19609510|NCT00842829|42058683|FG001|Dose Titration Period|Non-compliance to study drug|1|||
19609511|NCT00842829|42058684|FG002|Dose Titration Period|Non-compliance to study drug|0|||
19609512|NCT00842829|42058682|FG000|Treatment Period|Adverse Event|0|||
19609513|NCT00842829|42058683|FG001|Treatment Period|Adverse Event|0|||
19609514|NCT00842829|42058684|FG002|Treatment Period|Adverse Event|15|||
19609515|NCT00842829|42058682|FG000|Treatment Period|Lack of Efficacy|0|||
19609516|NCT00842829|42058683|FG001|Treatment Period|Lack of Efficacy|0|||
19701223|NCT00006604|42145803|FG015|Overall Study|Lost to Follow-up|1|||
19701224|NCT00006604|42145804|FG016|Overall Study|Lost to Follow-up|3|||
19701225|NCT00006604|42145788|FG000|Overall Study|Other Reason|0|||
19701226|NCT00006604|42145789|FG001|Overall Study|Other Reason|0|||
19701227|NCT00006604|42145790|FG002|Overall Study|Other Reason|0|||
19701228|NCT00006604|42145791|FG003|Overall Study|Other Reason|0|||
19701229|NCT00006604|42145792|FG004|Overall Study|Other Reason|0|||
19701230|NCT00006604|42145793|FG005|Overall Study|Other Reason|1|||
19701231|NCT00006604|42145794|FG006|Overall Study|Other Reason|0|||
19701232|NCT00006604|42145795|FG007|Overall Study|Other Reason|0|||
19701233|NCT00006604|42145796|FG008|Overall Study|Other Reason|0|||
19701234|NCT00006604|42145797|FG009|Overall Study|Other Reason|1|||
19701235|NCT00006604|42145798|FG010|Overall Study|Other Reason|0|||
19701236|NCT00006604|42145799|FG011|Overall Study|Other Reason|0|||
19701237|NCT00006604|42145800|FG012|Overall Study|Other Reason|0|||
19701238|NCT00006604|42145801|FG013|Overall Study|Other Reason|0|||
19701239|NCT00006604|42145802|FG014|Overall Study|Other Reason|0|||
19701240|NCT00006604|42145803|FG015|Overall Study|Other Reason|0|||
19701241|NCT00006604|42145804|FG016|Overall Study|Other Reason|0|||
19701242|NCT00006478|42145827|FG000|Overall Study|Vaccine could not be produced|1|||
19701243|NCT00006478|42145827|FG000|Overall Study|Physician Decision|6|||
19701244|NCT00436007|42145834|FG000|Overall Study|Withdrawal by Subject|5|||
19701245|NCT00436007|42145835|FG001|Overall Study|Withdrawal by Subject|3|||
19701246|NCT00436007|42145836|FG002|Overall Study|Withdrawal by Subject|4|||
19609517|NCT00842829|42058684|FG002|Treatment Period|Lack of Efficacy|6|||
19609518|NCT00842829|42058682|FG000|Treatment Period|Unstable persistent cancer pain|0|||
19609519|NCT00842829|42058683|FG001|Treatment Period|Unstable persistent cancer pain|0|||
19609520|NCT00842829|42058684|FG002|Treatment Period|Unstable persistent cancer pain|5|||
19609521|NCT00842829|42058682|FG000|Treatment Period|Withdrawal by Subject|0|||
19609522|NCT00842829|42058683|FG001|Treatment Period|Withdrawal by Subject|0|||
19609523|NCT00842829|42058684|FG002|Treatment Period|Withdrawal by Subject|11|||
19609524|NCT00842829|42058682|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
19609525|NCT00842829|42058683|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
19609526|NCT00842829|42058684|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
19609527|NCT00842829|42058682|FG000|Treatment Period|Protocol Violation|0|||
19609528|NCT00842829|42058683|FG001|Treatment Period|Protocol Violation|0|||
19609529|NCT00842829|42058684|FG002|Treatment Period|Protocol Violation|2|||
19609530|NCT00842829|42058682|FG000|Treatment Period|Other|0|||
19609531|NCT00842829|42058683|FG001|Treatment Period|Other|0|||
19609532|NCT00842829|42058684|FG002|Treatment Period|Other|18|||
19701247|NCT00436007|42145834|FG000|Overall Study|Lost to Follow-up|14|||
19390647|NCT00708097|41634429|FG002|Period 1|Protocol Violation|0|||
19390648|NCT00708097|41634430|FG003|Period 1|Protocol Violation|2|||
19390649|NCT00708097|41634431|FG004|Period 1|Protocol Violation|0|||
19390650|NCT00708097|41634427|FG000|Period 1|Other Reason|0|||
19609533|NCT00842829|42058682|FG000|Treatment Period|Non-compliance to study procedures|0|||
19609534|NCT00842829|42058683|FG001|Treatment Period|Non-compliance to study procedures|0|||
19609535|NCT00842829|42058684|FG002|Treatment Period|Non-compliance to study procedures|4|||
19609536|NCT00842829|42058682|FG000|Treatment Period|Unclear completion status|0|||
19701248|NCT00436007|42145835|FG001|Overall Study|Lost to Follow-up|10|||
19701249|NCT00436007|42145836|FG002|Overall Study|Lost to Follow-up|13|||
19701250|NCT00436007|42145834|FG000|Overall Study|Physician Decision|0|||
19701251|NCT00436007|42145835|FG001|Overall Study|Physician Decision|0|||
19609537|NCT00842829|42058683|FG001|Treatment Period|Unclear completion status|0|||
19609538|NCT00842829|42058684|FG002|Treatment Period|Unclear completion status|1|||
19609539|NCT00842829|42058682|FG000|Continuation Period|Adverse Event|0|||
19701252|NCT00436007|42145836|FG002|Overall Study|Physician Decision|2|||
19701253|NCT00436007|42145834|FG000|Overall Study|Death|0|||
19701254|NCT00436007|42145835|FG001|Overall Study|Death|1|||
19701255|NCT00436007|42145836|FG002|Overall Study|Death|3|||
19701256|NCT00436007|42145834|FG000|Overall Study|Other|0|||
19701257|NCT00436007|42145835|FG001|Overall Study|Other|0|||
19701258|NCT00436007|42145836|FG002|Overall Study|Other|1|||
19701259|NCT00435461|42145852|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
19701260|NCT00435461|42145853|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
19701261|NCT00435461|42145854|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
19701262|NCT00435461|42145852|FG000|Overall Study|Protocol Violation|6|||
19701263|NCT00435461|42145853|FG001|Overall Study|Protocol Violation|9|||
19701264|NCT00435461|42145854|FG002|Overall Study|Protocol Violation|10|||
19701265|NCT00435461|42145852|FG000|Overall Study|Participant randomized(inadequate score)|1|||
19701266|NCT00435461|42145853|FG001|Overall Study|Participant randomized(inadequate score)|0|||
19701267|NCT00435461|42145854|FG002|Overall Study|Participant randomized(inadequate score)|0|||
19701268|NCT00435461|42145852|FG000|Overall Study|Compliance less than 80 percent|1|||
19701269|NCT00435461|42145853|FG001|Overall Study|Compliance less than 80 percent|0|||
19701270|NCT00435461|42145854|FG002|Overall Study|Compliance less than 80 percent|0|||
19701271|NCT00435461|42145852|FG000|Overall Study|In error, two study medications switched|1|||
19701272|NCT00435461|42145853|FG001|Overall Study|In error, two study medications switched|0|||
19701273|NCT00435461|42145854|FG002|Overall Study|In error, two study medications switched|0|||
19701274|NCT00435461|42145852|FG000|Overall Study|Lack of Efficacy|2|||
19701275|NCT00435461|42145853|FG001|Overall Study|Lack of Efficacy|1|||
19701276|NCT00435461|42145854|FG002|Overall Study|Lack of Efficacy|0|||
19701277|NCT00435461|42145852|FG000|Overall Study|Withdrawal by Subject|1|||
19701278|NCT00435461|42145853|FG001|Overall Study|Withdrawal by Subject|0|||
19701279|NCT00435461|42145854|FG002|Overall Study|Withdrawal by Subject|2|||
19701280|NCT00435461|42145852|FG000|Overall Study|Randomized in error|1|||
19701281|NCT00435461|42145853|FG001|Overall Study|Randomized in error|0|||
19701282|NCT00435461|42145854|FG002|Overall Study|Randomized in error|0|||
19701283|NCT00435461|42145852|FG000|Overall Study|Participant could not tolerate symptoms|0|||
19701284|NCT00435461|42145853|FG001|Overall Study|Participant could not tolerate symptoms|0|||
19701285|NCT00435461|42145854|FG002|Overall Study|Participant could not tolerate symptoms|1|||
19701286|NCT00435461|42145852|FG000|Overall Study|Participant could not swallow capsule|0|||
19701287|NCT00435461|42145853|FG001|Overall Study|Participant could not swallow capsule|0|||
19701288|NCT00435461|42145854|FG002|Overall Study|Participant could not swallow capsule|1|||
19701289|NCT00435461|42145852|FG000|Overall Study|Pregnancy|2|||
19701290|NCT00435461|42145853|FG001|Overall Study|Pregnancy|0|||
19701291|NCT00435461|42145854|FG002|Overall Study|Pregnancy|0|||
19701292|NCT00435461|42145852|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
19701293|NCT00435461|42145853|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
19609540|NCT00842829|42058683|FG001|Continuation Period|Adverse Event|0|||
19609541|NCT00842829|42058684|FG002|Continuation Period|Adverse Event|32|||
19609542|NCT00842829|42058682|FG000|Continuation Period|Lack of Efficacy|0|||
19609543|NCT00842829|42058683|FG001|Continuation Period|Lack of Efficacy|0|||
19609544|NCT00842829|42058684|FG002|Continuation Period|Lack of Efficacy|6|||
19609545|NCT00842829|42058682|FG000|Continuation Period|Unstable persistent cancer pain|0|||
19609546|NCT00842829|42058683|FG001|Continuation Period|Unstable persistent cancer pain|0|||
19609547|NCT00842829|42058684|FG002|Continuation Period|Unstable persistent cancer pain|3|||
19701294|NCT00435461|42145854|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
19701295|NCT00435461|42145852|FG000|Overall Study|Participant ended study one day early|1|||
19390651|NCT00708097|41634428|FG001|Period 1|Other Reason|0|||
19390652|NCT00708097|41634429|FG002|Period 1|Other Reason|0|||
19390653|NCT00708097|41634430|FG003|Period 1|Other Reason|0|||
19390654|NCT00708097|41634431|FG004|Period 1|Other Reason|1|||
19390655|NCT00708097|41634427|FG000|Period 2|Protocol Violation|0|||
19390656|NCT00708097|41634428|FG001|Period 2|Protocol Violation|1|||
19390657|NCT00708097|41634429|FG002|Period 2|Protocol Violation|1|||
19390658|NCT00708097|41634430|FG003|Period 2|Protocol Violation|1|||
19390659|NCT00708097|41634431|FG004|Period 2|Protocol Violation|0|||
19390660|NCT02659631|41634458|FG000|Overall Study|Lost to Follow-up|0|||
19390661|NCT02659631|41634459|FG001|Overall Study|Lost to Follow-up|0|||
19390662|NCT02659631|41634460|FG002|Overall Study|Lost to Follow-up|2|||
19390663|NCT02659631|41634461|FG003|Overall Study|Lost to Follow-up|0|||
19390664|NCT02659631|41634462|FG004|Overall Study|Lost to Follow-up|0|||
19390665|NCT02659631|41634463|FG005|Overall Study|Lost to Follow-up|1|||
19390666|NCT02659631|41634464|FG006|Overall Study|Lost to Follow-up|0|||
19390667|NCT02659631|41634465|FG007|Overall Study|Lost to Follow-up|0|||
19390668|NCT02659631|41634466|FG008|Overall Study|Lost to Follow-up|0|||
19390669|NCT02659631|41634467|FG009|Overall Study|Lost to Follow-up|0|||
19609548|NCT00842829|42058682|FG000|Continuation Period|Withdrawal by Subject|0|||
19609549|NCT00842829|42058683|FG001|Continuation Period|Withdrawal by Subject|0|||
19609550|NCT00842829|42058684|FG002|Continuation Period|Withdrawal by Subject|10|||
19609551|NCT00842829|42058682|FG000|Continuation Period|Other|0|||
19609552|NCT00842829|42058683|FG001|Continuation Period|Other|0|||
19609553|NCT00842829|42058684|FG002|Continuation Period|Other|7|||
19609554|NCT00842829|42058682|FG000|Continuation Period|Non-compliance to study procedures|0|||
19609555|NCT00842829|42058683|FG001|Continuation Period|Non-compliance to study procedures|0|||
19609556|NCT00842829|42058684|FG002|Continuation Period|Non-compliance to study procedures|2|||
19609557|NCT00842829|42058682|FG000|Continuation Period|Non-compliance to study drug|0|||
19609558|NCT00842829|42058683|FG001|Continuation Period|Non-compliance to study drug|0|||
19609559|NCT00842829|42058684|FG002|Continuation Period|Non-compliance to study drug|1|||
19609560|NCT00653263|42058696|FG000|Overall Study|Withdrawal by Subject|1|||
19609561|NCT00653263|42058696|FG000|Overall Study|Physician Decision|1|||
19609562|NCT00842361|42058702|FG000|Overall Study|Protocol Violation|1|||
19609563|NCT00842361|42058703|FG001|Overall Study|Protocol Violation|0|||
19609564|NCT00842361|42058702|FG000|Overall Study|Unclassified|0|||
19609565|NCT00842361|42058703|FG001|Overall Study|Unclassified|2|||
19609566|NCT00841035|42058709|FG000|Phase 1 Overall Study|Physician Decision|13|||
19609567|NCT00642811|42058720|FG000|Overall Study|Adverse Event|2|||
19609568|NCT00642811|42058721|FG001|Overall Study|Adverse Event|3|||
19609569|NCT00642811|42058722|FG002|Overall Study|Adverse Event|0|||
19609570|NCT00642811|42058723|FG003|Overall Study|Adverse Event|0|||
19609571|NCT00642811|42058724|FG004|Overall Study|Adverse Event|0|||
19609572|NCT00642811|42058725|FG005|Overall Study|Adverse Event|1|||
19609573|NCT00642811|42058720|FG000|Overall Study|Developement of discontinuation criteria|0|||
19609574|NCT00642811|42058721|FG001|Overall Study|Developement of discontinuation criteria|0|||
19609575|NCT00642811|42058722|FG002|Overall Study|Developement of discontinuation criteria|0|||
19609576|NCT00642811|42058723|FG003|Overall Study|Developement of discontinuation criteria|0|||
19609577|NCT00642811|42058724|FG004|Overall Study|Developement of discontinuation criteria|1|||
19609578|NCT00642811|42058725|FG005|Overall Study|Developement of discontinuation criteria|0|||
19609579|NCT00642811|42058720|FG000|Overall Study|Severe Non-compliance to protocol|1|||
19609580|NCT00642811|42058721|FG001|Overall Study|Severe Non-compliance to protocol|0|||
19609581|NCT00642811|42058722|FG002|Overall Study|Severe Non-compliance to protocol|0|||
19609582|NCT00642811|42058723|FG003|Overall Study|Severe Non-compliance to protocol|0|||
19609583|NCT00642811|42058724|FG004|Overall Study|Severe Non-compliance to protocol|0|||
19609584|NCT00642811|42058725|FG005|Overall Study|Severe Non-compliance to protocol|0|||
19609585|NCT00642811|42058720|FG000|Overall Study|Other|0|||
19609586|NCT00642811|42058721|FG001|Overall Study|Other|1|||
19609587|NCT00642811|42058722|FG002|Overall Study|Other|0|||
19609588|NCT00642811|42058723|FG003|Overall Study|Other|1|||
19609589|NCT00642811|42058724|FG004|Overall Study|Other|0|||
19609590|NCT00642811|42058725|FG005|Overall Study|Other|0|||
19609591|NCT00838929|42058742|FG000|Overall Study|Protocol Violation|0|||
19609592|NCT00838929|42058743|FG001|Overall Study|Protocol Violation|1|||
19609593|NCT00838929|42058744|FG002|Overall Study|Protocol Violation|0|||
19609594|NCT00838929|42058742|FG000|Overall Study|Disease progression|0|||
19609595|NCT00838929|42058743|FG001|Overall Study|Disease progression|2|||
19609596|NCT00838929|42058744|FG002|Overall Study|Disease progression|1|||
19609597|NCT00916058|42058757|FG000|Phase 1|Screen Failure|0|||
19609598|NCT00916058|42058758|FG001|Phase 1|Screen Failure|0|||
19609599|NCT00916058|42058759|FG002|Phase 1|Screen Failure|0|||
19609600|NCT00916058|42058760|FG003|Phase 1|Screen Failure|0|||
19609601|NCT00916058|42058761|FG004|Phase 1|Screen Failure|0|||
19609602|NCT00916058|42058762|FG005|Phase 1|Screen Failure|1|||
19609603|NCT00916058|42058763|FG006|Phase 1|Screen Failure|0|||
19609604|NCT00916058|42058757|FG000|Phase 2|Screen Failure|0|||
19609605|NCT00916058|42058758|FG001|Phase 2|Screen Failure|0|||
19609606|NCT00916058|42058759|FG002|Phase 2|Screen Failure|0|||
19609607|NCT00916058|42058760|FG003|Phase 2|Screen Failure|0|||
19609608|NCT00916058|42058761|FG004|Phase 2|Screen Failure|0|||
19609609|NCT00916058|42058762|FG005|Phase 2|Screen Failure|0|||
19609610|NCT00916058|42058763|FG006|Phase 2|Screen Failure|3|||
19390670|NCT02659631|41634458|FG000|Overall Study|Withdrawal prior to treatment|0|||
19390671|NCT02659631|41634459|FG001|Overall Study|Withdrawal prior to treatment|0|||
19390672|NCT02659631|41634460|FG002|Overall Study|Withdrawal prior to treatment|0|||
19390673|NCT02659631|41634461|FG003|Overall Study|Withdrawal prior to treatment|0|||
19390674|NCT02659631|41634462|FG004|Overall Study|Withdrawal prior to treatment|1|||
19609611|NCT00912782|42058783|FG000|Overall Study|Death|2|||
19609612|NCT00912782|42058784|FG001|Overall Study|Death|1|||
19609613|NCT00912782|42058783|FG000|Overall Study|Lost to Follow-up|0|||
19609614|NCT00912782|42058784|FG001|Overall Study|Lost to Follow-up|1|||
19609615|NCT00912782|42058783|FG000|Overall Study|Did not receive vascular access type|1|||
19609616|NCT00912782|42058784|FG001|Overall Study|Did not receive vascular access type|2|||
19609617|NCT00912782|42058783|FG000|Overall Study|Relocated before study completion|0|||
19609618|NCT00912782|42058784|FG001|Overall Study|Relocated before study completion|1|||
19609619|NCT03444038|42058790|FG000|Overall Study|Adverse Event|12|||
19609620|NCT03444038|42058790|FG000|Overall Study|Withdrawal by Subject|7|||
19609621|NCT03444038|42058790|FG000|Overall Study|Lost to Follow-up|1|||
19609622|NCT03444038|42058790|FG000|Overall Study|Physician Decision|2|||
19609623|NCT03444038|42058790|FG000|Overall Study|Lack of Efficacy|7|||
19609624|NCT00911534|42058796|FG000|Overall Study|Adverse Event|4|||
19609625|NCT00911534|42058797|FG001|Overall Study|Adverse Event|4|||
19609626|NCT00911534|42058796|FG000|Overall Study|Lost to Follow-up|2|||
19609627|NCT00911534|42058797|FG001|Overall Study|Lost to Follow-up|4|||
19609628|NCT00911534|42058796|FG000|Overall Study|Withdrawal by Subject|2|||
19609629|NCT00911534|42058797|FG001|Overall Study|Withdrawal by Subject|1|||
19609630|NCT00911534|42058796|FG000|Overall Study|Lack of Efficacy|4|||
19609631|NCT00911534|42058797|FG001|Overall Study|Lack of Efficacy|1|||
19609632|NCT00911534|42058796|FG000|Overall Study|Withdrawal of consent|1|||
19609633|NCT00911534|42058797|FG001|Overall Study|Withdrawal of consent|4|||
19609634|NCT00911534|42058796|FG000|Overall Study|Other|2|||
19609635|NCT00911534|42058797|FG001|Overall Study|Other|2|||
19609636|NCT00911300|42058805|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
19609637|NCT00911300|42058806|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
19609638|NCT00911300|42058805|FG000|Overall Study|Death|1|||
19609639|NCT00911300|42058806|FG001|Overall Study|Death|0|||
19609640|NCT00911300|42058805|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
19609641|NCT00911300|42058806|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
19609642|NCT00911300|42058805|FG000|Overall Study|Adverse Event|14|||
19609643|NCT00911300|42058806|FG001|Overall Study|Adverse Event|6|||
19609644|NCT00911300|42058805|FG000|Overall Study|Protocol Violation|3|||
19609645|NCT00911300|42058806|FG001|Overall Study|Protocol Violation|2|||
19609646|NCT00911300|42058805|FG000|Overall Study|Consent Withdrawn|4|||
19609647|NCT00911300|42058806|FG001|Overall Study|Consent Withdrawn|12|||
19609648|NCT00911300|42058805|FG000|Overall Study|Coronary Angiography Performed|1|||
19609649|NCT00911300|42058806|FG001|Overall Study|Coronary Angiography Performed|0|||
19609650|NCT00911300|42058805|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
19609651|NCT00911300|42058806|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
19609652|NCT00911300|42058805|FG000|Overall Study|Received Commercial Treatment|1|||
19609653|NCT00911300|42058806|FG001|Overall Study|Received Commercial Treatment|0|||
19609654|NCT00911300|42058805|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
19609655|NCT00911300|42058806|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
19609656|NCT00911300|42058805|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
19609657|NCT00911300|42058806|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
19609658|NCT00911300|42058805|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
19609659|NCT00911300|42058806|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
19609660|NCT00911300|42058805|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
19609661|NCT00911300|42058806|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
19609662|NCT00911300|42058805|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
19609663|NCT00911300|42058806|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
19609664|NCT00911300|42058805|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
19609665|NCT00911300|42058806|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
19609666|NCT00911300|42058805|FG000|Overall Study|International Normalized Ratio Too High|0|||
19609667|NCT00911300|42058806|FG001|Overall Study|International Normalized Ratio Too High|1|||
19609668|NCT00911300|42058805|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
19609669|NCT00911300|42058806|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
19609670|NCT00911300|42058805|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
19609671|NCT00911300|42058806|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
19609672|NCT00911300|42058805|FG000|Overall Study|Physician Decision|0|||
19609673|NCT00911300|42058806|FG001|Overall Study|Physician Decision|1|||
19609674|NCT00911300|42058805|FG000|Overall Study|Treatment Stopped by Mistake|0|||
19609675|NCT00911300|42058806|FG001|Overall Study|Treatment Stopped by Mistake|1|||
19609676|NCT00911300|42058805|FG000|Overall Study|Randomized; No Study Medication Received|0|||
19609677|NCT00911300|42058806|FG001|Overall Study|Randomized; No Study Medication Received|2|||
19609678|NCT00911144|42058815|FG000|Overall Study|Withdrawal by Subject|16|||
19609679|NCT00911144|42058816|FG001|Overall Study|Withdrawal by Subject|5|||
19609680|NCT00910988|42058826|FG000|Overall Study|Lost to Follow-up|2|||
19609681|NCT00910988|42058827|FG001|Overall Study|Lost to Follow-up|4|||
19609682|NCT00910988|42058828|FG002|Overall Study|Lost to Follow-up|3|||
19609683|NCT00910988|42058829|FG003|Overall Study|Lost to Follow-up|0|||
19609684|NCT00644059|42058858|FG000|Overall Study|Lost to Follow-up|37|||
19609685|NCT00644059|42058859|FG001|Overall Study|Lost to Follow-up|34|||
19609686|NCT00644059|42058860|FG002|Overall Study|Lost to Follow-up|16|||
19609687|NCT00644059|42058858|FG000|Overall Study|Withdrawal by Subject|52|||
19609688|NCT00644059|42058859|FG001|Overall Study|Withdrawal by Subject|60|||
19609689|NCT00644059|42058860|FG002|Overall Study|Withdrawal by Subject|30|||
19609690|NCT00644059|42058858|FG000|Overall Study|Adverse Event|8|||
19609691|NCT00644059|42058859|FG001|Overall Study|Adverse Event|5|||
19609692|NCT00644059|42058860|FG002|Overall Study|Adverse Event|1|||
19609693|NCT00644059|42058858|FG000|Overall Study|Inappropriate Enrollment|1|||
19609694|NCT00644059|42058859|FG001|Overall Study|Inappropriate Enrollment|3|||
19609695|NCT00644059|42058860|FG002|Overall Study|Inappropriate Enrollment|0|||
19609696|NCT00644059|42058858|FG000|Overall Study|Protocol Deviation/violation|20|||
19609697|NCT00644059|42058859|FG001|Overall Study|Protocol Deviation/violation|19|||
19609698|NCT00644059|42058860|FG002|Overall Study|Protocol Deviation/violation|15|||
19609699|NCT00644059|42058858|FG000|Overall Study|Unable to classify|6|||
19609700|NCT00644059|42058859|FG001|Overall Study|Unable to classify|2|||
19609701|NCT00644059|42058860|FG002|Overall Study|Unable to classify|3|||
19609702|NCT00643279|42058911|FG000|Overall Study|Death|13|||
19609703|NCT00643279|42058912|FG001|Overall Study|Death|11|||
19609704|NCT00643279|42058911|FG000|Overall Study|Withdrawal by Subject|3|||
19609705|NCT00643279|42058912|FG001|Overall Study|Withdrawal by Subject|0|||
19609706|NCT00643279|42058911|FG000|Overall Study|Lost to Follow-up|0|||
19609707|NCT00643279|42058912|FG001|Overall Study|Lost to Follow-up|1|||
19609708|NCT00643279|42058911|FG000|Overall Study|Physician Decision|0|||
19609709|NCT00643279|42058912|FG001|Overall Study|Physician Decision|1|||
19609710|NCT00910910|42058922|FG000|Overall Study|Adverse Event|63|||
19609711|NCT00910910|42058923|FG001|Overall Study|Adverse Event|35|||
19609712|NCT00910910|42058922|FG000|Overall Study|PD without histologic change|27|||
19609713|NCT00910910|42058923|FG001|Overall Study|PD without histologic change|23|||
19609714|NCT00910910|42058922|FG000|Overall Study|PD with histologic change|0|||
19609715|NCT00910910|42058923|FG001|Overall Study|PD with histologic change|2|||
19609716|NCT00910910|42058922|FG000|Overall Study|Withdrawal by Subject|7|||
19609717|NCT00910910|42058923|FG001|Overall Study|Withdrawal by Subject|5|||
19609718|NCT00910910|42058922|FG000|Overall Study|Lost to Follow-up|2|||
19609719|NCT00910910|42058923|FG001|Overall Study|Lost to Follow-up|2|||
19609720|NCT00910910|42058922|FG000|Overall Study|Death|9|||
19609721|NCT00910910|42058923|FG001|Overall Study|Death|3|||
19609722|NCT00910910|42058922|FG000|Overall Study|Protocol Violation|2|||
19609723|NCT00910910|42058923|FG001|Overall Study|Protocol Violation|2|||
19609724|NCT00910910|42058922|FG000|Overall Study|Completed 13 cycles of treatment|0|||
19609725|NCT00910910|42058923|FG001|Overall Study|Completed 13 cycles of treatment|118|||
19609726|NCT00910910|42058922|FG000|Overall Study|Other|114|||
19609727|NCT00910910|42058923|FG001|Overall Study|Other|32|||
19609728|NCT00910910|42058922|FG000|Overall Study|Untreated before cycle 1|1|||
19609729|NCT00910910|42058923|FG001|Overall Study|Untreated before cycle 1|2|||
19609730|NCT00911768|42058931|FG000|Overall Study|Protocol Violation|5|||
19609731|NCT00911768|42058932|FG001|Overall Study|Protocol Violation|4|||
19609732|NCT00911768|42058931|FG000|Overall Study|Withdrawal by Subject|1|||
19609733|NCT00911768|42058932|FG001|Overall Study|Withdrawal by Subject|0|||
19609734|NCT00909038|42058938|FG000|Overall Study|Protocol Violation|187|||
19609735|NCT00909038|42058938|FG000|Overall Study|Non-evaluable Subjects|230|||
19609736|NCT00909428|42058945|FG000|Overall Study|Lost to Follow-up|13|||
19609737|NCT00909428|42058946|FG001|Overall Study|Lost to Follow-up|10|||
19609738|NCT00909428|42058947|FG002|Overall Study|Lost to Follow-up|9|||
19609739|NCT00908960|42058957|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
19609740|NCT00908960|42058958|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
19609741|NCT00908960|42058959|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
19609742|NCT00650767|42058977|FG000|Overall Study|Adverse Event|0|||
19609743|NCT00650767|42058978|FG001|Overall Study|Adverse Event|3|||
19609744|NCT00650767|42058979|FG002|Overall Study|Adverse Event|10|||
19609745|NCT00650767|42058980|FG003|Overall Study|Adverse Event|8|||
19609746|NCT00650767|42058977|FG000|Overall Study|Death|1|||
19609747|NCT00650767|42058978|FG001|Overall Study|Death|0|||
19609748|NCT00650767|42058979|FG002|Overall Study|Death|0|||
19609749|NCT00650767|42058980|FG003|Overall Study|Death|0|||
19609750|NCT00650767|42058977|FG000|Overall Study|Withdrawal by Subject|2|||
19609751|NCT00650767|42058978|FG001|Overall Study|Withdrawal by Subject|4|||
19609752|NCT00650767|42058979|FG002|Overall Study|Withdrawal by Subject|3|||
19609753|NCT00650767|42058980|FG003|Overall Study|Withdrawal by Subject|3|||
19609754|NCT00650767|42058977|FG000|Overall Study|Lost to Follow-up|1|||
19609755|NCT00650767|42058978|FG001|Overall Study|Lost to Follow-up|1|||
19609756|NCT00650767|42058979|FG002|Overall Study|Lost to Follow-up|1|||
19609757|NCT00650767|42058980|FG003|Overall Study|Lost to Follow-up|0|||
19609758|NCT00650767|42058977|FG000|Overall Study|Other|1|||
19609759|NCT00650767|42058978|FG001|Overall Study|Other|1|||
19609760|NCT00650767|42058979|FG002|Overall Study|Other|0|||
19609761|NCT00650767|42058980|FG003|Overall Study|Other|0|||
19609762|NCT00973349|42059006|FG000|Overall Study|Adverse Event|0|||
19609763|NCT00973349|42059007|FG001|Overall Study|Adverse Event|0|||
19609764|NCT00973349|42059008|FG002|Overall Study|Adverse Event|0|||
19609765|NCT00973349|42059009|FG003|Overall Study|Adverse Event|0|||
19609766|NCT00973349|42059010|FG004|Overall Study|Adverse Event|1|||
19609767|NCT00973349|42059011|FG005|Overall Study|Adverse Event|0|||
19609768|NCT00973349|42059012|FG006|Overall Study|Adverse Event|0|||
19609769|NCT00973349|42059013|FG007|Overall Study|Adverse Event|0|||
19609770|NCT00973349|42059014|FG008|Overall Study|Adverse Event|1|||
19478412|NCT01502371|41757695|FG003|Overall Study|Lack of Efficacy|2|||
19609771|NCT00973349|42059015|FG009|Overall Study|Adverse Event|0|||
19609772|NCT00973349|42059016|FG010|Overall Study|Adverse Event|0|||
19609773|NCT00973349|42059017|FG011|Overall Study|Adverse Event|0|||
19609774|NCT00973349|42059018|FG012|Overall Study|Adverse Event|0|||
19609775|NCT00973349|42059019|FG013|Overall Study|Adverse Event|0|||
19609776|NCT00973349|42059020|FG014|Overall Study|Adverse Event|1|||
19609777|NCT00973349|42059021|FG015|Overall Study|Adverse Event|0|||
19609778|NCT00973349|42059006|FG000|Overall Study|Withdrawal by Subject|1|||
19609779|NCT00973349|42059007|FG001|Overall Study|Withdrawal by Subject|2|||
19609780|NCT00973349|42059008|FG002|Overall Study|Withdrawal by Subject|2|||
19609781|NCT00973349|42059009|FG003|Overall Study|Withdrawal by Subject|3|||
19609782|NCT00973349|42059010|FG004|Overall Study|Withdrawal by Subject|2|||
19609783|NCT00973349|42059011|FG005|Overall Study|Withdrawal by Subject|0|||
19609784|NCT00973349|42059012|FG006|Overall Study|Withdrawal by Subject|2|||
19609785|NCT00973349|42059013|FG007|Overall Study|Withdrawal by Subject|2|||
19609786|NCT00973349|42059014|FG008|Overall Study|Withdrawal by Subject|0|||
19609787|NCT00973349|42059015|FG009|Overall Study|Withdrawal by Subject|2|||
19609788|NCT00973349|42059016|FG010|Overall Study|Withdrawal by Subject|0|||
19609789|NCT00973349|42059017|FG011|Overall Study|Withdrawal by Subject|1|||
19609790|NCT00973349|42059018|FG012|Overall Study|Withdrawal by Subject|0|||
19609791|NCT00973349|42059019|FG013|Overall Study|Withdrawal by Subject|0|||
19609792|NCT00973349|42059020|FG014|Overall Study|Withdrawal by Subject|0|||
19609793|NCT00973349|42059021|FG015|Overall Study|Withdrawal by Subject|0|||
19609794|NCT00973349|42059006|FG000|Overall Study|Lost to Follow-up|3|||
19609795|NCT00973349|42059007|FG001|Overall Study|Lost to Follow-up|1|||
19609796|NCT00973349|42059008|FG002|Overall Study|Lost to Follow-up|2|||
19609797|NCT00973349|42059009|FG003|Overall Study|Lost to Follow-up|2|||
19609798|NCT00973349|42059010|FG004|Overall Study|Lost to Follow-up|1|||
19609799|NCT00973349|42059011|FG005|Overall Study|Lost to Follow-up|3|||
19609800|NCT00973349|42059012|FG006|Overall Study|Lost to Follow-up|0|||
19390675|NCT02659631|41634463|FG005|Overall Study|Withdrawal prior to treatment|0|||
19390676|NCT02659631|41634464|FG006|Overall Study|Withdrawal prior to treatment|0|||
19390677|NCT02659631|41634465|FG007|Overall Study|Withdrawal prior to treatment|0|||
19390678|NCT02659631|41634466|FG008|Overall Study|Withdrawal prior to treatment|0|||
19390679|NCT02659631|41634467|FG009|Overall Study|Withdrawal prior to treatment|0|||
19390680|NCT02659631|41634458|FG000|Overall Study|Participant refused further follow-up|0|||
19390681|NCT02659631|41634459|FG001|Overall Study|Participant refused further follow-up|0|||
19390682|NCT02659631|41634460|FG002|Overall Study|Participant refused further follow-up|0|||
19390683|NCT02659631|41634461|FG003|Overall Study|Participant refused further follow-up|1|||
19390684|NCT02659631|41634462|FG004|Overall Study|Participant refused further follow-up|0|||
19390685|NCT02659631|41634463|FG005|Overall Study|Participant refused further follow-up|0|||
19390686|NCT02659631|41634464|FG006|Overall Study|Participant refused further follow-up|0|||
19390687|NCT02659631|41634465|FG007|Overall Study|Participant refused further follow-up|0|||
19390688|NCT02659631|41634466|FG008|Overall Study|Participant refused further follow-up|1|||
19390689|NCT02659631|41634467|FG009|Overall Study|Participant refused further follow-up|0|||
19390690|NCT02659631|41634458|FG000|Overall Study|Death (follow-up phase)|1|||
19390691|NCT02659631|41634459|FG001|Overall Study|Death (follow-up phase)|2|||
19390692|NCT02659631|41634460|FG002|Overall Study|Death (follow-up phase)|1|||
19390693|NCT02659631|41634461|FG003|Overall Study|Death (follow-up phase)|1|||
19390694|NCT02659631|41634462|FG004|Overall Study|Death (follow-up phase)|3|||
19390695|NCT02659631|41634463|FG005|Overall Study|Death (follow-up phase)|2|||
19390696|NCT02659631|41634464|FG006|Overall Study|Death (follow-up phase)|0|||
19390697|NCT02659631|41634465|FG007|Overall Study|Death (follow-up phase)|3|||
19390698|NCT02659631|41634466|FG008|Overall Study|Death (follow-up phase)|1|||
19390699|NCT02659631|41634467|FG009|Overall Study|Death (follow-up phase)|0|||
19390700|NCT02659631|41634458|FG000|Overall Study|Death (treatment phase)|0|||
19390701|NCT02659631|41634459|FG001|Overall Study|Death (treatment phase)|0|||
19390702|NCT02659631|41634460|FG002|Overall Study|Death (treatment phase)|0|||
19390703|NCT02659631|41634461|FG003|Overall Study|Death (treatment phase)|0|||
19390704|NCT02659631|41634462|FG004|Overall Study|Death (treatment phase)|1|||
19390705|NCT02659631|41634463|FG005|Overall Study|Death (treatment phase)|0|||
19390706|NCT02659631|41634464|FG006|Overall Study|Death (treatment phase)|1|||
19390707|NCT02659631|41634465|FG007|Overall Study|Death (treatment phase)|0|||
19390708|NCT02659631|41634466|FG008|Overall Study|Death (treatment phase)|0|||
19390709|NCT02659631|41634467|FG009|Overall Study|Death (treatment phase)|0|||
19390710|NCT02699125|41634491|FG000|Placebo|Lost to Follow-up|2|||
19390711|NCT02699125|41634492|FG001|Placebo|Lost to Follow-up|0|||
19390712|NCT02699125|41634491|FG000|Placebo|Protocol Violation|1|||
19390713|NCT02699125|41634492|FG001|Placebo|Protocol Violation|0|||
19390714|NCT02699125|41634491|FG000|Placebo|Withdrawal by Subject|0|||
19390715|NCT02699125|41634492|FG001|Placebo|Withdrawal by Subject|4|||
19390716|NCT02699125|41634491|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
19390717|NCT02699125|41634492|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
19390718|NCT02698891|41634502|FG000|Overall Study|Withdrawal by Subject|2|||
19390719|NCT02698891|41634502|FG000|Overall Study|deemed ineligible|1|||
19390720|NCT02698891|41634502|FG000|Overall Study|Adverse Event|9|||
19390721|NCT02698423|41634508|FG000|Overall Study|Lost to Follow-up|19|||
19390722|NCT02698423|41634509|FG001|Overall Study|Lost to Follow-up|24|||
19609801|NCT00973349|42059013|FG007|Overall Study|Lost to Follow-up|1|||
19609802|NCT00973349|42059014|FG008|Overall Study|Lost to Follow-up|2|||
19609803|NCT00973349|42059015|FG009|Overall Study|Lost to Follow-up|1|||
19609804|NCT00973349|42059016|FG010|Overall Study|Lost to Follow-up|0|||
19609805|NCT00973349|42059017|FG011|Overall Study|Lost to Follow-up|1|||
19609806|NCT00973349|42059018|FG012|Overall Study|Lost to Follow-up|0|||
19609807|NCT00973349|42059019|FG013|Overall Study|Lost to Follow-up|0|||
19390723|NCT02700997|41634517|FG000|Overall Study|Did not undergo CT imaging|1|||
19390724|NCT02700997|41634517|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
19390725|NCT02658149|41634523|FG000|Overall Study|Physician Decision|1|||
19390726|NCT02658149|41634524|FG001|Overall Study|Physician Decision|0|||
19390727|NCT02698189|41634532|FG000|Overall Study|Physician Decision|3|||
19390728|NCT02698189|41634533|FG001|Overall Study|Physician Decision|0|||
19390729|NCT02698189|41634532|FG000|Overall Study|Progressive disease|0|||
19390730|NCT02698189|41634533|FG001|Overall Study|Progressive disease|5|||
19390731|NCT02698189|41634532|FG000|Overall Study|Study terminated by sponsor|0|||
19390732|NCT02698189|41634533|FG001|Overall Study|Study terminated by sponsor|1|||
19390733|NCT02702011|41634545|FG000|Overall Study|Withdrawal by Subject|0|||
19390734|NCT02702011|41634546|FG001|Overall Study|Withdrawal by Subject|1|||
19390735|NCT02702011|41634547|FG002|Overall Study|Withdrawal by Subject|0|||
19390736|NCT02702011|41634548|FG003|Overall Study|Withdrawal by Subject|0|||
19390737|NCT02657369|41634558|FG000|Overall Study|Death|27|||
19390738|NCT02657369|41634558|FG000|Overall Study|Study terminated by sponsor|7|||
19390739|NCT02701777|41634566|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
19390740|NCT02701777|41634567|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
19390741|NCT02701777|41634568|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
19390742|NCT02701777|41634569|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
19390743|NCT02701777|41634566|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
19390744|NCT02701777|41634567|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
19390745|NCT02701777|41634568|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
19390746|NCT02701777|41634569|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
19390747|NCT01675661|41634585|FG000|Overall Study|Lost to Follow-up|22|||
19390748|NCT01675661|41634586|FG001|Overall Study|Lost to Follow-up|23|||
19390749|NCT01675661|41634585|FG000|Overall Study|Practical problems|9|||
19390750|NCT01675661|41634586|FG001|Overall Study|Practical problems|5|||
19390751|NCT01675661|41634585|FG000|Overall Study|Moved away|5|||
19390752|NCT01675661|41634586|FG001|Overall Study|Moved away|6|||
19390753|NCT01675661|41634585|FG000|Overall Study|Withdrawal by Subject|3|||
19390754|NCT01675661|41634586|FG001|Overall Study|Withdrawal by Subject|7|||
19390755|NCT01675661|41634585|FG000|Overall Study|Physician Decision|0|||
19390756|NCT01675661|41634586|FG001|Overall Study|Physician Decision|2|||
19390757|NCT01675661|41634585|FG000|Overall Study|Death|0|||
19390758|NCT01675661|41634586|FG001|Overall Study|Death|1|||
19390759|NCT01675661|41634585|FG000|Overall Study|Other reason|1|||
19390760|NCT01675661|41634586|FG001|Overall Study|Other reason|2|||
19390761|NCT01602341|41634594|FG000|Overall Study|Adverse Event|0|||
19390762|NCT01602341|41634595|FG001|Overall Study|Adverse Event|1|||
19390763|NCT02700919|41634608|FG000|Overall Study|Physician Decision|1|||
19390764|NCT02700919|41634609|FG001|Overall Study|Physician Decision|0|||
19390765|NCT02700919|41634610|FG002|Overall Study|Physician Decision|0|||
19390766|NCT02700919|41634608|FG000|Overall Study|Protocol Violation|1|||
19390767|NCT02700919|41634609|FG001|Overall Study|Protocol Violation|0|||
19390768|NCT02700919|41634610|FG002|Overall Study|Protocol Violation|0|||
19390769|NCT02700919|41634608|FG000|Overall Study|Adverse Event|1|||
19390770|NCT02700919|41634609|FG001|Overall Study|Adverse Event|3|||
19390771|NCT02700919|41634610|FG002|Overall Study|Adverse Event|1|||
19390772|NCT02700919|41634608|FG000|Overall Study|Withdrawal by Subject|5|||
19390773|NCT02700919|41634609|FG001|Overall Study|Withdrawal by Subject|8|||
19390774|NCT02700919|41634610|FG002|Overall Study|Withdrawal by Subject|2|||
19390775|NCT02700919|41634608|FG000|Overall Study|Lost to Follow-up|2|||
19390776|NCT02700919|41634609|FG001|Overall Study|Lost to Follow-up|0|||
19390777|NCT02700919|41634610|FG002|Overall Study|Lost to Follow-up|0|||
19390778|NCT02700919|41634608|FG000|Overall Study|Other|2|||
19390779|NCT02700919|41634609|FG001|Overall Study|Other|1|||
19390780|NCT02700919|41634610|FG002|Overall Study|Other|1|||
19390781|NCT01986010|41634635|FG000|Overall Study|Adverse Event|0|||
19390782|NCT01986010|41634636|FG001|Overall Study|Adverse Event|1|||
19390783|NCT01986010|41634637|FG002|Overall Study|Adverse Event|0|||
19390784|NCT01986010|41634638|FG003|Overall Study|Adverse Event|0|||
19390785|NCT01986010|41634639|FG004|Overall Study|Adverse Event|0|||
19390786|NCT01986010|41634640|FG005|Overall Study|Adverse Event|0|||
19390787|NCT01986010|41634641|FG006|Overall Study|Adverse Event|0|||
19390788|NCT01986010|41634642|FG007|Overall Study|Adverse Event|0|||
19390789|NCT01986010|41634643|FG008|Overall Study|Adverse Event|0|||
19390790|NCT01986010|41634644|FG009|Overall Study|Adverse Event|0|||
19609808|NCT00973349|42059020|FG014|Overall Study|Lost to Follow-up|0|||
19609809|NCT00973349|42059021|FG015|Overall Study|Lost to Follow-up|1|||
19390791|NCT01986010|41634645|FG010|Overall Study|Adverse Event|0|||
19609810|NCT00973349|42059006|FG000|Overall Study|Inappropriate enrolment|0|||
19609811|NCT00973349|42059007|FG001|Overall Study|Inappropriate enrolment|0|||
19609812|NCT00973349|42059008|FG002|Overall Study|Inappropriate enrolment|1|||
19609813|NCT00973349|42059009|FG003|Overall Study|Inappropriate enrolment|0|||
19609814|NCT00973349|42059010|FG004|Overall Study|Inappropriate enrolment|0|||
19609815|NCT00973349|42059011|FG005|Overall Study|Inappropriate enrolment|0|||
19609816|NCT00973349|42059012|FG006|Overall Study|Inappropriate enrolment|0|||
19609817|NCT00973349|42059013|FG007|Overall Study|Inappropriate enrolment|0|||
19609818|NCT00973349|42059014|FG008|Overall Study|Inappropriate enrolment|0|||
19609819|NCT00973349|42059015|FG009|Overall Study|Inappropriate enrolment|2|||
19609820|NCT00973349|42059016|FG010|Overall Study|Inappropriate enrolment|0|||
19609821|NCT00973349|42059017|FG011|Overall Study|Inappropriate enrolment|0|||
19609822|NCT00973349|42059018|FG012|Overall Study|Inappropriate enrolment|1|||
19609823|NCT00973349|42059019|FG013|Overall Study|Inappropriate enrolment|0|||
19609824|NCT00973349|42059020|FG014|Overall Study|Inappropriate enrolment|1|||
19609825|NCT00973349|42059021|FG015|Overall Study|Inappropriate enrolment|1|||
19609826|NCT00973349|42059006|FG000|Overall Study|Protocol Violation|0|||
19609827|NCT00973349|42059007|FG001|Overall Study|Protocol Violation|0|||
19609828|NCT00973349|42059008|FG002|Overall Study|Protocol Violation|0|||
19609829|NCT00973349|42059009|FG003|Overall Study|Protocol Violation|0|||
19609830|NCT00973349|42059010|FG004|Overall Study|Protocol Violation|0|||
19609831|NCT00973349|42059011|FG005|Overall Study|Protocol Violation|0|||
19609832|NCT00973349|42059012|FG006|Overall Study|Protocol Violation|0|||
19609833|NCT00973349|42059013|FG007|Overall Study|Protocol Violation|0|||
19609834|NCT00973349|42059014|FG008|Overall Study|Protocol Violation|1|||
19609835|NCT00973349|42059015|FG009|Overall Study|Protocol Violation|0|||
19609836|NCT00973349|42059016|FG010|Overall Study|Protocol Violation|0|||
19609837|NCT00973349|42059017|FG011|Overall Study|Protocol Violation|0|||
19609838|NCT00973349|42059018|FG012|Overall Study|Protocol Violation|0|||
19609839|NCT00973349|42059019|FG013|Overall Study|Protocol Violation|0|||
19609840|NCT00973349|42059020|FG014|Overall Study|Protocol Violation|0|||
19609841|NCT00973349|42059021|FG015|Overall Study|Protocol Violation|0|||
19609842|NCT00973349|42059006|FG000|Overall Study|Unable to classify|0|||
19609843|NCT00973349|42059007|FG001|Overall Study|Unable to classify|0|||
19609844|NCT00973349|42059008|FG002|Overall Study|Unable to classify|0|||
19609845|NCT00973349|42059009|FG003|Overall Study|Unable to classify|0|||
19609846|NCT00973349|42059010|FG004|Overall Study|Unable to classify|1|||
19609847|NCT00973349|42059011|FG005|Overall Study|Unable to classify|1|||
19609848|NCT00973349|42059012|FG006|Overall Study|Unable to classify|0|||
19609849|NCT00973349|42059013|FG007|Overall Study|Unable to classify|0|||
19609850|NCT00973349|42059014|FG008|Overall Study|Unable to classify|0|||
19609851|NCT00973349|42059015|FG009|Overall Study|Unable to classify|1|||
19609852|NCT00973349|42059016|FG010|Overall Study|Unable to classify|0|||
19609853|NCT00973349|42059017|FG011|Overall Study|Unable to classify|0|||
19609854|NCT00973349|42059018|FG012|Overall Study|Unable to classify|0|||
19609855|NCT00973349|42059019|FG013|Overall Study|Unable to classify|0|||
19609856|NCT00973349|42059020|FG014|Overall Study|Unable to classify|0|||
19609857|NCT00973349|42059021|FG015|Overall Study|Unable to classify|0|||
19609858|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Death|20|||
19609859|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Death|26|||
19609860|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
19609861|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
19609862|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
19609863|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
19609864|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
19609865|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
19609866|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
19609867|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
19609868|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
19609869|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
19609870|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
19609871|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
19609872|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
19609873|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
19609874|NCT00643201|42059049|FG000|Randomized, Completed 6 Months of Study|Other|107|||
19609875|NCT00643201|42059050|FG001|Randomized, Completed 6 Months of Study|Other|107|||
19609876|NCT00643201|42059049|FG000|Completed Study Follow Up|Death|28|||
19478413|NCT01502371|41757696|FG004|Overall Study|Lack of Efficacy|4|||
19609877|NCT00643201|42059050|FG001|Completed Study Follow Up|Death|34|||
19609878|NCT00643201|42059049|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
19609879|NCT00643201|42059050|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
19609880|NCT00643201|42059049|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
19609881|NCT00643201|42059050|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
19609882|NCT00643201|42059049|FG000|Completed Study Follow Up|non-specified|1|||
19609883|NCT00643201|42059050|FG001|Completed Study Follow Up|non-specified|0|||
19609884|NCT00643123|42059060|FG000|Overall Study|Lost to Follow-up|4|||
19609885|NCT00643123|42059061|FG001|Overall Study|Lost to Follow-up|0|||
19609886|NCT00643123|42059060|FG000|Overall Study|Withdrawal by Subject|1|||
19609887|NCT00643123|42059061|FG001|Overall Study|Withdrawal by Subject|1|||
19609888|NCT00968981|42059070|FG000|Overall Study|Adverse Event|2|||
19609889|NCT00968981|42059071|FG001|Overall Study|Adverse Event|0|||
19609890|NCT00968981|42059072|FG002|Overall Study|Adverse Event|0|||
19609891|NCT00968981|42059070|FG000|Overall Study|Disease Progression|14|||
19609892|NCT00968981|42059071|FG001|Overall Study|Disease Progression|16|||
19609893|NCT00968981|42059072|FG002|Overall Study|Disease Progression|13|||
19609894|NCT00968981|42059070|FG000|Overall Study|Lost to Follow-up|0|||
19609895|NCT00968981|42059071|FG001|Overall Study|Lost to Follow-up|0|||
19609896|NCT00968981|42059072|FG002|Overall Study|Lost to Follow-up|1|||
19609897|NCT00968981|42059070|FG000|Overall Study|Physician Decision|5|||
19609898|NCT00968981|42059071|FG001|Overall Study|Physician Decision|3|||
19609899|NCT00968981|42059072|FG002|Overall Study|Physician Decision|5|||
19609900|NCT00968981|42059070|FG000|Overall Study|Withdrawal by Subject|1|||
19609901|NCT00968981|42059071|FG001|Overall Study|Withdrawal by Subject|3|||
19609902|NCT00968981|42059072|FG002|Overall Study|Withdrawal by Subject|3|||
19609903|NCT00641719|42059083|FG000|Overall Study|Lack of Efficacy|1|||
19609904|NCT00641719|42059084|FG001|Overall Study|Lack of Efficacy|2|||
19609905|NCT00641719|42059083|FG000|Overall Study|Adverse Event|24|||
19609906|NCT00641719|42059084|FG001|Overall Study|Adverse Event|29|||
19609907|NCT00641719|42059083|FG000|Overall Study|Withdrawal by Subject|4|||
19609908|NCT00641719|42059084|FG001|Overall Study|Withdrawal by Subject|4|||
19609909|NCT00641719|42059083|FG000|Overall Study|Reason Not Specified|1|||
19609910|NCT00641719|42059084|FG001|Overall Study|Reason Not Specified|2|||
19609911|NCT00648895|42059092|FG000|Overall Study|Lack of Efficacy|0|||
19609912|NCT00648895|42059093|FG001|Overall Study|Lack of Efficacy|1|||
19609913|NCT00975221|42059101|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
19609914|NCT00975221|42059102|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
19609915|NCT00975221|42059101|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
19609916|NCT00975221|42059102|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
19609917|NCT00975221|42059101|FG000|Titration Phase (Weeks 1-12)|Other|0|||
19609918|NCT00975221|42059102|FG001|Titration Phase (Weeks 1-12)|Other|1|||
19609919|NCT00975221|42059101|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
19609920|NCT00975221|42059102|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
19609921|NCT00975221|42059101|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
19609922|NCT00975221|42059102|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
19609923|NCT00975221|42059101|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
19609924|NCT00975221|42059102|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
19609925|NCT00972179|42059117|FG000|Overall Study|Noncompliance|1|||
19609926|NCT00972179|42059118|FG001|Overall Study|Noncompliance|0|||
19609927|NCT00972179|42059119|FG002|Overall Study|Noncompliance|0|||
19609928|NCT00972179|42059120|FG003|Overall Study|Noncompliance|0|||
19609929|NCT00972179|42059121|FG004|Overall Study|Noncompliance|1|||
19609930|NCT00972179|42059122|FG005|Overall Study|Noncompliance|0|||
19609931|NCT00972179|42059123|FG006|Overall Study|Noncompliance|1|||
19609932|NCT00972179|42059117|FG000|Overall Study|Withdrawal by Subject|0|||
19609933|NCT00972179|42059118|FG001|Overall Study|Withdrawal by Subject|3|||
19609934|NCT00972179|42059119|FG002|Overall Study|Withdrawal by Subject|0|||
19609935|NCT00972179|42059120|FG003|Overall Study|Withdrawal by Subject|1|||
19609936|NCT00972179|42059121|FG004|Overall Study|Withdrawal by Subject|0|||
19609937|NCT00972179|42059122|FG005|Overall Study|Withdrawal by Subject|0|||
19609938|NCT00972179|42059123|FG006|Overall Study|Withdrawal by Subject|2|||
19609939|NCT00972179|42059117|FG000|Overall Study|Administrative Decision|0|||
19609940|NCT00972179|42059118|FG001|Overall Study|Administrative Decision|0|||
19609941|NCT00972179|42059119|FG002|Overall Study|Administrative Decision|0|||
19609942|NCT00972179|42059120|FG003|Overall Study|Administrative Decision|0|||
19609943|NCT00972179|42059121|FG004|Overall Study|Administrative Decision|1|||
19609944|NCT00972179|42059122|FG005|Overall Study|Administrative Decision|0|||
19609945|NCT00972179|42059123|FG006|Overall Study|Administrative Decision|0|||
19609946|NCT00972179|42059117|FG000|Overall Study|Lost to Follow-up|0|||
19609947|NCT00972179|42059118|FG001|Overall Study|Lost to Follow-up|0|||
19609948|NCT00972179|42059119|FG002|Overall Study|Lost to Follow-up|1|||
19609949|NCT00972179|42059120|FG003|Overall Study|Lost to Follow-up|0|||
19609950|NCT00972179|42059121|FG004|Overall Study|Lost to Follow-up|0|||
19609951|NCT00972179|42059122|FG005|Overall Study|Lost to Follow-up|3|||
19609952|NCT00972179|42059123|FG006|Overall Study|Lost to Follow-up|1|||
19800248|NCT02861807|42258318|FG001|Overall Study|Withdrawal by Subject|8|||
19609953|NCT00906698|42059149|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
19609954|NCT00906698|42059150|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
19609955|NCT00906698|42059151|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
19609956|NCT00906698|42059152|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
19609957|NCT00906698|42059153|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
19609958|NCT00906698|42059154|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
19609959|NCT00906698|42059149|FG000|Overall Study|Adverse Event|0|||
19609960|NCT00906698|42059150|FG001|Overall Study|Adverse Event|0|||
19609961|NCT00906698|42059151|FG002|Overall Study|Adverse Event|2|||
19609962|NCT00906698|42059152|FG003|Overall Study|Adverse Event|0|||
19609963|NCT00906698|42059153|FG004|Overall Study|Adverse Event|4|||
19609964|NCT00906698|42059154|FG005|Overall Study|Adverse Event|1|||
19609965|NCT00906698|42059149|FG000|Overall Study|Disease progression|3|||
19609966|NCT00906698|42059150|FG001|Overall Study|Disease progression|12|||
19609967|NCT00906698|42059151|FG002|Overall Study|Disease progression|4|||
19609968|NCT00906698|42059152|FG003|Overall Study|Disease progression|4|||
19609969|NCT00906698|42059153|FG004|Overall Study|Disease progression|12|||
19609970|NCT00906698|42059154|FG005|Overall Study|Disease progression|4|||
19609971|NCT00906698|42059149|FG000|Overall Study|Withdrawal by Subject|0|||
19609972|NCT00906698|42059150|FG001|Overall Study|Withdrawal by Subject|0|||
19609973|NCT00906698|42059151|FG002|Overall Study|Withdrawal by Subject|0|||
19609974|NCT00906698|42059152|FG003|Overall Study|Withdrawal by Subject|0|||
19609975|NCT00906698|42059153|FG004|Overall Study|Withdrawal by Subject|1|||
19609976|NCT00906698|42059154|FG005|Overall Study|Withdrawal by Subject|0|||
19609977|NCT00906698|42059149|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
19609978|NCT00906698|42059150|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
19609979|NCT00906698|42059151|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
19609980|NCT00906698|42059152|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
19609981|NCT00906698|42059153|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
19609982|NCT00906698|42059154|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
19609983|NCT00972023|42059186|FG000|Overall Study|Withdrawal by Subject|1|||
19609984|NCT00971945|42059192|FG000|Overall Study|Progressive Disease|3|||
19609985|NCT00971945|42059192|FG000|Overall Study|Change in treatment policy|1|||
19609986|NCT00971945|42059192|FG000|Overall Study|Other reasons|2|||
19609987|NCT00971867|42059196|FG000|Overall Study|Adverse Event|4|||
19609988|NCT00971867|42059196|FG000|Overall Study|Participant Withdrew Consent|1|||
19609989|NCT00971867|42059196|FG000|Overall Study|Disease Progression|6|||
19609990|NCT00971321|42059202|FG000|Up to Month 7|Withdrawal by Subject|1|||
19609991|NCT00971321|42059203|FG001|Up to Month 7|Withdrawal by Subject|0|||
19609992|NCT00971321|42059202|FG000|Up to Month 7|Migrated/moved from study area|3|||
19609993|NCT00971321|42059203|FG001|Up to Month 7|Migrated/moved from study area|2|||
19609994|NCT00971321|42059202|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
19609995|NCT00971321|42059203|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
19609996|NCT00971321|42059202|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
19609997|NCT00971321|42059203|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
19609998|NCT00971321|42059202|FG000|Up to Month 11-12|Lost to Follow-up|1|||
19609999|NCT00971321|42059203|FG001|Up to Month 11-12|Lost to Follow-up|0|||
19610000|NCT00648739|42059209|FG000|Overall Study|Adverse Event|1|||
19610001|NCT00648739|42059210|FG001|Overall Study|Adverse Event|0|||
19610002|NCT00648739|42059211|FG002|Overall Study|Adverse Event|1|||
19610003|NCT00648739|42059212|FG003|Overall Study|Adverse Event|2|||
19610004|NCT00648739|42059213|FG004|Overall Study|Adverse Event|1|||
19610005|NCT00648739|42059214|FG005|Overall Study|Adverse Event|0|||
19390792|NCT01986010|41634646|FG011|Overall Study|Adverse Event|0|||
19390793|NCT01986010|41634647|FG012|Overall Study|Adverse Event|0|||
19390794|NCT01986010|41634648|FG013|Overall Study|Adverse Event|0|||
19390795|NCT01986010|41634649|FG014|Overall Study|Adverse Event|0|||
19390796|NCT01986010|41634650|FG015|Overall Study|Adverse Event|1|||
19390797|NCT01986010|41634651|FG016|Overall Study|Adverse Event|0|||
19390798|NCT01986010|41634635|FG000|Overall Study|Lost to Follow-up|2|||
19390799|NCT01986010|41634636|FG001|Overall Study|Lost to Follow-up|1|||
19390800|NCT01986010|41634637|FG002|Overall Study|Lost to Follow-up|2|||
19390801|NCT01986010|41634638|FG003|Overall Study|Lost to Follow-up|2|||
19390802|NCT01986010|41634639|FG004|Overall Study|Lost to Follow-up|2|||
19390803|NCT01986010|41634640|FG005|Overall Study|Lost to Follow-up|2|||
19390804|NCT01986010|41634641|FG006|Overall Study|Lost to Follow-up|0|||
19390805|NCT01986010|41634642|FG007|Overall Study|Lost to Follow-up|0|||
19390806|NCT01986010|41634643|FG008|Overall Study|Lost to Follow-up|4|||
19390807|NCT01986010|41634644|FG009|Overall Study|Lost to Follow-up|2|||
19390808|NCT01986010|41634645|FG010|Overall Study|Lost to Follow-up|0|||
19390809|NCT01986010|41634646|FG011|Overall Study|Lost to Follow-up|1|||
19390810|NCT01986010|41634647|FG012|Overall Study|Lost to Follow-up|1|||
19610006|NCT00648739|42059215|FG006|Overall Study|Adverse Event|0|||
19610007|NCT00648739|42059209|FG000|Overall Study|Withdrawal by Subject|1|||
19610008|NCT00648739|42059210|FG001|Overall Study|Withdrawal by Subject|0|||
19610009|NCT00648739|42059211|FG002|Overall Study|Withdrawal by Subject|1|||
19610010|NCT00648739|42059212|FG003|Overall Study|Withdrawal by Subject|0|||
19610011|NCT00648739|42059213|FG004|Overall Study|Withdrawal by Subject|0|||
19610012|NCT00648739|42059214|FG005|Overall Study|Withdrawal by Subject|2|||
19390811|NCT01986010|41634648|FG013|Overall Study|Lost to Follow-up|1|||
19478414|NCT01502371|41757692|FG000|Overall Study|Physician Decision|3|||
19390812|NCT01986010|41634649|FG014|Overall Study|Lost to Follow-up|2|||
19390813|NCT01986010|41634650|FG015|Overall Study|Lost to Follow-up|0|||
19610013|NCT00648739|42059215|FG006|Overall Study|Withdrawal by Subject|0|||
19610014|NCT00648739|42059209|FG000|Overall Study|Lack of Efficacy|0|||
19610015|NCT00648739|42059210|FG001|Overall Study|Lack of Efficacy|0|||
19610016|NCT00648739|42059211|FG002|Overall Study|Lack of Efficacy|0|||
19610017|NCT00648739|42059212|FG003|Overall Study|Lack of Efficacy|0|||
19610018|NCT00648739|42059213|FG004|Overall Study|Lack of Efficacy|1|||
19610019|NCT00648739|42059214|FG005|Overall Study|Lack of Efficacy|2|||
19610020|NCT00648739|42059215|FG006|Overall Study|Lack of Efficacy|0|||
19610021|NCT00648739|42059209|FG000|Overall Study|Investigator Considered it Advisable|0|||
19610022|NCT00648739|42059210|FG001|Overall Study|Investigator Considered it Advisable|0|||
19610023|NCT00648739|42059211|FG002|Overall Study|Investigator Considered it Advisable|0|||
19610024|NCT00648739|42059212|FG003|Overall Study|Investigator Considered it Advisable|0|||
19610025|NCT00648739|42059213|FG004|Overall Study|Investigator Considered it Advisable|0|||
19610026|NCT00648739|42059214|FG005|Overall Study|Investigator Considered it Advisable|1|||
19610027|NCT00648739|42059215|FG006|Overall Study|Investigator Considered it Advisable|1|||
19610028|NCT00648739|42059209|FG000|Overall Study|Death|0|||
19610029|NCT00648739|42059210|FG001|Overall Study|Death|1|||
19610030|NCT00648739|42059211|FG002|Overall Study|Death|0|||
19610031|NCT00648739|42059212|FG003|Overall Study|Death|0|||
19610032|NCT00648739|42059213|FG004|Overall Study|Death|0|||
19610033|NCT00648739|42059214|FG005|Overall Study|Death|0|||
19610034|NCT00648739|42059215|FG006|Overall Study|Death|0|||
19610035|NCT00648739|42059209|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
19610036|NCT00648739|42059210|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
19610037|NCT00648739|42059211|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
19610038|NCT00648739|42059212|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
19610039|NCT00648739|42059213|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
19610040|NCT00648739|42059214|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
19610041|NCT00648739|42059215|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
19610042|NCT00648739|42059209|FG000|Overall Study|Follow-up Visits Not Completed|0|||
19610043|NCT00648739|42059210|FG001|Overall Study|Follow-up Visits Not Completed|1|||
19610044|NCT00648739|42059211|FG002|Overall Study|Follow-up Visits Not Completed|0|||
19610045|NCT00648739|42059212|FG003|Overall Study|Follow-up Visits Not Completed|0|||
19610046|NCT00648739|42059213|FG004|Overall Study|Follow-up Visits Not Completed|0|||
19610047|NCT00648739|42059214|FG005|Overall Study|Follow-up Visits Not Completed|0|||
19610048|NCT00648739|42059215|FG006|Overall Study|Follow-up Visits Not Completed|0|||
19610049|NCT00648037|42059236|FG000|Overall Study|Not Treated|1|||
19610050|NCT00648037|42059236|FG000|Overall Study|Withdrawal by Subject|1|||
19610051|NCT00648037|42059236|FG000|Overall Study|Adverse Event|11|||
19610052|NCT00648037|42059236|FG000|Overall Study|Relapse|2|||
19610053|NCT00648037|42059236|FG000|Overall Study|Other|1|||
19610054|NCT00627523|42059242|FG000|Overall Study|Lack of Efficacy|1|||
19610055|NCT00627523|42059243|FG001|Overall Study|Lack of Efficacy|0|||
19610056|NCT00627523|42059242|FG000|Overall Study|Withdrawal by Subject|0|||
19610057|NCT00627523|42059243|FG001|Overall Study|Withdrawal by Subject|2|||
19610058|NCT00627523|42059242|FG000|Overall Study|Other|1|||
19610059|NCT00627523|42059243|FG001|Overall Study|Other|0|||
19610060|NCT00640393|42059249|FG000|Part 1|Lost to Follow-up|2|||
19610061|NCT00640393|42059250|FG001|Part 1|Lost to Follow-up|0|||
19610062|NCT00640393|42059251|FG002|Part 1|Lost to Follow-up|0|||
19610063|NCT00640393|42059249|FG000|Part 1|Withdrawal by Subject|3|||
19610064|NCT00640393|42059250|FG001|Part 1|Withdrawal by Subject|0|||
19610065|NCT00640393|42059251|FG002|Part 1|Withdrawal by Subject|0|||
19610066|NCT00640393|42059249|FG000|Randomization|Withdrawn per protocol|17|||
19610067|NCT00640393|42059250|FG001|Randomization|Withdrawn per protocol|0|||
19610068|NCT00640393|42059251|FG002|Randomization|Withdrawn per protocol|0|||
19610069|NCT00640393|42059249|FG000|Randomization|Never randomized by site|2|||
19610070|NCT00640393|42059250|FG001|Randomization|Never randomized by site|0|||
19610071|NCT00640393|42059251|FG002|Randomization|Never randomized by site|0|||
19610072|NCT00640393|42059249|FG000|Part 2|Lost to Follow-up|0|||
19610073|NCT00640393|42059250|FG001|Part 2|Lost to Follow-up|2|||
19610074|NCT00640393|42059251|FG002|Part 2|Lost to Follow-up|2|||
19610075|NCT00640393|42059249|FG000|Part 2|Withdrawal by Subject|0|||
19610076|NCT00640393|42059250|FG001|Part 2|Withdrawal by Subject|6|||
19478415|NCT01502371|41757693|FG001|Overall Study|Physician Decision|0|||
19478416|NCT01502371|41757694|FG002|Overall Study|Physician Decision|0|||
19478417|NCT01502371|41757695|FG003|Overall Study|Physician Decision|0|||
19610077|NCT00640393|42059251|FG002|Part 2|Withdrawal by Subject|1|||
19610078|NCT00640393|42059249|FG000|Part 2|Non-adherence|0|||
19610079|NCT00640393|42059250|FG001|Part 2|Non-adherence|1|||
19610080|NCT00640393|42059251|FG002|Part 2|Non-adherence|0|||
19610081|NCT00640393|42059249|FG000|Part 2|Adverse Event|0|||
19610082|NCT00640393|42059250|FG001|Part 2|Adverse Event|1|||
19610083|NCT00640393|42059251|FG002|Part 2|Adverse Event|0|||
19610084|NCT00907478|42059262|FG000|Overall Study|Ineligibility determined|0|||
19610085|NCT00907478|42059263|FG001|Overall Study|Ineligibility determined|0|||
19610086|NCT00907478|42059264|FG002|Overall Study|Ineligibility determined|1|||
19610087|NCT00907478|42059262|FG000|Overall Study|Noncompliance|0|||
19610088|NCT00907478|42059263|FG001|Overall Study|Noncompliance|0|||
19610089|NCT00907478|42059264|FG002|Overall Study|Noncompliance|1|||
19610090|NCT00907478|42059262|FG000|Overall Study|Adverse Event|3|||
19610091|NCT00907478|42059263|FG001|Overall Study|Adverse Event|1|||
19610092|NCT00907478|42059264|FG002|Overall Study|Adverse Event|2|||
19610093|NCT00907478|42059262|FG000|Overall Study|Withdrawal by Subject|8|||
19610094|NCT00907478|42059263|FG001|Overall Study|Withdrawal by Subject|9|||
19610095|NCT00907478|42059264|FG002|Overall Study|Withdrawal by Subject|6|||
19610096|NCT00907478|42059262|FG000|Overall Study|Requirement for alternative therapy|1|||
19610097|NCT00907478|42059263|FG001|Overall Study|Requirement for alternative therapy|2|||
19610098|NCT00907478|42059264|FG002|Overall Study|Requirement for alternative therapy|3|||
19610099|NCT00907478|42059262|FG000|Overall Study|Physician Decision|2|||
19610100|NCT00907478|42059263|FG001|Overall Study|Physician Decision|0|||
19610101|NCT00907478|42059264|FG002|Overall Study|Physician Decision|3|||
19610102|NCT00907478|42059262|FG000|Overall Study|Death|4|||
19610103|NCT00907478|42059263|FG001|Overall Study|Death|2|||
19610104|NCT00907478|42059264|FG002|Overall Study|Death|1|||
19610105|NCT00907478|42059262|FG000|Overall Study|Protocol-specified criteria|5|||
19610106|NCT00907478|42059263|FG001|Overall Study|Protocol-specified criteria|2|||
19610107|NCT00907478|42059264|FG002|Overall Study|Protocol-specified criteria|3|||
19610108|NCT00907478|42059262|FG000|Overall Study|Pregnancy|0|||
19610109|NCT00907478|42059263|FG001|Overall Study|Pregnancy|1|||
19610110|NCT00907478|42059264|FG002|Overall Study|Pregnancy|1|||
19610111|NCT00907478|42059262|FG000|Overall Study|Lost to Follow-up|1|||
19610112|NCT00907478|42059263|FG001|Overall Study|Lost to Follow-up|0|||
19610113|NCT00907478|42059264|FG002|Overall Study|Lost to Follow-up|0|||
19610114|NCT00907478|42059262|FG000|Overall Study|Other|3|||
19610115|NCT00907478|42059263|FG001|Overall Study|Other|0|||
19610116|NCT00907478|42059264|FG002|Overall Study|Other|1|||
19610117|NCT00627445|42059276|FG000|Overall Study|Adverse Event|3|||
19610118|NCT00627445|42059277|FG001|Overall Study|Adverse Event|3|||
19610119|NCT00627445|42059276|FG000|Overall Study|Lack of Efficacy|0|||
19610120|NCT00627445|42059277|FG001|Overall Study|Lack of Efficacy|1|||
19610121|NCT00627445|42059276|FG000|Overall Study|Other|6|||
19610122|NCT00627445|42059277|FG001|Overall Study|Other|8|||
19610123|NCT00905840|42059285|FG000|Overall Study|Lost to Follow-up|11|||
19610124|NCT00905840|42059285|FG000|Overall Study|Death|3|||
19610125|NCT00905840|42059285|FG000|Overall Study|Withdrawal by Subject|1|||
19610126|NCT00905840|42059285|FG000|Overall Study|Adverse Event|1|||
19610127|NCT00626821|42059292|FG000|Overall Study|Adverse Event|44|||
19610128|NCT00626821|42059292|FG000|Overall Study|Protocol Violation|33|||
19610129|NCT00626821|42059292|FG000|Overall Study|Withdrawal by Subject|10|||
19610130|NCT00626821|42059292|FG000|Overall Study|Physician Decision|9|||
19610131|NCT00626821|42059292|FG000|Overall Study|Product dysfunction|21|||
19610132|NCT00626821|42059292|FG000|Overall Study|other/unknown reason|104|||
19610133|NCT00625183|42059296|FG000|Overall Study|Disease Progression|1|||
19610134|NCT00904982|42059306|FG000|Overall Study|Withdrawal by Subject|2|||
19610135|NCT00904982|42059307|FG001|Overall Study|Withdrawal by Subject|0|||
19610136|NCT00904982|42059308|FG002|Overall Study|Withdrawal by Subject|0|||
19610137|NCT00904982|42059309|FG003|Overall Study|Withdrawal by Subject|0|||
19610138|NCT00640315|42059321|FG000|Overall Study|Withdrawal by Subject|0|||
19610139|NCT00640315|42059322|FG001|Overall Study|Withdrawal by Subject|1|||
19610140|NCT00904748|42059328|FG000|Overall Study|Withdrawal by Subject|1|||
19610141|NCT00904748|42059329|FG001|Overall Study|Withdrawal by Subject|1|||
19610142|NCT00904748|42059330|FG002|Overall Study|Withdrawal by Subject|1|||
19610143|NCT00904748|42059331|FG003|Overall Study|Withdrawal by Subject|2|||
19610144|NCT00904748|42059332|FG004|Overall Study|Withdrawal by Subject|0|||
19610145|NCT00904748|42059333|FG005|Overall Study|Withdrawal by Subject|0|||
19610146|NCT00904748|42059328|FG000|Overall Study|Adverse Event|0|||
19610147|NCT00904748|42059329|FG001|Overall Study|Adverse Event|0|||
19610148|NCT00904748|42059330|FG002|Overall Study|Adverse Event|0|||
19610149|NCT00904748|42059331|FG003|Overall Study|Adverse Event|0|||
19610150|NCT00904748|42059332|FG004|Overall Study|Adverse Event|1|||
19610151|NCT00904748|42059333|FG005|Overall Study|Adverse Event|0|||
19610152|NCT00574405|42059344|FG000|Overall Study|Withdrawal by Subject|3|||
19610153|NCT00574405|42059345|FG001|Overall Study|Withdrawal by Subject|2|||
19610154|NCT00971243|42059356|FG000|Double Blind Period|Adverse Event|2|||
19610155|NCT00971243|42059357|FG001|Double Blind Period|Adverse Event|3|||
19610156|NCT00971243|42059358|FG002|Double Blind Period|Adverse Event|2|||
19610157|NCT00971243|42059359|FG003|Double Blind Period|Adverse Event|2|||
19610158|NCT00971243|42059360|FG004|Double Blind Period|Adverse Event|3|||
19610159|NCT00971243|42059356|FG000|Double Blind Period|Lost to Follow-up|0|||
19610160|NCT00971243|42059357|FG001|Double Blind Period|Lost to Follow-up|1|||
19800249|NCT02858401|42258331|FG000|Overall Study|Withdrew Consent|0|||
19610161|NCT00971243|42059358|FG002|Double Blind Period|Lost to Follow-up|1|||
19610162|NCT00971243|42059359|FG003|Double Blind Period|Lost to Follow-up|0|||
19610163|NCT00971243|42059360|FG004|Double Blind Period|Lost to Follow-up|1|||
19610164|NCT00971243|42059356|FG000|Double Blind Period|Physician Decision|10|||
19610165|NCT00971243|42059357|FG001|Double Blind Period|Physician Decision|6|||
19610166|NCT00971243|42059358|FG002|Double Blind Period|Physician Decision|7|||
19610167|NCT00971243|42059359|FG003|Double Blind Period|Physician Decision|6|||
19610168|NCT00971243|42059360|FG004|Double Blind Period|Physician Decision|7|||
19610169|NCT00971243|42059356|FG000|Double Blind Period|Protocol Violation|2|||
19610170|NCT00971243|42059357|FG001|Double Blind Period|Protocol Violation|0|||
19610171|NCT00971243|42059358|FG002|Double Blind Period|Protocol Violation|3|||
19610172|NCT00971243|42059359|FG003|Double Blind Period|Protocol Violation|2|||
19610173|NCT00971243|42059360|FG004|Double Blind Period|Protocol Violation|2|||
19610174|NCT00971243|42059356|FG000|Double Blind Period|Withdrawal by Subject|4|||
19610175|NCT00971243|42059357|FG001|Double Blind Period|Withdrawal by Subject|1|||
19610176|NCT00971243|42059358|FG002|Double Blind Period|Withdrawal by Subject|4|||
19610177|NCT00971243|42059359|FG003|Double Blind Period|Withdrawal by Subject|4|||
19610178|NCT00971243|42059360|FG004|Double Blind Period|Withdrawal by Subject|4|||
19610179|NCT00971243|42059356|FG000|Double Blind Period|Other reasons|1|||
19610180|NCT00971243|42059357|FG001|Double Blind Period|Other reasons|0|||
19610181|NCT00971243|42059358|FG002|Double Blind Period|Other reasons|2|||
19610182|NCT00971243|42059359|FG003|Double Blind Period|Other reasons|0|||
19610183|NCT00971243|42059360|FG004|Double Blind Period|Other reasons|1|||
19610184|NCT00971243|42059356|FG000|Open-label Period|Adverse Event|1|||
19610185|NCT00971243|42059357|FG001|Open-label Period|Adverse Event|0|||
19610186|NCT00971243|42059358|FG002|Open-label Period|Adverse Event|1|||
19610187|NCT00971243|42059359|FG003|Open-label Period|Adverse Event|1|||
19610188|NCT00971243|42059360|FG004|Open-label Period|Adverse Event|0|||
19610189|NCT00971243|42059356|FG000|Open-label Period|Physician Decision|5|||
19610190|NCT00971243|42059357|FG001|Open-label Period|Physician Decision|9|||
19610191|NCT00971243|42059358|FG002|Open-label Period|Physician Decision|3|||
19610192|NCT00971243|42059359|FG003|Open-label Period|Physician Decision|7|||
19610193|NCT00971243|42059360|FG004|Open-label Period|Physician Decision|2|||
19610194|NCT00971243|42059356|FG000|Open-label Period|Protocol Violation|1|||
19610195|NCT00971243|42059357|FG001|Open-label Period|Protocol Violation|1|||
19390814|NCT01986010|41634651|FG016|Overall Study|Lost to Follow-up|0|||
19390815|NCT01986010|41634635|FG000|Overall Study|Physician Decision|0|||
19390816|NCT01986010|41634636|FG001|Overall Study|Physician Decision|0|||
19390817|NCT01986010|41634637|FG002|Overall Study|Physician Decision|0|||
19390818|NCT01986010|41634638|FG003|Overall Study|Physician Decision|0|||
19390819|NCT01986010|41634639|FG004|Overall Study|Physician Decision|0|||
19390820|NCT01986010|41634640|FG005|Overall Study|Physician Decision|0|||
19390821|NCT01986010|41634641|FG006|Overall Study|Physician Decision|0|||
19390822|NCT01986010|41634642|FG007|Overall Study|Physician Decision|0|||
19390823|NCT01986010|41634643|FG008|Overall Study|Physician Decision|0|||
19390824|NCT01986010|41634644|FG009|Overall Study|Physician Decision|0|||
19390825|NCT01986010|41634645|FG010|Overall Study|Physician Decision|0|||
19390826|NCT01986010|41634646|FG011|Overall Study|Physician Decision|0|||
19390827|NCT01986010|41634647|FG012|Overall Study|Physician Decision|0|||
19390828|NCT01986010|41634648|FG013|Overall Study|Physician Decision|0|||
19390829|NCT01986010|41634649|FG014|Overall Study|Physician Decision|1|||
19390830|NCT01986010|41634650|FG015|Overall Study|Physician Decision|0|||
19390831|NCT01986010|41634651|FG016|Overall Study|Physician Decision|0|||
19390832|NCT01986010|41634635|FG000|Overall Study|Withdrawal by Subject|2|||
19390833|NCT01986010|41634636|FG001|Overall Study|Withdrawal by Subject|2|||
19390834|NCT01986010|41634637|FG002|Overall Study|Withdrawal by Subject|3|||
19390835|NCT01986010|41634638|FG003|Overall Study|Withdrawal by Subject|0|||
19390836|NCT01986010|41634639|FG004|Overall Study|Withdrawal by Subject|2|||
19390837|NCT01986010|41634640|FG005|Overall Study|Withdrawal by Subject|4|||
19390838|NCT01986010|41634641|FG006|Overall Study|Withdrawal by Subject|0|||
19390839|NCT01986010|41634642|FG007|Overall Study|Withdrawal by Subject|0|||
19390840|NCT01986010|41634643|FG008|Overall Study|Withdrawal by Subject|0|||
19390841|NCT01986010|41634644|FG009|Overall Study|Withdrawal by Subject|0|||
19390842|NCT01986010|41634645|FG010|Overall Study|Withdrawal by Subject|0|||
19390843|NCT01986010|41634646|FG011|Overall Study|Withdrawal by Subject|2|||
19390844|NCT01986010|41634647|FG012|Overall Study|Withdrawal by Subject|0|||
19390845|NCT01986010|41634648|FG013|Overall Study|Withdrawal by Subject|1|||
19390846|NCT01986010|41634649|FG014|Overall Study|Withdrawal by Subject|2|||
19390847|NCT01986010|41634650|FG015|Overall Study|Withdrawal by Subject|0|||
19390848|NCT01986010|41634651|FG016|Overall Study|Withdrawal by Subject|0|||
19390849|NCT01986010|41634635|FG000|Overall Study|Status Not Recorded|2|||
19610196|NCT00971243|42059358|FG002|Open-label Period|Protocol Violation|1|||
19610197|NCT00971243|42059359|FG003|Open-label Period|Protocol Violation|0|||
19610198|NCT00971243|42059360|FG004|Open-label Period|Protocol Violation|1|||
19610199|NCT00971243|42059356|FG000|Open-label Period|Withdrawal by Subject|1|||
19390850|NCT01986010|41634636|FG001|Overall Study|Status Not Recorded|4|||
19390851|NCT01986010|41634637|FG002|Overall Study|Status Not Recorded|2|||
19610200|NCT00971243|42059357|FG001|Open-label Period|Withdrawal by Subject|0|||
19610201|NCT00971243|42059358|FG002|Open-label Period|Withdrawal by Subject|0|||
19390852|NCT01986010|41634638|FG003|Overall Study|Status Not Recorded|0|||
19390853|NCT01986010|41634639|FG004|Overall Study|Status Not Recorded|1|||
19390854|NCT01986010|41634640|FG005|Overall Study|Status Not Recorded|2|||
19610202|NCT00971243|42059359|FG003|Open-label Period|Withdrawal by Subject|2|||
19610203|NCT00971243|42059360|FG004|Open-label Period|Withdrawal by Subject|1|||
19610204|NCT00971243|42059356|FG000|Open-label Period|Other reason|0|||
19610205|NCT00971243|42059357|FG001|Open-label Period|Other reason|0|||
19610206|NCT00971243|42059358|FG002|Open-label Period|Other reason|0|||
19610207|NCT00971243|42059359|FG003|Open-label Period|Other reason|0|||
19610208|NCT00971243|42059360|FG004|Open-label Period|Other reason|2|||
19610209|NCT00568555|42059374|FG000|Overall Study|Withdrawal by Subject|1|||
19610210|NCT00568555|42059375|FG001|Overall Study|Withdrawal by Subject|1|||
19610211|NCT00904670|42059383|FG000|Open Label Phase|Withdrawal by Subject|2|||
19610212|NCT00904670|42059384|FG001|Open Label Phase|Withdrawal by Subject|0|||
19610213|NCT00904670|42059383|FG000|Open Label Phase|Adverse Event|2|||
19610214|NCT00904670|42059384|FG001|Open Label Phase|Adverse Event|0|||
19610215|NCT00904670|42059383|FG000|Open Label Phase|Lack of Efficacy|1|||
19610216|NCT00904670|42059384|FG001|Open Label Phase|Lack of Efficacy|0|||
19610217|NCT00904670|42059383|FG000|Open Label Phase|Lost to Follow-up|1|||
19610218|NCT00904670|42059384|FG001|Open Label Phase|Lost to Follow-up|0|||
19610219|NCT00638443|42059392|FG000|First Intervention|Adverse Event|2|||
19610220|NCT00638443|42059393|FG001|First Intervention|Adverse Event|1|||
19610221|NCT00636181|42059404|FG000|Overall Study|Withdrawal by Subject|8|||
19610222|NCT00636181|42059405|FG001|Overall Study|Withdrawal by Subject|6|||
19610223|NCT00636181|42059406|FG002|Overall Study|Withdrawal by Subject|10|||
19610224|NCT00968669|42059418|FG000|Overall Study|Lost to Follow-up|5|||
19610225|NCT00968669|42059419|FG001|Overall Study|Lost to Follow-up|2|||
19610226|NCT00968669|42059420|FG002|Overall Study|Lost to Follow-up|1|||
19610227|NCT00968669|42059421|FG003|Overall Study|Lost to Follow-up|4|||
19610228|NCT00968669|42059418|FG000|Overall Study|Withdrawal by Subject|9|||
19610229|NCT00968669|42059419|FG001|Overall Study|Withdrawal by Subject|7|||
19610230|NCT00968669|42059420|FG002|Overall Study|Withdrawal by Subject|5|||
19610231|NCT00968669|42059421|FG003|Overall Study|Withdrawal by Subject|3|||
19610232|NCT00968669|42059418|FG000|Overall Study|Pregnancy|0|||
19610233|NCT00968669|42059419|FG001|Overall Study|Pregnancy|0|||
19610234|NCT00968669|42059420|FG002|Overall Study|Pregnancy|2|||
19610235|NCT00968669|42059421|FG003|Overall Study|Pregnancy|0|||
19610236|NCT00968669|42059418|FG000|Overall Study|AE|1|||
19610237|NCT00968669|42059419|FG001|Overall Study|AE|0|||
19610238|NCT00968669|42059420|FG002|Overall Study|AE|0|||
19610239|NCT00968669|42059421|FG003|Overall Study|AE|0|||
19610240|NCT00968669|42059418|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
19610241|NCT00968669|42059419|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
19610242|NCT00968669|42059420|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
19610243|NCT00968669|42059421|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
19610244|NCT00968669|42059418|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
19610245|NCT00968669|42059419|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
19610246|NCT00968669|42059420|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
19610247|NCT00968669|42059421|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
19610248|NCT00968669|42059418|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
19610249|NCT00968669|42059419|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
19610250|NCT00968669|42059420|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
19610251|NCT00968669|42059421|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
19610252|NCT00968669|42059418|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
19610253|NCT00968669|42059419|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
19610254|NCT00968669|42059420|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
19610255|NCT00968669|42059421|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
19610256|NCT00968669|42059418|FG000|Overall Study|EARLY WITHDRAWAL|0|||
19610257|NCT00968669|42059419|FG001|Overall Study|EARLY WITHDRAWAL|1|||
19610258|NCT00968669|42059420|FG002|Overall Study|EARLY WITHDRAWAL|0|||
19610259|NCT00968669|42059421|FG003|Overall Study|EARLY WITHDRAWAL|0|||
19610260|NCT00968669|42059418|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
19610261|NCT00968669|42059419|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
19390855|NCT01986010|41634641|FG006|Overall Study|Status Not Recorded|0|||
19390856|NCT01986010|41634642|FG007|Overall Study|Status Not Recorded|0|||
19390857|NCT01986010|41634643|FG008|Overall Study|Status Not Recorded|2|||
19390858|NCT01986010|41634644|FG009|Overall Study|Status Not Recorded|1|||
19390859|NCT01986010|41634645|FG010|Overall Study|Status Not Recorded|7|||
19390860|NCT01986010|41634646|FG011|Overall Study|Status Not Recorded|7|||
19390861|NCT01986010|41634647|FG012|Overall Study|Status Not Recorded|9|||
19390862|NCT01986010|41634648|FG013|Overall Study|Status Not Recorded|9|||
19390863|NCT01986010|41634649|FG014|Overall Study|Status Not Recorded|5|||
19390864|NCT01986010|41634650|FG015|Overall Study|Status Not Recorded|10|||
19390865|NCT01986010|41634651|FG016|Overall Study|Status Not Recorded|4|||
19478418|NCT01502371|41757696|FG004|Overall Study|Physician Decision|1|||
19478419|NCT01502371|41757692|FG000|Overall Study|Noncompliance with Study Drug|0|||
19610262|NCT00968669|42059420|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
19610263|NCT00968669|42059421|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
19610264|NCT00968669|42059418|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
19390866|NCT01963780|41634697|FG000|Overall Study|Death|7|||
19390867|NCT02009878|41634704|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
19390868|NCT02009878|41634705|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
19390869|NCT02009878|41634706|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
19390870|NCT02009722|41634716|FG000|Overall Study|Protocol Violation|1|||
19390871|NCT02009722|41634717|FG001|Overall Study|Protocol Violation|2|||
19610265|NCT00968669|42059419|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
19610266|NCT00968669|42059420|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
19610267|NCT00968669|42059421|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
19610268|NCT00968669|42059418|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
19610269|NCT00968669|42059419|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
19610270|NCT00968669|42059420|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
19610271|NCT00968669|42059421|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
19610272|NCT00968669|42059418|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
19610273|NCT00968669|42059419|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
19610274|NCT00968669|42059420|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
19610275|NCT00968669|42059421|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
19610276|NCT00968669|42059418|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
19610277|NCT00968669|42059419|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
19610278|NCT00968669|42059420|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
19610279|NCT00968669|42059421|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
19610280|NCT00968669|42059418|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
19610281|NCT00968669|42059419|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
19610282|NCT00968669|42059420|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
19610283|NCT00968669|42059421|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
19610284|NCT00968669|42059418|FG000|Overall Study|SPONSOR DECISION|0|||
19610285|NCT00968669|42059419|FG001|Overall Study|SPONSOR DECISION|1|||
19610286|NCT00968669|42059420|FG002|Overall Study|SPONSOR DECISION|0|||
19610287|NCT00968669|42059421|FG003|Overall Study|SPONSOR DECISION|0|||
19610288|NCT00968669|42059418|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
19610289|NCT00968669|42059419|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
19610290|NCT00968669|42059420|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
19610291|NCT00968669|42059421|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
19610292|NCT00968669|42059418|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
19610293|NCT00968669|42059419|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
19610294|NCT00968669|42059420|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
19610295|NCT00968669|42059421|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
19610296|NCT00968669|42059418|FG000|Overall Study|SUBJECT INCARCERATED|0|||
19610297|NCT00968669|42059419|FG001|Overall Study|SUBJECT INCARCERATED|1|||
19701296|NCT00435461|42145853|FG001|Overall Study|Participant ended study one day early|0|||
19701297|NCT00435461|42145854|FG002|Overall Study|Participant ended study one day early|0|||
19701298|NCT00435461|42145852|FG000|Overall Study|Noncompliance with study requirements|1|||
19701299|NCT00435461|42145853|FG001|Overall Study|Noncompliance with study requirements|1|||
19701300|NCT00435461|42145854|FG002|Overall Study|Noncompliance with study requirements|1|||
19701301|NCT00435461|42145852|FG000|Overall Study|Adverse Event|1|||
19701302|NCT00435461|42145853|FG001|Overall Study|Adverse Event|2|||
19701303|NCT00435461|42145854|FG002|Overall Study|Adverse Event|6|||
19701304|NCT00435461|42145852|FG000|Overall Study|Non-Compliance of diary|2|||
19701305|NCT00435461|42145853|FG001|Overall Study|Non-Compliance of diary|0|||
19701306|NCT00435461|42145854|FG002|Overall Study|Non-Compliance of diary|1|||
19701307|NCT00435461|42145852|FG000|Overall Study|Lost to Follow-up|1|||
19701308|NCT00435461|42145853|FG001|Overall Study|Lost to Follow-up|1|||
19701309|NCT00435461|42145854|FG002|Overall Study|Lost to Follow-up|2|||
19701310|NCT00006436|42145862|FG000|Overall Study|Refused further treatment|2|||
19701311|NCT00006436|42145862|FG000|Overall Study|Declined to participate (before treatment started)|1|||
19701312|NCT00434759|42145871|FG000|Overall Study|Lack of Efficacy|5|||
19701313|NCT00434759|42145872|FG001|Overall Study|Lack of Efficacy|4|||
19701314|NCT00434759|42145871|FG000|Overall Study|Withdrawal by Subject|17|||
19701315|NCT00434759|42145872|FG001|Overall Study|Withdrawal by Subject|1|||
19701316|NCT00434759|42145871|FG000|Overall Study|family affairs|2|||
19701317|NCT00434759|42145872|FG001|Overall Study|family affairs|0|||
19701318|NCT00440999|42145882|FG000|Overall Study|Adverse Event|0|||
19701319|NCT00440999|42145883|FG001|Overall Study|Adverse Event|2|||
19701320|NCT00440999|42145882|FG000|Overall Study|Lack of Efficacy|6|||
19701321|NCT00440999|42145883|FG001|Overall Study|Lack of Efficacy|7|||
19390872|NCT02009722|41634716|FG000|Overall Study|Did not receive intervention|0|||
19701322|NCT00440999|42145882|FG000|Overall Study|Lost to Follow-up|19|||
19701323|NCT00440999|42145883|FG001|Overall Study|Lost to Follow-up|12|||
19701324|NCT00440999|42145882|FG000|Overall Study|Protocol Violation|1|||
19701325|NCT00440999|42145883|FG001|Overall Study|Protocol Violation|0|||
19701326|NCT00440999|42145882|FG000|Overall Study|Withdrawal by Subject|2|||
19701327|NCT00440999|42145883|FG001|Overall Study|Withdrawal by Subject|5|||
19390873|NCT02009722|41634717|FG001|Overall Study|Did not receive intervention|1|||
19390874|NCT02655419|41634725|FG000|Overall Study|Enrolled but not treated|1|||
19701328|NCT00440999|42145882|FG000|Overall Study|Subjets missed the visit|1|||
19701329|NCT00440999|42145883|FG001|Overall Study|Subjets missed the visit|0|||
19701330|NCT00440999|42145882|FG000|Overall Study|Mixed infection at entry|1|||
19701331|NCT00440999|42145883|FG001|Overall Study|Mixed infection at entry|0|||
19701332|NCT00440999|42145882|FG000|Overall Study|P. falciparum malaria|5|||
19701333|NCT00440999|42145883|FG001|Overall Study|P. falciparum malaria|14|||
19701334|NCT00440999|42145882|FG000|Overall Study|Subj left hosp without inform staff|0|||
19701335|NCT00440999|42145883|FG001|Overall Study|Subj left hosp without inform staff|1|||
19701336|NCT00434213|42145891|FG000|Overall Study|Adverse Event|12|||
19701337|NCT00434213|42145891|FG000|Overall Study|Lack of Efficacy|9|||
19701338|NCT00434213|42145891|FG000|Overall Study|Lost to Follow-up|14|||
19701339|NCT00434213|42145891|FG000|Overall Study|Withdrawal by Subject|7|||
19701340|NCT00434213|42145891|FG000|Overall Study|Protocol Violation|3|||
19701341|NCT00434213|42145891|FG000|Overall Study|Unable to comply with study visit window|2|||
19701342|NCT00434213|42145891|FG000|Overall Study|Application site reaction|1|||
19701343|NCT00434213|42145891|FG000|Overall Study|Non-compliant to study schedule|1|||
19701344|NCT00006184|42145897|FG000|Overall Study|Death|1|||
19701345|NCT00006184|42145898|FG001|Overall Study|Death|0|||
19701346|NCT00434057|42145904|FG000|Overall Study|Withdrawal by Subject|1|||
19701347|NCT00433199|42145910|FG000|Double-Blind Period|Adverse Event|0|||
19701348|NCT00433199|42145911|FG001|Double-Blind Period|Adverse Event|25|||
19701349|NCT00433199|42145910|FG000|Double-Blind Period|Lack of Efficacy|0|||
19701350|NCT00433199|42145911|FG001|Double-Blind Period|Lack of Efficacy|2|||
19701351|NCT00433199|42145910|FG000|Double-Blind Period|Lost to Follow-up|2|||
19701352|NCT00433199|42145911|FG001|Double-Blind Period|Lost to Follow-up|5|||
19701353|NCT00433199|42145910|FG000|Double-Blind Period|Withdrawal by Subject|8|||
19701354|NCT00433199|42145911|FG001|Double-Blind Period|Withdrawal by Subject|19|||
19701355|NCT00433199|42145910|FG000|Double-Blind Period|Protocol Violation|1|||
19701356|NCT00433199|42145911|FG001|Double-Blind Period|Protocol Violation|10|||
19701357|NCT00433199|42145910|FG000|Double-Blind Period|Administrative|1|||
19701358|NCT00433199|42145911|FG001|Double-Blind Period|Administrative|5|||
19701359|NCT00433199|42145910|FG000|Open-Label Period|Adverse Event|0|||
19701360|NCT00433199|42145911|FG001|Open-Label Period|Adverse Event|19|||
19701361|NCT00433199|42145910|FG000|Open-Label Period|Lack of Efficacy|0|||
19800250|NCT02858401|42258332|FG001|Overall Study|Withdrew Consent|0|||
19800251|NCT02858401|42258333|FG002|Overall Study|Withdrew Consent|0|||
19800252|NCT02858401|42258334|FG003|Overall Study|Withdrew Consent|0|||
19800253|NCT02858401|42258335|FG004|Overall Study|Withdrew Consent|0|||
19800254|NCT02858401|42258336|FG005|Overall Study|Withdrew Consent|1|||
19800255|NCT02858401|42258337|FG006|Overall Study|Withdrew Consent|0|||
19800256|NCT02858401|42258331|FG000|Overall Study|Lost to Follow-up|0|||
19800257|NCT02858401|42258332|FG001|Overall Study|Lost to Follow-up|1|||
19800258|NCT02858401|42258333|FG002|Overall Study|Lost to Follow-up|0|||
19800259|NCT02858401|42258334|FG003|Overall Study|Lost to Follow-up|0|||
19800260|NCT02858401|42258335|FG004|Overall Study|Lost to Follow-up|0|||
19800261|NCT02858401|42258336|FG005|Overall Study|Lost to Follow-up|0|||
19701362|NCT00433199|42145911|FG001|Open-Label Period|Lack of Efficacy|2|||
19701363|NCT00433199|42145910|FG000|Open-Label Period|Lost to Follow-up|0|||
19701364|NCT00433199|42145911|FG001|Open-Label Period|Lost to Follow-up|3|||
19701365|NCT00433199|42145910|FG000|Open-Label Period|Withdrawal by Subject|0|||
19701366|NCT00433199|42145911|FG001|Open-Label Period|Withdrawal by Subject|7|||
19701367|NCT00433199|42145910|FG000|Open-Label Period|Protocol Violation|0|||
19701368|NCT00433199|42145911|FG001|Open-Label Period|Protocol Violation|2|||
19701369|NCT00433199|42145910|FG000|Open-Label Period|Administrative|0|||
19701370|NCT00433199|42145911|FG001|Open-Label Period|Administrative|1|||
19701371|NCT00006046|42145927|FG000|Overall Study|Adverse Event|3|||
19701372|NCT00006046|42145928|FG001|Overall Study|Adverse Event|0|||
19701373|NCT00006046|42145929|FG002|Overall Study|Adverse Event|0|||
19701374|NCT00006046|42145930|FG003|Overall Study|Adverse Event|0|||
19701375|NCT00006046|42145931|FG004|Overall Study|Adverse Event|0|||
19701376|NCT00006046|42145927|FG000|Overall Study|Disease Progression|2|||
19390875|NCT02655419|41634726|FG001|Overall Study|Enrolled but not treated|5|||
19390876|NCT02655419|41634725|FG000|Overall Study|Withdrawal by Subject|4|||
19390877|NCT02655419|41634726|FG001|Overall Study|Withdrawal by Subject|1|||
19390878|NCT02655419|41634725|FG000|Overall Study|Other|0|||
19390879|NCT02655419|41634726|FG001|Overall Study|Other|1|||
19390880|NCT01962922|41634738|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
19390881|NCT01962922|41634739|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
19390882|NCT01962922|41634738|FG000|PK Portion Day 7|non-compliance|1|||
19390883|NCT01962922|41634739|FG001|PK Portion Day 7|non-compliance|0|||
19701377|NCT00006046|42145928|FG001|Overall Study|Disease Progression|0|||
19701378|NCT00006046|42145929|FG002|Overall Study|Disease Progression|0|||
19701379|NCT00006046|42145930|FG003|Overall Study|Disease Progression|0|||
19701380|NCT00006046|42145931|FG004|Overall Study|Disease Progression|0|||
19701381|NCT00005908|42145943|FG000|Overall Study|Withdrawal by Subject|1|||
19800262|NCT02858401|42258337|FG006|Overall Study|Lost to Follow-up|0|||
19800263|NCT02857283|42258364|FG000|First Exposure|Withdrawal by Subject|1|||
19390884|NCT01962922|41634738|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
19800264|NCT02857283|42258365|FG001|First Exposure|Withdrawal by Subject|0|||
19800265|NCT02747927|42258383|FG000|Overall Study|Adverse Event|5|||
19800266|NCT02747927|42258384|FG001|Overall Study|Adverse Event|14|||
19800267|NCT02747927|42258383|FG000|Overall Study|Lost to Follow-up|22|||
19800268|NCT02747927|42258384|FG001|Overall Study|Lost to Follow-up|43|||
19800269|NCT02747927|42258383|FG000|Overall Study|Pregnancy|34|||
19800270|NCT02747927|42258384|FG001|Overall Study|Pregnancy|66|||
19800271|NCT02747927|42258383|FG000|Overall Study|Protocol Violation|2|||
19701382|NCT00005908|42145944|FG001|Overall Study|Withdrawal by Subject|0|||
19701383|NCT00432965|42145955|FG000|Overall Study|Lost to Follow-up|22|||
19701384|NCT00432965|42145956|FG001|Overall Study|Lost to Follow-up|19|||
19701385|NCT00432965|42145955|FG000|Overall Study|Withdrawal by Subject|13|||
19701386|NCT00432965|42145956|FG001|Overall Study|Withdrawal by Subject|13|||
19701387|NCT00432965|42145955|FG000|Overall Study|Physician Decision|14|||
19800272|NCT02747927|42258384|FG001|Overall Study|Protocol Violation|4|||
19800273|NCT02747927|42258383|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
19701388|NCT00432965|42145956|FG001|Overall Study|Physician Decision|13|||
19701389|NCT00432965|42145955|FG000|Overall Study|Lack of Efficacy|8|||
19701390|NCT00432965|42145956|FG001|Overall Study|Lack of Efficacy|13|||
19701391|NCT00432965|42145955|FG000|Overall Study|Non-compliance|7|||
19701392|NCT00432965|42145956|FG001|Overall Study|Non-compliance|0|||
19701393|NCT00432965|42145955|FG000|Overall Study|Adverse Event|22|||
19701394|NCT00432965|42145956|FG001|Overall Study|Adverse Event|19|||
19701395|NCT00432965|42145955|FG000|Overall Study|Death|3|||
19800274|NCT02747927|42258384|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
19800275|NCT02747927|42258383|FG000|Overall Study|Reason not Specified|11|||
19800276|NCT02747927|42258384|FG001|Overall Study|Reason not Specified|27|||
19800277|NCT02746679|42258392|FG000|Overall Study|Lost to Follow-up|4|||
19800278|NCT02746679|42258393|FG001|Overall Study|Lost to Follow-up|6|||
19800279|NCT02731131|42258401|FG000|Overall Study|Psychiatric Disorder|0|||
19701396|NCT00432965|42145956|FG001|Overall Study|Death|4|||
19701397|NCT00432965|42145955|FG000|Overall Study|Exclusionary Methods|1|||
19701398|NCT00432965|42145956|FG001|Overall Study|Exclusionary Methods|2|||
19701399|NCT00432965|42145955|FG000|Overall Study|Incomplete Data|4|||
19701400|NCT00432965|42145956|FG001|Overall Study|Incomplete Data|3|||
19701401|NCT00440297|42145964|FG000|Overall Study|Adverse Event|8|||
19701402|NCT00440297|42145965|FG001|Overall Study|Adverse Event|5|||
19701403|NCT00440297|42145964|FG000|Overall Study|Lost to Follow-up|1|||
19701404|NCT00440297|42145965|FG001|Overall Study|Lost to Follow-up|0|||
19701405|NCT00440297|42145964|FG000|Overall Study|Physician Decision|1|||
19701406|NCT00440297|42145965|FG001|Overall Study|Physician Decision|0|||
19701407|NCT00440297|42145964|FG000|Overall Study|Protocol Violation|11|||
19701408|NCT00440297|42145965|FG001|Overall Study|Protocol Violation|7|||
19800280|NCT02731131|42258402|FG001|Overall Study|Psychiatric Disorder|1|||
19800281|NCT02731131|42258401|FG000|Overall Study|Refused Therapy|0|||
19800282|NCT02731131|42258402|FG001|Overall Study|Refused Therapy|1|||
19800283|NCT02746705|42258410|FG000|Overall Study|Physician Decision|1|||
19800284|NCT02746705|42258411|FG001|Overall Study|Physician Decision|1|||
19800285|NCT02746705|42258410|FG000|Overall Study|Lost to Follow-up|1|||
19800286|NCT02746705|42258411|FG001|Overall Study|Lost to Follow-up|0|||
19800287|NCT02746705|42258410|FG000|Overall Study|outlier scores deemed not valid|0|||
19800288|NCT02746705|42258411|FG001|Overall Study|outlier scores deemed not valid|1|||
19800289|NCT02746627|42258420|FG000|Overall Study|Withdrawal by Subject|1|||
19800290|NCT02746627|42258421|FG001|Overall Study|Withdrawal by Subject|1|||
19800291|NCT02746627|42258422|FG002|Overall Study|Withdrawal by Subject|1|||
19800292|NCT02856113|42258432|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19800293|NCT02856113|42258433|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
19800294|NCT02856113|42258432|FG000|Overall Study|Significant Protocol Deviation|1|||
19800295|NCT02856113|42258433|FG001|Overall Study|Significant Protocol Deviation|0|||
19800296|NCT02856113|42258432|FG000|Overall Study|Lost to Follow-up|3|||
19800297|NCT02856113|42258433|FG001|Overall Study|Lost to Follow-up|5|||
19800298|NCT02856113|42258432|FG000|Overall Study|Voluntary Withdrawal|3|||
19800299|NCT02856113|42258433|FG001|Overall Study|Voluntary Withdrawal|5|||
19800300|NCT02856113|42258432|FG000|Overall Study|Pregnancy|0|||
19800301|NCT02856113|42258433|FG001|Overall Study|Pregnancy|1|||
19800302|NCT02856113|42258432|FG000|Overall Study|Principal Investigator Discretion|2|||
19800303|NCT02856113|42258433|FG001|Overall Study|Principal Investigator Discretion|1|||
19390885|NCT01962922|41634739|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
19701409|NCT00440297|42145964|FG000|Overall Study|Withdrawal by Subject|1|||
19701410|NCT00440297|42145965|FG001|Overall Study|Withdrawal by Subject|6|||
19701411|NCT00440297|42145964|FG000|Overall Study|Randomized by mistake|1|||
19701412|NCT00440297|42145965|FG001|Overall Study|Randomized by mistake|0|||
19800304|NCT02856113|42258432|FG000|Overall Study|Randomized but not Treated|1|||
19800305|NCT02856113|42258433|FG001|Overall Study|Randomized but not Treated|0|||
19800306|NCT02856113|42258432|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
19701413|NCT00432809|42145974|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
19701414|NCT00432809|42145975|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
19800307|NCT02856113|42258433|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
19800308|NCT02855411|42258440|FG000|Overall Study|Study terminated by sponsor|21|||
19701415|NCT00432809|42145976|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
19701416|NCT00432809|42145974|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
19701417|NCT00432809|42145975|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
19701418|NCT00432809|42145976|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
19800309|NCT02855411|42258440|FG000|Overall Study|Does not meet entrance criteria|14|||
19800310|NCT02745145|42258447|FG000|Overall Study|Adverse Event|1|||
19701419|NCT00431951|42145988|FG000|Overall Study|Inability to follow study procedures|1|||
19701420|NCT00431951|42145989|FG001|Overall Study|Inability to follow study procedures|0|||
19701421|NCT00431951|42145990|FG002|Overall Study|Inability to follow study procedures|1|||
19701422|NCT00431951|42145991|FG003|Overall Study|Inability to follow study procedures|2|||
19701423|NCT00431951|42145988|FG000|Overall Study|Lost to Follow-up|0|||
19701424|NCT00431951|42145989|FG001|Overall Study|Lost to Follow-up|1|||
19701425|NCT00431951|42145990|FG002|Overall Study|Lost to Follow-up|0|||
19701426|NCT00431951|42145991|FG003|Overall Study|Lost to Follow-up|0|||
19701427|NCT00431951|42145988|FG000|Overall Study|Withdrawal by Subject|0|||
19701428|NCT00431951|42145989|FG001|Overall Study|Withdrawal by Subject|1|||
19701429|NCT00431951|42145990|FG002|Overall Study|Withdrawal by Subject|0|||
19701430|NCT00431951|42145991|FG003|Overall Study|Withdrawal by Subject|0|||
19701431|NCT00431951|42145988|FG000|Overall Study|Adverse Event|0|||
19701432|NCT00431951|42145989|FG001|Overall Study|Adverse Event|0|||
19701433|NCT00431951|42145990|FG002|Overall Study|Adverse Event|1|||
19701434|NCT00431951|42145991|FG003|Overall Study|Adverse Event|0|||
19701435|NCT00004978|42146007|FG000|Overall Study|Death|107|||
19701436|NCT00004978|42146008|FG001|Overall Study|Death|116|||
19701437|NCT00004978|42146007|FG000|Overall Study|Lost to Follow-up|101|||
19701438|NCT00004978|42146008|FG001|Overall Study|Lost to Follow-up|108|||
19701439|NCT00004978|42146007|FG000|Overall Study|Withdrawal by Subject|17|||
19701440|NCT00004978|42146008|FG001|Overall Study|Withdrawal by Subject|26|||
19701441|NCT00004978|42146007|FG000|Overall Study|site closure - not in analysis cohort|19|||
19701442|NCT00004978|42146008|FG001|Overall Study|site closure - not in analysis cohort|20|||
19701443|NCT00430937|42146016|FG000|Overall Study|Adverse Event|3|||
19701444|NCT00430937|42146017|FG001|Overall Study|Adverse Event|8|||
19701445|NCT00430937|42146016|FG000|Overall Study|Death|0|||
19701446|NCT00430937|42146017|FG001|Overall Study|Death|1|||
19701447|NCT00430937|42146016|FG000|Overall Study|Lost to Follow-up|6|||
19701448|NCT00430937|42146017|FG001|Overall Study|Lost to Follow-up|6|||
19701449|NCT00430937|42146016|FG000|Overall Study|Withdrawal by Subject|5|||
19701450|NCT00430937|42146017|FG001|Overall Study|Withdrawal by Subject|2|||
19701451|NCT00430937|42146016|FG000|Overall Study|Protocol Violation|3|||
19701452|NCT00430937|42146017|FG001|Overall Study|Protocol Violation|2|||
19701453|NCT00430937|42146016|FG000|Overall Study|Lack of Efficacy|6|||
19701454|NCT00430937|42146017|FG001|Overall Study|Lack of Efficacy|5|||
19701455|NCT00430937|42146016|FG000|Overall Study|Inappropriate enrollment|2|||
19701456|NCT00430937|42146017|FG001|Overall Study|Inappropriate enrollment|1|||
19701457|NCT00430937|42146016|FG000|Overall Study|Administrative reasons|1|||
19701458|NCT00430937|42146017|FG001|Overall Study|Administrative reasons|0|||
19701459|NCT00430937|42146016|FG000|Overall Study|Protocol discontinuation criteria met|1|||
19701460|NCT00430937|42146017|FG001|Overall Study|Protocol discontinuation criteria met|2|||
19701461|NCT00430937|42146016|FG000|Overall Study|Unable to classify|0|||
19701462|NCT00430937|42146017|FG001|Overall Study|Unable to classify|1|||
19701463|NCT00004888|42146025|FG000|Overall Study|Adverse Event|5|||
19478420|NCT01502371|41757693|FG001|Overall Study|Noncompliance with Study Drug|0|||
19478421|NCT01502371|41757694|FG002|Overall Study|Noncompliance with Study Drug|1|||
19701464|NCT00004888|42146026|FG001|Overall Study|Adverse Event|10|||
19701465|NCT00004888|42146025|FG000|Overall Study|Withdrawal by Subject|0|||
19701466|NCT00004888|42146026|FG001|Overall Study|Withdrawal by Subject|3|||
19701467|NCT00004888|42146025|FG000|Overall Study|Physician Decision|1|||
19701468|NCT00004888|42146026|FG001|Overall Study|Physician Decision|1|||
19701469|NCT00004888|42146025|FG000|Overall Study|Progressive Disease|4|||
19701470|NCT00004888|42146026|FG001|Overall Study|Progressive Disease|9|||
19701471|NCT00004888|42146025|FG000|Overall Study|Death without progressive disease|0|||
19701472|NCT00004888|42146026|FG001|Overall Study|Death without progressive disease|1|||
19701473|NCT00004888|42146025|FG000|Overall Study|Toxic death|1|||
19701474|NCT00004888|42146026|FG001|Overall Study|Toxic death|0|||
19701475|NCT00004732|42146034|FG000|Overall Study|Withdrawal by Subject|36|||
19701476|NCT00004732|42146035|FG001|Overall Study|Withdrawal by Subject|64|||
19701477|NCT00004732|42146034|FG000|Overall Study|Lost to Follow-up|33|||
19701478|NCT00004732|42146035|FG001|Overall Study|Lost to Follow-up|47|||
19701479|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
19701480|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
19800311|NCT02745145|42258448|FG001|Overall Study|Adverse Event|0|||
19800312|NCT02745145|42258449|FG002|Overall Study|Adverse Event|0|||
19701481|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
19701482|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
19701483|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
19390886|NCT01962922|41634738|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
19390887|NCT01962922|41634739|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
19701484|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
19701485|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
19701486|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
19701487|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
19701488|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
19701489|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
19701490|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
19701491|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
19701492|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
19701493|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
19701494|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
19701495|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
19701496|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
19701497|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Death|0|||
19701498|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Death|1|||
19701499|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Death|0|||
19701500|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
19701501|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
19701502|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
19701503|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
19701504|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
19701505|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
19701506|NCT00430781|42146046|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
19701507|NCT00430781|42146047|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
19701508|NCT00430781|42146048|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
19701509|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
19701510|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
19701511|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
19701512|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
19701513|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
19701514|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
19701515|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
19701516|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
19701517|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
19701518|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
19701519|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
19701520|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
19701521|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Other|0|||
19701522|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Other|1|||
19701523|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Other|0|||
19701524|NCT00430781|42146046|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
19701525|NCT00430781|42146047|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
19701526|NCT00430781|42146048|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
19701527|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
19701528|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
19701529|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
19701530|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
19701531|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
19701532|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
19701533|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
19701534|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
19701535|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
19701536|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
19701537|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
19701538|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
19701539|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
19701540|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
19701541|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
19800313|NCT02745145|42258447|FG000|Overall Study|Death|0|||
19800314|NCT02745145|42258448|FG001|Overall Study|Death|1|||
19701542|NCT00430781|42146046|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
19701543|NCT00430781|42146047|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
19701544|NCT00430781|42146048|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
19701545|NCT00429299|42146062|FG000|Overall Study|Disease Progression|1|||
19701546|NCT00429299|42146063|FG001|Overall Study|Disease Progression|1|||
19800315|NCT02745145|42258449|FG002|Overall Study|Death|0|||
19390888|NCT01984684|41634747|FG000|Overall Study|Lost to Follow-up|25|||
19390889|NCT01984684|41634748|FG001|Overall Study|Lost to Follow-up|24|||
19390890|NCT01984684|41634747|FG000|Overall Study|Adverse Event|8|||
19390891|NCT01984684|41634748|FG001|Overall Study|Adverse Event|12|||
19390892|NCT01984684|41634747|FG000|Overall Study|Withdrawal by Subject|9|||
19390893|NCT01984684|41634748|FG001|Overall Study|Withdrawal by Subject|9|||
19390894|NCT01984684|41634747|FG000|Overall Study|Lack of Efficacy|3|||
19390895|NCT01984684|41634748|FG001|Overall Study|Lack of Efficacy|6|||
19390896|NCT01984684|41634747|FG000|Overall Study|Physician Decision|4|||
19390897|NCT01984684|41634748|FG001|Overall Study|Physician Decision|2|||
19390898|NCT01984684|41634747|FG000|Overall Study|Protocol Violation|4|||
19390899|NCT01984684|41634748|FG001|Overall Study|Protocol Violation|2|||
19390900|NCT01984684|41634747|FG000|Overall Study|Death|0|||
19701547|NCT00429299|42146064|FG002|Overall Study|Disease Progression|0|||
19701548|NCT00429299|42146062|FG000|Overall Study|Adverse Event|2|||
19390901|NCT01984684|41634748|FG001|Overall Study|Death|1|||
19390902|NCT01984684|41634747|FG000|Overall Study|Noncompliance with study drug|2|||
19390903|NCT01984684|41634748|FG001|Overall Study|Noncompliance with study drug|1|||
19390904|NCT01984684|41634747|FG000|Overall Study|Subject incarcerated|1|||
19390905|NCT01984684|41634748|FG001|Overall Study|Subject incarcerated|0|||
19390906|NCT01984684|41634747|FG000|Overall Study|Study drug not available at site|1|||
19390907|NCT01984684|41634748|FG001|Overall Study|Study drug not available at site|1|||
19390908|NCT01984684|41634747|FG000|Overall Study|Subject had inadequate IV access|0|||
19390909|NCT01984684|41634748|FG001|Overall Study|Subject had inadequate IV access|1|||
19390910|NCT02694523|41634756|FG000|Part A|Adverse Event|7|||
19390911|NCT02694523|41634757|FG001|Part A|Adverse Event|3|||
19390912|NCT02694523|41634758|FG002|Part A|Adverse Event|0|||
19390913|NCT02694523|41634759|FG003|Part A|Adverse Event|0|||
19390914|NCT02694523|41634760|FG004|Part A|Adverse Event|0|||
19390915|NCT02694523|41634761|FG005|Part A|Adverse Event|0|||
19390916|NCT02694523|41634762|FG006|Part A|Adverse Event|0|||
19390917|NCT02694523|41634756|FG000|Part A|Protocol Violation|1|||
19390918|NCT02694523|41634757|FG001|Part A|Protocol Violation|0|||
19390919|NCT02694523|41634758|FG002|Part A|Protocol Violation|0|||
19390920|NCT02694523|41634759|FG003|Part A|Protocol Violation|0|||
19390921|NCT02694523|41634760|FG004|Part A|Protocol Violation|0|||
19390922|NCT02694523|41634761|FG005|Part A|Protocol Violation|0|||
19390923|NCT02694523|41634762|FG006|Part A|Protocol Violation|0|||
19390924|NCT02694523|41634756|FG000|Part A|Lost to Follow-up|1|||
19390925|NCT02694523|41634757|FG001|Part A|Lost to Follow-up|2|||
19390926|NCT02694523|41634758|FG002|Part A|Lost to Follow-up|0|||
19390927|NCT02694523|41634759|FG003|Part A|Lost to Follow-up|0|||
19390928|NCT02694523|41634760|FG004|Part A|Lost to Follow-up|0|||
19390929|NCT02694523|41634761|FG005|Part A|Lost to Follow-up|0|||
19390930|NCT02694523|41634762|FG006|Part A|Lost to Follow-up|0|||
19390931|NCT02694523|41634756|FG000|Part A|Withdrawal by Subject|3|||
19390932|NCT02694523|41634757|FG001|Part A|Withdrawal by Subject|1|||
19390933|NCT02694523|41634758|FG002|Part A|Withdrawal by Subject|0|||
19390934|NCT02694523|41634759|FG003|Part A|Withdrawal by Subject|0|||
19390935|NCT02694523|41634760|FG004|Part A|Withdrawal by Subject|0|||
19390936|NCT02694523|41634761|FG005|Part A|Withdrawal by Subject|0|||
19390937|NCT02694523|41634762|FG006|Part A|Withdrawal by Subject|0|||
19390938|NCT02694523|41634756|FG000|Part A|Other|1|||
19390939|NCT02694523|41634757|FG001|Part A|Other|1|||
19390940|NCT02694523|41634758|FG002|Part A|Other|0|||
19390941|NCT02694523|41634759|FG003|Part A|Other|0|||
19390942|NCT02694523|41634760|FG004|Part A|Other|0|||
19390943|NCT02694523|41634761|FG005|Part A|Other|0|||
19390944|NCT02694523|41634762|FG006|Part A|Other|0|||
19390945|NCT02694523|41634756|FG000|Part B|Adverse Event|0|||
19478422|NCT01502371|41757695|FG003|Overall Study|Noncompliance with Study Drug|2|||
19701549|NCT00429299|42146063|FG001|Overall Study|Adverse Event|5|||
19701550|NCT00429299|42146064|FG002|Overall Study|Adverse Event|1|||
19701551|NCT00429299|42146062|FG000|Overall Study|Protocol Violation|1|||
19701552|NCT00429299|42146063|FG001|Overall Study|Protocol Violation|0|||
19701553|NCT00429299|42146064|FG002|Overall Study|Protocol Violation|0|||
19701554|NCT00429299|42146062|FG000|Overall Study|Withdrawal by Subject|0|||
19701555|NCT00429299|42146063|FG001|Overall Study|Withdrawal by Subject|1|||
19390946|NCT02694523|41634757|FG001|Part B|Adverse Event|0|||
19390947|NCT02694523|41634758|FG002|Part B|Adverse Event|7|||
19390948|NCT02694523|41634759|FG003|Part B|Adverse Event|1|||
19390949|NCT02694523|41634760|FG004|Part B|Adverse Event|1|||
19390950|NCT02694523|41634761|FG005|Part B|Adverse Event|2|||
19390951|NCT02694523|41634762|FG006|Part B|Adverse Event|0|||
19390952|NCT02694523|41634756|FG000|Part B|Protocol Violation|0|||
19390953|NCT02694523|41634757|FG001|Part B|Protocol Violation|0|||
19390954|NCT02694523|41634758|FG002|Part B|Protocol Violation|1|||
19390955|NCT02694523|41634759|FG003|Part B|Protocol Violation|0|||
19390956|NCT02694523|41634760|FG004|Part B|Protocol Violation|0|||
19390957|NCT02694523|41634761|FG005|Part B|Protocol Violation|0|||
19390958|NCT02694523|41634762|FG006|Part B|Protocol Violation|0|||
19701556|NCT00429299|42146064|FG002|Overall Study|Withdrawal by Subject|3|||
19800316|NCT02745145|42258447|FG000|Overall Study|Progressive disease|0|||
19390959|NCT02694523|41634756|FG000|Part B|Lost to Follow-up|0|||
19390960|NCT02694523|41634757|FG001|Part B|Lost to Follow-up|0|||
19390961|NCT02694523|41634758|FG002|Part B|Lost to Follow-up|2|||
19390962|NCT02694523|41634759|FG003|Part B|Lost to Follow-up|3|||
19390963|NCT02694523|41634760|FG004|Part B|Lost to Follow-up|2|||
19390964|NCT02694523|41634761|FG005|Part B|Lost to Follow-up|0|||
19390965|NCT02694523|41634762|FG006|Part B|Lost to Follow-up|1|||
19390966|NCT02694523|41634756|FG000|Part B|Withdrawal by Subject|0|||
19390967|NCT02694523|41634757|FG001|Part B|Withdrawal by Subject|0|||
19390968|NCT02694523|41634758|FG002|Part B|Withdrawal by Subject|9|||
19390969|NCT02694523|41634759|FG003|Part B|Withdrawal by Subject|0|||
19390970|NCT02694523|41634760|FG004|Part B|Withdrawal by Subject|1|||
19390971|NCT02694523|41634761|FG005|Part B|Withdrawal by Subject|3|||
19390972|NCT02694523|41634762|FG006|Part B|Withdrawal by Subject|0|||
19390973|NCT02694523|41634756|FG000|Part B|Other|0|||
19390974|NCT02694523|41634757|FG001|Part B|Other|0|||
19390975|NCT02694523|41634758|FG002|Part B|Other|1|||
19390976|NCT02694523|41634759|FG003|Part B|Other|0|||
19390977|NCT02694523|41634760|FG004|Part B|Other|0|||
19390978|NCT02694523|41634761|FG005|Part B|Other|0|||
19390979|NCT02694523|41634762|FG006|Part B|Other|1|||
19390980|NCT01353703|41634776|FG000|Overall Study|Migrated/moved from study area|1|||
19390981|NCT01353703|41634777|FG001|Overall Study|Migrated/moved from study area|0|||
19701557|NCT00428597|42146074|FG000|Overall Study|Randomized but not treated|3|||
19701558|NCT00428597|42146075|FG001|Overall Study|Randomized but not treated|3|||
19701559|NCT00428597|42146074|FG000|Overall Study|Objective Progression or Relapse|19|||
19701560|NCT00428597|42146075|FG001|Overall Study|Objective Progression or Relapse|47|||
19701561|NCT00428597|42146074|FG000|Overall Study|Study Terminated by Sponsor|41|||
19701562|NCT00428597|42146075|FG001|Overall Study|Study Terminated by Sponsor|16|||
19701563|NCT00428597|42146074|FG000|Overall Study|Adverse Event|15|||
19701564|NCT00428597|42146075|FG001|Overall Study|Adverse Event|7|||
19701565|NCT00428597|42146074|FG000|Overall Study|Global Deterioration of Health Status|1|||
19701566|NCT00428597|42146075|FG001|Overall Study|Global Deterioration of Health Status|5|||
19701567|NCT00428597|42146074|FG000|Overall Study|Protocol Violation|2|||
19701568|NCT00428597|42146075|FG001|Overall Study|Protocol Violation|1|||
19701569|NCT00428597|42146074|FG000|Overall Study|Withdrawal by Subject|2|||
19701570|NCT00428597|42146075|FG001|Overall Study|Withdrawal by Subject|1|||
19701571|NCT00428597|42146074|FG000|Overall Study|Other|1|||
19701572|NCT00428597|42146075|FG001|Overall Study|Other|1|||
19701573|NCT00428597|42146074|FG000|Overall Study|Lost to Follow-up|0|||
19701574|NCT00428597|42146075|FG001|Overall Study|Lost to Follow-up|1|||
19701575|NCT00428597|42146074|FG000|Overall Study|Pregnancy|1|||
19701576|NCT00428597|42146075|FG001|Overall Study|Pregnancy|0|||
19701577|NCT00428597|42146074|FG000|Overall Study|Death|1|||
19701578|NCT00428597|42146075|FG001|Overall Study|Death|3|||
19701579|NCT00428441|42146081|FG000|Overall Study|Lost to Follow-up|1|||
19701580|NCT00144339|42146087|FG000|Overall Study|Adverse Event|746|||
19701581|NCT00144339|42146088|FG001|Overall Study|Adverse Event|627|||
19701582|NCT00144339|42146087|FG000|Overall Study|Protocol Violation|75|||
19701583|NCT00144339|42146088|FG001|Overall Study|Protocol Violation|48|||
19701584|NCT00144339|42146087|FG000|Overall Study|Withdrawal by Subject|403|||
19701585|NCT00144339|42146088|FG001|Overall Study|Withdrawal by Subject|300|||
19800317|NCT02745145|42258448|FG001|Overall Study|Progressive disease|0|||
19800318|NCT02745145|42258449|FG002|Overall Study|Progressive disease|1|||
19800319|NCT02745145|42258447|FG000|Overall Study|Withdrew consent|1|||
19800320|NCT02745145|42258448|FG001|Overall Study|Withdrew consent|1|||
19800321|NCT02745145|42258449|FG002|Overall Study|Withdrew consent|1|||
19800322|NCT02745145|42258447|FG000|Overall Study|Study Termination|8|||
19800323|NCT02745145|42258448|FG001|Overall Study|Study Termination|3|||
19800324|NCT02745145|42258449|FG002|Overall Study|Study Termination|7|||
19800325|NCT02854631|42258468|FG000|Overall Study|Adverse Event|1|||
19800326|NCT02854631|42258469|FG001|Overall Study|Adverse Event|2|||
19800327|NCT02854631|42258468|FG000|Overall Study|Withdrew Consent|3|||
19390982|NCT02009332|41634791|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
19800328|NCT02854631|42258469|FG001|Overall Study|Withdrew Consent|2|||
19390983|NCT02009332|41634792|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
19800329|NCT02854631|42258468|FG000|Overall Study|Investigator's Discretion|2|||
19800330|NCT02854631|42258469|FG001|Overall Study|Investigator's Discretion|0|||
19390984|NCT02009332|41634793|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
19701586|NCT00144339|42146087|FG000|Overall Study|Lost to Follow-up|76|||
19390985|NCT02009332|41634794|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
19390986|NCT02009332|41634795|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
19390987|NCT02009332|41634796|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
19390988|NCT02009332|41634791|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
19390989|NCT02009332|41634792|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
19390990|NCT02009332|41634793|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
19701587|NCT00144339|42146088|FG001|Overall Study|Lost to Follow-up|64|||
19701588|NCT00144339|42146087|FG000|Overall Study|Other|58|||
19800331|NCT02854631|42258468|FG000|Overall Study|Death|12|||
19800332|NCT02854631|42258469|FG001|Overall Study|Death|8|||
19800333|NCT02854631|42258468|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
19701589|NCT00144339|42146088|FG001|Overall Study|Other|60|||
19701590|NCT00144027|42146096|FG000|Overall Study|Lost to Follow-up|1|||
19701591|NCT00144027|42146097|FG001|Overall Study|Lost to Follow-up|3|||
19701592|NCT00144027|42146096|FG000|Overall Study|Withdrawal by Subject|2|||
19701593|NCT00144027|42146097|FG001|Overall Study|Withdrawal by Subject|2|||
19701594|NCT00144027|42146096|FG000|Overall Study|did not complete baseline assessment|0|||
19701595|NCT00144027|42146097|FG001|Overall Study|did not complete baseline assessment|6|||
19701596|NCT00127803|42146107|FG000|Overall Study|Adverse Event|2|||
19701597|NCT00127803|42146108|FG001|Overall Study|Adverse Event|0|||
19701598|NCT00127803|42146109|FG002|Overall Study|Adverse Event|0|||
19701599|NCT00127803|42146110|FG003|Overall Study|Adverse Event|0|||
19701600|NCT00127803|42146107|FG000|Overall Study|Withdrawal by Subject|1|||
19701601|NCT00127803|42146108|FG001|Overall Study|Withdrawal by Subject|0|||
19701602|NCT00127803|42146109|FG002|Overall Study|Withdrawal by Subject|0|||
19701603|NCT00127803|42146110|FG003|Overall Study|Withdrawal by Subject|0|||
19701604|NCT00127803|42146107|FG000|Overall Study|Lost to Follow-up|0|||
19701605|NCT00127803|42146108|FG001|Overall Study|Lost to Follow-up|0|||
19701606|NCT00127803|42146109|FG002|Overall Study|Lost to Follow-up|0|||
19701607|NCT00127803|42146110|FG003|Overall Study|Lost to Follow-up|1|||
19701608|NCT00127413|42146124|FG000|Overall Study|Lost to Follow-up|6|||
19701609|NCT00127413|42146125|FG001|Overall Study|Lost to Follow-up|4|||
19701610|NCT00127413|42146126|FG002|Overall Study|Lost to Follow-up|8|||
19701611|NCT00127413|42146127|FG003|Overall Study|Lost to Follow-up|2|||
19701612|NCT00143403|42146139|FG000|Overall Study|Adverse Event|3|||
19800334|NCT02854631|42258469|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
19800335|NCT02854631|42258468|FG000|Overall Study|Protocol Violation|0|||
19800336|NCT02854631|42258469|FG001|Overall Study|Protocol Violation|1|||
19800337|NCT02854631|42258468|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
19800338|NCT02854631|42258469|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
19800339|NCT02854631|42258468|FG000|Overall Study|Lost to Follow-up|4|||
19800340|NCT02854631|42258469|FG001|Overall Study|Lost to Follow-up|2|||
19800341|NCT02855359|42258477|FG000|Overall Study|Death|2|||
19800342|NCT02855359|42258478|FG001|Overall Study|Death|2|||
19800343|NCT02855359|42258479|FG002|Overall Study|Death|0|||
19800344|NCT02855359|42258480|FG003|Overall Study|Death|0|||
19800345|NCT02855359|42258477|FG000|Overall Study|Study Termination by Sponsor|9|||
19701613|NCT00143403|42146140|FG001|Overall Study|Adverse Event|8|||
19701614|NCT00143403|42146139|FG000|Overall Study|Death|1|||
19701615|NCT00143403|42146140|FG001|Overall Study|Death|0|||
19800346|NCT02855359|42258478|FG001|Overall Study|Study Termination by Sponsor|11|||
19800347|NCT02855359|42258479|FG002|Overall Study|Study Termination by Sponsor|0|||
19800348|NCT02855359|42258480|FG003|Overall Study|Study Termination by Sponsor|0|||
19800349|NCT02853929|42258494|FG000|Overall Study|Lost to Follow-up|3|||
19800350|NCT02853929|42258495|FG001|Overall Study|Lost to Follow-up|0|||
19701616|NCT00143403|42146139|FG000|Overall Study|Withdrawal by Subject|3|||
19701617|NCT00143403|42146140|FG001|Overall Study|Withdrawal by Subject|12|||
19701618|NCT00143403|42146139|FG000|Overall Study|Relapse|15|||
19701619|NCT00143403|42146140|FG001|Overall Study|Relapse|7|||
19701620|NCT00143403|42146139|FG000|Overall Study|Protocol Violation|2|||
19701621|NCT00143403|42146140|FG001|Overall Study|Protocol Violation|2|||
19701622|NCT00143403|42146139|FG000|Overall Study|specified by site|4|||
19701623|NCT00143403|42146140|FG001|Overall Study|specified by site|9|||
19701624|NCT00143403|42146139|FG000|Overall Study|Randomized Not Treated|7|||
19701625|NCT00143403|42146140|FG001|Overall Study|Randomized Not Treated|8|||
19701626|NCT00220701|42146148|FG000|Overall Study|Lost to Follow-up|5|||
19701627|NCT00220701|42146149|FG001|Overall Study|Lost to Follow-up|4|||
19701628|NCT00127101|42146161|FG000|Base Protocol|Adverse Event|0|||
19701629|NCT00127101|42146162|FG001|Base Protocol|Adverse Event|2|||
19701630|NCT00127101|42146163|FG002|Base Protocol|Adverse Event|1|||
19701631|NCT00127101|42146164|FG003|Base Protocol|Adverse Event|0|||
19701632|NCT00127101|42146165|FG004|Base Protocol|Adverse Event|0|||
19701633|NCT00127101|42146166|FG005|Base Protocol|Adverse Event|0|||
19701634|NCT00127101|42146161|FG000|Base Protocol|Lack of Efficacy|1|||
19701635|NCT00127101|42146162|FG001|Base Protocol|Lack of Efficacy|0|||
19701636|NCT00127101|42146163|FG002|Base Protocol|Lack of Efficacy|0|||
19701637|NCT00127101|42146164|FG003|Base Protocol|Lack of Efficacy|0|||
19701638|NCT00127101|42146165|FG004|Base Protocol|Lack of Efficacy|2|||
19701639|NCT00127101|42146166|FG005|Base Protocol|Lack of Efficacy|0|||
19701640|NCT00127101|42146161|FG000|Base Protocol|Withdrawal by Subject|1|||
19701641|NCT00127101|42146162|FG001|Base Protocol|Withdrawal by Subject|2|||
19701642|NCT00127101|42146163|FG002|Base Protocol|Withdrawal by Subject|1|||
19701643|NCT00127101|42146164|FG003|Base Protocol|Withdrawal by Subject|0|||
19701644|NCT00127101|42146165|FG004|Base Protocol|Withdrawal by Subject|0|||
19701645|NCT00127101|42146166|FG005|Base Protocol|Withdrawal by Subject|1|||
19701646|NCT00127101|42146161|FG000|Continuation Phase|Adverse Event|0|||
19800351|NCT02853929|42258494|FG000|Overall Study|Withdrawal by Subject|1|||
19800352|NCT02853929|42258495|FG001|Overall Study|Withdrawal by Subject|0|||
19701647|NCT00127101|42146162|FG001|Continuation Phase|Adverse Event|0|||
19701648|NCT00127101|42146163|FG002|Continuation Phase|Adverse Event|0|||
19701649|NCT00127101|42146164|FG003|Continuation Phase|Adverse Event|0|||
19701650|NCT00127101|42146165|FG004|Continuation Phase|Adverse Event|1|||
19701651|NCT00127101|42146166|FG005|Continuation Phase|Adverse Event|1|||
19701652|NCT00127101|42146161|FG000|Continuation Phase|Lack of Efficacy|0|||
19701653|NCT00127101|42146162|FG001|Continuation Phase|Lack of Efficacy|0|||
19701654|NCT00127101|42146163|FG002|Continuation Phase|Lack of Efficacy|0|||
19701655|NCT00127101|42146164|FG003|Continuation Phase|Lack of Efficacy|0|||
19701656|NCT00127101|42146165|FG004|Continuation Phase|Lack of Efficacy|0|||
19701657|NCT00127101|42146166|FG005|Continuation Phase|Lack of Efficacy|1|||
19701658|NCT00127101|42146161|FG000|Continuation Phase|Withdrawal by Subject|0|||
19701659|NCT00127101|42146162|FG001|Continuation Phase|Withdrawal by Subject|0|||
19701660|NCT00127101|42146163|FG002|Continuation Phase|Withdrawal by Subject|1|||
19701661|NCT00127101|42146164|FG003|Continuation Phase|Withdrawal by Subject|0|||
19701662|NCT00127101|42146165|FG004|Continuation Phase|Withdrawal by Subject|2|||
19701663|NCT00127101|42146166|FG005|Continuation Phase|Withdrawal by Subject|1|||
19701664|NCT00126555|42146180|FG000|Overall Study|Withdrawal by Subject|1|||
19701665|NCT00126555|42146180|FG000|Overall Study|Adverse Event|2|||
19701666|NCT00126555|42146180|FG000|Overall Study|Progressive Disease|3|||
19701667|NCT00004228|42146203|FG000|Overall Study|Adverse Event|0|||
19701668|NCT00004228|42146204|FG001|Overall Study|Adverse Event|1|||
19701669|NCT00004228|42146205|FG002|Overall Study|Adverse Event|0|||
19701670|NCT00004228|42146206|FG003|Overall Study|Adverse Event|0|||
19701671|NCT00004228|42146207|FG004|Overall Study|Adverse Event|1|||
19701672|NCT00004228|42146208|FG005|Overall Study|Adverse Event|0|||
19701673|NCT00004228|42146209|FG006|Overall Study|Adverse Event|0|||
19701674|NCT00004228|42146203|FG000|Overall Study|Death|0|||
19701675|NCT00004228|42146204|FG001|Overall Study|Death|1|||
19701676|NCT00004228|42146205|FG002|Overall Study|Death|2|||
19701677|NCT00004228|42146206|FG003|Overall Study|Death|0|||
19701678|NCT00004228|42146207|FG004|Overall Study|Death|1|||
19701679|NCT00004228|42146208|FG005|Overall Study|Death|0|||
19701680|NCT00004228|42146209|FG006|Overall Study|Death|0|||
19701681|NCT00004228|42146203|FG000|Overall Study|Lack of Efficacy|1|||
19701682|NCT00004228|42146204|FG001|Overall Study|Lack of Efficacy|6|||
19701683|NCT00004228|42146205|FG002|Overall Study|Lack of Efficacy|5|||
19701684|NCT00004228|42146206|FG003|Overall Study|Lack of Efficacy|3|||
19701685|NCT00004228|42146207|FG004|Overall Study|Lack of Efficacy|9|||
19701686|NCT00004228|42146208|FG005|Overall Study|Lack of Efficacy|8|||
19701687|NCT00004228|42146209|FG006|Overall Study|Lack of Efficacy|4|||
19701688|NCT00004228|42146203|FG000|Overall Study|Lost to Follow-up|0|||
19701689|NCT00004228|42146204|FG001|Overall Study|Lost to Follow-up|0|||
19701690|NCT00004228|42146205|FG002|Overall Study|Lost to Follow-up|1|||
19701691|NCT00004228|42146206|FG003|Overall Study|Lost to Follow-up|0|||
19701692|NCT00004228|42146207|FG004|Overall Study|Lost to Follow-up|0|||
19701693|NCT00004228|42146208|FG005|Overall Study|Lost to Follow-up|0|||
19701694|NCT00004228|42146209|FG006|Overall Study|Lost to Follow-up|0|||
19701695|NCT00004228|42146203|FG000|Overall Study|Physician Decision|1|||
19701696|NCT00004228|42146204|FG001|Overall Study|Physician Decision|0|||
19701697|NCT00004228|42146205|FG002|Overall Study|Physician Decision|3|||
19701698|NCT00004228|42146206|FG003|Overall Study|Physician Decision|2|||
19701699|NCT00004228|42146207|FG004|Overall Study|Physician Decision|1|||
19701700|NCT00004228|42146208|FG005|Overall Study|Physician Decision|1|||
19701701|NCT00004228|42146209|FG006|Overall Study|Physician Decision|1|||
19701702|NCT00004228|42146203|FG000|Overall Study|Protocol Violation|0|||
19701703|NCT00004228|42146204|FG001|Overall Study|Protocol Violation|5|||
19701704|NCT00004228|42146205|FG002|Overall Study|Protocol Violation|2|||
19701705|NCT00004228|42146206|FG003|Overall Study|Protocol Violation|1|||
19701706|NCT00004228|42146207|FG004|Overall Study|Protocol Violation|1|||
19701707|NCT00004228|42146208|FG005|Overall Study|Protocol Violation|2|||
19701708|NCT00004228|42146209|FG006|Overall Study|Protocol Violation|0|||
19701709|NCT00004228|42146203|FG000|Overall Study|Withdrawal by Subject|3|||
19800353|NCT02853929|42258494|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
19800354|NCT02853929|42258495|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
19701710|NCT00004228|42146204|FG001|Overall Study|Withdrawal by Subject|0|||
19701711|NCT00004228|42146205|FG002|Overall Study|Withdrawal by Subject|1|||
19701712|NCT00004228|42146206|FG003|Overall Study|Withdrawal by Subject|0|||
19701713|NCT00004228|42146207|FG004|Overall Study|Withdrawal by Subject|2|||
19701714|NCT00004228|42146208|FG005|Overall Study|Withdrawal by Subject|1|||
19701715|NCT00004228|42146209|FG006|Overall Study|Withdrawal by Subject|2|||
19701716|NCT00004228|42146203|FG000|Overall Study|Other|0|||
19701717|NCT00004228|42146204|FG001|Overall Study|Other|0|||
19701718|NCT00004228|42146205|FG002|Overall Study|Other|1|||
19701719|NCT00004228|42146206|FG003|Overall Study|Other|0|||
19701720|NCT00004228|42146207|FG004|Overall Study|Other|0|||
19701721|NCT00004228|42146208|FG005|Overall Study|Other|0|||
19701722|NCT00004228|42146209|FG006|Overall Study|Other|0|||
19701723|NCT00004228|42146203|FG000|Overall Study|ineligible|4|||
19701724|NCT00004228|42146204|FG001|Overall Study|ineligible|2|||
19701725|NCT00004228|42146205|FG002|Overall Study|ineligible|4|||
19701726|NCT00004228|42146206|FG003|Overall Study|ineligible|1|||
19701727|NCT00004228|42146207|FG004|Overall Study|ineligible|1|||
19701728|NCT00004228|42146208|FG005|Overall Study|ineligible|2|||
19701729|NCT00004228|42146209|FG006|Overall Study|ineligible|5|||
19701730|NCT00003526|42146226|FG000|Overall Study|Not evaluable|6|||
19701731|NCT00195260|42146232|FG000|Part 1: Dose Escalation|Adverse Event|0|||
19701732|NCT00195260|42146233|FG001|Part 1: Dose Escalation|Adverse Event|1|||
19701733|NCT00195260|42146234|FG002|Part 1: Dose Escalation|Adverse Event|0|||
19701734|NCT00195260|42146235|FG003|Part 1: Dose Escalation|Adverse Event|1|||
19701735|NCT00195260|42146236|FG004|Part 1: Dose Escalation|Adverse Event|1|||
19701736|NCT00195260|42146237|FG005|Part 1: Dose Escalation|Adverse Event|0|||
19701737|NCT00195260|42146238|FG006|Part 1: Dose Escalation|Adverse Event|3|||
19701738|NCT00195260|42146239|FG007|Part 1: Dose Escalation|Adverse Event|0|||
19701739|NCT00195260|42146240|FG008|Part 1: Dose Escalation|Adverse Event|0|||
19701740|NCT00195260|42146241|FG009|Part 1: Dose Escalation|Adverse Event|0|||
19701741|NCT00195260|42146242|FG010|Part 1: Dose Escalation|Adverse Event|0|||
19701742|NCT00195260|42146232|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701743|NCT00195260|42146233|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701744|NCT00195260|42146234|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701745|NCT00195260|42146235|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701746|NCT00195260|42146236|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
19701747|NCT00195260|42146237|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701748|NCT00195260|42146238|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701749|NCT00195260|42146239|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
19701750|NCT00195260|42146240|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701751|NCT00195260|42146241|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701752|NCT00195260|42146242|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19701753|NCT00195260|42146232|FG000|Part 1: Dose Escalation|Death|0|||
19701754|NCT00195260|42146233|FG001|Part 1: Dose Escalation|Death|0|||
19701755|NCT00195260|42146234|FG002|Part 1: Dose Escalation|Death|0|||
19701756|NCT00195260|42146235|FG003|Part 1: Dose Escalation|Death|0|||
19701757|NCT00195260|42146236|FG004|Part 1: Dose Escalation|Death|0|||
19701758|NCT00195260|42146237|FG005|Part 1: Dose Escalation|Death|0|||
19701759|NCT00195260|42146238|FG006|Part 1: Dose Escalation|Death|0|||
19701760|NCT00195260|42146239|FG007|Part 1: Dose Escalation|Death|1|||
19701761|NCT00195260|42146240|FG008|Part 1: Dose Escalation|Death|0|||
19800355|NCT02730819|42258531|FG000|Overall Study|Lost to Follow-up|9|||
19800356|NCT02038946|42258535|FG000|Overall Study|Death|5|||
19800357|NCT02038946|42258535|FG000|Overall Study|Withdrawal by Subject|3|||
19800358|NCT02038946|42258535|FG000|Overall Study|Lost to Follow-up|2|||
19800359|NCT02038946|42258535|FG000|Overall Study|Other reasons|2|||
19800360|NCT03143829|42258541|FG000|Overall Study|Withdrawal by Subject|2|||
19800361|NCT03143829|42258542|FG001|Overall Study|Withdrawal by Subject|5|||
19800362|NCT03143829|42258541|FG000|Overall Study|Lost to Follow-up|0|||
19800363|NCT03143829|42258542|FG001|Overall Study|Lost to Follow-up|2|||
19800364|NCT03143829|42258541|FG000|Overall Study|Death|1|||
19800365|NCT03143829|42258542|FG001|Overall Study|Death|1|||
19800366|NCT03143829|42258541|FG000|Overall Study|changed treatment, no longer eligible|2|||
19800367|NCT03143829|42258542|FG001|Overall Study|changed treatment, no longer eligible|2|||
19800368|NCT02853331|42258550|FG000|Overall Study|Death|59|||
19800369|NCT02853331|42258551|FG001|Overall Study|Death|95|||
19800370|NCT02853331|42258550|FG000|Overall Study|Withdrawal by Subject|5|||
19800371|NCT02853331|42258551|FG001|Overall Study|Withdrawal by Subject|9|||
19800372|NCT02853331|42258550|FG000|Overall Study|Ongoing in study|368|||
19800373|NCT02853331|42258551|FG001|Overall Study|Ongoing in study|325|||
19800374|NCT01595061|42258557|FG000|Overall Study|Never Treated|3|||
19800375|NCT01595061|42258557|FG000|Overall Study|Inadequate Pathology|1|||
19800376|NCT02852005|42258578|FG000|Overall Study|Lost to Follow-up|0|||
19800377|NCT02852005|42258579|FG001|Overall Study|Lost to Follow-up|0|||
19800378|NCT02852005|42258580|FG002|Overall Study|Lost to Follow-up|0|||
19800379|NCT02852005|42258581|FG003|Overall Study|Lost to Follow-up|0|||
19800380|NCT02852005|42258582|FG004|Overall Study|Lost to Follow-up|1|||
19800381|NCT02852005|42258578|FG000|Overall Study|Withdrawal by Subject|1|||
19800382|NCT02852005|42258579|FG001|Overall Study|Withdrawal by Subject|0|||
19800383|NCT02852005|42258580|FG002|Overall Study|Withdrawal by Subject|0|||
19800384|NCT02852005|42258581|FG003|Overall Study|Withdrawal by Subject|0|||
19800385|NCT02852005|42258582|FG004|Overall Study|Withdrawal by Subject|0|||
19701762|NCT00195260|42146241|FG009|Part 1: Dose Escalation|Death|0|||
19800386|NCT02851615|42258598|FG000|Overall Study|Cognitive Issue|1|||
19800387|NCT02851615|42258599|FG001|Overall Study|Cognitive Issue|0|||
19701763|NCT00195260|42146242|FG010|Part 1: Dose Escalation|Death|0|||
19701764|NCT00195260|42146232|FG000|Part 1: Dose Escalation|Disease Progression|3|||
19701765|NCT00195260|42146233|FG001|Part 1: Dose Escalation|Disease Progression|2|||
19800388|NCT02851615|42258598|FG000|Overall Study|Lost to Follow-up|0|||
19800389|NCT02851615|42258599|FG001|Overall Study|Lost to Follow-up|4|||
19800390|NCT02849743|42258617|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
19800391|NCT02849743|42258618|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
19800392|NCT02849743|42258617|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
19800393|NCT02849743|42258618|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
19800394|NCT02851069|42258653|FG000|Overall Study|Failure to Return|3|||
19800395|NCT02851069|42258653|FG000|Overall Study|Other|3|||
19800396|NCT02849509|42258665|FG000|Overall Study|Worsening of disease under study|1|||
19800397|NCT02849509|42258666|FG001|Overall Study|Worsening of disease under study|1|||
19800398|NCT02849509|42258667|FG002|Overall Study|Worsening of disease under study|1|||
19800399|NCT02849509|42258665|FG000|Overall Study|Worsening of other pre-existing disease|0|||
19800400|NCT02849509|42258666|FG001|Overall Study|Worsening of other pre-existing disease|1|||
19800401|NCT02849509|42258667|FG002|Overall Study|Worsening of other pre-existing disease|2|||
19800402|NCT02849509|42258665|FG000|Overall Study|Other adverse event|36|||
19800403|NCT02849509|42258666|FG001|Overall Study|Other adverse event|41|||
19800404|NCT02849509|42258667|FG002|Overall Study|Other adverse event|8|||
19800405|NCT02849509|42258665|FG000|Overall Study|Withdrawal by Subject|6|||
19800406|NCT02849509|42258666|FG001|Overall Study|Withdrawal by Subject|17|||
19800407|NCT02849509|42258667|FG002|Overall Study|Withdrawal by Subject|12|||
19800408|NCT02849509|42258665|FG000|Overall Study|Lost to Follow-up|27|||
19800409|NCT02849509|42258666|FG001|Overall Study|Lost to Follow-up|67|||
19800410|NCT02849509|42258667|FG002|Overall Study|Lost to Follow-up|36|||
19800411|NCT02849509|42258665|FG000|Overall Study|Other, reason not specified|14|||
19800412|NCT02849509|42258666|FG001|Overall Study|Other, reason not specified|29|||
19800413|NCT02849509|42258667|FG002|Overall Study|Other, reason not specified|25|||
19800414|NCT02849509|42258665|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
19800415|NCT02849509|42258666|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
19800416|NCT02849509|42258667|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
19800417|NCT02853305|42258680|FG000|Overall Study|Death|244|||
19800418|NCT02853305|42258681|FG001|Overall Study|Death|207|||
19800419|NCT02853305|42258682|FG002|Overall Study|Death|263|||
19800420|NCT02853305|42258680|FG000|Overall Study|Withdrawal by Subject|2|||
19701766|NCT00195260|42146234|FG002|Part 1: Dose Escalation|Disease Progression|5|||
19701767|NCT00195260|42146235|FG003|Part 1: Dose Escalation|Disease Progression|6|||
19701768|NCT00195260|42146236|FG004|Part 1: Dose Escalation|Disease Progression|4|||
19701769|NCT00195260|42146237|FG005|Part 1: Dose Escalation|Disease Progression|6|||
19701770|NCT00195260|42146238|FG006|Part 1: Dose Escalation|Disease Progression|7|||
19701771|NCT00195260|42146239|FG007|Part 1: Dose Escalation|Disease Progression|4|||
19701772|NCT00195260|42146240|FG008|Part 1: Dose Escalation|Disease Progression|0|||
19701773|NCT00195260|42146241|FG009|Part 1: Dose Escalation|Disease Progression|0|||
19701774|NCT00195260|42146242|FG010|Part 1: Dose Escalation|Disease Progression|0|||
19701775|NCT00195260|42146232|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
19701776|NCT00195260|42146233|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
19701777|NCT00195260|42146234|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
19701778|NCT00195260|42146235|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701779|NCT00195260|42146236|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701780|NCT00195260|42146237|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
19701781|NCT00195260|42146238|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701782|NCT00195260|42146239|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701783|NCT00195260|42146240|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701784|NCT00195260|42146241|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19701785|NCT00195260|42146242|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
19800421|NCT02853305|42258681|FG001|Overall Study|Withdrawal by Subject|4|||
19800422|NCT02853305|42258682|FG002|Overall Study|Withdrawal by Subject|2|||
19800423|NCT02853305|42258680|FG000|Overall Study|Ongoing in Trial|105|||
19800424|NCT02853305|42258681|FG001|Overall Study|Ongoing in Trial|96|||
19800425|NCT02853305|42258682|FG002|Overall Study|Ongoing in Trial|87|||
19800426|NCT02848729|42258692|FG000|Overall Study|Withdrawal by Subject|1|||
19800427|NCT02848729|42258693|FG001|Overall Study|Withdrawal by Subject|0|||
19800428|NCT02848729|42258692|FG000|Overall Study|Emesis|15|||
19800429|NCT02848729|42258693|FG001|Overall Study|Emesis|11|||
19800430|NCT00158756|42258711|FG000|Overall Study|Withdrawal by Subject|5|||
19800431|NCT00158756|42258712|FG001|Overall Study|Withdrawal by Subject|0|||
19800432|NCT00158756|42258713|FG002|Overall Study|Withdrawal by Subject|6|||
19800433|NCT00158756|42258714|FG003|Overall Study|Withdrawal by Subject|1|||
19800434|NCT00158756|42258715|FG004|Overall Study|Withdrawal by Subject|3|||
19701786|NCT00195260|42146232|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701787|NCT00195260|42146233|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19800435|NCT00158756|42258711|FG000|Overall Study|Adverse Event|0|||
19800436|NCT00158756|42258712|FG001|Overall Study|Adverse Event|0|||
19800437|NCT00158756|42258713|FG002|Overall Study|Adverse Event|1|||
19800438|NCT00158756|42258714|FG003|Overall Study|Adverse Event|0|||
19800439|NCT00158756|42258715|FG004|Overall Study|Adverse Event|0|||
19800440|NCT00158756|42258711|FG000|Overall Study|Serious adverse event|0|||
19800441|NCT00158756|42258712|FG001|Overall Study|Serious adverse event|0|||
19800442|NCT00158756|42258713|FG002|Overall Study|Serious adverse event|1|||
19701788|NCT00195260|42146234|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701789|NCT00195260|42146235|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701790|NCT00195260|42146236|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701791|NCT00195260|42146237|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701792|NCT00195260|42146238|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701793|NCT00195260|42146239|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
19701794|NCT00195260|42146240|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
19800443|NCT00158756|42258714|FG003|Overall Study|Serious adverse event|0|||
19800444|NCT00158756|42258715|FG004|Overall Study|Serious adverse event|0|||
19800445|NCT02730195|42258727|FG000|Overall Study|Withdrawal by Subject|1|||
19800446|NCT02730351|42258735|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
19800447|NCT02730351|42258736|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
19701795|NCT00195260|42146241|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
19701796|NCT00195260|42146242|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
19701797|NCT00195260|42146232|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701798|NCT00195260|42146233|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701799|NCT00195260|42146234|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701800|NCT00195260|42146235|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701801|NCT00195260|42146236|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701802|NCT00195260|42146237|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701803|NCT00195260|42146238|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701804|NCT00195260|42146239|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
19701805|NCT00195260|42146240|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
19701806|NCT00195260|42146241|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
19701807|NCT00195260|42146242|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
19701808|NCT00195260|42146232|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701809|NCT00195260|42146233|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701810|NCT00195260|42146234|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701811|NCT00195260|42146235|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701812|NCT00195260|42146236|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701813|NCT00195260|42146237|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701814|NCT00195260|42146238|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701815|NCT00195260|42146239|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
19701816|NCT00195260|42146240|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
19800448|NCT02730351|42258735|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
19800449|NCT02730351|42258736|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
19800450|NCT02730351|42258735|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
19701817|NCT00195260|42146241|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
19800451|NCT02730351|42258736|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
19800452|NCT02730351|42258735|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
19800453|NCT02730351|42258736|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
19390991|NCT02009332|41634794|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
19390992|NCT02009332|41634795|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
19390993|NCT02009332|41634796|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
19390994|NCT02009332|41634791|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
19390995|NCT02009332|41634792|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
19390996|NCT02009332|41634793|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
19390997|NCT02009332|41634794|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
19390998|NCT02009332|41634795|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
19390999|NCT02009332|41634796|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
19391000|NCT01984294|41634813|FG000|Overall Study|Randomized but Never Treated|0|||
19391001|NCT01984294|41634814|FG001|Overall Study|Randomized but Never Treated|0|||
19391002|NCT01984294|41634815|FG002|Overall Study|Randomized but Never Treated|1|||
19391003|NCT01984294|41634813|FG000|Overall Study|Lack of Efficacy|4|||
19391004|NCT01984294|41634814|FG001|Overall Study|Lack of Efficacy|2|||
19391005|NCT01984294|41634815|FG002|Overall Study|Lack of Efficacy|6|||
19391006|NCT01984294|41634813|FG000|Overall Study|Adverse Event|0|||
19391007|NCT01984294|41634814|FG001|Overall Study|Adverse Event|1|||
19391008|NCT01984294|41634815|FG002|Overall Study|Adverse Event|0|||
19391009|NCT01962298|41634828|FG000|Overall Study|Protocol Violation|1|||
19391010|NCT01962298|41634829|FG001|Overall Study|Protocol Violation|0|||
19391011|NCT01962298|41634830|FG002|Overall Study|Protocol Violation|1|||
19391012|NCT01962298|41634831|FG003|Overall Study|Protocol Violation|1|||
19391013|NCT01962298|41634832|FG004|Overall Study|Protocol Violation|0|||
19391014|NCT01962298|41634828|FG000|Overall Study|Data quality insufficient|2|||
19391015|NCT01962298|41634829|FG001|Overall Study|Data quality insufficient|0|||
19391016|NCT01962298|41634830|FG002|Overall Study|Data quality insufficient|3|||
19701818|NCT00195260|42146242|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
19701819|NCT00195260|42146232|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19800454|NCT02730351|42258735|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
19800455|NCT02730351|42258736|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
19800456|NCT01376349|42258745|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
19800457|NCT01376349|42258746|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
19800458|NCT01376349|42258747|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
19800459|NCT01376349|42258745|FG000|Raondomized Treatment|Adverse Event|13|||
19800460|NCT01376349|42258746|FG001|Raondomized Treatment|Adverse Event|17|||
19800461|NCT01376349|42258747|FG002|Raondomized Treatment|Adverse Event|14|||
19800462|NCT01376349|42258745|FG000|Raondomized Treatment|Unkown|1|||
19800463|NCT01376349|42258746|FG001|Raondomized Treatment|Unkown|2|||
19800464|NCT01376349|42258747|FG002|Raondomized Treatment|Unkown|1|||
19800465|NCT01376349|42258745|FG000|Raondomized Treatment|Alternative Treatment|0|||
19800466|NCT01376349|42258746|FG001|Raondomized Treatment|Alternative Treatment|0|||
19800467|NCT01376349|42258747|FG002|Raondomized Treatment|Alternative Treatment|1|||
19800468|NCT00158600|42258785|FG000|Overall Study|unable to commit time to study|0|||
19800469|NCT00158600|42258786|FG001|Overall Study|unable to commit time to study|1|||
19800470|NCT00158600|42258785|FG000|Overall Study|Adverse Event|2|||
19800471|NCT00158600|42258786|FG001|Overall Study|Adverse Event|1|||
19800472|NCT00158600|42258785|FG000|Overall Study|Death|1|||
19800473|NCT00158600|42258786|FG001|Overall Study|Death|0|||
19800474|NCT00158600|42258785|FG000|Overall Study|Withdrawal by Subject|2|||
19800475|NCT00158600|42258786|FG001|Overall Study|Withdrawal by Subject|2|||
19800476|NCT01680458|42258797|FG000|Overall Study|Protocol Violation|3|||
19800477|NCT00709761|42258801|FG000|Overall Study|Withdrawal by Subject|8|||
19800478|NCT00709761|42258801|FG000|Overall Study|study closed/terminated|17|||
19800479|NCT00709761|42258801|FG000|Overall Study|Lost to Follow-up|2|||
19800480|NCT02358031|42258814|FG000|Overall Study|Death|226|||
19800481|NCT02358031|42258815|FG001|Overall Study|Death|204|||
19800482|NCT02358031|42258816|FG002|Overall Study|Death|249|||
19800483|NCT02358031|42258814|FG000|Overall Study|Lost to Follow-up|0|||
19800484|NCT02358031|42258815|FG001|Overall Study|Lost to Follow-up|1|||
19800485|NCT02358031|42258816|FG002|Overall Study|Lost to Follow-up|1|||
19800486|NCT02358031|42258814|FG000|Overall Study|Withdrawal by Subject|14|||
19800487|NCT02358031|42258815|FG001|Overall Study|Withdrawal by Subject|12|||
19800488|NCT02358031|42258816|FG002|Overall Study|Withdrawal by Subject|17|||
19800489|NCT02358031|42258814|FG000|Overall Study|Ongoing in Study|61|||
19800490|NCT02358031|42258815|FG001|Overall Study|Ongoing in Study|64|||
19800491|NCT02358031|42258816|FG002|Overall Study|Ongoing in Study|33|||
19800492|NCT02848651|42258824|FG000|Overall Study|Death|85|||
19800493|NCT02848651|42258824|FG000|Overall Study|Lost to Follow-up|1|||
19800494|NCT02848651|42258824|FG000|Overall Study|Non-Compliance|1|||
19800495|NCT02848651|42258824|FG000|Overall Study|Symptomatic Deterioration|1|||
19800496|NCT02848651|42258824|FG000|Overall Study|Physician Decision|4|||
19800497|NCT02848651|42258824|FG000|Overall Study|Withdrawal by Subject|14|||
19800498|NCT00709059|42258844|FG000|Overall Study|Lost to Follow-up|34|||
19800499|NCT00709059|42258844|FG000|Overall Study|Withdrawal by Subject|19|||
19478423|NCT01502371|41757696|FG004|Overall Study|Noncompliance with Study Drug|1|||
19610298|NCT00968669|42059420|FG002|Overall Study|SUBJECT INCARCERATED|0|||
19610299|NCT00968669|42059421|FG003|Overall Study|SUBJECT INCARCERATED|0|||
19701820|NCT00195260|42146233|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701821|NCT00195260|42146234|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701822|NCT00195260|42146235|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701823|NCT00195260|42146236|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701824|NCT00195260|42146237|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701825|NCT00195260|42146238|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701826|NCT00195260|42146239|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
19701827|NCT00195260|42146240|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
19701828|NCT00195260|42146241|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
19701829|NCT00195260|42146242|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
19701830|NCT00031486|42146272|FG000|Overall Study|Adverse Event|1|||
19701831|NCT00031486|42146273|FG001|Overall Study|Adverse Event|0|||
19701832|NCT00031486|42146272|FG000|Overall Study|Lost to Follow-up|0|||
19701833|NCT00031486|42146273|FG001|Overall Study|Lost to Follow-up|1|||
19701834|NCT00031486|42146272|FG000|Overall Study|Withdrawal by Subject|3|||
19701835|NCT00031486|42146273|FG001|Overall Study|Withdrawal by Subject|2|||
19800500|NCT00709059|42258844|FG000|Overall Study|Physician Decision|7|||
19800501|NCT00709059|42258844|FG000|Overall Study|Disease complication|3|||
19800502|NCT00709059|42258844|FG000|Overall Study|Side effects|20|||
19800503|NCT00709059|42258844|FG000|Overall Study|Serious side effects|11|||
19800504|NCT01678898|42258851|FG000|PB-102-F01|Adverse Event|0|||
19800505|NCT01678898|42258852|FG001|PB-102-F01|Adverse Event|1|||
19800506|NCT01678898|42258853|FG002|PB-102-F01|Adverse Event|0|||
19800507|NCT01678898|42258851|FG000|PB-102-F01|Physician Decision|0|||
19800508|NCT01678898|42258852|FG001|PB-102-F01|Physician Decision|1|||
19800509|NCT01678898|42258853|FG002|PB-102-F01|Physician Decision|0|||
19800510|NCT01678820|42258873|FG000|Overall Study|Study Terminated by Sponsor|45|||
19800511|NCT01678820|42258874|FG001|Overall Study|Study Terminated by Sponsor|43|||
19800512|NCT01678820|42258875|FG002|Overall Study|Study Terminated by Sponsor|43|||
19800513|NCT01678820|42258873|FG000|Overall Study|Withdrawal by Subject|2|||
19800514|NCT01678820|42258874|FG001|Overall Study|Withdrawal by Subject|5|||
19800515|NCT01678820|42258875|FG002|Overall Study|Withdrawal by Subject|2|||
19800516|NCT01678820|42258873|FG000|Overall Study|Protocol Specified Criteria|2|||
19800517|NCT01678820|42258874|FG001|Overall Study|Protocol Specified Criteria|3|||
19701836|NCT00031486|42146272|FG000|Overall Study|Death|0|||
19701837|NCT00031486|42146273|FG001|Overall Study|Death|3|||
19701838|NCT00031486|42146272|FG000|Overall Study|Non-compliant|0|||
19701839|NCT00031486|42146273|FG001|Overall Study|Non-compliant|4|||
19701840|NCT00031486|42146272|FG000|Overall Study|Did not meet eligibility requirement|2|||
19701841|NCT00031486|42146273|FG001|Overall Study|Did not meet eligibility requirement|1|||
19701842|NCT00031486|42146272|FG000|Overall Study|Other|1|||
19701843|NCT00031486|42146273|FG001|Overall Study|Other|1|||
19701844|NCT00003508|42146281|FG000|Overall Study|Not evaluable|5|||
19701845|NCT00003472|42146285|FG000|Overall Study|Not evaluable|3|||
19701846|NCT00003298|42146289|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
19701847|NCT00003298|42146289|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
19701848|NCT00003298|42146289|FG000|Surgery|Unresectable at surgery|3|||
19701849|NCT00003298|42146289|FG000|Surgery|Progression before surgery|2|||
19701850|NCT00003298|42146289|FG000|Surgery|Unevaluable and off study|2|||
19701851|NCT00003298|42146289|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
19701852|NCT00003298|42146289|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
19701853|NCT00003298|42146289|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
19701854|NCT00003298|42146289|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
19701855|NCT00003298|42146289|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
19701856|NCT00003298|42146289|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
19701857|NCT00003298|42146289|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
19701858|NCT00003298|42146289|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
19701859|NCT00003298|42146289|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
19701860|NCT00003298|42146289|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
19701861|NCT00002842|42146294|FG000|Overall Study|ineligible for surgical resection|27|||
19701862|NCT00143247|42146298|FG000|Overall Study|Death|8|||
19701863|NCT00143247|42146298|FG000|Overall Study|Adverse Event|19|||
19701864|NCT00143247|42146298|FG000|Overall Study|Lack of Efficacy|3|||
19701865|NCT00143247|42146298|FG000|Overall Study|Withdrawal by Subject|55|||
19701866|NCT00143247|42146298|FG000|Overall Study|Study terminated by sponsor|31|||
19701867|NCT00143247|42146298|FG000|Overall Study|Protocol Violation|15|||
19701868|NCT00143247|42146298|FG000|Overall Study|Lost to Follow-up|12|||
19701869|NCT00143247|42146298|FG000|Overall Study|following inaccurate lab adverse event|1|||
19701870|NCT00143247|42146298|FG000|Overall Study|Other|12|||
19701871|NCT00125853|42146302|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
19701872|NCT00125853|42146303|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
19701873|NCT00219141|42146312|FG000|Overall Study|Adverse Event|4|||
19701874|NCT00219141|42146313|FG001|Overall Study|Adverse Event|10|||
19800518|NCT01678820|42258875|FG002|Overall Study|Protocol Specified Criteria|1|||
19800519|NCT01678820|42258873|FG000|Overall Study|Adverse Event|2|||
19800520|NCT01678820|42258874|FG001|Overall Study|Adverse Event|2|||
19800521|NCT01678820|42258875|FG002|Overall Study|Adverse Event|2|||
19800522|NCT01678820|42258873|FG000|Overall Study|Lost to Follow-up|7|||
19800523|NCT01678820|42258874|FG001|Overall Study|Lost to Follow-up|2|||
19800524|NCT01678820|42258875|FG002|Overall Study|Lost to Follow-up|2|||
19800525|NCT01678820|42258873|FG000|Overall Study|Non-compliance with study drug|0|||
19800526|NCT01678820|42258874|FG001|Overall Study|Non-compliance with study drug|1|||
19800527|NCT01678820|42258875|FG002|Overall Study|Non-compliance with study drug|0|||
19800528|NCT01678820|42258873|FG000|Overall Study|Physician Decision|0|||
19800529|NCT01678820|42258874|FG001|Overall Study|Physician Decision|0|||
19800530|NCT01678820|42258875|FG002|Overall Study|Physician Decision|1|||
19800531|NCT01678820|42258873|FG000|Overall Study|Protocol Violation|4|||
19800532|NCT01678820|42258874|FG001|Overall Study|Protocol Violation|5|||
19800533|NCT01678820|42258875|FG002|Overall Study|Protocol Violation|4|||
19800534|NCT01678820|42258873|FG000|Overall Study|Not treated with double-blind study drug|0|||
19800535|NCT01678820|42258874|FG001|Overall Study|Not treated with double-blind study drug|2|||
19800536|NCT01678820|42258875|FG002|Overall Study|Not treated with double-blind study drug|2|||
19610300|NCT00968669|42059418|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
19701875|NCT00219141|42146314|FG002|Overall Study|Adverse Event|5|||
19701876|NCT00219141|42146312|FG000|Overall Study|Lack of Efficacy|3|||
19701877|NCT00219141|42146313|FG001|Overall Study|Lack of Efficacy|2|||
19701878|NCT00219141|42146314|FG002|Overall Study|Lack of Efficacy|0|||
19701879|NCT00219141|42146312|FG000|Overall Study|Administrative problems|0|||
19701880|NCT00219141|42146313|FG001|Overall Study|Administrative problems|1|||
19701881|NCT00219141|42146314|FG002|Overall Study|Administrative problems|0|||
19800537|NCT00770809|42258887|FG000|Overall Study|Adverse Event|9|||
19800538|NCT00770809|42258888|FG001|Overall Study|Adverse Event|1|||
19800539|NCT00770809|42258889|FG002|Overall Study|Adverse Event|12|||
19800540|NCT00770809|42258887|FG000|Overall Study|Death|1|||
19800541|NCT00770809|42258888|FG001|Overall Study|Death|0|||
19800542|NCT00770809|42258889|FG002|Overall Study|Death|0|||
19800543|NCT00770809|42258887|FG000|Overall Study|Withdrawal by Subject|3|||
19800544|NCT00770809|42258888|FG001|Overall Study|Withdrawal by Subject|3|||
19800545|NCT00770809|42258889|FG002|Overall Study|Withdrawal by Subject|7|||
19800546|NCT00770809|42258887|FG000|Overall Study|Progression|2|||
19800547|NCT00770809|42258888|FG001|Overall Study|Progression|2|||
19800548|NCT00770809|42258889|FG002|Overall Study|Progression|0|||
19800549|NCT00770809|42258887|FG000|Overall Study|Complicating illness|0|||
19800550|NCT00770809|42258888|FG001|Overall Study|Complicating illness|0|||
19800551|NCT00770809|42258889|FG002|Overall Study|Complicating illness|1|||
19800552|NCT00770809|42258887|FG000|Overall Study|Other Medical Reasons|2|||
19800553|NCT00770809|42258888|FG001|Overall Study|Other Medical Reasons|4|||
19800554|NCT00770809|42258889|FG002|Overall Study|Other Medical Reasons|3|||
19800555|NCT02660138|42258900|FG000|Overall Study|Adverse Event|0|||
19800556|NCT02660138|42258901|FG001|Overall Study|Adverse Event|3|||
19800557|NCT02660138|42258902|FG002|Overall Study|Adverse Event|2|||
19800558|NCT02660138|42258900|FG000|Overall Study|Lack of Efficacy|1|||
19800559|NCT02660138|42258901|FG001|Overall Study|Lack of Efficacy|2|||
19800560|NCT02660138|42258902|FG002|Overall Study|Lack of Efficacy|1|||
19800561|NCT02660138|42258900|FG000|Overall Study|Withdrawal by Subject|7|||
19800562|NCT02660138|42258901|FG001|Overall Study|Withdrawal by Subject|6|||
19800563|NCT02660138|42258902|FG002|Overall Study|Withdrawal by Subject|6|||
19800564|NCT02660138|42258900|FG000|Overall Study|Lost to Follow-up|4|||
19800565|NCT02660138|42258901|FG001|Overall Study|Lost to Follow-up|4|||
19800566|NCT02660138|42258902|FG002|Overall Study|Lost to Follow-up|1|||
19800567|NCT02660138|42258900|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
19800568|NCT02660138|42258901|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
19800569|NCT02660138|42258902|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
19800570|NCT02660138|42258900|FG000|Overall Study|Other|1|||
19800571|NCT02660138|42258901|FG001|Overall Study|Other|1|||
19800572|NCT02660138|42258902|FG002|Overall Study|Other|0|||
19800573|NCT02660138|42258900|FG000|Overall Study|Not treated|0|||
19800574|NCT02660138|42258901|FG001|Overall Study|Not treated|1|||
19800575|NCT02660138|42258902|FG002|Overall Study|Not treated|0|||
19800576|NCT01603394|42258913|FG000|Overall Study|Adverse Event|1|||
19800577|NCT02729025|42258919|FG000|Overall Study|Sponsor Decision|0|||
19800578|NCT02729025|42258920|FG001|Overall Study|Sponsor Decision|1|||
19800579|NCT03093350|42258926|FG000|Overall Study|Death|1|||
19391017|NCT01962298|41634831|FG003|Overall Study|Data quality insufficient|1|||
19391018|NCT01962298|41634832|FG004|Overall Study|Data quality insufficient|4|||
19391019|NCT01962298|41634828|FG000|Overall Study|Insufficient data|0|||
19391020|NCT01962298|41634829|FG001|Overall Study|Insufficient data|2|||
19391021|NCT01962298|41634830|FG002|Overall Study|Insufficient data|1|||
19391022|NCT01962298|41634831|FG003|Overall Study|Insufficient data|0|||
19391023|NCT01962298|41634832|FG004|Overall Study|Insufficient data|1|||
19391024|NCT01962298|41634828|FG000|Overall Study|Incorrect data recorded|0|||
19391025|NCT01962298|41634829|FG001|Overall Study|Incorrect data recorded|1|||
19391026|NCT01962298|41634830|FG002|Overall Study|Incorrect data recorded|0|||
19391027|NCT01962298|41634831|FG003|Overall Study|Incorrect data recorded|0|||
19391028|NCT01962298|41634832|FG004|Overall Study|Incorrect data recorded|0|||
19391029|NCT01962298|41634828|FG000|Overall Study|Physician Decision|0|||
19391030|NCT01962298|41634829|FG001|Overall Study|Physician Decision|1|||
19391031|NCT01962298|41634830|FG002|Overall Study|Physician Decision|0|||
19391032|NCT01962298|41634831|FG003|Overall Study|Physician Decision|0|||
19391033|NCT01962298|41634832|FG004|Overall Study|Physician Decision|1|||
19391034|NCT02693743|41634846|FG000|Overall Study|Physician Decision|1|||
19391035|NCT02693743|41634847|FG001|Overall Study|Physician Decision|0|||
19800580|NCT03093350|42258926|FG000|Overall Study|Signed consent, never began treartment|1|||
19800581|NCT01603082|42258932|FG000|Overall Study|Adverse Event|0|||
19391038|NCT02655887|41634863|FG000|Overall Study|Lost to Follow-up|3|||
19391039|NCT02655887|41634863|FG000|Overall Study|Death|4|||
19391040|NCT02655887|41634863|FG000|Overall Study|Withdrawal by Subject|3|||
19391041|NCT02655887|41634863|FG000|Overall Study|Missed 12-month follow-up visit|4|||
19391042|NCT02008318|41634869|FG000|Overall Study|Adverse Event|4|||
19391043|NCT02008318|41634870|FG001|Overall Study|Adverse Event|0|||
19701882|NCT00219141|42146312|FG000|Overall Study|Lost to Follow-up|2|||
19800582|NCT01603082|42258933|FG001|Overall Study|Adverse Event|1|||
19800583|NCT01603082|42258932|FG000|Overall Study|Withdrawal by Subject|1|||
19800584|NCT01603082|42258933|FG001|Overall Study|Withdrawal by Subject|0|||
19800585|NCT01603082|42258932|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
19800586|NCT01603082|42258933|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
19800587|NCT02499835|42258943|FG000|Overall Study|Withdrawal by Subject|1|||
19391044|NCT02008318|41634869|FG000|Overall Study|Physician Decision|2|||
19800588|NCT02499835|42258944|FG001|Overall Study|Withdrawal by Subject|0|||
19800589|NCT02499835|42258945|FG002|Overall Study|Withdrawal by Subject|0|||
19391045|NCT02008318|41634870|FG001|Overall Study|Physician Decision|0|||
19391046|NCT02008318|41634869|FG000|Overall Study|Progressive Disease|2|||
19800590|NCT02499835|42258946|FG003|Overall Study|Withdrawal by Subject|1|||
19800591|NCT02499835|42258943|FG000|Overall Study|Physician Decision|0|||
19800592|NCT02499835|42258944|FG001|Overall Study|Physician Decision|3|||
19800593|NCT02499835|42258945|FG002|Overall Study|Physician Decision|18|||
19701883|NCT00219141|42146313|FG001|Overall Study|Lost to Follow-up|4|||
19701884|NCT00219141|42146314|FG002|Overall Study|Lost to Follow-up|1|||
19701885|NCT00219141|42146312|FG000|Overall Study|Protocol Violation|3|||
19701886|NCT00219141|42146313|FG001|Overall Study|Protocol Violation|1|||
19701887|NCT00219141|42146314|FG002|Overall Study|Protocol Violation|1|||
19701888|NCT00219141|42146312|FG000|Overall Study|Withdrawal by Subject|1|||
19701889|NCT00219141|42146313|FG001|Overall Study|Withdrawal by Subject|3|||
19701890|NCT00219141|42146314|FG002|Overall Study|Withdrawal by Subject|5|||
19701891|NCT00219141|42146312|FG000|Overall Study|Condition no longer requires study drug|1|||
19701892|NCT00219141|42146313|FG001|Overall Study|Condition no longer requires study drug|0|||
19701893|NCT00219141|42146314|FG002|Overall Study|Condition no longer requires study drug|0|||
19701894|NCT00142935|42146325|FG000|Overall Study|Other reason|1|||
19701895|NCT00142935|42146326|FG001|Overall Study|Other reason|1|||
19701896|NCT00142935|42146327|FG002|Overall Study|Other reason|1|||
19701897|NCT00142935|42146325|FG000|Overall Study|Lost to Follow-up|2|||
19701898|NCT00142935|42146326|FG001|Overall Study|Lost to Follow-up|5|||
19701899|NCT00142935|42146327|FG002|Overall Study|Lost to Follow-up|5|||
19701900|NCT00142935|42146325|FG000|Overall Study|Death|0|||
19701901|NCT00142935|42146326|FG001|Overall Study|Death|2|||
19701902|NCT00142935|42146327|FG002|Overall Study|Death|1|||
19701903|NCT00233948|42146341|FG000|Overall Study|Adverse Event|1|||
19701904|NCT00233948|42146342|FG001|Overall Study|Adverse Event|0|||
19701905|NCT00233948|42146343|FG002|Overall Study|Adverse Event|0|||
19701906|NCT00233948|42146344|FG003|Overall Study|Adverse Event|0|||
19701907|NCT00233948|42146345|FG004|Overall Study|Adverse Event|0|||
19701908|NCT00233948|42146346|FG005|Overall Study|Adverse Event|0|||
19701909|NCT00233480|42146363|FG000|Overall Study|Underwent status II heart transplant|0|||
19701910|NCT00233480|42146364|FG001|Overall Study|Underwent status II heart transplant|1|||
19800594|NCT02499835|42258946|FG003|Overall Study|Physician Decision|7|||
19800595|NCT02499835|42258943|FG000|Overall Study|Adverse Event|0|||
19800596|NCT02499835|42258944|FG001|Overall Study|Adverse Event|0|||
19800597|NCT02499835|42258945|FG002|Overall Study|Adverse Event|0|||
19800598|NCT02499835|42258946|FG003|Overall Study|Adverse Event|1|||
19800599|NCT02499835|42258943|FG000|Overall Study|Disease progression|2|||
19800600|NCT02499835|42258944|FG001|Overall Study|Disease progression|1|||
19800601|NCT02499835|42258945|FG002|Overall Study|Disease progression|0|||
19800602|NCT02499835|42258946|FG003|Overall Study|Disease progression|7|||
19800603|NCT02846779|42258965|FG000|Overall Study|Lost Enrollment|83|||
19800604|NCT02846779|42258966|FG001|Overall Study|Lost Enrollment|82|||
19800605|NCT02846779|42258967|FG002|Overall Study|Lost Enrollment|86|||
19800606|NCT02846779|42258965|FG000|Overall Study|Less than 31 days of follow-up|56|||
19800607|NCT02846779|42258966|FG001|Overall Study|Less than 31 days of follow-up|45|||
19800608|NCT02846779|42258967|FG002|Overall Study|Less than 31 days of follow-up|52|||
19800609|NCT00406393|42258977|FG000|Overall Study|Did not undergo transplantation|2|||
19391047|NCT02008318|41634870|FG001|Overall Study|Progressive Disease|0|||
19391048|NCT02008318|41634869|FG000|Overall Study|Protocol Violation|1|||
19391049|NCT02008318|41634870|FG001|Overall Study|Protocol Violation|1|||
19391050|NCT02008318|41634869|FG000|Overall Study|Withdrawal by Subject|3|||
19391051|NCT02008318|41634870|FG001|Overall Study|Withdrawal by Subject|0|||
19391052|NCT01982812|41634881|FG000|Overall Study|Death|1|||
19391053|NCT01982812|41634882|FG001|Overall Study|Death|5|||
19391054|NCT01982812|41634881|FG000|Overall Study|Adverse Event|0|||
19391055|NCT01982812|41634882|FG001|Overall Study|Adverse Event|5|||
19391056|NCT02007070|41634888|FG000|Overall Study|Adverse Event|4|||
19391057|NCT02007070|41634888|FG000|Overall Study|Clinical Progression|4|||
19391058|NCT02007070|41634888|FG000|Overall Study|Death|1|||
19391059|NCT02007070|41634888|FG000|Overall Study|Protocol Violation|2|||
19391060|NCT02007070|41634888|FG000|Overall Study|Physician Decision|1|||
19391061|NCT02007070|41634888|FG000|Overall Study|Progressive Disease|21|||
19391062|NCT02006758|41634892|FG000|Overall Study|Protocol Violation|1|||
19391063|NCT02006758|41634892|FG000|Overall Study|Death|1|||
19391064|NCT02006758|41634892|FG000|Overall Study|Lost to Follow-up|4|||
19391065|NCT02006758|41634892|FG000|Overall Study|Withdrawal by Subject|4|||
19701911|NCT03801928|42146378|FG000|Overall Study|Adverse Event|1|||
19701912|NCT03801928|42146379|FG001|Overall Study|Adverse Event|0|||
19701913|NCT03801928|42146380|FG002|Overall Study|Adverse Event|1|||
19800610|NCT00406393|42258978|FG001|Overall Study|Did not undergo transplantation|1|||
19800611|NCT02845375|42258987|FG000|Overall Study|upper airway obstruction|1|||
19800612|NCT02845375|42258988|FG001|Overall Study|upper airway obstruction|2|||
19800613|NCT02845375|42258989|FG002|Overall Study|upper airway obstruction|1|||
19800614|NCT02658734|42258997|FG000|Overall Study|Adverse Event|2|||
19800615|NCT02658734|42258997|FG000|Overall Study|Death|4|||
19701914|NCT03801928|42146381|FG003|Overall Study|Adverse Event|2|||
19701915|NCT03801928|42146382|FG004|Overall Study|Adverse Event|0|||
19391066|NCT02006758|41634892|FG000|Overall Study|Procedurally excluded|1|||
19391067|NCT02006758|41634892|FG000|Overall Study|Other|2|||
19800616|NCT02658734|42258997|FG000|Overall Study|Lost to Follow-up|7|||
19800617|NCT02658734|42258997|FG000|Overall Study|Withdrawal of Consent|16|||
19800618|NCT02658734|42258997|FG000|Overall Study|Disease Progression|28|||
19800619|NCT02844439|42259001|FG000|Overall Study|Withdrawal by Subject|1|||
19800620|NCT02844439|42259001|FG000|Overall Study|Lost to Follow-up|2|||
19800621|NCT02844439|42259001|FG000|Overall Study|Termination by Sponsor|4|||
19800622|NCT02844439|42259001|FG000|Overall Study|Death|28|||
19800623|NCT02844439|42259001|FG000|Overall Study|Other|5|||
19800624|NCT01677182|42259015|FG000|Overall Study|Adverse Event|2|||
19800625|NCT01677182|42259016|FG001|Overall Study|Adverse Event|1|||
19800626|NCT01677182|42259017|FG002|Overall Study|Adverse Event|8|||
19800627|NCT01677182|42259015|FG000|Overall Study|Protocol Violation|5|||
19800628|NCT01677182|42259016|FG001|Overall Study|Protocol Violation|1|||
19800629|NCT01677182|42259017|FG002|Overall Study|Protocol Violation|4|||
19800630|NCT01677182|42259015|FG000|Overall Study|Lost to Follow-up|4|||
19800631|NCT01677182|42259016|FG001|Overall Study|Lost to Follow-up|0|||
19800632|NCT01677182|42259017|FG002|Overall Study|Lost to Follow-up|3|||
19800633|NCT01677182|42259015|FG000|Overall Study|Withdrawal by Subject|7|||
19800634|NCT01677182|42259016|FG001|Overall Study|Withdrawal by Subject|12|||
19800635|NCT01677182|42259017|FG002|Overall Study|Withdrawal by Subject|10|||
19800636|NCT01677182|42259015|FG000|Overall Study|Study termination|12|||
19800637|NCT01677182|42259016|FG001|Overall Study|Study termination|9|||
19800638|NCT01677182|42259017|FG002|Overall Study|Study termination|11|||
19800639|NCT01677182|42259015|FG000|Overall Study|Lack of Efficacy|3|||
19800640|NCT01677182|42259016|FG001|Overall Study|Lack of Efficacy|0|||
19800641|NCT01677182|42259017|FG002|Overall Study|Lack of Efficacy|1|||
19800642|NCT01677182|42259015|FG000|Overall Study|Other reasons|1|||
19800643|NCT01677182|42259016|FG001|Overall Study|Other reasons|5|||
19800644|NCT01677182|42259017|FG002|Overall Study|Other reasons|2|||
19800645|NCT02843659|42259028|FG000|Overall Study|Subject Withdrew Consent|0|||
19800646|NCT02843659|42259029|FG001|Overall Study|Subject Withdrew Consent|0|||
19800647|NCT02843659|42259030|FG002|Overall Study|Subject Withdrew Consent|1|||
19800648|NCT02843659|42259028|FG000|Overall Study|Administrative Reason by Sponsor|4|||
19800649|NCT02843659|42259029|FG001|Overall Study|Administrative Reason by Sponsor|5|||
19800650|NCT02843659|42259030|FG002|Overall Study|Administrative Reason by Sponsor|4|||
19800651|NCT02843659|42259028|FG000|Overall Study|Adverse Event|0|||
19800652|NCT02843659|42259029|FG001|Overall Study|Adverse Event|1|||
19800653|NCT02843659|42259030|FG002|Overall Study|Adverse Event|0|||
19800654|NCT00708435|42259040|FG000|Overall Study|Death / Serious Adverse Event|10|||
19800655|NCT00708435|42259041|FG001|Overall Study|Death / Serious Adverse Event|5|||
19800656|NCT00708435|42259040|FG000|Overall Study|Lost to Follow-up|9|||
19800657|NCT00708435|42259041|FG001|Overall Study|Lost to Follow-up|4|||
19800658|NCT00708435|42259040|FG000|Overall Study|Withdrawal by Subject|3|||
19800659|NCT00708435|42259041|FG001|Overall Study|Withdrawal by Subject|7|||
19800660|NCT00708435|42259040|FG000|Overall Study|Adverse Event|1|||
19800661|NCT00708435|42259041|FG001|Overall Study|Adverse Event|0|||
19800662|NCT00708435|42259040|FG000|Overall Study|Protocol Violation|0|||
19800663|NCT00708435|42259041|FG001|Overall Study|Protocol Violation|1|||
19800664|NCT00708435|42259040|FG000|Overall Study|Intervention by primary care physician|1|||
19800665|NCT00708435|42259041|FG001|Overall Study|Intervention by primary care physician|0|||
19800666|NCT00708435|42259040|FG000|Overall Study|Refused hospitalization|1|||
19800667|NCT00708435|42259041|FG001|Overall Study|Refused hospitalization|0|||
19800668|NCT02841787|42259052|FG000|Overall Study|Lost to Follow-up|1|||
19800669|NCT02841787|42259053|FG001|Overall Study|Lost to Follow-up|0|||
19800670|NCT02841787|42259054|FG002|Overall Study|Lost to Follow-up|0|||
19800671|NCT02841787|42259052|FG000|Overall Study|Symptoms dropped below threshold|1|||
19800672|NCT02841787|42259053|FG001|Overall Study|Symptoms dropped below threshold|0|||
19391068|NCT01960816|41634897|FG000|Overall Study|Lost to Follow-up|1|||
19391069|NCT01602419|41634901|FG000|Overall Study|Not treated with Wilate|9|||
19701916|NCT03801928|42146383|FG005|Overall Study|Adverse Event|2|||
19701917|NCT03801928|42146378|FG000|Overall Study|Lack of Efficacy|0|||
19701918|NCT03801928|42146379|FG001|Overall Study|Lack of Efficacy|0|||
19701919|NCT03801928|42146380|FG002|Overall Study|Lack of Efficacy|1|||
19701920|NCT03801928|42146381|FG003|Overall Study|Lack of Efficacy|0|||
19701921|NCT03801928|42146382|FG004|Overall Study|Lack of Efficacy|0|||
19701922|NCT03801928|42146383|FG005|Overall Study|Lack of Efficacy|0|||
19701923|NCT03801928|42146378|FG000|Overall Study|Lost to Follow-up|5|||
19701924|NCT03801928|42146379|FG001|Overall Study|Lost to Follow-up|1|||
19800673|NCT02841787|42259054|FG002|Overall Study|Symptoms dropped below threshold|0|||
19391070|NCT01602419|41634901|FG000|Overall Study|Adverse Drug Reaction|4|||
19701925|NCT03801928|42146380|FG002|Overall Study|Lost to Follow-up|1|||
19800674|NCT02841787|42259052|FG000|Overall Study|Withdrawal by Subject|1|||
19800675|NCT02841787|42259053|FG001|Overall Study|Withdrawal by Subject|4|||
19800676|NCT02841787|42259054|FG002|Overall Study|Withdrawal by Subject|0|||
19800677|NCT01376037|42259064|FG000|Overall Study|Lost to Follow-up|0|||
19800678|NCT01376037|42259065|FG001|Overall Study|Lost to Follow-up|2|||
19800679|NCT02657408|42259073|FG000|Overall Study|Adverse Event|3|||
19800680|NCT02657408|42259074|FG001|Overall Study|Adverse Event|7|||
19800681|NCT02841709|42259080|FG000|5th Intervention|Adverse Event|2|||
19800682|NCT02841709|42259081|FG001|5th Intervention|Adverse Event|0|||
19800683|NCT02841709|42259082|FG002|5th Intervention|Adverse Event|0|||
19701926|NCT03801928|42146381|FG003|Overall Study|Lost to Follow-up|4|||
19701927|NCT03801928|42146382|FG004|Overall Study|Lost to Follow-up|4|||
19701928|NCT03801928|42146383|FG005|Overall Study|Lost to Follow-up|2|||
19701929|NCT03801928|42146378|FG000|Overall Study|Withdrawal by Subject|0|||
19701930|NCT03801928|42146379|FG001|Overall Study|Withdrawal by Subject|0|||
19701931|NCT03801928|42146380|FG002|Overall Study|Withdrawal by Subject|2|||
19800684|NCT02841709|42259083|FG003|5th Intervention|Adverse Event|0|||
19800685|NCT02841709|42259084|FG004|5th Intervention|Adverse Event|2|||
19800686|NCT01353859|42259097|FG000|Overall Study|Adverse Event|3|||
19800687|NCT01353859|42259097|FG000|Overall Study|Lack of Efficacy|1|||
19800688|NCT02850965|42259103|FG000|Overall Study|Other than listed|3|||
19800689|NCT02850965|42259104|FG001|Overall Study|Other than listed|4|||
19800690|NCT02850965|42259103|FG000|Overall Study|Protocol Violation|0|||
19800691|NCT02850965|42259104|FG001|Overall Study|Protocol Violation|2|||
19800692|NCT02850965|42259103|FG000|Overall Study|Lost to Follow-up|5|||
19800693|NCT02850965|42259104|FG001|Overall Study|Lost to Follow-up|3|||
19800694|NCT02850965|42259103|FG000|Overall Study|Lack of Efficacy|4|||
19800695|NCT02850965|42259104|FG001|Overall Study|Lack of Efficacy|8|||
19800696|NCT02850965|42259103|FG000|Overall Study|Adverse Event|3|||
19800697|NCT02850965|42259104|FG001|Overall Study|Adverse Event|2|||
19800698|NCT02850965|42259103|FG000|Overall Study|Withdrawal by Subject|3|||
19800699|NCT02850965|42259104|FG001|Overall Study|Withdrawal by Subject|4|||
19800700|NCT02850965|42259103|FG000|Overall Study|Physician Decision|0|||
19800701|NCT02850965|42259104|FG001|Overall Study|Physician Decision|1|||
19800702|NCT02850965|42259103|FG000|Overall Study|Randomized but not treated|0|||
19800703|NCT02850965|42259104|FG001|Overall Study|Randomized but not treated|1|||
19800704|NCT01375959|42259112|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
19800705|NCT01375959|42259113|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
19800706|NCT01375959|42259112|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
19800707|NCT01375959|42259113|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
19800708|NCT01375959|42259112|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
19800709|NCT01375959|42259113|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
19800710|NCT00708201|42259123|FG000|Overall Study|Adverse Event|4|||
19800711|NCT00708201|42259124|FG001|Overall Study|Adverse Event|4|||
19800712|NCT00708201|42259123|FG000|Overall Study|Withdrawal by Subject|1|||
19800713|NCT00708201|42259124|FG001|Overall Study|Withdrawal by Subject|1|||
19800714|NCT00708201|42259123|FG000|Overall Study|Lost to Follow-up|2|||
19800715|NCT00708201|42259124|FG001|Overall Study|Lost to Follow-up|0|||
19800716|NCT00708201|42259123|FG000|Overall Study|Protocol Violation|0|||
19800717|NCT00708201|42259124|FG001|Overall Study|Protocol Violation|1|||
19800718|NCT02848313|42259132|FG000|Overall Study|Adverse Event|1|||
19800719|NCT02848313|42259133|FG001|Overall Study|Adverse Event|2|||
19800720|NCT02848313|42259132|FG000|Overall Study|Lack of Efficacy|0|||
19800721|NCT02848313|42259133|FG001|Overall Study|Lack of Efficacy|1|||
19800722|NCT02848313|42259132|FG000|Overall Study|Withdrawal by Subject|1|||
19391071|NCT01602419|41634901|FG000|Overall Study|Insurance issues|3|||
19391072|NCT01602419|41634901|FG000|Overall Study|Changed treatment centre|1|||
19391073|NCT01602419|41634901|FG000|Overall Study|Treatment centre closed|1|||
19391074|NCT01602419|41634901|FG000|Overall Study|Withdrawal by Subject|5|||
19391075|NCT01602419|41634901|FG000|Overall Study|Lost to Follow-up|6|||
19391076|NCT01981954|41634946|FG000|Titration Period|Protocol Deviation|1|||
19391077|NCT01981954|41634946|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
19391078|NCT02693119|41634952|FG000|Open-Label Period|Withdrawal by Subject|0|||
19391079|NCT02693119|41634953|FG001|Open-Label Period|Withdrawal by Subject|1|||
19391080|NCT01960348|41634991|FG000|Overall Study|Adverse event, not serious|2|||
19391081|NCT01960348|41634992|FG001|Overall Study|Adverse event, not serious|2|||
19391082|NCT01960348|41634991|FG000|Overall Study|Adverse event, serious fatal|6|||
19391083|NCT01960348|41634992|FG001|Overall Study|Adverse event, serious fatal|5|||
19391084|NCT01960348|41634991|FG000|Overall Study|Adverse event, serious non-fatal|0|||
19478424|NCT01502371|41757692|FG000|Overall Study|Technical Problems|1|||
19701932|NCT03801928|42146381|FG003|Overall Study|Withdrawal by Subject|1|||
19701933|NCT03801928|42146382|FG004|Overall Study|Withdrawal by Subject|0|||
19701934|NCT03801928|42146383|FG005|Overall Study|Withdrawal by Subject|0|||
19701935|NCT03801928|42146378|FG000|Overall Study|Other|0|||
19701936|NCT03801928|42146379|FG001|Overall Study|Other|2|||
19800723|NCT02848313|42259133|FG001|Overall Study|Withdrawal by Subject|1|||
19800724|NCT02848313|42259132|FG000|Overall Study|Lost to follow up|1|||
19800725|NCT02848313|42259133|FG001|Overall Study|Lost to follow up|0|||
19800726|NCT02728089|42259139|FG000|Overall Study|Physician Decision|2|||
19800727|NCT02728089|42259139|FG000|Overall Study|Withdrawal by Subject|1|||
19800728|NCT02840461|42259146|FG000|Overall Study|Adverse Event|1|||
19800729|NCT02840461|42259147|FG001|Overall Study|Adverse Event|5|||
19800730|NCT02840461|42259148|FG002|Overall Study|Adverse Event|3|||
19800731|NCT02840461|42259146|FG000|Overall Study|Lost to Follow-up|10|||
19800732|NCT02840461|42259147|FG001|Overall Study|Lost to Follow-up|7|||
19391085|NCT01960348|41634992|FG001|Overall Study|Adverse event, serious non-fatal|3|||
19391086|NCT01960348|41634991|FG000|Overall Study|Withdrawal by Subject|1|||
19391087|NCT01960348|41634992|FG001|Overall Study|Withdrawal by Subject|11|||
19391088|NCT01960348|41634991|FG000|Overall Study|Physician Decision|0|||
19391089|NCT01960348|41634992|FG001|Overall Study|Physician Decision|1|||
19391090|NCT01960348|41634991|FG000|Overall Study|Protocol Violation|1|||
19391091|NCT01960348|41634992|FG001|Overall Study|Protocol Violation|0|||
19391092|NCT02653625|41634998|FG000|Overall Study|Adverse Event|1|||
19391093|NCT02653625|41634998|FG000|Overall Study|Non-compliance with Study Drug|1|||
19391094|NCT02653625|41634998|FG000|Overall Study|Protocol Violation|1|||
19391095|NCT02653625|41634998|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
19391096|NCT01981096|41635004|FG000|Overall Study|Parent illness|1|||
19391097|NCT01981096|41635005|FG001|Overall Study|Parent illness|0|||
19391098|NCT01981096|41635004|FG000|Overall Study|Withdrawal by Subject|0|||
19391099|NCT01981096|41635005|FG001|Overall Study|Withdrawal by Subject|1|||
19391100|NCT01981096|41635004|FG000|Overall Study|Lost to Follow-up|2|||
19391101|NCT01981096|41635005|FG001|Overall Study|Lost to Follow-up|0|||
19391102|NCT02652767|41635011|FG000|Overall Study|Death|2|||
19391103|NCT02652767|41635011|FG000|Overall Study|Lost to Follow-up|1|||
19391104|NCT02652767|41635011|FG000|Overall Study|Withdrawal by Subject|1|||
19391105|NCT01980940|41635025|FG000|Overall Study|Protocol Violation|0|||
19391106|NCT01980940|41635026|FG001|Overall Study|Protocol Violation|0|||
19391107|NCT01980940|41635027|FG002|Overall Study|Protocol Violation|0|||
19391108|NCT01980940|41635028|FG003|Overall Study|Protocol Violation|0|||
19391109|NCT01980940|41635029|FG004|Overall Study|Protocol Violation|0|||
19391110|NCT01980940|41635030|FG005|Overall Study|Protocol Violation|2|||
19391111|NCT01980940|41635031|FG006|Overall Study|Protocol Violation|0|||
19391112|NCT01980940|41635032|FG007|Overall Study|Protocol Violation|0|||
19391113|NCT02699983|41635058|FG000|Overall Study|Withdrawal by Subject|1|||
19391114|NCT02699983|41635059|FG001|Overall Study|Withdrawal by Subject|0|||
19391115|NCT01960114|41635071|FG000|Overall Study|Adverse Event|1|||
19391116|NCT01960114|41635072|FG001|Overall Study|Adverse Event|0|||
19391117|NCT01960114|41635071|FG000|Overall Study|Could not swallow study medication|0|||
19391118|NCT01960114|41635072|FG001|Overall Study|Could not swallow study medication|1|||
19391119|NCT02005276|41635082|FG000|Overall Study|No longer interested|5|||
19391120|NCT02005276|41635083|FG001|Overall Study|No longer interested|2|||
19391121|NCT02005276|41635084|FG002|Overall Study|No longer interested|3|||
19391122|NCT02005276|41635085|FG003|Overall Study|No longer interested|3|||
19391123|NCT01980706|41635100|FG000|Overall Study|Withdrawal by Subject|9|||
19391124|NCT01980706|41635101|FG001|Overall Study|Withdrawal by Subject|6|||
19391125|NCT01980706|41635102|FG002|Overall Study|Withdrawal by Subject|2|||
19391126|NCT01980706|41635100|FG000|Overall Study|Adverse Event|1|||
19391127|NCT01980706|41635101|FG001|Overall Study|Adverse Event|2|||
19391128|NCT01980706|41635102|FG002|Overall Study|Adverse Event|5|||
19391129|NCT01980706|41635100|FG000|Overall Study|Lost to Follow-up|3|||
19391130|NCT01980706|41635101|FG001|Overall Study|Lost to Follow-up|4|||
19391131|NCT01980706|41635102|FG002|Overall Study|Lost to Follow-up|3|||
19391132|NCT01980706|41635100|FG000|Overall Study|miscellaneous|4|||
19391133|NCT01980706|41635101|FG001|Overall Study|miscellaneous|5|||
19391134|NCT01980706|41635102|FG002|Overall Study|miscellaneous|3|||
19391135|NCT02692417|41635112|FG000|Overall Study|Withdrawal by Subject|5|||
19391136|NCT02692417|41635113|FG001|Overall Study|Withdrawal by Subject|1|||
19391137|NCT02692417|41635112|FG000|Overall Study|Adverse Event|1|||
19391138|NCT02692417|41635113|FG001|Overall Study|Adverse Event|0|||
19391139|NCT02004886|41635123|FG000|Overall Study|Adverse Event|0|||
19391140|NCT02004886|41635124|FG001|Overall Study|Adverse Event|1|||
19391141|NCT02004886|41635125|FG002|Overall Study|Adverse Event|0|||
19391142|NCT02004886|41635126|FG003|Overall Study|Adverse Event|0|||
19391143|NCT02004886|41635123|FG000|Overall Study|Unable to attend future visits|1|||
19391144|NCT02004886|41635124|FG001|Overall Study|Unable to attend future visits|0|||
19391145|NCT02004886|41635125|FG002|Overall Study|Unable to attend future visits|0|||
19391146|NCT02004886|41635126|FG003|Overall Study|Unable to attend future visits|0|||
19391147|NCT01959880|41635140|FG000|Overall Study|Withdrawal by Subject|11|||
19391148|NCT01959880|41635141|FG001|Overall Study|Withdrawal by Subject|13|||
19391149|NCT01959880|41635142|FG002|Overall Study|Withdrawal by Subject|8|||
19391150|NCT01959880|41635143|FG003|Overall Study|Withdrawal by Subject|7|||
19391151|NCT01959880|41635140|FG000|Overall Study|Death|1|||
19391152|NCT01959880|41635141|FG001|Overall Study|Death|10|||
19391153|NCT01959880|41635142|FG002|Overall Study|Death|1|||
19391154|NCT01959880|41635143|FG003|Overall Study|Death|2|||
19391155|NCT01959880|41635140|FG000|Overall Study|Lost to Follow-up|95|||
19391156|NCT01959880|41635141|FG001|Overall Study|Lost to Follow-up|18|||
19391157|NCT01959880|41635142|FG002|Overall Study|Lost to Follow-up|15|||
19391158|NCT01959880|41635143|FG003|Overall Study|Lost to Follow-up|8|||
19391159|NCT01959880|41635140|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
19391160|NCT01959880|41635141|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
19391161|NCT01959880|41635142|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
19391162|NCT01959880|41635143|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
19610301|NCT00968669|42059419|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
19610302|NCT00968669|42059420|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
19610303|NCT00968669|42059421|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
19610304|NCT00968669|42059418|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
19610305|NCT00968669|42059419|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
19610306|NCT00968669|42059420|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
19610307|NCT00968669|42059421|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
19610308|NCT00568399|42059431|FG000|Overall Study|Death|2|||
19610309|NCT00568399|42059431|FG000|Overall Study|Adverse Event|5|||
19610310|NCT00568399|42059431|FG000|Overall Study|Withdrawal by Subject|8|||
19610311|NCT00975143|42059437|FG000|Overall Study|Adverse Event|19|||
19610312|NCT00975143|42059438|FG001|Overall Study|Adverse Event|15|||
19610313|NCT00975143|42059437|FG000|Overall Study|Withdrawal by Subject|15|||
19610314|NCT00975143|42059438|FG001|Overall Study|Withdrawal by Subject|15|||
19610315|NCT00975143|42059437|FG000|Overall Study|Lost to Follow-up|20|||
19610316|NCT00975143|42059438|FG001|Overall Study|Lost to Follow-up|16|||
19610317|NCT00975143|42059437|FG000|Overall Study|Non-compliance|5|||
19610318|NCT00975143|42059438|FG001|Overall Study|Non-compliance|8|||
19610319|NCT00975143|42059437|FG000|Overall Study|Physician Decision|1|||
19610320|NCT00975143|42059438|FG001|Overall Study|Physician Decision|2|||
19610321|NCT00975143|42059437|FG000|Overall Study|Details not available|10|||
19610322|NCT00975143|42059438|FG001|Overall Study|Details not available|4|||
19610323|NCT00974675|42059461|FG000|Overall Study|Adverse Event|2|||
19610324|NCT00974675|42059462|FG001|Overall Study|Adverse Event|1|||
19610325|NCT00974675|42059463|FG002|Overall Study|Adverse Event|1|||
19610326|NCT00974675|42059464|FG003|Overall Study|Adverse Event|1|||
19610327|NCT00974675|42059461|FG000|Overall Study|Physician Decision|0|||
19610328|NCT00974675|42059462|FG001|Overall Study|Physician Decision|0|||
19610329|NCT00974675|42059463|FG002|Overall Study|Physician Decision|1|||
19610330|NCT00974675|42059464|FG003|Overall Study|Physician Decision|0|||
19610331|NCT00974675|42059461|FG000|Overall Study|Participant on holiday; unable to attend|0|||
19610332|NCT00974675|42059462|FG001|Overall Study|Participant on holiday; unable to attend|0|||
19610333|NCT00974675|42059463|FG002|Overall Study|Participant on holiday; unable to attend|0|||
19610334|NCT00974675|42059464|FG003|Overall Study|Participant on holiday; unable to attend|1|||
19610335|NCT03657797|42059478|FG000|Overall Study|Lost to Follow-up|0|||
19610336|NCT03657797|42059479|FG001|Overall Study|Lost to Follow-up|1|||
19610337|NCT03657797|42059480|FG002|Overall Study|Lost to Follow-up|1|||
19610338|NCT03657797|42059481|FG003|Overall Study|Lost to Follow-up|0|||
19610339|NCT03657797|42059478|FG000|Overall Study|Physician Decision|0|||
19610340|NCT03657797|42059479|FG001|Overall Study|Physician Decision|1|||
19610341|NCT03657797|42059480|FG002|Overall Study|Physician Decision|0|||
19610342|NCT03657797|42059481|FG003|Overall Study|Physician Decision|0|||
19610343|NCT03657797|42059478|FG000|Overall Study|Withdrawal by Subject|0|||
19610344|NCT03657797|42059479|FG001|Overall Study|Withdrawal by Subject|1|||
19610345|NCT03657797|42059480|FG002|Overall Study|Withdrawal by Subject|2|||
19800733|NCT02840461|42259148|FG002|Overall Study|Lost to Follow-up|6|||
19701937|NCT03801928|42146380|FG002|Overall Study|Other|0|||
19701938|NCT03801928|42146381|FG003|Overall Study|Other|1|||
19701939|NCT03801928|42146382|FG004|Overall Study|Other|0|||
19701940|NCT03801928|42146383|FG005|Overall Study|Other|1|||
19701941|NCT00263588|42146402|FG000|Overall Study|Death|54|||
19701942|NCT00263588|42146403|FG001|Overall Study|Death|90|||
19701943|NCT00263588|42146402|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
19701944|NCT00263588|42146403|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
19610346|NCT03657797|42059481|FG003|Overall Study|Withdrawal by Subject|0|||
19610347|NCT03657797|42059478|FG000|Overall Study|Adverse Event|0|||
19701945|NCT00263588|42146402|FG000|Overall Study|Lost to Follow-up|7|||
19701946|NCT00263588|42146403|FG001|Overall Study|Lost to Follow-up|10|||
19701947|NCT00263588|42146402|FG000|Overall Study|Withdrawal by Subject|3|||
19701948|NCT00263588|42146403|FG001|Overall Study|Withdrawal by Subject|4|||
19701949|NCT00263588|42146402|FG000|Overall Study|Protocol Violation|0|||
19701950|NCT00263588|42146403|FG001|Overall Study|Protocol Violation|1|||
19701951|NCT00263588|42146402|FG000|Overall Study|Investigator decision|7|||
19701952|NCT00263588|42146403|FG001|Overall Study|Investigator decision|15|||
19701953|NCT00263588|42146402|FG000|Overall Study|Sponsor terminated study|0|||
19701954|NCT00263588|42146403|FG001|Overall Study|Sponsor terminated study|1|||
19701955|NCT00213135|42146413|FG000|Overall Study|Adverse Event|9|||
19701956|NCT00213135|42146414|FG001|Overall Study|Adverse Event|5|||
19701957|NCT00213135|42146415|FG002|Overall Study|Adverse Event|5|||
19800734|NCT02840461|42259146|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
19800735|NCT02840461|42259147|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
19610348|NCT03657797|42059479|FG001|Overall Study|Adverse Event|0|||
19610349|NCT03657797|42059480|FG002|Overall Study|Adverse Event|2|||
19610350|NCT03657797|42059481|FG003|Overall Study|Adverse Event|0|||
19610351|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
19610352|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
19610353|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
19800736|NCT02840461|42259148|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
19800737|NCT02840461|42259146|FG000|Overall Study|Protocol Violation|2|||
19800738|NCT02840461|42259147|FG001|Overall Study|Protocol Violation|3|||
19701958|NCT00213135|42146413|FG000|Overall Study|Lost to Follow-up|11|||
19701959|NCT00213135|42146414|FG001|Overall Study|Lost to Follow-up|8|||
19610354|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
19610355|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
19610356|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Death|1|||
19610357|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Death|0|||
19610358|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Death|0|||
19610359|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Death|0|||
19610360|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Death|0|||
19610361|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
19701960|NCT00213135|42146415|FG002|Overall Study|Lost to Follow-up|4|||
19701961|NCT00213135|42146413|FG000|Overall Study|Protocol Violation|4|||
19701962|NCT00213135|42146414|FG001|Overall Study|Protocol Violation|4|||
19701963|NCT00213135|42146415|FG002|Overall Study|Protocol Violation|10|||
19701964|NCT00213135|42146413|FG000|Overall Study|Death|1|||
19701965|NCT00213135|42146414|FG001|Overall Study|Death|1|||
19701966|NCT00213135|42146415|FG002|Overall Study|Death|2|||
19701967|NCT00213135|42146413|FG000|Overall Study|Disease progression|4|||
19701968|NCT00213135|42146414|FG001|Overall Study|Disease progression|5|||
19701969|NCT00213135|42146415|FG002|Overall Study|Disease progression|21|||
19701970|NCT00213135|42146413|FG000|Overall Study|Other|21|||
19701971|NCT00213135|42146414|FG001|Overall Study|Other|12|||
19701972|NCT00213135|42146415|FG002|Overall Study|Other|15|||
19701973|NCT00077974|42146423|FG000|Overall Study|Adverse Event|22|||
19701974|NCT00077974|42146423|FG000|Overall Study|Protocol Violation|1|||
19701975|NCT00077974|42146423|FG000|Overall Study|Withdrawal by Subject|3|||
19701976|NCT00077974|42146423|FG000|Overall Study|Lack of Efficacy|76|||
19701977|NCT00077974|42146423|FG000|Overall Study|Decision of Sponsor|2|||
19701978|NCT00124917|42146427|FG000|Overall Study|Physician Decision|3|||
19701979|NCT00141921|42146432|FG000|Overall Study|Remain on Study|28|||
19701980|NCT00141921|42146432|FG000|Overall Study|Withdrawal by Subject|42|||
19701981|NCT00141921|42146432|FG000|Overall Study|Lost to Follow-up|19|||
19701982|NCT00141921|42146432|FG000|Overall Study|Noncompliance|17|||
19701983|NCT00141921|42146432|FG000|Overall Study|Disease Progression|7|||
19701984|NCT00141921|42146432|FG000|Overall Study|Protocol Deviation|7|||
19701985|NCT00141921|42146432|FG000|Overall Study|Adverse Event|5|||
19701986|NCT00141921|42146432|FG000|Overall Study|Administrative Decision|2|||
19701987|NCT00141921|42146432|FG000|Overall Study|Pregnancy|4|||
19701988|NCT00141921|42146432|FG000|Overall Study|Ineligibility Determined|2|||
19701989|NCT00141921|42146432|FG000|Overall Study|Other|8|||
19701990|NCT00029146|42146438|FG000|Overall Study|Lost to Follow-up|2|||
19701991|NCT00029146|42146439|FG001|Overall Study|Lost to Follow-up|1|||
19701992|NCT00026494|42146449|FG000|Overall Study|Withdrawal by Subject|1|||
19701993|NCT00026494|42146450|FG001|Overall Study|Withdrawal by Subject|0|||
19701994|NCT00026494|42146451|FG002|Overall Study|Withdrawal by Subject|1|||
19701995|NCT00026494|42146452|FG003|Overall Study|Withdrawal by Subject|0|||
19701996|NCT00026494|42146449|FG000|Overall Study|Patient non-compliance|1|||
19701997|NCT00026494|42146450|FG001|Overall Study|Patient non-compliance|0|||
19701998|NCT00026494|42146451|FG002|Overall Study|Patient non-compliance|0|||
19701999|NCT00026494|42146452|FG003|Overall Study|Patient non-compliance|0|||
19702000|NCT00026494|42146449|FG000|Overall Study|Patient not treated|0|||
19702001|NCT00026494|42146450|FG001|Overall Study|Patient not treated|0|||
19702002|NCT00026494|42146451|FG002|Overall Study|Patient not treated|2|||
19702003|NCT00026494|42146452|FG003|Overall Study|Patient not treated|0|||
19702004|NCT00026494|42146449|FG000|Overall Study|Clinical progression|0|||
19702005|NCT00026494|42146450|FG001|Overall Study|Clinical progression|0|||
19702006|NCT00026494|42146451|FG002|Overall Study|Clinical progression|3|||
19702007|NCT00026494|42146452|FG003|Overall Study|Clinical progression|0|||
19702008|NCT00023764|42146462|FG000|Overall Study|Other|1|||
19800739|NCT02840461|42259148|FG002|Overall Study|Protocol Violation|1|||
19702009|NCT00023764|42146462|FG000|Overall Study|Adverse Event|4|||
19702010|NCT00023764|42146462|FG000|Overall Study|Withdrawal by Subject|1|||
19702011|NCT00023764|42146462|FG000|Overall Study|Progression of disease|6|||
19702012|NCT00023764|42146462|FG000|Overall Study|patient received other treatment|1|||
19702013|NCT00023764|42146462|FG000|Overall Study|delay in obtaining staging images|1|||
19702014|NCT00189488|42146469|FG000|Overall Study|Ineligibility determined|1|||
19702015|NCT00189488|42146470|FG001|Overall Study|Ineligibility determined|0|||
19702016|NCT00189488|42146469|FG000|Overall Study|Protocol deviation|2|||
19702017|NCT00189488|42146470|FG001|Overall Study|Protocol deviation|1|||
19702018|NCT00189488|42146469|FG000|Overall Study|Adverse Event|2|||
19702019|NCT00189488|42146470|FG001|Overall Study|Adverse Event|1|||
19702020|NCT00189488|42146469|FG000|Overall Study|Withdrawal by Subject|2|||
19702021|NCT00189488|42146470|FG001|Overall Study|Withdrawal by Subject|6|||
19702022|NCT00189488|42146469|FG000|Overall Study|Disease progression|2|||
19702023|NCT00189488|42146470|FG001|Overall Study|Disease progression|4|||
19702024|NCT00189488|42146469|FG000|Overall Study|Administrative Decision|0|||
19610362|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
19610363|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
19610364|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
19610365|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
19610366|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
19800740|NCT02840461|42259146|FG000|Overall Study|Withdrawal by Subject|10|||
19800741|NCT02840461|42259147|FG001|Overall Study|Withdrawal by Subject|6|||
19800742|NCT02840461|42259148|FG002|Overall Study|Withdrawal by Subject|2|||
19800743|NCT02840461|42259146|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
19800744|NCT02840461|42259147|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
19800745|NCT02840461|42259148|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
19800746|NCT02839681|42259157|FG000|Overall Study|Death|2|||
19800747|NCT01676012|42259161|FG000|Overall Study|Adverse Event|2|||
19800748|NCT01676012|42259161|FG000|Overall Study|incomplete set of videos|1|||
19800749|NCT02727777|42259168|FG000|Overall Study|Screen Failure|2|||
19800750|NCT02727777|42259169|FG001|Overall Study|Screen Failure|0|||
19800751|NCT02727777|42259170|FG002|Overall Study|Screen Failure|0|||
19800752|NCT02727777|42259168|FG000|Overall Study|Progressive disease|2|||
19800753|NCT02727777|42259169|FG001|Overall Study|Progressive disease|0|||
19800754|NCT02727777|42259170|FG002|Overall Study|Progressive disease|0|||
19800755|NCT00707577|42259180|FG000|Overall Study|Withdrawal by Subject|3|||
19800756|NCT00707577|42259181|FG001|Overall Study|Withdrawal by Subject|2|||
19800757|NCT00707577|42259180|FG000|Overall Study|Lost to Follow-up|34|||
19800758|NCT00707577|42259181|FG001|Overall Study|Lost to Follow-up|25|||
19800759|NCT00707577|42259180|FG000|Overall Study|Left employment|13|||
19800760|NCT00707577|42259181|FG001|Overall Study|Left employment|10|||
19800761|NCT00707577|42259180|FG000|Overall Study|Pregnancy|4|||
19800762|NCT00707577|42259181|FG001|Overall Study|Pregnancy|1|||
19800763|NCT01675622|42259189|FG000|Overall Study|Withdrawal by Subject|2|||
19800764|NCT01675622|42259190|FG001|Overall Study|Withdrawal by Subject|2|||
19800765|NCT01675622|42259189|FG000|Overall Study|Adverse Event|12|||
19800766|NCT01675622|42259190|FG001|Overall Study|Adverse Event|10|||
19800767|NCT01675622|42259189|FG000|Overall Study|Protocol Violation|4|||
19800768|NCT01675622|42259190|FG001|Overall Study|Protocol Violation|1|||
19800769|NCT01675622|42259189|FG000|Overall Study|Lack of Efficacy|2|||
19391163|NCT01959880|41635140|FG000|Overall Study|Study completed early-FDA approved|1003|||
19391164|NCT01959880|41635141|FG001|Overall Study|Study completed early-FDA approved|311|||
19391165|NCT01959880|41635142|FG002|Overall Study|Study completed early-FDA approved|179|||
19391166|NCT01959880|41635143|FG003|Overall Study|Study completed early-FDA approved|152|||
19391167|NCT01980628|41635153|FG000|Overall Study|Adverse Event|12|||
19391168|NCT01980628|41635153|FG000|Overall Study|Physician Decision|5|||
19391169|NCT01980628|41635153|FG000|Overall Study|Withdrawal by Subject|4|||
19391170|NCT01980628|41635153|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
19391171|NCT01979614|41635160|FG000|Overall Study|Adverse Event|1|||
19391172|NCT01979614|41635161|FG001|Overall Study|Adverse Event|1|||
19391173|NCT02654717|41635169|FG000|Overall Study|Adverse Event|2|||
19391174|NCT02654717|41635170|FG001|Overall Study|Adverse Event|2|||
19391175|NCT02654717|41635169|FG000|Overall Study|Protocol Violation|1|||
19391176|NCT02654717|41635170|FG001|Overall Study|Protocol Violation|2|||
19391177|NCT02654717|41635169|FG000|Overall Study|Withdrawal by Subject|0|||
19391178|NCT02654717|41635170|FG001|Overall Study|Withdrawal by Subject|1|||
19391179|NCT02654717|41635169|FG000|Overall Study|Non-permitted medication|3|||
19391180|NCT02654717|41635170|FG001|Overall Study|Non-permitted medication|0|||
19391181|NCT03343301|41635178|FG000|Overall Study|Withdrawal by Subject|1|||
19391182|NCT03343301|41635179|FG001|Overall Study|Withdrawal by Subject|1|||
19391183|NCT03343301|41635178|FG000|Overall Study|Death|0|||
19391184|NCT03343301|41635179|FG001|Overall Study|Death|2|||
19391185|NCT03343301|41635178|FG000|Overall Study|Other|0|||
19391186|NCT03343301|41635179|FG001|Overall Study|Other|6|||
19391187|NCT03343301|41635178|FG000|Overall Study|Missing|2|||
19391188|NCT03343301|41635179|FG001|Overall Study|Missing|0|||
19391189|NCT02696785|41635189|FG000|Blinded Treatment Period|Adverse Event|0|||
19391190|NCT02696785|41635190|FG001|Blinded Treatment Period|Adverse Event|1|||
19391191|NCT02696785|41635191|FG002|Blinded Treatment Period|Adverse Event|3|||
19391192|NCT02696785|41635192|FG003|Blinded Treatment Period|Adverse Event|0|||
19391193|NCT02696785|41635189|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
19391194|NCT02696785|41635190|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
19391195|NCT02696785|41635191|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
19391196|NCT02696785|41635192|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
19800770|NCT01675622|42259190|FG001|Overall Study|Lack of Efficacy|4|||
19800771|NCT01675622|42259189|FG000|Overall Study|Lost to Follow-up|1|||
19391197|NCT02696785|41635189|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
19391198|NCT02696785|41635190|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
19391199|NCT02696785|41635191|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
19391200|NCT02696785|41635192|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
19391201|NCT02696785|41635189|FG000|Blinded Treatment Period|Screen Failure|1|||
19478425|NCT01502371|41757693|FG001|Overall Study|Technical Problems|0|||
19800772|NCT01675622|42259190|FG001|Overall Study|Lost to Follow-up|3|||
19800773|NCT01675622|42259189|FG000|Overall Study|Other|5|||
19800774|NCT01675622|42259190|FG001|Overall Study|Other|4|||
19800775|NCT02655224|42259198|FG000|Overall Study|Adverse Event|1|||
19800776|NCT02655224|42259199|FG001|Overall Study|Adverse Event|1|||
19800777|NCT01675544|42259205|FG000|Overall Study|Withdrawal by Subject|2|||
19800778|NCT02838901|42259248|FG000|Overall Study|Withdrawal by Subject|1|||
19800779|NCT02838901|42259249|FG001|Overall Study|Withdrawal by Subject|1|||
19800780|NCT02838901|42259248|FG000|Overall Study|Lost to Follow-up|1|||
19800781|NCT02838901|42259249|FG001|Overall Study|Lost to Follow-up|1|||
19800782|NCT00706797|42259277|FG000|Overall Study|Lack of Efficacy|3|||
19800783|NCT00706797|42259278|FG001|Overall Study|Lack of Efficacy|0|||
19800784|NCT00706797|42259277|FG000|Overall Study|Adverse Event|0|||
19800785|NCT00706797|42259278|FG001|Overall Study|Adverse Event|3|||
19800786|NCT00706797|42259277|FG000|Overall Study|Withdrawal by Subject|8|||
19800787|NCT00706797|42259278|FG001|Overall Study|Withdrawal by Subject|1|||
19800788|NCT00706797|42259277|FG000|Overall Study|Death|1|||
19800789|NCT00706797|42259278|FG001|Overall Study|Death|0|||
19800790|NCT00706797|42259277|FG000|Overall Study|Discontinuation of study by sponsor|52|||
19800791|NCT00706797|42259278|FG001|Overall Study|Discontinuation of study by sponsor|63|||
19610367|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
19610368|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
19610369|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
19610370|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
19610371|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
19610372|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
19610373|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
19800792|NCT00706797|42259277|FG000|Overall Study|Protocol Violation|3|||
19800793|NCT00706797|42259278|FG001|Overall Study|Protocol Violation|2|||
19800794|NCT00706797|42259277|FG000|Overall Study|Lost to Follow-up|1|||
19391202|NCT02696785|41635190|FG001|Blinded Treatment Period|Screen Failure|0|||
19391203|NCT02696785|41635191|FG002|Blinded Treatment Period|Screen Failure|0|||
19702025|NCT00189488|42146470|FG001|Overall Study|Administrative Decision|2|||
19702026|NCT00189488|42146469|FG000|Overall Study|Death|5|||
19702027|NCT00189488|42146470|FG001|Overall Study|Death|8|||
19702028|NCT00189488|42146469|FG000|Overall Study|Other|1|||
19702029|NCT00189488|42146470|FG001|Overall Study|Other|0|||
19702030|NCT00233402|42146479|FG000|Overall Study|No pathology data|12|||
19702031|NCT00233402|42146480|FG001|Overall Study|No pathology data|9|||
19702032|NCT00233402|42146479|FG000|Overall Study|No Ta/T1|89|||
19702033|NCT00233402|42146480|FG001|Overall Study|No Ta/T1|94|||
19702034|NCT00233402|42146479|FG000|Overall Study|Lost to follow up etc|3|||
19702035|NCT00233402|42146480|FG001|Overall Study|Lost to follow up etc|21|||
19702036|NCT00233324|42146492|FG000|Main Study|Death|68|||
19610374|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
19610375|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
19610376|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
19610377|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
19610378|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
19610379|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
19610380|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
19610381|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
19702037|NCT00233324|42146493|FG001|Main Study|Death|60|||
19702038|NCT00233324|42146494|FG002|Main Study|Death|62|||
19702039|NCT00233324|42146495|FG003|Main Study|Death|47|||
19702040|NCT00233324|42146492|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
19702041|NCT00233324|42146493|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
19702042|NCT00233324|42146494|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
19702043|NCT00233324|42146495|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
19702044|NCT00233324|42146492|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
19610382|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
19610383|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
19702045|NCT00233324|42146493|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
19702046|NCT00233324|42146494|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
19702047|NCT00233324|42146495|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
19800795|NCT00706797|42259278|FG001|Overall Study|Lost to Follow-up|2|||
19800796|NCT00706797|42259277|FG000|Overall Study|Other|1|||
19800797|NCT00706797|42259278|FG001|Overall Study|Other|0|||
19800798|NCT00706641|42259284|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
19800799|NCT00706641|42259284|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
19800800|NCT00706641|42259284|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
19800801|NCT01362530|42259290|FG000|Base Study (Cycle 1)|Adverse Event|2|||
19800802|NCT01362530|42259291|FG001|Base Study (Cycle 1)|Adverse Event|0|||
19800803|NCT01362530|42259290|FG000|Base Study (Cycle 1)|Physician Decision|0|||
19800804|NCT01362530|42259291|FG001|Base Study (Cycle 1)|Physician Decision|1|||
19800805|NCT01362530|42259290|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
19702048|NCT00023452|42146514|FG000|Overall Study|Ineligible for Study|163|||
19702049|NCT00023452|42146515|FG001|Overall Study|Ineligible for Study|159|||
19702050|NCT00023452|42146514|FG000|Overall Study|Out of Window|129|||
19702051|NCT00023452|42146515|FG001|Overall Study|Out of Window|69|||
19702052|NCT00023452|42146514|FG000|Overall Study|Death|2|||
19702053|NCT00023452|42146515|FG001|Overall Study|Death|0|||
19702054|NCT00023452|42146514|FG000|Overall Study|Withdrawal by Subject|66|||
19702055|NCT00023452|42146515|FG001|Overall Study|Withdrawal by Subject|54|||
19702056|NCT00023452|42146514|FG000|Overall Study|Adverse Event|139|||
19702057|NCT00023452|42146515|FG001|Overall Study|Adverse Event|196|||
19702058|NCT00023452|42146514|FG000|Overall Study|Lost to Follow-up|293|||
19702059|NCT00023452|42146515|FG001|Overall Study|Lost to Follow-up|60|||
19702060|NCT00023452|42146514|FG000|Overall Study|Physician Decision|49|||
19702061|NCT00023452|42146515|FG001|Overall Study|Physician Decision|21|||
19702062|NCT00023452|42146514|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
19702063|NCT00023452|42146515|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
19702064|NCT00023452|42146514|FG000|Overall Study|Pregnant|53|||
19702065|NCT00023452|42146515|FG001|Overall Study|Pregnant|20|||
19702066|NCT00023452|42146514|FG000|Overall Study|Other|204|||
19702067|NCT00023452|42146515|FG001|Overall Study|Other|69|||
19702068|NCT00022672|42146527|FG000|Main Phase: 24 Months|Adverse Event|6|||
19702069|NCT00022672|42146528|FG001|Main Phase: 24 Months|Adverse Event|0|||
19702070|NCT00022672|42146527|FG000|Main Phase: 24 Months|Death|0|||
19702071|NCT00022672|42146528|FG001|Main Phase: 24 Months|Death|3|||
19702072|NCT00022672|42146527|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
19702073|NCT00022672|42146528|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
19702074|NCT00022672|42146527|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
19702075|NCT00022672|42146528|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
19702076|NCT00022672|42146527|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
19702077|NCT00022672|42146528|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
19702078|NCT00022672|42146527|FG000|Main Phase: 24 Months|Refused Treatment|3|||
19702079|NCT00022672|42146528|FG001|Main Phase: 24 Months|Refused Treatment|4|||
19702080|NCT00022672|42146527|FG000|Main Phase: 24 Months|Failure to Return|1|||
19702081|NCT00022672|42146528|FG001|Main Phase: 24 Months|Failure to Return|1|||
19702082|NCT00022672|42146527|FG000|Main Phase: 24 Months|Other|1|||
19702083|NCT00022672|42146528|FG001|Main Phase: 24 Months|Other|0|||
19702084|NCT00022672|42146527|FG000|Extension Phase|Adverse Event|1|||
19702085|NCT00022672|42146528|FG001|Extension Phase|Adverse Event|3|||
19702086|NCT00022672|42146527|FG000|Extension Phase|Death|0|||
19702087|NCT00022672|42146528|FG001|Extension Phase|Death|1|||
19702088|NCT00022672|42146527|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
19702089|NCT00022672|42146528|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
19702090|NCT00022672|42146527|FG000|Extension Phase|Refused Treatment|0|||
19702091|NCT00022672|42146528|FG001|Extension Phase|Refused Treatment|2|||
19702092|NCT00022672|42146527|FG000|Extension Phase|Other|1|||
19702093|NCT00022672|42146528|FG001|Extension Phase|Other|1|||
19702094|NCT00076804|42146537|FG000|Overall Study|Death|9|||
19702095|NCT00076804|42146538|FG001|Overall Study|Death|20|||
19702096|NCT00076804|42146537|FG000|Overall Study|Lost to Follow-up|9|||
19702097|NCT00076804|42146538|FG001|Overall Study|Lost to Follow-up|9|||
19702098|NCT00076804|42146537|FG000|Overall Study|Withdrawal by Subject|10|||
19702099|NCT00076804|42146538|FG001|Overall Study|Withdrawal by Subject|8|||
19702100|NCT00076804|42146537|FG000|Overall Study|Early study Closure|32|||
19702101|NCT00076804|42146538|FG001|Overall Study|Early study Closure|32|||
19702102|NCT00141453|42146546|FG000|Overall Study|Protocol Violation|6|||
19702103|NCT00141453|42146547|FG001|Overall Study|Protocol Violation|5|||
19702104|NCT00076570|42146555|FG000|Overall Study|Drug intolerance|8|||
19702105|NCT00076570|42146556|FG001|Overall Study|Drug intolerance|8|||
19702106|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
19702107|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
19702108|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
19702109|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
19702110|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
19702111|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
19702112|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
19702113|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
19373635|NCT02760407|41614836|FG003|Overall Study|Inadequately Enrolled|1|||
19702114|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
19702115|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
19702116|NCT00124449|42146564|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
19702117|NCT00124449|42146565|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
19702118|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
19702119|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
19702120|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
19800806|NCT01362530|42259291|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
19702121|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
19702122|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
19702123|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
19702124|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
19702125|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
19702126|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
19702127|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
19702128|NCT00124449|42146564|FG000|18-Month Untreated Observation Period|Relocated|1|||
19702129|NCT00124449|42146565|FG001|18-Month Untreated Observation Period|Relocated|0|||
19702130|NCT00076336|42146574|FG000|Overall Study|Death|13|||
19702131|NCT00076336|42146575|FG001|Overall Study|Death|17|||
19800807|NCT01362530|42259290|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
19800808|NCT01362530|42259291|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
19800809|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
19800810|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
19800811|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
19800812|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
19800813|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
19800814|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
19800815|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
19800816|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
19391204|NCT02696785|41635192|FG003|Blinded Treatment Period|Screen Failure|0|||
19391205|NCT02696785|41635189|FG000|Washout Period|Withdrawal by Subject|0|||
19391206|NCT02696785|41635190|FG001|Washout Period|Withdrawal by Subject|1|||
19391207|NCT02696785|41635191|FG002|Washout Period|Withdrawal by Subject|0|||
19391208|NCT02696785|41635192|FG003|Washout Period|Withdrawal by Subject|0|||
19610384|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
19610385|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
19610386|NCT00634933|42059498|FG000|Part A: Baseline to Week 24|Other|1|||
19610387|NCT00634933|42059499|FG001|Part A: Baseline to Week 24|Other|8|||
19391209|NCT02696785|41635189|FG000|Washout Period|Lack of Efficacy|0|||
19391210|NCT02696785|41635190|FG001|Washout Period|Lack of Efficacy|1|||
19391211|NCT02696785|41635191|FG002|Washout Period|Lack of Efficacy|0|||
19391212|NCT02696785|41635192|FG003|Washout Period|Lack of Efficacy|0|||
19391213|NCT02696785|41635189|FG000|Extended Treatment Period|Adverse Event|2|||
19391214|NCT02696785|41635190|FG001|Extended Treatment Period|Adverse Event|3|||
19391215|NCT02696785|41635191|FG002|Extended Treatment Period|Adverse Event|2|||
19391216|NCT02696785|41635192|FG003|Extended Treatment Period|Adverse Event|1|||
19391217|NCT02696785|41635189|FG000|Extended Treatment Period|Lack of Efficacy|0|||
19391218|NCT02696785|41635190|FG001|Extended Treatment Period|Lack of Efficacy|1|||
19391219|NCT02696785|41635191|FG002|Extended Treatment Period|Lack of Efficacy|0|||
19391220|NCT02696785|41635192|FG003|Extended Treatment Period|Lack of Efficacy|0|||
19391221|NCT02696785|41635189|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
19391222|NCT02696785|41635190|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
19391223|NCT02696785|41635191|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
19391224|NCT02696785|41635192|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
19610388|NCT00634933|42059500|FG002|Part A: Baseline to Week 24|Other|5|||
19610389|NCT00634933|42059501|FG003|Part A: Baseline to Week 24|Other|0|||
19391225|NCT02696785|41635189|FG000|Follow-up Period|Adverse Event|0|||
19478426|NCT01502371|41757694|FG002|Overall Study|Technical Problems|2|||
19610390|NCT00634933|42059502|FG004|Part A: Baseline to Week 24|Other|0|||
19610391|NCT00634933|42059498|FG000|Between Part A and Part B|Physician Decision|0|||
19610392|NCT00634933|42059499|FG001|Between Part A and Part B|Physician Decision|1|||
19610393|NCT00634933|42059500|FG002|Between Part A and Part B|Physician Decision|0|||
19610394|NCT00634933|42059501|FG003|Between Part A and Part B|Physician Decision|0|||
19610395|NCT00634933|42059502|FG004|Between Part A and Part B|Physician Decision|0|||
19610396|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
19610397|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
19610398|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
19610399|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
19610400|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
19610401|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
19610402|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
19610403|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
19702132|NCT00076336|42146574|FG000|Overall Study|Adverse Event|4|||
19702133|NCT00076336|42146575|FG001|Overall Study|Adverse Event|4|||
19610404|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
19391226|NCT02696785|41635190|FG001|Follow-up Period|Adverse Event|0|||
19391227|NCT02696785|41635191|FG002|Follow-up Period|Adverse Event|8|||
19391228|NCT02696785|41635192|FG003|Follow-up Period|Adverse Event|2|||
19391229|NCT02696785|41635189|FG000|Follow-up Period|Lost to Follow-up|0|||
19702134|NCT00076336|42146574|FG000|Overall Study|Lost to Follow-up|4|||
19702135|NCT00076336|42146575|FG001|Overall Study|Lost to Follow-up|4|||
19702136|NCT00076336|42146574|FG000|Overall Study|Non-Compliance|2|||
19702137|NCT00076336|42146575|FG001|Overall Study|Non-Compliance|0|||
19702138|NCT00076336|42146574|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
19702139|NCT00076336|42146575|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
19702140|NCT00076336|42146574|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
19702141|NCT00076336|42146575|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
19702142|NCT00076336|42146574|FG000|Overall Study|Liver Transplantation|3|||
19702143|NCT00076336|42146575|FG001|Overall Study|Liver Transplantation|3|||
19702144|NCT00076336|42146574|FG000|Overall Study|Virologic Breakthrough|14|||
19702145|NCT00076336|42146575|FG001|Overall Study|Virologic Breakthrough|16|||
19702146|NCT00076336|42146574|FG000|Overall Study|Treatment failure|4|||
19702147|NCT00076336|42146575|FG001|Overall Study|Treatment failure|5|||
19702148|NCT00185588|42146585|FG000|Overall Study|Adverse Event|3|||
19702149|NCT00185588|42146586|FG001|Overall Study|Adverse Event|1|||
19702150|NCT00185588|42146587|FG002|Overall Study|Adverse Event|4|||
19702151|NCT00185588|42146588|FG003|Overall Study|Adverse Event|2|||
19702152|NCT00185588|42146585|FG000|Overall Study|Lost to Follow-up|0|||
19702153|NCT00185588|42146586|FG001|Overall Study|Lost to Follow-up|0|||
19702154|NCT00185588|42146587|FG002|Overall Study|Lost to Follow-up|1|||
19702155|NCT00185588|42146588|FG003|Overall Study|Lost to Follow-up|2|||
19702156|NCT00185588|42146585|FG000|Overall Study|Withdrawal by Subject|0|||
19702157|NCT00185588|42146586|FG001|Overall Study|Withdrawal by Subject|1|||
19702158|NCT00185588|42146587|FG002|Overall Study|Withdrawal by Subject|0|||
19702159|NCT00185588|42146588|FG003|Overall Study|Withdrawal by Subject|0|||
19702160|NCT00185588|42146585|FG000|Overall Study|Physician Decision|0|||
19702161|NCT00185588|42146586|FG001|Overall Study|Physician Decision|0|||
19702162|NCT00185588|42146587|FG002|Overall Study|Physician Decision|1|||
19702163|NCT00185588|42146588|FG003|Overall Study|Physician Decision|0|||
19610405|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
19610406|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
19610407|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
19610408|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
19702164|NCT00232544|42146600|FG000|Overall Study|Lost to Follow-up|20|||
19702165|NCT00232544|42146601|FG001|Overall Study|Lost to Follow-up|15|||
19702166|NCT00231842|42146607|FG000|Overall Study|Withdrawal by Subject|3|||
19391230|NCT02696785|41635190|FG001|Follow-up Period|Lost to Follow-up|0|||
19391231|NCT02696785|41635191|FG002|Follow-up Period|Lost to Follow-up|0|||
19391232|NCT02696785|41635192|FG003|Follow-up Period|Lost to Follow-up|1|||
19391233|NCT02696785|41635189|FG000|Follow-up Period|Lack of Efficacy|0|||
19391234|NCT02696785|41635190|FG001|Follow-up Period|Lack of Efficacy|0|||
19391235|NCT02696785|41635191|FG002|Follow-up Period|Lack of Efficacy|0|||
19391236|NCT02696785|41635192|FG003|Follow-up Period|Lack of Efficacy|1|||
19391237|NCT02696785|41635189|FG000|Follow-up Period|Withdrawal by Subject|1|||
19391238|NCT02696785|41635190|FG001|Follow-up Period|Withdrawal by Subject|0|||
19610409|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
19610410|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
19391239|NCT02696785|41635191|FG002|Follow-up Period|Withdrawal by Subject|5|||
19391240|NCT02696785|41635192|FG003|Follow-up Period|Withdrawal by Subject|4|||
19391241|NCT02004262|41635226|FG000|Overall Study|Death|67|||
19391242|NCT02004262|41635227|FG001|Overall Study|Death|64|||
19391243|NCT02004262|41635228|FG002|Overall Study|Death|66|||
19391244|NCT02004262|41635229|FG003|Overall Study|Death|28|||
19391245|NCT02004262|41635230|FG004|Overall Study|Death|29|||
19391246|NCT02004262|41635231|FG005|Overall Study|Death|22|||
19391247|NCT02004262|41635226|FG000|Overall Study|Withdrawal by Subject|1|||
19391248|NCT02004262|41635227|FG001|Overall Study|Withdrawal by Subject|0|||
19391249|NCT02004262|41635228|FG002|Overall Study|Withdrawal by Subject|4|||
19391250|NCT02004262|41635229|FG003|Overall Study|Withdrawal by Subject|0|||
19391251|NCT02004262|41635230|FG004|Overall Study|Withdrawal by Subject|1|||
19610411|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
19610412|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
19610413|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
19610414|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
19610415|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
19610416|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
19702167|NCT00231842|42146607|FG000|Overall Study|Did not complete the last 3 cycle|8|||
19702168|NCT00076102|42146612|FG000|Overall Study|Clinical progression|1|||
19702169|NCT00076102|42146612|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
19391252|NCT02004262|41635231|FG005|Overall Study|Withdrawal by Subject|3|||
19391253|NCT02004262|41635226|FG000|Overall Study|Lost to Follow-up|1|||
19391254|NCT02004262|41635227|FG001|Overall Study|Lost to Follow-up|1|||
19391255|NCT02004262|41635228|FG002|Overall Study|Lost to Follow-up|0|||
19391256|NCT02004262|41635229|FG003|Overall Study|Lost to Follow-up|0|||
19391257|NCT02004262|41635230|FG004|Overall Study|Lost to Follow-up|0|||
19610417|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
19610418|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
19702170|NCT00076102|42146612|FG000|Overall Study|plexiform neurofibroma surgery|1|||
19702171|NCT00076102|42146612|FG000|Overall Study|refusal of further therapy|2|||
19610419|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
19610420|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
19610421|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
19610422|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
19610423|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
19610424|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
19610425|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
19610426|NCT00634933|42059498|FG000|Part B: Week 24 to Week 52|Other|0|||
19610427|NCT00634933|42059499|FG001|Part B: Week 24 to Week 52|Other|0|||
19610428|NCT00634933|42059500|FG002|Part B: Week 24 to Week 52|Other|5|||
19702172|NCT00231062|42146626|FG000|Overall Study|Physician Decision|6|||
19702173|NCT00184028|42146630|FG000|Overall Study|Death|1|||
19702174|NCT00184028|42146630|FG000|Overall Study|Lack of Efficacy|4|||
19702175|NCT00184028|42146630|FG000|Overall Study|Adverse Event|2|||
19702176|NCT00184028|42146630|FG000|Overall Study|Withdrawal by Subject|1|||
19702177|NCT00184028|42146630|FG000|Overall Study|Non-compliance|2|||
19610429|NCT00634933|42059501|FG003|Part B: Week 24 to Week 52|Other|0|||
19610430|NCT00634933|42059502|FG004|Part B: Week 24 to Week 52|Other|1|||
19610431|NCT00967499|42059516|FG000|Overall Study|Adverse Event|0|||
19610432|NCT00967499|42059517|FG001|Overall Study|Adverse Event|1|||
19610433|NCT00967499|42059516|FG000|Overall Study|Protocol Violation|1|||
19702178|NCT00183872|42146635|FG000|Overall Study|Death|3|||
19702179|NCT00183872|42146635|FG000|Overall Study|Adverse Event|9|||
19702180|NCT00183872|42146635|FG000|Overall Study|Withdrawal by Subject|2|||
19702181|NCT00183872|42146635|FG000|Overall Study|Drug delayed more than 28 days|2|||
19702182|NCT03815175|42146639|FG000|Overall Study|Subject Lost to Follow-up|6|||
19702183|NCT03815175|42146639|FG000|Overall Study|Subject Withdrew Consent|48|||
19702184|NCT03815175|42146639|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
19702185|NCT03815175|42146639|FG000|Overall Study|Death|86|||
19702186|NCT03815175|42146639|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
19702187|NCT03815175|42146639|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
19702188|NCT03815175|42146639|FG000|Overall Study|Other Status Change Reason|1|||
19702189|NCT03815175|42146639|FG000|Overall Study|Missed Visit|12|||
19702190|NCT00262028|42146652|FG000|Overall Study|Withdrawal by Subject|6|||
19702191|NCT00262028|42146653|FG001|Overall Study|Withdrawal by Subject|3|||
19702192|NCT00262028|42146654|FG002|Overall Study|Withdrawal by Subject|6|||
19702193|NCT00262028|42146655|FG003|Overall Study|Withdrawal by Subject|5|||
19702194|NCT00262028|42146656|FG004|Overall Study|Withdrawal by Subject|2|||
19702195|NCT00262028|42146657|FG005|Overall Study|Withdrawal by Subject|3|||
19702196|NCT00262028|42146658|FG006|Overall Study|Withdrawal by Subject|5|||
19702197|NCT00262028|42146659|FG007|Overall Study|Withdrawal by Subject|7|||
19702198|NCT00262028|42146660|FG008|Overall Study|Withdrawal by Subject|2|||
19702199|NCT00262028|42146652|FG000|Overall Study|Lost to Follow-up|7|||
19702200|NCT00262028|42146653|FG001|Overall Study|Lost to Follow-up|7|||
19702201|NCT00262028|42146654|FG002|Overall Study|Lost to Follow-up|5|||
19702202|NCT00262028|42146655|FG003|Overall Study|Lost to Follow-up|5|||
19702203|NCT00262028|42146656|FG004|Overall Study|Lost to Follow-up|4|||
19702204|NCT00262028|42146657|FG005|Overall Study|Lost to Follow-up|3|||
19702205|NCT00262028|42146658|FG006|Overall Study|Lost to Follow-up|3|||
19702206|NCT00262028|42146659|FG007|Overall Study|Lost to Follow-up|5|||
19702207|NCT00262028|42146660|FG008|Overall Study|Lost to Follow-up|6|||
19702208|NCT00262028|42146652|FG000|Overall Study|Administrative Reason|11|||
19702209|NCT00262028|42146653|FG001|Overall Study|Administrative Reason|14|||
19702210|NCT00262028|42146654|FG002|Overall Study|Administrative Reason|9|||
19702211|NCT00262028|42146655|FG003|Overall Study|Administrative Reason|12|||
19702212|NCT00262028|42146656|FG004|Overall Study|Administrative Reason|6|||
19702213|NCT00262028|42146657|FG005|Overall Study|Administrative Reason|7|||
19702214|NCT00262028|42146658|FG006|Overall Study|Administrative Reason|4|||
19702215|NCT00262028|42146659|FG007|Overall Study|Administrative Reason|6|||
19702216|NCT00262028|42146660|FG008|Overall Study|Administrative Reason|10|||
19702217|NCT00262028|42146652|FG000|Overall Study|Protocol Violation|0|||
19702218|NCT00262028|42146653|FG001|Overall Study|Protocol Violation|0|||
19702219|NCT00262028|42146654|FG002|Overall Study|Protocol Violation|0|||
19702220|NCT00262028|42146655|FG003|Overall Study|Protocol Violation|1|||
19702221|NCT00262028|42146656|FG004|Overall Study|Protocol Violation|0|||
19702222|NCT00262028|42146657|FG005|Overall Study|Protocol Violation|0|||
19702223|NCT00262028|42146658|FG006|Overall Study|Protocol Violation|0|||
19702224|NCT00262028|42146659|FG007|Overall Study|Protocol Violation|0|||
19702225|NCT00262028|42146660|FG008|Overall Study|Protocol Violation|0|||
19610434|NCT00967499|42059517|FG001|Overall Study|Protocol Violation|0|||
19610435|NCT00967499|42059516|FG000|Overall Study|Sponsor Decision|1|||
19702226|NCT00262028|42146652|FG000|Overall Study|Unable to classify|0|||
19702227|NCT00262028|42146653|FG001|Overall Study|Unable to classify|3|||
19800817|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
19800818|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
19800819|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
19800820|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
19800821|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
19800822|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
19800823|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
19800824|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
19800825|NCT01362530|42259290|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
19800826|NCT01362530|42259291|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
19800827|NCT02654054|42259301|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
19800828|NCT02654054|42259302|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
19800829|NCT02654054|42259303|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
19800830|NCT02654054|42259301|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
19800831|NCT02654054|42259302|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
19800832|NCT02654054|42259303|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
19800833|NCT02654054|42259301|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
19800834|NCT02654054|42259302|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
19800835|NCT02654054|42259303|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
19800836|NCT02654054|42259301|FG000|Post-Treatment Follow-Up Period|Other|1|||
19800837|NCT02654054|42259302|FG001|Post-Treatment Follow-Up Period|Other|0|||
19800838|NCT02654054|42259303|FG002|Post-Treatment Follow-Up Period|Other|4|||
19800839|NCT02654054|42259301|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
19800840|NCT02654054|42259302|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
19800841|NCT02654054|42259303|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
19800842|NCT02653664|42259324|FG000|Post-Treatment|Withdrawal by Subject|6|||
19800843|NCT02653664|42259325|FG001|Post-Treatment|Withdrawal by Subject|5|||
19800844|NCT02653664|42259326|FG002|Post-Treatment|Withdrawal by Subject|7|||
19800845|NCT02653664|42259324|FG000|Post-Treatment|Lost to Follow-up|8|||
19800846|NCT02653664|42259325|FG001|Post-Treatment|Lost to Follow-up|1|||
19800847|NCT02653664|42259326|FG002|Post-Treatment|Lost to Follow-up|7|||
19800848|NCT02653664|42259324|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
19800849|NCT02653664|42259325|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
19800850|NCT02653664|42259326|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
19800851|NCT02653664|42259324|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
19800852|NCT02653664|42259325|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
19800853|NCT02653664|42259326|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
19800854|NCT02653664|42259324|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
19800855|NCT02653664|42259325|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
19800856|NCT02653664|42259326|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
19800857|NCT02653664|42259324|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
19800858|NCT02653664|42259325|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
19800859|NCT02653664|42259326|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
19800860|NCT02653664|42259324|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
19800861|NCT02653664|42259325|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
19800862|NCT02653664|42259326|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
19800863|NCT02653664|42259324|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
19800864|NCT02653664|42259325|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
19610436|NCT00967499|42059517|FG001|Overall Study|Sponsor Decision|0|||
19610437|NCT00967499|42059516|FG000|Overall Study|Randomized but not treated|63|||
19610438|NCT00967499|42059517|FG001|Overall Study|Randomized but not treated|59|||
19610439|NCT03909971|42059525|FG000|Overall Study|Other Reasons Not Specified|0|||
19610440|NCT03909971|42059526|FG001|Overall Study|Other Reasons Not Specified|1|||
19610441|NCT03909971|42059525|FG000|Overall Study|Global Deterioration of Health Status|2|||
19610442|NCT03909971|42059526|FG001|Overall Study|Global Deterioration of Health Status|1|||
19610443|NCT03909971|42059525|FG000|Overall Study|Progressive Disease|6|||
19610444|NCT03909971|42059526|FG001|Overall Study|Progressive Disease|14|||
19610445|NCT03909971|42059525|FG000|Overall Study|Death|2|||
19610446|NCT03909971|42059526|FG001|Overall Study|Death|6|||
19610447|NCT00626275|42059533|FG000|Part A - Treatment Period 1|Adverse Event|1|||
19610448|NCT00626275|42059534|FG001|Part A - Treatment Period 1|Adverse Event|0|||
19610449|NCT00626275|42059535|FG002|Part A - Treatment Period 1|Adverse Event|0|||
19610450|NCT00626275|42059536|FG003|Part A - Treatment Period 1|Adverse Event|0|||
19610451|NCT00626275|42059537|FG004|Part A - Treatment Period 1|Adverse Event|0|||
19610452|NCT00626275|42059538|FG005|Part A - Treatment Period 1|Adverse Event|0|||
19610453|NCT00626275|42059539|FG006|Part A - Treatment Period 1|Adverse Event|0|||
19610454|NCT00626275|42059540|FG007|Part A - Treatment Period 1|Adverse Event|0|||
19610455|NCT00626275|42059533|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610456|NCT00626275|42059534|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610457|NCT00626275|42059535|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
19702228|NCT00262028|42146654|FG002|Overall Study|Unable to classify|0|||
19702229|NCT00262028|42146655|FG003|Overall Study|Unable to classify|0|||
19702230|NCT00262028|42146656|FG004|Overall Study|Unable to classify|0|||
19702231|NCT00262028|42146657|FG005|Overall Study|Unable to classify|0|||
19702232|NCT00262028|42146658|FG006|Overall Study|Unable to classify|0|||
19702233|NCT00262028|42146659|FG007|Overall Study|Unable to classify|0|||
19702234|NCT00262028|42146660|FG008|Overall Study|Unable to classify|1|||
19702235|NCT00183248|42146704|FG000|Overall Study|Lost to Follow-up|0|||
19702236|NCT00183248|42146705|FG001|Overall Study|Lost to Follow-up|1|||
19702237|NCT00183248|42146704|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
19702238|NCT00183248|42146705|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
19702239|NCT00183170|42146713|FG000|First Intervention|Did not complete study|1|||
19702240|NCT00183170|42146714|FG001|First Intervention|Did not complete study|0|||
19702241|NCT00183170|42146713|FG000|First Intervention|Did not meet targeted BrAC|1|||
19702242|NCT00183170|42146714|FG001|First Intervention|Did not meet targeted BrAC|0|||
19702243|NCT00183170|42146713|FG000|Washout 1 Week|Did not complete study|6|||
19391258|NCT02004262|41635231|FG005|Overall Study|Lost to Follow-up|0|||
19391259|NCT02004262|41635226|FG000|Overall Study|Study Terminated by Sponsor|4|||
19391260|NCT02004262|41635227|FG001|Overall Study|Study Terminated by Sponsor|3|||
19391261|NCT02004262|41635228|FG002|Overall Study|Study Terminated by Sponsor|2|||
19391262|NCT02004262|41635229|FG003|Overall Study|Study Terminated by Sponsor|1|||
19391263|NCT02004262|41635230|FG004|Overall Study|Study Terminated by Sponsor|1|||
19391264|NCT02004262|41635231|FG005|Overall Study|Study Terminated by Sponsor|5|||
19391265|NCT01675427|41635245|FG000|Overall Study|Withdrawal by Subject|7|||
19391266|NCT01675427|41635245|FG000|Overall Study|Participant Refused Sample Collection|18|||
19391267|NCT01675427|41635245|FG000|Overall Study|Sample not Collected by Mistake|2|||
19391268|NCT01675427|41635245|FG000|Overall Study|Lost to Follow-up|5|||
19391269|NCT01675427|41635245|FG000|Overall Study|Other|2|||
19391270|NCT01978912|41635283|FG000|Overall Study|Adverse Event|0|||
19391271|NCT01978912|41635284|FG001|Overall Study|Adverse Event|1|||
19391272|NCT01978912|41635285|FG002|Overall Study|Adverse Event|0|||
19391273|NCT01978912|41635286|FG003|Overall Study|Adverse Event|0|||
19391274|NCT01978912|41635283|FG000|Overall Study|Lost to Follow-up|1|||
19391275|NCT01978912|41635284|FG001|Overall Study|Lost to Follow-up|1|||
19391276|NCT01978912|41635285|FG002|Overall Study|Lost to Follow-up|0|||
19391277|NCT01978912|41635286|FG003|Overall Study|Lost to Follow-up|1|||
19391278|NCT01978912|41635283|FG000|Overall Study|Withdrawal by Subject|1|||
19391279|NCT01978912|41635284|FG001|Overall Study|Withdrawal by Subject|0|||
19391280|NCT01978912|41635285|FG002|Overall Study|Withdrawal by Subject|2|||
19391281|NCT01978912|41635286|FG003|Overall Study|Withdrawal by Subject|2|||
19391282|NCT01978912|41635283|FG000|Overall Study|Lumbar Surgery|1|||
19391283|NCT01978912|41635284|FG001|Overall Study|Lumbar Surgery|0|||
19391284|NCT01978912|41635285|FG002|Overall Study|Lumbar Surgery|1|||
19391285|NCT01978912|41635286|FG003|Overall Study|Lumbar Surgery|0|||
19391286|NCT01978912|41635283|FG000|Overall Study|Intradiscal Steroid Injection|0|||
19391287|NCT01978912|41635284|FG001|Overall Study|Intradiscal Steroid Injection|1|||
19391288|NCT01978912|41635285|FG002|Overall Study|Intradiscal Steroid Injection|0|||
19391289|NCT01978912|41635286|FG003|Overall Study|Intradiscal Steroid Injection|0|||
19391290|NCT01977898|41635298|FG000|Overall Study|Non functioning catheter|1|||
19391291|NCT01977898|41635299|FG001|Overall Study|Non functioning catheter|1|||
19391292|NCT02003638|41635307|FG000|Overall Study|Withdrawal by Subject|1|||
19391293|NCT02003638|41635308|FG001|Overall Study|Withdrawal by Subject|0|||
19391294|NCT02696317|41635314|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
19391295|NCT02696317|41635315|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
19391296|NCT02696317|41635314|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
19391297|NCT02696317|41635315|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
19391298|NCT01959412|41635323|FG000|Overall Study|Protocol deviation|1|||
19391299|NCT01959412|41635324|FG001|Overall Study|Protocol deviation|1|||
19391300|NCT01959412|41635325|FG002|Overall Study|Protocol deviation|0|||
19391301|NCT01959412|41635326|FG003|Overall Study|Protocol deviation|1|||
19391302|NCT01959412|41635327|FG004|Overall Study|Protocol deviation|3|||
19391303|NCT01959412|41635328|FG005|Overall Study|Protocol deviation|0|||
19478427|NCT01502371|41757695|FG003|Overall Study|Technical Problems|4|||
19478428|NCT01502371|41757696|FG004|Overall Study|Technical Problems|1|||
19478429|NCT01502371|41757692|FG000|Overall Study|Protocol Violation|9|||
19702244|NCT00183170|42146714|FG001|Washout 1 Week|Did not complete study|8|||
19391304|NCT01959412|41635323|FG000|Overall Study|Adverse Event|0|||
19391305|NCT01959412|41635324|FG001|Overall Study|Adverse Event|0|||
19391306|NCT01959412|41635325|FG002|Overall Study|Adverse Event|0|||
19391307|NCT01959412|41635326|FG003|Overall Study|Adverse Event|1|||
19391308|NCT01959412|41635327|FG004|Overall Study|Adverse Event|0|||
19391309|NCT01959412|41635328|FG005|Overall Study|Adverse Event|0|||
19391310|NCT01977820|41635344|FG000|Overall Study|Sponsor terminated the study|1|||
19391311|NCT01977820|41635345|FG001|Overall Study|Sponsor terminated the study|1|||
19478430|NCT01502371|41757693|FG001|Overall Study|Protocol Violation|5|||
19702245|NCT00183170|42146713|FG000|Second Intervention|Did not complete study|1|||
19702246|NCT00183170|42146714|FG001|Second Intervention|Did not complete study|0|||
19391312|NCT02003014|41635351|FG000|Overall Study|Case report forms uncollected|9|||
19391313|NCT02003014|41635351|FG000|Overall Study|Treatment started after contract period|1|||
19391314|NCT02003014|41635351|FG000|Overall Study|Patient did not visit the study site|5|||
19391315|NCT02003014|41635351|FG000|Overall Study|Investigator's transfer|4|||
19391316|NCT01977352|41635357|FG000|Overall Study|Lost to Follow-up|1|||
19391317|NCT01977352|41635358|FG001|Overall Study|Lost to Follow-up|2|||
19391318|NCT02001688|41635367|FG000|Overall Study|Withdrawal by Subject|0|||
19391319|NCT02001688|41635368|FG001|Overall Study|Withdrawal by Subject|0|||
19391320|NCT02001688|41635369|FG002|Overall Study|Withdrawal by Subject|1|||
19391321|NCT02001688|41635367|FG000|Overall Study|Adverse Event|0|||
19391322|NCT02001688|41635368|FG001|Overall Study|Adverse Event|1|||
19391323|NCT02001688|41635369|FG002|Overall Study|Adverse Event|0|||
19391324|NCT02001064|41635380|FG000|Overall Study|Withdrawal by Subject|2|||
19391325|NCT02001064|41635381|FG001|Overall Study|Withdrawal by Subject|1|||
19391326|NCT02000752|41635389|FG000|Overall Study|Dystocic delivery|19|||
19391327|NCT02000752|41635390|FG001|Overall Study|Dystocic delivery|8|||
19391328|NCT02000752|41635389|FG000|Overall Study|Shift Changes|12|||
19391329|NCT02000752|41635390|FG001|Overall Study|Shift Changes|5|||
19391330|NCT02000440|41635396|FG000|Overall Study|Adverse Event|3|||
19391331|NCT02000440|41635396|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
19391332|NCT02687815|41635402|FG000|Overall Study|Lost to Follow-up|2|||
19391333|NCT02687815|41635403|FG001|Overall Study|Lost to Follow-up|4|||
19391334|NCT02687815|41635402|FG000|Overall Study|Withdrawal by Subject|2|||
19391335|NCT02687815|41635403|FG001|Overall Study|Withdrawal by Subject|4|||
19391336|NCT01959334|41635411|FG000|Second Dose|Adverse Event|1|||
19391337|NCT01959334|41635412|FG001|Second Dose|Adverse Event|0|||
19391338|NCT01959334|41635411|FG000|Third Dose|Adverse Event|0|||
19391339|NCT01959334|41635412|FG001|Third Dose|Adverse Event|1|||
19391340|NCT02687581|41635422|FG000|Overall Study|Withdrawal by Subject|1|||
19391341|NCT02687581|41635423|FG001|Overall Study|Withdrawal by Subject|0|||
19391342|NCT02687581|41635424|FG002|Overall Study|Withdrawal by Subject|0|||
19391343|NCT02687581|41635425|FG003|Overall Study|Withdrawal by Subject|1|||
19391344|NCT02687581|41635422|FG000|Overall Study|Lost to Follow-up|2|||
19391345|NCT02687581|41635423|FG001|Overall Study|Lost to Follow-up|2|||
19391346|NCT02687581|41635424|FG002|Overall Study|Lost to Follow-up|0|||
19391347|NCT02687581|41635425|FG003|Overall Study|Lost to Follow-up|0|||
19391348|NCT02687581|41635422|FG000|Overall Study|the device is too small for the patient.|1|||
19391349|NCT02687581|41635423|FG001|Overall Study|the device is too small for the patient.|0|||
19391350|NCT02687581|41635424|FG002|Overall Study|the device is too small for the patient.|0|||
19391351|NCT02687581|41635425|FG003|Overall Study|the device is too small for the patient.|0|||
19391352|NCT01977040|41635435|FG000|Overall Study|Vasa previa not confirmed|2|||
19391353|NCT01958476|41635445|FG000|Overall Study|Parent requested exclusion from analysis|1|||
19391354|NCT01958476|41635446|FG001|Overall Study|Parent requested exclusion from analysis|0|||
19391355|NCT02695537|41635482|FG000|Overall Study|Adverse Event|3|||
19391356|NCT02695537|41635482|FG000|Overall Study|Lack of Efficacy|28|||
19391357|NCT02695537|41635482|FG000|Overall Study|Withdrawal by Subject|4|||
19391358|NCT02695537|41635482|FG000|Overall Study|Protocol Violation|3|||
19391359|NCT01353313|41635488|FG000|Overall Study|Lost to Follow-up|22|||
19391360|NCT01353313|41635489|FG001|Overall Study|Lost to Follow-up|23|||
19391361|NCT01353313|41635488|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
19391362|NCT01353313|41635489|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
19391363|NCT02691247|41635498|FG000|Overall Study|Withdrawal by Subject|1|||
19391364|NCT02691247|41635499|FG001|Overall Study|Withdrawal by Subject|2|||
19391365|NCT02691247|41635500|FG002|Overall Study|Withdrawal by Subject|2|||
19391366|NCT02691247|41635498|FG000|Overall Study|Lost to Follow-up|2|||
19391367|NCT02691247|41635499|FG001|Overall Study|Lost to Follow-up|0|||
19391368|NCT02691247|41635500|FG002|Overall Study|Lost to Follow-up|1|||
19391369|NCT01362491|41635511|FG000|Overall Study|Ineligible|1|||
19391370|NCT01362491|41635512|FG001|Overall Study|Ineligible|0|||
19478431|NCT01502371|41757694|FG002|Overall Study|Protocol Violation|6|||
19478432|NCT01502371|41757695|FG003|Overall Study|Protocol Violation|5|||
19478433|NCT01502371|41757696|FG004|Overall Study|Protocol Violation|10|||
19478434|NCT01502371|41757692|FG000|Overall Study|Excluded Medication|0|||
19391371|NCT01362491|41635513|FG002|Overall Study|Ineligible|0|||
19391372|NCT02687191|41635528|FG000|Overall Study|Death|0|||
19391373|NCT02687191|41635529|FG001|Overall Study|Death|1|||
19391374|NCT02687191|41635530|FG002|Overall Study|Death|1|||
19391375|NCT02687191|41635531|FG003|Overall Study|Death|0|||
19391376|NCT02687191|41635532|FG004|Overall Study|Death|1|||
19391377|NCT02687191|41635533|FG005|Overall Study|Death|1|||
19391378|NCT02687191|41635528|FG000|Overall Study|Withdrawal by Subject|0|||
19391379|NCT02687191|41635529|FG001|Overall Study|Withdrawal by Subject|0|||
19391380|NCT02687191|41635530|FG002|Overall Study|Withdrawal by Subject|0|||
19391381|NCT02687191|41635531|FG003|Overall Study|Withdrawal by Subject|1|||
19391382|NCT02687191|41635532|FG004|Overall Study|Withdrawal by Subject|0|||
19391383|NCT02687191|41635533|FG005|Overall Study|Withdrawal by Subject|0|||
19391384|NCT02687035|41635547|FG000|Overall Study|Withdrawal by Subject|1|||
19391385|NCT02687035|41635547|FG000|Overall Study|Death|87|||
19391386|NCT02687035|41635547|FG000|Overall Study|Lost to Follow-up|1|||
19391387|NCT02687035|41635547|FG000|Overall Study|Missed Visit|87|||
19391388|NCT02687035|41635547|FG000|Overall Study|Did not receive Study Device|8|||
19391389|NCT02691013|41635553|FG000|Overall Study|Withdrawal by Subject|3|||
19391390|NCT02691013|41635554|FG001|Overall Study|Withdrawal by Subject|0|||
19391391|NCT02690701|41635564|FG000|Treatment Period 1|Adverse Event|2|||
19391392|NCT02690701|41635565|FG001|Treatment Period 1|Adverse Event|2|||
19391393|NCT02690701|41635564|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19391394|NCT02690701|41635565|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19391395|NCT02690701|41635564|FG000|Treatment Period 2|Adverse Event|2|||
19391396|NCT02690701|41635565|FG001|Treatment Period 2|Adverse Event|0|||
19391397|NCT02690701|41635564|FG000|Treatment Period 2|Lack of Efficacy|1|||
19391398|NCT02690701|41635565|FG001|Treatment Period 2|Lack of Efficacy|0|||
19391399|NCT02690701|41635564|FG000|Treatment Period 2|Lost to Follow-up|0|||
19391400|NCT02690701|41635565|FG001|Treatment Period 2|Lost to Follow-up|2|||
19391401|NCT02690701|41635564|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19391402|NCT02690701|41635565|FG001|Treatment Period 2|Withdrawal by Subject|2|||
19391403|NCT02690701|41635564|FG000|Treatment Period 2|Protocol Violation|0|||
19391404|NCT02690701|41635565|FG001|Treatment Period 2|Protocol Violation|1|||
19391405|NCT02694757|41635572|FG000|Overall Study|Lack of Efficacy|3|||
19391406|NCT02684617|41635579|FG000|Overall Study|Adverse Event|1|||
19391407|NCT02684617|41635580|FG001|Overall Study|Adverse Event|0|||
19391408|NCT02684617|41635581|FG002|Overall Study|Adverse Event|1|||
19391409|NCT02684617|41635579|FG000|Overall Study|Death|8|||
19391410|NCT02684617|41635580|FG001|Overall Study|Death|16|||
19391411|NCT02684617|41635581|FG002|Overall Study|Death|28|||
19391412|NCT02684617|41635579|FG000|Overall Study|Withdrawal by Subject|2|||
19391413|NCT02684617|41635580|FG001|Overall Study|Withdrawal by Subject|0|||
19391414|NCT02684617|41635581|FG002|Overall Study|Withdrawal by Subject|4|||
19391415|NCT02684617|41635579|FG000|Overall Study|Screen Failure|1|||
19610458|NCT00626275|42059536|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610459|NCT00626275|42059537|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610460|NCT00626275|42059538|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610461|NCT00626275|42059539|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610462|NCT00626275|42059540|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
19610463|NCT00626275|42059533|FG000|Part B|Lost to Follow-up|0|||
19610464|NCT00626275|42059534|FG001|Part B|Lost to Follow-up|0|||
19610465|NCT00626275|42059535|FG002|Part B|Lost to Follow-up|0|||
19610466|NCT00626275|42059536|FG003|Part B|Lost to Follow-up|0|||
19610467|NCT00626275|42059537|FG004|Part B|Lost to Follow-up|0|||
19610468|NCT00626275|42059538|FG005|Part B|Lost to Follow-up|0|||
19702247|NCT00183170|42146713|FG000|Second Intervention|Did not meet targeted BrAC|0|||
19702248|NCT00183170|42146714|FG001|Second Intervention|Did not meet targeted BrAC|2|||
19702249|NCT00230282|42146720|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
19702250|NCT00230282|42146720|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
19702251|NCT00230282|42146720|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
19610469|NCT00626275|42059539|FG006|Part B|Lost to Follow-up|1|||
19610470|NCT00626275|42059540|FG007|Part B|Lost to Follow-up|0|||
19610471|NCT00626275|42059533|FG000|Part B|Withdrawal by Subject|0|||
19610472|NCT00626275|42059534|FG001|Part B|Withdrawal by Subject|0|||
19610473|NCT00626275|42059535|FG002|Part B|Withdrawal by Subject|0|||
19610474|NCT00626275|42059536|FG003|Part B|Withdrawal by Subject|0|||
19702252|NCT00230282|42146720|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
19702253|NCT00261950|42146724|FG000|Overall Study|Lost to Follow-up|2|||
19702254|NCT00261950|42146724|FG000|Overall Study|Death|6|||
19702255|NCT00261950|42146724|FG000|Overall Study|Withdrawal by Subject|5|||
19610475|NCT00626275|42059537|FG004|Part B|Withdrawal by Subject|0|||
19702256|NCT00261950|42146724|FG000|Overall Study|Other|1|||
19702257|NCT00261950|42146724|FG000|Overall Study|Physician Decision|1|||
19702258|NCT00261950|42146724|FG000|Overall Study|Protocol specified Criteria|11|||
19702259|NCT00230048|42146730|FG000|Overall Study|Lost to Follow-up|13|||
19702260|NCT00230048|42146731|FG001|Overall Study|Lost to Follow-up|18|||
19702261|NCT00229658|42146741|FG000|Overall Study|Administrative|2|||
19702262|NCT00229658|42146742|FG001|Overall Study|Administrative|1|||
19702263|NCT00229658|42146741|FG000|Overall Study|Investigator decision|13|||
19702264|NCT00229658|42146742|FG001|Overall Study|Investigator decision|10|||
19702265|NCT00229658|42146741|FG000|Overall Study|Other|80|||
19702266|NCT00229658|42146742|FG001|Overall Study|Other|60|||
19702267|NCT00229658|42146741|FG000|Overall Study|Lost to Follow-up|82|||
19391416|NCT02684617|41635580|FG001|Overall Study|Screen Failure|0|||
19391417|NCT02684617|41635581|FG002|Overall Study|Screen Failure|2|||
19391418|NCT02684617|41635579|FG000|Overall Study|Study Terminated by Sponsor|6|||
19610476|NCT00626275|42059538|FG005|Part B|Withdrawal by Subject|0|||
19610477|NCT00626275|42059539|FG006|Part B|Withdrawal by Subject|0|||
19391419|NCT02684617|41635580|FG001|Overall Study|Study Terminated by Sponsor|1|||
19391420|NCT02684617|41635581|FG002|Overall Study|Study Terminated by Sponsor|5|||
19610478|NCT00626275|42059540|FG007|Part B|Withdrawal by Subject|1|||
19610479|NCT00967343|42059554|FG000|Overall Study|Study termination by sponsor|12|||
19610480|NCT00967343|42059554|FG000|Overall Study|Death|24|||
19610481|NCT00967343|42059554|FG000|Overall Study|Relapse|1|||
19610482|NCT00967343|42059554|FG000|Overall Study|Lost to Follow-up|1|||
19610483|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
19610484|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
19610485|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
19610486|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
19610487|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
19610488|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
19610489|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
19610490|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
19610491|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
19610492|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
19610493|NCT00973973|42059560|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
19610494|NCT00973973|42059561|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
19610495|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
19610496|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
19610497|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
19610498|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
19610499|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
19610500|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
19610501|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
19610502|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
19610503|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
19610504|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
19610505|NCT00973973|42059560|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
19610506|NCT00973973|42059561|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
19610507|NCT00633139|42059570|FG000|Overall Study|Non compliance|0|||
19610508|NCT00633139|42059571|FG001|Overall Study|Non compliance|0|||
19610509|NCT00633139|42059572|FG002|Overall Study|Non compliance|1|||
19610510|NCT00633139|42059570|FG000|Overall Study|Withdrawal by Subject|0|||
19610511|NCT00633139|42059571|FG001|Overall Study|Withdrawal by Subject|1|||
19610512|NCT00633139|42059572|FG002|Overall Study|Withdrawal by Subject|0|||
19610513|NCT00965081|42059582|FG000|Overall Study|Adverse Event|14|||
19610514|NCT00965081|42059583|FG001|Overall Study|Adverse Event|9|||
19610515|NCT00965081|42059582|FG000|Overall Study|Lack of Efficacy|2|||
19610516|NCT00965081|42059583|FG001|Overall Study|Lack of Efficacy|5|||
19610517|NCT00965081|42059582|FG000|Overall Study|Lost to Follow-up|4|||
19610518|NCT00965081|42059583|FG001|Overall Study|Lost to Follow-up|5|||
19610519|NCT00965081|42059582|FG000|Overall Study|Physician Decision|2|||
19610520|NCT00965081|42059583|FG001|Overall Study|Physician Decision|0|||
19610521|NCT00965081|42059582|FG000|Overall Study|Protocol Violation|2|||
19610522|NCT00965081|42059583|FG001|Overall Study|Protocol Violation|5|||
19610523|NCT00965081|42059582|FG000|Overall Study|Sponsor Decision|1|||
19610524|NCT00965081|42059583|FG001|Overall Study|Sponsor Decision|0|||
19610525|NCT00965081|42059582|FG000|Overall Study|Withdrawal by Subject|4|||
19610526|NCT00965081|42059583|FG001|Overall Study|Withdrawal by Subject|7|||
19391421|NCT01999972|41635595|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
19391422|NCT01999972|41635596|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
19391423|NCT01999972|41635597|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
19391424|NCT01999972|41635598|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
19391425|NCT01999972|41635599|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
19391426|NCT01999972|41635600|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
19391427|NCT01999972|41635595|FG000|Dose Escalation Part|Death|0|||
19391428|NCT01999972|41635596|FG001|Dose Escalation Part|Death|1|||
19391429|NCT01999972|41635597|FG002|Dose Escalation Part|Death|0|||
19391430|NCT01999972|41635598|FG003|Dose Escalation Part|Death|0|||
19391431|NCT01999972|41635599|FG004|Dose Escalation Part|Death|0|||
19391432|NCT01999972|41635600|FG005|Dose Escalation Part|Death|0|||
19391433|NCT01999972|41635595|FG000|Dose Escalation Part|Enrolled but not treated|0|||
19391434|NCT01999972|41635596|FG001|Dose Escalation Part|Enrolled but not treated|0|||
19391435|NCT01999972|41635597|FG002|Dose Escalation Part|Enrolled but not treated|1|||
19391436|NCT01999972|41635598|FG003|Dose Escalation Part|Enrolled but not treated|1|||
19391437|NCT01999972|41635599|FG004|Dose Escalation Part|Enrolled but not treated|0|||
19391438|NCT01999972|41635600|FG005|Dose Escalation Part|Enrolled but not treated|0|||
19391439|NCT01999972|41635595|FG000|Dose Escalation Part|Disease progression|3|||
19391440|NCT01999972|41635596|FG001|Dose Escalation Part|Disease progression|2|||
19610527|NCT00965081|42059582|FG000|Overall Study|Switched to Rescue Arm|5|||
19610528|NCT00965081|42059583|FG001|Overall Study|Switched to Rescue Arm|12|||
19610529|NCT00961649|42059594|FG000|Overall Study|Adverse Event|4|||
19610530|NCT00961649|42059595|FG001|Overall Study|Adverse Event|0|||
19610531|NCT00961649|42059596|FG002|Overall Study|Adverse Event|0|||
19610532|NCT00961649|42059597|FG003|Overall Study|Adverse Event|2|||
19610533|NCT00961649|42059594|FG000|Overall Study|Inadequate control of IOP|0|||
19610534|NCT00961649|42059595|FG001|Overall Study|Inadequate control of IOP|0|||
19610535|NCT00961649|42059596|FG002|Overall Study|Inadequate control of IOP|0|||
19610536|NCT00961649|42059597|FG003|Overall Study|Inadequate control of IOP|1|||
19610537|NCT00961649|42059594|FG000|Overall Study|Patient has travel plans during holidays|0|||
19610538|NCT00961649|42059595|FG001|Overall Study|Patient has travel plans during holidays|0|||
19610539|NCT00961649|42059596|FG002|Overall Study|Patient has travel plans during holidays|1|||
19610540|NCT00961649|42059597|FG003|Overall Study|Patient has travel plans during holidays|0|||
19610541|NCT00961649|42059594|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
19610542|NCT00961649|42059595|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
19610543|NCT00961649|42059596|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
19610544|NCT00961649|42059597|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
19610545|NCT00961649|42059594|FG000|Overall Study|Study terminated by sponsor|4|||
19610546|NCT00961649|42059595|FG001|Overall Study|Study terminated by sponsor|4|||
19610547|NCT00961649|42059596|FG002|Overall Study|Study terminated by sponsor|4|||
19610548|NCT00961649|42059597|FG003|Overall Study|Study terminated by sponsor|1|||
19610549|NCT00632125|42059607|FG000|Overall Study|Death|82|||
19610550|NCT00632125|42059607|FG000|Overall Study|Withdrawal by Subject|44|||
19610551|NCT00632125|42059607|FG000|Overall Study|Adverse Event|36|||
19610552|NCT00632125|42059607|FG000|Overall Study|Renal transplantation|17|||
19610553|NCT00632125|42059607|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
19610554|NCT00632125|42059607|FG000|Overall Study|Non-compliance|8|||
19610555|NCT00632125|42059607|FG000|Overall Study|Development of uncontrolled hypertension|5|||
19610556|NCT00632125|42059607|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
19610557|NCT00903968|42059613|FG000|Overall Study|Adverse Event|0|||
19610558|NCT00903968|42059614|FG001|Overall Study|Adverse Event|0|||
19610559|NCT00903968|42059615|FG002|Overall Study|Adverse Event|0|||
19610560|NCT00903968|42059616|FG003|Overall Study|Adverse Event|0|||
19610561|NCT00903968|42059617|FG004|Overall Study|Adverse Event|0|||
19702268|NCT00229658|42146742|FG001|Overall Study|Lost to Follow-up|55|||
19702269|NCT00229658|42146741|FG000|Overall Study|Serious Adverse Event|2|||
19702270|NCT00229658|42146742|FG001|Overall Study|Serious Adverse Event|2|||
19702271|NCT00229658|42146741|FG000|Overall Study|Withdrawal of consent|46|||
19702272|NCT00229658|42146742|FG001|Overall Study|Withdrawal of consent|39|||
19702273|NCT00182078|42146750|FG000|Overall Study|Withdrawal by Subject|1|||
19702274|NCT00182078|42146751|FG001|Overall Study|Withdrawal by Subject|0|||
19702275|NCT00181844|42146757|FG000|Signed Consent|Withdrawal by Subject|5|||
19702276|NCT00181844|42146757|FG000|Signed Consent|Did not meet entrance criteria|7|||
19702277|NCT00181844|42146757|FG000|Exposed to Study Medication|Adverse Event|10|||
19702278|NCT00181844|42146757|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
19702279|NCT00181844|42146757|FG000|Exposed to Study Medication|Non-compliance|2|||
19702280|NCT00181844|42146757|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
19702281|NCT00181844|42146757|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
19702282|NCT00181766|42146761|FG000|Overall Study|Lost to Follow-up|6|||
19702283|NCT00181766|42146761|FG000|Overall Study|Adverse Event|4|||
19702284|NCT00181766|42146761|FG000|Overall Study|non-compliance|2|||
19702285|NCT00180674|42146765|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
19702286|NCT00180674|42146765|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
19702287|NCT00076024|42146776|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
19702288|NCT00076024|42146777|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
19702289|NCT00076024|42146778|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
19610562|NCT00903968|42059618|FG005|Overall Study|Adverse Event|0|||
19610563|NCT00903968|42059619|FG006|Overall Study|Adverse Event|1|||
19610564|NCT00903968|42059620|FG007|Overall Study|Adverse Event|8|||
19610565|NCT00903968|42059613|FG000|Overall Study|DLT|0|||
19610566|NCT00903968|42059614|FG001|Overall Study|DLT|0|||
19610567|NCT00903968|42059615|FG002|Overall Study|DLT|0|||
19610568|NCT00903968|42059616|FG003|Overall Study|DLT|0|||
19610569|NCT00903968|42059617|FG004|Overall Study|DLT|0|||
19610570|NCT00903968|42059618|FG005|Overall Study|DLT|0|||
19610571|NCT00903968|42059619|FG006|Overall Study|DLT|2|||
19702290|NCT00076024|42146779|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
19391441|NCT01999972|41635597|FG002|Dose Escalation Part|Disease progression|3|||
19610572|NCT00903968|42059620|FG007|Overall Study|DLT|0|||
19610573|NCT00903968|42059613|FG000|Overall Study|Withdrawal by Subject|1|||
19610574|NCT00903968|42059614|FG001|Overall Study|Withdrawal by Subject|0|||
19610575|NCT00903968|42059615|FG002|Overall Study|Withdrawal by Subject|1|||
19610576|NCT00903968|42059616|FG003|Overall Study|Withdrawal by Subject|0|||
19610577|NCT00903968|42059617|FG004|Overall Study|Withdrawal by Subject|1|||
19610578|NCT00903968|42059618|FG005|Overall Study|Withdrawal by Subject|1|||
19610579|NCT00903968|42059619|FG006|Overall Study|Withdrawal by Subject|0|||
19610580|NCT00903968|42059620|FG007|Overall Study|Withdrawal by Subject|4|||
19610581|NCT00903968|42059613|FG000|Overall Study|Non-Compliance|0|||
19610582|NCT00903968|42059614|FG001|Overall Study|Non-Compliance|0|||
19702291|NCT00076024|42146776|FG000|Phase 1, Lead-in|Adverse Event|1|||
19610583|NCT00903968|42059615|FG002|Overall Study|Non-Compliance|0|||
19610584|NCT00903968|42059616|FG003|Overall Study|Non-Compliance|0|||
19610585|NCT00903968|42059617|FG004|Overall Study|Non-Compliance|0|||
19610586|NCT00903968|42059618|FG005|Overall Study|Non-Compliance|1|||
19610587|NCT00903968|42059619|FG006|Overall Study|Non-Compliance|0|||
19610588|NCT00903968|42059620|FG007|Overall Study|Non-Compliance|0|||
19610589|NCT00903968|42059613|FG000|Overall Study|Physician Decision|0|||
19610590|NCT00903968|42059614|FG001|Overall Study|Physician Decision|0|||
19610591|NCT00903968|42059615|FG002|Overall Study|Physician Decision|0|||
19610592|NCT00903968|42059616|FG003|Overall Study|Physician Decision|0|||
19610593|NCT00903968|42059617|FG004|Overall Study|Physician Decision|0|||
19702292|NCT00076024|42146777|FG001|Phase 1, Lead-in|Adverse Event|0|||
19702293|NCT00076024|42146778|FG002|Phase 1, Lead-in|Adverse Event|0|||
19702294|NCT00076024|42146779|FG003|Phase 1, Lead-in|Adverse Event|0|||
19702295|NCT00076024|42146776|FG000|Phase 1, Lead-in|Clinical progression|1|||
19702296|NCT00076024|42146777|FG001|Phase 1, Lead-in|Clinical progression|0|||
19702297|NCT00076024|42146778|FG002|Phase 1, Lead-in|Clinical progression|0|||
19702298|NCT00076024|42146779|FG003|Phase 1, Lead-in|Clinical progression|0|||
19702299|NCT00076024|42146776|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
19702300|NCT00076024|42146777|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
19702301|NCT00076024|42146778|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
19610594|NCT00903968|42059618|FG005|Overall Study|Physician Decision|1|||
19610595|NCT00903968|42059619|FG006|Overall Study|Physician Decision|0|||
19610596|NCT00903968|42059620|FG007|Overall Study|Physician Decision|0|||
19610597|NCT00903968|42059613|FG000|Overall Study|Progressive Disease|2|||
19610598|NCT00903968|42059614|FG001|Overall Study|Progressive Disease|3|||
19610599|NCT00903968|42059615|FG002|Overall Study|Progressive Disease|2|||
19610600|NCT00903968|42059616|FG003|Overall Study|Progressive Disease|3|||
19610601|NCT00903968|42059617|FG004|Overall Study|Progressive Disease|3|||
19610602|NCT00903968|42059618|FG005|Overall Study|Progressive Disease|3|||
19610603|NCT00903968|42059619|FG006|Overall Study|Progressive Disease|0|||
19610604|NCT00903968|42059620|FG007|Overall Study|Progressive Disease|18|||
19610605|NCT00903968|42059613|FG000|Overall Study|Lack of Efficacy|0|||
19610606|NCT00903968|42059614|FG001|Overall Study|Lack of Efficacy|0|||
19610607|NCT00903968|42059615|FG002|Overall Study|Lack of Efficacy|0|||
19610608|NCT00903968|42059616|FG003|Overall Study|Lack of Efficacy|0|||
19610609|NCT00903968|42059617|FG004|Overall Study|Lack of Efficacy|0|||
19610610|NCT00903968|42059618|FG005|Overall Study|Lack of Efficacy|0|||
19610611|NCT00903968|42059619|FG006|Overall Study|Lack of Efficacy|0|||
19610612|NCT00903968|42059620|FG007|Overall Study|Lack of Efficacy|3|||
19610613|NCT00903344|42059643|FG000|Overall Study|Pregnancy|2|||
19610614|NCT00903344|42059644|FG001|Overall Study|Pregnancy|3|||
19610615|NCT00903344|42059643|FG000|Overall Study|Lost to Follow-up|3|||
19610616|NCT00903344|42059644|FG001|Overall Study|Lost to Follow-up|0|||
19610617|NCT00903032|42059652|FG000|Overall Study|Withdrawal by Subject|5|||
19610618|NCT00903032|42059653|FG001|Overall Study|Withdrawal by Subject|3|||
19610619|NCT00903032|42059652|FG000|Overall Study|Lost to Follow-up|2|||
19610620|NCT00903032|42059653|FG001|Overall Study|Lost to Follow-up|2|||
19702302|NCT00076024|42146779|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
19702303|NCT00076024|42146776|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
19702304|NCT00076024|42146777|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
19702305|NCT00076024|42146778|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
19702306|NCT00076024|42146779|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
19702307|NCT00076024|42146776|FG000|Phase 2, Double-blind|Adverse Event|0|||
19702308|NCT00076024|42146777|FG001|Phase 2, Double-blind|Adverse Event|25|||
19702309|NCT00076024|42146778|FG002|Phase 2, Double-blind|Adverse Event|6|||
19702310|NCT00076024|42146779|FG003|Phase 2, Double-blind|Adverse Event|0|||
19702311|NCT00076024|42146776|FG000|Phase 2, Double-blind|Un-specified|0|||
19702312|NCT00076024|42146777|FG001|Phase 2, Double-blind|Un-specified|14|||
19702313|NCT00076024|42146778|FG002|Phase 2, Double-blind|Un-specified|6|||
19702314|NCT00076024|42146779|FG003|Phase 2, Double-blind|Un-specified|0|||
19702315|NCT00076024|42146776|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
19702316|NCT00076024|42146777|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
19702317|NCT00076024|42146778|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
19702318|NCT00076024|42146779|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
19702319|NCT00076024|42146776|FG000|Phase 2, Open-label|Adverse Event|0|||
19702320|NCT00076024|42146777|FG001|Phase 2, Open-label|Adverse Event|0|||
19702321|NCT00076024|42146778|FG002|Phase 2, Open-label|Adverse Event|0|||
19702322|NCT00076024|42146779|FG003|Phase 2, Open-label|Adverse Event|2|||
19702323|NCT00076024|42146776|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
19610621|NCT00902564|42059668|FG000|Overall Study|Withdrawal by Subject|2|||
19610622|NCT00626197|42059675|FG000|Overall Study|Did not cooperate|2|||
19610623|NCT00626197|42059676|FG001|Overall Study|Did not cooperate|6|||
19610624|NCT00626197|42059677|FG002|Overall Study|Did not cooperate|1|||
19610625|NCT00626197|42059675|FG000|Overall Study|Failure to return|6|||
19610626|NCT00626197|42059676|FG001|Overall Study|Failure to return|5|||
19610627|NCT00626197|42059677|FG002|Overall Study|Failure to return|6|||
19610628|NCT00626197|42059675|FG000|Overall Study|Adverse event, serious fatal|3|||
19702324|NCT00076024|42146777|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
19702325|NCT00076024|42146778|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
19702326|NCT00076024|42146779|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
19702327|NCT00076024|42146776|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
19702328|NCT00076024|42146777|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
19702329|NCT00076024|42146778|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
19702330|NCT00076024|42146779|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
19702331|NCT00076024|42146776|FG000|Phase 2, Open-label|Other|0|||
19702332|NCT00076024|42146777|FG001|Phase 2, Open-label|Other|0|||
19702333|NCT00076024|42146778|FG002|Phase 2, Open-label|Other|0|||
19702334|NCT00076024|42146779|FG003|Phase 2, Open-label|Other|2|||
19702335|NCT00075478|42146790|FG000|Overall Study|not eligible|1|||
19702336|NCT00075478|42146791|FG001|Overall Study|not eligible|0|||
19702337|NCT00075478|42146790|FG000|Overall Study|Physician Decision|0|||
19702338|NCT00075478|42146791|FG001|Overall Study|Physician Decision|1|||
19702339|NCT00175916|42146797|FG000|Overall Study|Death|19|||
19702340|NCT00175916|42146797|FG000|Overall Study|Adverse Event|81|||
19702341|NCT00175916|42146797|FG000|Overall Study|Lack of Efficacy|354|||
19391442|NCT01999972|41635598|FG003|Dose Escalation Part|Disease progression|6|||
19391443|NCT01999972|41635599|FG004|Dose Escalation Part|Disease progression|0|||
19391444|NCT01999972|41635600|FG005|Dose Escalation Part|Disease progression|0|||
19391445|NCT01999972|41635595|FG000|Dose Escalation Part|Adverse Event|0|||
19391446|NCT01999972|41635596|FG001|Dose Escalation Part|Adverse Event|0|||
19391447|NCT01999972|41635597|FG002|Dose Escalation Part|Adverse Event|0|||
19391448|NCT01999972|41635598|FG003|Dose Escalation Part|Adverse Event|2|||
19391449|NCT01999972|41635599|FG004|Dose Escalation Part|Adverse Event|0|||
19391450|NCT01999972|41635600|FG005|Dose Escalation Part|Adverse Event|0|||
19391451|NCT01999972|41635595|FG000|Dose Escalation Part|Global deterioration of health status|1|||
19391452|NCT01999972|41635596|FG001|Dose Escalation Part|Global deterioration of health status|0|||
19391453|NCT01999972|41635597|FG002|Dose Escalation Part|Global deterioration of health status|0|||
19391454|NCT01999972|41635598|FG003|Dose Escalation Part|Global deterioration of health status|1|||
19391455|NCT01999972|41635599|FG004|Dose Escalation Part|Global deterioration of health status|0|||
19391456|NCT01999972|41635600|FG005|Dose Escalation Part|Global deterioration of health status|0|||
19391457|NCT01999972|41635595|FG000|Dose Expansion Part|Death|0|||
19391458|NCT01999972|41635596|FG001|Dose Expansion Part|Death|0|||
19391459|NCT01999972|41635597|FG002|Dose Expansion Part|Death|0|||
19391460|NCT01999972|41635598|FG003|Dose Expansion Part|Death|0|||
19391461|NCT01999972|41635599|FG004|Dose Expansion Part|Death|2|||
19391462|NCT01999972|41635600|FG005|Dose Expansion Part|Death|1|||
19391463|NCT01999972|41635595|FG000|Dose Expansion Part|Disease progression|0|||
19391464|NCT01999972|41635596|FG001|Dose Expansion Part|Disease progression|0|||
19391465|NCT01999972|41635597|FG002|Dose Expansion Part|Disease progression|0|||
19391466|NCT01999972|41635598|FG003|Dose Expansion Part|Disease progression|0|||
19391467|NCT01999972|41635599|FG004|Dose Expansion Part|Disease progression|9|||
19391468|NCT01999972|41635600|FG005|Dose Expansion Part|Disease progression|3|||
19391469|NCT01999972|41635595|FG000|Dose Expansion Part|Sponsor decision|0|||
19391470|NCT01999972|41635596|FG001|Dose Expansion Part|Sponsor decision|0|||
19391471|NCT01999972|41635597|FG002|Dose Expansion Part|Sponsor decision|0|||
19391472|NCT01999972|41635598|FG003|Dose Expansion Part|Sponsor decision|0|||
19391473|NCT01999972|41635599|FG004|Dose Expansion Part|Sponsor decision|1|||
19391474|NCT01999972|41635600|FG005|Dose Expansion Part|Sponsor decision|0|||
19391475|NCT01999972|41635595|FG000|Dose Expansion Part|Adverse Event|0|||
19391476|NCT01999972|41635596|FG001|Dose Expansion Part|Adverse Event|0|||
19391477|NCT01999972|41635597|FG002|Dose Expansion Part|Adverse Event|0|||
19391478|NCT01999972|41635598|FG003|Dose Expansion Part|Adverse Event|0|||
19391479|NCT01999972|41635599|FG004|Dose Expansion Part|Adverse Event|4|||
19391480|NCT01999972|41635600|FG005|Dose Expansion Part|Adverse Event|2|||
19391481|NCT01999972|41635595|FG000|Dose Expansion Part|Participant's non-compliance|0|||
19391482|NCT01999972|41635596|FG001|Dose Expansion Part|Participant's non-compliance|0|||
19391483|NCT01999972|41635597|FG002|Dose Expansion Part|Participant's non-compliance|0|||
19391484|NCT01999972|41635598|FG003|Dose Expansion Part|Participant's non-compliance|0|||
19391485|NCT01999972|41635599|FG004|Dose Expansion Part|Participant's non-compliance|0|||
19391486|NCT01999972|41635600|FG005|Dose Expansion Part|Participant's non-compliance|1|||
19391487|NCT01999972|41635595|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
19391488|NCT01999972|41635596|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
19391489|NCT01999972|41635597|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
19391490|NCT01999972|41635598|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
19391491|NCT01999972|41635599|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
19391492|NCT01999972|41635600|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
19391493|NCT01999972|41635595|FG000|Dose Expansion Part|Changed to standard of care|0|||
19391494|NCT01999972|41635596|FG001|Dose Expansion Part|Changed to standard of care|0|||
19702342|NCT00175916|42146797|FG000|Overall Study|Lost to Follow-up|17|||
19702343|NCT00175916|42146797|FG000|Overall Study|Subject Choice|98|||
19702344|NCT00175916|42146797|FG000|Overall Study|Lack of compliance|8|||
19702345|NCT00175916|42146797|FG000|Overall Study|Patient cannot record seizures|1|||
19610629|NCT00626197|42059676|FG001|Overall Study|Adverse event, serious fatal|6|||
19610630|NCT00626197|42059677|FG002|Overall Study|Adverse event, serious fatal|6|||
19391495|NCT01999972|41635597|FG002|Dose Expansion Part|Changed to standard of care|0|||
19391496|NCT01999972|41635598|FG003|Dose Expansion Part|Changed to standard of care|0|||
19391497|NCT01999972|41635599|FG004|Dose Expansion Part|Changed to standard of care|1|||
19391498|NCT01999972|41635600|FG005|Dose Expansion Part|Changed to standard of care|0|||
19391499|NCT01999894|41635616|FG000|Overall Study|Adverse Event|9|||
19391500|NCT01999894|41635616|FG000|Overall Study|Lack of Efficacy|5|||
19391501|NCT01999894|41635616|FG000|Overall Study|Protocol Violation|1|||
19391502|NCT01999894|41635616|FG000|Overall Study|Withdrawal by Subject|7|||
19391503|NCT01999894|41635616|FG000|Overall Study|Lost to Follow-up|10|||
19391504|NCT01999894|41635616|FG000|Overall Study|Other Reason|3|||
19391505|NCT01999894|41635616|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
19391506|NCT02679235|41635621|FG000|Overall Study|Withdrawal by Subject|3|||
19391507|NCT02679235|41635621|FG000|Overall Study|Adverse Event|1|||
19391508|NCT01976806|41635627|FG000|Overall Study|Lost to Follow-up|1|||
19391509|NCT01976806|41635628|FG001|Overall Study|Lost to Follow-up|4|||
19391510|NCT01976806|41635627|FG000|Overall Study|Adverse Event|1|||
19391511|NCT01976806|41635628|FG001|Overall Study|Adverse Event|1|||
19391512|NCT01976806|41635627|FG000|Overall Study|Withdrawal by Subject|1|||
19391513|NCT01976806|41635628|FG001|Overall Study|Withdrawal by Subject|1|||
19391514|NCT02679079|41635637|FG000|Overall Study|Adverse Event|2|||
19391515|NCT02679079|41635638|FG001|Overall Study|Adverse Event|0|||
19391516|NCT02679079|41635639|FG002|Overall Study|Adverse Event|2|||
19391517|NCT02679079|41635637|FG000|Overall Study|Protocol Violation|0|||
19391518|NCT02679079|41635638|FG001|Overall Study|Protocol Violation|1|||
19391519|NCT02679079|41635639|FG002|Overall Study|Protocol Violation|0|||
19391520|NCT02679079|41635637|FG000|Overall Study|Withdrawal by Subject|2|||
19391521|NCT02679079|41635638|FG001|Overall Study|Withdrawal by Subject|1|||
19391522|NCT02679079|41635639|FG002|Overall Study|Withdrawal by Subject|0|||
19391523|NCT02678923|41635649|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
19391524|NCT02678923|41635650|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
19391525|NCT02678923|41635649|FG000|Overall Study|Withdrawal by Subject|3|||
19391526|NCT02678923|41635650|FG001|Overall Study|Withdrawal by Subject|2|||
19391527|NCT02678923|41635649|FG000|Overall Study|Lost to Follow-up|1|||
19391528|NCT02678923|41635650|FG001|Overall Study|Lost to Follow-up|0|||
19610631|NCT00626197|42059675|FG000|Overall Study|Adverse Event|1|||
19610632|NCT00626197|42059676|FG001|Overall Study|Adverse Event|1|||
19610633|NCT00626197|42059677|FG002|Overall Study|Adverse Event|2|||
19610634|NCT00626197|42059675|FG000|Overall Study|Withdrawal by Subject|17|||
19610635|NCT00626197|42059676|FG001|Overall Study|Withdrawal by Subject|17|||
19610636|NCT00626197|42059677|FG002|Overall Study|Withdrawal by Subject|7|||
19702346|NCT00175916|42146797|FG000|Overall Study|Sponsor decision|17|||
19702347|NCT00175916|42146797|FG000|Overall Study|Vigabatrin intake|1|||
19702348|NCT00175916|42146797|FG000|Overall Study|Suicidal behaviour|1|||
19702349|NCT00175916|42146797|FG000|Overall Study|Withdrawal by Subject|1|||
19702350|NCT00175916|42146797|FG000|Overall Study|Seizure - free|4|||
19702351|NCT00175916|42146797|FG000|Overall Study|Administrative reason|1|||
19702352|NCT00175916|42146797|FG000|Overall Study|Pregnancy|1|||
19702353|NCT00175916|42146797|FG000|Overall Study|Patient's request|2|||
19702354|NCT00175916|42146797|FG000|Overall Study|Treating physiciant's choice|1|||
19702355|NCT00175916|42146797|FG000|Overall Study|Moved overseas|1|||
19702356|NCT00175916|42146797|FG000|Overall Study|Loss of job and economic burden|1|||
19702357|NCT00175916|42146797|FG000|Overall Study|Site was closed|9|||
19702358|NCT00175916|42146797|FG000|Overall Study|Patient went to prison|1|||
19702359|NCT00075400|42146802|FG000|Overall Study|Ineligible: wrong primary|1|||
19702360|NCT00075400|42146802|FG000|Overall Study|Never treated|2|||
19702361|NCT00228566|42146811|FG000|Overall Study|Adverse Event|31|||
19702362|NCT00228566|42146811|FG000|Overall Study|Lack of Efficacy|14|||
19702363|NCT00228566|42146811|FG000|Overall Study|Lost to Follow-up|16|||
19702364|NCT00228566|42146811|FG000|Overall Study|Physician Decision|5|||
19702365|NCT00228566|42146811|FG000|Overall Study|Withdrawal by Subject|4|||
19702366|NCT00228566|42146811|FG000|Overall Study|Miscellaneous|1|||
19702367|NCT00074152|42146817|FG000|Overall Study|Death|21|||
19391529|NCT02678923|41635649|FG000|Overall Study|Did Not Return for Study Visits|1|||
19391530|NCT02678923|41635650|FG001|Overall Study|Did Not Return for Study Visits|0|||
19391531|NCT01976728|41635660|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
19391532|NCT01976728|41635661|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
19391533|NCT01976728|41635662|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
19391534|NCT01976728|41635663|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
19702368|NCT00074152|42146818|FG001|Overall Study|Death|9|||
19702369|NCT00074152|42146817|FG000|Overall Study|Lack of Efficacy|34|||
19391535|NCT02689219|41635691|FG000|Overall Study|Death|1|||
19391536|NCT02689219|41635692|FG001|Overall Study|Death|1|||
19610637|NCT00626197|42059675|FG000|Overall Study|Administrative reasons|15|||
19702370|NCT00074152|42146818|FG001|Overall Study|Lack of Efficacy|24|||
19702371|NCT00261846|42146834|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
19702372|NCT00261846|42146835|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
19610638|NCT00626197|42059676|FG001|Overall Study|Administrative reasons|19|||
19610639|NCT00626197|42059677|FG002|Overall Study|Administrative reasons|55|||
19610640|NCT00623935|42059691|FG000|Overall Study|Death|1|||
19610641|NCT00623935|42059691|FG000|Overall Study|Patient Declined Transplant|1|||
19610642|NCT00623779|42059698|FG000|Overall Study|Adverse Event|1|||
19610643|NCT00623779|42059699|FG001|Overall Study|Adverse Event|3|||
19610644|NCT00623779|42059700|FG002|Overall Study|Adverse Event|0|||
19610645|NCT00623779|42059698|FG000|Overall Study|Criteria from CSR|2|||
19610646|NCT00623779|42059699|FG001|Overall Study|Criteria from CSR|0|||
19610647|NCT00623779|42059700|FG002|Overall Study|Criteria from CSR|1|||
19610648|NCT00629707|42059731|FG000|Overall Study|Withdrawal by Subject|0|||
19610649|NCT00629707|42059732|FG001|Overall Study|Withdrawal by Subject|1|||
19610650|NCT00629707|42059731|FG000|Overall Study|Physician Decision|0|||
19610651|NCT00629707|42059732|FG001|Overall Study|Physician Decision|1|||
19610652|NCT00902330|42059740|FG000|Overall Study|Too overwhelmed by treatment|2|||
19610653|NCT00902330|42059741|FG001|Overall Study|Too overwhelmed by treatment|5|||
19610654|NCT00902330|42059740|FG000|Overall Study|Adverse Event|1|||
19610655|NCT00902330|42059741|FG001|Overall Study|Adverse Event|0|||
19610656|NCT00902330|42059740|FG000|Overall Study|No post baseline data|1|||
19610657|NCT00902330|42059741|FG001|Overall Study|No post baseline data|0|||
19610658|NCT00901394|42059778|FG000|Overall Study|Physician Decision|1|||
19391537|NCT02689219|41635691|FG000|Overall Study|Disease Progression|10|||
19391538|NCT02689219|41635692|FG001|Overall Study|Disease Progression|6|||
19391539|NCT02683525|41635698|FG000|Overall Study|Lost to Follow-up|1|||
19391540|NCT02683525|41635698|FG000|Overall Study|Physician Decision|1|||
19391541|NCT02683525|41635698|FG000|Overall Study|Disease Progression|6|||
19610659|NCT00901394|42059779|FG001|Overall Study|Physician Decision|1|||
19610660|NCT00901394|42059780|FG002|Overall Study|Physician Decision|2|||
19610661|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610662|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610663|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610664|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
19610665|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610666|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
19610667|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610668|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610669|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610670|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610671|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610672|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610673|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19391542|NCT01976338|41635704|FG000|Overall Study|Physician Decision|0|||
19391543|NCT01976338|41635705|FG001|Overall Study|Physician Decision|1|||
19391544|NCT01976338|41635704|FG000|Overall Study|Lost to Follow-up|3|||
19391545|NCT01976338|41635705|FG001|Overall Study|Lost to Follow-up|0|||
19391546|NCT01976338|41635704|FG000|Overall Study|Withdrawal by Subject|5|||
19391547|NCT01976338|41635705|FG001|Overall Study|Withdrawal by Subject|2|||
19391548|NCT01976338|41635704|FG000|Overall Study|Adverse Event|5|||
19391549|NCT01976338|41635705|FG001|Overall Study|Adverse Event|1|||
19391550|NCT02674633|41635714|FG000|Overall Study|Lost to Follow-up|3|||
19391551|NCT02674633|41635715|FG001|Overall Study|Lost to Follow-up|2|||
19391552|NCT02674633|41635714|FG000|Overall Study|Physician Decision|1|||
19391553|NCT02674633|41635715|FG001|Overall Study|Physician Decision|0|||
19391554|NCT02674633|41635714|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19391555|NCT02674633|41635715|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
19391556|NCT02651987|41635723|FG000|Overall Study|Adverse Event|2|||
19391557|NCT02651987|41635724|FG001|Overall Study|Adverse Event|2|||
19391558|NCT02651987|41635723|FG000|Overall Study|Consent Withdrawn|2|||
19391559|NCT02651987|41635724|FG001|Overall Study|Consent Withdrawn|0|||
19391560|NCT02651987|41635723|FG000|Overall Study|Local PD|0|||
19391561|NCT02651987|41635724|FG001|Overall Study|Local PD|2|||
19391562|NCT02651987|41635723|FG000|Overall Study|Investigator Decision|1|||
19391563|NCT02651987|41635724|FG001|Overall Study|Investigator Decision|1|||
19478435|NCT01502371|41757693|FG001|Overall Study|Excluded Medication|1|||
19610674|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610675|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610676|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610677|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19391564|NCT02677987|41635735|FG000|Overall Study|Withdrawal by Subject|3|||
19391565|NCT02677987|41635736|FG001|Overall Study|Withdrawal by Subject|0|||
19391566|NCT02677987|41635735|FG000|Overall Study|Lost to Follow-up|1|||
19610678|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610679|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610680|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610681|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610682|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610683|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
19610684|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
19610685|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
19610686|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
19610687|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
19610688|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
19610689|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
19610690|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
19610691|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610692|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610693|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610694|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610695|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610696|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610697|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610698|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610699|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610700|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19702373|NCT00261846|42146836|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
19702374|NCT00261846|42146837|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19478436|NCT01502371|41757694|FG002|Overall Study|Excluded Medication|1|||
19478437|NCT01502371|41757695|FG003|Overall Study|Excluded Medication|0|||
19478438|NCT01502371|41757696|FG004|Overall Study|Excluded Medication|1|||
19478439|NCT01588496|41757712|FG000|Overall Study|Withdrawal by Subject|0|||
19478440|NCT01588496|41757713|FG001|Overall Study|Withdrawal by Subject|1|||
19702375|NCT00261846|42146838|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702376|NCT00261846|42146839|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702377|NCT00261846|42146840|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702378|NCT00261846|42146841|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702379|NCT00261846|42146842|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702380|NCT00261846|42146843|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702381|NCT00261846|42146844|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702382|NCT00261846|42146845|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
19702383|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702384|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702385|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702386|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
19702387|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702388|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702389|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702390|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702391|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
19702392|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702393|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702394|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
19702395|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702396|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702397|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702398|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
19702399|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
19702400|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
19702401|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
19702402|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
19702403|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702404|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
19702405|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702406|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
19702407|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19702408|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19800865|NCT02653664|42259326|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
19800866|NCT02653664|42259324|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
19610701|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19702409|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19702410|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
19702411|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
19702412|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19702413|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
19702414|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19702415|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
19702416|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
19702417|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
19702418|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
19702419|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
19702420|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
19702421|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
19702422|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
19702423|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
19702424|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
19702425|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
19702426|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
19702427|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
19702428|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
19702429|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
19702430|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
19702431|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
19702432|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
19702433|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
19702434|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
19702435|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
19702436|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
19702437|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
19702438|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
19702439|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
19702440|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
19702441|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
19702442|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
19702443|NCT00261846|42146834|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
19702444|NCT00261846|42146835|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
19702445|NCT00261846|42146836|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
19702446|NCT00261846|42146837|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
19702447|NCT00261846|42146838|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
19702448|NCT00261846|42146839|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
19702449|NCT00261846|42146840|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
19702450|NCT00261846|42146841|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
19702451|NCT00261846|42146842|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
19702452|NCT00261846|42146843|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
19702453|NCT00261846|42146844|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
19702454|NCT00261846|42146845|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
19702455|NCT00169442|42146890|FG000|Overall Study|Withdrawal by Subject|0|||
19702456|NCT00169442|42146891|FG001|Overall Study|Withdrawal by Subject|0|||
19702457|NCT00169442|42146892|FG002|Overall Study|Withdrawal by Subject|1|||
19702458|NCT00169442|42146893|FG003|Overall Study|Withdrawal by Subject|0|||
19702459|NCT00169442|42146894|FG004|Overall Study|Withdrawal by Subject|0|||
19702460|NCT00169442|42146895|FG005|Overall Study|Withdrawal by Subject|0|||
19702461|NCT00169442|42146890|FG000|Overall Study|Migrated/moved from study area|0|||
19702462|NCT00169442|42146891|FG001|Overall Study|Migrated/moved from study area|0|||
19702463|NCT00169442|42146892|FG002|Overall Study|Migrated/moved from study area|0|||
19702464|NCT00169442|42146893|FG003|Overall Study|Migrated/moved from study area|0|||
19702465|NCT00169442|42146894|FG004|Overall Study|Migrated/moved from study area|0|||
19702466|NCT00169442|42146895|FG005|Overall Study|Migrated/moved from study area|2|||
19702467|NCT00169442|42146890|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19702468|NCT00169442|42146891|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19702469|NCT00169442|42146892|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19702470|NCT00169442|42146893|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19702471|NCT00169442|42146894|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
19702472|NCT00169442|42146895|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
19702473|NCT00169442|42146890|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
19702474|NCT00169442|42146891|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
19702475|NCT00169442|42146892|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
19702476|NCT00169442|42146893|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
19702477|NCT00169442|42146894|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
19702478|NCT00169442|42146895|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
19702479|NCT00261716|42146913|FG000|Overall Study|Withdrawal by Subject|6|||
19702480|NCT00261716|42146914|FG001|Overall Study|Withdrawal by Subject|8|||
19702481|NCT00261716|42146913|FG000|Overall Study|Lost to Follow-up|0|||
19702482|NCT00261716|42146914|FG001|Overall Study|Lost to Follow-up|2|||
19702483|NCT03809104|42146924|FG000|Overall Study|Withdrawal by Subject|3|||
19702484|NCT00203502|42146928|FG000|Overall Study|Death|1|||
19702485|NCT03799198|42146934|FG000|Overall Study|Lost to Follow-up|4|||
19702486|NCT03799198|42146935|FG001|Overall Study|Lost to Follow-up|8|||
19702487|NCT03799198|42146934|FG000|Overall Study|Death|0|||
19702488|NCT03799198|42146935|FG001|Overall Study|Death|1|||
19702489|NCT00232596|42146943|FG000|6-Week Titration Phase|Adverse Event|6|||
19702490|NCT00232596|42146944|FG001|6-Week Titration Phase|Adverse Event|19|||
19702491|NCT00232596|42146943|FG000|6-Week Titration Phase|Failed to Return|2|||
19702492|NCT00232596|42146944|FG001|6-Week Titration Phase|Failed to Return|1|||
19702493|NCT00232596|42146943|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
19702494|NCT00232596|42146944|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
19702495|NCT00232596|42146943|FG000|6-Week Titration Phase|Protocol Violation|1|||
19702496|NCT00232596|42146944|FG001|6-Week Titration Phase|Protocol Violation|3|||
19702497|NCT00232596|42146943|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
19702498|NCT00232596|42146944|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
19702499|NCT00232596|42146943|FG000|6-Week Titration Phase|Other|3|||
19702500|NCT00232596|42146944|FG001|6-Week Titration Phase|Other|3|||
19702501|NCT00232596|42146943|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
19702502|NCT00232596|42146944|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
19702503|NCT00232596|42146943|FG000|12-Week Maintenance Phase|Adverse Event|7|||
19702504|NCT00232596|42146944|FG001|12-Week Maintenance Phase|Adverse Event|22|||
19702505|NCT00232596|42146943|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
19702506|NCT00232596|42146944|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
19702507|NCT00232596|42146943|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
19702508|NCT00232596|42146944|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
19702509|NCT00232596|42146943|FG000|12-Week Maintenance Phase|Other|1|||
19702510|NCT00232596|42146944|FG001|12-Week Maintenance Phase|Other|3|||
19702511|NCT00073918|42146962|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
19610702|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610703|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610704|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610705|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610706|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
19610707|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
19610708|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
19610709|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
19610710|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
19610711|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
19610712|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
19610713|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
19610714|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
19610715|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19702512|NCT00073918|42146962|FG000|Overall Study|Rapid disease progression|2|||
19702513|NCT00073918|42146962|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
19702514|NCT00231894|42146968|FG000|Overall Study|Withdrawal by Subject|1|||
19702515|NCT00231894|42146969|FG001|Overall Study|Withdrawal by Subject|1|||
19702516|NCT00203424|42146981|FG000|Treatment Period|Withdrawal by Subject|4|||
19702517|NCT00203424|42146981|FG000|Treatment Period|Adverse Event|5|||
19702518|NCT00203424|42146981|FG000|Treatment Period|progressive disease|2|||
19702519|NCT00203424|42146981|FG000|Follow-up Period|Withdrawal by Subject|1|||
19702520|NCT00203424|42146981|FG000|Follow-up Period|progressive disease|4|||
19702521|NCT00203424|42146981|FG000|Follow-up Period|Lost to Follow-up|1|||
19702522|NCT00203268|42146985|FG000|Early Treatment|only treated one headache|2|||
19702523|NCT00203268|42146985|FG000|Early Treatment|Lost to Follow-up|1|||
19702524|NCT00203268|42146985|FG000|Early Treatment|Withdrawal by Subject|1|||
19702525|NCT00168818|42146994|FG000|Overall Study|Adverse Event|23|||
19702526|NCT00168818|42146995|FG001|Overall Study|Adverse Event|29|||
19702527|NCT00168818|42146996|FG002|Overall Study|Adverse Event|31|||
19702528|NCT00168818|42146994|FG000|Overall Study|Protocol Violation|16|||
19702529|NCT00168818|42146995|FG001|Overall Study|Protocol Violation|11|||
19702530|NCT00168818|42146996|FG002|Overall Study|Protocol Violation|11|||
19702531|NCT00168818|42146994|FG000|Overall Study|Lost to Follow-up|13|||
19702532|NCT00168818|42146995|FG001|Overall Study|Lost to Follow-up|4|||
19702533|NCT00168818|42146996|FG002|Overall Study|Lost to Follow-up|15|||
19702534|NCT00168818|42146994|FG000|Overall Study|Withdrawal by Subject|43|||
19702535|NCT00168818|42146995|FG001|Overall Study|Withdrawal by Subject|41|||
19702536|NCT00168818|42146996|FG002|Overall Study|Withdrawal by Subject|37|||
19702537|NCT00168818|42146994|FG000|Overall Study|Other|22|||
19702538|NCT00168818|42146995|FG001|Overall Study|Other|24|||
19702539|NCT00168818|42146996|FG002|Overall Study|Other|30|||
19702540|NCT00168818|42146994|FG000|Treatment|Adverse Event|77|||
19702541|NCT00168818|42146995|FG001|Treatment|Adverse Event|89|||
19702542|NCT00168818|42146996|FG002|Treatment|Adverse Event|68|||
19702543|NCT00168818|42146994|FG000|Treatment|Protocol Violation|8|||
19702544|NCT00168818|42146995|FG001|Treatment|Protocol Violation|11|||
19702545|NCT00168818|42146996|FG002|Treatment|Protocol Violation|11|||
19610716|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19702546|NCT00168818|42146994|FG000|Treatment|Lost to Follow-up|0|||
19702547|NCT00168818|42146995|FG001|Treatment|Lost to Follow-up|2|||
19610717|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610718|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610719|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610720|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610721|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610722|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610723|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610724|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610725|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610726|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610727|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610728|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610729|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
19610730|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610731|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610732|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
19610733|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610734|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
19610735|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610736|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610737|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610738|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610739|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610740|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610741|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610742|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610743|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610744|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610745|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610746|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610747|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610748|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610749|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610750|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610751|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610752|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
19610753|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
19610754|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610755|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610756|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
19610757|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610758|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610759|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610760|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610761|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610762|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19702548|NCT00168818|42146996|FG002|Treatment|Lost to Follow-up|1|||
19610763|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610764|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610765|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610766|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610767|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610768|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19702549|NCT00168818|42146994|FG000|Treatment|Withdrawal by Subject|25|||
19702550|NCT00168818|42146995|FG001|Treatment|Withdrawal by Subject|20|||
19702551|NCT00168818|42146996|FG002|Treatment|Withdrawal by Subject|22|||
19702552|NCT00168818|42146994|FG000|Treatment|Other|23|||
19702553|NCT00168818|42146995|FG001|Treatment|Other|29|||
19702554|NCT00168818|42146996|FG002|Treatment|Other|31|||
19610769|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610770|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610771|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610772|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610773|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610774|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610775|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
19610776|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610777|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610778|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
19610779|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610780|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610781|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610782|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610783|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610784|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610785|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610786|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610787|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610788|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610789|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610790|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610791|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610792|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610793|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610794|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610795|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610796|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610797|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610798|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
19610799|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610800|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610801|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
19610802|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610803|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610804|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610805|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610806|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610807|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610808|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610809|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610810|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610811|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610812|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610813|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610814|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610815|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610816|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610817|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610818|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610819|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610820|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610821|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
19610822|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610823|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610824|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610825|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
19610826|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610827|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610828|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19702555|NCT00260832|42147006|FG000|Overall Study|Adverse Event|26|||
19702556|NCT00260832|42147007|FG001|Overall Study|Adverse Event|19|||
19800867|NCT02653664|42259325|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
19800868|NCT02653664|42259326|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
19610829|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610830|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610831|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610832|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610833|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610834|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610835|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19702557|NCT00260832|42147006|FG000|Overall Study|Progression|116|||
19702558|NCT00260832|42147007|FG001|Overall Study|Progression|96|||
19702559|NCT00260832|42147006|FG000|Overall Study|Withdrawal by Subject|15|||
19702560|NCT00260832|42147007|FG001|Overall Study|Withdrawal by Subject|17|||
19702561|NCT00260832|42147006|FG000|Overall Study|Physician Decision|15|||
19702562|NCT00260832|42147007|FG001|Overall Study|Physician Decision|9|||
19610836|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610837|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610838|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610839|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610840|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610841|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610842|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610843|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610844|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
19610845|NCT00896532|42059796|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610846|NCT00896532|42059797|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
19610847|NCT00896532|42059798|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610848|NCT00896532|42059799|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
19610849|NCT00896532|42059800|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
19610850|NCT00896532|42059801|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610851|NCT00896532|42059802|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610852|NCT00896532|42059803|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610853|NCT00896532|42059804|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610854|NCT00896532|42059805|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610855|NCT00896532|42059806|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610856|NCT00896532|42059807|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610857|NCT00896532|42059808|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610858|NCT00896532|42059809|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610859|NCT00896532|42059810|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610860|NCT00896532|42059811|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610861|NCT00896532|42059812|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610862|NCT00896532|42059813|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19800869|NCT02653664|42259324|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
19800870|NCT02653664|42259325|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
19800871|NCT02653664|42259326|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
19610863|NCT00896532|42059814|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610864|NCT00896532|42059815|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610865|NCT00896532|42059816|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610866|NCT00896532|42059817|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610867|NCT00896532|42059818|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
19610868|NCT00896532|42059796|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610869|NCT00896532|42059797|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610870|NCT00896532|42059798|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610871|NCT00896532|42059799|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610872|NCT00896532|42059800|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610873|NCT00896532|42059801|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610874|NCT00896532|42059802|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610875|NCT00896532|42059803|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610876|NCT00896532|42059804|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
19610877|NCT00896532|42059805|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610878|NCT00896532|42059806|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610879|NCT00896532|42059807|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19702563|NCT00260832|42147006|FG000|Overall Study|Death|43|||
19702564|NCT00260832|42147007|FG001|Overall Study|Death|62|||
19702565|NCT00260832|42147006|FG000|Overall Study|Other|10|||
19702566|NCT00260832|42147007|FG001|Overall Study|Other|7|||
19702567|NCT00260832|42147006|FG000|Overall Study|Protocol Violation|3|||
19800872|NCT02727699|42259348|FG000|Overall Study|Adverse Event|2|||
19391567|NCT02677987|41635736|FG001|Overall Study|Lost to Follow-up|0|||
19610880|NCT00896532|42059808|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610881|NCT00896532|42059809|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610882|NCT00896532|42059810|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610883|NCT00896532|42059811|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610884|NCT00896532|42059812|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610885|NCT00896532|42059813|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610886|NCT00896532|42059814|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610887|NCT00896532|42059815|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610888|NCT00896532|42059816|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610889|NCT00896532|42059817|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610890|NCT00896532|42059818|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
19610891|NCT00896532|42059796|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610892|NCT00896532|42059797|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610893|NCT00896532|42059798|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610894|NCT00896532|42059799|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610895|NCT00896532|42059800|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610896|NCT00896532|42059801|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610897|NCT00896532|42059802|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610898|NCT00896532|42059803|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610899|NCT00896532|42059804|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610900|NCT00896532|42059805|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610901|NCT00896532|42059806|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610902|NCT00896532|42059807|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610903|NCT00896532|42059808|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
19610904|NCT00896532|42059809|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610905|NCT00896532|42059810|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610906|NCT00896532|42059811|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610907|NCT00896532|42059812|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19702568|NCT00260832|42147007|FG001|Overall Study|Protocol Violation|1|||
19702569|NCT00168038|42147013|FG000|Overall Study|Adverse Event|1|||
19702570|NCT00168038|42147013|FG000|Overall Study|Therapy failure|1|||
19702571|NCT00167414|42147017|FG000|Overall Study|Death|10|||
19702572|NCT00166712|42147023|FG000|Overall Study|Death|0|||
19702573|NCT00166712|42147024|FG001|Overall Study|Death|1|||
19610908|NCT00896532|42059813|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610909|NCT00896532|42059814|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610910|NCT00896532|42059815|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610911|NCT00896532|42059816|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610912|NCT00896532|42059817|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610913|NCT00896532|42059818|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
19610914|NCT00896532|42059796|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610915|NCT00896532|42059797|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610916|NCT00896532|42059798|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610917|NCT00896532|42059799|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610918|NCT00896532|42059800|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610919|NCT00896532|42059801|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610920|NCT00896532|42059802|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610921|NCT00896532|42059803|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610922|NCT00896532|42059804|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610923|NCT00896532|42059805|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610924|NCT00896532|42059806|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
19610925|NCT00896532|42059807|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610926|NCT00896532|42059808|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
19610927|NCT00896532|42059809|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610928|NCT00896532|42059810|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610929|NCT00896532|42059811|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610930|NCT00896532|42059812|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610931|NCT00896532|42059813|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19702574|NCT00166712|42147023|FG000|Overall Study|Adverse Event|1|||
19702575|NCT00166712|42147024|FG001|Overall Study|Adverse Event|0|||
19702576|NCT00166712|42147023|FG000|Overall Study|Withdrawal by Subject|1|||
19702577|NCT00166712|42147024|FG001|Overall Study|Withdrawal by Subject|2|||
19610932|NCT00896532|42059814|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610933|NCT00896532|42059815|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610934|NCT00896532|42059816|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610935|NCT00896532|42059817|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610936|NCT00896532|42059818|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
19610937|NCT00896532|42059796|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610938|NCT00896532|42059797|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610939|NCT00896532|42059798|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610940|NCT00896532|42059799|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610941|NCT00896532|42059800|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610942|NCT00896532|42059801|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610943|NCT00896532|42059802|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610944|NCT00896532|42059803|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19391568|NCT01999114|41635755|FG000|Overall Study|Adverse Event|8|||
19391569|NCT01999114|41635756|FG001|Overall Study|Adverse Event|7|||
19391570|NCT01999114|41635757|FG002|Overall Study|Adverse Event|2|||
19391571|NCT01999114|41635758|FG003|Overall Study|Adverse Event|2|||
19391572|NCT01999114|41635759|FG004|Overall Study|Adverse Event|1|||
19391573|NCT01999114|41635755|FG000|Overall Study|Withdrawal by Subject|0|||
19391574|NCT01999114|41635756|FG001|Overall Study|Withdrawal by Subject|0|||
19391575|NCT01999114|41635757|FG002|Overall Study|Withdrawal by Subject|1|||
19391576|NCT01999114|41635758|FG003|Overall Study|Withdrawal by Subject|0|||
19391577|NCT01999114|41635759|FG004|Overall Study|Withdrawal by Subject|1|||
19391578|NCT01999114|41635755|FG000|Overall Study|Lost to Follow-up|0|||
19391579|NCT01999114|41635756|FG001|Overall Study|Lost to Follow-up|0|||
19391580|NCT01999114|41635757|FG002|Overall Study|Lost to Follow-up|1|||
19391581|NCT01999114|41635758|FG003|Overall Study|Lost to Follow-up|0|||
19391582|NCT01999114|41635759|FG004|Overall Study|Lost to Follow-up|0|||
19391583|NCT01999114|41635755|FG000|Overall Study|Administrative|0|||
19391584|NCT01999114|41635756|FG001|Overall Study|Administrative|0|||
19391585|NCT01999114|41635757|FG002|Overall Study|Administrative|1|||
19391586|NCT01999114|41635758|FG003|Overall Study|Administrative|1|||
19391587|NCT01999114|41635759|FG004|Overall Study|Administrative|2|||
19391588|NCT02682823|41635790|FG000|Overall Study|Withdrawal by Subject|0|||
19391589|NCT02682823|41635791|FG001|Overall Study|Withdrawal by Subject|0|||
19391590|NCT02682823|41635792|FG002|Overall Study|Withdrawal by Subject|1|||
19391591|NCT02682823|41635793|FG003|Overall Study|Withdrawal by Subject|0|||
19391592|NCT02682823|41635794|FG004|Overall Study|Withdrawal by Subject|1|||
19391593|NCT02682823|41635790|FG000|Overall Study|Protocol Deviation|0|||
19391594|NCT02682823|41635791|FG001|Overall Study|Protocol Deviation|1|||
19391595|NCT02682823|41635792|FG002|Overall Study|Protocol Deviation|0|||
19391596|NCT02682823|41635793|FG003|Overall Study|Protocol Deviation|0|||
19391597|NCT02682823|41635794|FG004|Overall Study|Protocol Deviation|0|||
19391598|NCT02682823|41635790|FG000|Overall Study|Adverse Event|0|||
19391599|NCT02682823|41635791|FG001|Overall Study|Adverse Event|0|||
19391600|NCT02682823|41635792|FG002|Overall Study|Adverse Event|0|||
19391601|NCT02682823|41635793|FG003|Overall Study|Adverse Event|1|||
19391602|NCT02682823|41635794|FG004|Overall Study|Adverse Event|0|||
19391603|NCT01374451|41635808|FG000|Overall Study|Administrative problems|1|||
19391604|NCT01374451|41635809|FG001|Overall Study|Administrative problems|0|||
19391605|NCT02674477|41635817|FG000|Overall Study|Protocol Violation|8|||
19391606|NCT02674477|41635818|FG001|Overall Study|Protocol Violation|2|||
19391607|NCT01352845|41635826|FG000|Overall Study|Lost to Follow-up|313|||
19391608|NCT01352845|41635827|FG001|Overall Study|Lost to Follow-up|92|||
19391609|NCT01352845|41635826|FG000|Overall Study|No Longer Willing to Participate|205|||
19391610|NCT01352845|41635827|FG001|Overall Study|No Longer Willing to Participate|58|||
19391611|NCT01352845|41635826|FG000|Overall Study|Withdrawal by Subject|48|||
19391612|NCT01352845|41635827|FG001|Overall Study|Withdrawal by Subject|16|||
19391613|NCT01352845|41635826|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
19391614|NCT01352845|41635827|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
19391615|NCT01352845|41635826|FG000|Overall Study|Pregnancy|27|||
19391616|NCT01352845|41635827|FG001|Overall Study|Pregnancy|7|||
19391617|NCT01352845|41635826|FG000|Overall Study|Adverse Event|22|||
19391618|NCT01352845|41635827|FG001|Overall Study|Adverse Event|6|||
19391619|NCT01352845|41635826|FG000|Overall Study|Other|17|||
19391620|NCT01352845|41635827|FG001|Overall Study|Other|7|||
19391621|NCT01352845|41635826|FG000|Overall Study|Protocol Violation|12|||
19391622|NCT01352845|41635827|FG001|Overall Study|Protocol Violation|6|||
19391623|NCT01352845|41635826|FG000|Overall Study|Death|3|||
19391624|NCT01352845|41635827|FG001|Overall Study|Death|0|||
19391625|NCT02674399|41635835|FG000|Overall Study|Lost to Follow-up|2|||
19391626|NCT02674399|41635836|FG001|Overall Study|Lost to Follow-up|0|||
19391627|NCT02676895|41635845|FG000|Overall Study|Administrative reason|1|||
19391628|NCT02676895|41635846|FG001|Overall Study|Administrative reason|0|||
19391629|NCT02676895|41635847|FG002|Overall Study|Administrative reason|0|||
19391630|NCT02676895|41635845|FG000|Overall Study|Protocol Violation|1|||
19391631|NCT02676895|41635846|FG001|Overall Study|Protocol Violation|0|||
19610945|NCT00896532|42059804|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610946|NCT00896532|42059805|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610947|NCT00896532|42059806|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610948|NCT00896532|42059807|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19391632|NCT02676895|41635847|FG002|Overall Study|Protocol Violation|0|||
19391633|NCT02676895|41635845|FG000|Overall Study|Adverse Event|0|||
19391634|NCT02676895|41635846|FG001|Overall Study|Adverse Event|3|||
19391635|NCT02676895|41635847|FG002|Overall Study|Adverse Event|1|||
19391636|NCT02676895|41635845|FG000|Overall Study|Lost to Follow-up|0|||
19391637|NCT02676895|41635846|FG001|Overall Study|Lost to Follow-up|0|||
19391638|NCT02676895|41635847|FG002|Overall Study|Lost to Follow-up|1|||
19391639|NCT02676895|41635845|FG000|Overall Study|Withdrawal by Subject|0|||
19391640|NCT02676895|41635846|FG001|Overall Study|Withdrawal by Subject|0|||
19391641|NCT02676895|41635847|FG002|Overall Study|Withdrawal by Subject|1|||
19391642|NCT02673697|41635858|FG000|Overall Study|Adverse Event|2|||
19391643|NCT02673697|41635859|FG001|Overall Study|Adverse Event|0|||
19391644|NCT02673697|41635858|FG000|Overall Study|Death|32|||
19391645|NCT02673697|41635859|FG001|Overall Study|Death|24|||
19391646|NCT02673697|41635858|FG000|Overall Study|Lost to Follow-up|5|||
19391647|NCT02673697|41635859|FG001|Overall Study|Lost to Follow-up|2|||
19391648|NCT02673697|41635858|FG000|Overall Study|Physician Decision|2|||
19391649|NCT02673697|41635859|FG001|Overall Study|Physician Decision|1|||
19391650|NCT02673697|41635858|FG000|Overall Study|Withdrawal by Subject|10|||
19391651|NCT02673697|41635859|FG001|Overall Study|Withdrawal by Subject|7|||
19391652|NCT02673697|41635858|FG000|Overall Study|Change subj medical status|1|||
19391653|NCT02673697|41635859|FG001|Overall Study|Change subj medical status|2|||
19391654|NCT02673697|41635858|FG000|Overall Study|Explant|10|||
19391655|NCT02673697|41635859|FG001|Overall Study|Explant|5|||
19391656|NCT02673697|41635858|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
19391657|NCT02673697|41635859|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
19391658|NCT05168579|41635867|FG000|Overall Study|Lack of Consent|1|||
19391659|NCT05168579|41635868|FG001|Overall Study|Lack of Consent|0|||
19391660|NCT05168579|41635867|FG000|Overall Study|Conflicts with time|2|||
19391661|NCT05168579|41635868|FG001|Overall Study|Conflicts with time|0|||
19391662|NCT05168579|41635867|FG000|Overall Study|Time slots were full|3|||
19391663|NCT05168579|41635868|FG001|Overall Study|Time slots were full|0|||
19391664|NCT05168579|41635867|FG000|Overall Study|Lost to Follow-up|0|||
19391665|NCT05168579|41635868|FG001|Overall Study|Lost to Follow-up|15|||
19391666|NCT02673619|41635881|FG000|Overall Study|Lost to Follow-up|1|||
19391667|NCT02673619|41635882|FG001|Overall Study|Lost to Follow-up|0|||
19391668|NCT02673619|41635883|FG002|Overall Study|Lost to Follow-up|0|||
19391669|NCT02673619|41635884|FG003|Overall Study|Lost to Follow-up|0|||
19391670|NCT02673619|41635881|FG000|Overall Study|Withdrawal by Subject|1|||
19391671|NCT02673619|41635882|FG001|Overall Study|Withdrawal by Subject|1|||
19391672|NCT02673619|41635883|FG002|Overall Study|Withdrawal by Subject|1|||
19391673|NCT02673619|41635884|FG003|Overall Study|Withdrawal by Subject|0|||
19391674|NCT02673619|41635881|FG000|Overall Study|Adverse Event|0|||
19391675|NCT02673619|41635882|FG001|Overall Study|Adverse Event|0|||
19391676|NCT02673619|41635883|FG002|Overall Study|Adverse Event|1|||
19391677|NCT02673619|41635884|FG003|Overall Study|Adverse Event|0|||
19391678|NCT02673619|41635881|FG000|Overall Study|Lack of Efficacy|0|||
19391679|NCT02673619|41635882|FG001|Overall Study|Lack of Efficacy|0|||
19391680|NCT02673619|41635883|FG002|Overall Study|Lack of Efficacy|1|||
19391681|NCT02673619|41635884|FG003|Overall Study|Lack of Efficacy|0|||
19391682|NCT02680639|41635906|FG000|Screening Period|Screen Failure|7|||
19391683|NCT02680639|41635907|FG001|Screening Period|Screen Failure|0|||
19391684|NCT02680639|41635908|FG002|Screening Period|Screen Failure|0|||
19391685|NCT01674725|41635920|FG000|Overall Study|Adverse Event|1|||
19391686|NCT01674725|41635921|FG001|Overall Study|Adverse Event|0|||
19391687|NCT01674725|41635920|FG000|Overall Study|Did not receive study drug|1|||
19391688|NCT01674725|41635921|FG001|Overall Study|Did not receive study drug|0|||
19391689|NCT01674725|41635920|FG000|Overall Study|Withdrawal by Subject|1|||
19391690|NCT01674725|41635921|FG001|Overall Study|Withdrawal by Subject|0|||
19391691|NCT01674725|41635920|FG000|Overall Study|Lost to Follow-up|0|||
19391692|NCT01674725|41635921|FG001|Overall Study|Lost to Follow-up|1|||
19391693|NCT01674569|41635927|FG000|Overall Study|Adverse Event|0|||
19391694|NCT01674569|41635928|FG001|Overall Study|Adverse Event|2|||
19391695|NCT01674569|41635929|FG002|Overall Study|Adverse Event|0|||
19391696|NCT01674569|41635930|FG003|Overall Study|Adverse Event|1|||
19391697|NCT01674569|41635931|FG004|Overall Study|Adverse Event|2|||
19391698|NCT01674569|41635932|FG005|Overall Study|Adverse Event|2|||
19391699|NCT01674569|41635927|FG000|Overall Study|Protocol Violation|0|||
19391700|NCT01674569|41635928|FG001|Overall Study|Protocol Violation|1|||
19391701|NCT01674569|41635929|FG002|Overall Study|Protocol Violation|1|||
19391702|NCT01674569|41635930|FG003|Overall Study|Protocol Violation|0|||
19391703|NCT01674569|41635931|FG004|Overall Study|Protocol Violation|0|||
19391704|NCT01674569|41635932|FG005|Overall Study|Protocol Violation|0|||
19391705|NCT01674569|41635927|FG000|Overall Study|Withdrawal by Subject|0|||
19391706|NCT01674569|41635928|FG001|Overall Study|Withdrawal by Subject|0|||
19391707|NCT01674569|41635929|FG002|Overall Study|Withdrawal by Subject|1|||
19391708|NCT01674569|41635930|FG003|Overall Study|Withdrawal by Subject|0|||
19391709|NCT01674569|41635931|FG004|Overall Study|Withdrawal by Subject|0|||
19391710|NCT01674569|41635932|FG005|Overall Study|Withdrawal by Subject|0|||
19702578|NCT00166712|42147023|FG000|Overall Study|Physician Decision|0|||
19702579|NCT00166712|42147024|FG001|Overall Study|Physician Decision|2|||
19702580|NCT00073528|42147036|FG000|Overall Study|Death|488|||
19702581|NCT00073528|42147037|FG001|Overall Study|Death|473|||
19702582|NCT00073528|42147036|FG000|Overall Study|Lost to Follow-up|52|||
19702583|NCT00073528|42147037|FG001|Overall Study|Lost to Follow-up|45|||
19702584|NCT00073528|42147036|FG000|Overall Study|Withdrawal by Subject|50|||
19702585|NCT00073528|42147037|FG001|Overall Study|Withdrawal by Subject|45|||
19702586|NCT00073528|42147036|FG000|Overall Study|Study terminated by Sponsor|10|||
19702587|NCT00073528|42147037|FG001|Overall Study|Study terminated by Sponsor|29|||
19702588|NCT00073528|42147036|FG000|Overall Study|Other|18|||
19702589|NCT00073528|42147037|FG001|Overall Study|Other|19|||
19702590|NCT00073528|42147036|FG000|Overall Study|Other|9|||
19702591|NCT00073528|42147037|FG001|Overall Study|Other|12|||
19702592|NCT00073528|42147036|FG000|Overall Study|Protocol Violation|3|||
19702593|NCT00073528|42147037|FG001|Overall Study|Protocol Violation|5|||
19702594|NCT03801148|42147047|FG000|Period 1 (2 Days)|Adverse Event|1|||
19702595|NCT03801148|42147048|FG001|Period 1 (2 Days)|Adverse Event|1|||
19702596|NCT03801148|42147049|FG002|Period 1 (2 Days)|Adverse Event|0|||
19702597|NCT03801148|42147050|FG003|Period 1 (2 Days)|Adverse Event|0|||
19702598|NCT03801148|42147047|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
19702599|NCT03801148|42147048|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
19702600|NCT03801148|42147049|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
19702601|NCT03801148|42147050|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
19702602|NCT03801148|42147047|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19702603|NCT03801148|42147048|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19702604|NCT03801148|42147049|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
19702605|NCT03801148|42147050|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
19702606|NCT03801148|42147047|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
19702607|NCT03801148|42147048|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
19702608|NCT03801148|42147049|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
19702609|NCT03801148|42147050|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
19702610|NCT00072280|42147062|FG000|Treatment|Found ineligible|1|||
19702611|NCT00072280|42147063|FG001|Treatment|Found ineligible|2|||
19702612|NCT00072280|42147062|FG000|Follow-up|Early termination of study|2|||
19702613|NCT00072280|42147063|FG001|Follow-up|Early termination of study|2|||
19702614|NCT00071812|42147072|FG000|24-Week Double-Blind Period|Adverse Event|2|||
19702615|NCT00071812|42147073|FG001|24-Week Double-Blind Period|Adverse Event|3|||
19391711|NCT01374217|41635936|FG000|Overall Study|Lack of Efficacy|13|||
19391712|NCT01674647|41635942|FG000|Treatment Period|Death|4|||
19391713|NCT01674647|41635943|FG001|Treatment Period|Death|1|||
19391714|NCT01674647|41635942|FG000|Treatment Period|Efficacy outcome reached|0|||
19391715|NCT01674647|41635943|FG001|Treatment Period|Efficacy outcome reached|1|||
19391716|NCT01674647|41635942|FG000|Treatment Period|Physician Decision|3|||
19391717|NCT01674647|41635943|FG001|Treatment Period|Physician Decision|1|||
19391718|NCT01674647|41635942|FG000|Treatment Period|Adverse Event|60|||
19391719|NCT01674647|41635943|FG001|Treatment Period|Adverse Event|22|||
19391720|NCT01674647|41635942|FG000|Treatment Period|Non-compliance with study drug|3|||
19391721|NCT01674647|41635943|FG001|Treatment Period|Non-compliance with study drug|0|||
19391722|NCT01674647|41635942|FG000|Treatment Period|Lost to Follow-up|1|||
19391723|NCT01674647|41635943|FG001|Treatment Period|Lost to Follow-up|1|||
19391724|NCT01674647|41635942|FG000|Treatment Period|Withdrawal by Subject|19|||
19391725|NCT01674647|41635943|FG001|Treatment Period|Withdrawal by Subject|16|||
19391726|NCT01674647|41635942|FG000|Treatment Period|Switching to other therapy|5|||
19391727|NCT01674647|41635943|FG001|Treatment Period|Switching to other therapy|2|||
19391728|NCT01674647|41635942|FG000|Treatment Period|Logistical difficulties|5|||
19391729|NCT01674647|41635943|FG001|Treatment Period|Logistical difficulties|8|||
19391730|NCT01674647|41635942|FG000|Treatment Period|Treatment failure|0|||
19391731|NCT01674647|41635943|FG001|Treatment Period|Treatment failure|14|||
19391732|NCT01674647|41635942|FG000|Treatment Period|Protocol Violation|56|||
19391733|NCT01674647|41635943|FG001|Treatment Period|Protocol Violation|36|||
19391734|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Death|3|||
19391735|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Death|2|||
19391736|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
19391737|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
19391738|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
19391739|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
19391740|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
19391741|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
19391742|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
19391743|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
19702616|NCT00071812|42147074|FG002|24-Week Double-Blind Period|Adverse Event|4|||
19702617|NCT00071812|42147075|FG003|24-Week Double-Blind Period|Adverse Event|4|||
19702618|NCT00071812|42147072|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
19702619|NCT00071812|42147073|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
19702620|NCT00071812|42147074|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
19391744|NCT01674647|41635942|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
19391745|NCT01674647|41635943|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
19391746|NCT02669407|41635949|FG000|Overall Study|Physician Decision|3|||
19391747|NCT02667457|41635955|FG000|Overall Study|Withdrawal by Subject|1|||
19391748|NCT02667457|41635956|FG001|Overall Study|Withdrawal by Subject|0|||
19391749|NCT02667457|41635955|FG000|Overall Study|Other Reason|0|||
19391750|NCT02667457|41635956|FG001|Overall Study|Other Reason|2|||
19391751|NCT02669095|41635965|FG000|Overall Study|Adverse Event|1|||
19391752|NCT02669095|41635966|FG001|Overall Study|Adverse Event|0|||
19391753|NCT02669095|41635965|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
19391754|NCT02669095|41635966|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
19391755|NCT02669095|41635965|FG000|Overall Study|Torn Lens|0|||
19610949|NCT00896532|42059808|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
19702621|NCT00071812|42147075|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
19702622|NCT00071812|42147072|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
19702623|NCT00071812|42147073|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
19702624|NCT00071812|42147074|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
19702625|NCT00071812|42147075|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
19702626|NCT00071812|42147072|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
19702627|NCT00071812|42147073|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
19702628|NCT00071812|42147074|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
19702629|NCT00071812|42147075|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
19702630|NCT00071812|42147072|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
19702631|NCT00071812|42147073|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
19702632|NCT00071812|42147074|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
19702633|NCT00071812|42147075|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
19702634|NCT00071812|42147072|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
19702635|NCT00071812|42147073|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
19702636|NCT00071812|42147074|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
19702637|NCT00071812|42147075|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
19702638|NCT00071812|42147072|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19702639|NCT00071812|42147073|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19702640|NCT00071812|42147074|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
19702641|NCT00071812|42147075|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
19702642|NCT00071812|42147072|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19702643|NCT00071812|42147073|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19702644|NCT00071812|42147074|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
19702645|NCT00071812|42147075|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
19702646|NCT00071812|42147072|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19702647|NCT00071812|42147073|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19702648|NCT00071812|42147074|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
19702649|NCT00071812|42147075|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
19702650|NCT00071812|42147072|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
19702651|NCT00071812|42147073|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
19702652|NCT00071812|42147074|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
19610950|NCT00896532|42059809|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
19702653|NCT00071812|42147075|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
19702654|NCT00071110|42147089|FG000|Overall Study|Protocol Violation|0|||
19702655|NCT00071110|42147090|FG001|Overall Study|Protocol Violation|4|||
19702656|NCT00071032|42147098|FG000|Overall Study|Lost to Follow-up|1|||
19702657|NCT00071032|42147099|FG001|Overall Study|Lost to Follow-up|1|||
19702658|NCT00071032|42147098|FG000|Overall Study|Withdrawal by Subject|8|||
19702659|NCT00071032|42147099|FG001|Overall Study|Withdrawal by Subject|6|||
19702660|NCT00071032|42147098|FG000|Overall Study|Missing Primary Outcome|0|||
19702661|NCT00071032|42147099|FG001|Overall Study|Missing Primary Outcome|1|||
19702662|NCT00259610|42147110|FG000|Overall Study|Withdrawal by Subject|33|||
19702663|NCT00259610|42147111|FG001|Overall Study|Withdrawal by Subject|25|||
19702664|NCT00259610|42147112|FG002|Overall Study|Withdrawal by Subject|29|||
19702665|NCT00259610|42147113|FG003|Overall Study|Withdrawal by Subject|19|||
19702666|NCT00259610|42147110|FG000|Overall Study|Lost to Follow-up|19|||
19702667|NCT00259610|42147111|FG001|Overall Study|Lost to Follow-up|8|||
19702668|NCT00259610|42147112|FG002|Overall Study|Lost to Follow-up|18|||
19702669|NCT00259610|42147113|FG003|Overall Study|Lost to Follow-up|15|||
19391756|NCT02669095|41635966|FG001|Overall Study|Torn Lens|1|||
19391757|NCT02669095|41635965|FG000|Overall Study|Visit 5 assessments not completed|0|||
19610951|NCT00896532|42059810|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610952|NCT00896532|42059811|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610953|NCT00896532|42059812|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610954|NCT00896532|42059813|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610955|NCT00896532|42059814|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19702670|NCT00259610|42147110|FG000|Overall Study|Physician Decision|6|||
19702671|NCT00259610|42147111|FG001|Overall Study|Physician Decision|4|||
19702672|NCT00259610|42147112|FG002|Overall Study|Physician Decision|7|||
19800873|NCT02727699|42259349|FG001|Overall Study|Adverse Event|0|||
19800874|NCT02727699|42259348|FG000|Overall Study|Withdrawal by Subject|5|||
19800875|NCT02727699|42259349|FG001|Overall Study|Withdrawal by Subject|3|||
19800876|NCT02727699|42259348|FG000|Overall Study|Protocol Violation|0|||
19800877|NCT02727699|42259349|FG001|Overall Study|Protocol Violation|1|||
19800878|NCT02727699|42259348|FG000|Overall Study|Physician Decision|0|||
19800879|NCT02727699|42259349|FG001|Overall Study|Physician Decision|1|||
19800880|NCT02727699|42259348|FG000|Overall Study|Lost to Follow-up|1|||
19800881|NCT02727699|42259349|FG001|Overall Study|Lost to Follow-up|0|||
19800882|NCT02727699|42259348|FG000|Overall Study|Sponsor Decision|1|||
19800883|NCT02727699|42259349|FG001|Overall Study|Sponsor Decision|0|||
19800884|NCT03576716|42259357|FG000|Overall Study|Withdrawal by Subject|0|||
19800885|NCT03576716|42259358|FG001|Overall Study|Withdrawal by Subject|1|||
19800886|NCT02847637|42259377|FG000|Overall Study|Withdrawal by Subject|0|||
19800887|NCT02847637|42259378|FG001|Overall Study|Withdrawal by Subject|1|||
19800888|NCT02847637|42259379|FG002|Overall Study|Withdrawal by Subject|1|||
19800889|NCT02847637|42259380|FG003|Overall Study|Withdrawal by Subject|0|||
19800890|NCT02847637|42259377|FG000|Overall Study|Lost to Follow-up|1|||
19800891|NCT02847637|42259378|FG001|Overall Study|Lost to Follow-up|1|||
19800892|NCT02847637|42259379|FG002|Overall Study|Lost to Follow-up|0|||
19800893|NCT02847637|42259380|FG003|Overall Study|Lost to Follow-up|0|||
19800894|NCT02652260|42259406|FG000|Overall Study|Pregnancy|0|||
19800895|NCT02652260|42259407|FG001|Overall Study|Pregnancy|1|||
19800896|NCT02652260|42259406|FG000|Overall Study|Withdrawal by Subject|0|||
19800897|NCT02652260|42259407|FG001|Overall Study|Withdrawal by Subject|1|||
19800898|NCT00706095|42259419|FG000|Overall Study|Progressive Disease|4|||
19800899|NCT00706095|42259420|FG001|Overall Study|Progressive Disease|5|||
19800900|NCT00706095|42259421|FG002|Overall Study|Progressive Disease|3|||
19800901|NCT00706095|42259419|FG000|Overall Study|Clinical Progression|1|||
19800902|NCT00706095|42259420|FG001|Overall Study|Clinical Progression|2|||
19702673|NCT00259610|42147113|FG003|Overall Study|Physician Decision|2|||
19702674|NCT00259610|42147110|FG000|Overall Study|Death|1|||
19702675|NCT00259610|42147111|FG001|Overall Study|Death|1|||
19702676|NCT00259610|42147112|FG002|Overall Study|Death|2|||
19702677|NCT00259610|42147113|FG003|Overall Study|Death|0|||
19702678|NCT00259610|42147110|FG000|Overall Study|non medical reason|6|||
19702679|NCT00259610|42147111|FG001|Overall Study|non medical reason|2|||
19702680|NCT00259610|42147112|FG002|Overall Study|non medical reason|10|||
19702681|NCT00259610|42147113|FG003|Overall Study|non medical reason|3|||
19702682|NCT00259610|42147110|FG000|Overall Study|Adverse Event|3|||
19702683|NCT00259610|42147111|FG001|Overall Study|Adverse Event|4|||
19702684|NCT00259610|42147112|FG002|Overall Study|Adverse Event|5|||
19702685|NCT00259610|42147113|FG003|Overall Study|Adverse Event|2|||
19702686|NCT00259610|42147110|FG000|Overall Study|Serious Adverse Event|8|||
19702687|NCT00259610|42147111|FG001|Overall Study|Serious Adverse Event|2|||
19702688|NCT00259610|42147112|FG002|Overall Study|Serious Adverse Event|2|||
19702689|NCT00259610|42147113|FG003|Overall Study|Serious Adverse Event|2|||
19702690|NCT00165776|42147127|FG000|Overall Study|Lack of Efficacy|0|||
19702691|NCT00165776|42147128|FG001|Overall Study|Lack of Efficacy|0|||
19702692|NCT00165776|42147129|FG002|Overall Study|Lack of Efficacy|0|||
19702693|NCT00165776|42147130|FG003|Overall Study|Lack of Efficacy|1|||
19702694|NCT00165776|42147127|FG000|Overall Study|Withdrawal by Subject|4|||
19702695|NCT00165776|42147128|FG001|Overall Study|Withdrawal by Subject|1|||
19702696|NCT00165776|42147129|FG002|Overall Study|Withdrawal by Subject|2|||
19702697|NCT00165776|42147130|FG003|Overall Study|Withdrawal by Subject|0|||
19702698|NCT00165776|42147127|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
19702699|NCT00165776|42147128|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
19800903|NCT00706095|42259421|FG002|Overall Study|Clinical Progression|2|||
19391758|NCT02669095|41635966|FG001|Overall Study|Visit 5 assessments not completed|1|||
19391759|NCT02667301|41635972|FG000|Overall Study|Adverse Event|1|||
19391760|NCT02667301|41635972|FG000|Overall Study|Lack of Efficacy|1|||
19391761|NCT04209725|41635978|FG000|Overall Study|Adverse Event|1|||
19391762|NCT02644967|41636071|FG000|Overall Study|Death|26|||
19391763|NCT02644967|41636071|FG000|Overall Study|Physician Decision|1|||
19391764|NCT02644967|41636071|FG000|Overall Study|Withdrawal by Subject|2|||
19391765|NCT02644967|41636071|FG000|Overall Study|Protocol Violation|1|||
19391766|NCT02644967|41636071|FG000|Overall Study|Progressive Disease|1|||
19391767|NCT02644967|41636071|FG000|Overall Study|Study Terminated by Sponsor|4|||
19391768|NCT02644343|41636075|FG000|Overall Study|Withdrawal by Subject|1|||
19391769|NCT02644109|41636081|FG000|Overall Study|Adverse Event|0|||
19702700|NCT00165776|42147129|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
19702701|NCT00165776|42147130|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
19702702|NCT00165698|42147142|FG000|Overall Study|Adverse Event|2|||
19800904|NCT00706095|42259419|FG000|Overall Study|Withdrawal by Subject|1|||
19800905|NCT00706095|42259420|FG001|Overall Study|Withdrawal by Subject|0|||
19800906|NCT00706095|42259421|FG002|Overall Study|Withdrawal by Subject|0|||
19702703|NCT00165698|42147143|FG001|Overall Study|Adverse Event|10|||
19702704|NCT00165698|42147142|FG000|Overall Study|Lost to Follow-up|2|||
19702705|NCT00165698|42147143|FG001|Overall Study|Lost to Follow-up|2|||
19702706|NCT00165698|42147142|FG000|Overall Study|Withdrawal by Subject|2|||
19702707|NCT00165698|42147143|FG001|Overall Study|Withdrawal by Subject|1|||
19702708|NCT00165698|42147142|FG000|Overall Study|Protocol Violation|1|||
19702709|NCT00165698|42147143|FG001|Overall Study|Protocol Violation|0|||
19702710|NCT00165698|42147142|FG000|Overall Study|Not Taken/Lost the medicine|1|||
19702711|NCT00165698|42147143|FG001|Overall Study|Not Taken/Lost the medicine|2|||
19702712|NCT00225758|42147149|FG000|Overall Study|Adverse Event|4|||
19702713|NCT00259298|42147155|FG000|Overall Study|Withdrawal by Subject|1|||
19702714|NCT00259298|42147155|FG000|Overall Study|Physician Decision|2|||
19702715|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
19702716|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
19702717|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
19702718|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
19702719|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
19702720|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
19702721|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
19702722|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
19702723|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
19702724|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
19702725|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
19702726|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
19702727|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
19702728|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
19702729|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
19702730|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
19702731|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
19702732|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
19702733|NCT03789292|42147165|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
19702734|NCT03789292|42147166|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
19391770|NCT02644109|41636082|FG001|Overall Study|Adverse Event|4|||
19391771|NCT02642159|41636090|FG000|Overall Study|Randomized but not treated|1|||
19391772|NCT02642159|41636091|FG001|Overall Study|Randomized but not treated|0|||
19391773|NCT02642159|41636090|FG000|Overall Study|Adverse Event|10|||
19391774|NCT02642159|41636091|FG001|Overall Study|Adverse Event|4|||
19391775|NCT02642159|41636090|FG000|Overall Study|Withdrawal by Subject|9|||
19391776|NCT02642159|41636091|FG001|Overall Study|Withdrawal by Subject|1|||
19391777|NCT02642159|41636090|FG000|Overall Study|Poor compliance to study protocol|1|||
19391778|NCT02642159|41636091|FG001|Overall Study|Poor compliance to study protocol|0|||
19391779|NCT02642159|41636090|FG000|Overall Study|Other than specified above|10|||
19391780|NCT02642159|41636091|FG001|Overall Study|Other than specified above|3|||
19391781|NCT02669017|41636107|FG000|Overall Study|Death|1|||
19391782|NCT02669017|41636108|FG001|Overall Study|Death|2|||
19391783|NCT02669017|41636109|FG002|Overall Study|Death|2|||
19391784|NCT02669017|41636110|FG003|Overall Study|Death|3|||
19391785|NCT02669017|41636111|FG004|Overall Study|Death|8|||
19391786|NCT02669017|41636112|FG005|Overall Study|Death|18|||
19391787|NCT02669017|41636113|FG006|Overall Study|Death|10|||
19391788|NCT02669017|41636114|FG007|Overall Study|Death|47|||
19391789|NCT02669017|41636115|FG008|Overall Study|Death|20|||
19391790|NCT02669017|41636107|FG000|Overall Study|Withdrawal by Subject|0|||
19391791|NCT02669017|41636108|FG001|Overall Study|Withdrawal by Subject|0|||
19391792|NCT02669017|41636109|FG002|Overall Study|Withdrawal by Subject|0|||
19391793|NCT02669017|41636110|FG003|Overall Study|Withdrawal by Subject|1|||
19391794|NCT02669017|41636111|FG004|Overall Study|Withdrawal by Subject|2|||
19391795|NCT02669017|41636112|FG005|Overall Study|Withdrawal by Subject|0|||
19391796|NCT02669017|41636113|FG006|Overall Study|Withdrawal by Subject|0|||
19391797|NCT02669017|41636114|FG007|Overall Study|Withdrawal by Subject|2|||
19391798|NCT02669017|41636115|FG008|Overall Study|Withdrawal by Subject|2|||
19391799|NCT02669017|41636107|FG000|Overall Study|Lost to Follow-up|0|||
19391800|NCT02669017|41636108|FG001|Overall Study|Lost to Follow-up|0|||
19391801|NCT02669017|41636109|FG002|Overall Study|Lost to Follow-up|0|||
19391802|NCT02669017|41636110|FG003|Overall Study|Lost to Follow-up|0|||
19391803|NCT02669017|41636111|FG004|Overall Study|Lost to Follow-up|0|||
19391804|NCT02669017|41636112|FG005|Overall Study|Lost to Follow-up|0|||
19391805|NCT02669017|41636113|FG006|Overall Study|Lost to Follow-up|0|||
19391806|NCT02669017|41636114|FG007|Overall Study|Lost to Follow-up|0|||
19391807|NCT02669017|41636115|FG008|Overall Study|Lost to Follow-up|1|||
19391808|NCT02669017|41636107|FG000|Overall Study|Miscellaneous|0|||
19391809|NCT02669017|41636108|FG001|Overall Study|Miscellaneous|0|||
19702735|NCT03789292|42147167|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
19702736|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
19702737|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
19702738|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
19702739|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
19702740|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
19702741|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
19702742|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
19702743|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
19702744|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
19702745|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
19702746|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
19702747|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
19702748|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
19702749|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
19702750|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
19702751|NCT03789292|42147165|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
19702752|NCT03789292|42147166|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
19800907|NCT02837731|42259431|FG000|Allocation|Admitted to General Floor|3|||
19800908|NCT02837731|42259432|FG001|Allocation|Admitted to General Floor|4|||
19800909|NCT02837731|42259431|FG000|Allocation|Immediate surgery/withdrew|2|||
19800910|NCT02837731|42259432|FG001|Allocation|Immediate surgery/withdrew|0|||
19800911|NCT02837731|42259431|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
19800912|NCT02837731|42259432|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
19800913|NCT02837731|42259431|FG000|Allocation|Withdrawal by Subject|2|||
19800914|NCT02837731|42259432|FG001|Allocation|Withdrawal by Subject|0|||
19800915|NCT02837731|42259431|FG000|Allocation|Device not available|1|||
19800916|NCT02837731|42259432|FG001|Allocation|Device not available|0|||
19800917|NCT02837731|42259431|FG000|Allocation|Protocol not implemented|7|||
19800918|NCT02837731|42259432|FG001|Allocation|Protocol not implemented|0|||
19800919|NCT02837731|42259431|FG000|Allocation|Moribund/Do not resuscitate|2|||
19800920|NCT02837731|42259432|FG001|Allocation|Moribund/Do not resuscitate|0|||
19800921|NCT02837731|42259431|FG000|Allocation|Did not meet sepsis criteria|1|||
19800922|NCT02837731|42259432|FG001|Allocation|Did not meet sepsis criteria|2|||
19800923|NCT02837731|42259431|FG000|Allocation|Known aortic abnormalities|0|||
19800924|NCT02837731|42259432|FG001|Allocation|Known aortic abnormalities|1|||
19800925|NCT02836873|42259440|FG000|Overall Study|Protocol Violation|0|||
19800926|NCT02836873|42259441|FG001|Overall Study|Protocol Violation|1|||
19800927|NCT02836873|42259440|FG000|Overall Study|Adverse Event|1|||
19800928|NCT02836873|42259441|FG001|Overall Study|Adverse Event|4|||
19800929|NCT02836873|42259440|FG000|Overall Study|Withdrawal by Subject|2|||
19800930|NCT02836873|42259441|FG001|Overall Study|Withdrawal by Subject|2|||
19800931|NCT02836873|42259440|FG000|Overall Study|Lost to Follow-up|1|||
19800932|NCT02836873|42259441|FG001|Overall Study|Lost to Follow-up|3|||
19800933|NCT02836873|42259440|FG000|Overall Study|Physician Decision|0|||
19800934|NCT02836873|42259441|FG001|Overall Study|Physician Decision|1|||
19800935|NCT02836873|42259440|FG000|Overall Study|Other|1|||
19391810|NCT02669017|41636109|FG002|Overall Study|Miscellaneous|0|||
19391811|NCT02669017|41636110|FG003|Overall Study|Miscellaneous|0|||
19391812|NCT02669017|41636111|FG004|Overall Study|Miscellaneous|2|||
19391813|NCT02669017|41636112|FG005|Overall Study|Miscellaneous|1|||
19391814|NCT02669017|41636113|FG006|Overall Study|Miscellaneous|1|||
19391815|NCT02669017|41636114|FG007|Overall Study|Miscellaneous|13|||
19391816|NCT02669017|41636115|FG008|Overall Study|Miscellaneous|2|||
19610956|NCT00896532|42059815|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610957|NCT00896532|42059816|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610958|NCT00896532|42059817|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19610959|NCT00896532|42059818|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
19391817|NCT02668393|41636145|FG000|Overall Study|Progressive disease|6|||
19391818|NCT02668393|41636146|FG001|Overall Study|Progressive disease|3|||
19391819|NCT02668393|41636145|FG000|Overall Study|Adverse Event|0|||
19391820|NCT02668393|41636146|FG001|Overall Study|Adverse Event|2|||
19391821|NCT02668393|41636145|FG000|Overall Study|Withdrawal from the trial|0|||
19391822|NCT02668393|41636146|FG001|Overall Study|Withdrawal from the trial|1|||
19391823|NCT02668393|41636145|FG000|Overall Study|Lack of benefit and side effects|1|||
19391824|NCT02668393|41636146|FG001|Overall Study|Lack of benefit and side effects|0|||
19391825|NCT01998958|41636160|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391826|NCT01998958|41636161|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
19391827|NCT01998958|41636162|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391828|NCT01998958|41636163|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19610960|NCT00896532|42059796|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
19800936|NCT02836873|42259441|FG001|Overall Study|Other|0|||
19800937|NCT02836249|42259449|FG000|Overall Study|Randomized but Never Treated|0|||
19800938|NCT02836249|42259450|FG001|Overall Study|Randomized but Never Treated|1|||
19610961|NCT00896532|42059797|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
19610962|NCT00896532|42059798|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
19610963|NCT00896532|42059799|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
19610964|NCT00896532|42059800|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
19702753|NCT03789292|42147167|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
19702754|NCT03781336|42147183|FG000|Overall Study|Withdrawal by Subject|2|||
19702755|NCT03781336|42147184|FG001|Overall Study|Withdrawal by Subject|2|||
19702756|NCT03780400|42147190|FG000|Overall Study|Lost to Follow-up|5|||
19702757|NCT03780400|42147190|FG000|Overall Study|Withdrawal by Subject|2|||
19702758|NCT03780244|42147196|FG000|Overall Study|Lost to Follow-up|1|||
19702759|NCT03780244|42147197|FG001|Overall Study|Lost to Follow-up|0|||
19702760|NCT03786718|42147203|FG000|Overall Study|Lost to Follow-up|3|||
19702761|NCT03786718|42147203|FG000|Overall Study|Withdrawal by Subject|1|||
19702762|NCT03786718|42147203|FG000|Overall Study|Did not use the intervention|2|||
19702763|NCT03786718|42147203|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
19702764|NCT03785548|42147210|FG000|Overall Study|age > 80|1|||
19800939|NCT02836249|42259449|FG000|Overall Study|Pregnancy|2|||
19800940|NCT02836249|42259450|FG001|Overall Study|Pregnancy|0|||
19800941|NCT02836249|42259449|FG000|Overall Study|Withdrew Consent|0|||
19800942|NCT02836249|42259450|FG001|Overall Study|Withdrew Consent|1|||
19800943|NCT02836249|42259449|FG000|Overall Study|Lost to Follow-up|0|||
19800944|NCT02836249|42259450|FG001|Overall Study|Lost to Follow-up|1|||
19800945|NCT02836249|42259449|FG000|Overall Study|Still on Study|121|||
19800946|NCT02836249|42259450|FG001|Overall Study|Still on Study|55|||
19800947|NCT01342081|42259468|FG000|Overall Study|Did not receive allocated intervention|0|||
19800948|NCT01342081|42259469|FG001|Overall Study|Did not receive allocated intervention|0|||
19800949|NCT01342081|42259470|FG002|Overall Study|Did not receive allocated intervention|1|||
19800950|NCT01342081|42259468|FG000|Overall Study|Adverse Event|1|||
19702765|NCT03785548|42147211|FG001|Overall Study|age > 80|0|||
19800951|NCT01342081|42259469|FG001|Overall Study|Adverse Event|0|||
19800952|NCT01342081|42259470|FG002|Overall Study|Adverse Event|0|||
19800953|NCT01342081|42259468|FG000|Overall Study|Physician Decision|0|||
19800954|NCT01342081|42259469|FG001|Overall Study|Physician Decision|1|||
19800955|NCT01342081|42259470|FG002|Overall Study|Physician Decision|0|||
19800956|NCT01342081|42259468|FG000|Overall Study|Withdrawal by Subject|1|||
19800957|NCT01342081|42259469|FG001|Overall Study|Withdrawal by Subject|1|||
19800958|NCT01342081|42259470|FG002|Overall Study|Withdrawal by Subject|0|||
19800959|NCT01341457|42259480|FG000|Overall Study|Adverse Event|2|||
19702766|NCT03785548|42147210|FG000|Overall Study|no Postop queries|1|||
19702767|NCT03785548|42147211|FG001|Overall Study|no Postop queries|0|||
19702768|NCT00141297|42147219|FG000|Overall Study|Adverse Event|0|||
19702769|NCT00141297|42147220|FG001|Overall Study|Adverse Event|0|||
19702770|NCT00141297|42147221|FG002|Overall Study|Adverse Event|1|||
19702771|NCT00141297|42147222|FG003|Overall Study|Adverse Event|0|||
19702772|NCT00141297|42147223|FG004|Overall Study|Adverse Event|1|||
19800960|NCT01341457|42259481|FG001|Overall Study|Adverse Event|0|||
19800961|NCT02832037|42259493|FG000|Overall Study|Administrative reasons|0|||
19800962|NCT02832037|42259494|FG001|Overall Study|Administrative reasons|0|||
19800963|NCT02832037|42259495|FG002|Overall Study|Administrative reasons|1|||
19800964|NCT02832037|42259496|FG003|Overall Study|Administrative reasons|0|||
19800965|NCT02832037|42259497|FG004|Overall Study|Administrative reasons|0|||
19800966|NCT02832037|42259493|FG000|Overall Study|Protocol Violation|3|||
19800967|NCT02832037|42259494|FG001|Overall Study|Protocol Violation|0|||
19800968|NCT02832037|42259495|FG002|Overall Study|Protocol Violation|4|||
19800969|NCT02832037|42259496|FG003|Overall Study|Protocol Violation|1|||
19800970|NCT02832037|42259497|FG004|Overall Study|Protocol Violation|2|||
19800971|NCT02832037|42259493|FG000|Overall Study|Lost to Follow-up|2|||
19800972|NCT02832037|42259494|FG001|Overall Study|Lost to Follow-up|0|||
19800973|NCT02832037|42259495|FG002|Overall Study|Lost to Follow-up|3|||
19800974|NCT02832037|42259496|FG003|Overall Study|Lost to Follow-up|0|||
19610965|NCT00896532|42059801|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
19610966|NCT00896532|42059802|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
19610967|NCT00896532|42059803|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
19610968|NCT00896532|42059804|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
19610969|NCT00896532|42059805|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
19610970|NCT00896532|42059806|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
19610971|NCT00896532|42059807|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
19610972|NCT00896532|42059808|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
19702773|NCT00141297|42147224|FG005|Overall Study|Adverse Event|1|||
19702774|NCT00141297|42147225|FG006|Overall Study|Adverse Event|0|||
19702775|NCT00141297|42147226|FG007|Overall Study|Adverse Event|1|||
19800975|NCT02832037|42259497|FG004|Overall Study|Lost to Follow-up|5|||
19800976|NCT02832037|42259493|FG000|Overall Study|Withdrawal by Subject|9|||
19800977|NCT02832037|42259494|FG001|Overall Study|Withdrawal by Subject|8|||
19800978|NCT02832037|42259495|FG002|Overall Study|Withdrawal by Subject|0|||
19800979|NCT02832037|42259496|FG003|Overall Study|Withdrawal by Subject|4|||
19800980|NCT02832037|42259497|FG004|Overall Study|Withdrawal by Subject|8|||
19800981|NCT02832037|42259493|FG000|Overall Study|Adverse Event|5|||
19800982|NCT02832037|42259494|FG001|Overall Study|Adverse Event|4|||
19800983|NCT02832037|42259495|FG002|Overall Study|Adverse Event|0|||
19800984|NCT02832037|42259496|FG003|Overall Study|Adverse Event|2|||
19800985|NCT02832037|42259497|FG004|Overall Study|Adverse Event|4|||
19800986|NCT01675154|42259513|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
19800987|NCT01675154|42259514|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
19800988|NCT01675154|42259515|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
19800989|NCT01675154|42259516|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
19800990|NCT02744755|42259540|FG000|Study Period 1|Protocol Violation|2|||
19800991|NCT02744755|42259541|FG001|Study Period 1|Protocol Violation|1|||
19800992|NCT02744755|42259540|FG000|Study Period 1|not defined|0|||
19800993|NCT02744755|42259541|FG001|Study Period 1|not defined|1|||
19800994|NCT02744755|42259540|FG000|Study Period 1|Pregnancy|1|||
19800995|NCT02744755|42259541|FG001|Study Period 1|Pregnancy|0|||
19800996|NCT02744755|42259540|FG000|Study Period 1|Adverse Event|1|||
19800997|NCT02744755|42259541|FG001|Study Period 1|Adverse Event|1|||
19800998|NCT02744755|42259540|FG000|Study Period 1|Lost to Follow-up|1|||
19702776|NCT00141297|42147227|FG008|Overall Study|Adverse Event|1|||
19702777|NCT00141297|42147228|FG009|Overall Study|Adverse Event|0|||
19702778|NCT00141297|42147219|FG000|Overall Study|Death|1|||
19702779|NCT00141297|42147220|FG001|Overall Study|Death|0|||
19702780|NCT00141297|42147221|FG002|Overall Study|Death|0|||
19702781|NCT00141297|42147222|FG003|Overall Study|Death|0|||
19702782|NCT00141297|42147223|FG004|Overall Study|Death|0|||
19702783|NCT00141297|42147224|FG005|Overall Study|Death|0|||
19702784|NCT00141297|42147225|FG006|Overall Study|Death|0|||
19702785|NCT00141297|42147226|FG007|Overall Study|Death|0|||
19702786|NCT00141297|42147227|FG008|Overall Study|Death|1|||
19702787|NCT00141297|42147228|FG009|Overall Study|Death|0|||
19702788|NCT00141297|42147219|FG000|Overall Study|Withdrawal by Subject|0|||
19702789|NCT00141297|42147220|FG001|Overall Study|Withdrawal by Subject|0|||
19702790|NCT00141297|42147221|FG002|Overall Study|Withdrawal by Subject|0|||
19702791|NCT00141297|42147222|FG003|Overall Study|Withdrawal by Subject|0|||
19702792|NCT00141297|42147223|FG004|Overall Study|Withdrawal by Subject|0|||
19702793|NCT00141297|42147224|FG005|Overall Study|Withdrawal by Subject|0|||
19702794|NCT00141297|42147225|FG006|Overall Study|Withdrawal by Subject|0|||
19702795|NCT00141297|42147226|FG007|Overall Study|Withdrawal by Subject|0|||
19702796|NCT00141297|42147227|FG008|Overall Study|Withdrawal by Subject|1|||
19702797|NCT00141297|42147228|FG009|Overall Study|Withdrawal by Subject|0|||
19702798|NCT00141297|42147219|FG000|Overall Study|Other|0|||
19702799|NCT00141297|42147220|FG001|Overall Study|Other|0|||
19702800|NCT00141297|42147221|FG002|Overall Study|Other|0|||
19702801|NCT00141297|42147222|FG003|Overall Study|Other|1|||
19702802|NCT00141297|42147223|FG004|Overall Study|Other|5|||
19702803|NCT00141297|42147224|FG005|Overall Study|Other|0|||
19702804|NCT00141297|42147225|FG006|Overall Study|Other|0|||
19702805|NCT00141297|42147226|FG007|Overall Study|Other|0|||
19702806|NCT00141297|42147227|FG008|Overall Study|Other|2|||
19702807|NCT00141297|42147228|FG009|Overall Study|Other|0|||
19702808|NCT00141297|42147219|FG000|Overall Study|Progressive Disease|2|||
19702809|NCT00141297|42147220|FG001|Overall Study|Progressive Disease|3|||
19702810|NCT00141297|42147221|FG002|Overall Study|Progressive Disease|6|||
19702811|NCT00141297|42147222|FG003|Overall Study|Progressive Disease|2|||
19702812|NCT00141297|42147223|FG004|Overall Study|Progressive Disease|15|||
19702813|NCT00141297|42147224|FG005|Overall Study|Progressive Disease|2|||
19702814|NCT00141297|42147225|FG006|Overall Study|Progressive Disease|3|||
19702815|NCT00141297|42147226|FG007|Overall Study|Progressive Disease|3|||
19702816|NCT00141297|42147227|FG008|Overall Study|Progressive Disease|15|||
19702817|NCT00141297|42147228|FG009|Overall Study|Progressive Disease|6|||
19702818|NCT00141297|42147219|FG000|Overall Study|Transitioned|0|||
19702819|NCT00141297|42147220|FG001|Overall Study|Transitioned|0|||
19702820|NCT00141297|42147221|FG002|Overall Study|Transitioned|0|||
19702821|NCT00141297|42147222|FG003|Overall Study|Transitioned|0|||
19702822|NCT00141297|42147223|FG004|Overall Study|Transitioned|1|||
19702823|NCT00141297|42147224|FG005|Overall Study|Transitioned|0|||
19702824|NCT00141297|42147225|FG006|Overall Study|Transitioned|0|||
19702825|NCT00141297|42147226|FG007|Overall Study|Transitioned|0|||
19702826|NCT00141297|42147227|FG008|Overall Study|Transitioned|0|||
19702827|NCT00141297|42147228|FG009|Overall Study|Transitioned|0|||
19702828|NCT00141219|42147263|FG000|Overall Study|Protocol violations|5|||
19702829|NCT00141219|42147264|FG001|Overall Study|Protocol violations|4|||
19702830|NCT00141219|42147263|FG000|Overall Study|Adverse Event|8|||
19702831|NCT00141219|42147264|FG001|Overall Study|Adverse Event|6|||
19702832|NCT00141219|42147263|FG000|Overall Study|Lack of Efficacy|5|||
19702833|NCT00141219|42147264|FG001|Overall Study|Lack of Efficacy|4|||
19800999|NCT02744755|42259541|FG001|Study Period 1|Lost to Follow-up|1|||
19801000|NCT02744755|42259540|FG000|Study Period 1|Lack of Efficacy|1|||
19801001|NCT02744755|42259541|FG001|Study Period 1|Lack of Efficacy|0|||
19801002|NCT02744755|42259540|FG000|Study Period 1|Withdrawal by Subject|8|||
19702834|NCT00141219|42147263|FG000|Overall Study|Withdrawal by Subject|6|||
19702835|NCT00141219|42147264|FG001|Overall Study|Withdrawal by Subject|2|||
19702836|NCT00162266|42147273|FG000|Double-Blind Period|Adverse Event|5|||
19702837|NCT00162266|42147274|FG001|Double-Blind Period|Adverse Event|9|||
19702838|NCT00162266|42147275|FG002|Double-Blind Period|Adverse Event|11|||
19702839|NCT00162266|42147276|FG003|Double-Blind Period|Adverse Event|0|||
19702840|NCT00162266|42147273|FG000|Double-Blind Period|Death|0|||
19702841|NCT00162266|42147274|FG001|Double-Blind Period|Death|1|||
19702842|NCT00162266|42147275|FG002|Double-Blind Period|Death|0|||
19801003|NCT02744755|42259541|FG001|Study Period 1|Withdrawal by Subject|4|||
19801004|NCT02744755|42259540|FG000|Study Period 2|Adverse Event|5|||
19801005|NCT02744755|42259541|FG001|Study Period 2|Adverse Event|0|||
19801006|NCT02744755|42259540|FG000|Study Period 2|Protocol Violation|1|||
19801007|NCT02744755|42259541|FG001|Study Period 2|Protocol Violation|0|||
19801008|NCT02744755|42259540|FG000|Study Period 2|not defined|3|||
19801009|NCT02744755|42259541|FG001|Study Period 2|not defined|2|||
19801010|NCT02744755|42259540|FG000|Study Period 2|Lost to Follow-up|0|||
19801011|NCT02744755|42259541|FG001|Study Period 2|Lost to Follow-up|2|||
19801012|NCT02744755|42259540|FG000|Study Period 2|Withdrawal by Subject|2|||
19801013|NCT02744755|42259541|FG001|Study Period 2|Withdrawal by Subject|2|||
19801014|NCT02744755|42259540|FG000|Study Period 2|Lack of Efficacy|3|||
19801015|NCT02744755|42259541|FG001|Study Period 2|Lack of Efficacy|2|||
19801016|NCT01356589|42259559|FG000|Overall Study|Enrolled, but not treated|3|||
19801017|NCT01356589|42259559|FG000|Overall Study|Dose data not recorded|2|||
19801018|NCT02830087|42259569|FG000|Overall Study|No study staff to follow-up patients|4|||
19801019|NCT02830087|42259570|FG001|Overall Study|No study staff to follow-up patients|4|||
19801020|NCT02830087|42259571|FG002|Overall Study|No study staff to follow-up patients|4|||
19801021|NCT02830087|42259572|FG003|Overall Study|No study staff to follow-up patients|3|||
19801022|NCT02830087|42259573|FG004|Overall Study|No study staff to follow-up patients|3|||
19801023|NCT02830087|42259574|FG005|Overall Study|No study staff to follow-up patients|3|||
19801024|NCT02829775|42259588|FG000|Overall Study|Death|1|||
19801025|NCT02829775|42259588|FG000|Overall Study|Withdrawal by Subject|3|||
19801026|NCT02829775|42259588|FG000|Overall Study|Disease remission|1|||
19801027|NCT01355497|42259609|FG000|Overall Study|Death|19|||
19801028|NCT01355497|42259610|FG001|Overall Study|Death|18|||
19801029|NCT01355497|42259609|FG000|Overall Study|Lost to Follow-up|3|||
19801030|NCT01355497|42259610|FG001|Overall Study|Lost to Follow-up|0|||
19801031|NCT01355497|42259609|FG000|Overall Study|Protocol Violation|0|||
19801032|NCT01355497|42259610|FG001|Overall Study|Protocol Violation|1|||
19801033|NCT01355497|42259609|FG000|Overall Study|other-not provided|9|||
19801034|NCT01355497|42259610|FG001|Overall Study|other-not provided|4|||
19801035|NCT01355497|42259609|FG000|Overall Study|Withdrawal by Subject|12|||
19801036|NCT01355497|42259610|FG001|Overall Study|Withdrawal by Subject|20|||
19801037|NCT01355497|42259609|FG000|Overall Study|noncompliance|1|||
19801038|NCT01355497|42259610|FG001|Overall Study|noncompliance|2|||
19801039|NCT01355497|42259609|FG000|Overall Study|progressive disease|11|||
19801040|NCT01355497|42259610|FG001|Overall Study|progressive disease|8|||
19801041|NCT01355497|42259609|FG000|Overall Study|Adverse Event|11|||
19801042|NCT01355497|42259610|FG001|Overall Study|Adverse Event|10|||
19801043|NCT01355575|42259616|FG000|Overall Study|Withdrawal by Subject|2|||
19801044|NCT02826421|42259628|FG000|Overall Study|Adverse Event|1|||
19801045|NCT02826421|42259629|FG001|Overall Study|Adverse Event|0|||
19801046|NCT02826421|42259630|FG002|Overall Study|Adverse Event|0|||
19801047|NCT02826421|42259631|FG003|Overall Study|Adverse Event|1|||
19801048|NCT02826421|42259628|FG000|Overall Study|Withdrawal by Subject|1|||
19801049|NCT02826421|42259629|FG001|Overall Study|Withdrawal by Subject|3|||
19801050|NCT02826421|42259630|FG002|Overall Study|Withdrawal by Subject|1|||
19801051|NCT02826421|42259631|FG003|Overall Study|Withdrawal by Subject|1|||
19801052|NCT02826421|42259628|FG000|Overall Study|Reason not given|1|||
19801053|NCT02826421|42259629|FG001|Overall Study|Reason not given|0|||
19801054|NCT02826421|42259630|FG002|Overall Study|Reason not given|1|||
19801055|NCT02826421|42259631|FG003|Overall Study|Reason not given|0|||
19801056|NCT02825251|42259644|FG000|Overall Study|Adverse Event|0|||
19801057|NCT02825251|42259645|FG001|Overall Study|Adverse Event|1|||
19478441|NCT01588496|41757714|FG002|Overall Study|Withdrawal by Subject|0|||
19801058|NCT02825251|42259644|FG000|Overall Study|Lost to Follow-up|0|||
19801059|NCT02825251|42259645|FG001|Overall Study|Lost to Follow-up|1|||
19801060|NCT02825251|42259644|FG000|Overall Study|Withdrawal by Subject|1|||
19801061|NCT02825251|42259645|FG001|Overall Study|Withdrawal by Subject|4|||
19801062|NCT02825251|42259644|FG000|Overall Study|Unclassified|2|||
19801063|NCT02825251|42259645|FG001|Overall Study|Unclassified|0|||
19702843|NCT00162266|42147276|FG003|Double-Blind Period|Death|0|||
19702844|NCT00162266|42147273|FG000|Double-Blind Period|Lost to Follow-up|1|||
19702845|NCT00162266|42147274|FG001|Double-Blind Period|Lost to Follow-up|2|||
19702846|NCT00162266|42147275|FG002|Double-Blind Period|Lost to Follow-up|0|||
19702847|NCT00162266|42147276|FG003|Double-Blind Period|Lost to Follow-up|0|||
19702848|NCT00162266|42147273|FG000|Double-Blind Period|Other Reason|1|||
19702849|NCT00162266|42147274|FG001|Double-Blind Period|Other Reason|0|||
19702850|NCT00162266|42147275|FG002|Double-Blind Period|Other Reason|1|||
19702851|NCT00162266|42147276|FG003|Double-Blind Period|Other Reason|0|||
19702852|NCT00162266|42147273|FG000|Double-Blind Period|Lack of Efficacy|13|||
19702853|NCT00162266|42147274|FG001|Double-Blind Period|Lack of Efficacy|17|||
19702854|NCT00162266|42147275|FG002|Double-Blind Period|Lack of Efficacy|30|||
19702855|NCT00162266|42147276|FG003|Double-Blind Period|Lack of Efficacy|0|||
19702856|NCT00162266|42147273|FG000|Double-Blind Period|Withdrawal by Subject|5|||
19702857|NCT00162266|42147274|FG001|Double-Blind Period|Withdrawal by Subject|2|||
19702858|NCT00162266|42147275|FG002|Double-Blind Period|Withdrawal by Subject|6|||
19702859|NCT00162266|42147276|FG003|Double-Blind Period|Withdrawal by Subject|0|||
19702860|NCT00162266|42147273|FG000|Open-Label Period|Death|0|||
19702861|NCT00162266|42147274|FG001|Open-Label Period|Death|0|||
19702862|NCT00162266|42147275|FG002|Open-Label Period|Death|0|||
19702863|NCT00162266|42147276|FG003|Open-Label Period|Death|7|||
19702864|NCT00162266|42147273|FG000|Open-Label Period|Adverse Event|0|||
19702865|NCT00162266|42147274|FG001|Open-Label Period|Adverse Event|0|||
19702866|NCT00162266|42147275|FG002|Open-Label Period|Adverse Event|0|||
19702867|NCT00162266|42147276|FG003|Open-Label Period|Adverse Event|46|||
19702868|NCT00162266|42147273|FG000|Open-Label Period|Lack of Efficacy|0|||
19702869|NCT00162266|42147274|FG001|Open-Label Period|Lack of Efficacy|0|||
19702870|NCT00162266|42147275|FG002|Open-Label Period|Lack of Efficacy|0|||
19702871|NCT00162266|42147276|FG003|Open-Label Period|Lack of Efficacy|26|||
19702872|NCT00162266|42147273|FG000|Open-Label Period|Lost to Follow-up|0|||
19702873|NCT00162266|42147274|FG001|Open-Label Period|Lost to Follow-up|0|||
19702874|NCT00162266|42147275|FG002|Open-Label Period|Lost to Follow-up|0|||
19702875|NCT00162266|42147276|FG003|Open-Label Period|Lost to Follow-up|3|||
19702876|NCT00162266|42147273|FG000|Open-Label Period|Withdrawal by Subject|0|||
19702877|NCT00162266|42147274|FG001|Open-Label Period|Withdrawal by Subject|0|||
19610973|NCT00896532|42059809|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
19610974|NCT00896532|42059810|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
19610975|NCT00896532|42059811|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
19610976|NCT00896532|42059812|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
19702878|NCT00162266|42147275|FG002|Open-Label Period|Withdrawal by Subject|0|||
19702879|NCT00162266|42147276|FG003|Open-Label Period|Withdrawal by Subject|31|||
19702880|NCT00162266|42147273|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
19702881|NCT00162266|42147274|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
19702882|NCT00162266|42147275|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
19702883|NCT00162266|42147276|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
19702884|NCT00162266|42147273|FG000|Open-Label Period|Other Reasons|0|||
19702885|NCT00162266|42147274|FG001|Open-Label Period|Other Reasons|0|||
19702886|NCT00162266|42147275|FG002|Open-Label Period|Other Reasons|0|||
19610977|NCT00896532|42059813|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
19610978|NCT00896532|42059814|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
19610979|NCT00896532|42059815|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
19610980|NCT00896532|42059816|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
19610981|NCT00896532|42059817|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
19610982|NCT00896532|42059818|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
19610983|NCT00896532|42059796|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610984|NCT00896532|42059797|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610985|NCT00896532|42059798|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610986|NCT00896532|42059799|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610987|NCT00896532|42059800|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610988|NCT00896532|42059801|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610989|NCT00896532|42059802|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610990|NCT00896532|42059803|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610991|NCT00896532|42059804|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610992|NCT00896532|42059805|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610993|NCT00896532|42059806|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610994|NCT00896532|42059807|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610995|NCT00896532|42059808|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610996|NCT00896532|42059809|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19610997|NCT00896532|42059810|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19702887|NCT00162266|42147276|FG003|Open-Label Period|Other Reasons|15|||
19702888|NCT00225212|42147328|FG000|Overall Study|Disease progression|2|||
19702889|NCT00225212|42147328|FG000|Overall Study|Death|1|||
19702890|NCT00225212|42147328|FG000|Overall Study|Adverse Event|2|||
19702891|NCT00225212|42147328|FG000|Overall Study|Intercurrent illness|1|||
19702892|NCT00162032|42147334|FG000|Overall Study|Lost to Follow-up|4|||
19702893|NCT00162032|42147335|FG001|Overall Study|Lost to Follow-up|2|||
19702894|NCT00162032|42147334|FG000|Overall Study|Reason not specified|1|||
19391829|NCT01998958|41636164|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391830|NCT01998958|41636165|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391831|NCT01998958|41636166|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391832|NCT01998958|41636167|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391833|NCT01998958|41636168|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391834|NCT01998958|41636169|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391835|NCT01998958|41636170|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391836|NCT01998958|41636171|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391837|NCT01998958|41636172|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391838|NCT01998958|41636173|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391839|NCT01998958|41636174|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391840|NCT01998958|41636175|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391841|NCT01998958|41636176|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391842|NCT01998958|41636177|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391843|NCT01998958|41636178|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391844|NCT01998958|41636179|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391845|NCT01998958|41636180|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391846|NCT01998958|41636181|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391847|NCT01998958|41636182|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391848|NCT01998958|41636183|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391849|NCT01998958|41636184|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391850|NCT01998958|41636185|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391851|NCT01998958|41636186|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391852|NCT01998958|41636187|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391853|NCT01998958|41636188|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391854|NCT01998958|41636189|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391855|NCT01998958|41636190|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391856|NCT01998958|41636191|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
19391857|NCT01998958|41636160|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391858|NCT01998958|41636161|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
19391859|NCT01998958|41636162|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391860|NCT01998958|41636163|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391861|NCT01998958|41636164|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391862|NCT01998958|41636165|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391863|NCT01998958|41636166|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391864|NCT01998958|41636167|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391865|NCT01998958|41636168|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391866|NCT01998958|41636169|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391867|NCT01998958|41636170|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391868|NCT01998958|41636171|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391869|NCT01998958|41636172|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391870|NCT01998958|41636173|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391871|NCT01998958|41636174|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391872|NCT01998958|41636175|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391873|NCT01998958|41636176|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391874|NCT01998958|41636177|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391875|NCT01998958|41636178|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391876|NCT01998958|41636179|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391877|NCT01998958|41636180|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391878|NCT01998958|41636181|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391879|NCT01998958|41636182|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391880|NCT01998958|41636183|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391881|NCT01998958|41636184|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391882|NCT01998958|41636185|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391883|NCT01998958|41636186|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391884|NCT01998958|41636187|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391885|NCT01998958|41636188|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391886|NCT01998958|41636189|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19610998|NCT00896532|42059811|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
19702895|NCT00162032|42147335|FG001|Overall Study|Reason not specified|0|||
19702896|NCT00258674|42147349|FG000|Overall Study|Death|32|||
19702897|NCT00258674|42147350|FG001|Overall Study|Death|53|||
19702898|NCT00258674|42147351|FG002|Overall Study|Death|34|||
19702899|NCT00258440|42147362|FG000|Overall Study|Withdrawal by Subject|0|||
19702900|NCT00258440|42147363|FG001|Overall Study|Withdrawal by Subject|0|||
19702901|NCT00258440|42147364|FG002|Overall Study|Withdrawal by Subject|1|||
19702902|NCT00224120|42147374|FG000|Overall Study|Adverse Event|10|||
19702903|NCT00224120|42147375|FG001|Overall Study|Adverse Event|4|||
19391887|NCT01998958|41636190|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391888|NCT01998958|41636191|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
19391889|NCT01998958|41636160|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
19702904|NCT00224120|42147374|FG000|Overall Study|Protocol Violation|1|||
19610999|NCT00896532|42059812|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
19611000|NCT00896532|42059813|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19611001|NCT00896532|42059814|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19611002|NCT00896532|42059815|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19611003|NCT00896532|42059816|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19611004|NCT00896532|42059817|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19611005|NCT00896532|42059818|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
19702905|NCT00224120|42147375|FG001|Overall Study|Protocol Violation|0|||
19702906|NCT00224120|42147374|FG000|Overall Study|Withdrawal by Subject|5|||
19702907|NCT00224120|42147375|FG001|Overall Study|Withdrawal by Subject|10|||
19702908|NCT00224120|42147374|FG000|Overall Study|Lack of Efficacy|0|||
19702909|NCT00224120|42147375|FG001|Overall Study|Lack of Efficacy|2|||
19702910|NCT00224120|42147374|FG000|Overall Study|Lost to Follow-up|2|||
19702911|NCT00224120|42147375|FG001|Overall Study|Lost to Follow-up|3|||
19702912|NCT00224120|42147374|FG000|Overall Study|Other|4|||
19702913|NCT00224120|42147375|FG001|Overall Study|Other|5|||
19702914|NCT00257660|42147383|FG000|Overall Study|Lack of Efficacy|5|||
19702915|NCT00257660|42147384|FG001|Overall Study|Lack of Efficacy|23|||
19702916|NCT00257660|42147383|FG000|Overall Study|Withdrawal by Subject|2|||
19702917|NCT00257660|42147384|FG001|Overall Study|Withdrawal by Subject|0|||
19702918|NCT00257660|42147383|FG000|Overall Study|Lost to Follow-up|1|||
19702919|NCT00257660|42147384|FG001|Overall Study|Lost to Follow-up|0|||
19702920|NCT00257660|42147383|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
19702921|NCT00257660|42147384|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
19702922|NCT00257660|42147383|FG000|Overall Study|No longer wanted to do blood draws|1|||
19702923|NCT00257660|42147384|FG001|Overall Study|No longer wanted to do blood draws|0|||
19702924|NCT00224042|42147392|FG000|Overall Study|Adverse Event|2|||
19702925|NCT00224042|42147393|FG001|Overall Study|Adverse Event|1|||
19702926|NCT00224042|42147392|FG000|Overall Study|Protocol Violation|0|||
19702927|NCT00224042|42147393|FG001|Overall Study|Protocol Violation|1|||
19702928|NCT00224042|42147392|FG000|Overall Study|Physician Decision|0|||
19702929|NCT00224042|42147393|FG001|Overall Study|Physician Decision|1|||
19702930|NCT00224042|42147392|FG000|Overall Study|Did not meet lab incusion criteria|2|||
19702931|NCT00224042|42147393|FG001|Overall Study|Did not meet lab incusion criteria|3|||
19702932|NCT00224042|42147392|FG000|Overall Study|Other|2|||
19702933|NCT00224042|42147393|FG001|Overall Study|Other|0|||
19702934|NCT03772522|42147401|FG000|Pre-intervention|Withdrawal by Subject|3|||
19702935|NCT03772522|42147402|FG001|Pre-intervention|Withdrawal by Subject|4|||
19702936|NCT03772522|42147401|FG000|Intervention|Withdrawal by Subject|1|||
19702937|NCT03772522|42147402|FG001|Intervention|Withdrawal by Subject|0|||
19702938|NCT03772522|42147401|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
19702939|NCT03772522|42147402|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
19702940|NCT00160706|42147412|FG000|Overall Study|Adverse Event|53|||
19702941|NCT00160706|42147412|FG000|Overall Study|Adverse Event and Other Reason|105|||
19702942|NCT00160706|42147412|FG000|Overall Study|Protocol Violation|3|||
19702943|NCT00160706|42147412|FG000|Overall Study|Withdrawal by Subject|41|||
19702944|NCT00160706|42147412|FG000|Overall Study|Withdrawal by Subject and Other|12|||
19702945|NCT00160706|42147412|FG000|Overall Study|Physician Decision|10|||
19702946|NCT00160706|42147412|FG000|Overall Study|Physician Decision and Other|3|||
19702947|NCT00160706|42147412|FG000|Overall Study|Lost to Follow-up|4|||
19702948|NCT00160706|42147412|FG000|Overall Study|Lost to Follow-up and Other|1|||
19702949|NCT00160706|42147412|FG000|Overall Study|Lack of Efficacy|42|||
19702950|NCT00160706|42147412|FG000|Overall Study|Lack of Efficacy and Other|1|||
19702951|NCT00160706|42147412|FG000|Overall Study|Other Reason|11|||
19702952|NCT00257192|42147418|FG000|Overall Study|Adverse Event|21|||
19702953|NCT00257192|42147419|FG001|Overall Study|Adverse Event|10|||
19702954|NCT00257192|42147418|FG000|Overall Study|Laboratory abnormality|1|||
19702955|NCT00257192|42147419|FG001|Overall Study|Laboratory abnormality|1|||
19702956|NCT00257192|42147418|FG000|Overall Study|Lost to Follow-up|3|||
19702957|NCT00257192|42147419|FG001|Overall Study|Lost to Follow-up|3|||
19611006|NCT00896532|42059796|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611007|NCT00896532|42059797|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611008|NCT00896532|42059798|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611009|NCT00896532|42059799|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611010|NCT00896532|42059800|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611011|NCT00896532|42059801|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611012|NCT00896532|42059802|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611013|NCT00896532|42059803|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611014|NCT00896532|42059804|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611015|NCT00896532|42059805|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611016|NCT00896532|42059806|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611017|NCT00896532|42059807|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611018|NCT00896532|42059808|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611019|NCT00896532|42059809|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611020|NCT00896532|42059810|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611021|NCT00896532|42059811|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
19611022|NCT00896532|42059812|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
19611023|NCT00896532|42059813|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
19611024|NCT00896532|42059814|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611025|NCT00896532|42059815|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19702958|NCT00257192|42147418|FG000|Overall Study|Insufficient clinical response|18|||
19702959|NCT00257192|42147419|FG001|Overall Study|Insufficient clinical response|18|||
19702960|NCT00257192|42147418|FG000|Overall Study|Withdrawal by Subject|14|||
19611026|NCT00896532|42059816|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611027|NCT00896532|42059817|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611028|NCT00896532|42059818|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
19611029|NCT00896532|42059796|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611030|NCT00896532|42059797|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611031|NCT00896532|42059798|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611032|NCT00896532|42059799|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611033|NCT00896532|42059800|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611034|NCT00896532|42059801|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611035|NCT00896532|42059802|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611036|NCT00896532|42059803|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19702961|NCT00257192|42147419|FG001|Overall Study|Withdrawal by Subject|2|||
19702962|NCT00257192|42147418|FG000|Overall Study|Randomized but not treated|0|||
19702963|NCT00257192|42147419|FG001|Overall Study|Randomized but not treated|1|||
19702964|NCT00257192|42147418|FG000|Overall Study|Study terminated by sponsor|1|||
19702965|NCT00257192|42147419|FG001|Overall Study|Study terminated by sponsor|0|||
19702966|NCT00257192|42147418|FG000|Overall Study|Miscellaneous|0|||
19702967|NCT00257192|42147419|FG001|Overall Study|Miscellaneous|4|||
19702968|NCT00256724|42147427|FG000|Overall Study|Physician Decision|2|||
19702969|NCT00256724|42147428|FG001|Overall Study|Physician Decision|5|||
19702970|NCT00256724|42147427|FG000|Overall Study|Protocol Violation|3|||
19702971|NCT00256724|42147428|FG001|Overall Study|Protocol Violation|3|||
19702972|NCT00157820|42147437|FG000|Randomized|Physician Decision|4|||
19702973|NCT00157820|42147438|FG001|Randomized|Physician Decision|2|||
19702974|NCT00157820|42147439|FG002|Randomized|Physician Decision|3|||
19702975|NCT00157820|42147437|FG000|Randomized|Withdrawal by Subject|1|||
19702976|NCT00157820|42147438|FG001|Randomized|Withdrawal by Subject|2|||
19702977|NCT00157820|42147439|FG002|Randomized|Withdrawal by Subject|3|||
19702978|NCT00157820|42147437|FG000|Randomized|Protocol Violation|2|||
19702979|NCT00157820|42147438|FG001|Randomized|Protocol Violation|1|||
19702980|NCT00157820|42147439|FG002|Randomized|Protocol Violation|2|||
19702981|NCT00157820|42147437|FG000|1st 8 Month|Death|7|||
19702982|NCT00157820|42147438|FG001|1st 8 Month|Death|8|||
19702983|NCT00157820|42147439|FG002|1st 8 Month|Death|3|||
19702984|NCT00157820|42147437|FG000|1st 8 Month|Lost to Follow-up|1|||
19702985|NCT00157820|42147438|FG001|1st 8 Month|Lost to Follow-up|2|||
19702986|NCT00157820|42147439|FG002|1st 8 Month|Lost to Follow-up|1|||
19702987|NCT00157820|42147437|FG000|1st 8 Month|Premature cross-over|0|||
19702988|NCT00157820|42147438|FG001|1st 8 Month|Premature cross-over|2|||
19702989|NCT00157820|42147439|FG002|1st 8 Month|Premature cross-over|2|||
19702990|NCT00157820|42147437|FG000|2nd 8 Months|Death|3|||
19702991|NCT00157820|42147438|FG001|2nd 8 Months|Death|1|||
19702992|NCT00157820|42147439|FG002|2nd 8 Months|Death|3|||
19702993|NCT00157820|42147437|FG000|2nd 8 Months|Lost to Follow-up|1|||
19702994|NCT00157820|42147438|FG001|2nd 8 Months|Lost to Follow-up|5|||
19702995|NCT00157820|42147439|FG002|2nd 8 Months|Lost to Follow-up|2|||
19702996|NCT00157820|42147437|FG000|2nd 8 Months|Premature cross-over|1|||
19702997|NCT00157820|42147438|FG001|2nd 8 Months|Premature cross-over|7|||
19702998|NCT00157820|42147439|FG002|2nd 8 Months|Premature cross-over|9|||
19702999|NCT00223808|42147451|FG000|Overall Study|<5 hrs therapy before discharge|3|||
19703000|NCT00223808|42147452|FG001|Overall Study|<5 hrs therapy before discharge|5|||
19703001|NCT00223808|42147453|FG002|Overall Study|<5 hrs therapy before discharge|5|||
19703002|NCT00154310|42147463|FG000|Overall Study|Adverse Event|19|||
19703003|NCT00154310|42147464|FG001|Overall Study|Adverse Event|9|||
19703004|NCT00154310|42147463|FG000|Overall Study|Lack of Efficacy|5|||
19703005|NCT00154310|42147464|FG001|Overall Study|Lack of Efficacy|4|||
19703006|NCT00154310|42147463|FG000|Overall Study|Protocol Violation|4|||
19703007|NCT00154310|42147464|FG001|Overall Study|Protocol Violation|2|||
19703008|NCT00154310|42147463|FG000|Overall Study|Withdrawal by Subject|9|||
19703009|NCT00154310|42147464|FG001|Overall Study|Withdrawal by Subject|3|||
19703010|NCT00154310|42147463|FG000|Overall Study|Lost to Follow-up|0|||
19703011|NCT00154310|42147464|FG001|Overall Study|Lost to Follow-up|8|||
19703012|NCT00154310|42147463|FG000|Overall Study|Administrative problems|0|||
19703013|NCT00154310|42147464|FG001|Overall Study|Administrative problems|1|||
19703014|NCT00154310|42147463|FG000|Overall Study|Death|0|||
19703015|NCT00154310|42147464|FG001|Overall Study|Death|1|||
19703016|NCT03771664|42147472|FG000|Overall Study|Adverse Event|1|||
19703017|NCT03771664|42147473|FG001|Overall Study|Adverse Event|0|||
19703018|NCT03771664|42147472|FG000|Overall Study|Lost to Follow-up|1|||
19703019|NCT03771664|42147473|FG001|Overall Study|Lost to Follow-up|0|||
19703020|NCT03771664|42147472|FG000|Overall Study|Withdrawal by Participant|1|||
19703021|NCT03771664|42147473|FG001|Overall Study|Withdrawal by Participant|4|||
19703022|NCT03771664|42147472|FG000|Overall Study|Randomized but not Treated|0|||
19703023|NCT03771664|42147473|FG001|Overall Study|Randomized but not Treated|1|||
19703024|NCT03771352|42147479|FG000|Overall Study|Screen failure|2|||
19478442|NCT01502293|41757725|FG000|Overall Study|Progressive Disease|20|||
19611037|NCT00896532|42059804|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19703025|NCT03771352|42147479|FG000|Overall Study|Withdrawal by Subject|2|||
19703026|NCT03770728|42147487|FG000|Overall Study|Adverse Event|1|||
19703027|NCT03770728|42147488|FG001|Overall Study|Adverse Event|0|||
19703028|NCT03770728|42147489|FG002|Overall Study|Adverse Event|1|||
19703029|NCT03770728|42147490|FG003|Overall Study|Adverse Event|0|||
19703030|NCT03770728|42147487|FG000|Overall Study|Poor compliance to protocol|0|||
19703031|NCT03770728|42147488|FG001|Overall Study|Poor compliance to protocol|0|||
19703032|NCT03770728|42147489|FG002|Overall Study|Poor compliance to protocol|1|||
19703033|NCT03770728|42147490|FG003|Overall Study|Poor compliance to protocol|0|||
19703034|NCT03770728|42147487|FG000|Overall Study|Withdrawal by Subject|13|||
19703035|NCT03770728|42147488|FG001|Overall Study|Withdrawal by Subject|8|||
19703036|NCT03770728|42147489|FG002|Overall Study|Withdrawal by Subject|9|||
19391890|NCT01998958|41636161|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
19391891|NCT01998958|41636162|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
19391892|NCT01998958|41636163|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
19391893|NCT01998958|41636164|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
19391894|NCT01998958|41636165|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
19391895|NCT01998958|41636166|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
19391896|NCT01998958|41636167|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
19391897|NCT01998958|41636168|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
19391898|NCT01998958|41636169|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
19391899|NCT01998958|41636170|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
19391900|NCT01998958|41636171|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
19391901|NCT01998958|41636172|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
19391902|NCT01998958|41636173|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
19391903|NCT01998958|41636174|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
19391904|NCT01998958|41636175|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
19391905|NCT01998958|41636176|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
19391906|NCT01998958|41636177|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
19391907|NCT01998958|41636178|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
19391908|NCT01998958|41636179|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
19391909|NCT01998958|41636180|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
19391910|NCT01998958|41636181|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
19391911|NCT01998958|41636182|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
19391912|NCT01998958|41636183|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
19391913|NCT01998958|41636184|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
19391914|NCT01998958|41636185|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
19391915|NCT01998958|41636186|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
19391916|NCT01998958|41636187|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
19391917|NCT01998958|41636188|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
19391918|NCT01998958|41636189|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
19391919|NCT01998958|41636190|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
19391920|NCT01998958|41636191|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
19703037|NCT03770728|42147490|FG003|Overall Study|Withdrawal by Subject|13|||
19703038|NCT03770728|42147487|FG000|Overall Study|Other than specified|24|||
19703039|NCT03770728|42147488|FG001|Overall Study|Other than specified|23|||
19703040|NCT03770728|42147489|FG002|Overall Study|Other than specified|21|||
19703041|NCT03770728|42147490|FG003|Overall Study|Other than specified|22|||
19703042|NCT03769090|42147505|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
19703043|NCT03769090|42147506|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
19703044|NCT03769090|42147507|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
19703045|NCT03769090|42147505|FG000|Overall Study|Withdrawal by Subject|52|||
19703046|NCT03769090|42147506|FG001|Overall Study|Withdrawal by Subject|62|||
19703047|NCT03769090|42147507|FG002|Overall Study|Withdrawal by Subject|74|||
19703048|NCT03769090|42147505|FG000|Overall Study|Death|4|||
19703049|NCT03769090|42147506|FG001|Overall Study|Death|2|||
19703050|NCT03769090|42147507|FG002|Overall Study|Death|2|||
19703051|NCT03769090|42147505|FG000|Overall Study|Adverse Event|7|||
19703052|NCT03769090|42147506|FG001|Overall Study|Adverse Event|7|||
19703053|NCT03769090|42147507|FG002|Overall Study|Adverse Event|8|||
19703054|NCT03769090|42147505|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
19703055|NCT03769090|42147506|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
19703056|NCT03769090|42147507|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
19703057|NCT03769090|42147505|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
19703058|NCT03769090|42147506|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
19703059|NCT03769090|42147507|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
19703060|NCT03769090|42147505|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
19703061|NCT03769090|42147506|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
19703062|NCT03769090|42147507|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
19703063|NCT03769090|42147505|FG000|Overall Study|Protocol Violation|5|||
19703064|NCT03769090|42147506|FG001|Overall Study|Protocol Violation|6|||
19703065|NCT03769090|42147507|FG002|Overall Study|Protocol Violation|8|||
19703066|NCT03769090|42147505|FG000|Overall Study|Pregnancy|1|||
19703067|NCT03769090|42147506|FG001|Overall Study|Pregnancy|0|||
19703068|NCT03769090|42147507|FG002|Overall Study|Pregnancy|3|||
19703069|NCT03769090|42147505|FG000|Overall Study|Lost to Follow-up|19|||
19703070|NCT03769090|42147506|FG001|Overall Study|Lost to Follow-up|25|||
19703071|NCT03769090|42147507|FG002|Overall Study|Lost to Follow-up|21|||
19703072|NCT03769090|42147505|FG000|Overall Study|Condition under investigation worsened|2|||
19703073|NCT03769090|42147506|FG001|Overall Study|Condition under investigation worsened|0|||
19703074|NCT03769090|42147507|FG002|Overall Study|Condition under investigation worsened|1|||
19703075|NCT03769090|42147505|FG000|Overall Study|Lack of Efficacy|1|||
19703076|NCT03769090|42147506|FG001|Overall Study|Lack of Efficacy|2|||
19703077|NCT03769090|42147507|FG002|Overall Study|Lack of Efficacy|2|||
19703078|NCT03769090|42147505|FG000|Overall Study|Other reasons|8|||
19703079|NCT03769090|42147506|FG001|Overall Study|Other reasons|12|||
19611038|NCT00896532|42059805|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611039|NCT00896532|42059806|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611040|NCT00896532|42059807|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611041|NCT00896532|42059808|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611042|NCT00896532|42059809|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611043|NCT00896532|42059810|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611044|NCT00896532|42059811|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611045|NCT00896532|42059812|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
19611046|NCT00896532|42059813|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611047|NCT00896532|42059814|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611048|NCT00896532|42059815|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611049|NCT00896532|42059816|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611050|NCT00896532|42059817|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611051|NCT00896532|42059818|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
19611052|NCT00896532|42059796|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
19611053|NCT00896532|42059797|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
19611054|NCT00896532|42059798|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
19611055|NCT00896532|42059799|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
19611056|NCT00896532|42059800|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
19611057|NCT00896532|42059801|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
19611058|NCT00896532|42059802|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
19611059|NCT00896532|42059803|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
19611060|NCT00896532|42059804|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
19611061|NCT00896532|42059805|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
19611062|NCT00896532|42059806|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
19611063|NCT00896532|42059807|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
19611064|NCT00896532|42059808|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
19611065|NCT00896532|42059809|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
19611066|NCT00896532|42059810|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
19611067|NCT00896532|42059811|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
19611068|NCT00896532|42059812|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
19611069|NCT00896532|42059813|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
19611070|NCT00896532|42059814|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
19611071|NCT00896532|42059815|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
19611072|NCT00896532|42059816|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
19611073|NCT00896532|42059817|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
19611074|NCT00896532|42059818|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
19611075|NCT00896532|42059796|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611076|NCT00896532|42059797|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611077|NCT00896532|42059798|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611078|NCT00896532|42059799|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611079|NCT00896532|42059800|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19703080|NCT03769090|42147507|FG002|Overall Study|Other reasons|15|||
19703081|NCT03559270|42147531|FG000|Overall Study|Adverse Event|6|||
19703082|NCT03559270|42147532|FG001|Overall Study|Adverse Event|5|||
19703083|NCT03559270|42147533|FG002|Overall Study|Adverse Event|3|||
19703084|NCT03559270|42147534|FG003|Overall Study|Adverse Event|0|||
19611080|NCT00896532|42059801|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611081|NCT00896532|42059802|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611082|NCT00896532|42059803|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611083|NCT00896532|42059804|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611084|NCT00896532|42059805|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611085|NCT00896532|42059806|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611086|NCT00896532|42059807|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611087|NCT00896532|42059808|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611088|NCT00896532|42059809|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611089|NCT00896532|42059810|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611090|NCT00896532|42059811|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611091|NCT00896532|42059812|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
19611092|NCT00896532|42059813|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611093|NCT00896532|42059814|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611094|NCT00896532|42059815|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611095|NCT00896532|42059816|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611096|NCT00896532|42059817|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611097|NCT00896532|42059818|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
19611098|NCT00896532|42059796|FG000|Months 48-72: Follow-on Phase|Death|0|||
19611099|NCT00896532|42059797|FG001|Months 48-72: Follow-on Phase|Death|0|||
19611100|NCT00896532|42059798|FG002|Months 48-72: Follow-on Phase|Death|0|||
19611101|NCT00896532|42059799|FG003|Months 48-72: Follow-on Phase|Death|0|||
19611102|NCT00896532|42059800|FG004|Months 48-72: Follow-on Phase|Death|0|||
19611103|NCT00896532|42059801|FG005|Months 48-72: Follow-on Phase|Death|0|||
19611104|NCT00896532|42059802|FG006|Months 48-72: Follow-on Phase|Death|0|||
19611105|NCT00896532|42059803|FG007|Months 48-72: Follow-on Phase|Death|0|||
19611106|NCT00896532|42059804|FG008|Months 48-72: Follow-on Phase|Death|0|||
19611107|NCT00896532|42059805|FG009|Months 48-72: Follow-on Phase|Death|0|||
19611108|NCT00896532|42059806|FG010|Months 48-72: Follow-on Phase|Death|0|||
19611109|NCT00896532|42059807|FG011|Months 48-72: Follow-on Phase|Death|0|||
19611110|NCT00896532|42059808|FG012|Months 48-72: Follow-on Phase|Death|0|||
19611111|NCT00896532|42059809|FG013|Months 48-72: Follow-on Phase|Death|0|||
19611112|NCT00896532|42059810|FG014|Months 48-72: Follow-on Phase|Death|0|||
19611113|NCT00896532|42059811|FG015|Months 48-72: Follow-on Phase|Death|0|||
19611114|NCT00896532|42059812|FG016|Months 48-72: Follow-on Phase|Death|0|||
19611115|NCT00896532|42059813|FG017|Months 48-72: Follow-on Phase|Death|0|||
19611116|NCT00896532|42059814|FG018|Months 48-72: Follow-on Phase|Death|1|||
19611117|NCT00896532|42059815|FG019|Months 48-72: Follow-on Phase|Death|0|||
19611118|NCT00896532|42059816|FG020|Months 48-72: Follow-on Phase|Death|0|||
19611119|NCT00896532|42059817|FG021|Months 48-72: Follow-on Phase|Death|0|||
19703085|NCT03559270|42147531|FG000|Overall Study|Lack of Efficacy|34|||
19703086|NCT03559270|42147532|FG001|Overall Study|Lack of Efficacy|52|||
19703087|NCT03559270|42147533|FG002|Overall Study|Lack of Efficacy|37|||
19703088|NCT03559270|42147534|FG003|Overall Study|Lack of Efficacy|2|||
19703089|NCT03559270|42147531|FG000|Overall Study|Death|0|||
19703090|NCT03559270|42147532|FG001|Overall Study|Death|2|||
19703091|NCT03559270|42147533|FG002|Overall Study|Death|0|||
19703092|NCT03559270|42147534|FG003|Overall Study|Death|0|||
19703093|NCT03559270|42147531|FG000|Overall Study|Lost to Follow-up|16|||
19703094|NCT03559270|42147532|FG001|Overall Study|Lost to Follow-up|4|||
19703095|NCT03559270|42147533|FG002|Overall Study|Lost to Follow-up|12|||
19391921|NCT01998958|41636160|FG000|Period 1 (Panel A and B)|Other|1|||
19703096|NCT03559270|42147534|FG003|Overall Study|Lost to Follow-up|3|||
19703097|NCT03559270|42147531|FG000|Overall Study|Sponsor Decision|38|||
19703098|NCT03559270|42147532|FG001|Overall Study|Sponsor Decision|31|||
19703099|NCT03559270|42147533|FG002|Overall Study|Sponsor Decision|35|||
19703100|NCT03559270|42147534|FG003|Overall Study|Sponsor Decision|18|||
19703101|NCT03559270|42147531|FG000|Overall Study|Withdrawal by Subject|19|||
19703102|NCT03559270|42147532|FG001|Overall Study|Withdrawal by Subject|21|||
19703103|NCT03559270|42147533|FG002|Overall Study|Withdrawal by Subject|18|||
19703104|NCT03559270|42147534|FG003|Overall Study|Withdrawal by Subject|7|||
19703105|NCT03559270|42147531|FG000|Overall Study|Physician Decision|3|||
19703106|NCT03559270|42147532|FG001|Overall Study|Physician Decision|2|||
19703107|NCT03559270|42147533|FG002|Overall Study|Physician Decision|1|||
19703108|NCT03559270|42147534|FG003|Overall Study|Physician Decision|0|||
19703109|NCT03559270|42147531|FG000|Overall Study|Pregnancy|0|||
19703110|NCT03559270|42147532|FG001|Overall Study|Pregnancy|1|||
19703111|NCT03559270|42147533|FG002|Overall Study|Pregnancy|0|||
19703112|NCT03559270|42147534|FG003|Overall Study|Pregnancy|0|||
19703113|NCT03559270|42147531|FG000|Overall Study|Protocol Violation|1|||
19703114|NCT03559270|42147532|FG001|Overall Study|Protocol Violation|0|||
19703115|NCT03559270|42147533|FG002|Overall Study|Protocol Violation|2|||
19703116|NCT03559270|42147534|FG003|Overall Study|Protocol Violation|0|||
19703117|NCT02685826|42147589|FG000|Overall Study|Adverse Event|2|||
19703118|NCT02685826|42147590|FG001|Overall Study|Adverse Event|0|||
19703119|NCT02685826|42147591|FG002|Overall Study|Adverse Event|1|||
19703120|NCT02685826|42147589|FG000|Overall Study|Progressive Disease|2|||
19703121|NCT02685826|42147590|FG001|Overall Study|Progressive Disease|1|||
19703122|NCT02685826|42147591|FG002|Overall Study|Progressive Disease|0|||
19703123|NCT02685826|42147589|FG000|Overall Study|Withdrawal by Subject|2|||
19703124|NCT02685826|42147590|FG001|Overall Study|Withdrawal by Subject|0|||
19703125|NCT02685826|42147591|FG002|Overall Study|Withdrawal by Subject|0|||
19703126|NCT02685826|42147589|FG000|Overall Study|Full Clinical Hold by FDA|19|||
19703127|NCT02685826|42147590|FG001|Overall Study|Full Clinical Hold by FDA|9|||
19703128|NCT02685826|42147591|FG002|Overall Study|Full Clinical Hold by FDA|20|||
19703129|NCT00114777|42147602|FG000|Randomization to Month 36|Death|10|||
19703130|NCT00114777|42147603|FG001|Randomization to Month 36|Death|4|||
19703131|NCT00114777|42147604|FG002|Randomization to Month 36|Death|3|||
19703132|NCT00114777|42147602|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
19703133|NCT00114777|42147603|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
19703134|NCT00114777|42147604|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
19703135|NCT00114777|42147602|FG000|Randomization to Month 36|Lack of Efficacy|19|||
19703136|NCT00114777|42147603|FG001|Randomization to Month 36|Lack of Efficacy|15|||
19703137|NCT00114777|42147604|FG002|Randomization to Month 36|Lack of Efficacy|17|||
19703138|NCT00114777|42147602|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
19703139|NCT00114777|42147603|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
19703140|NCT00114777|42147604|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
19703141|NCT00114777|42147602|FG000|Randomization to Month 36|Adverse Event|34|||
19703142|NCT00114777|42147603|FG001|Randomization to Month 36|Adverse Event|35|||
19703143|NCT00114777|42147604|FG002|Randomization to Month 36|Adverse Event|44|||
19703144|NCT00114777|42147602|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
19703145|NCT00114777|42147603|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
19703146|NCT00114777|42147604|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
19703147|NCT00114777|42147602|FG000|Randomization to Month 36|Other|9|||
19703148|NCT00114777|42147603|FG001|Randomization to Month 36|Other|3|||
19703149|NCT00114777|42147604|FG002|Randomization to Month 36|Other|12|||
19703150|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Death|8|||
19703151|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Death|13|||
19703152|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Death|7|||
19703153|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
19703154|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
19703155|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
19703156|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
19703157|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
19703158|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
19703159|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
19703160|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
19703161|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
19703162|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
19703163|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
19703164|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
19703165|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
19703166|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
19703167|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
19703168|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
19703169|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
19703170|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
19703171|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
19703172|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
19703173|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
19703174|NCT00114777|42147602|FG000|Long-Term Extension to Month 84|Other|2|||
19703175|NCT00114777|42147603|FG001|Long-Term Extension to Month 84|Other|0|||
19703176|NCT00114777|42147604|FG002|Long-Term Extension to Month 84|Other|2|||
19703177|NCT00139737|42147613|FG000|Overall Study|Withdrawal by Subject|190|||
19703178|NCT00139737|42147613|FG000|Overall Study|Adverse Event|58|||
19703179|NCT00139737|42147613|FG000|Overall Study|Lack of Efficacy|40|||
19703180|NCT00139737|42147613|FG000|Overall Study|Lost to Follow-up|8|||
19703181|NCT00139737|42147613|FG000|Overall Study|Death|3|||
19703182|NCT00139737|42147613|FG000|Overall Study|Laboratory Abnormality|2|||
19703183|NCT00139737|42147613|FG000|Overall Study|Protocol Violation|18|||
19703184|NCT00139737|42147613|FG000|Overall Study|Withdrew During Screening Phase|8|||
19703185|NCT00139737|42147613|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
19703186|NCT00139737|42147613|FG000|Overall Study|Screened, Not Treated|13|||
19703187|NCT00122187|42147619|FG000|Overall Study|Withdrew because of resource limitations|2|||
19703188|NCT00122187|42147620|FG001|Overall Study|Withdrew because of resource limitations|2|||
19703189|NCT00139659|42147630|FG000|Overall Study|Adverse Event|12|||
19703190|NCT00139659|42147631|FG001|Overall Study|Adverse Event|1|||
19703191|NCT00139659|42147630|FG000|Overall Study|Lack of Efficacy|1|||
19703192|NCT00139659|42147631|FG001|Overall Study|Lack of Efficacy|1|||
19703193|NCT00139659|42147630|FG000|Overall Study|Lost to Follow-up|7|||
19703194|NCT00139659|42147631|FG001|Overall Study|Lost to Follow-up|3|||
19703195|NCT00139659|42147630|FG000|Overall Study|Reason not Specified|6|||
19703196|NCT00139659|42147631|FG001|Overall Study|Reason not Specified|3|||
19703197|NCT00139659|42147630|FG000|Overall Study|Withdrawal by Subject|14|||
19703198|NCT00139659|42147631|FG001|Overall Study|Withdrawal by Subject|10|||
19703199|NCT00137631|42147643|FG000|Overall Study|Lost to Follow-up|37|||
19703200|NCT00137631|42147644|FG001|Overall Study|Lost to Follow-up|41|||
19703201|NCT00114231|42147652|FG000|Overall Study|No consent|2|||
19703202|NCT00114231|42147653|FG001|Overall Study|No consent|0|||
19703203|NCT00114231|42147652|FG000|Overall Study|QARC requirement not met|1|||
19703204|NCT00114231|42147653|FG001|Overall Study|QARC requirement not met|0|||
19703205|NCT00114231|42147652|FG000|Overall Study|Suspected metastatic disease|1|||
19703206|NCT00114231|42147653|FG001|Overall Study|Suspected metastatic disease|0|||
19703207|NCT00114231|42147652|FG000|Overall Study|No adenocarcinoma|1|||
19703208|NCT00114231|42147653|FG001|Overall Study|No adenocarcinoma|0|||
19703209|NCT00114231|42147652|FG000|Overall Study|Low creatinine clearance|0|||
19703210|NCT00114231|42147653|FG001|Overall Study|Low creatinine clearance|1|||
19703211|NCT00114231|42147652|FG000|Overall Study|Tumor size > 4cm|1|||
19703212|NCT00114231|42147653|FG001|Overall Study|Tumor size > 4cm|0|||
19703213|NCT00114231|42147652|FG000|Overall Study|Tumor fixed on digital exam|0|||
19703214|NCT00114231|42147653|FG001|Overall Study|Tumor fixed on digital exam|1|||
19703215|NCT00114231|42147652|FG000|Overall Study|No Absolute Neutrophil Count|2|||
19703216|NCT00114231|42147653|FG001|Overall Study|No Absolute Neutrophil Count|0|||
19703217|NCT00114231|42147652|FG000|Overall Study|Biopsy done after registration|1|||
19703218|NCT00114231|42147653|FG001|Overall Study|Biopsy done after registration|0|||
19703219|NCT00113919|42147658|FG000|Overall Study|Physician Decision|8|||
19703220|NCT00113919|42147658|FG000|Overall Study|Death|6|||
19703221|NCT00113841|42147664|FG000|Overall Study|Disease progression|0|||
19703222|NCT00113841|42147665|FG001|Overall Study|Disease progression|2|||
19703223|NCT00113841|42147664|FG000|Overall Study|Non-compliant|1|||
19703224|NCT00113841|42147665|FG001|Overall Study|Non-compliant|0|||
19703225|NCT00113607|42147673|FG000|Overall Study|Adverse Event|40|||
19703226|NCT00113607|42147674|FG001|Overall Study|Adverse Event|71|||
19703227|NCT00113607|42147673|FG000|Overall Study|Death|8|||
19703228|NCT00113607|42147674|FG001|Overall Study|Death|8|||
19703229|NCT00113607|42147673|FG000|Overall Study|Withdrawal by Subject|50|||
19703230|NCT00113607|42147674|FG001|Overall Study|Withdrawal by Subject|58|||
19703231|NCT00113607|42147673|FG000|Overall Study|Lost to Follow-up|0|||
19703232|NCT00113607|42147674|FG001|Overall Study|Lost to Follow-up|2|||
19703233|NCT00113607|42147673|FG000|Overall Study|Disease Progression|180|||
19703234|NCT00113607|42147674|FG001|Overall Study|Disease Progression|142|||
19703235|NCT00113607|42147673|FG000|Overall Study|Complete Response (Confirmed)|14|||
19703236|NCT00113607|42147674|FG001|Overall Study|Complete Response (Confirmed)|24|||
19703237|NCT00113607|42147673|FG000|Overall Study|Other|43|||
19703238|NCT00113607|42147674|FG001|Overall Study|Other|32|||
19703239|NCT00113529|42147681|FG000|Overall Study|Adverse Event|4|||
19703240|NCT00113529|42147681|FG000|Overall Study|Lack of Efficacy|20|||
19703241|NCT00113529|42147681|FG000|Overall Study|Decision of sponsor|6|||
19703242|NCT00113529|42147681|FG000|Overall Study|Withdrawal by Subject|4|||
19703243|NCT00134901|42147687|FG000|Overall Study|Lost to Follow-up|5|||
19703244|NCT00134901|42147688|FG001|Overall Study|Lost to Follow-up|5|||
19703245|NCT00134901|42147687|FG000|Overall Study|discontinued intervention|12|||
19703246|NCT00134901|42147688|FG001|Overall Study|discontinued intervention|10|||
19703247|NCT00122109|42147698|FG000|Overall Study|Did not meet criteria|6|||
19703248|NCT00122109|42147699|FG001|Overall Study|Did not meet criteria|7|||
19703249|NCT00113373|42147708|FG000|Overall Study|Ineligible: wrong primary|1|||
19703250|NCT00113373|42147708|FG000|Overall Study|Ineligible: second primary|1|||
19703251|NCT00113373|42147708|FG000|Overall Study|Never Treated|1|||
19703252|NCT00113295|42147719|FG000|Overall Study|Adverse Event|4|||
19703253|NCT00113295|42147720|FG001|Overall Study|Adverse Event|1|||
19703254|NCT00113295|42147719|FG000|Overall Study|Unrelated Medical Illness|1|||
19703255|NCT00113295|42147720|FG001|Overall Study|Unrelated Medical Illness|0|||
19703256|NCT00112905|42147728|FG000|Overall Study|Adverse Event|4|||
19703257|NCT00112905|42147728|FG000|Overall Study|Death|1|||
19703258|NCT00112905|42147728|FG000|Overall Study|Ineligibility|5|||
19703259|NCT00112905|42147728|FG000|Overall Study|Alternative treatment|1|||
19703260|NCT00112905|42147728|FG000|Overall Study|performance status was deteiorating|1|||
19703261|NCT00427895|42147736|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703262|NCT00427895|42147737|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703263|NCT00427895|42147738|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703264|NCT00427895|42147739|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
19703265|NCT00427895|42147740|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703266|NCT00427895|42147741|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703267|NCT00427895|42147742|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703268|NCT00427895|42147743|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
19703269|NCT00427895|42147736|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703270|NCT00427895|42147737|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703271|NCT00427895|42147738|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703272|NCT00427895|42147739|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703273|NCT00427895|42147740|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703274|NCT00427895|42147741|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703275|NCT00427895|42147742|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
19703276|NCT00427895|42147743|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
19703277|NCT00427895|42147736|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703278|NCT00427895|42147737|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703279|NCT00427895|42147738|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703280|NCT00427895|42147739|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703281|NCT00427895|42147740|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703282|NCT00427895|42147741|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703283|NCT00427895|42147742|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
19703284|NCT00427895|42147743|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
19703285|NCT00427895|42147736|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
19703286|NCT00427895|42147737|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
19703287|NCT00427895|42147738|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
19703288|NCT00427895|42147739|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
19703289|NCT00427895|42147740|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
19703290|NCT00427895|42147741|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
19703291|NCT00427895|42147742|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
19703292|NCT00427895|42147743|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
19703293|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
19703294|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
19703295|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
19703296|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
19703297|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
19703298|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
19703299|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
19703300|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
19703301|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
19703302|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
19703303|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
19703304|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
19703305|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
19703306|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
19703307|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
19703308|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
19703309|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
19703310|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
19703311|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703312|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703313|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703314|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703315|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703316|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
19703317|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
19703318|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
19703319|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
19703320|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
19703321|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
19703322|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
19703323|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
19703324|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
19703325|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703326|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703327|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703328|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
19703329|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703330|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703331|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703332|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
19703333|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
19703334|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
19703335|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
19703336|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
19703337|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
19703338|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
19703339|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
19703340|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
19703341|NCT00427895|42147736|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703342|NCT00427895|42147737|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703343|NCT00427895|42147738|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
19703344|NCT00427895|42147739|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
19703345|NCT00427895|42147740|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703346|NCT00427895|42147741|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703347|NCT00427895|42147742|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703348|NCT00427895|42147743|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
19703349|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
19703350|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
19703351|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
19703352|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
19703353|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
19703354|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
19703355|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
19703356|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
19703357|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
19703358|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
19703359|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
19703360|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
19703361|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
19703362|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
19703363|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
19703364|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
19703365|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
19703366|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
19703367|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
19703368|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
19703369|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
19703370|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
19703371|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
19703372|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
19703373|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703374|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
19703375|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703376|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703377|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703378|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703379|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703380|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
19703381|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Death|1|||
19703382|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Death|0|||
19703383|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Death|0|||
19703384|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Death|0|||
19703385|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Death|0|||
19703386|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Death|0|||
19703387|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Death|0|||
19703388|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Death|0|||
19703389|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703390|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703391|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
19703392|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
19703393|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703394|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703395|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703396|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
19703397|NCT00427895|42147736|FG000|Vax 1/Year 1 Follow-up|Other|0|||
19703398|NCT00427895|42147737|FG001|Vax 1/Year 1 Follow-up|Other|0|||
19703399|NCT00427895|42147738|FG002|Vax 1/Year 1 Follow-up|Other|0|||
19703400|NCT00427895|42147739|FG003|Vax 1/Year 1 Follow-up|Other|2|||
19703401|NCT00427895|42147740|FG004|Vax 1/Year 1 Follow-up|Other|0|||
19703402|NCT00427895|42147741|FG005|Vax 1/Year 1 Follow-up|Other|0|||
19703403|NCT00427895|42147742|FG006|Vax 1/Year 1 Follow-up|Other|0|||
19703404|NCT00427895|42147743|FG007|Vax 1/Year 1 Follow-up|Other|0|||
19703405|NCT00427895|42147736|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
19703406|NCT00427895|42147737|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
19703407|NCT00427895|42147738|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
19703408|NCT00427895|42147739|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
19703409|NCT00427895|42147740|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
19703410|NCT00427895|42147741|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
19703411|NCT00427895|42147742|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
19703412|NCT00427895|42147743|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
19703413|NCT00427349|42147782|FG000|Overall Study|Lack of Efficacy|23|||
19703414|NCT00427349|42147782|FG000|Overall Study|Adverse Event|14|||
19703415|NCT00427349|42147782|FG000|Overall Study|Death|1|||
19703416|NCT00427349|42147782|FG000|Overall Study|Withdrawal by Subject|3|||
19703417|NCT00427349|42147782|FG000|Overall Study|Alternative therapy|1|||
19703418|NCT00427349|42147782|FG000|Overall Study|Other|2|||
19703419|NCT00427349|42147782|FG000|Overall Study|Ineligible|1|||
19703420|NCT00427349|42147782|FG000|Overall Study|Never started therapy|1|||
19703421|NCT00425945|42147788|FG000|Overall Study|Concern about Supplement|2|||
19703422|NCT00425945|42147789|FG001|Overall Study|Concern about Supplement|0|||
19703423|NCT00425945|42147788|FG000|Overall Study|Inconvenience|0|||
19703424|NCT00425945|42147789|FG001|Overall Study|Inconvenience|2|||
19703425|NCT00425945|42147788|FG000|Overall Study|Lost to Follow-up|0|||
19703426|NCT00425945|42147789|FG001|Overall Study|Lost to Follow-up|2|||
19703427|NCT00425945|42147788|FG000|Overall Study|Began hypertension medication|1|||
19703428|NCT00425945|42147789|FG001|Overall Study|Began hypertension medication|0|||
19703429|NCT00425945|42147788|FG000|Overall Study|Began cancer treatments|1|||
19703430|NCT00425945|42147789|FG001|Overall Study|Began cancer treatments|0|||
19703431|NCT00425945|42147788|FG000|Overall Study|Moved from area|0|||
19703432|NCT00425945|42147789|FG001|Overall Study|Moved from area|1|||
19703433|NCT00416195|42147799|FG000|Overall Study|Adverse Event|1|||
19703434|NCT00416195|42147800|FG001|Overall Study|Adverse Event|2|||
19703435|NCT00416195|42147799|FG000|Overall Study|Protocol Violation|1|||
19703436|NCT00416195|42147800|FG001|Overall Study|Protocol Violation|1|||
19703437|NCT00416195|42147799|FG000|Overall Study|Other|0|||
19703438|NCT00416195|42147800|FG001|Overall Study|Other|1|||
19703439|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
19703440|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
19703441|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
19703442|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
19703443|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
19703444|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
19703445|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
19703446|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
19703447|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
19703448|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
19703449|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
19703450|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
19703451|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
19703452|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
19703453|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
19703454|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
19703455|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
19703456|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
19703457|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
19703458|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
19703459|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
19703460|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
19703461|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
19703462|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
19703463|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
19703464|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
19703465|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
19703466|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
19703467|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
19703468|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
19703469|NCT00121641|42147810|FG000|24-week Short-term Treatment Period|Other Reason|1|||
19703470|NCT00121641|42147811|FG001|24-week Short-term Treatment Period|Other Reason|0|||
19703471|NCT00121641|42147812|FG002|24-week Short-term Treatment Period|Other Reason|0|||
19703472|NCT00121641|42147813|FG003|24-week Short-term Treatment Period|Other Reason|0|||
19703473|NCT00121641|42147814|FG004|24-week Short-term Treatment Period|Other Reason|0|||
19703474|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
19703475|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
19703476|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
19703477|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
19703478|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
19703479|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
19703480|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
19703481|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
19703482|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
19703483|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
19703484|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
19703485|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
19703486|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
19703487|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
19703488|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
19703489|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
19703490|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
19703491|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
19703492|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
19703493|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
19703494|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
19703495|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
19703496|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
19703497|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
19703498|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
19703499|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
19703500|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
19703501|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
19703502|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
19703503|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
19703504|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
19703505|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
19703506|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
19703507|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
19703508|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
19703509|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
19703510|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
19703511|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
19703512|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
19703513|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
19703514|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Death|0|||
19703515|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Death|0|||
19703516|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Death|0|||
19703517|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Death|1|||
19703518|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Death|0|||
19703519|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Missing|0|||
19703520|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Missing|0|||
19703521|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Missing|1|||
19703522|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Missing|0|||
19703523|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Missing|0|||
19703524|NCT00121641|42147810|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
19703525|NCT00121641|42147811|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
19703526|NCT00121641|42147812|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
19703527|NCT00121641|42147813|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
19703528|NCT00121641|42147814|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
19703529|NCT00425555|42147830|FG000|Overall Study|Withdrawal by Subject|11|||
19703530|NCT00425555|42147831|FG001|Overall Study|Withdrawal by Subject|8|||
19703531|NCT00425555|42147830|FG000|Overall Study|Lost to Follow-up|0|||
19703532|NCT00425555|42147831|FG001|Overall Study|Lost to Follow-up|1|||
19703533|NCT00425555|42147830|FG000|Overall Study|Administrative problems|3|||
19703534|NCT00425555|42147831|FG001|Overall Study|Administrative problems|0|||
19703535|NCT00425555|42147830|FG000|Overall Study|Death|1|||
19703536|NCT00425555|42147831|FG001|Overall Study|Death|2|||
19703537|NCT00425555|42147830|FG000|Overall Study|New cancer therapy|2|||
19703538|NCT00425555|42147831|FG001|Overall Study|New cancer therapy|1|||
19703539|NCT00425555|42147830|FG000|Overall Study|Disease progression|36|||
19703540|NCT00425555|42147831|FG001|Overall Study|Disease progression|33|||
19703541|NCT00425555|42147830|FG000|Overall Study|Adverse Event|25|||
19703542|NCT00425555|42147831|FG001|Overall Study|Adverse Event|15|||
19703543|NCT00425555|42147830|FG000|Overall Study|Protocol Violation|1|||
19703544|NCT00425555|42147831|FG001|Overall Study|Protocol Violation|0|||
19703545|NCT00424775|42147840|FG000|Overall Study|Adverse Event|2|||
19703546|NCT00424775|42147841|FG001|Overall Study|Adverse Event|0|||
19703547|NCT00424775|42147840|FG000|Overall Study|Lack of Efficacy|1|||
19703548|NCT00424775|42147841|FG001|Overall Study|Lack of Efficacy|0|||
19703549|NCT00121485|42147847|FG000|Overall Study|Not implanted|1|||
19703550|NCT00121485|42147848|FG001|Overall Study|Not implanted|5|||
19703551|NCT00121485|42147847|FG000|Overall Study|Crossover|0|||
19391922|NCT01998958|41636161|FG001|Period 1 (Panel A and B)|Other|0|||
19391923|NCT01998958|41636162|FG002|Period 1 (Panel A and B)|Other|0|||
19391924|NCT01998958|41636163|FG003|Period 1 (Panel A and B)|Other|0|||
19703552|NCT00121485|42147848|FG001|Overall Study|Crossover|2|||
19703553|NCT01763866|42147879|FG000|Overall Study|Withdrawal by Subject|2|||
19703554|NCT01763866|42147880|FG001|Overall Study|Withdrawal by Subject|1|||
19703555|NCT01763866|42147881|FG002|Overall Study|Withdrawal by Subject|4|||
19703556|NCT01763866|42147882|FG003|Overall Study|Withdrawal by Subject|0|||
19703557|NCT01763866|42147883|FG004|Overall Study|Withdrawal by Subject|0|||
19703558|NCT01763866|42147884|FG005|Overall Study|Withdrawal by Subject|3|||
19703559|NCT01763866|42147885|FG006|Overall Study|Withdrawal by Subject|4|||
19703560|NCT01763866|42147886|FG007|Overall Study|Withdrawal by Subject|0|||
19703561|NCT01763866|42147887|FG008|Overall Study|Withdrawal by Subject|1|||
19611120|NCT00896532|42059818|FG022|Months 48-72: Follow-on Phase|Death|0|||
19611121|NCT00896532|42059796|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19703562|NCT01763866|42147888|FG009|Overall Study|Withdrawal by Subject|1|||
19391925|NCT01998958|41636164|FG004|Period 1 (Panel A and B)|Other|0|||
19391926|NCT01998958|41636165|FG005|Period 1 (Panel A and B)|Other|0|||
19391927|NCT01998958|41636166|FG006|Period 1 (Panel A and B)|Other|0|||
19391928|NCT01998958|41636167|FG007|Period 1 (Panel A and B)|Other|0|||
19391929|NCT01998958|41636168|FG008|Period 1 (Panel A and B)|Other|0|||
19391930|NCT01998958|41636169|FG009|Period 1 (Panel A and B)|Other|0|||
19391931|NCT01998958|41636170|FG010|Period 1 (Panel A and B)|Other|0|||
19611122|NCT00896532|42059797|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611123|NCT00896532|42059798|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611124|NCT00896532|42059799|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611125|NCT00896532|42059800|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611126|NCT00896532|42059801|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611127|NCT00896532|42059802|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611128|NCT00896532|42059803|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611129|NCT00896532|42059804|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611130|NCT00896532|42059805|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611131|NCT00896532|42059806|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611132|NCT00896532|42059807|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611133|NCT00896532|42059808|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611134|NCT00896532|42059809|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611135|NCT00896532|42059810|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611136|NCT00896532|42059811|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611137|NCT00896532|42059812|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611138|NCT00896532|42059813|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611139|NCT00896532|42059814|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611140|NCT00896532|42059815|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611141|NCT00896532|42059816|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611142|NCT00896532|42059817|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
19611143|NCT00896532|42059818|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
19611144|NCT00896532|42059796|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19391932|NCT01998958|41636171|FG011|Period 1 (Panel A and B)|Other|0|||
19703563|NCT01763866|42147889|FG010|Overall Study|Withdrawal by Subject|2|||
19703564|NCT01763866|42147890|FG011|Overall Study|Withdrawal by Subject|2|||
19703565|NCT01763866|42147891|FG012|Overall Study|Withdrawal by Subject|2|||
19703566|NCT01763866|42147892|FG013|Overall Study|Withdrawal by Subject|0|||
19703567|NCT01763866|42147893|FG014|Overall Study|Withdrawal by Subject|6|||
19703568|NCT01763866|42147894|FG015|Overall Study|Withdrawal by Subject|3|||
19703569|NCT01763866|42147895|FG016|Overall Study|Withdrawal by Subject|0|||
19703570|NCT01763866|42147896|FG017|Overall Study|Withdrawal by Subject|1|||
19703571|NCT01763866|42147897|FG018|Overall Study|Withdrawal by Subject|1|||
19703572|NCT01763866|42147898|FG019|Overall Study|Withdrawal by Subject|1|||
19703573|NCT01763866|42147899|FG020|Overall Study|Withdrawal by Subject|2|||
19703574|NCT01763866|42147900|FG021|Overall Study|Withdrawal by Subject|1|||
19703575|NCT01763866|42147901|FG022|Overall Study|Withdrawal by Subject|2|||
19703576|NCT01763866|42147902|FG023|Overall Study|Withdrawal by Subject|1|||
19703577|NCT01763866|42147879|FG000|Overall Study|Decision by sponsor|0|||
19703578|NCT01763866|42147880|FG001|Overall Study|Decision by sponsor|0|||
19703579|NCT01763866|42147881|FG002|Overall Study|Decision by sponsor|1|||
19703580|NCT01763866|42147882|FG003|Overall Study|Decision by sponsor|0|||
19703581|NCT01763866|42147883|FG004|Overall Study|Decision by sponsor|2|||
19703582|NCT01763866|42147884|FG005|Overall Study|Decision by sponsor|0|||
19703583|NCT01763866|42147885|FG006|Overall Study|Decision by sponsor|2|||
19703584|NCT01763866|42147886|FG007|Overall Study|Decision by sponsor|0|||
19703585|NCT01763866|42147887|FG008|Overall Study|Decision by sponsor|2|||
19703586|NCT01763866|42147888|FG009|Overall Study|Decision by sponsor|0|||
19703587|NCT01763866|42147889|FG010|Overall Study|Decision by sponsor|6|||
19703588|NCT01763866|42147890|FG011|Overall Study|Decision by sponsor|0|||
19703589|NCT01763866|42147891|FG012|Overall Study|Decision by sponsor|1|||
19703590|NCT01763866|42147892|FG013|Overall Study|Decision by sponsor|0|||
19703591|NCT01763866|42147893|FG014|Overall Study|Decision by sponsor|5|||
19703592|NCT01763866|42147894|FG015|Overall Study|Decision by sponsor|0|||
19703593|NCT01763866|42147895|FG016|Overall Study|Decision by sponsor|0|||
19703594|NCT01763866|42147896|FG017|Overall Study|Decision by sponsor|0|||
19703595|NCT01763866|42147897|FG018|Overall Study|Decision by sponsor|4|||
19703596|NCT01763866|42147898|FG019|Overall Study|Decision by sponsor|0|||
19703597|NCT01763866|42147899|FG020|Overall Study|Decision by sponsor|2|||
19703598|NCT01763866|42147900|FG021|Overall Study|Decision by sponsor|0|||
19703599|NCT01763866|42147901|FG022|Overall Study|Decision by sponsor|1|||
19703600|NCT01763866|42147902|FG023|Overall Study|Decision by sponsor|0|||
19703601|NCT01763866|42147879|FG000|Overall Study|Lost to Follow-up|0|||
19703602|NCT01763866|42147880|FG001|Overall Study|Lost to Follow-up|0|||
19703603|NCT01763866|42147881|FG002|Overall Study|Lost to Follow-up|0|||
19703604|NCT01763866|42147882|FG003|Overall Study|Lost to Follow-up|0|||
19703605|NCT01763866|42147883|FG004|Overall Study|Lost to Follow-up|0|||
19703606|NCT01763866|42147884|FG005|Overall Study|Lost to Follow-up|0|||
19703607|NCT01763866|42147885|FG006|Overall Study|Lost to Follow-up|1|||
19703608|NCT01763866|42147886|FG007|Overall Study|Lost to Follow-up|0|||
19703609|NCT01763866|42147887|FG008|Overall Study|Lost to Follow-up|0|||
19703610|NCT01763866|42147888|FG009|Overall Study|Lost to Follow-up|0|||
19703611|NCT01763866|42147889|FG010|Overall Study|Lost to Follow-up|0|||
19703612|NCT01763866|42147890|FG011|Overall Study|Lost to Follow-up|0|||
19703613|NCT01763866|42147891|FG012|Overall Study|Lost to Follow-up|1|||
19703614|NCT01763866|42147892|FG013|Overall Study|Lost to Follow-up|0|||
19703615|NCT01763866|42147893|FG014|Overall Study|Lost to Follow-up|1|||
19703616|NCT01763866|42147894|FG015|Overall Study|Lost to Follow-up|0|||
19703617|NCT01763866|42147895|FG016|Overall Study|Lost to Follow-up|0|||
19703618|NCT01763866|42147896|FG017|Overall Study|Lost to Follow-up|0|||
19703619|NCT01763866|42147897|FG018|Overall Study|Lost to Follow-up|1|||
19703620|NCT01763866|42147898|FG019|Overall Study|Lost to Follow-up|1|||
19703621|NCT01763866|42147899|FG020|Overall Study|Lost to Follow-up|0|||
19703622|NCT01763866|42147900|FG021|Overall Study|Lost to Follow-up|0|||
19703623|NCT01763866|42147901|FG022|Overall Study|Lost to Follow-up|0|||
19703624|NCT01763866|42147902|FG023|Overall Study|Lost to Follow-up|1|||
19703625|NCT01763866|42147879|FG000|Overall Study|Death|0|||
19703626|NCT01763866|42147880|FG001|Overall Study|Death|0|||
19703627|NCT01763866|42147881|FG002|Overall Study|Death|0|||
19703628|NCT01763866|42147882|FG003|Overall Study|Death|0|||
19703629|NCT01763866|42147883|FG004|Overall Study|Death|0|||
19703630|NCT01763866|42147884|FG005|Overall Study|Death|0|||
19703631|NCT01763866|42147885|FG006|Overall Study|Death|0|||
19703632|NCT01763866|42147886|FG007|Overall Study|Death|0|||
19703633|NCT01763866|42147887|FG008|Overall Study|Death|0|||
19703634|NCT01763866|42147888|FG009|Overall Study|Death|0|||
19703635|NCT01763866|42147889|FG010|Overall Study|Death|0|||
19703636|NCT01763866|42147890|FG011|Overall Study|Death|0|||
19703637|NCT01763866|42147891|FG012|Overall Study|Death|0|||
19703638|NCT01763866|42147892|FG013|Overall Study|Death|0|||
19703639|NCT01763866|42147893|FG014|Overall Study|Death|0|||
19703640|NCT01763866|42147894|FG015|Overall Study|Death|0|||
19703641|NCT01763866|42147895|FG016|Overall Study|Death|1|||
19703642|NCT01763866|42147896|FG017|Overall Study|Death|0|||
19703643|NCT01763866|42147897|FG018|Overall Study|Death|0|||
19703644|NCT01763866|42147898|FG019|Overall Study|Death|0|||
19703645|NCT01763866|42147899|FG020|Overall Study|Death|0|||
19703646|NCT01763866|42147900|FG021|Overall Study|Death|0|||
19703647|NCT01763866|42147901|FG022|Overall Study|Death|0|||
19703648|NCT01763866|42147902|FG023|Overall Study|Death|0|||
19703649|NCT00132873|42147952|FG000|Overall Study|Adverse Event|3|||
19703650|NCT00132873|42147952|FG000|Overall Study|Lost to Follow-up|1|||
19703651|NCT00132873|42147952|FG000|Overall Study|Lack of Efficacy|1|||
19703652|NCT00132873|42147952|FG000|Overall Study|Withdrawal by Subject|3|||
19703653|NCT00132873|42147952|FG000|Overall Study|Planned Pregnancy|1|||
19703654|NCT00120627|42147958|FG000|Overall Study|Withdrawal by Subject|5|||
19703655|NCT00120627|42147959|FG001|Overall Study|Withdrawal by Subject|5|||
19703656|NCT03762616|42147974|FG000|Overall Study|Protocol Violation|2|||
19703657|NCT04246996|42147982|FG000|Overall Study|Physician Decision|1|||
19703658|NCT04246996|42147983|FG001|Overall Study|Physician Decision|1|||
19703659|NCT04246996|42147982|FG000|Overall Study|Did not meet eligibility criteria|1|||
19703660|NCT04246996|42147983|FG001|Overall Study|Did not meet eligibility criteria|4|||
19611145|NCT00896532|42059797|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611146|NCT00896532|42059798|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611147|NCT00896532|42059799|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611148|NCT00896532|42059800|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611149|NCT00896532|42059801|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611150|NCT00896532|42059802|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611151|NCT00896532|42059803|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611152|NCT00896532|42059804|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611153|NCT00896532|42059805|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611154|NCT00896532|42059806|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611155|NCT00896532|42059807|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611156|NCT00896532|42059808|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19703661|NCT00424463|42147992|FG000|Overall Study|Adverse Event|2|||
19703662|NCT00424463|42147993|FG001|Overall Study|Adverse Event|3|||
19611157|NCT00896532|42059809|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611158|NCT00896532|42059810|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611159|NCT00896532|42059811|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611160|NCT00896532|42059812|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611161|NCT00896532|42059813|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611162|NCT00896532|42059814|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611163|NCT00896532|42059815|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611164|NCT00896532|42059816|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19703663|NCT00424463|42147994|FG002|Overall Study|Adverse Event|2|||
19703664|NCT00424463|42147992|FG000|Overall Study|Physician Decision|0|||
19703665|NCT00424463|42147993|FG001|Overall Study|Physician Decision|2|||
19478443|NCT01502293|41757726|FG001|Overall Study|Progressive Disease|12|||
19703666|NCT00424463|42147994|FG002|Overall Study|Physician Decision|2|||
19703667|NCT00424463|42147992|FG000|Overall Study|Withdrawal by Subject|4|||
19703668|NCT00424463|42147993|FG001|Overall Study|Withdrawal by Subject|2|||
19703669|NCT00424463|42147994|FG002|Overall Study|Withdrawal by Subject|5|||
19703670|NCT00424463|42147992|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
19703671|NCT00424463|42147993|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
19611165|NCT00896532|42059817|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
19611166|NCT00896532|42059818|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
19611167|NCT00574873|42059867|FG000|Overall Study|Withdrawal by Subject|18|||
19611168|NCT00574873|42059868|FG001|Overall Study|Withdrawal by Subject|19|||
19611169|NCT00574873|42059867|FG000|Overall Study|Investigator request|18|||
19611170|NCT00574873|42059868|FG001|Overall Study|Investigator request|8|||
19611171|NCT00574873|42059867|FG000|Overall Study|Death|15|||
19611172|NCT00574873|42059868|FG001|Overall Study|Death|14|||
19611173|NCT00574873|42059867|FG000|Overall Study|Lost to Follow-up|14|||
19611174|NCT00574873|42059868|FG001|Overall Study|Lost to Follow-up|5|||
19611175|NCT00574873|42059867|FG000|Overall Study|Other|40|||
19611176|NCT00574873|42059868|FG001|Overall Study|Other|4|||
19611177|NCT00574873|42059867|FG000|Overall Study|Discontinuation of study by sponsor|5|||
19611178|NCT00574873|42059868|FG001|Overall Study|Discontinuation of study by sponsor|199|||
19611179|NCT00574873|42059867|FG000|Overall Study|Blank, site closed per local regulations|2|||
19611180|NCT00574873|42059868|FG001|Overall Study|Blank, site closed per local regulations|2|||
19611181|NCT00574873|42059867|FG000|Overall Study|Extension Study|126|||
19611182|NCT00574873|42059868|FG001|Overall Study|Extension Study|0|||
19611183|NCT00902174|42059876|FG000|Overall Study|Adverse Event|27|||
19611184|NCT00902174|42059877|FG001|Overall Study|Adverse Event|7|||
19611185|NCT00902174|42059876|FG000|Overall Study|Lack of Efficacy|1|||
19611186|NCT00902174|42059877|FG001|Overall Study|Lack of Efficacy|5|||
19611187|NCT00902174|42059876|FG000|Overall Study|Death|2|||
19611188|NCT00902174|42059877|FG001|Overall Study|Death|2|||
19611189|NCT00902174|42059876|FG000|Overall Study|Withdrawal by Subject|2|||
19611190|NCT00902174|42059877|FG001|Overall Study|Withdrawal by Subject|1|||
19611191|NCT00902174|42059876|FG000|Overall Study|Abnormal labs|1|||
19611192|NCT00902174|42059877|FG001|Overall Study|Abnormal labs|1|||
19611193|NCT00902174|42059876|FG000|Overall Study|Protocol Violation|1|||
19611194|NCT00902174|42059877|FG001|Overall Study|Protocol Violation|1|||
19611195|NCT00902174|42059876|FG000|Overall Study|Administration problem|0|||
19611196|NCT00902174|42059877|FG001|Overall Study|Administration problem|1|||
19611197|NCT01609842|42059890|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
19611198|NCT01609842|42059891|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
19611199|NCT00623623|42059916|FG000|Overall Study|Previous enrolment into this study|1|||
19611200|NCT00623623|42059917|FG001|Overall Study|Previous enrolment into this study|1|||
19611201|NCT00896454|42059923|FG000|Overall Study|Death|10|||
19611202|NCT00896454|42059923|FG000|Overall Study|Adverse Event|8|||
19611203|NCT00896454|42059923|FG000|Overall Study|Disease Progression|5|||
19611204|NCT00896454|42059923|FG000|Overall Study|Other|4|||
19611205|NCT00896454|42059923|FG000|Overall Study|Requirement for alternative therapy|3|||
19611206|NCT00896454|42059923|FG000|Overall Study|Ongoing in study|2|||
19611207|NCT00896454|42059923|FG000|Overall Study|Withdrawal by Subject|1|||
19611208|NCT00629239|42059929|FG000|Overall Study|Adverse Event|7|||
19611209|NCT00629239|42059930|FG001|Overall Study|Adverse Event|4|||
19611210|NCT00629239|42059929|FG000|Overall Study|Physician Decision|1|||
19611211|NCT00629239|42059930|FG001|Overall Study|Physician Decision|0|||
19611212|NCT00625807|42059938|FG000|Overall Study|schedule conflict|2|||
19611213|NCT00625807|42059939|FG001|Overall Study|schedule conflict|8|||
19611214|NCT00629083|42059949|FG000|Overall Study|Adverse Event|0|||
19611215|NCT00629083|42059950|FG001|Overall Study|Adverse Event|2|||
19611216|NCT00629083|42059949|FG000|Overall Study|Lack of Efficacy|3|||
19611217|NCT00629083|42059950|FG001|Overall Study|Lack of Efficacy|1|||
19611218|NCT00629083|42059949|FG000|Overall Study|Withdrawal by Subject|10|||
19703672|NCT00424463|42147994|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
19703673|NCT00424463|42147992|FG000|Overall Study|Patient's convenience|0|||
19703674|NCT00424463|42147993|FG001|Overall Study|Patient's convenience|0|||
19703675|NCT00424463|42147994|FG002|Overall Study|Patient's convenience|1|||
19703676|NCT00424385|42148002|FG000|Cohort 0|Withdrawal by Subject|5|||
19703677|NCT00424385|42148002|FG000|Cohort 0|Physician Decision|1|||
19703678|NCT00424385|42148002|FG000|Cohort 1|Withdrawal by Subject|1|||
19703679|NCT00423917|42148008|FG000|Overall Study|Cancel|2|||
19703680|NCT00423917|42148008|FG000|Overall Study|Ineligible|1|||
19703681|NCT00845026|42148014|FG000|Study Period III|Adverse Event|23|||
19703682|NCT00845026|42148015|FG001|Study Period III|Adverse Event|19|||
19703683|NCT00845026|42148014|FG000|Study Period III|Perceived lack of efficacy|27|||
19703684|NCT00845026|42148015|FG001|Study Period III|Perceived lack of efficacy|15|||
19703685|NCT00845026|42148014|FG000|Study Period III|Withdrawal by Subject|19|||
19478444|NCT01502293|41757727|FG002|Overall Study|Progressive Disease|2|||
19611219|NCT00629083|42059950|FG001|Overall Study|Withdrawal by Subject|2|||
19703686|NCT00845026|42148015|FG001|Study Period III|Withdrawal by Subject|15|||
19611220|NCT00629083|42059949|FG000|Overall Study|Lost to Follow-up|12|||
19611221|NCT00629083|42059950|FG001|Overall Study|Lost to Follow-up|8|||
19611222|NCT00629083|42059949|FG000|Overall Study|Moved out of country/state|2|||
19611223|NCT00629083|42059950|FG001|Overall Study|Moved out of country/state|1|||
19611224|NCT00629083|42059949|FG000|Overall Study|Refused to return for 12 month visit|1|||
19703687|NCT00845026|42148014|FG000|Study Period III|Entry Criteria not met|8|||
19611225|NCT00629083|42059950|FG001|Overall Study|Refused to return for 12 month visit|0|||
19611226|NCT00901628|42059960|FG000|Overall Study|disconnection of catheter|4|||
19611227|NCT00901628|42059961|FG001|Overall Study|disconnection of catheter|8|||
19611228|NCT00901628|42059960|FG000|Overall Study|disconnection of drain|0|||
19611229|NCT00901628|42059961|FG001|Overall Study|disconnection of drain|1|||
19611230|NCT00901628|42059960|FG000|Overall Study|peroneal nerve palsy|0|||
19611231|NCT00901628|42059961|FG001|Overall Study|peroneal nerve palsy|1|||
19611232|NCT00623545|42059967|FG000|Overall Study|Adverse Event|6|||
19611233|NCT00623545|42059967|FG000|Overall Study|Withdrawal by Subject|4|||
19611234|NCT00628927|42059974|FG000|Overall Study|Problems performing blood draw|6|||
19611235|NCT00628927|42059975|FG001|Overall Study|Problems performing blood draw|0|||
19611236|NCT00628927|42059974|FG000|Overall Study|Lost to Follow-up|1|||
19611237|NCT00628927|42059975|FG001|Overall Study|Lost to Follow-up|0|||
19611238|NCT00628927|42059974|FG000|Overall Study|Equipment failure|1|||
19611239|NCT00628927|42059975|FG001|Overall Study|Equipment failure|0|||
19611240|NCT00623467|42059986|FG000|Overall Study|Lost to Follow-up|1|||
19611241|NCT00623467|42059986|FG000|Overall Study|Protocol Violation|4|||
19611242|NCT00623467|42059986|FG000|Overall Study|Withdrawal by Subject|2|||
19611243|NCT00838539|42060004|FG000|Overall Study|Disease Progression|2|||
19611244|NCT00838539|42060005|FG001|Overall Study|Disease Progression|4|||
19611245|NCT00838539|42060006|FG002|Overall Study|Disease Progression|3|||
19611246|NCT00838539|42060007|FG003|Overall Study|Disease Progression|2|||
19611247|NCT00838539|42060008|FG004|Overall Study|Disease Progression|4|||
19611248|NCT00838539|42060009|FG005|Overall Study|Disease Progression|2|||
19611249|NCT00838539|42060010|FG006|Overall Study|Disease Progression|3|||
19611250|NCT00838539|42060011|FG007|Overall Study|Disease Progression|4|||
19611251|NCT00838539|42060012|FG008|Overall Study|Disease Progression|4|||
19611252|NCT00838539|42060013|FG009|Overall Study|Disease Progression|5|||
19611253|NCT00838539|42060014|FG010|Overall Study|Disease Progression|1|||
19611254|NCT00838539|42060015|FG011|Overall Study|Disease Progression|4|||
19611255|NCT00838539|42060004|FG000|Overall Study|Adverse Event|1|||
19611256|NCT00838539|42060005|FG001|Overall Study|Adverse Event|1|||
19611257|NCT00838539|42060006|FG002|Overall Study|Adverse Event|1|||
19611258|NCT00838539|42060007|FG003|Overall Study|Adverse Event|1|||
19611259|NCT00838539|42060008|FG004|Overall Study|Adverse Event|2|||
19611260|NCT00838539|42060009|FG005|Overall Study|Adverse Event|1|||
19611261|NCT00838539|42060010|FG006|Overall Study|Adverse Event|0|||
19611262|NCT00838539|42060011|FG007|Overall Study|Adverse Event|2|||
19611263|NCT00838539|42060012|FG008|Overall Study|Adverse Event|0|||
19611264|NCT00838539|42060013|FG009|Overall Study|Adverse Event|1|||
19611265|NCT00838539|42060014|FG010|Overall Study|Adverse Event|2|||
19611266|NCT00838539|42060015|FG011|Overall Study|Adverse Event|0|||
19611267|NCT00838539|42060004|FG000|Overall Study|Withdrawal by Subject|0|||
19611268|NCT00838539|42060005|FG001|Overall Study|Withdrawal by Subject|1|||
19611269|NCT00838539|42060006|FG002|Overall Study|Withdrawal by Subject|0|||
19611270|NCT00838539|42060007|FG003|Overall Study|Withdrawal by Subject|0|||
19611271|NCT00838539|42060008|FG004|Overall Study|Withdrawal by Subject|0|||
19611272|NCT00838539|42060009|FG005|Overall Study|Withdrawal by Subject|0|||
19611273|NCT00838539|42060010|FG006|Overall Study|Withdrawal by Subject|0|||
19611274|NCT00838539|42060011|FG007|Overall Study|Withdrawal by Subject|0|||
19611275|NCT00838539|42060012|FG008|Overall Study|Withdrawal by Subject|0|||
19611276|NCT00838539|42060013|FG009|Overall Study|Withdrawal by Subject|1|||
19611277|NCT00838539|42060014|FG010|Overall Study|Withdrawal by Subject|2|||
19611278|NCT00838539|42060015|FG011|Overall Study|Withdrawal by Subject|0|||
19611279|NCT00838539|42060004|FG000|Overall Study|Death|0|||
19611280|NCT00838539|42060005|FG001|Overall Study|Death|0|||
19611281|NCT00838539|42060006|FG002|Overall Study|Death|0|||
19611282|NCT00838539|42060007|FG003|Overall Study|Death|0|||
19611283|NCT00838539|42060008|FG004|Overall Study|Death|0|||
19611284|NCT00838539|42060009|FG005|Overall Study|Death|0|||
19611285|NCT00838539|42060010|FG006|Overall Study|Death|1|||
19611286|NCT00838539|42060011|FG007|Overall Study|Death|0|||
19611287|NCT00838539|42060012|FG008|Overall Study|Death|0|||
19611288|NCT00838539|42060013|FG009|Overall Study|Death|0|||
19611289|NCT00838539|42060014|FG010|Overall Study|Death|0|||
19611290|NCT00838539|42060015|FG011|Overall Study|Death|0|||
19611291|NCT00838539|42060004|FG000|Overall Study|Physician Decision|0|||
19611292|NCT00838539|42060005|FG001|Overall Study|Physician Decision|0|||
19611293|NCT00838539|42060006|FG002|Overall Study|Physician Decision|0|||
19611294|NCT00838539|42060007|FG003|Overall Study|Physician Decision|0|||
19611295|NCT00838539|42060008|FG004|Overall Study|Physician Decision|0|||
19611296|NCT00838539|42060009|FG005|Overall Study|Physician Decision|0|||
19611297|NCT00838539|42060010|FG006|Overall Study|Physician Decision|0|||
19391933|NCT01998958|41636172|FG012|Period 1 (Panel A and B)|Other|0|||
19611298|NCT00838539|42060011|FG007|Overall Study|Physician Decision|0|||
19611299|NCT00838539|42060012|FG008|Overall Study|Physician Decision|1|||
19611300|NCT00838539|42060013|FG009|Overall Study|Physician Decision|0|||
19611301|NCT00838539|42060014|FG010|Overall Study|Physician Decision|0|||
19611302|NCT00838539|42060015|FG011|Overall Study|Physician Decision|0|||
19611303|NCT00838539|42060004|FG000|Overall Study|Clinical Progression|0|||
19611304|NCT00838539|42060005|FG001|Overall Study|Clinical Progression|0|||
19611305|NCT00838539|42060006|FG002|Overall Study|Clinical Progression|0|||
19611306|NCT00838539|42060007|FG003|Overall Study|Clinical Progression|0|||
19611307|NCT00838539|42060008|FG004|Overall Study|Clinical Progression|0|||
19611308|NCT00838539|42060009|FG005|Overall Study|Clinical Progression|0|||
19611309|NCT00838539|42060010|FG006|Overall Study|Clinical Progression|1|||
19611310|NCT00838539|42060011|FG007|Overall Study|Clinical Progression|0|||
19611311|NCT00838539|42060012|FG008|Overall Study|Clinical Progression|0|||
19373636|NCT02760407|41614833|FG000|Overall Study|Withdrawal By PI's Decision|0|||
19373637|NCT02760407|41614834|FG001|Overall Study|Withdrawal By PI's Decision|1|||
19373638|NCT02760407|41614835|FG002|Overall Study|Withdrawal By PI's Decision|0|||
19373639|NCT02760407|41614836|FG003|Overall Study|Withdrawal By PI's Decision|0|||
19373640|NCT02760407|41614833|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
19373641|NCT02760407|41614834|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
19373642|NCT02760407|41614835|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
19373643|NCT02760407|41614836|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
19373644|NCT02760407|41614833|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
19373645|NCT02760407|41614834|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
19373646|NCT02760407|41614835|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
19391934|NCT01998958|41636173|FG013|Period 1 (Panel A and B)|Other|0|||
19611312|NCT00838539|42060013|FG009|Overall Study|Clinical Progression|0|||
19611313|NCT00838539|42060014|FG010|Overall Study|Clinical Progression|0|||
19611314|NCT00838539|42060015|FG011|Overall Study|Clinical Progression|0|||
19611315|NCT00838539|42060004|FG000|Overall Study|Symptomatic Deterioration|0|||
19611316|NCT00838539|42060005|FG001|Overall Study|Symptomatic Deterioration|0|||
19611317|NCT00838539|42060006|FG002|Overall Study|Symptomatic Deterioration|1|||
19611318|NCT00838539|42060007|FG003|Overall Study|Symptomatic Deterioration|1|||
19611319|NCT00838539|42060008|FG004|Overall Study|Symptomatic Deterioration|0|||
19611320|NCT00838539|42060009|FG005|Overall Study|Symptomatic Deterioration|1|||
19611321|NCT00838539|42060010|FG006|Overall Study|Symptomatic Deterioration|0|||
19611322|NCT00838539|42060011|FG007|Overall Study|Symptomatic Deterioration|0|||
19611323|NCT00838539|42060012|FG008|Overall Study|Symptomatic Deterioration|0|||
19611324|NCT00838539|42060013|FG009|Overall Study|Symptomatic Deterioration|1|||
19611325|NCT00838539|42060014|FG010|Overall Study|Symptomatic Deterioration|0|||
19611326|NCT00838539|42060015|FG011|Overall Study|Symptomatic Deterioration|0|||
19611327|NCT00837759|42060055|FG000|Overall Study|Protocol Violation|3|||
19611328|NCT00837759|42060055|FG000|Overall Study|Lost to Follow-up|1|||
19611329|NCT00891774|42060059|FG000|Overall Study|Lost to Follow-up|5|||
19611330|NCT00891774|42060059|FG000|Overall Study|Illness (Self/Mother)|3|||
19611331|NCT00891774|42060059|FG000|Overall Study|Withdrawal by Subject|2|||
19611332|NCT00891774|42060059|FG000|Overall Study|Protocol Violation|4|||
19611333|NCT00837213|42060065|FG000|Overall Study|Lost to Follow-up|3|||
19611334|NCT00837213|42060066|FG001|Overall Study|Lost to Follow-up|2|||
19611335|NCT00837213|42060065|FG000|Overall Study|Withdrawal by Subject|2|||
19611336|NCT00837213|42060066|FG001|Overall Study|Withdrawal by Subject|2|||
19611337|NCT00837213|42060065|FG000|Overall Study|not stated|1|||
19611338|NCT00837213|42060066|FG001|Overall Study|not stated|1|||
19611339|NCT00902486|42060076|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
19611340|NCT00902486|42060077|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
19611341|NCT00902486|42060078|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
19611342|NCT00902486|42060079|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
19611343|NCT00902486|42060080|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
19611344|NCT00902486|42060081|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
19611345|NCT00902486|42060076|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
19611346|NCT00902486|42060077|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
19611347|NCT00902486|42060078|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
19611348|NCT00902486|42060079|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
19611349|NCT00902486|42060080|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
19611350|NCT00902486|42060081|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
19611351|NCT00902486|42060076|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
19611352|NCT00902486|42060077|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
19611353|NCT00902486|42060078|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
19611354|NCT00902486|42060079|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
19611355|NCT00902486|42060080|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
19611356|NCT00902486|42060081|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
19611357|NCT00902486|42060076|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
19611358|NCT00902486|42060077|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
19611359|NCT00902486|42060078|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
19611360|NCT00902486|42060079|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
19611361|NCT00902486|42060080|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
19611362|NCT00902486|42060081|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
19611363|NCT00902486|42060076|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
19611364|NCT00902486|42060077|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
19611365|NCT00902486|42060078|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
19611366|NCT00902486|42060079|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
19611367|NCT00902486|42060080|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
19611368|NCT00902486|42060081|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
19611369|NCT00902486|42060076|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
19611370|NCT00902486|42060077|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
19611371|NCT00902486|42060078|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
19611372|NCT00902486|42060079|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
19611373|NCT00902486|42060080|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
19611374|NCT00902486|42060081|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
19611375|NCT00902486|42060076|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
19611376|NCT00902486|42060077|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
19611377|NCT00902486|42060078|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
19611378|NCT00902486|42060079|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
19611379|NCT00902486|42060080|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
19611380|NCT00902486|42060081|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
19611381|NCT00902486|42060076|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
19611382|NCT00902486|42060077|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
19611383|NCT00902486|42060078|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
19611384|NCT00902486|42060079|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
19611385|NCT00902486|42060080|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
19611386|NCT00902486|42060081|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
19611387|NCT00902486|42060076|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
19611388|NCT00902486|42060077|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
19611389|NCT00902486|42060078|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
19611390|NCT00902486|42060079|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
19611391|NCT00902486|42060080|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
19611392|NCT00902486|42060081|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
19611393|NCT00902486|42060076|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
19611394|NCT00902486|42060077|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
19611395|NCT00902486|42060078|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
19611396|NCT00902486|42060079|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
19611397|NCT00902486|42060080|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
19611398|NCT00902486|42060081|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
19611399|NCT00902486|42060076|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
19611400|NCT00902486|42060077|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
19611401|NCT00902486|42060078|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
19611402|NCT00902486|42060079|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
19611403|NCT00902486|42060080|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
19611404|NCT00902486|42060081|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
19611405|NCT00836745|42060111|FG000|Overall Study|Death|2|||
19611406|NCT00836745|42060111|FG000|Overall Study|Lost to Follow-up|10|||
19611407|NCT00836745|42060111|FG000|Overall Study|Adverse Event|3|||
19611408|NCT00836745|42060111|FG000|Overall Study|Objective progression or relapse|4|||
19611409|NCT00836745|42060111|FG000|Overall Study|Other|2|||
19611410|NCT00891618|42060115|FG000|Overall Study|Withdrawal by Subject|1|||
19611411|NCT00836589|42060119|FG000|Overall Study|Lost to Follow-up|246|||
19611412|NCT00836589|42060119|FG000|Overall Study|Death|429|||
19611413|NCT00836589|42060119|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
19611414|NCT00574795|42060131|FG000|Infant Series|Withdrawal by Subject|2|||
19611415|NCT00574795|42060131|FG000|Infant Series|Protocol Violation|2|||
19611416|NCT00574795|42060131|FG000|Infant Series|Adverse Event|1|||
19611417|NCT00574795|42060131|FG000|After Infant Series|Withdrawal by Subject|1|||
19703688|NCT00845026|42148015|FG001|Study Period III|Entry Criteria not met|11|||
19703689|NCT00845026|42148014|FG000|Study Period III|Lost to Follow-up|4|||
19703690|NCT00845026|42148015|FG001|Study Period III|Lost to Follow-up|5|||
19703691|NCT00845026|42148014|FG000|Study Period III|Protocol Violation|8|||
19703692|NCT00845026|42148015|FG001|Study Period III|Protocol Violation|1|||
19703693|NCT00845026|42148014|FG000|Study Period III|Scheduled conflict|3|||
19611418|NCT00574795|42060131|FG000|After Infant Series|Adverse Event|2|||
19611419|NCT00574795|42060131|FG000|Toddler Dose|Withdrawal by Subject|1|||
19611420|NCT02297516|42060148|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
19611421|NCT02297516|42060149|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
19703694|NCT00845026|42148015|FG001|Study Period III|Scheduled conflict|1|||
19611422|NCT02297516|42060148|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
19611423|NCT02297516|42060149|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
19611424|NCT02297516|42060148|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
19611425|NCT02297516|42060149|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
19611426|NCT00836277|42060162|FG000|Overall Study|Not evaluable for response|6|||
19611427|NCT00835731|42060168|FG000|Overall Study|Withdrawal by Subject|1|||
19611428|NCT00835731|42060169|FG001|Overall Study|Withdrawal by Subject|0|||
19611429|NCT00835731|42060168|FG000|Overall Study|Physician Decision|1|||
19611430|NCT00835731|42060169|FG001|Overall Study|Physician Decision|1|||
19611431|NCT00835341|42060177|FG000|Overall Study|Lost to Follow-up|3|||
19611432|NCT00835341|42060178|FG001|Overall Study|Lost to Follow-up|12|||
19611433|NCT00574249|42060186|FG000|Overall Study|Adverse Event|6|||
19611434|NCT00574249|42060187|FG001|Overall Study|Adverse Event|18|||
19611435|NCT00574249|42060186|FG000|Overall Study|Lack of Efficacy|5|||
19611436|NCT00574249|42060187|FG001|Overall Study|Lack of Efficacy|3|||
19611437|NCT00574249|42060186|FG000|Overall Study|Lost to Follow-up|4|||
19611438|NCT00574249|42060187|FG001|Overall Study|Lost to Follow-up|3|||
19611439|NCT00574249|42060186|FG000|Overall Study|Protocol Violation|5|||
19611440|NCT00574249|42060187|FG001|Overall Study|Protocol Violation|2|||
19611441|NCT00574249|42060186|FG000|Overall Study|History of carcinoma|1|||
19611442|NCT00574249|42060187|FG001|Overall Study|History of carcinoma|0|||
19611443|NCT00574249|42060186|FG000|Overall Study|Withdrawal by Subject|3|||
19611444|NCT00574249|42060187|FG001|Overall Study|Withdrawal by Subject|0|||
19611445|NCT00574249|42060186|FG000|Overall Study|Physician Decision|1|||
19611446|NCT00574249|42060187|FG001|Overall Study|Physician Decision|0|||
19611447|NCT00574249|42060186|FG000|Overall Study|Pregnancy|1|||
19611448|NCT00574249|42060187|FG001|Overall Study|Pregnancy|0|||
19611449|NCT00574249|42060186|FG000|Overall Study|Excluded by company|0|||
19611450|NCT00574249|42060187|FG001|Overall Study|Excluded by company|1|||
19611451|NCT00574249|42060186|FG000|Overall Study|PPD test taken twice|0|||
19611452|NCT00574249|42060187|FG001|Overall Study|PPD test taken twice|1|||
19611453|NCT00891228|42060196|FG000|Overall Study|Adverse Event|0|||
19611454|NCT00891228|42060197|FG001|Overall Study|Adverse Event|2|||
19611455|NCT00891228|42060198|FG002|Overall Study|Adverse Event|3|||
19611456|NCT00891228|42060196|FG000|Overall Study|Withdrawal by Subject|2|||
19611457|NCT00891228|42060197|FG001|Overall Study|Withdrawal by Subject|4|||
19611458|NCT00891228|42060198|FG002|Overall Study|Withdrawal by Subject|5|||
19611459|NCT00891228|42060196|FG000|Overall Study|Protocol Violation|3|||
19611460|NCT00891228|42060197|FG001|Overall Study|Protocol Violation|1|||
19611461|NCT00891228|42060198|FG002|Overall Study|Protocol Violation|2|||
19611462|NCT00891228|42060196|FG000|Overall Study|Physician Decision|2|||
19611463|NCT00891228|42060197|FG001|Overall Study|Physician Decision|1|||
19611464|NCT00891228|42060198|FG002|Overall Study|Physician Decision|0|||
19611465|NCT00891228|42060196|FG000|Overall Study|Lost to Follow-up|4|||
19611466|NCT00891228|42060197|FG001|Overall Study|Lost to Follow-up|4|||
19611467|NCT00891228|42060198|FG002|Overall Study|Lost to Follow-up|5|||
19611468|NCT00891228|42060196|FG000|Overall Study|Pregnancy|0|||
19611469|NCT00891228|42060197|FG001|Overall Study|Pregnancy|1|||
19611470|NCT00891228|42060198|FG002|Overall Study|Pregnancy|0|||
19611471|NCT00896168|42060208|FG000|Overall Study|Adverse Event|4|||
19611472|NCT00896168|42060209|FG001|Overall Study|Adverse Event|7|||
19611473|NCT00896168|42060208|FG000|Overall Study|Treatment failure|8|||
19611474|NCT00896168|42060209|FG001|Overall Study|Treatment failure|10|||
19611475|NCT00896168|42060208|FG000|Overall Study|Lost to Follow-up|1|||
19611476|NCT00896168|42060209|FG001|Overall Study|Lost to Follow-up|1|||
19611477|NCT00896168|42060208|FG000|Overall Study|Other|1|||
19611478|NCT00896168|42060209|FG001|Overall Study|Other|1|||
19611479|NCT00833703|42060217|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
19611480|NCT00833703|42060218|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
19611481|NCT00833547|42060226|FG000|Overall Study|Withdrawal by Subject|2|||
19703695|NCT00845026|42148014|FG000|Study Period III|Subject is moving or has moved|2|||
19703696|NCT00845026|42148015|FG001|Study Period III|Subject is moving or has moved|4|||
19611482|NCT00833547|42060227|FG001|Overall Study|Withdrawal by Subject|2|||
19611483|NCT00833469|42060233|FG000|Overall Study|Withdrawal by Subject|1|||
19611484|NCT00833469|42060233|FG000|Overall Study|Lost to Follow-up|1|||
19611485|NCT00832377|42060237|FG000|Overall Study|Protocol Violation|1|||
19611486|NCT00892008|42060241|FG000|Overall Study|Death|5|||
19611487|NCT00892008|42060241|FG000|Overall Study|Lack of Efficacy|3|||
19611488|NCT00892008|42060241|FG000|Overall Study|Lost to Follow-up|142|||
19611489|NCT00892008|42060241|FG000|Overall Study|Other|378|||
19703697|NCT00845026|42148014|FG000|Study Period III|Transportation issues|1|||
19703698|NCT00845026|42148015|FG001|Study Period III|Transportation issues|1|||
19611490|NCT00892008|42060241|FG000|Overall Study|Adverse Event|37|||
19611491|NCT00623233|42060245|FG000|Overall Study|Adverse Event|10|||
19611492|NCT00623233|42060245|FG000|Overall Study|Physician Decision|10|||
19611493|NCT00623233|42060245|FG000|Overall Study|Lost to Follow-up|1|||
19611494|NCT00623233|42060245|FG000|Overall Study|Withdrawal by Subject|3|||
19611495|NCT03369236|42060251|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
19703699|NCT00845026|42148014|FG000|Study Period IV|Adverse Event|4|||
19703700|NCT00845026|42148015|FG001|Study Period IV|Adverse Event|0|||
19703701|NCT00845026|42148014|FG000|Study Period IV|Perceived lack of efficacy|2|||
19611496|NCT03369236|42060252|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
19611497|NCT03369236|42060251|FG000|Open-label Extension Period|Lack of Efficacy|2|||
19611498|NCT03369236|42060252|FG001|Open-label Extension Period|Lack of Efficacy|1|||
19611499|NCT03369236|42060251|FG000|Open-label Extension Period|Adverse Event|0|||
19611500|NCT03369236|42060252|FG001|Open-label Extension Period|Adverse Event|1|||
19611501|NCT03369236|42060251|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
19611502|NCT03369236|42060252|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
19611503|NCT00621751|42060275|FG000|Overall Study|Adverse Event|0|||
19611504|NCT00621751|42060276|FG001|Overall Study|Adverse Event|1|||
19611505|NCT00891930|42060293|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
19611506|NCT00891930|42060293|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
19611507|NCT00891930|42060293|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
19611508|NCT00891930|42060293|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
19611509|NCT00891930|42060293|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
19611510|NCT00895622|42060304|FG000|Overall Study|Protocol Violation|5|||
19611511|NCT00895622|42060305|FG001|Overall Study|Protocol Violation|4|||
19611512|NCT00895622|42060306|FG002|Overall Study|Protocol Violation|4|||
19611513|NCT00891462|42060325|FG000|Overall Study|Withdrawal by Subject|9|||
19611514|NCT00891462|42060326|FG001|Overall Study|Withdrawal by Subject|6|||
19611515|NCT00891462|42060327|FG002|Overall Study|Withdrawal by Subject|7|||
19611516|NCT00891462|42060325|FG000|Overall Study|Adverse Event|7|||
19611517|NCT00891462|42060326|FG001|Overall Study|Adverse Event|8|||
19611518|NCT00891462|42060327|FG002|Overall Study|Adverse Event|7|||
19611519|NCT00891462|42060325|FG000|Overall Study|Lack of Efficacy|10|||
19611520|NCT00891462|42060326|FG001|Overall Study|Lack of Efficacy|5|||
19611521|NCT00891462|42060327|FG002|Overall Study|Lack of Efficacy|1|||
19611522|NCT00891462|42060325|FG000|Overall Study|COPD exacerbation|7|||
19611523|NCT00891462|42060326|FG001|Overall Study|COPD exacerbation|4|||
19611524|NCT00891462|42060327|FG002|Overall Study|COPD exacerbation|1|||
19611525|NCT00891462|42060325|FG000|Overall Study|Other Reason|2|||
19611526|NCT00891462|42060326|FG001|Overall Study|Other Reason|5|||
19611527|NCT00891462|42060327|FG002|Overall Study|Other Reason|3|||
19611528|NCT00891462|42060325|FG000|Overall Study|Protocol Violation|2|||
19611529|NCT00891462|42060326|FG001|Overall Study|Protocol Violation|1|||
19611530|NCT00891462|42060327|FG002|Overall Study|Protocol Violation|3|||
19611531|NCT00891462|42060325|FG000|Overall Study|Inclusion/exclusion criteria|0|||
19611532|NCT00891462|42060326|FG001|Overall Study|Inclusion/exclusion criteria|2|||
19611533|NCT00891462|42060327|FG002|Overall Study|Inclusion/exclusion criteria|2|||
19611534|NCT00891462|42060325|FG000|Overall Study|Lost to Follow-up|0|||
19611535|NCT00891462|42060326|FG001|Overall Study|Lost to Follow-up|2|||
19611536|NCT00891462|42060327|FG002|Overall Study|Lost to Follow-up|0|||
19611537|NCT00900146|42060342|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
19611538|NCT00900146|42060343|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
19611539|NCT00900146|42060344|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
19611540|NCT00900146|42060345|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
19611541|NCT00900146|42060346|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
19611542|NCT00900146|42060342|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
19611543|NCT00900146|42060343|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
19611544|NCT00900146|42060344|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
19611545|NCT00900146|42060345|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
19611546|NCT00900146|42060346|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
19611547|NCT00900146|42060342|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
19703702|NCT00845026|42148015|FG001|Study Period IV|Perceived lack of efficacy|1|||
19703703|NCT00845026|42148014|FG000|Study Period IV|Protocol Violation|3|||
19703704|NCT00845026|42148015|FG001|Study Period IV|Protocol Violation|1|||
19703705|NCT00845026|42148014|FG000|Study Period IV|Lost to Follow-up|1|||
19703706|NCT00845026|42148015|FG001|Study Period IV|Lost to Follow-up|0|||
19703707|NCT00845026|42148014|FG000|Study Period IV|Withdrawal by Subject|4|||
19703708|NCT00845026|42148015|FG001|Study Period IV|Withdrawal by Subject|1|||
19703709|NCT00845026|42148014|FG000|Study Period IV|Entry Criteria Not Met|1|||
19703710|NCT00845026|42148015|FG001|Study Period IV|Entry Criteria Not Met|0|||
19703711|NCT00845026|42148014|FG000|Study Period IV|Subject is moving or has moved|0|||
19703712|NCT00845026|42148015|FG001|Study Period IV|Subject is moving or has moved|1|||
19391935|NCT01998958|41636174|FG014|Period 1 (Panel A and B)|Other|0|||
19611548|NCT00900146|42060343|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
19611549|NCT00900146|42060344|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
19703713|NCT00845026|42148014|FG000|Study Period IV|Scheduling conflict|1|||
19703714|NCT00845026|42148015|FG001|Study Period IV|Scheduling conflict|0|||
19703715|NCT00691678|42148023|FG000|Overall Study|Adverse Event|5|||
19703716|NCT00691678|42148023|FG000|Overall Study|life events, pain|11|||
19703717|NCT00423605|42148027|FG000|Overall Study|Adverse Event|129|||
19611550|NCT00900146|42060345|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
19611551|NCT00900146|42060346|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
19611552|NCT00900146|42060342|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
19611553|NCT00900146|42060343|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
19611554|NCT00900146|42060344|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
19703718|NCT00423605|42148027|FG000|Overall Study|Withdrawal by Subject|36|||
19703719|NCT00423605|42148027|FG000|Overall Study|Lost to Follow-up|15|||
19703720|NCT00423605|42148027|FG000|Overall Study|Lack of Efficacy|38|||
19611555|NCT00900146|42060345|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
19611556|NCT00900146|42060346|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
19611557|NCT00900146|42060342|FG000|Intermediate: Period III|Lost to Follow-up|2|||
19611558|NCT00900146|42060343|FG001|Intermediate: Period III|Lost to Follow-up|0|||
19611559|NCT00900146|42060344|FG002|Intermediate: Period III|Lost to Follow-up|0|||
19611560|NCT00900146|42060345|FG003|Intermediate: Period III|Lost to Follow-up|0|||
19611561|NCT00900146|42060346|FG004|Intermediate: Period III|Lost to Follow-up|1|||
19611562|NCT00900146|42060342|FG000|Intermediate: Period III|Administrative problems|85|||
19611563|NCT00900146|42060343|FG001|Intermediate: Period III|Administrative problems|92|||
19611564|NCT00900146|42060344|FG002|Intermediate: Period III|Administrative problems|84|||
19611565|NCT00900146|42060345|FG003|Intermediate: Period III|Administrative problems|90|||
19611566|NCT00900146|42060346|FG004|Intermediate: Period III|Administrative problems|163|||
19611567|NCT00895310|42060358|FG000|Overall Study|Withdrawal by Subject|1|||
19611568|NCT00895154|42060364|FG000|Overall Study|Lost to Follow-up|1|||
19611569|NCT00895154|42060365|FG001|Overall Study|Lost to Follow-up|1|||
19611570|NCT00895154|42060364|FG000|Overall Study|Withdrawal by Subject|0|||
19611571|NCT00895154|42060365|FG001|Overall Study|Withdrawal by Subject|1|||
19611572|NCT00888654|42060371|FG000|Overall Study|Problems swallowing oral meds.|1|||
19611573|NCT00888654|42060371|FG000|Overall Study|Not enough oral meds before surgery|3|||
19611574|NCT00888654|42060371|FG000|Overall Study|Surgery aborted|2|||
19611575|NCT00888654|42060371|FG000|Overall Study|Withdrawal by Subject|1|||
19611576|NCT00888654|42060371|FG000|Overall Study|Inelig. due to contraindication of med|1|||
19611577|NCT00888654|42060371|FG000|Overall Study|Change in surg date|1|||
19611578|NCT00888654|42060371|FG000|Overall Study|Stopped meds due to headaches|1|||
19611579|NCT00899678|42060378|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
19611580|NCT00899678|42060379|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
19611581|NCT00899678|42060380|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
19611582|NCT00899678|42060378|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
19611583|NCT00899678|42060379|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
19611584|NCT00899678|42060380|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
19611585|NCT00899678|42060378|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
19611586|NCT00899678|42060379|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
19611587|NCT00899678|42060380|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
19611588|NCT00899678|42060378|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
19611589|NCT00899678|42060379|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
19611590|NCT00899678|42060380|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
19611591|NCT00899678|42060378|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
19611592|NCT00899678|42060379|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
19611593|NCT00899678|42060380|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
19611594|NCT00899678|42060378|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
19611595|NCT00899678|42060379|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
19611596|NCT00899678|42060380|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
19611597|NCT00899678|42060378|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
19611598|NCT00899678|42060379|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
19611599|NCT00899678|42060380|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
19611600|NCT00899678|42060378|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
19611601|NCT00899678|42060379|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
19611602|NCT00899678|42060380|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
19611603|NCT00899678|42060378|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
19611604|NCT00899678|42060379|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
19611605|NCT00899678|42060380|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
19611606|NCT00887484|42060388|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
19611607|NCT00887484|42060388|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
19611608|NCT00887484|42060388|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
19611609|NCT00886938|42060397|FG000|Overall Study|Adverse Event|1|||
19611610|NCT00886938|42060397|FG000|Overall Study|Withdrawal by Subject|1|||
19611611|NCT00620659|42060401|FG000|Treatment Period 1|Adverse Event|1|||
19611612|NCT00620659|42060402|FG001|Treatment Period 1|Adverse Event|0|||
19611613|NCT00620659|42060403|FG002|Treatment Period 1|Adverse Event|0|||
19703721|NCT00423605|42148027|FG000|Overall Study|Sponsor Decision|3|||
19703722|NCT00423605|42148027|FG000|Overall Study|Physician Decision|8|||
19391936|NCT01998958|41636175|FG015|Period 1 (Panel A and B)|Other|0|||
19391937|NCT01998958|41636176|FG016|Period 1 (Panel A and B)|Other|0|||
19611614|NCT00620659|42060404|FG003|Treatment Period 1|Adverse Event|3|||
19611615|NCT00620659|42060405|FG004|Treatment Period 1|Adverse Event|0|||
19611616|NCT00620659|42060406|FG005|Treatment Period 1|Adverse Event|0|||
19611617|NCT00620659|42060401|FG000|Treatment Period 1|Protocol Violation|1|||
19611618|NCT00620659|42060402|FG001|Treatment Period 1|Protocol Violation|0|||
19611619|NCT00620659|42060403|FG002|Treatment Period 1|Protocol Violation|0|||
19611620|NCT00620659|42060404|FG003|Treatment Period 1|Protocol Violation|0|||
19611621|NCT00620659|42060405|FG004|Treatment Period 1|Protocol Violation|0|||
19611622|NCT00620659|42060406|FG005|Treatment Period 1|Protocol Violation|0|||
19611623|NCT00620659|42060401|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19611624|NCT00620659|42060402|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19611625|NCT00620659|42060403|FG002|Treatment Period 1|Withdrawal by Subject|1|||
19611626|NCT00620659|42060404|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19611627|NCT00620659|42060405|FG004|Treatment Period 1|Withdrawal by Subject|1|||
19611628|NCT00620659|42060406|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19611629|NCT00620659|42060401|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
19611630|NCT00620659|42060402|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
19611631|NCT00620659|42060403|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
19611632|NCT00620659|42060404|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
19611633|NCT00620659|42060405|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
19703723|NCT00423605|42148027|FG000|Overall Study|Protocol Violation|7|||
19703724|NCT00423605|42148027|FG000|Overall Study|Not one of the pre-specified options|5|||
19703725|NCT00003838|42148034|FG000|Overall Study|Death|0|||
19703726|NCT00003838|42148035|FG001|Overall Study|Death|12|||
19611634|NCT00620659|42060406|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
19611635|NCT00620659|42060401|FG000|Treatment Period 2|Adverse Event|0|||
19611636|NCT00620659|42060402|FG001|Treatment Period 2|Adverse Event|3|||
19611637|NCT00620659|42060403|FG002|Treatment Period 2|Adverse Event|0|||
19611638|NCT00620659|42060404|FG003|Treatment Period 2|Adverse Event|0|||
19611639|NCT00620659|42060405|FG004|Treatment Period 2|Adverse Event|2|||
19611640|NCT00620659|42060406|FG005|Treatment Period 2|Adverse Event|0|||
19611641|NCT00620659|42060401|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19611642|NCT00620659|42060402|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19611643|NCT00620659|42060403|FG002|Treatment Period 2|Withdrawal by Subject|1|||
19611644|NCT00620659|42060404|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19611645|NCT00620659|42060405|FG004|Treatment Period 2|Withdrawal by Subject|3|||
19611646|NCT00620659|42060406|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19611647|NCT00620659|42060401|FG000|Placebo Washout Period 2|Adverse Event|2|||
19611648|NCT00620659|42060402|FG001|Placebo Washout Period 2|Adverse Event|0|||
19611649|NCT00620659|42060403|FG002|Placebo Washout Period 2|Adverse Event|0|||
19611650|NCT00620659|42060404|FG003|Placebo Washout Period 2|Adverse Event|0|||
19611651|NCT00620659|42060405|FG004|Placebo Washout Period 2|Adverse Event|0|||
19611652|NCT00620659|42060406|FG005|Placebo Washout Period 2|Adverse Event|0|||
19611653|NCT00620659|42060401|FG000|Treatment Period 3|Adverse Event|0|||
19611654|NCT00620659|42060402|FG001|Treatment Period 3|Adverse Event|2|||
19611655|NCT00620659|42060403|FG002|Treatment Period 3|Adverse Event|0|||
19611656|NCT00620659|42060404|FG003|Treatment Period 3|Adverse Event|0|||
19611657|NCT00620659|42060405|FG004|Treatment Period 3|Adverse Event|0|||
19611658|NCT00620659|42060406|FG005|Treatment Period 3|Adverse Event|0|||
19703727|NCT00003838|42148036|FG002|Overall Study|Death|7|||
19703728|NCT00003838|42148034|FG000|Overall Study|Lost to Follow-up|0|||
19611659|NCT00620659|42060401|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19611660|NCT00620659|42060402|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19611661|NCT00620659|42060403|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19611662|NCT00620659|42060404|FG003|Treatment Period 3|Withdrawal by Subject|1|||
19611663|NCT00620659|42060405|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19611664|NCT00620659|42060406|FG005|Treatment Period 3|Withdrawal by Subject|0|||
19611665|NCT00894686|42060419|FG000|Overall Study|Withdrawal by Subject|50|||
19611666|NCT00894686|42060419|FG000|Overall Study|Physician Decision|1|||
19703729|NCT00003838|42148035|FG001|Overall Study|Lost to Follow-up|1|||
19703730|NCT00003838|42148036|FG002|Overall Study|Lost to Follow-up|1|||
19611667|NCT00894686|42060419|FG000|Overall Study|Other|5|||
19703731|NCT00003838|42148034|FG000|Overall Study|Disease Progression|0|||
19703732|NCT00003838|42148035|FG001|Overall Study|Disease Progression|12|||
19703733|NCT00003838|42148036|FG002|Overall Study|Disease Progression|0|||
19703734|NCT00423449|42148043|FG000|Overall Study|Clinical Adverse Event|1|||
19703735|NCT00423449|42148044|FG001|Overall Study|Clinical Adverse Event|0|||
19703736|NCT00423449|42148045|FG002|Overall Study|Clinical Adverse Event|1|||
19703737|NCT00423449|42148046|FG003|Overall Study|Clinical Adverse Event|8|||
19703738|NCT00423449|42148047|FG004|Overall Study|Clinical Adverse Event|2|||
19611668|NCT00885846|42060426|FG000|Overall Study|Withdrawal by Subject|2|||
19478445|NCT01502293|41757725|FG000|Overall Study|Withdrawal by Subject|3|||
19478446|NCT01502293|41757726|FG001|Overall Study|Withdrawal by Subject|3|||
19478447|NCT01502293|41757727|FG002|Overall Study|Withdrawal by Subject|1|||
19478448|NCT01502293|41757725|FG000|Overall Study|Adverse Event|0|||
19478449|NCT01502293|41757726|FG001|Overall Study|Adverse Event|2|||
19478450|NCT01502293|41757727|FG002|Overall Study|Adverse Event|0|||
19478451|NCT01502293|41757725|FG000|Overall Study|Reason Not Specified|2|||
19478452|NCT01502293|41757726|FG001|Overall Study|Reason Not Specified|0|||
19478453|NCT01502293|41757727|FG002|Overall Study|Reason Not Specified|0|||
19478454|NCT01502293|41757725|FG000|Overall Study|Physician Decision|0|||
19478455|NCT01502293|41757726|FG001|Overall Study|Physician Decision|0|||
19478456|NCT01502293|41757727|FG002|Overall Study|Physician Decision|1|||
19478457|NCT01474681|41757740|FG000|Overall Study|Death|0|||
19478458|NCT01474681|41757741|FG001|Overall Study|Death|3|||
19478459|NCT01474681|41757742|FG002|Overall Study|Death|2|||
19478460|NCT01474681|41757743|FG003|Overall Study|Death|6|||
19478461|NCT01459783|41757759|FG000|Baseline to 6 Months|Death|1|||
19478462|NCT01459783|41757760|FG001|Baseline to 6 Months|Death|0|||
19478463|NCT01459783|41757759|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
19478464|NCT01459783|41757760|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
19478465|NCT01459783|41757759|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
19478466|NCT01459783|41757760|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
19478467|NCT01459783|41757759|FG000|6 Months to 12 Months|Death|0|||
19478468|NCT01459783|41757760|FG001|6 Months to 12 Months|Death|1|||
19478469|NCT01459783|41757759|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
19478470|NCT01459783|41757760|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
19478471|NCT01459783|41757759|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
19478472|NCT01459783|41757760|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
19478473|NCT01459783|41757759|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
19478474|NCT01459783|41757760|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
19478475|NCT01588184|41757772|FG000|Overall Study|Death|1|||
19478476|NCT01588184|41757773|FG001|Overall Study|Death|0|||
19478477|NCT01588184|41757774|FG002|Overall Study|Death|0|||
19478478|NCT01588184|41757775|FG003|Overall Study|Death|1|||
19478479|NCT01588184|41757776|FG004|Overall Study|Death|1|||
19478480|NCT01588184|41757777|FG005|Overall Study|Death|1|||
19478481|NCT01588184|41757772|FG000|Overall Study|Withdrawal by Subject|2|||
19478482|NCT01588184|41757773|FG001|Overall Study|Withdrawal by Subject|4|||
19478483|NCT01588184|41757774|FG002|Overall Study|Withdrawal by Subject|0|||
19478484|NCT01588184|41757775|FG003|Overall Study|Withdrawal by Subject|1|||
19478485|NCT01588184|41757776|FG004|Overall Study|Withdrawal by Subject|0|||
19478486|NCT01588184|41757777|FG005|Overall Study|Withdrawal by Subject|0|||
19478487|NCT01588184|41757772|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
19478488|NCT01588184|41757773|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
19478489|NCT01588184|41757774|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
19478490|NCT01588184|41757775|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
19478491|NCT01588184|41757776|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
19478492|NCT01588184|41757777|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
19478493|NCT01588184|41757772|FG000|Overall Study|multiple reasons|0|||
19478494|NCT01588184|41757773|FG001|Overall Study|multiple reasons|3|||
19478495|NCT01588184|41757774|FG002|Overall Study|multiple reasons|0|||
19478496|NCT01588184|41757775|FG003|Overall Study|multiple reasons|1|||
19478497|NCT01588184|41757776|FG004|Overall Study|multiple reasons|0|||
19478498|NCT01588184|41757777|FG005|Overall Study|multiple reasons|0|||
19478499|NCT01588106|41757793|FG000|Overall Study|Withdrawal by Subject|5|||
19478500|NCT01588106|41757794|FG001|Overall Study|Withdrawal by Subject|4|||
19478501|NCT01564862|41757803|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
19478502|NCT01564862|41757804|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
19478503|NCT01564862|41757805|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
19478504|NCT01564862|41757803|FG000|Overall Study|Major Protocol Deviation|3|||
19478505|NCT01564862|41757804|FG001|Overall Study|Major Protocol Deviation|3|||
19478506|NCT01564862|41757805|FG002|Overall Study|Major Protocol Deviation|4|||
19478507|NCT01564862|41757803|FG000|Overall Study|Lost to Follow-up|10|||
19478508|NCT01564862|41757804|FG001|Overall Study|Lost to Follow-up|8|||
19611669|NCT00885846|42060427|FG001|Overall Study|Withdrawal by Subject|5|||
19478509|NCT01564862|41757805|FG002|Overall Study|Lost to Follow-up|6|||
19478510|NCT01564862|41757803|FG000|Overall Study|Voluntary Withdrawal|9|||
19478511|NCT01564862|41757804|FG001|Overall Study|Voluntary Withdrawal|6|||
19478512|NCT01564862|41757805|FG002|Overall Study|Voluntary Withdrawal|8|||
19611670|NCT00885846|42060428|FG002|Overall Study|Withdrawal by Subject|2|||
19478513|NCT01564862|41757803|FG000|Overall Study|Lack of Efficacy|1|||
19478514|NCT01564862|41757804|FG001|Overall Study|Lack of Efficacy|5|||
19478515|NCT01564862|41757805|FG002|Overall Study|Lack of Efficacy|6|||
19478516|NCT01564862|41757803|FG000|Overall Study|Other reason(s)|1|||
19478517|NCT01564862|41757804|FG001|Overall Study|Other reason(s)|0|||
19478518|NCT01564862|41757805|FG002|Overall Study|Other reason(s)|0|||
19478519|NCT01691378|41757815|FG000|Overall Study|Withdrawal by Subject|2|||
19478520|NCT01691378|41757816|FG001|Overall Study|Withdrawal by Subject|0|||
19478521|NCT01691378|41757815|FG000|Overall Study|Lost to Follow-up|5|||
19478522|NCT01691378|41757816|FG001|Overall Study|Lost to Follow-up|2|||
19478523|NCT01467479|41757825|FG000|Overall Study|No Study Medication|1|||
19478524|NCT01467479|41757826|FG001|Overall Study|No Study Medication|0|||
19478525|NCT01467479|41757827|FG002|Overall Study|No Study Medication|2|||
19478526|NCT01467479|41757825|FG000|Overall Study|Adverse Event|1|||
19478527|NCT01467479|41757826|FG001|Overall Study|Adverse Event|2|||
19478528|NCT01467479|41757827|FG002|Overall Study|Adverse Event|0|||
19478529|NCT01467479|41757825|FG000|Overall Study|Death|0|||
19478530|NCT01467479|41757826|FG001|Overall Study|Death|0|||
19478531|NCT01467479|41757827|FG002|Overall Study|Death|1|||
19478532|NCT01467479|41757825|FG000|Overall Study|Lost to Follow-up|2|||
19478533|NCT01467479|41757826|FG001|Overall Study|Lost to Follow-up|5|||
19478534|NCT01467479|41757827|FG002|Overall Study|Lost to Follow-up|3|||
19478535|NCT01467479|41757825|FG000|Overall Study|Withdrawal of Consent|3|||
19478536|NCT01467479|41757826|FG001|Overall Study|Withdrawal of Consent|7|||
19478537|NCT01467479|41757827|FG002|Overall Study|Withdrawal of Consent|7|||
19478538|NCT01467479|41757825|FG000|Overall Study|Study Terminated by Sponsor|1|||
19478539|NCT01467479|41757826|FG001|Overall Study|Study Terminated by Sponsor|3|||
19478540|NCT01467479|41757827|FG002|Overall Study|Study Terminated by Sponsor|3|||
19478541|NCT01467479|41757825|FG000|Overall Study|Other|1|||
19478542|NCT01467479|41757826|FG001|Overall Study|Other|0|||
19478543|NCT01467479|41757827|FG002|Overall Study|Other|0|||
19478544|NCT01466387|41757842|FG000|Overall Study|Adverse Event|0|||
19478545|NCT01466387|41757843|FG001|Overall Study|Adverse Event|0|||
19478546|NCT01466387|41757844|FG002|Overall Study|Adverse Event|1|||
19478547|NCT01466387|41757845|FG003|Overall Study|Adverse Event|1|||
19478548|NCT01466387|41757846|FG004|Overall Study|Adverse Event|0|||
19478549|NCT01466387|41757847|FG005|Overall Study|Adverse Event|0|||
19478550|NCT01466387|41757842|FG000|Overall Study|Lost to Follow-up|0|||
19478551|NCT01466387|41757843|FG001|Overall Study|Lost to Follow-up|0|||
19478552|NCT01466387|41757844|FG002|Overall Study|Lost to Follow-up|0|||
19478553|NCT01466387|41757845|FG003|Overall Study|Lost to Follow-up|0|||
19478554|NCT01466387|41757846|FG004|Overall Study|Lost to Follow-up|0|||
19478555|NCT01466387|41757847|FG005|Overall Study|Lost to Follow-up|1|||
19478556|NCT01466387|41757842|FG000|Overall Study|Protocol Violation|1|||
19478557|NCT01466387|41757843|FG001|Overall Study|Protocol Violation|0|||
19478558|NCT01466387|41757844|FG002|Overall Study|Protocol Violation|0|||
19478559|NCT01466387|41757845|FG003|Overall Study|Protocol Violation|1|||
19478560|NCT01466387|41757846|FG004|Overall Study|Protocol Violation|0|||
19478561|NCT01466387|41757847|FG005|Overall Study|Protocol Violation|0|||
19478562|NCT01564784|41757978|FG000|Overall Study|Other|1|||
19478563|NCT01564784|41757979|FG001|Overall Study|Other|0|||
19478564|NCT01564784|41757978|FG000|Overall Study|Subject refused further follow-up|1|||
19478565|NCT01564784|41757979|FG001|Overall Study|Subject refused further follow-up|6|||
19478566|NCT01564784|41757978|FG000|Overall Study|Lost to Follow-up|1|||
19478567|NCT01564784|41757979|FG001|Overall Study|Lost to Follow-up|1|||
19478568|NCT01564784|41757978|FG000|Overall Study|Death|131|||
19478569|NCT01564784|41757979|FG001|Overall Study|Death|126|||
19478570|NCT01564394|41758022|FG000|Overall Study|Withdrawal by Subject|6|||
19478571|NCT01564394|41758023|FG001|Overall Study|Withdrawal by Subject|10|||
19478572|NCT01690988|41758037|FG000|Overall Study|Withdrawal by Subject|2|||
19478573|NCT01690988|41758038|FG001|Overall Study|Withdrawal by Subject|2|||
19478574|NCT01690988|41758039|FG002|Overall Study|Withdrawal by Subject|3|||
19478575|NCT01690988|41758037|FG000|Overall Study|Physician Decision|0|||
19478576|NCT01690988|41758038|FG001|Overall Study|Physician Decision|0|||
19478577|NCT01690988|41758039|FG002|Overall Study|Physician Decision|1|||
19478578|NCT01690988|41758037|FG000|Overall Study|Operation Cancelled|1|||
19478579|NCT01690988|41758038|FG001|Overall Study|Operation Cancelled|1|||
19478580|NCT01690988|41758039|FG002|Overall Study|Operation Cancelled|0|||
19478581|NCT01690988|41758037|FG000|Overall Study|Determined ineligible|1|||
19478582|NCT01690988|41758038|FG001|Overall Study|Determined ineligible|0|||
19478583|NCT01690988|41758039|FG002|Overall Study|Determined ineligible|0|||
19478584|NCT01690988|41758037|FG000|Overall Study|Death|1|||
19478585|NCT01690988|41758038|FG001|Overall Study|Death|1|||
19478586|NCT01690988|41758039|FG002|Overall Study|Death|1|||
19478587|NCT01690988|41758037|FG000|Overall Study|Sedated|1|||
19478588|NCT01690988|41758038|FG001|Overall Study|Sedated|1|||
19478589|NCT01690988|41758039|FG002|Overall Study|Sedated|2|||
19478590|NCT01466153|41758070|FG000|Overall Study|Disease Progression|2|||
19478591|NCT01466153|41758071|FG001|Overall Study|Disease Progression|2|||
19478592|NCT01466153|41758072|FG002|Overall Study|Disease Progression|0|||
19478593|NCT01466153|41758070|FG000|Overall Study|Adverse Event|14|||
19478594|NCT01466153|41758071|FG001|Overall Study|Adverse Event|13|||
19478595|NCT01466153|41758072|FG002|Overall Study|Adverse Event|17|||
19478596|NCT01466153|41758070|FG000|Overall Study|Withdrawal of Consent|2|||
19611671|NCT00621517|42060438|FG000|Overall Study|Lost to Follow-up|3|||
19478597|NCT01466153|41758071|FG001|Overall Study|Withdrawal of Consent|0|||
19478598|NCT01466153|41758072|FG002|Overall Study|Withdrawal of Consent|0|||
19478599|NCT01466153|41758070|FG000|Overall Study|Investigator Discretion|3|||
19478600|NCT01466153|41758071|FG001|Overall Study|Investigator Discretion|2|||
19478601|NCT01466153|41758072|FG002|Overall Study|Investigator Discretion|2|||
19391938|NCT01998958|41636177|FG017|Period 1 (Panel A and B)|Other|0|||
19391939|NCT01998958|41636178|FG018|Period 1 (Panel A and B)|Other|0|||
19391940|NCT01998958|41636179|FG019|Period 1 (Panel A and B)|Other|0|||
19391941|NCT01998958|41636180|FG020|Period 1 (Panel A and B)|Other|0|||
19391942|NCT01998958|41636181|FG021|Period 1 (Panel A and B)|Other|0|||
19391943|NCT01998958|41636182|FG022|Period 1 (Panel A and B)|Other|0|||
19478602|NCT01466153|41758070|FG000|Overall Study|Randomized-Not Treated|2|||
19478603|NCT01466153|41758071|FG001|Overall Study|Randomized-Not Treated|3|||
19478604|NCT01466153|41758072|FG002|Overall Study|Randomized-Not Treated|4|||
19478605|NCT01466153|41758070|FG000|Overall Study|Other-Unspecified|6|||
19478606|NCT01466153|41758071|FG001|Overall Study|Other-Unspecified|4|||
19478607|NCT01466153|41758072|FG002|Overall Study|Other-Unspecified|2|||
19478608|NCT01474291|41758093|FG000|Overall Study|Not Evaluable for Efficacy|26|||
19478609|NCT01474291|41758093|FG000|Overall Study|Lack of Treatment Efficacy|88|||
19478610|NCT01474291|41758093|FG000|Overall Study|Adverse Event|53|||
19478611|NCT01474291|41758093|FG000|Overall Study|Lost to Follow-up|29|||
19478612|NCT01474291|41758093|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
19478613|NCT01474291|41758093|FG000|Overall Study|No Reason Reported|10|||
19478614|NCT01474291|41758093|FG000|Overall Study|Death|2|||
19478615|NCT01465997|41758102|FG000|Overall Study|Adverse Event|12|||
19478616|NCT01465997|41758103|FG001|Overall Study|Adverse Event|22|||
19478617|NCT01465997|41758102|FG000|Overall Study|Lack of Efficacy|13|||
19478618|NCT01465997|41758103|FG001|Overall Study|Lack of Efficacy|1|||
19478619|NCT01465997|41758102|FG000|Overall Study|Protocol Violation|1|||
19478620|NCT01465997|41758103|FG001|Overall Study|Protocol Violation|4|||
19478621|NCT01465997|41758102|FG000|Overall Study|Lost to Follow-up|6|||
19478622|NCT01465997|41758103|FG001|Overall Study|Lost to Follow-up|9|||
19478623|NCT01465997|41758102|FG000|Overall Study|Withdrawal by Subject|32|||
19478624|NCT01465997|41758103|FG001|Overall Study|Withdrawal by Subject|35|||
19478625|NCT01465997|41758102|FG000|Overall Study|investigator's decision|1|||
19478626|NCT01465997|41758103|FG001|Overall Study|investigator's decision|1|||
19478627|NCT01465997|41758102|FG000|Overall Study|Death|0|||
19478628|NCT01465997|41758103|FG001|Overall Study|Death|1|||
19478629|NCT01465997|41758102|FG000|Overall Study|sponsor's decision|1|||
19478630|NCT01465997|41758103|FG001|Overall Study|sponsor's decision|1|||
19478631|NCT01465997|41758102|FG000|Overall Study|subject withdrew consent|1|||
19478632|NCT01465997|41758103|FG001|Overall Study|subject withdrew consent|0|||
19478633|NCT01465997|41758102|FG000|Overall Study|local lab unblinded site|1|||
19478634|NCT01465997|41758103|FG001|Overall Study|local lab unblinded site|0|||
19478635|NCT01465997|41758102|FG000|Overall Study|withdrew before follow-up|0|||
19478636|NCT01465997|41758103|FG001|Overall Study|withdrew before follow-up|13|||
19478637|NCT01465997|41758102|FG000|Overall Study|decision by site staff|0|||
19478638|NCT01465997|41758103|FG001|Overall Study|decision by site staff|1|||
19478639|NCT01465997|41758102|FG000|Overall Study|subject left participation SP0993|0|||
19478640|NCT01465997|41758103|FG001|Overall Study|subject left participation SP0993|1|||
19478641|NCT01465763|41758124|FG000|Overall Study|Withdrawal by Subject|4|||
19478642|NCT01465763|41758125|FG001|Overall Study|Withdrawal by Subject|0|||
19478643|NCT01465763|41758126|FG002|Overall Study|Withdrawal by Subject|1|||
19478644|NCT01465763|41758124|FG000|Overall Study|Insufficient Clinical Response|11|||
19478645|NCT01465763|41758125|FG001|Overall Study|Insufficient Clinical Response|0|||
19478646|NCT01465763|41758126|FG002|Overall Study|Insufficient Clinical Response|1|||
19478647|NCT01465763|41758124|FG000|Overall Study|Adverse Event|9|||
19478648|NCT01465763|41758125|FG001|Overall Study|Adverse Event|0|||
19478649|NCT01465763|41758126|FG002|Overall Study|Adverse Event|1|||
19478650|NCT01465763|41758124|FG000|Overall Study|Other|2|||
19478651|NCT01465763|41758125|FG001|Overall Study|Other|0|||
19391944|NCT01998958|41636183|FG023|Period 1 (Panel A and B)|Other|0|||
19391945|NCT01998958|41636184|FG024|Period 1 (Panel A and B)|Other|0|||
19391946|NCT01998958|41636185|FG025|Period 1 (Panel A and B)|Other|0|||
19391947|NCT01998958|41636186|FG026|Period 1 (Panel A and B)|Other|0|||
19391948|NCT01998958|41636187|FG027|Period 1 (Panel A and B)|Other|0|||
19391949|NCT01998958|41636188|FG028|Period 1 (Panel A and B)|Other|0|||
19391950|NCT01998958|41636189|FG029|Period 1 (Panel A and B)|Other|0|||
19391951|NCT01998958|41636190|FG030|Period 1 (Panel A and B)|Other|0|||
19391952|NCT01998958|41636191|FG031|Period 1 (Panel A and B)|Other|0|||
19391953|NCT01998958|41636160|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
19391954|NCT01998958|41636161|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
19391955|NCT01998958|41636162|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
19391956|NCT01998958|41636163|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
19391957|NCT01998958|41636164|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
19391958|NCT01998958|41636165|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
19391959|NCT01998958|41636166|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
19478652|NCT01465763|41758126|FG002|Overall Study|Other|0|||
19478653|NCT01465763|41758124|FG000|Overall Study|Protocol Violation|4|||
19478654|NCT01465763|41758125|FG001|Overall Study|Protocol Violation|1|||
19478655|NCT01465763|41758126|FG002|Overall Study|Protocol Violation|1|||
19478656|NCT01465763|41758124|FG000|Overall Study|Death|1|||
19478657|NCT01465763|41758125|FG001|Overall Study|Death|0|||
19478658|NCT01465763|41758126|FG002|Overall Study|Death|0|||
19478659|NCT01690520|41758159|FG000|Overall Study|Death|25|||
19478660|NCT01690520|41758160|FG001|Overall Study|Death|21|||
19478661|NCT01690520|41758159|FG000|Overall Study|Lost to Follow-up|2|||
19478662|NCT01690520|41758160|FG001|Overall Study|Lost to Follow-up|3|||
19478663|NCT01690520|41758159|FG000|Overall Study|Withdrawal by Subject|2|||
19478664|NCT01690520|41758160|FG001|Overall Study|Withdrawal by Subject|0|||
19478665|NCT01690520|41758159|FG000|Overall Study|Relapse|0|||
19478666|NCT01690520|41758160|FG001|Overall Study|Relapse|1|||
19478667|NCT01690520|41758159|FG000|Overall Study|Other|0|||
19478668|NCT01690520|41758160|FG001|Overall Study|Other|1|||
19478669|NCT01690520|41758159|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
19478670|NCT01690520|41758160|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
19478671|NCT01563536|41758181|FG000|Overall Study|Withdrawal by Subject|0|||
19478672|NCT01563536|41758182|FG001|Overall Study|Withdrawal by Subject|2|||
19478673|NCT01563536|41758181|FG000|Overall Study|Lost to Follow-up|1|||
19478674|NCT01563536|41758182|FG001|Overall Study|Lost to Follow-up|0|||
19478675|NCT01690130|41758190|FG000|Overall Study|Subject have cancelled visit.|1|||
19478676|NCT01690130|41758191|FG001|Overall Study|Subject have cancelled visit.|0|||
19478677|NCT01690052|41758197|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
19478678|NCT01690052|41758198|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
19478679|NCT01689974|41758225|FG000|Overall Study|Termination of Study|5|||
19478680|NCT01689974|41758226|FG001|Overall Study|Termination of Study|5|||
19478681|NCT01587014|41758232|FG000|Overall Study|Death|2|||
19478682|NCT01458535|41758344|FG000|Overall Study|Other|0|||
19478683|NCT01458535|41758345|FG001|Overall Study|Other|0|||
19478684|NCT01458535|41758346|FG002|Overall Study|Other|0|||
19478685|NCT01458535|41758347|FG003|Overall Study|Other|0|||
19478686|NCT01458535|41758348|FG004|Overall Study|Other|1|||
19478687|NCT01458535|41758349|FG005|Overall Study|Other|1|||
19478688|NCT01458535|41758344|FG000|Overall Study|Withdrawal by Subject|0|||
19478689|NCT01458535|41758345|FG001|Overall Study|Withdrawal by Subject|0|||
19391960|NCT01998958|41636167|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
19391961|NCT01998958|41636168|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
19391962|NCT01998958|41636169|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
19391963|NCT01998958|41636170|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
19391964|NCT01998958|41636171|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
19391965|NCT01998958|41636172|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
19391966|NCT01998958|41636173|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
19391967|NCT01998958|41636174|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
19391968|NCT01998958|41636175|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
19391969|NCT01998958|41636176|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
19391970|NCT01998958|41636177|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
19391971|NCT01998958|41636178|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
19391972|NCT01998958|41636179|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
19391973|NCT01998958|41636180|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
19391974|NCT01998958|41636181|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
19391975|NCT01998958|41636182|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
19391976|NCT01998958|41636183|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
19391977|NCT01998958|41636184|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
19391978|NCT01998958|41636185|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
19391979|NCT01998958|41636186|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
19478690|NCT01458535|41758346|FG002|Overall Study|Withdrawal by Subject|2|||
19478691|NCT01458535|41758347|FG003|Overall Study|Withdrawal by Subject|0|||
19478692|NCT01458535|41758348|FG004|Overall Study|Withdrawal by Subject|1|||
19478693|NCT01458535|41758349|FG005|Overall Study|Withdrawal by Subject|1|||
19478694|NCT01458535|41758344|FG000|Overall Study|Lost to Follow-up|0|||
19478695|NCT01458535|41758345|FG001|Overall Study|Lost to Follow-up|2|||
19478696|NCT01458535|41758346|FG002|Overall Study|Lost to Follow-up|0|||
19478697|NCT01458535|41758347|FG003|Overall Study|Lost to Follow-up|3|||
19478698|NCT01458535|41758348|FG004|Overall Study|Lost to Follow-up|2|||
19391980|NCT01998958|41636187|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
19391981|NCT01998958|41636188|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
19391982|NCT01998958|41636189|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
19478699|NCT01458535|41758349|FG005|Overall Study|Lost to Follow-up|2|||
19478700|NCT01458535|41758344|FG000|Overall Study|Adverse Event|0|||
19391983|NCT01998958|41636190|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
19391984|NCT01998958|41636191|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
19391985|NCT01998958|41636160|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391986|NCT01998958|41636161|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19478701|NCT01458535|41758345|FG001|Overall Study|Adverse Event|0|||
19478702|NCT01458535|41758346|FG002|Overall Study|Adverse Event|0|||
19478703|NCT01458535|41758347|FG003|Overall Study|Adverse Event|1|||
19478704|NCT01458535|41758348|FG004|Overall Study|Adverse Event|0|||
19478705|NCT01458535|41758349|FG005|Overall Study|Adverse Event|0|||
19391987|NCT01998958|41636162|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391988|NCT01998958|41636163|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391989|NCT01998958|41636164|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391990|NCT01998958|41636165|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391991|NCT01998958|41636166|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391992|NCT01998958|41636167|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391993|NCT01998958|41636168|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19478706|NCT01464827|41758377|FG000|Overall Study|Adverse Event|0|||
19478707|NCT01464827|41758378|FG001|Overall Study|Adverse Event|0|||
19478708|NCT01464827|41758379|FG002|Overall Study|Adverse Event|0|||
19478709|NCT01464827|41758380|FG003|Overall Study|Adverse Event|0|||
19478710|NCT01464827|41758381|FG004|Overall Study|Adverse Event|0|||
19478711|NCT01464827|41758382|FG005|Overall Study|Adverse Event|0|||
19478712|NCT01464827|41758383|FG006|Overall Study|Adverse Event|0|||
19478713|NCT01464827|41758384|FG007|Overall Study|Adverse Event|0|||
19478714|NCT01464827|41758385|FG008|Overall Study|Adverse Event|0|||
19478715|NCT01464827|41758386|FG009|Overall Study|Adverse Event|0|||
19478716|NCT01464827|41758387|FG010|Overall Study|Adverse Event|0|||
19478717|NCT01464827|41758388|FG011|Overall Study|Adverse Event|0|||
19478718|NCT01464827|41758389|FG012|Overall Study|Adverse Event|1|||
19478719|NCT01464827|41758390|FG013|Overall Study|Adverse Event|0|||
19478720|NCT01464827|41758377|FG000|Overall Study|Withdrawal by Subject|1|||
19478721|NCT01464827|41758378|FG001|Overall Study|Withdrawal by Subject|0|||
19391994|NCT01998958|41636169|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391995|NCT01998958|41636170|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19478722|NCT01464827|41758379|FG002|Overall Study|Withdrawal by Subject|0|||
19478723|NCT01464827|41758380|FG003|Overall Study|Withdrawal by Subject|0|||
19478724|NCT01464827|41758381|FG004|Overall Study|Withdrawal by Subject|1|||
19478725|NCT01464827|41758382|FG005|Overall Study|Withdrawal by Subject|0|||
19478726|NCT01464827|41758383|FG006|Overall Study|Withdrawal by Subject|0|||
19478727|NCT01464827|41758384|FG007|Overall Study|Withdrawal by Subject|1|||
19478728|NCT01464827|41758385|FG008|Overall Study|Withdrawal by Subject|0|||
19478729|NCT01464827|41758386|FG009|Overall Study|Withdrawal by Subject|0|||
19478730|NCT01464827|41758387|FG010|Overall Study|Withdrawal by Subject|0|||
19478731|NCT01464827|41758388|FG011|Overall Study|Withdrawal by Subject|0|||
19478732|NCT01464827|41758389|FG012|Overall Study|Withdrawal by Subject|0|||
19478733|NCT01464827|41758390|FG013|Overall Study|Withdrawal by Subject|0|||
19478734|NCT01464827|41758377|FG000|Overall Study|Lost to Follow-up|0|||
19478735|NCT01464827|41758378|FG001|Overall Study|Lost to Follow-up|2|||
19478736|NCT01464827|41758379|FG002|Overall Study|Lost to Follow-up|0|||
19478737|NCT01464827|41758380|FG003|Overall Study|Lost to Follow-up|2|||
19478738|NCT01464827|41758381|FG004|Overall Study|Lost to Follow-up|3|||
19478739|NCT01464827|41758382|FG005|Overall Study|Lost to Follow-up|1|||
19391996|NCT01998958|41636171|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19478740|NCT01464827|41758383|FG006|Overall Study|Lost to Follow-up|2|||
19478741|NCT01464827|41758384|FG007|Overall Study|Lost to Follow-up|2|||
19478742|NCT01464827|41758385|FG008|Overall Study|Lost to Follow-up|0|||
19478743|NCT01464827|41758386|FG009|Overall Study|Lost to Follow-up|0|||
19478744|NCT01464827|41758387|FG010|Overall Study|Lost to Follow-up|0|||
19478745|NCT01464827|41758388|FG011|Overall Study|Lost to Follow-up|1|||
19478746|NCT01464827|41758389|FG012|Overall Study|Lost to Follow-up|0|||
19478747|NCT01464827|41758390|FG013|Overall Study|Lost to Follow-up|1|||
19478748|NCT01464827|41758377|FG000|Overall Study|Other|2|||
19478749|NCT01464827|41758378|FG001|Overall Study|Other|3|||
19478750|NCT01464827|41758379|FG002|Overall Study|Other|0|||
19478751|NCT01464827|41758380|FG003|Overall Study|Other|2|||
19478752|NCT01464827|41758381|FG004|Overall Study|Other|3|||
19478753|NCT01464827|41758382|FG005|Overall Study|Other|0|||
19478754|NCT01464827|41758383|FG006|Overall Study|Other|1|||
19478755|NCT01464827|41758384|FG007|Overall Study|Other|0|||
19478756|NCT01464827|41758385|FG008|Overall Study|Other|3|||
19478757|NCT01464827|41758386|FG009|Overall Study|Other|1|||
19478758|NCT01464827|41758387|FG010|Overall Study|Other|2|||
19478759|NCT01464827|41758388|FG011|Overall Study|Other|0|||
19478760|NCT01464827|41758389|FG012|Overall Study|Other|1|||
19478761|NCT01464827|41758390|FG013|Overall Study|Other|0|||
19478762|NCT01464827|41758377|FG000|Overall Study|Not Treated|0|||
19478763|NCT01464827|41758378|FG001|Overall Study|Not Treated|2|||
19478764|NCT01464827|41758379|FG002|Overall Study|Not Treated|0|||
19478765|NCT01464827|41758380|FG003|Overall Study|Not Treated|0|||
19478766|NCT01464827|41758381|FG004|Overall Study|Not Treated|1|||
19478767|NCT01464827|41758382|FG005|Overall Study|Not Treated|0|||
19478768|NCT01464827|41758383|FG006|Overall Study|Not Treated|1|||
19611672|NCT00621517|42060439|FG001|Overall Study|Lost to Follow-up|3|||
19478769|NCT01464827|41758384|FG007|Overall Study|Not Treated|0|||
19478770|NCT01464827|41758385|FG008|Overall Study|Not Treated|0|||
19478771|NCT01464827|41758386|FG009|Overall Study|Not Treated|2|||
19478772|NCT01464827|41758387|FG010|Overall Study|Not Treated|0|||
19478773|NCT01464827|41758388|FG011|Overall Study|Not Treated|1|||
19478774|NCT01464827|41758389|FG012|Overall Study|Not Treated|0|||
19478775|NCT01464827|41758390|FG013|Overall Study|Not Treated|2|||
19478776|NCT01463111|41758431|FG000|Overall Study|Withdrawal by Subject|2|||
19478777|NCT01463111|41758431|FG000|Overall Study|Lost to Follow-up|5|||
19478778|NCT01463111|41758431|FG000|Overall Study|Physician Decision|2|||
19478779|NCT01463033|41758437|FG000|Overall Study|Lost to Follow-up|4|||
19478780|NCT01463033|41758438|FG001|Overall Study|Lost to Follow-up|4|||
19478781|NCT01463033|41758437|FG000|Overall Study|Death|3|||
19611673|NCT00621517|42060438|FG000|Overall Study|Withdrawal by Subject|3|||
19391997|NCT01998958|41636172|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391998|NCT01998958|41636173|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19391999|NCT01998958|41636174|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
19392000|NCT01998958|41636175|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392001|NCT01998958|41636176|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392002|NCT01998958|41636177|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392003|NCT01998958|41636178|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
19478782|NCT01463033|41758438|FG001|Overall Study|Death|2|||
19478783|NCT01461707|41758447|FG000|Overall Study|Withdrawal by Subject|1|||
19478784|NCT01461707|41758448|FG001|Overall Study|Withdrawal by Subject|0|||
19478785|NCT01461551|41758457|FG000|Overall Study|Physician Decision|2|||
19478786|NCT01461551|41758458|FG001|Overall Study|Physician Decision|1|||
19478787|NCT01461551|41758459|FG002|Overall Study|Physician Decision|2|||
19478788|NCT01461005|41758467|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
19478789|NCT01460381|41758474|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
19478790|NCT01460381|41758475|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
19478791|NCT01473589|41758559|FG000|Overall Study|Adverse Event|1|||
19478792|NCT01473589|41758560|FG001|Overall Study|Adverse Event|1|||
19478793|NCT01473589|41758559|FG000|Overall Study|Death|2|||
19478794|NCT01473589|41758560|FG001|Overall Study|Death|0|||
19478795|NCT01473589|41758559|FG000|Overall Study|Lost to Follow-up|2|||
19478796|NCT01473589|41758560|FG001|Overall Study|Lost to Follow-up|2|||
19478797|NCT01473589|41758559|FG000|Overall Study|Protocol Violation|1|||
19478798|NCT01473589|41758560|FG001|Overall Study|Protocol Violation|0|||
19478799|NCT01473589|41758559|FG000|Overall Study|Withdrawal by Subject|5|||
19478800|NCT01473589|41758560|FG001|Overall Study|Withdrawal by Subject|11|||
19478801|NCT01473589|41758559|FG000|Overall Study|Physician Decision|0|||
19478802|NCT01473589|41758560|FG001|Overall Study|Physician Decision|1|||
19478803|NCT01473589|41758559|FG000|Overall Study|Entry criteria not met|0|||
19478804|NCT01473589|41758560|FG001|Overall Study|Entry criteria not met|1|||
19478805|NCT01500187|41758579|FG000|Overall Study|Lost to Follow-up|6|||
19478806|NCT01500187|41758580|FG001|Overall Study|Lost to Follow-up|0|||
19478807|NCT01500031|41758598|FG000|Overall Study|Death|1|||
19478808|NCT01500031|41758598|FG000|Overall Study|Withdrawal by Subject|4|||
19478809|NCT01473355|41758611|FG000|Overall Study|Protocol Violation|2|||
19478810|NCT01473355|41758611|FG000|Overall Study|Adverse Event|2|||
19478811|NCT01473355|41758611|FG000|Overall Study|Lost to Follow-up|2|||
19478812|NCT01472965|41758621|FG000|Overall Study|Withdrawal by Subject|1|||
19478813|NCT01472965|41758622|FG001|Overall Study|Withdrawal by Subject|0|||
19478814|NCT01457053|41758632|FG000|Overall Study|Unable to undergo selected treatment|1|||
19478815|NCT01457053|41758633|FG001|Overall Study|Unable to undergo selected treatment|1|||
19478816|NCT01472341|41758648|FG000|Overall Study|Started insulin therapy|55|||
19478817|NCT01472341|41758648|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
19478818|NCT01472341|41758648|FG000|Overall Study|Withdrawal by Subject|39|||
19478819|NCT01472341|41758648|FG000|Overall Study|Lost to Follow-up|52|||
19478820|NCT01472341|41758648|FG000|Overall Study|Laboratory parameters unavailable|25|||
19478821|NCT01472341|41758648|FG000|Overall Study|Death|9|||
19478822|NCT01472185|41758654|FG000|Overall Study|Randomized but Not Treated|0|||
19478823|NCT01472185|41758655|FG001|Overall Study|Randomized but Not Treated|1|||
19478824|NCT01472185|41758654|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
19478825|NCT01472185|41758655|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
19478826|NCT01472185|41758654|FG000|Overall Study|Hyperglycemia|5|||
19478827|NCT01472185|41758655|FG001|Overall Study|Hyperglycemia|2|||
19478828|NCT01472185|41758654|FG000|Overall Study|Investigator's Discretion|3|||
19478829|NCT01472185|41758655|FG001|Overall Study|Investigator's Discretion|1|||
19478830|NCT01472185|41758654|FG000|Overall Study|Lost to Follow-up|4|||
19478831|NCT01472185|41758655|FG001|Overall Study|Lost to Follow-up|1|||
19478832|NCT01472185|41758654|FG000|Overall Study|Protocol Violation|5|||
19478833|NCT01472185|41758655|FG001|Overall Study|Protocol Violation|1|||
19478834|NCT01472185|41758654|FG000|Overall Study|Subject Noncompliance|8|||
19478835|NCT01472185|41758655|FG001|Overall Study|Subject Noncompliance|15|||
19478836|NCT01472185|41758654|FG000|Overall Study|Subject Withdrew Consent|6|||
19478837|NCT01472185|41758655|FG001|Overall Study|Subject Withdrew Consent|3|||
19478838|NCT01456897|41758676|FG000|Overall Study|Adverse Event|19|||
19478839|NCT01456897|41758677|FG001|Overall Study|Adverse Event|22|||
19478840|NCT01456897|41758676|FG000|Overall Study|Protocol Violation|3|||
19478841|NCT01456897|41758677|FG001|Overall Study|Protocol Violation|4|||
19478842|NCT01456897|41758676|FG000|Overall Study|Physician Decision|5|||
19703739|NCT00423449|42148043|FG000|Overall Study|Death|1|||
19703740|NCT00423449|42148044|FG001|Overall Study|Death|0|||
19703741|NCT00423449|42148045|FG002|Overall Study|Death|2|||
19703742|NCT00423449|42148046|FG003|Overall Study|Death|1|||
19703743|NCT00423449|42148047|FG004|Overall Study|Death|1|||
19703744|NCT00423449|42148043|FG000|Overall Study|Progressive Disease|1|||
19478843|NCT01456897|41758677|FG001|Overall Study|Physician Decision|3|||
19478844|NCT01456897|41758676|FG000|Overall Study|Withdrawal by Subject|44|||
19478845|NCT01456897|41758677|FG001|Overall Study|Withdrawal by Subject|17|||
19478846|NCT01456897|41758676|FG000|Overall Study|Lack of Efficacy|4|||
19478847|NCT01456897|41758677|FG001|Overall Study|Lack of Efficacy|11|||
19478848|NCT01456195|41758690|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19478849|NCT01456195|41758691|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
19478850|NCT01456195|41758692|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
19478851|NCT01456195|41758690|FG000|Overall Study|Lost to Follow-up|3|||
19703745|NCT00423449|42148044|FG001|Overall Study|Progressive Disease|3|||
19703746|NCT00423449|42148045|FG002|Overall Study|Progressive Disease|8|||
19478852|NCT01456195|41758691|FG001|Overall Study|Lost to Follow-up|1|||
19478853|NCT01456195|41758692|FG002|Overall Study|Lost to Follow-up|3|||
19478854|NCT01456195|41758690|FG000|Overall Study|Voluntary Withdrawal|5|||
19478855|NCT01456195|41758691|FG001|Overall Study|Voluntary Withdrawal|3|||
19478856|NCT01456195|41758692|FG002|Overall Study|Voluntary Withdrawal|7|||
19478857|NCT01456195|41758690|FG000|Overall Study|Lack of Efficacy|0|||
19478858|NCT01456195|41758691|FG001|Overall Study|Lack of Efficacy|1|||
19478859|NCT01456195|41758692|FG002|Overall Study|Lack of Efficacy|0|||
19478860|NCT01456195|41758690|FG000|Overall Study|Other Reasons|2|||
19478861|NCT01456195|41758691|FG001|Overall Study|Other Reasons|1|||
19478862|NCT01456195|41758692|FG002|Overall Study|Other Reasons|3|||
19478863|NCT01456039|41758760|FG000|Phase 1 (First Step)|Disease Progression|1|||
19478864|NCT01456039|41758761|FG001|Phase 1 (First Step)|Disease Progression|1|||
19478865|NCT01456039|41758762|FG002|Phase 1 (First Step)|Disease Progression|0|||
19478866|NCT01456039|41758760|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
19478867|NCT01456039|41758761|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
19478868|NCT01456039|41758762|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
19478869|NCT01456039|41758760|FG000|Phase 1 (First Step)|Adverse Event|0|||
19611674|NCT00621517|42060439|FG001|Overall Study|Withdrawal by Subject|4|||
19611675|NCT00621517|42060438|FG000|Overall Study|Adverse Event|1|||
19611676|NCT00621517|42060439|FG001|Overall Study|Adverse Event|0|||
19611677|NCT00573937|42060447|FG000|Overall Study|Study Terminated|0|||
19611678|NCT00573937|42060448|FG001|Overall Study|Study Terminated|1|||
19703747|NCT00423449|42148046|FG003|Overall Study|Progressive Disease|11|||
19703748|NCT00423449|42148047|FG004|Overall Study|Progressive Disease|4|||
19392004|NCT01998958|41636179|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392005|NCT01998958|41636180|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392006|NCT01998958|41636181|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392007|NCT01998958|41636182|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392008|NCT01998958|41636183|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392009|NCT01998958|41636184|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392010|NCT01998958|41636185|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19703749|NCT00423449|42148043|FG000|Overall Study|Laboratory Adverse Event|0|||
19703750|NCT00423449|42148044|FG001|Overall Study|Laboratory Adverse Event|1|||
19703751|NCT00423449|42148045|FG002|Overall Study|Laboratory Adverse Event|2|||
19703752|NCT00423449|42148046|FG003|Overall Study|Laboratory Adverse Event|0|||
19392011|NCT01998958|41636186|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392012|NCT01998958|41636187|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392013|NCT01998958|41636188|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392014|NCT01998958|41636189|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392015|NCT01998958|41636190|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392016|NCT01998958|41636191|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
19392017|NCT01998958|41636160|FG000|Open Label Phase (Optional)|Adverse Event|0|||
19392018|NCT01998958|41636161|FG001|Open Label Phase (Optional)|Adverse Event|0|||
19392019|NCT01998958|41636162|FG002|Open Label Phase (Optional)|Adverse Event|0|||
19392020|NCT01998958|41636163|FG003|Open Label Phase (Optional)|Adverse Event|0|||
19392021|NCT01998958|41636164|FG004|Open Label Phase (Optional)|Adverse Event|0|||
19392022|NCT01998958|41636165|FG005|Open Label Phase (Optional)|Adverse Event|0|||
19392023|NCT01998958|41636166|FG006|Open Label Phase (Optional)|Adverse Event|0|||
19392024|NCT01998958|41636167|FG007|Open Label Phase (Optional)|Adverse Event|0|||
19392025|NCT01998958|41636168|FG008|Open Label Phase (Optional)|Adverse Event|0|||
19392026|NCT01998958|41636169|FG009|Open Label Phase (Optional)|Adverse Event|0|||
19392027|NCT01998958|41636170|FG010|Open Label Phase (Optional)|Adverse Event|0|||
19392028|NCT01998958|41636171|FG011|Open Label Phase (Optional)|Adverse Event|0|||
19392029|NCT01998958|41636172|FG012|Open Label Phase (Optional)|Adverse Event|0|||
19392030|NCT01998958|41636173|FG013|Open Label Phase (Optional)|Adverse Event|0|||
19392031|NCT01998958|41636174|FG014|Open Label Phase (Optional)|Adverse Event|0|||
19392032|NCT01998958|41636175|FG015|Open Label Phase (Optional)|Adverse Event|0|||
19392033|NCT01998958|41636176|FG016|Open Label Phase (Optional)|Adverse Event|0|||
19392034|NCT01998958|41636177|FG017|Open Label Phase (Optional)|Adverse Event|0|||
19392035|NCT01998958|41636178|FG018|Open Label Phase (Optional)|Adverse Event|0|||
19478870|NCT01456039|41758761|FG001|Phase 1 (First Step)|Adverse Event|3|||
19478871|NCT01456039|41758762|FG002|Phase 1 (First Step)|Adverse Event|0|||
19478872|NCT01456039|41758760|FG000|Phase 1 (First Step)|Other|0|||
19478873|NCT01456039|41758761|FG001|Phase 1 (First Step)|Other|1|||
19478874|NCT01456039|41758762|FG002|Phase 1 (First Step)|Other|0|||
19478875|NCT01456039|41758760|FG000|Phase 2 (Second Step)|Disease Progression|0|||
19478876|NCT01456039|41758761|FG001|Phase 2 (Second Step)|Disease Progression|0|||
19478877|NCT01456039|41758762|FG002|Phase 2 (Second Step)|Disease Progression|17|||
19478878|NCT01456039|41758760|FG000|Phase 2 (Second Step)|Adverse Event|0|||
19478879|NCT01456039|41758761|FG001|Phase 2 (Second Step)|Adverse Event|0|||
19478880|NCT01456039|41758762|FG002|Phase 2 (Second Step)|Adverse Event|10|||
19478881|NCT01456039|41758760|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
19478882|NCT01456039|41758761|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
19478883|NCT01456039|41758762|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
19478884|NCT01456039|41758760|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
19478885|NCT01456039|41758761|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
19478886|NCT01456039|41758762|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
19478887|NCT01456039|41758760|FG000|Phase 2 (Second Step)|Other|0|||
19478888|NCT01456039|41758761|FG001|Phase 2 (Second Step)|Other|0|||
19478889|NCT01456039|41758762|FG002|Phase 2 (Second Step)|Other|1|||
19478890|NCT01455415|41758780|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
19478891|NCT01455415|41758781|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
19478892|NCT01455415|41758780|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
19478893|NCT01455415|41758781|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
19478894|NCT01455415|41758780|FG000|Period 1|Drug Error not Associated to AE|0|||
19478895|NCT01455415|41758781|FG001|Period 1|Drug Error not Associated to AE|1|||
19478896|NCT01455415|41758780|FG000|Period 1|AE Not Related to Study Drug|2|||
19478897|NCT01455415|41758781|FG001|Period 1|AE Not Related to Study Drug|6|||
19478898|NCT01455415|41758780|FG000|Period 1|Withdrawal by Subject|4|||
19478899|NCT01455415|41758781|FG001|Period 1|Withdrawal by Subject|5|||
19478900|NCT01455415|41758780|FG000|Period 1|Unspecified Reason|1|||
19478901|NCT01455415|41758781|FG001|Period 1|Unspecified Reason|1|||
19478902|NCT01455415|41758780|FG000|Period 1|Protocol Violation|0|||
19478903|NCT01455415|41758781|FG001|Period 1|Protocol Violation|2|||
19478904|NCT01455415|41758780|FG000|Washout|AE Related to Study Drug|2|||
19478905|NCT01455415|41758781|FG001|Washout|AE Related to Study Drug|0|||
19478906|NCT01455415|41758780|FG000|Washout|Lost to Follow-up|1|||
19478907|NCT01455415|41758781|FG001|Washout|Lost to Follow-up|0|||
19478908|NCT01455415|41758780|FG000|Washout|Drug Error not Associated to AE|2|||
19478909|NCT01455415|41758781|FG001|Washout|Drug Error not Associated to AE|1|||
19478910|NCT01455415|41758780|FG000|Washout|AE Not Related to Study Drug|2|||
19478911|NCT01455415|41758781|FG001|Washout|AE Not Related to Study Drug|3|||
19478912|NCT01455415|41758780|FG000|Washout|Unspecified Reason|1|||
19478913|NCT01455415|41758781|FG001|Washout|Unspecified Reason|2|||
19392036|NCT01998958|41636179|FG019|Open Label Phase (Optional)|Adverse Event|0|||
19392037|NCT01998958|41636180|FG020|Open Label Phase (Optional)|Adverse Event|0|||
19478914|NCT01455415|41758780|FG000|Washout|Protocol Violation|0|||
19478915|NCT01455415|41758781|FG001|Washout|Protocol Violation|1|||
19478916|NCT01455415|41758780|FG000|Period 2|AE Related to Study Drug|1|||
19478917|NCT01455415|41758781|FG001|Period 2|AE Related to Study Drug|2|||
19478918|NCT01455415|41758780|FG000|Period 2|Lost to Follow-up|2|||
19478919|NCT01455415|41758781|FG001|Period 2|Lost to Follow-up|1|||
19478920|NCT01455415|41758780|FG000|Period 2|AE Not Related to Study Drug|2|||
19478921|NCT01455415|41758781|FG001|Period 2|AE Not Related to Study Drug|1|||
19478922|NCT01455415|41758780|FG000|Period 2|Lack of Efficacy|2|||
19392038|NCT01998958|41636181|FG021|Open Label Phase (Optional)|Adverse Event|0|||
19392039|NCT01998958|41636182|FG022|Open Label Phase (Optional)|Adverse Event|0|||
19392040|NCT01998958|41636183|FG023|Open Label Phase (Optional)|Adverse Event|1|||
19392041|NCT01998958|41636184|FG024|Open Label Phase (Optional)|Adverse Event|0|||
19392042|NCT01998958|41636185|FG025|Open Label Phase (Optional)|Adverse Event|0|||
19392043|NCT01998958|41636186|FG026|Open Label Phase (Optional)|Adverse Event|0|||
19392044|NCT01998958|41636187|FG027|Open Label Phase (Optional)|Adverse Event|0|||
19392045|NCT01998958|41636188|FG028|Open Label Phase (Optional)|Adverse Event|0|||
19392046|NCT01998958|41636189|FG029|Open Label Phase (Optional)|Adverse Event|0|||
19392047|NCT01998958|41636190|FG030|Open Label Phase (Optional)|Adverse Event|0|||
19392048|NCT01998958|41636191|FG031|Open Label Phase (Optional)|Adverse Event|0|||
19392049|NCT01998958|41636160|FG000|Open Label Phase (Optional)|Other|0|||
19392050|NCT01998958|41636161|FG001|Open Label Phase (Optional)|Other|0|||
19392051|NCT01998958|41636162|FG002|Open Label Phase (Optional)|Other|0|||
19392052|NCT01998958|41636163|FG003|Open Label Phase (Optional)|Other|0|||
19478923|NCT01455415|41758781|FG001|Period 2|Lack of Efficacy|0|||
19478924|NCT01455415|41758780|FG000|Period 2|Withdrawal by Subject|2|||
19478925|NCT01455415|41758781|FG001|Period 2|Withdrawal by Subject|3|||
19478926|NCT01455415|41758780|FG000|Period 2|Unspecified Reason|2|||
19478927|NCT01455415|41758781|FG001|Period 2|Unspecified Reason|3|||
19478928|NCT01455415|41758780|FG000|Period 2|Protocol Violation|2|||
19478929|NCT01455415|41758781|FG001|Period 2|Protocol Violation|0|||
19478930|NCT01455415|41758780|FG000|Follow-up|AE Related to Study Drug|0|||
19478931|NCT01455415|41758781|FG001|Follow-up|AE Related to Study Drug|1|||
19478932|NCT01455415|41758780|FG000|Follow-up|Lack of Efficacy|0|||
19478933|NCT01455415|41758781|FG001|Follow-up|Lack of Efficacy|1|||
19478934|NCT01455415|41758780|FG000|Follow-up|Withdrawal by Subject|2|||
19478935|NCT01455415|41758781|FG001|Follow-up|Withdrawal by Subject|0|||
19478936|NCT01455415|41758780|FG000|Follow-up|Unspecified Reason|1|||
19478937|NCT01455415|41758781|FG001|Follow-up|Unspecified Reason|0|||
19478938|NCT01471171|41758787|FG000|Treatment Period 1|Adverse Event|4|||
19478939|NCT01471171|41758788|FG001|Treatment Period 1|Adverse Event|1|||
19478940|NCT01471171|41758787|FG000|Treatment Period 2|Adverse Event|1|||
19478941|NCT01471171|41758788|FG001|Treatment Period 2|Adverse Event|0|||
19478942|NCT01471093|41758796|FG000|Overall Study|Adverse Event|1|||
19611679|NCT00573859|42060454|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
19703753|NCT00423449|42148047|FG004|Overall Study|Laboratory Adverse Event|0|||
19703754|NCT00423449|42148043|FG000|Overall Study|Other|0|||
19703755|NCT00423449|42148044|FG001|Overall Study|Other|0|||
19703756|NCT00423449|42148045|FG002|Overall Study|Other|0|||
19703757|NCT00423449|42148046|FG003|Overall Study|Other|1|||
19703758|NCT00423449|42148047|FG004|Overall Study|Other|0|||
19703759|NCT00423449|42148043|FG000|Overall Study|Protocol Violation|0|||
19703760|NCT00423449|42148044|FG001|Overall Study|Protocol Violation|0|||
19392053|NCT01998958|41636164|FG004|Open Label Phase (Optional)|Other|0|||
19392054|NCT01998958|41636165|FG005|Open Label Phase (Optional)|Other|0|||
19392055|NCT01998958|41636166|FG006|Open Label Phase (Optional)|Other|0|||
19392056|NCT01998958|41636167|FG007|Open Label Phase (Optional)|Other|0|||
19392057|NCT01998958|41636168|FG008|Open Label Phase (Optional)|Other|0|||
19392058|NCT01998958|41636169|FG009|Open Label Phase (Optional)|Other|0|||
19392059|NCT01998958|41636170|FG010|Open Label Phase (Optional)|Other|0|||
19392060|NCT01998958|41636171|FG011|Open Label Phase (Optional)|Other|0|||
19392061|NCT01998958|41636172|FG012|Open Label Phase (Optional)|Other|0|||
19392062|NCT01998958|41636173|FG013|Open Label Phase (Optional)|Other|0|||
19392063|NCT01998958|41636174|FG014|Open Label Phase (Optional)|Other|0|||
19392064|NCT01998958|41636175|FG015|Open Label Phase (Optional)|Other|0|||
19392065|NCT01998958|41636176|FG016|Open Label Phase (Optional)|Other|0|||
19392066|NCT01998958|41636177|FG017|Open Label Phase (Optional)|Other|0|||
19392067|NCT01998958|41636178|FG018|Open Label Phase (Optional)|Other|0|||
19392068|NCT01998958|41636179|FG019|Open Label Phase (Optional)|Other|0|||
19392069|NCT01998958|41636180|FG020|Open Label Phase (Optional)|Other|0|||
19392070|NCT01998958|41636181|FG021|Open Label Phase (Optional)|Other|0|||
19392071|NCT01998958|41636182|FG022|Open Label Phase (Optional)|Other|5|||
19392072|NCT01998958|41636183|FG023|Open Label Phase (Optional)|Other|1|||
19392073|NCT01998958|41636184|FG024|Open Label Phase (Optional)|Other|0|||
19392074|NCT01998958|41636185|FG025|Open Label Phase (Optional)|Other|0|||
19392075|NCT01998958|41636186|FG026|Open Label Phase (Optional)|Other|0|||
19392076|NCT01998958|41636187|FG027|Open Label Phase (Optional)|Other|0|||
19392077|NCT01998958|41636188|FG028|Open Label Phase (Optional)|Other|0|||
19392078|NCT01998958|41636189|FG029|Open Label Phase (Optional)|Other|0|||
19392079|NCT01998958|41636190|FG030|Open Label Phase (Optional)|Other|0|||
19392080|NCT01998958|41636191|FG031|Open Label Phase (Optional)|Other|0|||
19392081|NCT01998958|41636160|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392082|NCT01998958|41636161|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392083|NCT01998958|41636162|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392084|NCT01998958|41636163|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392085|NCT01998958|41636164|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392086|NCT01998958|41636165|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392087|NCT01998958|41636166|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392088|NCT01998958|41636167|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392089|NCT01998958|41636168|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392090|NCT01998958|41636169|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392091|NCT01998958|41636170|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392092|NCT01998958|41636171|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392093|NCT01998958|41636172|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392094|NCT01998958|41636173|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392095|NCT01998958|41636174|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
19478943|NCT01471093|41758797|FG001|Overall Study|Adverse Event|0|||
19478944|NCT01471093|41758798|FG002|Overall Study|Adverse Event|0|||
19392096|NCT01998958|41636175|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392097|NCT01998958|41636176|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392098|NCT01998958|41636177|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392099|NCT01998958|41636178|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392100|NCT01998958|41636179|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392101|NCT01998958|41636180|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392102|NCT01998958|41636181|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392103|NCT01998958|41636182|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
19392104|NCT01998958|41636183|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392105|NCT01998958|41636184|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392106|NCT01998958|41636185|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392107|NCT01998958|41636186|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
19478945|NCT01471093|41758799|FG003|Overall Study|Adverse Event|0|||
19478946|NCT01471015|41758808|FG000|Overall Study|Death|0|||
19478947|NCT01471015|41758809|FG001|Overall Study|Death|1|||
19478948|NCT01471015|41758810|FG002|Overall Study|Death|1|||
19478949|NCT01497067|41758818|FG000|Overall Study|Lost to Follow-up|56|||
19478950|NCT01497067|41758818|FG000|Overall Study|Adverse Event|3|||
19478951|NCT01497067|41758818|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
19478952|NCT01497067|41758818|FG000|Overall Study|Other|13|||
19478953|NCT01470469|41758848|FG000|Overall Study|Withdrawal by Subject|4|||
19478954|NCT01470469|41758849|FG001|Overall Study|Withdrawal by Subject|6|||
19478955|NCT01470469|41758848|FG000|Overall Study|Lack of Efficacy|1|||
19478956|NCT01470469|41758849|FG001|Overall Study|Lack of Efficacy|7|||
19478957|NCT01470469|41758848|FG000|Overall Study|Adverse Event|0|||
19478958|NCT01470469|41758849|FG001|Overall Study|Adverse Event|7|||
19478959|NCT01470469|41758848|FG000|Overall Study|Lost to Follow-up|2|||
19478960|NCT01470469|41758849|FG001|Overall Study|Lost to Follow-up|2|||
19478961|NCT01470469|41758848|FG000|Overall Study|Protocol Violation|1|||
19478962|NCT01470469|41758849|FG001|Overall Study|Protocol Violation|1|||
19478963|NCT01470469|41758848|FG000|Overall Study|Other|2|||
19478964|NCT01470469|41758849|FG001|Overall Study|Other|1|||
19478965|NCT01470001|41758857|FG000|Overall Study|Lost to Follow-up|1|||
19478966|NCT01470001|41758858|FG001|Overall Study|Lost to Follow-up|1|||
19478967|NCT01470001|41758857|FG000|Overall Study|Physician Decision|2|||
19478968|NCT01470001|41758858|FG001|Overall Study|Physician Decision|0|||
19392108|NCT01998958|41636187|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392109|NCT01998958|41636188|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392110|NCT01998958|41636189|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392111|NCT01998958|41636190|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392112|NCT01998958|41636191|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
19392113|NCT01998958|41636160|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
19478969|NCT01470001|41758857|FG000|Overall Study|Withdrawal by Subject|2|||
19478970|NCT01470001|41758858|FG001|Overall Study|Withdrawal by Subject|1|||
19478971|NCT01469377|41758867|FG000|Overall Study|Protocol Deviation|7|||
19478972|NCT01469377|41758868|FG001|Overall Study|Protocol Deviation|10|||
19478973|NCT01469377|41758869|FG002|Overall Study|Protocol Deviation|10|||
19478974|NCT01469377|41758867|FG000|Overall Study|Lost to Follow-up|3|||
19478975|NCT01469377|41758868|FG001|Overall Study|Lost to Follow-up|2|||
19478976|NCT01469377|41758869|FG002|Overall Study|Lost to Follow-up|5|||
19478977|NCT01469377|41758867|FG000|Overall Study|Withdrawal of Consent|12|||
19478978|NCT01469377|41758868|FG001|Overall Study|Withdrawal of Consent|14|||
19478979|NCT01469377|41758869|FG002|Overall Study|Withdrawal of Consent|15|||
19478980|NCT01469377|41758867|FG000|Overall Study|Adverse Event|8|||
19478981|NCT01469377|41758868|FG001|Overall Study|Adverse Event|18|||
19478982|NCT01469377|41758869|FG002|Overall Study|Adverse Event|36|||
19478983|NCT01469377|41758867|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19478984|NCT01469377|41758868|FG001|Overall Study|Insufficient Therapeutic Response|4|||
19478985|NCT01469377|41758869|FG002|Overall Study|Insufficient Therapeutic Response|0|||
19478986|NCT01469377|41758867|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19478987|NCT01469377|41758868|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19478988|NCT01469377|41758869|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19478989|NCT01469221|41758879|FG000|Double Blind Phase|Protocol Violation|1|||
19478990|NCT01469221|41758880|FG001|Double Blind Phase|Protocol Violation|0|||
19478991|NCT01469221|41758881|FG002|Double Blind Phase|Protocol Violation|0|||
19478992|NCT01469221|41758879|FG000|Double Blind Phase|Physician Decision|1|||
19478993|NCT01469221|41758880|FG001|Double Blind Phase|Physician Decision|1|||
19478994|NCT01469221|41758881|FG002|Double Blind Phase|Physician Decision|0|||
19478995|NCT01469221|41758879|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
19478996|NCT01469221|41758880|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
19478997|NCT01469221|41758881|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
19478998|NCT01453855|41758890|FG000|Overall Study|Adverse Event|3|||
19478999|NCT01453855|41758891|FG001|Overall Study|Adverse Event|4|||
19479000|NCT01453855|41758890|FG000|Overall Study|Lost to Follow-up|2|||
19479001|NCT01453855|41758891|FG001|Overall Study|Lost to Follow-up|1|||
19479002|NCT01453855|41758890|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
19479003|NCT01453855|41758891|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
19479004|NCT01453855|41758890|FG000|Overall Study|Noncompliance|1|||
19479005|NCT01453855|41758891|FG001|Overall Study|Noncompliance|0|||
19479006|NCT01453855|41758890|FG000|Overall Study|Inadequate Control of IOP|1|||
19479007|NCT01453855|41758891|FG001|Overall Study|Inadequate Control of IOP|5|||
19479008|NCT01453855|41758890|FG000|Overall Study|Other|0|||
19479009|NCT01453855|41758891|FG001|Overall Study|Other|1|||
19479010|NCT01469065|41758902|FG000|Overall Study|Lack of Efficacy|0|||
19479011|NCT01469065|41758903|FG001|Overall Study|Lack of Efficacy|0|||
19479012|NCT01469065|41758904|FG002|Overall Study|Lack of Efficacy|0|||
19479013|NCT01469065|41758905|FG003|Overall Study|Lack of Efficacy|0|||
19479014|NCT01469065|41758906|FG004|Overall Study|Lack of Efficacy|1|||
19479015|NCT01469065|41758902|FG000|Overall Study|Other|0|||
19479016|NCT01469065|41758903|FG001|Overall Study|Other|1|||
19479017|NCT01469065|41758904|FG002|Overall Study|Other|0|||
19479018|NCT01469065|41758905|FG003|Overall Study|Other|0|||
19479019|NCT01469065|41758906|FG004|Overall Study|Other|0|||
19479020|NCT01586624|41758930|FG000|Overall Study|Adverse Event|3|||
19479021|NCT01586624|41758931|FG001|Overall Study|Adverse Event|0|||
19479022|NCT01586624|41758932|FG002|Overall Study|Adverse Event|2|||
19479023|NCT01586624|41758933|FG003|Overall Study|Adverse Event|1|||
19479024|NCT01586624|41758934|FG004|Overall Study|Adverse Event|3|||
19479025|NCT01586624|41758935|FG005|Overall Study|Adverse Event|3|||
19479026|NCT01586624|41758936|FG006|Overall Study|Adverse Event|2|||
19479027|NCT01586624|41758937|FG007|Overall Study|Adverse Event|3|||
19479028|NCT01586624|41758930|FG000|Overall Study|Physician Decision|0|||
19479029|NCT01586624|41758931|FG001|Overall Study|Physician Decision|1|||
19479030|NCT01586624|41758932|FG002|Overall Study|Physician Decision|1|||
19479031|NCT01586624|41758933|FG003|Overall Study|Physician Decision|0|||
19479032|NCT01586624|41758934|FG004|Overall Study|Physician Decision|2|||
19479033|NCT01586624|41758935|FG005|Overall Study|Physician Decision|0|||
19479034|NCT01586624|41758936|FG006|Overall Study|Physician Decision|1|||
19479035|NCT01586624|41758937|FG007|Overall Study|Physician Decision|1|||
19479036|NCT01586624|41758930|FG000|Overall Study|Withdrawal by Subject|0|||
19479037|NCT01586624|41758931|FG001|Overall Study|Withdrawal by Subject|0|||
19479038|NCT01586624|41758932|FG002|Overall Study|Withdrawal by Subject|0|||
19479039|NCT01586624|41758933|FG003|Overall Study|Withdrawal by Subject|1|||
19479040|NCT01586624|41758934|FG004|Overall Study|Withdrawal by Subject|0|||
19479041|NCT01586624|41758935|FG005|Overall Study|Withdrawal by Subject|0|||
19479042|NCT01586624|41758936|FG006|Overall Study|Withdrawal by Subject|0|||
19479043|NCT01586624|41758937|FG007|Overall Study|Withdrawal by Subject|0|||
19479044|NCT01586624|41758930|FG000|Overall Study|Evidence of disease progression|1|||
19479045|NCT01586624|41758931|FG001|Overall Study|Evidence of disease progression|3|||
19479046|NCT01586624|41758932|FG002|Overall Study|Evidence of disease progression|2|||
19479047|NCT01586624|41758933|FG003|Overall Study|Evidence of disease progression|5|||
19479048|NCT01586624|41758934|FG004|Overall Study|Evidence of disease progression|3|||
19479049|NCT01586624|41758935|FG005|Overall Study|Evidence of disease progression|5|||
19479050|NCT01586624|41758936|FG006|Overall Study|Evidence of disease progression|4|||
19479051|NCT01586624|41758937|FG007|Overall Study|Evidence of disease progression|6|||
19479052|NCT01586624|41758930|FG000|Overall Study|Screen failure (no treatment received)|0|||
19479053|NCT01586624|41758931|FG001|Overall Study|Screen failure (no treatment received)|0|||
19479054|NCT01586624|41758932|FG002|Overall Study|Screen failure (no treatment received)|0|||
19479055|NCT01586624|41758933|FG003|Overall Study|Screen failure (no treatment received)|0|||
19479056|NCT01586624|41758934|FG004|Overall Study|Screen failure (no treatment received)|0|||
19479057|NCT01586624|41758935|FG005|Overall Study|Screen failure (no treatment received)|0|||
19479058|NCT01586624|41758936|FG006|Overall Study|Screen failure (no treatment received)|1|||
19479059|NCT01586624|41758937|FG007|Overall Study|Screen failure (no treatment received)|0|||
19479060|NCT01586156|41758959|FG000|Overall Study|Pregnancy|0|||
19479061|NCT01586156|41758960|FG001|Overall Study|Pregnancy|1|||
19479062|NCT01586156|41758961|FG002|Overall Study|Pregnancy|0|||
19479063|NCT01459913|41758973|FG000|Overall Study|Adverse Event|0|||
19479064|NCT01459913|41758974|FG001|Overall Study|Adverse Event|0|||
19479065|NCT01459913|41758975|FG002|Overall Study|Adverse Event|0|||
19479066|NCT01459913|41758976|FG003|Overall Study|Adverse Event|3|||
19479067|NCT01459913|41758973|FG000|Overall Study|Withdrawal by Subject|4|||
19479068|NCT01459913|41758974|FG001|Overall Study|Withdrawal by Subject|0|||
19479069|NCT01459913|41758975|FG002|Overall Study|Withdrawal by Subject|0|||
19479070|NCT01459913|41758976|FG003|Overall Study|Withdrawal by Subject|5|||
19479071|NCT01459913|41758973|FG000|Overall Study|Lost to Follow-up|7|||
19479072|NCT01459913|41758974|FG001|Overall Study|Lost to Follow-up|4|||
19479073|NCT01459913|41758975|FG002|Overall Study|Lost to Follow-up|1|||
19479074|NCT01459913|41758976|FG003|Overall Study|Lost to Follow-up|8|||
19479075|NCT01459913|41758973|FG000|Overall Study|Death|0|||
19479076|NCT01459913|41758974|FG001|Overall Study|Death|0|||
19479077|NCT01459913|41758975|FG002|Overall Study|Death|0|||
19479078|NCT01459913|41758976|FG003|Overall Study|Death|1|||
19611680|NCT00573859|42060454|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
19611681|NCT00831441|42060460|FG000|Randomized|Death|82|||
19479079|NCT01459913|41758973|FG000|Overall Study|Non- Compliance|0|||
19479080|NCT01459913|41758974|FG001|Overall Study|Non- Compliance|0|||
19479081|NCT01459913|41758975|FG002|Overall Study|Non- Compliance|0|||
19479082|NCT01459913|41758976|FG003|Overall Study|Non- Compliance|3|||
19479083|NCT01459913|41758973|FG000|Overall Study|Physician Decision|0|||
19479084|NCT01459913|41758974|FG001|Overall Study|Physician Decision|1|||
19479085|NCT01459913|41758975|FG002|Overall Study|Physician Decision|0|||
19479086|NCT01459913|41758976|FG003|Overall Study|Physician Decision|0|||
19479087|NCT01459913|41758973|FG000|Overall Study|Study Terminated by Sponsor|30|||
19479088|NCT01459913|41758974|FG001|Overall Study|Study Terminated by Sponsor|15|||
19479089|NCT01459913|41758975|FG002|Overall Study|Study Terminated by Sponsor|9|||
19479090|NCT01459913|41758976|FG003|Overall Study|Study Terminated by Sponsor|11|||
19479091|NCT01459913|41758973|FG000|Overall Study|Other|0|||
19479092|NCT01459913|41758974|FG001|Overall Study|Other|0|||
19479093|NCT01459913|41758975|FG002|Overall Study|Other|3|||
19479094|NCT01459913|41758976|FG003|Overall Study|Other|1|||
19479095|NCT01459913|41758973|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
19479096|NCT01459913|41758974|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
19479097|NCT01459913|41758975|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
19479098|NCT01459913|41758976|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
19479099|NCT01458587|41758990|FG000|Overall Study|Withdrawal by Subject|1|||
19479100|NCT01458587|41758991|FG001|Overall Study|Withdrawal by Subject|0|||
19479101|NCT01458275|41759002|FG000|Overall Study|Adverse Event|3|||
19479102|NCT01458275|41759003|FG001|Overall Study|Adverse Event|4|||
19479103|NCT01458275|41759004|FG002|Overall Study|Adverse Event|1|||
19479104|NCT01458275|41759002|FG000|Overall Study|Lost to Follow-up|3|||
19479105|NCT01458275|41759003|FG001|Overall Study|Lost to Follow-up|2|||
19479106|NCT01458275|41759004|FG002|Overall Study|Lost to Follow-up|5|||
19479107|NCT01458275|41759002|FG000|Overall Study|Protocol Violation|5|||
19479108|NCT01458275|41759003|FG001|Overall Study|Protocol Violation|5|||
19479109|NCT01458275|41759004|FG002|Overall Study|Protocol Violation|2|||
19479110|NCT01458275|41759002|FG000|Overall Study|Withdrawal by Subject|3|||
19479111|NCT01458275|41759003|FG001|Overall Study|Withdrawal by Subject|2|||
19479112|NCT01458275|41759004|FG002|Overall Study|Withdrawal by Subject|1|||
19479113|NCT01458119|41759014|FG000|Overall Study|Physician Decision|4|||
19479114|NCT01458119|41759014|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
19479115|NCT01458119|41759014|FG000|Overall Study|Pregnancy|1|||
19479116|NCT01458119|41759014|FG000|Overall Study|Death|2|||
19479117|NCT01458119|41759014|FG000|Overall Study|Adverse Event|1|||
19479118|NCT01458119|41759014|FG000|Overall Study|Consent Withdrawn by Participant|8|||
19479119|NCT01458119|41759014|FG000|Overall Study|Non-compliance With Study Drug|3|||
19479120|NCT01688882|41759029|FG000|Overall Study|Adverse Event|1|||
19479121|NCT01688882|41759030|FG001|Overall Study|Adverse Event|0|||
19479122|NCT01688882|41759029|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19479123|NCT01688882|41759030|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19479124|NCT01688882|41759029|FG000|Overall Study|Administrative problems|1|||
19479125|NCT01688882|41759030|FG001|Overall Study|Administrative problems|0|||
19479126|NCT01688726|41759042|FG000|Overall Study|Adverse Event|1|||
19479127|NCT01688726|41759043|FG001|Overall Study|Adverse Event|0|||
19479128|NCT01688726|41759042|FG000|Overall Study|Relocated abroad|0|||
19479129|NCT01688726|41759043|FG001|Overall Study|Relocated abroad|1|||
19479130|NCT01585766|41759059|FG000|Overall Study|Withdrawal by Subject|0|||
19479131|NCT01585766|41759060|FG001|Overall Study|Withdrawal by Subject|1|||
19479132|NCT01585766|41759061|FG002|Overall Study|Withdrawal by Subject|1|||
19479133|NCT01585766|41759062|FG003|Overall Study|Withdrawal by Subject|0|||
19479134|NCT01585766|41759063|FG004|Overall Study|Withdrawal by Subject|0|||
19479135|NCT01585766|41759064|FG005|Overall Study|Withdrawal by Subject|0|||
19479136|NCT01585766|41759059|FG000|Overall Study|Death|0|||
19479137|NCT01585766|41759060|FG001|Overall Study|Death|1|||
19479138|NCT01585766|41759061|FG002|Overall Study|Death|0|||
19479139|NCT01585766|41759062|FG003|Overall Study|Death|0|||
19479140|NCT01585766|41759063|FG004|Overall Study|Death|0|||
19479141|NCT01585766|41759064|FG005|Overall Study|Death|0|||
19479142|NCT01585766|41759059|FG000|Overall Study|Physician Decision|0|||
19479143|NCT01585766|41759060|FG001|Overall Study|Physician Decision|0|||
19479144|NCT01585766|41759061|FG002|Overall Study|Physician Decision|1|||
19479145|NCT01585766|41759062|FG003|Overall Study|Physician Decision|0|||
19479146|NCT01585766|41759063|FG004|Overall Study|Physician Decision|0|||
19479147|NCT01585766|41759064|FG005|Overall Study|Physician Decision|0|||
19479148|NCT01562444|41759088|FG000|Overall Study|Did not meet entry criteria|2|||
19479149|NCT01562444|41759089|FG001|Overall Study|Did not meet entry criteria|0|||
19479150|NCT01562444|41759090|FG002|Overall Study|Did not meet entry criteria|3|||
19479151|NCT01562444|41759088|FG000|Overall Study|Did not comply with blood draw schedule|1|||
19479152|NCT01562444|41759089|FG001|Overall Study|Did not comply with blood draw schedule|0|||
19611682|NCT00831441|42060461|FG001|Randomized|Death|81|||
19479153|NCT01562444|41759090|FG002|Overall Study|Did not comply with blood draw schedule|1|||
19479154|NCT01562444|41759088|FG000|Overall Study|Unavailable serological results|0|||
19479155|NCT01562444|41759089|FG001|Overall Study|Unavailable serological results|2|||
19479156|NCT01562444|41759090|FG002|Overall Study|Unavailable serological results|2|||
19479157|NCT01562444|41759088|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
19479158|NCT01562444|41759089|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
19479159|NCT01562444|41759090|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
19479160|NCT01562444|41759088|FG000|Overall Study|Protocol forbidden medication|1|||
19479161|NCT01562444|41759089|FG001|Overall Study|Protocol forbidden medication|0|||
19479162|NCT01562444|41759090|FG002|Overall Study|Protocol forbidden medication|0|||
19479163|NCT01457339|41759100|FG000|Period 3 (100 mg)|Adverse Event|0|||
19479164|NCT01457339|41759101|FG001|Period 3 (100 mg)|Adverse Event|1|||
19479165|NCT01457339|41759100|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
19479166|NCT01457339|41759101|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
19479167|NCT01457339|41759100|FG000|Period 6 (250 mg)|Family Emergency|1|||
19479168|NCT01457339|41759101|FG001|Period 6 (250 mg)|Family Emergency|0|||
19479169|NCT01457339|41759100|FG000|Period 6 (250 mg)|Personal appointment|0|||
19479170|NCT01457339|41759101|FG001|Period 6 (250 mg)|Personal appointment|1|||
19479171|NCT01456949|41759124|FG000|Enrollment|PI death- incomplete data|6|||
19479172|NCT01456949|41759124|FG000|Enrollment|Death|1|||
19479173|NCT01456949|41759124|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
19479174|NCT01456949|41759124|FG000|Enrollment|Physician Decision|10|||
19479175|NCT01456949|41759124|FG000|Enrollment|Withdrawal by Subject|7|||
19479176|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
19479177|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
19479178|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
19479179|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
19611683|NCT00831441|42060460|FG000|Randomized|Adverse Event|248|||
19611684|NCT00831441|42060461|FG001|Randomized|Adverse Event|321|||
19392114|NCT01998958|41636161|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392115|NCT01998958|41636162|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392116|NCT01998958|41636163|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392117|NCT01998958|41636164|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392118|NCT01998958|41636165|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392119|NCT01998958|41636166|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392120|NCT01998958|41636167|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392121|NCT01998958|41636168|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392122|NCT01998958|41636169|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392123|NCT01998958|41636170|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392124|NCT01998958|41636171|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392125|NCT01998958|41636172|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392126|NCT01998958|41636173|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392127|NCT01998958|41636174|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392128|NCT01998958|41636175|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392129|NCT01998958|41636176|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392130|NCT01998958|41636177|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392131|NCT01998958|41636178|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392132|NCT01998958|41636179|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392133|NCT01998958|41636180|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392134|NCT01998958|41636181|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
19392135|NCT01998958|41636182|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
19392136|NCT01998958|41636183|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392137|NCT01998958|41636184|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392138|NCT01998958|41636185|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392139|NCT01998958|41636186|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392140|NCT01998958|41636187|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392141|NCT01998958|41636188|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392142|NCT01998958|41636189|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392143|NCT01998958|41636190|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392144|NCT01998958|41636191|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
19392145|NCT01998958|41636160|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392146|NCT01998958|41636161|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392147|NCT01998958|41636162|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392148|NCT01998958|41636163|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392149|NCT01998958|41636164|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392150|NCT01998958|41636165|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392151|NCT01998958|41636166|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392152|NCT01998958|41636167|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19479180|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
19479181|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
19392153|NCT01998958|41636168|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392154|NCT01998958|41636169|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392155|NCT01998958|41636170|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392156|NCT01998958|41636171|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392157|NCT01998958|41636172|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392158|NCT01998958|41636173|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392159|NCT01998958|41636174|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392160|NCT01998958|41636175|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19479182|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
19479183|NCT01456949|41759124|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
19479184|NCT01456169|41759131|FG000|Overall Study|Adverse Event|1|||
19479185|NCT01456169|41759132|FG001|Overall Study|Adverse Event|2|||
19479186|NCT01456169|41759133|FG002|Overall Study|Adverse Event|7|||
19479187|NCT01456169|41759131|FG000|Overall Study|Major Protocol Deviation|3|||
19479188|NCT01456169|41759132|FG001|Overall Study|Major Protocol Deviation|2|||
19479189|NCT01456169|41759133|FG002|Overall Study|Major Protocol Deviation|3|||
19479190|NCT01456169|41759131|FG000|Overall Study|Voluntary Withdrawal|3|||
19479191|NCT01456169|41759132|FG001|Overall Study|Voluntary Withdrawal|0|||
19479192|NCT01456169|41759133|FG002|Overall Study|Voluntary Withdrawal|2|||
19479193|NCT01456169|41759131|FG000|Overall Study|Lack of Efficacy|2|||
19479194|NCT01456169|41759132|FG001|Overall Study|Lack of Efficacy|0|||
19479195|NCT01456169|41759133|FG002|Overall Study|Lack of Efficacy|0|||
19479196|NCT01456169|41759131|FG000|Overall Study|Other|1|||
19479197|NCT01456169|41759132|FG001|Overall Study|Other|1|||
19479198|NCT01456169|41759133|FG002|Overall Study|Other|0|||
19479199|NCT01454531|41759142|FG000|Overall Study|Adverse Event|14|||
19479200|NCT01454531|41759142|FG000|Overall Study|Withdrawal by Subject|5|||
19479201|NCT01454531|41759142|FG000|Overall Study|Lost to Follow-up|1|||
19479202|NCT01454531|41759142|FG000|Overall Study|Physician Decision|1|||
19479203|NCT01454531|41759142|FG000|Overall Study|Delay in IMP administration|1|||
19479204|NCT01454531|41759142|FG000|Overall Study|Other|1|||
19479205|NCT01454063|41759148|FG000|Randomized|Adverse Event|1|||
19479206|NCT01454063|41759149|FG001|Randomized|Adverse Event|1|||
19479207|NCT01454063|41759148|FG000|Randomized|Protocol Violation|0|||
19479208|NCT01454063|41759149|FG001|Randomized|Protocol Violation|1|||
19479209|NCT01453595|41759158|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19479210|NCT01453595|41759159|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
19479211|NCT01453595|41759160|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19479212|NCT01453439|41759168|FG000|Treatment Phase|Withdrawal by Subject|13|||
19479213|NCT01453439|41759169|FG001|Treatment Phase|Withdrawal by Subject|10|||
19479214|NCT01453439|41759168|FG000|Treatment Phase|Suicidal Ideation|2|||
19479215|NCT01453439|41759169|FG001|Treatment Phase|Suicidal Ideation|0|||
19479216|NCT01453439|41759168|FG000|Treatment Phase|Need for higher level of care|1|||
19479217|NCT01453439|41759169|FG001|Treatment Phase|Need for higher level of care|1|||
19479218|NCT01453439|41759168|FG000|Treatment Phase|Therapist conflict of interest|1|||
19479219|NCT01453439|41759169|FG001|Treatment Phase|Therapist conflict of interest|0|||
19479220|NCT01453439|41759168|FG000|Follow-up|Withdrawal by Subject|0|||
19479221|NCT01453439|41759169|FG001|Follow-up|Withdrawal by Subject|1|||
19479222|NCT01453439|41759168|FG000|Follow-up|Lost to Follow-up|5|||
19479223|NCT01453439|41759169|FG001|Follow-up|Lost to Follow-up|10|||
19479224|NCT01453361|41759175|FG000|Overall Study|Disease Progression|6|||
19479225|NCT01453361|41759175|FG000|Overall Study|Screen-Failures|10|||
19479226|NCT01585298|41759179|FG000|Overall Study|Study completion was not documented.|1|||
19479227|NCT01585298|41759179|FG000|Overall Study|Protocol deviation|1|||
19479228|NCT01585298|41759179|FG000|Overall Study|Administrative problems|4|||
19479229|NCT01585298|41759179|FG000|Overall Study|Lost to Follow-up|2|||
19479230|NCT01585298|41759179|FG000|Overall Study|Withdrawal by Subject|4|||
19479231|NCT01585298|41759179|FG000|Overall Study|Abnormal test procedure results|1|||
19479232|NCT01585298|41759179|FG000|Overall Study|Adverse Event|24|||
19479233|NCT01453205|41759186|FG000|Overall Study|Lost to Follow-up|3|||
19479234|NCT01453205|41759187|FG001|Overall Study|Lost to Follow-up|0|||
19479235|NCT01453205|41759188|FG002|Overall Study|Lost to Follow-up|1|||
19479236|NCT01453205|41759186|FG000|Overall Study|Withdrawal by Subject|8|||
19479237|NCT01453205|41759187|FG001|Overall Study|Withdrawal by Subject|3|||
19479238|NCT01453205|41759188|FG002|Overall Study|Withdrawal by Subject|0|||
19479239|NCT01453205|41759186|FG000|Overall Study|Death|24|||
19479240|NCT01453205|41759187|FG001|Overall Study|Death|22|||
19479241|NCT01453205|41759188|FG002|Overall Study|Death|18|||
19479242|NCT01453205|41759186|FG000|Overall Study|Other|45|||
19479243|NCT01453205|41759187|FG001|Overall Study|Other|27|||
19479244|NCT01453205|41759188|FG002|Overall Study|Other|35|||
19479245|NCT01453049|41759201|FG000|Overall Study|Protocol Violation|2|||
19479246|NCT01453049|41759202|FG001|Overall Study|Protocol Violation|5|||
19479247|NCT01453049|41759201|FG000|Overall Study|Lost to Follow-up|2|||
19479248|NCT01453049|41759202|FG001|Overall Study|Lost to Follow-up|1|||
19479249|NCT01453049|41759201|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
19479250|NCT01453049|41759202|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
19479251|NCT01453049|41759201|FG000|Overall Study|Withdrawal by Subject|1|||
19479252|NCT01453049|41759202|FG001|Overall Study|Withdrawal by Subject|0|||
19479253|NCT01453049|41759201|FG000|Overall Study|Randomized in Error|1|||
19479254|NCT01453049|41759202|FG001|Overall Study|Randomized in Error|0|||
19479255|NCT01452347|41759210|FG000|Overall Study|Adverse Event|2|||
19479256|NCT01452347|41759211|FG001|Overall Study|Adverse Event|1|||
19479257|NCT01452347|41759210|FG000|Overall Study|Non compliance protocol|2|||
19479258|NCT01452347|41759211|FG001|Overall Study|Non compliance protocol|0|||
19479259|NCT01452347|41759210|FG000|Overall Study|Lost to Follow-up|2|||
19479260|NCT01452347|41759211|FG001|Overall Study|Lost to Follow-up|0|||
19479261|NCT01452347|41759210|FG000|Overall Study|Withdrawal by Subject|3|||
19479262|NCT01452347|41759211|FG001|Overall Study|Withdrawal by Subject|3|||
19479263|NCT01452347|41759210|FG000|Overall Study|Not treated|6|||
19479264|NCT01452347|41759211|FG001|Overall Study|Not treated|3|||
19479265|NCT01452347|41759210|FG000|Overall Study|Other reason not defined above|2|||
19479266|NCT01452347|41759211|FG001|Overall Study|Other reason not defined above|0|||
19479267|NCT01451723|41759221|FG000|Overall Study|study halted|6|||
19479268|NCT01451723|41759222|FG001|Overall Study|study halted|5|||
19479269|NCT01451645|41759230|FG000|Overall Study|Protocol Violation|1|||
19479270|NCT01451645|41759231|FG001|Overall Study|Protocol Violation|0|||
19479271|NCT01451645|41759230|FG000|Overall Study|Adverse Event|0|||
19479272|NCT01451645|41759231|FG001|Overall Study|Adverse Event|3|||
19479273|NCT01451645|41759230|FG000|Overall Study|Withdrawal by Subject|4|||
19479274|NCT01451645|41759231|FG001|Overall Study|Withdrawal by Subject|2|||
19479275|NCT01451645|41759230|FG000|Overall Study|Lost to Follow-up|4|||
19479276|NCT01451645|41759231|FG001|Overall Study|Lost to Follow-up|3|||
19479277|NCT01450943|41759240|FG000|Overall Study|Screen failure, loss to follow-up|2|||
19479278|NCT01450943|41759241|FG001|Overall Study|Screen failure, loss to follow-up|7|||
19479279|NCT01450943|41759242|FG002|Overall Study|Screen failure, loss to follow-up|6|||
19479280|NCT01450631|41759256|FG000|Overall Study|Lost to Follow-up|2|||
19479281|NCT01450631|41759257|FG001|Overall Study|Lost to Follow-up|4|||
19479282|NCT01450631|41759256|FG000|Overall Study|Withdrawal by Subject|1|||
19479283|NCT01450631|41759257|FG001|Overall Study|Withdrawal by Subject|0|||
19479284|NCT01450007|41759266|FG000|Overall Study|Late exclusion before treatment|2|||
19479285|NCT01450007|41759267|FG001|Overall Study|Late exclusion before treatment|3|||
19479286|NCT01450007|41759268|FG002|Overall Study|Late exclusion before treatment|2|||
19479287|NCT01450007|41759266|FG000|Overall Study|Protocol Violation|0|||
19479288|NCT01450007|41759267|FG001|Overall Study|Protocol Violation|1|||
19479289|NCT01450007|41759268|FG002|Overall Study|Protocol Violation|1|||
19479290|NCT01450007|41759266|FG000|Overall Study|Adverse Event|0|||
19479291|NCT01450007|41759267|FG001|Overall Study|Adverse Event|1|||
19479292|NCT01450007|41759268|FG002|Overall Study|Adverse Event|0|||
19479293|NCT01496365|41759283|FG000|Overall Study|Adverse Event|2|||
19479294|NCT01496365|41759284|FG001|Overall Study|Adverse Event|3|||
19479295|NCT01496365|41759285|FG002|Overall Study|Adverse Event|3|||
19479296|NCT01496365|41759286|FG003|Overall Study|Adverse Event|2|||
19479297|NCT01496365|41759287|FG004|Overall Study|Adverse Event|5|||
19479298|NCT01496365|41759288|FG005|Overall Study|Adverse Event|6|||
19479299|NCT01496365|41759289|FG006|Overall Study|Adverse Event|4|||
19479300|NCT01496365|41759283|FG000|Overall Study|Withdrawal by Subject|6|||
19479301|NCT01496365|41759284|FG001|Overall Study|Withdrawal by Subject|6|||
19479302|NCT01496365|41759285|FG002|Overall Study|Withdrawal by Subject|0|||
19479303|NCT01496365|41759286|FG003|Overall Study|Withdrawal by Subject|1|||
19479304|NCT01496365|41759287|FG004|Overall Study|Withdrawal by Subject|3|||
19479305|NCT01496365|41759288|FG005|Overall Study|Withdrawal by Subject|2|||
19479306|NCT01496365|41759289|FG006|Overall Study|Withdrawal by Subject|1|||
19479307|NCT01496365|41759283|FG000|Overall Study|Protocol Violation|2|||
19479308|NCT01496365|41759284|FG001|Overall Study|Protocol Violation|1|||
19479309|NCT01496365|41759285|FG002|Overall Study|Protocol Violation|1|||
19479310|NCT01496365|41759286|FG003|Overall Study|Protocol Violation|0|||
19479311|NCT01496365|41759287|FG004|Overall Study|Protocol Violation|0|||
19479312|NCT01496365|41759288|FG005|Overall Study|Protocol Violation|1|||
19479313|NCT01496365|41759289|FG006|Overall Study|Protocol Violation|0|||
19479314|NCT01496365|41759283|FG000|Overall Study|Lack of Efficacy|1|||
19479315|NCT01496365|41759284|FG001|Overall Study|Lack of Efficacy|0|||
19479316|NCT01496365|41759285|FG002|Overall Study|Lack of Efficacy|0|||
19479317|NCT01496365|41759286|FG003|Overall Study|Lack of Efficacy|0|||
19479318|NCT01496365|41759287|FG004|Overall Study|Lack of Efficacy|0|||
19479319|NCT01496365|41759288|FG005|Overall Study|Lack of Efficacy|1|||
19479320|NCT01496365|41759289|FG006|Overall Study|Lack of Efficacy|0|||
19479321|NCT01496365|41759283|FG000|Overall Study|Lost to Follow-up|0|||
19479322|NCT01496365|41759284|FG001|Overall Study|Lost to Follow-up|1|||
19479323|NCT01496365|41759285|FG002|Overall Study|Lost to Follow-up|0|||
19479324|NCT01496365|41759286|FG003|Overall Study|Lost to Follow-up|0|||
19479325|NCT01496365|41759287|FG004|Overall Study|Lost to Follow-up|2|||
19479326|NCT01496365|41759288|FG005|Overall Study|Lost to Follow-up|0|||
19479327|NCT01496365|41759289|FG006|Overall Study|Lost to Follow-up|0|||
19479328|NCT01496365|41759283|FG000|Overall Study|Other|4|||
19479329|NCT01496365|41759284|FG001|Overall Study|Other|4|||
19479330|NCT01496365|41759285|FG002|Overall Study|Other|2|||
19479331|NCT01496365|41759286|FG003|Overall Study|Other|1|||
19479332|NCT01496365|41759287|FG004|Overall Study|Other|3|||
19479333|NCT01496365|41759288|FG005|Overall Study|Other|0|||
19479334|NCT01496365|41759289|FG006|Overall Study|Other|1|||
19479335|NCT01496287|41759305|FG000|Overall Study|Lost to Follow-up|1|||
19479336|NCT01496287|41759305|FG000|Overall Study|Incomplete anesthesia|5|||
19479337|NCT01495975|41759312|FG000|Overall Study|Lost to Follow-up|1|||
19479338|NCT01495975|41759313|FG001|Overall Study|Lost to Follow-up|0|||
19479339|NCT01468987|41759321|FG000|Overall Study|Adverse Event|12|||
19479340|NCT01468987|41759322|FG001|Overall Study|Adverse Event|9|||
19479341|NCT01468987|41759321|FG000|Overall Study|Death|4|||
19479342|NCT01468987|41759322|FG001|Overall Study|Death|1|||
19479343|NCT01468987|41759321|FG000|Overall Study|Lost to Follow-up|10|||
19479344|NCT01468987|41759322|FG001|Overall Study|Lost to Follow-up|5|||
19479345|NCT01468987|41759321|FG000|Overall Study|Protocol Violation|8|||
19479346|NCT01468987|41759322|FG001|Overall Study|Protocol Violation|2|||
19479347|NCT01468987|41759321|FG000|Overall Study|Withdrawal by Subject|28|||
19479348|NCT01468987|41759322|FG001|Overall Study|Withdrawal by Subject|28|||
19479349|NCT01468987|41759321|FG000|Overall Study|Physician Decision|8|||
19479350|NCT01468987|41759322|FG001|Overall Study|Physician Decision|15|||
19479351|NCT01468987|41759321|FG000|Overall Study|Sponsor Decision|1|||
19479352|NCT01468987|41759322|FG001|Overall Study|Sponsor Decision|0|||
19479353|NCT01687712|41759332|FG000|Cycle 1|Not Biochemically Pregnant|386|||
19479354|NCT01687712|41759333|FG001|Cycle 1|Not Biochemically Pregnant|348|||
19479355|NCT01687712|41759332|FG000|Cycle 1|Early Pregnancy Loss|43|||
19479356|NCT01687712|41759333|FG001|Cycle 1|Early Pregnancy Loss|60|||
19479357|NCT01687712|41759332|FG000|Cycle 1|Ectopic Pregnancy|5|||
19479358|NCT01687712|41759333|FG001|Cycle 1|Ectopic Pregnancy|5|||
19479359|NCT01687712|41759332|FG000|Cycle 1|Heterotropic Pregnancy|1|||
19479360|NCT01687712|41759333|FG001|Cycle 1|Heterotropic Pregnancy|0|||
19479361|NCT01687712|41759332|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
19479362|NCT01687712|41759333|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
19479363|NCT01687712|41759332|FG000|Cycle 1|Abortion|3|||
19479364|NCT01687712|41759333|FG001|Cycle 1|Abortion|0|||
19479365|NCT01687712|41759332|FG000|Cycle 1|Intrauterine Fetal Death|0|||
19392161|NCT01998958|41636176|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19703761|NCT00423449|42148045|FG002|Overall Study|Protocol Violation|2|||
19703762|NCT00423449|42148046|FG003|Overall Study|Protocol Violation|1|||
19703763|NCT00423449|42148047|FG004|Overall Study|Protocol Violation|0|||
19703764|NCT00423293|42148060|FG000|Overall Study|Ineligible / No protocol treatment|11|||
19703765|NCT00423137|42148068|FG000|Overall Study|Lost to Follow-up|0|||
19392162|NCT01998958|41636177|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392163|NCT01998958|41636178|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392164|NCT01998958|41636179|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392165|NCT01998958|41636180|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392166|NCT01998958|41636181|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
19392167|NCT01998958|41636182|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
19392168|NCT01998958|41636183|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
19392169|NCT01998958|41636184|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392170|NCT01998958|41636185|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392171|NCT01998958|41636186|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392172|NCT01998958|41636187|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392173|NCT01998958|41636188|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392174|NCT01998958|41636189|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392175|NCT01998958|41636190|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392176|NCT01998958|41636191|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
19392177|NCT01958164|41636243|FG000|Overall Study|Adverse Event|0|||
19392178|NCT01958164|41636244|FG001|Overall Study|Adverse Event|2|||
19392179|NCT01958164|41636243|FG000|Overall Study|Lost to Follow-up|2|||
19392180|NCT01958164|41636244|FG001|Overall Study|Lost to Follow-up|3|||
19479366|NCT01687712|41759333|FG001|Cycle 1|Intrauterine Fetal Death|1|||
19479367|NCT01687712|41759332|FG000|Cycle 1|Lost to Follow-up|1|||
19479368|NCT01687712|41759333|FG001|Cycle 1|Lost to Follow-up|1|||
19479369|NCT01687712|41759332|FG000|Cycle 2|Not Biochemically Pregnant|74|||
19479370|NCT01687712|41759333|FG001|Cycle 2|Not Biochemically Pregnant|77|||
19479371|NCT01687712|41759332|FG000|Cycle 2|Early Pregnancy Loss|18|||
19479372|NCT01687712|41759333|FG001|Cycle 2|Early Pregnancy Loss|16|||
19479373|NCT01687712|41759332|FG000|Cycle 2|Ectopic Pregnancy|0|||
19392181|NCT01976104|41636254|FG000|Overall Study|Adverse Event|0|||
19479374|NCT01687712|41759333|FG001|Cycle 2|Ectopic Pregnancy|1|||
19479375|NCT01687712|41759332|FG000|Cycle 2|Still Birth|1|||
19479376|NCT01687712|41759333|FG001|Cycle 2|Still Birth|0|||
19479377|NCT01687712|41759332|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
19479378|NCT01687712|41759333|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
19479379|NCT01687712|41759332|FG000|Cycle 3|Not Biochemically Pregnant|21|||
19479380|NCT01687712|41759333|FG001|Cycle 3|Not Biochemically Pregnant|22|||
19479381|NCT01687712|41759332|FG000|Cycle 3|Early Pregnancy Loss|1|||
19479382|NCT01687712|41759333|FG001|Cycle 3|Early Pregnancy Loss|2|||
19479383|NCT01687712|41759332|FG000|Cycle 3|Ectopic Pregnancy|1|||
19479384|NCT01687712|41759333|FG001|Cycle 3|Ectopic Pregnancy|0|||
19479385|NCT01687712|41759332|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
19479386|NCT01687712|41759333|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
19479387|NCT01603628|41759346|FG000|Overall Study|Personal Reasons|1|||
19479388|NCT01603628|41759347|FG001|Overall Study|Personal Reasons|1|||
19479389|NCT01603628|41759348|FG002|Overall Study|Personal Reasons|2|||
19479390|NCT01603628|41759346|FG000|Overall Study|Protocol Violation|1|||
19479391|NCT01603628|41759347|FG001|Overall Study|Protocol Violation|1|||
19479392|NCT01603628|41759348|FG002|Overall Study|Protocol Violation|0|||
19479393|NCT01603628|41759346|FG000|Overall Study|Lost to Follow-up|0|||
19479394|NCT01603628|41759347|FG001|Overall Study|Lost to Follow-up|1|||
19479395|NCT01603628|41759348|FG002|Overall Study|Lost to Follow-up|0|||
19479396|NCT01603628|41759346|FG000|Overall Study|Other Miscellaneous Reason|1|||
19479397|NCT01603628|41759347|FG001|Overall Study|Other Miscellaneous Reason|0|||
19479398|NCT01603628|41759348|FG002|Overall Study|Other Miscellaneous Reason|0|||
19479399|NCT01453153|41759359|FG000|Overall Study|Physician Decision|0|||
19479400|NCT01453153|41759360|FG001|Overall Study|Physician Decision|0|||
19479401|NCT01453153|41759361|FG002|Overall Study|Physician Decision|1|||
19479402|NCT01453153|41759359|FG000|Overall Study|Progressive Disease|3|||
19479403|NCT01453153|41759360|FG001|Overall Study|Progressive Disease|2|||
19479404|NCT01453153|41759361|FG002|Overall Study|Progressive Disease|16|||
19479405|NCT01453153|41759359|FG000|Overall Study|Withdrawal by Subject|0|||
19479406|NCT01453153|41759360|FG001|Overall Study|Withdrawal by Subject|1|||
19479407|NCT01453153|41759361|FG002|Overall Study|Withdrawal by Subject|2|||
19479408|NCT01453153|41759359|FG000|Overall Study|Adverse Event|1|||
19479409|NCT01453153|41759360|FG001|Overall Study|Adverse Event|1|||
19479410|NCT01453153|41759361|FG002|Overall Study|Adverse Event|1|||
19479411|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
19479412|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
19479413|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
19479414|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
19479415|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
19479416|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
19479417|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
19479418|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
19479419|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
19479420|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
19479421|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
19479422|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
19479423|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
19479424|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
19479425|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
19479426|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
19479427|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
19479428|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
19479429|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
19479430|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
19479431|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
19479432|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
19479433|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
19479434|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
19479435|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
19479436|NCT01584440|41759375|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
19479437|NCT01584440|41759376|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
19479438|NCT01584440|41759377|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
19479439|NCT01584440|41759378|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
19479440|NCT01584440|41759379|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
19479441|NCT01584440|41759375|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
19479442|NCT01584440|41759376|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
19479443|NCT01584440|41759377|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
19479444|NCT01584440|41759378|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
19479445|NCT01584440|41759379|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
19479446|NCT01584440|41759375|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
19479447|NCT01584440|41759376|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
19479448|NCT01584440|41759377|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
19479449|NCT01584440|41759378|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
19479450|NCT01584440|41759379|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
19479451|NCT01584440|41759375|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
19479452|NCT01584440|41759376|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
19479453|NCT01584440|41759377|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
19611685|NCT00831441|42060460|FG000|Randomized|Emergency procedure|2|||
19479454|NCT01584440|41759378|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
19479455|NCT01584440|41759379|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
19479456|NCT01687478|41759394|FG000|Overall Study|Adverse Event|3|||
19479457|NCT01687478|41759395|FG001|Overall Study|Adverse Event|10|||
19479458|NCT01687478|41759394|FG000|Overall Study|Lost to Follow-up|1|||
19479459|NCT01687478|41759395|FG001|Overall Study|Lost to Follow-up|3|||
19479460|NCT01687478|41759394|FG000|Overall Study|Protocol Violation|0|||
19479461|NCT01687478|41759395|FG001|Overall Study|Protocol Violation|2|||
19479462|NCT01687478|41759394|FG000|Overall Study|Withdrawal by Subject|21|||
19479463|NCT01687478|41759395|FG001|Overall Study|Withdrawal by Subject|19|||
19479464|NCT01687478|41759394|FG000|Overall Study|Physician Decision|1|||
19479465|NCT01687478|41759395|FG001|Overall Study|Physician Decision|3|||
19479466|NCT01687478|41759394|FG000|Overall Study|Entry Criteria Not Met|6|||
19479467|NCT01687478|41759395|FG001|Overall Study|Entry Criteria Not Met|2|||
19479468|NCT01468909|41759403|FG000|Overall Study|Never Treated|2|||
19479469|NCT01468909|41759404|FG001|Overall Study|Never Treated|2|||
19479470|NCT01468597|41759410|FG000|Overall Study|Found ineligible|17|||
19479471|NCT01468597|41759410|FG000|Overall Study|concomitant valves|12|||
19479472|NCT01468597|41759410|FG000|Overall Study|off-pump CABG|1|||
19479473|NCT01468597|41759410|FG000|Overall Study|no platelet function data|5|||
19479474|NCT01687166|41759418|FG000|Overall Study|Attempt subject|2|||
19479475|NCT01687166|41759419|FG001|Overall Study|Attempt subject|3|||
19479476|NCT01687166|41759420|FG002|Overall Study|Attempt subject|2|||
19479477|NCT01687166|41759421|FG003|Overall Study|Attempt subject|0|||
19479478|NCT01687166|41759418|FG000|Overall Study|Did not meet eligibility criteria|4|||
19479479|NCT01687166|41759419|FG001|Overall Study|Did not meet eligibility criteria|6|||
19479480|NCT01687166|41759420|FG002|Overall Study|Did not meet eligibility criteria|1|||
19479481|NCT01687166|41759421|FG003|Overall Study|Did not meet eligibility criteria|1|||
19479482|NCT01687166|41759418|FG000|Overall Study|Adverse Event|2|||
19479483|NCT01687166|41759419|FG001|Overall Study|Adverse Event|1|||
19479484|NCT01687166|41759420|FG002|Overall Study|Adverse Event|0|||
19479485|NCT01687166|41759421|FG003|Overall Study|Adverse Event|0|||
19479486|NCT01687166|41759418|FG000|Overall Study|Physician Decision|3|||
19479487|NCT01687166|41759419|FG001|Overall Study|Physician Decision|2|||
19479488|NCT01687166|41759420|FG002|Overall Study|Physician Decision|1|||
19392182|NCT01976104|41636255|FG001|Overall Study|Adverse Event|0|||
19479489|NCT01687166|41759421|FG003|Overall Study|Physician Decision|0|||
19479490|NCT01687166|41759418|FG000|Overall Study|Withdrawal by Subject|11|||
19479491|NCT01687166|41759419|FG001|Overall Study|Withdrawal by Subject|4|||
19479492|NCT01687166|41759420|FG002|Overall Study|Withdrawal by Subject|3|||
19479493|NCT01687166|41759421|FG003|Overall Study|Withdrawal by Subject|0|||
19479494|NCT01687166|41759418|FG000|Overall Study|Lost to Follow-up|2|||
19479495|NCT01687166|41759419|FG001|Overall Study|Lost to Follow-up|5|||
19479496|NCT01687166|41759420|FG002|Overall Study|Lost to Follow-up|1|||
19479497|NCT01687166|41759421|FG003|Overall Study|Lost to Follow-up|0|||
19479498|NCT01687166|41759418|FG000|Overall Study|Equipment/Device Availability|0|||
19479499|NCT01687166|41759419|FG001|Overall Study|Equipment/Device Availability|1|||
19479500|NCT01687166|41759420|FG002|Overall Study|Equipment/Device Availability|0|||
19479501|NCT01687166|41759421|FG003|Overall Study|Equipment/Device Availability|0|||
19479502|NCT01687166|41759418|FG000|Overall Study|Death|1|||
19479503|NCT01687166|41759419|FG001|Overall Study|Death|1|||
19479504|NCT01687166|41759420|FG002|Overall Study|Death|0|||
19479505|NCT01687166|41759421|FG003|Overall Study|Death|0|||
19479506|NCT01687166|41759418|FG000|Overall Study|Protocol Violation|1|||
19479507|NCT01687166|41759419|FG001|Overall Study|Protocol Violation|1|||
19479508|NCT01687166|41759420|FG002|Overall Study|Protocol Violation|1|||
19479509|NCT01687166|41759421|FG003|Overall Study|Protocol Violation|0|||
19479510|NCT01687166|41759418|FG000|Overall Study|Subject moved out of state|0|||
19479511|NCT01687166|41759419|FG001|Overall Study|Subject moved out of state|1|||
19479512|NCT01687166|41759420|FG002|Overall Study|Subject moved out of state|0|||
19479513|NCT01687166|41759421|FG003|Overall Study|Subject moved out of state|0|||
19479514|NCT01687166|41759418|FG000|Overall Study|Patient unable to be compliant|1|||
19479515|NCT01687166|41759419|FG001|Overall Study|Patient unable to be compliant|0|||
19479516|NCT01687166|41759420|FG002|Overall Study|Patient unable to be compliant|0|||
19479517|NCT01687166|41759421|FG003|Overall Study|Patient unable to be compliant|0|||
19479518|NCT01687166|41759418|FG000|Overall Study|Physician choice to use different device|1|||
19479519|NCT01687166|41759419|FG001|Overall Study|Physician choice to use different device|2|||
19392183|NCT01976104|41636256|FG002|Overall Study|Adverse Event|1|||
19392184|NCT01976104|41636257|FG003|Overall Study|Adverse Event|0|||
19392185|NCT01976104|41636254|FG000|Overall Study|Lost to Follow-up|3|||
19392186|NCT01976104|41636255|FG001|Overall Study|Lost to Follow-up|0|||
19392187|NCT01976104|41636256|FG002|Overall Study|Lost to Follow-up|1|||
19392188|NCT01976104|41636257|FG003|Overall Study|Lost to Follow-up|1|||
19392189|NCT01976104|41636254|FG000|Overall Study|Subject Choice|0|||
19479520|NCT01687166|41759420|FG002|Overall Study|Physician choice to use different device|4|||
19479521|NCT01687166|41759421|FG003|Overall Study|Physician choice to use different device|0|||
19392190|NCT01976104|41636255|FG001|Overall Study|Subject Choice|1|||
19479522|NCT01687166|41759418|FG000|Overall Study|Insurance|0|||
19479523|NCT01687166|41759419|FG001|Overall Study|Insurance|0|||
19479524|NCT01687166|41759420|FG002|Overall Study|Insurance|1|||
19479525|NCT01687166|41759421|FG003|Overall Study|Insurance|1|||
19479526|NCT01561976|41759435|FG000|Period 1|Adverse Event|0|||
19479527|NCT01561976|41759436|FG001|Period 1|Adverse Event|0|||
19479528|NCT01561976|41759437|FG002|Period 1|Adverse Event|1|||
19703766|NCT00423137|42148069|FG001|Overall Study|Lost to Follow-up|0|||
19703767|NCT00423137|42148070|FG002|Overall Study|Lost to Follow-up|1|||
19392191|NCT01976104|41636256|FG002|Overall Study|Subject Choice|0|||
19392192|NCT01976104|41636257|FG003|Overall Study|Subject Choice|1|||
19479529|NCT01561976|41759438|FG003|Period 1|Adverse Event|0|||
19479530|NCT01561976|41759439|FG004|Period 1|Adverse Event|0|||
19479531|NCT01561976|41759440|FG005|Period 1|Adverse Event|0|||
19479532|NCT01561976|41759435|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
19479533|NCT01561976|41759436|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
19392193|NCT01976104|41636254|FG000|Overall Study|Withdrawal by Subject|3|||
19392194|NCT01976104|41636255|FG001|Overall Study|Withdrawal by Subject|0|||
19392195|NCT01976104|41636256|FG002|Overall Study|Withdrawal by Subject|0|||
19392196|NCT01976104|41636257|FG003|Overall Study|Withdrawal by Subject|1|||
19392197|NCT01976104|41636254|FG000|Overall Study|Other|0|||
19392198|NCT01976104|41636255|FG001|Overall Study|Other|1|||
19392199|NCT01976104|41636256|FG002|Overall Study|Other|0|||
19392200|NCT01976104|41636257|FG003|Overall Study|Other|0|||
19479534|NCT01561976|41759437|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
19479535|NCT01561976|41759438|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
19479536|NCT01561976|41759439|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
19479537|NCT01561976|41759440|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
19479538|NCT01561976|41759435|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19479539|NCT01561976|41759436|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19479540|NCT01561976|41759437|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19479541|NCT01561976|41759438|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19479542|NCT01561976|41759439|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19479543|NCT01561976|41759440|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19479544|NCT01561976|41759435|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
19479545|NCT01561976|41759436|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
19479546|NCT01561976|41759437|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
19479547|NCT01561976|41759438|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
19479548|NCT01561976|41759439|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
19479549|NCT01561976|41759440|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
19479550|NCT01686932|41759450|FG000|Period 1|Adverse Event|1|||
19479551|NCT01686932|41759451|FG001|Period 1|Adverse Event|1|||
19479552|NCT01468207|41759459|FG000|Treatment Period 1|Adverse Event|1|||
19479553|NCT01468207|41759460|FG001|Treatment Period 1|Adverse Event|0|||
19479554|NCT01468207|41759461|FG002|Treatment Period 1|Adverse Event|0|||
19479555|NCT01468207|41759462|FG003|Treatment Period 1|Adverse Event|0|||
19479556|NCT01468207|41759463|FG004|Treatment Period 1|Adverse Event|0|||
19479557|NCT01468207|41759464|FG005|Treatment Period 1|Adverse Event|0|||
19479558|NCT01468207|41759459|FG000|Treatment Period 1|Protocol Violation|1|||
19479559|NCT01468207|41759460|FG001|Treatment Period 1|Protocol Violation|1|||
19479560|NCT01468207|41759461|FG002|Treatment Period 1|Protocol Violation|0|||
19479561|NCT01468207|41759462|FG003|Treatment Period 1|Protocol Violation|0|||
19479562|NCT01468207|41759463|FG004|Treatment Period 1|Protocol Violation|0|||
19479563|NCT01468207|41759464|FG005|Treatment Period 1|Protocol Violation|0|||
19479564|NCT01468207|41759459|FG000|Treatment Period 1|Withdrawal by Subject|5|||
19479565|NCT01468207|41759460|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19479566|NCT01468207|41759461|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19479567|NCT01468207|41759462|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19479568|NCT01468207|41759463|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19479569|NCT01468207|41759464|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19479570|NCT01468207|41759459|FG000|Treatment Period 1|Lost to Follow-up|2|||
19479571|NCT01468207|41759460|FG001|Treatment Period 1|Lost to Follow-up|1|||
19479572|NCT01468207|41759461|FG002|Treatment Period 1|Lost to Follow-up|0|||
19479573|NCT01468207|41759462|FG003|Treatment Period 1|Lost to Follow-up|0|||
19479574|NCT01468207|41759463|FG004|Treatment Period 1|Lost to Follow-up|0|||
19479575|NCT01468207|41759464|FG005|Treatment Period 1|Lost to Follow-up|0|||
19479576|NCT01468207|41759459|FG000|Treatment Period 1|Other|0|||
19479577|NCT01468207|41759460|FG001|Treatment Period 1|Other|2|||
19479578|NCT01468207|41759461|FG002|Treatment Period 1|Other|0|||
19479579|NCT01468207|41759462|FG003|Treatment Period 1|Other|0|||
19479580|NCT01468207|41759463|FG004|Treatment Period 1|Other|0|||
19611686|NCT00831441|42060461|FG001|Randomized|Emergency procedure|2|||
19611687|NCT00831441|42060460|FG000|Randomized|Elective procedure|26|||
19392201|NCT01372501|41636268|FG000|Overall Study|Adverse Event|4|||
19392202|NCT01372501|41636268|FG000|Overall Study|Device migration|1|||
19479581|NCT01468207|41759464|FG005|Treatment Period 1|Other|0|||
19479582|NCT01468207|41759459|FG000|Treatment Period 2|Adverse Event|0|||
19479583|NCT01468207|41759460|FG001|Treatment Period 2|Adverse Event|0|||
19479584|NCT01468207|41759461|FG002|Treatment Period 2|Adverse Event|6|||
19479585|NCT01468207|41759462|FG003|Treatment Period 2|Adverse Event|1|||
19479586|NCT01468207|41759463|FG004|Treatment Period 2|Adverse Event|2|||
19479587|NCT01468207|41759464|FG005|Treatment Period 2|Adverse Event|1|||
19479588|NCT01468207|41759459|FG000|Treatment Period 2|Lack of Efficacy|0|||
19479589|NCT01468207|41759460|FG001|Treatment Period 2|Lack of Efficacy|0|||
19479590|NCT01468207|41759461|FG002|Treatment Period 2|Lack of Efficacy|1|||
19479591|NCT01468207|41759462|FG003|Treatment Period 2|Lack of Efficacy|1|||
19479592|NCT01468207|41759463|FG004|Treatment Period 2|Lack of Efficacy|0|||
19479593|NCT01468207|41759464|FG005|Treatment Period 2|Lack of Efficacy|2|||
19479594|NCT01468207|41759459|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19479595|NCT01468207|41759460|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19479596|NCT01468207|41759461|FG002|Treatment Period 2|Withdrawal by Subject|5|||
19479597|NCT01468207|41759462|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19479598|NCT01468207|41759463|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19479599|NCT01468207|41759464|FG005|Treatment Period 2|Withdrawal by Subject|2|||
19479600|NCT01468207|41759459|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
19479601|NCT01468207|41759460|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
19479602|NCT01468207|41759461|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
19479603|NCT01468207|41759462|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
19479604|NCT01468207|41759463|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
19479605|NCT01468207|41759464|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
19479606|NCT01468207|41759459|FG000|Treatment Period 2|Lost to Follow-up|0|||
19479607|NCT01468207|41759460|FG001|Treatment Period 2|Lost to Follow-up|0|||
19479608|NCT01468207|41759461|FG002|Treatment Period 2|Lost to Follow-up|5|||
19479609|NCT01468207|41759462|FG003|Treatment Period 2|Lost to Follow-up|1|||
19479610|NCT01468207|41759463|FG004|Treatment Period 2|Lost to Follow-up|0|||
19479611|NCT01468207|41759464|FG005|Treatment Period 2|Lost to Follow-up|0|||
19479612|NCT01468207|41759459|FG000|Treatment Period 2|Other|0|||
19479613|NCT01468207|41759460|FG001|Treatment Period 2|Other|0|||
19479614|NCT01468207|41759461|FG002|Treatment Period 2|Other|5|||
19479615|NCT01468207|41759462|FG003|Treatment Period 2|Other|1|||
19392203|NCT01958008|41636277|FG000|Overall Study|Worsening of disease under study|0|||
19392204|NCT01958008|41636278|FG001|Overall Study|Worsening of disease under study|0|||
19392205|NCT01958008|41636279|FG002|Overall Study|Worsening of disease under study|1|||
19392206|NCT01958008|41636280|FG003|Overall Study|Worsening of disease under study|0|||
19392207|NCT01958008|41636277|FG000|Overall Study|Other adverse event|1|||
19392208|NCT01958008|41636278|FG001|Overall Study|Other adverse event|0|||
19392209|NCT01958008|41636279|FG002|Overall Study|Other adverse event|0|||
19392210|NCT01958008|41636280|FG003|Overall Study|Other adverse event|0|||
19392211|NCT01998880|41636308|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
19479616|NCT01468207|41759463|FG004|Treatment Period 2|Other|1|||
19479617|NCT01468207|41759464|FG005|Treatment Period 2|Other|2|||
19479618|NCT01494649|41759484|FG000|Overall Study|Lost to Follow-up|0|||
19479619|NCT01494649|41759485|FG001|Overall Study|Lost to Follow-up|1|||
19479620|NCT01686152|41759496|FG000|Overall Study|Withdrawal by Subject|11|||
19479621|NCT01686152|41759497|FG001|Overall Study|Withdrawal by Subject|11|||
19479622|NCT01686152|41759498|FG002|Overall Study|Withdrawal by Subject|3|||
19479623|NCT01686152|41759496|FG000|Overall Study|Drug Code Unblinded|0|||
19479624|NCT01686152|41759497|FG001|Overall Study|Drug Code Unblinded|1|||
19392212|NCT01998880|41636309|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
19479625|NCT01686152|41759498|FG002|Overall Study|Drug Code Unblinded|0|||
19479626|NCT01686152|41759496|FG000|Overall Study|Protocol Violation|6|||
19479627|NCT01686152|41759497|FG001|Overall Study|Protocol Violation|1|||
19479628|NCT01686152|41759498|FG002|Overall Study|Protocol Violation|0|||
19479629|NCT01686152|41759496|FG000|Overall Study|Adverse Event|12|||
19479630|NCT01686152|41759497|FG001|Overall Study|Adverse Event|11|||
19479631|NCT01686152|41759498|FG002|Overall Study|Adverse Event|0|||
19479632|NCT01686152|41759496|FG000|Overall Study|Lack of Efficacy|0|||
19479633|NCT01686152|41759497|FG001|Overall Study|Lack of Efficacy|0|||
19479634|NCT01686152|41759498|FG002|Overall Study|Lack of Efficacy|1|||
19479635|NCT01686152|41759496|FG000|Overall Study|IP Non-compliance|5|||
19611688|NCT00831441|42060461|FG001|Randomized|Elective procedure|25|||
19479636|NCT01686152|41759497|FG001|Overall Study|IP Non-compliance|5|||
19479637|NCT01686152|41759498|FG002|Overall Study|IP Non-compliance|0|||
19479638|NCT01686152|41759496|FG000|Overall Study|Lost to Follow-up|7|||
19479639|NCT01686152|41759497|FG001|Overall Study|Lost to Follow-up|6|||
19611689|NCT00831441|42060460|FG000|Randomized|Physician Decision|26|||
19479640|NCT01686152|41759498|FG002|Overall Study|Lost to Follow-up|5|||
19479641|NCT01452919|41759506|FG000|Open-Label Treatment|Adverse Event|5|||
19479642|NCT01452919|41759507|FG001|Open-Label Treatment|Adverse Event|0|||
19479643|NCT01452919|41759508|FG002|Open-Label Treatment|Adverse Event|0|||
19479644|NCT01452919|41759506|FG000|Open-Label Treatment|Lost to Follow-up|4|||
19611690|NCT00831441|42060461|FG001|Randomized|Physician Decision|35|||
19479645|NCT01452919|41759507|FG001|Open-Label Treatment|Lost to Follow-up|0|||
19479646|NCT01452919|41759508|FG002|Open-Label Treatment|Lost to Follow-up|0|||
19392213|NCT01998880|41636308|FG000|Overall Study|Disease Progression|1|||
19479647|NCT01452919|41759506|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
19479648|NCT01452919|41759507|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
19479649|NCT01452919|41759508|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
19479650|NCT01452919|41759506|FG000|Open-Label Treatment|Protocol Violation|4|||
19479651|NCT01452919|41759507|FG001|Open-Label Treatment|Protocol Violation|0|||
19479652|NCT01452919|41759508|FG002|Open-Label Treatment|Protocol Violation|0|||
19479653|NCT01452919|41759506|FG000|Open-Label Treatment|Sponsor Decision|1|||
19479654|NCT01452919|41759507|FG001|Open-Label Treatment|Sponsor Decision|0|||
19479655|NCT01452919|41759508|FG002|Open-Label Treatment|Sponsor Decision|0|||
19479656|NCT01452919|41759506|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
19479657|NCT01452919|41759507|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
19479658|NCT01452919|41759508|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
19479659|NCT01452919|41759506|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
19479660|NCT01452919|41759507|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
19479661|NCT01452919|41759508|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
19479662|NCT01452919|41759506|FG000|Randomization Treatment|Adverse Event|0|||
19479663|NCT01452919|41759507|FG001|Randomization Treatment|Adverse Event|0|||
19703768|NCT00423137|42148071|FG003|Overall Study|Lost to Follow-up|0|||
19703769|NCT00423137|42148068|FG000|Overall Study|Protocol Violation|0|||
19703770|NCT00423137|42148069|FG001|Overall Study|Protocol Violation|0|||
19703771|NCT00423137|42148070|FG002|Overall Study|Protocol Violation|0|||
19703772|NCT00423137|42148071|FG003|Overall Study|Protocol Violation|1|||
19703773|NCT00423137|42148068|FG000|Overall Study|Adverse Event Study disease worse|1|||
19703774|NCT00423137|42148069|FG001|Overall Study|Adverse Event Study disease worse|0|||
19703775|NCT00423137|42148070|FG002|Overall Study|Adverse Event Study disease worse|3|||
19703776|NCT00423137|42148071|FG003|Overall Study|Adverse Event Study disease worse|1|||
19703777|NCT00423137|42148068|FG000|Overall Study|Adverse Event Other|0|||
19703778|NCT00423137|42148069|FG001|Overall Study|Adverse Event Other|0|||
19703779|NCT00423137|42148070|FG002|Overall Study|Adverse Event Other|2|||
19703780|NCT00423137|42148071|FG003|Overall Study|Adverse Event Other|0|||
19479664|NCT01452919|41759508|FG002|Randomization Treatment|Adverse Event|2|||
19479665|NCT01452919|41759506|FG000|Randomization Treatment|Sponsor Decision|0|||
19479666|NCT01452919|41759507|FG001|Randomization Treatment|Sponsor Decision|1|||
19479667|NCT01452919|41759508|FG002|Randomization Treatment|Sponsor Decision|0|||
19479668|NCT01452919|41759506|FG000|Randomization Treatment|Withdrawal by Subject|0|||
19479669|NCT01452919|41759507|FG001|Randomization Treatment|Withdrawal by Subject|1|||
19479670|NCT01452919|41759508|FG002|Randomization Treatment|Withdrawal by Subject|0|||
19479671|NCT01452919|41759506|FG000|Randomization Treatment|Subject is moving or has moved|0|||
19479672|NCT01452919|41759507|FG001|Randomization Treatment|Subject is moving or has moved|1|||
19479673|NCT01452919|41759508|FG002|Randomization Treatment|Subject is moving or has moved|0|||
19479674|NCT01582178|41759520|FG000|Overall Study|Physician Decision|6|||
19479675|NCT01582178|41759521|FG001|Overall Study|Physician Decision|5|||
19479676|NCT01561898|41759531|FG000|Overall Study|Withdrawal by Subject|0|||
19479677|NCT01561898|41759532|FG001|Overall Study|Withdrawal by Subject|8|||
19479678|NCT01561898|41759533|FG002|Overall Study|Withdrawal by Subject|12|||
19479679|NCT01561898|41759534|FG003|Overall Study|Withdrawal by Subject|5|||
19479680|NCT01561898|41759531|FG000|Overall Study|Lack of Efficacy|0|||
19479681|NCT01561898|41759532|FG001|Overall Study|Lack of Efficacy|8|||
19479682|NCT01561898|41759533|FG002|Overall Study|Lack of Efficacy|10|||
19479683|NCT01561898|41759534|FG003|Overall Study|Lack of Efficacy|5|||
19479684|NCT01561898|41759531|FG000|Overall Study|Worsening of complications|0|||
19479685|NCT01561898|41759532|FG001|Overall Study|Worsening of complications|1|||
19479686|NCT01561898|41759533|FG002|Overall Study|Worsening of complications|0|||
19479687|NCT01561898|41759534|FG003|Overall Study|Worsening of complications|0|||
19479688|NCT01561898|41759531|FG000|Overall Study|Lost to Follow-up|0|||
19479689|NCT01561898|41759532|FG001|Overall Study|Lost to Follow-up|0|||
19479690|NCT01561898|41759533|FG002|Overall Study|Lost to Follow-up|1|||
19479691|NCT01561898|41759534|FG003|Overall Study|Lost to Follow-up|0|||
19479692|NCT01561898|41759531|FG000|Overall Study|Adverse Event|1|||
19479693|NCT01561898|41759532|FG001|Overall Study|Adverse Event|19|||
19479694|NCT01561898|41759533|FG002|Overall Study|Adverse Event|14|||
19479695|NCT01561898|41759534|FG003|Overall Study|Adverse Event|9|||
19611691|NCT00831441|42060460|FG000|Randomized|No longer met criteria|13|||
19611692|NCT00831441|42060461|FG001|Randomized|No longer met criteria|19|||
19703781|NCT00422903|42148086|FG000|Overall Study|Disease Progression|3|||
19703782|NCT00422903|42148087|FG001|Overall Study|Disease Progression|1|||
19703783|NCT00422903|42148086|FG000|Overall Study|Adverse Event|0|||
19703784|NCT00422903|42148087|FG001|Overall Study|Adverse Event|2|||
19479696|NCT01561898|41759531|FG000|Overall Study|Physician Decision|1|||
19479697|NCT01561898|41759532|FG001|Overall Study|Physician Decision|5|||
19479698|NCT01561898|41759533|FG002|Overall Study|Physician Decision|7|||
19479699|NCT01561898|41759534|FG003|Overall Study|Physician Decision|1|||
19703785|NCT00422903|42148086|FG000|Overall Study|Informed Consent Withdrawn|1|||
19703786|NCT00422903|42148087|FG001|Overall Study|Informed Consent Withdrawn|2|||
19703787|NCT00422669|42148096|FG000|Overall Study|The study was terminated early.|98|||
19479700|NCT01685840|41759544|FG000|Overall Study|Death|77|||
19479701|NCT01685840|41759545|FG001|Overall Study|Death|66|||
19479702|NCT01685840|41759544|FG000|Overall Study|Lost to Follow-up|27|||
19479703|NCT01685840|41759545|FG001|Overall Study|Lost to Follow-up|25|||
19479704|NCT01685840|41759544|FG000|Overall Study|Physician Decision|3|||
19479705|NCT01685840|41759545|FG001|Overall Study|Physician Decision|7|||
19479706|NCT01685840|41759544|FG000|Overall Study|Withdrawal by Subject|14|||
19479707|NCT01685840|41759545|FG001|Overall Study|Withdrawal by Subject|17|||
19479708|NCT01685840|41759544|FG000|Overall Study|Futility|197|||
19479709|NCT01685840|41759545|FG001|Overall Study|Futility|200|||
19479710|NCT01685840|41759544|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
19479711|NCT01685840|41759545|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
19479712|NCT01452529|41759555|FG000|Run-in Period|Adverse Event|96|||
19479713|NCT01452529|41759556|FG001|Run-in Period|Adverse Event|0|||
19479714|NCT01452529|41759557|FG002|Run-in Period|Adverse Event|0|||
19479715|NCT01452529|41759555|FG000|Run-in Period|Withdrawal by Subject|49|||
19479716|NCT01452529|41759556|FG001|Run-in Period|Withdrawal by Subject|0|||
19479717|NCT01452529|41759557|FG002|Run-in Period|Withdrawal by Subject|0|||
19479718|NCT01452529|41759555|FG000|Run-in Period|Lost to Follow-up|19|||
19479719|NCT01452529|41759556|FG001|Run-in Period|Lost to Follow-up|0|||
19479720|NCT01452529|41759557|FG002|Run-in Period|Lost to Follow-up|0|||
19479721|NCT01452529|41759555|FG000|Run-in Period|Lack of Efficacy|46|||
19479722|NCT01452529|41759556|FG001|Run-in Period|Lack of Efficacy|0|||
19479723|NCT01452529|41759557|FG002|Run-in Period|Lack of Efficacy|0|||
19479724|NCT01452529|41759555|FG000|Run-in Period|Confirmed or suspected diversion|23|||
19479725|NCT01452529|41759556|FG001|Run-in Period|Confirmed or suspected diversion|0|||
19479726|NCT01452529|41759557|FG002|Run-in Period|Confirmed or suspected diversion|0|||
19479727|NCT01452529|41759555|FG000|Run-in Period|Administrative|21|||
19479728|NCT01452529|41759556|FG001|Run-in Period|Administrative|0|||
19479729|NCT01452529|41759557|FG002|Run-in Period|Administrative|0|||
19479730|NCT01452529|41759555|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
19479731|NCT01452529|41759556|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
19479732|NCT01452529|41759557|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
19479733|NCT01452529|41759555|FG000|Double-blind (DB) Period|Adverse Event|0|||
19479734|NCT01452529|41759556|FG001|Double-blind (DB) Period|Adverse Event|18|||
19479735|NCT01452529|41759557|FG002|Double-blind (DB) Period|Adverse Event|11|||
19479736|NCT01452529|41759555|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
19479737|NCT01452529|41759556|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
19479738|NCT01452529|41759557|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
19479739|NCT01452529|41759555|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
19479740|NCT01452529|41759556|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
19479741|NCT01452529|41759557|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
19479742|NCT01452529|41759555|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
19479743|NCT01452529|41759556|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
19479744|NCT01452529|41759557|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
19479745|NCT01452529|41759555|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
19479746|NCT01452529|41759556|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
19479747|NCT01452529|41759557|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
19479748|NCT01452529|41759555|FG000|Double-blind (DB) Period|Administrative|0|||
19479749|NCT01452529|41759556|FG001|Double-blind (DB) Period|Administrative|11|||
19479750|NCT01452529|41759557|FG002|Double-blind (DB) Period|Administrative|7|||
19479751|NCT01560416|41759566|FG000|Randomized Phase|Crossover Participants|7|||
19479752|NCT01560416|41759567|FG001|Randomized Phase|Crossover Participants|0|||
19479753|NCT01685606|41759575|FG000|Overall Study|Withdrawal by Subject|1|||
19479754|NCT01685372|41759581|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
19479755|NCT01685372|41759582|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
19479756|NCT01685216|41759588|FG000|Overall Study|Did not receive study drug|1|||
19479757|NCT01685138|41759592|FG000|Overall Study|Lost to Follow-up|1|||
19479758|NCT01685138|41759592|FG000|Overall Study|Protocol Violation|1|||
19479759|NCT01685138|41759592|FG000|Overall Study|No longer requires treatment|1|||
19479760|NCT01685138|41759592|FG000|Overall Study|Subject/guardian decision|2|||
19479761|NCT01685138|41759592|FG000|Overall Study|Physician Decision|6|||
19479762|NCT01685138|41759592|FG000|Overall Study|Death|10|||
19479763|NCT01685138|41759592|FG000|Overall Study|Adverse Event|18|||
19479764|NCT01685138|41759592|FG000|Overall Study|Progressive disease|53|||
19479765|NCT01685060|41759596|FG000|Overall Study|Rollover patients|16|||
19479766|NCT01685060|41759596|FG000|Overall Study|Adverse Event|12|||
19479767|NCT01685060|41759596|FG000|Overall Study|Progressive disease|69|||
19479768|NCT01685060|41759596|FG000|Overall Study|Physician Decision|14|||
19479769|NCT01685060|41759596|FG000|Overall Study|Subject/guardian decision|20|||
19479770|NCT01685060|41759596|FG000|Overall Study|Lost to Follow-up|1|||
19479771|NCT01685060|41759596|FG000|Overall Study|Death|8|||
19479772|NCT01582100|41759600|FG000|Overall Study|Adverse Event|1|||
19479773|NCT01582100|41759600|FG000|Overall Study|Withdrawal by Subject|1|||
19479774|NCT01579916|41759606|FG000|Overall Study|Lost to Follow-up|6|||
19479775|NCT01579916|41759607|FG001|Overall Study|Lost to Follow-up|1|||
19479776|NCT01579916|41759606|FG000|Overall Study|Withdrawal by Subject|1|||
19479777|NCT01579916|41759607|FG001|Overall Study|Withdrawal by Subject|1|||
19479778|NCT01579916|41759606|FG000|Overall Study|Death|1|||
19479779|NCT01579916|41759607|FG001|Overall Study|Death|0|||
19479780|NCT01684202|41759617|FG000|Dose-escalation Period|Adverse Event|0|||
19479781|NCT01684202|41759618|FG001|Dose-escalation Period|Adverse Event|1|||
19479782|NCT01684202|41759619|FG002|Dose-escalation Period|Adverse Event|0|||
19479783|NCT01684202|41759620|FG003|Dose-escalation Period|Adverse Event|0|||
19479784|NCT01684202|41759617|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
19479785|NCT01684202|41759618|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
19479786|NCT01684202|41759619|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
19479787|NCT01684202|41759620|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
19479788|NCT01684202|41759617|FG000|Maintenance Period|Adverse Event|1|||
19479789|NCT01684202|41759618|FG001|Maintenance Period|Adverse Event|1|||
19479790|NCT01684202|41759619|FG002|Maintenance Period|Adverse Event|1|||
19479791|NCT01684202|41759620|FG003|Maintenance Period|Adverse Event|1|||
19479792|NCT01684202|41759617|FG000|Maintenance Period|Physician Decision|0|||
19479793|NCT01684202|41759618|FG001|Maintenance Period|Physician Decision|1|||
19479794|NCT01684202|41759619|FG002|Maintenance Period|Physician Decision|0|||
19479795|NCT01684202|41759620|FG003|Maintenance Period|Physician Decision|0|||
19479796|NCT01684202|41759617|FG000|Maintenance Period|Withdrawal by Subject|0|||
19479797|NCT01684202|41759618|FG001|Maintenance Period|Withdrawal by Subject|1|||
19479798|NCT01684202|41759619|FG002|Maintenance Period|Withdrawal by Subject|0|||
19479799|NCT01684202|41759620|FG003|Maintenance Period|Withdrawal by Subject|0|||
19479800|NCT01684046|41759630|FG000|Period 1, First 30 Days|Adverse Event|0|||
19479801|NCT01684046|41759631|FG001|Period 1, First 30 Days|Adverse Event|2|||
19479802|NCT01559090|41759640|FG000|Stage I|Withdrawal by Subject|2|||
19479803|NCT01559090|41759641|FG001|Stage I|Withdrawal by Subject|2|||
19479804|NCT01559090|41759642|FG002|Stage I|Withdrawal by Subject|3|||
19479805|NCT01559090|41759640|FG000|Stage II|Withdrawal by Subject|1|||
19479806|NCT01559090|41759641|FG001|Stage II|Withdrawal by Subject|0|||
19479807|NCT01559090|41759642|FG002|Stage II|Withdrawal by Subject|0|||
19479808|NCT01683266|41759652|FG000|Overall Study|Adverse Event|5|||
19479809|NCT01683266|41759653|FG001|Overall Study|Adverse Event|4|||
19479810|NCT01683266|41759652|FG000|Overall Study|Lack of Efficacy|5|||
19479811|NCT01683266|41759653|FG001|Overall Study|Lack of Efficacy|2|||
19479812|NCT01683266|41759652|FG000|Overall Study|Protocol Violation|13|||
19479813|NCT01683266|41759653|FG001|Overall Study|Protocol Violation|6|||
19479814|NCT01683266|41759652|FG000|Overall Study|Personal Reason|17|||
19479815|NCT01683266|41759653|FG001|Overall Study|Personal Reason|25|||
19479816|NCT01683266|41759652|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
19479817|NCT01683266|41759653|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
19479818|NCT01683266|41759652|FG000|Overall Study|Lost to Follow-up|5|||
19479819|NCT01683266|41759653|FG001|Overall Study|Lost to Follow-up|0|||
19479820|NCT01683266|41759652|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
19479821|NCT01683266|41759653|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
19479822|NCT01683266|41759652|FG000|Overall Study|Nonserious Hypoglycemia|0|||
19479823|NCT01683266|41759653|FG001|Overall Study|Nonserious Hypoglycemia|3|||
19479824|NCT01683266|41759652|FG000|Overall Study|Perceived Lack of Efficacy|1|||
19479825|NCT01683266|41759653|FG001|Overall Study|Perceived Lack of Efficacy|1|||
19479826|NCT01683266|41759652|FG000|Overall Study|Possibly Hypoglycemia|1|||
19479827|NCT01683266|41759653|FG001|Overall Study|Possibly Hypoglycemia|0|||
19479828|NCT01683266|41759652|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
19479829|NCT01683266|41759653|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
19479830|NCT01467661|41759659|FG000|Overall Study|Adverse Event|16|||
19479831|NCT01467661|41759659|FG000|Overall Study|Withdrawal by Subject|1|||
19479832|NCT01467661|41759659|FG000|Overall Study|Lack of Efficacy|3|||
19479833|NCT01467661|41759659|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
19479834|NCT01577186|41759665|FG000|Overall Study|Adverse Event|23|||
19479835|NCT01577186|41759665|FG000|Overall Study|Death|1|||
19611693|NCT00831441|42060460|FG000|Randomized|Withdrawal by Subject|178|||
19611694|NCT00831441|42060461|FG001|Randomized|Withdrawal by Subject|212|||
19611695|NCT00831441|42060460|FG000|Randomized|Lost to Follow-up|26|||
19611696|NCT00831441|42060461|FG001|Randomized|Lost to Follow-up|35|||
19611697|NCT00831441|42060460|FG000|Randomized|Administrative reason by sponsor|2780|||
19611698|NCT00831441|42060461|FG001|Randomized|Administrative reason by sponsor|2671|||
19611699|NCT00831441|42060460|FG000|Randomized|poor/non-compliance|30|||
19611700|NCT00831441|42060461|FG001|Randomized|poor/non-compliance|38|||
19479836|NCT01577186|41759665|FG000|Overall Study|Lost to Follow-up|28|||
19479837|NCT01577186|41759665|FG000|Overall Study|Withdrawal by Subject|35|||
19479838|NCT01577186|41759665|FG000|Overall Study|Insufficient Response|18|||
19479839|NCT01577186|41759665|FG000|Overall Study|Ineligible to Continue|15|||
19479840|NCT01577186|41759665|FG000|Overall Study|Non-Compliant|8|||
19479841|NCT01577186|41759665|FG000|Overall Study|Other|2|||
19479842|NCT01559012|41759671|FG000|Overall Study|Withdrawal by Subject|0|||
19479843|NCT01559012|41759672|FG001|Overall Study|Withdrawal by Subject|1|||
19611701|NCT00831441|42060460|FG000|Randomized|non-specified|276|||
19479844|NCT01451827|41759697|FG000|Overall Study|Adverse Event|2|||
19479845|NCT01451827|41759698|FG001|Overall Study|Adverse Event|0|||
19479846|NCT01451827|41759699|FG002|Overall Study|Adverse Event|1|||
19479847|NCT01451827|41759700|FG003|Overall Study|Adverse Event|1|||
19479848|NCT01451827|41759697|FG000|Overall Study|Protocol deviation|1|||
19479849|NCT01451827|41759698|FG001|Overall Study|Protocol deviation|0|||
19479850|NCT01451827|41759699|FG002|Overall Study|Protocol deviation|0|||
19479851|NCT01451827|41759700|FG003|Overall Study|Protocol deviation|0|||
19479852|NCT01451827|41759697|FG000|Overall Study|Lost to Follow-up|0|||
19479853|NCT01451827|41759698|FG001|Overall Study|Lost to Follow-up|3|||
19479854|NCT01451827|41759699|FG002|Overall Study|Lost to Follow-up|0|||
19479855|NCT01451827|41759700|FG003|Overall Study|Lost to Follow-up|2|||
19479856|NCT01451827|41759697|FG000|Overall Study|Participant met withdrawal criteria|0|||
19479857|NCT01451827|41759698|FG001|Overall Study|Participant met withdrawal criteria|2|||
19479858|NCT01451827|41759699|FG002|Overall Study|Participant met withdrawal criteria|0|||
19479859|NCT01451827|41759700|FG003|Overall Study|Participant met withdrawal criteria|0|||
19479860|NCT01451827|41759697|FG000|Overall Study|Withdrawal by Subject|0|||
19479861|NCT01451827|41759698|FG001|Overall Study|Withdrawal by Subject|0|||
19479862|NCT01451827|41759699|FG002|Overall Study|Withdrawal by Subject|1|||
19479863|NCT01451827|41759700|FG003|Overall Study|Withdrawal by Subject|1|||
19479864|NCT01557920|41759710|FG000|Overall Study|Withdrawal by Subject|2|||
19479865|NCT01557920|41759711|FG001|Overall Study|Withdrawal by Subject|3|||
19479866|NCT01557920|41759710|FG000|Overall Study|Lack of Efficacy|1|||
19392214|NCT01998880|41636309|FG001|Overall Study|Disease Progression|8|||
19392215|NCT01998880|41636308|FG000|Overall Study|Withdrew Consent|2|||
19392216|NCT01998880|41636309|FG001|Overall Study|Withdrew Consent|1|||
19392217|NCT01998880|41636308|FG000|Overall Study|Death|3|||
19479867|NCT01557920|41759711|FG001|Overall Study|Lack of Efficacy|0|||
19479868|NCT01467583|41759747|FG000|Overall Study|Death|1|||
19392218|NCT01998880|41636309|FG001|Overall Study|Death|6|||
19479869|NCT01467583|41759748|FG001|Overall Study|Death|1|||
19479870|NCT01467583|41759749|FG002|Overall Study|Death|0|||
19479871|NCT01467583|41759747|FG000|Overall Study|Withdrawal by Subject|1|||
19479872|NCT01467583|41759748|FG001|Overall Study|Withdrawal by Subject|0|||
19479873|NCT01467583|41759749|FG002|Overall Study|Withdrawal by Subject|0|||
19479874|NCT01467583|41759747|FG000|Overall Study|Protocol Violation|0|||
19479875|NCT01467583|41759748|FG001|Overall Study|Protocol Violation|0|||
19479876|NCT01467583|41759749|FG002|Overall Study|Protocol Violation|2|||
19479877|NCT01576718|41759766|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
19479878|NCT01576718|41759767|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19392219|NCT01998880|41636308|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19392220|NCT01998880|41636309|FG001|Overall Study|Insufficient Therapeutic Response|5|||
19479879|NCT01576718|41759768|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19479880|NCT01576718|41759769|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19479881|NCT01576718|41759770|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19479882|NCT01576718|41759771|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19479883|NCT01576718|41759772|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19479884|NCT01576718|41759766|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
19479885|NCT01576718|41759767|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479886|NCT01576718|41759768|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479887|NCT01576718|41759769|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479888|NCT01576718|41759770|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479889|NCT01576718|41759771|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479890|NCT01576718|41759772|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19479891|NCT01576718|41759766|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
19479892|NCT01576718|41759767|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19479893|NCT01576718|41759768|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19479894|NCT01576718|41759769|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19479895|NCT01576718|41759770|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19479896|NCT01576718|41759771|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19479897|NCT01576718|41759772|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19392221|NCT01998880|41636308|FG000|Overall Study|Administrative/Other|1|||
19392222|NCT01998880|41636309|FG001|Overall Study|Administrative/Other|1|||
19392223|NCT01998880|41636308|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
19392224|NCT01998880|41636309|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
19392225|NCT01998880|41636308|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
19392226|NCT01998880|41636309|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19392227|NCT01998880|41636308|FG000|Overall Study|Did Not Receive Treatment|3|||
19392228|NCT01998880|41636309|FG001|Overall Study|Did Not Receive Treatment|2|||
19392229|NCT01975948|41636319|FG000|Overall Study|Withdrawal by Subject|17|||
19479898|NCT01576718|41759766|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
19479899|NCT01576718|41759767|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479900|NCT01576718|41759768|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479901|NCT01576718|41759769|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479902|NCT01576718|41759770|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479903|NCT01576718|41759771|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479904|NCT01576718|41759772|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19479905|NCT01576718|41759766|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
19479906|NCT01576718|41759767|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19611702|NCT00831441|42060461|FG001|Randomized|non-specified|266|||
19611703|NCT00831441|42060460|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
19611704|NCT00831441|42060461|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
19611705|NCT00831441|42060460|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
19611706|NCT00831441|42060461|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
19611707|NCT00831441|42060460|FG000|Follow Up (30 Days)|Death|63|||
19611708|NCT00831441|42060461|FG001|Follow Up (30 Days)|Death|86|||
19703788|NCT00422669|42148097|FG001|Overall Study|The study was terminated early.|100|||
19703789|NCT00422669|42148098|FG002|Overall Study|The study was terminated early.|7|||
19703790|NCT00422591|42148104|FG000|Overall Study|Physician Decision|4|||
19703791|NCT00422591|42148104|FG000|Overall Study|Withdrawal by Subject|2|||
19703792|NCT00422513|42148110|FG000|Overall Study|Lack of Efficacy|4|||
19703793|NCT00422513|42148111|FG001|Overall Study|Lack of Efficacy|5|||
19703794|NCT00422513|42148110|FG000|Overall Study|Protocol Violation|23|||
19392230|NCT01975948|41636320|FG001|Overall Study|Withdrawal by Subject|21|||
19392231|NCT01975948|41636321|FG002|Overall Study|Withdrawal by Subject|7|||
19373647|NCT02760407|41614836|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
19373648|NCT02760407|41614833|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
19373649|NCT02760407|41614834|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
19373650|NCT02760407|41614835|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
19392232|NCT01975948|41636322|FG003|Overall Study|Withdrawal by Subject|6|||
19392233|NCT01975246|41636334|FG000|Overall Study|Adverse Event|2|||
19392234|NCT01975246|41636335|FG001|Overall Study|Adverse Event|1|||
19392235|NCT01975246|41636334|FG000|Overall Study|Lack of Efficacy|1|||
19703795|NCT00422513|42148111|FG001|Overall Study|Protocol Violation|7|||
19373651|NCT02760407|41614836|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
19373652|NCT02760407|41614833|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
19392236|NCT01975246|41636335|FG001|Overall Study|Lack of Efficacy|0|||
19479907|NCT01576718|41759768|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19479908|NCT01576718|41759769|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19479909|NCT01576718|41759770|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19479910|NCT01576718|41759771|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19479911|NCT01576718|41759772|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19479912|NCT01576718|41759766|FG000|Treatment Period|Adverse Event|0|||
19479913|NCT01576718|41759767|FG001|Treatment Period|Adverse Event|1|||
19479914|NCT01576718|41759768|FG002|Treatment Period|Adverse Event|1|||
19479915|NCT01576718|41759769|FG003|Treatment Period|Adverse Event|1|||
19479916|NCT01576718|41759770|FG004|Treatment Period|Adverse Event|1|||
19479917|NCT01576718|41759771|FG005|Treatment Period|Adverse Event|1|||
19479918|NCT01576718|41759772|FG006|Treatment Period|Adverse Event|0|||
19479919|NCT01576718|41759766|FG000|Treatment Period|Withdrawal by Subject|0|||
19479920|NCT01576718|41759767|FG001|Treatment Period|Withdrawal by Subject|1|||
19479921|NCT01576718|41759768|FG002|Treatment Period|Withdrawal by Subject|1|||
19479922|NCT01576718|41759769|FG003|Treatment Period|Withdrawal by Subject|0|||
19479923|NCT01576718|41759770|FG004|Treatment Period|Withdrawal by Subject|2|||
19479924|NCT01576718|41759771|FG005|Treatment Period|Withdrawal by Subject|4|||
19479925|NCT01576718|41759772|FG006|Treatment Period|Withdrawal by Subject|2|||
19479926|NCT01576718|41759766|FG000|Treatment Period|Physician Decision|0|||
19479927|NCT01576718|41759767|FG001|Treatment Period|Physician Decision|1|||
19479928|NCT01576718|41759768|FG002|Treatment Period|Physician Decision|1|||
19479929|NCT01576718|41759769|FG003|Treatment Period|Physician Decision|1|||
19479930|NCT01576718|41759770|FG004|Treatment Period|Physician Decision|1|||
19479931|NCT01576718|41759771|FG005|Treatment Period|Physician Decision|0|||
19479932|NCT01576718|41759772|FG006|Treatment Period|Physician Decision|0|||
19479933|NCT01576718|41759766|FG000|Treatment Period|Protocol Violation|0|||
19479934|NCT01576718|41759767|FG001|Treatment Period|Protocol Violation|5|||
19479935|NCT01576718|41759768|FG002|Treatment Period|Protocol Violation|4|||
19479936|NCT01576718|41759769|FG003|Treatment Period|Protocol Violation|10|||
19479937|NCT01576718|41759770|FG004|Treatment Period|Protocol Violation|6|||
19479938|NCT01576718|41759771|FG005|Treatment Period|Protocol Violation|8|||
19479939|NCT01576718|41759772|FG006|Treatment Period|Protocol Violation|12|||
19479940|NCT01576718|41759766|FG000|Treatment Period|Sponsor request|0|||
19479941|NCT01576718|41759767|FG001|Treatment Period|Sponsor request|1|||
19479942|NCT01576718|41759768|FG002|Treatment Period|Sponsor request|0|||
19479943|NCT01576718|41759769|FG003|Treatment Period|Sponsor request|0|||
19479944|NCT01576718|41759770|FG004|Treatment Period|Sponsor request|0|||
19479945|NCT01576718|41759771|FG005|Treatment Period|Sponsor request|1|||
19479946|NCT01576718|41759772|FG006|Treatment Period|Sponsor request|0|||
19479947|NCT01576718|41759766|FG000|Treatment Period|Met stopping criteria|0|||
19479948|NCT01576718|41759767|FG001|Treatment Period|Met stopping criteria|16|||
19479949|NCT01576718|41759768|FG002|Treatment Period|Met stopping criteria|13|||
19479950|NCT01576718|41759769|FG003|Treatment Period|Met stopping criteria|19|||
19479951|NCT01576718|41759770|FG004|Treatment Period|Met stopping criteria|16|||
19479952|NCT01576718|41759771|FG005|Treatment Period|Met stopping criteria|33|||
19479953|NCT01576718|41759772|FG006|Treatment Period|Met stopping criteria|15|||
19479954|NCT01576718|41759766|FG000|Treatment Period|Lost to Follow-up|0|||
19479955|NCT01576718|41759767|FG001|Treatment Period|Lost to Follow-up|0|||
19479956|NCT01576718|41759768|FG002|Treatment Period|Lost to Follow-up|0|||
19479957|NCT01576718|41759769|FG003|Treatment Period|Lost to Follow-up|0|||
19479958|NCT01576718|41759770|FG004|Treatment Period|Lost to Follow-up|1|||
19479959|NCT01576718|41759771|FG005|Treatment Period|Lost to Follow-up|0|||
19479960|NCT01576718|41759772|FG006|Treatment Period|Lost to Follow-up|0|||
19479961|NCT01576718|41759766|FG000|Treatment Period|Noncompliance to study medication|0|||
19479962|NCT01576718|41759767|FG001|Treatment Period|Noncompliance to study medication|0|||
19479963|NCT01576718|41759768|FG002|Treatment Period|Noncompliance to study medication|0|||
19479964|NCT01576718|41759769|FG003|Treatment Period|Noncompliance to study medication|0|||
19479965|NCT01576718|41759770|FG004|Treatment Period|Noncompliance to study medication|0|||
19479966|NCT01576718|41759771|FG005|Treatment Period|Noncompliance to study medication|1|||
19479967|NCT01576718|41759772|FG006|Treatment Period|Noncompliance to study medication|1|||
19479968|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
19479969|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
19479970|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
19479971|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
19479972|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
19479973|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
19479974|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
19479975|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
19479976|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
19479977|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
19479978|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
19479979|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
19479980|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
19479981|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
19479982|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
19479983|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
19479984|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
19479985|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
19479986|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Early termination|0|||
19479987|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Early termination|0|||
19479988|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Early termination|34|||
19479989|NCT01493557|41759789|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
19479990|NCT01493557|41759790|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
19479991|NCT01493557|41759791|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
19479992|NCT01493557|41759789|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
19479993|NCT01493557|41759790|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
19479994|NCT01493557|41759791|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
19479995|NCT01493557|41759789|FG000|Randomized to Management Strategies|Other adverse event|8|||
19479996|NCT01493557|41759790|FG001|Randomized to Management Strategies|Other adverse event|5|||
19479997|NCT01493557|41759791|FG002|Randomized to Management Strategies|Other adverse event|0|||
19479998|NCT01493557|41759789|FG000|Randomized to Management Strategies|Protocol Violation|3|||
19479999|NCT01493557|41759790|FG001|Randomized to Management Strategies|Protocol Violation|0|||
19480000|NCT01493557|41759791|FG002|Randomized to Management Strategies|Protocol Violation|0|||
19480001|NCT01493557|41759789|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
19392237|NCT01975246|41636334|FG000|Overall Study|Protocol Violation|1|||
19392238|NCT01975246|41636335|FG001|Overall Study|Protocol Violation|0|||
19392239|NCT01975246|41636334|FG000|Overall Study|Other than stated|0|||
19392240|NCT01975246|41636335|FG001|Overall Study|Other than stated|1|||
19392241|NCT01621126|41636341|FG000|Overall Study|Physician Decision|6|||
19392242|NCT01973998|41636347|FG000|Overall Study|Death|2|||
19392243|NCT01973998|41636348|FG001|Overall Study|Death|2|||
19480002|NCT01493557|41759790|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
19480003|NCT01493557|41759791|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
19480004|NCT01493557|41759789|FG000|Randomized to Management Strategies|Other than stated above|1|||
19480005|NCT01493557|41759790|FG001|Randomized to Management Strategies|Other than stated above|3|||
19480006|NCT01493557|41759791|FG002|Randomized to Management Strategies|Other than stated above|0|||
19480007|NCT01493557|41759789|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
19480008|NCT01493557|41759790|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
19480009|NCT01493557|41759791|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
19480010|NCT01493557|41759789|FG000|Adding the Second Strategy|Other adverse event|1|||
19480011|NCT01493557|41759790|FG001|Adding the Second Strategy|Other adverse event|2|||
19480012|NCT01493557|41759791|FG002|Adding the Second Strategy|Other adverse event|0|||
19480013|NCT01493557|41759789|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
19480014|NCT01493557|41759790|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
19480015|NCT01493557|41759791|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
19480016|NCT01451749|41759800|FG000|Overall Study|Protocol Violation|14|||
19480017|NCT01451749|41759801|FG001|Overall Study|Protocol Violation|7|||
19480018|NCT01451749|41759800|FG000|Overall Study|Lost to Follow-up|15|||
19703796|NCT00422513|42148110|FG000|Overall Study|Refused Treatment|4|||
19703797|NCT00422513|42148111|FG001|Overall Study|Refused Treatment|2|||
19703798|NCT00422513|42148110|FG000|Overall Study|Withdrawal by Subject|2|||
19703799|NCT00422513|42148111|FG001|Overall Study|Withdrawal by Subject|1|||
19703800|NCT00422513|42148110|FG000|Overall Study|early termination of the study|67|||
19703801|NCT00422513|42148111|FG001|Overall Study|early termination of the study|80|||
19703802|NCT00422513|42148110|FG000|Overall Study|Adverse Event|4|||
19703803|NCT00422513|42148111|FG001|Overall Study|Adverse Event|4|||
19480019|NCT01451749|41759801|FG001|Overall Study|Lost to Follow-up|5|||
19480020|NCT01451749|41759800|FG000|Overall Study|Meet the exclusion criteria,and|1|||
19480021|NCT01451749|41759801|FG001|Overall Study|Meet the exclusion criteria,and|1|||
19480022|NCT01451749|41759800|FG000|Overall Study|Adverse Event|2|||
19480023|NCT01451749|41759801|FG001|Overall Study|Adverse Event|0|||
19480024|NCT01451749|41759800|FG000|Overall Study|Withdrawal by Subject|0|||
19480025|NCT01451749|41759801|FG001|Overall Study|Withdrawal by Subject|1|||
19480026|NCT01576484|41759811|FG000|Overall Study|Adverse Event|1|||
19480027|NCT01576484|41759812|FG001|Overall Study|Adverse Event|1|||
19480028|NCT01576484|41759811|FG000|Overall Study|Protocol Violation|0|||
19480029|NCT01576484|41759812|FG001|Overall Study|Protocol Violation|2|||
19392244|NCT02664415|41636356|FG000|Overall Study|Adverse Event|1|||
19480030|NCT01576484|41759811|FG000|Overall Study|Sponsor Decision|2|||
19480031|NCT01576484|41759812|FG001|Overall Study|Sponsor Decision|8|||
19480032|NCT01576484|41759811|FG000|Overall Study|Withdrawal by Subject|0|||
19480033|NCT01576484|41759812|FG001|Overall Study|Withdrawal by Subject|3|||
19480034|NCT01576484|41759811|FG000|Overall Study|Other|2|||
19480035|NCT01576484|41759812|FG001|Overall Study|Other|5|||
19480036|NCT01467505|41759822|FG000|Overall Study|Adverse Event|1|||
19480037|NCT01467505|41759823|FG001|Overall Study|Adverse Event|0|||
19480038|NCT01467505|41759822|FG000|Overall Study|Withdrawal by Subject|4|||
19480039|NCT01467505|41759823|FG001|Overall Study|Withdrawal by Subject|0|||
19480040|NCT01467505|41759822|FG000|Overall Study|Study Terminated by Sponsor|28|||
19480041|NCT01467505|41759823|FG001|Overall Study|Study Terminated by Sponsor|3|||
19480042|NCT01467271|41759829|FG000|Overall Study|Death|84|||
19480043|NCT01467271|41759829|FG000|Overall Study|Lost to Follow-up|83|||
19480044|NCT01467271|41759829|FG000|Overall Study|Retraction of patient's consent|21|||
19480045|NCT01467271|41759829|FG000|Overall Study|Other reason|14|||
19480046|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Adverse Event|5|||
19480047|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Adverse Event|13|||
19480048|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Adverse Event|0|||
19480049|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
19480050|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
19480051|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
19480052|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
19480053|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
19480054|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
19480055|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
19480056|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
19480057|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
19480058|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
19480059|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
19480060|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
19480061|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
19480062|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
19480063|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
19480064|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Physician Decision|2|||
19480065|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Physician Decision|3|||
19480066|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Physician Decision|0|||
19480067|NCT01449929|41759835|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
19480068|NCT01449929|41759836|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
19480069|NCT01449929|41759837|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
19480070|NCT01449929|41759835|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
19480071|NCT01449929|41759836|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
19480072|NCT01449929|41759837|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
19480073|NCT01449929|41759835|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
19480074|NCT01449929|41759836|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
19480075|NCT01449929|41759837|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
19480076|NCT01449929|41759835|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
19480077|NCT01449929|41759836|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
19480078|NCT01449929|41759837|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
19480079|NCT01449539|41759847|FG000|Overall Study|Withdrawal by Subject|3|||
19480080|NCT01449539|41759847|FG000|Overall Study|Toxicity not study related|1|||
19480081|NCT01451515|41759854|FG000|Overall Study|Death|0|||
19480082|NCT01451515|41759855|FG001|Overall Study|Death|1|||
19480083|NCT01451515|41759856|FG002|Overall Study|Death|0|||
19480084|NCT01451515|41759854|FG000|Overall Study|Withdrawal by Subject|0|||
19480085|NCT01451515|41759855|FG001|Overall Study|Withdrawal by Subject|1|||
19480086|NCT01451515|41759856|FG002|Overall Study|Withdrawal by Subject|0|||
19480087|NCT01451515|41759854|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
19373653|NCT02760407|41614834|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
19373654|NCT02760407|41614835|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
19373655|NCT02760407|41614836|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
19373656|NCT02760407|41614833|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
19373657|NCT02760407|41614834|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
19373658|NCT02760407|41614835|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
19373659|NCT02760407|41614836|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
19373660|NCT02760407|41614833|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
19373661|NCT02760407|41614834|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
19373662|NCT02760407|41614835|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
19373663|NCT02760407|41614836|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
19373664|NCT02760407|41614833|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
19611709|NCT00831441|42060460|FG000|Follow Up (30 Days)|non-specified|16|||
19611710|NCT00831441|42060461|FG001|Follow Up (30 Days)|non-specified|26|||
19611711|NCT00831441|42060460|FG000|Follow Up (30 Days)|missing end of study status|0|||
19611712|NCT00831441|42060461|FG001|Follow Up (30 Days)|missing end of study status|1|||
19611713|NCT00831129|42060470|FG000|Overall Study|Adverse Event|0|||
19611714|NCT00831129|42060471|FG001|Overall Study|Adverse Event|1|||
19611715|NCT00831129|42060470|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
19480088|NCT01451515|41759855|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
19480089|NCT01451515|41759856|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
19480090|NCT01451515|41759854|FG000|Overall Study|Relapse (except CNS)|1|||
19480091|NCT01451515|41759855|FG001|Overall Study|Relapse (except CNS)|1|||
19480092|NCT01451515|41759856|FG002|Overall Study|Relapse (except CNS)|0|||
19480093|NCT01466881|41759867|FG000|Overall Study|Ineligible|5|||
19480094|NCT01466881|41759867|FG000|Overall Study|Adverse Event|6|||
19480095|NCT01466881|41759867|FG000|Overall Study|Progression/relapse|20|||
19480096|NCT01466881|41759867|FG000|Overall Study|Death|4|||
19480097|NCT01466881|41759867|FG000|Overall Study|Other reason not protocol specified|5|||
19480098|NCT01576406|41759879|FG000|Overall Study|Lost to Follow-up|1|||
19480099|NCT01576406|41759880|FG001|Overall Study|Lost to Follow-up|2|||
19480100|NCT01576406|41759881|FG002|Overall Study|Lost to Follow-up|0|||
19480101|NCT01576406|41759882|FG003|Overall Study|Lost to Follow-up|0|||
19480102|NCT01576406|41759883|FG004|Overall Study|Lost to Follow-up|0|||
19480103|NCT01576406|41759884|FG005|Overall Study|Lost to Follow-up|0|||
19480104|NCT01576406|41759879|FG000|Overall Study|Death|3|||
19480105|NCT01576406|41759880|FG001|Overall Study|Death|4|||
19480106|NCT01576406|41759881|FG002|Overall Study|Death|8|||
19480107|NCT01576406|41759882|FG003|Overall Study|Death|5|||
19480108|NCT01576406|41759883|FG004|Overall Study|Death|7|||
19480109|NCT01576406|41759884|FG005|Overall Study|Death|9|||
19480110|NCT01576406|41759879|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
19480111|NCT01576406|41759880|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
19480112|NCT01576406|41759881|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
19480113|NCT01576406|41759882|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
19480114|NCT01576406|41759883|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
19480115|NCT01576406|41759884|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
19480116|NCT01576406|41759879|FG000|Overall Study|Withdrawal the consent|2|||
19480117|NCT01576406|41759880|FG001|Overall Study|Withdrawal the consent|2|||
19480118|NCT01576406|41759881|FG002|Overall Study|Withdrawal the consent|5|||
19480119|NCT01576406|41759882|FG003|Overall Study|Withdrawal the consent|1|||
19480120|NCT01576406|41759883|FG004|Overall Study|Withdrawal the consent|1|||
19480121|NCT01576406|41759884|FG005|Overall Study|Withdrawal the consent|3|||
19480122|NCT01576406|41759879|FG000|Overall Study|Other|0|||
19480123|NCT01576406|41759880|FG001|Overall Study|Other|0|||
19480124|NCT01576406|41759881|FG002|Overall Study|Other|2|||
19480125|NCT01576406|41759882|FG003|Overall Study|Other|2|||
19480126|NCT01576406|41759883|FG004|Overall Study|Other|0|||
19480127|NCT01576406|41759884|FG005|Overall Study|Other|0|||
19480128|NCT01576172|41759900|FG000|Overall Study|Ineligible|2|||
19480129|NCT01576172|41759901|FG001|Overall Study|Ineligible|1|||
19480130|NCT01576172|41759900|FG000|Overall Study|Withdrawal by Subject|2|||
19480131|NCT01576172|41759901|FG001|Overall Study|Withdrawal by Subject|0|||
19480132|NCT01576172|41759900|FG000|Overall Study|Insurance issue|1|||
19480133|NCT01576172|41759901|FG001|Overall Study|Insurance issue|0|||
19480134|NCT01542788|41759911|FG000|Overall Study|Randomized but Not Treated|2|||
19480135|NCT01542788|41759912|FG001|Overall Study|Randomized but Not Treated|0|||
19480136|NCT01542788|41759911|FG000|Overall Study|Lack of Efficacy|41|||
19480137|NCT01542788|41759912|FG001|Overall Study|Lack of Efficacy|71|||
19480138|NCT01542788|41759911|FG000|Overall Study|Lost to Follow-up|5|||
19480139|NCT01542788|41759912|FG001|Overall Study|Lost to Follow-up|0|||
19480140|NCT01542788|41759911|FG000|Overall Study|Death|3|||
19480141|NCT01542788|41759912|FG001|Overall Study|Death|0|||
19480142|NCT01542788|41759911|FG000|Overall Study|Protocol Violation|2|||
19480143|NCT01542788|41759912|FG001|Overall Study|Protocol Violation|0|||
19480144|NCT01542788|41759911|FG000|Overall Study|Physician Decision|1|||
19480145|NCT01542788|41759912|FG001|Overall Study|Physician Decision|0|||
19480146|NCT01542788|41759911|FG000|Overall Study|Withdrawal by Subject|1|||
19480147|NCT01542788|41759912|FG001|Overall Study|Withdrawal by Subject|0|||
19480148|NCT01542632|41759924|FG000|Overall Study|Withdrawal of Consent|0|||
19480149|NCT01542632|41759925|FG001|Overall Study|Withdrawal of Consent|0|||
19480150|NCT01542632|41759926|FG002|Overall Study|Withdrawal of Consent|0|||
19611716|NCT00831129|42060471|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
19480151|NCT01542632|41759927|FG003|Overall Study|Withdrawal of Consent|2|||
19480152|NCT01542632|41759928|FG004|Overall Study|Withdrawal of Consent|3|||
19480153|NCT01542632|41759929|FG005|Overall Study|Withdrawal of Consent|0|||
19480154|NCT01542632|41759924|FG000|Overall Study|Adverse Event|0|||
19611717|NCT00620113|42060481|FG000|Overall Study|Adverse Event|3|||
19480155|NCT01542632|41759925|FG001|Overall Study|Adverse Event|0|||
19480156|NCT01542632|41759926|FG002|Overall Study|Adverse Event|1|||
19480157|NCT01542632|41759927|FG003|Overall Study|Adverse Event|0|||
19480158|NCT01542632|41759928|FG004|Overall Study|Adverse Event|0|||
19480159|NCT01542632|41759929|FG005|Overall Study|Adverse Event|0|||
19480160|NCT01542632|41759924|FG000|Overall Study|Lost to Follow-up|0|||
19480161|NCT01542632|41759925|FG001|Overall Study|Lost to Follow-up|1|||
19480162|NCT01542632|41759926|FG002|Overall Study|Lost to Follow-up|0|||
19480163|NCT01542632|41759927|FG003|Overall Study|Lost to Follow-up|0|||
19480164|NCT01542632|41759928|FG004|Overall Study|Lost to Follow-up|0|||
19480165|NCT01542632|41759929|FG005|Overall Study|Lost to Follow-up|0|||
19480166|NCT01542632|41759924|FG000|Overall Study|Sponsor/Investigator Decision|0|||
19480167|NCT01542632|41759925|FG001|Overall Study|Sponsor/Investigator Decision|0|||
19480168|NCT01542632|41759926|FG002|Overall Study|Sponsor/Investigator Decision|0|||
19480169|NCT01542632|41759927|FG003|Overall Study|Sponsor/Investigator Decision|0|||
19480170|NCT01542632|41759928|FG004|Overall Study|Sponsor/Investigator Decision|1|||
19480171|NCT01542632|41759929|FG005|Overall Study|Sponsor/Investigator Decision|0|||
19480172|NCT01557842|41759950|FG000|Overall Study|Lost to Follow-up|0|||
19480173|NCT01557842|41759951|FG001|Overall Study|Lost to Follow-up|1|||
19480174|NCT01557842|41759950|FG000|Overall Study|Death|1|||
19480175|NCT01557842|41759951|FG001|Overall Study|Death|0|||
19480176|NCT01557842|41759950|FG000|Overall Study|Lack of Efficacy|0|||
19480177|NCT01557842|41759951|FG001|Overall Study|Lack of Efficacy|1|||
19480178|NCT01557842|41759950|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
19480179|NCT01557842|41759951|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
19480180|NCT01557842|41759950|FG000|Overall Study|Study Terminated by Sponsor|3|||
19480181|NCT01557842|41759951|FG001|Overall Study|Study Terminated by Sponsor|4|||
19480182|NCT01557842|41759950|FG000|Overall Study|Not Ablated|2|||
19480183|NCT01557842|41759951|FG001|Overall Study|Not Ablated|0|||
19480184|NCT01541930|41759957|FG000|Overall Study|Withdrawal by Subject|1|||
19480185|NCT01576016|41759974|FG000|Lead Safety|Death|132|||
19480186|NCT01576016|41759975|FG001|Lead Safety|Death|0|||
19480187|NCT01576016|41759974|FG000|Lead Safety|Withdrawal by Subject|81|||
19480188|NCT01576016|41759975|FG001|Lead Safety|Withdrawal by Subject|0|||
19480189|NCT01576016|41759974|FG000|Lead Safety|System Explanted without Replacement|24|||
19480190|NCT01576016|41759975|FG001|Lead Safety|System Explanted without Replacement|0|||
19480191|NCT01576016|41759974|FG000|Lead Safety|Physician Decision|14|||
19480192|NCT01576016|41759975|FG001|Lead Safety|Physician Decision|0|||
19480193|NCT01576016|41759974|FG000|Lead Safety|Lost to Follow-up|13|||
19480194|NCT01576016|41759975|FG001|Lead Safety|Lost to Follow-up|0|||
19480195|NCT01576016|41759974|FG000|Lead Safety|Unsuccessful implant|2|||
19480196|NCT01576016|41759975|FG001|Lead Safety|Unsuccessful implant|0|||
19480197|NCT01576016|41759974|FG000|Lead Safety|Sponsor request|1|||
19480198|NCT01576016|41759975|FG001|Lead Safety|Sponsor request|0|||
19480199|NCT01576016|41759974|FG000|Lead Safety|Device replaced with CRT-D|1|||
19480200|NCT01576016|41759975|FG001|Lead Safety|Device replaced with CRT-D|0|||
19480201|NCT01576016|41759974|FG000|Lead Safety|Patient on Palliative Care|1|||
19480202|NCT01576016|41759975|FG001|Lead Safety|Patient on Palliative Care|0|||
19480203|NCT01576016|41759974|FG000|Lead Safety|Patient noncompliance|1|||
19480204|NCT01576016|41759975|FG001|Lead Safety|Patient noncompliance|0|||
19480205|NCT01576016|41759974|FG000|Lead Safety|Too far from study site|1|||
19480206|NCT01576016|41759975|FG001|Lead Safety|Too far from study site|0|||
19480207|NCT01576016|41759974|FG000|Lead Safety|System deactivated|1|||
19480208|NCT01576016|41759975|FG001|Lead Safety|System deactivated|0|||
19480209|NCT01576016|41759974|FG000|Lead Safety|Patient no longer followed by study PI|1|||
19480210|NCT01576016|41759975|FG001|Lead Safety|Patient no longer followed by study PI|0|||
19480211|NCT01576016|41759974|FG000|MRI Safety|Withdrawal by Subject|0|||
19480212|NCT01576016|41759975|FG001|MRI Safety|Withdrawal by Subject|10|||
19480213|NCT01576016|41759974|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
19480214|NCT01576016|41759975|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
19480215|NCT01576016|41759974|FG000|MRI Safety|Has not yet completed MRI scan|0|||
19480216|NCT01576016|41759975|FG001|MRI Safety|Has not yet completed MRI scan|56|||
19480217|NCT01576016|41759974|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
19480218|NCT01576016|41759975|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
19480219|NCT01540838|41759985|FG000|Overall Study|Open nasogastric tube|9|||
19480220|NCT01540838|41759986|FG001|Overall Study|Open nasogastric tube|7|||
19480221|NCT01540838|41759985|FG000|Overall Study|Treatment doses missing|8|||
19480222|NCT01540838|41759986|FG001|Overall Study|Treatment doses missing|12|||
19480223|NCT01540838|41759985|FG000|Overall Study|Additional antibiotic treatment|1|||
19480224|NCT01540838|41759986|FG001|Overall Study|Additional antibiotic treatment|2|||
19480225|NCT01540838|41759985|FG000|Overall Study|Died before treatment initiation|1|||
19480226|NCT01540838|41759986|FG001|Overall Study|Died before treatment initiation|1|||
19480227|NCT01540838|41759985|FG000|Overall Study|Not BM. Other treatment|3|||
19480228|NCT01540838|41759986|FG001|Overall Study|Not BM. Other treatment|1|||
19480229|NCT01451437|41760001|FG000|Overall Study|Adverse Event|0|||
19480230|NCT01451437|41760002|FG001|Overall Study|Adverse Event|0|||
19480231|NCT01451437|41760003|FG002|Overall Study|Adverse Event|0|||
19480232|NCT01451437|41760004|FG003|Overall Study|Adverse Event|0|||
19480233|NCT01451437|41760005|FG004|Overall Study|Adverse Event|0|||
19480234|NCT01451437|41760006|FG005|Overall Study|Adverse Event|1|||
19480235|NCT01451437|41760007|FG006|Overall Study|Adverse Event|1|||
19480236|NCT01451437|41760008|FG007|Overall Study|Adverse Event|2|||
19480237|NCT01451437|41760009|FG008|Overall Study|Adverse Event|1|||
19480238|NCT01451437|41760001|FG000|Overall Study|Physician Decision|1|||
19392245|NCT02664415|41636357|FG001|Overall Study|Adverse Event|0|||
19480239|NCT01451437|41760002|FG001|Overall Study|Physician Decision|1|||
19480240|NCT01451437|41760003|FG002|Overall Study|Physician Decision|2|||
19480241|NCT01451437|41760004|FG003|Overall Study|Physician Decision|0|||
19480242|NCT01451437|41760005|FG004|Overall Study|Physician Decision|0|||
19480243|NCT01451437|41760006|FG005|Overall Study|Physician Decision|0|||
19480244|NCT01451437|41760007|FG006|Overall Study|Physician Decision|0|||
19480245|NCT01451437|41760008|FG007|Overall Study|Physician Decision|0|||
19480246|NCT01451437|41760009|FG008|Overall Study|Physician Decision|0|||
19480247|NCT01451437|41760001|FG000|Overall Study|Disease Progression|0|||
19480248|NCT01451437|41760002|FG001|Overall Study|Disease Progression|0|||
19480249|NCT01451437|41760003|FG002|Overall Study|Disease Progression|1|||
19480250|NCT01451437|41760004|FG003|Overall Study|Disease Progression|1|||
19480251|NCT01451437|41760005|FG004|Overall Study|Disease Progression|3|||
19480252|NCT01451437|41760006|FG005|Overall Study|Disease Progression|2|||
19480253|NCT01451437|41760007|FG006|Overall Study|Disease Progression|3|||
19480254|NCT01451437|41760008|FG007|Overall Study|Disease Progression|1|||
19480255|NCT01451437|41760009|FG008|Overall Study|Disease Progression|3|||
19480256|NCT01451437|41760001|FG000|Overall Study|Protocol Violation|0|||
19480257|NCT01451437|41760002|FG001|Overall Study|Protocol Violation|0|||
19480258|NCT01451437|41760003|FG002|Overall Study|Protocol Violation|0|||
19480259|NCT01451437|41760004|FG003|Overall Study|Protocol Violation|0|||
19480260|NCT01451437|41760005|FG004|Overall Study|Protocol Violation|0|||
19480261|NCT01451437|41760006|FG005|Overall Study|Protocol Violation|0|||
19480262|NCT01451437|41760007|FG006|Overall Study|Protocol Violation|1|||
19480263|NCT01451437|41760008|FG007|Overall Study|Protocol Violation|0|||
19480264|NCT01451437|41760009|FG008|Overall Study|Protocol Violation|0|||
19480265|NCT01451437|41760001|FG000|Overall Study|Withdrawal by Subject|0|||
19480266|NCT01451437|41760002|FG001|Overall Study|Withdrawal by Subject|0|||
19480267|NCT01451437|41760003|FG002|Overall Study|Withdrawal by Subject|0|||
19480268|NCT01451437|41760004|FG003|Overall Study|Withdrawal by Subject|0|||
19480269|NCT01451437|41760005|FG004|Overall Study|Withdrawal by Subject|1|||
19480270|NCT01451437|41760006|FG005|Overall Study|Withdrawal by Subject|0|||
19480271|NCT01451437|41760007|FG006|Overall Study|Withdrawal by Subject|1|||
19480272|NCT01451437|41760008|FG007|Overall Study|Withdrawal by Subject|0|||
19480273|NCT01451437|41760009|FG008|Overall Study|Withdrawal by Subject|0|||
19480274|NCT01451203|41760040|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
19480275|NCT01451203|41760041|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
19480276|NCT01451203|41760040|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
19480277|NCT01451203|41760041|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
19480278|NCT01451203|41760040|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
19480279|NCT01451203|41760041|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
19480280|NCT01451203|41760040|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
19480281|NCT01451203|41760041|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
19480282|NCT01451203|41760040|FG000|Double-blind Treatment Period|Adverse Event|6|||
19480283|NCT01451203|41760041|FG001|Double-blind Treatment Period|Adverse Event|9|||
19392246|NCT02661061|41636365|FG000|Overall Study|Lack of Efficacy|1|||
19392247|NCT02661061|41636366|FG001|Overall Study|Lack of Efficacy|1|||
19392248|NCT02661061|41636365|FG000|Overall Study|Withdrawal by Subject|1|||
19392249|NCT02661061|41636366|FG001|Overall Study|Withdrawal by Subject|1|||
19392250|NCT01995838|41636379|FG000|Overall Study|Lost to Follow-up|0|||
19392251|NCT01995838|41636380|FG001|Overall Study|Lost to Follow-up|1|||
19392252|NCT01995838|41636381|FG002|Overall Study|Lost to Follow-up|0|||
19392253|NCT01995838|41636382|FG003|Overall Study|Lost to Follow-up|0|||
19392254|NCT01995838|41636383|FG004|Overall Study|Lost to Follow-up|0|||
19392255|NCT01995838|41636384|FG005|Overall Study|Lost to Follow-up|0|||
19392256|NCT01995838|41636385|FG006|Overall Study|Lost to Follow-up|1|||
19392257|NCT01995838|41636379|FG000|Overall Study|Participant choice|2|||
19392258|NCT01995838|41636380|FG001|Overall Study|Participant choice|0|||
19392259|NCT01995838|41636381|FG002|Overall Study|Participant choice|0|||
19392260|NCT01995838|41636382|FG003|Overall Study|Participant choice|0|||
19392261|NCT01995838|41636383|FG004|Overall Study|Participant choice|0|||
19392262|NCT01995838|41636384|FG005|Overall Study|Participant choice|1|||
19392263|NCT01995838|41636385|FG006|Overall Study|Participant choice|1|||
19392264|NCT01995838|41636379|FG000|Overall Study|Adverse Event|0|||
19392265|NCT01995838|41636380|FG001|Overall Study|Adverse Event|0|||
19480284|NCT01451203|41760040|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
19480285|NCT01451203|41760041|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
19480286|NCT01451203|41760040|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
19392266|NCT01995838|41636381|FG002|Overall Study|Adverse Event|0|||
19392267|NCT01995838|41636382|FG003|Overall Study|Adverse Event|0|||
19480287|NCT01451203|41760041|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
19480288|NCT01451203|41760040|FG000|Double-blind Treatment Period|Investigator decision|2|||
19480289|NCT01451203|41760041|FG001|Double-blind Treatment Period|Investigator decision|0|||
19480290|NCT01451203|41760040|FG000|Post-treatment Period|Consent withdrawn|2|||
19480291|NCT01451203|41760041|FG001|Post-treatment Period|Consent withdrawn|4|||
19480292|NCT01451203|41760040|FG000|Post-treatment Period|Lack of Efficacy|12|||
19480293|NCT01451203|41760041|FG001|Post-treatment Period|Lack of Efficacy|28|||
19480294|NCT01451203|41760040|FG000|Post-treatment Period|Adverse Event|0|||
19480295|NCT01451203|41760041|FG001|Post-treatment Period|Adverse Event|1|||
19480296|NCT01451203|41760040|FG000|Post-treatment Period|Investigator decision|0|||
19480297|NCT01451203|41760041|FG001|Post-treatment Period|Investigator decision|1|||
19480298|NCT01556438|41760049|FG000|Overall Study|Adverse Event|4|||
19480299|NCT01556438|41760050|FG001|Overall Study|Adverse Event|2|||
19480300|NCT01556438|41760049|FG000|Overall Study|Sponsor Decision|0|||
19480301|NCT01556438|41760050|FG001|Overall Study|Sponsor Decision|2|||
19703804|NCT00422513|42148110|FG000|Overall Study|Death|3|||
19480302|NCT01556438|41760049|FG000|Overall Study|Progressive Disease|0|||
19480303|NCT01556438|41760050|FG001|Overall Study|Progressive Disease|6|||
19480304|NCT01556438|41760049|FG000|Overall Study|Death|0|||
19480305|NCT01556438|41760050|FG001|Overall Study|Death|1|||
19480306|NCT01554176|41760076|FG000|Treatment Phase|Protocol Violation|1|||
19480307|NCT01554176|41760077|FG001|Treatment Phase|Protocol Violation|2|||
19480308|NCT01554176|41760078|FG002|Treatment Phase|Protocol Violation|0|||
19480309|NCT01554176|41760079|FG003|Treatment Phase|Protocol Violation|0|||
19480310|NCT01554176|41760080|FG004|Treatment Phase|Protocol Violation|0|||
19480311|NCT01554176|41760076|FG000|Treatment Phase|Physician Decision|1|||
19480312|NCT01554176|41760077|FG001|Treatment Phase|Physician Decision|1|||
19480313|NCT01554176|41760078|FG002|Treatment Phase|Physician Decision|0|||
19480314|NCT01554176|41760079|FG003|Treatment Phase|Physician Decision|0|||
19480315|NCT01554176|41760080|FG004|Treatment Phase|Physician Decision|0|||
19480316|NCT01554176|41760076|FG000|Treatment Phase|Lack of Efficacy|0|||
19480317|NCT01554176|41760077|FG001|Treatment Phase|Lack of Efficacy|1|||
19480318|NCT01554176|41760078|FG002|Treatment Phase|Lack of Efficacy|0|||
19480319|NCT01554176|41760079|FG003|Treatment Phase|Lack of Efficacy|0|||
19480320|NCT01554176|41760080|FG004|Treatment Phase|Lack of Efficacy|0|||
19480321|NCT01554176|41760076|FG000|Treatment Phase|Adverse event, non-fatal|1|||
19480322|NCT01554176|41760077|FG001|Treatment Phase|Adverse event, non-fatal|1|||
19480323|NCT01554176|41760078|FG002|Treatment Phase|Adverse event, non-fatal|0|||
19480324|NCT01554176|41760079|FG003|Treatment Phase|Adverse event, non-fatal|0|||
19480325|NCT01554176|41760080|FG004|Treatment Phase|Adverse event, non-fatal|0|||
19480326|NCT01554176|41760076|FG000|Treatment Phase|Non-compliance with study drug|1|||
19480327|NCT01554176|41760077|FG001|Treatment Phase|Non-compliance with study drug|0|||
19480328|NCT01554176|41760078|FG002|Treatment Phase|Non-compliance with study drug|0|||
19480329|NCT01554176|41760079|FG003|Treatment Phase|Non-compliance with study drug|0|||
19480330|NCT01554176|41760080|FG004|Treatment Phase|Non-compliance with study drug|0|||
19480331|NCT01554176|41760076|FG000|Treatment Phase|Withdrawal by Subject|1|||
19480332|NCT01554176|41760077|FG001|Treatment Phase|Withdrawal by Subject|0|||
19480333|NCT01554176|41760078|FG002|Treatment Phase|Withdrawal by Subject|0|||
19480334|NCT01554176|41760079|FG003|Treatment Phase|Withdrawal by Subject|0|||
19480335|NCT01554176|41760080|FG004|Treatment Phase|Withdrawal by Subject|0|||
19480336|NCT01554176|41760076|FG000|Treatment Phase|Lost to Follow-up|3|||
19480337|NCT01554176|41760077|FG001|Treatment Phase|Lost to Follow-up|0|||
19703805|NCT00422513|42148111|FG001|Overall Study|Death|7|||
19703806|NCT00202878|42148119|FG000|Overall Study|Death|964|||
19480338|NCT01554176|41760078|FG002|Treatment Phase|Lost to Follow-up|0|||
19480339|NCT01554176|41760079|FG003|Treatment Phase|Lost to Follow-up|0|||
19480340|NCT01554176|41760080|FG004|Treatment Phase|Lost to Follow-up|0|||
19480341|NCT01554176|41760076|FG000|Run-out Phase|Protocol Violation|0|||
19480342|NCT01554176|41760077|FG001|Run-out Phase|Protocol Violation|0|||
19480343|NCT01554176|41760078|FG002|Run-out Phase|Protocol Violation|0|||
19480344|NCT01554176|41760079|FG003|Run-out Phase|Protocol Violation|1|||
19480345|NCT01554176|41760080|FG004|Run-out Phase|Protocol Violation|0|||
19480346|NCT01466491|41760096|FG000|Overall Study|Protocol Violation|0|||
19480347|NCT01466491|41760097|FG001|Overall Study|Protocol Violation|3|||
19480348|NCT01466491|41760098|FG002|Overall Study|Protocol Violation|2|||
19480349|NCT01466491|41760099|FG003|Overall Study|Protocol Violation|0|||
19480350|NCT01466491|41760096|FG000|Overall Study|Missing Data|0|||
19480351|NCT01466491|41760097|FG001|Overall Study|Missing Data|0|||
19480352|NCT01466491|41760098|FG002|Overall Study|Missing Data|1|||
19480353|NCT01466491|41760099|FG003|Overall Study|Missing Data|0|||
19480354|NCT01466179|41760109|FG000|Overall Study|Ongoing in core study|2|||
19480355|NCT01466179|41760109|FG000|Overall Study|Physician Decision|46|||
19480356|NCT01466179|41760109|FG000|Overall Study|Progressive disease|43|||
19480357|NCT01466179|41760109|FG000|Overall Study|Adverse Event|32|||
19703807|NCT00202878|42148120|FG001|Overall Study|Death|968|||
19480358|NCT01466179|41760109|FG000|Overall Study|Disease relapse|23|||
19480359|NCT01466179|41760109|FG000|Overall Study|Lack of Efficacy|14|||
19480360|NCT01466179|41760109|FG000|Overall Study|Death|7|||
19480361|NCT01466179|41760109|FG000|Overall Study|Withdrawal by Subject|7|||
19480362|NCT01466179|41760109|FG000|Overall Study|Protocol Violation|2|||
19480363|NCT01466179|41760109|FG000|Overall Study|Other|3|||
19480364|NCT01493089|41760118|FG000|Overall Study|Protocol Violation|2|||
19480365|NCT01493089|41760119|FG001|Overall Study|Protocol Violation|2|||
19480366|NCT01493089|41760118|FG000|Overall Study|Withdrawal by Subject|1|||
19480367|NCT01493089|41760119|FG001|Overall Study|Withdrawal by Subject|0|||
19480368|NCT01493089|41760118|FG000|Overall Study|Physician Decision|0|||
19480369|NCT01493089|41760119|FG001|Overall Study|Physician Decision|1|||
19480370|NCT01450813|41760131|FG000|Overall Study|Physician Decision|1|||
19480371|NCT01450813|41760132|FG001|Overall Study|Physician Decision|1|||
19480372|NCT01450813|41760133|FG002|Overall Study|Physician Decision|0|||
19480373|NCT01450813|41760134|FG003|Overall Study|Physician Decision|3|||
19480374|NCT01539512|41760148|FG000|Overall Study|Adverse Event|9|||
19480375|NCT01539512|41760149|FG001|Overall Study|Adverse Event|7|||
19480376|NCT01539512|41760148|FG000|Overall Study|Physician Decision|1|||
19480377|NCT01539512|41760149|FG001|Overall Study|Physician Decision|1|||
19480378|NCT01539512|41760148|FG000|Overall Study|Withdrawal by Subject|12|||
19480379|NCT01539512|41760149|FG001|Overall Study|Withdrawal by Subject|5|||
19480380|NCT01539512|41760148|FG000|Overall Study|Richter's Transformation|1|||
19480381|NCT01539512|41760149|FG001|Overall Study|Richter's Transformation|0|||
19480382|NCT01449955|41760157|FG000|Overall Study|Withdrawal by Subject|1|||
19480383|NCT01449955|41760158|FG001|Overall Study|Withdrawal by Subject|2|||
19480384|NCT01574612|41760171|FG000|Overall Study|Adverse Event|3|||
19480385|NCT01574612|41760171|FG000|Overall Study|non compliant with drug|2|||
19480386|NCT01574612|41760171|FG000|Overall Study|Withdrawal by Subject|1|||
19480387|NCT01574612|41760171|FG000|Overall Study|Lost to Follow-up|2|||
19480388|NCT01573910|41760177|FG000|Overall Study|Adverse Event|4|||
19480389|NCT01573910|41760178|FG001|Overall Study|Adverse Event|4|||
19480390|NCT01573910|41760177|FG000|Overall Study|Lost to Follow-up|2|||
19480391|NCT01573910|41760178|FG001|Overall Study|Lost to Follow-up|1|||
19480392|NCT01573910|41760177|FG000|Overall Study|Withdrawal by Subject|0|||
19480393|NCT01573910|41760178|FG001|Overall Study|Withdrawal by Subject|1|||
19480394|NCT01573910|41760177|FG000|Overall Study|Protocol Violation|3|||
19480395|NCT01573910|41760178|FG001|Overall Study|Protocol Violation|0|||
19480396|NCT01573910|41760177|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
19480397|NCT01573910|41760178|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
19480398|NCT01491919|41760187|FG000|Overall Study|Insufficient PK sampling|1|||
19480399|NCT01491919|41760188|FG001|Overall Study|Insufficient PK sampling|2|||
19480400|NCT01491919|41760189|FG002|Overall Study|Insufficient PK sampling|1|||
19480401|NCT01573442|41760201|FG000|Overall Study|Cancels|9|||
19480402|NCT01573442|41760202|FG001|Overall Study|Cancels|10|||
19480403|NCT01491841|41760271|FG000|Overall Study|Screen Failure|10|||
19480404|NCT01491841|41760271|FG000|Overall Study|Withdrawal by Subject|1|||
19480405|NCT01553318|41760290|FG000|Overall Study|Protocol Violation|3|||
19480406|NCT01553318|41760291|FG001|Overall Study|Protocol Violation|2|||
19480407|NCT01572740|41760310|FG000|Overall Study|Adverse Event|1|||
19480408|NCT01572740|41760311|FG001|Overall Study|Adverse Event|1|||
19480409|NCT01572740|41760310|FG000|Overall Study|Withdrawal by Subject|1|||
19480410|NCT01572740|41760311|FG001|Overall Study|Withdrawal by Subject|1|||
19480411|NCT01572740|41760310|FG000|Overall Study|unclassified|4|||
19703808|NCT00202878|42148119|FG000|Overall Study|Only Vital Status Known|357|||
19392268|NCT01995838|41636383|FG004|Overall Study|Adverse Event|0|||
19392269|NCT01995838|41636384|FG005|Overall Study|Adverse Event|0|||
19392270|NCT01995838|41636385|FG006|Overall Study|Adverse Event|1|||
19392271|NCT01995838|41636379|FG000|Overall Study|Withdrawal by Subject|0|||
19392272|NCT01995838|41636380|FG001|Overall Study|Withdrawal by Subject|0|||
19392273|NCT01995838|41636381|FG002|Overall Study|Withdrawal by Subject|0|||
19392274|NCT01995838|41636382|FG003|Overall Study|Withdrawal by Subject|0|||
19392275|NCT01995838|41636383|FG004|Overall Study|Withdrawal by Subject|1|||
19392276|NCT01995838|41636384|FG005|Overall Study|Withdrawal by Subject|0|||
19392277|NCT01995838|41636385|FG006|Overall Study|Withdrawal by Subject|0|||
19392278|NCT01995838|41636379|FG000|Overall Study|Other|3|||
19392279|NCT01995838|41636380|FG001|Overall Study|Other|1|||
19392280|NCT01995838|41636381|FG002|Overall Study|Other|0|||
19392281|NCT01995838|41636382|FG003|Overall Study|Other|2|||
19392282|NCT01995838|41636383|FG004|Overall Study|Other|1|||
19392283|NCT01995838|41636384|FG005|Overall Study|Other|1|||
19392284|NCT01995838|41636385|FG006|Overall Study|Other|2|||
19392285|NCT01957462|41636402|FG000|Test Period 1|Withdrawal by Subject|1|||
19392286|NCT01957462|41636403|FG001|Test Period 1|Withdrawal by Subject|0|||
19392287|NCT01957462|41636402|FG000|Test Period 1|Adverse Event|1|||
19392288|NCT01957462|41636403|FG001|Test Period 1|Adverse Event|0|||
19392289|NCT01957150|41636411|FG000|Overall Study|Adverse Event|23|||
19392290|NCT01957150|41636412|FG001|Overall Study|Adverse Event|20|||
19392291|NCT01957150|41636411|FG000|Overall Study|Withdrawal by Subject|13|||
19392292|NCT01957150|41636412|FG001|Overall Study|Withdrawal by Subject|17|||
19392293|NCT01957150|41636411|FG000|Overall Study|Physician Decision|3|||
19480412|NCT01572740|41760311|FG001|Overall Study|unclassified|3|||
19480413|NCT01491607|41760321|FG000|Overall Study|Lost to Follow-up|7|||
19480414|NCT01491607|41760321|FG000|Overall Study|Withdrawal by Subject|3|||
19480415|NCT01449721|41760404|FG000|Overall Study|Physician Decision|0|||
19480416|NCT01449721|41760405|FG001|Overall Study|Physician Decision|1|||
19480417|NCT01449721|41760404|FG000|Overall Study|Physician Decision|0|||
19480418|NCT01449721|41760405|FG001|Overall Study|Physician Decision|1|||
19480419|NCT01553084|41760414|FG000|Overall Study|Withdrawal by Subject|15|||
19480420|NCT01553084|41760415|FG001|Overall Study|Withdrawal by Subject|13|||
19480421|NCT01553084|41760416|FG002|Overall Study|Withdrawal by Subject|35|||
19480422|NCT01536860|41760426|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
19480423|NCT01536860|41760427|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
19480424|NCT01536860|41760428|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
19480425|NCT01552928|41760440|FG000|Period 3|Adverse Event|0|||
19480426|NCT01552928|41760441|FG001|Period 3|Adverse Event|0|||
19480427|NCT01552928|41760442|FG002|Period 3|Adverse Event|1|||
19480428|NCT01552928|41760443|FG003|Period 3|Adverse Event|0|||
19480429|NCT01448707|41760462|FG000|Overall Study|Adverse Event|3|||
19480430|NCT01448707|41760463|FG001|Overall Study|Adverse Event|1|||
19480431|NCT01448707|41760462|FG000|Overall Study|Lost to Follow-up|2|||
19480432|NCT01448707|41760463|FG001|Overall Study|Lost to Follow-up|6|||
19480433|NCT01448707|41760462|FG000|Overall Study|Withdrawal by Subject|6|||
19480434|NCT01448707|41760463|FG001|Overall Study|Withdrawal by Subject|7|||
19480435|NCT01448707|41760462|FG000|Overall Study|Other|7|||
19480436|NCT01448707|41760463|FG001|Overall Study|Other|4|||
19480437|NCT01536704|41760469|FG000|Washout Period 1|Withdrawal by Subject|1|||
19480438|NCT01536704|41760470|FG001|Washout Period 1|Withdrawal by Subject|2|||
19480439|NCT01536704|41760471|FG002|Washout Period 1|Withdrawal by Subject|0|||
19480440|NCT01536704|41760472|FG003|Washout Period 1|Withdrawal by Subject|0|||
19480441|NCT01536704|41760469|FG000|Washout Period 2|Adverse Event|1|||
19480442|NCT01536704|41760470|FG001|Washout Period 2|Adverse Event|0|||
19480443|NCT01536704|41760471|FG002|Washout Period 2|Adverse Event|0|||
19480444|NCT01536704|41760472|FG003|Washout Period 2|Adverse Event|0|||
19480445|NCT01536704|41760469|FG000|Washout Period 2|Withdrawal by Subject|0|||
19480446|NCT01536704|41760470|FG001|Washout Period 2|Withdrawal by Subject|0|||
19480447|NCT01536704|41760471|FG002|Washout Period 2|Withdrawal by Subject|0|||
19480448|NCT01536704|41760472|FG003|Washout Period 2|Withdrawal by Subject|1|||
19480449|NCT01536704|41760469|FG000|Period 3|Adverse Event|0|||
19480450|NCT01536704|41760470|FG001|Period 3|Adverse Event|0|||
19480451|NCT01536704|41760471|FG002|Period 3|Adverse Event|0|||
19480452|NCT01536704|41760472|FG003|Period 3|Adverse Event|1|||
19480453|NCT01536704|41760469|FG000|Washout Period 3|Adverse Event|0|||
19480454|NCT01536704|41760470|FG001|Washout Period 3|Adverse Event|0|||
19480455|NCT01536704|41760471|FG002|Washout Period 3|Adverse Event|1|||
19480456|NCT01536704|41760472|FG003|Washout Period 3|Adverse Event|0|||
19480457|NCT01552772|41760486|FG000|Overall Study|Lost to Follow-up|2|||
19480458|NCT01552772|41760486|FG000|Overall Study|Adverse Event|1|||
19480459|NCT01552772|41760486|FG000|Overall Study|Protocol Deviation|1|||
19480460|NCT01552694|41760493|FG000|Overall Study|Lost to Follow-up|0|||
19480461|NCT01552694|41760494|FG001|Overall Study|Lost to Follow-up|1|||
19480462|NCT01552694|41760493|FG000|Overall Study|Protocol Violation|0|||
19480463|NCT01552694|41760494|FG001|Overall Study|Protocol Violation|1|||
19480464|NCT01464931|41760502|FG000|Overall Study|Withdrawal by Subject|1|||
19480465|NCT01464931|41760503|FG001|Overall Study|Withdrawal by Subject|0|||
19480466|NCT01536392|41760528|FG000|Overall Study|Adverse Event|2|||
19480467|NCT01536392|41760529|FG001|Overall Study|Adverse Event|2|||
19480468|NCT01536392|41760528|FG000|Overall Study|Physician Decision|2|||
19480469|NCT01536392|41760529|FG001|Overall Study|Physician Decision|3|||
19480470|NCT01536392|41760528|FG000|Overall Study|Withdrawal by Subject|3|||
19480471|NCT01536392|41760529|FG001|Overall Study|Withdrawal by Subject|6|||
19480472|NCT01536392|41760528|FG000|Overall Study|Non Compliance|3|||
19480473|NCT01536392|41760529|FG001|Overall Study|Non Compliance|4|||
19480474|NCT01536392|41760528|FG000|Overall Study|Completed therapy early|3|||
19480475|NCT01536392|41760529|FG001|Overall Study|Completed therapy early|0|||
19480476|NCT01464619|41760537|FG000|Overall Study|Lost to Follow-up|3|||
19480477|NCT01464619|41760538|FG001|Overall Study|Lost to Follow-up|4|||
19480478|NCT01447927|41760579|FG000|Overall Study|Adverse Event|4|||
19480479|NCT01447927|41760580|FG001|Overall Study|Adverse Event|3|||
19480480|NCT01447927|41760579|FG000|Overall Study|Withdrawal by Subject|1|||
19480481|NCT01447927|41760580|FG001|Overall Study|Withdrawal by Subject|0|||
19480482|NCT01490125|41760613|FG000|Period I|Adverse Event|4|||
19480483|NCT01490125|41760614|FG001|Period I|Adverse Event|1|||
19480484|NCT01490125|41760615|FG002|Period I|Adverse Event|1|||
19480485|NCT01490125|41760616|FG003|Period I|Adverse Event|3|||
19480486|NCT01490125|41760617|FG004|Period I|Adverse Event|2|||
19480487|NCT01490125|41760618|FG005|Period I|Adverse Event|4|||
19480488|NCT01490125|41760613|FG000|Period I|Protocol Violation|1|||
19480489|NCT01490125|41760614|FG001|Period I|Protocol Violation|1|||
19480490|NCT01490125|41760615|FG002|Period I|Protocol Violation|1|||
19480491|NCT01490125|41760616|FG003|Period I|Protocol Violation|1|||
19480492|NCT01490125|41760617|FG004|Period I|Protocol Violation|0|||
19480493|NCT01490125|41760618|FG005|Period I|Protocol Violation|0|||
19480494|NCT01490125|41760613|FG000|Period I|Withdrawal by Subject|1|||
19480495|NCT01490125|41760614|FG001|Period I|Withdrawal by Subject|3|||
19480496|NCT01490125|41760615|FG002|Period I|Withdrawal by Subject|2|||
19480497|NCT01490125|41760616|FG003|Period I|Withdrawal by Subject|1|||
19480498|NCT01490125|41760617|FG004|Period I|Withdrawal by Subject|2|||
19480499|NCT01490125|41760618|FG005|Period I|Withdrawal by Subject|1|||
19480500|NCT01490125|41760613|FG000|Period II|Adverse Event|2|||
19480501|NCT01490125|41760614|FG001|Period II|Adverse Event|3|||
19480502|NCT01490125|41760615|FG002|Period II|Adverse Event|2|||
19480503|NCT01490125|41760616|FG003|Period II|Adverse Event|2|||
19480504|NCT01490125|41760617|FG004|Period II|Adverse Event|4|||
19480505|NCT01490125|41760618|FG005|Period II|Adverse Event|2|||
19480506|NCT01490125|41760613|FG000|Period II|Protocol Violation|0|||
19480507|NCT01490125|41760614|FG001|Period II|Protocol Violation|0|||
19480508|NCT01490125|41760615|FG002|Period II|Protocol Violation|1|||
19703809|NCT00202878|42148120|FG001|Overall Study|Only Vital Status Known|356|||
19703810|NCT00202878|42148119|FG000|Overall Study|Lost to Follow-up|44|||
19703811|NCT00202878|42148120|FG001|Overall Study|Lost to Follow-up|49|||
19703812|NCT00202878|42148119|FG000|Overall Study|Site Closure|39|||
19703813|NCT00202878|42148120|FG001|Overall Study|Site Closure|36|||
19703814|NCT00202878|42148119|FG000|Overall Study|Withdrawal by Subject|795|||
19703815|NCT00202878|42148120|FG001|Overall Study|Withdrawal by Subject|808|||
19703816|NCT00414011|42148126|FG000|Overall Study|Physician Decision|3|||
19703817|NCT00414011|42148126|FG000|Overall Study|Withdrawal by Subject|2|||
19703818|NCT00231816|42148133|FG000|Overall Study|Adverse Event|1|||
19703819|NCT00231816|42148134|FG001|Overall Study|Adverse Event|0|||
19703820|NCT00231816|42148133|FG000|Overall Study|Lost to Follow-up|8|||
19703821|NCT00231816|42148134|FG001|Overall Study|Lost to Follow-up|5|||
19703822|NCT00231816|42148133|FG000|Overall Study|Protocol Violation|2|||
19703823|NCT00231816|42148134|FG001|Overall Study|Protocol Violation|3|||
19480509|NCT01490125|41760616|FG003|Period II|Protocol Violation|1|||
19703824|NCT00231816|42148133|FG000|Overall Study|Withdrawal by Subject|3|||
19703825|NCT00231816|42148134|FG001|Overall Study|Withdrawal by Subject|3|||
19703826|NCT00231816|42148133|FG000|Overall Study|Other|2|||
19703827|NCT00231816|42148134|FG001|Overall Study|Other|1|||
19703828|NCT00260208|42148143|FG000|Overall Study|Subject withdrew consent|11|||
19703829|NCT00260208|42148144|FG001|Overall Study|Subject withdrew consent|7|||
19703830|NCT00260208|42148143|FG000|Overall Study|Lost to Follow-up|6|||
19703831|NCT00260208|42148144|FG001|Overall Study|Lost to Follow-up|1|||
19703832|NCT00260208|42148143|FG000|Overall Study|Death|12|||
19703833|NCT00260208|42148144|FG001|Overall Study|Death|10|||
19703834|NCT00260208|42148143|FG000|Overall Study|Missing|18|||
19480510|NCT01490125|41760617|FG004|Period II|Protocol Violation|0|||
19480511|NCT01490125|41760618|FG005|Period II|Protocol Violation|0|||
19480512|NCT01490125|41760613|FG000|Period II|Lost to Follow-up|0|||
19480513|NCT01490125|41760614|FG001|Period II|Lost to Follow-up|1|||
19480514|NCT01490125|41760615|FG002|Period II|Lost to Follow-up|0|||
19480515|NCT01490125|41760616|FG003|Period II|Lost to Follow-up|0|||
19480516|NCT01490125|41760617|FG004|Period II|Lost to Follow-up|0|||
19480517|NCT01490125|41760618|FG005|Period II|Lost to Follow-up|0|||
19480518|NCT01490125|41760613|FG000|Period II|Withdrawal by Subject|1|||
19480519|NCT01490125|41760614|FG001|Period II|Withdrawal by Subject|0|||
19703835|NCT00260208|42148144|FG001|Overall Study|Missing|16|||
19703836|NCT00202644|42148152|FG000|Overall Study|Adverse Event|12|||
19703837|NCT00202644|42148153|FG001|Overall Study|Adverse Event|13|||
19392294|NCT01957150|41636412|FG001|Overall Study|Physician Decision|6|||
19392295|NCT01957150|41636411|FG000|Overall Study|Lost to Follow-up|4|||
19392296|NCT01957150|41636412|FG001|Overall Study|Lost to Follow-up|4|||
19392297|NCT01957150|41636411|FG000|Overall Study|Protocol Violation|1|||
19392298|NCT01957150|41636412|FG001|Overall Study|Protocol Violation|0|||
19392299|NCT01957150|41636411|FG000|Overall Study|Lack of Efficacy|11|||
19392300|NCT01957150|41636412|FG001|Overall Study|Lack of Efficacy|11|||
19703838|NCT00202644|42148152|FG000|Overall Study|Withdrawal by Subject|8|||
19392301|NCT01955122|41636420|FG000|Overall Study|Physician Decision|5|||
19392302|NCT01955122|41636421|FG001|Overall Study|Physician Decision|5|||
19480520|NCT01490125|41760615|FG002|Period II|Withdrawal by Subject|0|||
19480521|NCT01490125|41760616|FG003|Period II|Withdrawal by Subject|0|||
19480522|NCT01490125|41760617|FG004|Period II|Withdrawal by Subject|0|||
19480523|NCT01490125|41760618|FG005|Period II|Withdrawal by Subject|0|||
19392303|NCT01995526|41636433|FG000|Overall Study|Physician Decision|1|||
19392304|NCT01955044|41636440|FG000|Overall Study|Death|1|||
19392305|NCT01955044|41636441|FG001|Overall Study|Death|1|||
19392306|NCT01955044|41636442|FG002|Overall Study|Death|0|||
19392307|NCT01973218|41636452|FG000|Overall Study|Adverse Event|1|||
19392308|NCT01973218|41636453|FG001|Overall Study|Adverse Event|0|||
19480524|NCT01490125|41760613|FG000|Period III|Adverse Event|3|||
19480525|NCT01490125|41760614|FG001|Period III|Adverse Event|1|||
19480526|NCT01490125|41760615|FG002|Period III|Adverse Event|0|||
19480527|NCT01490125|41760616|FG003|Period III|Adverse Event|1|||
19480528|NCT01490125|41760617|FG004|Period III|Adverse Event|0|||
19480529|NCT01490125|41760618|FG005|Period III|Adverse Event|0|||
19480530|NCT01490125|41760613|FG000|Period III|Death|0|||
19480531|NCT01490125|41760614|FG001|Period III|Death|0|||
19480532|NCT01490125|41760615|FG002|Period III|Death|0|||
19480533|NCT01490125|41760616|FG003|Period III|Death|1|||
19480534|NCT01490125|41760617|FG004|Period III|Death|0|||
19480535|NCT01490125|41760618|FG005|Period III|Death|0|||
19480536|NCT01490125|41760613|FG000|Period III|Lack of Efficacy|0|||
19480537|NCT01490125|41760614|FG001|Period III|Lack of Efficacy|0|||
19480538|NCT01490125|41760615|FG002|Period III|Lack of Efficacy|0|||
19480539|NCT01490125|41760616|FG003|Period III|Lack of Efficacy|0|||
19480540|NCT01490125|41760617|FG004|Period III|Lack of Efficacy|1|||
19480541|NCT01490125|41760618|FG005|Period III|Lack of Efficacy|0|||
19480542|NCT01446913|41760629|FG000|Overall Study|Significant illness|1|||
19480543|NCT01446913|41760630|FG001|Overall Study|Significant illness|1|||
19480544|NCT01446913|41760631|FG002|Overall Study|Significant illness|1|||
19480545|NCT01446913|41760629|FG000|Overall Study|Withdrawal by Subject|5|||
19480546|NCT01446913|41760630|FG001|Overall Study|Withdrawal by Subject|3|||
19480547|NCT01446913|41760631|FG002|Overall Study|Withdrawal by Subject|5|||
19480548|NCT01446913|41760629|FG000|Overall Study|Physician Decision|0|||
19480549|NCT01446913|41760630|FG001|Overall Study|Physician Decision|0|||
19480550|NCT01446913|41760631|FG002|Overall Study|Physician Decision|2|||
19480551|NCT01446913|41760629|FG000|Overall Study|Lost to Follow-up|3|||
19480552|NCT01446913|41760630|FG001|Overall Study|Lost to Follow-up|5|||
19480553|NCT01446913|41760631|FG002|Overall Study|Lost to Follow-up|3|||
19480554|NCT01420549|41760662|FG000|Overall Study|Adverse Event|1|||
19480555|NCT01420549|41760663|FG001|Overall Study|Adverse Event|1|||
19480556|NCT01420549|41760662|FG000|Overall Study|Lost to Follow-up|2|||
19480557|NCT01420549|41760663|FG001|Overall Study|Lost to Follow-up|2|||
19480558|NCT01420549|41760662|FG000|Overall Study|Protocol Violation|0|||
19480559|NCT01420549|41760663|FG001|Overall Study|Protocol Violation|1|||
19480560|NCT01420549|41760662|FG000|Overall Study|Non-adherence to medication|4|||
19480561|NCT01420549|41760663|FG001|Overall Study|Non-adherence to medication|1|||
19480562|NCT01440595|41760684|FG000|Overall Study|Lost to Follow-up|0|||
19480563|NCT01440595|41760685|FG001|Overall Study|Lost to Follow-up|1|||
19480564|NCT01440595|41760686|FG002|Overall Study|Lost to Follow-up|0|||
19480565|NCT01440595|41760684|FG000|Overall Study|Study terminated by sponsor.|1|||
19480566|NCT01440595|41760685|FG001|Overall Study|Study terminated by sponsor.|2|||
19480567|NCT01440595|41760686|FG002|Overall Study|Study terminated by sponsor.|1|||
19480568|NCT01440517|41760692|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
19480569|NCT01440283|41760696|FG000|Overall Study|Death|3|||
19480570|NCT01440283|41760696|FG000|Overall Study|Withdrawal by Subject|4|||
19480571|NCT01440283|41760696|FG000|Overall Study|Physician Decision|3|||
19480572|NCT01440049|41760706|FG000|Overall Study|Adverse Event|5|||
19480573|NCT01439971|41760767|FG000|Overall Study|Required number in cohort dosed|0|||
19480574|NCT01439971|41760768|FG001|Overall Study|Required number in cohort dosed|1|||
19392309|NCT01973218|41636452|FG000|Overall Study|Withdrawal by Subject|1|||
19392310|NCT01973218|41636453|FG001|Overall Study|Withdrawal by Subject|0|||
19392311|NCT01954342|41636465|FG000|Overall Study|Missing data from 13-16week study visit|0|||
19392312|NCT01954342|41636466|FG001|Overall Study|Missing data from 13-16week study visit|0|||
19392313|NCT01954342|41636467|FG002|Overall Study|Missing data from 13-16week study visit|0|||
19392314|NCT01954342|41636468|FG003|Overall Study|Missing data from 13-16week study visit|1|||
19392315|NCT01954342|41636465|FG000|Overall Study|Miscarriage|0|||
19392316|NCT01954342|41636466|FG001|Overall Study|Miscarriage|0|||
19392317|NCT01954342|41636467|FG002|Overall Study|Miscarriage|0|||
19392318|NCT01954342|41636468|FG003|Overall Study|Miscarriage|3|||
19392319|NCT01954342|41636465|FG000|Overall Study|Lost to Follow-up|0|||
19392320|NCT01954342|41636466|FG001|Overall Study|Lost to Follow-up|0|||
19392321|NCT01954342|41636467|FG002|Overall Study|Lost to Follow-up|0|||
19392322|NCT01954342|41636468|FG003|Overall Study|Lost to Follow-up|5|||
19392323|NCT01954342|41636465|FG000|Overall Study|Preterm delivery|0|||
19392324|NCT01954342|41636466|FG001|Overall Study|Preterm delivery|0|||
19480575|NCT01439971|41760769|FG002|Overall Study|Required number in cohort dosed|2|||
19480576|NCT01439971|41760770|FG003|Overall Study|Required number in cohort dosed|0|||
19480577|NCT01439971|41760771|FG004|Overall Study|Required number in cohort dosed|1|||
19480578|NCT01551758|41760852|FG000|Overall Study|Adverse Event|29|||
19480579|NCT01551758|41760853|FG001|Overall Study|Adverse Event|43|||
19480580|NCT01551758|41760852|FG000|Overall Study|Lack of Efficacy|0|||
19480581|NCT01551758|41760853|FG001|Overall Study|Lack of Efficacy|1|||
19392325|NCT01954342|41636467|FG002|Overall Study|Preterm delivery|0|||
19392326|NCT01954342|41636468|FG003|Overall Study|Preterm delivery|3|||
19392327|NCT01954342|41636465|FG000|Overall Study|Pre-eclampsia|0|||
19392328|NCT01954342|41636466|FG001|Overall Study|Pre-eclampsia|0|||
19392329|NCT01954342|41636467|FG002|Overall Study|Pre-eclampsia|0|||
19392330|NCT01954342|41636468|FG003|Overall Study|Pre-eclampsia|4|||
19480582|NCT01551758|41760852|FG000|Overall Study|Protocol Violation|5|||
19480583|NCT01551758|41760853|FG001|Overall Study|Protocol Violation|6|||
19480584|NCT01551758|41760852|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
19480585|NCT01551758|41760853|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
19480586|NCT01551758|41760852|FG000|Overall Study|Lost to Follow-up|29|||
19480587|NCT01551758|41760853|FG001|Overall Study|Lost to Follow-up|25|||
19480588|NCT01551758|41760852|FG000|Overall Study|Physician Decision|9|||
19480589|NCT01551758|41760853|FG001|Overall Study|Physician Decision|3|||
19480590|NCT01551758|41760852|FG000|Overall Study|Withdrawal by Subject|14|||
19480591|NCT01551758|41760853|FG001|Overall Study|Withdrawal by Subject|17|||
19480592|NCT01449461|41761056|FG000|Overall Study|Adverse Event|0|||
19480593|NCT01449461|41761057|FG001|Overall Study|Adverse Event|3|||
19480594|NCT01449461|41761058|FG002|Overall Study|Adverse Event|2|||
19480595|NCT01449461|41761059|FG003|Overall Study|Adverse Event|3|||
19480596|NCT01449461|41761060|FG004|Overall Study|Adverse Event|4|||
19480597|NCT01449461|41761061|FG005|Overall Study|Adverse Event|4|||
19480598|NCT01449461|41761056|FG000|Overall Study|Death|0|||
19480599|NCT01449461|41761057|FG001|Overall Study|Death|2|||
19480600|NCT01449461|41761058|FG002|Overall Study|Death|0|||
19480601|NCT01449461|41761059|FG003|Overall Study|Death|0|||
19480602|NCT01449461|41761060|FG004|Overall Study|Death|7|||
19480603|NCT01449461|41761061|FG005|Overall Study|Death|1|||
19480604|NCT01449461|41761056|FG000|Overall Study|Physician Decision|0|||
19480605|NCT01449461|41761057|FG001|Overall Study|Physician Decision|1|||
19703839|NCT00202644|42148153|FG001|Overall Study|Withdrawal by Subject|6|||
19703840|NCT00202644|42148152|FG000|Overall Study|Lack of Efficacy|6|||
19703841|NCT00202644|42148153|FG001|Overall Study|Lack of Efficacy|6|||
19703842|NCT00202644|42148152|FG000|Overall Study|Lost to Follow-up|0|||
19480606|NCT01449461|41761058|FG002|Overall Study|Physician Decision|0|||
19480607|NCT01449461|41761059|FG003|Overall Study|Physician Decision|4|||
19480608|NCT01449461|41761060|FG004|Overall Study|Physician Decision|1|||
19480609|NCT01449461|41761061|FG005|Overall Study|Physician Decision|0|||
19480610|NCT01449461|41761056|FG000|Overall Study|Documented Progressive Disease|4|||
19480611|NCT01449461|41761057|FG001|Overall Study|Documented Progressive Disease|7|||
19480612|NCT01449461|41761058|FG002|Overall Study|Documented Progressive Disease|14|||
19480613|NCT01449461|41761059|FG003|Overall Study|Documented Progressive Disease|15|||
19480614|NCT01449461|41761060|FG004|Overall Study|Documented Progressive Disease|24|||
19480615|NCT01449461|41761061|FG005|Overall Study|Documented Progressive Disease|5|||
19480616|NCT01449461|41761056|FG000|Overall Study|Clinical Progressive Disease|2|||
19480617|NCT01449461|41761057|FG001|Overall Study|Clinical Progressive Disease|2|||
19480618|NCT01449461|41761058|FG002|Overall Study|Clinical Progressive Disease|0|||
19480619|NCT01449461|41761059|FG003|Overall Study|Clinical Progressive Disease|3|||
19480620|NCT01449461|41761060|FG004|Overall Study|Clinical Progressive Disease|4|||
19480621|NCT01449461|41761061|FG005|Overall Study|Clinical Progressive Disease|2|||
19480622|NCT01449461|41761056|FG000|Overall Study|Protocol Violation|0|||
19480623|NCT01449461|41761057|FG001|Overall Study|Protocol Violation|0|||
19480624|NCT01449461|41761058|FG002|Overall Study|Protocol Violation|0|||
19480625|NCT01449461|41761059|FG003|Overall Study|Protocol Violation|1|||
19480626|NCT01449461|41761060|FG004|Overall Study|Protocol Violation|0|||
19480627|NCT01449461|41761061|FG005|Overall Study|Protocol Violation|0|||
19480628|NCT01449461|41761056|FG000|Overall Study|Site Terminated by Sponsor|0|||
19480629|NCT01449461|41761057|FG001|Overall Study|Site Terminated by Sponsor|1|||
19480630|NCT01449461|41761058|FG002|Overall Study|Site Terminated by Sponsor|2|||
19480631|NCT01449461|41761059|FG003|Overall Study|Site Terminated by Sponsor|3|||
19480632|NCT01449461|41761060|FG004|Overall Study|Site Terminated by Sponsor|4|||
19480633|NCT01449461|41761061|FG005|Overall Study|Site Terminated by Sponsor|1|||
19703843|NCT00202644|42148153|FG001|Overall Study|Lost to Follow-up|1|||
19703844|NCT00202644|42148152|FG000|Overall Study|Other|9|||
19703845|NCT00202644|42148153|FG001|Overall Study|Other|1|||
19703846|NCT01235962|42148163|FG000|Overall Study|Withdrawal by Subject|20|||
19703847|NCT01235962|42148164|FG001|Overall Study|Withdrawal by Subject|19|||
19703848|NCT01235962|42148165|FG002|Overall Study|Withdrawal by Subject|62|||
19703849|NCT01235962|42148166|FG003|Overall Study|Withdrawal by Subject|49|||
19392331|NCT01954342|41636465|FG000|Overall Study|Unreliable Data|0|||
19392332|NCT01954342|41636466|FG001|Overall Study|Unreliable Data|0|||
19392333|NCT01954342|41636467|FG002|Overall Study|Unreliable Data|0|||
19480634|NCT01449461|41761056|FG000|Overall Study|Withdrawal by Subject|0|||
19480635|NCT01449461|41761057|FG001|Overall Study|Withdrawal by Subject|1|||
19480636|NCT01449461|41761058|FG002|Overall Study|Withdrawal by Subject|0|||
19480637|NCT01449461|41761059|FG003|Overall Study|Withdrawal by Subject|0|||
19480638|NCT01449461|41761060|FG004|Overall Study|Withdrawal by Subject|2|||
19480639|NCT01449461|41761061|FG005|Overall Study|Withdrawal by Subject|1|||
19480640|NCT01449461|41761056|FG000|Overall Study|Reason not Specified|0|||
19480641|NCT01449461|41761057|FG001|Overall Study|Reason not Specified|1|||
19480642|NCT01449461|41761058|FG002|Overall Study|Reason not Specified|0|||
19480643|NCT01449461|41761059|FG003|Overall Study|Reason not Specified|3|||
19480644|NCT01449461|41761060|FG004|Overall Study|Reason not Specified|2|||
19480645|NCT01449461|41761061|FG005|Overall Study|Reason not Specified|1|||
19480646|NCT01572038|41761097|FG000|Overall Study|Death|648|||
19480647|NCT01572038|41761097|FG000|Overall Study|Withdrawal by Subject|204|||
19480648|NCT01572038|41761097|FG000|Overall Study|Lost to Follow-up|81|||
19480649|NCT01572038|41761097|FG000|Overall Study|Physician Decision|20|||
19480650|NCT01572038|41761097|FG000|Overall Study|Patient Decision|14|||
19480651|NCT01572038|41761097|FG000|Overall Study|Progressive Disease|8|||
19480652|NCT01572038|41761097|FG000|Overall Study|Site Closed Before Completing Form|6|||
19480653|NCT01572038|41761097|FG000|Overall Study|Enrolled into Another Trial|3|||
19480654|NCT01572038|41761097|FG000|Overall Study|Participated in Another Trial|3|||
19480655|NCT01572038|41761097|FG000|Overall Study|Termination by Sponsor|2|||
19480656|NCT01572038|41761097|FG000|Overall Study|Patient Deterioration|1|||
19480657|NCT01572038|41761097|FG000|Overall Study|Sponsor Decision|1|||
19480658|NCT01448213|41761125|FG000|Overall Study|Lost to Follow-up|12|||
19480659|NCT01448213|41761126|FG001|Overall Study|Lost to Follow-up|10|||
19480660|NCT01448213|41761125|FG000|Overall Study|Adverse Event|4|||
19480661|NCT01448213|41761126|FG001|Overall Study|Adverse Event|10|||
19480662|NCT01448213|41761125|FG000|Overall Study|Protocol Violation|1|||
19480663|NCT01448213|41761126|FG001|Overall Study|Protocol Violation|2|||
19480664|NCT01448057|41761143|FG000|Overall Study|Protocol Violation|3|||
19480665|NCT01448057|41761144|FG001|Overall Study|Protocol Violation|2|||
19480666|NCT01448057|41761143|FG000|Overall Study|Lost to Follow-up|3|||
19480667|NCT01448057|41761144|FG001|Overall Study|Lost to Follow-up|0|||
19480668|NCT01448057|41761143|FG000|Overall Study|Adverse Event|0|||
19480669|NCT01448057|41761144|FG001|Overall Study|Adverse Event|2|||
19480670|NCT01448057|41761143|FG000|Overall Study|Withdrawal by Subject|2|||
19480671|NCT01448057|41761144|FG001|Overall Study|Withdrawal by Subject|0|||
19480672|NCT01447433|41761152|FG000|Overall Study|Lost to Follow-up|0|||
19480673|NCT01447433|41761153|FG001|Overall Study|Lost to Follow-up|2|||
19480674|NCT01447433|41761152|FG000|Overall Study|Withdrawal by Subject|3|||
19480675|NCT01447433|41761153|FG001|Overall Study|Withdrawal by Subject|3|||
19480676|NCT01447433|41761152|FG000|Overall Study|Protocol Violation|1|||
19480677|NCT01447433|41761153|FG001|Overall Study|Protocol Violation|1|||
19480678|NCT01446965|41761161|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
19480679|NCT01446965|41761162|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
19480680|NCT01446965|41761161|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
19480681|NCT01446965|41761162|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
19480682|NCT01446809|41761170|FG000|Overall Study|Adverse Event|0|||
19611718|NCT00620113|42060482|FG001|Overall Study|Adverse Event|2|||
19480683|NCT01446809|41761171|FG001|Overall Study|Adverse Event|0|||
19480684|NCT01446809|41761172|FG002|Overall Study|Adverse Event|1|||
19480685|NCT01446809|41761170|FG000|Overall Study|Failure to complete study procedures|0|||
19480686|NCT01446809|41761171|FG001|Overall Study|Failure to complete study procedures|0|||
19480687|NCT01446809|41761172|FG002|Overall Study|Failure to complete study procedures|1|||
19480688|NCT01446419|41761183|FG000|Overall Study|Death|1|||
19611719|NCT00620113|42060483|FG002|Overall Study|Adverse Event|2|||
19703850|NCT01235962|42148163|FG000|Overall Study|Lost to Follow-up|21|||
19611720|NCT00620113|42060484|FG003|Overall Study|Adverse Event|1|||
19703851|NCT01235962|42148164|FG001|Overall Study|Lost to Follow-up|16|||
19703852|NCT01235962|42148165|FG002|Overall Study|Lost to Follow-up|47|||
19703853|NCT01235962|42148166|FG003|Overall Study|Lost to Follow-up|32|||
19703854|NCT01235962|42148163|FG000|Overall Study|Physician Decision|5|||
19703855|NCT01235962|42148164|FG001|Overall Study|Physician Decision|0|||
19703856|NCT01235962|42148165|FG002|Overall Study|Physician Decision|9|||
19703857|NCT01235962|42148166|FG003|Overall Study|Physician Decision|5|||
19703858|NCT00259740|42148186|FG000|Overall Study|Physician Decision|1|||
19703859|NCT00259740|42148187|FG001|Overall Study|Physician Decision|1|||
19703860|NCT00259740|42148186|FG000|Overall Study|Adverse Event|0|||
19703861|NCT00259740|42148187|FG001|Overall Study|Adverse Event|2|||
19703862|NCT00259740|42148186|FG000|Overall Study|Withdrawal by Subject|2|||
19703863|NCT00259740|42148187|FG001|Overall Study|Withdrawal by Subject|6|||
19703864|NCT00259740|42148186|FG000|Overall Study|Death|1|||
19703865|NCT00259740|42148187|FG001|Overall Study|Death|1|||
19703866|NCT00259740|42148186|FG000|Overall Study|Disease progression|19|||
19480689|NCT01446419|41761184|FG001|Overall Study|Death|0|||
19480690|NCT01446419|41761183|FG000|Overall Study|Withdrawal by Subject|1|||
19480691|NCT01446419|41761184|FG001|Overall Study|Withdrawal by Subject|1|||
19703867|NCT00259740|42148187|FG001|Overall Study|Disease progression|36|||
19703868|NCT00259740|42148186|FG000|Overall Study|Ongoing|17|||
19392334|NCT01954342|41636468|FG003|Overall Study|Unreliable Data|2|||
19392335|NCT01972438|41636480|FG000|Baseline-Month 3 Crossover Period|Death|1|||
19611721|NCT00620113|42060481|FG000|Overall Study|Lack of Efficacy|2|||
19611722|NCT00620113|42060482|FG001|Overall Study|Lack of Efficacy|3|||
19611723|NCT00620113|42060483|FG002|Overall Study|Lack of Efficacy|0|||
19611724|NCT00620113|42060484|FG003|Overall Study|Lack of Efficacy|2|||
19611725|NCT00620113|42060481|FG000|Overall Study|Physician Decision|1|||
19611726|NCT00620113|42060482|FG001|Overall Study|Physician Decision|0|||
19611727|NCT00620113|42060483|FG002|Overall Study|Physician Decision|0|||
19611728|NCT00620113|42060484|FG003|Overall Study|Physician Decision|2|||
19611729|NCT00620113|42060481|FG000|Overall Study|Protocol Violation|2|||
19611730|NCT00620113|42060482|FG001|Overall Study|Protocol Violation|1|||
19611731|NCT00620113|42060483|FG002|Overall Study|Protocol Violation|0|||
19611732|NCT00620113|42060484|FG003|Overall Study|Protocol Violation|0|||
19611733|NCT00620113|42060481|FG000|Overall Study|Withdrawal by Subject|5|||
19611734|NCT00620113|42060482|FG001|Overall Study|Withdrawal by Subject|1|||
19611735|NCT00620113|42060483|FG002|Overall Study|Withdrawal by Subject|3|||
19611736|NCT00620113|42060484|FG003|Overall Study|Withdrawal by Subject|5|||
19611737|NCT00830115|42060494|FG000|Overall Study|Adverse Event|2|||
19611738|NCT00830115|42060494|FG000|Overall Study|Improvement/recovery|1|||
19611739|NCT00830037|42060502|FG000|Overall Study|Withdrawal by Subject|2|||
19611740|NCT00830037|42060503|FG001|Overall Study|Withdrawal by Subject|3|||
19611741|NCT00830037|42060502|FG000|Overall Study|Lost to Follow-up|1|||
19611742|NCT00830037|42060503|FG001|Overall Study|Lost to Follow-up|2|||
19611743|NCT00830037|42060502|FG000|Overall Study|Active when terminated by DSMB|15|||
19611744|NCT00830037|42060503|FG001|Overall Study|Active when terminated by DSMB|14|||
19611745|NCT00829413|42060509|FG000|Overall Study|No study drug admimnistered|13|||
19611746|NCT00829413|42060509|FG000|Overall Study|Training Patients|67|||
19703869|NCT00259740|42148187|FG001|Overall Study|Ongoing|3|||
19703870|NCT00259740|42148186|FG000|Overall Study|Other|3|||
19703871|NCT00259740|42148187|FG001|Overall Study|Other|0|||
19703872|NCT00259740|42148186|FG000|Overall Study|Requirement for alternative therapy|0|||
19703873|NCT00259740|42148187|FG001|Overall Study|Requirement for alternative therapy|4|||
19703874|NCT00201006|42148196|FG000|Overall Study|Withdrawal by Subject|7|||
19703875|NCT00201006|42148197|FG001|Overall Study|Withdrawal by Subject|2|||
19703876|NCT00201006|42148198|FG002|Overall Study|Withdrawal by Subject|3|||
19703877|NCT00201006|42148196|FG000|Overall Study|Adverse Event|1|||
19703878|NCT00201006|42148197|FG001|Overall Study|Adverse Event|0|||
19703879|NCT00201006|42148198|FG002|Overall Study|Adverse Event|1|||
19703880|NCT00200850|42148209|FG000|Overall Study|relocation|1|||
19703881|NCT00200850|42148210|FG001|Overall Study|relocation|0|||
19703882|NCT00200850|42148211|FG002|Overall Study|relocation|1|||
19703883|NCT00200850|42148209|FG000|Overall Study|too busy|1|||
19703884|NCT00200850|42148210|FG001|Overall Study|too busy|0|||
19392336|NCT01972438|41636481|FG001|Baseline-Month 3 Crossover Period|Death|0|||
19611747|NCT00829413|42060509|FG000|Overall Study|No truth standard procedure available|9|||
19703885|NCT00200850|42148211|FG002|Overall Study|too busy|0|||
19703886|NCT00200850|42148209|FG000|Overall Study|Pregnancy|0|||
19392337|NCT01972438|41636480|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
19392338|NCT01972438|41636481|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
19392339|NCT01972438|41636480|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
19392340|NCT01972438|41636481|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
19392341|NCT01972438|41636480|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
19392342|NCT01972438|41636481|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
19392343|NCT01972438|41636480|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
19392344|NCT01972438|41636481|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
19392345|NCT01972438|41636480|FG000|Months 6-12 Study Period|Death|1|||
19392346|NCT01972438|41636481|FG001|Months 6-12 Study Period|Death|0|||
19611748|NCT00829413|42060509|FG000|Overall Study|Technically inadequate truth standard|2|||
19611749|NCT00829413|42060509|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
19611750|NCT00829179|42060520|FG000|Overall Study|Withdrawal by Subject|1|||
19392347|NCT01972438|41636480|FG000|Months 6-12 Study Period|Early Study Closure|2|||
19392348|NCT01972438|41636481|FG001|Months 6-12 Study Period|Early Study Closure|2|||
19392349|NCT01972438|41636480|FG000|Post Month 12 Study Period|Early Study Closure|3|||
19392350|NCT01972438|41636481|FG001|Post Month 12 Study Period|Early Study Closure|4|||
19392351|NCT01946152|41636493|FG000|Overall Study|Adverse Event|1|||
19392352|NCT01946152|41636494|FG001|Overall Study|Adverse Event|0|||
19480692|NCT01446419|41761183|FG000|Overall Study|Terminated per protocol|3|||
19480693|NCT01446419|41761184|FG001|Overall Study|Terminated per protocol|0|||
19480694|NCT01445951|41761193|FG000|Overall Study|Adverse Event|16|||
19480695|NCT01445951|41761194|FG001|Overall Study|Adverse Event|9|||
19480696|NCT01445951|41761195|FG002|Overall Study|Adverse Event|0|||
19480697|NCT01445951|41761193|FG000|Overall Study|Protocol Violation|2|||
19480698|NCT01445951|41761194|FG001|Overall Study|Protocol Violation|2|||
19480699|NCT01445951|41761195|FG002|Overall Study|Protocol Violation|2|||
19480700|NCT01445951|41761193|FG000|Overall Study|Withdrawal by Subject|21|||
19480701|NCT01445951|41761194|FG001|Overall Study|Withdrawal by Subject|16|||
19480702|NCT01445951|41761195|FG002|Overall Study|Withdrawal by Subject|8|||
19480703|NCT01445951|41761193|FG000|Overall Study|Physician Decision|3|||
19480704|NCT01445951|41761194|FG001|Overall Study|Physician Decision|1|||
19480705|NCT01445951|41761195|FG002|Overall Study|Physician Decision|0|||
19480706|NCT01445951|41761193|FG000|Overall Study|Lost to Follow-up|1|||
19480707|NCT01445951|41761194|FG001|Overall Study|Lost to Follow-up|2|||
19480708|NCT01445951|41761195|FG002|Overall Study|Lost to Follow-up|4|||
19480709|NCT01445951|41761193|FG000|Overall Study|Pregnancy|0|||
19480710|NCT01445951|41761194|FG001|Overall Study|Pregnancy|1|||
19392353|NCT01946152|41636495|FG002|Overall Study|Adverse Event|0|||
19392354|NCT01946152|41636496|FG003|Overall Study|Adverse Event|0|||
19480711|NCT01445951|41761195|FG002|Overall Study|Pregnancy|4|||
19480712|NCT01445951|41761193|FG000|Overall Study|Death|0|||
19392355|NCT01946152|41636493|FG000|Overall Study|Withdrawal by Subject|0|||
19392356|NCT01946152|41636494|FG001|Overall Study|Withdrawal by Subject|2|||
19611751|NCT00591591|42060526|FG000|Overall Study|Withdrawal by Subject|1|||
19392357|NCT01946152|41636495|FG002|Overall Study|Withdrawal by Subject|0|||
19392358|NCT01946152|41636496|FG003|Overall Study|Withdrawal by Subject|0|||
19480713|NCT01445951|41761194|FG001|Overall Study|Death|0|||
19480714|NCT01445951|41761195|FG002|Overall Study|Death|1|||
19480715|NCT01445951|41761193|FG000|Overall Study|Non-compliance with study drug|1|||
19480716|NCT01445951|41761194|FG001|Overall Study|Non-compliance with study drug|2|||
19480717|NCT01445951|41761195|FG002|Overall Study|Non-compliance with study drug|0|||
19480718|NCT01445951|41761193|FG000|Overall Study|Non-compliance with protocol|0|||
19480719|NCT01445951|41761194|FG001|Overall Study|Non-compliance with protocol|1|||
19480720|NCT01445951|41761195|FG002|Overall Study|Non-compliance with protocol|0|||
19611752|NCT00591591|42060527|FG001|Overall Study|Withdrawal by Subject|37|||
19611753|NCT00591591|42060526|FG000|Overall Study|Lack of Efficacy|10|||
19611754|NCT00591591|42060527|FG001|Overall Study|Lack of Efficacy|2|||
19611755|NCT00828945|42060533|FG000|Overall Study|Death|4|||
19611756|NCT00828945|42060533|FG000|Overall Study|Participant was missing|1|||
19611757|NCT00828945|42060533|FG000|Overall Study|Other|36|||
19611758|NCT00966875|42060546|FG000|Part A|Adverse Event|2|||
19480721|NCT01445951|41761193|FG000|Overall Study|Sponsor decision - subject travel|0|||
19611759|NCT00966875|42060547|FG001|Part A|Adverse Event|1|||
19480722|NCT01445951|41761194|FG001|Overall Study|Sponsor decision - subject travel|1|||
19480723|NCT01445951|41761195|FG002|Overall Study|Sponsor decision - subject travel|0|||
19480724|NCT01445951|41761193|FG000|Overall Study|Cough|0|||
19480725|NCT01445951|41761194|FG001|Overall Study|Cough|1|||
19480726|NCT01445951|41761195|FG002|Overall Study|Cough|0|||
19480727|NCT01445171|41761203|FG000|Overall Study|Lost to Follow-up|11|||
19480728|NCT01445171|41761203|FG000|Overall Study|Withdrawal by Subject|16|||
19480729|NCT01445171|41761203|FG000|Overall Study|Death|51|||
19480730|NCT01445171|41761203|FG000|Overall Study|Subjects declined to return for followup|9|||
19480731|NCT01445171|41761203|FG000|Overall Study|Consented but did not receive device|8|||
19480732|NCT01444781|41761212|FG000|Overall Study|Lost to Follow-up|0|||
19480733|NCT01444781|41761213|FG001|Overall Study|Lost to Follow-up|3|||
19480734|NCT01444781|41761214|FG002|Overall Study|Lost to Follow-up|1|||
19480735|NCT01444781|41761212|FG000|Overall Study|Withdrawal by Subject|3|||
19480736|NCT01444781|41761213|FG001|Overall Study|Withdrawal by Subject|1|||
19480737|NCT01444781|41761214|FG002|Overall Study|Withdrawal by Subject|2|||
19480738|NCT01444391|41761229|FG000|Overall Study|Death|1|||
19480739|NCT01443923|41761235|FG000|Overall Study|Adverse Event|1|||
19480740|NCT01443923|41761236|FG001|Overall Study|Adverse Event|0|||
19480741|NCT01551212|41761248|FG000|Overall Study|Graft loss/Retransplantation|0|||
19480742|NCT01551212|41761249|FG001|Overall Study|Graft loss/Retransplantation|1|||
19480743|NCT01551212|41761248|FG000|Overall Study|Administrative problems|1|||
19480744|NCT01551212|41761249|FG001|Overall Study|Administrative problems|2|||
19480745|NCT01551212|41761248|FG000|Overall Study|Lost to Follow-up|0|||
19480746|NCT01551212|41761249|FG001|Overall Study|Lost to Follow-up|1|||
19480747|NCT01551212|41761248|FG000|Overall Study|Protocol Violation|0|||
19480748|NCT01551212|41761249|FG001|Overall Study|Protocol Violation|1|||
19480749|NCT01551212|41761248|FG000|Overall Study|Withdrawal by Subject|0|||
19480750|NCT01551212|41761249|FG001|Overall Study|Withdrawal by Subject|7|||
19480751|NCT01551212|41761248|FG000|Overall Study|Death|2|||
19480752|NCT01551212|41761249|FG001|Overall Study|Death|4|||
19480753|NCT01551212|41761248|FG000|Overall Study|Never Received Study Treatment|2|||
19480754|NCT01551212|41761249|FG001|Overall Study|Never Received Study Treatment|4|||
19480755|NCT01550744|41761309|FG000|Open-Label|Lost to Follow-up|7|||
19480756|NCT01550744|41761310|FG001|Open-Label|Lost to Follow-up|0|||
19480757|NCT01550744|41761311|FG002|Open-Label|Lost to Follow-up|0|||
19480758|NCT01550744|41761309|FG000|Open-Label|Withdrawal by Subject|13|||
19480759|NCT01550744|41761310|FG001|Open-Label|Withdrawal by Subject|0|||
19480760|NCT01550744|41761311|FG002|Open-Label|Withdrawal by Subject|0|||
19480761|NCT01550744|41761309|FG000|Open-Label|Adverse Event|11|||
19480762|NCT01550744|41761310|FG001|Open-Label|Adverse Event|0|||
19480763|NCT01550744|41761311|FG002|Open-Label|Adverse Event|0|||
19480764|NCT01550744|41761309|FG000|Open-Label|Lack of Efficacy|4|||
19480765|NCT01550744|41761310|FG001|Open-Label|Lack of Efficacy|0|||
19480766|NCT01550744|41761311|FG002|Open-Label|Lack of Efficacy|0|||
19480767|NCT01550744|41761309|FG000|Open-Label|Protocol Violation|4|||
19480768|NCT01550744|41761310|FG001|Open-Label|Protocol Violation|0|||
19480769|NCT01550744|41761311|FG002|Open-Label|Protocol Violation|0|||
19480770|NCT01550744|41761309|FG000|Open-Label|Not all 3 study drug injections received|2|||
19480771|NCT01550744|41761310|FG001|Open-Label|Not all 3 study drug injections received|0|||
19480772|NCT01550744|41761311|FG002|Open-Label|Not all 3 study drug injections received|0|||
19480773|NCT01550744|41761309|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
19480774|NCT01550744|41761310|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
19480775|NCT01550744|41761311|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
19480776|NCT01550744|41761309|FG000|Open-Label|Other|1|||
19480777|NCT01550744|41761310|FG001|Open-Label|Other|0|||
19480778|NCT01550744|41761311|FG002|Open-Label|Other|0|||
19480779|NCT01550744|41761309|FG000|Double-Blind|Lost to Follow-up|0|||
19480780|NCT01550744|41761310|FG001|Double-Blind|Lost to Follow-up|6|||
19611760|NCT00966875|42060548|FG002|Part A|Adverse Event|0|||
19611761|NCT00966875|42060549|FG003|Part A|Adverse Event|1|||
19611762|NCT00966875|42060550|FG004|Part A|Adverse Event|0|||
19611763|NCT00966875|42060551|FG005|Part A|Adverse Event|1|||
19703887|NCT00200850|42148210|FG001|Overall Study|Pregnancy|0|||
19480781|NCT01550744|41761311|FG002|Double-Blind|Lost to Follow-up|12|||
19480782|NCT01550744|41761309|FG000|Double-Blind|Withdrawal by Subject|0|||
19480783|NCT01550744|41761310|FG001|Double-Blind|Withdrawal by Subject|2|||
19480784|NCT01550744|41761311|FG002|Double-Blind|Withdrawal by Subject|15|||
19480785|NCT01550744|41761309|FG000|Double-Blind|Adverse Event|0|||
19480786|NCT01550744|41761310|FG001|Double-Blind|Adverse Event|4|||
19480787|NCT01550744|41761311|FG002|Double-Blind|Adverse Event|15|||
19480788|NCT01550744|41761309|FG000|Double-Blind|Death|0|||
19480789|NCT01550744|41761310|FG001|Double-Blind|Death|1|||
19480790|NCT01550744|41761311|FG002|Double-Blind|Death|0|||
19480791|NCT01550744|41761309|FG000|Double-Blind|Lack of Efficacy|0|||
19480792|NCT01550744|41761310|FG001|Double-Blind|Lack of Efficacy|2|||
19480793|NCT01550744|41761311|FG002|Double-Blind|Lack of Efficacy|8|||
19480794|NCT01550744|41761309|FG000|Double-Blind|Protocol Violation|0|||
19611764|NCT00966875|42060552|FG006|Part A|Adverse Event|0|||
19703888|NCT00200850|42148211|FG002|Overall Study|Pregnancy|1|||
19480795|NCT01550744|41761310|FG001|Double-Blind|Protocol Violation|0|||
19480796|NCT01550744|41761311|FG002|Double-Blind|Protocol Violation|4|||
19392359|NCT01946152|41636493|FG000|Overall Study|Progression|0|||
19392360|NCT01946152|41636494|FG001|Overall Study|Progression|1|||
19392361|NCT01946152|41636495|FG002|Overall Study|Progression|4|||
19392362|NCT01946152|41636496|FG003|Overall Study|Progression|7|||
19392363|NCT01946152|41636493|FG000|Overall Study|Physician Decision|0|||
19392364|NCT01946152|41636494|FG001|Overall Study|Physician Decision|0|||
19480797|NCT01550744|41761309|FG000|Double-Blind|Pregnancy|0|||
19480798|NCT01550744|41761310|FG001|Double-Blind|Pregnancy|0|||
19480799|NCT01550744|41761311|FG002|Double-Blind|Pregnancy|3|||
19480800|NCT01550744|41761309|FG000|Double-Blind|Other|0|||
19480801|NCT01550744|41761310|FG001|Double-Blind|Other|2|||
19480802|NCT01550744|41761311|FG002|Double-Blind|Other|10|||
19480803|NCT01549964|41761372|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
19480804|NCT01549964|41761373|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
19480805|NCT01549964|41761374|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
19480806|NCT01549964|41761375|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
19480807|NCT01549964|41761372|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
19480808|NCT01549964|41761373|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
19480809|NCT01549964|41761374|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
19480810|NCT01549964|41761375|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
19480811|NCT01549964|41761372|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
19480812|NCT01549964|41761373|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
19480813|NCT01549964|41761374|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
19480814|NCT01549964|41761375|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
19480815|NCT01549964|41761372|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
19480816|NCT01549964|41761373|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
19480817|NCT01549964|41761374|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
19480818|NCT01549964|41761375|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
19480819|NCT01549964|41761372|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
19480820|NCT01549964|41761373|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
19480821|NCT01549964|41761374|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
19480822|NCT01549964|41761375|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
19480823|NCT01549964|41761372|FG000|24-Week Treatment Period|Other|1|||
19480824|NCT01549964|41761373|FG001|24-Week Treatment Period|Other|0|||
19480825|NCT01549964|41761374|FG002|24-Week Treatment Period|Other|1|||
19480826|NCT01549964|41761375|FG003|24-Week Treatment Period|Other|0|||
19480827|NCT01549964|41761372|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
19480828|NCT01549964|41761373|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
19480829|NCT01549964|41761374|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
19480830|NCT01549964|41761375|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
19480831|NCT01549964|41761372|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
19480832|NCT01549964|41761373|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
19480833|NCT01549964|41761374|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
19480834|NCT01549964|41761375|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
19480835|NCT01549964|41761372|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
19480836|NCT01549964|41761373|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
19480837|NCT01549964|41761374|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
19480838|NCT01549964|41761375|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
19480839|NCT01549964|41761372|FG000|80-Week Extension Period|Pregnancy|0|||
19480840|NCT01549964|41761373|FG001|80-Week Extension Period|Pregnancy|0|||
19480841|NCT01549964|41761374|FG002|80-Week Extension Period|Pregnancy|1|||
19480842|NCT01549964|41761375|FG003|80-Week Extension Period|Pregnancy|0|||
19480843|NCT01549964|41761372|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
19480844|NCT01549964|41761373|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
19480845|NCT01549964|41761374|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
19480846|NCT01549964|41761375|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
19480847|NCT01549964|41761372|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
19392365|NCT01946152|41636495|FG002|Overall Study|Physician Decision|1|||
19392366|NCT01946152|41636496|FG003|Overall Study|Physician Decision|0|||
19392367|NCT01946152|41636493|FG000|Overall Study|Second malignancy|0|||
19392368|NCT01946152|41636494|FG001|Overall Study|Second malignancy|0|||
19392369|NCT01946152|41636495|FG002|Overall Study|Second malignancy|1|||
19392370|NCT01946152|41636496|FG003|Overall Study|Second malignancy|0|||
19480848|NCT01549964|41761373|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
19480849|NCT01549964|41761374|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
19480850|NCT01549964|41761375|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
19611765|NCT00966875|42060553|FG007|Part A|Adverse Event|3|||
19392371|NCT01946152|41636493|FG000|Overall Study|Adverse Event|0|||
19392372|NCT01946152|41636494|FG001|Overall Study|Adverse Event|0|||
19392373|NCT01946152|41636495|FG002|Overall Study|Adverse Event|0|||
19392374|NCT01946152|41636496|FG003|Overall Study|Adverse Event|1|||
19480851|NCT01549964|41761372|FG000|80-Week Extension Period|Lost to Follow-up|1|||
19480852|NCT01549964|41761373|FG001|80-Week Extension Period|Lost to Follow-up|0|||
19392375|NCT01945996|41636510|FG000|Overall Study|Lost to Follow-up|3|||
19392376|NCT01945996|41636511|FG001|Overall Study|Lost to Follow-up|5|||
19480853|NCT01549964|41761374|FG002|80-Week Extension Period|Lost to Follow-up|2|||
19392377|NCT01971346|41636519|FG000|Overall Study|Protocol Violation|3|||
19392378|NCT01971346|41636519|FG000|Overall Study|Lost to Follow-up|2|||
19392379|NCT01971346|41636519|FG000|Overall Study|Withdrawal by Subject|2|||
19392380|NCT01971346|41636519|FG000|Overall Study|Physician Decision|1|||
19392381|NCT01945216|41636534|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
19392382|NCT01945216|41636534|FG000|Overall Study|Protocol Violation|42|||
19392383|NCT01945216|41636534|FG000|Overall Study|CRF not assured by investigators|5|||
19392384|NCT02641379|41636553|FG000|Overall Study|Exclusion criterion during screening|1|||
19392385|NCT02641379|41636554|FG001|Overall Study|Exclusion criterion during screening|0|||
19480854|NCT01549964|41761375|FG003|80-Week Extension Period|Lost to Follow-up|1|||
19480855|NCT01549964|41761372|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
19480856|NCT01549964|41761373|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
19480857|NCT01549964|41761374|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
19480858|NCT01549964|41761375|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
19480859|NCT01570244|41761457|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
19480860|NCT01535222|41761492|FG000|Overall Study|Inclusion/exclusion|0|||
19480861|NCT01535222|41761493|FG001|Overall Study|Inclusion/exclusion|0|||
19480862|NCT01535222|41761494|FG002|Overall Study|Inclusion/exclusion|1|||
19480863|NCT01535222|41761495|FG003|Overall Study|Inclusion/exclusion|0|||
19480864|NCT01535222|41761496|FG004|Overall Study|Inclusion/exclusion|0|||
19480865|NCT01535222|41761497|FG005|Overall Study|Inclusion/exclusion|0|||
19480866|NCT01549886|41761513|FG000|Overall Study|Sponsor's decision|2|||
19480867|NCT01549886|41761514|FG001|Overall Study|Sponsor's decision|3|||
19480868|NCT01443845|41761543|FG000|Overall Study|Protocol Violation|43|||
19480869|NCT01443845|41761544|FG001|Overall Study|Protocol Violation|45|||
19480870|NCT01443845|41761543|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
19480871|NCT01443845|41761544|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
19480872|NCT01443845|41761543|FG000|Overall Study|Deterioration in pulmonary function|1|||
19480873|NCT01443845|41761544|FG001|Overall Study|Deterioration in pulmonary function|4|||
19480874|NCT01443845|41761543|FG000|Overall Study|Lack of Efficacy|10|||
19480875|NCT01443845|41761544|FG001|Overall Study|Lack of Efficacy|5|||
19480876|NCT01443845|41761543|FG000|Overall Study|Adverse Event|64|||
19480877|NCT01443845|41761544|FG001|Overall Study|Adverse Event|138|||
19480878|NCT01443845|41761543|FG000|Overall Study|Withdrawal by Subject|63|||
19480879|NCT01443845|41761544|FG001|Overall Study|Withdrawal by Subject|67|||
19480880|NCT01443845|41761543|FG000|Overall Study|Military Conflict - Site Terminated|20|||
19480881|NCT01443845|41761544|FG001|Overall Study|Military Conflict - Site Terminated|21|||
19480882|NCT01443845|41761543|FG000|Overall Study|Lost to Follow-up|9|||
19480883|NCT01443845|41761544|FG001|Overall Study|Lost to Follow-up|13|||
19480884|NCT01549652|41761553|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
19480885|NCT01549652|41761554|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
19480886|NCT01549652|41761555|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
19392386|NCT02641379|41636555|FG002|Overall Study|Exclusion criterion during screening|0|||
19392387|NCT02641379|41636556|FG003|Overall Study|Exclusion criterion during screening|1|||
19480887|NCT01549652|41761556|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
19480888|NCT01549652|41761553|FG000|Overall Study|Study Drug Titration Failure|5|||
19480889|NCT01549652|41761554|FG001|Overall Study|Study Drug Titration Failure|6|||
19480890|NCT01549652|41761555|FG002|Overall Study|Study Drug Titration Failure|0|||
19480891|NCT01549652|41761556|FG003|Overall Study|Study Drug Titration Failure|0|||
19480892|NCT01549652|41761553|FG000|Overall Study|Withdrawal Effect|0|||
19480893|NCT01549652|41761554|FG001|Overall Study|Withdrawal Effect|2|||
19480894|NCT01549652|41761555|FG002|Overall Study|Withdrawal Effect|0|||
19480895|NCT01549652|41761556|FG003|Overall Study|Withdrawal Effect|0|||
19480896|NCT01549652|41761553|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
19480897|NCT01549652|41761554|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
19480898|NCT01549652|41761555|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
19480899|NCT01549652|41761556|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
19480900|NCT01549652|41761553|FG000|Overall Study|Problem with Infusion|1|||
19480901|NCT01549652|41761554|FG001|Overall Study|Problem with Infusion|0|||
19480902|NCT01549652|41761555|FG002|Overall Study|Problem with Infusion|0|||
19480903|NCT01549652|41761556|FG003|Overall Study|Problem with Infusion|0|||
19480904|NCT01549652|41761553|FG000|Overall Study|Titration Non-Compliance|1|||
19480905|NCT01549652|41761554|FG001|Overall Study|Titration Non-Compliance|3|||
19480906|NCT01549652|41761555|FG002|Overall Study|Titration Non-Compliance|4|||
19480907|NCT01549652|41761556|FG003|Overall Study|Titration Non-Compliance|5|||
19480908|NCT01549652|41761553|FG000|Overall Study|Titration Side Effects|0|||
19480909|NCT01549652|41761554|FG001|Overall Study|Titration Side Effects|0|||
19480910|NCT01549652|41761555|FG002|Overall Study|Titration Side Effects|6|||
19480911|NCT01549652|41761556|FG003|Overall Study|Titration Side Effects|3|||
19392388|NCT02641379|41636557|FG004|Overall Study|Exclusion criterion during screening|2|||
19392389|NCT02641379|41636558|FG005|Overall Study|Exclusion criterion during screening|0|||
19392390|NCT02641379|41636559|FG006|Overall Study|Exclusion criterion during screening|0|||
19392391|NCT02641379|41636560|FG007|Overall Study|Exclusion criterion during screening|0|||
19392392|NCT02641379|41636561|FG008|Overall Study|Exclusion criterion during screening|0|||
19392393|NCT02641379|41636562|FG009|Overall Study|Exclusion criterion during screening|0|||
19392394|NCT02641379|41636563|FG010|Overall Study|Exclusion criterion during screening|0|||
19392395|NCT02641379|41636553|FG000|Overall Study|Withdrawal of informed consent|0|||
19392396|NCT02641379|41636554|FG001|Overall Study|Withdrawal of informed consent|1|||
19392397|NCT02641379|41636555|FG002|Overall Study|Withdrawal of informed consent|0|||
19392398|NCT02641379|41636556|FG003|Overall Study|Withdrawal of informed consent|0|||
19392399|NCT02641379|41636557|FG004|Overall Study|Withdrawal of informed consent|0|||
19392400|NCT02641379|41636558|FG005|Overall Study|Withdrawal of informed consent|0|||
19392401|NCT02641379|41636559|FG006|Overall Study|Withdrawal of informed consent|0|||
19392402|NCT02641379|41636560|FG007|Overall Study|Withdrawal of informed consent|1|||
19392403|NCT02641379|41636561|FG008|Overall Study|Withdrawal of informed consent|0|||
19392404|NCT02641379|41636562|FG009|Overall Study|Withdrawal of informed consent|0|||
19392405|NCT02641379|41636563|FG010|Overall Study|Withdrawal of informed consent|0|||
19392406|NCT02641379|41636553|FG000|Overall Study|Adverse Event|7|||
19392407|NCT02641379|41636554|FG001|Overall Study|Adverse Event|8|||
19392408|NCT02641379|41636555|FG002|Overall Study|Adverse Event|2|||
19392409|NCT02641379|41636556|FG003|Overall Study|Adverse Event|2|||
19392410|NCT02641379|41636557|FG004|Overall Study|Adverse Event|5|||
19392411|NCT02641379|41636558|FG005|Overall Study|Adverse Event|1|||
19392412|NCT02641379|41636559|FG006|Overall Study|Adverse Event|5|||
19392413|NCT02641379|41636560|FG007|Overall Study|Adverse Event|0|||
19392414|NCT02641379|41636561|FG008|Overall Study|Adverse Event|1|||
19392415|NCT02641379|41636562|FG009|Overall Study|Adverse Event|1|||
19392416|NCT02641379|41636563|FG010|Overall Study|Adverse Event|5|||
19392417|NCT02641379|41636553|FG000|Overall Study|Lack of Efficacy|0|||
19392418|NCT02641379|41636554|FG001|Overall Study|Lack of Efficacy|0|||
19392419|NCT02641379|41636555|FG002|Overall Study|Lack of Efficacy|2|||
19392420|NCT02641379|41636556|FG003|Overall Study|Lack of Efficacy|0|||
19392421|NCT02641379|41636557|FG004|Overall Study|Lack of Efficacy|0|||
19392422|NCT02641379|41636558|FG005|Overall Study|Lack of Efficacy|2|||
19392423|NCT02641379|41636559|FG006|Overall Study|Lack of Efficacy|0|||
19392424|NCT02641379|41636560|FG007|Overall Study|Lack of Efficacy|5|||
19392425|NCT02641379|41636561|FG008|Overall Study|Lack of Efficacy|0|||
19392426|NCT02641379|41636562|FG009|Overall Study|Lack of Efficacy|0|||
19392427|NCT02641379|41636563|FG010|Overall Study|Lack of Efficacy|0|||
19392428|NCT02641379|41636553|FG000|Overall Study|Participant unable to attend study visit|4|||
19392429|NCT02641379|41636554|FG001|Overall Study|Participant unable to attend study visit|10|||
19392430|NCT02641379|41636555|FG002|Overall Study|Participant unable to attend study visit|1|||
19392431|NCT02641379|41636556|FG003|Overall Study|Participant unable to attend study visit|2|||
19392432|NCT02641379|41636557|FG004|Overall Study|Participant unable to attend study visit|5|||
19392433|NCT02641379|41636558|FG005|Overall Study|Participant unable to attend study visit|1|||
19392434|NCT02641379|41636559|FG006|Overall Study|Participant unable to attend study visit|1|||
19392435|NCT02641379|41636560|FG007|Overall Study|Participant unable to attend study visit|1|||
19392436|NCT02641379|41636561|FG008|Overall Study|Participant unable to attend study visit|0|||
19392437|NCT02641379|41636562|FG009|Overall Study|Participant unable to attend study visit|2|||
19392438|NCT02641379|41636563|FG010|Overall Study|Participant unable to attend study visit|0|||
19392439|NCT02641379|41636553|FG000|Overall Study|Participant's compliance|0|||
19392440|NCT02641379|41636554|FG001|Overall Study|Participant's compliance|1|||
19392441|NCT02641379|41636555|FG002|Overall Study|Participant's compliance|0|||
19392442|NCT02641379|41636556|FG003|Overall Study|Participant's compliance|1|||
19392443|NCT02641379|41636557|FG004|Overall Study|Participant's compliance|0|||
19392444|NCT02641379|41636558|FG005|Overall Study|Participant's compliance|2|||
19392445|NCT02641379|41636559|FG006|Overall Study|Participant's compliance|0|||
19392446|NCT02641379|41636560|FG007|Overall Study|Participant's compliance|0|||
19392447|NCT02641379|41636561|FG008|Overall Study|Participant's compliance|1|||
19480912|NCT01549652|41761553|FG000|Overall Study|Withdrawal by Subject|0|||
19480913|NCT01549652|41761554|FG001|Overall Study|Withdrawal by Subject|0|||
19480914|NCT01549652|41761555|FG002|Overall Study|Withdrawal by Subject|5|||
19480915|NCT01549652|41761556|FG003|Overall Study|Withdrawal by Subject|3|||
19480916|NCT01569464|41761564|FG000|Overall Study|Adverse Event|4|||
19480917|NCT01569464|41761565|FG001|Overall Study|Adverse Event|0|||
19480918|NCT01569464|41761564|FG000|Overall Study|Lack of Efficacy|1|||
19480919|NCT01569464|41761565|FG001|Overall Study|Lack of Efficacy|0|||
19480920|NCT01569464|41761564|FG000|Overall Study|Protocol Violation|1|||
19480921|NCT01569464|41761565|FG001|Overall Study|Protocol Violation|0|||
19480922|NCT01569464|41761564|FG000|Overall Study|Lost to Follow-up|2|||
19480923|NCT01569464|41761565|FG001|Overall Study|Lost to Follow-up|3|||
19480924|NCT01569464|41761564|FG000|Overall Study|Withdrawal by Subject|1|||
19480925|NCT01569464|41761565|FG001|Overall Study|Withdrawal by Subject|1|||
19480926|NCT01569464|41761564|FG000|Overall Study|Other|1|||
19480927|NCT01569464|41761565|FG001|Overall Study|Other|1|||
19480928|NCT01534676|41761575|FG000|Overall Study|Study closed due to poor enrollment|2|||
19480929|NCT01534676|41761576|FG001|Overall Study|Study closed due to poor enrollment|1|||
19480930|NCT01442675|41761582|FG000|Overall Study|Protocol Violation|6|||
19480931|NCT01442675|41761582|FG000|Overall Study|Lost to Follow-up|2|||
19480932|NCT01442675|41761582|FG000|Overall Study|Withdrawal by Subject|4|||
19480933|NCT01534520|41761589|FG000|Overall Study|Adverse Event|0|||
19480934|NCT01534520|41761590|FG001|Overall Study|Adverse Event|1|||
19480935|NCT01534208|41761620|FG000|Overall Study|Lost to Follow-up|19|||
19480936|NCT01534208|41761621|FG001|Overall Study|Lost to Follow-up|14|||
19480937|NCT01534208|41761620|FG000|Overall Study|Withdrawal by Subject|6|||
19480938|NCT01534208|41761621|FG001|Overall Study|Withdrawal by Subject|20|||
19480939|NCT01534208|41761620|FG000|Overall Study|Adverse Event|15|||
19480940|NCT01534208|41761621|FG001|Overall Study|Adverse Event|8|||
19480941|NCT01534208|41761620|FG000|Overall Study|Physician Decision|2|||
19480942|NCT01534208|41761621|FG001|Overall Study|Physician Decision|0|||
19480943|NCT01534208|41761620|FG000|Overall Study|Lack of Efficacy|0|||
19480944|NCT01534208|41761621|FG001|Overall Study|Lack of Efficacy|3|||
19480945|NCT01534208|41761620|FG000|Overall Study|Protocol Violation|2|||
19480946|NCT01534208|41761621|FG001|Overall Study|Protocol Violation|2|||
19480947|NCT01534208|41761620|FG000|Overall Study|Sponsor decision|4|||
19480948|NCT01534208|41761621|FG001|Overall Study|Sponsor decision|1|||
19480949|NCT01534208|41761620|FG000|Overall Study|Subject relocation|2|||
19480950|NCT01534208|41761621|FG001|Overall Study|Subject relocation|0|||
19480951|NCT01534208|41761620|FG000|Overall Study|Lab assessment|2|||
19480952|NCT01534208|41761621|FG001|Overall Study|Lab assessment|1|||
19480953|NCT01534208|41761620|FG000|Overall Study|Eligibility error|3|||
19480954|NCT01534208|41761621|FG001|Overall Study|Eligibility error|0|||
19480955|NCT01534208|41761620|FG000|Overall Study|PCP decision|1|||
19480956|NCT01534208|41761621|FG001|Overall Study|PCP decision|0|||
19480957|NCT01534208|41761620|FG000|Overall Study|Needed prohibited meds|1|||
19611766|NCT00966875|42060554|FG008|Part A|Adverse Event|3|||
19480958|NCT01534208|41761621|FG001|Overall Study|Needed prohibited meds|0|||
19480959|NCT01548638|41761627|FG000|Overall Study|Protocol Violation|3|||
19480960|NCT01548638|41761627|FG000|Overall Study|Withdrawal by Subject|1|||
19480961|NCT01533428|41761651|FG000|Overall Study|Adverse Event|0|||
19480962|NCT01533428|41761652|FG001|Overall Study|Adverse Event|1|||
19392448|NCT02641379|41636562|FG009|Overall Study|Participant's compliance|1|||
19392449|NCT02641379|41636563|FG010|Overall Study|Participant's compliance|1|||
19392450|NCT02641379|41636553|FG000|Overall Study|Participant cannot be reached|4|||
19703889|NCT00200850|42148209|FG000|Overall Study|Poor adherence|0|||
19703890|NCT00200850|42148210|FG001|Overall Study|Poor adherence|0|||
19703891|NCT00200850|42148211|FG002|Overall Study|Poor adherence|1|||
19703892|NCT00200850|42148209|FG000|Overall Study|optic neuritis|0|||
19480963|NCT01533428|41761651|FG000|Overall Study|Lost to Follow-up|2|||
19480964|NCT01533428|41761652|FG001|Overall Study|Lost to Follow-up|1|||
19480965|NCT01533428|41761651|FG000|Overall Study|Withdrawal by Subject|7|||
19480966|NCT01533428|41761652|FG001|Overall Study|Withdrawal by Subject|6|||
19480967|NCT01517984|41761661|FG000|Overall Study|Lost to Follow-up|0|||
19480968|NCT01517984|41761662|FG001|Overall Study|Lost to Follow-up|1|||
19480969|NCT01517984|41761663|FG002|Overall Study|Lost to Follow-up|0|||
19480970|NCT01517984|41761664|FG003|Overall Study|Lost to Follow-up|0|||
19480971|NCT01517984|41761661|FG000|Overall Study|Withdrawal by Subject|1|||
19480972|NCT01517984|41761662|FG001|Overall Study|Withdrawal by Subject|8|||
19480973|NCT01517984|41761663|FG002|Overall Study|Withdrawal by Subject|4|||
19480974|NCT01517984|41761664|FG003|Overall Study|Withdrawal by Subject|1|||
19480975|NCT01517984|41761661|FG000|Overall Study|Screen Failure|4|||
19480976|NCT01517984|41761662|FG001|Overall Study|Screen Failure|0|||
19480977|NCT01517984|41761663|FG002|Overall Study|Screen Failure|0|||
19480978|NCT01517984|41761664|FG003|Overall Study|Screen Failure|0|||
19480979|NCT01517984|41761661|FG000|Overall Study|Ineligible for randomization|0|||
19480980|NCT01517984|41761662|FG001|Overall Study|Ineligible for randomization|14|||
19480981|NCT01517984|41761663|FG002|Overall Study|Ineligible for randomization|0|||
19480982|NCT01517984|41761664|FG003|Overall Study|Ineligible for randomization|0|||
19480983|NCT01517750|41761692|FG000|Overall Study|Lost to Follow-up|1|||
19480984|NCT01517750|41761693|FG001|Overall Study|Lost to Follow-up|2|||
19480985|NCT01517750|41761694|FG002|Overall Study|Lost to Follow-up|4|||
19392451|NCT02641379|41636554|FG001|Overall Study|Participant cannot be reached|4|||
19392452|NCT02641379|41636555|FG002|Overall Study|Participant cannot be reached|0|||
19392453|NCT02641379|41636556|FG003|Overall Study|Participant cannot be reached|8|||
19392454|NCT02641379|41636557|FG004|Overall Study|Participant cannot be reached|2|||
19392455|NCT02641379|41636558|FG005|Overall Study|Participant cannot be reached|1|||
19480986|NCT01517750|41761695|FG003|Overall Study|Lost to Follow-up|1|||
19480987|NCT01548404|41761720|FG000|Overall Study|Adverse Event|3|||
19480988|NCT01548404|41761721|FG001|Overall Study|Adverse Event|1|||
19480989|NCT01548404|41761720|FG000|Overall Study|Physician Decision|2|||
19480990|NCT01548404|41761721|FG001|Overall Study|Physician Decision|1|||
19480991|NCT01548404|41761720|FG000|Overall Study|Inadequate response to study treatment|23|||
19480992|NCT01548404|41761721|FG001|Overall Study|Inadequate response to study treatment|7|||
19480993|NCT01548404|41761720|FG000|Overall Study|Lost to Follow-up|2|||
19480994|NCT01548404|41761721|FG001|Overall Study|Lost to Follow-up|0|||
19480995|NCT01548404|41761720|FG000|Overall Study|Withdrawal by Subject|0|||
19480996|NCT01548404|41761721|FG001|Overall Study|Withdrawal by Subject|3|||
19480997|NCT01548404|41761720|FG000|Overall Study|Other than specified above|0|||
19480998|NCT01548404|41761721|FG001|Overall Study|Other than specified above|2|||
19703893|NCT00200850|42148210|FG001|Overall Study|optic neuritis|0|||
19703894|NCT00200850|42148211|FG002|Overall Study|optic neuritis|1|||
19703895|NCT00200850|42148209|FG000|Overall Study|Adverse Event|1|||
19703896|NCT00200850|42148210|FG001|Overall Study|Adverse Event|1|||
19392456|NCT02641379|41636559|FG006|Overall Study|Participant cannot be reached|0|||
19392457|NCT02641379|41636560|FG007|Overall Study|Participant cannot be reached|1|||
19392458|NCT02641379|41636561|FG008|Overall Study|Participant cannot be reached|0|||
19392459|NCT02641379|41636562|FG009|Overall Study|Participant cannot be reached|2|||
19392460|NCT02641379|41636563|FG010|Overall Study|Participant cannot be reached|1|||
19392461|NCT02641379|41636553|FG000|Overall Study|PCR positive at Week 24|15|||
19392462|NCT02641379|41636554|FG001|Overall Study|PCR positive at Week 24|21|||
19392463|NCT02641379|41636555|FG002|Overall Study|PCR positive at Week 24|62|||
19392464|NCT02641379|41636556|FG003|Overall Study|PCR positive at Week 24|0|||
19392465|NCT02641379|41636557|FG004|Overall Study|PCR positive at Week 24|0|||
19392466|NCT02641379|41636558|FG005|Overall Study|PCR positive at Week 24|6|||
19392467|NCT02641379|41636559|FG006|Overall Study|PCR positive at Week 24|3|||
19392468|NCT02641379|41636560|FG007|Overall Study|PCR positive at Week 24|8|||
19392469|NCT02641379|41636561|FG008|Overall Study|PCR positive at Week 24|0|||
19392470|NCT02641379|41636562|FG009|Overall Study|PCR positive at Week 24|1|||
19392471|NCT02641379|41636563|FG010|Overall Study|PCR positive at Week 24|0|||
19392472|NCT02641379|41636553|FG000|Overall Study|PCR positive at follow up 2|1|||
19392473|NCT02641379|41636554|FG001|Overall Study|PCR positive at follow up 2|0|||
19480999|NCT01547780|41761735|FG000|Baseline PET Scan|Physician Decision|1|||
19703897|NCT00200850|42148211|FG002|Overall Study|Adverse Event|2|||
19481000|NCT01547780|41761736|FG001|Baseline PET Scan|Physician Decision|0|||
19481001|NCT01547780|41761737|FG002|Baseline PET Scan|Physician Decision|1|||
19481002|NCT01547780|41761738|FG003|Baseline PET Scan|Physician Decision|0|||
19481003|NCT01547780|41761735|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
19481004|NCT01547780|41761736|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
19481005|NCT01547780|41761737|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
19481006|NCT01547780|41761738|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
19481007|NCT01547390|41761760|FG000|Overall Study|Withdrawal by Subject|10|||
19481008|NCT01547390|41761761|FG001|Overall Study|Withdrawal by Subject|7|||
19481009|NCT01547390|41761760|FG000|Overall Study|termination of pregnancy|0|||
19481010|NCT01547390|41761761|FG001|Overall Study|termination of pregnancy|1|||
19392474|NCT02641379|41636555|FG002|Overall Study|PCR positive at follow up 2|0|||
19392475|NCT02641379|41636556|FG003|Overall Study|PCR positive at follow up 2|0|||
19392476|NCT02641379|41636557|FG004|Overall Study|PCR positive at follow up 2|0|||
19392477|NCT02641379|41636558|FG005|Overall Study|PCR positive at follow up 2|0|||
19392478|NCT02641379|41636559|FG006|Overall Study|PCR positive at follow up 2|0|||
19392479|NCT02641379|41636560|FG007|Overall Study|PCR positive at follow up 2|0|||
19481011|NCT01547390|41761760|FG000|Overall Study|Lost to Follow-up|0|||
19481012|NCT01547390|41761761|FG001|Overall Study|Lost to Follow-up|2|||
19392480|NCT02641379|41636561|FG008|Overall Study|PCR positive at follow up 2|0|||
19392481|NCT02641379|41636562|FG009|Overall Study|PCR positive at follow up 2|0|||
19611767|NCT00966875|42060546|FG000|Part A|Entry Criteria|0|||
19611768|NCT00966875|42060547|FG001|Part A|Entry Criteria|0|||
19611769|NCT00966875|42060548|FG002|Part A|Entry Criteria|0|||
19611770|NCT00966875|42060549|FG003|Part A|Entry Criteria|0|||
19611771|NCT00966875|42060550|FG004|Part A|Entry Criteria|0|||
19611772|NCT00966875|42060551|FG005|Part A|Entry Criteria|2|||
19611773|NCT00966875|42060552|FG006|Part A|Entry Criteria|0|||
19611774|NCT00966875|42060553|FG007|Part A|Entry Criteria|0|||
19611775|NCT00966875|42060554|FG008|Part A|Entry Criteria|0|||
19611776|NCT00966875|42060546|FG000|Part A|Lack of Efficacy|0|||
19611777|NCT00966875|42060547|FG001|Part A|Lack of Efficacy|1|||
19611778|NCT00966875|42060548|FG002|Part A|Lack of Efficacy|0|||
19611779|NCT00966875|42060549|FG003|Part A|Lack of Efficacy|0|||
19611780|NCT00966875|42060550|FG004|Part A|Lack of Efficacy|0|||
19611781|NCT00966875|42060551|FG005|Part A|Lack of Efficacy|0|||
19611782|NCT00966875|42060552|FG006|Part A|Lack of Efficacy|4|||
19392482|NCT02641379|41636563|FG010|Overall Study|PCR positive at follow up 2|0|||
19392483|NCT02641379|41636553|FG000|Overall Study|Participant showed relapse|1|||
19392484|NCT02641379|41636554|FG001|Overall Study|Participant showed relapse|0|||
19392485|NCT02641379|41636555|FG002|Overall Study|Participant showed relapse|0|||
19392486|NCT02641379|41636556|FG003|Overall Study|Participant showed relapse|0|||
19392487|NCT02641379|41636557|FG004|Overall Study|Participant showed relapse|0|||
19392488|NCT02641379|41636558|FG005|Overall Study|Participant showed relapse|0|||
19392489|NCT02641379|41636559|FG006|Overall Study|Participant showed relapse|1|||
19392490|NCT02641379|41636560|FG007|Overall Study|Participant showed relapse|0|||
19392491|NCT02641379|41636561|FG008|Overall Study|Participant showed relapse|0|||
19392492|NCT02641379|41636562|FG009|Overall Study|Participant showed relapse|0|||
19392493|NCT02641379|41636563|FG010|Overall Study|Participant showed relapse|0|||
19392494|NCT02641379|41636553|FG000|Overall Study|Participant stopped study/treatment|1|||
19392495|NCT02641379|41636554|FG001|Overall Study|Participant stopped study/treatment|3|||
19481013|NCT01547390|41761760|FG000|Overall Study|Adverse Event|3|||
19481014|NCT01547390|41761761|FG001|Overall Study|Adverse Event|0|||
19481015|NCT01546922|41761767|FG000|First Period of 10 Weeks|Protocol Violation|3|||
19481016|NCT01546922|41761768|FG001|First Period of 10 Weeks|Protocol Violation|1|||
19481017|NCT01546922|41761767|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
19481018|NCT01546922|41761768|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
19481019|NCT01546922|41761767|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
19481020|NCT01546922|41761768|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
19481021|NCT01546922|41761767|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
19481022|NCT01546922|41761768|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
19611783|NCT00966875|42060553|FG007|Part A|Lack of Efficacy|0|||
19611784|NCT00966875|42060554|FG008|Part A|Lack of Efficacy|0|||
19611785|NCT00966875|42060546|FG000|Part A|Lost to Follow-up|2|||
19392496|NCT02641379|41636555|FG002|Overall Study|Participant stopped study/treatment|1|||
19392497|NCT02641379|41636556|FG003|Overall Study|Participant stopped study/treatment|0|||
19392498|NCT02641379|41636557|FG004|Overall Study|Participant stopped study/treatment|0|||
19392499|NCT02641379|41636558|FG005|Overall Study|Participant stopped study/treatment|1|||
19392500|NCT02641379|41636559|FG006|Overall Study|Participant stopped study/treatment|2|||
19392501|NCT02641379|41636560|FG007|Overall Study|Participant stopped study/treatment|0|||
19392502|NCT02641379|41636561|FG008|Overall Study|Participant stopped study/treatment|1|||
19481023|NCT01546922|41761767|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
19481024|NCT01546922|41761768|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
19481025|NCT01532648|41761785|FG000|Overall Study|Lost to Follow-up|3|||
19481026|NCT01532648|41761786|FG001|Overall Study|Lost to Follow-up|4|||
19611786|NCT00966875|42060547|FG001|Part A|Lost to Follow-up|0|||
19611787|NCT00966875|42060548|FG002|Part A|Lost to Follow-up|0|||
19481027|NCT01532648|41761785|FG000|Overall Study|Lack of Efficacy|4|||
19481028|NCT01532648|41761786|FG001|Overall Study|Lack of Efficacy|1|||
19481029|NCT01532648|41761785|FG000|Overall Study|Protocol Violation|1|||
19481030|NCT01532648|41761786|FG001|Overall Study|Protocol Violation|1|||
19481031|NCT01532648|41761785|FG000|Overall Study|Adverse Event|12|||
19481032|NCT01532648|41761786|FG001|Overall Study|Adverse Event|9|||
19481033|NCT01532648|41761785|FG000|Overall Study|Withdrawal by Subject|16|||
19481034|NCT01532648|41761786|FG001|Overall Study|Withdrawal by Subject|2|||
19481035|NCT01532570|41761816|FG000|Overall Study|Lack of Efficacy|1|||
19481036|NCT01532570|41761817|FG001|Overall Study|Lack of Efficacy|0|||
19481037|NCT01532570|41761818|FG002|Overall Study|Lack of Efficacy|0|||
19481038|NCT01532570|41761819|FG003|Overall Study|Lack of Efficacy|0|||
19481039|NCT01532570|41761816|FG000|Overall Study|Withdrawal by Subject|0|||
19392503|NCT02641379|41636562|FG009|Overall Study|Participant stopped study/treatment|0|||
19481040|NCT01532570|41761817|FG001|Overall Study|Withdrawal by Subject|1|||
19481041|NCT01532570|41761818|FG002|Overall Study|Withdrawal by Subject|0|||
19481042|NCT01532570|41761819|FG003|Overall Study|Withdrawal by Subject|0|||
19481043|NCT01532414|41761865|FG000|Overall Study|Lost to Follow-up|3|||
19481044|NCT01532414|41761866|FG001|Overall Study|Lost to Follow-up|0|||
19481045|NCT01532414|41761867|FG002|Overall Study|Lost to Follow-up|1|||
19611788|NCT00966875|42060549|FG003|Part A|Lost to Follow-up|0|||
19611789|NCT00966875|42060550|FG004|Part A|Lost to Follow-up|0|||
19611790|NCT00966875|42060551|FG005|Part A|Lost to Follow-up|1|||
19481046|NCT01532414|41761865|FG000|Overall Study|Withdrawal by Subject|3|||
19481047|NCT01532414|41761866|FG001|Overall Study|Withdrawal by Subject|0|||
19481048|NCT01532414|41761867|FG002|Overall Study|Withdrawal by Subject|0|||
19481049|NCT01532414|41761865|FG000|Overall Study|No V6 semen sample|0|||
19481050|NCT01532414|41761866|FG001|Overall Study|No V6 semen sample|1|||
19481051|NCT01532414|41761867|FG002|Overall Study|No V6 semen sample|0|||
19481052|NCT01532414|41761865|FG000|Overall Study|Adverse Event|0|||
19481053|NCT01532414|41761866|FG001|Overall Study|Adverse Event|1|||
19481054|NCT01532414|41761867|FG002|Overall Study|Adverse Event|1|||
19481055|NCT01532414|41761865|FG000|Overall Study|Unable to complete 24 hour PK|0|||
19481056|NCT01532414|41761866|FG001|Overall Study|Unable to complete 24 hour PK|0|||
19392504|NCT02641379|41636563|FG010|Overall Study|Participant stopped study/treatment|0|||
19392505|NCT02641379|41636553|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
19392506|NCT02641379|41636554|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
19392507|NCT02641379|41636555|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
19392508|NCT02641379|41636556|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
19392509|NCT02641379|41636557|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
19392510|NCT02641379|41636558|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
19392511|NCT02641379|41636559|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
19392512|NCT02641379|41636560|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
19392513|NCT02641379|41636561|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
19392514|NCT02641379|41636562|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
19392515|NCT02641379|41636563|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
19481057|NCT01532414|41761867|FG002|Overall Study|Unable to complete 24 hour PK|1|||
19481058|NCT01532414|41761865|FG000|Overall Study|Withdrawn by sponsor|1|||
19481059|NCT01532414|41761866|FG001|Overall Study|Withdrawn by sponsor|0|||
19481060|NCT01532414|41761867|FG002|Overall Study|Withdrawn by sponsor|0|||
19481061|NCT01441973|41761877|FG000|Overall Study|Disease progression|8|||
19481062|NCT01441973|41761878|FG001|Overall Study|Disease progression|6|||
19481063|NCT01441973|41761877|FG000|Overall Study|Adverse event unrelated to study drug|3|||
19481064|NCT01441973|41761878|FG001|Overall Study|Adverse event unrelated to study drug|2|||
19481065|NCT01441973|41761877|FG000|Overall Study|Participant request to discontinue|1|||
19481066|NCT01441973|41761878|FG001|Overall Study|Participant request to discontinue|1|||
19481067|NCT01441973|41761877|FG000|Overall Study|Poor compliance/noncompliance|0|||
19481068|NCT01441973|41761878|FG001|Overall Study|Poor compliance/noncompliance|1|||
19481069|NCT01441973|41761877|FG000|Overall Study|Administrative reason by sponsor|3|||
19481070|NCT01441973|41761878|FG001|Overall Study|Administrative reason by sponsor|5|||
19481071|NCT01441973|41761877|FG000|Overall Study|Participant withdrew consent|0|||
19481072|NCT01441973|41761878|FG001|Overall Study|Participant withdrew consent|1|||
19481073|NCT01575899|41761897|FG000|Overall Study|Lost to Follow-up|3|||
19611791|NCT00966875|42060552|FG006|Part A|Lost to Follow-up|0|||
19611792|NCT00966875|42060553|FG007|Part A|Lost to Follow-up|0|||
19481074|NCT01575899|41761898|FG001|Overall Study|Lost to Follow-up|4|||
19481075|NCT01575899|41761899|FG002|Overall Study|Lost to Follow-up|2|||
19481076|NCT01575899|41761897|FG000|Overall Study|Protocol Violation|2|||
19481077|NCT01575899|41761898|FG001|Overall Study|Protocol Violation|1|||
19481078|NCT01575899|41761899|FG002|Overall Study|Protocol Violation|0|||
19481079|NCT01440881|41761911|FG000|Overall Study|Death|0|||
19481080|NCT01440881|41761912|FG001|Overall Study|Death|1|||
19481081|NCT01575197|41761927|FG000|Overall Study|Migration out of study area|1|||
19481082|NCT01575197|41761928|FG001|Overall Study|Migration out of study area|5|||
19611793|NCT00966875|42060554|FG008|Part A|Lost to Follow-up|0|||
19611794|NCT00966875|42060546|FG000|Part A|Parent/Caregiver Decision|0|||
19481083|NCT01575197|41761929|FG002|Overall Study|Migration out of study area|4|||
19481084|NCT01575197|41761927|FG000|Overall Study|SAE|0|||
19481085|NCT01575197|41761928|FG001|Overall Study|SAE|1|||
19481086|NCT01575197|41761929|FG002|Overall Study|SAE|0|||
19481087|NCT01575197|41761927|FG000|Overall Study|Lost to Follow-up|0|||
19481088|NCT01575197|41761928|FG001|Overall Study|Lost to Follow-up|1|||
19481089|NCT01575197|41761929|FG002|Overall Study|Lost to Follow-up|0|||
19481090|NCT01575197|41761927|FG000|Overall Study|Withdrawal by Subject|0|||
19481091|NCT01575197|41761928|FG001|Overall Study|Withdrawal by Subject|1|||
19481092|NCT01575197|41761929|FG002|Overall Study|Withdrawal by Subject|1|||
19481093|NCT01575197|41761927|FG000|Overall Study|Protocol Violation|2|||
19481094|NCT01575197|41761928|FG001|Overall Study|Protocol Violation|1|||
19481095|NCT01575197|41761929|FG002|Overall Study|Protocol Violation|1|||
19481096|NCT01574651|41761960|FG000|Overall Study|Lost to Follow-up|2|||
19481097|NCT01574651|41761961|FG001|Overall Study|Lost to Follow-up|4|||
19481098|NCT01574651|41761960|FG000|Overall Study|Administrative problems|0|||
19481099|NCT01574651|41761961|FG001|Overall Study|Administrative problems|1|||
19481100|NCT01574651|41761960|FG000|Overall Study|Death|3|||
19481101|NCT01574651|41761961|FG001|Overall Study|Death|3|||
19481102|NCT01574651|41761960|FG000|Overall Study|Patient's inability to use the device|0|||
19481103|NCT01574651|41761961|FG001|Overall Study|Patient's inability to use the device|1|||
19481104|NCT01574651|41761960|FG000|Overall Study|Adverse Event|36|||
19481105|NCT01574651|41761961|FG001|Overall Study|Adverse Event|27|||
19481106|NCT01574651|41761960|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19481107|NCT01574651|41761961|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19481108|NCT01574651|41761960|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19481109|NCT01574651|41761961|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19481110|NCT01574651|41761960|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
19481111|NCT01574651|41761961|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19481112|NCT01574651|41761960|FG000|Overall Study|Protocol Violation|3|||
19481113|NCT01574651|41761961|FG001|Overall Study|Protocol Violation|5|||
19481114|NCT01574651|41761960|FG000|Overall Study|Withdrawal by Subject|9|||
19481115|NCT01574651|41761961|FG001|Overall Study|Withdrawal by Subject|10|||
19481116|NCT01440803|41761973|FG000|Overall Study|Met study stopping rule|2|||
19481117|NCT01440803|41761974|FG001|Overall Study|Met study stopping rule|1|||
19481118|NCT01440803|41761973|FG000|Overall Study|Lost to Follow-up|0|||
19481119|NCT01440803|41761974|FG001|Overall Study|Lost to Follow-up|2|||
19481120|NCT01440803|41761973|FG000|Overall Study|Withdrawal by Subject|0|||
19481121|NCT01440803|41761974|FG001|Overall Study|Withdrawal by Subject|1|||
19481122|NCT01517282|41761985|FG000|Overall Study|Consent withdrawn|0|||
19481123|NCT01517282|41761986|FG001|Overall Study|Consent withdrawn|1|||
19481124|NCT01517282|41761987|FG002|Overall Study|Consent withdrawn|1|||
19481125|NCT01517282|41761988|FG003|Overall Study|Consent withdrawn|1|||
19481126|NCT01517282|41761985|FG000|Overall Study|Physician Decision|1|||
19481127|NCT01517282|41761986|FG001|Overall Study|Physician Decision|0|||
19481128|NCT01517282|41761987|FG002|Overall Study|Physician Decision|0|||
19481129|NCT01517282|41761988|FG003|Overall Study|Physician Decision|0|||
19481130|NCT01440647|41762009|FG000|Overall Study|Death|2|||
19392516|NCT02641379|41636553|FG000|Overall Study|Financial problems|0|||
19392517|NCT02641379|41636554|FG001|Overall Study|Financial problems|1|||
19392518|NCT02641379|41636555|FG002|Overall Study|Financial problems|0|||
19392519|NCT02641379|41636556|FG003|Overall Study|Financial problems|0|||
19392520|NCT02641379|41636557|FG004|Overall Study|Financial problems|0|||
19392521|NCT02641379|41636558|FG005|Overall Study|Financial problems|0|||
19392522|NCT02641379|41636559|FG006|Overall Study|Financial problems|0|||
19392523|NCT02641379|41636560|FG007|Overall Study|Financial problems|0|||
19392524|NCT02641379|41636561|FG008|Overall Study|Financial problems|0|||
19392525|NCT02641379|41636562|FG009|Overall Study|Financial problems|0|||
19392526|NCT02641379|41636563|FG010|Overall Study|Financial problems|0|||
19392527|NCT02641379|41636553|FG000|Overall Study|PCR positive at Week 68|0|||
19392528|NCT02641379|41636554|FG001|Overall Study|PCR positive at Week 68|1|||
19392529|NCT02641379|41636555|FG002|Overall Study|PCR positive at Week 68|0|||
19481131|NCT01440647|41762010|FG001|Overall Study|Death|3|||
19481132|NCT01516970|41762018|FG000|Overall Study|Lost to Follow-up|7|||
19481133|NCT01516970|41762019|FG001|Overall Study|Lost to Follow-up|8|||
19481134|NCT01516970|41762018|FG000|Overall Study|Adverse Event|1|||
19481135|NCT01516970|41762019|FG001|Overall Study|Adverse Event|5|||
19481136|NCT01516970|41762018|FG000|Overall Study|Withdrawal by Subject|1|||
19481137|NCT01516970|41762019|FG001|Overall Study|Withdrawal by Subject|1|||
19481138|NCT01516970|41762018|FG000|Overall Study|Other|9|||
19481139|NCT01516970|41762019|FG001|Overall Study|Other|7|||
19481140|NCT01516892|41762040|FG000|Overall Study|Adverse Event|25|||
19481141|NCT01516892|41762040|FG000|Overall Study|Lack of Efficacy|35|||
19481142|NCT01516892|41762040|FG000|Overall Study|Pregnancy|5|||
19481143|NCT01516892|41762040|FG000|Overall Study|Lost to Follow-up|82|||
19481144|NCT01516892|41762040|FG000|Overall Study|Subject Withdrew Consent|92|||
19481145|NCT01516892|41762040|FG000|Overall Study|Protocol Violation|60|||
19392530|NCT02641379|41636556|FG003|Overall Study|PCR positive at Week 68|0|||
19392531|NCT02641379|41636557|FG004|Overall Study|PCR positive at Week 68|0|||
19481146|NCT01516892|41762040|FG000|Overall Study|Other Miscellaneous Reasons|43|||
19481147|NCT01516892|41762040|FG000|Overall Study|Missing|1|||
19481148|NCT01516736|41762065|FG000|Overall Study|Withdrawal by Subject|10|||
19481149|NCT01516736|41762066|FG001|Overall Study|Withdrawal by Subject|4|||
19481150|NCT01516736|41762065|FG000|Overall Study|Adverse Event|4|||
19481151|NCT01516736|41762066|FG001|Overall Study|Adverse Event|5|||
19481152|NCT01516736|41762065|FG000|Overall Study|Death|3|||
19481153|NCT01516736|41762066|FG001|Overall Study|Death|1|||
19481154|NCT01516736|41762065|FG000|Overall Study|Physician Decision|2|||
19481155|NCT01516736|41762066|FG001|Overall Study|Physician Decision|1|||
19481156|NCT01516736|41762065|FG000|Overall Study|Lack of Efficacy|1|||
19481157|NCT01516736|41762066|FG001|Overall Study|Lack of Efficacy|0|||
19481158|NCT01516736|41762065|FG000|Overall Study|Protocol Violation|0|||
19392532|NCT02641379|41636558|FG005|Overall Study|PCR positive at Week 68|0|||
19481159|NCT01516736|41762066|FG001|Overall Study|Protocol Violation|1|||
19481160|NCT01516736|41762065|FG000|Overall Study|Other (not specified)|0|||
19481161|NCT01516736|41762066|FG001|Overall Study|Other (not specified)|1|||
19481162|NCT01546688|41762078|FG000|Overall Study|Adverse Event|0|||
19481163|NCT01546688|41762079|FG001|Overall Study|Adverse Event|4|||
19481164|NCT01546688|41762078|FG000|Overall Study|Withdrawal by Subject|2|||
19481165|NCT01546688|41762079|FG001|Overall Study|Withdrawal by Subject|1|||
19481166|NCT01546688|41762078|FG000|Overall Study|Lack of Efficacy|1|||
19481167|NCT01546688|41762079|FG001|Overall Study|Lack of Efficacy|0|||
19481168|NCT01516034|41762085|FG000|Overall Study|Physician Decision|1|||
19481169|NCT01516034|41762085|FG000|Overall Study|Lack of Efficacy|7|||
19481170|NCT01440569|41762096|FG000|Main Study|Enrolled but not treated|1|||
19481171|NCT01440569|41762097|FG001|Main Study|Enrolled but not treated|0|||
19481172|NCT01440569|41762096|FG000|Main Study|Adverse Event|9|||
19481173|NCT01440569|41762097|FG001|Main Study|Adverse Event|0|||
19481174|NCT01440569|41762096|FG000|Main Study|Pregnancy|1|||
19481175|NCT01440569|41762097|FG001|Main Study|Pregnancy|0|||
19481176|NCT01440569|41762096|FG000|Main Study|Investigator's Discretion|1|||
19481177|NCT01440569|41762097|FG001|Main Study|Investigator's Discretion|1|||
19481178|NCT01440569|41762096|FG000|Main Study|Withdrew Consent|7|||
19481179|NCT01440569|41762097|FG001|Main Study|Withdrew Consent|1|||
19481180|NCT01440569|41762096|FG000|Main Study|Lost to Follow-up|13|||
19481181|NCT01440569|41762097|FG001|Main Study|Lost to Follow-up|2|||
19481182|NCT01440569|41762096|FG000|Main Study|Subject Non-Compliance|3|||
19481183|NCT01440569|41762097|FG001|Main Study|Subject Non-Compliance|0|||
19481184|NCT01440569|41762096|FG000|Main Study|Protocol Violation|1|||
19481185|NCT01440569|41762097|FG001|Main Study|Protocol Violation|0|||
19481186|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Adverse Event|3|||
19481187|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Adverse Event|0|||
19481188|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Pregnancy|1|||
19481189|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Pregnancy|0|||
19481190|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
19481191|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
19481192|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
19392533|NCT02641379|41636559|FG006|Overall Study|PCR positive at Week 68|0|||
19392534|NCT02641379|41636560|FG007|Overall Study|PCR positive at Week 68|0|||
19392535|NCT02641379|41636561|FG008|Overall Study|PCR positive at Week 68|0|||
19392536|NCT02641379|41636562|FG009|Overall Study|PCR positive at Week 68|0|||
19392537|NCT02641379|41636563|FG010|Overall Study|PCR positive at Week 68|0|||
19392538|NCT02641379|41636553|FG000|Overall Study|PCR positive at Week 48|0|||
19392539|NCT02641379|41636554|FG001|Overall Study|PCR positive at Week 48|1|||
19392540|NCT02641379|41636555|FG002|Overall Study|PCR positive at Week 48|0|||
19392541|NCT02641379|41636556|FG003|Overall Study|PCR positive at Week 48|0|||
19392542|NCT02641379|41636557|FG004|Overall Study|PCR positive at Week 48|0|||
19392543|NCT02641379|41636558|FG005|Overall Study|PCR positive at Week 48|0|||
19392544|NCT02641379|41636559|FG006|Overall Study|PCR positive at Week 48|0|||
19392545|NCT02641379|41636560|FG007|Overall Study|PCR positive at Week 48|0|||
19392546|NCT02641379|41636561|FG008|Overall Study|PCR positive at Week 48|0|||
19392547|NCT02641379|41636562|FG009|Overall Study|PCR positive at Week 48|0|||
19392548|NCT02641379|41636563|FG010|Overall Study|PCR positive at Week 48|0|||
19392549|NCT02641379|41636553|FG000|Overall Study|PCR not performed at Week 12|0|||
19392550|NCT02641379|41636554|FG001|Overall Study|PCR not performed at Week 12|0|||
19392551|NCT02641379|41636555|FG002|Overall Study|PCR not performed at Week 12|1|||
19392552|NCT02641379|41636556|FG003|Overall Study|PCR not performed at Week 12|0|||
19481193|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
19481194|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
19481195|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
19481196|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
19481197|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
19481198|NCT01440569|41762096|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
19481199|NCT01440569|41762097|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
19481200|NCT01546142|41762120|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
19481201|NCT01546142|41762121|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
19481202|NCT01546142|41762120|FG000|Overall Study|Subject Noncompliance|1|||
19481203|NCT01546142|41762121|FG001|Overall Study|Subject Noncompliance|1|||
19481204|NCT01546142|41762120|FG000|Overall Study|Adverse Event|6|||
19481205|NCT01546142|41762121|FG001|Overall Study|Adverse Event|3|||
19481206|NCT01546142|41762120|FG000|Overall Study|Lost to Follow-up|20|||
19481207|NCT01546142|41762121|FG001|Overall Study|Lost to Follow-up|15|||
19481208|NCT01546142|41762120|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
19481209|NCT01546142|41762121|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
19481210|NCT01546142|41762120|FG000|Overall Study|Subject Randomized but Not Treated|1|||
19481211|NCT01546142|41762121|FG001|Overall Study|Subject Randomized but Not Treated|0|||
19481212|NCT01440101|41762155|FG000|Overall Study|Adverse Event|2|||
19481213|NCT01440101|41762156|FG001|Overall Study|Adverse Event|0|||
19481214|NCT01440101|41762157|FG002|Overall Study|Adverse Event|0|||
19481215|NCT01440101|41762155|FG000|Overall Study|Withdrawal by Subject|0|||
19481216|NCT01440101|41762156|FG001|Overall Study|Withdrawal by Subject|3|||
19481217|NCT01440101|41762157|FG002|Overall Study|Withdrawal by Subject|1|||
19481218|NCT01440101|41762155|FG000|Overall Study|Other|0|||
19481219|NCT01440101|41762156|FG001|Overall Study|Other|1|||
19481220|NCT01440101|41762157|FG002|Overall Study|Other|0|||
19392553|NCT02641379|41636557|FG004|Overall Study|PCR not performed at Week 12|0|||
19392554|NCT02641379|41636558|FG005|Overall Study|PCR not performed at Week 12|0|||
19392555|NCT02641379|41636559|FG006|Overall Study|PCR not performed at Week 12|0|||
19392556|NCT02641379|41636560|FG007|Overall Study|PCR not performed at Week 12|0|||
19392557|NCT02641379|41636561|FG008|Overall Study|PCR not performed at Week 12|0|||
19392558|NCT02641379|41636562|FG009|Overall Study|PCR not performed at Week 12|0|||
19392559|NCT02641379|41636563|FG010|Overall Study|PCR not performed at Week 12|0|||
19392560|NCT02641379|41636553|FG000|Overall Study|No PCR at baseline|0|||
19392561|NCT02641379|41636554|FG001|Overall Study|No PCR at baseline|0|||
19392562|NCT02641379|41636555|FG002|Overall Study|No PCR at baseline|1|||
19392563|NCT02641379|41636556|FG003|Overall Study|No PCR at baseline|0|||
19392564|NCT02641379|41636557|FG004|Overall Study|No PCR at baseline|0|||
19392565|NCT02641379|41636558|FG005|Overall Study|No PCR at baseline|0|||
19392566|NCT02641379|41636559|FG006|Overall Study|No PCR at baseline|0|||
19392567|NCT02641379|41636560|FG007|Overall Study|No PCR at baseline|0|||
19392568|NCT02641379|41636561|FG008|Overall Study|No PCR at baseline|0|||
19392569|NCT02641379|41636562|FG009|Overall Study|No PCR at baseline|0|||
19392570|NCT02641379|41636563|FG010|Overall Study|No PCR at baseline|0|||
19392571|NCT02641379|41636553|FG000|Overall Study|PCR positive at Week 28|0|||
19392572|NCT02641379|41636554|FG001|Overall Study|PCR positive at Week 28|0|||
19392573|NCT02641379|41636555|FG002|Overall Study|PCR positive at Week 28|1|||
19392574|NCT02641379|41636556|FG003|Overall Study|PCR positive at Week 28|0|||
19392575|NCT02641379|41636557|FG004|Overall Study|PCR positive at Week 28|0|||
19392576|NCT02641379|41636558|FG005|Overall Study|PCR positive at Week 28|0|||
19392577|NCT02641379|41636559|FG006|Overall Study|PCR positive at Week 28|0|||
19392578|NCT02641379|41636560|FG007|Overall Study|PCR positive at Week 28|0|||
19392579|NCT02641379|41636561|FG008|Overall Study|PCR positive at Week 28|0|||
19392580|NCT02641379|41636562|FG009|Overall Study|PCR positive at Week 28|0|||
19392581|NCT02641379|41636563|FG010|Overall Study|PCR positive at Week 28|0|||
19392582|NCT02641379|41636553|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
19392583|NCT02641379|41636554|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
19392584|NCT02641379|41636555|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
19392585|NCT02641379|41636556|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
19392586|NCT02641379|41636557|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
19392587|NCT02641379|41636558|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
19392588|NCT02641379|41636559|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
19392589|NCT02641379|41636560|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
19392590|NCT02641379|41636561|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
19392591|NCT02641379|41636562|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
19392592|NCT02641379|41636563|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
19392593|NCT02641379|41636553|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
19392594|NCT02641379|41636554|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
19392595|NCT02641379|41636555|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
19392596|NCT02641379|41636556|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
19392597|NCT02641379|41636557|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
19481221|NCT01530464|41762168|FG000|Washout (24h)|Withdrawal by Subject|1|||
19481222|NCT01530464|41762169|FG001|Washout (24h)|Withdrawal by Subject|0|||
19481223|NCT01530464|41762168|FG000|Washout (24h)|Withdrawal by Subject|0|||
19611795|NCT00966875|42060547|FG001|Part A|Parent/Caregiver Decision|0|||
19481224|NCT01530464|41762169|FG001|Washout (24h)|Withdrawal by Subject|1|||
19481225|NCT01439945|41762236|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
19481226|NCT01439945|41762237|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
19481227|NCT01439945|41762238|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
19481228|NCT01439945|41762239|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
19481229|NCT01439945|41762236|FG000|Double-Blind Treatment Phase|Ineligible|1|||
19481230|NCT01439945|41762237|FG001|Double-Blind Treatment Phase|Ineligible|2|||
19481231|NCT01439945|41762238|FG002|Double-Blind Treatment Phase|Ineligible|0|||
19481232|NCT01439945|41762239|FG003|Double-Blind Treatment Phase|Ineligible|1|||
19481233|NCT01420081|41762344|FG000|Overall Study|Death|1|||
19481234|NCT01420081|41762345|FG001|Overall Study|Death|0|||
19481235|NCT01420081|41762346|FG002|Overall Study|Death|8|||
19481236|NCT01420081|41762347|FG003|Overall Study|Death|0|||
19481237|NCT01420081|41762348|FG004|Overall Study|Death|7|||
19481238|NCT01420081|41762349|FG005|Overall Study|Death|12|||
19481239|NCT01420081|41762350|FG006|Overall Study|Death|0|||
19481240|NCT01420081|41762351|FG007|Overall Study|Death|1|||
19481241|NCT01420081|41762352|FG008|Overall Study|Death|1|||
19481242|NCT01420081|41762344|FG000|Overall Study|Lost to Follow-up|0|||
19481243|NCT01420081|41762345|FG001|Overall Study|Lost to Follow-up|0|||
19481244|NCT01420081|41762346|FG002|Overall Study|Lost to Follow-up|0|||
19481245|NCT01420081|41762347|FG003|Overall Study|Lost to Follow-up|0|||
19481246|NCT01420081|41762348|FG004|Overall Study|Lost to Follow-up|1|||
19481247|NCT01420081|41762349|FG005|Overall Study|Lost to Follow-up|1|||
19481248|NCT01420081|41762350|FG006|Overall Study|Lost to Follow-up|0|||
19481249|NCT01420081|41762351|FG007|Overall Study|Lost to Follow-up|0|||
19481250|NCT01420081|41762352|FG008|Overall Study|Lost to Follow-up|0|||
19481251|NCT01420081|41762344|FG000|Overall Study|Study Terminated by Sponsor|2|||
19481252|NCT01420081|41762345|FG001|Overall Study|Study Terminated by Sponsor|1|||
19481253|NCT01420081|41762346|FG002|Overall Study|Study Terminated by Sponsor|1|||
19481254|NCT01420081|41762347|FG003|Overall Study|Study Terminated by Sponsor|3|||
19481255|NCT01420081|41762348|FG004|Overall Study|Study Terminated by Sponsor|11|||
19481256|NCT01420081|41762349|FG005|Overall Study|Study Terminated by Sponsor|7|||
19481257|NCT01420081|41762350|FG006|Overall Study|Study Terminated by Sponsor|3|||
19481258|NCT01420081|41762351|FG007|Overall Study|Study Terminated by Sponsor|2|||
19481259|NCT01420081|41762352|FG008|Overall Study|Study Terminated by Sponsor|2|||
19481260|NCT01420081|41762344|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
19481261|NCT01420081|41762345|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
19481262|NCT01420081|41762346|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
19481263|NCT01420081|41762347|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
19481264|NCT01420081|41762348|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
19481265|NCT01420081|41762349|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
19481266|NCT01420081|41762350|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
19481267|NCT01420081|41762351|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
19481268|NCT01420081|41762352|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
19481269|NCT01420081|41762344|FG000|Overall Study|Other Reasons|0|||
19481270|NCT01420081|41762345|FG001|Overall Study|Other Reasons|0|||
19481271|NCT01420081|41762346|FG002|Overall Study|Other Reasons|1|||
19481272|NCT01420081|41762347|FG003|Overall Study|Other Reasons|0|||
19481273|NCT01420081|41762348|FG004|Overall Study|Other Reasons|0|||
19481274|NCT01420081|41762349|FG005|Overall Study|Other Reasons|0|||
19481275|NCT01420081|41762350|FG006|Overall Study|Other Reasons|0|||
19481276|NCT01420081|41762351|FG007|Overall Study|Other Reasons|0|||
19481277|NCT01420081|41762352|FG008|Overall Study|Other Reasons|0|||
19481278|NCT01439867|41762370|FG000|Overall Study|Non-compliance|0|||
19481279|NCT01439867|41762371|FG001|Overall Study|Non-compliance|1|||
19481280|NCT01439867|41762370|FG000|Overall Study|Withdrawal by Subject|1|||
19481281|NCT01439867|41762371|FG001|Overall Study|Withdrawal by Subject|2|||
19481282|NCT01439867|41762370|FG000|Overall Study|Administrative Decision|4|||
19481283|NCT01439867|41762371|FG001|Overall Study|Administrative Decision|5|||
19481284|NCT01439867|41762370|FG000|Overall Study|Protocol-specified Criteria|1|||
19481285|NCT01439867|41762371|FG001|Overall Study|Protocol-specified Criteria|0|||
19481286|NCT01439711|41762388|FG000|Overall Study|Ineligible|13|||
19481287|NCT01439711|41762388|FG000|Overall Study|Cancel|3|||
19481288|NCT01439711|41762388|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
19481289|NCT01439711|41762388|FG000|Overall Study|Adverse Event|5|||
19481290|NCT01439711|41762388|FG000|Overall Study|Withdrawal by Subject|3|||
19481291|NCT01439711|41762388|FG000|Overall Study|Progression During Active Tx|3|||
19481292|NCT01439711|41762388|FG000|Overall Study|Noncompliance|3|||
19481293|NCT01439711|41762388|FG000|Overall Study|No MRI|9|||
19481294|NCT01439555|41762392|FG000|Overall Study|Protocol Violation|1|||
19481295|NCT01544582|41762412|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
19481296|NCT01544582|41762413|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
19481297|NCT01544582|41762414|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
19481298|NCT01544582|41762415|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
19481299|NCT01544582|41762412|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
19481300|NCT01544582|41762413|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
19481301|NCT01544582|41762414|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
19481302|NCT01544582|41762415|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
19481303|NCT01544582|41762412|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
19481304|NCT01544582|41762413|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
19481305|NCT01544582|41762414|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
19481306|NCT01544582|41762415|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
19481307|NCT01544582|41762412|FG000|Analysis Population|Physician Decision|0|||
19481308|NCT01544582|41762413|FG001|Analysis Population|Physician Decision|13|||
19481309|NCT01544582|41762414|FG002|Analysis Population|Physician Decision|10|||
19481310|NCT01544582|41762415|FG003|Analysis Population|Physician Decision|9|||
19481311|NCT01544582|41762412|FG000|Analysis Population|Safety Reason|0|||
19481312|NCT01544582|41762413|FG001|Analysis Population|Safety Reason|33|||
19481313|NCT01544582|41762414|FG002|Analysis Population|Safety Reason|31|||
19481314|NCT01544582|41762415|FG003|Analysis Population|Safety Reason|8|||
19481315|NCT01544582|41762412|FG000|Analysis Population|Effectiveness Reason|0|||
19481316|NCT01544582|41762413|FG001|Analysis Population|Effectiveness Reason|48|||
19481317|NCT01544582|41762414|FG002|Analysis Population|Effectiveness Reason|29|||
19481318|NCT01544582|41762415|FG003|Analysis Population|Effectiveness Reason|12|||
19481319|NCT01544582|41762412|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
19481320|NCT01544582|41762413|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
19481321|NCT01544582|41762414|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
19481322|NCT01544582|41762415|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
19481323|NCT01544582|41762412|FG000|Analysis Population|Lost to Follow-up|0|||
19481324|NCT01544582|41762413|FG001|Analysis Population|Lost to Follow-up|6|||
19481325|NCT01544582|41762414|FG002|Analysis Population|Lost to Follow-up|6|||
19481326|NCT01544582|41762415|FG003|Analysis Population|Lost to Follow-up|5|||
19481327|NCT01544582|41762412|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
19481328|NCT01544582|41762413|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
19481329|NCT01544582|41762414|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
19481330|NCT01544582|41762415|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
19481331|NCT01544582|41762412|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
19481332|NCT01544582|41762413|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
19481333|NCT01544582|41762414|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
19481334|NCT01544582|41762415|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
19481335|NCT01544582|41762412|FG000|Analysis Population|Intolerance|0|||
19481336|NCT01544582|41762413|FG001|Analysis Population|Intolerance|1|||
19481337|NCT01544582|41762414|FG002|Analysis Population|Intolerance|0|||
19481338|NCT01544582|41762415|FG003|Analysis Population|Intolerance|0|||
19481339|NCT01544582|41762412|FG000|Analysis Population|Liver Transplantation|0|||
19481340|NCT01544582|41762413|FG001|Analysis Population|Liver Transplantation|0|||
19481341|NCT01544582|41762414|FG002|Analysis Population|Liver Transplantation|1|||
19481342|NCT01544582|41762415|FG003|Analysis Population|Liver Transplantation|0|||
19481343|NCT01544582|41762412|FG000|Analysis Population|No Social Insurance|0|||
19481344|NCT01544582|41762413|FG001|Analysis Population|No Social Insurance|0|||
19481345|NCT01544582|41762414|FG002|Analysis Population|No Social Insurance|1|||
19481346|NCT01544582|41762415|FG003|Analysis Population|No Social Insurance|0|||
19481347|NCT01544582|41762412|FG000|Analysis Population|Poor Adherence|0|||
19481348|NCT01544582|41762413|FG001|Analysis Population|Poor Adherence|0|||
19481349|NCT01544582|41762414|FG002|Analysis Population|Poor Adherence|1|||
19481350|NCT01544582|41762415|FG003|Analysis Population|Poor Adherence|0|||
19481351|NCT01544582|41762412|FG000|Analysis Population|Poor Participant Compliance|0|||
19481352|NCT01544582|41762413|FG001|Analysis Population|Poor Participant Compliance|1|||
19481353|NCT01544582|41762414|FG002|Analysis Population|Poor Participant Compliance|0|||
19481354|NCT01544582|41762415|FG003|Analysis Population|Poor Participant Compliance|0|||
19481355|NCT01544582|41762412|FG000|Analysis Population|Programmed Surgery|0|||
19481356|NCT01544582|41762413|FG001|Analysis Population|Programmed Surgery|1|||
19481357|NCT01544582|41762414|FG002|Analysis Population|Programmed Surgery|0|||
19481358|NCT01544582|41762415|FG003|Analysis Population|Programmed Surgery|0|||
19481359|NCT01544582|41762412|FG000|Analysis Population|Participant in Jail|0|||
19481360|NCT01544582|41762413|FG001|Analysis Population|Participant in Jail|0|||
19481361|NCT01544582|41762414|FG002|Analysis Population|Participant in Jail|1|||
19481362|NCT01544582|41762415|FG003|Analysis Population|Participant in Jail|0|||
19481363|NCT01439165|41762443|FG000|Overall Study|Protocol Violation|3|||
19481364|NCT01439165|41762444|FG001|Overall Study|Protocol Violation|0|||
19481365|NCT01439165|41762443|FG000|Overall Study|Lost to Follow-up|11|||
19481366|NCT01439165|41762444|FG001|Overall Study|Lost to Follow-up|1|||
19481367|NCT01439165|41762443|FG000|Overall Study|Withdrawal by Subject|7|||
19481368|NCT01439165|41762444|FG001|Overall Study|Withdrawal by Subject|1|||
19481369|NCT01529606|41762458|FG000|Overall Study|Lost to Follow-up|21|||
19481370|NCT01529606|41762459|FG001|Overall Study|Lost to Follow-up|18|||
19481371|NCT01439009|41762476|FG000|Overall Study|Physician Decision|5|||
19481372|NCT01439009|41762477|FG001|Overall Study|Physician Decision|3|||
19481373|NCT01439009|41762476|FG000|Overall Study|Protocol Violation|2|||
19481374|NCT01439009|41762477|FG001|Overall Study|Protocol Violation|0|||
19481375|NCT01439009|41762476|FG000|Overall Study|Deviation of exclusion criteria|1|||
19481376|NCT01439009|41762477|FG001|Overall Study|Deviation of exclusion criteria|0|||
19481377|NCT01572389|41762496|FG000|Overall Study|Death|1|||
19481378|NCT01572389|41762497|FG001|Overall Study|Death|3|||
19481379|NCT01572389|41762496|FG000|Overall Study|Withdrawal by Subject|14|||
19481380|NCT01572389|41762497|FG001|Overall Study|Withdrawal by Subject|2|||
19481381|NCT01572389|41762496|FG000|Overall Study|Lost to Follow-up|25|||
19481382|NCT01572389|41762497|FG001|Overall Study|Lost to Follow-up|14|||
19481383|NCT01572389|41762496|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
19481384|NCT01572389|41762497|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
19481385|NCT01571453|41762509|FG000|Overall Study|Adverse Event|14|||
19481386|NCT01571453|41762510|FG001|Overall Study|Adverse Event|32|||
19481387|NCT01571453|41762509|FG000|Overall Study|Lack of Efficacy|8|||
19481388|NCT01571453|41762510|FG001|Overall Study|Lack of Efficacy|3|||
19481389|NCT01571453|41762509|FG000|Overall Study|Non-compliance|2|||
19392598|NCT02641379|41636558|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
19392599|NCT02641379|41636559|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
19392600|NCT02641379|41636560|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
19392601|NCT02641379|41636561|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
19392602|NCT02641379|41636562|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
19392603|NCT02641379|41636563|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
19392604|NCT02641379|41636553|FG000|Overall Study|Baseline viral load unavailable|0|||
19392605|NCT02641379|41636554|FG001|Overall Study|Baseline viral load unavailable|0|||
19392606|NCT02641379|41636555|FG002|Overall Study|Baseline viral load unavailable|0|||
19392607|NCT02641379|41636556|FG003|Overall Study|Baseline viral load unavailable|1|||
19392608|NCT02641379|41636557|FG004|Overall Study|Baseline viral load unavailable|0|||
19392609|NCT02641379|41636558|FG005|Overall Study|Baseline viral load unavailable|0|||
19392610|NCT02641379|41636559|FG006|Overall Study|Baseline viral load unavailable|0|||
19392611|NCT02641379|41636560|FG007|Overall Study|Baseline viral load unavailable|0|||
19392612|NCT02641379|41636561|FG008|Overall Study|Baseline viral load unavailable|0|||
19392613|NCT02641379|41636562|FG009|Overall Study|Baseline viral load unavailable|0|||
19392614|NCT02641379|41636563|FG010|Overall Study|Baseline viral load unavailable|0|||
19392615|NCT02641379|41636553|FG000|Overall Study|Blood could not be drawn|0|||
19481390|NCT01571453|41762510|FG001|Overall Study|Non-compliance|4|||
19481391|NCT01571453|41762509|FG000|Overall Study|Protocol Violation|1|||
19481392|NCT01571453|41762510|FG001|Overall Study|Protocol Violation|5|||
19481393|NCT01571453|41762509|FG000|Overall Study|Withdrawal of consent|5|||
19481394|NCT01571453|41762510|FG001|Overall Study|Withdrawal of consent|13|||
19481395|NCT01571453|41762509|FG000|Overall Study|Lost to Follow-up|4|||
19481396|NCT01571453|41762510|FG001|Overall Study|Lost to Follow-up|2|||
19481397|NCT01571453|41762509|FG000|Overall Study|Administrative or other reason(s)|4|||
19481398|NCT01571453|41762510|FG001|Overall Study|Administrative or other reason(s)|3|||
19481399|NCT01446289|41762520|FG000|Overall Study|Withdrawal by Subject|1|||
19481400|NCT01446289|41762521|FG001|Overall Study|Withdrawal by Subject|0|||
19481401|NCT01446289|41762522|FG002|Overall Study|Withdrawal by Subject|1|||
19481402|NCT01446289|41762523|FG003|Overall Study|Withdrawal by Subject|0|||
19481403|NCT01438541|41762535|FG000|Overall Study|Physician Decision|1|||
19481404|NCT01438541|41762535|FG000|Overall Study|Withdrawal by Subject|1|||
19481405|NCT01438541|41762535|FG000|Overall Study|discharge from the hospital|5|||
19481406|NCT01419769|41762539|FG000|Overall Study|Did not receive the AXIOS stent|3|||
19481407|NCT01419769|41762539|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
19481408|NCT01438307|41762545|FG000|Overall Study|Death|1|||
19481409|NCT01438307|41762546|FG001|Overall Study|Death|1|||
19481410|NCT01444651|41762554|FG000|Overall Study|Adverse Event|3|||
19481411|NCT01444651|41762555|FG001|Overall Study|Adverse Event|2|||
19481412|NCT01444651|41762554|FG000|Overall Study|Lost to Follow-up|5|||
19481413|NCT01444651|41762555|FG001|Overall Study|Lost to Follow-up|5|||
19481414|NCT01444651|41762554|FG000|Overall Study|Non-fasting|2|||
19481415|NCT01444651|41762555|FG001|Overall Study|Non-fasting|1|||
19481416|NCT01444651|41762554|FG000|Overall Study|Missing data|1|||
19481417|NCT01444651|41762555|FG001|Overall Study|Missing data|1|||
19481418|NCT01570751|41762563|FG000|Period A (16 Weeks)|Protocol Violation|1|||
19481419|NCT01570751|41762564|FG001|Period A (16 Weeks)|Protocol Violation|1|||
19481420|NCT01570751|41762563|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
19481421|NCT01570751|41762564|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
19481422|NCT01570751|41762563|FG000|Period A (16 Weeks)|Unclassified|2|||
19481423|NCT01570751|41762564|FG001|Period A (16 Weeks)|Unclassified|3|||
19481424|NCT01570751|41762563|FG000|Period B (16 Weeks)|Adverse Event|1|||
19481425|NCT01570751|41762564|FG001|Period B (16 Weeks)|Adverse Event|0|||
19481426|NCT01570751|41762563|FG000|Period B (16 Weeks)|Protocol Violation|0|||
19481427|NCT01570751|41762564|FG001|Period B (16 Weeks)|Protocol Violation|1|||
19481428|NCT01419535|41762574|FG000|Overall Study|could not maintain iv line|1|||
19481429|NCT01419535|41762575|FG001|Overall Study|could not maintain iv line|1|||
19481430|NCT01419535|41762574|FG000|Overall Study|Withdrawal by Subject|0|||
19481431|NCT01419535|41762575|FG001|Overall Study|Withdrawal by Subject|1|||
19481432|NCT01438151|41762581|FG000|Overall Study|study terminated|8|||
19481433|NCT01418365|41762607|FG000|First Intervention|Withdrawal by Subject|0|||
19481434|NCT01418365|41762608|FG001|First Intervention|Withdrawal by Subject|1|||
19481435|NCT01418365|41762607|FG000|First Intervention|Non-compliance|1|||
19481436|NCT01418365|41762608|FG001|First Intervention|Non-compliance|0|||
19481437|NCT01418365|41762607|FG000|Second Intervention|Withdrawal by Subject|0|||
19481438|NCT01418365|41762608|FG001|Second Intervention|Withdrawal by Subject|1|||
19481439|NCT01437995|41762643|FG000|Overall Study|Lost to Follow-up|11|||
19481440|NCT01437995|41762644|FG001|Overall Study|Lost to Follow-up|18|||
19481441|NCT01437995|41762645|FG002|Overall Study|Lost to Follow-up|20|||
19481442|NCT01439347|41762694|FG000|Overall Study|Death|10|||
19481443|NCT01439347|41762695|FG001|Overall Study|Death|9|||
19481444|NCT01439347|41762694|FG000|Overall Study|Withdrawal by Subject|0|||
19481445|NCT01439347|41762695|FG001|Overall Study|Withdrawal by Subject|1|||
19481446|NCT01439347|41762694|FG000|Overall Study|Physician Decision|1|||
19481447|NCT01439347|41762695|FG001|Overall Study|Physician Decision|0|||
19481448|NCT01439347|41762694|FG000|Overall Study|Sponsor Terminated Study|2|||
19481449|NCT01439347|41762695|FG001|Overall Study|Sponsor Terminated Study|3|||
19481450|NCT01438957|41762742|FG000|Overall Study|Physician Decision|1|||
19481451|NCT01438957|41762743|FG001|Overall Study|Physician Decision|1|||
19481452|NCT01438957|41762744|FG002|Overall Study|Physician Decision|0|||
19481453|NCT01438957|41762745|FG003|Overall Study|Physician Decision|1|||
19481454|NCT01438957|41762746|FG004|Overall Study|Physician Decision|0|||
19481455|NCT01444417|41762795|FG000|Overall Study|Ineligibility Determined|0|||
19481456|NCT01444417|41762796|FG001|Overall Study|Ineligibility Determined|1|||
19481457|NCT01444417|41762795|FG000|Overall Study|Withdrawal by Subject|2|||
19481458|NCT01444417|41762796|FG001|Overall Study|Withdrawal by Subject|0|||
19481459|NCT01444027|41762823|FG000|Overall Study|Withdrawal by Subject|4|||
19481460|NCT01444027|41762824|FG001|Overall Study|Withdrawal by Subject|10|||
19481461|NCT01444027|41762825|FG002|Overall Study|Withdrawal by Subject|24|||
19481462|NCT01444027|41762823|FG000|Overall Study|Lost to Follow-up|26|||
19481463|NCT01444027|41762824|FG001|Overall Study|Lost to Follow-up|20|||
19481464|NCT01444027|41762825|FG002|Overall Study|Lost to Follow-up|14|||
19481465|NCT01438489|41762867|FG000|Overall Study|Lost to Follow-up|4|||
19481466|NCT01438489|41762868|FG001|Overall Study|Lost to Follow-up|2|||
19481467|NCT01438489|41762869|FG002|Overall Study|Lost to Follow-up|2|||
19481468|NCT01438489|41762867|FG000|Overall Study|Withdrawal by Subject|11|||
19481469|NCT01438489|41762868|FG001|Overall Study|Withdrawal by Subject|3|||
19481470|NCT01438489|41762869|FG002|Overall Study|Withdrawal by Subject|8|||
19481471|NCT01438489|41762867|FG000|Overall Study|Death|0|||
19481472|NCT01438489|41762868|FG001|Overall Study|Death|0|||
19481473|NCT01438489|41762869|FG002|Overall Study|Death|1|||
19481474|NCT01438489|41762867|FG000|Overall Study|Sponsor decision|4|||
19481475|NCT01438489|41762868|FG001|Overall Study|Sponsor decision|1|||
19481476|NCT01438489|41762869|FG002|Overall Study|Sponsor decision|4|||
19481477|NCT01438489|41762867|FG000|Overall Study|Subject choice/Subject moved|2|||
19481478|NCT01438489|41762868|FG001|Overall Study|Subject choice/Subject moved|1|||
19481479|NCT01438489|41762869|FG002|Overall Study|Subject choice/Subject moved|1|||
19481480|NCT01438489|41762867|FG000|Overall Study|Investigator decision|0|||
19481481|NCT01438489|41762868|FG001|Overall Study|Investigator decision|1|||
19481482|NCT01438489|41762869|FG002|Overall Study|Investigator decision|0|||
19481483|NCT01438489|41762867|FG000|Overall Study|AE/SAEs|2|||
19481484|NCT01438489|41762868|FG001|Overall Study|AE/SAEs|1|||
19481485|NCT01438489|41762869|FG002|Overall Study|AE/SAEs|1|||
19481486|NCT01438489|41762867|FG000|Overall Study|Received prohibited medication|1|||
19481487|NCT01438489|41762868|FG001|Overall Study|Received prohibited medication|0|||
19481488|NCT01438489|41762869|FG002|Overall Study|Received prohibited medication|0|||
19481489|NCT01438489|41762867|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
19481490|NCT01438489|41762868|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
19481491|NCT01438489|41762869|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
19481492|NCT01438489|41762867|FG000|Overall Study|Inadequate venous access|0|||
19481493|NCT01438489|41762868|FG001|Overall Study|Inadequate venous access|2|||
19481494|NCT01438489|41762869|FG002|Overall Study|Inadequate venous access|0|||
19481495|NCT01418209|41762895|FG000|Overall Study|Withdrawal by Subject|1|||
19481496|NCT01418209|41762896|FG001|Overall Study|Withdrawal by Subject|0|||
19481497|NCT01418209|41762897|FG002|Overall Study|Withdrawal by Subject|1|||
19481498|NCT01418209|41762895|FG000|Overall Study|Did not provide hot flash diary data|1|||
19481499|NCT01418209|41762896|FG001|Overall Study|Did not provide hot flash diary data|3|||
19481500|NCT01418209|41762897|FG002|Overall Study|Did not provide hot flash diary data|3|||
19481501|NCT01570361|41762916|FG000|Overall Study|Subject discontinued|1|||
19481502|NCT01570361|41762917|FG001|Overall Study|Subject discontinued|2|||
19481503|NCT01570361|41762916|FG000|Overall Study|Sponsor closing the study|51|||
19481504|NCT01570361|41762917|FG001|Overall Study|Sponsor closing the study|50|||
19481505|NCT01570361|41762916|FG000|Overall Study|Subject excluded|5|||
19481506|NCT01570361|41762917|FG001|Overall Study|Subject excluded|3|||
19481507|NCT01570361|41762916|FG000|Overall Study|Subject withdrew consent|14|||
19481508|NCT01570361|41762917|FG001|Overall Study|Subject withdrew consent|9|||
19481509|NCT01570361|41762916|FG000|Overall Study|Adverse Event|2|||
19481510|NCT01570361|41762917|FG001|Overall Study|Adverse Event|1|||
19481511|NCT01570361|41762916|FG000|Overall Study|Lost to Follow-up|4|||
19481512|NCT01570361|41762917|FG001|Overall Study|Lost to Follow-up|4|||
19481513|NCT01570361|41762916|FG000|Overall Study|Death|5|||
19481514|NCT01570361|41762917|FG001|Overall Study|Death|4|||
19481515|NCT01570361|41762916|FG000|Overall Study|Other|0|||
19481516|NCT01570361|41762917|FG001|Overall Study|Other|2|||
19481517|NCT01417195|41762928|FG000|Overall Study|Stimulation failure|1|||
19481518|NCT01417195|41762929|FG001|Overall Study|Stimulation failure|0|||
19481519|NCT01417195|41762928|FG000|Overall Study|No embryos for transfer|0|||
19481520|NCT01417195|41762929|FG001|Overall Study|No embryos for transfer|1|||
19481521|NCT01417195|41762928|FG000|Overall Study|No transfer due to risk of OHSS|1|||
19481522|NCT01417195|41762929|FG001|Overall Study|No transfer due to risk of OHSS|0|||
19481523|NCT01417195|41762928|FG000|Overall Study|No transfer due to elevated progesterone|1|||
19481524|NCT01417195|41762929|FG001|Overall Study|No transfer due to elevated progesterone|0|||
19481525|NCT01438411|41762954|FG000|Overall Study|Adverse Event|8|||
19481526|NCT01438411|41762954|FG000|Overall Study|Lost to Follow-up|1|||
19481527|NCT01438411|41762954|FG000|Overall Study|Lack of Efficacy|1|||
19481528|NCT01438411|41762954|FG000|Overall Study|Withdrawal by Subject|3|||
19481529|NCT01443403|41762966|FG000|Overall Study|Adverse Event|1|||
19481530|NCT01443403|41762967|FG001|Overall Study|Adverse Event|1|||
19611796|NCT00966875|42060548|FG002|Part A|Parent/Caregiver Decision|0|||
19611797|NCT00966875|42060549|FG003|Part A|Parent/Caregiver Decision|1|||
19481531|NCT01443403|41762968|FG002|Overall Study|Adverse Event|4|||
19481532|NCT01443403|41762969|FG003|Overall Study|Adverse Event|5|||
19481533|NCT01443403|41762966|FG000|Overall Study|Withdrawal by Subject|0|||
19481534|NCT01443403|41762967|FG001|Overall Study|Withdrawal by Subject|1|||
19481535|NCT01443403|41762968|FG002|Overall Study|Withdrawal by Subject|2|||
19611798|NCT00966875|42060550|FG004|Part A|Parent/Caregiver Decision|0|||
19611799|NCT00966875|42060551|FG005|Part A|Parent/Caregiver Decision|0|||
19611800|NCT00966875|42060552|FG006|Part A|Parent/Caregiver Decision|0|||
19611801|NCT00966875|42060553|FG007|Part A|Parent/Caregiver Decision|0|||
19611802|NCT00966875|42060554|FG008|Part A|Parent/Caregiver Decision|0|||
19611803|NCT00966875|42060546|FG000|Part A|Physician Decision|0|||
19611804|NCT00966875|42060547|FG001|Part A|Physician Decision|0|||
19611805|NCT00966875|42060548|FG002|Part A|Physician Decision|0|||
19611806|NCT00966875|42060549|FG003|Part A|Physician Decision|0|||
19611807|NCT00966875|42060550|FG004|Part A|Physician Decision|1|||
19611808|NCT00966875|42060551|FG005|Part A|Physician Decision|0|||
19611809|NCT00966875|42060552|FG006|Part A|Physician Decision|1|||
19611810|NCT00966875|42060553|FG007|Part A|Physician Decision|0|||
19611811|NCT00966875|42060554|FG008|Part A|Physician Decision|2|||
19611812|NCT00966875|42060546|FG000|Part A|Sponsor Decision|0|||
19611813|NCT00966875|42060547|FG001|Part A|Sponsor Decision|0|||
19703898|NCT03812224|42148221|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
19703899|NCT03812224|42148222|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
19703900|NCT03812224|42148221|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
19703901|NCT03812224|42148222|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
19703902|NCT03812224|42148221|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
19703903|NCT03812224|42148222|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
19703904|NCT03812224|42148221|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
19703905|NCT03812224|42148222|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
19703906|NCT00231114|42148231|FG000|Randomized|Withdrawal by Subject|6|||
19703907|NCT00231114|42148232|FG001|Randomized|Withdrawal by Subject|3|||
19392616|NCT02641379|41636554|FG001|Overall Study|Blood could not be drawn|0|||
19392617|NCT02641379|41636555|FG002|Overall Study|Blood could not be drawn|0|||
19392618|NCT02641379|41636556|FG003|Overall Study|Blood could not be drawn|0|||
19392619|NCT02641379|41636557|FG004|Overall Study|Blood could not be drawn|1|||
19392620|NCT02641379|41636558|FG005|Overall Study|Blood could not be drawn|0|||
19392621|NCT02641379|41636559|FG006|Overall Study|Blood could not be drawn|0|||
19392622|NCT02641379|41636560|FG007|Overall Study|Blood could not be drawn|0|||
19392623|NCT02641379|41636561|FG008|Overall Study|Blood could not be drawn|0|||
19392624|NCT02641379|41636562|FG009|Overall Study|Blood could not be drawn|0|||
19392625|NCT02641379|41636563|FG010|Overall Study|Blood could not be drawn|0|||
19392626|NCT02641379|41636553|FG000|Overall Study|Protocol Violation|0|||
19392627|NCT02641379|41636554|FG001|Overall Study|Protocol Violation|0|||
19611814|NCT00966875|42060548|FG002|Part A|Sponsor Decision|1|||
19611815|NCT00966875|42060549|FG003|Part A|Sponsor Decision|0|||
19611816|NCT00966875|42060550|FG004|Part A|Sponsor Decision|1|||
19611817|NCT00966875|42060551|FG005|Part A|Sponsor Decision|0|||
19611818|NCT00966875|42060552|FG006|Part A|Sponsor Decision|0|||
19611819|NCT00966875|42060553|FG007|Part A|Sponsor Decision|2|||
19611820|NCT00966875|42060554|FG008|Part A|Sponsor Decision|1|||
19611821|NCT00966875|42060546|FG000|Part A|Withdrawal by Subject|2|||
19611822|NCT00966875|42060547|FG001|Part A|Withdrawal by Subject|2|||
19611823|NCT00966875|42060548|FG002|Part A|Withdrawal by Subject|1|||
19611824|NCT00966875|42060549|FG003|Part A|Withdrawal by Subject|1|||
19611825|NCT00966875|42060550|FG004|Part A|Withdrawal by Subject|3|||
19611826|NCT00966875|42060551|FG005|Part A|Withdrawal by Subject|0|||
19611827|NCT00966875|42060552|FG006|Part A|Withdrawal by Subject|5|||
19611828|NCT00966875|42060553|FG007|Part A|Withdrawal by Subject|1|||
19611829|NCT00966875|42060554|FG008|Part A|Withdrawal by Subject|1|||
19392628|NCT02641379|41636555|FG002|Overall Study|Protocol Violation|0|||
19392629|NCT02641379|41636556|FG003|Overall Study|Protocol Violation|0|||
19481536|NCT01443403|41762969|FG003|Overall Study|Withdrawal by Subject|1|||
19481537|NCT01443403|41762966|FG000|Overall Study|Lost to Follow-up|0|||
19481538|NCT01443403|41762967|FG001|Overall Study|Lost to Follow-up|0|||
19481539|NCT01443403|41762968|FG002|Overall Study|Lost to Follow-up|0|||
19481540|NCT01443403|41762969|FG003|Overall Study|Lost to Follow-up|1|||
19481541|NCT01443403|41762966|FG000|Overall Study|Protocol Violation|2|||
19481542|NCT01443403|41762967|FG001|Overall Study|Protocol Violation|1|||
19481543|NCT01443403|41762968|FG002|Overall Study|Protocol Violation|1|||
19481544|NCT01443403|41762969|FG003|Overall Study|Protocol Violation|1|||
19481545|NCT01443403|41762966|FG000|Overall Study|Use of Prohibited Treatment|2|||
19481546|NCT01443403|41762967|FG001|Overall Study|Use of Prohibited Treatment|3|||
19481547|NCT01443403|41762968|FG002|Overall Study|Use of Prohibited Treatment|0|||
19481548|NCT01443403|41762969|FG003|Overall Study|Use of Prohibited Treatment|0|||
19481549|NCT01443403|41762966|FG000|Overall Study|Other - Miscellaneous|1|||
19481550|NCT01443403|41762967|FG001|Overall Study|Other - Miscellaneous|0|||
19481551|NCT01443403|41762968|FG002|Overall Study|Other - Miscellaneous|0|||
19481552|NCT01443403|41762969|FG003|Overall Study|Other - Miscellaneous|1|||
19481553|NCT01438177|41762982|FG000|Overall Study|Withdrawal by Subject|1|||
19481554|NCT01438177|41762982|FG000|Overall Study|Initiation of new therapy|1|||
19481555|NCT01442779|41762986|FG000|Overall Study|Withdrawal by Subject|3|||
19481556|NCT01442779|41762986|FG000|Overall Study|Death|3|||
19481557|NCT01442779|41762986|FG000|Overall Study|Non-compliance|1|||
19481558|NCT01416805|41762992|FG000|Overall Study|Lost to Follow-up|4|||
19392630|NCT02641379|41636557|FG004|Overall Study|Protocol Violation|2|||
19392631|NCT02641379|41636558|FG005|Overall Study|Protocol Violation|0|||
19392632|NCT02641379|41636559|FG006|Overall Study|Protocol Violation|0|||
19392633|NCT02641379|41636560|FG007|Overall Study|Protocol Violation|0|||
19392634|NCT02641379|41636561|FG008|Overall Study|Protocol Violation|1|||
19392635|NCT02641379|41636562|FG009|Overall Study|Protocol Violation|0|||
19392636|NCT02641379|41636563|FG010|Overall Study|Protocol Violation|0|||
19392637|NCT02641379|41636553|FG000|Overall Study|Participation in sili rescue study|0|||
19392638|NCT02641379|41636554|FG001|Overall Study|Participation in sili rescue study|0|||
19392639|NCT02641379|41636555|FG002|Overall Study|Participation in sili rescue study|0|||
19392640|NCT02641379|41636556|FG003|Overall Study|Participation in sili rescue study|0|||
19392641|NCT02641379|41636557|FG004|Overall Study|Participation in sili rescue study|0|||
19392642|NCT02641379|41636558|FG005|Overall Study|Participation in sili rescue study|1|||
19392643|NCT02641379|41636559|FG006|Overall Study|Participation in sili rescue study|0|||
19392644|NCT02641379|41636560|FG007|Overall Study|Participation in sili rescue study|0|||
19392645|NCT02641379|41636561|FG008|Overall Study|Participation in sili rescue study|0|||
19392646|NCT02641379|41636562|FG009|Overall Study|Participation in sili rescue study|0|||
19392647|NCT02641379|41636563|FG010|Overall Study|Participation in sili rescue study|0|||
19392648|NCT02641379|41636553|FG000|Overall Study|Lost to Follow-up|0|||
19392649|NCT02641379|41636554|FG001|Overall Study|Lost to Follow-up|0|||
19392650|NCT02641379|41636555|FG002|Overall Study|Lost to Follow-up|0|||
19392651|NCT02641379|41636556|FG003|Overall Study|Lost to Follow-up|0|||
19392652|NCT02641379|41636557|FG004|Overall Study|Lost to Follow-up|0|||
19392653|NCT02641379|41636558|FG005|Overall Study|Lost to Follow-up|0|||
19392654|NCT02641379|41636559|FG006|Overall Study|Lost to Follow-up|0|||
19481559|NCT01416805|41762993|FG001|Overall Study|Lost to Follow-up|4|||
19481560|NCT01437943|41763001|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
19481561|NCT01437943|41763002|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
19481562|NCT01437943|41763001|FG000|Overall Study|Subject expressed pregnancy plans|1|||
19481563|NCT01437943|41763002|FG001|Overall Study|Subject expressed pregnancy plans|0|||
19481564|NCT01437943|41763001|FG000|Overall Study|Adverse Event|2|||
19481565|NCT01437943|41763002|FG001|Overall Study|Adverse Event|0|||
19481566|NCT01570283|41763011|FG000|Cohort 1: Dose Level 1|Death|0|||
19481567|NCT01570283|41763012|FG001|Cohort 1: Dose Level 1|Death|1|||
19392655|NCT02641379|41636560|FG007|Overall Study|Lost to Follow-up|0|||
19481568|NCT01570283|41763013|FG002|Cohort 1: Dose Level 1|Death|0|||
19481569|NCT01570283|41763014|FG003|Cohort 1: Dose Level 1|Death|0|||
19481570|NCT01570283|41763015|FG004|Cohort 1: Dose Level 1|Death|0|||
19481571|NCT01570283|41763016|FG005|Cohort 1: Dose Level 1|Death|0|||
19481572|NCT01570283|41763011|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
19481573|NCT01570283|41763012|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
19481574|NCT01570283|41763013|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
19611830|NCT00966875|42060546|FG000|Part A|Protocol Violation|0|||
19611831|NCT00966875|42060547|FG001|Part A|Protocol Violation|0|||
19611832|NCT00966875|42060548|FG002|Part A|Protocol Violation|0|||
19481575|NCT01570283|41763014|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
19392656|NCT02641379|41636561|FG008|Overall Study|Lost to Follow-up|1|||
19392657|NCT02641379|41636562|FG009|Overall Study|Lost to Follow-up|0|||
19392658|NCT02641379|41636563|FG010|Overall Study|Lost to Follow-up|0|||
19392659|NCT02641379|41636553|FG000|Overall Study|Source data not found|0|||
19481576|NCT01570283|41763015|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
19481577|NCT01570283|41763016|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
19481578|NCT01570283|41763011|FG000|Cohort 2: Dose Level 2|Death|0|||
19481579|NCT01570283|41763012|FG001|Cohort 2: Dose Level 2|Death|0|||
19481580|NCT01570283|41763013|FG002|Cohort 2: Dose Level 2|Death|1|||
19481581|NCT01570283|41763014|FG003|Cohort 2: Dose Level 2|Death|0|||
19481582|NCT01570283|41763015|FG004|Cohort 2: Dose Level 2|Death|0|||
19481583|NCT01570283|41763016|FG005|Cohort 2: Dose Level 2|Death|0|||
19611833|NCT00966875|42060549|FG003|Part A|Protocol Violation|0|||
19611834|NCT00966875|42060550|FG004|Part A|Protocol Violation|0|||
19611835|NCT00966875|42060551|FG005|Part A|Protocol Violation|0|||
19611836|NCT00966875|42060552|FG006|Part A|Protocol Violation|2|||
19611837|NCT00966875|42060553|FG007|Part A|Protocol Violation|1|||
19611838|NCT00966875|42060554|FG008|Part A|Protocol Violation|1|||
19611839|NCT00966875|42060546|FG000|Part B|Adverse Event|0|||
19611840|NCT00966875|42060547|FG001|Part B|Adverse Event|1|||
19611841|NCT00966875|42060548|FG002|Part B|Adverse Event|1|||
19611842|NCT00966875|42060549|FG003|Part B|Adverse Event|0|||
19611843|NCT00966875|42060550|FG004|Part B|Adverse Event|1|||
19611844|NCT00966875|42060551|FG005|Part B|Adverse Event|0|||
19611845|NCT00966875|42060552|FG006|Part B|Adverse Event|5|||
19611846|NCT00966875|42060553|FG007|Part B|Adverse Event|2|||
19611847|NCT00966875|42060554|FG008|Part B|Adverse Event|2|||
19611848|NCT00966875|42060546|FG000|Part B|Death|0|||
19611849|NCT00966875|42060547|FG001|Part B|Death|0|||
19611850|NCT00966875|42060548|FG002|Part B|Death|1|||
19611851|NCT00966875|42060549|FG003|Part B|Death|0|||
19611852|NCT00966875|42060550|FG004|Part B|Death|0|||
19611853|NCT00966875|42060551|FG005|Part B|Death|0|||
19611854|NCT00966875|42060552|FG006|Part B|Death|0|||
19611855|NCT00966875|42060553|FG007|Part B|Death|1|||
19611856|NCT00966875|42060554|FG008|Part B|Death|0|||
19611857|NCT00966875|42060546|FG000|Part B|Lack of Efficacy|2|||
19611858|NCT00966875|42060547|FG001|Part B|Lack of Efficacy|1|||
19611859|NCT00966875|42060548|FG002|Part B|Lack of Efficacy|1|||
19611860|NCT00966875|42060549|FG003|Part B|Lack of Efficacy|1|||
19611861|NCT00966875|42060550|FG004|Part B|Lack of Efficacy|2|||
19611862|NCT00966875|42060551|FG005|Part B|Lack of Efficacy|3|||
19611863|NCT00966875|42060552|FG006|Part B|Lack of Efficacy|12|||
19611864|NCT00966875|42060553|FG007|Part B|Lack of Efficacy|9|||
19611865|NCT00966875|42060554|FG008|Part B|Lack of Efficacy|6|||
19611866|NCT00966875|42060546|FG000|Part B|Lost to Follow-up|0|||
19611867|NCT00966875|42060547|FG001|Part B|Lost to Follow-up|0|||
19611868|NCT00966875|42060548|FG002|Part B|Lost to Follow-up|0|||
19611869|NCT00966875|42060549|FG003|Part B|Lost to Follow-up|1|||
19611870|NCT00966875|42060550|FG004|Part B|Lost to Follow-up|0|||
19611871|NCT00966875|42060551|FG005|Part B|Lost to Follow-up|0|||
19611872|NCT00966875|42060552|FG006|Part B|Lost to Follow-up|0|||
19703908|NCT00231114|42148231|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
19392660|NCT02641379|41636554|FG001|Overall Study|Source data not found|0|||
19392661|NCT02641379|41636555|FG002|Overall Study|Source data not found|0|||
19392662|NCT02641379|41636556|FG003|Overall Study|Source data not found|0|||
19392663|NCT02641379|41636557|FG004|Overall Study|Source data not found|0|||
19392664|NCT02641379|41636558|FG005|Overall Study|Source data not found|1|||
19392665|NCT02641379|41636559|FG006|Overall Study|Source data not found|0|||
19392666|NCT02641379|41636560|FG007|Overall Study|Source data not found|0|||
19392667|NCT02641379|41636561|FG008|Overall Study|Source data not found|0|||
19392668|NCT02641379|41636562|FG009|Overall Study|Source data not found|0|||
19481584|NCT01570283|41763011|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
19481585|NCT01570283|41763012|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
19481586|NCT01570283|41763013|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
19703909|NCT00231114|42148232|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
19392669|NCT02641379|41636563|FG010|Overall Study|Source data not found|0|||
19611873|NCT00966875|42060553|FG007|Part B|Lost to Follow-up|0|||
19611874|NCT00966875|42060554|FG008|Part B|Lost to Follow-up|1|||
19611875|NCT00966875|42060546|FG000|Part B|Physician Decision|0|||
19611876|NCT00966875|42060547|FG001|Part B|Physician Decision|0|||
19611877|NCT00966875|42060548|FG002|Part B|Physician Decision|1|||
19611878|NCT00966875|42060549|FG003|Part B|Physician Decision|0|||
19611879|NCT00966875|42060550|FG004|Part B|Physician Decision|2|||
19611880|NCT00966875|42060551|FG005|Part B|Physician Decision|1|||
19611881|NCT00966875|42060552|FG006|Part B|Physician Decision|0|||
19611882|NCT00966875|42060553|FG007|Part B|Physician Decision|0|||
19611883|NCT00966875|42060554|FG008|Part B|Physician Decision|2|||
19611884|NCT00966875|42060546|FG000|Part B|Sponsor Decision|1|||
19611885|NCT00966875|42060547|FG001|Part B|Sponsor Decision|0|||
19611886|NCT00966875|42060548|FG002|Part B|Sponsor Decision|0|||
19611887|NCT00966875|42060549|FG003|Part B|Sponsor Decision|0|||
19611888|NCT00966875|42060550|FG004|Part B|Sponsor Decision|0|||
19703910|NCT00231114|42148231|FG000|Post-Treatment Period|Lost to Follow-up|6|||
19703911|NCT00231114|42148232|FG001|Post-Treatment Period|Lost to Follow-up|1|||
19611889|NCT00966875|42060551|FG005|Part B|Sponsor Decision|1|||
19611890|NCT00966875|42060552|FG006|Part B|Sponsor Decision|0|||
19611891|NCT00966875|42060553|FG007|Part B|Sponsor Decision|2|||
19611892|NCT00966875|42060554|FG008|Part B|Sponsor Decision|1|||
19611893|NCT00966875|42060546|FG000|Part B|Withdrawal by Subject|2|||
19611894|NCT00966875|42060547|FG001|Part B|Withdrawal by Subject|1|||
19611895|NCT00966875|42060548|FG002|Part B|Withdrawal by Subject|2|||
19611896|NCT00966875|42060549|FG003|Part B|Withdrawal by Subject|1|||
19611897|NCT00966875|42060550|FG004|Part B|Withdrawal by Subject|2|||
19611898|NCT00966875|42060551|FG005|Part B|Withdrawal by Subject|1|||
19611899|NCT00966875|42060552|FG006|Part B|Withdrawal by Subject|4|||
19611900|NCT00966875|42060553|FG007|Part B|Withdrawal by Subject|5|||
19611901|NCT00966875|42060554|FG008|Part B|Withdrawal by Subject|5|||
19611902|NCT00966875|42060546|FG000|Part B|Entry Criteria|0|||
19611903|NCT00966875|42060547|FG001|Part B|Entry Criteria|0|||
19611904|NCT00966875|42060548|FG002|Part B|Entry Criteria|0|||
19611905|NCT00966875|42060549|FG003|Part B|Entry Criteria|0|||
19703912|NCT00231114|42148231|FG000|Post-Treatment Period|Physician Decision|1|||
19481587|NCT01570283|41763014|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
19611906|NCT00966875|42060550|FG004|Part B|Entry Criteria|0|||
19611907|NCT00966875|42060551|FG005|Part B|Entry Criteria|0|||
19611908|NCT00966875|42060552|FG006|Part B|Entry Criteria|1|||
19611909|NCT00966875|42060553|FG007|Part B|Entry Criteria|0|||
19611910|NCT00966875|42060554|FG008|Part B|Entry Criteria|1|||
19611911|NCT00828711|42060630|FG000|Overall Study|Lost to Follow-up|1|||
19611912|NCT00828711|42060631|FG001|Overall Study|Lost to Follow-up|0|||
19611913|NCT00828711|42060632|FG002|Overall Study|Lost to Follow-up|0|||
19611914|NCT00966719|42060642|FG000|Overall Study|Lost to Follow-up|6|||
19611915|NCT00966719|42060643|FG001|Overall Study|Lost to Follow-up|11|||
19611916|NCT00818649|42060649|FG000|Overall Study|Declining performance status|2|||
19611917|NCT00818649|42060649|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
19611918|NCT00818649|42060649|FG000|Overall Study|Adverse Event|1|||
19611919|NCT00961571|42060654|FG000|Overall Study|Physician Decision|39|||
19611920|NCT00964223|42060658|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
19611921|NCT00620815|42060666|FG000|Overall Study|Adverse Event|1|||
19611922|NCT00620815|42060667|FG001|Overall Study|Adverse Event|1|||
19611923|NCT00620815|42060668|FG002|Overall Study|Adverse Event|2|||
19611924|NCT00620815|42060666|FG000|Overall Study|Withdrawal by Subject|1|||
19611925|NCT00620815|42060667|FG001|Overall Study|Withdrawal by Subject|2|||
19611926|NCT00620815|42060668|FG002|Overall Study|Withdrawal by Subject|0|||
19481588|NCT01570283|41763015|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
19481589|NCT01570283|41763016|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
19481590|NCT01570283|41763011|FG000|Cohort 3: Dose Level 3|Death|0|||
19481591|NCT01570283|41763012|FG001|Cohort 3: Dose Level 3|Death|0|||
19481592|NCT01570283|41763013|FG002|Cohort 3: Dose Level 3|Death|0|||
19481593|NCT01570283|41763014|FG003|Cohort 3: Dose Level 3|Death|0|||
19481594|NCT01570283|41763015|FG004|Cohort 3: Dose Level 3|Death|0|||
19481595|NCT01570283|41763016|FG005|Cohort 3: Dose Level 3|Death|1|||
19481596|NCT01570283|41763011|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
19481597|NCT01570283|41763012|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
19481598|NCT01570283|41763013|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
19481599|NCT01570283|41763014|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
19481600|NCT01570283|41763015|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
19481601|NCT01570283|41763016|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
19481602|NCT01436357|41763032|FG000|Overall Study|Death|5|||
19481603|NCT01436357|41763033|FG001|Overall Study|Death|1|||
19481604|NCT01436357|41763032|FG000|Overall Study|Enrolled but not vaccinated|1|||
19481605|NCT01436357|41763033|FG001|Overall Study|Enrolled but not vaccinated|1|||
19481606|NCT01436357|41763032|FG000|Overall Study|Incarceration|18|||
19481607|NCT01436357|41763033|FG001|Overall Study|Incarceration|20|||
19481608|NCT01436357|41763032|FG000|Overall Study|Lost to Follow-up|67|||
19481609|NCT01436357|41763033|FG001|Overall Study|Lost to Follow-up|61|||
19611927|NCT00620815|42060666|FG000|Overall Study|Lost to Follow-up|1|||
19703913|NCT00231114|42148232|FG001|Post-Treatment Period|Physician Decision|0|||
19481610|NCT01436357|41763032|FG000|Overall Study|Protocol Violation|1|||
19481611|NCT01436357|41763033|FG001|Overall Study|Protocol Violation|0|||
19481612|NCT01436357|41763032|FG000|Overall Study|Withdrawal by Subject|26|||
19481613|NCT01436357|41763033|FG001|Overall Study|Withdrawal by Subject|38|||
19611928|NCT00620815|42060667|FG001|Overall Study|Lost to Follow-up|6|||
19611929|NCT00620815|42060668|FG002|Overall Study|Lost to Follow-up|3|||
19611930|NCT00620815|42060666|FG000|Overall Study|Inappropriate enrolment|0|||
19611931|NCT00620815|42060667|FG001|Overall Study|Inappropriate enrolment|0|||
19611932|NCT00620815|42060668|FG002|Overall Study|Inappropriate enrolment|1|||
19611933|NCT00620815|42060666|FG000|Overall Study|Protocol Violation|1|||
19611934|NCT00620815|42060667|FG001|Overall Study|Protocol Violation|2|||
19611935|NCT00620815|42060668|FG002|Overall Study|Protocol Violation|1|||
19481614|NCT01436357|41763032|FG000|Overall Study|Physician Decision|3|||
19481615|NCT01436357|41763033|FG001|Overall Study|Physician Decision|4|||
19481616|NCT01436357|41763032|FG000|Overall Study|Moved out of area|1|||
19481617|NCT01436357|41763033|FG001|Overall Study|Moved out of area|2|||
19481618|NCT01436357|41763032|FG000|Overall Study|Subject in rehab|0|||
19481619|NCT01436357|41763033|FG001|Overall Study|Subject in rehab|1|||
19481620|NCT01436201|41763039|FG000|Overall Study|Adverse Event|2|||
19481621|NCT01436201|41763039|FG000|Overall Study|Withdrawal by Subject|1|||
19481622|NCT01436201|41763039|FG000|Overall Study|Protocol Violation|1|||
19481623|NCT01437397|41763050|FG000|Overall Study|Lost to Follow-up|9|||
19481624|NCT01437397|41763051|FG001|Overall Study|Lost to Follow-up|4|||
19481625|NCT01437397|41763052|FG002|Overall Study|Lost to Follow-up|2|||
19481626|NCT01437397|41763053|FG003|Overall Study|Lost to Follow-up|4|||
19481627|NCT01437397|41763054|FG004|Overall Study|Lost to Follow-up|5|||
19481628|NCT01437397|41763050|FG000|Overall Study|Withdrawal by Subject|11|||
19481629|NCT01437397|41763051|FG001|Overall Study|Withdrawal by Subject|12|||
19481630|NCT01437397|41763052|FG002|Overall Study|Withdrawal by Subject|24|||
19481631|NCT01437397|41763053|FG003|Overall Study|Withdrawal by Subject|11|||
19481632|NCT01437397|41763054|FG004|Overall Study|Withdrawal by Subject|22|||
19481633|NCT01437397|41763050|FG000|Overall Study|Protocol Violation|10|||
19481634|NCT01437397|41763051|FG001|Overall Study|Protocol Violation|12|||
19611936|NCT03372941|42060694|FG000|Overall Study|Lost to Follow-up|2|||
19611937|NCT03372941|42060695|FG001|Overall Study|Lost to Follow-up|4|||
19611938|NCT00619957|42060703|FG000|Month 24 Double-Blind|Adverse Event|9|||
19611939|NCT00619957|42060704|FG001|Month 24 Double-Blind|Adverse Event|7|||
19481635|NCT01437397|41763052|FG002|Overall Study|Protocol Violation|13|||
19481636|NCT01437397|41763053|FG003|Overall Study|Protocol Violation|21|||
19481637|NCT01437397|41763054|FG004|Overall Study|Protocol Violation|19|||
19481638|NCT01437397|41763050|FG000|Overall Study|Lack of Efficacy|5|||
19481639|NCT01437397|41763051|FG001|Overall Study|Lack of Efficacy|4|||
19481640|NCT01437397|41763052|FG002|Overall Study|Lack of Efficacy|8|||
19481641|NCT01437397|41763053|FG003|Overall Study|Lack of Efficacy|10|||
19481642|NCT01437397|41763054|FG004|Overall Study|Lack of Efficacy|20|||
19481643|NCT01437397|41763050|FG000|Overall Study|Adverse Event|21|||
19481644|NCT01437397|41763051|FG001|Overall Study|Adverse Event|22|||
19481645|NCT01437397|41763052|FG002|Overall Study|Adverse Event|16|||
19481646|NCT01437397|41763053|FG003|Overall Study|Adverse Event|14|||
19481647|NCT01437397|41763054|FG004|Overall Study|Adverse Event|21|||
19481648|NCT01437397|41763050|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
19481649|NCT01437397|41763051|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
19481650|NCT01437397|41763052|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
19481651|NCT01437397|41763053|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
19481652|NCT01437397|41763054|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
19392670|NCT02641379|41636553|FG000|Overall Study|Participant showed weight reduction|0|||
19392671|NCT02641379|41636554|FG001|Overall Study|Participant showed weight reduction|0|||
19392672|NCT02641379|41636555|FG002|Overall Study|Participant showed weight reduction|0|||
19392673|NCT02641379|41636556|FG003|Overall Study|Participant showed weight reduction|0|||
19392674|NCT02641379|41636557|FG004|Overall Study|Participant showed weight reduction|0|||
19392675|NCT02641379|41636558|FG005|Overall Study|Participant showed weight reduction|0|||
19481653|NCT01437319|41763066|FG000|Phase I|Lost to Follow-up|2|||
19481654|NCT01437319|41763067|FG001|Phase I|Lost to Follow-up|0|||
19481655|NCT01437319|41763068|FG002|Phase I|Lost to Follow-up|0|||
19481656|NCT01437319|41763066|FG000|Phase I|Protocol Violation|1|||
19481657|NCT01437319|41763067|FG001|Phase I|Protocol Violation|0|||
19481658|NCT01437319|41763068|FG002|Phase I|Protocol Violation|0|||
19392676|NCT02641379|41636559|FG006|Overall Study|Participant showed weight reduction|0|||
19392677|NCT02641379|41636560|FG007|Overall Study|Participant showed weight reduction|1|||
19392678|NCT02641379|41636561|FG008|Overall Study|Participant showed weight reduction|0|||
19481659|NCT01437319|41763066|FG000|Phase I|Study related symptoms/complaints|27|||
19611940|NCT00619957|42060703|FG000|Month 24 Double-Blind|Protocol Violation|1|||
19481660|NCT01437319|41763067|FG001|Phase I|Study related symptoms/complaints|0|||
19481661|NCT01437319|41763068|FG002|Phase I|Study related symptoms/complaints|0|||
19481662|NCT01437319|41763066|FG000|Phase I|Withdrawal by Subject|25|||
19481663|NCT01437319|41763067|FG001|Phase I|Withdrawal by Subject|0|||
19481664|NCT01437319|41763068|FG002|Phase I|Withdrawal by Subject|0|||
19481665|NCT01437319|41763066|FG000|Phase II|Withdrawal by Subject|0|||
19481666|NCT01437319|41763067|FG001|Phase II|Withdrawal by Subject|8|||
19481667|NCT01437319|41763068|FG002|Phase II|Withdrawal by Subject|16|||
19481668|NCT01437319|41763066|FG000|Phase II|Lost to Follow-up|0|||
19481669|NCT01437319|41763067|FG001|Phase II|Lost to Follow-up|7|||
19481670|NCT01437319|41763068|FG002|Phase II|Lost to Follow-up|2|||
19481671|NCT01437319|41763066|FG000|Phase II|Study related symptoms/complaints|0|||
19481672|NCT01437319|41763067|FG001|Phase II|Study related symptoms/complaints|28|||
19481673|NCT01437319|41763068|FG002|Phase II|Study related symptoms/complaints|19|||
19481674|NCT01437319|41763066|FG000|Phase II|Protocol Violation|0|||
19481675|NCT01437319|41763067|FG001|Phase II|Protocol Violation|1|||
19611941|NCT00619957|42060704|FG001|Month 24 Double-Blind|Protocol Violation|0|||
19481676|NCT01437319|41763068|FG002|Phase II|Protocol Violation|0|||
19392679|NCT02641379|41636562|FG009|Overall Study|Participant showed weight reduction|0|||
19392680|NCT02641379|41636563|FG010|Overall Study|Participant showed weight reduction|0|||
19392681|NCT02641379|41636553|FG000|Overall Study|Non-response Week 12|0|||
19392682|NCT02641379|41636554|FG001|Overall Study|Non-response Week 12|0|||
19481677|NCT01416571|41763077|FG000|Overall Study|Lost to Follow-up|2|||
19481678|NCT01442155|41763098|FG000|Overall Study|Complete remission|35|||
19481679|NCT01442155|41763098|FG000|Overall Study|Recurrence|26|||
19481680|NCT01442155|41763098|FG000|Overall Study|Adverse Event|2|||
19481681|NCT01442155|41763098|FG000|Overall Study|Lost to Follow-up|2|||
19481682|NCT01416181|41763104|FG000|Part 1|Other|10|||
19481683|NCT01416181|41763105|FG001|Part 1|Other|24|||
19703914|NCT00231114|42148231|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
19703915|NCT00231114|42148232|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
19703916|NCT03543046|42148242|FG000|Overall Study|Adverse Event|1|||
19703917|NCT03543046|42148243|FG001|Overall Study|Adverse Event|1|||
19703918|NCT03543046|42148242|FG000|Overall Study|Physician Decision|1|||
19703919|NCT03543046|42148243|FG001|Overall Study|Physician Decision|1|||
19703920|NCT03543046|42148242|FG000|Overall Study|Protocol Violation|1|||
19703921|NCT03543046|42148243|FG001|Overall Study|Protocol Violation|0|||
19703922|NCT00259272|42148262|FG000|Overall Study|Adverse Event|2|||
19703923|NCT00259272|42148263|FG001|Overall Study|Adverse Event|1|||
19703924|NCT00259272|42148264|FG002|Overall Study|Adverse Event|0|||
19703925|NCT00259272|42148265|FG003|Overall Study|Adverse Event|3|||
19703926|NCT00259272|42148262|FG000|Overall Study|Lack of Efficacy|5|||
19703927|NCT00259272|42148263|FG001|Overall Study|Lack of Efficacy|1|||
19703928|NCT00259272|42148264|FG002|Overall Study|Lack of Efficacy|2|||
19703929|NCT00259272|42148265|FG003|Overall Study|Lack of Efficacy|6|||
19703930|NCT00259272|42148262|FG000|Overall Study|Physician Decision|1|||
19703931|NCT00259272|42148263|FG001|Overall Study|Physician Decision|2|||
19703932|NCT00259272|42148264|FG002|Overall Study|Physician Decision|1|||
19703933|NCT00259272|42148265|FG003|Overall Study|Physician Decision|3|||
19703934|NCT00259272|42148262|FG000|Overall Study|Protocol Violation|2|||
19392683|NCT02641379|41636555|FG002|Overall Study|Non-response Week 12|0|||
19392684|NCT02641379|41636556|FG003|Overall Study|Non-response Week 12|0|||
19481684|NCT01416181|41763104|FG000|Part 1|Death|0|||
19481685|NCT01416181|41763105|FG001|Part 1|Death|1|||
19481686|NCT01416181|41763104|FG000|Part 1|Investigator Decision|7|||
19481687|NCT01416181|41763105|FG001|Part 1|Investigator Decision|6|||
19481688|NCT01416181|41763104|FG000|Part 1|Withdrawal by Subject|74|||
19481689|NCT01416181|41763105|FG001|Part 1|Withdrawal by Subject|48|||
19481690|NCT01416181|41763104|FG000|Part 1|Lack of Efficacy|16|||
19481691|NCT01416181|41763105|FG001|Part 1|Lack of Efficacy|8|||
19481692|NCT01416181|41763104|FG000|Part 1|Lost to Follow-up|1|||
19481693|NCT01416181|41763105|FG001|Part 1|Lost to Follow-up|1|||
19392685|NCT02641379|41636557|FG004|Overall Study|Non-response Week 12|0|||
19392686|NCT02641379|41636558|FG005|Overall Study|Non-response Week 12|0|||
19392687|NCT02641379|41636559|FG006|Overall Study|Non-response Week 12|0|||
19392688|NCT02641379|41636560|FG007|Overall Study|Non-response Week 12|1|||
19392689|NCT02641379|41636561|FG008|Overall Study|Non-response Week 12|0|||
19392690|NCT02641379|41636562|FG009|Overall Study|Non-response Week 12|0|||
19392691|NCT02641379|41636563|FG010|Overall Study|Non-response Week 12|0|||
19392692|NCT02641379|41636553|FG000|Overall Study|No 2 Log drop at Week 12|0|||
19392693|NCT02641379|41636554|FG001|Overall Study|No 2 Log drop at Week 12|0|||
19481694|NCT01416181|41763104|FG000|Part 1|Adverse Event|15|||
19481695|NCT01416181|41763105|FG001|Part 1|Adverse Event|18|||
19703935|NCT00259272|42148263|FG001|Overall Study|Protocol Violation|0|||
19703936|NCT00259272|42148264|FG002|Overall Study|Protocol Violation|0|||
19703937|NCT00259272|42148265|FG003|Overall Study|Protocol Violation|1|||
19703938|NCT00259272|42148262|FG000|Overall Study|Sponsor Decision|0|||
19703939|NCT00259272|42148263|FG001|Overall Study|Sponsor Decision|1|||
19703940|NCT00259272|42148264|FG002|Overall Study|Sponsor Decision|0|||
19481696|NCT01416181|41763104|FG000|Part 1|Ongoing in Follow-Up|14|||
19481697|NCT01416181|41763105|FG001|Part 1|Ongoing in Follow-Up|8|||
19481698|NCT01416181|41763104|FG000|Part 2|Adverse Event|11|||
19481699|NCT01416181|41763105|FG001|Part 2|Adverse Event|4|||
19481700|NCT01416181|41763104|FG000|Part 2|Other|234|||
19481701|NCT01416181|41763105|FG001|Part 2|Other|267|||
19703941|NCT00259272|42148265|FG003|Overall Study|Sponsor Decision|0|||
19481702|NCT01416181|41763104|FG000|Part 2|Investigator Decision|6|||
19481703|NCT01416181|41763105|FG001|Part 2|Investigator Decision|7|||
19481704|NCT01416181|41763104|FG000|Part 2|Withdrawal by Subject|14|||
19481705|NCT01416181|41763105|FG001|Part 2|Withdrawal by Subject|5|||
19481706|NCT01416181|41763104|FG000|Part 2|Lack of Efficacy|4|||
19481707|NCT01416181|41763105|FG001|Part 2|Lack of Efficacy|1|||
19481708|NCT01416181|41763104|FG000|Part 2|Lost to Follow-up|2|||
19481709|NCT01416181|41763105|FG001|Part 2|Lost to Follow-up|2|||
19481710|NCT01441765|41763113|FG000|Overall Study|Death|1|||
19481711|NCT01441765|41763114|FG001|Overall Study|Death|0|||
19481712|NCT01419665|41763122|FG000|Combination Treatment|Adverse Event|7|||
19481713|NCT01419665|41763123|FG001|Combination Treatment|Adverse Event|10|||
19481714|NCT01419665|41763122|FG000|Combination Treatment|Physician Decision|5|||
19481715|NCT01419665|41763123|FG001|Combination Treatment|Physician Decision|8|||
19481716|NCT01419665|41763122|FG000|Combination Treatment|Protocol Violation|6|||
19481717|NCT01419665|41763123|FG001|Combination Treatment|Protocol Violation|2|||
19481718|NCT01419665|41763122|FG000|Combination Treatment|disease progression|10|||
19481719|NCT01419665|41763123|FG001|Combination Treatment|disease progression|9|||
19481720|NCT01419665|41763122|FG000|Combination Treatment|Death|5|||
19481721|NCT01419665|41763123|FG001|Combination Treatment|Death|7|||
19481722|NCT01419665|41763122|FG000|Combination Treatment|administrative problems|0|||
19481723|NCT01419665|41763123|FG001|Combination Treatment|administrative problems|1|||
19481724|NCT01419665|41763122|FG000|Combination Treatment|Withdrawal by Subject|5|||
19481725|NCT01419665|41763123|FG001|Combination Treatment|Withdrawal by Subject|4|||
19481726|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
19481727|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
19481728|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
19481729|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
19481730|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
19481731|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
19481732|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
19481733|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
19481734|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
19481735|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
19481736|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
19481737|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
19481738|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Death|1|||
19481739|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Death|2|||
19481740|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
19481741|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
19481742|NCT01419665|41763122|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
19611942|NCT00619957|42060703|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
19703942|NCT00259272|42148262|FG000|Overall Study|Withdrawal by Subject|4|||
19481743|NCT01419665|41763123|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
19481744|NCT01419665|41763122|FG000|Open Label Phase|Death|1|||
19481745|NCT01419665|41763123|FG001|Open Label Phase|Death|0|||
19481746|NCT01419665|41763122|FG000|Open Label Phase|disease progression|0|||
19481747|NCT01419665|41763123|FG001|Open Label Phase|disease progression|1|||
19481748|NCT01436305|41763134|FG000|Overall Study|Death|1|||
19481749|NCT01436305|41763135|FG001|Overall Study|Death|0|||
19481750|NCT01436305|41763136|FG002|Overall Study|Death|0|||
19481751|NCT01436305|41763134|FG000|Overall Study|Lost to Follow-up|0|||
19481752|NCT01436305|41763135|FG001|Overall Study|Lost to Follow-up|1|||
19481753|NCT01436305|41763136|FG002|Overall Study|Lost to Follow-up|0|||
19481754|NCT01436305|41763134|FG000|Overall Study|Withdrawal by Subject|1|||
19481755|NCT01436305|41763135|FG001|Overall Study|Withdrawal by Subject|3|||
19481756|NCT01436305|41763136|FG002|Overall Study|Withdrawal by Subject|0|||
19481757|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
19481758|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
19481759|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
19481760|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
19481761|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481762|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481763|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
19481764|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481765|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481766|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
19481767|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481768|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481769|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
19481770|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
19481771|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
19481772|NCT01436149|41763146|FG000|Antidepressant Lead-in Phase|Other|119|||
19481773|NCT01436149|41763147|FG001|Antidepressant Lead-in Phase|Other|0|||
19481774|NCT01436149|41763148|FG002|Antidepressant Lead-in Phase|Other|0|||
19481775|NCT01436149|41763146|FG000|Randomized Phase|Adverse Event|9|||
19481776|NCT01436149|41763147|FG001|Randomized Phase|Adverse Event|10|||
19481777|NCT01436149|41763148|FG002|Randomized Phase|Adverse Event|11|||
19481778|NCT01436149|41763146|FG000|Randomized Phase|Protocol Violation|4|||
19481779|NCT01436149|41763147|FG001|Randomized Phase|Protocol Violation|5|||
19481780|NCT01436149|41763148|FG002|Randomized Phase|Protocol Violation|0|||
19481781|NCT01436149|41763146|FG000|Randomized Phase|Withdrawal by Subject|16|||
19481782|NCT01436149|41763147|FG001|Randomized Phase|Withdrawal by Subject|10|||
19481783|NCT01436149|41763148|FG002|Randomized Phase|Withdrawal by Subject|10|||
19481784|NCT01436149|41763146|FG000|Randomized Phase|Lost to Follow-up|34|||
19481785|NCT01436149|41763147|FG001|Randomized Phase|Lost to Follow-up|5|||
19481786|NCT01436149|41763148|FG002|Randomized Phase|Lost to Follow-up|6|||
19481787|NCT01436149|41763146|FG000|Randomized Phase|Lack of Efficacy|0|||
19481788|NCT01436149|41763147|FG001|Randomized Phase|Lack of Efficacy|0|||
19481789|NCT01436149|41763148|FG002|Randomized Phase|Lack of Efficacy|1|||
19481790|NCT01436149|41763146|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
19481791|NCT01436149|41763147|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
19481792|NCT01436149|41763148|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
19481793|NCT01436149|41763146|FG000|Randomized Phase|Other|12|||
19481794|NCT01436149|41763147|FG001|Randomized Phase|Other|5|||
19481795|NCT01436149|41763148|FG002|Randomized Phase|Other|11|||
19481796|NCT01415401|41763154|FG000|Overall Study|Adverse Event|5|||
19481797|NCT01415401|41763154|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
19481798|NCT01415401|41763154|FG000|Overall Study|Terminated by Sponsor|1|||
19481799|NCT01414855|41763158|FG000|Overall Study|Death|17|||
19481800|NCT01414855|41763158|FG000|Overall Study|Lost to Follow-up|5|||
19481801|NCT01414855|41763158|FG000|Overall Study|Withdrawal by Subject|7|||
19481802|NCT01527500|41763166|FG000|Part A|Administrative|11|||
19481803|NCT01527500|41763167|FG001|Part A|Administrative|7|||
19481804|NCT01527500|41763166|FG000|Part A|Adverse Event|4|||
19481805|NCT01527500|41763167|FG001|Part A|Adverse Event|2|||
19481806|NCT01527500|41763166|FG000|Part A|Death|4|||
19481807|NCT01527500|41763167|FG001|Part A|Death|1|||
19481808|NCT01527500|41763166|FG000|Part A|Lost to Follow-up|0|||
19481809|NCT01527500|41763167|FG001|Part A|Lost to Follow-up|1|||
19481810|NCT01527500|41763166|FG000|Part A|Protocol Deviation|9|||
19481811|NCT01527500|41763167|FG001|Part A|Protocol Deviation|2|||
19481812|NCT01527500|41763166|FG000|Part A|Withdrawal by Subject|2|||
19481813|NCT01527500|41763167|FG001|Part A|Withdrawal by Subject|0|||
19481814|NCT01527500|41763166|FG000|Part B|Adverse Event|1|||
19481815|NCT01527500|41763167|FG001|Part B|Adverse Event|0|||
19481816|NCT01527110|41763192|FG000|Overall Study|Adverse Event|1|||
19481817|NCT01441063|41763196|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
19481818|NCT01441063|41763196|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
19481819|NCT01436071|41763205|FG000|Overall Study|Adverse Event|1|||
19481820|NCT01436071|41763206|FG001|Overall Study|Adverse Event|0|||
19481821|NCT01436071|41763205|FG000|Overall Study|Lack of Efficacy|16|||
19481822|NCT01436071|41763206|FG001|Overall Study|Lack of Efficacy|7|||
19481823|NCT01436071|41763205|FG000|Overall Study|Protocol Violation|0|||
19481824|NCT01436071|41763206|FG001|Overall Study|Protocol Violation|1|||
19481825|NCT01436071|41763205|FG000|Overall Study|Lost to Follow-up|3|||
19481826|NCT01436071|41763206|FG001|Overall Study|Lost to Follow-up|1|||
19481827|NCT01436071|41763205|FG000|Overall Study|Physician Decision|1|||
19481828|NCT01436071|41763206|FG001|Overall Study|Physician Decision|0|||
19481829|NCT01436071|41763205|FG000|Overall Study|Withdrawal by Subject|2|||
19481830|NCT01436071|41763206|FG001|Overall Study|Withdrawal by Subject|2|||
19481831|NCT01436071|41763205|FG000|Overall Study|Did Not Receive Trial Medication|3|||
19392694|NCT02641379|41636555|FG002|Overall Study|No 2 Log drop at Week 12|0|||
19392695|NCT02641379|41636556|FG003|Overall Study|No 2 Log drop at Week 12|0|||
19392696|NCT02641379|41636557|FG004|Overall Study|No 2 Log drop at Week 12|0|||
19392697|NCT02641379|41636558|FG005|Overall Study|No 2 Log drop at Week 12|0|||
19392698|NCT02641379|41636559|FG006|Overall Study|No 2 Log drop at Week 12|0|||
19392699|NCT02641379|41636560|FG007|Overall Study|No 2 Log drop at Week 12|0|||
19392700|NCT02641379|41636561|FG008|Overall Study|No 2 Log drop at Week 12|0|||
19392701|NCT02641379|41636562|FG009|Overall Study|No 2 Log drop at Week 12|0|||
19392702|NCT02641379|41636563|FG010|Overall Study|No 2 Log drop at Week 12|1|||
19392703|NCT02641379|41636553|FG000|Overall Study|Negative PCR result|0|||
19481832|NCT01436071|41763206|FG001|Overall Study|Did Not Receive Trial Medication|3|||
19481833|NCT01514864|41763214|FG000|Overall Study|Disease progression|7|||
19481834|NCT01514864|41763215|FG001|Overall Study|Disease progression|5|||
19481835|NCT01514864|41763214|FG000|Overall Study|Study drug toxicity|2|||
19481836|NCT01514864|41763215|FG001|Overall Study|Study drug toxicity|0|||
19481837|NCT01514240|41763224|FG000|Overall Study|Adverse Event|4|||
19481838|NCT01514240|41763225|FG001|Overall Study|Adverse Event|4|||
19481839|NCT01514240|41763224|FG000|Overall Study|Subject Decision|2|||
19481840|NCT01514240|41763225|FG001|Overall Study|Subject Decision|7|||
19392704|NCT02641379|41636554|FG001|Overall Study|Negative PCR result|0|||
19392705|NCT02641379|41636555|FG002|Overall Study|Negative PCR result|0|||
19392706|NCT02641379|41636556|FG003|Overall Study|Negative PCR result|0|||
19392707|NCT02641379|41636557|FG004|Overall Study|Negative PCR result|0|||
19392708|NCT02641379|41636558|FG005|Overall Study|Negative PCR result|0|||
19392709|NCT02641379|41636559|FG006|Overall Study|Negative PCR result|0|||
19392710|NCT02641379|41636560|FG007|Overall Study|Negative PCR result|0|||
19392711|NCT02641379|41636561|FG008|Overall Study|Negative PCR result|0|||
19392712|NCT02641379|41636562|FG009|Overall Study|Negative PCR result|1|||
19392713|NCT02641379|41636563|FG010|Overall Study|Negative PCR result|0|||
19392714|NCT02641379|41636553|FG000|Overall Study|Participant's PCR high|0|||
19392715|NCT02641379|41636554|FG001|Overall Study|Participant's PCR high|0|||
19392716|NCT02641379|41636555|FG002|Overall Study|Participant's PCR high|0|||
19392717|NCT02641379|41636556|FG003|Overall Study|Participant's PCR high|0|||
19392718|NCT02641379|41636557|FG004|Overall Study|Participant's PCR high|0|||
19392719|NCT02641379|41636558|FG005|Overall Study|Participant's PCR high|0|||
19392720|NCT02641379|41636559|FG006|Overall Study|Participant's PCR high|0|||
19392721|NCT02641379|41636560|FG007|Overall Study|Participant's PCR high|1|||
19481841|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
19481842|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
19481843|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
19481844|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
19481845|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
19481846|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
19481847|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
19481848|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481849|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481850|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481851|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
19481852|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
19611943|NCT00619957|42060704|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
19611944|NCT00619957|42060703|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
19611945|NCT00619957|42060704|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
19611946|NCT00619957|42060703|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
19611947|NCT00619957|42060704|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
19611948|NCT00619957|42060703|FG000|Month 48 Open-Label|Adverse Event|4|||
19611949|NCT00619957|42060704|FG001|Month 48 Open-Label|Adverse Event|4|||
19611950|NCT00619957|42060703|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
19611951|NCT00619957|42060704|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
19611952|NCT00619957|42060703|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
19611953|NCT00619957|42060704|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
19611954|NCT00961415|42060714|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
19611955|NCT00961415|42060715|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
19611956|NCT00961415|42060716|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
19611957|NCT00961415|42060714|FG000|Induction Treatment Phase|Death|77|||
19611958|NCT00961415|42060715|FG001|Induction Treatment Phase|Death|0|||
19611959|NCT00961415|42060716|FG002|Induction Treatment Phase|Death|0|||
19611960|NCT00961415|42060714|FG000|Induction Treatment Phase|Protocol Violation|1|||
19611961|NCT00961415|42060715|FG001|Induction Treatment Phase|Protocol Violation|0|||
19611962|NCT00961415|42060716|FG002|Induction Treatment Phase|Protocol Violation|0|||
19611963|NCT00961415|42060714|FG000|Induction Treatment Phase|Physician Decision|2|||
19611964|NCT00961415|42060715|FG001|Induction Treatment Phase|Physician Decision|0|||
19611965|NCT00961415|42060716|FG002|Induction Treatment Phase|Physician Decision|0|||
19611966|NCT00961415|42060714|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
19611967|NCT00961415|42060715|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
19611968|NCT00961415|42060716|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
19611969|NCT00961415|42060714|FG000|Induction Treatment Phase|Other Reason|5|||
19611970|NCT00961415|42060715|FG001|Induction Treatment Phase|Other Reason|0|||
19611971|NCT00961415|42060716|FG002|Induction Treatment Phase|Other Reason|0|||
19611972|NCT00961415|42060714|FG000|Maintenance Treatment Phase|Death|0|||
19611973|NCT00961415|42060715|FG001|Maintenance Treatment Phase|Death|42|||
19611974|NCT00961415|42060716|FG002|Maintenance Treatment Phase|Death|34|||
19392722|NCT02641379|41636561|FG008|Overall Study|Participant's PCR high|0|||
19392723|NCT02641379|41636562|FG009|Overall Study|Participant's PCR high|0|||
19392724|NCT02641379|41636563|FG010|Overall Study|Participant's PCR high|0|||
19392725|NCT02641379|41636553|FG000|Overall Study|Participant treated after Week 24|0|||
19481853|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
19481854|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19611975|NCT00961415|42060714|FG000|Maintenance Treatment Phase|Investigators decision|0|||
19611976|NCT00961415|42060715|FG001|Maintenance Treatment Phase|Investigators decision|2|||
19611977|NCT00961415|42060716|FG002|Maintenance Treatment Phase|Investigators decision|0|||
19611978|NCT00961415|42060714|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19611979|NCT00961415|42060715|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
19611980|NCT00961415|42060716|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
19611981|NCT00961415|42060714|FG000|Maintenance Treatment Phase|Other reason|0|||
19611982|NCT00961415|42060715|FG001|Maintenance Treatment Phase|Other reason|1|||
19611983|NCT00961415|42060716|FG002|Maintenance Treatment Phase|Other reason|3|||
19611984|NCT00963599|42060734|FG000|Overall Study|Adverse Event|2|||
19611985|NCT00963599|42060735|FG001|Overall Study|Adverse Event|0|||
19611986|NCT00963599|42060736|FG002|Overall Study|Adverse Event|1|||
19611987|NCT00963599|42060737|FG003|Overall Study|Adverse Event|2|||
19481855|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481856|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481857|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481858|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
19481859|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
19481860|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481861|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481862|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481863|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481864|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
19481865|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
19481866|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481867|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481868|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481869|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481870|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481871|NCT01435759|41763236|FG000|Antidepressant Lead-in Phase|Other|119|||
19481872|NCT01435759|41763237|FG001|Antidepressant Lead-in Phase|Other|0|||
19481873|NCT01435759|41763238|FG002|Antidepressant Lead-in Phase|Other|0|||
19481874|NCT01435759|41763239|FG003|Antidepressant Lead-in Phase|Other|0|||
19481875|NCT01435759|41763240|FG004|Antidepressant Lead-in Phase|Other|0|||
19481876|NCT01435759|41763241|FG005|Antidepressant Lead-in Phase|Other|0|||
19481877|NCT01435759|41763236|FG000|Double-blind Phase|Adverse Event|7|||
19481878|NCT01435759|41763237|FG001|Double-blind Phase|Adverse Event|0|||
19481879|NCT01435759|41763238|FG002|Double-blind Phase|Adverse Event|1|||
19481880|NCT01435759|41763239|FG003|Double-blind Phase|Adverse Event|1|||
19481881|NCT01435759|41763240|FG004|Double-blind Phase|Adverse Event|1|||
19611988|NCT00963599|42060734|FG000|Overall Study|Lack of Efficacy|0|||
19611989|NCT00963599|42060735|FG001|Overall Study|Lack of Efficacy|2|||
19392726|NCT02641379|41636554|FG001|Overall Study|Participant treated after Week 24|0|||
19392727|NCT02641379|41636555|FG002|Overall Study|Participant treated after Week 24|0|||
19392728|NCT02641379|41636556|FG003|Overall Study|Participant treated after Week 24|0|||
19392729|NCT02641379|41636557|FG004|Overall Study|Participant treated after Week 24|0|||
19392730|NCT02641379|41636558|FG005|Overall Study|Participant treated after Week 24|0|||
19392731|NCT02641379|41636559|FG006|Overall Study|Participant treated after Week 24|0|||
19392732|NCT02641379|41636560|FG007|Overall Study|Participant treated after Week 24|0|||
19392733|NCT02641379|41636561|FG008|Overall Study|Participant treated after Week 24|1|||
19392734|NCT02641379|41636562|FG009|Overall Study|Participant treated after Week 24|0|||
19392735|NCT02641379|41636563|FG010|Overall Study|Participant treated after Week 24|0|||
19481882|NCT01435759|41763241|FG005|Double-blind Phase|Adverse Event|3|||
19611990|NCT00963599|42060736|FG002|Overall Study|Lack of Efficacy|1|||
19611991|NCT00963599|42060737|FG003|Overall Study|Lack of Efficacy|4|||
19611992|NCT00963599|42060734|FG000|Overall Study|Lost to Follow-up|0|||
19481883|NCT01435759|41763236|FG000|Double-blind Phase|Protocol Violation|2|||
19481884|NCT01435759|41763237|FG001|Double-blind Phase|Protocol Violation|0|||
19481885|NCT01435759|41763238|FG002|Double-blind Phase|Protocol Violation|1|||
19481886|NCT01435759|41763239|FG003|Double-blind Phase|Protocol Violation|2|||
19481887|NCT01435759|41763240|FG004|Double-blind Phase|Protocol Violation|0|||
19481888|NCT01435759|41763241|FG005|Double-blind Phase|Protocol Violation|1|||
19481889|NCT01435759|41763236|FG000|Double-blind Phase|Withdrawal by Subject|17|||
19481890|NCT01435759|41763237|FG001|Double-blind Phase|Withdrawal by Subject|4|||
19481891|NCT01435759|41763238|FG002|Double-blind Phase|Withdrawal by Subject|3|||
19481892|NCT01435759|41763239|FG003|Double-blind Phase|Withdrawal by Subject|4|||
19481893|NCT01435759|41763240|FG004|Double-blind Phase|Withdrawal by Subject|2|||
19481894|NCT01435759|41763241|FG005|Double-blind Phase|Withdrawal by Subject|2|||
19481895|NCT01435759|41763236|FG000|Double-blind Phase|Lost to Follow-up|31|||
19481896|NCT01435759|41763237|FG001|Double-blind Phase|Lost to Follow-up|1|||
19481897|NCT01435759|41763238|FG002|Double-blind Phase|Lost to Follow-up|2|||
19481898|NCT01435759|41763239|FG003|Double-blind Phase|Lost to Follow-up|0|||
19481899|NCT01435759|41763240|FG004|Double-blind Phase|Lost to Follow-up|3|||
19481900|NCT01435759|41763241|FG005|Double-blind Phase|Lost to Follow-up|3|||
19481901|NCT01435759|41763236|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
19481902|NCT01435759|41763237|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481903|NCT01435759|41763238|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481904|NCT01435759|41763239|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481905|NCT01435759|41763240|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
19481906|NCT01435759|41763241|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
19481907|NCT01435759|41763236|FG000|Double-blind Phase|Other|8|||
19481908|NCT01435759|41763237|FG001|Double-blind Phase|Other|2|||
19481909|NCT01435759|41763238|FG002|Double-blind Phase|Other|0|||
19481910|NCT01435759|41763239|FG003|Double-blind Phase|Other|2|||
19481911|NCT01435759|41763240|FG004|Double-blind Phase|Other|0|||
19481912|NCT01435759|41763241|FG005|Double-blind Phase|Other|0|||
19481913|NCT01393405|41763253|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
19481914|NCT01393405|41763254|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
19481915|NCT01393405|41763255|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
19481916|NCT01393405|41763253|FG000|Induction Period (week1-16)|Adverse Event|16|||
19481917|NCT01393405|41763254|FG001|Induction Period (week1-16)|Adverse Event|0|||
19481918|NCT01393405|41763255|FG002|Induction Period (week1-16)|Adverse Event|0|||
19481919|NCT01393405|41763253|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
19481920|NCT01393405|41763254|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
19481921|NCT01393405|41763255|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
19481922|NCT01393405|41763253|FG000|Maintenance Period Week|Lack of Efficacy|0|||
19481923|NCT01393405|41763254|FG001|Maintenance Period Week|Lack of Efficacy|22|||
19481924|NCT01393405|41763255|FG002|Maintenance Period Week|Lack of Efficacy|22|||
19481925|NCT01393405|41763253|FG000|Maintenance Period Week|Adverse Event|0|||
19481926|NCT01393405|41763254|FG001|Maintenance Period Week|Adverse Event|5|||
19481927|NCT01393405|41763255|FG002|Maintenance Period Week|Adverse Event|2|||
19481928|NCT01393405|41763253|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
19481929|NCT01393405|41763254|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
19481930|NCT01393405|41763255|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
19481931|NCT01393405|41763253|FG000|Maintenance Period Week|Lost to Follow-up|0|||
19481932|NCT01393405|41763254|FG001|Maintenance Period Week|Lost to Follow-up|1|||
19481933|NCT01393405|41763255|FG002|Maintenance Period Week|Lost to Follow-up|0|||
19481934|NCT01419197|41763267|FG000|Overall Study|Death|247|||
19481935|NCT01419197|41763268|FG001|Overall Study|Death|122|||
19481936|NCT01419197|41763267|FG000|Overall Study|Physician Decision|4|||
19481937|NCT01419197|41763268|FG001|Overall Study|Physician Decision|4|||
19481938|NCT01419197|41763267|FG000|Overall Study|Non-compliance|3|||
19611993|NCT00963599|42060735|FG001|Overall Study|Lost to Follow-up|1|||
19611994|NCT00963599|42060736|FG002|Overall Study|Lost to Follow-up|1|||
19611995|NCT00963599|42060737|FG003|Overall Study|Lost to Follow-up|1|||
19611996|NCT00963599|42060734|FG000|Overall Study|Protocol Violation|2|||
19611997|NCT00963599|42060735|FG001|Overall Study|Protocol Violation|2|||
19611998|NCT00963599|42060736|FG002|Overall Study|Protocol Violation|3|||
19703943|NCT00259272|42148263|FG001|Overall Study|Withdrawal by Subject|2|||
19481939|NCT01419197|41763268|FG001|Overall Study|Non-compliance|1|||
19481940|NCT01419197|41763267|FG000|Overall Study|Withdrawal by Subject|33|||
19481941|NCT01419197|41763268|FG001|Overall Study|Withdrawal by Subject|32|||
19481942|NCT01419197|41763267|FG000|Overall Study|Study Completed by Sponsor|103|||
19481943|NCT01419197|41763268|FG001|Overall Study|Study Completed by Sponsor|34|||
19481944|NCT01419197|41763267|FG000|Overall Study|Reason Not Specified|0|||
19481945|NCT01419197|41763268|FG001|Overall Study|Reason Not Specified|1|||
19481946|NCT01419197|41763267|FG000|Overall Study|Lost to Follow-up|14|||
19481947|NCT01419197|41763268|FG001|Overall Study|Lost to Follow-up|4|||
19481948|NCT01414075|41763279|FG000|Overall Study|Adverse Event|1|||
19481949|NCT01414075|41763280|FG001|Overall Study|Adverse Event|0|||
19611999|NCT00963599|42060737|FG003|Overall Study|Protocol Violation|4|||
19612000|NCT00963599|42060734|FG000|Overall Study|Withdrawal by Subject|2|||
19612001|NCT00963599|42060735|FG001|Overall Study|Withdrawal by Subject|1|||
19612002|NCT00963599|42060736|FG002|Overall Study|Withdrawal by Subject|3|||
19612003|NCT00963599|42060737|FG003|Overall Study|Withdrawal by Subject|3|||
19612004|NCT00619801|42060749|FG000|Overall Study|Lack of Efficacy|0|||
19612005|NCT00619801|42060750|FG001|Overall Study|Lack of Efficacy|1|||
19612006|NCT00619801|42060749|FG000|Overall Study|Withdrawal by Subject|1|||
19612007|NCT00619801|42060750|FG001|Overall Study|Withdrawal by Subject|1|||
19612008|NCT00619801|42060749|FG000|Overall Study|Loss of efficacy|0|||
19392736|NCT02641379|41636553|FG000|Overall Study|Missing PCR result at Week 8|0|||
19392737|NCT02641379|41636554|FG001|Overall Study|Missing PCR result at Week 8|0|||
19392738|NCT02641379|41636555|FG002|Overall Study|Missing PCR result at Week 8|0|||
19392739|NCT02641379|41636556|FG003|Overall Study|Missing PCR result at Week 8|0|||
19392740|NCT02641379|41636557|FG004|Overall Study|Missing PCR result at Week 8|0|||
19392741|NCT02641379|41636558|FG005|Overall Study|Missing PCR result at Week 8|0|||
19392742|NCT02641379|41636559|FG006|Overall Study|Missing PCR result at Week 8|0|||
19392743|NCT02641379|41636560|FG007|Overall Study|Missing PCR result at Week 8|0|||
19392744|NCT02641379|41636561|FG008|Overall Study|Missing PCR result at Week 8|0|||
19392745|NCT02641379|41636562|FG009|Overall Study|Missing PCR result at Week 8|1|||
19392746|NCT02641379|41636563|FG010|Overall Study|Missing PCR result at Week 8|0|||
19481950|NCT01414075|41763281|FG002|Overall Study|Adverse Event|1|||
19481951|NCT01414075|41763282|FG003|Overall Study|Adverse Event|0|||
19481952|NCT01414075|41763279|FG000|Overall Study|Death|1|||
19481953|NCT01414075|41763280|FG001|Overall Study|Death|0|||
19481954|NCT01414075|41763281|FG002|Overall Study|Death|0|||
19481955|NCT01414075|41763282|FG003|Overall Study|Death|1|||
19481956|NCT01414075|41763279|FG000|Overall Study|Withdrawal by Subject|0|||
19481957|NCT01414075|41763280|FG001|Overall Study|Withdrawal by Subject|0|||
19481958|NCT01414075|41763281|FG002|Overall Study|Withdrawal by Subject|0|||
19481959|NCT01414075|41763282|FG003|Overall Study|Withdrawal by Subject|1|||
19481960|NCT01414075|41763279|FG000|Overall Study|Other than specified|1|||
19481961|NCT01414075|41763280|FG001|Overall Study|Other than specified|0|||
19481962|NCT01414075|41763281|FG002|Overall Study|Other than specified|1|||
19481963|NCT01414075|41763282|FG003|Overall Study|Other than specified|0|||
19481964|NCT01434823|41763294|FG000|Overall Study|Incomplete data in medical record|4|||
19481965|NCT01434823|41763295|FG001|Overall Study|Incomplete data in medical record|7|||
19481966|NCT01513460|41763305|FG000|Overall Study|Death|0|||
19481967|NCT01513460|41763306|FG001|Overall Study|Death|0|||
19481968|NCT01513460|41763307|FG002|Overall Study|Death|1|||
19481969|NCT01513460|41763305|FG000|Overall Study|Lost to Follow-up|0|||
19481970|NCT01513460|41763306|FG001|Overall Study|Lost to Follow-up|0|||
19481971|NCT01513460|41763307|FG002|Overall Study|Lost to Follow-up|2|||
19481972|NCT01513460|41763305|FG000|Overall Study|Abnormal laboratory value|1|||
19481973|NCT01513460|41763306|FG001|Overall Study|Abnormal laboratory value|0|||
19481974|NCT01513460|41763307|FG002|Overall Study|Abnormal laboratory value|1|||
19481975|NCT01513460|41763305|FG000|Overall Study|Lack of Efficacy|1|||
19481976|NCT01513460|41763306|FG001|Overall Study|Lack of Efficacy|2|||
19481977|NCT01513460|41763307|FG002|Overall Study|Lack of Efficacy|5|||
19481978|NCT01513460|41763305|FG000|Overall Study|Protocol deviations|3|||
19481979|NCT01513460|41763306|FG001|Overall Study|Protocol deviations|4|||
19481980|NCT01513460|41763307|FG002|Overall Study|Protocol deviations|3|||
19481981|NCT01513460|41763305|FG000|Overall Study|Withdrawal by Subject|7|||
19481982|NCT01513460|41763306|FG001|Overall Study|Withdrawal by Subject|8|||
19481983|NCT01513460|41763307|FG002|Overall Study|Withdrawal by Subject|21|||
19481984|NCT01513460|41763305|FG000|Overall Study|Adverse Event|16|||
19481985|NCT01513460|41763306|FG001|Overall Study|Adverse Event|18|||
19481986|NCT01513460|41763307|FG002|Overall Study|Adverse Event|23|||
19481987|NCT01513460|41763305|FG000|Overall Study|Abnormal test procedure|1|||
19481988|NCT01513460|41763306|FG001|Overall Study|Abnormal test procedure|0|||
19481989|NCT01513460|41763307|FG002|Overall Study|Abnormal test procedure|0|||
19481990|NCT01392547|41763317|FG000|Overall Study|Adverse Event|2|||
19392747|NCT02641379|41636553|FG000|Overall Study|PCR positive|0|||
19392748|NCT02641379|41636554|FG001|Overall Study|PCR positive|0|||
19392749|NCT02641379|41636555|FG002|Overall Study|PCR positive|0|||
19392750|NCT02641379|41636556|FG003|Overall Study|PCR positive|0|||
19392751|NCT02641379|41636557|FG004|Overall Study|PCR positive|0|||
19392752|NCT02641379|41636558|FG005|Overall Study|PCR positive|0|||
19481991|NCT01392547|41763317|FG000|Overall Study|Non-compliance|2|||
19481992|NCT01392547|41763317|FG000|Overall Study|Withdrawal criteria|3|||
19481993|NCT01392547|41763317|FG000|Overall Study|Unclassified|1|||
19481994|NCT01435655|41763323|FG000|Overall Study|Death|2|||
19481995|NCT01435655|41763323|FG000|Overall Study|Other|1|||
19481996|NCT01434667|41763329|FG000|Overall Study|Lost to Follow-up|5|||
19481997|NCT01434667|41763330|FG001|Overall Study|Lost to Follow-up|10|||
19481998|NCT01513148|41763338|FG000|Overall Study|Protocol Violation|2|||
19481999|NCT01513148|41763339|FG001|Overall Study|Protocol Violation|2|||
19612009|NCT00619801|42060750|FG001|Overall Study|Loss of efficacy|1|||
19612010|NCT00962741|42060756|FG000|Overall Study|Failed to return|3|||
19612011|NCT00962741|42060756|FG000|Overall Study|Lost to Follow-up|2|||
19392753|NCT02641379|41636559|FG006|Overall Study|PCR positive|1|||
19482000|NCT01418339|41763387|FG000|Overall Study|Adverse Event|5|||
19482001|NCT01418339|41763388|FG001|Overall Study|Adverse Event|2|||
19482002|NCT01418339|41763387|FG000|Overall Study|Subject Withdrew Consent|1|||
19482003|NCT01418339|41763388|FG001|Overall Study|Subject Withdrew Consent|2|||
19482004|NCT01418339|41763387|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
19482005|NCT01418339|41763388|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
19482006|NCT01512368|41763394|FG000|Overall Study|Protocol Violation|3|||
19482007|NCT01412983|41763398|FG000|1st Period|Ineligible|0|||
19482008|NCT01412983|41763399|FG001|1st Period|Ineligible|1|||
19482009|NCT01412983|41763398|FG000|1st Period|Positive slit lamp finding|0|||
19482010|NCT01412983|41763399|FG001|1st Period|Positive slit lamp finding|1|||
19482011|NCT01412983|41763398|FG000|1st Period|Unacceptable lens movement|0|||
19482012|NCT01412983|41763399|FG001|1st Period|Unacceptable lens movement|1|||
19482013|NCT01412983|41763398|FG000|1st Period|Inability to maintain wear|0|||
19482014|NCT01412983|41763399|FG001|1st Period|Inability to maintain wear|1|||
19482015|NCT01417481|41763408|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
19482016|NCT01417481|41763409|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
19482017|NCT01392469|41763415|FG000|Overall Study|Adverse Event|2|||
19482018|NCT01392469|41763415|FG000|Overall Study|Withdrawal by Subject|1|||
19482019|NCT01392469|41763415|FG000|Overall Study|Protocol Violation|1|||
19482020|NCT01435577|41763432|FG000|Overall Study|Adverse Event|10|||
19482021|NCT01435577|41763433|FG001|Overall Study|Adverse Event|0|||
19482022|NCT01435577|41763432|FG000|Overall Study|Lack of Efficacy|7|||
19482023|NCT01435577|41763433|FG001|Overall Study|Lack of Efficacy|51|||
19482024|NCT01435577|41763432|FG000|Overall Study|Alternative treatment started|0|||
19482025|NCT01435577|41763433|FG001|Overall Study|Alternative treatment started|1|||
19612012|NCT00962741|42060756|FG000|Overall Study|Withdrawal by Subject|1|||
19612013|NCT00962741|42060756|FG000|Overall Study|Lack of Efficacy|1|||
19612014|NCT00962741|42060756|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
19612015|NCT00619645|42060760|FG000|Overall Study|Adverse Event|1|||
19612016|NCT00619177|42060764|FG000|Overall Study|Adverse Event|18|||
19612017|NCT00619177|42060764|FG000|Overall Study|Lost to Follow-up|2|||
19612018|NCT00619177|42060764|FG000|Overall Study|Lack of Efficacy|1|||
19612019|NCT00619177|42060764|FG000|Overall Study|Missing termination information|481|||
19612020|NCT00619177|42060764|FG000|Overall Study|Not specified reasons|6|||
19612021|NCT00818259|42060775|FG000|Part I|Withdrawal by Subject|1|||
19612022|NCT00818259|42060776|FG001|Part I|Withdrawal by Subject|0|||
19612023|NCT00818259|42060777|FG002|Part I|Withdrawal by Subject|0|||
19612024|NCT00818259|42060778|FG003|Part I|Withdrawal by Subject|0|||
19612025|NCT00818259|42060779|FG004|Part I|Withdrawal by Subject|0|||
19612026|NCT00818259|42060780|FG005|Part I|Withdrawal by Subject|0|||
19612027|NCT00818259|42060781|FG006|Part I|Withdrawal by Subject|0|||
19612028|NCT00818259|42060782|FG007|Part I|Withdrawal by Subject|0|||
19612029|NCT00818259|42060783|FG008|Part I|Withdrawal by Subject|0|||
19612030|NCT00818259|42060775|FG000|Part II|Physician Decision|0|||
19612031|NCT00818259|42060776|FG001|Part II|Physician Decision|0|||
19612032|NCT00818259|42060777|FG002|Part II|Physician Decision|1|||
19612033|NCT00818259|42060778|FG003|Part II|Physician Decision|0|||
19612034|NCT00818259|42060779|FG004|Part II|Physician Decision|0|||
19612035|NCT00818259|42060780|FG005|Part II|Physician Decision|0|||
19612036|NCT00818259|42060781|FG006|Part II|Physician Decision|0|||
19612037|NCT00818259|42060782|FG007|Part II|Physician Decision|0|||
19392754|NCT02641379|41636560|FG007|Overall Study|PCR positive|0|||
19482026|NCT01411891|41763445|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
19482027|NCT01411891|41763446|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
19482028|NCT01416389|41763454|FG000|Overall Study|Lost to Follow-up|1|||
19482029|NCT01416389|41763455|FG001|Overall Study|Lost to Follow-up|0|||
19392755|NCT02641379|41636561|FG008|Overall Study|PCR positive|0|||
19392756|NCT02641379|41636562|FG009|Overall Study|PCR positive|0|||
19392757|NCT02641379|41636563|FG010|Overall Study|PCR positive|0|||
19392758|NCT02660983|41636594|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
19392759|NCT02660983|41636595|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
19392760|NCT02660983|41636594|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
19392761|NCT02660983|41636595|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
19392762|NCT02660983|41636594|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
19392763|NCT02660983|41636595|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
19482030|NCT01416389|41763454|FG000|Overall Study|Started New Therapy|2|||
19612038|NCT00818259|42060783|FG008|Part II|Physician Decision|0|||
19612039|NCT00818259|42060775|FG000|Part II|Lack of Efficacy|0|||
19612040|NCT00818259|42060776|FG001|Part II|Lack of Efficacy|0|||
19612041|NCT00818259|42060777|FG002|Part II|Lack of Efficacy|0|||
19612042|NCT00818259|42060778|FG003|Part II|Lack of Efficacy|1|||
19612043|NCT00818259|42060779|FG004|Part II|Lack of Efficacy|0|||
19612044|NCT00818259|42060780|FG005|Part II|Lack of Efficacy|0|||
19612045|NCT00818259|42060781|FG006|Part II|Lack of Efficacy|0|||
19612046|NCT00818259|42060782|FG007|Part II|Lack of Efficacy|0|||
19612047|NCT00818259|42060783|FG008|Part II|Lack of Efficacy|0|||
19482031|NCT01416389|41763455|FG001|Overall Study|Started New Therapy|0|||
19482032|NCT01544348|41763471|FG000|Overall Study|Lost to Follow-up|1|||
19482033|NCT01544348|41763472|FG001|Overall Study|Lost to Follow-up|0|||
19482034|NCT01544348|41763473|FG002|Overall Study|Lost to Follow-up|0|||
19482035|NCT01544348|41763474|FG003|Overall Study|Lost to Follow-up|0|||
19482036|NCT01544348|41763475|FG004|Overall Study|Lost to Follow-up|0|||
19482037|NCT01544348|41763476|FG005|Overall Study|Lost to Follow-up|0|||
19482038|NCT01544348|41763477|FG006|Overall Study|Lost to Follow-up|1|||
19482039|NCT01544348|41763478|FG007|Overall Study|Lost to Follow-up|0|||
19482040|NCT01544348|41763471|FG000|Overall Study|Withdrawal by Subject|1|||
19482041|NCT01544348|41763472|FG001|Overall Study|Withdrawal by Subject|0|||
19482042|NCT01544348|41763473|FG002|Overall Study|Withdrawal by Subject|0|||
19482043|NCT01544348|41763474|FG003|Overall Study|Withdrawal by Subject|0|||
19482044|NCT01544348|41763475|FG004|Overall Study|Withdrawal by Subject|1|||
19482045|NCT01544348|41763476|FG005|Overall Study|Withdrawal by Subject|2|||
19482046|NCT01544348|41763477|FG006|Overall Study|Withdrawal by Subject|1|||
19482047|NCT01544348|41763478|FG007|Overall Study|Withdrawal by Subject|0|||
19482048|NCT01544348|41763471|FG000|Overall Study|Physician Decision|0|||
19482049|NCT01544348|41763472|FG001|Overall Study|Physician Decision|0|||
19482050|NCT01544348|41763473|FG002|Overall Study|Physician Decision|0|||
19482051|NCT01544348|41763474|FG003|Overall Study|Physician Decision|0|||
19482052|NCT01544348|41763475|FG004|Overall Study|Physician Decision|0|||
19482053|NCT01544348|41763476|FG005|Overall Study|Physician Decision|1|||
19482054|NCT01544348|41763477|FG006|Overall Study|Physician Decision|0|||
19482055|NCT01544348|41763478|FG007|Overall Study|Physician Decision|0|||
19482056|NCT01416155|41763503|FG000|Overall Study|Adverse Event|8|||
19612048|NCT00818259|42060775|FG000|Part II|Not Treated|0|||
19612049|NCT00818259|42060776|FG001|Part II|Not Treated|0|||
19612050|NCT00818259|42060777|FG002|Part II|Not Treated|0|||
19612051|NCT00818259|42060778|FG003|Part II|Not Treated|1|||
19612052|NCT00818259|42060779|FG004|Part II|Not Treated|0|||
19612053|NCT00818259|42060780|FG005|Part II|Not Treated|0|||
19612054|NCT00818259|42060781|FG006|Part II|Not Treated|0|||
19612055|NCT00818259|42060782|FG007|Part II|Not Treated|0|||
19612056|NCT00818259|42060783|FG008|Part II|Not Treated|0|||
19612057|NCT00818259|42060775|FG000|Part IV|Physician Decision|0|||
19612058|NCT00818259|42060776|FG001|Part IV|Physician Decision|0|||
19612059|NCT00818259|42060777|FG002|Part IV|Physician Decision|0|||
19612060|NCT00818259|42060778|FG003|Part IV|Physician Decision|0|||
19612061|NCT00818259|42060779|FG004|Part IV|Physician Decision|0|||
19612062|NCT00818259|42060780|FG005|Part IV|Physician Decision|1|||
19612063|NCT00818259|42060781|FG006|Part IV|Physician Decision|0|||
19612064|NCT00818259|42060782|FG007|Part IV|Physician Decision|0|||
19612065|NCT00818259|42060783|FG008|Part IV|Physician Decision|0|||
19612066|NCT00818259|42060775|FG000|Part V|Adverse Event|0|||
19612067|NCT00818259|42060776|FG001|Part V|Adverse Event|0|||
19612068|NCT00818259|42060777|FG002|Part V|Adverse Event|0|||
19612069|NCT00818259|42060778|FG003|Part V|Adverse Event|0|||
19612070|NCT00818259|42060779|FG004|Part V|Adverse Event|0|||
19612071|NCT00818259|42060780|FG005|Part V|Adverse Event|0|||
19612072|NCT00818259|42060781|FG006|Part V|Adverse Event|0|||
19612073|NCT00818259|42060782|FG007|Part V|Adverse Event|1|||
19612074|NCT00818259|42060783|FG008|Part V|Adverse Event|0|||
19612075|NCT00619099|42060801|FG000|Overall Study|Progressive Disease|7|||
19612076|NCT00619099|42060802|FG001|Overall Study|Progressive Disease|5|||
19612077|NCT00619099|42060801|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
19612078|NCT00619099|42060802|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
19612079|NCT00619099|42060801|FG000|Overall Study|Adverse Event|4|||
19612080|NCT00619099|42060802|FG001|Overall Study|Adverse Event|3|||
19612081|NCT00619099|42060801|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
19612082|NCT00619099|42060802|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
19612083|NCT00619099|42060801|FG000|Overall Study|Withdrawal by Subject|10|||
19612084|NCT00619099|42060802|FG001|Overall Study|Withdrawal by Subject|2|||
19612085|NCT00619099|42060801|FG000|Overall Study|Physician Decision|9|||
19612086|NCT00619099|42060802|FG001|Overall Study|Physician Decision|6|||
19482057|NCT01416155|41763503|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
19482058|NCT01416155|41763503|FG000|Overall Study|Withdrawal by Subject|33|||
19612087|NCT00962585|42060812|FG000|Overall Study|Adverse Event|0|||
19482059|NCT01416155|41763503|FG000|Overall Study|Investigator decision|8|||
19482060|NCT01416155|41763503|FG000|Overall Study|Other|7|||
19482061|NCT01415921|41763509|FG000|Overall Study|Adverse Event|0|||
19612088|NCT00962585|42060813|FG001|Overall Study|Adverse Event|2|||
19482062|NCT01415921|41763510|FG001|Overall Study|Adverse Event|1|||
19612089|NCT00962585|42060814|FG002|Overall Study|Adverse Event|1|||
19612090|NCT00962585|42060815|FG003|Overall Study|Adverse Event|0|||
19612091|NCT00962585|42060812|FG000|Overall Study|Lost to Follow-up|3|||
19612092|NCT00962585|42060813|FG001|Overall Study|Lost to Follow-up|0|||
19612093|NCT00962585|42060814|FG002|Overall Study|Lost to Follow-up|1|||
19612094|NCT00962585|42060815|FG003|Overall Study|Lost to Follow-up|0|||
19612095|NCT00962585|42060812|FG000|Overall Study|Protocol Violation|0|||
19612096|NCT00962585|42060813|FG001|Overall Study|Protocol Violation|0|||
19612097|NCT00962585|42060814|FG002|Overall Study|Protocol Violation|1|||
19612098|NCT00962585|42060815|FG003|Overall Study|Protocol Violation|0|||
19612099|NCT00962585|42060812|FG000|Overall Study|Withdrawal by Subject|1|||
19612100|NCT00962585|42060813|FG001|Overall Study|Withdrawal by Subject|0|||
19612101|NCT00962585|42060814|FG002|Overall Study|Withdrawal by Subject|0|||
19612102|NCT00962585|42060815|FG003|Overall Study|Withdrawal by Subject|0|||
19612103|NCT00962585|42060812|FG000|Overall Study|Withdrew Consent|2|||
19612104|NCT00962585|42060813|FG001|Overall Study|Withdrew Consent|0|||
19612105|NCT00962585|42060814|FG002|Overall Study|Withdrew Consent|0|||
19612106|NCT00962585|42060815|FG003|Overall Study|Withdrew Consent|0|||
19612107|NCT00621985|42060827|FG000|Dexamethasone Admission|Adverse Event|1|||
19612108|NCT00961259|42060837|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
19612109|NCT00961259|42060838|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
19612110|NCT00961259|42060839|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
19612111|NCT00961181|42060848|FG000|Overall Study|Death|2|||
19612112|NCT00961181|42060848|FG000|Overall Study|Withdrawal by Subject|2|||
19612113|NCT00961181|42060848|FG000|Overall Study|Lost to Follow-up|1|||
19612114|NCT00817635|42060857|FG000|Overall Study|Adverse Event|1|||
19612115|NCT00817635|42060858|FG001|Overall Study|Adverse Event|0|||
19612116|NCT00817635|42060859|FG002|Overall Study|Adverse Event|0|||
19612117|NCT00817635|42060860|FG003|Overall Study|Adverse Event|1|||
19612118|NCT00817635|42060861|FG004|Overall Study|Adverse Event|1|||
19703944|NCT00259272|42148264|FG002|Overall Study|Withdrawal by Subject|2|||
19703945|NCT00259272|42148265|FG003|Overall Study|Withdrawal by Subject|7|||
19703946|NCT00259272|42148262|FG000|Overall Study|Lost to Follow-up|1|||
19703947|NCT00259272|42148263|FG001|Overall Study|Lost to Follow-up|0|||
19703948|NCT00259272|42148264|FG002|Overall Study|Lost to Follow-up|0|||
19703949|NCT00259272|42148265|FG003|Overall Study|Lost to Follow-up|1|||
19703950|NCT00421889|42148298|FG000|Overall Study|Adverse Event|1|||
19612119|NCT00817635|42060857|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
19612120|NCT00817635|42060858|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
19612121|NCT00817635|42060859|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
19612122|NCT00817635|42060860|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
19612123|NCT00817635|42060861|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
19612124|NCT00817635|42060857|FG000|Overall Study|Withdrawal by Subject|2|||
19612125|NCT00817635|42060858|FG001|Overall Study|Withdrawal by Subject|1|||
19612126|NCT00817635|42060859|FG002|Overall Study|Withdrawal by Subject|0|||
19612127|NCT00817635|42060860|FG003|Overall Study|Withdrawal by Subject|1|||
19612128|NCT00817635|42060861|FG004|Overall Study|Withdrawal by Subject|2|||
19612129|NCT00817635|42060857|FG000|Overall Study|Lost to Follow-up|0|||
19612130|NCT00817635|42060858|FG001|Overall Study|Lost to Follow-up|1|||
19612131|NCT00817635|42060859|FG002|Overall Study|Lost to Follow-up|0|||
19612132|NCT00817635|42060860|FG003|Overall Study|Lost to Follow-up|1|||
19612133|NCT00817635|42060861|FG004|Overall Study|Lost to Follow-up|0|||
19703951|NCT00421889|42148299|FG001|Overall Study|Adverse Event|0|||
19703952|NCT00421889|42148300|FG002|Overall Study|Adverse Event|1|||
19703953|NCT00421889|42148301|FG003|Overall Study|Adverse Event|1|||
19703954|NCT00421889|42148302|FG004|Overall Study|Adverse Event|1|||
19703955|NCT00421889|42148303|FG005|Overall Study|Adverse Event|4|||
19703956|NCT00421889|42148304|FG006|Overall Study|Adverse Event|1|||
19703957|NCT00421889|42148305|FG007|Overall Study|Adverse Event|0|||
19703958|NCT00421889|42148306|FG008|Overall Study|Adverse Event|2|||
19703959|NCT00421889|42148298|FG000|Overall Study|Withdrawal by Subject|1|||
19703960|NCT00421889|42148299|FG001|Overall Study|Withdrawal by Subject|3|||
19703961|NCT00421889|42148300|FG002|Overall Study|Withdrawal by Subject|0|||
19703962|NCT00421889|42148301|FG003|Overall Study|Withdrawal by Subject|0|||
19703963|NCT00421889|42148302|FG004|Overall Study|Withdrawal by Subject|2|||
19703964|NCT00421889|42148303|FG005|Overall Study|Withdrawal by Subject|0|||
19703965|NCT00421889|42148304|FG006|Overall Study|Withdrawal by Subject|0|||
19703966|NCT00421889|42148305|FG007|Overall Study|Withdrawal by Subject|0|||
19703967|NCT00421889|42148306|FG008|Overall Study|Withdrawal by Subject|0|||
19703968|NCT00421889|42148298|FG000|Overall Study|Death|0|||
19703969|NCT00421889|42148299|FG001|Overall Study|Death|0|||
19703970|NCT00421889|42148300|FG002|Overall Study|Death|0|||
19703971|NCT00421889|42148301|FG003|Overall Study|Death|0|||
19703972|NCT00421889|42148302|FG004|Overall Study|Death|1|||
19703973|NCT00421889|42148303|FG005|Overall Study|Death|1|||
19703974|NCT00421889|42148304|FG006|Overall Study|Death|0|||
19703975|NCT00421889|42148305|FG007|Overall Study|Death|0|||
19703976|NCT00421889|42148306|FG008|Overall Study|Death|0|||
19703977|NCT00421889|42148298|FG000|Overall Study|Progressive disease|3|||
19703978|NCT00421889|42148299|FG001|Overall Study|Progressive disease|2|||
19612134|NCT00817635|42060857|FG000|Overall Study|Administrative Problems|0|||
19612135|NCT00817635|42060858|FG001|Overall Study|Administrative Problems|0|||
19612136|NCT00817635|42060859|FG002|Overall Study|Administrative Problems|0|||
19612137|NCT00817635|42060860|FG003|Overall Study|Administrative Problems|0|||
19612138|NCT00817635|42060861|FG004|Overall Study|Administrative Problems|1|||
19612139|NCT00817635|42060857|FG000|Overall Study|Protocol Violation|5|||
19612140|NCT00817635|42060858|FG001|Overall Study|Protocol Violation|1|||
19612141|NCT00817635|42060859|FG002|Overall Study|Protocol Violation|3|||
19612142|NCT00817635|42060860|FG003|Overall Study|Protocol Violation|2|||
19612143|NCT00817635|42060861|FG004|Overall Study|Protocol Violation|3|||
19612144|NCT00817479|42060882|FG000|Overall Study|Physician Decision|1|||
19612145|NCT00817479|42060883|FG001|Overall Study|Physician Decision|1|||
19612146|NCT00961961|42060893|FG000|Phase I|Withdrawal by Subject|7|||
19612147|NCT00961961|42060894|FG001|Phase I|Withdrawal by Subject|0|||
19612148|NCT00961961|42060895|FG002|Phase I|Withdrawal by Subject|0|||
19612149|NCT00961961|42060896|FG003|Phase I|Withdrawal by Subject|0|||
19612150|NCT00961961|42060893|FG000|Phase I|Lost to Follow-up|10|||
19612151|NCT00961961|42060894|FG001|Phase I|Lost to Follow-up|0|||
19612152|NCT00961961|42060895|FG002|Phase I|Lost to Follow-up|0|||
19612153|NCT00961961|42060896|FG003|Phase I|Lost to Follow-up|0|||
19612154|NCT00961961|42060893|FG000|Phase I|Lack of Efficacy|94|||
19612155|NCT00961961|42060894|FG001|Phase I|Lack of Efficacy|0|||
19612156|NCT00961961|42060895|FG002|Phase I|Lack of Efficacy|0|||
19612157|NCT00961961|42060896|FG003|Phase I|Lack of Efficacy|0|||
19612158|NCT00961961|42060893|FG000|Phase I|Adverse Event|7|||
19612159|NCT00961961|42060894|FG001|Phase I|Adverse Event|0|||
19612160|NCT00961961|42060895|FG002|Phase I|Adverse Event|0|||
19612161|NCT00961961|42060896|FG003|Phase I|Adverse Event|0|||
19612162|NCT00961961|42060893|FG000|Phase I|Physician Decision|8|||
19612163|NCT00961961|42060894|FG001|Phase I|Physician Decision|0|||
19612164|NCT00961961|42060895|FG002|Phase I|Physician Decision|0|||
19612165|NCT00961961|42060896|FG003|Phase I|Physician Decision|0|||
19612166|NCT00961961|42060893|FG000|Phase II|Lost to Follow-up|0|||
19703979|NCT00421889|42148300|FG002|Overall Study|Progressive disease|2|||
19703980|NCT00421889|42148301|FG003|Overall Study|Progressive disease|3|||
19612167|NCT00961961|42060894|FG001|Phase II|Lost to Follow-up|0|||
19612168|NCT00961961|42060895|FG002|Phase II|Lost to Follow-up|10|||
19703981|NCT00421889|42148302|FG004|Overall Study|Progressive disease|2|||
19703982|NCT00421889|42148303|FG005|Overall Study|Progressive disease|21|||
19612169|NCT00961961|42060896|FG003|Phase II|Lost to Follow-up|7|||
19612170|NCT00961961|42060893|FG000|Phase II|Adverse Event|0|||
19612171|NCT00961961|42060894|FG001|Phase II|Adverse Event|0|||
19703983|NCT00421889|42148304|FG006|Overall Study|Progressive disease|3|||
19703984|NCT00421889|42148305|FG007|Overall Study|Progressive disease|1|||
19703985|NCT00421889|42148306|FG008|Overall Study|Progressive disease|5|||
19703986|NCT00421889|42148298|FG000|Overall Study|Patient/Investigator request|0|||
19703987|NCT00421889|42148299|FG001|Overall Study|Patient/Investigator request|0|||
19703988|NCT00421889|42148300|FG002|Overall Study|Patient/Investigator request|0|||
19703989|NCT00421889|42148301|FG003|Overall Study|Patient/Investigator request|0|||
19703990|NCT00421889|42148302|FG004|Overall Study|Patient/Investigator request|0|||
19703991|NCT00421889|42148303|FG005|Overall Study|Patient/Investigator request|9|||
19703992|NCT00421889|42148304|FG006|Overall Study|Patient/Investigator request|0|||
19703993|NCT00421889|42148305|FG007|Overall Study|Patient/Investigator request|1|||
19703994|NCT00421889|42148306|FG008|Overall Study|Patient/Investigator request|3|||
19703995|NCT00421889|42148298|FG000|Overall Study|Lost to Follow-up|0|||
19703996|NCT00421889|42148299|FG001|Overall Study|Lost to Follow-up|0|||
19703997|NCT00421889|42148300|FG002|Overall Study|Lost to Follow-up|0|||
19703998|NCT00421889|42148301|FG003|Overall Study|Lost to Follow-up|0|||
19703999|NCT00421889|42148302|FG004|Overall Study|Lost to Follow-up|0|||
19704000|NCT00421889|42148303|FG005|Overall Study|Lost to Follow-up|0|||
19704001|NCT00421889|42148304|FG006|Overall Study|Lost to Follow-up|0|||
19704002|NCT00421889|42148305|FG007|Overall Study|Lost to Follow-up|0|||
19704003|NCT00421889|42148306|FG008|Overall Study|Lost to Follow-up|1|||
19704004|NCT00421733|42148333|FG000|Overall Study|Adverse Event|4|||
19704005|NCT00421733|42148334|FG001|Overall Study|Adverse Event|9|||
19704006|NCT00421733|42148335|FG002|Overall Study|Adverse Event|2|||
19704007|NCT00421733|42148333|FG000|Overall Study|Lost to Follow-up|1|||
19704008|NCT00421733|42148334|FG001|Overall Study|Lost to Follow-up|2|||
19704009|NCT00421733|42148335|FG002|Overall Study|Lost to Follow-up|4|||
19704010|NCT00421733|42148333|FG000|Overall Study|Withdrawal by Subject|1|||
19704011|NCT00421733|42148334|FG001|Overall Study|Withdrawal by Subject|2|||
19704012|NCT00421733|42148335|FG002|Overall Study|Withdrawal by Subject|7|||
19704013|NCT00421733|42148333|FG000|Overall Study|Death|0|||
19612172|NCT00961961|42060895|FG002|Phase II|Adverse Event|0|||
19612173|NCT00961961|42060896|FG003|Phase II|Adverse Event|1|||
19612174|NCT00961961|42060893|FG000|Phase II|Physician Decision|0|||
19612175|NCT00961961|42060894|FG001|Phase II|Physician Decision|0|||
19612176|NCT00961961|42060895|FG002|Phase II|Physician Decision|1|||
19612177|NCT00961961|42060896|FG003|Phase II|Physician Decision|0|||
19612178|NCT00961961|42060893|FG000|Phase II|Withdrawal by Subject|0|||
19612179|NCT00961961|42060894|FG001|Phase II|Withdrawal by Subject|0|||
19612180|NCT00961961|42060895|FG002|Phase II|Withdrawal by Subject|1|||
19612181|NCT00961961|42060896|FG003|Phase II|Withdrawal by Subject|0|||
19612182|NCT00817089|42060920|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
19612183|NCT00817089|42060921|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
19612184|NCT00817089|42060922|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
19612185|NCT00817089|42060923|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
19612186|NCT00817089|42060920|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
19612187|NCT00817089|42060921|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
19612188|NCT00817089|42060922|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
19612189|NCT00817089|42060923|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
19612190|NCT00815919|42060937|FG000|Overall Study|Unrelated Fungal Infection|1|||
19612191|NCT00815919|42060937|FG000|Overall Study|AML Relapse|1|||
19612192|NCT00815919|42060937|FG000|Overall Study|Lack of Efficacy|2|||
19612193|NCT00957905|42060943|FG000|Part B|Not Treated|0|||
19612194|NCT00957905|42060944|FG001|Part B|Not Treated|1|||
19612195|NCT00957905|42060943|FG000|Part B|Physician Decision|0|||
19482063|NCT01415921|41763509|FG000|Overall Study|Physician Decision|1|||
19612196|NCT00957905|42060944|FG001|Part B|Physician Decision|1|||
19612197|NCT00957905|42060943|FG000|Part B|Death|0|||
19612198|NCT00957905|42060944|FG001|Part B|Death|1|||
19612199|NCT00957905|42060943|FG000|Part B|Protocol Violation|0|||
19612200|NCT00957905|42060944|FG001|Part B|Protocol Violation|1|||
19612201|NCT00960323|42060950|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
19612202|NCT00617929|42060958|FG000|Overall Study|Physician Decision|1|||
19612203|NCT00815295|42060965|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
19612204|NCT00815295|42060966|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
19612205|NCT00815295|42060967|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
19612206|NCT00814983|42060977|FG000|Overall Study|Screen failure|1|||
19612207|NCT00814983|42060978|FG001|Overall Study|Screen failure|0|||
19612208|NCT00814983|42060977|FG000|Overall Study|Withdrawal by Subject|1|||
19612209|NCT00814983|42060978|FG001|Overall Study|Withdrawal by Subject|0|||
19612210|NCT00814983|42060977|FG000|Overall Study|Graft failure|1|||
19612211|NCT00814983|42060978|FG001|Overall Study|Graft failure|0|||
19612212|NCT00960869|42060986|FG000|Overall Study|Adverse Event|17|||
19612213|NCT00960869|42060987|FG001|Overall Study|Adverse Event|26|||
19612214|NCT00960869|42060986|FG000|Overall Study|Withdrawal by Subject|16|||
19612215|NCT00960869|42060987|FG001|Overall Study|Withdrawal by Subject|14|||
19612216|NCT00960869|42060986|FG000|Overall Study|Lost to Follow-up|1|||
19612217|NCT00960869|42060987|FG001|Overall Study|Lost to Follow-up|4|||
19612218|NCT00960869|42060986|FG000|Overall Study|Misc|19|||
19612219|NCT00960869|42060987|FG001|Overall Study|Misc|18|||
19612220|NCT00618787|42060995|FG000|Overall Study|Adverse Event|0|||
19612221|NCT00618787|42060996|FG001|Overall Study|Adverse Event|1|||
19612222|NCT00618787|42060995|FG000|Overall Study|Withdrawal by Subject|2|||
19612223|NCT00618787|42060996|FG001|Overall Study|Withdrawal by Subject|1|||
19612224|NCT00618787|42060995|FG000|Overall Study|Lost to Follow-up|1|||
19612225|NCT00618787|42060996|FG001|Overall Study|Lost to Follow-up|0|||
19612226|NCT00813813|42061004|FG000|Overall Study|Withdrawal by Subject|1|||
19612227|NCT00813813|42061005|FG001|Overall Study|Withdrawal by Subject|1|||
19612228|NCT00813813|42061004|FG000|Overall Study|Lost to Follow-up|2|||
19612229|NCT00813813|42061005|FG001|Overall Study|Lost to Follow-up|7|||
19704014|NCT00421733|42148334|FG001|Overall Study|Death|3|||
19392764|NCT02660983|41636594|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
19482064|NCT01415921|41763510|FG001|Overall Study|Physician Decision|1|||
19612230|NCT00813813|42061004|FG000|Overall Study|Other|0|||
19704015|NCT00421733|42148335|FG002|Overall Study|Death|0|||
19704016|NCT00421733|42148333|FG000|Overall Study|Required dialysis|1|||
19704017|NCT00421733|42148334|FG001|Overall Study|Required dialysis|0|||
19704018|NCT00421733|42148335|FG002|Overall Study|Required dialysis|0|||
19704019|NCT00421733|42148333|FG000|Overall Study|Administrative|2|||
19704020|NCT00421733|42148334|FG001|Overall Study|Administrative|0|||
19612231|NCT00813813|42061005|FG001|Overall Study|Other|1|||
19612232|NCT00960011|42061013|FG000|Overall Study|Death|5|||
19612233|NCT00960011|42061014|FG001|Overall Study|Death|0|||
19612234|NCT00960011|42061013|FG000|Overall Study|Lost to Follow-up|6|||
19612235|NCT00960011|42061014|FG001|Overall Study|Lost to Follow-up|2|||
19612236|NCT00617851|42061058|FG000|Overall Study|Death|0|||
19612237|NCT00617851|42061059|FG001|Overall Study|Death|0|||
19612238|NCT00617851|42061060|FG002|Overall Study|Death|0|||
19612239|NCT00617851|42061061|FG003|Overall Study|Death|1|||
19612240|NCT00617851|42061058|FG000|Overall Study|Withdrawal by Subject|14|||
19612241|NCT00617851|42061059|FG001|Overall Study|Withdrawal by Subject|7|||
19612242|NCT00617851|42061060|FG002|Overall Study|Withdrawal by Subject|12|||
19612243|NCT00617851|42061061|FG003|Overall Study|Withdrawal by Subject|4|||
19704021|NCT00421733|42148335|FG002|Overall Study|Administrative|0|||
19704022|NCT00421733|42148333|FG000|Overall Study|Did not satisfy entry criteria|1|||
19704023|NCT00421733|42148334|FG001|Overall Study|Did not satisfy entry criteria|3|||
19704024|NCT00421733|42148335|FG002|Overall Study|Did not satisfy entry criteria|2|||
19704025|NCT00421733|42148333|FG000|Overall Study|Sponsor request|1|||
19704026|NCT00421733|42148334|FG001|Overall Study|Sponsor request|0|||
19704027|NCT00421733|42148335|FG002|Overall Study|Sponsor request|3|||
19704028|NCT00421733|42148333|FG000|Overall Study|Protocol deviation|4|||
19704029|NCT00421733|42148334|FG001|Overall Study|Protocol deviation|7|||
19704030|NCT00421733|42148335|FG002|Overall Study|Protocol deviation|2|||
19612244|NCT00617851|42061058|FG000|Overall Study|Lost to Follow-up|27|||
19612245|NCT00617851|42061059|FG001|Overall Study|Lost to Follow-up|29|||
19612246|NCT00617851|42061060|FG002|Overall Study|Lost to Follow-up|31|||
19612247|NCT00617851|42061061|FG003|Overall Study|Lost to Follow-up|19|||
19612248|NCT00617851|42061058|FG000|Overall Study|Inappropriate Enrollment|5|||
19612249|NCT00617851|42061059|FG001|Overall Study|Inappropriate Enrollment|4|||
19612250|NCT00617851|42061060|FG002|Overall Study|Inappropriate Enrollment|1|||
19612251|NCT00617851|42061061|FG003|Overall Study|Inappropriate Enrollment|1|||
19612252|NCT00617851|42061058|FG000|Overall Study|Unable to classify|1|||
19612253|NCT00617851|42061059|FG001|Overall Study|Unable to classify|0|||
19612254|NCT00617851|42061060|FG002|Overall Study|Unable to classify|1|||
19612255|NCT00617851|42061061|FG003|Overall Study|Unable to classify|0|||
19612256|NCT00812955|42061085|FG000|Overall Study|Adverse Event|7|||
19612257|NCT00812955|42061086|FG001|Overall Study|Adverse Event|6|||
19612258|NCT00812955|42061087|FG002|Overall Study|Adverse Event|3|||
19612259|NCT00812955|42061088|FG003|Overall Study|Adverse Event|4|||
19612260|NCT00812955|42061085|FG000|Overall Study|Lost to Follow-up|2|||
19612261|NCT00812955|42061086|FG001|Overall Study|Lost to Follow-up|1|||
19612262|NCT00812955|42061087|FG002|Overall Study|Lost to Follow-up|1|||
19612263|NCT00812955|42061088|FG003|Overall Study|Lost to Follow-up|2|||
19612264|NCT00812955|42061085|FG000|Overall Study|Withdrawal by Subject|1|||
19612265|NCT00812955|42061086|FG001|Overall Study|Withdrawal by Subject|0|||
19612266|NCT00812955|42061087|FG002|Overall Study|Withdrawal by Subject|1|||
19612267|NCT00812955|42061088|FG003|Overall Study|Withdrawal by Subject|2|||
19612268|NCT00812955|42061085|FG000|Overall Study|randomized in error|0|||
19612269|NCT00812955|42061086|FG001|Overall Study|randomized in error|0|||
19612270|NCT00812955|42061087|FG002|Overall Study|randomized in error|1|||
19612271|NCT00812955|42061088|FG003|Overall Study|randomized in error|0|||
19612272|NCT00619489|42061104|FG000|Overall Study|Adverse Event|0|||
19612273|NCT00619489|42061105|FG001|Overall Study|Adverse Event|7|||
19612274|NCT00619489|42061104|FG000|Overall Study|Withdrawal by Subject|1|||
19612275|NCT00619489|42061105|FG001|Overall Study|Withdrawal by Subject|1|||
19612276|NCT00619489|42061104|FG000|Overall Study|Lack of Efficacy|0|||
19612277|NCT00619489|42061105|FG001|Overall Study|Lack of Efficacy|11|||
19612278|NCT00619489|42061104|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
19612279|NCT00619489|42061105|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
19612280|NCT00959699|42061113|FG000|Treatment Period|Adverse Event|3|||
19612281|NCT00959699|42061114|FG001|Treatment Period|Adverse Event|13|||
19612282|NCT00959699|42061113|FG000|Treatment Period|Lack of Efficacy|15|||
19612283|NCT00959699|42061114|FG001|Treatment Period|Lack of Efficacy|6|||
19612284|NCT00959699|42061113|FG000|Treatment Period|Lost to Follow-up|0|||
19612285|NCT00959699|42061114|FG001|Treatment Period|Lost to Follow-up|1|||
19612286|NCT00959699|42061113|FG000|Treatment Period|Withdrawal by Subject|1|||
19612287|NCT00959699|42061114|FG001|Treatment Period|Withdrawal by Subject|3|||
19612288|NCT00959699|42061113|FG000|Treatment Period|Non-Compliance with Protocol|0|||
19704031|NCT00421343|42148347|FG000|Overall Study|Death|1|||
19704032|NCT00421343|42148347|FG000|Overall Study|Withdrawal by Subject|2|||
19704033|NCT00421343|42148347|FG000|Overall Study|Lost to Follow-up|3|||
19612289|NCT00959699|42061114|FG001|Treatment Period|Non-Compliance with Protocol|1|||
19612290|NCT00959699|42061113|FG000|Treatment Period|Did not receive treatment|0|||
19612291|NCT00959699|42061114|FG001|Treatment Period|Did not receive treatment|1|||
19612292|NCT00959699|42061113|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
19612293|NCT00959699|42061114|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
19704034|NCT00230178|42148354|FG000|Overall Study|Adverse Event|1|||
19612294|NCT00959699|42061113|FG000|Follow-up Period|Lost to Follow-up|3|||
19612295|NCT00959699|42061114|FG001|Follow-up Period|Lost to Follow-up|2|||
19612296|NCT00959699|42061113|FG000|Follow-up Period|Withdrawal by Subject|3|||
19612297|NCT00959699|42061114|FG001|Follow-up Period|Withdrawal by Subject|4|||
19612298|NCT00617773|42061121|FG000|Overall Study|Physician Decision|1|||
19612299|NCT00617773|42061121|FG000|Overall Study|Lack of compliance with the protocol|1|||
19612300|NCT00617773|42061121|FG000|Overall Study|Withdrawal by Subject|1|||
19612301|NCT00617773|42061121|FG000|Overall Study|Death|1|||
19612302|NCT00617773|42061121|FG000|Overall Study|Progressive disease|19|||
19612303|NCT00617773|42061121|FG000|Overall Study|Protocol Violation|1|||
19612304|NCT00956813|42061127|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
19612305|NCT00956813|42061128|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
19612306|NCT00956813|42061127|FG000|Flaxseed and Placebo|Ineligible|3|||
19612307|NCT00956813|42061128|FG001|Flaxseed and Placebo|Ineligible|1|||
19612308|NCT00955955|42061138|FG000|Overall Study|Lost to Follow-up|2|||
19612309|NCT00955955|42061139|FG001|Overall Study|Lost to Follow-up|0|||
19612310|NCT00955955|42061140|FG002|Overall Study|Lost to Follow-up|0|||
19612311|NCT00955721|42061156|FG000|Overall Study|Physician Decision|1|||
19612312|NCT00955721|42061157|FG001|Overall Study|Physician Decision|0|||
19612313|NCT00955721|42061156|FG000|Overall Study|Death|1|||
19612314|NCT00955721|42061157|FG001|Overall Study|Death|0|||
19612315|NCT00955721|42061156|FG000|Overall Study|Withdrawal by Subject|1|||
19612316|NCT00955721|42061157|FG001|Overall Study|Withdrawal by Subject|0|||
19704035|NCT00230178|42148355|FG001|Overall Study|Adverse Event|5|||
19704036|NCT00230178|42148356|FG002|Overall Study|Adverse Event|2|||
19704037|NCT00230178|42148354|FG000|Overall Study|Withdrawal by Subject|0|||
19704038|NCT00230178|42148355|FG001|Overall Study|Withdrawal by Subject|0|||
19704039|NCT00230178|42148356|FG002|Overall Study|Withdrawal by Subject|1|||
19704040|NCT00230178|42148354|FG000|Overall Study|Various other reasons|3|||
19704041|NCT00230178|42148355|FG001|Overall Study|Various other reasons|2|||
19704042|NCT00230178|42148356|FG002|Overall Study|Various other reasons|4|||
19704043|NCT00413777|42148366|FG000|Fixed-dose Period|Lost to Follow-up|1|||
19704044|NCT00413777|42148367|FG001|Fixed-dose Period|Lost to Follow-up|1|||
19704045|NCT00413777|42148366|FG000|Fixed-dose Period|Adverse Event|2|||
19704046|NCT00413777|42148367|FG001|Fixed-dose Period|Adverse Event|1|||
19704047|NCT00413777|42148366|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
19704048|NCT00413777|42148367|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
19704049|NCT00413777|42148366|FG000|Fixed-dose Period|Withdrew Consent|0|||
19704050|NCT00413777|42148367|FG001|Fixed-dose Period|Withdrew Consent|1|||
19704051|NCT00197028|42148375|FG000|Overall Study|Adverse Event|2|||
19704052|NCT00197028|42148376|FG001|Overall Study|Adverse Event|2|||
19704053|NCT00197028|42148375|FG000|Overall Study|Protocol Violation|2|||
19704054|NCT00197028|42148376|FG001|Overall Study|Protocol Violation|1|||
19704055|NCT00197028|42148375|FG000|Overall Study|Withdrawal by Subject|8|||
19704056|NCT00197028|42148376|FG001|Overall Study|Withdrawal by Subject|12|||
19704057|NCT00197028|42148375|FG000|Overall Study|Lost to Follow-up|1|||
19704058|NCT00197028|42148376|FG001|Overall Study|Lost to Follow-up|0|||
19612317|NCT00573469|42061167|FG000|Overall Study|Adverse Event|1|||
19612318|NCT00573469|42061168|FG001|Overall Study|Adverse Event|1|||
19612319|NCT00573469|42061169|FG002|Overall Study|Adverse Event|1|||
19612320|NCT00573469|42061167|FG000|Overall Study|Withdrawal by Subject|0|||
19612321|NCT00573469|42061168|FG001|Overall Study|Withdrawal by Subject|2|||
19612322|NCT00573469|42061169|FG002|Overall Study|Withdrawal by Subject|0|||
19612323|NCT00573469|42061167|FG000|Overall Study|Other|5|||
19612324|NCT00573469|42061168|FG001|Overall Study|Other|1|||
19612325|NCT00573469|42061169|FG002|Overall Study|Other|3|||
19612326|NCT00812565|42061185|FG000|Overall Study|Did Not Receive Study Medication|1|||
19612327|NCT00812565|42061186|FG001|Overall Study|Did Not Receive Study Medication|1|||
19612328|NCT00812565|42061187|FG002|Overall Study|Did Not Receive Study Medication|0|||
19612329|NCT00812565|42061188|FG003|Overall Study|Did Not Receive Study Medication|0|||
19612330|NCT00812565|42061189|FG004|Overall Study|Did Not Receive Study Medication|0|||
19612331|NCT00812565|42061190|FG005|Overall Study|Did Not Receive Study Medication|0|||
19612332|NCT00812565|42061191|FG006|Overall Study|Did Not Receive Study Medication|0|||
19612333|NCT00812565|42061192|FG007|Overall Study|Did Not Receive Study Medication|0|||
19612334|NCT00812565|42061185|FG000|Overall Study|Adverse Event|0|||
19612335|NCT00812565|42061186|FG001|Overall Study|Adverse Event|0|||
19612336|NCT00812565|42061187|FG002|Overall Study|Adverse Event|0|||
19612337|NCT00812565|42061188|FG003|Overall Study|Adverse Event|2|||
19612338|NCT00812565|42061189|FG004|Overall Study|Adverse Event|0|||
19612339|NCT00812565|42061190|FG005|Overall Study|Adverse Event|0|||
19612340|NCT00812565|42061191|FG006|Overall Study|Adverse Event|0|||
19612341|NCT00812565|42061192|FG007|Overall Study|Adverse Event|1|||
19612342|NCT00812565|42061185|FG000|Overall Study|Did Not Come to Study Visit|1|||
19704059|NCT00197028|42148375|FG000|Overall Study|Other|3|||
19704060|NCT00197028|42148376|FG001|Overall Study|Other|6|||
19704061|NCT00420641|42148385|FG000|Overall Study|Adverse Event|3|||
19704062|NCT00420641|42148386|FG001|Overall Study|Adverse Event|25|||
19704063|NCT00420641|42148387|FG002|Overall Study|Adverse Event|10|||
19704064|NCT00420641|42148385|FG000|Overall Study|Lost to Follow-up|2|||
19612343|NCT00812565|42061186|FG001|Overall Study|Did Not Come to Study Visit|0|||
19704065|NCT00420641|42148386|FG001|Overall Study|Lost to Follow-up|4|||
19704066|NCT00420641|42148387|FG002|Overall Study|Lost to Follow-up|2|||
19704067|NCT00420641|42148385|FG000|Overall Study|Protocol Violation|8|||
19704068|NCT00420641|42148386|FG001|Overall Study|Protocol Violation|8|||
19704069|NCT00420641|42148387|FG002|Overall Study|Protocol Violation|7|||
19612344|NCT00812565|42061187|FG002|Overall Study|Did Not Come to Study Visit|0|||
19612345|NCT00812565|42061188|FG003|Overall Study|Did Not Come to Study Visit|0|||
19612346|NCT00812565|42061189|FG004|Overall Study|Did Not Come to Study Visit|0|||
19612347|NCT00812565|42061190|FG005|Overall Study|Did Not Come to Study Visit|0|||
19612348|NCT00812565|42061191|FG006|Overall Study|Did Not Come to Study Visit|0|||
19612349|NCT00812565|42061192|FG007|Overall Study|Did Not Come to Study Visit|0|||
19612350|NCT00812565|42061185|FG000|Overall Study|Withdrawal of Consent|1|||
19612351|NCT00812565|42061186|FG001|Overall Study|Withdrawal of Consent|0|||
19612352|NCT00812565|42061187|FG002|Overall Study|Withdrawal of Consent|0|||
19612353|NCT00812565|42061188|FG003|Overall Study|Withdrawal of Consent|0|||
19612354|NCT00812565|42061189|FG004|Overall Study|Withdrawal of Consent|1|||
19612355|NCT00812565|42061190|FG005|Overall Study|Withdrawal of Consent|0|||
19612356|NCT00812565|42061191|FG006|Overall Study|Withdrawal of Consent|0|||
19612357|NCT00812565|42061192|FG007|Overall Study|Withdrawal of Consent|0|||
19612358|NCT00812565|42061185|FG000|Overall Study|Reason Not Specified|0|||
19704070|NCT00420641|42148385|FG000|Overall Study|Withdrawal by Subject|15|||
19704071|NCT00420641|42148386|FG001|Overall Study|Withdrawal by Subject|21|||
19704072|NCT00420641|42148387|FG002|Overall Study|Withdrawal by Subject|14|||
19704073|NCT00420641|42148385|FG000|Overall Study|Lack of Efficacy|6|||
19704074|NCT00420641|42148386|FG001|Overall Study|Lack of Efficacy|5|||
19704075|NCT00420641|42148387|FG002|Overall Study|Lack of Efficacy|4|||
19704076|NCT00420641|42148385|FG000|Overall Study|Non-compliance|7|||
19704077|NCT00420641|42148386|FG001|Overall Study|Non-compliance|5|||
19704078|NCT00420641|42148387|FG002|Overall Study|Non-compliance|4|||
19704079|NCT00420641|42148385|FG000|Overall Study|Other|4|||
19704080|NCT00420641|42148386|FG001|Overall Study|Other|4|||
19482065|NCT01415921|41763509|FG000|Overall Study|Withdrawal by Subject|0|||
19482066|NCT01415921|41763510|FG001|Overall Study|Withdrawal by Subject|1|||
19482067|NCT01415921|41763509|FG000|Overall Study|Other|2|||
19482068|NCT01415921|41763510|FG001|Overall Study|Other|0|||
19482069|NCT01415531|41763518|FG000|Overall Study|Adverse Event|7|||
19482070|NCT01415531|41763519|FG001|Overall Study|Adverse Event|10|||
19482071|NCT01415531|41763518|FG000|Overall Study|Lack of Efficacy|3|||
19482072|NCT01415531|41763519|FG001|Overall Study|Lack of Efficacy|2|||
19482073|NCT01415531|41763518|FG000|Overall Study|Protocol Violation|0|||
19482074|NCT01415531|41763519|FG001|Overall Study|Protocol Violation|1|||
19482075|NCT01415531|41763518|FG000|Overall Study|Withdrawal by Subject|5|||
19482076|NCT01415531|41763519|FG001|Overall Study|Withdrawal by Subject|4|||
19482077|NCT01415531|41763518|FG000|Overall Study|Lost to Follow-up|6|||
19482078|NCT01415531|41763519|FG001|Overall Study|Lost to Follow-up|14|||
19482079|NCT01415531|41763518|FG000|Overall Study|Lack of Compliance|1|||
19482080|NCT01415531|41763519|FG001|Overall Study|Lack of Compliance|4|||
19482081|NCT01415531|41763518|FG000|Overall Study|Other Reasons|3|||
19482082|NCT01415531|41763519|FG001|Overall Study|Other Reasons|2|||
19482083|NCT01544114|41763528|FG000|Overall Study|Withdrawal by Subject|0|||
19482084|NCT01544114|41763529|FG001|Overall Study|Withdrawal by Subject|0|||
19482085|NCT01544114|41763530|FG002|Overall Study|Withdrawal by Subject|3|||
19482086|NCT01544114|41763528|FG000|Overall Study|Lost to Follow-up|0|||
19482087|NCT01544114|41763529|FG001|Overall Study|Lost to Follow-up|2|||
19482088|NCT01544114|41763530|FG002|Overall Study|Lost to Follow-up|0|||
19482089|NCT01544114|41763528|FG000|Overall Study|Adverse Event|1|||
19482090|NCT01544114|41763529|FG001|Overall Study|Adverse Event|1|||
19482091|NCT01544114|41763530|FG002|Overall Study|Adverse Event|2|||
19482092|NCT01544114|41763528|FG000|Overall Study|Protocol Violation|0|||
19482093|NCT01544114|41763529|FG001|Overall Study|Protocol Violation|1|||
19482094|NCT01544114|41763530|FG002|Overall Study|Protocol Violation|0|||
19482095|NCT01435265|41763542|FG000|Overall Study|Lost to Follow-up|0|||
19482096|NCT01435265|41763543|FG001|Overall Study|Lost to Follow-up|1|||
19482097|NCT01433263|41763551|FG000|Overall Study|Adverse Event|3|||
19482098|NCT01433263|41763552|FG001|Overall Study|Adverse Event|1|||
19482099|NCT01433263|41763551|FG000|Overall Study|Death|5|||
19482100|NCT01433263|41763552|FG001|Overall Study|Death|3|||
19482101|NCT01433263|41763551|FG000|Overall Study|Lost to Follow-up|0|||
19482102|NCT01433263|41763552|FG001|Overall Study|Lost to Follow-up|1|||
19704081|NCT00420641|42148387|FG002|Overall Study|Other|3|||
19482103|NCT01433263|41763551|FG000|Overall Study|Protocol Deviation|1|||
19482104|NCT01433263|41763552|FG001|Overall Study|Protocol Deviation|0|||
19482105|NCT01433263|41763551|FG000|Overall Study|Withdrawal by Subject|10|||
19612359|NCT00812565|42061186|FG001|Overall Study|Reason Not Specified|0|||
19704082|NCT00257556|42148397|FG000|Overall Study|Adverse Event|1|||
19482106|NCT01433263|41763552|FG001|Overall Study|Withdrawal by Subject|7|||
19482107|NCT01432951|41763561|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
19482108|NCT01432327|41763570|FG000|Posttest 3 Months|depression|3|||
19482109|NCT01432327|41763571|FG001|Posttest 3 Months|depression|0|||
19482110|NCT01432327|41763572|FG002|Posttest 3 Months|depression|0|||
19482111|NCT01432327|41763573|FG003|Posttest 3 Months|depression|0|||
19482112|NCT01432327|41763570|FG000|Posttest 3 Months|Lost to Follow-up|1|||
19482113|NCT01432327|41763571|FG001|Posttest 3 Months|Lost to Follow-up|0|||
19482114|NCT01432327|41763572|FG002|Posttest 3 Months|Lost to Follow-up|2|||
19482115|NCT01432327|41763573|FG003|Posttest 3 Months|Lost to Follow-up|1|||
19482116|NCT01432327|41763570|FG000|Posttest 3 Months|Allergic reaction|0|||
19482117|NCT01432327|41763571|FG001|Posttest 3 Months|Allergic reaction|2|||
19482118|NCT01432327|41763572|FG002|Posttest 3 Months|Allergic reaction|0|||
19482119|NCT01432327|41763573|FG003|Posttest 3 Months|Allergic reaction|0|||
19482120|NCT01432327|41763570|FG000|Posttest 6 Months|Lost to Follow-up|0|||
19482121|NCT01432327|41763571|FG001|Posttest 6 Months|Lost to Follow-up|0|||
19482122|NCT01432327|41763572|FG002|Posttest 6 Months|Lost to Follow-up|3|||
19482123|NCT01432327|41763573|FG003|Posttest 6 Months|Lost to Follow-up|2|||
19482124|NCT01432327|41763570|FG000|Posttest 6 Months|Allergic reaction|0|||
19482125|NCT01432327|41763571|FG001|Posttest 6 Months|Allergic reaction|0|||
19482126|NCT01432327|41763572|FG002|Posttest 6 Months|Allergic reaction|1|||
19482127|NCT01432327|41763573|FG003|Posttest 6 Months|Allergic reaction|0|||
19392765|NCT02660983|41636595|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
19392766|NCT02660983|41636594|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
19392767|NCT02660983|41636595|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
19482128|NCT01432327|41763570|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
19482129|NCT01432327|41763571|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
19482130|NCT01432327|41763572|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
19482131|NCT01432327|41763573|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
19482132|NCT01432327|41763570|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
19482133|NCT01432327|41763571|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
19482134|NCT01432327|41763572|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
19482135|NCT01432327|41763573|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
19482136|NCT01432327|41763570|FG000|Posttest 1 Year|Lost to Follow-up|0|||
19482137|NCT01432327|41763571|FG001|Posttest 1 Year|Lost to Follow-up|0|||
19482138|NCT01432327|41763572|FG002|Posttest 1 Year|Lost to Follow-up|4|||
19482139|NCT01432327|41763573|FG003|Posttest 1 Year|Lost to Follow-up|2|||
19482140|NCT01432327|41763570|FG000|Posttest 1 Year|Allergic reaction|0|||
19482141|NCT01432327|41763571|FG001|Posttest 1 Year|Allergic reaction|0|||
19482142|NCT01432327|41763572|FG002|Posttest 1 Year|Allergic reaction|1|||
19482143|NCT01432327|41763573|FG003|Posttest 1 Year|Allergic reaction|1|||
19482144|NCT01410799|41763583|FG000|Overall Study|PI decision|13|||
19482145|NCT01432171|41763589|FG000|Overall Study|Death|1|||
19482146|NCT01432171|41763590|FG001|Overall Study|Death|2|||
19482147|NCT01432171|41763589|FG000|Overall Study|Lost to Follow-up|6|||
19482148|NCT01432171|41763590|FG001|Overall Study|Lost to Follow-up|5|||
19482149|NCT01432171|41763589|FG000|Overall Study|Withdrawal by Subject|3|||
19482150|NCT01432171|41763590|FG001|Overall Study|Withdrawal by Subject|1|||
19482151|NCT01432171|41763589|FG000|Overall Study|Noncompliance|2|||
19482152|NCT01432171|41763590|FG001|Overall Study|Noncompliance|3|||
19482153|NCT01432171|41763589|FG000|Overall Study|Insurance denial trial coverage|1|||
19482154|NCT01432171|41763590|FG001|Overall Study|Insurance denial trial coverage|0|||
19482155|NCT01432171|41763589|FG000|Overall Study|Patient moved to palliative care|1|||
19482156|NCT01432171|41763590|FG001|Overall Study|Patient moved to palliative care|0|||
19482157|NCT01435031|41763600|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
19482158|NCT01435031|41763600|FG000|ITT at 1 Month|Death|1|||
19482159|NCT01435031|41763600|FG000|ITT at 1 Month|Lost to Follow-up|4|||
19482160|NCT01435031|41763600|FG000|ITT at 6 Months|Death|2|||
19482161|NCT01435031|41763600|FG000|ITT at 6 Months|Lost to Follow-up|3|||
19482162|NCT01435031|41763600|FG000|ITT at 1 Year|Death|1|||
19482163|NCT01435031|41763600|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
19392768|NCT02660983|41636594|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
19392769|NCT02660983|41636595|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
19392770|NCT02660983|41636594|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
19392771|NCT02660983|41636595|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
19392772|NCT01953328|41636610|FG000|Overall Study|Withdrawal by Subject|0|||
19392773|NCT01953328|41636611|FG001|Overall Study|Withdrawal by Subject|0|||
19392774|NCT01953328|41636612|FG002|Overall Study|Withdrawal by Subject|0|||
19392775|NCT01953328|41636613|FG003|Overall Study|Withdrawal by Subject|0|||
19482164|NCT01435031|41763600|FG000|ITT at 1 Year|Lost to Follow-up|6|||
19482165|NCT01435031|41763600|FG000|ITT at 2 Years|Death|7|||
19482166|NCT01435031|41763600|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
19482167|NCT01435031|41763600|FG000|ITT at 2 Years|Lost to Follow-up|4|||
19482168|NCT01435031|41763600|FG000|ITT at 3 Years|Death|5|||
19482169|NCT01435031|41763600|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
19704083|NCT00257556|42148398|FG001|Overall Study|Adverse Event|4|||
19482170|NCT01435031|41763600|FG000|ITT at 3 Years|Lost to Follow-up|4|||
19482171|NCT01435031|41763600|FG000|ITT at 4 Years|Death|4|||
19482172|NCT01435031|41763600|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
19482173|NCT01435031|41763600|FG000|ITT at 4 Years|Lost to Follow-up|1|||
19482174|NCT01433549|41763604|FG000|Phase 2: Second Study Product|Adverse Event|0|||
19482175|NCT01433549|41763605|FG001|Phase 2: Second Study Product|Adverse Event|1|||
19482176|NCT01414205|41763613|FG000|Overall Study|Death|5|||
19482177|NCT01414205|41763614|FG001|Overall Study|Death|1|||
19482178|NCT01414205|41763613|FG000|Overall Study|Lost to Follow-up|1|||
19482179|NCT01414205|41763614|FG001|Overall Study|Lost to Follow-up|4|||
19482180|NCT01414205|41763613|FG000|Overall Study|Physician Decision|0|||
19482181|NCT01414205|41763614|FG001|Overall Study|Physician Decision|1|||
19482182|NCT01414205|41763613|FG000|Overall Study|Randomized but not Treated|1|||
19482183|NCT01414205|41763614|FG001|Overall Study|Randomized but not Treated|1|||
19482184|NCT01433471|41763622|FG000|Overall Study|Withdrawal by Subject|0|||
19482185|NCT01433471|41763623|FG001|Overall Study|Withdrawal by Subject|1|||
19482186|NCT01433159|41763633|FG000|Overall Study|Adverse Event|1|||
19482187|NCT01433159|41763634|FG001|Overall Study|Adverse Event|0|||
19482188|NCT01433159|41763633|FG000|Overall Study|Physician Decision|1|||
19482189|NCT01433159|41763634|FG001|Overall Study|Physician Decision|0|||
19482190|NCT01433159|41763633|FG000|Overall Study|Protocol Violation|0|||
19482191|NCT01433159|41763634|FG001|Overall Study|Protocol Violation|1|||
19482192|NCT01413503|41763649|FG000|Overall Study|Lost to Follow-up|1|||
19482193|NCT01413191|41763653|FG000|Overall Study|Lost to Follow-up|5|||
19482194|NCT01413191|41763653|FG000|Overall Study|Disease Progression|5|||
19482195|NCT01413191|41763653|FG000|Overall Study|Death|1|||
19482196|NCT02036970|41763667|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
19482197|NCT02036970|41763668|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
19482198|NCT02036970|41763669|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
19482199|NCT02036970|41763670|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
19482200|NCT02036970|41763671|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
19482201|NCT02036970|41763672|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
19482202|NCT02036970|41763673|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
19482203|NCT02036970|41763674|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
19482204|NCT02036970|41763675|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
19482205|NCT02036970|41763676|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
19482206|NCT02036970|41763667|FG000|Part 1: Day 1 Through Week 16|Death|0|||
19482207|NCT02036970|41763668|FG001|Part 1: Day 1 Through Week 16|Death|0|||
19482208|NCT02036970|41763669|FG002|Part 1: Day 1 Through Week 16|Death|0|||
19612360|NCT00812565|42061187|FG002|Overall Study|Reason Not Specified|0|||
19612361|NCT00812565|42061188|FG003|Overall Study|Reason Not Specified|0|||
19612362|NCT00812565|42061189|FG004|Overall Study|Reason Not Specified|0|||
19612363|NCT00812565|42061190|FG005|Overall Study|Reason Not Specified|1|||
19612364|NCT00812565|42061191|FG006|Overall Study|Reason Not Specified|0|||
19612365|NCT00812565|42061192|FG007|Overall Study|Reason Not Specified|0|||
19612366|NCT00812487|42061212|FG000|Overall Study|Lost to Follow-up|2|||
19482209|NCT02036970|41763670|FG003|Part 1: Day 1 Through Week 16|Death|0|||
19482210|NCT02036970|41763671|FG004|Part 1: Day 1 Through Week 16|Death|0|||
19482211|NCT02036970|41763672|FG005|Part 1: Day 1 Through Week 16|Death|0|||
19482212|NCT02036970|41763673|FG006|Part 1: Day 1 Through Week 16|Death|0|||
19482213|NCT02036970|41763674|FG007|Part 1: Day 1 Through Week 16|Death|0|||
19482214|NCT02036970|41763675|FG008|Part 1: Day 1 Through Week 16|Death|1|||
19482215|NCT02036970|41763676|FG009|Part 1: Day 1 Through Week 16|Death|0|||
19482216|NCT02036970|41763667|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
19482217|NCT02036970|41763668|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19612367|NCT00812487|42061213|FG001|Overall Study|Lost to Follow-up|0|||
19392776|NCT01953328|41636614|FG004|Overall Study|Withdrawal by Subject|1|||
19392777|NCT01953328|41636615|FG005|Overall Study|Withdrawal by Subject|0|||
19392778|NCT01953328|41636616|FG006|Overall Study|Withdrawal by Subject|0|||
19392779|NCT01953328|41636617|FG007|Overall Study|Withdrawal by Subject|0|||
19392780|NCT01953328|41636610|FG000|Overall Study|Lost to Follow-up|0|||
19392781|NCT01953328|41636611|FG001|Overall Study|Lost to Follow-up|0|||
19392782|NCT01953328|41636612|FG002|Overall Study|Lost to Follow-up|0|||
19392783|NCT01953328|41636613|FG003|Overall Study|Lost to Follow-up|0|||
19392784|NCT01953328|41636614|FG004|Overall Study|Lost to Follow-up|1|||
19392785|NCT01953328|41636615|FG005|Overall Study|Lost to Follow-up|0|||
19392786|NCT01953328|41636616|FG006|Overall Study|Lost to Follow-up|0|||
19392787|NCT01953328|41636617|FG007|Overall Study|Lost to Follow-up|0|||
19392788|NCT02640755|41636637|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
19392789|NCT02640755|41636638|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
19482218|NCT02036970|41763669|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
19482219|NCT02036970|41763670|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482220|NCT02036970|41763671|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482221|NCT02036970|41763672|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482222|NCT02036970|41763673|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482223|NCT02036970|41763674|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482224|NCT02036970|41763675|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
19482225|NCT02036970|41763676|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
19482226|NCT02036970|41763667|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482227|NCT02036970|41763668|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482228|NCT02036970|41763669|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482229|NCT02036970|41763670|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482230|NCT02036970|41763671|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
19482231|NCT02036970|41763672|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482232|NCT02036970|41763673|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482233|NCT02036970|41763674|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
19482234|NCT02036970|41763675|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
19482235|NCT02036970|41763676|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
19482236|NCT02036970|41763667|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482237|NCT02036970|41763668|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482238|NCT02036970|41763669|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19612368|NCT00812487|42061212|FG000|Overall Study|Withdrawal by Subject|3|||
19612369|NCT00812487|42061213|FG001|Overall Study|Withdrawal by Subject|2|||
19612370|NCT00812487|42061212|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
19612371|NCT00812487|42061213|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
19612372|NCT00812487|42061212|FG000|Overall Study|Protocol Violation|0|||
19612373|NCT00812487|42061213|FG001|Overall Study|Protocol Violation|1|||
19612374|NCT00617461|42061223|FG000|First Treatment Intervention Period|Adverse Event|2|||
19612375|NCT00617461|42061224|FG001|First Treatment Intervention Period|Adverse Event|0|||
19612376|NCT00617461|42061223|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
19612377|NCT00617461|42061224|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
19482239|NCT02036970|41763670|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
19482240|NCT02036970|41763671|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482241|NCT02036970|41763672|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482242|NCT02036970|41763673|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482243|NCT02036970|41763674|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482244|NCT02036970|41763675|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482245|NCT02036970|41763676|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
19482246|NCT02036970|41763667|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
19482247|NCT02036970|41763668|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
19482248|NCT02036970|41763669|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
19482249|NCT02036970|41763670|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
19482250|NCT02036970|41763671|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
19482251|NCT02036970|41763672|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
19482252|NCT02036970|41763673|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
19482253|NCT02036970|41763674|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
19482254|NCT02036970|41763675|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
19482255|NCT02036970|41763676|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
19482256|NCT02036970|41763667|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482257|NCT02036970|41763668|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482258|NCT02036970|41763669|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482259|NCT02036970|41763670|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482260|NCT02036970|41763671|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482261|NCT02036970|41763672|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482262|NCT02036970|41763673|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482263|NCT02036970|41763674|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
19482264|NCT02036970|41763675|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482265|NCT02036970|41763676|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
19482266|NCT02036970|41763667|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482267|NCT02036970|41763668|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
19482268|NCT02036970|41763669|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
19482269|NCT02036970|41763670|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482270|NCT02036970|41763671|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482271|NCT02036970|41763672|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482272|NCT02036970|41763673|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482273|NCT02036970|41763674|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482274|NCT02036970|41763675|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
19482275|NCT02036970|41763676|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
19482276|NCT02036970|41763667|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
19482277|NCT02036970|41763668|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
19482278|NCT02036970|41763669|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
19482279|NCT02036970|41763670|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
19482280|NCT02036970|41763671|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
19612378|NCT00617461|42061223|FG000|First Treatment Intervention Period|Protocol Violation|2|||
19612379|NCT00617461|42061224|FG001|First Treatment Intervention Period|Protocol Violation|1|||
19612380|NCT00617461|42061223|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
19482281|NCT02036970|41763672|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
19482282|NCT02036970|41763673|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
19482283|NCT02036970|41763674|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
19482284|NCT02036970|41763675|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
19482285|NCT02036970|41763676|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
19482286|NCT01412957|41763710|FG000|Overall Study|Withdrawal by Subject|6|||
19482287|NCT01412957|41763711|FG001|Overall Study|Withdrawal by Subject|22|||
19482288|NCT01412957|41763710|FG000|Overall Study|Lost to Follow-up|7|||
19482289|NCT01412957|41763711|FG001|Overall Study|Lost to Follow-up|2|||
19482290|NCT01412957|41763710|FG000|Overall Study|Death|136|||
19482291|NCT01412957|41763711|FG001|Overall Study|Death|133|||
19482292|NCT01432457|41763720|FG000|Overall Study|Adverse Event|7|||
19482293|NCT01432457|41763721|FG001|Overall Study|Adverse Event|10|||
19482294|NCT01432457|41763722|FG002|Overall Study|Adverse Event|16|||
19482295|NCT01432457|41763720|FG000|Overall Study|Lack of Efficacy|2|||
19482296|NCT01432457|41763721|FG001|Overall Study|Lack of Efficacy|1|||
19482297|NCT01432457|41763722|FG002|Overall Study|Lack of Efficacy|1|||
19482298|NCT01432457|41763720|FG000|Overall Study|Lost to Follow-up|11|||
19482299|NCT01432457|41763721|FG001|Overall Study|Lost to Follow-up|15|||
19482300|NCT01432457|41763722|FG002|Overall Study|Lost to Follow-up|20|||
19482301|NCT01432457|41763720|FG000|Overall Study|Protocol Violation|3|||
19482302|NCT01432457|41763721|FG001|Overall Study|Protocol Violation|2|||
19482303|NCT01432457|41763722|FG002|Overall Study|Protocol Violation|6|||
19482304|NCT01432457|41763720|FG000|Overall Study|Withdrawal by Subject|6|||
19612381|NCT00617461|42061224|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
19612382|NCT00617461|42061223|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
19612383|NCT00617461|42061224|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
19612384|NCT00617461|42061223|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
19612385|NCT00617461|42061224|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
19612386|NCT00617461|42061223|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
19612387|NCT00617461|42061224|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
19704084|NCT00257556|42148397|FG000|Overall Study|Physician Decision|6|||
19704085|NCT00257556|42148398|FG001|Overall Study|Physician Decision|0|||
19704086|NCT00257556|42148397|FG000|Overall Study|Did not meet hCG criterion|3|||
19612388|NCT00617461|42061223|FG000|Second Treatment Intervention Period|Adverse Event|0|||
19612389|NCT00617461|42061224|FG001|Second Treatment Intervention Period|Adverse Event|1|||
19612390|NCT00617461|42061223|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
19612391|NCT00617461|42061224|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
19612392|NCT00617461|42061223|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
19612393|NCT00617461|42061224|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
19612394|NCT00617461|42061223|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
19612395|NCT00617461|42061224|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
19612396|NCT00812331|42061251|FG000|Overall Study|Adverse Event|1|||
19612397|NCT00812331|42061252|FG001|Overall Study|Adverse Event|0|||
19612398|NCT00812331|42061253|FG002|Overall Study|Adverse Event|0|||
19612399|NCT00812331|42061254|FG003|Overall Study|Adverse Event|0|||
19612400|NCT00812331|42061255|FG004|Overall Study|Adverse Event|0|||
19612401|NCT00812253|42061265|FG000|Overall Study|Withdrawal by Subject|3|||
19612402|NCT00812253|42061266|FG001|Overall Study|Withdrawal by Subject|2|||
19612403|NCT00812253|42061265|FG000|Overall Study|Protocol Violation|1|||
19612404|NCT00812253|42061266|FG001|Overall Study|Protocol Violation|1|||
19612405|NCT00812253|42061265|FG000|Overall Study|Lost to Follow-up|2|||
19612406|NCT00812253|42061266|FG001|Overall Study|Lost to Follow-up|0|||
19612407|NCT00616759|42061274|FG000|Overall Study|Physician Decision|2|||
19612408|NCT00616759|42061275|FG001|Overall Study|Physician Decision|0|||
19612409|NCT00616759|42061274|FG000|Overall Study|Withdrawal by Subject|1|||
19612410|NCT00616759|42061275|FG001|Overall Study|Withdrawal by Subject|2|||
19612411|NCT00812097|42061285|FG000|Overall Study|Death|3|||
19612412|NCT00812097|42061286|FG001|Overall Study|Death|10|||
19612413|NCT00812097|42061287|FG002|Overall Study|Death|3|||
19612414|NCT00812097|42061288|FG003|Overall Study|Death|3|||
19612415|NCT00812097|42061285|FG000|Overall Study|Withdrawal by Subject|14|||
19612416|NCT00812097|42061286|FG001|Overall Study|Withdrawal by Subject|12|||
19612417|NCT00812097|42061287|FG002|Overall Study|Withdrawal by Subject|8|||
19612418|NCT00812097|42061288|FG003|Overall Study|Withdrawal by Subject|2|||
19612419|NCT00812097|42061285|FG000|Overall Study|Lost to Follow-up|90|||
19612420|NCT00812097|42061286|FG001|Overall Study|Lost to Follow-up|14|||
19612421|NCT00812097|42061287|FG002|Overall Study|Lost to Follow-up|17|||
19704087|NCT00257556|42148398|FG001|Overall Study|Did not meet hCG criterion|0|||
19482305|NCT01432457|41763721|FG001|Overall Study|Withdrawal by Subject|11|||
19612422|NCT00812097|42061288|FG003|Overall Study|Lost to Follow-up|5|||
19612423|NCT00812097|42061285|FG000|Overall Study|Explantation of study device(s)|27|||
19612424|NCT00812097|42061286|FG001|Overall Study|Explantation of study device(s)|29|||
19612425|NCT00812097|42061287|FG002|Overall Study|Explantation of study device(s)|14|||
19612426|NCT00812097|42061288|FG003|Overall Study|Explantation of study device(s)|20|||
19704088|NCT00257556|42148397|FG000|Overall Study|other reason|4|||
19482306|NCT01432457|41763722|FG002|Overall Study|Withdrawal by Subject|9|||
19482307|NCT01432457|41763720|FG000|Overall Study|Reasons not defined|2|||
19612427|NCT00812097|42061285|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
19392790|NCT02640755|41636637|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
19392791|NCT02640755|41636638|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
19392792|NCT02640755|41636637|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
19392793|NCT02640755|41636638|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
19392794|NCT02640677|41636645|FG000|Overall Study|Lost to Follow-up|1|||
19392795|NCT02640677|41636645|FG000|Overall Study|Withdrawal by Subject|1|||
19392796|NCT02643251|41636662|FG000|Overall Study|Adverse Event|3|||
19392797|NCT02643251|41636663|FG001|Overall Study|Adverse Event|1|||
19392798|NCT02643251|41636662|FG000|Overall Study|Withdrawal by Subject|2|||
19392799|NCT02643251|41636663|FG001|Overall Study|Withdrawal by Subject|0|||
19392800|NCT02643251|41636662|FG000|Overall Study|Lost to Follow-up|4|||
19392801|NCT02643251|41636663|FG001|Overall Study|Lost to Follow-up|1|||
19392802|NCT02643251|41636662|FG000|Overall Study|Protocol Violation|1|||
19392803|NCT02643251|41636663|FG001|Overall Study|Protocol Violation|0|||
19392804|NCT02643251|41636662|FG000|Overall Study|PI Decision to terminate patient|1|||
19392805|NCT02643251|41636663|FG001|Overall Study|PI Decision to terminate patient|0|||
19392806|NCT01970878|41636673|FG000|Overall Study|Withdrawal by Subject|11|||
19392807|NCT01970878|41636674|FG001|Overall Study|Withdrawal by Subject|10|||
19392808|NCT01970878|41636675|FG002|Overall Study|Withdrawal by Subject|14|||
19392809|NCT01970878|41636676|FG003|Overall Study|Withdrawal by Subject|7|||
19392810|NCT01970878|41636673|FG000|Overall Study|Lost to Follow-up|1|||
19392811|NCT01970878|41636674|FG001|Overall Study|Lost to Follow-up|3|||
19392812|NCT01970878|41636675|FG002|Overall Study|Lost to Follow-up|2|||
19392813|NCT01970878|41636676|FG003|Overall Study|Lost to Follow-up|4|||
19392814|NCT01970878|41636673|FG000|Overall Study|Administrative Reasons|1|||
19392815|NCT01970878|41636674|FG001|Overall Study|Administrative Reasons|0|||
19392816|NCT01970878|41636675|FG002|Overall Study|Administrative Reasons|0|||
19392817|NCT01970878|41636676|FG003|Overall Study|Administrative Reasons|4|||
19392818|NCT01970878|41636673|FG000|Overall Study|Lack of Efficacy|2|||
19392819|NCT01970878|41636674|FG001|Overall Study|Lack of Efficacy|1|||
19392820|NCT01970878|41636675|FG002|Overall Study|Lack of Efficacy|2|||
19392821|NCT01970878|41636676|FG003|Overall Study|Lack of Efficacy|0|||
19392822|NCT01970878|41636673|FG000|Overall Study|Adverse Event|12|||
19392823|NCT01970878|41636674|FG001|Overall Study|Adverse Event|7|||
19392824|NCT01970878|41636675|FG002|Overall Study|Adverse Event|4|||
19392825|NCT01970878|41636676|FG003|Overall Study|Adverse Event|3|||
19392826|NCT01970878|41636673|FG000|Overall Study|Protocol Specified Criteria|10|||
19392827|NCT01970878|41636674|FG001|Overall Study|Protocol Specified Criteria|4|||
19392828|NCT01970878|41636675|FG002|Overall Study|Protocol Specified Criteria|3|||
19392829|NCT01970878|41636676|FG003|Overall Study|Protocol Specified Criteria|6|||
19392830|NCT01970878|41636673|FG000|Overall Study|Physician Decision|0|||
19392831|NCT01970878|41636674|FG001|Overall Study|Physician Decision|1|||
19392832|NCT01970878|41636675|FG002|Overall Study|Physician Decision|1|||
19392833|NCT01970878|41636676|FG003|Overall Study|Physician Decision|0|||
19392834|NCT01970878|41636673|FG000|Overall Study|No Completion Status|0|||
19392835|NCT01970878|41636674|FG001|Overall Study|No Completion Status|1|||
19392836|NCT01970878|41636675|FG002|Overall Study|No Completion Status|0|||
19392837|NCT01970878|41636676|FG003|Overall Study|No Completion Status|0|||
19392838|NCT01970488|41636688|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
19392839|NCT01970488|41636689|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
19612428|NCT00812097|42061286|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
19612429|NCT00812097|42061287|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
19612430|NCT00812097|42061288|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
19612431|NCT00811941|42061300|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
19612432|NCT00811941|42061301|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
19612433|NCT00811941|42061300|FG000|All Treated Patients|Adverse Event|2|||
19612434|NCT00811941|42061301|FG001|All Treated Patients|Adverse Event|43|||
19612435|NCT00811941|42061300|FG000|All Treated Patients|Lack of Efficacy|2|||
19612436|NCT00811941|42061301|FG001|All Treated Patients|Lack of Efficacy|3|||
19612437|NCT00811941|42061300|FG000|All Treated Patients|Non-compliance|1|||
19612438|NCT00811941|42061301|FG001|All Treated Patients|Non-compliance|8|||
19612439|NCT00811941|42061300|FG000|All Treated Patients|Protocol Violation|5|||
19612440|NCT00811941|42061301|FG001|All Treated Patients|Protocol Violation|17|||
19612441|NCT00811941|42061300|FG000|All Treated Patients|Withdrawal by Subject|35|||
19392840|NCT01970488|41636690|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
19392841|NCT01970488|41636691|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
19392842|NCT01970488|41636692|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
19392843|NCT01970488|41636688|FG000|Part 1: Through Week 16|Protocol Violation|1|||
19392844|NCT01970488|41636689|FG001|Part 1: Through Week 16|Protocol Violation|2|||
19482308|NCT01432457|41763721|FG001|Overall Study|Reasons not defined|3|||
19482309|NCT01432457|41763722|FG002|Overall Study|Reasons not defined|4|||
19482310|NCT01432457|41763720|FG000|Overall Study|Did not take study drug|6|||
19612442|NCT00811941|42061301|FG001|All Treated Patients|Withdrawal by Subject|94|||
19612443|NCT00811941|42061300|FG000|All Treated Patients|Lost to Follow-up|3|||
19612444|NCT00811941|42061301|FG001|All Treated Patients|Lost to Follow-up|12|||
19612445|NCT00811941|42061300|FG000|All Treated Patients|Other Reason|4|||
19704089|NCT00257556|42148398|FG001|Overall Study|other reason|6|||
19704090|NCT00228384|42148406|FG000|Overall Study|Death|9|||
19704091|NCT00228384|42148407|FG001|Overall Study|Death|3|||
19704092|NCT00228384|42148406|FG000|Overall Study|Lost to Follow-up|6|||
19482311|NCT01432457|41763721|FG001|Overall Study|Did not take study drug|6|||
19482312|NCT01432457|41763722|FG002|Overall Study|Did not take study drug|3|||
19482313|NCT01390441|41763744|FG000|Treatment Period|Protocol Violation|0|||
19482314|NCT01390441|41763745|FG001|Treatment Period|Protocol Violation|1|||
19482315|NCT01390441|41763746|FG002|Treatment Period|Protocol Violation|0|||
19482316|NCT01390441|41763747|FG003|Treatment Period|Protocol Violation|0|||
19482317|NCT01390441|41763748|FG004|Treatment Period|Protocol Violation|0|||
19482318|NCT01390441|41763744|FG000|Treatment Period|Physician Decision|0|||
19482319|NCT01390441|41763745|FG001|Treatment Period|Physician Decision|0|||
19482320|NCT01390441|41763746|FG002|Treatment Period|Physician Decision|0|||
19482321|NCT01390441|41763747|FG003|Treatment Period|Physician Decision|1|||
19482322|NCT01390441|41763748|FG004|Treatment Period|Physician Decision|0|||
19482323|NCT01390441|41763744|FG000|Treatment Period|Lack of Efficacy|0|||
19482324|NCT01390441|41763745|FG001|Treatment Period|Lack of Efficacy|0|||
19482325|NCT01390441|41763746|FG002|Treatment Period|Lack of Efficacy|0|||
19482326|NCT01390441|41763747|FG003|Treatment Period|Lack of Efficacy|0|||
19482327|NCT01390441|41763748|FG004|Treatment Period|Lack of Efficacy|1|||
19482328|NCT01390441|41763744|FG000|Treatment Period|Unknown due to early stopping of study|0|||
19482329|NCT01390441|41763745|FG001|Treatment Period|Unknown due to early stopping of study|0|||
19482330|NCT01390441|41763746|FG002|Treatment Period|Unknown due to early stopping of study|8|||
19482331|NCT01390441|41763747|FG003|Treatment Period|Unknown due to early stopping of study|11|||
19482332|NCT01390441|41763748|FG004|Treatment Period|Unknown due to early stopping of study|7|||
19482333|NCT01390441|41763744|FG000|Treatment Period|Adverse Event|0|||
19482334|NCT01390441|41763745|FG001|Treatment Period|Adverse Event|0|||
19482335|NCT01390441|41763746|FG002|Treatment Period|Adverse Event|1|||
19482336|NCT01390441|41763747|FG003|Treatment Period|Adverse Event|1|||
19482337|NCT01390441|41763748|FG004|Treatment Period|Adverse Event|2|||
19482338|NCT01390441|41763744|FG000|Treatment Period|Withdrawal by Subject|0|||
19482339|NCT01390441|41763745|FG001|Treatment Period|Withdrawal by Subject|0|||
19482340|NCT01390441|41763746|FG002|Treatment Period|Withdrawal by Subject|1|||
19482341|NCT01390441|41763747|FG003|Treatment Period|Withdrawal by Subject|0|||
19482342|NCT01390441|41763748|FG004|Treatment Period|Withdrawal by Subject|1|||
19482343|NCT01390441|41763744|FG000|Treatment Period|Lost to Follow-up|1|||
19482344|NCT01390441|41763745|FG001|Treatment Period|Lost to Follow-up|0|||
19482345|NCT01390441|41763746|FG002|Treatment Period|Lost to Follow-up|0|||
19482346|NCT01390441|41763747|FG003|Treatment Period|Lost to Follow-up|0|||
19482347|NCT01390441|41763748|FG004|Treatment Period|Lost to Follow-up|0|||
19482348|NCT01390441|41763744|FG000|Extension Period|Protocol Violation|3|||
19482349|NCT01390441|41763745|FG001|Extension Period|Protocol Violation|1|||
19482350|NCT01390441|41763746|FG002|Extension Period|Protocol Violation|0|||
19482351|NCT01390441|41763747|FG003|Extension Period|Protocol Violation|1|||
19482352|NCT01390441|41763748|FG004|Extension Period|Protocol Violation|0|||
19482353|NCT01412879|41763797|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
19482354|NCT01412879|41763798|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
19482355|NCT01412879|41763799|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
19482356|NCT01412879|41763797|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
19482357|NCT01412879|41763798|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
19482358|NCT01412879|41763799|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
19482359|NCT01412879|41763797|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
19482360|NCT01412879|41763798|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
19612446|NCT00811941|42061301|FG001|All Treated Patients|Other Reason|14|||
19612447|NCT00811473|42061309|FG000|Overall Study|Adverse Event|3|||
19612448|NCT00811473|42061310|FG001|Overall Study|Adverse Event|12|||
19612449|NCT00811473|42061309|FG000|Overall Study|Lost to Follow-up|5|||
19612450|NCT00811473|42061310|FG001|Overall Study|Lost to Follow-up|1|||
19612451|NCT00811473|42061309|FG000|Overall Study|Withdrawal by Subject|2|||
19612452|NCT00811473|42061310|FG001|Overall Study|Withdrawal by Subject|4|||
19612453|NCT00811473|42061309|FG000|Overall Study|Severe non-compliance to protocol|2|||
19612454|NCT00811473|42061310|FG001|Overall Study|Severe non-compliance to protocol|4|||
19482361|NCT01412879|41763799|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
19482362|NCT01412879|41763797|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
19482363|NCT01412879|41763798|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
19482364|NCT01412879|41763799|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
19482365|NCT01412879|41763797|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
19612455|NCT00811473|42061309|FG000|Overall Study|Lack of therapeutic response|4|||
19704093|NCT00228384|42148407|FG001|Overall Study|Lost to Follow-up|10|||
19482366|NCT01412879|41763798|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
19482367|NCT01412879|41763799|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
19482368|NCT01431079|41763811|FG000|Overall Study|Lost to Follow-up|35|||
19482369|NCT01431079|41763812|FG001|Overall Study|Lost to Follow-up|39|||
19482370|NCT01430611|41763844|FG000|Overall Study|Adverse Event|0|||
19482371|NCT01430611|41763845|FG001|Overall Study|Adverse Event|1|||
19482372|NCT01430611|41763844|FG000|Overall Study|Protocol Violation|1|||
19482373|NCT01430611|41763845|FG001|Overall Study|Protocol Violation|0|||
19482374|NCT01430611|41763844|FG000|Overall Study|Lost to Follow-up|1|||
19482375|NCT01430611|41763845|FG001|Overall Study|Lost to Follow-up|0|||
19482376|NCT01430611|41763844|FG000|Overall Study|Withdrawal by Subject|15|||
19482377|NCT01430611|41763845|FG001|Overall Study|Withdrawal by Subject|14|||
19482378|NCT01409707|41763854|FG000|Overall Study|Withdrawal by Subject|5|||
19482379|NCT01409707|41763855|FG001|Overall Study|Withdrawal by Subject|17|||
19482380|NCT01409707|41763856|FG002|Overall Study|Withdrawal by Subject|16|||
19482381|NCT01389973|41763863|FG000|Overall Study|Lost to Follow-up|1|||
19482382|NCT01389973|41763863|FG000|Overall Study|Trial Stopped by Sponsor|9|||
19482383|NCT01389973|41763863|FG000|Overall Study|Other|10|||
19482384|NCT01389817|41763883|FG000|Overall Study|Physician Decision|1|||
19482385|NCT01389817|41763884|FG001|Overall Study|Physician Decision|0|||
19482386|NCT01389817|41763883|FG000|Overall Study|Lost to Follow-up|1|||
19482387|NCT01389817|41763884|FG001|Overall Study|Lost to Follow-up|0|||
19482388|NCT01389817|41763883|FG000|Overall Study|Withdrawal by Subject|2|||
19482389|NCT01389817|41763884|FG001|Overall Study|Withdrawal by Subject|0|||
19482390|NCT01430455|41763899|FG000|Overall Study|Withdrawal by Subject|1|||
19482391|NCT01430455|41763899|FG000|Overall Study|Switched to follow-up phase|1|||
19482392|NCT01429441|41763927|FG000|Overall Study|Adverse Event|5|||
19482393|NCT01429441|41763928|FG001|Overall Study|Adverse Event|1|||
19482394|NCT01429441|41763927|FG000|Overall Study|Death|0|||
19482395|NCT01429441|41763928|FG001|Overall Study|Death|2|||
19482396|NCT01429441|41763927|FG000|Overall Study|Lost to Follow-up|5|||
19482397|NCT01429441|41763928|FG001|Overall Study|Lost to Follow-up|2|||
19482398|NCT01429441|41763927|FG000|Overall Study|Physician Decision|1|||
19482399|NCT01429441|41763928|FG001|Overall Study|Physician Decision|0|||
19482400|NCT01429441|41763927|FG000|Overall Study|Withdrawal by Subject|27|||
19482401|NCT01429441|41763928|FG001|Overall Study|Withdrawal by Subject|18|||
19482402|NCT01429285|41763963|FG000|Overall Study|Protocol Violation|9|||
19482403|NCT01429285|41763964|FG001|Overall Study|Protocol Violation|4|||
19482404|NCT01429285|41763963|FG000|Overall Study|Missing Data|5|||
19482405|NCT01429285|41763964|FG001|Overall Study|Missing Data|3|||
19482406|NCT01429285|41763963|FG000|Overall Study|Erroneously Enrolled Twice|8|||
19482407|NCT01429285|41763964|FG001|Overall Study|Erroneously Enrolled Twice|2|||
19482408|NCT01429051|41764041|FG000|Titration Phase|Death|1|||
19482409|NCT01429051|41764041|FG000|Titration Phase|Withdrawal by Subject|7|||
19482410|NCT01429051|41764041|FG000|Titration Phase|Physician Decision|1|||
19482411|NCT01429051|41764041|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
19482412|NCT01429051|41764041|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
19482413|NCT01429051|41764041|FG000|Efficacy Phase|Adverse Event|1|||
19482414|NCT01429051|41764041|FG000|Efficacy Phase|Death|1|||
19482415|NCT01429051|41764041|FG000|Tolerability Phase|Death|5|||
19482416|NCT01429051|41764041|FG000|Tolerability Phase|Adverse Event|2|||
19482417|NCT01429051|41764041|FG000|Tolerability Phase|Withdrawal by Subject|5|||
19482418|NCT01429051|41764041|FG000|Tolerability Phase|Physician Decision|1|||
19482419|NCT01429051|41764041|FG000|Tolerability Phase|Other|2|||
19482420|NCT01428661|41764074|FG000|Double-Masked Phase|Protocol Violation|9|||
19482421|NCT01428661|41764075|FG001|Double-Masked Phase|Protocol Violation|4|||
19482422|NCT01428661|41764076|FG002|Double-Masked Phase|Protocol Violation|0|||
19482423|NCT01428661|41764074|FG000|Double-Masked Phase|Adverse Event|13|||
19482424|NCT01428661|41764075|FG001|Double-Masked Phase|Adverse Event|4|||
19482425|NCT01428661|41764076|FG002|Double-Masked Phase|Adverse Event|0|||
19482426|NCT01428661|41764074|FG000|Double-Masked Phase|Lost to Follow-up|14|||
19482427|NCT01428661|41764075|FG001|Double-Masked Phase|Lost to Follow-up|14|||
19482428|NCT01428661|41764076|FG002|Double-Masked Phase|Lost to Follow-up|0|||
19482429|NCT01428661|41764074|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
19482430|NCT01428661|41764075|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
19482431|NCT01428661|41764076|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
19482432|NCT01428661|41764074|FG000|Double-Masked Phase|Lack of Efficacy|2|||
19482433|NCT01428661|41764075|FG001|Double-Masked Phase|Lack of Efficacy|1|||
19482434|NCT01428661|41764076|FG002|Double-Masked Phase|Lack of Efficacy|0|||
19482435|NCT01428661|41764074|FG000|Double-Masked Phase|*Various|1|||
19482436|NCT01428661|41764075|FG001|Double-Masked Phase|*Various|6|||
19482437|NCT01428661|41764076|FG002|Double-Masked Phase|*Various|0|||
19482438|NCT01428661|41764074|FG000|Open Label Extension|Protocol Violation|0|||
19482439|NCT01428661|41764075|FG001|Open Label Extension|Protocol Violation|0|||
19482440|NCT01428661|41764076|FG002|Open Label Extension|Protocol Violation|9|||
19482441|NCT01428661|41764074|FG000|Open Label Extension|Adverse Event|0|||
19482442|NCT01428661|41764075|FG001|Open Label Extension|Adverse Event|0|||
19482443|NCT01428661|41764076|FG002|Open Label Extension|Adverse Event|15|||
19482444|NCT01428661|41764074|FG000|Open Label Extension|Lost to Follow-up|0|||
19482445|NCT01428661|41764075|FG001|Open Label Extension|Lost to Follow-up|0|||
19482446|NCT01428661|41764076|FG002|Open Label Extension|Lost to Follow-up|38|||
19482447|NCT01428661|41764074|FG000|Open Label Extension|Withdrawal by Subject|0|||
19482448|NCT01428661|41764075|FG001|Open Label Extension|Withdrawal by Subject|0|||
19482449|NCT01428661|41764076|FG002|Open Label Extension|Withdrawal by Subject|49|||
19482450|NCT01428661|41764074|FG000|Open Label Extension|Lack of Efficacy|0|||
19482451|NCT01428661|41764075|FG001|Open Label Extension|Lack of Efficacy|0|||
19482452|NCT01428661|41764076|FG002|Open Label Extension|Lack of Efficacy|24|||
19482453|NCT01428661|41764074|FG000|Open Label Extension|**Various|0|||
19482454|NCT01428661|41764075|FG001|Open Label Extension|**Various|0|||
19482455|NCT01428661|41764076|FG002|Open Label Extension|**Various|185|||
19482456|NCT01428583|41764084|FG000|Overall Study|Adverse Event|75|||
19482457|NCT01428583|41764084|FG000|Overall Study|Withdrawal by Subject|51|||
19482458|NCT01428583|41764084|FG000|Overall Study|Lack of Efficacy|37|||
19482459|NCT01428583|41764084|FG000|Overall Study|Lost to Follow-up|17|||
19482460|NCT01428583|41764084|FG000|Overall Study|Death|1|||
19482461|NCT01428583|41764084|FG000|Overall Study|Pregnancy|1|||
19482462|NCT01428583|41764084|FG000|Overall Study|Protocol Violation|1|||
19482463|NCT01428583|41764084|FG000|Overall Study|Physician Decision|12|||
19482464|NCT01428583|41764084|FG000|Overall Study|Non-compliant|25|||
19482465|NCT01428583|41764084|FG000|Overall Study|Confirmed positive urine drug test|8|||
19482466|NCT01428583|41764084|FG000|Overall Study|Sponsor's request|3|||
19482467|NCT01428583|41764084|FG000|Overall Study|Other|6|||
19482468|NCT01428193|41764101|FG000|Overall Study|Physician Decision|1|||
19482469|NCT01428193|41764101|FG000|Overall Study|Elevated screening liver enzymes|1|||
19482470|NCT01428115|41764105|FG000|Overall Study|Lack of Efficacy|3|||
19482471|NCT01428115|41764105|FG000|Overall Study|Lost to Follow-up|10|||
19482472|NCT01428115|41764105|FG000|Overall Study|Pregnancy|1|||
19482473|NCT01428115|41764105|FG000|Overall Study|Protocol Violation|3|||
19482474|NCT01428115|41764105|FG000|Overall Study|Withdrawal by Subject|4|||
19482475|NCT01427803|41764112|FG000|Overall Study|Lost to Follow-up|32|||
19392845|NCT01970488|41636690|FG002|Part 1: Through Week 16|Protocol Violation|0|||
19392846|NCT01970488|41636691|FG003|Part 1: Through Week 16|Protocol Violation|0|||
19392847|NCT01970488|41636692|FG004|Part 1: Through Week 16|Protocol Violation|0|||
19392848|NCT01970488|41636688|FG000|Part 1: Through Week 16|Adverse Event|6|||
19392849|NCT01970488|41636689|FG001|Part 1: Through Week 16|Adverse Event|5|||
19392850|NCT01970488|41636690|FG002|Part 1: Through Week 16|Adverse Event|0|||
19392851|NCT01970488|41636691|FG003|Part 1: Through Week 16|Adverse Event|0|||
19392852|NCT01970488|41636692|FG004|Part 1: Through Week 16|Adverse Event|0|||
19392853|NCT01970488|41636688|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
19392854|NCT01970488|41636689|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
19392855|NCT01970488|41636690|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
19392856|NCT01970488|41636691|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
19392857|NCT01970488|41636692|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
19392858|NCT01970488|41636688|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
19392859|NCT01970488|41636689|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
19392860|NCT01970488|41636690|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
19392861|NCT01970488|41636691|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
19392862|NCT01970488|41636692|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
19392863|NCT01970488|41636688|FG000|Part 2: Post Week 16|Physician Decision|0|||
19392864|NCT01970488|41636689|FG001|Part 2: Post Week 16|Physician Decision|0|||
19392865|NCT01970488|41636690|FG002|Part 2: Post Week 16|Physician Decision|0|||
19392866|NCT01970488|41636691|FG003|Part 2: Post Week 16|Physician Decision|0|||
19392867|NCT01970488|41636692|FG004|Part 2: Post Week 16|Physician Decision|1|||
19392868|NCT01970488|41636688|FG000|Part 2: Post Week 16|Non-compliance|0|||
19392869|NCT01970488|41636689|FG001|Part 2: Post Week 16|Non-compliance|0|||
19392870|NCT01970488|41636690|FG002|Part 2: Post Week 16|Non-compliance|1|||
19392871|NCT01970488|41636691|FG003|Part 2: Post Week 16|Non-compliance|0|||
19392872|NCT01970488|41636692|FG004|Part 2: Post Week 16|Non-compliance|0|||
19392873|NCT01970488|41636688|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
19392874|NCT01970488|41636689|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
19392875|NCT01970488|41636690|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
19392876|NCT01970488|41636691|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
19392877|NCT01970488|41636692|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
19482476|NCT01427803|41764113|FG001|Overall Study|Lost to Follow-up|26|||
19482477|NCT01427803|41764112|FG000|Overall Study|Withdrawal by Subject|20|||
19482478|NCT01427803|41764113|FG001|Overall Study|Withdrawal by Subject|0|||
19482479|NCT01427803|41764112|FG000|Overall Study|Unable to complete full treatment period|6|||
19482480|NCT01427803|41764113|FG001|Overall Study|Unable to complete full treatment period|0|||
19392878|NCT01970488|41636688|FG000|Part 2: Post Week 16|Adverse Event|0|||
19392879|NCT01970488|41636689|FG001|Part 2: Post Week 16|Adverse Event|0|||
19392880|NCT01970488|41636690|FG002|Part 2: Post Week 16|Adverse Event|5|||
19392881|NCT01970488|41636691|FG003|Part 2: Post Week 16|Adverse Event|1|||
19392882|NCT01970488|41636692|FG004|Part 2: Post Week 16|Adverse Event|1|||
19392883|NCT01970488|41636688|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
19482481|NCT01427803|41764112|FG000|Overall Study|Protocol Violation|1|||
19392884|NCT01970488|41636689|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
19392885|NCT01970488|41636690|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
19392886|NCT01970488|41636691|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
19392887|NCT01970488|41636692|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
19392888|NCT01970488|41636688|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
19392889|NCT01970488|41636689|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
19392890|NCT01970488|41636690|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
19392891|NCT01970488|41636691|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
19392892|NCT01970488|41636692|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
19392893|NCT02661217|41636709|FG000|Overall Study|Physician Decision|12|||
19392894|NCT02661217|41636710|FG001|Overall Study|Physician Decision|15|||
19392895|NCT02661217|41636709|FG000|Overall Study|Lost to Follow-up|1|||
19392896|NCT02661217|41636710|FG001|Overall Study|Lost to Follow-up|4|||
19392897|NCT02661217|41636709|FG000|Overall Study|Protocol Deviation|0|||
19392898|NCT02661217|41636710|FG001|Overall Study|Protocol Deviation|4|||
19392899|NCT02661217|41636709|FG000|Overall Study|Non-compliance with study treatment|5|||
19392900|NCT02661217|41636710|FG001|Overall Study|Non-compliance with study treatment|5|||
19392901|NCT02661217|41636709|FG000|Overall Study|Death|21|||
19392902|NCT02661217|41636710|FG001|Overall Study|Death|15|||
19482482|NCT01427803|41764113|FG001|Overall Study|Protocol Violation|0|||
19482483|NCT01427803|41764112|FG000|Overall Study|Physician Decision|3|||
19482484|NCT01427803|41764113|FG001|Overall Study|Physician Decision|0|||
19482485|NCT01427803|41764112|FG000|Overall Study|did not take product|1|||
19482486|NCT01427803|41764113|FG001|Overall Study|did not take product|0|||
19482487|NCT01408537|41764117|FG000|Overall Study|Withdrawal by Subject|2|||
19482488|NCT01408537|41764117|FG000|Overall Study|Protocol Violation|3|||
19482489|NCT01408537|41764117|FG000|Overall Study|Lost to Follow-up|3|||
19482490|NCT01408459|41764150|FG000|Overall Study|Withdrawal by Subject|1|||
19482491|NCT01408459|41764151|FG001|Overall Study|Withdrawal by Subject|1|||
19482492|NCT01408303|41764170|FG000|Overall Study|Adverse Event|3|||
19482493|NCT01408303|41764171|FG001|Overall Study|Adverse Event|7|||
19482494|NCT01408303|41764172|FG002|Overall Study|Adverse Event|2|||
19482495|NCT01408303|41764170|FG000|Overall Study|Lost to Follow-up|0|||
19482496|NCT01408303|41764171|FG001|Overall Study|Lost to Follow-up|1|||
19482497|NCT01408303|41764172|FG002|Overall Study|Lost to Follow-up|2|||
19482498|NCT01408303|41764170|FG000|Overall Study|Withdrawal by Subject|2|||
19482499|NCT01408303|41764171|FG001|Overall Study|Withdrawal by Subject|3|||
19482500|NCT01408303|41764172|FG002|Overall Study|Withdrawal by Subject|1|||
19482501|NCT01408303|41764170|FG000|Overall Study|Protocol Violation|0|||
19482502|NCT01408303|41764171|FG001|Overall Study|Protocol Violation|1|||
19482503|NCT01408303|41764172|FG002|Overall Study|Protocol Violation|0|||
19482504|NCT01408303|41764170|FG000|Overall Study|Noncompliance|1|||
19482505|NCT01408303|41764171|FG001|Overall Study|Noncompliance|0|||
19482506|NCT01408303|41764172|FG002|Overall Study|Noncompliance|1|||
19482507|NCT01408147|41764193|FG000|Overall Study|Withdrawal by Subject|0|||
19482508|NCT01408147|41764194|FG001|Overall Study|Withdrawal by Subject|1|||
19482509|NCT01407367|41764202|FG000|Overall Study|Death|24|||
19482510|NCT01407367|41764203|FG001|Overall Study|Death|32|||
19482511|NCT01407367|41764202|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
19482512|NCT01407367|41764203|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
19482513|NCT01407367|41764202|FG000|Overall Study|Withdrawal by Subject|4|||
19482514|NCT01407367|41764203|FG001|Overall Study|Withdrawal by Subject|15|||
19482515|NCT01407367|41764202|FG000|Overall Study|Lost to Follow-up|0|||
19482516|NCT01407367|41764203|FG001|Overall Study|Lost to Follow-up|2|||
19482517|NCT01405027|41764239|FG000|Overall Study|Withdrawn consent|3|||
19482518|NCT01405027|41764240|FG001|Overall Study|Withdrawn consent|0|||
19482519|NCT01405027|41764239|FG000|Overall Study|Lost to Follow-up|16|||
19482520|NCT01405027|41764240|FG001|Overall Study|Lost to Follow-up|24|||
19482521|NCT01405027|41764239|FG000|Overall Study|Investigator judgement|0|||
19482522|NCT01405027|41764240|FG001|Overall Study|Investigator judgement|2|||
19482523|NCT01405027|41764239|FG000|Overall Study|Death|1|||
19482524|NCT01405027|41764240|FG001|Overall Study|Death|0|||
19482525|NCT01405027|41764239|FG000|Overall Study|Other or Unknown|12|||
19482526|NCT01405027|41764240|FG001|Overall Study|Other or Unknown|25|||
19482527|NCT01412801|41764261|FG000|Overall Study|Death|0|||
19482528|NCT01412801|41764262|FG001|Overall Study|Death|1|||
19482529|NCT01412801|41764263|FG002|Overall Study|Death|0|||
19482530|NCT01412801|41764264|FG003|Overall Study|Death|4|||
19482531|NCT01412801|41764265|FG004|Overall Study|Death|2|||
19704094|NCT00228384|42148406|FG000|Overall Study|Surgical Intervention (bypass)|5|||
19482532|NCT01412801|41764266|FG005|Overall Study|Death|2|||
19482533|NCT01412801|41764261|FG000|Overall Study|Lost to Follow-up|1|||
19392903|NCT02661217|41636709|FG000|Overall Study|Adverse Event|10|||
19392904|NCT02661217|41636710|FG001|Overall Study|Adverse Event|8|||
19392905|NCT02661217|41636709|FG000|Overall Study|Withdrawal by Subject|15|||
19392906|NCT02661217|41636710|FG001|Overall Study|Withdrawal by Subject|19|||
19482534|NCT01412801|41764262|FG001|Overall Study|Lost to Follow-up|2|||
19482535|NCT01412801|41764263|FG002|Overall Study|Lost to Follow-up|4|||
19482536|NCT01412801|41764264|FG003|Overall Study|Lost to Follow-up|0|||
19482537|NCT01412801|41764265|FG004|Overall Study|Lost to Follow-up|1|||
19482538|NCT01412801|41764266|FG005|Overall Study|Lost to Follow-up|1|||
19482539|NCT01412801|41764261|FG000|Overall Study|Withdrawal by Subject|3|||
19482540|NCT01412801|41764262|FG001|Overall Study|Withdrawal by Subject|2|||
19482541|NCT01412801|41764263|FG002|Overall Study|Withdrawal by Subject|1|||
19482542|NCT01412801|41764264|FG003|Overall Study|Withdrawal by Subject|0|||
19482543|NCT01412801|41764265|FG004|Overall Study|Withdrawal by Subject|0|||
19482544|NCT01412801|41764266|FG005|Overall Study|Withdrawal by Subject|0|||
19482545|NCT01412801|41764261|FG000|Overall Study|Relocated to another area|0|||
19482546|NCT01412801|41764262|FG001|Overall Study|Relocated to another area|0|||
19482547|NCT01412801|41764263|FG002|Overall Study|Relocated to another area|2|||
19482548|NCT01412801|41764264|FG003|Overall Study|Relocated to another area|0|||
19482549|NCT01412801|41764265|FG004|Overall Study|Relocated to another area|0|||
19482550|NCT01412801|41764266|FG005|Overall Study|Relocated to another area|0|||
19482551|NCT01525628|41764314|FG000|Overall Study|Adverse Event|1|||
19482552|NCT01525628|41764315|FG001|Overall Study|Adverse Event|1|||
19482553|NCT01525628|41764316|FG002|Overall Study|Adverse Event|2|||
19482554|NCT01525628|41764317|FG003|Overall Study|Adverse Event|0|||
19482555|NCT01525628|41764318|FG004|Overall Study|Adverse Event|1|||
19482556|NCT01525628|41764314|FG000|Overall Study|Lack of Efficacy|0|||
19482557|NCT01525628|41764315|FG001|Overall Study|Lack of Efficacy|2|||
19482558|NCT01525628|41764316|FG002|Overall Study|Lack of Efficacy|2|||
19482559|NCT01525628|41764317|FG003|Overall Study|Lack of Efficacy|1|||
19482560|NCT01525628|41764318|FG004|Overall Study|Lack of Efficacy|2|||
19482561|NCT01525628|41764314|FG000|Overall Study|Protocol Violation|0|||
19482562|NCT01525628|41764315|FG001|Overall Study|Protocol Violation|0|||
19482563|NCT01525628|41764316|FG002|Overall Study|Protocol Violation|1|||
19482564|NCT01525628|41764317|FG003|Overall Study|Protocol Violation|0|||
19482565|NCT01525628|41764318|FG004|Overall Study|Protocol Violation|0|||
19482566|NCT01525628|41764314|FG000|Overall Study|Lost to Follow-up|1|||
19482567|NCT01525628|41764315|FG001|Overall Study|Lost to Follow-up|1|||
19482568|NCT01525628|41764316|FG002|Overall Study|Lost to Follow-up|0|||
19482569|NCT01525628|41764317|FG003|Overall Study|Lost to Follow-up|0|||
19482570|NCT01525628|41764318|FG004|Overall Study|Lost to Follow-up|0|||
19482571|NCT01525628|41764314|FG000|Overall Study|Withdrawal by Subject|0|||
19482572|NCT01525628|41764315|FG001|Overall Study|Withdrawal by Subject|1|||
19482573|NCT01525628|41764316|FG002|Overall Study|Withdrawal by Subject|0|||
19482574|NCT01525628|41764317|FG003|Overall Study|Withdrawal by Subject|0|||
19482575|NCT01525628|41764318|FG004|Overall Study|Withdrawal by Subject|0|||
19482576|NCT01525628|41764314|FG000|Overall Study|Other reason not defined above|0|||
19482577|NCT01525628|41764315|FG001|Overall Study|Other reason not defined above|0|||
19482578|NCT01525628|41764316|FG002|Overall Study|Other reason not defined above|0|||
19482579|NCT01525628|41764317|FG003|Overall Study|Other reason not defined above|3|||
19482580|NCT01525628|41764318|FG004|Overall Study|Other reason not defined above|0|||
19482581|NCT01412021|41764336|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
19482582|NCT01412021|41764336|FG000|Overall Study|Treatment Prior to Approval|3|||
19482583|NCT01412021|41764336|FG000|Overall Study|Transferred to Other Hospital|9|||
19482584|NCT01426789|41764342|FG000|Part 1|Protocol deviation|0|||
19482585|NCT01426789|41764343|FG001|Part 1|Protocol deviation|1|||
19482586|NCT01426789|41764344|FG002|Part 1|Protocol deviation|0|||
19482587|NCT01426789|41764345|FG003|Part 1|Protocol deviation|0|||
19482588|NCT01426789|41764346|FG004|Part 1|Protocol deviation|0|||
19482589|NCT01426789|41764347|FG005|Part 1|Protocol deviation|0|||
19482590|NCT01426789|41764342|FG000|Part 1|Lost to Follow-up|1|||
19482591|NCT01426789|41764343|FG001|Part 1|Lost to Follow-up|2|||
19482592|NCT01426789|41764344|FG002|Part 1|Lost to Follow-up|0|||
19482593|NCT01426789|41764345|FG003|Part 1|Lost to Follow-up|0|||
19482594|NCT01426789|41764346|FG004|Part 1|Lost to Follow-up|0|||
19482595|NCT01426789|41764347|FG005|Part 1|Lost to Follow-up|0|||
19482596|NCT01426789|41764342|FG000|Part 1|Lack of Efficacy|2|||
19482597|NCT01426789|41764343|FG001|Part 1|Lack of Efficacy|1|||
19482598|NCT01426789|41764344|FG002|Part 1|Lack of Efficacy|0|||
19482599|NCT01426789|41764345|FG003|Part 1|Lack of Efficacy|0|||
19482600|NCT01426789|41764346|FG004|Part 1|Lack of Efficacy|0|||
19482601|NCT01426789|41764347|FG005|Part 1|Lack of Efficacy|0|||
19482602|NCT01426789|41764342|FG000|Part 1|Adverse Event|3|||
19482603|NCT01426789|41764343|FG001|Part 1|Adverse Event|0|||
19482604|NCT01426789|41764344|FG002|Part 1|Adverse Event|0|||
19482605|NCT01426789|41764345|FG003|Part 1|Adverse Event|0|||
19482606|NCT01426789|41764346|FG004|Part 1|Adverse Event|0|||
19482607|NCT01426789|41764347|FG005|Part 1|Adverse Event|0|||
19482608|NCT01426789|41764342|FG000|Part 2|Protocol deviation|0|||
19482609|NCT01426789|41764343|FG001|Part 2|Protocol deviation|0|||
19482610|NCT01426789|41764344|FG002|Part 2|Protocol deviation|1|||
19482611|NCT01426789|41764345|FG003|Part 2|Protocol deviation|0|||
19482612|NCT01426789|41764346|FG004|Part 2|Protocol deviation|0|||
19482613|NCT01426789|41764347|FG005|Part 2|Protocol deviation|0|||
19482614|NCT01426789|41764342|FG000|Part 2|Death|0|||
19482615|NCT01426789|41764343|FG001|Part 2|Death|0|||
19482616|NCT01426789|41764344|FG002|Part 2|Death|1|||
19482617|NCT01426789|41764345|FG003|Part 2|Death|0|||
19482618|NCT01426789|41764346|FG004|Part 2|Death|1|||
19482619|NCT01426789|41764347|FG005|Part 2|Death|0|||
19482620|NCT01426789|41764342|FG000|Part 2|Administrative problems|0|||
19482621|NCT01426789|41764343|FG001|Part 2|Administrative problems|0|||
19482622|NCT01426789|41764344|FG002|Part 2|Administrative problems|2|||
19482623|NCT01426789|41764345|FG003|Part 2|Administrative problems|0|||
19482624|NCT01426789|41764346|FG004|Part 2|Administrative problems|1|||
19482625|NCT01426789|41764347|FG005|Part 2|Administrative problems|0|||
19482626|NCT01426789|41764342|FG000|Part 2|Lost to Follow-up|0|||
19482627|NCT01426789|41764343|FG001|Part 2|Lost to Follow-up|0|||
19482628|NCT01426789|41764344|FG002|Part 2|Lost to Follow-up|4|||
19482629|NCT01426789|41764345|FG003|Part 2|Lost to Follow-up|0|||
19482630|NCT01426789|41764346|FG004|Part 2|Lost to Follow-up|1|||
19482631|NCT01426789|41764347|FG005|Part 2|Lost to Follow-up|0|||
19482632|NCT01426789|41764342|FG000|Part 2|Withdrawal by Subject|0|||
19482633|NCT01426789|41764343|FG001|Part 2|Withdrawal by Subject|0|||
19482634|NCT01426789|41764344|FG002|Part 2|Withdrawal by Subject|0|||
19482635|NCT01426789|41764345|FG003|Part 2|Withdrawal by Subject|1|||
19482636|NCT01426789|41764346|FG004|Part 2|Withdrawal by Subject|2|||
19482637|NCT01426789|41764347|FG005|Part 2|Withdrawal by Subject|0|||
19482638|NCT01426789|41764342|FG000|Part 2|Lack of Efficacy|0|||
19482639|NCT01426789|41764343|FG001|Part 2|Lack of Efficacy|0|||
19482640|NCT01426789|41764344|FG002|Part 2|Lack of Efficacy|5|||
19482641|NCT01426789|41764345|FG003|Part 2|Lack of Efficacy|0|||
19482642|NCT01426789|41764346|FG004|Part 2|Lack of Efficacy|2|||
19482643|NCT01426789|41764347|FG005|Part 2|Lack of Efficacy|0|||
19482644|NCT01426789|41764342|FG000|Part 2|Adverse Event|0|||
19482645|NCT01426789|41764343|FG001|Part 2|Adverse Event|0|||
19482646|NCT01426789|41764344|FG002|Part 2|Adverse Event|2|||
19482647|NCT01426789|41764345|FG003|Part 2|Adverse Event|0|||
19482648|NCT01426789|41764346|FG004|Part 2|Adverse Event|1|||
19482649|NCT01426789|41764347|FG005|Part 2|Adverse Event|0|||
19482650|NCT01426009|41764368|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
19482651|NCT01426009|41764368|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
19482652|NCT01426009|41764368|FG000|Washout 1|Withdrawal by Subject|1|||
19482653|NCT01426009|41764368|FG000|Washout 1|Personal Reasons|1|||
19482654|NCT01426009|41764368|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
19482655|NCT01426009|41764368|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
19482656|NCT01426009|41764368|FG000|Washout 2|electrive surgery|1|||
19482657|NCT01426009|41764368|FG000|Washout 3|personal reasons|1|||
19482658|NCT01426009|41764368|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
19482659|NCT01426009|41764368|FG000|Washout 4|Lost to Follow-up|1|||
19482660|NCT01411319|41764397|FG000|Overall Study|Lost to Follow-up|1|||
19482661|NCT01543958|41764401|FG000|Overall Study|Loss to follow-up|3|||
19482662|NCT01543958|41764401|FG000|Overall Study|ART initiation|1|||
19482663|NCT01411085|41764405|FG000|Overall Study|Physician Decision|1|||
19482664|NCT01411085|41764405|FG000|Overall Study|Protocol Violation|1|||
19482665|NCT01411085|41764405|FG000|Overall Study|Adverse Event|1|||
19482666|NCT01543490|41764411|FG000|Overall Study|Adverse Event|4|||
19482667|NCT01543490|41764412|FG001|Overall Study|Adverse Event|0|||
19482668|NCT01543490|41764411|FG000|Overall Study|Physician Decision|1|||
19482669|NCT01543490|41764412|FG001|Overall Study|Physician Decision|0|||
19482670|NCT01543490|41764411|FG000|Overall Study|Lack of Efficacy|3|||
19482671|NCT01543490|41764412|FG001|Overall Study|Lack of Efficacy|3|||
19482672|NCT01543490|41764411|FG000|Overall Study|Lost to Follow-up|5|||
19482673|NCT01543490|41764412|FG001|Overall Study|Lost to Follow-up|0|||
19482674|NCT01543490|41764411|FG000|Overall Study|Withdrawal by Subject|2|||
19482675|NCT01543490|41764412|FG001|Overall Study|Withdrawal by Subject|0|||
19392907|NCT02661217|41636709|FG000|Overall Study|Did not enter follow-up epoch|7|||
19392908|NCT02661217|41636710|FG001|Overall Study|Did not enter follow-up epoch|10|||
19392909|NCT02661217|41636709|FG000|Overall Study|Death - no study drug received|1|||
19392910|NCT02661217|41636710|FG001|Overall Study|Death - no study drug received|2|||
19392911|NCT02661217|41636709|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
19392912|NCT02661217|41636710|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
19392913|NCT01952080|41636721|FG000|Overall Study|Withdrawal by Subject|0|||
19482676|NCT01543490|41764411|FG000|Overall Study|Other-Various Administrative Reasons|1|||
19482677|NCT01543490|41764412|FG001|Overall Study|Other-Various Administrative Reasons|2|||
19482678|NCT01404949|41764418|FG000|Overall Study|Not Treated|1|||
19482679|NCT01431521|41764426|FG000|Overall Study|Withdrawal by Subject|0|||
19482680|NCT01431521|41764427|FG001|Overall Study|Withdrawal by Subject|0|||
19482681|NCT01431521|41764428|FG002|Overall Study|Withdrawal by Subject|1|||
19482682|NCT01431521|41764429|FG003|Overall Study|Withdrawal by Subject|0|||
19482683|NCT01404325|41764514|FG000|Overall Study|Lost to Follow-up|1|||
19482684|NCT01404325|41764515|FG001|Overall Study|Lost to Follow-up|0|||
19482685|NCT01404325|41764514|FG000|Overall Study|Death|2|||
19482686|NCT01404325|41764515|FG001|Overall Study|Death|0|||
19482687|NCT01404325|41764514|FG000|Overall Study|Graft loss/Retransplantation|1|||
19482688|NCT01404325|41764515|FG001|Overall Study|Graft loss/Retransplantation|0|||
19482689|NCT01404325|41764514|FG000|Overall Study|non-specified reason|0|||
19482690|NCT01404325|41764515|FG001|Overall Study|non-specified reason|2|||
19482691|NCT01425463|41764536|FG000|Overall Study|Adverse Event|5|||
19482692|NCT01425463|41764537|FG001|Overall Study|Adverse Event|7|||
19482693|NCT01425463|41764536|FG000|Overall Study|Lack of Efficacy|1|||
19482694|NCT01425463|41764537|FG001|Overall Study|Lack of Efficacy|1|||
19482695|NCT01425463|41764536|FG000|Overall Study|Protocol Violation|2|||
19482696|NCT01425463|41764537|FG001|Overall Study|Protocol Violation|2|||
19482697|NCT01425463|41764536|FG000|Overall Study|Lost to Follow-up|5|||
19482698|NCT01425463|41764537|FG001|Overall Study|Lost to Follow-up|2|||
19482699|NCT01425463|41764536|FG000|Overall Study|Withdrawal by Subject|7|||
19482700|NCT01425463|41764537|FG001|Overall Study|Withdrawal by Subject|5|||
19482701|NCT01425463|41764536|FG000|Overall Study|Unknown Reason|4|||
19482702|NCT01425463|41764537|FG001|Overall Study|Unknown Reason|7|||
19482703|NCT04655586|41764559|FG000|Overall Study|Physician Decision|1|||
19482704|NCT04655586|41764560|FG001|Overall Study|Physician Decision|3|||
19482705|NCT04655586|41764561|FG002|Overall Study|Physician Decision|4|||
19482706|NCT04655586|41764559|FG000|Overall Study|Withdrawal by Subject|1|||
19482707|NCT04655586|41764560|FG001|Overall Study|Withdrawal by Subject|3|||
19482708|NCT04655586|41764561|FG002|Overall Study|Withdrawal by Subject|1|||
19482709|NCT01388647|41764584|FG000|Overall Study|Adverse Event|1|||
19482710|NCT01388647|41764585|FG001|Overall Study|Adverse Event|2|||
19482711|NCT01402063|41764660|FG000|Overall Study|Withdrawal by Subject|3|||
19482712|NCT01402063|41764661|FG001|Overall Study|Withdrawal by Subject|3|||
19482713|NCT01796301|41764669|FG000|Overall Study|Withdrawal by Subject|15|||
19482714|NCT01796301|41764670|FG001|Overall Study|Withdrawal by Subject|15|||
19482715|NCT01796301|41764669|FG000|Overall Study|Lost to Follow-up|3|||
19482716|NCT01796301|41764670|FG001|Overall Study|Lost to Follow-up|3|||
19482717|NCT01796301|41764669|FG000|Overall Study|Death|0|||
19482718|NCT01796301|41764670|FG001|Overall Study|Death|1|||
19482719|NCT01796301|41764669|FG000|Overall Study|Decision by Sponsor|0|||
19482720|NCT01796301|41764670|FG001|Overall Study|Decision by Sponsor|1|||
19482721|NCT01388335|41764689|FG000|Period 1|Progressive Disease|1|||
19482722|NCT01388335|41764689|FG000|Period 2|Progressive Disease|2|||
19482723|NCT01388335|41764689|FG000|Period 2|Sponsor Decision|1|||
19482724|NCT01388335|41764689|FG000|Safety Extension|Progressive Disease|7|||
19482725|NCT01401361|41764745|FG000|Overall Study|Withdrawal by Subject|16|||
19482726|NCT01401361|41764745|FG000|Overall Study|Lack of Efficacy|6|||
19482727|NCT01401361|41764745|FG000|Overall Study|Physician Decision|1|||
19482728|NCT01401361|41764745|FG000|Overall Study|Lost to Follow-up|3|||
19482729|NCT01401361|41764745|FG000|Overall Study|Subject/family decision post procedure|2|||
19482730|NCT01401283|41764751|FG000|Overall Study|surgery cancelled|5|||
19482731|NCT01401283|41764752|FG001|Overall Study|surgery cancelled|8|||
19482732|NCT01401283|41764751|FG000|Overall Study|preoperative arrhythmia|5|||
19482733|NCT01401283|41764752|FG001|Overall Study|preoperative arrhythmia|0|||
19482734|NCT01401283|41764751|FG000|Overall Study|no central venous access|0|||
19482735|NCT01401283|41764752|FG001|Overall Study|no central venous access|1|||
19482736|NCT01401283|41764751|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
19482737|NCT01401283|41764752|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
19482738|NCT01422889|41764775|FG000|Overall Study|No Data Entered for Study Stent|9|||
19482739|NCT01400971|41764779|FG000|Overall Study|Death|82|||
19482740|NCT01400971|41764779|FG000|Overall Study|Lost to Follow-up|196|||
19482741|NCT01400971|41764779|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
19482742|NCT01400971|41764779|FG000|Overall Study|Physician Decision|57|||
19482743|NCT01400971|41764779|FG000|Overall Study|Withdrawal by Subject|158|||
19482744|NCT01400971|41764779|FG000|Overall Study|Other|422|||
19482745|NCT01387789|41764783|FG000|Overall Study|Adverse Event|5|||
19482746|NCT01387789|41764783|FG000|Overall Study|Lack of Efficacy|2|||
19482747|NCT01387789|41764783|FG000|Overall Study|Lost to Follow-up|1|||
19482748|NCT01400893|41764794|FG000|Overall Study|Death|27|||
19482749|NCT01400893|41764795|FG001|Overall Study|Death|21|||
19482750|NCT01400893|41764794|FG000|Overall Study|Lost to Follow-up|0|||
19482751|NCT01400893|41764795|FG001|Overall Study|Lost to Follow-up|6|||
19482752|NCT01400815|41764835|FG000|Overall Study|Adverse Event|3|||
19482753|NCT01400815|41764836|FG001|Overall Study|Adverse Event|0|||
19482754|NCT01400815|41764835|FG000|Overall Study|Death|0|||
19482755|NCT01400815|41764836|FG001|Overall Study|Death|1|||
19482756|NCT01400815|41764835|FG000|Overall Study|Lost to Follow-up|18|||
19482757|NCT01400815|41764836|FG001|Overall Study|Lost to Follow-up|11|||
19482758|NCT01400815|41764835|FG000|Overall Study|Protocol Violation|0|||
19482759|NCT01400815|41764836|FG001|Overall Study|Protocol Violation|1|||
19482760|NCT01400815|41764835|FG000|Overall Study|Physician Decision|1|||
19482761|NCT01400815|41764836|FG001|Overall Study|Physician Decision|0|||
19482762|NCT01400815|41764835|FG000|Overall Study|Withdrawal by Subject|15|||
19482763|NCT01400815|41764836|FG001|Overall Study|Withdrawal by Subject|8|||
19482764|NCT01400815|41764835|FG000|Overall Study|Subject in jail|1|||
19482765|NCT01400815|41764836|FG001|Overall Study|Subject in jail|0|||
19482766|NCT01400503|41764890|FG000|Overall Study|Withdrawal by Subject|1|||
19482767|NCT01400503|41764890|FG000|Overall Study|Study Terminated by Sponsor|58|||
19482768|NCT01400503|41764890|FG000|Overall Study|Other|1|||
19482769|NCT01400425|41764906|FG000|Overall Study|Withdrawal by Subject|10|||
19482770|NCT01421719|41764912|FG000|Overall Study|Withdrawal by Subject|4|||
19482771|NCT01421641|41764919|FG000|Overall Study|Protocol Violation|2|||
19482772|NCT01421641|41764920|FG001|Overall Study|Protocol Violation|2|||
19482773|NCT01385995|41764928|FG000|Period 1, 2 Months|Physician Decision|1|||
19482774|NCT01385995|41764929|FG001|Period 1, 2 Months|Physician Decision|0|||
19482775|NCT01421017|41764940|FG000|Overall Study|Withdrawal by Subject|2|||
19482776|NCT01421017|41764941|FG001|Overall Study|Withdrawal by Subject|0|||
19482777|NCT01421017|41764942|FG002|Overall Study|Withdrawal by Subject|0|||
19482778|NCT01421017|41764940|FG000|Overall Study|POD|0|||
19482779|NCT01421017|41764941|FG001|Overall Study|POD|6|||
19482780|NCT01421017|41764942|FG002|Overall Study|POD|3|||
19482781|NCT01420627|41764989|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
19482782|NCT01400113|41764999|FG000|Overall Study|Withdrawal by Subject|1|||
19482783|NCT01400113|41765000|FG001|Overall Study|Withdrawal by Subject|1|||
19482784|NCT01399723|41765008|FG000|Overall Study|Lost to Follow-up|0|||
19482785|NCT01399723|41765009|FG001|Overall Study|Lost to Follow-up|1|||
19482786|NCT01385371|41765018|FG000|Overall Study|Adverse Event|54|||
19482787|NCT01385371|41765019|FG001|Overall Study|Adverse Event|19|||
19482788|NCT01385371|41765018|FG000|Overall Study|Lost to Follow-up|16|||
19482789|NCT01385371|41765019|FG001|Overall Study|Lost to Follow-up|16|||
19482790|NCT01385371|41765018|FG000|Overall Study|Withdrawal by Subject|52|||
19482791|NCT01385371|41765019|FG001|Overall Study|Withdrawal by Subject|39|||
19482792|NCT01385371|41765018|FG000|Overall Study|Protocol Violation|25|||
19482793|NCT01385371|41765019|FG001|Overall Study|Protocol Violation|21|||
19482794|NCT01385371|41765018|FG000|Overall Study|Administrative|2|||
19482795|NCT01385371|41765019|FG001|Overall Study|Administrative|2|||
19482796|NCT01399099|41765025|FG000|Overall Study|Lost to Follow-up|11|||
19482797|NCT01399099|41765025|FG000|Overall Study|Physician Decision|1|||
19482798|NCT01399099|41765025|FG000|Overall Study|Protocol Violation|1|||
19482799|NCT01399099|41765025|FG000|Overall Study|Skin Irritation|13|||
19482800|NCT01399099|41765025|FG000|Overall Study|Infection|1|||
19482801|NCT01399099|41765025|FG000|Overall Study|Miscellaneous|4|||
19482802|NCT01398787|41765030|FG000|Overall Study|Adverse Event|1|||
19482803|NCT01383499|41765036|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
19482804|NCT01383499|41765037|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19482805|NCT01383499|41765038|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19482806|NCT01383499|41765039|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
19482807|NCT01397461|41765055|FG000|Overall Study|Withdrawal by Subject|2|||
19482808|NCT01397461|41765056|FG001|Overall Study|Withdrawal by Subject|1|||
19482809|NCT01397461|41765057|FG002|Overall Study|Withdrawal by Subject|0|||
19482810|NCT01397461|41765055|FG000|Overall Study|Lost to Follow-up|0|||
19482811|NCT01397461|41765056|FG001|Overall Study|Lost to Follow-up|2|||
19482812|NCT01397461|41765057|FG002|Overall Study|Lost to Follow-up|1|||
19482813|NCT01397461|41765055|FG000|Overall Study|Lack of Efficacy|0|||
19482814|NCT01397461|41765056|FG001|Overall Study|Lack of Efficacy|3|||
19482815|NCT01397461|41765057|FG002|Overall Study|Lack of Efficacy|0|||
19482816|NCT01397461|41765055|FG000|Overall Study|Not treated|0|||
19482817|NCT01397461|41765056|FG001|Overall Study|Not treated|0|||
19482818|NCT01397461|41765057|FG002|Overall Study|Not treated|1|||
19482819|NCT01382251|41765067|FG000|Overall Study|Surgeries cancelled or delayed|16|||
19482820|NCT01382251|41765068|FG001|Overall Study|Surgeries cancelled or delayed|16|||
19482821|NCT01382251|41765067|FG000|Overall Study|Lost to Follow-up|4|||
19482822|NCT01382251|41765068|FG001|Overall Study|Lost to Follow-up|4|||
19482823|NCT01382251|41765067|FG000|Overall Study|Contacted after study closed|1|||
19482824|NCT01382251|41765068|FG001|Overall Study|Contacted after study closed|1|||
19482825|NCT01396525|41765073|FG000|Overall Study|Withdrawal by Subject|8|||
19482826|NCT01396525|41765073|FG000|Overall Study|Death|14|||
19482827|NCT01396525|41765073|FG000|Overall Study|Lost to Follow-up|4|||
19482828|NCT02849652|41765085|FG000|Overall Study|Lost to Follow-up|104|||
19482829|NCT02849652|41765086|FG001|Overall Study|Lost to Follow-up|35|||
19482830|NCT02849652|41765087|FG002|Overall Study|Lost to Follow-up|116|||
19482831|NCT02849652|41765088|FG003|Overall Study|Lost to Follow-up|22|||
19482832|NCT02849652|41765085|FG000|Overall Study|Withdrawal by Subject|10|||
19482833|NCT02849652|41765086|FG001|Overall Study|Withdrawal by Subject|2|||
19482834|NCT02849652|41765087|FG002|Overall Study|Withdrawal by Subject|8|||
19482835|NCT02849652|41765088|FG003|Overall Study|Withdrawal by Subject|4|||
19482836|NCT01396447|41765100|FG000|Overall Study|Did Not Receive Treatment|3|||
19482837|NCT01396447|41765101|FG001|Overall Study|Did Not Receive Treatment|2|||
19482838|NCT01396447|41765102|FG002|Overall Study|Did Not Receive Treatment|1|||
19482839|NCT01396447|41765103|FG003|Overall Study|Did Not Receive Treatment|0|||
19482840|NCT01396447|41765100|FG000|Overall Study|Adverse Event|15|||
19482841|NCT01396447|41765101|FG001|Overall Study|Adverse Event|12|||
19482842|NCT01396447|41765102|FG002|Overall Study|Adverse Event|12|||
19482843|NCT01396447|41765103|FG003|Overall Study|Adverse Event|17|||
19482844|NCT01396447|41765100|FG000|Overall Study|Insufficient Therapeutic Response|5|||
19482845|NCT01396447|41765101|FG001|Overall Study|Insufficient Therapeutic Response|5|||
19482846|NCT01396447|41765102|FG002|Overall Study|Insufficient Therapeutic Response|2|||
19482847|NCT01396447|41765103|FG003|Overall Study|Insufficient Therapeutic Response|4|||
19482848|NCT01396447|41765100|FG000|Overall Study|Protocol Violation|5|||
19482849|NCT01396447|41765101|FG001|Overall Study|Protocol Violation|2|||
19482850|NCT01396447|41765102|FG002|Overall Study|Protocol Violation|3|||
19482851|NCT01396447|41765103|FG003|Overall Study|Protocol Violation|7|||
19482852|NCT01396447|41765100|FG000|Overall Study|Withdrawal of Consent|11|||
19482853|NCT01396447|41765101|FG001|Overall Study|Withdrawal of Consent|9|||
19482854|NCT01396447|41765102|FG002|Overall Study|Withdrawal of Consent|4|||
19482855|NCT01396447|41765103|FG003|Overall Study|Withdrawal of Consent|15|||
19482856|NCT01396447|41765100|FG000|Overall Study|Lost to Follow-up|4|||
19482857|NCT01396447|41765101|FG001|Overall Study|Lost to Follow-up|8|||
19482858|NCT01396447|41765102|FG002|Overall Study|Lost to Follow-up|7|||
19482859|NCT01396447|41765103|FG003|Overall Study|Lost to Follow-up|9|||
19482860|NCT01396447|41765100|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19482861|NCT01396447|41765101|FG001|Overall Study|Other Miscellaneous Reasons|2|||
19482862|NCT01396447|41765102|FG002|Overall Study|Other Miscellaneous Reasons|1|||
19482863|NCT01396447|41765103|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19482864|NCT01678560|41765187|FG000|Overall Study|Physician Decision|4|||
19482865|NCT01678560|41765188|FG001|Overall Study|Physician Decision|4|||
19482866|NCT01678560|41765187|FG000|Overall Study|Death|0|||
19482867|NCT01678560|41765188|FG001|Overall Study|Death|1|||
19482868|NCT01678560|41765187|FG000|Overall Study|Withdrawal by Subject|0|||
19482869|NCT01678560|41765188|FG001|Overall Study|Withdrawal by Subject|1|||
19482870|NCT01381549|41765227|FG000|Overall Study|Ineligible: No organisms isolated|0|||
19482871|NCT01381549|41765228|FG001|Overall Study|Ineligible: No organisms isolated|0|||
19482872|NCT01381549|41765229|FG002|Overall Study|Ineligible: No organisms isolated|1|||
19482873|NCT00159432|41765238|FG000|Overall Study|Adverse Event|1|||
19482874|NCT00159432|41765238|FG000|Overall Study|Death|1|||
19482875|NCT00159432|41765238|FG000|Overall Study|Lack of Efficacy|8|||
19482876|NCT01396057|41765244|FG000|Overall Study|Adverse Event|2|||
19482877|NCT01396057|41765245|FG001|Overall Study|Adverse Event|6|||
19482878|NCT01396057|41765244|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19482879|NCT01396057|41765245|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
19482880|NCT01396057|41765244|FG000|Overall Study|Protocol deviation|4|||
19482881|NCT01396057|41765245|FG001|Overall Study|Protocol deviation|4|||
19482882|NCT01396057|41765244|FG000|Overall Study|Consent withdrawn|3|||
19482883|NCT01396057|41765245|FG001|Overall Study|Consent withdrawn|2|||
19482884|NCT01380769|41765262|FG000|Overall Study|Withdrawal by Subject|7|||
19482885|NCT01380769|41765263|FG001|Overall Study|Withdrawal by Subject|11|||
19392914|NCT01952080|41636722|FG001|Overall Study|Withdrawal by Subject|0|||
19392915|NCT01952080|41636723|FG002|Overall Study|Withdrawal by Subject|0|||
19392916|NCT01952080|41636724|FG003|Overall Study|Withdrawal by Subject|1|||
19482886|NCT01380769|41765262|FG000|Overall Study|Physician Decision|1|||
19482887|NCT01380769|41765263|FG001|Overall Study|Physician Decision|1|||
19482888|NCT01380769|41765262|FG000|Overall Study|Adverse Event|1|||
19482889|NCT01380769|41765263|FG001|Overall Study|Adverse Event|1|||
19482890|NCT01380769|41765262|FG000|Overall Study|Protocol Violation|0|||
19392917|NCT01952080|41636721|FG000|Overall Study|Protocol Non-compliance|0|||
19392918|NCT01952080|41636722|FG001|Overall Study|Protocol Non-compliance|1|||
19392919|NCT01952080|41636723|FG002|Overall Study|Protocol Non-compliance|0|||
19392920|NCT01952080|41636724|FG003|Overall Study|Protocol Non-compliance|0|||
19482891|NCT01380769|41765263|FG001|Overall Study|Protocol Violation|1|||
19392921|NCT01951378|41636736|FG000|Overall Study|Study Terminated-Not completed|23|||
19482892|NCT01395901|41765271|FG000|Overall Study|Lost to Follow-up|4|||
19482893|NCT01395901|41765272|FG001|Overall Study|Lost to Follow-up|0|||
19392922|NCT01951378|41636737|FG001|Overall Study|Study Terminated-Not completed|17|||
19392923|NCT01944670|41636743|FG000|Overall Study|Lost to Follow-up|2|||
19392924|NCT01361009|41636751|FG000|Overall Study|Protocol Violation|116|||
19392925|NCT01944046|41636757|FG000|Randomized to DB|Adverse Event|5|||
19392926|NCT01944046|41636758|FG001|Randomized to DB|Adverse Event|2|||
19392927|NCT01944046|41636757|FG000|Randomized to DB|Clinical Worsening|3|||
19392928|NCT01944046|41636758|FG001|Randomized to DB|Clinical Worsening|2|||
19392929|NCT01944046|41636757|FG000|Randomized to DB|Lost to Follow-up|3|||
19392930|NCT01944046|41636758|FG001|Randomized to DB|Lost to Follow-up|3|||
19392931|NCT01944046|41636757|FG000|Randomized to DB|Withdrawal by Subject|2|||
19392932|NCT01944046|41636758|FG001|Randomized to DB|Withdrawal by Subject|4|||
19392933|NCT01944046|41636757|FG000|Randomized to DB|Physician Decision|1|||
19392934|NCT01944046|41636758|FG001|Randomized to DB|Physician Decision|2|||
19392935|NCT01944046|41636757|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
19392936|NCT01944046|41636758|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
19392937|NCT01944046|41636757|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
19392938|NCT01944046|41636758|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
19482894|NCT01395901|41765271|FG000|Overall Study|Randomized but not received study drug|5|||
19482895|NCT01395901|41765272|FG001|Overall Study|Randomized but not received study drug|4|||
19482896|NCT01395901|41765271|FG000|Overall Study|Adverse Event|0|||
19482897|NCT01395901|41765272|FG001|Overall Study|Adverse Event|1|||
19482898|NCT01395901|41765271|FG000|Overall Study|Withdrawal of consent|1|||
19482899|NCT01395901|41765272|FG001|Overall Study|Withdrawal of consent|0|||
19482900|NCT01395823|41765280|FG000|Overall Study|Death|4|||
19482901|NCT01395823|41765281|FG001|Overall Study|Death|4|||
19482902|NCT01395823|41765280|FG000|Overall Study|Physician Decision|3|||
19482903|NCT01395823|41765281|FG001|Overall Study|Physician Decision|1|||
19482904|NCT01395823|41765280|FG000|Overall Study|Lost to Follow-up|1|||
19482905|NCT01395823|41765281|FG001|Overall Study|Lost to Follow-up|0|||
19482906|NCT01395823|41765280|FG000|Overall Study|Transplant|1|||
19482907|NCT01395823|41765281|FG001|Overall Study|Transplant|0|||
19482908|NCT01395823|41765280|FG000|Overall Study|GI symptoms|1|||
19482909|NCT01395823|41765281|FG001|Overall Study|GI symptoms|0|||
19482910|NCT01395823|41765280|FG000|Overall Study|Withdrawal by Subject|5|||
19482911|NCT01395823|41765281|FG001|Overall Study|Withdrawal by Subject|4|||
19482912|NCT00158184|41765289|FG000|Overall Study|personal issues|3|||
19482913|NCT00158184|41765290|FG001|Overall Study|personal issues|1|||
19482914|NCT00158184|41765289|FG000|Overall Study|failed for follow unit/study rules|2|||
19482915|NCT00158184|41765290|FG001|Overall Study|failed for follow unit/study rules|0|||
19482916|NCT00158184|41765289|FG000|Overall Study|Adverse Event|1|||
19482917|NCT00158184|41765290|FG001|Overall Study|Adverse Event|1|||
19482918|NCT01380691|41765298|FG000|Washout (7 Days)|Protocol Violation|0|||
19482919|NCT01380691|41765299|FG001|Washout (7 Days)|Protocol Violation|0|||
19482920|NCT01380691|41765300|FG002|Washout (7 Days)|Protocol Violation|0|||
19482921|NCT01380691|41765301|FG003|Washout (7 Days)|Protocol Violation|1|||
19482922|NCT01380691|41765298|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
19482923|NCT01380691|41765299|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
19482924|NCT01380691|41765300|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
19482925|NCT01380691|41765301|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
19482926|NCT01380535|41765327|FG000|Overall Study|Adverse Event|3|||
19482927|NCT01380535|41765328|FG001|Overall Study|Adverse Event|3|||
19482928|NCT01380535|41765327|FG000|Overall Study|Death|3|||
19482929|NCT01380535|41765328|FG001|Overall Study|Death|0|||
19482930|NCT01380535|41765327|FG000|Overall Study|Study site closed|0|||
19482931|NCT01380535|41765328|FG001|Overall Study|Study site closed|5|||
19482932|NCT01380535|41765327|FG000|Overall Study|Withdrawal by Subject|1|||
19482933|NCT01380535|41765328|FG001|Overall Study|Withdrawal by Subject|2|||
19482934|NCT01380535|41765327|FG000|Overall Study|Protocol Violation|0|||
19482935|NCT01380535|41765328|FG001|Overall Study|Protocol Violation|2|||
19482936|NCT01380535|41765327|FG000|Overall Study|Lack of Efficacy|0|||
19482937|NCT01380535|41765328|FG001|Overall Study|Lack of Efficacy|3|||
19482938|NCT01380379|41765338|FG000|Overall Study|Pregnancy|1|||
19482939|NCT01380145|41765342|FG000|Overall Study|Progressive disease|4|||
19482940|NCT03420222|41765368|FG000|Overall Study|Withdrawal by Subject|5|||
19482941|NCT03420222|41765369|FG001|Overall Study|Withdrawal by Subject|0|||
19482942|NCT03420222|41765368|FG000|Overall Study|Physician Decision|0|||
19482943|NCT03420222|41765369|FG001|Overall Study|Physician Decision|1|||
19482944|NCT01394185|41765375|FG000|Overall Study|Withdrawal by Subject|2|||
19612456|NCT00811473|42061310|FG001|Overall Study|Lack of therapeutic response|1|||
19392939|NCT01944046|41636757|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
19392940|NCT01944046|41636758|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
19392941|NCT01944046|41636757|FG000|Open Label Eligible and Consented|Adverse Event|6|||
19482945|NCT01394185|41765376|FG001|Overall Study|Withdrawal by Subject|0|||
19482946|NCT01394185|41765377|FG002|Overall Study|Withdrawal by Subject|0|||
19482947|NCT01394185|41765378|FG003|Overall Study|Withdrawal by Subject|0|||
19392942|NCT01944046|41636758|FG001|Open Label Eligible and Consented|Adverse Event|1|||
19482948|NCT01394185|41765379|FG004|Overall Study|Withdrawal by Subject|1|||
19392943|NCT01944046|41636757|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
19392944|NCT01944046|41636758|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
19392945|NCT01944046|41636757|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
19392946|NCT01944046|41636758|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
19392947|NCT01969084|41636770|FG000|Overall Study|Adverse Event|0|||
19392948|NCT01969084|41636771|FG001|Overall Study|Adverse Event|1|||
19392949|NCT01942486|41636781|FG000|Overall Study|Lost to Follow-up|27|||
19392950|NCT01941940|41636785|FG000|Overall Study|Adverse Event|11|||
19392951|NCT01941940|41636785|FG000|Overall Study|Lost to Follow-up|2|||
19392952|NCT01941940|41636785|FG000|Overall Study|Physician Decision|2|||
19392953|NCT01941940|41636785|FG000|Overall Study|Withdrawal by Subject|15|||
19482949|NCT01394185|41765380|FG005|Overall Study|Withdrawal by Subject|0|||
19482950|NCT01394185|41765375|FG000|Overall Study|Change in protocol|3|||
19482951|NCT01394185|41765376|FG001|Overall Study|Change in protocol|0|||
19482952|NCT01394185|41765377|FG002|Overall Study|Change in protocol|0|||
19482953|NCT01394185|41765378|FG003|Overall Study|Change in protocol|0|||
19482954|NCT01394185|41765379|FG004|Overall Study|Change in protocol|3|||
19482955|NCT01394185|41765380|FG005|Overall Study|Change in protocol|0|||
19482956|NCT01394185|41765375|FG000|Overall Study|Protocol Violation|1|||
19482957|NCT01394185|41765376|FG001|Overall Study|Protocol Violation|0|||
19482958|NCT01394185|41765377|FG002|Overall Study|Protocol Violation|0|||
19482959|NCT01394185|41765378|FG003|Overall Study|Protocol Violation|1|||
19482960|NCT01394185|41765379|FG004|Overall Study|Protocol Violation|0|||
19482961|NCT01394185|41765380|FG005|Overall Study|Protocol Violation|1|||
19482962|NCT01677936|41765413|FG000|Overall Study|Lost to Follow-up|4|||
19482963|NCT01677936|41765414|FG001|Overall Study|Lost to Follow-up|1|||
19482964|NCT01677936|41765413|FG000|Overall Study|Protocol Violation|3|||
19482965|NCT01677936|41765414|FG001|Overall Study|Protocol Violation|0|||
19482966|NCT01677936|41765413|FG000|Overall Study|Adverse Event|1|||
19482967|NCT01677936|41765414|FG001|Overall Study|Adverse Event|0|||
19482968|NCT01677936|41765413|FG000|Overall Study|Lost to Follow-up|1|||
19482969|NCT01677936|41765414|FG001|Overall Study|Lost to Follow-up|0|||
19482970|NCT01677936|41765413|FG000|Overall Study|Protocol Violation|0|||
19482971|NCT01677936|41765414|FG001|Overall Study|Protocol Violation|4|||
19482972|NCT01525550|41765445|FG000|Overall Study|Lost to Follow-up|8|||
19482973|NCT01525550|41765446|FG001|Overall Study|Lost to Follow-up|2|||
19482974|NCT01525550|41765445|FG000|Overall Study|Death|19|||
19482975|NCT01525550|41765446|FG001|Overall Study|Death|28|||
19482976|NCT01525550|41765445|FG000|Overall Study|Other|0|||
19392954|NCT01941940|41636785|FG000|Overall Study|Death|1|||
19392955|NCT01941940|41636785|FG000|Overall Study|Other|1|||
19392956|NCT01941940|41636785|FG000|Overall Study|Other|1|||
19392957|NCT01968694|41636791|FG000|Washout (1 Month)|Lost to Follow-up|0|||
19392958|NCT01968694|41636792|FG001|Washout (1 Month)|Lost to Follow-up|1|||
19392959|NCT01968226|41636800|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
19392960|NCT02640053|41636806|FG000|Overall Study|Withdrawal by Subject|2|||
19392961|NCT02640053|41636807|FG001|Overall Study|Withdrawal by Subject|1|||
19392962|NCT02640053|41636806|FG000|Overall Study|Adverse Event|1|||
19392963|NCT02640053|41636807|FG001|Overall Study|Adverse Event|1|||
19482977|NCT01525550|41765446|FG001|Overall Study|Other|4|||
19482978|NCT01525550|41765445|FG000|Overall Study|Sponsor's Decision|30|||
19482979|NCT01525550|41765446|FG001|Overall Study|Sponsor's Decision|11|||
19392964|NCT02640053|41636806|FG000|Overall Study|Alternative Therapy|1|||
19482980|NCT01525550|41765445|FG000|Overall Study|Withdrawal by Subject|4|||
19482981|NCT01525550|41765446|FG001|Overall Study|Withdrawal by Subject|0|||
19482982|NCT00211237|41765458|FG000|Baseline|Withdrew|1|||
19482983|NCT00211237|41765459|FG001|Baseline|Withdrew|3|||
19482984|NCT00211237|41765460|FG002|Baseline|Withdrew|0|||
19482985|NCT00211237|41765458|FG000|Baseline|Refused random assignment|1|||
19482986|NCT00211237|41765459|FG001|Baseline|Refused random assignment|0|||
19482987|NCT00211237|41765460|FG002|Baseline|Refused random assignment|0|||
19482988|NCT00211237|41765458|FG000|1 Month|Death|2|||
19482989|NCT00211237|41765459|FG001|1 Month|Death|1|||
19482990|NCT00211237|41765460|FG002|1 Month|Death|0|||
19482991|NCT00211237|41765458|FG000|1 Month|Lost to Follow-up|0|||
19482992|NCT00211237|41765459|FG001|1 Month|Lost to Follow-up|2|||
19482993|NCT00211237|41765460|FG002|1 Month|Lost to Follow-up|0|||
19704095|NCT00228384|42148407|FG001|Overall Study|Surgical Intervention (bypass)|5|||
19392965|NCT02640053|41636807|FG001|Overall Study|Alternative Therapy|1|||
19392966|NCT02640053|41636806|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
19392967|NCT02640053|41636807|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
19392968|NCT01950364|41636815|FG000|Overall Study|Adverse Event|3|||
19392969|NCT01950364|41636816|FG001|Overall Study|Adverse Event|0|||
19392970|NCT01950364|41636815|FG000|Overall Study|Stem Cell Transplant|2|||
19392971|NCT01950364|41636816|FG001|Overall Study|Stem Cell Transplant|6|||
19392972|NCT01950364|41636815|FG000|Overall Study|Disease Progression|5|||
19482994|NCT00211237|41765458|FG000|1 Month|Withdrew|0|||
19482995|NCT00211237|41765459|FG001|1 Month|Withdrew|4|||
19482996|NCT00211237|41765460|FG002|1 Month|Withdrew|0|||
19482997|NCT00211237|41765458|FG000|1 Month|Additional surgery needed|1|||
19482998|NCT00211237|41765459|FG001|1 Month|Additional surgery needed|0|||
19392973|NCT01950364|41636816|FG001|Overall Study|Disease Progression|2|||
19392974|NCT01950364|41636815|FG000|Overall Study|Withdrawal by Subject|0|||
19392975|NCT01950364|41636816|FG001|Overall Study|Withdrawal by Subject|1|||
19482999|NCT00211237|41765460|FG002|1 Month|Additional surgery needed|0|||
19483000|NCT00211237|41765458|FG000|1 Month|Non-medical problem|0|||
19483001|NCT00211237|41765459|FG001|1 Month|Non-medical problem|2|||
19483002|NCT00211237|41765460|FG002|1 Month|Non-medical problem|0|||
19483003|NCT00211237|41765458|FG000|3 Months|Death|7|||
19483004|NCT00211237|41765459|FG001|3 Months|Death|3|||
19483005|NCT00211237|41765460|FG002|3 Months|Death|0|||
19483006|NCT00211237|41765458|FG000|3 Months|Could not comply with protocol|1|||
19483007|NCT00211237|41765459|FG001|3 Months|Could not comply with protocol|0|||
19483008|NCT00211237|41765460|FG002|3 Months|Could not comply with protocol|0|||
19483009|NCT00211237|41765458|FG000|3 Months|Withdrew|0|||
19483010|NCT00211237|41765459|FG001|3 Months|Withdrew|1|||
19483011|NCT00211237|41765460|FG002|3 Months|Withdrew|0|||
19483012|NCT00211237|41765458|FG000|3 Months|Non-medical problem|0|||
19483013|NCT00211237|41765459|FG001|3 Months|Non-medical problem|0|||
19483014|NCT00211237|41765460|FG002|3 Months|Non-medical problem|1|||
19483015|NCT00211237|41765458|FG000|6 Months|Death|6|||
19483016|NCT00211237|41765459|FG001|6 Months|Death|0|||
19483017|NCT00211237|41765460|FG002|6 Months|Death|3|||
19483018|NCT00211237|41765458|FG000|6 Months|Lost to Follow-up|2|||
19483019|NCT00211237|41765459|FG001|6 Months|Lost to Follow-up|0|||
19483020|NCT00211237|41765460|FG002|6 Months|Lost to Follow-up|0|||
19483021|NCT00211237|41765458|FG000|6 Months|Could not comply with protocol|0|||
19483022|NCT00211237|41765459|FG001|6 Months|Could not comply with protocol|2|||
19483023|NCT00211237|41765460|FG002|6 Months|Could not comply with protocol|0|||
19483024|NCT00211237|41765458|FG000|12 Months|Death|8|||
19483025|NCT00211237|41765459|FG001|12 Months|Death|2|||
19483026|NCT00211237|41765460|FG002|12 Months|Death|3|||
19483027|NCT00211237|41765458|FG000|12 Months|Lost to Follow-up|1|||
19483028|NCT00211237|41765459|FG001|12 Months|Lost to Follow-up|0|||
19483029|NCT00211237|41765460|FG002|12 Months|Lost to Follow-up|1|||
19483030|NCT00211237|41765458|FG000|12 Months|Withdrew|0|||
19392976|NCT01950364|41636815|FG000|Overall Study|Protocol Violation|0|||
19392977|NCT01950364|41636816|FG001|Overall Study|Protocol Violation|1|||
19392978|NCT01968070|41636840|FG000|Period 1|Withdrawal by Subject|0|||
19392979|NCT01968070|41636841|FG001|Period 1|Withdrawal by Subject|1|||
19392980|NCT01968070|41636842|FG002|Period 1|Withdrawal by Subject|0|||
19392981|NCT01968070|41636843|FG003|Period 1|Withdrawal by Subject|0|||
19392982|NCT01968070|41636844|FG004|Period 1|Withdrawal by Subject|0|||
19392983|NCT01968070|41636845|FG005|Period 1|Withdrawal by Subject|0|||
19483031|NCT00211237|41765459|FG001|12 Months|Withdrew|0|||
19483032|NCT00211237|41765460|FG002|12 Months|Withdrew|1|||
19483033|NCT00211237|41765458|FG000|12 Months|unrelated medical problem|0|||
19483034|NCT00211237|41765459|FG001|12 Months|unrelated medical problem|0|||
19483035|NCT00211237|41765460|FG002|12 Months|unrelated medical problem|1|||
19483036|NCT01489358|41765480|FG000|Overall Study|Lost to Follow-up|0|||
19483037|NCT01489358|41765481|FG001|Overall Study|Lost to Follow-up|0|||
19483038|NCT01489358|41765482|FG002|Overall Study|Lost to Follow-up|2|||
19483039|NCT01525238|41765493|FG000|Overall Study|Withdrawal by Subject|1|||
19483040|NCT01525238|41765494|FG001|Overall Study|Withdrawal by Subject|0|||
19483041|NCT01525238|41765495|FG002|Overall Study|Withdrawal by Subject|0|||
19483042|NCT01525082|41765516|FG000|Overall Study|Death|1|||
19483043|NCT01488578|41765523|FG000|Overall Study|Protocol Violation|1836|||
19483044|NCT01524770|41765564|FG000|First Intervention|Withdrawal by Subject|1|||
19483045|NCT01524770|41765565|FG001|First Intervention|Withdrawal by Subject|0|||
19483046|NCT01524770|41765564|FG000|First Intervention|Adverse Event|1|||
19483047|NCT01524770|41765565|FG001|First Intervention|Adverse Event|1|||
19483048|NCT01524770|41765564|FG000|First Intervention|Protocol Violation|1|||
19483049|NCT01524770|41765565|FG001|First Intervention|Protocol Violation|0|||
19483050|NCT01524692|41765571|FG000|Overall Study|Withdrawal by Subject|3|||
19483051|NCT01431287|41765590|FG000|Overall Study|not treated|0|||
19483052|NCT01431287|41765591|FG001|Overall Study|not treated|0|||
19483053|NCT01431287|41765592|FG002|Overall Study|not treated|1|||
19483054|NCT01431287|41765593|FG003|Overall Study|not treated|0|||
19483055|NCT01431287|41765594|FG004|Overall Study|not treated|0|||
19483056|NCT01431287|41765590|FG000|Overall Study|Adverse Event|59|||
19483057|NCT01431287|41765591|FG001|Overall Study|Adverse Event|57|||
19392984|NCT01968070|41636846|FG006|Period 1|Withdrawal by Subject|1|||
19392985|NCT01968070|41636847|FG007|Period 1|Withdrawal by Subject|0|||
19392986|NCT01968070|41636848|FG008|Period 1|Withdrawal by Subject|0|||
19392987|NCT01968070|41636849|FG009|Period 1|Withdrawal by Subject|0|||
19483058|NCT01431287|41765592|FG002|Overall Study|Adverse Event|53|||
19483059|NCT01431287|41765593|FG003|Overall Study|Adverse Event|33|||
19483060|NCT01431287|41765594|FG004|Overall Study|Adverse Event|41|||
19483061|NCT01431287|41765590|FG000|Overall Study|Non compliant with protocol|6|||
19483062|NCT01431287|41765591|FG001|Overall Study|Non compliant with protocol|6|||
19483063|NCT01431287|41765592|FG002|Overall Study|Non compliant with protocol|5|||
19483064|NCT01431287|41765593|FG003|Overall Study|Non compliant with protocol|6|||
19483065|NCT01431287|41765594|FG004|Overall Study|Non compliant with protocol|5|||
19483066|NCT01431287|41765590|FG000|Overall Study|Lost to Follow-up|0|||
19483067|NCT01431287|41765591|FG001|Overall Study|Lost to Follow-up|3|||
19483068|NCT01431287|41765592|FG002|Overall Study|Lost to Follow-up|2|||
19483069|NCT01431287|41765593|FG003|Overall Study|Lost to Follow-up|3|||
19483070|NCT01431287|41765594|FG004|Overall Study|Lost to Follow-up|1|||
19483071|NCT01431287|41765590|FG000|Overall Study|Consent withdrawn not due to AE|29|||
19483072|NCT01431287|41765591|FG001|Overall Study|Consent withdrawn not due to AE|30|||
19483073|NCT01431287|41765592|FG002|Overall Study|Consent withdrawn not due to AE|34|||
19483074|NCT01431287|41765593|FG003|Overall Study|Consent withdrawn not due to AE|19|||
19483075|NCT01431287|41765594|FG004|Overall Study|Consent withdrawn not due to AE|29|||
19483076|NCT01431287|41765590|FG000|Overall Study|not stated above|4|||
19483077|NCT01431287|41765591|FG001|Overall Study|not stated above|2|||
19483078|NCT01431287|41765592|FG002|Overall Study|not stated above|2|||
19483079|NCT01431287|41765593|FG003|Overall Study|not stated above|2|||
19483080|NCT01431287|41765594|FG004|Overall Study|not stated above|1|||
19483081|NCT01274715|41765640|FG000|Overall Study|Lost to Follow-up|1|||
19483082|NCT01274715|41765640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
19483083|NCT01274715|41765640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
19483084|NCT01274715|41765640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
19483085|NCT01410227|41765644|FG000|Overall Study|Adverse Event|1|||
19483086|NCT01410227|41765645|FG001|Overall Study|Adverse Event|0|||
19483087|NCT01410227|41765646|FG002|Overall Study|Adverse Event|0|||
19483088|NCT01410227|41765647|FG003|Overall Study|Adverse Event|0|||
19483089|NCT01410227|41765644|FG000|Overall Study|Withdrawal by Subject|3|||
19483090|NCT01410227|41765645|FG001|Overall Study|Withdrawal by Subject|0|||
19483091|NCT01410227|41765646|FG002|Overall Study|Withdrawal by Subject|1|||
19483092|NCT01410227|41765647|FG003|Overall Study|Withdrawal by Subject|0|||
19483093|NCT01410227|41765644|FG000|Overall Study|Pregnancy|0|||
19483094|NCT01410227|41765645|FG001|Overall Study|Pregnancy|0|||
19483095|NCT01410227|41765646|FG002|Overall Study|Pregnancy|0|||
19483096|NCT01410227|41765647|FG003|Overall Study|Pregnancy|1|||
19483097|NCT01410227|41765644|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
19483098|NCT01410227|41765645|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
19483099|NCT01410227|41765646|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
19483100|NCT01410227|41765647|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
19483101|NCT01274559|41765659|FG000|Overall Study|Adverse Event|57|||
19483102|NCT01274559|41765660|FG001|Overall Study|Adverse Event|13|||
19483103|NCT01274559|41765659|FG000|Overall Study|Death|1|||
19392988|NCT01968070|41636850|FG010|Period 1|Withdrawal by Subject|0|||
19392989|NCT01968070|41636851|FG011|Period 1|Withdrawal by Subject|0|||
19392990|NCT01968070|41636852|FG012|Period 1|Withdrawal by Subject|0|||
19392991|NCT01968070|41636853|FG013|Period 1|Withdrawal by Subject|0|||
19392992|NCT01968070|41636854|FG014|Period 1|Withdrawal by Subject|0|||
19392993|NCT01968070|41636855|FG015|Period 1|Withdrawal by Subject|1|||
19392994|NCT01968070|41636856|FG016|Period 1|Withdrawal by Subject|0|||
19483104|NCT01274559|41765660|FG001|Overall Study|Death|1|||
19483105|NCT01274559|41765659|FG000|Overall Study|Lost to Follow-up|3|||
19483106|NCT01274559|41765660|FG001|Overall Study|Lost to Follow-up|3|||
19483107|NCT01274559|41765659|FG000|Overall Study|Non-compliance with Study Drug|2|||
19483108|NCT01274559|41765660|FG001|Overall Study|Non-compliance with Study Drug|4|||
19483109|NCT01274559|41765659|FG000|Overall Study|Physician Decision|2|||
19483110|NCT01274559|41765660|FG001|Overall Study|Physician Decision|1|||
19483111|NCT01274559|41765659|FG000|Overall Study|Protocol Violation|28|||
19483112|NCT01274559|41765660|FG001|Overall Study|Protocol Violation|23|||
19483113|NCT01274559|41765659|FG000|Overall Study|Study Terminated by Sponsor|79|||
19483114|NCT01274559|41765660|FG001|Overall Study|Study Terminated by Sponsor|87|||
19483115|NCT01274559|41765659|FG000|Overall Study|Withdrawal by Subject|25|||
19483116|NCT01274559|41765660|FG001|Overall Study|Withdrawal by Subject|13|||
19483117|NCT01409993|41765668|FG000|Overall Study|Adverse Event|4|||
19483118|NCT01409993|41765669|FG001|Overall Study|Adverse Event|4|||
19483119|NCT01409993|41765670|FG002|Overall Study|Adverse Event|3|||
19483120|NCT01409993|41765671|FG003|Overall Study|Adverse Event|1|||
19483121|NCT01409993|41765668|FG000|Overall Study|Withdrawal by Subject|0|||
19483122|NCT01409993|41765669|FG001|Overall Study|Withdrawal by Subject|0|||
19483123|NCT01409993|41765670|FG002|Overall Study|Withdrawal by Subject|0|||
19483124|NCT01409993|41765671|FG003|Overall Study|Withdrawal by Subject|4|||
19483125|NCT01409993|41765668|FG000|Overall Study|Lost to Follow-up|0|||
19483126|NCT01409993|41765669|FG001|Overall Study|Lost to Follow-up|1|||
19483127|NCT01409993|41765670|FG002|Overall Study|Lost to Follow-up|0|||
19483128|NCT01409993|41765671|FG003|Overall Study|Lost to Follow-up|0|||
19483129|NCT01273623|41765685|FG000|Overall Study|did not meet IVUS criteria|29|||
19483130|NCT01409915|41765693|FG000|Overall Study|Adverse Event|0|||
19392995|NCT01968070|41636857|FG017|Period 1|Withdrawal by Subject|0|||
19392996|NCT01968070|41636840|FG000|Period 1|Protocol Violation|0|||
19483131|NCT01409915|41765694|FG001|Overall Study|Adverse Event|2|||
19483132|NCT01409915|41765693|FG000|Overall Study|Withdrawal by Subject|0|||
19483133|NCT01409915|41765694|FG001|Overall Study|Withdrawal by Subject|1|||
19483134|NCT01409915|41765693|FG000|Overall Study|Protocol Violation|1|||
19483135|NCT01409915|41765694|FG001|Overall Study|Protocol Violation|0|||
19483136|NCT01272921|41765702|FG000|Overall Study|Protocol Violation|2|||
19483137|NCT01272921|41765703|FG001|Overall Study|Protocol Violation|1|||
19483138|NCT01409837|41765713|FG000|Overall Study|Withdrawal by Subject|2|||
19483139|NCT01409837|41765714|FG001|Overall Study|Withdrawal by Subject|1|||
19483140|NCT01409837|41765713|FG000|Overall Study|Lost to Follow-up|1|||
19483141|NCT01409837|41765714|FG001|Overall Study|Lost to Follow-up|0|||
19483142|NCT01409837|41765713|FG000|Overall Study|Physician Decision|0|||
19483143|NCT01409837|41765714|FG001|Overall Study|Physician Decision|1|||
19483144|NCT01430585|41765733|FG000|Overall Study|Death|1|||
19483145|NCT01430585|41765733|FG000|Overall Study|Objective Progression or Relapse|3|||
19483146|NCT01430585|41765733|FG000|Overall Study|Study Terminated by Sponsor|3|||
19483147|NCT01430585|41765733|FG000|Overall Study|Other|7|||
19483148|NCT01408901|41765756|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
19483149|NCT01408901|41765757|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
19483150|NCT01408901|41765758|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
19483151|NCT01408901|41765759|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
19483152|NCT01408901|41765756|FG000|6-Week Follow-Up|Death|1|||
19483153|NCT01408901|41765757|FG001|6-Week Follow-Up|Death|0|||
19483154|NCT01408901|41765758|FG002|6-Week Follow-Up|Death|0|||
19483155|NCT01408901|41765759|FG003|6-Week Follow-Up|Death|0|||
19483156|NCT01408901|41765756|FG000|6-Week Follow-Up|Cancelled visit|0|||
19483157|NCT01408901|41765757|FG001|6-Week Follow-Up|Cancelled visit|1|||
19483158|NCT01408901|41765758|FG002|6-Week Follow-Up|Cancelled visit|0|||
19483159|NCT01408901|41765759|FG003|6-Week Follow-Up|Cancelled visit|2|||
19483160|NCT01408901|41765756|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
19483161|NCT01408901|41765757|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
19483162|NCT01408901|41765758|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
19483163|NCT01408901|41765759|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
19483164|NCT01408901|41765756|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
19483165|NCT01408901|41765757|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
19483166|NCT01408901|41765758|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
19483167|NCT01408901|41765759|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
19483168|NCT01408901|41765756|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
19483169|NCT01408901|41765757|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
19483170|NCT01408901|41765758|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
19483171|NCT01408901|41765759|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
19483172|NCT01408901|41765756|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
19483173|NCT01408901|41765757|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
19483174|NCT01408901|41765758|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
19483175|NCT01408901|41765759|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
19483176|NCT01408901|41765756|FG000|26-Week Follow-Up|Death|0|||
19483177|NCT01408901|41765757|FG001|26-Week Follow-Up|Death|1|||
19392997|NCT01968070|41636841|FG001|Period 1|Protocol Violation|0|||
19392998|NCT01968070|41636842|FG002|Period 1|Protocol Violation|0|||
19392999|NCT01968070|41636843|FG003|Period 1|Protocol Violation|1|||
19483178|NCT01408901|41765758|FG002|26-Week Follow-Up|Death|0|||
19483179|NCT01408901|41765759|FG003|26-Week Follow-Up|Death|0|||
19483180|NCT01428713|41765775|FG000|Overall Study|Non-compliance|2|||
19393000|NCT01968070|41636844|FG004|Period 1|Protocol Violation|1|||
19393001|NCT01968070|41636845|FG005|Period 1|Protocol Violation|0|||
19393002|NCT01968070|41636846|FG006|Period 1|Protocol Violation|0|||
19393003|NCT01968070|41636847|FG007|Period 1|Protocol Violation|0|||
19393004|NCT01968070|41636848|FG008|Period 1|Protocol Violation|0|||
19483181|NCT01428713|41765776|FG001|Overall Study|Non-compliance|2|||
19483182|NCT01428713|41765775|FG000|Overall Study|Withdrawal by Subject|1|||
19483183|NCT01428713|41765776|FG001|Overall Study|Withdrawal by Subject|1|||
19483184|NCT01428713|41765775|FG000|Overall Study|Adverse Event|0|||
19483185|NCT01428713|41765776|FG001|Overall Study|Adverse Event|2|||
19483186|NCT01408277|41765784|FG000|Overall Study|Adverse Event|3|||
19483187|NCT01408277|41765785|FG001|Overall Study|Adverse Event|4|||
19483188|NCT01408277|41765784|FG000|Overall Study|Lost to Follow-up|1|||
19483189|NCT01408277|41765785|FG001|Overall Study|Lost to Follow-up|0|||
19483190|NCT01408277|41765784|FG000|Overall Study|Withdrawal by Subject|2|||
19483191|NCT01408277|41765785|FG001|Overall Study|Withdrawal by Subject|0|||
19483192|NCT01408277|41765784|FG000|Overall Study|Protocol Violation|2|||
19483193|NCT01408277|41765785|FG001|Overall Study|Protocol Violation|0|||
19483194|NCT01408043|41765791|FG000|Overall Study|unable to collect cells|1|||
19612457|NCT00811473|42061309|FG000|Overall Study|Condition under investigation worsened|1|||
19483195|NCT01524224|41765803|FG000|Overall Study|Progressive Disease|1|||
19483196|NCT01524224|41765804|FG001|Overall Study|Progressive Disease|0|||
19483197|NCT01524224|41765805|FG002|Overall Study|Progressive Disease|2|||
19393005|NCT01968070|41636849|FG009|Period 1|Protocol Violation|0|||
19393006|NCT01968070|41636850|FG010|Period 1|Protocol Violation|0|||
19393007|NCT01968070|41636851|FG011|Period 1|Protocol Violation|0|||
19483198|NCT01524224|41765806|FG003|Overall Study|Progressive Disease|1|||
19483199|NCT01524224|41765807|FG004|Overall Study|Progressive Disease|2|||
19483200|NCT01524224|41765808|FG005|Overall Study|Progressive Disease|1|||
19483201|NCT01524224|41765809|FG006|Overall Study|Progressive Disease|1|||
19483202|NCT01524224|41765810|FG007|Overall Study|Progressive Disease|5|||
19483203|NCT01524224|41765803|FG000|Overall Study|Withdrawal by Subject|2|||
19483204|NCT01524224|41765804|FG001|Overall Study|Withdrawal by Subject|0|||
19483205|NCT01524224|41765805|FG002|Overall Study|Withdrawal by Subject|0|||
19483206|NCT01524224|41765806|FG003|Overall Study|Withdrawal by Subject|0|||
19483207|NCT01524224|41765807|FG004|Overall Study|Withdrawal by Subject|0|||
19483208|NCT01524224|41765808|FG005|Overall Study|Withdrawal by Subject|0|||
19483209|NCT01524224|41765809|FG006|Overall Study|Withdrawal by Subject|2|||
19483210|NCT01524224|41765810|FG007|Overall Study|Withdrawal by Subject|0|||
19483211|NCT01524224|41765803|FG000|Overall Study|Adverse Event|0|||
19483212|NCT01524224|41765804|FG001|Overall Study|Adverse Event|1|||
19483213|NCT01524224|41765805|FG002|Overall Study|Adverse Event|0|||
19483214|NCT01524224|41765806|FG003|Overall Study|Adverse Event|0|||
19483215|NCT01524224|41765807|FG004|Overall Study|Adverse Event|0|||
19483216|NCT01524224|41765808|FG005|Overall Study|Adverse Event|1|||
19483217|NCT01524224|41765809|FG006|Overall Study|Adverse Event|0|||
19483218|NCT01524224|41765810|FG007|Overall Study|Adverse Event|0|||
19483219|NCT01524224|41765803|FG000|Overall Study|Physician Decision|0|||
19483220|NCT01524224|41765804|FG001|Overall Study|Physician Decision|0|||
19483221|NCT01524224|41765805|FG002|Overall Study|Physician Decision|0|||
19483222|NCT01524224|41765806|FG003|Overall Study|Physician Decision|1|||
19483223|NCT01524224|41765807|FG004|Overall Study|Physician Decision|1|||
19483224|NCT01524224|41765808|FG005|Overall Study|Physician Decision|0|||
19483225|NCT01524224|41765809|FG006|Overall Study|Physician Decision|0|||
19483226|NCT01524224|41765810|FG007|Overall Study|Physician Decision|1|||
19483227|NCT01524224|41765803|FG000|Overall Study|Sponsor Decision|0|||
19483228|NCT01524224|41765804|FG001|Overall Study|Sponsor Decision|0|||
19483229|NCT01524224|41765805|FG002|Overall Study|Sponsor Decision|0|||
19483230|NCT01524224|41765806|FG003|Overall Study|Sponsor Decision|0|||
19483231|NCT01524224|41765807|FG004|Overall Study|Sponsor Decision|1|||
19483232|NCT01524224|41765808|FG005|Overall Study|Sponsor Decision|0|||
19483233|NCT01524224|41765809|FG006|Overall Study|Sponsor Decision|0|||
19483234|NCT01524224|41765810|FG007|Overall Study|Sponsor Decision|0|||
19483235|NCT00219349|41765828|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
19483236|NCT00219349|41765828|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
19483237|NCT00219349|41765828|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
19483238|NCT00219349|41765828|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
19483239|NCT01523756|41765832|FG000|Baseline Period|Adverse Event|0|||
19483240|NCT01523756|41765833|FG001|Baseline Period|Adverse Event|1|||
19483241|NCT01523756|41765832|FG000|Test Period 1|Adverse Event|1|||
19483242|NCT01523756|41765833|FG001|Test Period 1|Adverse Event|0|||
19483243|NCT01523756|41765832|FG000|Test Period 2|Withdrawal by Subject|0|||
19483244|NCT01523756|41765833|FG001|Test Period 2|Withdrawal by Subject|1|||
19483245|NCT00218257|41765841|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
19483246|NCT00218257|41765842|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
19483247|NCT01523366|41765853|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19483248|NCT01523366|41765854|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19483249|NCT01523366|41765853|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
19483250|NCT01523366|41765854|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
19483251|NCT01427933|41765864|FG000|Overall Study|Withdrawal by Subject|5|||
19483252|NCT01427933|41765865|FG001|Overall Study|Withdrawal by Subject|8|||
19483253|NCT01427933|41765864|FG000|Overall Study|Lost to Follow-up|1|||
19483254|NCT01427933|41765865|FG001|Overall Study|Lost to Follow-up|5|||
19483255|NCT01427933|41765864|FG000|Overall Study|Other|1|||
19483256|NCT01427933|41765865|FG001|Overall Study|Other|0|||
19483257|NCT01427933|41765864|FG000|Overall Study|Investigator's Decision|1|||
19483258|NCT01427933|41765865|FG001|Overall Study|Investigator's Decision|0|||
19483259|NCT00217087|41765874|FG000|Overall Study|decided to have esophagectomy|1|||
19483260|NCT00217087|41765875|FG001|Overall Study|decided to have esophagectomy|2|||
19483261|NCT00217087|41765874|FG000|Overall Study|completed less than 12 months return|10|||
19483262|NCT00217087|41765875|FG001|Overall Study|completed less than 12 months return|18|||
19483263|NCT01406873|41765889|FG000|Overall Study|Withdrawal by Subject|1|||
19483264|NCT01406873|41765890|FG001|Overall Study|Withdrawal by Subject|1|||
19483265|NCT01406795|41765906|FG000|Overall Study|Withdrawal by Subject|1|||
19483266|NCT01406717|41765912|FG000|Overall Study|Subject non-compliance|4|||
19612458|NCT00811473|42061310|FG001|Overall Study|Condition under investigation worsened|3|||
19704096|NCT00228384|42148406|FG000|Overall Study|Withdrawal by Subject|9|||
19483267|NCT01406717|41765913|FG001|Overall Study|Subject non-compliance|3|||
19612459|NCT00811473|42061309|FG000|Overall Study|Other 2|4|||
19483268|NCT01406717|41765912|FG000|Overall Study|Protocol Violation|5|||
19483269|NCT01406717|41765913|FG001|Overall Study|Protocol Violation|1|||
19483270|NCT01406717|41765912|FG000|Overall Study|Lost to Follow-up|14|||
19612460|NCT00811473|42061310|FG001|Overall Study|Other 2|1|||
19483271|NCT01406717|41765913|FG001|Overall Study|Lost to Follow-up|8|||
19483272|NCT01406717|41765912|FG000|Overall Study|Withdrawal by Subject|19|||
19483273|NCT01406717|41765913|FG001|Overall Study|Withdrawal by Subject|15|||
19483274|NCT01406717|41765912|FG000|Overall Study|Adverse Event|1|||
19483275|NCT01406717|41765913|FG001|Overall Study|Adverse Event|2|||
19483276|NCT01406717|41765912|FG000|Overall Study|Lack of Efficacy|0|||
19483277|NCT01406717|41765913|FG001|Overall Study|Lack of Efficacy|1|||
19483278|NCT01406717|41765912|FG000|Overall Study|Non-completion of visit activity|0|||
19483279|NCT01406717|41765913|FG001|Overall Study|Non-completion of visit activity|1|||
19483280|NCT01406015|41765931|FG000|Overall Study|Withdrawal by Subject|3|||
19483281|NCT01406015|41765932|FG001|Overall Study|Withdrawal by Subject|3|||
19483282|NCT00215683|41765941|FG000|Overall Study|Adverse Event|15|||
19483283|NCT00215683|41765942|FG001|Overall Study|Adverse Event|16|||
19483284|NCT00215683|41765943|FG002|Overall Study|Adverse Event|15|||
19483285|NCT00215683|41765941|FG000|Overall Study|Lack of Efficacy|5|||
19483286|NCT00215683|41765942|FG001|Overall Study|Lack of Efficacy|1|||
19483287|NCT00215683|41765943|FG002|Overall Study|Lack of Efficacy|2|||
19483288|NCT00215683|41765941|FG000|Overall Study|Lost to Follow-up|0|||
19483289|NCT00215683|41765942|FG001|Overall Study|Lost to Follow-up|2|||
19483290|NCT00215683|41765943|FG002|Overall Study|Lost to Follow-up|1|||
19483291|NCT00215683|41765941|FG000|Overall Study|Withdrawal by Subject|9|||
19483292|NCT00215683|41765942|FG001|Overall Study|Withdrawal by Subject|4|||
19483293|NCT00215683|41765943|FG002|Overall Study|Withdrawal by Subject|13|||
19483294|NCT00215683|41765941|FG000|Overall Study|Physician Decision|0|||
19483295|NCT00215683|41765942|FG001|Overall Study|Physician Decision|0|||
19483296|NCT00215683|41765943|FG002|Overall Study|Physician Decision|1|||
19483297|NCT00215683|41765941|FG000|Overall Study|Difficult to attend visits|0|||
19483298|NCT00215683|41765942|FG001|Overall Study|Difficult to attend visits|1|||
19483299|NCT00215683|41765943|FG002|Overall Study|Difficult to attend visits|0|||
19483300|NCT00215683|41765941|FG000|Overall Study|No study drug available|0|||
19483301|NCT00215683|41765942|FG001|Overall Study|No study drug available|1|||
19483302|NCT00215683|41765943|FG002|Overall Study|No study drug available|0|||
19483303|NCT00215683|41765941|FG000|Overall Study|Intermittent therapy required|0|||
19483304|NCT00215683|41765942|FG001|Overall Study|Intermittent therapy required|1|||
19483305|NCT00215683|41765943|FG002|Overall Study|Intermittent therapy required|0|||
19483306|NCT00215137|41765951|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
19483307|NCT00215137|41765952|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
19483308|NCT00215137|41765953|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
19483309|NCT00215137|41765951|FG000|Randomization Period|Lost to Follow-up|0|||
19483310|NCT00215137|41765952|FG001|Randomization Period|Lost to Follow-up|1|||
19483311|NCT00215137|41765953|FG002|Randomization Period|Lost to Follow-up|0|||
19483312|NCT00215137|41765951|FG000|Randomization Period|Withdrawal by Subject|0|||
19483313|NCT00215137|41765952|FG001|Randomization Period|Withdrawal by Subject|1|||
19483314|NCT00215137|41765953|FG002|Randomization Period|Withdrawal by Subject|0|||
19483315|NCT00214201|41765963|FG000|Overall Study|Withdrawal by Subject|2|||
19483316|NCT00214201|41765964|FG001|Overall Study|Withdrawal by Subject|0|||
19483317|NCT00214201|41765963|FG000|Overall Study|Death|0|||
19483318|NCT00214201|41765964|FG001|Overall Study|Death|2|||
19483319|NCT01486784|41765977|FG000|Overall Study|Withdrawal by Subject|0|||
19483320|NCT01486784|41765978|FG001|Overall Study|Withdrawal by Subject|0|||
19483321|NCT01486784|41765979|FG002|Overall Study|Withdrawal by Subject|1|||
19483322|NCT01486784|41765980|FG003|Overall Study|Withdrawal by Subject|0|||
19483323|NCT01486784|41765981|FG004|Overall Study|Withdrawal by Subject|1|||
19483324|NCT01486784|41765982|FG005|Overall Study|Withdrawal by Subject|2|||
19483325|NCT01486784|41765977|FG000|Overall Study|Subject did not meet entry criteria|0|||
19393008|NCT01968070|41636852|FG012|Period 1|Protocol Violation|0|||
19393009|NCT01968070|41636853|FG013|Period 1|Protocol Violation|0|||
19393010|NCT01968070|41636854|FG014|Period 1|Protocol Violation|0|||
19393011|NCT01968070|41636855|FG015|Period 1|Protocol Violation|0|||
19393012|NCT01968070|41636856|FG016|Period 1|Protocol Violation|0|||
19393013|NCT01968070|41636857|FG017|Period 1|Protocol Violation|0|||
19393014|NCT01968070|41636840|FG000|Period 1|Lost to Follow-up|0|||
19393015|NCT01968070|41636841|FG001|Period 1|Lost to Follow-up|0|||
19393016|NCT01968070|41636842|FG002|Period 1|Lost to Follow-up|0|||
19393017|NCT01968070|41636843|FG003|Period 1|Lost to Follow-up|1|||
19393018|NCT01968070|41636844|FG004|Period 1|Lost to Follow-up|0|||
19393019|NCT01968070|41636845|FG005|Period 1|Lost to Follow-up|0|||
19483326|NCT01486784|41765978|FG001|Overall Study|Subject did not meet entry criteria|0|||
19483327|NCT01486784|41765979|FG002|Overall Study|Subject did not meet entry criteria|0|||
19483328|NCT01486784|41765980|FG003|Overall Study|Subject did not meet entry criteria|0|||
19483329|NCT01486784|41765981|FG004|Overall Study|Subject did not meet entry criteria|1|||
19483330|NCT01486784|41765982|FG005|Overall Study|Subject did not meet entry criteria|0|||
19483331|NCT01486784|41765977|FG000|Overall Study|Death|0|||
19483332|NCT01486784|41765978|FG001|Overall Study|Death|0|||
19483333|NCT01486784|41765979|FG002|Overall Study|Death|0|||
19483334|NCT01486784|41765980|FG003|Overall Study|Death|0|||
19483335|NCT01486784|41765981|FG004|Overall Study|Death|0|||
19483336|NCT01486784|41765982|FG005|Overall Study|Death|1|||
19483337|NCT01521884|41765996|FG000|Overall Study|Non Responders|10|||
19483338|NCT01521884|41765996|FG000|Overall Study|Adverse Event|5|||
19393020|NCT01968070|41636846|FG006|Period 1|Lost to Follow-up|0|||
19393021|NCT01968070|41636847|FG007|Period 1|Lost to Follow-up|0|||
19393022|NCT01968070|41636848|FG008|Period 1|Lost to Follow-up|0|||
19393023|NCT01968070|41636849|FG009|Period 1|Lost to Follow-up|0|||
19393024|NCT01968070|41636850|FG010|Period 1|Lost to Follow-up|0|||
19393025|NCT01968070|41636851|FG011|Period 1|Lost to Follow-up|0|||
19483339|NCT01521884|41765996|FG000|Overall Study|Pregnancy|1|||
19483340|NCT01521884|41765996|FG000|Overall Study|Withdrawal by Subject|1|||
19483341|NCT01521884|41765996|FG000|Overall Study|Physician Decision|2|||
19483342|NCT01521884|41765996|FG000|Overall Study|Protocol Violation|3|||
19483343|NCT01521884|41765996|FG000|Overall Study|Participant non-eligible|1|||
19483344|NCT01521884|41765996|FG000|Overall Study|Lost to Follow-up|4|||
19483345|NCT01677858|41766005|FG000|Overall Study|Adverse Event|0|||
19483346|NCT01677858|41766006|FG001|Overall Study|Adverse Event|0|||
19483347|NCT01677858|41766007|FG002|Overall Study|Adverse Event|2|||
19483348|NCT01677858|41766008|FG003|Overall Study|Adverse Event|3|||
19483349|NCT01677858|41766009|FG004|Overall Study|Adverse Event|13|||
19483350|NCT01677858|41766005|FG000|Overall Study|Death|0|||
19483351|NCT01677858|41766006|FG001|Overall Study|Death|0|||
19483352|NCT01677858|41766007|FG002|Overall Study|Death|0|||
19483353|NCT01677858|41766008|FG003|Overall Study|Death|0|||
19483354|NCT01677858|41766009|FG004|Overall Study|Death|1|||
19483355|NCT01677858|41766005|FG000|Overall Study|Physician Decision|1|||
19483356|NCT01677858|41766006|FG001|Overall Study|Physician Decision|0|||
19483357|NCT01677858|41766007|FG002|Overall Study|Physician Decision|2|||
19483358|NCT01677858|41766008|FG003|Overall Study|Physician Decision|0|||
19483359|NCT01677858|41766009|FG004|Overall Study|Physician Decision|12|||
19483360|NCT01677858|41766005|FG000|Overall Study|Progressive Disease|2|||
19483361|NCT01677858|41766006|FG001|Overall Study|Progressive Disease|1|||
19483362|NCT01677858|41766007|FG002|Overall Study|Progressive Disease|9|||
19483363|NCT01677858|41766008|FG003|Overall Study|Progressive Disease|3|||
19483364|NCT01677858|41766009|FG004|Overall Study|Progressive Disease|43|||
19483365|NCT01677858|41766005|FG000|Overall Study|Withdrawal by Subject|0|||
19483366|NCT01677858|41766006|FG001|Overall Study|Withdrawal by Subject|1|||
19483367|NCT01677858|41766007|FG002|Overall Study|Withdrawal by Subject|1|||
19483368|NCT01677858|41766008|FG003|Overall Study|Withdrawal by Subject|0|||
19483369|NCT01677858|41766009|FG004|Overall Study|Withdrawal by Subject|15|||
19483370|NCT01677858|41766005|FG000|Overall Study|Lost to Follow-up|0|||
19483371|NCT01677858|41766006|FG001|Overall Study|Lost to Follow-up|0|||
19483372|NCT01677858|41766007|FG002|Overall Study|Lost to Follow-up|0|||
19483373|NCT01677858|41766008|FG003|Overall Study|Lost to Follow-up|0|||
19483374|NCT01677858|41766009|FG004|Overall Study|Lost to Follow-up|1|||
19393026|NCT01968070|41636852|FG012|Period 1|Lost to Follow-up|0|||
19393027|NCT01968070|41636853|FG013|Period 1|Lost to Follow-up|0|||
19393028|NCT01968070|41636854|FG014|Period 1|Lost to Follow-up|0|||
19393029|NCT01968070|41636855|FG015|Period 1|Lost to Follow-up|0|||
19483375|NCT01486316|41766029|FG000|Overall Study|Device explanted with/without re-implant|3|||
19483376|NCT01486316|41766030|FG001|Overall Study|Device explanted with/without re-implant|2|||
19483377|NCT01486316|41766031|FG002|Overall Study|Device explanted with/without re-implant|0|||
19483378|NCT01486316|41766032|FG003|Overall Study|Device explanted with/without re-implant|2|||
19483379|NCT01486316|41766029|FG000|Overall Study|Not meeting eligibility criteria|0|||
19483380|NCT01486316|41766030|FG001|Overall Study|Not meeting eligibility criteria|0|||
19483381|NCT01486316|41766031|FG002|Overall Study|Not meeting eligibility criteria|1|||
19483382|NCT01486316|41766032|FG003|Overall Study|Not meeting eligibility criteria|0|||
19483383|NCT01486316|41766029|FG000|Overall Study|Withdrawal by Subject|1|||
19483384|NCT01486316|41766030|FG001|Overall Study|Withdrawal by Subject|0|||
19483385|NCT01486316|41766031|FG002|Overall Study|Withdrawal by Subject|3|||
19483386|NCT01486316|41766032|FG003|Overall Study|Withdrawal by Subject|0|||
19483387|NCT01486316|41766029|FG000|Overall Study|Physician Decision|0|||
19483388|NCT01486316|41766030|FG001|Overall Study|Physician Decision|0|||
19483389|NCT01486316|41766031|FG002|Overall Study|Physician Decision|1|||
19483390|NCT01486316|41766032|FG003|Overall Study|Physician Decision|0|||
19483391|NCT01486316|41766029|FG000|Overall Study|Death|0|||
19483392|NCT01486316|41766030|FG001|Overall Study|Death|1|||
19483393|NCT01486316|41766031|FG002|Overall Study|Death|0|||
19483394|NCT01486316|41766032|FG003|Overall Study|Death|0|||
19393030|NCT01968070|41636856|FG016|Period 1|Lost to Follow-up|0|||
19393031|NCT01968070|41636857|FG017|Period 1|Lost to Follow-up|0|||
19393032|NCT01968070|41636840|FG000|Period 1|Adverse Event|0|||
19393033|NCT01968070|41636841|FG001|Period 1|Adverse Event|0|||
19483395|NCT01486238|41766043|FG000|Overall Study|Death|0|||
19483396|NCT01486238|41766044|FG001|Overall Study|Death|2|||
19483397|NCT01486238|41766043|FG000|Overall Study|Withdrawal by Subject|2|||
19483398|NCT01486238|41766044|FG001|Overall Study|Withdrawal by Subject|1|||
19483399|NCT01486238|41766043|FG000|Overall Study|Lost to Follow-up|0|||
19483400|NCT01486238|41766044|FG001|Overall Study|Lost to Follow-up|3|||
19483401|NCT01602744|41766052|FG000|Overall Study|Death|17|||
19483402|NCT01602744|41766053|FG001|Overall Study|Death|15|||
19483403|NCT01602744|41766052|FG000|Overall Study|Lost to Follow-up|13|||
19483404|NCT01602744|41766053|FG001|Overall Study|Lost to Follow-up|8|||
19483405|NCT03598777|41766064|FG000|Overall Study|Study Terminated by Sponsor|3|||
19483406|NCT03598777|41766065|FG001|Overall Study|Study Terminated by Sponsor|0|||
19483407|NCT03598777|41766066|FG002|Overall Study|Study Terminated by Sponsor|0|||
19483408|NCT03598777|41766067|FG003|Overall Study|Study Terminated by Sponsor|0|||
19483409|NCT03598777|41766068|FG004|Overall Study|Study Terminated by Sponsor|15|||
19483410|NCT03598777|41766064|FG000|Overall Study|Withdrawal by Subject|1|||
19483411|NCT03598777|41766065|FG001|Overall Study|Withdrawal by Subject|1|||
19483412|NCT03598777|41766066|FG002|Overall Study|Withdrawal by Subject|0|||
19483413|NCT03598777|41766067|FG003|Overall Study|Withdrawal by Subject|0|||
19483414|NCT03598777|41766068|FG004|Overall Study|Withdrawal by Subject|0|||
19483415|NCT03598777|41766064|FG000|Overall Study|Adverse Event|1|||
19483416|NCT03598777|41766065|FG001|Overall Study|Adverse Event|0|||
19483417|NCT03598777|41766066|FG002|Overall Study|Adverse Event|0|||
19483418|NCT03598777|41766067|FG003|Overall Study|Adverse Event|0|||
19483419|NCT03598777|41766068|FG004|Overall Study|Adverse Event|0|||
19483420|NCT03598777|41766064|FG000|Overall Study|Lost to Follow-up|1|||
19483421|NCT03598777|41766065|FG001|Overall Study|Lost to Follow-up|0|||
19483422|NCT03598777|41766066|FG002|Overall Study|Lost to Follow-up|0|||
19483423|NCT03598777|41766067|FG003|Overall Study|Lost to Follow-up|0|||
19483424|NCT03598777|41766068|FG004|Overall Study|Lost to Follow-up|0|||
19483425|NCT03594955|41766083|FG000|Overall Study|Adverse Event|1|||
19483426|NCT03594955|41766083|FG000|Overall Study|Progressive disease|5|||
19483427|NCT03594955|41766083|FG000|Overall Study|Sponsor's decision|1|||
19483428|NCT01677624|41766111|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
19483429|NCT01272219|41766157|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
19483430|NCT01272219|41766158|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
19483431|NCT01272219|41766159|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
19483432|NCT01272219|41766160|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
19483433|NCT01272219|41766161|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
19483434|NCT01272219|41766162|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
19483435|NCT01272219|41766157|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
19483436|NCT01272219|41766158|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
19483437|NCT01272219|41766159|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
19483438|NCT01272219|41766160|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
19483439|NCT01272219|41766161|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
19483440|NCT01272219|41766162|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
19483441|NCT01272219|41766157|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
19483442|NCT01272219|41766158|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
19483443|NCT01272219|41766159|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
19483444|NCT01272219|41766160|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
19483445|NCT01272219|41766161|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
19483446|NCT01272219|41766162|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
19483447|NCT01272219|41766157|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
19483448|NCT01272219|41766158|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
19483449|NCT01272219|41766159|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
19483450|NCT01272219|41766160|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
19483451|NCT01272219|41766161|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
19483452|NCT01272219|41766162|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
19483453|NCT01272219|41766157|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
19483454|NCT01272219|41766158|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
19483455|NCT01272219|41766159|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
19483456|NCT01272219|41766160|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
19483457|NCT01272219|41766161|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
19483458|NCT01272219|41766162|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
19483459|NCT01272219|41766157|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
19483460|NCT01272219|41766158|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
19483461|NCT01272219|41766159|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
19483462|NCT01272219|41766160|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
19483463|NCT01272219|41766161|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
19483464|NCT01272219|41766162|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
19483465|NCT01272219|41766157|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
19483466|NCT01272219|41766158|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
19483467|NCT01272219|41766159|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
19483468|NCT01272219|41766160|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
19483469|NCT01272219|41766161|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
19483470|NCT01272219|41766162|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
19483471|NCT01272219|41766157|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
19483472|NCT01272219|41766158|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
19483473|NCT01272219|41766159|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
19483474|NCT01272219|41766160|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
19483475|NCT01272219|41766161|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
19483476|NCT01272219|41766162|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
19483477|NCT01272219|41766157|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
19483478|NCT01272219|41766158|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
19483479|NCT01272219|41766159|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
19483480|NCT01272219|41766160|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
19483481|NCT01272219|41766161|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
19483482|NCT01272219|41766162|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
19483483|NCT01272219|41766157|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
19483484|NCT01272219|41766158|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
19483485|NCT01272219|41766159|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
19483486|NCT01272219|41766160|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
19483487|NCT01272219|41766161|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
19483488|NCT01272219|41766162|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
19483489|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
19393034|NCT01968070|41636842|FG002|Period 1|Adverse Event|0|||
19393035|NCT01968070|41636843|FG003|Period 1|Adverse Event|0|||
19393036|NCT01968070|41636844|FG004|Period 1|Adverse Event|0|||
19393037|NCT01968070|41636845|FG005|Period 1|Adverse Event|0|||
19393038|NCT01968070|41636846|FG006|Period 1|Adverse Event|1|||
19393039|NCT01968070|41636847|FG007|Period 1|Adverse Event|0|||
19393040|NCT01968070|41636848|FG008|Period 1|Adverse Event|0|||
19393041|NCT01968070|41636849|FG009|Period 1|Adverse Event|0|||
19393042|NCT01968070|41636850|FG010|Period 1|Adverse Event|0|||
19393043|NCT01968070|41636851|FG011|Period 1|Adverse Event|0|||
19393044|NCT01968070|41636852|FG012|Period 1|Adverse Event|0|||
19393045|NCT01968070|41636853|FG013|Period 1|Adverse Event|0|||
19393046|NCT01968070|41636854|FG014|Period 1|Adverse Event|0|||
19393047|NCT01968070|41636855|FG015|Period 1|Adverse Event|0|||
19393048|NCT01968070|41636856|FG016|Period 1|Adverse Event|0|||
19393049|NCT01968070|41636857|FG017|Period 1|Adverse Event|0|||
19393050|NCT01968070|41636840|FG000|Period 1|Physician Decision|0|||
19393051|NCT01968070|41636841|FG001|Period 1|Physician Decision|0|||
19393052|NCT01968070|41636842|FG002|Period 1|Physician Decision|0|||
19393053|NCT01968070|41636843|FG003|Period 1|Physician Decision|0|||
19393054|NCT01968070|41636844|FG004|Period 1|Physician Decision|0|||
19393055|NCT01968070|41636845|FG005|Period 1|Physician Decision|0|||
19393056|NCT01968070|41636846|FG006|Period 1|Physician Decision|0|||
19393057|NCT01968070|41636847|FG007|Period 1|Physician Decision|0|||
19393058|NCT01968070|41636848|FG008|Period 1|Physician Decision|0|||
19393059|NCT01968070|41636849|FG009|Period 1|Physician Decision|0|||
19393060|NCT01968070|41636850|FG010|Period 1|Physician Decision|0|||
19393061|NCT01968070|41636851|FG011|Period 1|Physician Decision|1|||
19393062|NCT01968070|41636852|FG012|Period 1|Physician Decision|0|||
19393063|NCT01968070|41636853|FG013|Period 1|Physician Decision|0|||
19393064|NCT01968070|41636854|FG014|Period 1|Physician Decision|0|||
19393065|NCT01968070|41636855|FG015|Period 1|Physician Decision|0|||
19393066|NCT01968070|41636856|FG016|Period 1|Physician Decision|0|||
19393067|NCT01968070|41636857|FG017|Period 1|Physician Decision|0|||
19393068|NCT01968070|41636840|FG000|Period 2|Withdrawal by Subject|0|||
19393069|NCT01968070|41636841|FG001|Period 2|Withdrawal by Subject|0|||
19393070|NCT01968070|41636842|FG002|Period 2|Withdrawal by Subject|0|||
19393071|NCT01968070|41636843|FG003|Period 2|Withdrawal by Subject|0|||
19393072|NCT01968070|41636844|FG004|Period 2|Withdrawal by Subject|1|||
19393073|NCT01968070|41636845|FG005|Period 2|Withdrawal by Subject|0|||
19393074|NCT01968070|41636846|FG006|Period 2|Withdrawal by Subject|0|||
19393075|NCT01968070|41636847|FG007|Period 2|Withdrawal by Subject|0|||
19393076|NCT01968070|41636848|FG008|Period 2|Withdrawal by Subject|0|||
19393077|NCT01968070|41636849|FG009|Period 2|Withdrawal by Subject|0|||
19393078|NCT01968070|41636850|FG010|Period 2|Withdrawal by Subject|0|||
19393079|NCT01968070|41636851|FG011|Period 2|Withdrawal by Subject|0|||
19393080|NCT01968070|41636852|FG012|Period 2|Withdrawal by Subject|0|||
19393081|NCT01968070|41636853|FG013|Period 2|Withdrawal by Subject|0|||
19393082|NCT01968070|41636854|FG014|Period 2|Withdrawal by Subject|0|||
19393083|NCT01968070|41636855|FG015|Period 2|Withdrawal by Subject|0|||
19393084|NCT01968070|41636856|FG016|Period 2|Withdrawal by Subject|0|||
19393085|NCT01968070|41636857|FG017|Period 2|Withdrawal by Subject|0|||
19393086|NCT01949662|41636897|FG000|Overall Study|Death|9|||
19393087|NCT01949662|41636898|FG001|Overall Study|Death|7|||
19393088|NCT01949662|41636897|FG000|Overall Study|Discharged before an agitation event|8|||
19393089|NCT01949662|41636898|FG001|Overall Study|Discharged before an agitation event|3|||
19393090|NCT01949662|41636897|FG000|Overall Study|Dropped out|1|||
19393091|NCT01949662|41636898|FG001|Overall Study|Dropped out|3|||
19393092|NCT01949662|41636897|FG000|Overall Study|Ineligible|0|||
19393093|NCT01949662|41636898|FG001|Overall Study|Ineligible|1|||
19393094|NCT01918774|41636904|FG000|Overall Study|Lost prior to first CBTw session|4|||
19393095|NCT01918774|41636904|FG000|Overall Study|Lost to Follow-up|1|||
19393096|NCT01949116|41636910|FG000|Overall Study|Death|2|||
19393097|NCT01949116|41636911|FG001|Overall Study|Death|0|||
19393098|NCT01949116|41636910|FG000|Overall Study|Lost to Follow-up|1|||
19393099|NCT01949116|41636911|FG001|Overall Study|Lost to Follow-up|3|||
19393100|NCT01949116|41636910|FG000|Overall Study|Withdrawal by Subject|5|||
19393101|NCT01949116|41636911|FG001|Overall Study|Withdrawal by Subject|3|||
19393102|NCT01673009|41636921|FG000|Overall Study|Physician Decision|5|||
19483490|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
19483491|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
19483492|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
19483493|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
19483494|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
19483495|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
19483496|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
19483497|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
19483498|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
19483499|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
19483500|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
19483501|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
19483502|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
19483503|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
19483504|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
19483505|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
19483506|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
19483507|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
19483508|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
19483509|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
19483510|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
19483511|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
19483512|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
19483513|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
19483514|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
19483515|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
19483516|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
19483517|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
19483518|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
19483519|NCT01272219|41766157|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
19483520|NCT01272219|41766158|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
19483521|NCT01272219|41766159|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
19483522|NCT01272219|41766160|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
19483523|NCT01272219|41766161|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
19483524|NCT01272219|41766162|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
19483525|NCT01510028|41766179|FG000|Overall Study|Lack of Efficacy|1|||
19483526|NCT01510028|41766180|FG001|Overall Study|Lack of Efficacy|0|||
19483527|NCT01510028|41766181|FG002|Overall Study|Lack of Efficacy|0|||
19483528|NCT01510028|41766182|FG003|Overall Study|Lack of Efficacy|0|||
19483529|NCT01521494|41766203|FG000|Overall Study|Adverse Event|1|||
19483530|NCT01521494|41766204|FG001|Overall Study|Adverse Event|2|||
19483531|NCT01521494|41766205|FG002|Overall Study|Adverse Event|9|||
19483532|NCT01521494|41766206|FG003|Overall Study|Adverse Event|6|||
19483533|NCT01521494|41766207|FG004|Overall Study|Adverse Event|2|||
19483534|NCT01521494|41766203|FG000|Overall Study|Lack of Efficacy|0|||
19483535|NCT01521494|41766204|FG001|Overall Study|Lack of Efficacy|0|||
19483536|NCT01521494|41766205|FG002|Overall Study|Lack of Efficacy|0|||
19483537|NCT01521494|41766206|FG003|Overall Study|Lack of Efficacy|0|||
19483538|NCT01521494|41766207|FG004|Overall Study|Lack of Efficacy|2|||
19483539|NCT01521494|41766203|FG000|Overall Study|Withdrawal by Subject|1|||
19483540|NCT01521494|41766204|FG001|Overall Study|Withdrawal by Subject|1|||
19483541|NCT01521494|41766205|FG002|Overall Study|Withdrawal by Subject|0|||
19483542|NCT01521494|41766206|FG003|Overall Study|Withdrawal by Subject|2|||
19483543|NCT01521494|41766207|FG004|Overall Study|Withdrawal by Subject|0|||
19483544|NCT01521494|41766203|FG000|Overall Study|Decrease in serum phosphate|0|||
19483545|NCT01521494|41766204|FG001|Overall Study|Decrease in serum phosphate|2|||
19483546|NCT01521494|41766205|FG002|Overall Study|Decrease in serum phosphate|3|||
19483547|NCT01521494|41766206|FG003|Overall Study|Decrease in serum phosphate|12|||
19483548|NCT01521494|41766207|FG004|Overall Study|Decrease in serum phosphate|0|||
19483549|NCT01521494|41766203|FG000|Overall Study|Decrease in serum calcium|0|||
19483550|NCT01521494|41766204|FG001|Overall Study|Decrease in serum calcium|0|||
19483551|NCT01521494|41766205|FG002|Overall Study|Decrease in serum calcium|0|||
19483552|NCT01521494|41766206|FG003|Overall Study|Decrease in serum calcium|1|||
19483553|NCT01521494|41766207|FG004|Overall Study|Decrease in serum calcium|1|||
19483554|NCT01521494|41766203|FG000|Overall Study|Physician Decision|0|||
19483555|NCT01521494|41766204|FG001|Overall Study|Physician Decision|0|||
19483556|NCT01521494|41766205|FG002|Overall Study|Physician Decision|0|||
19483557|NCT01521494|41766206|FG003|Overall Study|Physician Decision|0|||
19483558|NCT01521494|41766207|FG004|Overall Study|Physician Decision|2|||
19612461|NCT00811473|42061309|FG000|Overall Study|Incorrect Enrollment|1|||
19612462|NCT00811473|42061310|FG001|Overall Study|Incorrect Enrollment|0|||
19483559|NCT01270971|41766221|FG000|Overall Study|Withdrawal by Subject|24|||
19483560|NCT01270971|41766222|FG001|Overall Study|Withdrawal by Subject|11|||
19483561|NCT01270971|41766221|FG000|Overall Study|Lost to Follow-up|18|||
19483562|NCT01270971|41766222|FG001|Overall Study|Lost to Follow-up|5|||
19483563|NCT01270971|41766221|FG000|Overall Study|Adverse Event|1|||
19483564|NCT01270971|41766222|FG001|Overall Study|Adverse Event|2|||
19483565|NCT01270971|41766221|FG000|Overall Study|Non compliance|2|||
19483566|NCT01270971|41766222|FG001|Overall Study|Non compliance|2|||
19483567|NCT01270971|41766221|FG000|Overall Study|Non-specific|7|||
19483568|NCT01270971|41766222|FG001|Overall Study|Non-specific|3|||
19393103|NCT01673009|41636921|FG000|Overall Study|Withdrawal by Subject|8|||
19393104|NCT01939366|41636930|FG000|Overall Study|Adverse Event|8|||
19393105|NCT01939366|41636931|FG001|Overall Study|Adverse Event|17|||
19393106|NCT01939366|41636932|FG002|Overall Study|Adverse Event|30|||
19393107|NCT01939366|41636933|FG003|Overall Study|Adverse Event|8|||
19393108|NCT01939366|41636934|FG004|Overall Study|Adverse Event|5|||
19393109|NCT01939366|41636930|FG000|Overall Study|Lack of Efficacy|2|||
19393110|NCT01939366|41636931|FG001|Overall Study|Lack of Efficacy|1|||
19393111|NCT01939366|41636932|FG002|Overall Study|Lack of Efficacy|1|||
19393112|NCT01939366|41636933|FG003|Overall Study|Lack of Efficacy|1|||
19393113|NCT01939366|41636934|FG004|Overall Study|Lack of Efficacy|3|||
19393114|NCT01939366|41636930|FG000|Overall Study|Lost to Follow-up|1|||
19393115|NCT01939366|41636931|FG001|Overall Study|Lost to Follow-up|1|||
19483569|NCT01270503|41766249|FG000|Overall Study|Lost to Follow-up|1|||
19483570|NCT01277211|41766266|FG000|Overall Study|Adverse Event|60|||
19483571|NCT01277211|41766267|FG001|Overall Study|Adverse Event|22|||
19483572|NCT01277211|41766266|FG000|Overall Study|Pregnancy|9|||
19483573|NCT01277211|41766267|FG001|Overall Study|Pregnancy|4|||
19483574|NCT01277211|41766266|FG000|Overall Study|Lost to Follow-up|14|||
19483575|NCT01277211|41766267|FG001|Overall Study|Lost to Follow-up|9|||
19483576|NCT01277211|41766266|FG000|Overall Study|Did not wish to continue|17|||
19483577|NCT01277211|41766267|FG001|Overall Study|Did not wish to continue|0|||
19483578|NCT01277211|41766266|FG000|Overall Study|Withdrew Consent|9|||
19483579|NCT01277211|41766267|FG001|Overall Study|Withdrew Consent|9|||
19483580|NCT01277211|41766266|FG000|Overall Study|Non-compliance with protocol|13|||
19483581|NCT01277211|41766267|FG001|Overall Study|Non-compliance with protocol|4|||
19483582|NCT01277211|41766266|FG000|Overall Study|Did not meet protocol eligibility|1|||
19483583|NCT01277211|41766267|FG001|Overall Study|Did not meet protocol eligibility|0|||
19483584|NCT01277211|41766266|FG000|Overall Study|Administrative|3|||
19483585|NCT01277211|41766267|FG001|Overall Study|Administrative|0|||
19483586|NCT01277211|41766266|FG000|Overall Study|Pregnancy wish|0|||
19483587|NCT01277211|41766267|FG001|Overall Study|Pregnancy wish|2|||
19483588|NCT01277211|41766266|FG000|Overall Study|Discontinued prior to treatment|24|||
19483589|NCT01277211|41766267|FG001|Overall Study|Discontinued prior to treatment|13|||
19483590|NCT01676220|41766275|FG000|Overall Study|Randomized But Not Treated|4|||
19483591|NCT01676220|41766276|FG001|Overall Study|Randomized But Not Treated|1|||
19483592|NCT01676220|41766275|FG000|Overall Study|Adverse Event|10|||
19483593|NCT01676220|41766276|FG001|Overall Study|Adverse Event|8|||
19483594|NCT01676220|41766275|FG000|Overall Study|Lack of Efficacy|2|||
19483595|NCT01676220|41766276|FG001|Overall Study|Lack of Efficacy|5|||
19483596|NCT01676220|41766275|FG000|Overall Study|Protocol Violation|11|||
19483597|NCT01676220|41766276|FG001|Overall Study|Protocol Violation|12|||
19483598|NCT01676220|41766275|FG000|Overall Study|Received Rescue Therapy|14|||
19483599|NCT01676220|41766276|FG001|Overall Study|Received Rescue Therapy|22|||
19483600|NCT01676220|41766275|FG000|Overall Study|Personal Reason|34|||
19483601|NCT01676220|41766276|FG001|Overall Study|Personal Reason|45|||
19483602|NCT01676220|41766275|FG000|Overall Study|Lost to Follow-up|11|||
19483603|NCT01676220|41766276|FG001|Overall Study|Lost to Follow-up|18|||
19483604|NCT01676220|41766275|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
19483605|NCT01676220|41766276|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
19483606|NCT01676220|41766275|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
19483607|NCT01676220|41766276|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
19483608|NCT01676220|41766275|FG000|Overall Study|Perceived Lack of Efficacy|3|||
19612463|NCT00811473|42061309|FG000|Overall Study|Safety Reasons|1|||
19483609|NCT01676220|41766276|FG001|Overall Study|Perceived Lack of Efficacy|1|||
19483610|NCT01676220|41766275|FG000|Overall Study|Non Serious Hypoglycemia|2|||
19393116|NCT01939366|41636932|FG002|Overall Study|Lost to Follow-up|0|||
19483611|NCT01676220|41766276|FG001|Overall Study|Non Serious Hypoglycemia|0|||
19483612|NCT01676220|41766275|FG000|Overall Study|No More Need of Insulin|1|||
19483613|NCT01676220|41766276|FG001|Overall Study|No More Need of Insulin|0|||
19483614|NCT01485614|41766306|FG000|Randomization|Not Treated|1|||
19483615|NCT01485614|41766307|FG001|Randomization|Not Treated|0|||
19483616|NCT01485614|41766308|FG002|Randomization|Not Treated|0|||
19483617|NCT01485614|41766309|FG003|Randomization|Not Treated|0|||
19483618|NCT01485614|41766306|FG000|Weeks 0-20|Lost to Follow-up|2|||
19483619|NCT01485614|41766307|FG001|Weeks 0-20|Lost to Follow-up|0|||
19483620|NCT01485614|41766308|FG002|Weeks 0-20|Lost to Follow-up|0|||
19483621|NCT01485614|41766309|FG003|Weeks 0-20|Lost to Follow-up|0|||
19483622|NCT01485614|41766306|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
19483623|NCT01485614|41766307|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
19483624|NCT01485614|41766308|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
19483625|NCT01485614|41766309|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
19483626|NCT01485614|41766306|FG000|Weeks 0-20|Withdrawal by Subject|3|||
19483627|NCT01485614|41766307|FG001|Weeks 0-20|Withdrawal by Subject|2|||
19483628|NCT01485614|41766308|FG002|Weeks 0-20|Withdrawal by Subject|1|||
19483629|NCT01485614|41766309|FG003|Weeks 0-20|Withdrawal by Subject|0|||
19483630|NCT01485614|41766306|FG000|Weeks 20-54|Lost to Follow-up|4|||
19483631|NCT01485614|41766307|FG001|Weeks 20-54|Lost to Follow-up|3|||
19483632|NCT01485614|41766308|FG002|Weeks 20-54|Lost to Follow-up|1|||
19483633|NCT01485614|41766309|FG003|Weeks 20-54|Lost to Follow-up|0|||
19483634|NCT01485614|41766306|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
19483635|NCT01485614|41766307|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
19483636|NCT01485614|41766308|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
19483637|NCT01485614|41766309|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
19483638|NCT01485614|41766306|FG000|Weeks 20-54|Withdrawal by Subject|5|||
19483639|NCT01485614|41766307|FG001|Weeks 20-54|Withdrawal by Subject|3|||
19483640|NCT01485614|41766308|FG002|Weeks 20-54|Withdrawal by Subject|0|||
19483641|NCT01485614|41766309|FG003|Weeks 20-54|Withdrawal by Subject|0|||
19483642|NCT01485536|41766359|FG000|Overall Study|Withdrawal by Subject|3|||
19483643|NCT01485536|41766359|FG000|Overall Study|Adverse Event|1|||
19483644|NCT02658630|41766363|FG000|Overall Study|Withdrawal by Subject|4|||
19483645|NCT01484912|41766369|FG000|Overall Study|Withdrawal by Subject|1|||
19483646|NCT01484912|41766370|FG001|Overall Study|Withdrawal by Subject|0|||
19483647|NCT01484912|41766369|FG000|Overall Study|Physician Decision|0|||
19483648|NCT01484912|41766370|FG001|Overall Study|Physician Decision|1|||
19483649|NCT01520870|41766376|FG000|Overall Study|Withdrawal by Subject|2|||
19483650|NCT01520714|41766382|FG000|Overall Study|Protocol Violation|0|||
19483651|NCT01520714|41766383|FG001|Overall Study|Protocol Violation|3|||
19483652|NCT01520714|41766382|FG000|Overall Study|Adverse Event|0|||
19483653|NCT01520714|41766383|FG001|Overall Study|Adverse Event|2|||
19483654|NCT01520714|41766382|FG000|Overall Study|Lack of Efficacy|0|||
19483655|NCT01520714|41766383|FG001|Overall Study|Lack of Efficacy|1|||
19483656|NCT02659098|41766402|FG000|Overall Study|Withdrawal by Subject|7|||
19483657|NCT01508936|41766413|FG000|Overall Study|Adverse Event|11|||
19483658|NCT01508936|41766414|FG001|Overall Study|Adverse Event|32|||
19483659|NCT01508936|41766413|FG000|Overall Study|Lack of Efficacy|0|||
19483660|NCT01508936|41766414|FG001|Overall Study|Lack of Efficacy|1|||
19483661|NCT01508936|41766413|FG000|Overall Study|Withdrawal by Subject|4|||
19483662|NCT01508936|41766414|FG001|Overall Study|Withdrawal by Subject|18|||
19483663|NCT01508936|41766413|FG000|Overall Study|Protocol Violation|2|||
19483664|NCT01508936|41766414|FG001|Overall Study|Protocol Violation|3|||
19483665|NCT01508936|41766413|FG000|Overall Study|Lost to Follow-up|2|||
19483666|NCT01508936|41766414|FG001|Overall Study|Lost to Follow-up|9|||
19483667|NCT01508936|41766413|FG000|Overall Study|Other|0|||
19483668|NCT01508936|41766414|FG001|Overall Study|Other|5|||
19483669|NCT01508936|41766413|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
19483670|NCT01508936|41766414|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
19483671|NCT01508702|41766435|FG000|Overall Study|Adverse Event|7|||
19483672|NCT01508702|41766436|FG001|Overall Study|Adverse Event|3|||
19483673|NCT01508702|41766435|FG000|Overall Study|Gout flare|2|||
19483674|NCT01508702|41766436|FG001|Overall Study|Gout flare|0|||
19483675|NCT01508702|41766435|FG000|Overall Study|Protocol Violation|2|||
19483676|NCT01508702|41766436|FG001|Overall Study|Protocol Violation|1|||
19483677|NCT01508702|41766435|FG000|Overall Study|Lost to Follow-up|1|||
19483678|NCT01508702|41766436|FG001|Overall Study|Lost to Follow-up|2|||
19483679|NCT01508702|41766435|FG000|Overall Study|Withdrawal by Subject|11|||
19483680|NCT01508702|41766436|FG001|Overall Study|Withdrawal by Subject|7|||
19483681|NCT01484834|41766450|FG000|Overall Study|Lost to Follow-up|5|||
19483682|NCT01484834|41766451|FG001|Overall Study|Lost to Follow-up|8|||
19483683|NCT01484834|41766452|FG002|Overall Study|Lost to Follow-up|1|||
19483684|NCT01484834|41766453|FG003|Overall Study|Lost to Follow-up|4|||
19483685|NCT01484132|41766463|FG000|Overall Study|Lost to Follow-up|8|||
19483686|NCT01484132|41766463|FG000|Overall Study|Difficulty with time commitment|2|||
19483687|NCT01484132|41766463|FG000|Overall Study|Ineligible|1|||
19483688|NCT01484132|41766463|FG000|Overall Study|No pre-treatment urine sample collected|1|||
19483689|NCT01484132|41766463|FG000|Overall Study|No post-treatment urine sample collected|10|||
19483690|NCT01276041|41766467|FG000|Overall Study|Adverse Event|2|||
19483691|NCT01276041|41766467|FG000|Overall Study|Protocol Violation|1|||
19483692|NCT01275339|41766475|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
19483693|NCT01275339|41766476|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
19483694|NCT01275339|41766477|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
19483695|NCT01275339|41766478|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
19483696|NCT01275339|41766475|FG000|Overall Study|Withdrawal by Subject|0|||
19483697|NCT01275339|41766476|FG001|Overall Study|Withdrawal by Subject|0|||
19483698|NCT01275339|41766477|FG002|Overall Study|Withdrawal by Subject|1|||
19483699|NCT01275339|41766478|FG003|Overall Study|Withdrawal by Subject|0|||
19483700|NCT01520402|41766488|FG000|Overall Study|Withdrawal by Subject|2|||
19483701|NCT01520402|41766488|FG000|Overall Study|Physician Decision|3|||
19483702|NCT01520324|41766503|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
19483703|NCT01519934|41766507|FG000|Overall Study|Lost to Follow-up|3|||
19483704|NCT01484054|41766511|FG000|Period 1|Withdrawal by Subject|0|||
19483705|NCT01484054|41766512|FG001|Period 1|Withdrawal by Subject|1|||
19483706|NCT01483820|41766519|FG000|Overall Study|Lack of Efficacy|6|||
19483707|NCT01483820|41766519|FG000|Overall Study|Adverse Event|1|||
19483708|NCT01483820|41766519|FG000|Overall Study|Death|1|||
19483709|NCT01507298|41766534|FG000|Overall Study|Protocol Violation|0|||
19483710|NCT01507298|41766535|FG001|Overall Study|Protocol Violation|6|||
19483711|NCT01483118|41766544|FG000|Overall Study|Lost to Follow-up|12|||
19483712|NCT01483118|41766545|FG001|Overall Study|Lost to Follow-up|16|||
19393117|NCT01939366|41636933|FG003|Overall Study|Lost to Follow-up|0|||
19393118|NCT01939366|41636934|FG004|Overall Study|Lost to Follow-up|0|||
19393119|NCT01939366|41636930|FG000|Overall Study|Withdrawal by Subject|1|||
19393120|NCT01939366|41636931|FG001|Overall Study|Withdrawal by Subject|0|||
19393121|NCT01939366|41636932|FG002|Overall Study|Withdrawal by Subject|2|||
19393122|NCT01939366|41636933|FG003|Overall Study|Withdrawal by Subject|2|||
19393123|NCT01939366|41636934|FG004|Overall Study|Withdrawal by Subject|3|||
19393124|NCT01939366|41636930|FG000|Overall Study|Inclusion criteria not met|0|||
19393125|NCT01939366|41636931|FG001|Overall Study|Inclusion criteria not met|1|||
19393126|NCT01939366|41636932|FG002|Overall Study|Inclusion criteria not met|1|||
19393127|NCT01939366|41636933|FG003|Overall Study|Inclusion criteria not met|0|||
19393128|NCT01939366|41636934|FG004|Overall Study|Inclusion criteria not met|1|||
19393129|NCT01939366|41636930|FG000|Overall Study|Other|0|||
19393130|NCT01939366|41636931|FG001|Overall Study|Other|0|||
19483713|NCT01506908|41766555|FG000|Overall Study|Adverse Event|1|||
19483714|NCT01506908|41766556|FG001|Overall Study|Adverse Event|0|||
19483715|NCT01519778|41766564|FG000|Overall Study|Withdrawal by Subject|3|||
19483716|NCT01519778|41766564|FG000|Overall Study|Lost to Follow-up|10|||
19483717|NCT01519778|41766564|FG000|Overall Study|Physician Decision|1|||
19483718|NCT01519700|41766572|FG000|Overall Study|Death|1|||
19483719|NCT01519700|41766573|FG001|Overall Study|Death|0|||
19483720|NCT01519700|41766574|FG002|Overall Study|Death|0|||
19483721|NCT01519700|41766575|FG003|Overall Study|Death|0|||
19483722|NCT01519700|41766572|FG000|Overall Study|Lost to Follow-up|0|||
19483723|NCT01519700|41766573|FG001|Overall Study|Lost to Follow-up|0|||
19483724|NCT01519700|41766574|FG002|Overall Study|Lost to Follow-up|1|||
19483725|NCT01519700|41766575|FG003|Overall Study|Lost to Follow-up|1|||
19483726|NCT01519700|41766572|FG000|Overall Study|Physician Decision|1|||
19483727|NCT01519700|41766573|FG001|Overall Study|Physician Decision|1|||
19483728|NCT01519700|41766574|FG002|Overall Study|Physician Decision|3|||
19483729|NCT01519700|41766575|FG003|Overall Study|Physician Decision|0|||
19483730|NCT01519700|41766572|FG000|Overall Study|Withdrawal by Subject|5|||
19483731|NCT01519700|41766573|FG001|Overall Study|Withdrawal by Subject|3|||
19393131|NCT01939366|41636932|FG002|Overall Study|Other|2|||
19393132|NCT01939366|41636933|FG003|Overall Study|Other|2|||
19483732|NCT01519700|41766574|FG002|Overall Study|Withdrawal by Subject|3|||
19483733|NCT01519700|41766575|FG003|Overall Study|Withdrawal by Subject|2|||
19483734|NCT01519700|41766572|FG000|Overall Study|Other Reason|2|||
19483735|NCT01519700|41766573|FG001|Overall Study|Other Reason|2|||
19483736|NCT01519700|41766574|FG002|Overall Study|Other Reason|0|||
19483737|NCT01519700|41766575|FG003|Overall Study|Other Reason|4|||
19483738|NCT02656680|41766593|FG000|Overall Study|Lost to Follow-up|0|||
19483739|NCT02656680|41766594|FG001|Overall Study|Lost to Follow-up|1|||
19483740|NCT02658084|41766630|FG000|Overall Study|Withdrawal by Subject|1|||
19483741|NCT02658084|41766631|FG001|Overall Study|Withdrawal by Subject|0|||
19483742|NCT02658084|41766630|FG000|Overall Study|Study Termination|1|||
19483743|NCT02658084|41766631|FG001|Overall Study|Study Termination|0|||
19483744|NCT01482962|41766647|FG000|Overall Study|Progressive Disease|65|||
19483745|NCT01482962|41766648|FG001|Overall Study|Progressive Disease|53|||
19483746|NCT01482962|41766647|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
19483747|NCT01482962|41766648|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
19483748|NCT01482962|41766647|FG000|Overall Study|Adverse Event|18|||
19483749|NCT01482962|41766648|FG001|Overall Study|Adverse Event|22|||
19393133|NCT01939366|41636934|FG004|Overall Study|Other|1|||
19483750|NCT01482962|41766647|FG000|Overall Study|Withdrawal by Participant|8|||
19483751|NCT01482962|41766648|FG001|Overall Study|Withdrawal by Participant|13|||
19393134|NCT01939366|41636930|FG000|Overall Study|Protocol Violation|0|||
19393135|NCT01939366|41636931|FG001|Overall Study|Protocol Violation|0|||
19393136|NCT01939366|41636932|FG002|Overall Study|Protocol Violation|0|||
19483752|NCT01482962|41766647|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
19483753|NCT01482962|41766648|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
19483754|NCT01482962|41766647|FG000|Overall Study|Other Reason|1|||
19704097|NCT00228384|42148407|FG001|Overall Study|Withdrawal by Subject|10|||
19483755|NCT01482962|41766648|FG001|Overall Study|Other Reason|5|||
19483756|NCT01482962|41766647|FG000|Overall Study|Study Terminated by Sponsor|5|||
19483757|NCT01482962|41766648|FG001|Overall Study|Study Terminated by Sponsor|2|||
19483758|NCT01482962|41766647|FG000|Overall Study|Did not Receive Study Drug|1|||
19483759|NCT01482962|41766648|FG001|Overall Study|Did not Receive Study Drug|6|||
19483760|NCT02655666|41766656|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
19483761|NCT01506596|41766660|FG000|Overall Study|ineligible pathology|1|||
19483762|NCT01482884|41766679|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
19483763|NCT01482884|41766680|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
19483764|NCT01482884|41766679|FG000|Overall Study|Protocol Violation|1|||
19393137|NCT01939366|41636933|FG003|Overall Study|Protocol Violation|1|||
19393138|NCT01939366|41636934|FG004|Overall Study|Protocol Violation|0|||
19483765|NCT01482884|41766680|FG001|Overall Study|Protocol Violation|0|||
19483766|NCT01482884|41766679|FG000|Overall Study|Lost to Follow-up|2|||
19483767|NCT01482884|41766680|FG001|Overall Study|Lost to Follow-up|2|||
19483768|NCT01482884|41766679|FG000|Overall Study|Lack of Efficacy|0|||
19483769|NCT01482884|41766680|FG001|Overall Study|Lack of Efficacy|1|||
19483770|NCT01482884|41766679|FG000|Overall Study|Adverse Event|2|||
19483771|NCT01482884|41766680|FG001|Overall Study|Adverse Event|1|||
19483772|NCT01482884|41766679|FG000|Overall Study|Withdrawal by Subject|8|||
19483773|NCT01482884|41766680|FG001|Overall Study|Withdrawal by Subject|13|||
19483774|NCT01518374|41766686|FG000|Overall Study|Withdrawal by Subject|2|||
19483775|NCT01518374|41766686|FG000|Overall Study|Protocol Violation|3|||
19483776|NCT01518374|41766686|FG000|Overall Study|Lost to Follow-up|2|||
19483777|NCT01481324|41766693|FG000|Overall Study|Missing Data|0|||
19393139|NCT01939366|41636930|FG000|Overall Study|Sponsor decision|0|||
19393140|NCT01939366|41636931|FG001|Overall Study|Sponsor decision|0|||
19393141|NCT01939366|41636932|FG002|Overall Study|Sponsor decision|0|||
19393142|NCT01939366|41636933|FG003|Overall Study|Sponsor decision|0|||
19393143|NCT01939366|41636934|FG004|Overall Study|Sponsor decision|2|||
19393144|NCT01939366|41636930|FG000|Overall Study|GCP non-compliance at site|2|||
19393145|NCT01939366|41636931|FG001|Overall Study|GCP non-compliance at site|3|||
19393146|NCT01939366|41636932|FG002|Overall Study|GCP non-compliance at site|2|||
19393147|NCT01939366|41636933|FG003|Overall Study|GCP non-compliance at site|3|||
19393148|NCT01939366|41636934|FG004|Overall Study|GCP non-compliance at site|3|||
19393149|NCT01918306|41636948|FG000|Overall Study|progresive disease|4|||
19393150|NCT01918306|41636949|FG001|Overall Study|progresive disease|0|||
19393151|NCT01918306|41636950|FG002|Overall Study|progresive disease|1|||
19393152|NCT01918306|41636951|FG003|Overall Study|progresive disease|1|||
19393153|NCT01918306|41636948|FG000|Overall Study|Withdrawal by Subject|0|||
19393154|NCT01918306|41636949|FG001|Overall Study|Withdrawal by Subject|0|||
19393155|NCT01918306|41636950|FG002|Overall Study|Withdrawal by Subject|0|||
19393156|NCT01918306|41636951|FG003|Overall Study|Withdrawal by Subject|2|||
19393157|NCT01918306|41636948|FG000|Overall Study|neutropenia|1|||
19393158|NCT01918306|41636949|FG001|Overall Study|neutropenia|0|||
19393159|NCT01918306|41636950|FG002|Overall Study|neutropenia|0|||
19393160|NCT01918306|41636951|FG003|Overall Study|neutropenia|0|||
19393161|NCT01918306|41636948|FG000|Overall Study|Lack of Efficacy|1|||
19393162|NCT01918306|41636949|FG001|Overall Study|Lack of Efficacy|0|||
19393163|NCT01918306|41636950|FG002|Overall Study|Lack of Efficacy|0|||
19483778|NCT01481324|41766694|FG001|Overall Study|Missing Data|2|||
19483779|NCT01481324|41766695|FG002|Overall Study|Missing Data|2|||
19483780|NCT01602510|41766703|FG000|Open Label Phase|Adverse Event|46|||
19483781|NCT01602510|41766704|FG001|Open Label Phase|Adverse Event|0|||
19483782|NCT01602510|41766705|FG002|Open Label Phase|Adverse Event|0|||
19483783|NCT01602510|41766703|FG000|Open Label Phase|Lack of Efficacy|22|||
19483784|NCT01602510|41766704|FG001|Open Label Phase|Lack of Efficacy|0|||
19483785|NCT01602510|41766705|FG002|Open Label Phase|Lack of Efficacy|0|||
19483786|NCT01602510|41766703|FG000|Open Label Phase|Protocol Violation|15|||
19483787|NCT01602510|41766704|FG001|Open Label Phase|Protocol Violation|0|||
19483788|NCT01602510|41766705|FG002|Open Label Phase|Protocol Violation|0|||
19483789|NCT01602510|41766703|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
19483790|NCT01602510|41766704|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
19483791|NCT01602510|41766705|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
19483792|NCT01602510|41766703|FG000|Open Label Phase|Lost to Follow-up|22|||
19393164|NCT01918306|41636951|FG003|Overall Study|Lack of Efficacy|0|||
19393165|NCT01918306|41636948|FG000|Overall Study|progress disease, crossover|0|||
19393166|NCT01918306|41636949|FG001|Overall Study|progress disease, crossover|0|||
19393167|NCT01918306|41636950|FG002|Overall Study|progress disease, crossover|1|||
19483793|NCT01602510|41766704|FG001|Open Label Phase|Lost to Follow-up|0|||
19483794|NCT01602510|41766705|FG002|Open Label Phase|Lost to Follow-up|0|||
19612464|NCT00811473|42061310|FG001|Overall Study|Safety Reasons|0|||
19483795|NCT01602510|41766703|FG000|Open Label Phase|Physician Decision|19|||
19483796|NCT01602510|41766704|FG001|Open Label Phase|Physician Decision|0|||
19483797|NCT01602510|41766705|FG002|Open Label Phase|Physician Decision|0|||
19483798|NCT01602510|41766703|FG000|Open Label Phase|Withdrawal by Subject|57|||
19483799|NCT01602510|41766704|FG001|Open Label Phase|Withdrawal by Subject|0|||
19483800|NCT01602510|41766705|FG002|Open Label Phase|Withdrawal by Subject|0|||
19483801|NCT01602510|41766703|FG000|Randomized Phase|Adverse Event|0|||
19483802|NCT01602510|41766704|FG001|Randomized Phase|Adverse Event|2|||
19483803|NCT01602510|41766705|FG002|Randomized Phase|Adverse Event|6|||
19483804|NCT01602510|41766703|FG000|Randomized Phase|Lack of Efficacy|0|||
19483805|NCT01602510|41766704|FG001|Randomized Phase|Lack of Efficacy|4|||
19483806|NCT01602510|41766705|FG002|Randomized Phase|Lack of Efficacy|4|||
19483807|NCT01602510|41766703|FG000|Randomized Phase|Protocol Violation|0|||
19483808|NCT01602510|41766704|FG001|Randomized Phase|Protocol Violation|3|||
19483809|NCT01602510|41766705|FG002|Randomized Phase|Protocol Violation|3|||
19483810|NCT01602510|41766703|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
19483811|NCT01602510|41766704|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
19483812|NCT01602510|41766705|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
19483813|NCT01602510|41766703|FG000|Randomized Phase|Lost to Follow-up|0|||
19483814|NCT01602510|41766704|FG001|Randomized Phase|Lost to Follow-up|1|||
19483815|NCT01602510|41766705|FG002|Randomized Phase|Lost to Follow-up|3|||
19483816|NCT01602510|41766703|FG000|Randomized Phase|Physician Decision|0|||
19483817|NCT01602510|41766704|FG001|Randomized Phase|Physician Decision|0|||
19483818|NCT01602510|41766705|FG002|Randomized Phase|Physician Decision|2|||
19483819|NCT01602510|41766703|FG000|Randomized Phase|Withdrawal by Subject|0|||
19483820|NCT01602510|41766704|FG001|Randomized Phase|Withdrawal by Subject|6|||
19483821|NCT01602510|41766705|FG002|Randomized Phase|Withdrawal by Subject|7|||
19483822|NCT01675596|41766720|FG000|Overall Study|Death|6|||
19483823|NCT01675596|41766720|FG000|Overall Study|Exit with other reason|1|||
19483824|NCT01675596|41766720|FG000|Overall Study|Missed Visit|1|||
19483825|NCT02653326|41766730|FG000|Overall Study|Lost to Follow-up|10|||
19483826|NCT02653326|41766731|FG001|Overall Study|Lost to Follow-up|7|||
19483827|NCT02653170|41766740|FG000|Overall Study|Withdrawal by Subject|3|||
19483828|NCT02653170|41766741|FG001|Overall Study|Withdrawal by Subject|8|||
19483829|NCT02653170|41766742|FG002|Overall Study|Withdrawal by Subject|3|||
19483830|NCT02653170|41766740|FG000|Overall Study|withdrawn by study team|2|||
19483831|NCT02653170|41766741|FG001|Overall Study|withdrawn by study team|4|||
19483832|NCT02653170|41766742|FG002|Overall Study|withdrawn by study team|5|||
19483833|NCT02653170|41766740|FG000|Overall Study|Lost to Follow-up|12|||
19483834|NCT02653170|41766741|FG001|Overall Study|Lost to Follow-up|4|||
19483835|NCT02653170|41766742|FG002|Overall Study|Lost to Follow-up|10|||
19483836|NCT01463696|41766771|FG000|Overall Study|Adverse Event|0|||
19483837|NCT01463696|41766772|FG001|Overall Study|Adverse Event|1|||
19483838|NCT01463696|41766773|FG002|Overall Study|Adverse Event|0|||
19483839|NCT01463696|41766774|FG003|Overall Study|Adverse Event|2|||
19483840|NCT01463696|41766775|FG004|Overall Study|Adverse Event|0|||
19483841|NCT01463696|41766776|FG005|Overall Study|Adverse Event|1|||
19483842|NCT01463696|41766777|FG006|Overall Study|Adverse Event|3|||
19483843|NCT01463696|41766778|FG007|Overall Study|Adverse Event|2|||
19483844|NCT01463696|41766771|FG000|Overall Study|Lost to Follow-up|0|||
19483845|NCT01463696|41766772|FG001|Overall Study|Lost to Follow-up|0|||
19483846|NCT01463696|41766773|FG002|Overall Study|Lost to Follow-up|1|||
19483847|NCT01463696|41766774|FG003|Overall Study|Lost to Follow-up|0|||
19483848|NCT01463696|41766775|FG004|Overall Study|Lost to Follow-up|0|||
19483849|NCT01463696|41766776|FG005|Overall Study|Lost to Follow-up|0|||
19483850|NCT01463696|41766777|FG006|Overall Study|Lost to Follow-up|0|||
19483851|NCT01463696|41766778|FG007|Overall Study|Lost to Follow-up|0|||
19483852|NCT01463696|41766771|FG000|Overall Study|Progressive Disease|0|||
19483853|NCT01463696|41766772|FG001|Overall Study|Progressive Disease|1|||
19483854|NCT01463696|41766773|FG002|Overall Study|Progressive Disease|0|||
19483855|NCT01463696|41766774|FG003|Overall Study|Progressive Disease|1|||
19483856|NCT01463696|41766775|FG004|Overall Study|Progressive Disease|0|||
19483857|NCT01463696|41766776|FG005|Overall Study|Progressive Disease|1|||
19483858|NCT01463696|41766777|FG006|Overall Study|Progressive Disease|4|||
19483859|NCT01463696|41766778|FG007|Overall Study|Progressive Disease|2|||
19483860|NCT01463696|41766771|FG000|Overall Study|Withdrawal by Subject|0|||
19483861|NCT01463696|41766772|FG001|Overall Study|Withdrawal by Subject|0|||
19483862|NCT01463696|41766773|FG002|Overall Study|Withdrawal by Subject|0|||
19483863|NCT01463696|41766774|FG003|Overall Study|Withdrawal by Subject|1|||
19483864|NCT01463696|41766775|FG004|Overall Study|Withdrawal by Subject|1|||
19483865|NCT01463696|41766776|FG005|Overall Study|Withdrawal by Subject|1|||
19483866|NCT01463696|41766777|FG006|Overall Study|Withdrawal by Subject|2|||
19483867|NCT01463696|41766778|FG007|Overall Study|Withdrawal by Subject|0|||
19483868|NCT01463696|41766771|FG000|Overall Study|Not Treated|0|||
19483869|NCT01463696|41766772|FG001|Overall Study|Not Treated|0|||
19483870|NCT01463696|41766773|FG002|Overall Study|Not Treated|0|||
19483871|NCT01463696|41766774|FG003|Overall Study|Not Treated|0|||
19483872|NCT01463696|41766775|FG004|Overall Study|Not Treated|0|||
19393168|NCT01918306|41636951|FG003|Overall Study|progress disease, crossover|0|||
19393169|NCT01917526|41636973|FG000|Overall Study|Protocol Violation|1|||
19393170|NCT01917526|41636974|FG001|Overall Study|Protocol Violation|1|||
19393171|NCT01948258|41636980|FG000|Overall Study|Pregnancy|41|||
19393172|NCT01948258|41636980|FG000|Overall Study|Did not complete by cut-off date|35|||
19393173|NCT01948258|41636980|FG000|Overall Study|Lost to Follow-up|27|||
19393174|NCT01948258|41636980|FG000|Overall Study|Withdrawal by SPD|8|||
19393175|NCT01948258|41636980|FG000|Overall Study|Withdrawal by Subject|6|||
19393176|NCT01948258|41636980|FG000|Overall Study|Health Care Professional|43|||
19393177|NCT01948258|41636980|FG000|Overall Study|Removed from statistical analysis|2|||
19393178|NCT01916980|41636986|FG000|Overall Study|Adverse Event|4|||
19393179|NCT01916980|41636987|FG001|Overall Study|Adverse Event|2|||
19483873|NCT01463696|41766776|FG005|Overall Study|Not Treated|0|||
19483874|NCT01463696|41766777|FG006|Overall Study|Not Treated|1|||
19483875|NCT01463696|41766778|FG007|Overall Study|Not Treated|0|||
19483876|NCT02653482|41766798|FG000|Overall Study|Death|1|||
19483877|NCT02653482|41766799|FG001|Overall Study|Death|1|||
19483878|NCT01362348|41766805|FG000|Overall Study|Protocol-defined stopping criteria|9|||
19483879|NCT01362348|41766805|FG000|Overall Study|Study closed/terminated|5|||
19483880|NCT01675128|41766875|FG000|Overall Study|Disease progression on study|1|||
19483881|NCT01675128|41766876|FG001|Overall Study|Disease progression on study|1|||
19483882|NCT01675128|41766877|FG002|Overall Study|Disease progression on study|1|||
19483883|NCT01675128|41766875|FG000|Overall Study|Refused further treatment|1|||
19483884|NCT01675128|41766876|FG001|Overall Study|Refused further treatment|0|||
19483885|NCT01675128|41766877|FG002|Overall Study|Refused further treatment|0|||
19483886|NCT01675128|41766875|FG000|Overall Study|Pulmonary complication; off study|0|||
19483887|NCT01675128|41766876|FG001|Overall Study|Pulmonary complication; off study|1|||
19483888|NCT01675128|41766877|FG002|Overall Study|Pulmonary complication; off study|0|||
19483889|NCT01427309|41766923|FG000|Overall Study|Lost to Follow-up|130|||
19483890|NCT01427309|41766924|FG001|Overall Study|Lost to Follow-up|145|||
19483891|NCT01427309|41766925|FG002|Overall Study|Lost to Follow-up|122|||
19483892|NCT01427309|41766926|FG003|Overall Study|Lost to Follow-up|135|||
19483893|NCT01427309|41766923|FG000|Overall Study|Protocol Violation|42|||
19483894|NCT01427309|41766924|FG001|Overall Study|Protocol Violation|69|||
19483895|NCT01427309|41766925|FG002|Overall Study|Protocol Violation|125|||
19483896|NCT01427309|41766926|FG003|Overall Study|Protocol Violation|124|||
19483897|NCT01427309|41766923|FG000|Overall Study|Adverse Event|0|||
19483898|NCT01427309|41766924|FG001|Overall Study|Adverse Event|0|||
19483899|NCT01427309|41766925|FG002|Overall Study|Adverse Event|3|||
19483900|NCT01427309|41766926|FG003|Overall Study|Adverse Event|1|||
19483901|NCT01427309|41766923|FG000|Overall Study|Serious adverse event|52|||
19483902|NCT01427309|41766924|FG001|Overall Study|Serious adverse event|45|||
19483903|NCT01427309|41766925|FG002|Overall Study|Serious adverse event|50|||
19483904|NCT01427309|41766926|FG003|Overall Study|Serious adverse event|61|||
19483905|NCT01427309|41766923|FG000|Overall Study|Withdrawal by Subject|148|||
19483906|NCT01427309|41766924|FG001|Overall Study|Withdrawal by Subject|148|||
19483907|NCT01427309|41766925|FG002|Overall Study|Withdrawal by Subject|61|||
19483908|NCT01427309|41766926|FG003|Overall Study|Withdrawal by Subject|55|||
19483909|NCT01426373|41766936|FG000|Overall Study|Adverse Event|6|||
19483910|NCT01426373|41766936|FG000|Overall Study|Lost to Follow-up|14|||
19483911|NCT01426373|41766936|FG000|Overall Study|Participant Convenience|10|||
19483912|NCT01426373|41766936|FG000|Overall Study|Miscellaneous Reasons|4|||
19483913|NCT01426217|41766944|FG000|Overall Study|lost sample|8|||
19483914|NCT01426217|41766945|FG001|Overall Study|lost sample|14|||
19483915|NCT01425749|41766953|FG000|Overall Study|progression of melanoma|0|||
19483916|NCT01425749|41766954|FG001|Overall Study|progression of melanoma|1|||
19483917|NCT01403987|41766970|FG000|Overall Study|Residents forgot their secret PIN|18|||
19483918|NCT01403987|41766971|FG001|Overall Study|Residents forgot their secret PIN|17|||
19483919|NCT01403987|41766972|FG002|Overall Study|Residents forgot their secret PIN|18|||
19483920|NCT01425359|41766982|FG000|Overall Study|Randomized but Not Treated|2|||
19483921|NCT01425359|41766983|FG001|Overall Study|Randomized but Not Treated|3|||
19483922|NCT01425359|41766982|FG000|Overall Study|Adverse Event|9|||
19483923|NCT01425359|41766983|FG001|Overall Study|Adverse Event|8|||
19483924|NCT01425359|41766982|FG000|Overall Study|Revascularization|0|||
19483925|NCT01425359|41766983|FG001|Overall Study|Revascularization|1|||
19483926|NCT01425359|41766982|FG000|Overall Study|Death|0|||
19483927|NCT01425359|41766983|FG001|Overall Study|Death|1|||
19483928|NCT01425359|41766982|FG000|Overall Study|Unsatisfactory Response|1|||
19483929|NCT01425359|41766983|FG001|Overall Study|Unsatisfactory Response|0|||
19483930|NCT01425359|41766982|FG000|Overall Study|Protocol Violation|1|||
19483931|NCT01425359|41766983|FG001|Overall Study|Protocol Violation|2|||
19483932|NCT01425359|41766982|FG000|Overall Study|Subject Withdrew Consent|1|||
19483933|NCT01425359|41766983|FG001|Overall Study|Subject Withdrew Consent|2|||
19483934|NCT01425359|41766982|FG000|Overall Study|Investigator's Discretion|2|||
19483935|NCT01425359|41766983|FG001|Overall Study|Investigator's Discretion|0|||
19393180|NCT01916980|41636986|FG000|Overall Study|Lack of Efficacy|2|||
19483936|NCT01425359|41766982|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
19483937|NCT01425359|41766983|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
19483938|NCT01403051|41767003|FG000|Overall Study|Protocol Violation|2|||
19483939|NCT01403051|41767004|FG001|Overall Study|Protocol Violation|0|||
19483940|NCT01403051|41767003|FG000|Overall Study|Death|1|||
19483941|NCT01403051|41767004|FG001|Overall Study|Death|0|||
19483942|NCT01403051|41767003|FG000|Overall Study|Withdrawal by Subject|2|||
19393181|NCT01916980|41636987|FG001|Overall Study|Lack of Efficacy|2|||
19393182|NCT01916980|41636986|FG000|Overall Study|Withdrawal by Subject|1|||
19393183|NCT01916980|41636987|FG001|Overall Study|Withdrawal by Subject|0|||
19483943|NCT01403051|41767004|FG001|Overall Study|Withdrawal by Subject|1|||
19483944|NCT01403051|41767003|FG000|Overall Study|Lost to Follow-up|5|||
19483945|NCT01403051|41767004|FG001|Overall Study|Lost to Follow-up|5|||
19483946|NCT04115748|41767019|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
19483947|NCT04115748|41767020|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
19483948|NCT04115748|41767021|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
19483949|NCT04115748|41767022|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
19483950|NCT04115748|41767023|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483951|NCT04115748|41767024|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483952|NCT04115748|41767025|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483953|NCT04115748|41767026|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483954|NCT04115748|41767027|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483955|NCT04115748|41767028|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
19483956|NCT04115748|41767019|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483957|NCT04115748|41767020|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483958|NCT04115748|41767021|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483959|NCT04115748|41767022|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
19483960|NCT04115748|41767023|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483961|NCT04115748|41767024|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483962|NCT04115748|41767025|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483963|NCT04115748|41767026|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19393184|NCT02637557|41637003|FG000|Overall Study|Adverse Event|3|||
19393185|NCT02637557|41637004|FG001|Overall Study|Adverse Event|1|||
19393186|NCT02637557|41637005|FG002|Overall Study|Adverse Event|3|||
19483964|NCT04115748|41767027|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483965|NCT04115748|41767028|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
19483966|NCT04115748|41767019|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
19483967|NCT04115748|41767020|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
19483968|NCT04115748|41767021|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
19483969|NCT04115748|41767022|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
19483970|NCT04115748|41767023|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
19483971|NCT04115748|41767024|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
19483972|NCT04115748|41767025|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
19483973|NCT04115748|41767026|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
19483974|NCT04115748|41767027|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
19483975|NCT04115748|41767028|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
19483976|NCT04115748|41767019|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483977|NCT04115748|41767020|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483978|NCT04115748|41767021|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483979|NCT04115748|41767022|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483980|NCT04115748|41767023|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483981|NCT04115748|41767024|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483982|NCT04115748|41767025|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483983|NCT04115748|41767026|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483984|NCT04115748|41767027|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
19483985|NCT04115748|41767028|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
19483986|NCT02652624|41767085|FG000|Randomized Phase|Pregnancy|3|||
19483987|NCT02652624|41767086|FG001|Randomized Phase|Pregnancy|1|||
19483988|NCT02652624|41767085|FG000|Randomized Phase|Investigator's Discretion|0|||
19393187|NCT02637557|41637006|FG003|Overall Study|Adverse Event|3|||
19393188|NCT02637557|41637003|FG000|Overall Study|Lost to Follow-up|1|||
19393189|NCT02637557|41637004|FG001|Overall Study|Lost to Follow-up|1|||
19483989|NCT02652624|41767086|FG001|Randomized Phase|Investigator's Discretion|2|||
19483990|NCT02652624|41767085|FG000|Randomized Phase|Death|0|||
19483991|NCT02652624|41767086|FG001|Randomized Phase|Death|1|||
19483992|NCT02652624|41767085|FG000|Randomized Phase|Lost to Follow-up|0|||
19483993|NCT02652624|41767086|FG001|Randomized Phase|Lost to Follow-up|1|||
19483994|NCT02652624|41767085|FG000|Extension Phase|Lost to Follow-up|3|||
19483995|NCT02652624|41767086|FG001|Extension Phase|Lost to Follow-up|1|||
19483996|NCT02652624|41767085|FG000|Extension Phase|Pregnancy|1|||
19483997|NCT02652624|41767086|FG001|Extension Phase|Pregnancy|1|||
19483998|NCT02652624|41767085|FG000|Extension Phase|Adverse Event|0|||
19393190|NCT02637557|41637005|FG002|Overall Study|Lost to Follow-up|0|||
19393191|NCT02637557|41637006|FG003|Overall Study|Lost to Follow-up|1|||
19483999|NCT02652624|41767086|FG001|Extension Phase|Adverse Event|1|||
19484000|NCT02652624|41767085|FG000|Extension Phase|Withdrew Consent|0|||
19484001|NCT02652624|41767086|FG001|Extension Phase|Withdrew Consent|1|||
19484002|NCT00249795|41767096|FG000|Overall Study|Not treated|16|||
19484003|NCT00249795|41767097|FG001|Overall Study|Not treated|14|||
19484004|NCT00249795|41767096|FG000|Overall Study|Symptomatic hypotension|127|||
19484005|NCT00249795|41767097|FG001|Overall Study|Symptomatic hypotension|64|||
19484006|NCT00249795|41767096|FG000|Overall Study|Other Serious Adverse Event|84|||
19484007|NCT00249795|41767097|FG001|Overall Study|Other Serious Adverse Event|93|||
19484008|NCT00249795|41767096|FG000|Overall Study|Qualifying condition not present|26|||
19484009|NCT00249795|41767097|FG001|Overall Study|Qualifying condition not present|29|||
19484010|NCT00249795|41767096|FG000|Overall Study|Withdrawal by Subject|678|||
19484011|NCT00249795|41767097|FG001|Overall Study|Withdrawal by Subject|742|||
19484012|NCT00249795|41767096|FG000|Overall Study|Thromboembolic / outcome event|39|||
19484013|NCT00249795|41767097|FG001|Overall Study|Thromboembolic / outcome event|45|||
19484014|NCT00249795|41767096|FG000|Overall Study|Oral anticoagulant required|2|||
19484015|NCT00249795|41767097|FG001|Overall Study|Oral anticoagulant required|0|||
19484016|NCT00249795|41767096|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
19484017|NCT00249795|41767097|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
19484018|NCT00249795|41767096|FG000|Overall Study|Non-compliance|71|||
19484019|NCT00249795|41767097|FG001|Overall Study|Non-compliance|69|||
19484020|NCT00249795|41767096|FG000|Overall Study|Study drug intolerance|3|||
19484021|NCT00249795|41767097|FG001|Overall Study|Study drug intolerance|3|||
19484022|NCT00249795|41767096|FG000|Overall Study|Other adverse events (non-serious)|188|||
19484023|NCT00249795|41767097|FG001|Overall Study|Other adverse events (non-serious)|159|||
19484024|NCT00249795|41767096|FG000|Overall Study|Physician withdrew consent|71|||
19484025|NCT00249795|41767097|FG001|Overall Study|Physician withdrew consent|63|||
19484026|NCT00249795|41767096|FG000|Overall Study|Surgery / procedure|4|||
19484027|NCT00249795|41767097|FG001|Overall Study|Surgery / procedure|5|||
19484028|NCT00249795|41767096|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
19484029|NCT00249795|41767097|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
19484030|NCT00249795|41767096|FG000|Overall Study|Lightheadedness / dizziness|15|||
19484031|NCT00249795|41767097|FG001|Overall Study|Lightheadedness / dizziness|11|||
19484032|NCT00249795|41767096|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
19484033|NCT00249795|41767097|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
19484034|NCT00249795|41767096|FG000|Overall Study|Other contraindicated medication|1|||
19484035|NCT00249795|41767097|FG001|Overall Study|Other contraindicated medication|1|||
19484036|NCT00249795|41767096|FG000|Overall Study|Event related to cardiac condition|17|||
19484037|NCT00249795|41767097|FG001|Overall Study|Event related to cardiac condition|16|||
19484038|NCT00249795|41767096|FG000|Overall Study|Patient not wish to continue after May08|4|||
19484039|NCT00249795|41767097|FG001|Overall Study|Patient not wish to continue after May08|6|||
19484040|NCT00249795|41767096|FG000|Overall Study|Site not agree to continue after May08|1|||
19484041|NCT00249795|41767097|FG001|Overall Study|Site not agree to continue after May08|1|||
19484042|NCT00249795|41767096|FG000|Overall Study|Lost to Follow-up|0|||
19484043|NCT00249795|41767097|FG001|Overall Study|Lost to Follow-up|2|||
19484044|NCT00249795|41767096|FG000|Overall Study|Missing|0|||
19484045|NCT00249795|41767097|FG001|Overall Study|Missing|1|||
19484046|NCT02651220|41767106|FG000|Overall Study|Adverse Event|1|||
19484047|NCT02651220|41767107|FG001|Overall Study|Adverse Event|5|||
19484048|NCT02651220|41767108|FG002|Overall Study|Adverse Event|1|||
19484049|NCT02651220|41767106|FG000|Overall Study|Lost to Follow-up|8|||
19484050|NCT02651220|41767107|FG001|Overall Study|Lost to Follow-up|14|||
19484051|NCT02651220|41767108|FG002|Overall Study|Lost to Follow-up|14|||
19484052|NCT02651220|41767106|FG000|Overall Study|Non-Compliance with Study Drug|4|||
19484053|NCT02651220|41767107|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19484054|NCT02651220|41767108|FG002|Overall Study|Non-Compliance with Study Drug|1|||
19484055|NCT02651220|41767106|FG000|Overall Study|Pregnancy|1|||
19484056|NCT02651220|41767107|FG001|Overall Study|Pregnancy|0|||
19484057|NCT02651220|41767108|FG002|Overall Study|Pregnancy|1|||
19484058|NCT02651220|41767106|FG000|Overall Study|Protocol Violation|0|||
19484059|NCT02651220|41767107|FG001|Overall Study|Protocol Violation|0|||
19484060|NCT02651220|41767108|FG002|Overall Study|Protocol Violation|1|||
19484061|NCT02651220|41767106|FG000|Overall Study|Withdrawal by Subject|5|||
19484062|NCT02651220|41767107|FG001|Overall Study|Withdrawal by Subject|6|||
19484063|NCT02651220|41767108|FG002|Overall Study|Withdrawal by Subject|8|||
19484064|NCT02651220|41767106|FG000|Overall Study|Miscellaneous|4|||
19484065|NCT02651220|41767107|FG001|Overall Study|Miscellaneous|1|||
19484066|NCT02651220|41767108|FG002|Overall Study|Miscellaneous|2|||
19484067|NCT02651220|41767106|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19484068|NCT02651220|41767107|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19484069|NCT02651220|41767108|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
19484070|NCT00247611|41767156|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
19484071|NCT00247611|41767157|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
19484072|NCT00247611|41767156|FG000|Baselined|Completed baseline only|9|||
19393192|NCT02637557|41637003|FG000|Overall Study|Physician Decision|1|||
19484073|NCT00247611|41767157|FG001|Baselined|Completed baseline only|8|||
19484074|NCT00246753|41767173|FG000|Overall Study|Withdrawal by Subject|2|||
19484075|NCT00246753|41767173|FG000|Overall Study|Physician Decision|2|||
19484076|NCT00246753|41767173|FG000|Overall Study|Adverse Event|2|||
19484077|NCT00246753|41767173|FG000|Overall Study|Unacceptable toxicity|2|||
19484078|NCT00246129|41767190|FG000|Overall Study|Lost to Follow-up|1|||
19484079|NCT00246129|41767191|FG001|Overall Study|Lost to Follow-up|0|||
19484080|NCT00246129|41767190|FG000|Overall Study|Death|2|||
19484081|NCT00246129|41767191|FG001|Overall Study|Death|1|||
19484082|NCT00246129|41767190|FG000|Overall Study|suffered primary non-function|1|||
19484083|NCT00246129|41767191|FG001|Overall Study|suffered primary non-function|0|||
19484084|NCT00246129|41767190|FG000|Overall Study|grafts failed|3|||
19484085|NCT00246129|41767191|FG001|Overall Study|grafts failed|1|||
19484086|NCT03182868|41767214|FG000|Overall Study|Protocol Violation|3|||
19484087|NCT03182868|41767215|FG001|Overall Study|Protocol Violation|0|||
19484088|NCT03182868|41767216|FG002|Overall Study|Protocol Violation|4|||
19484089|NCT03182868|41767217|FG003|Overall Study|Protocol Violation|1|||
19484090|NCT03182868|41767218|FG004|Overall Study|Protocol Violation|8|||
19484091|NCT00245583|41767242|FG000|Overall Study|Lost to Follow-up|1|||
19484092|NCT00245583|41767243|FG001|Overall Study|Lost to Follow-up|5|||
19484093|NCT00245583|41767242|FG000|Overall Study|Adverse Event|2|||
19484094|NCT00245583|41767243|FG001|Overall Study|Adverse Event|1|||
19484095|NCT00245583|41767242|FG000|Overall Study|Lack of Efficacy|1|||
19484096|NCT00245583|41767243|FG001|Overall Study|Lack of Efficacy|0|||
19484097|NCT00245583|41767242|FG000|Overall Study|Withdrawal by Subject|2|||
19484098|NCT00245583|41767243|FG001|Overall Study|Withdrawal by Subject|3|||
19484099|NCT02652156|41767263|FG000|Overall Study|Physician Decision|1|||
19484100|NCT02652156|41767264|FG001|Overall Study|Physician Decision|0|||
19393193|NCT02637557|41637004|FG001|Overall Study|Physician Decision|0|||
19393194|NCT02637557|41637005|FG002|Overall Study|Physician Decision|0|||
19393195|NCT02637557|41637006|FG003|Overall Study|Physician Decision|0|||
19393196|NCT02637557|41637003|FG000|Overall Study|Protocol Violation|2|||
19393197|NCT02637557|41637004|FG001|Overall Study|Protocol Violation|0|||
19393198|NCT02637557|41637005|FG002|Overall Study|Protocol Violation|2|||
19393199|NCT02637557|41637006|FG003|Overall Study|Protocol Violation|1|||
19393200|NCT02637557|41637003|FG000|Overall Study|Withdrawal by Subject|1|||
19484101|NCT02652156|41767265|FG002|Overall Study|Physician Decision|0|||
19484102|NCT01675050|41767312|FG000|Period One Treatment|Withdrawal by Subject|1|||
19484103|NCT01675050|41767313|FG001|Period One Treatment|Withdrawal by Subject|0|||
19484104|NCT00244881|41767332|FG000|Overall Study|Withdrawal by Subject|3|||
19484105|NCT00244725|41767363|FG000|Overall Study|Lost to Follow-up|3|||
19484106|NCT00244725|41767364|FG001|Overall Study|Lost to Follow-up|4|||
19484107|NCT00244725|41767365|FG002|Overall Study|Lost to Follow-up|9|||
19484108|NCT00244725|41767366|FG003|Overall Study|Lost to Follow-up|2|||
19484109|NCT00244725|41767363|FG000|Overall Study|Withdrawal by Subject|9|||
19484110|NCT00244725|41767364|FG001|Overall Study|Withdrawal by Subject|7|||
19484111|NCT00244725|41767365|FG002|Overall Study|Withdrawal by Subject|7|||
19484112|NCT00244725|41767366|FG003|Overall Study|Withdrawal by Subject|8|||
19484113|NCT00244725|41767363|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
19484114|NCT00244725|41767364|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
19484115|NCT00244725|41767365|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
19484116|NCT00244725|41767366|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
19484117|NCT00244725|41767363|FG000|Overall Study|Physician Decision|3|||
19484118|NCT00244725|41767364|FG001|Overall Study|Physician Decision|0|||
19484119|NCT00244725|41767365|FG002|Overall Study|Physician Decision|1|||
19484120|NCT00244725|41767366|FG003|Overall Study|Physician Decision|2|||
19484121|NCT00244725|41767363|FG000|Overall Study|Adverse Events|3|||
19484122|NCT00244725|41767364|FG001|Overall Study|Adverse Events|1|||
19484123|NCT00244725|41767365|FG002|Overall Study|Adverse Events|4|||
19484124|NCT00244725|41767366|FG003|Overall Study|Adverse Events|4|||
19484125|NCT00244725|41767363|FG000|Overall Study|Withdrwal by participant|1|||
19484126|NCT00244725|41767364|FG001|Overall Study|Withdrwal by participant|0|||
19484127|NCT00244725|41767365|FG002|Overall Study|Withdrwal by participant|0|||
19484128|NCT00244725|41767366|FG003|Overall Study|Withdrwal by participant|1|||
19484129|NCT00244725|41767363|FG000|Overall Study|Liver function test abnormality|2|||
19484130|NCT00244725|41767364|FG001|Overall Study|Liver function test abnormality|0|||
19484131|NCT00244725|41767365|FG002|Overall Study|Liver function test abnormality|0|||
19484132|NCT00244725|41767366|FG003|Overall Study|Liver function test abnormality|1|||
19484133|NCT00244725|41767363|FG000|Overall Study|Sponsor withdrew the participant|1|||
19484134|NCT00244725|41767364|FG001|Overall Study|Sponsor withdrew the participant|0|||
19484135|NCT00244725|41767365|FG002|Overall Study|Sponsor withdrew the participant|0|||
19484136|NCT00244725|41767366|FG003|Overall Study|Sponsor withdrew the participant|1|||
19484137|NCT00244725|41767363|FG000|Overall Study|Mediciation Error|0|||
19484138|NCT00244725|41767364|FG001|Overall Study|Mediciation Error|1|||
19393201|NCT02637557|41637004|FG001|Overall Study|Withdrawal by Subject|3|||
19484139|NCT00244725|41767365|FG002|Overall Study|Mediciation Error|0|||
19484140|NCT00244725|41767366|FG003|Overall Study|Mediciation Error|0|||
19484141|NCT00244725|41767363|FG000|Overall Study|Rehab Refused to allow participantion|0|||
19484142|NCT00244725|41767364|FG001|Overall Study|Rehab Refused to allow participantion|1|||
19484143|NCT00244725|41767365|FG002|Overall Study|Rehab Refused to allow participantion|0|||
19484144|NCT00244725|41767366|FG003|Overall Study|Rehab Refused to allow participantion|0|||
19484145|NCT00244725|41767363|FG000|Overall Study|Headache|0|||
19484146|NCT00244725|41767364|FG001|Overall Study|Headache|1|||
19484147|NCT00244725|41767365|FG002|Overall Study|Headache|0|||
19484148|NCT00244725|41767366|FG003|Overall Study|Headache|0|||
19484149|NCT00244725|41767363|FG000|Overall Study|Received prohibited medication|0|||
19484150|NCT00244725|41767364|FG001|Overall Study|Received prohibited medication|1|||
19484151|NCT00244725|41767365|FG002|Overall Study|Received prohibited medication|0|||
19484152|NCT00244725|41767366|FG003|Overall Study|Received prohibited medication|1|||
19484153|NCT00244725|41767363|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
19484154|NCT00244725|41767364|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
19484155|NCT00244725|41767365|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
19484156|NCT00244725|41767366|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
19484157|NCT00244725|41767363|FG000|Overall Study|Administrative reason|0|||
19484158|NCT00244725|41767364|FG001|Overall Study|Administrative reason|0|||
19484159|NCT00244725|41767365|FG002|Overall Study|Administrative reason|1|||
19484160|NCT00244725|41767366|FG003|Overall Study|Administrative reason|0|||
19484161|NCT00244725|41767363|FG000|Overall Study|Vomit|0|||
19484162|NCT00244725|41767364|FG001|Overall Study|Vomit|0|||
19484163|NCT00244725|41767365|FG002|Overall Study|Vomit|1|||
19484164|NCT00244725|41767366|FG003|Overall Study|Vomit|0|||
19484165|NCT00244725|41767363|FG000|Overall Study|Failed to follow-up|0|||
19484166|NCT00244725|41767364|FG001|Overall Study|Failed to follow-up|0|||
19484167|NCT00244725|41767365|FG002|Overall Study|Failed to follow-up|1|||
19484168|NCT00244725|41767366|FG003|Overall Study|Failed to follow-up|1|||
19484169|NCT02649894|41767378|FG000|Overall Study|Adverse Event|1|||
19484170|NCT02649894|41767379|FG001|Overall Study|Adverse Event|0|||
19484171|NCT02649894|41767378|FG000|Overall Study|Physician Decision|0|||
19484172|NCT02649894|41767379|FG001|Overall Study|Physician Decision|1|||
19484173|NCT02649894|41767378|FG000|Overall Study|Withdrawal by Subject|5|||
19484174|NCT02649894|41767379|FG001|Overall Study|Withdrawal by Subject|2|||
19484175|NCT02649894|41767378|FG000|Overall Study|Lost to Follow-up|2|||
19484176|NCT02649894|41767379|FG001|Overall Study|Lost to Follow-up|1|||
19484177|NCT02649894|41767378|FG000|Overall Study|Death|30|||
19484178|NCT02649894|41767379|FG001|Overall Study|Death|7|||
19484179|NCT02649894|41767378|FG000|Overall Study|Other, not specified|6|||
19484180|NCT02649894|41767379|FG001|Overall Study|Other, not specified|0|||
19484181|NCT01278615|41767385|FG000|Overall Study|Withdrawal by Subject|2|||
19484182|NCT01505114|41767411|FG000|Overall Study|Withdrawal by Subject|5|||
19484183|NCT01505114|41767412|FG001|Overall Study|Withdrawal by Subject|4|||
19484184|NCT01505114|41767413|FG002|Overall Study|Withdrawal by Subject|4|||
19484185|NCT01505114|41767414|FG003|Overall Study|Withdrawal by Subject|7|||
19484186|NCT01505114|41767411|FG000|Overall Study|Death|1|||
19484187|NCT01505114|41767412|FG001|Overall Study|Death|0|||
19484188|NCT01505114|41767413|FG002|Overall Study|Death|0|||
19484189|NCT01505114|41767414|FG003|Overall Study|Death|1|||
19484190|NCT01505114|41767411|FG000|Overall Study|unable to adhere to visit schedule|3|||
19484191|NCT01505114|41767412|FG001|Overall Study|unable to adhere to visit schedule|2|||
19484192|NCT01505114|41767413|FG002|Overall Study|unable to adhere to visit schedule|3|||
19484193|NCT01505114|41767414|FG003|Overall Study|unable to adhere to visit schedule|3|||
19484194|NCT01505114|41767411|FG000|Overall Study|Lost to Follow-up|11|||
19484195|NCT01505114|41767412|FG001|Overall Study|Lost to Follow-up|5|||
19484196|NCT01505114|41767413|FG002|Overall Study|Lost to Follow-up|8|||
19484197|NCT01505114|41767414|FG003|Overall Study|Lost to Follow-up|7|||
19484198|NCT01505114|41767411|FG000|Overall Study|relocated|4|||
19484199|NCT01505114|41767412|FG001|Overall Study|relocated|2|||
19484200|NCT01505114|41767413|FG002|Overall Study|relocated|2|||
19484201|NCT01505114|41767414|FG003|Overall Study|relocated|3|||
19484202|NCT01505114|41767411|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
19484203|NCT01505114|41767412|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
19484204|NCT01505114|41767413|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
19484205|NCT01505114|41767414|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
19484206|NCT01505114|41767411|FG000|Overall Study|staff safety concerns|0|||
19484207|NCT01505114|41767412|FG001|Overall Study|staff safety concerns|0|||
19484208|NCT01505114|41767413|FG002|Overall Study|staff safety concerns|0|||
19484209|NCT01505114|41767414|FG003|Overall Study|staff safety concerns|1|||
19484210|NCT01505114|41767411|FG000|Overall Study|investigator decision|1|||
19484211|NCT01505114|41767412|FG001|Overall Study|investigator decision|0|||
19484212|NCT01505114|41767413|FG002|Overall Study|investigator decision|1|||
19484213|NCT01505114|41767414|FG003|Overall Study|investigator decision|0|||
19484214|NCT02651922|41767446|FG000|Overall Study|due to exclusion criteria|2|||
19484215|NCT01277757|41767450|FG000|Overall Study|Disease Progression|1|||
19484216|NCT01277757|41767450|FG000|Overall Study|Withdrawal by Subject|1|||
19484217|NCT01276821|41767456|FG000|Overall Study|Protocol Violation|0|||
19484218|NCT01276821|41767457|FG001|Overall Study|Protocol Violation|1|||
19484219|NCT00245037|41767463|FG000|Overall Study|Death|17|||
19484220|NCT00241839|41767469|FG000|Overall Study|Withdrawal by Subject|18|||
19484221|NCT00241839|41767470|FG001|Overall Study|Withdrawal by Subject|17|||
19484222|NCT00241839|41767469|FG000|Overall Study|Adverse Event|1|||
19484223|NCT00241839|41767470|FG001|Overall Study|Adverse Event|1|||
19484224|NCT02651688|41767479|FG000|Overall Study|Non-compliance|0|||
19484225|NCT02651688|41767480|FG001|Overall Study|Non-compliance|0|||
19484226|NCT02651688|41767481|FG002|Overall Study|Non-compliance|1|||
19484227|NCT02651688|41767479|FG000|Overall Study|Principal Investigator (PI) decision|0|||
19484228|NCT02651688|41767480|FG001|Overall Study|Principal Investigator (PI) decision|2|||
19484229|NCT02651688|41767481|FG002|Overall Study|Principal Investigator (PI) decision|0|||
19484230|NCT02651688|41767479|FG000|Overall Study|Lost to Follow-up|1|||
19484231|NCT02651688|41767480|FG001|Overall Study|Lost to Follow-up|3|||
19484232|NCT02651688|41767481|FG002|Overall Study|Lost to Follow-up|0|||
19484233|NCT02651688|41767479|FG000|Overall Study|Withdrawal by Subject|1|||
19484234|NCT02651688|41767480|FG001|Overall Study|Withdrawal by Subject|0|||
19484235|NCT02651688|41767481|FG002|Overall Study|Withdrawal by Subject|2|||
19484236|NCT01276353|41767491|FG000|Double-blind|Adverse Event|2|||
19484237|NCT01276353|41767492|FG001|Double-blind|Adverse Event|0|||
19484238|NCT01276353|41767491|FG000|Double-blind|Withdrawal by Subject|1|||
19484239|NCT01276353|41767492|FG001|Double-blind|Withdrawal by Subject|0|||
19484240|NCT01276353|41767491|FG000|Extension|Adverse Event|2|||
19484241|NCT01276353|41767492|FG001|Extension|Adverse Event|5|||
19484242|NCT01276353|41767491|FG000|Extension|Withdrawal by Subject|1|||
19484243|NCT01276353|41767492|FG001|Extension|Withdrawal by Subject|2|||
19484244|NCT01276353|41767491|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
19484245|NCT01276353|41767492|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
19484246|NCT01276353|41767491|FG000|Extension|Physician Decision|1|||
19484247|NCT01276353|41767492|FG001|Extension|Physician Decision|0|||
19484248|NCT01276353|41767491|FG000|Extension|Prohibited concomitant medications|0|||
19484249|NCT01276353|41767492|FG001|Extension|Prohibited concomitant medications|1|||
19484250|NCT02536794|41767527|FG000|Reached 1st Response Assessment|Adverse Event|2|||
19484251|NCT02536794|41767527|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
19484252|NCT02536794|41767527|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
19484253|NCT02536794|41767527|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
19484254|NCT02536794|41767527|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
19484255|NCT02536794|41767527|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
19484256|NCT01480076|41767606|FG000|Overall Study|Run-in Failure|52|||
19484257|NCT01480076|41767606|FG000|Overall Study|Adverse Event|39|||
19484258|NCT01480076|41767606|FG000|Overall Study|Death|2|||
19484259|NCT01480076|41767606|FG000|Overall Study|Disease Progression|5|||
19484260|NCT01480076|41767606|FG000|Overall Study|Non-compliance With Study Protocol|15|||
19484261|NCT01480076|41767606|FG000|Overall Study|Withdrawal by Subject|105|||
19484262|NCT01480076|41767606|FG000|Overall Study|Lost to Follow-up|7|||
19484263|NCT01480076|41767606|FG000|Overall Study|Investigator Decision|13|||
19484264|NCT01480076|41767606|FG000|Overall Study|Other|52|||
19484265|NCT02650128|41767694|FG000|Overall Study|Death|2|||
19484266|NCT01362270|41767709|FG000|Overall Study|Withdrawal by Subject|1|||
19484267|NCT01362270|41767710|FG001|Overall Study|Withdrawal by Subject|0|||
19484268|NCT01362270|41767709|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
19484269|NCT01362270|41767710|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
19484270|NCT01362270|41767709|FG000|Overall Study|Met excl. criteria before 1st session|1|||
19484271|NCT01362270|41767710|FG001|Overall Study|Met excl. criteria before 1st session|1|||
19484272|NCT00089479|41767731|FG000|Overall Study|Death|108|||
19484273|NCT00089479|41767732|FG001|Overall Study|Death|75|||
19484274|NCT00089479|41767731|FG000|Overall Study|Withdrawal by Subject|86|||
19484275|NCT00089479|41767732|FG001|Overall Study|Withdrawal by Subject|107|||
19484276|NCT00089479|41767731|FG000|Overall Study|Lost to Follow-up|137|||
19484277|NCT00089479|41767732|FG001|Overall Study|Lost to Follow-up|107|||
19484278|NCT01463306|41767741|FG000|Overall Study|Adverse Event|6|||
19484279|NCT01463306|41767742|FG001|Overall Study|Adverse Event|9|||
19484280|NCT01463306|41767743|FG002|Overall Study|Adverse Event|3|||
19484281|NCT01463306|41767741|FG000|Overall Study|Death|3|||
19484282|NCT01463306|41767742|FG001|Overall Study|Death|3|||
19484283|NCT01463306|41767743|FG002|Overall Study|Death|0|||
19484284|NCT01463306|41767741|FG000|Overall Study|Lack of Efficacy|22|||
19484285|NCT01463306|41767742|FG001|Overall Study|Lack of Efficacy|16|||
19484286|NCT01463306|41767743|FG002|Overall Study|Lack of Efficacy|1|||
19484287|NCT01463306|41767741|FG000|Overall Study|Lost to Follow-up|5|||
19484288|NCT01463306|41767742|FG001|Overall Study|Lost to Follow-up|2|||
19484289|NCT01463306|41767743|FG002|Overall Study|Lost to Follow-up|0|||
19484290|NCT01463306|41767741|FG000|Overall Study|Protocol Violation|4|||
19484291|NCT01463306|41767742|FG001|Overall Study|Protocol Violation|0|||
19484292|NCT01463306|41767743|FG002|Overall Study|Protocol Violation|0|||
19484293|NCT01463306|41767741|FG000|Overall Study|Withdrawal by Subject|19|||
19484294|NCT01463306|41767742|FG001|Overall Study|Withdrawal by Subject|9|||
19484295|NCT01463306|41767743|FG002|Overall Study|Withdrawal by Subject|1|||
19484296|NCT01463306|41767741|FG000|Overall Study|Other|26|||
19484297|NCT01463306|41767742|FG001|Overall Study|Other|13|||
19484298|NCT01463306|41767743|FG002|Overall Study|Other|0|||
19484299|NCT01463306|41767741|FG000|Overall Study|Approval expiry at site|1|||
19484300|NCT01463306|41767742|FG001|Overall Study|Approval expiry at site|0|||
19484301|NCT01463306|41767743|FG002|Overall Study|Approval expiry at site|0|||
19484302|NCT01504412|41767772|FG000|Overall Study|Adverse Event|1|||
19484303|NCT01504412|41767773|FG001|Overall Study|Adverse Event|8|||
19484304|NCT01504412|41767774|FG002|Overall Study|Adverse Event|1|||
19484305|NCT01504412|41767775|FG003|Overall Study|Adverse Event|7|||
19484306|NCT01504412|41767776|FG004|Overall Study|Adverse Event|10|||
19484307|NCT01504412|41767772|FG000|Overall Study|Withdrawal by Subject|2|||
19484308|NCT01504412|41767773|FG001|Overall Study|Withdrawal by Subject|1|||
19484309|NCT01504412|41767774|FG002|Overall Study|Withdrawal by Subject|1|||
19484310|NCT01504412|41767775|FG003|Overall Study|Withdrawal by Subject|5|||
19484311|NCT01504412|41767776|FG004|Overall Study|Withdrawal by Subject|1|||
19484312|NCT01504412|41767772|FG000|Overall Study|Other|2|||
19484313|NCT01504412|41767773|FG001|Overall Study|Other|1|||
19484314|NCT01504412|41767774|FG002|Overall Study|Other|1|||
19484315|NCT01504412|41767775|FG003|Overall Study|Other|6|||
19484316|NCT01504412|41767776|FG004|Overall Study|Other|1|||
19484317|NCT01504412|41767772|FG000|Overall Study|Lost to Follow-up|0|||
19484318|NCT01504412|41767773|FG001|Overall Study|Lost to Follow-up|2|||
19484319|NCT01504412|41767774|FG002|Overall Study|Lost to Follow-up|0|||
19484320|NCT01504412|41767775|FG003|Overall Study|Lost to Follow-up|0|||
19484321|NCT01504412|41767776|FG004|Overall Study|Lost to Follow-up|0|||
19484322|NCT01504412|41767772|FG000|Overall Study|Lack of Efficacy|0|||
19484323|NCT01504412|41767773|FG001|Overall Study|Lack of Efficacy|0|||
19484324|NCT01504412|41767774|FG002|Overall Study|Lack of Efficacy|1|||
19484325|NCT01504412|41767775|FG003|Overall Study|Lack of Efficacy|0|||
19484326|NCT01504412|41767776|FG004|Overall Study|Lack of Efficacy|1|||
19484327|NCT01504412|41767772|FG000|Overall Study|Death|0|||
19484328|NCT01504412|41767773|FG001|Overall Study|Death|0|||
19484329|NCT01504412|41767774|FG002|Overall Study|Death|0|||
19484330|NCT01504412|41767775|FG003|Overall Study|Death|1|||
19704098|NCT00228384|42148406|FG000|Overall Study|Physician Decision|0|||
19704099|NCT00228384|42148407|FG001|Overall Study|Physician Decision|1|||
19704100|NCT00257166|42148415|FG000|Overall Study|Adverse Event|18|||
19484331|NCT01504412|41767776|FG004|Overall Study|Death|0|||
19484332|NCT01503164|41767806|FG000|Overall Study|Withdrawal by Subject|2|||
19484333|NCT01503164|41767807|FG001|Overall Study|Withdrawal by Subject|1|||
19484334|NCT00088465|41767813|FG000|Overall Study|Withdrawal by Subject|290|||
19484335|NCT00088465|41767813|FG000|Overall Study|Adverse Event|77|||
19484336|NCT00088465|41767813|FG000|Overall Study|Lost to Follow-up|57|||
19484337|NCT00088465|41767813|FG000|Overall Study|Physician Decision|45|||
19484338|NCT00088465|41767813|FG000|Overall Study|Sponsor Decision|37|||
19484339|NCT00088465|41767813|FG000|Overall Study|Lack of Efficacy|27|||
19484340|NCT00088465|41767813|FG000|Overall Study|Protocol Violation|17|||
19484341|NCT00088465|41767813|FG000|Overall Study|Death|11|||
19484342|NCT00088153|41767841|FG000|Overall Study|Physician Decision|3|||
19484343|NCT00088153|41767842|FG001|Overall Study|Physician Decision|3|||
19484344|NCT00088153|41767841|FG000|Overall Study|Withdrawal by Subject|10|||
19484345|NCT00088153|41767842|FG001|Overall Study|Withdrawal by Subject|10|||
19484346|NCT00088153|41767841|FG000|Overall Study|Lost to Follow-up|11|||
19484347|NCT00088153|41767842|FG001|Overall Study|Lost to Follow-up|12|||
19484348|NCT00087685|41767861|FG000|Overall Study|Adverse Event|5|||
19484349|NCT00087685|41767861|FG000|Overall Study|Non-Compliance|1|||
19484350|NCT00087685|41767861|FG000|Overall Study|Progressive Disease|5|||
19484351|NCT00087685|41767861|FG000|Overall Study|Withdrawal by Subject|3|||
19484352|NCT01502228|41767865|FG000|Overall Study|Death|1|||
19484353|NCT01502072|41767872|FG000|Overall Study|Withdrawal by Subject|1|||
19484354|NCT01502072|41767873|FG001|Overall Study|Withdrawal by Subject|0|||
19484355|NCT01502072|41767874|FG002|Overall Study|Withdrawal by Subject|0|||
19484356|NCT01502072|41767872|FG000|Overall Study|Death|0|||
19484357|NCT01502072|41767873|FG001|Overall Study|Death|1|||
19484358|NCT01502072|41767874|FG002|Overall Study|Death|0|||
19484359|NCT01462370|41767882|FG000|Overall Study|Lack of Qualifying Event|1|||
19484360|NCT01462370|41767883|FG001|Overall Study|Lack of Qualifying Event|1|||
19704101|NCT00257166|42148416|FG001|Overall Study|Adverse Event|13|||
19484361|NCT01462370|41767882|FG000|Overall Study|Physician Decision|0|||
19484362|NCT01462370|41767883|FG001|Overall Study|Physician Decision|1|||
19484363|NCT01462370|41767882|FG000|Overall Study|Withdrawal by Subject|0|||
19484364|NCT01462370|41767883|FG001|Overall Study|Withdrawal by Subject|3|||
19484365|NCT01479764|41767891|FG000|Randomized|Adverse Event|1|||
19484366|NCT01479764|41767892|FG001|Randomized|Adverse Event|1|||
19484367|NCT01479764|41767891|FG000|Randomized|Withdrawal by Subject|1|||
19484368|NCT01479764|41767892|FG001|Randomized|Withdrawal by Subject|0|||
19484369|NCT01479764|41767891|FG000|Treated|Lost to Follow-up|0|||
19704102|NCT00257166|42148415|FG000|Overall Study|Laboratory abnormality|1|||
19484370|NCT01479764|41767892|FG001|Treated|Lost to Follow-up|2|||
19484371|NCT01479530|41767900|FG000|Overall Study|Adverse Event|5|||
19393202|NCT02637557|41637005|FG002|Overall Study|Withdrawal by Subject|4|||
19393203|NCT02637557|41637006|FG003|Overall Study|Withdrawal by Subject|2|||
19393204|NCT02638493|41637019|FG000|Overall Study|Inability to provide semen samples|2|||
19393205|NCT02638493|41637020|FG001|Overall Study|Inability to provide semen samples|0|||
19393206|NCT02638493|41637021|FG002|Overall Study|Inability to provide semen samples|0|||
19393207|NCT02638337|41637031|FG000|Overall Study|Adverse Event|6|||
19393208|NCT02638337|41637032|FG001|Overall Study|Adverse Event|10|||
19393209|NCT02638337|41637031|FG000|Overall Study|Protocol Violation|3|||
19393210|NCT02638337|41637032|FG001|Overall Study|Protocol Violation|0|||
19393211|NCT02638337|41637031|FG000|Overall Study|Withdrawal by Subject|13|||
19393212|NCT02638337|41637032|FG001|Overall Study|Withdrawal by Subject|16|||
19393213|NCT02638337|41637031|FG000|Overall Study|Lost to Follow-up|7|||
19393214|NCT02638337|41637032|FG001|Overall Study|Lost to Follow-up|7|||
19393215|NCT02638337|41637031|FG000|Overall Study|Other - Miscellaneous|4|||
19393216|NCT02638337|41637032|FG001|Overall Study|Other - Miscellaneous|3|||
19393217|NCT02638259|41637040|FG000|Treatment Period 1|Adverse Event|1|||
19393218|NCT02638259|41637041|FG001|Treatment Period 1|Adverse Event|5|||
19393219|NCT02638259|41637040|FG000|Treatment Period 1|Death|0|||
19393220|NCT02638259|41637041|FG001|Treatment Period 1|Death|1|||
19393221|NCT02638259|41637040|FG000|Treatment Period 1|Lack of Efficacy|0|||
19393222|NCT02638259|41637041|FG001|Treatment Period 1|Lack of Efficacy|1|||
19393223|NCT02638259|41637040|FG000|Treatment Period 1|Protocol Violation|0|||
19393224|NCT02638259|41637041|FG001|Treatment Period 1|Protocol Violation|3|||
19393225|NCT02638259|41637040|FG000|Treatment Period 1|Withdrawal by Subject|4|||
19393226|NCT02638259|41637041|FG001|Treatment Period 1|Withdrawal by Subject|6|||
19393227|NCT02638259|41637040|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
19393228|NCT02638259|41637041|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
19393229|NCT02638259|41637040|FG000|Treatment Period 2|Adverse Event|5|||
19393230|NCT02638259|41637041|FG001|Treatment Period 2|Adverse Event|4|||
19393231|NCT02638259|41637040|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19393232|NCT02638259|41637041|FG001|Treatment Period 2|Withdrawal by Subject|7|||
19393233|NCT02637323|41637053|FG000|Overall Study|Lost to Follow-up|2|||
19393234|NCT02637323|41637054|FG001|Overall Study|Lost to Follow-up|0|||
19393235|NCT02637323|41637053|FG000|Overall Study|Protocol Violation|0|||
19393236|NCT02637323|41637054|FG001|Overall Study|Protocol Violation|1|||
19393237|NCT03573817|41637063|FG000|Overall Study|Adverse Event|0|||
19393238|NCT03573817|41637064|FG001|Overall Study|Adverse Event|2|||
19393239|NCT03573817|41637063|FG000|Overall Study|Protocol Violation|0|||
19393240|NCT03573817|41637064|FG001|Overall Study|Protocol Violation|1|||
19393241|NCT03573817|41637063|FG000|Overall Study|Withdrawal by Subject|1|||
19393242|NCT03573817|41637064|FG001|Overall Study|Withdrawal by Subject|1|||
19393243|NCT02638103|41637079|FG000|Overall Study|Adverse Event|13|||
19393244|NCT02638103|41637080|FG001|Overall Study|Adverse Event|12|||
19393245|NCT02638103|41637081|FG002|Overall Study|Adverse Event|19|||
19393246|NCT02638103|41637082|FG003|Overall Study|Adverse Event|12|||
19393247|NCT02638103|41637079|FG000|Overall Study|Withdrawal by Subject|43|||
19393248|NCT02638103|41637080|FG001|Overall Study|Withdrawal by Subject|53|||
19393249|NCT02638103|41637081|FG002|Overall Study|Withdrawal by Subject|30|||
19393250|NCT02638103|41637082|FG003|Overall Study|Withdrawal by Subject|61|||
19393251|NCT02638103|41637079|FG000|Overall Study|Protocol Violation|1|||
19393252|NCT02638103|41637080|FG001|Overall Study|Protocol Violation|2|||
19393253|NCT02638103|41637081|FG002|Overall Study|Protocol Violation|1|||
19393254|NCT02638103|41637082|FG003|Overall Study|Protocol Violation|4|||
19393255|NCT02638103|41637079|FG000|Overall Study|Pregnancy|2|||
19393256|NCT02638103|41637080|FG001|Overall Study|Pregnancy|3|||
19393257|NCT02638103|41637081|FG002|Overall Study|Pregnancy|0|||
19393258|NCT02638103|41637082|FG003|Overall Study|Pregnancy|1|||
19393259|NCT02638103|41637079|FG000|Overall Study|Non-compliance to Study Procedures|2|||
19393260|NCT02638103|41637080|FG001|Overall Study|Non-compliance to Study Procedures|1|||
19393261|NCT02638103|41637081|FG002|Overall Study|Non-compliance to Study Procedures|1|||
19393262|NCT02638103|41637082|FG003|Overall Study|Non-compliance to Study Procedures|1|||
19393263|NCT02638103|41637079|FG000|Overall Study|Lost to Follow-up|26|||
19393264|NCT02638103|41637080|FG001|Overall Study|Lost to Follow-up|33|||
19393265|NCT02638103|41637081|FG002|Overall Study|Lost to Follow-up|20|||
19393266|NCT02638103|41637082|FG003|Overall Study|Lost to Follow-up|37|||
19393267|NCT02638103|41637079|FG000|Overall Study|Lack of Efficacy|14|||
19393268|NCT02638103|41637080|FG001|Overall Study|Lack of Efficacy|10|||
19393269|NCT02638103|41637081|FG002|Overall Study|Lack of Efficacy|12|||
19393270|NCT02638103|41637082|FG003|Overall Study|Lack of Efficacy|22|||
19393271|NCT02638103|41637079|FG000|Overall Study|Other than specified|5|||
19393272|NCT02638103|41637080|FG001|Overall Study|Other than specified|4|||
19393273|NCT02638103|41637081|FG002|Overall Study|Other than specified|2|||
19393274|NCT02638103|41637082|FG003|Overall Study|Other than specified|4|||
19393275|NCT03551743|41637104|FG000|Overall Study|Adverse Event|1|||
19393276|NCT03551743|41637105|FG001|Overall Study|Adverse Event|0|||
19393277|NCT03551743|41637106|FG002|Overall Study|Adverse Event|0|||
19484372|NCT01479530|41767901|FG001|Overall Study|Adverse Event|6|||
19484373|NCT01479530|41767900|FG000|Overall Study|Lack of Efficacy|0|||
19484374|NCT01479530|41767901|FG001|Overall Study|Lack of Efficacy|1|||
19484375|NCT01479530|41767900|FG000|Overall Study|Protocol Violation|2|||
19484376|NCT01479530|41767901|FG001|Overall Study|Protocol Violation|3|||
19484377|NCT01479530|41767900|FG000|Overall Study|Withdrawal of Consent|3|||
19484378|NCT01479530|41767901|FG001|Overall Study|Withdrawal of Consent|2|||
19484379|NCT01479374|41767910|FG000|Overall Study|Adverse Event|2|||
19484380|NCT01479374|41767911|FG001|Overall Study|Adverse Event|1|||
19484381|NCT01479374|41767912|FG002|Overall Study|Adverse Event|0|||
19484382|NCT01479374|41767910|FG000|Overall Study|Lost to Follow-up|1|||
19484383|NCT01479374|41767911|FG001|Overall Study|Lost to Follow-up|2|||
19484384|NCT01479374|41767912|FG002|Overall Study|Lost to Follow-up|0|||
19484385|NCT01479374|41767910|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
19484386|NCT01479374|41767911|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
19484387|NCT01479374|41767912|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
19484388|NCT01479374|41767910|FG000|Overall Study|Other|0|||
19484389|NCT01479374|41767911|FG001|Overall Study|Other|4|||
19484390|NCT01479374|41767912|FG002|Overall Study|Other|5|||
19484391|NCT00087529|41767922|FG000|Overall Study|Death|1|||
19484392|NCT00087529|41767923|FG001|Overall Study|Death|0|||
19484393|NCT00087529|41767922|FG000|Overall Study|Adverse Event|0|||
19484394|NCT00087529|41767923|FG001|Overall Study|Adverse Event|8|||
19484395|NCT00087529|41767922|FG000|Overall Study|Pregnancy|0|||
19484396|NCT00087529|41767923|FG001|Overall Study|Pregnancy|1|||
19484397|NCT00087529|41767922|FG000|Overall Study|Lost to Follow-up|2|||
19484398|NCT00087529|41767923|FG001|Overall Study|Lost to Follow-up|3|||
19484399|NCT00087529|41767922|FG000|Overall Study|Participant Decision|14|||
19484400|NCT00087529|41767923|FG001|Overall Study|Participant Decision|37|||
19484401|NCT00087529|41767922|FG000|Overall Study|Physician Decision|4|||
19484402|NCT00087529|41767923|FG001|Overall Study|Physician Decision|8|||
19484403|NCT00087529|41767922|FG000|Overall Study|Initiation of Excluded Therapy|0|||
19484404|NCT00087529|41767923|FG001|Overall Study|Initiation of Excluded Therapy|1|||
19484405|NCT00087529|41767922|FG000|Overall Study|Participant Noncompliance|0|||
19484406|NCT00087529|41767923|FG001|Overall Study|Participant Noncompliance|1|||
19484407|NCT00087529|41767922|FG000|Overall Study|Disease Progression|5|||
19484408|NCT00087529|41767923|FG001|Overall Study|Disease Progression|4|||
19484409|NCT00087529|41767922|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
19484410|NCT00087529|41767923|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
19484411|NCT01500434|41767946|FG000|Overall Study|Death|1|||
19484412|NCT01500434|41767946|FG000|Overall Study|Withdrawal by Subject|1|||
19484413|NCT01500434|41767946|FG000|Overall Study|Missed 12-month follow-up|5|||
19484414|NCT00087139|41767953|FG000|Overall Study|Adverse Event|18|||
19484415|NCT00087139|41767954|FG001|Overall Study|Adverse Event|17|||
19484416|NCT00087139|41767955|FG002|Overall Study|Adverse Event|13|||
19484417|NCT00087139|41767953|FG000|Overall Study|Death|2|||
19484418|NCT00087139|41767954|FG001|Overall Study|Death|1|||
19484419|NCT00087139|41767955|FG002|Overall Study|Death|0|||
19484420|NCT00087139|41767953|FG000|Overall Study|Withdrawal by Subject|3|||
19484421|NCT00087139|41767954|FG001|Overall Study|Withdrawal by Subject|2|||
19484422|NCT00087139|41767955|FG002|Overall Study|Withdrawal by Subject|2|||
19484423|NCT00087139|41767953|FG000|Overall Study|Physician Decision|1|||
19484424|NCT00087139|41767954|FG001|Overall Study|Physician Decision|1|||
19484425|NCT00087139|41767955|FG002|Overall Study|Physician Decision|1|||
19484426|NCT00087139|41767953|FG000|Overall Study|Disease progression|9|||
19484427|NCT00087139|41767954|FG001|Overall Study|Disease progression|19|||
19484428|NCT00087139|41767955|FG002|Overall Study|Disease progression|12|||
19484429|NCT00087139|41767953|FG000|Overall Study|Ineligible|4|||
19484430|NCT00087139|41767954|FG001|Overall Study|Ineligible|7|||
19484431|NCT00087139|41767955|FG002|Overall Study|Ineligible|4|||
19484432|NCT00087139|41767953|FG000|Overall Study|Symptomatic deterioration|1|||
19484433|NCT00087139|41767954|FG001|Overall Study|Symptomatic deterioration|1|||
19484434|NCT00087139|41767955|FG002|Overall Study|Symptomatic deterioration|3|||
19484435|NCT00087139|41767953|FG000|Overall Study|Use of coumadin|1|||
19484436|NCT00087139|41767954|FG001|Overall Study|Use of coumadin|0|||
19484437|NCT00087139|41767955|FG002|Overall Study|Use of coumadin|0|||
19484438|NCT00087139|41767953|FG000|Overall Study|Response achieved|0|||
19484439|NCT00087139|41767954|FG001|Overall Study|Response achieved|1|||
19484440|NCT00087139|41767955|FG002|Overall Study|Response achieved|0|||
19484441|NCT00087139|41767953|FG000|Overall Study|Extradural disease|0|||
19484442|NCT00087139|41767954|FG001|Overall Study|Extradural disease|0|||
19484443|NCT00087139|41767955|FG002|Overall Study|Extradural disease|1|||
19484444|NCT01500278|41768007|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
19484445|NCT01500278|41768008|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
19484446|NCT01500278|41768007|FG000|Week 0 - Week 12|Protocol Violation|10|||
19484447|NCT01500278|41768008|FG001|Week 0 - Week 12|Protocol Violation|16|||
19484448|NCT01500278|41768007|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
19484449|NCT01500278|41768008|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
19484450|NCT01500278|41768007|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
19484451|NCT01500278|41768008|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
19484452|NCT01500278|41768007|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
19484453|NCT01500278|41768008|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
19484454|NCT01500278|41768007|FG000|Week 0 - Week 12|Patient decision|1|||
19484455|NCT01500278|41768008|FG001|Week 0 - Week 12|Patient decision|0|||
19484456|NCT01500278|41768007|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
19484457|NCT01500278|41768008|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
19484458|NCT01500278|41768007|FG000|Week 0 - Week 12|Investigator decision|1|||
19484459|NCT01500278|41768008|FG001|Week 0 - Week 12|Investigator decision|0|||
19484460|NCT01500278|41768007|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
19484461|NCT01500278|41768008|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
19484462|NCT01500278|41768007|FG000|Week 0 - Week 12|Sponsor decision|1|||
19484463|NCT01500278|41768008|FG001|Week 0 - Week 12|Sponsor decision|0|||
19484464|NCT01500278|41768007|FG000|Week 0 - Week 12|Personal reason|0|||
19484465|NCT01500278|41768008|FG001|Week 0 - Week 12|Personal reason|1|||
19484466|NCT01500278|41768007|FG000|Week 0 - Week 12|Other serious disease|0|||
19484467|NCT01500278|41768008|FG001|Week 0 - Week 12|Other serious disease|1|||
19484468|NCT01500278|41768007|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
19484469|NCT01500278|41768008|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
19484470|NCT01500278|41768007|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
19484471|NCT01500278|41768008|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
19484472|NCT01500278|41768007|FG000|Week 13 - Week 104|Protocol Violation|6|||
19484473|NCT01500278|41768008|FG001|Week 13 - Week 104|Protocol Violation|6|||
19484474|NCT01500278|41768007|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
19484475|NCT01500278|41768008|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
19484476|NCT01500278|41768007|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
19484477|NCT01500278|41768008|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
19484478|NCT01500278|41768007|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
19484479|NCT01500278|41768008|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
19484480|NCT01500278|41768007|FG000|Week 13 - Week 104|Non/bad compliance|7|||
19484481|NCT01500278|41768008|FG001|Week 13 - Week 104|Non/bad compliance|5|||
19484482|NCT01500278|41768007|FG000|Week 13 - Week 104|Recurrent infections|1|||
19484483|NCT01500278|41768008|FG001|Week 13 - Week 104|Recurrent infections|0|||
19484484|NCT01500278|41768007|FG000|Week 13 - Week 104|False positive test|1|||
19484485|NCT01500278|41768008|FG001|Week 13 - Week 104|False positive test|2|||
19484486|NCT01500278|41768007|FG000|Week 13 - Week 104|Sponsor request|4|||
19484487|NCT01500278|41768008|FG001|Week 13 - Week 104|Sponsor request|0|||
19484488|NCT01500278|41768007|FG000|Week 13 - Week 104|Withdrawn in error|1|||
19484489|NCT01500278|41768008|FG001|Week 13 - Week 104|Withdrawn in error|0|||
19484490|NCT01500278|41768007|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
19484491|NCT01500278|41768008|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
19484492|NCT01500278|41768007|FG000|Week 13 - Week 104|Protocol deviation|1|||
19484493|NCT01500278|41768008|FG001|Week 13 - Week 104|Protocol deviation|0|||
19484494|NCT01500278|41768007|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
19484495|NCT01500278|41768008|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
19484496|NCT01500278|41768007|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
19484497|NCT01500278|41768008|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
19484498|NCT01500278|41768007|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
19484499|NCT01500278|41768008|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
19484500|NCT01500278|41768007|FG000|Week 13 - Week 104|Relocation|0|||
19484501|NCT01500278|41768008|FG001|Week 13 - Week 104|Relocation|1|||
19484502|NCT01500278|41768007|FG000|Week 13 - Week 104|Sponsor decision|0|||
19484503|NCT01500278|41768008|FG001|Week 13 - Week 104|Sponsor decision|2|||
19484504|NCT01500278|41768007|FG000|Week 13 - Week 104|Medical monitor decision|0|||
19393278|NCT03551743|41637107|FG003|Overall Study|Adverse Event|0|||
19393279|NCT03551743|41637104|FG000|Overall Study|Withdrawal by Subject|1|||
19393280|NCT03551743|41637105|FG001|Overall Study|Withdrawal by Subject|0|||
19393281|NCT03551743|41637106|FG002|Overall Study|Withdrawal by Subject|0|||
19484505|NCT01500278|41768008|FG001|Week 13 - Week 104|Medical monitor decision|2|||
19484506|NCT01500278|41768007|FG000|Week 13 - Week 104|Personal reason|0|||
19484507|NCT01500278|41768008|FG001|Week 13 - Week 104|Personal reason|1|||
19484508|NCT01500278|41768007|FG000|Week 13 - Week 104|Not completed|0|||
19704103|NCT00257166|42148416|FG001|Overall Study|Laboratory abnormality|0|||
19393282|NCT03551743|41637107|FG003|Overall Study|Withdrawal by Subject|0|||
19393283|NCT02636699|41637119|FG000|Overall Study|Adverse Event|4|||
19393284|NCT02636699|41637120|FG001|Overall Study|Adverse Event|0|||
19393285|NCT02636699|41637119|FG000|Overall Study|Lost to Follow-up|3|||
19393286|NCT02636699|41637120|FG001|Overall Study|Lost to Follow-up|3|||
19393287|NCT02636699|41637119|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
19393288|NCT02636699|41637120|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
19484509|NCT01500278|41768008|FG001|Week 13 - Week 104|Not completed|1|||
19393289|NCT02636699|41637119|FG000|Overall Study|Physician Decision|0|||
19393290|NCT02636699|41637120|FG001|Overall Study|Physician Decision|1|||
19484510|NCT01500278|41768007|FG000|Week 13 - Week 104|Death|2|||
19484511|NCT01500278|41768008|FG001|Week 13 - Week 104|Death|4|||
19484512|NCT01500278|41768007|FG000|Week 13 - Week 104|Adverse Event|54|||
19484513|NCT01500278|41768008|FG001|Week 13 - Week 104|Adverse Event|54|||
19484514|NCT00086281|41768031|FG000|Phase 1|Adverse Event|0|||
19484515|NCT00086281|41768032|FG001|Phase 1|Adverse Event|0|||
19484516|NCT00086281|41768033|FG002|Phase 1|Adverse Event|0|||
19484517|NCT00086281|41768034|FG003|Phase 1|Adverse Event|0|||
19484518|NCT00086281|41768035|FG004|Phase 1|Adverse Event|0|||
19484519|NCT00086281|41768036|FG005|Phase 1|Adverse Event|0|||
19484520|NCT00086281|41768037|FG006|Phase 1|Adverse Event|0|||
19484521|NCT00086281|41768038|FG007|Phase 1|Adverse Event|0|||
19484522|NCT00086281|41768039|FG008|Phase 1|Adverse Event|0|||
19484523|NCT00086281|41768040|FG009|Phase 1|Adverse Event|1|||
19484524|NCT00086281|41768041|FG010|Phase 1|Adverse Event|2|||
19484525|NCT00086281|41768042|FG011|Phase 1|Adverse Event|1|||
19484526|NCT00086281|41768043|FG012|Phase 1|Adverse Event|1|||
19484527|NCT00086281|41768044|FG013|Phase 1|Adverse Event|1|||
19484528|NCT00086281|41768045|FG014|Phase 1|Adverse Event|2|||
19484529|NCT00086281|41768031|FG000|Phase 1|Protocol Violation|0|||
19484530|NCT00086281|41768032|FG001|Phase 1|Protocol Violation|0|||
19484531|NCT00086281|41768033|FG002|Phase 1|Protocol Violation|0|||
19484532|NCT00086281|41768034|FG003|Phase 1|Protocol Violation|0|||
19484533|NCT00086281|41768035|FG004|Phase 1|Protocol Violation|0|||
19484534|NCT00086281|41768036|FG005|Phase 1|Protocol Violation|0|||
19484535|NCT00086281|41768037|FG006|Phase 1|Protocol Violation|0|||
19484536|NCT00086281|41768038|FG007|Phase 1|Protocol Violation|0|||
19484537|NCT00086281|41768039|FG008|Phase 1|Protocol Violation|0|||
19484538|NCT00086281|41768040|FG009|Phase 1|Protocol Violation|0|||
19484539|NCT00086281|41768041|FG010|Phase 1|Protocol Violation|1|||
19484540|NCT00086281|41768042|FG011|Phase 1|Protocol Violation|0|||
19484541|NCT00086281|41768043|FG012|Phase 1|Protocol Violation|0|||
19484542|NCT00086281|41768044|FG013|Phase 1|Protocol Violation|0|||
19484543|NCT00086281|41768045|FG014|Phase 1|Protocol Violation|0|||
19484544|NCT00086281|41768031|FG000|Phase 1|Serious Adverse Event|0|||
19484545|NCT00086281|41768032|FG001|Phase 1|Serious Adverse Event|0|||
19484546|NCT00086281|41768033|FG002|Phase 1|Serious Adverse Event|0|||
19484547|NCT00086281|41768034|FG003|Phase 1|Serious Adverse Event|0|||
19484548|NCT00086281|41768035|FG004|Phase 1|Serious Adverse Event|0|||
19484549|NCT00086281|41768036|FG005|Phase 1|Serious Adverse Event|0|||
19484550|NCT00086281|41768037|FG006|Phase 1|Serious Adverse Event|0|||
19484551|NCT00086281|41768038|FG007|Phase 1|Serious Adverse Event|0|||
19484552|NCT00086281|41768039|FG008|Phase 1|Serious Adverse Event|0|||
19484553|NCT00086281|41768040|FG009|Phase 1|Serious Adverse Event|0|||
19484554|NCT00086281|41768041|FG010|Phase 1|Serious Adverse Event|0|||
19484555|NCT00086281|41768042|FG011|Phase 1|Serious Adverse Event|0|||
19484556|NCT00086281|41768043|FG012|Phase 1|Serious Adverse Event|0|||
19484557|NCT00086281|41768044|FG013|Phase 1|Serious Adverse Event|0|||
19484558|NCT00086281|41768045|FG014|Phase 1|Serious Adverse Event|1|||
19484559|NCT00086281|41768031|FG000|Phase 2|Adverse Event|0|||
19484560|NCT00086281|41768032|FG001|Phase 2|Adverse Event|0|||
19484561|NCT00086281|41768033|FG002|Phase 2|Adverse Event|0|||
19484562|NCT00086281|41768034|FG003|Phase 2|Adverse Event|0|||
19484563|NCT00086281|41768035|FG004|Phase 2|Adverse Event|0|||
19484564|NCT00086281|41768036|FG005|Phase 2|Adverse Event|0|||
19393291|NCT02636699|41637119|FG000|Overall Study|Withdrawal by Subject|13|||
19393292|NCT02636699|41637120|FG001|Overall Study|Withdrawal by Subject|6|||
19393293|NCT02636699|41637119|FG000|Overall Study|Other|3|||
19393294|NCT02636699|41637120|FG001|Overall Study|Other|1|||
19393295|NCT02634983|41637126|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
19484565|NCT00086281|41768037|FG006|Phase 2|Adverse Event|0|||
19484566|NCT00086281|41768038|FG007|Phase 2|Adverse Event|0|||
19484567|NCT00086281|41768039|FG008|Phase 2|Adverse Event|0|||
19484568|NCT00086281|41768040|FG009|Phase 2|Adverse Event|0|||
19484569|NCT00086281|41768041|FG010|Phase 2|Adverse Event|0|||
19484570|NCT00086281|41768042|FG011|Phase 2|Adverse Event|0|||
19484571|NCT00086281|41768043|FG012|Phase 2|Adverse Event|1|||
19484572|NCT00086281|41768044|FG013|Phase 2|Adverse Event|1|||
19484573|NCT00086281|41768045|FG014|Phase 2|Adverse Event|0|||
19393296|NCT02634983|41637127|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
19484574|NCT00086047|41768057|FG000|Overall Study|Lost to Follow-up|7|||
19484575|NCT00086047|41768058|FG001|Overall Study|Lost to Follow-up|6|||
19484576|NCT00086047|41768057|FG000|Overall Study|Physician Decision|0|||
19484577|NCT00086047|41768058|FG001|Overall Study|Physician Decision|1|||
19393297|NCT02633501|41637139|FG000|Overall Study|Adverse Event|0|||
19484578|NCT01478828|41768070|FG000|Overall Study|Adverse Event|1|||
19484579|NCT00085423|41768075|FG000|Overall Study|Withdrawal by Subject|1|||
19484580|NCT00085423|41768075|FG000|Overall Study|screen failure|1|||
19484581|NCT00084487|41768079|FG000|Overall Study|Death|1|||
19484582|NCT01425281|41768119|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
19484583|NCT01425281|41768120|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
19484584|NCT01425281|41768119|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
19484585|NCT01425281|41768120|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
19484586|NCT01425281|41768119|FG000|At 180-day Clinical Follow-up|Death|0|||
19484587|NCT01425281|41768120|FG001|At 180-day Clinical Follow-up|Death|1|||
19484588|NCT01425281|41768119|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
19484589|NCT01425281|41768120|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
19484590|NCT01425281|41768119|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
19484591|NCT01425281|41768120|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
19484592|NCT01425281|41768119|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
19484593|NCT01425281|41768120|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
19484594|NCT01425281|41768119|FG000|At 2-year Clinical Follow-up|Death|2|||
19484595|NCT01425281|41768120|FG001|At 2-year Clinical Follow-up|Death|0|||
19484596|NCT01425281|41768119|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
19484597|NCT01425281|41768120|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
19484598|NCT01425281|41768119|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
19484599|NCT01425281|41768120|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
19484600|NCT01425281|41768119|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
19484601|NCT01425281|41768120|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
19484602|NCT01425281|41768119|FG000|At 3-year Clinical Follow-up|Death|2|||
19484603|NCT01425281|41768120|FG001|At 3-year Clinical Follow-up|Death|3|||
19484604|NCT01425281|41768119|FG000|At 4-year Clinical Follow-up|Death|7|||
19484605|NCT01425281|41768120|FG001|At 4-year Clinical Follow-up|Death|3|||
19484606|NCT01425281|41768119|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
19484607|NCT01425281|41768120|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
19484608|NCT01425281|41768119|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
19484609|NCT01425281|41768120|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
19484610|NCT01425281|41768119|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
19484611|NCT01425281|41768120|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
19484612|NCT01425281|41768119|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
19484613|NCT01425281|41768120|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
19484614|NCT01425281|41768119|FG000|At 5-year Clinical Follow-up|Death|2|||
19484615|NCT01425281|41768120|FG001|At 5-year Clinical Follow-up|Death|0|||
19484616|NCT01425281|41768119|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
19484617|NCT01425281|41768120|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
19484618|NCT01425281|41768119|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
19484619|NCT01425281|41768120|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
19484620|NCT01425281|41768119|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
19484621|NCT01425281|41768120|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
19484622|NCT02648724|41768148|FG000|Overall Study|Withdrawal by Subject|0|||
19484623|NCT02648724|41768149|FG001|Overall Study|Withdrawal by Subject|1|||
19484624|NCT02648724|41768150|FG002|Overall Study|Withdrawal by Subject|1|||
19484625|NCT02648724|41768151|FG003|Overall Study|Withdrawal by Subject|0|||
19484626|NCT02648724|41768152|FG004|Overall Study|Withdrawal by Subject|1|||
19484627|NCT02648724|41768153|FG005|Overall Study|Withdrawal by Subject|0|||
19484628|NCT02648724|41768154|FG006|Overall Study|Withdrawal by Subject|0|||
19484629|NCT02648724|41768148|FG000|Overall Study|Progressive disease|2|||
19484630|NCT02648724|41768149|FG001|Overall Study|Progressive disease|2|||
19484631|NCT02648724|41768150|FG002|Overall Study|Progressive disease|2|||
19484632|NCT02648724|41768151|FG003|Overall Study|Progressive disease|3|||
19484633|NCT02648724|41768152|FG004|Overall Study|Progressive disease|22|||
19484634|NCT02648724|41768153|FG005|Overall Study|Progressive disease|7|||
19484635|NCT02648724|41768154|FG006|Overall Study|Progressive disease|8|||
19484636|NCT02648724|41768148|FG000|Overall Study|Other reason (unknown)|1|||
19393298|NCT02633501|41637140|FG001|Overall Study|Adverse Event|0|||
19393299|NCT02633501|41637141|FG002|Overall Study|Adverse Event|1|||
19393300|NCT02633501|41637142|FG003|Overall Study|Adverse Event|0|||
19393301|NCT02633501|41637143|FG004|Overall Study|Adverse Event|1|||
19393302|NCT02633501|41637144|FG005|Overall Study|Adverse Event|1|||
19393303|NCT02633501|41637139|FG000|Overall Study|Withdrawal by Subject|2|||
19393304|NCT02633501|41637140|FG001|Overall Study|Withdrawal by Subject|1|||
19393305|NCT02633501|41637141|FG002|Overall Study|Withdrawal by Subject|2|||
19393306|NCT02633501|41637142|FG003|Overall Study|Withdrawal by Subject|2|||
19393307|NCT02633501|41637143|FG004|Overall Study|Withdrawal by Subject|1|||
19393308|NCT02633501|41637144|FG005|Overall Study|Withdrawal by Subject|3|||
19393309|NCT02633501|41637139|FG000|Overall Study|Various other reasons|0|||
19393310|NCT02633501|41637140|FG001|Overall Study|Various other reasons|2|||
19393311|NCT02633501|41637141|FG002|Overall Study|Various other reasons|4|||
19393312|NCT02633501|41637142|FG003|Overall Study|Various other reasons|1|||
19484637|NCT02648724|41768149|FG001|Overall Study|Other reason (unknown)|0|||
19484638|NCT02648724|41768150|FG002|Overall Study|Other reason (unknown)|0|||
19393313|NCT02633501|41637143|FG004|Overall Study|Various other reasons|7|||
19393314|NCT02633501|41637144|FG005|Overall Study|Various other reasons|11|||
19484639|NCT02648724|41768151|FG003|Overall Study|Other reason (unknown)|0|||
19484640|NCT02648724|41768152|FG004|Overall Study|Other reason (unknown)|0|||
19484641|NCT02648724|41768153|FG005|Overall Study|Other reason (unknown)|0|||
19484642|NCT02648724|41768154|FG006|Overall Study|Other reason (unknown)|0|||
19484643|NCT02648724|41768148|FG000|Overall Study|Protocol Violation|0|||
19484644|NCT02648724|41768149|FG001|Overall Study|Protocol Violation|0|||
19484645|NCT02648724|41768150|FG002|Overall Study|Protocol Violation|0|||
19484646|NCT02648724|41768151|FG003|Overall Study|Protocol Violation|0|||
19484647|NCT02648724|41768152|FG004|Overall Study|Protocol Violation|1|||
19484648|NCT02648724|41768153|FG005|Overall Study|Protocol Violation|0|||
19484649|NCT02648724|41768154|FG006|Overall Study|Protocol Violation|0|||
19484650|NCT02648724|41768148|FG000|Overall Study|Death|0|||
19484651|NCT02648724|41768149|FG001|Overall Study|Death|0|||
19484652|NCT02648724|41768150|FG002|Overall Study|Death|0|||
19484653|NCT02648724|41768151|FG003|Overall Study|Death|0|||
19484654|NCT02648724|41768152|FG004|Overall Study|Death|0|||
19484655|NCT02648724|41768153|FG005|Overall Study|Death|0|||
19484656|NCT02648724|41768154|FG006|Overall Study|Death|3|||
19484657|NCT02648724|41768148|FG000|Overall Study|Physician Decision|0|||
19484658|NCT02648724|41768149|FG001|Overall Study|Physician Decision|0|||
19484659|NCT02648724|41768150|FG002|Overall Study|Physician Decision|0|||
19484660|NCT02648724|41768151|FG003|Overall Study|Physician Decision|0|||
19484661|NCT02648724|41768152|FG004|Overall Study|Physician Decision|1|||
19484662|NCT02648724|41768153|FG005|Overall Study|Physician Decision|0|||
19484663|NCT02648724|41768154|FG006|Overall Study|Physician Decision|1|||
19484664|NCT02648724|41768148|FG000|Overall Study|Transferred to named patient program|0|||
19484665|NCT02648724|41768149|FG001|Overall Study|Transferred to named patient program|0|||
19484666|NCT02648724|41768150|FG002|Overall Study|Transferred to named patient program|0|||
19484667|NCT02648724|41768151|FG003|Overall Study|Transferred to named patient program|0|||
19484668|NCT02648724|41768152|FG004|Overall Study|Transferred to named patient program|0|||
19484669|NCT02648724|41768153|FG005|Overall Study|Transferred to named patient program|1|||
19484670|NCT02648724|41768154|FG006|Overall Study|Transferred to named patient program|0|||
19484671|NCT01402817|41768186|FG000|Overall Study|Withdrawal by Subject|3|||
19484672|NCT01402817|41768186|FG000|Overall Study|Study Suspended by FDA|8|||
19484673|NCT01425203|41768193|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
19484674|NCT01425203|41768194|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
19484675|NCT01425203|41768195|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
19484676|NCT01425203|41768193|FG000|Treatment Phase|Failure at futility timepoint|8|||
19484677|NCT01425203|41768194|FG001|Treatment Phase|Failure at futility timepoint|27|||
19484678|NCT01425203|41768195|FG002|Treatment Phase|Failure at futility timepoint|0|||
19484679|NCT01425203|41768193|FG000|Treatment Phase|Other virologic failure criteria|5|||
19484680|NCT01425203|41768194|FG001|Treatment Phase|Other virologic failure criteria|3|||
19484681|NCT01425203|41768195|FG002|Treatment Phase|Other virologic failure criteria|0|||
19484682|NCT01425203|41768193|FG000|Treatment Phase|Unidentified reasons|11|||
19484683|NCT01425203|41768194|FG001|Treatment Phase|Unidentified reasons|5|||
19484684|NCT01425203|41768195|FG002|Treatment Phase|Unidentified reasons|0|||
19484685|NCT01425203|41768193|FG000|Treatment Phase|Did not receive treatment|0|||
19484686|NCT01425203|41768194|FG001|Treatment Phase|Did not receive treatment|1|||
19484687|NCT01425203|41768195|FG002|Treatment Phase|Did not receive treatment|0|||
19484688|NCT01425203|41768193|FG000|Crossover Phase|Failure at futility timepoint|0|||
19484689|NCT01425203|41768194|FG001|Crossover Phase|Failure at futility timepoint|0|||
19484690|NCT01425203|41768195|FG002|Crossover Phase|Failure at futility timepoint|3|||
19484691|NCT01425203|41768193|FG000|Crossover Phase|Other virologic failure criteria|0|||
19484692|NCT01425203|41768194|FG001|Crossover Phase|Other virologic failure criteria|0|||
19484693|NCT01425203|41768195|FG002|Crossover Phase|Other virologic failure criteria|3|||
19484694|NCT00081289|41768205|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
19484695|NCT00081289|41768206|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
19484696|NCT00081289|41768205|FG000|Overall Study|Ineligible / no protocol treatment|3|||
19484697|NCT00081289|41768206|FG001|Overall Study|Ineligible / no protocol treatment|4|||
19484698|NCT01478594|41768215|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
19484699|NCT01478594|41768216|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
19484700|NCT01478594|41768215|FG000|Overall Study|Death|45|||
19484701|NCT01478594|41768216|FG001|Overall Study|Death|18|||
19484702|NCT01478594|41768215|FG000|Overall Study|Lost to Follow-up|3|||
19484703|NCT01478594|41768216|FG001|Overall Study|Lost to Follow-up|1|||
19484704|NCT01478594|41768215|FG000|Overall Study|Withdrawal by Subject|9|||
19484705|NCT01478594|41768216|FG001|Overall Study|Withdrawal by Subject|3|||
19484706|NCT01478594|41768215|FG000|Overall Study|Study Closed by Sponsor|8|||
19484707|NCT01478594|41768216|FG001|Overall Study|Study Closed by Sponsor|5|||
19484708|NCT01424813|41768277|FG000|Overall Study|Withdrawal by Subject|3|||
19484709|NCT01424813|41768278|FG001|Overall Study|Withdrawal by Subject|0|||
19484710|NCT01424813|41768277|FG000|Overall Study|Protocol Violation|1|||
19484711|NCT01424813|41768278|FG001|Overall Study|Protocol Violation|0|||
19484712|NCT01424813|41768277|FG000|Overall Study|Other|1|||
19484713|NCT01424813|41768278|FG001|Overall Study|Other|2|||
19484714|NCT00080899|41768284|FG000|Overall Study|Adverse Event|1|||
19484715|NCT00089635|41768288|FG000|Overall Study|Adverse Event|2|||
19484716|NCT00089635|41768288|FG000|Overall Study|Death|17|||
19484717|NCT00089635|41768288|FG000|Overall Study|Disease Progression|12|||
19484718|NCT00089635|41768288|FG000|Overall Study|Lost to Follow-up|3|||
19484719|NCT00089635|41768288|FG000|Overall Study|Withdrawal by Subject|6|||
19484720|NCT00089635|41768288|FG000|Overall Study|Ineligibility determined|1|||
19484721|NCT00089635|41768288|FG000|Overall Study|Other|2|||
19484722|NCT01500200|41768302|FG000|Stage 1|Adverse Event|1|||
19484723|NCT01500200|41768303|FG001|Stage 1|Adverse Event|4|||
19484724|NCT01500200|41768304|FG002|Stage 1|Adverse Event|5|||
19484725|NCT01500200|41768305|FG003|Stage 1|Adverse Event|0|||
19484726|NCT01500200|41768306|FG004|Stage 1|Adverse Event|0|||
19393315|NCT02633501|41637139|FG000|Overall Study|Lost to Follow-up|0|||
19393316|NCT02633501|41637140|FG001|Overall Study|Lost to Follow-up|0|||
19393317|NCT02633501|41637141|FG002|Overall Study|Lost to Follow-up|0|||
19393318|NCT02633501|41637142|FG003|Overall Study|Lost to Follow-up|1|||
19393319|NCT02633501|41637143|FG004|Overall Study|Lost to Follow-up|2|||
19393320|NCT02633501|41637144|FG005|Overall Study|Lost to Follow-up|0|||
19393321|NCT03138499|41637165|FG000|Overall Study|Lost to Follow-up|1|||
19393322|NCT03138499|41637166|FG001|Overall Study|Lost to Follow-up|0|||
19393323|NCT03138499|41637165|FG000|Overall Study|Participants withdrew consent|1|||
19393324|NCT03138499|41637166|FG001|Overall Study|Participants withdrew consent|0|||
19393325|NCT03138499|41637165|FG000|Overall Study|Participant discontinued study before treatment|0|||
19393326|NCT03138499|41637166|FG001|Overall Study|Participant discontinued study before treatment|1|||
19393327|NCT03138499|41637165|FG000|Overall Study|Disease Progression|2|||
19393328|NCT03138499|41637166|FG001|Overall Study|Disease Progression|6|||
19393329|NCT03138499|41637165|FG000|Overall Study|Study drug toxicity|2|||
19393330|NCT03138499|41637166|FG001|Overall Study|Study drug toxicity|2|||
19393331|NCT03138499|41637165|FG000|Overall Study|Participant request to discontinue study treatment|1|||
19393332|NCT03138499|41637166|FG001|Overall Study|Participant request to discontinue study treatment|1|||
19393333|NCT03138499|41637165|FG000|Overall Study|Other reasons|2|||
19393334|NCT03138499|41637166|FG001|Overall Study|Other reasons|0|||
19393335|NCT04508621|41637175|FG000|Overall Study|Adverse Event|39|||
19484727|NCT01500200|41768307|FG005|Stage 1|Adverse Event|0|||
19484728|NCT01500200|41768302|FG000|Stage 1|Lost to Follow-up|2|||
19484729|NCT01500200|41768303|FG001|Stage 1|Lost to Follow-up|2|||
19484730|NCT01500200|41768304|FG002|Stage 1|Lost to Follow-up|1|||
19484731|NCT01500200|41768305|FG003|Stage 1|Lost to Follow-up|0|||
19484732|NCT01500200|41768306|FG004|Stage 1|Lost to Follow-up|0|||
19484733|NCT01500200|41768307|FG005|Stage 1|Lost to Follow-up|0|||
19484734|NCT01500200|41768302|FG000|Stage 1|Withdrawal by Subject|3|||
19484735|NCT01500200|41768303|FG001|Stage 1|Withdrawal by Subject|0|||
19484736|NCT01500200|41768304|FG002|Stage 1|Withdrawal by Subject|0|||
19484737|NCT01500200|41768305|FG003|Stage 1|Withdrawal by Subject|0|||
19393336|NCT04508621|41637176|FG001|Overall Study|Adverse Event|16|||
19393337|NCT04508621|41637175|FG000|Overall Study|Lack of Efficacy|2|||
19393338|NCT04508621|41637176|FG001|Overall Study|Lack of Efficacy|8|||
19393339|NCT04508621|41637175|FG000|Overall Study|Physician Decision|0|||
19393340|NCT04508621|41637176|FG001|Overall Study|Physician Decision|1|||
19393341|NCT04508621|41637175|FG000|Overall Study|Withdrawal by Subject|10|||
19393342|NCT04508621|41637176|FG001|Overall Study|Withdrawal by Subject|14|||
19393343|NCT04508621|41637175|FG000|Overall Study|Lost to Follow-up|12|||
19393344|NCT04508621|41637176|FG001|Overall Study|Lost to Follow-up|9|||
19393345|NCT04508621|41637175|FG000|Overall Study|COVID-19 related crisis|3|||
19393346|NCT04508621|41637176|FG001|Overall Study|COVID-19 related crisis|0|||
19484738|NCT01500200|41768306|FG004|Stage 1|Withdrawal by Subject|0|||
19484739|NCT01500200|41768307|FG005|Stage 1|Withdrawal by Subject|0|||
19484740|NCT01500200|41768302|FG000|Stage 1|Noncompliance with Study Drug|1|||
19484741|NCT01500200|41768303|FG001|Stage 1|Noncompliance with Study Drug|0|||
19484742|NCT01500200|41768304|FG002|Stage 1|Noncompliance with Study Drug|0|||
19484743|NCT01500200|41768305|FG003|Stage 1|Noncompliance with Study Drug|0|||
19484744|NCT01500200|41768306|FG004|Stage 1|Noncompliance with Study Drug|0|||
19484745|NCT01500200|41768307|FG005|Stage 1|Noncompliance with Study Drug|0|||
19484746|NCT01500200|41768302|FG000|Stage 1|Physician Decision|1|||
19484747|NCT01500200|41768303|FG001|Stage 1|Physician Decision|0|||
19484748|NCT01500200|41768304|FG002|Stage 1|Physician Decision|0|||
19484749|NCT01500200|41768305|FG003|Stage 1|Physician Decision|0|||
19484750|NCT01500200|41768306|FG004|Stage 1|Physician Decision|0|||
19484751|NCT01500200|41768307|FG005|Stage 1|Physician Decision|0|||
19484752|NCT01500200|41768302|FG000|Stage 2|Adverse Event|0|||
19484753|NCT01500200|41768303|FG001|Stage 2|Adverse Event|0|||
19393347|NCT04508621|41637175|FG000|Overall Study|Subject non-compliance|1|||
19484754|NCT01500200|41768304|FG002|Stage 2|Adverse Event|0|||
19484755|NCT01500200|41768305|FG003|Stage 2|Adverse Event|0|||
19484756|NCT01500200|41768306|FG004|Stage 2|Adverse Event|5|||
19393348|NCT04508621|41637176|FG001|Overall Study|Subject non-compliance|0|||
19393349|NCT03591107|41637184|FG000|Overall Study|Same patient in both arms|1|||
19393350|NCT03591107|41637185|FG001|Overall Study|Same patient in both arms|1|||
19484757|NCT01500200|41768307|FG005|Stage 2|Adverse Event|4|||
19484758|NCT01478360|41768323|FG000|Overall Study|Lost to Follow-up|1|||
19484759|NCT01478360|41768324|FG001|Overall Study|Lost to Follow-up|0|||
19484760|NCT01478360|41768323|FG000|Overall Study|Adverse Event|0|||
19484761|NCT01478360|41768324|FG001|Overall Study|Adverse Event|1|||
19484762|NCT01478360|41768323|FG000|Overall Study|Administrative problems|1|||
19484763|NCT01478360|41768324|FG001|Overall Study|Administrative problems|2|||
19484764|NCT01461980|41768342|FG000|Overall Study|Other|9|||
19484765|NCT01461980|41768343|FG001|Overall Study|Other|8|||
19484766|NCT01461980|41768344|FG002|Overall Study|Other|6|||
19484767|NCT01461980|41768342|FG000|Overall Study|Medication error|7|||
19484768|NCT01461980|41768343|FG001|Overall Study|Medication error|5|||
19484769|NCT01461980|41768344|FG002|Overall Study|Medication error|6|||
19484770|NCT01461980|41768342|FG000|Overall Study|Adverse Event|12|||
19484771|NCT01461980|41768343|FG001|Overall Study|Adverse Event|5|||
19484772|NCT01461980|41768344|FG002|Overall Study|Adverse Event|6|||
19484773|NCT01461980|41768342|FG000|Overall Study|Protocol Violation|12|||
19484774|NCT01461980|41768343|FG001|Overall Study|Protocol Violation|19|||
19484775|NCT01461980|41768344|FG002|Overall Study|Protocol Violation|16|||
19484776|NCT01461980|41768342|FG000|Overall Study|No longer meets eligibility criteria|18|||
19484777|NCT01461980|41768343|FG001|Overall Study|No longer meets eligibility criteria|9|||
19484778|NCT01461980|41768344|FG002|Overall Study|No longer meets eligibility criteria|19|||
19484779|NCT01461980|41768342|FG000|Overall Study|Lost to Follow-up|52|||
19484780|NCT01461980|41768343|FG001|Overall Study|Lost to Follow-up|53|||
19484781|NCT01461980|41768344|FG002|Overall Study|Lost to Follow-up|51|||
19484782|NCT01461980|41768342|FG000|Overall Study|No longer willing to participate|52|||
19484783|NCT01461980|41768343|FG001|Overall Study|No longer willing to participate|38|||
19484784|NCT01461980|41768344|FG002|Overall Study|No longer willing to participate|54|||
19484785|NCT01461980|41768342|FG000|Overall Study|Randomized but not vaccinated|4|||
19484786|NCT01461980|41768343|FG001|Overall Study|Randomized but not vaccinated|8|||
19484787|NCT01461980|41768344|FG002|Overall Study|Randomized but not vaccinated|7|||
19484788|NCT01424501|41768359|FG000|Overall Study|Withdrawal by Subject|1|||
19484789|NCT01424501|41768360|FG001|Overall Study|Withdrawal by Subject|0|||
19484790|NCT01424501|41768361|FG002|Overall Study|Withdrawal by Subject|1|||
19484791|NCT01424501|41768362|FG003|Overall Study|Withdrawal by Subject|0|||
19484792|NCT01424501|41768363|FG004|Overall Study|Withdrawal by Subject|0|||
19484793|NCT01424501|41768364|FG005|Overall Study|Withdrawal by Subject|0|||
19484794|NCT01424501|41768359|FG000|Overall Study|Lost to Follow-up|0|||
19484795|NCT01424501|41768360|FG001|Overall Study|Lost to Follow-up|1|||
19484796|NCT01424501|41768361|FG002|Overall Study|Lost to Follow-up|1|||
19484797|NCT01424501|41768362|FG003|Overall Study|Lost to Follow-up|0|||
19484798|NCT01424501|41768363|FG004|Overall Study|Lost to Follow-up|0|||
19484799|NCT01424501|41768364|FG005|Overall Study|Lost to Follow-up|0|||
19484800|NCT01401959|41768445|FG000|Enrolled|Withdrawal by Subject|1|||
19484801|NCT01401959|41768446|FG001|Enrolled|Withdrawal by Subject|0|||
19484802|NCT01401959|41768447|FG002|Enrolled|Withdrawal by Subject|0|||
19484803|NCT01401959|41768445|FG000|Treated|Disease Progression|2|||
19484804|NCT01401959|41768446|FG001|Treated|Disease Progression|2|||
19484805|NCT01401959|41768447|FG002|Treated|Disease Progression|1|||
19484806|NCT01401959|41768445|FG000|Treated|Adverse Event|4|||
19484807|NCT01401959|41768446|FG001|Treated|Adverse Event|3|||
19484808|NCT01401959|41768447|FG002|Treated|Adverse Event|2|||
19484809|NCT01401959|41768445|FG000|Treated|Withdrawal by Subject|1|||
19484810|NCT01401959|41768446|FG001|Treated|Withdrawal by Subject|2|||
19484811|NCT01401959|41768447|FG002|Treated|Withdrawal by Subject|2|||
19484812|NCT01401959|41768445|FG000|Treated|Protocol Violation|0|||
19484813|NCT01401959|41768446|FG001|Treated|Protocol Violation|1|||
19484814|NCT01401959|41768447|FG002|Treated|Protocol Violation|0|||
19484815|NCT01478048|41768477|FG000|Overall Study|Disease Progression|52|||
19484816|NCT01478048|41768478|FG001|Overall Study|Disease Progression|35|||
19484817|NCT01478048|41768477|FG000|Overall Study|study drug toxicity|11|||
19484818|NCT01478048|41768478|FG001|Overall Study|study drug toxicity|14|||
19484819|NCT01478048|41768477|FG000|Overall Study|Adverse Event|2|||
19484820|NCT01478048|41768478|FG001|Overall Study|Adverse Event|11|||
19484821|NCT01478048|41768477|FG000|Overall Study|subject request to discontinue treatment|3|||
19484822|NCT01478048|41768478|FG001|Overall Study|subject request to discontinue treatment|5|||
19484823|NCT01478048|41768477|FG000|Overall Study|Withdrawal by Subject|2|||
19484824|NCT01478048|41768478|FG001|Overall Study|Withdrawal by Subject|5|||
19484825|NCT01478048|41768477|FG000|Overall Study|non-specified|6|||
19484826|NCT01478048|41768478|FG001|Overall Study|non-specified|4|||
19484827|NCT01478048|41768477|FG000|Overall Study|poor/non-compliance|0|||
19484828|NCT01478048|41768478|FG001|Overall Study|poor/non-compliance|1|||
19484829|NCT01478048|41768477|FG000|Overall Study|no longer meets study criteria|1|||
19484830|NCT01478048|41768478|FG001|Overall Study|no longer meets study criteria|0|||
19484831|NCT01424189|41768486|FG000|Overall Study|Adverse Event|1|||
19484832|NCT01424189|41768487|FG001|Overall Study|Adverse Event|0|||
19484833|NCT01424189|41768486|FG000|Overall Study|Lost to Follow-up|4|||
19484834|NCT01424189|41768487|FG001|Overall Study|Lost to Follow-up|1|||
19484835|NCT01424189|41768486|FG000|Overall Study|Withdrawal by Subject|4|||
19484836|NCT01424189|41768487|FG001|Overall Study|Withdrawal by Subject|4|||
19484837|NCT01424189|41768486|FG000|Overall Study|Subject moved|1|||
19484838|NCT01424189|41768487|FG001|Overall Study|Subject moved|0|||
19484839|NCT01424189|41768486|FG000|Overall Study|Death|3|||
19484840|NCT01424189|41768487|FG001|Overall Study|Death|1|||
19484841|NCT01401647|41768500|FG000|Overall Study|Withdrawal by Subject|1|||
19484842|NCT01401647|41768501|FG001|Overall Study|Withdrawal by Subject|5|||
19484843|NCT01401647|41768502|FG002|Overall Study|Withdrawal by Subject|2|||
19484844|NCT01401647|41768500|FG000|Overall Study|Lost to Follow-up|3|||
19484845|NCT01401647|41768501|FG001|Overall Study|Lost to Follow-up|3|||
19484846|NCT01401647|41768502|FG002|Overall Study|Lost to Follow-up|1|||
19484847|NCT01499810|41768510|FG000|Overall Study|Lost to Follow-up|10|||
19484848|NCT01499810|41768510|FG000|Overall Study|Protocol Violation|1|||
19484849|NCT01499810|41768510|FG000|Overall Study|Withdrawal by Subject|1|||
19484850|NCT01423253|41768515|FG000|Overall Study|Adverse Event|2|||
19484851|NCT01423253|41768515|FG000|Overall Study|Lack of Efficacy|2|||
19484852|NCT01423253|41768515|FG000|Overall Study|Lost to Follow-up|1|||
19393351|NCT03591107|41637184|FG000|Overall Study|Sought care at other clinics|0|||
19393352|NCT03591107|41637185|FG001|Overall Study|Sought care at other clinics|2|||
19393353|NCT03591107|41637184|FG000|Overall Study|Discharged from clinic|0|||
19393354|NCT03591107|41637185|FG001|Overall Study|Discharged from clinic|1|||
19393355|NCT03591107|41637184|FG000|Overall Study|Withdrawal by Subject|0|||
19393356|NCT03591107|41637185|FG001|Overall Study|Withdrawal by Subject|1|||
19393357|NCT02922023|41637198|FG000|Overall Study|Lost to Follow-up|2|||
19393358|NCT02922023|41637199|FG001|Overall Study|Lost to Follow-up|0|||
19393359|NCT01672853|41637208|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
19393360|NCT01672853|41637209|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
19393361|NCT01672853|41637210|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
19484853|NCT01423253|41768515|FG000|Overall Study|Protocol Violation|2|||
19484854|NCT01423253|41768515|FG000|Overall Study|Withdrawal by Subject|2|||
19484855|NCT01477892|41768521|FG000|Overall Study|Withdrawal by Subject|0|||
19484856|NCT01477892|41768522|FG001|Overall Study|Withdrawal by Subject|2|||
19484857|NCT01422239|41768535|FG000|Overall Study|Lost to Follow-up|4|||
19484858|NCT01422239|41768536|FG001|Overall Study|Lost to Follow-up|3|||
19484859|NCT01499576|41768542|FG000|Overall Study|Physician Decision|12|||
19484860|NCT01499576|41768542|FG000|Overall Study|Withdrawal by Subject|9|||
19484861|NCT01476722|41768556|FG000|Overall Study|Adverse Event|1|||
19484862|NCT01476644|41768569|FG000|Overall Study|Death|5|||
19484863|NCT01476644|41768569|FG000|Overall Study|moved to another state|2|||
19484864|NCT01476644|41768569|FG000|Overall Study|Lost to Follow-up|19|||
19484865|NCT01476644|41768569|FG000|Overall Study|Withdrawal by Subject|13|||
19484866|NCT01421459|41768593|FG000|Overall Study|Adverse Event|6|||
19484867|NCT01421459|41768594|FG001|Overall Study|Adverse Event|10|||
19484868|NCT01421459|41768593|FG000|Overall Study|Death|1|||
19484869|NCT01421459|41768594|FG001|Overall Study|Death|1|||
19484870|NCT01421459|41768593|FG000|Overall Study|Lack of Efficacy|1|||
19484871|NCT01421459|41768594|FG001|Overall Study|Lack of Efficacy|2|||
19484872|NCT01421459|41768593|FG000|Overall Study|Lost to Follow-up|8|||
19484873|NCT01421459|41768594|FG001|Overall Study|Lost to Follow-up|9|||
19484874|NCT01421459|41768593|FG000|Overall Study|Physician Decision|9|||
19484875|NCT01421459|41768594|FG001|Overall Study|Physician Decision|9|||
19484876|NCT01421459|41768593|FG000|Overall Study|Protocol Violation|8|||
19484877|NCT01421459|41768594|FG001|Overall Study|Protocol Violation|5|||
19484878|NCT01421459|41768593|FG000|Overall Study|Withdrawal by Subject|12|||
19484879|NCT01421459|41768594|FG001|Overall Study|Withdrawal by Subject|16|||
19484880|NCT01498952|41768602|FG000|Overall Study|Death|2|||
19484881|NCT01498952|41768603|FG001|Overall Study|Death|2|||
19484882|NCT01498952|41768604|FG002|Overall Study|Death|0|||
19484883|NCT01498952|41768605|FG003|Overall Study|Death|0|||
19484884|NCT01498952|41768606|FG004|Overall Study|Death|0|||
19484885|NCT01461044|41768638|FG000|Overall Study|Death|58|||
19484886|NCT01461044|41768639|FG001|Overall Study|Death|35|||
19484887|NCT01461044|41768638|FG000|Overall Study|Lost to Follow-up|12|||
19484888|NCT01461044|41768639|FG001|Overall Study|Lost to Follow-up|5|||
19484889|NCT01421303|41768672|FG000|Overall Study|Lost to Follow-up|13|||
19484890|NCT01421303|41768672|FG000|Overall Study|Non compliance with study procedure|1|||
19484891|NCT01421303|41768672|FG000|Overall Study|Other|7|||
19484892|NCT01421303|41768672|FG000|Overall Study|Withdrawal by Subject|1|||
19484893|NCT01475474|41768676|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
19484894|NCT01475474|41768676|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
19484895|NCT01400243|41768683|FG000|Overall Study|Protocol Violation|8|||
19393362|NCT01672853|41637208|FG000|Overall Study|Pregnancy|0|||
19484896|NCT01400243|41768684|FG001|Overall Study|Protocol Violation|11|||
19484897|NCT01475162|41768701|FG000|Overall Study|Physician Decision|1|||
19484898|NCT01475162|41768701|FG000|Overall Study|Death|10|||
19484899|NCT01475162|41768701|FG000|Overall Study|Study closed for safety|3|||
19484900|NCT01421225|41768708|FG000|Overall Study|Withdrawal by Subject|0|||
19484901|NCT01421225|41768709|FG001|Overall Study|Withdrawal by Subject|1|||
19484902|NCT01498640|41768725|FG000|Overall Study|Lost to Follow-up|1|||
19484903|NCT01498640|41768725|FG000|Overall Study|Death|1|||
19484904|NCT01498640|41768725|FG000|Overall Study|Other|3|||
19484905|NCT01498484|41768737|FG000|Overall Study|Death|6|||
19484906|NCT01498484|41768738|FG001|Overall Study|Death|3|||
19484907|NCT01498484|41768739|FG002|Overall Study|Death|1|||
19484908|NCT01498484|41768740|FG003|Overall Study|Death|1|||
19484909|NCT01498484|41768741|FG004|Overall Study|Death|0|||
19484910|NCT01498484|41768742|FG005|Overall Study|Death|0|||
19484911|NCT01498484|41768743|FG006|Overall Study|Death|10|||
19484912|NCT01498484|41768744|FG007|Overall Study|Death|1|||
19484913|NCT01498484|41768745|FG008|Overall Study|Death|0|||
19484914|NCT01498484|41768737|FG000|Overall Study|Physician Decision|3|||
19484915|NCT01498484|41768738|FG001|Overall Study|Physician Decision|2|||
19484916|NCT01498484|41768739|FG002|Overall Study|Physician Decision|1|||
19484917|NCT01498484|41768740|FG003|Overall Study|Physician Decision|1|||
19484918|NCT01498484|41768741|FG004|Overall Study|Physician Decision|0|||
19484919|NCT01498484|41768742|FG005|Overall Study|Physician Decision|0|||
19484920|NCT01498484|41768743|FG006|Overall Study|Physician Decision|8|||
19484921|NCT01498484|41768744|FG007|Overall Study|Physician Decision|13|||
19484922|NCT01498484|41768745|FG008|Overall Study|Physician Decision|1|||
19484923|NCT01498484|41768737|FG000|Overall Study|Adverse Event|0|||
19484924|NCT01498484|41768738|FG001|Overall Study|Adverse Event|0|||
19484925|NCT01498484|41768739|FG002|Overall Study|Adverse Event|0|||
19484926|NCT01498484|41768740|FG003|Overall Study|Adverse Event|0|||
19484927|NCT01498484|41768741|FG004|Overall Study|Adverse Event|0|||
19484928|NCT01498484|41768742|FG005|Overall Study|Adverse Event|1|||
19484929|NCT01498484|41768743|FG006|Overall Study|Adverse Event|0|||
19484930|NCT01498484|41768744|FG007|Overall Study|Adverse Event|0|||
19484931|NCT01498484|41768745|FG008|Overall Study|Adverse Event|0|||
19484932|NCT01498484|41768737|FG000|Overall Study|Withdrawal by Subject|0|||
19484933|NCT01498484|41768738|FG001|Overall Study|Withdrawal by Subject|0|||
19484934|NCT01498484|41768739|FG002|Overall Study|Withdrawal by Subject|0|||
19484935|NCT01498484|41768740|FG003|Overall Study|Withdrawal by Subject|1|||
19484936|NCT01498484|41768741|FG004|Overall Study|Withdrawal by Subject|0|||
19484937|NCT01498484|41768742|FG005|Overall Study|Withdrawal by Subject|0|||
19484938|NCT01498484|41768743|FG006|Overall Study|Withdrawal by Subject|1|||
19484939|NCT01498484|41768744|FG007|Overall Study|Withdrawal by Subject|0|||
19484940|NCT01498484|41768745|FG008|Overall Study|Withdrawal by Subject|0|||
19612465|NCT00617305|42061323|FG000|Overall Study|Adverse Event|4|||
19612466|NCT00617305|42061324|FG001|Overall Study|Adverse Event|0|||
19612467|NCT00617305|42061325|FG002|Overall Study|Adverse Event|0|||
19612468|NCT00617305|42061323|FG000|Overall Study|Death|1|||
19612469|NCT00617305|42061324|FG001|Overall Study|Death|0|||
19612470|NCT00617305|42061325|FG002|Overall Study|Death|0|||
19612471|NCT00617305|42061323|FG000|Overall Study|Physician Decision|1|||
19484941|NCT01498484|41768737|FG000|Overall Study|Other|5|||
19484942|NCT01498484|41768738|FG001|Overall Study|Other|2|||
19484943|NCT01498484|41768739|FG002|Overall Study|Other|0|||
19484944|NCT01498484|41768740|FG003|Overall Study|Other|0|||
19484945|NCT01498484|41768741|FG004|Overall Study|Other|1|||
19484946|NCT01498484|41768742|FG005|Overall Study|Other|0|||
19484947|NCT01498484|41768743|FG006|Overall Study|Other|3|||
19484948|NCT01498484|41768744|FG007|Overall Study|Other|0|||
19484949|NCT01498484|41768745|FG008|Overall Study|Other|1|||
19484950|NCT01474772|41768754|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
19484951|NCT01474772|41768755|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
19484952|NCT01474772|41768754|FG000|Period 1|AE not Related to Study Drug|1|||
19484953|NCT01474772|41768755|FG001|Period 1|AE not Related to Study Drug|0|||
19484954|NCT01474772|41768754|FG000|Period 1|Withdrawal by Subject|3|||
19484955|NCT01474772|41768755|FG001|Period 1|Withdrawal by Subject|1|||
19484956|NCT01474772|41768754|FG000|Period 1|Lost to Follow-up|1|||
19484957|NCT01474772|41768755|FG001|Period 1|Lost to Follow-up|0|||
19484958|NCT01474772|41768754|FG000|Period 1|Reason not Specified|1|||
19484959|NCT01474772|41768755|FG001|Period 1|Reason not Specified|1|||
19484960|NCT01474772|41768754|FG000|Washout|AE not Related to Study Drug|2|||
19484961|NCT01474772|41768755|FG001|Washout|AE not Related to Study Drug|0|||
19484962|NCT01474772|41768754|FG000|Washout|Withdrawal by Subject|1|||
19484963|NCT01474772|41768755|FG001|Washout|Withdrawal by Subject|0|||
19484964|NCT01474772|41768754|FG000|Washout|Lost to Follow-up|0|||
19612472|NCT00617305|42061324|FG001|Overall Study|Physician Decision|0|||
19484965|NCT01474772|41768755|FG001|Washout|Lost to Follow-up|1|||
19484966|NCT01474772|41768754|FG000|Washout|Reason not Specified|0|||
19484967|NCT01474772|41768755|FG001|Washout|Reason not Specified|1|||
19484968|NCT01474772|41768754|FG000|Period 2|Death|0|||
19484969|NCT01474772|41768755|FG001|Period 2|Death|1|||
19484970|NCT01474772|41768754|FG000|Period 2|AE Related to Study Drug|0|||
19484971|NCT01474772|41768755|FG001|Period 2|AE Related to Study Drug|1|||
19612473|NCT00617305|42061325|FG002|Overall Study|Physician Decision|0|||
19484972|NCT01474772|41768754|FG000|Period 2|AE not Related to Study Drug|4|||
19484973|NCT01474772|41768755|FG001|Period 2|AE not Related to Study Drug|1|||
19484974|NCT01474772|41768754|FG000|Period 2|Lack of Efficacy|1|||
19484975|NCT01474772|41768755|FG001|Period 2|Lack of Efficacy|0|||
19484976|NCT01474772|41768754|FG000|Period 2|Withdrawal by Subject|3|||
19484977|NCT01474772|41768755|FG001|Period 2|Withdrawal by Subject|4|||
19484978|NCT01474772|41768754|FG000|Period 2|Lost to Follow-up|1|||
19484979|NCT01474772|41768755|FG001|Period 2|Lost to Follow-up|1|||
19484980|NCT01474772|41768754|FG000|Period 2|Reason not Specified|0|||
19484981|NCT01474772|41768755|FG001|Period 2|Reason not Specified|2|||
19484982|NCT01474772|41768754|FG000|Follow-up|AE not Related to Study Drug|0|||
19484983|NCT01474772|41768755|FG001|Follow-up|AE not Related to Study Drug|1|||
19484984|NCT01421147|41768763|FG000|Treatment Period|Adverse Event|2|||
19484985|NCT01421147|41768764|FG001|Treatment Period|Adverse Event|3|||
19484986|NCT01421147|41768763|FG000|Treatment Period|Lost to Follow-up|2|||
19484987|NCT01421147|41768764|FG001|Treatment Period|Lost to Follow-up|1|||
19484988|NCT01421147|41768763|FG000|Treatment Period|Physician Decision|2|||
19484989|NCT01421147|41768764|FG001|Treatment Period|Physician Decision|2|||
19484990|NCT01421147|41768763|FG000|Treatment Period|Withdrawal by Subject|10|||
19484991|NCT01421147|41768764|FG001|Treatment Period|Withdrawal by Subject|5|||
19484992|NCT01421147|41768763|FG000|Extension Period|Adverse Event|0|||
19484993|NCT01421147|41768764|FG001|Extension Period|Adverse Event|2|||
19484994|NCT01421147|41768763|FG000|Extension Period|Death|0|||
19484995|NCT01421147|41768764|FG001|Extension Period|Death|1|||
19484996|NCT01421147|41768763|FG000|Extension Period|Lost to Follow-up|2|||
19484997|NCT01421147|41768764|FG001|Extension Period|Lost to Follow-up|5|||
19484998|NCT01421147|41768763|FG000|Extension Period|Physician Decision|1|||
19484999|NCT01421147|41768764|FG001|Extension Period|Physician Decision|0|||
19485000|NCT01421147|41768763|FG000|Extension Period|Withdrawal by Subject|5|||
19485001|NCT01421147|41768764|FG001|Extension Period|Withdrawal by Subject|3|||
19485002|NCT01497938|41768781|FG000|Overall Study|Adverse Event|0|||
19485003|NCT01497938|41768782|FG001|Overall Study|Adverse Event|1|||
19485004|NCT01497938|41768781|FG000|Overall Study|Physician Decision|0|||
19485005|NCT01497938|41768782|FG001|Overall Study|Physician Decision|1|||
19485006|NCT01497938|41768781|FG000|Overall Study|Withdrawal by Subject|4|||
19485007|NCT01497938|41768782|FG001|Overall Study|Withdrawal by Subject|0|||
19485008|NCT01497938|41768781|FG000|Overall Study|Device Violation|1|||
19485009|NCT01497938|41768782|FG001|Overall Study|Device Violation|0|||
19485010|NCT01460342|41768832|FG000|Overall Study|Adverse Event|5|||
19485011|NCT01460342|41768833|FG001|Overall Study|Adverse Event|4|||
19485012|NCT01460342|41768832|FG000|Overall Study|Lost to Follow-up|1|||
19485013|NCT01460342|41768833|FG001|Overall Study|Lost to Follow-up|2|||
19485014|NCT01460342|41768832|FG000|Overall Study|Protocol Violation|0|||
19485015|NCT01460342|41768833|FG001|Overall Study|Protocol Violation|1|||
19485016|NCT01460342|41768832|FG000|Overall Study|Withdrawal by Subject|3|||
19485017|NCT01460342|41768833|FG001|Overall Study|Withdrawal by Subject|4|||
19485018|NCT01460342|41768832|FG000|Overall Study|Physician Decision|1|||
19485019|NCT01460342|41768833|FG001|Overall Study|Physician Decision|3|||
19485020|NCT01460342|41768832|FG000|Overall Study|Lack of Efficacy|1|||
19485021|NCT01460342|41768833|FG001|Overall Study|Lack of Efficacy|0|||
19485022|NCT01459796|41768865|FG000|Overall Study|Non compliance with protocol|2|||
19485023|NCT01459796|41768866|FG001|Overall Study|Non compliance with protocol|4|||
19485024|NCT01459796|41768865|FG000|Overall Study|Adverse Event|5|||
19485025|NCT01459796|41768866|FG001|Overall Study|Adverse Event|5|||
19485026|NCT01459796|41768865|FG000|Overall Study|Withdrawal by Subject|6|||
19485027|NCT01459796|41768866|FG001|Overall Study|Withdrawal by Subject|3|||
19485028|NCT01459796|41768865|FG000|Overall Study|Lost to Follow-up|5|||
19485029|NCT01459796|41768866|FG001|Overall Study|Lost to Follow-up|4|||
19485030|NCT01459796|41768865|FG000|Overall Study|Reason unspecified|1|||
19485031|NCT01459796|41768866|FG001|Overall Study|Reason unspecified|2|||
19485032|NCT01459796|41768865|FG000|Overall Study|Decision by the sponsor|75|||
19393363|NCT01672853|41637209|FG001|Overall Study|Pregnancy|1|||
19393364|NCT01672853|41637210|FG002|Overall Study|Pregnancy|0|||
19393365|NCT01672853|41637208|FG000|Overall Study|Investigator's Discretion|1|||
19393366|NCT01672853|41637209|FG001|Overall Study|Investigator's Discretion|0|||
19393367|NCT01672853|41637210|FG002|Overall Study|Investigator's Discretion|0|||
19393368|NCT01672853|41637208|FG000|Overall Study|Withdrew Consent|5|||
19393369|NCT01672853|41637209|FG001|Overall Study|Withdrew Consent|5|||
19393370|NCT01672853|41637210|FG002|Overall Study|Withdrew Consent|5|||
19485033|NCT01459796|41768866|FG001|Overall Study|Decision by the sponsor|108|||
19485034|NCT01459718|41768876|FG000|Overall Study|Physician Decision|1|||
19485035|NCT01459718|41768876|FG000|Overall Study|Lost to Follow-up|1|||
19485036|NCT01459718|41768876|FG000|Overall Study|Adverse Event|1|||
19485037|NCT02900976|41768886|FG000|Overall Study|Adverse Event|0|||
19485038|NCT02900976|41768887|FG001|Overall Study|Adverse Event|1|||
19485039|NCT02900976|41768886|FG000|Overall Study|Physician Decision|0|||
19485040|NCT02900976|41768887|FG001|Overall Study|Physician Decision|2|||
19485041|NCT02900976|41768886|FG000|Overall Study|Progressive disease|0|||
19485042|NCT02900976|41768887|FG001|Overall Study|Progressive disease|6|||
19485043|NCT01474538|41768900|FG000|Treatment Period 1|Death|1|||
19485044|NCT01474538|41768901|FG001|Treatment Period 1|Death|0|||
19393371|NCT01672853|41637208|FG000|Overall Study|Adverse Event|4|||
19393372|NCT01672853|41637209|FG001|Overall Study|Adverse Event|6|||
19485045|NCT01474538|41768900|FG000|Treatment Period 1|Physician Decision|1|||
19485046|NCT01474538|41768901|FG001|Treatment Period 1|Physician Decision|0|||
19485047|NCT01474538|41768900|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19485048|NCT01474538|41768901|FG001|Treatment Period 1|Withdrawal by Subject|3|||
19485049|NCT01474538|41768900|FG000|Treatment Period 1|Protocol Violation|0|||
19485050|NCT01474538|41768901|FG001|Treatment Period 1|Protocol Violation|1|||
19485051|NCT01474538|41768900|FG000|Treatment Period 2|Death|1|||
19485052|NCT01474538|41768901|FG001|Treatment Period 2|Death|0|||
19393373|NCT01672853|41637210|FG002|Overall Study|Adverse Event|8|||
19393374|NCT01672853|41637208|FG000|Overall Study|Lost to Follow-up|0|||
19393375|NCT01672853|41637209|FG001|Overall Study|Lost to Follow-up|1|||
19393376|NCT01672853|41637210|FG002|Overall Study|Lost to Follow-up|0|||
19393377|NCT01672853|41637208|FG000|Overall Study|Randomized but Never Treated|0|||
19393378|NCT01672853|41637209|FG001|Overall Study|Randomized but Never Treated|0|||
19393379|NCT01672853|41637210|FG002|Overall Study|Randomized but Never Treated|1|||
19393380|NCT01603459|41637218|FG000|Overall Study|Adverse Event|5|||
19393381|NCT01603459|41637218|FG000|Overall Study|Withdrawal by Subject|5|||
19485053|NCT01474538|41768900|FG000|Treatment Period 2|Adverse Event|1|||
19485054|NCT01474538|41768901|FG001|Treatment Period 2|Adverse Event|1|||
19485055|NCT01474538|41768900|FG000|Treatment Period 2|Withdrawal by Subject|2|||
19485056|NCT01474538|41768901|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19485057|NCT01474538|41768900|FG000|Treatment Period 2|Sponsor decision|1|||
19485058|NCT01474538|41768901|FG001|Treatment Period 2|Sponsor decision|0|||
19485059|NCT01474538|41768900|FG000|Treatment Period 2|Physician Decision|0|||
19485060|NCT01474538|41768901|FG001|Treatment Period 2|Physician Decision|1|||
19485061|NCT01474538|41768900|FG000|Treatment Period 2|Protocol Violation|1|||
19485062|NCT01474538|41768901|FG001|Treatment Period 2|Protocol Violation|0|||
19485063|NCT02647788|41768909|FG000|Overall Study|Lost to Follow-up|13|||
19485064|NCT02647788|41768910|FG001|Overall Study|Lost to Follow-up|11|||
19485065|NCT02647788|41768909|FG000|Overall Study|Did not want opiate|0|||
19485066|NCT02647788|41768910|FG001|Overall Study|Did not want opiate|1|||
19485067|NCT02647788|41768909|FG000|Overall Study|Withdrawal by Subject|1|||
19485068|NCT02647788|41768910|FG001|Overall Study|Withdrawal by Subject|0|||
19485069|NCT02647788|41768909|FG000|Overall Study|Felt itchy with assigned medication|1|||
19485070|NCT02647788|41768910|FG001|Overall Study|Felt itchy with assigned medication|0|||
19485071|NCT02647788|41768909|FG000|Overall Study|Felt nauseous with assigned medication|1|||
19485072|NCT02647788|41768910|FG001|Overall Study|Felt nauseous with assigned medication|1|||
19485073|NCT01459016|41768916|FG000|Overall Study|Withdrawal by Subject|11|||
19485074|NCT01459016|41768916|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
19485075|NCT01458392|41768958|FG000|Overall Study|Death|2|||
19485076|NCT01458392|41768959|FG001|Overall Study|Death|11|||
19485077|NCT01458392|41768960|FG002|Overall Study|Death|22|||
19485078|NCT01458392|41768958|FG000|Overall Study|At the discretion of the sponsor|0|||
19485079|NCT01458392|41768959|FG001|Overall Study|At the discretion of the sponsor|2|||
19485080|NCT01458392|41768960|FG002|Overall Study|At the discretion of the sponsor|7|||
19485081|NCT01458392|41768958|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
19485082|NCT01458392|41768959|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
19485083|NCT01458392|41768960|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
19393382|NCT01603459|41637218|FG000|Overall Study|Lost to Follow-up|3|||
19393383|NCT01603459|41637218|FG000|Overall Study|Predefined discontinuation criteria|3|||
19393384|NCT01603459|41637218|FG000|Overall Study|Non-compliance|1|||
19393385|NCT01603459|41637218|FG000|Overall Study|Administrative reason|1|||
19393386|NCT01678807|41637257|FG000|Overall Study|Adverse Event|4|||
19393387|NCT01678807|41637258|FG001|Overall Study|Adverse Event|4|||
19393388|NCT01678807|41637259|FG002|Overall Study|Adverse Event|0|||
19393389|NCT01678807|41637257|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
19485084|NCT01421069|41768972|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
19485085|NCT01421069|41768972|FG000|Parent Study|Failed to return|3|||
19485086|NCT01421069|41768972|FG000|Parent Study|Withdrawal by Subject|1|||
19485087|NCT01421069|41768972|FG000|Parent Study|Lost to Follow-up|2|||
19485088|NCT01421069|41768972|FG000|Parent Study|Lack of Efficacy|1|||
19485089|NCT01421069|41768972|FG000|Overall Period for Extension Study|Other|2|||
19485090|NCT01421069|41768972|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
19485091|NCT01421069|41768972|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
19485092|NCT01421069|41768972|FG000|Overall Period for Extension Study|Pregnancy|1|||
19485093|NCT01421069|41768972|FG000|Overall Period for Extension Study|Adverse Event|1|||
19485094|NCT01421069|41768972|FG000|Overall Period for Extension Study|Protocol Violation|1|||
19485095|NCT01421069|41768972|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
19485096|NCT01421069|41768972|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
19485097|NCT01421069|41768972|FG000|Active Treatment Period|Other|1|||
19485098|NCT01421069|41768972|FG000|Active Treatment Period|No longer willing to participate in study|8|||
19393390|NCT01678807|41637258|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
19393391|NCT01678807|41637259|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
19393392|NCT03073525|41637270|FG000|Overall Study|Withdrawal by Subject|0|||
19485099|NCT01421069|41768972|FG000|Active Treatment Period|Insufficient clinical response|1|||
19485100|NCT01421069|41768972|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
19485101|NCT01421069|41768972|FG000|Active Treatment Period|Pregnancy|1|||
19485102|NCT01421069|41768972|FG000|Active Treatment Period|Adverse Event|1|||
19485103|NCT01421069|41768972|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
19485104|NCT01421069|41768972|FG000|Active Treatment Period|Enrolled in observational period|29|||
19485105|NCT01421069|41768972|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
19485106|NCT01421069|41768972|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
19485107|NCT01421069|41768972|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
19485108|NCT01421069|41768972|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
19485109|NCT01421069|41768972|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
19485110|NCT01421069|41768972|FG000|2b. Retreatment Period|Protocol Violation|1|||
19485111|NCT01421069|41768972|FG000|Observational Period|Other|1|||
19485112|NCT01421069|41768972|FG000|Observational Period|No longer willing to participate in study|4|||
19485113|NCT01421069|41768972|FG000|Observational Period|Lost to Follow-up|3|||
19485114|NCT01473836|41769004|FG000|Overall Study|Adverse Event|4|||
19485115|NCT01473836|41769004|FG000|Overall Study|Lack of Efficacy|1|||
19485116|NCT01473836|41769004|FG000|Overall Study|Does not meet entrance criteria|1|||
19485117|NCT01473758|41769044|FG000|Cycle 1|Adverse Event|10|||
19485118|NCT01473758|41769045|FG001|Cycle 1|Adverse Event|2|||
19393393|NCT03073525|41637271|FG001|Overall Study|Withdrawal by Subject|0|||
19393394|NCT03073525|41637272|FG002|Overall Study|Withdrawal by Subject|3|||
19393395|NCT02631551|41637293|FG000|Overall Study|Adverse Event|1|||
19393396|NCT02631551|41637294|FG001|Overall Study|Adverse Event|2|||
19393397|NCT02631551|41637295|FG002|Overall Study|Adverse Event|4|||
19393398|NCT02631551|41637296|FG003|Overall Study|Adverse Event|0|||
19393399|NCT02631551|41637293|FG000|Overall Study|Lack of Efficacy|0|||
19393400|NCT02631551|41637294|FG001|Overall Study|Lack of Efficacy|0|||
19393401|NCT02631551|41637295|FG002|Overall Study|Lack of Efficacy|1|||
19393402|NCT02631551|41637296|FG003|Overall Study|Lack of Efficacy|0|||
19393403|NCT02631551|41637293|FG000|Overall Study|Lost to Follow-up|1|||
19393404|NCT02631551|41637294|FG001|Overall Study|Lost to Follow-up|2|||
19393405|NCT02631551|41637295|FG002|Overall Study|Lost to Follow-up|0|||
19393406|NCT02631551|41637296|FG003|Overall Study|Lost to Follow-up|3|||
19393407|NCT02631551|41637293|FG000|Overall Study|Withdrawal by Subject|2|||
19393408|NCT02631551|41637294|FG001|Overall Study|Withdrawal by Subject|2|||
19393409|NCT02631551|41637295|FG002|Overall Study|Withdrawal by Subject|0|||
19393410|NCT02631551|41637296|FG003|Overall Study|Withdrawal by Subject|5|||
19393411|NCT02631551|41637293|FG000|Overall Study|Protocol deviation|3|||
19393412|NCT02631551|41637294|FG001|Overall Study|Protocol deviation|6|||
19393413|NCT02631551|41637295|FG002|Overall Study|Protocol deviation|3|||
19393414|NCT02631551|41637296|FG003|Overall Study|Protocol deviation|0|||
19393415|NCT02631551|41637293|FG000|Overall Study|Non-compliance with study procedures|0|||
19393416|NCT02631551|41637294|FG001|Overall Study|Non-compliance with study procedures|0|||
19393417|NCT02631551|41637295|FG002|Overall Study|Non-compliance with study procedures|1|||
19393418|NCT02631551|41637296|FG003|Overall Study|Non-compliance with study procedures|1|||
19393419|NCT02631551|41637293|FG000|Overall Study|Non-compliance with study drug|1|||
19393420|NCT02631551|41637294|FG001|Overall Study|Non-compliance with study drug|0|||
19393421|NCT02631551|41637295|FG002|Overall Study|Non-compliance with study drug|0|||
19393422|NCT02631551|41637296|FG003|Overall Study|Non-compliance with study drug|0|||
19393423|NCT02631551|41637293|FG000|Overall Study|Other, specific reasons not collected|5|||
19393424|NCT02631551|41637294|FG001|Overall Study|Other, specific reasons not collected|7|||
19393425|NCT02631551|41637295|FG002|Overall Study|Other, specific reasons not collected|2|||
19393426|NCT02631551|41637296|FG003|Overall Study|Other, specific reasons not collected|2|||
19393427|NCT01680991|41637309|FG000|Overall Study|Adverse Event|1|||
19393428|NCT01680991|41637310|FG001|Overall Study|Adverse Event|0|||
19393429|NCT01680991|41637311|FG002|Overall Study|Adverse Event|0|||
19393430|NCT01680991|41637309|FG000|Overall Study|Death|1|||
19393431|NCT01680991|41637310|FG001|Overall Study|Death|0|||
19393432|NCT01680991|41637311|FG002|Overall Study|Death|1|||
19393433|NCT01680991|41637309|FG000|Overall Study|Protocol Violation|0|||
19485119|NCT01473758|41769046|FG002|Cycle 1|Adverse Event|0|||
19485120|NCT01473758|41769047|FG003|Cycle 1|Adverse Event|0|||
19485121|NCT01473758|41769044|FG000|Cycle 1|Withdrawal by Subject|1|||
19485122|NCT01473758|41769045|FG001|Cycle 1|Withdrawal by Subject|1|||
19485123|NCT01473758|41769046|FG002|Cycle 1|Withdrawal by Subject|0|||
19485124|NCT01473758|41769047|FG003|Cycle 1|Withdrawal by Subject|0|||
19485125|NCT01473758|41769044|FG000|Cycle 2|Adverse Event|0|||
19393434|NCT01680991|41637310|FG001|Overall Study|Protocol Violation|1|||
19393435|NCT01680991|41637311|FG002|Overall Study|Protocol Violation|0|||
19393436|NCT01680991|41637309|FG000|Overall Study|Withdrawal by Subject|5|||
19393437|NCT01680991|41637310|FG001|Overall Study|Withdrawal by Subject|1|||
19393438|NCT01680991|41637311|FG002|Overall Study|Withdrawal by Subject|0|||
19393439|NCT01680991|41637309|FG000|Overall Study|Progressive disease (PD)|0|||
19393440|NCT01680991|41637310|FG001|Overall Study|Progressive disease (PD)|10|||
19485126|NCT01473758|41769045|FG001|Cycle 2|Adverse Event|0|||
19485127|NCT01473758|41769046|FG002|Cycle 2|Adverse Event|5|||
19485128|NCT01473758|41769047|FG003|Cycle 2|Adverse Event|0|||
19485129|NCT01420679|41769057|FG000|Overall Study|Disease Progression|3|||
19485130|NCT01420679|41769058|FG001|Overall Study|Disease Progression|2|||
19485131|NCT01420679|41769057|FG000|Overall Study|Adverse Event|4|||
19485132|NCT01420679|41769058|FG001|Overall Study|Adverse Event|0|||
19485133|NCT01420679|41769057|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
19485134|NCT01420679|41769058|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
19485135|NCT01420679|41769057|FG000|Overall Study|Patient Decision|1|||
19485136|NCT01420679|41769058|FG001|Overall Study|Patient Decision|0|||
19485137|NCT01420679|41769057|FG000|Overall Study|Investigator Decision|1|||
19485138|NCT01420679|41769058|FG001|Overall Study|Investigator Decision|2|||
19485139|NCT01420679|41769057|FG000|Overall Study|Sponsor Decision|3|||
19485140|NCT01420679|41769058|FG001|Overall Study|Sponsor Decision|3|||
19485141|NCT01420679|41769057|FG000|Overall Study|Other|1|||
19485142|NCT01420679|41769058|FG001|Overall Study|Other|0|||
19485143|NCT01496846|41769075|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
19485144|NCT01496846|41769076|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
19485145|NCT01496846|41769077|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
19485146|NCT01496846|41769078|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
19485147|NCT01496846|41769079|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
19485148|NCT01496846|41769080|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
19485149|NCT00964002|41769091|FG000|Overall Study|Protocol Violation|8|||
19485150|NCT01399697|41769103|FG000|Overall Study|Adverse Event|13|||
19485151|NCT01399697|41769104|FG001|Overall Study|Adverse Event|3|||
19485152|NCT01399697|41769105|FG002|Overall Study|Adverse Event|1|||
19485153|NCT01399697|41769103|FG000|Overall Study|Lost to Follow-up|2|||
19485154|NCT01399697|41769104|FG001|Overall Study|Lost to Follow-up|0|||
19485155|NCT01399697|41769105|FG002|Overall Study|Lost to Follow-up|0|||
19485156|NCT01399697|41769103|FG000|Overall Study|Withdrawal by Subject|8|||
19485157|NCT01399697|41769104|FG001|Overall Study|Withdrawal by Subject|0|||
19485158|NCT01399697|41769105|FG002|Overall Study|Withdrawal by Subject|0|||
19485159|NCT01399697|41769103|FG000|Overall Study|Investigator Decisión|1|||
19485160|NCT01399697|41769104|FG001|Overall Study|Investigator Decisión|0|||
19485161|NCT01399697|41769105|FG002|Overall Study|Investigator Decisión|2|||
19485162|NCT01399697|41769103|FG000|Overall Study|Lack of Efficacy|9|||
19485163|NCT01399697|41769104|FG001|Overall Study|Lack of Efficacy|0|||
19485164|NCT01399697|41769105|FG002|Overall Study|Lack of Efficacy|1|||
19485165|NCT01399697|41769103|FG000|Overall Study|Protocol Violation|2|||
19485166|NCT01399697|41769104|FG001|Overall Study|Protocol Violation|0|||
19485167|NCT01399697|41769105|FG002|Overall Study|Protocol Violation|0|||
19485168|NCT01399697|41769103|FG000|Overall Study|Non-Compliant|1|||
19485169|NCT01399697|41769104|FG001|Overall Study|Non-Compliant|0|||
19485170|NCT01399697|41769105|FG002|Overall Study|Non-Compliant|0|||
19485171|NCT01399697|41769103|FG000|Overall Study|Inclusion Error|2|||
19485172|NCT01399697|41769104|FG001|Overall Study|Inclusion Error|0|||
19485173|NCT01399697|41769105|FG002|Overall Study|Inclusion Error|0|||
19485174|NCT01399697|41769103|FG000|Overall Study|Positive result for hepatitis B|1|||
19485175|NCT01399697|41769104|FG001|Overall Study|Positive result for hepatitis B|0|||
19485176|NCT01399697|41769105|FG002|Overall Study|Positive result for hepatitis B|0|||
19485177|NCT01399697|41769103|FG000|Overall Study|Clinical RA remission|1|||
19485178|NCT01399697|41769104|FG001|Overall Study|Clinical RA remission|0|||
19485179|NCT01399697|41769105|FG002|Overall Study|Clinical RA remission|0|||
19485180|NCT01399697|41769103|FG000|Overall Study|Sponsor Decision|1|||
19485181|NCT01399697|41769104|FG001|Overall Study|Sponsor Decision|0|||
19485182|NCT01399697|41769105|FG002|Overall Study|Sponsor Decision|0|||
19485183|NCT01473602|41769139|FG000|Overall Study|Adverse Event|1|||
19485184|NCT01473602|41769140|FG001|Overall Study|Adverse Event|2|||
19485185|NCT01473602|41769139|FG000|Overall Study|Death|0|||
19485186|NCT01473602|41769140|FG001|Overall Study|Death|1|||
19485187|NCT01473602|41769139|FG000|Overall Study|Lost to Follow-up|1|||
19485188|NCT01473602|41769140|FG001|Overall Study|Lost to Follow-up|1|||
19485189|NCT01473602|41769139|FG000|Overall Study|Withdrawal by Subject|5|||
19485190|NCT01473602|41769140|FG001|Overall Study|Withdrawal by Subject|4|||
19485191|NCT01473602|41769139|FG000|Overall Study|Physician Decision|1|||
19485192|NCT01473602|41769140|FG001|Overall Study|Physician Decision|0|||
19485193|NCT01496612|41769148|FG000|1st Intervention|Adverse Event|1|||
19485194|NCT01496612|41769149|FG001|1st Intervention|Adverse Event|0|||
19485195|NCT01496612|41769148|FG000|1st Intervention|Withdrawal by Subject|1|||
19485196|NCT01496612|41769149|FG001|1st Intervention|Withdrawal by Subject|0|||
19485197|NCT00790218|41769166|FG000|Overall Study|Death|1|||
19485198|NCT00790218|41769167|FG001|Overall Study|Death|0|||
19485199|NCT00790218|41769168|FG002|Overall Study|Death|0|||
19485200|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
19485201|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
19485202|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
19485203|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
19485204|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
19485205|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
19485206|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
19485207|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
19485208|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
19485209|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
19485210|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
19485211|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
19485212|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
19485213|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
19485214|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
19485215|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
19485216|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
19485217|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
19485218|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
19485219|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
19485220|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
19485221|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
19485222|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
19485223|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
19485224|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
19485225|NCT01457924|41769194|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
19485226|NCT01457924|41769195|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
19485227|NCT01457924|41769196|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
19485228|NCT01457924|41769197|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
19485229|NCT01457924|41769198|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
19485230|NCT01457924|41769194|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
19485231|NCT01457924|41769195|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
19485232|NCT01457924|41769196|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
19485233|NCT01457924|41769197|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
19485234|NCT01457924|41769198|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
19485235|NCT01457924|41769194|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
19485236|NCT01457924|41769195|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
19485237|NCT01457924|41769196|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
19485238|NCT01457924|41769197|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
19485239|NCT01457924|41769198|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
19485240|NCT01457924|41769194|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
19485241|NCT01457924|41769195|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
19485242|NCT01457924|41769196|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
19485243|NCT01457924|41769197|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
19485244|NCT01457924|41769198|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
19485245|NCT01457924|41769194|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
19485246|NCT01457924|41769195|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
19485247|NCT01457924|41769196|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
19485248|NCT01457924|41769197|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
19485249|NCT01457924|41769198|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
19485250|NCT01457924|41769194|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
19485251|NCT01457924|41769195|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
19485252|NCT01457924|41769196|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
19485253|NCT01457924|41769197|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
19485254|NCT01457924|41769198|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
19485255|NCT01457924|41769194|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
19485256|NCT01457924|41769195|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
19485257|NCT01457924|41769196|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
19485258|NCT01457924|41769197|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
19485259|NCT01457924|41769198|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
19485260|NCT01457924|41769194|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
19485261|NCT01457924|41769195|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
19485262|NCT01457924|41769196|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
19485263|NCT01457924|41769197|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
19485264|NCT01457924|41769198|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
19485265|NCT01399619|41769219|FG000|Overall Study|Adverse Event|10|||
19485266|NCT01399619|41769220|FG001|Overall Study|Adverse Event|0|||
19612474|NCT00617305|42061323|FG000|Overall Study|Protocol Violation|1|||
19485267|NCT01399619|41769221|FG002|Overall Study|Adverse Event|4|||
19485268|NCT01399619|41769222|FG003|Overall Study|Adverse Event|10|||
19485269|NCT01399619|41769219|FG000|Overall Study|Lack of Efficacy|9|||
19485270|NCT01399619|41769220|FG001|Overall Study|Lack of Efficacy|0|||
19485271|NCT01399619|41769221|FG002|Overall Study|Lack of Efficacy|5|||
19485272|NCT01399619|41769222|FG003|Overall Study|Lack of Efficacy|0|||
19485273|NCT01399619|41769219|FG000|Overall Study|Withdrawal by Subject|6|||
19485274|NCT01399619|41769220|FG001|Overall Study|Withdrawal by Subject|0|||
19485275|NCT01399619|41769221|FG002|Overall Study|Withdrawal by Subject|3|||
19485276|NCT01399619|41769222|FG003|Overall Study|Withdrawal by Subject|4|||
19485277|NCT01399619|41769219|FG000|Overall Study|Protocol Violation|0|||
19485278|NCT01399619|41769220|FG001|Overall Study|Protocol Violation|0|||
19485279|NCT01399619|41769221|FG002|Overall Study|Protocol Violation|0|||
19485280|NCT01399619|41769222|FG003|Overall Study|Protocol Violation|1|||
19485281|NCT01399619|41769219|FG000|Overall Study|Not treated|0|||
19485282|NCT01399619|41769220|FG001|Overall Study|Not treated|0|||
19485283|NCT01399619|41769221|FG002|Overall Study|Not treated|0|||
19485284|NCT01399619|41769222|FG003|Overall Study|Not treated|2|||
19485285|NCT01496456|41769237|FG000|Overall Study|Protocol Violation|1|||
19485286|NCT01496456|41769237|FG000|Overall Study|Lost to Follow-up|7|||
19485287|NCT04999111|41769400|FG000|Overall Study|Lost to Follow-up|0|||
19485288|NCT04999111|41769401|FG001|Overall Study|Lost to Follow-up|3|||
19485289|NCT04999111|41769402|FG002|Overall Study|Lost to Follow-up|1|||
19485290|NCT04999111|41769403|FG003|Overall Study|Lost to Follow-up|1|||
19485291|NCT04999111|41769404|FG004|Overall Study|Lost to Follow-up|1|||
19485292|NCT04999111|41769405|FG005|Overall Study|Lost to Follow-up|1|||
19485293|NCT04999111|41769400|FG000|Overall Study|Physician Decision|0|||
19485294|NCT04999111|41769401|FG001|Overall Study|Physician Decision|0|||
19485295|NCT04999111|41769402|FG002|Overall Study|Physician Decision|0|||
19485296|NCT04999111|41769403|FG003|Overall Study|Physician Decision|1|||
19485297|NCT04999111|41769404|FG004|Overall Study|Physician Decision|0|||
19485298|NCT04999111|41769405|FG005|Overall Study|Physician Decision|0|||
19485299|NCT04999111|41769400|FG000|Overall Study|Withdrawal by Subject|3|||
19485300|NCT04999111|41769401|FG001|Overall Study|Withdrawal by Subject|3|||
19485301|NCT04999111|41769402|FG002|Overall Study|Withdrawal by Subject|2|||
19485302|NCT04999111|41769403|FG003|Overall Study|Withdrawal by Subject|1|||
19485303|NCT04999111|41769404|FG004|Overall Study|Withdrawal by Subject|3|||
19485304|NCT04999111|41769405|FG005|Overall Study|Withdrawal by Subject|0|||
19485305|NCT04999111|41769400|FG000|Overall Study|Other|1|||
19485306|NCT04999111|41769401|FG001|Overall Study|Other|1|||
19485307|NCT04999111|41769402|FG002|Overall Study|Other|1|||
19485308|NCT04999111|41769403|FG003|Overall Study|Other|0|||
19485309|NCT04999111|41769404|FG004|Overall Study|Other|0|||
19485310|NCT04999111|41769405|FG005|Overall Study|Other|0|||
19485311|NCT04999111|41769400|FG000|Overall Study|Ongoing|326|||
19485312|NCT04999111|41769401|FG001|Overall Study|Ongoing|321|||
19485313|NCT04999111|41769402|FG002|Overall Study|Ongoing|112|||
19485314|NCT04999111|41769403|FG003|Overall Study|Ongoing|323|||
19485315|NCT04999111|41769404|FG004|Overall Study|Ongoing|322|||
19485316|NCT04999111|41769405|FG005|Overall Study|Ongoing|105|||
19485317|NCT04999111|41769400|FG000|Overall Study|Randomized but not vaccinated|1|||
19485318|NCT04999111|41769401|FG001|Overall Study|Randomized but not vaccinated|2|||
19485319|NCT04999111|41769402|FG002|Overall Study|Randomized but not vaccinated|0|||
19485320|NCT04999111|41769403|FG003|Overall Study|Randomized but not vaccinated|3|||
19485321|NCT04999111|41769404|FG004|Overall Study|Randomized but not vaccinated|3|||
19485322|NCT04999111|41769405|FG005|Overall Study|Randomized but not vaccinated|0|||
19485323|NCT01673646|41769466|FG000|Overall Study|Adverse Event|2|||
19485324|NCT01673646|41769467|FG001|Overall Study|Adverse Event|1|||
19485325|NCT01673646|41769468|FG002|Overall Study|Adverse Event|1|||
19485326|NCT01673646|41769466|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19485327|NCT01673646|41769467|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19485328|NCT01673646|41769468|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19485329|NCT01673646|41769466|FG000|Overall Study|Condition no longer requires study drug|0|||
19485330|NCT01673646|41769467|FG001|Overall Study|Condition no longer requires study drug|1|||
19485331|NCT01673646|41769468|FG002|Overall Study|Condition no longer requires study drug|0|||
19485332|NCT01673646|41769466|FG000|Overall Study|Withdrawal by Subject|0|||
19485333|NCT01673646|41769467|FG001|Overall Study|Withdrawal by Subject|2|||
19485334|NCT01673646|41769468|FG002|Overall Study|Withdrawal by Subject|2|||
19485335|NCT01673646|41769466|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
19485336|NCT01673646|41769467|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
19485337|NCT01673646|41769468|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
19485338|NCT02647944|41769482|FG000|Overall Study|Withdrawal by Subject|0|||
19485339|NCT02647944|41769483|FG001|Overall Study|Withdrawal by Subject|3|||
19485340|NCT02647944|41769482|FG000|Overall Study|Adverse Event|2|||
19485341|NCT02647944|41769483|FG001|Overall Study|Adverse Event|0|||
19485342|NCT01397825|41769564|FG000|Overall Study|Progressive Disease|10|||
19485343|NCT01397825|41769565|FG001|Overall Study|Progressive Disease|3|||
19485344|NCT01397825|41769566|FG002|Overall Study|Progressive Disease|11|||
19485345|NCT01397825|41769567|FG003|Overall Study|Progressive Disease|1|||
19485346|NCT01397825|41769568|FG004|Overall Study|Progressive Disease|0|||
19485347|NCT01397825|41769564|FG000|Overall Study|Symptomatic Deterioration|2|||
19485348|NCT01397825|41769565|FG001|Overall Study|Symptomatic Deterioration|0|||
19485349|NCT01397825|41769566|FG002|Overall Study|Symptomatic Deterioration|4|||
19485350|NCT01397825|41769567|FG003|Overall Study|Symptomatic Deterioration|0|||
19485351|NCT01397825|41769568|FG004|Overall Study|Symptomatic Deterioration|0|||
19485352|NCT01397825|41769564|FG000|Overall Study|Adverse Event|0|||
19485353|NCT01397825|41769565|FG001|Overall Study|Adverse Event|1|||
19485354|NCT01397825|41769566|FG002|Overall Study|Adverse Event|5|||
19485355|NCT01397825|41769567|FG003|Overall Study|Adverse Event|1|||
19485356|NCT01397825|41769568|FG004|Overall Study|Adverse Event|0|||
19485357|NCT01397825|41769564|FG000|Overall Study|Withdrawal by Subject|1|||
19485358|NCT01397825|41769565|FG001|Overall Study|Withdrawal by Subject|0|||
19485359|NCT01397825|41769566|FG002|Overall Study|Withdrawal by Subject|5|||
19485360|NCT01397825|41769567|FG003|Overall Study|Withdrawal by Subject|1|||
19485361|NCT01397825|41769568|FG004|Overall Study|Withdrawal by Subject|0|||
19485362|NCT01397747|41769591|FG000|Overall Study|Multitarget DNA test excluded|689|||
19485363|NCT01397747|41769591|FG000|Overall Study|Colonoscopy excluded|304|||
19485364|NCT01397747|41769591|FG000|Overall Study|FIT excluded|34|||
19485365|NCT01397201|41769629|FG000|Overall Study|Not treated|0|||
19485366|NCT01397201|41769630|FG001|Overall Study|Not treated|0|||
19485367|NCT01397201|41769631|FG002|Overall Study|Not treated|1|||
19485368|NCT01397201|41769632|FG003|Overall Study|Not treated|0|||
19485369|NCT01397201|41769633|FG004|Overall Study|Not treated|0|||
19485370|NCT01397201|41769629|FG000|Overall Study|Not yet defined|3|||
19485371|NCT01397201|41769630|FG001|Overall Study|Not yet defined|6|||
19485372|NCT01397201|41769631|FG002|Overall Study|Not yet defined|5|||
19485373|NCT01397201|41769632|FG003|Overall Study|Not yet defined|5|||
19485374|NCT01397201|41769633|FG004|Overall Study|Not yet defined|4|||
19485375|NCT01397201|41769629|FG000|Overall Study|Adverse Event|2|||
19485376|NCT01397201|41769630|FG001|Overall Study|Adverse Event|0|||
19485377|NCT01397201|41769631|FG002|Overall Study|Adverse Event|0|||
19485378|NCT01397201|41769632|FG003|Overall Study|Adverse Event|0|||
19485379|NCT01397201|41769633|FG004|Overall Study|Adverse Event|0|||
19485380|NCT01393613|41769667|FG000|Overall Study|Adverse Event|11|||
19485381|NCT01393613|41769668|FG001|Overall Study|Adverse Event|11|||
19485382|NCT01393613|41769669|FG002|Overall Study|Adverse Event|13|||
19485383|NCT01393613|41769670|FG003|Overall Study|Adverse Event|22|||
19485384|NCT01393613|41769667|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
19485385|NCT01393613|41769668|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
19485386|NCT01393613|41769669|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
19485387|NCT01393613|41769670|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
19485388|NCT01393613|41769667|FG000|Overall Study|Physician Decision|2|||
19485389|NCT01393613|41769668|FG001|Overall Study|Physician Decision|0|||
19485390|NCT01393613|41769669|FG002|Overall Study|Physician Decision|0|||
19485391|NCT01393613|41769670|FG003|Overall Study|Physician Decision|1|||
19485392|NCT01393613|41769667|FG000|Overall Study|Withdrawal by Subject|15|||
19485393|NCT01393613|41769668|FG001|Overall Study|Withdrawal by Subject|25|||
19485394|NCT01393613|41769669|FG002|Overall Study|Withdrawal by Subject|23|||
19485395|NCT01393613|41769670|FG003|Overall Study|Withdrawal by Subject|21|||
19485396|NCT01393613|41769667|FG000|Overall Study|Protocol Deviation|2|||
19485397|NCT01393613|41769668|FG001|Overall Study|Protocol Deviation|1|||
19485398|NCT01393613|41769669|FG002|Overall Study|Protocol Deviation|0|||
19485399|NCT01393613|41769670|FG003|Overall Study|Protocol Deviation|0|||
19485400|NCT01393613|41769667|FG000|Overall Study|Lack of Efficacy|9|||
19485401|NCT01393613|41769668|FG001|Overall Study|Lack of Efficacy|20|||
19485402|NCT01393613|41769669|FG002|Overall Study|Lack of Efficacy|16|||
19485403|NCT01393613|41769670|FG003|Overall Study|Lack of Efficacy|21|||
19485404|NCT01396421|41769720|FG000|Overall Study|Lost to Follow-up|0|||
19485405|NCT01396421|41769721|FG001|Overall Study|Lost to Follow-up|0|||
19485406|NCT01396421|41769722|FG002|Overall Study|Lost to Follow-up|0|||
19485407|NCT01396421|41769723|FG003|Overall Study|Lost to Follow-up|1|||
19485408|NCT01396421|41769720|FG000|Overall Study|Adverse Event|17|||
19485409|NCT01396421|41769721|FG001|Overall Study|Adverse Event|15|||
19485410|NCT01396421|41769722|FG002|Overall Study|Adverse Event|12|||
19485411|NCT01396421|41769723|FG003|Overall Study|Adverse Event|32|||
19485412|NCT01396421|41769720|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
19485413|NCT01396421|41769721|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
19485414|NCT01396421|41769722|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
19485415|NCT01396421|41769723|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
19485416|NCT01396421|41769720|FG000|Overall Study|Physician Decision|1|||
19485417|NCT01396421|41769721|FG001|Overall Study|Physician Decision|1|||
19485418|NCT01396421|41769722|FG002|Overall Study|Physician Decision|0|||
19485419|NCT01396421|41769723|FG003|Overall Study|Physician Decision|3|||
19485420|NCT01396421|41769720|FG000|Overall Study|Withdrawal by Subject|31|||
19485421|NCT01396421|41769721|FG001|Overall Study|Withdrawal by Subject|24|||
19485422|NCT01396421|41769722|FG002|Overall Study|Withdrawal by Subject|13|||
19485423|NCT01396421|41769723|FG003|Overall Study|Withdrawal by Subject|21|||
19485424|NCT01396421|41769720|FG000|Overall Study|Protocol Deviation|2|||
19485425|NCT01396421|41769721|FG001|Overall Study|Protocol Deviation|1|||
19485426|NCT01396421|41769722|FG002|Overall Study|Protocol Deviation|1|||
19612475|NCT00617305|42061324|FG001|Overall Study|Protocol Violation|0|||
19485427|NCT01396421|41769723|FG003|Overall Study|Protocol Deviation|0|||
19485428|NCT01396421|41769720|FG000|Overall Study|Lack of Efficacy|7|||
19485429|NCT01396421|41769721|FG001|Overall Study|Lack of Efficacy|17|||
19485430|NCT01396421|41769722|FG002|Overall Study|Lack of Efficacy|7|||
19485431|NCT01396421|41769723|FG003|Overall Study|Lack of Efficacy|18|||
19485432|NCT01396265|41769781|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
19485433|NCT02647866|41769826|FG000|Overall Study|Adverse Event|0|||
19485434|NCT02647866|41769827|FG001|Overall Study|Adverse Event|0|||
19485435|NCT02647866|41769828|FG002|Overall Study|Adverse Event|2|||
19485436|NCT02647866|41769829|FG003|Overall Study|Adverse Event|2|||
19485437|NCT02647866|41769830|FG004|Overall Study|Adverse Event|1|||
19393441|NCT01680991|41637311|FG002|Overall Study|Progressive disease (PD)|0|||
19393442|NCT01680991|41637309|FG000|Overall Study|Physician Decision|0|||
19393443|NCT01680991|41637310|FG001|Overall Study|Physician Decision|7|||
19393444|NCT01680991|41637311|FG002|Overall Study|Physician Decision|2|||
19485438|NCT02647866|41769826|FG000|Overall Study|Disease Worsening|3|||
19485439|NCT02647866|41769827|FG001|Overall Study|Disease Worsening|1|||
19485440|NCT02647866|41769828|FG002|Overall Study|Disease Worsening|0|||
19485441|NCT02647866|41769829|FG003|Overall Study|Disease Worsening|0|||
19485442|NCT02647866|41769830|FG004|Overall Study|Disease Worsening|1|||
19485443|NCT02647866|41769826|FG000|Overall Study|Withdrawal by Subject|1|||
19485444|NCT02647866|41769827|FG001|Overall Study|Withdrawal by Subject|1|||
19485445|NCT02647866|41769828|FG002|Overall Study|Withdrawal by Subject|2|||
19485446|NCT02647866|41769829|FG003|Overall Study|Withdrawal by Subject|4|||
19485447|NCT02647866|41769830|FG004|Overall Study|Withdrawal by Subject|4|||
19485448|NCT02647866|41769826|FG000|Overall Study|Physician Decision|0|||
19485449|NCT02647866|41769827|FG001|Overall Study|Physician Decision|1|||
19485450|NCT02647866|41769828|FG002|Overall Study|Physician Decision|1|||
19485451|NCT02647866|41769829|FG003|Overall Study|Physician Decision|0|||
19485452|NCT02647866|41769830|FG004|Overall Study|Physician Decision|2|||
19485453|NCT02647866|41769826|FG000|Overall Study|Death|0|||
19485454|NCT02647866|41769827|FG001|Overall Study|Death|1|||
19485455|NCT02647866|41769828|FG002|Overall Study|Death|0|||
19485456|NCT02647866|41769829|FG003|Overall Study|Death|0|||
19485457|NCT02647866|41769830|FG004|Overall Study|Death|0|||
19485458|NCT02647866|41769826|FG000|Overall Study|Subject moved to different country|1|||
19485459|NCT02647866|41769827|FG001|Overall Study|Subject moved to different country|0|||
19485460|NCT02647866|41769828|FG002|Overall Study|Subject moved to different country|0|||
19485461|NCT02647866|41769829|FG003|Overall Study|Subject moved to different country|0|||
19485462|NCT02647866|41769830|FG004|Overall Study|Subject moved to different country|0|||
19485463|NCT01396187|41769890|FG000|Overall Study|Adverse Event|0|||
19485464|NCT01396187|41769891|FG001|Overall Study|Adverse Event|1|||
19485465|NCT01396187|41769892|FG002|Overall Study|Adverse Event|0|||
19485466|NCT01396187|41769893|FG003|Overall Study|Adverse Event|0|||
19485467|NCT01396187|41769894|FG004|Overall Study|Adverse Event|0|||
19485468|NCT01396187|41769890|FG000|Overall Study|Withdrawal by Subject|0|||
19485469|NCT01396187|41769891|FG001|Overall Study|Withdrawal by Subject|1|||
19485470|NCT01396187|41769892|FG002|Overall Study|Withdrawal by Subject|1|||
19485471|NCT01396187|41769893|FG003|Overall Study|Withdrawal by Subject|0|||
19485472|NCT01396187|41769894|FG004|Overall Study|Withdrawal by Subject|0|||
19485473|NCT01396187|41769890|FG000|Overall Study|Other|1|||
19485474|NCT01396187|41769891|FG001|Overall Study|Other|1|||
19485475|NCT01396187|41769892|FG002|Overall Study|Other|0|||
19485476|NCT01396187|41769893|FG003|Overall Study|Other|0|||
19485477|NCT01396187|41769894|FG004|Overall Study|Other|1|||
19485478|NCT01393301|41769933|FG000|Overall Study|Lost to Follow-up|5|||
19485479|NCT01393301|41769934|FG001|Overall Study|Lost to Follow-up|3|||
19485480|NCT01393301|41769933|FG000|Overall Study|Withdrawal by Subject|2|||
19485481|NCT01393301|41769934|FG001|Overall Study|Withdrawal by Subject|0|||
19485482|NCT01393301|41769933|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
19485483|NCT01393301|41769934|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
19485484|NCT01392677|41769950|FG000|Overall Study|Adverse Event|3|||
19485485|NCT01392677|41769951|FG001|Overall Study|Adverse Event|1|||
19485486|NCT01392677|41769950|FG000|Overall Study|Withdrawal by Subject|0|||
19485487|NCT01392677|41769951|FG001|Overall Study|Withdrawal by Subject|2|||
19485488|NCT01392677|41769950|FG000|Overall Study|Incorrect enrollment|2|||
19485489|NCT01392677|41769951|FG001|Overall Study|Incorrect enrollment|3|||
19485490|NCT01392677|41769950|FG000|Overall Study|Other reason|3|||
19485491|NCT01392677|41769951|FG001|Overall Study|Other reason|2|||
19393445|NCT01680991|41637309|FG000|Overall Study|Bad physical condition|0|||
19393446|NCT01680991|41637310|FG001|Overall Study|Bad physical condition|0|||
19393447|NCT01680991|41637311|FG002|Overall Study|Bad physical condition|1|||
19485492|NCT01392443|41770000|FG000|Overall Study|Disease progression|30|||
19485493|NCT01392443|41770000|FG000|Overall Study|Adverse Event|24|||
19485494|NCT01392443|41770000|FG000|Overall Study|Death|7|||
19485495|NCT01392443|41770000|FG000|Overall Study|Withdrawal by Subject|5|||
19393448|NCT01680991|41637309|FG000|Overall Study|PD confirmed in other hospital|1|||
19393449|NCT01680991|41637310|FG001|Overall Study|PD confirmed in other hospital|0|||
19485496|NCT01392443|41770000|FG000|Overall Study|Lost to Follow-up|1|||
19485497|NCT01392443|41770000|FG000|Overall Study|Protocol Violation|1|||
19485498|NCT01391819|41770004|FG000|Overall Study|Withdrawal by Subject|56|||
19485499|NCT01391819|41770004|FG000|Overall Study|Migrated/moved from study area|82|||
19485500|NCT01391819|41770004|FG000|Overall Study|Lost to Follow-up|252|||
19485501|NCT01391819|41770004|FG000|Overall Study|Death|3|||
19485502|NCT01391819|41770004|FG000|Overall Study|Other|9|||
19485503|NCT03845023|41770015|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
19485504|NCT03845023|41770016|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
19485505|NCT03845023|41770017|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
19485506|NCT03845023|41770018|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
19485507|NCT03845023|41770015|FG000|Follow-Up (14 Days)|Adverse Event|0|||
19485508|NCT03845023|41770016|FG001|Follow-Up (14 Days)|Adverse Event|0|||
19485509|NCT03845023|41770017|FG002|Follow-Up (14 Days)|Adverse Event|1|||
19485510|NCT03845023|41770018|FG003|Follow-Up (14 Days)|Adverse Event|1|||
19485511|NCT01395017|41770080|FG000|Overall Study|Lost to Follow-up|1|||
19485512|NCT01395017|41770081|FG001|Overall Study|Lost to Follow-up|0|||
19485513|NCT01395017|41770080|FG000|Overall Study|Adverse Event|26|||
19485514|NCT01395017|41770081|FG001|Overall Study|Adverse Event|12|||
19485515|NCT01395017|41770080|FG000|Overall Study|Physician Decision|11|||
19485516|NCT01395017|41770081|FG001|Overall Study|Physician Decision|15|||
19485517|NCT01395017|41770080|FG000|Overall Study|Withdrawal by Subject|14|||
19485518|NCT01395017|41770081|FG001|Overall Study|Withdrawal by Subject|8|||
19485519|NCT01395017|41770080|FG000|Overall Study|Protocol deviation|1|||
19485520|NCT01395017|41770081|FG001|Overall Study|Protocol deviation|2|||
19485521|NCT01395017|41770080|FG000|Overall Study|Death|4|||
19485522|NCT01395017|41770081|FG001|Overall Study|Death|3|||
19485523|NCT01395017|41770080|FG000|Overall Study|Disease progression|42|||
19485524|NCT01395017|41770081|FG001|Overall Study|Disease progression|58|||
19485525|NCT01395017|41770080|FG000|Overall Study|Sponsor discontinued study|1|||
19485526|NCT01395017|41770081|FG001|Overall Study|Sponsor discontinued study|4|||
19485527|NCT02647320|41770133|FG000|Overall Study|Adverse Event|0|||
19485528|NCT02647320|41770134|FG001|Overall Study|Adverse Event|1|||
19485529|NCT02647320|41770135|FG002|Overall Study|Adverse Event|3|||
19485530|NCT02647320|41770136|FG003|Overall Study|Adverse Event|2|||
19485531|NCT02647320|41770137|FG004|Overall Study|Adverse Event|1|||
19485532|NCT02647320|41770133|FG000|Overall Study|Protocol Violation|0|||
19485533|NCT02647320|41770134|FG001|Overall Study|Protocol Violation|0|||
19485534|NCT02647320|41770135|FG002|Overall Study|Protocol Violation|3|||
19485535|NCT02647320|41770136|FG003|Overall Study|Protocol Violation|0|||
19485536|NCT02647320|41770137|FG004|Overall Study|Protocol Violation|0|||
19485537|NCT02647320|41770133|FG000|Overall Study|Withdrawal by Subject|7|||
19485538|NCT02647320|41770134|FG001|Overall Study|Withdrawal by Subject|4|||
19485539|NCT02647320|41770135|FG002|Overall Study|Withdrawal by Subject|2|||
19485540|NCT02647320|41770136|FG003|Overall Study|Withdrawal by Subject|2|||
19485541|NCT02647320|41770137|FG004|Overall Study|Withdrawal by Subject|7|||
19485542|NCT02647320|41770133|FG000|Overall Study|Persistent hyperglycemia|0|||
19485543|NCT02647320|41770134|FG001|Overall Study|Persistent hyperglycemia|1|||
19485544|NCT02647320|41770135|FG002|Overall Study|Persistent hyperglycemia|1|||
19485545|NCT02647320|41770136|FG003|Overall Study|Persistent hyperglycemia|1|||
19485546|NCT02647320|41770137|FG004|Overall Study|Persistent hyperglycemia|1|||
19485547|NCT02647320|41770133|FG000|Overall Study|Study terminated by sponsor|1|||
19485548|NCT02647320|41770134|FG001|Overall Study|Study terminated by sponsor|1|||
19485549|NCT02647320|41770135|FG002|Overall Study|Study terminated by sponsor|1|||
19485550|NCT02647320|41770136|FG003|Overall Study|Study terminated by sponsor|1|||
19485551|NCT02647320|41770137|FG004|Overall Study|Study terminated by sponsor|2|||
19485552|NCT02647320|41770133|FG000|Overall Study|Reason not provided|0|||
19485553|NCT02647320|41770134|FG001|Overall Study|Reason not provided|0|||
19485554|NCT02647320|41770135|FG002|Overall Study|Reason not provided|1|||
19485555|NCT02647320|41770136|FG003|Overall Study|Reason not provided|0|||
19485556|NCT02647320|41770137|FG004|Overall Study|Reason not provided|2|||
19485557|NCT02647320|41770133|FG000|Overall Study|Lost to Follow-up|1|||
19485558|NCT02647320|41770134|FG001|Overall Study|Lost to Follow-up|1|||
19485559|NCT02647320|41770135|FG002|Overall Study|Lost to Follow-up|0|||
19485560|NCT02647320|41770136|FG003|Overall Study|Lost to Follow-up|0|||
19485561|NCT02647320|41770137|FG004|Overall Study|Lost to Follow-up|0|||
19485562|NCT02647320|41770133|FG000|Overall Study|Develop anemia|1|||
19485563|NCT02647320|41770134|FG001|Overall Study|Develop anemia|0|||
19485564|NCT02647320|41770135|FG002|Overall Study|Develop anemia|0|||
19485565|NCT02647320|41770136|FG003|Overall Study|Develop anemia|0|||
19485566|NCT02647320|41770137|FG004|Overall Study|Develop anemia|0|||
19485567|NCT02647320|41770133|FG000|Overall Study|Lack of Efficacy|0|||
19485568|NCT02647320|41770134|FG001|Overall Study|Lack of Efficacy|0|||
19485569|NCT02647320|41770135|FG002|Overall Study|Lack of Efficacy|0|||
19485570|NCT02647320|41770136|FG003|Overall Study|Lack of Efficacy|1|||
19485571|NCT02647320|41770137|FG004|Overall Study|Lack of Efficacy|0|||
19485572|NCT02647320|41770133|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
19485573|NCT02647320|41770134|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
19485574|NCT02647320|41770135|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
19485575|NCT02647320|41770136|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
19485576|NCT02647320|41770137|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
19485577|NCT03458325|41770160|FG000|Overall Study|Withdrawal by Subject|1|||
19485578|NCT02646618|41770169|FG000|Overall Study|Lost to Follow-up|10|||
19485579|NCT02646618|41770170|FG001|Overall Study|Lost to Follow-up|14|||
19485580|NCT02644122|41770210|FG000|Overall Study|Withdrawal by Subject|1|||
19485581|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
19485582|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
19485583|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
19485584|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
19485585|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
19485586|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
19485587|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
19485588|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
19485589|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
19485590|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
19485591|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
19485592|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
19485593|NCT02294461|41770217|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
19485594|NCT02294461|41770218|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
19485595|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
19485596|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
19485597|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
19485598|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
19485599|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
19485600|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
19485601|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
19485602|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
19485603|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
19485604|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
19485605|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
19485606|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
19485607|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
19485608|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
19485609|NCT02294461|41770217|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
19485610|NCT02294461|41770218|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
19485611|NCT01394939|41770257|FG000|Overall Study|Adverse Event|1|||
19485612|NCT01394939|41770258|FG001|Overall Study|Adverse Event|3|||
19485613|NCT01394939|41770259|FG002|Overall Study|Adverse Event|0|||
19485614|NCT01394939|41770260|FG003|Overall Study|Adverse Event|2|||
19485615|NCT01394939|41770257|FG000|Overall Study|Death|0|||
19485616|NCT01394939|41770258|FG001|Overall Study|Death|2|||
19485617|NCT01394939|41770259|FG002|Overall Study|Death|0|||
19485618|NCT01394939|41770260|FG003|Overall Study|Death|0|||
19485619|NCT01394939|41770257|FG000|Overall Study|Physician Decision|0|||
19485620|NCT01394939|41770258|FG001|Overall Study|Physician Decision|1|||
19485621|NCT01394939|41770259|FG002|Overall Study|Physician Decision|0|||
19485622|NCT01394939|41770260|FG003|Overall Study|Physician Decision|0|||
19485623|NCT01394939|41770257|FG000|Overall Study|Withdrawal by Subject|0|||
19485624|NCT01394939|41770258|FG001|Overall Study|Withdrawal by Subject|2|||
19485625|NCT01394939|41770259|FG002|Overall Study|Withdrawal by Subject|0|||
19485626|NCT01394939|41770260|FG003|Overall Study|Withdrawal by Subject|2|||
19485627|NCT01394939|41770257|FG000|Overall Study|Others|0|||
19485628|NCT01394939|41770258|FG001|Overall Study|Others|2|||
19485629|NCT01394939|41770259|FG002|Overall Study|Others|0|||
19485630|NCT01394939|41770260|FG003|Overall Study|Others|3|||
19485631|NCT01394627|41770274|FG000|First Intervention (1 Day)|poor intravenous access|0|||
19485632|NCT01394627|41770275|FG001|First Intervention (1 Day)|poor intravenous access|1|||
19485633|NCT01394627|41770274|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
19485634|NCT01394627|41770275|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
19485635|NCT01391663|41770294|FG000|Overall Study|Withdrawal by Subject|0|||
19485636|NCT01391663|41770295|FG001|Overall Study|Withdrawal by Subject|0|||
19485637|NCT01391663|41770296|FG002|Overall Study|Withdrawal by Subject|1|||
19485638|NCT01391663|41770297|FG003|Overall Study|Withdrawal by Subject|0|||
19485639|NCT02641392|41770318|FG000|Overall Study|Lost to Follow-up|0|||
19485640|NCT02641392|41770319|FG001|Overall Study|Lost to Follow-up|0|||
19485641|NCT02641392|41770320|FG002|Overall Study|Lost to Follow-up|2|||
19485642|NCT02641392|41770318|FG000|Overall Study|Withdrawal by Subject|0|||
19485643|NCT02641392|41770319|FG001|Overall Study|Withdrawal by Subject|0|||
19485644|NCT02641392|41770320|FG002|Overall Study|Withdrawal by Subject|17|||
19485645|NCT02641392|41770318|FG000|Overall Study|Adverse Event|0|||
19485646|NCT02641392|41770319|FG001|Overall Study|Adverse Event|1|||
19485647|NCT02641392|41770320|FG002|Overall Study|Adverse Event|25|||
19485648|NCT02641392|41770318|FG000|Overall Study|Study Terminated by Sponsor|4|||
19485649|NCT02641392|41770319|FG001|Overall Study|Study Terminated by Sponsor|12|||
19485650|NCT02641392|41770320|FG002|Overall Study|Study Terminated by Sponsor|144|||
19485651|NCT02641392|41770318|FG000|Overall Study|Lack of Efficacy|0|||
19485652|NCT02641392|41770319|FG001|Overall Study|Lack of Efficacy|0|||
19485653|NCT02641392|41770320|FG002|Overall Study|Lack of Efficacy|101|||
19485654|NCT02641392|41770318|FG000|Overall Study|Miscellaneous|0|||
19485655|NCT02641392|41770319|FG001|Overall Study|Miscellaneous|0|||
19485656|NCT02641392|41770320|FG002|Overall Study|Miscellaneous|3|||
19485657|NCT02641392|41770318|FG000|Overall Study|Death|0|||
19485658|NCT02641392|41770319|FG001|Overall Study|Death|0|||
19485659|NCT02641392|41770320|FG002|Overall Study|Death|1|||
19485660|NCT04440007|41770330|FG000|Overall Study|Adverse Event|0|||
19485661|NCT04440007|41770331|FG001|Overall Study|Adverse Event|1|||
19485662|NCT04440007|41770330|FG000|Overall Study|Lost to Follow-up|1|||
19485663|NCT04440007|41770331|FG001|Overall Study|Lost to Follow-up|3|||
19485664|NCT04440007|41770330|FG000|Overall Study|Death|7|||
19485665|NCT04440007|41770331|FG001|Overall Study|Death|2|||
19485666|NCT04440007|41770330|FG000|Overall Study|Physician Decision|1|||
19485667|NCT04440007|41770331|FG001|Overall Study|Physician Decision|1|||
19485668|NCT04440007|41770330|FG000|Overall Study|Withdrawal by Subject|2|||
19485669|NCT04440007|41770331|FG001|Overall Study|Withdrawal by Subject|1|||
19485670|NCT04440007|41770330|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
19485671|NCT04440007|41770331|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
19485672|NCT04440007|41770330|FG000|Overall Study|Discontinued prior to dosing|0|||
19485673|NCT04440007|41770331|FG001|Overall Study|Discontinued prior to dosing|2|||
19485674|NCT01391507|41770350|FG000|Overall Study|Death|0|||
19485675|NCT01391507|41770351|FG001|Overall Study|Death|0|||
19485676|NCT01391507|41770352|FG002|Overall Study|Death|0|||
19485677|NCT01391507|41770353|FG003|Overall Study|Death|1|||
19485678|NCT01391507|41770350|FG000|Overall Study|Adverse Event|1|||
19485679|NCT01391507|41770351|FG001|Overall Study|Adverse Event|1|||
19485680|NCT01391507|41770352|FG002|Overall Study|Adverse Event|2|||
19485681|NCT01391507|41770353|FG003|Overall Study|Adverse Event|2|||
19485682|NCT01391507|41770350|FG000|Overall Study|Withdrawal by Subject|1|||
19485683|NCT01391507|41770351|FG001|Overall Study|Withdrawal by Subject|2|||
19485684|NCT01391507|41770352|FG002|Overall Study|Withdrawal by Subject|1|||
19485685|NCT01391507|41770353|FG003|Overall Study|Withdrawal by Subject|1|||
19485686|NCT01391507|41770350|FG000|Overall Study|Lack of Efficacy|0|||
19485687|NCT01391507|41770351|FG001|Overall Study|Lack of Efficacy|0|||
19485688|NCT01391507|41770352|FG002|Overall Study|Lack of Efficacy|0|||
19485689|NCT01391507|41770353|FG003|Overall Study|Lack of Efficacy|1|||
19485690|NCT01391507|41770350|FG000|Overall Study|Protocol Violation|2|||
19485691|NCT01391507|41770351|FG001|Overall Study|Protocol Violation|1|||
19485692|NCT01391507|41770352|FG002|Overall Study|Protocol Violation|1|||
19485693|NCT01391507|41770353|FG003|Overall Study|Protocol Violation|2|||
19485694|NCT01473524|41770375|FG000|DB Phase|Adverse Event|4|||
19485695|NCT01473524|41770376|FG001|DB Phase|Adverse Event|8|||
19485696|NCT01473524|41770377|FG002|DB Phase|Adverse Event|2|||
19485697|NCT01473524|41770378|FG003|DB Phase|Adverse Event|0|||
19485698|NCT01473524|41770379|FG004|DB Phase|Adverse Event|0|||
19485699|NCT01473524|41770380|FG005|DB Phase|Adverse Event|0|||
19485700|NCT01473524|41770375|FG000|DB Phase|Death|1|||
19485701|NCT01473524|41770376|FG001|DB Phase|Death|0|||
19485702|NCT01473524|41770377|FG002|DB Phase|Death|0|||
19485703|NCT01473524|41770378|FG003|DB Phase|Death|0|||
19485704|NCT01473524|41770379|FG004|DB Phase|Death|0|||
19485705|NCT01473524|41770380|FG005|DB Phase|Death|0|||
19485706|NCT01473524|41770375|FG000|DB Phase|Withdrawal by Subject|2|||
19485707|NCT01473524|41770376|FG001|DB Phase|Withdrawal by Subject|1|||
19485708|NCT01473524|41770377|FG002|DB Phase|Withdrawal by Subject|1|||
19485709|NCT01473524|41770378|FG003|DB Phase|Withdrawal by Subject|0|||
19485710|NCT01473524|41770379|FG004|DB Phase|Withdrawal by Subject|0|||
19485711|NCT01473524|41770380|FG005|DB Phase|Withdrawal by Subject|0|||
19485712|NCT01473524|41770375|FG000|LTSE Phase|Withdrawal by Subject|0|||
19485713|NCT01473524|41770376|FG001|LTSE Phase|Withdrawal by Subject|0|||
19485714|NCT01473524|41770377|FG002|LTSE Phase|Withdrawal by Subject|0|||
19485715|NCT01473524|41770378|FG003|LTSE Phase|Withdrawal by Subject|3|||
19485716|NCT01473524|41770379|FG004|LTSE Phase|Withdrawal by Subject|3|||
19485717|NCT01473524|41770380|FG005|LTSE Phase|Withdrawal by Subject|6|||
19485718|NCT01473524|41770375|FG000|LTSE Phase|Death|0|||
19485719|NCT01473524|41770376|FG001|LTSE Phase|Death|0|||
19485720|NCT01473524|41770377|FG002|LTSE Phase|Death|0|||
19485721|NCT01473524|41770378|FG003|LTSE Phase|Death|0|||
19485722|NCT01473524|41770379|FG004|LTSE Phase|Death|1|||
19485723|NCT01473524|41770380|FG005|LTSE Phase|Death|0|||
19485724|NCT01473524|41770375|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
19485725|NCT01473524|41770376|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
19485726|NCT01473524|41770377|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
19485727|NCT01473524|41770378|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
19485728|NCT01473524|41770379|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
19485729|NCT01473524|41770380|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
19485730|NCT01473524|41770375|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
19485731|NCT01473524|41770376|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
19485732|NCT01473524|41770377|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
19485733|NCT01473524|41770378|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
19485734|NCT01473524|41770379|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
19485735|NCT01473524|41770380|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
19485736|NCT01473524|41770375|FG000|LTSE Phase|Lost to Follow-up|0|||
19485737|NCT01473524|41770376|FG001|LTSE Phase|Lost to Follow-up|0|||
19485738|NCT01473524|41770377|FG002|LTSE Phase|Lost to Follow-up|0|||
19485739|NCT01473524|41770378|FG003|LTSE Phase|Lost to Follow-up|1|||
19485740|NCT01473524|41770379|FG004|LTSE Phase|Lost to Follow-up|3|||
19485741|NCT01473524|41770380|FG005|LTSE Phase|Lost to Follow-up|2|||
19485742|NCT01473524|41770375|FG000|LTSE Phase|Principal Investigator Decision|0|||
19485743|NCT01473524|41770376|FG001|LTSE Phase|Principal Investigator Decision|0|||
19485744|NCT01473524|41770377|FG002|LTSE Phase|Principal Investigator Decision|0|||
19485745|NCT01473524|41770378|FG003|LTSE Phase|Principal Investigator Decision|1|||
19485746|NCT01473524|41770379|FG004|LTSE Phase|Principal Investigator Decision|1|||
19485747|NCT01473524|41770380|FG005|LTSE Phase|Principal Investigator Decision|3|||
19485748|NCT01473524|41770375|FG000|LTSE Phase|Liver Transplantation|0|||
19485749|NCT01473524|41770376|FG001|LTSE Phase|Liver Transplantation|0|||
19485750|NCT01473524|41770377|FG002|LTSE Phase|Liver Transplantation|0|||
19485751|NCT01473524|41770378|FG003|LTSE Phase|Liver Transplantation|0|||
19485752|NCT01473524|41770379|FG004|LTSE Phase|Liver Transplantation|0|||
19485753|NCT01473524|41770380|FG005|LTSE Phase|Liver Transplantation|1|||
19485754|NCT01473524|41770375|FG000|LTSE Phase|Pregnancy|0|||
19485755|NCT01473524|41770376|FG001|LTSE Phase|Pregnancy|0|||
19485756|NCT01473524|41770377|FG002|LTSE Phase|Pregnancy|0|||
19485757|NCT01473524|41770378|FG003|LTSE Phase|Pregnancy|1|||
19485758|NCT01473524|41770379|FG004|LTSE Phase|Pregnancy|0|||
19485759|NCT01473524|41770380|FG005|LTSE Phase|Pregnancy|0|||
19485760|NCT01473524|41770375|FG000|LTSE Phase|Protocol Violation|0|||
19485761|NCT01473524|41770376|FG001|LTSE Phase|Protocol Violation|0|||
19485762|NCT01473524|41770377|FG002|LTSE Phase|Protocol Violation|0|||
19485763|NCT01473524|41770378|FG003|LTSE Phase|Protocol Violation|0|||
19485764|NCT01473524|41770379|FG004|LTSE Phase|Protocol Violation|0|||
19485765|NCT01473524|41770380|FG005|LTSE Phase|Protocol Violation|1|||
19485766|NCT01390649|41770411|FG000|Overall Study|Physician Decision|1|||
19485767|NCT01390181|41770415|FG000|Overall Study|Lost to Follow-up|1|||
19485768|NCT01390181|41770415|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
19485769|NCT02641080|41770421|FG000|Overall Study|Physician Decision|2|||
19485770|NCT02641080|41770422|FG001|Overall Study|Physician Decision|0|||
19485771|NCT02641080|41770421|FG000|Overall Study|Withdrawal by Subject|0|||
19485772|NCT02641080|41770422|FG001|Overall Study|Withdrawal by Subject|1|||
19485773|NCT02641080|41770421|FG000|Overall Study|Rehab Center denied use of pumps|0|||
19485774|NCT02641080|41770422|FG001|Overall Study|Rehab Center denied use of pumps|3|||
19485775|NCT02641080|41770421|FG000|Overall Study|Lost to Follow-up|0|||
19485776|NCT02641080|41770422|FG001|Overall Study|Lost to Follow-up|3|||
19485777|NCT01457846|41770430|FG000|Overall Study|Death before treatment|1|||
19485778|NCT01457846|41770431|FG001|Overall Study|Death before treatment|2|||
19485779|NCT01457846|41770430|FG000|Overall Study|Did not receive treatment|0|||
19485780|NCT01457846|41770431|FG001|Overall Study|Did not receive treatment|1|||
19485781|NCT01457846|41770430|FG000|Overall Study|Death|27|||
19485782|NCT01457846|41770431|FG001|Overall Study|Death|16|||
19485783|NCT01457846|41770430|FG000|Overall Study|Unclassified reason for not completed|11|||
19485784|NCT01457846|41770431|FG001|Overall Study|Unclassified reason for not completed|10|||
19485785|NCT01457846|41770430|FG000|Overall Study|Withdrawal by Subject|1|||
19485786|NCT01457846|41770431|FG001|Overall Study|Withdrawal by Subject|1|||
19485787|NCT01457846|41770430|FG000|Overall Study|Lost to Follow-up|1|||
19485788|NCT01457846|41770431|FG001|Overall Study|Lost to Follow-up|0|||
19485789|NCT01496066|41770443|FG000|Overall Study|Lost to Follow-up|8|||
19485790|NCT01496066|41770444|FG001|Overall Study|Lost to Follow-up|5|||
19485791|NCT01496066|41770443|FG000|Overall Study|Explant|3|||
19485792|NCT01496066|41770444|FG001|Overall Study|Explant|0|||
19485793|NCT01496066|41770443|FG000|Overall Study|Death|1|||
19485794|NCT01496066|41770444|FG001|Overall Study|Death|4|||
19485795|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
19485796|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
19485797|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
19485798|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
19485799|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
19485800|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
19485801|NCT01389323|41770457|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
19485802|NCT01389323|41770457|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
19485803|NCT01389323|41770457|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
19612476|NCT00617305|42061325|FG002|Overall Study|Protocol Violation|1|||
19485804|NCT01389323|41770457|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
19485805|NCT01389323|41770457|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
19485806|NCT01389245|41770468|FG000|Overall Study|Protocol Violation|10|||
19485807|NCT01389245|41770468|FG000|Overall Study|Lost to Follow-up|3|||
19485808|NCT01389245|41770468|FG000|Overall Study|Withdrawal by Subject|2|||
19485809|NCT01494818|41770474|FG000|Overall Study|Relocation|1|||
19485810|NCT01494818|41770475|FG001|Overall Study|Relocation|2|||
19485811|NCT01494818|41770474|FG000|Overall Study|Lost to Follow-up|1|||
19485812|NCT01494818|41770475|FG001|Overall Study|Lost to Follow-up|0|||
19485813|NCT01494584|41770481|FG000|Overall Study|Study Closed/Terminated|1|||
19485814|NCT01388543|41770506|FG000|Day 14|Adverse Event|1|||
19485815|NCT01388543|41770507|FG001|Day 14|Adverse Event|4|||
19485816|NCT00512317|41770571|FG000|Overall Study|Insufficient clinical response|36|||
19485817|NCT00512317|41770571|FG000|Overall Study|Withdrawal by Subject|23|||
19485818|NCT00512317|41770571|FG000|Overall Study|Sponsor closure of study|21|||
19485819|NCT00512317|41770571|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
19485820|NCT00512317|41770571|FG000|Overall Study|Adverse Event|13|||
19485821|NCT00512317|41770571|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
19485822|NCT00512317|41770571|FG000|Overall Study|Lost to Follow-up|2|||
19485823|NCT00512317|41770571|FG000|Overall Study|Other|2|||
19485824|NCT01494506|41770587|FG000|Overall Study|Lack of Efficacy|77|||
19485825|NCT01494506|41770588|FG001|Overall Study|Lack of Efficacy|83|||
19485826|NCT01494506|41770589|FG002|Overall Study|Lack of Efficacy|57|||
19485827|NCT01494506|41770587|FG000|Overall Study|Adverse Event|17|||
19485828|NCT01494506|41770588|FG001|Overall Study|Adverse Event|10|||
19485829|NCT01494506|41770589|FG002|Overall Study|Adverse Event|11|||
19485830|NCT01494506|41770587|FG000|Overall Study|Death|9|||
19485831|NCT01494506|41770588|FG001|Overall Study|Death|5|||
19485832|NCT01494506|41770589|FG002|Overall Study|Death|2|||
19485833|NCT01494506|41770587|FG000|Overall Study|Physician Decision|7|||
19485834|NCT01494506|41770588|FG001|Overall Study|Physician Decision|5|||
19485835|NCT01494506|41770589|FG002|Overall Study|Physician Decision|4|||
19485836|NCT01494506|41770587|FG000|Overall Study|Withdrawal by Subject|17|||
19485837|NCT01494506|41770588|FG001|Overall Study|Withdrawal by Subject|20|||
19485838|NCT01494506|41770589|FG002|Overall Study|Withdrawal by Subject|14|||
19485839|NCT01494506|41770587|FG000|Overall Study|Clinical Deterioration|21|||
19485840|NCT01494506|41770588|FG001|Overall Study|Clinical Deterioration|17|||
19485841|NCT01494506|41770589|FG002|Overall Study|Clinical Deterioration|13|||
19485842|NCT01494506|41770587|FG000|Overall Study|Sponsor Decision|0|||
19485843|NCT01494506|41770588|FG001|Overall Study|Sponsor Decision|0|||
19485844|NCT01494506|41770589|FG002|Overall Study|Sponsor Decision|1|||
19485845|NCT01494506|41770587|FG000|Overall Study|Other|0|||
19485846|NCT01494506|41770588|FG001|Overall Study|Other|3|||
19485847|NCT01494506|41770589|FG002|Overall Study|Other|1|||
19485848|NCT02643420|41770601|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
19485849|NCT02643420|41770602|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
19485850|NCT02643420|41770601|FG000|Overall Study|Withdrawal by Subject|25|||
19485851|NCT02643420|41770602|FG001|Overall Study|Withdrawal by Subject|19|||
19485852|NCT02643420|41770601|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
19485853|NCT02643420|41770602|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
19485854|NCT02643420|41770601|FG000|Overall Study|Lost to Follow-up|6|||
19485855|NCT02643420|41770602|FG001|Overall Study|Lost to Follow-up|10|||
19485856|NCT02643420|41770601|FG000|Overall Study|Investigator Decision|2|||
19485857|NCT02643420|41770602|FG001|Overall Study|Investigator Decision|4|||
19485858|NCT02643420|41770601|FG000|Overall Study|Sponsor decision|1|||
19485859|NCT02643420|41770602|FG001|Overall Study|Sponsor decision|1|||
19485860|NCT02643420|41770601|FG000|Overall Study|Death|0|||
19485861|NCT02643420|41770602|FG001|Overall Study|Death|2|||
19485862|NCT02643420|41770601|FG000|Overall Study|Reason not Specified|8|||
19485863|NCT02643420|41770602|FG001|Overall Study|Reason not Specified|7|||
19485864|NCT03485911|41770617|FG000|Overall Study|Withdrawal by Subject|0|||
19485865|NCT03485911|41770618|FG001|Overall Study|Withdrawal by Subject|2|||
19485866|NCT03485911|41770619|FG002|Overall Study|Withdrawal by Subject|2|||
19485867|NCT03485911|41770617|FG000|Overall Study|Adverse Event|1|||
19485868|NCT03485911|41770618|FG001|Overall Study|Adverse Event|0|||
19485869|NCT03485911|41770619|FG002|Overall Study|Adverse Event|1|||
19485870|NCT03485911|41770617|FG000|Overall Study|High frequency of HAE attacks|0|||
19485871|NCT03485911|41770618|FG001|Overall Study|High frequency of HAE attacks|0|||
19485872|NCT03485911|41770619|FG002|Overall Study|High frequency of HAE attacks|1|||
19485873|NCT01456130|41770638|FG000|Overall Study|Adverse Event|4|||
19485874|NCT01456130|41770638|FG000|Overall Study|Voluntary Withdrawal|1|||
19485875|NCT01456130|41770638|FG000|Overall Study|Lack of Efficacy|4|||
19485876|NCT01456130|41770638|FG000|Overall Study|Other|1|||
19485877|NCT01456052|41770645|FG000|Overall Study|Adverse Event|1|||
19485878|NCT01456052|41770646|FG001|Overall Study|Adverse Event|1|||
19485879|NCT01456052|41770647|FG002|Overall Study|Adverse Event|2|||
19485880|NCT01456052|41770645|FG000|Overall Study|Consent withdrawn|0|||
19485881|NCT01456052|41770646|FG001|Overall Study|Consent withdrawn|2|||
19485882|NCT01456052|41770647|FG002|Overall Study|Consent withdrawn|1|||
19485883|NCT01456052|41770645|FG000|Overall Study|Protocol Violation|0|||
19485884|NCT01456052|41770646|FG001|Overall Study|Protocol Violation|1|||
19485885|NCT01456052|41770647|FG002|Overall Study|Protocol Violation|0|||
19485886|NCT01456052|41770645|FG000|Overall Study|Physician Decision|1|||
19485887|NCT01456052|41770646|FG001|Overall Study|Physician Decision|0|||
19485888|NCT01456052|41770647|FG002|Overall Study|Physician Decision|1|||
19485889|NCT01456052|41770645|FG000|Overall Study|Treatment Failure|0|||
19485890|NCT01456052|41770646|FG001|Overall Study|Treatment Failure|1|||
19485891|NCT01456052|41770647|FG002|Overall Study|Treatment Failure|1|||
19485892|NCT01387607|41770658|FG000|Overall Study|Adverse Event|23|||
19485893|NCT01387607|41770659|FG001|Overall Study|Adverse Event|11|||
19485894|NCT01387607|41770658|FG000|Overall Study|Lack of Efficacy|8|||
19485895|NCT01387607|41770659|FG001|Overall Study|Lack of Efficacy|6|||
19485896|NCT01387607|41770658|FG000|Overall Study|Lost to Follow-up|2|||
19485897|NCT01387607|41770659|FG001|Overall Study|Lost to Follow-up|1|||
19612477|NCT00617305|42061323|FG000|Overall Study|Withdrawal by Subject|1|||
19485898|NCT01387607|41770658|FG000|Overall Study|No longer meets eligibility criteria|0|||
19485899|NCT01387607|41770659|FG001|Overall Study|No longer meets eligibility criteria|1|||
19485900|NCT01387607|41770658|FG000|Overall Study|Protocol Violation|1|||
19485901|NCT01387607|41770659|FG001|Overall Study|Protocol Violation|5|||
19485902|NCT01387607|41770658|FG000|Overall Study|Withdrawal by Subject|13|||
19485903|NCT01387607|41770659|FG001|Overall Study|Withdrawal by Subject|14|||
19485904|NCT01387607|41770658|FG000|Overall Study|Other|1|||
19485905|NCT01387607|41770659|FG001|Overall Study|Other|1|||
19485906|NCT01387607|41770658|FG000|Overall Study|Randomized, not treated|3|||
19485907|NCT01387607|41770659|FG001|Overall Study|Randomized, not treated|6|||
19485908|NCT03451045|41770668|FG000|Overall Study|Lack of Efficacy|3|||
19485909|NCT03451045|41770669|FG001|Overall Study|Lack of Efficacy|2|||
19485910|NCT03451045|41770670|FG002|Overall Study|Lack of Efficacy|2|||
19485911|NCT03451045|41770668|FG000|Overall Study|Physician Decision|1|||
19485912|NCT03451045|41770669|FG001|Overall Study|Physician Decision|1|||
19485913|NCT03451045|41770670|FG002|Overall Study|Physician Decision|1|||
19485914|NCT03451045|41770668|FG000|Overall Study|Withdrawal by Subject|4|||
19485915|NCT03451045|41770669|FG001|Overall Study|Withdrawal by Subject|0|||
19485916|NCT03451045|41770670|FG002|Overall Study|Withdrawal by Subject|5|||
19485917|NCT03451045|41770668|FG000|Overall Study|Pregnancy|0|||
19485918|NCT03451045|41770669|FG001|Overall Study|Pregnancy|0|||
19485919|NCT03451045|41770670|FG002|Overall Study|Pregnancy|2|||
19485920|NCT03451045|41770668|FG000|Overall Study|Adverse Event|7|||
19485921|NCT03451045|41770669|FG001|Overall Study|Adverse Event|1|||
19485922|NCT03451045|41770670|FG002|Overall Study|Adverse Event|3|||
19485923|NCT03451045|41770668|FG000|Overall Study|Non-compliance with study|2|||
19485924|NCT03451045|41770669|FG001|Overall Study|Non-compliance with study|0|||
19485925|NCT03451045|41770670|FG002|Overall Study|Non-compliance with study|1|||
19485926|NCT03451045|41770668|FG000|Overall Study|any other reason|10|||
19485927|NCT03451045|41770669|FG001|Overall Study|any other reason|2|||
19485928|NCT03451045|41770670|FG002|Overall Study|any other reason|13|||
19485929|NCT03219567|41770681|FG000|Overall Study|Withdrawal by Subject|0|||
19485930|NCT03219567|41770682|FG001|Overall Study|Withdrawal by Subject|1|||
19485931|NCT01386125|41770691|FG000|Overall Study|Lost to Follow-up|3|||
19485932|NCT01386125|41770692|FG001|Overall Study|Lost to Follow-up|9|||
19485933|NCT01386125|41770691|FG000|Overall Study|Physician Decision|0|||
19485934|NCT01386125|41770692|FG001|Overall Study|Physician Decision|1|||
19485935|NCT01386125|41770691|FG000|Overall Study|Protocol Violation|5|||
19485936|NCT01386125|41770692|FG001|Overall Study|Protocol Violation|7|||
19485937|NCT01386125|41770691|FG000|Overall Study|Disease Progress|1|||
19485938|NCT01386125|41770692|FG001|Overall Study|Disease Progress|2|||
19485939|NCT01386125|41770691|FG000|Overall Study|Withdrawal by Subject|13|||
19485940|NCT01386125|41770692|FG001|Overall Study|Withdrawal by Subject|12|||
19485941|NCT01386125|41770691|FG000|Overall Study|Adverse Event|2|||
19485942|NCT01386125|41770692|FG001|Overall Study|Adverse Event|5|||
19485943|NCT01386125|41770691|FG000|Overall Study|Lack of Efficacy|0|||
19485944|NCT01386125|41770692|FG001|Overall Study|Lack of Efficacy|1|||
19485945|NCT01386125|41770691|FG000|Overall Study|Participant Leaving Country|1|||
19485946|NCT01386125|41770692|FG001|Overall Study|Participant Leaving Country|0|||
19485947|NCT01384877|41770700|FG000|Treatment 2|Lost to Follow-up|2|||
19485948|NCT01384877|41770701|FG001|Treatment 2|Lost to Follow-up|2|||
19485949|NCT00114517|41770711|FG000|Overall Study|Adverse Event|6|||
19485950|NCT00114517|41770712|FG001|Overall Study|Adverse Event|1|||
19485951|NCT00114517|41770713|FG002|Overall Study|Adverse Event|6|||
19485952|NCT00114517|41770714|FG003|Overall Study|Adverse Event|3|||
19485953|NCT00114517|41770711|FG000|Overall Study|Lost to Follow-up|2|||
19485954|NCT00114517|41770712|FG001|Overall Study|Lost to Follow-up|2|||
19485955|NCT00114517|41770713|FG002|Overall Study|Lost to Follow-up|2|||
19485956|NCT00114517|41770714|FG003|Overall Study|Lost to Follow-up|1|||
19485957|NCT00114517|41770711|FG000|Overall Study|Too busy|3|||
19485958|NCT00114517|41770712|FG001|Overall Study|Too busy|1|||
19485959|NCT00114517|41770713|FG002|Overall Study|Too busy|1|||
19485960|NCT00114517|41770714|FG003|Overall Study|Too busy|2|||
19485961|NCT00114517|41770711|FG000|Overall Study|Moved from area|0|||
19485962|NCT00114517|41770712|FG001|Overall Study|Moved from area|3|||
19485963|NCT00114517|41770713|FG002|Overall Study|Moved from area|2|||
19485964|NCT00114517|41770714|FG003|Overall Study|Moved from area|1|||
19485965|NCT00114517|41770711|FG000|Overall Study|Did not want estradiol|1|||
19485966|NCT00114517|41770712|FG001|Overall Study|Did not want estradiol|1|||
19485967|NCT00114517|41770713|FG002|Overall Study|Did not want estradiol|0|||
19485968|NCT00114517|41770714|FG003|Overall Study|Did not want estradiol|0|||
19485969|NCT00114517|41770711|FG000|Overall Study|Armed-services duty|0|||
19485970|NCT00114517|41770712|FG001|Overall Study|Armed-services duty|1|||
19485971|NCT00114517|41770713|FG002|Overall Study|Armed-services duty|0|||
19485972|NCT00114517|41770714|FG003|Overall Study|Armed-services duty|1|||
19485973|NCT00114517|41770711|FG000|Overall Study|Competing family issue|0|||
19485974|NCT00114517|41770712|FG001|Overall Study|Competing family issue|1|||
19485975|NCT00114517|41770713|FG002|Overall Study|Competing family issue|0|||
19485976|NCT00114517|41770714|FG003|Overall Study|Competing family issue|1|||
19485977|NCT00114517|41770711|FG000|Overall Study|Physician Decision|0|||
19485978|NCT00114517|41770712|FG001|Overall Study|Physician Decision|1|||
19485979|NCT00114517|41770713|FG002|Overall Study|Physician Decision|0|||
19485980|NCT00114517|41770714|FG003|Overall Study|Physician Decision|0|||
19485981|NCT00114517|41770711|FG000|Overall Study|Lost interest|0|||
19485982|NCT00114517|41770712|FG001|Overall Study|Lost interest|0|||
19485983|NCT00114517|41770713|FG002|Overall Study|Lost interest|1|||
19485984|NCT00114517|41770714|FG003|Overall Study|Lost interest|0|||
19485985|NCT00114517|41770711|FG000|Overall Study|Weight increase|0|||
19485986|NCT00114517|41770712|FG001|Overall Study|Weight increase|0|||
19485987|NCT00114517|41770713|FG002|Overall Study|Weight increase|1|||
19485988|NCT00114517|41770714|FG003|Overall Study|Weight increase|0|||
19485989|NCT00114517|41770711|FG000|Overall Study|Concern about blood clots|0|||
19485990|NCT00114517|41770712|FG001|Overall Study|Concern about blood clots|0|||
19485991|NCT00114517|41770713|FG002|Overall Study|Concern about blood clots|1|||
19485992|NCT00114517|41770714|FG003|Overall Study|Concern about blood clots|0|||
19485993|NCT00114517|41770711|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
19485994|NCT00114517|41770712|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
19485995|NCT00114517|41770713|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
19485996|NCT00114517|41770714|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
19485997|NCT01384019|41770722|FG000|Overall Study|Withdrawal by Subject|3|||
19485998|NCT01384019|41770723|FG001|Overall Study|Withdrawal by Subject|0|||
19485999|NCT01384019|41770722|FG000|Overall Study|Death|1|||
19486000|NCT01384019|41770723|FG001|Overall Study|Death|0|||
19486001|NCT01384019|41770722|FG000|Overall Study|MRI refusal|6|||
19486002|NCT01384019|41770723|FG001|Overall Study|MRI refusal|6|||
19486003|NCT00033631|41770731|FG000|Overall Study|Protocol Violation|14|||
19486004|NCT00033631|41770732|FG001|Overall Study|Protocol Violation|11|||
19486005|NCT00033631|41770731|FG000|Overall Study|Withdrawal by Subject|4|||
19486006|NCT00033631|41770732|FG001|Overall Study|Withdrawal by Subject|4|||
19486007|NCT01471574|41770743|FG000|Treatment Period|Lack of Efficacy|12|||
19486008|NCT01471574|41770744|FG001|Treatment Period|Lack of Efficacy|4|||
19486009|NCT01471574|41770745|FG002|Treatment Period|Lack of Efficacy|14|||
19486010|NCT01471574|41770746|FG003|Treatment Period|Lack of Efficacy|1|||
19486011|NCT01471574|41770743|FG000|Treatment Period|Adverse Event|7|||
19486012|NCT01471574|41770744|FG001|Treatment Period|Adverse Event|3|||
19486013|NCT01471574|41770745|FG002|Treatment Period|Adverse Event|6|||
19486014|NCT01471574|41770746|FG003|Treatment Period|Adverse Event|1|||
19486015|NCT01471574|41770743|FG000|Treatment Period|Withdrawal by Subject|5|||
19486016|NCT01471574|41770744|FG001|Treatment Period|Withdrawal by Subject|1|||
19486017|NCT01471574|41770745|FG002|Treatment Period|Withdrawal by Subject|1|||
19704104|NCT00257166|42148415|FG000|Overall Study|Lost to Follow-up|8|||
19704105|NCT00257166|42148416|FG001|Overall Study|Lost to Follow-up|1|||
19704106|NCT00257166|42148415|FG000|Overall Study|Withdrawal by Subject|9|||
19704107|NCT00257166|42148416|FG001|Overall Study|Withdrawal by Subject|2|||
19704108|NCT00257166|42148415|FG000|Overall Study|Other|16|||
19704109|NCT00257166|42148416|FG001|Overall Study|Other|21|||
19704110|NCT00257166|42148415|FG000|Overall Study|Randomized, but not treated|1|||
19704111|NCT00257166|42148416|FG001|Overall Study|Randomized, but not treated|0|||
19704112|NCT00227370|42148424|FG000|Overall Study|Withdrawal by Subject|1|||
19704113|NCT00227370|42148425|FG001|Overall Study|Withdrawal by Subject|2|||
19704114|NCT00227370|42148424|FG000|Overall Study|Death|3|||
19704115|NCT00227370|42148425|FG001|Overall Study|Death|4|||
19704116|NCT00227370|42148424|FG000|Overall Study|Adverse Event|6|||
19704117|NCT00227370|42148425|FG001|Overall Study|Adverse Event|11|||
19704118|NCT00227370|42148424|FG000|Overall Study|Physician Decision|9|||
19704119|NCT00227370|42148425|FG001|Overall Study|Physician Decision|6|||
19704120|NCT00227370|42148424|FG000|Overall Study|Other reasons|2|||
19704121|NCT00227370|42148425|FG001|Overall Study|Other reasons|1|||
19704122|NCT00191100|42148433|FG000|Overall Study|Adverse Event|18|||
19704123|NCT00191100|42148434|FG001|Overall Study|Adverse Event|1|||
19704124|NCT00191100|42148433|FG000|Overall Study|Lost to Follow-up|2|||
19704125|NCT00191100|42148434|FG001|Overall Study|Lost to Follow-up|0|||
19704126|NCT00191100|42148433|FG000|Overall Study|Patient Moved|0|||
19704127|NCT00191100|42148434|FG001|Overall Study|Patient Moved|1|||
19704128|NCT00191100|42148433|FG000|Overall Study|Withdrawal by Subject|9|||
19704129|NCT00191100|42148434|FG001|Overall Study|Withdrawal by Subject|3|||
19486018|NCT01471574|41770746|FG003|Treatment Period|Withdrawal by Subject|0|||
19704130|NCT00191100|42148433|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
19486019|NCT01471574|41770743|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
19486020|NCT01471574|41770744|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
19486021|NCT01471574|41770745|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
19486022|NCT01471574|41770746|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
19486023|NCT01471574|41770743|FG000|Treatment Period|Lost to Follow-up|1|||
19486024|NCT01471574|41770744|FG001|Treatment Period|Lost to Follow-up|2|||
19486025|NCT01471574|41770745|FG002|Treatment Period|Lost to Follow-up|2|||
19704131|NCT00191100|42148434|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
19704132|NCT00191100|42148433|FG000|Overall Study|Clinical Relapse|2|||
19704133|NCT00191100|42148434|FG001|Overall Study|Clinical Relapse|1|||
19704134|NCT00191100|42148433|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
19704135|NCT00191100|42148434|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
19704136|NCT00191100|42148433|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
19704137|NCT00191100|42148434|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
19704138|NCT00191100|42148433|FG000|Overall Study|Physician Decision|3|||
19704139|NCT00191100|42148434|FG001|Overall Study|Physician Decision|1|||
19704140|NCT00191100|42148433|FG000|Overall Study|Death from Study Drug Toxicity|2|||
19704141|NCT00191100|42148434|FG001|Overall Study|Death from Study Drug Toxicity|0|||
19704142|NCT00191100|42148433|FG000|Overall Study|Protocol Violation|1|||
19704143|NCT00191100|42148434|FG001|Overall Study|Protocol Violation|1|||
19704144|NCT00191100|42148433|FG000|Overall Study|Death from Other Cause|1|||
19704145|NCT00191100|42148434|FG001|Overall Study|Death from Other Cause|0|||
19704146|NCT00191100|42148433|FG000|Overall Study|Reason Not Specified|0|||
19704147|NCT00191100|42148434|FG001|Overall Study|Reason Not Specified|1|||
19704148|NCT00189540|42148442|FG000|Overall Study|Withdrawal by Subject|3|||
19704149|NCT00189540|42148443|FG001|Overall Study|Withdrawal by Subject|0|||
19704150|NCT00189540|42148442|FG000|Overall Study|Death|4|||
19704151|NCT00189540|42148443|FG001|Overall Study|Death|1|||
19704152|NCT00257010|42148449|FG000|Overall Study|Lack of Efficacy|11|||
19704153|NCT00257010|42148449|FG000|Overall Study|Lost to Follow-up|53|||
19704154|NCT00257010|42148449|FG000|Overall Study|Withdrawal by Subject|34|||
19704155|NCT00257010|42148449|FG000|Overall Study|Adverse Event|10|||
19704156|NCT00257010|42148449|FG000|Overall Study|various|11|||
19704157|NCT00257010|42148449|FG000|Overall Study|no headache reported|9|||
19704158|NCT00256854|42148459|FG000|Overall Study|Withdrawal by Subject|2|||
19704159|NCT00256854|42148460|FG001|Overall Study|Withdrawal by Subject|3|||
19704160|NCT00256854|42148461|FG002|Overall Study|Withdrawal by Subject|0|||
19704161|NCT00256854|42148462|FG003|Overall Study|Withdrawal by Subject|0|||
19704162|NCT00256854|42148463|FG004|Overall Study|Withdrawal by Subject|0|||
19704163|NCT00256854|42148464|FG005|Overall Study|Withdrawal by Subject|0|||
19704164|NCT00256854|42148459|FG000|Overall Study|Lack of Efficacy|1|||
19704165|NCT00256854|42148460|FG001|Overall Study|Lack of Efficacy|0|||
19704166|NCT00256854|42148461|FG002|Overall Study|Lack of Efficacy|0|||
19704167|NCT00256854|42148462|FG003|Overall Study|Lack of Efficacy|0|||
19704168|NCT00256854|42148463|FG004|Overall Study|Lack of Efficacy|0|||
19704169|NCT00256854|42148464|FG005|Overall Study|Lack of Efficacy|0|||
19704170|NCT00256854|42148459|FG000|Overall Study|Protocol Violation|0|||
19704171|NCT00256854|42148460|FG001|Overall Study|Protocol Violation|1|||
19704172|NCT00256854|42148461|FG002|Overall Study|Protocol Violation|1|||
19704173|NCT00256854|42148462|FG003|Overall Study|Protocol Violation|1|||
19704174|NCT00256854|42148463|FG004|Overall Study|Protocol Violation|0|||
19704175|NCT00256854|42148464|FG005|Overall Study|Protocol Violation|0|||
19704176|NCT00256854|42148459|FG000|Overall Study|Adverse Event|0|||
19704177|NCT00256854|42148460|FG001|Overall Study|Adverse Event|0|||
19704178|NCT00256854|42148461|FG002|Overall Study|Adverse Event|2|||
19704179|NCT00256854|42148462|FG003|Overall Study|Adverse Event|2|||
19704180|NCT00256854|42148463|FG004|Overall Study|Adverse Event|0|||
19704181|NCT00256854|42148464|FG005|Overall Study|Adverse Event|1|||
19704182|NCT00256854|42148459|FG000|Overall Study|Not compliant with the study drug|0|||
19704183|NCT00256854|42148460|FG001|Overall Study|Not compliant with the study drug|0|||
19704184|NCT00256854|42148461|FG002|Overall Study|Not compliant with the study drug|0|||
19704185|NCT00256854|42148462|FG003|Overall Study|Not compliant with the study drug|0|||
19704186|NCT00256854|42148463|FG004|Overall Study|Not compliant with the study drug|1|||
19704187|NCT00256854|42148464|FG005|Overall Study|Not compliant with the study drug|0|||
19704188|NCT00189462|42148481|FG000|Overall Study|Lack of Efficacy|5|||
19704189|NCT00189462|42148482|FG001|Overall Study|Lack of Efficacy|1|||
19704190|NCT00189462|42148481|FG000|Overall Study|Lost to Follow-up|18|||
19612478|NCT00617305|42061324|FG001|Overall Study|Withdrawal by Subject|0|||
19612479|NCT00617305|42061325|FG002|Overall Study|Withdrawal by Subject|0|||
19612480|NCT00811395|42061342|FG000|Extension Treatment|Adverse Event|1|||
19612481|NCT00811395|42061343|FG001|Extension Treatment|Adverse Event|2|||
19704191|NCT00189462|42148482|FG001|Overall Study|Lost to Follow-up|20|||
19612482|NCT00811395|42061344|FG002|Extension Treatment|Adverse Event|2|||
19612483|NCT00811395|42061345|FG003|Extension Treatment|Adverse Event|2|||
19612484|NCT00811395|42061346|FG004|Extension Treatment|Adverse Event|0|||
19612485|NCT00811395|42061347|FG005|Extension Treatment|Adverse Event|1|||
19612486|NCT00811395|42061342|FG000|Extension Treatment|Progressive disease|1|||
19612487|NCT00811395|42061343|FG001|Extension Treatment|Progressive disease|1|||
19612488|NCT00811395|42061344|FG002|Extension Treatment|Progressive disease|0|||
19612489|NCT00811395|42061345|FG003|Extension Treatment|Progressive disease|0|||
19612490|NCT00811395|42061346|FG004|Extension Treatment|Progressive disease|0|||
19704192|NCT00256698|42148490|FG000|Overall Study|Withdrawal by Subject|7|||
19704193|NCT00256698|42148491|FG001|Overall Study|Withdrawal by Subject|7|||
19704194|NCT00256698|42148490|FG000|Overall Study|Adverse Event|13|||
19612491|NCT00811395|42061347|FG005|Extension Treatment|Progressive disease|0|||
19612492|NCT00811395|42061342|FG000|Extension Treatment|Participant did not wish to continue|0|||
19704195|NCT00256698|42148491|FG001|Overall Study|Adverse Event|6|||
19486026|NCT01471574|41770746|FG003|Treatment Period|Lost to Follow-up|0|||
19486027|NCT01471574|41770743|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
19486028|NCT01471574|41770744|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
19486029|NCT01471574|41770745|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
19486030|NCT01471574|41770746|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
19486031|NCT01471574|41770743|FG000|Treatment Period|Other|1|||
19486032|NCT01471574|41770744|FG001|Treatment Period|Other|0|||
19486033|NCT01471574|41770745|FG002|Treatment Period|Other|0|||
19486034|NCT01471574|41770746|FG003|Treatment Period|Other|0|||
19486035|NCT01471574|41770743|FG000|Follow-up Period|Withdrawal by Subject|3|||
19486036|NCT01471574|41770744|FG001|Follow-up Period|Withdrawal by Subject|0|||
19486037|NCT01471574|41770745|FG002|Follow-up Period|Withdrawal by Subject|3|||
19486038|NCT01471574|41770746|FG003|Follow-up Period|Withdrawal by Subject|1|||
19486039|NCT01471574|41770743|FG000|Follow-up Period|Lost to Follow-up|4|||
19486040|NCT01471574|41770744|FG001|Follow-up Period|Lost to Follow-up|1|||
19486041|NCT01471574|41770745|FG002|Follow-up Period|Lost to Follow-up|3|||
19486042|NCT01471574|41770746|FG003|Follow-up Period|Lost to Follow-up|2|||
19486043|NCT01471574|41770743|FG000|Follow-up Period|Death|0|||
19486044|NCT01471574|41770744|FG001|Follow-up Period|Death|0|||
19486045|NCT01471574|41770745|FG002|Follow-up Period|Death|1|||
19486046|NCT01471574|41770746|FG003|Follow-up Period|Death|0|||
19486047|NCT01471574|41770743|FG000|Follow-up Period|Follow-up no longer required|0|||
19486048|NCT01471574|41770744|FG001|Follow-up Period|Follow-up no longer required|1|||
19486049|NCT01471574|41770745|FG002|Follow-up Period|Follow-up no longer required|0|||
19486050|NCT01471574|41770746|FG003|Follow-up Period|Follow-up no longer required|0|||
19486051|NCT01383707|41770762|FG000|Overall Study|Consent withdrawal|6|||
19486052|NCT01383707|41770762|FG000|Overall Study|Death|19|||
19486053|NCT01383707|41770762|FG000|Overall Study|Other|8|||
19486054|NCT01383707|41770762|FG000|Overall Study|Sponsor's decision|2|||
19486055|NCT01383707|41770762|FG000|Overall Study|Adverse Event|14|||
19486056|NCT01383707|41770762|FG000|Overall Study|Progressive disease|23|||
19486057|NCT01383317|41770768|FG000|Overall Study|Lost to Follow-up|2|||
19486058|NCT01383317|41770769|FG001|Overall Study|Lost to Follow-up|1|||
19486059|NCT01383317|41770768|FG000|Overall Study|Death|1|||
19486060|NCT01383317|41770769|FG001|Overall Study|Death|0|||
19486061|NCT01383317|41770768|FG000|Overall Study|Adverse Event|0|||
19486062|NCT01383317|41770769|FG001|Overall Study|Adverse Event|1|||
19486063|NCT01455428|41770777|FG000|Overall Study|Protocol Violation|2|||
19486064|NCT01455428|41770778|FG001|Overall Study|Protocol Violation|1|||
19486065|NCT01455428|41770777|FG000|Overall Study|Adverse Event|6|||
19486066|NCT01455428|41770778|FG001|Overall Study|Adverse Event|2|||
19486067|NCT01455428|41770777|FG000|Overall Study|Lost to Follow-up|1|||
19486068|NCT01455428|41770778|FG001|Overall Study|Lost to Follow-up|1|||
19486069|NCT01455428|41770777|FG000|Overall Study|Withdrawal by Subject|2|||
19486070|NCT01455428|41770778|FG001|Overall Study|Withdrawal by Subject|5|||
19486071|NCT01455428|41770777|FG000|Overall Study|Did not meet entrance criteria|0|||
19486072|NCT01455428|41770778|FG001|Overall Study|Did not meet entrance criteria|2|||
19486073|NCT01455428|41770777|FG000|Overall Study|Insufficient clinical response|0|||
19486074|NCT01455428|41770778|FG001|Overall Study|Insufficient clinical response|2|||
19486075|NCT01455428|41770777|FG000|Overall Study|Did not receive treatment|1|||
19486076|NCT01455428|41770778|FG001|Overall Study|Did not receive treatment|1|||
19486077|NCT01455428|41770777|FG000|Overall Study|Other|2|||
19486078|NCT01455428|41770778|FG001|Overall Study|Other|4|||
19486079|NCT01383161|41770786|FG000|Overall Study|Adverse Event|5|||
19486080|NCT01383161|41770787|FG001|Overall Study|Adverse Event|1|||
19486081|NCT01383161|41770786|FG000|Overall Study|Withdrawal by Subject|0|||
19486082|NCT01383161|41770787|FG001|Overall Study|Withdrawal by Subject|2|||
19486083|NCT01383161|41770786|FG000|Overall Study|Lack of Efficacy|0|||
19486084|NCT01383161|41770787|FG001|Overall Study|Lack of Efficacy|1|||
19486085|NCT01382225|41770813|FG000|Overall Study|Adverse Event|3|||
19486086|NCT01382225|41770814|FG001|Overall Study|Adverse Event|2|||
19486087|NCT01382225|41770813|FG000|Overall Study|Protocol Violation|2|||
19486088|NCT01382225|41770814|FG001|Overall Study|Protocol Violation|1|||
19486089|NCT01382225|41770813|FG000|Overall Study|Subject Withdrew Consent|5|||
19486090|NCT01382225|41770814|FG001|Overall Study|Subject Withdrew Consent|2|||
19486091|NCT01382225|41770813|FG000|Overall Study|Other|4|||
19486092|NCT01382225|41770814|FG001|Overall Study|Other|2|||
19486093|NCT01381679|41770820|FG000|Overall Study|Adverse Event|3|||
19486094|NCT01381679|41770820|FG000|Overall Study|Lost to Follow-up|885|||
19486095|NCT01455194|41770827|FG000|Overall Study|Screen Failure|20|||
19486096|NCT01455194|41770828|FG001|Overall Study|Screen Failure|0|||
19486097|NCT01455194|41770829|FG002|Overall Study|Screen Failure|0|||
19486098|NCT01455194|41770830|FG003|Overall Study|Screen Failure|0|||
19486099|NCT01455194|41770827|FG000|Overall Study|Randomisation Failure|90|||
19486100|NCT01455194|41770828|FG001|Overall Study|Randomisation Failure|0|||
19486101|NCT01455194|41770829|FG002|Overall Study|Randomisation Failure|0|||
19486102|NCT01455194|41770830|FG003|Overall Study|Randomisation Failure|0|||
19704196|NCT00256698|42148490|FG000|Overall Study|Protocol Violation|6|||
19486103|NCT01455194|41770827|FG000|Overall Study|Deterioration in asthma|12|||
19486104|NCT01455194|41770828|FG001|Overall Study|Deterioration in asthma|6|||
19486105|NCT01455194|41770829|FG002|Overall Study|Deterioration in asthma|14|||
19486106|NCT01455194|41770830|FG003|Overall Study|Deterioration in asthma|9|||
19486107|NCT01455194|41770827|FG000|Overall Study|Adverse Event|1|||
19486108|NCT01455194|41770828|FG001|Overall Study|Adverse Event|1|||
19486109|NCT01455194|41770829|FG002|Overall Study|Adverse Event|1|||
19486110|NCT01455194|41770830|FG003|Overall Study|Adverse Event|3|||
19486111|NCT01455194|41770827|FG000|Overall Study|Withdrawal by Subject|21|||
19486112|NCT01455194|41770828|FG001|Overall Study|Withdrawal by Subject|16|||
19486113|NCT01455194|41770829|FG002|Overall Study|Withdrawal by Subject|12|||
19486114|NCT01455194|41770830|FG003|Overall Study|Withdrawal by Subject|9|||
19486115|NCT01455194|41770827|FG000|Overall Study|Lost to Follow-up|2|||
19486116|NCT01455194|41770828|FG001|Overall Study|Lost to Follow-up|0|||
19486117|NCT01455194|41770829|FG002|Overall Study|Lost to Follow-up|1|||
19486118|NCT01455194|41770830|FG003|Overall Study|Lost to Follow-up|1|||
19486119|NCT01455194|41770827|FG000|Overall Study|Pregnancy|0|||
19486120|NCT01455194|41770828|FG001|Overall Study|Pregnancy|1|||
19486121|NCT01455194|41770829|FG002|Overall Study|Pregnancy|1|||
19486122|NCT01455194|41770830|FG003|Overall Study|Pregnancy|0|||
19486123|NCT01455194|41770827|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
19486124|NCT01455194|41770828|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
19486125|NCT01455194|41770829|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
19486126|NCT01455194|41770830|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
19486127|NCT01455194|41770827|FG000|Overall Study|Miscellaneous|4|||
19486128|NCT01455194|41770828|FG001|Overall Study|Miscellaneous|5|||
19486129|NCT01455194|41770829|FG002|Overall Study|Miscellaneous|1|||
19486130|NCT01455194|41770830|FG003|Overall Study|Miscellaneous|4|||
19486131|NCT01454726|41770854|FG000|Overall Study|Withdrawal by Subject|0|||
19486132|NCT01454726|41770855|FG001|Overall Study|Withdrawal by Subject|1|||
19486133|NCT01361568|41770867|FG000|Overall Study|Adverse Event|0|||
19486134|NCT01361568|41770868|FG001|Overall Study|Adverse Event|0|||
19486135|NCT01361568|41770869|FG002|Overall Study|Adverse Event|0|||
19486136|NCT01361568|41770870|FG003|Overall Study|Adverse Event|0|||
19486137|NCT01361568|41770871|FG004|Overall Study|Adverse Event|1|||
19486138|NCT01361568|41770872|FG005|Overall Study|Adverse Event|0|||
19486139|NCT01361568|41770867|FG000|Overall Study|Physician Decision|0|||
19486140|NCT01361568|41770868|FG001|Overall Study|Physician Decision|0|||
19486141|NCT01361568|41770869|FG002|Overall Study|Physician Decision|0|||
19486142|NCT01361568|41770870|FG003|Overall Study|Physician Decision|0|||
19486143|NCT01361568|41770871|FG004|Overall Study|Physician Decision|0|||
19486144|NCT01361568|41770872|FG005|Overall Study|Physician Decision|1|||
19486145|NCT01361568|41770867|FG000|Overall Study|Withdrawal by Subject|2|||
19486146|NCT01361568|41770868|FG001|Overall Study|Withdrawal by Subject|1|||
19486147|NCT01361568|41770869|FG002|Overall Study|Withdrawal by Subject|0|||
19486148|NCT01361568|41770870|FG003|Overall Study|Withdrawal by Subject|0|||
19486149|NCT01361568|41770871|FG004|Overall Study|Withdrawal by Subject|0|||
19486150|NCT01361568|41770872|FG005|Overall Study|Withdrawal by Subject|1|||
19486151|NCT03084367|41770887|FG000|Overall Study|Lost to Follow-up|32|||
19486152|NCT03084367|41770887|FG000|Overall Study|Withdrawal by Subject|4|||
19486153|NCT03084367|41770887|FG000|Overall Study|Other|1|||
19486154|NCT01454570|41770900|FG000|Overall Study|Withdrawal by Subject|2|||
19486155|NCT01454570|41770900|FG000|Overall Study|Screen Failure|7|||
19486156|NCT01494350|41770913|FG000|Overall Study|Worsening of lesion|1|||
19486157|NCT03281629|41770923|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
19486158|NCT03281629|41770924|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
19486159|NCT03281629|41770923|FG000|Overall Study|Death|0|||
19486160|NCT03281629|41770924|FG001|Overall Study|Death|1|||
19486161|NCT03281629|41770923|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
19486162|NCT03281629|41770924|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
19486163|NCT00218543|41770930|FG000|Overall Study|Lost to Follow-up|8|||
19486164|NCT00218543|41770930|FG000|Overall Study|relocated|1|||
19486165|NCT00218543|41770930|FG000|Overall Study|Withdrawal by Subject|1|||
19486166|NCT00218543|41770930|FG000|Overall Study|Physician Decision|3|||
19486167|NCT00218543|41770930|FG000|Overall Study|Adverse Event|2|||
19486168|NCT00216671|41770945|FG000|Overall Study|Adverse Event|4|||
19486169|NCT00216671|41770946|FG001|Overall Study|Adverse Event|9|||
19486170|NCT00216671|41770945|FG000|Overall Study|Pregnancy|0|||
19704197|NCT00256698|42148491|FG001|Overall Study|Protocol Violation|5|||
19704198|NCT00256698|42148490|FG000|Overall Study|Lost to Follow-up|1|||
19704199|NCT00256698|42148491|FG001|Overall Study|Lost to Follow-up|3|||
19486171|NCT00216671|41770946|FG001|Overall Study|Pregnancy|1|||
19486172|NCT00216671|41770945|FG000|Overall Study|Withdrawal by Subject|4|||
19486173|NCT00216671|41770946|FG001|Overall Study|Withdrawal by Subject|2|||
19486174|NCT00216671|41770945|FG000|Overall Study|Refused Injections|3|||
19486175|NCT00216671|41770946|FG001|Overall Study|Refused Injections|13|||
19486176|NCT00216671|41770945|FG000|Overall Study|No Need to Continue Medication|1|||
19704200|NCT00256698|42148490|FG000|Overall Study|disease progression|97|||
19486177|NCT00216671|41770946|FG001|Overall Study|No Need to Continue Medication|1|||
19486178|NCT00216671|41770945|FG000|Overall Study|Insufficient Response|9|||
19486179|NCT00216671|41770946|FG001|Overall Study|Insufficient Response|4|||
19486180|NCT00216671|41770945|FG000|Overall Study|Lost to Follow-up|3|||
19486181|NCT00216671|41770946|FG001|Overall Study|Lost to Follow-up|5|||
19486182|NCT00216671|41770945|FG000|Overall Study|Non compliant|2|||
19486183|NCT00216671|41770946|FG001|Overall Study|Non compliant|2|||
19486184|NCT00216671|41770945|FG000|Overall Study|Ineligible|0|||
19486185|NCT00216671|41770946|FG001|Overall Study|Ineligible|2|||
19486186|NCT00216671|41770945|FG000|Overall Study|Physician Decision|1|||
19486187|NCT00216671|41770946|FG001|Overall Study|Physician Decision|1|||
19486188|NCT00216671|41770945|FG000|Overall Study|Protocol Violation|3|||
19486189|NCT00216671|41770946|FG001|Overall Study|Protocol Violation|5|||
19486190|NCT00216671|41770945|FG000|Overall Study|Relapse|1|||
19486191|NCT00216671|41770946|FG001|Overall Study|Relapse|0|||
19486192|NCT00216671|41770945|FG000|Overall Study|Investigator Illness|0|||
19486193|NCT00216671|41770946|FG001|Overall Study|Investigator Illness|1|||
19486194|NCT00216671|41770945|FG000|Overall Study|Patient Moved|0|||
19486195|NCT00216671|41770946|FG001|Overall Study|Patient Moved|1|||
19486196|NCT00216671|41770945|FG000|Overall Study|Ineligible, no efficacy data|2|||
19486197|NCT00216671|41770946|FG001|Overall Study|Ineligible, no efficacy data|2|||
19486198|NCT00216671|41770945|FG000|Overall Study|Insufficient Response Adverse Event|2|||
19486199|NCT00216671|41770946|FG001|Overall Study|Insufficient Response Adverse Event|1|||
19486200|NCT00216203|41770952|FG000|Overall Study|Withdrawal by Subject|2|||
19486201|NCT02644668|41770978|FG000|Overall Study|Adverse Event|2|||
19486202|NCT02644668|41770979|FG001|Overall Study|Adverse Event|0|||
19486203|NCT02644668|41770980|FG002|Overall Study|Adverse Event|1|||
19486204|NCT02644668|41770978|FG000|Overall Study|Protocol Violation|0|||
19486205|NCT02644668|41770979|FG001|Overall Study|Protocol Violation|0|||
19486206|NCT02644668|41770980|FG002|Overall Study|Protocol Violation|1|||
19486207|NCT02644668|41770978|FG000|Overall Study|Withdrawal by Subject|0|||
19486208|NCT02644668|41770979|FG001|Overall Study|Withdrawal by Subject|0|||
19486209|NCT02644668|41770980|FG002|Overall Study|Withdrawal by Subject|1|||
19486210|NCT04115293|41771001|FG000|Overall Study|Adverse Event|0|||
19486211|NCT04115293|41771002|FG001|Overall Study|Adverse Event|2|||
19486212|NCT04115293|41771001|FG000|Overall Study|Withdrawal by Subject|2|||
19486213|NCT04115293|41771002|FG001|Overall Study|Withdrawal by Subject|1|||
19486214|NCT04115293|41771001|FG000|Overall Study|Physician Decision|1|||
19486215|NCT04115293|41771002|FG001|Overall Study|Physician Decision|0|||
19486216|NCT04115293|41771001|FG000|Overall Study|Death|1|||
19486217|NCT04115293|41771002|FG001|Overall Study|Death|1|||
19486218|NCT02644356|41771008|FG000|Overall Study|Withdrawal by Subject|2|||
19486219|NCT01494038|41771049|FG000|Overall Study|Protocol Violation|1|||
19486220|NCT01494038|41771050|FG001|Overall Study|Protocol Violation|1|||
19486221|NCT01494038|41771049|FG000|Overall Study|Lost to Follow-up|18|||
19486222|NCT01494038|41771050|FG001|Overall Study|Lost to Follow-up|20|||
19486223|NCT01494038|41771049|FG000|Overall Study|Withdrawal by Subject|44|||
19486224|NCT01494038|41771050|FG001|Overall Study|Withdrawal by Subject|34|||
19486225|NCT01494038|41771049|FG000|Overall Study|Not able to get to clinic|21|||
19486226|NCT01494038|41771050|FG001|Overall Study|Not able to get to clinic|15|||
19486227|NCT01494038|41771049|FG000|Overall Study|Not willing to adhere to reqs|2|||
19486228|NCT01494038|41771050|FG001|Overall Study|Not willing to adhere to reqs|9|||
19486229|NCT01494038|41771049|FG000|Overall Study|Death|2|||
19486230|NCT01494038|41771050|FG001|Overall Study|Death|4|||
19486231|NCT02640612|41771087|FG000|Overall Study|Adverse Event|6|||
19486232|NCT02640612|41771088|FG001|Overall Study|Adverse Event|7|||
19486233|NCT02640612|41771089|FG002|Overall Study|Adverse Event|2|||
19486234|NCT02640612|41771087|FG000|Overall Study|Death|1|||
19486235|NCT02640612|41771088|FG001|Overall Study|Death|0|||
19486236|NCT02640612|41771089|FG002|Overall Study|Death|0|||
19486237|NCT02640612|41771087|FG000|Overall Study|Withdrawal by Subject|10|||
19486238|NCT02640612|41771088|FG001|Overall Study|Withdrawal by Subject|3|||
19486239|NCT02640612|41771089|FG002|Overall Study|Withdrawal by Subject|3|||
19486240|NCT02640612|41771087|FG000|Overall Study|Lost to Follow-up|4|||
19486241|NCT02640612|41771088|FG001|Overall Study|Lost to Follow-up|1|||
19486242|NCT02640612|41771089|FG002|Overall Study|Lost to Follow-up|1|||
19486243|NCT02640612|41771087|FG000|Overall Study|Protocol Violation|0|||
19486244|NCT02640612|41771088|FG001|Overall Study|Protocol Violation|2|||
19486245|NCT02640612|41771089|FG002|Overall Study|Protocol Violation|0|||
19486246|NCT02640612|41771087|FG000|Overall Study|Lack of Efficacy|1|||
19486247|NCT02640612|41771088|FG001|Overall Study|Lack of Efficacy|1|||
19486248|NCT02640612|41771089|FG002|Overall Study|Lack of Efficacy|0|||
19486249|NCT00639769|41771097|FG000|Overall Study|Death|2|||
19486250|NCT00639769|41771097|FG000|Overall Study|Adverse Event|7|||
19486251|NCT00639769|41771097|FG000|Overall Study|Lack of Efficacy|1|||
19486252|NCT00639769|41771097|FG000|Overall Study|Disease progression|26|||
19486253|NCT00639769|41771097|FG000|Overall Study|Withdrawal by Subject|4|||
19486254|NCT00639457|41771103|FG000|Overall Study|Withdrawal by Subject|2|||
19486255|NCT00639457|41771104|FG001|Overall Study|Withdrawal by Subject|3|||
19486256|NCT00639379|41771110|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
19486257|NCT00639379|41771111|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
19486258|NCT00639379|41771110|FG000|Period 1 - 2 Weeks|lens issue|3|||
19486259|NCT00639379|41771111|FG001|Period 1 - 2 Weeks|lens issue|0|||
19486260|NCT00639223|41771119|FG000|Overall Study|Lost to Follow-up|0|||
19486261|NCT00639223|41771120|FG001|Overall Study|Lost to Follow-up|2|||
19486262|NCT00638989|41771129|FG000|Overall Study|Lost to Follow-up|0|||
19486263|NCT00638989|41771130|FG001|Overall Study|Lost to Follow-up|0|||
19486264|NCT00638989|41771131|FG002|Overall Study|Lost to Follow-up|1|||
19486265|NCT00637273|41771152|FG000|Overall Study|Adverse Event|11|||
19486266|NCT00637273|41771153|FG001|Overall Study|Adverse Event|5|||
19486267|NCT00637273|41771154|FG002|Overall Study|Adverse Event|7|||
19486268|NCT00637273|41771152|FG000|Overall Study|Lost to Follow-up|8|||
19486269|NCT00637273|41771153|FG001|Overall Study|Lost to Follow-up|9|||
19486270|NCT00637273|41771154|FG002|Overall Study|Lost to Follow-up|13|||
19486271|NCT00637273|41771152|FG000|Overall Study|Protocol Violation|2|||
19486272|NCT00637273|41771153|FG001|Overall Study|Protocol Violation|4|||
19486273|NCT00637273|41771154|FG002|Overall Study|Protocol Violation|1|||
19486274|NCT00637273|41771152|FG000|Overall Study|Withdrawal of Consent|18|||
19486275|NCT00637273|41771153|FG001|Overall Study|Withdrawal of Consent|6|||
19486276|NCT00637273|41771154|FG002|Overall Study|Withdrawal of Consent|18|||
19486277|NCT00637273|41771152|FG000|Overall Study|Investigator Decision|1|||
19486278|NCT00637273|41771153|FG001|Overall Study|Investigator Decision|3|||
19486279|NCT00637273|41771154|FG002|Overall Study|Investigator Decision|1|||
19486280|NCT00637273|41771152|FG000|Overall Study|Administrative|2|||
19486281|NCT00637273|41771153|FG001|Overall Study|Administrative|0|||
19486282|NCT00637273|41771154|FG002|Overall Study|Administrative|0|||
19486283|NCT00637273|41771152|FG000|Overall Study|Loss of Glucose Control|1|||
19486284|NCT00637273|41771153|FG001|Overall Study|Loss of Glucose Control|1|||
19486285|NCT00637273|41771154|FG002|Overall Study|Loss of Glucose Control|1|||
19486286|NCT00988351|41771164|FG000|Overall Study|Withdrawal by Subject|8|||
19486287|NCT00988351|41771165|FG001|Overall Study|Withdrawal by Subject|0|||
19486288|NCT00988351|41771164|FG000|Overall Study|Lost to Follow-up|6|||
19486289|NCT00988351|41771165|FG001|Overall Study|Lost to Follow-up|9|||
19486290|NCT00988351|41771164|FG000|Overall Study|not using CPAP|5|||
19486291|NCT00988351|41771165|FG001|Overall Study|not using CPAP|3|||
19486292|NCT00988117|41771171|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
19486293|NCT00988117|41771171|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
19486294|NCT00637195|41771178|FG000|Overall Study|Lost to Follow-up|1|||
19486295|NCT00637195|41771179|FG001|Overall Study|Lost to Follow-up|0|||
19486296|NCT00637195|41771178|FG000|Overall Study|Other|2|||
19486297|NCT00637195|41771179|FG001|Overall Study|Other|0|||
19486298|NCT00637195|41771178|FG000|Overall Study|Withdrawal by Subject|0|||
19486299|NCT00637195|41771179|FG001|Overall Study|Withdrawal by Subject|1|||
19486300|NCT00636961|41771197|FG000|Period 1|Administrative problems|1|||
19486301|NCT00636961|41771198|FG001|Period 1|Administrative problems|1|||
19486302|NCT00636961|41771197|FG000|Period 2|Adverse Event|1|||
19486303|NCT00636961|41771198|FG001|Period 2|Adverse Event|0|||
19486304|NCT00635089|41771213|FG000|Overall Study|Adverse Event|7|||
19486305|NCT00635089|41771213|FG000|Overall Study|Lack of Efficacy|28|||
19486306|NCT00635089|41771213|FG000|Overall Study|Protocol Deviation|4|||
19486307|NCT00635089|41771213|FG000|Overall Study|Lost to Follow-up|8|||
19486308|NCT00635089|41771213|FG000|Overall Study|Other|31|||
19486309|NCT01493414|41771230|FG000|Overall Study|Adverse Event|405|||
19486310|NCT01493414|41771230|FG000|Overall Study|Disease progression|204|||
19486311|NCT01493414|41771230|FG000|Overall Study|Death|101|||
19486312|NCT01493414|41771230|FG000|Overall Study|Physician Decision|93|||
19486313|NCT01493414|41771230|FG000|Overall Study|Withdrawal by Subject|79|||
19486314|NCT01493414|41771230|FG000|Overall Study|Protocol deviation|27|||
19486315|NCT01493414|41771230|FG000|Overall Study|Administrative problems|25|||
19486316|NCT01493414|41771230|FG000|Overall Study|Lost to Follow-up|16|||
19486317|NCT00634543|41771240|FG000|Overall Study|Other|1|||
19486318|NCT00634543|41771241|FG001|Overall Study|Other|2|||
19486319|NCT00634543|41771240|FG000|Overall Study|Protocol Violation|3|||
19486320|NCT00634543|41771241|FG001|Overall Study|Protocol Violation|3|||
19486321|NCT00634543|41771240|FG000|Overall Study|Adverse Event|11|||
19486322|NCT00634543|41771241|FG001|Overall Study|Adverse Event|11|||
19486323|NCT00634543|41771240|FG000|Overall Study|Withdrawal by Subject|4|||
19486324|NCT00634543|41771241|FG001|Overall Study|Withdrawal by Subject|4|||
19486325|NCT00634543|41771240|FG000|Overall Study|Lost to Follow-up|0|||
19486326|NCT00634543|41771241|FG001|Overall Study|Lost to Follow-up|1|||
19486327|NCT00985465|41771249|FG000|Overall Study|Withdrawal by Subject|1|||
19486328|NCT00985465|41771250|FG001|Overall Study|Withdrawal by Subject|2|||
19486329|NCT00985465|41771249|FG000|Overall Study|Considered to be part of the other group|0|||
19486330|NCT00985465|41771250|FG001|Overall Study|Considered to be part of the other group|1|||
19486331|NCT01049919|41771259|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
19486332|NCT01049919|41771260|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
19486333|NCT01049919|41771259|FG000|Overall Study|Withdrawal by Subject|5|||
19704201|NCT00256698|42148491|FG001|Overall Study|disease progression|105|||
19486334|NCT01049919|41771260|FG001|Overall Study|Withdrawal by Subject|0|||
19486335|NCT01049919|41771259|FG000|Overall Study|Lost to Follow-up|6|||
19486336|NCT01049919|41771260|FG001|Overall Study|Lost to Follow-up|1|||
19486337|NCT01049919|41771259|FG000|Overall Study|Physician Decision|2|||
19486338|NCT01049919|41771260|FG001|Overall Study|Physician Decision|0|||
19486339|NCT01049919|41771259|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
19486340|NCT01049919|41771260|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
19486341|NCT01049919|41771259|FG000|Overall Study|Early study termination by sponsor.|2|||
19486342|NCT01049919|41771260|FG001|Overall Study|Early study termination by sponsor.|0|||
19486343|NCT01049373|41771268|FG000|Overall Study|Protocol Violation|9|||
19486344|NCT01049373|41771269|FG001|Overall Study|Protocol Violation|9|||
19486345|NCT01049373|41771268|FG000|Overall Study|Withdrawal by Subject|8|||
19486346|NCT01049373|41771269|FG001|Overall Study|Withdrawal by Subject|5|||
19486347|NCT01049373|41771268|FG000|Overall Study|Adverse Event|3|||
19486348|NCT01049373|41771269|FG001|Overall Study|Adverse Event|3|||
19486349|NCT01049373|41771268|FG000|Overall Study|Lost to Follow-up|9|||
19486350|NCT01049373|41771269|FG001|Overall Study|Lost to Follow-up|4|||
19486351|NCT01049373|41771268|FG000|Overall Study|no evaluable study values|9|||
19486352|NCT01049373|41771269|FG001|Overall Study|no evaluable study values|21|||
19486353|NCT01049373|41771268|FG000|Overall Study|Other|1|||
19486354|NCT01049373|41771269|FG001|Overall Study|Other|1|||
19486355|NCT01049373|41771268|FG000|Overall Study|Non-cooperation|0|||
19486356|NCT01049373|41771269|FG001|Overall Study|Non-cooperation|1|||
19486357|NCT00985231|41771279|FG000|Overall Study|ineligible|1|||
19486358|NCT00985231|41771280|FG001|Overall Study|ineligible|0|||
19486359|NCT00985231|41771279|FG000|Overall Study|Protocol Violation|1|||
19486360|NCT00985231|41771280|FG001|Overall Study|Protocol Violation|0|||
19486361|NCT00985231|41771279|FG000|Overall Study|Withdrawal by Subject|1|||
19486362|NCT00985231|41771280|FG001|Overall Study|Withdrawal by Subject|0|||
19486363|NCT00985231|41771279|FG000|Overall Study|Lost to Follow-up|0|||
19486364|NCT00985231|41771280|FG001|Overall Study|Lost to Follow-up|1|||
19486365|NCT00985231|41771279|FG000|Overall Study|Study related symptoms & complaints|0|||
19486366|NCT00985231|41771280|FG001|Overall Study|Study related symptoms & complaints|2|||
19486367|NCT01048671|41771300|FG000|Overall Study|Protocol Violation|0|||
19486368|NCT01048671|41771301|FG001|Overall Study|Protocol Violation|1|||
19486369|NCT01048671|41771302|FG002|Overall Study|Protocol Violation|1|||
19486370|NCT01360866|41771314|FG000|Overall Study|Lost to Follow-up|11|||
19486371|NCT01360866|41771315|FG001|Overall Study|Lost to Follow-up|28|||
19486372|NCT01360866|41771316|FG002|Overall Study|Lost to Follow-up|41|||
19486373|NCT01360866|41771317|FG003|Overall Study|Lost to Follow-up|0|||
19486374|NCT01360866|41771314|FG000|Overall Study|Adverse Event|56|||
19486375|NCT01360866|41771315|FG001|Overall Study|Adverse Event|61|||
19486376|NCT01360866|41771316|FG002|Overall Study|Adverse Event|134|||
19486377|NCT01360866|41771317|FG003|Overall Study|Adverse Event|6|||
19486378|NCT01360866|41771314|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
19486379|NCT01360866|41771315|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
19486380|NCT01360866|41771316|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
19486381|NCT01360866|41771317|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
19486382|NCT01360866|41771314|FG000|Overall Study|Withdrawn by Investigator|9|||
19486383|NCT01360866|41771315|FG001|Overall Study|Withdrawn by Investigator|8|||
19486384|NCT01360866|41771316|FG002|Overall Study|Withdrawn by Investigator|31|||
19486385|NCT01360866|41771317|FG003|Overall Study|Withdrawn by Investigator|2|||
19486386|NCT01360866|41771314|FG000|Overall Study|Withdrawal by participant|79|||
19486387|NCT01360866|41771315|FG001|Overall Study|Withdrawal by participant|89|||
19486388|NCT01360866|41771316|FG002|Overall Study|Withdrawal by participant|168|||
19486389|NCT01360866|41771317|FG003|Overall Study|Withdrawal by participant|8|||
19486390|NCT01360866|41771314|FG000|Overall Study|Protocol Deviation|25|||
19486391|NCT01360866|41771315|FG001|Overall Study|Protocol Deviation|33|||
19486392|NCT01360866|41771316|FG002|Overall Study|Protocol Deviation|61|||
19486393|NCT01360866|41771317|FG003|Overall Study|Protocol Deviation|2|||
19486394|NCT01360866|41771314|FG000|Overall Study|Lack of Efficacy|30|||
19486395|NCT01360866|41771315|FG001|Overall Study|Lack of Efficacy|40|||
19486396|NCT01360866|41771316|FG002|Overall Study|Lack of Efficacy|30|||
19486397|NCT01360866|41771317|FG003|Overall Study|Lack of Efficacy|4|||
19486398|NCT00985153|41771331|FG000|Overall Study|Lost to Follow-up|16|||
19704202|NCT00256698|42148490|FG000|Overall Study|still ongoing at data cut-off|41|||
19486399|NCT00985153|41771332|FG001|Overall Study|Lost to Follow-up|19|||
19486400|NCT00985153|41771333|FG002|Overall Study|Lost to Follow-up|17|||
19486401|NCT00985153|41771334|FG003|Overall Study|Lost to Follow-up|20|||
19486402|NCT00985153|41771331|FG000|Overall Study|Protocol Violation|3|||
19486403|NCT00985153|41771332|FG001|Overall Study|Protocol Violation|2|||
19486404|NCT00985153|41771333|FG002|Overall Study|Protocol Violation|4|||
19486405|NCT00985153|41771334|FG003|Overall Study|Protocol Violation|3|||
19486406|NCT00985153|41771331|FG000|Overall Study|Withdrawal by Subject|6|||
19486407|NCT00985153|41771332|FG001|Overall Study|Withdrawal by Subject|11|||
19486408|NCT00985153|41771333|FG002|Overall Study|Withdrawal by Subject|11|||
19486409|NCT00985153|41771334|FG003|Overall Study|Withdrawal by Subject|10|||
19486410|NCT00985153|41771331|FG000|Overall Study|Missed One or More Bleeds|7|||
19486411|NCT00985153|41771332|FG001|Overall Study|Missed One or More Bleeds|7|||
19486412|NCT00985153|41771333|FG002|Overall Study|Missed One or More Bleeds|8|||
19486413|NCT00985153|41771334|FG003|Overall Study|Missed One or More Bleeds|10|||
19486414|NCT00985153|41771331|FG000|Overall Study|Incomplete Safety Follow-up|3|||
19486415|NCT00985153|41771332|FG001|Overall Study|Incomplete Safety Follow-up|5|||
19486416|NCT00985153|41771333|FG002|Overall Study|Incomplete Safety Follow-up|4|||
19486417|NCT00985153|41771334|FG003|Overall Study|Incomplete Safety Follow-up|4|||
19486418|NCT01047345|41771346|FG000|Base Study|Adverse Event|3|||
19486419|NCT01047345|41771347|FG001|Base Study|Adverse Event|0|||
19486420|NCT01047345|41771348|FG002|Base Study|Adverse Event|0|||
19486421|NCT01047345|41771346|FG000|Base Study|Lost to Follow-up|4|||
19486422|NCT01047345|41771347|FG001|Base Study|Lost to Follow-up|1|||
19486423|NCT01047345|41771348|FG002|Base Study|Lost to Follow-up|0|||
19486424|NCT01047345|41771346|FG000|Base Study|Protocol Violation|3|||
19486425|NCT01047345|41771347|FG001|Base Study|Protocol Violation|1|||
19486426|NCT01047345|41771348|FG002|Base Study|Protocol Violation|0|||
19486427|NCT01047345|41771346|FG000|Base Study|Withdrawal by Subject|12|||
19486428|NCT01047345|41771347|FG001|Base Study|Withdrawal by Subject|4|||
19486429|NCT01047345|41771348|FG002|Base Study|Withdrawal by Subject|0|||
19486430|NCT01047345|41771346|FG000|Extension|Withdrawal by Subject|0|||
19486431|NCT01047345|41771347|FG001|Extension|Withdrawal by Subject|0|||
19486432|NCT01047345|41771348|FG002|Extension|Withdrawal by Subject|1|||
19486433|NCT01047345|41771346|FG000|Extension|Lost to Follow-up|0|||
19486434|NCT01047345|41771347|FG001|Extension|Lost to Follow-up|0|||
19486435|NCT01047345|41771348|FG002|Extension|Lost to Follow-up|5|||
19486436|NCT01046877|41771356|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
19486437|NCT01046877|41771356|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
19486438|NCT00984061|41771360|FG000|Clarithromycin Alone|Protocol Violation|1|||
19486439|NCT01046643|41771369|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
19486440|NCT01046643|41771370|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
19486441|NCT01046643|41771371|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
19486442|NCT01046643|41771372|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
19486443|NCT00983905|41771382|FG000|Theophylline Alone|Adverse Event|1|||
19486444|NCT00983905|41771382|FG000|Colchicine Alone|Adverse Event|2|||
19486445|NCT01046565|41771389|FG000|Overall Study|Adverse Event|2|||
19486446|NCT01046565|41771389|FG000|Overall Study|Withdrawal by Subject|7|||
19486447|NCT00983827|41771398|FG000|Overall Study|Withdrawal by Subject|1|||
19486448|NCT00983749|41771404|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
19486449|NCT00983749|41771405|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
19486450|NCT01046253|41771413|FG000|Second Intervention|Adverse Event|0|||
19486451|NCT01046253|41771414|FG001|Second Intervention|Adverse Event|1|||
19486452|NCT01046253|41771413|FG000|Second Intervention|Protocol Violation|0|||
19486453|NCT01046253|41771414|FG001|Second Intervention|Protocol Violation|1|||
19486454|NCT00983515|41771420|FG000|Ritonavir Alone|liver panel out of range|6|||
19486455|NCT00983515|41771420|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
19486456|NCT00982735|41771427|FG000|Overall Study|Lost to Follow-up|6|||
19486457|NCT00982735|41771427|FG000|Overall Study|Patient ineligible for trial|224|||
19486458|NCT01361178|41771433|FG000|Overall Study|Death|13|||
19486459|NCT01361178|41771434|FG001|Overall Study|Death|0|||
19486460|NCT00981799|41771444|FG000|Overall Study|Adverse Event|1|||
19486461|NCT00981799|41771445|FG001|Overall Study|Adverse Event|1|||
19486462|NCT00981799|41771446|FG002|Overall Study|Adverse Event|0|||
19486463|NCT00981799|41771447|FG003|Overall Study|Adverse Event|0|||
19486464|NCT00981175|41771461|FG000|Primary Dose Vaccination|Adverse Event|1|||
19486465|NCT00981175|41771462|FG001|Primary Dose Vaccination|Adverse Event|0|||
19486466|NCT00981175|41771461|FG000|Primary Dose Vaccination|Protocol Violation|0|||
19486467|NCT00981175|41771462|FG001|Primary Dose Vaccination|Protocol Violation|1|||
19486468|NCT00981175|41771461|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
19486469|NCT00981175|41771462|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
19486470|NCT00981175|41771461|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
19486471|NCT00981175|41771462|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
19486472|NCT00981019|41771475|FG000|Overall Study|Did not respond|65|||
19486473|NCT00981019|41771475|FG000|Overall Study|Did not match target population|94|||
19704203|NCT00256698|42148491|FG001|Overall Study|still ongoing at data cut-off|46|||
19704204|NCT00256698|42148490|FG000|Overall Study|withdrawn due to osteoporosis|1|||
19486474|NCT00981019|41771475|FG000|Overall Study|Inadvertent exclusion|239|||
19486475|NCT00981019|41771475|FG000|Overall Study|Hit the survey after closure|79|||
19486476|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
19486477|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
19486478|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
19486479|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
19486480|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
19486481|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
19486482|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
19486483|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
19486484|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
19486485|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
19486486|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
19486487|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
19486488|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
19486489|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
19486490|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
19486491|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
19486492|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
19486493|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
19486494|NCT01045161|41771482|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
19486495|NCT01045161|41771483|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
19486496|NCT01045161|41771484|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
19486497|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
19486498|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
19486499|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
19486500|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
19486501|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
19486502|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
19486503|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
19486504|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
19486505|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
19486506|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
19486507|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
19486508|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
19486509|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
19486510|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
19486511|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
19486512|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
19486513|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
19486514|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
19486515|NCT01045161|41771482|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
19486516|NCT01045161|41771483|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
19486517|NCT01045161|41771484|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
19486518|NCT00633217|41771503|FG000|Overall Study|Adverse Event|5|||
19486519|NCT00633217|41771504|FG001|Overall Study|Adverse Event|9|||
19486520|NCT00633217|41771503|FG000|Overall Study|Lack of Efficacy|0|||
19486521|NCT00633217|41771504|FG001|Overall Study|Lack of Efficacy|2|||
19486522|NCT00633217|41771503|FG000|Overall Study|Protocol Violation|3|||
19486523|NCT00633217|41771504|FG001|Overall Study|Protocol Violation|7|||
19486524|NCT00633217|41771503|FG000|Overall Study|Lost to Follow-up|2|||
19486525|NCT00633217|41771504|FG001|Overall Study|Lost to Follow-up|2|||
19486526|NCT00633217|41771503|FG000|Overall Study|Investigator Discretion|2|||
19486527|NCT00633217|41771504|FG001|Overall Study|Investigator Discretion|0|||
19486528|NCT00633217|41771503|FG000|Overall Study|Withdrew Consent|3|||
19486529|NCT00633217|41771504|FG001|Overall Study|Withdrew Consent|3|||
19486530|NCT01673490|41771510|FG000|Overall Study|Lost to Follow-up|1|||
19486531|NCT01673490|41771510|FG000|Overall Study|Adverse Event|3|||
19486532|NCT01673490|41771510|FG000|Overall Study|Withdrawal by Subject|3|||
19486533|NCT00215657|41771522|FG000|Overall Study|Adverse Event|5|||
19486534|NCT00215657|41771523|FG001|Overall Study|Adverse Event|1|||
19486535|NCT00215657|41771524|FG002|Overall Study|Adverse Event|3|||
19486536|NCT00215657|41771525|FG003|Overall Study|Adverse Event|0|||
19486537|NCT00215657|41771526|FG004|Overall Study|Adverse Event|3|||
19486538|NCT00215657|41771527|FG005|Overall Study|Adverse Event|1|||
19486539|NCT00215657|41771528|FG006|Overall Study|Adverse Event|0|||
19486540|NCT00215657|41771529|FG007|Overall Study|Adverse Event|3|||
19486541|NCT00215657|41771522|FG000|Overall Study|Withdrawal by Subject|6|||
19486542|NCT00215657|41771523|FG001|Overall Study|Withdrawal by Subject|3|||
19486543|NCT00215657|41771524|FG002|Overall Study|Withdrawal by Subject|3|||
19486544|NCT00215657|41771525|FG003|Overall Study|Withdrawal by Subject|1|||
19486545|NCT00215657|41771526|FG004|Overall Study|Withdrawal by Subject|6|||
19486546|NCT00215657|41771527|FG005|Overall Study|Withdrawal by Subject|1|||
19486547|NCT00215657|41771528|FG006|Overall Study|Withdrawal by Subject|10|||
19486548|NCT00215657|41771529|FG007|Overall Study|Withdrawal by Subject|3|||
19486549|NCT00215657|41771522|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
19486550|NCT00215657|41771523|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
19486551|NCT00215657|41771524|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
19486552|NCT00215657|41771525|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
19486553|NCT00215657|41771526|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
19486554|NCT00215657|41771527|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
19486555|NCT00215657|41771528|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
19486556|NCT00215657|41771529|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
19486557|NCT00215657|41771522|FG000|Overall Study|Insufficient testosterone response|5|||
19486558|NCT00215657|41771523|FG001|Overall Study|Insufficient testosterone response|4|||
19486559|NCT00215657|41771524|FG002|Overall Study|Insufficient testosterone response|1|||
19486560|NCT00215657|41771525|FG003|Overall Study|Insufficient testosterone response|12|||
19486561|NCT00215657|41771526|FG004|Overall Study|Insufficient testosterone response|8|||
19486562|NCT00215657|41771527|FG005|Overall Study|Insufficient testosterone response|12|||
19486563|NCT00215657|41771528|FG006|Overall Study|Insufficient testosterone response|4|||
19486564|NCT00215657|41771529|FG007|Overall Study|Insufficient testosterone response|7|||
19486565|NCT00215657|41771522|FG000|Overall Study|Other|3|||
19486566|NCT00215657|41771523|FG001|Overall Study|Other|1|||
19486567|NCT00215657|41771524|FG002|Overall Study|Other|2|||
19486568|NCT00215657|41771525|FG003|Overall Study|Other|3|||
19486569|NCT00215657|41771526|FG004|Overall Study|Other|5|||
19486570|NCT00215657|41771527|FG005|Overall Study|Other|4|||
19486571|NCT00215657|41771528|FG006|Overall Study|Other|6|||
19486572|NCT00215657|41771529|FG007|Overall Study|Other|1|||
19486573|NCT00633061|41771549|FG000|Overall Study|Study closed|86|||
19486574|NCT00633061|41771550|FG001|Overall Study|Study closed|0|||
19486575|NCT00632827|41771558|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
19486576|NCT00632827|41771558|FG000|Overall Study|Death|2|||
19486577|NCT00632827|41771558|FG000|Overall Study|Adverse Event|5|||
19486578|NCT00632827|41771558|FG000|Overall Study|Lost to Follow-up|1|||
19486579|NCT00214019|41771563|FG000|Overall Study|Lost to Follow-up|11|||
19486580|NCT00214019|41771563|FG000|Overall Study|Withdrawal by Subject|2|||
19486581|NCT00214019|41771563|FG000|Overall Study|Screen Failed prior to randomization|17|||
19486582|NCT00210119|41771570|FG000|Overall Study|Protocol Violation|1|||
19486583|NCT00210119|41771570|FG000|Overall Study|Withdrawal by Subject|1|||
19486584|NCT01044459|41771576|FG000|Overall Study|Withdrawal by Subject|21|||
19486585|NCT01044459|41771577|FG001|Overall Study|Withdrawal by Subject|28|||
19486586|NCT01044459|41771576|FG000|Overall Study|Terminated by Sponsor|22|||
19486587|NCT01044459|41771577|FG001|Overall Study|Terminated by Sponsor|21|||
19486588|NCT01044459|41771576|FG000|Overall Study|Adverse Event|22|||
19486589|NCT01044459|41771577|FG001|Overall Study|Adverse Event|20|||
19486590|NCT01044459|41771576|FG000|Overall Study|Lack of Efficacy|23|||
19486591|NCT01044459|41771577|FG001|Overall Study|Lack of Efficacy|12|||
19486592|NCT01044459|41771576|FG000|Overall Study|Protocol Violation|11|||
19486593|NCT01044459|41771577|FG001|Overall Study|Protocol Violation|16|||
19486594|NCT01044459|41771576|FG000|Overall Study|Other Reason|7|||
19486595|NCT01044459|41771577|FG001|Overall Study|Other Reason|14|||
19486596|NCT01044459|41771576|FG000|Overall Study|COPD exacerbation|9|||
19486597|NCT01044459|41771577|FG001|Overall Study|COPD exacerbation|8|||
19486598|NCT01044459|41771576|FG000|Overall Study|Lost to Follow-up|18|||
19486599|NCT01044459|41771577|FG001|Overall Study|Lost to Follow-up|12|||
19486600|NCT00980005|41771585|FG000|Overall Study|Withdrawal by Subject|6|||
19486601|NCT00980005|41771586|FG001|Overall Study|Withdrawal by Subject|17|||
19486602|NCT00980005|41771585|FG000|Overall Study|Lost to Follow-up|37|||
19486603|NCT00980005|41771586|FG001|Overall Study|Lost to Follow-up|43|||
19486604|NCT00980005|41771585|FG000|Overall Study|Other|4|||
19486605|NCT00980005|41771586|FG001|Overall Study|Other|3|||
19486606|NCT01044303|41771596|FG000|Overall Study|Lost to Follow-up|2|||
19486607|NCT00983437|41771603|FG000|Overall Study|Adverse Event|9|||
19486608|NCT00983437|41771603|FG000|Overall Study|Lack of Efficacy|1|||
19486609|NCT00983437|41771603|FG000|Overall Study|Withdrawal by Subject|8|||
19486610|NCT00983437|41771603|FG000|Overall Study|Noncompliance to Study Procedures|1|||
19486611|NCT00983437|41771603|FG000|Overall Study|Lost to Follow-up|2|||
19486612|NCT00983437|41771603|FG000|Overall Study|Other Reason|26|||
19486613|NCT01042977|41771609|FG000|Overall Study|Adverse Event|4|||
19486614|NCT01042977|41771610|FG001|Overall Study|Adverse Event|12|||
19486615|NCT01042977|41771609|FG000|Overall Study|Death|2|||
19486616|NCT01042977|41771610|FG001|Overall Study|Death|1|||
19486617|NCT01042977|41771609|FG000|Overall Study|Withdrawal by Subject|8|||
19486618|NCT01042977|41771610|FG001|Overall Study|Withdrawal by Subject|16|||
19486619|NCT01042977|41771609|FG000|Overall Study|Lost to Follow-up|0|||
19486620|NCT01042977|41771610|FG001|Overall Study|Lost to Follow-up|2|||
19486621|NCT01042977|41771609|FG000|Overall Study|Poor/non-compliance|3|||
19486622|NCT01042977|41771610|FG001|Overall Study|Poor/non-compliance|4|||
19486623|NCT01042977|41771609|FG000|Overall Study|Subject no longer meets study criteria|15|||
19486624|NCT01042977|41771610|FG001|Overall Study|Subject no longer meets study criteria|13|||
19486625|NCT01042977|41771609|FG000|Overall Study|Incorrect enrollment|6|||
19486626|NCT01042977|41771610|FG001|Overall Study|Incorrect enrollment|4|||
19486627|NCT01042977|41771609|FG000|Overall Study|Safety|0|||
19486628|NCT01042977|41771610|FG001|Overall Study|Safety|2|||
19486629|NCT01042977|41771609|FG000|Overall Study|Administrative reason by sponsor|0|||
19486630|NCT01042977|41771610|FG001|Overall Study|Administrative reason by sponsor|1|||
19486631|NCT01042977|41771609|FG000|Overall Study|Various|3|||
19486632|NCT01042977|41771610|FG001|Overall Study|Various|0|||
19486633|NCT01041573|41771620|FG000|Overall Study|Withdrawal by Subject|2|||
19486634|NCT01041573|41771621|FG001|Overall Study|Withdrawal by Subject|5|||
19486635|NCT01041573|41771622|FG002|Overall Study|Withdrawal by Subject|2|||
19486636|NCT01041573|41771623|FG003|Overall Study|Withdrawal by Subject|0|||
19486637|NCT01041573|41771620|FG000|Overall Study|Death|1|||
19486638|NCT01041573|41771621|FG001|Overall Study|Death|0|||
19486639|NCT01041573|41771622|FG002|Overall Study|Death|0|||
19486640|NCT01041573|41771623|FG003|Overall Study|Death|0|||
19486641|NCT01041573|41771620|FG000|Overall Study|Lost to Follow-up|0|||
19486642|NCT01041573|41771621|FG001|Overall Study|Lost to Follow-up|1|||
19486643|NCT01041573|41771622|FG002|Overall Study|Lost to Follow-up|2|||
19486644|NCT01041573|41771623|FG003|Overall Study|Lost to Follow-up|1|||
19486645|NCT01041573|41771620|FG000|Overall Study|Adverse Event|0|||
19486646|NCT01041573|41771621|FG001|Overall Study|Adverse Event|2|||
19486647|NCT01041573|41771622|FG002|Overall Study|Adverse Event|0|||
19486648|NCT01041573|41771623|FG003|Overall Study|Adverse Event|0|||
19486649|NCT01041573|41771620|FG000|Overall Study|relocation|1|||
19486650|NCT01041573|41771621|FG001|Overall Study|relocation|4|||
19486651|NCT01041573|41771622|FG002|Overall Study|relocation|3|||
19486652|NCT01041573|41771623|FG003|Overall Study|relocation|1|||
19486653|NCT01041573|41771620|FG000|Overall Study|further blood extraction|0|||
19486654|NCT01041573|41771621|FG001|Overall Study|further blood extraction|1|||
19486655|NCT01041573|41771622|FG002|Overall Study|further blood extraction|0|||
19486656|NCT01041573|41771623|FG003|Overall Study|further blood extraction|0|||
19486657|NCT01041573|41771620|FG000|Overall Study|positive to anti-HCV|1|||
19486658|NCT01041573|41771621|FG001|Overall Study|positive to anti-HCV|0|||
19486659|NCT01041573|41771622|FG002|Overall Study|positive to anti-HCV|0|||
19486660|NCT01041573|41771623|FG003|Overall Study|positive to anti-HCV|0|||
19486661|NCT01041495|41771650|FG000|Overall Study|Withdrawal by Subject|2|||
19486662|NCT01041495|41771651|FG001|Overall Study|Withdrawal by Subject|5|||
19486663|NCT01041495|41771650|FG000|Overall Study|Adverse Event|2|||
19486664|NCT01041495|41771651|FG001|Overall Study|Adverse Event|1|||
19486665|NCT01041495|41771650|FG000|Overall Study|Lost to Follow-up|0|||
19486666|NCT01041495|41771651|FG001|Overall Study|Lost to Follow-up|1|||
19486667|NCT01041417|41771659|FG000|Overall Study|Adverse Event|5|||
19486668|NCT01041417|41771660|FG001|Overall Study|Adverse Event|2|||
19486669|NCT01041417|41771659|FG000|Overall Study|Lost to Follow-up|1|||
19486670|NCT01041417|41771660|FG001|Overall Study|Lost to Follow-up|1|||
19486671|NCT01041417|41771659|FG000|Overall Study|Death|1|||
19486672|NCT01041417|41771660|FG001|Overall Study|Death|0|||
19486673|NCT01040871|41771670|FG000|Overall Study|Adverse Event|6|||
19486674|NCT01040871|41771671|FG001|Overall Study|Adverse Event|2|||
19486675|NCT01040871|41771670|FG000|Overall Study|Withdrawal by Subject|2|||
19486676|NCT01040871|41771671|FG001|Overall Study|Withdrawal by Subject|0|||
19486677|NCT01040871|41771670|FG000|Overall Study|Death|1|||
19486678|NCT01040871|41771671|FG001|Overall Study|Death|3|||
19486679|NCT01040871|41771670|FG000|Overall Study|Lack of Efficacy|1|||
19486680|NCT01040871|41771671|FG001|Overall Study|Lack of Efficacy|1|||
19486681|NCT01040871|41771670|FG000|Overall Study|drug supply issue|1|||
19486682|NCT01040871|41771671|FG001|Overall Study|drug supply issue|0|||
19486683|NCT01040871|41771670|FG000|Overall Study|Randomized and Not Treated|2|||
19486684|NCT01040871|41771671|FG001|Overall Study|Randomized and Not Treated|1|||
19486685|NCT01040169|41771679|FG000|Overall Study|Lost to Follow-up|3|||
19486686|NCT01040169|41771680|FG001|Overall Study|Lost to Follow-up|8|||
19486687|NCT01673178|41771700|FG000|Overall Study|Lost to Follow-up|0|||
19486688|NCT01673178|41771701|FG001|Overall Study|Lost to Follow-up|1|||
19486689|NCT01673178|41771702|FG002|Overall Study|Lost to Follow-up|0|||
19486690|NCT01673178|41771703|FG003|Overall Study|Lost to Follow-up|0|||
19486691|NCT01673178|41771704|FG004|Overall Study|Lost to Follow-up|0|||
19486692|NCT01673178|41771700|FG000|Overall Study|Withdrawal by Subject|0|||
19486693|NCT01673178|41771701|FG001|Overall Study|Withdrawal by Subject|0|||
19486694|NCT01673178|41771702|FG002|Overall Study|Withdrawal by Subject|1|||
19486695|NCT01673178|41771703|FG003|Overall Study|Withdrawal by Subject|4|||
19486696|NCT01673178|41771704|FG004|Overall Study|Withdrawal by Subject|2|||
19486697|NCT01673178|41771700|FG000|Overall Study|Protocol Violation|1|||
19486698|NCT01673178|41771701|FG001|Overall Study|Protocol Violation|1|||
19486699|NCT01673178|41771702|FG002|Overall Study|Protocol Violation|0|||
19486700|NCT01673178|41771703|FG003|Overall Study|Protocol Violation|1|||
19486701|NCT01673178|41771704|FG004|Overall Study|Protocol Violation|0|||
19486702|NCT01673178|41771700|FG000|Overall Study|Adverse Event|1|||
19486703|NCT01673178|41771701|FG001|Overall Study|Adverse Event|0|||
19486704|NCT01673178|41771702|FG002|Overall Study|Adverse Event|0|||
19486705|NCT01673178|41771703|FG003|Overall Study|Adverse Event|2|||
19486706|NCT01673178|41771704|FG004|Overall Study|Adverse Event|0|||
19486707|NCT01673178|41771700|FG000|Overall Study|Other|1|||
19486708|NCT01673178|41771701|FG001|Overall Study|Other|0|||
19486709|NCT01673178|41771702|FG002|Overall Study|Other|2|||
19486710|NCT01673178|41771703|FG003|Overall Study|Other|1|||
19486711|NCT01673178|41771704|FG004|Overall Study|Other|0|||
19486712|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
19486713|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
19486714|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
19486715|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
19486716|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
19486717|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
19486718|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
19486719|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
19486720|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
19486721|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
19486722|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
19486723|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
19486724|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
19486725|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
19486726|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
19486727|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
19486728|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
19486729|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
19486730|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
19486731|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
19486732|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
19486733|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
19486734|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
19486735|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
19486736|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
19486737|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
19486738|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
19486739|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
19486740|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
19486741|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
19486742|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
19486743|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
19486744|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
19486745|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
19486746|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
19486747|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
19486748|NCT03593213|41771733|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
19486749|NCT03593213|41771734|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
19486750|NCT03593213|41771735|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
19486751|NCT03593213|41771736|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
19486752|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
19612493|NCT00811395|42061343|FG001|Extension Treatment|Participant did not wish to continue|3|||
19612494|NCT00811395|42061344|FG002|Extension Treatment|Participant did not wish to continue|0|||
19612495|NCT00811395|42061345|FG003|Extension Treatment|Participant did not wish to continue|1|||
19612496|NCT00811395|42061346|FG004|Extension Treatment|Participant did not wish to continue|0|||
19612497|NCT00811395|42061347|FG005|Extension Treatment|Participant did not wish to continue|1|||
19612498|NCT00811395|42061342|FG000|Extension Treatment|Other than above|0|||
19612499|NCT00811395|42061343|FG001|Extension Treatment|Other than above|0|||
19612500|NCT00811395|42061344|FG002|Extension Treatment|Other than above|1|||
19612501|NCT00811395|42061345|FG003|Extension Treatment|Other than above|0|||
19612502|NCT00811395|42061346|FG004|Extension Treatment|Other than above|0|||
19612503|NCT00811395|42061347|FG005|Extension Treatment|Other than above|0|||
19612504|NCT00955409|42061374|FG000|Overall Study|Lack of Efficacy|1|||
19612505|NCT00955409|42061375|FG001|Overall Study|Lack of Efficacy|0|||
19612506|NCT00955409|42061376|FG002|Overall Study|Lack of Efficacy|0|||
19612507|NCT00955409|42061377|FG003|Overall Study|Lack of Efficacy|0|||
19612508|NCT00955409|42061378|FG004|Overall Study|Lack of Efficacy|0|||
19612509|NCT00955409|42061379|FG005|Overall Study|Lack of Efficacy|0|||
19612510|NCT00955409|42061380|FG006|Overall Study|Lack of Efficacy|0|||
19612511|NCT00955409|42061381|FG007|Overall Study|Lack of Efficacy|0|||
19612512|NCT00955409|42061382|FG008|Overall Study|Lack of Efficacy|0|||
19612513|NCT00955409|42061383|FG009|Overall Study|Lack of Efficacy|0|||
19612514|NCT00955409|42061374|FG000|Overall Study|Withdrawal by Subject|1|||
19612515|NCT00955409|42061375|FG001|Overall Study|Withdrawal by Subject|0|||
19612516|NCT00955409|42061376|FG002|Overall Study|Withdrawal by Subject|5|||
19612517|NCT00955409|42061377|FG003|Overall Study|Withdrawal by Subject|2|||
19486753|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
19486754|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
19486755|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
19486756|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
19486757|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
19486758|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
19486759|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
19486760|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
19486761|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
19486762|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
19486763|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
19486764|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
19486765|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
19486766|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
19486767|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
19486768|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
19486769|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
19486770|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
19486771|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
19486772|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
19486773|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
19486774|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
19486775|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
19486776|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
19486777|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
19486778|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
19486779|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
19486780|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
19486781|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
19486782|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
19486783|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
19486784|NCT03593213|41771733|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
19486785|NCT03593213|41771734|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
19486786|NCT03593213|41771735|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
19486787|NCT03593213|41771736|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
19486788|NCT00013611|41771780|FG000|Overall Study|Lost to Follow-up|91|||
19486789|NCT00013611|41771781|FG001|Overall Study|Lost to Follow-up|100|||
19486790|NCT00010257|41771789|FG000|Overall Study|Withdrawal by Subject|1|||
19486791|NCT00010257|41771790|FG001|Overall Study|Withdrawal by Subject|0|||
19486792|NCT00211757|41771828|FG000|Overall Study|Withdrawal by Subject|1|||
19486793|NCT00211757|41771829|FG001|Overall Study|Withdrawal by Subject|1|||
19486794|NCT00211757|41771828|FG000|Overall Study|Lack of Efficacy|0|||
19486795|NCT00211757|41771829|FG001|Overall Study|Lack of Efficacy|1|||
19486796|NCT02639052|41771846|FG000|Overall Study|Lost to Follow-up|1|||
19486797|NCT02635776|41771953|FG000|Overall Study|Physician Decision|1|||
19486798|NCT02635776|41771954|FG001|Overall Study|Physician Decision|0|||
19486799|NCT02635776|41771953|FG000|Overall Study|Adverse Event|51|||
19486800|NCT02635776|41771954|FG001|Overall Study|Adverse Event|3|||
19486801|NCT02635776|41771953|FG000|Overall Study|Withdrawal by Subject|41|||
19486802|NCT02635776|41771954|FG001|Overall Study|Withdrawal by Subject|7|||
19486803|NCT02635776|41771953|FG000|Overall Study|Lost to Follow-up|4|||
19486804|NCT02635776|41771954|FG001|Overall Study|Lost to Follow-up|0|||
19486805|NCT02635776|41771953|FG000|Overall Study|Other reasons|5|||
19486806|NCT02635776|41771954|FG001|Overall Study|Other reasons|1|||
19486807|NCT02704403|41771968|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
19486808|NCT02704403|41771969|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
19486809|NCT02704403|41771968|FG000|Overall Study|Administrative reasons by sponsor|1251|||
19486810|NCT02704403|41771969|FG001|Overall Study|Administrative reasons by sponsor|616|||
19486811|NCT02704403|41771968|FG000|Overall Study|Death|4|||
19486812|NCT02704403|41771969|FG001|Overall Study|Death|3|||
19486813|NCT02704403|41771968|FG000|Overall Study|Endpoint event|52|||
19486814|NCT02704403|41771969|FG001|Overall Study|Endpoint event|24|||
19486815|NCT02704403|41771968|FG000|Overall Study|Lost to Follow-up|22|||
19486816|NCT02704403|41771969|FG001|Overall Study|Lost to Follow-up|11|||
19486817|NCT02704403|41771968|FG000|Overall Study|Protocol Violation|15|||
19486818|NCT02704403|41771969|FG001|Overall Study|Protocol Violation|15|||
19486819|NCT02704403|41771968|FG000|Overall Study|Adverse Event|2|||
19486820|NCT02704403|41771969|FG001|Overall Study|Adverse Event|0|||
19486821|NCT02704403|41771968|FG000|Overall Study|Withdrawal by Subject|85|||
19486822|NCT02704403|41771969|FG001|Overall Study|Withdrawal by Subject|45|||
19486823|NCT02704403|41771968|FG000|Overall Study|Investigator decision|1|||
19486824|NCT02704403|41771969|FG001|Overall Study|Investigator decision|1|||
19486825|NCT02704403|41771968|FG000|Overall Study|Follow-up not possible|1|||
19486826|NCT02704403|41771969|FG001|Overall Study|Follow-up not possible|2|||
19486827|NCT02636868|41772004|FG000|Overall Study|Death|0|||
19486828|NCT02636868|41772005|FG001|Overall Study|Death|1|||
19486829|NCT02636868|41772006|FG002|Overall Study|Death|2|||
19486830|NCT02635386|41772087|FG000|Overall Study|Pregnancy|2|||
19486831|NCT02635386|41772088|FG001|Overall Study|Pregnancy|0|||
19486832|NCT02635386|41772089|FG002|Overall Study|Pregnancy|0|||
19486833|NCT02635386|41772090|FG003|Overall Study|Pregnancy|0|||
19486834|NCT02635386|41772091|FG004|Overall Study|Pregnancy|2|||
19486835|NCT02635386|41772087|FG000|Overall Study|Withdrawal by Subject|1|||
19486836|NCT02635386|41772088|FG001|Overall Study|Withdrawal by Subject|1|||
19486837|NCT02635386|41772089|FG002|Overall Study|Withdrawal by Subject|0|||
19486838|NCT02635386|41772090|FG003|Overall Study|Withdrawal by Subject|1|||
19486839|NCT02635386|41772091|FG004|Overall Study|Withdrawal by Subject|0|||
19486840|NCT02635386|41772087|FG000|Overall Study|Physician Decision|0|||
19486841|NCT02635386|41772088|FG001|Overall Study|Physician Decision|1|||
19486842|NCT02635386|41772089|FG002|Overall Study|Physician Decision|0|||
19486843|NCT02635386|41772090|FG003|Overall Study|Physician Decision|0|||
19486844|NCT02635386|41772091|FG004|Overall Study|Physician Decision|0|||
19486845|NCT02635386|41772087|FG000|Overall Study|Moved Out of State|0|||
19486846|NCT02635386|41772088|FG001|Overall Study|Moved Out of State|1|||
19486847|NCT02635386|41772089|FG002|Overall Study|Moved Out of State|0|||
19486848|NCT02635386|41772090|FG003|Overall Study|Moved Out of State|0|||
19486849|NCT02635386|41772091|FG004|Overall Study|Moved Out of State|0|||
19486850|NCT02635386|41772087|FG000|Overall Study|Noncompliant|0|||
19486851|NCT02635386|41772088|FG001|Overall Study|Noncompliant|2|||
19486852|NCT02635386|41772089|FG002|Overall Study|Noncompliant|1|||
19486853|NCT02635386|41772090|FG003|Overall Study|Noncompliant|1|||
19486854|NCT02635386|41772091|FG004|Overall Study|Noncompliant|1|||
19486855|NCT02635386|41772087|FG000|Overall Study|side effects|0|||
19486856|NCT02635386|41772088|FG001|Overall Study|side effects|0|||
19486857|NCT02635386|41772089|FG002|Overall Study|side effects|1|||
19486858|NCT02635386|41772090|FG003|Overall Study|side effects|4|||
19486859|NCT02635386|41772091|FG004|Overall Study|side effects|6|||
19486860|NCT02635386|41772087|FG000|Overall Study|needed other major surgery|0|||
19486861|NCT02635386|41772088|FG001|Overall Study|needed other major surgery|1|||
19486862|NCT02635386|41772089|FG002|Overall Study|needed other major surgery|0|||
19486863|NCT02635386|41772090|FG003|Overall Study|needed other major surgery|0|||
19486864|NCT02635386|41772091|FG004|Overall Study|needed other major surgery|0|||
19486865|NCT02635386|41772087|FG000|Overall Study|Other medical problems not drug related|0|||
19486866|NCT02635386|41772088|FG001|Overall Study|Other medical problems not drug related|0|||
19486867|NCT02635386|41772089|FG002|Overall Study|Other medical problems not drug related|0|||
19486868|NCT02635386|41772090|FG003|Overall Study|Other medical problems not drug related|1|||
19486869|NCT02635386|41772091|FG004|Overall Study|Other medical problems not drug related|0|||
19486870|NCT02634606|41772198|FG000|Overall Study|unable to obtain the drug at start|13|||
19486871|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
19486872|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
19486873|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
19486874|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
19486875|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
19486876|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
19486877|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
19486878|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
19486879|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
19486880|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
19486881|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
19486882|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
19486883|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
19486884|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
19393450|NCT01680991|41637311|FG002|Overall Study|PD confirmed in other hospital|0|||
19486885|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
19486886|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
19486887|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
19486888|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
19486889|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
19486890|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
19486891|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
19486892|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
19486893|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
19486894|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
19486895|NCT01672866|41772244|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
19486896|NCT01672866|41772245|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
19612518|NCT00955409|42061378|FG004|Overall Study|Withdrawal by Subject|0|||
19612519|NCT00955409|42061379|FG005|Overall Study|Withdrawal by Subject|0|||
19612520|NCT00955409|42061380|FG006|Overall Study|Withdrawal by Subject|2|||
19612521|NCT00955409|42061381|FG007|Overall Study|Withdrawal by Subject|0|||
19612522|NCT00955409|42061382|FG008|Overall Study|Withdrawal by Subject|1|||
19612523|NCT00955409|42061383|FG009|Overall Study|Withdrawal by Subject|0|||
19612524|NCT00955409|42061374|FG000|Overall Study|Caregiver Request|2|||
19612525|NCT00955409|42061375|FG001|Overall Study|Caregiver Request|0|||
19612526|NCT00955409|42061376|FG002|Overall Study|Caregiver Request|6|||
19612527|NCT00955409|42061377|FG003|Overall Study|Caregiver Request|5|||
19612528|NCT00955409|42061378|FG004|Overall Study|Caregiver Request|0|||
19612529|NCT00955409|42061379|FG005|Overall Study|Caregiver Request|2|||
19612530|NCT00955409|42061380|FG006|Overall Study|Caregiver Request|3|||
19612531|NCT00955409|42061381|FG007|Overall Study|Caregiver Request|1|||
19612532|NCT00955409|42061382|FG008|Overall Study|Caregiver Request|3|||
19612533|NCT00955409|42061383|FG009|Overall Study|Caregiver Request|0|||
19612534|NCT00955409|42061374|FG000|Overall Study|Investigator Request|0|||
19612535|NCT00955409|42061375|FG001|Overall Study|Investigator Request|0|||
19612536|NCT00955409|42061376|FG002|Overall Study|Investigator Request|1|||
19612537|NCT00955409|42061377|FG003|Overall Study|Investigator Request|0|||
19612538|NCT00955409|42061378|FG004|Overall Study|Investigator Request|0|||
19612539|NCT00955409|42061379|FG005|Overall Study|Investigator Request|0|||
19612540|NCT00955409|42061380|FG006|Overall Study|Investigator Request|0|||
19612541|NCT00955409|42061381|FG007|Overall Study|Investigator Request|0|||
19612542|NCT00955409|42061382|FG008|Overall Study|Investigator Request|0|||
19612543|NCT00955409|42061383|FG009|Overall Study|Investigator Request|0|||
19612544|NCT00955409|42061374|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
19612545|NCT00955409|42061375|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19612546|NCT00955409|42061376|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
19612547|NCT00955409|42061377|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
19612548|NCT00955409|42061378|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
19612549|NCT00955409|42061379|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
19612550|NCT00955409|42061380|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
19612551|NCT00955409|42061381|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
19612552|NCT00955409|42061382|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
19612553|NCT00955409|42061383|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
19612554|NCT00955409|42061374|FG000|Overall Study|Lost to Follow-up|0|||
19612555|NCT00955409|42061375|FG001|Overall Study|Lost to Follow-up|0|||
19612556|NCT00955409|42061376|FG002|Overall Study|Lost to Follow-up|1|||
19612557|NCT00955409|42061377|FG003|Overall Study|Lost to Follow-up|0|||
19612558|NCT00955409|42061378|FG004|Overall Study|Lost to Follow-up|0|||
19612559|NCT00955409|42061379|FG005|Overall Study|Lost to Follow-up|0|||
19612560|NCT00955409|42061380|FG006|Overall Study|Lost to Follow-up|1|||
19612561|NCT00955409|42061381|FG007|Overall Study|Lost to Follow-up|0|||
19612562|NCT00955409|42061382|FG008|Overall Study|Lost to Follow-up|0|||
19612563|NCT00955409|42061383|FG009|Overall Study|Lost to Follow-up|0|||
19612564|NCT00955409|42061374|FG000|Overall Study|Failed to Return|2|||
19612565|NCT00955409|42061375|FG001|Overall Study|Failed to Return|0|||
19612566|NCT00955409|42061376|FG002|Overall Study|Failed to Return|0|||
19612567|NCT00955409|42061377|FG003|Overall Study|Failed to Return|0|||
19612568|NCT00955409|42061378|FG004|Overall Study|Failed to Return|0|||
19612569|NCT00955409|42061379|FG005|Overall Study|Failed to Return|0|||
19393451|NCT02819479|41637321|FG000|Overall Study|Adverse Event|2|||
19393452|NCT04064411|41637328|FG000|Overall Study|Adverse Event|29|||
19393453|NCT04064411|41637329|FG001|Overall Study|Adverse Event|19|||
19393454|NCT04064411|41637328|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
19393455|NCT04064411|41637329|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
19393456|NCT04064411|41637328|FG000|Overall Study|Protocol Deviation|0|||
19393457|NCT04064411|41637329|FG001|Overall Study|Protocol Deviation|2|||
19393458|NCT04064411|41637328|FG000|Overall Study|Withdrawal by Subject|25|||
19393459|NCT04064411|41637329|FG001|Overall Study|Withdrawal by Subject|29|||
19393460|NCT04064411|41637328|FG000|Overall Study|Lost to Follow-up|5|||
19393461|NCT04064411|41637329|FG001|Overall Study|Lost to Follow-up|2|||
19393462|NCT04064411|41637328|FG000|Overall Study|Other than Specified|4|||
19393463|NCT04064411|41637329|FG001|Overall Study|Other than Specified|1|||
19612570|NCT00955409|42061380|FG006|Overall Study|Failed to Return|0|||
19612571|NCT00955409|42061381|FG007|Overall Study|Failed to Return|2|||
19612572|NCT00955409|42061382|FG008|Overall Study|Failed to Return|0|||
19612573|NCT00955409|42061383|FG009|Overall Study|Failed to Return|0|||
19612574|NCT00955409|42061374|FG000|Overall Study|Adverse Event (AE)|2|||
19612575|NCT00955409|42061375|FG001|Overall Study|Adverse Event (AE)|0|||
19393464|NCT04064411|41637328|FG000|Overall Study|Death|1|||
19393465|NCT04064411|41637329|FG001|Overall Study|Death|0|||
19393466|NCT02004691|41637337|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
19486897|NCT01672866|41772246|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
19486898|NCT01672866|41772244|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
19486899|NCT01672866|41772245|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
19486900|NCT01672866|41772246|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
19486901|NCT01672866|41772244|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
19486902|NCT01672866|41772245|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
19486903|NCT01672866|41772246|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
19486904|NCT01672866|41772244|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
19486905|NCT01672866|41772245|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
19486906|NCT01672866|41772246|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
19486907|NCT01672866|41772244|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
19486908|NCT01672866|41772245|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
19486909|NCT01672866|41772246|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
19486910|NCT04465877|41772472|FG000|Overall Study|Noncompliant with study requirements|0|||
19486911|NCT04465877|41772473|FG001|Overall Study|Noncompliant with study requirements|0|||
19486912|NCT04465877|41772474|FG002|Overall Study|Noncompliant with study requirements|1|||
19486913|NCT04465877|41772475|FG003|Overall Study|Noncompliant with study requirements|0|||
19486914|NCT04267133|41772532|FG000|Overall Study|Withdrawal by Subject|1|||
19486915|NCT04267133|41772532|FG000|Overall Study|Adverse Event|4|||
19486916|NCT02631876|41772663|FG000|Overall Study|Death|96|||
19486917|NCT02631876|41772664|FG001|Overall Study|Death|50|||
19486918|NCT02631876|41772663|FG000|Overall Study|Investigator's discretion|1|||
19486919|NCT02631876|41772664|FG001|Overall Study|Investigator's discretion|0|||
19486920|NCT02631876|41772663|FG000|Overall Study|Lost to Follow-up|2|||
19486921|NCT02631876|41772664|FG001|Overall Study|Lost to Follow-up|0|||
19486922|NCT02631876|41772663|FG000|Overall Study|Withdrawal by Subject|16|||
19486923|NCT02631876|41772664|FG001|Overall Study|Withdrawal by Subject|9|||
19486924|NCT02631876|41772663|FG000|Overall Study|Other than specified|4|||
19486925|NCT02631876|41772664|FG001|Overall Study|Other than specified|4|||
19486926|NCT02633046|41772693|FG000|Overall Study|Adverse Event|8|||
19486927|NCT02633046|41772693|FG000|Overall Study|Physician Decision|7|||
19486928|NCT02633046|41772693|FG000|Overall Study|Withdrawal by Subject|8|||
19486929|NCT02633046|41772693|FG000|Overall Study|Increased proteinuria|2|||
19486930|NCT02633046|41772693|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
19486931|NCT02633046|41772693|FG000|Overall Study|Mutual decision patient and physician|1|||
19486932|NCT01672788|41772752|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
19486933|NCT01672788|41772753|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
19486934|NCT01672788|41772754|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
19486935|NCT01672788|41772755|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
19486936|NCT02632110|41772770|FG000|Overall Study|Withdrawal by Subject|1|||
19486937|NCT02632110|41772771|FG001|Overall Study|Withdrawal by Subject|1|||
19486938|NCT02632110|41772772|FG002|Overall Study|Withdrawal by Subject|0|||
19486939|NCT02632110|41772773|FG003|Overall Study|Withdrawal by Subject|0|||
19486940|NCT02632110|41772774|FG004|Overall Study|Withdrawal by Subject|1|||
19486941|NCT02632110|41772775|FG005|Overall Study|Withdrawal by Subject|1|||
19486942|NCT02632110|41772776|FG006|Overall Study|Withdrawal by Subject|3|||
19486943|NCT02632110|41772777|FG007|Overall Study|Withdrawal by Subject|3|||
19486944|NCT02632110|41772778|FG008|Overall Study|Withdrawal by Subject|1|||
19486945|NCT02632110|41772779|FG009|Overall Study|Withdrawal by Subject|1|||
19486946|NCT01672710|41773021|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
19486947|NCT01672710|41773022|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
19486948|NCT01672710|41773021|FG000|3 Month Follow up|Lost to Follow-up|2|||
19486949|NCT01672710|41773022|FG001|3 Month Follow up|Lost to Follow-up|3|||
19486950|NCT01672710|41773021|FG000|3 Month Follow up|follow up due after termination date|4|||
19486951|NCT01672710|41773022|FG001|3 Month Follow up|follow up due after termination date|1|||
19486952|NCT02630472|41773057|FG000|Overall Study|Physician Decision|10|||
19486953|NCT02630472|41773058|FG001|Overall Study|Physician Decision|0|||
19393467|NCT02004691|41637338|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
19393468|NCT02004691|41637337|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
19393469|NCT02004691|41637338|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
19393470|NCT02004691|41637337|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
19486954|NCT01670526|41773094|FG000|Overall Study|Withdrawal by Subject|3|||
19486955|NCT01670526|41773095|FG001|Overall Study|Withdrawal by Subject|1|||
19486956|NCT01670526|41773094|FG000|Overall Study|Lost to Follow-up|9|||
19486957|NCT01670526|41773095|FG001|Overall Study|Lost to Follow-up|5|||
19486958|NCT02630706|41773139|FG000|Overall Study|Adverse Event|2|||
19486959|NCT02630706|41773140|FG001|Overall Study|Adverse Event|1|||
19393471|NCT02004691|41637338|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
19393472|NCT02004691|41637337|FG000|ETP: Ongoing From Week 52|Other|0|||
19486960|NCT02630706|41773141|FG002|Overall Study|Adverse Event|1|||
19486961|NCT02630706|41773139|FG000|Overall Study|Lost to Follow-up|0|||
19486962|NCT02630706|41773140|FG001|Overall Study|Lost to Follow-up|1|||
19486963|NCT02630706|41773141|FG002|Overall Study|Lost to Follow-up|2|||
19486964|NCT02630706|41773139|FG000|Overall Study|Physician Decision|1|||
19486965|NCT02630706|41773140|FG001|Overall Study|Physician Decision|1|||
19486966|NCT02630706|41773141|FG002|Overall Study|Physician Decision|0|||
19486967|NCT02630706|41773139|FG000|Overall Study|Pregnancy|0|||
19486968|NCT02630706|41773140|FG001|Overall Study|Pregnancy|1|||
19486969|NCT02630706|41773141|FG002|Overall Study|Pregnancy|0|||
19486970|NCT02630706|41773139|FG000|Overall Study|Withdrawal by Subject|4|||
19486971|NCT02630706|41773140|FG001|Overall Study|Withdrawal by Subject|5|||
19486972|NCT02630706|41773141|FG002|Overall Study|Withdrawal by Subject|7|||
19486973|NCT02089997|41773318|FG000|Overall Study|Case report forms uncollected|99|||
19486974|NCT02089997|41773318|FG000|Overall Study|Protocol Violation|147|||
19486975|NCT01363661|41773324|FG000|Overall Study|Adverse Event|9|||
19486976|NCT01363661|41773325|FG001|Overall Study|Adverse Event|2|||
19486977|NCT01363661|41773324|FG000|Overall Study|Withdrawal by Subject|1|||
19486978|NCT01363661|41773325|FG001|Overall Study|Withdrawal by Subject|1|||
19486979|NCT01363661|41773324|FG000|Overall Study|Protocol Violation|1|||
19486980|NCT01363661|41773325|FG001|Overall Study|Protocol Violation|0|||
19486981|NCT01363661|41773324|FG000|Overall Study|Lost to Follow-up|3|||
19486982|NCT01363661|41773325|FG001|Overall Study|Lost to Follow-up|1|||
19612576|NCT00955409|42061376|FG002|Overall Study|Adverse Event (AE)|0|||
19612577|NCT00955409|42061377|FG003|Overall Study|Adverse Event (AE)|0|||
19612578|NCT00955409|42061378|FG004|Overall Study|Adverse Event (AE)|0|||
19612579|NCT00955409|42061379|FG005|Overall Study|Adverse Event (AE)|1|||
19612580|NCT00955409|42061380|FG006|Overall Study|Adverse Event (AE)|2|||
19612581|NCT00955409|42061381|FG007|Overall Study|Adverse Event (AE)|0|||
19612582|NCT00955409|42061382|FG008|Overall Study|Adverse Event (AE)|2|||
19612583|NCT00955409|42061383|FG009|Overall Study|Adverse Event (AE)|0|||
19612584|NCT00955409|42061374|FG000|Overall Study|Reason not Specified|2|||
19612585|NCT00955409|42061375|FG001|Overall Study|Reason not Specified|1|||
19612586|NCT00955409|42061376|FG002|Overall Study|Reason not Specified|13|||
19612587|NCT00955409|42061377|FG003|Overall Study|Reason not Specified|1|||
19612588|NCT00955409|42061378|FG004|Overall Study|Reason not Specified|2|||
19612589|NCT00955409|42061379|FG005|Overall Study|Reason not Specified|0|||
19612590|NCT00955409|42061380|FG006|Overall Study|Reason not Specified|16|||
19612591|NCT00955409|42061381|FG007|Overall Study|Reason not Specified|0|||
19612592|NCT00955409|42061382|FG008|Overall Study|Reason not Specified|8|||
19612593|NCT00955409|42061383|FG009|Overall Study|Reason not Specified|1|||
19612594|NCT00615901|42061409|FG000|Overall Study|Withdrawal by Subject|2|||
19612595|NCT00615901|42061409|FG000|Overall Study|Adverse Event|7|||
19612596|NCT00616603|42061421|FG000|Overall Study|Physician Decision|2|||
19612597|NCT00616603|42061422|FG001|Overall Study|Physician Decision|0|||
19612598|NCT00616603|42061423|FG002|Overall Study|Physician Decision|2|||
19612599|NCT00810693|42061434|FG000|Treatment Period|Adverse Event|8|||
19612600|NCT00810693|42061435|FG001|Treatment Period|Adverse Event|1|||
19612601|NCT00810693|42061436|FG002|Treatment Period|Adverse Event|7|||
19612602|NCT00810693|42061434|FG000|Treatment Period|Death|0|||
19612603|NCT00810693|42061435|FG001|Treatment Period|Death|1|||
19612604|NCT00810693|42061436|FG002|Treatment Period|Death|2|||
19612605|NCT00810693|42061434|FG000|Treatment Period|Lack of Efficacy|0|||
19612606|NCT00810693|42061435|FG001|Treatment Period|Lack of Efficacy|0|||
19612607|NCT00810693|42061436|FG002|Treatment Period|Lack of Efficacy|1|||
19612608|NCT00810693|42061434|FG000|Treatment Period|Lost to Follow-up|1|||
19612609|NCT00810693|42061435|FG001|Treatment Period|Lost to Follow-up|0|||
19612610|NCT00810693|42061436|FG002|Treatment Period|Lost to Follow-up|0|||
19612611|NCT00810693|42061434|FG000|Treatment Period|Non-compliance|1|||
19612612|NCT00810693|42061435|FG001|Treatment Period|Non-compliance|0|||
19612613|NCT00810693|42061436|FG002|Treatment Period|Non-compliance|0|||
19612614|NCT00810693|42061434|FG000|Treatment Period|Protocol Violation|1|||
19612615|NCT00810693|42061435|FG001|Treatment Period|Protocol Violation|2|||
19612616|NCT00810693|42061436|FG002|Treatment Period|Protocol Violation|2|||
19612617|NCT00810693|42061434|FG000|Treatment Period|Withdrawal by Subject|6|||
19612618|NCT00810693|42061435|FG001|Treatment Period|Withdrawal by Subject|2|||
19612619|NCT00810693|42061436|FG002|Treatment Period|Withdrawal by Subject|3|||
19612620|NCT00810693|42061434|FG000|Treatment Period|Not treated|0|||
19612621|NCT00810693|42061435|FG001|Treatment Period|Not treated|1|||
19486983|NCT02628600|41773333|FG000|Overall Study|Death|2|||
19486984|NCT02628600|41773334|FG001|Overall Study|Death|1|||
19612622|NCT00810693|42061436|FG002|Treatment Period|Not treated|1|||
19612623|NCT00810693|42061434|FG000|Follow-up Period (FUP)|Adverse Event|3|||
19612624|NCT00810693|42061435|FG001|Follow-up Period (FUP)|Adverse Event|1|||
19393473|NCT02004691|41637338|FG001|ETP: Ongoing From Week 52|Other|1|||
19612625|NCT00810693|42061436|FG002|Follow-up Period (FUP)|Adverse Event|1|||
19612626|NCT00810693|42061434|FG000|Follow-up Period (FUP)|Death|2|||
19612627|NCT00810693|42061435|FG001|Follow-up Period (FUP)|Death|0|||
19612628|NCT00810693|42061436|FG002|Follow-up Period (FUP)|Death|1|||
19486985|NCT02628600|41773333|FG000|Overall Study|Adverse Event|3|||
19486986|NCT02628600|41773334|FG001|Overall Study|Adverse Event|20|||
19486987|NCT02628600|41773333|FG000|Overall Study|Protocol Violation|0|||
19486988|NCT02628600|41773334|FG001|Overall Study|Protocol Violation|1|||
19486989|NCT02628600|41773333|FG000|Overall Study|Lack of Efficacy|2|||
19486990|NCT02628600|41773334|FG001|Overall Study|Lack of Efficacy|0|||
19486991|NCT02628600|41773333|FG000|Overall Study|Withdrawal by Subject|13|||
19486992|NCT02628600|41773334|FG001|Overall Study|Withdrawal by Subject|8|||
19486993|NCT02628600|41773333|FG000|Overall Study|Lost to Follow-up|1|||
19486994|NCT02628600|41773334|FG001|Overall Study|Lost to Follow-up|0|||
19486995|NCT02628600|41773333|FG000|Overall Study|Physician Decision|2|||
19486996|NCT02628600|41773334|FG001|Overall Study|Physician Decision|2|||
19486997|NCT02628600|41773333|FG000|Overall Study|Other not specified|1|||
19486998|NCT02628600|41773334|FG001|Overall Study|Other not specified|0|||
19486999|NCT00591318|41773351|FG000|Overall Study|Lack of Efficacy|2|||
19487000|NCT00591318|41773352|FG001|Overall Study|Lack of Efficacy|0|||
19487001|NCT00591318|41773351|FG000|Overall Study|Adverse Event|2|||
19487002|NCT00591318|41773352|FG001|Overall Study|Adverse Event|0|||
19487003|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
19487004|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
19487005|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
19487006|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
19612629|NCT00810693|42061434|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
19612630|NCT00810693|42061435|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
19612631|NCT00810693|42061436|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
19612632|NCT00810693|42061434|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
19704205|NCT00256698|42148491|FG001|Overall Study|withdrawn due to osteoporosis|0|||
19704206|NCT00256698|42148490|FG000|Overall Study|Prematurely Discontinued|1|||
19704207|NCT00256698|42148491|FG001|Overall Study|Prematurely Discontinued|0|||
19612633|NCT00810693|42061435|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
19612634|NCT00810693|42061436|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
19612635|NCT00810693|42061434|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
19612636|NCT00810693|42061435|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
19612637|NCT00810693|42061436|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
19704208|NCT00189306|42148497|FG000|Treatment Period|Withdrawal by Subject|2|||
19704209|NCT00189306|42148497|FG000|Treatment Period|Adverse Event|2|||
19704210|NCT00189306|42148497|FG000|Treatment Period|Protocol Violation|1|||
19704211|NCT00189306|42148497|FG000|Posttreatment Period|Death|1|||
19704212|NCT00189306|42148497|FG000|Posttreatment Period|Withdrawal by Subject|2|||
19704213|NCT00189306|42148497|FG000|Posttreatment Period|Noncompliance|1|||
19704214|NCT00189306|42148497|FG000|Posttreatment Period|Target lesion excised|1|||
19704215|NCT00189306|42148497|FG000|Posttreatment Period|Protocol Violation|1|||
19704216|NCT00189306|42148497|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
19704217|NCT00189306|42148497|FG000|Posttreatment Period|Local skin reaction/sign|1|||
19704218|NCT00189306|42148497|FG000|Long-Term Follow-up|Adverse Event|2|||
19704219|NCT00189306|42148497|FG000|Long-Term Follow-up|Death|4|||
19704220|NCT00189306|42148497|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
19704221|NCT00189306|42148497|FG000|Long-Term Follow-up|Intercurrent disease|2|||
19704222|NCT00189306|42148497|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
19704223|NCT00189306|42148497|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
19704224|NCT00187278|42148503|FG000|Overall Study|Protocol Violation|10|||
19704225|NCT00187278|42148504|FG001|Overall Study|Protocol Violation|13|||
19704226|NCT00256308|42148512|FG000|Overall Study|Death|2|||
19704227|NCT00255840|42148518|FG000|Overall Study|Lost to Follow-up|10|||
19704228|NCT00255840|42148519|FG001|Overall Study|Lost to Follow-up|14|||
19704229|NCT00255840|42148518|FG000|Overall Study|Discontinued intervention|53|||
19704230|NCT00255840|42148519|FG001|Overall Study|Discontinued intervention|56|||
19704231|NCT00224874|42148529|FG000|Overall Study|Withdrawal by Subject|0|||
19704232|NCT00224874|42148530|FG001|Overall Study|Withdrawal by Subject|0|||
19704233|NCT00224874|42148531|FG002|Overall Study|Withdrawal by Subject|1|||
19704234|NCT00224874|42148532|FG003|Overall Study|Withdrawal by Subject|0|||
19704235|NCT00186186|42148542|FG000|Overall Study|Lack of Efficacy|3|||
19704236|NCT00186186|42148542|FG000|Overall Study|Withdrawal by Subject|3|||
19704237|NCT00186186|42148542|FG000|Overall Study|Not reported as to reason|2|||
19704238|NCT00185640|42148547|FG000|Overall Study|Not Eligible|4|||
19704239|NCT00185640|42148547|FG000|Overall Study|Withdrawal by Subject|3|||
19704240|NCT00185640|42148547|FG000|Overall Study|Death|138|||
19704241|NCT03760666|42148554|FG000|Overall Study|Adverse Event|2|||
19704242|NCT03760666|42148555|FG001|Overall Study|Adverse Event|4|||
19487007|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
19487008|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Adverse Event|60|||
19487009|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Adverse Event|0|||
19487010|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Adverse Event|0|||
19487011|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Adverse Event|0|||
19487012|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Adverse Event|0|||
19612638|NCT00573313|42061448|FG000|Overall Study|Protocol Violation|5|||
19612639|NCT00573313|42061449|FG001|Overall Study|Protocol Violation|0|||
19487013|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
19393474|NCT02004691|41637337|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
19393475|NCT02004691|41637338|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
19393476|NCT02629133|41637346|FG000|Overall Study|Lost to Follow-up|3|||
19487014|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
19487015|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
19487016|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
19487017|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
19487018|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Physician Decision|10|||
19487019|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Physician Decision|0|||
19487020|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Physician Decision|0|||
19487021|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Physician Decision|0|||
19487022|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Physician Decision|0|||
19487023|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
19487024|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
19487025|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
19487026|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
19487027|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
19487028|NCT01360632|41773365|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
19487029|NCT01360632|41773366|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
19487030|NCT01360632|41773367|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
19487031|NCT01360632|41773368|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
19487032|NCT01360632|41773369|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
19487033|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
19487034|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
19487035|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
19487036|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
19487037|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
19487038|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Adverse Event|0|||
19487039|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Adverse Event|3|||
19487040|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Adverse Event|9|||
19487041|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Adverse Event|3|||
19487042|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Adverse Event|0|||
19487043|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
19487044|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
19487045|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
19487046|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
19487047|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
19487048|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Physician Decision|0|||
19487049|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Physician Decision|0|||
19487050|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Physician Decision|0|||
19487051|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Physician Decision|1|||
19487052|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Physician Decision|0|||
19487053|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
19487054|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
19487055|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
19487056|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
19487057|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
19487058|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
19487059|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
19487060|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
19487061|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
19487062|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
19487063|NCT01360632|41773365|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
19487064|NCT01360632|41773366|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
19487065|NCT01360632|41773367|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
19487066|NCT01360632|41773368|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
19487067|NCT01360632|41773369|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
19487068|NCT01360632|41773365|FG000|Phase A+|Lost to Follow-up|0|||
19487069|NCT01360632|41773366|FG001|Phase A+|Lost to Follow-up|0|||
19487070|NCT01360632|41773367|FG002|Phase A+|Lost to Follow-up|0|||
19487071|NCT01360632|41773368|FG003|Phase A+|Lost to Follow-up|0|||
19487072|NCT01360632|41773369|FG004|Phase A+|Lost to Follow-up|2|||
19487073|NCT01360632|41773365|FG000|Phase A+|Adverse Event|0|||
19487074|NCT01360632|41773366|FG001|Phase A+|Adverse Event|0|||
19487075|NCT01360632|41773367|FG002|Phase A+|Adverse Event|0|||
19487076|NCT01360632|41773368|FG003|Phase A+|Adverse Event|0|||
19487077|NCT01360632|41773369|FG004|Phase A+|Adverse Event|2|||
19487078|NCT01360632|41773365|FG000|Phase A+|Met Withdrawal Criteria|0|||
19487079|NCT01360632|41773366|FG001|Phase A+|Met Withdrawal Criteria|0|||
19487080|NCT01360632|41773367|FG002|Phase A+|Met Withdrawal Criteria|0|||
19487081|NCT01360632|41773368|FG003|Phase A+|Met Withdrawal Criteria|0|||
19487082|NCT01360632|41773369|FG004|Phase A+|Met Withdrawal Criteria|7|||
19487083|NCT01360632|41773365|FG000|Phase A+|Physician Decision|0|||
19487084|NCT01360632|41773366|FG001|Phase A+|Physician Decision|0|||
19487085|NCT01360632|41773367|FG002|Phase A+|Physician Decision|0|||
19487086|NCT01360632|41773368|FG003|Phase A+|Physician Decision|0|||
19487087|NCT01360632|41773369|FG004|Phase A+|Physician Decision|3|||
19487088|NCT01360632|41773365|FG000|Phase A+|Withdrawal by Subject|0|||
19487089|NCT01360632|41773366|FG001|Phase A+|Withdrawal by Subject|0|||
19704243|NCT03760666|42148556|FG002|Overall Study|Adverse Event|1|||
19704244|NCT03760666|42148554|FG000|Overall Study|AML Disease Progression|3|||
19487090|NCT01360632|41773367|FG002|Phase A+|Withdrawal by Subject|0|||
19487091|NCT01360632|41773368|FG003|Phase A+|Withdrawal by Subject|0|||
19487092|NCT01360632|41773369|FG004|Phase A+|Withdrawal by Subject|8|||
19487093|NCT01360632|41773365|FG000|Phase A+|Protocol Deviation|0|||
19487094|NCT01360632|41773366|FG001|Phase A+|Protocol Deviation|0|||
19487095|NCT01360632|41773367|FG002|Phase A+|Protocol Deviation|0|||
19487096|NCT01360632|41773368|FG003|Phase A+|Protocol Deviation|0|||
19487097|NCT01360632|41773369|FG004|Phase A+|Protocol Deviation|3|||
19487098|NCT04157400|41773415|FG000|Overall Study|Withdrawal by Subject|1|||
19487099|NCT04157400|41773415|FG000|Overall Study|Lost to Follow-up|3|||
19487100|NCT02626182|41773496|FG000|Overall Study|Adverse Event|2|||
19487101|NCT02626182|41773497|FG001|Overall Study|Adverse Event|0|||
19487102|NCT01669902|41773604|FG000|Overall Study|Adverse Event|11|||
19487103|NCT01669902|41773604|FG000|Overall Study|Lack of Efficacy|10|||
19487104|NCT01669902|41773604|FG000|Overall Study|Other|8|||
19487105|NCT01670292|41773637|FG000|Overall Study|Lost to Follow-up|14|||
19487106|NCT01360554|41773874|FG000|Overall Study|Death|359|||
19487107|NCT01360554|41773875|FG001|Overall Study|Death|371|||
19487108|NCT01360554|41773874|FG000|Overall Study|Lost to Follow-up|4|||
19487109|NCT01360554|41773875|FG001|Overall Study|Lost to Follow-up|4|||
19487110|NCT01360554|41773874|FG000|Overall Study|Withdrawal by Subject|23|||
19487111|NCT01360554|41773875|FG001|Overall Study|Withdrawal by Subject|24|||
19487112|NCT01360554|41773874|FG000|Overall Study|Study terminated by sponsor|49|||
19487113|NCT01360554|41773875|FG001|Overall Study|Study terminated by sponsor|37|||
19487114|NCT01360554|41773874|FG000|Overall Study|Other, not specified|1|||
19487115|NCT01360554|41773875|FG001|Overall Study|Other, not specified|0|||
19487116|NCT01360554|41773874|FG000|Overall Study|Randomized but not treated.|3|||
19487117|NCT01360554|41773875|FG001|Overall Study|Randomized but not treated.|3|||
19487118|NCT01360398|41773897|FG000|Overall Study|Withdrawal by Subject|14|||
19487119|NCT01360398|41773897|FG000|Overall Study|Other|7|||
19487120|NCT01360398|41773897|FG000|Overall Study|Migrated/moved from study area|1|||
19487121|NCT02626026|41773907|FG000|Overall Study|Randomized but Never Treated|0|||
19487122|NCT02626026|41773908|FG001|Overall Study|Randomized but Never Treated|0|||
19487123|NCT02626026|41773909|FG002|Overall Study|Randomized but Never Treated|0|||
19487124|NCT02626026|41773910|FG003|Overall Study|Randomized but Never Treated|0|||
19487125|NCT02626026|41773911|FG004|Overall Study|Randomized but Never Treated|1|||
19487126|NCT02626026|41773912|FG005|Overall Study|Randomized but Never Treated|0|||
19487127|NCT01765296|41774172|FG000|Overall Study|Protocol Violation|0|||
19487128|NCT01765296|41774173|FG001|Overall Study|Protocol Violation|5|||
19487129|NCT01765296|41774174|FG002|Overall Study|Protocol Violation|4|||
19487130|NCT01765296|41774172|FG000|Overall Study|Withdrawal by Subject|4|||
19487131|NCT01765296|41774173|FG001|Overall Study|Withdrawal by Subject|2|||
19487132|NCT01765296|41774174|FG002|Overall Study|Withdrawal by Subject|2|||
19487133|NCT01765296|41774172|FG000|Overall Study|Adverse Event|1|||
19487134|NCT01765296|41774173|FG001|Overall Study|Adverse Event|13|||
19487135|NCT01765296|41774174|FG002|Overall Study|Adverse Event|5|||
19487136|NCT01765296|41774172|FG000|Overall Study|Lack of Efficacy|0|||
19487137|NCT01765296|41774173|FG001|Overall Study|Lack of Efficacy|0|||
19487138|NCT01765296|41774174|FG002|Overall Study|Lack of Efficacy|2|||
19487139|NCT02089685|41774248|FG000|Overall Study|Adverse Event|1|||
19487140|NCT02089685|41774249|FG001|Overall Study|Adverse Event|0|||
19487141|NCT02089685|41774250|FG002|Overall Study|Adverse Event|0|||
19487142|NCT02089685|41774251|FG003|Overall Study|Adverse Event|0|||
19487143|NCT02089685|41774252|FG004|Overall Study|Adverse Event|1|||
19487144|NCT02089685|41774253|FG005|Overall Study|Adverse Event|0|||
19487145|NCT02089685|41774248|FG000|Overall Study|Clinical Progression|4|||
19487146|NCT02089685|41774249|FG001|Overall Study|Clinical Progression|0|||
19487147|NCT02089685|41774250|FG002|Overall Study|Clinical Progression|0|||
19487148|NCT02089685|41774251|FG003|Overall Study|Clinical Progression|5|||
19487149|NCT02089685|41774252|FG004|Overall Study|Clinical Progression|1|||
19487150|NCT02089685|41774253|FG005|Overall Study|Clinical Progression|2|||
19487151|NCT02089685|41774248|FG000|Overall Study|Excluded Medication|1|||
19487152|NCT02089685|41774249|FG001|Overall Study|Excluded Medication|0|||
19487153|NCT02089685|41774250|FG002|Overall Study|Excluded Medication|0|||
19487154|NCT02089685|41774251|FG003|Overall Study|Excluded Medication|11|||
19487155|NCT02089685|41774252|FG004|Overall Study|Excluded Medication|2|||
19487156|NCT02089685|41774253|FG005|Overall Study|Excluded Medication|1|||
19487157|NCT02089685|41774248|FG000|Overall Study|Progressive disease|13|||
19487158|NCT02089685|41774249|FG001|Overall Study|Progressive disease|10|||
19487159|NCT02089685|41774250|FG002|Overall Study|Progressive disease|3|||
19487160|NCT02089685|41774251|FG003|Overall Study|Progressive disease|51|||
19487161|NCT02089685|41774252|FG004|Overall Study|Progressive disease|17|||
19487162|NCT02089685|41774253|FG005|Overall Study|Progressive disease|12|||
19487163|NCT02089685|41774248|FG000|Overall Study|Follow up ended by sponsor|2|||
19487164|NCT02089685|41774249|FG001|Overall Study|Follow up ended by sponsor|2|||
19487165|NCT02089685|41774250|FG002|Overall Study|Follow up ended by sponsor|0|||
19487166|NCT02089685|41774251|FG003|Overall Study|Follow up ended by sponsor|70|||
19487167|NCT02089685|41774252|FG004|Overall Study|Follow up ended by sponsor|26|||
19487168|NCT02089685|41774253|FG005|Overall Study|Follow up ended by sponsor|26|||
19487169|NCT02089685|41774248|FG000|Overall Study|Withdrawal by Subject|0|||
19487170|NCT02089685|41774249|FG001|Overall Study|Withdrawal by Subject|2|||
19487171|NCT02089685|41774250|FG002|Overall Study|Withdrawal by Subject|0|||
19487172|NCT02089685|41774251|FG003|Overall Study|Withdrawal by Subject|8|||
19487173|NCT02089685|41774252|FG004|Overall Study|Withdrawal by Subject|1|||
19487174|NCT02089685|41774253|FG005|Overall Study|Withdrawal by Subject|1|||
19487175|NCT02089685|41774248|FG000|Overall Study|Status not recorded|1|||
19487176|NCT02089685|41774249|FG001|Overall Study|Status not recorded|0|||
19487177|NCT02089685|41774250|FG002|Overall Study|Status not recorded|0|||
19487178|NCT02089685|41774251|FG003|Overall Study|Status not recorded|0|||
19487179|NCT02089685|41774252|FG004|Overall Study|Status not recorded|1|||
19487180|NCT02089685|41774253|FG005|Overall Study|Status not recorded|0|||
19487181|NCT02089685|41774248|FG000|Overall Study|Death|0|||
19487182|NCT02089685|41774249|FG001|Overall Study|Death|0|||
19487183|NCT02089685|41774250|FG002|Overall Study|Death|0|||
19487184|NCT02089685|41774251|FG003|Overall Study|Death|7|||
19487185|NCT02089685|41774252|FG004|Overall Study|Death|2|||
19487186|NCT02089685|41774253|FG005|Overall Study|Death|5|||
19487187|NCT02089685|41774248|FG000|Overall Study|Lost to Follow-up|0|||
19487188|NCT02089685|41774249|FG001|Overall Study|Lost to Follow-up|0|||
19487189|NCT02089685|41774250|FG002|Overall Study|Lost to Follow-up|0|||
19487190|NCT02089685|41774251|FG003|Overall Study|Lost to Follow-up|1|||
19487191|NCT02089685|41774252|FG004|Overall Study|Lost to Follow-up|0|||
19487192|NCT02089685|41774253|FG005|Overall Study|Lost to Follow-up|0|||
19487193|NCT02089685|41774248|FG000|Overall Study|Physician Decision|0|||
19487194|NCT02089685|41774249|FG001|Overall Study|Physician Decision|0|||
19487195|NCT02089685|41774250|FG002|Overall Study|Physician Decision|0|||
19487196|NCT02089685|41774251|FG003|Overall Study|Physician Decision|0|||
19487197|NCT02089685|41774252|FG004|Overall Study|Physician Decision|0|||
19487198|NCT02089685|41774253|FG005|Overall Study|Physician Decision|4|||
19487199|NCT02089685|41774248|FG000|Overall Study|Screen failure|1|||
19487200|NCT02089685|41774249|FG001|Overall Study|Screen failure|0|||
19487201|NCT02089685|41774250|FG002|Overall Study|Screen failure|0|||
19487202|NCT02089685|41774251|FG003|Overall Study|Screen failure|0|||
19487203|NCT02089685|41774252|FG004|Overall Study|Screen failure|0|||
19487204|NCT02089685|41774253|FG005|Overall Study|Screen failure|0|||
19487205|NCT02088905|41774322|FG000|Overall Study|Withdrawal by Subject|5|||
19487206|NCT02088905|41774323|FG001|Overall Study|Withdrawal by Subject|1|||
19487207|NCT02088047|41774331|FG000|Overall Study|Withdrawal by Subject|1|||
19487208|NCT02088047|41774332|FG001|Overall Study|Withdrawal by Subject|0|||
19487209|NCT02086565|41774358|FG000|Overall Study|Lost to Follow-up|9|||
19487210|NCT02086565|41774359|FG001|Overall Study|Lost to Follow-up|7|||
19487211|NCT02086565|41774358|FG000|Overall Study|Withdrawal by Subject|2|||
19487212|NCT02086565|41774359|FG001|Overall Study|Withdrawal by Subject|1|||
19487213|NCT02086565|41774358|FG000|Overall Study|Death|3|||
19487214|NCT02086565|41774359|FG001|Overall Study|Death|2|||
19487215|NCT02086565|41774358|FG000|Overall Study|withdrawn by research team|2|||
19487216|NCT02086565|41774359|FG001|Overall Study|withdrawn by research team|2|||
19487217|NCT02085941|41774367|FG000|Overall Study|Lack of Efficacy|1|||
19487218|NCT02085941|41774368|FG001|Overall Study|Lack of Efficacy|0|||
19487219|NCT02085941|41774367|FG000|Overall Study|Death|6|||
19487220|NCT02085941|41774368|FG001|Overall Study|Death|1|||
19487221|NCT02085941|41774367|FG000|Overall Study|Lost to Follow-up|1|||
19487222|NCT02085941|41774368|FG001|Overall Study|Lost to Follow-up|0|||
19487223|NCT02085941|41774367|FG000|Overall Study|Physician Decision|0|||
19487224|NCT02085941|41774368|FG001|Overall Study|Physician Decision|2|||
19487225|NCT02085785|41774376|FG000|Overall Study|Withdrawal by Subject|2|||
19487226|NCT02085785|41774377|FG001|Overall Study|Withdrawal by Subject|1|||
19487227|NCT02085785|41774376|FG000|Overall Study|Lost to Follow-up|0|||
19487228|NCT02085785|41774377|FG001|Overall Study|Lost to Follow-up|1|||
19487229|NCT02085161|41774405|FG000|Overall Study|Not Treated|1|||
19487230|NCT02085161|41774406|FG001|Overall Study|Not Treated|0|||
19487231|NCT02085161|41774407|FG002|Overall Study|Not Treated|0|||
19487232|NCT02085161|41774408|FG003|Overall Study|Not Treated|0|||
19487233|NCT02085161|41774405|FG000|Overall Study|Adverse Event|8|||
19487234|NCT02085161|41774406|FG001|Overall Study|Adverse Event|5|||
19487235|NCT02085161|41774407|FG002|Overall Study|Adverse Event|4|||
19487236|NCT02085161|41774408|FG003|Overall Study|Adverse Event|5|||
19487237|NCT02085161|41774405|FG000|Overall Study|Protocol Violation|0|||
19487238|NCT02085161|41774406|FG001|Overall Study|Protocol Violation|1|||
19487239|NCT02085161|41774407|FG002|Overall Study|Protocol Violation|0|||
19487240|NCT02085161|41774408|FG003|Overall Study|Protocol Violation|1|||
19487241|NCT02085161|41774405|FG000|Overall Study|Withdrawal by Subject|2|||
19487242|NCT02085161|41774406|FG001|Overall Study|Withdrawal by Subject|4|||
19487243|NCT02085161|41774407|FG002|Overall Study|Withdrawal by Subject|0|||
19487244|NCT02085161|41774408|FG003|Overall Study|Withdrawal by Subject|3|||
19487245|NCT02085161|41774405|FG000|Overall Study|Other Reason|1|||
19487246|NCT02085161|41774406|FG001|Overall Study|Other Reason|0|||
19487247|NCT02085161|41774407|FG002|Overall Study|Other Reason|1|||
19487248|NCT02085161|41774408|FG003|Overall Study|Other Reason|1|||
19487249|NCT02082977|41775308|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
19487250|NCT02082977|41775309|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
19487251|NCT02082977|41775310|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
19487252|NCT02082977|41775311|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
19487253|NCT02082977|41775312|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
19487254|NCT02082977|41775313|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
19487255|NCT02082977|41775314|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
19487256|NCT02082977|41775315|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
19487257|NCT02082977|41775316|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
19487258|NCT02082977|41775317|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
19487259|NCT02082977|41775308|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487260|NCT02082977|41775309|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487261|NCT02082977|41775310|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487262|NCT02082977|41775311|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487263|NCT02082977|41775312|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487264|NCT02082977|41775313|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487265|NCT02082977|41775314|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487266|NCT02082977|41775315|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
19487267|NCT02082977|41775316|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487268|NCT02082977|41775317|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
19487269|NCT02082977|41775308|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487270|NCT02082977|41775309|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487271|NCT02082977|41775310|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487272|NCT02082977|41775311|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487273|NCT02082977|41775312|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487274|NCT02082977|41775313|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
19487275|NCT02082977|41775314|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487276|NCT02082977|41775315|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487277|NCT02082977|41775316|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487278|NCT02082977|41775317|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
19487279|NCT02082977|41775308|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
19487280|NCT02082977|41775309|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
19487281|NCT02082977|41775310|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
19487282|NCT02082977|41775311|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
19487283|NCT02082977|41775312|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
19487284|NCT02082977|41775313|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
19487285|NCT02082977|41775314|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
19487286|NCT02082977|41775315|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
19487287|NCT02082977|41775316|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
19487288|NCT02082977|41775317|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
19487289|NCT02082977|41775308|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487290|NCT02082977|41775309|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487291|NCT02082977|41775310|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487292|NCT02082977|41775311|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487293|NCT02082977|41775312|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487294|NCT02082977|41775313|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487295|NCT02082977|41775314|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487296|NCT02082977|41775315|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
19487297|NCT02082977|41775316|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487298|NCT02082977|41775317|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
19487299|NCT01624259|41775351|FG000|Overall Study|Adverse Event|18|||
19487300|NCT01624259|41775352|FG001|Overall Study|Adverse Event|18|||
19487301|NCT01624259|41775351|FG000|Overall Study|Protocol Violation|1|||
19487302|NCT01624259|41775352|FG001|Overall Study|Protocol Violation|2|||
19487303|NCT01624259|41775351|FG000|Overall Study|Withdrawal by Subject|5|||
19487304|NCT01624259|41775352|FG001|Overall Study|Withdrawal by Subject|7|||
19487305|NCT01624259|41775351|FG000|Overall Study|Physician Decision|1|||
19487306|NCT01624259|41775352|FG001|Overall Study|Physician Decision|1|||
19487307|NCT01624259|41775351|FG000|Overall Study|Lost to Follow-up|2|||
19487308|NCT01624259|41775352|FG001|Overall Study|Lost to Follow-up|3|||
19487309|NCT01624259|41775351|FG000|Overall Study|Abnormal laboratory measure|3|||
19487310|NCT01624259|41775352|FG001|Overall Study|Abnormal laboratory measure|0|||
19487311|NCT02081417|41775362|FG000|Overall Study|Lost to Follow-up|26|||
19487312|NCT02081417|41775363|FG001|Overall Study|Lost to Follow-up|23|||
19487313|NCT02081417|41775362|FG000|Overall Study|Moved Away|1|||
19487314|NCT02081417|41775363|FG001|Overall Study|Moved Away|2|||
19487315|NCT02081417|41775362|FG000|Overall Study|Incarcerated|2|||
19487316|NCT02081417|41775363|FG001|Overall Study|Incarcerated|2|||
19487317|NCT02081417|41775362|FG000|Overall Study|Death|4|||
19487318|NCT02081417|41775363|FG001|Overall Study|Death|3|||
19487319|NCT02081417|41775362|FG000|Overall Study|Withdrawal by Subject|4|||
19487320|NCT02081417|41775363|FG001|Overall Study|Withdrawal by Subject|0|||
19487321|NCT02081417|41775362|FG000|Overall Study|Admitted to Residential Treatment|2|||
19487322|NCT02081417|41775363|FG001|Overall Study|Admitted to Residential Treatment|0|||
19487323|NCT02081417|41775362|FG000|Overall Study|Did not start treatment|17|||
19487324|NCT02081417|41775363|FG001|Overall Study|Did not start treatment|21|||
19487325|NCT02081183|41775371|FG000|Overall Study|Lost to Follow-up|0|||
19487326|NCT02081183|41775372|FG001|Overall Study|Lost to Follow-up|1|||
19487327|NCT02081183|41775371|FG000|Overall Study|Protocol Violation|1|||
19487328|NCT02081183|41775372|FG001|Overall Study|Protocol Violation|0|||
19487329|NCT02081183|41775371|FG000|Overall Study|Other|3|||
19487330|NCT02081183|41775372|FG001|Overall Study|Other|3|||
19487331|NCT02080871|41775378|FG000|Overall Study|Death|1|||
19487332|NCT02080871|41775378|FG000|Overall Study|Lost to Follow-up|1|||
19487333|NCT02080481|41775384|FG000|Overall Study|Never received a block.|1|||
19487334|NCT02080481|41775385|FG001|Overall Study|Never received a block.|0|||
19487335|NCT02080403|41775393|FG000|Overall Study|Adverse Event|5|||
19487336|NCT02080403|41775394|FG001|Overall Study|Adverse Event|1|||
19487337|NCT02080403|41775393|FG000|Overall Study|Death|0|||
19487338|NCT02080403|41775394|FG001|Overall Study|Death|2|||
19487339|NCT02080403|41775393|FG000|Overall Study|Lost to Follow-up|2|||
19487340|NCT02080403|41775394|FG001|Overall Study|Lost to Follow-up|0|||
19487341|NCT02080403|41775393|FG000|Overall Study|Pregnancy|0|||
19487342|NCT02080403|41775394|FG001|Overall Study|Pregnancy|1|||
19487343|NCT02080403|41775393|FG000|Overall Study|Protocol Violation|3|||
19487344|NCT02080403|41775394|FG001|Overall Study|Protocol Violation|7|||
19487345|NCT02080403|41775393|FG000|Overall Study|Withdrawal by Subject|5|||
19487346|NCT02080403|41775394|FG001|Overall Study|Withdrawal by Subject|1|||
19487347|NCT02080091|41775400|FG000|Overall Study|Study Terminated|22|||
19487348|NCT02080091|41775400|FG000|Overall Study|Death|1|||
19487349|NCT02080091|41775400|FG000|Overall Study|Withdrawal by Subject|1|||
19487350|NCT02080091|41775400|FG000|Overall Study|Other|1|||
19487351|NCT02079077|41775406|FG000|Overall Study|Lost to Follow-up|5|||
19487352|NCT02079077|41775407|FG001|Overall Study|Lost to Follow-up|7|||
19487353|NCT02079077|41775406|FG000|Overall Study|Became STIs Positive|1|||
19487354|NCT02079077|41775407|FG001|Overall Study|Became STIs Positive|2|||
19487355|NCT02078219|41775435|FG000|Overall Study|Other|2|||
19487356|NCT02078219|41775436|FG001|Overall Study|Other|2|||
19487357|NCT02078219|41775437|FG002|Overall Study|Other|3|||
19487358|NCT02078219|41775438|FG003|Overall Study|Other|0|||
19487359|NCT02078219|41775439|FG004|Overall Study|Other|1|||
19487360|NCT02078219|41775435|FG000|Overall Study|Withdrawal by Subject|0|||
19487361|NCT02078219|41775436|FG001|Overall Study|Withdrawal by Subject|1|||
19487362|NCT02078219|41775437|FG002|Overall Study|Withdrawal by Subject|0|||
19487363|NCT02078219|41775438|FG003|Overall Study|Withdrawal by Subject|1|||
19487364|NCT02078219|41775439|FG004|Overall Study|Withdrawal by Subject|1|||
19487365|NCT02078219|41775435|FG000|Overall Study|Protocol Violation|0|||
19487366|NCT02078219|41775436|FG001|Overall Study|Protocol Violation|0|||
19487367|NCT02078219|41775437|FG002|Overall Study|Protocol Violation|0|||
19487368|NCT02078219|41775438|FG003|Overall Study|Protocol Violation|1|||
19487369|NCT02078219|41775439|FG004|Overall Study|Protocol Violation|0|||
19487370|NCT02078219|41775435|FG000|Overall Study|Death|0|||
19487371|NCT02078219|41775436|FG001|Overall Study|Death|0|||
19487372|NCT02078219|41775437|FG002|Overall Study|Death|0|||
19487373|NCT02078219|41775438|FG003|Overall Study|Death|1|||
19487374|NCT02078219|41775439|FG004|Overall Study|Death|0|||
19487375|NCT02078219|41775435|FG000|Overall Study|Adverse Event|1|||
19487376|NCT02078219|41775436|FG001|Overall Study|Adverse Event|1|||
19487377|NCT02078219|41775437|FG002|Overall Study|Adverse Event|3|||
19487378|NCT02078219|41775438|FG003|Overall Study|Adverse Event|1|||
19487379|NCT02078219|41775439|FG004|Overall Study|Adverse Event|0|||
19487380|NCT02076113|41775453|FG000|Overall Study|Lost to Follow-up|4|||
19487381|NCT02076113|41775454|FG001|Overall Study|Lost to Follow-up|1|||
19487382|NCT02076113|41775453|FG000|Overall Study|Withdrawal by Subject|2|||
19487383|NCT02076113|41775454|FG001|Overall Study|Withdrawal by Subject|3|||
19393477|NCT02629133|41637347|FG001|Overall Study|Lost to Follow-up|1|||
19393478|NCT02629133|41637346|FG000|Overall Study|Withdrawal by Subject|1|||
19393479|NCT02629133|41637347|FG001|Overall Study|Withdrawal by Subject|1|||
19393480|NCT02660359|41637356|FG000|Overall Study|Protocol Deviation|0|||
19393481|NCT02660359|41637357|FG001|Overall Study|Protocol Deviation|0|||
19393482|NCT02660359|41637358|FG002|Overall Study|Protocol Deviation|1|||
19393483|NCT02660359|41637356|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
19487384|NCT02076113|41775453|FG000|Overall Study|Death|1|||
19487385|NCT02076113|41775454|FG001|Overall Study|Death|3|||
19487386|NCT02075255|41775466|FG000|Overall Study|Study specific withdrawal criteria|0|||
19487387|NCT02075255|41775467|FG001|Overall Study|Study specific withdrawal criteria|1|||
19487388|NCT02075255|41775468|FG002|Overall Study|Study specific withdrawal criteria|1|||
19704245|NCT03760666|42148555|FG001|Overall Study|AML Disease Progression|3|||
19487389|NCT02075255|41775466|FG000|Overall Study|Withdrawal by Subject|4|||
19487390|NCT02075255|41775467|FG001|Overall Study|Withdrawal by Subject|1|||
19487391|NCT02075255|41775468|FG002|Overall Study|Withdrawal by Subject|0|||
19393484|NCT02660359|41637357|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
19487392|NCT02075255|41775466|FG000|Overall Study|Lost to Follow-up|0|||
19487393|NCT02075255|41775467|FG001|Overall Study|Lost to Follow-up|0|||
19487394|NCT02075255|41775468|FG002|Overall Study|Lost to Follow-up|1|||
19487395|NCT02075255|41775466|FG000|Overall Study|Adverse Event|0|||
19487396|NCT02075255|41775467|FG001|Overall Study|Adverse Event|0|||
19487397|NCT02075255|41775468|FG002|Overall Study|Adverse Event|1|||
19487398|NCT02075255|41775466|FG000|Overall Study|Death|0|||
19487399|NCT02075255|41775467|FG001|Overall Study|Death|2|||
19487400|NCT02075255|41775468|FG002|Overall Study|Death|0|||
19487401|NCT02400671|41775639|FG000|Overall Study|Death|5|||
19487402|NCT02400671|41775640|FG001|Overall Study|Death|3|||
19487403|NCT02400671|41775641|FG002|Overall Study|Death|4|||
19487404|NCT02400671|41775639|FG000|Overall Study|Lost to Follow-up|20|||
19487405|NCT02400671|41775640|FG001|Overall Study|Lost to Follow-up|27|||
19487406|NCT02400671|41775641|FG002|Overall Study|Lost to Follow-up|24|||
19487407|NCT02400671|41775639|FG000|Overall Study|Withdrawal by Subject|2|||
19487408|NCT02400671|41775640|FG001|Overall Study|Withdrawal by Subject|2|||
19487409|NCT02400671|41775641|FG002|Overall Study|Withdrawal by Subject|0|||
19487410|NCT00089999|41775651|FG000|Overall Study|Adverse Event|4|||
19487411|NCT00089999|41775652|FG001|Overall Study|Adverse Event|7|||
19487412|NCT00089999|41775651|FG000|Overall Study|Withdrawal by Subject|0|||
19487413|NCT00089999|41775652|FG001|Overall Study|Withdrawal by Subject|4|||
19487414|NCT00089999|41775651|FG000|Overall Study|Lost to Follow-up|2|||
19487415|NCT00089999|41775652|FG001|Overall Study|Lost to Follow-up|1|||
19487416|NCT00089999|41775651|FG000|Overall Study|Radiological Progression of Cancer|52|||
19487417|NCT00089999|41775652|FG001|Overall Study|Radiological Progression of Cancer|44|||
19487418|NCT00089999|41775651|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
19487419|NCT00089999|41775652|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
19487420|NCT00089999|41775651|FG000|Overall Study|Death|3|||
19487421|NCT00089999|41775652|FG001|Overall Study|Death|3|||
19487422|NCT00089999|41775651|FG000|Overall Study|Poor General Condition|1|||
19487423|NCT00089999|41775652|FG001|Overall Study|Poor General Condition|0|||
19487424|NCT00089999|41775651|FG000|Overall Study|Clinical Progression|1|||
19487425|NCT00089999|41775652|FG001|Overall Study|Clinical Progression|2|||
19487426|NCT00089999|41775651|FG000|Overall Study|Physician Decision|2|||
19487427|NCT00089999|41775652|FG001|Overall Study|Physician Decision|2|||
19487428|NCT00089999|41775651|FG000|Overall Study|Patient Underwent Surgery|2|||
19487429|NCT00089999|41775652|FG001|Overall Study|Patient Underwent Surgery|0|||
19487430|NCT00089999|41775651|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
19487431|NCT00089999|41775652|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
19487432|NCT00089843|41775663|FG000|Overall Study|Withdrawal by Subject|1|||
19487433|NCT00089843|41775664|FG001|Overall Study|Withdrawal by Subject|4|||
19487434|NCT00089843|41775665|FG002|Overall Study|Withdrawal by Subject|5|||
19487435|NCT00089843|41775666|FG003|Overall Study|Withdrawal by Subject|6|||
19487436|NCT00089843|41775663|FG000|Overall Study|Physician Decision|1|||
19487437|NCT00089843|41775664|FG001|Overall Study|Physician Decision|0|||
19487438|NCT00089843|41775665|FG002|Overall Study|Physician Decision|0|||
19487439|NCT00089843|41775666|FG003|Overall Study|Physician Decision|1|||
19487440|NCT00089297|41775676|FG000|Overall Study|Adverse Event|9|||
19487441|NCT00089297|41775676|FG000|Overall Study|Death|1|||
19487442|NCT00089297|41775676|FG000|Overall Study|Withdrawal by Subject|12|||
19487443|NCT00089297|41775676|FG000|Overall Study|Disease progression|2|||
19487444|NCT00089297|41775676|FG000|Overall Study|Ineligible|11|||
19487445|NCT00089297|41775676|FG000|Overall Study|Secondary malignancy|1|||
19487446|NCT00089297|41775676|FG000|Overall Study|IRB approval not ready|1|||
19487447|NCT00089297|41775676|FG000|Overall Study|Non-compliance|1|||
19487448|NCT00088907|41775718|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
19487449|NCT00088907|41775719|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
19487450|NCT00088907|41775718|FG000|Randomized Study (Step 1)|Adverse Event|14|||
19487451|NCT00088907|41775719|FG001|Randomized Study (Step 1)|Adverse Event|19|||
19487452|NCT00088907|41775718|FG000|Randomized Study (Step 1)|Death|11|||
19487453|NCT00088907|41775719|FG001|Randomized Study (Step 1)|Death|12|||
19487454|NCT00088907|41775718|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
19487455|NCT00088907|41775719|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
19487456|NCT00088907|41775718|FG000|Randomized Study (Step 1)|complicating disease|3|||
19487457|NCT00088907|41775719|FG001|Randomized Study (Step 1)|complicating disease|1|||
19487458|NCT00088907|41775718|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
19487459|NCT00088907|41775719|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
19487460|NCT00088907|41775718|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
19487461|NCT00088907|41775719|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
19487462|NCT00088907|41775718|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
19487463|NCT00088907|41775719|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
19487464|NCT00088907|41775718|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
19487465|NCT00088907|41775719|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
19487466|NCT00088907|41775718|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
19487467|NCT00088907|41775719|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
19487468|NCT00088907|41775718|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
19487469|NCT00088907|41775719|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
19487470|NCT00088829|41775726|FG000|Overall Study|PI left institution and study was close|22|||
19487471|NCT00088595|41775730|FG000|Overall Study|Adverse Event|11|||
19487472|NCT00088595|41775730|FG000|Overall Study|Withdrawal by Subject|8|||
19487473|NCT00088595|41775730|FG000|Overall Study|Ongoing (After Core)|7|||
19487474|NCT00088595|41775730|FG000|Overall Study|New Cancer Therapy|2|||
19487475|NCT00088205|41775744|FG000|Overall Study|Adverse Event|4|||
19487476|NCT00088205|41775744|FG000|Overall Study|Progressive Disease|51|||
19487477|NCT00088205|41775744|FG000|Overall Study|Physician Decision|1|||
19487478|NCT00088205|41775744|FG000|Overall Study|Death Due to Study Disease|4|||
19487479|NCT00085709|41775838|FG000|Overall Study|Adverse Event|8|||
19487480|NCT00085709|41775839|FG001|Overall Study|Adverse Event|0|||
19487481|NCT00085709|41775838|FG000|Overall Study|Death|8|||
19487482|NCT00085709|41775839|FG001|Overall Study|Death|2|||
19487483|NCT00085709|41775838|FG000|Overall Study|Refusal unrelated to adverse events|1|||
19487484|NCT00085709|41775839|FG001|Overall Study|Refusal unrelated to adverse events|2|||
19487485|NCT00085709|41775838|FG000|Overall Study|Progression|3|||
19487486|NCT00085709|41775839|FG001|Overall Study|Progression|4|||
19487487|NCT00085709|41775838|FG000|Overall Study|Not protocol specified|12|||
19487488|NCT00085709|41775839|FG001|Overall Study|Not protocol specified|22|||
19487489|NCT00085709|41775838|FG000|Overall Study|Not eligible|19|||
19487490|NCT00085709|41775839|FG001|Overall Study|Not eligible|19|||
19487491|NCT00085709|41775838|FG000|Overall Study|Withdrawal by Subject|2|||
19487492|NCT00085709|41775839|FG001|Overall Study|Withdrawal by Subject|1|||
19487493|NCT00085631|41775874|FG000|Overall Study|Missing Data|4|||
19487494|NCT00085631|41775875|FG001|Overall Study|Missing Data|11|||
19487495|NCT00085631|41775876|FG002|Overall Study|Missing Data|7|||
19487496|NCT00084929|41775892|FG000|Overall Study|ineligible - medical contraindication|1|||
19487497|NCT00084929|41775892|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
19487498|NCT00084929|41775892|FG000|Overall Study|Ineligible - Medical history|6|||
19487499|NCT00084929|41775892|FG000|Overall Study|Withdrawal by Subject|10|||
19487500|NCT00084929|41775892|FG000|Overall Study|Missing/incomplete CTC exam|9|||
19487501|NCT00084929|41775892|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
19487502|NCT00084617|41775950|FG000|Overall Study|Withdrawal by Subject|7|||
19487503|NCT00084617|41775950|FG000|Overall Study|Lack of Efficacy|1|||
19487504|NCT00084617|41775950|FG000|Overall Study|Protocol Violation|1|||
19487505|NCT00083915|41776064|FG000|Overall Study|Death|6|||
19487506|NCT00083915|41776065|FG001|Overall Study|Death|3|||
19487507|NCT00083915|41776064|FG000|Overall Study|Physician Decision|11|||
19487508|NCT00083915|41776065|FG001|Overall Study|Physician Decision|6|||
19487509|NCT00083915|41776064|FG000|Overall Study|Withdrawal by Subject|8|||
19487510|NCT00083915|41776065|FG001|Overall Study|Withdrawal by Subject|3|||
19487511|NCT00083915|41776064|FG000|Overall Study|disease progression|18|||
19487512|NCT00083915|41776065|FG001|Overall Study|disease progression|23|||
19487513|NCT00083915|41776064|FG000|Overall Study|Failure to collect|3|||
19487514|NCT00083915|41776065|FG001|Overall Study|Failure to collect|0|||
19487515|NCT00083915|41776064|FG000|Overall Study|No response|3|||
19487516|NCT00083915|41776065|FG001|Overall Study|No response|1|||
19487517|NCT00083915|41776064|FG000|Overall Study|Insurance issues|1|||
19487518|NCT00083915|41776065|FG001|Overall Study|Insurance issues|1|||
19487519|NCT00632749|41776889|FG000|Overall Study|Progressive disease|3|||
19487520|NCT00632749|41776890|FG001|Overall Study|Progressive disease|2|||
19487521|NCT00632749|41776891|FG002|Overall Study|Progressive disease|2|||
19487522|NCT00632749|41776892|FG003|Overall Study|Progressive disease|2|||
19487523|NCT00632749|41776893|FG004|Overall Study|Progressive disease|4|||
19487524|NCT00632749|41776894|FG005|Overall Study|Progressive disease|4|||
19487525|NCT00632749|41776895|FG006|Overall Study|Progressive disease|3|||
19487526|NCT00632749|41776896|FG007|Overall Study|Progressive disease|2|||
19487527|NCT00632749|41776897|FG008|Overall Study|Progressive disease|3|||
19487528|NCT00632749|41776898|FG009|Overall Study|Progressive disease|2|||
19487529|NCT00632749|41776899|FG010|Overall Study|Progressive disease|4|||
19487530|NCT00632749|41776900|FG011|Overall Study|Progressive disease|3|||
19487531|NCT00632749|41776901|FG012|Overall Study|Progressive disease|2|||
19487532|NCT00632749|41776902|FG013|Overall Study|Progressive disease|4|||
19487533|NCT00632749|41776889|FG000|Overall Study|Other Adverse event|1|||
19487534|NCT00632749|41776890|FG001|Overall Study|Other Adverse event|1|||
19487535|NCT00632749|41776891|FG002|Overall Study|Other Adverse event|1|||
19487536|NCT00632749|41776892|FG003|Overall Study|Other Adverse event|1|||
19487537|NCT00632749|41776893|FG004|Overall Study|Other Adverse event|2|||
19487538|NCT00632749|41776894|FG005|Overall Study|Other Adverse event|4|||
19487539|NCT00632749|41776895|FG006|Overall Study|Other Adverse event|1|||
19487540|NCT00632749|41776896|FG007|Overall Study|Other Adverse event|2|||
19487541|NCT00632749|41776897|FG008|Overall Study|Other Adverse event|2|||
19487542|NCT00632749|41776898|FG009|Overall Study|Other Adverse event|0|||
19487543|NCT00632749|41776899|FG010|Overall Study|Other Adverse event|1|||
19487544|NCT00632749|41776900|FG011|Overall Study|Other Adverse event|0|||
19487545|NCT00632749|41776901|FG012|Overall Study|Other Adverse event|1|||
19487546|NCT00632749|41776902|FG013|Overall Study|Other Adverse event|0|||
19487547|NCT00632749|41776889|FG000|Overall Study|Refuse to continue medication|0|||
19487548|NCT00632749|41776890|FG001|Overall Study|Refuse to continue medication|0|||
19487549|NCT00632749|41776891|FG002|Overall Study|Refuse to continue medication|0|||
19487550|NCT00632749|41776892|FG003|Overall Study|Refuse to continue medication|1|||
19487551|NCT00632749|41776893|FG004|Overall Study|Refuse to continue medication|0|||
19487552|NCT00632749|41776894|FG005|Overall Study|Refuse to continue medication|0|||
19487553|NCT00632749|41776895|FG006|Overall Study|Refuse to continue medication|0|||
19487554|NCT00632749|41776896|FG007|Overall Study|Refuse to continue medication|0|||
19487555|NCT00632749|41776897|FG008|Overall Study|Refuse to continue medication|0|||
19487556|NCT00632749|41776898|FG009|Overall Study|Refuse to continue medication|1|||
19487557|NCT00632749|41776899|FG010|Overall Study|Refuse to continue medication|0|||
19487558|NCT00632749|41776900|FG011|Overall Study|Refuse to continue medication|0|||
19487559|NCT00632749|41776901|FG012|Overall Study|Refuse to continue medication|0|||
19487560|NCT00632749|41776902|FG013|Overall Study|Refuse to continue medication|0|||
19487561|NCT00632749|41776889|FG000|Overall Study|Reason other than those specified above|0|||
19487562|NCT00632749|41776890|FG001|Overall Study|Reason other than those specified above|2|||
19487563|NCT00632749|41776891|FG002|Overall Study|Reason other than those specified above|0|||
19487564|NCT00632749|41776892|FG003|Overall Study|Reason other than those specified above|0|||
19487565|NCT00632749|41776893|FG004|Overall Study|Reason other than those specified above|1|||
19487566|NCT00632749|41776894|FG005|Overall Study|Reason other than those specified above|0|||
19487567|NCT00632749|41776895|FG006|Overall Study|Reason other than those specified above|1|||
19487568|NCT00632749|41776896|FG007|Overall Study|Reason other than those specified above|0|||
19487569|NCT00632749|41776897|FG008|Overall Study|Reason other than those specified above|0|||
19487570|NCT00632749|41776898|FG009|Overall Study|Reason other than those specified above|0|||
19487571|NCT00632749|41776899|FG010|Overall Study|Reason other than those specified above|2|||
19487572|NCT00632749|41776900|FG011|Overall Study|Reason other than those specified above|1|||
19487573|NCT00632749|41776901|FG012|Overall Study|Reason other than those specified above|0|||
19487574|NCT00632749|41776902|FG013|Overall Study|Reason other than those specified above|2|||
19487575|NCT00632359|41776972|FG000|Overall Study|Withdrawal by Subject|2|||
19487576|NCT00632203|41776979|FG000|Overall Study|Did not start study treatment|1|||
19487577|NCT00632203|41776980|FG001|Overall Study|Did not start study treatment|0|||
19487578|NCT03830333|41777001|FG000|Overall Study|Death|0|||
19487579|NCT03830333|41777002|FG001|Overall Study|Death|1|||
19487580|NCT03830333|41777001|FG000|Overall Study|Withdrawal by Subject|5|||
19487581|NCT03830333|41777002|FG001|Overall Study|Withdrawal by Subject|1|||
19487582|NCT03830333|41777001|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
19487583|NCT03830333|41777002|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
19487584|NCT00631969|41777088|FG000|Overall Study|Adverse Event|3|||
19612640|NCT00573313|42061450|FG002|Overall Study|Protocol Violation|6|||
19612641|NCT00573313|42061451|FG003|Overall Study|Protocol Violation|0|||
19612642|NCT00953615|42061477|FG000|Overall Study|Adverse Event|1|||
19612643|NCT00810615|42061483|FG000|Overall Study|Withdrawal by Subject|1|||
19612644|NCT00810615|42061484|FG001|Overall Study|Withdrawal by Subject|1|||
19612645|NCT00573391|42061509|FG000|Overall Study|study stopped|2|||
19612646|NCT00573391|42061510|FG001|Overall Study|study stopped|2|||
19612647|NCT00573391|42061509|FG000|Overall Study|Death|1|||
19612648|NCT00573391|42061510|FG001|Overall Study|Death|0|||
19612649|NCT00590967|42061518|FG000|Overall Study|Withdrawal by Subject|1|||
19612650|NCT00590967|42061519|FG001|Overall Study|Withdrawal by Subject|1|||
19612651|NCT00590967|42061518|FG000|Overall Study|Ineligible|1|||
19612652|NCT00590967|42061519|FG001|Overall Study|Ineligible|0|||
19612653|NCT00590967|42061518|FG000|Overall Study|Poor performance status|0|||
19612654|NCT00590967|42061519|FG001|Overall Study|Poor performance status|1|||
19612655|NCT00590967|42061518|FG000|Overall Study|Non-compliant|0|||
19612656|NCT00590967|42061519|FG001|Overall Study|Non-compliant|2|||
19612657|NCT00590967|42061518|FG000|Overall Study|Did not sign consent form|0|||
19612658|NCT00590967|42061519|FG001|Overall Study|Did not sign consent form|1|||
19612659|NCT00590967|42061518|FG000|Overall Study|Did not receive chemo per protocol|1|||
19612660|NCT00590967|42061519|FG001|Overall Study|Did not receive chemo per protocol|0|||
19612661|NCT00590577|42061529|FG000|Overall Study|Lack of Efficacy|31|||
19612662|NCT00590577|42061530|FG001|Overall Study|Lack of Efficacy|28|||
19612663|NCT00590577|42061531|FG002|Overall Study|Lack of Efficacy|23|||
19612664|NCT00590577|42061532|FG003|Overall Study|Lack of Efficacy|45|||
19612665|NCT00590577|42061529|FG000|Overall Study|Withdrawal by Subject|23|||
19612666|NCT00590577|42061530|FG001|Overall Study|Withdrawal by Subject|28|||
19612667|NCT00590577|42061531|FG002|Overall Study|Withdrawal by Subject|30|||
19612668|NCT00590577|42061532|FG003|Overall Study|Withdrawal by Subject|26|||
19612669|NCT00590577|42061529|FG000|Overall Study|Adverse Event|10|||
19612670|NCT00590577|42061530|FG001|Overall Study|Adverse Event|10|||
19612671|NCT00590577|42061531|FG002|Overall Study|Adverse Event|13|||
19612672|NCT00590577|42061532|FG003|Overall Study|Adverse Event|11|||
19612673|NCT00590577|42061529|FG000|Overall Study|Lost to Follow-up|12|||
19612674|NCT00590577|42061530|FG001|Overall Study|Lost to Follow-up|6|||
19612675|NCT00590577|42061531|FG002|Overall Study|Lost to Follow-up|6|||
19487585|NCT00631969|41777089|FG001|Overall Study|Adverse Event|1|||
19487586|NCT00631969|41777088|FG000|Overall Study|Lack of Efficacy|2|||
19487587|NCT00631969|41777089|FG001|Overall Study|Lack of Efficacy|8|||
19487588|NCT00631969|41777088|FG000|Overall Study|Lost to Follow-up|2|||
19487589|NCT00631969|41777089|FG001|Overall Study|Lost to Follow-up|1|||
19487590|NCT00631969|41777088|FG000|Overall Study|Protocol Violation|1|||
19487591|NCT00631969|41777089|FG001|Overall Study|Protocol Violation|1|||
19487592|NCT00631969|41777088|FG000|Overall Study|Consent Withdrawn|5|||
19487593|NCT00631969|41777089|FG001|Overall Study|Consent Withdrawn|7|||
19487594|NCT00631969|41777088|FG000|Overall Study|Noncompliant With Study Medication|0|||
19487595|NCT00631969|41777089|FG001|Overall Study|Noncompliant With Study Medication|1|||
19487596|NCT00631969|41777088|FG000|Overall Study|No Drug Exposure|2|||
19487597|NCT00631969|41777089|FG001|Overall Study|No Drug Exposure|2|||
19487598|NCT00631657|41777125|FG000|6-Month Treatment Period|Adverse Event|47|||
19487599|NCT00631657|41777126|FG001|6-Month Treatment Period|Adverse Event|0|||
19487600|NCT00631657|41777127|FG002|6-Month Treatment Period|Adverse Event|7|||
19487601|NCT00631657|41777125|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
19487602|NCT00631657|41777126|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
19487603|NCT00631657|41777127|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
19487604|NCT00631657|41777125|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
19487605|NCT00631657|41777126|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
19487606|NCT00631657|41777127|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
19487607|NCT00631657|41777125|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
19487608|NCT00631657|41777126|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
19487609|NCT00631657|41777127|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
19487610|NCT00631657|41777125|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
19487611|NCT00631657|41777126|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
19487612|NCT00631657|41777127|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
19487613|NCT00631657|41777125|FG000|6-Month Treatment Period|Other|16|||
19487614|NCT00631657|41777126|FG001|6-Month Treatment Period|Other|0|||
19487615|NCT00631657|41777127|FG002|6-Month Treatment Period|Other|4|||
19487616|NCT00631657|41777125|FG000|6-Month Treatment Period|Not Treated|2|||
19487617|NCT00631657|41777126|FG001|6-Month Treatment Period|Not Treated|0|||
19487618|NCT00631657|41777127|FG002|6-Month Treatment Period|Not Treated|1|||
19487619|NCT00631657|41777125|FG000|7-Day Discontinuation Period|Not Treated|1|||
19487620|NCT00631657|41777126|FG001|7-Day Discontinuation Period|Not Treated|1|||
19487621|NCT00631657|41777127|FG002|7-Day Discontinuation Period|Not Treated|1|||
19487622|NCT00631657|41777125|FG000|7-Day Discontinuation Period|Other|1|||
19487623|NCT00631657|41777126|FG001|7-Day Discontinuation Period|Other|0|||
19487624|NCT00631657|41777127|FG002|7-Day Discontinuation Period|Other|0|||
19487625|NCT00631189|41777165|FG000|Initial Phase|Protocol Violation|347|||
19487626|NCT00631189|41777166|FG001|Initial Phase|Protocol Violation|0|||
19487627|NCT00631189|41777167|FG002|Initial Phase|Protocol Violation|0|||
19487628|NCT00631189|41777168|FG003|Initial Phase|Protocol Violation|0|||
19487629|NCT00631189|41777165|FG000|Initial Phase|Withdrawal by Subject|4|||
19487630|NCT00631189|41777166|FG001|Initial Phase|Withdrawal by Subject|0|||
19487631|NCT00631189|41777167|FG002|Initial Phase|Withdrawal by Subject|0|||
19487632|NCT00631189|41777168|FG003|Initial Phase|Withdrawal by Subject|0|||
19487633|NCT00631189|41777165|FG000|Treatment Phase|Withdrawal by Subject|0|||
19487634|NCT00631189|41777166|FG001|Treatment Phase|Withdrawal by Subject|2|||
19487635|NCT00631189|41777167|FG002|Treatment Phase|Withdrawal by Subject|1|||
19487636|NCT00631189|41777168|FG003|Treatment Phase|Withdrawal by Subject|1|||
19487637|NCT00631189|41777165|FG000|Treatment Phase|Protocol Violation|0|||
19487638|NCT00631189|41777166|FG001|Treatment Phase|Protocol Violation|1|||
19487639|NCT00631189|41777167|FG002|Treatment Phase|Protocol Violation|6|||
19487640|NCT00631189|41777168|FG003|Treatment Phase|Protocol Violation|2|||
19487641|NCT00631189|41777165|FG000|Treatment Phase|Adverse Event|0|||
19487642|NCT00631189|41777166|FG001|Treatment Phase|Adverse Event|3|||
19487643|NCT00631189|41777167|FG002|Treatment Phase|Adverse Event|2|||
19487644|NCT00631189|41777168|FG003|Treatment Phase|Adverse Event|4|||
19487645|NCT00631189|41777165|FG000|Treatment Phase|Lost to Follow-up|0|||
19487646|NCT00631189|41777166|FG001|Treatment Phase|Lost to Follow-up|1|||
19487647|NCT00631189|41777167|FG002|Treatment Phase|Lost to Follow-up|0|||
19487648|NCT00631189|41777168|FG003|Treatment Phase|Lost to Follow-up|0|||
19487649|NCT00631189|41777165|FG000|Treatment Phase|Pregnancy|0|||
19487650|NCT00631189|41777166|FG001|Treatment Phase|Pregnancy|0|||
19487651|NCT00631189|41777167|FG002|Treatment Phase|Pregnancy|1|||
19487652|NCT00631189|41777168|FG003|Treatment Phase|Pregnancy|0|||
19487653|NCT00631189|41777165|FG000|Treatment Phase|patient did not take pravastatin|0|||
19487654|NCT00631189|41777166|FG001|Treatment Phase|patient did not take pravastatin|0|||
19487655|NCT00631189|41777167|FG002|Treatment Phase|patient did not take pravastatin|1|||
19487656|NCT00631189|41777168|FG003|Treatment Phase|patient did not take pravastatin|0|||
19487657|NCT00630877|41777181|FG000|Overall Study|Adverse Event|11|||
19487658|NCT00630877|41777182|FG001|Overall Study|Adverse Event|8|||
19487659|NCT00630877|41777183|FG002|Overall Study|Adverse Event|7|||
19487660|NCT00630877|41777181|FG000|Overall Study|Withdrawal by Subject|3|||
19487661|NCT00630877|41777182|FG001|Overall Study|Withdrawal by Subject|4|||
19487662|NCT00630877|41777183|FG002|Overall Study|Withdrawal by Subject|0|||
19487663|NCT00630877|41777181|FG000|Overall Study|Lost to Follow-up|2|||
19487664|NCT00630877|41777182|FG001|Overall Study|Lost to Follow-up|0|||
19487665|NCT00630877|41777183|FG002|Overall Study|Lost to Follow-up|0|||
19487666|NCT00630877|41777181|FG000|Overall Study|Noncompliance|2|||
19487667|NCT00630877|41777182|FG001|Overall Study|Noncompliance|3|||
19487668|NCT00630877|41777183|FG002|Overall Study|Noncompliance|1|||
19487669|NCT00630877|41777181|FG000|Overall Study|Protocol violation|1|||
19487670|NCT00630877|41777182|FG001|Overall Study|Protocol violation|0|||
19487671|NCT00630877|41777183|FG002|Overall Study|Protocol violation|1|||
19487672|NCT00630877|41777181|FG000|Overall Study|Personal reasons|0|||
19487673|NCT00630877|41777182|FG001|Overall Study|Personal reasons|0|||
19487674|NCT00630877|41777183|FG002|Overall Study|Personal reasons|1|||
19487675|NCT02915783|41777195|FG000|Overall Study|Death|21|||
19487676|NCT02915783|41777195|FG000|Overall Study|Lost to Follow-up|1|||
19487677|NCT02915783|41777195|FG000|Overall Study|Withdrawal by Subject|2|||
19487678|NCT00630331|41777210|FG000|Overall Study|Death|2|||
19487679|NCT00630331|41777211|FG001|Overall Study|Death|1|||
19487680|NCT00630331|41777212|FG002|Overall Study|Death|1|||
19487681|NCT00630331|41777210|FG000|Overall Study|Adverse Event|1|||
19487682|NCT00630331|41777211|FG001|Overall Study|Adverse Event|0|||
19487683|NCT00630331|41777212|FG002|Overall Study|Adverse Event|0|||
19487684|NCT00630331|41777210|FG000|Overall Study|Withdrawal by Subject|12|||
19487685|NCT00630331|41777211|FG001|Overall Study|Withdrawal by Subject|7|||
19487686|NCT00630331|41777212|FG002|Overall Study|Withdrawal by Subject|5|||
19487687|NCT00630331|41777210|FG000|Overall Study|Lost to Follow-up|175|||
19487688|NCT00630331|41777211|FG001|Overall Study|Lost to Follow-up|143|||
19487689|NCT00630331|41777212|FG002|Overall Study|Lost to Follow-up|170|||
19487690|NCT00630331|41777210|FG000|Overall Study|Inappropriate enrollment|3|||
19487691|NCT00630331|41777211|FG001|Overall Study|Inappropriate enrollment|6|||
19487692|NCT00630331|41777212|FG002|Overall Study|Inappropriate enrollment|3|||
19487693|NCT00630331|41777210|FG000|Overall Study|Unable to classify|9|||
19487694|NCT00630331|41777211|FG001|Overall Study|Unable to classify|4|||
19487695|NCT00630331|41777212|FG002|Overall Study|Unable to classify|3|||
19487696|NCT00630331|41777210|FG000|Overall Study|Protocol Violation|4|||
19487697|NCT00630331|41777211|FG001|Overall Study|Protocol Violation|5|||
19487698|NCT00630331|41777212|FG002|Overall Study|Protocol Violation|6|||
19487699|NCT00639509|41777264|FG000|Overall Study|Death|1|||
19487700|NCT00638963|41777270|FG000|Overall Study|Withdrawal by Subject|1|||
19487701|NCT00638963|41777271|FG001|Overall Study|Withdrawal by Subject|0|||
19487702|NCT00638183|41777277|FG000|Overall Study|Adverse Event|23|||
19487703|NCT00638183|41777277|FG000|Overall Study|Lack of Efficacy|14|||
19487704|NCT00638183|41777277|FG000|Overall Study|Physician Decision|9|||
19487705|NCT00638183|41777277|FG000|Overall Study|Lost to Follow-up|46|||
19487706|NCT00638183|41777277|FG000|Overall Study|Other reason not defined above|27|||
19487707|NCT00638027|41777283|FG000|Overall Study|Adverse Event|0|||
19487708|NCT00638027|41777284|FG001|Overall Study|Adverse Event|2|||
19487709|NCT00636155|41777290|FG000|Overall Study|Adverse Event|8|||
19487710|NCT00636155|41777290|FG000|Overall Study|Lack of Efficacy|1|||
19487711|NCT00636155|41777290|FG000|Overall Study|Withdrawal by Subject|3|||
19487712|NCT00636155|41777290|FG000|Overall Study|Stem cell transplant|1|||
19487713|NCT00636155|41777290|FG000|Overall Study|Physician Decision|5|||
19487714|NCT00634907|41777296|FG000|Overall Study|Withdrawal by Subject|3|||
19487715|NCT00634907|41777297|FG001|Overall Study|Withdrawal by Subject|0|||
19487716|NCT00634907|41777296|FG000|Overall Study|Physician Decision|3|||
19487717|NCT00634907|41777297|FG001|Overall Study|Physician Decision|9|||
19487718|NCT00634907|41777296|FG000|Overall Study|Withdrawal by Subject|11|||
19487719|NCT00634907|41777297|FG001|Overall Study|Withdrawal by Subject|8|||
19487720|NCT00634751|41777311|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
19487721|NCT00634751|41777312|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
19487722|NCT00634751|41777313|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
19487723|NCT00634751|41777314|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
19487724|NCT00634751|41777311|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
19487725|NCT00634751|41777312|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
19487726|NCT00634751|41777313|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
19487727|NCT00634751|41777314|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
19487728|NCT00634751|41777311|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
19487729|NCT00634751|41777312|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
19487730|NCT00634751|41777313|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
19487731|NCT00634751|41777314|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
19487732|NCT00634049|41777353|FG000|Overall Study|Never received study drug|1|||
19487733|NCT00634049|41777353|FG000|Overall Study|Died prior to receiving study drug|1|||
19487734|NCT00634049|41777353|FG000|Overall Study|Screening failure|1|||
19487735|NCT00632099|41777392|FG000|Overall Study|Lost to Follow-up|3|||
19487736|NCT00632099|41777393|FG001|Overall Study|Lost to Follow-up|3|||
19487737|NCT00632021|41777401|FG000|Overall Study|Withdrawal/death|4|||
19487738|NCT00632021|41777402|FG001|Overall Study|Withdrawal/death|7|||
19487739|NCT00631475|41777409|FG000|Overall Study|Death|18|||
19487740|NCT00631475|41777409|FG000|Overall Study|Adverse Event|14|||
19487741|NCT00631475|41777409|FG000|Overall Study|Withdrew consent|5|||
19487742|NCT00631475|41777409|FG000|Overall Study|Preparation for lung transplant|8|||
19487743|NCT00631163|41777430|FG000|Number of Participants in Year 1|Adverse Event|12|||
19487744|NCT00631163|41777430|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
19487745|NCT00631163|41777430|FG000|Number of Participants in Year 1|Death|6|||
19487746|NCT00631163|41777430|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
19487747|NCT00631163|41777430|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
19487748|NCT00631163|41777430|FG000|Number of Participants in Year 1|Administrative problems|6|||
19487749|NCT00631163|41777430|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
19487750|NCT00631163|41777430|FG000|Number of Participants in Year 2|Adverse Event|1|||
19487751|NCT00631163|41777430|FG000|Number of Participants in Year 2|Protocol Violation|1|||
19487752|NCT00631163|41777430|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
19487753|NCT00631007|41777447|FG000|Overall Study|Adverse Event|0|||
19487754|NCT00631007|41777448|FG001|Overall Study|Adverse Event|2|||
19487755|NCT00631007|41777449|FG002|Overall Study|Adverse Event|0|||
19487756|NCT00631007|41777450|FG003|Overall Study|Adverse Event|2|||
19487757|NCT00631007|41777451|FG004|Overall Study|Adverse Event|3|||
19487758|NCT00631007|41777452|FG005|Overall Study|Adverse Event|2|||
19487759|NCT00631007|41777447|FG000|Overall Study|Lost to Follow-up|2|||
19487760|NCT00631007|41777448|FG001|Overall Study|Lost to Follow-up|1|||
19487761|NCT00631007|41777449|FG002|Overall Study|Lost to Follow-up|2|||
19487762|NCT00631007|41777450|FG003|Overall Study|Lost to Follow-up|4|||
19487763|NCT00631007|41777451|FG004|Overall Study|Lost to Follow-up|5|||
19487764|NCT00631007|41777452|FG005|Overall Study|Lost to Follow-up|3|||
19487765|NCT00631007|41777447|FG000|Overall Study|Physician Decision|1|||
19487766|NCT00631007|41777448|FG001|Overall Study|Physician Decision|0|||
19487767|NCT00631007|41777449|FG002|Overall Study|Physician Decision|1|||
19487768|NCT00631007|41777450|FG003|Overall Study|Physician Decision|0|||
19487769|NCT00631007|41777451|FG004|Overall Study|Physician Decision|0|||
19487770|NCT00631007|41777452|FG005|Overall Study|Physician Decision|2|||
19487771|NCT00631007|41777447|FG000|Overall Study|Persistent Hyperglycemia|2|||
19487772|NCT00631007|41777448|FG001|Overall Study|Persistent Hyperglycemia|2|||
19487773|NCT00631007|41777449|FG002|Overall Study|Persistent Hyperglycemia|5|||
19487774|NCT00631007|41777450|FG003|Overall Study|Persistent Hyperglycemia|1|||
19487775|NCT00631007|41777451|FG004|Overall Study|Persistent Hyperglycemia|2|||
19487776|NCT00631007|41777452|FG005|Overall Study|Persistent Hyperglycemia|5|||
19487777|NCT00631007|41777447|FG000|Overall Study|Withdrawal by Subject|4|||
19487778|NCT00631007|41777448|FG001|Overall Study|Withdrawal by Subject|5|||
19487779|NCT00631007|41777449|FG002|Overall Study|Withdrawal by Subject|2|||
19487780|NCT00631007|41777450|FG003|Overall Study|Withdrawal by Subject|2|||
19487781|NCT00631007|41777451|FG004|Overall Study|Withdrawal by Subject|1|||
19487782|NCT00631007|41777452|FG005|Overall Study|Withdrawal by Subject|3|||
19487783|NCT00631007|41777447|FG000|Overall Study|Other|2|||
19487784|NCT00631007|41777448|FG001|Overall Study|Other|1|||
19487785|NCT00631007|41777449|FG002|Overall Study|Other|0|||
19487786|NCT00631007|41777450|FG003|Overall Study|Other|0|||
19487787|NCT00631007|41777451|FG004|Overall Study|Other|1|||
19487788|NCT00631007|41777452|FG005|Overall Study|Other|0|||
19487789|NCT00630539|41777479|FG000|Overall Study|Adverse Event|1|||
19487790|NCT00630539|41777480|FG001|Overall Study|Adverse Event|3|||
19487791|NCT00630539|41777481|FG002|Overall Study|Adverse Event|1|||
19487792|NCT00630539|41777482|FG003|Overall Study|Adverse Event|2|||
19487793|NCT00630539|41777479|FG000|Overall Study|Withdrawal by Subject|0|||
19487794|NCT00630539|41777480|FG001|Overall Study|Withdrawal by Subject|1|||
19487795|NCT00630539|41777481|FG002|Overall Study|Withdrawal by Subject|0|||
19487796|NCT00630539|41777482|FG003|Overall Study|Withdrawal by Subject|1|||
19487797|NCT00630305|41777560|FG000|Overall Study|Withdrawal by Subject|1|||
19487798|NCT00630305|41777560|FG000|Overall Study|Inability to insert contact lens|1|||
19487799|NCT01926197|41777795|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
19487800|NCT01926197|41777796|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
19487801|NCT01926197|41777795|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
19487802|NCT01926197|41777796|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
19487803|NCT00989963|41777821|FG000|Overall Study|Adverse Event|1|||
19487804|NCT00989963|41777822|FG001|Overall Study|Adverse Event|1|||
19487805|NCT00989963|41777823|FG002|Overall Study|Adverse Event|1|||
19487806|NCT00989573|41777861|FG000|Overall Study|Adverse Event|8|||
19487807|NCT00989573|41777862|FG001|Overall Study|Adverse Event|12|||
19487808|NCT00989573|41777863|FG002|Overall Study|Adverse Event|4|||
19487809|NCT00989573|41777861|FG000|Overall Study|Physician Decision|0|||
19487810|NCT00989573|41777862|FG001|Overall Study|Physician Decision|2|||
19487811|NCT00989573|41777863|FG002|Overall Study|Physician Decision|0|||
19487812|NCT00989573|41777861|FG000|Overall Study|Protocol Violation|1|||
19487813|NCT00989573|41777862|FG001|Overall Study|Protocol Violation|1|||
19487814|NCT00989573|41777863|FG002|Overall Study|Protocol Violation|1|||
19487815|NCT00989573|41777861|FG000|Overall Study|Withdrawal by Subject|4|||
19487816|NCT00989573|41777862|FG001|Overall Study|Withdrawal by Subject|7|||
19487817|NCT00989573|41777863|FG002|Overall Study|Withdrawal by Subject|3|||
19487818|NCT04126213|41777937|FG000|Overall Study|Lost to Follow-up|9|||
19487819|NCT04126213|41777938|FG001|Overall Study|Lost to Follow-up|1|||
19487820|NCT04126213|41777939|FG002|Overall Study|Lost to Follow-up|5|||
19487821|NCT04126213|41777940|FG003|Overall Study|Lost to Follow-up|10|||
19487822|NCT04126213|41777941|FG004|Overall Study|Lost to Follow-up|4|||
19487823|NCT04126213|41777942|FG005|Overall Study|Lost to Follow-up|7|||
19487824|NCT04126213|41777937|FG000|Overall Study|Withdrawal by Subject|3|||
19373665|NCT02760407|41614834|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
19373666|NCT02760407|41614835|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
19373667|NCT02760407|41614836|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
19373668|NCT02760407|41614833|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
19373669|NCT02760407|41614834|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
19487825|NCT04126213|41777938|FG001|Overall Study|Withdrawal by Subject|2|||
19487826|NCT04126213|41777939|FG002|Overall Study|Withdrawal by Subject|1|||
19487827|NCT04126213|41777940|FG003|Overall Study|Withdrawal by Subject|1|||
19487828|NCT04126213|41777941|FG004|Overall Study|Withdrawal by Subject|1|||
19487829|NCT04126213|41777942|FG005|Overall Study|Withdrawal by Subject|1|||
19487830|NCT04126213|41777937|FG000|Overall Study|Other|0|||
19487831|NCT04126213|41777938|FG001|Overall Study|Other|0|||
19487832|NCT04126213|41777939|FG002|Overall Study|Other|2|||
19487833|NCT04126213|41777940|FG003|Overall Study|Other|2|||
19487834|NCT04126213|41777941|FG004|Overall Study|Other|0|||
19487835|NCT04126213|41777942|FG005|Overall Study|Other|1|||
19487836|NCT04126213|41777937|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19487837|NCT04126213|41777938|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
19487838|NCT04126213|41777939|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19487839|NCT04126213|41777940|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19487840|NCT04126213|41777941|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19487841|NCT04126213|41777942|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
19487842|NCT04128319|41777959|FG000|Overall Study|Death|3|||
19487843|NCT05038293|41778005|FG000|Overall Study|device was not operating properly for one subject.|1|||
19487844|NCT05038293|41778006|FG001|Overall Study|device was not operating properly for one subject.|0|||
19487845|NCT05038293|41778005|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
19487846|NCT05038293|41778006|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
19487847|NCT05013008|41778014|FG000|Overall Study|Exclusion from mBFAS|5|||
19487848|NCT05013008|41778015|FG001|Overall Study|Exclusion from mBFAS|25|||
19487849|NCT04753164|41778032|FG000|Overall Study|Adverse Event|0|||
19487850|NCT04753164|41778033|FG001|Overall Study|Adverse Event|2|||
19487851|NCT04753164|41778032|FG000|Overall Study|Withdrawal by Subject|9|||
19487852|NCT04753164|41778033|FG001|Overall Study|Withdrawal by Subject|7|||
19487853|NCT04753164|41778032|FG000|Overall Study|Lost to Follow-up|6|||
19487854|NCT04753164|41778033|FG001|Overall Study|Lost to Follow-up|6|||
19487855|NCT04753164|41778032|FG000|Overall Study|Other|12|||
19487856|NCT04753164|41778033|FG001|Overall Study|Other|5|||
19487857|NCT04729101|41778041|FG000|Overall Study|Adverse Event|1|||
19487858|NCT04729101|41778042|FG001|Overall Study|Adverse Event|0|||
19487859|NCT04729101|41778041|FG000|Overall Study|Physician Decision|1|||
19487860|NCT04729101|41778042|FG001|Overall Study|Physician Decision|0|||
19487861|NCT04729101|41778041|FG000|Overall Study|Withdrawal by Subject|1|||
19487862|NCT04729101|41778042|FG001|Overall Study|Withdrawal by Subject|0|||
19487863|NCT04569968|41778054|FG000|Overall Study|Lost to Follow-up|2|||
19487864|NCT04569968|41778055|FG001|Overall Study|Lost to Follow-up|5|||
19487865|NCT04569968|41778054|FG000|Overall Study|Story of head and/or neck surgery|2|||
19487866|NCT04569968|41778055|FG001|Overall Study|Story of head and/or neck surgery|2|||
19487867|NCT04569968|41778054|FG000|Overall Study|Time of stroke onset|8|||
19487868|NCT04569968|41778055|FG001|Overall Study|Time of stroke onset|7|||
19487869|NCT04569968|41778054|FG000|Overall Study|Type of strokr|12|||
19487870|NCT04569968|41778055|FG001|Overall Study|Type of strokr|8|||
19487871|NCT04569968|41778054|FG000|Overall Study|Cooperation|8|||
19487872|NCT04569968|41778055|FG001|Overall Study|Cooperation|8|||
19487873|NCT04569968|41778054|FG000|Overall Study|Age interval|17|||
19487874|NCT04569968|41778055|FG001|Overall Study|Age interval|6|||
19487875|NCT04569968|41778054|FG000|Overall Study|Denial of participation to the study|0|||
19487876|NCT04569968|41778055|FG001|Overall Study|Denial of participation to the study|3|||
19487877|NCT04569968|41778054|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
19487878|NCT04569968|41778055|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
19487879|NCT04569968|41778054|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
19487880|NCT04569968|41778055|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
19487881|NCT04569968|41778054|FG000|Overall Study|Quarantine|1|||
19487882|NCT04569968|41778055|FG001|Overall Study|Quarantine|0|||
19487883|NCT04569968|41778054|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
19612676|NCT00590577|42061532|FG003|Overall Study|Lost to Follow-up|9|||
19487884|NCT04569968|41778055|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
19487885|NCT04569968|41778054|FG000|Overall Study|Repetitive stroke|8|||
19487886|NCT04569968|41778055|FG001|Overall Study|Repetitive stroke|0|||
19487887|NCT04569968|41778054|FG000|Overall Study|Insufficient mastication|1|||
19487888|NCT04569968|41778055|FG001|Overall Study|Insufficient mastication|0|||
19487889|NCT04569968|41778054|FG000|Overall Study|Infection|1|||
19487890|NCT04569968|41778055|FG001|Overall Study|Infection|0|||
19487891|NCT03515811|41778081|FG000|Overall Study|Lost to Follow-up|2|||
19487892|NCT03515811|41778082|FG001|Overall Study|Lost to Follow-up|1|||
19487893|NCT03515811|41778081|FG000|Overall Study|Protocol Violation|1|||
19487894|NCT03515811|41778082|FG001|Overall Study|Protocol Violation|1|||
19487895|NCT03515811|41778081|FG000|Overall Study|Death|1|||
19487896|NCT03515811|41778082|FG001|Overall Study|Death|1|||
19487897|NCT03515811|41778081|FG000|Overall Study|Withdrawal by Subject|0|||
19487898|NCT03515811|41778082|FG001|Overall Study|Withdrawal by Subject|2|||
19487899|NCT03515811|41778081|FG000|Overall Study|Technical Problems|1|||
19487900|NCT03515811|41778082|FG001|Overall Study|Technical Problems|0|||
19487901|NCT03515811|41778081|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
19487902|NCT03515811|41778082|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
19487903|NCT03515811|41778081|FG000|Overall Study|COVID-19|0|||
19487904|NCT03515811|41778082|FG001|Overall Study|COVID-19|1|||
19487905|NCT03385304|41778093|FG000|Overall Study|Death|19|||
19487906|NCT03385304|41778094|FG001|Overall Study|Death|7|||
19487907|NCT03385304|41778093|FG000|Overall Study|Lost to Follow-up|17|||
19487908|NCT03385304|41778094|FG001|Overall Study|Lost to Follow-up|14|||
19487909|NCT03385304|41778093|FG000|Overall Study|Withdrawal by Subject|3|||
19487910|NCT03385304|41778094|FG001|Overall Study|Withdrawal by Subject|2|||
19487911|NCT03385304|41778093|FG000|Overall Study|Incarceration|2|||
19487912|NCT03385304|41778094|FG001|Overall Study|Incarceration|3|||
19487913|NCT03325608|41778104|FG000|Overall Study|Lost to Follow-up|47|||
19487914|NCT03325608|41778105|FG001|Overall Study|Lost to Follow-up|47|||
19487915|NCT03325608|41778106|FG002|Overall Study|Lost to Follow-up|41|||
19487916|NCT03325608|41778107|FG003|Overall Study|Lost to Follow-up|41|||
19487917|NCT03325608|41778104|FG000|Overall Study|Death|44|||
19487918|NCT03325608|41778105|FG001|Overall Study|Death|0|||
19487919|NCT03325608|41778106|FG002|Overall Study|Death|41|||
19487920|NCT03325608|41778107|FG003|Overall Study|Death|0|||
19487921|NCT03325608|41778104|FG000|Overall Study|Death of Care Recipient|0|||
19487922|NCT03325608|41778105|FG001|Overall Study|Death of Care Recipient|44|||
19487923|NCT03325608|41778106|FG002|Overall Study|Death of Care Recipient|0|||
19487924|NCT03325608|41778107|FG003|Overall Study|Death of Care Recipient|41|||
19487925|NCT03325608|41778104|FG000|Overall Study|Withdrawal by Subject|44|||
19487926|NCT03325608|41778105|FG001|Overall Study|Withdrawal by Subject|44|||
19487927|NCT03325608|41778106|FG002|Overall Study|Withdrawal by Subject|30|||
19487928|NCT03325608|41778107|FG003|Overall Study|Withdrawal by Subject|30|||
19487929|NCT03183141|41778117|FG000|Overall Study|Withdrawal by Subject|2|||
19487930|NCT03183141|41778118|FG001|Overall Study|Withdrawal by Subject|4|||
19487931|NCT03183141|41778117|FG000|Overall Study|Death|0|||
19487932|NCT03183141|41778118|FG001|Overall Study|Death|8|||
19487933|NCT03173248|41778126|FG000|Overall Study|Death|28|||
19487934|NCT03173248|41778127|FG001|Overall Study|Death|46|||
19487935|NCT03173248|41778126|FG000|Overall Study|Lost to Follow-up|0|||
19487936|NCT03173248|41778127|FG001|Overall Study|Lost to Follow-up|1|||
19487937|NCT03173248|41778126|FG000|Overall Study|Withdrawal by Subject|6|||
19487938|NCT03173248|41778127|FG001|Overall Study|Withdrawal by Subject|4|||
19487939|NCT03173248|41778126|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
19487940|NCT03173248|41778127|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
19487941|NCT02957539|41778136|FG000|Baseline to Week 16|Lost to Follow-up|8|||
19487942|NCT02957539|41778137|FG001|Baseline to Week 16|Lost to Follow-up|10|||
19487943|NCT02957539|41778138|FG002|Baseline to Week 16|Lost to Follow-up|16|||
19487944|NCT02957539|41778136|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
19487945|NCT02957539|41778137|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
19487946|NCT02957539|41778138|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
19487947|NCT02957539|41778136|FG000|Week 16 to 32|Withdrawal by Subject|3|||
19487948|NCT02957539|41778137|FG001|Week 16 to 32|Withdrawal by Subject|3|||
19487949|NCT02957539|41778138|FG002|Week 16 to 32|Withdrawal by Subject|1|||
19487950|NCT02957539|41778136|FG000|Week 16 to 32|Lost to Follow-up|8|||
19487951|NCT02957539|41778137|FG001|Week 16 to 32|Lost to Follow-up|7|||
19487952|NCT02957539|41778138|FG002|Week 16 to 32|Lost to Follow-up|5|||
19487953|NCT02957539|41778136|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
19487954|NCT02957539|41778137|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
19487955|NCT02957539|41778138|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
19487956|NCT02957539|41778136|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
19487957|NCT02957539|41778137|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
19487958|NCT02957539|41778138|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
19487959|NCT02928224|41778153|FG000|Overall Study|Randomized, Not Treated|0|||
19487960|NCT02928224|41778154|FG001|Overall Study|Randomized, Not Treated|2|||
19487961|NCT02928224|41778155|FG002|Overall Study|Randomized, Not Treated|4|||
19487962|NCT02928224|41778156|FG003|Overall Study|Randomized, Not Treated|28|||
19487963|NCT02928224|41778153|FG000|Overall Study|Treatment Ongoing|6|||
19487964|NCT02928224|41778154|FG001|Overall Study|Treatment Ongoing|78|||
19487965|NCT02928224|41778155|FG002|Overall Study|Treatment Ongoing|78|||
19487966|NCT02928224|41778156|FG003|Overall Study|Treatment Ongoing|37|||
19487967|NCT02928224|41778153|FG000|Overall Study|Progressive Disease|23|||
19487968|NCT02928224|41778154|FG001|Overall Study|Progressive Disease|104|||
19487969|NCT02928224|41778155|FG002|Overall Study|Progressive Disease|101|||
19487970|NCT02928224|41778156|FG003|Overall Study|Progressive Disease|103|||
19487971|NCT02928224|41778153|FG000|Overall Study|Adverse Event|2|||
19487972|NCT02928224|41778154|FG001|Overall Study|Adverse Event|11|||
19487973|NCT02928224|41778155|FG002|Overall Study|Adverse Event|11|||
19487974|NCT02928224|41778156|FG003|Overall Study|Adverse Event|10|||
19393485|NCT02660359|41637358|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
19393486|NCT02660359|41637356|FG000|Overall Study|Lack of Efficacy|1|||
19393487|NCT02660359|41637357|FG001|Overall Study|Lack of Efficacy|1|||
19393488|NCT02660359|41637358|FG002|Overall Study|Lack of Efficacy|1|||
19393489|NCT02660359|41637356|FG000|Overall Study|Adverse Event|0|||
19487975|NCT02928224|41778153|FG000|Overall Study|Changes in Patient's Condition|3|||
19487976|NCT02928224|41778154|FG001|Overall Study|Changes in Patient's Condition|9|||
19487977|NCT02928224|41778155|FG002|Overall Study|Changes in Patient's Condition|9|||
19487978|NCT02928224|41778156|FG003|Overall Study|Changes in Patient's Condition|13|||
19487979|NCT02928224|41778153|FG000|Overall Study|Death|1|||
19487980|NCT02928224|41778154|FG001|Overall Study|Death|7|||
19487981|NCT02928224|41778155|FG002|Overall Study|Death|5|||
19487982|NCT02928224|41778156|FG003|Overall Study|Death|11|||
19487983|NCT02928224|41778153|FG000|Overall Study|Withdrawal by Subject|1|||
19487984|NCT02928224|41778154|FG001|Overall Study|Withdrawal by Subject|4|||
19487985|NCT02928224|41778155|FG002|Overall Study|Withdrawal by Subject|3|||
19487986|NCT02928224|41778156|FG003|Overall Study|Withdrawal by Subject|9|||
19487987|NCT02928224|41778153|FG000|Overall Study|Dose Interruptions>28|1|||
19487988|NCT02928224|41778154|FG001|Overall Study|Dose Interruptions>28|2|||
19487989|NCT02928224|41778155|FG002|Overall Study|Dose Interruptions>28|2|||
19487990|NCT02928224|41778156|FG003|Overall Study|Dose Interruptions>28|4|||
19487991|NCT02928224|41778153|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
19487992|NCT02928224|41778154|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
19487993|NCT02928224|41778155|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
19487994|NCT02928224|41778156|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
19487995|NCT02928224|41778153|FG000|Overall Study|Physician Decision|0|||
19487996|NCT02928224|41778154|FG001|Overall Study|Physician Decision|2|||
19487997|NCT02928224|41778155|FG002|Overall Study|Physician Decision|4|||
19487998|NCT02928224|41778156|FG003|Overall Study|Physician Decision|2|||
19487999|NCT02928224|41778153|FG000|Overall Study|not listed|0|||
19488000|NCT02928224|41778154|FG001|Overall Study|not listed|3|||
19488001|NCT02928224|41778155|FG002|Overall Study|not listed|1|||
19488002|NCT02928224|41778156|FG003|Overall Study|not listed|0|||
19488003|NCT02690077|41778173|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
19488004|NCT02690077|41778174|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
19488005|NCT02690077|41778173|FG000|Overall Study|Withdrawal by Subject|0|||
19488006|NCT02690077|41778174|FG001|Overall Study|Withdrawal by Subject|5|||
19488007|NCT02690077|41778173|FG000|Overall Study|Excluded by IRB|0|||
19488008|NCT02690077|41778174|FG001|Overall Study|Excluded by IRB|2|||
19488009|NCT02652949|41778180|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
19488010|NCT02652949|41778180|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
19488011|NCT02652949|41778180|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
19488012|NCT02652949|41778180|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
19488013|NCT02652949|41778180|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
19488014|NCT02652949|41778180|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
19488015|NCT02652949|41778180|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
19488016|NCT02652949|41778180|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
19488017|NCT02652949|41778180|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
19488018|NCT02652949|41778180|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
19488019|NCT02652949|41778180|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
19488020|NCT02652949|41778180|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
19488021|NCT02652949|41778180|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
19488022|NCT02652949|41778180|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
19488023|NCT02652949|41778180|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
19488024|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Adverse Event|6|||
19488025|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Adverse Event|14|||
19488026|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Death|3|||
19488027|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Death|1|||
19488028|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
19393490|NCT02660359|41637357|FG001|Overall Study|Adverse Event|1|||
19393491|NCT02660359|41637358|FG002|Overall Study|Adverse Event|0|||
19488029|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
19488030|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
19488031|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
19488032|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
19488033|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
19488034|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
19488035|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
19488036|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
19488037|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
19488038|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Physician Decision|2|||
19488039|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Physician Decision|4|||
19488040|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Pregnancy|2|||
19488041|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Pregnancy|1|||
19488042|NCT02275780|41778193|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
19488043|NCT02275780|41778194|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
19488044|NCT02275780|41778193|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
19488045|NCT02275780|41778194|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
19488046|NCT02158091|41778203|FG000|Overall Study|DLT|2|||
19488047|NCT02158091|41778204|FG001|Overall Study|DLT|1|||
19488048|NCT02158091|41778205|FG002|Overall Study|DLT|0|||
19488049|NCT01828112|41778215|FG000|Overall Study|Adverse Event|6|||
19488050|NCT01828112|41778216|FG001|Overall Study|Adverse Event|8|||
19488051|NCT01828112|41778215|FG000|Overall Study|Death|9|||
19488052|NCT01828112|41778216|FG001|Overall Study|Death|5|||
19488053|NCT01828112|41778215|FG000|Overall Study|Physician Decision|5|||
19488054|NCT01828112|41778216|FG001|Overall Study|Physician Decision|5|||
19488055|NCT01828112|41778215|FG000|Overall Study|Progressive disease|56|||
19488056|NCT01828112|41778216|FG001|Overall Study|Progressive disease|82|||
19488057|NCT01828112|41778215|FG000|Overall Study|Subject/guardian decision|6|||
19488058|NCT01828112|41778216|FG001|Overall Study|Subject/guardian decision|8|||
19488059|NCT00545077|41778224|FG000|Overall Study|Treatment not received|5|||
19488060|NCT00545077|41778225|FG001|Overall Study|Treatment not received|1|||
19488061|NCT00545077|41778224|FG000|Overall Study|Disease Progression|131|||
19488062|NCT00545077|41778225|FG001|Overall Study|Disease Progression|98|||
19488063|NCT00545077|41778224|FG000|Overall Study|Withdrawal by Subject|3|||
19488064|NCT00545077|41778225|FG001|Overall Study|Withdrawal by Subject|14|||
19488065|NCT00545077|41778224|FG000|Overall Study|Physician Decision|6|||
19488066|NCT00545077|41778225|FG001|Overall Study|Physician Decision|3|||
19488067|NCT00545077|41778224|FG000|Overall Study|Lost to Follow-up|2|||
19488068|NCT00545077|41778225|FG001|Overall Study|Lost to Follow-up|0|||
19488069|NCT00545077|41778224|FG000|Overall Study|Protocol Violation|1|||
19488070|NCT00545077|41778225|FG001|Overall Study|Protocol Violation|0|||
19488071|NCT00545077|41778224|FG000|Overall Study|Adverse Event|0|||
19488072|NCT00545077|41778225|FG001|Overall Study|Adverse Event|31|||
19488073|NCT00545077|41778224|FG000|Overall Study|Death|0|||
19488074|NCT00545077|41778225|FG001|Overall Study|Death|8|||
19488075|NCT00130533|41778233|FG000|Overall Study|Withdrawal by Subject|33|||
19488076|NCT00130533|41778234|FG001|Overall Study|Withdrawal by Subject|6|||
19488077|NCT00130533|41778233|FG000|Overall Study|Adverse Event|34|||
19488078|NCT00130533|41778234|FG001|Overall Study|Adverse Event|1|||
19488079|NCT00130533|41778233|FG000|Overall Study|Disease relapse|9|||
19488080|NCT00130533|41778234|FG001|Overall Study|Disease relapse|13|||
19488081|NCT00130533|41778233|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
19488082|NCT00130533|41778234|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
19488083|NCT00130533|41778233|FG000|Overall Study|Death|4|||
19488084|NCT00130533|41778234|FG001|Overall Study|Death|2|||
19488085|NCT00130533|41778233|FG000|Overall Study|Protocol Violation|5|||
19488086|NCT00130533|41778234|FG001|Overall Study|Protocol Violation|1|||
19488087|NCT00130533|41778233|FG000|Overall Study|Lost to Follow-up|1|||
19488088|NCT00130533|41778234|FG001|Overall Study|Lost to Follow-up|1|||
19488089|NCT00130533|41778233|FG000|Overall Study|Sponsor´s decision|2|||
19488090|NCT00130533|41778234|FG001|Overall Study|Sponsor´s decision|0|||
19488091|NCT00130533|41778233|FG000|Overall Study|Second Primary Malignancy|0|||
19488092|NCT00130533|41778234|FG001|Overall Study|Second Primary Malignancy|1|||
19488093|NCT00130533|41778233|FG000|Overall Study|Other|12|||
19488094|NCT00130533|41778234|FG001|Overall Study|Other|5|||
19488095|NCT00129935|41778242|FG000|Overall Study|Adverse Event|18|||
19488096|NCT00129935|41778243|FG001|Overall Study|Adverse Event|56|||
19488097|NCT00129935|41778242|FG000|Overall Study|Death|1|||
19612677|NCT00590577|42061529|FG000|Overall Study|Pregnancy|0|||
19488098|NCT00129935|41778243|FG001|Overall Study|Death|1|||
19488099|NCT00129935|41778242|FG000|Overall Study|Withdrawal by Subject|7|||
19488100|NCT00129935|41778243|FG001|Overall Study|Withdrawal by Subject|20|||
19488101|NCT00129935|41778242|FG000|Overall Study|Protocol Violation|0|||
19488102|NCT00129935|41778243|FG001|Overall Study|Protocol Violation|4|||
19488103|NCT00129935|41778242|FG000|Overall Study|Physician Decision|3|||
19488104|NCT00129935|41778243|FG001|Overall Study|Physician Decision|4|||
19488105|NCT00129935|41778242|FG000|Overall Study|Recurrence|1|||
19488106|NCT00129935|41778243|FG001|Overall Study|Recurrence|3|||
19488107|NCT00129935|41778242|FG000|Overall Study|Second primary|0|||
19488108|NCT00129935|41778243|FG001|Overall Study|Second primary|1|||
19488109|NCT00129935|41778242|FG000|Overall Study|Other|3|||
19488110|NCT00129935|41778243|FG001|Overall Study|Other|2|||
19488111|NCT00129935|41778242|FG000|Overall Study|Crossed to the other arm|2|||
19612678|NCT00590577|42061530|FG001|Overall Study|Pregnancy|1|||
19704246|NCT03760666|42148556|FG002|Overall Study|AML Disease Progression|0|||
19704247|NCT03760666|42148554|FG000|Overall Study|Physician Decision|0|||
19612679|NCT00590577|42061531|FG002|Overall Study|Pregnancy|0|||
19612680|NCT00590577|42061532|FG003|Overall Study|Pregnancy|0|||
19704248|NCT03760666|42148555|FG001|Overall Study|Physician Decision|3|||
19704249|NCT03760666|42148556|FG002|Overall Study|Physician Decision|0|||
19704250|NCT03760666|42148554|FG000|Overall Study|Withdrawal by Subject|0|||
19704251|NCT03760666|42148555|FG001|Overall Study|Withdrawal by Subject|1|||
19704252|NCT03760666|42148556|FG002|Overall Study|Withdrawal by Subject|0|||
19704253|NCT03760510|42148569|FG000|Overall Study|Not ventilated for 24 hours|105|||
19704254|NCT03760510|42148570|FG001|Overall Study|Not ventilated for 24 hours|97|||
19704255|NCT00224484|42148579|FG000|Overall Study|Serious Adverse Event|1|||
19704256|NCT00224484|42148580|FG001|Overall Study|Serious Adverse Event|1|||
19704257|NCT00224484|42148581|FG002|Overall Study|Serious Adverse Event|0|||
19704258|NCT00224484|42148579|FG000|Overall Study|Non-Serious Adverse Event|5|||
19704259|NCT00224484|42148580|FG001|Overall Study|Non-Serious Adverse Event|7|||
19704260|NCT00224484|42148581|FG002|Overall Study|Non-Serious Adverse Event|3|||
19612681|NCT00590577|42061529|FG000|Overall Study|Various reasons|1|||
19612682|NCT00590577|42061530|FG001|Overall Study|Various reasons|3|||
19612683|NCT00590577|42061531|FG002|Overall Study|Various reasons|1|||
19612684|NCT00590577|42061532|FG003|Overall Study|Various reasons|2|||
19612685|NCT00614575|42061542|FG000|Overall Study|Adverse Event|106|||
19612686|NCT00614575|42061542|FG000|Overall Study|Lost to Follow-up|55|||
19612687|NCT00614575|42061542|FG000|Overall Study|Lack of Efficacy|14|||
19612688|NCT00614575|42061542|FG000|Overall Study|Withdrawal by Subject|6|||
19612689|NCT00614575|42061542|FG000|Overall Study|Death|3|||
19612690|NCT00614575|42061542|FG000|Overall Study|Physician Decision|2|||
19612691|NCT00614575|42061542|FG000|Overall Study|No data were collected.|18|||
19612692|NCT00614575|42061542|FG000|Overall Study|Irregularly enrolled patients|23|||
19612693|NCT00614575|42061542|FG000|Overall Study|No treatment|1|||
19612694|NCT00805935|42061550|FG000|Overall Study|Stimulation Failure|1|||
19704261|NCT00224484|42148579|FG000|Overall Study|Protocol Violation|2|||
19704262|NCT00224484|42148580|FG001|Overall Study|Protocol Violation|2|||
19488112|NCT00129935|41778243|FG001|Overall Study|Crossed to the other arm|1|||
19488113|NCT00129935|41778242|FG000|Overall Study|Incorrect study treatment|1|||
19612695|NCT00805935|42061551|FG001|Overall Study|Stimulation Failure|5|||
19612696|NCT00805935|42061552|FG002|Overall Study|Stimulation Failure|2|||
19612697|NCT00805935|42061553|FG003|Overall Study|Stimulation Failure|2|||
19612698|NCT00805935|42061550|FG000|Overall Study|Cycle cancelled|0|||
19612699|NCT00805935|42061551|FG001|Overall Study|Cycle cancelled|0|||
19612700|NCT00805935|42061552|FG002|Overall Study|Cycle cancelled|2|||
19612701|NCT00805935|42061553|FG003|Overall Study|Cycle cancelled|0|||
19612702|NCT00805935|42061550|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
19612703|NCT00805935|42061551|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
19612704|NCT00805935|42061552|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
19612705|NCT00805935|42061553|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
19612706|NCT00805935|42061550|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
19612707|NCT00805935|42061551|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
19612708|NCT00805935|42061552|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
19612709|NCT00805935|42061553|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
19612710|NCT00805935|42061550|FG000|Overall Study|Lost to Follow-up|1|||
19612711|NCT00805935|42061551|FG001|Overall Study|Lost to Follow-up|0|||
19612712|NCT00805935|42061552|FG002|Overall Study|Lost to Follow-up|0|||
19612713|NCT00805935|42061553|FG003|Overall Study|Lost to Follow-up|0|||
19612714|NCT00805935|42061550|FG000|Overall Study|No positive serum pregnancy|8|||
19612715|NCT00805935|42061551|FG001|Overall Study|No positive serum pregnancy|7|||
19704263|NCT00224484|42148581|FG002|Overall Study|Protocol Violation|0|||
19704264|NCT00224484|42148579|FG000|Overall Study|Withdrawal by Subject|49|||
19488114|NCT00129935|41778243|FG001|Overall Study|Incorrect study treatment|0|||
19488115|NCT01647828|41778258|FG000|Overall Study|Death|3|||
19488116|NCT01647828|41778259|FG001|Overall Study|Death|4|||
19612716|NCT00805935|42061552|FG002|Overall Study|No positive serum pregnancy|6|||
19612717|NCT00805935|42061553|FG003|Overall Study|No positive serum pregnancy|5|||
19488117|NCT01647828|41778260|FG002|Overall Study|Death|4|||
19488118|NCT01647828|41778261|FG003|Overall Study|Death|5|||
19488119|NCT01647828|41778262|FG004|Overall Study|Death|6|||
19488120|NCT01647828|41778263|FG005|Overall Study|Death|3|||
19488121|NCT01647828|41778264|FG006|Overall Study|Death|10|||
19488122|NCT01647828|41778265|FG007|Overall Study|Death|60|||
19488123|NCT01647828|41778266|FG008|Overall Study|Death|71|||
19488124|NCT01647828|41778258|FG000|Overall Study|Withdrawal by Subject|2|||
19488125|NCT01647828|41778259|FG001|Overall Study|Withdrawal by Subject|0|||
19488126|NCT01647828|41778260|FG002|Overall Study|Withdrawal by Subject|0|||
19488127|NCT01647828|41778261|FG003|Overall Study|Withdrawal by Subject|1|||
19488128|NCT01647828|41778262|FG004|Overall Study|Withdrawal by Subject|0|||
19488129|NCT01647828|41778263|FG005|Overall Study|Withdrawal by Subject|0|||
19488130|NCT01647828|41778264|FG006|Overall Study|Withdrawal by Subject|1|||
19488131|NCT01647828|41778265|FG007|Overall Study|Withdrawal by Subject|0|||
19488132|NCT01647828|41778266|FG008|Overall Study|Withdrawal by Subject|2|||
19488133|NCT01647828|41778258|FG000|Overall Study|Study terminated by Sponsor|0|||
19488134|NCT01647828|41778259|FG001|Overall Study|Study terminated by Sponsor|0|||
19488135|NCT01647828|41778260|FG002|Overall Study|Study terminated by Sponsor|0|||
19488136|NCT01647828|41778261|FG003|Overall Study|Study terminated by Sponsor|0|||
19488137|NCT01647828|41778262|FG004|Overall Study|Study terminated by Sponsor|0|||
19488138|NCT01647828|41778263|FG005|Overall Study|Study terminated by Sponsor|0|||
19488139|NCT01647828|41778264|FG006|Overall Study|Study terminated by Sponsor|1|||
19488140|NCT01647828|41778265|FG007|Overall Study|Study terminated by Sponsor|26|||
19488141|NCT01647828|41778266|FG008|Overall Study|Study terminated by Sponsor|16|||
19488142|NCT01647828|41778258|FG000|Overall Study|Lost to Follow-up|0|||
19488143|NCT01647828|41778259|FG001|Overall Study|Lost to Follow-up|0|||
19488144|NCT01647828|41778260|FG002|Overall Study|Lost to Follow-up|0|||
19488145|NCT01647828|41778261|FG003|Overall Study|Lost to Follow-up|0|||
19488146|NCT01647828|41778262|FG004|Overall Study|Lost to Follow-up|0|||
19488147|NCT01647828|41778263|FG005|Overall Study|Lost to Follow-up|0|||
19488148|NCT01647828|41778264|FG006|Overall Study|Lost to Follow-up|0|||
19488149|NCT01647828|41778265|FG007|Overall Study|Lost to Follow-up|2|||
19488150|NCT01647828|41778266|FG008|Overall Study|Lost to Follow-up|0|||
19488151|NCT00989261|41778288|FG000|Overall Study|Still in follow up|12|||
19488152|NCT00989261|41778289|FG001|Overall Study|Still in follow up|21|||
19488153|NCT00989261|41778288|FG000|Overall Study|Withdrawal by Subject|0|||
19488154|NCT00989261|41778289|FG001|Overall Study|Withdrawal by Subject|1|||
19612718|NCT00805935|42061550|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
19612719|NCT00805935|42061551|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
19612720|NCT00805935|42061552|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
19612721|NCT00805935|42061553|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
19612722|NCT00805935|42061550|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
19612723|NCT00805935|42061551|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
19612724|NCT00805935|42061552|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
19612725|NCT00805935|42061553|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
19612726|NCT00805935|42061550|FG000|Overall Study|Biochemical pregnancy|0|||
19612727|NCT00805935|42061551|FG001|Overall Study|Biochemical pregnancy|1|||
19612728|NCT00805935|42061552|FG002|Overall Study|Biochemical pregnancy|0|||
19612729|NCT00805935|42061553|FG003|Overall Study|Biochemical pregnancy|0|||
19612730|NCT00805935|42061550|FG000|Overall Study|Chemical pregnancy|0|||
19612731|NCT00805935|42061551|FG001|Overall Study|Chemical pregnancy|5|||
19612732|NCT00805935|42061552|FG002|Overall Study|Chemical pregnancy|3|||
19612733|NCT00805935|42061553|FG003|Overall Study|Chemical pregnancy|2|||
19612734|NCT00805935|42061550|FG000|Overall Study|Ectopic pregnancy|0|||
19612735|NCT00805935|42061551|FG001|Overall Study|Ectopic pregnancy|0|||
19612736|NCT00805935|42061552|FG002|Overall Study|Ectopic pregnancy|1|||
19612737|NCT00805935|42061553|FG003|Overall Study|Ectopic pregnancy|0|||
19612738|NCT00805935|42061550|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
19612739|NCT00805935|42061551|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
19612740|NCT00805935|42061552|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
19612741|NCT00805935|42061553|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
19612742|NCT00805545|42061567|FG000|Overall Study|Protocol Violation|3|||
19612743|NCT00805545|42061568|FG001|Overall Study|Protocol Violation|2|||
19488155|NCT00989261|41778288|FG000|Overall Study|Lost to Follow-up|3|||
19488156|NCT00989261|41778289|FG001|Overall Study|Lost to Follow-up|0|||
19488157|NCT00988559|41778308|FG000|Overall Study|Withdrawal by Subject|1|||
19488158|NCT00988559|41778309|FG001|Overall Study|Withdrawal by Subject|1|||
19488159|NCT00988559|41778310|FG002|Overall Study|Withdrawal by Subject|0|||
19488160|NCT00988559|41778311|FG003|Overall Study|Withdrawal by Subject|1|||
19488161|NCT00988559|41778308|FG000|Overall Study|Pregnancy|0|||
19488162|NCT00988559|41778309|FG001|Overall Study|Pregnancy|1|||
19488163|NCT00988559|41778310|FG002|Overall Study|Pregnancy|1|||
19612744|NCT00805545|42061567|FG000|Overall Study|Protocol Violation|3|||
19488164|NCT00988559|41778311|FG003|Overall Study|Pregnancy|0|||
19488165|NCT00988559|41778308|FG000|Overall Study|Lost to Follow-up|0|||
19488166|NCT00988559|41778309|FG001|Overall Study|Lost to Follow-up|0|||
19488167|NCT00988559|41778310|FG002|Overall Study|Lost to Follow-up|1|||
19488168|NCT00988559|41778311|FG003|Overall Study|Lost to Follow-up|0|||
19488169|NCT00988169|41778321|FG000|Overall Study|Withdrawal by Subject|1|||
19488170|NCT00988091|41778348|FG000|Double-blind Period|Withdrawal by Subject|15|||
19488171|NCT00988091|41778349|FG001|Double-blind Period|Withdrawal by Subject|13|||
19488172|NCT00988091|41778348|FG000|Double-blind Period|Lost to Follow-up|12|||
19488173|NCT00988091|41778349|FG001|Double-blind Period|Lost to Follow-up|14|||
19488174|NCT00988091|41778348|FG000|Double-blind Period|Other|8|||
19488175|NCT00988091|41778349|FG001|Double-blind Period|Other|8|||
19488176|NCT00988091|41778348|FG000|Double-blind Period|Adverse Event|6|||
19488177|NCT00988091|41778349|FG001|Double-blind Period|Adverse Event|9|||
19488178|NCT00988091|41778348|FG000|Double-blind Period|Use of exclusionary medication|2|||
19488179|NCT00988091|41778349|FG001|Double-blind Period|Use of exclusionary medication|3|||
19488180|NCT00988091|41778348|FG000|Open-label Period|Adverse Event|4|||
19488181|NCT00988091|41778349|FG001|Open-label Period|Adverse Event|7|||
19488182|NCT00988091|41778348|FG000|Open-label Period|Use of exclusionary medication|1|||
19488183|NCT00988091|41778349|FG001|Open-label Period|Use of exclusionary medication|1|||
19488184|NCT00988091|41778348|FG000|Open-label Period|Protocol Violation|1|||
19488185|NCT00988091|41778349|FG001|Open-label Period|Protocol Violation|1|||
19488186|NCT00988091|41778348|FG000|Open-label Period|Withdrawal by Subject|10|||
19488187|NCT00988091|41778349|FG001|Open-label Period|Withdrawal by Subject|16|||
19488188|NCT00988091|41778348|FG000|Open-label Period|Lost to Follow-up|3|||
19488189|NCT00988091|41778349|FG001|Open-label Period|Lost to Follow-up|5|||
19488190|NCT00988091|41778348|FG000|Open-label Period|Other|2|||
19488191|NCT00988091|41778349|FG001|Open-label Period|Other|3|||
19488192|NCT02623218|41778639|FG000|Overall Study|Lost to Follow-up|0|||
19488193|NCT02623218|41778640|FG001|Overall Study|Lost to Follow-up|1|||
19488194|NCT02623218|41778641|FG002|Overall Study|Lost to Follow-up|0|||
19488195|NCT02623218|41778642|FG003|Overall Study|Lost to Follow-up|0|||
19488196|NCT02623218|41778643|FG004|Overall Study|Lost to Follow-up|0|||
19488197|NCT02622828|41778677|FG000|Overall Study|participant withdrew|3|||
19488198|NCT02621424|41778793|FG000|Overall Study|Withdrawal by Subject|1|||
19488199|NCT02621424|41778794|FG001|Overall Study|Withdrawal by Subject|2|||
19488200|NCT02621034|41778822|FG000|Overall Study|Lost to Follow-up|3|||
19488201|NCT02621034|41778823|FG001|Overall Study|Lost to Follow-up|2|||
19488202|NCT02621034|41778824|FG002|Overall Study|Lost to Follow-up|5|||
19488203|NCT02620020|41778906|FG000|Overall Study|Adverse Event|8|||
19488204|NCT02620020|41778907|FG001|Overall Study|Adverse Event|4|||
19488205|NCT02620020|41778908|FG002|Overall Study|Adverse Event|3|||
19488206|NCT02620020|41778909|FG003|Overall Study|Adverse Event|5|||
19488207|NCT02620020|41778906|FG000|Overall Study|Lost to Follow-up|4|||
19488208|NCT02620020|41778907|FG001|Overall Study|Lost to Follow-up|8|||
19488209|NCT02620020|41778908|FG002|Overall Study|Lost to Follow-up|1|||
19488210|NCT02620020|41778909|FG003|Overall Study|Lost to Follow-up|4|||
19488211|NCT02620020|41778906|FG000|Overall Study|Physician Decision|7|||
19488212|NCT02620020|41778907|FG001|Overall Study|Physician Decision|4|||
19488213|NCT02620020|41778908|FG002|Overall Study|Physician Decision|3|||
19488214|NCT02620020|41778909|FG003|Overall Study|Physician Decision|4|||
19488215|NCT02620020|41778906|FG000|Overall Study|Protocol Violation|5|||
19488216|NCT02620020|41778907|FG001|Overall Study|Protocol Violation|2|||
19488217|NCT02620020|41778908|FG002|Overall Study|Protocol Violation|1|||
19488218|NCT02620020|41778909|FG003|Overall Study|Protocol Violation|1|||
19488219|NCT02620020|41778906|FG000|Overall Study|Withdrawal by Subject|20|||
19488220|NCT02620020|41778907|FG001|Overall Study|Withdrawal by Subject|16|||
19488221|NCT02620020|41778908|FG002|Overall Study|Withdrawal by Subject|17|||
19488222|NCT02620020|41778909|FG003|Overall Study|Withdrawal by Subject|12|||
19488223|NCT02620020|41778906|FG000|Overall Study|Death|0|||
19488224|NCT02620020|41778907|FG001|Overall Study|Death|1|||
19488225|NCT02620020|41778908|FG002|Overall Study|Death|0|||
19488226|NCT02620020|41778909|FG003|Overall Study|Death|0|||
19488227|NCT02549989|41778919|FG000|Overall Study|Adverse Event|4|||
19488228|NCT02549989|41778919|FG000|Overall Study|Death|1|||
19488229|NCT02549989|41778919|FG000|Overall Study|Lack of Efficacy|19|||
19488230|NCT02549989|41778919|FG000|Overall Study|Withdrawal by Subject|3|||
19488231|NCT00987935|41779078|FG000|Overall Study|Progressive disease|3|||
19488232|NCT00987935|41779079|FG001|Overall Study|Progressive disease|2|||
19488233|NCT00987935|41779080|FG002|Overall Study|Progressive disease|3|||
19488234|NCT00987935|41779081|FG003|Overall Study|Progressive disease|2|||
19612745|NCT00805545|42061568|FG001|Overall Study|Protocol Violation|1|||
19393492|NCT02660359|41637356|FG000|Overall Study|Other|2|||
19393493|NCT02660359|41637357|FG001|Overall Study|Other|1|||
19488235|NCT00987935|41779082|FG004|Overall Study|Progressive disease|5|||
19488236|NCT00987935|41779083|FG005|Overall Study|Progressive disease|3|||
19488237|NCT00987935|41779084|FG006|Overall Study|Progressive disease|9|||
19488238|NCT00987935|41779085|FG007|Overall Study|Progressive disease|48|||
19488239|NCT00987935|41779086|FG008|Overall Study|Progressive disease|23|||
19488240|NCT00987935|41779078|FG000|Overall Study|Adverse Event|0|||
19488241|NCT00987935|41779079|FG001|Overall Study|Adverse Event|1|||
19488242|NCT00987935|41779080|FG002|Overall Study|Adverse Event|0|||
19488243|NCT00987935|41779081|FG003|Overall Study|Adverse Event|1|||
19488244|NCT00987935|41779082|FG004|Overall Study|Adverse Event|1|||
19488245|NCT00987935|41779083|FG005|Overall Study|Adverse Event|0|||
19488246|NCT00987935|41779084|FG006|Overall Study|Adverse Event|2|||
19488247|NCT00987935|41779085|FG007|Overall Study|Adverse Event|10|||
19488248|NCT00987935|41779086|FG008|Overall Study|Adverse Event|6|||
19488249|NCT00987935|41779078|FG000|Overall Study|Refused to continue taking trial med.|1|||
19488250|NCT00987935|41779079|FG001|Overall Study|Refused to continue taking trial med.|0|||
19488251|NCT00987935|41779080|FG002|Overall Study|Refused to continue taking trial med.|0|||
19488252|NCT00987935|41779081|FG003|Overall Study|Refused to continue taking trial med.|0|||
19488253|NCT00987935|41779082|FG004|Overall Study|Refused to continue taking trial med.|1|||
19488254|NCT00987935|41779083|FG005|Overall Study|Refused to continue taking trial med.|0|||
19488255|NCT00987935|41779084|FG006|Overall Study|Refused to continue taking trial med.|4|||
19488256|NCT00987935|41779085|FG007|Overall Study|Refused to continue taking trial med.|4|||
19488257|NCT00987935|41779086|FG008|Overall Study|Refused to continue taking trial med.|2|||
19488258|NCT00987935|41779078|FG000|Overall Study|Reason other than those specified above|0|||
19488259|NCT00987935|41779079|FG001|Overall Study|Reason other than those specified above|0|||
19488260|NCT00987935|41779080|FG002|Overall Study|Reason other than those specified above|0|||
19488261|NCT00987935|41779081|FG003|Overall Study|Reason other than those specified above|0|||
19488262|NCT00987935|41779082|FG004|Overall Study|Reason other than those specified above|0|||
19488263|NCT00987935|41779083|FG005|Overall Study|Reason other than those specified above|0|||
19488264|NCT00987935|41779084|FG006|Overall Study|Reason other than those specified above|0|||
19488265|NCT00987935|41779085|FG007|Overall Study|Reason other than those specified above|0|||
19488266|NCT00987935|41779086|FG008|Overall Study|Reason other than those specified above|1|||
19488267|NCT01597050|41779114|FG000|Overall Study|Withdrawal by Subject|1|||
19488268|NCT01597050|41779115|FG001|Overall Study|Withdrawal by Subject|0|||
19488269|NCT00987623|41779132|FG000|Overall Study|Lost to Follow-up|2|||
19488270|NCT00987623|41779133|FG001|Overall Study|Lost to Follow-up|1|||
19488271|NCT00987623|41779132|FG000|Overall Study|Time/job conflict|2|||
19488272|NCT00987623|41779133|FG001|Overall Study|Time/job conflict|0|||
19488273|NCT00987623|41779132|FG000|Overall Study|Discomfort|1|||
19488274|NCT00987623|41779133|FG001|Overall Study|Discomfort|0|||
19488275|NCT00987623|41779132|FG000|Overall Study|Biomicroscopy|0|||
19488276|NCT00987623|41779133|FG001|Overall Study|Biomicroscopy|1|||
19488277|NCT00987623|41779132|FG000|Overall Study|Influenza|0|||
19488278|NCT00987623|41779133|FG001|Overall Study|Influenza|1|||
19488279|NCT00987467|41779139|FG000|Overall Study|Lost to Follow-up|2|||
19488280|NCT00986921|41779150|FG000|Overall Study|Physician Decision|1|||
19488281|NCT00986921|41779151|FG001|Overall Study|Physician Decision|0|||
19488282|NCT01596972|41779162|FG000|Overall Study|Physician Decision|1|||
19488283|NCT01596972|41779163|FG001|Overall Study|Physician Decision|9|||
19488284|NCT01596972|41779162|FG000|Overall Study|Lost to Follow-up|0|||
19488285|NCT01596972|41779163|FG001|Overall Study|Lost to Follow-up|4|||
19488286|NCT01596972|41779162|FG000|Overall Study|Withdrawal by Subject|0|||
19488287|NCT01596972|41779163|FG001|Overall Study|Withdrawal by Subject|1|||
19488288|NCT00985751|41779264|FG000|Overall Study|Adverse Event|0|||
19488289|NCT00985751|41779265|FG001|Overall Study|Adverse Event|0|||
19488290|NCT00985751|41779266|FG002|Overall Study|Adverse Event|0|||
19488291|NCT00985751|41779267|FG003|Overall Study|Adverse Event|0|||
19488292|NCT00985751|41779268|FG004|Overall Study|Adverse Event|1|||
19488293|NCT01596582|41779313|FG000|Overall Study|Deemed ineligible after study visit|3|||
19488294|NCT01596582|41779314|FG001|Overall Study|Deemed ineligible after study visit|6|||
19488295|NCT01596582|41779313|FG000|Overall Study|Missing all outcome data|1|||
19488296|NCT01596582|41779314|FG001|Overall Study|Missing all outcome data|1|||
19488297|NCT01596504|41779330|FG000|Overall Study|Participant's Private Reason|0|||
19488298|NCT01596504|41779331|FG001|Overall Study|Participant's Private Reason|1|||
19488299|NCT01596504|41779332|FG002|Overall Study|Participant's Private Reason|0|||
19488300|NCT01596504|41779330|FG000|Overall Study|Adverse Event|1|||
19488301|NCT01596504|41779331|FG001|Overall Study|Adverse Event|2|||
19488302|NCT01596504|41779332|FG002|Overall Study|Adverse Event|1|||
19488303|NCT01596504|41779330|FG000|Overall Study|Withdrawal by Subject|1|||
19488304|NCT01596504|41779331|FG001|Overall Study|Withdrawal by Subject|0|||
19488305|NCT01596504|41779332|FG002|Overall Study|Withdrawal by Subject|0|||
19393494|NCT02660359|41637358|FG002|Overall Study|Other|3|||
19393495|NCT02660359|41637356|FG000|Overall Study|Withdrawal by Subject|7|||
19393496|NCT02660359|41637357|FG001|Overall Study|Withdrawal by Subject|5|||
19393497|NCT02660359|41637358|FG002|Overall Study|Withdrawal by Subject|8|||
19393498|NCT02660359|41637356|FG000|Overall Study|Lost to Follow-up|3|||
19393499|NCT02660359|41637357|FG001|Overall Study|Lost to Follow-up|3|||
19393500|NCT02660359|41637358|FG002|Overall Study|Lost to Follow-up|0|||
19393501|NCT02628743|41637366|FG000|Overall Study|Other|3|||
19393502|NCT02628743|41637366|FG000|Overall Study|Withdrawal by Subject|50|||
19393503|NCT02628743|41637366|FG000|Overall Study|Study Terminated by Sponsor|76|||
19393504|NCT02628743|41637366|FG000|Overall Study|Physician Decision|2|||
19393505|NCT03839459|41637370|FG000|Overall Study|Withdrawal by Subject|2|||
19393506|NCT03839459|41637370|FG000|Overall Study|progression of disease|3|||
19488306|NCT02616900|41779387|FG000|Overall Study|Lack of Efficacy|7|||
19488307|NCT02616900|41779387|FG000|Overall Study|Lost to Follow-up|2|||
19488308|NCT02616900|41779387|FG000|Overall Study|Protocol Violation|5|||
19488309|NCT02616900|41779387|FG000|Overall Study|Withdrawal by Subject|3|||
19488310|NCT02616900|41779387|FG000|Overall Study|Incomplete data|6|||
19488311|NCT00985673|41779499|FG000|Overall Study|Lost to Follow-up|6|||
19488312|NCT00985673|41779500|FG001|Overall Study|Lost to Follow-up|7|||
19488313|NCT00985673|41779501|FG002|Overall Study|Lost to Follow-up|6|||
19488314|NCT00985673|41779502|FG003|Overall Study|Lost to Follow-up|10|||
19488315|NCT00985673|41779503|FG004|Overall Study|Lost to Follow-up|5|||
19488316|NCT00985673|41779504|FG005|Overall Study|Lost to Follow-up|3|||
19488317|NCT00985673|41779499|FG000|Overall Study|Withdrawal by Subject|0|||
19488318|NCT00985673|41779500|FG001|Overall Study|Withdrawal by Subject|4|||
19488319|NCT00985673|41779501|FG002|Overall Study|Withdrawal by Subject|5|||
19488320|NCT00985673|41779502|FG003|Overall Study|Withdrawal by Subject|2|||
19488321|NCT00985673|41779503|FG004|Overall Study|Withdrawal by Subject|2|||
19488322|NCT00985673|41779504|FG005|Overall Study|Withdrawal by Subject|3|||
19488323|NCT00985673|41779499|FG000|Overall Study|Other|1|||
19488324|NCT00985673|41779500|FG001|Overall Study|Other|0|||
19488325|NCT00985673|41779501|FG002|Overall Study|Other|1|||
19488326|NCT00985673|41779502|FG003|Overall Study|Other|0|||
19488327|NCT00985673|41779503|FG004|Overall Study|Other|1|||
19488328|NCT00985673|41779504|FG005|Overall Study|Other|0|||
19488329|NCT00985439|41779550|FG000|Overall Study|Adverse Event|0|||
19488330|NCT00985439|41779551|FG001|Overall Study|Adverse Event|0|||
19488331|NCT00985439|41779552|FG002|Overall Study|Adverse Event|1|||
19488332|NCT00985439|41779553|FG003|Overall Study|Adverse Event|0|||
19488333|NCT02618928|41779563|FG000|Overall Study|Failure to Return|28|||
19488334|NCT02618928|41779563|FG000|Overall Study|Insufficient Virological Response|1|||
19488335|NCT02618928|41779563|FG000|Overall Study|Withdrawal by Subject|2|||
19488336|NCT02618928|41779563|FG000|Overall Study|Death|3|||
19488337|NCT02618928|41779563|FG000|Overall Study|Other|11|||
19488338|NCT02618928|41779563|FG000|Overall Study|Missing|6|||
19488339|NCT02618928|41779563|FG000|Overall Study|Treatment Never Started|7|||
19488340|NCT00983957|41779574|FG000|Overall Study|Adverse Event|1|||
19488341|NCT00983957|41779574|FG000|Overall Study|Personal Reasons|1|||
19488342|NCT00981461|41779619|FG000|Overall Study|Lost to Follow-up|5|||
19488343|NCT00981461|41779620|FG001|Overall Study|Lost to Follow-up|2|||
19488344|NCT00981149|41779637|FG000|Overall Study|Lost to Follow-up|1|||
19488345|NCT00981149|41779638|FG001|Overall Study|Lost to Follow-up|2|||
19488346|NCT00981149|41779637|FG000|Overall Study|Withdrawal by Subject|1|||
19488347|NCT00981149|41779638|FG001|Overall Study|Withdrawal by Subject|1|||
19488348|NCT01595646|41779696|FG000|Overall Study|Withdrawal by Subject|1|||
19488349|NCT01595646|41779697|FG001|Overall Study|Withdrawal by Subject|0|||
19488350|NCT01595646|41779698|FG002|Overall Study|Withdrawal by Subject|0|||
19488351|NCT02618616|41779735|FG000|Overall Study|Lack of Efficacy|4|||
19488352|NCT02618616|41779736|FG001|Overall Study|Lack of Efficacy|0|||
19488353|NCT02618616|41779735|FG000|Overall Study|Pregnancy|0|||
19488354|NCT02618616|41779736|FG001|Overall Study|Pregnancy|1|||
19488355|NCT02618616|41779735|FG000|Overall Study|Adverse Event|8|||
19488356|NCT02618616|41779736|FG001|Overall Study|Adverse Event|0|||
19488357|NCT02618616|41779735|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
19488358|NCT02618616|41779736|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
19488359|NCT02618616|41779735|FG000|Overall Study|Consent withdrawn by subject|8|||
19488360|NCT02618616|41779736|FG001|Overall Study|Consent withdrawn by subject|5|||
19488361|NCT02618616|41779735|FG000|Overall Study|Lost to Follow-up|0|||
19488362|NCT02618616|41779736|FG001|Overall Study|Lost to Follow-up|1|||
19488363|NCT02618382|41779815|FG000|Overall Study|Physician Decision|1|||
19488364|NCT02618382|41779815|FG000|Overall Study|Withdrawal by Subject|1|||
19488365|NCT02618382|41779815|FG000|Overall Study|Protocol Violation|1|||
19488366|NCT00980057|41779833|FG000|Overall Study|Death|13|||
19488367|NCT00980057|41779834|FG001|Overall Study|Death|3|||
19488368|NCT00980057|41779833|FG000|Overall Study|Adverse Event|0|||
19488369|NCT00980057|41779834|FG001|Overall Study|Adverse Event|1|||
19488370|NCT00980057|41779833|FG000|Overall Study|Physician Decision|4|||
19488371|NCT00980057|41779834|FG001|Overall Study|Physician Decision|0|||
19488372|NCT00980057|41779833|FG000|Overall Study|Lost to Follow-up|1|||
19488373|NCT00980057|41779834|FG001|Overall Study|Lost to Follow-up|0|||
19488374|NCT00980057|41779833|FG000|Overall Study|Withdrawal by Subject|1|||
19488375|NCT00980057|41779834|FG001|Overall Study|Withdrawal by Subject|1|||
19488376|NCT04126733|41779972|FG000|Treatment Period|Other Reason|1|||
19488377|NCT04126733|41779972|FG000|Treatment Period|Death|1|||
19488378|NCT04126733|41779972|FG000|Treatment Period|Physician Decision|3|||
19488379|NCT04126733|41779972|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
19488380|NCT04126733|41779972|FG000|Treatment Period|Adverse Event|7|||
19488381|NCT04126733|41779972|FG000|Treatment Period|Progressive Disease - Radiological Progression|44|||
19488382|NCT04126733|41779972|FG000|Treatment Period|Ongoing with Study Treatment|7|||
19488383|NCT04126733|41779972|FG000|Active Follow-up Period|Death|13|||
19488384|NCT04126733|41779972|FG000|Active Follow-up Period|Other Reason|1|||
19488385|NCT04126733|41779972|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
19488386|NCT04126733|41779972|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
19488387|NCT04126733|41779972|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
19488388|NCT04126733|41779972|FG000|Long-term Follow-up Period|Death|5|||
19488389|NCT02614794|41780007|FG000|Overall Study|On treatment|118|||
19488390|NCT02614794|41780008|FG001|Overall Study|On treatment|27|||
19488391|NCT02614794|41780007|FG000|Overall Study|In long term follow up|148|||
19488392|NCT02614794|41780008|FG001|Overall Study|In long term follow up|85|||
19488393|NCT02614794|41780007|FG000|Overall Study|Death|126|||
19488394|NCT02614794|41780008|FG001|Overall Study|Death|84|||
19488395|NCT02614794|41780007|FG000|Overall Study|Withdrawal by Subject|16|||
19488396|NCT02614794|41780008|FG001|Overall Study|Withdrawal by Subject|5|||
19488397|NCT02614794|41780007|FG000|Overall Study|Lost to Follow-up|2|||
19488398|NCT02614794|41780008|FG001|Overall Study|Lost to Follow-up|0|||
19488399|NCT02614794|41780007|FG000|Overall Study|Physician Decision|0|||
19488400|NCT02614794|41780008|FG001|Overall Study|Physician Decision|1|||
19488401|NCT00988247|41780016|FG000|Overall Study|Adverse Event|17|||
19488402|NCT00988247|41780017|FG001|Overall Study|Adverse Event|3|||
19488403|NCT00988247|41780016|FG000|Overall Study|Withdrawal by Subject|44|||
19488404|NCT00988247|41780017|FG001|Overall Study|Withdrawal by Subject|13|||
19488405|NCT00988247|41780016|FG000|Overall Study|Pregnancy|1|||
19488406|NCT00988247|41780017|FG001|Overall Study|Pregnancy|2|||
19488407|NCT00988247|41780016|FG000|Overall Study|Lost to Follow-up|11|||
19488408|NCT00988247|41780017|FG001|Overall Study|Lost to Follow-up|2|||
19488409|NCT00988247|41780016|FG000|Overall Study|Protocol Violation|4|||
19488410|NCT00988247|41780017|FG001|Overall Study|Protocol Violation|5|||
19488411|NCT00988247|41780016|FG000|Overall Study|Sponsor requested withdrawal|3|||
19488412|NCT00988247|41780017|FG001|Overall Study|Sponsor requested withdrawal|1|||
19488413|NCT00988247|41780016|FG000|Overall Study|Other|3|||
19488414|NCT00988247|41780017|FG001|Overall Study|Other|0|||
19488415|NCT00984659|41780027|FG000|2-week Run-in Period|Adverse Event|8|||
19488416|NCT00984659|41780028|FG001|2-week Run-in Period|Adverse Event|0|||
19488417|NCT00984659|41780029|FG002|2-week Run-in Period|Adverse Event|0|||
19488418|NCT00984659|41780030|FG003|2-week Run-in Period|Adverse Event|0|||
19488419|NCT00984659|41780027|FG000|2-week Run-in Period|Protocol Violation|5|||
19488420|NCT00984659|41780028|FG001|2-week Run-in Period|Protocol Violation|0|||
19488421|NCT00984659|41780029|FG002|2-week Run-in Period|Protocol Violation|0|||
19488422|NCT00984659|41780030|FG003|2-week Run-in Period|Protocol Violation|0|||
19488423|NCT00984659|41780027|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
19488424|NCT00984659|41780028|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
19488425|NCT00984659|41780029|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
19488426|NCT00984659|41780030|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
19488427|NCT00984659|41780027|FG000|2-week Run-in Period|Lost to Follow-up|3|||
19488428|NCT00984659|41780028|FG001|2-week Run-in Period|Lost to Follow-up|0|||
19488429|NCT00984659|41780029|FG002|2-week Run-in Period|Lost to Follow-up|0|||
19488430|NCT00984659|41780030|FG003|2-week Run-in Period|Lost to Follow-up|0|||
19488431|NCT00984659|41780027|FG000|2-week Run-in Period|Physician Decision|10|||
19488432|NCT00984659|41780028|FG001|2-week Run-in Period|Physician Decision|0|||
19488433|NCT00984659|41780029|FG002|2-week Run-in Period|Physician Decision|0|||
19488434|NCT00984659|41780030|FG003|2-week Run-in Period|Physician Decision|0|||
19488435|NCT00984659|41780027|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
19488436|NCT00984659|41780028|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19488437|NCT00984659|41780029|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19488438|NCT00984659|41780030|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
19488439|NCT00984659|41780027|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
19488440|NCT00984659|41780028|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19488441|NCT00984659|41780029|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19488442|NCT00984659|41780030|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
19488443|NCT00984659|41780027|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
19488444|NCT00984659|41780028|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
19488445|NCT00984659|41780029|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
19488446|NCT00984659|41780030|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
19488447|NCT00984659|41780027|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
19488448|NCT00984659|41780028|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
19488449|NCT00984659|41780029|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
19488450|NCT00984659|41780030|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
19488451|NCT00984659|41780027|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
19488452|NCT00984659|41780028|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
19488453|NCT00984659|41780029|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
19612746|NCT00590031|42061600|FG000|Overall Study|Adverse Event|3|||
19488454|NCT00984659|41780030|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
19488455|NCT00984659|41780027|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
19488456|NCT00984659|41780028|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
19488457|NCT00984659|41780029|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
19488458|NCT00984659|41780030|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
19488459|NCT00984659|41780027|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19488460|NCT00984659|41780028|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
19488461|NCT00984659|41780029|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
19488462|NCT00984659|41780030|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
19488463|NCT00982319|41780039|FG000|Overall Study|Surgery date change|1|||
19488464|NCT00982319|41780040|FG001|Overall Study|Surgery date change|0|||
19488465|NCT00982319|41780039|FG000|Overall Study|Preop values out of acceptable range|1|||
19488466|NCT00982319|41780040|FG001|Overall Study|Preop values out of acceptable range|1|||
19612747|NCT00590031|42061600|FG000|Overall Study|Withdrawal by Subject|1|||
19612748|NCT00590031|42061600|FG000|Overall Study|Metastatic Disease|1|||
19612749|NCT00590031|42061600|FG000|Overall Study|Admin Hold|1|||
19612750|NCT00615199|42061608|FG000|Overall Study|Adverse Event|3|||
19612751|NCT00615199|42061609|FG001|Overall Study|Adverse Event|1|||
19612752|NCT00615199|42061610|FG002|Overall Study|Adverse Event|1|||
19488467|NCT00982319|41780039|FG000|Overall Study|Pregnancy|0|||
19488468|NCT00982319|41780040|FG001|Overall Study|Pregnancy|1|||
19488469|NCT02612064|41780064|FG000|Overall Study|Withdrawal by Subject|1|||
19488470|NCT02612064|41780065|FG001|Overall Study|Withdrawal by Subject|1|||
19488471|NCT02612064|41780064|FG000|Overall Study|Other|0|||
19488472|NCT02612064|41780065|FG001|Overall Study|Other|2|||
19488473|NCT02614560|41780084|FG000|Overall Study|Death|6|||
19488474|NCT02614560|41780085|FG001|Overall Study|Death|2|||
19488475|NCT01669122|41780113|FG000|Period I|Lost to Follow-up|1|||
19488476|NCT01669122|41780113|FG000|Washout Period II|Protocol Violation|2|||
19488477|NCT02611752|41780146|FG000|Overall Study|Adverse Event|0|||
19488478|NCT02611752|41780147|FG001|Overall Study|Adverse Event|1|||
19488479|NCT02611362|41780168|FG000|Overall Study|Withdrawal by Subject|7|||
19488480|NCT02611362|41780169|FG001|Overall Study|Withdrawal by Subject|2|||
19488481|NCT02611362|41780168|FG000|Overall Study|Lost to Follow-up|2|||
19488482|NCT02611362|41780169|FG001|Overall Study|Lost to Follow-up|4|||
19488483|NCT01594476|41780189|FG000|Overall Study|Protocol Violation|1|||
19488484|NCT01594476|41780190|FG001|Overall Study|Protocol Violation|3|||
19488485|NCT01668966|41780204|FG000|Overall Study|Withdrawal by Subject|1|||
19488486|NCT01668966|41780204|FG000|Overall Study|Death|1|||
19488487|NCT01668966|41780204|FG000|Overall Study|Not treated|2|||
19488488|NCT02609724|41780211|FG000|Overall Study|Death|2|||
19488489|NCT02609724|41780212|FG001|Overall Study|Death|0|||
19488490|NCT02609724|41780213|FG002|Overall Study|Death|1|||
19488491|NCT02609724|41780211|FG000|Overall Study|Withdrawal by Subject|1|||
19488492|NCT02609724|41780212|FG001|Overall Study|Withdrawal by Subject|2|||
19488493|NCT02609724|41780213|FG002|Overall Study|Withdrawal by Subject|3|||
19488494|NCT02609724|41780211|FG000|Overall Study|Illness|2|||
19488495|NCT02609724|41780212|FG001|Overall Study|Illness|1|||
19488496|NCT02609724|41780213|FG002|Overall Study|Illness|0|||
19488497|NCT02610816|41780246|FG000|Phase 1|Withdrawal by Subject|2|||
19488498|NCT02610816|41780247|FG001|Phase 1|Withdrawal by Subject|6|||
19488499|NCT02610816|41780248|FG002|Phase 1|Withdrawal by Subject|0|||
19488500|NCT02610816|41780249|FG003|Phase 1|Withdrawal by Subject|0|||
19488501|NCT02610816|41780246|FG000|Phase 1|Lost to Follow-up|2|||
19488502|NCT02610816|41780247|FG001|Phase 1|Lost to Follow-up|1|||
19488503|NCT02610816|41780248|FG002|Phase 1|Lost to Follow-up|0|||
19488504|NCT02610816|41780249|FG003|Phase 1|Lost to Follow-up|0|||
19488505|NCT02610816|41780246|FG000|Phase 1|Physician Decision|0|||
19488506|NCT02610816|41780247|FG001|Phase 1|Physician Decision|1|||
19488507|NCT02610816|41780248|FG002|Phase 1|Physician Decision|0|||
19488508|NCT02610816|41780249|FG003|Phase 1|Physician Decision|0|||
19488509|NCT02610816|41780246|FG000|Phase 2|Withdrawal by Subject|0|||
19488510|NCT02610816|41780247|FG001|Phase 2|Withdrawal by Subject|0|||
19488511|NCT02610816|41780248|FG002|Phase 2|Withdrawal by Subject|9|||
19488512|NCT02610816|41780249|FG003|Phase 2|Withdrawal by Subject|3|||
19612753|NCT00615199|42061611|FG003|Overall Study|Adverse Event|0|||
19612754|NCT00615199|42061608|FG000|Overall Study|Lack of Efficacy|2|||
19612755|NCT00615199|42061609|FG001|Overall Study|Lack of Efficacy|0|||
19488513|NCT02610816|41780246|FG000|Phase 2|Lost to Follow-up|0|||
19488514|NCT02610816|41780247|FG001|Phase 2|Lost to Follow-up|0|||
19488515|NCT02610816|41780248|FG002|Phase 2|Lost to Follow-up|2|||
19488516|NCT02610816|41780249|FG003|Phase 2|Lost to Follow-up|0|||
19488517|NCT02610816|41780246|FG000|Phase 2|Physician Decision|0|||
19488518|NCT02610816|41780247|FG001|Phase 2|Physician Decision|0|||
19488519|NCT02610816|41780248|FG002|Phase 2|Physician Decision|0|||
19488520|NCT02610816|41780249|FG003|Phase 2|Physician Decision|2|||
19488521|NCT02610816|41780246|FG000|Phase 2|Pregnancy|0|||
19488522|NCT02610816|41780247|FG001|Phase 2|Pregnancy|0|||
19488523|NCT02610816|41780248|FG002|Phase 2|Pregnancy|0|||
19488524|NCT02610816|41780249|FG003|Phase 2|Pregnancy|1|||
19488525|NCT02612610|41780345|FG000|Overall Study|Withdrawal by Subject|1|||
19488526|NCT02612610|41780346|FG001|Overall Study|Withdrawal by Subject|1|||
19488527|NCT02612610|41780347|FG002|Overall Study|Withdrawal by Subject|0|||
19612756|NCT00615199|42061610|FG002|Overall Study|Lack of Efficacy|0|||
19488528|NCT02612610|41780348|FG003|Overall Study|Withdrawal by Subject|2|||
19488529|NCT02612610|41780345|FG000|Overall Study|Adverse Event|2|||
19488530|NCT02612610|41780346|FG001|Overall Study|Adverse Event|2|||
19488531|NCT02612610|41780347|FG002|Overall Study|Adverse Event|3|||
19488532|NCT02612610|41780348|FG003|Overall Study|Adverse Event|10|||
19488533|NCT02612610|41780345|FG000|Overall Study|Lost to Follow-up|0|||
19488534|NCT02612610|41780346|FG001|Overall Study|Lost to Follow-up|1|||
19488535|NCT02612610|41780347|FG002|Overall Study|Lost to Follow-up|0|||
19488536|NCT02612610|41780348|FG003|Overall Study|Lost to Follow-up|0|||
19488537|NCT02612610|41780345|FG000|Overall Study|Protocol Violation|0|||
19488538|NCT02612610|41780346|FG001|Overall Study|Protocol Violation|1|||
19488539|NCT02612610|41780347|FG002|Overall Study|Protocol Violation|1|||
19488540|NCT02612610|41780348|FG003|Overall Study|Protocol Violation|0|||
19488541|NCT02612610|41780345|FG000|Overall Study|Lack of Efficacy|1|||
19488542|NCT02612610|41780346|FG001|Overall Study|Lack of Efficacy|2|||
19488543|NCT02612610|41780347|FG002|Overall Study|Lack of Efficacy|0|||
19488544|NCT02612610|41780348|FG003|Overall Study|Lack of Efficacy|1|||
19488545|NCT02612610|41780345|FG000|Overall Study|Physician Decision|0|||
19488546|NCT02612610|41780346|FG001|Overall Study|Physician Decision|1|||
19488547|NCT02612610|41780347|FG002|Overall Study|Physician Decision|0|||
19488548|NCT02612610|41780348|FG003|Overall Study|Physician Decision|0|||
19488549|NCT02612610|41780345|FG000|Overall Study|Noncompliance|1|||
19488550|NCT02612610|41780346|FG001|Overall Study|Noncompliance|0|||
19488551|NCT02612610|41780347|FG002|Overall Study|Noncompliance|0|||
19488552|NCT02612610|41780348|FG003|Overall Study|Noncompliance|0|||
19488553|NCT02612610|41780345|FG000|Overall Study|Cough Improvement|0|||
19488554|NCT02612610|41780346|FG001|Overall Study|Cough Improvement|0|||
19488555|NCT02612610|41780347|FG002|Overall Study|Cough Improvement|1|||
19488556|NCT02612610|41780348|FG003|Overall Study|Cough Improvement|0|||
19488557|NCT02610192|41780557|FG000|Overall Study|Received other treatment|8|||
19488558|NCT02610192|41780557|FG000|Overall Study|Physician Decision|1|||
19488559|NCT02609178|41780710|FG000|First Crown|Withdrawal by Subject|0|||
19488560|NCT02609178|41780711|FG001|First Crown|Withdrawal by Subject|0|||
19488561|NCT02609178|41780712|FG002|First Crown|Withdrawal by Subject|1|||
19488562|NCT02609178|41780713|FG003|First Crown|Withdrawal by Subject|1|||
19488563|NCT02609178|41780714|FG004|First Crown|Withdrawal by Subject|0|||
19488564|NCT02609178|41780715|FG005|First Crown|Withdrawal by Subject|0|||
19488565|NCT02607228|41780939|FG000|Overall Study|Progressive Disease|4|||
19488566|NCT02607228|41780940|FG001|Overall Study|Progressive Disease|3|||
19488567|NCT02607228|41780941|FG002|Overall Study|Progressive Disease|1|||
19488568|NCT02607228|41780942|FG003|Overall Study|Progressive Disease|5|||
19488569|NCT02607228|41780943|FG004|Overall Study|Progressive Disease|4|||
19488570|NCT02607228|41780944|FG005|Overall Study|Progressive Disease|3|||
19488571|NCT02607228|41780945|FG006|Overall Study|Progressive Disease|1|||
19488572|NCT02607228|41780939|FG000|Overall Study|Adverse Event|1|||
19488573|NCT02607228|41780940|FG001|Overall Study|Adverse Event|0|||
19488574|NCT02607228|41780941|FG002|Overall Study|Adverse Event|1|||
19488575|NCT02607228|41780942|FG003|Overall Study|Adverse Event|0|||
19612757|NCT00615199|42061611|FG003|Overall Study|Lack of Efficacy|1|||
19612758|NCT00615199|42061608|FG000|Overall Study|Lost to Follow-up|1|||
19612759|NCT00615199|42061609|FG001|Overall Study|Lost to Follow-up|0|||
19612760|NCT00615199|42061610|FG002|Overall Study|Lost to Follow-up|0|||
19612761|NCT00615199|42061611|FG003|Overall Study|Lost to Follow-up|0|||
19612762|NCT00615199|42061608|FG000|Overall Study|Other|0|||
19612763|NCT00615199|42061609|FG001|Overall Study|Other|0|||
19612764|NCT00615199|42061610|FG002|Overall Study|Other|0|||
19612765|NCT00615199|42061611|FG003|Overall Study|Other|1|||
19612766|NCT00615199|42061608|FG000|Overall Study|Withdrawal by Subject|2|||
19612767|NCT00615199|42061609|FG001|Overall Study|Withdrawal by Subject|1|||
19612768|NCT00615199|42061610|FG002|Overall Study|Withdrawal by Subject|0|||
19612769|NCT00615199|42061611|FG003|Overall Study|Withdrawal by Subject|0|||
19612770|NCT00613951|42061624|FG000|Overall Study|Adverse Event|1|||
19612771|NCT00613951|42061625|FG001|Overall Study|Adverse Event|0|||
19612772|NCT00613951|42061626|FG002|Overall Study|Adverse Event|1|||
19612773|NCT00613951|42061624|FG000|Overall Study|Lack of Efficacy|0|||
19612774|NCT00613951|42061625|FG001|Overall Study|Lack of Efficacy|1|||
19612775|NCT00613951|42061626|FG002|Overall Study|Lack of Efficacy|1|||
19488576|NCT02607228|41780943|FG004|Overall Study|Adverse Event|1|||
19488577|NCT02607228|41780944|FG005|Overall Study|Adverse Event|1|||
19488578|NCT02607228|41780945|FG006|Overall Study|Adverse Event|1|||
19488579|NCT02607228|41780939|FG000|Overall Study|Investigator's Discretion|0|||
19488580|NCT02607228|41780940|FG001|Overall Study|Investigator's Discretion|0|||
19488581|NCT02607228|41780941|FG002|Overall Study|Investigator's Discretion|1|||
19488582|NCT02607228|41780942|FG003|Overall Study|Investigator's Discretion|0|||
19488583|NCT02607228|41780943|FG004|Overall Study|Investigator's Discretion|0|||
19488584|NCT02607228|41780944|FG005|Overall Study|Investigator's Discretion|1|||
19488585|NCT02607228|41780945|FG006|Overall Study|Investigator's Discretion|0|||
19488586|NCT02607228|41780939|FG000|Overall Study|Withdrew Consent|0|||
19488587|NCT02607228|41780940|FG001|Overall Study|Withdrew Consent|1|||
19612776|NCT00613951|42061624|FG000|Overall Study|Protocol Violation|1|||
19488588|NCT02607228|41780941|FG002|Overall Study|Withdrew Consent|0|||
19488589|NCT02607228|41780942|FG003|Overall Study|Withdrew Consent|0|||
19488590|NCT02607228|41780943|FG004|Overall Study|Withdrew Consent|0|||
19488591|NCT02607228|41780944|FG005|Overall Study|Withdrew Consent|1|||
19488592|NCT02607228|41780945|FG006|Overall Study|Withdrew Consent|0|||
19488593|NCT02607228|41780939|FG000|Overall Study|Study Terminated by Sponsor|0|||
19488594|NCT02607228|41780940|FG001|Overall Study|Study Terminated by Sponsor|0|||
19488595|NCT02607228|41780941|FG002|Overall Study|Study Terminated by Sponsor|0|||
19488596|NCT02607228|41780942|FG003|Overall Study|Study Terminated by Sponsor|1|||
19488597|NCT02607228|41780943|FG004|Overall Study|Study Terminated by Sponsor|0|||
19488598|NCT02607228|41780944|FG005|Overall Study|Study Terminated by Sponsor|0|||
19488599|NCT02607228|41780945|FG006|Overall Study|Study Terminated by Sponsor|0|||
19488600|NCT01668654|41780987|FG000|Overall Study|Study Closed/Terminated|3|||
19488601|NCT01668654|41780987|FG000|Overall Study|Withdrawal by Subject|1|||
19488602|NCT02608476|41781081|FG000|Overall Study|Withdrawal by Subject|30|||
19488603|NCT02608476|41781082|FG001|Overall Study|Withdrawal by Subject|37|||
19488604|NCT02608476|41781081|FG000|Overall Study|Lost to Follow-up|24|||
19488605|NCT02608476|41781082|FG001|Overall Study|Lost to Follow-up|24|||
19488606|NCT02608476|41781081|FG000|Overall Study|Adverse Event|2|||
19488607|NCT02608476|41781082|FG001|Overall Study|Adverse Event|8|||
19488608|NCT02608476|41781081|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
19488609|NCT02608476|41781082|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
19488610|NCT02608476|41781081|FG000|Overall Study|Noncompliance with treatment|1|||
19488611|NCT02608476|41781082|FG001|Overall Study|Noncompliance with treatment|5|||
19488612|NCT02608476|41781081|FG000|Overall Study|Lack of Efficacy|3|||
19488613|NCT02608476|41781082|FG001|Overall Study|Lack of Efficacy|1|||
19488614|NCT02608476|41781081|FG000|Overall Study|Other|0|||
19488615|NCT02608476|41781082|FG001|Overall Study|Other|1|||
19488616|NCT02608476|41781081|FG000|Overall Study|Physician Decision|1|||
19488617|NCT02608476|41781082|FG001|Overall Study|Physician Decision|0|||
19488618|NCT02608476|41781081|FG000|Overall Study|Pregnancy|0|||
19488619|NCT02608476|41781082|FG001|Overall Study|Pregnancy|1|||
19488620|NCT02608476|41781081|FG000|Overall Study|Progressive disease|1|||
19488621|NCT02608476|41781082|FG001|Overall Study|Progressive disease|0|||
19488622|NCT02607306|41781220|FG000|Overall Study|Adverse Event|8|||
19488623|NCT02607306|41781221|FG001|Overall Study|Adverse Event|6|||
19488624|NCT02607306|41781222|FG002|Overall Study|Adverse Event|6|||
19488625|NCT02607306|41781220|FG000|Overall Study|Unclassified|1|||
19488626|NCT02607306|41781221|FG001|Overall Study|Unclassified|4|||
19488627|NCT02607306|41781222|FG002|Overall Study|Unclassified|0|||
19488628|NCT02607306|41781220|FG000|Overall Study|Withdrawal by Subject|8|||
19488629|NCT02607306|41781221|FG001|Overall Study|Withdrawal by Subject|10|||
19488630|NCT02607306|41781222|FG002|Overall Study|Withdrawal by Subject|2|||
19488631|NCT02607306|41781220|FG000|Overall Study|Lack of Efficacy|0|||
19488632|NCT02607306|41781221|FG001|Overall Study|Lack of Efficacy|1|||
19488633|NCT02607306|41781222|FG002|Overall Study|Lack of Efficacy|1|||
19488634|NCT02607306|41781220|FG000|Overall Study|Protocol Violation|4|||
19488635|NCT02607306|41781221|FG001|Overall Study|Protocol Violation|2|||
19488636|NCT02607306|41781222|FG002|Overall Study|Protocol Violation|1|||
19488637|NCT02603952|41781545|FG000|Overall Study|Withdrawal by Subject|1|||
19488638|NCT02603952|41781546|FG001|Overall Study|Withdrawal by Subject|0|||
19488639|NCT02603952|41781547|FG002|Overall Study|Withdrawal by Subject|0|||
19488640|NCT02603952|41781548|FG003|Overall Study|Withdrawal by Subject|0|||
19488641|NCT02603952|41781545|FG000|Overall Study|Received oseltamivir by error|0|||
19488642|NCT02603952|41781546|FG001|Overall Study|Received oseltamivir by error|0|||
19488643|NCT02603952|41781547|FG002|Overall Study|Received oseltamivir by error|0|||
19612777|NCT00613951|42061625|FG001|Overall Study|Protocol Violation|1|||
19612778|NCT00613951|42061626|FG002|Overall Study|Protocol Violation|1|||
19612779|NCT00613951|42061624|FG000|Overall Study|Unclassified|5|||
19612780|NCT00613951|42061625|FG001|Overall Study|Unclassified|3|||
19612781|NCT00613951|42061626|FG002|Overall Study|Unclassified|2|||
19612782|NCT00805467|42061641|FG000|Overall Study|Lack of Efficacy|0|||
19612783|NCT00805467|42061642|FG001|Overall Study|Lack of Efficacy|8|||
19612784|NCT00805467|42061643|FG002|Overall Study|Lack of Efficacy|13|||
19612785|NCT00805467|42061644|FG003|Overall Study|Lack of Efficacy|86|||
19612786|NCT00805467|42061641|FG000|Overall Study|Lost to Follow-up|0|||
19612787|NCT00805467|42061642|FG001|Overall Study|Lost to Follow-up|1|||
19488644|NCT02603952|41781548|FG003|Overall Study|Received oseltamivir by error|1|||
19488645|NCT02603172|41782081|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488646|NCT02603172|41782082|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488647|NCT02603172|41782083|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
19488648|NCT02603172|41782084|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488649|NCT02603172|41782085|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488650|NCT02603172|41782086|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488651|NCT02603172|41782087|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488652|NCT02603172|41782088|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
19488653|NCT02605824|41782195|FG000|Overall Study|Physician Decision|1|||
19612788|NCT00805467|42061643|FG002|Overall Study|Lost to Follow-up|7|||
19488654|NCT02605824|41782196|FG001|Overall Study|Physician Decision|0|||
19488655|NCT02605122|41782326|FG000|Overall Study|Withdrawal by Subject|4|||
19488656|NCT02605122|41782327|FG001|Overall Study|Withdrawal by Subject|1|||
19612789|NCT00805467|42061644|FG003|Overall Study|Lost to Follow-up|21|||
19612790|NCT00805467|42061641|FG000|Overall Study|Withdrawal by Subject|0|||
19612791|NCT00805467|42061642|FG001|Overall Study|Withdrawal by Subject|6|||
19612792|NCT00805467|42061643|FG002|Overall Study|Withdrawal by Subject|45|||
19612793|NCT00805467|42061644|FG003|Overall Study|Withdrawal by Subject|50|||
19612794|NCT00805467|42061641|FG000|Overall Study|Protocol Violation|0|||
19612795|NCT00805467|42061642|FG001|Overall Study|Protocol Violation|3|||
19612796|NCT00805467|42061643|FG002|Overall Study|Protocol Violation|0|||
19612797|NCT00805467|42061644|FG003|Overall Study|Protocol Violation|5|||
19612798|NCT00805467|42061641|FG000|Overall Study|Adverse Event|0|||
19612799|NCT00805467|42061642|FG001|Overall Study|Adverse Event|13|||
19612800|NCT00805467|42061643|FG002|Overall Study|Adverse Event|26|||
19612801|NCT00805467|42061644|FG003|Overall Study|Adverse Event|57|||
19612802|NCT00805467|42061641|FG000|Overall Study|Death|0|||
19612803|NCT00805467|42061642|FG001|Overall Study|Death|2|||
19612804|NCT00805467|42061643|FG002|Overall Study|Death|7|||
19612805|NCT00805467|42061644|FG003|Overall Study|Death|5|||
19612806|NCT00805467|42061641|FG000|Overall Study|Physician Decision|0|||
19612807|NCT00805467|42061642|FG001|Overall Study|Physician Decision|1|||
19612808|NCT00805467|42061643|FG002|Overall Study|Physician Decision|2|||
19612809|NCT00805467|42061644|FG003|Overall Study|Physician Decision|6|||
19612810|NCT00805467|42061641|FG000|Overall Study|Not reported|0|||
19612811|NCT00805467|42061642|FG001|Overall Study|Not reported|0|||
19612812|NCT00805467|42061643|FG002|Overall Study|Not reported|3|||
19612813|NCT00805467|42061644|FG003|Overall Study|Not reported|7|||
19612814|NCT00958841|42061654|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19612815|NCT00958841|42061654|FG000|Overall Study|Abnormal test procedure result(s)|3|||
19612816|NCT00958841|42061654|FG000|Overall Study|Administrative problems|1|||
19612817|NCT00958841|42061654|FG000|Overall Study|Adverse Event|8|||
19612818|NCT00958841|42061654|FG000|Overall Study|New cancer therapy|5|||
19612819|NCT00958841|42061654|FG000|Overall Study|Withdrawal by Subject|1|||
19612820|NCT00958841|42061654|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
19612821|NCT00958841|42061654|FG000|Overall Study|Completed M6/did not enter extension|27|||
19612822|NCT00958841|42061654|FG000|Overall Study|Discontinued prior to M*|28|||
19612823|NCT03927105|42061717|FG000|Overall Study|Death|1|||
19612824|NCT03927105|42061717|FG000|Overall Study|In observation for potential re-treatment|2|||
19612825|NCT03927105|42061717|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
19612826|NCT00613327|42061721|FG000|Overall Study|Adverse Event|38|||
19612827|NCT00613327|42061721|FG000|Overall Study|Lost to Follow-up|8|||
19612828|NCT00613327|42061721|FG000|Overall Study|Withdrawal by Subject|6|||
19612829|NCT00613327|42061721|FG000|Overall Study|Protocol Violation|2|||
19612830|NCT00613327|42061721|FG000|Overall Study|Other|47|||
19612831|NCT00954941|42061727|FG000|Overall Study|Received treatment at home|1|||
19612832|NCT00954941|42061728|FG001|Overall Study|Received treatment at home|0|||
19612833|NCT00954941|42061727|FG000|Overall Study|Withdrawal by Subject|1|||
19612834|NCT00954941|42061728|FG001|Overall Study|Withdrawal by Subject|0|||
19612835|NCT00954941|42061727|FG000|Overall Study|Insurance Denial|2|||
19612836|NCT00954941|42061728|FG001|Overall Study|Insurance Denial|2|||
19704265|NCT00224484|42148580|FG001|Overall Study|Withdrawal by Subject|18|||
19612837|NCT00954941|42061727|FG000|Overall Study|Physician Decision|2|||
19612838|NCT00954941|42061728|FG001|Overall Study|Physician Decision|2|||
19612839|NCT00954941|42061727|FG000|Overall Study|Ineligible|2|||
19612840|NCT00954941|42061728|FG001|Overall Study|Ineligible|2|||
19612841|NCT00954941|42061727|FG000|Overall Study|Adverse Event|0|||
19612842|NCT00954941|42061728|FG001|Overall Study|Adverse Event|1|||
19612843|NCT00954707|42061734|FG000|Overall Study|Death|34|||
19612844|NCT00954707|42061734|FG000|Overall Study|Withdrawal by Subject|100|||
19612845|NCT00954707|42061734|FG000|Overall Study|Lost to Follow-up|33|||
19612846|NCT00589797|42061740|FG000|Overall Study|Death|1|||
19612847|NCT00589797|42061741|FG001|Overall Study|Death|0|||
19612848|NCT00589797|42061740|FG000|Overall Study|Lost to Follow-up|12|||
19612849|NCT00589797|42061741|FG001|Overall Study|Lost to Follow-up|9|||
19612850|NCT00589797|42061740|FG000|Overall Study|Physician Decision|8|||
19612851|NCT00589797|42061741|FG001|Overall Study|Physician Decision|3|||
19612852|NCT00589797|42061740|FG000|Overall Study|Withdrawal by Subject|6|||
19612853|NCT00589797|42061741|FG001|Overall Study|Withdrawal by Subject|5|||
19612854|NCT00589797|42061740|FG000|Overall Study|Non-Randomized Training Subjects|46|||
19612855|NCT00589797|42061741|FG001|Overall Study|Non-Randomized Training Subjects|6|||
19612856|NCT00613171|42061747|FG000|Overall Study|Adverse Event|7|||
19488657|NCT02605122|41782326|FG000|Overall Study|Lost to Follow-up|1|||
19488658|NCT02605122|41782327|FG001|Overall Study|Lost to Follow-up|1|||
19612857|NCT00613171|42061747|FG000|Overall Study|Withdrawal by Subject|3|||
19612858|NCT00613171|42061747|FG000|Overall Study|Reason not Specified|4|||
19612859|NCT00896480|42061752|FG000|Overall Study|Disease progression/recurrence|21|||
19612860|NCT00953225|42061761|FG000|Overall Study|Withdrawal by Subject|2|||
19488659|NCT01454102|41782367|FG000|Overall Study|Continuing in the treatment period|0|||
19488660|NCT01454102|41782368|FG001|Overall Study|Continuing in the treatment period|0|||
19488661|NCT01454102|41782369|FG002|Overall Study|Continuing in the treatment period|0|||
19488662|NCT01454102|41782370|FG003|Overall Study|Continuing in the treatment period|0|||
19488663|NCT01454102|41782371|FG004|Overall Study|Continuing in the treatment period|3|||
19488664|NCT01454102|41782372|FG005|Overall Study|Continuing in the treatment period|3|||
19488665|NCT01454102|41782373|FG006|Overall Study|Continuing in the treatment period|2|||
19488666|NCT01454102|41782374|FG007|Overall Study|Continuing in the treatment period|0|||
19488667|NCT01454102|41782375|FG008|Overall Study|Continuing in the treatment period|1|||
19488668|NCT01454102|41782376|FG009|Overall Study|Continuing in the treatment period|0|||
19488669|NCT01454102|41782377|FG010|Overall Study|Continuing in the treatment period|0|||
19488670|NCT01454102|41782378|FG011|Overall Study|Continuing in the treatment period|4|||
19488671|NCT01454102|41782379|FG012|Overall Study|Continuing in the treatment period|7|||
19488672|NCT01454102|41782380|FG013|Overall Study|Continuing in the treatment period|4|||
19488673|NCT01454102|41782381|FG014|Overall Study|Continuing in the treatment period|3|||
19488674|NCT01454102|41782382|FG015|Overall Study|Continuing in the treatment period|1|||
19488675|NCT02602080|41782487|FG000|Overall Study|Protocol Violation|6|||
19488676|NCT02602080|41782488|FG001|Overall Study|Protocol Violation|1|||
19488677|NCT02602080|41782489|FG002|Overall Study|Protocol Violation|3|||
19488678|NCT02604342|41782573|FG000|Overall Study|Death|32|||
19488679|NCT02604342|41782574|FG001|Overall Study|Death|16|||
19488680|NCT02604342|41782573|FG000|Overall Study|Progression of disease|1|||
19488681|NCT02604342|41782574|FG001|Overall Study|Progression of disease|0|||
19488682|NCT02604342|41782573|FG000|Overall Study|Withdrawal by Subject|5|||
19488683|NCT02604342|41782574|FG001|Overall Study|Withdrawal by Subject|6|||
19488684|NCT02604342|41782573|FG000|Overall Study|Other|1|||
19488685|NCT02604342|41782574|FG001|Overall Study|Other|0|||
19488686|NCT02604342|41782573|FG000|Overall Study|Study Termination by Sponsor|1|||
19488687|NCT02604342|41782574|FG001|Overall Study|Study Termination by Sponsor|0|||
19488688|NCT02604342|41782573|FG000|Overall Study|Lost to Follow-up|1|||
19488689|NCT02604342|41782574|FG001|Overall Study|Lost to Follow-up|1|||
19488690|NCT02604342|41782573|FG000|Overall Study|Physician Decision|2|||
19488691|NCT02604342|41782574|FG001|Overall Study|Physician Decision|0|||
19488692|NCT02604264|41782603|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
19488693|NCT02604264|41782604|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
19488694|NCT02601300|41782641|FG000|Induction Phase|Lack of Efficacy|2|||
19488695|NCT02601300|41782641|FG000|Induction Phase|Protocol Violation|1|||
19488696|NCT02601300|41782641|FG000|Extension Phase|Withdrawal by Subject|3|||
19488697|NCT02601300|41782641|FG000|Extension Phase|Adverse Event|4|||
19488698|NCT02601300|41782641|FG000|Extension Phase|Lack of Efficacy|10|||
19488699|NCT01471340|41782680|FG000|Overall Study|Death|5|||
19488700|NCT01471340|41782681|FG001|Overall Study|Death|4|||
19488701|NCT01471340|41782680|FG000|Overall Study|Lost to Follow-up|0|||
19488702|NCT01471340|41782681|FG001|Overall Study|Lost to Follow-up|1|||
19488703|NCT01471340|41782680|FG000|Overall Study|Investigational site closure|0|||
19488704|NCT01471340|41782681|FG001|Overall Study|Investigational site closure|1|||
19488705|NCT01471340|41782680|FG000|Overall Study|Invalid informed consent|1|||
19488706|NCT01471340|41782681|FG001|Overall Study|Invalid informed consent|0|||
19488707|NCT01492400|41782703|FG000|Overall Study|Miscellaneous Reasons|2|||
19488708|NCT01492400|41782704|FG001|Overall Study|Miscellaneous Reasons|3|||
19488709|NCT01492400|41782703|FG000|Overall Study|Personal Reasons|0|||
19488710|NCT01492400|41782704|FG001|Overall Study|Personal Reasons|5|||
19488711|NCT01492400|41782703|FG000|Overall Study|Lost to Follow-up|3|||
19488712|NCT01492400|41782704|FG001|Overall Study|Lost to Follow-up|1|||
19488713|NCT01492400|41782703|FG000|Overall Study|Pregnancy|0|||
19488714|NCT01492400|41782704|FG001|Overall Study|Pregnancy|1|||
19488715|NCT01492400|41782703|FG000|Overall Study|Lack of Efficacy|1|||
19488716|NCT01492400|41782704|FG001|Overall Study|Lack of Efficacy|1|||
19488717|NCT01492400|41782703|FG000|Overall Study|Adverse Event|10|||
19488718|NCT01492400|41782704|FG001|Overall Study|Adverse Event|5|||
19488719|NCT02596854|41782829|FG000|Overall Study|Withdrawn|8|||
19488720|NCT02592876|41782974|FG000|Overall Study|Withdrawal by Subject|3|||
19488721|NCT02592876|41782975|FG001|Overall Study|Withdrawal by Subject|3|||
19488722|NCT02592876|41782974|FG000|Overall Study|Study Termination by Sponsor|32|||
19488723|NCT02592876|41782975|FG001|Overall Study|Study Termination by Sponsor|27|||
19488724|NCT02592876|41782974|FG000|Overall Study|Lost to Follow-up|0|||
19488725|NCT02592876|41782975|FG001|Overall Study|Lost to Follow-up|1|||
19488726|NCT02592876|41782974|FG000|Overall Study|Death|6|||
19488727|NCT02592876|41782975|FG001|Overall Study|Death|9|||
19488728|NCT01492088|41782992|FG000|Overall Study|Withdrawal by Patient|0|||
19488729|NCT01492088|41782993|FG001|Overall Study|Withdrawal by Patient|2|||
19488730|NCT01492088|41782994|FG002|Overall Study|Withdrawal by Patient|0|||
19488731|NCT01492088|41782992|FG000|Overall Study|Death|1|||
19488732|NCT01492088|41782993|FG001|Overall Study|Death|6|||
19488733|NCT01492088|41782994|FG002|Overall Study|Death|2|||
19488734|NCT01492088|41782992|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
19488735|NCT01492088|41782993|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
19488736|NCT01492088|41782994|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
19488737|NCT01492088|41782992|FG000|Overall Study|Alive at Last Follow-up|0|||
19488738|NCT01492088|41782993|FG001|Overall Study|Alive at Last Follow-up|6|||
19488739|NCT01492088|41782994|FG002|Overall Study|Alive at Last Follow-up|11|||
19488740|NCT02592798|41783236|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
19488741|NCT02592798|41783237|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
19488742|NCT02592798|41783236|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
19488743|NCT02592798|41783237|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
19488744|NCT02592798|41783236|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
19488745|NCT02592798|41783237|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
19488746|NCT02592798|41783236|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
19488747|NCT02592798|41783237|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
19488748|NCT02592798|41783236|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
19488749|NCT02592798|41783237|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
19488750|NCT02592798|41783236|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
19488751|NCT02592798|41783237|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
19488752|NCT02592798|41783236|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
19488753|NCT02592798|41783237|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
19488754|NCT02592798|41783236|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
19488755|NCT02592798|41783237|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
19488756|NCT02592798|41783236|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
19488757|NCT02592798|41783237|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
19488758|NCT02592798|41783236|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
19488759|NCT02592798|41783237|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
19488760|NCT02592798|41783236|FG000|Transition From DB2 to OLE|Other reasons|1|||
19488761|NCT02592798|41783237|FG001|Transition From DB2 to OLE|Other reasons|0|||
19488762|NCT02592798|41783236|FG000|Open Label Period (OLE)|Other reasons|0|||
19488763|NCT02592798|41783237|FG001|Open Label Period (OLE)|Other reasons|2|||
19488764|NCT02592798|41783236|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
19488765|NCT02592798|41783237|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
19488766|NCT02592798|41783236|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
19488767|NCT02592798|41783237|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
19488768|NCT02592798|41783236|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
19488769|NCT02592798|41783237|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
19488770|NCT02592798|41783236|FG000|Open Label Period (OLE)|Adverse Event|0|||
19488771|NCT02592798|41783237|FG001|Open Label Period (OLE)|Adverse Event|1|||
19488772|NCT00081653|41783277|FG000|Overall Study|Adverse Event|23|||
19488773|NCT00081653|41783278|FG001|Overall Study|Adverse Event|17|||
19488774|NCT00081653|41783277|FG000|Overall Study|Lost to Follow-up|2|||
19488775|NCT00081653|41783278|FG001|Overall Study|Lost to Follow-up|4|||
19488776|NCT00081653|41783277|FG000|Overall Study|Refused Treatment|18|||
19488777|NCT00081653|41783278|FG001|Overall Study|Refused Treatment|14|||
19488778|NCT00081653|41783277|FG000|Overall Study|Low bone mineral density|1|||
19488779|NCT00081653|41783278|FG001|Overall Study|Low bone mineral density|0|||
19488780|NCT00081653|41783277|FG000|Overall Study|Bone loss|2|||
19488781|NCT00081653|41783278|FG001|Overall Study|Bone loss|0|||
19488782|NCT00081653|41783277|FG000|Overall Study|Participant leaving country|1|||
19488783|NCT00081653|41783278|FG001|Overall Study|Participant leaving country|0|||
19488784|NCT00081653|41783277|FG000|Overall Study|Loss of bone mass|0|||
19488785|NCT00081653|41783278|FG001|Overall Study|Loss of bone mass|2|||
19488786|NCT02596620|41783348|FG000|Overall Study|Lost to Follow-up|1|||
19488787|NCT02596620|41783349|FG001|Overall Study|Lost to Follow-up|1|||
19488788|NCT02596230|41783505|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
19488789|NCT02596230|41783506|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
19488790|NCT02596230|41783507|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
19488791|NCT02596230|41783508|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
19612861|NCT00953225|42061762|FG001|Overall Study|Withdrawal by Subject|0|||
19612862|NCT00613015|42061774|FG000|Overall Study|Lost to Follow-up|0|||
19612863|NCT00613015|42061775|FG001|Overall Study|Lost to Follow-up|1|||
19612864|NCT00613015|42061776|FG002|Overall Study|Lost to Follow-up|3|||
19612865|NCT00613015|42061777|FG003|Overall Study|Lost to Follow-up|3|||
19612866|NCT00613015|42061778|FG004|Overall Study|Lost to Follow-up|2|||
19612867|NCT00613015|42061779|FG005|Overall Study|Lost to Follow-up|3|||
19612868|NCT00803595|42061796|FG000|Overall Study|Adverse Event|3|||
19612869|NCT00803595|42061797|FG001|Overall Study|Adverse Event|4|||
19612870|NCT00803595|42061798|FG002|Overall Study|Adverse Event|1|||
19704266|NCT00224484|42148581|FG002|Overall Study|Withdrawal by Subject|16|||
19704267|NCT00224484|42148579|FG000|Overall Study|Migrated/moved from study area|18|||
19704268|NCT00224484|42148580|FG001|Overall Study|Migrated/moved from study area|5|||
19704269|NCT00224484|42148581|FG002|Overall Study|Migrated/moved from study area|5|||
19704270|NCT00224484|42148579|FG000|Overall Study|Lost to Follow-up|66|||
19704271|NCT00224484|42148580|FG001|Overall Study|Lost to Follow-up|28|||
19704272|NCT00224484|42148581|FG002|Overall Study|Lost to Follow-up|36|||
19488792|NCT02596230|41783509|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
19488793|NCT02596230|41783505|FG000|Objective 2, One Year|Lost to Follow-up|0|||
19488794|NCT02596230|41783506|FG001|Objective 2, One Year|Lost to Follow-up|41|||
19488795|NCT02596230|41783507|FG002|Objective 2, One Year|Lost to Follow-up|41|||
19488796|NCT02596230|41783508|FG003|Objective 2, One Year|Lost to Follow-up|32|||
19488797|NCT02596230|41783509|FG004|Objective 2, One Year|Lost to Follow-up|46|||
19488798|NCT02596230|41783505|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
19488799|NCT02596230|41783506|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
19488800|NCT02596230|41783507|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
19488801|NCT02596230|41783508|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
19488802|NCT02596230|41783509|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
19488803|NCT02596230|41783505|FG000|Objective 2, One Year|Adverse drug reaction|0|||
19488804|NCT02596230|41783506|FG001|Objective 2, One Year|Adverse drug reaction|1|||
19488805|NCT02596230|41783507|FG002|Objective 2, One Year|Adverse drug reaction|0|||
19488806|NCT02596230|41783508|FG003|Objective 2, One Year|Adverse drug reaction|0|||
19488807|NCT02596230|41783509|FG004|Objective 2, One Year|Adverse drug reaction|0|||
19488808|NCT02596230|41783505|FG000|Objective 2, One Year|Death|0|||
19488809|NCT02596230|41783506|FG001|Objective 2, One Year|Death|12|||
19488810|NCT02596230|41783507|FG002|Objective 2, One Year|Death|41|||
19488811|NCT02596230|41783508|FG003|Objective 2, One Year|Death|21|||
19488812|NCT02596230|41783509|FG004|Objective 2, One Year|Death|30|||
19488813|NCT02596230|41783505|FG000|Objective 2, One Year|Other|0|||
19488814|NCT02596230|41783506|FG001|Objective 2, One Year|Other|3|||
19488815|NCT02596230|41783507|FG002|Objective 2, One Year|Other|2|||
19488816|NCT02596230|41783508|FG003|Objective 2, One Year|Other|0|||
19488817|NCT02596230|41783509|FG004|Objective 2, One Year|Other|0|||
19488818|NCT01667562|41783558|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
19488819|NCT01667562|41783559|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
19488820|NCT01667562|41783558|FG000|Erlotinib Phase|Lost to Follow-up|0|||
19488821|NCT01667562|41783559|FG001|Erlotinib Phase|Lost to Follow-up|1|||
19488822|NCT01667562|41783558|FG000|Erlotinib Phase|Adverse Event|0|||
19488823|NCT01667562|41783559|FG001|Erlotinib Phase|Adverse Event|1|||
19488824|NCT01667562|41783558|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
19488825|NCT01667562|41783559|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
19488826|NCT02595528|41783596|FG000|Overall Study|Withdrawal by Subject|1|||
19488827|NCT02595528|41783597|FG001|Overall Study|Withdrawal by Subject|2|||
19488828|NCT02595528|41783598|FG002|Overall Study|Withdrawal by Subject|1|||
19488829|NCT02595528|41783599|FG003|Overall Study|Withdrawal by Subject|3|||
19488830|NCT02595528|41783596|FG000|Overall Study|Lost to Follow-up|1|||
19488831|NCT02595528|41783597|FG001|Overall Study|Lost to Follow-up|1|||
19488832|NCT02595528|41783598|FG002|Overall Study|Lost to Follow-up|0|||
19488833|NCT02595528|41783599|FG003|Overall Study|Lost to Follow-up|1|||
19488834|NCT02595450|41783627|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
19488835|NCT02595450|41783627|FG000|Overall Study|Enrolled, but not treated|8|||
19488836|NCT02592018|41783631|FG000|Overall Study|Adverse Event|1|||
19488837|NCT02592018|41783631|FG000|Overall Study|Lost to Follow-up|1|||
19488838|NCT02591238|41783639|FG000|Overall Study|Pregnancy|1|||
19488839|NCT02591238|41783640|FG001|Overall Study|Pregnancy|0|||
19488840|NCT02591238|41783641|FG002|Overall Study|Pregnancy|0|||
19488841|NCT02591238|41783642|FG003|Overall Study|Pregnancy|0|||
19488842|NCT02591238|41783639|FG000|Overall Study|Withdrawal by Subject|0|||
19488843|NCT02591238|41783640|FG001|Overall Study|Withdrawal by Subject|0|||
19488844|NCT02591238|41783641|FG002|Overall Study|Withdrawal by Subject|0|||
19488845|NCT02591238|41783642|FG003|Overall Study|Withdrawal by Subject|1|||
19488846|NCT02591238|41783639|FG000|Overall Study|influenza|0|||
19488847|NCT02591238|41783640|FG001|Overall Study|influenza|0|||
19488848|NCT02591238|41783641|FG002|Overall Study|influenza|0|||
19488849|NCT02591238|41783642|FG003|Overall Study|influenza|1|||
19488850|NCT02591238|41783639|FG000|Overall Study|personal circumstances|0|||
19488851|NCT02591238|41783640|FG001|Overall Study|personal circumstances|0|||
19488852|NCT02591238|41783641|FG002|Overall Study|personal circumstances|0|||
19488853|NCT02591238|41783642|FG003|Overall Study|personal circumstances|1|||
19488854|NCT02591238|41783639|FG000|Overall Study|personal circumstances|0|||
19488855|NCT02591238|41783640|FG001|Overall Study|personal circumstances|1|||
19488856|NCT02591238|41783641|FG002|Overall Study|personal circumstances|0|||
19488857|NCT02591238|41783642|FG003|Overall Study|personal circumstances|0|||
19488858|NCT02597946|41783724|FG000|Overall Study|Withdrawal by Subject|1|||
19488859|NCT02597946|41783724|FG000|Overall Study|Progressive disease|16|||
19488860|NCT02597946|41783724|FG000|Overall Study|Other than above|1|||
19488861|NCT02597712|41783730|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
19488862|NCT02597712|41783731|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
19488863|NCT02597712|41783730|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
19488864|NCT02597712|41783731|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
19488865|NCT02597712|41783730|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
19488866|NCT02597712|41783731|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
19488867|NCT02597478|41783739|FG000|Overall Study|Withdrawal by Subject|2|||
19488868|NCT02597478|41783740|FG001|Overall Study|Withdrawal by Subject|0|||
19488869|NCT02597478|41783739|FG000|Overall Study|Change of opioid dose|1|||
19488870|NCT02597478|41783740|FG001|Overall Study|Change of opioid dose|0|||
19488871|NCT02597478|41783739|FG000|Overall Study|Insufficient exertional dyspnea|0|||
19488872|NCT02597478|41783740|FG001|Overall Study|Insufficient exertional dyspnea|1|||
19488873|NCT01471028|41783835|FG000|VTI-208|Adverse Event|39|||
19488874|NCT01471028|41783836|FG001|VTI-208|Adverse Event|41|||
19488875|NCT01471028|41783835|FG000|VTI-208|Withdrawal by Subject|0|||
19488876|NCT01471028|41783836|FG001|VTI-208|Withdrawal by Subject|2|||
19488877|NCT01471028|41783835|FG000|VTI-208|Lost to Follow-up|1|||
19488878|NCT01471028|41783836|FG001|VTI-208|Lost to Follow-up|1|||
19488879|NCT01471028|41783835|FG000|VTI-208E|Death|7|||
19488880|NCT01471028|41783836|FG001|VTI-208E|Death|10|||
19488881|NCT01471028|41783835|FG000|VTI-208E|Withdrawal by Subject|1|||
19488882|NCT01471028|41783836|FG001|VTI-208E|Withdrawal by Subject|0|||
19488883|NCT01471028|41783835|FG000|VTI-208E|Lost to Follow-up|0|||
19488884|NCT01471028|41783836|FG001|VTI-208E|Lost to Follow-up|2|||
19488885|NCT01491854|41783850|FG000|Overall Study|mainly due to premature termination|93|||
19488886|NCT01491854|41783850|FG000|Overall Study|Death|1|||
19488887|NCT01491854|41783850|FG000|Overall Study|Withdrawal by Subject|3|||
19488888|NCT01491854|41783850|FG000|Overall Study|Lost to Follow-up|33|||
19488889|NCT01470248|41783858|FG000|Overall Study|Withdrawal by Subject|1|||
19488890|NCT01490918|41783878|FG000|Overall Study|Lost to Follow-up|2|||
19488891|NCT01490918|41783879|FG001|Overall Study|Lost to Follow-up|1|||
19488892|NCT01490918|41783880|FG002|Overall Study|Lost to Follow-up|0|||
19488893|NCT01490918|41783878|FG000|Overall Study|Withdrawal by Subject|7|||
19488894|NCT01490918|41783879|FG001|Overall Study|Withdrawal by Subject|8|||
19488895|NCT01490918|41783880|FG002|Overall Study|Withdrawal by Subject|3|||
19488896|NCT01490918|41783878|FG000|Overall Study|Adverse Event|0|||
19488897|NCT01490918|41783879|FG001|Overall Study|Adverse Event|0|||
19488898|NCT01490918|41783880|FG002|Overall Study|Adverse Event|1|||
19488899|NCT01490918|41783878|FG000|Overall Study|other cause|4|||
19488900|NCT01490918|41783879|FG001|Overall Study|other cause|5|||
19488901|NCT01490918|41783880|FG002|Overall Study|other cause|8|||
19488902|NCT01490840|41783912|FG000|Phase 1|Lost to Follow-up|1|||
19488903|NCT01490840|41783913|FG001|Phase 1|Lost to Follow-up|0|||
19488904|NCT01490840|41783912|FG000|Phase 1|Adverse Event|2|||
19488905|NCT01490840|41783913|FG001|Phase 1|Adverse Event|1|||
19488906|NCT01490840|41783912|FG000|Phase 1|Withdrawal by Subject|6|||
19488907|NCT01490840|41783913|FG001|Phase 1|Withdrawal by Subject|5|||
19488908|NCT01490840|41783912|FG000|Phase 1|Visit 6a omitted|1|||
19488909|NCT01490840|41783913|FG001|Phase 1|Visit 6a omitted|0|||
19488910|NCT01490840|41783912|FG000|Phase 2|Withdrawal by Subject|4|||
19488911|NCT01490840|41783913|FG001|Phase 2|Withdrawal by Subject|3|||
19488912|NCT01490840|41783912|FG000|Phase 2|Permanent interruption of fingolimod|0|||
19488913|NCT01490840|41783913|FG001|Phase 2|Permanent interruption of fingolimod|1|||
19612871|NCT00803595|42061796|FG000|Overall Study|Protocol Violation|7|||
19612872|NCT00803595|42061797|FG001|Overall Study|Protocol Violation|2|||
19612873|NCT00803595|42061798|FG002|Overall Study|Protocol Violation|12|||
19612874|NCT00803595|42061796|FG000|Overall Study|Withdrawal by Subject|5|||
19612875|NCT00803595|42061797|FG001|Overall Study|Withdrawal by Subject|2|||
19612876|NCT00803595|42061798|FG002|Overall Study|Withdrawal by Subject|3|||
19612877|NCT00953927|42061808|FG000|Overall Study|Lost to Follow-up|61|||
19612878|NCT00953927|42061809|FG001|Overall Study|Lost to Follow-up|65|||
19612879|NCT00953927|42061808|FG000|Overall Study|Withdrawal by Subject|36|||
19612880|NCT00953927|42061809|FG001|Overall Study|Withdrawal by Subject|25|||
19612881|NCT00953927|42061808|FG000|Overall Study|Death|7|||
19488914|NCT01490840|41783912|FG000|Phase 2|Lost to Follow-up|1|||
19488915|NCT01490840|41783913|FG001|Phase 2|Lost to Follow-up|1|||
19488916|NCT01490840|41783912|FG000|Phase 2|Adverse Event|1|||
19488917|NCT01490840|41783913|FG001|Phase 2|Adverse Event|1|||
19488918|NCT01490450|41783945|FG000|Period 1|Lack of Efficacy|2|||
19488919|NCT01490450|41783946|FG001|Period 1|Lack of Efficacy|0|||
19488920|NCT01490450|41783947|FG002|Period 1|Lack of Efficacy|3|||
19488921|NCT01490450|41783948|FG003|Period 1|Lack of Efficacy|0|||
19488922|NCT01490450|41783945|FG000|Period 1|Adverse Event|0|||
19488923|NCT01490450|41783946|FG001|Period 1|Adverse Event|0|||
19488924|NCT01490450|41783947|FG002|Period 1|Adverse Event|0|||
19488925|NCT01490450|41783948|FG003|Period 1|Adverse Event|5|||
19612882|NCT00953927|42061809|FG001|Overall Study|Death|4|||
19488926|NCT01490450|41783945|FG000|Period 1|Request to discontinue treatment|1|||
19488927|NCT01490450|41783946|FG001|Period 1|Request to discontinue treatment|0|||
19488928|NCT01490450|41783947|FG002|Period 1|Request to discontinue treatment|0|||
19488929|NCT01490450|41783948|FG003|Period 1|Request to discontinue treatment|0|||
19488930|NCT01490450|41783945|FG000|Period 1|Withdrawal by Subject|0|||
19488931|NCT01490450|41783946|FG001|Period 1|Withdrawal by Subject|0|||
19612883|NCT00953927|42061808|FG000|Overall Study|Other study discontinuation|1|||
19612884|NCT00953927|42061809|FG001|Overall Study|Other study discontinuation|1|||
19488932|NCT01490450|41783947|FG002|Period 1|Withdrawal by Subject|0|||
19488933|NCT01490450|41783948|FG003|Period 1|Withdrawal by Subject|3|||
19612885|NCT00611767|42061817|FG000|Overall Study|Withdrawal by Subject|4|||
19612886|NCT00611767|42061818|FG001|Overall Study|Withdrawal by Subject|1|||
19612887|NCT00611767|42061817|FG000|Overall Study|Thiopental not available|3|||
19612888|NCT00611767|42061818|FG001|Overall Study|Thiopental not available|0|||
19612889|NCT00611767|42061817|FG000|Overall Study|didn't like the medication|1|||
19612890|NCT00611767|42061818|FG001|Overall Study|didn't like the medication|1|||
19612891|NCT00611767|42061817|FG000|Overall Study|Physician Decision|1|||
19612892|NCT00611767|42061818|FG001|Overall Study|Physician Decision|0|||
19612893|NCT00803361|42061826|FG000|Overall Study|Adverse Event|13|||
19612894|NCT00803361|42061827|FG001|Overall Study|Adverse Event|3|||
19612895|NCT00803361|42061826|FG000|Overall Study|Lack of Efficacy|4|||
19612896|NCT00803361|42061827|FG001|Overall Study|Lack of Efficacy|13|||
19612897|NCT00803361|42061826|FG000|Overall Study|Lost to Follow-up|1|||
19612898|NCT00803361|42061827|FG001|Overall Study|Lost to Follow-up|2|||
19612899|NCT00803361|42061826|FG000|Overall Study|Physician Decision|1|||
19612900|NCT00803361|42061827|FG001|Overall Study|Physician Decision|0|||
19612901|NCT00803361|42061826|FG000|Overall Study|Protocol Violation|2|||
19612902|NCT00803361|42061827|FG001|Overall Study|Protocol Violation|4|||
19612903|NCT00803361|42061826|FG000|Overall Study|Withdrawal by Subject|5|||
19612904|NCT00803361|42061827|FG001|Overall Study|Withdrawal by Subject|6|||
19612905|NCT00611533|42061833|FG000|First Intervention (6 Weeks)|Never started study|0|||
19612906|NCT00611533|42061834|FG001|First Intervention (6 Weeks)|Never started study|1|||
19612907|NCT00611533|42061833|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
19612908|NCT00611533|42061834|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
19612909|NCT00611533|42061833|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
19612910|NCT00611533|42061834|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
19612911|NCT00953147|42061853|FG000|Overall Study|Adverse Event|8|||
19612912|NCT00953147|42061854|FG001|Overall Study|Adverse Event|16|||
19612913|NCT00953147|42061855|FG002|Overall Study|Adverse Event|6|||
19612914|NCT00953147|42061853|FG000|Overall Study|Protocol Violation|2|||
19612915|NCT00953147|42061854|FG001|Overall Study|Protocol Violation|8|||
19612916|NCT00953147|42061855|FG002|Overall Study|Protocol Violation|4|||
19612917|NCT00953147|42061853|FG000|Overall Study|Withdrawal by Subject|13|||
19612918|NCT00953147|42061854|FG001|Overall Study|Withdrawal by Subject|15|||
19612919|NCT00953147|42061855|FG002|Overall Study|Withdrawal by Subject|12|||
19612920|NCT00953147|42061853|FG000|Overall Study|Lost to Follow-up|8|||
19612921|NCT00953147|42061854|FG001|Overall Study|Lost to Follow-up|9|||
19612922|NCT00953147|42061855|FG002|Overall Study|Lost to Follow-up|4|||
19612923|NCT00953147|42061853|FG000|Overall Study|Physician Decision|2|||
19612924|NCT00953147|42061854|FG001|Overall Study|Physician Decision|7|||
19612925|NCT00953147|42061855|FG002|Overall Study|Physician Decision|3|||
19612926|NCT00953147|42061853|FG000|Overall Study|Other|4|||
19612927|NCT00953147|42061854|FG001|Overall Study|Other|11|||
19612928|NCT00953147|42061855|FG002|Overall Study|Other|13|||
19612929|NCT00803205|42061865|FG000|Overall Study|Adverse Event|7|||
19612930|NCT00803205|42061866|FG001|Overall Study|Adverse Event|2|||
19612931|NCT00803205|42061865|FG000|Overall Study|Lost to Follow-up|1|||
19612932|NCT00803205|42061866|FG001|Overall Study|Lost to Follow-up|0|||
19612933|NCT00803205|42061865|FG000|Overall Study|Withdrawal by Subject|9|||
19612934|NCT00803205|42061866|FG001|Overall Study|Withdrawal by Subject|9|||
19612935|NCT00803205|42061865|FG000|Overall Study|Physician Decision|1|||
19612936|NCT00803205|42061866|FG001|Overall Study|Physician Decision|0|||
19612937|NCT00803205|42061865|FG000|Overall Study|Protocol Violation|1|||
19612938|NCT00803205|42061866|FG001|Overall Study|Protocol Violation|1|||
19612939|NCT00803205|42061865|FG000|Overall Study|Medical Monitor Decision|1|||
19612940|NCT00803205|42061866|FG001|Overall Study|Medical Monitor Decision|0|||
19612941|NCT00803205|42061865|FG000|Overall Study|Acquired a Lung Infection|0|||
19612942|NCT00803205|42061866|FG001|Overall Study|Acquired a Lung Infection|1|||
19612943|NCT00803205|42061865|FG000|Overall Study|Sponsor Decision|0|||
19612944|NCT00803205|42061866|FG001|Overall Study|Sponsor Decision|1|||
19612945|NCT00952523|42061872|FG000|Overall Study|Withdrawal by Subject|7|||
19612946|NCT02232737|42061881|FG000|Overall Study|Lost to Follow-up|18|||
19612947|NCT02232737|42061882|FG001|Overall Study|Lost to Follow-up|28|||
19612948|NCT02232737|42061883|FG002|Overall Study|Lost to Follow-up|33|||
19612949|NCT02232737|42061881|FG000|Overall Study|Personal reasons|7|||
19612950|NCT02232737|42061882|FG001|Overall Study|Personal reasons|8|||
19612951|NCT02232737|42061883|FG002|Overall Study|Personal reasons|14|||
19612952|NCT02232737|42061881|FG000|Overall Study|Adverse Event|6|||
19704273|NCT00224484|42148579|FG000|Overall Study|Reason not specified|5|||
19612953|NCT02232737|42061882|FG001|Overall Study|Adverse Event|3|||
19612954|NCT02232737|42061883|FG002|Overall Study|Adverse Event|8|||
19612955|NCT02232737|42061881|FG000|Overall Study|Incarcerated|2|||
19612956|NCT02232737|42061882|FG001|Overall Study|Incarcerated|1|||
19612957|NCT02232737|42061883|FG002|Overall Study|Incarcerated|2|||
19612958|NCT02232737|42061881|FG000|Overall Study|Withdrawal by Subject|0|||
19612959|NCT02232737|42061882|FG001|Overall Study|Withdrawal by Subject|1|||
19612960|NCT02232737|42061883|FG002|Overall Study|Withdrawal by Subject|2|||
19612961|NCT02232737|42061881|FG000|Overall Study|Death|0|||
19612962|NCT02232737|42061882|FG001|Overall Study|Death|1|||
19612963|NCT02232737|42061883|FG002|Overall Study|Death|1|||
19612964|NCT02232737|42061881|FG000|Overall Study|Physician Decision|1|||
19612965|NCT02232737|42061882|FG001|Overall Study|Physician Decision|3|||
19612966|NCT02232737|42061883|FG002|Overall Study|Physician Decision|1|||
19612967|NCT02232737|42061881|FG000|Overall Study|Protocol Violation|1|||
19612968|NCT02232737|42061882|FG001|Overall Study|Protocol Violation|0|||
19612969|NCT02232737|42061883|FG002|Overall Study|Protocol Violation|1|||
19612970|NCT02232737|42061881|FG000|Overall Study|Reason unknown|1|||
19612971|NCT02232737|42061882|FG001|Overall Study|Reason unknown|0|||
19612972|NCT02232737|42061883|FG002|Overall Study|Reason unknown|0|||
19612973|NCT00952367|42061891|FG000|Overall Study|Withdrawal by Subject|2|||
19612974|NCT00952367|42061891|FG000|Overall Study|Noncoordination|1|||
19612975|NCT00952367|42061891|FG000|Overall Study|Protocol Violation|3|||
19612976|NCT00948857|42061897|FG000|Overall Study|Lost to Follow-up|1|||
19612977|NCT00948857|42061898|FG001|Overall Study|Lost to Follow-up|0|||
19612978|NCT00948389|42061913|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
19612979|NCT00948389|42061914|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
19612980|NCT00948389|42061915|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
19612981|NCT00948389|42061916|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
19612982|NCT00948389|42061917|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
19612983|NCT00948389|42061913|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
19612984|NCT00948389|42061914|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
19612985|NCT00948389|42061915|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
19612986|NCT00948389|42061916|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
19612987|NCT00948389|42061917|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
19612988|NCT00948389|42061913|FG000|Overall Study|Both Progression and Toxicity|1|||
19612989|NCT00948389|42061914|FG001|Overall Study|Both Progression and Toxicity|0|||
19612990|NCT00948389|42061915|FG002|Overall Study|Both Progression and Toxicity|0|||
19612991|NCT00948389|42061916|FG003|Overall Study|Both Progression and Toxicity|0|||
19612992|NCT00948389|42061917|FG004|Overall Study|Both Progression and Toxicity|0|||
19612993|NCT00948155|42061933|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
19612994|NCT00948155|42061934|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
19612995|NCT00948155|42061933|FG000|Washout 14 Days|Lost to Follow-up|1|||
19612996|NCT00948155|42061934|FG001|Washout 14 Days|Lost to Follow-up|2|||
19612997|NCT00958217|42061944|FG000|Overall Study|Death|2|||
19612998|NCT00958217|42061945|FG001|Overall Study|Death|1|||
19612999|NCT00958217|42061944|FG000|Overall Study|Withdrawal by Subject|4|||
19613000|NCT00958217|42061945|FG001|Overall Study|Withdrawal by Subject|3|||
19613001|NCT00958217|42061944|FG000|Overall Study|Lost to Follow-up|17|||
19613002|NCT00958217|42061945|FG001|Overall Study|Lost to Follow-up|19|||
19613003|NCT00958217|42061944|FG000|Overall Study|Moved out of area|1|||
19613004|NCT00958217|42061945|FG001|Overall Study|Moved out of area|1|||
19613005|NCT00958217|42061944|FG000|Overall Study|Inpatient hospitalization|0|||
19613006|NCT00958217|42061945|FG001|Overall Study|Inpatient hospitalization|1|||
19488934|NCT01490450|41783945|FG000|Period 1|No longer met study criteria|0|||
19488935|NCT01490450|41783946|FG001|Period 1|No longer met study criteria|1|||
19488936|NCT01490450|41783947|FG002|Period 1|No longer met study criteria|1|||
19488937|NCT01490450|41783948|FG003|Period 1|No longer met study criteria|0|||
19488938|NCT01490450|41783945|FG000|Period 2|Lack of Efficacy|0|||
19488939|NCT01490450|41783946|FG001|Period 2|Lack of Efficacy|0|||
19488940|NCT01490450|41783947|FG002|Period 2|Lack of Efficacy|0|||
19488941|NCT01490450|41783948|FG003|Period 2|Lack of Efficacy|1|||
19613007|NCT00891020|42061955|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
19613008|NCT00891020|42061956|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
19613009|NCT00891020|42061957|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
19613010|NCT00891020|42061955|FG000|24 Week Treatment Period|Death|0|||
19613011|NCT00891020|42061956|FG001|24 Week Treatment Period|Death|2|||
19613012|NCT00891020|42061957|FG002|24 Week Treatment Period|Death|0|||
19613013|NCT00891020|42061955|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
19613014|NCT00891020|42061956|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
19613015|NCT00891020|42061957|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
19613016|NCT00891020|42061955|FG000|24 Week Treatment Period|Failure to return|4|||
19613017|NCT00891020|42061956|FG001|24 Week Treatment Period|Failure to return|5|||
19613018|NCT00891020|42061957|FG002|24 Week Treatment Period|Failure to return|5|||
19613019|NCT00891020|42061955|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
19613020|NCT00891020|42061956|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
19613021|NCT00891020|42061957|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
19613022|NCT00891020|42061955|FG000|24 Week Treatment Period|Other protocol violation|1|||
19613023|NCT00891020|42061956|FG001|24 Week Treatment Period|Other protocol violation|1|||
19613024|NCT00891020|42061957|FG002|24 Week Treatment Period|Other protocol violation|2|||
19613025|NCT00891020|42061955|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
19613026|NCT00891020|42061956|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
19613027|NCT00891020|42061957|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
19488942|NCT01490450|41783945|FG000|Period 2|Adverse Event|1|||
19488943|NCT01490450|41783946|FG001|Period 2|Adverse Event|1|||
19488944|NCT01490450|41783947|FG002|Period 2|Adverse Event|0|||
19488945|NCT01490450|41783948|FG003|Period 2|Adverse Event|1|||
19488946|NCT01490450|41783945|FG000|Period 2|Withdrawal by Subject|1|||
19488947|NCT01490450|41783946|FG001|Period 2|Withdrawal by Subject|0|||
19488948|NCT01490450|41783947|FG002|Period 2|Withdrawal by Subject|0|||
19488949|NCT01490450|41783948|FG003|Period 2|Withdrawal by Subject|0|||
19488950|NCT01490450|41783945|FG000|Period 2|Lost to Follow-up|0|||
19488951|NCT01490450|41783946|FG001|Period 2|Lost to Follow-up|0|||
19488952|NCT01490450|41783947|FG002|Period 2|Lost to Follow-up|0|||
19488953|NCT01490450|41783948|FG003|Period 2|Lost to Follow-up|2|||
19488954|NCT01469546|41783992|FG000|Received 5 mg Dose|Adverse Event|13|||
19488955|NCT01469546|41783992|FG000|Received 5 mg Dose|Death|2|||
19488956|NCT01469546|41783992|FG000|Received 5 mg Dose|Protocol Violation|2|||
19488957|NCT01469546|41783992|FG000|Received 5 mg Dose|Progressive Disease|3|||
19488958|NCT01469546|41783992|FG000|Received 5 mg Dose|Physician Decision|3|||
19488959|NCT00081497|41783998|FG000|Overall Study|Adverse Event|2|||
19488960|NCT00081497|41783999|FG001|Overall Study|Adverse Event|0|||
19488961|NCT00081497|41783998|FG000|Overall Study|Death|0|||
19488962|NCT00081497|41783999|FG001|Overall Study|Death|1|||
19488963|NCT00081497|41783998|FG000|Overall Study|Withdrawal by Subject|1|||
19488964|NCT00081497|41783999|FG001|Overall Study|Withdrawal by Subject|0|||
19488965|NCT00081497|41783998|FG000|Overall Study|Non-compliance|0|||
19488966|NCT00081497|41783999|FG001|Overall Study|Non-compliance|1|||
19488967|NCT00081263|41784013|FG000|Overall Study|clerical error|1|||
19488968|NCT00081263|41784014|FG001|Overall Study|clerical error|0|||
19488969|NCT00081263|41784013|FG000|Overall Study|wrong cell type|7|||
19488970|NCT00081263|41784014|FG001|Overall Study|wrong cell type|5|||
19488971|NCT00081263|41784013|FG000|Overall Study|improper pre-protocol therapy|0|||
19488972|NCT00081263|41784014|FG001|Overall Study|improper pre-protocol therapy|1|||
19488973|NCT00081263|41784013|FG000|Overall Study|Inadequate pathology|0|||
19488974|NCT00081263|41784014|FG001|Overall Study|Inadequate pathology|1|||
19488975|NCT00081263|41784013|FG000|Overall Study|Never treated|4|||
19488976|NCT00081263|41784014|FG001|Overall Study|Never treated|5|||
19488977|NCT00081263|41784013|FG000|Overall Study|Inadequate data|5|||
19613028|NCT00891020|42061955|FG000|24 Week Treatment Period|Withdrew consent|6|||
19613029|NCT00891020|42061956|FG001|24 Week Treatment Period|Withdrew consent|3|||
19613030|NCT00891020|42061957|FG002|24 Week Treatment Period|Withdrew consent|15|||
19613031|NCT00891020|42061955|FG000|24 Week Treatment Period|Administrative/Other|5|||
19613032|NCT00891020|42061956|FG001|24 Week Treatment Period|Administrative/Other|6|||
19613033|NCT00891020|42061957|FG002|24 Week Treatment Period|Administrative/Other|1|||
19613034|NCT00891020|42061955|FG000|Long-term Extension Period|Adverse Event|1|||
19613035|NCT00891020|42061956|FG001|Long-term Extension Period|Adverse Event|11|||
19613036|NCT00891020|42061957|FG002|Long-term Extension Period|Adverse Event|10|||
19613037|NCT00891020|42061955|FG000|Long-term Extension Period|Death|0|||
19613038|NCT00891020|42061956|FG001|Long-term Extension Period|Death|0|||
19613039|NCT00891020|42061957|FG002|Long-term Extension Period|Death|1|||
19613040|NCT00891020|42061955|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
19613041|NCT00891020|42061956|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
19613042|NCT00891020|42061957|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
19613043|NCT00891020|42061955|FG000|Long-term Extension Period|Protocol Violation|0|||
19613044|NCT00891020|42061956|FG001|Long-term Extension Period|Protocol Violation|1|||
19613045|NCT00891020|42061957|FG002|Long-term Extension Period|Protocol Violation|1|||
19613046|NCT00891020|42061955|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
19613047|NCT00891020|42061956|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
19613048|NCT00891020|42061957|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
19613049|NCT00891020|42061955|FG000|Long-term Extension Period|Failure to return|0|||
19613050|NCT00891020|42061956|FG001|Long-term Extension Period|Failure to return|2|||
19613051|NCT00891020|42061957|FG002|Long-term Extension Period|Failure to return|3|||
19613052|NCT00891020|42061955|FG000|Long-term Extension Period|Administrative|1|||
19613053|NCT00891020|42061956|FG001|Long-term Extension Period|Administrative|2|||
19613054|NCT00891020|42061957|FG002|Long-term Extension Period|Administrative|2|||
19613055|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
19613056|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
19613057|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
19613058|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
19613059|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
19613060|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
19613061|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
19488978|NCT00081263|41784014|FG001|Overall Study|Inadequate data|10|||
19488979|NCT01490294|41784024|FG000|Overall Study|Prematurely discontinuation|4|||
19488980|NCT01490294|41784025|FG001|Overall Study|Prematurely discontinuation|0|||
19613062|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
19488981|NCT01490294|41784026|FG002|Overall Study|Prematurely discontinuation|1|||
19488982|NCT01490294|41784027|FG003|Overall Study|Prematurely discontinuation|1|||
19488983|NCT01490294|41784024|FG000|Overall Study|Adverse Event|1|||
19488984|NCT01490294|41784025|FG001|Overall Study|Adverse Event|0|||
19488985|NCT01490294|41784026|FG002|Overall Study|Adverse Event|0|||
19488986|NCT01490294|41784027|FG003|Overall Study|Adverse Event|0|||
19488987|NCT00080483|41784054|FG000|Overall Study|Lost to Follow-up|1|||
19488988|NCT00080483|41784055|FG001|Overall Study|Lost to Follow-up|1|||
19488989|NCT00080483|41784054|FG000|Overall Study|Physician Decision|1|||
19488990|NCT00080483|41784055|FG001|Overall Study|Physician Decision|1|||
19488991|NCT00089141|41784076|FG000|Overall Study|Termination of trial|18|||
19488992|NCT00089141|41784077|FG001|Overall Study|Termination of trial|24|||
19488993|NCT02588664|41784140|FG000|Overall Study|Death|56|||
19488994|NCT02588664|41784141|FG001|Overall Study|Death|55|||
19488995|NCT02588664|41784140|FG000|Overall Study|Lost to Follow-up|1305|||
19488996|NCT02588664|41784141|FG001|Overall Study|Lost to Follow-up|990|||
19488997|NCT00083759|41784204|FG000|Overall Study|Adverse Event|5|||
19488998|NCT00083759|41784205|FG001|Overall Study|Adverse Event|3|||
19488999|NCT00083759|41784204|FG000|Overall Study|Lost to Follow-up|1|||
19489000|NCT00083759|41784205|FG001|Overall Study|Lost to Follow-up|0|||
19489001|NCT00083759|41784204|FG000|Overall Study|Death|1|||
19489002|NCT00083759|41784205|FG001|Overall Study|Death|1|||
19489003|NCT00083759|41784204|FG000|Overall Study|Inadequate Therapeutic Response|32|||
19489004|NCT00083759|41784205|FG001|Overall Study|Inadequate Therapeutic Response|35|||
19489005|NCT00083759|41784204|FG000|Overall Study|Subject Withdrew Consent|2|||
19489006|NCT00083759|41784205|FG001|Overall Study|Subject Withdrew Consent|2|||
19489007|NCT00083759|41784204|FG000|Overall Study|Non-Compliance|1|||
19489008|NCT00083759|41784205|FG001|Overall Study|Non-Compliance|0|||
19489009|NCT00083759|41784204|FG000|Overall Study|Sponsor's Discretion|28|||
19489010|NCT00083759|41784205|FG001|Overall Study|Sponsor's Discretion|29|||
19489011|NCT00083759|41784204|FG000|Overall Study|Other|14|||
19489012|NCT00083759|41784205|FG001|Overall Study|Other|13|||
19489013|NCT00089609|41784323|FG000|Overall Study|Withdrawal by Subject|3|||
19489014|NCT00089609|41784324|FG001|Overall Study|Withdrawal by Subject|1|||
19489015|NCT02440581|41784456|FG000|Overall Study|Death|0|||
19489016|NCT02440581|41784457|FG001|Overall Study|Death|0|||
19489017|NCT02440581|41784458|FG002|Overall Study|Death|7|||
19489018|NCT02440581|41784459|FG003|Overall Study|Death|5|||
19489019|NCT02440581|41784456|FG000|Overall Study|Transplanted|1|||
19489020|NCT02440581|41784457|FG001|Overall Study|Transplanted|0|||
19489021|NCT02440581|41784458|FG002|Overall Study|Transplanted|3|||
19489022|NCT02440581|41784459|FG003|Overall Study|Transplanted|2|||
19489023|NCT02440581|41784456|FG000|Overall Study|Withdrawal by Subject|4|||
19489024|NCT02440581|41784457|FG001|Overall Study|Withdrawal by Subject|11|||
19489025|NCT02440581|41784458|FG002|Overall Study|Withdrawal by Subject|3|||
19489026|NCT02440581|41784459|FG003|Overall Study|Withdrawal by Subject|7|||
19489027|NCT01359150|41784471|FG000|Overall Study|Lack of Efficacy|1|||
19489028|NCT01359150|41784472|FG001|Overall Study|Lack of Efficacy|1|||
19489029|NCT01359150|41784471|FG000|Overall Study|Withdrawal by Subject|1|||
19489030|NCT01359150|41784472|FG001|Overall Study|Withdrawal by Subject|1|||
19489031|NCT01359150|41784471|FG000|Overall Study|Adverse Event|4|||
19489032|NCT01359150|41784472|FG001|Overall Study|Adverse Event|3|||
19489033|NCT01359150|41784471|FG000|Overall Study|Other|1|||
19489034|NCT01359150|41784472|FG001|Overall Study|Other|0|||
19489035|NCT01469000|41784533|FG000|Overall Study|Withdrawal by Subject|16|||
19489036|NCT01469000|41784534|FG001|Overall Study|Withdrawal by Subject|3|||
19489037|NCT01469000|41784533|FG000|Overall Study|Sponsor Decision|4|||
19489038|NCT01469000|41784534|FG001|Overall Study|Sponsor Decision|1|||
19489039|NCT01490060|41784547|FG000|Cycle 1|Change of Treatment|0|||
19489040|NCT01490060|41784548|FG001|Cycle 1|Change of Treatment|1|||
19489041|NCT01490060|41784549|FG002|Cycle 1|Change of Treatment|1|||
19489042|NCT01490060|41784550|FG003|Cycle 1|Change of Treatment|1|||
19489043|NCT01490060|41784547|FG000|Cycle 1|Insurance Denied|0|||
19489044|NCT01490060|41784548|FG001|Cycle 1|Insurance Denied|0|||
19489045|NCT01490060|41784549|FG002|Cycle 1|Insurance Denied|2|||
19489046|NCT01490060|41784550|FG003|Cycle 1|Insurance Denied|0|||
19489047|NCT01490060|41784547|FG000|Cycle 1|Withdrawal by Subject|0|||
19489048|NCT01490060|41784548|FG001|Cycle 1|Withdrawal by Subject|0|||
19489049|NCT01490060|41784549|FG002|Cycle 1|Withdrawal by Subject|0|||
19489050|NCT01490060|41784550|FG003|Cycle 1|Withdrawal by Subject|1|||
19489051|NCT01490060|41784547|FG000|Cycle 1|Treatment at Another Facility|0|||
19489052|NCT01490060|41784548|FG001|Cycle 1|Treatment at Another Facility|0|||
19489053|NCT01490060|41784549|FG002|Cycle 1|Treatment at Another Facility|0|||
19489054|NCT01490060|41784550|FG003|Cycle 1|Treatment at Another Facility|1|||
19489055|NCT01490060|41784547|FG000|Cycle 2|Change of Treatment|1|||
19489056|NCT01490060|41784548|FG001|Cycle 2|Change of Treatment|1|||
19489057|NCT01490060|41784549|FG002|Cycle 2|Change of Treatment|0|||
19489058|NCT01490060|41784550|FG003|Cycle 2|Change of Treatment|0|||
19489059|NCT01490060|41784547|FG000|Cycle 2|Non-Compliance|0|||
19489060|NCT01490060|41784548|FG001|Cycle 2|Non-Compliance|0|||
19489061|NCT01490060|41784549|FG002|Cycle 2|Non-Compliance|1|||
19489062|NCT01490060|41784550|FG003|Cycle 2|Non-Compliance|0|||
19489063|NCT01490060|41784547|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
19489064|NCT01490060|41784548|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
19489065|NCT01490060|41784549|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
19489066|NCT01490060|41784550|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
19489067|NCT01452152|41784602|FG000|Overall Study|Study termination by sponsor|5|||
19489068|NCT01452152|41784603|FG001|Overall Study|Study termination by sponsor|0|||
19489069|NCT01452152|41784604|FG002|Overall Study|Study termination by sponsor|4|||
19489070|NCT01451762|41784615|FG000|Overall Study|Lost to Follow-up|3|||
19489071|NCT01451762|41784616|FG001|Overall Study|Lost to Follow-up|6|||
19489072|NCT01451762|41784617|FG002|Overall Study|Lost to Follow-up|6|||
19489073|NCT01468844|41784652|FG000|Overall Study|Adverse Event|1|||
19489074|NCT01468844|41784653|FG001|Overall Study|Adverse Event|0|||
19489075|NCT01468844|41784652|FG000|Overall Study|Withdrawal by Subject|1|||
19489076|NCT01468844|41784653|FG001|Overall Study|Withdrawal by Subject|0|||
19489077|NCT01451606|41784677|FG000|Overall Study|Withdrawal by Subject|4|||
19489078|NCT01451606|41784678|FG001|Overall Study|Withdrawal by Subject|3|||
19489079|NCT00473343|41784733|FG000|Overall Study|Adverse Event|9|||
19489080|NCT00473343|41784733|FG000|Overall Study|Lost to Follow-up|8|||
19489081|NCT00473343|41784733|FG000|Overall Study|Treatment failure|27|||
19489082|NCT00473343|41784733|FG000|Overall Study|Withdrew consent|3|||
19489083|NCT00473343|41784733|FG000|Overall Study|Other un-specified reason|3|||
19489084|NCT02587962|41785190|FG000|Overall Study|Adverse Event|0|||
19489085|NCT02587962|41785191|FG001|Overall Study|Adverse Event|0|||
19489086|NCT02587962|41785192|FG002|Overall Study|Adverse Event|1|||
19489087|NCT02587962|41785193|FG003|Overall Study|Adverse Event|0|||
19489088|NCT02587962|41785194|FG004|Overall Study|Adverse Event|0|||
19489089|NCT02587962|41785190|FG000|Overall Study|Withdrawal by Subject|0|||
19489090|NCT02587962|41785191|FG001|Overall Study|Withdrawal by Subject|0|||
19489091|NCT02587962|41785192|FG002|Overall Study|Withdrawal by Subject|1|||
19489092|NCT02587962|41785193|FG003|Overall Study|Withdrawal by Subject|1|||
19489093|NCT02587962|41785194|FG004|Overall Study|Withdrawal by Subject|4|||
19489094|NCT02587962|41785190|FG000|Overall Study|Radiological progression|2|||
19489095|NCT02587962|41785191|FG001|Overall Study|Radiological progression|2|||
19489096|NCT02587962|41785192|FG002|Overall Study|Radiological progression|2|||
19489097|NCT02587962|41785193|FG003|Overall Study|Radiological progression|5|||
19489098|NCT02587962|41785194|FG004|Overall Study|Radiological progression|10|||
19489099|NCT02587962|41785190|FG000|Overall Study|Clinical progression|0|||
19489100|NCT02587962|41785191|FG001|Overall Study|Clinical progression|1|||
19489101|NCT02587962|41785192|FG002|Overall Study|Clinical progression|2|||
19489102|NCT02587962|41785193|FG003|Overall Study|Clinical progression|0|||
19489103|NCT02587962|41785194|FG004|Overall Study|Clinical progression|1|||
19489104|NCT01440374|41785348|FG000|Part 1: Open-label Phase|Adverse Event|5|||
19489105|NCT01440374|41785349|FG001|Part 1: Open-label Phase|Adverse Event|0|||
19489106|NCT01440374|41785350|FG002|Part 1: Open-label Phase|Adverse Event|0|||
19489107|NCT01440374|41785351|FG003|Part 1: Open-label Phase|Adverse Event|0|||
19489108|NCT01440374|41785348|FG000|Part 1: Open-label Phase|Physician Decision|1|||
19489109|NCT01440374|41785349|FG001|Part 1: Open-label Phase|Physician Decision|0|||
19489110|NCT01440374|41785350|FG002|Part 1: Open-label Phase|Physician Decision|0|||
19489111|NCT01440374|41785351|FG003|Part 1: Open-label Phase|Physician Decision|0|||
19489112|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
19489113|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
19489114|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
19489115|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
19489116|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
19489117|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
19489118|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
19489119|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
19489120|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
19489121|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
19489122|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
19489123|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
19489124|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
19489125|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
19489126|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
19489127|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
19489128|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
19489129|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
19489130|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
19489131|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
19489132|NCT01440374|41785348|FG000|Part 2; Double-blind Phase|Not treated|0|||
19489133|NCT01440374|41785349|FG001|Part 2; Double-blind Phase|Not treated|0|||
19489134|NCT01440374|41785350|FG002|Part 2; Double-blind Phase|Not treated|1|||
19489135|NCT01440374|41785351|FG003|Part 2; Double-blind Phase|Not treated|0|||
19489136|NCT01440374|41785348|FG000|Part 3: Extension|Withdrawal by Subject|0|||
19489137|NCT01440374|41785349|FG001|Part 3: Extension|Withdrawal by Subject|0|||
19489138|NCT01440374|41785350|FG002|Part 3: Extension|Withdrawal by Subject|0|||
19489139|NCT01440374|41785351|FG003|Part 3: Extension|Withdrawal by Subject|5|||
19489140|NCT01440374|41785348|FG000|Part 3: Extension|Adverse Event|0|||
19489141|NCT01440374|41785349|FG001|Part 3: Extension|Adverse Event|0|||
19489142|NCT01440374|41785350|FG002|Part 3: Extension|Adverse Event|0|||
19489143|NCT01440374|41785351|FG003|Part 3: Extension|Adverse Event|13|||
19489144|NCT01440374|41785348|FG000|Part 3: Extension|Physician Decision|0|||
19489145|NCT01440374|41785349|FG001|Part 3: Extension|Physician Decision|0|||
19489146|NCT01440374|41785350|FG002|Part 3: Extension|Physician Decision|0|||
19489147|NCT01440374|41785351|FG003|Part 3: Extension|Physician Decision|14|||
19489148|NCT01666782|41785499|FG000|Overall Study|Received 2 doses of vaccine|0|||
19489149|NCT01666782|41785500|FG001|Overall Study|Received 2 doses of vaccine|1|||
19393507|NCT02630693|41637376|FG000|Overall Study|No receive treatment|0|||
19393508|NCT02630693|41637377|FG001|Overall Study|No receive treatment|1|||
19489150|NCT01666782|41785499|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
19489151|NCT01666782|41785500|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
19489152|NCT01439360|41785516|FG000|Overall Study|Adverse Event|4|||
19489153|NCT01439360|41785517|FG001|Overall Study|Adverse Event|16|||
19489154|NCT01439360|41785516|FG000|Overall Study|Lost to Follow-up|43|||
19489155|NCT01439360|41785517|FG001|Overall Study|Lost to Follow-up|58|||
19489156|NCT01439360|41785516|FG000|Overall Study|Others|10|||
19489157|NCT01439360|41785517|FG001|Overall Study|Others|5|||
19489158|NCT01439360|41785516|FG000|Overall Study|Protocol Violation|1|||
19489159|NCT01439360|41785517|FG001|Overall Study|Protocol Violation|0|||
19489160|NCT01439360|41785516|FG000|Overall Study|Withdrawal by Subject|140|||
19489161|NCT01439360|41785517|FG001|Overall Study|Withdrawal by Subject|129|||
19489162|NCT01439282|41785697|FG000|Overall Study|Adverse Event|5|||
19489163|NCT01439282|41785698|FG001|Overall Study|Adverse Event|0|||
19489164|NCT01439282|41785697|FG000|Overall Study|Withdrawal by Subject|2|||
19489165|NCT01439282|41785698|FG001|Overall Study|Withdrawal by Subject|0|||
19489166|NCT01439282|41785697|FG000|Overall Study|Other|1|||
19489167|NCT01439282|41785698|FG001|Overall Study|Other|1|||
19489168|NCT01439204|41785718|FG000|Overall Study|Withdrawal by Subject|0|||
19489169|NCT01439204|41785719|FG001|Overall Study|Withdrawal by Subject|1|||
19489170|NCT01439204|41785718|FG000|Overall Study|Lost to Follow-up|0|||
19489171|NCT01439204|41785719|FG001|Overall Study|Lost to Follow-up|2|||
19489172|NCT01439204|41785718|FG000|Overall Study|No longer meets study criteria|1|||
19489173|NCT01439204|41785719|FG001|Overall Study|No longer meets study criteria|0|||
19489174|NCT01439204|41785718|FG000|Overall Study|poor/non-compliance|3|||
19489175|NCT01439204|41785719|FG001|Overall Study|poor/non-compliance|0|||
19489176|NCT01439126|41785765|FG000|Overall Study|Adverse Event|2|||
19489177|NCT01439126|41785766|FG001|Overall Study|Adverse Event|0|||
19489178|NCT01439126|41785765|FG000|Overall Study|Withdrawal by Subject|5|||
19489179|NCT01439126|41785766|FG001|Overall Study|Withdrawal by Subject|21|||
19489180|NCT01439126|41785765|FG000|Overall Study|Protocol Violation|6|||
19489181|NCT01439126|41785766|FG001|Overall Study|Protocol Violation|4|||
19489182|NCT01439126|41785765|FG000|Overall Study|Lost to Follow-up|6|||
19489183|NCT01439126|41785766|FG001|Overall Study|Lost to Follow-up|3|||
19393509|NCT05059301|41637386|FG000|Overall Study|Adverse Event|0|||
19393510|NCT05059301|41637387|FG001|Overall Study|Adverse Event|2|||
19393511|NCT05059301|41637388|FG002|Overall Study|Adverse Event|2|||
19393512|NCT05059301|41637386|FG000|Overall Study|Lost to Follow-up|2|||
19393513|NCT05059301|41637387|FG001|Overall Study|Lost to Follow-up|3|||
19393514|NCT05059301|41637388|FG002|Overall Study|Lost to Follow-up|3|||
19393515|NCT01938430|41637414|FG000|Overall Study|Randomized but Not Treated|0|||
19393516|NCT01938430|41637415|FG001|Overall Study|Randomized but Not Treated|0|||
19393517|NCT01938430|41637416|FG002|Overall Study|Randomized but Not Treated|0|||
19393518|NCT01938430|41637417|FG003|Overall Study|Randomized but Not Treated|0|||
19393519|NCT01938430|41637418|FG004|Overall Study|Randomized but Not Treated|0|||
19393520|NCT01938430|41637419|FG005|Overall Study|Randomized but Not Treated|0|||
19393521|NCT01938430|41637420|FG006|Overall Study|Randomized but Not Treated|0|||
19393522|NCT01938430|41637421|FG007|Overall Study|Randomized but Not Treated|0|||
19393523|NCT01938430|41637422|FG008|Overall Study|Randomized but Not Treated|0|||
19393524|NCT01938430|41637423|FG009|Overall Study|Randomized but Not Treated|0|||
19489184|NCT01439126|41785765|FG000|Overall Study|Other-Use of prohibited treatment|0|||
19489185|NCT01439126|41785766|FG001|Overall Study|Other-Use of prohibited treatment|2|||
19489186|NCT01439126|41785765|FG000|Overall Study|Other-Miscellaneous|12|||
19489187|NCT01439126|41785766|FG001|Overall Study|Other-Miscellaneous|12|||
19489188|NCT01449812|41785792|FG000|Overall Study|Migrated/moved from study area|1|||
19489189|NCT01449812|41785793|FG001|Overall Study|Migrated/moved from study area|0|||
19489190|NCT01449812|41785794|FG002|Overall Study|Migrated/moved from study area|0|||
19489191|NCT01449812|41785792|FG000|Overall Study|Withdrawal by Subject|0|||
19393525|NCT01938430|41637424|FG010|Overall Study|Randomized but Not Treated|1|||
19393526|NCT01938430|41637425|FG011|Overall Study|Randomized but Not Treated|0|||
19393527|NCT01938430|41637426|FG012|Overall Study|Randomized but Not Treated|0|||
19489192|NCT01449812|41785793|FG001|Overall Study|Withdrawal by Subject|0|||
19489193|NCT01449812|41785794|FG002|Overall Study|Withdrawal by Subject|1|||
19489194|NCT01449812|41785792|FG000|Overall Study|Lost to Follow-up|1|||
19489195|NCT01449812|41785793|FG001|Overall Study|Lost to Follow-up|0|||
19489196|NCT01449812|41785794|FG002|Overall Study|Lost to Follow-up|0|||
19489197|NCT01665144|41785847|FG000|Overall Study|New therapy for study indication|2|||
19489198|NCT01665144|41785848|FG001|Overall Study|New therapy for study indication|1|||
19489199|NCT01665144|41785847|FG000|Overall Study|Technical problems|2|||
19489200|NCT01665144|41785848|FG001|Overall Study|Technical problems|0|||
19489201|NCT01665144|41785847|FG000|Overall Study|Death|3|||
19489202|NCT01665144|41785848|FG001|Overall Study|Death|1|||
19489203|NCT01665144|41785847|FG000|Overall Study|Protocol deviation|3|||
19489204|NCT01665144|41785848|FG001|Overall Study|Protocol deviation|1|||
19489205|NCT01665144|41785847|FG000|Overall Study|Non-compliance w/study treatment|5|||
19489206|NCT01665144|41785848|FG001|Overall Study|Non-compliance w/study treatment|0|||
19489207|NCT01665144|41785847|FG000|Overall Study|Progressive disease|8|||
19489208|NCT01665144|41785848|FG001|Overall Study|Progressive disease|4|||
19489209|NCT01665144|41785847|FG000|Overall Study|Lost to Follow-up|9|||
19489210|NCT01665144|41785848|FG001|Overall Study|Lost to Follow-up|8|||
19489211|NCT01665144|41785847|FG000|Overall Study|Physician Decision|13|||
19489212|NCT01665144|41785848|FG001|Overall Study|Physician Decision|1|||
19489213|NCT01665144|41785847|FG000|Overall Study|Lack of Efficacy|16|||
19489214|NCT01665144|41785848|FG001|Overall Study|Lack of Efficacy|11|||
19489215|NCT01665144|41785847|FG000|Overall Study|Adverse Event|45|||
19489216|NCT01665144|41785848|FG001|Overall Study|Adverse Event|18|||
19489217|NCT01665144|41785847|FG000|Overall Study|Withdrawal by Subject|96|||
19489218|NCT01665144|41785848|FG001|Overall Study|Withdrawal by Subject|77|||
19489219|NCT01466660|41785987|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
19489220|NCT01466660|41785988|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
19489221|NCT01466660|41785987|FG000|Overall Study|Worsening of underlying cancer disease|5|||
19489222|NCT01466660|41785988|FG001|Overall Study|Worsening of underlying cancer disease|2|||
19489223|NCT01466660|41785987|FG000|Overall Study|Other adverse event|19|||
19489224|NCT01466660|41785988|FG001|Overall Study|Other adverse event|18|||
19489225|NCT01466660|41785987|FG000|Overall Study|Protocol Violation|2|||
19489226|NCT01466660|41785988|FG001|Overall Study|Protocol Violation|1|||
19489227|NCT01466660|41785987|FG000|Overall Study|Refused continuation of trial medication|4|||
19489228|NCT01466660|41785988|FG001|Overall Study|Refused continuation of trial medication|3|||
19489229|NCT01466660|41785987|FG000|Overall Study|Other reason not defined above|10|||
19489230|NCT01466660|41785988|FG001|Overall Study|Other reason not defined above|8|||
19489231|NCT01466348|41786013|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
19489232|NCT01466348|41786014|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
19489233|NCT01466270|41786037|FG000|Overall Study|Withdrawal by Subject|4|||
19489234|NCT01466270|41786038|FG001|Overall Study|Withdrawal by Subject|1|||
19489235|NCT01466270|41786037|FG000|Overall Study|Physician Decision|1|||
19489236|NCT01466270|41786038|FG001|Overall Study|Physician Decision|0|||
19489237|NCT01466270|41786037|FG000|Overall Study|Lost to Follow-up|1|||
19489238|NCT01466270|41786038|FG001|Overall Study|Lost to Follow-up|3|||
19489239|NCT01466270|41786037|FG000|Overall Study|Progression|1|||
19489240|NCT01466270|41786038|FG001|Overall Study|Progression|0|||
19489241|NCT01466270|41786037|FG000|Overall Study|Toxicity|4|||
19489242|NCT01466270|41786038|FG001|Overall Study|Toxicity|1|||
19489243|NCT01466270|41786037|FG000|Overall Study|Multiple|1|||
19489244|NCT01466270|41786038|FG001|Overall Study|Multiple|1|||
19489245|NCT01466192|41786071|FG000|Overall Study|Physician Decision|1|||
19489246|NCT01466192|41786071|FG000|Overall Study|Withdrawal by Subject|3|||
19489247|NCT01438814|41786091|FG000|Overall Study|Adverse Event|3|||
19489248|NCT01438814|41786092|FG001|Overall Study|Adverse Event|3|||
19489249|NCT01438814|41786091|FG000|Overall Study|Protocol Violation|1|||
19489250|NCT01438814|41786092|FG001|Overall Study|Protocol Violation|2|||
19489251|NCT01438814|41786091|FG000|Overall Study|Lost to Follow-up|4|||
19489252|NCT01438814|41786092|FG001|Overall Study|Lost to Follow-up|3|||
19489253|NCT01438814|41786091|FG000|Overall Study|Withdrawal by Subject|4|||
19489254|NCT01438814|41786092|FG001|Overall Study|Withdrawal by Subject|2|||
19489255|NCT01438814|41786091|FG000|Overall Study|Other|2|||
19489256|NCT01438814|41786092|FG001|Overall Study|Other|4|||
19489257|NCT02926833|41786673|FG000|Overall Study|Full Consent Withdrawal|0|||
19489258|NCT02926833|41786674|FG001|Overall Study|Full Consent Withdrawal|0|||
19489259|NCT02926833|41786675|FG002|Overall Study|Full Consent Withdrawal|0|||
19489260|NCT02926833|41786676|FG003|Overall Study|Full Consent Withdrawal|2|||
19489261|NCT02926833|41786673|FG000|Overall Study|Death|1|||
19489262|NCT02926833|41786674|FG001|Overall Study|Death|1|||
19489263|NCT02926833|41786675|FG002|Overall Study|Death|1|||
19489264|NCT02926833|41786676|FG003|Overall Study|Death|7|||
19489265|NCT02926833|41786673|FG000|Overall Study|Still on study|2|||
19489266|NCT02926833|41786674|FG001|Overall Study|Still on study|3|||
19489267|NCT02926833|41786675|FG002|Overall Study|Still on study|5|||
19489268|NCT02926833|41786676|FG003|Overall Study|Still on study|14|||
19489269|NCT02926833|41786673|FG000|Overall Study|Adverse Event|0|||
19489270|NCT02926833|41786674|FG001|Overall Study|Adverse Event|0|||
19489271|NCT02926833|41786675|FG002|Overall Study|Adverse Event|1|||
19489272|NCT02926833|41786676|FG003|Overall Study|Adverse Event|0|||
19489273|NCT02851797|41786723|FG000|Overall Study|Withdrawal by Subject|4|||
19489274|NCT02851797|41786724|FG001|Overall Study|Withdrawal by Subject|2|||
19489275|NCT02851797|41786723|FG000|Overall Study|Adverse Event|3|||
19489276|NCT02851797|41786724|FG001|Overall Study|Adverse Event|0|||
19489277|NCT01666314|41786948|FG000|Overall Study|Adverse Event|3|||
19489278|NCT01666314|41786949|FG001|Overall Study|Adverse Event|13|||
19489279|NCT01666314|41786950|FG002|Overall Study|Adverse Event|7|||
19489280|NCT01666314|41786951|FG003|Overall Study|Adverse Event|7|||
19489281|NCT01666314|41786948|FG000|Overall Study|Progressive Disease|11|||
19489282|NCT01666314|41786949|FG001|Overall Study|Progressive Disease|9|||
19489283|NCT01666314|41786950|FG002|Overall Study|Progressive Disease|19|||
19489284|NCT01666314|41786951|FG003|Overall Study|Progressive Disease|20|||
19489285|NCT01666314|41786948|FG000|Overall Study|Symptomatic Deterioration|1|||
19489286|NCT01666314|41786949|FG001|Overall Study|Symptomatic Deterioration|0|||
19489287|NCT01666314|41786950|FG002|Overall Study|Symptomatic Deterioration|2|||
19489288|NCT01666314|41786951|FG003|Overall Study|Symptomatic Deterioration|0|||
19489289|NCT01666314|41786948|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
19489290|NCT01666314|41786949|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
19489291|NCT01666314|41786950|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
19489292|NCT01666314|41786951|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
19489293|NCT01666314|41786948|FG000|Overall Study|Withdrawal by Subject|1|||
19489294|NCT01666314|41786949|FG001|Overall Study|Withdrawal by Subject|1|||
19489295|NCT01666314|41786950|FG002|Overall Study|Withdrawal by Subject|2|||
19489296|NCT01666314|41786951|FG003|Overall Study|Withdrawal by Subject|3|||
19489297|NCT01666314|41786948|FG000|Overall Study|Reason not Specified|10|||
19489298|NCT01666314|41786949|FG001|Overall Study|Reason not Specified|7|||
19489299|NCT01666314|41786950|FG002|Overall Study|Reason not Specified|5|||
19489300|NCT01666314|41786951|FG003|Overall Study|Reason not Specified|5|||
19489301|NCT01666002|41786982|FG000|Overall Study|Lost to Follow-up|5|||
19489302|NCT01666002|41786983|FG001|Overall Study|Lost to Follow-up|0|||
19489303|NCT01665768|41787055|FG000|Overall Study|Adverse Event|3|||
19489304|NCT01665768|41787055|FG000|Overall Study|Lack of Efficacy|19|||
19489305|NCT01665768|41787055|FG000|Overall Study|Withdrawal by Subject|1|||
19489306|NCT02584452|41787263|FG000|Overall Study|Physician Decision|1|||
19489307|NCT02584452|41787264|FG001|Overall Study|Physician Decision|1|||
19489308|NCT02584452|41787263|FG000|Overall Study|Lost to Follow-up|1|||
19489309|NCT02584452|41787264|FG001|Overall Study|Lost to Follow-up|1|||
19489310|NCT02586012|41787311|FG000|Overall Study|Withdrawal by Subject|1|||
19489311|NCT02586012|41787312|FG001|Overall Study|Withdrawal by Subject|1|||
19489312|NCT02586012|41787313|FG002|Overall Study|Withdrawal by Subject|0|||
19489313|NCT02586012|41787314|FG003|Overall Study|Withdrawal by Subject|1|||
19489314|NCT02586012|41787315|FG004|Overall Study|Withdrawal by Subject|0|||
19489315|NCT02586012|41787316|FG005|Overall Study|Withdrawal by Subject|2|||
19489316|NCT02586012|41787311|FG000|Overall Study|Protocol Violation|0|||
19489317|NCT02586012|41787312|FG001|Overall Study|Protocol Violation|0|||
19489318|NCT02586012|41787313|FG002|Overall Study|Protocol Violation|0|||
19489319|NCT02586012|41787314|FG003|Overall Study|Protocol Violation|0|||
19489320|NCT02586012|41787315|FG004|Overall Study|Protocol Violation|0|||
19489321|NCT02586012|41787316|FG005|Overall Study|Protocol Violation|1|||
19489322|NCT02586012|41787311|FG000|Overall Study|study terminated|0|||
19489323|NCT02586012|41787312|FG001|Overall Study|study terminated|2|||
19489324|NCT02586012|41787313|FG002|Overall Study|study terminated|1|||
19489325|NCT02586012|41787314|FG003|Overall Study|study terminated|1|||
19489326|NCT02586012|41787315|FG004|Overall Study|study terminated|1|||
19489327|NCT02586012|41787316|FG005|Overall Study|study terminated|0|||
19489328|NCT02582814|41787327|FG000|Overall Study|Study-specific withdrawal criteria|1|||
19489329|NCT02582814|41787328|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19489330|NCT02582814|41787327|FG000|Overall Study|Withdrawal by Subject|4|||
19489331|NCT02582814|41787328|FG001|Overall Study|Withdrawal by Subject|3|||
19489332|NCT02582814|41787327|FG000|Overall Study|Adverse Event|4|||
19489333|NCT02582814|41787328|FG001|Overall Study|Adverse Event|4|||
19489334|NCT02585934|41787476|FG000|Overall Study|Lost to Follow-up|2|||
19489335|NCT02585934|41787477|FG001|Overall Study|Lost to Follow-up|2|||
19489336|NCT02585934|41787476|FG000|Overall Study|Protocol Violation|14|||
19489337|NCT02585934|41787477|FG001|Overall Study|Protocol Violation|11|||
19489338|NCT02585934|41787476|FG000|Overall Study|Adverse Event|21|||
19489339|NCT02585934|41787477|FG001|Overall Study|Adverse Event|22|||
19489340|NCT02585934|41787476|FG000|Overall Study|Physician Decision|3|||
19489341|NCT02585934|41787477|FG001|Overall Study|Physician Decision|2|||
19489342|NCT02585934|41787476|FG000|Overall Study|Withdrawal by Subject|7|||
19489343|NCT02585934|41787477|FG001|Overall Study|Withdrawal by Subject|21|||
19489344|NCT02585934|41787476|FG000|Overall Study|Lack of Efficacy|2|||
19489345|NCT02585934|41787477|FG001|Overall Study|Lack of Efficacy|1|||
19489346|NCT02585934|41787476|FG000|Overall Study|Death|2|||
19489347|NCT02585934|41787477|FG001|Overall Study|Death|0|||
19489348|NCT02585934|41787476|FG000|Overall Study|Caregiver Withdrew Consent|7|||
19489349|NCT02585934|41787477|FG001|Overall Study|Caregiver Withdrew Consent|7|||
19489350|NCT02585934|41787476|FG000|Overall Study|Sponsor Termination|1|||
19489351|NCT02585934|41787477|FG001|Overall Study|Sponsor Termination|2|||
19489352|NCT02585934|41787476|FG000|Overall Study|Another Reason|10|||
19489353|NCT02585934|41787477|FG001|Overall Study|Another Reason|5|||
19489354|NCT02582658|41787506|FG000|Overall Study|Failure to Return|10|||
19489355|NCT02582658|41787506|FG000|Overall Study|Insufficient Virological Response|2|||
19489356|NCT02582658|41787506|FG000|Overall Study|Withdrawn Consent|1|||
19489357|NCT02582658|41787506|FG000|Overall Study|Death|1|||
19489358|NCT02582658|41787506|FG000|Overall Study|Not further specified|11|||
19489359|NCT02585778|41787608|FG000|Overall Study|Adverse Event|17|||
19489360|NCT02585778|41787609|FG001|Overall Study|Adverse Event|4|||
19489361|NCT02585778|41787608|FG000|Overall Study|Participant did not wish to continue|9|||
19489362|NCT02585778|41787609|FG001|Overall Study|Participant did not wish to continue|4|||
19489363|NCT02585778|41787608|FG000|Overall Study|Poor compliance to study protocol|0|||
19489364|NCT02585778|41787609|FG001|Overall Study|Poor compliance to study protocol|2|||
19489365|NCT02585778|41787608|FG000|Overall Study|Death|0|||
19489366|NCT02585778|41787609|FG001|Overall Study|Death|1|||
19489367|NCT02585778|41787608|FG000|Overall Study|Randomized but not treated|1|||
19489368|NCT02585778|41787609|FG001|Overall Study|Randomized but not treated|2|||
19489369|NCT02585778|41787608|FG000|Overall Study|Other than specified above|6|||
19489370|NCT02585778|41787609|FG001|Overall Study|Other than specified above|2|||
19489371|NCT01438424|41787632|FG000|Overall Study|Continuing treatment|29|||
19489372|NCT01438424|41787632|FG000|Overall Study|Minimal virologic response|95|||
19613063|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
19613064|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
19613065|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
19613066|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
19613067|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
19613068|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
19613069|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
19613070|NCT00611455|42061969|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
19613071|NCT00611455|42061970|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
19613072|NCT00611455|42061971|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
19613073|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
19613074|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
19613075|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
19613076|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
19613077|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
19613078|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
19393528|NCT01938430|41637427|FG013|Overall Study|Randomized but Not Treated|1|||
19393529|NCT01938430|41637414|FG000|Overall Study|Adverse Event|0|||
19393530|NCT01938430|41637415|FG001|Overall Study|Adverse Event|0|||
19393531|NCT01938430|41637416|FG002|Overall Study|Adverse Event|0|||
19393532|NCT01938430|41637417|FG003|Overall Study|Adverse Event|0|||
19393533|NCT01938430|41637418|FG004|Overall Study|Adverse Event|0|||
19489373|NCT01438424|41787632|FG000|Overall Study|Not identified|55|||
19613079|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
19613080|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
19613081|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
19393534|NCT01938430|41637419|FG005|Overall Study|Adverse Event|0|||
19393535|NCT01938430|41637420|FG006|Overall Study|Adverse Event|1|||
19489374|NCT01438424|41787632|FG000|Overall Study|Withdrawal by Subject|104|||
19489375|NCT01438424|41787632|FG000|Overall Study|Progression of chronic hepatitis B|22|||
19489376|NCT01438424|41787632|FG000|Overall Study|Death|22|||
19489377|NCT01438424|41787632|FG000|Overall Study|Adverse Event|17|||
19489378|NCT01438424|41787632|FG000|Overall Study|Lost to Follow-up|17|||
19489379|NCT01438424|41787632|FG000|Overall Study|Abnormal laboratory test result|14|||
19489380|NCT01438424|41787632|FG000|Overall Study|Need for drug prohibited by protocol|14|||
19489381|NCT01438424|41787632|FG000|Overall Study|Pregnancy|7|||
19489382|NCT01438424|41787632|FG000|Overall Study|No longer met inclusion criteria|1|||
19489383|NCT01438424|41787632|FG000|Overall Study|Participant noncompliance|20|||
19489384|NCT02580240|41787648|FG000|Overall Study|Physician Decision|2|||
19489385|NCT02580240|41787649|FG001|Overall Study|Physician Decision|0|||
19489386|NCT01465958|41787655|FG000|Run-in Phase|Protocol Violation|1|||
19489387|NCT01465958|41787656|FG001|Run-in Phase|Protocol Violation|0|||
19489388|NCT01465958|41787655|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
19489389|NCT01465958|41787656|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
19489390|NCT02581488|41787869|FG000|Overall Study|Adverse Event|6|||
19489391|NCT02581488|41787870|FG001|Overall Study|Adverse Event|7|||
19489392|NCT02581488|41787869|FG000|Overall Study|Lost to Follow-up|1|||
19489393|NCT02581488|41787870|FG001|Overall Study|Lost to Follow-up|0|||
19489394|NCT02581488|41787869|FG000|Overall Study|Withdrawal by Subject|1|||
19489395|NCT02581488|41787870|FG001|Overall Study|Withdrawal by Subject|0|||
19489396|NCT02581488|41787869|FG000|Overall Study|Non-Compliance|1|||
19489397|NCT02581488|41787870|FG001|Overall Study|Non-Compliance|0|||
19489398|NCT02581488|41787869|FG000|Overall Study|Protocol Violation|0|||
19489399|NCT02581488|41787870|FG001|Overall Study|Protocol Violation|4|||
19489400|NCT02581410|41787913|FG000|Vaccination Phase|Adverse Event|2|||
19489401|NCT02581410|41787914|FG001|Vaccination Phase|Adverse Event|1|||
19489402|NCT02581410|41787913|FG000|Vaccination Phase|Withdrawal by Subject|0|||
19489403|NCT02581410|41787914|FG001|Vaccination Phase|Withdrawal by Subject|1|||
19489404|NCT02581410|41787913|FG000|Vaccination Phase|Migrated/moved from study area|0|||
19489405|NCT02581410|41787914|FG001|Vaccination Phase|Migrated/moved from study area|1|||
19489406|NCT02581410|41787913|FG000|End of Study Phase|Adverse Event|4|||
19489407|NCT02581410|41787914|FG001|End of Study Phase|Adverse Event|3|||
19489408|NCT02581410|41787913|FG000|End of Study Phase|Withdrawal by Subject|1|||
19489409|NCT02581410|41787914|FG001|End of Study Phase|Withdrawal by Subject|2|||
19489410|NCT02581410|41787913|FG000|End of Study Phase|Migrated/moved from study area|0|||
19489411|NCT02581410|41787914|FG001|End of Study Phase|Migrated/moved from study area|3|||
19489412|NCT02581410|41787913|FG000|End of Study Phase|Lost to Follow-up|0|||
19489413|NCT02581410|41787914|FG001|End of Study Phase|Lost to Follow-up|2|||
19489414|NCT02581410|41787913|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
19489415|NCT02581410|41787914|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
19489416|NCT01664130|41787990|FG000|Overall Study|competing secondary disease|2|||
19489417|NCT02579928|41788021|FG000|Overall Study|Withdrawal by Subject|1|||
19489418|NCT02579928|41788022|FG001|Overall Study|Withdrawal by Subject|0|||
19489419|NCT00551460|41788116|FG000|Overall Study|Adverse Event|1|||
19489420|NCT00551460|41788116|FG000|Overall Study|Withdrawal by Subject|1|||
19489421|NCT00551460|41788116|FG000|Overall Study|Physician Decision|1|||
19489422|NCT00551460|41788116|FG000|Overall Study|Death|7|||
19489423|NCT00551460|41788116|FG000|Overall Study|Ineligible|4|||
19489424|NCT00551460|41788116|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
19489425|NCT02579772|41788177|FG000|Overall Study|Withdrawal by Subject|0|||
19489426|NCT02579772|41788178|FG001|Overall Study|Withdrawal by Subject|1|||
19489427|NCT02579772|41788177|FG000|Overall Study|Usage of additional antioxidants|1|||
19489428|NCT02579772|41788178|FG001|Overall Study|Usage of additional antioxidants|0|||
19489429|NCT02579772|41788177|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
19489430|NCT02579772|41788178|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
19489431|NCT02579616|41788251|FG000|Overall Study|Participants did not receive treatment|3|||
19489432|NCT04027608|41788328|FG000|Overall Study|Withdrawal by Subject|13|||
19489433|NCT04027608|41788329|FG001|Overall Study|Withdrawal by Subject|2|||
19489434|NCT04027608|41788328|FG000|Overall Study|Protocol Violation|2|||
19489435|NCT04027608|41788329|FG001|Overall Study|Protocol Violation|1|||
19489436|NCT04027608|41788328|FG000|Overall Study|Physician Decision|1|||
19489437|NCT04027608|41788329|FG001|Overall Study|Physician Decision|0|||
19489438|NCT04027608|41788328|FG000|Overall Study|Lost to Follow-up|20|||
19489439|NCT04027608|41788329|FG001|Overall Study|Lost to Follow-up|4|||
19489440|NCT01664052|41788420|FG000|Phase 1|No device placement|6|||
19489441|NCT01664052|41788421|FG001|Phase 1|No device placement|0|||
19489442|NCT01664052|41788420|FG000|Phase 1|No HSG 1 hr post placement|1|||
19489443|NCT01664052|41788421|FG001|Phase 1|No HSG 1 hr post placement|0|||
19489444|NCT01664052|41788420|FG000|Phase 2|No device placement|0|||
19489445|NCT01664052|41788421|FG001|Phase 2|No device placement|4|||
19489446|NCT01465802|41788468|FG000|Overall Study|Study terminated by sponsor|1|||
19489447|NCT01465802|41788469|FG001|Overall Study|Study terminated by sponsor|0|||
19489448|NCT01465802|41788470|FG002|Overall Study|Study terminated by sponsor|0|||
19489449|NCT01465802|41788471|FG003|Overall Study|Study terminated by sponsor|1|||
19489450|NCT01465802|41788472|FG004|Overall Study|Study terminated by sponsor|7|||
19489451|NCT01465802|41788468|FG000|Overall Study|Withdrawal by Subject|7|||
19489452|NCT01465802|41788469|FG001|Overall Study|Withdrawal by Subject|7|||
19489453|NCT01465802|41788470|FG002|Overall Study|Withdrawal by Subject|0|||
19489454|NCT01465802|41788471|FG003|Overall Study|Withdrawal by Subject|8|||
19489455|NCT01465802|41788472|FG004|Overall Study|Withdrawal by Subject|1|||
19489456|NCT01465802|41788468|FG000|Overall Study|Lost to Follow-up|1|||
19489457|NCT01465802|41788469|FG001|Overall Study|Lost to Follow-up|1|||
19489458|NCT01465802|41788470|FG002|Overall Study|Lost to Follow-up|0|||
19489459|NCT01465802|41788471|FG003|Overall Study|Lost to Follow-up|0|||
19489460|NCT01465802|41788472|FG004|Overall Study|Lost to Follow-up|0|||
19489461|NCT01465802|41788468|FG000|Overall Study|Reason not specified|9|||
19489462|NCT01465802|41788469|FG001|Overall Study|Reason not specified|4|||
19489463|NCT01465802|41788470|FG002|Overall Study|Reason not specified|0|||
19489464|NCT01465802|41788471|FG003|Overall Study|Reason not specified|10|||
19489465|NCT01465802|41788472|FG004|Overall Study|Reason not specified|2|||
19489466|NCT01465802|41788468|FG000|Overall Study|Death|15|||
19489467|NCT01465802|41788469|FG001|Overall Study|Death|12|||
19489468|NCT01465802|41788470|FG002|Overall Study|Death|0|||
19489469|NCT01465802|41788471|FG003|Overall Study|Death|10|||
19489470|NCT01465802|41788472|FG004|Overall Study|Death|2|||
19489471|NCT01437878|41788517|FG000|Overall Study|Withdrawal by Subject|1|||
19489472|NCT01437878|41788518|FG001|Overall Study|Withdrawal by Subject|0|||
19489473|NCT01465178|41788544|FG000|Overall Study|Withdrawal by Subject|1|||
19489474|NCT01465178|41788545|FG001|Overall Study|Withdrawal by Subject|0|||
19489475|NCT01445678|41788651|FG000|Overall Study|Adverse Event|12|||
19489476|NCT01445678|41788652|FG001|Overall Study|Adverse Event|8|||
19489477|NCT01445678|41788651|FG000|Overall Study|Lack of Efficacy|0|||
19489478|NCT01445678|41788652|FG001|Overall Study|Lack of Efficacy|2|||
19489479|NCT01445678|41788651|FG000|Overall Study|Lost to Follow-up|8|||
19489480|NCT01445678|41788652|FG001|Overall Study|Lost to Follow-up|5|||
19489481|NCT01445678|41788651|FG000|Overall Study|Protocol Violation|1|||
19489482|NCT01445678|41788652|FG001|Overall Study|Protocol Violation|1|||
19489483|NCT01445678|41788651|FG000|Overall Study|Withdrawal by Subject|9|||
19489484|NCT01445678|41788652|FG001|Overall Study|Withdrawal by Subject|5|||
19489485|NCT03769194|41788671|FG000|Overall Study|Withdrawal by Subject|0|||
19489486|NCT03769194|41788672|FG001|Overall Study|Withdrawal by Subject|7|||
19489487|NCT03769194|41788673|FG002|Overall Study|Withdrawal by Subject|4|||
19489488|NCT03769194|41788674|FG003|Overall Study|Withdrawal by Subject|1|||
19489489|NCT03769194|41788671|FG000|Overall Study|moved from study area|0|||
19489490|NCT03769194|41788672|FG001|Overall Study|moved from study area|2|||
19489491|NCT03769194|41788673|FG002|Overall Study|moved from study area|1|||
19489492|NCT03769194|41788674|FG003|Overall Study|moved from study area|1|||
19489493|NCT03769194|41788671|FG000|Overall Study|Lost to Follow-up|3|||
19489494|NCT03769194|41788672|FG001|Overall Study|Lost to Follow-up|6|||
19489495|NCT03769194|41788673|FG002|Overall Study|Lost to Follow-up|3|||
19489496|NCT03769194|41788674|FG003|Overall Study|Lost to Follow-up|6|||
19489497|NCT03769194|41788671|FG000|Overall Study|other|1|||
19489498|NCT03769194|41788672|FG001|Overall Study|other|3|||
19489499|NCT03769194|41788673|FG002|Overall Study|other|0|||
19489500|NCT03769194|41788674|FG003|Overall Study|other|1|||
19489501|NCT01465022|41788700|FG000|Overall Study|Lost to Follow-up|15|||
19489502|NCT01465022|41788701|FG001|Overall Study|Lost to Follow-up|14|||
19489503|NCT01465022|41788702|FG002|Overall Study|Lost to Follow-up|0|||
19489504|NCT01465022|41788700|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
19489505|NCT01465022|41788701|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
19489506|NCT01465022|41788702|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
19489507|NCT01465022|41788700|FG000|Overall Study|Not Randomized|0|||
19489508|NCT01465022|41788701|FG001|Overall Study|Not Randomized|0|||
19489509|NCT01465022|41788702|FG002|Overall Study|Not Randomized|70|||
19489510|NCT01464788|41788746|FG000|Overall Study|Lost to Follow-up|0|||
19489511|NCT01464788|41788747|FG001|Overall Study|Lost to Follow-up|1|||
19489512|NCT01464788|41788748|FG002|Overall Study|Lost to Follow-up|0|||
19489513|NCT01464788|41788746|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
19489514|NCT01464788|41788747|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
19489515|NCT01464788|41788748|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
19489516|NCT01444898|41788758|FG000|Overall Study|Withdrawal by Subject|1|||
19489517|NCT01419626|41788780|FG000|Overall Study|Protocol Violation|3|||
19489518|NCT01419626|41788781|FG001|Overall Study|Protocol Violation|2|||
19489519|NCT01419626|41788782|FG002|Overall Study|Protocol Violation|2|||
19489520|NCT01419626|41788780|FG000|Overall Study|Withdrawal by Subject|1|||
19489521|NCT01419626|41788781|FG001|Overall Study|Withdrawal by Subject|0|||
19489522|NCT01419626|41788782|FG002|Overall Study|Withdrawal by Subject|0|||
19489523|NCT01419626|41788780|FG000|Overall Study|Lost to Follow-up|0|||
19489524|NCT01419626|41788781|FG001|Overall Study|Lost to Follow-up|1|||
19489525|NCT01419626|41788782|FG002|Overall Study|Lost to Follow-up|1|||
19489526|NCT01444742|41788830|FG000|Overall Study|Death|1|||
19489527|NCT01444430|41789030|FG000|Overall Study|Withdrawal by Subject|53|||
19489528|NCT01444430|41789031|FG001|Overall Study|Withdrawal by Subject|72|||
19489529|NCT01444430|41789030|FG000|Overall Study|Death|6|||
19489530|NCT01444430|41789031|FG001|Overall Study|Death|8|||
19489531|NCT01444430|41789030|FG000|Overall Study|Lost to Follow-up|2|||
19489532|NCT01444430|41789031|FG001|Overall Study|Lost to Follow-up|0|||
19489533|NCT01444430|41789030|FG000|Overall Study|CRF termination module not completed.|0|||
19489534|NCT01444430|41789031|FG001|Overall Study|CRF termination module not completed.|1|||
19489535|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
19489536|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
19489537|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
19489538|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
19489539|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
19489540|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
19489541|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
19489542|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
19489543|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
19489544|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
19489545|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
19489546|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
19489547|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
19489548|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19489549|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
19489550|NCT01436162|41789107|FG000|Single-blind Lead-in Phase|Other|107|||
19489551|NCT01436162|41789108|FG001|Single-blind Lead-in Phase|Other|0|||
19489552|NCT01436162|41789109|FG002|Single-blind Lead-in Phase|Other|0|||
19489553|NCT01436162|41789107|FG000|Randomized Phase|Adverse Event|1|||
19489554|NCT01436162|41789108|FG001|Randomized Phase|Adverse Event|5|||
19489555|NCT01436162|41789109|FG002|Randomized Phase|Adverse Event|6|||
19489556|NCT01436162|41789107|FG000|Randomized Phase|Protocol Violation|4|||
19489557|NCT01436162|41789108|FG001|Randomized Phase|Protocol Violation|4|||
19489558|NCT01436162|41789109|FG002|Randomized Phase|Protocol Violation|2|||
19489559|NCT01436162|41789107|FG000|Randomized Phase|Withdrawal by Subject|16|||
19489560|NCT01436162|41789108|FG001|Randomized Phase|Withdrawal by Subject|9|||
19489561|NCT01436162|41789109|FG002|Randomized Phase|Withdrawal by Subject|8|||
19489562|NCT01436162|41789107|FG000|Randomized Phase|Lost to Follow-up|17|||
19489563|NCT01436162|41789108|FG001|Randomized Phase|Lost to Follow-up|5|||
19489564|NCT01436162|41789109|FG002|Randomized Phase|Lost to Follow-up|4|||
19489565|NCT01436162|41789107|FG000|Randomized Phase|Lack of Efficacy|0|||
19489566|NCT01436162|41789108|FG001|Randomized Phase|Lack of Efficacy|1|||
19489567|NCT01436162|41789109|FG002|Randomized Phase|Lack of Efficacy|1|||
19489568|NCT01436162|41789107|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
19489569|NCT01436162|41789108|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
19489570|NCT01436162|41789109|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
19489571|NCT01436162|41789107|FG000|Randomized Phase|Other|2|||
19489572|NCT01436162|41789108|FG001|Randomized Phase|Other|5|||
19489573|NCT01436162|41789109|FG002|Randomized Phase|Other|4|||
19489574|NCT02579382|41789121|FG000|Main Study Phase|Lost to Follow-up|0|||
19489575|NCT02579382|41789122|FG001|Main Study Phase|Lost to Follow-up|0|||
19489576|NCT02579382|41789123|FG002|Main Study Phase|Lost to Follow-up|2|||
19489577|NCT02579382|41789124|FG003|Main Study Phase|Lost to Follow-up|0|||
19489578|NCT02579382|41789121|FG000|Main Study Phase|Withdrew Consent|0|||
19489579|NCT02579382|41789122|FG001|Main Study Phase|Withdrew Consent|0|||
19489580|NCT02579382|41789123|FG002|Main Study Phase|Withdrew Consent|0|||
19489581|NCT02579382|41789124|FG003|Main Study Phase|Withdrew Consent|2|||
19489582|NCT02579382|41789121|FG000|Main Study Phase|Lack of Efficacy|0|||
19489583|NCT02579382|41789122|FG001|Main Study Phase|Lack of Efficacy|0|||
19489584|NCT02579382|41789123|FG002|Main Study Phase|Lack of Efficacy|0|||
19489585|NCT02579382|41789124|FG003|Main Study Phase|Lack of Efficacy|1|||
19489586|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
19489587|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
19489588|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
19489589|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
19489590|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
19489591|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
19489592|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
19489593|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
19489594|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
19489595|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
19489596|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
19489597|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
19489598|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
19489599|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
19489600|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
19489601|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
19489602|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
19489603|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
19489604|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
19489605|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
19489606|NCT02579382|41789121|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
19489607|NCT02579382|41789122|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
19489608|NCT02579382|41789123|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
19489609|NCT02579382|41789124|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
19489610|NCT01436084|41789160|FG000|Overall Study|Disease Progression|2|||
19489611|NCT01436084|41789160|FG000|Overall Study|Withdrawal by Subject|1|||
19489612|NCT01436084|41789160|FG000|Overall Study|Early Closure of Study|1|||
19489613|NCT01419314|41789175|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
19489614|NCT01419314|41789176|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
19489615|NCT01419314|41789175|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
19489616|NCT01419314|41789176|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
19489617|NCT01419314|41789175|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
19489618|NCT01419314|41789176|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
19489619|NCT01419236|41789233|FG000|Overall Study|Adverse Event|1|||
19489620|NCT01419236|41789234|FG001|Overall Study|Adverse Event|0|||
19489621|NCT01419236|41789233|FG000|Overall Study|Lack of Efficacy|0|||
19489622|NCT01419236|41789234|FG001|Overall Study|Lack of Efficacy|1|||
19489623|NCT01419236|41789233|FG000|Overall Study|Lost to Follow-up|1|||
19489624|NCT01419236|41789234|FG001|Overall Study|Lost to Follow-up|0|||
19489625|NCT01419236|41789233|FG000|Overall Study|Physician Decision|1|||
19489626|NCT01419236|41789234|FG001|Overall Study|Physician Decision|0|||
19489627|NCT01419236|41789233|FG000|Overall Study|Withdrawal by Subject|1|||
19489628|NCT01419236|41789234|FG001|Overall Study|Withdrawal by Subject|4|||
19489629|NCT01419236|41789233|FG000|Overall Study|Entry Criteria Not Met|1|||
19489630|NCT01419236|41789234|FG001|Overall Study|Entry Criteria Not Met|0|||
19489631|NCT01419080|41789244|FG000|Overall Study|Withdrawal by Subject|75|||
19489632|NCT01419080|41789244|FG000|Overall Study|Death|30|||
19489633|NCT01419080|41789244|FG000|Overall Study|Lost to Follow-up|23|||
19489634|NCT01419080|41789244|FG000|Overall Study|Too Ill|3|||
19489635|NCT03323658|41789253|FG000|Overall Study|Adverse Event|0|||
19489636|NCT03323658|41789254|FG001|Overall Study|Adverse Event|1|||
19489637|NCT03323658|41789255|FG002|Overall Study|Adverse Event|0|||
19489638|NCT01443026|41789280|FG000|Overall Study|Physician Decision|1|||
19489639|NCT01443026|41789281|FG001|Overall Study|Physician Decision|0|||
19489640|NCT01443026|41789280|FG000|Overall Study|Death|0|||
19489641|NCT01443026|41789281|FG001|Overall Study|Death|1|||
19489642|NCT01443026|41789280|FG000|Overall Study|Withdrawal by Subject|0|||
19489643|NCT01443026|41789281|FG001|Overall Study|Withdrawal by Subject|3|||
19489644|NCT01443026|41789280|FG000|Overall Study|Lost to Follow-up|2|||
19489645|NCT01443026|41789281|FG001|Overall Study|Lost to Follow-up|1|||
19489646|NCT01442714|41789306|FG000|Overall Study|Death|11|||
19489647|NCT01442714|41789306|FG000|Overall Study|Withdrawal by Subject|1|||
19489648|NCT01418378|41789319|FG000|Overall Study|Death|1|||
19489649|NCT01418378|41789320|FG001|Overall Study|Death|2|||
19489650|NCT01418378|41789319|FG000|Overall Study|Physician Decision|0|||
19489651|NCT01418378|41789320|FG001|Overall Study|Physician Decision|1|||
19489652|NCT01418378|41789319|FG000|Overall Study|ligament imbalance|0|||
19489653|NCT01418378|41789320|FG001|Overall Study|ligament imbalance|1|||
19489654|NCT01418378|41789319|FG000|Overall Study|developed chronic myopathy|0|||
19489655|NCT01418378|41789320|FG001|Overall Study|developed chronic myopathy|1|||
19489656|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
19489657|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
19489658|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
19489659|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
19489660|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
19489661|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
19489662|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
19489663|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
19489664|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
19489665|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
19489666|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
19489667|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
19489668|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
19489669|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
19489670|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
19489671|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
19489672|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
19489673|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
19489674|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
19489675|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
19489676|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
19489677|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
19489678|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
19489679|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
19489680|NCT01435928|41789341|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
19489681|NCT01435928|41789342|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
19489682|NCT01435928|41789343|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
19489683|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
19489684|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
19489685|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
19489686|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
19489687|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
19489688|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
19489689|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
19489690|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
19489691|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
19489692|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
19489693|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
19489694|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
19489695|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
19489696|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
19489697|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
19489698|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
19489699|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
19489700|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
19489701|NCT01435928|41789341|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
19489702|NCT01435928|41789342|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
19489703|NCT01435928|41789343|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
19489704|NCT01416272|41789355|FG000|Overall Study|Unacceptable distance visual acuity|2|||
19489705|NCT01416272|41789355|FG000|Overall Study|Lost to Follow-up|1|||
19489706|NCT01416272|41789355|FG000|Overall Study|Study related complaints|1|||
19489707|NCT01435772|41789854|FG000|Overall Study|Adverse Event|1|||
19489708|NCT01435772|41789855|FG001|Overall Study|Adverse Event|0|||
19489709|NCT01435772|41789856|FG002|Overall Study|Adverse Event|2|||
19489710|NCT01435772|41789854|FG000|Overall Study|Withdrawal by Subject|0|||
19489711|NCT01435772|41789855|FG001|Overall Study|Withdrawal by Subject|1|||
19489712|NCT01435772|41789856|FG002|Overall Study|Withdrawal by Subject|3|||
19489713|NCT01435772|41789854|FG000|Overall Study|Other - study termination|2|||
19489714|NCT01435772|41789855|FG001|Overall Study|Other - study termination|2|||
19489715|NCT01435772|41789856|FG002|Overall Study|Other - study termination|10|||
19489716|NCT01435616|41790075|FG000|Overall Study|Adverse Event|39|||
19489717|NCT01435616|41790076|FG001|Overall Study|Adverse Event|21|||
19489718|NCT01435616|41790075|FG000|Overall Study|Death|7|||
19489719|NCT01435616|41790076|FG001|Overall Study|Death|2|||
19489720|NCT01435616|41790075|FG000|Overall Study|Lost to Follow-up|22|||
19489721|NCT01435616|41790076|FG001|Overall Study|Lost to Follow-up|13|||
19489722|NCT01435616|41790075|FG000|Overall Study|Protocol Violation|16|||
19489723|NCT01435616|41790076|FG001|Overall Study|Protocol Violation|13|||
19489724|NCT01435616|41790075|FG000|Overall Study|Withdrawal by Subject|66|||
19489725|NCT01435616|41790076|FG001|Overall Study|Withdrawal by Subject|24|||
19489726|NCT01435616|41790075|FG000|Overall Study|Physician Decision|20|||
19489727|NCT01435616|41790076|FG001|Overall Study|Physician Decision|7|||
19489728|NCT01435616|41790075|FG000|Overall Study|Sponsor Decision|1|||
19489729|NCT01435616|41790076|FG001|Overall Study|Sponsor Decision|0|||
19489730|NCT01435460|41790126|FG000|Overall Study|Adverse Event|2|||
19489731|NCT01435460|41790127|FG001|Overall Study|Adverse Event|1|||
19489732|NCT01435460|41790126|FG000|Overall Study|Lost to Follow-up|6|||
19489733|NCT01435460|41790127|FG001|Overall Study|Lost to Follow-up|1|||
19489734|NCT01435460|41790126|FG000|Overall Study|Withdrawal by Subject|1|||
19489735|NCT01435460|41790127|FG001|Overall Study|Withdrawal by Subject|3|||
19489736|NCT01435460|41790126|FG000|Overall Study|Protocol Violation|0|||
19489737|NCT01435460|41790127|FG001|Overall Study|Protocol Violation|1|||
19489738|NCT01435460|41790126|FG000|Overall Study|Did not meet eligibility criteria|2|||
19489739|NCT01435460|41790127|FG001|Overall Study|Did not meet eligibility criteria|0|||
19489740|NCT01435382|41790213|FG000|Overall Study|Lost to Follow-up|1|||
19489741|NCT01435382|41790214|FG001|Overall Study|Lost to Follow-up|0|||
19489742|NCT01435382|41790215|FG002|Overall Study|Lost to Follow-up|1|||
19489743|NCT01435382|41790216|FG003|Overall Study|Lost to Follow-up|0|||
19489744|NCT01435382|41790213|FG000|Overall Study|Withdrawal by Subject|0|||
19489745|NCT01435382|41790214|FG001|Overall Study|Withdrawal by Subject|2|||
19489746|NCT01435382|41790215|FG002|Overall Study|Withdrawal by Subject|0|||
19489747|NCT01435382|41790216|FG003|Overall Study|Withdrawal by Subject|1|||
19489748|NCT01414166|41790281|FG000|Overall Study|Adverse Event|10|||
19489749|NCT01414166|41790282|FG001|Overall Study|Adverse Event|2|||
19489750|NCT01414166|41790281|FG000|Overall Study|Lost to Follow-up|4|||
19489751|NCT01414166|41790282|FG001|Overall Study|Lost to Follow-up|1|||
19489752|NCT01414166|41790281|FG000|Overall Study|Non-compliance with study drug|2|||
19489753|NCT01414166|41790282|FG001|Overall Study|Non-compliance with study drug|0|||
19489754|NCT01414166|41790281|FG000|Overall Study|Physician Decision|2|||
19489755|NCT01414166|41790282|FG001|Overall Study|Physician Decision|0|||
19489756|NCT01414166|41790281|FG000|Overall Study|Protocol Violation|2|||
19489757|NCT01414166|41790282|FG001|Overall Study|Protocol Violation|0|||
19489758|NCT01414166|41790281|FG000|Overall Study|Study terminated by Sponsor|68|||
19489759|NCT01414166|41790282|FG001|Overall Study|Study terminated by Sponsor|75|||
19489760|NCT01414166|41790281|FG000|Overall Study|Withdrawal by Subject|3|||
19489761|NCT01414166|41790282|FG001|Overall Study|Withdrawal by Subject|5|||
19489762|NCT01434680|41790292|FG000|Overall Study|Withdrawal by Subject|1|||
19489763|NCT01434680|41790293|FG001|Overall Study|Withdrawal by Subject|0|||
19489764|NCT01434680|41790294|FG002|Overall Study|Withdrawal by Subject|2|||
19489765|NCT01434680|41790295|FG003|Overall Study|Withdrawal by Subject|0|||
19489766|NCT01434680|41790292|FG000|Overall Study|Lost to Follow-up|1|||
19489767|NCT01434680|41790293|FG001|Overall Study|Lost to Follow-up|1|||
19489768|NCT01434680|41790294|FG002|Overall Study|Lost to Follow-up|0|||
19489769|NCT01434680|41790295|FG003|Overall Study|Lost to Follow-up|0|||
19489770|NCT01434680|41790292|FG000|Overall Study|Protocol Violation|1|||
19489771|NCT01434680|41790293|FG001|Overall Study|Protocol Violation|1|||
19489772|NCT01434680|41790294|FG002|Overall Study|Protocol Violation|0|||
19489773|NCT01434680|41790295|FG003|Overall Study|Protocol Violation|0|||
19489774|NCT01433978|41790428|FG000|Core Study|Adverse Event, Non-Fatal|0|||
19489775|NCT01433978|41790429|FG001|Core Study|Adverse Event, Non-Fatal|1|||
19489776|NCT01433978|41790430|FG002|Core Study|Adverse Event, Non-Fatal|0|||
19489777|NCT01433978|41790428|FG000|Core Study|Lack of Efficacy|5|||
19489778|NCT01433978|41790429|FG001|Core Study|Lack of Efficacy|1|||
19489779|NCT01433978|41790430|FG002|Core Study|Lack of Efficacy|0|||
19489780|NCT01433978|41790428|FG000|Core Study|Study Terminated by Sponsor|6|||
19489781|NCT01433978|41790429|FG001|Core Study|Study Terminated by Sponsor|9|||
19489782|NCT01433978|41790430|FG002|Core Study|Study Terminated by Sponsor|0|||
19489783|NCT01433978|41790428|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
19489784|NCT01433978|41790429|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
19489785|NCT01433978|41790430|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
19489786|NCT01433978|41790428|FG000|Extension Phase|Lack of Efficacy|0|||
19489787|NCT01433978|41790429|FG001|Extension Phase|Lack of Efficacy|0|||
19489788|NCT01433978|41790430|FG002|Extension Phase|Lack of Efficacy|1|||
19489789|NCT01433978|41790428|FG000|Extension Phase|Study Terminated by Sponsor|0|||
19489790|NCT01433978|41790429|FG001|Extension Phase|Study Terminated by Sponsor|0|||
19489791|NCT01433978|41790430|FG002|Extension Phase|Study Terminated by Sponsor|4|||
19489792|NCT01433354|41790479|FG000|Overall Study|Adverse Event|6|||
19489793|NCT01433354|41790479|FG000|Overall Study|Lost to Follow-up|1|||
19489794|NCT01433354|41790479|FG000|Overall Study|Administrative problems|90|||
19489795|NCT01433354|41790479|FG000|Overall Study|Protocol Violation|2|||
19489796|NCT01433354|41790479|FG000|Overall Study|Lack of Efficacy|17|||
19489797|NCT01433354|41790479|FG000|Overall Study|Subject Withdrew Consent|3|||
19489798|NCT00559845|41791043|FG000|Overall Study|Withdrew Consent|1|||
19489799|NCT00559845|41791043|FG000|Overall Study|Disease Progression|1|||
19489800|NCT00559845|41791043|FG000|Overall Study|Adverse Event|3|||
19489801|NCT00559845|41791043|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
19489802|NCT00559845|41791043|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
19489803|NCT01393964|41791146|FG000|Overall Study|Disease Progression|4|||
19489804|NCT01393964|41791147|FG001|Overall Study|Disease Progression|3|||
19489805|NCT01393964|41791148|FG002|Overall Study|Disease Progression|5|||
19613082|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
19613083|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
19489806|NCT01393964|41791146|FG000|Overall Study|Study drug toxicity|1|||
19489807|NCT01393964|41791147|FG001|Overall Study|Study drug toxicity|0|||
19489808|NCT01393964|41791148|FG002|Overall Study|Study drug toxicity|0|||
19489809|NCT01393964|41791146|FG000|Overall Study|Withdrawal by Subject|0|||
19489810|NCT01393964|41791147|FG001|Overall Study|Withdrawal by Subject|0|||
19489811|NCT01393964|41791148|FG002|Overall Study|Withdrawal by Subject|1|||
19489812|NCT01393964|41791146|FG000|Overall Study|Adverse event unrelated to study drug|0|||
19489813|NCT01393964|41791147|FG001|Overall Study|Adverse event unrelated to study drug|3|||
19489814|NCT01393964|41791148|FG002|Overall Study|Adverse event unrelated to study drug|0|||
19489815|NCT01393964|41791146|FG000|Overall Study|Subject request stop study treatment|0|||
19489816|NCT01393964|41791147|FG001|Overall Study|Subject request stop study treatment|1|||
19489817|NCT01393964|41791148|FG002|Overall Study|Subject request stop study treatment|0|||
19489818|NCT01393964|41791146|FG000|Overall Study|Subject decided to move to transplant|1|||
19489819|NCT01393964|41791147|FG001|Overall Study|Subject decided to move to transplant|0|||
19489820|NCT01393964|41791148|FG002|Overall Study|Subject decided to move to transplant|0|||
19489821|NCT01393964|41791146|FG000|Overall Study|Subject switched to commercial supply|1|||
19489822|NCT01393964|41791147|FG001|Overall Study|Subject switched to commercial supply|0|||
19489823|NCT01393964|41791148|FG002|Overall Study|Subject switched to commercial supply|2|||
19489824|NCT01393964|41791146|FG000|Overall Study|Subject plateaued in terms of effect|1|||
19489825|NCT01393964|41791147|FG001|Overall Study|Subject plateaued in terms of effect|0|||
19489826|NCT01393964|41791148|FG002|Overall Study|Subject plateaued in terms of effect|0|||
19489827|NCT01393964|41791146|FG000|Overall Study|Investigator removed subject from study|0|||
19489828|NCT01393964|41791147|FG001|Overall Study|Investigator removed subject from study|1|||
19489829|NCT01393964|41791148|FG002|Overall Study|Investigator removed subject from study|0|||
19489830|NCT01393964|41791146|FG000|Overall Study|Subject converted to roll-over study|0|||
19489831|NCT01393964|41791147|FG001|Overall Study|Subject converted to roll-over study|1|||
19489832|NCT01393964|41791148|FG002|Overall Study|Subject converted to roll-over study|0|||
19489833|NCT01393964|41791146|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
19489834|NCT01393964|41791147|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
19489835|NCT01393964|41791148|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
19489836|NCT01393730|41791236|FG000|Overall Study|Withdrawal by Subject|3|||
19489837|NCT01393730|41791236|FG000|Overall Study|Other|2|||
19489838|NCT01393730|41791236|FG000|Overall Study|Adverse Event|1|||
19489839|NCT01393106|41791255|FG000|Overall Study|Adverse Event|3|||
19489840|NCT01393106|41791255|FG000|Overall Study|Withdrawal by Subject|1|||
19489841|NCT01393106|41791255|FG000|Overall Study|Lack of Efficacy|1|||
19489842|NCT00553059|41791261|FG000|Overall Study|Deemed ineligible|1|||
19489843|NCT00553059|41791262|FG001|Overall Study|Deemed ineligible|1|||
19489844|NCT00553059|41791261|FG000|Overall Study|Drug supply not available|0|||
19489845|NCT00553059|41791262|FG001|Overall Study|Drug supply not available|1|||
19489846|NCT01413542|41791295|FG000|Overall Study|Physician Decision|1|||
19489847|NCT01413542|41791296|FG001|Overall Study|Physician Decision|0|||
19489848|NCT01413542|41791297|FG002|Overall Study|Physician Decision|3|||
19489849|NCT01413542|41791298|FG003|Overall Study|Physician Decision|0|||
19489850|NCT01413542|41791295|FG000|Overall Study|Adverse Event|0|||
19489851|NCT01413542|41791296|FG001|Overall Study|Adverse Event|0|||
19489852|NCT01413542|41791297|FG002|Overall Study|Adverse Event|0|||
19489853|NCT01413542|41791298|FG003|Overall Study|Adverse Event|1|||
19489854|NCT01432730|41791330|FG000|Period 1|Adverse Event|2|||
19489855|NCT01432730|41791331|FG001|Period 1|Adverse Event|0|||
19489856|NCT01432730|41791330|FG000|Period 2|Adverse Event|0|||
19489857|NCT01432730|41791331|FG001|Period 2|Adverse Event|4|||
19489858|NCT01432574|41791346|FG000|Overall Study|Moved|2|||
19489859|NCT01432574|41791346|FG000|Overall Study|Not interested|1|||
19489860|NCT01392560|41791379|FG000|Overall Study|Adverse Event|2|||
19489861|NCT01392560|41791379|FG000|Overall Study|not entered|8|||
19489862|NCT01392560|41791379|FG000|Overall Study|discontinued during placebo run-in|2|||
19489863|NCT00552279|41791431|FG000|Overall Study|Adverse Event|0|||
19489864|NCT00552279|41791432|FG001|Overall Study|Adverse Event|1|||
19489865|NCT00552279|41791431|FG000|Overall Study|Withdrawal by Subject|12|||
19489866|NCT00552279|41791432|FG001|Overall Study|Withdrawal by Subject|1|||
19489867|NCT00552279|41791431|FG000|Overall Study|Lost to Follow-up|1|||
19489868|NCT00552279|41791432|FG001|Overall Study|Lost to Follow-up|0|||
19489869|NCT00552279|41791431|FG000|Overall Study|Other|1|||
19489870|NCT00552279|41791432|FG001|Overall Study|Other|1|||
19489871|NCT00559377|41791473|FG000|Overall Study|Withdrawal by Subject|9|||
19489872|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
19489873|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
19489874|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
19489875|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
19489876|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
19489877|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
19489878|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
19489879|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
19489880|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
19489881|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
19489882|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
19489883|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
19489884|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
19489885|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
19489886|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
19489887|NCT01412060|41791480|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
19489888|NCT01412060|41791481|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
19489889|NCT01412060|41791482|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
19489890|NCT01412060|41791480|FG000|Period Between RIP and SP|Adverse Event|4|||
19489891|NCT01412060|41791481|FG001|Period Between RIP and SP|Adverse Event|0|||
19489892|NCT01412060|41791482|FG002|Period Between RIP and SP|Adverse Event|0|||
19489893|NCT01412060|41791480|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
19489894|NCT01412060|41791481|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
19489895|NCT01412060|41791482|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
19489896|NCT01412060|41791480|FG000|Period Between RIP and SP|Protocol Violation|2|||
19489897|NCT01412060|41791481|FG001|Period Between RIP and SP|Protocol Violation|0|||
19489898|NCT01412060|41791482|FG002|Period Between RIP and SP|Protocol Violation|0|||
19489899|NCT01412060|41791480|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
19489900|NCT01412060|41791481|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
19489901|NCT01412060|41791482|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
19489902|NCT01412060|41791480|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
19489903|NCT01412060|41791481|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
19489904|NCT01412060|41791482|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
19489905|NCT01412060|41791480|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
19489906|NCT01412060|41791481|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
19489907|NCT01412060|41791482|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
19489908|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
19489909|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
19489910|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
19489911|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
19489912|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
19489913|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
19489914|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
19489915|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
19489916|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
19489917|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
19489918|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
19489919|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
19489920|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
19489921|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
19489922|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
19489923|NCT01412060|41791480|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
19489924|NCT01412060|41791481|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
19489925|NCT01412060|41791482|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
19489926|NCT01412060|41791480|FG000|Period Between SP and DBP|Protocol Violation|2|||
19489927|NCT01412060|41791481|FG001|Period Between SP and DBP|Protocol Violation|0|||
19489928|NCT01412060|41791482|FG002|Period Between SP and DBP|Protocol Violation|0|||
19489929|NCT01412060|41791480|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
19489930|NCT01412060|41791481|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
19489931|NCT01412060|41791482|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
19489932|NCT01412060|41791480|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
19489933|NCT01412060|41791481|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
19489934|NCT01412060|41791482|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
19489935|NCT01412060|41791480|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
19489936|NCT01412060|41791481|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
19489937|NCT01412060|41791482|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
19489938|NCT01412060|41791480|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
19489939|NCT01412060|41791481|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
19489940|NCT01412060|41791482|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
19489941|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
19489942|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
19489943|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
19489944|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
19489945|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
19489946|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
19489947|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
19489948|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
19489949|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
19489950|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
19489951|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
19489952|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
19489953|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
19489954|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
19489955|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
19489956|NCT01412060|41791480|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
19489957|NCT01412060|41791481|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
19489958|NCT01412060|41791482|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
19489959|NCT00551421|41791513|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
19489960|NCT01891643|41791533|FG000|Overall Study|Adverse event unrelated to study drug|2|||
19489961|NCT01891643|41791534|FG001|Overall Study|Adverse event unrelated to study drug|5|||
19489962|NCT01891643|41791533|FG000|Overall Study|Disease Progression|4|||
19489963|NCT01891643|41791534|FG001|Overall Study|Disease Progression|3|||
19489964|NCT01891643|41791533|FG000|Overall Study|Study Drug Toxicity|3|||
19489965|NCT01891643|41791534|FG001|Overall Study|Study Drug Toxicity|0|||
19489966|NCT01891643|41791533|FG000|Overall Study|Maximum Clinical Benefit|0|||
19489967|NCT01891643|41791534|FG001|Overall Study|Maximum Clinical Benefit|1|||
19489968|NCT01891643|41791533|FG000|Overall Study|Poor/Non-compliance|0|||
19489969|NCT01891643|41791534|FG001|Overall Study|Poor/Non-compliance|1|||
19489970|NCT01891643|41791533|FG000|Overall Study|Participant request to discontinue|1|||
19489971|NCT01891643|41791534|FG001|Overall Study|Participant request to discontinue|0|||
19489972|NCT01392326|41791668|FG000|Overall Study|Death|2|||
19489973|NCT01392326|41791669|FG001|Overall Study|Death|0|||
19489974|NCT01392326|41791670|FG002|Overall Study|Death|0|||
19489975|NCT01392326|41791668|FG000|Overall Study|Withdrawal by Subject|12|||
19489976|NCT01392326|41791669|FG001|Overall Study|Withdrawal by Subject|11|||
19489977|NCT01392326|41791670|FG002|Overall Study|Withdrawal by Subject|15|||
19489978|NCT01392326|41791668|FG000|Overall Study|Protocol Violation|2|||
19489979|NCT01392326|41791669|FG001|Overall Study|Protocol Violation|0|||
19489980|NCT01392326|41791670|FG002|Overall Study|Protocol Violation|0|||
19613084|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
19613085|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
19613086|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
19613087|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
19613088|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
19613089|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
19613090|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
19704274|NCT00224484|42148580|FG001|Overall Study|Reason not specified|4|||
19704275|NCT00224484|42148581|FG002|Overall Study|Reason not specified|2|||
19704276|NCT00254982|42148594|FG000|Overall Study|Other|2|||
19704277|NCT00254982|42148595|FG001|Overall Study|Other|1|||
19613091|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
19613092|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
19613093|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
19613094|NCT00611455|42061969|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
19613095|NCT00611455|42061970|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
19613096|NCT00611455|42061971|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
19613097|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
19613098|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
19613099|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
19613100|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
19704278|NCT00254982|42148594|FG000|Overall Study|Lack of Efficacy|5|||
19489981|NCT01392326|41791668|FG000|Overall Study|Pregnancy|0|||
19489982|NCT01392326|41791669|FG001|Overall Study|Pregnancy|0|||
19489983|NCT01392326|41791670|FG002|Overall Study|Pregnancy|1|||
19489984|NCT01392326|41791668|FG000|Overall Study|Physician Decision|7|||
19489985|NCT01392326|41791669|FG001|Overall Study|Physician Decision|5|||
19489986|NCT01392326|41791670|FG002|Overall Study|Physician Decision|2|||
19489987|NCT01392326|41791668|FG000|Overall Study|Lost to Follow-up|1|||
19489988|NCT01392326|41791669|FG001|Overall Study|Lost to Follow-up|3|||
19489989|NCT01392326|41791670|FG002|Overall Study|Lost to Follow-up|4|||
19489990|NCT01392326|41791668|FG000|Overall Study|Lack of Efficacy|14|||
19489991|NCT01392326|41791669|FG001|Overall Study|Lack of Efficacy|10|||
19489992|NCT01392326|41791670|FG002|Overall Study|Lack of Efficacy|15|||
19489993|NCT01392326|41791668|FG000|Overall Study|Adverse Event|9|||
19489994|NCT01392326|41791669|FG001|Overall Study|Adverse Event|6|||
19704279|NCT00254982|42148595|FG001|Overall Study|Lack of Efficacy|3|||
19704280|NCT00254982|42148594|FG000|Overall Study|Lost to Follow-up|5|||
19704281|NCT00254982|42148595|FG001|Overall Study|Lost to Follow-up|3|||
19704282|NCT00254982|42148594|FG000|Overall Study|Adverse Event|18|||
19489995|NCT01392326|41791670|FG002|Overall Study|Adverse Event|11|||
19489996|NCT01432262|41791713|FG000|Overall Study|Withdrawal by Subject|2|||
19489997|NCT01432262|41791714|FG001|Overall Study|Withdrawal by Subject|1|||
19489998|NCT01410890|41791734|FG000|Overall Study|Withdrawal by Subject|0|||
19489999|NCT01410890|41791735|FG001|Overall Study|Withdrawal by Subject|1|||
19490000|NCT01431950|41791745|FG000|Overall Study|Study Site Closed/Terminated|7|||
19490001|NCT01431950|41791746|FG001|Overall Study|Study Site Closed/Terminated|3|||
19490002|NCT01431950|41791745|FG000|Overall Study|Withdrawal by Subject|4|||
19490003|NCT01431950|41791746|FG001|Overall Study|Withdrawal by Subject|3|||
19490004|NCT01431950|41791745|FG000|Overall Study|Protocol Violation|2|||
19490005|NCT01431950|41791746|FG001|Overall Study|Protocol Violation|3|||
19490006|NCT01431950|41791745|FG000|Overall Study|Adverse Event|2|||
19490007|NCT01431950|41791746|FG001|Overall Study|Adverse Event|2|||
19490008|NCT01431950|41791745|FG000|Overall Study|Physician Decision|2|||
19490009|NCT01431950|41791746|FG001|Overall Study|Physician Decision|1|||
19490010|NCT01431950|41791745|FG000|Overall Study|Lack of Efficacy|2|||
19490011|NCT01431950|41791746|FG001|Overall Study|Lack of Efficacy|1|||
19490012|NCT01431950|41791745|FG000|Overall Study|Lost to Follow-up|0|||
19490013|NCT01431950|41791746|FG001|Overall Study|Lost to Follow-up|1|||
19490014|NCT01431950|41791745|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19490015|NCT01431950|41791746|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19490016|NCT00551031|41791757|FG000|Overall Study|Adverse Event|0|||
19490017|NCT00551031|41791758|FG001|Overall Study|Adverse Event|1|||
19490018|NCT00551031|41791759|FG002|Overall Study|Adverse Event|0|||
19490019|NCT00551031|41791760|FG003|Overall Study|Adverse Event|0|||
19490020|NCT00551031|41791761|FG004|Overall Study|Adverse Event|0|||
19490021|NCT00551031|41791757|FG000|Overall Study|Protocol Violation|1|||
19490022|NCT00551031|41791758|FG001|Overall Study|Protocol Violation|1|||
19490023|NCT00551031|41791759|FG002|Overall Study|Protocol Violation|0|||
19490024|NCT00551031|41791760|FG003|Overall Study|Protocol Violation|0|||
19490025|NCT00551031|41791761|FG004|Overall Study|Protocol Violation|0|||
19490026|NCT00551031|41791757|FG000|Overall Study|Lost to Follow-up|0|||
19490027|NCT00551031|41791758|FG001|Overall Study|Lost to Follow-up|1|||
19490028|NCT00551031|41791759|FG002|Overall Study|Lost to Follow-up|0|||
19490029|NCT00551031|41791760|FG003|Overall Study|Lost to Follow-up|1|||
19490030|NCT00551031|41791761|FG004|Overall Study|Lost to Follow-up|1|||
19490031|NCT00551031|41791757|FG000|Overall Study|Withdrawal by Subject|0|||
19704283|NCT00254982|42148595|FG001|Overall Study|Adverse Event|16|||
19490032|NCT00551031|41791758|FG001|Overall Study|Withdrawal by Subject|4|||
19490033|NCT00551031|41791759|FG002|Overall Study|Withdrawal by Subject|1|||
19490034|NCT00551031|41791760|FG003|Overall Study|Withdrawal by Subject|2|||
19490035|NCT00551031|41791761|FG004|Overall Study|Withdrawal by Subject|0|||
19490036|NCT00551031|41791757|FG000|Overall Study|Serious Adverse Event|0|||
19490037|NCT00551031|41791758|FG001|Overall Study|Serious Adverse Event|2|||
19490038|NCT00551031|41791759|FG002|Overall Study|Serious Adverse Event|1|||
19490039|NCT00551031|41791760|FG003|Overall Study|Serious Adverse Event|0|||
19490040|NCT00551031|41791761|FG004|Overall Study|Serious Adverse Event|0|||
19490041|NCT00551031|41791757|FG000|Overall Study|Did not receive vaccine|1|||
19490042|NCT00551031|41791758|FG001|Overall Study|Did not receive vaccine|2|||
19490043|NCT00551031|41791759|FG002|Overall Study|Did not receive vaccine|0|||
19490044|NCT00551031|41791760|FG003|Overall Study|Did not receive vaccine|0|||
19490045|NCT00551031|41791761|FG004|Overall Study|Did not receive vaccine|0|||
19490046|NCT01431716|41791773|FG000|Overall Study|Withdrawal of consent|1|||
19490047|NCT00550953|41791779|FG000|Overall Study|Adverse Event|4|||
19490048|NCT00550953|41791780|FG001|Overall Study|Adverse Event|3|||
19490049|NCT00550953|41791779|FG000|Overall Study|Not able to visit the site|2|||
19490050|NCT00550953|41791780|FG001|Overall Study|Not able to visit the site|3|||
19490051|NCT00558831|41791815|FG000|Overall Study|Lost to Follow-up|1|||
19490052|NCT01431638|41791824|FG000|Overall Study|Adverse Event|1|||
19490053|NCT01431638|41791825|FG001|Overall Study|Adverse Event|3|||
19490054|NCT01431638|41791826|FG002|Overall Study|Adverse Event|1|||
19490055|NCT01431638|41791824|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19490056|NCT01431638|41791825|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19490057|NCT01431638|41791826|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
19490058|NCT01431638|41791824|FG000|Overall Study|Participants condition no longer requires study drug|0|||
19490059|NCT01431638|41791825|FG001|Overall Study|Participants condition no longer requires study drug|1|||
19490060|NCT01431638|41791826|FG002|Overall Study|Participants condition no longer requires study drug|0|||
19490061|NCT01431638|41791824|FG000|Overall Study|Participant withdrew consent|14|||
19490062|NCT01431638|41791825|FG001|Overall Study|Participant withdrew consent|5|||
19490063|NCT01431638|41791826|FG002|Overall Study|Participant withdrew consent|8|||
19490064|NCT01431638|41791824|FG000|Overall Study|Lost to Follow-up|7|||
19490065|NCT01431638|41791825|FG001|Overall Study|Lost to Follow-up|9|||
19490066|NCT01431638|41791826|FG002|Overall Study|Lost to Follow-up|7|||
19490067|NCT01431638|41791824|FG000|Overall Study|Administrative problems|1|||
19490068|NCT01431638|41791825|FG001|Overall Study|Administrative problems|4|||
19490069|NCT01431638|41791826|FG002|Overall Study|Administrative problems|6|||
19490070|NCT01431638|41791824|FG000|Overall Study|Death|1|||
19613101|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
19490071|NCT01431638|41791825|FG001|Overall Study|Death|0|||
19490072|NCT01431638|41791826|FG002|Overall Study|Death|0|||
19490073|NCT01431638|41791824|FG000|Overall Study|Protocol deviation|1|||
19490074|NCT01431638|41791825|FG001|Overall Study|Protocol deviation|1|||
19490075|NCT01431638|41791826|FG002|Overall Study|Protocol deviation|4|||
19490076|NCT01431638|41791824|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
19490077|NCT01431638|41791825|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
19490078|NCT01431638|41791826|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
19490079|NCT01392170|41791834|FG000|Overall Study|Withdrawal by Subject|1|||
19490080|NCT01392170|41791834|FG000|Overall Study|Ineligible|1|||
19490081|NCT00558753|41791840|FG000|Overall Study|Lost to Follow-up|5|||
19490082|NCT00558753|41791841|FG001|Overall Study|Lost to Follow-up|7|||
19490083|NCT01391546|41791849|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
19490084|NCT01391546|41791850|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
19490085|NCT01410110|41791859|FG000|Overall Study|Withdrawal by Subject|4|||
19490086|NCT01410110|41791860|FG001|Overall Study|Withdrawal by Subject|2|||
19490087|NCT01391000|41791868|FG000|Overall Study|Lost to Follow-up|2|||
19490088|NCT01391000|41791869|FG001|Overall Study|Lost to Follow-up|0|||
19490089|NCT01390844|41791944|FG000|Treatment Phase|Adverse Event|12|||
19490090|NCT01390844|41791945|FG001|Treatment Phase|Adverse Event|2|||
19490091|NCT01390844|41791946|FG002|Treatment Phase|Adverse Event|3|||
19490092|NCT01390844|41791947|FG003|Treatment Phase|Adverse Event|2|||
19490093|NCT01390844|41791944|FG000|Treatment Phase|Treatment Failure|23|||
19490094|NCT01390844|41791945|FG001|Treatment Phase|Treatment Failure|25|||
19490095|NCT01390844|41791946|FG002|Treatment Phase|Treatment Failure|10|||
19490096|NCT01390844|41791947|FG003|Treatment Phase|Treatment Failure|13|||
19490097|NCT01390844|41791944|FG000|Treatment Phase|Non-Medical Reasons|5|||
19490098|NCT01390844|41791945|FG001|Treatment Phase|Non-Medical Reasons|1|||
19490099|NCT01390844|41791946|FG002|Treatment Phase|Non-Medical Reasons|8|||
19490100|NCT01390844|41791947|FG003|Treatment Phase|Non-Medical Reasons|1|||
19490101|NCT01390844|41791944|FG000|Treatment Phase|Non-GCP Compliant|0|||
19490102|NCT01390844|41791945|FG001|Treatment Phase|Non-GCP Compliant|0|||
19490103|NCT01390844|41791946|FG002|Treatment Phase|Non-GCP Compliant|10|||
19490104|NCT01390844|41791947|FG003|Treatment Phase|Non-GCP Compliant|3|||
19490105|NCT01390844|41791944|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
19490106|NCT01390844|41791945|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
19490107|NCT01390844|41791946|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
19490108|NCT01390844|41791947|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
19490109|NCT01430624|41791960|FG000|Overall Study|Lost to Follow-up|23|||
19490110|NCT01430624|41791961|FG001|Overall Study|Lost to Follow-up|29|||
19490111|NCT01430624|41791962|FG002|Overall Study|Lost to Follow-up|27|||
19490112|NCT01430624|41791960|FG000|Overall Study|technical or eligibility|5|||
19490113|NCT01430624|41791961|FG001|Overall Study|technical or eligibility|5|||
19490114|NCT01430624|41791962|FG002|Overall Study|technical or eligibility|2|||
19490115|NCT01430468|41791987|FG000|Overall Study|Physician Decision|2|||
19490116|NCT01430468|41791988|FG001|Overall Study|Physician Decision|1|||
19490117|NCT01430468|41791987|FG000|Overall Study|Withdrawal by Subject|5|||
19490118|NCT01430468|41791988|FG001|Overall Study|Withdrawal by Subject|5|||
19490119|NCT01409564|41792009|FG000|Overall Study|low medication compliance|4|||
19490120|NCT01409564|41792010|FG001|Overall Study|low medication compliance|3|||
19490121|NCT01409564|41792009|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
19490122|NCT01409564|41792010|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
19490123|NCT01390298|41792020|FG000|Overall Study|Death|1|||
19490124|NCT01390298|41792020|FG000|Overall Study|long term ICU admission|1|||
19490125|NCT01390298|41792020|FG000|Overall Study|Withdrawal by Subject|14|||
19490126|NCT01390298|41792020|FG000|Overall Study|Lost to Follow-up|7|||
19490127|NCT01390298|41792020|FG000|Overall Study|Surgery cancelled|1|||
19490128|NCT01390220|41792038|FG000|Test Dose Phase|Adverse Event|17|||
19490129|NCT01390220|41792039|FG001|Test Dose Phase|Adverse Event|0|||
19490130|NCT01390220|41792040|FG002|Test Dose Phase|Adverse Event|0|||
19490131|NCT01390220|41792038|FG000|Test Dose Phase|Withdrawal by Subject|8|||
19490132|NCT01390220|41792039|FG001|Test Dose Phase|Withdrawal by Subject|0|||
19490133|NCT01390220|41792040|FG002|Test Dose Phase|Withdrawal by Subject|0|||
19490134|NCT01390220|41792038|FG000|Test Dose Phase|Lost to Follow-up|2|||
19490135|NCT01390220|41792039|FG001|Test Dose Phase|Lost to Follow-up|0|||
19490136|NCT01390220|41792040|FG002|Test Dose Phase|Lost to Follow-up|0|||
19490137|NCT01390220|41792038|FG000|Test Dose Phase|Protocol Violation|8|||
19490138|NCT01390220|41792039|FG001|Test Dose Phase|Protocol Violation|0|||
19490139|NCT01390220|41792040|FG002|Test Dose Phase|Protocol Violation|0|||
19704284|NCT00254982|42148594|FG000|Overall Study|Withdrawal by Subject|1|||
19490140|NCT01390220|41792038|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
19704285|NCT00254982|42148595|FG001|Overall Study|Withdrawal by Subject|1|||
19704286|NCT00254982|42148594|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
19490141|NCT01390220|41792039|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
19490142|NCT01390220|41792040|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
19490143|NCT01390220|41792038|FG000|Test Dose Phase|Study/Site closure|6|||
19490144|NCT01390220|41792039|FG001|Test Dose Phase|Study/Site closure|0|||
19490145|NCT01390220|41792040|FG002|Test Dose Phase|Study/Site closure|0|||
19490146|NCT01390220|41792038|FG000|Test Dose Phase|Caregiver no longer available|5|||
19490147|NCT01390220|41792039|FG001|Test Dose Phase|Caregiver no longer available|0|||
19490148|NCT01390220|41792040|FG002|Test Dose Phase|Caregiver no longer available|0|||
19490149|NCT01390220|41792038|FG000|Test Dose Phase|Noncompliance|2|||
19490150|NCT01390220|41792039|FG001|Test Dose Phase|Noncompliance|0|||
19490151|NCT01390220|41792040|FG002|Test Dose Phase|Noncompliance|0|||
19490152|NCT01390220|41792038|FG000|Test Dose Phase|Logistical|6|||
19490153|NCT01390220|41792039|FG001|Test Dose Phase|Logistical|0|||
19490154|NCT01390220|41792040|FG002|Test Dose Phase|Logistical|0|||
19490155|NCT01390220|41792038|FG000|Comparative Phase|Withdrawal by Subject|0|||
19490156|NCT01390220|41792039|FG001|Comparative Phase|Withdrawal by Subject|1|||
19490157|NCT01390220|41792040|FG002|Comparative Phase|Withdrawal by Subject|0|||
19490158|NCT00550173|41792070|FG000|Overall Study|Death|45|||
19490159|NCT00550173|41792071|FG001|Overall Study|Death|38|||
19490160|NCT00550173|41792072|FG002|Overall Study|Death|50|||
19490161|NCT00550173|41792070|FG000|Overall Study|Physician Decision|1|||
19490162|NCT00550173|41792071|FG001|Overall Study|Physician Decision|2|||
19490163|NCT00550173|41792072|FG002|Overall Study|Physician Decision|2|||
19490164|NCT00550173|41792070|FG000|Overall Study|Withdrawal by Subject|9|||
19490165|NCT00550173|41792071|FG001|Overall Study|Withdrawal by Subject|12|||
19490166|NCT00550173|41792072|FG002|Overall Study|Withdrawal by Subject|17|||
19490167|NCT00550173|41792070|FG000|Overall Study|Sponsor Decision|13|||
19490168|NCT00550173|41792071|FG001|Overall Study|Sponsor Decision|7|||
19490169|NCT00550173|41792072|FG002|Overall Study|Sponsor Decision|1|||
19490170|NCT00550173|41792070|FG000|Overall Study|Lost to Follow-up|4|||
19490171|NCT00550173|41792071|FG001|Overall Study|Lost to Follow-up|4|||
19490172|NCT00550173|41792072|FG002|Overall Study|Lost to Follow-up|3|||
19490173|NCT01429298|41792083|FG000|Overall Study|Protocol Violation|4|||
19490174|NCT01429298|41792084|FG001|Overall Study|Protocol Violation|6|||
19490175|NCT01408706|41792096|FG000|Overall Study|Physician Decision|1|||
19490176|NCT01408706|41792097|FG001|Overall Study|Physician Decision|0|||
19490177|NCT01408628|41792105|FG000|Consented|Withdrawal by Subject|12|||
19490178|NCT01408628|41792105|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
19490179|NCT01408628|41792105|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
19490180|NCT01408628|41792105|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
19490181|NCT01389752|41792110|FG000|Study Period 1|Sponsor decision|0|||
19490182|NCT01389752|41792111|FG001|Study Period 1|Sponsor decision|2|||
19490183|NCT01389752|41792110|FG000|Study Period 2|Sponsor decision|1|||
19490184|NCT01389752|41792111|FG001|Study Period 2|Sponsor decision|0|||
19490185|NCT01428128|41792118|FG000|Overall Study|Withdrawal by Subject|4|||
19490186|NCT01428128|41792118|FG000|Overall Study|Screen failure by p53|10|||
19490187|NCT01428128|41792118|FG000|Overall Study|Received Neulasta in one cycle|2|||
19490188|NCT01428128|41792118|FG000|Overall Study|Adverse Event|1|||
19490189|NCT01407926|41792123|FG000|Overall Study|Lost to Follow-up|55|||
19490190|NCT01427972|41792150|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490191|NCT01427972|41792151|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490192|NCT01427972|41792152|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490193|NCT01427972|41792153|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490194|NCT01427972|41792154|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490195|NCT01427972|41792155|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490196|NCT01427972|41792156|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490197|NCT01427972|41792157|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
19490198|NCT01427972|41792158|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490199|NCT01427972|41792159|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490200|NCT01427972|41792160|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490201|NCT01427972|41792161|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
19490202|NCT01427972|41792150|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490203|NCT01427972|41792151|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490204|NCT01427972|41792152|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490205|NCT01427972|41792153|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490206|NCT01427972|41792154|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490207|NCT01427972|41792155|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
19490208|NCT01427972|41792156|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490209|NCT01427972|41792157|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490210|NCT01427972|41792158|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490211|NCT01427972|41792159|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490212|NCT01427972|41792160|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490213|NCT01427972|41792161|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
19490214|NCT01427972|41792150|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490215|NCT01427972|41792151|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
19490216|NCT01427972|41792152|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19704287|NCT00254982|42148595|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
19490217|NCT01427972|41792153|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490218|NCT01427972|41792154|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490219|NCT01427972|41792155|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490220|NCT01427972|41792156|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490221|NCT01427972|41792157|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490222|NCT01427972|41792158|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490223|NCT01427972|41792159|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490224|NCT01427972|41792160|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490225|NCT01427972|41792161|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
19490226|NCT01427738|41792198|FG000|Overall Study|Death|12|||
19490227|NCT01427738|41792199|FG001|Overall Study|Death|9|||
19490228|NCT01427738|41792198|FG000|Overall Study|Severe debilitation, unable to continue|0|||
19490229|NCT01427738|41792199|FG001|Overall Study|Severe debilitation, unable to continue|1|||
19490230|NCT01427738|41792198|FG000|Overall Study|Subject unable to get to clinic|5|||
19490231|NCT01427738|41792199|FG001|Overall Study|Subject unable to get to clinic|2|||
19490232|NCT01427738|41792198|FG000|Overall Study|Withdrawal by Subject|0|||
19490233|NCT01427738|41792199|FG001|Overall Study|Withdrawal by Subject|2|||
19490234|NCT01427738|41792198|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
19490235|NCT01427738|41792199|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
19490236|NCT01427738|41792198|FG000|Overall Study|Lost to Follow-up|1|||
19490237|NCT01427738|41792199|FG001|Overall Study|Lost to Follow-up|5|||
19490238|NCT01426958|41792205|FG000|Overall Study|Adverse Event|2|||
19490239|NCT02578992|41792383|FG000|Overall Study|equipment not available or malfunction|3|||
19490240|NCT02578992|41792384|FG001|Overall Study|equipment not available or malfunction|3|||
19490241|NCT00558519|41792448|FG000|Overall Study|Ph+|20|||
19490242|NCT00558519|41792448|FG000|Overall Study|Ineligible|1|||
19490243|NCT00558519|41792448|FG000|Overall Study|Insufficient data|1|||
19490244|NCT00558519|41792448|FG000|Overall Study|Never received treatment|1|||
19490245|NCT00558285|41792492|FG000|Overall Study|Adverse Event|1|||
19490246|NCT00558285|41792493|FG001|Overall Study|Adverse Event|1|||
19490247|NCT00558285|41792494|FG002|Overall Study|Adverse Event|4|||
19490248|NCT00558285|41792495|FG003|Overall Study|Adverse Event|1|||
19490249|NCT00558285|41792496|FG004|Overall Study|Adverse Event|2|||
19490250|NCT00558285|41792492|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19490251|NCT00558285|41792493|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19490252|NCT00558285|41792494|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19490253|NCT00558285|41792495|FG003|Overall Study|Abnormal test procedure result(s)|0|||
19490254|NCT00558285|41792496|FG004|Overall Study|Abnormal test procedure result(s)|0|||
19490255|NCT00558285|41792492|FG000|Overall Study|Subject withdrew consent|2|||
19490256|NCT00558285|41792493|FG001|Overall Study|Subject withdrew consent|0|||
19490257|NCT00558285|41792494|FG002|Overall Study|Subject withdrew consent|1|||
19490258|NCT00558285|41792495|FG003|Overall Study|Subject withdrew consent|1|||
19490259|NCT00558285|41792496|FG004|Overall Study|Subject withdrew consent|1|||
19490260|NCT00558285|41792492|FG000|Overall Study|Lost to Follow-up|1|||
19490261|NCT00558285|41792493|FG001|Overall Study|Lost to Follow-up|1|||
19490262|NCT00558285|41792494|FG002|Overall Study|Lost to Follow-up|0|||
19490263|NCT00558285|41792495|FG003|Overall Study|Lost to Follow-up|0|||
19490264|NCT00558285|41792496|FG004|Overall Study|Lost to Follow-up|0|||
19490265|NCT00558285|41792492|FG000|Overall Study|Administrative problems|0|||
19490266|NCT00558285|41792493|FG001|Overall Study|Administrative problems|0|||
19490267|NCT00558285|41792494|FG002|Overall Study|Administrative problems|0|||
19490268|NCT00558285|41792495|FG003|Overall Study|Administrative problems|1|||
19490269|NCT00558285|41792496|FG004|Overall Study|Administrative problems|1|||
19490270|NCT00558285|41792492|FG000|Overall Study|Protocol deviation|1|||
19490271|NCT00558285|41792493|FG001|Overall Study|Protocol deviation|1|||
19490272|NCT00558285|41792494|FG002|Overall Study|Protocol deviation|0|||
19490273|NCT00558285|41792495|FG003|Overall Study|Protocol deviation|1|||
19490274|NCT00558285|41792496|FG004|Overall Study|Protocol deviation|0|||
19490275|NCT01389596|41792511|FG000|Overall Study|Protocol Violation|3|||
19490276|NCT01389596|41792512|FG001|Overall Study|Protocol Violation|4|||
19490277|NCT01389596|41792513|FG002|Overall Study|Protocol Violation|3|||
19490278|NCT01389596|41792511|FG000|Overall Study|Withdrawal by Subject|1|||
19490279|NCT01389596|41792512|FG001|Overall Study|Withdrawal by Subject|2|||
19490280|NCT01389596|41792513|FG002|Overall Study|Withdrawal by Subject|2|||
19490281|NCT01389596|41792511|FG000|Overall Study|Insufficient Clinical Response|3|||
19490282|NCT01389596|41792512|FG001|Overall Study|Insufficient Clinical Response|4|||
19490283|NCT01389596|41792513|FG002|Overall Study|Insufficient Clinical Response|5|||
19490284|NCT01389596|41792511|FG000|Overall Study|Adverse Event|1|||
19490285|NCT01389596|41792512|FG001|Overall Study|Adverse Event|4|||
19490286|NCT01389596|41792513|FG002|Overall Study|Adverse Event|0|||
19490287|NCT01389596|41792511|FG000|Overall Study|Death|0|||
19490288|NCT01389596|41792512|FG001|Overall Study|Death|1|||
19490289|NCT01389596|41792513|FG002|Overall Study|Death|0|||
19490290|NCT01389596|41792511|FG000|Overall Study|Other Unspecified|2|||
19490291|NCT01389596|41792512|FG001|Overall Study|Other Unspecified|1|||
19490292|NCT01389596|41792513|FG002|Overall Study|Other Unspecified|0|||
19490293|NCT01405898|41792549|FG000|Overall Study|Withdrawal by Subject|2|||
19490294|NCT01405898|41792550|FG001|Overall Study|Withdrawal by Subject|2|||
19490295|NCT01389128|41792576|FG000|Overall Study|Fetal distress|1|||
19490296|NCT01389128|41792577|FG001|Overall Study|Fetal distress|0|||
19490297|NCT01389128|41792576|FG000|Overall Study|Cervix dilation stop|1|||
19490298|NCT01389128|41792577|FG001|Overall Study|Cervix dilation stop|2|||
19490299|NCT01389128|41792576|FG000|Overall Study|Rapid labor evolution|3|||
19490300|NCT01389128|41792577|FG001|Overall Study|Rapid labor evolution|2|||
19490301|NCT01389128|41792576|FG000|Overall Study|Intolerance to procedure|0|||
19490302|NCT01389128|41792577|FG001|Overall Study|Intolerance to procedure|2|||
19490303|NCT01388816|41792608|FG000|Overall Study|Adverse Event|0|||
19490304|NCT01388816|41792609|FG001|Overall Study|Adverse Event|2|||
19490305|NCT01388816|41792610|FG002|Overall Study|Adverse Event|0|||
19490306|NCT01388816|41792611|FG003|Overall Study|Adverse Event|0|||
19490307|NCT01388816|41792608|FG000|Overall Study|Lost to Follow-up|0|||
19490308|NCT01388816|41792609|FG001|Overall Study|Lost to Follow-up|1|||
19490309|NCT01388816|41792610|FG002|Overall Study|Lost to Follow-up|0|||
19490310|NCT01388816|41792611|FG003|Overall Study|Lost to Follow-up|0|||
19490311|NCT01388816|41792608|FG000|Overall Study|Withdrawal by Subject|2|||
19490312|NCT01388816|41792609|FG001|Overall Study|Withdrawal by Subject|1|||
19490313|NCT01388816|41792610|FG002|Overall Study|Withdrawal by Subject|1|||
19490314|NCT01388816|41792611|FG003|Overall Study|Withdrawal by Subject|0|||
19490315|NCT01388816|41792608|FG000|Overall Study|Protocol Violation|0|||
19490316|NCT01388816|41792609|FG001|Overall Study|Protocol Violation|0|||
19490317|NCT01388816|41792610|FG002|Overall Study|Protocol Violation|2|||
19490318|NCT01388816|41792611|FG003|Overall Study|Protocol Violation|0|||
19490319|NCT00555477|41792765|FG000|Overall Study|Adverse Event|0|||
19490320|NCT00555477|41792766|FG001|Overall Study|Adverse Event|9|||
19490321|NCT00555477|41792765|FG000|Overall Study|Withdrawal by Subject|1|||
19490322|NCT00555477|41792766|FG001|Overall Study|Withdrawal by Subject|2|||
19490323|NCT00555477|41792765|FG000|Overall Study|Physician Decision|1|||
19490324|NCT00555477|41792766|FG001|Overall Study|Physician Decision|2|||
19490325|NCT00554619|41792783|FG000|Overall Study|Adverse Event|1|||
19490326|NCT00554619|41792783|FG000|Overall Study|Physician Decision|1|||
19490327|NCT00554619|41792783|FG000|Overall Study|Liver Function Test Abnormality|1|||
19490328|NCT01426412|41792843|FG000|Overall Study|Withdrawal by Subject|1|||
19490329|NCT01426412|41792844|FG001|Overall Study|Withdrawal by Subject|0|||
19490330|NCT01426412|41792845|FG002|Overall Study|Withdrawal by Subject|0|||
19490331|NCT01426412|41792846|FG003|Overall Study|Withdrawal by Subject|0|||
19490332|NCT01426412|41792847|FG004|Overall Study|Withdrawal by Subject|1|||
19490333|NCT01426412|41792848|FG005|Overall Study|Withdrawal by Subject|0|||
19490334|NCT01426412|41792849|FG006|Overall Study|Withdrawal by Subject|0|||
19490335|NCT01426412|41792850|FG007|Overall Study|Withdrawal by Subject|3|||
19490336|NCT01426412|41792851|FG008|Overall Study|Withdrawal by Subject|1|||
19490337|NCT00554229|41793046|FG000|Overall Study|Lost to Follow-up|3|||
19490338|NCT00554229|41793047|FG001|Overall Study|Lost to Follow-up|6|||
19490339|NCT00554229|41793046|FG000|Overall Study|Withdrawal by Subject|29|||
19490340|NCT00554229|41793047|FG001|Overall Study|Withdrawal by Subject|37|||
19490341|NCT00554229|41793046|FG000|Overall Study|Adverse Event|71|||
19490342|NCT00554229|41793047|FG001|Overall Study|Adverse Event|39|||
19704288|NCT00254982|42148594|FG000|Overall Study|Protocol deviation|1|||
19704289|NCT00254982|42148595|FG001|Overall Study|Protocol deviation|1|||
19704290|NCT00254982|42148594|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
19704291|NCT00254982|42148595|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
19704292|NCT00254982|42148594|FG000|Overall Study|Malignancy|0|||
19613102|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
19613103|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
19490343|NCT00554229|41793046|FG000|Overall Study|Protocol Violation|3|||
19490344|NCT00554229|41793047|FG001|Overall Study|Protocol Violation|3|||
19490345|NCT00554229|41793046|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
19490346|NCT00554229|41793047|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
19490347|NCT00554229|41793046|FG000|Overall Study|Randomised but no treatment received|1|||
19490348|NCT00554229|41793047|FG001|Overall Study|Randomised but no treatment received|0|||
19490349|NCT05065983|41793127|FG000|Overall Study|Lost to Follow-up|2|||
19490350|NCT01405820|41793161|FG000|Randomized Treatment Period|Adverse Event|3|||
19490351|NCT01405820|41793162|FG001|Randomized Treatment Period|Adverse Event|3|||
19490352|NCT01405820|41793163|FG002|Randomized Treatment Period|Adverse Event|3|||
19490353|NCT01405820|41793164|FG003|Randomized Treatment Period|Adverse Event|0|||
19490354|NCT01405820|41793165|FG004|Randomized Treatment Period|Adverse Event|2|||
19490355|NCT01405820|41793166|FG005|Randomized Treatment Period|Adverse Event|1|||
19490356|NCT01405820|41793161|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
19490357|NCT01405820|41793162|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
19490358|NCT01405820|41793163|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
19490359|NCT01405820|41793164|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
19613104|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
19704293|NCT00254982|42148595|FG001|Overall Study|Malignancy|2|||
19373670|NCT02760407|41614835|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
19490360|NCT01405820|41793165|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
19490361|NCT01405820|41793166|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
19490362|NCT01405820|41793161|FG000|Randomized Treatment Period|Other|2|||
19490363|NCT01405820|41793162|FG001|Randomized Treatment Period|Other|2|||
19490364|NCT01405820|41793163|FG002|Randomized Treatment Period|Other|1|||
19490365|NCT01405820|41793164|FG003|Randomized Treatment Period|Other|1|||
19490366|NCT01405820|41793165|FG004|Randomized Treatment Period|Other|0|||
19490367|NCT01405820|41793166|FG005|Randomized Treatment Period|Other|0|||
19490368|NCT01405820|41793161|FG000|Randomized Treatment Period|Physician Decision|0|||
19490369|NCT01405820|41793162|FG001|Randomized Treatment Period|Physician Decision|2|||
19490370|NCT01405820|41793163|FG002|Randomized Treatment Period|Physician Decision|1|||
19490371|NCT01405820|41793164|FG003|Randomized Treatment Period|Physician Decision|0|||
19490372|NCT01405820|41793165|FG004|Randomized Treatment Period|Physician Decision|0|||
19490373|NCT01405820|41793166|FG005|Randomized Treatment Period|Physician Decision|0|||
19490374|NCT01405820|41793161|FG000|Randomized Treatment Period|Rescue|0|||
19490375|NCT01405820|41793162|FG001|Randomized Treatment Period|Rescue|1|||
19490376|NCT01405820|41793163|FG002|Randomized Treatment Period|Rescue|13|||
19490377|NCT01405820|41793164|FG003|Randomized Treatment Period|Rescue|10|||
19490378|NCT01405820|41793165|FG004|Randomized Treatment Period|Rescue|8|||
19490379|NCT01405820|41793166|FG005|Randomized Treatment Period|Rescue|8|||
19393536|NCT01938430|41637421|FG007|Overall Study|Adverse Event|0|||
19490380|NCT01405820|41793161|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
19490381|NCT01405820|41793162|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
19490382|NCT01405820|41793163|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
19490383|NCT01405820|41793164|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
19490384|NCT01405820|41793165|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
19490385|NCT01405820|41793166|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
19490386|NCT01405820|41793161|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
19490387|NCT01405820|41793162|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
19490388|NCT01405820|41793163|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
19490389|NCT01405820|41793164|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
19490390|NCT01405820|41793165|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
19490391|NCT01405820|41793166|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
19490392|NCT01405820|41793161|FG000|Randomized Treatment Period|Death|0|||
19490393|NCT01405820|41793162|FG001|Randomized Treatment Period|Death|0|||
19490394|NCT01405820|41793163|FG002|Randomized Treatment Period|Death|0|||
19490395|NCT01405820|41793164|FG003|Randomized Treatment Period|Death|1|||
19490396|NCT01405820|41793165|FG004|Randomized Treatment Period|Death|0|||
19490397|NCT01405820|41793166|FG005|Randomized Treatment Period|Death|0|||
19490398|NCT01405820|41793161|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
19490399|NCT01405820|41793162|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
19490400|NCT01405820|41793163|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
19490401|NCT01405820|41793164|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
19490402|NCT01405820|41793165|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
19490403|NCT01405820|41793166|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
19490404|NCT01405820|41793161|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
19490405|NCT01405820|41793162|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
19490406|NCT01405820|41793163|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
19490407|NCT01405820|41793164|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
19490408|NCT01405820|41793165|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
19490409|NCT01405820|41793166|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
19490410|NCT01405820|41793161|FG000|Open-Label Treatment Period|Other|1|||
19490411|NCT01405820|41793162|FG001|Open-Label Treatment Period|Other|1|||
19490412|NCT01405820|41793163|FG002|Open-Label Treatment Period|Other|1|||
19490413|NCT01405820|41793164|FG003|Open-Label Treatment Period|Other|1|||
19490414|NCT01405820|41793165|FG004|Open-Label Treatment Period|Other|1|||
19490415|NCT01405820|41793166|FG005|Open-Label Treatment Period|Other|1|||
19490416|NCT01405820|41793161|FG000|Open-Label Treatment Period|Physician Decision|0|||
19490417|NCT01405820|41793162|FG001|Open-Label Treatment Period|Physician Decision|0|||
19490418|NCT01405820|41793163|FG002|Open-Label Treatment Period|Physician Decision|1|||
19490419|NCT01405820|41793164|FG003|Open-Label Treatment Period|Physician Decision|2|||
19490420|NCT01405820|41793165|FG004|Open-Label Treatment Period|Physician Decision|1|||
19490421|NCT01405820|41793166|FG005|Open-Label Treatment Period|Physician Decision|0|||
19490422|NCT01405820|41793161|FG000|Open-Label Treatment Period|Adverse Event|0|||
19490423|NCT01405820|41793162|FG001|Open-Label Treatment Period|Adverse Event|0|||
19490424|NCT01405820|41793163|FG002|Open-Label Treatment Period|Adverse Event|0|||
19490425|NCT01405820|41793164|FG003|Open-Label Treatment Period|Adverse Event|1|||
19490426|NCT01405820|41793165|FG004|Open-Label Treatment Period|Adverse Event|0|||
19490427|NCT01405820|41793166|FG005|Open-Label Treatment Period|Adverse Event|0|||
19490428|NCT01405742|41793195|FG000|Overall Study|Lost to Follow-up|1|||
19490429|NCT01405742|41793196|FG001|Overall Study|Lost to Follow-up|0|||
19490430|NCT01425632|41793225|FG000|Overall Study|Adverse Event|0|||
19490431|NCT01425632|41793226|FG001|Overall Study|Adverse Event|1|||
19490432|NCT01425632|41793227|FG002|Overall Study|Adverse Event|1|||
19490433|NCT01425632|41793225|FG000|Overall Study|Physician Decision|1|||
19490434|NCT01425632|41793226|FG001|Overall Study|Physician Decision|0|||
19490435|NCT01425632|41793227|FG002|Overall Study|Physician Decision|0|||
19490436|NCT01425632|41793225|FG000|Overall Study|Protocol Violation|0|||
19490437|NCT01425632|41793226|FG001|Overall Study|Protocol Violation|0|||
19490438|NCT01425632|41793227|FG002|Overall Study|Protocol Violation|2|||
19613105|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
19393537|NCT01938430|41637422|FG008|Overall Study|Adverse Event|0|||
19393538|NCT01938430|41637423|FG009|Overall Study|Adverse Event|0|||
19393539|NCT01938430|41637424|FG010|Overall Study|Adverse Event|0|||
19393540|NCT01938430|41637425|FG011|Overall Study|Adverse Event|0|||
19393541|NCT01938430|41637426|FG012|Overall Study|Adverse Event|0|||
19393542|NCT01938430|41637427|FG013|Overall Study|Adverse Event|0|||
19393543|NCT01938430|41637414|FG000|Overall Study|Death|1|||
19393544|NCT01938430|41637415|FG001|Overall Study|Death|2|||
19393545|NCT01938430|41637416|FG002|Overall Study|Death|2|||
19490439|NCT01425632|41793225|FG000|Overall Study|Withdrawal by Subject|0|||
19490440|NCT01425632|41793226|FG001|Overall Study|Withdrawal by Subject|0|||
19490441|NCT01425632|41793227|FG002|Overall Study|Withdrawal by Subject|1|||
19490442|NCT01405508|41793264|FG000|Overall Study|AE, non-serious non-fatal|1|||
19490443|NCT01405508|41793265|FG001|Overall Study|AE, non-serious non-fatal|1|||
19490444|NCT01405508|41793266|FG002|Overall Study|AE, non-serious non-fatal|0|||
19490445|NCT01405508|41793267|FG003|Overall Study|AE, non-serious non-fatal|0|||
19490446|NCT01405196|41793403|FG000|Overall Study|Study Terminated by Sponsor|0|||
19490447|NCT01405196|41793404|FG001|Overall Study|Study Terminated by Sponsor|0|||
19490448|NCT01405196|41793405|FG002|Overall Study|Study Terminated by Sponsor|9|||
19490449|NCT01405196|41793406|FG003|Overall Study|Study Terminated by Sponsor|0|||
19490450|NCT01405196|41793403|FG000|Overall Study|Other|2|||
19490451|NCT01405196|41793404|FG001|Overall Study|Other|2|||
19490452|NCT01405196|41793405|FG002|Overall Study|Other|5|||
19490453|NCT01405196|41793406|FG003|Overall Study|Other|0|||
19490454|NCT01405196|41793403|FG000|Overall Study|Withdrawal by Subject|4|||
19490455|NCT01405196|41793404|FG001|Overall Study|Withdrawal by Subject|6|||
19490456|NCT01405196|41793405|FG002|Overall Study|Withdrawal by Subject|3|||
19490457|NCT01405196|41793406|FG003|Overall Study|Withdrawal by Subject|6|||
19490458|NCT01405196|41793403|FG000|Overall Study|Adverse Event|2|||
19490459|NCT01405196|41793404|FG001|Overall Study|Adverse Event|2|||
19490460|NCT01405196|41793405|FG002|Overall Study|Adverse Event|0|||
19490461|NCT01405196|41793406|FG003|Overall Study|Adverse Event|2|||
19490462|NCT01405196|41793403|FG000|Overall Study|Death|1|||
19490463|NCT01405196|41793404|FG001|Overall Study|Death|0|||
19490464|NCT01405196|41793405|FG002|Overall Study|Death|3|||
19490465|NCT01405196|41793406|FG003|Overall Study|Death|0|||
19490466|NCT01405196|41793403|FG000|Overall Study|Lost to Follow-up|2|||
19490467|NCT01405196|41793404|FG001|Overall Study|Lost to Follow-up|2|||
19490468|NCT01405196|41793405|FG002|Overall Study|Lost to Follow-up|3|||
19490469|NCT01405196|41793406|FG003|Overall Study|Lost to Follow-up|1|||
19490470|NCT01402700|41793456|FG000|Overall Study|Death|3|||
19490471|NCT01402700|41793456|FG000|Overall Study|Withdrawal by Subject|3|||
19490472|NCT01402700|41793456|FG000|Overall Study|Missed Visit|1|||
19490473|NCT01424930|41793578|FG000|Overall Study|Adverse Event|0|||
19490474|NCT01424930|41793579|FG001|Overall Study|Adverse Event|1|||
19490475|NCT01424930|41793578|FG000|Overall Study|Death|1|||
19490476|NCT01424930|41793579|FG001|Overall Study|Death|0|||
19490477|NCT01424930|41793578|FG000|Overall Study|Progressive Disease|3|||
19490478|NCT01424930|41793579|FG001|Overall Study|Progressive Disease|6|||
19490479|NCT01424930|41793578|FG000|Overall Study|Screen Failure|0|||
19490480|NCT01424930|41793579|FG001|Overall Study|Screen Failure|1|||
19490481|NCT01424930|41793578|FG000|Overall Study|Reason not specified|0|||
19490482|NCT01424930|41793579|FG001|Overall Study|Reason not specified|6|||
19490483|NCT01424306|41793594|FG000|Overall Study|Protocol Violation|0|||
19490484|NCT01424306|41793595|FG001|Overall Study|Protocol Violation|0|||
19490485|NCT01424306|41793596|FG002|Overall Study|Protocol Violation|0|||
19490486|NCT01424306|41793597|FG003|Overall Study|Protocol Violation|0|||
19490487|NCT01424306|41793598|FG004|Overall Study|Protocol Violation|1|||
19490488|NCT01424306|41793599|FG005|Overall Study|Protocol Violation|0|||
19490489|NCT01424228|41793643|FG000|Overall Study|Withdrawal by Subject|27|||
19490490|NCT01424228|41793644|FG001|Overall Study|Withdrawal by Subject|11|||
19490491|NCT01424228|41793643|FG000|Overall Study|Adverse Event|10|||
19490492|NCT01424228|41793644|FG001|Overall Study|Adverse Event|14|||
19490493|NCT01424228|41793643|FG000|Overall Study|Sponsor's decision|9|||
19490494|NCT01424228|41793644|FG001|Overall Study|Sponsor's decision|12|||
19490495|NCT01424228|41793643|FG000|Overall Study|Lack of Efficacy|5|||
19490496|NCT01424228|41793644|FG001|Overall Study|Lack of Efficacy|7|||
19490497|NCT01424228|41793643|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
19490498|NCT01424228|41793644|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
19490499|NCT01424228|41793643|FG000|Overall Study|Non-compliance|2|||
19490500|NCT01424228|41793644|FG001|Overall Study|Non-compliance|0|||
19490501|NCT01424228|41793643|FG000|Overall Study|Worsening of symptoms|1|||
19490502|NCT01424228|41793644|FG001|Overall Study|Worsening of symptoms|0|||
19490503|NCT01424228|41793643|FG000|Overall Study|Unplanned journey|0|||
19490504|NCT01424228|41793644|FG001|Overall Study|Unplanned journey|1|||
19490505|NCT01423916|41793653|FG000|Overall Study|Adverse Event|5|||
19490506|NCT01423916|41793654|FG001|Overall Study|Adverse Event|9|||
19490507|NCT01423916|41793655|FG002|Overall Study|Adverse Event|2|||
19490508|NCT01423916|41793653|FG000|Overall Study|Met Withdrawal Criteria|1|||
19490509|NCT01423916|41793654|FG001|Overall Study|Met Withdrawal Criteria|1|||
19490510|NCT01423916|41793655|FG002|Overall Study|Met Withdrawal Criteria|1|||
19490511|NCT01423916|41793653|FG000|Overall Study|Physician Decision|1|||
19490512|NCT01423916|41793654|FG001|Overall Study|Physician Decision|0|||
19490513|NCT01423916|41793655|FG002|Overall Study|Physician Decision|1|||
19490514|NCT01423916|41793653|FG000|Overall Study|Withdrawal by Subject|3|||
19490515|NCT01423916|41793654|FG001|Overall Study|Withdrawal by Subject|10|||
19490516|NCT01423916|41793655|FG002|Overall Study|Withdrawal by Subject|3|||
19490517|NCT01423916|41793653|FG000|Overall Study|Protocol Deviation|1|||
19490518|NCT01423916|41793654|FG001|Overall Study|Protocol Deviation|0|||
19490519|NCT01423916|41793655|FG002|Overall Study|Protocol Deviation|0|||
19490520|NCT01423604|41793774|FG000|Safety Run-In|Adverse Event|3|||
19490521|NCT01423604|41793775|FG001|Safety Run-In|Adverse Event|0|||
19490522|NCT01423604|41793774|FG000|Safety Run-In|Death|1|||
19490523|NCT01423604|41793775|FG001|Safety Run-In|Death|0|||
19490524|NCT01423604|41793774|FG000|Safety Run-In|Physician Decision|1|||
19490525|NCT01423604|41793775|FG001|Safety Run-In|Physician Decision|0|||
19490526|NCT01423604|41793774|FG000|Safety Run-In|Disease progression|3|||
19490527|NCT01423604|41793775|FG001|Safety Run-In|Disease progression|0|||
19490528|NCT01423604|41793774|FG000|Safety Run-In|Patient decision|1|||
19490529|NCT01423604|41793775|FG001|Safety Run-In|Patient decision|0|||
19490530|NCT01423604|41793774|FG000|Randomized|Adverse Event|4|||
19490531|NCT01423604|41793775|FG001|Randomized|Adverse Event|10|||
19490532|NCT01423604|41793774|FG000|Randomized|Death|1|||
19490533|NCT01423604|41793775|FG001|Randomized|Death|0|||
19490534|NCT01423604|41793774|FG000|Randomized|Physician Decision|16|||
19490535|NCT01423604|41793775|FG001|Randomized|Physician Decision|13|||
19490536|NCT01423604|41793774|FG000|Randomized|Other - unspecified|37|||
19490537|NCT01423604|41793775|FG001|Randomized|Other - unspecified|31|||
19490538|NCT01423604|41793774|FG000|Randomized|Patient decision|5|||
19490539|NCT01423604|41793775|FG001|Randomized|Patient decision|9|||
19490540|NCT01402544|41793791|FG000|Overall Study|Withdrawal by Subject|6|||
19490541|NCT01401842|41793797|FG000|Overall Study|Withdrawal by Subject|3|||
19490542|NCT01401842|41793798|FG001|Overall Study|Withdrawal by Subject|2|||
19490543|NCT01401842|41793797|FG000|Overall Study|academic reason|4|||
19490544|NCT01401842|41793798|FG001|Overall Study|academic reason|1|||
19490545|NCT01401842|41793797|FG000|Overall Study|changed companies|20|||
19490546|NCT01401842|41793798|FG001|Overall Study|changed companies|34|||
19490547|NCT01401842|41793797|FG000|Overall Study|discharged from US Army|3|||
19490548|NCT01401842|41793798|FG001|Overall Study|discharged from US Army|4|||
19490549|NCT01401842|41793797|FG000|Overall Study|invalid follow-up strength data|1|||
19490550|NCT01401842|41793798|FG001|Overall Study|invalid follow-up strength data|4|||
19490551|NCT01401842|41793797|FG000|Overall Study|on profile|9|||
19490552|NCT01401842|41793798|FG001|Overall Study|on profile|5|||
19490553|NCT01401842|41793797|FG000|Overall Study|other/unknown|28|||
19490554|NCT01401842|41793798|FG001|Overall Study|other/unknown|17|||
19490555|NCT01422824|41793804|FG000|Overall Study|Case record form not evaluated|1|||
19490556|NCT01422824|41793804|FG000|Overall Study|Lost to Follow-up|37|||
19490557|NCT01401530|41793867|FG000|Overall Study|Disease Progression|1|||
19490558|NCT01401530|41793868|FG001|Overall Study|Disease Progression|2|||
19490559|NCT01401530|41793869|FG002|Overall Study|Disease Progression|1|||
19490560|NCT01401530|41793867|FG000|Overall Study|Adverse Event|1|||
19490561|NCT01401530|41793868|FG001|Overall Study|Adverse Event|1|||
19490562|NCT01401530|41793869|FG002|Overall Study|Adverse Event|1|||
19490563|NCT01401530|41793867|FG000|Overall Study|Participant Choice|1|||
19490564|NCT01401530|41793868|FG001|Overall Study|Participant Choice|2|||
19490565|NCT01401530|41793869|FG002|Overall Study|Participant Choice|1|||
19490566|NCT01401530|41793867|FG000|Overall Study|Physician Decision|0|||
19490567|NCT01401530|41793868|FG001|Overall Study|Physician Decision|1|||
19490568|NCT01401530|41793869|FG002|Overall Study|Physician Decision|0|||
19613106|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
19613107|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
19613108|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
19613109|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
19613110|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
19613111|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
19613112|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
19613113|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
19613114|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
19613115|NCT00611455|42061969|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
19613116|NCT00611455|42061970|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
19613117|NCT00611455|42061971|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
19613118|NCT00952289|42061983|FG000|All Participants|Death|9|||
19613119|NCT00952289|42061984|FG001|All Participants|Death|9|||
19613120|NCT00952289|42061983|FG000|All Participants|Adverse Event|8|||
19613121|NCT00952289|42061984|FG001|All Participants|Adverse Event|8|||
19613122|NCT00952289|42061983|FG000|All Participants|Disease progression|3|||
19613123|NCT00952289|42061984|FG001|All Participants|Disease progression|12|||
19393546|NCT01938430|41637417|FG003|Overall Study|Death|1|||
19393547|NCT01938430|41637418|FG004|Overall Study|Death|0|||
19393548|NCT01938430|41637419|FG005|Overall Study|Death|0|||
19393549|NCT01938430|41637420|FG006|Overall Study|Death|1|||
19393550|NCT01938430|41637421|FG007|Overall Study|Death|1|||
19393551|NCT01938430|41637422|FG008|Overall Study|Death|2|||
19613124|NCT00952289|42061983|FG000|All Participants|Withdrawal by Subject|1|||
19613125|NCT00952289|42061984|FG001|All Participants|Withdrawal by Subject|10|||
19613126|NCT00952289|42061983|FG000|All Participants|Data lost during site relocation|0|||
19613127|NCT00952289|42061984|FG001|All Participants|Data lost during site relocation|1|||
19613128|NCT00952289|42061983|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
19393552|NCT01938430|41637423|FG009|Overall Study|Death|3|||
19393553|NCT01938430|41637424|FG010|Overall Study|Death|0|||
19393554|NCT01938430|41637425|FG011|Overall Study|Death|0|||
19490569|NCT01387022|41793881|FG000|Overall Study|Death|1|||
19613129|NCT00952289|42061984|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
19613130|NCT00952289|42061983|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
19613131|NCT00952289|42061984|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
19613132|NCT00952289|42061983|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
19613133|NCT00952289|42061984|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
19613134|NCT00952289|42061983|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
19613135|NCT00952289|42061984|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
19613136|NCT00952289|42061983|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
19613137|NCT00952289|42061984|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
19613138|NCT00947531|42061992|FG000|Overall Study|Withdrawal by Subject|10|||
19613139|NCT00947531|42061993|FG001|Overall Study|Withdrawal by Subject|7|||
19613140|NCT00947531|42061992|FG000|Overall Study|Administrative Reason|0|||
19613141|NCT00947531|42061993|FG001|Overall Study|Administrative Reason|1|||
19613142|NCT00947531|42061992|FG000|Overall Study|Adverse Event|2|||
19613143|NCT00947531|42061993|FG001|Overall Study|Adverse Event|2|||
19613144|NCT00947531|42061992|FG000|Overall Study|Lack of Efficacy|1|||
19613145|NCT00947531|42061993|FG001|Overall Study|Lack of Efficacy|0|||
19613146|NCT00947531|42061992|FG000|Overall Study|Other|1|||
19613147|NCT00947531|42061993|FG001|Overall Study|Other|1|||
19613148|NCT00612313|42062001|FG000|Overall Study|Withdrawal by Subject|6|||
19613149|NCT00612313|42062002|FG001|Overall Study|Withdrawal by Subject|9|||
19613150|NCT00612313|42062001|FG000|Overall Study|Lost to Follow-up|11|||
19613151|NCT00612313|42062002|FG001|Overall Study|Lost to Follow-up|4|||
19613152|NCT00890552|42062014|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
19613153|NCT00890552|42062014|FG000|On-treatment|Early prog disease/ death|10|||
19613154|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
19613155|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
19613156|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
19613157|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
19613158|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
19613159|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
19613160|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
19613161|NCT00946985|42062018|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
19613162|NCT00946985|42062018|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
19613163|NCT00611923|42062024|FG000|Overall Study|Withdrawal by Subject|2|||
19613164|NCT00611923|42062025|FG001|Overall Study|Withdrawal by Subject|2|||
19613165|NCT00609973|42062035|FG000|Overall Study|Adverse Event|2|||
19613166|NCT00609973|42062036|FG001|Overall Study|Adverse Event|1|||
19613167|NCT00609973|42062035|FG000|Overall Study|Protocol Violation|4|||
19613168|NCT00609973|42062036|FG001|Overall Study|Protocol Violation|3|||
19613169|NCT00609973|42062035|FG000|Overall Study|Lost to Follow-up|2|||
19613170|NCT00609973|42062036|FG001|Overall Study|Lost to Follow-up|1|||
19613171|NCT00609973|42062035|FG000|Overall Study|Withdrawal by Subject|0|||
19613172|NCT00609973|42062036|FG001|Overall Study|Withdrawal by Subject|1|||
19613173|NCT00803049|42062046|FG000|Overall Study|Adverse Event|21|||
19613174|NCT00803049|42062047|FG001|Overall Study|Adverse Event|33|||
19613175|NCT00803049|42062048|FG002|Overall Study|Adverse Event|13|||
19613176|NCT00803049|42062049|FG003|Overall Study|Adverse Event|27|||
19613177|NCT00803049|42062046|FG000|Overall Study|Lack of Efficacy|10|||
19613178|NCT00803049|42062047|FG001|Overall Study|Lack of Efficacy|19|||
19613179|NCT00803049|42062048|FG002|Overall Study|Lack of Efficacy|6|||
19613180|NCT00803049|42062049|FG003|Overall Study|Lack of Efficacy|13|||
19613181|NCT00803049|42062046|FG000|Overall Study|Lost to Follow-up|0|||
19613182|NCT00803049|42062047|FG001|Overall Study|Lost to Follow-up|2|||
19613183|NCT00803049|42062048|FG002|Overall Study|Lost to Follow-up|0|||
19613184|NCT00803049|42062049|FG003|Overall Study|Lost to Follow-up|3|||
19613185|NCT00803049|42062046|FG000|Overall Study|Death|2|||
19613186|NCT00803049|42062047|FG001|Overall Study|Death|1|||
19613187|NCT00803049|42062048|FG002|Overall Study|Death|0|||
19613188|NCT00803049|42062049|FG003|Overall Study|Death|2|||
19613189|NCT00803049|42062046|FG000|Overall Study|Progressive Disease|6|||
19613190|NCT00803049|42062047|FG001|Overall Study|Progressive Disease|10|||
19613191|NCT00803049|42062048|FG002|Overall Study|Progressive Disease|6|||
19613192|NCT00803049|42062049|FG003|Overall Study|Progressive Disease|6|||
19613193|NCT00803049|42062046|FG000|Overall Study|Withdrawal by Subject|19|||
19613194|NCT00803049|42062047|FG001|Overall Study|Withdrawal by Subject|43|||
19613195|NCT00803049|42062048|FG002|Overall Study|Withdrawal by Subject|16|||
19613196|NCT00803049|42062049|FG003|Overall Study|Withdrawal by Subject|44|||
19613197|NCT00803049|42062046|FG000|Overall Study|Protocol Violation|0|||
19613198|NCT00803049|42062047|FG001|Overall Study|Protocol Violation|1|||
19613199|NCT00803049|42062048|FG002|Overall Study|Protocol Violation|1|||
19613200|NCT00803049|42062049|FG003|Overall Study|Protocol Violation|0|||
19613201|NCT00803049|42062046|FG000|Overall Study|Randomized and Not Treated|0|||
19613202|NCT00803049|42062047|FG001|Overall Study|Randomized and Not Treated|0|||
19613203|NCT00803049|42062048|FG002|Overall Study|Randomized and Not Treated|0|||
19613204|NCT00803049|42062049|FG003|Overall Study|Randomized and Not Treated|2|||
19613205|NCT00803049|42062046|FG000|Overall Study|Other than Specified Above|3|||
19613206|NCT00803049|42062047|FG001|Overall Study|Other than Specified Above|9|||
19613207|NCT00803049|42062048|FG002|Overall Study|Other than Specified Above|2|||
19613208|NCT00803049|42062049|FG003|Overall Study|Other than Specified Above|5|||
19490570|NCT01387022|41793882|FG001|Overall Study|Death|1|||
19490571|NCT01387022|41793881|FG000|Overall Study|Lost to Follow-up|0|||
19490572|NCT01387022|41793882|FG001|Overall Study|Lost to Follow-up|3|||
19490573|NCT01386944|41793908|FG000|Overall Study|Adverse Event|26|||
19490574|NCT01386944|41793908|FG000|Overall Study|Lack of Efficacy|14|||
19490575|NCT01386944|41793908|FG000|Overall Study|Lost to Follow-up|8|||
19490576|NCT01386944|41793908|FG000|Overall Study|Unspecified reason|8|||
19490577|NCT01386788|41793919|FG000|Overall Study|Lost to Follow-up|2|||
19490578|NCT01386554|41793984|FG000|Overall Study|Lost to Follow-up|0|||
19490579|NCT01386554|41793985|FG001|Overall Study|Lost to Follow-up|0|||
19490580|NCT01386554|41793986|FG002|Overall Study|Lost to Follow-up|1|||
19490581|NCT01386554|41793984|FG000|Overall Study|Adverse Event|2|||
19490582|NCT01386554|41793985|FG001|Overall Study|Adverse Event|5|||
19490583|NCT01386554|41793986|FG002|Overall Study|Adverse Event|2|||
19613209|NCT00890084|42062059|FG000|Overall Study|Adverse Event|16|||
19613210|NCT00890084|42062059|FG000|Overall Study|Lost to Follow-up|126|||
19613211|NCT00802893|42062072|FG000|Overall Study|study terminated|3|||
19613212|NCT00608569|42062093|FG000|Overall Study|Death|4|||
19613213|NCT00608569|42062094|FG001|Overall Study|Death|3|||
19613214|NCT00608569|42062093|FG000|Overall Study|Lost to Follow-up|4|||
19613215|NCT00608569|42062094|FG001|Overall Study|Lost to Follow-up|5|||
19613216|NCT00608569|42062093|FG000|Overall Study|Withdrawal by Subject|1|||
19613217|NCT00608569|42062094|FG001|Overall Study|Withdrawal by Subject|0|||
19490584|NCT01386554|41793984|FG000|Overall Study|Progressive disease|1|||
19490585|NCT01386554|41793985|FG001|Overall Study|Progressive disease|2|||
19490586|NCT01386554|41793986|FG002|Overall Study|Progressive disease|2|||
19490587|NCT01386554|41793984|FG000|Overall Study|Administration of live vaccines|0|||
19490588|NCT01386554|41793985|FG001|Overall Study|Administration of live vaccines|1|||
19490589|NCT01386554|41793986|FG002|Overall Study|Administration of live vaccines|0|||
19490590|NCT01386554|41793984|FG000|Overall Study|Investigator discretion|0|||
19490591|NCT01386554|41793985|FG001|Overall Study|Investigator discretion|0|||
19490592|NCT01386554|41793986|FG002|Overall Study|Investigator discretion|1|||
19490593|NCT01386554|41793984|FG000|Overall Study|Reason not collected|0|||
19490594|NCT01386554|41793985|FG001|Overall Study|Reason not collected|1|||
19490595|NCT01386554|41793986|FG002|Overall Study|Reason not collected|0|||
19490596|NCT01386008|41794011|FG000|Overall Study|exited w/o incident /study discontinued|17|||
19490597|NCT01386008|41794011|FG000|Overall Study|Adverse Event|3|||
19490598|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
19490599|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
19490600|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
19490601|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
19490602|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
19490603|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
19490604|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
19490605|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
19490606|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
19490607|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
19490608|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
19490609|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
19490610|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
19490611|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
19490612|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
19490613|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
19490614|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
19490615|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
19490616|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
19490617|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
19490618|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
19490619|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
19490620|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
19490621|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
19490622|NCT01421342|41794168|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
19490623|NCT01421342|41794169|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
19490624|NCT01421342|41794170|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
19613218|NCT00608569|42062093|FG000|Overall Study|Adverse Event|1|||
19613219|NCT00608569|42062094|FG001|Overall Study|Adverse Event|0|||
19613220|NCT00608569|42062093|FG000|Overall Study|Unable to adhere with study requirements|0|||
19490625|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
19490626|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
19490627|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
19490628|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
19490629|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
19490630|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
19490631|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
19490632|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
19490633|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
19490634|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
19490635|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
19490636|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
19490637|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
19490638|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
19490639|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
19490640|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
19490641|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
19490642|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
19490643|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
19490644|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
19490645|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
19490646|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
19490647|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
19490648|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
19490649|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
19490650|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
19490651|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
19490652|NCT01421342|41794168|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
19490653|NCT01421342|41794169|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
19490654|NCT01421342|41794170|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
19490655|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
19490656|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
19490657|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
19490658|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
19490659|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
19490660|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
19490661|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
19490662|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
19490663|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
19490664|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
19490665|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
19490666|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
19490667|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
19490668|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
19490669|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
19490670|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
19490671|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
19490672|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
19490673|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
19490674|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
19490675|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
19490676|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
19613221|NCT00608569|42062094|FG001|Overall Study|Unable to adhere with study requirements|1|||
19613222|NCT00610675|42062100|FG000|Overall Study|Untreated|4|||
19613223|NCT00610675|42062100|FG000|Overall Study|Adverse Event|67|||
19613224|NCT00610675|42062100|FG000|Overall Study|Insufficient Effect|31|||
19613225|NCT00610675|42062100|FG000|Overall Study|Withdrawal by Subject|28|||
19613226|NCT00610675|42062100|FG000|Overall Study|Reasons unrelated to trial|27|||
19613227|NCT00610675|42062100|FG000|Overall Study|Lack of Compliance|7|||
19613228|NCT00610675|42062100|FG000|Overall Study|Lost to Follow-up|31|||
19613229|NCT00610675|42062100|FG000|Overall Study|Other reason (not specified)|25|||
19613230|NCT00888134|42062104|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
19613231|NCT00888134|42062104|FG000|Follow-up|being followed for long-term survival|1|||
19613232|NCT00573157|42062111|FG000|Overall Study|Adverse Event|3|||
19613233|NCT00573157|42062112|FG001|Overall Study|Adverse Event|1|||
19490677|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
19490678|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
19490679|NCT01421342|41794168|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
19490680|NCT01421342|41794169|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
19490681|NCT01421342|41794170|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
19490682|NCT01384760|41794193|FG000|Overall Study|Lost to Follow-up|0|||
19490683|NCT01384760|41794194|FG001|Overall Study|Lost to Follow-up|6|||
19490684|NCT01384760|41794193|FG000|Overall Study|Protocol Violation|16|||
19490685|NCT01384760|41794194|FG001|Overall Study|Protocol Violation|0|||
19490686|NCT01384292|41794234|FG000|Part B|Severe non-compliance to protocol|1|||
19490687|NCT01384292|41794235|FG001|Part B|Severe non-compliance to protocol|0|||
19490688|NCT01384292|41794236|FG002|Part B|Severe non-compliance to protocol|0|||
19490689|NCT01401452|41794246|FG000|Overall Study|Adverse reaction|9|||
19490690|NCT01401452|41794246|FG000|Overall Study|Lost to Follow-up|12|||
19490691|NCT01401452|41794246|FG000|Overall Study|Lack of Efficacy|30|||
19490692|NCT01401452|41794246|FG000|Overall Study|Participant developed breast cancer|1|||
19490693|NCT01401452|41794246|FG000|Overall Study|Tx stopped due to financial reasons|1|||
19490694|NCT01401452|41794246|FG000|Overall Study|Tx stopped by psychiatrist|1|||
19490695|NCT01401452|41794246|FG000|Overall Study|No more visits within the 36 wk followup|4|||
19490696|NCT01401452|41794246|FG000|Overall Study|Subject did not come to follow up visits|2|||
19490697|NCT01401452|41794246|FG000|Overall Study|Subject didn't return for routine visits|1|||
19490698|NCT01401452|41794246|FG000|Overall Study|Subject moved to another city|1|||
19490699|NCT01401452|41794246|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
19490700|NCT01401452|41794246|FG000|Overall Study|Psoriatic arthritis|1|||
19490701|NCT01401452|41794246|FG000|Overall Study|Participant stopped Tx|2|||
19490702|NCT01401452|41794246|FG000|Overall Study|Discontinuation for personal reasons|1|||
19490703|NCT01401452|41794246|FG000|Overall Study|Treatment failure|1|||
19490704|NCT01401452|41794246|FG000|Overall Study|Unsatisfactory output|1|||
19490705|NCT01401452|41794246|FG000|Overall Study|Subject withdrew because of Tx success|1|||
19490706|NCT01401452|41794246|FG000|Overall Study|Subject chose to discontinue treatment|1|||
19490707|NCT01401452|41794246|FG000|Overall Study|Participant withdrew consent|1|||
19490708|NCT01401062|41794281|FG000|Overall Study|Death|9|||
19490709|NCT01401062|41794282|FG001|Overall Study|Death|7|||
19490710|NCT01401062|41794281|FG000|Overall Study|Physician Decision|1|||
19490711|NCT01401062|41794282|FG001|Overall Study|Physician Decision|0|||
19490712|NCT01401062|41794281|FG000|Overall Study|Withdrawal by Subject|1|||
19490713|NCT01401062|41794282|FG001|Overall Study|Withdrawal by Subject|1|||
19490714|NCT01400516|41794315|FG000|Primary Trial|Withdrawal by Subject|0|||
19490715|NCT01400516|41794316|FG001|Primary Trial|Withdrawal by Subject|2|||
19490716|NCT01383356|41794322|FG000|Period 1|Adverse Event|5|||
19490717|NCT01383356|41794323|FG001|Period 1|Adverse Event|3|||
19490718|NCT01383356|41794322|FG000|Period 1|Non-compliance|3|||
19490719|NCT01383356|41794323|FG001|Period 1|Non-compliance|0|||
19490720|NCT01383356|41794322|FG000|Period 1|Out of Range Mid-study-Test|0|||
19490721|NCT01383356|41794323|FG001|Period 1|Out of Range Mid-study-Test|1|||
19490722|NCT01383356|41794322|FG000|Period 1|Personal|0|||
19490723|NCT01383356|41794323|FG001|Period 1|Personal|2|||
19490724|NCT01399736|41794374|FG000|Overall Study|Withdrawal by Subject|4|||
19490725|NCT01399736|41794375|FG001|Overall Study|Withdrawal by Subject|2|||
19490726|NCT01399736|41794374|FG000|Overall Study|Lost to Follow-up|0|||
19490727|NCT01399736|41794375|FG001|Overall Study|Lost to Follow-up|2|||
19490728|NCT01381874|41794508|FG000|Overall Study|Lost to Follow-up|1|||
19490729|NCT01381874|41794509|FG001|Overall Study|Lost to Follow-up|1|||
19490730|NCT01381874|41794510|FG002|Overall Study|Lost to Follow-up|0|||
19490731|NCT01381874|41794508|FG000|Overall Study|Withdrawal by Subject|9|||
19490732|NCT01381874|41794509|FG001|Overall Study|Withdrawal by Subject|10|||
19490733|NCT01381874|41794510|FG002|Overall Study|Withdrawal by Subject|9|||
19490734|NCT01381874|41794508|FG000|Overall Study|Other|67|||
19490735|NCT01381874|41794509|FG001|Overall Study|Other|52|||
19490736|NCT01381874|41794510|FG002|Overall Study|Other|67|||
19490737|NCT01399190|41794518|FG000|Overall Study|Not Eligible for Final Analysis|5|||
19490738|NCT01399190|41794518|FG000|Overall Study|Adverse Event|8|||
19490739|NCT01399190|41794518|FG000|Overall Study|Participant's Request|5|||
19490740|NCT01399190|41794518|FG000|Overall Study|Physician Decision|2|||
19490741|NCT01381718|41794536|FG000|Overall Study|Withdrawal by Subject|2|||
19490742|NCT01381718|41794537|FG001|Overall Study|Withdrawal by Subject|5|||
19490743|NCT01381718|41794536|FG000|Overall Study|Lost to Follow-up|3|||
19490744|NCT01381718|41794537|FG001|Overall Study|Lost to Follow-up|5|||
19490745|NCT01381718|41794536|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
19490746|NCT01381718|41794537|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
19490747|NCT01398956|41794556|FG000|Overall Study|Withdrawal by Subject|4|||
19490748|NCT01398956|41794556|FG000|Overall Study|AE, non-serious non-fatal|4|||
19613234|NCT00573157|42062111|FG000|Overall Study|Other|1|||
19613235|NCT00573157|42062112|FG001|Overall Study|Other|1|||
19490749|NCT01398956|41794556|FG000|Overall Study|Withdrawal Criteria No.3|1|||
19704294|NCT00254982|42148594|FG000|Overall Study|Opportunistic infection|1|||
19704295|NCT00254982|42148595|FG001|Overall Study|Opportunistic infection|0|||
19704296|NCT00254982|42148594|FG000|Overall Study|Abnormal liver function tests|2|||
19490750|NCT01398956|41794556|FG000|Overall Study|Subject moved a long distance|1|||
19490751|NCT01381562|41794582|FG000|Overall Study|Adverse Event|0|||
19490752|NCT01381562|41794583|FG001|Overall Study|Adverse Event|1|||
19490753|NCT01381562|41794584|FG002|Overall Study|Adverse Event|0|||
19490754|NCT01381016|41794607|FG000|Overall Study|Lost to Follow-up|1|||
19490755|NCT01381016|41794608|FG001|Overall Study|Lost to Follow-up|1|||
19490756|NCT01381016|41794607|FG000|Overall Study|Screen Failure|2|||
19490757|NCT01381016|41794608|FG001|Overall Study|Screen Failure|2|||
19490758|NCT01381016|41794607|FG000|Overall Study|Withdrawal by Subject|0|||
19490759|NCT01381016|41794608|FG001|Overall Study|Withdrawal by Subject|1|||
19490760|NCT01381016|41794607|FG000|Overall Study|Physician Decision|0|||
19490761|NCT01381016|41794608|FG001|Overall Study|Physician Decision|2|||
19490762|NCT01398410|41794635|FG000|Overall Study|Adverse Event|12|||
19490763|NCT01398410|41794636|FG001|Overall Study|Adverse Event|16|||
19490764|NCT01398410|41794635|FG000|Overall Study|Participants Choice|8|||
19490765|NCT01398410|41794636|FG001|Overall Study|Participants Choice|11|||
19490766|NCT01398410|41794635|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
19490767|NCT01398410|41794636|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
19490768|NCT01398410|41794635|FG000|Overall Study|Other|36|||
19393555|NCT01938430|41637426|FG012|Overall Study|Death|0|||
19393556|NCT01938430|41637427|FG013|Overall Study|Death|0|||
19393557|NCT01938430|41637414|FG000|Overall Study|Investigator's Discretion|0|||
19393558|NCT01938430|41637415|FG001|Overall Study|Investigator's Discretion|0|||
19393559|NCT01938430|41637416|FG002|Overall Study|Investigator's Discretion|1|||
19393560|NCT01938430|41637417|FG003|Overall Study|Investigator's Discretion|0|||
19393561|NCT01938430|41637418|FG004|Overall Study|Investigator's Discretion|0|||
19393562|NCT01938430|41637419|FG005|Overall Study|Investigator's Discretion|0|||
19393563|NCT01938430|41637420|FG006|Overall Study|Investigator's Discretion|0|||
19393564|NCT01938430|41637421|FG007|Overall Study|Investigator's Discretion|0|||
19490769|NCT01398410|41794636|FG001|Overall Study|Other|29|||
19490770|NCT01380782|41794702|FG000|Overall Study|Adverse Event|0|||
19490771|NCT01380782|41794703|FG001|Overall Study|Adverse Event|1|||
19490772|NCT01380782|41794704|FG002|Overall Study|Adverse Event|0|||
19490773|NCT01380782|41794705|FG003|Overall Study|Adverse Event|0|||
19490774|NCT01380782|41794702|FG000|Overall Study|Death|1|||
19704297|NCT00254982|42148595|FG001|Overall Study|Abnormal liver function tests|1|||
19613236|NCT00802737|42062121|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
19613237|NCT00802737|42062122|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
19393565|NCT01938430|41637422|FG008|Overall Study|Investigator's Discretion|0|||
19393566|NCT01938430|41637423|FG009|Overall Study|Investigator's Discretion|0|||
19613238|NCT00802737|42062123|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
19613239|NCT00802737|42062121|FG000|Overall Study|Death|6|||
19613240|NCT00802737|42062122|FG001|Overall Study|Death|5|||
19613241|NCT00802737|42062123|FG002|Overall Study|Death|1|||
19613242|NCT00802737|42062121|FG000|Overall Study|Adverse Event|1|||
19613243|NCT00802737|42062122|FG001|Overall Study|Adverse Event|0|||
19613244|NCT00802737|42062123|FG002|Overall Study|Adverse Event|0|||
19613245|NCT00802737|42062121|FG000|Overall Study|Received Prohibited Therapy|1|||
19613246|NCT00802737|42062122|FG001|Overall Study|Received Prohibited Therapy|0|||
19613247|NCT00802737|42062123|FG002|Overall Study|Received Prohibited Therapy|0|||
19613248|NCT00802737|42062121|FG000|Overall Study|Ongoing CLL-Treatment|0|||
19613249|NCT00802737|42062122|FG001|Overall Study|Ongoing CLL-Treatment|1|||
19613250|NCT00802737|42062123|FG002|Overall Study|Ongoing CLL-Treatment|0|||
19613251|NCT00802737|42062121|FG000|Overall Study|Participant too Unwell|0|||
19613252|NCT00802737|42062122|FG001|Overall Study|Participant too Unwell|2|||
19704298|NCT03759340|42148601|FG000|Overall Study|Adverse Event|2|||
19704299|NCT03759340|42148601|FG000|Overall Study|Lost to Follow-up|1|||
19704300|NCT03759340|42148601|FG000|Overall Study|Withdrawal by Subject|15|||
19704301|NCT03759340|42148601|FG000|Overall Study|Study Terminated by Sponsor|38|||
19704302|NCT00224016|42148607|FG000|Titration Period|Withdrawal by Subject|0|||
19704303|NCT00224016|42148608|FG001|Titration Period|Withdrawal by Subject|1|||
19704304|NCT00224016|42148607|FG000|Titration Period|Lost to Follow-up|1|||
19704305|NCT00224016|42148608|FG001|Titration Period|Lost to Follow-up|0|||
19704306|NCT00224016|42148607|FG000|Maintenance Period|Withdrawal by Subject|2|||
19704307|NCT00224016|42148608|FG001|Maintenance Period|Withdrawal by Subject|0|||
19704308|NCT00224016|42148607|FG000|Maintenance Period|Lost to Follow-up|0|||
19704309|NCT00224016|42148608|FG001|Maintenance Period|Lost to Follow-up|1|||
19704310|NCT03757234|42148619|FG000|Overall Study|Adverse Event|0|||
19704311|NCT03757234|42148620|FG001|Overall Study|Adverse Event|0|||
19704312|NCT03757234|42148621|FG002|Overall Study|Adverse Event|0|||
19393567|NCT01938430|41637424|FG010|Overall Study|Investigator's Discretion|0|||
19490775|NCT01380782|41794703|FG001|Overall Study|Death|0|||
19490776|NCT01380782|41794704|FG002|Overall Study|Death|0|||
19490777|NCT01380782|41794705|FG003|Overall Study|Death|0|||
19490778|NCT01380782|41794702|FG000|Overall Study|Lack of Efficacy|10|||
19490779|NCT01380782|41794703|FG001|Overall Study|Lack of Efficacy|9|||
19490780|NCT01380782|41794704|FG002|Overall Study|Lack of Efficacy|10|||
19490781|NCT01380782|41794705|FG003|Overall Study|Lack of Efficacy|3|||
19490782|NCT01380782|41794702|FG000|Overall Study|Physician Decision|1|||
19490783|NCT01380782|41794703|FG001|Overall Study|Physician Decision|0|||
19490784|NCT01380782|41794704|FG002|Overall Study|Physician Decision|0|||
19490785|NCT01380782|41794705|FG003|Overall Study|Physician Decision|0|||
19490786|NCT01380782|41794702|FG000|Overall Study|Withdrawal by Subject|0|||
19490787|NCT01380782|41794703|FG001|Overall Study|Withdrawal by Subject|0|||
19490788|NCT01380782|41794704|FG002|Overall Study|Withdrawal by Subject|1|||
19490789|NCT01380782|41794705|FG003|Overall Study|Withdrawal by Subject|1|||
19490790|NCT01398176|41794719|FG000|Overall Study|Lost to Follow-up|1|||
19490791|NCT01398176|41794720|FG001|Overall Study|Lost to Follow-up|3|||
19490792|NCT01398176|41794719|FG000|Overall Study|Physician Decision|2|||
19490793|NCT01398176|41794720|FG001|Overall Study|Physician Decision|3|||
19490794|NCT01397786|41794773|FG000|Phase A|Lost to Follow-up|0|||
19490795|NCT01397786|41794774|FG001|Phase A|Lost to Follow-up|0|||
19490796|NCT01397786|41794775|FG002|Phase A|Lost to Follow-up|6|||
19490797|NCT01397786|41794773|FG000|Phase A|Adverse Event|0|||
19490798|NCT01397786|41794774|FG001|Phase A|Adverse Event|0|||
19490799|NCT01397786|41794775|FG002|Phase A|Adverse Event|8|||
19490800|NCT01397786|41794773|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
19490801|NCT01397786|41794774|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
19490802|NCT01397786|41794775|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
19490803|NCT01397786|41794773|FG000|Phase A|Physician Decision|0|||
19490804|NCT01397786|41794774|FG001|Phase A|Physician Decision|0|||
19490805|NCT01397786|41794775|FG002|Phase A|Physician Decision|1|||
19490806|NCT01397786|41794773|FG000|Phase A|Withdrawal by Subject|0|||
19490807|NCT01397786|41794774|FG001|Phase A|Withdrawal by Subject|0|||
19490808|NCT01397786|41794775|FG002|Phase A|Withdrawal by Subject|5|||
19490809|NCT01397786|41794773|FG000|Phase A|Lack of Efficacy|0|||
19490810|NCT01397786|41794774|FG001|Phase A|Lack of Efficacy|0|||
19490811|NCT01397786|41794775|FG002|Phase A|Lack of Efficacy|1|||
19490812|NCT01397786|41794773|FG000|Phase B|Lost to Follow-up|22|||
19490813|NCT01397786|41794774|FG001|Phase B|Lost to Follow-up|12|||
19490814|NCT01397786|41794775|FG002|Phase B|Lost to Follow-up|22|||
19490815|NCT01397786|41794773|FG000|Phase B|Adverse Event|109|||
19490816|NCT01397786|41794774|FG001|Phase B|Adverse Event|23|||
19490817|NCT01397786|41794775|FG002|Phase B|Adverse Event|27|||
19490818|NCT01397786|41794773|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
19490819|NCT01397786|41794774|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
19490820|NCT01397786|41794775|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
19490821|NCT01397786|41794773|FG000|Phase B|Physician Decision|9|||
19490822|NCT01397786|41794774|FG001|Phase B|Physician Decision|1|||
19490823|NCT01397786|41794775|FG002|Phase B|Physician Decision|3|||
19490824|NCT01397786|41794773|FG000|Phase B|Withdrawal by Subject|102|||
19490825|NCT01397786|41794774|FG001|Phase B|Withdrawal by Subject|45|||
19490826|NCT01397786|41794775|FG002|Phase B|Withdrawal by Subject|30|||
19490827|NCT01397786|41794773|FG000|Phase B|Protocol Deviation|1|||
19490828|NCT01397786|41794774|FG001|Phase B|Protocol Deviation|2|||
19490829|NCT01397786|41794775|FG002|Phase B|Protocol Deviation|4|||
19490830|NCT01397786|41794773|FG000|Phase B|Lack of Efficacy|22|||
19490831|NCT01397786|41794774|FG001|Phase B|Lack of Efficacy|7|||
19490832|NCT01397786|41794775|FG002|Phase B|Lack of Efficacy|14|||
19490833|NCT01397552|41794834|FG000|Overall Study|Adverse Event|1|||
19490834|NCT01397552|41794835|FG001|Overall Study|Adverse Event|0|||
19490835|NCT01397552|41794834|FG000|Overall Study|Withdrawal by Subject|2|||
19490836|NCT01397552|41794835|FG001|Overall Study|Withdrawal by Subject|1|||
19490837|NCT01397162|41794855|FG000|Overall Study|Adverse Event|4|||
19490838|NCT01397162|41794856|FG001|Overall Study|Adverse Event|0|||
19490839|NCT01397162|41794857|FG002|Overall Study|Adverse Event|0|||
19490840|NCT01397162|41794858|FG003|Overall Study|Adverse Event|0|||
19490841|NCT01397162|41794859|FG004|Overall Study|Adverse Event|0|||
19490842|NCT01397162|41794855|FG000|Overall Study|Not yet defined|3|||
19490843|NCT01397162|41794856|FG001|Overall Study|Not yet defined|4|||
19490844|NCT01397162|41794857|FG002|Overall Study|Not yet defined|3|||
19490845|NCT01397162|41794858|FG003|Overall Study|Not yet defined|5|||
19490846|NCT01397162|41794859|FG004|Overall Study|Not yet defined|3|||
19490847|NCT01397084|41794892|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
19490848|NCT01397084|41794892|FG000|Overall Study|Protocol Violation|2|||
19490849|NCT01397084|41794892|FG000|Overall Study|Adverse Event|2|||
19490850|NCT01397084|41794892|FG000|Overall Study|Withdrawal by Subject|1|||
19490851|NCT01397084|41794892|FG000|Overall Study|Lost to Follow-up|1|||
19490852|NCT01397084|41794892|FG000|Overall Study|Used other proton pump inhibitor|1|||
19490853|NCT01396148|41794932|FG000|Overall Study|Patient Decision|1|||
19490854|NCT01396070|41794965|FG000|Overall Study|Withdrawal by Subject|2|||
19490855|NCT01396070|41794965|FG000|Overall Study|Death|2|||
19490856|NCT01396070|41794965|FG000|Overall Study|Adverse Event|8|||
19490857|NCT01396070|41794965|FG000|Overall Study|Physician Decision|3|||
19490858|NCT01396070|41794965|FG000|Overall Study|Lack of Efficacy|4|||
19490859|NCT01395914|41794982|FG000|Overall Study|Unrelated to study drug AE|6|||
19490860|NCT01395914|41794983|FG001|Overall Study|Unrelated to study drug AE|1|||
19490861|NCT01395914|41794982|FG000|Overall Study|Death|23|||
19490862|NCT01395914|41794983|FG001|Overall Study|Death|17|||
19490863|NCT01395914|41794982|FG000|Overall Study|Other|9|||
19490864|NCT01395914|41794983|FG001|Overall Study|Other|3|||
19490865|NCT01395914|41794982|FG000|Overall Study|Withdrawal by patient|27|||
19490866|NCT01395914|41794983|FG001|Overall Study|Withdrawal by patient|14|||
19490867|NCT01395914|41794982|FG000|Overall Study|Study drug-related AE|1|||
19490868|NCT01395914|41794983|FG001|Overall Study|Study drug-related AE|0|||
19490869|NCT01395914|41794982|FG000|Overall Study|Lost to Follow-up|6|||
19490870|NCT01395914|41794983|FG001|Overall Study|Lost to Follow-up|2|||
19490871|NCT01395758|41795245|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
19490872|NCT01395758|41795246|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
19490873|NCT01395758|41795247|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
19490874|NCT01395524|41795301|FG000|Overall Study|Non-compliance with study schedule|1|||
19490875|NCT01395524|41795302|FG001|Overall Study|Non-compliance with study schedule|0|||
19490876|NCT01395524|41795303|FG002|Overall Study|Non-compliance with study schedule|1|||
19490877|NCT01395524|41795301|FG000|Overall Study|Lost to Follow-up|3|||
19490878|NCT01395524|41795302|FG001|Overall Study|Lost to Follow-up|1|||
19490879|NCT01395524|41795303|FG002|Overall Study|Lost to Follow-up|1|||
19490880|NCT01395524|41795301|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
19490881|NCT01395524|41795302|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
19490882|NCT01395524|41795303|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
19490883|NCT01395524|41795301|FG000|Overall Study|Severe noncompliance with protocol|1|||
19490884|NCT01395524|41795302|FG001|Overall Study|Severe noncompliance with protocol|0|||
19490885|NCT01395524|41795303|FG002|Overall Study|Severe noncompliance with protocol|0|||
19490886|NCT01395524|41795301|FG000|Overall Study|Adverse Event|4|||
19490887|NCT01395524|41795302|FG001|Overall Study|Adverse Event|4|||
19490888|NCT01395524|41795303|FG002|Overall Study|Adverse Event|3|||
19490889|NCT01395524|41795301|FG000|Overall Study|Death|1|||
19490890|NCT01395524|41795302|FG001|Overall Study|Death|0|||
19490891|NCT01395524|41795303|FG002|Overall Study|Death|0|||
19490892|NCT01395524|41795301|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
19490893|NCT01395524|41795302|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19490894|NCT01395524|41795303|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19490895|NCT01395524|41795301|FG000|Overall Study|Withdrawal by Subject|4|||
19490896|NCT01395524|41795302|FG001|Overall Study|Withdrawal by Subject|8|||
19490897|NCT01395524|41795303|FG002|Overall Study|Withdrawal by Subject|8|||
19490898|NCT01395524|41795301|FG000|Overall Study|Did not receive treatment|1|||
19490899|NCT01395524|41795302|FG001|Overall Study|Did not receive treatment|1|||
19490900|NCT01395524|41795303|FG002|Overall Study|Did not receive treatment|3|||
19490901|NCT01395524|41795301|FG000|Overall Study|Subject had spinal surgery|0|||
19490902|NCT01395524|41795302|FG001|Overall Study|Subject had spinal surgery|0|||
19490903|NCT01395524|41795303|FG002|Overall Study|Subject had spinal surgery|1|||
19490904|NCT01395368|41795311|FG000|Overall Study|Physician Decision|14|||
19490905|NCT01395368|41795311|FG000|Overall Study|Withdrawal by Subject|2|||
19490906|NCT01394978|41795318|FG000|Overall Study|Withdrawal by Subject|2|||
19490907|NCT01394978|41795319|FG001|Overall Study|Withdrawal by Subject|4|||
19490908|NCT01394978|41795318|FG000|Overall Study|Lost to Follow-up|13|||
19490909|NCT01394978|41795319|FG001|Overall Study|Lost to Follow-up|20|||
19490910|NCT01394978|41795318|FG000|Overall Study|Death|6|||
19490911|NCT01394978|41795319|FG001|Overall Study|Death|7|||
19490912|NCT01394276|41795326|FG000|Overall Study|Related Adverse event (AEs)|15|||
19490913|NCT01394276|41795326|FG000|Overall Study|Not related AEs|9|||
19490914|NCT01394276|41795326|FG000|Overall Study|Remission of disease|2|||
19490915|NCT01394276|41795326|FG000|Overall Study|Insufficient therapeutic effect|17|||
19490916|NCT01394276|41795326|FG000|Overall Study|Insufficient compliance|9|||
19490917|NCT01394276|41795326|FG000|Overall Study|Lost to Follow-up|5|||
19490918|NCT01394276|41795326|FG000|Overall Study|Participant moved to another site|1|||
19490919|NCT01394276|41795326|FG000|Overall Study|Pregnancy|1|||
19490920|NCT01394276|41795326|FG000|Overall Study|unavailability of drug at the Hospital|2|||
19490921|NCT01394276|41795326|FG000|Overall Study|Symptoms of concurrent diseases|1|||
19490922|NCT00211172|41795426|FG000|Overall Study|Died or lost health plan eligibility|39|||
19490923|NCT00211172|41795427|FG001|Overall Study|Died or lost health plan eligibility|32|||
19490924|NCT00210626|41795478|FG000|Overall Study|Adverse Event|1|||
19490925|NCT00210626|41795479|FG001|Overall Study|Adverse Event|2|||
19490926|NCT00210626|41795478|FG000|Overall Study|Protocol Violation|1|||
19490927|NCT00210626|41795479|FG001|Overall Study|Protocol Violation|5|||
19490928|NCT00210626|41795478|FG000|Overall Study|Lost to Follow-up|11|||
19490929|NCT00210626|41795479|FG001|Overall Study|Lost to Follow-up|11|||
19490930|NCT00210626|41795478|FG000|Overall Study|Death|1|||
19490931|NCT00210626|41795479|FG001|Overall Study|Death|0|||
19704313|NCT03757234|42148622|FG003|Overall Study|Adverse Event|0|||
19490932|NCT00210626|41795478|FG000|Overall Study|Withdrawal by Subject|29|||
19490933|NCT00210626|41795479|FG001|Overall Study|Withdrawal by Subject|20|||
19490934|NCT00210626|41795478|FG000|Overall Study|Physician Decision|0|||
19490935|NCT00210626|41795479|FG001|Overall Study|Physician Decision|2|||
19490936|NCT00210626|41795478|FG000|Overall Study|Sponser Request|1|||
19490937|NCT00210626|41795479|FG001|Overall Study|Sponser Request|0|||
19490938|NCT00210626|41795478|FG000|Overall Study|Other|4|||
19490939|NCT00210626|41795479|FG001|Overall Study|Other|5|||
19490940|NCT00217022|41795501|FG000|Overall Study|Withdrawal by Subject|1|||
19490941|NCT00217022|41795502|FG001|Overall Study|Withdrawal by Subject|1|||
19490942|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
19490943|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
19490944|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
19490945|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
19490946|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
19490947|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
19490948|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
19490949|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
19490950|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
19490951|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
19490952|NCT00219284|41795849|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
19490953|NCT00219284|41795850|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
19490954|NCT00219284|41795849|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
19490955|NCT00219284|41795850|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
19490956|NCT00219284|41795849|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
19490957|NCT00219284|41795850|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
19490958|NCT00219284|41795849|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
19490959|NCT00219284|41795850|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
19490960|NCT00216476|41795989|FG000|Overall Study|Withdrawal by Subject|59|||
19490961|NCT00216476|41795990|FG001|Overall Study|Withdrawal by Subject|72|||
19490962|NCT00216476|41795991|FG002|Overall Study|Withdrawal by Subject|9|||
19490963|NCT00216476|41795989|FG000|Overall Study|Lost to Follow-up|10|||
19490964|NCT00216476|41795990|FG001|Overall Study|Lost to Follow-up|9|||
19490965|NCT00216476|41795991|FG002|Overall Study|Lost to Follow-up|1|||
19490966|NCT00216476|41795989|FG000|Overall Study|Adverse Event|6|||
19490967|NCT00216476|41795990|FG001|Overall Study|Adverse Event|10|||
19490968|NCT00216476|41795991|FG002|Overall Study|Adverse Event|1|||
19490969|NCT00216476|41795989|FG000|Overall Study|Lack of Efficacy|4|||
19490970|NCT00216476|41795990|FG001|Overall Study|Lack of Efficacy|3|||
19490971|NCT00216476|41795991|FG002|Overall Study|Lack of Efficacy|0|||
19490972|NCT00216476|41795989|FG000|Overall Study|Death|2|||
19490973|NCT00216476|41795990|FG001|Overall Study|Death|0|||
19490974|NCT00216476|41795991|FG002|Overall Study|Death|0|||
19490975|NCT00216476|41795989|FG000|Overall Study|Pregnancy|0|||
19490976|NCT00216476|41795990|FG001|Overall Study|Pregnancy|1|||
19490977|NCT00216476|41795991|FG002|Overall Study|Pregnancy|1|||
19490978|NCT00216476|41795989|FG000|Overall Study|Other|0|||
19490979|NCT00216476|41795990|FG001|Overall Study|Other|0|||
19490980|NCT00216476|41795991|FG002|Overall Study|Other|1|||
19490981|NCT00216476|41795989|FG000|Overall Study|Refuses Injection|11|||
19490982|NCT00216476|41795990|FG001|Overall Study|Refuses Injection|0|||
19490983|NCT00216476|41795991|FG002|Overall Study|Refuses Injection|0|||
19490984|NCT00216476|41795989|FG000|Overall Study|No Further Need for Treatment|3|||
19490985|NCT00216476|41795990|FG001|Overall Study|No Further Need for Treatment|4|||
19490986|NCT00216476|41795991|FG002|Overall Study|No Further Need for Treatment|1|||
19490987|NCT00216476|41795989|FG000|Overall Study|Non-compliance|0|||
19490988|NCT00216476|41795990|FG001|Overall Study|Non-compliance|4|||
19490989|NCT00216476|41795991|FG002|Overall Study|Non-compliance|1|||
19490990|NCT00216476|41795989|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
19490991|NCT00216476|41795990|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
19490992|NCT00216476|41795991|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
19490993|NCT00216476|41795989|FG000|Overall Study|Administrative Reasons|1|||
19490994|NCT00216476|41795990|FG001|Overall Study|Administrative Reasons|1|||
19490995|NCT00216476|41795991|FG002|Overall Study|Administrative Reasons|0|||
19490996|NCT00216476|41795989|FG000|Overall Study|Protocol Deviation|5|||
19490997|NCT00216476|41795990|FG001|Overall Study|Protocol Deviation|1|||
19490998|NCT00216476|41795991|FG002|Overall Study|Protocol Deviation|0|||
19490999|NCT00216476|41795989|FG000|Overall Study|Patient Moved|2|||
19491000|NCT00216476|41795990|FG001|Overall Study|Patient Moved|2|||
19491001|NCT00216476|41795991|FG002|Overall Study|Patient Moved|0|||
19491002|NCT00216086|41796042|FG000|Overall Study|Protocol Violation|1|||
19491003|NCT00216086|41796042|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
19491004|NCT00216086|41796042|FG000|Overall Study|Social Reasons|2|||
19491005|NCT00215150|41796073|FG000|Open Label Phase|Lost to Follow-up|7|||
19491006|NCT00215150|41796073|FG000|Open Label Phase|Withdrawal by Subject|1|||
19491007|NCT00215150|41796073|FG000|Open Label Phase|Did not complete a post base visit|13|||
19491008|NCT00215150|41796073|FG000|Open Label Phase|Did not meet randomization criteria|9|||
19491009|NCT00215150|41796073|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
19613253|NCT00802737|42062123|FG002|Overall Study|Participant too Unwell|0|||
19491010|NCT00215150|41796073|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
19491011|NCT00215150|41796073|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
19491012|NCT00214136|41796081|FG000|Overall Study|Death|5|||
19491013|NCT00213980|41796087|FG000|Overall Study|Withdrawal by Subject|3|||
19491014|NCT00213980|41796088|FG001|Overall Study|Withdrawal by Subject|1|||
19491015|NCT00213980|41796087|FG000|Overall Study|Adverse Event|1|||
19491016|NCT00213980|41796088|FG001|Overall Study|Adverse Event|1|||
19491017|NCT00213980|41796087|FG000|Overall Study|Disease progression|0|||
19491018|NCT00213980|41796088|FG001|Overall Study|Disease progression|2|||
19491019|NCT00213980|41796087|FG000|Overall Study|Developed ovarian cancer|1|||
19491020|NCT00213980|41796088|FG001|Overall Study|Developed ovarian cancer|0|||
19491021|NCT00213980|41796087|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
19491022|NCT00213980|41796088|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
19491023|NCT04388527|41796528|FG000|Overall Study|Death|14|||
19491024|NCT04388527|41796528|FG000|Overall Study|Withdrawal by Subject|2|||
19491025|NCT04388527|41796528|FG000|Overall Study|Lost to Follow-up|1|||
19491026|NCT04149002|41796776|FG000|Overall Study|Lost to Follow-up|1|||
19491027|NCT04149002|41796777|FG001|Overall Study|Lost to Follow-up|0|||
19491028|NCT04149002|41796776|FG000|Overall Study|Withdrawal by Subject|1|||
19491029|NCT04149002|41796777|FG001|Overall Study|Withdrawal by Subject|0|||
19491030|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
19491031|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
19491032|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
19491033|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
19491034|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
19491035|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
19491036|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
19491037|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
19491038|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
19491039|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
19491040|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Death|2|||
19491041|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Death|1|||
19491042|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Death|4|||
19491043|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Death|0|||
19491044|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Death|0|||
19491045|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
19491046|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
19491047|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
19491048|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
19491049|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
19491050|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Other Reason|1|||
19491051|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Other Reason|3|||
19393568|NCT01938430|41637425|FG011|Overall Study|Investigator's Discretion|0|||
19393569|NCT01938430|41637426|FG012|Overall Study|Investigator's Discretion|0|||
19393570|NCT01938430|41637427|FG013|Overall Study|Investigator's Discretion|0|||
19393571|NCT01938430|41637414|FG000|Overall Study|Lack of Efficacy|3|||
19393572|NCT01938430|41637415|FG001|Overall Study|Lack of Efficacy|1|||
19393573|NCT01938430|41637416|FG002|Overall Study|Lack of Efficacy|1|||
19393574|NCT01938430|41637417|FG003|Overall Study|Lack of Efficacy|1|||
19393575|NCT01938430|41637418|FG004|Overall Study|Lack of Efficacy|0|||
19393576|NCT01938430|41637419|FG005|Overall Study|Lack of Efficacy|0|||
19393577|NCT01938430|41637420|FG006|Overall Study|Lack of Efficacy|0|||
19393578|NCT01938430|41637421|FG007|Overall Study|Lack of Efficacy|0|||
19393579|NCT01938430|41637422|FG008|Overall Study|Lack of Efficacy|1|||
19393580|NCT01938430|41637423|FG009|Overall Study|Lack of Efficacy|0|||
19393581|NCT01938430|41637424|FG010|Overall Study|Lack of Efficacy|2|||
19393582|NCT01938430|41637425|FG011|Overall Study|Lack of Efficacy|1|||
19393583|NCT01938430|41637426|FG012|Overall Study|Lack of Efficacy|0|||
19393584|NCT01938430|41637427|FG013|Overall Study|Lack of Efficacy|0|||
19393585|NCT01938430|41637414|FG000|Overall Study|Lost to Follow-up|0|||
19393586|NCT01938430|41637415|FG001|Overall Study|Lost to Follow-up|0|||
19393587|NCT01938430|41637416|FG002|Overall Study|Lost to Follow-up|1|||
19491052|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Other Reason|2|||
19491053|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Other Reason|0|||
19491054|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Other Reason|0|||
19491055|NCT00555321|41796860|FG000|Treatment Phase up to 12-months|Never treated|2|||
19491056|NCT00555321|41796861|FG001|Treatment Phase up to 12-months|Never treated|3|||
19491057|NCT00555321|41796862|FG002|Treatment Phase up to 12-months|Never treated|1|||
19491058|NCT00555321|41796863|FG003|Treatment Phase up to 12-months|Never treated|0|||
19491059|NCT00555321|41796864|FG004|Treatment Phase up to 12-months|Never treated|4|||
19491060|NCT00555321|41796860|FG000|Long-term Extension Phase|Adverse Event|2|||
19491061|NCT00555321|41796861|FG001|Long-term Extension Phase|Adverse Event|5|||
19393588|NCT01938430|41637417|FG003|Overall Study|Lost to Follow-up|0|||
19491062|NCT00555321|41796862|FG002|Long-term Extension Phase|Adverse Event|2|||
19704314|NCT03757234|42148623|FG004|Overall Study|Adverse Event|1|||
19491063|NCT00555321|41796863|FG003|Long-term Extension Phase|Adverse Event|1|||
19491064|NCT00555321|41796864|FG004|Long-term Extension Phase|Adverse Event|0|||
19491065|NCT00555321|41796860|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
19491066|NCT00555321|41796861|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
19491067|NCT00555321|41796862|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
19491068|NCT00555321|41796863|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
19491069|NCT00555321|41796864|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
19491070|NCT00555321|41796860|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
19491071|NCT00555321|41796861|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
19491072|NCT00555321|41796862|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
19491073|NCT00555321|41796863|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
19491074|NCT00555321|41796864|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
19491075|NCT00555321|41796860|FG000|Long-term Extension Phase|Death|2|||
19491076|NCT00555321|41796861|FG001|Long-term Extension Phase|Death|0|||
19491077|NCT00555321|41796862|FG002|Long-term Extension Phase|Death|0|||
19491078|NCT00555321|41796863|FG003|Long-term Extension Phase|Death|3|||
19491079|NCT00555321|41796864|FG004|Long-term Extension Phase|Death|0|||
19491080|NCT00555321|41796860|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
19491081|NCT00555321|41796861|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
19491082|NCT00555321|41796862|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
19491083|NCT00555321|41796863|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
19491084|NCT00555321|41796864|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
19491085|NCT00555321|41796860|FG000|Long-term Extension Phase|Other Reason|1|||
19491086|NCT00555321|41796861|FG001|Long-term Extension Phase|Other Reason|0|||
19491087|NCT00555321|41796862|FG002|Long-term Extension Phase|Other Reason|2|||
19491088|NCT00555321|41796863|FG003|Long-term Extension Phase|Other Reason|0|||
19491089|NCT00555321|41796864|FG004|Long-term Extension Phase|Other Reason|0|||
19491090|NCT03589976|41797385|FG000|Overall Study|Death|5|||
19491091|NCT03589976|41797386|FG001|Overall Study|Death|1|||
19491092|NCT03589976|41797385|FG000|Overall Study|Adverse Event|5|||
19491093|NCT03589976|41797386|FG001|Overall Study|Adverse Event|1|||
19491094|NCT03589976|41797385|FG000|Overall Study|Withdrawal by Subject|4|||
19491095|NCT03589976|41797386|FG001|Overall Study|Withdrawal by Subject|1|||
19491096|NCT03589976|41797385|FG000|Overall Study|Lost to Follow-up|1|||
19491097|NCT03589976|41797386|FG001|Overall Study|Lost to Follow-up|0|||
19491098|NCT03589976|41797385|FG000|Overall Study|Other|4|||
19491099|NCT03589976|41797386|FG001|Overall Study|Other|3|||
19491100|NCT03029780|41797542|FG000|Overall Study|Disease Progression|20|||
19491101|NCT03029780|41797543|FG001|Overall Study|Disease Progression|22|||
19491102|NCT03029780|41797542|FG000|Overall Study|Study Drug Toxicity|15|||
19491103|NCT03029780|41797543|FG001|Overall Study|Study Drug Toxicity|11|||
19491104|NCT03029780|41797542|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
19491105|NCT03029780|41797543|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
19491106|NCT03029780|41797542|FG000|Overall Study|Participant request to discontinue study treatment|4|||
19491107|NCT03029780|41797543|FG001|Overall Study|Participant request to discontinue study treatment|1|||
19491108|NCT03029780|41797542|FG000|Overall Study|Maximum clinical benefit|1|||
19491109|NCT03029780|41797543|FG001|Overall Study|Maximum clinical benefit|0|||
19491110|NCT03029780|41797542|FG000|Overall Study|Participant no longer meets study criteria|0|||
19491111|NCT03029780|41797543|FG001|Overall Study|Participant no longer meets study criteria|1|||
19491112|NCT03029780|41797542|FG000|Overall Study|Other reasons|6|||
19491113|NCT03029780|41797543|FG001|Overall Study|Other reasons|6|||
19491114|NCT03029780|41797542|FG000|Overall Study|Not reported|1|||
19491115|NCT03029780|41797543|FG001|Overall Study|Not reported|1|||
19491116|NCT03029780|41797542|FG000|Overall Study|Death|2|||
19491117|NCT03029780|41797543|FG001|Overall Study|Death|6|||
19491118|NCT03029234|41797603|FG000|Overall Study|Sponsor Decision|1|||
19491119|NCT03029234|41797603|FG000|Overall Study|Withdrawal by Subject|5|||
19491120|NCT03029234|41797603|FG000|Overall Study|Death|91|||
19491121|NCT03029234|41797603|FG000|Overall Study|Lost to Follow-up|2|||
19491122|NCT03018080|41798201|FG000|Overall Study|Death|11|||
19373671|NCT02760407|41614836|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
19491123|NCT03018080|41798202|FG001|Overall Study|Death|19|||
19491124|NCT03018080|41798201|FG000|Overall Study|Still On Study (in follow up)|10|||
19491125|NCT03018080|41798202|FG001|Overall Study|Still On Study (in follow up)|0|||
19491126|NCT00557193|41798256|FG000|Induction|Adverse Event|2|||
19491127|NCT00557193|41798257|FG001|Induction|Adverse Event|0|||
19491128|NCT00557193|41798258|FG002|Induction|Adverse Event|0|||
19491129|NCT00557193|41798259|FG003|Induction|Adverse Event|0|||
19491130|NCT00557193|41798260|FG004|Induction|Adverse Event|0|||
19491131|NCT00557193|41798261|FG005|Induction|Adverse Event|0|||
19491132|NCT00557193|41798256|FG000|Induction|Death|6|||
19491133|NCT00557193|41798257|FG001|Induction|Death|0|||
19491134|NCT00557193|41798258|FG002|Induction|Death|0|||
19491135|NCT00557193|41798259|FG003|Induction|Death|0|||
19491136|NCT00557193|41798260|FG004|Induction|Death|0|||
19491137|NCT00557193|41798261|FG005|Induction|Death|0|||
19491138|NCT00557193|41798256|FG000|Induction|Physician Decision|3|||
19491139|NCT00557193|41798257|FG001|Induction|Physician Decision|0|||
19491140|NCT00557193|41798258|FG002|Induction|Physician Decision|0|||
19491141|NCT00557193|41798259|FG003|Induction|Physician Decision|0|||
19491142|NCT00557193|41798260|FG004|Induction|Physician Decision|0|||
19491143|NCT00557193|41798261|FG005|Induction|Physician Decision|0|||
19491144|NCT00557193|41798256|FG000|Induction|Withdrawal by Subject|1|||
19491145|NCT00557193|41798257|FG001|Induction|Withdrawal by Subject|0|||
19491146|NCT00557193|41798258|FG002|Induction|Withdrawal by Subject|0|||
19491147|NCT00557193|41798259|FG003|Induction|Withdrawal by Subject|0|||
19491148|NCT00557193|41798260|FG004|Induction|Withdrawal by Subject|0|||
19491149|NCT00557193|41798261|FG005|Induction|Withdrawal by Subject|0|||
19491150|NCT00557193|41798256|FG000|Induction|Refusal of Further Protocol Therapy|2|||
19491151|NCT00557193|41798257|FG001|Induction|Refusal of Further Protocol Therapy|0|||
19491152|NCT00557193|41798258|FG002|Induction|Refusal of Further Protocol Therapy|0|||
19491153|NCT00557193|41798259|FG003|Induction|Refusal of Further Protocol Therapy|0|||
19491154|NCT00557193|41798260|FG004|Induction|Refusal of Further Protocol Therapy|0|||
19491155|NCT00557193|41798261|FG005|Induction|Refusal of Further Protocol Therapy|0|||
19491156|NCT00557193|41798256|FG000|Induction|Ineligible|8|||
19491157|NCT00557193|41798257|FG001|Induction|Ineligible|0|||
19491158|NCT00557193|41798258|FG002|Induction|Ineligible|0|||
19491159|NCT00557193|41798259|FG003|Induction|Ineligible|0|||
19491160|NCT00557193|41798260|FG004|Induction|Ineligible|0|||
19491161|NCT00557193|41798261|FG005|Induction|Ineligible|0|||
19491162|NCT00557193|41798256|FG000|Induction|Inevaluable for post Induction|2|||
19491163|NCT00557193|41798257|FG001|Induction|Inevaluable for post Induction|0|||
19491164|NCT00557193|41798258|FG002|Induction|Inevaluable for post Induction|0|||
19491165|NCT00557193|41798259|FG003|Induction|Inevaluable for post Induction|0|||
19491166|NCT00557193|41798260|FG004|Induction|Inevaluable for post Induction|0|||
19491167|NCT00557193|41798261|FG005|Induction|Inevaluable for post Induction|0|||
19491168|NCT00557193|41798256|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
19491169|NCT00557193|41798257|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
19491170|NCT00557193|41798258|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
19491171|NCT00557193|41798259|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
19491172|NCT00557193|41798260|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
19491173|NCT00557193|41798261|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
19491174|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
19491175|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
19491176|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
19491177|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
19491178|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
19491179|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
19491180|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
19491181|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
19491182|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
19491183|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
19491184|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
19491185|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
19491186|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
19491187|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
19491188|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
19491189|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
19491190|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
19491191|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
19491192|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
19491193|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
19491194|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
19491195|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
19491196|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
19491197|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
19491198|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
19491199|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
19491200|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
19491201|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
19491202|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
19491203|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
19491204|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
19491205|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
19491206|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
19613254|NCT00588861|42062134|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
19491207|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
19491208|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
19491209|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
19491210|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
19491211|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
19491212|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
19491213|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
19491214|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
19491215|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
19491216|NCT00557193|41798256|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
19491217|NCT00557193|41798257|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
19491218|NCT00557193|41798258|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
19491219|NCT00557193|41798259|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
19491220|NCT00557193|41798260|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
19491221|NCT00557193|41798261|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
19491222|NCT03991299|41798317|FG000|Overall Study|Study closed, sponsor decision|3|||
19491223|NCT03991299|41798317|FG000|Overall Study|Withdrawal by Subject|1|||
19491224|NCT03155373|41798335|FG000|Overall Study|No longer required surgery|1|||
19491225|NCT03155373|41798335|FG000|Overall Study|Protocol Violation|1|||
19491226|NCT03155373|41798335|FG000|Overall Study|Death|2|||
19491227|NCT03155373|41798335|FG000|Overall Study|Withdrawal by Subject|3|||
19491228|NCT02775903|41799040|FG000|Overall Study|Death|7|||
19491229|NCT02775903|41799041|FG001|Overall Study|Death|11|||
19491230|NCT02775903|41799042|FG002|Overall Study|Death|12|||
19491231|NCT02775903|41799043|FG003|Overall Study|Death|11|||
19491232|NCT02775903|41799040|FG000|Overall Study|Adverse Event|0|||
19491233|NCT02775903|41799041|FG001|Overall Study|Adverse Event|1|||
19491234|NCT02775903|41799042|FG002|Overall Study|Adverse Event|12|||
19491235|NCT02775903|41799043|FG003|Overall Study|Adverse Event|3|||
19491236|NCT02775903|41799040|FG000|Overall Study|Progressive disease|15|||
19491237|NCT02775903|41799041|FG001|Overall Study|Progressive disease|14|||
19491238|NCT02775903|41799042|FG002|Overall Study|Progressive disease|30|||
19491239|NCT02775903|41799043|FG003|Overall Study|Progressive disease|20|||
19491240|NCT02775903|41799040|FG000|Overall Study|Lack of Efficacy|2|||
19491241|NCT02775903|41799041|FG001|Overall Study|Lack of Efficacy|2|||
19491242|NCT02775903|41799042|FG002|Overall Study|Lack of Efficacy|2|||
19491243|NCT02775903|41799043|FG003|Overall Study|Lack of Efficacy|6|||
19491244|NCT02775903|41799040|FG000|Overall Study|Withdrawal by Subject|7|||
19491245|NCT02775903|41799041|FG001|Overall Study|Withdrawal by Subject|5|||
19491246|NCT02775903|41799042|FG002|Overall Study|Withdrawal by Subject|5|||
19491247|NCT02775903|41799043|FG003|Overall Study|Withdrawal by Subject|8|||
19491248|NCT02775903|41799040|FG000|Overall Study|Other reasons|7|||
19491249|NCT02775903|41799041|FG001|Overall Study|Other reasons|8|||
19491250|NCT02775903|41799042|FG002|Overall Study|Other reasons|2|||
19491251|NCT02775903|41799043|FG003|Overall Study|Other reasons|12|||
19613255|NCT00588861|42062135|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
19613256|NCT00588861|42062134|FG000|6 Months|Patients did not return for follow-up|98|||
19613257|NCT00588861|42062135|FG001|6 Months|Patients did not return for follow-up|73|||
19613258|NCT00588861|42062134|FG000|1 Year|Patients did not return for follow-up|89|||
19613259|NCT00588861|42062135|FG001|1 Year|Patients did not return for follow-up|82|||
19613260|NCT00588861|42062134|FG000|2 Years|Patients did not return for follow-up|92|||
19613261|NCT00588861|42062135|FG001|2 Years|Patients did not return for follow-up|87|||
19613262|NCT00588861|42062134|FG000|4 Years|Patients did not return for follow-up|91|||
19613263|NCT00588861|42062135|FG001|4 Years|Patients did not return for follow-up|103|||
19613264|NCT00588861|42062134|FG000|6 Years|Patients did not return for follow-up|104|||
19613265|NCT00588861|42062135|FG001|6 Years|Patients did not return for follow-up|109|||
19613266|NCT00588861|42062134|FG000|8 Years|Patients did not return for follow-up|105|||
19613267|NCT00588861|42062135|FG001|8 Years|Patients did not return for follow-up|114|||
19613268|NCT00588861|42062134|FG000|10 Years|Incomplete due to study termination|107|||
19613269|NCT00588861|42062135|FG001|10 Years|Incomplete due to study termination|114|||
19613270|NCT00887978|42062143|FG000|Overall Study|Adverse Event|18|||
19613271|NCT00887978|42062144|FG001|Overall Study|Adverse Event|5|||
19613272|NCT00887978|42062143|FG000|Overall Study|Clinical Worsening|4|||
19613273|NCT00887978|42062144|FG001|Overall Study|Clinical Worsening|4|||
19613274|NCT00887978|42062143|FG000|Overall Study|Death|2|||
19613275|NCT00887978|42062144|FG001|Overall Study|Death|3|||
19613276|NCT00887978|42062143|FG000|Overall Study|Withdrawal by Subject|1|||
19613277|NCT00887978|42062144|FG001|Overall Study|Withdrawal by Subject|2|||
19613278|NCT00887978|42062143|FG000|Overall Study|Lost to Follow-up|0|||
19613279|NCT00887978|42062144|FG001|Overall Study|Lost to Follow-up|1|||
19491252|NCT02723019|41799116|FG000|Overall Study|Death|17|||
19491253|NCT02723019|41799117|FG001|Overall Study|Death|13|||
19491254|NCT02723019|41799116|FG000|Overall Study|Withdrawal by Subject|11|||
19491255|NCT02723019|41799117|FG001|Overall Study|Withdrawal by Subject|7|||
19491256|NCT02723019|41799116|FG000|Overall Study|Lost to Follow-up|57|||
19491257|NCT02723019|41799117|FG001|Overall Study|Lost to Follow-up|70|||
19491258|NCT02152995|41799205|FG000|Overall Study|Withdrawal by Subject|1|||
19491259|NCT02152995|41799206|FG001|Overall Study|Withdrawal by Subject|0|||
19491260|NCT00088166|41799382|FG000|Overall Study|Adverse Event|11|||
19491261|NCT00088166|41799383|FG001|Overall Study|Adverse Event|9|||
19491262|NCT00088166|41799382|FG000|Overall Study|Death|3|||
19491263|NCT00088166|41799383|FG001|Overall Study|Death|1|||
19491264|NCT00088166|41799382|FG000|Overall Study|Lost to Follow-up|0|||
19491265|NCT00088166|41799383|FG001|Overall Study|Lost to Follow-up|1|||
19491266|NCT00088166|41799382|FG000|Overall Study|Physician Decision|4|||
19491267|NCT00088166|41799383|FG001|Overall Study|Physician Decision|1|||
19491268|NCT00088166|41799382|FG000|Overall Study|Protocol Violation|1|||
19491269|NCT00088166|41799383|FG001|Overall Study|Protocol Violation|5|||
19491270|NCT00088166|41799382|FG000|Overall Study|Patient deterioration|29|||
19491271|NCT00088166|41799383|FG001|Overall Study|Patient deterioration|39|||
19491272|NCT00088166|41799382|FG000|Overall Study|Withdrawal by Subject|5|||
19491273|NCT00088166|41799383|FG001|Overall Study|Withdrawal by Subject|5|||
19491274|NCT00087698|41799427|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
19491275|NCT00087698|41799427|FG000|Overall Study|Death from Other Causes|3|||
19491276|NCT00087698|41799427|FG000|Overall Study|Adverse Event|4|||
19491277|NCT00087698|41799427|FG000|Overall Study|Withdrawal by Subject|4|||
19491278|NCT00087698|41799427|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
19491279|NCT00087698|41799427|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
19491280|NCT00087698|41799427|FG000|Overall Study|Clinical Relapse|1|||
19491281|NCT00087698|41799427|FG000|Overall Study|Death from Study Disease|2|||
19491282|NCT00087698|41799427|FG000|Overall Study|Death from Study Drug Toxicity|2|||
19491283|NCT00087698|41799427|FG000|Overall Study|Protocol Violation|1|||
19491284|NCT00087152|41799445|FG000|Overall Study|Ineligible|6|||
19491285|NCT00086996|41799497|FG000|Overall Study|Adverse Event|29|||
19491286|NCT00086996|41799497|FG000|Overall Study|Death|4|||
19491287|NCT00086996|41799497|FG000|Overall Study|progression/relapse|7|||
19491288|NCT00086996|41799497|FG000|Overall Study|Withdrawal by Subject|13|||
19491289|NCT00086996|41799497|FG000|Overall Study|Other|6|||
19491290|NCT00086996|41799497|FG000|Overall Study|not eligible|5|||
19491291|NCT00086684|41799799|FG000|Overall Study|Adverse Event|12|||
19491292|NCT00086684|41799800|FG001|Overall Study|Adverse Event|17|||
19491293|NCT00086684|41799801|FG002|Overall Study|Adverse Event|14|||
19491294|NCT00086684|41799799|FG000|Overall Study|Lack of Efficacy|6|||
19491295|NCT00086684|41799800|FG001|Overall Study|Lack of Efficacy|6|||
19491296|NCT00086684|41799801|FG002|Overall Study|Lack of Efficacy|5|||
19491297|NCT00086684|41799799|FG000|Overall Study|Lost to Follow-up|15|||
19491298|NCT00086684|41799800|FG001|Overall Study|Lost to Follow-up|8|||
19491299|NCT00086684|41799801|FG002|Overall Study|Lost to Follow-up|10|||
19491300|NCT00086684|41799799|FG000|Overall Study|Protocol Violation|8|||
19491301|NCT00086684|41799800|FG001|Overall Study|Protocol Violation|3|||
19491302|NCT00086684|41799801|FG002|Overall Study|Protocol Violation|0|||
19491303|NCT00086684|41799799|FG000|Overall Study|Withdrawal by Subject|0|||
19491304|NCT00086684|41799800|FG001|Overall Study|Withdrawal by Subject|4|||
19491305|NCT00086684|41799801|FG002|Overall Study|Withdrawal by Subject|10|||
19491306|NCT00086684|41799799|FG000|Overall Study|NONCOMPLIANCE|5|||
19491307|NCT00086684|41799800|FG001|Overall Study|NONCOMPLIANCE|7|||
19491308|NCT00086684|41799801|FG002|Overall Study|NONCOMPLIANCE|6|||
19491309|NCT00086684|41799799|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
19491310|NCT00086684|41799800|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
19491311|NCT00086684|41799801|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
19491312|NCT00086684|41799799|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
19491313|NCT00086684|41799800|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
19491314|NCT00086684|41799801|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
19491315|NCT00086684|41799799|FG000|Overall Study|Other|4|||
19491316|NCT00086684|41799800|FG001|Overall Study|Other|2|||
19491317|NCT00086684|41799801|FG002|Overall Study|Other|3|||
19491318|NCT00082628|41799865|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
19491319|NCT00082628|41799866|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
19491320|NCT00082628|41799867|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
19393589|NCT01938430|41637418|FG004|Overall Study|Lost to Follow-up|0|||
19491321|NCT00082628|41799868|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
19491322|NCT00082628|41799869|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
19491323|NCT00082628|41799865|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
19491324|NCT00082628|41799866|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
19491325|NCT00082628|41799867|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
19704315|NCT03757234|42148619|FG000|Overall Study|Lost to Follow-up|1|||
19491326|NCT00082628|41799868|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
19491327|NCT00082628|41799869|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
19491328|NCT00082628|41799865|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
19491329|NCT00082628|41799866|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
19491330|NCT00082628|41799867|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
19491331|NCT00082628|41799868|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
19491332|NCT00082628|41799869|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
19491333|NCT00082628|41799865|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
19491334|NCT00082628|41799866|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
19491335|NCT00082628|41799867|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
19491336|NCT00082628|41799868|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
19491337|NCT00082628|41799869|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
19491338|NCT00082628|41799865|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
19491339|NCT00082628|41799866|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
19491340|NCT00082628|41799867|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
19491341|NCT00082628|41799868|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
19491342|NCT00082628|41799869|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
19491343|NCT00082628|41799865|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
19491344|NCT00082628|41799866|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
19491345|NCT00082628|41799867|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
19491346|NCT00082628|41799868|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
19491347|NCT00082628|41799869|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
19491348|NCT00082628|41799865|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
19491349|NCT00082628|41799866|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
19491350|NCT00082628|41799867|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
19491351|NCT00082628|41799868|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
19491352|NCT00082628|41799869|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
19491353|NCT02993263|41800233|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
19491354|NCT01274533|41800278|FG000|Overall Study|Withdrawal by Subject|1|||
19491355|NCT01274533|41800278|FG000|Overall Study|Non-compliance|1|||
19491356|NCT01274533|41800278|FG000|Overall Study|Disease progression|2|||
19491357|NCT01273597|41800282|FG000|Overall Study|Adverse Event|5|||
19491358|NCT01273597|41800282|FG000|Overall Study|Underwent Kidney Transplantation|2|||
19491359|NCT01273597|41800282|FG000|Overall Study|Reason Not Reported|1|||
19491360|NCT01273519|41800289|FG000|Overall Study|Adverse Event|3|||
19491361|NCT01273519|41800290|FG001|Overall Study|Adverse Event|0|||
19491362|NCT01273519|41800291|FG002|Overall Study|Adverse Event|0|||
19491363|NCT01273519|41800289|FG000|Overall Study|Lost to Follow-up|2|||
19491364|NCT01273519|41800290|FG001|Overall Study|Lost to Follow-up|1|||
19491365|NCT01273519|41800291|FG002|Overall Study|Lost to Follow-up|3|||
19491366|NCT01273519|41800289|FG000|Overall Study|Lack of Efficacy|8|||
19491367|NCT01273519|41800290|FG001|Overall Study|Lack of Efficacy|3|||
19491368|NCT01273519|41800291|FG002|Overall Study|Lack of Efficacy|4|||
19491369|NCT01273519|41800289|FG000|Overall Study|Other|6|||
19491370|NCT01273519|41800290|FG001|Overall Study|Other|1|||
19491371|NCT01273519|41800291|FG002|Overall Study|Other|1|||
19491372|NCT01272661|41800348|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
19491373|NCT01272661|41800349|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
19491374|NCT01272661|41800350|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
19491375|NCT04276051|41800510|FG000|Overall Study|Lost to Follow-up|0|||
19491376|NCT04276051|41800511|FG001|Overall Study|Lost to Follow-up|1|||
19491377|NCT04276051|41800510|FG000|Overall Study|Physician Decision|0|||
19491378|NCT04276051|41800511|FG001|Overall Study|Physician Decision|1|||
19491379|NCT04276051|41800510|FG000|Overall Study|Withdrawal by Subject|1|||
19491380|NCT04276051|41800511|FG001|Overall Study|Withdrawal by Subject|1|||
19491381|NCT00081770|41800771|FG000|Overall Study|Adverse Event|130|||
19491382|NCT00081770|41800772|FG001|Overall Study|Adverse Event|98|||
19491383|NCT00081770|41800773|FG002|Overall Study|Adverse Event|136|||
19491384|NCT00081770|41800771|FG000|Overall Study|Lack of Efficacy|262|||
19491385|NCT00081770|41800772|FG001|Overall Study|Lack of Efficacy|357|||
19491386|NCT00081770|41800773|FG002|Overall Study|Lack of Efficacy|211|||
19491387|NCT00081770|41800771|FG000|Overall Study|Lost to Follow-up|45|||
19491388|NCT00081770|41800772|FG001|Overall Study|Lost to Follow-up|34|||
19491389|NCT00081770|41800773|FG002|Overall Study|Lost to Follow-up|45|||
19491390|NCT00081770|41800771|FG000|Overall Study|Protocol Violation|15|||
19491391|NCT00081770|41800772|FG001|Overall Study|Protocol Violation|10|||
19491392|NCT00081770|41800773|FG002|Overall Study|Protocol Violation|10|||
19491393|NCT00081770|41800771|FG000|Overall Study|Withdrawal by Subject|45|||
19491394|NCT00081770|41800772|FG001|Overall Study|Withdrawal by Subject|40|||
19491395|NCT00081770|41800773|FG002|Overall Study|Withdrawal by Subject|42|||
19491396|NCT00081770|41800771|FG000|Overall Study|Did not meet protocol eligibility|2|||
19491397|NCT00081770|41800772|FG001|Overall Study|Did not meet protocol eligibility|0|||
19491398|NCT00081770|41800773|FG002|Overall Study|Did not meet protocol eligibility|3|||
19491399|NCT00081770|41800771|FG000|Overall Study|Administrative|1|||
19491400|NCT00081770|41800772|FG001|Overall Study|Administrative|0|||
19491401|NCT00081770|41800773|FG002|Overall Study|Administrative|1|||
19491402|NCT00081770|41800771|FG000|Overall Study|Other|2|||
19491403|NCT00081770|41800772|FG001|Overall Study|Other|7|||
19491404|NCT00081770|41800773|FG002|Overall Study|Other|8|||
19491405|NCT00081458|41800873|FG000|Overall Study|Adverse Event|1|||
19491406|NCT00081458|41800874|FG001|Overall Study|Adverse Event|5|||
19491407|NCT00081458|41800875|FG002|Overall Study|Adverse Event|2|||
19491408|NCT00081458|41800873|FG000|Overall Study|Withdrawal by Subject|0|||
19491409|NCT00081458|41800874|FG001|Overall Study|Withdrawal by Subject|3|||
19491410|NCT00081458|41800875|FG002|Overall Study|Withdrawal by Subject|1|||
19491411|NCT00081458|41800873|FG000|Overall Study|Randomized but not dosed|0|||
19491412|NCT00081458|41800874|FG001|Overall Study|Randomized but not dosed|0|||
19491413|NCT00081458|41800875|FG002|Overall Study|Randomized but not dosed|1|||
19491414|NCT01271803|41800952|FG000|Overall Study|Progressive disease|0|||
19491415|NCT01271803|41800953|FG001|Overall Study|Progressive disease|0|||
19491416|NCT01271803|41800954|FG002|Overall Study|Progressive disease|2|||
19491417|NCT01271803|41800952|FG000|Overall Study|Death|53|||
19491418|NCT01271803|41800953|FG001|Overall Study|Death|34|||
19491419|NCT01271803|41800954|FG002|Overall Study|Death|0|||
19491420|NCT01271803|41800952|FG000|Overall Study|Withdrawal by Subject|1|||
19491421|NCT01271803|41800953|FG001|Overall Study|Withdrawal by Subject|5|||
19491422|NCT01271803|41800954|FG002|Overall Study|Withdrawal by Subject|0|||
19491423|NCT01271803|41800952|FG000|Overall Study|Lost to Follow-up|1|||
19491424|NCT01271803|41800953|FG001|Overall Study|Lost to Follow-up|0|||
19491425|NCT01271803|41800954|FG002|Overall Study|Lost to Follow-up|0|||
19491426|NCT00080288|41801005|FG000|Overall Study|Adverse Event|7|||
19491427|NCT00080288|41801006|FG001|Overall Study|Adverse Event|4|||
19491428|NCT00080288|41801005|FG000|Overall Study|Lost to Follow-up|3|||
19491429|NCT00080288|41801006|FG001|Overall Study|Lost to Follow-up|5|||
19491430|NCT00080288|41801005|FG000|Overall Study|Physician Decision|6|||
19491431|NCT00080288|41801006|FG001|Overall Study|Physician Decision|2|||
19491432|NCT00080288|41801005|FG000|Overall Study|Withdrawal by Subject|3|||
19491433|NCT00080288|41801006|FG001|Overall Study|Withdrawal by Subject|16|||
19491434|NCT00080288|41801005|FG000|Overall Study|Miscellaneous|11|||
19491435|NCT00080288|41801006|FG001|Overall Study|Miscellaneous|11|||
19491436|NCT01271725|41801077|FG000|Part A|Progressive disease according to RECIST|8|||
19491437|NCT01271725|41801078|FG001|Part A|Progressive disease according to RECIST|0|||
19491438|NCT01271725|41801077|FG000|Part A|Clinical signs/symptoms of progression|2|||
19491439|NCT01271725|41801078|FG001|Part A|Clinical signs/symptoms of progression|0|||
19491440|NCT01271725|41801077|FG000|Part A|Other Adverse Event|8|||
19491441|NCT01271725|41801078|FG001|Part A|Other Adverse Event|0|||
19491442|NCT01271725|41801077|FG000|Part A|Lost to Follow-up|1|||
19491443|NCT01271725|41801078|FG001|Part A|Lost to Follow-up|0|||
19491444|NCT01271725|41801077|FG000|Part A|Withdrawal by Subject|12|||
19491445|NCT01271725|41801078|FG001|Part A|Withdrawal by Subject|0|||
19491446|NCT01271725|41801077|FG000|Part A|Other than specified|3|||
19491447|NCT01271725|41801078|FG001|Part A|Other than specified|0|||
19491448|NCT01271725|41801077|FG000|Part A|Protocol Violation|1|||
19491449|NCT01271725|41801078|FG001|Part A|Protocol Violation|0|||
19491450|NCT01271725|41801077|FG000|Part B|Other than specified|0|||
19491451|NCT01271725|41801078|FG001|Part B|Other than specified|2|||
19491452|NCT01271725|41801077|FG000|Part B|Clinical signs/symptoms of progression|0|||
19491453|NCT01271725|41801078|FG001|Part B|Clinical signs/symptoms of progression|2|||
19491454|NCT01271725|41801077|FG000|Part B|Other Adverse Event|0|||
19491455|NCT01271725|41801078|FG001|Part B|Other Adverse Event|1|||
19491456|NCT01271725|41801077|FG000|Part B|Protocol Violation|0|||
19491457|NCT01271725|41801078|FG001|Part B|Protocol Violation|1|||
19491458|NCT01271725|41801077|FG000|Part B|Withdrawal by Subject|0|||
19491459|NCT01271725|41801078|FG001|Part B|Withdrawal by Subject|6|||
19491460|NCT01270321|41801103|FG000|Overall Study|Death|3|||
19491461|NCT01270321|41801104|FG001|Overall Study|Death|1|||
19491462|NCT01270321|41801105|FG002|Overall Study|Death|4|||
19491463|NCT01270321|41801103|FG000|Overall Study|Adverse Event|7|||
19491464|NCT01270321|41801104|FG001|Overall Study|Adverse Event|9|||
19491465|NCT01270321|41801105|FG002|Overall Study|Adverse Event|5|||
19491466|NCT00249769|41801180|FG000|Overall Study|Withdrawal by Subject|1|||
19491467|NCT00249769|41801181|FG001|Overall Study|Withdrawal by Subject|10|||
19491468|NCT00249769|41801182|FG002|Overall Study|Withdrawal by Subject|6|||
19491469|NCT00249769|41801180|FG000|Overall Study|Migration from Study Area|1|||
19491470|NCT00249769|41801181|FG001|Overall Study|Migration from Study Area|3|||
19491471|NCT00249769|41801182|FG002|Overall Study|Migration from Study Area|14|||
19491472|NCT00249769|41801180|FG000|Overall Study|Miscellaneous|0|||
19491473|NCT00249769|41801181|FG001|Overall Study|Miscellaneous|2|||
19491474|NCT00249769|41801182|FG002|Overall Study|Miscellaneous|2|||
19491475|NCT00249769|41801180|FG000|Overall Study|Adverse Event|0|||
19491476|NCT00249769|41801181|FG001|Overall Study|Adverse Event|0|||
19491477|NCT00249769|41801182|FG002|Overall Study|Adverse Event|1|||
19491478|NCT00249769|41801180|FG000|Overall Study|Physician Decision|0|||
19491479|NCT00249769|41801181|FG001|Overall Study|Physician Decision|0|||
19491480|NCT00249769|41801182|FG002|Overall Study|Physician Decision|2|||
19491481|NCT00249769|41801180|FG000|Overall Study|Lost to Follow-up|0|||
19491482|NCT00249769|41801181|FG001|Overall Study|Lost to Follow-up|0|||
19491483|NCT00249769|41801182|FG002|Overall Study|Lost to Follow-up|3|||
19491484|NCT00249613|41801192|FG000|12 Month Follow-up|Death|1|||
19491485|NCT00249613|41801193|FG001|12 Month Follow-up|Death|1|||
19491486|NCT00249613|41801192|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
19491487|NCT00249613|41801193|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
19491488|NCT00249613|41801192|FG000|12 Month Follow-up|Lost to Follow-up|10|||
19491489|NCT00249613|41801193|FG001|12 Month Follow-up|Lost to Follow-up|8|||
19491490|NCT00248833|41801229|FG000|Overall Study|Adverse Event|2|||
19491491|NCT00248833|41801230|FG001|Overall Study|Adverse Event|0|||
19491492|NCT00248833|41801231|FG002|Overall Study|Adverse Event|0|||
19491493|NCT00248833|41801229|FG000|Overall Study|Withdrawal by Subject|0|||
19491494|NCT00248833|41801230|FG001|Overall Study|Withdrawal by Subject|1|||
19491495|NCT00248833|41801231|FG002|Overall Study|Withdrawal by Subject|1|||
19491496|NCT00248833|41801229|FG000|Overall Study|Lost to Follow-up|1|||
19491497|NCT00248833|41801230|FG001|Overall Study|Lost to Follow-up|1|||
19491498|NCT00248833|41801231|FG002|Overall Study|Lost to Follow-up|1|||
19491499|NCT00248833|41801229|FG000|Overall Study|Other|0|||
19491500|NCT00248833|41801230|FG001|Overall Study|Other|1|||
19491501|NCT00248833|41801231|FG002|Overall Study|Other|0|||
19491502|NCT00247273|41801411|FG000|Overall Study|Adverse Event|85|||
19491503|NCT00247273|41801412|FG001|Overall Study|Adverse Event|80|||
19491504|NCT00247273|41801411|FG000|Overall Study|Physician Decision|6|||
19491505|NCT00247273|41801412|FG001|Overall Study|Physician Decision|3|||
19491506|NCT00247273|41801411|FG000|Overall Study|Lost to Follow-up|7|||
19491507|NCT00247273|41801412|FG001|Overall Study|Lost to Follow-up|7|||
19491508|NCT00247273|41801411|FG000|Overall Study|Withdrawal by Subject|46|||
19491509|NCT00247273|41801412|FG001|Overall Study|Withdrawal by Subject|47|||
19491510|NCT00247273|41801411|FG000|Overall Study|Did not take any study drug|2|||
19491511|NCT00247273|41801412|FG001|Overall Study|Did not take any study drug|0|||
19491512|NCT00246259|41801500|FG000|Overall Study|Other|3|||
19491513|NCT00246259|41801501|FG001|Overall Study|Other|3|||
19491514|NCT00246259|41801500|FG000|Overall Study|Not stable by Week 18|2|||
19491515|NCT00246259|41801501|FG001|Overall Study|Not stable by Week 18|1|||
19491516|NCT00246259|41801500|FG000|Overall Study|Participant non-compliant|4|||
19491517|NCT00246259|41801501|FG001|Overall Study|Participant non-compliant|9|||
19491518|NCT00246259|41801500|FG000|Overall Study|Lack of Efficacy|2|||
19491519|NCT00246259|41801501|FG001|Overall Study|Lack of Efficacy|2|||
19491520|NCT00246259|41801500|FG000|Overall Study|Investigator withdrew participant|2|||
19491521|NCT00246259|41801501|FG001|Overall Study|Investigator withdrew participant|0|||
19491522|NCT00246259|41801500|FG000|Overall Study|Adverse Event|5|||
19491523|NCT00246259|41801501|FG001|Overall Study|Adverse Event|0|||
19491524|NCT00246259|41801500|FG000|Overall Study|Lost to Follow-up|3|||
19491525|NCT00246259|41801501|FG001|Overall Study|Lost to Follow-up|4|||
19491526|NCT00246259|41801500|FG000|Overall Study|Withdrawal by Subject|5|||
19491527|NCT00246259|41801501|FG001|Overall Study|Withdrawal by Subject|1|||
19491528|NCT00246259|41801500|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
19491529|NCT00246259|41801501|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
19491530|NCT00246025|41801553|FG000|Overall Study|Adverse Event|7|||
19491531|NCT00246025|41801554|FG001|Overall Study|Adverse Event|9|||
19491532|NCT00246025|41801555|FG002|Overall Study|Adverse Event|9|||
19491533|NCT00246025|41801556|FG003|Overall Study|Adverse Event|10|||
19491534|NCT00246025|41801553|FG000|Overall Study|Withdrawal by Subject|3|||
19491535|NCT00246025|41801554|FG001|Overall Study|Withdrawal by Subject|0|||
19491536|NCT00246025|41801555|FG002|Overall Study|Withdrawal by Subject|1|||
19491537|NCT00246025|41801556|FG003|Overall Study|Withdrawal by Subject|2|||
19491538|NCT00246025|41801553|FG000|Overall Study|unsuitable medical history was found|0|||
19491539|NCT00246025|41801554|FG001|Overall Study|unsuitable medical history was found|0|||
19491540|NCT00246025|41801555|FG002|Overall Study|unsuitable medical history was found|0|||
19491541|NCT00246025|41801556|FG003|Overall Study|unsuitable medical history was found|1|||
19491542|NCT00245011|41801699|FG000|Overall Study|Lack of Efficacy|1|||
19491543|NCT00244933|41801712|FG000|Overall Study|Not response evaluable|2|||
19491544|NCT00244855|41801722|FG000|Overall Study|Withdrawal by Subject|0|||
19491545|NCT00244855|41801723|FG001|Overall Study|Withdrawal by Subject|1|||
19491546|NCT00244621|41801753|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19491547|NCT00244621|41801754|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
19491548|NCT00244621|41801755|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
19491549|NCT00244621|41801753|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
19491550|NCT00244621|41801754|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
19491551|NCT00244621|41801755|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19613280|NCT00608023|42062153|FG000|Overall Study|Withdrawal by Subject|8|||
19491552|NCT00244621|41801753|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
19491553|NCT00244621|41801754|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
19491554|NCT00244621|41801755|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
19491555|NCT00244621|41801753|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
19491556|NCT00244621|41801754|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
19491557|NCT00244621|41801755|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
19491558|NCT00244621|41801753|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
19491559|NCT00244621|41801754|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
19491560|NCT00244621|41801755|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
19491561|NCT00244621|41801753|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
19491562|NCT00244621|41801754|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
19491563|NCT00244621|41801755|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
19491564|NCT00244621|41801753|FG000|Open-label Treatment Period|Adverse Event|0|||
19491565|NCT00244621|41801754|FG001|Open-label Treatment Period|Adverse Event|0|||
19491566|NCT00244621|41801755|FG002|Open-label Treatment Period|Adverse Event|1|||
19491567|NCT00244621|41801753|FG000|Open-label Treatment Period|Moved abroad|0|||
19491568|NCT00244621|41801754|FG001|Open-label Treatment Period|Moved abroad|0|||
19491569|NCT00244621|41801755|FG002|Open-label Treatment Period|Moved abroad|1|||
19704316|NCT03757234|42148620|FG001|Overall Study|Lost to Follow-up|0|||
19704317|NCT03757234|42148621|FG002|Overall Study|Lost to Follow-up|0|||
19704318|NCT03757234|42148622|FG003|Overall Study|Lost to Follow-up|0|||
19704319|NCT03757234|42148623|FG004|Overall Study|Lost to Follow-up|1|||
19704320|NCT03757234|42148619|FG000|Overall Study|Withdrawal by Subject|1|||
19704321|NCT03757234|42148620|FG001|Overall Study|Withdrawal by Subject|1|||
19491570|NCT00243841|41801838|FG000|Overall Study|Physician Decision|0|||
19491571|NCT00243841|41801839|FG001|Overall Study|Physician Decision|0|||
19491572|NCT00243841|41801840|FG002|Overall Study|Physician Decision|1|||
19491573|NCT00243841|41801841|FG003|Overall Study|Physician Decision|0|||
19491574|NCT00243841|41801842|FG004|Overall Study|Physician Decision|0|||
19491575|NCT00243841|41801843|FG005|Overall Study|Physician Decision|2|||
19491576|NCT03100149|41801969|FG000|Overall Study|Adverse Event|0|||
19491577|NCT03100149|41801970|FG001|Overall Study|Adverse Event|1|||
19491578|NCT03100149|41801971|FG002|Overall Study|Adverse Event|0|||
19491579|NCT03100149|41801969|FG000|Overall Study|Participant Moved out of Country|0|||
19491580|NCT03100149|41801970|FG001|Overall Study|Participant Moved out of Country|0|||
19491581|NCT03100149|41801971|FG002|Overall Study|Participant Moved out of Country|1|||
19491582|NCT03100149|41801969|FG000|Overall Study|Withdrawal by Subject|0|||
19491583|NCT03100149|41801970|FG001|Overall Study|Withdrawal by Subject|3|||
19491584|NCT03100149|41801971|FG002|Overall Study|Withdrawal by Subject|1|||
19491585|NCT02980731|41802062|FG000|Overall Study|Death|63|||
19491586|NCT02980731|41802062|FG000|Overall Study|Withdrawal by Subject|6|||
19491587|NCT02980731|41802062|FG000|Overall Study|Lost to Follow-up|5|||
19491588|NCT02980731|41802062|FG000|Overall Study|Study terminated by Sponsor|4|||
19491589|NCT02980731|41802062|FG000|Overall Study|Completed survival follow-up period|65|||
19491590|NCT02980731|41802062|FG000|Overall Study|COVID-19 infection|1|||
19491591|NCT02980731|41802062|FG000|Overall Study|Other, not specified|66|||
19491592|NCT02641587|41802102|FG000|Confinement Period|Adverse Event|1|||
19491593|NCT02641587|41802103|FG001|Confinement Period|Adverse Event|0|||
19491594|NCT02641587|41802102|FG000|Confinement Period|Withdrawal by Subject|2|||
19491595|NCT02641587|41802103|FG001|Confinement Period|Withdrawal by Subject|1|||
19491596|NCT02641587|41802102|FG000|Ambulatory Period|Withdrawal by Subject|1|||
19491597|NCT02641587|41802103|FG001|Ambulatory Period|Withdrawal by Subject|0|||
19491598|NCT04672083|41802221|FG000|Overall Study|Lost to Follow-up|1|||
19491599|NCT04672083|41802222|FG001|Overall Study|Lost to Follow-up|0|||
19491600|NCT04672083|41802223|FG002|Overall Study|Lost to Follow-up|0|||
19491601|NCT04672083|41802224|FG003|Overall Study|Lost to Follow-up|0|||
19491602|NCT04672083|41802225|FG004|Overall Study|Lost to Follow-up|0|||
19491603|NCT02094261|41802304|FG000|Overall Study|Death|24|||
19491604|NCT02094261|41802304|FG000|Overall Study|Lost to Follow-up|1|||
19491605|NCT02094261|41802304|FG000|Overall Study|Withdrawal by Subject|4|||
19491606|NCT02094261|41802304|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
19491607|NCT01781637|41802332|FG000|Overall Study|Adverse Event|1|||
19704322|NCT03757234|42148621|FG002|Overall Study|Withdrawal by Subject|0|||
19491608|NCT01781637|41802333|FG001|Overall Study|Adverse Event|0|||
19491609|NCT01781637|41802332|FG000|Overall Study|Lack of Efficacy|2|||
19491610|NCT01781637|41802333|FG001|Overall Study|Lack of Efficacy|6|||
19491611|NCT01781637|41802332|FG000|Overall Study|Withdrawal by Subject|1|||
19491612|NCT01781637|41802333|FG001|Overall Study|Withdrawal by Subject|0|||
19491613|NCT01459497|41802381|FG000|Overall Study|Inability to meet trial constraints.|1|||
19491614|NCT01459497|41802382|FG001|Overall Study|Inability to meet trial constraints.|0|||
19491615|NCT01459497|41802381|FG000|Overall Study|Physician Decision|1|||
19491616|NCT01459497|41802382|FG001|Overall Study|Physician Decision|1|||
19491617|NCT01459497|41802381|FG000|Overall Study|Hospitalization.|0|||
19491618|NCT01459497|41802382|FG001|Overall Study|Hospitalization.|3|||
19704323|NCT03757234|42148622|FG003|Overall Study|Withdrawal by Subject|1|||
19704324|NCT03757234|42148623|FG004|Overall Study|Withdrawal by Subject|2|||
19491619|NCT01459497|41802381|FG000|Overall Study|Disease progression.|0|||
19491620|NCT01459497|41802382|FG001|Overall Study|Disease progression.|1|||
19491621|NCT04723394|41802660|FG000|Overall Study|Adverse Event|0|||
19491622|NCT04723394|41802661|FG001|Overall Study|Adverse Event|2|||
19491623|NCT04723394|41802660|FG000|Overall Study|Death|6|||
19491624|NCT04723394|41802661|FG001|Overall Study|Death|5|||
19491625|NCT04723394|41802660|FG000|Overall Study|Lost to Follow-up|2|||
19491626|NCT04723394|41802661|FG001|Overall Study|Lost to Follow-up|2|||
19491627|NCT04723394|41802660|FG000|Overall Study|Physician Decision|2|||
19491628|NCT04723394|41802661|FG001|Overall Study|Physician Decision|0|||
19491629|NCT04723394|41802660|FG000|Overall Study|Withdrawal by Subject|10|||
19491630|NCT04723394|41802661|FG001|Overall Study|Withdrawal by Subject|8|||
19491631|NCT04723394|41802660|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
19491632|NCT04723394|41802661|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|5|||
19491633|NCT04723394|41802660|FG000|Overall Study|Still Ongoing at Data Cut-Off|436|||
19491634|NCT04723394|41802661|FG001|Overall Study|Still Ongoing at Data Cut-Off|432|||
19491635|NCT04575584|41802740|FG000|Overall Study|Death|6|||
19491636|NCT04575584|41802741|FG001|Overall Study|Death|4|||
19491637|NCT04575584|41802742|FG002|Overall Study|Death|6|||
19491638|NCT04575584|41802743|FG003|Overall Study|Death|2|||
19491639|NCT04575584|41802744|FG004|Overall Study|Death|0|||
19491640|NCT04575584|41802745|FG005|Overall Study|Death|0|||
19491641|NCT04575584|41802740|FG000|Overall Study|Lost to Follow-up|1|||
19491642|NCT04575584|41802741|FG001|Overall Study|Lost to Follow-up|1|||
19491643|NCT04575584|41802742|FG002|Overall Study|Lost to Follow-up|1|||
19491644|NCT04575584|41802743|FG003|Overall Study|Lost to Follow-up|1|||
19491645|NCT04575584|41802744|FG004|Overall Study|Lost to Follow-up|0|||
19491646|NCT04575584|41802745|FG005|Overall Study|Lost to Follow-up|0|||
19491647|NCT04575584|41802740|FG000|Overall Study|Physician Decision|0|||
19491648|NCT04575584|41802741|FG001|Overall Study|Physician Decision|1|||
19491649|NCT04575584|41802742|FG002|Overall Study|Physician Decision|1|||
19491650|NCT04575584|41802743|FG003|Overall Study|Physician Decision|1|||
19491651|NCT04575584|41802744|FG004|Overall Study|Physician Decision|0|||
19491652|NCT04575584|41802745|FG005|Overall Study|Physician Decision|0|||
19491653|NCT04575584|41802740|FG000|Overall Study|Withdrawal by Subject|7|||
19491654|NCT04575584|41802741|FG001|Overall Study|Withdrawal by Subject|9|||
19491655|NCT04575584|41802742|FG002|Overall Study|Withdrawal by Subject|5|||
19491656|NCT04575584|41802743|FG003|Overall Study|Withdrawal by Subject|3|||
19491657|NCT04575584|41802744|FG004|Overall Study|Withdrawal by Subject|0|||
19491658|NCT04575584|41802745|FG005|Overall Study|Withdrawal by Subject|0|||
19491659|NCT04575584|41802740|FG000|Overall Study|Not recorded|0|||
19491660|NCT04575584|41802741|FG001|Overall Study|Not recorded|0|||
19491661|NCT04575584|41802742|FG002|Overall Study|Not recorded|0|||
19491662|NCT04575584|41802743|FG003|Overall Study|Not recorded|1|||
19491663|NCT04575584|41802744|FG004|Overall Study|Not recorded|0|||
19491664|NCT04575584|41802745|FG005|Overall Study|Not recorded|0|||
19491665|NCT03726879|41802761|FG000|Overall Study|Death|6|||
19491666|NCT03726879|41802762|FG001|Overall Study|Death|4|||
19491667|NCT03726879|41802761|FG000|Overall Study|Physician Decision|0|||
19491668|NCT03726879|41802762|FG001|Overall Study|Physician Decision|2|||
19491669|NCT03726879|41802761|FG000|Overall Study|Protocol Violation|0|||
19491670|NCT03726879|41802762|FG001|Overall Study|Protocol Violation|1|||
19491671|NCT03726879|41802761|FG000|Overall Study|Withdrawal by Subject|5|||
19491672|NCT03726879|41802762|FG001|Overall Study|Withdrawal by Subject|5|||
19491673|NCT03726879|41802761|FG000|Overall Study|TSH result is unstable|0|||
19491674|NCT03726879|41802762|FG001|Overall Study|TSH result is unstable|1|||
19491675|NCT03726879|41802761|FG000|Overall Study|Continuing on Study|215|||
19491676|NCT03726879|41802762|FG001|Overall Study|Continuing on Study|215|||
19491677|NCT03721965|41802793|FG000|Overall Study|Death|1|||
19491678|NCT03721965|41802793|FG000|Overall Study|Study Terminated by Sponsor|1|||
19491679|NCT03873116|41802849|FG000|Overall Study|Study drug discontinuation due to rash|0|||
19491680|NCT03873116|41802850|FG001|Overall Study|Study drug discontinuation due to rash|0|||
19491681|NCT03873116|41802851|FG002|Overall Study|Study drug discontinuation due to rash|1|||
19491682|NCT02312258|41803137|FG000|Overall Study|Adverse Event|15|||
19491683|NCT02312258|41803138|FG001|Overall Study|Adverse Event|47|||
19491684|NCT02312258|41803137|FG000|Overall Study|Lost to Follow-up|0|||
19491685|NCT02312258|41803138|FG001|Overall Study|Lost to Follow-up|1|||
19704325|NCT03757234|42148619|FG000|Overall Study|Other|1|||
19491686|NCT02312258|41803137|FG000|Overall Study|Progressive Disease|174|||
19491687|NCT02312258|41803138|FG001|Overall Study|Progressive Disease|188|||
19491688|NCT02312258|41803137|FG000|Overall Study|Withdrawal by Subject|8|||
19491689|NCT02312258|41803138|FG001|Overall Study|Withdrawal by Subject|9|||
19491690|NCT02312258|41803137|FG000|Overall Study|Reason not Specified|11|||
19491691|NCT02312258|41803138|FG001|Overall Study|Reason not Specified|31|||
19491692|NCT02312258|41803137|FG000|Overall Study|Participants Ongoing Treatment|43|||
19491693|NCT02312258|41803138|FG001|Overall Study|Participants Ongoing Treatment|83|||
19491694|NCT03686384|41803308|FG000|Overall Study|Lack of Efficacy|4|||
19491695|NCT03686384|41803309|FG001|Overall Study|Lack of Efficacy|13|||
19491696|NCT03686384|41803308|FG000|Overall Study|Lost to Follow-up|3|||
19491697|NCT03686384|41803309|FG001|Overall Study|Lost to Follow-up|0|||
19491698|NCT03686384|41803308|FG000|Overall Study|Physician Decision|0|||
19491699|NCT03686384|41803309|FG001|Overall Study|Physician Decision|1|||
19491700|NCT03686384|41803308|FG000|Overall Study|Took prohibited medication|0|||
19491701|NCT03686384|41803309|FG001|Overall Study|Took prohibited medication|1|||
19491702|NCT00240331|41803381|FG000|Overall Study|Withdrawal by Subject|125|||
19491703|NCT00240331|41803382|FG001|Overall Study|Withdrawal by Subject|132|||
19491704|NCT00240331|41803381|FG000|Overall Study|Option selected by investigator|1|||
19491705|NCT00240331|41803382|FG001|Overall Study|Option selected by investigator|2|||
19491706|NCT00240097|41803388|FG000|Part I|Adverse Event|1|||
19491707|NCT00240097|41803388|FG000|Part I|Death|1|||
19491708|NCT00240097|41803388|FG000|Part I|histology|1|||
19491709|NCT00240097|41803388|FG000|Part I|unevaluable|1|||
19491710|NCT00240097|41803388|FG000|Part II|did not continue from Part I|23|||
19491711|NCT03620162|41803479|FG000|Overall Study|Physician Decision|4|||
19491712|NCT03620162|41803480|FG001|Overall Study|Physician Decision|0|||
19491713|NCT03620162|41803481|FG002|Overall Study|Physician Decision|1|||
19491714|NCT03620162|41803482|FG003|Overall Study|Physician Decision|0|||
19491715|NCT03620162|41803483|FG004|Overall Study|Physician Decision|2|||
19491716|NCT03620162|41803479|FG000|Overall Study|Lost to Follow-up|2|||
19491717|NCT03620162|41803480|FG001|Overall Study|Lost to Follow-up|6|||
19491718|NCT03620162|41803481|FG002|Overall Study|Lost to Follow-up|7|||
19491719|NCT03620162|41803482|FG003|Overall Study|Lost to Follow-up|3|||
19491720|NCT03620162|41803483|FG004|Overall Study|Lost to Follow-up|2|||
19491721|NCT03620162|41803479|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
19491722|NCT03620162|41803480|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
19491723|NCT03620162|41803481|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
19491724|NCT03620162|41803482|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
19491725|NCT03620162|41803483|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
19491726|NCT00248287|41803499|FG000|Overall Study|Adverse Event|11|||
19491727|NCT00248287|41803500|FG001|Overall Study|Adverse Event|10|||
19491728|NCT00248287|41803499|FG000|Overall Study|Death|1|||
19491729|NCT00248287|41803500|FG001|Overall Study|Death|0|||
19491730|NCT00248287|41803499|FG000|Overall Study|Lost to Follow-up|0|||
19491731|NCT00248287|41803500|FG001|Overall Study|Lost to Follow-up|1|||
19491732|NCT00248287|41803499|FG000|Overall Study|Investigator Request|4|||
19491733|NCT00248287|41803500|FG001|Overall Study|Investigator Request|3|||
19491734|NCT00248287|41803499|FG000|Overall Study|Patient Request|5|||
19491735|NCT00248287|41803500|FG001|Overall Study|Patient Request|3|||
19491736|NCT00248287|41803499|FG000|Overall Study|Other|3|||
19491737|NCT00248287|41803500|FG001|Overall Study|Other|2|||
19491738|NCT03084302|41803633|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
19613281|NCT00608023|42062154|FG001|Overall Study|Withdrawal by Subject|10|||
19491739|NCT03084302|41803633|FG000|Overall Study|No valid objective monitor data|6|||
19491740|NCT01279681|41803766|FG000|Overall Study|Disease Progression|9|||
19491741|NCT01279681|41803767|FG001|Overall Study|Disease Progression|6|||
19491742|NCT01279681|41803766|FG000|Overall Study|Withdrawal by Subject|3|||
19491743|NCT01279681|41803767|FG001|Overall Study|Withdrawal by Subject|4|||
19491744|NCT01279681|41803766|FG000|Overall Study|Adverse Event|2|||
19491745|NCT01279681|41803767|FG001|Overall Study|Adverse Event|3|||
19491746|NCT01279681|41803766|FG000|Overall Study|Death|0|||
19491747|NCT01279681|41803767|FG001|Overall Study|Death|1|||
19491748|NCT01279681|41803766|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
19491749|NCT01279681|41803767|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
19491750|NCT01279681|41803766|FG000|Overall Study|Physician Decision|1|||
19491751|NCT01279681|41803767|FG001|Overall Study|Physician Decision|0|||
19491752|NCT01279681|41803766|FG000|Overall Study|Other Reason|0|||
19491753|NCT01279681|41803767|FG001|Overall Study|Other Reason|2|||
19491754|NCT01279057|41803785|FG000|Overall Study|Adverse Event|1|||
19491755|NCT01279057|41803786|FG001|Overall Study|Adverse Event|0|||
19491756|NCT01279057|41803787|FG002|Overall Study|Adverse Event|1|||
19491757|NCT01279057|41803785|FG000|Overall Study|Insufficient therapeutic response|0|||
19491758|NCT01279057|41803786|FG001|Overall Study|Insufficient therapeutic response|0|||
19491759|NCT01279057|41803787|FG002|Overall Study|Insufficient therapeutic response|1|||
19491760|NCT01279057|41803785|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
19491761|NCT01279057|41803786|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
19491762|NCT01279057|41803787|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
19491763|NCT01279057|41803785|FG000|Overall Study|Withdrew consent|2|||
19491764|NCT01279057|41803786|FG001|Overall Study|Withdrew consent|0|||
19491765|NCT01279057|41803787|FG002|Overall Study|Withdrew consent|1|||
19491766|NCT01279057|41803785|FG000|Overall Study|Pregnancy|0|||
19491767|NCT01279057|41803786|FG001|Overall Study|Pregnancy|1|||
19491768|NCT01279057|41803787|FG002|Overall Study|Pregnancy|0|||
19491769|NCT01279057|41803785|FG000|Overall Study|Other|3|||
19491770|NCT01279057|41803786|FG001|Overall Study|Other|3|||
19491771|NCT01279057|41803787|FG002|Overall Study|Other|0|||
19491772|NCT02999633|41803795|FG000|Overall Study|Adverse Event|2|||
19491773|NCT02999633|41803795|FG000|Overall Study|Progressive disease|12|||
19491774|NCT01278745|41803897|FG000|Overall Study|Death|2|||
19491775|NCT01278745|41803898|FG001|Overall Study|Death|5|||
19491776|NCT01278745|41803899|FG002|Overall Study|Death|7|||
19491777|NCT01278745|41803900|FG003|Overall Study|Death|0|||
19491778|NCT01278745|41803897|FG000|Overall Study|Physician Decision|1|||
19491779|NCT01278745|41803898|FG001|Overall Study|Physician Decision|0|||
19491780|NCT01278745|41803899|FG002|Overall Study|Physician Decision|0|||
19491781|NCT01278745|41803900|FG003|Overall Study|Physician Decision|9|||
19491782|NCT01278745|41803897|FG000|Overall Study|Withdrawal by Subject|1|||
19491783|NCT01278745|41803898|FG001|Overall Study|Withdrawal by Subject|1|||
19491784|NCT01278745|41803899|FG002|Overall Study|Withdrawal by Subject|5|||
19491785|NCT01278745|41803900|FG003|Overall Study|Withdrawal by Subject|1|||
19491786|NCT01278745|41803897|FG000|Overall Study|Sponsor Decision|1|||
19491787|NCT01278745|41803898|FG001|Overall Study|Sponsor Decision|0|||
19491788|NCT01278745|41803899|FG002|Overall Study|Sponsor Decision|62|||
19491789|NCT01278745|41803900|FG003|Overall Study|Sponsor Decision|6|||
19491790|NCT01278745|41803897|FG000|Overall Study|Ineligible|0|||
19491791|NCT01278745|41803898|FG001|Overall Study|Ineligible|0|||
19491792|NCT01278745|41803899|FG002|Overall Study|Ineligible|42|||
19491793|NCT01278745|41803900|FG003|Overall Study|Ineligible|61|||
19491794|NCT01278745|41803897|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
19491795|NCT01278745|41803898|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
19491796|NCT01278745|41803899|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
19491797|NCT01278745|41803900|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
19491798|NCT03006926|41803910|FG000|Overall Study|Death|0|||
19491799|NCT03006926|41803911|FG001|Overall Study|Death|33|||
19491800|NCT03006926|41803910|FG000|Overall Study|Ongoing Survival Follow-up|0|||
19491801|NCT03006926|41803911|FG001|Overall Study|Ongoing Survival Follow-up|26|||
19491802|NCT03006926|41803910|FG000|Overall Study|Ongoing-on Treatment|0|||
19491803|NCT03006926|41803911|FG001|Overall Study|Ongoing-on Treatment|36|||
19491804|NCT03006926|41803910|FG000|Overall Study|Lost to Follow-up|0|||
19491805|NCT03006926|41803911|FG001|Overall Study|Lost to Follow-up|1|||
19491806|NCT03006926|41803910|FG000|Overall Study|Withdrawal by Subject|0|||
19491807|NCT03006926|41803911|FG001|Overall Study|Withdrawal by Subject|2|||
19491808|NCT01277887|41803973|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
19491809|NCT01277887|41803974|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
19491810|NCT01277887|41803973|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
19491811|NCT01277887|41803974|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
19491812|NCT01277887|41803973|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
19491813|NCT01277887|41803974|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
19491814|NCT01276327|41803988|FG000|Overall Study|Adverse Event|1|||
19704326|NCT03757234|42148620|FG001|Overall Study|Other|1|||
19491815|NCT01276327|41803989|FG001|Overall Study|Adverse Event|3|||
19491816|NCT01276327|41803988|FG000|Overall Study|Withdrawal by Subject|1|||
19491817|NCT01276327|41803989|FG001|Overall Study|Withdrawal by Subject|0|||
19491818|NCT00639002|41804111|FG000|Overall Study|Death|1|||
19491819|NCT00639002|41804111|FG000|Overall Study|Adverse Event|1|||
19491820|NCT00639002|41804111|FG000|Overall Study|Protocol Violation|1|||
19491821|NCT00639002|41804111|FG000|Overall Study|Disease progression|3|||
19491822|NCT00639002|41804111|FG000|Overall Study|Physician Decision|6|||
19491823|NCT00639002|41804111|FG000|Overall Study|Lack of Efficacy|1|||
19491824|NCT00638846|41804147|FG000|Overall Study|Adverse Event|0|||
19491825|NCT00638846|41804148|FG001|Overall Study|Adverse Event|1|||
19491826|NCT00638846|41804147|FG000|Overall Study|Lost to Follow-up|3|||
19491827|NCT00638846|41804148|FG001|Overall Study|Lost to Follow-up|2|||
19491828|NCT00638846|41804147|FG000|Overall Study|lens issue|1|||
19491829|NCT00638846|41804148|FG001|Overall Study|lens issue|3|||
19491830|NCT00638456|41804156|FG000|Overall Study|Withdrawal by Subject|6|||
19491831|NCT00638456|41804157|FG001|Overall Study|Withdrawal by Subject|2|||
19704327|NCT03757234|42148621|FG002|Overall Study|Other|0|||
19491832|NCT00638378|41804186|FG000|Overall Study|Death|2|||
19491833|NCT00638378|41804186|FG000|Overall Study|Adverse Event|1|||
19491834|NCT00638378|41804186|FG000|Overall Study|Disease progression|15|||
19491835|NCT00638378|41804186|FG000|Overall Study|Physician Decision|4|||
19491836|NCT03807349|41804363|FG000|Overall Study|Early Study Termination|9|||
19491837|NCT03802825|41804373|FG000|Overall Study|Lost to follow-up for intervention|12|||
19491838|NCT03802825|41804374|FG001|Overall Study|Lost to follow-up for intervention|3|||
19491839|NCT03802825|41804373|FG000|Overall Study|Received only 1 component of intervention|0|||
19491840|NCT03802825|41804374|FG001|Overall Study|Received only 1 component of intervention|13|||
19491841|NCT03808909|41804393|FG000|Overall Study|Lost to Follow-up|3|||
19491842|NCT03808909|41804394|FG001|Overall Study|Lost to Follow-up|0|||
19491843|NCT03802513|41804415|FG000|Overall Study|Lost to Follow-up|1|||
19491844|NCT01276223|41804606|FG000|Overall Study|Adverse Event|7|||
19491845|NCT01276223|41804607|FG001|Overall Study|Adverse Event|4|||
19491846|NCT01276223|41804608|FG002|Overall Study|Adverse Event|1|||
19491847|NCT01276223|41804606|FG000|Overall Study|Lost to Follow-up|0|||
19491848|NCT01276223|41804607|FG001|Overall Study|Lost to Follow-up|0|||
19491849|NCT01276223|41804608|FG002|Overall Study|Lost to Follow-up|1|||
19491850|NCT01276223|41804606|FG000|Overall Study|Other|0|||
19491851|NCT01276223|41804607|FG001|Overall Study|Other|0|||
19491852|NCT01276223|41804608|FG002|Overall Study|Other|1|||
19491853|NCT01276223|41804606|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
19491854|NCT01276223|41804607|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
19491855|NCT01276223|41804608|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
19491856|NCT01276223|41804606|FG000|Overall Study|Protocol Violation|1|||
19491857|NCT01276223|41804607|FG001|Overall Study|Protocol Violation|0|||
19491858|NCT01276223|41804608|FG002|Overall Study|Protocol Violation|0|||
19491859|NCT01275833|41804617|FG000|Overall Study|Study terminated|1|||
19491860|NCT01275833|41804618|FG001|Overall Study|Study terminated|1|||
19491861|NCT01275755|41804626|FG000|Double-blind Treatment Period|Adverse Event|0|||
19491862|NCT01275755|41804627|FG001|Double-blind Treatment Period|Adverse Event|2|||
19491863|NCT01275755|41804626|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
19491864|NCT01275755|41804627|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
19491865|NCT01275755|41804626|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
19491866|NCT01275755|41804627|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
19491867|NCT01275755|41804626|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
19491868|NCT01275755|41804627|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
19491869|NCT01275131|41804658|FG000|Period 1|Withdrawal by Subject|1|||
19491870|NCT01275131|41804659|FG001|Period 1|Withdrawal by Subject|0|||
19491871|NCT01275131|41804660|FG002|Period 1|Withdrawal by Subject|3|||
19491872|NCT01275131|41804661|FG003|Period 1|Withdrawal by Subject|2|||
19491873|NCT01275131|41804658|FG000|Period 1|Physician Decision|1|||
19491874|NCT01275131|41804659|FG001|Period 1|Physician Decision|0|||
19491875|NCT01275131|41804660|FG002|Period 1|Physician Decision|0|||
19491876|NCT01275131|41804661|FG003|Period 1|Physician Decision|0|||
19491877|NCT01275131|41804658|FG000|Period 2 (Crossover)|Adverse Event|0|||
19491878|NCT01275131|41804659|FG001|Period 2 (Crossover)|Adverse Event|1|||
19491879|NCT01275131|41804660|FG002|Period 2 (Crossover)|Adverse Event|0|||
19491880|NCT01275131|41804661|FG003|Period 2 (Crossover)|Adverse Event|0|||
19491881|NCT01275131|41804658|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
19491882|NCT01275131|41804659|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
19491883|NCT01275131|41804660|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
19491884|NCT01275131|41804661|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
19373672|NCT02760407|41614833|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
19373673|NCT02760407|41614834|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
19491885|NCT01274429|41804690|FG000|Overall Study|Study closed do to lack of funding|5|||
19491886|NCT01273883|41804694|FG000|First Intervention|Adverse Event|2|||
19491887|NCT01273883|41804695|FG001|First Intervention|Adverse Event|1|||
19491888|NCT01273883|41804694|FG000|Second Intervention|Lost to Follow-up|1|||
19491889|NCT01273883|41804695|FG001|Second Intervention|Lost to Follow-up|1|||
19491890|NCT01273883|41804694|FG000|Second Intervention|Lack of Efficacy|1|||
19491891|NCT01273883|41804695|FG001|Second Intervention|Lack of Efficacy|0|||
19491892|NCT01273805|41804703|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
19491893|NCT01273805|41804704|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
19491894|NCT01273181|41804714|FG000|Phase I, Dose 1|Study termination|1|||
19491895|NCT01273181|41804715|FG001|Phase I, Dose 1|Study termination|0|||
19491896|NCT01273181|41804716|FG002|Phase I, Dose 1|Study termination|0|||
19491897|NCT01273181|41804717|FG003|Phase I, Dose 1|Study termination|0|||
19491898|NCT01273181|41804714|FG000|Phase I, Dose 2|Death during treatment|0|||
19491899|NCT01273181|41804715|FG001|Phase I, Dose 2|Death during treatment|1|||
19491900|NCT01273181|41804716|FG002|Phase I, Dose 2|Death during treatment|0|||
19491901|NCT01273181|41804717|FG003|Phase I, Dose 2|Death during treatment|0|||
19491902|NCT01273181|41804714|FG000|Phase 2, Dose 1|Study termination|0|||
19491903|NCT01273181|41804715|FG001|Phase 2, Dose 1|Study termination|0|||
19491904|NCT01273181|41804716|FG002|Phase 2, Dose 1|Study termination|1|||
19491905|NCT01273181|41804717|FG003|Phase 2, Dose 1|Study termination|0|||
19491906|NCT01273181|41804714|FG000|Phase 2, Dose 2|Death during treatment|0|||
19491907|NCT01273181|41804715|FG001|Phase 2, Dose 2|Death during treatment|0|||
19491908|NCT01273181|41804716|FG002|Phase 2, Dose 2|Death during treatment|0|||
19491909|NCT01273181|41804717|FG003|Phase 2, Dose 2|Death during treatment|1|||
19491910|NCT01272947|41804733|FG000|Overall Study|Abnormal Laboratory Value|2|||
19491911|NCT01272947|41804734|FG001|Overall Study|Abnormal Laboratory Value|2|||
19491912|NCT01279343|41804742|FG000|Overall Study|Did not receive treatment|2|||
19491913|NCT01279343|41804743|FG001|Overall Study|Did not receive treatment|6|||
19491914|NCT01278797|41804749|FG000|Period 1|Adverse Event|0|||
19491915|NCT01278797|41804750|FG001|Period 1|Adverse Event|1|||
19491916|NCT01278797|41804749|FG000|Period 1|Protocol Violation|1|||
19491917|NCT01278797|41804750|FG001|Period 1|Protocol Violation|0|||
19491918|NCT01272869|41804758|FG000|Period 2 (14 Days)|Adverse Event|1|||
19491919|NCT01272869|41804759|FG001|Period 2 (14 Days)|Adverse Event|0|||
19491920|NCT01272635|41804767|FG000|Overall Study|Lost to Follow-up|31|||
19491921|NCT01272635|41804768|FG001|Overall Study|Lost to Follow-up|20|||
19491922|NCT01272635|41804769|FG002|Overall Study|Lost to Follow-up|31|||
19491923|NCT01272635|41804770|FG003|Overall Study|Lost to Follow-up|23|||
19491924|NCT01272011|41804781|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
19491925|NCT01272011|41804782|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
19491926|NCT01272011|41804783|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
19491927|NCT01270841|41804804|FG000|Overall Study|Adverse Event|0|||
19491928|NCT01270841|41804805|FG001|Overall Study|Adverse Event|1|||
19491929|NCT01270841|41804806|FG002|Overall Study|Adverse Event|0|||
19491930|NCT01270841|41804807|FG003|Overall Study|Adverse Event|3|||
19491931|NCT01270841|41804804|FG000|Overall Study|Withdrawal by Subject|3|||
19491932|NCT01270841|41804805|FG001|Overall Study|Withdrawal by Subject|2|||
19491933|NCT01270841|41804806|FG002|Overall Study|Withdrawal by Subject|3|||
19491934|NCT01270841|41804807|FG003|Overall Study|Withdrawal by Subject|3|||
19491935|NCT01270841|41804804|FG000|Overall Study|Lost to Follow-up|3|||
19491936|NCT01270841|41804805|FG001|Overall Study|Lost to Follow-up|1|||
19491937|NCT01270841|41804806|FG002|Overall Study|Lost to Follow-up|4|||
19491938|NCT01270841|41804807|FG003|Overall Study|Lost to Follow-up|2|||
19491939|NCT01270841|41804804|FG000|Overall Study|Physician Decision|0|||
19491940|NCT01270841|41804805|FG001|Overall Study|Physician Decision|1|||
19491941|NCT01270841|41804806|FG002|Overall Study|Physician Decision|0|||
19491942|NCT01270841|41804807|FG003|Overall Study|Physician Decision|0|||
19491943|NCT01270841|41804804|FG000|Overall Study|Did not qualify|6|||
19491944|NCT01270841|41804805|FG001|Overall Study|Did not qualify|3|||
19491945|NCT01270841|41804806|FG002|Overall Study|Did not qualify|4|||
19491946|NCT01270841|41804807|FG003|Overall Study|Did not qualify|5|||
19491947|NCT01270841|41804804|FG000|Overall Study|Protocol Violation|1|||
19491948|NCT01270841|41804805|FG001|Overall Study|Protocol Violation|5|||
19491949|NCT01270841|41804806|FG002|Overall Study|Protocol Violation|0|||
19491950|NCT01270841|41804807|FG003|Overall Study|Protocol Violation|0|||
19491951|NCT01270841|41804804|FG000|Overall Study|Enrolled in error|0|||
19491952|NCT01270841|41804805|FG001|Overall Study|Enrolled in error|1|||
19491953|NCT01270841|41804806|FG002|Overall Study|Enrolled in error|0|||
19491954|NCT01270841|41804807|FG003|Overall Study|Enrolled in error|0|||
19491955|NCT01270139|41804820|FG000|Overall Study|Adverse Event|8|||
19491956|NCT01270139|41804821|FG001|Overall Study|Adverse Event|17|||
19491957|NCT01270139|41804822|FG002|Overall Study|Adverse Event|18|||
19491958|NCT01270139|41804820|FG000|Overall Study|Lost to Follow-up|10|||
19491959|NCT01270139|41804821|FG001|Overall Study|Lost to Follow-up|9|||
19491960|NCT01270139|41804822|FG002|Overall Study|Lost to Follow-up|2|||
19491961|NCT01278407|41804840|FG000|Confirmatory Phase|Adverse Event|5|||
19491962|NCT01278407|41804841|FG001|Confirmatory Phase|Adverse Event|10|||
19491963|NCT01278407|41804842|FG002|Confirmatory Phase|Adverse Event|1|||
19491964|NCT01278407|41804843|FG003|Confirmatory Phase|Adverse Event|0|||
19491965|NCT01278407|41804844|FG004|Confirmatory Phase|Adverse Event|0|||
19491966|NCT01278407|41804840|FG000|Confirmatory Phase|Participant's Choice|3|||
19491967|NCT01278407|41804841|FG001|Confirmatory Phase|Participant's Choice|5|||
19491968|NCT01278407|41804842|FG002|Confirmatory Phase|Participant's Choice|3|||
19491969|NCT01278407|41804843|FG003|Confirmatory Phase|Participant's Choice|0|||
19491970|NCT01278407|41804844|FG004|Confirmatory Phase|Participant's Choice|0|||
19491971|NCT01278407|41804840|FG000|Confirmatory Phase|Other|1|||
19491972|NCT01278407|41804841|FG001|Confirmatory Phase|Other|1|||
19491973|NCT01278407|41804842|FG002|Confirmatory Phase|Other|2|||
19491974|NCT01278407|41804843|FG003|Confirmatory Phase|Other|0|||
19491975|NCT01278407|41804844|FG004|Confirmatory Phase|Other|0|||
19491976|NCT01278407|41804840|FG000|Extension Phase|Adverse Event|0|||
19491977|NCT01278407|41804841|FG001|Extension Phase|Adverse Event|0|||
19613282|NCT00608023|42062155|FG002|Overall Study|Withdrawal by Subject|7|||
19491978|NCT01278407|41804842|FG002|Extension Phase|Adverse Event|0|||
19491979|NCT01278407|41804843|FG003|Extension Phase|Adverse Event|7|||
19491980|NCT01278407|41804844|FG004|Extension Phase|Adverse Event|16|||
19491981|NCT01278407|41804840|FG000|Extension Phase|Participant's Choice|0|||
19491982|NCT01278407|41804841|FG001|Extension Phase|Participant's Choice|0|||
19491983|NCT01278407|41804842|FG002|Extension Phase|Participant's Choice|0|||
19491984|NCT01278407|41804843|FG003|Extension Phase|Participant's Choice|4|||
19491985|NCT01278407|41804844|FG004|Extension Phase|Participant's Choice|11|||
19491986|NCT01278407|41804840|FG000|Extension Phase|Other|0|||
19393590|NCT01938430|41637419|FG005|Overall Study|Lost to Follow-up|1|||
19393591|NCT01938430|41637420|FG006|Overall Study|Lost to Follow-up|0|||
19393592|NCT01938430|41637421|FG007|Overall Study|Lost to Follow-up|0|||
19491987|NCT01278407|41804841|FG001|Extension Phase|Other|0|||
19491988|NCT01278407|41804842|FG002|Extension Phase|Other|0|||
19491989|NCT01278407|41804843|FG003|Extension Phase|Other|1|||
19491990|NCT01278407|41804844|FG004|Extension Phase|Other|3|||
19491991|NCT01278173|41804854|FG000|Overall Study|Lack of Efficacy|13|||
19491992|NCT01278173|41804854|FG000|Overall Study|Adverse Event|8|||
19491993|NCT01278173|41804854|FG000|Overall Study|Administrative or other reason|4|||
19491994|NCT01278173|41804854|FG000|Overall Study|Protocol Violation|1|||
19491995|NCT01278173|41804854|FG000|Overall Study|Withdrawal by Subject|1|||
19491996|NCT01277861|41804898|FG000|Overall Study|Physician Decision|2|||
19491997|NCT01277861|41804899|FG001|Overall Study|Physician Decision|2|||
19491998|NCT01277549|41804926|FG000|Overall Study|Failed to meet eligibility criteria|13|||
19491999|NCT01277549|41804927|FG001|Overall Study|Failed to meet eligibility criteria|9|||
19492000|NCT01277549|41804926|FG000|Overall Study|Withdrawal by Subject|1|||
19492001|NCT01277549|41804927|FG001|Overall Study|Withdrawal by Subject|3|||
19492002|NCT01277549|41804926|FG000|Overall Study|Protocol Violation|10|||
19492003|NCT01277549|41804927|FG001|Overall Study|Protocol Violation|1|||
19492004|NCT01277549|41804926|FG000|Overall Study|Physician Decision|2|||
19492005|NCT01277549|41804927|FG001|Overall Study|Physician Decision|1|||
19492006|NCT01276847|41804939|FG000|Overall Study|Withdrawal by Subject|1|||
19492007|NCT01276847|41804940|FG001|Overall Study|Withdrawal by Subject|0|||
19492008|NCT01276847|41804941|FG002|Overall Study|Withdrawal by Subject|0|||
19492009|NCT01276457|41804973|FG000|Core Study|Adverse Event|6|||
19492010|NCT01276457|41804974|FG001|Core Study|Adverse Event|3|||
19492011|NCT01276457|41804973|FG000|Core Study|Lost to Follow-up|1|||
19492012|NCT01276457|41804974|FG001|Core Study|Lost to Follow-up|2|||
19492013|NCT01276457|41804973|FG000|Core Study|Administrative problems|1|||
19492014|NCT01276457|41804974|FG001|Core Study|Administrative problems|1|||
19492015|NCT01276457|41804973|FG000|Core Study|Death|2|||
19492016|NCT01276457|41804974|FG001|Core Study|Death|2|||
19492017|NCT01276457|41804973|FG000|Core Study|Lack of Efficacy|3|||
19492018|NCT01276457|41804974|FG001|Core Study|Lack of Efficacy|12|||
19613283|NCT00608023|42062153|FG000|Overall Study|Adverse Event|1|||
19613284|NCT00608023|42062154|FG001|Overall Study|Adverse Event|4|||
19613285|NCT00608023|42062155|FG002|Overall Study|Adverse Event|5|||
19613286|NCT00608023|42062153|FG000|Overall Study|Lost to Follow-up|2|||
19704328|NCT03757234|42148622|FG003|Overall Study|Other|0|||
19704329|NCT03757234|42148623|FG004|Overall Study|Other|0|||
19704330|NCT00223080|42148637|FG000|Overall Study|Withdrawal by Subject|253|||
19704331|NCT00223080|42148638|FG001|Overall Study|Withdrawal by Subject|232|||
19704332|NCT00223080|42148637|FG000|Overall Study|Required contraindicated med|0|||
19704333|NCT00223080|42148638|FG001|Overall Study|Required contraindicated med|1|||
19613287|NCT00608023|42062154|FG001|Overall Study|Lost to Follow-up|2|||
19613288|NCT00608023|42062155|FG002|Overall Study|Lost to Follow-up|1|||
19613289|NCT00608023|42062153|FG000|Overall Study|Protocol Violation|1|||
19613290|NCT00608023|42062154|FG001|Overall Study|Protocol Violation|3|||
19613291|NCT00608023|42062155|FG002|Overall Study|Protocol Violation|1|||
19613292|NCT00608023|42062153|FG000|Overall Study|Unknown reason|0|||
19613293|NCT00608023|42062154|FG001|Overall Study|Unknown reason|3|||
19613294|NCT00608023|42062155|FG002|Overall Study|Unknown reason|0|||
19613295|NCT00802659|42062170|FG000|Overall Study|Physician Decision|0|||
19613296|NCT00802659|42062171|FG001|Overall Study|Physician Decision|1|||
19613297|NCT00802659|42062172|FG002|Overall Study|Physician Decision|0|||
19613298|NCT00802659|42062173|FG003|Overall Study|Physician Decision|0|||
19613299|NCT00607789|42062185|FG000|Overall Study|Adverse Event|3|||
19613300|NCT00607789|42062186|FG001|Overall Study|Adverse Event|0|||
19613301|NCT00607789|42062185|FG000|Overall Study|Lack of Efficacy|0|||
19613302|NCT00607789|42062186|FG001|Overall Study|Lack of Efficacy|1|||
19704334|NCT00223080|42148637|FG000|Overall Study|Non-compliant|7|||
19704335|NCT00223080|42148638|FG001|Overall Study|Non-compliant|7|||
19393593|NCT01938430|41637422|FG008|Overall Study|Lost to Follow-up|0|||
19393594|NCT01938430|41637423|FG009|Overall Study|Lost to Follow-up|0|||
19393595|NCT01938430|41637424|FG010|Overall Study|Lost to Follow-up|0|||
19393596|NCT01938430|41637425|FG011|Overall Study|Lost to Follow-up|0|||
19492019|NCT01276457|41804973|FG000|Extension Study|Lost to Follow-up|3|||
19492020|NCT01276457|41804974|FG001|Extension Study|Lost to Follow-up|0|||
19492021|NCT01276457|41804973|FG000|Extension Study|Death|0|||
19492022|NCT01276457|41804974|FG001|Extension Study|Death|1|||
19613303|NCT00607789|42062185|FG000|Overall Study|Inadequate adherence|3|||
19393597|NCT01938430|41637426|FG012|Overall Study|Lost to Follow-up|0|||
19492023|NCT01276457|41804973|FG000|Extension Study|Lack of Efficacy|3|||
19492024|NCT01276457|41804974|FG001|Extension Study|Lack of Efficacy|1|||
19613304|NCT00607789|42062186|FG001|Overall Study|Inadequate adherence|0|||
19492025|NCT01276379|41805064|FG000|Overall Study|Screening failure|40|||
19492026|NCT03809663|41805360|FG000|Overall Study|Decision by sponsor|24|||
19492027|NCT03809663|41805361|FG001|Overall Study|Decision by sponsor|18|||
19492028|NCT03809663|41805362|FG002|Overall Study|Decision by sponsor|20|||
19492029|NCT03809663|41805363|FG003|Overall Study|Decision by sponsor|20|||
19492030|NCT03809663|41805364|FG004|Overall Study|Decision by sponsor|0|||
19492031|NCT03809663|41805365|FG005|Overall Study|Decision by sponsor|0|||
19492032|NCT03809663|41805360|FG000|Overall Study|Withdrawal by Subject|26|||
19492033|NCT03809663|41805361|FG001|Overall Study|Withdrawal by Subject|22|||
19492034|NCT03809663|41805362|FG002|Overall Study|Withdrawal by Subject|27|||
19492035|NCT03809663|41805363|FG003|Overall Study|Withdrawal by Subject|26|||
19492036|NCT03809663|41805364|FG004|Overall Study|Withdrawal by Subject|0|||
19492037|NCT03809663|41805365|FG005|Overall Study|Withdrawal by Subject|0|||
19492038|NCT03809663|41805360|FG000|Overall Study|Lost to Follow-up|1|||
19492039|NCT03809663|41805361|FG001|Overall Study|Lost to Follow-up|4|||
19492040|NCT03809663|41805362|FG002|Overall Study|Lost to Follow-up|1|||
19492041|NCT03809663|41805363|FG003|Overall Study|Lost to Follow-up|1|||
19492042|NCT03809663|41805364|FG004|Overall Study|Lost to Follow-up|0|||
19492043|NCT03809663|41805365|FG005|Overall Study|Lost to Follow-up|0|||
19492044|NCT00249821|41805427|FG000|Overall Study|Technical problem|0|||
19492045|NCT00249821|41805428|FG001|Overall Study|Technical problem|1|||
19492046|NCT00248651|41805503|FG000|Overall Study|Withdrawal by Subject|28|||
19492047|NCT00248651|41805504|FG001|Overall Study|Withdrawal by Subject|40|||
19492048|NCT00248651|41805505|FG002|Overall Study|Withdrawal by Subject|32|||
19492049|NCT00248495|41805542|FG000|Overall Study|Withdrawal by Subject|1|||
19492050|NCT03802565|41805639|FG000|Overall Study|Adverse Event|0|||
19492051|NCT03802565|41805640|FG001|Overall Study|Adverse Event|1|||
19492052|NCT03802565|41805641|FG002|Overall Study|Adverse Event|2|||
19492053|NCT03802565|41805642|FG003|Overall Study|Adverse Event|1|||
19492054|NCT03802565|41805643|FG004|Overall Study|Adverse Event|1|||
19492055|NCT03802565|41805639|FG000|Overall Study|Withdrawal by Subject|2|||
19492056|NCT03802565|41805640|FG001|Overall Study|Withdrawal by Subject|2|||
19492057|NCT03802565|41805641|FG002|Overall Study|Withdrawal by Subject|2|||
19492058|NCT03802565|41805642|FG003|Overall Study|Withdrawal by Subject|0|||
19492059|NCT03802565|41805643|FG004|Overall Study|Withdrawal by Subject|1|||
19492060|NCT03802565|41805639|FG000|Overall Study|Protocol Violation|2|||
19492061|NCT03802565|41805640|FG001|Overall Study|Protocol Violation|1|||
19492062|NCT03802565|41805641|FG002|Overall Study|Protocol Violation|4|||
19492063|NCT03802565|41805642|FG003|Overall Study|Protocol Violation|5|||
19492064|NCT03802565|41805643|FG004|Overall Study|Protocol Violation|1|||
19492065|NCT03802565|41805639|FG000|Overall Study|Lost to Follow-up|0|||
19492066|NCT03802565|41805640|FG001|Overall Study|Lost to Follow-up|0|||
19492067|NCT03802565|41805641|FG002|Overall Study|Lost to Follow-up|1|||
19492068|NCT03802565|41805642|FG003|Overall Study|Lost to Follow-up|0|||
19492069|NCT03802565|41805643|FG004|Overall Study|Lost to Follow-up|0|||
19492070|NCT03802565|41805639|FG000|Overall Study|Subjects Related to Each Other|1|||
19492071|NCT03802565|41805640|FG001|Overall Study|Subjects Related to Each Other|0|||
19492072|NCT03802565|41805641|FG002|Overall Study|Subjects Related to Each Other|0|||
19492073|NCT03802565|41805642|FG003|Overall Study|Subjects Related to Each Other|2|||
19492074|NCT03802565|41805643|FG004|Overall Study|Subjects Related to Each Other|1|||
19492075|NCT03802565|41805639|FG000|Overall Study|Elevated Enzymes|0|||
19492076|NCT03802565|41805640|FG001|Overall Study|Elevated Enzymes|0|||
19492077|NCT03802565|41805641|FG002|Overall Study|Elevated Enzymes|0|||
19492078|NCT03802565|41805642|FG003|Overall Study|Elevated Enzymes|0|||
19492079|NCT03802565|41805643|FG004|Overall Study|Elevated Enzymes|2|||
19492080|NCT00245765|41805687|FG000|Overall Study|Adverse Event|1|||
19492081|NCT00245765|41805688|FG001|Overall Study|Adverse Event|1|||
19492082|NCT00245765|41805689|FG002|Overall Study|Adverse Event|0|||
19492083|NCT00245765|41805687|FG000|Overall Study|Lack of Efficacy|14|||
19492084|NCT00245765|41805688|FG001|Overall Study|Lack of Efficacy|7|||
19492085|NCT00245765|41805689|FG002|Overall Study|Lack of Efficacy|0|||
19492086|NCT00245765|41805687|FG000|Overall Study|Lost to Follow-up|1|||
19492087|NCT00245765|41805688|FG001|Overall Study|Lost to Follow-up|2|||
19492088|NCT00245765|41805689|FG002|Overall Study|Lost to Follow-up|0|||
19492089|NCT00245765|41805687|FG000|Overall Study|Withdrawal by Subject|1|||
19492090|NCT00245765|41805688|FG001|Overall Study|Withdrawal by Subject|0|||
19492091|NCT00245765|41805689|FG002|Overall Study|Withdrawal by Subject|3|||
19492092|NCT00245765|41805687|FG000|Overall Study|Other reason|2|||
19492093|NCT00245765|41805688|FG001|Overall Study|Other reason|0|||
19492094|NCT00245765|41805689|FG002|Overall Study|Other reason|1|||
19492095|NCT00245765|41805687|FG000|Overall Study|Other|13|||
19492096|NCT00245765|41805688|FG001|Overall Study|Other|4|||
19492097|NCT00245765|41805689|FG002|Overall Study|Other|4|||
19492098|NCT00245063|41805761|FG000|Overall Study|Adverse Event|6|||
19492099|NCT00245063|41805762|FG001|Overall Study|Adverse Event|5|||
19492100|NCT00245063|41805761|FG000|Overall Study|Death|1|||
19492101|NCT00245063|41805762|FG001|Overall Study|Death|0|||
19492102|NCT04329091|41805827|FG000|Overall Study|Physician Decision|5|||
19492103|NCT00244751|41805834|FG000|Overall Study|Adverse Event|7|||
19492104|NCT00244751|41805835|FG001|Overall Study|Adverse Event|7|||
19492105|NCT00244751|41805836|FG002|Overall Study|Adverse Event|5|||
19492106|NCT00244751|41805834|FG000|Overall Study|Lost to Follow-up|0|||
19492107|NCT00244751|41805835|FG001|Overall Study|Lost to Follow-up|1|||
19492108|NCT00244751|41805836|FG002|Overall Study|Lost to Follow-up|0|||
19492109|NCT00244751|41805834|FG000|Overall Study|Protocol Violation|1|||
19492110|NCT00244751|41805835|FG001|Overall Study|Protocol Violation|0|||
19492111|NCT00244751|41805836|FG002|Overall Study|Protocol Violation|1|||
19492112|NCT00244751|41805834|FG000|Overall Study|Withdrawal by Subject|7|||
19492113|NCT00244751|41805835|FG001|Overall Study|Withdrawal by Subject|5|||
19492114|NCT00244751|41805836|FG002|Overall Study|Withdrawal by Subject|3|||
19492115|NCT00244751|41805834|FG000|Overall Study|Elevated liver enzymes|1|||
19492116|NCT00244751|41805835|FG001|Overall Study|Elevated liver enzymes|0|||
19492117|NCT00244751|41805836|FG002|Overall Study|Elevated liver enzymes|0|||
19492118|NCT00244751|41805834|FG000|Overall Study|Lack of compliance with protocol|0|||
19492119|NCT00244751|41805835|FG001|Overall Study|Lack of compliance with protocol|1|||
19492120|NCT00244751|41805836|FG002|Overall Study|Lack of compliance with protocol|0|||
19492121|NCT00244751|41805834|FG000|Overall Study|Safety reasons|0|||
19492122|NCT00244751|41805835|FG001|Overall Study|Safety reasons|1|||
19492123|NCT00244751|41805836|FG002|Overall Study|Safety reasons|0|||
19492124|NCT00244751|41805834|FG000|Overall Study|Participant randomized by mistake|0|||
19492125|NCT00244751|41805835|FG001|Overall Study|Participant randomized by mistake|0|||
19492126|NCT00244751|41805836|FG002|Overall Study|Participant randomized by mistake|1|||
19492127|NCT00243659|41805878|FG000|Overall Study|Withdrawal by Subject|1|||
19492128|NCT00243659|41805879|FG001|Overall Study|Withdrawal by Subject|1|||
19492129|NCT00243659|41805878|FG000|Overall Study|Protocol Violation|1|||
19492130|NCT00243659|41805879|FG001|Overall Study|Protocol Violation|2|||
19492131|NCT00243347|41805894|FG000|Overall Study|Lack of Efficacy|4|||
19492132|NCT00243347|41805894|FG000|Overall Study|Adverse Event|2|||
19492133|NCT00243347|41805894|FG000|Overall Study|Death|1|||
19492134|NCT00243347|41805894|FG000|Overall Study|Withdrawal by Subject|5|||
19492135|NCT00243347|41805894|FG000|Overall Study|Condition worsened|7|||
19492136|NCT00243269|41805902|FG000|Overall Study|Protocol Violation|2|||
19492137|NCT00243269|41805903|FG001|Overall Study|Protocol Violation|1|||
19492138|NCT00243269|41805904|FG002|Overall Study|Protocol Violation|0|||
19492139|NCT00243269|41805905|FG003|Overall Study|Protocol Violation|1|||
19492140|NCT00243269|41805902|FG000|Overall Study|Lost to Follow-up|1|||
19492141|NCT00243269|41805903|FG001|Overall Study|Lost to Follow-up|0|||
19492142|NCT00243269|41805904|FG002|Overall Study|Lost to Follow-up|1|||
19492143|NCT00243269|41805905|FG003|Overall Study|Lost to Follow-up|3|||
19492144|NCT00242567|41807142|FG000|Overall Study|Adverse Event|70|||
19492145|NCT00242567|41807143|FG001|Overall Study|Adverse Event|43|||
19492146|NCT00242567|41807142|FG000|Overall Study|Disease Progression|17|||
19492147|NCT00242567|41807143|FG001|Overall Study|Disease Progression|22|||
19492148|NCT00242567|41807142|FG000|Overall Study|Symptomatic deterioration|9|||
19492149|NCT00242567|41807143|FG001|Overall Study|Symptomatic deterioration|3|||
19492150|NCT00242567|41807142|FG000|Overall Study|Lack of Efficacy|2|||
19492151|NCT00242567|41807143|FG001|Overall Study|Lack of Efficacy|2|||
19492152|NCT00242567|41807142|FG000|Overall Study|Lost to Follow-up|9|||
19492153|NCT00242567|41807143|FG001|Overall Study|Lost to Follow-up|19|||
19492154|NCT00242567|41807142|FG000|Overall Study|Withdrawal by Subject|33|||
19492155|NCT00242567|41807143|FG001|Overall Study|Withdrawal by Subject|28|||
19492156|NCT00242567|41807142|FG000|Overall Study|Protocol Violation|12|||
19492157|NCT00242567|41807143|FG001|Overall Study|Protocol Violation|12|||
19492158|NCT00242567|41807142|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
19492159|NCT00242567|41807143|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
19492160|NCT00242567|41807142|FG000|Overall Study|Other|14|||
19492161|NCT00242567|41807143|FG001|Overall Study|Other|9|||
19492162|NCT00241631|41807153|FG000|Run in (2 Weeks)|Physician Decision|3|||
19492163|NCT00241631|41807154|FG001|Run in (2 Weeks)|Physician Decision|3|||
19492164|NCT00241631|41807153|FG000|Phase 1 (4 Weeks)|sore throat|1|||
19492165|NCT00241631|41807154|FG001|Phase 1 (4 Weeks)|sore throat|0|||
19492166|NCT00241631|41807153|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
19492167|NCT00241631|41807154|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
19492168|NCT00241631|41807153|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
19492169|NCT00241631|41807154|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
19492170|NCT00241631|41807153|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
19492171|NCT00241631|41807154|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
19492172|NCT00240071|41807169|FG000|Overall Study|Withdrawal by Subject|3|||
19492173|NCT03761277|41808157|FG000|Enrollment to Implant|Screen Failure|17|||
19492174|NCT03761277|41808157|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
19492175|NCT03761277|41808157|FG000|Enrollment to Implant|Physician Decision|2|||
19492176|NCT03761277|41808157|FG000|Enrollment to Implant|Site Closure|3|||
19492177|NCT03761277|41808157|FG000|Enrollment to Implant|Sponsor Request|2|||
19492178|NCT03761277|41808157|FG000|Post-Implant to 6 Months|Adverse Event|2|||
19492179|NCT03761277|41808157|FG000|Post-Implant to 6 Months|Death|1|||
19492180|NCT03761277|41808157|FG000|Post-Implant to 6 Months|Site Closure|2|||
19613305|NCT00607789|42062185|FG000|Overall Study|Lost to Follow-up|0|||
19492181|NCT03761277|41808157|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
19492182|NCT03761277|41808157|FG000|6 Months to 12 Months|Physician Decision|2|||
19492183|NCT03761277|41808157|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
19492184|NCT04099641|41808208|FG000|Overall Study|Death|46|||
19492185|NCT04099641|41808209|FG001|Overall Study|Death|12|||
19492186|NCT04099641|41808208|FG000|Overall Study|Lost to Follow-up|1|||
19492187|NCT04099641|41808209|FG001|Overall Study|Lost to Follow-up|0|||
19492188|NCT04099641|41808208|FG000|Overall Study|Withdrawal by Subject|2|||
19492189|NCT04099641|41808209|FG001|Overall Study|Withdrawal by Subject|0|||
19393598|NCT01938430|41637427|FG013|Overall Study|Lost to Follow-up|0|||
19393599|NCT01938430|41637414|FG000|Overall Study|Withdrew Consent|0|||
19393600|NCT01938430|41637415|FG001|Overall Study|Withdrew Consent|0|||
19393601|NCT01938430|41637416|FG002|Overall Study|Withdrew Consent|0|||
19393602|NCT01938430|41637417|FG003|Overall Study|Withdrew Consent|0|||
19393603|NCT01938430|41637418|FG004|Overall Study|Withdrew Consent|0|||
19393604|NCT01938430|41637419|FG005|Overall Study|Withdrew Consent|0|||
19393605|NCT01938430|41637420|FG006|Overall Study|Withdrew Consent|0|||
19393606|NCT01938430|41637421|FG007|Overall Study|Withdrew Consent|0|||
19393607|NCT01938430|41637422|FG008|Overall Study|Withdrew Consent|1|||
19393608|NCT01938430|41637423|FG009|Overall Study|Withdrew Consent|0|||
19393609|NCT01938430|41637424|FG010|Overall Study|Withdrew Consent|0|||
19393610|NCT01938430|41637425|FG011|Overall Study|Withdrew Consent|0|||
19393611|NCT01938430|41637426|FG012|Overall Study|Withdrew Consent|0|||
19393612|NCT01938430|41637427|FG013|Overall Study|Withdrew Consent|0|||
19393613|NCT01937884|41637484|FG000|Overall Study|Withdrawal by Subject|1|||
19393614|NCT01937884|41637485|FG001|Overall Study|Withdrawal by Subject|0|||
19393615|NCT01916824|41637495|FG000|Overall Study|Lost to Follow-up|3|||
19393616|NCT01916824|41637496|FG001|Overall Study|Lost to Follow-up|6|||
19393617|NCT01916824|41637495|FG000|Overall Study|Physician Decision|2|||
19393618|NCT01916824|41637496|FG001|Overall Study|Physician Decision|0|||
19393619|NCT01916824|41637495|FG000|Overall Study|Withdrawal by Subject|2|||
19393620|NCT01916824|41637496|FG001|Overall Study|Withdrawal by Subject|3|||
19393621|NCT01915732|41637504|FG000|Overall Study|Withdrawal by Subject|18|||
19393622|NCT01915732|41637505|FG001|Overall Study|Withdrawal by Subject|18|||
19393623|NCT01915732|41637504|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
19393624|NCT01915732|41637505|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
19393625|NCT01915732|41637504|FG000|Overall Study|Adverse Event|12|||
19393626|NCT01915732|41637505|FG001|Overall Study|Adverse Event|4|||
19393627|NCT01915732|41637504|FG000|Overall Study|Protocol Violation|5|||
19393628|NCT01915732|41637505|FG001|Overall Study|Protocol Violation|5|||
19393629|NCT01915732|41637504|FG000|Overall Study|Lack of Efficacy|6|||
19393630|NCT01915732|41637505|FG001|Overall Study|Lack of Efficacy|11|||
19393631|NCT01915732|41637504|FG000|Overall Study|Lost to Follow-up|22|||
19393632|NCT01915732|41637505|FG001|Overall Study|Lost to Follow-up|26|||
19393633|NCT01915732|41637504|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
19393634|NCT01915732|41637505|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
19393635|NCT01915732|41637504|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
19393636|NCT01915732|41637505|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
19393637|NCT01915732|41637504|FG000|Overall Study|Drug Release Error|1|||
19393638|NCT01915732|41637505|FG001|Overall Study|Drug Release Error|0|||
19393639|NCT01915732|41637504|FG000|Overall Study|Recovered|1|||
19393640|NCT01915732|41637505|FG001|Overall Study|Recovered|0|||
19393641|NCT01915732|41637504|FG000|Overall Study|Pregnancy|1|||
19393642|NCT01915732|41637505|FG001|Overall Study|Pregnancy|0|||
19393643|NCT01915732|41637504|FG000|Overall Study|Poor Perceived Efficacy|1|||
19393644|NCT01915732|41637505|FG001|Overall Study|Poor Perceived Efficacy|0|||
19393645|NCT01915732|41637504|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
19393646|NCT01915732|41637505|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
19393647|NCT01915732|41637504|FG000|Overall Study|Got Well|0|||
19393648|NCT01915732|41637505|FG001|Overall Study|Got Well|1|||
19393649|NCT01915732|41637504|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
19393650|NCT01915732|41637505|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
19393651|NCT01915732|41637504|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
19393652|NCT01915732|41637505|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
19393653|NCT01915732|41637504|FG000|Overall Study|Job Transfer|0|||
19393654|NCT01915732|41637505|FG001|Overall Study|Job Transfer|1|||
19393655|NCT01915732|41637504|FG000|Overall Study|Improper Facial Procedure|0|||
19393656|NCT01915732|41637505|FG001|Overall Study|Improper Facial Procedure|1|||
19492190|NCT02499328|41808247|FG000|Overall Study|Withdrawal by Subject|1|||
19492191|NCT02499328|41808248|FG001|Overall Study|Withdrawal by Subject|1|||
19492192|NCT02499328|41808249|FG002|Overall Study|Withdrawal by Subject|5|||
19492193|NCT02499328|41808250|FG003|Overall Study|Withdrawal by Subject|3|||
19492194|NCT02499328|41808251|FG004|Overall Study|Withdrawal by Subject|5|||
19393657|NCT01915732|41637504|FG000|Overall Study|Poor Conscious Effect|0|||
19393658|NCT01915732|41637505|FG001|Overall Study|Poor Conscious Effect|1|||
19393659|NCT01936948|41637515|FG000|Overall Study|no 30-day follow-up data|0|||
19492195|NCT02499328|41808252|FG005|Overall Study|Withdrawal by Subject|0|||
19492196|NCT02499328|41808253|FG006|Overall Study|Withdrawal by Subject|0|||
19492197|NCT02499328|41808254|FG007|Overall Study|Withdrawal by Subject|0|||
19492198|NCT02499328|41808255|FG008|Overall Study|Withdrawal by Subject|2|||
19492199|NCT02499328|41808256|FG009|Overall Study|Withdrawal by Subject|2|||
19492200|NCT02499328|41808257|FG010|Overall Study|Withdrawal by Subject|0|||
19492201|NCT02499328|41808258|FG011|Overall Study|Withdrawal by Subject|3|||
19492202|NCT02499328|41808259|FG012|Overall Study|Withdrawal by Subject|7|||
19492203|NCT02499328|41808260|FG013|Overall Study|Withdrawal by Subject|3|||
19492204|NCT02499328|41808261|FG014|Overall Study|Withdrawal by Subject|1|||
19492205|NCT02499328|41808262|FG015|Overall Study|Withdrawal by Subject|0|||
19492206|NCT02499328|41808263|FG016|Overall Study|Withdrawal by Subject|0|||
19492207|NCT02499328|41808264|FG017|Overall Study|Withdrawal by Subject|3|||
19492208|NCT02499328|41808265|FG018|Overall Study|Withdrawal by Subject|0|||
19492209|NCT02499328|41808247|FG000|Overall Study|Lost to Follow-up|0|||
19492210|NCT02499328|41808248|FG001|Overall Study|Lost to Follow-up|1|||
19492211|NCT02499328|41808249|FG002|Overall Study|Lost to Follow-up|1|||
19492212|NCT02499328|41808250|FG003|Overall Study|Lost to Follow-up|2|||
19492213|NCT02499328|41808251|FG004|Overall Study|Lost to Follow-up|0|||
19492214|NCT02499328|41808252|FG005|Overall Study|Lost to Follow-up|0|||
19492215|NCT02499328|41808253|FG006|Overall Study|Lost to Follow-up|0|||
19492216|NCT02499328|41808254|FG007|Overall Study|Lost to Follow-up|2|||
19492217|NCT02499328|41808255|FG008|Overall Study|Lost to Follow-up|3|||
19492218|NCT02499328|41808256|FG009|Overall Study|Lost to Follow-up|0|||
19492219|NCT02499328|41808257|FG010|Overall Study|Lost to Follow-up|0|||
19492220|NCT02499328|41808258|FG011|Overall Study|Lost to Follow-up|0|||
19492221|NCT02499328|41808259|FG012|Overall Study|Lost to Follow-up|0|||
19492222|NCT02499328|41808260|FG013|Overall Study|Lost to Follow-up|0|||
19492223|NCT02499328|41808261|FG014|Overall Study|Lost to Follow-up|0|||
19492224|NCT02499328|41808262|FG015|Overall Study|Lost to Follow-up|0|||
19492225|NCT02499328|41808263|FG016|Overall Study|Lost to Follow-up|0|||
19492226|NCT02499328|41808264|FG017|Overall Study|Lost to Follow-up|0|||
19492227|NCT02499328|41808265|FG018|Overall Study|Lost to Follow-up|1|||
19492228|NCT02499328|41808247|FG000|Overall Study|Death|0|||
19704336|NCT00223080|42148637|FG000|Overall Study|Moved from study area|37|||
19704337|NCT00223080|42148638|FG001|Overall Study|Moved from study area|47|||
19492229|NCT02499328|41808248|FG001|Overall Study|Death|3|||
19492230|NCT02499328|41808249|FG002|Overall Study|Death|3|||
19492231|NCT02499328|41808250|FG003|Overall Study|Death|2|||
19492232|NCT02499328|41808251|FG004|Overall Study|Death|4|||
19492233|NCT02499328|41808252|FG005|Overall Study|Death|7|||
19492234|NCT02499328|41808253|FG006|Overall Study|Death|3|||
19492235|NCT02499328|41808254|FG007|Overall Study|Death|0|||
19492236|NCT02499328|41808255|FG008|Overall Study|Death|2|||
19492237|NCT02499328|41808256|FG009|Overall Study|Death|6|||
19492238|NCT02499328|41808257|FG010|Overall Study|Death|6|||
19492239|NCT02499328|41808258|FG011|Overall Study|Death|20|||
19492240|NCT02499328|41808259|FG012|Overall Study|Death|9|||
19492241|NCT02499328|41808260|FG013|Overall Study|Death|7|||
19492242|NCT02499328|41808261|FG014|Overall Study|Death|3|||
19492243|NCT02499328|41808262|FG015|Overall Study|Death|1|||
19492244|NCT02499328|41808263|FG016|Overall Study|Death|1|||
19492245|NCT02499328|41808264|FG017|Overall Study|Death|16|||
19492246|NCT02499328|41808265|FG018|Overall Study|Death|5|||
19492247|NCT02499328|41808247|FG000|Overall Study|"Other"|2|||
19492248|NCT02499328|41808248|FG001|Overall Study|"Other"|2|||
19492249|NCT02499328|41808249|FG002|Overall Study|"Other"|1|||
19492250|NCT02499328|41808250|FG003|Overall Study|"Other"|3|||
19492251|NCT02499328|41808251|FG004|Overall Study|"Other"|6|||
19492252|NCT02499328|41808252|FG005|Overall Study|"Other"|2|||
19492253|NCT02499328|41808253|FG006|Overall Study|"Other"|3|||
19492254|NCT02499328|41808254|FG007|Overall Study|"Other"|4|||
19492255|NCT02499328|41808255|FG008|Overall Study|"Other"|6|||
19492256|NCT02499328|41808256|FG009|Overall Study|"Other"|16|||
19492257|NCT02499328|41808257|FG010|Overall Study|"Other"|13|||
19492258|NCT02499328|41808258|FG011|Overall Study|"Other"|31|||
19492259|NCT02499328|41808259|FG012|Overall Study|"Other"|8|||
19492260|NCT02499328|41808260|FG013|Overall Study|"Other"|7|||
19492261|NCT02499328|41808261|FG014|Overall Study|"Other"|6|||
19492262|NCT02499328|41808262|FG015|Overall Study|"Other"|0|||
19492263|NCT02499328|41808263|FG016|Overall Study|"Other"|0|||
19492264|NCT02499328|41808264|FG017|Overall Study|"Other"|34|||
19492265|NCT02499328|41808265|FG018|Overall Study|"Other"|43|||
19492266|NCT02499328|41808247|FG000|Overall Study|Disease Progression|0|||
19492267|NCT02499328|41808248|FG001|Overall Study|Disease Progression|0|||
19492268|NCT02499328|41808249|FG002|Overall Study|Disease Progression|0|||
19492269|NCT02499328|41808250|FG003|Overall Study|Disease Progression|0|||
19492270|NCT02499328|41808251|FG004|Overall Study|Disease Progression|0|||
19492271|NCT02499328|41808252|FG005|Overall Study|Disease Progression|0|||
19492272|NCT02499328|41808253|FG006|Overall Study|Disease Progression|1|||
19492273|NCT02499328|41808254|FG007|Overall Study|Disease Progression|0|||
19492274|NCT02499328|41808255|FG008|Overall Study|Disease Progression|1|||
19492275|NCT02499328|41808256|FG009|Overall Study|Disease Progression|0|||
19492276|NCT02499328|41808257|FG010|Overall Study|Disease Progression|1|||
19492277|NCT02499328|41808258|FG011|Overall Study|Disease Progression|0|||
19492278|NCT02499328|41808259|FG012|Overall Study|Disease Progression|0|||
19492279|NCT02499328|41808260|FG013|Overall Study|Disease Progression|0|||
19492280|NCT02499328|41808261|FG014|Overall Study|Disease Progression|0|||
19492281|NCT02499328|41808262|FG015|Overall Study|Disease Progression|0|||
19492282|NCT02499328|41808263|FG016|Overall Study|Disease Progression|0|||
19492283|NCT02499328|41808264|FG017|Overall Study|Disease Progression|2|||
19492284|NCT02499328|41808265|FG018|Overall Study|Disease Progression|0|||
19492285|NCT02499328|41808247|FG000|Overall Study|Adverse Event|1|||
19492286|NCT02499328|41808248|FG001|Overall Study|Adverse Event|0|||
19492287|NCT02499328|41808249|FG002|Overall Study|Adverse Event|0|||
19492288|NCT02499328|41808250|FG003|Overall Study|Adverse Event|1|||
19492289|NCT02499328|41808251|FG004|Overall Study|Adverse Event|0|||
19492290|NCT02499328|41808252|FG005|Overall Study|Adverse Event|0|||
19492291|NCT02499328|41808253|FG006|Overall Study|Adverse Event|0|||
19492292|NCT02499328|41808254|FG007|Overall Study|Adverse Event|0|||
19492293|NCT02499328|41808255|FG008|Overall Study|Adverse Event|0|||
19492294|NCT02499328|41808256|FG009|Overall Study|Adverse Event|0|||
19492295|NCT02499328|41808257|FG010|Overall Study|Adverse Event|0|||
19492296|NCT02499328|41808258|FG011|Overall Study|Adverse Event|0|||
19492297|NCT02499328|41808259|FG012|Overall Study|Adverse Event|1|||
19492298|NCT02499328|41808260|FG013|Overall Study|Adverse Event|0|||
19492299|NCT02499328|41808261|FG014|Overall Study|Adverse Event|0|||
19492300|NCT02499328|41808262|FG015|Overall Study|Adverse Event|0|||
19492301|NCT02499328|41808263|FG016|Overall Study|Adverse Event|0|||
19492302|NCT02499328|41808264|FG017|Overall Study|Adverse Event|0|||
19492303|NCT02499328|41808265|FG018|Overall Study|Adverse Event|0|||
19492304|NCT03123393|41808455|FG000|Overall Study|Study Terminated by Sponsor|6|||
19492305|NCT03123393|41808456|FG001|Overall Study|Study Terminated by Sponsor|9|||
19492306|NCT03123393|41808455|FG000|Overall Study|Withdrawal by Subject|2|||
19492307|NCT03123393|41808456|FG001|Overall Study|Withdrawal by Subject|1|||
19492308|NCT03123393|41808455|FG000|Overall Study|Reason not Specified|13|||
19492309|NCT03123393|41808456|FG001|Overall Study|Reason not Specified|13|||
19492310|NCT02834247|41809087|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
19492311|NCT02834247|41809088|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
19492312|NCT02834247|41809089|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
19492313|NCT02834247|41809090|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
19492314|NCT02834247|41809087|FG000|Dose Escalation Phase|Death|5|||
19492315|NCT02834247|41809088|FG001|Dose Escalation Phase|Death|6|||
19492316|NCT02834247|41809089|FG002|Dose Escalation Phase|Death|5|||
19492317|NCT02834247|41809090|FG003|Dose Escalation Phase|Death|0|||
19492318|NCT02834247|41809087|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
19492319|NCT02834247|41809088|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
19492320|NCT02834247|41809089|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
19492321|NCT02834247|41809090|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
19492322|NCT02834247|41809087|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
19492323|NCT02834247|41809088|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
19492324|NCT02834247|41809089|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
19492325|NCT02834247|41809090|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19492326|NCT02834247|41809087|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
19492327|NCT02834247|41809088|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
19492328|NCT02834247|41809089|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
19492329|NCT02834247|41809090|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
19492330|NCT02834247|41809087|FG000|Dose Expansion Phase|Death|0|||
19492331|NCT02834247|41809088|FG001|Dose Expansion Phase|Death|0|||
19492332|NCT02834247|41809089|FG002|Dose Expansion Phase|Death|0|||
19492333|NCT02834247|41809090|FG003|Dose Expansion Phase|Death|8|||
19492334|NCT02834247|41809087|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
19492335|NCT02834247|41809088|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
19492336|NCT02834247|41809089|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
19492337|NCT02834247|41809090|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
19492338|NCT02834247|41809087|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
19492339|NCT02834247|41809088|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
19492340|NCT02834247|41809089|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
19492341|NCT02834247|41809090|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
19492342|NCT01839331|41810416|FG000|Overall Study|Early Termination|3|||
19492343|NCT01839331|41810417|FG001|Overall Study|Early Termination|0|||
19492344|NCT01839331|41810418|FG002|Overall Study|Early Termination|1|||
19492345|NCT01839331|41810419|FG003|Overall Study|Early Termination|2|||
19492346|NCT01839331|41810416|FG000|Overall Study|Protocol Violation|1|||
19492347|NCT01839331|41810417|FG001|Overall Study|Protocol Violation|6|||
19492348|NCT01839331|41810418|FG002|Overall Study|Protocol Violation|4|||
19492349|NCT01839331|41810419|FG003|Overall Study|Protocol Violation|3|||
19492350|NCT02733042|41810565|FG000|Treatment Period|Adverse Event|1|||
19492351|NCT02733042|41810566|FG001|Treatment Period|Adverse Event|0|||
19492352|NCT02733042|41810567|FG002|Treatment Period|Adverse Event|1|||
19492353|NCT02733042|41810568|FG003|Treatment Period|Adverse Event|1|||
19492354|NCT02733042|41810569|FG004|Treatment Period|Adverse Event|0|||
19492355|NCT02733042|41810570|FG005|Treatment Period|Adverse Event|0|||
19492356|NCT02733042|41810571|FG006|Treatment Period|Adverse Event|0|||
19492357|NCT02733042|41810572|FG007|Treatment Period|Adverse Event|0|||
19492358|NCT02733042|41810573|FG008|Treatment Period|Adverse Event|0|||
19492359|NCT02733042|41810574|FG009|Treatment Period|Adverse Event|0|||
19492360|NCT02733042|41810575|FG010|Treatment Period|Adverse Event|2|||
19492361|NCT02733042|41810576|FG011|Treatment Period|Adverse Event|2|||
19492362|NCT02733042|41810577|FG012|Treatment Period|Adverse Event|0|||
19492363|NCT02733042|41810578|FG013|Treatment Period|Adverse Event|2|||
19492364|NCT02733042|41810579|FG014|Treatment Period|Adverse Event|0|||
19492365|NCT02733042|41810580|FG015|Treatment Period|Adverse Event|0|||
19492366|NCT02733042|41810581|FG016|Treatment Period|Adverse Event|0|||
19492367|NCT02733042|41810582|FG017|Treatment Period|Adverse Event|1|||
19492368|NCT02733042|41810583|FG018|Treatment Period|Adverse Event|0|||
19492369|NCT02733042|41810565|FG000|Treatment Period|Progressive Disease|2|||
19492370|NCT02733042|41810566|FG001|Treatment Period|Progressive Disease|1|||
19492371|NCT02733042|41810567|FG002|Treatment Period|Progressive Disease|3|||
19492372|NCT02733042|41810568|FG003|Treatment Period|Progressive Disease|1|||
19492373|NCT02733042|41810569|FG004|Treatment Period|Progressive Disease|1|||
19492374|NCT02733042|41810570|FG005|Treatment Period|Progressive Disease|3|||
19492375|NCT02733042|41810571|FG006|Treatment Period|Progressive Disease|0|||
19492376|NCT02733042|41810572|FG007|Treatment Period|Progressive Disease|3|||
19492377|NCT02733042|41810573|FG008|Treatment Period|Progressive Disease|3|||
19492378|NCT02733042|41810574|FG009|Treatment Period|Progressive Disease|0|||
19492379|NCT02733042|41810575|FG010|Treatment Period|Progressive Disease|2|||
19492380|NCT02733042|41810576|FG011|Treatment Period|Progressive Disease|2|||
19492381|NCT02733042|41810577|FG012|Treatment Period|Progressive Disease|8|||
19492382|NCT02733042|41810578|FG013|Treatment Period|Progressive Disease|1|||
19492383|NCT02733042|41810579|FG014|Treatment Period|Progressive Disease|4|||
19492384|NCT02733042|41810580|FG015|Treatment Period|Progressive Disease|7|||
19492385|NCT02733042|41810581|FG016|Treatment Period|Progressive Disease|2|||
19492386|NCT02733042|41810582|FG017|Treatment Period|Progressive Disease|3|||
19492387|NCT02733042|41810583|FG018|Treatment Period|Progressive Disease|4|||
19492388|NCT02733042|41810565|FG000|Treatment Period|Withdrawal by Subject|0|||
19492389|NCT02733042|41810566|FG001|Treatment Period|Withdrawal by Subject|1|||
19492390|NCT02733042|41810567|FG002|Treatment Period|Withdrawal by Subject|2|||
19492391|NCT02733042|41810568|FG003|Treatment Period|Withdrawal by Subject|1|||
19492392|NCT02733042|41810569|FG004|Treatment Period|Withdrawal by Subject|0|||
19492393|NCT02733042|41810570|FG005|Treatment Period|Withdrawal by Subject|0|||
19492394|NCT02733042|41810571|FG006|Treatment Period|Withdrawal by Subject|0|||
19492395|NCT02733042|41810572|FG007|Treatment Period|Withdrawal by Subject|0|||
19492396|NCT02733042|41810573|FG008|Treatment Period|Withdrawal by Subject|1|||
19492397|NCT02733042|41810574|FG009|Treatment Period|Withdrawal by Subject|1|||
19492398|NCT02733042|41810575|FG010|Treatment Period|Withdrawal by Subject|0|||
19492399|NCT02733042|41810576|FG011|Treatment Period|Withdrawal by Subject|2|||
19492400|NCT02733042|41810577|FG012|Treatment Period|Withdrawal by Subject|1|||
19492401|NCT02733042|41810578|FG013|Treatment Period|Withdrawal by Subject|1|||
19492402|NCT02733042|41810579|FG014|Treatment Period|Withdrawal by Subject|0|||
19492403|NCT02733042|41810580|FG015|Treatment Period|Withdrawal by Subject|0|||
19492404|NCT02733042|41810581|FG016|Treatment Period|Withdrawal by Subject|0|||
19492405|NCT02733042|41810582|FG017|Treatment Period|Withdrawal by Subject|0|||
19492406|NCT02733042|41810583|FG018|Treatment Period|Withdrawal by Subject|0|||
19492407|NCT02733042|41810565|FG000|Treatment Period|Other|0|||
19492408|NCT02733042|41810566|FG001|Treatment Period|Other|0|||
19492409|NCT02733042|41810567|FG002|Treatment Period|Other|1|||
19492410|NCT02733042|41810568|FG003|Treatment Period|Other|0|||
19492411|NCT02733042|41810569|FG004|Treatment Period|Other|0|||
19492412|NCT02733042|41810570|FG005|Treatment Period|Other|0|||
19492413|NCT02733042|41810571|FG006|Treatment Period|Other|0|||
19492414|NCT02733042|41810572|FG007|Treatment Period|Other|0|||
19492415|NCT02733042|41810573|FG008|Treatment Period|Other|0|||
19492416|NCT02733042|41810574|FG009|Treatment Period|Other|1|||
19492417|NCT02733042|41810575|FG010|Treatment Period|Other|1|||
19492418|NCT02733042|41810576|FG011|Treatment Period|Other|0|||
19492419|NCT02733042|41810577|FG012|Treatment Period|Other|0|||
19492420|NCT02733042|41810578|FG013|Treatment Period|Other|0|||
19492421|NCT02733042|41810579|FG014|Treatment Period|Other|0|||
19492422|NCT02733042|41810580|FG015|Treatment Period|Other|1|||
19492423|NCT02733042|41810581|FG016|Treatment Period|Other|0|||
19492424|NCT02733042|41810582|FG017|Treatment Period|Other|1|||
19492425|NCT02733042|41810583|FG018|Treatment Period|Other|0|||
19492426|NCT02733042|41810565|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
19492427|NCT02733042|41810566|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
19492428|NCT02733042|41810567|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
19492429|NCT02733042|41810568|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
19492430|NCT02733042|41810569|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
19492431|NCT02733042|41810570|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
19492432|NCT02733042|41810571|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
19613306|NCT00607789|42062186|FG001|Overall Study|Lost to Follow-up|5|||
19492433|NCT02733042|41810572|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
19492434|NCT02733042|41810573|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
19492435|NCT02733042|41810574|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
19492436|NCT02733042|41810575|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
19492437|NCT02733042|41810576|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
19492438|NCT02733042|41810577|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
19492439|NCT02733042|41810578|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
19492440|NCT02733042|41810579|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
19492441|NCT02733042|41810580|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
19492442|NCT02733042|41810581|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
19492443|NCT02733042|41810582|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
19492444|NCT02733042|41810583|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
19492445|NCT02733042|41810565|FG000|Treatment Period|Death|0|||
19492446|NCT02733042|41810566|FG001|Treatment Period|Death|0|||
19492447|NCT02733042|41810567|FG002|Treatment Period|Death|0|||
19492448|NCT02733042|41810568|FG003|Treatment Period|Death|0|||
19492449|NCT02733042|41810569|FG004|Treatment Period|Death|0|||
19492450|NCT02733042|41810570|FG005|Treatment Period|Death|0|||
19492451|NCT02733042|41810571|FG006|Treatment Period|Death|1|||
19492452|NCT02733042|41810572|FG007|Treatment Period|Death|0|||
19492453|NCT02733042|41810573|FG008|Treatment Period|Death|1|||
19492454|NCT02733042|41810574|FG009|Treatment Period|Death|0|||
19492455|NCT02733042|41810575|FG010|Treatment Period|Death|1|||
19492456|NCT02733042|41810576|FG011|Treatment Period|Death|0|||
19492457|NCT02733042|41810577|FG012|Treatment Period|Death|0|||
19492458|NCT02733042|41810578|FG013|Treatment Period|Death|0|||
19492459|NCT02733042|41810579|FG014|Treatment Period|Death|1|||
19492460|NCT02733042|41810580|FG015|Treatment Period|Death|2|||
19492461|NCT02733042|41810581|FG016|Treatment Period|Death|0|||
19492462|NCT02733042|41810582|FG017|Treatment Period|Death|0|||
19492463|NCT02733042|41810583|FG018|Treatment Period|Death|0|||
19492464|NCT02733042|41810565|FG000|Follow-up Period|Ongoing on Follow-up|2|||
19492465|NCT02733042|41810566|FG001|Follow-up Period|Ongoing on Follow-up|2|||
19492466|NCT02733042|41810567|FG002|Follow-up Period|Ongoing on Follow-up|4|||
19492467|NCT02733042|41810568|FG003|Follow-up Period|Ongoing on Follow-up|2|||
19492468|NCT02733042|41810569|FG004|Follow-up Period|Ongoing on Follow-up|0|||
19492469|NCT02733042|41810570|FG005|Follow-up Period|Ongoing on Follow-up|0|||
19492470|NCT02733042|41810571|FG006|Follow-up Period|Ongoing on Follow-up|0|||
19492471|NCT02733042|41810572|FG007|Follow-up Period|Ongoing on Follow-up|1|||
19492472|NCT02733042|41810573|FG008|Follow-up Period|Ongoing on Follow-up|0|||
19492473|NCT02733042|41810574|FG009|Follow-up Period|Ongoing on Follow-up|2|||
19492474|NCT02733042|41810575|FG010|Follow-up Period|Ongoing on Follow-up|4|||
19492475|NCT02733042|41810576|FG011|Follow-up Period|Ongoing on Follow-up|9|||
19492476|NCT02733042|41810577|FG012|Follow-up Period|Ongoing on Follow-up|1|||
19492477|NCT02733042|41810578|FG013|Follow-up Period|Ongoing on Follow-up|3|||
19492478|NCT02733042|41810579|FG014|Follow-up Period|Ongoing on Follow-up|0|||
19492479|NCT02733042|41810580|FG015|Follow-up Period|Ongoing on Follow-up|0|||
19492480|NCT02733042|41810581|FG016|Follow-up Period|Ongoing on Follow-up|0|||
19492481|NCT02733042|41810582|FG017|Follow-up Period|Ongoing on Follow-up|1|||
19492482|NCT02733042|41810583|FG018|Follow-up Period|Ongoing on Follow-up|0|||
19492483|NCT02733042|41810565|FG000|Follow-up Period|Death|1|||
19492484|NCT02733042|41810566|FG001|Follow-up Period|Death|1|||
19492485|NCT02733042|41810567|FG002|Follow-up Period|Death|2|||
19492486|NCT02733042|41810568|FG003|Follow-up Period|Death|0|||
19492487|NCT02733042|41810569|FG004|Follow-up Period|Death|1|||
19492488|NCT02733042|41810570|FG005|Follow-up Period|Death|2|||
19492489|NCT02733042|41810571|FG006|Follow-up Period|Death|0|||
19492490|NCT02733042|41810572|FG007|Follow-up Period|Death|3|||
19492491|NCT02733042|41810573|FG008|Follow-up Period|Death|3|||
19492492|NCT02733042|41810574|FG009|Follow-up Period|Death|0|||
19492493|NCT02733042|41810575|FG010|Follow-up Period|Death|0|||
19492494|NCT02733042|41810576|FG011|Follow-up Period|Death|0|||
19492495|NCT02733042|41810577|FG012|Follow-up Period|Death|8|||
19492496|NCT02733042|41810578|FG013|Follow-up Period|Death|1|||
19492497|NCT02733042|41810579|FG014|Follow-up Period|Death|1|||
19704338|NCT00223080|42148637|FG000|Overall Study|Lost to Follow-up|259|||
19492498|NCT02733042|41810580|FG015|Follow-up Period|Death|4|||
19492499|NCT02733042|41810581|FG016|Follow-up Period|Death|0|||
19492500|NCT02733042|41810582|FG017|Follow-up Period|Death|1|||
19492501|NCT02733042|41810583|FG018|Follow-up Period|Death|2|||
19492502|NCT02733042|41810565|FG000|Follow-up Period|Other|0|||
19492503|NCT02733042|41810566|FG001|Follow-up Period|Other|0|||
19492504|NCT02733042|41810567|FG002|Follow-up Period|Other|0|||
19492505|NCT02733042|41810568|FG003|Follow-up Period|Other|1|||
19492506|NCT02733042|41810569|FG004|Follow-up Period|Other|0|||
19492507|NCT02733042|41810570|FG005|Follow-up Period|Other|0|||
19492508|NCT02733042|41810571|FG006|Follow-up Period|Other|0|||
19492509|NCT02733042|41810572|FG007|Follow-up Period|Other|0|||
19492510|NCT02733042|41810573|FG008|Follow-up Period|Other|0|||
19492511|NCT02733042|41810574|FG009|Follow-up Period|Other|0|||
19492512|NCT02733042|41810575|FG010|Follow-up Period|Other|0|||
19492513|NCT02733042|41810576|FG011|Follow-up Period|Other|0|||
19492514|NCT02733042|41810577|FG012|Follow-up Period|Other|0|||
19492515|NCT02733042|41810578|FG013|Follow-up Period|Other|0|||
19492516|NCT02733042|41810579|FG014|Follow-up Period|Other|0|||
19492517|NCT02733042|41810580|FG015|Follow-up Period|Other|0|||
19492518|NCT02733042|41810581|FG016|Follow-up Period|Other|0|||
19492519|NCT02733042|41810582|FG017|Follow-up Period|Other|0|||
19492520|NCT02733042|41810583|FG018|Follow-up Period|Other|0|||
19492521|NCT02733042|41810565|FG000|Follow-up Period|Withdrawal by Subject|0|||
19492522|NCT02733042|41810566|FG001|Follow-up Period|Withdrawal by Subject|0|||
19492523|NCT02733042|41810567|FG002|Follow-up Period|Withdrawal by Subject|0|||
19492524|NCT02733042|41810568|FG003|Follow-up Period|Withdrawal by Subject|0|||
19492525|NCT02733042|41810569|FG004|Follow-up Period|Withdrawal by Subject|0|||
19492526|NCT02733042|41810570|FG005|Follow-up Period|Withdrawal by Subject|0|||
19492527|NCT02733042|41810571|FG006|Follow-up Period|Withdrawal by Subject|0|||
19492528|NCT02733042|41810572|FG007|Follow-up Period|Withdrawal by Subject|0|||
19492529|NCT02733042|41810573|FG008|Follow-up Period|Withdrawal by Subject|1|||
19492530|NCT02733042|41810574|FG009|Follow-up Period|Withdrawal by Subject|0|||
19492531|NCT02733042|41810575|FG010|Follow-up Period|Withdrawal by Subject|1|||
19492532|NCT02733042|41810576|FG011|Follow-up Period|Withdrawal by Subject|0|||
19492533|NCT02733042|41810577|FG012|Follow-up Period|Withdrawal by Subject|0|||
19492534|NCT02733042|41810578|FG013|Follow-up Period|Withdrawal by Subject|0|||
19492535|NCT02733042|41810579|FG014|Follow-up Period|Withdrawal by Subject|0|||
19492536|NCT02733042|41810580|FG015|Follow-up Period|Withdrawal by Subject|1|||
19492537|NCT02733042|41810581|FG016|Follow-up Period|Withdrawal by Subject|0|||
19492538|NCT02733042|41810582|FG017|Follow-up Period|Withdrawal by Subject|0|||
19492539|NCT02733042|41810583|FG018|Follow-up Period|Withdrawal by Subject|0|||
19492540|NCT02426658|41810771|FG000|Overall Study|Withdrawal by Subject|1|||
19492541|NCT02426658|41810771|FG000|Overall Study|Patient expired before treatment|2|||
19492542|NCT01606176|41810855|FG000|Overall Study|Adverse Event|2|||
19492543|NCT01606176|41810856|FG001|Overall Study|Adverse Event|3|||
19492544|NCT01606176|41810855|FG000|Overall Study|Disease progression|1|||
19492545|NCT01606176|41810856|FG001|Overall Study|Disease progression|0|||
19492546|NCT01606176|41810855|FG000|Overall Study|Withdrawal by Subject|1|||
19492547|NCT01606176|41810856|FG001|Overall Study|Withdrawal by Subject|0|||
19492548|NCT01663896|41810922|FG000|Overall Study|Various reasons|43|||
19492549|NCT02576652|41810975|FG000|Overall Study|Withdrawal by Subject|2|||
19492550|NCT02575950|41811059|FG000|Overall Study|Withdrawal by Subject|0|||
19492551|NCT02575950|41811060|FG001|Overall Study|Withdrawal by Subject|0|||
19492552|NCT02575950|41811061|FG002|Overall Study|Withdrawal by Subject|0|||
19492553|NCT02575950|41811062|FG003|Overall Study|Withdrawal by Subject|2|||
19492554|NCT02575950|41811059|FG000|Overall Study|Lost to Follow-up|0|||
19492555|NCT02575950|41811060|FG001|Overall Study|Lost to Follow-up|1|||
19492556|NCT02575950|41811061|FG002|Overall Study|Lost to Follow-up|0|||
19492557|NCT02575950|41811062|FG003|Overall Study|Lost to Follow-up|3|||
19492558|NCT01049581|41811170|FG000|Overall Study|Lost to Follow-up|2|||
19492559|NCT01049581|41811171|FG001|Overall Study|Lost to Follow-up|1|||
19613307|NCT00607789|42062185|FG000|Overall Study|Withdrawal by Subject|1|||
19613308|NCT00607789|42062186|FG001|Overall Study|Withdrawal by Subject|0|||
19613309|NCT00887822|42062194|FG000|Overall Study|Insufficient therapeutic response|53|||
19492564|NCT02571972|41811198|FG000|Overall Study|Protocol Violation|2|||
19492565|NCT02571972|41811198|FG000|Overall Study|Withdrawal by Subject|2|||
19492566|NCT02166905|41811287|FG000|Overall Study|Withdrawal by Subject|1|||
19492567|NCT02166905|41811288|FG001|Overall Study|Withdrawal by Subject|0|||
19492568|NCT02166905|41811289|FG002|Overall Study|Withdrawal by Subject|0|||
19492569|NCT02166905|41811290|FG003|Overall Study|Withdrawal by Subject|0|||
19492570|NCT01501955|41811337|FG000|Overall Study|Withdrawal by Subject|1|||
19492571|NCT01501955|41811338|FG001|Overall Study|Withdrawal by Subject|0|||
19492572|NCT01501955|41811337|FG000|Overall Study|Adverse Event|1|||
19492573|NCT01501955|41811338|FG001|Overall Study|Adverse Event|3|||
19492574|NCT02574312|41811466|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
19492575|NCT02574312|41811467|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
19492576|NCT01049035|41811489|FG000|Overall Study|Serious adverse event|0|||
19492577|NCT01049035|41811490|FG001|Overall Study|Serious adverse event|1|||
19492578|NCT01049035|41811491|FG002|Overall Study|Serious adverse event|1|||
19492579|NCT01049035|41811492|FG003|Overall Study|Serious adverse event|2|||
19492580|NCT01049035|41811493|FG004|Overall Study|Serious adverse event|0|||
19492581|NCT01049035|41811494|FG005|Overall Study|Serious adverse event|0|||
19492582|NCT01049035|41811495|FG006|Overall Study|Serious adverse event|0|||
19492583|NCT01049035|41811489|FG000|Overall Study|Other adverse event (AE)|0|||
19492584|NCT01049035|41811490|FG001|Overall Study|Other adverse event (AE)|0|||
19492585|NCT01049035|41811491|FG002|Overall Study|Other adverse event (AE)|0|||
19492586|NCT01049035|41811492|FG003|Overall Study|Other adverse event (AE)|1|||
19492587|NCT01049035|41811493|FG004|Overall Study|Other adverse event (AE)|0|||
19492588|NCT01049035|41811494|FG005|Overall Study|Other adverse event (AE)|0|||
19492589|NCT01049035|41811495|FG006|Overall Study|Other adverse event (AE)|0|||
19492590|NCT01049035|41811489|FG000|Overall Study|Non-compliance with the protocol|12|||
19492591|NCT01049035|41811490|FG001|Overall Study|Non-compliance with the protocol|6|||
19492592|NCT01049035|41811491|FG002|Overall Study|Non-compliance with the protocol|14|||
19492593|NCT01049035|41811492|FG003|Overall Study|Non-compliance with the protocol|5|||
19492594|NCT01049035|41811493|FG004|Overall Study|Non-compliance with the protocol|3|||
19492595|NCT01049035|41811494|FG005|Overall Study|Non-compliance with the protocol|4|||
19492596|NCT01049035|41811495|FG006|Overall Study|Non-compliance with the protocol|10|||
19492597|NCT01049035|41811489|FG000|Overall Study|Lost to Follow-up|5|||
19492598|NCT01049035|41811490|FG001|Overall Study|Lost to Follow-up|4|||
19492599|NCT01049035|41811491|FG002|Overall Study|Lost to Follow-up|4|||
19492600|NCT01049035|41811492|FG003|Overall Study|Lost to Follow-up|1|||
19492601|NCT01049035|41811493|FG004|Overall Study|Lost to Follow-up|0|||
19492602|NCT01049035|41811494|FG005|Overall Study|Lost to Follow-up|3|||
19492603|NCT01049035|41811495|FG006|Overall Study|Lost to Follow-up|3|||
19492604|NCT01049035|41811489|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
19492605|NCT01049035|41811490|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
19492606|NCT01049035|41811491|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
19492607|NCT01049035|41811492|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
19492608|NCT01049035|41811493|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
19613310|NCT00887822|42062195|FG001|Overall Study|Insufficient therapeutic response|55|||
19613311|NCT00887822|42062194|FG000|Overall Study|Adverse Event|14|||
19613312|NCT00887822|42062195|FG001|Overall Study|Adverse Event|17|||
19613313|NCT00887822|42062194|FG000|Overall Study|Failure to return|11|||
19613314|NCT00887822|42062195|FG001|Overall Study|Failure to return|11|||
19613315|NCT00887822|42062194|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
19613316|NCT00887822|42062195|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
19492609|NCT01049035|41811494|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
19492610|NCT01049035|41811495|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
19492611|NCT01048333|41811521|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
19492612|NCT01048333|41811522|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
19492613|NCT01048333|41811523|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
19492614|NCT01048333|41811524|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
19492615|NCT01048333|41811525|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
19492616|NCT01048333|41811526|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
19492617|NCT02323113|41811541|FG000|Overall Study|Adverse Event|3|||
19492618|NCT02323113|41811542|FG001|Overall Study|Adverse Event|3|||
19492619|NCT02323113|41811543|FG002|Overall Study|Adverse Event|2|||
19492620|NCT02323113|41811544|FG003|Overall Study|Adverse Event|5|||
19492621|NCT02323113|41811545|FG004|Overall Study|Adverse Event|8|||
19492622|NCT02323113|41811546|FG005|Overall Study|Adverse Event|3|||
19492623|NCT02323113|41811547|FG006|Overall Study|Adverse Event|6|||
19492624|NCT02323113|41811548|FG007|Overall Study|Adverse Event|0|||
19492625|NCT02323113|41811541|FG000|Overall Study|Progressive Disease|0|||
19492626|NCT02323113|41811542|FG001|Overall Study|Progressive Disease|1|||
19492627|NCT02323113|41811543|FG002|Overall Study|Progressive Disease|1|||
19492628|NCT02323113|41811544|FG003|Overall Study|Progressive Disease|0|||
19492629|NCT02323113|41811545|FG004|Overall Study|Progressive Disease|0|||
19492630|NCT02323113|41811546|FG005|Overall Study|Progressive Disease|3|||
19492631|NCT02323113|41811547|FG006|Overall Study|Progressive Disease|0|||
19492632|NCT02323113|41811548|FG007|Overall Study|Progressive Disease|0|||
19492633|NCT02323113|41811541|FG000|Overall Study|Symptomatic Deterioration|0|||
19492634|NCT02323113|41811542|FG001|Overall Study|Symptomatic Deterioration|0|||
19492635|NCT02323113|41811543|FG002|Overall Study|Symptomatic Deterioration|1|||
19492636|NCT02323113|41811544|FG003|Overall Study|Symptomatic Deterioration|0|||
19492637|NCT02323113|41811545|FG004|Overall Study|Symptomatic Deterioration|1|||
19492638|NCT02323113|41811546|FG005|Overall Study|Symptomatic Deterioration|0|||
19492639|NCT02323113|41811547|FG006|Overall Study|Symptomatic Deterioration|0|||
19492640|NCT02323113|41811548|FG007|Overall Study|Symptomatic Deterioration|0|||
19492641|NCT02323113|41811541|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
19492642|NCT02323113|41811542|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
19492643|NCT02323113|41811543|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
19492644|NCT02323113|41811544|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
19492645|NCT02323113|41811545|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
19492646|NCT02323113|41811546|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
19492647|NCT02323113|41811547|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
19492648|NCT02323113|41811548|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
19492649|NCT02323113|41811541|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492650|NCT02323113|41811542|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
19492651|NCT02323113|41811543|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492652|NCT02323113|41811544|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492653|NCT02323113|41811545|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19613317|NCT00887822|42062194|FG000|Overall Study|Administrative/Other than specified|5|||
19492654|NCT02323113|41811546|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492655|NCT02323113|41811547|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492656|NCT02323113|41811548|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
19492657|NCT02281383|41811599|FG000|Overall Study|Progressive Disease|1|||
19492658|NCT02281383|41811599|FG000|Overall Study|Withdrawal by Subject|6|||
19492659|NCT02281383|41811599|FG000|Overall Study|Protocol Violation|2|||
19492660|NCT02281383|41811599|FG000|Overall Study|Death|1|||
19492661|NCT02281383|41811599|FG000|Overall Study|Adverse Event|2|||
19492662|NCT01047553|41811605|FG000|Overall Study|Adverse Event|10|||
19492663|NCT01047553|41811606|FG001|Overall Study|Adverse Event|5|||
19492664|NCT01047553|41811605|FG000|Overall Study|Withdrawal by Subject|4|||
19492665|NCT01047553|41811606|FG001|Overall Study|Withdrawal by Subject|2|||
19492666|NCT01047553|41811605|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
19492667|NCT01047553|41811606|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
19492668|NCT01047553|41811605|FG000|Overall Study|Lost to Follow-up|1|||
19492669|NCT01047553|41811606|FG001|Overall Study|Lost to Follow-up|0|||
19492670|NCT01047553|41811605|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
19492671|NCT01047553|41811606|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
19492672|NCT01047553|41811605|FG000|Overall Study|PI's decision|0|||
19492673|NCT01047553|41811606|FG001|Overall Study|PI's decision|1|||
19492674|NCT01047007|41811640|FG000|Overall Study|Adverse Event|0|||
19492675|NCT01047007|41811641|FG001|Overall Study|Adverse Event|2|||
19492676|NCT01047007|41811642|FG002|Overall Study|Adverse Event|1|||
19492677|NCT01047007|41811643|FG003|Overall Study|Adverse Event|0|||
19492678|NCT01047007|41811640|FG000|Overall Study|Progressive Disease|2|||
19492679|NCT01047007|41811641|FG001|Overall Study|Progressive Disease|4|||
19492680|NCT01047007|41811642|FG002|Overall Study|Progressive Disease|1|||
19492681|NCT01047007|41811643|FG003|Overall Study|Progressive Disease|0|||
19492682|NCT01046695|41811655|FG000|Overall Study|Subject had a pacemaker|0|||
19492683|NCT01046695|41811656|FG001|Overall Study|Subject had a pacemaker|1|||
19492684|NCT01046695|41811655|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
19492685|NCT01046695|41811656|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
19492686|NCT03304379|41811671|FG000|Overall Study|Protocol Violation|8|||
19492687|NCT03304379|41811672|FG001|Overall Study|Protocol Violation|10|||
19492688|NCT03304379|41811673|FG002|Overall Study|Protocol Violation|5|||
19492689|NCT03304379|41811674|FG003|Overall Study|Protocol Violation|0|||
19492690|NCT03304379|41811675|FG004|Overall Study|Protocol Violation|2|||
19492691|NCT03304379|41811671|FG000|Overall Study|Adverse Event|4|||
19492692|NCT03304379|41811672|FG001|Overall Study|Adverse Event|20|||
19492693|NCT03304379|41811673|FG002|Overall Study|Adverse Event|17|||
19492694|NCT03304379|41811674|FG003|Overall Study|Adverse Event|1|||
19492695|NCT03304379|41811675|FG004|Overall Study|Adverse Event|0|||
19492696|NCT03304379|41811671|FG000|Overall Study|Lack of Efficacy|17|||
19492697|NCT03304379|41811672|FG001|Overall Study|Lack of Efficacy|16|||
19492698|NCT03304379|41811673|FG002|Overall Study|Lack of Efficacy|20|||
19492699|NCT03304379|41811674|FG003|Overall Study|Lack of Efficacy|0|||
19492700|NCT03304379|41811675|FG004|Overall Study|Lack of Efficacy|0|||
19492701|NCT03304379|41811671|FG000|Overall Study|Physician Decision|6|||
19492702|NCT03304379|41811672|FG001|Overall Study|Physician Decision|10|||
19492703|NCT03304379|41811673|FG002|Overall Study|Physician Decision|6|||
19492704|NCT03304379|41811674|FG003|Overall Study|Physician Decision|9|||
19492705|NCT03304379|41811675|FG004|Overall Study|Physician Decision|10|||
19492706|NCT03304379|41811671|FG000|Overall Study|Withdrawal by Subject|26|||
19492707|NCT03304379|41811672|FG001|Overall Study|Withdrawal by Subject|58|||
19492708|NCT03304379|41811673|FG002|Overall Study|Withdrawal by Subject|66|||
19492709|NCT03304379|41811674|FG003|Overall Study|Withdrawal by Subject|3|||
19492710|NCT03304379|41811675|FG004|Overall Study|Withdrawal by Subject|5|||
19492711|NCT03304379|41811671|FG000|Overall Study|Lost to Follow-up|8|||
19492712|NCT03304379|41811672|FG001|Overall Study|Lost to Follow-up|24|||
19492713|NCT03304379|41811673|FG002|Overall Study|Lost to Follow-up|35|||
19492714|NCT03304379|41811674|FG003|Overall Study|Lost to Follow-up|4|||
19492715|NCT03304379|41811675|FG004|Overall Study|Lost to Follow-up|0|||
19492716|NCT03304379|41811671|FG000|Overall Study|Death|1|||
19492717|NCT03304379|41811672|FG001|Overall Study|Death|2|||
19492718|NCT03304379|41811673|FG002|Overall Study|Death|0|||
19492719|NCT03304379|41811674|FG003|Overall Study|Death|0|||
19492720|NCT03304379|41811675|FG004|Overall Study|Death|0|||
19492721|NCT03304379|41811671|FG000|Overall Study|Other|0|||
19492722|NCT03304379|41811672|FG001|Overall Study|Other|1|||
19492723|NCT03304379|41811673|FG002|Overall Study|Other|0|||
19492724|NCT03304379|41811674|FG003|Overall Study|Other|0|||
19492725|NCT03304379|41811675|FG004|Overall Study|Other|0|||
19704339|NCT00223080|42148638|FG001|Overall Study|Lost to Follow-up|284|||
19492726|NCT01044745|41811730|FG000|Overall Study|Ineiligible|2|||
19492727|NCT01044433|41811753|FG000|Overall Study|Lost to Follow-up|3|||
19492728|NCT01044433|41811753|FG000|Overall Study|Withdrawal by Subject|3|||
19492729|NCT01043185|41811758|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
19492730|NCT01043185|41811759|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
19492731|NCT01043185|41811760|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
19492732|NCT01043185|41811761|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
19492733|NCT01043185|41811762|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
19492734|NCT01043185|41811763|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
19492735|NCT01043185|41811764|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
19492736|NCT01043185|41811765|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
19492737|NCT01043185|41811766|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
19492738|NCT01043185|41811767|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
19492739|NCT01042093|41811792|FG000|Overall Study|Protocol Violation|2|||
19492740|NCT01042093|41811793|FG001|Overall Study|Protocol Violation|2|||
19492741|NCT01042093|41811794|FG002|Overall Study|Protocol Violation|2|||
19492742|NCT01042093|41811795|FG003|Overall Study|Protocol Violation|3|||
19492743|NCT01042093|41811792|FG000|Overall Study|Withdrawal by Subject|0|||
19492744|NCT01042093|41811793|FG001|Overall Study|Withdrawal by Subject|0|||
19492745|NCT01042093|41811794|FG002|Overall Study|Withdrawal by Subject|0|||
19492746|NCT01042093|41811795|FG003|Overall Study|Withdrawal by Subject|1|||
19492747|NCT01041859|41811825|FG000|Open-Label Titration|Adverse Event|69|||
19492748|NCT01041859|41811826|FG001|Open-Label Titration|Adverse Event|0|||
19492749|NCT01041859|41811827|FG002|Open-Label Titration|Adverse Event|0|||
19492750|NCT01041859|41811825|FG000|Open-Label Titration|Lack of Efficacy|3|||
19492751|NCT01041859|41811826|FG001|Open-Label Titration|Lack of Efficacy|0|||
19492752|NCT01041859|41811827|FG002|Open-Label Titration|Lack of Efficacy|0|||
19492753|NCT01041859|41811825|FG000|Open-Label Titration|Lost to Follow-up|1|||
19492754|NCT01041859|41811826|FG001|Open-Label Titration|Lost to Follow-up|0|||
19492755|NCT01041859|41811827|FG002|Open-Label Titration|Lost to Follow-up|0|||
19492756|NCT01041859|41811825|FG000|Open-Label Titration|Physician Decision|1|||
19492757|NCT01041859|41811826|FG001|Open-Label Titration|Physician Decision|0|||
19492758|NCT01041859|41811827|FG002|Open-Label Titration|Physician Decision|0|||
19492759|NCT01041859|41811825|FG000|Open-Label Titration|Protocol Violation|1|||
19492760|NCT01041859|41811826|FG001|Open-Label Titration|Protocol Violation|0|||
19492761|NCT01041859|41811827|FG002|Open-Label Titration|Protocol Violation|0|||
19492762|NCT01041859|41811825|FG000|Open-Label Titration|Other|7|||
19492763|NCT01041859|41811826|FG001|Open-Label Titration|Other|0|||
19492764|NCT01041859|41811827|FG002|Open-Label Titration|Other|0|||
19492765|NCT01041859|41811825|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
19492766|NCT01041859|41811826|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
19492767|NCT01041859|41811827|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
19492768|NCT01041859|41811825|FG000|Open-Label Titration|Withdrawal by Subject|11|||
19492769|NCT01041859|41811826|FG001|Open-Label Titration|Withdrawal by Subject|0|||
19492770|NCT01041859|41811827|FG002|Open-Label Titration|Withdrawal by Subject|0|||
19492771|NCT01041859|41811825|FG000|Double-Blind Maintenance|Adverse Event|0|||
19492772|NCT01041859|41811826|FG001|Double-Blind Maintenance|Adverse Event|23|||
19492773|NCT01041859|41811827|FG002|Double-Blind Maintenance|Adverse Event|13|||
19492774|NCT01041859|41811825|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
19492775|NCT01041859|41811826|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
19492776|NCT01041859|41811827|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
19492777|NCT01041859|41811825|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
19492778|NCT01041859|41811826|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
19492779|NCT01041859|41811827|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
19492780|NCT01041859|41811825|FG000|Double-Blind Maintenance|Physician Decision|0|||
19492781|NCT01041859|41811826|FG001|Double-Blind Maintenance|Physician Decision|2|||
19492782|NCT01041859|41811827|FG002|Double-Blind Maintenance|Physician Decision|1|||
19492783|NCT01041859|41811825|FG000|Double-Blind Maintenance|Protocol Violation|0|||
19492784|NCT01041859|41811826|FG001|Double-Blind Maintenance|Protocol Violation|1|||
19492785|NCT01041859|41811827|FG002|Double-Blind Maintenance|Protocol Violation|3|||
19492786|NCT01041859|41811825|FG000|Double-Blind Maintenance|Other|0|||
19492787|NCT01041859|41811826|FG001|Double-Blind Maintenance|Other|6|||
19492788|NCT01041859|41811827|FG002|Double-Blind Maintenance|Other|2|||
19492789|NCT01041859|41811825|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
19492790|NCT01041859|41811826|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
19492791|NCT01041859|41811827|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
19492792|NCT01041859|41811825|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
19704340|NCT00223080|42148637|FG000|Overall Study|Death|85|||
19492793|NCT01041859|41811826|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
19492794|NCT01041859|41811827|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
19492795|NCT01040845|41811836|FG000|Overall Study|Withdrawal by Subject|1|||
19492796|NCT01040845|41811837|FG001|Overall Study|Withdrawal by Subject|1|||
19492797|NCT01040845|41811836|FG000|Overall Study|Physician Decision|1|||
19492798|NCT01040845|41811837|FG001|Overall Study|Physician Decision|0|||
19492799|NCT01040689|41811845|FG000|Overall Study|Adverse Event|0|||
19704341|NCT00223080|42148638|FG001|Overall Study|Death|74|||
19492800|NCT01040689|41811846|FG001|Overall Study|Adverse Event|0|||
19492801|NCT01040689|41811847|FG002|Overall Study|Adverse Event|2|||
19492802|NCT01040689|41811848|FG003|Overall Study|Adverse Event|4|||
19492803|NCT01040689|41811845|FG000|Overall Study|Lack of Efficacy|0|||
19492804|NCT01040689|41811846|FG001|Overall Study|Lack of Efficacy|0|||
19492805|NCT01040689|41811847|FG002|Overall Study|Lack of Efficacy|1|||
19492806|NCT01040689|41811848|FG003|Overall Study|Lack of Efficacy|0|||
19492807|NCT01040689|41811845|FG000|Overall Study|Lost to Follow-up|1|||
19492808|NCT01040689|41811846|FG001|Overall Study|Lost to Follow-up|0|||
19492809|NCT01040689|41811847|FG002|Overall Study|Lost to Follow-up|0|||
19492810|NCT01040689|41811848|FG003|Overall Study|Lost to Follow-up|0|||
19492811|NCT01040689|41811845|FG000|Overall Study|Withdrawal by Subject|2|||
19492812|NCT01040689|41811846|FG001|Overall Study|Withdrawal by Subject|1|||
19492813|NCT01040689|41811847|FG002|Overall Study|Withdrawal by Subject|1|||
19492814|NCT01040689|41811848|FG003|Overall Study|Withdrawal by Subject|0|||
19492815|NCT01040689|41811845|FG000|Overall Study|Other reasons not listed above|0|||
19492816|NCT01040689|41811846|FG001|Overall Study|Other reasons not listed above|1|||
19492817|NCT01040689|41811847|FG002|Overall Study|Other reasons not listed above|0|||
19492818|NCT01040689|41811848|FG003|Overall Study|Other reasons not listed above|0|||
19492819|NCT01047319|41811897|FG000|Overall Study|Teva requested participant withdrawal|3|||
19492820|NCT01047319|41811898|FG001|Overall Study|Teva requested participant withdrawal|0|||
19492821|NCT01047319|41811899|FG002|Overall Study|Teva requested participant withdrawal|1|||
19492822|NCT01047319|41811897|FG000|Overall Study|Protocol Violation|3|||
19492823|NCT01047319|41811898|FG001|Overall Study|Protocol Violation|2|||
19492824|NCT01047319|41811899|FG002|Overall Study|Protocol Violation|4|||
19492825|NCT01047319|41811897|FG000|Overall Study|Lack of Efficacy|4|||
19492826|NCT01047319|41811898|FG001|Overall Study|Lack of Efficacy|3|||
19492827|NCT01047319|41811899|FG002|Overall Study|Lack of Efficacy|3|||
19492828|NCT01047319|41811897|FG000|Overall Study|Death|5|||
19492829|NCT01047319|41811898|FG001|Overall Study|Death|1|||
19492830|NCT01047319|41811899|FG002|Overall Study|Death|5|||
19492831|NCT01047319|41811897|FG000|Overall Study|Pregnancy|13|||
19492832|NCT01047319|41811898|FG001|Overall Study|Pregnancy|8|||
19492833|NCT01047319|41811899|FG002|Overall Study|Pregnancy|8|||
19492834|NCT01047319|41811897|FG000|Overall Study|Physician Decision|12|||
19492835|NCT01047319|41811898|FG001|Overall Study|Physician Decision|9|||
19492836|NCT01047319|41811899|FG002|Overall Study|Physician Decision|10|||
19492837|NCT01047319|41811897|FG000|Overall Study|Lost to Follow-up|14|||
19492838|NCT01047319|41811898|FG001|Overall Study|Lost to Follow-up|10|||
19492839|NCT01047319|41811899|FG002|Overall Study|Lost to Follow-up|10|||
19492840|NCT01047319|41811897|FG000|Overall Study|Adverse Event|16|||
19492841|NCT01047319|41811898|FG001|Overall Study|Adverse Event|27|||
19492842|NCT01047319|41811899|FG002|Overall Study|Adverse Event|21|||
19492843|NCT01047319|41811897|FG000|Overall Study|Withdrawal by Subject|77|||
19492844|NCT01047319|41811898|FG001|Overall Study|Withdrawal by Subject|75|||
19492845|NCT01047319|41811899|FG002|Overall Study|Withdrawal by Subject|87|||
19492846|NCT01047319|41811897|FG000|Overall Study|Study terminated by Sponsor|198|||
19492847|NCT01047319|41811898|FG001|Overall Study|Study terminated by Sponsor|215|||
19492848|NCT01047319|41811899|FG002|Overall Study|Study terminated by Sponsor|203|||
19492849|NCT00014911|41812216|FG000|Overall Study|Adverse Event|1|||
19492850|NCT00014911|41812216|FG000|Overall Study|Lost to Follow-up|1|||
19492851|NCT00014911|41812216|FG000|Overall Study|Withdrawal by Subject|6|||
19492852|NCT00014911|41812216|FG000|Overall Study|Unknown Reasons|2|||
19492853|NCT00014911|41812216|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
19492854|NCT01049009|41812789|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
19492855|NCT01049009|41812790|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
19492856|NCT01049009|41812789|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19492857|NCT01049009|41812790|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19492858|NCT01049009|41812789|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
19492859|NCT01049009|41812790|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
19492860|NCT01049009|41812789|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
19492861|NCT01049009|41812790|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
19492862|NCT01047683|41812812|FG000|Overall Study|Adverse Event|3|||
19492863|NCT01047683|41812813|FG001|Overall Study|Adverse Event|1|||
19613318|NCT00887822|42062195|FG001|Overall Study|Administrative/Other than specified|4|||
19492864|NCT01047683|41812814|FG002|Overall Study|Adverse Event|0|||
19492865|NCT01047683|41812812|FG000|Overall Study|Withdrew Consent|1|||
19492866|NCT01047683|41812813|FG001|Overall Study|Withdrew Consent|4|||
19492867|NCT01047683|41812814|FG002|Overall Study|Withdrew Consent|2|||
19492868|NCT01047683|41812812|FG000|Overall Study|Lost to Follow-up|0|||
19492869|NCT01047683|41812813|FG001|Overall Study|Lost to Follow-up|1|||
19492870|NCT01047683|41812814|FG002|Overall Study|Lost to Follow-up|0|||
19492871|NCT01047683|41812812|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
19492872|NCT01047683|41812813|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
19492873|NCT01047683|41812814|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
19492874|NCT01047293|41812902|FG000|Overall Study|DLT criteria not fulfilled|1|||
19492875|NCT01047293|41812903|FG001|Overall Study|DLT criteria not fulfilled|1|||
19492876|NCT01047293|41812904|FG002|Overall Study|DLT criteria not fulfilled|0|||
19492877|NCT01047293|41812905|FG003|Overall Study|DLT criteria not fulfilled|0|||
19492878|NCT01045967|41812914|FG000|Second Intervention|Protocol Violation|0|||
19492879|NCT01045967|41812915|FG001|Second Intervention|Protocol Violation|1|||
19492880|NCT01045421|41813501|FG000|Phase 1|Progressive Disease|0|||
19492881|NCT01045421|41813502|FG001|Phase 1|Progressive Disease|0|||
19492882|NCT01045421|41813503|FG002|Phase 1|Progressive Disease|0|||
19492883|NCT01045421|41813504|FG003|Phase 1|Progressive Disease|0|||
19492884|NCT01045421|41813505|FG004|Phase 1|Progressive Disease|1|||
19492885|NCT01045421|41813506|FG005|Phase 1|Progressive Disease|0|||
19492886|NCT01045421|41813507|FG006|Phase 1|Progressive Disease|0|||
19492887|NCT01045421|41813508|FG007|Phase 1|Progressive Disease|0|||
19492888|NCT01045421|41813509|FG008|Phase 1|Progressive Disease|0|||
19492889|NCT01045421|41813510|FG009|Phase 1|Progressive Disease|0|||
19492890|NCT01045421|41813511|FG010|Phase 1|Progressive Disease|0|||
19492891|NCT01045421|41813501|FG000|Phase 1|Withdrawal by Subject|0|||
19492892|NCT01045421|41813502|FG001|Phase 1|Withdrawal by Subject|0|||
19492893|NCT01045421|41813503|FG002|Phase 1|Withdrawal by Subject|0|||
19492894|NCT01045421|41813504|FG003|Phase 1|Withdrawal by Subject|1|||
19492895|NCT01045421|41813505|FG004|Phase 1|Withdrawal by Subject|0|||
19492896|NCT01045421|41813506|FG005|Phase 1|Withdrawal by Subject|0|||
19492897|NCT01045421|41813507|FG006|Phase 1|Withdrawal by Subject|0|||
19492898|NCT01045421|41813508|FG007|Phase 1|Withdrawal by Subject|0|||
19492899|NCT01045421|41813509|FG008|Phase 1|Withdrawal by Subject|0|||
19492900|NCT01045421|41813510|FG009|Phase 1|Withdrawal by Subject|0|||
19492901|NCT01045421|41813511|FG010|Phase 1|Withdrawal by Subject|0|||
19492902|NCT01045421|41813501|FG000|Phase 2|Progressive Disease|0|||
19492903|NCT01045421|41813502|FG001|Phase 2|Progressive Disease|0|||
19492904|NCT01045421|41813503|FG002|Phase 2|Progressive Disease|0|||
19492905|NCT01045421|41813504|FG003|Phase 2|Progressive Disease|0|||
19492906|NCT01045421|41813505|FG004|Phase 2|Progressive Disease|0|||
19492907|NCT01045421|41813506|FG005|Phase 2|Progressive Disease|0|||
19492908|NCT01045421|41813507|FG006|Phase 2|Progressive Disease|0|||
19492909|NCT01045421|41813508|FG007|Phase 2|Progressive Disease|1|||
19492910|NCT01045421|41813509|FG008|Phase 2|Progressive Disease|1|||
19492911|NCT01045421|41813510|FG009|Phase 2|Progressive Disease|1|||
19492912|NCT01045421|41813511|FG010|Phase 2|Progressive Disease|1|||
19492913|NCT01045421|41813501|FG000|Phase 2|Death|0|||
19492914|NCT01045421|41813502|FG001|Phase 2|Death|0|||
19492915|NCT01045421|41813503|FG002|Phase 2|Death|0|||
19492916|NCT01045421|41813504|FG003|Phase 2|Death|0|||
19492917|NCT01045421|41813505|FG004|Phase 2|Death|0|||
19492918|NCT01045421|41813506|FG005|Phase 2|Death|0|||
19492919|NCT01045421|41813507|FG006|Phase 2|Death|0|||
19492920|NCT01045421|41813508|FG007|Phase 2|Death|1|||
19492921|NCT01045421|41813509|FG008|Phase 2|Death|1|||
19492922|NCT01045421|41813510|FG009|Phase 2|Death|2|||
19492923|NCT01045421|41813511|FG010|Phase 2|Death|0|||
19492924|NCT01045421|41813501|FG000|Phase 2|Other|0|||
19492925|NCT01045421|41813502|FG001|Phase 2|Other|0|||
19492926|NCT01045421|41813503|FG002|Phase 2|Other|0|||
19492927|NCT01045421|41813504|FG003|Phase 2|Other|0|||
19492928|NCT01045421|41813505|FG004|Phase 2|Other|0|||
19492929|NCT01045421|41813506|FG005|Phase 2|Other|0|||
19492930|NCT01045421|41813507|FG006|Phase 2|Other|0|||
19492931|NCT01045421|41813508|FG007|Phase 2|Other|3|||
19492932|NCT01045421|41813509|FG008|Phase 2|Other|0|||
19492933|NCT01045421|41813510|FG009|Phase 2|Other|0|||
19492934|NCT01045421|41813511|FG010|Phase 2|Other|1|||
19492935|NCT01042535|41813559|FG000|Overall Study|disease progression prior to treatment|3|||
19492936|NCT01042535|41813559|FG000|Overall Study|disease progression during treatment|3|||
19492937|NCT01042535|41813559|FG000|Overall Study|complications from other disease|2|||
19492938|NCT01041287|41813565|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
19492939|NCT01041287|41813566|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
19492940|NCT01041287|41813565|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
19492941|NCT01041287|41813566|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
19492942|NCT01040351|41813587|FG000|Overall Study|poor ovarian response|1|||
19704342|NCT00223080|42148637|FG000|Overall Study|Other|14|||
19704343|NCT00223080|42148638|FG001|Overall Study|Other|11|||
19492943|NCT01040351|41813588|FG001|Overall Study|poor ovarian response|2|||
19492944|NCT02049957|41813608|FG000|Overall Study|Progressive Disease|5|||
19492945|NCT02049957|41813609|FG001|Overall Study|Progressive Disease|4|||
19492946|NCT02049957|41813610|FG002|Overall Study|Progressive Disease|2|||
19492947|NCT02049957|41813611|FG003|Overall Study|Progressive Disease|2|||
19492948|NCT02049957|41813612|FG004|Overall Study|Progressive Disease|6|||
19704344|NCT00223080|42148637|FG000|Overall Study|Reason not provided|141|||
19492949|NCT02049957|41813613|FG005|Overall Study|Progressive Disease|35|||
19492950|NCT02049957|41813614|FG006|Overall Study|Progressive Disease|7|||
19613319|NCT00887822|42062194|FG000|Overall Study|Death|2|||
19492951|NCT02049957|41813615|FG007|Overall Study|Progressive Disease|26|||
19492952|NCT02049957|41813616|FG008|Overall Study|Progressive Disease|6|||
19492953|NCT02049957|41813608|FG000|Overall Study|Adverse Event|1|||
19492954|NCT02049957|41813609|FG001|Overall Study|Adverse Event|1|||
19492955|NCT02049957|41813610|FG002|Overall Study|Adverse Event|1|||
19492956|NCT02049957|41813611|FG003|Overall Study|Adverse Event|0|||
19492957|NCT02049957|41813612|FG004|Overall Study|Adverse Event|0|||
19492958|NCT02049957|41813613|FG005|Overall Study|Adverse Event|5|||
19492959|NCT02049957|41813614|FG006|Overall Study|Adverse Event|0|||
19492960|NCT02049957|41813615|FG007|Overall Study|Adverse Event|6|||
19492961|NCT02049957|41813616|FG008|Overall Study|Adverse Event|1|||
19492962|NCT02049957|41813608|FG000|Overall Study|Study Terminated by Sponsor|0|||
19492963|NCT02049957|41813609|FG001|Overall Study|Study Terminated by Sponsor|1|||
19492964|NCT02049957|41813610|FG002|Overall Study|Study Terminated by Sponsor|0|||
19492965|NCT02049957|41813611|FG003|Overall Study|Study Terminated by Sponsor|0|||
19492966|NCT02049957|41813612|FG004|Overall Study|Study Terminated by Sponsor|0|||
19492967|NCT02049957|41813613|FG005|Overall Study|Study Terminated by Sponsor|0|||
19492968|NCT02049957|41813614|FG006|Overall Study|Study Terminated by Sponsor|1|||
19492969|NCT02049957|41813615|FG007|Overall Study|Study Terminated by Sponsor|0|||
19492970|NCT02049957|41813616|FG008|Overall Study|Study Terminated by Sponsor|0|||
19492971|NCT02049957|41813608|FG000|Overall Study|Withdrawal by Subject|0|||
19492972|NCT02049957|41813609|FG001|Overall Study|Withdrawal by Subject|0|||
19492973|NCT02049957|41813610|FG002|Overall Study|Withdrawal by Subject|0|||
19492974|NCT02049957|41813611|FG003|Overall Study|Withdrawal by Subject|1|||
19492975|NCT02049957|41813612|FG004|Overall Study|Withdrawal by Subject|0|||
19492976|NCT02049957|41813613|FG005|Overall Study|Withdrawal by Subject|2|||
19492977|NCT02049957|41813614|FG006|Overall Study|Withdrawal by Subject|0|||
19492978|NCT02049957|41813615|FG007|Overall Study|Withdrawal by Subject|3|||
19492979|NCT02049957|41813616|FG008|Overall Study|Withdrawal by Subject|1|||
19492980|NCT02049957|41813608|FG000|Overall Study|Physician Decision|0|||
19492981|NCT02049957|41813609|FG001|Overall Study|Physician Decision|0|||
19492982|NCT02049957|41813610|FG002|Overall Study|Physician Decision|0|||
19492983|NCT02049957|41813611|FG003|Overall Study|Physician Decision|0|||
19492984|NCT02049957|41813612|FG004|Overall Study|Physician Decision|0|||
19492985|NCT02049957|41813613|FG005|Overall Study|Physician Decision|1|||
19492986|NCT02049957|41813614|FG006|Overall Study|Physician Decision|0|||
19492987|NCT02049957|41813615|FG007|Overall Study|Physician Decision|0|||
19492988|NCT02049957|41813616|FG008|Overall Study|Physician Decision|0|||
19492989|NCT03400943|41813788|FG000|Treatment Period 1|Adverse Event|0|||
19492990|NCT03400943|41813789|FG001|Treatment Period 1|Adverse Event|0|||
19492991|NCT03400943|41813790|FG002|Treatment Period 1|Adverse Event|0|||
19492992|NCT03400943|41813791|FG003|Treatment Period 1|Adverse Event|1|||
19492993|NCT03400943|41813788|FG000|Treatment Period 1|Lost to Follow-up|1|||
19492994|NCT03400943|41813789|FG001|Treatment Period 1|Lost to Follow-up|0|||
19492995|NCT03400943|41813790|FG002|Treatment Period 1|Lost to Follow-up|0|||
19492996|NCT03400943|41813791|FG003|Treatment Period 1|Lost to Follow-up|0|||
19492997|NCT03400943|41813788|FG000|Treatment Period 1|Protocol Violation|0|||
19492998|NCT03400943|41813789|FG001|Treatment Period 1|Protocol Violation|1|||
19492999|NCT03400943|41813790|FG002|Treatment Period 1|Protocol Violation|1|||
19493000|NCT03400943|41813791|FG003|Treatment Period 1|Protocol Violation|0|||
19493001|NCT03400943|41813788|FG000|Treatment Period 1|Study terminated by sponsor|2|||
19493002|NCT03400943|41813789|FG001|Treatment Period 1|Study terminated by sponsor|0|||
19493003|NCT03400943|41813790|FG002|Treatment Period 1|Study terminated by sponsor|0|||
19493004|NCT03400943|41813791|FG003|Treatment Period 1|Study terminated by sponsor|1|||
19493005|NCT03400943|41813788|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19493006|NCT03400943|41813789|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19493007|NCT03400943|41813790|FG002|Treatment Period 1|Withdrawal by Subject|3|||
19493008|NCT03400943|41813791|FG003|Treatment Period 1|Withdrawal by Subject|1|||
19493009|NCT03400943|41813788|FG000|Treatment Period 1|Other|2|||
19493010|NCT03400943|41813789|FG001|Treatment Period 1|Other|1|||
19493011|NCT03400943|41813790|FG002|Treatment Period 1|Other|2|||
19493012|NCT03400943|41813791|FG003|Treatment Period 1|Other|2|||
19493013|NCT03400943|41813788|FG000|Post-treatment Period 1|Adverse Event|2|||
19493014|NCT03400943|41813789|FG001|Post-treatment Period 1|Adverse Event|0|||
19493015|NCT03400943|41813790|FG002|Post-treatment Period 1|Adverse Event|0|||
19493016|NCT03400943|41813791|FG003|Post-treatment Period 1|Adverse Event|0|||
19493017|NCT03400943|41813788|FG000|Post-treatment Period 1|Protocol Violation|1|||
19493018|NCT03400943|41813789|FG001|Post-treatment Period 1|Protocol Violation|0|||
19493019|NCT03400943|41813790|FG002|Post-treatment Period 1|Protocol Violation|0|||
19493020|NCT03400943|41813791|FG003|Post-treatment Period 1|Protocol Violation|0|||
19493021|NCT03400943|41813788|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
19493022|NCT03400943|41813789|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
19493023|NCT03400943|41813790|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
19493024|NCT03400943|41813791|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
19493025|NCT03400943|41813788|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
19493026|NCT03400943|41813789|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
19493027|NCT03400943|41813790|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
19493028|NCT03400943|41813791|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
19493029|NCT03400943|41813788|FG000|Post-treatment Period 1|Other|2|||
19493030|NCT03400943|41813789|FG001|Post-treatment Period 1|Other|0|||
19493031|NCT03400943|41813790|FG002|Post-treatment Period 1|Other|4|||
19493032|NCT03400943|41813791|FG003|Post-treatment Period 1|Other|5|||
19493033|NCT03400943|41813788|FG000|Treatment Period 2|Study terminated by sponsor|0|||
19493034|NCT03400943|41813789|FG001|Treatment Period 2|Study terminated by sponsor|1|||
19493035|NCT03400943|41813790|FG002|Treatment Period 2|Study terminated by sponsor|0|||
19493036|NCT03400943|41813791|FG003|Treatment Period 2|Study terminated by sponsor|0|||
19493037|NCT03400943|41813788|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19493038|NCT03400943|41813789|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19493039|NCT03400943|41813790|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19493040|NCT03400943|41813791|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19493041|NCT03400943|41813788|FG000|Treatment Period 2|Other|1|||
19493042|NCT03400943|41813789|FG001|Treatment Period 2|Other|6|||
19493043|NCT03400943|41813790|FG002|Treatment Period 2|Other|0|||
19493044|NCT03400943|41813791|FG003|Treatment Period 2|Other|0|||
19493045|NCT03400943|41813788|FG000|Follow-up Period|Withdrawal by Subject|1|||
19493046|NCT03400943|41813789|FG001|Follow-up Period|Withdrawal by Subject|0|||
19493047|NCT03400943|41813790|FG002|Follow-up Period|Withdrawal by Subject|0|||
19493048|NCT03400943|41813791|FG003|Follow-up Period|Withdrawal by Subject|0|||
19493049|NCT00014495|41813898|FG000|Overall Study|Death|0|||
19493050|NCT00014495|41813899|FG001|Overall Study|Death|0|||
19493051|NCT00014495|41813900|FG002|Overall Study|Death|1|||
19493052|NCT00014495|41813901|FG003|Overall Study|Death|0|||
19493053|NCT00014495|41813898|FG000|Overall Study|Clinical deterioration|0|||
19493054|NCT00014495|41813899|FG001|Overall Study|Clinical deterioration|0|||
19493055|NCT00014495|41813900|FG002|Overall Study|Clinical deterioration|0|||
19493056|NCT00014495|41813901|FG003|Overall Study|Clinical deterioration|1|||
19493057|NCT03439293|41815793|FG000|Overall Study|Ongoing on Treatment|15|||
19493058|NCT03439293|41815793|FG000|Overall Study|Ongoing off Treatment|19|||
19493059|NCT03439293|41815793|FG000|Overall Study|Death|18|||
19493060|NCT03439293|41815793|FG000|Overall Study|Withdrawal by Subject|7|||
19493061|NCT03439293|41815793|FG000|Overall Study|Lost to Follow-up|2|||
19493062|NCT01351623|41815941|FG000|Overall Study|Protocol Violation|2|||
19493063|NCT01351623|41815941|FG000|Overall Study|Adverse Event|4|||
19493064|NCT01351623|41815941|FG000|Overall Study|Withdrawal by Subject|1|||
19493065|NCT01351623|41815941|FG000|Overall Study|Death|2|||
19493066|NCT03670953|41816078|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
19493067|NCT03670953|41816079|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
19493068|NCT03670953|41816080|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
19493069|NCT03670953|41816081|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
19493070|NCT03670953|41816078|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
19493071|NCT03670953|41816079|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
19493072|NCT03670953|41816080|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
19493073|NCT03670953|41816081|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
19493074|NCT03670953|41816078|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
19493075|NCT03670953|41816079|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
19493076|NCT03670953|41816080|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
19493077|NCT03670953|41816081|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
19493078|NCT03670953|41816078|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
19493079|NCT03670953|41816079|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
19493080|NCT03670953|41816080|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
19493081|NCT03670953|41816081|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
19493082|NCT03670953|41816078|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
19493083|NCT03670953|41816079|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
19493084|NCT03670953|41816080|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
19493085|NCT03670953|41816081|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
19493086|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
19493087|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
19493088|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
19493089|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
19493090|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
19493091|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
19493092|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
19493093|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
19493094|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
19493095|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
19493096|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
19493097|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
19493098|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
19493099|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
19493100|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
19493101|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
19493102|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
19493103|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
19493104|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
19493105|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
19493106|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
19493107|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
19493108|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
19493109|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
19493110|NCT03670953|41816078|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
19493111|NCT03670953|41816079|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
19493112|NCT03670953|41816080|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
19493113|NCT03670953|41816081|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
19493114|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
19493115|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
19493116|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
19493117|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
19493118|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
19493119|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
19493120|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
19493121|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
19493122|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
19493123|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
19493124|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
19493125|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
19493126|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
19493127|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
19493128|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
19493129|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
19493130|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
19493131|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
19493132|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
19493133|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
19493134|NCT03670953|41816078|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
19493135|NCT03670953|41816079|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
19493136|NCT03670953|41816080|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
19493137|NCT03670953|41816081|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
19493138|NCT02519348|41816132|FG000|Overall Study|Death|31|||
19493139|NCT02519348|41816133|FG001|Overall Study|Death|74|||
19493140|NCT02519348|41816134|FG002|Overall Study|Death|47|||
19493141|NCT02519348|41816135|FG003|Overall Study|Death|54|||
19493142|NCT02519348|41816136|FG004|Overall Study|Death|63|||
19493143|NCT02519348|41816137|FG005|Overall Study|Death|18|||
19493144|NCT02519348|41816138|FG006|Overall Study|Death|2|||
19493145|NCT02519348|41816139|FG007|Overall Study|Death|5|||
19493146|NCT02519348|41816140|FG008|Overall Study|Death|5|||
19493147|NCT02519348|41816132|FG000|Overall Study|Withdrawal by Subject|4|||
19493148|NCT02519348|41816133|FG001|Overall Study|Withdrawal by Subject|7|||
19493149|NCT02519348|41816134|FG002|Overall Study|Withdrawal by Subject|4|||
19493150|NCT02519348|41816135|FG003|Overall Study|Withdrawal by Subject|3|||
19493151|NCT02519348|41816136|FG004|Overall Study|Withdrawal by Subject|3|||
19493152|NCT02519348|41816137|FG005|Overall Study|Withdrawal by Subject|2|||
19493153|NCT02519348|41816138|FG006|Overall Study|Withdrawal by Subject|0|||
19493154|NCT02519348|41816139|FG007|Overall Study|Withdrawal by Subject|0|||
19493155|NCT02519348|41816140|FG008|Overall Study|Withdrawal by Subject|1|||
19493156|NCT02519348|41816132|FG000|Overall Study|Lost to Follow-up|0|||
19493157|NCT02519348|41816133|FG001|Overall Study|Lost to Follow-up|0|||
19493158|NCT02519348|41816134|FG002|Overall Study|Lost to Follow-up|1|||
19493159|NCT02519348|41816135|FG003|Overall Study|Lost to Follow-up|0|||
19493160|NCT02519348|41816136|FG004|Overall Study|Lost to Follow-up|2|||
19493161|NCT02519348|41816137|FG005|Overall Study|Lost to Follow-up|1|||
19493162|NCT02519348|41816138|FG006|Overall Study|Lost to Follow-up|1|||
19493163|NCT02519348|41816139|FG007|Overall Study|Lost to Follow-up|0|||
19493164|NCT02519348|41816140|FG008|Overall Study|Lost to Follow-up|0|||
19493165|NCT02519348|41816132|FG000|Overall Study|Other|0|||
19493166|NCT02519348|41816133|FG001|Overall Study|Other|3|||
19493167|NCT02519348|41816134|FG002|Overall Study|Other|0|||
19493168|NCT02519348|41816135|FG003|Overall Study|Other|0|||
19493169|NCT02519348|41816136|FG004|Overall Study|Other|1|||
19493170|NCT02519348|41816137|FG005|Overall Study|Other|0|||
19493171|NCT02519348|41816138|FG006|Overall Study|Other|0|||
19493172|NCT02519348|41816139|FG007|Overall Study|Other|0|||
19493173|NCT02519348|41816140|FG008|Overall Study|Other|0|||
19493174|NCT02519348|41816132|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
19493175|NCT02519348|41816133|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
19493176|NCT02519348|41816134|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
19493177|NCT02519348|41816135|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
19493178|NCT02519348|41816136|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
19493179|NCT02519348|41816137|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
19493180|NCT02519348|41816138|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
19493181|NCT02519348|41816139|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
19493182|NCT02519348|41816140|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
19493183|NCT00636818|41816161|FG000|Overall Study|Adverse Event|1|||
19493184|NCT00636818|41816161|FG000|Overall Study|Lost to Follow-up|2|||
19493185|NCT00636818|41816161|FG000|Overall Study|Entry Criteria Exclusion|3|||
19493186|NCT00636818|41816161|FG000|Overall Study|Protocol Violation|1|||
19493187|NCT00636818|41816161|FG000|Overall Study|Withdrawal by Subject|4|||
19493188|NCT03127137|41816167|FG000|Overall Study|Requested sedation after consent|1|||
19493189|NCT03127137|41816168|FG001|Overall Study|Requested sedation after consent|0|||
19493190|NCT03127137|41816167|FG000|Overall Study|Malfunction in electronic data collection|1|||
19493191|NCT03127137|41816168|FG001|Overall Study|Malfunction in electronic data collection|0|||
19704345|NCT00223080|42148638|FG001|Overall Study|Reason not provided|140|||
19493192|NCT03127137|41816167|FG000|Overall Study|Post procedure testing could not be obtained|0|||
19493193|NCT03127137|41816168|FG001|Overall Study|Post procedure testing could not be obtained|1|||
19493194|NCT00636506|41816176|FG000|Overall Study|Lost to Follow-up|8|||
19493195|NCT00636506|41816176|FG000|Overall Study|Explanted|1|||
19493196|NCT00636506|41816176|FG000|Overall Study|Withdrawal by Subject|6|||
19493197|NCT00636506|41816176|FG000|Overall Study|Procedure aborted|1|||
19493198|NCT00636194|41816200|FG000|Overall Study|Study related symptoms and complaints|1|||
19493199|NCT00636194|41816201|FG001|Overall Study|Study related symptoms and complaints|0|||
19493200|NCT00636194|41816200|FG000|Overall Study|Protocol Violation|2|||
19493201|NCT00636194|41816201|FG001|Overall Study|Protocol Violation|0|||
19493202|NCT00635804|41816267|FG000|Overall Study|Adverse Event|0|||
19493203|NCT00635804|41816268|FG001|Overall Study|Adverse Event|0|||
19493204|NCT00635804|41816269|FG002|Overall Study|Adverse Event|0|||
19493205|NCT00635804|41816270|FG003|Overall Study|Adverse Event|0|||
19493206|NCT00635804|41816271|FG004|Overall Study|Adverse Event|0|||
19493207|NCT00635804|41816272|FG005|Overall Study|Adverse Event|1|||
19493208|NCT00635804|41816273|FG006|Overall Study|Adverse Event|0|||
19493209|NCT00635804|41816274|FG007|Overall Study|Adverse Event|0|||
19493210|NCT00635804|41816267|FG000|Overall Study|Withdrawal by Subject|1|||
19493211|NCT00635804|41816268|FG001|Overall Study|Withdrawal by Subject|0|||
19493212|NCT00635804|41816269|FG002|Overall Study|Withdrawal by Subject|0|||
19493213|NCT00635804|41816270|FG003|Overall Study|Withdrawal by Subject|0|||
19493214|NCT00635804|41816271|FG004|Overall Study|Withdrawal by Subject|0|||
19493215|NCT00635804|41816272|FG005|Overall Study|Withdrawal by Subject|0|||
19493216|NCT00635804|41816273|FG006|Overall Study|Withdrawal by Subject|0|||
19493217|NCT00635804|41816274|FG007|Overall Study|Withdrawal by Subject|0|||
19493218|NCT00635648|41816304|FG000|Overall Study|Adverse Event|12|||
19493219|NCT00635648|41816304|FG000|Overall Study|Withdrawal by Subject|9|||
19493220|NCT00635648|41816304|FG000|Overall Study|Physician Decision|4|||
19493221|NCT00635648|41816304|FG000|Overall Study|Rapid progression of baseline disease|4|||
19493222|NCT00635648|41816304|FG000|Overall Study|Use of other antifungal agent needed|1|||
19493223|NCT00635648|41816304|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
19493224|NCT00635648|41816304|FG000|Overall Study|Noncompliance with protocol|1|||
19493225|NCT00635648|41816304|FG000|Overall Study|Other reason|2|||
19493226|NCT03056001|41816308|FG000|Overall Study|Death|24|||
19493227|NCT03056001|41816308|FG000|Overall Study|Still On Study (in follow up)|1|||
19493228|NCT00635102|41816333|FG000|Overall Study|Withdrawal by Subject|7|||
19493229|NCT00635102|41816334|FG001|Overall Study|Withdrawal by Subject|8|||
19493230|NCT00635024|41816349|FG000|Overall Study|Adverse Event|1|||
19493231|NCT00634244|41816398|FG000|Overall Study|Never started treatment|0|||
19493232|NCT00634244|41816399|FG001|Overall Study|Never started treatment|1|||
19493233|NCT00634244|41816400|FG002|Overall Study|Never started treatment|0|||
19493234|NCT00634244|41816398|FG000|Overall Study|Death|1|||
19493235|NCT00634244|41816399|FG001|Overall Study|Death|6|||
19493236|NCT00634244|41816400|FG002|Overall Study|Death|0|||
19493237|NCT00634244|41816398|FG000|Overall Study|Adverse Event|0|||
19493238|NCT00634244|41816399|FG001|Overall Study|Adverse Event|2|||
19493239|NCT00634244|41816400|FG002|Overall Study|Adverse Event|0|||
19493240|NCT00634244|41816398|FG000|Overall Study|Withdrawal by Subject|0|||
19493241|NCT00634244|41816399|FG001|Overall Study|Withdrawal by Subject|1|||
19493242|NCT00634244|41816400|FG002|Overall Study|Withdrawal by Subject|0|||
19493243|NCT00634244|41816398|FG000|Overall Study|Physician Decision|0|||
19493244|NCT00634244|41816399|FG001|Overall Study|Physician Decision|1|||
19493245|NCT00634244|41816400|FG002|Overall Study|Physician Decision|0|||
19493246|NCT00634244|41816398|FG000|Overall Study|Disease progression/relapse|0|||
19493247|NCT00634244|41816399|FG001|Overall Study|Disease progression/relapse|1|||
19493248|NCT00634244|41816400|FG002|Overall Study|Disease progression/relapse|0|||
19493249|NCT00634244|41816398|FG000|Overall Study|Other complicating disease|0|||
19493250|NCT00634244|41816399|FG001|Overall Study|Other complicating disease|1|||
19493251|NCT00634244|41816400|FG002|Overall Study|Other complicating disease|0|||
19493252|NCT00634088|41816584|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
19493253|NCT00634088|41816585|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
19493254|NCT00634088|41816586|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
19493255|NCT00634088|41816587|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
19493256|NCT00634088|41816584|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
19493257|NCT00634088|41816585|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
19493258|NCT00634088|41816586|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
19493259|NCT00634088|41816587|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
19493260|NCT00634088|41816584|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
19493261|NCT00634088|41816585|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
19493262|NCT00634088|41816586|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
19493263|NCT00634088|41816587|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
19493264|NCT00634088|41816584|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
19493265|NCT00634088|41816585|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
19493266|NCT00634088|41816586|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
19493267|NCT00634088|41816587|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
19493268|NCT00634088|41816584|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
19493269|NCT00634088|41816585|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
19493270|NCT00634088|41816586|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
19493271|NCT00634088|41816587|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
19493272|NCT00634088|41816584|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
19493273|NCT00634088|41816585|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
19493274|NCT00634088|41816586|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
19493275|NCT00634088|41816587|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
19493276|NCT00634010|41816698|FG000|Overall Study|Adverse Event|2|||
19493277|NCT00634010|41816699|FG001|Overall Study|Adverse Event|5|||
19493278|NCT00634010|41816698|FG000|Overall Study|Withdrawal by Subject|5|||
19493279|NCT00634010|41816699|FG001|Overall Study|Withdrawal by Subject|6|||
19493280|NCT00634010|41816698|FG000|Overall Study|Physician Decision|1|||
19493281|NCT00634010|41816699|FG001|Overall Study|Physician Decision|1|||
19493282|NCT00634010|41816698|FG000|Overall Study|Disease Progression|1|||
19493283|NCT00634010|41816699|FG001|Overall Study|Disease Progression|1|||
19493284|NCT00634010|41816698|FG000|Overall Study|Non-Compliant|1|||
19493285|NCT00634010|41816699|FG001|Overall Study|Non-Compliant|1|||
19493286|NCT00633932|41816712|FG000|Overall Study|Adverse Event|1|||
19493287|NCT00633932|41816713|FG001|Overall Study|Adverse Event|3|||
19493288|NCT00633932|41816714|FG002|Overall Study|Adverse Event|4|||
19493289|NCT00633932|41816712|FG000|Overall Study|Withdrawal by Subject|3|||
19493290|NCT00633932|41816713|FG001|Overall Study|Withdrawal by Subject|9|||
19493291|NCT00633932|41816714|FG002|Overall Study|Withdrawal by Subject|1|||
19493292|NCT00633932|41816712|FG000|Overall Study|Lost to Follow-up|1|||
19493293|NCT00633932|41816713|FG001|Overall Study|Lost to Follow-up|0|||
19493294|NCT00633932|41816714|FG002|Overall Study|Lost to Follow-up|2|||
19493295|NCT00633932|41816712|FG000|Overall Study|Protocol Violation|5|||
19493296|NCT00633932|41816713|FG001|Overall Study|Protocol Violation|2|||
19493297|NCT00633932|41816714|FG002|Overall Study|Protocol Violation|3|||
19493298|NCT00633932|41816712|FG000|Overall Study|Physician Decision|0|||
19493299|NCT00633932|41816713|FG001|Overall Study|Physician Decision|0|||
19493300|NCT00633932|41816714|FG002|Overall Study|Physician Decision|1|||
19493301|NCT00633932|41816712|FG000|Overall Study|Doctor's judgement|1|||
19493302|NCT00633932|41816713|FG001|Overall Study|Doctor's judgement|0|||
19493303|NCT00633932|41816714|FG002|Overall Study|Doctor's judgement|0|||
19493304|NCT00633932|41816712|FG000|Overall Study|Moved Away|1|||
19493305|NCT00633932|41816713|FG001|Overall Study|Moved Away|0|||
19493306|NCT00633932|41816714|FG002|Overall Study|Moved Away|0|||
19493307|NCT00633464|41816844|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
19493308|NCT00633464|41816845|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
19493309|NCT00633464|41816844|FG000|Overall Study|Never Treated (Randomized in error)|0|||
19493310|NCT00633464|41816845|FG001|Overall Study|Never Treated (Randomized in error)|1|||
19493311|NCT00633152|41816891|FG000|Overall Study|Adverse Event|1|||
19493312|NCT00633152|41816892|FG001|Overall Study|Adverse Event|0|||
19493313|NCT00633152|41816891|FG000|Overall Study|Randomized, did not receive study drug|5|||
19493314|NCT00633152|41816892|FG001|Overall Study|Randomized, did not receive study drug|2|||
19493315|NCT00633152|41816891|FG000|Overall Study|Withdrawal by Subject|1|||
19493316|NCT00633152|41816892|FG001|Overall Study|Withdrawal by Subject|1|||
19493317|NCT00633152|41816891|FG000|Overall Study|Lost to Follow-up|4|||
19493318|NCT00633152|41816892|FG001|Overall Study|Lost to Follow-up|1|||
19493319|NCT00633152|41816891|FG000|Overall Study|Miscellaneous Other|3|||
19493320|NCT00633152|41816892|FG001|Overall Study|Miscellaneous Other|2|||
19493321|NCT00633074|41816911|FG000|Overall Study|Adverse Event|1|||
19493322|NCT00633074|41816912|FG001|Overall Study|Adverse Event|0|||
19493323|NCT00630344|41817099|FG000|Overall Study|Adverse Event|5|||
19493324|NCT00630344|41817099|FG000|Overall Study|Progressive Disease|19|||
19493325|NCT00630344|41817099|FG000|Overall Study|Physician Decision|9|||
19493326|NCT00630344|41817099|FG000|Overall Study|Withdrawal by Subject|1|||
19493327|NCT00630344|41817099|FG000|Overall Study|Intercurrent Illness|1|||
19493328|NCT00630344|41817099|FG000|Overall Study|Other|1|||
19493329|NCT02913261|41817125|FG000|Overall Study|Technical problems|0|||
19493330|NCT02913261|41817126|FG001|Overall Study|Technical problems|1|||
19493331|NCT02913261|41817125|FG000|Overall Study|Lack of Efficacy|32|||
19493332|NCT02913261|41817126|FG001|Overall Study|Lack of Efficacy|69|||
19493333|NCT02913261|41817125|FG000|Overall Study|Adverse Event|27|||
19493334|NCT02913261|41817126|FG001|Overall Study|Adverse Event|5|||
19493335|NCT02913261|41817125|FG000|Overall Study|Death|25|||
19493336|NCT02913261|41817126|FG001|Overall Study|Death|22|||
19493337|NCT02913261|41817125|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
19493338|NCT02913261|41817126|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
19493339|NCT02913261|41817125|FG000|Overall Study|Disease relapse|8|||
19493340|NCT02913261|41817126|FG001|Overall Study|Disease relapse|13|||
19493341|NCT02913261|41817125|FG000|Overall Study|Physician Decision|8|||
19493342|NCT02913261|41817126|FG001|Overall Study|Physician Decision|9|||
19493343|NCT02913261|41817125|FG000|Overall Study|Subject/guardian decision|4|||
19493344|NCT02913261|41817126|FG001|Overall Study|Subject/guardian decision|6|||
19493345|NCT02913261|41817125|FG000|Overall Study|Graft loss|2|||
19493346|NCT02913261|41817126|FG001|Overall Study|Graft loss|0|||
19493347|NCT00635882|41817190|FG000|Overall Study|Protocol Violation|1|||
19493348|NCT00635882|41817191|FG001|Overall Study|Protocol Violation|0|||
19493349|NCT00635882|41817192|FG002|Overall Study|Protocol Violation|0|||
19493350|NCT00635882|41817193|FG003|Overall Study|Protocol Violation|0|||
19493351|NCT00635882|41817194|FG004|Overall Study|Protocol Violation|0|||
19493352|NCT00635882|41817195|FG005|Overall Study|Protocol Violation|0|||
19493353|NCT02393859|41817263|FG000|Overall Study|Decision by Sponsor|1|||
19493354|NCT02393859|41817264|FG001|Overall Study|Decision by Sponsor|1|||
19493355|NCT02393859|41817263|FG000|Overall Study|Withdrawal by Subject|5|||
19493356|NCT02393859|41817264|FG001|Overall Study|Withdrawal by Subject|2|||
19493357|NCT02393859|41817263|FG000|Overall Study|Death|16|||
19493358|NCT02393859|41817264|FG001|Overall Study|Death|8|||
19493359|NCT02393859|41817263|FG000|Overall Study|Continuing Study|32|||
19493360|NCT02393859|41817264|FG001|Overall Study|Continuing Study|43|||
19493361|NCT00986570|41817456|FG000|Overall Study|Lost to Follow-up|6|||
19493362|NCT00986570|41817456|FG000|Overall Study|Potential bias for objective assessment|1|||
19493363|NCT00986258|41817460|FG000|Observation Period|Not eligible to be dosed|11|||
19493364|NCT00986258|41817460|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
19493365|NCT00986258|41817460|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
19493366|NCT00986258|41817460|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
19493367|NCT00986258|41817460|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
19493368|NCT00986258|41817460|FG000|Titration and Optimal Dose Period|Other|1|||
19493369|NCT00986258|41817460|FG000|Maintenance Period|Adverse Event|5|||
19493370|NCT00986258|41817460|FG000|Maintenance Period|Lack of Efficacy|2|||
19493371|NCT00986258|41817460|FG000|Maintenance Period|Withdrawal by Subject|2|||
19493372|NCT00986180|41817476|FG000|Overall Study|Adverse Event|21|||
19493373|NCT00986180|41817477|FG001|Overall Study|Adverse Event|23|||
19493374|NCT00986180|41817476|FG000|Overall Study|Lack of Efficacy|4|||
19493375|NCT00986180|41817477|FG001|Overall Study|Lack of Efficacy|3|||
19493376|NCT00986180|41817476|FG000|Overall Study|Lost to Follow-up|5|||
19493377|NCT00986180|41817477|FG001|Overall Study|Lost to Follow-up|7|||
19493378|NCT00986180|41817476|FG000|Overall Study|Physician Decision|1|||
19493379|NCT00986180|41817477|FG001|Overall Study|Physician Decision|3|||
19493380|NCT00986180|41817476|FG000|Overall Study|Protocol Violation|2|||
19493381|NCT00986180|41817477|FG001|Overall Study|Protocol Violation|0|||
19493382|NCT00986180|41817476|FG000|Overall Study|Withdrawal by Subject|1|||
19493383|NCT00986180|41817477|FG001|Overall Study|Withdrawal by Subject|9|||
19493384|NCT00986180|41817476|FG000|Overall Study|Miscellanies|10|||
19493385|NCT00986180|41817477|FG001|Overall Study|Miscellanies|11|||
19493386|NCT00986102|41817659|FG000|Overall Study|Lost to Follow-up|0|||
19493387|NCT00986102|41817660|FG001|Overall Study|Lost to Follow-up|1|||
19493388|NCT00986102|41817661|FG002|Overall Study|Lost to Follow-up|0|||
19493389|NCT00986102|41817662|FG003|Overall Study|Lost to Follow-up|1|||
19493390|NCT00986102|41817659|FG000|Overall Study|Withdrawal by Subject|1|||
19493391|NCT00986102|41817660|FG001|Overall Study|Withdrawal by Subject|1|||
19493392|NCT00986102|41817661|FG002|Overall Study|Withdrawal by Subject|0|||
19493393|NCT00986102|41817662|FG003|Overall Study|Withdrawal by Subject|0|||
19493394|NCT00985946|41817685|FG000|Overall Study|Lost to Follow-up|6|||
19493395|NCT00985946|41817685|FG000|Overall Study|Withdrawal by Subject|1|||
19493396|NCT00985790|41817700|FG000|Overall Study|Withdrawal by Subject|1|||
19493397|NCT00985790|41817701|FG001|Overall Study|Withdrawal by Subject|1|||
19493398|NCT00985790|41817700|FG000|Overall Study|Lost to Follow-up|6|||
19493399|NCT00985790|41817701|FG001|Overall Study|Lost to Follow-up|7|||
19493400|NCT00985712|41817728|FG000|Overall Study|Adverse Event|0|||
19493401|NCT00985712|41817729|FG001|Overall Study|Adverse Event|1|||
19493402|NCT00985712|41817728|FG000|Overall Study|Lost to Follow-up|2|||
19493403|NCT00985712|41817729|FG001|Overall Study|Lost to Follow-up|2|||
19493404|NCT00985712|41817728|FG000|Overall Study|Protocol Violation|0|||
19393660|NCT01936948|41637516|FG001|Overall Study|no 30-day follow-up data|3|||
19393661|NCT01936948|41637517|FG002|Overall Study|no 30-day follow-up data|3|||
19393662|NCT01936948|41637518|FG003|Overall Study|no 30-day follow-up data|3|||
19393663|NCT01936870|41637526|FG000|Overall Study|No Visit After Treatment|176|||
19393664|NCT01936870|41637526|FG000|Overall Study|Protocol Violation|12|||
19393665|NCT01936870|41637526|FG000|Overall Study|No Drug Administration|1|||
19393666|NCT01618864|41637530|FG000|Overall Study|Withdrawal by Subject|2|||
19393667|NCT01618864|41637530|FG000|Overall Study|Lost to Follow-up|2|||
19393668|NCT01618708|41637541|FG000|Overall Study|Adverse Event|10|||
19393669|NCT01618708|41637542|FG001|Overall Study|Adverse Event|10|||
19393670|NCT01618708|41637541|FG000|Overall Study|Lost to Follow-up|3|||
19393671|NCT01618708|41637542|FG001|Overall Study|Lost to Follow-up|3|||
19393672|NCT01618708|41637541|FG000|Overall Study|Withdrawal by Subject|17|||
19393673|NCT01618708|41637542|FG001|Overall Study|Withdrawal by Subject|22|||
19393674|NCT01618708|41637541|FG000|Overall Study|Lack of Efficacy|8|||
19393675|NCT01618708|41637542|FG001|Overall Study|Lack of Efficacy|8|||
19393676|NCT01618708|41637541|FG000|Overall Study|Technical problems|2|||
19393677|NCT01618708|41637542|FG001|Overall Study|Technical problems|0|||
19493405|NCT00985712|41817729|FG001|Overall Study|Protocol Violation|1|||
19493406|NCT00985712|41817728|FG000|Overall Study|Withdrawal by Subject|4|||
19493407|NCT00985712|41817729|FG001|Overall Study|Withdrawal by Subject|1|||
19493408|NCT00985712|41817728|FG000|Overall Study|Sponsor decision|0|||
19493409|NCT00985712|41817729|FG001|Overall Study|Sponsor decision|2|||
19493410|NCT00985166|41817836|FG000|Overall Study|Lost to Follow-up|3|||
19493411|NCT00985166|41817837|FG001|Overall Study|Lost to Follow-up|2|||
19493412|NCT00985166|41817838|FG002|Overall Study|Lost to Follow-up|2|||
19493413|NCT00985166|41817836|FG000|Overall Study|Withdrawal by Subject|3|||
19493414|NCT00985166|41817837|FG001|Overall Study|Withdrawal by Subject|2|||
19493415|NCT00985166|41817838|FG002|Overall Study|Withdrawal by Subject|0|||
19493416|NCT00985166|41817836|FG000|Overall Study|Test not done|2|||
19493417|NCT00985166|41817837|FG001|Overall Study|Test not done|0|||
19493418|NCT00985166|41817838|FG002|Overall Study|Test not done|4|||
19493419|NCT00985166|41817836|FG000|Overall Study|Other|1|||
19493420|NCT00985166|41817837|FG001|Overall Study|Other|0|||
19493421|NCT00985166|41817838|FG002|Overall Study|Other|1|||
19493422|NCT02184195|41818000|FG000|Overall Study|Patients ongoing Study Treatment|19|||
19493423|NCT02184195|41818001|FG001|Overall Study|Patients ongoing Study Treatment|7|||
19493424|NCT01341405|41818102|FG000|Overall Study|Adverse Event|0|||
19493425|NCT01341405|41818103|FG001|Overall Study|Adverse Event|1|||
19493426|NCT01341405|41818104|FG002|Overall Study|Adverse Event|1|||
19493427|NCT01341405|41818102|FG000|Overall Study|Withdrawal by Subject|3|||
19493428|NCT01341405|41818103|FG001|Overall Study|Withdrawal by Subject|2|||
19493429|NCT01341405|41818104|FG002|Overall Study|Withdrawal by Subject|1|||
19493430|NCT02516241|41819311|FG000|Overall Study|Death|255|||
19493431|NCT02516241|41819312|FG001|Overall Study|Death|262|||
19493432|NCT02516241|41819313|FG002|Overall Study|Death|270|||
19493433|NCT02516241|41819311|FG000|Overall Study|Lost to Follow-up|1|||
19493434|NCT02516241|41819312|FG001|Overall Study|Lost to Follow-up|1|||
19493435|NCT02516241|41819313|FG002|Overall Study|Lost to Follow-up|3|||
19493436|NCT02516241|41819311|FG000|Overall Study|Withdrawal by Subject|2|||
19493437|NCT02516241|41819312|FG001|Overall Study|Withdrawal by Subject|7|||
19493438|NCT02516241|41819313|FG002|Overall Study|Withdrawal by Subject|12|||
19493439|NCT02516241|41819311|FG000|Overall Study|participants ongoing at data cut-off|84|||
19493440|NCT02516241|41819312|FG001|Overall Study|participants ongoing at data cut-off|76|||
19493441|NCT02516241|41819313|FG002|Overall Study|participants ongoing at data cut-off|59|||
19493442|NCT00633945|41819386|FG000|Overall Study|Physician Decision|2|||
19493443|NCT02574078|41819659|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493444|NCT02574078|41819660|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493445|NCT02574078|41819661|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493446|NCT02574078|41819662|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493447|NCT02574078|41819663|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493448|NCT02574078|41819664|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19493449|NCT02574078|41819665|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
19493450|NCT02574078|41819666|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493451|NCT02574078|41819667|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19493452|NCT02574078|41819668|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493453|NCT02574078|41819669|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493454|NCT02574078|41819670|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493455|NCT02574078|41819671|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19493456|NCT02574078|41819659|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
19493457|NCT02574078|41819660|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
19493458|NCT02574078|41819661|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
19493459|NCT02574078|41819662|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
19493460|NCT02574078|41819663|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
19493461|NCT02574078|41819664|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
19493462|NCT02574078|41819665|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
19493463|NCT02574078|41819666|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
19493464|NCT02574078|41819667|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
19493465|NCT02574078|41819668|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
19493466|NCT02574078|41819669|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
19493467|NCT02574078|41819670|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
19493468|NCT02574078|41819671|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
19493469|NCT02574078|41819659|FG000|Pre-Treatment Period|Other reasons|0|||
19493470|NCT02574078|41819660|FG001|Pre-Treatment Period|Other reasons|0|||
19493471|NCT02574078|41819661|FG002|Pre-Treatment Period|Other reasons|0|||
19493472|NCT02574078|41819662|FG003|Pre-Treatment Period|Other reasons|0|||
19493473|NCT02574078|41819663|FG004|Pre-Treatment Period|Other reasons|0|||
19493474|NCT02574078|41819664|FG005|Pre-Treatment Period|Other reasons|0|||
19493475|NCT02574078|41819665|FG006|Pre-Treatment Period|Other reasons|2|||
19493476|NCT02574078|41819666|FG007|Pre-Treatment Period|Other reasons|0|||
19493477|NCT02574078|41819667|FG008|Pre-Treatment Period|Other reasons|0|||
19493478|NCT02574078|41819668|FG009|Pre-Treatment Period|Other reasons|0|||
19493479|NCT02574078|41819669|FG010|Pre-Treatment Period|Other reasons|2|||
19493480|NCT02574078|41819670|FG011|Pre-Treatment Period|Other reasons|0|||
19493481|NCT02574078|41819671|FG012|Pre-Treatment Period|Other reasons|0|||
19493482|NCT02574078|41819659|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
19493483|NCT02574078|41819660|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
19493484|NCT02574078|41819661|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
19493485|NCT02574078|41819662|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
19493486|NCT02574078|41819663|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
19493487|NCT02574078|41819664|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
19493488|NCT02574078|41819665|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
19493489|NCT02574078|41819666|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
19493490|NCT02574078|41819667|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
19493491|NCT02574078|41819668|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
19493492|NCT02574078|41819669|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
19493493|NCT02574078|41819670|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
19493494|NCT02574078|41819671|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
19493495|NCT02574078|41819659|FG000|Treatment Period|Disease progression|6|||
19493496|NCT02574078|41819660|FG001|Treatment Period|Disease progression|4|||
19493497|NCT02574078|41819661|FG002|Treatment Period|Disease progression|7|||
19493498|NCT02574078|41819662|FG003|Treatment Period|Disease progression|18|||
19493499|NCT02574078|41819663|FG004|Treatment Period|Disease progression|16|||
19493500|NCT02574078|41819664|FG005|Treatment Period|Disease progression|26|||
19493501|NCT02574078|41819665|FG006|Treatment Period|Disease progression|5|||
19493502|NCT02574078|41819666|FG007|Treatment Period|Disease progression|9|||
19493503|NCT02574078|41819667|FG008|Treatment Period|Disease progression|8|||
19493504|NCT02574078|41819668|FG009|Treatment Period|Disease progression|5|||
19493505|NCT02574078|41819669|FG010|Treatment Period|Disease progression|20|||
19493506|NCT02574078|41819670|FG011|Treatment Period|Disease progression|29|||
19493507|NCT02574078|41819671|FG012|Treatment Period|Disease progression|2|||
19493508|NCT02574078|41819659|FG000|Treatment Period|Study drug toxicity|1|||
19493509|NCT02574078|41819660|FG001|Treatment Period|Study drug toxicity|1|||
19493510|NCT02574078|41819661|FG002|Treatment Period|Study drug toxicity|0|||
19493511|NCT02574078|41819662|FG003|Treatment Period|Study drug toxicity|5|||
19493512|NCT02574078|41819663|FG004|Treatment Period|Study drug toxicity|3|||
19493513|NCT02574078|41819664|FG005|Treatment Period|Study drug toxicity|1|||
19493514|NCT02574078|41819665|FG006|Treatment Period|Study drug toxicity|2|||
19493515|NCT02574078|41819666|FG007|Treatment Period|Study drug toxicity|0|||
19493516|NCT02574078|41819667|FG008|Treatment Period|Study drug toxicity|2|||
19493517|NCT02574078|41819668|FG009|Treatment Period|Study drug toxicity|1|||
19493518|NCT02574078|41819669|FG010|Treatment Period|Study drug toxicity|16|||
19493519|NCT02574078|41819670|FG011|Treatment Period|Study drug toxicity|2|||
19493520|NCT02574078|41819671|FG012|Treatment Period|Study drug toxicity|4|||
19493521|NCT02574078|41819659|FG000|Treatment Period|Death|2|||
19493522|NCT02574078|41819660|FG001|Treatment Period|Death|0|||
19493523|NCT02574078|41819661|FG002|Treatment Period|Death|0|||
19493524|NCT02574078|41819662|FG003|Treatment Period|Death|0|||
19493525|NCT02574078|41819663|FG004|Treatment Period|Death|1|||
19493526|NCT02574078|41819664|FG005|Treatment Period|Death|1|||
19493527|NCT02574078|41819665|FG006|Treatment Period|Death|1|||
19493528|NCT02574078|41819666|FG007|Treatment Period|Death|1|||
19493529|NCT02574078|41819667|FG008|Treatment Period|Death|7|||
19493530|NCT02574078|41819668|FG009|Treatment Period|Death|1|||
19493531|NCT02574078|41819669|FG010|Treatment Period|Death|0|||
19493532|NCT02574078|41819670|FG011|Treatment Period|Death|2|||
19493533|NCT02574078|41819671|FG012|Treatment Period|Death|1|||
19493534|NCT02574078|41819659|FG000|Treatment Period|Adverse event unrelated to drug|0|||
19493535|NCT02574078|41819660|FG001|Treatment Period|Adverse event unrelated to drug|0|||
19493536|NCT02574078|41819661|FG002|Treatment Period|Adverse event unrelated to drug|1|||
19493537|NCT02574078|41819662|FG003|Treatment Period|Adverse event unrelated to drug|0|||
19493538|NCT02574078|41819663|FG004|Treatment Period|Adverse event unrelated to drug|2|||
19493539|NCT02574078|41819664|FG005|Treatment Period|Adverse event unrelated to drug|3|||
19493540|NCT02574078|41819665|FG006|Treatment Period|Adverse event unrelated to drug|0|||
19493541|NCT02574078|41819666|FG007|Treatment Period|Adverse event unrelated to drug|0|||
19493542|NCT02574078|41819667|FG008|Treatment Period|Adverse event unrelated to drug|1|||
19493543|NCT02574078|41819668|FG009|Treatment Period|Adverse event unrelated to drug|2|||
19493544|NCT02574078|41819669|FG010|Treatment Period|Adverse event unrelated to drug|4|||
19493545|NCT02574078|41819670|FG011|Treatment Period|Adverse event unrelated to drug|1|||
19493546|NCT02574078|41819671|FG012|Treatment Period|Adverse event unrelated to drug|0|||
19493547|NCT02574078|41819659|FG000|Treatment Period|Administrative reason by Sponsor|0|||
19704346|NCT00223080|42148637|FG000|Overall Study|Adverse Event|0|||
19493548|NCT02574078|41819660|FG001|Treatment Period|Administrative reason by Sponsor|1|||
19493549|NCT02574078|41819661|FG002|Treatment Period|Administrative reason by Sponsor|0|||
19493550|NCT02574078|41819662|FG003|Treatment Period|Administrative reason by Sponsor|0|||
19493551|NCT02574078|41819663|FG004|Treatment Period|Administrative reason by Sponsor|0|||
19493552|NCT02574078|41819664|FG005|Treatment Period|Administrative reason by Sponsor|0|||
19493553|NCT02574078|41819665|FG006|Treatment Period|Administrative reason by Sponsor|1|||
19493554|NCT02574078|41819666|FG007|Treatment Period|Administrative reason by Sponsor|0|||
19493555|NCT02574078|41819667|FG008|Treatment Period|Administrative reason by Sponsor|0|||
19493556|NCT02574078|41819668|FG009|Treatment Period|Administrative reason by Sponsor|0|||
19493557|NCT02574078|41819669|FG010|Treatment Period|Administrative reason by Sponsor|0|||
19493558|NCT02574078|41819670|FG011|Treatment Period|Administrative reason by Sponsor|0|||
19493559|NCT02574078|41819671|FG012|Treatment Period|Administrative reason by Sponsor|3|||
19493560|NCT02574078|41819659|FG000|Treatment Period|Other reasons|1|||
19493561|NCT02574078|41819660|FG001|Treatment Period|Other reasons|0|||
19493562|NCT02574078|41819661|FG002|Treatment Period|Other reasons|1|||
19493563|NCT02574078|41819662|FG003|Treatment Period|Other reasons|3|||
19493564|NCT02574078|41819663|FG004|Treatment Period|Other reasons|3|||
19493565|NCT02574078|41819664|FG005|Treatment Period|Other reasons|1|||
19493566|NCT02574078|41819665|FG006|Treatment Period|Other reasons|2|||
19493567|NCT02574078|41819666|FG007|Treatment Period|Other reasons|1|||
19493568|NCT02574078|41819667|FG008|Treatment Period|Other reasons|3|||
19493569|NCT02574078|41819668|FG009|Treatment Period|Other reasons|1|||
19493570|NCT02574078|41819669|FG010|Treatment Period|Other reasons|1|||
19493571|NCT02574078|41819670|FG011|Treatment Period|Other reasons|3|||
19493572|NCT02574078|41819671|FG012|Treatment Period|Other reasons|1|||
19493573|NCT02574078|41819659|FG000|Treatment Period|Participant request to stop drug|0|||
19493574|NCT02574078|41819660|FG001|Treatment Period|Participant request to stop drug|0|||
19493575|NCT02574078|41819661|FG002|Treatment Period|Participant request to stop drug|0|||
19493576|NCT02574078|41819662|FG003|Treatment Period|Participant request to stop drug|2|||
19493577|NCT02574078|41819663|FG004|Treatment Period|Participant request to stop drug|4|||
19493578|NCT02574078|41819664|FG005|Treatment Period|Participant request to stop drug|0|||
19493579|NCT02574078|41819665|FG006|Treatment Period|Participant request to stop drug|1|||
19493580|NCT02574078|41819666|FG007|Treatment Period|Participant request to stop drug|0|||
19493581|NCT02574078|41819667|FG008|Treatment Period|Participant request to stop drug|3|||
19493582|NCT02574078|41819668|FG009|Treatment Period|Participant request to stop drug|2|||
19493583|NCT02574078|41819669|FG010|Treatment Period|Participant request to stop drug|2|||
19493584|NCT02574078|41819670|FG011|Treatment Period|Participant request to stop drug|4|||
19493585|NCT02574078|41819671|FG012|Treatment Period|Participant request to stop drug|1|||
19493586|NCT02574078|41819659|FG000|Treatment Period|Participant withdrew consent|0|||
19493587|NCT02574078|41819660|FG001|Treatment Period|Participant withdrew consent|0|||
19493588|NCT02574078|41819661|FG002|Treatment Period|Participant withdrew consent|0|||
19493589|NCT02574078|41819662|FG003|Treatment Period|Participant withdrew consent|0|||
19493590|NCT02574078|41819663|FG004|Treatment Period|Participant withdrew consent|1|||
19493591|NCT02574078|41819664|FG005|Treatment Period|Participant withdrew consent|1|||
19493592|NCT02574078|41819665|FG006|Treatment Period|Participant withdrew consent|0|||
19493593|NCT02574078|41819666|FG007|Treatment Period|Participant withdrew consent|1|||
19493594|NCT02574078|41819667|FG008|Treatment Period|Participant withdrew consent|0|||
19493595|NCT02574078|41819668|FG009|Treatment Period|Participant withdrew consent|2|||
19493596|NCT02574078|41819669|FG010|Treatment Period|Participant withdrew consent|1|||
19493597|NCT02574078|41819670|FG011|Treatment Period|Participant withdrew consent|4|||
19493598|NCT02574078|41819671|FG012|Treatment Period|Participant withdrew consent|1|||
19493599|NCT02574078|41819659|FG000|Treatment Period|Participant no longer meets criteria|0|||
19493600|NCT02574078|41819660|FG001|Treatment Period|Participant no longer meets criteria|0|||
19493601|NCT02574078|41819661|FG002|Treatment Period|Participant no longer meets criteria|0|||
19493602|NCT02574078|41819662|FG003|Treatment Period|Participant no longer meets criteria|0|||
19493603|NCT02574078|41819663|FG004|Treatment Period|Participant no longer meets criteria|1|||
19493604|NCT02574078|41819664|FG005|Treatment Period|Participant no longer meets criteria|0|||
19493605|NCT02574078|41819665|FG006|Treatment Period|Participant no longer meets criteria|0|||
19493606|NCT02574078|41819666|FG007|Treatment Period|Participant no longer meets criteria|0|||
19493607|NCT02574078|41819667|FG008|Treatment Period|Participant no longer meets criteria|0|||
19493608|NCT02574078|41819668|FG009|Treatment Period|Participant no longer meets criteria|1|||
19613320|NCT00887822|42062195|FG001|Overall Study|Death|3|||
19493609|NCT02574078|41819669|FG010|Treatment Period|Participant no longer meets criteria|1|||
19613321|NCT00887822|42062194|FG000|Overall Study|Protocol Violation|0|||
19493610|NCT02574078|41819670|FG011|Treatment Period|Participant no longer meets criteria|1|||
19493611|NCT02574078|41819671|FG012|Treatment Period|Participant no longer meets criteria|0|||
19493612|NCT02574078|41819659|FG000|Treatment Period|Lost to Follow-up|0|||
19493613|NCT02574078|41819660|FG001|Treatment Period|Lost to Follow-up|0|||
19493614|NCT02574078|41819661|FG002|Treatment Period|Lost to Follow-up|0|||
19493615|NCT02574078|41819662|FG003|Treatment Period|Lost to Follow-up|0|||
19493616|NCT02574078|41819663|FG004|Treatment Period|Lost to Follow-up|0|||
19493617|NCT02574078|41819664|FG005|Treatment Period|Lost to Follow-up|0|||
19493618|NCT02574078|41819665|FG006|Treatment Period|Lost to Follow-up|0|||
19493619|NCT02574078|41819666|FG007|Treatment Period|Lost to Follow-up|0|||
19493620|NCT02574078|41819667|FG008|Treatment Period|Lost to Follow-up|0|||
19493621|NCT02574078|41819668|FG009|Treatment Period|Lost to Follow-up|1|||
19493622|NCT02574078|41819669|FG010|Treatment Period|Lost to Follow-up|0|||
19493623|NCT02574078|41819670|FG011|Treatment Period|Lost to Follow-up|1|||
19493624|NCT02574078|41819671|FG012|Treatment Period|Lost to Follow-up|0|||
19493625|NCT02574078|41819659|FG000|Treatment Period|Maximum clinical benefit|0|||
19493626|NCT02574078|41819660|FG001|Treatment Period|Maximum clinical benefit|0|||
19493627|NCT02574078|41819661|FG002|Treatment Period|Maximum clinical benefit|0|||
19493628|NCT02574078|41819662|FG003|Treatment Period|Maximum clinical benefit|0|||
19493629|NCT02574078|41819663|FG004|Treatment Period|Maximum clinical benefit|0|||
19493630|NCT02574078|41819664|FG005|Treatment Period|Maximum clinical benefit|0|||
19493631|NCT02574078|41819665|FG006|Treatment Period|Maximum clinical benefit|0|||
19493632|NCT02574078|41819666|FG007|Treatment Period|Maximum clinical benefit|0|||
19493633|NCT02574078|41819667|FG008|Treatment Period|Maximum clinical benefit|0|||
19493634|NCT02574078|41819668|FG009|Treatment Period|Maximum clinical benefit|1|||
19493635|NCT02574078|41819669|FG010|Treatment Period|Maximum clinical benefit|0|||
19493636|NCT02574078|41819670|FG011|Treatment Period|Maximum clinical benefit|0|||
19493637|NCT02574078|41819671|FG012|Treatment Period|Maximum clinical benefit|0|||
19493638|NCT02565810|41819789|FG000|Overall Study|Withdrawal by Subject|1|||
19493639|NCT02561832|41819954|FG000|Overall Study|Withdrawal by Subject|1|||
19493640|NCT02561832|41819955|FG001|Overall Study|Withdrawal by Subject|1|||
19493641|NCT02561832|41819954|FG000|Overall Study|Adverse Event|3|||
19493642|NCT02561832|41819955|FG001|Overall Study|Adverse Event|0|||
19493643|NCT02561832|41819954|FG000|Overall Study|Disease progression|3|||
19493644|NCT02561832|41819955|FG001|Overall Study|Disease progression|3|||
19493645|NCT00985088|41821616|FG000|Overall Study|Serious Adverse Event|1|||
19493646|NCT00985088|41821617|FG001|Overall Study|Serious Adverse Event|1|||
19493647|NCT00985088|41821618|FG002|Overall Study|Serious Adverse Event|0|||
19493648|NCT00985088|41821619|FG003|Overall Study|Serious Adverse Event|0|||
19493649|NCT00985088|41821620|FG004|Overall Study|Serious Adverse Event|0|||
19493650|NCT00985088|41821621|FG005|Overall Study|Serious Adverse Event|0|||
19493651|NCT00985088|41821622|FG006|Overall Study|Serious Adverse Event|0|||
19493652|NCT00985088|41821623|FG007|Overall Study|Serious Adverse Event|1|||
19493653|NCT00985088|41821616|FG000|Overall Study|Adverse Event|0|||
19493654|NCT00985088|41821617|FG001|Overall Study|Adverse Event|0|||
19493655|NCT00985088|41821618|FG002|Overall Study|Adverse Event|1|||
19493656|NCT00985088|41821619|FG003|Overall Study|Adverse Event|0|||
19493657|NCT00985088|41821620|FG004|Overall Study|Adverse Event|0|||
19493658|NCT00985088|41821621|FG005|Overall Study|Adverse Event|0|||
19493659|NCT00985088|41821622|FG006|Overall Study|Adverse Event|0|||
19493660|NCT00985088|41821623|FG007|Overall Study|Adverse Event|0|||
19493661|NCT00985088|41821616|FG000|Overall Study|Withdrawal by Subject|4|||
19493662|NCT00985088|41821617|FG001|Overall Study|Withdrawal by Subject|0|||
19493663|NCT00985088|41821618|FG002|Overall Study|Withdrawal by Subject|0|||
19493664|NCT00985088|41821619|FG003|Overall Study|Withdrawal by Subject|1|||
19493665|NCT00985088|41821620|FG004|Overall Study|Withdrawal by Subject|3|||
19493666|NCT00985088|41821621|FG005|Overall Study|Withdrawal by Subject|2|||
19493667|NCT00985088|41821622|FG006|Overall Study|Withdrawal by Subject|1|||
19493668|NCT00985088|41821623|FG007|Overall Study|Withdrawal by Subject|2|||
19493669|NCT00985088|41821616|FG000|Overall Study|Migrated/moved from study area|0|||
19493670|NCT00985088|41821617|FG001|Overall Study|Migrated/moved from study area|0|||
19493671|NCT00985088|41821618|FG002|Overall Study|Migrated/moved from study area|1|||
19493672|NCT00985088|41821619|FG003|Overall Study|Migrated/moved from study area|0|||
19493673|NCT00985088|41821620|FG004|Overall Study|Migrated/moved from study area|0|||
19493674|NCT00985088|41821621|FG005|Overall Study|Migrated/moved from study area|0|||
19493675|NCT00985088|41821622|FG006|Overall Study|Migrated/moved from study area|0|||
19493676|NCT00985088|41821623|FG007|Overall Study|Migrated/moved from study area|1|||
19493677|NCT00985088|41821616|FG000|Overall Study|Lost to Follow-up|6|||
19493678|NCT00985088|41821617|FG001|Overall Study|Lost to Follow-up|1|||
19493679|NCT00985088|41821618|FG002|Overall Study|Lost to Follow-up|2|||
19493680|NCT00985088|41821619|FG003|Overall Study|Lost to Follow-up|6|||
19493681|NCT00985088|41821620|FG004|Overall Study|Lost to Follow-up|6|||
19493682|NCT00985088|41821621|FG005|Overall Study|Lost to Follow-up|5|||
19493683|NCT00985088|41821622|FG006|Overall Study|Lost to Follow-up|3|||
19493684|NCT00985088|41821623|FG007|Overall Study|Lost to Follow-up|2|||
19493685|NCT00984542|41821669|FG000|Overall Study|disease progression|19|||
19493686|NCT00984542|41821669|FG000|Overall Study|toxicity|7|||
19493687|NCT00984542|41821669|FG000|Overall Study|Death|7|||
19493688|NCT00984542|41821669|FG000|Overall Study|complicating disease|3|||
19493689|NCT00984542|41821669|FG000|Overall Study|Withdrawal by Subject|3|||
19493690|NCT00984542|41821669|FG000|Overall Study|clinical deterioration|2|||
19493691|NCT00983918|41821678|FG000|Overall Study|conversion to open cholecystectomy|0|||
19493692|NCT00983918|41821679|FG001|Overall Study|conversion to open cholecystectomy|2|||
19493693|NCT00983918|41821680|FG002|Overall Study|conversion to open cholecystectomy|2|||
19493694|NCT00983918|41821681|FG003|Overall Study|conversion to open cholecystectomy|2|||
19493695|NCT00983528|41821691|FG000|Overall Study|Death|4|||
19493696|NCT00983528|41821691|FG000|Overall Study|Lost to Follow-up|1|||
19493697|NCT00983528|41821691|FG000|Overall Study|Study Terminated|1|||
19493698|NCT00983372|41821695|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
19493699|NCT00983372|41821695|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
19493700|NCT00983372|41821695|FG000|Diltiazem ER Alone|Adverse Event|1|||
19493701|NCT00983294|41821727|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
19493702|NCT00983294|41821727|FG000|Colchicine With Azithromycin|Adverse Event|1|||
19493703|NCT00982280|41821743|FG000|Observation Period|Not eligible to be dosed|19|||
19493704|NCT00982280|41821743|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
19493705|NCT00982280|41821743|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
19493706|NCT00982280|41821743|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
19493707|NCT00982280|41821743|FG000|Maintenance Period|Adverse Event|1|||
19493708|NCT00981578|41821761|FG000|Overall Study|Death|1|||
19493709|NCT00981578|41821761|FG000|Overall Study|Withdrawal by Subject|2|||
19493710|NCT00980798|41821784|FG000|Overall Study|Adverse Event|7|||
19493711|NCT00980798|41821785|FG001|Overall Study|Adverse Event|36|||
19493712|NCT00980798|41821784|FG000|Overall Study|Lack of Efficacy|16|||
19493713|NCT00980798|41821785|FG001|Overall Study|Lack of Efficacy|5|||
19493714|NCT00980798|41821784|FG000|Overall Study|Lost to Follow-up|0|||
19493715|NCT00980798|41821785|FG001|Overall Study|Lost to Follow-up|1|||
19493716|NCT00980798|41821784|FG000|Overall Study|Physician Decision|2|||
19493717|NCT00980798|41821785|FG001|Overall Study|Physician Decision|1|||
19493718|NCT00980798|41821784|FG000|Overall Study|Withdrawal by Subject|8|||
19493719|NCT00980798|41821785|FG001|Overall Study|Withdrawal by Subject|11|||
19493720|NCT00980798|41821784|FG000|Overall Study|Other|0|||
19493721|NCT00980798|41821785|FG001|Overall Study|Other|1|||
19493722|NCT00980330|41821930|FG000|Overall Study|Adverse Event|0|||
19493723|NCT00980330|41821931|FG001|Overall Study|Adverse Event|0|||
19493724|NCT00980330|41821932|FG002|Overall Study|Adverse Event|0|||
19493725|NCT00980330|41821933|FG003|Overall Study|Adverse Event|1|||
19493726|NCT00980330|41821934|FG004|Overall Study|Adverse Event|0|||
19493727|NCT00980330|41821935|FG005|Overall Study|Adverse Event|0|||
19493728|NCT00980330|41821936|FG006|Overall Study|Adverse Event|0|||
19493729|NCT00980330|41821930|FG000|Overall Study|Lost to Follow-up|1|||
19493730|NCT00980330|41821931|FG001|Overall Study|Lost to Follow-up|1|||
19493731|NCT00980330|41821932|FG002|Overall Study|Lost to Follow-up|4|||
19493732|NCT00980330|41821933|FG003|Overall Study|Lost to Follow-up|2|||
19493733|NCT00980330|41821934|FG004|Overall Study|Lost to Follow-up|1|||
19493734|NCT00980330|41821935|FG005|Overall Study|Lost to Follow-up|1|||
19493735|NCT00980330|41821936|FG006|Overall Study|Lost to Follow-up|2|||
19493736|NCT00980330|41821930|FG000|Overall Study|Withdrawal by Subject|2|||
19493737|NCT00980330|41821931|FG001|Overall Study|Withdrawal by Subject|4|||
19493738|NCT00980330|41821932|FG002|Overall Study|Withdrawal by Subject|4|||
19493739|NCT00980330|41821933|FG003|Overall Study|Withdrawal by Subject|1|||
19493740|NCT00980330|41821934|FG004|Overall Study|Withdrawal by Subject|3|||
19493741|NCT00980330|41821935|FG005|Overall Study|Withdrawal by Subject|2|||
19493742|NCT00980330|41821936|FG006|Overall Study|Withdrawal by Subject|5|||
19493743|NCT00980330|41821930|FG000|Overall Study|(not specified)|2|||
19493744|NCT00980330|41821931|FG001|Overall Study|(not specified)|0|||
19493745|NCT00980330|41821932|FG002|Overall Study|(not specified)|0|||
19493746|NCT00980330|41821933|FG003|Overall Study|(not specified)|1|||
19493747|NCT00980330|41821934|FG004|Overall Study|(not specified)|1|||
19493748|NCT00980330|41821935|FG005|Overall Study|(not specified)|1|||
19493749|NCT00980330|41821936|FG006|Overall Study|(not specified)|0|||
19493750|NCT00980174|41821980|FG000|Overall Study|Withdrawal by Subject|1|||
19493751|NCT00980174|41821981|FG001|Overall Study|Withdrawal by Subject|4|||
19493752|NCT00980174|41821980|FG000|Overall Study|Adverse Event|0|||
19493753|NCT00980174|41821981|FG001|Overall Study|Adverse Event|3|||
19493754|NCT00980174|41821980|FG000|Overall Study|Ineligibility determined|2|||
19493755|NCT00980174|41821981|FG001|Overall Study|Ineligibility determined|1|||
19493756|NCT00980174|41821980|FG000|Overall Study|Death|1|||
19493757|NCT00980174|41821981|FG001|Overall Study|Death|1|||
19493758|NCT00980174|41821980|FG000|Overall Study|Other|0|||
19493759|NCT00980174|41821981|FG001|Overall Study|Other|1|||
19704347|NCT00223080|42148638|FG001|Overall Study|Adverse Event|1|||
19493760|NCT00980018|41822009|FG000|Overall Study|Adverse Event|8|||
19493761|NCT00980018|41822009|FG000|Overall Study|Patient withdrew consent|3|||
19493762|NCT00980018|41822009|FG000|Overall Study|Lost to Follow-up|1|||
19493763|NCT00981656|41822030|FG000|Overall Study|Protocol Violation|1|||
19493764|NCT00981656|41822030|FG000|Overall Study|Did not start protocol treatment|2|||
19493765|NCT00988052|41822036|FG000|Overall Study|Missing|1|||
19493766|NCT00988052|41822037|FG001|Overall Study|Missing|0|||
19613322|NCT00887822|42062195|FG001|Overall Study|Protocol Violation|1|||
19493767|NCT00988052|41822036|FG000|Overall Study|Teva requested subject withdrawal|3|||
19493768|NCT00988052|41822037|FG001|Overall Study|Teva requested subject withdrawal|1|||
19493769|NCT00988052|41822036|FG000|Overall Study|Death|1|||
19493770|NCT00988052|41822037|FG001|Overall Study|Death|3|||
19493771|NCT00988052|41822036|FG000|Overall Study|Protocol Violation|6|||
19493772|NCT00988052|41822037|FG001|Overall Study|Protocol Violation|5|||
19493773|NCT00988052|41822036|FG000|Overall Study|Pregnancy|6|||
19493774|NCT00988052|41822037|FG001|Overall Study|Pregnancy|6|||
19493775|NCT00988052|41822036|FG000|Overall Study|Lack of Efficacy|8|||
19493776|NCT00988052|41822037|FG001|Overall Study|Lack of Efficacy|7|||
19493777|NCT00988052|41822036|FG000|Overall Study|Lost to Follow-up|6|||
19493778|NCT00988052|41822037|FG001|Overall Study|Lost to Follow-up|11|||
19493779|NCT00988052|41822036|FG000|Overall Study|Physician Decision|27|||
19493780|NCT00988052|41822037|FG001|Overall Study|Physician Decision|28|||
19493781|NCT00988052|41822036|FG000|Overall Study|Adverse Event|35|||
19493782|NCT00988052|41822037|FG001|Overall Study|Adverse Event|28|||
19493783|NCT00988052|41822036|FG000|Overall Study|Withdrawal by Subject|90|||
19493784|NCT00988052|41822037|FG001|Overall Study|Withdrawal by Subject|91|||
19493785|NCT00988052|41822036|FG000|Overall Study|Study terminated by sponsor|240|||
19493786|NCT00988052|41822037|FG001|Overall Study|Study terminated by sponsor|236|||
19493787|NCT02569710|41822138|FG000|Overall Study|Adverse Event|1|||
19493788|NCT02569710|41822139|FG001|Overall Study|Adverse Event|0|||
19493789|NCT02569710|41822140|FG002|Overall Study|Adverse Event|0|||
19493790|NCT02569710|41822141|FG003|Overall Study|Adverse Event|0|||
19493791|NCT02569710|41822142|FG004|Overall Study|Adverse Event|0|||
19493792|NCT02569710|41822143|FG005|Overall Study|Adverse Event|0|||
19493793|NCT02569710|41822144|FG006|Overall Study|Adverse Event|0|||
19493794|NCT02569710|41822145|FG007|Overall Study|Adverse Event|0|||
19493795|NCT02569710|41822146|FG008|Overall Study|Adverse Event|0|||
19493796|NCT02569710|41822147|FG009|Overall Study|Adverse Event|0|||
19493797|NCT02569710|41822138|FG000|Overall Study|Lost to Follow-up|0|||
19493798|NCT02569710|41822139|FG001|Overall Study|Lost to Follow-up|0|||
19493799|NCT02569710|41822140|FG002|Overall Study|Lost to Follow-up|0|||
19493800|NCT02569710|41822141|FG003|Overall Study|Lost to Follow-up|0|||
19493801|NCT02569710|41822142|FG004|Overall Study|Lost to Follow-up|0|||
19493802|NCT02569710|41822143|FG005|Overall Study|Lost to Follow-up|0|||
19493803|NCT02569710|41822144|FG006|Overall Study|Lost to Follow-up|1|||
19493804|NCT02569710|41822145|FG007|Overall Study|Lost to Follow-up|0|||
19493805|NCT02569710|41822146|FG008|Overall Study|Lost to Follow-up|1|||
19493806|NCT02569710|41822147|FG009|Overall Study|Lost to Follow-up|0|||
19493807|NCT02569710|41822138|FG000|Overall Study|Virologic failure|0|||
19493808|NCT02569710|41822139|FG001|Overall Study|Virologic failure|0|||
19493809|NCT02569710|41822140|FG002|Overall Study|Virologic failure|0|||
19393678|NCT01618708|41637541|FG000|Overall Study|Other than specified above|1|||
19393679|NCT01618708|41637542|FG001|Overall Study|Other than specified above|1|||
19393680|NCT01618708|41637541|FG000|Overall Study|Randomized but not treated|3|||
19393681|NCT01618708|41637542|FG001|Overall Study|Randomized but not treated|2|||
19393682|NCT00790933|41637558|FG000|Overall Study|Adverse Event|94|||
19393683|NCT00790933|41637559|FG001|Overall Study|Adverse Event|119|||
19393684|NCT00790933|41637560|FG002|Overall Study|Adverse Event|65|||
19393685|NCT00790933|41637561|FG003|Overall Study|Adverse Event|5|||
19393686|NCT00790933|41637562|FG004|Overall Study|Adverse Event|69|||
19393687|NCT00790933|41637558|FG000|Overall Study|Protocol Violation(s)|8|||
19393688|NCT00790933|41637559|FG001|Overall Study|Protocol Violation(s)|18|||
19393689|NCT00790933|41637560|FG002|Overall Study|Protocol Violation(s)|7|||
19393690|NCT00790933|41637561|FG003|Overall Study|Protocol Violation(s)|0|||
19393691|NCT00790933|41637562|FG004|Overall Study|Protocol Violation(s)|12|||
19393692|NCT00790933|41637558|FG000|Overall Study|Lack of Efficacy|192|||
19393693|NCT00790933|41637559|FG001|Overall Study|Lack of Efficacy|176|||
19393694|NCT00790933|41637560|FG002|Overall Study|Lack of Efficacy|130|||
19393695|NCT00790933|41637561|FG003|Overall Study|Lack of Efficacy|1|||
19393696|NCT00790933|41637562|FG004|Overall Study|Lack of Efficacy|121|||
19393697|NCT00790933|41637558|FG000|Overall Study|Study Terminated by Sponsor|0|||
19393698|NCT00790933|41637559|FG001|Overall Study|Study Terminated by Sponsor|0|||
19393699|NCT00790933|41637560|FG002|Overall Study|Study Terminated by Sponsor|1|||
19393700|NCT00790933|41637561|FG003|Overall Study|Study Terminated by Sponsor|0|||
19393701|NCT00790933|41637562|FG004|Overall Study|Study Terminated by Sponsor|0|||
19393702|NCT00790933|41637558|FG000|Overall Study|Withdrawal by Subject|123|||
19393703|NCT00790933|41637559|FG001|Overall Study|Withdrawal by Subject|120|||
19393704|NCT00790933|41637560|FG002|Overall Study|Withdrawal by Subject|52|||
19393705|NCT00790933|41637561|FG003|Overall Study|Withdrawal by Subject|6|||
19393706|NCT00790933|41637562|FG004|Overall Study|Withdrawal by Subject|50|||
19393707|NCT00790933|41637558|FG000|Overall Study|Lost to Follow-up|13|||
19393708|NCT00790933|41637559|FG001|Overall Study|Lost to Follow-up|31|||
19493810|NCT02569710|41822141|FG003|Overall Study|Virologic failure|0|||
19493811|NCT02569710|41822142|FG004|Overall Study|Virologic failure|1|||
19493812|NCT02569710|41822143|FG005|Overall Study|Virologic failure|0|||
19493813|NCT02569710|41822144|FG006|Overall Study|Virologic failure|1|||
19493814|NCT02569710|41822145|FG007|Overall Study|Virologic failure|0|||
19493815|NCT02569710|41822146|FG008|Overall Study|Virologic failure|0|||
19493816|NCT02569710|41822147|FG009|Overall Study|Virologic failure|0|||
19493817|NCT02569710|41822138|FG000|Overall Study|Withdrawal by Subject|0|||
19493818|NCT02569710|41822139|FG001|Overall Study|Withdrawal by Subject|0|||
19493819|NCT02569710|41822140|FG002|Overall Study|Withdrawal by Subject|0|||
19493820|NCT02569710|41822141|FG003|Overall Study|Withdrawal by Subject|0|||
19493821|NCT02569710|41822142|FG004|Overall Study|Withdrawal by Subject|0|||
19493822|NCT02569710|41822143|FG005|Overall Study|Withdrawal by Subject|1|||
19493823|NCT02569710|41822144|FG006|Overall Study|Withdrawal by Subject|0|||
19493824|NCT02569710|41822145|FG007|Overall Study|Withdrawal by Subject|0|||
19493825|NCT02569710|41822146|FG008|Overall Study|Withdrawal by Subject|0|||
19493826|NCT02569710|41822147|FG009|Overall Study|Withdrawal by Subject|0|||
19493827|NCT02569476|41822249|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
19493828|NCT02569476|41822249|FG000|Overall Study|Death|33|||
19493829|NCT02569476|41822249|FG000|Overall Study|Withdrawal by Subject|9|||
19493830|NCT02569476|41822249|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
19493831|NCT02569476|41822249|FG000|Overall Study|Palliative care|1|||
19493832|NCT02569476|41822249|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
19493833|NCT02569476|41822249|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
19493834|NCT02565576|41822321|FG000|Overall Study|abnormal lab value|2|||
19493835|NCT02565576|41822322|FG001|Overall Study|abnormal lab value|0|||
19493836|NCT02565576|41822321|FG000|Overall Study|subject / guardian decision|1|||
19493837|NCT02565576|41822322|FG001|Overall Study|subject / guardian decision|3|||
19493838|NCT02565576|41822321|FG000|Overall Study|Lost to Follow-up|1|||
19493839|NCT02565576|41822322|FG001|Overall Study|Lost to Follow-up|0|||
19493840|NCT02565576|41822321|FG000|Overall Study|Death|0|||
19493841|NCT02565576|41822322|FG001|Overall Study|Death|2|||
19493842|NCT02565576|41822321|FG000|Overall Study|Adverse Event|1|||
19493843|NCT02565576|41822322|FG001|Overall Study|Adverse Event|0|||
19493844|NCT02569398|41822353|FG000|Overall Study|Adverse Event|0|||
19493845|NCT02569398|41822354|FG001|Overall Study|Adverse Event|1|||
19493846|NCT02569398|41822355|FG002|Overall Study|Adverse Event|6|||
19493847|NCT02569398|41822353|FG000|Overall Study|Withdrawal by Subject|43|||
19493848|NCT02569398|41822354|FG001|Overall Study|Withdrawal by Subject|43|||
19493849|NCT02569398|41822355|FG002|Overall Study|Withdrawal by Subject|30|||
19493850|NCT02569398|41822353|FG000|Overall Study|Study terminated by sponsor|130|||
19493851|NCT02569398|41822354|FG001|Overall Study|Study terminated by sponsor|131|||
19493852|NCT02569398|41822355|FG002|Overall Study|Study terminated by sponsor|134|||
19493853|NCT02569398|41822353|FG000|Overall Study|Other|12|||
19493854|NCT02569398|41822354|FG001|Overall Study|Other|14|||
19493855|NCT02569398|41822355|FG002|Overall Study|Other|13|||
19493856|NCT02569242|41822399|FG000|Overall Study|Death|1|||
19493857|NCT02569242|41822400|FG001|Overall Study|Death|0|||
19493858|NCT02569242|41822399|FG000|Overall Study|Withdrawal by Subject|0|||
19493859|NCT02569242|41822400|FG001|Overall Study|Withdrawal by Subject|1|||
19493860|NCT01663740|41822468|FG000|Overall Study|Lost to Follow-up|1|||
19493861|NCT01663740|41822469|FG001|Overall Study|Lost to Follow-up|4|||
19493862|NCT01663740|41822468|FG000|Overall Study|Other|9|||
19493863|NCT01663740|41822469|FG001|Overall Study|Other|2|||
19493864|NCT01663740|41822468|FG000|Overall Study|Inclusion/Exclusion not met|1|||
19493865|NCT01663740|41822469|FG001|Overall Study|Inclusion/Exclusion not met|0|||
19493866|NCT01663740|41822468|FG000|Overall Study|Death|0|||
19493867|NCT01663740|41822469|FG001|Overall Study|Death|1|||
19493868|NCT01663740|41822468|FG000|Overall Study|Withdrawal by Subject|2|||
19493869|NCT01663740|41822469|FG001|Overall Study|Withdrawal by Subject|1|||
19493870|NCT01663740|41822468|FG000|Overall Study|No end of study status|3|||
19493871|NCT01663740|41822469|FG001|Overall Study|No end of study status|0|||
19493872|NCT01663506|41822585|FG000|Overall Study|Lack of Efficacy|3|||
19493873|NCT01663506|41822585|FG000|Overall Study|Consent Withdrawal by Subject|1|||
19493874|NCT01663506|41822585|FG000|Overall Study|Lost to Follow-up|1|||
19493875|NCT01663506|41822585|FG000|Overall Study|Adverse Event|1|||
19704348|NCT00220740|42148646|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
19493876|NCT01663506|41822585|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
19493877|NCT02568384|41822589|FG000|Overall Study|Mobile devices incompatible with App|2|||
19493878|NCT02965976|41822685|FG000|Overall Study|Withdrawal by Subject|2|||
19493879|NCT02965976|41822686|FG001|Overall Study|Withdrawal by Subject|0|||
19493880|NCT04125680|41822704|FG000|Overall Study|Lost to Follow-up|15|||
19493881|NCT02565186|41822728|FG000|Overall Study|Adverse Event|113|||
19493882|NCT02565186|41822729|FG001|Overall Study|Adverse Event|148|||
19493883|NCT02565186|41822728|FG000|Overall Study|Lost to Follow-up|102|||
19493884|NCT02565186|41822729|FG001|Overall Study|Lost to Follow-up|93|||
19493885|NCT02565186|41822728|FG000|Overall Study|Non-Compliance|57|||
19493886|NCT02565186|41822729|FG001|Overall Study|Non-Compliance|55|||
19493887|NCT02565186|41822728|FG000|Overall Study|Withdrawal by Subject|229|||
19493888|NCT02565186|41822729|FG001|Overall Study|Withdrawal by Subject|214|||
19493889|NCT02565186|41822728|FG000|Overall Study|Physician Decision|18|||
19393709|NCT00790933|41637560|FG002|Overall Study|Lost to Follow-up|10|||
19493890|NCT02565186|41822729|FG001|Overall Study|Physician Decision|16|||
19493891|NCT02565186|41822728|FG000|Overall Study|Sponsor Request|5|||
19493892|NCT02565186|41822729|FG001|Overall Study|Sponsor Request|9|||
19493893|NCT02565186|41822728|FG000|Overall Study|Missing|1|||
19493894|NCT02565186|41822729|FG001|Overall Study|Missing|0|||
19493895|NCT02565186|41822728|FG000|Overall Study|Did Not Receive Study Drug|55|||
19493896|NCT02565186|41822729|FG001|Overall Study|Did Not Receive Study Drug|86|||
19493897|NCT02568072|41822735|FG000|Overall Study|Unavailable for appointment|23|||
19493898|NCT02568072|41822735|FG000|Overall Study|Unable to contact|3|||
19493899|NCT02568072|41822735|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
19493900|NCT02568072|41822735|FG000|Overall Study|Withdrawal by Subject|1|||
19493901|NCT02568072|41822735|FG000|Overall Study|Sustained injury, marathon not run|24|||
19493902|NCT02565108|41822742|FG000|Overall Study|Adverse Event|1|||
19493903|NCT02565108|41822743|FG001|Overall Study|Adverse Event|0|||
19493904|NCT02565108|41822742|FG000|Overall Study|Withdrew Consent|1|||
19493905|NCT02565108|41822743|FG001|Overall Study|Withdrew Consent|0|||
19493906|NCT02564952|41822749|FG000|Overall Study|Adverse Event|6|||
19493907|NCT02564952|41822749|FG000|Overall Study|Lost to Follow-up|1|||
19493908|NCT02564952|41822749|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
19493909|NCT02564952|41822749|FG000|Overall Study|Withdrawal by Subject|1|||
19493910|NCT02564952|41822749|FG000|Overall Study|Low Efficacy|1|||
19493911|NCT02564952|41822749|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
19493912|NCT02566902|41822755|FG000|Overall Study|Protocol Violation|2|||
19493913|NCT02566902|41822756|FG001|Overall Study|Protocol Violation|1|||
19493914|NCT02564796|41822764|FG000|Overall Study|Physician Decision|2|||
19493915|NCT02564796|41822765|FG001|Overall Study|Physician Decision|2|||
19493916|NCT02564718|41822773|FG000|Overall Study|Withdrew from treatment|0|||
19493917|NCT02564718|41822774|FG001|Overall Study|Withdrew from treatment|1|||
19493918|NCT01453946|41822780|FG000|Overall Study|Did not receive drug for the taper phase|1|||
19493919|NCT01453946|41822780|FG000|Overall Study|Protocol Violation|2|||
19493920|NCT01453946|41822780|FG000|Overall Study|Lack of Efficacy|3|||
19493921|NCT01453946|41822780|FG000|Overall Study|Adverse Event|3|||
19493922|NCT02563548|41822902|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
19493923|NCT02563548|41822903|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
19493924|NCT02563548|41822904|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
19493925|NCT02563548|41822905|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
19493926|NCT02563548|41822906|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
19493927|NCT02563548|41822907|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
19493928|NCT02563548|41822902|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
19493929|NCT02563548|41822903|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
19493930|NCT02563548|41822904|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
19493931|NCT02563548|41822905|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
19493932|NCT02563548|41822906|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
19493933|NCT02563548|41822907|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
19493934|NCT02563548|41822902|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
19493935|NCT02563548|41822903|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
19493936|NCT02563548|41822904|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
19493937|NCT02563548|41822905|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
19493938|NCT02563548|41822906|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
19493939|NCT02563548|41822907|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
19493940|NCT02563548|41822902|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
19493941|NCT02563548|41822903|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
19493942|NCT02563548|41822904|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
19493943|NCT02563548|41822905|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
19493944|NCT02563548|41822906|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
19493945|NCT02563548|41822907|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
19493946|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
19493947|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
19493948|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
19493949|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
19493950|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
19493951|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
19493952|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
19493953|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
19493954|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
19493955|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
19493956|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
19493957|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
19493958|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
19493959|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
19493960|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
19493961|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
19493962|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
19493963|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
19493964|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
19493965|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
19493966|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
19493967|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
19493968|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
19493969|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
19493970|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
19493971|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
19493972|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
19493973|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
19493974|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
19493975|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
19493976|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
19493977|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
19493978|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
19493979|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
19493980|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
19493981|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
19493982|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
19493983|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
19493984|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
19493985|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
19493986|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
19493987|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
19493988|NCT02563548|41822902|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
19493989|NCT02563548|41822903|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
19493990|NCT02563548|41822904|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
19493991|NCT02563548|41822905|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
19493992|NCT02563548|41822906|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
19493993|NCT02563548|41822907|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
19493994|NCT02559570|41822988|FG000|Overall Study|Adverse Event|0|||
19493995|NCT02559570|41822989|FG001|Overall Study|Adverse Event|2|||
19493996|NCT02559570|41822990|FG002|Overall Study|Adverse Event|0|||
19493997|NCT02559570|41822991|FG003|Overall Study|Adverse Event|1|||
19493998|NCT02559570|41822992|FG004|Overall Study|Adverse Event|0|||
19493999|NCT02559570|41822988|FG000|Overall Study|Withdrawal of Consent|0|||
19494000|NCT02559570|41822989|FG001|Overall Study|Withdrawal of Consent|0|||
19494001|NCT02559570|41822990|FG002|Overall Study|Withdrawal of Consent|1|||
19494002|NCT02559570|41822991|FG003|Overall Study|Withdrawal of Consent|2|||
19494003|NCT02559570|41822992|FG004|Overall Study|Withdrawal of Consent|1|||
19494004|NCT02559570|41822988|FG000|Overall Study|Lost to Follow-up|1|||
19494005|NCT02559570|41822989|FG001|Overall Study|Lost to Follow-up|0|||
19494006|NCT02559570|41822990|FG002|Overall Study|Lost to Follow-up|0|||
19494007|NCT02559570|41822991|FG003|Overall Study|Lost to Follow-up|0|||
19494008|NCT02559570|41822992|FG004|Overall Study|Lost to Follow-up|0|||
19494009|NCT02559570|41822988|FG000|Overall Study|Protocol Violation|1|||
19494010|NCT02559570|41822989|FG001|Overall Study|Protocol Violation|0|||
19494011|NCT02559570|41822990|FG002|Overall Study|Protocol Violation|0|||
19494012|NCT02559570|41822991|FG003|Overall Study|Protocol Violation|0|||
19494013|NCT02559570|41822992|FG004|Overall Study|Protocol Violation|1|||
19494014|NCT02559570|41822988|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19494015|NCT02559570|41822989|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19494016|NCT02559570|41822990|FG002|Overall Study|Other Miscellaneous Reasons|1|||
19494017|NCT02559570|41822991|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19494018|NCT02559570|41822992|FG004|Overall Study|Other Miscellaneous Reasons|0|||
19494019|NCT02559414|41823347|FG000|Overall Study|Lost to Follow-up|0|||
19494020|NCT02559414|41823348|FG001|Overall Study|Lost to Follow-up|1|||
19494021|NCT02559414|41823349|FG002|Overall Study|Lost to Follow-up|0|||
19494022|NCT02559414|41823347|FG000|Overall Study|Withdrawal by Subject|1|||
19494023|NCT02559414|41823348|FG001|Overall Study|Withdrawal by Subject|0|||
19494024|NCT02559414|41823349|FG002|Overall Study|Withdrawal by Subject|1|||
19494025|NCT02559414|41823347|FG000|Overall Study|Other|0|||
19494026|NCT02559414|41823348|FG001|Overall Study|Other|1|||
19494027|NCT02559414|41823349|FG002|Overall Study|Other|1|||
19494028|NCT02558790|41823428|FG000|Overall Study|Lost to Follow-up|2|||
19494029|NCT02558790|41823428|FG000|Overall Study|Physician Decision|1|||
19494030|NCT02558790|41823428|FG000|Overall Study|Withdrawal by Subject|1|||
19494031|NCT02558790|41823428|FG000|Overall Study|Screen Fail|3|||
19494032|NCT02556138|41823450|FG000|Overall Study|Withdrawal by Subject|1|||
19494033|NCT02558400|41823533|FG000|Overall Study|Adverse Event|47|||
19494034|NCT02558400|41823534|FG001|Overall Study|Adverse Event|53|||
19494035|NCT02558400|41823535|FG002|Overall Study|Adverse Event|4|||
19494036|NCT02558400|41823533|FG000|Overall Study|Withdrawal by Subject|13|||
19494037|NCT02558400|41823534|FG001|Overall Study|Withdrawal by Subject|9|||
19494038|NCT02558400|41823535|FG002|Overall Study|Withdrawal by Subject|8|||
19494039|NCT02558400|41823533|FG000|Overall Study|Non-Compliant|0|||
19494040|NCT02558400|41823534|FG001|Overall Study|Non-Compliant|1|||
19494041|NCT02558400|41823535|FG002|Overall Study|Non-Compliant|3|||
19494042|NCT02558400|41823533|FG000|Overall Study|Lost to Follow-up|5|||
19494043|NCT02558400|41823534|FG001|Overall Study|Lost to Follow-up|5|||
19494044|NCT02558400|41823535|FG002|Overall Study|Lost to Follow-up|4|||
19494045|NCT02558400|41823533|FG000|Overall Study|Lack of Efficacy|0|||
19494046|NCT02558400|41823534|FG001|Overall Study|Lack of Efficacy|13|||
19494047|NCT02558400|41823535|FG002|Overall Study|Lack of Efficacy|1|||
19494048|NCT02558400|41823533|FG000|Overall Study|Disallowed Concurrent Medication|6|||
19494049|NCT02558400|41823534|FG001|Overall Study|Disallowed Concurrent Medication|7|||
19494050|NCT02558400|41823535|FG002|Overall Study|Disallowed Concurrent Medication|5|||
19494051|NCT02558400|41823533|FG000|Overall Study|Physician Decision|2|||
19494052|NCT02558400|41823534|FG001|Overall Study|Physician Decision|2|||
19494053|NCT02558400|41823535|FG002|Overall Study|Physician Decision|0|||
19494054|NCT02558400|41823533|FG000|Overall Study|Protocol Violation|6|||
19494055|NCT02558400|41823534|FG001|Overall Study|Protocol Violation|3|||
19494056|NCT02558400|41823535|FG002|Overall Study|Protocol Violation|8|||
19494057|NCT02558400|41823533|FG000|Overall Study|Death|0|||
19494058|NCT02558400|41823534|FG001|Overall Study|Death|1|||
19494059|NCT02558400|41823535|FG002|Overall Study|Death|0|||
19494060|NCT02558400|41823533|FG000|Overall Study|Ineligible for the study|0|||
19494061|NCT02558400|41823534|FG001|Overall Study|Ineligible for the study|2|||
19494062|NCT02558400|41823535|FG002|Overall Study|Ineligible for the study|0|||
19494063|NCT01662648|41823671|FG000|Overall Study|Death|1|||
19494064|NCT01662648|41823672|FG001|Overall Study|Death|3|||
19494065|NCT01662648|41823671|FG000|Overall Study|Adverse Event|40|||
19494066|NCT01662648|41823672|FG001|Overall Study|Adverse Event|37|||
19494067|NCT01662648|41823671|FG000|Overall Study|Lack of Efficacy|17|||
19494068|NCT01662648|41823672|FG001|Overall Study|Lack of Efficacy|16|||
19494069|NCT01662648|41823671|FG000|Overall Study|Participant ineligible to continue trial|1|||
19494070|NCT01662648|41823672|FG001|Overall Study|Participant ineligible to continue trial|1|||
19494071|NCT01662648|41823671|FG000|Overall Study|Lost to Follow-up|24|||
19494072|NCT01662648|41823672|FG001|Overall Study|Lost to Follow-up|36|||
19494073|NCT01662648|41823671|FG000|Overall Study|Withdrawal by Subject|36|||
19494074|NCT01662648|41823672|FG001|Overall Study|Withdrawal by Subject|53|||
19494075|NCT01662648|41823671|FG000|Overall Study|Participant non-compliant|16|||
19494076|NCT01662648|41823672|FG001|Overall Study|Participant non-compliant|20|||
19494077|NCT01662648|41823671|FG000|Overall Study|Other|8|||
19494078|NCT01662648|41823672|FG001|Overall Study|Other|11|||
19494079|NCT01662648|41823671|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
19494080|NCT01662648|41823672|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
19494081|NCT01662648|41823671|FG000|Overall Study|LOE and other reason unspecified|1|||
19494082|NCT01662648|41823672|FG001|Overall Study|LOE and other reason unspecified|0|||
19494083|NCT01662648|41823671|FG000|Overall Study|LOE and Participant non-compliant|0|||
19494084|NCT01662648|41823672|FG001|Overall Study|LOE and Participant non-compliant|1|||
19494085|NCT02556918|41823737|FG000|Overall Study|Protocol Violation|5|||
19494086|NCT02556918|41823738|FG001|Overall Study|Protocol Violation|6|||
19494087|NCT02556918|41823737|FG000|Overall Study|Withdrawal by Subject|4|||
19494088|NCT02556918|41823738|FG001|Overall Study|Withdrawal by Subject|4|||
19494089|NCT01662492|41823854|FG000|Overall Study|Other miscellaneous reasons.|1|||
19494090|NCT01662492|41823855|FG001|Overall Study|Other miscellaneous reasons.|0|||
19494091|NCT01662492|41823856|FG002|Overall Study|Other miscellaneous reasons.|1|||
19494092|NCT01662492|41823854|FG000|Overall Study|Withdrawal by Subject|0|||
19494093|NCT01662492|41823855|FG001|Overall Study|Withdrawal by Subject|0|||
19494094|NCT01662492|41823856|FG002|Overall Study|Withdrawal by Subject|1|||
19494095|NCT01662492|41823854|FG000|Overall Study|Protocol Violation|1|||
19494096|NCT01662492|41823855|FG001|Overall Study|Protocol Violation|0|||
19494097|NCT01662492|41823856|FG002|Overall Study|Protocol Violation|0|||
19494098|NCT01662492|41823854|FG000|Overall Study|Lost to Follow-up|0|||
19704349|NCT00220740|42148647|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
19494099|NCT01662492|41823855|FG001|Overall Study|Lost to Follow-up|0|||
19494100|NCT01662492|41823856|FG002|Overall Study|Lost to Follow-up|2|||
19494101|NCT01662492|41823854|FG000|Overall Study|Lack of Efficacy|1|||
19494102|NCT01662492|41823855|FG001|Overall Study|Lack of Efficacy|1|||
19494103|NCT01662492|41823856|FG002|Overall Study|Lack of Efficacy|2|||
19494104|NCT02552238|41824026|FG000|Overall Study|Withdrawal by Subject|2|||
19494105|NCT02552238|41824026|FG000|Overall Study|Adverse Event|2|||
19494106|NCT01662102|41824244|FG000|Overall Study|Sponsor's decision|1|||
19494107|NCT01662102|41824245|FG001|Overall Study|Sponsor's decision|0|||
19494108|NCT02554656|41824285|FG000|Overall Study|Protocol Violation|3|||
19494109|NCT03414684|41824445|FG000|First-course Treatment|Complete response|0|||
19494110|NCT03414684|41824446|FG001|First-course Treatment|Complete response|1|||
19494111|NCT03414684|41824445|FG000|First-course Treatment|Intercurrent illness|1|||
19494112|NCT03414684|41824446|FG001|First-course Treatment|Intercurrent illness|0|||
19494113|NCT03414684|41824445|FG000|First-course Treatment|Progressive Disease|31|||
19494114|NCT03414684|41824446|FG001|First-course Treatment|Progressive Disease|32|||
19494115|NCT03414684|41824445|FG000|First-course Treatment|Adverse Event|1|||
19494116|NCT03414684|41824446|FG001|First-course Treatment|Adverse Event|2|||
19494117|NCT03414684|41824445|FG000|First-course Treatment|Physician Decision|0|||
19494118|NCT03414684|41824446|FG001|First-course Treatment|Physician Decision|1|||
19494119|NCT03414684|41824445|FG000|First-course Treatment|Withdrawal by Subject|0|||
19494120|NCT03414684|41824446|FG001|First-course Treatment|Withdrawal by Subject|1|||
19494121|NCT03414684|41824445|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
19494122|NCT03414684|41824446|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
19494123|NCT03414684|41824445|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
19494124|NCT03414684|41824446|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
19494125|NCT03414684|41824445|FG000|First-course Treatment|Still on treatment|3|||
19494126|NCT03414684|41824446|FG001|First-course Treatment|Still on treatment|0|||
19494127|NCT03414684|41824445|FG000|First-course Treatment|Never started protocol therapy|2|||
19494128|NCT03414684|41824446|FG001|First-course Treatment|Never started protocol therapy|1|||
19494129|NCT03414684|41824445|FG000|Crossover Treatment|Progressive disease|0|||
19494130|NCT03414684|41824446|FG001|Crossover Treatment|Progressive disease|12|||
19494131|NCT03414684|41824445|FG000|Crossover Treatment|Adverse Event|0|||
19494132|NCT03414684|41824446|FG001|Crossover Treatment|Adverse Event|3|||
19494133|NCT03414684|41824445|FG000|Crossover Treatment|Physician Decision|0|||
19494134|NCT03414684|41824446|FG001|Crossover Treatment|Physician Decision|1|||
19494135|NCT03414684|41824445|FG000|Crossover Treatment|Still on treatment|0|||
19494136|NCT03414684|41824446|FG001|Crossover Treatment|Still on treatment|2|||
19494137|NCT02551692|41824525|FG000|Overall Study|Lost to Follow-up|0|||
19494138|NCT02551692|41824526|FG001|Overall Study|Lost to Follow-up|1|||
19494139|NCT02551692|41824527|FG002|Overall Study|Lost to Follow-up|4|||
19494140|NCT02551692|41824525|FG000|Overall Study|Withdrawal by Subject|1|||
19494141|NCT02551692|41824526|FG001|Overall Study|Withdrawal by Subject|0|||
19494142|NCT02551692|41824527|FG002|Overall Study|Withdrawal by Subject|1|||
19494143|NCT02553330|41824614|FG000|Overall Study|Study Terminated by Sponsor|2|||
19494144|NCT02553330|41824615|FG001|Overall Study|Study Terminated by Sponsor|13|||
19494145|NCT02553330|41824616|FG002|Overall Study|Study Terminated by Sponsor|12|||
19494146|NCT02553330|41824614|FG000|Overall Study|Withdrawal by Subject|3|||
19494147|NCT02553330|41824615|FG001|Overall Study|Withdrawal by Subject|19|||
19494148|NCT02553330|41824616|FG002|Overall Study|Withdrawal by Subject|21|||
19494149|NCT02553330|41824614|FG000|Overall Study|Other|0|||
19494150|NCT02553330|41824615|FG001|Overall Study|Other|1|||
19494151|NCT02553330|41824616|FG002|Overall Study|Other|0|||
19494152|NCT02553330|41824614|FG000|Overall Study|Non compliance to study treatment|0|||
19494153|NCT02553330|41824615|FG001|Overall Study|Non compliance to study treatment|1|||
19494154|NCT02553330|41824616|FG002|Overall Study|Non compliance to study treatment|0|||
19494155|NCT02553330|41824614|FG000|Overall Study|Adverse Event|0|||
19494156|NCT02553330|41824615|FG001|Overall Study|Adverse Event|1|||
19494157|NCT02553330|41824616|FG002|Overall Study|Adverse Event|0|||
19494158|NCT02553330|41824614|FG000|Overall Study|Lost to Follow-up|0|||
19494159|NCT02553330|41824615|FG001|Overall Study|Lost to Follow-up|4|||
19494160|NCT02553330|41824616|FG002|Overall Study|Lost to Follow-up|4|||
19494161|NCT02550288|41824658|FG000|Overall Study|Adverse Event|0|||
19494162|NCT02550288|41824659|FG001|Overall Study|Adverse Event|1|||
19494163|NCT02550288|41824660|FG002|Overall Study|Adverse Event|0|||
19494164|NCT02550288|41824661|FG003|Overall Study|Adverse Event|0|||
19494165|NCT02550288|41824662|FG004|Overall Study|Adverse Event|0|||
19494166|NCT02550288|41824658|FG000|Overall Study|Physician Decision|0|||
19494167|NCT02550288|41824659|FG001|Overall Study|Physician Decision|0|||
19494168|NCT02550288|41824660|FG002|Overall Study|Physician Decision|0|||
19494169|NCT02550288|41824661|FG003|Overall Study|Physician Decision|1|||
19494170|NCT02550288|41824662|FG004|Overall Study|Physician Decision|0|||
19704350|NCT00220740|42148646|FG000|Efficacy Period|Adverse Event|1|||
19494171|NCT02550288|41824658|FG000|Overall Study|Protocol Violation|2|||
19494172|NCT02550288|41824659|FG001|Overall Study|Protocol Violation|2|||
19494173|NCT02550288|41824660|FG002|Overall Study|Protocol Violation|1|||
19494174|NCT02550288|41824661|FG003|Overall Study|Protocol Violation|0|||
19494175|NCT02550288|41824662|FG004|Overall Study|Protocol Violation|3|||
19494176|NCT02550288|41824658|FG000|Overall Study|Participant moved|0|||
19704351|NCT00220740|42148647|FG001|Efficacy Period|Adverse Event|1|||
19494177|NCT02550288|41824659|FG001|Overall Study|Participant moved|0|||
19494178|NCT02550288|41824660|FG002|Overall Study|Participant moved|0|||
19494179|NCT02550288|41824661|FG003|Overall Study|Participant moved|1|||
19494180|NCT02550288|41824662|FG004|Overall Study|Participant moved|0|||
19494181|NCT02550288|41824658|FG000|Overall Study|Withdrawal by Subject|0|||
19494182|NCT02550288|41824659|FG001|Overall Study|Withdrawal by Subject|0|||
19494183|NCT02550288|41824660|FG002|Overall Study|Withdrawal by Subject|0|||
19494184|NCT02550288|41824661|FG003|Overall Study|Withdrawal by Subject|1|||
19494185|NCT02550288|41824662|FG004|Overall Study|Withdrawal by Subject|0|||
19494186|NCT01662336|41824727|FG000|Overall Study|Adverse Event|1|||
19494187|NCT01662336|41824727|FG000|Overall Study|No longer on LPV/r|30|||
19494188|NCT01662336|41824727|FG000|Overall Study|Other|29|||
19373674|NCT02760407|41614835|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
19373675|NCT02760407|41614836|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
19373676|NCT00805129|41614847|FG000|Overall Study|Not treated|1|||
19373677|NCT02668185|41614851|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
19373678|NCT02668185|41614852|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
19373679|NCT02668185|41614851|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
19373680|NCT02668185|41614852|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
19393710|NCT00790933|41637561|FG003|Overall Study|Lost to Follow-up|1|||
19494189|NCT01662336|41824727|FG000|Overall Study|Withdrawal by Subject|6|||
19494190|NCT02549352|41824746|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
19494191|NCT02549352|41824747|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
19494192|NCT02549352|41824746|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
19494193|NCT02549352|41824747|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
19494194|NCT02549352|41824746|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
19494195|NCT02549352|41824747|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
19494196|NCT02549352|41824746|FG000|12-month Follow-up|Withdrawal by Subject|4|||
19494197|NCT02549352|41824747|FG001|12-month Follow-up|Withdrawal by Subject|5|||
19494198|NCT02549352|41824746|FG000|12-month Follow-up|Lost to Follow-up|3|||
19494199|NCT02549352|41824747|FG001|12-month Follow-up|Lost to Follow-up|2|||
19494200|NCT02549352|41824746|FG000|12-month Follow-up|Death|0|||
19494201|NCT02549352|41824747|FG001|12-month Follow-up|Death|1|||
19494202|NCT02549352|41824746|FG000|12-month Follow-up|Protocol Violation|0|||
19494203|NCT02549352|41824747|FG001|12-month Follow-up|Protocol Violation|1|||
19494204|NCT02549352|41824746|FG000|12-month Follow-up|Other|1|||
19494205|NCT02549352|41824747|FG001|12-month Follow-up|Other|3|||
19494206|NCT02554890|41824937|FG000|Double-blind|Adverse Event|45|||
19494207|NCT02554890|41824938|FG001|Double-blind|Adverse Event|51|||
19494208|NCT02554890|41824937|FG000|Double-blind|Death|6|||
19494209|NCT02554890|41824938|FG001|Double-blind|Death|4|||
19494210|NCT02554890|41824937|FG000|Double-blind|Protocol Violation|1|||
19494211|NCT02554890|41824938|FG001|Double-blind|Protocol Violation|1|||
19494212|NCT02554890|41824937|FG000|Double-blind|Physician Decision|4|||
19494213|NCT02554890|41824938|FG001|Double-blind|Physician Decision|3|||
19494214|NCT02554890|41824937|FG000|Double-blind|Subject/Guardian decision|21|||
19494215|NCT02554890|41824938|FG001|Double-blind|Subject/Guardian decision|16|||
19494216|NCT02554890|41824937|FG000|Double-blind|Lost to Follow-up|7|||
19494217|NCT02554890|41824938|FG001|Double-blind|Lost to Follow-up|5|||
19494218|NCT02554890|41824937|FG000|Double-blind|Technical problems|1|||
19494219|NCT02554890|41824938|FG001|Double-blind|Technical problems|0|||
19494220|NCT02554890|41824937|FG000|Double-blind|Withdrawal by Subject|5|||
19494221|NCT02554890|41824938|FG001|Double-blind|Withdrawal by Subject|6|||
19494222|NCT02554890|41824937|FG000|Double-blind|Noncompliance with study treatment|6|||
19494223|NCT02554890|41824938|FG001|Double-blind|Noncompliance with study treatment|5|||
19494224|NCT02554890|41824937|FG000|Open-label|Adverse Event|0|||
19494225|NCT02554890|41824938|FG001|Open-label|Adverse Event|30|||
19494226|NCT02554890|41824937|FG000|Open-label|Death|0|||
19494227|NCT02554890|41824938|FG001|Open-label|Death|1|||
19494228|NCT02554890|41824937|FG000|Open-label|Physician Decision|0|||
19494229|NCT02554890|41824938|FG001|Open-label|Physician Decision|1|||
19494230|NCT02554890|41824937|FG000|Open-label|Subject/Guardian decision|0|||
19494231|NCT02554890|41824938|FG001|Open-label|Subject/Guardian decision|11|||
19494232|NCT02554890|41824937|FG000|Open-label|Lost to Follow-up|0|||
19494233|NCT02554890|41824938|FG001|Open-label|Lost to Follow-up|7|||
19494234|NCT02554890|41824937|FG000|Open-label|Technical problems|0|||
19494235|NCT02554890|41824938|FG001|Open-label|Technical problems|1|||
19494236|NCT02554890|41824937|FG000|Open-label|Withdrawal by Subject|0|||
19494237|NCT02554890|41824938|FG001|Open-label|Withdrawal by Subject|1|||
19494238|NCT02552316|41824955|FG000|Overall Study|Withdrawal by Subject|1|||
19494239|NCT02552316|41824955|FG000|Overall Study|Withdrawal due to non-compliance|1|||
19494240|NCT02543346|41825003|FG000|Second Priming Visit|Withdrawal by Subject|0|||
19494241|NCT02543346|41825004|FG001|Second Priming Visit|Withdrawal by Subject|2|||
19494242|NCT02543346|41825005|FG002|Second Priming Visit|Withdrawal by Subject|2|||
19494243|NCT02543346|41825006|FG003|Second Priming Visit|Withdrawal by Subject|2|||
19494244|NCT02543346|41825003|FG000|Second Priming Visit|Adverse Event|1|||
19494245|NCT02543346|41825004|FG001|Second Priming Visit|Adverse Event|0|||
19494246|NCT02543346|41825005|FG002|Second Priming Visit|Adverse Event|0|||
19494247|NCT02543346|41825006|FG003|Second Priming Visit|Adverse Event|0|||
19494248|NCT02549196|41825020|FG000|Overall Study|Protocol Violation|0|||
19373681|NCT02668185|41614851|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
19494249|NCT02549196|41825021|FG001|Overall Study|Protocol Violation|0|||
19494250|NCT02549196|41825022|FG002|Overall Study|Protocol Violation|0|||
19494251|NCT02549196|41825023|FG003|Overall Study|Protocol Violation|1|||
19494252|NCT02549196|41825020|FG000|Overall Study|Withdrawal by Subject|1|||
19494253|NCT02549196|41825021|FG001|Overall Study|Withdrawal by Subject|0|||
19494254|NCT02549196|41825022|FG002|Overall Study|Withdrawal by Subject|1|||
19494255|NCT02549196|41825023|FG003|Overall Study|Withdrawal by Subject|0|||
19494256|NCT02904954|41825035|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
19494257|NCT02904954|41825036|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
19494258|NCT02904954|41825035|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
19494259|NCT02904954|41825036|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
19494260|NCT02904954|41825035|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
19494261|NCT02904954|41825036|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
19494262|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Recurrence|2|||
19494263|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Recurrence|0|||
19494264|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Adverse Event|2|||
19494265|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Adverse Event|6|||
19494266|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Participant wishes|12|||
19494267|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Participant wishes|7|||
19494268|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Physician Decision|2|||
19494269|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Physician Decision|1|||
19494270|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
19494271|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
19494272|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Death|0|||
19494273|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Death|1|||
19494274|NCT02904954|41825035|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
19494275|NCT02904954|41825036|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
19494276|NCT02548962|41825152|FG000|Overall Study|Withdrawal by Subject|1|||
19494277|NCT02548962|41825153|FG001|Overall Study|Withdrawal by Subject|0|||
19494278|NCT02548650|41825180|FG000|Triple Therapy|Adverse Event|1|||
19494279|NCT02548650|41825181|FG001|Triple Therapy|Adverse Event|0|||
19494280|NCT02548650|41825180|FG000|Triple Therapy|Withdrawal by Subject|0|||
19494281|NCT02548650|41825181|FG001|Triple Therapy|Withdrawal by Subject|4|||
19494282|NCT02548650|41825180|FG000|Double Therapy|Adverse Event|1|||
19494283|NCT02548650|41825181|FG001|Double Therapy|Adverse Event|1|||
19494284|NCT02548650|41825180|FG000|Double Therapy|Withdrawal by Subject|0|||
19494285|NCT02548650|41825181|FG001|Double Therapy|Withdrawal by Subject|1|||
19494286|NCT02535000|41825276|FG000|Overall Study|Cancellation of surgery.|1|||
19494287|NCT02535000|41825277|FG001|Overall Study|Cancellation of surgery.|2|||
19494288|NCT03110562|41825406|FG000|Overall Study|Withdrawal by Subject|37|||
19494289|NCT03110562|41825407|FG001|Overall Study|Withdrawal by Subject|35|||
19494290|NCT03110562|41825406|FG000|Overall Study|Death|47|||
19494291|NCT03110562|41825407|FG001|Overall Study|Death|61|||
19494292|NCT03110562|41825406|FG000|Overall Study|Lost to Follow-up|7|||
19494293|NCT03110562|41825407|FG001|Overall Study|Lost to Follow-up|6|||
19494294|NCT03110562|41825406|FG000|Overall Study|Other|2|||
19494295|NCT03110562|41825407|FG001|Overall Study|Other|1|||
19494296|NCT03110562|41825406|FG000|Overall Study|Randomized but never treated|0|||
19494297|NCT03110562|41825407|FG001|Overall Study|Randomized but never treated|3|||
19494298|NCT03110562|41825406|FG000|Overall Study|Ongoing|102|||
19494299|NCT03110562|41825407|FG001|Overall Study|Ongoing|101|||
19494300|NCT02546856|41825450|FG000|4 Months Evaluation|Death|2|||
19494301|NCT02546856|41825451|FG001|4 Months Evaluation|Death|3|||
19494302|NCT02546856|41825450|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
19494303|NCT02546856|41825451|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
19494304|NCT02546856|41825450|FG000|4 Months Evaluation|Lost to Follow-up|3|||
19494305|NCT02546856|41825451|FG001|4 Months Evaluation|Lost to Follow-up|3|||
19494306|NCT02546856|41825450|FG000|4 Months Evaluation|Physician Decision|3|||
19494307|NCT02546856|41825451|FG001|4 Months Evaluation|Physician Decision|0|||
19494308|NCT02546856|41825450|FG000|4 Months Evaluation|Working or living abroad|5|||
19494309|NCT02546856|41825451|FG001|4 Months Evaluation|Working or living abroad|1|||
19704352|NCT00220740|42148646|FG000|Efficacy Period|Withdrawal by Subject|1|||
19494310|NCT02546856|41825450|FG000|4 Months Evaluation|reasons not due to titration|4|||
19494311|NCT02546856|41825451|FG001|4 Months Evaluation|reasons not due to titration|1|||
19494312|NCT02546856|41825450|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
19494313|NCT02546856|41825451|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
19494314|NCT02546856|41825450|FG000|6 Months Evaluation|Death|1|||
19494315|NCT02546856|41825451|FG001|6 Months Evaluation|Death|1|||
19494316|NCT02546856|41825450|FG000|6 Months Evaluation|Lost to Follow-up|1|||
19494317|NCT02546856|41825451|FG001|6 Months Evaluation|Lost to Follow-up|1|||
19494318|NCT02546856|41825450|FG000|6 Months Evaluation|Working or living abroad|6|||
19494319|NCT02546856|41825451|FG001|6 Months Evaluation|Working or living abroad|4|||
19494320|NCT02546856|41825450|FG000|6 Months Evaluation|reasons not due to titration|0|||
19494321|NCT02546856|41825451|FG001|6 Months Evaluation|reasons not due to titration|1|||
19494322|NCT02696616|41825576|FG000|Overall Study|Adverse Event|0|||
19494323|NCT02696616|41825577|FG001|Overall Study|Adverse Event|1|||
19494324|NCT02696616|41825578|FG002|Overall Study|Adverse Event|0|||
19494325|NCT02696616|41825579|FG003|Overall Study|Adverse Event|0|||
19494326|NCT02696616|41825580|FG004|Overall Study|Adverse Event|0|||
19494327|NCT02696616|41825581|FG005|Overall Study|Adverse Event|0|||
19494328|NCT02696616|41825582|FG006|Overall Study|Adverse Event|0|||
19494329|NCT01661790|41825633|FG000|Overall Study|Lost to Follow-up|0|||
19494330|NCT01661790|41825634|FG001|Overall Study|Lost to Follow-up|2|||
19494331|NCT02546544|41825654|FG000|Overall Study|Disease Progression|14|||
19494332|NCT02546544|41825654|FG000|Overall Study|Adverse Event|1|||
19494333|NCT02546544|41825654|FG000|Overall Study|Withdrawal by Subject|1|||
19494334|NCT02533674|41826294|FG000|Dose Level I|Progressive disease|1|||
19494335|NCT02533674|41826295|FG001|Dose Level I|Progressive disease|0|||
19494336|NCT02533674|41826296|FG002|Dose Level I|Progressive disease|0|||
19494337|NCT02533674|41826297|FG003|Dose Level I|Progressive disease|0|||
19494338|NCT02533674|41826298|FG004|Dose Level I|Progressive disease|0|||
19494339|NCT02533674|41826299|FG005|Dose Level I|Progressive disease|0|||
19494340|NCT02533674|41826300|FG006|Dose Level I|Progressive disease|0|||
19494341|NCT02533674|41826301|FG007|Dose Level I|Progressive disease|0|||
19494342|NCT02533674|41826294|FG000|Dose Level I|Withdrawal by Subject|1|||
19494343|NCT02533674|41826295|FG001|Dose Level I|Withdrawal by Subject|0|||
19494344|NCT02533674|41826296|FG002|Dose Level I|Withdrawal by Subject|0|||
19494345|NCT02533674|41826297|FG003|Dose Level I|Withdrawal by Subject|0|||
19494346|NCT02533674|41826298|FG004|Dose Level I|Withdrawal by Subject|0|||
19494347|NCT02533674|41826299|FG005|Dose Level I|Withdrawal by Subject|0|||
19494348|NCT02533674|41826300|FG006|Dose Level I|Withdrawal by Subject|0|||
19494349|NCT02533674|41826301|FG007|Dose Level I|Withdrawal by Subject|0|||
19494350|NCT02533674|41826294|FG000|Dose Level I|Physician Decision|1|||
19494351|NCT02533674|41826295|FG001|Dose Level I|Physician Decision|0|||
19494352|NCT02533674|41826296|FG002|Dose Level I|Physician Decision|0|||
19494353|NCT02533674|41826297|FG003|Dose Level I|Physician Decision|0|||
19494354|NCT02533674|41826298|FG004|Dose Level I|Physician Decision|0|||
19494355|NCT02533674|41826299|FG005|Dose Level I|Physician Decision|0|||
19494356|NCT02533674|41826300|FG006|Dose Level I|Physician Decision|0|||
19494357|NCT02533674|41826301|FG007|Dose Level I|Physician Decision|0|||
19494358|NCT02533674|41826294|FG000|Dose Level I|Death|1|||
19494359|NCT02533674|41826295|FG001|Dose Level I|Death|0|||
19494360|NCT02533674|41826296|FG002|Dose Level I|Death|0|||
19494361|NCT02533674|41826297|FG003|Dose Level I|Death|0|||
19494362|NCT02533674|41826298|FG004|Dose Level I|Death|0|||
19494363|NCT02533674|41826299|FG005|Dose Level I|Death|0|||
19494364|NCT02533674|41826300|FG006|Dose Level I|Death|0|||
19494365|NCT02533674|41826301|FG007|Dose Level I|Death|0|||
19494366|NCT02533674|41826294|FG000|Dose Level I|Never Treated|1|||
19494367|NCT02533674|41826295|FG001|Dose Level I|Never Treated|0|||
19494368|NCT02533674|41826296|FG002|Dose Level I|Never Treated|0|||
19494369|NCT02533674|41826297|FG003|Dose Level I|Never Treated|0|||
19494370|NCT02533674|41826298|FG004|Dose Level I|Never Treated|0|||
19494371|NCT02533674|41826299|FG005|Dose Level I|Never Treated|0|||
19494372|NCT02533674|41826300|FG006|Dose Level I|Never Treated|0|||
19494373|NCT02533674|41826301|FG007|Dose Level I|Never Treated|0|||
19494374|NCT02533674|41826294|FG000|Dose Level II|Progressive disease|0|||
19494375|NCT02533674|41826295|FG001|Dose Level II|Progressive disease|3|||
19494376|NCT02533674|41826296|FG002|Dose Level II|Progressive disease|0|||
19494377|NCT02533674|41826297|FG003|Dose Level II|Progressive disease|0|||
19494378|NCT02533674|41826298|FG004|Dose Level II|Progressive disease|0|||
19494379|NCT02533674|41826299|FG005|Dose Level II|Progressive disease|0|||
19494380|NCT02533674|41826300|FG006|Dose Level II|Progressive disease|0|||
19494381|NCT02533674|41826301|FG007|Dose Level II|Progressive disease|0|||
19494382|NCT02533674|41826294|FG000|Dose Level II|Withdrawal by Subject|0|||
19494383|NCT02533674|41826295|FG001|Dose Level II|Withdrawal by Subject|1|||
19494384|NCT02533674|41826296|FG002|Dose Level II|Withdrawal by Subject|0|||
19494385|NCT02533674|41826297|FG003|Dose Level II|Withdrawal by Subject|0|||
19494386|NCT02533674|41826298|FG004|Dose Level II|Withdrawal by Subject|0|||
19494387|NCT02533674|41826299|FG005|Dose Level II|Withdrawal by Subject|0|||
19704353|NCT00220740|42148647|FG001|Efficacy Period|Withdrawal by Subject|0|||
19704354|NCT00220740|42148646|FG000|Efficacy Period|Protocol Violation|1|||
19494388|NCT02533674|41826300|FG006|Dose Level II|Withdrawal by Subject|0|||
19494389|NCT02533674|41826301|FG007|Dose Level II|Withdrawal by Subject|0|||
19494390|NCT02533674|41826294|FG000|Dose Level II|Treatment-related AE|0|||
19494391|NCT02533674|41826295|FG001|Dose Level II|Treatment-related AE|1|||
19494392|NCT02533674|41826296|FG002|Dose Level II|Treatment-related AE|0|||
19494393|NCT02533674|41826297|FG003|Dose Level II|Treatment-related AE|0|||
19494394|NCT02533674|41826298|FG004|Dose Level II|Treatment-related AE|0|||
19494395|NCT02533674|41826299|FG005|Dose Level II|Treatment-related AE|0|||
19494396|NCT02533674|41826300|FG006|Dose Level II|Treatment-related AE|0|||
19494397|NCT02533674|41826301|FG007|Dose Level II|Treatment-related AE|0|||
19494398|NCT02533674|41826294|FG000|Dose Level II|Physician Decision|0|||
19494399|NCT02533674|41826295|FG001|Dose Level II|Physician Decision|1|||
19494400|NCT02533674|41826296|FG002|Dose Level II|Physician Decision|0|||
19494401|NCT02533674|41826297|FG003|Dose Level II|Physician Decision|0|||
19494402|NCT02533674|41826298|FG004|Dose Level II|Physician Decision|0|||
19494403|NCT02533674|41826299|FG005|Dose Level II|Physician Decision|0|||
19494404|NCT02533674|41826300|FG006|Dose Level II|Physician Decision|0|||
19494405|NCT02533674|41826301|FG007|Dose Level II|Physician Decision|0|||
19494406|NCT02533674|41826294|FG000|Dose Level II|Non-treatment-related AE|0|||
19494407|NCT02533674|41826295|FG001|Dose Level II|Non-treatment-related AE|1|||
19494408|NCT02533674|41826296|FG002|Dose Level II|Non-treatment-related AE|0|||
19494409|NCT02533674|41826297|FG003|Dose Level II|Non-treatment-related AE|0|||
19494410|NCT02533674|41826298|FG004|Dose Level II|Non-treatment-related AE|0|||
19494411|NCT02533674|41826299|FG005|Dose Level II|Non-treatment-related AE|0|||
19494412|NCT02533674|41826300|FG006|Dose Level II|Non-treatment-related AE|0|||
19494413|NCT02533674|41826301|FG007|Dose Level II|Non-treatment-related AE|0|||
19494414|NCT02533674|41826294|FG000|Dose Level III|Progressive disease|0|||
19494415|NCT02533674|41826295|FG001|Dose Level III|Progressive disease|0|||
19494416|NCT02533674|41826296|FG002|Dose Level III|Progressive disease|2|||
19494417|NCT02533674|41826297|FG003|Dose Level III|Progressive disease|0|||
19494418|NCT02533674|41826298|FG004|Dose Level III|Progressive disease|0|||
19494419|NCT02533674|41826299|FG005|Dose Level III|Progressive disease|0|||
19494420|NCT02533674|41826300|FG006|Dose Level III|Progressive disease|0|||
19494421|NCT02533674|41826301|FG007|Dose Level III|Progressive disease|0|||
19494422|NCT02533674|41826294|FG000|Dose Level III|Withdrawal by Subject|0|||
19494423|NCT02533674|41826295|FG001|Dose Level III|Withdrawal by Subject|0|||
19494424|NCT02533674|41826296|FG002|Dose Level III|Withdrawal by Subject|1|||
19494425|NCT02533674|41826297|FG003|Dose Level III|Withdrawal by Subject|0|||
19494426|NCT02533674|41826298|FG004|Dose Level III|Withdrawal by Subject|0|||
19494427|NCT02533674|41826299|FG005|Dose Level III|Withdrawal by Subject|0|||
19494428|NCT02533674|41826300|FG006|Dose Level III|Withdrawal by Subject|0|||
19494429|NCT02533674|41826301|FG007|Dose Level III|Withdrawal by Subject|0|||
19494430|NCT02533674|41826294|FG000|Dose Level III|Treatment-related AE|0|||
19494431|NCT02533674|41826295|FG001|Dose Level III|Treatment-related AE|0|||
19494432|NCT02533674|41826296|FG002|Dose Level III|Treatment-related AE|1|||
19494433|NCT02533674|41826297|FG003|Dose Level III|Treatment-related AE|0|||
19494434|NCT02533674|41826298|FG004|Dose Level III|Treatment-related AE|0|||
19494435|NCT02533674|41826299|FG005|Dose Level III|Treatment-related AE|0|||
19494436|NCT02533674|41826300|FG006|Dose Level III|Treatment-related AE|0|||
19494437|NCT02533674|41826301|FG007|Dose Level III|Treatment-related AE|0|||
19494438|NCT02533674|41826294|FG000|Dose Level IV|Progressive disease|0|||
19494439|NCT02533674|41826295|FG001|Dose Level IV|Progressive disease|0|||
19494440|NCT02533674|41826296|FG002|Dose Level IV|Progressive disease|0|||
19494441|NCT02533674|41826297|FG003|Dose Level IV|Progressive disease|3|||
19494442|NCT02533674|41826298|FG004|Dose Level IV|Progressive disease|0|||
19494443|NCT02533674|41826299|FG005|Dose Level IV|Progressive disease|0|||
19494444|NCT02533674|41826300|FG006|Dose Level IV|Progressive disease|0|||
19494445|NCT02533674|41826301|FG007|Dose Level IV|Progressive disease|0|||
19494446|NCT02533674|41826294|FG000|Dose Level IV|Withdrawal by Subject|0|||
19494447|NCT02533674|41826295|FG001|Dose Level IV|Withdrawal by Subject|0|||
19494448|NCT02533674|41826296|FG002|Dose Level IV|Withdrawal by Subject|0|||
19494449|NCT02533674|41826297|FG003|Dose Level IV|Withdrawal by Subject|1|||
19494450|NCT02533674|41826298|FG004|Dose Level IV|Withdrawal by Subject|0|||
19494451|NCT02533674|41826299|FG005|Dose Level IV|Withdrawal by Subject|0|||
19494452|NCT02533674|41826300|FG006|Dose Level IV|Withdrawal by Subject|0|||
19494453|NCT02533674|41826301|FG007|Dose Level IV|Withdrawal by Subject|0|||
19494454|NCT02533674|41826294|FG000|Dose Level IV|Physician Decision|0|||
19494455|NCT02533674|41826295|FG001|Dose Level IV|Physician Decision|0|||
19494456|NCT02533674|41826296|FG002|Dose Level IV|Physician Decision|0|||
19494457|NCT02533674|41826297|FG003|Dose Level IV|Physician Decision|1|||
19494458|NCT02533674|41826298|FG004|Dose Level IV|Physician Decision|0|||
19494459|NCT02533674|41826299|FG005|Dose Level IV|Physician Decision|0|||
19494460|NCT02533674|41826300|FG006|Dose Level IV|Physician Decision|0|||
19494461|NCT02533674|41826301|FG007|Dose Level IV|Physician Decision|0|||
19494462|NCT02533674|41826294|FG000|Dose Level V|Progressive disease|0|||
19494463|NCT02533674|41826295|FG001|Dose Level V|Progressive disease|0|||
19494464|NCT02533674|41826296|FG002|Dose Level V|Progressive disease|0|||
19494465|NCT02533674|41826297|FG003|Dose Level V|Progressive disease|0|||
19494466|NCT02533674|41826298|FG004|Dose Level V|Progressive disease|3|||
19494467|NCT02533674|41826299|FG005|Dose Level V|Progressive disease|0|||
19494468|NCT02533674|41826300|FG006|Dose Level V|Progressive disease|0|||
19494469|NCT02533674|41826301|FG007|Dose Level V|Progressive disease|0|||
19494470|NCT02533674|41826294|FG000|Dose Level V|Withdrawal by Subject|0|||
19494471|NCT02533674|41826295|FG001|Dose Level V|Withdrawal by Subject|0|||
19494472|NCT02533674|41826296|FG002|Dose Level V|Withdrawal by Subject|0|||
19494473|NCT02533674|41826297|FG003|Dose Level V|Withdrawal by Subject|0|||
19494474|NCT02533674|41826298|FG004|Dose Level V|Withdrawal by Subject|1|||
19494475|NCT02533674|41826299|FG005|Dose Level V|Withdrawal by Subject|0|||
19494476|NCT02533674|41826300|FG006|Dose Level V|Withdrawal by Subject|0|||
19494477|NCT02533674|41826301|FG007|Dose Level V|Withdrawal by Subject|0|||
19494478|NCT02533674|41826294|FG000|Dose Level V|Physician Decision|0|||
19494479|NCT02533674|41826295|FG001|Dose Level V|Physician Decision|0|||
19494480|NCT02533674|41826296|FG002|Dose Level V|Physician Decision|0|||
19494481|NCT02533674|41826297|FG003|Dose Level V|Physician Decision|0|||
19494482|NCT02533674|41826298|FG004|Dose Level V|Physician Decision|1|||
19494483|NCT02533674|41826299|FG005|Dose Level V|Physician Decision|0|||
19494484|NCT02533674|41826300|FG006|Dose Level V|Physician Decision|0|||
19494485|NCT02533674|41826301|FG007|Dose Level V|Physician Decision|0|||
19494486|NCT02533674|41826294|FG000|Dose Level VI|Progressive disease|0|||
19494487|NCT02533674|41826295|FG001|Dose Level VI|Progressive disease|0|||
19494488|NCT02533674|41826296|FG002|Dose Level VI|Progressive disease|0|||
19494489|NCT02533674|41826297|FG003|Dose Level VI|Progressive disease|0|||
19494490|NCT02533674|41826298|FG004|Dose Level VI|Progressive disease|0|||
19494491|NCT02533674|41826299|FG005|Dose Level VI|Progressive disease|7|||
19494492|NCT02533674|41826300|FG006|Dose Level VI|Progressive disease|0|||
19494493|NCT02533674|41826301|FG007|Dose Level VI|Progressive disease|0|||
19494494|NCT02533674|41826294|FG000|Dose Level VI|Withdrawal by Subject|0|||
19494495|NCT02533674|41826295|FG001|Dose Level VI|Withdrawal by Subject|0|||
19494496|NCT02533674|41826296|FG002|Dose Level VI|Withdrawal by Subject|0|||
19494497|NCT02533674|41826297|FG003|Dose Level VI|Withdrawal by Subject|0|||
19494498|NCT02533674|41826298|FG004|Dose Level VI|Withdrawal by Subject|0|||
19494499|NCT02533674|41826299|FG005|Dose Level VI|Withdrawal by Subject|1|||
19494500|NCT02533674|41826300|FG006|Dose Level VI|Withdrawal by Subject|0|||
19494501|NCT02533674|41826301|FG007|Dose Level VI|Withdrawal by Subject|0|||
19494502|NCT02533674|41826294|FG000|Dose Level VI|Treatment-related AE|0|||
19494503|NCT02533674|41826295|FG001|Dose Level VI|Treatment-related AE|0|||
19494504|NCT02533674|41826296|FG002|Dose Level VI|Treatment-related AE|0|||
19494505|NCT02533674|41826297|FG003|Dose Level VI|Treatment-related AE|0|||
19494506|NCT02533674|41826298|FG004|Dose Level VI|Treatment-related AE|0|||
19494507|NCT02533674|41826299|FG005|Dose Level VI|Treatment-related AE|1|||
19494508|NCT02533674|41826300|FG006|Dose Level VI|Treatment-related AE|0|||
19494509|NCT02533674|41826301|FG007|Dose Level VI|Treatment-related AE|0|||
19494510|NCT02533674|41826294|FG000|Dose Level VII|Progressive disease|0|||
19494511|NCT02533674|41826295|FG001|Dose Level VII|Progressive disease|0|||
19494512|NCT02533674|41826296|FG002|Dose Level VII|Progressive disease|0|||
19494513|NCT02533674|41826297|FG003|Dose Level VII|Progressive disease|0|||
19494514|NCT02533674|41826298|FG004|Dose Level VII|Progressive disease|0|||
19494515|NCT02533674|41826299|FG005|Dose Level VII|Progressive disease|0|||
19494516|NCT02533674|41826300|FG006|Dose Level VII|Progressive disease|10|||
19494517|NCT02533674|41826301|FG007|Dose Level VII|Progressive disease|0|||
19494518|NCT02533674|41826294|FG000|Dose Level VII|Withdrawal by Subject|0|||
19494519|NCT02533674|41826295|FG001|Dose Level VII|Withdrawal by Subject|0|||
19494520|NCT02533674|41826296|FG002|Dose Level VII|Withdrawal by Subject|0|||
19494521|NCT02533674|41826297|FG003|Dose Level VII|Withdrawal by Subject|0|||
19494522|NCT02533674|41826298|FG004|Dose Level VII|Withdrawal by Subject|0|||
19494523|NCT02533674|41826299|FG005|Dose Level VII|Withdrawal by Subject|0|||
19494524|NCT02533674|41826300|FG006|Dose Level VII|Withdrawal by Subject|3|||
19494525|NCT02533674|41826301|FG007|Dose Level VII|Withdrawal by Subject|0|||
19494526|NCT02533674|41826294|FG000|Dose Level VII|Treatment-related AE|0|||
19494527|NCT02533674|41826295|FG001|Dose Level VII|Treatment-related AE|0|||
19494528|NCT02533674|41826296|FG002|Dose Level VII|Treatment-related AE|0|||
19494529|NCT02533674|41826297|FG003|Dose Level VII|Treatment-related AE|0|||
19494530|NCT02533674|41826298|FG004|Dose Level VII|Treatment-related AE|0|||
19494531|NCT02533674|41826299|FG005|Dose Level VII|Treatment-related AE|0|||
19494532|NCT02533674|41826300|FG006|Dose Level VII|Treatment-related AE|1|||
19494533|NCT02533674|41826301|FG007|Dose Level VII|Treatment-related AE|0|||
19494534|NCT02533674|41826294|FG000|Dose Level VII|Death|0|||
19494535|NCT02533674|41826295|FG001|Dose Level VII|Death|0|||
19494536|NCT02533674|41826296|FG002|Dose Level VII|Death|0|||
19494537|NCT02533674|41826297|FG003|Dose Level VII|Death|0|||
19494538|NCT02533674|41826298|FG004|Dose Level VII|Death|0|||
19494539|NCT02533674|41826299|FG005|Dose Level VII|Death|0|||
19494540|NCT02533674|41826300|FG006|Dose Level VII|Death|2|||
19494541|NCT02533674|41826301|FG007|Dose Level VII|Death|0|||
19494542|NCT02533674|41826294|FG000|Dose Level VIII|Progressive disease|0|||
19494543|NCT02533674|41826295|FG001|Dose Level VIII|Progressive disease|0|||
19494544|NCT02533674|41826296|FG002|Dose Level VIII|Progressive disease|0|||
19494545|NCT02533674|41826297|FG003|Dose Level VIII|Progressive disease|0|||
19494546|NCT02533674|41826298|FG004|Dose Level VIII|Progressive disease|0|||
19373682|NCT02668185|41614852|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
19494547|NCT02533674|41826299|FG005|Dose Level VIII|Progressive disease|0|||
19494548|NCT02533674|41826300|FG006|Dose Level VIII|Progressive disease|0|||
19494549|NCT02533674|41826301|FG007|Dose Level VIII|Progressive disease|3|||
19494550|NCT02533674|41826294|FG000|Dose Level VIII|Withdrawal by Subject|0|||
19494551|NCT02533674|41826295|FG001|Dose Level VIII|Withdrawal by Subject|0|||
19494552|NCT02533674|41826296|FG002|Dose Level VIII|Withdrawal by Subject|0|||
19494553|NCT02533674|41826297|FG003|Dose Level VIII|Withdrawal by Subject|0|||
19494554|NCT02533674|41826298|FG004|Dose Level VIII|Withdrawal by Subject|0|||
19494555|NCT02533674|41826299|FG005|Dose Level VIII|Withdrawal by Subject|0|||
19494556|NCT02533674|41826300|FG006|Dose Level VIII|Withdrawal by Subject|0|||
19494557|NCT02533674|41826301|FG007|Dose Level VIII|Withdrawal by Subject|1|||
19494558|NCT02533674|41826294|FG000|Dose Level VIII|Treatment-related AE|0|||
19494559|NCT02533674|41826295|FG001|Dose Level VIII|Treatment-related AE|0|||
19494560|NCT02533674|41826296|FG002|Dose Level VIII|Treatment-related AE|0|||
19494561|NCT02533674|41826297|FG003|Dose Level VIII|Treatment-related AE|0|||
19494562|NCT02533674|41826298|FG004|Dose Level VIII|Treatment-related AE|0|||
19494563|NCT02533674|41826299|FG005|Dose Level VIII|Treatment-related AE|0|||
19494564|NCT02533674|41826300|FG006|Dose Level VIII|Treatment-related AE|0|||
19494565|NCT02533674|41826301|FG007|Dose Level VIII|Treatment-related AE|1|||
19494566|NCT02533674|41826294|FG000|Dose Level VIII|Never treated|0|||
19494567|NCT02533674|41826295|FG001|Dose Level VIII|Never treated|0|||
19494568|NCT02533674|41826296|FG002|Dose Level VIII|Never treated|0|||
19494569|NCT02533674|41826297|FG003|Dose Level VIII|Never treated|0|||
19494570|NCT02533674|41826298|FG004|Dose Level VIII|Never treated|0|||
19494571|NCT02533674|41826299|FG005|Dose Level VIII|Never treated|0|||
19494572|NCT02533674|41826300|FG006|Dose Level VIII|Never treated|0|||
19494573|NCT02533674|41826301|FG007|Dose Level VIII|Never treated|1|||
19494574|NCT02540850|41826322|FG000|Overall Study|Lost to Follow-up|69|||
19494575|NCT02540850|41826323|FG001|Overall Study|Lost to Follow-up|66|||
19494576|NCT02540850|41826324|FG002|Overall Study|Lost to Follow-up|34|||
19494577|NCT01662024|41826332|FG000|Overall Study|Pregnancy|2|||
19494578|NCT01662024|41826332|FG000|Overall Study|Withdrawal by Subject|3|||
19494579|NCT02544750|41826414|FG000|Overall Study|Physician Decision|3|||
19494580|NCT02544750|41826415|FG001|Overall Study|Physician Decision|1|||
19494581|NCT02544750|41826414|FG000|Overall Study|Other reasons|69|||
19494582|NCT02544750|41826415|FG001|Overall Study|Other reasons|39|||
19494583|NCT02544750|41826414|FG000|Overall Study|Met withdrawal criteria|2|||
19494584|NCT02544750|41826415|FG001|Overall Study|Met withdrawal criteria|2|||
19494585|NCT02544750|41826414|FG000|Overall Study|Transition To Commercial Product|1|||
19494586|NCT02544750|41826415|FG001|Overall Study|Transition To Commercial Product|0|||
19494587|NCT02544750|41826414|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
19494588|NCT02544750|41826415|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
19494589|NCT02544750|41826414|FG000|Overall Study|Adverse Event|8|||
19494590|NCT02544750|41826415|FG001|Overall Study|Adverse Event|10|||
19494591|NCT02544750|41826414|FG000|Overall Study|Withdrawal by Subject|10|||
19494592|NCT02544750|41826415|FG001|Overall Study|Withdrawal by Subject|4|||
19494593|NCT02544750|41826414|FG000|Overall Study|Lost to Follow-up|1|||
19494594|NCT02544750|41826415|FG001|Overall Study|Lost to Follow-up|0|||
19494595|NCT02540538|41826461|FG000|Overall Study|Pregnancy|0|||
19494596|NCT02540538|41826462|FG001|Overall Study|Pregnancy|1|||
19494597|NCT02540538|41826463|FG002|Overall Study|Pregnancy|0|||
19494598|NCT04697056|41826496|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
19494599|NCT04697056|41826497|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
19494600|NCT02181738|41826621|FG000|Overall Study|Death|1|||
19494601|NCT02181738|41826622|FG001|Overall Study|Death|1|||
19494602|NCT02181738|41826623|FG002|Overall Study|Death|6|||
19494603|NCT02181738|41826624|FG003|Overall Study|Death|1|||
19494604|NCT02181738|41826621|FG000|Overall Study|Subject Withdrew Consent|1|||
19494605|NCT02181738|41826622|FG001|Overall Study|Subject Withdrew Consent|3|||
19494606|NCT02181738|41826623|FG002|Overall Study|Subject Withdrew Consent|2|||
19494607|NCT02181738|41826624|FG003|Overall Study|Subject Withdrew Consent|1|||
19494608|NCT02181738|41826621|FG000|Overall Study|Lost to Follow-up|0|||
19494609|NCT02181738|41826622|FG001|Overall Study|Lost to Follow-up|4|||
19494610|NCT02181738|41826623|FG002|Overall Study|Lost to Follow-up|2|||
19494611|NCT02181738|41826624|FG003|Overall Study|Lost to Follow-up|0|||
19494612|NCT02181738|41826621|FG000|Overall Study|Patient Return to Home Country|0|||
19494613|NCT02181738|41826622|FG001|Overall Study|Patient Return to Home Country|1|||
19494614|NCT02181738|41826623|FG002|Overall Study|Patient Return to Home Country|0|||
19494615|NCT02181738|41826624|FG003|Overall Study|Patient Return to Home Country|0|||
19494616|NCT03493282|41826655|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
19494617|NCT03493282|41826656|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
19494618|NCT03493282|41826657|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
19494619|NCT03493282|41826655|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
19494620|NCT03493282|41826656|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
19494621|NCT03493282|41826657|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
19494622|NCT02532972|41826671|FG000|Overall Study|Withdrawal by Subject|1|||
19494623|NCT03187834|41826724|FG000|Overall Study|Lost to Follow-up|0|||
19494624|NCT03187834|41826725|FG001|Overall Study|Lost to Follow-up|1|||
19494625|NCT03187834|41826726|FG002|Overall Study|Lost to Follow-up|2|||
19494626|NCT03187834|41826727|FG003|Overall Study|Lost to Follow-up|2|||
19494627|NCT03187834|41826724|FG000|Overall Study|Had invalid anthropometric measurements|5|||
19613323|NCT00887822|42062194|FG000|Overall Study|Randomized but not treated|0|||
19494628|NCT03187834|41826725|FG001|Overall Study|Had invalid anthropometric measurements|3|||
19494629|NCT03187834|41826726|FG002|Overall Study|Had invalid anthropometric measurements|4|||
19613324|NCT00887822|42062195|FG001|Overall Study|Randomized but not treated|1|||
19494630|NCT03187834|41826727|FG003|Overall Study|Had invalid anthropometric measurements|2|||
19494631|NCT03713944|41826880|FG000|Study Treatment|Patient non-compliance|1|||
19494632|NCT03713944|41826880|FG000|Study Treatment|Alternative Cancer Therapy|3|||
19494633|NCT03713944|41826880|FG000|Study Treatment|Disease Progression|18|||
19494634|NCT03713944|41826880|FG000|Study Treatment|AE/Side Effects/Complications|2|||
19494635|NCT03713944|41826880|FG000|Study Treatment|Death|2|||
19494636|NCT03713944|41826880|FG000|Study Treatment|Withdrawal by Subject|1|||
19494637|NCT03713944|41826880|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
19494638|NCT03713944|41826880|FG000|Study Treatment|Symptomatic Deterioration|2|||
19494639|NCT03713944|41826880|FG000|Follow up|Withdrawal by Subject|2|||
19494640|NCT03713944|41826880|FG000|Follow up|Death|11|||
19494641|NCT03713944|41826880|FG000|Follow up|Study Terminated|3|||
19494642|NCT02325154|41826980|FG000|Overall Study|Physician Decision|1|||
19494643|NCT00493870|41827107|FG000|Overall Study|Lost to Follow-up|12|||
19494644|NCT00493870|41827108|FG001|Overall Study|Lost to Follow-up|15|||
19494645|NCT04439344|41827393|FG000|Overall Study|Never started threapy|3|||
19494646|NCT04439344|41827393|FG000|Overall Study|Ineligible|3|||
19494647|NCT04439344|41827393|FG000|Overall Study|Adverse Event|13|||
19494648|NCT04439344|41827393|FG000|Overall Study|Death|2|||
19494649|NCT04439344|41827393|FG000|Overall Study|Disease progression|29|||
19494650|NCT04439344|41827393|FG000|Overall Study|Withdrawal by Subject|2|||
19494651|NCT04439344|41827393|FG000|Overall Study|Alternative therapy|1|||
19494652|NCT04439279|41827397|FG000|Overall Study|Adverse Event|7|||
19494653|NCT04439279|41827397|FG000|Overall Study|Death|4|||
19494654|NCT04439279|41827397|FG000|Overall Study|Disease progression|17|||
19494655|NCT04439279|41827397|FG000|Overall Study|Complicating disease|3|||
19494656|NCT04439279|41827397|FG000|Overall Study|Withdrawal by Subject|2|||
19494657|NCT04439279|41827397|FG000|Overall Study|Ineligible|1|||
19494658|NCT04439279|41827397|FG000|Overall Study|Treatment still ongoing|1|||
19494659|NCT04439175|41827401|FG000|Overall Study|Never started treatment|4|||
19494660|NCT04439175|41827401|FG000|Overall Study|Ineligible|5|||
19494661|NCT04439175|41827401|FG000|Overall Study|Adverse Event|6|||
19494662|NCT04439175|41827401|FG000|Overall Study|Death|4|||
19494663|NCT04439175|41827401|FG000|Overall Study|Disease progression|44|||
19494664|NCT04439175|41827401|FG000|Overall Study|Withdrawal by Subject|4|||
19494665|NCT04439175|41827401|FG000|Overall Study|Alternative Therapy|1|||
19494666|NCT04439175|41827401|FG000|Overall Study|Other|2|||
19494667|NCT04232215|41827416|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
19494668|NCT04232215|41827417|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
19494669|NCT03951753|41827430|FG000|Overall Study|Adverse Event|1|||
19494670|NCT03951753|41827431|FG001|Overall Study|Adverse Event|0|||
19494671|NCT03951753|41827432|FG002|Overall Study|Adverse Event|3|||
19494672|NCT03951753|41827430|FG000|Overall Study|Withdrawal by Subject|3|||
19494673|NCT03951753|41827431|FG001|Overall Study|Withdrawal by Subject|1|||
19494674|NCT03951753|41827432|FG002|Overall Study|Withdrawal by Subject|0|||
19494675|NCT03951753|41827430|FG000|Overall Study|Lost to Follow-up|0|||
19494676|NCT03951753|41827431|FG001|Overall Study|Lost to Follow-up|0|||
19494677|NCT03951753|41827432|FG002|Overall Study|Lost to Follow-up|1|||
19494678|NCT03941964|41827442|FG000|Overall Study|Adverse Event|1|||
19494679|NCT03941964|41827443|FG001|Overall Study|Adverse Event|8|||
19494680|NCT03941964|41827442|FG000|Overall Study|Progressive disease|7|||
19494681|NCT03941964|41827443|FG001|Overall Study|Progressive disease|3|||
19494682|NCT03941964|41827442|FG000|Overall Study|Lack of Efficacy|0|||
19494683|NCT03941964|41827443|FG001|Overall Study|Lack of Efficacy|1|||
19494684|NCT03941964|41827442|FG000|Overall Study|Death|3|||
19494685|NCT03941964|41827443|FG001|Overall Study|Death|1|||
19494686|NCT03941964|41827442|FG000|Overall Study|Withdrew consent|1|||
19494687|NCT03941964|41827443|FG001|Overall Study|Withdrew consent|3|||
19494688|NCT03941964|41827442|FG000|Overall Study|Physician Decision|9|||
19494689|NCT03941964|41827443|FG001|Overall Study|Physician Decision|2|||
19494690|NCT03941964|41827442|FG000|Overall Study|Other, not specified|2|||
19494691|NCT03941964|41827443|FG001|Overall Study|Other, not specified|1|||
19494692|NCT03837509|41827473|FG000|Phase 1|Death|5|||
19494693|NCT03837509|41827474|FG001|Phase 1|Death|2|||
19494694|NCT03837509|41827475|FG002|Phase 1|Death|0|||
19494695|NCT03837509|41827476|FG003|Phase 1|Death|0|||
19494696|NCT03837509|41827477|FG004|Phase 1|Death|0|||
19494697|NCT03837509|41827473|FG000|Phase 2|Death|0|||
19494698|NCT03837509|41827474|FG001|Phase 2|Death|0|||
19494699|NCT03837509|41827475|FG002|Phase 2|Death|0|||
19494700|NCT03837509|41827476|FG003|Phase 2|Death|1|||
19494701|NCT03837509|41827477|FG004|Phase 2|Death|1|||
19494702|NCT03822117|41827497|FG000|Overall Study|Death|18|||
19494703|NCT03822117|41827498|FG001|Overall Study|Death|17|||
19494704|NCT03822117|41827499|FG002|Overall Study|Death|12|||
19494705|NCT03822117|41827500|FG003|Overall Study|Death|4|||
19494706|NCT03822117|41827497|FG000|Overall Study|Lost to Follow-up|1|||
19494707|NCT03822117|41827498|FG001|Overall Study|Lost to Follow-up|2|||
19494708|NCT03822117|41827499|FG002|Overall Study|Lost to Follow-up|3|||
19494709|NCT03822117|41827500|FG003|Overall Study|Lost to Follow-up|0|||
19494710|NCT03822117|41827497|FG000|Overall Study|Study Terminated by Sponsor|25|||
19494711|NCT03822117|41827498|FG001|Overall Study|Study Terminated by Sponsor|11|||
19494712|NCT03822117|41827499|FG002|Overall Study|Study Terminated by Sponsor|6|||
19494713|NCT03822117|41827500|FG003|Overall Study|Study Terminated by Sponsor|0|||
19494714|NCT03822117|41827497|FG000|Overall Study|Withdrawal by Subject|4|||
19494715|NCT03822117|41827498|FG001|Overall Study|Withdrawal by Subject|0|||
19494716|NCT03822117|41827499|FG002|Overall Study|Withdrawal by Subject|3|||
19494717|NCT03822117|41827500|FG003|Overall Study|Withdrawal by Subject|0|||
19494718|NCT03822117|41827497|FG000|Overall Study|Disease Progression|1|||
19494719|NCT03822117|41827498|FG001|Overall Study|Disease Progression|2|||
19494720|NCT03822117|41827499|FG002|Overall Study|Disease Progression|1|||
19494721|NCT03822117|41827500|FG003|Overall Study|Disease Progression|0|||
19494722|NCT03822117|41827497|FG000|Overall Study|Never Returned to Hospital|0|||
19494723|NCT03822117|41827498|FG001|Overall Study|Never Returned to Hospital|0|||
19494724|NCT03822117|41827499|FG002|Overall Study|Never Returned to Hospital|1|||
19494725|NCT03822117|41827500|FG003|Overall Study|Never Returned to Hospital|0|||
19494726|NCT03497897|41827514|FG000|Overall Study|Adverse Event|1|||
19494727|NCT03497897|41827515|FG001|Overall Study|Adverse Event|1|||
19494728|NCT03497897|41827516|FG002|Overall Study|Adverse Event|1|||
19494729|NCT03497897|41827514|FG000|Overall Study|Lost to Follow-up|2|||
19494730|NCT03497897|41827515|FG001|Overall Study|Lost to Follow-up|0|||
19494731|NCT03497897|41827516|FG002|Overall Study|Lost to Follow-up|2|||
19494732|NCT03497897|41827514|FG000|Overall Study|Physician Decision|1|||
19494733|NCT03497897|41827515|FG001|Overall Study|Physician Decision|0|||
19494734|NCT03497897|41827516|FG002|Overall Study|Physician Decision|0|||
19494735|NCT03497897|41827514|FG000|Overall Study|Subject/Guardian Decision|2|||
19494736|NCT03497897|41827515|FG001|Overall Study|Subject/Guardian Decision|1|||
19494737|NCT03497897|41827516|FG002|Overall Study|Subject/Guardian Decision|3|||
19494738|NCT03428217|41827527|FG000|Overall Study|Death|89|||
19494739|NCT03428217|41827528|FG001|Overall Study|Death|93|||
19494740|NCT03428217|41827527|FG000|Overall Study|Withdrawal by Subject|8|||
19494741|NCT03428217|41827528|FG001|Overall Study|Withdrawal by Subject|7|||
19494742|NCT03428217|41827527|FG000|Overall Study|Lost to Follow-up|1|||
19494743|NCT03428217|41827528|FG001|Overall Study|Lost to Follow-up|3|||
19494744|NCT03428217|41827527|FG000|Overall Study|Study terminated by sponsor|124|||
19494745|NCT03428217|41827528|FG001|Overall Study|Study terminated by sponsor|118|||
19494746|NCT03428217|41827527|FG000|Overall Study|Other, Not Specified|1|||
19494747|NCT03428217|41827528|FG001|Overall Study|Other, Not Specified|0|||
19494748|NCT03189719|41827538|FG000|Overall Study|Death|260|||
19494749|NCT03189719|41827539|FG001|Overall Study|Death|308|||
19494750|NCT03189719|41827538|FG000|Overall Study|Withdrawal by Subject|5|||
19494751|NCT03189719|41827539|FG001|Overall Study|Withdrawal by Subject|3|||
19494752|NCT03189719|41827538|FG000|Overall Study|Ongoing in Study|108|||
19494753|NCT03189719|41827539|FG001|Overall Study|Ongoing in Study|65|||
19494754|NCT02969525|41827550|FG000|Double-Blind Period|Adverse Event|0|||
19494755|NCT02969525|41827551|FG001|Double-Blind Period|Adverse Event|0|||
19494756|NCT02969525|41827552|FG002|Double-Blind Period|Adverse Event|1|||
19494757|NCT02969525|41827553|FG003|Double-Blind Period|Adverse Event|1|||
19494758|NCT02969525|41827554|FG004|Double-Blind Period|Adverse Event|0|||
19494759|NCT02969525|41827555|FG005|Double-Blind Period|Adverse Event|0|||
19494760|NCT02969525|41827556|FG006|Double-Blind Period|Adverse Event|0|||
19494761|NCT02969525|41827557|FG007|Double-Blind Period|Adverse Event|0|||
19494762|NCT02969525|41827558|FG008|Double-Blind Period|Adverse Event|0|||
19494763|NCT02969525|41827559|FG009|Double-Blind Period|Adverse Event|0|||
19494764|NCT02969525|41827560|FG010|Double-Blind Period|Adverse Event|0|||
19494765|NCT02969525|41827561|FG011|Double-Blind Period|Adverse Event|0|||
19494766|NCT02969525|41827550|FG000|Double-Blind Period|LOW EGFR|0|||
19494767|NCT02969525|41827551|FG001|Double-Blind Period|LOW EGFR|0|||
19494768|NCT02969525|41827552|FG002|Double-Blind Period|LOW EGFR|0|||
19494769|NCT02969525|41827553|FG003|Double-Blind Period|LOW EGFR|1|||
19494770|NCT02969525|41827554|FG004|Double-Blind Period|LOW EGFR|0|||
19494771|NCT02969525|41827555|FG005|Double-Blind Period|LOW EGFR|0|||
19494772|NCT02969525|41827556|FG006|Double-Blind Period|LOW EGFR|0|||
19494773|NCT02969525|41827557|FG007|Double-Blind Period|LOW EGFR|0|||
19494774|NCT02969525|41827558|FG008|Double-Blind Period|LOW EGFR|0|||
19373683|NCT02668185|41614851|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
19494775|NCT02969525|41827559|FG009|Double-Blind Period|LOW EGFR|0|||
19494776|NCT02969525|41827560|FG010|Double-Blind Period|LOW EGFR|0|||
19494777|NCT02969525|41827561|FG011|Double-Blind Period|LOW EGFR|0|||
19494778|NCT02969525|41827550|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
19494779|NCT02969525|41827551|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494780|NCT02969525|41827552|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494781|NCT02969525|41827553|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
19494782|NCT02969525|41827554|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494783|NCT02969525|41827555|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494784|NCT02969525|41827556|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494785|NCT02969525|41827557|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494786|NCT02969525|41827558|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494787|NCT02969525|41827559|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494788|NCT02969525|41827560|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494789|NCT02969525|41827561|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
19494790|NCT02969525|41827550|FG000|Dose-Blind Period|Adverse Event|0|||
19494791|NCT02969525|41827551|FG001|Dose-Blind Period|Adverse Event|0|||
19494792|NCT02969525|41827552|FG002|Dose-Blind Period|Adverse Event|0|||
19494793|NCT02969525|41827553|FG003|Dose-Blind Period|Adverse Event|0|||
19494794|NCT02969525|41827554|FG004|Dose-Blind Period|Adverse Event|0|||
19494795|NCT02969525|41827555|FG005|Dose-Blind Period|Adverse Event|0|||
19494796|NCT02969525|41827556|FG006|Dose-Blind Period|Adverse Event|0|||
19494797|NCT02969525|41827557|FG007|Dose-Blind Period|Adverse Event|0|||
19494798|NCT02969525|41827558|FG008|Dose-Blind Period|Adverse Event|0|||
19494799|NCT02969525|41827559|FG009|Dose-Blind Period|Adverse Event|1|||
19494800|NCT02969525|41827560|FG010|Dose-Blind Period|Adverse Event|1|||
19494801|NCT02969525|41827561|FG011|Dose-Blind Period|Adverse Event|1|||
19494802|NCT02969525|41827550|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
19494803|NCT02969525|41827551|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
19494804|NCT02969525|41827552|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
19494805|NCT02969525|41827553|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
19494806|NCT02969525|41827554|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
19494807|NCT02969525|41827555|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
19494808|NCT02969525|41827556|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
19494809|NCT02969525|41827557|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
19494810|NCT02969525|41827558|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
19494811|NCT02969525|41827559|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
19494812|NCT02969525|41827560|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
19494813|NCT02969525|41827561|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
19494814|NCT02969525|41827550|FG000|Dose-Blind Period|Non-cooperating patient|0|||
19494815|NCT02969525|41827551|FG001|Dose-Blind Period|Non-cooperating patient|0|||
19494816|NCT02969525|41827552|FG002|Dose-Blind Period|Non-cooperating patient|0|||
19494817|NCT02969525|41827553|FG003|Dose-Blind Period|Non-cooperating patient|0|||
19494818|NCT02969525|41827554|FG004|Dose-Blind Period|Non-cooperating patient|0|||
19494819|NCT02969525|41827555|FG005|Dose-Blind Period|Non-cooperating patient|0|||
19494820|NCT02969525|41827556|FG006|Dose-Blind Period|Non-cooperating patient|0|||
19494821|NCT02969525|41827557|FG007|Dose-Blind Period|Non-cooperating patient|0|||
19494822|NCT02969525|41827558|FG008|Dose-Blind Period|Non-cooperating patient|0|||
19494823|NCT02969525|41827559|FG009|Dose-Blind Period|Non-cooperating patient|0|||
19494824|NCT02969525|41827560|FG010|Dose-Blind Period|Non-cooperating patient|0|||
19494825|NCT02969525|41827561|FG011|Dose-Blind Period|Non-cooperating patient|1|||
19494826|NCT02969525|41827550|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494827|NCT02969525|41827551|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494828|NCT02969525|41827552|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494829|NCT02969525|41827553|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494830|NCT02969525|41827554|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494831|NCT02969525|41827555|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494832|NCT02969525|41827556|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494833|NCT02969525|41827557|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494834|NCT02969525|41827558|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494835|NCT02969525|41827559|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494836|NCT02969525|41827560|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
19494837|NCT02969525|41827561|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
19494838|NCT02399813|41827599|FG000|Overall Study|Progressive Disease-Radiographic|2|||
19494839|NCT02399813|41827599|FG000|Overall Study|Death|20|||
19494840|NCT02399813|41827599|FG000|Overall Study|Withdrawal by Subject|3|||
19494841|NCT02399813|41827599|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
19494842|NCT02399813|41827599|FG000|Overall Study|Lost to Follow-up|2|||
19494843|NCT02399813|41827599|FG000|Overall Study|Other than specified|5|||
19494844|NCT02291055|41827608|FG000|Overall Study|Death|2|||
19494845|NCT02291055|41827609|FG001|Overall Study|Death|2|||
19494846|NCT02291055|41827610|FG002|Overall Study|Death|5|||
19494847|NCT02291055|41827611|FG003|Overall Study|Death|8|||
19494848|NCT02291055|41827612|FG004|Overall Study|Death|12|||
19494849|NCT02291055|41827608|FG000|Overall Study|Lost to Follow-up|0|||
19494850|NCT02291055|41827609|FG001|Overall Study|Lost to Follow-up|0|||
19494851|NCT02291055|41827610|FG002|Overall Study|Lost to Follow-up|0|||
19494852|NCT02291055|41827611|FG003|Overall Study|Lost to Follow-up|1|||
19494853|NCT02291055|41827612|FG004|Overall Study|Lost to Follow-up|2|||
19494854|NCT02291055|41827608|FG000|Overall Study|Withdrawal by Subject|3|||
19494855|NCT02291055|41827609|FG001|Overall Study|Withdrawal by Subject|1|||
19494856|NCT02291055|41827610|FG002|Overall Study|Withdrawal by Subject|1|||
19494857|NCT02291055|41827611|FG003|Overall Study|Withdrawal by Subject|5|||
19494858|NCT02291055|41827612|FG004|Overall Study|Withdrawal by Subject|10|||
19494859|NCT02291055|41827608|FG000|Overall Study|Progressive Disease|0|||
19494860|NCT02291055|41827609|FG001|Overall Study|Progressive Disease|0|||
19393711|NCT00790933|41637562|FG004|Overall Study|Lost to Follow-up|15|||
19494861|NCT02291055|41827610|FG002|Overall Study|Progressive Disease|1|||
19494862|NCT02291055|41827611|FG003|Overall Study|Progressive Disease|4|||
19494863|NCT02291055|41827612|FG004|Overall Study|Progressive Disease|2|||
19494864|NCT02291055|41827608|FG000|Overall Study|Study Terminated by Sponsor|0|||
19494865|NCT02291055|41827609|FG001|Overall Study|Study Terminated by Sponsor|0|||
19494866|NCT02291055|41827610|FG002|Overall Study|Study Terminated by Sponsor|0|||
19494867|NCT02291055|41827611|FG003|Overall Study|Study Terminated by Sponsor|5|||
19494868|NCT02291055|41827612|FG004|Overall Study|Study Terminated by Sponsor|1|||
19494869|NCT02291055|41827608|FG000|Overall Study|Other|0|||
19494870|NCT02291055|41827609|FG001|Overall Study|Other|2|||
19494871|NCT02291055|41827610|FG002|Overall Study|Other|1|||
19494872|NCT02291055|41827611|FG003|Overall Study|Other|4|||
19494873|NCT02291055|41827612|FG004|Overall Study|Other|0|||
19494874|NCT01970865|41827645|FG000|Overall Study|Death|3|||
19494875|NCT01970865|41827646|FG001|Overall Study|Death|1|||
19494876|NCT01970865|41827647|FG002|Overall Study|Death|3|||
19494877|NCT01970865|41827648|FG003|Overall Study|Death|4|||
19494878|NCT01970865|41827649|FG004|Overall Study|Death|6|||
19494879|NCT01970865|41827650|FG005|Overall Study|Death|3|||
19494880|NCT01970865|41827651|FG006|Overall Study|Death|1|||
19494881|NCT01970865|41827652|FG007|Overall Study|Death|3|||
19494882|NCT01970865|41827653|FG008|Overall Study|Death|2|||
19494883|NCT01970865|41827654|FG009|Overall Study|Death|1|||
19494884|NCT01970865|41827655|FG010|Overall Study|Death|1|||
19494885|NCT01970865|41827656|FG011|Overall Study|Death|4|||
19494886|NCT01970865|41827657|FG012|Overall Study|Death|14|||
19494887|NCT01970865|41827658|FG013|Overall Study|Death|19|||
19494888|NCT01970865|41827659|FG014|Overall Study|Death|15|||
19494889|NCT01970865|41827660|FG015|Overall Study|Death|10|||
19494890|NCT01970865|41827661|FG016|Overall Study|Death|1|||
19494891|NCT01970865|41827645|FG000|Overall Study|Lost to Follow-up|0|||
19494892|NCT01970865|41827646|FG001|Overall Study|Lost to Follow-up|0|||
19494893|NCT01970865|41827647|FG002|Overall Study|Lost to Follow-up|0|||
19494894|NCT01970865|41827648|FG003|Overall Study|Lost to Follow-up|1|||
19494895|NCT01970865|41827649|FG004|Overall Study|Lost to Follow-up|1|||
19494896|NCT01970865|41827650|FG005|Overall Study|Lost to Follow-up|0|||
19494897|NCT01970865|41827651|FG006|Overall Study|Lost to Follow-up|0|||
19494898|NCT01970865|41827652|FG007|Overall Study|Lost to Follow-up|0|||
19494899|NCT01970865|41827653|FG008|Overall Study|Lost to Follow-up|0|||
19494900|NCT01970865|41827654|FG009|Overall Study|Lost to Follow-up|0|||
19494901|NCT01970865|41827655|FG010|Overall Study|Lost to Follow-up|0|||
19494902|NCT01970865|41827656|FG011|Overall Study|Lost to Follow-up|0|||
19494903|NCT01970865|41827657|FG012|Overall Study|Lost to Follow-up|1|||
19494904|NCT01970865|41827658|FG013|Overall Study|Lost to Follow-up|0|||
19494905|NCT01970865|41827659|FG014|Overall Study|Lost to Follow-up|0|||
19494906|NCT01970865|41827660|FG015|Overall Study|Lost to Follow-up|0|||
19494907|NCT01970865|41827661|FG016|Overall Study|Lost to Follow-up|0|||
19494908|NCT01970865|41827645|FG000|Overall Study|Withdrawal by Subject|0|||
19494909|NCT01970865|41827646|FG001|Overall Study|Withdrawal by Subject|0|||
19494910|NCT01970865|41827647|FG002|Overall Study|Withdrawal by Subject|0|||
19494911|NCT01970865|41827648|FG003|Overall Study|Withdrawal by Subject|1|||
19494912|NCT01970865|41827649|FG004|Overall Study|Withdrawal by Subject|2|||
19494913|NCT01970865|41827650|FG005|Overall Study|Withdrawal by Subject|0|||
19494914|NCT01970865|41827651|FG006|Overall Study|Withdrawal by Subject|0|||
19494915|NCT01970865|41827652|FG007|Overall Study|Withdrawal by Subject|0|||
19494916|NCT01970865|41827653|FG008|Overall Study|Withdrawal by Subject|0|||
19494917|NCT01970865|41827654|FG009|Overall Study|Withdrawal by Subject|0|||
19494918|NCT01970865|41827655|FG010|Overall Study|Withdrawal by Subject|0|||
19494919|NCT01970865|41827656|FG011|Overall Study|Withdrawal by Subject|1|||
19494920|NCT01970865|41827657|FG012|Overall Study|Withdrawal by Subject|2|||
19494921|NCT01970865|41827658|FG013|Overall Study|Withdrawal by Subject|5|||
19494922|NCT01970865|41827659|FG014|Overall Study|Withdrawal by Subject|2|||
19494923|NCT01970865|41827660|FG015|Overall Study|Withdrawal by Subject|7|||
19494924|NCT01970865|41827661|FG016|Overall Study|Withdrawal by Subject|0|||
19494925|NCT01970865|41827645|FG000|Overall Study|Other|0|||
19494926|NCT01970865|41827646|FG001|Overall Study|Other|0|||
19494927|NCT01970865|41827647|FG002|Overall Study|Other|0|||
19494928|NCT01970865|41827648|FG003|Overall Study|Other|1|||
19494929|NCT01970865|41827649|FG004|Overall Study|Other|0|||
19494930|NCT01970865|41827650|FG005|Overall Study|Other|0|||
19494931|NCT01970865|41827651|FG006|Overall Study|Other|0|||
19494932|NCT01970865|41827652|FG007|Overall Study|Other|0|||
19494933|NCT01970865|41827653|FG008|Overall Study|Other|0|||
19494934|NCT01970865|41827654|FG009|Overall Study|Other|0|||
19494935|NCT01970865|41827655|FG010|Overall Study|Other|0|||
19494936|NCT01970865|41827656|FG011|Overall Study|Other|0|||
19494937|NCT01970865|41827657|FG012|Overall Study|Other|0|||
19494938|NCT01970865|41827658|FG013|Overall Study|Other|1|||
19494939|NCT01970865|41827659|FG014|Overall Study|Other|0|||
19494940|NCT01970865|41827660|FG015|Overall Study|Other|1|||
19494941|NCT01970865|41827661|FG016|Overall Study|Other|0|||
19494942|NCT01970865|41827645|FG000|Overall Study|Study ongoing|0|||
19494943|NCT01970865|41827646|FG001|Overall Study|Study ongoing|2|||
19494944|NCT01970865|41827647|FG002|Overall Study|Study ongoing|0|||
19494945|NCT01970865|41827648|FG003|Overall Study|Study ongoing|6|||
19494946|NCT01970865|41827649|FG004|Overall Study|Study ongoing|8|||
19494947|NCT01970865|41827650|FG005|Overall Study|Study ongoing|0|||
19494948|NCT01970865|41827651|FG006|Overall Study|Study ongoing|2|||
19494949|NCT01970865|41827652|FG007|Overall Study|Study ongoing|0|||
19494950|NCT01970865|41827653|FG008|Overall Study|Study ongoing|1|||
19494951|NCT01970865|41827654|FG009|Overall Study|Study ongoing|3|||
19494952|NCT01970865|41827655|FG010|Overall Study|Study ongoing|29|||
19494953|NCT01970865|41827656|FG011|Overall Study|Study ongoing|22|||
19494954|NCT01970865|41827657|FG012|Overall Study|Study ongoing|43|||
19494955|NCT01970865|41827658|FG013|Overall Study|Study ongoing|41|||
19494956|NCT01970865|41827659|FG014|Overall Study|Study ongoing|29|||
19494957|NCT01970865|41827660|FG015|Overall Study|Study ongoing|29|||
19494958|NCT01970865|41827661|FG016|Overall Study|Study ongoing|2|||
19494959|NCT00723697|41827722|FG000|Overall Study|Physician questionnaires not received|2|||
19494960|NCT00723697|41827722|FG000|Overall Study|Missing Informed Consent Form|10|||
19494961|NCT00723697|41827722|FG000|Overall Study|Other exclusion criteria applied|6|||
19494962|NCT00684073|41827729|FG000|Selection|Selection/non-selection criteria|3|||
19494963|NCT00684073|41827729|FG000|Selection|Death|1|||
19494964|NCT00684073|41827729|FG000|Selection|noncompliance|1|||
19494965|NCT00684073|41827729|FG000|Selection|Lost to Follow-up|1|||
19494966|NCT00684073|41827729|FG000|Selection|request of the sponsor|1|||
19494967|NCT00684073|41827729|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
19494968|NCT02539368|41829696|FG000|Overall Study|Death|4|||
19494969|NCT02539368|41829697|FG001|Overall Study|Death|2|||
19494970|NCT02539368|41829698|FG002|Overall Study|Death|1|||
19494971|NCT02539368|41829699|FG003|Overall Study|Death|0|||
19494972|NCT02539368|41829700|FG004|Overall Study|Death|0|||
19494973|NCT02539368|41829696|FG000|Overall Study|Withdrawal by Subject|44|||
19494974|NCT02539368|41829697|FG001|Overall Study|Withdrawal by Subject|35|||
19494975|NCT02539368|41829698|FG002|Overall Study|Withdrawal by Subject|9|||
19494976|NCT02539368|41829699|FG003|Overall Study|Withdrawal by Subject|1|||
19494977|NCT02539368|41829700|FG004|Overall Study|Withdrawal by Subject|3|||
19494978|NCT02539368|41829696|FG000|Overall Study|Physician Decision|49|||
19494979|NCT02539368|41829697|FG001|Overall Study|Physician Decision|15|||
19494980|NCT02539368|41829698|FG002|Overall Study|Physician Decision|7|||
19494981|NCT02539368|41829699|FG003|Overall Study|Physician Decision|0|||
19494982|NCT02539368|41829700|FG004|Overall Study|Physician Decision|2|||
19494983|NCT02539368|41829696|FG000|Overall Study|Lost to Follow-up|96|||
19494984|NCT02539368|41829697|FG001|Overall Study|Lost to Follow-up|21|||
19494985|NCT02539368|41829698|FG002|Overall Study|Lost to Follow-up|16|||
19494986|NCT02539368|41829699|FG003|Overall Study|Lost to Follow-up|4|||
19494987|NCT02539368|41829700|FG004|Overall Study|Lost to Follow-up|3|||
19494988|NCT02539368|41829696|FG000|Overall Study|Adverse Event|44|||
19494989|NCT02539368|41829697|FG001|Overall Study|Adverse Event|5|||
19494990|NCT02539368|41829698|FG002|Overall Study|Adverse Event|9|||
19494991|NCT02539368|41829699|FG003|Overall Study|Adverse Event|0|||
19494992|NCT02539368|41829700|FG004|Overall Study|Adverse Event|3|||
19494993|NCT02539368|41829696|FG000|Overall Study|Participant Non-compliant|13|||
19494994|NCT02539368|41829697|FG001|Overall Study|Participant Non-compliant|2|||
19494995|NCT02539368|41829698|FG002|Overall Study|Participant Non-compliant|1|||
19494996|NCT02539368|41829699|FG003|Overall Study|Participant Non-compliant|1|||
19494997|NCT02539368|41829700|FG004|Overall Study|Participant Non-compliant|0|||
19494998|NCT02539368|41829696|FG000|Overall Study|Other|145|||
19494999|NCT02539368|41829697|FG001|Overall Study|Other|18|||
19495000|NCT02539368|41829698|FG002|Overall Study|Other|24|||
19495001|NCT02539368|41829699|FG003|Overall Study|Other|1|||
19495002|NCT02539368|41829700|FG004|Overall Study|Other|3|||
19495003|NCT02539368|41829696|FG000|Overall Study|Missing|10|||
19495004|NCT02539368|41829697|FG001|Overall Study|Missing|3|||
19495005|NCT02539368|41829698|FG002|Overall Study|Missing|0|||
19495006|NCT02539368|41829699|FG003|Overall Study|Missing|0|||
19495007|NCT02539368|41829700|FG004|Overall Study|Missing|0|||
19495008|NCT02539134|41829853|FG000|Overall Study|Lost to Follow-up|1|||
19495009|NCT02539134|41829854|FG001|Overall Study|Lost to Follow-up|0|||
19495010|NCT02539134|41829855|FG002|Overall Study|Lost to Follow-up|0|||
19495011|NCT02539134|41829856|FG003|Overall Study|Lost to Follow-up|0|||
19495012|NCT02539134|41829857|FG004|Overall Study|Lost to Follow-up|0|||
19495013|NCT02539134|41829858|FG005|Overall Study|Lost to Follow-up|0|||
19495014|NCT02538900|41829962|FG000|Overall Study|Death|2|||
19495015|NCT02538900|41829963|FG001|Overall Study|Death|2|||
19495016|NCT02538900|41829964|FG002|Overall Study|Death|2|||
19495017|NCT02538900|41829962|FG000|Overall Study|Withdrawal by Subject|18|||
19495018|NCT02538900|41829963|FG001|Overall Study|Withdrawal by Subject|16|||
19495019|NCT02538900|41829964|FG002|Overall Study|Withdrawal by Subject|15|||
19495020|NCT02941926|41830274|FG000|Overall Study|Progressive disease|1109|||
19495021|NCT02941926|41830274|FG000|Overall Study|Adverse Event|504|||
19495022|NCT02941926|41830274|FG000|Overall Study|Subject/guardian decision|127|||
19495023|NCT02941926|41830274|FG000|Overall Study|Physician Decision|112|||
19495024|NCT02941926|41830274|FG000|Overall Study|Death|46|||
19495025|NCT02941926|41830274|FG000|Overall Study|Protocol deviation|34|||
19495026|NCT02941926|41830274|FG000|Overall Study|Lost to Follow-up|8|||
19495027|NCT02941926|41830274|FG000|Overall Study|Technical problems|5|||
19495028|NCT01986348|41830459|FG000|Overall Study|Death|8|||
19495029|NCT01986348|41830460|FG001|Overall Study|Death|22|||
19495030|NCT01986348|41830461|FG002|Overall Study|Death|10|||
19495031|NCT01986348|41830462|FG003|Overall Study|Death|21|||
19495032|NCT01986348|41830459|FG000|Overall Study|Lost to Follow-up|0|||
19495033|NCT01986348|41830460|FG001|Overall Study|Lost to Follow-up|0|||
19495034|NCT01986348|41830461|FG002|Overall Study|Lost to Follow-up|0|||
19495035|NCT01986348|41830462|FG003|Overall Study|Lost to Follow-up|2|||
19495036|NCT01986348|41830459|FG000|Overall Study|Physician Decision|0|||
19495037|NCT01986348|41830460|FG001|Overall Study|Physician Decision|0|||
19495038|NCT01986348|41830461|FG002|Overall Study|Physician Decision|0|||
19495039|NCT01986348|41830462|FG003|Overall Study|Physician Decision|1|||
19495040|NCT01986348|41830459|FG000|Overall Study|Progressive Disease|0|||
19495041|NCT01986348|41830460|FG001|Overall Study|Progressive Disease|0|||
19495042|NCT01986348|41830461|FG002|Overall Study|Progressive Disease|2|||
19495043|NCT01986348|41830462|FG003|Overall Study|Progressive Disease|0|||
19495044|NCT01986348|41830459|FG000|Overall Study|Withdrawal by Participant|0|||
19495045|NCT01986348|41830460|FG001|Overall Study|Withdrawal by Participant|1|||
19495046|NCT01986348|41830461|FG002|Overall Study|Withdrawal by Participant|2|||
19495047|NCT01986348|41830462|FG003|Overall Study|Withdrawal by Participant|1|||
19495048|NCT01986348|41830459|FG000|Overall Study|Study Terminated by Sponsor|0|||
19495049|NCT01986348|41830460|FG001|Overall Study|Study Terminated by Sponsor|0|||
19495050|NCT01986348|41830461|FG002|Overall Study|Study Terminated by Sponsor|0|||
19495051|NCT01986348|41830462|FG003|Overall Study|Study Terminated by Sponsor|3|||
19495052|NCT01986348|41830459|FG000|Overall Study|Other-unspecified|0|||
19495053|NCT01986348|41830460|FG001|Overall Study|Other-unspecified|1|||
19495054|NCT01986348|41830461|FG002|Overall Study|Other-unspecified|0|||
19495055|NCT01986348|41830462|FG003|Overall Study|Other-unspecified|2|||
19495056|NCT02543892|41831040|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
19495057|NCT02543892|41831041|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
19495058|NCT02543892|41831042|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
19495059|NCT02543892|41831043|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
19495060|NCT02543892|41831044|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
19495061|NCT02543892|41831045|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
19495062|NCT02543892|41831046|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
19495063|NCT02543892|41831047|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
19495064|NCT02543892|41831040|FG000|Received Vaccination 2|Physician Decision|0|||
19495065|NCT02543892|41831041|FG001|Received Vaccination 2|Physician Decision|0|||
19495066|NCT02543892|41831042|FG002|Received Vaccination 2|Physician Decision|0|||
19495067|NCT02543892|41831043|FG003|Received Vaccination 2|Physician Decision|0|||
19495068|NCT02543892|41831044|FG004|Received Vaccination 2|Physician Decision|0|||
19495069|NCT02543892|41831045|FG005|Received Vaccination 2|Physician Decision|1|||
19495070|NCT02543892|41831046|FG006|Received Vaccination 2|Physician Decision|0|||
19495071|NCT02543892|41831047|FG007|Received Vaccination 2|Physician Decision|0|||
19495072|NCT02543892|41831040|FG000|Received Vaccination 2|Adverse Event|0|||
19495073|NCT02543892|41831041|FG001|Received Vaccination 2|Adverse Event|1|||
19495074|NCT02543892|41831042|FG002|Received Vaccination 2|Adverse Event|0|||
19495075|NCT02543892|41831043|FG003|Received Vaccination 2|Adverse Event|0|||
19495076|NCT02543892|41831044|FG004|Received Vaccination 2|Adverse Event|0|||
19495077|NCT02543892|41831045|FG005|Received Vaccination 2|Adverse Event|0|||
19495078|NCT02543892|41831046|FG006|Received Vaccination 2|Adverse Event|0|||
19495079|NCT02543892|41831047|FG007|Received Vaccination 2|Adverse Event|0|||
19495080|NCT02543892|41831040|FG000|Had Immunology Data|Withdrawal by Subject|0|||
19495081|NCT02543892|41831041|FG001|Had Immunology Data|Withdrawal by Subject|0|||
19495082|NCT02543892|41831042|FG002|Had Immunology Data|Withdrawal by Subject|0|||
19495083|NCT02543892|41831043|FG003|Had Immunology Data|Withdrawal by Subject|0|||
19495084|NCT02543892|41831044|FG004|Had Immunology Data|Withdrawal by Subject|0|||
19495085|NCT02543892|41831045|FG005|Had Immunology Data|Withdrawal by Subject|0|||
19495086|NCT02543892|41831046|FG006|Had Immunology Data|Withdrawal by Subject|1|||
19495087|NCT02543892|41831047|FG007|Had Immunology Data|Withdrawal by Subject|0|||
19495088|NCT02543658|41831128|FG000|Overall Study|Lack of Efficacy|0|||
19495089|NCT02543658|41831129|FG001|Overall Study|Lack of Efficacy|4|||
19495090|NCT01607892|41831884|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
19495091|NCT01607892|41831885|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
19495092|NCT01607892|41831886|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
19495093|NCT01607892|41831887|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
19495094|NCT01607892|41831888|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
19495095|NCT01607892|41831884|FG000|Overall Study|Death|4|||
19495096|NCT01607892|41831885|FG001|Overall Study|Death|2|||
19495097|NCT01607892|41831886|FG002|Overall Study|Death|8|||
19495098|NCT01607892|41831887|FG003|Overall Study|Death|10|||
19495099|NCT01607892|41831888|FG004|Overall Study|Death|3|||
19495100|NCT01607892|41831884|FG000|Overall Study|Investigator discretion|2|||
19495101|NCT01607892|41831885|FG001|Overall Study|Investigator discretion|4|||
19495102|NCT01607892|41831886|FG002|Overall Study|Investigator discretion|4|||
19495103|NCT01607892|41831887|FG003|Overall Study|Investigator discretion|8|||
19495104|NCT01607892|41831888|FG004|Overall Study|Investigator discretion|0|||
19495105|NCT01607892|41831884|FG000|Overall Study|Other treatments became available|1|||
19495106|NCT01607892|41831885|FG001|Overall Study|Other treatments became available|1|||
19495107|NCT01607892|41831886|FG002|Overall Study|Other treatments became available|0|||
19495108|NCT01607892|41831887|FG003|Overall Study|Other treatments became available|0|||
19495109|NCT01607892|41831888|FG004|Overall Study|Other treatments became available|2|||
19495110|NCT01607892|41831884|FG000|Overall Study|Intercurrent illness|1|||
19495111|NCT01607892|41831885|FG001|Overall Study|Intercurrent illness|0|||
19495112|NCT01607892|41831886|FG002|Overall Study|Intercurrent illness|0|||
19495113|NCT01607892|41831887|FG003|Overall Study|Intercurrent illness|3|||
19495114|NCT01607892|41831888|FG004|Overall Study|Intercurrent illness|0|||
19495115|NCT01607892|41831884|FG000|Overall Study|Non-Compliance with study procedures|0|||
19495116|NCT01607892|41831885|FG001|Overall Study|Non-Compliance with study procedures|0|||
19495117|NCT01607892|41831886|FG002|Overall Study|Non-Compliance with study procedures|1|||
19495118|NCT01607892|41831887|FG003|Overall Study|Non-Compliance with study procedures|0|||
19495119|NCT01607892|41831888|FG004|Overall Study|Non-Compliance with study procedures|0|||
19495120|NCT01607892|41831884|FG000|Overall Study|Consent withdrawn by participant|9|||
19495121|NCT01607892|41831885|FG001|Overall Study|Consent withdrawn by participant|4|||
19495122|NCT01607892|41831886|FG002|Overall Study|Consent withdrawn by participant|24|||
19495123|NCT01607892|41831887|FG003|Overall Study|Consent withdrawn by participant|14|||
19495124|NCT01607892|41831888|FG004|Overall Study|Consent withdrawn by participant|4|||
19495125|NCT01607892|41831884|FG000|Overall Study|Disease progression|38|||
19495126|NCT01607892|41831885|FG001|Overall Study|Disease progression|13|||
19495127|NCT01607892|41831886|FG002|Overall Study|Disease progression|37|||
19495128|NCT01607892|41831887|FG003|Overall Study|Disease progression|57|||
19495129|NCT01607892|41831888|FG004|Overall Study|Disease progression|9|||
19495130|NCT01607892|41831884|FG000|Overall Study|Incidence or severity of Adverse events|3|||
19495131|NCT01607892|41831885|FG001|Overall Study|Incidence or severity of Adverse events|3|||
19495132|NCT01607892|41831886|FG002|Overall Study|Incidence or severity of Adverse events|7|||
19495133|NCT01607892|41831887|FG003|Overall Study|Incidence or severity of Adverse events|2|||
19495134|NCT01607892|41831888|FG004|Overall Study|Incidence or severity of Adverse events|6|||
19495135|NCT02530242|41831934|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
19495136|NCT02530242|41831935|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
19495137|NCT02537574|41831959|FG000|Overall Study|Adverse Event|1|||
19495138|NCT02537574|41831960|FG001|Overall Study|Adverse Event|3|||
19495139|NCT02537574|41831961|FG002|Overall Study|Adverse Event|2|||
19495140|NCT02537574|41831959|FG000|Overall Study|Lost to Follow-up|40|||
19495141|NCT02537574|41831960|FG001|Overall Study|Lost to Follow-up|51|||
19495142|NCT02537574|41831961|FG002|Overall Study|Lost to Follow-up|55|||
19495143|NCT02537574|41831959|FG000|Overall Study|Noncompliance with study drug|0|||
19495144|NCT02537574|41831960|FG001|Overall Study|Noncompliance with study drug|1|||
19495145|NCT02537574|41831961|FG002|Overall Study|Noncompliance with study drug|1|||
19495146|NCT02537574|41831959|FG000|Overall Study|Physician Decision|2|||
19495147|NCT02537574|41831960|FG001|Overall Study|Physician Decision|0|||
19495148|NCT02537574|41831961|FG002|Overall Study|Physician Decision|0|||
19495149|NCT02537574|41831959|FG000|Overall Study|Protocol Violation|4|||
19495150|NCT02537574|41831960|FG001|Overall Study|Protocol Violation|2|||
19495151|NCT02537574|41831961|FG002|Overall Study|Protocol Violation|3|||
19495152|NCT02537574|41831959|FG000|Overall Study|Withdrawal by Subject|37|||
19495153|NCT02537574|41831960|FG001|Overall Study|Withdrawal by Subject|27|||
19495154|NCT02537574|41831961|FG002|Overall Study|Withdrawal by Subject|29|||
19495155|NCT02537574|41831959|FG000|Overall Study|Lack of Efficacy|14|||
19495156|NCT02537574|41831960|FG001|Overall Study|Lack of Efficacy|16|||
19495157|NCT02537574|41831961|FG002|Overall Study|Lack of Efficacy|15|||
19495158|NCT02537574|41831959|FG000|Overall Study|Duplicate Patient|1|||
19495159|NCT02537574|41831960|FG001|Overall Study|Duplicate Patient|0|||
19495160|NCT02537574|41831961|FG002|Overall Study|Duplicate Patient|0|||
19495161|NCT02537574|41831959|FG000|Overall Study|Patient not Stable|0|||
19495162|NCT02537574|41831960|FG001|Overall Study|Patient not Stable|1|||
19495163|NCT02537574|41831961|FG002|Overall Study|Patient not Stable|0|||
19495164|NCT02537574|41831959|FG000|Overall Study|Incarceration|0|||
19495165|NCT02537574|41831960|FG001|Overall Study|Incarceration|1|||
19495166|NCT02537574|41831961|FG002|Overall Study|Incarceration|0|||
19495167|NCT02537574|41831959|FG000|Overall Study|Failed Naloxone Challenge|0|||
19495168|NCT02537574|41831960|FG001|Overall Study|Failed Naloxone Challenge|1|||
19495169|NCT02537574|41831961|FG002|Overall Study|Failed Naloxone Challenge|0|||
19495170|NCT02537574|41831959|FG000|Overall Study|Transportation Issues|0|||
19495171|NCT02537574|41831960|FG001|Overall Study|Transportation Issues|0|||
19495172|NCT02537574|41831961|FG002|Overall Study|Transportation Issues|1|||
19495173|NCT02537574|41831959|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
19613325|NCT00951665|42062207|FG000|Phase 1b|Adverse Event|2|||
19704355|NCT00220740|42148647|FG001|Efficacy Period|Protocol Violation|0|||
19495174|NCT02537574|41831960|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
19495175|NCT02537574|41831961|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
19495176|NCT02537574|41831959|FG000|Overall Study|Noncompliance with Protocol|0|||
19495177|NCT02537574|41831960|FG001|Overall Study|Noncompliance with Protocol|0|||
19495178|NCT02537574|41831961|FG002|Overall Study|Noncompliance with Protocol|1|||
19495179|NCT02531802|41832626|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
19495180|NCT02531802|41832627|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
19495181|NCT02531802|41832628|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
19495182|NCT02531802|41832629|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
19495183|NCT02531802|41832630|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
19495184|NCT02531802|41832631|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
19495185|NCT02531802|41832632|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
19495186|NCT02531802|41832633|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
19495187|NCT02531802|41832634|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
19495188|NCT02531802|41832635|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
19495189|NCT02531802|41832636|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
19495190|NCT02531802|41832637|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
19495191|NCT02531802|41832638|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
19495192|NCT02531802|41832639|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
19495193|NCT02531802|41832640|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
19495194|NCT02531802|41832641|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
19495195|NCT02531802|41832642|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
19495196|NCT02531802|41832643|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
19495197|NCT02531802|41832644|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
19495198|NCT02531802|41832645|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
19495199|NCT02531802|41832646|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
19495200|NCT02531802|41832626|FG000|Received Vaccination 2|Physician Decision|0|||
19495201|NCT02531802|41832627|FG001|Received Vaccination 2|Physician Decision|0|||
19495202|NCT02531802|41832628|FG002|Received Vaccination 2|Physician Decision|0|||
19495203|NCT02531802|41832629|FG003|Received Vaccination 2|Physician Decision|0|||
19495204|NCT02531802|41832630|FG004|Received Vaccination 2|Physician Decision|0|||
19495205|NCT02531802|41832631|FG005|Received Vaccination 2|Physician Decision|1|||
19495206|NCT02531802|41832632|FG006|Received Vaccination 2|Physician Decision|0|||
19495207|NCT02531802|41832633|FG007|Received Vaccination 2|Physician Decision|0|||
19495208|NCT02531802|41832634|FG008|Received Vaccination 2|Physician Decision|0|||
19495209|NCT02531802|41832635|FG009|Received Vaccination 2|Physician Decision|2|||
19495210|NCT02531802|41832636|FG010|Received Vaccination 2|Physician Decision|0|||
19495211|NCT02531802|41832637|FG011|Received Vaccination 2|Physician Decision|0|||
19495212|NCT02531802|41832638|FG012|Received Vaccination 2|Physician Decision|0|||
19495213|NCT02531802|41832639|FG013|Received Vaccination 2|Physician Decision|1|||
19495214|NCT02531802|41832640|FG014|Received Vaccination 2|Physician Decision|0|||
19495215|NCT02531802|41832641|FG015|Received Vaccination 2|Physician Decision|0|||
19495216|NCT02531802|41832642|FG016|Received Vaccination 2|Physician Decision|0|||
19495217|NCT02531802|41832643|FG017|Received Vaccination 2|Physician Decision|1|||
19495218|NCT02531802|41832644|FG018|Received Vaccination 2|Physician Decision|0|||
19495219|NCT02531802|41832645|FG019|Received Vaccination 2|Physician Decision|0|||
19495220|NCT02531802|41832646|FG020|Received Vaccination 2|Physician Decision|0|||
19495221|NCT02531802|41832626|FG000|Received Vaccination 2|Adverse Event|0|||
19495222|NCT02531802|41832627|FG001|Received Vaccination 2|Adverse Event|0|||
19495223|NCT02531802|41832628|FG002|Received Vaccination 2|Adverse Event|0|||
19495224|NCT02531802|41832629|FG003|Received Vaccination 2|Adverse Event|0|||
19495225|NCT02531802|41832630|FG004|Received Vaccination 2|Adverse Event|0|||
19495226|NCT02531802|41832631|FG005|Received Vaccination 2|Adverse Event|2|||
19495227|NCT02531802|41832632|FG006|Received Vaccination 2|Adverse Event|0|||
19495228|NCT02531802|41832633|FG007|Received Vaccination 2|Adverse Event|0|||
19495229|NCT02531802|41832634|FG008|Received Vaccination 2|Adverse Event|0|||
19495230|NCT02531802|41832635|FG009|Received Vaccination 2|Adverse Event|0|||
19495231|NCT02531802|41832636|FG010|Received Vaccination 2|Adverse Event|0|||
19495232|NCT02531802|41832637|FG011|Received Vaccination 2|Adverse Event|0|||
19495233|NCT02531802|41832638|FG012|Received Vaccination 2|Adverse Event|0|||
19495234|NCT02531802|41832639|FG013|Received Vaccination 2|Adverse Event|0|||
19495235|NCT02531802|41832640|FG014|Received Vaccination 2|Adverse Event|0|||
19495236|NCT02531802|41832641|FG015|Received Vaccination 2|Adverse Event|0|||
19495237|NCT02531802|41832642|FG016|Received Vaccination 2|Adverse Event|0|||
19495238|NCT02531802|41832643|FG017|Received Vaccination 2|Adverse Event|2|||
19495239|NCT02531802|41832644|FG018|Received Vaccination 2|Adverse Event|1|||
19495240|NCT02531802|41832645|FG019|Received Vaccination 2|Adverse Event|0|||
19495241|NCT02531802|41832646|FG020|Received Vaccination 2|Adverse Event|1|||
19495242|NCT02531802|41832626|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
19495243|NCT02531802|41832627|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
19495244|NCT02531802|41832628|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
19495245|NCT02531802|41832629|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
19495246|NCT02531802|41832630|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
19495247|NCT02531802|41832631|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
19495248|NCT02531802|41832632|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
19495249|NCT02531802|41832633|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
19495250|NCT02531802|41832634|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
19495251|NCT02531802|41832635|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
19495252|NCT02531802|41832636|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
19495253|NCT02531802|41832637|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
19495254|NCT02531802|41832638|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
19495255|NCT02531802|41832639|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
19495256|NCT02531802|41832640|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
19495257|NCT02531802|41832641|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
19495258|NCT02531802|41832642|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
19495259|NCT02531802|41832643|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
19495260|NCT02531802|41832644|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
19495261|NCT02531802|41832645|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
19495262|NCT02531802|41832646|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
19495263|NCT01602666|41832749|FG000|Induction Chemotherapy|Death|2|||
19495264|NCT01602666|41832750|FG001|Induction Chemotherapy|Death|1|||
19495265|NCT01602666|41832749|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
19495266|NCT01602666|41832750|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
19495267|NCT01602666|41832749|FG000|Induction Chemotherapy|Physician Decision|12|||
19495268|NCT01602666|41832750|FG001|Induction Chemotherapy|Physician Decision|5|||
19495269|NCT01602666|41832749|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
19495270|NCT01602666|41832750|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
19495271|NCT01602666|41832749|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
19495272|NCT01602666|41832750|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
19495273|NCT01602666|41832749|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
19495274|NCT01602666|41832750|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
19495275|NCT01602666|41832749|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
19495276|NCT01602666|41832750|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
19495277|NCT01602666|41832749|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
19495278|NCT01602666|41832750|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
19495279|NCT01602666|41832749|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
19495280|NCT01602666|41832750|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
19495281|NCT01602666|41832749|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
19495282|NCT01602666|41832750|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
19495283|NCT01602666|41832749|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
19495284|NCT01602666|41832750|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
19495285|NCT02531646|41832761|FG000|Overall Study|equip. image processing issue|5|||
19495286|NCT02531646|41832762|FG001|Overall Study|equip. image processing issue|1|||
19495287|NCT02531646|41832763|FG002|Overall Study|equip. image processing issue|0|||
19495288|NCT02536404|41832828|FG000|Overall Study|Adverse Event|5|||
19495289|NCT02536404|41832829|FG001|Overall Study|Adverse Event|0|||
19495290|NCT02536404|41832828|FG000|Overall Study|Withdrawal by Subject|4|||
19495291|NCT02536404|41832829|FG001|Overall Study|Withdrawal by Subject|1|||
19495292|NCT02536404|41832828|FG000|Overall Study|Physician Decision|10|||
19495293|NCT02536404|41832829|FG001|Overall Study|Physician Decision|0|||
19495294|NCT02536404|41832828|FG000|Overall Study|Sponsor decision|1|||
19495295|NCT02536404|41832829|FG001|Overall Study|Sponsor decision|0|||
19704356|NCT00220740|42148646|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
19495326|NCT02527200|41833791|FG000|Overall Study|Withdrawal by Subject|3|||
19495327|NCT02527200|41833792|FG001|Overall Study|Withdrawal by Subject|2|||
19495328|NCT02527200|41833793|FG002|Overall Study|Withdrawal by Subject|1|||
19495329|NCT02527200|41833794|FG003|Overall Study|Withdrawal by Subject|0|||
19495330|NCT02527200|41833791|FG000|Overall Study|Unclassified|0|||
19495331|NCT02527200|41833792|FG001|Overall Study|Unclassified|1|||
19495332|NCT02527200|41833793|FG002|Overall Study|Unclassified|0|||
19495333|NCT02527200|41833794|FG003|Overall Study|Unclassified|0|||
19495334|NCT02527200|41833791|FG000|Overall Study|Lost to Follow-up|0|||
19495335|NCT02527200|41833792|FG001|Overall Study|Lost to Follow-up|0|||
19495336|NCT02527200|41833793|FG002|Overall Study|Lost to Follow-up|1|||
19495337|NCT02527200|41833794|FG003|Overall Study|Lost to Follow-up|0|||
19495338|NCT01659996|41833841|FG000|Overall Study|Protocol Violation|3|||
19495339|NCT01659996|41833842|FG001|Overall Study|Protocol Violation|3|||
19495340|NCT01659996|41833843|FG002|Overall Study|Protocol Violation|3|||
19495341|NCT01659996|41833841|FG000|Overall Study|Lost to Follow-up|1|||
19495342|NCT01659996|41833842|FG001|Overall Study|Lost to Follow-up|3|||
19495343|NCT01659996|41833843|FG002|Overall Study|Lost to Follow-up|2|||
19495344|NCT01659996|41833841|FG000|Overall Study|Adverse Event|0|||
19495345|NCT01659996|41833842|FG001|Overall Study|Adverse Event|0|||
19495346|NCT01659996|41833843|FG002|Overall Study|Adverse Event|1|||
19495347|NCT01659996|41833841|FG000|Overall Study|Withdrawal by Subject|4|||
19495348|NCT01659996|41833842|FG001|Overall Study|Withdrawal by Subject|1|||
19495349|NCT01659996|41833843|FG002|Overall Study|Withdrawal by Subject|5|||
19495350|NCT00980460|41834094|FG000|Overall Study|Death|0|||
19495351|NCT00980460|41834095|FG001|Overall Study|Death|0|||
19495352|NCT00980460|41834096|FG002|Overall Study|Death|1|||
19495353|NCT00980460|41834097|FG003|Overall Study|Death|2|||
19495354|NCT00980460|41834098|FG004|Overall Study|Death|1|||
19495355|NCT00980460|41834094|FG000|Overall Study|Lack of Efficacy|0|||
19495356|NCT00980460|41834095|FG001|Overall Study|Lack of Efficacy|0|||
19495357|NCT00980460|41834096|FG002|Overall Study|Lack of Efficacy|10|||
19495358|NCT00980460|41834097|FG003|Overall Study|Lack of Efficacy|6|||
19495359|NCT00980460|41834098|FG004|Overall Study|Lack of Efficacy|8|||
19495360|NCT00980460|41834094|FG000|Overall Study|Lost to Follow-up|0|||
19495361|NCT00980460|41834095|FG001|Overall Study|Lost to Follow-up|0|||
19495362|NCT00980460|41834096|FG002|Overall Study|Lost to Follow-up|0|||
19495363|NCT00980460|41834097|FG003|Overall Study|Lost to Follow-up|1|||
19495364|NCT00980460|41834098|FG004|Overall Study|Lost to Follow-up|0|||
19495365|NCT00980460|41834094|FG000|Overall Study|Physician Decision|0|||
19495366|NCT00980460|41834095|FG001|Overall Study|Physician Decision|0|||
19495367|NCT00980460|41834096|FG002|Overall Study|Physician Decision|11|||
19495368|NCT00980460|41834097|FG003|Overall Study|Physician Decision|5|||
19495369|NCT00980460|41834098|FG004|Overall Study|Physician Decision|3|||
19495370|NCT00980460|41834094|FG000|Overall Study|Withdrawal by Subject|0|||
19495371|NCT00980460|41834095|FG001|Overall Study|Withdrawal by Subject|0|||
19495372|NCT00980460|41834096|FG002|Overall Study|Withdrawal by Subject|1|||
19495373|NCT00980460|41834097|FG003|Overall Study|Withdrawal by Subject|0|||
19495374|NCT00980460|41834098|FG004|Overall Study|Withdrawal by Subject|0|||
19495375|NCT00980460|41834094|FG000|Overall Study|Ineligible|0|||
19495376|NCT00980460|41834095|FG001|Overall Study|Ineligible|2|||
19495377|NCT00980460|41834096|FG002|Overall Study|Ineligible|3|||
19495378|NCT00980460|41834097|FG003|Overall Study|Ineligible|1|||
19495379|NCT00980460|41834098|FG004|Overall Study|Ineligible|4|||
19495380|NCT00980460|41834094|FG000|Overall Study|Refusal of further therapy|0|||
19495381|NCT00980460|41834095|FG001|Overall Study|Refusal of further therapy|2|||
19495382|NCT00980460|41834096|FG002|Overall Study|Refusal of further therapy|3|||
19495383|NCT00980460|41834097|FG003|Overall Study|Refusal of further therapy|2|||
19495384|NCT00980460|41834098|FG004|Overall Study|Refusal of further therapy|0|||
19495385|NCT00980460|41834094|FG000|Overall Study|No therapy within 42 days of resection|0|||
19495386|NCT00980460|41834095|FG001|Overall Study|No therapy within 42 days of resection|0|||
19495387|NCT00980460|41834096|FG002|Overall Study|No therapy within 42 days of resection|3|||
19495388|NCT00980460|41834097|FG003|Overall Study|No therapy within 42 days of resection|1|||
19495389|NCT00980460|41834098|FG004|Overall Study|No therapy within 42 days of resection|0|||
19495390|NCT00980460|41834094|FG000|Overall Study|No transplant by protocol timepoints|0|||
19495391|NCT00980460|41834095|FG001|Overall Study|No transplant by protocol timepoints|0|||
19613326|NCT00951665|42062208|FG001|Phase 1b|Adverse Event|1|||
19495392|NCT00980460|41834096|FG002|Overall Study|No transplant by protocol timepoints|3|||
19495393|NCT00980460|41834097|FG003|Overall Study|No transplant by protocol timepoints|0|||
19495394|NCT00980460|41834098|FG004|Overall Study|No transplant by protocol timepoints|0|||
19495395|NCT00389610|41834168|FG000|Overall Study|Disease Progression|0|||
19495396|NCT00389610|41834169|FG001|Overall Study|Disease Progression|19|||
19495397|NCT00389610|41834168|FG000|Overall Study|Death|0|||
19495398|NCT00389610|41834169|FG001|Overall Study|Death|1|||
19495399|NCT00389610|41834168|FG000|Overall Study|Physician Decision|0|||
19495400|NCT00389610|41834169|FG001|Overall Study|Physician Decision|1|||
19495401|NCT00389610|41834168|FG000|Overall Study|Withdrawal by Subject|0|||
19495402|NCT00389610|41834169|FG001|Overall Study|Withdrawal by Subject|1|||
19495403|NCT02525874|41834244|FG000|Overall Study|Other|1|||
19495404|NCT02525874|41834244|FG000|Overall Study|Investigator Decision|1|||
19495405|NCT02525874|41834244|FG000|Overall Study|Consent withdrawn|22|||
19495406|NCT02525874|41834244|FG000|Overall Study|Non-compliance with study drug|3|||
19495407|NCT02525874|41834244|FG000|Overall Study|Adverse Event|17|||
19495408|NCT02525874|41834244|FG000|Overall Study|Lost to Follow-up|7|||
19495409|NCT02525874|41834244|FG000|Overall Study|Disease progression, defined by protocol|2|||
19495410|NCT02525874|41834244|FG000|Overall Study|Disease relapse|4|||
19495411|NCT02525874|41834244|FG000|Overall Study|Alternative Treatment for MS|2|||
19495412|NCT02525874|41834244|FG000|Overall Study|New lesions in Brain|1|||
19495413|NCT02528214|41834254|FG000|Overall Study|Protocol Violation|0|||
19495414|NCT02528214|41834255|FG001|Overall Study|Protocol Violation|1|||
19495415|NCT02528214|41834254|FG000|Overall Study|Adverse Event|0|||
19495416|NCT02528214|41834255|FG001|Overall Study|Adverse Event|1|||
19495417|NCT02528214|41834254|FG000|Overall Study|Other than specified above|0|||
19495418|NCT02528214|41834255|FG001|Overall Study|Other than specified above|1|||
19495419|NCT02524158|41834312|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
19495420|NCT02524158|41834313|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
19495421|NCT02524158|41834312|FG000|12-weeks Assessment|Lost to Follow-up|18|||
19495422|NCT02524158|41834313|FG001|12-weeks Assessment|Lost to Follow-up|12|||
19495423|NCT02524158|41834312|FG000|6-month Assessment|Withdrawal by Subject|1|||
19495424|NCT02524158|41834313|FG001|6-month Assessment|Withdrawal by Subject|1|||
19495425|NCT02524158|41834312|FG000|6-month Assessment|Lost to Follow-up|21|||
19495426|NCT02524158|41834313|FG001|6-month Assessment|Lost to Follow-up|20|||
19495427|NCT02525094|41834333|FG000|Overall Study|Lost to Follow-up|2|||
19495428|NCT02525094|41834334|FG001|Overall Study|Lost to Follow-up|1|||
19495429|NCT02525094|41834333|FG000|Overall Study|Withdrawal by Subject|5|||
19495430|NCT02525094|41834334|FG001|Overall Study|Withdrawal by Subject|6|||
19495431|NCT02525094|41834333|FG000|Overall Study|Not Treated|1|||
19495432|NCT02525094|41834334|FG001|Overall Study|Not Treated|1|||
19495433|NCT01657266|41834491|FG000|Overall Study|Lost to Follow-up|2|||
19495434|NCT01657266|41834492|FG001|Overall Study|Lost to Follow-up|2|||
19495435|NCT01657266|41834491|FG000|Overall Study|Adverse Event|2|||
19495436|NCT01657266|41834492|FG001|Overall Study|Adverse Event|3|||
19495437|NCT01657032|41834577|FG000|Overall Study|Lost to Follow-up|0|||
19495438|NCT01657032|41834578|FG001|Overall Study|Lost to Follow-up|7|||
19495439|NCT01657500|41834706|FG000|Overall Study|set impropperly matched|3|||
19495440|NCT01657500|41834707|FG001|Overall Study|set impropperly matched|3|||
19495441|NCT01657500|41834706|FG000|Overall Study|Lost to Follow-up|2|||
19495442|NCT01657500|41834707|FG001|Overall Study|Lost to Follow-up|2|||
19495443|NCT01658904|41834720|FG000|Overall Study|Principal Investigator discretion|2|||
19495444|NCT01658904|41834721|FG001|Overall Study|Principal Investigator discretion|0|||
19495445|NCT01658904|41834722|FG002|Overall Study|Principal Investigator discretion|0|||
19495446|NCT01658514|41834906|FG000|Overall Study|Protocol Violation|1|||
19495447|NCT01658514|41834907|FG001|Overall Study|Protocol Violation|0|||
19495448|NCT01658514|41834908|FG002|Overall Study|Protocol Violation|2|||
19495449|NCT01658436|41834929|FG000|Overall Study|Adverse Event|6|||
19495450|NCT01658436|41834930|FG001|Overall Study|Adverse Event|5|||
19495451|NCT01658436|41834929|FG000|Overall Study|Physician Decision|1|||
19495452|NCT01658436|41834930|FG001|Overall Study|Physician Decision|0|||
19495453|NCT01658436|41834929|FG000|Overall Study|Progressive disease|12|||
19495454|NCT01658436|41834930|FG001|Overall Study|Progressive disease|4|||
19495455|NCT01658436|41834929|FG000|Overall Study|Study terminated by sponsor|0|||
19495456|NCT01658436|41834930|FG001|Overall Study|Study terminated by sponsor|1|||
19495457|NCT01658436|41834929|FG000|Overall Study|Subject/guardian decision|0|||
19495458|NCT01658436|41834930|FG001|Overall Study|Subject/guardian decision|1|||
19495459|NCT01658436|41834929|FG000|Overall Study|Death|1|||
19495460|NCT01658436|41834930|FG001|Overall Study|Death|0|||
19495461|NCT01656408|41835498|FG000|Overall Study|Adverse Event|0|||
19495462|NCT01656408|41835499|FG001|Overall Study|Adverse Event|0|||
19495463|NCT01656408|41835500|FG002|Overall Study|Adverse Event|1|||
19495464|NCT01656408|41835501|FG003|Overall Study|Adverse Event|0|||
19495465|NCT01656408|41835502|FG004|Overall Study|Adverse Event|0|||
19495466|NCT01656408|41835503|FG005|Overall Study|Adverse Event|1|||
19495467|NCT01656408|41835504|FG006|Overall Study|Adverse Event|1|||
19495468|NCT01656408|41835505|FG007|Overall Study|Adverse Event|0|||
19495469|NCT01656408|41835506|FG008|Overall Study|Adverse Event|1|||
19495470|NCT01656408|41835507|FG009|Overall Study|Adverse Event|0|||
19495471|NCT01656408|41835498|FG000|Overall Study|Physician Decision|1|||
19495472|NCT01656408|41835499|FG001|Overall Study|Physician Decision|0|||
19495473|NCT01656408|41835500|FG002|Overall Study|Physician Decision|1|||
19495474|NCT01656408|41835501|FG003|Overall Study|Physician Decision|0|||
19495475|NCT01656408|41835502|FG004|Overall Study|Physician Decision|1|||
19495476|NCT01656408|41835503|FG005|Overall Study|Physician Decision|1|||
19495477|NCT01656408|41835504|FG006|Overall Study|Physician Decision|0|||
19495478|NCT01656408|41835505|FG007|Overall Study|Physician Decision|1|||
19495479|NCT01656408|41835506|FG008|Overall Study|Physician Decision|1|||
19495480|NCT01656408|41835507|FG009|Overall Study|Physician Decision|3|||
19495481|NCT01364298|41836016|FG000|Overall Study|Adverse Event|3|||
19495482|NCT01364298|41836017|FG001|Overall Study|Adverse Event|4|||
19495483|NCT01364298|41836016|FG000|Overall Study|Lack of adherence to treatment|1|||
19495484|NCT01364298|41836017|FG001|Overall Study|Lack of adherence to treatment|3|||
19495485|NCT01364298|41836016|FG000|Overall Study|Lack of Efficacy|1|||
19495486|NCT01364298|41836017|FG001|Overall Study|Lack of Efficacy|0|||
19495487|NCT01364298|41836016|FG000|Overall Study|Lost to Follow-up|5|||
19495488|NCT01364298|41836017|FG001|Overall Study|Lost to Follow-up|10|||
19495489|NCT01364298|41836016|FG000|Overall Study|Withdrawal by Subject|3|||
19495490|NCT01364298|41836017|FG001|Overall Study|Withdrawal by Subject|3|||
19495491|NCT01364298|41836016|FG000|Overall Study|Other|1|||
19495492|NCT01364298|41836017|FG001|Overall Study|Other|3|||
19495493|NCT01364922|41836076|FG000|Open-label (OL) Period|Adverse Event|7|||
19495494|NCT01364922|41836077|FG001|Open-label (OL) Period|Adverse Event|0|||
19495495|NCT01364922|41836078|FG002|Open-label (OL) Period|Adverse Event|0|||
19495496|NCT01364922|41836076|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
19495497|NCT01364922|41836077|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
19495498|NCT01364922|41836078|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
19495499|NCT01364922|41836076|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
19495500|NCT01364922|41836077|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
19495501|NCT01364922|41836078|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
19495502|NCT01364922|41836076|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
19495503|NCT01364922|41836077|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
19495504|NCT01364922|41836078|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
19495505|NCT01364922|41836076|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
19495506|NCT01364922|41836077|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
19495507|NCT01364922|41836078|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
19495508|NCT01364922|41836076|FG000|Open-label (OL) Period|Other, Unspecified|1|||
19495509|NCT01364922|41836077|FG001|Open-label (OL) Period|Other, Unspecified|0|||
19495510|NCT01364922|41836078|FG002|Open-label (OL) Period|Other, Unspecified|0|||
19495511|NCT01364922|41836076|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
19495512|NCT01364922|41836077|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
19495513|NCT01364922|41836078|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
19495514|NCT01364922|41836076|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
19495515|NCT01364922|41836077|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
19495516|NCT01364922|41836078|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
19495517|NCT01364922|41836076|FG000|Double-Blind (DB) Period|Adverse Event|0|||
19495518|NCT01364922|41836077|FG001|Double-Blind (DB) Period|Adverse Event|0|||
19495519|NCT01364922|41836078|FG002|Double-Blind (DB) Period|Adverse Event|1|||
19495520|NCT01364922|41836076|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
19495521|NCT01364922|41836077|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
19495522|NCT01364922|41836078|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
19495523|NCT02522286|41836252|FG000|Overall Study|Withdrawal by Subject|3|||
19495524|NCT02522286|41836253|FG001|Overall Study|Withdrawal by Subject|0|||
19495525|NCT02522286|41836254|FG002|Overall Study|Withdrawal by Subject|0|||
19495526|NCT02522286|41836255|FG003|Overall Study|Withdrawal by Subject|3|||
19495527|NCT02520726|41836276|FG000|Overall Study|Lost to Follow-up|3|||
19495528|NCT02520726|41836277|FG001|Overall Study|Lost to Follow-up|2|||
19495529|NCT02519712|41836300|FG000|Overall Study|Disease Relapse|1|||
19495530|NCT02519712|41836300|FG000|Overall Study|Disease Progression|1|||
19495531|NCT02519712|41836300|FG000|Overall Study|Accruals are donors|2|||
19495532|NCT02516202|41836564|FG000|Overall Study|Withdrawal by Subject|1|||
19495533|NCT02516202|41836565|FG001|Overall Study|Withdrawal by Subject|0|||
19495534|NCT02516202|41836566|FG002|Overall Study|Withdrawal by Subject|1|||
19495535|NCT02516202|41836564|FG000|Overall Study|Lost to Follow-up|1|||
19495536|NCT02516202|41836565|FG001|Overall Study|Lost to Follow-up|1|||
19495537|NCT02516202|41836566|FG002|Overall Study|Lost to Follow-up|1|||
19495538|NCT02516202|41836564|FG000|Overall Study|Stopped Follow-up|0|||
19495539|NCT02516202|41836565|FG001|Overall Study|Stopped Follow-up|0|||
19495540|NCT02516202|41836566|FG002|Overall Study|Stopped Follow-up|1|||
19495541|NCT02518620|41836772|FG000|Overall Study|Adverse Event|23|||
19495542|NCT02518620|41836773|FG001|Overall Study|Adverse Event|11|||
19613327|NCT00951665|42062209|FG002|Phase 1b|Adverse Event|0|||
19495543|NCT02518620|41836772|FG000|Overall Study|Lack of Efficacy|2|||
19495544|NCT02518620|41836773|FG001|Overall Study|Lack of Efficacy|0|||
19613328|NCT00951665|42062210|FG003|Phase 1b|Adverse Event|1|||
19495545|NCT02518620|41836772|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19495546|NCT02518620|41836773|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19495547|NCT02518620|41836772|FG000|Overall Study|Physician Decision|1|||
19495548|NCT02518620|41836773|FG001|Overall Study|Physician Decision|1|||
19495549|NCT02518620|41836772|FG000|Overall Study|Sponsor's Decision|0|||
19495550|NCT02518620|41836773|FG001|Overall Study|Sponsor's Decision|3|||
19495551|NCT02518620|41836772|FG000|Overall Study|Lost to Follow-up|1|||
19495552|NCT02518620|41836773|FG001|Overall Study|Lost to Follow-up|1|||
19495553|NCT02518620|41836772|FG000|Overall Study|Withdrawal by Subject|17|||
19495554|NCT02518620|41836773|FG001|Overall Study|Withdrawal by Subject|9|||
19495555|NCT02518620|41836772|FG000|Overall Study|Death|1|||
19495556|NCT02518620|41836773|FG001|Overall Study|Death|0|||
19495557|NCT02518620|41836772|FG000|Overall Study|Pregnancy Wish|3|||
19495558|NCT02518620|41836773|FG001|Overall Study|Pregnancy Wish|0|||
19495559|NCT02518620|41836772|FG000|Overall Study|Pregnancy|1|||
19495560|NCT02518620|41836773|FG001|Overall Study|Pregnancy|0|||
19495561|NCT02518620|41836772|FG000|Overall Study|Relocation|2|||
19495562|NCT02518620|41836773|FG001|Overall Study|Relocation|1|||
19495563|NCT01653912|41836957|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
19495564|NCT01653912|41836958|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
19495565|NCT01653912|41836959|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
19495566|NCT01653912|41836960|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
19495567|NCT01653912|41836961|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
19495568|NCT01653912|41836962|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
19495569|NCT01653912|41836957|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
19495570|NCT01653912|41836958|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
19495571|NCT01653912|41836959|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
19393712|NCT00790933|41637558|FG000|Overall Study|Reason Not Specified|8|||
19393713|NCT00790933|41637559|FG001|Overall Study|Reason Not Specified|16|||
19393714|NCT00790933|41637560|FG002|Overall Study|Reason Not Specified|4|||
19393715|NCT00790933|41637561|FG003|Overall Study|Reason Not Specified|1|||
19393716|NCT00790933|41637562|FG004|Overall Study|Reason Not Specified|9|||
19393717|NCT02161211|41637581|FG000|Overall Study|Lost to Follow-up|21|||
19393718|NCT02161211|41637582|FG001|Overall Study|Lost to Follow-up|27|||
19393719|NCT02161211|41637583|FG002|Overall Study|Lost to Follow-up|21|||
19393720|NCT02161211|41637581|FG000|Overall Study|Dropped|12|||
19393721|NCT02161211|41637582|FG001|Overall Study|Dropped|5|||
19393722|NCT02161211|41637583|FG002|Overall Study|Dropped|9|||
19393723|NCT01676701|41637593|FG000|Overall Study|Protocol Violation|1|||
19393724|NCT01676701|41637594|FG001|Overall Study|Protocol Violation|0|||
19393725|NCT01676701|41637593|FG000|Overall Study|Sponsor Decision|3|||
19393726|NCT01676701|41637594|FG001|Overall Study|Sponsor Decision|4|||
19393727|NCT01670279|41637605|FG000|Overall Study|Adverse Event|0|||
19393728|NCT01670279|41637606|FG001|Overall Study|Adverse Event|1|||
19393729|NCT01670279|41637607|FG002|Overall Study|Adverse Event|0|||
19495572|NCT01653912|41836960|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
19495573|NCT01653912|41836961|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
19495574|NCT01653912|41836962|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
19495575|NCT01653912|41836957|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
19495576|NCT01653912|41836958|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
19495577|NCT01653912|41836959|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
19495578|NCT01653912|41836960|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
19495579|NCT01653912|41836961|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
19495580|NCT01653912|41836962|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
19495581|NCT01653912|41836957|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495582|NCT01653912|41836958|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495583|NCT01653912|41836959|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495584|NCT01653912|41836960|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
19495585|NCT01653912|41836961|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495586|NCT01653912|41836962|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495587|NCT01653912|41836957|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
19495588|NCT01653912|41836958|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
19495589|NCT01653912|41836959|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
19393730|NCT01670279|41637608|FG003|Overall Study|Adverse Event|0|||
19495590|NCT01653912|41836960|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
19495591|NCT01653912|41836961|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
19495592|NCT01653912|41836962|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
19495593|NCT01653912|41836957|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
19495594|NCT01653912|41836958|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
19495595|NCT01653912|41836959|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
19495596|NCT01653912|41836960|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
19704357|NCT00220740|42148647|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
19393731|NCT01670279|41637605|FG000|Overall Study|Physician Decision|0|||
19393732|NCT01670279|41637606|FG001|Overall Study|Physician Decision|1|||
19495597|NCT01653912|41836961|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
19495598|NCT01653912|41836962|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
19495599|NCT01653912|41836957|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495600|NCT01653912|41836958|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495601|NCT01653912|41836959|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495602|NCT01653912|41836960|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495603|NCT01653912|41836961|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
19495604|NCT01653912|41836962|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
19495605|NCT02483520|41836988|FG000|Overall Study|Lost to Follow-up|3|||
19495606|NCT02483520|41836989|FG001|Overall Study|Lost to Follow-up|4|||
19495607|NCT02483520|41836988|FG000|Overall Study|Withdrawal by Subject|4|||
19495608|NCT02483520|41836989|FG001|Overall Study|Withdrawal by Subject|14|||
19495609|NCT02483520|41836988|FG000|Overall Study|Hospitalized|2|||
19495610|NCT02483520|41836989|FG001|Overall Study|Hospitalized|3|||
19495611|NCT02483520|41836988|FG000|Overall Study|Moved to LTC|2|||
19495612|NCT02483520|41836989|FG001|Overall Study|Moved to LTC|3|||
19495613|NCT02514174|41836995|FG000|Overall Study|Patient refused to continue medication|1|||
19495614|NCT02514174|41836995|FG000|Overall Study|Adverse Event|2|||
19495615|NCT02514174|41836995|FG000|Overall Study|Study closed by sponsor|9|||
19495616|NCT02514174|41836995|FG000|Overall Study|Progressive disease|11|||
19495617|NCT02514174|41836995|FG000|Overall Study|Treatment change|1|||
19495618|NCT02514174|41836995|FG000|Overall Study|Treated off study with Afatinib.|1|||
19495619|NCT02482428|41837055|FG000|Overall Study|Lost to Follow-up|4|||
19495620|NCT02482428|41837056|FG001|Overall Study|Lost to Follow-up|9|||
19495621|NCT02482428|41837057|FG002|Overall Study|Lost to Follow-up|1|||
19495622|NCT02482428|41837058|FG003|Overall Study|Lost to Follow-up|2|||
19495623|NCT02482428|41837059|FG004|Overall Study|Lost to Follow-up|4|||
19495624|NCT02482428|41837055|FG000|Overall Study|Physician Decision|0|||
19495625|NCT02482428|41837056|FG001|Overall Study|Physician Decision|0|||
19495626|NCT02482428|41837057|FG002|Overall Study|Physician Decision|0|||
19495627|NCT02482428|41837058|FG003|Overall Study|Physician Decision|0|||
19495628|NCT02482428|41837059|FG004|Overall Study|Physician Decision|1|||
19495629|NCT02482428|41837055|FG000|Overall Study|protocol deviation|1|||
19495630|NCT02482428|41837056|FG001|Overall Study|protocol deviation|1|||
19495631|NCT02482428|41837057|FG002|Overall Study|protocol deviation|0|||
19495632|NCT02482428|41837058|FG003|Overall Study|protocol deviation|0|||
19495633|NCT02482428|41837059|FG004|Overall Study|protocol deviation|0|||
19495634|NCT02482428|41837055|FG000|Overall Study|subject/guardian decision|4|||
19495635|NCT02482428|41837056|FG001|Overall Study|subject/guardian decision|2|||
19495636|NCT02482428|41837057|FG002|Overall Study|subject/guardian decision|0|||
19495637|NCT02482428|41837058|FG003|Overall Study|subject/guardian decision|0|||
19495638|NCT02482428|41837059|FG004|Overall Study|subject/guardian decision|2|||
19495639|NCT02480712|41837113|FG000|Overall Study|Enrolled but Never Treated|1|||
19495640|NCT02480712|41837113|FG000|Overall Study|Lost to Follow-up|5|||
19495641|NCT02480712|41837113|FG000|Overall Study|Withdrew Consent|3|||
19495642|NCT02480712|41837113|FG000|Overall Study|Death|1|||
19495643|NCT02480712|41837113|FG000|Overall Study|Lack of Efficacy|1|||
19495644|NCT02513550|41838431|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
19495645|NCT02513550|41838432|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
19495646|NCT02513550|41838433|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
19495647|NCT02513550|41838434|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
19495648|NCT02513550|41838435|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
19495649|NCT02513550|41838436|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
19495650|NCT02513550|41838431|FG000|Double Blind Treatment Period|Adverse Event|5|||
19495651|NCT02513550|41838432|FG001|Double Blind Treatment Period|Adverse Event|13|||
19495652|NCT02513550|41838433|FG002|Double Blind Treatment Period|Adverse Event|17|||
19495653|NCT02513550|41838434|FG003|Double Blind Treatment Period|Adverse Event|0|||
19495654|NCT02513550|41838435|FG004|Double Blind Treatment Period|Adverse Event|1|||
19495655|NCT02513550|41838436|FG005|Double Blind Treatment Period|Adverse Event|0|||
19495656|NCT02513550|41838431|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
19495657|NCT02513550|41838432|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
19495658|NCT02513550|41838433|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
19495659|NCT02513550|41838434|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
19495660|NCT02513550|41838435|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
19495661|NCT02513550|41838436|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
19495662|NCT02513550|41838431|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
19495663|NCT02513550|41838432|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
19495664|NCT02513550|41838433|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
19495665|NCT02513550|41838434|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
19495666|NCT02513550|41838435|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
19495667|NCT02513550|41838436|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
19495668|NCT02513550|41838431|FG000|Double Blind Treatment Period|Protocol Violation|1|||
19495669|NCT02513550|41838432|FG001|Double Blind Treatment Period|Protocol Violation|1|||
19704358|NCT00184002|42148655|FG000|Overall Study|Adverse Event|9|||
19495670|NCT02513550|41838433|FG002|Double Blind Treatment Period|Protocol Violation|4|||
19495671|NCT02513550|41838434|FG003|Double Blind Treatment Period|Protocol Violation|0|||
19495672|NCT02513550|41838435|FG004|Double Blind Treatment Period|Protocol Violation|0|||
19495673|NCT02513550|41838436|FG005|Double Blind Treatment Period|Protocol Violation|0|||
19495674|NCT02513550|41838431|FG000|Double Blind Treatment Period|Physician Decision|2|||
19495675|NCT02513550|41838432|FG001|Double Blind Treatment Period|Physician Decision|0|||
19495676|NCT02513550|41838433|FG002|Double Blind Treatment Period|Physician Decision|4|||
19495677|NCT02513550|41838434|FG003|Double Blind Treatment Period|Physician Decision|0|||
19495678|NCT02513550|41838435|FG004|Double Blind Treatment Period|Physician Decision|0|||
19495679|NCT02513550|41838436|FG005|Double Blind Treatment Period|Physician Decision|0|||
19495680|NCT02513550|41838431|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
19495681|NCT02513550|41838432|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
19495682|NCT02513550|41838433|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
19495683|NCT02513550|41838434|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
19495684|NCT02513550|41838435|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
19495685|NCT02513550|41838436|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
19495686|NCT02513550|41838431|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
19495687|NCT02513550|41838432|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
19495688|NCT02513550|41838433|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
19495689|NCT02513550|41838434|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
19704359|NCT00184002|42148655|FG000|Overall Study|Death|3|||
19373684|NCT02668185|41614852|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
19495690|NCT02513550|41838435|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
19495691|NCT02513550|41838436|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
19704360|NCT00184002|42148655|FG000|Overall Study|Physician Decision|1|||
19495692|NCT02513550|41838431|FG000|Double Blind Treatment Period|Due to personal business|2|||
19495693|NCT02513550|41838432|FG001|Double Blind Treatment Period|Due to personal business|0|||
19495694|NCT02513550|41838433|FG002|Double Blind Treatment Period|Due to personal business|1|||
19495695|NCT02513550|41838434|FG003|Double Blind Treatment Period|Due to personal business|0|||
19495696|NCT02513550|41838435|FG004|Double Blind Treatment Period|Due to personal business|0|||
19495697|NCT02513550|41838436|FG005|Double Blind Treatment Period|Due to personal business|0|||
19495698|NCT02513550|41838431|FG000|Double Blind Treatment Period|Death|1|||
19495699|NCT02513550|41838432|FG001|Double Blind Treatment Period|Death|0|||
19495700|NCT02513550|41838433|FG002|Double Blind Treatment Period|Death|2|||
19495701|NCT02513550|41838434|FG003|Double Blind Treatment Period|Death|0|||
19495702|NCT02513550|41838435|FG004|Double Blind Treatment Period|Death|0|||
19495703|NCT02513550|41838436|FG005|Double Blind Treatment Period|Death|0|||
19495704|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
19495705|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
19495706|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
19495707|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
19495708|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
19495709|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
19495710|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
19495711|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
19495712|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
19495713|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
19495714|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
19495715|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
19495716|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
19613329|NCT00951665|42062211|FG004|Phase 1b|Adverse Event|0|||
19613330|NCT00951665|42062212|FG005|Phase 1b|Adverse Event|0|||
19613331|NCT00951665|42062207|FG000|Phase 1b|Death|1|||
19613332|NCT00951665|42062208|FG001|Phase 1b|Death|0|||
19613333|NCT00951665|42062209|FG002|Phase 1b|Death|2|||
19613334|NCT00951665|42062210|FG003|Phase 1b|Death|0|||
19613335|NCT00951665|42062211|FG004|Phase 1b|Death|0|||
19613336|NCT00951665|42062212|FG005|Phase 1b|Death|0|||
19613337|NCT00951665|42062207|FG000|Phase 1b|Physician Decision|4|||
19613338|NCT00951665|42062208|FG001|Phase 1b|Physician Decision|0|||
19495717|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
19495718|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
19495719|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
19495720|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
19495721|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
19495722|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
19495723|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
19495724|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
19495725|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
19495726|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
19495727|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
19495728|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
19495729|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
19495730|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
19495731|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
19495732|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
19495733|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
19495734|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Death|0|||
19495735|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Death|0|||
19495736|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Death|1|||
19495737|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Death|0|||
19495738|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Death|0|||
19495739|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Death|0|||
19495740|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
19495741|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
19495742|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
19495743|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
19495744|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
19495745|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
19495746|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
19495747|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
19495748|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
19613339|NCT00951665|42062209|FG002|Phase 1b|Physician Decision|1|||
19613340|NCT00951665|42062210|FG003|Phase 1b|Physician Decision|0|||
19613341|NCT00951665|42062211|FG004|Phase 1b|Physician Decision|0|||
19495749|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
19495750|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
19495751|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
19495752|NCT02513550|41838431|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
19495753|NCT02513550|41838432|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
19495754|NCT02513550|41838433|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
19495755|NCT02513550|41838434|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
19495756|NCT02513550|41838435|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
19495757|NCT02513550|41838436|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
19495758|NCT02513472|41838762|FG000|Overall Study|Radiological Disease Progression|45|||
19495759|NCT02513472|41838763|FG001|Overall Study|Radiological Disease Progression|57|||
19495760|NCT02513472|41838762|FG000|Overall Study|Clinical Disease Progression|5|||
19495761|NCT02513472|41838763|FG001|Overall Study|Clinical Disease Progression|13|||
19495762|NCT02513472|41838762|FG000|Overall Study|Adverse Event|8|||
19495763|NCT02513472|41838763|FG001|Overall Study|Adverse Event|11|||
19495764|NCT02513472|41838762|FG000|Overall Study|Withdrawal by Subject|0|||
19495765|NCT02513472|41838763|FG001|Overall Study|Withdrawal by Subject|4|||
19495766|NCT02513472|41838762|FG000|Overall Study|Subject Choice|2|||
19495767|NCT02513472|41838763|FG001|Overall Study|Subject Choice|7|||
19495768|NCT02513472|41838762|FG000|Overall Study|Treatment Completed as per Protocol|3|||
19495769|NCT02513472|41838763|FG001|Overall Study|Treatment Completed as per Protocol|3|||
19495770|NCT02513472|41838762|FG000|Overall Study|Other|3|||
19495771|NCT02513472|41838763|FG001|Overall Study|Other|6|||
19495772|NCT04490395|41838992|FG000|Overall Study|Lost to Follow-up|0|||
19495773|NCT04490395|41838993|FG001|Overall Study|Lost to Follow-up|1|||
19495774|NCT03843541|41839436|FG000|Overall Study|Adverse Event|4|||
19495775|NCT03843541|41839437|FG001|Overall Study|Adverse Event|2|||
19495776|NCT03843541|41839438|FG002|Overall Study|Adverse Event|3|||
19495777|NCT03843541|41839436|FG000|Overall Study|Death|1|||
19495778|NCT03843541|41839437|FG001|Overall Study|Death|0|||
19495779|NCT03843541|41839438|FG002|Overall Study|Death|0|||
19495780|NCT03843541|41839436|FG000|Overall Study|Lack of adherence to study medication|0|||
19495781|NCT03843541|41839437|FG001|Overall Study|Lack of adherence to study medication|0|||
19495782|NCT03843541|41839438|FG002|Overall Study|Lack of adherence to study medication|1|||
19495783|NCT03843541|41839436|FG000|Overall Study|Physician Decision|1|||
19495784|NCT03843541|41839437|FG001|Overall Study|Physician Decision|2|||
19495785|NCT03843541|41839438|FG002|Overall Study|Physician Decision|2|||
19495786|NCT03843541|41839436|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
19495787|NCT03843541|41839437|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
19495788|NCT03843541|41839438|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
19495789|NCT03843541|41839436|FG000|Overall Study|Withdrawal by Subject|6|||
19495790|NCT03843541|41839437|FG001|Overall Study|Withdrawal by Subject|9|||
19495791|NCT03843541|41839438|FG002|Overall Study|Withdrawal by Subject|7|||
19495792|NCT03843541|41839436|FG000|Overall Study|Administration of rescue mucolytic|0|||
19495793|NCT03843541|41839437|FG001|Overall Study|Administration of rescue mucolytic|0|||
19495794|NCT03843541|41839438|FG002|Overall Study|Administration of rescue mucolytic|1|||
19495795|NCT03843541|41839436|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
19495796|NCT03843541|41839437|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
19495797|NCT03843541|41839438|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
19495798|NCT02992418|41840705|FG000|Overall Study|Withdrawal by Subject|11|||
19495799|NCT02992418|41840706|FG001|Overall Study|Withdrawal by Subject|12|||
19495800|NCT02992418|41840705|FG000|Overall Study|Non-compliance with the protocol|308|||
19495801|NCT02992418|41840706|FG001|Overall Study|Non-compliance with the protocol|308|||
19495802|NCT02992418|41840705|FG000|Overall Study|Lost to Follow-up|27|||
19495803|NCT02992418|41840706|FG001|Overall Study|Lost to Follow-up|22|||
19495804|NCT01276106|41840948|FG000|Overall Study|Adverse Event|3|||
19495805|NCT01276106|41840949|FG001|Overall Study|Adverse Event|3|||
19495806|NCT01276106|41840950|FG002|Overall Study|Adverse Event|11|||
19495807|NCT01276106|41840951|FG003|Overall Study|Adverse Event|3|||
19495808|NCT01276106|41840948|FG000|Overall Study|Withdrawal by Subject|6|||
19495809|NCT01276106|41840949|FG001|Overall Study|Withdrawal by Subject|3|||
19495810|NCT01276106|41840950|FG002|Overall Study|Withdrawal by Subject|1|||
19495811|NCT01276106|41840951|FG003|Overall Study|Withdrawal by Subject|6|||
19495812|NCT01276106|41840948|FG000|Overall Study|Lack of Efficacy|0|||
19495813|NCT01276106|41840949|FG001|Overall Study|Lack of Efficacy|1|||
19495814|NCT01276106|41840950|FG002|Overall Study|Lack of Efficacy|0|||
19495815|NCT01276106|41840951|FG003|Overall Study|Lack of Efficacy|1|||
19495816|NCT01276106|41840948|FG000|Overall Study|Lost to Follow-up|2|||
19495817|NCT01276106|41840949|FG001|Overall Study|Lost to Follow-up|1|||
19613342|NCT00951665|42062212|FG005|Phase 1b|Physician Decision|0|||
19613343|NCT00951665|42062207|FG000|Phase 1b|Withdrawal by Subject|0|||
19373685|NCT02742181|41614863|FG000|Overall Study|Physician Decision|1|||
19495818|NCT01276106|41840950|FG002|Overall Study|Lost to Follow-up|1|||
19495819|NCT01276106|41840951|FG003|Overall Study|Lost to Follow-up|0|||
19495820|NCT01276106|41840948|FG000|Overall Study|Physician Decision|0|||
19495821|NCT01276106|41840949|FG001|Overall Study|Physician Decision|0|||
19495822|NCT01276106|41840950|FG002|Overall Study|Physician Decision|1|||
19495823|NCT01276106|41840951|FG003|Overall Study|Physician Decision|1|||
19495824|NCT01276106|41840948|FG000|Overall Study|Protocol Violation|1|||
19495825|NCT01276106|41840949|FG001|Overall Study|Protocol Violation|1|||
19495826|NCT01276106|41840950|FG002|Overall Study|Protocol Violation|0|||
19495827|NCT01276106|41840951|FG003|Overall Study|Protocol Violation|2|||
19495828|NCT01276106|41840948|FG000|Overall Study|Insufficient therapeutic effects|0|||
19495829|NCT01276106|41840949|FG001|Overall Study|Insufficient therapeutic effects|0|||
19495830|NCT01276106|41840950|FG002|Overall Study|Insufficient therapeutic effects|2|||
19495831|NCT01276106|41840951|FG003|Overall Study|Insufficient therapeutic effects|0|||
19495832|NCT01275170|41840969|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
19495833|NCT01275170|41840970|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495834|NCT01275170|41840971|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495835|NCT01275170|41840972|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495836|NCT01275170|41840973|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495837|NCT01275170|41840974|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495838|NCT01275170|41840975|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495839|NCT01275170|41840976|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
19495840|NCT01273064|41841023|FG000|Overall Study|Adverse Event|5|||
19495841|NCT01273064|41841024|FG001|Overall Study|Adverse Event|1|||
19495842|NCT01273064|41841025|FG002|Overall Study|Adverse Event|3|||
19495843|NCT01273064|41841026|FG003|Overall Study|Adverse Event|2|||
19495844|NCT01273064|41841027|FG004|Overall Study|Adverse Event|1|||
19495845|NCT01273064|41841023|FG000|Overall Study|Withdrawal by Subject|4|||
19495846|NCT01273064|41841024|FG001|Overall Study|Withdrawal by Subject|2|||
19495847|NCT01273064|41841025|FG002|Overall Study|Withdrawal by Subject|2|||
19495848|NCT01273064|41841026|FG003|Overall Study|Withdrawal by Subject|2|||
19495849|NCT01273064|41841027|FG004|Overall Study|Withdrawal by Subject|0|||
19495850|NCT01273064|41841023|FG000|Overall Study|Study Termination|13|||
19495851|NCT01273064|41841024|FG001|Overall Study|Study Termination|27|||
19495852|NCT01273064|41841025|FG002|Overall Study|Study Termination|26|||
19495853|NCT01273064|41841026|FG003|Overall Study|Study Termination|16|||
19495854|NCT01273064|41841027|FG004|Overall Study|Study Termination|8|||
19495855|NCT01273064|41841023|FG000|Overall Study|Lost to Follow-up|1|||
19495856|NCT01273064|41841024|FG001|Overall Study|Lost to Follow-up|0|||
19495857|NCT01273064|41841025|FG002|Overall Study|Lost to Follow-up|0|||
19495858|NCT01273064|41841026|FG003|Overall Study|Lost to Follow-up|0|||
19495859|NCT01273064|41841027|FG004|Overall Study|Lost to Follow-up|0|||
19495860|NCT01273064|41841023|FG000|Overall Study|Physician Decision|0|||
19495861|NCT01273064|41841024|FG001|Overall Study|Physician Decision|0|||
19495862|NCT01273064|41841025|FG002|Overall Study|Physician Decision|0|||
19495863|NCT01273064|41841026|FG003|Overall Study|Physician Decision|0|||
19495864|NCT01273064|41841027|FG004|Overall Study|Physician Decision|1|||
19495865|NCT01272908|41841039|FG000|Initial Treatment Period|Adverse Event|1|||
19495866|NCT01272908|41841039|FG000|Initial Treatment Period|Lack of Efficacy|5|||
19495867|NCT01272908|41841039|FG000|Initial Treatment Period|Protocol Violation|1|||
19495868|NCT01272908|41841039|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
19495869|NCT01272908|41841039|FG000|Re-Treatment Period|Adverse Event|2|||
19495870|NCT01272908|41841039|FG000|Re-Treatment Period|Lack of Efficacy|3|||
19495871|NCT01272908|41841039|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
19495872|NCT01271504|41841049|FG000|Overall Study|Death|7|||
19495873|NCT01271504|41841050|FG001|Overall Study|Death|6|||
19495874|NCT01271504|41841051|FG002|Overall Study|Death|32|||
19495875|NCT01271504|41841052|FG003|Overall Study|Death|32|||
19495876|NCT01271504|41841049|FG000|Overall Study|Lost to Follow-up|0|||
19495877|NCT01271504|41841050|FG001|Overall Study|Lost to Follow-up|1|||
19495878|NCT01271504|41841051|FG002|Overall Study|Lost to Follow-up|3|||
19495879|NCT01271504|41841052|FG003|Overall Study|Lost to Follow-up|1|||
19495880|NCT01271504|41841049|FG000|Overall Study|Protocol Violation|0|||
19495881|NCT01271504|41841050|FG001|Overall Study|Protocol Violation|0|||
19495882|NCT01271504|41841051|FG002|Overall Study|Protocol Violation|0|||
19495883|NCT01271504|41841052|FG003|Overall Study|Protocol Violation|2|||
19495884|NCT01271504|41841049|FG000|Overall Study|Administrative Reasons|0|||
19495885|NCT01271504|41841050|FG001|Overall Study|Administrative Reasons|0|||
19495886|NCT01271504|41841051|FG002|Overall Study|Administrative Reasons|6|||
19495887|NCT01271504|41841052|FG003|Overall Study|Administrative Reasons|5|||
19495888|NCT01271504|41841049|FG000|Overall Study|Withdrawal by Subject|0|||
19495889|NCT01271504|41841050|FG001|Overall Study|Withdrawal by Subject|0|||
19495890|NCT01271504|41841051|FG002|Overall Study|Withdrawal by Subject|1|||
19495891|NCT01271504|41841052|FG003|Overall Study|Withdrawal by Subject|3|||
19495892|NCT01271504|41841049|FG000|Overall Study|Other|0|||
19495893|NCT01271504|41841050|FG001|Overall Study|Other|1|||
19495894|NCT01271504|41841051|FG002|Overall Study|Other|2|||
19495895|NCT01271504|41841052|FG003|Overall Study|Other|0|||
19495896|NCT01270958|41841095|FG000|Overall Study|Lost to Follow-up|2|||
19495897|NCT01270958|41841095|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
19495898|NCT01270880|41841099|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
19495899|NCT01270802|41841105|FG000|Overall Study|Withdrawal by Subject|1|||
19495900|NCT01270802|41841106|FG001|Overall Study|Withdrawal by Subject|0|||
19495901|NCT01270802|41841105|FG000|Overall Study|Adverse Event|1|||
19495902|NCT01270802|41841106|FG001|Overall Study|Adverse Event|0|||
19495903|NCT01270802|41841105|FG000|Overall Study|Lost to Follow-up|0|||
19495904|NCT01270802|41841106|FG001|Overall Study|Lost to Follow-up|1|||
19495905|NCT01270256|41841115|FG000|Overall Study|Withdrawal by Subject|1|||
19495906|NCT01270256|41841116|FG001|Overall Study|Withdrawal by Subject|0|||
19495907|NCT01279616|41841186|FG000|Overall Study|donor could not be located|5|||
19495908|NCT01279616|41841186|FG000|Overall Study|no signs of sickle cell disease|2|||
19495909|NCT01279070|41841197|FG000|Overall Study|Withdrawal by Subject|2|||
19495910|NCT01279070|41841198|FG001|Overall Study|Withdrawal by Subject|3|||
19495911|NCT01279070|41841197|FG000|Overall Study|Acute exacerbation|3|||
19495912|NCT01279070|41841198|FG001|Overall Study|Acute exacerbation|1|||
19495913|NCT01277744|41841208|FG000|Overall Study|Physician Decision|2|||
19495914|NCT01277822|41841214|FG000|Overall Study|Adverse Event|2|||
19495915|NCT01277822|41841215|FG001|Overall Study|Adverse Event|1|||
19495916|NCT01277822|41841214|FG000|Overall Study|Withdrawal by Subject|6|||
19495917|NCT01277822|41841215|FG001|Overall Study|Withdrawal by Subject|7|||
19495918|NCT01277822|41841214|FG000|Overall Study|Physician Decision|1|||
19495919|NCT01277822|41841215|FG001|Overall Study|Physician Decision|1|||
19495920|NCT01277822|41841214|FG000|Overall Study|Protocol Violation|1|||
19495921|NCT01277822|41841215|FG001|Overall Study|Protocol Violation|0|||
19495922|NCT01277822|41841214|FG000|Overall Study|Lost to Follow-up|2|||
19495923|NCT01277822|41841215|FG001|Overall Study|Lost to Follow-up|1|||
19495924|NCT01277822|41841214|FG000|Overall Study|Contraindicated medication used|2|||
19495925|NCT01277822|41841215|FG001|Overall Study|Contraindicated medication used|1|||
19495926|NCT01277822|41841214|FG000|Overall Study|Participant moved|1|||
19495927|NCT01277822|41841215|FG001|Overall Study|Participant moved|0|||
19495928|NCT01277666|41841224|FG000|Overall Study|Adverse Event|26|||
19495929|NCT01277666|41841225|FG001|Overall Study|Adverse Event|25|||
19495930|NCT01277666|41841226|FG002|Overall Study|Adverse Event|20|||
19495931|NCT01277666|41841224|FG000|Overall Study|Lack of Efficacy|8|||
19495932|NCT01277666|41841225|FG001|Overall Study|Lack of Efficacy|20|||
19495933|NCT01277666|41841226|FG002|Overall Study|Lack of Efficacy|12|||
19495934|NCT01277666|41841224|FG000|Overall Study|Protocol Violation|2|||
19495935|NCT01277666|41841225|FG001|Overall Study|Protocol Violation|3|||
19495936|NCT01277666|41841226|FG002|Overall Study|Protocol Violation|2|||
19495937|NCT01277666|41841224|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
19495938|NCT01277666|41841225|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
19495939|NCT01277666|41841226|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
19495940|NCT01277666|41841224|FG000|Overall Study|Lost to Follow-up|1|||
19495941|NCT01277666|41841225|FG001|Overall Study|Lost to Follow-up|1|||
19495942|NCT01277666|41841226|FG002|Overall Study|Lost to Follow-up|2|||
19495943|NCT01277666|41841224|FG000|Overall Study|Withdrawal by Subject|7|||
19495944|NCT01277666|41841225|FG001|Overall Study|Withdrawal by Subject|8|||
19495945|NCT01277666|41841226|FG002|Overall Study|Withdrawal by Subject|6|||
19495946|NCT01277666|41841224|FG000|Overall Study|Death|0|||
19495947|NCT01277666|41841225|FG001|Overall Study|Death|0|||
19495948|NCT01277666|41841226|FG002|Overall Study|Death|1|||
19495949|NCT00249002|41841234|FG000|Overall Study|Adverse Event|2|||
19495950|NCT00249002|41841234|FG000|Overall Study|Study cancellation|3|||
19495951|NCT00249002|41841234|FG000|Overall Study|Other|2|||
19495952|NCT01277042|41841240|FG000|Overall Study|Adverse Event|4|||
19495953|NCT01277042|41841241|FG001|Overall Study|Adverse Event|3|||
19495954|NCT01277042|41841240|FG000|Overall Study|Lost to Follow-up|2|||
19495955|NCT01277042|41841241|FG001|Overall Study|Lost to Follow-up|2|||
19495956|NCT01277042|41841240|FG000|Overall Study|Withdrawal by Subject|2|||
19495957|NCT01277042|41841241|FG001|Overall Study|Withdrawal by Subject|0|||
19495958|NCT00246740|41841281|FG000|Initial Enrollment|Death|1|||
19495959|NCT00246740|41841282|FG001|Initial Enrollment|Death|0|||
19495960|NCT00246740|41841281|FG000|Initial Enrollment|Additional surgery scheduled|0|||
19495961|NCT00246740|41841282|FG001|Initial Enrollment|Additional surgery scheduled|2|||
19495962|NCT00246740|41841281|FG000|Initial Enrollment|Surgery schedule change|4|||
19495963|NCT00246740|41841282|FG001|Initial Enrollment|Surgery schedule change|4|||
19495964|NCT00246740|41841281|FG000|Initial Enrollment|Other|1|||
19495965|NCT00246740|41841282|FG001|Initial Enrollment|Other|2|||
19495966|NCT00245102|41841327|FG000|Overall Study|Not Treated|1|||
19495967|NCT00245102|41841328|FG001|Overall Study|Not Treated|0|||
19495968|NCT00245102|41841329|FG002|Overall Study|Not Treated|1|||
19495969|NCT00245102|41841330|FG003|Overall Study|Not Treated|0|||
19495970|NCT00245102|41841331|FG004|Overall Study|Not Treated|0|||
19495971|NCT00245102|41841332|FG005|Overall Study|Not Treated|0|||
19495972|NCT00245102|41841327|FG000|Overall Study|Protocol Violation|1|||
19613344|NCT00951665|42062208|FG001|Phase 1b|Withdrawal by Subject|1|||
19495973|NCT00245102|41841328|FG001|Overall Study|Protocol Violation|0|||
19495974|NCT00245102|41841329|FG002|Overall Study|Protocol Violation|0|||
19495975|NCT00245102|41841330|FG003|Overall Study|Protocol Violation|0|||
19495976|NCT00245102|41841331|FG004|Overall Study|Protocol Violation|0|||
19495977|NCT00245102|41841332|FG005|Overall Study|Protocol Violation|0|||
19495978|NCT00245102|41841327|FG000|Overall Study|Death|0|||
19495979|NCT00245102|41841328|FG001|Overall Study|Death|0|||
19495980|NCT00245102|41841329|FG002|Overall Study|Death|0|||
19495981|NCT00245102|41841330|FG003|Overall Study|Death|1|||
19495982|NCT00245102|41841331|FG004|Overall Study|Death|0|||
19495983|NCT00245102|41841332|FG005|Overall Study|Death|0|||
19495984|NCT00245102|41841327|FG000|Overall Study|Adverse Event|4|||
19495985|NCT00245102|41841328|FG001|Overall Study|Adverse Event|2|||
19495986|NCT00245102|41841329|FG002|Overall Study|Adverse Event|5|||
19495987|NCT00245102|41841330|FG003|Overall Study|Adverse Event|1|||
19495988|NCT00245102|41841331|FG004|Overall Study|Adverse Event|0|||
19495989|NCT00245102|41841332|FG005|Overall Study|Adverse Event|2|||
19495990|NCT00245102|41841327|FG000|Overall Study|Decline in performance|0|||
19495991|NCT00245102|41841328|FG001|Overall Study|Decline in performance|2|||
19495992|NCT00245102|41841329|FG002|Overall Study|Decline in performance|0|||
19495993|NCT00245102|41841330|FG003|Overall Study|Decline in performance|1|||
19495994|NCT00245102|41841331|FG004|Overall Study|Decline in performance|0|||
19495995|NCT00245102|41841332|FG005|Overall Study|Decline in performance|2|||
19495996|NCT00245102|41841327|FG000|Overall Study|Participant needed surgery|0|||
19495997|NCT00245102|41841328|FG001|Overall Study|Participant needed surgery|0|||
19495998|NCT00245102|41841329|FG002|Overall Study|Participant needed surgery|1|||
19495999|NCT00245102|41841330|FG003|Overall Study|Participant needed surgery|0|||
19496000|NCT00245102|41841331|FG004|Overall Study|Participant needed surgery|0|||
19496001|NCT00245102|41841332|FG005|Overall Study|Participant needed surgery|0|||
19496002|NCT00245102|41841327|FG000|Overall Study|Clinical progression|1|||
19496003|NCT00245102|41841328|FG001|Overall Study|Clinical progression|0|||
19496004|NCT00245102|41841329|FG002|Overall Study|Clinical progression|0|||
19496005|NCT00245102|41841330|FG003|Overall Study|Clinical progression|0|||
19496006|NCT00245102|41841331|FG004|Overall Study|Clinical progression|0|||
19496007|NCT00245102|41841332|FG005|Overall Study|Clinical progression|0|||
19496008|NCT00244712|41841377|FG000|Overall Study|Adverse Event|20|||
19496009|NCT00244712|41841378|FG001|Overall Study|Adverse Event|21|||
19496010|NCT00244712|41841377|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
19496011|NCT00244712|41841378|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
19496012|NCT00244712|41841377|FG000|Overall Study|Lack of Compliance|10|||
19496013|NCT00244712|41841378|FG001|Overall Study|Lack of Compliance|11|||
19496014|NCT00244712|41841377|FG000|Overall Study|Lost to Follow-up|45|||
19496015|NCT00244712|41841378|FG001|Overall Study|Lost to Follow-up|52|||
19496016|NCT00244712|41841377|FG000|Overall Study|Withdrawal by Subject|13|||
19496017|NCT00244712|41841378|FG001|Overall Study|Withdrawal by Subject|23|||
19496018|NCT00244712|41841377|FG000|Overall Study|Protocol Violation, disease progression|13|||
19496019|NCT00244712|41841378|FG001|Overall Study|Protocol Violation, disease progression|11|||
19496020|NCT00243932|41841396|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
19496021|NCT00243932|41841397|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
19496022|NCT00243932|41841398|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
19496023|NCT00243386|41841406|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
19496024|NCT00243386|41841407|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
19496025|NCT00243386|41841408|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
19496026|NCT00243386|41841406|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
19496027|NCT00243386|41841407|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
19496028|NCT00243386|41841408|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
19496029|NCT00243386|41841406|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
19496030|NCT00243386|41841407|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
19496031|NCT00243386|41841408|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
19496032|NCT00243386|41841406|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
19496033|NCT00243386|41841407|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
19496034|NCT00243386|41841408|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
19704361|NCT00184002|42148655|FG000|Overall Study|Withdrawal by Subject|4|||
19704362|NCT00165672|42148661|FG000|Overall Study|Adverse Event|0|||
19704363|NCT00165672|42148662|FG001|Overall Study|Adverse Event|1|||
19496035|NCT00243386|41841406|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
19496036|NCT00243386|41841407|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
19496037|NCT00243386|41841408|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
19496038|NCT00243386|41841406|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
19496039|NCT00243386|41841407|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
19496040|NCT00243386|41841408|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
19496041|NCT00243386|41841406|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
19496042|NCT00243386|41841407|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
19613345|NCT00951665|42062209|FG002|Phase 1b|Withdrawal by Subject|0|||
19496043|NCT00243386|41841408|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
19496044|NCT00243386|41841406|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
19496045|NCT00243386|41841407|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
19496046|NCT00243386|41841408|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
19496047|NCT00243230|41841467|FG000|Double-Blind Period|Adverse Event|0|||
19496048|NCT00243230|41841468|FG001|Double-Blind Period|Adverse Event|2|||
19496049|NCT00243230|41841469|FG002|Double-Blind Period|Adverse Event|2|||
19496050|NCT00243230|41841470|FG003|Double-Blind Period|Adverse Event|0|||
19496051|NCT00243230|41841467|FG000|Double-Blind Period|Withdrawal by Subject|1|||
19496052|NCT00243230|41841468|FG001|Double-Blind Period|Withdrawal by Subject|0|||
19496053|NCT00243230|41841469|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19496054|NCT00243230|41841470|FG003|Double-Blind Period|Withdrawal by Subject|0|||
19496055|NCT00243230|41841467|FG000|Double-Blind Period|Protocol Violation|0|||
19496056|NCT00243230|41841468|FG001|Double-Blind Period|Protocol Violation|0|||
19496057|NCT00243230|41841469|FG002|Double-Blind Period|Protocol Violation|1|||
19496058|NCT00243230|41841470|FG003|Double-Blind Period|Protocol Violation|0|||
19496059|NCT00243230|41841467|FG000|Double-Blind Period|Randomized but Not Treated|0|||
19496060|NCT00243230|41841468|FG001|Double-Blind Period|Randomized but Not Treated|0|||
19496061|NCT00243230|41841469|FG002|Double-Blind Period|Randomized but Not Treated|2|||
19496062|NCT00243230|41841470|FG003|Double-Blind Period|Randomized but Not Treated|0|||
19496063|NCT00243230|41841467|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
19496064|NCT00243230|41841468|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
19496065|NCT00243230|41841469|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
19496066|NCT00243230|41841470|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
19496067|NCT00243230|41841467|FG000|Open Label Period|Adverse Event|0|||
19496068|NCT00243230|41841468|FG001|Open Label Period|Adverse Event|0|||
19496069|NCT00243230|41841469|FG002|Open Label Period|Adverse Event|0|||
19496070|NCT00243230|41841470|FG003|Open Label Period|Adverse Event|2|||
19496071|NCT00243230|41841467|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
19496072|NCT00243230|41841468|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
19496073|NCT00243230|41841469|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
19496074|NCT00243230|41841470|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
19496075|NCT00243230|41841467|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
19496076|NCT00243230|41841468|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
19496077|NCT00243230|41841469|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
19496078|NCT00243230|41841470|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
19496079|NCT00243230|41841467|FG000|Open Label Period|Lost to Follow-up|0|||
19496080|NCT00243230|41841468|FG001|Open Label Period|Lost to Follow-up|0|||
19496081|NCT00243230|41841469|FG002|Open Label Period|Lost to Follow-up|0|||
19496082|NCT00243230|41841470|FG003|Open Label Period|Lost to Follow-up|2|||
19496083|NCT00243230|41841467|FG000|Open Label Period|Withdrawal by Subject|0|||
19496084|NCT00243230|41841468|FG001|Open Label Period|Withdrawal by Subject|0|||
19496085|NCT00243230|41841469|FG002|Open Label Period|Withdrawal by Subject|0|||
19496086|NCT00243230|41841470|FG003|Open Label Period|Withdrawal by Subject|2|||
19496087|NCT00243230|41841467|FG000|Open Label Period|Protocol Violation|0|||
19496088|NCT00243230|41841468|FG001|Open Label Period|Protocol Violation|0|||
19496089|NCT00243230|41841469|FG002|Open Label Period|Protocol Violation|0|||
19496090|NCT00243230|41841470|FG003|Open Label Period|Protocol Violation|2|||
19496091|NCT00243230|41841467|FG000|Open Label Period|Administrative Reason|0|||
19496092|NCT00243230|41841468|FG001|Open Label Period|Administrative Reason|0|||
19496093|NCT00243230|41841469|FG002|Open Label Period|Administrative Reason|0|||
19496094|NCT00243230|41841470|FG003|Open Label Period|Administrative Reason|63|||
19496095|NCT00243074|41841480|FG000|Overall Study|Ineligible|6|||
19496096|NCT00243074|41841480|FG000|Overall Study|Adverse Event|6|||
19496097|NCT00243074|41841480|FG000|Overall Study|Withdrawal by Subject|2|||
19496098|NCT00243074|41841480|FG000|Overall Study|Lack of Efficacy|36|||
19496099|NCT00243074|41841480|FG000|Overall Study|Death|2|||
19496100|NCT00243074|41841480|FG000|Overall Study|not protocol specified|1|||
19496101|NCT00243074|41841480|FG000|Overall Study|Did not receive any treatment|1|||
19496102|NCT00241358|41841488|FG000|Overall Study|Determined to be not ineligible|0|||
19496103|NCT00241358|41841489|FG001|Overall Study|Determined to be not ineligible|1|||
19496104|NCT00241358|41841490|FG002|Overall Study|Determined to be not ineligible|1|||
19496105|NCT00241280|41841499|FG000|Overall Study|Adverse Event|2|||
19496106|NCT00241280|41841500|FG001|Overall Study|Adverse Event|6|||
19496107|NCT00241280|41841499|FG000|Overall Study|Discomfort|11|||
19496108|NCT00241280|41841500|FG001|Overall Study|Discomfort|16|||
19496109|NCT00241280|41841499|FG000|Overall Study|Pregnancy|1|||
19496110|NCT00241280|41841500|FG001|Overall Study|Pregnancy|5|||
19496111|NCT00241280|41841499|FG000|Overall Study|Lost to Follow-up|5|||
19496112|NCT00241280|41841500|FG001|Overall Study|Lost to Follow-up|8|||
19496113|NCT00241280|41841499|FG000|Overall Study|Withdrawal by Subject|7|||
19496114|NCT00241280|41841500|FG001|Overall Study|Withdrawal by Subject|4|||
19496115|NCT00241280|41841499|FG000|Overall Study|Protocol Violation|4|||
19496116|NCT00241280|41841500|FG001|Overall Study|Protocol Violation|10|||
19496117|NCT00241280|41841499|FG000|Overall Study|Relocation|4|||
19496118|NCT00241280|41841500|FG001|Overall Study|Relocation|4|||
19496119|NCT00241280|41841499|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
19496120|NCT00241280|41841500|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
19496121|NCT00241280|41841499|FG000|Overall Study|Unsatisfactory Visual Response|1|||
19496122|NCT00241280|41841500|FG001|Overall Study|Unsatisfactory Visual Response|1|||
19496123|NCT00241280|41841499|FG000|Overall Study|Diabetic|1|||
19496124|NCT00241280|41841500|FG001|Overall Study|Diabetic|0|||
19496125|NCT00241280|41841499|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
19496126|NCT00241280|41841500|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
19496127|NCT00241280|41841499|FG000|Overall Study|Dispensed incorrect test article|1|||
19496128|NCT00241280|41841500|FG001|Overall Study|Dispensed incorrect test article|2|||
19496129|NCT00241280|41841499|FG000|Overall Study|Unacceptable Fit|0|||
19496130|NCT00241280|41841500|FG001|Overall Study|Unacceptable Fit|1|||
19496131|NCT00241280|41841499|FG000|Overall Study|Scheduling Conflict|0|||
19496132|NCT00241280|41841500|FG001|Overall Study|Scheduling Conflict|2|||
19496133|NCT00241280|41841499|FG000|Overall Study|History of Ocular Surgery|0|||
19496134|NCT00241280|41841500|FG001|Overall Study|History of Ocular Surgery|1|||
19496135|NCT00241280|41841499|FG000|Overall Study|Coating on Lens|1|||
19496136|NCT00241280|41841500|FG001|Overall Study|Coating on Lens|0|||
19496137|NCT00241280|41841499|FG000|Overall Study|Excessive Dryness|0|||
19496138|NCT00241280|41841500|FG001|Overall Study|Excessive Dryness|1|||
19496139|NCT04278872|41842096|FG000|Overall Study|Adverse Event|1|||
19496140|NCT04278872|41842097|FG001|Overall Study|Adverse Event|0|||
19496141|NCT04278872|41842096|FG000|Overall Study|Protocol Violation|0|||
19496142|NCT04278872|41842097|FG001|Overall Study|Protocol Violation|1|||
19496143|NCT04278872|41842096|FG000|Overall Study|Study Termination|2|||
19496144|NCT04278872|41842097|FG001|Overall Study|Study Termination|0|||
19496145|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
19496146|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
19496147|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
19496148|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
19496149|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
19496150|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
19496151|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
19496152|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
19496153|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
19496154|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
19496155|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
19496156|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
19496157|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
19496158|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
19496159|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
19496160|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
19496161|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
19496162|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
19496163|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
19496164|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
19496165|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
19496166|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
19496167|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
19496168|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
19496169|NCT02513160|41844567|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
19496170|NCT02513160|41844568|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
19496171|NCT02513160|41844569|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
19496172|NCT02513160|41844570|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
19496173|NCT02513160|41844567|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
19496174|NCT02513160|41844568|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
19496175|NCT02513160|41844569|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
19496176|NCT02513160|41844570|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
19496177|NCT02513160|41844567|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
19496178|NCT02513160|41844568|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
19496179|NCT02513160|41844569|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
19496180|NCT02513160|41844570|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
19496181|NCT02513160|41844567|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
19496182|NCT02513160|41844568|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
19496183|NCT02513160|41844569|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
19496184|NCT02513160|41844570|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
19496185|NCT02513160|41844567|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
19496186|NCT02513160|41844568|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
19496187|NCT02513160|41844569|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
19496188|NCT02513160|41844570|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
19496189|NCT02513160|41844567|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
19496190|NCT02513160|41844568|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
19496191|NCT02513160|41844569|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
19496192|NCT02513160|41844570|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
19496193|NCT02480010|41844605|FG000|Overall Study|Adverse Event|3|||
19496194|NCT02480010|41844606|FG001|Overall Study|Adverse Event|1|||
19496195|NCT02480010|41844605|FG000|Overall Study|Death|1|||
19496196|NCT02480010|41844606|FG001|Overall Study|Death|0|||
19496197|NCT02480010|41844605|FG000|Overall Study|Insufficient therapeutic response|31|||
19496198|NCT02480010|41844606|FG001|Overall Study|Insufficient therapeutic response|29|||
19496199|NCT02480010|41844605|FG000|Overall Study|Refused Treatment|0|||
19496200|NCT02480010|41844606|FG001|Overall Study|Refused Treatment|3|||
19496201|NCT02512302|41844634|FG000|Period 1|Adverse Event|0|||
19496202|NCT02512302|41844635|FG001|Period 1|Adverse Event|1|||
19496203|NCT02512302|41844636|FG002|Period 1|Adverse Event|0|||
19496204|NCT02512302|41844637|FG003|Period 1|Adverse Event|0|||
19496205|NCT02512302|41844638|FG004|Period 1|Adverse Event|0|||
19496206|NCT02512302|41844639|FG005|Period 1|Adverse Event|0|||
19496207|NCT02512302|41844640|FG006|Period 1|Adverse Event|0|||
19496208|NCT02512302|41844641|FG007|Period 1|Adverse Event|0|||
19496209|NCT02512302|41844642|FG008|Period 1|Adverse Event|0|||
19496210|NCT02512302|41844643|FG009|Period 1|Adverse Event|0|||
19496211|NCT02512302|41844634|FG000|Period 2|Adverse Event|0|||
19496212|NCT02512302|41844635|FG001|Period 2|Adverse Event|0|||
19496213|NCT02512302|41844636|FG002|Period 2|Adverse Event|0|||
19496214|NCT02512302|41844637|FG003|Period 2|Adverse Event|0|||
19496215|NCT02512302|41844638|FG004|Period 2|Adverse Event|0|||
19496216|NCT02512302|41844639|FG005|Period 2|Adverse Event|0|||
19496217|NCT02512302|41844640|FG006|Period 2|Adverse Event|0|||
19496218|NCT02512302|41844641|FG007|Period 2|Adverse Event|0|||
19496219|NCT02512302|41844642|FG008|Period 2|Adverse Event|0|||
19496220|NCT02512302|41844643|FG009|Period 2|Adverse Event|1|||
19496221|NCT02512302|41844634|FG000|Period 3|Lost to Follow-up|0|||
19496222|NCT02512302|41844635|FG001|Period 3|Lost to Follow-up|0|||
19496223|NCT02512302|41844636|FG002|Period 3|Lost to Follow-up|1|||
19496224|NCT02512302|41844637|FG003|Period 3|Lost to Follow-up|0|||
19496225|NCT02512302|41844638|FG004|Period 3|Lost to Follow-up|0|||
19496226|NCT02512302|41844639|FG005|Period 3|Lost to Follow-up|0|||
19496227|NCT02512302|41844640|FG006|Period 3|Lost to Follow-up|0|||
19496228|NCT02512302|41844641|FG007|Period 3|Lost to Follow-up|0|||
19496229|NCT02512302|41844642|FG008|Period 3|Lost to Follow-up|0|||
19496230|NCT02512302|41844643|FG009|Period 3|Lost to Follow-up|0|||
19496231|NCT02512302|41844634|FG000|Period 4|Adverse Event|0|||
19496232|NCT02512302|41844635|FG001|Period 4|Adverse Event|0|||
19496233|NCT02512302|41844636|FG002|Period 4|Adverse Event|0|||
19496234|NCT02512302|41844637|FG003|Period 4|Adverse Event|0|||
19496235|NCT02512302|41844638|FG004|Period 4|Adverse Event|0|||
19496236|NCT02512302|41844639|FG005|Period 4|Adverse Event|0|||
19496237|NCT02512302|41844640|FG006|Period 4|Adverse Event|1|||
19496238|NCT02512302|41844641|FG007|Period 4|Adverse Event|0|||
19496239|NCT02512302|41844642|FG008|Period 4|Adverse Event|0|||
19496240|NCT02512302|41844643|FG009|Period 4|Adverse Event|0|||
19496241|NCT02512068|41844751|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
19496242|NCT02512068|41844752|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
19496243|NCT02512068|41844751|FG000|Overall Study|Major Protocol Deviation|1|||
19496244|NCT02512068|41844752|FG001|Overall Study|Major Protocol Deviation|0|||
19496245|NCT02512068|41844751|FG000|Overall Study|Voluntary Withdrawal|0|||
19496246|NCT02512068|41844752|FG001|Overall Study|Voluntary Withdrawal|1|||
19496247|NCT02512068|41844751|FG000|Overall Study|Lack of Efficacy|0|||
19496248|NCT02512068|41844752|FG001|Overall Study|Lack of Efficacy|1|||
19496249|NCT02512068|41844751|FG000|Overall Study|Reason Not Specified|3|||
19496250|NCT02512068|41844752|FG001|Overall Study|Reason Not Specified|5|||
19496251|NCT02511678|41844767|FG000|Overall Study|Withdrawal by Subject|2|||
19496252|NCT02511678|41844767|FG000|Overall Study|Lost to Follow-up|4|||
19496253|NCT02511678|41844767|FG000|Overall Study|Death|19|||
19496254|NCT02511678|41844767|FG000|Overall Study|Adverse Event|1|||
19496255|NCT02511678|41844767|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
19496256|NCT02511678|41844767|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
19496257|NCT02511678|41844767|FG000|Overall Study|Required Radiofrequency Ablation|1|||
19496258|NCT02511678|41844767|FG000|Overall Study|Biopsy was Negative|1|||
19496259|NCT02511678|41844767|FG000|Overall Study|Protocol Violation|1|||
19496260|NCT02511678|41844767|FG000|Overall Study|Received Radiation Treatment|1|||
19496261|NCT02518464|41844794|FG000|Overall Study|Adverse Event|2|||
19496262|NCT02510820|41844798|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
19496263|NCT02510820|41844799|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
19496264|NCT02510820|41844798|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19496265|NCT02510820|41844799|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
19496266|NCT02510664|41844809|FG000|Overall Study|Transferred Care|9|||
19496267|NCT02510664|41844810|FG001|Overall Study|Transferred Care|9|||
19496268|NCT02510664|41844811|FG002|Overall Study|Transferred Care|0|||
19496269|NCT02510664|41844809|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
19496270|NCT02510664|41844810|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
19496271|NCT02510664|41844811|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
19496272|NCT02510664|41844809|FG000|Overall Study|Time Constraints|1|||
19496273|NCT02510664|41844810|FG001|Overall Study|Time Constraints|1|||
19496274|NCT02510664|41844811|FG002|Overall Study|Time Constraints|0|||
19496275|NCT02510040|41844836|FG000|Overall Study|Deemed no longer eligible|18|||
19496276|NCT02510040|41844837|FG001|Overall Study|Deemed no longer eligible|3|||
19496277|NCT02510040|41844838|FG002|Overall Study|Deemed no longer eligible|1|||
19496278|NCT01363986|41844856|FG000|Overall Study|Disease progression|1|||
19496279|NCT02478372|41844890|FG000|Overall Study|Protocol Violation|12|||
19496280|NCT02478372|41844891|FG001|Overall Study|Protocol Violation|8|||
19496281|NCT02478372|41844890|FG000|Overall Study|Lost to Follow-up|1|||
19496282|NCT02478372|41844891|FG001|Overall Study|Lost to Follow-up|4|||
19496283|NCT02478372|41844890|FG000|Overall Study|Death|0|||
19496284|NCT02478372|41844891|FG001|Overall Study|Death|2|||
19496285|NCT01654536|41844903|FG000|Overall Study|Lost to Follow-up|5|||
19496286|NCT01654536|41844904|FG001|Overall Study|Lost to Follow-up|5|||
19496287|NCT01654536|41844903|FG000|Overall Study|Physician Decision|12|||
19496288|NCT01654536|41844904|FG001|Overall Study|Physician Decision|8|||
19496289|NCT01654536|41844903|FG000|Overall Study|Withdrawal by Subject|27|||
19496290|NCT01654536|41844904|FG001|Overall Study|Withdrawal by Subject|25|||
19496291|NCT01654380|41844913|FG000|Part B, Period 1|Physician Decision|0|||
19496292|NCT01654380|41844914|FG001|Part B, Period 1|Physician Decision|0|||
19496293|NCT01654380|41844915|FG002|Part B, Period 1|Physician Decision|1|||
19496294|NCT01654380|41844916|FG003|Part B, Period 1|Physician Decision|0|||
19496295|NCT02477670|41844935|FG000|Stage 1|Adverse Event|2|||
19496296|NCT02477670|41844936|FG001|Stage 1|Adverse Event|7|||
19496297|NCT02477670|41844937|FG002|Stage 1|Adverse Event|0|||
19496298|NCT02477670|41844938|FG003|Stage 1|Adverse Event|0|||
19496299|NCT02477670|41844939|FG004|Stage 1|Adverse Event|0|||
19496300|NCT02477670|41844940|FG005|Stage 1|Adverse Event|0|||
19496301|NCT02477670|41844941|FG006|Stage 1|Adverse Event|0|||
19496302|NCT02477670|41844935|FG000|Stage 1|Lost to Follow-up|0|||
19496303|NCT02477670|41844936|FG001|Stage 1|Lost to Follow-up|2|||
19496304|NCT02477670|41844937|FG002|Stage 1|Lost to Follow-up|0|||
19496305|NCT02477670|41844938|FG003|Stage 1|Lost to Follow-up|0|||
19496306|NCT02477670|41844939|FG004|Stage 1|Lost to Follow-up|0|||
19496307|NCT02477670|41844940|FG005|Stage 1|Lost to Follow-up|0|||
19496308|NCT02477670|41844941|FG006|Stage 1|Lost to Follow-up|0|||
19496309|NCT02477670|41844935|FG000|Stage 1|Withdrawal by Subject|1|||
19496310|NCT02477670|41844936|FG001|Stage 1|Withdrawal by Subject|2|||
19496311|NCT02477670|41844937|FG002|Stage 1|Withdrawal by Subject|0|||
19496312|NCT02477670|41844938|FG003|Stage 1|Withdrawal by Subject|0|||
19496313|NCT02477670|41844939|FG004|Stage 1|Withdrawal by Subject|0|||
19496314|NCT02477670|41844940|FG005|Stage 1|Withdrawal by Subject|0|||
19496315|NCT02477670|41844941|FG006|Stage 1|Withdrawal by Subject|0|||
19496316|NCT02477670|41844935|FG000|Stage 1|Non-compliance with Study Drug|1|||
19496317|NCT02477670|41844936|FG001|Stage 1|Non-compliance with Study Drug|2|||
19496318|NCT02477670|41844937|FG002|Stage 1|Non-compliance with Study Drug|0|||
19496319|NCT02477670|41844938|FG003|Stage 1|Non-compliance with Study Drug|0|||
19496320|NCT02477670|41844939|FG004|Stage 1|Non-compliance with Study Drug|0|||
19496321|NCT02477670|41844940|FG005|Stage 1|Non-compliance with Study Drug|0|||
19496322|NCT02477670|41844941|FG006|Stage 1|Non-compliance with Study Drug|0|||
19496323|NCT02477670|41844935|FG000|Stage 2|Adverse Event|0|||
19496324|NCT02477670|41844936|FG001|Stage 2|Adverse Event|0|||
19496325|NCT02477670|41844937|FG002|Stage 2|Adverse Event|1|||
19496326|NCT02477670|41844938|FG003|Stage 2|Adverse Event|0|||
19496327|NCT02477670|41844939|FG004|Stage 2|Adverse Event|0|||
19496328|NCT02477670|41844940|FG005|Stage 2|Adverse Event|0|||
19496329|NCT02477670|41844941|FG006|Stage 2|Adverse Event|0|||
19496330|NCT02477670|41844935|FG000|Stage 2|Antipsychotic Medication Changed|0|||
19496331|NCT02477670|41844936|FG001|Stage 2|Antipsychotic Medication Changed|0|||
19496332|NCT02477670|41844937|FG002|Stage 2|Antipsychotic Medication Changed|1|||
19496333|NCT02477670|41844938|FG003|Stage 2|Antipsychotic Medication Changed|0|||
19496334|NCT02477670|41844939|FG004|Stage 2|Antipsychotic Medication Changed|0|||
19496335|NCT02477670|41844940|FG005|Stage 2|Antipsychotic Medication Changed|0|||
19496336|NCT02477670|41844941|FG006|Stage 2|Antipsychotic Medication Changed|0|||
19496337|NCT02477670|41844935|FG000|Stage 2|Withdrawal by Subject|0|||
19496338|NCT02477670|41844936|FG001|Stage 2|Withdrawal by Subject|0|||
19496339|NCT02477670|41844937|FG002|Stage 2|Withdrawal by Subject|0|||
19496340|NCT02477670|41844938|FG003|Stage 2|Withdrawal by Subject|1|||
19496341|NCT02477670|41844939|FG004|Stage 2|Withdrawal by Subject|0|||
19496342|NCT02477670|41844940|FG005|Stage 2|Withdrawal by Subject|0|||
19496343|NCT02477670|41844941|FG006|Stage 2|Withdrawal by Subject|0|||
19496344|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
19496345|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
19496346|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
19496347|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
19496348|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Other|2|||
19496349|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
19496350|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
19496351|NCT02509026|41844952|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
19496352|NCT02509026|41844952|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
19496353|NCT02509026|41844952|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
19496354|NCT02509026|41844952|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
19496355|NCT02509026|41844952|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
19496356|NCT02509026|41844952|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
19496357|NCT02476968|41845335|FG000|Overall Study|Other|0|||
19496358|NCT02476968|41845336|FG001|Overall Study|Other|2|||
19496359|NCT02476968|41845337|FG002|Overall Study|Other|0|||
19496360|NCT02476968|41845335|FG000|Overall Study|Lost to Follow-up|10|||
19496361|NCT02476968|41845336|FG001|Overall Study|Lost to Follow-up|0|||
19496362|NCT02476968|41845337|FG002|Overall Study|Lost to Follow-up|1|||
19496363|NCT02476968|41845335|FG000|Overall Study|Death|48|||
19496364|NCT02476968|41845336|FG001|Overall Study|Death|8|||
19496365|NCT02476968|41845337|FG002|Overall Study|Death|1|||
19496366|NCT02476968|41845335|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19496367|NCT02476968|41845336|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19496368|NCT02476968|41845337|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
19496369|NCT02476968|41845335|FG000|Overall Study|Patient decision|37|||
19613346|NCT00951665|42062210|FG003|Phase 1b|Withdrawal by Subject|0|||
19613347|NCT00951665|42062211|FG004|Phase 1b|Withdrawal by Subject|0|||
19613348|NCT00951665|42062212|FG005|Phase 1b|Withdrawal by Subject|0|||
19613349|NCT00951665|42062207|FG000|Phase 1b|Disease Progression|13|||
19613350|NCT00951665|42062208|FG001|Phase 1b|Disease Progression|2|||
19613351|NCT00951665|42062209|FG002|Phase 1b|Disease Progression|14|||
19613352|NCT00951665|42062210|FG003|Phase 1b|Disease Progression|0|||
19613353|NCT00951665|42062211|FG004|Phase 1b|Disease Progression|0|||
19613354|NCT00951665|42062212|FG005|Phase 1b|Disease Progression|0|||
19613355|NCT00951665|42062207|FG000|Phase 1b|Protocol Violation|2|||
19613356|NCT00951665|42062208|FG001|Phase 1b|Protocol Violation|0|||
19613357|NCT00951665|42062209|FG002|Phase 1b|Protocol Violation|0|||
19613358|NCT00951665|42062210|FG003|Phase 1b|Protocol Violation|0|||
19613359|NCT00951665|42062211|FG004|Phase 1b|Protocol Violation|0|||
19613360|NCT00951665|42062212|FG005|Phase 1b|Protocol Violation|0|||
19613361|NCT00951665|42062207|FG000|Phase 2a|Adverse Event|0|||
19613362|NCT00951665|42062208|FG001|Phase 2a|Adverse Event|0|||
19613363|NCT00951665|42062209|FG002|Phase 2a|Adverse Event|0|||
19613364|NCT00951665|42062210|FG003|Phase 2a|Adverse Event|0|||
19613365|NCT00951665|42062211|FG004|Phase 2a|Adverse Event|2|||
19613366|NCT00951665|42062212|FG005|Phase 2a|Adverse Event|0|||
19613367|NCT00951665|42062207|FG000|Phase 2a|Death|0|||
19613368|NCT00951665|42062208|FG001|Phase 2a|Death|0|||
19613369|NCT00951665|42062209|FG002|Phase 2a|Death|0|||
19613370|NCT00951665|42062210|FG003|Phase 2a|Death|0|||
19613371|NCT00951665|42062211|FG004|Phase 2a|Death|1|||
19613372|NCT00951665|42062212|FG005|Phase 2a|Death|1|||
19613373|NCT00951665|42062207|FG000|Phase 2a|Lost to Follow-up|0|||
19613374|NCT00951665|42062208|FG001|Phase 2a|Lost to Follow-up|0|||
19613375|NCT00951665|42062209|FG002|Phase 2a|Lost to Follow-up|0|||
19613376|NCT00951665|42062210|FG003|Phase 2a|Lost to Follow-up|0|||
19613377|NCT00951665|42062211|FG004|Phase 2a|Lost to Follow-up|1|||
19613378|NCT00951665|42062212|FG005|Phase 2a|Lost to Follow-up|0|||
19613379|NCT00951665|42062207|FG000|Phase 2a|Physician Decision|0|||
19613380|NCT00951665|42062208|FG001|Phase 2a|Physician Decision|0|||
19613381|NCT00951665|42062209|FG002|Phase 2a|Physician Decision|0|||
19613382|NCT00951665|42062210|FG003|Phase 2a|Physician Decision|0|||
19613383|NCT00951665|42062211|FG004|Phase 2a|Physician Decision|0|||
19613384|NCT00951665|42062212|FG005|Phase 2a|Physician Decision|1|||
19613385|NCT00951665|42062207|FG000|Phase 2a|Withdrawal by Subject|0|||
19613386|NCT00951665|42062208|FG001|Phase 2a|Withdrawal by Subject|0|||
19613387|NCT00951665|42062209|FG002|Phase 2a|Withdrawal by Subject|0|||
19613388|NCT00951665|42062210|FG003|Phase 2a|Withdrawal by Subject|0|||
19613389|NCT00951665|42062211|FG004|Phase 2a|Withdrawal by Subject|2|||
19393733|NCT01670279|41637607|FG002|Overall Study|Physician Decision|0|||
19496370|NCT02476968|41845336|FG001|Overall Study|Patient decision|8|||
19496371|NCT02476968|41845337|FG002|Overall Study|Patient decision|0|||
19613390|NCT00951665|42062212|FG005|Phase 2a|Withdrawal by Subject|0|||
19613391|NCT00951665|42062207|FG000|Phase 2a|Disease Progression|0|||
19613392|NCT00951665|42062208|FG001|Phase 2a|Disease Progression|0|||
19613393|NCT00951665|42062209|FG002|Phase 2a|Disease Progression|0|||
19613394|NCT00951665|42062210|FG003|Phase 2a|Disease Progression|0|||
19613395|NCT00951665|42062211|FG004|Phase 2a|Disease Progression|6|||
19613396|NCT00951665|42062212|FG005|Phase 2a|Disease Progression|5|||
19613397|NCT00801099|42062246|FG000|Overall Study|Lost to Follow-up|101|||
19613398|NCT00887744|42062250|FG000|Overall Study|Adverse Event|3|||
19613399|NCT00887744|42062250|FG000|Overall Study|Death|1|||
19613400|NCT00887744|42062250|FG000|Overall Study|Lost to Follow-up|3|||
19613401|NCT00887744|42062250|FG000|Overall Study|Withdrawal by Subject|18|||
19613402|NCT00887744|42062250|FG000|Overall Study|Various reasons|9|||
19613403|NCT04280081|42062254|FG000|Overall Study|Adverse Event|4|||
19613404|NCT04280081|42062254|FG000|Overall Study|Death|2|||
19613405|NCT04280081|42062254|FG000|Overall Study|Progressive Disease|6|||
19613406|NCT00951509|42062267|FG000|Overall Study|Withdrawal by Subject|2|||
19613407|NCT00610441|42062279|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
19496372|NCT02476578|41845358|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
19496373|NCT02476578|41845359|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
19496374|NCT02476578|41845358|FG000|Overall Study|Lost to Follow-up|6|||
19496375|NCT02476578|41845359|FG001|Overall Study|Lost to Follow-up|13|||
19496376|NCT02504892|41845377|FG000|Overall Study|Adverse event-pneumonitis|2|||
19496377|NCT02504502|41845383|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
19496378|NCT02504502|41845384|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
19496379|NCT02504502|41845383|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
19496380|NCT02504502|41845384|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
19496381|NCT02504424|41845412|FG000|Overall Study|Withdrawal by Subject|2|||
19496382|NCT02548832|41845752|FG000|Overall Study|Lost to Follow-up|2|||
19496383|NCT02548832|41845753|FG001|Overall Study|Lost to Follow-up|2|||
19496384|NCT02548832|41845754|FG002|Overall Study|Lost to Follow-up|2|||
19496385|NCT02504268|41846004|FG000|Overall Study|Adverse Event|18|||
19496386|NCT02504268|41846005|FG001|Overall Study|Adverse Event|8|||
19496387|NCT02504268|41846006|FG002|Overall Study|Adverse Event|14|||
19496388|NCT02504268|41846007|FG003|Overall Study|Adverse Event|0|||
19496389|NCT02504268|41846008|FG004|Overall Study|Adverse Event|0|||
19496390|NCT02504268|41846009|FG005|Overall Study|Adverse Event|0|||
19496391|NCT02504268|41846010|FG006|Overall Study|Adverse Event|0|||
19496392|NCT02504268|41846011|FG007|Overall Study|Adverse Event|0|||
19496393|NCT02504268|41846012|FG008|Overall Study|Adverse Event|0|||
19496394|NCT02504268|41846004|FG000|Overall Study|Withdrawal of Consent|11|||
19496395|NCT02504268|41846005|FG001|Overall Study|Withdrawal of Consent|10|||
19496396|NCT02504268|41846006|FG002|Overall Study|Withdrawal of Consent|3|||
19496397|NCT02504268|41846007|FG003|Overall Study|Withdrawal of Consent|0|||
19496398|NCT02504268|41846008|FG004|Overall Study|Withdrawal of Consent|0|||
19496399|NCT02504268|41846009|FG005|Overall Study|Withdrawal of Consent|0|||
19496400|NCT02504268|41846010|FG006|Overall Study|Withdrawal of Consent|0|||
19496401|NCT02504268|41846011|FG007|Overall Study|Withdrawal of Consent|0|||
19496402|NCT02504268|41846012|FG008|Overall Study|Withdrawal of Consent|0|||
19496403|NCT02504268|41846004|FG000|Overall Study|Pregnancy|2|||
19496404|NCT02504268|41846005|FG001|Overall Study|Pregnancy|0|||
19496405|NCT02504268|41846006|FG002|Overall Study|Pregnancy|0|||
19496406|NCT02504268|41846007|FG003|Overall Study|Pregnancy|0|||
19496407|NCT02504268|41846008|FG004|Overall Study|Pregnancy|0|||
19496408|NCT02504268|41846009|FG005|Overall Study|Pregnancy|0|||
19496409|NCT02504268|41846010|FG006|Overall Study|Pregnancy|0|||
19496410|NCT02504268|41846011|FG007|Overall Study|Pregnancy|0|||
19496411|NCT02504268|41846012|FG008|Overall Study|Pregnancy|0|||
19496412|NCT02504268|41846004|FG000|Overall Study|Lost to Follow-up|3|||
19496413|NCT02504268|41846005|FG001|Overall Study|Lost to Follow-up|6|||
19496414|NCT02504268|41846006|FG002|Overall Study|Lost to Follow-up|4|||
19496415|NCT02504268|41846007|FG003|Overall Study|Lost to Follow-up|0|||
19496416|NCT02504268|41846008|FG004|Overall Study|Lost to Follow-up|0|||
19496417|NCT02504268|41846009|FG005|Overall Study|Lost to Follow-up|0|||
19496418|NCT02504268|41846010|FG006|Overall Study|Lost to Follow-up|0|||
19496419|NCT02504268|41846011|FG007|Overall Study|Lost to Follow-up|0|||
19496420|NCT02504268|41846012|FG008|Overall Study|Lost to Follow-up|0|||
19613408|NCT00610441|42062280|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
19613409|NCT00610441|42062281|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
19613410|NCT00610441|42062282|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
19613411|NCT00610441|42062279|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
19496421|NCT02504268|41846004|FG000|Overall Study|Death|1|||
19496422|NCT02504268|41846005|FG001|Overall Study|Death|1|||
19496423|NCT02504268|41846006|FG002|Overall Study|Death|0|||
19496424|NCT02504268|41846007|FG003|Overall Study|Death|0|||
19496425|NCT02504268|41846008|FG004|Overall Study|Death|0|||
19496426|NCT02504268|41846009|FG005|Overall Study|Death|0|||
19496427|NCT02504268|41846010|FG006|Overall Study|Death|0|||
19496428|NCT02504268|41846011|FG007|Overall Study|Death|0|||
19496429|NCT02504268|41846012|FG008|Overall Study|Death|0|||
19496430|NCT02504268|41846004|FG000|Overall Study|Subject Request to Discontinue|11|||
19496431|NCT02504268|41846005|FG001|Overall Study|Subject Request to Discontinue|3|||
19496432|NCT02504268|41846006|FG002|Overall Study|Subject Request to Discontinue|6|||
19496433|NCT02504268|41846007|FG003|Overall Study|Subject Request to Discontinue|0|||
19613412|NCT00610441|42062280|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
19496434|NCT02504268|41846008|FG004|Overall Study|Subject Request to Discontinue|0|||
19496435|NCT02504268|41846009|FG005|Overall Study|Subject Request to Discontinue|0|||
19496436|NCT02504268|41846010|FG006|Overall Study|Subject Request to Discontinue|0|||
19496437|NCT02504268|41846011|FG007|Overall Study|Subject Request to Discontinue|0|||
19496438|NCT02504268|41846012|FG008|Overall Study|Subject Request to Discontinue|0|||
19496439|NCT02504268|41846004|FG000|Overall Study|No Longer Meets Study Criteria|2|||
19496440|NCT02504268|41846005|FG001|Overall Study|No Longer Meets Study Criteria|3|||
19496441|NCT02504268|41846006|FG002|Overall Study|No Longer Meets Study Criteria|0|||
19496442|NCT02504268|41846007|FG003|Overall Study|No Longer Meets Study Criteria|0|||
19496443|NCT02504268|41846008|FG004|Overall Study|No Longer Meets Study Criteria|0|||
19496444|NCT02504268|41846009|FG005|Overall Study|No Longer Meets Study Criteria|0|||
19496445|NCT02504268|41846010|FG006|Overall Study|No Longer Meets Study Criteria|0|||
19496446|NCT02504268|41846011|FG007|Overall Study|No Longer Meets Study Criteria|0|||
19496447|NCT02504268|41846012|FG008|Overall Study|No Longer Meets Study Criteria|0|||
19496448|NCT02504268|41846004|FG000|Overall Study|Lack of Efficacy|11|||
19496449|NCT02504268|41846005|FG001|Overall Study|Lack of Efficacy|35|||
19496450|NCT02504268|41846006|FG002|Overall Study|Lack of Efficacy|9|||
19496451|NCT02504268|41846007|FG003|Overall Study|Lack of Efficacy|0|||
19496452|NCT02504268|41846008|FG004|Overall Study|Lack of Efficacy|0|||
19496453|NCT02504268|41846009|FG005|Overall Study|Lack of Efficacy|0|||
19496454|NCT02504268|41846010|FG006|Overall Study|Lack of Efficacy|0|||
19496455|NCT02504268|41846011|FG007|Overall Study|Lack of Efficacy|0|||
19496456|NCT02504268|41846012|FG008|Overall Study|Lack of Efficacy|0|||
19496457|NCT02504268|41846004|FG000|Overall Study|Poor/Non-Compliance|3|||
19496458|NCT02504268|41846005|FG001|Overall Study|Poor/Non-Compliance|2|||
19496459|NCT02504268|41846006|FG002|Overall Study|Poor/Non-Compliance|3|||
19496460|NCT02504268|41846007|FG003|Overall Study|Poor/Non-Compliance|0|||
19496461|NCT02504268|41846008|FG004|Overall Study|Poor/Non-Compliance|0|||
19496462|NCT02504268|41846009|FG005|Overall Study|Poor/Non-Compliance|0|||
19496463|NCT02504268|41846010|FG006|Overall Study|Poor/Non-Compliance|0|||
19496464|NCT02504268|41846011|FG007|Overall Study|Poor/Non-Compliance|0|||
19496465|NCT02504268|41846012|FG008|Overall Study|Poor/Non-Compliance|0|||
19496466|NCT02504268|41846004|FG000|Overall Study|Not Disclosed|1|||
19496467|NCT02504268|41846005|FG001|Overall Study|Not Disclosed|0|||
19496468|NCT02504268|41846006|FG002|Overall Study|Not Disclosed|2|||
19496469|NCT02504268|41846007|FG003|Overall Study|Not Disclosed|0|||
19496470|NCT02504268|41846008|FG004|Overall Study|Not Disclosed|0|||
19496471|NCT02504268|41846009|FG005|Overall Study|Not Disclosed|0|||
19496472|NCT02504268|41846010|FG006|Overall Study|Not Disclosed|0|||
19496473|NCT02504268|41846011|FG007|Overall Study|Not Disclosed|0|||
19496474|NCT02504268|41846012|FG008|Overall Study|Not Disclosed|0|||
19496475|NCT01654302|41846070|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
19496476|NCT01654302|41846071|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
19496477|NCT02476422|41846087|FG000|Overall Study|Subject/guardian decision|0|||
19496478|NCT02476422|41846088|FG001|Overall Study|Subject/guardian decision|1|||
19496479|NCT02475954|41846100|FG000|Overall Study|Withdrawal by Subject|2|||
19496480|NCT02475954|41846101|FG001|Overall Study|Withdrawal by Subject|2|||
19496481|NCT02475954|41846100|FG000|Overall Study|Lost to Follow-up|11|||
19496482|NCT02475954|41846101|FG001|Overall Study|Lost to Follow-up|9|||
19496483|NCT02475954|41846100|FG000|Overall Study|Death|1|||
19496484|NCT02475954|41846101|FG001|Overall Study|Death|1|||
19496485|NCT02475564|41846128|FG000|Overall Study|Withdrawal by Subject|1|||
19496486|NCT02475564|41846129|FG001|Overall Study|Withdrawal by Subject|0|||
19496487|NCT02475564|41846128|FG000|Overall Study|Lost to Follow-up|2|||
19496488|NCT02475564|41846129|FG001|Overall Study|Lost to Follow-up|1|||
19496489|NCT02475564|41846128|FG000|Overall Study|Intense Menstrual bleeding|1|||
19496490|NCT02475564|41846129|FG001|Overall Study|Intense Menstrual bleeding|0|||
19496491|NCT02503332|41846412|FG000|Overall Study|Adverse Event|17|||
19496492|NCT02503332|41846413|FG001|Overall Study|Adverse Event|5|||
19496493|NCT02503332|41846414|FG002|Overall Study|Adverse Event|3|||
19496494|NCT02503332|41846415|FG003|Overall Study|Adverse Event|1|||
19496495|NCT02503332|41846412|FG000|Overall Study|Investigator's Decision|5|||
19496496|NCT02503332|41846413|FG001|Overall Study|Investigator's Decision|1|||
19496497|NCT02503332|41846414|FG002|Overall Study|Investigator's Decision|0|||
19496498|NCT02503332|41846415|FG003|Overall Study|Investigator's Decision|0|||
19496499|NCT02503332|41846412|FG000|Overall Study|Sponsor's Decision|1|||
19496500|NCT02503332|41846413|FG001|Overall Study|Sponsor's Decision|0|||
19496501|NCT02503332|41846414|FG002|Overall Study|Sponsor's Decision|0|||
19496502|NCT02503332|41846415|FG003|Overall Study|Sponsor's Decision|1|||
19496503|NCT02503332|41846412|FG000|Overall Study|Subject Request|6|||
19496504|NCT02503332|41846413|FG001|Overall Study|Subject Request|5|||
19496505|NCT02503332|41846414|FG002|Overall Study|Subject Request|2|||
19496506|NCT02503332|41846415|FG003|Overall Study|Subject Request|1|||
19496507|NCT02503332|41846412|FG000|Overall Study|Death|0|||
19496508|NCT02503332|41846413|FG001|Overall Study|Death|2|||
19496509|NCT02503332|41846414|FG002|Overall Study|Death|2|||
19496510|NCT02503332|41846415|FG003|Overall Study|Death|0|||
19496511|NCT02503332|41846412|FG000|Overall Study|Other|5|||
19496512|NCT02503332|41846413|FG001|Overall Study|Other|6|||
19496513|NCT02503332|41846414|FG002|Overall Study|Other|1|||
19496514|NCT02503332|41846415|FG003|Overall Study|Other|1|||
19496515|NCT02502864|41846433|FG000|Overall Study|Withdrawal by Subject|1|||
19496516|NCT02474082|41846467|FG000|Overall Study|Adverse Event|2|||
19496517|NCT02474082|41846468|FG001|Overall Study|Adverse Event|32|||
19496518|NCT02474082|41846467|FG000|Overall Study|Withdrawal of informed consent|1|||
19496519|NCT02474082|41846468|FG001|Overall Study|Withdrawal of informed consent|11|||
19496520|NCT02474082|41846467|FG000|Overall Study|Lost to Follow-up|2|||
19496521|NCT02474082|41846468|FG001|Overall Study|Lost to Follow-up|2|||
19496522|NCT02474082|41846467|FG000|Overall Study|Dose tapering not achieved|0|||
19496523|NCT02474082|41846468|FG001|Overall Study|Dose tapering not achieved|4|||
19496524|NCT02474082|41846467|FG000|Overall Study|Participant/guardian decision|1|||
19496525|NCT02474082|41846468|FG001|Overall Study|Participant/guardian decision|2|||
19496526|NCT02474082|41846467|FG000|Overall Study|Non-compliance with study treatment|0|||
19496527|NCT02474082|41846468|FG001|Overall Study|Non-compliance with study treatment|2|||
19496528|NCT02474082|41846467|FG000|Overall Study|Protocol deviation|0|||
19496529|NCT02474082|41846468|FG001|Overall Study|Protocol deviation|1|||
19496530|NCT02501928|41846578|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
19496531|NCT02501928|41846579|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
19496532|NCT02501928|41846580|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
19496533|NCT02501928|41846581|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
19496534|NCT02501928|41846582|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
19496535|NCT02501928|41846583|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
19496536|NCT02473614|41846647|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
19496537|NCT02473614|41846648|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
19496538|NCT02500758|41846670|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
19496539|NCT02500758|41846671|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
19496540|NCT02500758|41846670|FG000|Washout (1 Week)|Lost to Follow-up|2|||
19496541|NCT02500758|41846671|FG001|Washout (1 Week)|Lost to Follow-up|2|||
19496542|NCT02500758|41846670|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
19496543|NCT02500758|41846671|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
19496544|NCT02500758|41846670|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
19496545|NCT02500758|41846671|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
19496546|NCT02500758|41846670|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
19496547|NCT02500758|41846671|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
19496548|NCT02500056|41846685|FG000|Overall Study|Lost to Follow-up|3|||
19496549|NCT02500056|41846686|FG001|Overall Study|Lost to Follow-up|7|||
19496550|NCT02500056|41846685|FG000|Overall Study|Recurrence|1|||
19496551|NCT02500056|41846686|FG001|Overall Study|Recurrence|0|||
19496552|NCT02500056|41846685|FG000|Overall Study|Death|3|||
19496553|NCT02500056|41846686|FG001|Overall Study|Death|1|||
19496554|NCT02472756|41846735|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
19496555|NCT02472756|41846735|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
19496556|NCT02472756|41846735|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
19496557|NCT02472756|41846735|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
19496558|NCT02472756|41846735|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
19496559|NCT02498652|41846745|FG000|Overall Study|Protocol Violation|0|||
19496560|NCT02498652|41846746|FG001|Overall Study|Protocol Violation|1|||
19496561|NCT03213158|41846770|FG000|Overall Study|Withdrawal by Subject|1|||
19496562|NCT03213158|41846770|FG000|Overall Study|Physician Decision|2|||
19496563|NCT02498418|41846777|FG000|Overall Study|Lack of Efficacy|0|||
19496564|NCT02498418|41846778|FG001|Overall Study|Lack of Efficacy|0|||
19496565|NCT02498418|41846779|FG002|Overall Study|Lack of Efficacy|1|||
19496566|NCT02498418|41846777|FG000|Overall Study|Withdrawal by Subject|2|||
19496567|NCT02498418|41846778|FG001|Overall Study|Withdrawal by Subject|0|||
19496568|NCT02498418|41846779|FG002|Overall Study|Withdrawal by Subject|3|||
19496569|NCT02498418|41846777|FG000|Overall Study|Lost to Follow-up|0|||
19496570|NCT02498418|41846778|FG001|Overall Study|Lost to Follow-up|1|||
19496571|NCT02498418|41846779|FG002|Overall Study|Lost to Follow-up|1|||
19496572|NCT02498418|41846777|FG000|Overall Study|Participant taken prohibited medication|0|||
19496573|NCT02498418|41846778|FG001|Overall Study|Participant taken prohibited medication|1|||
19496574|NCT02498418|41846779|FG002|Overall Study|Participant taken prohibited medication|1|||
19496575|NCT02472366|41846797|FG000|Overall Study|Lost to Follow-up|1|||
19496576|NCT02472366|41846798|FG001|Overall Study|Lost to Follow-up|0|||
19496577|NCT03217136|41846806|FG000|Overall Study|Lost to Follow-up|2|||
19496578|NCT03217136|41846807|FG001|Overall Study|Lost to Follow-up|1|||
19496579|NCT03217136|41846806|FG000|Overall Study|Site Randomized Participant in Error|0|||
19373686|NCT02742181|41614864|FG001|Overall Study|Physician Decision|0|||
19496580|NCT03217136|41846807|FG001|Overall Study|Site Randomized Participant in Error|1|||
19496581|NCT03217136|41846806|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
19496582|NCT03217136|41846807|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
19496583|NCT03217136|41846806|FG000|Overall Study|Dispensing Error|1|||
19496584|NCT03217136|41846807|FG001|Overall Study|Dispensing Error|0|||
19496585|NCT03217136|41846806|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19496586|NCT03217136|41846807|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19496587|NCT03219164|41846815|FG000|Overall Study|Study Terminated by Sponsor|16|||
19496588|NCT03219164|41846816|FG001|Overall Study|Study Terminated by Sponsor|12|||
19496589|NCT03219164|41846815|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
19496590|NCT03219164|41846816|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
19496591|NCT03219164|41846815|FG000|Overall Study|Lost to Follow-up|1|||
19496592|NCT03219164|41846816|FG001|Overall Study|Lost to Follow-up|1|||
19496593|NCT03219164|41846815|FG000|Overall Study|Adverse Event|1|||
19496594|NCT03219164|41846816|FG001|Overall Study|Adverse Event|0|||
19496595|NCT03219164|41846815|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19496596|NCT03219164|41846816|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19496597|NCT03219164|41846815|FG000|Overall Study|Protocol Violation|0|||
19496598|NCT03219164|41846816|FG001|Overall Study|Protocol Violation|1|||
19496599|NCT03219164|41846815|FG000|Overall Study|Withdrew Assent|1|||
19496600|NCT03219164|41846816|FG001|Overall Study|Withdrew Assent|0|||
19496601|NCT02471586|41846834|FG000|Overall Study|Lost to Follow-up|3|||
19496602|NCT02471586|41846835|FG001|Overall Study|Lost to Follow-up|8|||
19496603|NCT02471586|41846836|FG002|Overall Study|Lost to Follow-up|4|||
19496604|NCT02471586|41846834|FG000|Overall Study|Death|2|||
19496605|NCT02471586|41846835|FG001|Overall Study|Death|2|||
19496606|NCT02471586|41846836|FG002|Overall Study|Death|0|||
19496607|NCT02470806|41846987|FG000|Overall Study|Lost to Follow-up|1|||
19496608|NCT02470806|41846988|FG001|Overall Study|Lost to Follow-up|1|||
19496609|NCT02470806|41846987|FG000|Overall Study|Adverse Event|5|||
19496610|NCT02470806|41846988|FG001|Overall Study|Adverse Event|2|||
19496611|NCT02470806|41846987|FG000|Overall Study|Protocol Violation|4|||
19496612|NCT02470806|41846988|FG001|Overall Study|Protocol Violation|11|||
19496613|NCT02470806|41846987|FG000|Overall Study|Physician Decision|0|||
19496614|NCT02470806|41846988|FG001|Overall Study|Physician Decision|3|||
19496615|NCT02470806|41846987|FG000|Overall Study|Withdrawal by Subject|3|||
19496616|NCT02470806|41846988|FG001|Overall Study|Withdrawal by Subject|10|||
19496617|NCT02470806|41846987|FG000|Overall Study|Lack of Efficacy|5|||
19496618|NCT02470806|41846988|FG001|Overall Study|Lack of Efficacy|15|||
19496619|NCT01363908|41847030|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
19496620|NCT01363908|41847031|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
19496621|NCT01363908|41847030|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
19496622|NCT01363908|41847031|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
19496623|NCT01363908|41847030|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
19496624|NCT01363908|41847031|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
19496625|NCT01363908|41847030|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
19496626|NCT01363908|41847031|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
19496627|NCT02497404|41847069|FG000|Overall Study|Adverse Event|1|||
19496628|NCT02496702|41847102|FG000|Overall Study|Lost to Follow-up|8|||
19496629|NCT02496702|41847103|FG001|Overall Study|Lost to Follow-up|6|||
19496630|NCT02496702|41847102|FG000|Overall Study|Only partially tested|0|||
19496631|NCT02496702|41847103|FG001|Overall Study|Only partially tested|2|||
19496632|NCT02469246|41847179|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
19496633|NCT02469246|41847180|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
19496634|NCT02469246|41847179|FG000|Double-Blind Phase|Adverse Event|12|||
19496635|NCT02469246|41847180|FG001|Double-Blind Phase|Adverse Event|9|||
19496636|NCT02469246|41847179|FG000|Double-Blind Phase|Death|2|||
19496637|NCT02469246|41847180|FG001|Double-Blind Phase|Death|0|||
19496638|NCT02469246|41847179|FG000|Double-Blind Phase|Lack of Efficacy|2|||
19496639|NCT02469246|41847180|FG001|Double-Blind Phase|Lack of Efficacy|1|||
19496640|NCT02469246|41847179|FG000|Double-Blind Phase|Investigator's Discretion|8|||
19496641|NCT02469246|41847180|FG001|Double-Blind Phase|Investigator's Discretion|8|||
19496642|NCT02469246|41847179|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
19496643|NCT02469246|41847180|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19496644|NCT02469246|41847179|FG000|Double-Blind Phase|Protocol Violation|1|||
19496645|NCT02469246|41847180|FG001|Double-Blind Phase|Protocol Violation|1|||
19496646|NCT02469246|41847179|FG000|Double-Blind Phase|Withdrew Consent|25|||
19496647|NCT02469246|41847180|FG001|Double-Blind Phase|Withdrew Consent|25|||
19496648|NCT02469246|41847179|FG000|Double-Blind Phase|Lost to Follow-up|9|||
19496649|NCT02469246|41847180|FG001|Double-Blind Phase|Lost to Follow-up|5|||
19496650|NCT02469168|41847199|FG000|Overall Study|Trial closed|1|||
19496651|NCT02469168|41847200|FG001|Overall Study|Trial closed|0|||
19704364|NCT00180414|42148670|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
19704365|NCT00180414|42148671|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
19496652|NCT02469090|41847208|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
19496653|NCT02469090|41847209|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
19496654|NCT02469090|41847210|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
19496655|NCT02469090|41847208|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
19496656|NCT02469090|41847209|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
19704366|NCT00174252|42148677|FG000|Overall Study|Protocol Violation|2|||
19496657|NCT02469090|41847210|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
19496658|NCT02469090|41847208|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
19496659|NCT02469090|41847209|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
19496660|NCT02469090|41847210|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
19496661|NCT02469090|41847208|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
19496662|NCT02469090|41847209|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
19496663|NCT02469090|41847210|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
19496664|NCT02469090|41847208|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
19496665|NCT02469090|41847209|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
19496666|NCT02469090|41847210|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
19496667|NCT02469090|41847208|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
19496668|NCT02469090|41847209|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
19496669|NCT02469090|41847210|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
19496670|NCT02469090|41847208|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
19496671|NCT02469090|41847209|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
19496672|NCT02469090|41847210|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
19496673|NCT02469090|41847208|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
19496674|NCT02469090|41847209|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
19496675|NCT02469090|41847210|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
19496676|NCT02496000|41847220|FG000|Overall Study|Withdrawal by Subject|1|||
19496677|NCT02496000|41847221|FG001|Overall Study|Withdrawal by Subject|2|||
19496678|NCT02496000|41847222|FG002|Overall Study|Withdrawal by Subject|0|||
19496679|NCT02496000|41847220|FG000|Overall Study|Lost to Follow-up|1|||
19496680|NCT02496000|41847221|FG001|Overall Study|Lost to Follow-up|0|||
19496681|NCT02496000|41847222|FG002|Overall Study|Lost to Follow-up|1|||
19496682|NCT02496000|41847220|FG000|Overall Study|Protocol Violation|0|||
19496683|NCT02496000|41847221|FG001|Overall Study|Protocol Violation|0|||
19496684|NCT02496000|41847222|FG002|Overall Study|Protocol Violation|1|||
19496685|NCT02496000|41847220|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
19496686|NCT02496000|41847221|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
19496687|NCT02496000|41847222|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
19496688|NCT02496000|41847220|FG000|Overall Study|undetermined|0|||
19496689|NCT02496000|41847221|FG001|Overall Study|undetermined|1|||
19496690|NCT02496000|41847222|FG002|Overall Study|undetermined|0|||
19496691|NCT02468934|41847231|FG000|Overall Study|Withdrawal by Subject|4|||
19496692|NCT02468934|41847231|FG000|Overall Study|Screen Failure|3|||
19496693|NCT02517528|41847237|FG000|Overall Study|Withdrawal by Subject|1|||
19496694|NCT02495844|41847243|FG000|Overall Study|Lack of Efficacy|1|||
19496695|NCT02495844|41847244|FG001|Overall Study|Lack of Efficacy|2|||
19496696|NCT02495844|41847243|FG000|Overall Study|AE, non-fatal|0|||
19496697|NCT02495844|41847244|FG001|Overall Study|AE, non-fatal|1|||
19496698|NCT02495844|41847243|FG000|Overall Study|Hepatitis Positivity|0|||
19496699|NCT02495844|41847244|FG001|Overall Study|Hepatitis Positivity|1|||
19496700|NCT02468778|41847255|FG000|Overall Study|Death|2|||
19496701|NCT02468778|41847256|FG001|Overall Study|Death|1|||
19496702|NCT02468778|41847257|FG002|Overall Study|Death|0|||
19496703|NCT02468778|41847255|FG000|Overall Study|Lost to Follow-up|1|||
19496704|NCT02468778|41847256|FG001|Overall Study|Lost to Follow-up|2|||
19496705|NCT02468778|41847257|FG002|Overall Study|Lost to Follow-up|2|||
19496706|NCT02468778|41847255|FG000|Overall Study|Withdrawal by Subject|0|||
19496707|NCT02468778|41847256|FG001|Overall Study|Withdrawal by Subject|1|||
19496708|NCT02468778|41847257|FG002|Overall Study|Withdrawal by Subject|1|||
19496709|NCT01727336|41847271|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
19496710|NCT01727336|41847272|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
19496711|NCT01727336|41847273|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
19496712|NCT01727336|41847274|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
19496713|NCT01727336|41847275|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
19496714|NCT01727336|41847276|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
19496715|NCT01727336|41847271|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
19496716|NCT01727336|41847272|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
19496717|NCT01727336|41847273|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
19496718|NCT01727336|41847274|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
19496719|NCT01727336|41847275|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
19496720|NCT01727336|41847276|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
19496721|NCT01727336|41847271|FG000|Part 2 Blinded|Death|0|||
19496722|NCT01727336|41847272|FG001|Part 2 Blinded|Death|0|||
19496723|NCT01727336|41847273|FG002|Part 2 Blinded|Death|0|||
19496724|NCT01727336|41847274|FG003|Part 2 Blinded|Death|0|||
19496725|NCT01727336|41847275|FG004|Part 2 Blinded|Death|20|||
19496726|NCT01727336|41847276|FG005|Part 2 Blinded|Death|16|||
19496727|NCT01727336|41847271|FG000|Part 2 Blinded|Lack of Efficacy|0|||
19496728|NCT01727336|41847272|FG001|Part 2 Blinded|Lack of Efficacy|0|||
19496729|NCT01727336|41847273|FG002|Part 2 Blinded|Lack of Efficacy|0|||
19496730|NCT01727336|41847274|FG003|Part 2 Blinded|Lack of Efficacy|0|||
19496731|NCT01727336|41847275|FG004|Part 2 Blinded|Lack of Efficacy|42|||
19496732|NCT01727336|41847276|FG005|Part 2 Blinded|Lack of Efficacy|44|||
19496733|NCT01727336|41847271|FG000|Part 2 Blinded|Lost to Follow-up|0|||
19496734|NCT01727336|41847272|FG001|Part 2 Blinded|Lost to Follow-up|0|||
19496735|NCT01727336|41847273|FG002|Part 2 Blinded|Lost to Follow-up|0|||
19496736|NCT01727336|41847274|FG003|Part 2 Blinded|Lost to Follow-up|0|||
19496737|NCT01727336|41847275|FG004|Part 2 Blinded|Lost to Follow-up|0|||
19496738|NCT01727336|41847276|FG005|Part 2 Blinded|Lost to Follow-up|1|||
19496739|NCT01727336|41847271|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
19496740|NCT01727336|41847272|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
19496741|NCT01727336|41847273|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
19496742|NCT01727336|41847274|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
19496743|NCT01727336|41847275|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
19496744|NCT01727336|41847276|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
19496745|NCT01727336|41847271|FG000|Part 2 Blinded|use of prohibited medications|0|||
19496746|NCT01727336|41847272|FG001|Part 2 Blinded|use of prohibited medications|0|||
19496747|NCT01727336|41847273|FG002|Part 2 Blinded|use of prohibited medications|0|||
19496748|NCT01727336|41847274|FG003|Part 2 Blinded|use of prohibited medications|0|||
19496749|NCT01727336|41847275|FG004|Part 2 Blinded|use of prohibited medications|1|||
19496750|NCT01727336|41847276|FG005|Part 2 Blinded|use of prohibited medications|3|||
19496751|NCT02466516|41847310|FG000|Overall Study|Adverse Event|1|||
19496752|NCT02466516|41847311|FG001|Overall Study|Adverse Event|1|||
19496753|NCT02466516|41847312|FG002|Overall Study|Adverse Event|0|||
19496754|NCT02466516|41847313|FG003|Overall Study|Adverse Event|0|||
19496755|NCT02466516|41847314|FG004|Overall Study|Adverse Event|0|||
19496756|NCT02466516|41847310|FG000|Overall Study|Withdrew Consent|1|||
19496757|NCT02466516|41847311|FG001|Overall Study|Withdrew Consent|0|||
19496758|NCT02466516|41847312|FG002|Overall Study|Withdrew Consent|0|||
19496759|NCT02466516|41847313|FG003|Overall Study|Withdrew Consent|0|||
19496760|NCT02466516|41847314|FG004|Overall Study|Withdrew Consent|0|||
19496761|NCT02466516|41847310|FG000|Overall Study|Lost to Follow-up|2|||
19496762|NCT02466516|41847311|FG001|Overall Study|Lost to Follow-up|0|||
19496763|NCT02466516|41847312|FG002|Overall Study|Lost to Follow-up|1|||
19496764|NCT02466516|41847313|FG003|Overall Study|Lost to Follow-up|0|||
19496765|NCT02466516|41847314|FG004|Overall Study|Lost to Follow-up|0|||
19496766|NCT01725152|41847328|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
19496767|NCT01725152|41847329|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
19496768|NCT01725152|41847328|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
19496769|NCT01725152|41847329|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
19496770|NCT01725152|41847328|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
19496771|NCT01725152|41847329|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
19496772|NCT01725152|41847328|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
19496773|NCT01725152|41847329|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
19496774|NCT01049984|41847345|FG000|Overall Study|Withdrawal by Subject|1|||
19496775|NCT01049984|41847346|FG001|Overall Study|Withdrawal by Subject|5|||
19496776|NCT01049984|41847345|FG000|Overall Study|Protocol Violation|3|||
19496777|NCT01049984|41847346|FG001|Overall Study|Protocol Violation|4|||
19496778|NCT01049984|41847345|FG000|Overall Study|Lost to Follow-up|2|||
19496779|NCT01049984|41847346|FG001|Overall Study|Lost to Follow-up|1|||
19496780|NCT01049984|41847345|FG000|Overall Study|Adverse Event|13|||
19496781|NCT01049984|41847346|FG001|Overall Study|Adverse Event|7|||
19496782|NCT01049984|41847345|FG000|Overall Study|Treatment failure|0|||
19496783|NCT01049984|41847346|FG001|Overall Study|Treatment failure|2|||
19496784|NCT01049360|41847352|FG000|Period 1|Adverse Event|0|||
19496785|NCT01049360|41847353|FG001|Period 1|Adverse Event|1|||
19496786|NCT01049360|41847354|FG002|Period 1|Adverse Event|0|||
19496787|NCT01049360|41847355|FG003|Period 1|Adverse Event|1|||
19496788|NCT01049360|41847356|FG004|Period 1|Adverse Event|0|||
19496789|NCT01049360|41847357|FG005|Period 1|Adverse Event|0|||
19496790|NCT01049360|41847358|FG006|Period 1|Adverse Event|0|||
19496791|NCT01049360|41847359|FG007|Period 1|Adverse Event|1|||
19496792|NCT01049360|41847360|FG008|Period 1|Adverse Event|0|||
19496793|NCT01049360|41847361|FG009|Period 1|Adverse Event|0|||
19496794|NCT01049360|41847362|FG010|Period 1|Adverse Event|0|||
19496795|NCT01049360|41847363|FG011|Period 1|Adverse Event|0|||
19496796|NCT01049360|41847364|FG012|Period 1|Adverse Event|1|||
19496797|NCT01049360|41847365|FG013|Period 1|Adverse Event|1|||
19496798|NCT01049360|41847366|FG014|Period 1|Adverse Event|0|||
19496799|NCT01049360|41847367|FG015|Period 1|Adverse Event|0|||
19496800|NCT01049360|41847368|FG016|Period 1|Adverse Event|1|||
19704367|NCT00169104|42148685|FG000|Overall Study|Withdrawal by Subject|2|||
19704368|NCT00169104|42148686|FG001|Overall Study|Withdrawal by Subject|0|||
19704369|NCT00169104|42148685|FG000|Overall Study|Protocol Violation|0|||
19704370|NCT00169104|42148686|FG001|Overall Study|Protocol Violation|1|||
19704371|NCT00169104|42148685|FG000|Overall Study|Physician Decision|0|||
19373687|NCT02742103|41614872|FG000|Overall Study|Protocol Violation|1|||
19613413|NCT00610441|42062281|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
19613414|NCT00610441|42062282|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
19613415|NCT00610441|42062279|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
19613416|NCT00610441|42062280|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
19613417|NCT00610441|42062281|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
19496801|NCT01049360|41847369|FG017|Period 1|Adverse Event|0|||
19496802|NCT01049360|41847370|FG018|Period 1|Adverse Event|1|||
19496803|NCT01049360|41847371|FG019|Period 1|Adverse Event|0|||
19496804|NCT01049360|41847352|FG000|Period 1|Did not meet inc/exc criteria|0|||
19496805|NCT01049360|41847353|FG001|Period 1|Did not meet inc/exc criteria|0|||
19496806|NCT01049360|41847354|FG002|Period 1|Did not meet inc/exc criteria|0|||
19496807|NCT01049360|41847355|FG003|Period 1|Did not meet inc/exc criteria|0|||
19496808|NCT01049360|41847356|FG004|Period 1|Did not meet inc/exc criteria|0|||
19496809|NCT01049360|41847357|FG005|Period 1|Did not meet inc/exc criteria|0|||
19496810|NCT01049360|41847358|FG006|Period 1|Did not meet inc/exc criteria|0|||
19496811|NCT01049360|41847359|FG007|Period 1|Did not meet inc/exc criteria|1|||
19496812|NCT01049360|41847360|FG008|Period 1|Did not meet inc/exc criteria|1|||
19496813|NCT01049360|41847361|FG009|Period 1|Did not meet inc/exc criteria|0|||
19496814|NCT01049360|41847362|FG010|Period 1|Did not meet inc/exc criteria|0|||
19496815|NCT01049360|41847363|FG011|Period 1|Did not meet inc/exc criteria|0|||
19496816|NCT01049360|41847364|FG012|Period 1|Did not meet inc/exc criteria|0|||
19496817|NCT01049360|41847365|FG013|Period 1|Did not meet inc/exc criteria|0|||
19496818|NCT01049360|41847366|FG014|Period 1|Did not meet inc/exc criteria|0|||
19496819|NCT01049360|41847367|FG015|Period 1|Did not meet inc/exc criteria|0|||
19496820|NCT01049360|41847368|FG016|Period 1|Did not meet inc/exc criteria|0|||
19496821|NCT01049360|41847369|FG017|Period 1|Did not meet inc/exc criteria|0|||
19496822|NCT01049360|41847370|FG018|Period 1|Did not meet inc/exc criteria|0|||
19496823|NCT01049360|41847371|FG019|Period 1|Did not meet inc/exc criteria|0|||
19496824|NCT01049360|41847352|FG000|Period 1|Withdrawal by Subject|0|||
19496825|NCT01049360|41847353|FG001|Period 1|Withdrawal by Subject|0|||
19496826|NCT01049360|41847354|FG002|Period 1|Withdrawal by Subject|0|||
19496827|NCT01049360|41847355|FG003|Period 1|Withdrawal by Subject|0|||
19496828|NCT01049360|41847356|FG004|Period 1|Withdrawal by Subject|0|||
19496829|NCT01049360|41847357|FG005|Period 1|Withdrawal by Subject|0|||
19496830|NCT01049360|41847358|FG006|Period 1|Withdrawal by Subject|0|||
19496831|NCT01049360|41847359|FG007|Period 1|Withdrawal by Subject|0|||
19496832|NCT01049360|41847360|FG008|Period 1|Withdrawal by Subject|1|||
19496833|NCT01049360|41847361|FG009|Period 1|Withdrawal by Subject|0|||
19496834|NCT01049360|41847362|FG010|Period 1|Withdrawal by Subject|1|||
19496835|NCT01049360|41847363|FG011|Period 1|Withdrawal by Subject|0|||
19496836|NCT01049360|41847364|FG012|Period 1|Withdrawal by Subject|1|||
19613418|NCT00610441|42062282|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
19613419|NCT00610441|42062279|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
19704372|NCT00169104|42148686|FG001|Overall Study|Physician Decision|1|||
19496837|NCT01049360|41847365|FG013|Period 1|Withdrawal by Subject|0|||
19496838|NCT01049360|41847366|FG014|Period 1|Withdrawal by Subject|0|||
19496839|NCT01049360|41847367|FG015|Period 1|Withdrawal by Subject|0|||
19496840|NCT01049360|41847368|FG016|Period 1|Withdrawal by Subject|0|||
19496841|NCT01049360|41847369|FG017|Period 1|Withdrawal by Subject|0|||
19496842|NCT01049360|41847370|FG018|Period 1|Withdrawal by Subject|0|||
19496843|NCT01049360|41847371|FG019|Period 1|Withdrawal by Subject|0|||
19496844|NCT01049360|41847352|FG000|Period 2|Protocol Violation|0|||
19496845|NCT01049360|41847353|FG001|Period 2|Protocol Violation|0|||
19496846|NCT01049360|41847354|FG002|Period 2|Protocol Violation|0|||
19496847|NCT01049360|41847355|FG003|Period 2|Protocol Violation|1|||
19496848|NCT01049360|41847356|FG004|Period 2|Protocol Violation|0|||
19704373|NCT00163020|42148695|FG000|Overall Study|Lost to Follow-up|0|||
19496849|NCT01049360|41847357|FG005|Period 2|Protocol Violation|0|||
19496850|NCT01049360|41847358|FG006|Period 2|Protocol Violation|0|||
19496851|NCT01049360|41847359|FG007|Period 2|Protocol Violation|0|||
19496852|NCT01049360|41847360|FG008|Period 2|Protocol Violation|0|||
19496853|NCT01049360|41847361|FG009|Period 2|Protocol Violation|0|||
19496854|NCT01049360|41847362|FG010|Period 2|Protocol Violation|0|||
19496855|NCT01049360|41847363|FG011|Period 2|Protocol Violation|0|||
19496856|NCT01049360|41847364|FG012|Period 2|Protocol Violation|0|||
19496857|NCT01049360|41847365|FG013|Period 2|Protocol Violation|0|||
19496858|NCT01049360|41847366|FG014|Period 2|Protocol Violation|1|||
19496859|NCT01049360|41847367|FG015|Period 2|Protocol Violation|1|||
19496860|NCT01049360|41847368|FG016|Period 2|Protocol Violation|0|||
19496861|NCT01049360|41847369|FG017|Period 2|Protocol Violation|0|||
19496862|NCT01049360|41847370|FG018|Period 2|Protocol Violation|0|||
19496863|NCT01049360|41847371|FG019|Period 2|Protocol Violation|0|||
19496864|NCT01049360|41847352|FG000|Period 2|Adverse Event|0|||
19496865|NCT01049360|41847353|FG001|Period 2|Adverse Event|1|||
19496866|NCT01049360|41847354|FG002|Period 2|Adverse Event|0|||
19496867|NCT01049360|41847355|FG003|Period 2|Adverse Event|0|||
19496868|NCT01049360|41847356|FG004|Period 2|Adverse Event|0|||
19496869|NCT01049360|41847357|FG005|Period 2|Adverse Event|0|||
19496870|NCT01049360|41847358|FG006|Period 2|Adverse Event|0|||
19496871|NCT01049360|41847359|FG007|Period 2|Adverse Event|0|||
19496872|NCT01049360|41847360|FG008|Period 2|Adverse Event|1|||
19496873|NCT01049360|41847361|FG009|Period 2|Adverse Event|0|||
19496874|NCT01049360|41847362|FG010|Period 2|Adverse Event|0|||
19496875|NCT01049360|41847363|FG011|Period 2|Adverse Event|0|||
19496876|NCT01049360|41847364|FG012|Period 2|Adverse Event|0|||
19496877|NCT01049360|41847365|FG013|Period 2|Adverse Event|0|||
19496878|NCT01049360|41847366|FG014|Period 2|Adverse Event|0|||
19496879|NCT01049360|41847367|FG015|Period 2|Adverse Event|0|||
19496880|NCT01049360|41847368|FG016|Period 2|Adverse Event|0|||
19496881|NCT01049360|41847369|FG017|Period 2|Adverse Event|0|||
19496882|NCT01049360|41847370|FG018|Period 2|Adverse Event|0|||
19496883|NCT01049360|41847371|FG019|Period 2|Adverse Event|1|||
19496884|NCT01049360|41847352|FG000|Period 2|Withdrawal by Subject|0|||
19496885|NCT01049360|41847353|FG001|Period 2|Withdrawal by Subject|0|||
19496886|NCT01049360|41847354|FG002|Period 2|Withdrawal by Subject|0|||
19496887|NCT01049360|41847355|FG003|Period 2|Withdrawal by Subject|1|||
19496888|NCT01049360|41847356|FG004|Period 2|Withdrawal by Subject|0|||
19496889|NCT01049360|41847357|FG005|Period 2|Withdrawal by Subject|0|||
19496890|NCT01049360|41847358|FG006|Period 2|Withdrawal by Subject|0|||
19496891|NCT01049360|41847359|FG007|Period 2|Withdrawal by Subject|0|||
19496892|NCT01049360|41847360|FG008|Period 2|Withdrawal by Subject|0|||
19496893|NCT01049360|41847361|FG009|Period 2|Withdrawal by Subject|0|||
19496894|NCT01049360|41847362|FG010|Period 2|Withdrawal by Subject|0|||
19496895|NCT01049360|41847363|FG011|Period 2|Withdrawal by Subject|0|||
19496896|NCT01049360|41847364|FG012|Period 2|Withdrawal by Subject|0|||
19496897|NCT01049360|41847365|FG013|Period 2|Withdrawal by Subject|0|||
19496898|NCT01049360|41847366|FG014|Period 2|Withdrawal by Subject|1|||
19496899|NCT01049360|41847367|FG015|Period 2|Withdrawal by Subject|0|||
19496900|NCT01049360|41847368|FG016|Period 2|Withdrawal by Subject|0|||
19496901|NCT01049360|41847369|FG017|Period 2|Withdrawal by Subject|0|||
19496902|NCT01049360|41847370|FG018|Period 2|Withdrawal by Subject|0|||
19496903|NCT01049360|41847371|FG019|Period 2|Withdrawal by Subject|1|||
19613420|NCT00610441|42062280|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
19613421|NCT00610441|42062281|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
19613422|NCT00610441|42062282|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
19613423|NCT00610441|42062279|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
19613424|NCT00610441|42062280|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
19613425|NCT00610441|42062281|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
19613426|NCT00610441|42062282|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
19613427|NCT00610441|42062279|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
19613428|NCT00610441|42062280|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
19613429|NCT00610441|42062281|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
19613430|NCT00610441|42062282|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
19496904|NCT01049360|41847352|FG000|Period 2|Lack of Efficacy|0|||
19496905|NCT01049360|41847353|FG001|Period 2|Lack of Efficacy|0|||
19496906|NCT01049360|41847354|FG002|Period 2|Lack of Efficacy|0|||
19496907|NCT01049360|41847355|FG003|Period 2|Lack of Efficacy|0|||
19496908|NCT01049360|41847356|FG004|Period 2|Lack of Efficacy|0|||
19496909|NCT01049360|41847357|FG005|Period 2|Lack of Efficacy|1|||
19496910|NCT01049360|41847358|FG006|Period 2|Lack of Efficacy|0|||
19496911|NCT01049360|41847359|FG007|Period 2|Lack of Efficacy|0|||
19496912|NCT01049360|41847360|FG008|Period 2|Lack of Efficacy|0|||
19496913|NCT01049360|41847361|FG009|Period 2|Lack of Efficacy|0|||
19496914|NCT01049360|41847362|FG010|Period 2|Lack of Efficacy|0|||
19496915|NCT01049360|41847363|FG011|Period 2|Lack of Efficacy|0|||
19496916|NCT01049360|41847364|FG012|Period 2|Lack of Efficacy|0|||
19496917|NCT01049360|41847365|FG013|Period 2|Lack of Efficacy|0|||
19496918|NCT01049360|41847366|FG014|Period 2|Lack of Efficacy|0|||
19496919|NCT01049360|41847367|FG015|Period 2|Lack of Efficacy|0|||
19496920|NCT01049360|41847368|FG016|Period 2|Lack of Efficacy|0|||
19613431|NCT00610441|42062279|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
19613432|NCT00610441|42062280|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
19613433|NCT00610441|42062281|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
19613434|NCT00610441|42062282|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
19613435|NCT00610441|42062279|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
19496921|NCT01049360|41847369|FG017|Period 2|Lack of Efficacy|0|||
19496922|NCT01049360|41847370|FG018|Period 2|Lack of Efficacy|0|||
19496923|NCT01049360|41847371|FG019|Period 2|Lack of Efficacy|0|||
19496924|NCT01049360|41847352|FG000|Period 4|Protocol Violation|0|||
19496925|NCT01049360|41847353|FG001|Period 4|Protocol Violation|0|||
19496926|NCT01049360|41847354|FG002|Period 4|Protocol Violation|0|||
19496927|NCT01049360|41847355|FG003|Period 4|Protocol Violation|0|||
19496928|NCT01049360|41847356|FG004|Period 4|Protocol Violation|0|||
19496929|NCT01049360|41847357|FG005|Period 4|Protocol Violation|0|||
19496930|NCT01049360|41847358|FG006|Period 4|Protocol Violation|0|||
19496931|NCT01049360|41847359|FG007|Period 4|Protocol Violation|0|||
19496932|NCT01049360|41847360|FG008|Period 4|Protocol Violation|0|||
19496933|NCT01049360|41847361|FG009|Period 4|Protocol Violation|0|||
19496934|NCT01049360|41847362|FG010|Period 4|Protocol Violation|0|||
19496935|NCT01049360|41847363|FG011|Period 4|Protocol Violation|0|||
19496936|NCT01049360|41847364|FG012|Period 4|Protocol Violation|0|||
19496937|NCT01049360|41847365|FG013|Period 4|Protocol Violation|0|||
19496938|NCT01049360|41847366|FG014|Period 4|Protocol Violation|0|||
19496939|NCT01049360|41847367|FG015|Period 4|Protocol Violation|0|||
19496940|NCT01049360|41847368|FG016|Period 4|Protocol Violation|0|||
19496941|NCT01049360|41847369|FG017|Period 4|Protocol Violation|1|||
19496942|NCT01049360|41847370|FG018|Period 4|Protocol Violation|0|||
19496943|NCT01049360|41847371|FG019|Period 4|Protocol Violation|0|||
19496944|NCT01049360|41847352|FG000|Period 4|Withdrawal by Subject|0|||
19496945|NCT01049360|41847353|FG001|Period 4|Withdrawal by Subject|0|||
19496946|NCT01049360|41847354|FG002|Period 4|Withdrawal by Subject|0|||
19496947|NCT01049360|41847355|FG003|Period 4|Withdrawal by Subject|1|||
19496948|NCT01049360|41847356|FG004|Period 4|Withdrawal by Subject|0|||
19496949|NCT01049360|41847357|FG005|Period 4|Withdrawal by Subject|0|||
19496950|NCT01049360|41847358|FG006|Period 4|Withdrawal by Subject|0|||
19496951|NCT01049360|41847359|FG007|Period 4|Withdrawal by Subject|0|||
19496952|NCT01049360|41847360|FG008|Period 4|Withdrawal by Subject|0|||
19496953|NCT01049360|41847361|FG009|Period 4|Withdrawal by Subject|0|||
19496954|NCT01049360|41847362|FG010|Period 4|Withdrawal by Subject|0|||
19496955|NCT01049360|41847363|FG011|Period 4|Withdrawal by Subject|0|||
19496956|NCT01049360|41847364|FG012|Period 4|Withdrawal by Subject|0|||
19496957|NCT01049360|41847365|FG013|Period 4|Withdrawal by Subject|0|||
19496958|NCT01049360|41847366|FG014|Period 4|Withdrawal by Subject|0|||
19496959|NCT01049360|41847367|FG015|Period 4|Withdrawal by Subject|0|||
19496960|NCT01049360|41847368|FG016|Period 4|Withdrawal by Subject|0|||
19496961|NCT01049360|41847369|FG017|Period 4|Withdrawal by Subject|0|||
19496962|NCT01049360|41847370|FG018|Period 4|Withdrawal by Subject|0|||
19496963|NCT01049360|41847371|FG019|Period 4|Withdrawal by Subject|0|||
19496964|NCT02494596|41847383|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19496965|NCT02494596|41847384|FG001|Overall Study|Insufficient Therapeutic Response|3|||
19496966|NCT02494596|41847385|FG002|Overall Study|Insufficient Therapeutic Response|1|||
19496967|NCT02494596|41847383|FG000|Overall Study|Adverse Event|0|||
19496968|NCT02494596|41847384|FG001|Overall Study|Adverse Event|1|||
19496969|NCT02494596|41847385|FG002|Overall Study|Adverse Event|0|||
19613436|NCT00610441|42062280|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
19613437|NCT00610441|42062281|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
19613438|NCT00610441|42062282|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
19613439|NCT00610441|42062279|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
19613440|NCT00610441|42062280|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
19613441|NCT00610441|42062281|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
19613442|NCT00610441|42062282|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
19613443|NCT00799617|42062296|FG000|Main Testosterone Trial|Randomized in error|1|||
19613444|NCT00799617|42062297|FG001|Main Testosterone Trial|Randomized in error|1|||
19613445|NCT00799617|42062296|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
19393734|NCT01670279|41637608|FG003|Overall Study|Physician Decision|0|||
19496970|NCT02494596|41847383|FG000|Overall Study|Refused Treatment|0|||
19496971|NCT02494596|41847384|FG001|Overall Study|Refused Treatment|1|||
19496972|NCT02494596|41847385|FG002|Overall Study|Refused Treatment|0|||
19496973|NCT02494206|41847404|FG000|Overall Study|Adverse Event|1|||
19496974|NCT02494206|41847404|FG000|Overall Study|Disease Progression|1|||
19496975|NCT01048502|41847421|FG000|Overall Study|Lost to Follow-up|2|||
19496976|NCT01048502|41847422|FG001|Overall Study|Lost to Follow-up|0|||
19496977|NCT01048502|41847423|FG002|Overall Study|Lost to Follow-up|0|||
19496978|NCT01048502|41847424|FG003|Overall Study|Lost to Follow-up|0|||
19496979|NCT01048502|41847421|FG000|Overall Study|Adverse Event|1|||
19496980|NCT01048502|41847422|FG001|Overall Study|Adverse Event|0|||
19496981|NCT01048502|41847423|FG002|Overall Study|Adverse Event|0|||
19496982|NCT01048502|41847424|FG003|Overall Study|Adverse Event|0|||
19496983|NCT01048502|41847421|FG000|Overall Study|Withdrawal by Subject|1|||
19496984|NCT01048502|41847422|FG001|Overall Study|Withdrawal by Subject|4|||
19496985|NCT01048502|41847423|FG002|Overall Study|Withdrawal by Subject|5|||
19496986|NCT01048502|41847424|FG003|Overall Study|Withdrawal by Subject|3|||
19496987|NCT01048502|41847421|FG000|Overall Study|Physician Decision|0|||
19496988|NCT01048502|41847422|FG001|Overall Study|Physician Decision|3|||
19496989|NCT01048502|41847423|FG002|Overall Study|Physician Decision|0|||
19496990|NCT01048502|41847424|FG003|Overall Study|Physician Decision|1|||
19496991|NCT02465034|41847437|FG000|Overall Study|Withdrawal by Subject|1|||
19496992|NCT02465034|41847438|FG001|Overall Study|Withdrawal by Subject|1|||
19496993|NCT02465034|41847437|FG000|Overall Study|Screen fail|2|||
19496994|NCT02465034|41847438|FG001|Overall Study|Screen fail|0|||
19496995|NCT02465034|41847437|FG000|Overall Study|Could not be scheduled for study visit|0|||
19496996|NCT02465034|41847438|FG001|Overall Study|Could not be scheduled for study visit|5|||
19496997|NCT02516982|41847465|FG000|Overall Study|Called in to antenatal appointment|32|||
19496998|NCT02516982|41847466|FG001|Overall Study|Called in to antenatal appointment|35|||
19496999|NCT02516982|41847467|FG002|Overall Study|Called in to antenatal appointment|0|||
19497000|NCT02516982|41847468|FG003|Overall Study|Called in to antenatal appointment|0|||
19497001|NCT02516982|41847465|FG000|Overall Study|Withdrawal by Subject|0|||
19497002|NCT02516982|41847466|FG001|Overall Study|Withdrawal by Subject|0|||
19497003|NCT02516982|41847467|FG002|Overall Study|Withdrawal by Subject|1|||
19497004|NCT02516982|41847468|FG003|Overall Study|Withdrawal by Subject|2|||
19497005|NCT02516982|41847465|FG000|Overall Study|Protocol Violation|0|||
19497006|NCT02516982|41847466|FG001|Overall Study|Protocol Violation|0|||
19497007|NCT02516982|41847467|FG002|Overall Study|Protocol Violation|1|||
19497008|NCT02516982|41847468|FG003|Overall Study|Protocol Violation|1|||
19497009|NCT02516982|41847465|FG000|Overall Study|Did not install the app|0|||
19497010|NCT02516982|41847466|FG001|Overall Study|Did not install the app|0|||
19497011|NCT02516982|41847467|FG002|Overall Study|Did not install the app|46|||
19497012|NCT02516982|41847468|FG003|Overall Study|Did not install the app|47|||
19497013|NCT02464410|41847513|FG000|Overall Study|Death|3|||
19497014|NCT02464410|41847514|FG001|Overall Study|Death|4|||
19497015|NCT02464410|41847513|FG000|Overall Study|Lost to Follow-up|7|||
19497016|NCT02464410|41847514|FG001|Overall Study|Lost to Follow-up|9|||
19497017|NCT02464410|41847513|FG000|Overall Study|Withdrawal by Subject|12|||
19497018|NCT02464410|41847514|FG001|Overall Study|Withdrawal by Subject|3|||
19497019|NCT01047332|41847522|FG000|Overall Study|SEMS Obstruction|11|||
19497020|NCT01047332|41847523|FG001|Overall Study|SEMS Obstruction|20|||
19497021|NCT01047332|41847522|FG000|Overall Study|Died Unobstructed|38|||
19497022|NCT01047332|41847523|FG001|Overall Study|Died Unobstructed|41|||
19497023|NCT01047332|41847522|FG000|Overall Study|Lost to Follow-up|8|||
19497024|NCT01047332|41847523|FG001|Overall Study|Lost to Follow-up|3|||
19497025|NCT01046396|41847529|FG000|Overall Study|Withdrawal by Subject|5|||
19497026|NCT01046084|41847555|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
19497027|NCT01046084|41847556|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
19497028|NCT01045694|41847575|FG000|Overall Study|Withdrawal by Subject|2|||
19497029|NCT01044290|41847635|FG000|Follow-up 1|Death|3|||
19497030|NCT01044290|41847636|FG001|Follow-up 1|Death|3|||
19497031|NCT01044290|41847637|FG002|Follow-up 1|Death|1|||
19497032|NCT01044290|41847635|FG000|Follow-up 1|Withdrawal by Subject|2|||
19497033|NCT01044290|41847636|FG001|Follow-up 1|Withdrawal by Subject|2|||
19497034|NCT01044290|41847637|FG002|Follow-up 1|Withdrawal by Subject|0|||
19497035|NCT01044290|41847635|FG000|Follow-Up 2|Death|0|||
19497036|NCT01044290|41847636|FG001|Follow-Up 2|Death|1|||
19497037|NCT01044290|41847637|FG002|Follow-Up 2|Death|1|||
19497038|NCT01044290|41847635|FG000|Follow-Up 2|Withdrawal by Subject|0|||
19497039|NCT01044290|41847636|FG001|Follow-Up 2|Withdrawal by Subject|1|||
19497040|NCT01044290|41847637|FG002|Follow-Up 2|Withdrawal by Subject|1|||
19497041|NCT01041638|41847718|FG000|Overall Study|Adverse Event|4|||
19497042|NCT01041638|41847718|FG000|Overall Study|Death|1|||
19497043|NCT01041638|41847718|FG000|Overall Study|Lack of Efficacy|7|||
19497044|NCT01041638|41847718|FG000|Overall Study|Physician Decision|4|||
19497045|NCT01041638|41847718|FG000|Overall Study|Withdrawal by Subject|11|||
19497046|NCT01045460|41847742|FG000|Overall Study|Physician Decision|3|||
19497047|NCT01045460|41847743|FG001|Overall Study|Physician Decision|2|||
19497048|NCT01045460|41847742|FG000|Overall Study|Lost to Follow-up|0|||
19497049|NCT01045460|41847743|FG001|Overall Study|Lost to Follow-up|1|||
19497050|NCT01045460|41847742|FG000|Overall Study|Lack of Efficacy|3|||
19497051|NCT01045460|41847743|FG001|Overall Study|Lack of Efficacy|0|||
19497052|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
19497053|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
19497054|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
19497055|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
19497056|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
19497057|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
19497058|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
19497059|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
19497060|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
19497061|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
19497062|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
19497063|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
19497064|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
19497065|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
19497066|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
19497067|NCT05014919|41847754|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
19497068|NCT05014919|41847755|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
19497069|NCT05014919|41847756|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
19497070|NCT05014919|41847754|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
19497071|NCT05014919|41847755|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
19497072|NCT05014919|41847756|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
19497073|NCT05014919|41847754|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
19497074|NCT05014919|41847755|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
19497075|NCT05014919|41847756|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
19497076|NCT03409796|41847799|FG000|Overall Study|Adverse Event|2|||
19497077|NCT03409796|41847800|FG001|Overall Study|Adverse Event|0|||
19497078|NCT03409796|41847799|FG000|Overall Study|Other|0|||
19497079|NCT03409796|41847800|FG001|Overall Study|Other|1|||
19497080|NCT02462928|41847809|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
19497081|NCT02462928|41847810|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
19497082|NCT02462928|41847811|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
19497083|NCT02462928|41847809|FG000|Overall Study|Adverse Event|47|||
19497084|NCT02462928|41847810|FG001|Overall Study|Adverse Event|51|||
19497085|NCT02462928|41847811|FG002|Overall Study|Adverse Event|25|||
19497086|NCT02462928|41847809|FG000|Overall Study|Lack of Efficacy|3|||
19497087|NCT02462928|41847810|FG001|Overall Study|Lack of Efficacy|8|||
19497088|NCT02462928|41847811|FG002|Overall Study|Lack of Efficacy|3|||
19497089|NCT02462928|41847809|FG000|Overall Study|Lost to Follow-up|4|||
19613446|NCT00799617|42062297|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
19613447|NCT00799617|42062296|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
19613448|NCT00799617|42062297|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
19613449|NCT00799617|42062296|FG000|Sexual Funtion Trial|No Baseline Data|4|||
19613450|NCT00799617|42062297|FG001|Sexual Funtion Trial|No Baseline Data|7|||
19613451|NCT00799617|42062296|FG000|Physical Function Trial|Lost to Follow-up|6|||
19613452|NCT00799617|42062297|FG001|Physical Function Trial|Lost to Follow-up|11|||
19613453|NCT00799617|42062296|FG000|Vitality Trial|Lost to Follow-up|7|||
19613454|NCT00799617|42062297|FG001|Vitality Trial|Lost to Follow-up|22|||
19393735|NCT01670279|41637605|FG000|Overall Study|Participant met withdrawal criteria|0|||
19393736|NCT01670279|41637606|FG001|Overall Study|Participant met withdrawal criteria|0|||
19393737|NCT01670279|41637607|FG002|Overall Study|Participant met withdrawal criteria|0|||
19497090|NCT02462928|41847810|FG001|Overall Study|Lost to Follow-up|4|||
19497091|NCT02462928|41847811|FG002|Overall Study|Lost to Follow-up|1|||
19497092|NCT02462928|41847809|FG000|Overall Study|Withdrawal by Patient|31|||
19497093|NCT02462928|41847810|FG001|Overall Study|Withdrawal by Patient|21|||
19497094|NCT02462928|41847811|FG002|Overall Study|Withdrawal by Patient|21|||
19497095|NCT02462928|41847809|FG000|Overall Study|Protocol Violation|0|||
19497096|NCT02462928|41847810|FG001|Overall Study|Protocol Violation|1|||
19497097|NCT02462928|41847811|FG002|Overall Study|Protocol Violation|0|||
19497098|NCT02462928|41847809|FG000|Overall Study|Reason not Specified|4|||
19497099|NCT02462928|41847810|FG001|Overall Study|Reason not Specified|6|||
19497100|NCT02462928|41847811|FG002|Overall Study|Reason not Specified|5|||
19497101|NCT00019604|41847828|FG000|Overall Study|Death|1|||
19497102|NCT00019604|41847828|FG000|Overall Study|Progressive disease|23|||
19497103|NCT00019604|41847828|FG000|Overall Study|Refused treatment|1|||
19497104|NCT00019604|41847828|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
19497105|NCT00019604|41847828|FG000|Overall Study|Going to have liver transplant|1|||
19497106|NCT00019604|41847828|FG000|Overall Study|Move to a different study|1|||
19497107|NCT00019604|41847828|FG000|Overall Study|Non compliant on systemic CH|1|||
19497108|NCT00019604|41847828|FG000|Overall Study|Non compliant|1|||
19497109|NCT00019604|41847828|FG000|Overall Study|Resectable disease|1|||
19497110|NCT00019604|41847828|FG000|Overall Study|Started new chemo regimen|1|||
19497111|NCT00019604|41847828|FG000|Overall Study|Pt going to immunotherapy study|1|||
19497112|NCT00019604|41847828|FG000|Overall Study|Too much disease|1|||
19497113|NCT00019604|41847828|FG000|Overall Study|Unable to evaluate|1|||
19497114|NCT00019604|41847828|FG000|Overall Study|Details for other not available|4|||
19497115|NCT02492958|41847844|FG000|Overall Study|Withdrawal by Subject|0|||
19613455|NCT00799617|42062296|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
19613456|NCT00799617|42062297|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
19613457|NCT00799617|42062296|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
19613458|NCT00799617|42062297|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
19613459|NCT00799617|42062296|FG000|Bone Trial|Month 12 scan not available|6|||
19613460|NCT00799617|42062297|FG001|Bone Trial|Month 12 scan not available|16|||
19613461|NCT00799617|42062296|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
19613462|NCT00799617|42062297|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
19704374|NCT00163020|42148696|FG001|Overall Study|Lost to Follow-up|2|||
19704375|NCT00252720|42148706|FG000|Overall Study|Withdrawal by Subject|95|||
19497116|NCT02492958|41847845|FG001|Overall Study|Withdrawal by Subject|0|||
19497117|NCT02492958|41847846|FG002|Overall Study|Withdrawal by Subject|1|||
19497118|NCT02492958|41847847|FG003|Overall Study|Withdrawal by Subject|0|||
19497119|NCT02492958|41847844|FG000|Overall Study|Adverse Event|1|||
19497120|NCT02492958|41847845|FG001|Overall Study|Adverse Event|0|||
19497121|NCT02492958|41847846|FG002|Overall Study|Adverse Event|1|||
19613463|NCT00799617|42062296|FG000|Anemia Trial|Withdrawal by Subject|3|||
19704376|NCT00252720|42148707|FG001|Overall Study|Withdrawal by Subject|97|||
19704377|NCT00252720|42148706|FG000|Overall Study|Death|7|||
19704378|NCT00252720|42148707|FG001|Overall Study|Death|8|||
19704379|NCT00252720|42148706|FG000|Overall Study|Moving|23|||
19704380|NCT00252720|42148707|FG001|Overall Study|Moving|42|||
19704381|NCT00252720|42148706|FG000|Overall Study|Mainly patients lost to follow-up|7|||
19497122|NCT02492958|41847847|FG003|Overall Study|Adverse Event|0|||
19497123|NCT02492880|41847857|FG000|Overall Study|Lost to Follow-up|1|||
19613464|NCT00799617|42062297|FG001|Anemia Trial|Withdrawal by Subject|3|||
19704382|NCT00252720|42148707|FG001|Overall Study|Mainly patients lost to follow-up|18|||
19704383|NCT00167778|42148713|FG000|Overall Study|Withdrawal by Subject|1|||
19704384|NCT00167310|42148720|FG000|Overall Study|Protocol Violation|5|||
19704385|NCT00167310|42148721|FG001|Overall Study|Protocol Violation|3|||
19704386|NCT00167310|42148720|FG000|Overall Study|Withdrawal by Subject|3|||
19704387|NCT00167310|42148721|FG001|Overall Study|Withdrawal by Subject|7|||
19704388|NCT03754582|42148727|FG000|Treatment Phase|Adverse Event|0|||
19704389|NCT03754582|42148728|FG001|Treatment Phase|Adverse Event|1|||
19704390|NCT03754582|42148729|FG002|Treatment Phase|Adverse Event|0|||
19704391|NCT03754582|42148727|FG000|Follow-up Phase|Other|0|||
19704392|NCT03754582|42148728|FG001|Follow-up Phase|Other|0|||
19704393|NCT03754582|42148729|FG002|Follow-up Phase|Other|1|||
19704394|NCT00161616|42148747|FG000|Overall Study|Withdrawal by Subject|6|||
19393738|NCT01670279|41637608|FG003|Overall Study|Participant met withdrawal criteria|1|||
19497124|NCT02492880|41847857|FG000|Overall Study|Protocol Violation|1|||
19497125|NCT02516592|41847863|FG000|Overall Study|Patient withdrew consent|5|||
19497126|NCT02516592|41847864|FG001|Overall Study|Patient withdrew consent|2|||
19497127|NCT02516592|41847863|FG000|Overall Study|Protocol deviation|4|||
19497128|NCT02516592|41847864|FG001|Overall Study|Protocol deviation|4|||
19497129|NCT02516592|41847863|FG000|Overall Study|Lost to Follow-up|2|||
19497130|NCT02516592|41847864|FG001|Overall Study|Lost to Follow-up|3|||
19497131|NCT02516592|41847863|FG000|Overall Study|Patient/guardian decision|2|||
19497132|NCT02516592|41847864|FG001|Overall Study|Patient/guardian decision|1|||
19497133|NCT02516592|41847863|FG000|Overall Study|Adverse Event|1|||
19497134|NCT02516592|41847864|FG001|Overall Study|Adverse Event|2|||
19497135|NCT02516592|41847863|FG000|Overall Study|Abnormal test procedure result|1|||
19497136|NCT02516592|41847864|FG001|Overall Study|Abnormal test procedure result|0|||
19497137|NCT02516592|41847863|FG000|Overall Study|Death|1|||
19497138|NCT02516592|41847864|FG001|Overall Study|Death|1|||
19497139|NCT02492100|41847892|FG000|Overall Study|Death|1|||
19497140|NCT02461758|41847915|FG000|Overall Study|Lost to Follow-up|0|||
19497141|NCT02461758|41847916|FG001|Overall Study|Lost to Follow-up|1|||
19497142|NCT02461758|41847917|FG002|Overall Study|Lost to Follow-up|1|||
19497143|NCT02461758|41847918|FG003|Overall Study|Lost to Follow-up|0|||
19497144|NCT02461290|41847940|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
19497145|NCT02461290|41847940|FG000|Overall Study|Lost to Follow-up|3|||
19497146|NCT02461134|41847944|FG000|Overall Study|Adverse Event|1|||
19497147|NCT02460978|41847973|FG000|Overall Study|Adverse Event|17|||
19497148|NCT02460978|41847974|FG001|Overall Study|Adverse Event|11|||
19497149|NCT02460978|41847975|FG002|Overall Study|Adverse Event|11|||
19497150|NCT02460978|41847973|FG000|Overall Study|Withdrawal by Subject|5|||
19497151|NCT02460978|41847974|FG001|Overall Study|Withdrawal by Subject|5|||
19497152|NCT02460978|41847975|FG002|Overall Study|Withdrawal by Subject|14|||
19497153|NCT02460978|41847973|FG000|Overall Study|Lost to Follow-up|2|||
19497154|NCT02460978|41847974|FG001|Overall Study|Lost to Follow-up|3|||
19497155|NCT02460978|41847975|FG002|Overall Study|Lost to Follow-up|1|||
19497156|NCT02460978|41847973|FG000|Overall Study|Protocol Violation|1|||
19497157|NCT02460978|41847974|FG001|Overall Study|Protocol Violation|1|||
19497158|NCT02460978|41847975|FG002|Overall Study|Protocol Violation|1|||
19497159|NCT02460978|41847973|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
19497160|NCT02460978|41847974|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
19497161|NCT02460978|41847975|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
19497162|NCT02460978|41847973|FG000|Overall Study|Pregnancy|0|||
19497163|NCT02460978|41847974|FG001|Overall Study|Pregnancy|0|||
19497164|NCT02460978|41847975|FG002|Overall Study|Pregnancy|2|||
19497165|NCT02489448|41847990|FG000|Overall Study|Death|3|||
19497166|NCT02489448|41847990|FG000|Overall Study|Withdrawal by Subject|2|||
19497167|NCT02488980|41848007|FG000|Overall Study|Protocol Violation|2|||
19497168|NCT02488980|41848008|FG001|Overall Study|Protocol Violation|2|||
19393739|NCT02627495|41637616|FG000|Overall Study|Withdrawal by Subject|4|||
19497169|NCT02488980|41848009|FG002|Overall Study|Protocol Violation|2|||
19497170|NCT02460822|41848021|FG000|Overall Study|Withdrawal by Subject|1|||
19497171|NCT02488824|41848027|FG000|Overall Study|Adverse Event|1|||
19497172|NCT02488824|41848028|FG001|Overall Study|Adverse Event|1|||
19497173|NCT02308241|41848131|FG000|Overall Study|Withdrawal by Subject|3|||
19497174|NCT02460198|41848170|FG000|Overall Study|Adverse Event|1|||
19497175|NCT02460198|41848171|FG001|Overall Study|Adverse Event|3|||
19497176|NCT02460198|41848170|FG000|Overall Study|Death|36|||
19497177|NCT02460198|41848171|FG001|Overall Study|Death|28|||
19497178|NCT02460198|41848170|FG000|Overall Study|Lost to Follow-up|1|||
19497179|NCT02460198|41848171|FG001|Overall Study|Lost to Follow-up|1|||
19497180|NCT02460198|41848170|FG000|Overall Study|Transferred to Extension Study|15|||
19704395|NCT00161616|42148748|FG001|Overall Study|Withdrawal by Subject|5|||
19704396|NCT00161616|42148747|FG000|Overall Study|Physician Decision|1|||
19497181|NCT02460198|41848171|FG001|Overall Study|Transferred to Extension Study|15|||
19497182|NCT02460198|41848170|FG000|Overall Study|Withdrawal by Subject|2|||
19497183|NCT02460198|41848171|FG001|Overall Study|Withdrawal by Subject|4|||
19497184|NCT02460198|41848170|FG000|Overall Study|Site Terminated By Sponsor|0|||
19497185|NCT02460198|41848171|FG001|Overall Study|Site Terminated By Sponsor|1|||
19497186|NCT02460198|41848170|FG000|Overall Study|Did Not Continue on Extension Study|6|||
19497187|NCT02460198|41848171|FG001|Overall Study|Did Not Continue on Extension Study|11|||
19497188|NCT02487810|41848191|FG000|Overall Study|Withdrawal by Subject|1|||
19497189|NCT02487810|41848192|FG001|Overall Study|Withdrawal by Subject|0|||
19497190|NCT02452320|41848200|FG000|Overall Study|Adverse Event|0|||
19497191|NCT02452320|41848201|FG001|Overall Study|Adverse Event|1|||
19497192|NCT02459964|41848210|FG000|Overall Study|Withdrawal by Subject|0|||
19497193|NCT02459964|41848211|FG001|Overall Study|Withdrawal by Subject|0|||
19497194|NCT02459964|41848212|FG002|Overall Study|Withdrawal by Subject|1|||
19497195|NCT02459964|41848210|FG000|Overall Study|Abnormal EKG changes|0|||
19497196|NCT02459964|41848211|FG001|Overall Study|Abnormal EKG changes|0|||
19497197|NCT02459964|41848212|FG002|Overall Study|Abnormal EKG changes|1|||
19497198|NCT02451930|41848289|FG000|Overall Study|Death|0|||
19497199|NCT02451930|41848290|FG001|Overall Study|Death|15|||
19497200|NCT02451930|41848289|FG000|Overall Study|Lost to Follow-up|0|||
19497201|NCT02451930|41848290|FG001|Overall Study|Lost to Follow-up|3|||
19497202|NCT02451930|41848289|FG000|Overall Study|Sponsor Decision|2|||
19497203|NCT02451930|41848290|FG001|Overall Study|Sponsor Decision|10|||
19497204|NCT02451930|41848289|FG000|Overall Study|Withdrawal by Subject|0|||
19497205|NCT02451930|41848290|FG001|Overall Study|Withdrawal by Subject|1|||
19497206|NCT02451930|41848289|FG000|Overall Study|Other|0|||
19497207|NCT02451930|41848290|FG001|Overall Study|Other|1|||
19497208|NCT02451696|41848326|FG000|Overall Study|Surgery postponed|1|||
19497209|NCT02451696|41848327|FG001|Overall Study|Surgery postponed|0|||
19497210|NCT02459418|41848350|FG000|Overall Study|Exclusion Criteria|4|||
19497211|NCT02459418|41848351|FG001|Overall Study|Exclusion Criteria|0|||
19497212|NCT02459418|41848350|FG000|Overall Study|Protocol Violation|0|||
19497213|NCT02459418|41848351|FG001|Overall Study|Protocol Violation|2|||
19497214|NCT02459418|41848350|FG000|Overall Study|Physician Decision|0|||
19497215|NCT02459418|41848351|FG001|Overall Study|Physician Decision|2|||
19497216|NCT02459418|41848350|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
19497217|NCT02459418|41848351|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
19497218|NCT02459418|41848350|FG000|Overall Study|Adverse Event|0|||
19497219|NCT02459418|41848351|FG001|Overall Study|Adverse Event|1|||
19497220|NCT02459418|41848350|FG000|Overall Study|Withdrawal by Subject|1|||
19497221|NCT02459418|41848351|FG001|Overall Study|Withdrawal by Subject|1|||
19497222|NCT02459418|41848350|FG000|Overall Study|Elevated Creatine Kinase|1|||
19497223|NCT02459418|41848351|FG001|Overall Study|Elevated Creatine Kinase|0|||
19497224|NCT02459418|41848350|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
19497225|NCT02459418|41848351|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
19497226|NCT02487498|41848381|FG000|Period: Period 1|Adverse Event|2|||
19497227|NCT02487498|41848382|FG001|Period: Period 1|Adverse Event|4|||
19497228|NCT02487498|41848381|FG000|Period: Period 1|Subject/guardian decision|2|||
19497229|NCT02487498|41848382|FG001|Period: Period 1|Subject/guardian decision|4|||
19497230|NCT02487498|41848381|FG000|Period: Period 1|Lost to Follow-up|0|||
19497231|NCT02487498|41848382|FG001|Period: Period 1|Lost to Follow-up|2|||
19497232|NCT02487498|41848381|FG000|Period: Period 1|Lack of Efficacy|1|||
19497233|NCT02487498|41848382|FG001|Period: Period 1|Lack of Efficacy|0|||
19497234|NCT02487498|41848381|FG000|Period: Period 1|Physician Decision|0|||
19497235|NCT02487498|41848382|FG001|Period: Period 1|Physician Decision|1|||
19497236|NCT02487498|41848381|FG000|Period: Period 1|Protocol deviation|1|||
19497237|NCT02487498|41848382|FG001|Period: Period 1|Protocol deviation|0|||
19497238|NCT02487498|41848381|FG000|Period: Washout|Subject/guardian decision|0|||
19497239|NCT02487498|41848382|FG001|Period: Washout|Subject/guardian decision|5|||
19497240|NCT02487498|41848381|FG000|Period: Washout|Lack of Efficacy|1|||
19497241|NCT02487498|41848382|FG001|Period: Washout|Lack of Efficacy|1|||
19497242|NCT02487498|41848381|FG000|Period: Washout|Physician Decision|1|||
19497243|NCT02487498|41848382|FG001|Period: Washout|Physician Decision|0|||
19497244|NCT02487498|41848381|FG000|Period: Washout|Non-compliance with study treatment|0|||
19497245|NCT02487498|41848382|FG001|Period: Washout|Non-compliance with study treatment|1|||
19497246|NCT02487498|41848381|FG000|Period: Period 2|Adverse Event|2|||
19497247|NCT02487498|41848382|FG001|Period: Period 2|Adverse Event|2|||
19497248|NCT02487498|41848381|FG000|Period: Period 2|Subject/guardian decision|2|||
19497249|NCT02487498|41848382|FG001|Period: Period 2|Subject/guardian decision|1|||
19497250|NCT02487498|41848381|FG000|Period: Period 2|Lost to Follow-up|1|||
19497251|NCT02487498|41848382|FG001|Period: Period 2|Lost to Follow-up|1|||
19497252|NCT02487498|41848381|FG000|Period: Period 2|Death|0|||
19497253|NCT02487498|41848382|FG001|Period: Period 2|Death|1|||
19497254|NCT02487498|41848381|FG000|Period: Period 2|Physician Decision|1|||
19497255|NCT02487498|41848382|FG001|Period: Period 2|Physician Decision|0|||
19497256|NCT02487108|41848393|FG000|Overall Study|Adverse Event|1|||
19497257|NCT02487108|41848394|FG001|Overall Study|Adverse Event|6|||
19497258|NCT02487108|41848395|FG002|Overall Study|Adverse Event|12|||
19497259|NCT02487108|41848396|FG003|Overall Study|Adverse Event|6|||
19497260|NCT02487108|41848393|FG000|Overall Study|Withdrawal by Subject|8|||
19497261|NCT02487108|41848394|FG001|Overall Study|Withdrawal by Subject|5|||
19497262|NCT02487108|41848395|FG002|Overall Study|Withdrawal by Subject|5|||
19497263|NCT02487108|41848396|FG003|Overall Study|Withdrawal by Subject|0|||
19497264|NCT02487108|41848393|FG000|Overall Study|Non-compliance to study medication|3|||
19497265|NCT02487108|41848394|FG001|Overall Study|Non-compliance to study medication|2|||
19497266|NCT02487108|41848395|FG002|Overall Study|Non-compliance to study medication|5|||
19497267|NCT02487108|41848396|FG003|Overall Study|Non-compliance to study medication|4|||
19497268|NCT02487108|41848393|FG000|Overall Study|Protocol Violation|1|||
19497269|NCT02487108|41848394|FG001|Overall Study|Protocol Violation|1|||
19497270|NCT02487108|41848395|FG002|Overall Study|Protocol Violation|2|||
19497271|NCT02487108|41848396|FG003|Overall Study|Protocol Violation|0|||
19497272|NCT02487108|41848393|FG000|Overall Study|Non-compliance to study procedures|0|||
19497273|NCT02487108|41848394|FG001|Overall Study|Non-compliance to study procedures|0|||
19497274|NCT02487108|41848395|FG002|Overall Study|Non-compliance to study procedures|0|||
19497275|NCT02487108|41848396|FG003|Overall Study|Non-compliance to study procedures|1|||
19497276|NCT02487108|41848393|FG000|Overall Study|Other than specified|3|||
19497277|NCT02487108|41848394|FG001|Overall Study|Other than specified|2|||
19497278|NCT02487108|41848395|FG002|Overall Study|Other than specified|2|||
19497279|NCT02487108|41848396|FG003|Overall Study|Other than specified|0|||
19497280|NCT02487030|41848413|FG000|Overall Study|Lack of Efficacy|2|||
19497281|NCT02487030|41848414|FG001|Overall Study|Lack of Efficacy|4|||
19497282|NCT02487030|41848415|FG002|Overall Study|Lack of Efficacy|1|||
19497283|NCT02487030|41848416|FG003|Overall Study|Lack of Efficacy|0|||
19497284|NCT02487030|41848417|FG004|Overall Study|Lack of Efficacy|1|||
19497285|NCT02487030|41848418|FG005|Overall Study|Lack of Efficacy|0|||
19497286|NCT02487030|41848419|FG006|Overall Study|Lack of Efficacy|0|||
19497287|NCT02487030|41848413|FG000|Overall Study|Lost to Follow-up|0|||
19497288|NCT02487030|41848414|FG001|Overall Study|Lost to Follow-up|0|||
19497289|NCT02487030|41848415|FG002|Overall Study|Lost to Follow-up|1|||
19497290|NCT02487030|41848416|FG003|Overall Study|Lost to Follow-up|1|||
19497291|NCT02487030|41848417|FG004|Overall Study|Lost to Follow-up|0|||
19497292|NCT02487030|41848418|FG005|Overall Study|Lost to Follow-up|1|||
19497293|NCT02487030|41848419|FG006|Overall Study|Lost to Follow-up|0|||
19497294|NCT02487030|41848413|FG000|Overall Study|Adverse Event|0|||
19497295|NCT02487030|41848414|FG001|Overall Study|Adverse Event|0|||
19497296|NCT02487030|41848415|FG002|Overall Study|Adverse Event|0|||
19497297|NCT02487030|41848416|FG003|Overall Study|Adverse Event|1|||
19497298|NCT02487030|41848417|FG004|Overall Study|Adverse Event|0|||
19497299|NCT02487030|41848418|FG005|Overall Study|Adverse Event|0|||
19497300|NCT02487030|41848419|FG006|Overall Study|Adverse Event|0|||
19497301|NCT02487030|41848413|FG000|Overall Study|Death|0|||
19497302|NCT02487030|41848414|FG001|Overall Study|Death|0|||
19497303|NCT02487030|41848415|FG002|Overall Study|Death|0|||
19497304|NCT02487030|41848416|FG003|Overall Study|Death|0|||
19497305|NCT02487030|41848417|FG004|Overall Study|Death|1|||
19497306|NCT02487030|41848418|FG005|Overall Study|Death|0|||
19497307|NCT02487030|41848419|FG006|Overall Study|Death|0|||
19497308|NCT02486952|41848436|FG000|Overall Study|Not Started Induction Therapy|3|||
19497309|NCT02486952|41848436|FG000|Overall Study|Adverse Event|1|||
19497310|NCT02486952|41848436|FG000|Overall Study|Death|15|||
19497311|NCT02486952|41848436|FG000|Overall Study|Lack of Efficacy|3|||
19497312|NCT02486952|41848436|FG000|Overall Study|Lost to Follow-up|26|||
19497313|NCT02486952|41848436|FG000|Overall Study|Other|2|||
19497314|NCT02486796|41848442|FG000|Overall Study|Withdrawal by Subject|1|||
19497315|NCT02486796|41848443|FG001|Overall Study|Withdrawal by Subject|1|||
19497316|NCT02486796|41848442|FG000|Overall Study|Physician Decision|1|||
19497317|NCT02486796|41848443|FG001|Overall Study|Physician Decision|0|||
19497318|NCT02459262|41848460|FG000|Overall Study|Withdrawal by Subject|0|||
19497319|NCT02459262|41848461|FG001|Overall Study|Withdrawal by Subject|0|||
19497320|NCT02459262|41848462|FG002|Overall Study|Withdrawal by Subject|0|||
19497321|NCT02459262|41848463|FG003|Overall Study|Withdrawal by Subject|0|||
19497322|NCT02459262|41848464|FG004|Overall Study|Withdrawal by Subject|0|||
19497323|NCT02459262|41848465|FG005|Overall Study|Withdrawal by Subject|0|||
19497324|NCT02459262|41848466|FG006|Overall Study|Withdrawal by Subject|0|||
19497325|NCT02459262|41848467|FG007|Overall Study|Withdrawal by Subject|0|||
19497326|NCT02459262|41848468|FG008|Overall Study|Withdrawal by Subject|0|||
19497327|NCT02459262|41848469|FG009|Overall Study|Withdrawal by Subject|1|||
19497328|NCT02459262|41848470|FG010|Overall Study|Withdrawal by Subject|0|||
19497329|NCT02450526|41848554|FG000|DB Period (Cycle 1)|Adverse Event|0|||
19497330|NCT02450526|41848555|FG001|DB Period (Cycle 1)|Adverse Event|0|||
19497331|NCT02450526|41848556|FG002|DB Period (Cycle 1)|Adverse Event|2|||
19497332|NCT02450526|41848557|FG003|DB Period (Cycle 1)|Adverse Event|0|||
19497333|NCT02450526|41848558|FG004|DB Period (Cycle 1)|Adverse Event|0|||
19497334|NCT02450526|41848554|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
19497335|NCT02450526|41848555|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
19497336|NCT02450526|41848556|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
19497337|NCT02450526|41848557|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
19497338|NCT02450526|41848558|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
19497339|NCT02450526|41848554|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
19497340|NCT02450526|41848555|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
19497341|NCT02450526|41848556|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
19497342|NCT02450526|41848557|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
19497343|NCT02450526|41848558|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
19497344|NCT02450526|41848554|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
19497345|NCT02450526|41848555|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
19497346|NCT02450526|41848556|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
19497347|NCT02450526|41848557|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
19497348|NCT02450526|41848558|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
19497349|NCT02450526|41848554|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
19497350|NCT02450526|41848555|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
19497351|NCT02450526|41848556|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
19497352|NCT02450526|41848557|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
19497353|NCT02450526|41848558|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
19497354|NCT02450526|41848554|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
19497355|NCT02450526|41848555|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
19497356|NCT02450526|41848556|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
19497357|NCT02450526|41848557|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
19497358|NCT02450526|41848558|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
19497359|NCT02450526|41848554|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
19497360|NCT02450526|41848555|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
19497361|NCT02450526|41848556|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
19497362|NCT02450526|41848557|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
19497363|NCT02450526|41848558|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
19497364|NCT02450526|41848554|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
19497365|NCT02450526|41848555|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
19497366|NCT02450526|41848556|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
19497367|NCT02450526|41848557|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
19497368|NCT02450526|41848558|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
19497369|NCT02458638|41848625|FG000|Overall Study|Death|309|||
19497370|NCT02458638|41848625|FG000|Overall Study|End of Cohort/End of Study|67|||
19497371|NCT02458638|41848625|FG000|Overall Study|Lost to Follow-up|31|||
19497372|NCT02458638|41848625|FG000|Overall Study|Other Reasons|4|||
19497373|NCT02458638|41848625|FG000|Overall Study|Physician Decision|1|||
19497374|NCT02458638|41848625|FG000|Overall Study|Withdrawal by Subject|47|||
19497375|NCT02458092|41848763|FG000|Overall Study|Withdrawal by Subject|1|||
19497376|NCT02458092|41848764|FG001|Overall Study|Withdrawal by Subject|0|||
19497377|NCT02449902|41848787|FG000|Overall Study|Adverse Event|0|||
19497378|NCT02449902|41848788|FG001|Overall Study|Adverse Event|1|||
19497379|NCT02449902|41848787|FG000|Overall Study|Withdrawal by Subject|0|||
19497380|NCT02449902|41848788|FG001|Overall Study|Withdrawal by Subject|1|||
19497381|NCT02449044|41848796|FG000|Overall Study|Lost to Follow-up|2|||
19497382|NCT02449044|41848796|FG000|Overall Study|Withdrawal by Subject|13|||
19497383|NCT02449044|41848796|FG000|Overall Study|Adverse Event|30|||
19497384|NCT02449044|41848796|FG000|Overall Study|Met Withdrawal Criteria|7|||
19497385|NCT02449044|41848796|FG000|Overall Study|Physician Decision|9|||
19497386|NCT02449044|41848796|FG000|Overall Study|Sponsor Discontinued Trial|3|||
19497387|NCT02448810|41849687|FG000|Overall Study|Adverse Event|0|||
19497388|NCT02448810|41849688|FG001|Overall Study|Adverse Event|0|||
19497389|NCT02448810|41849689|FG002|Overall Study|Adverse Event|1|||
19497390|NCT02448810|41849690|FG003|Overall Study|Adverse Event|0|||
19497391|NCT02448810|41849691|FG004|Overall Study|Adverse Event|0|||
19497392|NCT02448810|41849692|FG005|Overall Study|Adverse Event|0|||
19497393|NCT02448810|41849693|FG006|Overall Study|Adverse Event|0|||
19497394|NCT02448810|41849694|FG007|Overall Study|Adverse Event|0|||
19497395|NCT02448810|41849687|FG000|Overall Study|Withdrawal by Subject|0|||
19497396|NCT02448810|41849688|FG001|Overall Study|Withdrawal by Subject|0|||
19497397|NCT02448810|41849689|FG002|Overall Study|Withdrawal by Subject|1|||
19497398|NCT02448810|41849690|FG003|Overall Study|Withdrawal by Subject|0|||
19497399|NCT02448810|41849691|FG004|Overall Study|Withdrawal by Subject|3|||
19497400|NCT02448810|41849692|FG005|Overall Study|Withdrawal by Subject|5|||
19497401|NCT02448810|41849693|FG006|Overall Study|Withdrawal by Subject|0|||
19497402|NCT02448810|41849694|FG007|Overall Study|Withdrawal by Subject|2|||
19497403|NCT02448810|41849687|FG000|Overall Study|Other (study terminated by sponsor)|0|||
19497404|NCT02448810|41849688|FG001|Overall Study|Other (study terminated by sponsor)|0|||
19497405|NCT02448810|41849689|FG002|Overall Study|Other (study terminated by sponsor)|0|||
19497406|NCT02448810|41849690|FG003|Overall Study|Other (study terminated by sponsor)|0|||
19497407|NCT02448810|41849691|FG004|Overall Study|Other (study terminated by sponsor)|4|||
19704397|NCT00161616|42148748|FG001|Overall Study|Physician Decision|0|||
19497408|NCT02448810|41849692|FG005|Overall Study|Other (study terminated by sponsor)|2|||
19497409|NCT02448810|41849693|FG006|Overall Study|Other (study terminated by sponsor)|2|||
19704398|NCT00161616|42148747|FG000|Overall Study|Death|1|||
19497410|NCT02448810|41849694|FG007|Overall Study|Other (study terminated by sponsor)|1|||
19497411|NCT02448810|41849687|FG000|Overall Study|Death|1|||
19497412|NCT02448810|41849688|FG001|Overall Study|Death|0|||
19497413|NCT02448810|41849689|FG002|Overall Study|Death|1|||
19497414|NCT02448810|41849690|FG003|Overall Study|Death|0|||
19497415|NCT02448810|41849691|FG004|Overall Study|Death|1|||
19497416|NCT02448810|41849692|FG005|Overall Study|Death|0|||
19497417|NCT02448810|41849693|FG006|Overall Study|Death|0|||
19497418|NCT02448810|41849694|FG007|Overall Study|Death|0|||
19497419|NCT02448810|41849687|FG000|Overall Study|Other (Progressive disease)|2|||
19497420|NCT02448810|41849688|FG001|Overall Study|Other (Progressive disease)|2|||
19497421|NCT02448810|41849689|FG002|Overall Study|Other (Progressive disease)|0|||
19497422|NCT02448810|41849690|FG003|Overall Study|Other (Progressive disease)|3|||
19497423|NCT02448810|41849691|FG004|Overall Study|Other (Progressive disease)|23|||
19497424|NCT02448810|41849692|FG005|Overall Study|Other (Progressive disease)|9|||
19497425|NCT02448810|41849693|FG006|Overall Study|Other (Progressive disease)|14|||
19497426|NCT02448810|41849694|FG007|Overall Study|Other (Progressive disease)|5|||
19497427|NCT02448810|41849687|FG000|Overall Study|Lost to Follow-up|0|||
19497428|NCT02448810|41849688|FG001|Overall Study|Lost to Follow-up|1|||
19497429|NCT02448810|41849689|FG002|Overall Study|Lost to Follow-up|0|||
19497430|NCT02448810|41849690|FG003|Overall Study|Lost to Follow-up|0|||
19497431|NCT02448810|41849691|FG004|Overall Study|Lost to Follow-up|0|||
19497432|NCT02448810|41849692|FG005|Overall Study|Lost to Follow-up|0|||
19497433|NCT02448810|41849693|FG006|Overall Study|Lost to Follow-up|0|||
19497434|NCT02448810|41849694|FG007|Overall Study|Lost to Follow-up|0|||
19497435|NCT02448810|41849687|FG000|Overall Study|Other (unspecified)|0|||
19497436|NCT02448810|41849688|FG001|Overall Study|Other (unspecified)|0|||
19497437|NCT02448810|41849689|FG002|Overall Study|Other (unspecified)|0|||
19497438|NCT02448810|41849690|FG003|Overall Study|Other (unspecified)|0|||
19497439|NCT02448810|41849691|FG004|Overall Study|Other (unspecified)|0|||
19497440|NCT02448810|41849692|FG005|Overall Study|Other (unspecified)|0|||
19497441|NCT02448810|41849693|FG006|Overall Study|Other (unspecified)|2|||
19497442|NCT02448810|41849694|FG007|Overall Study|Other (unspecified)|0|||
19497443|NCT02457546|41849767|FG000|Overall Study|Other reasons|4|||
19497444|NCT02457546|41849768|FG001|Overall Study|Other reasons|1|||
19497445|NCT02457546|41849767|FG000|Overall Study|Refused to complete study/procedures|1|||
19497446|NCT02457546|41849768|FG001|Overall Study|Refused to complete study/procedures|1|||
19497447|NCT02457546|41849767|FG000|Overall Study|Lost to Follow-up|4|||
19497448|NCT02457546|41849768|FG001|Overall Study|Lost to Follow-up|1|||
19497449|NCT02457546|41849767|FG000|Overall Study|Adverse Event|0|||
19497450|NCT02457546|41849768|FG001|Overall Study|Adverse Event|1|||
19497451|NCT02447952|41849789|FG000|Overall Study|Adverse Event|2|||
19497452|NCT02447952|41849789|FG000|Overall Study|Physician Decision|1|||
19497453|NCT02447952|41849789|FG000|Overall Study|Withdrawal by Subject|4|||
19497454|NCT02447718|41849823|FG000|Overall Study|Lost to Follow-up|8|||
19497455|NCT02447718|41849824|FG001|Overall Study|Lost to Follow-up|0|||
19497456|NCT02447718|41849823|FG000|Overall Study|Withdrawal by Subject|3|||
19497457|NCT02447718|41849824|FG001|Overall Study|Withdrawal by Subject|0|||
19497458|NCT02447718|41849823|FG000|Overall Study|Screen Failure|1|||
19497459|NCT02447718|41849824|FG001|Overall Study|Screen Failure|0|||
19393740|NCT01670045|41637620|FG000|Overall Study|Withdrawal by Subject|3|||
19393741|NCT01670045|41637620|FG000|Overall Study|Adverse Event|1|||
19393742|NCT01670045|41637620|FG000|Overall Study|Death|1|||
19393743|NCT01670045|41637620|FG000|Overall Study|Lost to Follow-up|11|||
19393744|NCT01669421|41637624|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
19393745|NCT01669421|41637624|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
19393746|NCT01671059|41637638|FG000|Overall Study|Adverse Event|4|||
19393747|NCT01671059|41637638|FG000|Overall Study|Lack of Efficacy|1|||
19393748|NCT01669811|41637654|FG000|Overall Study|Investigator decision|0|||
19393749|NCT01669811|41637655|FG001|Overall Study|Investigator decision|1|||
19393750|NCT01669811|41637654|FG000|Overall Study|Withdrawal by Subject|1|||
19393751|NCT01669811|41637655|FG001|Overall Study|Withdrawal by Subject|2|||
19393752|NCT01669811|41637654|FG000|Overall Study|Adverse Event|2|||
19393753|NCT01669811|41637655|FG001|Overall Study|Adverse Event|6|||
19393754|NCT01669811|41637654|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19393755|NCT01669811|41637655|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
19393756|NCT01669577|41637661|FG000|Overall Study|Death|22|||
19393757|NCT01669577|41637661|FG000|Overall Study|Lost to Follow-up|78|||
19393758|NCT01669577|41637661|FG000|Overall Study|Physician Decision|34|||
19497460|NCT02486406|41850001|FG000|Overall Study|Withdrew consent|1|||
19497461|NCT02486406|41850002|FG001|Overall Study|Withdrew consent|0|||
19497462|NCT02486406|41850003|FG002|Overall Study|Withdrew consent|0|||
19497463|NCT02486406|41850004|FG003|Overall Study|Withdrew consent|1|||
19497464|NCT02486406|41850001|FG000|Overall Study|Lost to Follow-up|1|||
19497465|NCT02486406|41850002|FG001|Overall Study|Lost to Follow-up|3|||
19497466|NCT02486406|41850003|FG002|Overall Study|Lost to Follow-up|1|||
19497467|NCT02486406|41850004|FG003|Overall Study|Lost to Follow-up|3|||
19393759|NCT02658175|41637668|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
19497468|NCT02486406|41850001|FG000|Overall Study|Other, not specified|0|||
19613465|NCT00607087|42062306|FG000|Overall Study|Withdrawal by Subject|9|||
19613466|NCT00607087|42062307|FG001|Overall Study|Withdrawal by Subject|4|||
19613467|NCT00607087|42062308|FG002|Overall Study|Withdrawal by Subject|4|||
19613468|NCT00607087|42062306|FG000|Overall Study|Adverse Event|3|||
19613469|NCT00607087|42062307|FG001|Overall Study|Adverse Event|2|||
19613470|NCT00607087|42062308|FG002|Overall Study|Adverse Event|3|||
19613471|NCT00607087|42062306|FG000|Overall Study|Other reason|1|||
19613472|NCT00607087|42062307|FG001|Overall Study|Other reason|5|||
19613473|NCT00607087|42062308|FG002|Overall Study|Other reason|2|||
19613474|NCT00607087|42062306|FG000|Overall Study|Poor compliance to protocol|1|||
19613475|NCT00607087|42062307|FG001|Overall Study|Poor compliance to protocol|0|||
19613476|NCT00607087|42062308|FG002|Overall Study|Poor compliance to protocol|1|||
19613477|NCT00607087|42062306|FG000|Overall Study|Lost to Follow-up|1|||
19613478|NCT00607087|42062307|FG001|Overall Study|Lost to Follow-up|0|||
19613479|NCT00607087|42062308|FG002|Overall Study|Lost to Follow-up|0|||
19613480|NCT00607087|42062306|FG000|Period 1|Withdrawal by Subject|7|||
19613481|NCT00607087|42062307|FG001|Period 1|Withdrawal by Subject|2|||
19613482|NCT00607087|42062308|FG002|Period 1|Withdrawal by Subject|3|||
19613483|NCT00607087|42062306|FG000|Period 1|Adverse Event|3|||
19613484|NCT00607087|42062307|FG001|Period 1|Adverse Event|0|||
19613485|NCT00607087|42062308|FG002|Period 1|Adverse Event|0|||
19613486|NCT00607087|42062306|FG000|Period 1|Poor compliance to protocol|1|||
19613487|NCT00607087|42062307|FG001|Period 1|Poor compliance to protocol|0|||
19613488|NCT00607087|42062308|FG002|Period 1|Poor compliance to protocol|0|||
19497469|NCT02486406|41850002|FG001|Overall Study|Other, not specified|0|||
19497470|NCT02486406|41850003|FG002|Overall Study|Other, not specified|1|||
19497471|NCT02486406|41850004|FG003|Overall Study|Other, not specified|0|||
19497472|NCT02485704|41850076|FG000|Overall Study|Lost to Follow-up|4|||
19497473|NCT02485704|41850077|FG001|Overall Study|Lost to Follow-up|5|||
19497474|NCT02485704|41850076|FG000|Overall Study|Withdrawal by Subject|0|||
19497475|NCT02485704|41850077|FG001|Overall Study|Withdrawal by Subject|3|||
19497476|NCT02485704|41850076|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
19497477|NCT02485704|41850077|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
19497478|NCT02485158|41850087|FG000|Overall Study|Withdrawal by Subject|3|||
19497479|NCT02485158|41850087|FG000|Overall Study|expected drug side effect|1|||
19497480|NCT02455518|41850106|FG000|Overall Study|Protocol Violation|0|||
19497481|NCT02455518|41850107|FG001|Overall Study|Protocol Violation|1|||
19497482|NCT02455518|41850108|FG002|Overall Study|Protocol Violation|1|||
19497483|NCT02455518|41850109|FG003|Overall Study|Protocol Violation|3|||
19497484|NCT02873195|41850257|FG000|Overall Study|Ineligible|5|||
19497485|NCT02873195|41850258|FG001|Overall Study|Ineligible|0|||
19497486|NCT02435849|41850293|FG000|Overall Study|Enrolled but not infused|18|||
19497487|NCT02435849|41850293|FG000|Overall Study|Death|16|||
19497488|NCT02435849|41850293|FG000|Overall Study|Lack of Efficacy|9|||
19497489|NCT02435849|41850293|FG000|Overall Study|New therapy for study indication|7|||
19497490|NCT02435849|41850293|FG000|Overall Study|Subject/guardian decision|2|||
19497491|NCT02435849|41850293|FG000|Overall Study|Study follow-up ongoing|45|||
19497492|NCT02240069|41850340|FG000|Overall Study|Withdrawal by Subject|5|||
19497493|NCT02240069|41850341|FG001|Overall Study|Withdrawal by Subject|5|||
19497494|NCT02240069|41850342|FG002|Overall Study|Withdrawal by Subject|2|||
19497495|NCT02484690|41850428|FG000|Overall Study|Adverse Event|1|||
19497496|NCT02484690|41850429|FG001|Overall Study|Adverse Event|3|||
19497497|NCT02484690|41850430|FG002|Overall Study|Adverse Event|0|||
19497498|NCT02484690|41850431|FG003|Overall Study|Adverse Event|0|||
19497499|NCT02484690|41850432|FG004|Overall Study|Adverse Event|5|||
19497500|NCT02484690|41850428|FG000|Overall Study|Death|0|||
19497501|NCT02484690|41850429|FG001|Overall Study|Death|0|||
19497502|NCT02484690|41850430|FG002|Overall Study|Death|0|||
19497503|NCT02484690|41850431|FG003|Overall Study|Death|0|||
19497504|NCT02484690|41850432|FG004|Overall Study|Death|1|||
19497505|NCT02484690|41850428|FG000|Overall Study|Withdrawal by Subject|1|||
19497506|NCT02484690|41850429|FG001|Overall Study|Withdrawal by Subject|3|||
19497507|NCT02484690|41850430|FG002|Overall Study|Withdrawal by Subject|1|||
19497508|NCT02484690|41850431|FG003|Overall Study|Withdrawal by Subject|2|||
19497509|NCT02484690|41850432|FG004|Overall Study|Withdrawal by Subject|0|||
19497510|NCT02484690|41850428|FG000|Overall Study|Physician Decision|2|||
19497511|NCT02484690|41850429|FG001|Overall Study|Physician Decision|0|||
19497512|NCT02484690|41850430|FG002|Overall Study|Physician Decision|1|||
19497513|NCT02484690|41850431|FG003|Overall Study|Physician Decision|0|||
19497514|NCT02484690|41850432|FG004|Overall Study|Physician Decision|0|||
19613489|NCT00607087|42062306|FG000|Period 1|Lost to Follow-up|1|||
19613490|NCT00607087|42062307|FG001|Period 1|Lost to Follow-up|0|||
19373688|NCT02742103|41614873|FG001|Overall Study|Protocol Violation|0|||
19497515|NCT02484690|41850428|FG000|Overall Study|Lost to Follow-up|0|||
19497516|NCT02484690|41850429|FG001|Overall Study|Lost to Follow-up|0|||
19497517|NCT02484690|41850430|FG002|Overall Study|Lost to Follow-up|1|||
19497518|NCT02484690|41850431|FG003|Overall Study|Lost to Follow-up|0|||
19613491|NCT00607087|42062308|FG002|Period 1|Lost to Follow-up|0|||
19613492|NCT00607087|42062306|FG000|Period 1|Other reason|0|||
19613493|NCT00607087|42062307|FG001|Period 1|Other reason|4|||
19497519|NCT02484690|41850432|FG004|Overall Study|Lost to Follow-up|0|||
19497520|NCT01654224|41850456|FG000|Overall Study|Lost to Follow-up|2|||
19497521|NCT01654224|41850457|FG001|Overall Study|Lost to Follow-up|2|||
19497522|NCT01654224|41850456|FG000|Overall Study|Did not receive allocation|1|||
19497523|NCT01654224|41850457|FG001|Overall Study|Did not receive allocation|8|||
19497524|NCT01654224|41850456|FG000|Overall Study|Insufficient blood sample|3|||
19497525|NCT01654224|41850457|FG001|Overall Study|Insufficient blood sample|2|||
19497526|NCT02447328|41850463|FG000|Overall Study|Withdrawal by Subject|1|||
19497527|NCT02447250|41850467|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
19497528|NCT02447250|41850467|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
19497529|NCT02447250|41850467|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
19497530|NCT02447172|41850571|FG000|Overall Study|Adverse Event|11|||
19497531|NCT02447172|41850572|FG001|Overall Study|Adverse Event|8|||
19497532|NCT02447172|41850573|FG002|Overall Study|Adverse Event|7|||
19497533|NCT02447172|41850571|FG000|Overall Study|Death|3|||
19497534|NCT02447172|41850572|FG001|Overall Study|Death|1|||
19497535|NCT02447172|41850573|FG002|Overall Study|Death|0|||
19497536|NCT02447172|41850571|FG000|Overall Study|Protocol Violation|2|||
19497537|NCT02447172|41850572|FG001|Overall Study|Protocol Violation|1|||
19497538|NCT02447172|41850573|FG002|Overall Study|Protocol Violation|2|||
19497539|NCT02447172|41850571|FG000|Overall Study|Lost to Follow-up|7|||
19497540|NCT02447172|41850572|FG001|Overall Study|Lost to Follow-up|4|||
19497541|NCT02447172|41850573|FG002|Overall Study|Lost to Follow-up|4|||
19497542|NCT02447172|41850571|FG000|Overall Study|Withdrawal by Subject|5|||
19497543|NCT02447172|41850572|FG001|Overall Study|Withdrawal by Subject|1|||
19497544|NCT02447172|41850573|FG002|Overall Study|Withdrawal by Subject|3|||
19497545|NCT02447172|41850571|FG000|Overall Study|protocol specific treatment unrelated|3|||
19497546|NCT02447172|41850572|FG001|Overall Study|protocol specific treatment unrelated|0|||
19497547|NCT02447172|41850573|FG002|Overall Study|protocol specific treatment unrelated|2|||
19497548|NCT02455050|41850606|FG000|Treatment Period 1|Lost to Follow-up|1|||
19497549|NCT02455050|41850607|FG001|Treatment Period 1|Lost to Follow-up|1|||
19497550|NCT02455050|41850608|FG002|Treatment Period 1|Lost to Follow-up|1|||
19497551|NCT02455050|41850609|FG003|Treatment Period 1|Lost to Follow-up|2|||
19497552|NCT02455050|41850606|FG000|Treatment Period 2|Lost to Follow-up|1|||
19497553|NCT02455050|41850607|FG001|Treatment Period 2|Lost to Follow-up|0|||
19497554|NCT02455050|41850608|FG002|Treatment Period 2|Lost to Follow-up|2|||
19497555|NCT02455050|41850609|FG003|Treatment Period 2|Lost to Follow-up|1|||
19497556|NCT02418468|41850649|FG000|Overall Study|Adverse Event|1|||
19497557|NCT02418468|41850650|FG001|Overall Study|Adverse Event|0|||
19497558|NCT02418468|41850649|FG000|Overall Study|Withdrawal of informed consent|1|||
19497559|NCT02418468|41850650|FG001|Overall Study|Withdrawal of informed consent|1|||
19497560|NCT02418156|41850656|FG000|Overall Study|Lost to Follow-up|12|||
19497561|NCT02418156|41850656|FG000|Overall Study|Death|2|||
19497562|NCT02418156|41850656|FG000|Overall Study|Physician Decision|1|||
19497563|NCT02418156|41850656|FG000|Overall Study|Withdrawal by Subject|1|||
19497564|NCT02418156|41850656|FG000|Overall Study|Subject refused to return|1|||
19497565|NCT02418000|41850785|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
19497566|NCT02418000|41850786|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497567|NCT02418000|41850787|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497568|NCT02418000|41850788|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497569|NCT02418000|41850789|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497570|NCT02418000|41850785|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
19497571|NCT02418000|41850786|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
19497572|NCT02418000|41850787|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
19497573|NCT02418000|41850788|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
19497574|NCT02418000|41850789|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
19497575|NCT02418000|41850785|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
19497576|NCT02418000|41850786|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
19497577|NCT02418000|41850787|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
19497578|NCT02418000|41850788|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
19497579|NCT02418000|41850789|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
19497580|NCT02418000|41850785|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497581|NCT02418000|41850786|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
19497582|NCT02418000|41850787|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497583|NCT02418000|41850788|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497584|NCT02418000|41850789|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
19497585|NCT02418000|41850785|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
19497586|NCT02418000|41850786|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
19497587|NCT02418000|41850787|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
19497588|NCT02418000|41850788|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
19613494|NCT00607087|42062308|FG002|Period 1|Other reason|2|||
19613495|NCT00607087|42062306|FG000|Period 2|Withdrawal by Subject|0|||
19497589|NCT02418000|41850789|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
19497590|NCT02418000|41850785|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497591|NCT02418000|41850786|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497592|NCT02418000|41850787|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
19497593|NCT02418000|41850788|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497594|NCT02418000|41850789|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497595|NCT02418000|41850785|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497596|NCT02418000|41850786|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497597|NCT02418000|41850787|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497598|NCT02418000|41850788|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
19497599|NCT02418000|41850789|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497600|NCT02418000|41850785|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
19497601|NCT02418000|41850786|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
19497602|NCT02418000|41850787|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
19497603|NCT02418000|41850788|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
19497604|NCT02418000|41850789|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
19497605|NCT02418000|41850785|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497606|NCT02418000|41850786|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497607|NCT02418000|41850787|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497608|NCT02418000|41850788|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
19497609|NCT02418000|41850789|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
19497610|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
19497611|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
19497612|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
19497613|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
19497614|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
19497615|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
19497616|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
19497617|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
19497618|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
19497619|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
19497620|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
19497621|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
19497622|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
19497623|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
19497624|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
19497625|NCT02417064|41850893|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
19497626|NCT02417064|41850894|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
19497627|NCT02417064|41850895|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
19497628|NCT02417064|41850893|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
19497629|NCT02417064|41850894|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
19497630|NCT02417064|41850895|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
19497631|NCT02417064|41850893|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
19497632|NCT02417064|41850894|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
19497633|NCT02417064|41850895|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
19497634|NCT02417064|41850893|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
19497635|NCT02417064|41850894|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
19497636|NCT02417064|41850895|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
19497637|NCT02417064|41850893|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
19497638|NCT02417064|41850894|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
19497639|NCT02417064|41850895|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
19497640|NCT02417064|41850893|FG000|Follow-up Phase (24 Weeks)|Other|2|||
19497641|NCT02417064|41850894|FG001|Follow-up Phase (24 Weeks)|Other|2|||
19497642|NCT02417064|41850895|FG002|Follow-up Phase (24 Weeks)|Other|3|||
19613496|NCT00607087|42062307|FG001|Period 2|Withdrawal by Subject|1|||
19613497|NCT00607087|42062308|FG002|Period 2|Withdrawal by Subject|1|||
19613498|NCT00607087|42062306|FG000|Period 2|Other reason|1|||
19613499|NCT00607087|42062307|FG001|Period 2|Other reason|1|||
19613500|NCT00607087|42062308|FG002|Period 2|Other reason|0|||
19613501|NCT00607087|42062306|FG000|Period 2|Adverse Event|0|||
19613502|NCT00607087|42062307|FG001|Period 2|Adverse Event|1|||
19613503|NCT00607087|42062308|FG002|Period 2|Adverse Event|3|||
19393760|NCT02658175|41637669|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
19497643|NCT01653132|41850910|FG000|First Intervention|Protocol Violation|1|||
19497644|NCT01653132|41850911|FG001|First Intervention|Protocol Violation|0|||
19497645|NCT02453334|41850936|FG000|Overall Study|Death|15|||
19497646|NCT02453334|41850937|FG001|Overall Study|Death|13|||
19497647|NCT02453334|41850936|FG000|Overall Study|Adverse Event|2|||
19497648|NCT02453334|41850937|FG001|Overall Study|Adverse Event|1|||
19497649|NCT02453334|41850936|FG000|Overall Study|Lost to Follow-up|5|||
19497650|NCT02453334|41850937|FG001|Overall Study|Lost to Follow-up|9|||
19497651|NCT02453334|41850936|FG000|Overall Study|Physician Decision|1|||
19497652|NCT02453334|41850937|FG001|Overall Study|Physician Decision|0|||
19497653|NCT02453334|41850936|FG000|Overall Study|Withdrawal by Subject|17|||
19497654|NCT02453334|41850937|FG001|Overall Study|Withdrawal by Subject|13|||
19497655|NCT02453334|41850936|FG000|Overall Study|Other reason|1|||
19497656|NCT02453334|41850937|FG001|Overall Study|Other reason|4|||
19497657|NCT02443740|41851023|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497658|NCT02443740|41851024|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497659|NCT02443740|41851025|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497660|NCT02443740|41851026|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497661|NCT02443740|41851027|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497662|NCT02443740|41851028|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
19497663|NCT02443740|41851029|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497664|NCT02443740|41851030|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497665|NCT02443740|41851031|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497666|NCT02443740|41851032|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497667|NCT02443740|41851033|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
19497668|NCT02443740|41851023|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
19497669|NCT02443740|41851024|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497670|NCT02443740|41851025|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497671|NCT02443740|41851026|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497672|NCT02443740|41851027|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497673|NCT02443740|41851028|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497674|NCT02443740|41851029|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
19497675|NCT02443740|41851030|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497676|NCT02443740|41851031|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497677|NCT02443740|41851032|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497678|NCT02443740|41851033|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
19497679|NCT02443740|41851023|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497680|NCT02443740|41851024|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497681|NCT02443740|41851025|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497682|NCT02443740|41851026|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497683|NCT02443740|41851027|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497684|NCT02443740|41851028|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
19497685|NCT02443740|41851029|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497686|NCT02443740|41851030|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497687|NCT02443740|41851031|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497688|NCT02443740|41851032|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497689|NCT02443740|41851033|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
19497690|NCT02416908|41851264|FG000|Dose Escalation Phase|Adverse Event|0|||
19497691|NCT02416908|41851265|FG001|Dose Escalation Phase|Adverse Event|0|||
19497692|NCT02416908|41851266|FG002|Dose Escalation Phase|Adverse Event|3|||
19497693|NCT02416908|41851267|FG003|Dose Escalation Phase|Adverse Event|0|||
19497694|NCT02416908|41851264|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
19497695|NCT02416908|41851265|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
19497696|NCT02416908|41851266|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
19497697|NCT02416908|41851267|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19497698|NCT02453256|41851357|FG000|Double Blind Period|Death|1|||
19497699|NCT02453256|41851358|FG001|Double Blind Period|Death|1|||
19497700|NCT02453256|41851357|FG000|Double Blind Period|Adverse Event|3|||
19497701|NCT02453256|41851358|FG001|Double Blind Period|Adverse Event|2|||
19497702|NCT02453256|41851357|FG000|Double Blind Period|Withdrawal by Subject|9|||
19497703|NCT02453256|41851358|FG001|Double Blind Period|Withdrawal by Subject|5|||
19497704|NCT02453256|41851357|FG000|Double Blind Period|Other|0|||
19497705|NCT02453256|41851358|FG001|Double Blind Period|Other|1|||
19497706|NCT02453256|41851357|FG000|Open Label Period|Adverse Event|1|||
19497707|NCT02453256|41851358|FG001|Open Label Period|Adverse Event|3|||
19497708|NCT02453256|41851357|FG000|Open Label Period|Death|0|||
19497709|NCT02453256|41851358|FG001|Open Label Period|Death|1|||
19497710|NCT02453256|41851357|FG000|Open Label Period|Lost to Follow-up|1|||
19497711|NCT02453256|41851358|FG001|Open Label Period|Lost to Follow-up|0|||
19497712|NCT02453256|41851357|FG000|Open Label Period|Other|0|||
19497713|NCT02453256|41851358|FG001|Open Label Period|Other|2|||
19497714|NCT02453256|41851357|FG000|Open Label Period|Withdrawal by Subject|5|||
19497715|NCT02453256|41851358|FG001|Open Label Period|Withdrawal by Subject|1|||
19497716|NCT02442804|41851373|FG000|Overall Study|Withdrawal by Subject|0|||
19497717|NCT02442804|41851374|FG001|Overall Study|Withdrawal by Subject|1|||
19497718|NCT02442804|41851373|FG000|Overall Study|Adverse Event|1|||
19497719|NCT02442804|41851374|FG001|Overall Study|Adverse Event|0|||
19497720|NCT02414958|41851463|FG000|Overall Study|Adverse Event|6|||
19497721|NCT02414958|41851464|FG001|Overall Study|Adverse Event|6|||
19497722|NCT02414958|41851465|FG002|Overall Study|Adverse Event|3|||
19613504|NCT00607087|42062306|FG000|Period 2|Poor compliance to protocol|0|||
19613505|NCT00607087|42062307|FG001|Period 2|Poor compliance to protocol|0|||
19613506|NCT00607087|42062308|FG002|Period 2|Poor compliance to protocol|1|||
19613507|NCT00607087|42062306|FG000|Period 3|Withdrawal by Subject|2|||
19613508|NCT00607087|42062307|FG001|Period 3|Withdrawal by Subject|1|||
19613509|NCT00607087|42062308|FG002|Period 3|Withdrawal by Subject|0|||
19613510|NCT00607087|42062306|FG000|Period 3|Adverse Event|0|||
19613511|NCT00607087|42062307|FG001|Period 3|Adverse Event|1|||
19613512|NCT00607087|42062308|FG002|Period 3|Adverse Event|0|||
19613513|NCT00610363|42062318|FG000|Overall Study|Non-compliance with protocol|0|||
19613514|NCT00610363|42062319|FG001|Overall Study|Non-compliance with protocol|1|||
19613515|NCT00610363|42062318|FG000|Overall Study|Adverse Event|3|||
19613516|NCT00610363|42062319|FG001|Overall Study|Adverse Event|1|||
19613517|NCT00610363|42062318|FG000|Overall Study|Lack of Efficacy|2|||
19613518|NCT00610363|42062319|FG001|Overall Study|Lack of Efficacy|0|||
19613519|NCT00610363|42062318|FG000|Overall Study|Lost to Follow-up|4|||
19497723|NCT02414958|41851463|FG000|Overall Study|Protocol Violation|10|||
19497724|NCT02414958|41851464|FG001|Overall Study|Protocol Violation|3|||
19497725|NCT02414958|41851465|FG002|Overall Study|Protocol Violation|1|||
19497726|NCT02414958|41851463|FG000|Overall Study|Lost to Follow-up|7|||
19497727|NCT02414958|41851464|FG001|Overall Study|Lost to Follow-up|4|||
19497728|NCT02414958|41851465|FG002|Overall Study|Lost to Follow-up|0|||
19497729|NCT02414958|41851463|FG000|Overall Study|Withdrawal by Subject|5|||
19497730|NCT02414958|41851464|FG001|Overall Study|Withdrawal by Subject|3|||
19497731|NCT02414958|41851465|FG002|Overall Study|Withdrawal by Subject|5|||
19497732|NCT02414958|41851463|FG000|Overall Study|Other than specified|4|||
19497733|NCT02414958|41851464|FG001|Overall Study|Other than specified|4|||
19497734|NCT02414958|41851465|FG002|Overall Study|Other than specified|5|||
19497735|NCT02452476|41851538|FG000|Overall Study|Death|4|||
19497736|NCT02452476|41851539|FG001|Overall Study|Death|7|||
19613520|NCT00610363|42062319|FG001|Overall Study|Lost to Follow-up|0|||
19613521|NCT00610363|42062318|FG000|Overall Study|Withdrawal by Subject|1|||
19613522|NCT00610363|42062319|FG001|Overall Study|Withdrawal by Subject|0|||
19613523|NCT00610363|42062318|FG000|Overall Study|Other than specified above|1|||
19613524|NCT00610363|42062319|FG001|Overall Study|Other than specified above|1|||
19497737|NCT02452476|41851538|FG000|Overall Study|Lost to Follow-up|1|||
19497738|NCT02452476|41851539|FG001|Overall Study|Lost to Follow-up|1|||
19497739|NCT02452476|41851538|FG000|Overall Study|Physician Decision|1|||
19497740|NCT02452476|41851539|FG001|Overall Study|Physician Decision|1|||
19497741|NCT02452476|41851538|FG000|Overall Study|Not treated|5|||
19497742|NCT02452476|41851539|FG001|Overall Study|Not treated|1|||
19497743|NCT02442336|41851554|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
19497744|NCT02442336|41851554|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
19497745|NCT02442336|41851554|FG000|Overall Study|Lost to Follow-up|11|||
19497746|NCT02452398|41851558|FG000|Overall Study|Adverse Event|1|||
19497747|NCT02452398|41851558|FG000|Overall Study|Lost to Follow-up|28|||
19497748|NCT02452398|41851558|FG000|Overall Study|Physician Decision|2|||
19497749|NCT02452398|41851558|FG000|Overall Study|Withdrawal by Subject|6|||
19497750|NCT02452398|41851558|FG000|Overall Study|Moved away|4|||
19497751|NCT02413398|41851564|FG000|Overall Study|Lost to Follow-up|2|||
19497752|NCT02413398|41851565|FG001|Overall Study|Lost to Follow-up|4|||
19497753|NCT02413398|41851564|FG000|Overall Study|Withdrawal by Subject|1|||
19497754|NCT02413398|41851565|FG001|Overall Study|Withdrawal by Subject|1|||
19497755|NCT02413398|41851564|FG000|Overall Study|Other Eligibility criteria|1|||
19497756|NCT02413398|41851565|FG001|Overall Study|Other Eligibility criteria|2|||
19497757|NCT02441946|41851574|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
19497758|NCT02441946|41851575|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
19497759|NCT02441946|41851576|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
19497760|NCT02441946|41851574|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
19497761|NCT02441946|41851575|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
19497762|NCT02441946|41851576|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
19497763|NCT02441946|41851574|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19497764|NCT02441946|41851575|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
19613525|NCT00887588|42062328|FG000|Core Period|Death|1|||
19613526|NCT00887588|42062329|FG001|Core Period|Death|1|||
19613527|NCT00887588|42062328|FG000|Core Period|Lost to Follow-up|3|||
19497765|NCT02441946|41851576|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19497766|NCT02441946|41851574|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
19497767|NCT02441946|41851575|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
19497768|NCT02441946|41851576|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
19497769|NCT02441946|41851574|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
19497770|NCT02441946|41851575|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
19497771|NCT02441946|41851576|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
19497772|NCT02441946|41851574|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
19497773|NCT02441946|41851575|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
19497774|NCT02441946|41851576|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
19497775|NCT02441946|41851574|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
19497776|NCT02441946|41851575|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
19497777|NCT02441946|41851576|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
19497778|NCT02441946|41851574|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
19497779|NCT02441946|41851575|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
19497780|NCT02441946|41851576|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
19497781|NCT02441946|41851574|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
19497782|NCT02441946|41851575|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
19497783|NCT02441946|41851576|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
19497784|NCT02441946|41851574|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
19497785|NCT02441946|41851575|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
19497786|NCT02441946|41851576|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
19497787|NCT02441946|41851574|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
19497788|NCT02441946|41851575|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
19497789|NCT02441946|41851576|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
19497790|NCT02387580|41851610|FG000|Overall Study|Withdrawal by Subject|0|||
19497791|NCT02387580|41851611|FG001|Overall Study|Withdrawal by Subject|0|||
19497792|NCT02387580|41851612|FG002|Overall Study|Withdrawal by Subject|0|||
19497793|NCT02387580|41851613|FG003|Overall Study|Withdrawal by Subject|1|||
19497794|NCT02387580|41851614|FG004|Overall Study|Withdrawal by Subject|0|||
19497795|NCT02387580|41851615|FG005|Overall Study|Withdrawal by Subject|0|||
19497796|NCT02440854|41851631|FG000|Overall Study|Relocation of patient|1|||
19497797|NCT02440854|41851631|FG000|Overall Study|Death|6|||
19497798|NCT02440854|41851631|FG000|Overall Study|Lost to Follow-up|10|||
19497799|NCT02440854|41851631|FG000|Overall Study|Afatinib discontinuation|46|||
19497800|NCT02440854|41851631|FG000|Overall Study|stopped study at earlier timepoint|14|||
19497801|NCT02440854|41851631|FG000|Overall Study|Study medication not received|1|||
19497802|NCT02440854|41851631|FG000|Overall Study|Violation of inclusion criteria|2|||
19497803|NCT02412852|41851686|FG000|Overall Study|Withdrawal by Subject|0|||
19497804|NCT02412852|41851687|FG001|Overall Study|Withdrawal by Subject|1|||
19497805|NCT02412852|41851688|FG002|Overall Study|Withdrawal by Subject|0|||
19497806|NCT02412852|41851689|FG003|Overall Study|Withdrawal by Subject|0|||
19497807|NCT02412852|41851686|FG000|Overall Study|Physician Decision|0|||
19497808|NCT02412852|41851687|FG001|Overall Study|Physician Decision|0|||
19497809|NCT02412852|41851688|FG002|Overall Study|Physician Decision|0|||
19497810|NCT02412852|41851689|FG003|Overall Study|Physician Decision|1|||
19497811|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
19497812|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
19497813|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
19497814|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
19497815|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
19497816|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
19497817|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
19497818|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
19497819|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
19497820|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
19497821|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
19497822|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
19497823|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
19497824|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
19497825|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
19497826|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
19497827|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
19497828|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
19497829|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
19497830|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
19497831|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
19497832|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
19497833|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
19497834|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
19497835|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
19497836|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Other|1|||
19497837|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Other|0|||
19497838|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Other|0|||
19497839|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Other|0|||
19497840|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Other|0|||
19497841|NCT02386098|41851745|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
19497842|NCT02386098|41851746|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
19497843|NCT02386098|41851747|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
19497844|NCT02386098|41851748|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
19497845|NCT02386098|41851749|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
19497846|NCT02412618|41851792|FG000|Overall Study|Withdrawal by Subject|1|||
19497847|NCT02412618|41851793|FG001|Overall Study|Withdrawal by Subject|1|||
19497848|NCT02412618|41851792|FG000|Overall Study|Expulsion|1|||
19497849|NCT02412618|41851793|FG001|Overall Study|Expulsion|1|||
19497850|NCT00585195|41851990|FG000|Overall Study|Adverse Event|0|||
19497851|NCT00585195|41851991|FG001|Overall Study|Adverse Event|0|||
19497852|NCT00585195|41851992|FG002|Overall Study|Adverse Event|0|||
19497853|NCT00585195|41851993|FG003|Overall Study|Adverse Event|0|||
19497854|NCT00585195|41851994|FG004|Overall Study|Adverse Event|2|||
19497855|NCT00585195|41851995|FG005|Overall Study|Adverse Event|1|||
19497856|NCT00585195|41851996|FG006|Overall Study|Adverse Event|0|||
19497857|NCT00585195|41851997|FG007|Overall Study|Adverse Event|1|||
19497858|NCT00585195|41851998|FG008|Overall Study|Adverse Event|0|||
19497859|NCT00585195|41851999|FG009|Overall Study|Adverse Event|0|||
19497860|NCT00585195|41852000|FG010|Overall Study|Adverse Event|3|||
19497861|NCT00585195|41852001|FG011|Overall Study|Adverse Event|0|||
19497862|NCT00585195|41852002|FG012|Overall Study|Adverse Event|8|||
19497863|NCT00585195|41852003|FG013|Overall Study|Adverse Event|6|||
19497864|NCT00585195|41852004|FG014|Overall Study|Adverse Event|4|||
19497865|NCT00585195|41852005|FG015|Overall Study|Adverse Event|1|||
19497866|NCT00585195|41852006|FG016|Overall Study|Adverse Event|14|||
19497867|NCT00585195|41852007|FG017|Overall Study|Adverse Event|9|||
19497868|NCT00585195|41852008|FG018|Overall Study|Adverse Event|2|||
19497869|NCT00585195|41852009|FG019|Overall Study|Adverse Event|3|||
19497870|NCT00585195|41852010|FG020|Overall Study|Adverse Event|1|||
19497871|NCT00585195|41851990|FG000|Overall Study|Progressive Disease|2|||
19497872|NCT00585195|41851991|FG001|Overall Study|Progressive Disease|2|||
19497873|NCT00585195|41851992|FG002|Overall Study|Progressive Disease|5|||
19497874|NCT00585195|41851993|FG003|Overall Study|Progressive Disease|4|||
19497875|NCT00585195|41851994|FG004|Overall Study|Progressive Disease|6|||
19497876|NCT00585195|41851995|FG005|Overall Study|Progressive Disease|4|||
19497877|NCT00585195|41851996|FG006|Overall Study|Progressive Disease|6|||
19497878|NCT00585195|41851997|FG007|Overall Study|Progressive Disease|3|||
19497879|NCT00585195|41851998|FG008|Overall Study|Progressive Disease|0|||
19497880|NCT00585195|41851999|FG009|Overall Study|Progressive Disease|5|||
19497881|NCT00585195|41852000|FG010|Overall Study|Progressive Disease|2|||
19497882|NCT00585195|41852001|FG011|Overall Study|Progressive Disease|25|||
19497883|NCT00585195|41852002|FG012|Overall Study|Progressive Disease|29|||
19497884|NCT00585195|41852003|FG013|Overall Study|Progressive Disease|26|||
19497885|NCT00585195|41852004|FG014|Overall Study|Progressive Disease|21|||
19497886|NCT00585195|41852005|FG015|Overall Study|Progressive Disease|12|||
19497887|NCT00585195|41852006|FG016|Overall Study|Progressive Disease|94|||
19497888|NCT00585195|41852007|FG017|Overall Study|Progressive Disease|42|||
19497889|NCT00585195|41852008|FG018|Overall Study|Progressive Disease|4|||
19497890|NCT00585195|41852009|FG019|Overall Study|Progressive Disease|9|||
19497891|NCT00585195|41852010|FG020|Overall Study|Progressive Disease|8|||
19497892|NCT00585195|41851990|FG000|Overall Study|Withdrawal by Subject|1|||
19497893|NCT00585195|41851991|FG001|Overall Study|Withdrawal by Subject|1|||
19497894|NCT00585195|41851992|FG002|Overall Study|Withdrawal by Subject|2|||
19497895|NCT00585195|41851993|FG003|Overall Study|Withdrawal by Subject|2|||
19497896|NCT00585195|41851994|FG004|Overall Study|Withdrawal by Subject|0|||
19497897|NCT00585195|41851995|FG005|Overall Study|Withdrawal by Subject|0|||
19497898|NCT00585195|41851996|FG006|Overall Study|Withdrawal by Subject|0|||
19497899|NCT00585195|41851997|FG007|Overall Study|Withdrawal by Subject|1|||
19497900|NCT00585195|41851998|FG008|Overall Study|Withdrawal by Subject|0|||
19497901|NCT00585195|41851999|FG009|Overall Study|Withdrawal by Subject|0|||
19497902|NCT00585195|41852000|FG010|Overall Study|Withdrawal by Subject|3|||
19497903|NCT00585195|41852001|FG011|Overall Study|Withdrawal by Subject|8|||
19497904|NCT00585195|41852002|FG012|Overall Study|Withdrawal by Subject|15|||
19497905|NCT00585195|41852003|FG013|Overall Study|Withdrawal by Subject|0|||
19497906|NCT00585195|41852004|FG014|Overall Study|Withdrawal by Subject|3|||
19497907|NCT00585195|41852005|FG015|Overall Study|Withdrawal by Subject|0|||
19497908|NCT00585195|41852006|FG016|Overall Study|Withdrawal by Subject|7|||
19497909|NCT00585195|41852007|FG017|Overall Study|Withdrawal by Subject|1|||
19497910|NCT00585195|41852008|FG018|Overall Study|Withdrawal by Subject|2|||
19497911|NCT00585195|41852009|FG019|Overall Study|Withdrawal by Subject|2|||
19497912|NCT00585195|41852010|FG020|Overall Study|Withdrawal by Subject|0|||
19497913|NCT00585195|41851990|FG000|Overall Study|Other|0|||
19497914|NCT00585195|41851991|FG001|Overall Study|Other|1|||
19497915|NCT00585195|41851992|FG002|Overall Study|Other|1|||
19497916|NCT00585195|41851993|FG003|Overall Study|Other|1|||
19497917|NCT00585195|41851994|FG004|Overall Study|Other|0|||
19497918|NCT00585195|41851995|FG005|Overall Study|Other|1|||
19497919|NCT00585195|41851996|FG006|Overall Study|Other|0|||
19497920|NCT00585195|41851997|FG007|Overall Study|Other|0|||
19497921|NCT00585195|41851998|FG008|Overall Study|Other|2|||
19497922|NCT00585195|41851999|FG009|Overall Study|Other|1|||
19497923|NCT00585195|41852000|FG010|Overall Study|Other|0|||
19497924|NCT00585195|41852001|FG011|Overall Study|Other|19|||
19497925|NCT00585195|41852002|FG012|Overall Study|Other|24|||
19497926|NCT00585195|41852003|FG013|Overall Study|Other|7|||
19497927|NCT00585195|41852004|FG014|Overall Study|Other|11|||
19497928|NCT00585195|41852005|FG015|Overall Study|Other|3|||
19497929|NCT00585195|41852006|FG016|Overall Study|Other|28|||
19497930|NCT00585195|41852007|FG017|Overall Study|Other|12|||
19497931|NCT00585195|41852008|FG018|Overall Study|Other|10|||
19497932|NCT00585195|41852009|FG019|Overall Study|Other|4|||
19497933|NCT00585195|41852010|FG020|Overall Study|Other|2|||
19497934|NCT00585195|41851990|FG000|Overall Study|Randomized not treated|0|||
19497935|NCT00585195|41851991|FG001|Overall Study|Randomized not treated|0|||
19497936|NCT00585195|41851992|FG002|Overall Study|Randomized not treated|1|||
19497937|NCT00585195|41851993|FG003|Overall Study|Randomized not treated|0|||
19497938|NCT00585195|41851994|FG004|Overall Study|Randomized not treated|1|||
19497939|NCT00585195|41851995|FG005|Overall Study|Randomized not treated|0|||
19497940|NCT00585195|41851996|FG006|Overall Study|Randomized not treated|1|||
19497941|NCT00585195|41851997|FG007|Overall Study|Randomized not treated|0|||
19497942|NCT00585195|41851998|FG008|Overall Study|Randomized not treated|0|||
19497943|NCT00585195|41851999|FG009|Overall Study|Randomized not treated|0|||
19497944|NCT00585195|41852000|FG010|Overall Study|Randomized not treated|2|||
19497945|NCT00585195|41852001|FG011|Overall Study|Randomized not treated|0|||
19497946|NCT00585195|41852002|FG012|Overall Study|Randomized not treated|0|||
19497947|NCT00585195|41852003|FG013|Overall Study|Randomized not treated|0|||
19497948|NCT00585195|41852004|FG014|Overall Study|Randomized not treated|0|||
19497949|NCT00585195|41852005|FG015|Overall Study|Randomized not treated|1|||
19497950|NCT00585195|41852006|FG016|Overall Study|Randomized not treated|0|||
19497951|NCT00585195|41852007|FG017|Overall Study|Randomized not treated|1|||
19497952|NCT00585195|41852008|FG018|Overall Study|Randomized not treated|3|||
19497953|NCT00585195|41852009|FG019|Overall Study|Randomized not treated|0|||
19497954|NCT00585195|41852010|FG020|Overall Study|Randomized not treated|2|||
19497955|NCT00585195|41851990|FG000|Overall Study|Death|0|||
19497956|NCT00585195|41851991|FG001|Overall Study|Death|0|||
19497957|NCT00585195|41851992|FG002|Overall Study|Death|0|||
19497958|NCT00585195|41851993|FG003|Overall Study|Death|0|||
19497959|NCT00585195|41851994|FG004|Overall Study|Death|0|||
19497960|NCT00585195|41851995|FG005|Overall Study|Death|0|||
19497961|NCT00585195|41851996|FG006|Overall Study|Death|0|||
19497962|NCT00585195|41851997|FG007|Overall Study|Death|0|||
19497963|NCT00585195|41851998|FG008|Overall Study|Death|1|||
19497964|NCT00585195|41851999|FG009|Overall Study|Death|0|||
19497965|NCT00585195|41852000|FG010|Overall Study|Death|1|||
19497966|NCT00585195|41852001|FG011|Overall Study|Death|1|||
19497967|NCT00585195|41852002|FG012|Overall Study|Death|7|||
19497968|NCT00585195|41852003|FG013|Overall Study|Death|2|||
19497969|NCT00585195|41852004|FG014|Overall Study|Death|8|||
19497970|NCT00585195|41852005|FG015|Overall Study|Death|2|||
19497971|NCT00585195|41852006|FG016|Overall Study|Death|11|||
19497972|NCT00585195|41852007|FG017|Overall Study|Death|0|||
19497973|NCT00585195|41852008|FG018|Overall Study|Death|0|||
19497974|NCT00585195|41852009|FG019|Overall Study|Death|0|||
19497975|NCT00585195|41852010|FG020|Overall Study|Death|1|||
19497976|NCT00585195|41851990|FG000|Overall Study|Lost to Follow-up|0|||
19497977|NCT00585195|41851991|FG001|Overall Study|Lost to Follow-up|0|||
19497978|NCT00585195|41851992|FG002|Overall Study|Lost to Follow-up|0|||
19497979|NCT00585195|41851993|FG003|Overall Study|Lost to Follow-up|0|||
19613528|NCT00887588|42062329|FG001|Core Period|Lost to Follow-up|1|||
19613529|NCT00887588|42062328|FG000|Core Period|Withdrawal by Subject|6|||
19613530|NCT00887588|42062329|FG001|Core Period|Withdrawal by Subject|8|||
19613531|NCT00887588|42062328|FG000|Core Period|Adverse Event|9|||
19613532|NCT00887588|42062329|FG001|Core Period|Adverse Event|11|||
19497980|NCT00585195|41851994|FG004|Overall Study|Lost to Follow-up|0|||
19497981|NCT00585195|41851995|FG005|Overall Study|Lost to Follow-up|0|||
19497982|NCT00585195|41851996|FG006|Overall Study|Lost to Follow-up|0|||
19497983|NCT00585195|41851997|FG007|Overall Study|Lost to Follow-up|0|||
19497984|NCT00585195|41851998|FG008|Overall Study|Lost to Follow-up|0|||
19497985|NCT00585195|41851999|FG009|Overall Study|Lost to Follow-up|0|||
19497986|NCT00585195|41852000|FG010|Overall Study|Lost to Follow-up|0|||
19497987|NCT00585195|41852001|FG011|Overall Study|Lost to Follow-up|0|||
19497988|NCT00585195|41852002|FG012|Overall Study|Lost to Follow-up|1|||
19497989|NCT00585195|41852003|FG013|Overall Study|Lost to Follow-up|0|||
19497990|NCT00585195|41852004|FG014|Overall Study|Lost to Follow-up|0|||
19497991|NCT00585195|41852005|FG015|Overall Study|Lost to Follow-up|0|||
19497992|NCT00585195|41852006|FG016|Overall Study|Lost to Follow-up|0|||
19497993|NCT00585195|41852007|FG017|Overall Study|Lost to Follow-up|2|||
19497994|NCT00585195|41852008|FG018|Overall Study|Lost to Follow-up|0|||
19497995|NCT00585195|41852009|FG019|Overall Study|Lost to Follow-up|0|||
19613533|NCT00887588|42062328|FG000|Extension Period|Adverse Event|4|||
19497996|NCT00585195|41852010|FG020|Overall Study|Lost to Follow-up|0|||
19497997|NCT00585195|41851990|FG000|Overall Study|Site Terminated by Sponsor|0|||
19497998|NCT00585195|41851991|FG001|Overall Study|Site Terminated by Sponsor|0|||
19497999|NCT00585195|41851992|FG002|Overall Study|Site Terminated by Sponsor|0|||
19498000|NCT00585195|41851993|FG003|Overall Study|Site Terminated by Sponsor|0|||
19498001|NCT00585195|41851994|FG004|Overall Study|Site Terminated by Sponsor|0|||
19498002|NCT00585195|41851995|FG005|Overall Study|Site Terminated by Sponsor|0|||
19498003|NCT00585195|41851996|FG006|Overall Study|Site Terminated by Sponsor|0|||
19498004|NCT00585195|41851997|FG007|Overall Study|Site Terminated by Sponsor|0|||
19498005|NCT00585195|41851998|FG008|Overall Study|Site Terminated by Sponsor|0|||
19498006|NCT00585195|41851999|FG009|Overall Study|Site Terminated by Sponsor|0|||
19498007|NCT00585195|41852000|FG010|Overall Study|Site Terminated by Sponsor|0|||
19498008|NCT00585195|41852001|FG011|Overall Study|Site Terminated by Sponsor|0|||
19498009|NCT00585195|41852002|FG012|Overall Study|Site Terminated by Sponsor|1|||
19498010|NCT00585195|41852003|FG013|Overall Study|Site Terminated by Sponsor|0|||
19498011|NCT00585195|41852004|FG014|Overall Study|Site Terminated by Sponsor|0|||
19498012|NCT00585195|41852005|FG015|Overall Study|Site Terminated by Sponsor|0|||
19498013|NCT00585195|41852006|FG016|Overall Study|Site Terminated by Sponsor|0|||
19498014|NCT00585195|41852007|FG017|Overall Study|Site Terminated by Sponsor|0|||
19498015|NCT00585195|41852008|FG018|Overall Study|Site Terminated by Sponsor|0|||
19498016|NCT00585195|41852009|FG019|Overall Study|Site Terminated by Sponsor|0|||
19498017|NCT00585195|41852010|FG020|Overall Study|Site Terminated by Sponsor|0|||
19498018|NCT00585195|41851990|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
19498019|NCT00585195|41851991|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
19498020|NCT00585195|41851992|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
19498021|NCT00585195|41851993|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
19498022|NCT00585195|41851994|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
19498023|NCT00585195|41851995|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
19498024|NCT00585195|41851996|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
19498025|NCT00585195|41851997|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
19498026|NCT00585195|41851998|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
19498027|NCT00585195|41851999|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
19498028|NCT00585195|41852000|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
19498029|NCT00585195|41852001|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
19613534|NCT00887588|42062329|FG001|Extension Period|Adverse Event|4|||
19613535|NCT00887588|42062328|FG000|Extension Period|Death|0|||
19613536|NCT00887588|42062329|FG001|Extension Period|Death|1|||
19613537|NCT00887588|42062328|FG000|Extension Period|Protocol deviation|1|||
19613538|NCT00887588|42062329|FG001|Extension Period|Protocol deviation|0|||
19613539|NCT00887588|42062328|FG000|Extension Period|Lost to Follow-up|1|||
19613540|NCT00887588|42062329|FG001|Extension Period|Lost to Follow-up|0|||
19613541|NCT00945893|42062337|FG000|Overall Study|Lost to Follow-up|2|||
19613542|NCT00945893|42062338|FG001|Overall Study|Lost to Follow-up|8|||
19613543|NCT00945893|42062337|FG000|Overall Study|Withdrawal of consent|1|||
19613544|NCT00945893|42062338|FG001|Overall Study|Withdrawal of consent|2|||
19613545|NCT00799383|42062350|FG000|Overall Study|Protocol Violation|1|||
19613546|NCT00799383|42062351|FG001|Overall Study|Protocol Violation|1|||
19613547|NCT00799383|42062350|FG000|Overall Study|Adverse Event|0|||
19498030|NCT00585195|41852002|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
19498031|NCT00585195|41852003|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
19498032|NCT00585195|41852004|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
19498033|NCT00585195|41852005|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
19498034|NCT00585195|41852006|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
19498035|NCT00585195|41852007|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
19498036|NCT00585195|41852008|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
19498037|NCT00585195|41852009|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
19498038|NCT00585195|41852010|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
19498039|NCT02439216|41852182|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
19498040|NCT02439216|41852183|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19498041|NCT02439216|41852184|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19498042|NCT02439216|41852185|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19498043|NCT02439216|41852186|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19704399|NCT00161616|42148748|FG001|Overall Study|Death|1|||
19498044|NCT02439216|41852187|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19498045|NCT02439216|41852188|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19498046|NCT02439216|41852189|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19704400|NCT00161616|42148747|FG000|Overall Study|Lost to Follow-up|17|||
19704401|NCT00161616|42148748|FG001|Overall Study|Lost to Follow-up|13|||
19704402|NCT00161616|42148747|FG000|Overall Study|Protocol deviation|1|||
19704403|NCT00161616|42148748|FG001|Overall Study|Protocol deviation|0|||
19704404|NCT00252564|42148756|FG000|Overall Study|Adverse Event|17|||
19498047|NCT02439216|41852190|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
19613548|NCT00799383|42062351|FG001|Overall Study|Adverse Event|1|||
19704405|NCT00252564|42148757|FG001|Overall Study|Adverse Event|13|||
19704406|NCT00252564|42148756|FG000|Overall Study|Unrelated Complication|2|||
19498048|NCT02439216|41852182|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498049|NCT02439216|41852183|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498050|NCT02439216|41852184|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498051|NCT02439216|41852185|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498052|NCT02439216|41852186|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498053|NCT02439216|41852187|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498054|NCT02439216|41852188|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498055|NCT02439216|41852189|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
19498056|NCT02439216|41852190|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
19498057|NCT02439216|41852182|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498058|NCT02439216|41852183|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498059|NCT02439216|41852184|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498060|NCT02439216|41852185|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498061|NCT02439216|41852186|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498062|NCT02439216|41852187|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498063|NCT02439216|41852188|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
19498064|NCT02439216|41852189|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
19498065|NCT02439216|41852190|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
19498066|NCT02439216|41852182|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498067|NCT02439216|41852183|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498068|NCT02439216|41852184|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498069|NCT02439216|41852185|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498070|NCT02439216|41852186|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498071|NCT02439216|41852187|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498072|NCT02439216|41852188|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498073|NCT02439216|41852189|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
19498074|NCT02439216|41852190|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
19498075|NCT02439216|41852182|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498076|NCT02439216|41852183|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19613549|NCT00799383|42062350|FG000|Overall Study|Lost to Follow-up|1|||
19613550|NCT00799383|42062351|FG001|Overall Study|Lost to Follow-up|2|||
19498077|NCT02439216|41852184|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498078|NCT02439216|41852185|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498079|NCT02439216|41852186|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498080|NCT02439216|41852187|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498081|NCT02439216|41852188|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
19498082|NCT02439216|41852189|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
19498083|NCT02439216|41852190|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
19498084|NCT02439138|41852218|FG000|Overall Study|Adverse Event|1|||
19498085|NCT02439138|41852218|FG000|Overall Study|PI decision to terminate the study|2|||
19498086|NCT02438826|41852594|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
19498087|NCT02438826|41852595|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
19498088|NCT02438826|41852596|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
19498089|NCT02438826|41852597|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
19498090|NCT02438826|41852594|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
19498091|NCT02438826|41852595|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19498092|NCT02438826|41852596|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19498093|NCT02438826|41852597|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19498094|NCT02438826|41852594|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
19498095|NCT02438826|41852595|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
19498096|NCT02438826|41852596|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19498097|NCT02438826|41852597|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19498098|NCT02438826|41852594|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
19498099|NCT02438826|41852595|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
19498100|NCT02438826|41852596|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
19498101|NCT02438826|41852597|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
19498102|NCT02438826|41852594|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
19498103|NCT02438826|41852595|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
19498104|NCT02438826|41852596|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
19498105|NCT02438826|41852597|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
19498106|NCT02438826|41852594|FG000|Open-Label Treatment Phase|Adverse Event|11|||
19498107|NCT02438826|41852595|FG001|Open-Label Treatment Phase|Adverse Event|6|||
19498108|NCT02438826|41852596|FG002|Open-Label Treatment Phase|Adverse Event|0|||
19498109|NCT02438826|41852597|FG003|Open-Label Treatment Phase|Adverse Event|0|||
19613551|NCT00799383|42062350|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
19498110|NCT02438826|41852594|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
19498111|NCT02438826|41852595|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
19498112|NCT02438826|41852596|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
19498113|NCT02438826|41852597|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
19498114|NCT02438826|41852594|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
19498115|NCT02438826|41852595|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
19498116|NCT02438826|41852596|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
19498117|NCT02438826|41852597|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
19498118|NCT02438826|41852594|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
19498119|NCT02438826|41852595|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
19498120|NCT02438826|41852596|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
19498121|NCT02438826|41852597|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
19498122|NCT02438826|41852594|FG000|Post-Treatment Phase|Adverse Event|3|||
19498123|NCT02438826|41852595|FG001|Post-Treatment Phase|Adverse Event|0|||
19498124|NCT02438826|41852596|FG002|Post-Treatment Phase|Adverse Event|0|||
19498125|NCT02438826|41852597|FG003|Post-Treatment Phase|Adverse Event|0|||
19498126|NCT02438826|41852594|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
19498127|NCT02438826|41852595|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
19498128|NCT02438826|41852596|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
19498129|NCT02438826|41852597|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
19498130|NCT02438826|41852594|FG000|Post-Treatment Phase|Physician Decision|1|||
19498131|NCT02438826|41852595|FG001|Post-Treatment Phase|Physician Decision|0|||
19498132|NCT02438826|41852596|FG002|Post-Treatment Phase|Physician Decision|0|||
19498133|NCT02438826|41852597|FG003|Post-Treatment Phase|Physician Decision|0|||
19498134|NCT02438826|41852594|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
19498135|NCT02438826|41852595|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
19498136|NCT02438826|41852596|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
19498137|NCT02438826|41852597|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
19498138|NCT02438280|41852614|FG000|Overall Study|Physician Decision|1|||
19498139|NCT02438280|41852615|FG001|Overall Study|Physician Decision|0|||
19498140|NCT02385708|41852633|FG000|Overall Study|Withdrawal by Subject|0|||
19498141|NCT02385708|41852634|FG001|Overall Study|Withdrawal by Subject|2|||
19498142|NCT02385708|41852633|FG000|Overall Study|Withdrawn - surgery canceled|2|||
19498143|NCT02385708|41852634|FG001|Overall Study|Withdrawn - surgery canceled|5|||
19498144|NCT02385708|41852633|FG000|Overall Study|Investigator decision|5|||
19498145|NCT02385708|41852634|FG001|Overall Study|Investigator decision|7|||
19498146|NCT02385708|41852633|FG000|Overall Study|Protocol Violation|1|||
19498147|NCT02385708|41852634|FG001|Overall Study|Protocol Violation|1|||
19498148|NCT02411448|41853363|FG000|Overall Study|Withdrawal by Subject|1|||
19498149|NCT02411448|41853364|FG001|Overall Study|Withdrawal by Subject|14|||
19498150|NCT02411448|41853365|FG002|Overall Study|Withdrawal by Subject|9|||
19498151|NCT02411448|41853363|FG000|Overall Study|Other|0|||
19498152|NCT02411448|41853364|FG001|Overall Study|Other|2|||
19498153|NCT02411448|41853365|FG002|Overall Study|Other|0|||
19498154|NCT02411448|41853363|FG000|Overall Study|Did not receive study treatment|0|||
19498155|NCT02411448|41853364|FG001|Overall Study|Did not receive study treatment|3|||
19498156|NCT02411448|41853365|FG002|Overall Study|Did not receive study treatment|0|||
19498157|NCT02411448|41853363|FG000|Overall Study|Alive on study treatment|3|||
19498158|NCT02411448|41853364|FG001|Overall Study|Alive on study treatment|64|||
19498159|NCT02411448|41853365|FG002|Overall Study|Alive on study treatment|43|||
19498160|NCT02385084|41853390|FG000|Period 2|Protocol Violation|0|||
19498161|NCT02385084|41853391|FG001|Period 2|Protocol Violation|0|||
19498162|NCT02385084|41853392|FG002|Period 2|Protocol Violation|1|||
19498163|NCT02385084|41853393|FG003|Period 2|Protocol Violation|0|||
19498164|NCT02385084|41853394|FG004|Period 2|Protocol Violation|0|||
19498165|NCT02385084|41853395|FG005|Period 2|Protocol Violation|0|||
19498166|NCT02411292|41853404|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
19498167|NCT02411292|41853404|FG000|Overall Study|Death|2|||
19498168|NCT02411292|41853404|FG000|Overall Study|Lost to Follow-up|3|||
19498169|NCT02384850|41853467|FG000|Overall Study|Withdrawal by Subject|2|||
19498170|NCT02384850|41853468|FG001|Overall Study|Withdrawal by Subject|2|||
19498171|NCT02437890|41853690|FG000|Overall Study|Non-compliance to study drug|0|||
19498172|NCT02437890|41853691|FG001|Overall Study|Non-compliance to study drug|1|||
19498173|NCT02437890|41853692|FG002|Overall Study|Non-compliance to study drug|0|||
19498174|NCT02437890|41853693|FG003|Overall Study|Non-compliance to study drug|0|||
19498175|NCT02437890|41853694|FG004|Overall Study|Non-compliance to study drug|1|||
19498176|NCT02437890|41853690|FG000|Overall Study|Sponsor's decision|1|||
19498177|NCT02437890|41853691|FG001|Overall Study|Sponsor's decision|1|||
19498178|NCT02437890|41853692|FG002|Overall Study|Sponsor's decision|4|||
19498179|NCT02437890|41853693|FG003|Overall Study|Sponsor's decision|0|||
19498180|NCT02437890|41853694|FG004|Overall Study|Sponsor's decision|2|||
19498181|NCT02437890|41853690|FG000|Overall Study|Physician Decision|0|||
19498182|NCT02437890|41853691|FG001|Overall Study|Physician Decision|0|||
19498183|NCT02437890|41853692|FG002|Overall Study|Physician Decision|0|||
19498184|NCT02437890|41853693|FG003|Overall Study|Physician Decision|1|||
19498185|NCT02437890|41853694|FG004|Overall Study|Physician Decision|0|||
19498186|NCT02437890|41853690|FG000|Overall Study|Unable to attend visit(s)|1|||
19498187|NCT02437890|41853691|FG001|Overall Study|Unable to attend visit(s)|0|||
19498188|NCT02437890|41853692|FG002|Overall Study|Unable to attend visit(s)|0|||
19498189|NCT02437890|41853693|FG003|Overall Study|Unable to attend visit(s)|0|||
19498190|NCT02437890|41853694|FG004|Overall Study|Unable to attend visit(s)|0|||
19498191|NCT02437890|41853690|FG000|Overall Study|Lack of Efficacy|1|||
19498192|NCT02437890|41853691|FG001|Overall Study|Lack of Efficacy|3|||
19498193|NCT02437890|41853692|FG002|Overall Study|Lack of Efficacy|0|||
19498194|NCT02437890|41853693|FG003|Overall Study|Lack of Efficacy|3|||
19498195|NCT02437890|41853694|FG004|Overall Study|Lack of Efficacy|1|||
19498196|NCT02437890|41853690|FG000|Overall Study|Adverse Event|4|||
19498197|NCT02437890|41853691|FG001|Overall Study|Adverse Event|9|||
19498198|NCT02437890|41853692|FG002|Overall Study|Adverse Event|5|||
19498199|NCT02437890|41853693|FG003|Overall Study|Adverse Event|11|||
19498200|NCT02437890|41853694|FG004|Overall Study|Adverse Event|7|||
19498201|NCT02437890|41853690|FG000|Overall Study|Withdrawal by Subject|1|||
19498202|NCT02437890|41853691|FG001|Overall Study|Withdrawal by Subject|2|||
19498203|NCT02437890|41853692|FG002|Overall Study|Withdrawal by Subject|6|||
19498204|NCT02437890|41853693|FG003|Overall Study|Withdrawal by Subject|5|||
19498205|NCT02437890|41853694|FG004|Overall Study|Withdrawal by Subject|5|||
19498206|NCT02437890|41853690|FG000|Overall Study|Death|0|||
19498207|NCT02437890|41853691|FG001|Overall Study|Death|0|||
19498208|NCT02437890|41853692|FG002|Overall Study|Death|0|||
19498209|NCT02437890|41853693|FG003|Overall Study|Death|2|||
19498210|NCT02437890|41853694|FG004|Overall Study|Death|0|||
19498211|NCT02384538|41853755|FG000|Overall Study|Adverse Event|1|||
19498212|NCT02384538|41853756|FG001|Overall Study|Adverse Event|4|||
19498213|NCT02384538|41853755|FG000|Overall Study|Lack of Efficacy|4|||
19498214|NCT02384538|41853756|FG001|Overall Study|Lack of Efficacy|4|||
19498215|NCT02384538|41853755|FG000|Overall Study|Withdrew Consent|0|||
19498216|NCT02384538|41853756|FG001|Overall Study|Withdrew Consent|4|||
19498217|NCT02384538|41853755|FG000|Overall Study|Other|1|||
19498218|NCT02384538|41853756|FG001|Overall Study|Other|3|||
19498219|NCT02410824|41853780|FG000|First Intervention (One Week)|Headache|0|||
19498220|NCT02410824|41853781|FG001|First Intervention (One Week)|Headache|1|||
19498221|NCT02384460|41853811|FG000|Overall Study|Protocol Violation|0|||
19498222|NCT02384460|41853812|FG001|Overall Study|Protocol Violation|1|||
19498223|NCT02384460|41853811|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
19498224|NCT02384460|41853812|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
19498225|NCT02384460|41853811|FG000|Overall Study|Adverse Event|5|||
19498226|NCT02384460|41853812|FG001|Overall Study|Adverse Event|2|||
19498227|NCT02384460|41853811|FG000|Overall Study|Withdrawal by Subject|0|||
19498228|NCT02384460|41853812|FG001|Overall Study|Withdrawal by Subject|3|||
19498229|NCT02384460|41853811|FG000|Overall Study|Elective medical treatment|1|||
19498230|NCT02384460|41853812|FG001|Overall Study|Elective medical treatment|0|||
19498231|NCT02384460|41853811|FG000|Overall Study|Non-compliance|1|||
19613552|NCT00799383|42062351|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
19613553|NCT00799383|42062350|FG000|Overall Study|Withdrawal by Subject|0|||
19613554|NCT00799383|42062351|FG001|Overall Study|Withdrawal by Subject|1|||
19613555|NCT00610207|42062357|FG000|Overall Study|Lost to Follow-up|3|||
19613556|NCT00798759|42062363|FG000|Overall Study|Adverse Event|3|||
19613557|NCT00798759|42062364|FG001|Overall Study|Adverse Event|3|||
19613558|NCT00798759|42062363|FG000|Overall Study|Lost to Follow-up|1|||
19613559|NCT00798759|42062364|FG001|Overall Study|Lost to Follow-up|1|||
19613560|NCT00798759|42062363|FG000|Overall Study|Protocol Violation|4|||
19613561|NCT00798759|42062364|FG001|Overall Study|Protocol Violation|8|||
19613562|NCT00798759|42062363|FG000|Overall Study|Other|0|||
19613563|NCT00798759|42062364|FG001|Overall Study|Other|1|||
19613564|NCT00887432|42062372|FG000|Overall Study|Start Excluded Therapy|3|||
19613565|NCT00887432|42062373|FG001|Overall Study|Start Excluded Therapy|0|||
19613566|NCT00887432|42062372|FG000|Overall Study|Did not complete treatment|6|||
19613567|NCT00887432|42062373|FG001|Overall Study|Did not complete treatment|8|||
19613568|NCT00887432|42062372|FG000|Overall Study|Protocol Violation|2|||
19613569|NCT00887432|42062373|FG001|Overall Study|Protocol Violation|3|||
19613570|NCT00887432|42062372|FG000|Overall Study|Withdrawal by Subject|3|||
19498232|NCT02384460|41853812|FG001|Overall Study|Non-compliance|0|||
19498233|NCT02384382|41853835|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
19498234|NCT02384382|41853835|FG000|Overall Study|Death|1|||
19498235|NCT02384382|41853835|FG000|Overall Study|Adverse Event|1|||
19498236|NCT02384382|41853835|FG000|Overall Study|Disease progression|16|||
19613571|NCT00887432|42062373|FG001|Overall Study|Withdrawal by Subject|2|||
19498237|NCT02437188|41853855|FG000|Overall Study|Randomized but did not receive surgery|4|||
19613572|NCT00887432|42062372|FG000|Overall Study|Lost to Follow-up|1|||
19613573|NCT00887432|42062373|FG001|Overall Study|Lost to Follow-up|0|||
19498238|NCT02437188|41853856|FG001|Overall Study|Randomized but did not receive surgery|8|||
19498239|NCT02437188|41853855|FG000|Overall Study|Adverse Event|0|||
19498240|NCT02437188|41853856|FG001|Overall Study|Adverse Event|1|||
19498241|NCT02383758|41853878|FG000|Overall Study|Withdrawal by Subject|0|||
19498242|NCT02383758|41853879|FG001|Overall Study|Withdrawal by Subject|2|||
19498243|NCT02410278|41853929|FG000|Run-in Period|Adverse Event|5|||
19498244|NCT02410278|41853930|FG001|Run-in Period|Adverse Event|0|||
19498245|NCT02410278|41853931|FG002|Run-in Period|Adverse Event|0|||
19498246|NCT02410278|41853929|FG000|Run-in Period|GSRS Threshold Not Met|30|||
19498247|NCT02410278|41853930|FG001|Run-in Period|GSRS Threshold Not Met|0|||
19498248|NCT02410278|41853931|FG002|Run-in Period|GSRS Threshold Not Met|0|||
19498249|NCT02410278|41853929|FG000|Run-in Period|Lost to Follow-up|1|||
19498250|NCT02410278|41853930|FG001|Run-in Period|Lost to Follow-up|0|||
19498251|NCT02410278|41853931|FG002|Run-in Period|Lost to Follow-up|0|||
19498252|NCT02410278|41853929|FG000|Run-in Period|Withdrawal by Subject|1|||
19498253|NCT02410278|41853930|FG001|Run-in Period|Withdrawal by Subject|0|||
19498254|NCT02410278|41853931|FG002|Run-in Period|Withdrawal by Subject|0|||
19498255|NCT02410278|41853929|FG000|Run-in Period|Pregnancy|1|||
19498256|NCT02410278|41853930|FG001|Run-in Period|Pregnancy|0|||
19498257|NCT02410278|41853931|FG002|Run-in Period|Pregnancy|0|||
19498258|NCT02410278|41853929|FG000|Study Treatment Period|Adverse Event|0|||
19498259|NCT02410278|41853930|FG001|Study Treatment Period|Adverse Event|6|||
19498260|NCT02410278|41853931|FG002|Study Treatment Period|Adverse Event|3|||
19498261|NCT02410278|41853929|FG000|Study Treatment Period|Physician Decision|0|||
19498262|NCT02410278|41853930|FG001|Study Treatment Period|Physician Decision|0|||
19498263|NCT02410278|41853931|FG002|Study Treatment Period|Physician Decision|1|||
19498264|NCT02410278|41853929|FG000|Study Treatment Period|Withdrawal by Subject|0|||
19498265|NCT02410278|41853930|FG001|Study Treatment Period|Withdrawal by Subject|1|||
19498266|NCT02410278|41853931|FG002|Study Treatment Period|Withdrawal by Subject|0|||
19498267|NCT02410278|41853929|FG000|Study Treatment Period|Other|0|||
19498268|NCT02410278|41853930|FG001|Study Treatment Period|Other|3|||
19498269|NCT02410278|41853931|FG002|Study Treatment Period|Other|0|||
19498270|NCT02410278|41853929|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
19498271|NCT02410278|41853930|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
19498272|NCT02410278|41853931|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
19498273|NCT02410200|41853964|FG000|Overall Study|Adverse Event|2|||
19498274|NCT02383056|41853983|FG000|Overall Study|Adverse Event|1|||
19498275|NCT02383056|41853984|FG001|Overall Study|Adverse Event|0|||
19498276|NCT02383056|41853983|FG000|Overall Study|Lost to Follow-up|0|||
19498277|NCT02383056|41853984|FG001|Overall Study|Lost to Follow-up|2|||
19498278|NCT02409732|41853990|FG000|Overall Study|Withdrawal by Subject|4|||
19498279|NCT02409732|41853990|FG000|Overall Study|Lost to Follow-up|2|||
19498280|NCT01650636|41854001|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
19498281|NCT01650636|41854002|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
19498282|NCT01650636|41854001|FG000|Washout up to 5 Months|Physician Decision|2|||
19498283|NCT01650636|41854002|FG001|Washout up to 5 Months|Physician Decision|2|||
19498284|NCT01650636|41854001|FG000|Washout up to 5 Months|Death|1|||
19498285|NCT01650636|41854002|FG001|Washout up to 5 Months|Death|0|||
19498286|NCT01650636|41854001|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
19498287|NCT01650636|41854002|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
19498288|NCT01650636|41854001|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
19498289|NCT01650636|41854002|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
19498290|NCT01650636|41854001|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
19498291|NCT01650636|41854002|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
19498292|NCT02436876|41854012|FG000|Overall Study|Lost to Follow-up|0|||
19498293|NCT02436876|41854013|FG001|Overall Study|Lost to Follow-up|1|||
19498294|NCT02436876|41854014|FG002|Overall Study|Lost to Follow-up|1|||
19498295|NCT02436876|41854015|FG003|Overall Study|Lost to Follow-up|1|||
19498296|NCT02436876|41854012|FG000|Overall Study|Withdrawal by Subject|1|||
19498297|NCT02436876|41854013|FG001|Overall Study|Withdrawal by Subject|0|||
19498298|NCT02436876|41854014|FG002|Overall Study|Withdrawal by Subject|0|||
19498299|NCT02436876|41854015|FG003|Overall Study|Withdrawal by Subject|1|||
19498300|NCT02436876|41854012|FG000|Overall Study|Physician Decision|0|||
19498301|NCT02436876|41854013|FG001|Overall Study|Physician Decision|2|||
19498302|NCT02436876|41854014|FG002|Overall Study|Physician Decision|1|||
19498303|NCT02436876|41854015|FG003|Overall Study|Physician Decision|0|||
19498304|NCT02436876|41854012|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
19498305|NCT02436876|41854013|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
19498306|NCT02436876|41854014|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
19498307|NCT02436876|41854015|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
19498308|NCT02382276|41854044|FG000|Overall Study|Withdrawal by Subject|4|||
19498309|NCT02382276|41854045|FG001|Overall Study|Withdrawal by Subject|8|||
19498310|NCT02382276|41854046|FG002|Overall Study|Withdrawal by Subject|5|||
19498311|NCT02382276|41854044|FG000|Overall Study|Adverse Event|7|||
19498312|NCT02382276|41854045|FG001|Overall Study|Adverse Event|2|||
19498313|NCT02382276|41854046|FG002|Overall Study|Adverse Event|32|||
19498314|NCT02382276|41854044|FG000|Overall Study|Physician Decision|0|||
19498315|NCT02382276|41854045|FG001|Overall Study|Physician Decision|0|||
19498316|NCT02382276|41854046|FG002|Overall Study|Physician Decision|2|||
19613574|NCT00887432|42062372|FG000|Overall Study|No reason provided|0|||
19498317|NCT02436408|41854087|FG000|Overall Study|Death|1|||
19498318|NCT02436330|41854110|FG000|Cohort 1|Lost to Follow-up|5|||
19498319|NCT02436330|41854111|FG001|Cohort 1|Lost to Follow-up|2|||
19498320|NCT02436330|41854110|FG000|Cohort 1|Withdrawal by Subject|0|||
19498321|NCT02436330|41854111|FG001|Cohort 1|Withdrawal by Subject|1|||
19498322|NCT02436330|41854110|FG000|Cohort 2|Lost to Follow-up|2|||
19498323|NCT02436330|41854111|FG001|Cohort 2|Lost to Follow-up|0|||
19498324|NCT02436330|41854110|FG000|Cohort 2|Withdrawal by Subject|2|||
19498325|NCT02436330|41854111|FG001|Cohort 2|Withdrawal by Subject|3|||
19498326|NCT02436330|41854110|FG000|Cohort 3|Lost to Follow-up|1|||
19498327|NCT02436330|41854111|FG001|Cohort 3|Lost to Follow-up|0|||
19498328|NCT02436330|41854110|FG000|Cohort 3|Withdrawal by Subject|4|||
19498329|NCT02436330|41854111|FG001|Cohort 3|Withdrawal by Subject|0|||
19498330|NCT02436330|41854110|FG000|Cohort 4|Lost to Follow-up|1|||
19498331|NCT02436330|41854111|FG001|Cohort 4|Lost to Follow-up|0|||
19498332|NCT02436330|41854110|FG000|Cohort 4|Withdrawal by Subject|1|||
19498333|NCT02436330|41854111|FG001|Cohort 4|Withdrawal by Subject|0|||
19498334|NCT02436330|41854110|FG000|Cohort 5|Lost to Follow-up|3|||
19498335|NCT02436330|41854111|FG001|Cohort 5|Lost to Follow-up|2|||
19498336|NCT02436330|41854110|FG000|Cohort 5|Withdrawal by Subject|3|||
19498337|NCT02436330|41854111|FG001|Cohort 5|Withdrawal by Subject|2|||
19498338|NCT02436330|41854110|FG000|Cohort 6|Lost to Follow-up|2|||
19498339|NCT02436330|41854111|FG001|Cohort 6|Lost to Follow-up|0|||
19498340|NCT02436330|41854110|FG000|Cohort 6|Withdrawal by Subject|1|||
19498341|NCT02436330|41854111|FG001|Cohort 6|Withdrawal by Subject|1|||
19498342|NCT01650558|41854148|FG000|Overall Study|Migration out of study area|61|||
19498343|NCT01650558|41854149|FG001|Overall Study|Migration out of study area|71|||
19498344|NCT01650558|41854150|FG002|Overall Study|Migration out of study area|56|||
19498345|NCT01650558|41854148|FG000|Overall Study|Lost to Follow-up|10|||
19498346|NCT01650558|41854149|FG001|Overall Study|Lost to Follow-up|13|||
19498347|NCT01650558|41854150|FG002|Overall Study|Lost to Follow-up|6|||
19613575|NCT00887432|42062373|FG001|Overall Study|No reason provided|1|||
19613576|NCT00951275|42062379|FG000|Overall Study|Administrative Reason|1|||
19613577|NCT00951275|42062379|FG000|Overall Study|Adverse Event|7|||
19613578|NCT00951275|42062379|FG000|Overall Study|Withdrawal by Subject|4|||
19613579|NCT00951275|42062379|FG000|Overall Study|Protocol Violation|1|||
19613580|NCT00798603|42062383|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
19613581|NCT00798603|42062383|FG000|Overall Study|Withdrawal by Subject|10|||
19613582|NCT00798603|42062383|FG000|Overall Study|Adverse Event|22|||
19613583|NCT00798603|42062383|FG000|Overall Study|Physician Decision|1|||
19613584|NCT00798603|42062383|FG000|Overall Study|Lack of insurance coverage|1|||
19613585|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
19613586|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
19613587|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
19613588|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
19613589|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
19613590|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
19613591|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
19613592|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
19613593|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
19613594|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
19613595|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
19613596|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
19613597|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
19613598|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
19613599|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
19613600|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
19613601|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
19613602|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
19613603|NCT00887354|42062389|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
19613604|NCT00887354|42062390|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
19613605|NCT00887354|42062389|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
19613606|NCT00887354|42062390|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
19613607|NCT00887354|42062389|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
19613608|NCT00887354|42062390|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
19498348|NCT01650558|41854148|FG000|Overall Study|Death|10|||
19498349|NCT01650558|41854149|FG001|Overall Study|Death|6|||
19498350|NCT01650558|41854150|FG002|Overall Study|Death|8|||
19498351|NCT01650558|41854148|FG000|Overall Study|Withdrawal by Subject|1|||
19498352|NCT01650558|41854149|FG001|Overall Study|Withdrawal by Subject|1|||
19498353|NCT01650558|41854150|FG002|Overall Study|Withdrawal by Subject|3|||
19498354|NCT01650558|41854148|FG000|Overall Study|Non-compliant participant|1|||
19498355|NCT01650558|41854149|FG001|Overall Study|Non-compliant participant|0|||
19498356|NCT01650558|41854150|FG002|Overall Study|Non-compliant participant|2|||
19498357|NCT01650558|41854148|FG000|Overall Study|Physician Decision|0|||
19498358|NCT01650558|41854149|FG001|Overall Study|Physician Decision|1|||
19498359|NCT01650558|41854150|FG002|Overall Study|Physician Decision|0|||
19498360|NCT02408484|41854189|FG000|Overall Study|Withdrawal by Subject|3|||
19498361|NCT02408484|41854189|FG000|Overall Study|Not treated during study period|1|||
19498362|NCT02380248|41854217|FG000|Overall Study|Lost to Follow-up|11|||
19498363|NCT02380248|41854217|FG000|Overall Study|Withdrawal by Subject|3|||
19498364|NCT02408016|41854264|FG000|Overall Study|Death|6|||
19498365|NCT02408016|41854265|FG001|Overall Study|Death|1|||
19498366|NCT02408016|41854266|FG002|Overall Study|Death|0|||
19498367|NCT02408016|41854264|FG000|Overall Study|Physician Decision|0|||
19498368|NCT02408016|41854265|FG001|Overall Study|Physician Decision|2|||
19498369|NCT02408016|41854266|FG002|Overall Study|Physician Decision|0|||
19498370|NCT02407704|41854330|FG000|Overall Study|Lost to Follow-up|0|||
19498371|NCT02407704|41854331|FG001|Overall Study|Lost to Follow-up|0|||
19498372|NCT02407704|41854332|FG002|Overall Study|Lost to Follow-up|0|||
19498373|NCT02407704|41854333|FG003|Overall Study|Lost to Follow-up|2|||
19498374|NCT02407704|41854330|FG000|Overall Study|Protocol Violation|0|||
19498375|NCT02407704|41854331|FG001|Overall Study|Protocol Violation|0|||
19498376|NCT02407704|41854332|FG002|Overall Study|Protocol Violation|0|||
19498377|NCT02407704|41854333|FG003|Overall Study|Protocol Violation|1|||
19498378|NCT02407704|41854330|FG000|Overall Study|Withdrawal by Subject|0|||
19498379|NCT02407704|41854331|FG001|Overall Study|Withdrawal by Subject|0|||
19498380|NCT02407704|41854332|FG002|Overall Study|Withdrawal by Subject|1|||
19498381|NCT02407704|41854333|FG003|Overall Study|Withdrawal by Subject|0|||
19498382|NCT02406612|41854354|FG000|Overall Study|Screening Failure|3|||
19498383|NCT02406612|41854355|FG001|Overall Study|Screening Failure|0|||
19498384|NCT02406612|41854354|FG000|Overall Study|Intra-procedural Exclusion|1|||
19498385|NCT02406612|41854355|FG001|Overall Study|Intra-procedural Exclusion|3|||
19498386|NCT02406612|41854354|FG000|Overall Study|Guidewire Failure|0|||
19498387|NCT02406612|41854355|FG001|Overall Study|Guidewire Failure|1|||
19498388|NCT02405442|41854499|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
19498389|NCT02405442|41854500|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
19498390|NCT02405442|41854501|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
19498391|NCT02405442|41854502|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
19498392|NCT02405442|41854499|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
19498393|NCT02405442|41854500|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
19498394|NCT02405442|41854501|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
19498395|NCT02405442|41854502|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
19498396|NCT02405442|41854499|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
19498397|NCT02405442|41854500|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
19498398|NCT02405442|41854501|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
19498399|NCT02405442|41854502|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
19498400|NCT02405442|41854499|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
19498401|NCT02405442|41854500|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
19498402|NCT02405442|41854501|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
19498403|NCT02405442|41854502|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
19498404|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
19498405|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
19498406|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
19498407|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
19498408|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
19498409|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
19498410|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
19498411|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
19498412|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
19498413|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
19498414|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
19498415|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
19498416|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
19498417|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
19498418|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
19498419|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
19498420|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
19613609|NCT00887354|42062389|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
19613610|NCT00887354|42062390|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
19613611|NCT00887354|42062389|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
19613612|NCT00887354|42062390|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
19613613|NCT00887354|42062389|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
19613614|NCT00887354|42062390|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
19613615|NCT00951041|42062399|FG000|Overall Study|Withdrawal by Subject|1|||
19613616|NCT00951041|42062400|FG001|Overall Study|Withdrawal by Subject|1|||
19613617|NCT00951041|42062399|FG000|Overall Study|Lost to Follow-up|1|||
19613618|NCT00951041|42062400|FG001|Overall Study|Lost to Follow-up|0|||
19613619|NCT00951041|42062399|FG000|Overall Study|Other|3|||
19613620|NCT00951041|42062400|FG001|Overall Study|Other|0|||
19613621|NCT02763462|42062407|FG000|Overall Study|Protocol Violation|6|||
19613622|NCT00610129|42062411|FG000|Overall Study|Not treated since patients ineligible|3|||
19613623|NCT00945815|42062415|FG000|Overall Study|Death|3|||
19613624|NCT00945815|42062415|FG000|Overall Study|Not protocol specified|1|||
19613625|NCT00945815|42062415|FG000|Overall Study|Ineligible|3|||
19613626|NCT00945815|42062415|FG000|Overall Study|Did not begin protocol therapy|1|||
19613627|NCT00606307|42062419|FG000|Overall Study|Adverse Event|2|||
19613628|NCT00606307|42062419|FG000|Overall Study|Withdrawal by Subject|2|||
19613629|NCT00606307|42062419|FG000|Overall Study|Disease progression|6|||
19613630|NCT00606307|42062419|FG000|Overall Study|QTc prolongation|1|||
19613631|NCT00798369|42062429|FG000|Overall Study|Subject withdrew consent|0|||
19613632|NCT00798369|42062430|FG001|Overall Study|Subject withdrew consent|0|||
19498421|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
19498422|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
19498423|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
19498424|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
19498425|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
19498426|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
19498427|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
19498428|NCT02405442|41854499|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
19498429|NCT02405442|41854500|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
19498430|NCT02405442|41854501|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
19498431|NCT02405442|41854502|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
19498432|NCT02405442|41854499|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
19498433|NCT02405442|41854500|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
19498434|NCT02405442|41854501|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
19498435|NCT02405442|41854502|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
19498436|NCT02405442|41854499|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
19498437|NCT02405442|41854500|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
19498438|NCT02405442|41854501|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
19498439|NCT02405442|41854502|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
19498440|NCT02405442|41854499|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
19498441|NCT02405442|41854500|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
19498442|NCT02405442|41854501|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
19498443|NCT02405442|41854502|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
19498444|NCT02404350|41854618|FG000|Overall Study|Adverse Event|2|||
19498445|NCT02404350|41854619|FG001|Overall Study|Adverse Event|2|||
19498446|NCT02404350|41854620|FG002|Overall Study|Adverse Event|3|||
19498447|NCT02404350|41854621|FG003|Overall Study|Adverse Event|9|||
19498448|NCT02404350|41854618|FG000|Overall Study|Lack of Efficacy|3|||
19498449|NCT02404350|41854619|FG001|Overall Study|Lack of Efficacy|1|||
19498450|NCT02404350|41854620|FG002|Overall Study|Lack of Efficacy|0|||
19498451|NCT02404350|41854621|FG003|Overall Study|Lack of Efficacy|3|||
19498452|NCT02404350|41854618|FG000|Overall Study|Lost to Follow-up|2|||
19498453|NCT02404350|41854619|FG001|Overall Study|Lost to Follow-up|0|||
19498454|NCT02404350|41854620|FG002|Overall Study|Lost to Follow-up|0|||
19498455|NCT02404350|41854621|FG003|Overall Study|Lost to Follow-up|1|||
19498456|NCT02404350|41854618|FG000|Overall Study|Physician Decision|1|||
19498457|NCT02404350|41854619|FG001|Overall Study|Physician Decision|0|||
19498458|NCT02404350|41854620|FG002|Overall Study|Physician Decision|0|||
19498459|NCT02404350|41854621|FG003|Overall Study|Physician Decision|2|||
19498460|NCT02404350|41854618|FG000|Overall Study|Pregnancy|0|||
19498461|NCT02404350|41854619|FG001|Overall Study|Pregnancy|0|||
19498462|NCT02404350|41854620|FG002|Overall Study|Pregnancy|0|||
19498463|NCT02404350|41854621|FG003|Overall Study|Pregnancy|1|||
19498464|NCT02404350|41854618|FG000|Overall Study|Withdrawal by Subject|7|||
19498465|NCT02404350|41854619|FG001|Overall Study|Withdrawal by Subject|3|||
19498466|NCT02404350|41854620|FG002|Overall Study|Withdrawal by Subject|3|||
19498467|NCT02404350|41854621|FG003|Overall Study|Withdrawal by Subject|19|||
19498468|NCT02404350|41854618|FG000|Overall Study|Due to Non-compliance with treatment|0|||
19498469|NCT02404350|41854619|FG001|Overall Study|Due to Non-compliance with treatment|0|||
19498470|NCT02404350|41854620|FG002|Overall Study|Due to Non-compliance with treatment|0|||
19498471|NCT02404350|41854621|FG003|Overall Study|Due to Non-compliance with treatment|1|||
19498472|NCT02404350|41854618|FG000|Overall Study|Due to Technical problems|0|||
19498473|NCT02404350|41854619|FG001|Overall Study|Due to Technical problems|0|||
19498474|NCT02404350|41854620|FG002|Overall Study|Due to Technical problems|0|||
19498475|NCT02404350|41854621|FG003|Overall Study|Due to Technical problems|1|||
19498476|NCT02434770|41854920|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
19498477|NCT02434770|41854921|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
19498478|NCT02434770|41854922|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
19498479|NCT02434770|41854920|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
19498480|NCT02434770|41854921|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
19498481|NCT02434770|41854922|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
19498482|NCT02434770|41854920|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
19498483|NCT02434770|41854921|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
19498484|NCT02434770|41854922|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
19498485|NCT02434770|41854920|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
19498486|NCT02434770|41854921|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
19498487|NCT02434770|41854922|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
19498488|NCT02434770|41854920|FG000|Week 1 to Week 18|Death|1|||
19498489|NCT02434770|41854921|FG001|Week 1 to Week 18|Death|0|||
19498490|NCT02434770|41854922|FG002|Week 1 to Week 18|Death|0|||
19498491|NCT02434770|41854920|FG000|Week 18 to Week|Lost to Follow-up|2|||
19498492|NCT02434770|41854921|FG001|Week 18 to Week|Lost to Follow-up|2|||
19498493|NCT02434770|41854922|FG002|Week 18 to Week|Lost to Follow-up|1|||
19498494|NCT02434770|41854920|FG000|Week 18 to Week|Withdrawal by Subject|0|||
19498495|NCT02434770|41854921|FG001|Week 18 to Week|Withdrawal by Subject|0|||
19498496|NCT02434770|41854922|FG002|Week 18 to Week|Withdrawal by Subject|2|||
19498497|NCT02434770|41854920|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
19498498|NCT02434770|41854921|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
19498499|NCT02434770|41854922|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
19498500|NCT02433834|41854953|FG000|Overall Study|Protocol-specified criteria|7|||
19498501|NCT02433834|41854953|FG000|Overall Study|Protocol Violation|3|||
19498502|NCT02433834|41854953|FG000|Overall Study|Lost to Follow-up|6|||
19498503|NCT02433834|41854953|FG000|Overall Study|Withdrawal by Subject|14|||
19498504|NCT02433834|41854953|FG000|Overall Study|Adverse Event|6|||
19498505|NCT02433834|41854953|FG000|Overall Study|Physician Decision|1|||
19498506|NCT02433678|41854997|FG000|Overall Study|Lost to Follow-up|1|||
19498507|NCT02433678|41854998|FG001|Overall Study|Lost to Follow-up|2|||
19498508|NCT02433288|41855011|FG000|Overall Study|Severe non-compliance to protocol|13|||
19498509|NCT02433288|41855012|FG001|Overall Study|Severe non-compliance to protocol|7|||
19498510|NCT02433288|41855011|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
19498511|NCT02433288|41855012|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
19498512|NCT02433288|41855011|FG000|Overall Study|Withdrawal by Subject|101|||
19498513|NCT02433288|41855012|FG001|Overall Study|Withdrawal by Subject|99|||
19498514|NCT02433288|41855011|FG000|Overall Study|Lost to Follow-up|2|||
19498515|NCT02433288|41855012|FG001|Overall Study|Lost to Follow-up|14|||
19498516|NCT02433288|41855011|FG000|Overall Study|Death|0|||
19498517|NCT02433288|41855012|FG001|Overall Study|Death|3|||
19498518|NCT02433210|41855032|FG000|Overall Study|Physician Decision|1|||
19498519|NCT02433210|41855033|FG001|Overall Study|Physician Decision|0|||
19498520|NCT02433210|41855034|FG002|Overall Study|Physician Decision|0|||
19498521|NCT02432040|41855169|FG000|Overall Study|Lack of Efficacy|3|||
19498522|NCT02432040|41855170|FG001|Overall Study|Lack of Efficacy|0|||
19498523|NCT02432040|41855169|FG000|Overall Study|Lost to Follow-up|4|||
19498524|NCT02432040|41855170|FG001|Overall Study|Lost to Follow-up|5|||
19498525|NCT02432040|41855169|FG000|Overall Study|Physician Decision|1|||
19498526|NCT02432040|41855170|FG001|Overall Study|Physician Decision|1|||
19498527|NCT02431806|41855202|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
19498528|NCT02431806|41855203|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
19498529|NCT02431806|41855204|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
19498530|NCT02431806|41855205|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
19498531|NCT02431806|41855202|FG000|Double-blind Treatment Period|Adverse Event|4|||
19498532|NCT02431806|41855203|FG001|Double-blind Treatment Period|Adverse Event|7|||
19498533|NCT02431806|41855204|FG002|Double-blind Treatment Period|Adverse Event|11|||
19498534|NCT02431806|41855205|FG003|Double-blind Treatment Period|Adverse Event|7|||
19498535|NCT02431806|41855202|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
19498536|NCT02431806|41855203|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
19498537|NCT02431806|41855204|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
19498538|NCT02431806|41855205|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
19498539|NCT02431806|41855202|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
19498540|NCT02431806|41855203|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
19498541|NCT02431806|41855204|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
19498542|NCT02431806|41855205|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
19704407|NCT00252564|42148757|FG001|Overall Study|Unrelated Complication|1|||
19704408|NCT00252564|42148756|FG000|Overall Study|Disease Progression|14|||
19704409|NCT00252564|42148757|FG001|Overall Study|Disease Progression|20|||
19498543|NCT02431806|41855202|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
19498544|NCT02431806|41855203|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
19498545|NCT02431806|41855204|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
19498546|NCT02431806|41855205|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
19498547|NCT02431806|41855202|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
19498548|NCT02431806|41855203|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
19498549|NCT02431806|41855204|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
19498550|NCT02431806|41855205|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
19498551|NCT02431806|41855202|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
19498552|NCT02431806|41855203|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
19498553|NCT02431806|41855204|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
19498554|NCT02431806|41855205|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
19498555|NCT01650246|41855246|FG000|Overall Study|Adverse Event|23|||
19498556|NCT01650246|41855246|FG000|Overall Study|Protocol Violation|5|||
19498557|NCT01650246|41855246|FG000|Overall Study|Sponsor terminated study|53|||
19498558|NCT01650246|41855246|FG000|Overall Study|Lost to Follow-up|5|||
19498559|NCT01650246|41855246|FG000|Overall Study|Withdrawal by Subject|26|||
19498560|NCT01650246|41855246|FG000|Overall Study|Death|1|||
19498561|NCT01650246|41855246|FG000|Overall Study|Lack of Efficacy|30|||
19498562|NCT01652664|41855265|FG000|Overall Study|Treatment Failure|5|||
19613633|NCT00798369|42062431|FG002|Overall Study|Subject withdrew consent|1|||
19613634|NCT00798369|42062432|FG003|Overall Study|Subject withdrew consent|1|||
19613635|NCT00798369|42062433|FG004|Overall Study|Subject withdrew consent|0|||
19613636|NCT00798369|42062434|FG005|Overall Study|Subject withdrew consent|2|||
19498563|NCT01652664|41855266|FG001|Overall Study|Treatment Failure|1|||
19498564|NCT01652664|41855265|FG000|Overall Study|Inadequate IOP control|1|||
19498565|NCT01652664|41855266|FG001|Overall Study|Inadequate IOP control|0|||
19498566|NCT02379390|41855306|FG000|Overall Study|Adverse Event|1|||
19498567|NCT02379390|41855307|FG001|Overall Study|Adverse Event|1|||
19498568|NCT02379390|41855306|FG000|Overall Study|Investigator's decision|1|||
19498569|NCT02379390|41855307|FG001|Overall Study|Investigator's decision|0|||
19498570|NCT02379390|41855306|FG000|Overall Study|Study Termination|0|||
19498571|NCT02379390|41855307|FG001|Overall Study|Study Termination|1|||
19498572|NCT02379078|41855318|FG000|Overall Study|Lost to Follow-up|33|||
19498573|NCT02379078|41855319|FG001|Overall Study|Lost to Follow-up|30|||
19498574|NCT02379078|41855318|FG000|Overall Study|Withdrawal by Subject|6|||
19498575|NCT02379078|41855319|FG001|Overall Study|Withdrawal by Subject|5|||
19498576|NCT01714739|41855412|FG000|Overall Study|Disease progression|3|||
19498577|NCT01714739|41855413|FG001|Overall Study|Disease progression|5|||
19498578|NCT01714739|41855414|FG002|Overall Study|Disease progression|5|||
19498579|NCT01714739|41855415|FG003|Overall Study|Disease progression|204|||
19498580|NCT01714739|41855416|FG004|Overall Study|Disease progression|1|||
19498581|NCT01714739|41855417|FG005|Overall Study|Disease progression|3|||
19498582|NCT01714739|41855418|FG006|Overall Study|Disease progression|5|||
19498583|NCT01714739|41855412|FG000|Overall Study|Study drug toxicity|1|||
19498584|NCT01714739|41855413|FG001|Overall Study|Study drug toxicity|1|||
19498585|NCT01714739|41855414|FG002|Overall Study|Study drug toxicity|1|||
19613637|NCT00798369|42062429|FG000|Overall Study|Lost to Follow-up|1|||
19613638|NCT00798369|42062430|FG001|Overall Study|Lost to Follow-up|1|||
19613639|NCT00798369|42062431|FG002|Overall Study|Lost to Follow-up|1|||
19613640|NCT00798369|42062432|FG003|Overall Study|Lost to Follow-up|0|||
19613641|NCT00798369|42062433|FG004|Overall Study|Lost to Follow-up|1|||
19613642|NCT00798369|42062434|FG005|Overall Study|Lost to Follow-up|0|||
19704410|NCT00252564|42148756|FG000|Overall Study|Death|0|||
19613643|NCT00798369|42062429|FG000|Overall Study|Adminstrative problems|0|||
19613644|NCT00798369|42062430|FG001|Overall Study|Adminstrative problems|0|||
19613645|NCT00798369|42062431|FG002|Overall Study|Adminstrative problems|0|||
19613646|NCT00798369|42062432|FG003|Overall Study|Adminstrative problems|0|||
19613647|NCT00798369|42062433|FG004|Overall Study|Adminstrative problems|0|||
19613648|NCT00798369|42062434|FG005|Overall Study|Adminstrative problems|1|||
19704411|NCT00252564|42148757|FG001|Overall Study|Death|3|||
19704412|NCT00252564|42148756|FG000|Overall Study|Physician Decision|1|||
19704413|NCT00252564|42148757|FG001|Overall Study|Physician Decision|0|||
19704414|NCT00252564|42148756|FG000|Overall Study|Lost to Follow-up|1|||
19704415|NCT00252564|42148757|FG001|Overall Study|Lost to Follow-up|0|||
19704416|NCT00252564|42148756|FG000|Overall Study|Patient Request|4|||
19613649|NCT00950963|42062451|FG000|Overall Study|Lost to Follow-up|29|||
19613650|NCT00950963|42062452|FG001|Overall Study|Lost to Follow-up|24|||
19613651|NCT00608959|42062460|FG000|Part 1|Did not meet eligibility criteria|1|||
19613652|NCT00945659|42062473|FG000|Overall Study|Lost to Follow-up|7|||
19613653|NCT00945659|42062474|FG001|Overall Study|Lost to Follow-up|20|||
19704417|NCT00252564|42148757|FG001|Overall Study|Patient Request|5|||
19498586|NCT01714739|41855415|FG003|Overall Study|Study drug toxicity|15|||
19613654|NCT00945659|42062475|FG002|Overall Study|Lost to Follow-up|17|||
19704418|NCT00252564|42148756|FG000|Overall Study|Withdrawal by Subject|0|||
19498587|NCT01714739|41855416|FG004|Overall Study|Study drug toxicity|0|||
19498588|NCT01714739|41855417|FG005|Overall Study|Study drug toxicity|0|||
19498589|NCT01714739|41855418|FG006|Overall Study|Study drug toxicity|5|||
19498590|NCT01714739|41855412|FG000|Overall Study|Death|0|||
19498591|NCT01714739|41855413|FG001|Overall Study|Death|0|||
19498592|NCT01714739|41855414|FG002|Overall Study|Death|0|||
19613655|NCT00798135|42062483|FG000|Overall Study|Disease progression, relapse|11|||
19613656|NCT00798135|42062483|FG000|Overall Study|Disease progression, refractory|1|||
19613657|NCT00798135|42062483|FG000|Overall Study|Physician Decision|1|||
19613658|NCT00941603|42062493|FG000|Overall Study|Adverse Event|10|||
19613659|NCT00941603|42062494|FG001|Overall Study|Adverse Event|15|||
19613660|NCT00941603|42062495|FG002|Overall Study|Adverse Event|5|||
19613661|NCT00941603|42062496|FG003|Overall Study|Adverse Event|1|||
19613662|NCT00941603|42062497|FG004|Overall Study|Adverse Event|4|||
19613663|NCT00941603|42062498|FG005|Overall Study|Adverse Event|0|||
19613664|NCT00941603|42062493|FG000|Overall Study|Lost to Follow-up|0|||
19613665|NCT00941603|42062494|FG001|Overall Study|Lost to Follow-up|0|||
19613666|NCT00941603|42062495|FG002|Overall Study|Lost to Follow-up|0|||
19613667|NCT00941603|42062496|FG003|Overall Study|Lost to Follow-up|1|||
19613668|NCT00941603|42062497|FG004|Overall Study|Lost to Follow-up|0|||
19613669|NCT00941603|42062498|FG005|Overall Study|Lost to Follow-up|2|||
19613670|NCT00941603|42062493|FG000|Overall Study|Withdrawal by Subject|0|||
19498593|NCT01714739|41855415|FG003|Overall Study|Death|1|||
19498594|NCT01714739|41855416|FG004|Overall Study|Death|0|||
19498595|NCT01714739|41855417|FG005|Overall Study|Death|0|||
19498596|NCT01714739|41855418|FG006|Overall Study|Death|0|||
19498597|NCT01714739|41855412|FG000|Overall Study|Adverse Event unrelated to drug|0|||
19498598|NCT01714739|41855413|FG001|Overall Study|Adverse Event unrelated to drug|0|||
19498599|NCT01714739|41855414|FG002|Overall Study|Adverse Event unrelated to drug|3|||
19498600|NCT01714739|41855415|FG003|Overall Study|Adverse Event unrelated to drug|21|||
19498601|NCT01714739|41855416|FG004|Overall Study|Adverse Event unrelated to drug|0|||
19498602|NCT01714739|41855417|FG005|Overall Study|Adverse Event unrelated to drug|0|||
19498603|NCT01714739|41855418|FG006|Overall Study|Adverse Event unrelated to drug|0|||
19498604|NCT01714739|41855412|FG000|Overall Study|Participant request to stop therapy|0|||
19498605|NCT01714739|41855413|FG001|Overall Study|Participant request to stop therapy|1|||
19498606|NCT01714739|41855414|FG002|Overall Study|Participant request to stop therapy|0|||
19498607|NCT01714739|41855415|FG003|Overall Study|Participant request to stop therapy|6|||
19613671|NCT00941603|42062494|FG001|Overall Study|Withdrawal by Subject|0|||
19613672|NCT00941603|42062495|FG002|Overall Study|Withdrawal by Subject|0|||
19498608|NCT01714739|41855416|FG004|Overall Study|Participant request to stop therapy|0|||
19498609|NCT01714739|41855417|FG005|Overall Study|Participant request to stop therapy|0|||
19498610|NCT01714739|41855418|FG006|Overall Study|Participant request to stop therapy|0|||
19498611|NCT01714739|41855412|FG000|Overall Study|Participant withdrew consent|0|||
19498612|NCT01714739|41855413|FG001|Overall Study|Participant withdrew consent|1|||
19498613|NCT01714739|41855414|FG002|Overall Study|Participant withdrew consent|0|||
19498614|NCT01714739|41855415|FG003|Overall Study|Participant withdrew consent|8|||
19498615|NCT01714739|41855416|FG004|Overall Study|Participant withdrew consent|0|||
19498616|NCT01714739|41855417|FG005|Overall Study|Participant withdrew consent|0|||
19498617|NCT01714739|41855418|FG006|Overall Study|Participant withdrew consent|0|||
19498618|NCT01714739|41855412|FG000|Overall Study|Lost to Follow-up|0|||
19498619|NCT01714739|41855413|FG001|Overall Study|Lost to Follow-up|0|||
19498620|NCT01714739|41855414|FG002|Overall Study|Lost to Follow-up|0|||
19498621|NCT01714739|41855415|FG003|Overall Study|Lost to Follow-up|1|||
19498622|NCT01714739|41855416|FG004|Overall Study|Lost to Follow-up|0|||
19498623|NCT01714739|41855417|FG005|Overall Study|Lost to Follow-up|0|||
19498624|NCT01714739|41855418|FG006|Overall Study|Lost to Follow-up|0|||
19498625|NCT01714739|41855412|FG000|Overall Study|Maximum clinical benefit|0|||
19498626|NCT01714739|41855413|FG001|Overall Study|Maximum clinical benefit|1|||
19498627|NCT01714739|41855414|FG002|Overall Study|Maximum clinical benefit|1|||
19498628|NCT01714739|41855415|FG003|Overall Study|Maximum clinical benefit|3|||
19498629|NCT01714739|41855416|FG004|Overall Study|Maximum clinical benefit|0|||
19498630|NCT01714739|41855417|FG005|Overall Study|Maximum clinical benefit|0|||
19498631|NCT01714739|41855418|FG006|Overall Study|Maximum clinical benefit|0|||
19498632|NCT01714739|41855412|FG000|Overall Study|Poor/non-comliance|0|||
19498633|NCT01714739|41855413|FG001|Overall Study|Poor/non-comliance|1|||
19498634|NCT01714739|41855414|FG002|Overall Study|Poor/non-comliance|0|||
19498635|NCT01714739|41855415|FG003|Overall Study|Poor/non-comliance|1|||
19498636|NCT01714739|41855416|FG004|Overall Study|Poor/non-comliance|0|||
19498637|NCT01714739|41855417|FG005|Overall Study|Poor/non-comliance|0|||
19613673|NCT00941603|42062496|FG003|Overall Study|Withdrawal by Subject|2|||
19613674|NCT00941603|42062497|FG004|Overall Study|Withdrawal by Subject|0|||
19613675|NCT00941603|42062498|FG005|Overall Study|Withdrawal by Subject|1|||
19498638|NCT01714739|41855418|FG006|Overall Study|Poor/non-comliance|0|||
19498639|NCT01714739|41855412|FG000|Overall Study|No longer meets study criteria|0|||
19498640|NCT01714739|41855413|FG001|Overall Study|No longer meets study criteria|0|||
19498641|NCT01714739|41855414|FG002|Overall Study|No longer meets study criteria|0|||
19498642|NCT01714739|41855415|FG003|Overall Study|No longer meets study criteria|1|||
19498643|NCT01714739|41855416|FG004|Overall Study|No longer meets study criteria|0|||
19498644|NCT01714739|41855417|FG005|Overall Study|No longer meets study criteria|0|||
19613676|NCT00941603|42062493|FG000|Overall Study|Protocol Violation|0|||
19498645|NCT01714739|41855418|FG006|Overall Study|No longer meets study criteria|0|||
19498646|NCT01714739|41855412|FG000|Overall Study|Other reason|0|||
19498647|NCT01714739|41855413|FG001|Overall Study|Other reason|0|||
19498648|NCT01714739|41855414|FG002|Overall Study|Other reason|0|||
19498649|NCT01714739|41855415|FG003|Overall Study|Other reason|3|||
19498650|NCT01714739|41855416|FG004|Overall Study|Other reason|1|||
19498651|NCT01714739|41855417|FG005|Overall Study|Other reason|0|||
19613677|NCT00941603|42062494|FG001|Overall Study|Protocol Violation|1|||
19613678|NCT00941603|42062495|FG002|Overall Study|Protocol Violation|0|||
19498652|NCT01714739|41855418|FG006|Overall Study|Other reason|0|||
19498653|NCT00609791|41855486|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
19498654|NCT03823287|41857439|FG000|Overall Study|Withdrawal by Subject|25|||
19498655|NCT03823287|41857440|FG001|Overall Study|Withdrawal by Subject|17|||
19498656|NCT03823287|41857439|FG000|Overall Study|Death|13|||
19498657|NCT03823287|41857440|FG001|Overall Study|Death|7|||
19498658|NCT03823287|41857439|FG000|Overall Study|Lost to Follow-up|7|||
19498659|NCT03823287|41857440|FG001|Overall Study|Lost to Follow-up|8|||
19498660|NCT03823287|41857439|FG000|Overall Study|Adverse Event|6|||
19498661|NCT03823287|41857440|FG001|Overall Study|Adverse Event|8|||
19498662|NCT03823287|41857439|FG000|Overall Study|Physician Decision|5|||
19498663|NCT03823287|41857440|FG001|Overall Study|Physician Decision|2|||
19498664|NCT03823287|41857439|FG000|Overall Study|Lack of Efficacy|2|||
19498665|NCT03823287|41857440|FG001|Overall Study|Lack of Efficacy|0|||
19498666|NCT03823287|41857439|FG000|Overall Study|Other|2|||
19498667|NCT03823287|41857440|FG001|Overall Study|Other|4|||
19498668|NCT03707925|41857601|FG000|Overall Study|Inevaluable|1|||
19498669|NCT03461757|41857661|FG000|Overall Study|Adverse Event|1|||
19498670|NCT03461757|41857662|FG001|Overall Study|Adverse Event|0|||
19498671|NCT03461757|41857661|FG000|Overall Study|Lost to Follow-up|13|||
19498672|NCT03461757|41857662|FG001|Overall Study|Lost to Follow-up|7|||
19498673|NCT03461757|41857661|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
19498674|NCT03461757|41857662|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
19498675|NCT03461757|41857661|FG000|Overall Study|Non-compliance with study treatment|0|||
19498676|NCT03461757|41857662|FG001|Overall Study|Non-compliance with study treatment|1|||
19498677|NCT03461757|41857661|FG000|Overall Study|Pregnancy|2|||
19613679|NCT00941603|42062496|FG003|Overall Study|Protocol Violation|0|||
19498678|NCT03461757|41857662|FG001|Overall Study|Pregnancy|0|||
19498679|NCT03461757|41857661|FG000|Overall Study|Protocol Violation|1|||
19498680|NCT03461757|41857662|FG001|Overall Study|Protocol Violation|1|||
19498681|NCT03461757|41857661|FG000|Overall Study|Withdrawal by Subject|7|||
19498682|NCT03461757|41857662|FG001|Overall Study|Withdrawal by Subject|7|||
19498683|NCT03461757|41857661|FG000|Overall Study|Other Reasons|1|||
19498684|NCT03461757|41857662|FG001|Overall Study|Other Reasons|4|||
19498685|NCT03235479|41858179|FG000|Overall Study|Lost to Follow-up|8|||
19498686|NCT03235479|41858180|FG001|Overall Study|Lost to Follow-up|11|||
19498687|NCT03235479|41858179|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
19498688|NCT03235479|41858180|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
19498689|NCT03235479|41858179|FG000|Overall Study|Pregnancy|1|||
19498690|NCT03235479|41858180|FG001|Overall Study|Pregnancy|0|||
19498691|NCT03235479|41858179|FG000|Overall Study|Protocol Deviation|1|||
19498692|NCT03235479|41858180|FG001|Overall Study|Protocol Deviation|3|||
19498693|NCT03235479|41858179|FG000|Overall Study|Technical Problems|3|||
19498694|NCT03235479|41858180|FG001|Overall Study|Technical Problems|2|||
19498695|NCT03235479|41858179|FG000|Overall Study|Withdrawal by Subject|2|||
19498696|NCT03235479|41858180|FG001|Overall Study|Withdrawal by Subject|2|||
19498697|NCT03235479|41858179|FG000|Overall Study|Other Reasons|3|||
19498698|NCT03235479|41858180|FG001|Overall Study|Other Reasons|5|||
19498699|NCT03193437|41858236|FG000|Overall Study|Adverse Event|4|||
19613680|NCT00941603|42062497|FG004|Overall Study|Protocol Violation|0|||
19613681|NCT00941603|42062498|FG005|Overall Study|Protocol Violation|0|||
19613682|NCT00941603|42062493|FG000|Overall Study|Did not meet protocol eligibility|1|||
19613683|NCT00941603|42062494|FG001|Overall Study|Did not meet protocol eligibility|0|||
19613684|NCT00941603|42062495|FG002|Overall Study|Did not meet protocol eligibility|0|||
19613685|NCT00941603|42062496|FG003|Overall Study|Did not meet protocol eligibility|0|||
19613686|NCT00941603|42062497|FG004|Overall Study|Did not meet protocol eligibility|0|||
19613687|NCT00941603|42062498|FG005|Overall Study|Did not meet protocol eligibility|0|||
19613688|NCT04533438|42062514|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
19613689|NCT04533438|42062515|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
19613690|NCT00797823|42062525|FG000|First Period (Initial Randomization)|Physician Decision|1|||
19613691|NCT00797823|42062526|FG001|First Period (Initial Randomization)|Physician Decision|0|||
19613692|NCT00797823|42062527|FG002|First Period (Initial Randomization)|Physician Decision|0|||
19613693|NCT00797667|42062537|FG000|Overall Study|Lack of Efficacy|0|||
19613694|NCT00797667|42062538|FG001|Overall Study|Lack of Efficacy|1|||
19498700|NCT03193437|41858236|FG000|Overall Study|Withdrawal by Subject|2|||
19498701|NCT03193437|41858236|FG000|Overall Study|Disease Progression|2|||
19498702|NCT02906787|41858289|FG000|Overall Study|Withdrawal by Subject|12|||
19498703|NCT02906787|41858290|FG001|Overall Study|Withdrawal by Subject|10|||
19498704|NCT02906787|41858289|FG000|Overall Study|Missed|24|||
19498705|NCT02906787|41858290|FG001|Overall Study|Missed|22|||
19498706|NCT02450331|41858677|FG000|Overall Study|Death|120|||
19498707|NCT02450331|41858678|FG001|Overall Study|Death|114|||
19498708|NCT02450331|41858677|FG000|Overall Study|Lost to Follow-up|9|||
19498709|NCT02450331|41858678|FG001|Overall Study|Lost to Follow-up|7|||
19498710|NCT02450331|41858677|FG000|Overall Study|Withdrawal by Subject|50|||
19498711|NCT02450331|41858678|FG001|Overall Study|Withdrawal by Subject|39|||
19498712|NCT02450331|41858677|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179|||
19498713|NCT02450331|41858678|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208|||
19498714|NCT02450331|41858677|FG000|Overall Study|On-Study Status: In Survival follow-up|45|||
19498715|NCT02450331|41858678|FG001|Overall Study|On-Study Status: In Survival follow-up|38|||
19498716|NCT02107443|41858896|FG000|Overall Study|Death|42|||
19613695|NCT00797667|42062539|FG002|Overall Study|Lack of Efficacy|0|||
19613696|NCT00797667|42062537|FG000|Overall Study|Lost to Follow-up|8|||
19613697|NCT00797667|42062538|FG001|Overall Study|Lost to Follow-up|12|||
19613698|NCT00797667|42062539|FG002|Overall Study|Lost to Follow-up|2|||
19613699|NCT00797667|42062537|FG000|Overall Study|Physician Decision|3|||
19613700|NCT00797667|42062538|FG001|Overall Study|Physician Decision|1|||
19613701|NCT00797667|42062539|FG002|Overall Study|Physician Decision|0|||
19613702|NCT00797667|42062537|FG000|Overall Study|Pregnancy|2|||
19613703|NCT00797667|42062538|FG001|Overall Study|Pregnancy|0|||
19613704|NCT00797667|42062539|FG002|Overall Study|Pregnancy|0|||
19613705|NCT00797667|42062537|FG000|Overall Study|Protocol Violation|2|||
19498717|NCT02107443|41858897|FG001|Overall Study|Death|30|||
19498718|NCT02107443|41858896|FG000|Overall Study|Study Protocol Violation|3|||
19498719|NCT02107443|41858897|FG001|Overall Study|Study Protocol Violation|1|||
19498720|NCT02107443|41858896|FG000|Overall Study|Registered but Not Eligible|0|||
19498721|NCT02107443|41858897|FG001|Overall Study|Registered but Not Eligible|1|||
19498722|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
19498723|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
19498724|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
19498725|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
19498726|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Changed Mind|2|||
19498727|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Changed Mind|0|||
19498728|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
19498729|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
19613706|NCT00797667|42062538|FG001|Overall Study|Protocol Violation|7|||
19498730|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
19498731|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
19498732|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
19498733|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
19498734|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
19498735|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
19498736|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Other Medical|9|||
19498737|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Other Medical|5|||
19498738|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Disease Progression|4|||
19498739|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Disease Progression|2|||
19498740|NCT02107443|41858896|FG000|Overall Study|Withdrawal: Personal Issues|0|||
19498741|NCT02107443|41858897|FG001|Overall Study|Withdrawal: Personal Issues|3|||
19498742|NCT00559949|41859814|FG000|Overall Study|Progressive Disease during cycle 1|1|||
19498743|NCT00559949|41859814|FG000|Overall Study|Adverse Event|1|||
19498744|NCT00559949|41859814|FG000|Overall Study|Withdrawal by Subject|4|||
19498745|NCT00559949|41859814|FG000|Overall Study|No disease evaluation per protocol|1|||
19498746|NCT00559637|41859870|FG000|Overall Study|Adverse Event|22|||
19498747|NCT00559637|41859870|FG000|Overall Study|Withdrawal by Subject|4|||
19498748|NCT00559637|41859870|FG000|Overall Study|Protocol Violation|6|||
19373689|NCT02742103|41614872|FG000|Overall Study|Death|2|||
19373690|NCT02742103|41614873|FG001|Overall Study|Death|2|||
19373691|NCT02742103|41614872|FG000|Overall Study|Adverse Event|1|||
19373692|NCT02742103|41614873|FG001|Overall Study|Adverse Event|0|||
19373693|NCT02742103|41614872|FG000|Overall Study|Moved to another town|0|||
19373694|NCT02742103|41614873|FG001|Overall Study|Moved to another town|1|||
19373695|NCT02742103|41614872|FG000|Overall Study|Withdrawal by Subject|5|||
19373696|NCT02742103|41614873|FG001|Overall Study|Withdrawal by Subject|2|||
19373697|NCT02741713|41614881|FG000|Overall Study|Surgery type changed intra-operatively|2|||
19373698|NCT02741713|41614882|FG001|Overall Study|Surgery type changed intra-operatively|1|||
19373699|NCT02663271|41614889|FG000|Overall Study|Withdrawal by Subject|5|||
19373700|NCT02663271|41614889|FG000|Overall Study|Lack of Efficacy|1|||
19373701|NCT02742649|41614896|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
19373702|NCT02742649|41614897|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
19373703|NCT02742649|41614898|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
19373704|NCT02742649|41614899|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
19373705|NCT02742649|41614900|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
19373706|NCT02742649|41614896|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19373707|NCT02742649|41614897|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19373708|NCT02742649|41614898|FG002|Double-Blind Treatment Period|Adverse Event|0|||
19373709|NCT02742649|41614899|FG003|Double-Blind Treatment Period|Adverse Event|0|||
19373710|NCT02742649|41614900|FG004|Double-Blind Treatment Period|Adverse Event|0|||
19373711|NCT02742649|41614896|FG000|Open-Label Period|Lost to Follow-up|0|||
19373712|NCT02742649|41614897|FG001|Open-Label Period|Lost to Follow-up|0|||
19373713|NCT02742649|41614898|FG002|Open-Label Period|Lost to Follow-up|0|||
19373714|NCT02742649|41614899|FG003|Open-Label Period|Lost to Follow-up|0|||
19393761|NCT02658175|41637670|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
19498749|NCT00559637|41859870|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
19498750|NCT00559637|41859870|FG000|Overall Study|Failure to return|6|||
19498751|NCT00559637|41859870|FG000|Overall Study|Insufficient response|3|||
19498752|NCT00559637|41859870|FG000|Overall Study|Started requiring dialysis after month 7|2|||
19613707|NCT00797667|42062539|FG002|Overall Study|Protocol Violation|0|||
19613708|NCT00797667|42062537|FG000|Overall Study|Study Terminated by Sponsor|217|||
19613709|NCT00797667|42062538|FG001|Overall Study|Study Terminated by Sponsor|216|||
19613710|NCT00797667|42062539|FG002|Overall Study|Study Terminated by Sponsor|115|||
19613711|NCT00797667|42062537|FG000|Overall Study|Withdrawal by Subject|9|||
19498753|NCT00559637|41859870|FG000|Overall Study|Suspected lung cancer|1|||
19498754|NCT00559637|41859870|FG000|Overall Study|Participation in another study|1|||
19498755|NCT00559637|41859870|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
19498756|NCT00559637|41859870|FG000|Overall Study|Change of center|1|||
19498757|NCT00559637|41859870|FG000|Overall Study|Change of home|1|||
19498758|NCT00559637|41859870|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
19498759|NCT02431260|41859972|FG000|Overall Study|Subject Decision|0|||
19498760|NCT02431260|41859973|FG001|Overall Study|Subject Decision|1|||
19498761|NCT02431260|41859974|FG002|Overall Study|Subject Decision|1|||
19498762|NCT02431260|41859975|FG003|Overall Study|Subject Decision|0|||
19498763|NCT02431260|41859976|FG004|Overall Study|Subject Decision|0|||
19393762|NCT02658175|41637668|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
19393763|NCT02658175|41637669|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
19613712|NCT00797667|42062538|FG001|Overall Study|Withdrawal by Subject|14|||
19373715|NCT02742649|41614900|FG004|Open-Label Period|Lost to Follow-up|1|||
19373716|NCT02665689|41614913|FG000|Overall Study|Adverse Event|1|||
19373717|NCT02665689|41614914|FG001|Overall Study|Adverse Event|0|||
19373718|NCT02665689|41614913|FG000|Overall Study|Trial termination|1|||
19613713|NCT00797667|42062539|FG002|Overall Study|Withdrawal by Subject|2|||
19613714|NCT00797667|42062537|FG000|Overall Study|Adverse Event|19|||
19613715|NCT00797667|42062538|FG001|Overall Study|Adverse Event|8|||
19613716|NCT00797667|42062539|FG002|Overall Study|Adverse Event|8|||
19613717|NCT00950807|42062547|FG000|Treatment Period 1|Lack of Efficacy|1|||
19613718|NCT00950807|42062548|FG001|Treatment Period 1|Lack of Efficacy|0|||
19613719|NCT00950807|42062549|FG002|Treatment Period 1|Lack of Efficacy|0|||
19613720|NCT00950807|42062550|FG003|Treatment Period 1|Lack of Efficacy|0|||
19613721|NCT00950807|42062551|FG004|Treatment Period 1|Lack of Efficacy|0|||
19613722|NCT00950807|42062552|FG005|Treatment Period 1|Lack of Efficacy|1|||
19613723|NCT00950807|42062553|FG006|Treatment Period 1|Lack of Efficacy|0|||
19704419|NCT00252564|42148757|FG001|Overall Study|Withdrawal by Subject|2|||
19393764|NCT02658175|41637670|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
19393765|NCT02658175|41637668|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
19393766|NCT02658175|41637669|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
19393767|NCT02658175|41637670|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
19393768|NCT02658175|41637668|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
19393769|NCT02658175|41637669|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
19393770|NCT02658175|41637670|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
19393771|NCT02658175|41637668|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
19393772|NCT02658175|41637669|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
19498764|NCT02431260|41859977|FG005|Overall Study|Subject Decision|0|||
19498765|NCT02431260|41859978|FG006|Overall Study|Subject Decision|0|||
19498766|NCT02431260|41859979|FG007|Overall Study|Subject Decision|0|||
19498767|NCT02431260|41859980|FG008|Overall Study|Subject Decision|1|||
19498768|NCT02431260|41859981|FG009|Overall Study|Subject Decision|1|||
19498769|NCT02431260|41859982|FG010|Overall Study|Subject Decision|0|||
19498770|NCT02431260|41859983|FG011|Overall Study|Subject Decision|1|||
19498771|NCT02431260|41859984|FG012|Overall Study|Subject Decision|0|||
19498772|NCT02431260|41859985|FG013|Overall Study|Subject Decision|0|||
19498773|NCT02431260|41859972|FG000|Overall Study|Death|4|||
19498774|NCT02431260|41859973|FG001|Overall Study|Death|4|||
19498775|NCT02431260|41859974|FG002|Overall Study|Death|3|||
19498776|NCT02431260|41859975|FG003|Overall Study|Death|4|||
19498777|NCT02431260|41859976|FG004|Overall Study|Death|2|||
19498778|NCT02431260|41859977|FG005|Overall Study|Death|2|||
19498779|NCT02431260|41859978|FG006|Overall Study|Death|3|||
19498780|NCT02431260|41859979|FG007|Overall Study|Death|1|||
19498781|NCT02431260|41859980|FG008|Overall Study|Death|6|||
19498782|NCT02431260|41859981|FG009|Overall Study|Death|6|||
19498783|NCT02431260|41859982|FG010|Overall Study|Death|3|||
19498784|NCT02431260|41859983|FG011|Overall Study|Death|2|||
19498785|NCT02431260|41859984|FG012|Overall Study|Death|5|||
19498786|NCT02431260|41859985|FG013|Overall Study|Death|1|||
19498787|NCT02431260|41859972|FG000|Overall Study|Lost to Follow-up|0|||
19498788|NCT02431260|41859973|FG001|Overall Study|Lost to Follow-up|0|||
19498789|NCT02431260|41859974|FG002|Overall Study|Lost to Follow-up|0|||
19498790|NCT02431260|41859975|FG003|Overall Study|Lost to Follow-up|0|||
19498791|NCT02431260|41859976|FG004|Overall Study|Lost to Follow-up|0|||
19498792|NCT02431260|41859977|FG005|Overall Study|Lost to Follow-up|1|||
19498793|NCT02431260|41859978|FG006|Overall Study|Lost to Follow-up|0|||
19498794|NCT02431260|41859979|FG007|Overall Study|Lost to Follow-up|0|||
19498795|NCT02431260|41859980|FG008|Overall Study|Lost to Follow-up|0|||
19498796|NCT02431260|41859981|FG009|Overall Study|Lost to Follow-up|0|||
19498797|NCT02431260|41859982|FG010|Overall Study|Lost to Follow-up|0|||
19498798|NCT02431260|41859983|FG011|Overall Study|Lost to Follow-up|0|||
19498799|NCT02431260|41859984|FG012|Overall Study|Lost to Follow-up|0|||
19498800|NCT02431260|41859985|FG013|Overall Study|Lost to Follow-up|0|||
19498801|NCT02431260|41859972|FG000|Overall Study|Study Terminated by the Sponsor|0|||
19498802|NCT02431260|41859973|FG001|Overall Study|Study Terminated by the Sponsor|0|||
19498803|NCT02431260|41859974|FG002|Overall Study|Study Terminated by the Sponsor|2|||
19498804|NCT02431260|41859975|FG003|Overall Study|Study Terminated by the Sponsor|1|||
19498805|NCT02431260|41859976|FG004|Overall Study|Study Terminated by the Sponsor|1|||
19498806|NCT02431260|41859977|FG005|Overall Study|Study Terminated by the Sponsor|0|||
19498807|NCT02431260|41859978|FG006|Overall Study|Study Terminated by the Sponsor|1|||
19498808|NCT02431260|41859979|FG007|Overall Study|Study Terminated by the Sponsor|2|||
19498809|NCT02431260|41859980|FG008|Overall Study|Study Terminated by the Sponsor|1|||
19498810|NCT02431260|41859981|FG009|Overall Study|Study Terminated by the Sponsor|1|||
19498811|NCT02431260|41859982|FG010|Overall Study|Study Terminated by the Sponsor|1|||
19498812|NCT02431260|41859983|FG011|Overall Study|Study Terminated by the Sponsor|0|||
19498813|NCT02431260|41859984|FG012|Overall Study|Study Terminated by the Sponsor|4|||
19613724|NCT00950807|42062554|FG007|Treatment Period 1|Lack of Efficacy|0|||
19498814|NCT02431260|41859985|FG013|Overall Study|Study Terminated by the Sponsor|0|||
19498815|NCT02431260|41859972|FG000|Overall Study|Physician Decision|0|||
19498816|NCT02431260|41859973|FG001|Overall Study|Physician Decision|0|||
19498817|NCT02431260|41859974|FG002|Overall Study|Physician Decision|0|||
19498818|NCT02431260|41859975|FG003|Overall Study|Physician Decision|0|||
19498819|NCT02431260|41859976|FG004|Overall Study|Physician Decision|0|||
19498820|NCT02431260|41859977|FG005|Overall Study|Physician Decision|1|||
19498821|NCT02431260|41859978|FG006|Overall Study|Physician Decision|0|||
19498822|NCT02431260|41859979|FG007|Overall Study|Physician Decision|0|||
19498823|NCT02431260|41859980|FG008|Overall Study|Physician Decision|0|||
19498824|NCT02431260|41859981|FG009|Overall Study|Physician Decision|0|||
19498825|NCT02431260|41859982|FG010|Overall Study|Physician Decision|0|||
19498826|NCT02431260|41859983|FG011|Overall Study|Physician Decision|0|||
19498827|NCT02431260|41859984|FG012|Overall Study|Physician Decision|0|||
19498828|NCT02431260|41859985|FG013|Overall Study|Physician Decision|0|||
19498829|NCT02431260|41859972|FG000|Overall Study|Other Unspecified|0|||
19498830|NCT02431260|41859973|FG001|Overall Study|Other Unspecified|0|||
19498831|NCT02431260|41859974|FG002|Overall Study|Other Unspecified|0|||
19498832|NCT02431260|41859975|FG003|Overall Study|Other Unspecified|0|||
19498833|NCT02431260|41859976|FG004|Overall Study|Other Unspecified|0|||
19498834|NCT02431260|41859977|FG005|Overall Study|Other Unspecified|0|||
19498835|NCT02431260|41859978|FG006|Overall Study|Other Unspecified|0|||
19498836|NCT02431260|41859979|FG007|Overall Study|Other Unspecified|0|||
19498837|NCT02431260|41859980|FG008|Overall Study|Other Unspecified|0|||
19498838|NCT02431260|41859981|FG009|Overall Study|Other Unspecified|0|||
19498839|NCT02431260|41859982|FG010|Overall Study|Other Unspecified|0|||
19498840|NCT02431260|41859983|FG011|Overall Study|Other Unspecified|1|||
19498841|NCT02431260|41859984|FG012|Overall Study|Other Unspecified|1|||
19498842|NCT02431260|41859985|FG013|Overall Study|Other Unspecified|0|||
19498843|NCT02430870|41860180|FG000|Part 2|Voluntary Withdrawal|0|||
19498844|NCT02430870|41860181|FG001|Part 2|Voluntary Withdrawal|0|||
19498845|NCT02430870|41860182|FG002|Part 2|Voluntary Withdrawal|0|||
19498846|NCT02430870|41860183|FG003|Part 2|Voluntary Withdrawal|0|||
19498847|NCT02430870|41860184|FG004|Part 2|Voluntary Withdrawal|0|||
19498848|NCT02430870|41860185|FG005|Part 2|Voluntary Withdrawal|0|||
19498849|NCT02430870|41860186|FG006|Part 2|Voluntary Withdrawal|1|||
19498850|NCT02430870|41860187|FG007|Part 2|Voluntary Withdrawal|0|||
19498851|NCT02430870|41860180|FG000|Part 2|Other Reason Not Specified|0|||
19498852|NCT02430870|41860181|FG001|Part 2|Other Reason Not Specified|0|||
19498853|NCT02430870|41860182|FG002|Part 2|Other Reason Not Specified|0|||
19498854|NCT02430870|41860183|FG003|Part 2|Other Reason Not Specified|0|||
19498855|NCT02430870|41860184|FG004|Part 2|Other Reason Not Specified|0|||
19498856|NCT02430870|41860185|FG005|Part 2|Other Reason Not Specified|0|||
19498857|NCT02430870|41860186|FG006|Part 2|Other Reason Not Specified|0|||
19613725|NCT00950807|42062555|FG008|Treatment Period 1|Lack of Efficacy|0|||
19613726|NCT00950807|42062556|FG009|Treatment Period 1|Lack of Efficacy|0|||
19498858|NCT02430870|41860187|FG007|Part 2|Other Reason Not Specified|1|||
19498859|NCT02430480|41860242|FG000|Overall Study|Death|1|||
19498860|NCT02430480|41860242|FG000|Overall Study|Anesthesia concerns|1|||
19498861|NCT02430480|41860242|FG000|Overall Study|Progressed on treatment|1|||
19498862|NCT02429934|41860260|FG000|Overall Study|Withdrawal by Subject|0|||
19498863|NCT02429934|41860261|FG001|Overall Study|Withdrawal by Subject|2|||
19498864|NCT02429934|41860260|FG000|Overall Study|Adverse Event|2|||
19498865|NCT02429934|41860261|FG001|Overall Study|Adverse Event|0|||
19498866|NCT02429934|41860260|FG000|Overall Study|Lost to Follow-up|1|||
19498867|NCT02429934|41860261|FG001|Overall Study|Lost to Follow-up|1|||
19498868|NCT02429934|41860260|FG000|Overall Study|Physician Decision|1|||
19498869|NCT02429934|41860261|FG001|Overall Study|Physician Decision|0|||
19498870|NCT02429856|41860275|FG000|Overall Study|Death|12|||
19498871|NCT02429856|41860276|FG001|Overall Study|Death|13|||
19498872|NCT02429856|41860275|FG000|Overall Study|Lost to Follow-up|6|||
19498873|NCT02429856|41860276|FG001|Overall Study|Lost to Follow-up|5|||
19498874|NCT02429856|41860275|FG000|Overall Study|Withdrawal by Subject|1|||
19498875|NCT02429856|41860276|FG001|Overall Study|Withdrawal by Subject|1|||
19498876|NCT02429778|41860286|FG000|Overall Study|Lost to Follow-up|2|||
19498877|NCT02429778|41860287|FG001|Overall Study|Lost to Follow-up|0|||
19498878|NCT02429778|41860286|FG000|Overall Study|Withdrawal by Subject|5|||
19498879|NCT02429778|41860287|FG001|Overall Study|Withdrawal by Subject|0|||
19498880|NCT02403180|41860295|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
19498881|NCT02403180|41860296|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
19498882|NCT02403180|41860295|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
19498883|NCT02403180|41860296|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
19498884|NCT02402322|41860314|FG000|Pretreatment|Withdrawal by Subject|3|||
19498885|NCT02402322|41860315|FG001|Pretreatment|Withdrawal by Subject|1|||
19498886|NCT02402322|41860316|FG002|Pretreatment|Withdrawal by Subject|1|||
19498887|NCT02402322|41860314|FG000|Follow-up|Withdrawal by Subject|6|||
19613727|NCT00950807|42062547|FG000|Treatment Period 1|Protocol Violation|1|||
19613728|NCT00950807|42062548|FG001|Treatment Period 1|Protocol Violation|0|||
19498888|NCT02402322|41860315|FG001|Follow-up|Withdrawal by Subject|3|||
19498889|NCT02402322|41860316|FG002|Follow-up|Withdrawal by Subject|24|||
19498890|NCT00558467|41860343|FG000|Overall Study|Adverse Event|1|||
19498891|NCT00558467|41860344|FG001|Overall Study|Adverse Event|2|||
19498892|NCT00558467|41860343|FG000|Overall Study|Lack of Efficacy|0|||
19498893|NCT00558467|41860344|FG001|Overall Study|Lack of Efficacy|1|||
19498894|NCT00558467|41860343|FG000|Overall Study|Patient moving out of state|0|||
19498895|NCT00558467|41860344|FG001|Overall Study|Patient moving out of state|1|||
19498896|NCT02402166|41860350|FG000|Overall Study|Adverse Event|2|||
19498897|NCT02402166|41860350|FG000|Overall Study|Withdrawal by Subject|2|||
19498898|NCT02402166|41860350|FG000|Overall Study|Lost to Follow-up|1|||
19498899|NCT02378220|41860370|FG000|Overall Study|Death|6|||
19498900|NCT02378220|41860371|FG001|Overall Study|Death|1|||
19498901|NCT04226495|41860380|FG000|Overall Study|Withdrawal by Subject|3|||
19498902|NCT04226495|41860381|FG001|Overall Study|Withdrawal by Subject|3|||
19498903|NCT04226495|41860380|FG000|Overall Study|PI discretion|2|||
19498904|NCT04226495|41860381|FG001|Overall Study|PI discretion|4|||
19498905|NCT02401308|41860389|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
19498906|NCT02401308|41860390|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
19498907|NCT02401230|41860399|FG000|Overall Study|Adverse Event|3|||
19498908|NCT02401230|41860400|FG001|Overall Study|Adverse Event|2|||
19498909|NCT02401230|41860401|FG002|Overall Study|Adverse Event|0|||
19498910|NCT02401230|41860399|FG000|Overall Study|Withdrawal by Subject|2|||
19498911|NCT02401230|41860400|FG001|Overall Study|Withdrawal by Subject|1|||
19498912|NCT02401230|41860401|FG002|Overall Study|Withdrawal by Subject|1|||
19498913|NCT02401230|41860399|FG000|Overall Study|Lost to Follow-up|1|||
19498914|NCT02401230|41860400|FG001|Overall Study|Lost to Follow-up|3|||
19498915|NCT02401230|41860401|FG002|Overall Study|Lost to Follow-up|3|||
19498916|NCT02429310|41860442|FG000|Overall Study|Lost to Follow-up|1|||
19498917|NCT02429310|41860443|FG001|Overall Study|Lost to Follow-up|2|||
19498918|NCT02429310|41860442|FG000|Overall Study|Protocol Violation|1|||
19498919|NCT02429310|41860443|FG001|Overall Study|Protocol Violation|1|||
19498920|NCT02428608|41860469|FG000|Overall Study|Pregnancy|2|||
19498921|NCT02428608|41860469|FG000|Overall Study|Lost to Follow-up|37|||
19498922|NCT02428608|41860469|FG000|Overall Study|Withdrawal by Subject|2|||
19498923|NCT02428608|41860469|FG000|Overall Study|scheduling conflicts|15|||
19498924|NCT02428608|41860469|FG000|Overall Study|moved away|10|||
19498925|NCT02428608|41860469|FG000|Overall Study|Death|1|||
19498926|NCT02428608|41860469|FG000|Overall Study|various|16|||
19498927|NCT02428296|41860489|FG000|Overall Study|Adverse Event|7|||
19498928|NCT02428296|41860489|FG000|Overall Study|Withdrawal by Subject|2|||
19498929|NCT02427984|41860503|FG000|Overall Study|Lost to Follow-up|13|||
19498930|NCT02427984|41860504|FG001|Overall Study|Lost to Follow-up|5|||
19498931|NCT02427984|41860505|FG002|Overall Study|Lost to Follow-up|18|||
19498932|NCT00556673|41860744|FG000|Overall Study|Protocol deviation|3|||
19498933|NCT00556673|41860745|FG001|Overall Study|Protocol deviation|2|||
19498934|NCT00555425|41860874|FG000|Overall Study|Missed Medication > 1 wk|34|||
19498935|NCT00555425|41860875|FG001|Overall Study|Missed Medication > 1 wk|15|||
19498936|NCT00555425|41860874|FG000|Overall Study|Missed 3 physician management visits|1|||
19498937|NCT00555425|41860875|FG001|Overall Study|Missed 3 physician management visits|0|||
19498938|NCT00555425|41860874|FG000|Overall Study|Met criteria for protective transfer|16|||
19498939|NCT00555425|41860875|FG001|Overall Study|Met criteria for protective transfer|3|||
19498940|NCT00555425|41860874|FG000|Overall Study|Became pregnant and transferred care|0|||
19498941|NCT00555425|41860875|FG001|Overall Study|Became pregnant and transferred care|1|||
19498942|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
19498943|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
19498944|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
19498945|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
19498946|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
19498947|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
19498948|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
19498949|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
19498950|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
19498951|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
19498952|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
19498953|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
19498954|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
19498955|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
19498956|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
19613729|NCT00950807|42062549|FG002|Treatment Period 1|Protocol Violation|0|||
19704420|NCT00166296|42148765|FG000|Overall Study|Withdrawal by Subject|1|||
19498957|NCT00554099|41861056|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
19498958|NCT00554099|41861057|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
19498959|NCT00554099|41861058|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
19498960|NCT00554099|41861056|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
19498961|NCT00554099|41861057|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
19498962|NCT00554099|41861058|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
19498963|NCT00554099|41861056|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
19498964|NCT00554099|41861057|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
19498965|NCT00554099|41861058|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
19498966|NCT00554099|41861056|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
19498967|NCT00554099|41861057|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
19498968|NCT00554099|41861058|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
19498969|NCT02377362|41861092|FG000|Part A Second Treatment|Protocol Violation|0|||
19498970|NCT02377362|41861093|FG001|Part A Second Treatment|Protocol Violation|0|||
19498971|NCT02377362|41861094|FG002|Part A Second Treatment|Protocol Violation|0|||
19498972|NCT02377362|41861095|FG003|Part A Second Treatment|Protocol Violation|0|||
19498973|NCT02377362|41861096|FG004|Part A Second Treatment|Protocol Violation|1|||
19498974|NCT02377362|41861097|FG005|Part A Second Treatment|Protocol Violation|0|||
19498975|NCT02377362|41861098|FG006|Part A Second Treatment|Protocol Violation|0|||
19498976|NCT02377362|41861099|FG007|Part A Second Treatment|Protocol Violation|0|||
19498977|NCT02377362|41861100|FG008|Part A Second Treatment|Protocol Violation|0|||
19498978|NCT02377362|41861101|FG009|Part A Second Treatment|Protocol Violation|0|||
19498979|NCT02377362|41861102|FG010|Part A Second Treatment|Protocol Violation|0|||
19498980|NCT02377362|41861103|FG011|Part A Second Treatment|Protocol Violation|0|||
19498981|NCT02377362|41861104|FG012|Part A Second Treatment|Protocol Violation|0|||
19498982|NCT02377362|41861092|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498983|NCT02377362|41861093|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498984|NCT02377362|41861094|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498985|NCT02377362|41861095|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
19498986|NCT02377362|41861096|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
19498987|NCT02377362|41861097|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
19498988|NCT02377362|41861098|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498989|NCT02377362|41861099|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498990|NCT02377362|41861100|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498991|NCT02377362|41861101|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498992|NCT02377362|41861102|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498993|NCT02377362|41861103|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498994|NCT02377362|41861104|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
19498995|NCT02377362|41861092|FG000|Part B Overall|Protocol Violation|0|||
19498996|NCT02377362|41861093|FG001|Part B Overall|Protocol Violation|0|||
19498997|NCT02377362|41861094|FG002|Part B Overall|Protocol Violation|0|||
19498998|NCT02377362|41861095|FG003|Part B Overall|Protocol Violation|0|||
19498999|NCT02377362|41861096|FG004|Part B Overall|Protocol Violation|0|||
19499000|NCT02377362|41861097|FG005|Part B Overall|Protocol Violation|0|||
19499001|NCT02377362|41861098|FG006|Part B Overall|Protocol Violation|0|||
19499002|NCT02377362|41861099|FG007|Part B Overall|Protocol Violation|0|||
19499003|NCT02377362|41861100|FG008|Part B Overall|Protocol Violation|0|||
19499004|NCT02377362|41861101|FG009|Part B Overall|Protocol Violation|1|||
19499005|NCT02377362|41861102|FG010|Part B Overall|Protocol Violation|0|||
19499006|NCT02377362|41861103|FG011|Part B Overall|Protocol Violation|0|||
19499007|NCT02377362|41861104|FG012|Part B Overall|Protocol Violation|0|||
19499008|NCT02377362|41861092|FG000|Part B Overall|Adverse Event|0|||
19499009|NCT02377362|41861093|FG001|Part B Overall|Adverse Event|0|||
19499010|NCT02377362|41861094|FG002|Part B Overall|Adverse Event|0|||
19499011|NCT02377362|41861095|FG003|Part B Overall|Adverse Event|0|||
19499012|NCT02377362|41861096|FG004|Part B Overall|Adverse Event|0|||
19499013|NCT02377362|41861097|FG005|Part B Overall|Adverse Event|0|||
19499014|NCT02377362|41861098|FG006|Part B Overall|Adverse Event|1|||
19499015|NCT02377362|41861099|FG007|Part B Overall|Adverse Event|1|||
19499016|NCT02377362|41861100|FG008|Part B Overall|Adverse Event|0|||
19499017|NCT02377362|41861101|FG009|Part B Overall|Adverse Event|0|||
19499018|NCT02377362|41861102|FG010|Part B Overall|Adverse Event|0|||
19499019|NCT02377362|41861103|FG011|Part B Overall|Adverse Event|0|||
19499020|NCT02377362|41861104|FG012|Part B Overall|Adverse Event|0|||
19499021|NCT02377362|41861092|FG000|Part B Overall|Withdrawal by Subject|0|||
19499022|NCT02377362|41861093|FG001|Part B Overall|Withdrawal by Subject|0|||
19499023|NCT02377362|41861094|FG002|Part B Overall|Withdrawal by Subject|0|||
19499024|NCT02377362|41861095|FG003|Part B Overall|Withdrawal by Subject|0|||
19499025|NCT02377362|41861096|FG004|Part B Overall|Withdrawal by Subject|0|||
19499026|NCT02377362|41861097|FG005|Part B Overall|Withdrawal by Subject|0|||
19499027|NCT02377362|41861098|FG006|Part B Overall|Withdrawal by Subject|1|||
19499028|NCT02377362|41861099|FG007|Part B Overall|Withdrawal by Subject|0|||
19499029|NCT02377362|41861100|FG008|Part B Overall|Withdrawal by Subject|0|||
19499030|NCT02377362|41861101|FG009|Part B Overall|Withdrawal by Subject|0|||
19499031|NCT02377362|41861102|FG010|Part B Overall|Withdrawal by Subject|0|||
19613730|NCT00950807|42062550|FG003|Treatment Period 1|Protocol Violation|0|||
19613731|NCT00950807|42062551|FG004|Treatment Period 1|Protocol Violation|0|||
19499032|NCT02377362|41861103|FG011|Part B Overall|Withdrawal by Subject|1|||
19499033|NCT02377362|41861104|FG012|Part B Overall|Withdrawal by Subject|0|||
19499034|NCT00553631|41861144|FG000|Overall Study|Withdrawal by Subject|0|||
19499035|NCT00553631|41861145|FG001|Overall Study|Withdrawal by Subject|1|||
19499036|NCT00553631|41861144|FG000|Overall Study|Lost to Follow-up|1|||
19499037|NCT00553631|41861145|FG001|Overall Study|Lost to Follow-up|0|||
19499038|NCT00553319|41861163|FG000|Overall Study|Lost to Follow-up|10|||
19499039|NCT00553319|41861164|FG001|Overall Study|Lost to Follow-up|9|||
19499040|NCT00553319|41861165|FG002|Overall Study|Lost to Follow-up|5|||
19499041|NCT00553319|41861163|FG000|Overall Study|wanted treatment elsewhere|2|||
19499042|NCT00553319|41861164|FG001|Overall Study|wanted treatment elsewhere|1|||
19499043|NCT00553319|41861165|FG002|Overall Study|wanted treatment elsewhere|1|||
19499044|NCT00553319|41861163|FG000|Overall Study|non-compliance|0|||
19499045|NCT00553319|41861164|FG001|Overall Study|non-compliance|0|||
19499046|NCT00553319|41861165|FG002|Overall Study|non-compliance|2|||
19499047|NCT00553319|41861163|FG000|Overall Study|incarceration|1|||
19499048|NCT00553319|41861164|FG001|Overall Study|incarceration|0|||
19499049|NCT00553319|41861165|FG002|Overall Study|incarceration|0|||
19499050|NCT00553319|41861163|FG000|Overall Study|moved|1|||
19499051|NCT00553319|41861164|FG001|Overall Study|moved|0|||
19499052|NCT00553319|41861165|FG002|Overall Study|moved|1|||
19499053|NCT01649856|41861351|FG000|Overall Study|Withdrawal by Subject|14|||
19499054|NCT01649856|41861352|FG001|Overall Study|Withdrawal by Subject|14|||
19499055|NCT01649856|41861351|FG000|Overall Study|Protocol Violation|4|||
19499056|NCT01649856|41861352|FG001|Overall Study|Protocol Violation|4|||
19499057|NCT01649856|41861351|FG000|Overall Study|Treatment Failure|1|||
19499058|NCT01649856|41861352|FG001|Overall Study|Treatment Failure|1|||
19499059|NCT01649856|41861351|FG000|Overall Study|Death|69|||
19499060|NCT01649856|41861352|FG001|Overall Study|Death|34|||
19499061|NCT01649856|41861351|FG000|Overall Study|Stable or Progressed Disease|5|||
19499062|NCT01649856|41861352|FG001|Overall Study|Stable or Progressed Disease|3|||
19499063|NCT01649856|41861351|FG000|Overall Study|Lost to Follow-up|20|||
19499064|NCT01649856|41861352|FG001|Overall Study|Lost to Follow-up|16|||
19499065|NCT01649856|41861351|FG000|Overall Study|Lack of Compliance|6|||
19499066|NCT01649856|41861352|FG001|Overall Study|Lack of Compliance|1|||
19499067|NCT01649856|41861351|FG000|Overall Study|Other|20|||
19613732|NCT00950807|42062552|FG005|Treatment Period 1|Protocol Violation|0|||
19613733|NCT00950807|42062553|FG006|Treatment Period 1|Protocol Violation|0|||
19613734|NCT00950807|42062554|FG007|Treatment Period 1|Protocol Violation|0|||
19613735|NCT00950807|42062555|FG008|Treatment Period 1|Protocol Violation|0|||
19613736|NCT00950807|42062556|FG009|Treatment Period 1|Protocol Violation|0|||
19613737|NCT00950807|42062547|FG000|Treatment Period 1|Lost to Follow-up|0|||
19613738|NCT00950807|42062548|FG001|Treatment Period 1|Lost to Follow-up|0|||
19613739|NCT00950807|42062549|FG002|Treatment Period 1|Lost to Follow-up|1|||
19499068|NCT01649856|41861352|FG001|Overall Study|Other|5|||
19499069|NCT02375724|41861373|FG000|Overall Study|Lack of Efficacy|1|||
19499070|NCT02375724|41861374|FG001|Overall Study|Lack of Efficacy|1|||
19499071|NCT02375724|41861373|FG000|Overall Study|Withdrawal by Subject|1|||
19499072|NCT02375724|41861374|FG001|Overall Study|Withdrawal by Subject|1|||
19499073|NCT02375724|41861373|FG000|Overall Study|Lost to Follow-up|1|||
19499074|NCT02375724|41861374|FG001|Overall Study|Lost to Follow-up|0|||
19499075|NCT02375724|41861373|FG000|Overall Study|Protocol Violation|1|||
19499076|NCT02375724|41861374|FG001|Overall Study|Protocol Violation|0|||
19499077|NCT02375724|41861373|FG000|Overall Study|Adverse Event|2|||
19499078|NCT02375724|41861374|FG001|Overall Study|Adverse Event|4|||
19499079|NCT02398188|41861382|FG000|Overall Study|Adverse Event|2|||
19499080|NCT02398188|41861383|FG001|Overall Study|Adverse Event|3|||
19499081|NCT02398188|41861382|FG000|Overall Study|Lost to Follow-up|5|||
19499082|NCT02398188|41861383|FG001|Overall Study|Lost to Follow-up|0|||
19499083|NCT02398188|41861382|FG000|Overall Study|Non-compliance|4|||
19499084|NCT02398188|41861383|FG001|Overall Study|Non-compliance|4|||
19499085|NCT02398188|41861382|FG000|Overall Study|Protocol Violation|6|||
19499086|NCT02398188|41861383|FG001|Overall Study|Protocol Violation|10|||
19499087|NCT02398188|41861382|FG000|Overall Study|Sponsor Decision|2|||
19613740|NCT00950807|42062550|FG003|Treatment Period 1|Lost to Follow-up|0|||
19613741|NCT00950807|42062551|FG004|Treatment Period 1|Lost to Follow-up|0|||
19499088|NCT02398188|41861383|FG001|Overall Study|Sponsor Decision|1|||
19499089|NCT02398188|41861382|FG000|Overall Study|Pregnancy|1|||
19499090|NCT02398188|41861383|FG001|Overall Study|Pregnancy|0|||
19499091|NCT02398188|41861382|FG000|Overall Study|Withdrawal by Subject|7|||
19499092|NCT02398188|41861383|FG001|Overall Study|Withdrawal by Subject|16|||
19613742|NCT00950807|42062552|FG005|Treatment Period 1|Lost to Follow-up|0|||
19613743|NCT00950807|42062553|FG006|Treatment Period 1|Lost to Follow-up|0|||
19613744|NCT00950807|42062554|FG007|Treatment Period 1|Lost to Follow-up|0|||
19499093|NCT02426580|41861391|FG000|Overall Study|Death|2|||
19499094|NCT02426580|41861392|FG001|Overall Study|Death|2|||
19499095|NCT02426580|41861391|FG000|Overall Study|Lost to Follow-up|0|||
19499096|NCT02426580|41861392|FG001|Overall Study|Lost to Follow-up|9|||
19499097|NCT02426580|41861391|FG000|Overall Study|transfer to hemodialysis|5|||
19499098|NCT02426580|41861392|FG001|Overall Study|transfer to hemodialysis|5|||
19499099|NCT02426580|41861391|FG000|Overall Study|Kidney transplant|3|||
19499100|NCT02426580|41861392|FG001|Overall Study|Kidney transplant|0|||
19499101|NCT02426580|41861391|FG000|Overall Study|Allergic to egg white|1|||
19499102|NCT02426580|41861392|FG001|Overall Study|Allergic to egg white|0|||
19499103|NCT01651260|41861398|FG000|Overall Study|unable to apply product|3|||
19499104|NCT02425098|41861418|FG000|Overall Study|Lost to Follow-up|7|||
19499105|NCT02425098|41861419|FG001|Overall Study|Lost to Follow-up|7|||
19499106|NCT02425098|41861418|FG000|Overall Study|Withdrawal by Subject|4|||
19499107|NCT02425098|41861419|FG001|Overall Study|Withdrawal by Subject|8|||
19499108|NCT02425098|41861418|FG000|Overall Study|Pregnancy|2|||
19499109|NCT02425098|41861419|FG001|Overall Study|Pregnancy|0|||
19499110|NCT02425098|41861418|FG000|Overall Study|Reason not Specified|0|||
19499111|NCT02425098|41861419|FG001|Overall Study|Reason not Specified|1|||
19499112|NCT02424630|41861427|FG000|Overall Study|No rotator cuff tear|1|||
19499113|NCT02424630|41861428|FG001|Overall Study|No rotator cuff tear|2|||
19499114|NCT02424630|41861427|FG000|Overall Study|Open procedure|0|||
19499115|NCT02424630|41861428|FG001|Overall Study|Open procedure|1|||
19499116|NCT02397408|41861434|FG000|Overall Study|Physician Decision|4|||
19499117|NCT02397408|41861434|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
19499118|NCT02397096|41861440|FG000|Day 1 to Week 24|Adverse Event|7|||
19499119|NCT02397096|41861441|FG001|Day 1 to Week 24|Adverse Event|1|||
19499120|NCT02397096|41861440|FG000|Day 1 to Week 24|Death|1|||
19499121|NCT02397096|41861441|FG001|Day 1 to Week 24|Death|0|||
19499122|NCT02397096|41861440|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
19499123|NCT02397096|41861441|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
19499124|NCT02397096|41861440|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
19499125|NCT02397096|41861441|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
19499126|NCT02397096|41861440|FG000|Day 1 to Week 24|Physician Decision|2|||
19499127|NCT02397096|41861441|FG001|Day 1 to Week 24|Physician Decision|3|||
19499128|NCT02397096|41861440|FG000|Day 1 to Week 24|Protocol Violation|1|||
19499129|NCT02397096|41861441|FG001|Day 1 to Week 24|Protocol Violation|4|||
19499130|NCT02397096|41861440|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
19499131|NCT02397096|41861441|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
19499132|NCT02397096|41861440|FG000|Week 24 to Week 48|Adverse Event|6|||
19499133|NCT02397096|41861441|FG001|Week 24 to Week 48|Adverse Event|2|||
19499134|NCT02397096|41861440|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
19499135|NCT02397096|41861441|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
19499136|NCT02397096|41861440|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
19499137|NCT02397096|41861441|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
19499138|NCT02397096|41861440|FG000|Week 24 to Week 48|Physician Decision|2|||
19499139|NCT02397096|41861441|FG001|Week 24 to Week 48|Physician Decision|1|||
19499140|NCT02397096|41861440|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
19499141|NCT02397096|41861441|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
19499142|NCT02397096|41861440|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
19499143|NCT02397096|41861441|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
19499144|NCT02397096|41861440|FG000|Study Extensions|Ongoing|399|||
19499145|NCT02397096|41861441|FG001|Study Extensions|Ongoing|202|||
19499146|NCT02372058|41861451|FG000|Overall Study|Withdrawal by Subject|3|||
19499147|NCT02396316|41861459|FG000|Overall Study|Physician Decision|1|||
19499148|NCT02396316|41861460|FG001|Overall Study|Physician Decision|0|||
19499149|NCT02396316|41861459|FG000|Overall Study|Progressive disease|6|||
19499150|NCT02396316|41861460|FG001|Overall Study|Progressive disease|3|||
19499151|NCT02396316|41861459|FG000|Overall Study|Protocol Violation|0|||
19499152|NCT02396316|41861460|FG001|Overall Study|Protocol Violation|1|||
19499153|NCT02396316|41861459|FG000|Overall Study|Treatment unblinded|0|||
19499154|NCT02396316|41861460|FG001|Overall Study|Treatment unblinded|1|||
19499155|NCT02395536|41861470|FG000|Overall Study|Lost to Follow-up|4|||
19499156|NCT02395536|41861471|FG001|Overall Study|Lost to Follow-up|4|||
19499157|NCT02395536|41861470|FG000|Overall Study|Death|2|||
19499158|NCT02395536|41861471|FG001|Overall Study|Death|0|||
19499159|NCT02395536|41861470|FG000|Overall Study|Physician Decision|4|||
19499160|NCT02395536|41861471|FG001|Overall Study|Physician Decision|6|||
19499161|NCT02395536|41861470|FG000|Overall Study|Withdrawal by Subject|9|||
19499162|NCT02395536|41861471|FG001|Overall Study|Withdrawal by Subject|17|||
19499163|NCT02395536|41861470|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
19499164|NCT02395536|41861471|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
19499165|NCT02395536|41861470|FG000|Overall Study|Insurance issue|0|||
19499166|NCT02395536|41861471|FG001|Overall Study|Insurance issue|1|||
19613745|NCT00950807|42062555|FG008|Treatment Period 1|Lost to Follow-up|0|||
19499167|NCT00552929|41861487|FG000|Overall Study|Lost to Follow-up|0|||
19499168|NCT00552929|41861488|FG001|Overall Study|Lost to Follow-up|0|||
19499169|NCT00552929|41861489|FG002|Overall Study|Lost to Follow-up|0|||
19499170|NCT00552929|41861490|FG003|Overall Study|Lost to Follow-up|0|||
19499171|NCT00552929|41861491|FG004|Overall Study|Lost to Follow-up|0|||
19499172|NCT00552929|41861492|FG005|Overall Study|Lost to Follow-up|0|||
19499173|NCT00552929|41861493|FG006|Overall Study|Lost to Follow-up|0|||
19499174|NCT00552929|41861494|FG007|Overall Study|Lost to Follow-up|0|||
19499175|NCT00552929|41861495|FG008|Overall Study|Lost to Follow-up|1|||
19499176|NCT00552929|41861496|FG009|Overall Study|Lost to Follow-up|0|||
19499177|NCT00552929|41861487|FG000|Overall Study|Not Eligible|0|||
19499178|NCT00552929|41861488|FG001|Overall Study|Not Eligible|0|||
19499179|NCT00552929|41861489|FG002|Overall Study|Not Eligible|0|||
19499180|NCT00552929|41861490|FG003|Overall Study|Not Eligible|0|||
19613746|NCT00950807|42062556|FG009|Treatment Period 1|Lost to Follow-up|0|||
19499181|NCT00552929|41861491|FG004|Overall Study|Not Eligible|0|||
19499182|NCT00552929|41861492|FG005|Overall Study|Not Eligible|1|||
19499183|NCT00552929|41861493|FG006|Overall Study|Not Eligible|0|||
19499184|NCT00552929|41861494|FG007|Overall Study|Not Eligible|0|||
19499185|NCT00552929|41861495|FG008|Overall Study|Not Eligible|0|||
19499186|NCT00552929|41861496|FG009|Overall Study|Not Eligible|0|||
19499187|NCT02395302|41861518|FG000|Overall Study|Screen Failure|3|||
19499188|NCT02395302|41861518|FG000|Overall Study|Run In Failure|7|||
19499189|NCT02395302|41861518|FG000|Overall Study|Withdrawal by Subject|2|||
19499190|NCT02395302|41861518|FG000|Overall Study|Physician Decision|2|||
19499191|NCT02371980|41861552|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
19499192|NCT02371980|41861553|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
19499193|NCT02371980|41861554|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
19499194|NCT02371980|41861555|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
19499195|NCT02371980|41861556|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
19499196|NCT02371980|41861552|FG000|Open-label Period|Significant Protocol Deviation|19|||
19499197|NCT02371980|41861553|FG001|Open-label Period|Significant Protocol Deviation|0|||
19499198|NCT02371980|41861554|FG002|Open-label Period|Significant Protocol Deviation|0|||
19499199|NCT02371980|41861555|FG003|Open-label Period|Significant Protocol Deviation|0|||
19499200|NCT02371980|41861556|FG004|Open-label Period|Significant Protocol Deviation|0|||
19499201|NCT02371980|41861552|FG000|Open-label Period|Noncompliance with Study Drug|10|||
19499202|NCT02371980|41861553|FG001|Open-label Period|Noncompliance with Study Drug|0|||
19499203|NCT02371980|41861554|FG002|Open-label Period|Noncompliance with Study Drug|0|||
19499204|NCT02371980|41861555|FG003|Open-label Period|Noncompliance with Study Drug|0|||
19499205|NCT02371980|41861556|FG004|Open-label Period|Noncompliance with Study Drug|0|||
19499206|NCT02371980|41861552|FG000|Open-label Period|Lost to Follow-up|55|||
19613747|NCT00950807|42062547|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19613748|NCT00950807|42062548|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19613749|NCT00950807|42062549|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19613750|NCT00950807|42062550|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19613751|NCT00950807|42062551|FG004|Treatment Period 1|Withdrawal by Subject|1|||
19613752|NCT00950807|42062552|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19613753|NCT00950807|42062553|FG006|Treatment Period 1|Withdrawal by Subject|0|||
19613754|NCT00950807|42062554|FG007|Treatment Period 1|Withdrawal by Subject|0|||
19613755|NCT00950807|42062555|FG008|Treatment Period 1|Withdrawal by Subject|1|||
19613756|NCT00950807|42062556|FG009|Treatment Period 1|Withdrawal by Subject|0|||
19613757|NCT00950807|42062547|FG000|Treatment Period 1|Adverse Event|0|||
19613758|NCT00950807|42062548|FG001|Treatment Period 1|Adverse Event|0|||
19613759|NCT00950807|42062549|FG002|Treatment Period 1|Adverse Event|0|||
19613760|NCT00950807|42062550|FG003|Treatment Period 1|Adverse Event|0|||
19613761|NCT00950807|42062551|FG004|Treatment Period 1|Adverse Event|0|||
19613762|NCT00950807|42062552|FG005|Treatment Period 1|Adverse Event|1|||
19613763|NCT00950807|42062553|FG006|Treatment Period 1|Adverse Event|0|||
19613764|NCT00950807|42062554|FG007|Treatment Period 1|Adverse Event|0|||
19613765|NCT00950807|42062555|FG008|Treatment Period 1|Adverse Event|0|||
19613766|NCT00950807|42062556|FG009|Treatment Period 1|Adverse Event|0|||
19613767|NCT00950807|42062547|FG000|Washout Period 1|Lack of Efficacy|0|||
19613768|NCT00950807|42062548|FG001|Washout Period 1|Lack of Efficacy|0|||
19613769|NCT00950807|42062549|FG002|Washout Period 1|Lack of Efficacy|0|||
19613770|NCT00950807|42062550|FG003|Washout Period 1|Lack of Efficacy|0|||
19613771|NCT00950807|42062551|FG004|Washout Period 1|Lack of Efficacy|0|||
19613772|NCT00950807|42062552|FG005|Washout Period 1|Lack of Efficacy|0|||
19613773|NCT00950807|42062553|FG006|Washout Period 1|Lack of Efficacy|1|||
19613774|NCT00950807|42062554|FG007|Washout Period 1|Lack of Efficacy|0|||
19613775|NCT00950807|42062555|FG008|Washout Period 1|Lack of Efficacy|0|||
19613776|NCT00950807|42062556|FG009|Washout Period 1|Lack of Efficacy|0|||
19613777|NCT00950807|42062547|FG000|Washout Period 1|Withdrawal by Subject|0|||
19613778|NCT00950807|42062548|FG001|Washout Period 1|Withdrawal by Subject|0|||
19613779|NCT00950807|42062549|FG002|Washout Period 1|Withdrawal by Subject|0|||
19613780|NCT00950807|42062550|FG003|Washout Period 1|Withdrawal by Subject|0|||
19613781|NCT00950807|42062551|FG004|Washout Period 1|Withdrawal by Subject|0|||
19613782|NCT00950807|42062552|FG005|Washout Period 1|Withdrawal by Subject|0|||
19613783|NCT00950807|42062553|FG006|Washout Period 1|Withdrawal by Subject|0|||
19613784|NCT00950807|42062554|FG007|Washout Period 1|Withdrawal by Subject|0|||
19613785|NCT00950807|42062555|FG008|Washout Period 1|Withdrawal by Subject|1|||
19613786|NCT00950807|42062556|FG009|Washout Period 1|Withdrawal by Subject|0|||
19613787|NCT00950807|42062547|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
19613788|NCT00950807|42062548|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19704421|NCT00166296|42148766|FG001|Overall Study|Withdrawal by Subject|3|||
19704422|NCT00166296|42148765|FG000|Overall Study|Adverse Event|2|||
19499207|NCT02371980|41861553|FG001|Open-label Period|Lost to Follow-up|0|||
19499208|NCT02371980|41861554|FG002|Open-label Period|Lost to Follow-up|0|||
19499209|NCT02371980|41861555|FG003|Open-label Period|Lost to Follow-up|0|||
19613789|NCT00950807|42062549|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19613790|NCT00950807|42062550|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19499210|NCT02371980|41861556|FG004|Open-label Period|Lost to Follow-up|0|||
19499211|NCT02371980|41861552|FG000|Open-label Period|Voluntary Withdrawal|91|||
19499212|NCT02371980|41861553|FG001|Open-label Period|Voluntary Withdrawal|0|||
19499213|NCT02371980|41861554|FG002|Open-label Period|Voluntary Withdrawal|0|||
19499214|NCT02371980|41861555|FG003|Open-label Period|Voluntary Withdrawal|0|||
19499215|NCT02371980|41861556|FG004|Open-label Period|Voluntary Withdrawal|0|||
19499216|NCT02371980|41861552|FG000|Open-label Period|Pregnancy|1|||
19499217|NCT02371980|41861553|FG001|Open-label Period|Pregnancy|0|||
19499218|NCT02371980|41861554|FG002|Open-label Period|Pregnancy|0|||
19499219|NCT02371980|41861555|FG003|Open-label Period|Pregnancy|0|||
19499220|NCT02371980|41861556|FG004|Open-label Period|Pregnancy|0|||
19499221|NCT02371980|41861552|FG000|Open-label Period|Lack of Efficacy|116|||
19499222|NCT02371980|41861553|FG001|Open-label Period|Lack of Efficacy|0|||
19499223|NCT02371980|41861554|FG002|Open-label Period|Lack of Efficacy|0|||
19499224|NCT02371980|41861555|FG003|Open-label Period|Lack of Efficacy|0|||
19499225|NCT02371980|41861556|FG004|Open-label Period|Lack of Efficacy|0|||
19499226|NCT02371980|41861552|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
19499227|NCT02371980|41861553|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
19499228|NCT02371980|41861554|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
19499229|NCT02371980|41861555|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
19499230|NCT02371980|41861556|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
19499231|NCT02371980|41861552|FG000|Open-label Period|Reason not Specified|9|||
19499232|NCT02371980|41861553|FG001|Open-label Period|Reason not Specified|0|||
19499233|NCT02371980|41861554|FG002|Open-label Period|Reason not Specified|0|||
19499234|NCT02371980|41861555|FG003|Open-label Period|Reason not Specified|0|||
19499235|NCT02371980|41861556|FG004|Open-label Period|Reason not Specified|0|||
19499236|NCT02371980|41861552|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
19499237|NCT02371980|41861553|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
19499238|NCT02371980|41861554|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
19499239|NCT02371980|41861555|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
19499240|NCT02371980|41861556|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
19499241|NCT02371980|41861552|FG000|Double-blind Period|Significant Protocol Deviation|0|||
19499242|NCT02371980|41861553|FG001|Double-blind Period|Significant Protocol Deviation|2|||
19499243|NCT02371980|41861554|FG002|Double-blind Period|Significant Protocol Deviation|7|||
19499244|NCT02371980|41861555|FG003|Double-blind Period|Significant Protocol Deviation|3|||
19499245|NCT02371980|41861556|FG004|Double-blind Period|Significant Protocol Deviation|3|||
19499246|NCT02371980|41861552|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
19499247|NCT02371980|41861553|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
19499248|NCT02371980|41861554|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
19499249|NCT02371980|41861555|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
19499250|NCT02371980|41861556|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
19499251|NCT02371980|41861552|FG000|Double-blind Period|Lost to Follow-up|0|||
19499252|NCT02371980|41861553|FG001|Double-blind Period|Lost to Follow-up|8|||
19499253|NCT02371980|41861554|FG002|Double-blind Period|Lost to Follow-up|8|||
19499254|NCT02371980|41861555|FG003|Double-blind Period|Lost to Follow-up|6|||
19499255|NCT02371980|41861556|FG004|Double-blind Period|Lost to Follow-up|5|||
19499256|NCT02371980|41861552|FG000|Double-blind Period|Voluntary Withdrawal|0|||
19499257|NCT02371980|41861553|FG001|Double-blind Period|Voluntary Withdrawal|12|||
19499258|NCT02371980|41861554|FG002|Double-blind Period|Voluntary Withdrawal|8|||
19499259|NCT02371980|41861555|FG003|Double-blind Period|Voluntary Withdrawal|9|||
19499260|NCT02371980|41861556|FG004|Double-blind Period|Voluntary Withdrawal|11|||
19499261|NCT02371980|41861552|FG000|Double-blind Period|Relapse|0|||
19499262|NCT02371980|41861553|FG001|Double-blind Period|Relapse|50|||
19499263|NCT02371980|41861554|FG002|Double-blind Period|Relapse|25|||
19499264|NCT02371980|41861555|FG003|Double-blind Period|Relapse|25|||
19499265|NCT02371980|41861556|FG004|Double-blind Period|Relapse|26|||
19499266|NCT02371980|41861552|FG000|Double-blind Period|Reason not Specified|0|||
19499267|NCT02371980|41861553|FG001|Double-blind Period|Reason not Specified|3|||
19499268|NCT02371980|41861554|FG002|Double-blind Period|Reason not Specified|3|||
19499269|NCT02371980|41861555|FG003|Double-blind Period|Reason not Specified|2|||
19499270|NCT02371980|41861556|FG004|Double-blind Period|Reason not Specified|1|||
19499271|NCT02371980|41861552|FG000|Double-blind Period|Missing|0|||
19499272|NCT02371980|41861553|FG001|Double-blind Period|Missing|1|||
19499273|NCT02371980|41861554|FG002|Double-blind Period|Missing|0|||
19499274|NCT02371980|41861555|FG003|Double-blind Period|Missing|0|||
19499275|NCT02371980|41861556|FG004|Double-blind Period|Missing|0|||
19499276|NCT02371746|41861696|FG000|Overall Study|Consent withdrawn|0|||
19499277|NCT02371746|41861697|FG001|Overall Study|Consent withdrawn|0|||
19499278|NCT02371746|41861698|FG002|Overall Study|Consent withdrawn|0|||
19499279|NCT02371746|41861699|FG003|Overall Study|Consent withdrawn|0|||
19499280|NCT02371746|41861700|FG004|Overall Study|Consent withdrawn|0|||
19613791|NCT00950807|42062551|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19613792|NCT00950807|42062552|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19499281|NCT02371746|41861701|FG005|Overall Study|Consent withdrawn|0|||
19499282|NCT02371746|41861702|FG006|Overall Study|Consent withdrawn|1|||
19499283|NCT02421666|41861750|FG000|6-month Follow-up|Lost to Follow-up|8|||
19499284|NCT02421666|41861751|FG001|6-month Follow-up|Lost to Follow-up|7|||
19499285|NCT02421666|41861750|FG000|6-month Follow-up|Withdrawal by Subject|5|||
19613793|NCT00950807|42062553|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
19613794|NCT00950807|42062554|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
19613795|NCT00950807|42062555|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19613796|NCT00950807|42062556|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
19613797|NCT00950807|42062547|FG000|Washout Period 1|Adverse Event|2|||
19613798|NCT00950807|42062548|FG001|Washout Period 1|Adverse Event|0|||
19613799|NCT00950807|42062549|FG002|Washout Period 1|Adverse Event|0|||
19613800|NCT00950807|42062550|FG003|Washout Period 1|Adverse Event|1|||
19613801|NCT00950807|42062551|FG004|Washout Period 1|Adverse Event|1|||
19499286|NCT02421666|41861751|FG001|6-month Follow-up|Withdrawal by Subject|6|||
19499287|NCT02421666|41861750|FG000|12-month Follow-up|Lost to Follow-up|5|||
19499288|NCT02421666|41861751|FG001|12-month Follow-up|Lost to Follow-up|5|||
19499289|NCT02421666|41861750|FG000|12-month Follow-up|Withdrawal by Subject|6|||
19499290|NCT02421666|41861751|FG001|12-month Follow-up|Withdrawal by Subject|11|||
19499291|NCT02394756|41861761|FG000|Period 1|Lens Discomfort|0|||
19499292|NCT02394756|41861762|FG001|Period 1|Lens Discomfort|0|||
19499293|NCT02394756|41861763|FG002|Period 1|Lens Discomfort|0|||
19499294|NCT02394756|41861764|FG003|Period 1|Lens Discomfort|0|||
19499295|NCT02394756|41861765|FG004|Period 1|Lens Discomfort|0|||
19499296|NCT02394756|41861766|FG005|Period 1|Lens Discomfort|1|||
19499297|NCT02394756|41861761|FG000|Period 1|Withdrawal by Subject|0|||
19499298|NCT02394756|41861762|FG001|Period 1|Withdrawal by Subject|1|||
19499299|NCT02394756|41861763|FG002|Period 1|Withdrawal by Subject|1|||
19499300|NCT02394756|41861764|FG003|Period 1|Withdrawal by Subject|1|||
19499301|NCT02394756|41861765|FG004|Period 1|Withdrawal by Subject|0|||
19499302|NCT02394756|41861766|FG005|Period 1|Withdrawal by Subject|0|||
19499303|NCT02394756|41861761|FG000|Period 2|Unsatisfactory Visual Response|0|||
19613802|NCT00950807|42062552|FG005|Washout Period 1|Adverse Event|0|||
19613803|NCT00950807|42062553|FG006|Washout Period 1|Adverse Event|0|||
19499304|NCT02394756|41861762|FG001|Period 2|Unsatisfactory Visual Response|0|||
19499305|NCT02394756|41861763|FG002|Period 2|Unsatisfactory Visual Response|0|||
19499306|NCT02394756|41861764|FG003|Period 2|Unsatisfactory Visual Response|0|||
19499307|NCT02394756|41861765|FG004|Period 2|Unsatisfactory Visual Response|1|||
19499308|NCT02394756|41861766|FG005|Period 2|Unsatisfactory Visual Response|0|||
19499309|NCT02370888|41861787|FG000|Overall Study|disease progression|2|||
19499310|NCT02370888|41861787|FG000|Overall Study|did not meet chimerism criteria|6|||
19499311|NCT02394600|41861811|FG000|Overall Study|Adverse Event|3|||
19499312|NCT02394600|41861812|FG001|Overall Study|Adverse Event|0|||
19499313|NCT02394600|41861811|FG000|Overall Study|Lost to Follow-up|0|||
19499314|NCT02394600|41861812|FG001|Overall Study|Lost to Follow-up|1|||
19499315|NCT02394600|41861811|FG000|Overall Study|Withdrawal by Subject|0|||
19499316|NCT02394600|41861812|FG001|Overall Study|Withdrawal by Subject|1|||
19499317|NCT02394600|41861811|FG000|Overall Study|Protocol Violation|1|||
19499318|NCT02394600|41861812|FG001|Overall Study|Protocol Violation|0|||
19499319|NCT04685499|41861828|FG000|Overall Study|Study Terminated Early|1|||
19499320|NCT02421588|41861904|FG000|Overall Study|Non-treatment-related AE|8|||
19499321|NCT02421588|41861905|FG001|Overall Study|Non-treatment-related AE|8|||
19499322|NCT02421588|41861904|FG000|Overall Study|Progressive disease|152|||
19499323|NCT02421588|41861905|FG001|Overall Study|Progressive disease|135|||
19499324|NCT02421588|41861904|FG000|Overall Study|Death|11|||
19499325|NCT02421588|41861905|FG001|Overall Study|Death|3|||
19499326|NCT02421588|41861904|FG000|Overall Study|Physician Decision|8|||
19499327|NCT02421588|41861905|FG001|Overall Study|Physician Decision|17|||
19499328|NCT02421588|41861904|FG000|Overall Study|Other reason not specified|3|||
19499329|NCT02421588|41861905|FG001|Overall Study|Other reason not specified|1|||
19499330|NCT02421588|41861904|FG000|Overall Study|Symptomatic deterioration|13|||
19499331|NCT02421588|41861905|FG001|Overall Study|Symptomatic deterioration|19|||
19499332|NCT02421588|41861904|FG000|Overall Study|Treatment-related AE|10|||
19499333|NCT02421588|41861905|FG001|Overall Study|Treatment-related AE|14|||
19499334|NCT02421588|41861904|FG000|Overall Study|Withdrawal by Subject|14|||
19499335|NCT02421588|41861905|FG001|Overall Study|Withdrawal by Subject|16|||
19499336|NCT02421588|41861904|FG000|Overall Study|Not treated|2|||
19499337|NCT02421588|41861905|FG001|Overall Study|Not treated|8|||
19499338|NCT02421510|41861914|FG000|Overall Study|Other|4|||
19499339|NCT02421510|41861915|FG001|Overall Study|Other|2|||
19499340|NCT02421510|41861916|FG002|Overall Study|Other|3|||
19499341|NCT02421510|41861914|FG000|Overall Study|Protocol Violation|1|||
19499342|NCT02421510|41861915|FG001|Overall Study|Protocol Violation|2|||
19613804|NCT00950807|42062554|FG007|Washout Period 1|Adverse Event|0|||
19613805|NCT00950807|42062555|FG008|Washout Period 1|Adverse Event|0|||
19613806|NCT00950807|42062556|FG009|Washout Period 1|Adverse Event|0|||
19499343|NCT02421510|41861916|FG002|Overall Study|Protocol Violation|0|||
19499344|NCT02421510|41861914|FG000|Overall Study|Death|1|||
19499345|NCT02421510|41861915|FG001|Overall Study|Death|0|||
19499346|NCT02421510|41861916|FG002|Overall Study|Death|0|||
19499347|NCT02421510|41861914|FG000|Overall Study|Noncompliance with study drug|1|||
19499348|NCT02421510|41861915|FG001|Overall Study|Noncompliance with study drug|0|||
19499349|NCT02421510|41861916|FG002|Overall Study|Noncompliance with study drug|0|||
19499350|NCT02421510|41861914|FG000|Overall Study|Physician Decision|1|||
19499351|NCT02421510|41861915|FG001|Overall Study|Physician Decision|1|||
19499352|NCT02421510|41861916|FG002|Overall Study|Physician Decision|3|||
19499353|NCT02421510|41861914|FG000|Overall Study|Adverse Event|9|||
19499354|NCT02421510|41861915|FG001|Overall Study|Adverse Event|10|||
19499355|NCT02421510|41861916|FG002|Overall Study|Adverse Event|18|||
19499356|NCT02421510|41861914|FG000|Overall Study|Pregnancy|1|||
19499357|NCT02421510|41861915|FG001|Overall Study|Pregnancy|1|||
19499358|NCT02421510|41861916|FG002|Overall Study|Pregnancy|0|||
19499359|NCT02421510|41861914|FG000|Overall Study|Withdrawal by Subject|14|||
19499360|NCT02421510|41861915|FG001|Overall Study|Withdrawal by Subject|18|||
19499361|NCT02421510|41861916|FG002|Overall Study|Withdrawal by Subject|12|||
19499362|NCT02421510|41861914|FG000|Overall Study|Lost to Follow-up|1|||
19499363|NCT02421510|41861915|FG001|Overall Study|Lost to Follow-up|1|||
19499364|NCT02421510|41861916|FG002|Overall Study|Lost to Follow-up|0|||
19499365|NCT00552617|41861934|FG000|Overall Study|Not Treated|0|||
19499366|NCT00552617|41861935|FG001|Overall Study|Not Treated|0|||
19499367|NCT00552617|41861936|FG002|Overall Study|Not Treated|1|||
19499368|NCT00552617|41861937|FG003|Overall Study|Not Treated|0|||
19499369|NCT00552617|41861938|FG004|Overall Study|Not Treated|0|||
19499370|NCT00552617|41861939|FG005|Overall Study|Not Treated|0|||
19499371|NCT00552617|41861940|FG006|Overall Study|Not Treated|0|||
19499372|NCT00552617|41861941|FG007|Overall Study|Not Treated|0|||
19499373|NCT00552617|41861942|FG008|Overall Study|Not Treated|0|||
19499374|NCT00552617|41861943|FG009|Overall Study|Not Treated|1|||
19499375|NCT00552617|41861934|FG000|Overall Study|Lost to Follow-up|0|||
19499376|NCT00552617|41861935|FG001|Overall Study|Lost to Follow-up|0|||
19499377|NCT00552617|41861936|FG002|Overall Study|Lost to Follow-up|0|||
19499378|NCT00552617|41861937|FG003|Overall Study|Lost to Follow-up|1|||
19499379|NCT00552617|41861938|FG004|Overall Study|Lost to Follow-up|0|||
19499380|NCT00552617|41861939|FG005|Overall Study|Lost to Follow-up|2|||
19499381|NCT00552617|41861940|FG006|Overall Study|Lost to Follow-up|0|||
19499382|NCT00552617|41861941|FG007|Overall Study|Lost to Follow-up|0|||
19499383|NCT00552617|41861942|FG008|Overall Study|Lost to Follow-up|2|||
19499384|NCT00552617|41861943|FG009|Overall Study|Lost to Follow-up|0|||
19499385|NCT02421120|41861965|FG000|Overall Study|Adverse Event|1|||
19499386|NCT02420262|41861971|FG000|Overall Study|Adverse Event|1|||
19499387|NCT02420262|41861972|FG001|Overall Study|Adverse Event|0|||
19499388|NCT02420262|41861971|FG000|Overall Study|Withdrawal by Subject|1|||
19499389|NCT02420262|41861972|FG001|Overall Study|Withdrawal by Subject|4|||
19499390|NCT02420262|41861971|FG000|Overall Study|Unclassified|0|||
19499391|NCT02420262|41861972|FG001|Overall Study|Unclassified|1|||
19499392|NCT00552305|41861978|FG000|Overall Study|Adverse Event|43|||
19499393|NCT00552305|41861978|FG000|Overall Study|Lack of Efficacy|120|||
19499394|NCT00552305|41861978|FG000|Overall Study|Lost to Follow-up|4|||
19499395|NCT00552305|41861978|FG000|Overall Study|Protocol Violation|3|||
19499396|NCT00552305|41861978|FG000|Overall Study|Withdrawal by Subject|44|||
19499397|NCT00552305|41861978|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
19499398|NCT00552305|41861978|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
19499399|NCT00552305|41861978|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
19499400|NCT00552305|41861978|FG000|Overall Study|Unsatisfactory compliance|11|||
19499401|NCT00552305|41861978|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
19499402|NCT00552305|41861978|FG000|Overall Study|AE/Other: prohibited drug required|1|||
19499403|NCT00552305|41861978|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
19499404|NCT00552305|41861978|FG000|Overall Study|Other: Site closed|4|||
19499405|NCT00552305|41861978|FG000|Overall Study|Other: Personal problems|1|||
19499406|NCT00552305|41861978|FG000|Overall Study|Other: Unable to attend visits|1|||
19499407|NCT00552305|41861978|FG000|Overall Study|Other: Subject underwent surgery|4|||
19499408|NCT00552305|41861978|FG000|Overall Study|Other: Subject became pregnant|1|||
19499409|NCT00552305|41861978|FG000|Overall Study|Other: Health problems, not drug related|1|||
19499410|NCT00552305|41861978|FG000|Overall Study|Other: Subject moved from area|2|||
19499411|NCT00552305|41861978|FG000|Overall Study|Other: Subject incarcerated|1|||
19499412|NCT00552305|41861978|FG000|Overall Study|Other: Subject went to rehab|1|||
19499413|NCT00552071|41862004|FG000|Overall Study|Adverse Event|1|||
19499414|NCT00552071|41862005|FG001|Overall Study|Adverse Event|0|||
19499415|NCT00552071|41862004|FG000|Overall Study|Lack of Efficacy|1|||
19499416|NCT00552071|41862005|FG001|Overall Study|Lack of Efficacy|0|||
19499417|NCT00552071|41862004|FG000|Overall Study|Physician Decision|1|||
19499418|NCT00552071|41862005|FG001|Overall Study|Physician Decision|0|||
19499419|NCT00552071|41862004|FG000|Overall Study|Pregnancy|1|||
19499420|NCT00552071|41862005|FG001|Overall Study|Pregnancy|0|||
19499421|NCT00552071|41862004|FG000|Overall Study|Death|0|||
19499422|NCT00552071|41862005|FG001|Overall Study|Death|1|||
19499423|NCT00552071|41862004|FG000|Overall Study|Withdrawal by Subject|0|||
19499424|NCT00552071|41862005|FG001|Overall Study|Withdrawal by Subject|1|||
19499425|NCT00551759|41862013|FG000|Overall Study|Adverse Event|7|||
19499426|NCT00551759|41862013|FG000|Overall Study|Death|5|||
19499427|NCT00551759|41862013|FG000|Overall Study|Ineligible|1|||
19499428|NCT00551525|41862017|FG000|Overall Study|Protocol Violation|5|||
19499429|NCT02370498|41862044|FG000|Overall Study|Adverse Event|10|||
19499430|NCT02370498|41862045|FG001|Overall Study|Adverse Event|8|||
19499431|NCT02370498|41862044|FG000|Overall Study|Death|263|||
19499432|NCT02370498|41862045|FG001|Overall Study|Death|265|||
19499433|NCT02370498|41862044|FG000|Overall Study|Protocol Violation|1|||
19499434|NCT02370498|41862045|FG001|Overall Study|Protocol Violation|2|||
19499435|NCT02370498|41862044|FG000|Overall Study|Withdrawal by Subject|7|||
19499436|NCT02370498|41862045|FG001|Overall Study|Withdrawal by Subject|12|||
19499437|NCT02370498|41862044|FG000|Overall Study|Sponsor's decision|15|||
19499438|NCT02370498|41862045|FG001|Overall Study|Sponsor's decision|9|||
19499439|NCT02347332|41862070|FG000|Overall Study|Not treated|5|||
19499440|NCT02347332|41862071|FG001|Overall Study|Not treated|2|||
19499441|NCT02347332|41862070|FG000|Overall Study|Progressive disease|141|||
19499442|NCT02347332|41862071|FG001|Overall Study|Progressive disease|159|||
19499443|NCT02347332|41862070|FG000|Overall Study|Adverse Event|50|||
19499444|NCT02347332|41862071|FG001|Overall Study|Adverse Event|41|||
19499445|NCT02347332|41862070|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
19499446|NCT02347332|41862071|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
19499447|NCT02347332|41862070|FG000|Overall Study|Protocol Violation|1|||
19499448|NCT02347332|41862071|FG001|Overall Study|Protocol Violation|1|||
19499449|NCT02347332|41862070|FG000|Overall Study|Lost to Follow-up|2|||
19499450|NCT02347332|41862071|FG001|Overall Study|Lost to Follow-up|1|||
19499451|NCT02347332|41862070|FG000|Overall Study|Physician Decision|4|||
19499452|NCT02347332|41862071|FG001|Overall Study|Physician Decision|3|||
19499453|NCT02347332|41862070|FG000|Overall Study|Withdrawal by Subject|20|||
19499454|NCT02347332|41862071|FG001|Overall Study|Withdrawal by Subject|14|||
19499455|NCT02347332|41862070|FG000|Overall Study|Protocol requirement|1|||
19499456|NCT02347332|41862071|FG001|Overall Study|Protocol requirement|1|||
19499457|NCT02347332|41862070|FG000|Overall Study|Switch Post-Trial program|0|||
19499458|NCT02347332|41862071|FG001|Overall Study|Switch Post-Trial program|1|||
19499459|NCT02347176|41862094|FG000|Overall Study|Lost to Follow-up|2|||
19499460|NCT02347176|41862095|FG001|Overall Study|Lost to Follow-up|3|||
19499461|NCT02347176|41862096|FG002|Overall Study|Lost to Follow-up|1|||
19499462|NCT02347176|41862097|FG003|Overall Study|Lost to Follow-up|1|||
19499463|NCT02347176|41862094|FG000|Overall Study|Withdrawal by Subject|9|||
19499464|NCT02347176|41862095|FG001|Overall Study|Withdrawal by Subject|5|||
19499465|NCT02347176|41862096|FG002|Overall Study|Withdrawal by Subject|5|||
19499466|NCT02347176|41862097|FG003|Overall Study|Withdrawal by Subject|3|||
19499467|NCT02347176|41862094|FG000|Overall Study|Other|1|||
19499468|NCT02347176|41862095|FG001|Overall Study|Other|2|||
19499469|NCT02347176|41862096|FG002|Overall Study|Other|2|||
19499470|NCT02347176|41862097|FG003|Overall Study|Other|0|||
19499471|NCT02370420|41862109|FG000|Overall Study|Physician Decision|3|||
19499472|NCT02370420|41862110|FG001|Overall Study|Physician Decision|3|||
19499473|NCT02370420|41862109|FG000|Overall Study|Lost to Follow-up|11|||
19499474|NCT02370420|41862110|FG001|Overall Study|Lost to Follow-up|9|||
19499475|NCT02347098|41862132|FG000|Overall Study|Death|1|||
19499476|NCT02347098|41862133|FG001|Overall Study|Death|0|||
19499477|NCT02347098|41862132|FG000|Overall Study|Withdrawal by Subject|1|||
19499478|NCT02347098|41862133|FG001|Overall Study|Withdrawal by Subject|0|||
19499479|NCT02347098|41862132|FG000|Overall Study|Lost to Follow-up|2|||
19499480|NCT02347098|41862133|FG001|Overall Study|Lost to Follow-up|2|||
19499481|NCT02347098|41862132|FG000|Overall Study|Refuse Follow-up Visit|1|||
19499482|NCT02347098|41862133|FG001|Overall Study|Refuse Follow-up Visit|5|||
19499483|NCT02347098|41862132|FG000|Overall Study|no visit due to illness|2|||
19499484|NCT02347098|41862133|FG001|Overall Study|no visit due to illness|1|||
19499485|NCT02346708|41862150|FG000|Overall Study|Adverse Event|2|||
19499486|NCT02346708|41862151|FG001|Overall Study|Adverse Event|0|||
19499487|NCT02346708|41862150|FG000|Overall Study|Protocol Violation|0|||
19499488|NCT02346708|41862151|FG001|Overall Study|Protocol Violation|1|||
19499489|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499490|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
19499491|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
19499492|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
19499493|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499494|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499495|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499496|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499497|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499498|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19613807|NCT00950807|42062547|FG000|Treatment Period 2|Lack of Efficacy|1|||
19499499|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499500|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19704423|NCT00166296|42148766|FG001|Overall Study|Adverse Event|4|||
19704424|NCT00166296|42148765|FG000|Overall Study|Lost to Follow-up|4|||
19499501|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499502|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499503|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499504|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499505|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499506|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499507|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499508|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499509|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499510|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499511|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499512|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
19499513|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499514|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
19499515|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499516|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499517|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499518|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499519|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499520|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499521|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499522|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499523|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499524|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499525|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499526|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499527|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499528|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499529|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499530|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499531|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499532|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499533|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499534|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499535|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499536|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
19499537|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499538|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
19499539|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499540|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499541|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499542|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499543|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499544|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499545|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499546|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499547|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499548|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499549|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499550|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499551|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499552|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499553|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499554|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499555|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499556|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499557|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499558|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499559|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499560|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
19499561|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
19499562|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
19499563|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
19499564|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
19499565|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499566|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499567|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499568|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499569|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499570|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499571|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499572|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499573|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499574|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499575|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499576|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499577|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499578|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499579|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499580|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499581|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499582|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19613808|NCT00950807|42062548|FG001|Treatment Period 2|Lack of Efficacy|0|||
19613809|NCT00950807|42062549|FG002|Treatment Period 2|Lack of Efficacy|0|||
19499583|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499584|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
19499585|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
19499586|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
19499587|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
19499588|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
19499589|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499590|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499591|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499592|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499593|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499594|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19613810|NCT00950807|42062550|FG003|Treatment Period 2|Lack of Efficacy|0|||
19613811|NCT00950807|42062551|FG004|Treatment Period 2|Lack of Efficacy|0|||
19613812|NCT00950807|42062552|FG005|Treatment Period 2|Lack of Efficacy|0|||
19613813|NCT00950807|42062553|FG006|Treatment Period 2|Lack of Efficacy|0|||
19613814|NCT00950807|42062554|FG007|Treatment Period 2|Lack of Efficacy|0|||
19613815|NCT00950807|42062555|FG008|Treatment Period 2|Lack of Efficacy|0|||
19613816|NCT00950807|42062556|FG009|Treatment Period 2|Lack of Efficacy|0|||
19613817|NCT00950807|42062547|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19613818|NCT00950807|42062548|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19613819|NCT00950807|42062549|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19613820|NCT00950807|42062550|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19613821|NCT00950807|42062551|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19613822|NCT00950807|42062552|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19613823|NCT00950807|42062553|FG006|Treatment Period 2|Withdrawal by Subject|1|||
19613824|NCT00950807|42062554|FG007|Treatment Period 2|Withdrawal by Subject|2|||
19613825|NCT00950807|42062555|FG008|Treatment Period 2|Withdrawal by Subject|0|||
19613826|NCT00950807|42062556|FG009|Treatment Period 2|Withdrawal by Subject|0|||
19613827|NCT00950807|42062547|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
19613828|NCT00950807|42062548|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613829|NCT00950807|42062549|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613830|NCT00950807|42062550|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613831|NCT00950807|42062551|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613832|NCT00950807|42062552|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19704425|NCT00166296|42148766|FG001|Overall Study|Lost to Follow-up|2|||
19499595|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499596|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499597|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499598|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499599|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499600|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499601|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499602|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499603|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499604|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499605|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499606|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499607|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499608|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
19499609|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499610|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
19499611|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499612|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
19499613|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499614|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499615|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499616|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499617|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499618|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499619|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499620|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499621|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499622|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499623|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499624|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499625|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499626|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499627|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499628|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499629|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499630|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499631|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499632|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
19499633|NCT02346240|41862641|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499634|NCT02346240|41862642|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499635|NCT02346240|41862643|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
19499636|NCT02346240|41862644|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499637|NCT02346240|41862645|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499638|NCT02346240|41862646|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499639|NCT02346240|41862647|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499640|NCT02346240|41862648|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499641|NCT02346240|41862649|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499642|NCT02346240|41862650|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499643|NCT02346240|41862651|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499644|NCT02346240|41862652|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499645|NCT02346240|41862653|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499646|NCT02346240|41862654|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499647|NCT02346240|41862655|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499648|NCT02346240|41862656|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499649|NCT02346240|41862657|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499650|NCT02346240|41862658|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19613833|NCT00950807|42062553|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613834|NCT00950807|42062554|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19499651|NCT02346240|41862659|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499652|NCT02346240|41862660|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499653|NCT02346240|41862661|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499654|NCT02346240|41862662|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499655|NCT02346240|41862663|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499656|NCT02346240|41862664|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
19499657|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19613835|NCT00950807|42062555|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613836|NCT00950807|42062556|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19613837|NCT00950807|42062547|FG000|Treatment Period 2|Adverse Event|0|||
19613838|NCT00950807|42062548|FG001|Treatment Period 2|Adverse Event|1|||
19613839|NCT00950807|42062549|FG002|Treatment Period 2|Adverse Event|0|||
19613840|NCT00950807|42062550|FG003|Treatment Period 2|Adverse Event|1|||
19613841|NCT00950807|42062551|FG004|Treatment Period 2|Adverse Event|0|||
19613842|NCT00950807|42062552|FG005|Treatment Period 2|Adverse Event|1|||
19613843|NCT00950807|42062553|FG006|Treatment Period 2|Adverse Event|0|||
19613844|NCT00950807|42062554|FG007|Treatment Period 2|Adverse Event|1|||
19613845|NCT00950807|42062555|FG008|Treatment Period 2|Adverse Event|0|||
19613846|NCT00950807|42062556|FG009|Treatment Period 2|Adverse Event|0|||
19613847|NCT00950807|42062547|FG000|Washout Period 2|Lack of Efficacy|1|||
19613848|NCT00950807|42062548|FG001|Washout Period 2|Lack of Efficacy|0|||
19499658|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499659|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499660|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499661|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499662|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499663|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499664|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
19499665|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
19499666|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499667|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499668|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499669|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499670|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
19499671|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
19499672|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
19499673|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
19613849|NCT00950807|42062549|FG002|Washout Period 2|Lack of Efficacy|0|||
19613850|NCT00950807|42062550|FG003|Washout Period 2|Lack of Efficacy|0|||
19499674|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499675|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499676|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499677|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499678|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499679|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499680|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19499681|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499682|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499683|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499684|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499685|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499686|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499687|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499688|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499689|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499690|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499691|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499692|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499693|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499694|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
19499695|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499696|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
19499697|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499698|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499699|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499700|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499701|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499702|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499703|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499704|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19499705|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499706|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499707|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499708|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499709|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499710|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499711|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499712|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499713|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499714|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499715|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499716|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499717|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499718|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499719|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
19499720|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499721|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499722|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499723|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499724|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499725|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499726|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499727|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499728|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19499729|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499730|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499731|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499732|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499733|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499734|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499735|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499736|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499737|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499738|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499739|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499740|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
19499741|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499742|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
19499743|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
19499744|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
19499745|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19499746|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499747|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499748|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499749|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499750|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499751|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499752|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19499753|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499754|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499755|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499756|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499757|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499758|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499759|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499760|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499761|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499762|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499763|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499764|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499765|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499766|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
19499767|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
19499768|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
19499769|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
19499770|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499771|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499772|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499773|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499774|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499775|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499776|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19499777|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499778|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499779|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499780|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499781|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499782|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499783|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
19499784|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499785|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499786|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499787|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499788|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499789|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499790|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499791|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499792|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499793|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499794|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499795|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499796|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499797|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499798|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499799|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19613851|NCT00950807|42062551|FG004|Washout Period 2|Lack of Efficacy|0|||
19613852|NCT00950807|42062552|FG005|Washout Period 2|Lack of Efficacy|0|||
19613853|NCT00950807|42062553|FG006|Washout Period 2|Lack of Efficacy|0|||
19613854|NCT00950807|42062554|FG007|Washout Period 2|Lack of Efficacy|0|||
19613855|NCT00950807|42062555|FG008|Washout Period 2|Lack of Efficacy|0|||
19613856|NCT00950807|42062556|FG009|Washout Period 2|Lack of Efficacy|0|||
19613857|NCT00950807|42062547|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613858|NCT00950807|42062548|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
19613859|NCT00950807|42062549|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613860|NCT00950807|42062550|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613861|NCT00950807|42062551|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
19613862|NCT00950807|42062552|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613863|NCT00950807|42062553|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
19499800|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
19499801|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499802|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499803|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499804|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499805|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499806|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499807|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499808|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499809|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
19613864|NCT00950807|42062554|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
19613865|NCT00950807|42062555|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613866|NCT00950807|42062556|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
19613867|NCT00950807|42062547|FG000|Washout Period 2|Adverse Event|3|||
19613868|NCT00950807|42062548|FG001|Washout Period 2|Adverse Event|0|||
19613869|NCT00950807|42062549|FG002|Washout Period 2|Adverse Event|0|||
19613870|NCT00950807|42062550|FG003|Washout Period 2|Adverse Event|1|||
19613871|NCT00950807|42062551|FG004|Washout Period 2|Adverse Event|0|||
19499810|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499811|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19613872|NCT00950807|42062552|FG005|Washout Period 2|Adverse Event|0|||
19613873|NCT00950807|42062553|FG006|Washout Period 2|Adverse Event|0|||
19613874|NCT00950807|42062554|FG007|Washout Period 2|Adverse Event|0|||
19613875|NCT00950807|42062555|FG008|Washout Period 2|Adverse Event|0|||
19613876|NCT00950807|42062556|FG009|Washout Period 2|Adverse Event|0|||
19613877|NCT00950807|42062547|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19613878|NCT00950807|42062548|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19613879|NCT00950807|42062549|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19613880|NCT00950807|42062550|FG003|Treatment Period 3|Withdrawal by Subject|0|||
19613881|NCT00950807|42062551|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19613882|NCT00950807|42062552|FG005|Treatment Period 3|Withdrawal by Subject|0|||
19613883|NCT00950807|42062553|FG006|Treatment Period 3|Withdrawal by Subject|0|||
19613884|NCT00950807|42062554|FG007|Treatment Period 3|Withdrawal by Subject|0|||
19613885|NCT00950807|42062555|FG008|Treatment Period 3|Withdrawal by Subject|0|||
19613886|NCT00950807|42062556|FG009|Treatment Period 3|Withdrawal by Subject|1|||
19613887|NCT00950807|42062547|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
19613888|NCT00950807|42062548|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613889|NCT00950807|42062549|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613890|NCT00950807|42062550|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613891|NCT00950807|42062551|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613892|NCT00950807|42062552|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613893|NCT00950807|42062553|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613894|NCT00950807|42062554|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
19499812|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
19499813|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499814|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
19499815|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
19499816|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499817|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19613895|NCT00950807|42062555|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613896|NCT00950807|42062556|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19613897|NCT00950807|42062547|FG000|Treatment Period 3|Adverse Event|0|||
19613898|NCT00950807|42062548|FG001|Treatment Period 3|Adverse Event|0|||
19613899|NCT00950807|42062549|FG002|Treatment Period 3|Adverse Event|0|||
19613900|NCT00950807|42062550|FG003|Treatment Period 3|Adverse Event|0|||
19613901|NCT00950807|42062551|FG004|Treatment Period 3|Adverse Event|0|||
19613902|NCT00950807|42062552|FG005|Treatment Period 3|Adverse Event|0|||
19613903|NCT00950807|42062553|FG006|Treatment Period 3|Adverse Event|1|||
19613904|NCT00950807|42062554|FG007|Treatment Period 3|Adverse Event|0|||
19613905|NCT00950807|42062555|FG008|Treatment Period 3|Adverse Event|0|||
19613906|NCT00950807|42062556|FG009|Treatment Period 3|Adverse Event|0|||
19613907|NCT00797511|42062578|FG000|Overall Study|Withdrawal by Subject|1|||
19613908|NCT00608881|42062585|FG000|Overall Study|Death|22|||
19613909|NCT00608881|42062586|FG001|Overall Study|Death|13|||
19613910|NCT00608881|42062585|FG000|Overall Study|Adverse Event|5|||
19613911|NCT00608881|42062586|FG001|Overall Study|Adverse Event|3|||
19613912|NCT00608881|42062585|FG000|Overall Study|Lost to Follow-up|28|||
19613913|NCT00608881|42062586|FG001|Overall Study|Lost to Follow-up|14|||
19613914|NCT00608881|42062585|FG000|Overall Study|Withdrawal by Subject|18|||
19613915|NCT00608881|42062586|FG001|Overall Study|Withdrawal by Subject|29|||
19613916|NCT00608881|42062585|FG000|Overall Study|Physician Decision|5|||
19613917|NCT00608881|42062586|FG001|Overall Study|Physician Decision|5|||
19613918|NCT00608881|42062585|FG000|Overall Study|Institutionalized|1|||
19613919|NCT00608881|42062586|FG001|Overall Study|Institutionalized|2|||
19613920|NCT00945191|42062592|FG000|Overall Study|Did not achieve a complete response|18|||
19613921|NCT00945191|42062592|FG000|Overall Study|Participant relocated to another state|1|||
19613922|NCT00945191|42062592|FG000|Overall Study|Disease progression|3|||
19613923|NCT00945191|42062592|FG000|Overall Study|Serious adverse event or adverse event|1|||
19613924|NCT00945191|42062592|FG000|Overall Study|Investigator's discretion|1|||
19613925|NCT00606931|42062596|FG000|Overall Study|Withdrawal by Subject|3|||
19613926|NCT00792909|42062603|FG000|Overall Study|Withdrawal by Subject|0|||
19613927|NCT00792909|42062604|FG001|Overall Study|Withdrawal by Subject|1|||
19613928|NCT00792909|42062605|FG002|Overall Study|Withdrawal by Subject|0|||
19613929|NCT00944645|42062616|FG000|Period 2|Adverse Event|1|||
19613930|NCT00944645|42062617|FG001|Period 2|Adverse Event|0|||
19613931|NCT00944645|42062616|FG000|Period 2|Lost to Follow-up|0|||
19613932|NCT00944645|42062617|FG001|Period 2|Lost to Follow-up|3|||
19613933|NCT00944645|42062616|FG000|Period 2|Withdrawal by Subject|7|||
19499818|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499819|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499820|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499821|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499822|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499823|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19499824|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
19613934|NCT00944645|42062617|FG001|Period 2|Withdrawal by Subject|6|||
19613935|NCT00606229|42062623|FG000|Overall Study|Adverse Event|11|||
19613936|NCT00606229|42062623|FG000|Overall Study|Lack of Efficacy|1|||
19613937|NCT00606229|42062623|FG000|Overall Study|Withdrawal by Subject|4|||
19613938|NCT00606229|42062623|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
19613939|NCT00606229|42062623|FG000|Overall Study|change of residence or other commitments|2|||
19613940|NCT00950651|42062629|FG000|Overall Study|Adverse Event|17|||
19613941|NCT00950651|42062630|FG001|Overall Study|Adverse Event|20|||
19613942|NCT00950651|42062629|FG000|Overall Study|Death|1|||
19613943|NCT00950651|42062630|FG001|Overall Study|Death|0|||
19613944|NCT00950651|42062629|FG000|Overall Study|Lack of Efficacy|2|||
19613945|NCT00950651|42062630|FG001|Overall Study|Lack of Efficacy|2|||
19613946|NCT00950651|42062629|FG000|Overall Study|Protocol Violation|3|||
19613947|NCT00950651|42062630|FG001|Overall Study|Protocol Violation|4|||
19499825|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499826|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499827|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499828|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499829|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499830|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19613948|NCT00950651|42062629|FG000|Overall Study|Withdrawal by Subject|8|||
19613949|NCT00950651|42062630|FG001|Overall Study|Withdrawal by Subject|9|||
19613950|NCT00605293|42062638|FG000|Overall Study|Death|2|||
19613951|NCT00605293|42062639|FG001|Overall Study|Death|1|||
19613952|NCT00605293|42062638|FG000|Overall Study|Insufficient Therapeutic Response|2|||
19613953|NCT00605293|42062639|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19613954|NCT00605293|42062638|FG000|Overall Study|Adverse Event|1|||
19613955|NCT00605293|42062639|FG001|Overall Study|Adverse Event|0|||
19613956|NCT00605293|42062638|FG000|Overall Study|Holidays Dialysis Out|1|||
19613957|NCT00605293|42062639|FG001|Overall Study|Holidays Dialysis Out|0|||
19613958|NCT00605293|42062638|FG000|Overall Study|Blood Transfusion|7|||
19613959|NCT00605293|42062639|FG001|Overall Study|Blood Transfusion|1|||
19613960|NCT00605293|42062638|FG000|Overall Study|Renal Transplantation|3|||
19613961|NCT00605293|42062639|FG001|Overall Study|Renal Transplantation|1|||
19613962|NCT00605293|42062638|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
19613963|NCT00605293|42062639|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
19613964|NCT00605293|42062638|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
19613965|NCT00605293|42062639|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
19613966|NCT00605293|42062638|FG000|Overall Study|Principal Investigator Decision|0|||
19613967|NCT00605293|42062639|FG001|Overall Study|Principal Investigator Decision|1|||
19499831|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499832|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499833|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499834|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
19499835|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499836|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499837|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499838|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499839|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499840|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499841|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499842|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499843|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499844|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499845|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499846|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499847|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499848|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
19499849|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499850|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499851|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499852|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499853|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499854|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499855|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499856|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499857|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499858|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499859|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
19499860|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499861|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499862|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499863|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499864|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499865|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499866|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499867|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499868|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499869|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499870|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499871|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499872|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
19499873|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499874|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499875|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499876|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499877|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499878|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499879|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499880|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499881|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19613968|NCT00572533|42062647|FG000|Overall Study|Death|4|||
19613969|NCT00572533|42062648|FG001|Overall Study|Death|1|||
19613970|NCT00572533|42062647|FG000|Overall Study|Received Kidney Transplant|2|||
19613971|NCT00572533|42062648|FG001|Overall Study|Received Kidney Transplant|1|||
19613972|NCT00572533|42062647|FG000|Overall Study|Social Issues|1|||
19613973|NCT00572533|42062648|FG001|Overall Study|Social Issues|0|||
19613974|NCT00572533|42062647|FG000|Overall Study|Transfer out of Facility|0|||
19613975|NCT00572533|42062648|FG001|Overall Study|Transfer out of Facility|1|||
19613976|NCT00949715|42062656|FG000|Overall Study|Physician Decision|1|||
19613977|NCT00949715|42062657|FG001|Overall Study|Physician Decision|0|||
19613978|NCT00949715|42062656|FG000|Overall Study|Lost to Follow-up|1|||
19613979|NCT00949715|42062657|FG001|Overall Study|Lost to Follow-up|0|||
19613980|NCT00949715|42062656|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
19613981|NCT00949715|42062657|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
19613982|NCT00791661|42062665|FG000|7 Day Wash-out|Adverse Event|0|||
19613983|NCT00791661|42062666|FG001|7 Day Wash-out|Adverse Event|0|||
19613984|NCT00791661|42062667|FG002|7 Day Wash-out|Adverse Event|1|||
19613985|NCT00791661|42062665|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
19613986|NCT00791661|42062666|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
19613987|NCT00791661|42062667|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
19613988|NCT00943787|42062691|FG000|Overall Study|Physician Decision|4|||
19613989|NCT00943787|42062691|FG000|Overall Study|Withdrawal by Subject|3|||
19613990|NCT00949325|42062695|FG000|Overall Study|Adverse Event|0|||
19499882|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499883|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499884|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499885|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499886|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499887|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
19613991|NCT00949325|42062696|FG001|Overall Study|Adverse Event|2|||
19613992|NCT00949325|42062697|FG002|Overall Study|Adverse Event|0|||
19499888|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499889|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499890|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499891|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499892|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19613993|NCT00943319|42062713|FG000|Overall Study|Death|1|||
19499893|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19613994|NCT00790647|42062717|FG000|Overall Study|Adverse Event|1|||
19613995|NCT00790569|42062726|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
19613996|NCT00790569|42062727|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
19613997|NCT00790569|42062728|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
19613998|NCT00790569|42062726|FG000|End of Treatment (6 Month Interview)|Death|0|||
19613999|NCT00790569|42062727|FG001|End of Treatment (6 Month Interview)|Death|2|||
19614000|NCT00790569|42062728|FG002|End of Treatment (6 Month Interview)|Death|1|||
19614001|NCT00790569|42062726|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
19614002|NCT00790569|42062727|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
19614003|NCT00790569|42062728|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
19614004|NCT00790569|42062726|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
19614005|NCT00790569|42062727|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
19614006|NCT00790569|42062728|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
19614007|NCT00790569|42062726|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
19499894|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499895|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19499896|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
19614008|NCT00790569|42062727|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
19614009|NCT00790569|42062728|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
19614010|NCT00790569|42062726|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
19614011|NCT00790569|42062727|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
19614012|NCT00790569|42062728|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
19614013|NCT00939029|42062738|FG000|Overall Study|Withdrawal by Subject|3|||
19614014|NCT00939029|42062739|FG001|Overall Study|Withdrawal by Subject|7|||
19614015|NCT00939029|42062738|FG000|Overall Study|Lost to Follow-up|3|||
19614016|NCT00939029|42062739|FG001|Overall Study|Lost to Follow-up|4|||
19614017|NCT00939029|42062738|FG000|Overall Study|Adverse Event|0|||
19614018|NCT00939029|42062739|FG001|Overall Study|Adverse Event|1|||
19614019|NCT00587847|42062745|FG000|Overall Study|Lack of Efficacy|5|||
19614020|NCT00587847|42062745|FG000|Overall Study|Adverse Event|2|||
19614021|NCT00784563|42062753|FG000|Years 1 & 2|Withdrawal by Subject|3|||
19614022|NCT00784563|42062754|FG001|Years 1 & 2|Withdrawal by Subject|2|||
19373719|NCT02665689|41614914|FG001|Overall Study|Trial termination|1|||
19499897|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499898|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499899|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499900|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499901|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499902|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499903|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499904|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499905|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499906|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499907|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499908|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499909|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499910|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499911|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
19499912|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499913|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499914|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499915|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499916|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499917|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499918|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499919|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499920|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
19499921|NCT02346240|41862641|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499922|NCT02346240|41862642|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499923|NCT02346240|41862643|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499924|NCT02346240|41862644|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499925|NCT02346240|41862645|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499926|NCT02346240|41862646|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499927|NCT02346240|41862647|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499928|NCT02346240|41862648|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499929|NCT02346240|41862649|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499930|NCT02346240|41862650|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499931|NCT02346240|41862651|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499932|NCT02346240|41862652|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499933|NCT02346240|41862653|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499934|NCT02346240|41862654|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499935|NCT02346240|41862655|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
19499936|NCT02346240|41862656|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499937|NCT02346240|41862657|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499938|NCT02346240|41862658|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499939|NCT02346240|41862659|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499940|NCT02346240|41862660|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499941|NCT02346240|41862661|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499942|NCT02346240|41862662|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499943|NCT02346240|41862663|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499944|NCT02346240|41862664|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
19499945|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499946|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499947|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499948|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499949|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499950|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499951|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499952|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499953|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499954|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499955|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499956|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499957|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499958|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499959|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499960|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499961|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
19499962|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
19499963|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
19499964|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
19499965|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
19499966|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
19499967|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
19499968|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
19499969|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499970|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499971|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499972|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499973|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499974|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499975|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499976|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499977|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499978|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499979|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499980|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499981|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499982|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499983|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499984|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499985|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499986|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499987|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
19499988|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
19499989|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499990|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
19499991|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499992|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
19499993|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499994|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499995|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499996|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499997|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499998|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19499999|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500000|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500001|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500002|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500003|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500004|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500005|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500006|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500007|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500008|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500009|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500010|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500011|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19500012|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500013|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500014|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19500015|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19393773|NCT02658175|41637670|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
19500016|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19500017|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19614023|NCT00784563|42062755|FG002|Years 1 & 2|Withdrawal by Subject|0|||
19393774|NCT02658175|41637668|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
19393775|NCT02658175|41637669|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
19500018|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500019|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500020|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500021|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500022|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500023|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500024|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500025|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500026|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500027|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500028|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500029|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500030|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500031|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500032|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500033|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500034|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500035|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500036|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500037|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500038|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
19500039|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500040|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
19500041|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500042|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500043|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500044|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500045|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500046|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500047|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500048|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500049|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500050|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500051|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500052|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500053|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500054|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500055|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500056|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500057|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500058|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
19500059|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
19500060|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
19500061|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19500062|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
19500063|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
19500064|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
19500065|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500066|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500067|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500068|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500069|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500070|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500071|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500072|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500073|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500074|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500075|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500076|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500077|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19614024|NCT00784563|42062753|FG000|Years 1 & 2|Adverse Event|0|||
19614025|NCT00784563|42062754|FG001|Years 1 & 2|Adverse Event|3|||
19614026|NCT00784563|42062755|FG002|Years 1 & 2|Adverse Event|0|||
19614027|NCT00784563|42062753|FG000|Year 3|Withdrawal by Subject|0|||
19614028|NCT00784563|42062754|FG001|Year 3|Withdrawal by Subject|0|||
19614029|NCT00784563|42062755|FG002|Year 3|Withdrawal by Subject|2|||
19614030|NCT00784563|42062753|FG000|Year 3|Adverse Event|0|||
19614031|NCT00784563|42062754|FG001|Year 3|Adverse Event|0|||
19614032|NCT00784563|42062755|FG002|Year 3|Adverse Event|1|||
19614033|NCT00938717|42062763|FG000|Overall Study|Adverse Event|10|||
19614034|NCT00938717|42062764|FG001|Overall Study|Adverse Event|41|||
19614035|NCT00938717|42062763|FG000|Overall Study|Protocol Violation|11|||
19614036|NCT00938717|42062764|FG001|Overall Study|Protocol Violation|8|||
19500078|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500079|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500080|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500081|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500082|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500083|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
19500084|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
19500085|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19500086|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
19500087|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
19500088|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
19500089|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500090|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500091|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500092|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500093|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500094|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500095|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500096|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500097|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500098|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500099|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500100|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500101|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500102|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500103|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500104|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500105|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500106|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500107|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
19500108|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500109|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
19500110|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
19500111|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
19500112|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
19500113|NCT02346240|41862641|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500114|NCT02346240|41862642|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500115|NCT02346240|41862643|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500116|NCT02346240|41862644|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500117|NCT02346240|41862645|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500118|NCT02346240|41862646|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500119|NCT02346240|41862647|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500120|NCT02346240|41862648|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500121|NCT02346240|41862649|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500122|NCT02346240|41862650|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500123|NCT02346240|41862651|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500124|NCT02346240|41862652|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500125|NCT02346240|41862653|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500126|NCT02346240|41862654|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500127|NCT02346240|41862655|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500128|NCT02346240|41862656|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500129|NCT02346240|41862657|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19614037|NCT00938717|42062763|FG000|Overall Study|Withdrawal by Subject|26|||
19614038|NCT00938717|42062764|FG001|Overall Study|Withdrawal by Subject|24|||
19500130|NCT02346240|41862658|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500131|NCT02346240|41862659|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
19500132|NCT02346240|41862660|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500133|NCT02346240|41862661|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500134|NCT02346240|41862662|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500135|NCT02346240|41862663|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500136|NCT02346240|41862664|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
19500137|NCT02392104|41862715|FG000|Overall Study|discontinuation of warfarin|3|||
19500138|NCT02392104|41862715|FG000|Overall Study|bleeding event|1|||
19500139|NCT02392104|41862715|FG000|Overall Study|transferred care to another doctor|2|||
19500140|NCT02392104|41862715|FG000|Overall Study|INR goal range changed|1|||
19500141|NCT02392104|41862715|FG000|Overall Study|admitted to skilled nursing facility|3|||
19500142|NCT02392104|41862715|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
19500143|NCT02391948|41862733|FG000|6-month Assessment|Death|0|||
19500144|NCT02391948|41862734|FG001|6-month Assessment|Death|0|||
19500145|NCT02391948|41862735|FG002|6-month Assessment|Death|0|||
19500146|NCT02391948|41862736|FG003|6-month Assessment|Death|0|||
19500147|NCT02391948|41862737|FG004|6-month Assessment|Death|1|||
19500148|NCT02391948|41862733|FG000|6-month Assessment|Withdrawal by Subject|0|||
19500149|NCT02391948|41862734|FG001|6-month Assessment|Withdrawal by Subject|0|||
19500150|NCT02391948|41862735|FG002|6-month Assessment|Withdrawal by Subject|1|||
19500151|NCT02391948|41862736|FG003|6-month Assessment|Withdrawal by Subject|2|||
19500152|NCT02391948|41862737|FG004|6-month Assessment|Withdrawal by Subject|0|||
19500153|NCT02391948|41862733|FG000|6-month Assessment|Lost to Follow-up|4|||
19500154|NCT02391948|41862734|FG001|6-month Assessment|Lost to Follow-up|5|||
19500155|NCT02391948|41862735|FG002|6-month Assessment|Lost to Follow-up|2|||
19500156|NCT02391948|41862736|FG003|6-month Assessment|Lost to Follow-up|3|||
19500157|NCT02391948|41862737|FG004|6-month Assessment|Lost to Follow-up|1|||
19500158|NCT02391948|41862733|FG000|6-month Assessment|Medical issue/illness|1|||
19500159|NCT02391948|41862734|FG001|6-month Assessment|Medical issue/illness|1|||
19500160|NCT02391948|41862735|FG002|6-month Assessment|Medical issue/illness|0|||
19500161|NCT02391948|41862736|FG003|6-month Assessment|Medical issue/illness|0|||
19500162|NCT02391948|41862737|FG004|6-month Assessment|Medical issue/illness|0|||
19500163|NCT02391948|41862733|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
19500164|NCT02391948|41862734|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
19500165|NCT02391948|41862735|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
19500166|NCT02391948|41862736|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
19500167|NCT02391948|41862737|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
19500168|NCT02391948|41862733|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
19500169|NCT02391948|41862734|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
19500170|NCT02391948|41862735|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
19500171|NCT02391948|41862736|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
19500172|NCT02391948|41862737|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
19500173|NCT02391948|41862733|FG000|12-month Assessment|Death|0|||
19500174|NCT02391948|41862734|FG001|12-month Assessment|Death|0|||
19500175|NCT02391948|41862735|FG002|12-month Assessment|Death|0|||
19500176|NCT02391948|41862736|FG003|12-month Assessment|Death|1|||
19500177|NCT02391948|41862737|FG004|12-month Assessment|Death|0|||
19500178|NCT02391948|41862733|FG000|12-month Assessment|Withdrawal by Subject|1|||
19500179|NCT02391948|41862734|FG001|12-month Assessment|Withdrawal by Subject|0|||
19500180|NCT02391948|41862735|FG002|12-month Assessment|Withdrawal by Subject|0|||
19500181|NCT02391948|41862736|FG003|12-month Assessment|Withdrawal by Subject|1|||
19500182|NCT02391948|41862737|FG004|12-month Assessment|Withdrawal by Subject|0|||
19500183|NCT02391948|41862733|FG000|12-month Assessment|Lost to Follow-up|5|||
19500184|NCT02391948|41862734|FG001|12-month Assessment|Lost to Follow-up|4|||
19500185|NCT02391948|41862735|FG002|12-month Assessment|Lost to Follow-up|4|||
19500186|NCT02391948|41862736|FG003|12-month Assessment|Lost to Follow-up|4|||
19500187|NCT02391948|41862737|FG004|12-month Assessment|Lost to Follow-up|5|||
19500188|NCT02391948|41862733|FG000|12-month Assessment|Medical issue/illness|0|||
19500189|NCT02391948|41862734|FG001|12-month Assessment|Medical issue/illness|1|||
19500190|NCT02391948|41862735|FG002|12-month Assessment|Medical issue/illness|0|||
19500191|NCT02391948|41862736|FG003|12-month Assessment|Medical issue/illness|1|||
19500192|NCT02391948|41862737|FG004|12-month Assessment|Medical issue/illness|0|||
19500193|NCT02391948|41862733|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
19500194|NCT02391948|41862734|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
19500195|NCT02391948|41862735|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
19500196|NCT02391948|41862736|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
19500197|NCT02391948|41862737|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
19500198|NCT02391948|41862733|FG000|18-month Assessment|Death|0|||
19500199|NCT02391948|41862734|FG001|18-month Assessment|Death|0|||
19500200|NCT02391948|41862735|FG002|18-month Assessment|Death|0|||
19500201|NCT02391948|41862736|FG003|18-month Assessment|Death|1|||
19500202|NCT02391948|41862737|FG004|18-month Assessment|Death|1|||
19500203|NCT02391948|41862733|FG000|18-month Assessment|Withdrawal by Subject|1|||
19500204|NCT02391948|41862734|FG001|18-month Assessment|Withdrawal by Subject|0|||
19500205|NCT02391948|41862735|FG002|18-month Assessment|Withdrawal by Subject|0|||
19500206|NCT02391948|41862736|FG003|18-month Assessment|Withdrawal by Subject|1|||
19500207|NCT02391948|41862737|FG004|18-month Assessment|Withdrawal by Subject|0|||
19500208|NCT02391948|41862733|FG000|18-month Assessment|Lost to Follow-up|2|||
19500209|NCT02391948|41862734|FG001|18-month Assessment|Lost to Follow-up|6|||
19500210|NCT02391948|41862735|FG002|18-month Assessment|Lost to Follow-up|2|||
19500211|NCT02391948|41862736|FG003|18-month Assessment|Lost to Follow-up|2|||
19500212|NCT02391948|41862737|FG004|18-month Assessment|Lost to Follow-up|3|||
19500213|NCT02391948|41862733|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
19500214|NCT02391948|41862734|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
19500215|NCT02391948|41862735|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
19500216|NCT02391948|41862736|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
19500217|NCT02391948|41862737|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
19500218|NCT02391948|41862733|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
19500219|NCT02391948|41862734|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
19500220|NCT02391948|41862735|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
19500221|NCT02391948|41862736|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
19500222|NCT02391948|41862737|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
19500223|NCT02391948|41862733|FG000|24-month Assessment|Death|0|||
19500224|NCT02391948|41862734|FG001|24-month Assessment|Death|0|||
19500225|NCT02391948|41862735|FG002|24-month Assessment|Death|0|||
19500226|NCT02391948|41862736|FG003|24-month Assessment|Death|0|||
19614039|NCT00938717|42062763|FG000|Overall Study|Lost to Follow-up|13|||
19614040|NCT00938717|42062764|FG001|Overall Study|Lost to Follow-up|18|||
19500227|NCT02391948|41862737|FG004|24-month Assessment|Death|1|||
19500228|NCT02391948|41862733|FG000|24-month Assessment|Withdrawal by Subject|1|||
19500229|NCT02391948|41862734|FG001|24-month Assessment|Withdrawal by Subject|1|||
19500230|NCT02391948|41862735|FG002|24-month Assessment|Withdrawal by Subject|0|||
19500231|NCT02391948|41862736|FG003|24-month Assessment|Withdrawal by Subject|0|||
19500232|NCT02391948|41862737|FG004|24-month Assessment|Withdrawal by Subject|1|||
19500233|NCT02391948|41862733|FG000|24-month Assessment|Lost to Follow-up|5|||
19500234|NCT02391948|41862734|FG001|24-month Assessment|Lost to Follow-up|4|||
19500235|NCT02391948|41862735|FG002|24-month Assessment|Lost to Follow-up|0|||
19500236|NCT02391948|41862736|FG003|24-month Assessment|Lost to Follow-up|0|||
19500237|NCT02391948|41862737|FG004|24-month Assessment|Lost to Follow-up|0|||
19500238|NCT02391948|41862733|FG000|24-month Assessment|Medical issue/illness|0|||
19500239|NCT02391948|41862734|FG001|24-month Assessment|Medical issue/illness|0|||
19500240|NCT02391948|41862735|FG002|24-month Assessment|Medical issue/illness|1|||
19500241|NCT02391948|41862736|FG003|24-month Assessment|Medical issue/illness|0|||
19500242|NCT02391948|41862737|FG004|24-month Assessment|Medical issue/illness|0|||
19500243|NCT02391948|41862733|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
19500244|NCT02391948|41862734|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
19500245|NCT02391948|41862735|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
19500246|NCT02391948|41862736|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
19500247|NCT02391948|41862737|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
19500248|NCT02369874|41862980|FG000|Overall Study|Lost to Follow-up|2|||
19500249|NCT02369874|41862981|FG001|Overall Study|Lost to Follow-up|2|||
19500250|NCT02369874|41862982|FG002|Overall Study|Lost to Follow-up|2|||
19500251|NCT02369874|41862980|FG000|Overall Study|Withdrawal by Subject|7|||
19500252|NCT02369874|41862981|FG001|Overall Study|Withdrawal by Subject|9|||
19500253|NCT02369874|41862982|FG002|Overall Study|Withdrawal by Subject|27|||
19500254|NCT02369874|41862980|FG000|Overall Study|Miscellaneous|1|||
19500255|NCT02369874|41862981|FG001|Overall Study|Miscellaneous|1|||
19500256|NCT02369874|41862982|FG002|Overall Study|Miscellaneous|0|||
19500257|NCT02369874|41862980|FG000|Overall Study|On Treatment/Off Study|34|||
19500258|NCT02369874|41862981|FG001|Overall Study|On Treatment/Off Study|45|||
19500259|NCT02369874|41862982|FG002|Overall Study|On Treatment/Off Study|32|||
19500260|NCT02345226|41863094|FG000|Double-Blind Phase|Adverse Event|5|||
19500261|NCT02345226|41863095|FG001|Double-Blind Phase|Adverse Event|6|||
19500262|NCT02345226|41863094|FG000|Double-Blind Phase|Death|3|||
19500263|NCT02345226|41863095|FG001|Double-Blind Phase|Death|0|||
19500264|NCT02345226|41863094|FG000|Double-Blind Phase|Pregnancy|0|||
19500265|NCT02345226|41863095|FG001|Double-Blind Phase|Pregnancy|1|||
19614041|NCT00938717|42062763|FG000|Overall Study|Lack of Efficacy|33|||
19704426|NCT00252174|42148775|FG000|Overall Study|Withdrawal by Subject|0|||
19500266|NCT02345226|41863094|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19500267|NCT02345226|41863095|FG001|Double-Blind Phase|Lack of Efficacy|0|||
19500268|NCT02345226|41863094|FG000|Double-Blind Phase|Investigator's Discretion|4|||
19500269|NCT02345226|41863095|FG001|Double-Blind Phase|Investigator's Discretion|3|||
19614042|NCT00938717|42062764|FG001|Overall Study|Lack of Efficacy|15|||
19500270|NCT02345226|41863094|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19500271|NCT02345226|41863095|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
19500272|NCT02345226|41863094|FG000|Double-Blind Phase|Withdrew Consent|41|||
19500273|NCT02345226|41863095|FG001|Double-Blind Phase|Withdrew Consent|39|||
19500274|NCT02345226|41863094|FG000|Double-Blind Phase|Lost to Follow-up|12|||
19500275|NCT02345226|41863095|FG001|Double-Blind Phase|Lost to Follow-up|16|||
19500276|NCT02345226|41863094|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
19500277|NCT02345226|41863095|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
19500278|NCT02345226|41863094|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
19500279|NCT02345226|41863095|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
19500280|NCT02368314|41863145|FG000|Overall Study|Withdrawal by Subject|2|||
19500281|NCT02368314|41863146|FG001|Overall Study|Withdrawal by Subject|1|||
19500282|NCT02368314|41863145|FG000|Overall Study|Adverse Event|1|||
19500283|NCT02368314|41863146|FG001|Overall Study|Adverse Event|2|||
19614043|NCT00938717|42062763|FG000|Overall Study|Other reason|5|||
19614044|NCT00938717|42062764|FG001|Overall Study|Other reason|2|||
19614045|NCT00587223|42062770|FG000|Overall Study|Adverse Event|1|||
19614046|NCT00938639|42062779|FG000|Overall Study|Moved away from study area|0|||
19500284|NCT02366910|41863156|FG000|Overall Study|Withdrawal by Subject|2|||
19500285|NCT02366910|41863156|FG000|Overall Study|Screen Failure|3|||
19500286|NCT01649232|41863174|FG000|Overall Study|Physician Decision|2|||
19500287|NCT01649232|41863175|FG001|Overall Study|Physician Decision|0|||
19500288|NCT00551369|41864056|FG000|Overall Study|Protocol Violation|5|||
19500289|NCT00551369|41864056|FG000|Overall Study|Withdrawal by Subject|1|||
19500290|NCT00551369|41864056|FG000|Overall Study|Not treated per protocol and re|1|||
19500291|NCT00551291|41864069|FG000|Overall Study|Physician Decision|1|||
19500292|NCT00551213|41864175|FG000|Overall Study|Adverse Event|6|||
19500293|NCT00551213|41864176|FG001|Overall Study|Adverse Event|3|||
19614047|NCT00938639|42062780|FG001|Overall Study|Moved away from study area|1|||
19614048|NCT00938639|42062779|FG000|Overall Study|Lost to Follow-up|1|||
19614049|NCT00938639|42062780|FG001|Overall Study|Lost to Follow-up|2|||
19614050|NCT00938639|42062779|FG000|Overall Study|Family issues|1|||
19614051|NCT00938639|42062780|FG001|Overall Study|Family issues|1|||
19614052|NCT00938639|42062779|FG000|Overall Study|Participant noncompliance|1|||
19614053|NCT00938639|42062780|FG001|Overall Study|Participant noncompliance|0|||
19614054|NCT00783705|42062792|FG000|Overall Study|Adverse Event|2|||
19614055|NCT00783705|42062793|FG001|Overall Study|Adverse Event|0|||
19614056|NCT00783705|42062792|FG000|Overall Study|Withdrawal by Subject|3|||
19614057|NCT00783705|42062793|FG001|Overall Study|Withdrawal by Subject|2|||
19614058|NCT00783705|42062792|FG000|Overall Study|Lost to Follow-up|1|||
19614059|NCT00783705|42062793|FG001|Overall Study|Lost to Follow-up|3|||
19614060|NCT00604669|42062799|FG000|Overall Study|lack of information in chart|7|||
19614061|NCT00938327|42062803|FG000|Overall Study|Adverse Event|2|||
19614062|NCT00938327|42062803|FG000|Overall Study|Protocol Violation|1|||
19614063|NCT00938327|42062803|FG000|Overall Study|Withdrawal by Subject|4|||
19614064|NCT00938327|42062803|FG000|Overall Study|Lost to Follow-up|37|||
19614065|NCT00938327|42062803|FG000|Overall Study|2nd dose received outside of the study|7|||
19614066|NCT00938327|42062803|FG000|Overall Study|Vaccine not received as out of stock|9|||
19614067|NCT00887198|42062809|FG000|Randomized Period|Ongoing|42|||
19614068|NCT00887198|42062810|FG001|Randomized Period|Ongoing|0|||
19614069|NCT00887198|42062811|FG002|Randomized Period|Ongoing|0|||
19614070|NCT00887198|42062809|FG000|Randomized Period|Adverse Event|50|||
19614071|NCT00887198|42062810|FG001|Randomized Period|Adverse Event|33|||
19614072|NCT00887198|42062811|FG002|Randomized Period|Adverse Event|0|||
19614073|NCT00887198|42062809|FG000|Randomized Period|Lost to Follow-up|1|||
19614074|NCT00887198|42062810|FG001|Randomized Period|Lost to Follow-up|0|||
19614075|NCT00887198|42062811|FG002|Randomized Period|Lost to Follow-up|0|||
19614076|NCT00887198|42062809|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
19614077|NCT00887198|42062810|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
19614078|NCT00887198|42062811|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
19614079|NCT00887198|42062809|FG000|Randomized Period|Withdrawal by Subject|41|||
19614080|NCT00887198|42062810|FG001|Randomized Period|Withdrawal by Subject|56|||
19614081|NCT00887198|42062811|FG002|Randomized Period|Withdrawal by Subject|0|||
19614082|NCT00887198|42062809|FG000|Randomized Period|Progressive disease|366|||
19614083|NCT00887198|42062810|FG001|Randomized Period|Progressive disease|370|||
19614084|NCT00887198|42062811|FG002|Randomized Period|Progressive disease|0|||
19614085|NCT00887198|42062809|FG000|Randomized Period|Other|42|||
19614086|NCT00887198|42062810|FG001|Randomized Period|Other|30|||
19614087|NCT00887198|42062811|FG002|Randomized Period|Other|0|||
19614088|NCT00887198|42062809|FG000|Randomized Period|Randomized, Not treated|4|||
19500294|NCT00551213|41864175|FG000|Overall Study|Progressive Disease|41|||
19500295|NCT00551213|41864176|FG001|Overall Study|Progressive Disease|12|||
19500296|NCT00551213|41864175|FG000|Overall Study|Withdrawal by Subject|2|||
19500297|NCT00551213|41864176|FG001|Overall Study|Withdrawal by Subject|0|||
19500298|NCT00551213|41864175|FG000|Overall Study|Not Treated|1|||
19614089|NCT00887198|42062810|FG001|Randomized Period|Randomized, Not treated|2|||
19614090|NCT00887198|42062811|FG002|Randomized Period|Randomized, Not treated|0|||
19614091|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
19614092|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
19500299|NCT00551213|41864176|FG001|Overall Study|Not Treated|2|||
19500300|NCT00550043|41864313|FG000|Overall Study|Adverse Event|0|||
19500301|NCT00550043|41864314|FG001|Overall Study|Adverse Event|0|||
19500302|NCT00550043|41864315|FG002|Overall Study|Adverse Event|0|||
19500303|NCT00550043|41864316|FG003|Overall Study|Adverse Event|1|||
19500304|NCT00550043|41864317|FG004|Overall Study|Adverse Event|1|||
19500305|NCT00550043|41864313|FG000|Overall Study|Subject Withdrew Consent|0|||
19500306|NCT00550043|41864314|FG001|Overall Study|Subject Withdrew Consent|2|||
19500307|NCT00550043|41864315|FG002|Overall Study|Subject Withdrew Consent|1|||
19500308|NCT00550043|41864316|FG003|Overall Study|Subject Withdrew Consent|0|||
19500309|NCT00550043|41864317|FG004|Overall Study|Subject Withdrew Consent|0|||
19500310|NCT00550043|41864313|FG000|Overall Study|Other Reasons- Unspecified|0|||
19500311|NCT00550043|41864314|FG001|Overall Study|Other Reasons- Unspecified|1|||
19500312|NCT00550043|41864315|FG002|Overall Study|Other Reasons- Unspecified|0|||
19500313|NCT00550043|41864316|FG003|Overall Study|Other Reasons- Unspecified|1|||
19500314|NCT00550043|41864317|FG004|Overall Study|Other Reasons- Unspecified|0|||
19500315|NCT03188822|41865045|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
19500316|NCT03188822|41865045|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
19500317|NCT04976777|41865188|FG000|Overall Study|COVID-19 Infection|1|||
19500318|NCT04976777|41865189|FG001|Overall Study|COVID-19 Infection|0|||
19500319|NCT00555971|41865372|FG000|Overall Study|Adverse Event|1|||
19500320|NCT00555971|41865373|FG001|Overall Study|Adverse Event|1|||
19500321|NCT02343120|41866249|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
19500322|NCT02343120|41866250|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
19500323|NCT02343120|41866251|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
19500324|NCT02343120|41866252|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
19500325|NCT02343120|41866253|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
19500326|NCT02343120|41866249|FG000|Part 1: Dose Escalation|Death|1|||
19500327|NCT02343120|41866250|FG001|Part 1: Dose Escalation|Death|2|||
19500328|NCT02343120|41866251|FG002|Part 1: Dose Escalation|Death|2|||
19500329|NCT02343120|41866252|FG003|Part 1: Dose Escalation|Death|2|||
19500330|NCT02343120|41866253|FG004|Part 1: Dose Escalation|Death|1|||
19500331|NCT02343120|41866249|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
19500332|NCT02343120|41866250|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
19500333|NCT02343120|41866251|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
19500334|NCT02343120|41866252|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
19500335|NCT02343120|41866253|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
19500336|NCT02343120|41866249|FG000|Part 2: Expansion|Sponsor decision|0|||
19500337|NCT02343120|41866250|FG001|Part 2: Expansion|Sponsor decision|0|||
19500338|NCT02343120|41866251|FG002|Part 2: Expansion|Sponsor decision|0|||
19500339|NCT02343120|41866252|FG003|Part 2: Expansion|Sponsor decision|165|||
19500340|NCT02343120|41866253|FG004|Part 2: Expansion|Sponsor decision|67|||
19500341|NCT02343120|41866249|FG000|Part 2: Expansion|Death|0|||
19500342|NCT02343120|41866250|FG001|Part 2: Expansion|Death|0|||
19500343|NCT02343120|41866251|FG002|Part 2: Expansion|Death|0|||
19500344|NCT02343120|41866252|FG003|Part 2: Expansion|Death|74|||
19500345|NCT02343120|41866253|FG004|Part 2: Expansion|Death|17|||
19500346|NCT02343120|41866249|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
19500347|NCT02343120|41866250|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
19500348|NCT02343120|41866251|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
19500349|NCT02343120|41866252|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
19500350|NCT02343120|41866253|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
19500351|NCT02343120|41866249|FG000|Part 2: Expansion|Lost to Follow-up|0|||
19500352|NCT02343120|41866250|FG001|Part 2: Expansion|Lost to Follow-up|0|||
19500353|NCT02343120|41866251|FG002|Part 2: Expansion|Lost to Follow-up|0|||
19500354|NCT02343120|41866252|FG003|Part 2: Expansion|Lost to Follow-up|5|||
19500355|NCT02343120|41866253|FG004|Part 2: Expansion|Lost to Follow-up|2|||
19500356|NCT02343120|41866249|FG000|Part 2: Expansion|Other|0|||
19500357|NCT02343120|41866250|FG001|Part 2: Expansion|Other|0|||
19500358|NCT02343120|41866251|FG002|Part 2: Expansion|Other|0|||
19500359|NCT02343120|41866252|FG003|Part 2: Expansion|Other|1|||
19500360|NCT02343120|41866253|FG004|Part 2: Expansion|Other|5|||
19500361|NCT02343120|41866249|FG000|Part 2: Expansion|Adverse Event|0|||
19614093|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
19614094|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
19614095|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
19614096|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
19500362|NCT02343120|41866250|FG001|Part 2: Expansion|Adverse Event|0|||
19500363|NCT02343120|41866251|FG002|Part 2: Expansion|Adverse Event|0|||
19500364|NCT02343120|41866252|FG003|Part 2: Expansion|Adverse Event|1|||
19500365|NCT02343120|41866253|FG004|Part 2: Expansion|Adverse Event|1|||
19500366|NCT02342886|41866519|FG000|Overall Study|Treatment non-compliance|1|||
19500367|NCT02342886|41866520|FG001|Overall Study|Treatment non-compliance|0|||
19500368|NCT02342886|41866521|FG002|Overall Study|Treatment non-compliance|0|||
19500369|NCT02342886|41866522|FG003|Overall Study|Treatment non-compliance|1|||
19614097|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
19614098|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
19614099|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
19614100|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
19614101|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
19614102|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
19614103|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
19614104|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
19614105|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
19614106|NCT00887198|42062809|FG000|Cross Over (Placebo to AA)|Other|0|||
19614107|NCT00887198|42062810|FG001|Cross Over (Placebo to AA)|Other|0|||
19614108|NCT00887198|42062811|FG002|Cross Over (Placebo to AA)|Other|19|||
19614109|NCT00782067|42062819|FG000|Overall Study|Adverse Event|35|||
19614110|NCT00782067|42062819|FG000|Overall Study|Subject withdrew consent|11|||
19614111|NCT00782067|42062819|FG000|Overall Study|Lost to Follow-up|2|||
19614112|NCT00782067|42062819|FG000|Overall Study|Administrative problems|14|||
19614113|NCT00782067|42062819|FG000|Overall Study|Death|9|||
19614114|NCT00782067|42062819|FG000|Overall Study|Disease progression|43|||
19614115|NCT00782067|42062819|FG000|Overall Study|Protocol deviation|2|||
19614116|NCT00886340|42062825|FG000|Overall Study|Withdrawal by Subject|0|||
19614117|NCT00886340|42062826|FG001|Overall Study|Withdrawal by Subject|7|||
19500370|NCT02342886|41866523|FG004|Overall Study|Treatment non-compliance|0|||
19500371|NCT02342886|41866519|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
19500372|NCT02342886|41866520|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
19500373|NCT02342886|41866521|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
19500374|NCT02342886|41866522|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
19500375|NCT02342886|41866523|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
19500376|NCT02342886|41866519|FG000|Overall Study|Adverse event/specific toxicity|4|||
19500377|NCT02342886|41866520|FG001|Overall Study|Adverse event/specific toxicity|3|||
19500378|NCT02342886|41866521|FG002|Overall Study|Adverse event/specific toxicity|11|||
19500379|NCT02342886|41866522|FG003|Overall Study|Adverse event/specific toxicity|2|||
19500380|NCT02342886|41866523|FG004|Overall Study|Adverse event/specific toxicity|1|||
19500381|NCT02342886|41866519|FG000|Overall Study|Lost to Follow-up|1|||
19500382|NCT02342886|41866520|FG001|Overall Study|Lost to Follow-up|0|||
19500383|NCT02342886|41866521|FG002|Overall Study|Lost to Follow-up|0|||
19500384|NCT02342886|41866522|FG003|Overall Study|Lost to Follow-up|0|||
19500385|NCT02342886|41866523|FG004|Overall Study|Lost to Follow-up|0|||
19500386|NCT02342886|41866519|FG000|Overall Study|Death|1|||
19500387|NCT02342886|41866520|FG001|Overall Study|Death|2|||
19500388|NCT02342886|41866521|FG002|Overall Study|Death|1|||
19500389|NCT02342886|41866522|FG003|Overall Study|Death|0|||
19500390|NCT02342886|41866523|FG004|Overall Study|Death|1|||
19500391|NCT02342886|41866519|FG000|Overall Study|Withdrawal by Subject|0|||
19500392|NCT02342886|41866520|FG001|Overall Study|Withdrawal by Subject|1|||
19500393|NCT02342886|41866521|FG002|Overall Study|Withdrawal by Subject|0|||
19500394|NCT02342886|41866522|FG003|Overall Study|Withdrawal by Subject|1|||
19500395|NCT02342886|41866523|FG004|Overall Study|Withdrawal by Subject|0|||
19500396|NCT02342886|41866519|FG000|Overall Study|Investigator/sponsor decision|0|||
19500397|NCT02342886|41866520|FG001|Overall Study|Investigator/sponsor decision|2|||
19500398|NCT02342886|41866521|FG002|Overall Study|Investigator/sponsor decision|0|||
19500399|NCT02342886|41866522|FG003|Overall Study|Investigator/sponsor decision|3|||
19500400|NCT02342886|41866523|FG004|Overall Study|Investigator/sponsor decision|1|||
19500401|NCT02342886|41866519|FG000|Overall Study|Pregnancy|0|||
19614118|NCT00605215|42062835|FG000|Overall Study|Death|0|||
19614119|NCT00605215|42062836|FG001|Overall Study|Death|0|||
19500402|NCT02342886|41866520|FG001|Overall Study|Pregnancy|0|||
19500403|NCT02342886|41866521|FG002|Overall Study|Pregnancy|2|||
19500404|NCT02342886|41866522|FG003|Overall Study|Pregnancy|0|||
19500405|NCT02342886|41866523|FG004|Overall Study|Pregnancy|0|||
19500406|NCT02342886|41866519|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
19500407|NCT02342886|41866520|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
19500408|NCT02342886|41866521|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
19500409|NCT02342886|41866522|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
19500410|NCT02342886|41866523|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
19500411|NCT02342886|41866519|FG000|Overall Study|Protocol Violation|0|||
19500412|NCT02342886|41866520|FG001|Overall Study|Protocol Violation|0|||
19500413|NCT02342886|41866521|FG002|Overall Study|Protocol Violation|0|||
19500414|NCT02342886|41866522|FG003|Overall Study|Protocol Violation|2|||
19500415|NCT02342886|41866523|FG004|Overall Study|Protocol Violation|0|||
19500416|NCT02390076|41866559|FG000|Overall Study|Lost to Follow-up|2|||
19500417|NCT02390076|41866560|FG001|Overall Study|Lost to Follow-up|1|||
19500418|NCT02390076|41866561|FG002|Overall Study|Lost to Follow-up|4|||
19500419|NCT02389998|41866580|FG000|Overall Study|car accident|1|||
19500420|NCT02389998|41866581|FG001|Overall Study|car accident|0|||
19500421|NCT02389764|41866607|FG000|Overall Study|Lack of Efficacy|9|||
19500422|NCT02366130|41866678|FG000|Overall Study|Withdrawal by Subject|3|||
19500423|NCT02366130|41866678|FG000|Overall Study|Ineligible|6|||
19500424|NCT02389452|41866740|FG000|Overall Study|Lost to Follow-up|13|||
19500425|NCT02389452|41866740|FG000|Overall Study|Adverse Event|1|||
19500426|NCT02389452|41866740|FG000|Overall Study|Withdrawal by Subject|5|||
19500427|NCT02389452|41866740|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
19500428|NCT02365584|41866778|FG000|Overall Study|Adverse Event|2|||
19500429|NCT02365584|41866779|FG001|Overall Study|Adverse Event|2|||
19500430|NCT02365584|41866778|FG000|Overall Study|Withdrawal by Subject|1|||
19500431|NCT02365584|41866779|FG001|Overall Study|Withdrawal by Subject|0|||
19500432|NCT02365584|41866778|FG000|Overall Study|Disease Progression|9|||
19500433|NCT02365584|41866779|FG001|Overall Study|Disease Progression|12|||
19500434|NCT02342418|41866791|FG000|Overall Study|Adverse Event|0|||
19500435|NCT02342418|41866792|FG001|Overall Study|Adverse Event|1|||
19500436|NCT02365506|41866833|FG000|Overall Study|Investigator's Discretion|0|||
19500437|NCT02365506|41866834|FG001|Overall Study|Investigator's Discretion|0|||
19500438|NCT02365506|41866835|FG002|Overall Study|Investigator's Discretion|1|||
19500439|NCT02312934|41866872|FG000|Overall Study|Lost to Follow-up|1|||
19500440|NCT02312934|41866873|FG001|Overall Study|Lost to Follow-up|0|||
19500441|NCT02312934|41866872|FG000|Overall Study|Physician Decision|1|||
19500442|NCT02312934|41866873|FG001|Overall Study|Physician Decision|0|||
19500443|NCT02341482|41866907|FG000|Overall Study|Adverse Event|1|||
19500444|NCT02312856|41866947|FG000|Overall Study|Death|1|||
19500445|NCT02312856|41866947|FG000|Overall Study|Lost to Follow-up|3|||
19500446|NCT01602120|41867412|FG000|Overall Study|Adverse Event|3|||
19500447|NCT01602120|41867413|FG001|Overall Study|Adverse Event|6|||
19500448|NCT01602120|41867414|FG002|Overall Study|Adverse Event|0|||
19500449|NCT01602120|41867415|FG003|Overall Study|Adverse Event|2|||
19500450|NCT01602120|41867412|FG000|Overall Study|Death|0|||
19500451|NCT01602120|41867413|FG001|Overall Study|Death|4|||
19500452|NCT01602120|41867414|FG002|Overall Study|Death|0|||
19500453|NCT01602120|41867415|FG003|Overall Study|Death|0|||
19500454|NCT01602120|41867412|FG000|Overall Study|Lost to Follow-up|0|||
19500455|NCT01602120|41867413|FG001|Overall Study|Lost to Follow-up|1|||
19500456|NCT01602120|41867414|FG002|Overall Study|Lost to Follow-up|0|||
19500457|NCT01602120|41867415|FG003|Overall Study|Lost to Follow-up|1|||
19500458|NCT01602120|41867412|FG000|Overall Study|Protocol Violation|1|||
19500459|NCT01602120|41867413|FG001|Overall Study|Protocol Violation|1|||
19500460|NCT01602120|41867414|FG002|Overall Study|Protocol Violation|0|||
19500461|NCT01602120|41867415|FG003|Overall Study|Protocol Violation|0|||
19500462|NCT01602120|41867412|FG000|Overall Study|Non-compliance|0|||
19500463|NCT01602120|41867413|FG001|Overall Study|Non-compliance|3|||
19500464|NCT01602120|41867414|FG002|Overall Study|Non-compliance|0|||
19500465|NCT01602120|41867415|FG003|Overall Study|Non-compliance|1|||
19500466|NCT01602120|41867412|FG000|Overall Study|Withdrawal by Subject|8|||
19500467|NCT01602120|41867413|FG001|Overall Study|Withdrawal by Subject|17|||
19500468|NCT01602120|41867414|FG002|Overall Study|Withdrawal by Subject|0|||
19500469|NCT01602120|41867415|FG003|Overall Study|Withdrawal by Subject|3|||
19500470|NCT01602120|41867412|FG000|Overall Study|Study Terminated by Sponsor|12|||
19500471|NCT01602120|41867413|FG001|Overall Study|Study Terminated by Sponsor|24|||
19500472|NCT01602120|41867414|FG002|Overall Study|Study Terminated by Sponsor|17|||
19500473|NCT01602120|41867415|FG003|Overall Study|Study Terminated by Sponsor|44|||
19500474|NCT01602120|41867412|FG000|Overall Study|Physician Decision|2|||
19500475|NCT01602120|41867413|FG001|Overall Study|Physician Decision|3|||
19500476|NCT01602120|41867414|FG002|Overall Study|Physician Decision|0|||
19500477|NCT01602120|41867415|FG003|Overall Study|Physician Decision|0|||
19500478|NCT01602120|41867412|FG000|Overall Study|Unspecified Reason|3|||
19500479|NCT01602120|41867413|FG001|Overall Study|Unspecified Reason|1|||
19500480|NCT01602120|41867414|FG002|Overall Study|Unspecified Reason|0|||
19500481|NCT01602120|41867415|FG003|Overall Study|Unspecified Reason|2|||
19500482|NCT02049515|41868291|FG000|Overall Study|Adverse Event|46|||
19500483|NCT02049515|41868292|FG001|Overall Study|Adverse Event|2|||
19500484|NCT02049515|41868291|FG000|Overall Study|Protocol-specified Disease Progression|23|||
19500485|NCT02049515|41868292|FG001|Overall Study|Protocol-specified Disease Progression|2|||
19500486|NCT02049515|41868291|FG000|Overall Study|Death|6|||
19500487|NCT02049515|41868292|FG001|Overall Study|Death|0|||
19500488|NCT02049515|41868291|FG000|Overall Study|Physician Decision|5|||
19500489|NCT02049515|41868292|FG001|Overall Study|Physician Decision|1|||
19500490|NCT02049515|41868291|FG000|Overall Study|Withdrawal by Subject|3|||
19500491|NCT02049515|41868292|FG001|Overall Study|Withdrawal by Subject|0|||
19500492|NCT02049515|41868291|FG000|Overall Study|Termination of the Study by Sponsor|2|||
19500493|NCT02049515|41868292|FG001|Overall Study|Termination of the Study by Sponsor|0|||
19500494|NCT02049515|41868291|FG000|Overall Study|Protocol Violation|1|||
19500495|NCT02049515|41868292|FG001|Overall Study|Protocol Violation|1|||
19500496|NCT02049515|41868291|FG000|Overall Study|Clinical Deterioration|1|||
19500497|NCT02049515|41868292|FG001|Overall Study|Clinical Deterioration|0|||
19500498|NCT02049515|41868291|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
19500499|NCT02049515|41868292|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
19500500|NCT02049515|41868291|FG000|Overall Study|Treatment Interruption >42 Days|1|||
19500501|NCT02049515|41868292|FG001|Overall Study|Treatment Interruption >42 Days|0|||
19500502|NCT02049515|41868291|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
19500503|NCT02049515|41868292|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
19500504|NCT04436744|41868827|FG000|Overall Study|Adverse Event|1|||
19500505|NCT04436744|41868828|FG001|Overall Study|Adverse Event|1|||
19500506|NCT04436744|41868827|FG000|Overall Study|Death|1|||
19500507|NCT04436744|41868828|FG001|Overall Study|Death|0|||
19614120|NCT00605215|42062837|FG002|Overall Study|Death|1|||
19614121|NCT00605215|42062835|FG000|Overall Study|Adverse Event|19|||
19614122|NCT00605215|42062836|FG001|Overall Study|Adverse Event|21|||
19614123|NCT00605215|42062837|FG002|Overall Study|Adverse Event|26|||
19614124|NCT00605215|42062835|FG000|Overall Study|Refusal to sign the re-consent form|8|||
19614125|NCT00605215|42062836|FG001|Overall Study|Refusal to sign the re-consent form|3|||
19614126|NCT00605215|42062837|FG002|Overall Study|Refusal to sign the re-consent form|3|||
19614127|NCT00605215|42062835|FG000|Overall Study|Withdrawal by Subject|39|||
19614128|NCT00605215|42062836|FG001|Overall Study|Withdrawal by Subject|37|||
19614129|NCT00605215|42062837|FG002|Overall Study|Withdrawal by Subject|27|||
19614130|NCT00605215|42062835|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
19614131|NCT00605215|42062836|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
19614132|NCT00605215|42062837|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
19614133|NCT00605215|42062835|FG000|Overall Study|Protocol Violation|3|||
19614134|NCT00605215|42062836|FG001|Overall Study|Protocol Violation|4|||
19614135|NCT00605215|42062837|FG002|Overall Study|Protocol Violation|1|||
19614136|NCT00605215|42062835|FG000|Overall Study|Pregnancy|8|||
19614137|NCT00605215|42062836|FG001|Overall Study|Pregnancy|5|||
19614138|NCT00605215|42062837|FG002|Overall Study|Pregnancy|4|||
19614139|NCT00605215|42062835|FG000|Overall Study|Lost to Follow-up|8|||
19614140|NCT00605215|42062836|FG001|Overall Study|Lost to Follow-up|5|||
19393776|NCT02658175|41637670|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
19393777|NCT02658175|41637668|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
19393778|NCT02658175|41637669|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
19393779|NCT02658175|41637670|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
19393780|NCT02658175|41637668|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
19393781|NCT02658175|41637669|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
19393782|NCT02658175|41637670|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
19393783|NCT02658175|41637668|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
19393784|NCT02658175|41637669|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
19393785|NCT02658175|41637670|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
19393786|NCT02658175|41637668|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
19500508|NCT04436744|41868827|FG000|Overall Study|Lost to Follow-up|0|||
19500509|NCT04436744|41868828|FG001|Overall Study|Lost to Follow-up|2|||
19500510|NCT04436744|41868827|FG000|Overall Study|Physician Decision|0|||
19500511|NCT04436744|41868828|FG001|Overall Study|Physician Decision|1|||
19500512|NCT04436744|41868827|FG000|Overall Study|Progressive Disease|0|||
19393787|NCT02658175|41637669|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
19393788|NCT02658175|41637670|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
19500513|NCT04436744|41868828|FG001|Overall Study|Progressive Disease|4|||
19500514|NCT04436744|41868827|FG000|Overall Study|Protocol Deviation|1|||
19500515|NCT04436744|41868828|FG001|Overall Study|Protocol Deviation|1|||
19500516|NCT04436744|41868827|FG000|Overall Study|Withdrawal by Subject|1|||
19614141|NCT00605215|42062837|FG002|Overall Study|Lost to Follow-up|2|||
19500517|NCT04436744|41868828|FG001|Overall Study|Withdrawal by Subject|2|||
19500518|NCT04359758|41868868|FG000|Overall Study|Lost to Follow-up|0|||
19500519|NCT04359758|41868869|FG001|Overall Study|Lost to Follow-up|2|||
19500520|NCT04359758|41868868|FG000|Overall Study|Protocol Violation|3|||
19500521|NCT04359758|41868869|FG001|Overall Study|Protocol Violation|0|||
19500522|NCT02243306|41868984|FG000|Overall Study|Adverse Event|0|||
19500523|NCT02243306|41868985|FG001|Overall Study|Adverse Event|1|||
19614142|NCT00605215|42062835|FG000|Overall Study|Other than specified|0|||
19614143|NCT00605215|42062836|FG001|Overall Study|Other than specified|2|||
19614144|NCT00605215|42062837|FG002|Overall Study|Other than specified|1|||
19614145|NCT00604279|42062847|FG000|Overall Study|Lack of Efficacy|22|||
19614146|NCT00604279|42062848|FG001|Overall Study|Lack of Efficacy|9|||
19614147|NCT00604279|42062847|FG000|Overall Study|Lost to Follow-up|9|||
19614148|NCT00604279|42062848|FG001|Overall Study|Lost to Follow-up|14|||
19614149|NCT00604279|42062847|FG000|Overall Study|Pregnancy|2|||
19614150|NCT00604279|42062848|FG001|Overall Study|Pregnancy|0|||
19614151|NCT00604279|42062847|FG000|Overall Study|Protocol Violation|3|||
19500524|NCT02243306|41868984|FG000|Overall Study|Other: Reached stopping criteria|0|||
19500525|NCT02243306|41868985|FG001|Overall Study|Other: Reached stopping criteria|1|||
19500526|NCT02243306|41868984|FG000|Overall Study|Physician Decision|0|||
19500527|NCT02243306|41868985|FG001|Overall Study|Physician Decision|1|||
19500528|NCT03214679|41869145|FG000|Overall Study|Lost to Follow-up|12|||
19500529|NCT03214679|41869146|FG001|Overall Study|Lost to Follow-up|14|||
19500530|NCT03214679|41869145|FG000|Overall Study|not eligible|2|||
19500531|NCT03214679|41869146|FG001|Overall Study|not eligible|0|||
19500532|NCT01602380|41869493|FG000|Overall Study|Death|63|||
19500533|NCT01602380|41869494|FG001|Overall Study|Death|68|||
19500534|NCT01602380|41869493|FG000|Overall Study|Withdrawal by Subject|22|||
19500535|NCT01602380|41869494|FG001|Overall Study|Withdrawal by Subject|29|||
19500536|NCT01602380|41869493|FG000|Overall Study|Lost to Follow-up|6|||
19500537|NCT01602380|41869494|FG001|Overall Study|Lost to Follow-up|1|||
19393789|NCT02625623|41637680|FG000|Overall Study|Participants randomized but not treated|9|||
19393790|NCT02625623|41637681|FG001|Overall Study|Participants randomized but not treated|1|||
19393791|NCT02658019|41637689|FG000|Overall Study|Adverse Event|1|||
19500538|NCT01602380|41869493|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19500539|NCT01602380|41869494|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
19500540|NCT01242800|41869529|FG000|Overall Study|Patient refusal|0|||
19500541|NCT01242800|41869530|FG001|Overall Study|Patient refusal|10|||
19500542|NCT01242800|41869529|FG000|Overall Study|Physician Decision|0|||
19500543|NCT01242800|41869530|FG001|Overall Study|Physician Decision|1|||
19500544|NCT01242800|41869529|FG000|Overall Study|Disease progression|0|||
19500545|NCT01242800|41869530|FG001|Overall Study|Disease progression|3|||
19500546|NCT01242800|41869529|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
19500547|NCT01242800|41869530|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
19500548|NCT01242800|41869529|FG000|Overall Study|Reasons not reported|0|||
19500549|NCT01242800|41869530|FG001|Overall Study|Reasons not reported|4|||
19500550|NCT01349465|41870455|FG000|Overall Study|Adverse Event|1|||
19614152|NCT00604279|42062848|FG001|Overall Study|Protocol Violation|1|||
19614153|NCT00604279|42062847|FG000|Overall Study|Withdrawal by Subject|16|||
19500551|NCT01349465|41870456|FG001|Overall Study|Adverse Event|0|||
19500552|NCT01349465|41870455|FG000|Overall Study|Death|3|||
19500553|NCT01349465|41870456|FG001|Overall Study|Death|0|||
19500554|NCT01349465|41870455|FG000|Overall Study|Lost to Follow-up|10|||
19500555|NCT01349465|41870456|FG001|Overall Study|Lost to Follow-up|1|||
19500556|NCT01349465|41870455|FG000|Overall Study|Withdrawal by Subject|4|||
19614154|NCT00604279|42062848|FG001|Overall Study|Withdrawal by Subject|5|||
19614155|NCT00604279|42062847|FG000|Overall Study|Adverse Event|4|||
19393792|NCT02624687|41637695|FG000|Overall Study|Withdrawal by Subject|1|||
19500557|NCT01349465|41870456|FG001|Overall Study|Withdrawal by Subject|2|||
19500558|NCT01349465|41870455|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
19500559|NCT01349465|41870456|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
19500560|NCT01648764|41871575|FG000|Overall Study|Progressive Disease|0|||
19500561|NCT01648764|41871576|FG001|Overall Study|Progressive Disease|1|||
19500562|NCT01648764|41871577|FG002|Overall Study|Progressive Disease|0|||
19500563|NCT01648764|41871578|FG003|Overall Study|Progressive Disease|0|||
19500564|NCT01648764|41871579|FG004|Overall Study|Progressive Disease|0|||
19500565|NCT01648764|41871580|FG005|Overall Study|Progressive Disease|1|||
19500566|NCT01648764|41871581|FG006|Overall Study|Progressive Disease|1|||
19500567|NCT01648764|41871582|FG007|Overall Study|Progressive Disease|0|||
19500568|NCT01648764|41871583|FG008|Overall Study|Progressive Disease|0|||
19500569|NCT01648764|41871584|FG009|Overall Study|Progressive Disease|2|||
19500570|NCT01648764|41871585|FG010|Overall Study|Progressive Disease|0|||
19500571|NCT01648764|41871586|FG011|Overall Study|Progressive Disease|1|||
19500572|NCT01648764|41871587|FG012|Overall Study|Progressive Disease|2|||
19500573|NCT01648764|41871588|FG013|Overall Study|Progressive Disease|1|||
19393793|NCT02624687|41637696|FG001|Overall Study|Withdrawal by Subject|1|||
19500574|NCT01648764|41871575|FG000|Overall Study|Adverse Event|0|||
19500575|NCT01648764|41871576|FG001|Overall Study|Adverse Event|0|||
19500576|NCT01648764|41871577|FG002|Overall Study|Adverse Event|0|||
19500577|NCT01648764|41871578|FG003|Overall Study|Adverse Event|0|||
19500578|NCT01648764|41871579|FG004|Overall Study|Adverse Event|0|||
19500579|NCT01648764|41871580|FG005|Overall Study|Adverse Event|1|||
19500580|NCT01648764|41871581|FG006|Overall Study|Adverse Event|0|||
19500581|NCT01648764|41871582|FG007|Overall Study|Adverse Event|0|||
19500582|NCT01648764|41871583|FG008|Overall Study|Adverse Event|0|||
19500583|NCT01648764|41871584|FG009|Overall Study|Adverse Event|1|||
19500584|NCT01648764|41871585|FG010|Overall Study|Adverse Event|0|||
19500585|NCT01648764|41871586|FG011|Overall Study|Adverse Event|3|||
19500586|NCT01648764|41871587|FG012|Overall Study|Adverse Event|1|||
19500587|NCT01648764|41871588|FG013|Overall Study|Adverse Event|1|||
19500588|NCT01648764|41871575|FG000|Overall Study|Death|0|||
19500589|NCT01648764|41871576|FG001|Overall Study|Death|0|||
19500590|NCT01648764|41871577|FG002|Overall Study|Death|0|||
19500591|NCT01648764|41871578|FG003|Overall Study|Death|0|||
19500592|NCT01648764|41871579|FG004|Overall Study|Death|0|||
19500593|NCT01648764|41871580|FG005|Overall Study|Death|0|||
19500594|NCT01648764|41871581|FG006|Overall Study|Death|1|||
19500595|NCT01648764|41871582|FG007|Overall Study|Death|0|||
19500596|NCT01648764|41871583|FG008|Overall Study|Death|0|||
19500597|NCT01648764|41871584|FG009|Overall Study|Death|0|||
19500598|NCT01648764|41871585|FG010|Overall Study|Death|0|||
19500599|NCT01648764|41871586|FG011|Overall Study|Death|0|||
19500600|NCT01648764|41871587|FG012|Overall Study|Death|0|||
19500601|NCT01648764|41871588|FG013|Overall Study|Death|1|||
19500602|NCT01648764|41871575|FG000|Overall Study|Withdrawal by Subject|0|||
19500603|NCT01648764|41871576|FG001|Overall Study|Withdrawal by Subject|0|||
19500604|NCT01648764|41871577|FG002|Overall Study|Withdrawal by Subject|0|||
19500605|NCT01648764|41871578|FG003|Overall Study|Withdrawal by Subject|0|||
19500606|NCT01648764|41871579|FG004|Overall Study|Withdrawal by Subject|0|||
19500607|NCT01648764|41871580|FG005|Overall Study|Withdrawal by Subject|0|||
19500608|NCT01648764|41871581|FG006|Overall Study|Withdrawal by Subject|2|||
19500609|NCT01648764|41871582|FG007|Overall Study|Withdrawal by Subject|0|||
19500610|NCT01648764|41871583|FG008|Overall Study|Withdrawal by Subject|0|||
19500611|NCT01648764|41871584|FG009|Overall Study|Withdrawal by Subject|0|||
19500612|NCT01648764|41871585|FG010|Overall Study|Withdrawal by Subject|0|||
19500613|NCT01648764|41871586|FG011|Overall Study|Withdrawal by Subject|0|||
19500614|NCT01648764|41871587|FG012|Overall Study|Withdrawal by Subject|1|||
19500615|NCT01648764|41871588|FG013|Overall Study|Withdrawal by Subject|0|||
19500616|NCT01648764|41871575|FG000|Overall Study|Investigator Decision|0|||
19500617|NCT01648764|41871576|FG001|Overall Study|Investigator Decision|0|||
19500618|NCT01648764|41871577|FG002|Overall Study|Investigator Decision|0|||
19500619|NCT01648764|41871578|FG003|Overall Study|Investigator Decision|0|||
19500620|NCT01648764|41871579|FG004|Overall Study|Investigator Decision|0|||
19500621|NCT01648764|41871580|FG005|Overall Study|Investigator Decision|0|||
19500622|NCT01648764|41871581|FG006|Overall Study|Investigator Decision|1|||
19500623|NCT01648764|41871582|FG007|Overall Study|Investigator Decision|0|||
19500624|NCT01648764|41871583|FG008|Overall Study|Investigator Decision|0|||
19500625|NCT01648764|41871584|FG009|Overall Study|Investigator Decision|0|||
19500626|NCT01648764|41871585|FG010|Overall Study|Investigator Decision|0|||
19500627|NCT01648764|41871586|FG011|Overall Study|Investigator Decision|1|||
19500628|NCT01648764|41871587|FG012|Overall Study|Investigator Decision|0|||
19500629|NCT01648764|41871588|FG013|Overall Study|Investigator Decision|0|||
19500630|NCT02364336|41871624|FG000|Overall Study|Adverse Event|0|||
19500631|NCT02364336|41871625|FG001|Overall Study|Adverse Event|1|||
19500632|NCT02810951|41871856|FG000|Overall Study|Adverse Event|1|||
19500633|NCT02310906|41871952|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
19500634|NCT02310906|41871953|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
19500635|NCT02310906|41871954|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
19500636|NCT02310906|41871955|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
19500637|NCT02310906|41871952|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
19500638|NCT02310906|41871953|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
19500639|NCT02310906|41871954|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
19500640|NCT02310906|41871955|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
19500641|NCT02310906|41871952|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
19614156|NCT00604279|42062848|FG001|Overall Study|Adverse Event|5|||
19614157|NCT00604279|42062847|FG000|Overall Study|Other|8|||
19614158|NCT00604279|42062848|FG001|Overall Study|Other|4|||
19500642|NCT02310906|41871953|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
19500643|NCT02310906|41871954|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
19500644|NCT02310906|41871955|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
19614159|NCT00938015|42062854|FG000|Overall Study|Death|2|||
19500645|NCT02310906|41871952|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
19500646|NCT02310906|41871953|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
19614160|NCT00938015|42062854|FG000|Overall Study|Lost to Follow-up|32|||
19614161|NCT00938015|42062854|FG000|Overall Study|Adverse Event|32|||
19614162|NCT00938015|42062854|FG000|Overall Study|Non-responder|52|||
19614163|NCT00938015|42062854|FG000|Overall Study|Reason not related to Etanercept|29|||
19614164|NCT00781911|42062860|FG000|Overall Study|Adverse Event|4|||
19614165|NCT00781911|42062861|FG001|Overall Study|Adverse Event|4|||
19614166|NCT00781911|42062860|FG000|Overall Study|Withdrawal by Subject|1|||
19614167|NCT00781911|42062861|FG001|Overall Study|Withdrawal by Subject|2|||
19614168|NCT00781911|42062860|FG000|Overall Study|Physician Decision|0|||
19614169|NCT00781911|42062861|FG001|Overall Study|Physician Decision|2|||
19500647|NCT02310906|41871954|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
19500648|NCT02310906|41871955|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
19500649|NCT02340780|41871996|FG000|Overall Study|Ineligible|1|||
19500650|NCT02340078|41872009|FG000|Overall Study|Protocol Violation|1|||
19500651|NCT02340000|41872025|FG000|Time Period 1|Withdrawal by Subject|6|||
19500652|NCT02340000|41872026|FG001|Time Period 1|Withdrawal by Subject|8|||
19500653|NCT02340000|41872025|FG000|Time Period 1|Lost to Follow-up|6|||
19500654|NCT02340000|41872026|FG001|Time Period 1|Lost to Follow-up|7|||
19500655|NCT02340000|41872025|FG000|Time Period 2|Withdrawal by Subject|9|||
19500656|NCT02340000|41872026|FG001|Time Period 2|Withdrawal by Subject|7|||
19500657|NCT02340000|41872025|FG000|Time Period 2|Lost to Follow-up|10|||
19500658|NCT02340000|41872026|FG001|Time Period 2|Lost to Follow-up|8|||
19500659|NCT02364180|41872057|FG000|Overall Study|Screen Fail|1|||
19500660|NCT02310750|41872706|FG000|HP Period 1|Lost to Follow-up|0|||
19500661|NCT02310750|41872707|FG001|HP Period 1|Lost to Follow-up|0|||
19500662|NCT02310750|41872708|FG002|HP Period 1|Lost to Follow-up|0|||
19500663|NCT02310750|41872709|FG003|HP Period 1|Lost to Follow-up|0|||
19500664|NCT02310750|41872710|FG004|HP Period 1|Lost to Follow-up|0|||
19500665|NCT02310750|41872711|FG005|HP Period 1|Lost to Follow-up|0|||
19500666|NCT02310750|41872712|FG006|HP Period 1|Lost to Follow-up|1|||
19500667|NCT02310750|41872713|FG007|HP Period 1|Lost to Follow-up|0|||
19500668|NCT02310750|41872714|FG008|HP Period 1|Lost to Follow-up|0|||
19500669|NCT02310750|41872715|FG009|HP Period 1|Lost to Follow-up|0|||
19500670|NCT02310750|41872716|FG010|HP Period 1|Lost to Follow-up|0|||
19500671|NCT02310750|41872717|FG011|HP Period 1|Lost to Follow-up|0|||
19500672|NCT02310750|41872718|FG012|HP Period 1|Lost to Follow-up|0|||
19500673|NCT02310750|41872719|FG013|HP Period 1|Lost to Follow-up|0|||
19500674|NCT02310750|41872720|FG014|HP Period 1|Lost to Follow-up|0|||
19614170|NCT00781911|42062860|FG000|Overall Study|Sponsor Decision|1|||
19614171|NCT00781911|42062861|FG001|Overall Study|Sponsor Decision|0|||
19614172|NCT00605917|42062869|FG000|Overall Study|Protocol Violation|79|||
19614173|NCT00781599|42062906|FG000|Overall Study|Lost to Follow-up|7|||
19614174|NCT00781599|42062907|FG001|Overall Study|Lost to Follow-up|4|||
19614175|NCT00605839|42062925|FG000|Overall Study|Protocol Violation|1|||
19614176|NCT00605839|42062926|FG001|Overall Study|Protocol Violation|0|||
19614177|NCT00605839|42062927|FG002|Overall Study|Protocol Violation|0|||
19500675|NCT02310750|41872721|FG015|HP Period 1|Lost to Follow-up|0|||
19500676|NCT02310750|41872706|FG000|HP Period 1|Withdrawal by Subject|1|||
19500677|NCT02310750|41872707|FG001|HP Period 1|Withdrawal by Subject|0|||
19500678|NCT02310750|41872708|FG002|HP Period 1|Withdrawal by Subject|0|||
19500679|NCT02310750|41872709|FG003|HP Period 1|Withdrawal by Subject|1|||
19500680|NCT02310750|41872710|FG004|HP Period 1|Withdrawal by Subject|0|||
19500681|NCT02310750|41872711|FG005|HP Period 1|Withdrawal by Subject|0|||
19500682|NCT02310750|41872712|FG006|HP Period 1|Withdrawal by Subject|0|||
19500683|NCT02310750|41872713|FG007|HP Period 1|Withdrawal by Subject|0|||
19500684|NCT02310750|41872714|FG008|HP Period 1|Withdrawal by Subject|0|||
19500685|NCT02310750|41872715|FG009|HP Period 1|Withdrawal by Subject|0|||
19500686|NCT02310750|41872716|FG010|HP Period 1|Withdrawal by Subject|0|||
19500687|NCT02310750|41872717|FG011|HP Period 1|Withdrawal by Subject|0|||
19500688|NCT02310750|41872718|FG012|HP Period 1|Withdrawal by Subject|0|||
19500689|NCT02310750|41872719|FG013|HP Period 1|Withdrawal by Subject|0|||
19500690|NCT02310750|41872720|FG014|HP Period 1|Withdrawal by Subject|0|||
19500691|NCT02310750|41872721|FG015|HP Period 1|Withdrawal by Subject|0|||
19500692|NCT02310750|41872706|FG000|HP Washout 1|Lost to Follow-up|0|||
19500693|NCT02310750|41872707|FG001|HP Washout 1|Lost to Follow-up|0|||
19500694|NCT02310750|41872708|FG002|HP Washout 1|Lost to Follow-up|1|||
19500695|NCT02310750|41872709|FG003|HP Washout 1|Lost to Follow-up|1|||
19500696|NCT02310750|41872710|FG004|HP Washout 1|Lost to Follow-up|2|||
19500697|NCT02310750|41872711|FG005|HP Washout 1|Lost to Follow-up|2|||
19614178|NCT00781365|42062937|FG000|Overall Study|Withdrawal by Subject|13|||
19500698|NCT02310750|41872712|FG006|HP Washout 1|Lost to Follow-up|3|||
19500699|NCT02310750|41872713|FG007|HP Washout 1|Lost to Follow-up|0|||
19500700|NCT02310750|41872714|FG008|HP Washout 1|Lost to Follow-up|0|||
19500701|NCT02310750|41872715|FG009|HP Washout 1|Lost to Follow-up|0|||
19500702|NCT02310750|41872716|FG010|HP Washout 1|Lost to Follow-up|0|||
19500703|NCT02310750|41872717|FG011|HP Washout 1|Lost to Follow-up|0|||
19500704|NCT02310750|41872718|FG012|HP Washout 1|Lost to Follow-up|0|||
19500705|NCT02310750|41872719|FG013|HP Washout 1|Lost to Follow-up|0|||
19500706|NCT02310750|41872720|FG014|HP Washout 1|Lost to Follow-up|0|||
19500707|NCT02310750|41872721|FG015|HP Washout 1|Lost to Follow-up|0|||
19614179|NCT00781365|42062938|FG001|Overall Study|Withdrawal by Subject|8|||
19500708|NCT02310750|41872706|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500709|NCT02310750|41872707|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500710|NCT02310750|41872708|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19614180|NCT00781365|42062937|FG000|Overall Study|Did Not Attend Visit|20|||
19614181|NCT00781365|42062938|FG001|Overall Study|Did Not Attend Visit|28|||
19500711|NCT02310750|41872709|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
19500712|NCT02310750|41872710|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500713|NCT02310750|41872711|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
19500714|NCT02310750|41872712|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500715|NCT02310750|41872713|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500716|NCT02310750|41872714|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
19500717|NCT02310750|41872715|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
19500718|NCT02310750|41872716|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500719|NCT02310750|41872717|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500720|NCT02310750|41872718|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500721|NCT02310750|41872719|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500722|NCT02310750|41872720|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19614182|NCT00781365|42062937|FG000|Overall Study|Language barrier|1|||
19614183|NCT00781365|42062938|FG001|Overall Study|Language barrier|0|||
19614184|NCT00937547|42062947|FG000|Overall Study|misdiagnosis|1|||
19614185|NCT00937547|42062948|FG001|Overall Study|misdiagnosis|6|||
19614186|NCT00937547|42062949|FG002|Overall Study|misdiagnosis|7|||
19614187|NCT00780975|42062957|FG000|Overall Study|Progressive disease|3|||
19500723|NCT02310750|41872721|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
19500724|NCT02310750|41872706|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500725|NCT02310750|41872707|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500726|NCT02310750|41872708|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500727|NCT02310750|41872709|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500728|NCT02310750|41872710|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500729|NCT02310750|41872711|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500730|NCT02310750|41872712|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500731|NCT02310750|41872713|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500732|NCT02310750|41872714|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500733|NCT02310750|41872715|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
19500734|NCT02310750|41872716|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500735|NCT02310750|41872717|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500736|NCT02310750|41872718|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500737|NCT02310750|41872719|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500738|NCT02310750|41872720|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500739|NCT02310750|41872721|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
19500740|NCT02310750|41872706|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500741|NCT02310750|41872707|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500742|NCT02310750|41872708|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500743|NCT02310750|41872709|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500744|NCT02310750|41872710|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500745|NCT02310750|41872711|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500746|NCT02310750|41872712|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500747|NCT02310750|41872713|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
19500748|NCT02310750|41872714|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
19500749|NCT02310750|41872715|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
19500750|NCT02310750|41872716|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500751|NCT02310750|41872717|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500752|NCT02310750|41872718|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500753|NCT02310750|41872719|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500754|NCT02310750|41872720|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500755|NCT02310750|41872721|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
19500756|NCT02310750|41872706|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500757|NCT02310750|41872707|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19614188|NCT00780975|42062957|FG000|Overall Study|Toxicity|5|||
19614189|NCT00780273|42062961|FG000|Overall Study|Death|1|||
19614190|NCT00780273|42062961|FG000|Overall Study|Lost to Follow-up|1|||
19614191|NCT00779259|42062966|FG000|Quinine Alone|Adverse Event|2|||
19614192|NCT00779025|42062984|FG000|Overall Study|Withdrawal by Subject|1|||
19614193|NCT00936065|42062992|FG000|Overall Study|Adverse Event|1|||
19614194|NCT00936065|42062993|FG001|Overall Study|Adverse Event|0|||
19614195|NCT00936065|42062994|FG002|Overall Study|Adverse Event|1|||
19614196|NCT00936065|42062992|FG000|Overall Study|Lack of Efficacy|1|||
19614197|NCT00936065|42062993|FG001|Overall Study|Lack of Efficacy|0|||
19614198|NCT00936065|42062994|FG002|Overall Study|Lack of Efficacy|1|||
19614199|NCT00936065|42062992|FG000|Overall Study|Lost to Follow-up|1|||
19500758|NCT02310750|41872708|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500759|NCT02310750|41872709|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500760|NCT02310750|41872710|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500761|NCT02310750|41872711|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500762|NCT02310750|41872712|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500763|NCT02310750|41872713|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
19500764|NCT02310750|41872714|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
19500765|NCT02310750|41872715|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500766|NCT02310750|41872716|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500767|NCT02310750|41872717|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500768|NCT02310750|41872718|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500769|NCT02310750|41872719|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500770|NCT02310750|41872720|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500771|NCT02310750|41872721|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
19500772|NCT02310750|41872706|FG000|HP Washout 2|Lost to Follow-up|0|||
19500773|NCT02310750|41872707|FG001|HP Washout 2|Lost to Follow-up|0|||
19500774|NCT02310750|41872708|FG002|HP Washout 2|Lost to Follow-up|0|||
19500775|NCT02310750|41872709|FG003|HP Washout 2|Lost to Follow-up|0|||
19500776|NCT02310750|41872710|FG004|HP Washout 2|Lost to Follow-up|1|||
19500777|NCT02310750|41872711|FG005|HP Washout 2|Lost to Follow-up|0|||
19500778|NCT02310750|41872712|FG006|HP Washout 2|Lost to Follow-up|7|||
19500779|NCT02310750|41872713|FG007|HP Washout 2|Lost to Follow-up|0|||
19500780|NCT02310750|41872714|FG008|HP Washout 2|Lost to Follow-up|0|||
19500781|NCT02310750|41872715|FG009|HP Washout 2|Lost to Follow-up|0|||
19500782|NCT02310750|41872716|FG010|HP Washout 2|Lost to Follow-up|0|||
19500783|NCT02310750|41872717|FG011|HP Washout 2|Lost to Follow-up|0|||
19500784|NCT02310750|41872718|FG012|HP Washout 2|Lost to Follow-up|0|||
19500785|NCT02310750|41872719|FG013|HP Washout 2|Lost to Follow-up|0|||
19500786|NCT02310750|41872720|FG014|HP Washout 2|Lost to Follow-up|0|||
19500787|NCT02310750|41872721|FG015|HP Washout 2|Lost to Follow-up|0|||
19500788|NCT02310672|41872826|FG000|Overall Study|Death|1|||
19500789|NCT02310672|41872826|FG000|Overall Study|Lost to Follow-up|1|||
19500790|NCT02310672|41872826|FG000|Overall Study|Withdrawal by Subject|1|||
19500791|NCT02310672|41872826|FG000|Overall Study|Sponsor's decision|12|||
19500792|NCT02363946|41872972|FG000|Overall Study|Lost to Follow-up|0|||
19500793|NCT02363946|41872973|FG001|Overall Study|Lost to Follow-up|0|||
19500794|NCT02363946|41872974|FG002|Overall Study|Lost to Follow-up|0|||
19500795|NCT02363946|41872975|FG003|Overall Study|Lost to Follow-up|0|||
19500796|NCT02363946|41872976|FG004|Overall Study|Lost to Follow-up|0|||
19500797|NCT02363946|41872977|FG005|Overall Study|Lost to Follow-up|0|||
19500798|NCT02363946|41872978|FG006|Overall Study|Lost to Follow-up|0|||
19500799|NCT02363946|41872979|FG007|Overall Study|Lost to Follow-up|1|||
19500800|NCT02363946|41872980|FG008|Overall Study|Lost to Follow-up|0|||
19500801|NCT02363946|41872981|FG009|Overall Study|Lost to Follow-up|0|||
19500802|NCT02363946|41872982|FG010|Overall Study|Lost to Follow-up|0|||
19500803|NCT02363946|41872983|FG011|Overall Study|Lost to Follow-up|0|||
19500804|NCT02363946|41872984|FG012|Overall Study|Lost to Follow-up|0|||
19500805|NCT02363478|41873012|FG000|Overall Study|Lost to Follow-up|4|||
19500806|NCT02363478|41873012|FG000|Overall Study|Adverse Event|4|||
19500807|NCT02310126|41873019|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
19500808|NCT02310126|41873020|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
19500809|NCT02310126|41873019|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
19500810|NCT02310126|41873020|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
19500811|NCT02338362|41873028|FG000|Overall Study|Withdrawal by Subject|1|||
19500812|NCT02338362|41873029|FG001|Overall Study|Withdrawal by Subject|1|||
19500813|NCT02363322|41873037|FG000|Overall Study|Lost to Follow-up|1|||
19500814|NCT02363322|41873038|FG001|Overall Study|Lost to Follow-up|0|||
19500815|NCT02361762|41873046|FG000|Overall Study|Withdrawal by Subject|0|||
19614200|NCT00936065|42062993|FG001|Overall Study|Lost to Follow-up|0|||
19614201|NCT00936065|42062994|FG002|Overall Study|Lost to Follow-up|0|||
19614202|NCT00936065|42062992|FG000|Overall Study|Protocol Violation|1|||
19500816|NCT02361762|41873047|FG001|Overall Study|Withdrawal by Subject|1|||
19500817|NCT02361762|41873046|FG000|Overall Study|Lost to Follow-up|0|||
19500818|NCT02361762|41873047|FG001|Overall Study|Lost to Follow-up|1|||
19500819|NCT02337738|41873056|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
19500820|NCT02337738|41873057|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
19500821|NCT02337738|41873058|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
19500822|NCT02337738|41873056|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
19500823|NCT02337738|41873057|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
19500824|NCT02337738|41873058|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
19500825|NCT02337738|41873056|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
19500826|NCT02337738|41873057|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
19500827|NCT02337738|41873058|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
19614203|NCT00936065|42062993|FG001|Overall Study|Protocol Violation|2|||
19614204|NCT00936065|42062994|FG002|Overall Study|Protocol Violation|1|||
19614205|NCT00936065|42062992|FG000|Overall Study|Withdrawal by Subject|0|||
19614206|NCT00936065|42062993|FG001|Overall Study|Withdrawal by Subject|2|||
19614207|NCT00936065|42062994|FG002|Overall Study|Withdrawal by Subject|4|||
19614208|NCT04441788|42063005|FG000|Overall Study|Voluntary Withdrawl|0|||
19614209|NCT04441788|42063006|FG001|Overall Study|Voluntary Withdrawl|1|||
19614210|NCT04441788|42063007|FG002|Overall Study|Voluntary Withdrawl|0|||
19614211|NCT04441788|42063005|FG000|Overall Study|Ineligibility|1|||
19614212|NCT04441788|42063006|FG001|Overall Study|Ineligibility|0|||
19614213|NCT04441788|42063007|FG002|Overall Study|Ineligibility|0|||
19614214|NCT04441788|42063005|FG000|Overall Study|Adverse Event|0|||
19614215|NCT04441788|42063006|FG001|Overall Study|Adverse Event|0|||
19614216|NCT04441788|42063007|FG002|Overall Study|Adverse Event|4|||
19614217|NCT04441788|42063005|FG000|Overall Study|Study Terminated by Sponsor|16|||
19614218|NCT04441788|42063006|FG001|Overall Study|Study Terminated by Sponsor|16|||
19614219|NCT04441788|42063007|FG002|Overall Study|Study Terminated by Sponsor|12|||
19500828|NCT02337738|41873056|FG000|Overall Study|Voluntary Withdrawal|10|||
19500829|NCT02337738|41873057|FG001|Overall Study|Voluntary Withdrawal|5|||
19500830|NCT02337738|41873058|FG002|Overall Study|Voluntary Withdrawal|2|||
19500831|NCT02337738|41873056|FG000|Overall Study|Lack of Efficacy|2|||
19500832|NCT02337738|41873057|FG001|Overall Study|Lack of Efficacy|4|||
19500833|NCT02337738|41873058|FG002|Overall Study|Lack of Efficacy|0|||
19500834|NCT02337738|41873056|FG000|Overall Study|Investigator's Judgment|1|||
19500835|NCT02337738|41873057|FG001|Overall Study|Investigator's Judgment|1|||
19500836|NCT02337738|41873058|FG002|Overall Study|Investigator's Judgment|3|||
19500837|NCT02309112|41873069|FG000|Overall Study|Withdrawal by Subject|1|||
19500838|NCT02309112|41873070|FG001|Overall Study|Withdrawal by Subject|0|||
19500839|NCT02309112|41873071|FG002|Overall Study|Withdrawal by Subject|1|||
19500840|NCT02309112|41873069|FG000|Overall Study|Lost to Follow-up|0|||
19500841|NCT02309112|41873070|FG001|Overall Study|Lost to Follow-up|1|||
19614220|NCT00604825|42063023|FG000|Overall Study|Adverse Event|2|||
19614221|NCT00604825|42063024|FG001|Overall Study|Adverse Event|6|||
19614222|NCT00604825|42063025|FG002|Overall Study|Adverse Event|7|||
19614223|NCT00604825|42063026|FG003|Overall Study|Adverse Event|4|||
19614224|NCT00604825|42063023|FG000|Overall Study|Lost to Follow-up|0|||
19614225|NCT00604825|42063024|FG001|Overall Study|Lost to Follow-up|3|||
19614226|NCT00604825|42063025|FG002|Overall Study|Lost to Follow-up|1|||
19614227|NCT00604825|42063026|FG003|Overall Study|Lost to Follow-up|0|||
19614228|NCT00604825|42063023|FG000|Overall Study|Protocol Violation|0|||
19500842|NCT02309112|41873071|FG002|Overall Study|Lost to Follow-up|0|||
19704427|NCT00252174|42148776|FG001|Overall Study|Withdrawal by Subject|1|||
19500844|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
19500845|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
19500846|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
19500847|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
19500848|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
19500849|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
19500850|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
19500851|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
19500852|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
19500853|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
19500854|NCT02361216|41873087|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
19500855|NCT02361216|41873088|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
19500856|NCT02360280|41873099|FG000|Overall Study|Withdrawal by Subject|2|||
19500857|NCT02360280|41873100|FG001|Overall Study|Withdrawal by Subject|0|||
19500858|NCT02360280|41873099|FG000|Overall Study|Adverse Event|0|||
19500859|NCT02360280|41873100|FG001|Overall Study|Adverse Event|1|||
19500860|NCT02360280|41873099|FG000|Overall Study|Lost to Follow-up|1|||
19500861|NCT02360280|41873100|FG001|Overall Study|Lost to Follow-up|0|||
19500862|NCT00559988|41873530|FG000|Overall Study|Death|147|||
19500863|NCT00559988|41873531|FG001|Overall Study|Death|140|||
19500864|NCT00559988|41873530|FG000|Overall Study|Withdrawal by Subject|152|||
19500865|NCT00559988|41873531|FG001|Overall Study|Withdrawal by Subject|139|||
19500866|NCT00559988|41873530|FG000|Overall Study|Lost to Follow-up|42|||
19500867|NCT00559988|41873531|FG001|Overall Study|Lost to Follow-up|56|||
19500868|NCT00559988|41873530|FG000|Overall Study|ICD device explanted|10|||
19500869|NCT00559988|41873531|FG001|Overall Study|ICD device explanted|17|||
19500870|NCT00559754|41873593|FG000|Overall Study|Disease progression|1|||
19500871|NCT00559754|41873593|FG000|Overall Study|Adverse Event|5|||
19500872|NCT00559754|41873593|FG000|Overall Study|Protocol Violation|1|||
19614229|NCT00604825|42063024|FG001|Overall Study|Protocol Violation|1|||
19614230|NCT00604825|42063025|FG002|Overall Study|Protocol Violation|0|||
19614231|NCT00604825|42063026|FG003|Overall Study|Protocol Violation|0|||
19614232|NCT00604825|42063023|FG000|Overall Study|Withdrawal by Subject|4|||
19500873|NCT00559754|41873593|FG000|Overall Study|Investigator criteria|2|||
19500874|NCT00559754|41873593|FG000|Overall Study|Withdrawal by Subject|2|||
19500875|NCT00559364|41873707|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
19500876|NCT00559364|41873708|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
19500877|NCT02308020|41873771|FG000|Overall Study|Lost to Follow-up|1|||
19500878|NCT02308020|41873772|FG001|Overall Study|Lost to Follow-up|7|||
19500879|NCT02308020|41873773|FG002|Overall Study|Lost to Follow-up|0|||
19500880|NCT02308020|41873774|FG003|Overall Study|Lost to Follow-up|0|||
19500881|NCT02308020|41873775|FG004|Overall Study|Lost to Follow-up|1|||
19500882|NCT02308020|41873776|FG005|Overall Study|Lost to Follow-up|2|||
19500883|NCT02308020|41873771|FG000|Overall Study|Sponsor Decision|0|||
19500884|NCT02308020|41873772|FG001|Overall Study|Sponsor Decision|8|||
19500885|NCT02308020|41873773|FG002|Overall Study|Sponsor Decision|0|||
19500886|NCT02308020|41873774|FG003|Overall Study|Sponsor Decision|2|||
19500887|NCT02308020|41873775|FG004|Overall Study|Sponsor Decision|2|||
19500888|NCT02308020|41873776|FG005|Overall Study|Sponsor Decision|1|||
19500889|NCT02308020|41873771|FG000|Overall Study|Withdrawal by Subject|3|||
19500890|NCT02308020|41873772|FG001|Overall Study|Withdrawal by Subject|5|||
19500891|NCT02308020|41873773|FG002|Overall Study|Withdrawal by Subject|3|||
19500892|NCT02308020|41873774|FG003|Overall Study|Withdrawal by Subject|2|||
19500893|NCT02308020|41873775|FG004|Overall Study|Withdrawal by Subject|1|||
19500894|NCT02308020|41873776|FG005|Overall Study|Withdrawal by Subject|2|||
19500895|NCT02359890|41873796|FG000|Overall Study|Not meeting eligibility|4|||
19500896|NCT02359890|41873796|FG000|Overall Study|Never treated with study catheter|6|||
19500897|NCT02306850|41873800|FG000|Overall Study|Lack of Efficacy|2|||
19500898|NCT02306694|41873805|FG000|Overall Study|Withdrawal by Subject|3|||
19500899|NCT02306694|41873805|FG000|Overall Study|Lost to Follow-up|1|||
19500900|NCT01648140|41873817|FG000|Overall Study|Physician Decision|1|||
19500901|NCT01648140|41873818|FG001|Overall Study|Physician Decision|0|||
19500902|NCT01648140|41873819|FG002|Overall Study|Physician Decision|0|||
19500903|NCT01648140|41873820|FG003|Overall Study|Physician Decision|0|||
19500904|NCT01648140|41873817|FG000|Overall Study|Lack of Efficacy|4|||
19500905|NCT01648140|41873818|FG001|Overall Study|Lack of Efficacy|7|||
19500906|NCT01648140|41873819|FG002|Overall Study|Lack of Efficacy|1|||
19500907|NCT01648140|41873820|FG003|Overall Study|Lack of Efficacy|0|||
19500908|NCT01648140|41873817|FG000|Overall Study|Adverse Event|3|||
19500909|NCT01648140|41873818|FG001|Overall Study|Adverse Event|1|||
19500910|NCT01648140|41873819|FG002|Overall Study|Adverse Event|2|||
19500911|NCT01648140|41873820|FG003|Overall Study|Adverse Event|0|||
19500912|NCT01648140|41873817|FG000|Overall Study|Withdrawal by Subject|2|||
19614233|NCT00604825|42063024|FG001|Overall Study|Withdrawal by Subject|3|||
19614234|NCT00604825|42063025|FG002|Overall Study|Withdrawal by Subject|5|||
19614235|NCT00604825|42063026|FG003|Overall Study|Withdrawal by Subject|5|||
19614236|NCT00604825|42063023|FG000|Overall Study|Lack of Efficacy|3|||
19614237|NCT00604825|42063024|FG001|Overall Study|Lack of Efficacy|2|||
19614238|NCT00604825|42063025|FG002|Overall Study|Lack of Efficacy|1|||
19614239|NCT00604825|42063026|FG003|Overall Study|Lack of Efficacy|0|||
19614240|NCT00604825|42063023|FG000|Overall Study|Did not meet eligibility criteria|0|||
19614241|NCT00604825|42063024|FG001|Overall Study|Did not meet eligibility criteria|0|||
19614242|NCT00604825|42063025|FG002|Overall Study|Did not meet eligibility criteria|2|||
19614243|NCT00604825|42063026|FG003|Overall Study|Did not meet eligibility criteria|0|||
19614244|NCT00604825|42063023|FG000|Overall Study|Physician Decision|0|||
19614245|NCT00604825|42063024|FG001|Overall Study|Physician Decision|0|||
19614246|NCT00604825|42063025|FG002|Overall Study|Physician Decision|0|||
19614247|NCT00604825|42063026|FG003|Overall Study|Physician Decision|1|||
19614248|NCT00604825|42063023|FG000|Overall Study|Exclusion criterion met|0|||
19614249|NCT00604825|42063024|FG001|Overall Study|Exclusion criterion met|0|||
19614250|NCT00604825|42063025|FG002|Overall Study|Exclusion criterion met|0|||
19614251|NCT00604825|42063026|FG003|Overall Study|Exclusion criterion met|1|||
19614252|NCT00937391|42063038|FG000|Stage 2|Withdrawal by Subject|1|||
19614253|NCT00937157|42063055|FG000|Overall Study|Pregnancy|1|||
19614254|NCT00937157|42063055|FG000|Overall Study|Lost to Follow-up|3|||
19614255|NCT00777153|42063062|FG000|Overall Study|Lost to Follow-up|1|||
19614256|NCT00777153|42063063|FG001|Overall Study|Lost to Follow-up|1|||
19614257|NCT00777153|42063064|FG002|Overall Study|Lost to Follow-up|0|||
19614258|NCT00777153|42063062|FG000|Overall Study|Death|85|||
19614259|NCT00777153|42063063|FG001|Overall Study|Death|73|||
19614260|NCT00777153|42063064|FG002|Overall Study|Death|33|||
19614261|NCT00777153|42063062|FG000|Overall Study|Withdrawal by Subject|3|||
19614262|NCT00777153|42063063|FG001|Overall Study|Withdrawal by Subject|4|||
19500913|NCT01648140|41873818|FG001|Overall Study|Withdrawal by Subject|3|||
19500914|NCT01648140|41873819|FG002|Overall Study|Withdrawal by Subject|3|||
19500915|NCT01648140|41873820|FG003|Overall Study|Withdrawal by Subject|2|||
19500916|NCT01648140|41873817|FG000|Overall Study|Lost to Follow-up|2|||
19500917|NCT01648140|41873818|FG001|Overall Study|Lost to Follow-up|1|||
19500918|NCT01648140|41873819|FG002|Overall Study|Lost to Follow-up|2|||
19614263|NCT00777153|42063064|FG002|Overall Study|Withdrawal by Subject|3|||
19614264|NCT00777153|42063062|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
19614265|NCT00777153|42063063|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
19614266|NCT00777153|42063064|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
19614267|NCT00567541|42063078|FG000|Overall Study|Adverse Event|0|||
19614268|NCT00567541|42063079|FG001|Overall Study|Adverse Event|1|||
19614269|NCT00776997|42063085|FG000|Overall Study|Adverse Event|2|||
19614270|NCT00940823|42063091|FG000|Overall Study|Death|8|||
19614271|NCT00940823|42063092|FG001|Overall Study|Death|12|||
19614272|NCT00940823|42063091|FG000|Overall Study|Lost to Follow-up|27|||
19614273|NCT00940823|42063092|FG001|Overall Study|Lost to Follow-up|20|||
19614274|NCT00936611|42063100|FG000|Overall Study|Progressive Disease|3|||
19614275|NCT00936611|42063100|FG000|Overall Study|New Systemic Therapy|22|||
19614276|NCT00936611|42063100|FG000|Overall Study|Lost to Follow-up|1|||
19614277|NCT00936611|42063100|FG000|Overall Study|Withdrawal by Subject|2|||
19614278|NCT00936611|42063100|FG000|Overall Study|Still on Follow-up|1|||
19614279|NCT00936611|42063100|FG000|Overall Study|Still on Active Therapy|7|||
19614280|NCT00936611|42063100|FG000|Overall Study|Ineligible for Study Drug|3|||
19614281|NCT00936221|42063123|FG000|Overall Study|Withdrawal by Subject|1|||
19614282|NCT00936221|42063124|FG001|Overall Study|Withdrawal by Subject|1|||
19614283|NCT00776919|42063134|FG000|Overall Study|Withdrawal by Subject|16|||
19614284|NCT00776919|42063135|FG001|Overall Study|Withdrawal by Subject|14|||
19614285|NCT00776919|42063136|FG002|Overall Study|Withdrawal by Subject|15|||
19614286|NCT00776919|42063137|FG003|Overall Study|Withdrawal by Subject|26|||
19614287|NCT00776919|42063134|FG000|Overall Study|Lost to Follow-up|8|||
19614288|NCT00776919|42063135|FG001|Overall Study|Lost to Follow-up|12|||
19614289|NCT00776919|42063136|FG002|Overall Study|Lost to Follow-up|11|||
19614290|NCT00776919|42063137|FG003|Overall Study|Lost to Follow-up|8|||
19614291|NCT00776919|42063134|FG000|Overall Study|Adverse Event|1|||
19614292|NCT00776919|42063135|FG001|Overall Study|Adverse Event|0|||
19614293|NCT00776919|42063136|FG002|Overall Study|Adverse Event|2|||
19614294|NCT00776919|42063137|FG003|Overall Study|Adverse Event|2|||
19614295|NCT00776919|42063134|FG000|Overall Study|Protocol Violation|1|||
19614296|NCT00776919|42063135|FG001|Overall Study|Protocol Violation|2|||
19614297|NCT00776919|42063136|FG002|Overall Study|Protocol Violation|0|||
19614298|NCT00776919|42063137|FG003|Overall Study|Protocol Violation|1|||
19614299|NCT00776919|42063134|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
19614300|NCT00776919|42063135|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
19614301|NCT00776919|42063136|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
19614302|NCT00776919|42063137|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
19614303|NCT00775983|42063164|FG000|Overall Study|Protocol Violation|1|||
19614304|NCT00775983|42063165|FG001|Overall Study|Protocol Violation|2|||
19614305|NCT00775593|42063171|FG000|Overall Study|Unmet eligibility criteria|6|||
19614306|NCT00775593|42063171|FG000|Overall Study|Death|1|||
19614307|NCT00939809|42063175|FG000|Overall Study|Adverse Event|2|||
19614308|NCT00939809|42063175|FG000|Overall Study|Death|1|||
19614309|NCT00934661|42063181|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
19614310|NCT00934661|42063182|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
19614311|NCT00775437|42063188|FG000|Overall Study|Loss of efficacy|2|||
19614312|NCT00775437|42063188|FG000|Overall Study|Withdrawal by Subject|3|||
19614313|NCT00775437|42063188|FG000|Overall Study|Lost to Follow-up|1|||
19614314|NCT00775203|42063194|FG000|Overall Study|Adverse Event|25|||
19614315|NCT00775203|42063195|FG001|Overall Study|Adverse Event|6|||
19614316|NCT00775203|42063194|FG000|Overall Study|Lack of Efficacy|8|||
19614317|NCT00775203|42063195|FG001|Overall Study|Lack of Efficacy|9|||
19614318|NCT00775203|42063194|FG000|Overall Study|Withdrawal by Subject|11|||
19614319|NCT00775203|42063195|FG001|Overall Study|Withdrawal by Subject|9|||
19614320|NCT00775203|42063194|FG000|Overall Study|Lost to Follow-up|11|||
19614321|NCT00775203|42063195|FG001|Overall Study|Lost to Follow-up|15|||
19614322|NCT00775203|42063194|FG000|Overall Study|Administrative reason|2|||
19614323|NCT00775203|42063195|FG001|Overall Study|Administrative reason|0|||
19614324|NCT00775203|42063194|FG000|Overall Study|Noncompliance|4|||
19614325|NCT00775203|42063195|FG001|Overall Study|Noncompliance|2|||
19614326|NCT00775203|42063194|FG000|Overall Study|Protocol Violation|0|||
19614327|NCT00775203|42063195|FG001|Overall Study|Protocol Violation|1|||
19614328|NCT00775203|42063194|FG000|Overall Study|Entered other study|1|||
19614329|NCT00775203|42063195|FG001|Overall Study|Entered other study|0|||
19614330|NCT00775203|42063194|FG000|Overall Study|Physician Decision|0|||
19614331|NCT00775203|42063195|FG001|Overall Study|Physician Decision|1|||
19614332|NCT00568321|42063204|FG000|Overall Study|Adverse Event|1|||
19614333|NCT00568321|42063205|FG001|Overall Study|Adverse Event|0|||
19614334|NCT00568321|42063206|FG002|Overall Study|Adverse Event|0|||
19614335|NCT00568321|42063204|FG000|Overall Study|Lack of Efficacy|8|||
19614336|NCT00568321|42063205|FG001|Overall Study|Lack of Efficacy|5|||
19614337|NCT00568321|42063206|FG002|Overall Study|Lack of Efficacy|6|||
19614338|NCT00568321|42063204|FG000|Overall Study|Lost to Follow-up|0|||
19614339|NCT00568321|42063205|FG001|Overall Study|Lost to Follow-up|0|||
19614340|NCT00568321|42063206|FG002|Overall Study|Lost to Follow-up|1|||
19614341|NCT00568321|42063204|FG000|Overall Study|Withdrawal by Subject|2|||
19614342|NCT00568321|42063205|FG001|Overall Study|Withdrawal by Subject|0|||
19614343|NCT00568321|42063206|FG002|Overall Study|Withdrawal by Subject|0|||
19614344|NCT00568321|42063204|FG000|Overall Study|Protocol Violation|0|||
19614345|NCT00568321|42063205|FG001|Overall Study|Protocol Violation|0|||
19614346|NCT00568321|42063206|FG002|Overall Study|Protocol Violation|1|||
19614347|NCT00568321|42063204|FG000|Overall Study|Randomized, not treated|2|||
19614348|NCT00568321|42063205|FG001|Overall Study|Randomized, not treated|0|||
19614349|NCT00568321|42063206|FG002|Overall Study|Randomized, not treated|1|||
19614350|NCT00774345|42063218|FG000|Pre-treatment|Other reasons|2|||
19614351|NCT00774345|42063219|FG001|Pre-treatment|Other reasons|0|||
19614352|NCT00774345|42063218|FG000|Treatment|Adverse Event|61|||
19614353|NCT00774345|42063219|FG001|Treatment|Adverse Event|15|||
19614354|NCT00774345|42063218|FG000|Treatment|Progressive Disease without histologic transformation|51|||
19614355|NCT00774345|42063219|FG001|Treatment|Progressive Disease without histologic transformation|111|||
19614356|NCT00774345|42063218|FG000|Treatment|Progressive Disease with histologic transformation|4|||
19614357|NCT00774345|42063219|FG001|Treatment|Progressive Disease with histologic transformation|2|||
19614358|NCT00774345|42063218|FG000|Treatment|Withdrawal by Subject|5|||
19614359|NCT00774345|42063219|FG001|Treatment|Withdrawal by Subject|2|||
19614360|NCT00774345|42063218|FG000|Treatment|Lost to Follow-up|1|||
19614361|NCT00774345|42063219|FG001|Treatment|Lost to Follow-up|1|||
19614362|NCT00774345|42063218|FG000|Treatment|Death|4|||
19614363|NCT00774345|42063219|FG001|Treatment|Death|0|||
19614364|NCT00774345|42063218|FG000|Treatment|Other Reasons|32|||
19614365|NCT00774345|42063219|FG001|Treatment|Other Reasons|26|||
19614366|NCT00773253|42063231|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
19614367|NCT00773253|42063232|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
19614368|NCT00773175|42063242|FG000|Overall Study|Adverse Event|2|||
19614369|NCT00773175|42063243|FG001|Overall Study|Adverse Event|0|||
19614370|NCT00773175|42063242|FG000|Overall Study|Consent Withdrawn|0|||
19614371|NCT00773175|42063243|FG001|Overall Study|Consent Withdrawn|2|||
19614372|NCT00566527|42063257|FG000|Overall Study|Reason not provided|3|||
19614373|NCT00566527|42063258|FG001|Overall Study|Reason not provided|11|||
19614374|NCT00566527|42063259|FG002|Overall Study|Reason not provided|10|||
19614375|NCT00566527|42063257|FG000|Overall Study|Adverse Event|2|||
19614376|NCT00566527|42063258|FG001|Overall Study|Adverse Event|0|||
19614377|NCT00566527|42063259|FG002|Overall Study|Adverse Event|1|||
19614378|NCT00566527|42063257|FG000|Overall Study|Physician Decision|3|||
19614379|NCT00566527|42063258|FG001|Overall Study|Physician Decision|8|||
19614380|NCT00566527|42063259|FG002|Overall Study|Physician Decision|20|||
19614381|NCT00566527|42063257|FG000|Overall Study|Lost to Follow-up|3|||
19614382|NCT00566527|42063258|FG001|Overall Study|Lost to Follow-up|4|||
19614383|NCT00566527|42063259|FG002|Overall Study|Lost to Follow-up|4|||
19614384|NCT00566527|42063257|FG000|Overall Study|Withdrawal by Subject|6|||
19614385|NCT00566527|42063258|FG001|Overall Study|Withdrawal by Subject|43|||
19614386|NCT00566527|42063259|FG002|Overall Study|Withdrawal by Subject|43|||
19614387|NCT00773097|42063269|FG000|Overall Study|Withdrawal by Subject|1|||
19614388|NCT00773097|42063269|FG000|Overall Study|Physician Decision|6|||
19614389|NCT00933335|42063275|FG000|Overall Study|Lost to Follow-up|1|||
19500919|NCT01648140|41873820|FG003|Overall Study|Lost to Follow-up|0|||
19500920|NCT02336178|41873839|FG000|Overall Study|Lost to Follow-up|1|||
19500921|NCT02336178|41873839|FG000|Overall Study|Protocol Violation|1|||
19500922|NCT02336178|41873839|FG000|Overall Study|Withdrawal by Subject|1|||
19500923|NCT02336178|41873839|FG000|Overall Study|Other|1|||
19500924|NCT02357940|41873853|FG000|Overall Study|Adverse Event|0|||
19500925|NCT02357940|41873854|FG001|Overall Study|Adverse Event|1|||
19500926|NCT02357940|41873853|FG000|Overall Study|Investigator's judgement|0|||
19500927|NCT02357940|41873854|FG001|Overall Study|Investigator's judgement|1|||
19500928|NCT02335242|41873862|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
19500929|NCT02335242|41873863|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
19500930|NCT02335242|41873862|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
19500931|NCT02335242|41873863|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
19500932|NCT02335242|41873862|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
19500933|NCT02335242|41873863|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
19500934|NCT02334384|41873875|FG000|Overall Study|Lost to Follow-up|1|||
19500935|NCT02334384|41873876|FG001|Overall Study|Lost to Follow-up|1|||
19500936|NCT02334306|41873884|FG000|Double-blind Period|Adverse Event|0|||
19500937|NCT02334306|41873885|FG001|Double-blind Period|Adverse Event|1|||
19614390|NCT00933335|42063276|FG001|Overall Study|Lost to Follow-up|3|||
19614391|NCT00933335|42063275|FG000|Overall Study|Withdrawal by Subject|0|||
19614392|NCT00933335|42063276|FG001|Overall Study|Withdrawal by Subject|1|||
19614393|NCT00933335|42063275|FG000|Overall Study|Progressive Disease|0|||
19614394|NCT00933335|42063276|FG001|Overall Study|Progressive Disease|11|||
19500938|NCT02334306|41873884|FG000|Double-blind Period|Withdrawal by Subject|1|||
19500939|NCT02334306|41873885|FG001|Double-blind Period|Withdrawal by Subject|1|||
19500940|NCT02305758|41873894|FG000|Overall Study|Death|27|||
19500941|NCT02305758|41873895|FG001|Overall Study|Death|27|||
19614395|NCT00933335|42063275|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
19614396|NCT00933335|42063276|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
19614397|NCT00933335|42063275|FG000|Overall Study|Co-morbid Illness|1|||
19500942|NCT02305758|41873894|FG000|Overall Study|Withdrew consent|9|||
19500943|NCT02305758|41873895|FG001|Overall Study|Withdrew consent|2|||
19500944|NCT02305758|41873894|FG000|Overall Study|Lost to Follow-up|6|||
19500945|NCT02305758|41873895|FG001|Overall Study|Lost to Follow-up|1|||
19500946|NCT02305758|41873894|FG000|Overall Study|Study Terminated by Sponsor|21|||
19500947|NCT02305758|41873895|FG001|Overall Study|Study Terminated by Sponsor|34|||
19500948|NCT02305758|41873894|FG000|Overall Study|Other, not specified|2|||
19500949|NCT02305758|41873895|FG001|Overall Study|Other, not specified|1|||
19500950|NCT02305446|41873901|FG000|Overall Study|Adverse Event|1|||
19500951|NCT02303574|41874038|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500952|NCT02303574|41874039|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500953|NCT02303574|41874040|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
19500954|NCT02303574|41874041|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500955|NCT02303574|41874042|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500956|NCT02303574|41874043|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500957|NCT02303574|41874044|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500958|NCT02303574|41874045|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500959|NCT02303574|41874046|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500960|NCT02303574|41874047|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
19500961|NCT02303574|41874038|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500962|NCT02303574|41874039|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500963|NCT02303574|41874040|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500964|NCT02303574|41874041|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500965|NCT02303574|41874042|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500966|NCT02303574|41874043|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500967|NCT02303574|41874044|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500968|NCT02303574|41874045|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
19500969|NCT02303574|41874046|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500970|NCT02303574|41874047|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
19500971|NCT02354976|41874083|FG000|Overall Study|Other - reason not specified|1|||
19500972|NCT02354976|41874084|FG001|Overall Study|Other - reason not specified|0|||
19500973|NCT02354976|41874085|FG002|Overall Study|Other - reason not specified|1|||
19500974|NCT02354976|41874083|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
19500975|NCT02354976|41874084|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
19500976|NCT02354976|41874085|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
19500977|NCT02354976|41874083|FG000|Overall Study|Adverse Event|1|||
19500978|NCT02354976|41874084|FG001|Overall Study|Adverse Event|0|||
19500979|NCT02354976|41874085|FG002|Overall Study|Adverse Event|2|||
19500980|NCT02303262|41874093|FG000|Overall Study|Withdrawal by Subject|2|||
19500981|NCT00558896|41874104|FG000|Overall Study|Adverse Event|1|||
19500982|NCT00558896|41874105|FG001|Overall Study|Adverse Event|1|||
19500983|NCT00558896|41874106|FG002|Overall Study|Adverse Event|1|||
19500984|NCT00558896|41874107|FG003|Overall Study|Adverse Event|3|||
19500985|NCT00558896|41874108|FG004|Overall Study|Adverse Event|4|||
19500986|NCT00558896|41874109|FG005|Overall Study|Adverse Event|10|||
19500987|NCT00558896|41874110|FG006|Overall Study|Adverse Event|3|||
19500988|NCT00558896|41874104|FG000|Overall Study|Death|3|||
19500989|NCT00558896|41874105|FG001|Overall Study|Death|0|||
19500990|NCT00558896|41874106|FG002|Overall Study|Death|2|||
19500991|NCT00558896|41874107|FG003|Overall Study|Death|3|||
19500992|NCT00558896|41874108|FG004|Overall Study|Death|2|||
19500993|NCT00558896|41874109|FG005|Overall Study|Death|2|||
19500994|NCT00558896|41874110|FG006|Overall Study|Death|6|||
19500995|NCT00558896|41874104|FG000|Overall Study|Withdrawal by Subject|2|||
19500996|NCT00558896|41874105|FG001|Overall Study|Withdrawal by Subject|1|||
19500997|NCT00558896|41874106|FG002|Overall Study|Withdrawal by Subject|1|||
19500998|NCT00558896|41874107|FG003|Overall Study|Withdrawal by Subject|1|||
19500999|NCT00558896|41874108|FG004|Overall Study|Withdrawal by Subject|1|||
19501000|NCT00558896|41874109|FG005|Overall Study|Withdrawal by Subject|5|||
19501001|NCT00558896|41874110|FG006|Overall Study|Withdrawal by Subject|5|||
19501002|NCT00558896|41874104|FG000|Overall Study|Alternative Treatment|2|||
19501003|NCT00558896|41874105|FG001|Overall Study|Alternative Treatment|2|||
19501004|NCT00558896|41874106|FG002|Overall Study|Alternative Treatment|0|||
19501005|NCT00558896|41874107|FG003|Overall Study|Alternative Treatment|2|||
19501006|NCT00558896|41874108|FG004|Overall Study|Alternative Treatment|6|||
19501007|NCT00558896|41874109|FG005|Overall Study|Alternative Treatment|7|||
19501008|NCT00558896|41874110|FG006|Overall Study|Alternative Treatment|1|||
19501009|NCT00558896|41874104|FG000|Overall Study|Physician discretion|3|||
19501010|NCT00558896|41874105|FG001|Overall Study|Physician discretion|2|||
19501011|NCT00558896|41874106|FG002|Overall Study|Physician discretion|1|||
19501012|NCT00558896|41874107|FG003|Overall Study|Physician discretion|2|||
19501013|NCT00558896|41874108|FG004|Overall Study|Physician discretion|1|||
19501014|NCT00558896|41874109|FG005|Overall Study|Physician discretion|3|||
19501015|NCT00558896|41874110|FG006|Overall Study|Physician discretion|3|||
19501016|NCT00558896|41874104|FG000|Overall Study|Continues on treatment|10|||
19501017|NCT00558896|41874105|FG001|Overall Study|Continues on treatment|1|||
19501018|NCT00558896|41874106|FG002|Overall Study|Continues on treatment|0|||
19501019|NCT00558896|41874107|FG003|Overall Study|Continues on treatment|1|||
19501020|NCT00558896|41874108|FG004|Overall Study|Continues on treatment|9|||
19501021|NCT00558896|41874109|FG005|Overall Study|Continues on treatment|25|||
19501022|NCT00558896|41874110|FG006|Overall Study|Continues on treatment|6|||
19501023|NCT00558428|41874244|FG000|Overall Study|Adverse Event|6|||
19501024|NCT00558428|41874245|FG001|Overall Study|Adverse Event|22|||
19501025|NCT00558428|41874246|FG002|Overall Study|Adverse Event|3|||
19501026|NCT00558428|41874247|FG003|Overall Study|Adverse Event|4|||
19501027|NCT00558428|41874244|FG000|Overall Study|Lost to Follow-up|0|||
19501028|NCT00558428|41874245|FG001|Overall Study|Lost to Follow-up|1|||
19501029|NCT00558428|41874246|FG002|Overall Study|Lost to Follow-up|0|||
19501030|NCT00558428|41874247|FG003|Overall Study|Lost to Follow-up|0|||
19501031|NCT00558428|41874244|FG000|Overall Study|Lack of Efficacy|0|||
19501032|NCT00558428|41874245|FG001|Overall Study|Lack of Efficacy|0|||
19501033|NCT00558428|41874246|FG002|Overall Study|Lack of Efficacy|1|||
19501034|NCT00558428|41874247|FG003|Overall Study|Lack of Efficacy|2|||
19501035|NCT00558428|41874244|FG000|Overall Study|Non compliant with protocol|1|||
19501036|NCT00558428|41874245|FG001|Overall Study|Non compliant with protocol|0|||
19501037|NCT00558428|41874246|FG002|Overall Study|Non compliant with protocol|0|||
19501038|NCT00558428|41874247|FG003|Overall Study|Non compliant with protocol|3|||
19501039|NCT00558428|41874244|FG000|Overall Study|Consent withdrawn|2|||
19501040|NCT00558428|41874245|FG001|Overall Study|Consent withdrawn|1|||
19501041|NCT00558428|41874246|FG002|Overall Study|Consent withdrawn|0|||
19501042|NCT00558428|41874247|FG003|Overall Study|Consent withdrawn|1|||
19501043|NCT00558428|41874244|FG000|Overall Study|Other|3|||
19501044|NCT00558428|41874245|FG001|Overall Study|Other|0|||
19501045|NCT00558428|41874246|FG002|Overall Study|Other|0|||
19501046|NCT00558428|41874247|FG003|Overall Study|Other|1|||
19501047|NCT00558272|41874286|FG000|Overall Study|Adverse Event|10|||
19501048|NCT00558272|41874287|FG001|Overall Study|Adverse Event|0|||
19501049|NCT00558272|41874286|FG000|Overall Study|Death|1|||
19501050|NCT00558272|41874287|FG001|Overall Study|Death|0|||
19501051|NCT00558272|41874286|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
19501052|NCT00558272|41874287|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
19501053|NCT00558272|41874286|FG000|Overall Study|AZ study team decision|0|||
19501054|NCT00558272|41874287|FG001|Overall Study|AZ study team decision|1|||
19501055|NCT00558272|41874286|FG000|Overall Study|Incorrectly enrolled|1|||
19501056|NCT00558272|41874287|FG001|Overall Study|Incorrectly enrolled|0|||
19501057|NCT00558272|41874286|FG000|Overall Study|Withdrawal by Subject|0|||
19501058|NCT00558272|41874287|FG001|Overall Study|Withdrawal by Subject|1|||
19501059|NCT00557492|41874451|FG000|Overall Study|Change in health insurance|1|||
19501060|NCT02354586|41874554|FG000|Overall Study|Death|230|||
19501061|NCT02354586|41874554|FG000|Overall Study|Withdrawal by Subject|59|||
19501062|NCT02354586|41874554|FG000|Overall Study|Lost to Follow-up|11|||
19501063|NCT02354586|41874554|FG000|Overall Study|Sponsor decision|51|||
19501064|NCT02354586|41874554|FG000|Overall Study|Site closure|2|||
19614398|NCT00933335|42063276|FG001|Overall Study|Co-morbid Illness|0|||
19614399|NCT00772941|42063288|FG000|Overall Study|CRFs not available|195|||
19614400|NCT00772941|42063288|FG000|Overall Study|Study not completed|16|||
19614401|NCT00772941|42063288|FG000|Overall Study|Missed Visits|374|||
19501065|NCT02354586|41874554|FG000|Overall Study|Intercurrent illness|1|||
19501066|NCT02354586|41874554|FG000|Overall Study|Protocol Violation|3|||
19501067|NCT02354586|41874554|FG000|Overall Study|Physician Decision|13|||
19501068|NCT02354586|41874554|FG000|Overall Study|Lack of Efficacy|86|||
19614402|NCT00772941|42063288|FG000|Overall Study|Poor Compliance|7|||
19614403|NCT00772941|42063288|FG000|Overall Study|GPSP Violation|90|||
19614404|NCT00772707|42063315|FG000|Overall Study|Withdrawn|3|||
19614405|NCT00772629|42063321|FG000|Overall Study|Subject was not vaccinated|1|||
19614406|NCT00772629|42063322|FG001|Overall Study|Subject was not vaccinated|0|||
19614407|NCT00939341|42063328|FG000|Overall Study|Adverse Event|15|||
19614408|NCT00939341|42063328|FG000|Overall Study|Pregnancy|1|||
19501069|NCT02354586|41874554|FG000|Overall Study|Adverse Event|7|||
19501070|NCT02332824|41874579|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
19501071|NCT02332824|41874580|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
19614409|NCT00939341|42063328|FG000|Overall Study|Lost to Follow-up|23|||
19614410|NCT00939341|42063328|FG000|Overall Study|Withdrawal by Subject|13|||
19614411|NCT00939341|42063328|FG000|Overall Study|Protocol Violation|6|||
19501072|NCT02332824|41874581|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
19501073|NCT02332824|41874582|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
19501074|NCT02332824|41874583|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
19501075|NCT02332824|41874584|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
19501076|NCT02332824|41874579|FG000|Overall Study|Voluntary Withdrawal|1|||
19501077|NCT02332824|41874580|FG001|Overall Study|Voluntary Withdrawal|0|||
19501078|NCT02332824|41874581|FG002|Overall Study|Voluntary Withdrawal|0|||
19501079|NCT02332824|41874582|FG003|Overall Study|Voluntary Withdrawal|0|||
19614412|NCT00939341|42063328|FG000|Overall Study|Incorrect enrolment|8|||
19501080|NCT02332824|41874583|FG004|Overall Study|Voluntary Withdrawal|0|||
19501081|NCT02332824|41874584|FG005|Overall Study|Voluntary Withdrawal|0|||
19501082|NCT02332824|41874579|FG000|Overall Study|Inconvenient schedule|1|||
19501083|NCT02332824|41874580|FG001|Overall Study|Inconvenient schedule|1|||
19501084|NCT02332824|41874581|FG002|Overall Study|Inconvenient schedule|0|||
19501085|NCT02332824|41874582|FG003|Overall Study|Inconvenient schedule|0|||
19501086|NCT02332824|41874583|FG004|Overall Study|Inconvenient schedule|0|||
19501087|NCT02332824|41874584|FG005|Overall Study|Inconvenient schedule|0|||
19501088|NCT02332824|41874579|FG000|Overall Study|Transfer|0|||
19501089|NCT02332824|41874580|FG001|Overall Study|Transfer|0|||
19501090|NCT02332824|41874581|FG002|Overall Study|Transfer|1|||
19501091|NCT02332824|41874582|FG003|Overall Study|Transfer|1|||
19614413|NCT04292470|42063357|FG000|Overall Study|Withdrawal by Subject|0|||
19614414|NCT04292470|42063358|FG001|Overall Study|Withdrawal by Subject|1|||
19614415|NCT04217590|42063366|FG000|Overall Study|Other|1|||
19704428|NCT00252174|42148777|FG002|Overall Study|Withdrawal by Subject|0|||
19704429|NCT00165984|42148785|FG000|Overall Study|Death|15|||
19501092|NCT02332824|41874583|FG004|Overall Study|Transfer|0|||
19501093|NCT02332824|41874584|FG005|Overall Study|Transfer|0|||
19501094|NCT00556712|41874731|FG000|Overall Study|Adverse Event|7|||
19501095|NCT00556712|41874732|FG001|Overall Study|Adverse Event|19|||
19501096|NCT00556712|41874731|FG000|Overall Study|Death|5|||
19501097|NCT00556712|41874732|FG001|Overall Study|Death|10|||
19501098|NCT00556712|41874731|FG000|Overall Study|Progressive Disease|383|||
19501099|NCT00556712|41874732|FG001|Overall Study|Progressive Disease|320|||
19501100|NCT00556712|41874731|FG000|Overall Study|Protocol Violation|3|||
19501101|NCT00556712|41874732|FG001|Overall Study|Protocol Violation|2|||
19501102|NCT00556712|41874731|FG000|Overall Study|Refused Treatment|17|||
19501103|NCT00556712|41874732|FG001|Overall Study|Refused Treatment|16|||
19501104|NCT00556712|41874731|FG000|Overall Study|Failure to Return|2|||
19501105|NCT00556712|41874732|FG001|Overall Study|Failure to Return|3|||
19501106|NCT00556712|41874731|FG000|Overall Study|Other|2|||
19501107|NCT00556712|41874732|FG001|Overall Study|Other|2|||
19501108|NCT00556712|41874731|FG000|Overall Study|Ongoing at Data Cutoff|32|||
19501109|NCT00556712|41874732|FG001|Overall Study|Ongoing at Data Cutoff|66|||
19501110|NCT00556322|41874806|FG000|Overall Study|Insufficient therapeutic response|158|||
19501111|NCT00556322|41874807|FG001|Overall Study|Insufficient therapeutic response|168|||
19501112|NCT00556322|41874806|FG000|Overall Study|Adverse Event|7|||
19501113|NCT00556322|41874807|FG001|Overall Study|Adverse Event|4|||
19501114|NCT00556322|41874806|FG000|Overall Study|Other|4|||
19501115|NCT00556322|41874807|FG001|Overall Study|Other|1|||
19501116|NCT00556322|41874806|FG000|Overall Study|Lost to Follow-up|5|||
19501117|NCT00556322|41874807|FG001|Overall Study|Lost to Follow-up|3|||
19501118|NCT00556322|41874806|FG000|Overall Study|Withdrawal by Subject|19|||
19501119|NCT00556322|41874807|FG001|Overall Study|Withdrawal by Subject|7|||
19501120|NCT00556322|41874806|FG000|Overall Study|Protocol Violation|5|||
19501121|NCT00556322|41874807|FG001|Overall Study|Protocol Violation|1|||
19501122|NCT00556322|41874806|FG000|Overall Study|Ongoing at data cutoff|3|||
19501123|NCT00556322|41874807|FG001|Overall Study|Ongoing at data cutoff|5|||
19501124|NCT00556322|41874806|FG000|Overall Study|Death|20|||
19501125|NCT00556322|41874807|FG001|Overall Study|Death|14|||
19501126|NCT00556166|41874825|FG000|Overall Study|Withdrawal by Subject|1|||
19501127|NCT02332590|41874985|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
19501128|NCT02332590|41874986|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
19501129|NCT02332590|41874985|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
19501130|NCT02332590|41874986|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
19501131|NCT02332590|41874985|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
19501132|NCT02332590|41874986|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
19501133|NCT02332590|41874985|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
19501134|NCT02332590|41874986|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
19501135|NCT02332590|41874985|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
19501136|NCT02332590|41874986|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
19501137|NCT02332590|41874985|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
19501138|NCT02332590|41874986|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
19501139|NCT02332590|41874985|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
19501140|NCT02332590|41874986|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
19501141|NCT02332590|41874985|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
19501142|NCT02332590|41874986|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
19501143|NCT02332590|41874985|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
19501144|NCT02332590|41874986|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
19501145|NCT00554840|41875057|FG000|Overall Study|Physician Decision|0|||
19501146|NCT00554840|41875058|FG001|Overall Study|Physician Decision|1|||
19501147|NCT02302716|41875083|FG000|Overall Study|Adverse Event|1|||
19501148|NCT02302716|41875084|FG001|Overall Study|Adverse Event|1|||
19501149|NCT02302716|41875083|FG000|Overall Study|Death|0|||
19501150|NCT02302716|41875084|FG001|Overall Study|Death|1|||
19501151|NCT02302716|41875083|FG000|Overall Study|Lack of Efficacy|0|||
19501152|NCT02302716|41875084|FG001|Overall Study|Lack of Efficacy|1|||
19501153|NCT02302716|41875083|FG000|Overall Study|Lost to Follow-up|2|||
19501154|NCT02302716|41875084|FG001|Overall Study|Lost to Follow-up|4|||
19501155|NCT02302716|41875083|FG000|Overall Study|Physician Decision|3|||
19501156|NCT02302716|41875084|FG001|Overall Study|Physician Decision|4|||
19501157|NCT02302716|41875083|FG000|Overall Study|Withdrawal by Subject|13|||
19501158|NCT02302716|41875084|FG001|Overall Study|Withdrawal by Subject|7|||
19501159|NCT02302716|41875083|FG000|Overall Study|Protocol Violation|0|||
19501160|NCT02302716|41875084|FG001|Overall Study|Protocol Violation|1|||
19501161|NCT00554606|41875113|FG000|Overall Study|Adverse Event|3|||
19501162|NCT00554606|41875113|FG000|Overall Study|Abnormal laboratory values|1|||
19501163|NCT00554606|41875113|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
19501164|NCT00554606|41875113|FG000|Overall Study|Subject withdrew consent|2|||
19501165|NCT00554606|41875113|FG000|Overall Study|Lost to Follow-up|2|||
19501166|NCT00554606|41875113|FG000|Overall Study|Administrative problems|60|||
19501167|NCT00554606|41875113|FG000|Overall Study|Death|1|||
19501168|NCT00554606|41875113|FG000|Overall Study|Protocol deviation|2|||
19501169|NCT02354508|41875149|FG000|Period 1: Core Phase|Adverse Event|1|||
19501170|NCT02354508|41875150|FG001|Period 1: Core Phase|Adverse Event|1|||
19501171|NCT02354508|41875151|FG002|Period 1: Core Phase|Adverse Event|2|||
19501172|NCT02354508|41875149|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
19501173|NCT02354508|41875150|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
19501174|NCT02354508|41875151|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
19501175|NCT02354508|41875149|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
19501176|NCT02354508|41875150|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
19501177|NCT02354508|41875151|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
19614416|NCT04217590|42063367|FG001|Overall Study|Other|1|||
19614417|NCT04217590|42063366|FG000|Overall Study|Withdrawal by Subject|3|||
19614418|NCT04217590|42063367|FG001|Overall Study|Withdrawal by Subject|1|||
19614419|NCT04217590|42063366|FG000|Overall Study|Death|0|||
19614420|NCT04217590|42063367|FG001|Overall Study|Death|1|||
19614421|NCT03963232|42063448|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
19614422|NCT03963232|42063449|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
19614423|NCT03963232|42063448|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
19501178|NCT02354508|41875149|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
19501179|NCT02354508|41875150|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
19501180|NCT02354508|41875151|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
19501181|NCT02354508|41875149|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
19501182|NCT02354508|41875150|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
19501183|NCT02354508|41875151|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
19501184|NCT02354508|41875149|FG000|Period 2: Extension Phase|Physician Decision|5|||
19501185|NCT02354508|41875150|FG001|Period 2: Extension Phase|Physician Decision|0|||
19501186|NCT02354508|41875151|FG002|Period 2: Extension Phase|Physician Decision|1|||
19501187|NCT02354508|41875149|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
19501188|NCT02354508|41875150|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
19501189|NCT02354508|41875151|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
19501190|NCT02354508|41875149|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
19501191|NCT02354508|41875150|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
19501192|NCT02354508|41875151|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
19501193|NCT02354508|41875149|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
19501194|NCT02354508|41875150|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
19501195|NCT02354508|41875151|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
19501196|NCT00554216|41875203|FG000|Overall Study|Lost to Follow-up|92|||
19501197|NCT00554216|41875204|FG001|Overall Study|Lost to Follow-up|31|||
19501198|NCT00554216|41875205|FG002|Overall Study|Lost to Follow-up|63|||
19501199|NCT00554216|41875203|FG000|Overall Study|Adverse Event|16|||
19501200|NCT00554216|41875204|FG001|Overall Study|Adverse Event|16|||
19501201|NCT00554216|41875205|FG002|Overall Study|Adverse Event|36|||
19501202|NCT00554216|41875203|FG000|Overall Study|Withdrawal by Subject|92|||
19501203|NCT00554216|41875204|FG001|Overall Study|Withdrawal by Subject|31|||
19501204|NCT00554216|41875205|FG002|Overall Study|Withdrawal by Subject|43|||
19614424|NCT03963232|42063449|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
19501205|NCT00554216|41875203|FG000|Overall Study|Non compliance|10|||
19501206|NCT00554216|41875204|FG001|Overall Study|Non compliance|4|||
19501207|NCT00554216|41875205|FG002|Overall Study|Non compliance|5|||
19501208|NCT00554216|41875203|FG000|Overall Study|Pregnancy|2|||
19501209|NCT00554216|41875204|FG001|Overall Study|Pregnancy|1|||
19501210|NCT00554216|41875205|FG002|Overall Study|Pregnancy|14|||
19501211|NCT00554216|41875203|FG000|Overall Study|Restricted med|3|||
19501212|NCT00554216|41875204|FG001|Overall Study|Restricted med|1|||
19501213|NCT00554216|41875205|FG002|Overall Study|Restricted med|1|||
19704430|NCT00160680|42148794|FG000|Overall Study|Adverse Event|0|||
19501214|NCT00554216|41875203|FG000|Overall Study|Other|12|||
19501215|NCT00554216|41875204|FG001|Overall Study|Other|7|||
19501216|NCT00554216|41875205|FG002|Overall Study|Other|10|||
19501217|NCT00554216|41875203|FG000|Overall Study|Lack of Efficacy|15|||
19501218|NCT00554216|41875204|FG001|Overall Study|Lack of Efficacy|3|||
19501219|NCT00554216|41875205|FG002|Overall Study|Lack of Efficacy|0|||
19501220|NCT02353572|41875230|FG000|Overall Study|Withdrawal by Subject|1|||
19501221|NCT02353572|41875230|FG000|Overall Study|Study terminated|2|||
19501222|NCT00552578|41875242|FG000|Overall Study|Lost to Follow-up|1|||
19501223|NCT00552578|41875243|FG001|Overall Study|Lost to Follow-up|1|||
19501224|NCT02301936|41875251|FG000|Overall Study|Lost to Follow-up|1|||
19501225|NCT02301936|41875252|FG001|Overall Study|Lost to Follow-up|0|||
19501226|NCT02352090|41875267|FG000|Overall Study|general malaise|1|||
19501227|NCT02352090|41875268|FG001|Overall Study|general malaise|0|||
19501228|NCT02352090|41875269|FG002|Overall Study|general malaise|0|||
19501229|NCT02352090|41875267|FG000|Overall Study|non-specified mild side-effects|0|||
19501230|NCT02352090|41875268|FG001|Overall Study|non-specified mild side-effects|0|||
19501231|NCT02352090|41875269|FG002|Overall Study|non-specified mild side-effects|2|||
19501232|NCT00552344|41875304|FG000|Overall Study|Lack of Efficacy|55|||
19501233|NCT00552344|41875304|FG000|Overall Study|Loss of efficacy|75|||
19501234|NCT00552344|41875304|FG000|Overall Study|Lost to Follow-up|8|||
19501235|NCT00552344|41875304|FG000|Overall Study|Withdrawal by Subject|48|||
19501236|NCT00552344|41875304|FG000|Overall Study|SAE, non-fatal|6|||
19501237|NCT00552344|41875304|FG000|Overall Study|AE, non-serious non-fatal|38|||
19501238|NCT00552344|41875304|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
19501239|NCT00552344|41875304|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
19501240|NCT00552344|41875304|FG000|Overall Study|Other Reason|22|||
19501241|NCT00553514|41875341|FG000|Overall Study|Protocol deviation|0|||
19501242|NCT00553514|41875342|FG001|Overall Study|Protocol deviation|0|||
19501243|NCT00553514|41875343|FG002|Overall Study|Protocol deviation|0|||
19501244|NCT00553514|41875344|FG003|Overall Study|Protocol deviation|1|||
19501245|NCT00553514|41875345|FG004|Overall Study|Protocol deviation|0|||
19501246|NCT00553514|41875341|FG000|Overall Study|Lack of ovarian response|4|||
19501247|NCT00553514|41875342|FG001|Overall Study|Lack of ovarian response|5|||
19501248|NCT00553514|41875343|FG002|Overall Study|Lack of ovarian response|5|||
19501249|NCT00553514|41875344|FG003|Overall Study|Lack of ovarian response|5|||
19501250|NCT00553514|41875345|FG004|Overall Study|Lack of ovarian response|6|||
19501251|NCT00553514|41875341|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
19501252|NCT00553514|41875342|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
19501253|NCT00553514|41875343|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
19501254|NCT00553514|41875344|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
19501255|NCT00553514|41875345|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
19501256|NCT00553514|41875341|FG000|Overall Study|Risk of multiple pregnancy|0|||
19501257|NCT00553514|41875342|FG001|Overall Study|Risk of multiple pregnancy|2|||
19501258|NCT00553514|41875343|FG002|Overall Study|Risk of multiple pregnancy|0|||
19501259|NCT00553514|41875344|FG003|Overall Study|Risk of multiple pregnancy|1|||
19501260|NCT00553514|41875345|FG004|Overall Study|Risk of multiple pregnancy|0|||
19501261|NCT00553514|41875341|FG000|Overall Study|Other|1|||
19501262|NCT00553514|41875342|FG001|Overall Study|Other|1|||
19501263|NCT00553514|41875343|FG002|Overall Study|Other|0|||
19501264|NCT00553514|41875344|FG003|Overall Study|Other|0|||
19501265|NCT00553514|41875345|FG004|Overall Study|Other|1|||
19501266|NCT00553436|41875369|FG000|Overall Study|Conversion to another procedure|1|||
19501267|NCT00553202|41875400|FG000|Overall Study|Death|16|||
19501268|NCT00553202|41875400|FG000|Overall Study|Lost to Follow-up|1|||
19614425|NCT03963232|42063448|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
19501269|NCT00553202|41875400|FG000|Overall Study|Physician Decision|28|||
19501270|NCT00553202|41875400|FG000|Overall Study|Withdrawal by Subject|1|||
19501271|NCT00553202|41875400|FG000|Overall Study|No donor identified|16|||
19501272|NCT00553202|41875400|FG000|Overall Study|Fails to meet organ function|6|||
19501273|NCT00552188|41875424|FG000|Overall Study|Adverse Event|0|||
19501274|NCT00552188|41875425|FG001|Overall Study|Adverse Event|2|||
19501275|NCT00552188|41875424|FG000|Overall Study|Lost to Follow-up|2|||
19501276|NCT00552188|41875425|FG001|Overall Study|Lost to Follow-up|1|||
19501277|NCT00552188|41875424|FG000|Overall Study|Withdrawal of consent|0|||
19501278|NCT00552188|41875425|FG001|Overall Study|Withdrawal of consent|1|||
19501279|NCT00552188|41875424|FG000|Overall Study|Subject returned to home country|0|||
19501280|NCT00552188|41875425|FG001|Overall Study|Subject returned to home country|1|||
19501281|NCT00552110|41875445|FG000|Overall Study|Serious or Life-Threatening AE|0|||
19501282|NCT00552110|41875446|FG001|Overall Study|Serious or Life-Threatening AE|0|||
19501283|NCT00552110|41875447|FG002|Overall Study|Serious or Life-Threatening AE|1|||
19501284|NCT00552110|41875448|FG003|Overall Study|Serious or Life-Threatening AE|0|||
19501285|NCT00552110|41875449|FG004|Overall Study|Serious or Life-Threatening AE|0|||
19501286|NCT00552110|41875445|FG000|Overall Study|Lack of Efficacy|1|||
19501287|NCT00552110|41875446|FG001|Overall Study|Lack of Efficacy|0|||
19501288|NCT00552110|41875447|FG002|Overall Study|Lack of Efficacy|0|||
19501289|NCT00552110|41875448|FG003|Overall Study|Lack of Efficacy|1|||
19501290|NCT00552110|41875449|FG004|Overall Study|Lack of Efficacy|4|||
19501291|NCT00552110|41875445|FG000|Overall Study|Withdrawal by Subject|0|||
19501292|NCT00552110|41875446|FG001|Overall Study|Withdrawal by Subject|2|||
19501293|NCT00552110|41875447|FG002|Overall Study|Withdrawal by Subject|0|||
19501294|NCT00552110|41875448|FG003|Overall Study|Withdrawal by Subject|3|||
19501295|NCT00552110|41875449|FG004|Overall Study|Withdrawal by Subject|2|||
19501296|NCT00552110|41875445|FG000|Overall Study|Lost to Follow-up|0|||
19501297|NCT00552110|41875446|FG001|Overall Study|Lost to Follow-up|0|||
19501298|NCT00552110|41875447|FG002|Overall Study|Lost to Follow-up|0|||
19501299|NCT00552110|41875448|FG003|Overall Study|Lost to Follow-up|1|||
19501300|NCT00552110|41875449|FG004|Overall Study|Lost to Follow-up|1|||
19501301|NCT00552110|41875445|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
19501302|NCT00552110|41875446|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
19501303|NCT00552110|41875447|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
19501304|NCT00552110|41875448|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
19501305|NCT00552110|41875449|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
19501306|NCT00552110|41875445|FG000|Overall Study|Withdrawn per Sponsor|0|||
19501307|NCT00552110|41875446|FG001|Overall Study|Withdrawn per Sponsor|1|||
19501308|NCT00552110|41875447|FG002|Overall Study|Withdrawn per Sponsor|0|||
19501309|NCT00552110|41875448|FG003|Overall Study|Withdrawn per Sponsor|0|||
19501310|NCT00552110|41875449|FG004|Overall Study|Withdrawn per Sponsor|1|||
19501311|NCT00552110|41875445|FG000|Overall Study|Use of Prohibited Medication|1|||
19501312|NCT00552110|41875446|FG001|Overall Study|Use of Prohibited Medication|1|||
19501313|NCT00552110|41875447|FG002|Overall Study|Use of Prohibited Medication|0|||
19614426|NCT03963232|42063449|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
19614427|NCT03963232|42063448|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
19614428|NCT03963232|42063449|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
19614429|NCT03963232|42063448|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
19614430|NCT03963232|42063449|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
19614431|NCT03963232|42063448|FG000|Open-Label Treatment Phase|Adverse Event|1|||
19614432|NCT03963232|42063449|FG001|Open-Label Treatment Phase|Adverse Event|2|||
19614433|NCT03963232|42063448|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
19614434|NCT03963232|42063449|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
19614435|NCT03963232|42063448|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
19614436|NCT03963232|42063449|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
19704431|NCT00160680|42148795|FG001|Overall Study|Adverse Event|1|||
19393794|NCT02624687|41637695|FG000|Overall Study|medical leave from work|0|||
19501314|NCT00552110|41875448|FG003|Overall Study|Use of Prohibited Medication|0|||
19501315|NCT00552110|41875449|FG004|Overall Study|Use of Prohibited Medication|0|||
19501316|NCT00552110|41875445|FG000|Overall Study|Delay of Study due to Relabeling|0|||
19501317|NCT00552110|41875446|FG001|Overall Study|Delay of Study due to Relabeling|0|||
19501318|NCT00552110|41875447|FG002|Overall Study|Delay of Study due to Relabeling|0|||
19501319|NCT00552110|41875448|FG003|Overall Study|Delay of Study due to Relabeling|1|||
19501320|NCT00552110|41875449|FG004|Overall Study|Delay of Study due to Relabeling|0|||
19501321|NCT00552110|41875445|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
19501322|NCT00552110|41875446|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
19501323|NCT00552110|41875447|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
19501324|NCT00552110|41875448|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
19501325|NCT00552110|41875449|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
19501326|NCT00552110|41875445|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
19501327|NCT00552110|41875446|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
19501328|NCT00552110|41875447|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
19501329|NCT00552110|41875448|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
19501330|NCT00552110|41875449|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
19501331|NCT02301624|41875472|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
19501332|NCT02301624|41875473|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
19501333|NCT02301624|41875472|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
19501334|NCT02301624|41875473|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
19501335|NCT02301624|41875472|FG000|Open-label Maintenance Phase|Adverse Event|2|||
19501336|NCT02301624|41875473|FG001|Open-label Maintenance Phase|Adverse Event|5|||
19501337|NCT02301624|41875472|FG000|Open-label Maintenance Phase|Physician Decision|3|||
19501338|NCT02301624|41875473|FG001|Open-label Maintenance Phase|Physician Decision|3|||
19501339|NCT02301624|41875472|FG000|Open-label Maintenance Phase|Death|2|||
19501340|NCT02301624|41875473|FG001|Open-label Maintenance Phase|Death|1|||
19501341|NCT02301624|41875472|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
19501342|NCT02301624|41875473|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
19501343|NCT02301546|41875514|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
19614437|NCT03963232|42063448|FG000|Open-Label Treatment Phase|Pregnancy|1|||
19704432|NCT00160680|42148794|FG000|Overall Study|Lack of Efficacy|2|||
19501344|NCT02301546|41875515|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
19501345|NCT02301546|41875514|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
19501346|NCT02301546|41875515|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
19501347|NCT02301546|41875514|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
19501348|NCT02301546|41875515|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
19501349|NCT02301546|41875514|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
19501350|NCT02301546|41875515|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
19501351|NCT02301546|41875514|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
19501352|NCT02301546|41875515|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
19501353|NCT02301546|41875514|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
19501354|NCT02301546|41875515|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
19501355|NCT02301546|41875514|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
19501356|NCT02301546|41875515|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
19501357|NCT02351934|41875539|FG000|Allocation|POD weight<pre-op weight|3|||
19501358|NCT02351934|41875540|FG001|Allocation|POD weight<pre-op weight|0|||
19501359|NCT02351934|41875539|FG000|Allocation|Hypotension preventing administration|2|||
19501360|NCT02351934|41875540|FG001|Allocation|Hypotension preventing administration|0|||
19393795|NCT02624687|41637696|FG001|Overall Study|medical leave from work|1|||
19393796|NCT01675765|41637704|FG000|Overall Study|Progressive disease|4|||
19501361|NCT02351934|41875539|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
19501362|NCT02351934|41875540|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
19501363|NCT02351934|41875539|FG000|Follow-Up|POD weight<pre-op weight|3|||
19501364|NCT02351934|41875540|FG001|Follow-Up|POD weight<pre-op weight|0|||
19501365|NCT02351934|41875539|FG000|Follow-Up|Acute Kidney Injury|1|||
19501366|NCT02351934|41875540|FG001|Follow-Up|Acute Kidney Injury|0|||
19501367|NCT02351934|41875539|FG000|Follow-Up|Early dismissal|3|||
19501368|NCT02351934|41875540|FG001|Follow-Up|Early dismissal|0|||
19501369|NCT02351934|41875539|FG000|Follow-Up|Hypotension|3|||
19501370|NCT02351934|41875540|FG001|Follow-Up|Hypotension|0|||
19501371|NCT02351934|41875539|FG000|Follow-Up|No documentation|2|||
19501372|NCT02351934|41875540|FG001|Follow-Up|No documentation|0|||
19501373|NCT02351934|41875539|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
19501374|NCT02351934|41875540|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
19501375|NCT02351934|41875539|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
19501376|NCT02351934|41875540|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
19501377|NCT02301390|41875548|FG000|Overall Study|Withdrawal by Subject|3|||
19501378|NCT02301390|41875549|FG001|Overall Study|Withdrawal by Subject|5|||
19501379|NCT02301390|41875548|FG000|Overall Study|Protocol Violation|1|||
19501380|NCT02301390|41875549|FG001|Overall Study|Protocol Violation|0|||
19501381|NCT02301390|41875548|FG000|Overall Study|Physician Decision|1|||
19501382|NCT02301390|41875549|FG001|Overall Study|Physician Decision|0|||
19501383|NCT02301390|41875548|FG000|Overall Study|Lost to Follow-up|0|||
19501384|NCT02301390|41875549|FG001|Overall Study|Lost to Follow-up|1|||
19501385|NCT02301390|41875548|FG000|Overall Study|Death|2|||
19501386|NCT02301390|41875549|FG001|Overall Study|Death|2|||
19501387|NCT02301390|41875548|FG000|Overall Study|Procedure not completed|0|||
19501388|NCT02301390|41875549|FG001|Overall Study|Procedure not completed|4|||
19501389|NCT02301390|41875548|FG000|Overall Study|Missed multiple visits|1|||
19501390|NCT02301390|41875549|FG001|Overall Study|Missed multiple visits|1|||
19501391|NCT02301390|41875548|FG000|Overall Study|study terminated|2|||
19501392|NCT02301390|41875549|FG001|Overall Study|study terminated|0|||
19501393|NCT02351856|41875589|FG000|Overall Study|Adverse Event|2|||
19501394|NCT02351856|41875589|FG000|Overall Study|Physician Decision|5|||
19501395|NCT02351856|41875589|FG000|Overall Study|Study terminated by sponsor|1|||
19501396|NCT02349360|41875629|FG000|Overall Study|Withdrawal by Subject|0|||
19501397|NCT02349360|41875630|FG001|Overall Study|Withdrawal by Subject|1|||
19501398|NCT00551642|41875655|FG000|Treatment Period|Protocol Deviation|6|||
19501399|NCT00551642|41875656|FG001|Treatment Period|Protocol Deviation|11|||
19501400|NCT00551642|41875655|FG000|Treatment Period|Delivery device failure|1|||
19501401|NCT00551642|41875656|FG001|Treatment Period|Delivery device failure|3|||
19501402|NCT00551642|41875655|FG000|Treatment Period|Physician Decision|0|||
19501403|NCT00551642|41875656|FG001|Treatment Period|Physician Decision|1|||
19501404|NCT00551642|41875655|FG000|Treatment Period|Death|33|||
19501405|NCT00551642|41875656|FG001|Treatment Period|Death|31|||
19501406|NCT00551642|41875655|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
19501407|NCT00551642|41875656|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
19501408|NCT00551642|41875655|FG000|Treatment Period|Adverse Event|15|||
19501409|NCT00551642|41875656|FG001|Treatment Period|Adverse Event|12|||
19501410|NCT00551642|41875655|FG000|Treatment Period|Withdrawal by Subject|2|||
19501411|NCT00551642|41875656|FG001|Treatment Period|Withdrawal by Subject|1|||
19501412|NCT00550550|41875750|FG000|Overall Study|Adverse Event|13|||
19501413|NCT00550550|41875751|FG001|Overall Study|Adverse Event|5|||
19501414|NCT00550550|41875750|FG000|Overall Study|Treatment Failure|0|||
19501415|NCT00550550|41875751|FG001|Overall Study|Treatment Failure|1|||
19501416|NCT00550550|41875750|FG000|Overall Study|Lost to Follow-up|4|||
19501417|NCT00550550|41875751|FG001|Overall Study|Lost to Follow-up|0|||
19501418|NCT00550550|41875750|FG000|Overall Study|Withdrawal by Subject|10|||
19501419|NCT00550550|41875751|FG001|Overall Study|Withdrawal by Subject|8|||
19501420|NCT00550550|41875750|FG000|Overall Study|Protocol Violation|5|||
19501421|NCT00550550|41875751|FG001|Overall Study|Protocol Violation|14|||
19501422|NCT00550550|41875750|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
19614438|NCT03963232|42063449|FG001|Open-Label Treatment Phase|Pregnancy|0|||
19393797|NCT01675765|41637705|FG001|Overall Study|Progressive disease|4|||
19501423|NCT00550550|41875751|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
19501424|NCT00550550|41875750|FG000|Overall Study|Randomized But Not Treated|1|||
19501425|NCT00550550|41875751|FG001|Overall Study|Randomized But Not Treated|0|||
19614439|NCT03963232|42063448|FG000|Follow-up Phase|Withdrawal by Subject|7|||
19614440|NCT03963232|42063449|FG001|Follow-up Phase|Withdrawal by Subject|5|||
19614441|NCT03963232|42063448|FG000|Follow-up Phase|Protocol Violation|0|||
19614442|NCT03963232|42063449|FG001|Follow-up Phase|Protocol Violation|2|||
19614443|NCT03963232|42063448|FG000|Follow-up Phase|Adverse Event|0|||
19614444|NCT03963232|42063449|FG001|Follow-up Phase|Adverse Event|1|||
19614445|NCT03963232|42063448|FG000|Follow-up Phase|Lost to Follow-up|0|||
19614446|NCT03963232|42063449|FG001|Follow-up Phase|Lost to Follow-up|1|||
19614447|NCT03856593|42063473|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
19614448|NCT03856593|42063474|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
19614449|NCT03845296|42063484|FG000|Overall Study|On Treatment|2|||
19614450|NCT03845296|42063485|FG001|Overall Study|On Treatment|1|||
19614451|NCT03845296|42063484|FG000|Overall Study|Adverse Event|4|||
19614452|NCT03845296|42063485|FG001|Overall Study|Adverse Event|11|||
19501426|NCT02301156|41875802|FG000|Overall Study|Adverse Event|13|||
19501427|NCT02301156|41875803|FG001|Overall Study|Adverse Event|14|||
19501428|NCT02301156|41875802|FG000|Overall Study|Death|1|||
19501429|NCT02301156|41875803|FG001|Overall Study|Death|5|||
19501430|NCT02301156|41875802|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
19501431|NCT02301156|41875803|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
19501432|NCT02301156|41875802|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
19501433|NCT02301156|41875803|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
19501434|NCT02301156|41875802|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
19501435|NCT02301156|41875803|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
19501436|NCT02301156|41875802|FG000|Overall Study|Reason not Specified|6|||
19501437|NCT02301156|41875803|FG001|Overall Study|Reason not Specified|3|||
19501438|NCT02300610|41875993|FG000|Overall Study|Withdrawal by Subject|1|||
19501439|NCT02300610|41875994|FG001|Overall Study|Withdrawal by Subject|0|||
19501440|NCT02300610|41875995|FG002|Overall Study|Withdrawal by Subject|1|||
19501441|NCT02300298|41876040|FG000|Disposition for Nintedanib|Progressive disease|10|||
19501442|NCT02300298|41876041|FG001|Disposition for Nintedanib|Progressive disease|0|||
19501443|NCT02300298|41876040|FG000|Disposition for Docetaxel|Progressive disease|0|||
19501444|NCT02300298|41876041|FG001|Disposition for Docetaxel|Progressive disease|6|||
19501445|NCT02300298|41876040|FG000|Disposition for Docetaxel|other adverse event|0|||
19501446|NCT02300298|41876041|FG001|Disposition for Docetaxel|other adverse event|4|||
19501447|NCT02300220|41876047|FG000|Overall Study|Lost to Follow-up|1|||
19501448|NCT02300220|41876048|FG001|Overall Study|Lost to Follow-up|2|||
19501449|NCT02300220|41876047|FG000|Overall Study|Death|1|||
19501450|NCT02300220|41876048|FG001|Overall Study|Death|1|||
19501451|NCT02300220|41876047|FG000|Overall Study|Adverse Event|1|||
19501452|NCT02300220|41876048|FG001|Overall Study|Adverse Event|1|||
19501453|NCT02300220|41876047|FG000|Overall Study|Protocol Violation|1|||
19501454|NCT02300220|41876048|FG001|Overall Study|Protocol Violation|0|||
19501455|NCT02300220|41876047|FG000|Overall Study|Withdrawal by Subject|0|||
19501456|NCT02300220|41876048|FG001|Overall Study|Withdrawal by Subject|2|||
19501457|NCT02300220|41876047|FG000|Overall Study|Did not tolerate IMP|0|||
19501458|NCT02300220|41876048|FG001|Overall Study|Did not tolerate IMP|1|||
19501459|NCT02327130|41876072|FG000|Overall Study|Discharged in less than 5 days|5|||
19501460|NCT02327130|41876072|FG000|Overall Study|Physician Decision|2|||
19501461|NCT02327130|41876072|FG000|Overall Study|Unable to provide breath sample|1|||
19501462|NCT02327130|41876072|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
19501463|NCT02327130|41876072|FG000|Overall Study|Met exclusion criteria|3|||
19501464|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501465|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
19501466|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
19501467|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501468|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501469|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501470|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501471|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501472|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501473|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501474|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501475|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19614453|NCT03845296|42063484|FG000|Overall Study|Refusal unrelated to adverse event|0|||
19614454|NCT03845296|42063485|FG001|Overall Study|Refusal unrelated to adverse event|1|||
19704433|NCT00160680|42148795|FG001|Overall Study|Lack of Efficacy|1|||
19704434|NCT00160680|42148794|FG000|Overall Study|Lost to Follow-up|3|||
19704435|NCT00160680|42148795|FG001|Overall Study|Lost to Follow-up|2|||
19501476|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501477|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501478|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19501479|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
19501480|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
19501481|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501482|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501483|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501484|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501485|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501486|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501487|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501488|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501489|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501490|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501491|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501492|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501493|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19501494|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
19501495|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
19501496|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
19501497|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501498|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501499|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501500|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501501|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501502|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501503|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501504|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501505|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501506|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501507|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501508|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19501509|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501510|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501511|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
19501512|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501513|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501514|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501515|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501516|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501517|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501518|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501519|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501520|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501521|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501522|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501523|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
19501524|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501525|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501526|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
19501527|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501528|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501529|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501530|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501531|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501532|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501533|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501534|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501535|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501536|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501537|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501538|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
19501539|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501540|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501541|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
19501542|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501543|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501544|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501545|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501546|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501547|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501548|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501549|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501550|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501551|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501552|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501553|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
19501554|NCT02326272|41876127|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501555|NCT02326272|41876128|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501556|NCT02326272|41876129|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
19501557|NCT02326272|41876130|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501558|NCT02326272|41876131|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501559|NCT02326272|41876132|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501560|NCT02326272|41876133|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501561|NCT02326272|41876134|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501562|NCT02326272|41876135|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501563|NCT02326272|41876136|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501564|NCT02326272|41876137|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501565|NCT02326272|41876138|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501566|NCT02326272|41876139|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501567|NCT02326272|41876140|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501568|NCT02326272|41876141|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
19501569|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501570|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501571|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501572|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501573|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
19501574|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
19501575|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
19614455|NCT03845296|42063484|FG000|Overall Study|Progression/relapse|14|||
19614456|NCT03845296|42063485|FG001|Overall Study|Progression/relapse|18|||
19614457|NCT03845296|42063484|FG000|Overall Study|Death|4|||
19614458|NCT03845296|42063485|FG001|Overall Study|Death|0|||
19614459|NCT03845296|42063484|FG000|Overall Study|Other - not protocol specified|1|||
19614460|NCT03845296|42063485|FG001|Overall Study|Other - not protocol specified|3|||
19614461|NCT03785925|42063491|FG000|Overall Study|Withdrawal by Subject|15|||
19614462|NCT03785925|42063491|FG000|Overall Study|Lost to Follow-up|1|||
19614463|NCT03427411|42063509|FG000|Overall Study|Screen failure - platelets too low|0|||
19614464|NCT03427411|42063510|FG001|Overall Study|Screen failure - platelets too low|1|||
19614465|NCT03330106|42063518|FG000|Part A|Withdrawal by Subject|1|||
19614466|NCT03330106|42063519|FG001|Part A|Withdrawal by Subject|1|||
19614467|NCT03330106|42063520|FG002|Part A|Withdrawal by Subject|0|||
19614468|NCT03330106|42063521|FG003|Part A|Withdrawal by Subject|0|||
19614469|NCT03330106|42063518|FG000|Part A|Death|2|||
19614470|NCT03330106|42063519|FG001|Part A|Death|1|||
19614471|NCT03330106|42063520|FG002|Part A|Death|0|||
19614472|NCT03330106|42063521|FG003|Part A|Death|0|||
19614473|NCT03330106|42063518|FG000|Part A|Adverse Event|0|||
19614474|NCT03330106|42063519|FG001|Part A|Adverse Event|1|||
19614475|NCT03330106|42063520|FG002|Part A|Adverse Event|0|||
19614476|NCT03330106|42063521|FG003|Part A|Adverse Event|0|||
19614477|NCT03330106|42063518|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
19614478|NCT03330106|42063519|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
19614479|NCT03330106|42063520|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
19614480|NCT03330106|42063521|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
19614481|NCT03330106|42063518|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
19614482|NCT03330106|42063519|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
19614483|NCT03330106|42063520|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
19501576|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
19501577|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
19501578|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501579|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501580|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501581|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501582|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501583|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19501584|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501585|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501586|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501587|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501588|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501589|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
19501590|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
19501591|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501592|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
19501593|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
19501594|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501595|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501596|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501597|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501598|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
19501599|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501600|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501601|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501602|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501603|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501604|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
19614484|NCT03330106|42063521|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
19614485|NCT03330106|42063518|FG000|Part A|Progressive Disease|0|||
19614486|NCT03330106|42063519|FG001|Part A|Progressive Disease|1|||
19614487|NCT03330106|42063520|FG002|Part A|Progressive Disease|0|||
19614488|NCT03330106|42063521|FG003|Part A|Progressive Disease|0|||
19614489|NCT03330106|42063518|FG000|Part B|Lost to Follow-up|0|||
19501605|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501606|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
19501607|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501608|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501609|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501610|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501611|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501612|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501613|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19501614|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501615|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501616|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501617|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19501618|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501619|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
19501620|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19501621|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19501622|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501623|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19501624|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501625|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501626|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501627|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501628|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19501629|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501630|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501631|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19614490|NCT03330106|42063519|FG001|Part B|Lost to Follow-up|0|||
19614491|NCT03330106|42063520|FG002|Part B|Lost to Follow-up|0|||
19614492|NCT03330106|42063521|FG003|Part B|Lost to Follow-up|1|||
19501632|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501633|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501634|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501635|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501636|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
19501637|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501638|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501639|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501640|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501641|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501642|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19501643|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
19614493|NCT03330106|42063518|FG000|Part B|Withdrawal by Subject|0|||
19614494|NCT03330106|42063519|FG001|Part B|Withdrawal by Subject|0|||
19614495|NCT03330106|42063520|FG002|Part B|Withdrawal by Subject|4|||
19614496|NCT03330106|42063521|FG003|Part B|Withdrawal by Subject|0|||
19614497|NCT03330106|42063518|FG000|Part B|Death|0|||
19614498|NCT03330106|42063519|FG001|Part B|Death|0|||
19614499|NCT03330106|42063520|FG002|Part B|Death|2|||
19614500|NCT03330106|42063521|FG003|Part B|Death|0|||
19614501|NCT03330106|42063518|FG000|Part B|Clinical Progression|0|||
19614502|NCT03330106|42063519|FG001|Part B|Clinical Progression|0|||
19614503|NCT03330106|42063520|FG002|Part B|Clinical Progression|1|||
19614504|NCT03330106|42063521|FG003|Part B|Clinical Progression|1|||
19614505|NCT03330106|42063518|FG000|Part B|Symptomatic Deterioration|0|||
19614506|NCT03330106|42063519|FG001|Part B|Symptomatic Deterioration|0|||
19614507|NCT03330106|42063520|FG002|Part B|Symptomatic Deterioration|0|||
19614508|NCT03330106|42063521|FG003|Part B|Symptomatic Deterioration|1|||
19614509|NCT03330106|42063518|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
19614510|NCT03330106|42063519|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
19614511|NCT03330106|42063520|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
19614512|NCT03330106|42063521|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
19614513|NCT03330106|42063518|FG000|Part B|Progressive Disease|0|||
19614514|NCT03330106|42063519|FG001|Part B|Progressive Disease|0|||
19614515|NCT03330106|42063520|FG002|Part B|Progressive Disease|11|||
19614516|NCT03330106|42063521|FG003|Part B|Progressive Disease|4|||
19501644|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501645|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501646|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501647|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501648|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501649|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501650|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
19501651|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501652|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501653|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501654|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501655|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501656|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19501657|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19614517|NCT03164564|42063533|FG000|Overall Study|Death|3|||
19614518|NCT03164564|42063534|FG001|Overall Study|Death|0|||
19614519|NCT03164564|42063533|FG000|Overall Study|Withdrawal by Subject|20|||
19614520|NCT03164564|42063534|FG001|Overall Study|Withdrawal by Subject|15|||
19614521|NCT03164564|42063533|FG000|Overall Study|Lost to Follow-up|2|||
19614522|NCT03164564|42063534|FG001|Overall Study|Lost to Follow-up|0|||
19614523|NCT03164564|42063533|FG000|Overall Study|Physician Decision|0|||
19614524|NCT03164564|42063534|FG001|Overall Study|Physician Decision|1|||
19614525|NCT03164564|42063533|FG000|Overall Study|Adverse Event|0|||
19614526|NCT03164564|42063534|FG001|Overall Study|Adverse Event|1|||
19614527|NCT03164564|42063533|FG000|Overall Study|Ongoing|1586|||
19614528|NCT03164564|42063534|FG001|Overall Study|Ongoing|1586|||
19393798|NCT01675765|41637704|FG000|Overall Study|Adverse Event|1|||
19393799|NCT01675765|41637705|FG001|Overall Study|Adverse Event|2|||
19393800|NCT01675765|41637704|FG000|Overall Study|Withdrawal by Subject|2|||
19393801|NCT01675765|41637705|FG001|Overall Study|Withdrawal by Subject|0|||
19393802|NCT01675765|41637704|FG000|Overall Study|Death|1|||
19393803|NCT01675765|41637705|FG001|Overall Study|Death|0|||
19393804|NCT01675765|41637704|FG000|Overall Study|Clinical progression|3|||
19393805|NCT01675765|41637705|FG001|Overall Study|Clinical progression|2|||
19393806|NCT02625233|41637713|FG000|Overall Study|Adverse Event|2|||
19393807|NCT02625233|41637714|FG001|Overall Study|Adverse Event|0|||
19501658|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19614529|NCT02821754|42063558|FG000|Overall Study|Procedure not required prior to amendment change|13|||
19501659|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19614530|NCT02821754|42063559|FG001|Overall Study|Procedure not required prior to amendment change|11|||
19614531|NCT02821754|42063560|FG002|Overall Study|Procedure not required prior to amendment change|0|||
19614532|NCT02821754|42063558|FG000|Overall Study|Participant's Clinical status|2|||
19614533|NCT02821754|42063559|FG001|Overall Study|Participant's Clinical status|0|||
19614534|NCT02821754|42063560|FG002|Overall Study|Participant's Clinical status|0|||
19614535|NCT02821754|42063558|FG000|Overall Study|Participant removed for noncompliance|1|||
19614536|NCT02821754|42063559|FG001|Overall Study|Participant removed for noncompliance|0|||
19501660|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501661|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501662|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501663|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501664|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501665|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501666|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501667|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
19501668|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501669|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501670|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501671|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501672|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501673|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
19501674|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501675|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501676|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501677|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501678|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501679|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
19501680|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
19501681|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
19501682|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
19501683|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501684|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501685|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501686|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501687|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501688|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
19501689|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501690|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501691|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501692|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501693|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501694|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
19501695|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501696|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501697|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501698|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501699|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501700|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501701|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501702|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501703|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
19501704|NCT02326272|41876127|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501705|NCT02326272|41876128|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501706|NCT02326272|41876129|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501707|NCT02326272|41876130|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501708|NCT02326272|41876131|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19614537|NCT02821754|42063560|FG002|Overall Study|Participant removed for noncompliance|0|||
19614538|NCT02821754|42063558|FG000|Overall Study|Drug not available.|0|||
19614539|NCT02821754|42063559|FG001|Overall Study|Drug not available.|0|||
19614540|NCT02821754|42063560|FG002|Overall Study|Drug not available.|1|||
19501709|NCT02326272|41876132|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501710|NCT02326272|41876133|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
19501711|NCT02326272|41876134|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501712|NCT02326272|41876135|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501713|NCT02326272|41876136|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501714|NCT02326272|41876137|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501715|NCT02326272|41876138|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501716|NCT02326272|41876139|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501717|NCT02326272|41876140|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501718|NCT02326272|41876141|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
19501719|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
19501720|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
19501721|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
19501722|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
19501723|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
19501724|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
19501725|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
19501726|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
19501727|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
19501728|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
19501729|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
19501730|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
19501731|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
19501732|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
19501733|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
19501734|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501735|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501736|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501737|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501738|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501739|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501740|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501741|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501742|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501743|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501744|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
19501745|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
19501746|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
19501747|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19501748|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
19501749|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501750|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501751|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501752|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501753|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501754|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501755|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501756|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501757|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501758|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501759|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19501760|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501761|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19501762|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501763|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19501764|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501765|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501766|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501767|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501768|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501769|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501770|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501771|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501772|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501773|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501774|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501775|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
19501776|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501777|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501778|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19501779|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501780|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501781|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501782|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501783|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501784|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501785|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501786|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501787|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501788|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501789|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
19501790|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501791|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
19501792|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19501793|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
19501794|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501795|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501796|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501797|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501798|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501799|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501800|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501801|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501802|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501803|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501804|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501805|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
19501806|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501807|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19501808|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
19501809|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501810|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501811|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501812|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501813|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501814|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501815|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501816|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501817|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501818|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501819|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501820|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
19501821|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
19501822|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19501823|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
19501824|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501825|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501826|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501827|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501828|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501829|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501830|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501831|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501832|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19704436|NCT00160680|42148794|FG000|Overall Study|Withdrawal by Subject|4|||
19704437|NCT00160680|42148795|FG001|Overall Study|Withdrawal by Subject|9|||
19704438|NCT00160524|42148801|FG000|Overall Study|Adverse Event|119|||
19704439|NCT00160524|42148801|FG000|Overall Study|Adverse Event and Other|94|||
19501833|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501834|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501835|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
19501836|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501837|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501838|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
19501839|NCT02326272|41876127|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501840|NCT02326272|41876128|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501841|NCT02326272|41876129|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501842|NCT02326272|41876130|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501843|NCT02326272|41876131|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501844|NCT02326272|41876132|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501845|NCT02326272|41876133|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501846|NCT02326272|41876134|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501847|NCT02326272|41876135|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501848|NCT02326272|41876136|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501849|NCT02326272|41876137|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501850|NCT02326272|41876138|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501851|NCT02326272|41876139|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
19501852|NCT02326272|41876140|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501853|NCT02326272|41876141|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
19501854|NCT02325414|41876178|FG000|Overall Study|Withdrawal by Subject|3|||
19501855|NCT02325414|41876179|FG001|Overall Study|Withdrawal by Subject|1|||
19501856|NCT02325414|41876178|FG000|Overall Study|Lost to Follow-up|5|||
19501857|NCT02325414|41876179|FG001|Overall Study|Lost to Follow-up|5|||
19501858|NCT02349048|41876197|FG000|Overall Study|Withdrawal by Subject|4|||
19501859|NCT02349048|41876198|FG001|Overall Study|Withdrawal by Subject|0|||
19501860|NCT02349048|41876197|FG000|Overall Study|Lost to Follow-up|1|||
19501861|NCT02349048|41876198|FG001|Overall Study|Lost to Follow-up|0|||
19501862|NCT02299206|41876245|FG000|Overall Study|Lost to Follow-up|1|||
19501863|NCT02299206|41876245|FG000|Overall Study|Withdrawal by Subject|1|||
19501864|NCT02298192|41876264|FG000|Overall Study|Unclassified|3|||
19501865|NCT02298192|41876265|FG001|Overall Study|Unclassified|2|||
19501866|NCT02298192|41876264|FG000|Overall Study|Withdrawal criteria|2|||
19501867|NCT02298192|41876265|FG001|Overall Study|Withdrawal criteria|0|||
19501868|NCT02298192|41876264|FG000|Overall Study|Withdrawal by Subject|6|||
19501869|NCT02298192|41876265|FG001|Overall Study|Withdrawal by Subject|1|||
19501870|NCT02298192|41876264|FG000|Overall Study|Lost to Follow-up|2|||
19501871|NCT02298192|41876265|FG001|Overall Study|Lost to Follow-up|1|||
19501872|NCT02298192|41876264|FG000|Overall Study|Adverse Event|6|||
19501873|NCT02298192|41876265|FG001|Overall Study|Adverse Event|2|||
19501874|NCT02280408|41876391|FG000|Overall Study|Lost to Follow-up|0|||
19501875|NCT02280408|41876392|FG001|Overall Study|Lost to Follow-up|2|||
19501876|NCT02280408|41876393|FG002|Overall Study|Lost to Follow-up|0|||
19501877|NCT02280408|41876394|FG003|Overall Study|Lost to Follow-up|0|||
19501878|NCT02296476|41876470|FG000|Overall Study|Disease Progression|6|||
19501879|NCT02296476|41876471|FG001|Overall Study|Disease Progression|4|||
19501880|NCT02296476|41876472|FG002|Overall Study|Disease Progression|2|||
19501881|NCT00552032|41876513|FG000|Overall Study|Withdrawal by Subject|2|||
19501882|NCT00552032|41876514|FG001|Overall Study|Withdrawal by Subject|2|||
19501883|NCT00552032|41876513|FG000|Overall Study|Protocol Violation|7|||
19501884|NCT00552032|41876514|FG001|Overall Study|Protocol Violation|12|||
19501885|NCT00552032|41876513|FG000|Overall Study|Lost to Follow-up|8|||
19501886|NCT00552032|41876514|FG001|Overall Study|Lost to Follow-up|5|||
19501887|NCT02988817|41877274|FG000|Overall Study|Withdrawal by Subject|1|||
19501888|NCT02988817|41877275|FG001|Overall Study|Withdrawal by Subject|0|||
19501889|NCT02988817|41877276|FG002|Overall Study|Withdrawal by Subject|0|||
19501890|NCT02988817|41877277|FG003|Overall Study|Withdrawal by Subject|1|||
19501891|NCT02988817|41877278|FG004|Overall Study|Withdrawal by Subject|3|||
19501892|NCT02988817|41877279|FG005|Overall Study|Withdrawal by Subject|1|||
19501893|NCT02988817|41877280|FG006|Overall Study|Withdrawal by Subject|2|||
19501894|NCT02988817|41877281|FG007|Overall Study|Withdrawal by Subject|1|||
19501895|NCT02988817|41877282|FG008|Overall Study|Withdrawal by Subject|1|||
19501896|NCT02988817|41877283|FG009|Overall Study|Withdrawal by Subject|1|||
19501897|NCT02988817|41877284|FG010|Overall Study|Withdrawal by Subject|1|||
19614541|NCT02821754|42063558|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
19614542|NCT02821754|42063559|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
19614543|NCT02821754|42063560|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
19614544|NCT02742246|42063569|FG000|Overall Study|Never initiated treatment|5|||
19614545|NCT02742246|42063570|FG001|Overall Study|Never initiated treatment|3|||
19614546|NCT02742246|42063571|FG002|Overall Study|Never initiated treatment|1|||
19501898|NCT02988817|41877285|FG011|Overall Study|Withdrawal by Subject|12|||
19614547|NCT02742246|42063569|FG000|Overall Study|dropped out during treatment|14|||
19614548|NCT02742246|42063570|FG001|Overall Study|dropped out during treatment|14|||
19614549|NCT02742246|42063571|FG002|Overall Study|dropped out during treatment|11|||
19501899|NCT02988817|41877286|FG012|Overall Study|Withdrawal by Subject|6|||
19501900|NCT02988817|41877287|FG013|Overall Study|Withdrawal by Subject|6|||
19501901|NCT02988817|41877288|FG014|Overall Study|Withdrawal by Subject|4|||
19501902|NCT02988817|41877289|FG015|Overall Study|Withdrawal by Subject|5|||
19501903|NCT02988817|41877290|FG016|Overall Study|Withdrawal by Subject|4|||
19501904|NCT02988817|41877291|FG017|Overall Study|Withdrawal by Subject|11|||
19501905|NCT02988817|41877292|FG018|Overall Study|Withdrawal by Subject|4|||
19501906|NCT02988817|41877293|FG019|Overall Study|Withdrawal by Subject|2|||
19501907|NCT02988817|41877274|FG000|Overall Study|Death|0|||
19501908|NCT02988817|41877275|FG001|Overall Study|Death|1|||
19501909|NCT02988817|41877276|FG002|Overall Study|Death|3|||
19501910|NCT02988817|41877277|FG003|Overall Study|Death|1|||
19501911|NCT02988817|41877278|FG004|Overall Study|Death|6|||
19501912|NCT02988817|41877279|FG005|Overall Study|Death|10|||
19501913|NCT02988817|41877280|FG006|Overall Study|Death|1|||
19501914|NCT02988817|41877281|FG007|Overall Study|Death|2|||
19501915|NCT02988817|41877282|FG008|Overall Study|Death|1|||
19501916|NCT02988817|41877283|FG009|Overall Study|Death|5|||
19501917|NCT02988817|41877284|FG010|Overall Study|Death|1|||
19501918|NCT02988817|41877285|FG011|Overall Study|Death|8|||
19501919|NCT02988817|41877286|FG012|Overall Study|Death|9|||
19501920|NCT02988817|41877287|FG013|Overall Study|Death|17|||
19501921|NCT02988817|41877288|FG014|Overall Study|Death|18|||
19501922|NCT02988817|41877289|FG015|Overall Study|Death|30|||
19501923|NCT02988817|41877290|FG016|Overall Study|Death|17|||
19501924|NCT02988817|41877291|FG017|Overall Study|Death|38|||
19501925|NCT02988817|41877292|FG018|Overall Study|Death|14|||
19501926|NCT02988817|41877293|FG019|Overall Study|Death|16|||
19501927|NCT02988817|41877274|FG000|Overall Study|Other|0|||
19501928|NCT02988817|41877275|FG001|Overall Study|Other|0|||
19501929|NCT02988817|41877276|FG002|Overall Study|Other|0|||
19501930|NCT02988817|41877277|FG003|Overall Study|Other|1|||
19501931|NCT02988817|41877278|FG004|Overall Study|Other|1|||
19501932|NCT02988817|41877279|FG005|Overall Study|Other|0|||
19501933|NCT02988817|41877280|FG006|Overall Study|Other|0|||
19501934|NCT02988817|41877281|FG007|Overall Study|Other|0|||
19501935|NCT02988817|41877282|FG008|Overall Study|Other|0|||
19501936|NCT02988817|41877283|FG009|Overall Study|Other|0|||
19501937|NCT02988817|41877284|FG010|Overall Study|Other|0|||
19501938|NCT02988817|41877285|FG011|Overall Study|Other|0|||
19501939|NCT02988817|41877286|FG012|Overall Study|Other|0|||
19501940|NCT02988817|41877287|FG013|Overall Study|Other|0|||
19501941|NCT02988817|41877288|FG014|Overall Study|Other|0|||
19501942|NCT02988817|41877289|FG015|Overall Study|Other|1|||
19501943|NCT02988817|41877290|FG016|Overall Study|Other|0|||
19501944|NCT02988817|41877291|FG017|Overall Study|Other|0|||
19501945|NCT02988817|41877292|FG018|Overall Study|Other|0|||
19501946|NCT02988817|41877293|FG019|Overall Study|Other|0|||
19501947|NCT02988817|41877274|FG000|Overall Study|Lost to Follow-up|0|||
19501948|NCT02988817|41877275|FG001|Overall Study|Lost to Follow-up|0|||
19501949|NCT02988817|41877276|FG002|Overall Study|Lost to Follow-up|0|||
19501950|NCT02988817|41877277|FG003|Overall Study|Lost to Follow-up|0|||
19501951|NCT02988817|41877278|FG004|Overall Study|Lost to Follow-up|0|||
19501952|NCT02988817|41877279|FG005|Overall Study|Lost to Follow-up|0|||
19501953|NCT02988817|41877280|FG006|Overall Study|Lost to Follow-up|0|||
19501954|NCT02988817|41877281|FG007|Overall Study|Lost to Follow-up|0|||
19501955|NCT02988817|41877282|FG008|Overall Study|Lost to Follow-up|1|||
19501956|NCT02988817|41877283|FG009|Overall Study|Lost to Follow-up|0|||
19501957|NCT02988817|41877284|FG010|Overall Study|Lost to Follow-up|1|||
19501958|NCT02988817|41877285|FG011|Overall Study|Lost to Follow-up|1|||
19501959|NCT02988817|41877286|FG012|Overall Study|Lost to Follow-up|0|||
19501960|NCT02988817|41877287|FG013|Overall Study|Lost to Follow-up|0|||
19501961|NCT02988817|41877288|FG014|Overall Study|Lost to Follow-up|1|||
19501962|NCT02988817|41877289|FG015|Overall Study|Lost to Follow-up|1|||
19501963|NCT02988817|41877290|FG016|Overall Study|Lost to Follow-up|2|||
19501964|NCT02988817|41877291|FG017|Overall Study|Lost to Follow-up|3|||
19501965|NCT02988817|41877292|FG018|Overall Study|Lost to Follow-up|0|||
19501966|NCT02988817|41877293|FG019|Overall Study|Lost to Follow-up|0|||
19501967|NCT02988817|41877274|FG000|Overall Study|Sponsor decision|0|||
19501968|NCT02988817|41877275|FG001|Overall Study|Sponsor decision|0|||
19501969|NCT02988817|41877276|FG002|Overall Study|Sponsor decision|0|||
19501970|NCT02988817|41877277|FG003|Overall Study|Sponsor decision|0|||
19501971|NCT02988817|41877278|FG004|Overall Study|Sponsor decision|0|||
19501972|NCT02988817|41877279|FG005|Overall Study|Sponsor decision|0|||
19501973|NCT02988817|41877280|FG006|Overall Study|Sponsor decision|0|||
19501974|NCT02988817|41877281|FG007|Overall Study|Sponsor decision|0|||
19501975|NCT02988817|41877282|FG008|Overall Study|Sponsor decision|0|||
19501976|NCT02988817|41877283|FG009|Overall Study|Sponsor decision|0|||
19501977|NCT02988817|41877284|FG010|Overall Study|Sponsor decision|0|||
19501978|NCT02988817|41877285|FG011|Overall Study|Sponsor decision|1|||
19501979|NCT02988817|41877286|FG012|Overall Study|Sponsor decision|1|||
19501980|NCT02988817|41877287|FG013|Overall Study|Sponsor decision|2|||
19501981|NCT02988817|41877288|FG014|Overall Study|Sponsor decision|2|||
19501982|NCT02988817|41877289|FG015|Overall Study|Sponsor decision|6|||
19501983|NCT02988817|41877290|FG016|Overall Study|Sponsor decision|2|||
19501984|NCT02988817|41877291|FG017|Overall Study|Sponsor decision|3|||
19501985|NCT02988817|41877292|FG018|Overall Study|Sponsor decision|2|||
19501986|NCT02988817|41877293|FG019|Overall Study|Sponsor decision|7|||
19501987|NCT02988817|41877274|FG000|Overall Study|Physician Decision|0|||
19501988|NCT02988817|41877275|FG001|Overall Study|Physician Decision|0|||
19614550|NCT02742246|42063569|FG000|Overall Study|Death|1|||
19614551|NCT02742246|42063570|FG001|Overall Study|Death|0|||
19614552|NCT02742246|42063571|FG002|Overall Study|Death|0|||
19614553|NCT02708108|42063581|FG000|Overall Study|Death|1|||
19614554|NCT02708108|42063582|FG001|Overall Study|Death|2|||
19614555|NCT02708108|42063581|FG000|Overall Study|Regimen change|1|||
19614556|NCT02708108|42063582|FG001|Overall Study|Regimen change|0|||
19614557|NCT02708108|42063581|FG000|Overall Study|No MRD and no imaging available|0|||
19614558|NCT02708108|42063582|FG001|Overall Study|No MRD and no imaging available|1|||
19614559|NCT02619682|42063589|FG000|Overall Study|Withdrawal by Subject|3|||
19614560|NCT02619682|42063589|FG000|Overall Study|Lack of Efficacy|8|||
19614561|NCT02619682|42063589|FG000|Overall Study|new secondary cancer|1|||
19501989|NCT02988817|41877276|FG002|Overall Study|Physician Decision|0|||
19501990|NCT02988817|41877277|FG003|Overall Study|Physician Decision|0|||
19501991|NCT02988817|41877278|FG004|Overall Study|Physician Decision|0|||
19501992|NCT02988817|41877279|FG005|Overall Study|Physician Decision|0|||
19501993|NCT02988817|41877280|FG006|Overall Study|Physician Decision|0|||
19704440|NCT00160524|42148801|FG000|Overall Study|Protocol Violation|16|||
19704441|NCT00160524|42148801|FG000|Overall Study|Protocol Violation and Other|2|||
19704442|NCT00160524|42148801|FG000|Overall Study|Withdrawal by Subject|141|||
19704443|NCT00160524|42148801|FG000|Overall Study|Withdrawal by Subject and Other|17|||
19501994|NCT02988817|41877281|FG007|Overall Study|Physician Decision|0|||
19501995|NCT02988817|41877282|FG008|Overall Study|Physician Decision|0|||
19501996|NCT02988817|41877283|FG009|Overall Study|Physician Decision|0|||
19501997|NCT02988817|41877284|FG010|Overall Study|Physician Decision|0|||
19501998|NCT02988817|41877285|FG011|Overall Study|Physician Decision|0|||
19501999|NCT02988817|41877286|FG012|Overall Study|Physician Decision|0|||
19502000|NCT02988817|41877287|FG013|Overall Study|Physician Decision|0|||
19502001|NCT02988817|41877288|FG014|Overall Study|Physician Decision|0|||
19502002|NCT02988817|41877289|FG015|Overall Study|Physician Decision|1|||
19502003|NCT02988817|41877290|FG016|Overall Study|Physician Decision|0|||
19502004|NCT02988817|41877291|FG017|Overall Study|Physician Decision|0|||
19502005|NCT02988817|41877292|FG018|Overall Study|Physician Decision|1|||
19502006|NCT02988817|41877293|FG019|Overall Study|Physician Decision|1|||
19502007|NCT03312530|41877417|FG000|Overall Study|Death|5|||
19502008|NCT03312530|41877418|FG001|Overall Study|Death|5|||
19614562|NCT02619682|42063589|FG000|Overall Study|post surgery complications|2|||
19614563|NCT02617589|42063595|FG000|Randomization|Request to Discontinue Study Treatment|1|||
19614564|NCT02617589|42063596|FG001|Randomization|Request to Discontinue Study Treatment|3|||
19614565|NCT02617589|42063595|FG000|Randomization|Participant Withdrew Consent|1|||
19614566|NCT02617589|42063596|FG001|Randomization|Participant Withdrew Consent|2|||
19614567|NCT02617589|42063595|FG000|Treatment|Other Reasons|3|||
19614568|NCT02617589|42063596|FG001|Treatment|Other Reasons|3|||
19614569|NCT02617589|42063595|FG000|Treatment|Poor/Non Compliance|1|||
19614570|NCT02617589|42063596|FG001|Treatment|Poor/Non Compliance|1|||
19614571|NCT02617589|42063595|FG000|Treatment|Maximum Clinical Benefit|0|||
19614572|NCT02617589|42063596|FG001|Treatment|Maximum Clinical Benefit|2|||
19614573|NCT02617589|42063595|FG000|Treatment|Participant Withdrew Consent|2|||
19614574|NCT02617589|42063596|FG001|Treatment|Participant Withdrew Consent|6|||
19614575|NCT02617589|42063595|FG000|Treatment|Participant Request to Discontinue|12|||
19614576|NCT02617589|42063596|FG001|Treatment|Participant Request to Discontinue|21|||
19614577|NCT02617589|42063595|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
19614578|NCT02617589|42063596|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
19614579|NCT02617589|42063595|FG000|Treatment|Death|1|||
19614580|NCT02617589|42063596|FG001|Treatment|Death|1|||
19704444|NCT00160524|42148801|FG000|Overall Study|Physician Decision|27|||
19502009|NCT03312530|41877419|FG002|Overall Study|Death|4|||
19502010|NCT03312530|41877420|FG003|Overall Study|Death|10|||
19614581|NCT02617589|42063595|FG000|Treatment|Study Drug Toxicity|27|||
19614582|NCT02617589|42063596|FG001|Treatment|Study Drug Toxicity|20|||
19614583|NCT02617589|42063595|FG000|Treatment|Disease Progression|216|||
19614584|NCT02617589|42063596|FG001|Treatment|Disease Progression|136|||
19614585|NCT02500797|42063610|FG000|Overall Study|Cancel (rapid disease progression)|0|||
19704445|NCT00160524|42148801|FG000|Overall Study|Physician Decision and Other|6|||
19502011|NCT03312530|41877421|FG004|Overall Study|Death|8|||
19502012|NCT03312530|41877417|FG000|Overall Study|Lost to Follow-up|0|||
19502013|NCT03312530|41877418|FG001|Overall Study|Lost to Follow-up|0|||
19502014|NCT03312530|41877419|FG002|Overall Study|Lost to Follow-up|0|||
19502015|NCT03312530|41877420|FG003|Overall Study|Lost to Follow-up|1|||
19502016|NCT03312530|41877421|FG004|Overall Study|Lost to Follow-up|0|||
19502017|NCT03312530|41877417|FG000|Overall Study|Participant in another sponsor study.|0|||
19502018|NCT03312530|41877418|FG001|Overall Study|Participant in another sponsor study.|0|||
19502019|NCT03312530|41877419|FG002|Overall Study|Participant in another sponsor study.|0|||
19502020|NCT03312530|41877420|FG003|Overall Study|Participant in another sponsor study.|1|||
19502021|NCT03312530|41877421|FG004|Overall Study|Participant in another sponsor study.|0|||
19502022|NCT03312530|41877417|FG000|Overall Study|Study terminated by sponsor|1|||
19502023|NCT03312530|41877418|FG001|Overall Study|Study terminated by sponsor|0|||
19502024|NCT03312530|41877419|FG002|Overall Study|Study terminated by sponsor|2|||
19502025|NCT03312530|41877420|FG003|Overall Study|Study terminated by sponsor|3|||
19502026|NCT03312530|41877421|FG004|Overall Study|Study terminated by sponsor|7|||
19502027|NCT03312530|41877417|FG000|Overall Study|Withdrawal by Subject|0|||
19502028|NCT03312530|41877418|FG001|Overall Study|Withdrawal by Subject|1|||
19502029|NCT03312530|41877419|FG002|Overall Study|Withdrawal by Subject|0|||
19502030|NCT03312530|41877420|FG003|Overall Study|Withdrawal by Subject|0|||
19502031|NCT03312530|41877421|FG004|Overall Study|Withdrawal by Subject|0|||
19502032|NCT03312530|41877417|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
19502033|NCT03312530|41877418|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
19502034|NCT03312530|41877419|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
19502035|NCT03312530|41877420|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
19502036|NCT03312530|41877421|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
19502037|NCT02296320|41877552|FG000|Overall Study|Withdrawal by Subject|4|||
19502038|NCT02296320|41877553|FG001|Overall Study|Withdrawal by Subject|0|||
19502039|NCT02296320|41877554|FG002|Overall Study|Withdrawal by Subject|2|||
19502040|NCT02296320|41877552|FG000|Overall Study|Death|24|||
19502041|NCT02296320|41877553|FG001|Overall Study|Death|3|||
19502042|NCT02296320|41877554|FG002|Overall Study|Death|27|||
19502043|NCT02296320|41877552|FG000|Overall Study|Lost to Follow-up|5|||
19502044|NCT02296320|41877553|FG001|Overall Study|Lost to Follow-up|2|||
19502045|NCT02296320|41877554|FG002|Overall Study|Lost to Follow-up|7|||
19502046|NCT02296320|41877552|FG000|Overall Study|Not treated|2|||
19502047|NCT02296320|41877553|FG001|Overall Study|Not treated|0|||
19614586|NCT02500797|42063611|FG001|Overall Study|Cancel (rapid disease progression)|0|||
19614587|NCT02500797|42063612|FG002|Overall Study|Cancel (rapid disease progression)|0|||
19614588|NCT02500797|42063613|FG003|Overall Study|Cancel (rapid disease progression)|0|||
19614589|NCT02500797|42063614|FG004|Overall Study|Cancel (rapid disease progression)|1|||
19614590|NCT02500797|42063615|FG005|Overall Study|Cancel (rapid disease progression)|1|||
19614591|NCT02500797|42063616|FG006|Overall Study|Cancel (rapid disease progression)|0|||
19614592|NCT02500797|42063617|FG007|Overall Study|Cancel (rapid disease progression)|0|||
19614593|NCT02500797|42063610|FG000|Overall Study|Withdrawal by Subject|1|||
19614594|NCT02500797|42063611|FG001|Overall Study|Withdrawal by Subject|0|||
19614595|NCT02500797|42063612|FG002|Overall Study|Withdrawal by Subject|0|||
19614596|NCT02500797|42063613|FG003|Overall Study|Withdrawal by Subject|0|||
19614597|NCT02500797|42063614|FG004|Overall Study|Withdrawal by Subject|0|||
19614598|NCT02500797|42063615|FG005|Overall Study|Withdrawal by Subject|0|||
19614599|NCT02500797|42063616|FG006|Overall Study|Withdrawal by Subject|0|||
19614600|NCT02500797|42063617|FG007|Overall Study|Withdrawal by Subject|0|||
19614601|NCT02471807|42063642|FG000|Overall Study|Death|14|||
19614602|NCT02471807|42063642|FG000|Overall Study|Withdrawal by Subject|2|||
19614603|NCT02471807|42063642|FG000|Overall Study|Explant|5|||
19614604|NCT02471807|42063642|FG000|Overall Study|Lost to Follow-up|1|||
19614605|NCT02364557|42063648|FG000|Overall Study|Protocol Violation|3|||
19614606|NCT02364557|42063649|FG001|Overall Study|Protocol Violation|1|||
19614607|NCT02337829|42063685|FG000|Overall Study|Death|0|||
19614608|NCT02337829|42063686|FG001|Overall Study|Death|1|||
19614609|NCT02337829|42063687|FG002|Overall Study|Death|0|||
19614610|NCT02337829|42063688|FG003|Overall Study|Death|0|||
19614611|NCT02337829|42063685|FG000|Overall Study|Study terminated by sponsor|12|||
19614612|NCT02337829|42063686|FG001|Overall Study|Study terminated by sponsor|10|||
19614613|NCT02337829|42063687|FG002|Overall Study|Study terminated by sponsor|5|||
19614614|NCT02337829|42063688|FG003|Overall Study|Study terminated by sponsor|6|||
19614615|NCT02337829|42063685|FG000|Overall Study|discontinued for other reasons|6|||
19614616|NCT02337829|42063686|FG001|Overall Study|discontinued for other reasons|3|||
19614617|NCT02337829|42063687|FG002|Overall Study|discontinued for other reasons|1|||
19614618|NCT02337829|42063688|FG003|Overall Study|discontinued for other reasons|4|||
19704446|NCT00160524|42148801|FG000|Overall Study|Lost to Follow-up|13|||
19704447|NCT00160524|42148801|FG000|Overall Study|Lost to Follow-up and Other|1|||
19614619|NCT02257528|42063700|FG000|Overall Study|Never received study treatment|1|||
19614620|NCT01899326|42063704|FG000|Overall Study|Withdrawal by Subject|1|||
19614621|NCT01899326|42063704|FG000|Overall Study|Adverse Event|2|||
19704448|NCT00160524|42148801|FG000|Overall Study|Lack of Efficacy|21|||
19393808|NCT02656693|41637723|FG000|Overall Study|Pregnancy|1|||
19614622|NCT01899326|42063704|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
19614623|NCT01856192|42063711|FG000|Overall Study|Adverse Event|12|||
19614624|NCT01856192|42063712|FG001|Overall Study|Adverse Event|4|||
19614625|NCT01856192|42063711|FG000|Overall Study|Alternative therapy|0|||
19614626|NCT01856192|42063712|FG001|Overall Study|Alternative therapy|3|||
19614627|NCT01856192|42063711|FG000|Overall Study|Death|3|||
19614628|NCT01856192|42063712|FG001|Overall Study|Death|5|||
19614629|NCT01856192|42063711|FG000|Overall Study|Lack of Efficacy|0|||
19614630|NCT01856192|42063712|FG001|Overall Study|Lack of Efficacy|5|||
19614631|NCT01856192|42063711|FG000|Overall Study|Withdrawal by Subject|1|||
19614632|NCT01856192|42063712|FG001|Overall Study|Withdrawal by Subject|1|||
19614633|NCT01856192|42063711|FG000|Overall Study|Other diseases|1|||
19614634|NCT01856192|42063712|FG001|Overall Study|Other diseases|0|||
19614635|NCT01856192|42063711|FG000|Overall Study|Never started treatment|7|||
19614636|NCT01856192|42063712|FG001|Overall Study|Never started treatment|5|||
19614637|NCT01856192|42063711|FG000|Overall Study|Path ineligible|20|||
19614638|NCT01856192|42063712|FG001|Overall Study|Path ineligible|34|||
19614639|NCT01856192|42063711|FG000|Overall Study|Non-path ineligible|2|||
19614640|NCT01856192|42063712|FG001|Overall Study|Non-path ineligible|2|||
19502048|NCT02296320|41877554|FG002|Overall Study|Not treated|0|||
19502049|NCT02296320|41877552|FG000|Overall Study|Not - specified|0|||
19502050|NCT02296320|41877553|FG001|Overall Study|Not - specified|0|||
19502051|NCT02296320|41877554|FG002|Overall Study|Not - specified|1|||
19502052|NCT02296242|41877593|FG000|Overall Study|Death|1|||
19502053|NCT02296242|41877594|FG001|Overall Study|Death|1|||
19502054|NCT02296242|41877595|FG002|Overall Study|Death|1|||
19502055|NCT02296242|41877596|FG003|Overall Study|Death|1|||
19502056|NCT02296242|41877597|FG004|Overall Study|Death|1|||
19502057|NCT02296242|41877593|FG000|Overall Study|Withdrawal by Subject|0|||
19502058|NCT02296242|41877594|FG001|Overall Study|Withdrawal by Subject|0|||
19502059|NCT02296242|41877595|FG002|Overall Study|Withdrawal by Subject|1|||
19502060|NCT02296242|41877596|FG003|Overall Study|Withdrawal by Subject|1|||
19502061|NCT02296242|41877597|FG004|Overall Study|Withdrawal by Subject|3|||
19502062|NCT02296242|41877593|FG000|Overall Study|Disease Progression|1|||
19502063|NCT02296242|41877594|FG001|Overall Study|Disease Progression|3|||
19502064|NCT02296242|41877595|FG002|Overall Study|Disease Progression|2|||
19502065|NCT02296242|41877596|FG003|Overall Study|Disease Progression|8|||
19502066|NCT02296242|41877597|FG004|Overall Study|Disease Progression|11|||
19502067|NCT02296242|41877593|FG000|Overall Study|Unacceptable Toxicity|0|||
19502068|NCT02296242|41877594|FG001|Overall Study|Unacceptable Toxicity|0|||
19502069|NCT02296242|41877595|FG002|Overall Study|Unacceptable Toxicity|0|||
19502070|NCT02296242|41877596|FG003|Overall Study|Unacceptable Toxicity|0|||
19502071|NCT02296242|41877597|FG004|Overall Study|Unacceptable Toxicity|1|||
19502072|NCT02296242|41877593|FG000|Overall Study|Patient Condition Changed|0|||
19502073|NCT02296242|41877594|FG001|Overall Study|Patient Condition Changed|0|||
19502074|NCT02296242|41877595|FG002|Overall Study|Patient Condition Changed|2|||
19502075|NCT02296242|41877596|FG003|Overall Study|Patient Condition Changed|0|||
19502076|NCT02296242|41877597|FG004|Overall Study|Patient Condition Changed|1|||
19502077|NCT02296242|41877593|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
19502078|NCT02296242|41877594|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
19502079|NCT02296242|41877595|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
19502080|NCT02296242|41877596|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
19502081|NCT02296242|41877597|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
19502082|NCT02296242|41877593|FG000|Overall Study|Lost to Follow-up|1|||
19502083|NCT02296242|41877594|FG001|Overall Study|Lost to Follow-up|0|||
19502084|NCT02296242|41877595|FG002|Overall Study|Lost to Follow-up|0|||
19502085|NCT02296242|41877596|FG003|Overall Study|Lost to Follow-up|0|||
19502086|NCT02296242|41877597|FG004|Overall Study|Lost to Follow-up|0|||
19502087|NCT02296242|41877593|FG000|Overall Study|Need for Hydroxyurea|2|||
19502088|NCT02296242|41877594|FG001|Overall Study|Need for Hydroxyurea|0|||
19502089|NCT02296242|41877595|FG002|Overall Study|Need for Hydroxyurea|0|||
19502090|NCT02296242|41877596|FG003|Overall Study|Need for Hydroxyurea|0|||
19502091|NCT02296242|41877597|FG004|Overall Study|Need for Hydroxyurea|0|||
19502092|NCT02296242|41877593|FG000|Overall Study|Screened for Other Protocol|0|||
19502093|NCT02296242|41877594|FG001|Overall Study|Screened for Other Protocol|1|||
19502094|NCT02296242|41877595|FG002|Overall Study|Screened for Other Protocol|0|||
19502095|NCT02296242|41877596|FG003|Overall Study|Screened for Other Protocol|0|||
19502096|NCT02296242|41877597|FG004|Overall Study|Screened for Other Protocol|0|||
19502097|NCT02296242|41877593|FG000|Overall Study|Physician Decision|0|||
19502098|NCT02296242|41877594|FG001|Overall Study|Physician Decision|1|||
19502099|NCT02296242|41877595|FG002|Overall Study|Physician Decision|0|||
19614641|NCT01856192|42063711|FG000|Overall Study|Physician Decision|1|||
19614642|NCT01856192|42063712|FG001|Overall Study|Physician Decision|1|||
19614643|NCT01856192|42063711|FG000|Overall Study|Suspicion of progressive disease|1|||
19502100|NCT02296242|41877596|FG003|Overall Study|Physician Decision|1|||
19502101|NCT02296242|41877597|FG004|Overall Study|Physician Decision|0|||
19614644|NCT01856192|42063712|FG001|Overall Study|Suspicion of progressive disease|0|||
19614645|NCT01856192|42063711|FG000|Overall Study|Non-compliance|1|||
19502102|NCT02296242|41877593|FG000|Overall Study|Alternative Treatment|0|||
19502103|NCT02296242|41877594|FG001|Overall Study|Alternative Treatment|0|||
19502104|NCT02296242|41877595|FG002|Overall Study|Alternative Treatment|0|||
19502105|NCT02296242|41877596|FG003|Overall Study|Alternative Treatment|1|||
19502106|NCT02296242|41877597|FG004|Overall Study|Alternative Treatment|0|||
19502107|NCT02296242|41877593|FG000|Overall Study|Adverse Event|0|||
19502108|NCT02296242|41877594|FG001|Overall Study|Adverse Event|0|||
19502109|NCT02296242|41877595|FG002|Overall Study|Adverse Event|0|||
19502110|NCT02296242|41877596|FG003|Overall Study|Adverse Event|1|||
19502111|NCT02296242|41877597|FG004|Overall Study|Adverse Event|0|||
19502112|NCT02296242|41877593|FG000|Overall Study|Lack of Efficacy|0|||
19502113|NCT02296242|41877594|FG001|Overall Study|Lack of Efficacy|0|||
19502114|NCT02296242|41877595|FG002|Overall Study|Lack of Efficacy|0|||
19502115|NCT02296242|41877596|FG003|Overall Study|Lack of Efficacy|0|||
19502116|NCT02296242|41877597|FG004|Overall Study|Lack of Efficacy|3|||
19502117|NCT02295774|41877617|FG000|Overall Study|Physician Decision|1|||
19502118|NCT02295774|41877617|FG000|Overall Study|Withdrawal by Subject|2|||
19502119|NCT02294682|41877632|FG000|Overall Study|Could not swallow pills|1|||
19502120|NCT02294682|41877633|FG001|Overall Study|Could not swallow pills|0|||
19502121|NCT02294604|41877642|FG000|Overall Study|Did not provide samples for culture|0|||
19502122|NCT02294604|41877643|FG001|Overall Study|Did not provide samples for culture|1|||
19502123|NCT02294604|41877644|FG002|Overall Study|Did not provide samples for culture|0|||
19502124|NCT02294604|41877642|FG000|Overall Study|Culture contamination|1|||
19502125|NCT02294604|41877643|FG001|Overall Study|Culture contamination|2|||
19502126|NCT02294604|41877644|FG002|Overall Study|Culture contamination|0|||
19502127|NCT01645176|41877663|FG000|Overall Study|Lack of Efficacy|4|||
19502128|NCT01645176|41877663|FG000|Overall Study|did not complete final MRI|1|||
19502129|NCT02322216|41877678|FG000|Overall Study|Adverse Event|1|||
19502130|NCT02322216|41877679|FG001|Overall Study|Adverse Event|0|||
19502131|NCT02322216|41877678|FG000|Overall Study|Withdrawal by Subject|1|||
19502132|NCT02322216|41877679|FG001|Overall Study|Withdrawal by Subject|4|||
19502133|NCT01647516|41877720|FG000|Induction Period (IP)|Physician Decision|2|||
19502134|NCT01647516|41877721|FG001|Induction Period (IP)|Physician Decision|0|||
19502135|NCT01647516|41877722|FG002|Induction Period (IP)|Physician Decision|0|||
19614646|NCT01856192|42063712|FG001|Overall Study|Non-compliance|0|||
19614647|NCT01572480|42063718|FG000|Participants Enrolled|Withdrawal by Subject|1|||
19614648|NCT01572480|42063718|FG000|Drug Administration|Discontinued drug/Off Study|1|||
19614649|NCT01572480|42063718|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
19614650|NCT01572480|42063718|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
19614651|NCT01126190|42063725|FG000|Double-Blind Phase|Death|0|||
19614652|NCT01126190|42063726|FG001|Double-Blind Phase|Death|1|||
19614653|NCT01126190|42063727|FG002|Double-Blind Phase|Death|0|||
19614654|NCT01126190|42063725|FG000|Double-Blind Phase|Adverse Event|1|||
19614655|NCT01126190|42063726|FG001|Double-Blind Phase|Adverse Event|2|||
19614656|NCT01126190|42063727|FG002|Double-Blind Phase|Adverse Event|0|||
19502136|NCT01647516|41877723|FG003|Induction Period (IP)|Physician Decision|0|||
19502137|NCT01647516|41877724|FG004|Induction Period (IP)|Physician Decision|0|||
19502138|NCT01647516|41877725|FG005|Induction Period (IP)|Physician Decision|0|||
19502139|NCT01647516|41877720|FG000|Induction Period (IP)|Adverse Event|1|||
19502140|NCT01647516|41877721|FG001|Induction Period (IP)|Adverse Event|2|||
19502141|NCT01647516|41877722|FG002|Induction Period (IP)|Adverse Event|0|||
19502142|NCT01647516|41877723|FG003|Induction Period (IP)|Adverse Event|0|||
19502143|NCT01647516|41877724|FG004|Induction Period (IP)|Adverse Event|0|||
19502144|NCT01647516|41877725|FG005|Induction Period (IP)|Adverse Event|0|||
19502145|NCT01647516|41877720|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
19502146|NCT01647516|41877721|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
19502147|NCT01647516|41877722|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
19502148|NCT01647516|41877723|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
19502149|NCT01647516|41877724|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
19502150|NCT01647516|41877725|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
19502151|NCT01647516|41877720|FG000|Induction Period (IP)|Participant Choice|0|||
19502152|NCT01647516|41877721|FG001|Induction Period (IP)|Participant Choice|0|||
19502153|NCT01647516|41877722|FG002|Induction Period (IP)|Participant Choice|1|||
19502154|NCT01647516|41877723|FG003|Induction Period (IP)|Participant Choice|0|||
19502155|NCT01647516|41877724|FG004|Induction Period (IP)|Participant Choice|0|||
19614657|NCT01126190|42063725|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
19614658|NCT01126190|42063726|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
19502156|NCT01647516|41877725|FG005|Induction Period (IP)|Participant Choice|0|||
19502157|NCT01647516|41877720|FG000|Induction Period (IP)|Lack of Efficacy|1|||
19502158|NCT01647516|41877721|FG001|Induction Period (IP)|Lack of Efficacy|0|||
19502159|NCT01647516|41877722|FG002|Induction Period (IP)|Lack of Efficacy|0|||
19502160|NCT01647516|41877723|FG003|Induction Period (IP)|Lack of Efficacy|0|||
19614659|NCT01126190|42063727|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19614660|NCT01126190|42063725|FG000|Double-Blind Phase|Request of Investigator|1|||
19614661|NCT01126190|42063726|FG001|Double-Blind Phase|Request of Investigator|0|||
19502161|NCT01647516|41877724|FG004|Induction Period (IP)|Lack of Efficacy|0|||
19502162|NCT01647516|41877725|FG005|Induction Period (IP)|Lack of Efficacy|0|||
19502163|NCT01647516|41877720|FG000|Induction Period (IP)|No study drug received|1|||
19502164|NCT01647516|41877721|FG001|Induction Period (IP)|No study drug received|1|||
19502165|NCT01647516|41877722|FG002|Induction Period (IP)|No study drug received|0|||
19502166|NCT01647516|41877723|FG003|Induction Period (IP)|No study drug received|0|||
19502167|NCT01647516|41877724|FG004|Induction Period (IP)|No study drug received|0|||
19502168|NCT01647516|41877725|FG005|Induction Period (IP)|No study drug received|0|||
19502169|NCT01647516|41877720|FG000|Maintenance Period (MP)|Adverse Event|2|||
19502170|NCT01647516|41877721|FG001|Maintenance Period (MP)|Adverse Event|1|||
19502171|NCT01647516|41877722|FG002|Maintenance Period (MP)|Adverse Event|0|||
19502172|NCT01647516|41877723|FG003|Maintenance Period (MP)|Adverse Event|0|||
19502173|NCT01647516|41877724|FG004|Maintenance Period (MP)|Adverse Event|0|||
19502174|NCT01647516|41877725|FG005|Maintenance Period (MP)|Adverse Event|0|||
19502175|NCT01647516|41877720|FG000|Maintenance Period (MP)|Non-compliance|1|||
19502176|NCT01647516|41877721|FG001|Maintenance Period (MP)|Non-compliance|0|||
19502177|NCT01647516|41877722|FG002|Maintenance Period (MP)|Non-compliance|0|||
19502178|NCT01647516|41877723|FG003|Maintenance Period (MP)|Non-compliance|0|||
19502179|NCT01647516|41877724|FG004|Maintenance Period (MP)|Non-compliance|0|||
19502180|NCT01647516|41877725|FG005|Maintenance Period (MP)|Non-compliance|0|||
19614662|NCT01126190|42063727|FG002|Double-Blind Phase|Request of Investigator|0|||
19614663|NCT01126190|42063725|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
19614664|NCT01126190|42063726|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
19614665|NCT01126190|42063727|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
19614666|NCT01126190|42063725|FG000|Double-Blind Phase|Non-compliance|1|||
19614667|NCT01126190|42063726|FG001|Double-Blind Phase|Non-compliance|0|||
19614668|NCT01126190|42063727|FG002|Double-Blind Phase|Non-compliance|0|||
19614669|NCT01126190|42063725|FG000|Double-Blind Phase|Lost to Follow-up|1|||
19502181|NCT01647516|41877720|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
19502182|NCT01647516|41877721|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
19502183|NCT01647516|41877722|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
19502184|NCT01647516|41877723|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
19502185|NCT01647516|41877724|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
19502186|NCT01647516|41877725|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
19502187|NCT01647516|41877720|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
19502188|NCT01647516|41877721|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
19502189|NCT01647516|41877722|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
19502190|NCT01647516|41877723|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
19614670|NCT01126190|42063726|FG001|Double-Blind Phase|Lost to Follow-up|3|||
19614671|NCT01126190|42063727|FG002|Double-Blind Phase|Lost to Follow-up|0|||
19614672|NCT01126190|42063725|FG000|Open-Label Phase|Death|0|||
19614673|NCT01126190|42063726|FG001|Open-Label Phase|Death|0|||
19502191|NCT01647516|41877724|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
19502192|NCT01647516|41877725|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
19502193|NCT01647516|41877720|FG000|Open-Label Period|Adverse Event|0|||
19502194|NCT01647516|41877721|FG001|Open-Label Period|Adverse Event|0|||
19502195|NCT01647516|41877722|FG002|Open-Label Period|Adverse Event|0|||
19502196|NCT01647516|41877723|FG003|Open-Label Period|Adverse Event|5|||
19502197|NCT01647516|41877724|FG004|Open-Label Period|Adverse Event|6|||
19502198|NCT01647516|41877725|FG005|Open-Label Period|Adverse Event|3|||
19502199|NCT01647516|41877720|FG000|Open-Label Period|Pregnancy|0|||
19502200|NCT01647516|41877721|FG001|Open-Label Period|Pregnancy|0|||
19502201|NCT01647516|41877722|FG002|Open-Label Period|Pregnancy|0|||
19502202|NCT01647516|41877723|FG003|Open-Label Period|Pregnancy|0|||
19502203|NCT01647516|41877724|FG004|Open-Label Period|Pregnancy|0|||
19502204|NCT01647516|41877725|FG005|Open-Label Period|Pregnancy|1|||
19502205|NCT01647516|41877720|FG000|Open-Label Period|Non-compliance|0|||
19502206|NCT01647516|41877721|FG001|Open-Label Period|Non-compliance|0|||
19502207|NCT01647516|41877722|FG002|Open-Label Period|Non-compliance|0|||
19502208|NCT01647516|41877723|FG003|Open-Label Period|Non-compliance|1|||
19502209|NCT01647516|41877724|FG004|Open-Label Period|Non-compliance|0|||
19614674|NCT01126190|42063727|FG002|Open-Label Phase|Death|1|||
19704449|NCT00160524|42148801|FG000|Overall Study|Lack of Efficacy and Other|1|||
19393809|NCT02656693|41637724|FG001|Overall Study|Pregnancy|1|||
19393810|NCT02656693|41637725|FG002|Overall Study|Pregnancy|1|||
19502210|NCT01647516|41877725|FG005|Open-Label Period|Non-compliance|1|||
19502211|NCT01647516|41877720|FG000|Open-Label Period|Physician Decision|0|||
19502212|NCT01647516|41877721|FG001|Open-Label Period|Physician Decision|0|||
19502213|NCT01647516|41877722|FG002|Open-Label Period|Physician Decision|0|||
19614675|NCT01126190|42063725|FG000|Open-Label Phase|Adverse Event|0|||
19614676|NCT01126190|42063726|FG001|Open-Label Phase|Adverse Event|0|||
19614677|NCT01126190|42063727|FG002|Open-Label Phase|Adverse Event|4|||
19502214|NCT01647516|41877723|FG003|Open-Label Period|Physician Decision|1|||
19614678|NCT01126190|42063725|FG000|Open-Label Phase|Withdrawal by Subject|0|||
19614679|NCT01126190|42063726|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19502215|NCT01647516|41877724|FG004|Open-Label Period|Physician Decision|1|||
19614680|NCT01126190|42063727|FG002|Open-Label Phase|Withdrawal by Subject|6|||
19614681|NCT00939185|42063760|FG000|Overall Study|Adverse Event|3|||
19614682|NCT00939185|42063760|FG000|Overall Study|Lack of Efficacy|1|||
19614683|NCT00939185|42063760|FG000|Overall Study|Lost to Follow-up|6|||
19614684|NCT00939185|42063760|FG000|Overall Study|Other|3|||
19614685|NCT00939185|42063760|FG000|Overall Study|Withdrawal by Subject|2|||
19614686|NCT00939185|42063760|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
19502216|NCT01647516|41877725|FG005|Open-Label Period|Physician Decision|0|||
19502217|NCT01647516|41877720|FG000|Open-Label Period|Withdrawal by Subject|0|||
19502218|NCT01647516|41877721|FG001|Open-Label Period|Withdrawal by Subject|0|||
19502219|NCT01647516|41877722|FG002|Open-Label Period|Withdrawal by Subject|0|||
19502220|NCT01647516|41877723|FG003|Open-Label Period|Withdrawal by Subject|9|||
19502221|NCT01647516|41877724|FG004|Open-Label Period|Withdrawal by Subject|11|||
19502222|NCT01647516|41877725|FG005|Open-Label Period|Withdrawal by Subject|6|||
19502223|NCT01647516|41877720|FG000|Open-Label Period|Lost to Follow-up|0|||
19502224|NCT01647516|41877721|FG001|Open-Label Period|Lost to Follow-up|0|||
19502225|NCT01647516|41877722|FG002|Open-Label Period|Lost to Follow-up|0|||
19502226|NCT01647516|41877723|FG003|Open-Label Period|Lost to Follow-up|1|||
19502227|NCT01647516|41877724|FG004|Open-Label Period|Lost to Follow-up|0|||
19502228|NCT01647516|41877725|FG005|Open-Label Period|Lost to Follow-up|1|||
19502229|NCT01647516|41877720|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
19502230|NCT01647516|41877721|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
19502231|NCT01647516|41877722|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
19502232|NCT01647516|41877723|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
19502233|NCT01647516|41877724|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
19502234|NCT01647516|41877725|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
19502235|NCT01647516|41877720|FG000|Open-Label Period|Lack of Efficacy|0|||
19502236|NCT01647516|41877721|FG001|Open-Label Period|Lack of Efficacy|0|||
19502237|NCT01647516|41877722|FG002|Open-Label Period|Lack of Efficacy|0|||
19502238|NCT01647516|41877723|FG003|Open-Label Period|Lack of Efficacy|7|||
19502239|NCT01647516|41877724|FG004|Open-Label Period|Lack of Efficacy|9|||
19502240|NCT01647516|41877725|FG005|Open-Label Period|Lack of Efficacy|10|||
19502241|NCT01647516|41877720|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
19502242|NCT01647516|41877721|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
19502243|NCT01647516|41877722|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
19502244|NCT01647516|41877723|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
19502245|NCT01647516|41877724|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
19502246|NCT01647516|41877725|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
19502247|NCT01647516|41877720|FG000|Open-Label Period|No completion / discontinuation visit|0|||
19502248|NCT01647516|41877721|FG001|Open-Label Period|No completion / discontinuation visit|0|||
19502249|NCT01647516|41877722|FG002|Open-Label Period|No completion / discontinuation visit|0|||
19502250|NCT01647516|41877723|FG003|Open-Label Period|No completion / discontinuation visit|0|||
19502251|NCT01647516|41877724|FG004|Open-Label Period|No completion / discontinuation visit|2|||
19502252|NCT01647516|41877725|FG005|Open-Label Period|No completion / discontinuation visit|1|||
19502253|NCT01647282|41877742|FG000|Overall Study|Physician Decision|7|||
19502254|NCT01647282|41877743|FG001|Overall Study|Physician Decision|5|||
19502255|NCT02321514|41877749|FG000|Overall Study|Death|15|||
19502256|NCT02321514|41877749|FG000|Overall Study|Missed Visit|7|||
19502257|NCT02321514|41877749|FG000|Overall Study|Study Exit|3|||
19502258|NCT02321436|41877755|FG000|Overall Study|Withdrawal by Subject|1|||
19502259|NCT02321436|41877756|FG001|Overall Study|Withdrawal by Subject|0|||
19502260|NCT02321436|41877755|FG000|Overall Study|Lost to Follow-up|0|||
19614687|NCT03977155|42063767|FG000|Overall Study|Adverse Event|3|||
19614688|NCT03977155|42063768|FG001|Overall Study|Adverse Event|0|||
19614689|NCT03977155|42063769|FG002|Overall Study|Adverse Event|0|||
19614690|NCT03977155|42063767|FG000|Overall Study|Lost to Follow-up|0|||
19614691|NCT03977155|42063768|FG001|Overall Study|Lost to Follow-up|1|||
19614692|NCT03977155|42063769|FG002|Overall Study|Lost to Follow-up|0|||
19614693|NCT03977155|42063767|FG000|Overall Study|Withdrawal by Subject|1|||
19614694|NCT03977155|42063768|FG001|Overall Study|Withdrawal by Subject|1|||
19614695|NCT03977155|42063769|FG002|Overall Study|Withdrawal by Subject|2|||
19614696|NCT03977155|42063767|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
19502261|NCT02321436|41877756|FG001|Overall Study|Lost to Follow-up|1|||
19502262|NCT02319642|41877765|FG000|Overall Study|Adverse Event|2|||
19502263|NCT02319642|41877766|FG001|Overall Study|Adverse Event|4|||
19502264|NCT02319642|41877765|FG000|Overall Study|Lack of Efficacy|1|||
19502265|NCT02319642|41877766|FG001|Overall Study|Lack of Efficacy|1|||
19502266|NCT02319642|41877765|FG000|Overall Study|Withdrawal by Subject|1|||
19614697|NCT03977155|42063768|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
19614698|NCT03977155|42063769|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
19502267|NCT02319642|41877766|FG001|Overall Study|Withdrawal by Subject|1|||
19502268|NCT02280096|41877776|FG000|Overall Study|Pregnancy|1|||
19614699|NCT00930059|42063794|FG000|Overall Study|Death|1|||
19614700|NCT00930059|42063795|FG001|Overall Study|Death|0|||
19614701|NCT00930059|42063794|FG000|Overall Study|Did not meet entrance criteria|1|||
19614702|NCT00930059|42063795|FG001|Overall Study|Did not meet entrance criteria|1|||
19614703|NCT00930059|42063794|FG000|Overall Study|Withdrawal by Subject|3|||
19614704|NCT00930059|42063795|FG001|Overall Study|Withdrawal by Subject|4|||
19614705|NCT00930059|42063794|FG000|Overall Study|Other|1|||
19614706|NCT00930059|42063795|FG001|Overall Study|Other|0|||
19614707|NCT00930059|42063794|FG000|Overall Study|1 site terminated by sponsor|1|||
19614708|NCT00930059|42063795|FG001|Overall Study|1 site terminated by sponsor|1|||
19614709|NCT00930059|42063794|FG000|Overall Study|Adverse Event|1|||
19614710|NCT00930059|42063795|FG001|Overall Study|Adverse Event|6|||
19614711|NCT00772005|42063814|FG000|Overall Study|Adverse Event|9|||
19614712|NCT00772005|42063815|FG001|Overall Study|Adverse Event|14|||
19614713|NCT00772005|42063816|FG002|Overall Study|Adverse Event|10|||
19614714|NCT00772005|42063817|FG003|Overall Study|Adverse Event|13|||
19614715|NCT00772005|42063814|FG000|Overall Study|Lack of Efficacy|0|||
19614716|NCT00772005|42063815|FG001|Overall Study|Lack of Efficacy|1|||
19704450|NCT00160524|42148801|FG000|Overall Study|Other|20|||
19502269|NCT02280096|41877777|FG001|Overall Study|Pregnancy|0|||
19502270|NCT02280096|41877776|FG000|Overall Study|Functional neurological disorder|1|||
19502271|NCT02280096|41877777|FG001|Overall Study|Functional neurological disorder|0|||
19502272|NCT02280096|41877776|FG000|Overall Study|Lack of attachment|0|||
19502273|NCT02280096|41877777|FG001|Overall Study|Lack of attachment|1|||
19502274|NCT02279862|41877794|FG000|Overall Study|Study drug toxicity|3|||
19502275|NCT02279862|41877795|FG001|Overall Study|Study drug toxicity|6|||
19502276|NCT02279862|41877794|FG000|Overall Study|No longer meets criteria|0|||
19502277|NCT02279862|41877795|FG001|Overall Study|No longer meets criteria|1|||
19502278|NCT02279862|41877794|FG000|Overall Study|Administrative reason by sponsor|0|||
19502279|NCT02279862|41877795|FG001|Overall Study|Administrative reason by sponsor|1|||
19502280|NCT02279862|41877794|FG000|Overall Study|Disease progression|5|||
19502281|NCT02279862|41877795|FG001|Overall Study|Disease progression|2|||
19502282|NCT02279862|41877794|FG000|Overall Study|Study closed by sponsor|16|||
19502283|NCT02279862|41877795|FG001|Overall Study|Study closed by sponsor|13|||
19502284|NCT02279862|41877794|FG000|Overall Study|Other|1|||
19502285|NCT02279862|41877795|FG001|Overall Study|Other|2|||
19502286|NCT02279862|41877794|FG000|Overall Study|Withdrawal by Subject|1|||
19502287|NCT02279862|41877795|FG001|Overall Study|Withdrawal by Subject|0|||
19373720|NCT02665689|41614913|FG000|Overall Study|Lost to Follow-up|0|||
19373721|NCT02665689|41614914|FG001|Overall Study|Lost to Follow-up|1|||
19502288|NCT02318940|41877803|FG000|Overall Study|lost the record|1|||
19502289|NCT02318940|41877804|FG001|Overall Study|lost the record|0|||
19502290|NCT02294058|41877813|FG000|Overall Study|Adverse Event|16|||
19502291|NCT02294058|41877814|FG001|Overall Study|Adverse Event|7|||
19502292|NCT02294058|41877815|FG002|Overall Study|Adverse Event|13|||
19502293|NCT02294058|41877813|FG000|Overall Study|Lack of Efficacy|3|||
19614717|NCT00772005|42063816|FG002|Overall Study|Lack of Efficacy|0|||
19614718|NCT00772005|42063817|FG003|Overall Study|Lack of Efficacy|0|||
19614719|NCT00772005|42063814|FG000|Overall Study|Withdrawal by Subject|3|||
19704451|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
19502294|NCT02294058|41877814|FG001|Overall Study|Lack of Efficacy|3|||
19502295|NCT02294058|41877815|FG002|Overall Study|Lack of Efficacy|0|||
19502296|NCT02294058|41877813|FG000|Overall Study|Lost to Follow-up|1|||
19502297|NCT02294058|41877814|FG001|Overall Study|Lost to Follow-up|0|||
19502298|NCT02294058|41877815|FG002|Overall Study|Lost to Follow-up|2|||
19502299|NCT02294058|41877813|FG000|Overall Study|Withdrawal by Subject|10|||
19502300|NCT02294058|41877814|FG001|Overall Study|Withdrawal by Subject|14|||
19502301|NCT02294058|41877815|FG002|Overall Study|Withdrawal by Subject|13|||
19502302|NCT02294058|41877813|FG000|Overall Study|Physician Decision|2|||
19502303|NCT02294058|41877814|FG001|Overall Study|Physician Decision|1|||
19502304|NCT02294058|41877815|FG002|Overall Study|Physician Decision|0|||
19502305|NCT02294058|41877813|FG000|Overall Study|Miscellaneous|4|||
19502306|NCT02294058|41877814|FG001|Overall Study|Miscellaneous|1|||
19502307|NCT02294058|41877815|FG002|Overall Study|Miscellaneous|1|||
19502308|NCT02293902|41877827|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
19502309|NCT02293902|41877828|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
19502310|NCT02293902|41877829|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
19502311|NCT02293902|41877830|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
19502312|NCT02293902|41877831|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
19502313|NCT02293902|41877827|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
19502314|NCT02293902|41877828|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
19502315|NCT02293902|41877829|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
19502316|NCT02293902|41877830|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
19502317|NCT02293902|41877831|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
19502318|NCT02293902|41877827|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
19502319|NCT02293902|41877828|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
19502320|NCT02293902|41877829|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
19614720|NCT00772005|42063815|FG001|Overall Study|Withdrawal by Subject|7|||
19614721|NCT00772005|42063816|FG002|Overall Study|Withdrawal by Subject|10|||
19614722|NCT00772005|42063817|FG003|Overall Study|Withdrawal by Subject|2|||
19614723|NCT00772005|42063814|FG000|Overall Study|Protocol Violation|2|||
19614724|NCT00772005|42063815|FG001|Overall Study|Protocol Violation|4|||
19614725|NCT00772005|42063816|FG002|Overall Study|Protocol Violation|1|||
19614726|NCT00772005|42063817|FG003|Overall Study|Protocol Violation|6|||
19614727|NCT00772005|42063814|FG000|Overall Study|Lost to Follow-up|7|||
19614728|NCT00772005|42063815|FG001|Overall Study|Lost to Follow-up|3|||
19614729|NCT00772005|42063816|FG002|Overall Study|Lost to Follow-up|6|||
19614730|NCT00772005|42063817|FG003|Overall Study|Lost to Follow-up|3|||
19614731|NCT00772005|42063814|FG000|Overall Study|Non-compliance with study procedures|1|||
19614732|NCT00772005|42063815|FG001|Overall Study|Non-compliance with study procedures|1|||
19614733|NCT00772005|42063816|FG002|Overall Study|Non-compliance with study procedures|0|||
19614734|NCT00772005|42063817|FG003|Overall Study|Non-compliance with study procedures|1|||
19614735|NCT00772005|42063814|FG000|Overall Study|Non-compliance with drug administration|3|||
19614736|NCT00772005|42063815|FG001|Overall Study|Non-compliance with drug administration|0|||
19614737|NCT00772005|42063816|FG002|Overall Study|Non-compliance with drug administration|1|||
19614738|NCT00772005|42063817|FG003|Overall Study|Non-compliance with drug administration|1|||
19614739|NCT00939107|42063829|FG000|Overall Study|Lost to Follow-up|14|||
19614740|NCT00939107|42063830|FG001|Overall Study|Lost to Follow-up|12|||
19614741|NCT00927485|42063838|FG000|Overall Study|Adverse Event|4|||
19614742|NCT00927485|42063839|FG001|Overall Study|Adverse Event|2|||
19614743|NCT00927485|42063838|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
19614744|NCT00927485|42063839|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
19614745|NCT00927251|42063845|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
19614746|NCT00927095|42063852|FG000|Overall Study|Adverse Event|3|||
19614747|NCT00927095|42063853|FG001|Overall Study|Adverse Event|1|||
19614748|NCT00927095|42063854|FG002|Overall Study|Adverse Event|0|||
19614749|NCT00927095|42063852|FG000|Overall Study|Withdrawal by Subject|2|||
19614750|NCT00927095|42063853|FG001|Overall Study|Withdrawal by Subject|1|||
19614751|NCT00927095|42063854|FG002|Overall Study|Withdrawal by Subject|1|||
19704452|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Adverse Event|9|||
19502321|NCT02293902|41877830|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
19614752|NCT00927095|42063852|FG000|Overall Study|Physician Decision|1|||
19614753|NCT00927095|42063853|FG001|Overall Study|Physician Decision|2|||
19614754|NCT00927095|42063854|FG002|Overall Study|Physician Decision|1|||
19502322|NCT02293902|41877831|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
19614755|NCT00932165|42063862|FG000|Overall Study|Lost to Follow-up|1|||
19614756|NCT00926783|42063869|FG000|Overall Study|Incomplete CFAE Procedures|3|||
19614757|NCT00926783|42063870|FG001|Overall Study|Incomplete CFAE Procedures|3|||
19614758|NCT00929669|42063876|FG000|Overall Study|elevated glucose levels|1|||
19614759|NCT00566995|42063880|FG000|Overall Study|Toxicity|4|||
19614760|NCT00566995|42063880|FG000|Overall Study|Withdrew consent|3|||
19704453|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Death|4|||
19393811|NCT02656693|41637723|FG000|Overall Study|Bariatric surgery|0|||
19502323|NCT02293902|41877827|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
19614761|NCT00926393|42063886|FG000|Overall Study|Withdrawal by Subject|1|||
19614762|NCT00926393|42063887|FG001|Overall Study|Withdrawal by Subject|2|||
19614763|NCT00926393|42063886|FG000|Overall Study|Adverse Event|1|||
19502324|NCT02293902|41877828|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
19502325|NCT02293902|41877829|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
19502326|NCT02293902|41877830|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
19502327|NCT02293902|41877831|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
19502328|NCT02293902|41877827|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
19502329|NCT02293902|41877828|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
19502330|NCT02293902|41877829|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
19502331|NCT02293902|41877830|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
19502332|NCT02293902|41877831|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
19502333|NCT02278614|41877851|FG000|Overall Study|Withdrawal by Subject|3|||
19502334|NCT02278614|41877852|FG001|Overall Study|Withdrawal by Subject|5|||
19502335|NCT02278614|41877851|FG000|Overall Study|Adverse Event|1|||
19502336|NCT02278614|41877852|FG001|Overall Study|Adverse Event|0|||
19502337|NCT02278614|41877851|FG000|Overall Study|left eye was not eligible|1|||
19502338|NCT02278614|41877852|FG001|Overall Study|left eye was not eligible|0|||
19502339|NCT02318706|41877862|FG000|Double-blind Phase|Adverse Event|7|||
19502340|NCT02318706|41877863|FG001|Double-blind Phase|Adverse Event|4|||
19502341|NCT02318706|41877864|FG002|Double-blind Phase|Adverse Event|3|||
19502342|NCT02318706|41877865|FG003|Double-blind Phase|Adverse Event|10|||
19502343|NCT02318706|41877866|FG004|Double-blind Phase|Adverse Event|0|||
19502344|NCT02318706|41877862|FG000|Double-blind Phase|Lost to Follow-up|1|||
19502345|NCT02318706|41877863|FG001|Double-blind Phase|Lost to Follow-up|0|||
19502346|NCT02318706|41877864|FG002|Double-blind Phase|Lost to Follow-up|0|||
19502347|NCT02318706|41877865|FG003|Double-blind Phase|Lost to Follow-up|0|||
19502348|NCT02318706|41877866|FG004|Double-blind Phase|Lost to Follow-up|0|||
19502349|NCT02318706|41877862|FG000|Double-blind Phase|Protocol Violation|4|||
19502350|NCT02318706|41877863|FG001|Double-blind Phase|Protocol Violation|2|||
19502351|NCT02318706|41877864|FG002|Double-blind Phase|Protocol Violation|4|||
19502352|NCT02318706|41877865|FG003|Double-blind Phase|Protocol Violation|3|||
19502353|NCT02318706|41877866|FG004|Double-blind Phase|Protocol Violation|0|||
19502354|NCT02318706|41877862|FG000|Double-blind Phase|Withdrawal by Subject|9|||
19502355|NCT02318706|41877863|FG001|Double-blind Phase|Withdrawal by Subject|5|||
19502356|NCT02318706|41877864|FG002|Double-blind Phase|Withdrawal by Subject|7|||
19502357|NCT02318706|41877865|FG003|Double-blind Phase|Withdrawal by Subject|10|||
19502358|NCT02318706|41877866|FG004|Double-blind Phase|Withdrawal by Subject|0|||
19502359|NCT02318706|41877862|FG000|Double-blind Phase|Other|4|||
19502360|NCT02318706|41877863|FG001|Double-blind Phase|Other|1|||
19502361|NCT02318706|41877864|FG002|Double-blind Phase|Other|2|||
19502362|NCT02318706|41877865|FG003|Double-blind Phase|Other|1|||
19502363|NCT02318706|41877866|FG004|Double-blind Phase|Other|0|||
19502364|NCT02318706|41877862|FG000|Double-blind Phase|Death|0|||
19502365|NCT02318706|41877863|FG001|Double-blind Phase|Death|0|||
19502366|NCT02318706|41877864|FG002|Double-blind Phase|Death|2|||
19502367|NCT02318706|41877865|FG003|Double-blind Phase|Death|0|||
19502368|NCT02318706|41877866|FG004|Double-blind Phase|Death|0|||
19502369|NCT02318706|41877862|FG000|Open-label Extension Phase|Adverse Event|0|||
19502370|NCT02318706|41877863|FG001|Open-label Extension Phase|Adverse Event|0|||
19502371|NCT02318706|41877864|FG002|Open-label Extension Phase|Adverse Event|0|||
19502372|NCT02318706|41877865|FG003|Open-label Extension Phase|Adverse Event|0|||
19502373|NCT02318706|41877866|FG004|Open-label Extension Phase|Adverse Event|21|||
19502374|NCT02318706|41877862|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
19502375|NCT02318706|41877863|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
19502376|NCT02318706|41877864|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
19502377|NCT02318706|41877865|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
19502378|NCT02318706|41877866|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
19502379|NCT02318706|41877862|FG000|Open-label Extension Phase|Death|0|||
19502380|NCT02318706|41877863|FG001|Open-label Extension Phase|Death|0|||
19502381|NCT02318706|41877864|FG002|Open-label Extension Phase|Death|0|||
19502382|NCT02318706|41877865|FG003|Open-label Extension Phase|Death|0|||
19502383|NCT02318706|41877866|FG004|Open-label Extension Phase|Death|1|||
19614764|NCT00926393|42063887|FG001|Overall Study|Adverse Event|1|||
19614765|NCT00926237|42063893|FG000|Overall Study|Withdrawal by Subject|2|||
19502384|NCT02318706|41877862|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
19614766|NCT00926237|42063894|FG001|Overall Study|Withdrawal by Subject|1|||
19502385|NCT02318706|41877863|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
19502386|NCT02318706|41877864|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
19502387|NCT02318706|41877865|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
19502388|NCT02318706|41877866|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
19502389|NCT05208866|41877900|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
19502390|NCT04747275|41877913|FG000|Overall Study|Study terminated|0|||
19502391|NCT04747275|41877914|FG001|Overall Study|Study terminated|1|||
19502392|NCT04583280|41877922|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
19614767|NCT00931463|42063906|FG000|Overall Study|Death|8|||
19502393|NCT04583280|41877923|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
19502394|NCT04489940|41877942|FG000|Overall Study|Other|2|||
19502395|NCT04489940|41877942|FG000|Overall Study|Withdrawal by Subject|2|||
19502396|NCT04489940|41877942|FG000|Overall Study|Death|5|||
19502397|NCT04489940|41877942|FG000|Overall Study|Lost to Follow-up|1|||
19502398|NCT04365257|41877948|FG000|Overall Study|Physician Decision|1|||
19502399|NCT04365257|41877949|FG001|Overall Study|Physician Decision|0|||
19502400|NCT04365257|41877948|FG000|Overall Study|Patient Noncompliance|1|||
19502401|NCT04365257|41877949|FG001|Overall Study|Patient Noncompliance|0|||
19502402|NCT04365257|41877948|FG000|Overall Study|Withdrawal by Subject|0|||
19502403|NCT04365257|41877949|FG001|Overall Study|Withdrawal by Subject|1|||
19502404|NCT03395223|41877981|FG000|Overall Study|Lost to Follow-up|3|||
19502405|NCT03395223|41877981|FG000|Overall Study|Other|1|||
19502406|NCT03072238|41878002|FG000|Overall Study|Withdrawal by Subject|30|||
19502407|NCT03072238|41878003|FG001|Overall Study|Withdrawal by Subject|51|||
19502408|NCT03072238|41878002|FG000|Overall Study|Lost to Follow-up|7|||
19502409|NCT03072238|41878003|FG001|Overall Study|Lost to Follow-up|4|||
19502410|NCT03072238|41878002|FG000|Overall Study|Physician Decision|1|||
19502411|NCT03072238|41878003|FG001|Overall Study|Physician Decision|3|||
19502412|NCT03072238|41878002|FG000|Overall Study|Death|139|||
19502413|NCT03072238|41878003|FG001|Overall Study|Death|121|||
19502414|NCT03072238|41878002|FG000|Overall Study|Other|0|||
19502415|NCT03072238|41878003|FG001|Overall Study|Other|1|||
19502416|NCT03072238|41878002|FG000|Overall Study|Ongoing on study|377|||
19502417|NCT03072238|41878003|FG001|Overall Study|Ongoing on study|367|||
19502418|NCT02937818|41878023|FG000|Overall Study|Participants decision|1|||
19502419|NCT02937818|41878024|FG001|Overall Study|Participants decision|0|||
19502420|NCT02937818|41878025|FG002|Overall Study|Participants decision|1|||
19502421|NCT02937818|41878026|FG003|Overall Study|Participants decision|1|||
19502422|NCT02937818|41878023|FG000|Overall Study|Adverse Event|2|||
19502423|NCT02937818|41878024|FG001|Overall Study|Adverse Event|4|||
19502424|NCT02937818|41878025|FG002|Overall Study|Adverse Event|1|||
19502425|NCT02937818|41878026|FG003|Overall Study|Adverse Event|1|||
19502426|NCT02937818|41878023|FG000|Overall Study|Disease progression|17|||
19502427|NCT02937818|41878024|FG001|Overall Study|Disease progression|14|||
19502428|NCT02937818|41878025|FG002|Overall Study|Disease progression|7|||
19502429|NCT02937818|41878026|FG003|Overall Study|Disease progression|18|||
19502430|NCT02937818|41878023|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
19502431|NCT02937818|41878024|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
19502432|NCT02937818|41878025|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
19502433|NCT02937818|41878026|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
19502434|NCT02937818|41878023|FG000|Overall Study|Condition under investigation worsened|0|||
19502435|NCT02937818|41878024|FG001|Overall Study|Condition under investigation worsened|0|||
19502436|NCT02937818|41878025|FG002|Overall Study|Condition under investigation worsened|1|||
19502437|NCT02937818|41878026|FG003|Overall Study|Condition under investigation worsened|0|||
19502438|NCT02937818|41878023|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
19502439|NCT02937818|41878024|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
19502440|NCT02937818|41878025|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
19502441|NCT02937818|41878026|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
19502442|NCT02864940|41878041|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
19502443|NCT02864940|41878042|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
19502444|NCT02799602|41878063|FG000|Overall Study|Protocol Violation|1|||
19502445|NCT02799602|41878064|FG001|Overall Study|Protocol Violation|0|||
19502446|NCT02799602|41878063|FG000|Overall Study|Physician Decision|3|||
19502447|NCT02799602|41878064|FG001|Overall Study|Physician Decision|7|||
19502448|NCT02799602|41878063|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
19502449|NCT02799602|41878064|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
19502450|NCT02799602|41878063|FG000|Overall Study|Lost to Follow-up|4|||
19502451|NCT02799602|41878064|FG001|Overall Study|Lost to Follow-up|1|||
19502452|NCT02799602|41878063|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
19502453|NCT02799602|41878064|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
19502454|NCT02799602|41878063|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
19502455|NCT02799602|41878064|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
19502456|NCT02799602|41878063|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
19502457|NCT02799602|41878064|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
19502458|NCT02799602|41878063|FG000|Overall Study|Withdrawal by Subject|25|||
19502459|NCT02799602|41878064|FG001|Overall Study|Withdrawal by Subject|37|||
19502460|NCT02799602|41878063|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
19502461|NCT02799602|41878064|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
19502462|NCT02799602|41878063|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
19502463|NCT02799602|41878064|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
19502464|NCT02799602|41878063|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
19502465|NCT02799602|41878064|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
19502466|NCT02799602|41878063|FG000|Overall Study|Death|8|||
19502467|NCT02799602|41878064|FG001|Overall Study|Death|5|||
19502468|NCT02799602|41878063|FG000|Overall Study|Other|3|||
19502469|NCT02799602|41878064|FG001|Overall Study|Other|3|||
19502470|NCT02799602|41878063|FG000|Overall Study|GCP violation|1|||
19502471|NCT02799602|41878064|FG001|Overall Study|GCP violation|0|||
19502472|NCT02756611|41878070|FG000|Overall Study|Death|70|||
19502473|NCT02756611|41878070|FG000|Overall Study|Withdrawal by Subject|2|||
19502474|NCT02756611|41878070|FG000|Overall Study|Lost to Follow-up|3|||
19502475|NCT02756611|41878070|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
19502476|NCT02756611|41878070|FG000|Overall Study|Other|10|||
19502477|NCT02624518|41878074|FG000|Overall Study|Physician Decision|1|||
19502478|NCT02287623|41878080|FG000|Overall Study|Protocol Violation|0|||
19502479|NCT02287623|41878081|FG001|Overall Study|Protocol Violation|1|||
19502480|NCT01794520|41878103|FG000|Overall Study|Adverse events- related to progression|0|||
19502481|NCT01794520|41878104|FG001|Overall Study|Adverse events- related to progression|0|||
19502482|NCT01794520|41878105|FG002|Overall Study|Adverse events- related to progression|1|||
19502483|NCT01794520|41878106|FG003|Overall Study|Adverse events- related to progression|2|||
19502484|NCT01794520|41878107|FG004|Overall Study|Adverse events- related to progression|0|||
19502485|NCT01794520|41878108|FG005|Overall Study|Adverse events- related to progression|1|||
19502486|NCT01794520|41878109|FG006|Overall Study|Adverse events- related to progression|0|||
19502487|NCT01794520|41878103|FG000|Overall Study|Adverse event- not related to progression|1|||
19502488|NCT01794520|41878104|FG001|Overall Study|Adverse event- not related to progression|1|||
19502489|NCT01794520|41878105|FG002|Overall Study|Adverse event- not related to progression|0|||
19502490|NCT01794520|41878106|FG003|Overall Study|Adverse event- not related to progression|0|||
19502491|NCT01794520|41878107|FG004|Overall Study|Adverse event- not related to progression|2|||
19502492|NCT01794520|41878108|FG005|Overall Study|Adverse event- not related to progression|0|||
19502493|NCT01794520|41878109|FG006|Overall Study|Adverse event- not related to progression|0|||
19502494|NCT01794520|41878103|FG000|Overall Study|Progressive disease|5|||
19502495|NCT01794520|41878104|FG001|Overall Study|Progressive disease|6|||
19502496|NCT01794520|41878105|FG002|Overall Study|Progressive disease|2|||
19502497|NCT01794520|41878106|FG003|Overall Study|Progressive disease|5|||
19502498|NCT01794520|41878107|FG004|Overall Study|Progressive disease|27|||
19502499|NCT01794520|41878108|FG005|Overall Study|Progressive disease|18|||
19502500|NCT01794520|41878109|FG006|Overall Study|Progressive disease|0|||
19502501|NCT01794520|41878103|FG000|Overall Study|Withdrew consent|0|||
19502502|NCT01794520|41878104|FG001|Overall Study|Withdrew consent|0|||
19502503|NCT01794520|41878105|FG002|Overall Study|Withdrew consent|1|||
19502504|NCT01794520|41878106|FG003|Overall Study|Withdrew consent|1|||
19502505|NCT01794520|41878107|FG004|Overall Study|Withdrew consent|0|||
19502506|NCT01794520|41878108|FG005|Overall Study|Withdrew consent|0|||
19502507|NCT01794520|41878109|FG006|Overall Study|Withdrew consent|0|||
19502508|NCT01794520|41878103|FG000|Overall Study|Lost to Follow-up|0|||
19502509|NCT01794520|41878104|FG001|Overall Study|Lost to Follow-up|0|||
19502510|NCT01794520|41878105|FG002|Overall Study|Lost to Follow-up|0|||
19502511|NCT01794520|41878106|FG003|Overall Study|Lost to Follow-up|0|||
19502512|NCT01794520|41878107|FG004|Overall Study|Lost to Follow-up|1|||
19502513|NCT01794520|41878108|FG005|Overall Study|Lost to Follow-up|0|||
19502514|NCT01794520|41878109|FG006|Overall Study|Lost to Follow-up|0|||
19502515|NCT01794520|41878103|FG000|Overall Study|Toxicity|0|||
19502516|NCT01794520|41878104|FG001|Overall Study|Toxicity|2|||
19502517|NCT01794520|41878105|FG002|Overall Study|Toxicity|0|||
19393812|NCT02656693|41637724|FG001|Overall Study|Bariatric surgery|1|||
19502518|NCT01794520|41878106|FG003|Overall Study|Toxicity|0|||
19502519|NCT01794520|41878107|FG004|Overall Study|Toxicity|0|||
19502520|NCT01794520|41878108|FG005|Overall Study|Toxicity|0|||
19502521|NCT01794520|41878109|FG006|Overall Study|Toxicity|0|||
19502522|NCT01794520|41878103|FG000|Overall Study|Study terminated by sponsor|0|||
19502523|NCT01794520|41878104|FG001|Overall Study|Study terminated by sponsor|0|||
19502524|NCT01794520|41878105|FG002|Overall Study|Study terminated by sponsor|1|||
19502525|NCT01794520|41878106|FG003|Overall Study|Study terminated by sponsor|0|||
19502526|NCT01794520|41878107|FG004|Overall Study|Study terminated by sponsor|1|||
19502527|NCT01794520|41878108|FG005|Overall Study|Study terminated by sponsor|0|||
19502528|NCT01794520|41878109|FG006|Overall Study|Study terminated by sponsor|7|||
19502529|NCT01794520|41878103|FG000|Overall Study|Death|0|||
19502530|NCT01794520|41878104|FG001|Overall Study|Death|0|||
19502531|NCT01794520|41878105|FG002|Overall Study|Death|0|||
19502532|NCT01794520|41878106|FG003|Overall Study|Death|0|||
19502533|NCT01794520|41878107|FG004|Overall Study|Death|1|||
19502534|NCT01794520|41878108|FG005|Overall Study|Death|0|||
19502535|NCT01794520|41878109|FG006|Overall Study|Death|22|||
19502536|NCT01794520|41878103|FG000|Overall Study|Other, not specified|0|||
19502537|NCT01794520|41878104|FG001|Overall Study|Other, not specified|0|||
19502538|NCT01794520|41878105|FG002|Overall Study|Other, not specified|1|||
19502539|NCT01794520|41878106|FG003|Overall Study|Other, not specified|1|||
19614768|NCT00931463|42063907|FG001|Overall Study|Death|4|||
19502540|NCT01794520|41878107|FG004|Overall Study|Other, not specified|4|||
19502541|NCT01794520|41878108|FG005|Overall Study|Other, not specified|1|||
19502542|NCT01794520|41878109|FG006|Overall Study|Other, not specified|2|||
19502543|NCT01774019|41878132|FG000|Overall Study|No longer meets protocol criteria|2|||
19502544|NCT01774019|41878133|FG001|Overall Study|No longer meets protocol criteria|0|||
19502545|NCT01774019|41878132|FG000|Overall Study|Withdrawal by Subject|1|||
19502546|NCT01774019|41878133|FG001|Overall Study|Withdrawal by Subject|0|||
19502547|NCT01774019|41878132|FG000|Overall Study|Surgery delayed > 120 days|1|||
19502548|NCT01774019|41878133|FG001|Overall Study|Surgery delayed > 120 days|0|||
19502549|NCT01774019|41878132|FG000|Overall Study|Patient refused surgery|1|||
19502550|NCT01774019|41878133|FG001|Overall Study|Patient refused surgery|1|||
19502551|NCT01774019|41878132|FG000|Overall Study|Unable to implant study device|1|||
19502552|NCT01774019|41878133|FG001|Overall Study|Unable to implant study device|0|||
19502553|NCT01774019|41878132|FG000|Overall Study|Lost to Follow-up|0|||
19502554|NCT01774019|41878133|FG001|Overall Study|Lost to Follow-up|3|||
19502555|NCT00846742|41878184|FG000|Overall Study|Withdrawal by Subject|1|||
19502556|NCT03251924|41878514|FG000|Overall Study|Disease Progression|6|||
19502557|NCT03251924|41878515|FG001|Overall Study|Disease Progression|6|||
19502558|NCT03251924|41878516|FG002|Overall Study|Disease Progression|7|||
19502559|NCT03251924|41878517|FG003|Overall Study|Disease Progression|8|||
19502560|NCT03251924|41878518|FG004|Overall Study|Disease Progression|8|||
19502561|NCT03251924|41878519|FG005|Overall Study|Disease Progression|7|||
19502562|NCT03251924|41878520|FG006|Overall Study|Disease Progression|6|||
19502563|NCT03251924|41878521|FG007|Overall Study|Disease Progression|10|||
19502564|NCT03251924|41878522|FG008|Overall Study|Disease Progression|6|||
19502565|NCT03251924|41878514|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
19502566|NCT03251924|41878515|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
19502567|NCT03251924|41878516|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
19502568|NCT03251924|41878517|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
19502569|NCT03251924|41878518|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
19502570|NCT03251924|41878519|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
19502571|NCT03251924|41878520|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
19502572|NCT03251924|41878521|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
19502573|NCT03251924|41878522|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
19502574|NCT03251924|41878514|FG000|Overall Study|Death|0|||
19502575|NCT03251924|41878515|FG001|Overall Study|Death|1|||
19502576|NCT03251924|41878516|FG002|Overall Study|Death|0|||
19502577|NCT03251924|41878517|FG003|Overall Study|Death|1|||
19502578|NCT03251924|41878518|FG004|Overall Study|Death|1|||
19502579|NCT03251924|41878519|FG005|Overall Study|Death|1|||
19502580|NCT03251924|41878520|FG006|Overall Study|Death|0|||
19502581|NCT03251924|41878521|FG007|Overall Study|Death|0|||
19502582|NCT03251924|41878522|FG008|Overall Study|Death|0|||
19502583|NCT03251924|41878514|FG000|Overall Study|Study Drug Toxicity|0|||
19502584|NCT03251924|41878515|FG001|Overall Study|Study Drug Toxicity|0|||
19502585|NCT03251924|41878516|FG002|Overall Study|Study Drug Toxicity|0|||
19502586|NCT03251924|41878517|FG003|Overall Study|Study Drug Toxicity|1|||
19502587|NCT03251924|41878518|FG004|Overall Study|Study Drug Toxicity|0|||
19502588|NCT03251924|41878519|FG005|Overall Study|Study Drug Toxicity|0|||
19502589|NCT03251924|41878520|FG006|Overall Study|Study Drug Toxicity|0|||
19502590|NCT03251924|41878521|FG007|Overall Study|Study Drug Toxicity|0|||
19502591|NCT03251924|41878522|FG008|Overall Study|Study Drug Toxicity|1|||
19502592|NCT03251924|41878514|FG000|Overall Study|Other Reasons|0|||
19502593|NCT03251924|41878515|FG001|Overall Study|Other Reasons|0|||
19502594|NCT03251924|41878516|FG002|Overall Study|Other Reasons|0|||
19502595|NCT03251924|41878517|FG003|Overall Study|Other Reasons|0|||
19502596|NCT03251924|41878518|FG004|Overall Study|Other Reasons|0|||
19502597|NCT03251924|41878519|FG005|Overall Study|Other Reasons|0|||
19502598|NCT03251924|41878520|FG006|Overall Study|Other Reasons|0|||
19502599|NCT03251924|41878521|FG007|Overall Study|Other Reasons|0|||
19502600|NCT03251924|41878522|FG008|Overall Study|Other Reasons|1|||
19502601|NCT03251924|41878514|FG000|Overall Study|Participant request to discontinue study treatment|0|||
19502602|NCT03251924|41878515|FG001|Overall Study|Participant request to discontinue study treatment|0|||
19502603|NCT03251924|41878516|FG002|Overall Study|Participant request to discontinue study treatment|0|||
19502604|NCT03251924|41878517|FG003|Overall Study|Participant request to discontinue study treatment|0|||
19502605|NCT03251924|41878518|FG004|Overall Study|Participant request to discontinue study treatment|0|||
19502606|NCT03251924|41878519|FG005|Overall Study|Participant request to discontinue study treatment|0|||
19502607|NCT03251924|41878520|FG006|Overall Study|Participant request to discontinue study treatment|0|||
19502608|NCT03251924|41878521|FG007|Overall Study|Participant request to discontinue study treatment|1|||
19502609|NCT03251924|41878522|FG008|Overall Study|Participant request to discontinue study treatment|0|||
19502610|NCT01350141|41878718|FG000|Overall Study|Lost to Follow-up|1|||
19502611|NCT01350141|41878719|FG001|Overall Study|Lost to Follow-up|0|||
19502612|NCT01350141|41878720|FG002|Overall Study|Lost to Follow-up|1|||
19502613|NCT01350141|41878718|FG000|Overall Study|Withdrawal by Subject|1|||
19502614|NCT01350141|41878719|FG001|Overall Study|Withdrawal by Subject|0|||
19502615|NCT01350141|41878720|FG002|Overall Study|Withdrawal by Subject|0|||
19502616|NCT01350141|41878718|FG000|Overall Study|Randomized but not treated|1|||
19502617|NCT01350141|41878719|FG001|Overall Study|Randomized but not treated|0|||
19502618|NCT01350141|41878720|FG002|Overall Study|Randomized but not treated|0|||
19502619|NCT05045625|41879259|FG000|Overall Study|Lost to Follow-up|3|||
19502620|NCT04830969|41879641|FG000|Overall Study|Withdrawal by Subject|6|||
19502621|NCT04830969|41879642|FG001|Overall Study|Withdrawal by Subject|2|||
19502622|NCT04830969|41879641|FG000|Overall Study|Protocol Violation|3|||
19502623|NCT04830969|41879642|FG001|Overall Study|Protocol Violation|9|||
19502624|NCT04830969|41879641|FG000|Overall Study|Lost to Follow-up|4|||
19502625|NCT04830969|41879642|FG001|Overall Study|Lost to Follow-up|4|||
19502626|NCT03706079|41879809|FG000|Predecessor Study|Death|0|||
19502627|NCT03706079|41879810|FG001|Predecessor Study|Death|2|||
19502628|NCT03706079|41879811|FG002|Predecessor Study|Death|0|||
19502629|NCT03706079|41879812|FG003|Predecessor Study|Death|1|||
19502630|NCT03706079|41879813|FG004|Predecessor Study|Death|0|||
19502631|NCT03706079|41879814|FG005|Predecessor Study|Death|0|||
19502632|NCT03706079|41879809|FG000|Predecessor Study|Lost to Follow-up|5|||
19502633|NCT03706079|41879810|FG001|Predecessor Study|Lost to Follow-up|2|||
19502634|NCT03706079|41879811|FG002|Predecessor Study|Lost to Follow-up|0|||
19502635|NCT03706079|41879812|FG003|Predecessor Study|Lost to Follow-up|0|||
19502636|NCT03706079|41879813|FG004|Predecessor Study|Lost to Follow-up|1|||
19502637|NCT03706079|41879814|FG005|Predecessor Study|Lost to Follow-up|0|||
19502638|NCT03706079|41879809|FG000|Predecessor Study|Withdrawal by Subject|8|||
19502639|NCT03706079|41879810|FG001|Predecessor Study|Withdrawal by Subject|15|||
19502640|NCT03706079|41879811|FG002|Predecessor Study|Withdrawal by Subject|0|||
19502641|NCT03706079|41879812|FG003|Predecessor Study|Withdrawal by Subject|5|||
19502642|NCT03706079|41879813|FG004|Predecessor Study|Withdrawal by Subject|2|||
19502643|NCT03706079|41879814|FG005|Predecessor Study|Withdrawal by Subject|0|||
19502644|NCT03706079|41879809|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
19502645|NCT03706079|41879810|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
19502646|NCT03706079|41879811|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
19502647|NCT03706079|41879812|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
19502648|NCT03706079|41879813|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
19502649|NCT03706079|41879814|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
19502650|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
19502651|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
19502652|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
19502653|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
19502654|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
19502655|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
19502656|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
19502657|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
19502658|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
19502659|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
19502660|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
19502661|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
19502662|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
19502663|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
19502664|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
19502665|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
19502666|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
19502667|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
19502668|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
19502669|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
19502670|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
19502671|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
19502672|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
19393813|NCT02656693|41637725|FG002|Overall Study|Bariatric surgery|2|||
19393814|NCT02633293|41637733|FG000|Overall Study|Death|56|||
19502673|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
19502674|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
19502675|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
19502676|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
19614769|NCT00931463|42063906|FG000|Overall Study|Withdrawal by Subject|5|||
19614770|NCT00931463|42063907|FG001|Overall Study|Withdrawal by Subject|0|||
19614771|NCT00931463|42063906|FG000|Overall Study|Lost to Follow-up|4|||
19502677|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
19502678|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
19502679|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
19502680|NCT03706079|41879809|FG000|Long Term Extension (DESTINATION)|Death|8|||
19502681|NCT03706079|41879810|FG001|Long Term Extension (DESTINATION)|Death|2|||
19502682|NCT03706079|41879811|FG002|Long Term Extension (DESTINATION)|Death|2|||
19502683|NCT03706079|41879812|FG003|Long Term Extension (DESTINATION)|Death|1|||
19502684|NCT03706079|41879813|FG004|Long Term Extension (DESTINATION)|Death|0|||
19502685|NCT03706079|41879814|FG005|Long Term Extension (DESTINATION)|Death|0|||
19502686|NCT02384993|41879974|FG000|Overall Study|Adverse Event|0|||
19502687|NCT02384993|41879975|FG001|Overall Study|Adverse Event|1|||
19502688|NCT01352117|41880023|FG000|Overall Study|Death|15|||
19502689|NCT01352117|41880024|FG001|Overall Study|Death|16|||
19502690|NCT01352117|41880023|FG000|Overall Study|Withdrawal by Subject|1|||
19502691|NCT01352117|41880024|FG001|Overall Study|Withdrawal by Subject|0|||
19502692|NCT01352117|41880023|FG000|Overall Study|Lost to Follow-up|2|||
19502693|NCT01352117|41880024|FG001|Overall Study|Lost to Follow-up|7|||
19502694|NCT01352117|41880023|FG000|Overall Study|Non-adherent to study requirements|1|||
19502695|NCT01352117|41880024|FG001|Overall Study|Non-adherent to study requirements|1|||
19502696|NCT01352117|41880023|FG000|Overall Study|Did not initiate study treatment|1|||
19502697|NCT01352117|41880024|FG001|Overall Study|Did not initiate study treatment|0|||
19502698|NCT01352117|41880023|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
19502699|NCT01352117|41880024|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
19502700|NCT03578237|41880116|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
19502701|NCT03578237|41880117|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
19502702|NCT04173507|41880196|FG000|Overall Study|On Treatment|3|||
19502703|NCT04173507|41880196|FG000|Overall Study|Adverse Event|3|||
19502704|NCT04173507|41880196|FG000|Overall Study|Progression/Relapse|34|||
19502705|NCT04173507|41880196|FG000|Overall Study|Death|2|||
19502706|NCT02220725|41880204|FG000|Overall Study|Lost to Follow-up|0|||
19502707|NCT02220725|41880205|FG001|Overall Study|Lost to Follow-up|0|||
19502708|NCT02220725|41880206|FG002|Overall Study|Lost to Follow-up|0|||
19502709|NCT02220725|41880207|FG003|Overall Study|Lost to Follow-up|1|||
19502710|NCT02220725|41880204|FG000|Overall Study|Withdrawal by Subject|0|||
19502711|NCT02220725|41880205|FG001|Overall Study|Withdrawal by Subject|0|||
19502712|NCT02220725|41880206|FG002|Overall Study|Withdrawal by Subject|0|||
19502713|NCT02220725|41880207|FG003|Overall Study|Withdrawal by Subject|1|||
19502714|NCT03335475|41880239|FG000|Overall Study|Did not wear accelerometer|4|||
19502715|NCT03335475|41880240|FG001|Overall Study|Did not wear accelerometer|0|||
19502716|NCT03335475|41880239|FG000|Overall Study|Withdrawal by Subject|0|||
19502717|NCT03335475|41880240|FG001|Overall Study|Withdrawal by Subject|1|||
19502718|NCT02422615|41880248|FG000|Overall Study|Progressive disease|193|||
19502719|NCT02422615|41880249|FG001|Overall Study|Progressive disease|142|||
19502720|NCT02422615|41880248|FG000|Overall Study|Adverse Event|41|||
19502721|NCT02422615|41880249|FG001|Overall Study|Adverse Event|10|||
19502722|NCT02422615|41880248|FG000|Overall Study|Physician Decision|22|||
19502723|NCT02422615|41880249|FG001|Overall Study|Physician Decision|7|||
19502724|NCT02422615|41880248|FG000|Overall Study|Subject/guardian decision|21|||
19502725|NCT02422615|41880249|FG001|Overall Study|Subject/guardian decision|5|||
19502726|NCT02422615|41880248|FG000|Overall Study|Death|2|||
19502727|NCT02422615|41880249|FG001|Overall Study|Death|0|||
19502728|NCT02422615|41880248|FG000|Overall Study|Protocol Violation|1|||
19502729|NCT02422615|41880249|FG001|Overall Study|Protocol Violation|1|||
19502730|NCT02422615|41880248|FG000|Overall Study|Technical problems|0|||
19502731|NCT02422615|41880249|FG001|Overall Study|Technical problems|1|||
19502732|NCT02259517|41880271|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
19502733|NCT02259517|41880272|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
19502734|NCT02259517|41880273|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
19502735|NCT02259517|41880271|FG000|Overall Study|Withdrawal by Subject|0|||
19502736|NCT02259517|41880272|FG001|Overall Study|Withdrawal by Subject|0|||
19502737|NCT02259517|41880273|FG002|Overall Study|Withdrawal by Subject|3|||
19502738|NCT02277990|41880316|FG000|Overall Study|Death|170|||
19502739|NCT02277990|41880317|FG001|Overall Study|Death|188|||
19614772|NCT00931463|42063907|FG001|Overall Study|Lost to Follow-up|1|||
19704454|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
19393815|NCT02633293|41637733|FG000|Overall Study|Progressive Disease|12|||
19502740|NCT02277990|41880316|FG000|Overall Study|Withdrawal by Subject|64|||
19502741|NCT02277990|41880317|FG001|Overall Study|Withdrawal by Subject|53|||
19502742|NCT02277990|41880316|FG000|Overall Study|Physician Decision|40|||
19502743|NCT02277990|41880317|FG001|Overall Study|Physician Decision|34|||
19502744|NCT02277990|41880316|FG000|Overall Study|Lost to Follow-up|66|||
19502745|NCT02277990|41880317|FG001|Overall Study|Lost to Follow-up|69|||
19502746|NCT02277990|41880316|FG000|Overall Study|Had other reason|26|||
19502747|NCT02277990|41880317|FG001|Overall Study|Had other reason|32|||
19502748|NCT02317614|41880339|FG000|Overall Study|Lost to Follow-up|1|||
19502749|NCT02317614|41880340|FG001|Overall Study|Lost to Follow-up|1|||
19502750|NCT02317614|41880339|FG000|Overall Study|Withdrawal by Subject|1|||
19502751|NCT02317614|41880340|FG001|Overall Study|Withdrawal by Subject|0|||
19502752|NCT02317614|41880339|FG000|Overall Study|Death|1|||
19502753|NCT02317614|41880340|FG001|Overall Study|Death|1|||
19502754|NCT02276040|41880353|FG000|Overall Study|Physician Decision|15|||
19502755|NCT02315664|41880359|FG000|Overall Study|Lost to Follow-up|1|||
19502756|NCT02315664|41880360|FG001|Overall Study|Lost to Follow-up|1|||
19502757|NCT02315664|41880359|FG000|Overall Study|Withdrawal by Subject|0|||
19502758|NCT02315664|41880360|FG001|Overall Study|Withdrawal by Subject|3|||
19502759|NCT02314728|41880388|FG000|Overall Study|Protocol Violation|1|||
19502760|NCT02314728|41880389|FG001|Overall Study|Protocol Violation|0|||
19502761|NCT02314728|41880388|FG000|Overall Study|Lost to Follow-up|0|||
19502762|NCT02314728|41880389|FG001|Overall Study|Lost to Follow-up|1|||
19502763|NCT02275338|41880408|FG000|Overall Study|Adverse Event|15|||
19502764|NCT02275338|41880408|FG000|Overall Study|Lack of Efficacy|3|||
19502765|NCT02275338|41880408|FG000|Overall Study|Withdrawal by Subject|4|||
19502766|NCT02275338|41880408|FG000|Overall Study|Disease progression (death)|1|||
19502767|NCT02275338|41880408|FG000|Overall Study|Ineligible to start Phase 2|4|||
19502768|NCT02275338|41880408|FG000|Overall Study|Reason not specified|5|||
19502769|NCT02275338|41880408|FG000|Overall Study|Does not meet entry criteria|1|||
19502770|NCT02313558|41880415|FG000|Overall Study|Withdrawal by Subject|2|||
19502771|NCT02313558|41880416|FG001|Overall Study|Withdrawal by Subject|0|||
19502772|NCT02313558|41880415|FG000|Overall Study|Lost to Follow-up|4|||
19502773|NCT02313558|41880416|FG001|Overall Study|Lost to Follow-up|4|||
19502774|NCT01646268|41880444|FG000|Overall Study|Adverse Event|6|||
19502775|NCT01646268|41880445|FG001|Overall Study|Adverse Event|7|||
19502776|NCT01646268|41880444|FG000|Overall Study|Lack of Efficacy|1|||
19502777|NCT01646268|41880445|FG001|Overall Study|Lack of Efficacy|3|||
19502778|NCT01646268|41880444|FG000|Overall Study|Protocol Violation|0|||
19502779|NCT01646268|41880445|FG001|Overall Study|Protocol Violation|1|||
19502780|NCT01646268|41880444|FG000|Overall Study|Withdrawal by Subject|2|||
19502781|NCT01646268|41880445|FG001|Overall Study|Withdrawal by Subject|5|||
19502782|NCT01646268|41880444|FG000|Overall Study|Other|2|||
19502783|NCT01646268|41880445|FG001|Overall Study|Other|0|||
19502784|NCT02275026|41880451|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
19502785|NCT02275026|41880451|FG000|Overall Study|Withdrawal by Subject|4|||
19502786|NCT02275026|41880451|FG000|Overall Study|Ineligible due to medical history|13|||
19502787|NCT02275026|41880451|FG000|Overall Study|MRI malfunction precluded testing|1|||
19502788|NCT02275026|41880451|FG000|Overall Study|Ineligible after MRI findings|1|||
19502789|NCT02275026|41880451|FG000|Overall Study|Lost to Follow-up|2|||
19502790|NCT02275026|41880451|FG000|Overall Study|Scanner failure|1|||
19502791|NCT02711852|41880527|FG000|Overall Study|Death|5|||
19502792|NCT02711852|41880527|FG000|Overall Study|Lost to Follow-up|1|||
19502793|NCT02711852|41880527|FG000|Overall Study|Completed follow-up|3|||
19502794|NCT02711852|41880527|FG000|Overall Study|Withdrawal by Subject|1|||
19502795|NCT04579250|41880567|FG000|Overall Study|Withdrawal by Subject|1|||
19502796|NCT04579250|41880568|FG001|Overall Study|Withdrawal by Subject|1|||
19614773|NCT00929201|42063913|FG000|Period 1|Withdrawal by Subject|0|||
19614774|NCT00929201|42063914|FG001|Period 1|Withdrawal by Subject|1|||
19614775|NCT00926003|42063924|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
19614776|NCT00926003|42063925|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
19614777|NCT00926003|42063926|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
19614778|NCT00926003|42063924|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
19614779|NCT00926003|42063925|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
19614780|NCT00926003|42063926|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
19614781|NCT00928889|42063936|FG000|Overall Study|Lost to Follow-up|3|||
19614782|NCT00928889|42063937|FG001|Overall Study|Lost to Follow-up|1|||
19614783|NCT00928889|42063936|FG000|Overall Study|Protocol Violation|0|||
19614784|NCT00928889|42063937|FG001|Overall Study|Protocol Violation|1|||
19614785|NCT00928889|42063936|FG000|Overall Study|Adverse Event|1|||
19614786|NCT00928889|42063937|FG001|Overall Study|Adverse Event|0|||
19614787|NCT00928889|42063936|FG000|Overall Study|Other|1|||
19614788|NCT00928889|42063937|FG001|Overall Study|Other|0|||
19502797|NCT04579250|41880569|FG002|Overall Study|Withdrawal by Subject|0|||
19502798|NCT04579250|41880567|FG000|Overall Study|Lost to Follow-up|1|||
19502799|NCT04579250|41880568|FG001|Overall Study|Lost to Follow-up|1|||
19502800|NCT04579250|41880569|FG002|Overall Study|Lost to Follow-up|0|||
19502801|NCT04579250|41880567|FG000|Overall Study|Moved from area|0|||
19502802|NCT04579250|41880568|FG001|Overall Study|Moved from area|1|||
19502803|NCT04579250|41880569|FG002|Overall Study|Moved from area|2|||
19502804|NCT03175367|41880596|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
19502805|NCT03175367|41880597|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
19614789|NCT03978091|42063949|FG000|Overall Study|Lost to Follow-up|0|||
19502806|NCT03175367|41880598|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
19502807|NCT03175367|41880599|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
19502808|NCT03175367|41880600|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
19614790|NCT03978091|42063950|FG001|Overall Study|Lost to Follow-up|0|||
19614791|NCT03978091|42063951|FG002|Overall Study|Lost to Follow-up|1|||
19614792|NCT03978091|42063952|FG003|Overall Study|Lost to Follow-up|0|||
19614793|NCT03978091|42063953|FG004|Overall Study|Lost to Follow-up|0|||
19614794|NCT03978091|42063954|FG005|Overall Study|Lost to Follow-up|0|||
19614795|NCT03978091|42063949|FG000|Overall Study|Withdrawal by Subject|0|||
19614796|NCT03978091|42063950|FG001|Overall Study|Withdrawal by Subject|0|||
19502809|NCT03175367|41880601|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
19502810|NCT03175367|41880602|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
19502811|NCT03175367|41880596|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
19502812|NCT03175367|41880597|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
19502813|NCT03175367|41880598|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
19502814|NCT03175367|41880599|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
19502815|NCT03175367|41880600|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
19502816|NCT03175367|41880601|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
19502817|NCT03175367|41880602|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
19502818|NCT03175367|41880596|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19502819|NCT03175367|41880597|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19502820|NCT03175367|41880598|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
19502821|NCT03175367|41880599|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
19502822|NCT03175367|41880600|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19502823|NCT03175367|41880601|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
19502824|NCT03175367|41880602|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
19502825|NCT03175367|41880596|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
19502826|NCT03175367|41880597|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
19502827|NCT03175367|41880598|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
19502828|NCT03175367|41880599|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
19502829|NCT03175367|41880600|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
19502830|NCT03175367|41880601|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
19502831|NCT03175367|41880602|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
19502832|NCT03175367|41880596|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19502833|NCT03175367|41880597|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19502834|NCT03175367|41880598|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
19502835|NCT03175367|41880599|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19502836|NCT03175367|41880600|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
19502837|NCT03175367|41880601|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19502838|NCT03175367|41880602|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
19502839|NCT03175367|41880596|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502840|NCT03175367|41880597|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502841|NCT03175367|41880598|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502842|NCT03175367|41880599|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502843|NCT03175367|41880600|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502844|NCT03175367|41880601|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
19502845|NCT03175367|41880602|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
19502846|NCT03175367|41880596|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19502847|NCT03175367|41880597|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19502848|NCT03175367|41880598|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19502849|NCT03175367|41880599|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19502850|NCT03175367|41880600|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
19502851|NCT03175367|41880601|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
19502852|NCT03175367|41880602|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
19502853|NCT03174275|41880659|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
19502854|NCT03174275|41880659|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
19502855|NCT03174275|41880659|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
19502856|NCT03174275|41880659|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
19502857|NCT03174275|41880659|FG000|Adjuvant Chemotherapy|Progression|1|||
19502858|NCT03174275|41880659|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
19502859|NCT03174275|41880659|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
19502860|NCT03174275|41880659|FG000|Adjuvant Durvalumab|Progression|1|||
19502861|NCT03174275|41880659|FG000|Adjuvant Durvalumab|Adverse Event|3|||
19502862|NCT03174275|41880659|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
19502863|NCT03174275|41880659|FG000|Adjuvant Radiotherapy|Progression|1|||
19502864|NCT03174275|41880659|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
19502865|NCT03990363|41880760|FG000|Overall Study|Withdrawal by Subject|10|||
19502866|NCT03990363|41880761|FG001|Overall Study|Withdrawal by Subject|9|||
19614797|NCT03978091|42063951|FG002|Overall Study|Withdrawal by Subject|0|||
19614798|NCT03978091|42063952|FG003|Overall Study|Withdrawal by Subject|1|||
19614799|NCT03978091|42063953|FG004|Overall Study|Withdrawal by Subject|1|||
19502867|NCT03990363|41880762|FG002|Overall Study|Withdrawal by Subject|18|||
19502868|NCT03990363|41880763|FG003|Overall Study|Withdrawal by Subject|11|||
19502869|NCT03990363|41880764|FG004|Overall Study|Withdrawal by Subject|9|||
19502870|NCT03990363|41880760|FG000|Overall Study|Physician Decision|1|||
19502871|NCT03990363|41880761|FG001|Overall Study|Physician Decision|0|||
19502872|NCT03990363|41880762|FG002|Overall Study|Physician Decision|0|||
19502873|NCT03990363|41880763|FG003|Overall Study|Physician Decision|0|||
19502874|NCT03990363|41880764|FG004|Overall Study|Physician Decision|0|||
19502875|NCT03990363|41880760|FG000|Overall Study|Adverse Event|1|||
19502876|NCT03990363|41880761|FG001|Overall Study|Adverse Event|3|||
19502877|NCT03990363|41880762|FG002|Overall Study|Adverse Event|2|||
19502878|NCT03990363|41880763|FG003|Overall Study|Adverse Event|2|||
19502879|NCT03990363|41880764|FG004|Overall Study|Adverse Event|0|||
19502880|NCT03990363|41880760|FG000|Overall Study|Death|14|||
19502881|NCT03990363|41880761|FG001|Overall Study|Death|8|||
19502882|NCT03990363|41880762|FG002|Overall Study|Death|14|||
19502883|NCT03990363|41880763|FG003|Overall Study|Death|10|||
19502884|NCT03990363|41880764|FG004|Overall Study|Death|11|||
19502885|NCT03990363|41880760|FG000|Overall Study|Failure to meet randomization criteria|0|||
19502886|NCT03990363|41880761|FG001|Overall Study|Failure to meet randomization criteria|1|||
19502887|NCT03990363|41880762|FG002|Overall Study|Failure to meet randomization criteria|1|||
19502888|NCT03990363|41880763|FG003|Overall Study|Failure to meet randomization criteria|0|||
19502889|NCT03990363|41880764|FG004|Overall Study|Failure to meet randomization criteria|0|||
19502890|NCT03990363|41880760|FG000|Overall Study|Lost to Follow-up|0|||
19502891|NCT03990363|41880761|FG001|Overall Study|Lost to Follow-up|0|||
19502892|NCT03990363|41880762|FG002|Overall Study|Lost to Follow-up|0|||
19502893|NCT03990363|41880763|FG003|Overall Study|Lost to Follow-up|1|||
19502894|NCT03990363|41880764|FG004|Overall Study|Lost to Follow-up|2|||
19502895|NCT03990363|41880760|FG000|Overall Study|Non-compliance with study drug|2|||
19502896|NCT03990363|41880761|FG001|Overall Study|Non-compliance with study drug|1|||
19502897|NCT03990363|41880762|FG002|Overall Study|Non-compliance with study drug|2|||
19502898|NCT03990363|41880763|FG003|Overall Study|Non-compliance with study drug|0|||
19502899|NCT03990363|41880764|FG004|Overall Study|Non-compliance with study drug|0|||
19502900|NCT03990363|41880760|FG000|Overall Study|Study terminated by sponsor|0|||
19502901|NCT03990363|41880761|FG001|Overall Study|Study terminated by sponsor|1|||
19502902|NCT03990363|41880762|FG002|Overall Study|Study terminated by sponsor|0|||
19502903|NCT03990363|41880763|FG003|Overall Study|Study terminated by sponsor|0|||
19502904|NCT03990363|41880764|FG004|Overall Study|Study terminated by sponsor|0|||
19502905|NCT03990363|41880760|FG000|Overall Study|Site terminated by sponsor|2|||
19502906|NCT03990363|41880761|FG001|Overall Study|Site terminated by sponsor|1|||
19502907|NCT03990363|41880762|FG002|Overall Study|Site terminated by sponsor|2|||
19502908|NCT03990363|41880763|FG003|Overall Study|Site terminated by sponsor|0|||
19502909|NCT03990363|41880764|FG004|Overall Study|Site terminated by sponsor|2|||
19502910|NCT03990363|41880760|FG000|Overall Study|Not categorized|5|||
19502911|NCT03990363|41880761|FG001|Overall Study|Not categorized|5|||
19502912|NCT03990363|41880762|FG002|Overall Study|Not categorized|3|||
19502913|NCT03990363|41880763|FG003|Overall Study|Not categorized|2|||
19502914|NCT03990363|41880764|FG004|Overall Study|Not categorized|2|||
19502915|NCT04661839|41880834|FG000|Overall Study|Not Treated|0|||
19502916|NCT04661839|41880835|FG001|Overall Study|Not Treated|0|||
19502917|NCT04661839|41880836|FG002|Overall Study|Not Treated|1|||
19502918|NCT04661839|41880837|FG003|Overall Study|Not Treated|0|||
19502919|NCT04661839|41880834|FG000|Overall Study|Lost to Follow-up|1|||
19502920|NCT04661839|41880835|FG001|Overall Study|Lost to Follow-up|0|||
19502921|NCT04661839|41880836|FG002|Overall Study|Lost to Follow-up|0|||
19502922|NCT04661839|41880837|FG003|Overall Study|Lost to Follow-up|1|||
19502923|NCT02240485|41880938|FG000|3 Months Post-admission|Lost to Follow-up|1|||
19502924|NCT02240485|41880939|FG001|3 Months Post-admission|Lost to Follow-up|5|||
19502925|NCT02240485|41880938|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
19502926|NCT02240485|41880939|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
19502927|NCT02240485|41880938|FG000|9 Months Post-admission|Lost to Follow-up|3|||
19502928|NCT02240485|41880939|FG001|9 Months Post-admission|Lost to Follow-up|1|||
19502929|NCT02240485|41880938|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
19502930|NCT02240485|41880939|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
19502931|NCT02240485|41880938|FG000|18 Months Post-admission|Lost to Follow-up|1|||
19502932|NCT02240485|41880939|FG001|18 Months Post-admission|Lost to Follow-up|1|||
19502933|NCT02240485|41880938|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
19502934|NCT02240485|41880939|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
19614800|NCT03978091|42063954|FG005|Overall Study|Withdrawal by Subject|0|||
19614801|NCT00564733|42063977|FG000|Overall Study|Withdrawal by Subject|4|||
19393816|NCT02633293|41637733|FG000|Overall Study|Adverse Event|29|||
19502935|NCT04149535|41880962|FG000|Overall Study|Death|11|||
19502936|NCT04149535|41880963|FG001|Overall Study|Death|7|||
19502937|NCT04149535|41880962|FG000|Overall Study|Physician Decision|10|||
19502938|NCT04149535|41880963|FG001|Overall Study|Physician Decision|4|||
19502939|NCT04149535|41880962|FG000|Overall Study|Withdrawal by Subject|6|||
19614802|NCT00564733|42063977|FG000|Overall Study|Ineligible|5|||
19614803|NCT00931385|42063981|FG000|Overall Study|Adverse Event|2|||
19614804|NCT00931385|42063982|FG001|Overall Study|Adverse Event|1|||
19614805|NCT00931385|42063983|FG002|Overall Study|Adverse Event|0|||
19614806|NCT00931385|42063984|FG003|Overall Study|Adverse Event|3|||
19614807|NCT00931385|42063981|FG000|Overall Study|Protocol Violation|0|||
19614808|NCT00931385|42063982|FG001|Overall Study|Protocol Violation|0|||
19614809|NCT00931385|42063983|FG002|Overall Study|Protocol Violation|1|||
19614810|NCT00931385|42063984|FG003|Overall Study|Protocol Violation|0|||
19614811|NCT00931385|42063981|FG000|Overall Study|Withdrawal by Subject|0|||
19502940|NCT04149535|41880963|FG001|Overall Study|Withdrawal by Subject|7|||
19502941|NCT04149535|41880962|FG000|Overall Study|Not described|2|||
19502942|NCT04149535|41880963|FG001|Overall Study|Not described|0|||
19502943|NCT02210559|41880981|FG000|Overall Study|Progressive Disease|3|||
19502944|NCT02210559|41880982|FG001|Overall Study|Progressive Disease|2|||
19502945|NCT02210559|41880981|FG000|Overall Study|Adverse Event|2|||
19614812|NCT00931385|42063982|FG001|Overall Study|Withdrawal by Subject|1|||
19502946|NCT02210559|41880982|FG001|Overall Study|Adverse Event|2|||
19502947|NCT02210559|41880981|FG000|Overall Study|Physician Decision|1|||
19502948|NCT02210559|41880982|FG001|Overall Study|Physician Decision|0|||
19502949|NCT02210559|41880981|FG000|Overall Study|Withdrawal by Subject|0|||
19502950|NCT02210559|41880982|FG001|Overall Study|Withdrawal by Subject|1|||
19502951|NCT02210559|41880981|FG000|Overall Study|Other than specified|0|||
19502952|NCT02210559|41880982|FG001|Overall Study|Other than specified|1|||
19502953|NCT02073279|41881139|FG000|Double-blind Period|Adverse Event|1|||
19502954|NCT02073279|41881140|FG001|Double-blind Period|Adverse Event|1|||
19502955|NCT02073279|41881139|FG000|Double-blind Period|Switched to another treatment|1|||
19502956|NCT02073279|41881140|FG001|Double-blind Period|Switched to another treatment|2|||
19502957|NCT02073279|41881139|FG000|Double-blind Period|Protocol Violation|0|||
19502958|NCT02073279|41881140|FG001|Double-blind Period|Protocol Violation|1|||
19502959|NCT02073279|41881139|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
19502960|NCT02073279|41881140|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
19502961|NCT02073279|41881139|FG000|Double-blind Period|Withdrawal by Subject|2|||
19502962|NCT02073279|41881140|FG001|Double-blind Period|Withdrawal by Subject|2|||
19502963|NCT02073279|41881139|FG000|Open-label Extension Period|Adverse Event|1|||
19614813|NCT00931385|42063983|FG002|Overall Study|Withdrawal by Subject|0|||
19614814|NCT00931385|42063984|FG003|Overall Study|Withdrawal by Subject|1|||
19614815|NCT00931385|42063981|FG000|Overall Study|Lost to Follow-up|0|||
19614816|NCT00931385|42063982|FG001|Overall Study|Lost to Follow-up|0|||
19614817|NCT00931385|42063983|FG002|Overall Study|Lost to Follow-up|0|||
19614818|NCT00931385|42063984|FG003|Overall Study|Lost to Follow-up|1|||
19614819|NCT00565747|42064000|FG000|Overall Study|No embryo transfer|67|||
19614820|NCT00565747|42064001|FG001|Overall Study|No embryo transfer|73|||
19614821|NCT00563797|42064009|FG000|Overall Study|Lost to Follow-up|7|||
19614822|NCT00563797|42064010|FG001|Overall Study|Lost to Follow-up|2|||
19614823|NCT00771927|42064029|FG000|Overall Study|Adverse Event|100|||
19614824|NCT00771927|42064030|FG001|Overall Study|Adverse Event|105|||
19614825|NCT00771927|42064029|FG000|Overall Study|Lack of Efficacy|70|||
19614826|NCT00771927|42064030|FG001|Overall Study|Lack of Efficacy|42|||
19614827|NCT00771927|42064029|FG000|Overall Study|Lost to Follow-up|46|||
19614828|NCT00771927|42064030|FG001|Overall Study|Lost to Follow-up|46|||
19614829|NCT00771927|42064029|FG000|Overall Study|Withdrawal by Subject|16|||
19614830|NCT00771927|42064030|FG001|Overall Study|Withdrawal by Subject|17|||
19614831|NCT00771927|42064029|FG000|Overall Study|Other reason|23|||
19614832|NCT00771927|42064030|FG001|Overall Study|Other reason|27|||
19614833|NCT00771849|42064038|FG000|Overall Study|Lost to Follow-up|1|||
19614834|NCT00771849|42064039|FG001|Overall Study|Lost to Follow-up|2|||
19614835|NCT00771849|42064038|FG000|Overall Study|Withdrawal by Subject|1|||
19614836|NCT00771849|42064039|FG001|Overall Study|Withdrawal by Subject|1|||
19614837|NCT00771849|42064038|FG000|Overall Study|Not vaccinated|0|||
19502964|NCT02073279|41881140|FG001|Open-label Extension Period|Adverse Event|0|||
19502965|NCT02073279|41881139|FG000|Open-label Extension Period|Lack of Efficacy|1|||
19502966|NCT02073279|41881140|FG001|Open-label Extension Period|Lack of Efficacy|0|||
19502967|NCT02073279|41881139|FG000|Open-label Extension Period|Lost to Follow-up|0|||
19502968|NCT02073279|41881140|FG001|Open-label Extension Period|Lost to Follow-up|4|||
19502969|NCT02073279|41881139|FG000|Open-label Extension Period|Switched to another treatment|1|||
19502970|NCT02073279|41881140|FG001|Open-label Extension Period|Switched to another treatment|4|||
19502971|NCT02073279|41881139|FG000|Open-label Extension Period|Protocol Violation|0|||
19614838|NCT00771849|42064039|FG001|Overall Study|Not vaccinated|1|||
19614839|NCT00564889|42064045|FG000|Overall Study|Death|7|||
19614840|NCT00564889|42064045|FG000|Overall Study|Adverse Event|12|||
19614841|NCT00564889|42064045|FG000|Overall Study|Alternative treatment|3|||
19614842|NCT00564889|42064045|FG000|Overall Study|Disease progression|3|||
19614843|NCT00564889|42064045|FG000|Overall Study|Other, not specified|4|||
19614844|NCT04143594|42064053|FG000|Overall Study|Still on study|48|||
19614845|NCT04143594|42064054|FG001|Overall Study|Still on study|42|||
19502972|NCT02073279|41881140|FG001|Open-label Extension Period|Protocol Violation|1|||
19614846|NCT04143594|42064055|FG002|Overall Study|Still on study|48|||
19502973|NCT02073279|41881139|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
19502974|NCT02073279|41881140|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
19502975|NCT02073279|41881139|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
19502976|NCT02073279|41881140|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
19502977|NCT01673867|41881396|FG000|Randomization|Adverse event unrelated to study drug|1|||
19502978|NCT01673867|41881397|FG001|Randomization|Adverse event unrelated to study drug|0|||
19502979|NCT01673867|41881396|FG000|Randomization|Participant request to discontinue study treatment|0|||
19502980|NCT01673867|41881397|FG001|Randomization|Participant request to discontinue study treatment|4|||
19502981|NCT01673867|41881396|FG000|Randomization|Withdrawal by participant|0|||
19502982|NCT01673867|41881397|FG001|Randomization|Withdrawal by participant|12|||
19502983|NCT01673867|41881396|FG000|Randomization|Lost to Follow-up|0|||
19502984|NCT01673867|41881397|FG001|Randomization|Lost to Follow-up|1|||
19502985|NCT01673867|41881396|FG000|Randomization|Participant no longer meets study criteria|4|||
19502986|NCT01673867|41881397|FG001|Randomization|Participant no longer meets study criteria|5|||
19502987|NCT01673867|41881396|FG000|Treatment|Disease Progression|208|||
19502988|NCT01673867|41881397|FG001|Treatment|Disease Progression|178|||
19502989|NCT01673867|41881396|FG000|Treatment|Study Drug Toxicity|23|||
19502990|NCT01673867|41881397|FG001|Treatment|Study Drug Toxicity|43|||
19502991|NCT01673867|41881396|FG000|Treatment|Death|2|||
19502992|NCT01673867|41881397|FG001|Treatment|Death|3|||
19502993|NCT01673867|41881396|FG000|Treatment|Adverse event unrelated to study drug|23|||
19502994|NCT01673867|41881397|FG001|Treatment|Adverse event unrelated to study drug|10|||
19502995|NCT01673867|41881396|FG000|Treatment|Participant request to discontinue study treatment|7|||
19502996|NCT01673867|41881397|FG001|Treatment|Participant request to discontinue study treatment|17|||
19502997|NCT01673867|41881396|FG000|Treatment|Withdrawal by participant|5|||
19502998|NCT01673867|41881397|FG001|Treatment|Withdrawal by participant|5|||
19502999|NCT01673867|41881396|FG000|Treatment|Maximum clinical benefit|1|||
19503000|NCT01673867|41881397|FG001|Treatment|Maximum clinical benefit|10|||
19503001|NCT01673867|41881396|FG000|Treatment|Participant no longer meets study criteria|2|||
19503002|NCT01673867|41881397|FG001|Treatment|Participant no longer meets study criteria|0|||
19503003|NCT01673867|41881396|FG000|Treatment|Administrative reason by sponsor|3|||
19503004|NCT01673867|41881397|FG001|Treatment|Administrative reason by sponsor|0|||
19503005|NCT01673867|41881396|FG000|Treatment|Other reason|11|||
19503006|NCT01673867|41881397|FG001|Treatment|Other reason|2|||
19503007|NCT02041533|41881493|FG000|Pre-Treatment Period|Disease Progression|1|||
19503008|NCT02041533|41881494|FG001|Pre-Treatment Period|Disease Progression|1|||
19503009|NCT02041533|41881493|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
19503010|NCT02041533|41881494|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
19503011|NCT02041533|41881493|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
19503012|NCT02041533|41881494|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
19503013|NCT02041533|41881493|FG000|Treatment Period|Disease progression|189|||
19503014|NCT02041533|41881494|FG001|Treatment Period|Disease progression|146|||
19503015|NCT02041533|41881493|FG000|Treatment Period|Study drug toxicity|30|||
19503016|NCT02041533|41881494|FG001|Treatment Period|Study drug toxicity|34|||
19503017|NCT02041533|41881493|FG000|Treatment Period|Death|1|||
19503018|NCT02041533|41881494|FG001|Treatment Period|Death|0|||
19503019|NCT02041533|41881493|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
19503020|NCT02041533|41881494|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
19503021|NCT02041533|41881493|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
19503022|NCT02041533|41881494|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
19503023|NCT02041533|41881493|FG000|Treatment Period|Participant withdrew consent|2|||
19614847|NCT04143594|42064056|FG003|Overall Study|Still on study|18|||
19614848|NCT04143594|42064053|FG000|Overall Study|Withdrew consent|0|||
19614849|NCT04143594|42064054|FG001|Overall Study|Withdrew consent|6|||
19614850|NCT04143594|42064055|FG002|Overall Study|Withdrew consent|1|||
19503024|NCT02041533|41881494|FG001|Treatment Period|Participant withdrew consent|2|||
19503025|NCT02041533|41881493|FG000|Treatment Period|Maximum clinical benefit|0|||
19614851|NCT04143594|42064056|FG003|Overall Study|Withdrew consent|1|||
19614852|NCT04143594|42064053|FG000|Overall Study|Lost to Follow-up|2|||
19503026|NCT02041533|41881494|FG001|Treatment Period|Maximum clinical benefit|18|||
19503027|NCT02041533|41881493|FG000|Treatment Period|Poor/Non-compliance|1|||
19503028|NCT02041533|41881494|FG001|Treatment Period|Poor/Non-compliance|0|||
19503029|NCT02041533|41881493|FG000|Treatment Period|Administrative reason by sponsor|1|||
19503030|NCT02041533|41881494|FG001|Treatment Period|Administrative reason by sponsor|0|||
19503031|NCT02041533|41881493|FG000|Treatment Period|Other reasons|9|||
19614853|NCT04143594|42064054|FG001|Overall Study|Lost to Follow-up|2|||
19614854|NCT04143594|42064055|FG002|Overall Study|Lost to Follow-up|3|||
19373722|NCT02665455|41614920|FG000|Overall Study|Withdrawal by Subject|6|||
19373723|NCT02665455|41614920|FG000|Overall Study|Lost to Follow-up|1|||
19373724|NCT02665455|41614920|FG000|Overall Study|Adverse Event|1|||
19373725|NCT02665455|41614920|FG000|Overall Study|Protocol Violation|1|||
19614855|NCT04143594|42064056|FG003|Overall Study|Lost to Follow-up|0|||
19373726|NCT02755805|41614926|FG000|Overall Study|Lost to Follow-up|1|||
19373727|NCT02755805|41614927|FG001|Overall Study|Lost to Follow-up|2|||
19373728|NCT02755805|41614926|FG000|Overall Study|Refused assessments|1|||
19373729|NCT02755805|41614927|FG001|Overall Study|Refused assessments|0|||
19373730|NCT02755805|41614926|FG000|Overall Study|Withdrawal by Subject|0|||
19503032|NCT02041533|41881494|FG001|Treatment Period|Other reasons|2|||
19503033|NCT02041533|41881493|FG000|Treatment Period|Not Reported|0|||
19503034|NCT02041533|41881494|FG001|Treatment Period|Not Reported|1|||
19503035|NCT02907203|41881501|FG000|Overall Study|Death|1|||
19503036|NCT02907203|41881501|FG000|Overall Study|Lost to Follow-up|3|||
19503037|NCT02907203|41881501|FG000|Overall Study|Withdrawal by Subject|3|||
19503038|NCT02907203|41881501|FG000|Overall Study|Surgical bypass|1|||
19503039|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
19503040|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
19503041|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
19503042|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
19503043|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
19503044|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
19503045|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
19503046|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
19503047|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Death|1|||
19503048|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Death|1|||
19503049|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
19503050|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
19503051|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
19503052|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
19503053|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
19503054|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
19503055|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
19503056|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
19503057|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
19503058|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
19503059|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
19503060|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
19503061|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
19503062|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
19503063|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
19503064|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
19503065|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
19503066|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
19503067|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
19503068|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
19503069|NCT00559585|41882685|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
19503070|NCT00559585|41882686|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
19503071|NCT00559585|41882685|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
19503072|NCT00559585|41882686|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
19503073|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
19503074|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
19503075|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
19503076|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
19503077|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
19503078|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
19503079|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
19503080|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
19503081|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
19503082|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
19503083|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
19503084|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
19503085|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
19503086|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
19503087|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
19503088|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
19503089|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
19503090|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
19503091|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
19503092|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
19373731|NCT02755805|41614927|FG001|Overall Study|Withdrawal by Subject|2|||
19503093|NCT00559585|41882685|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
19503094|NCT00559585|41882686|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
19503095|NCT00559507|41882726|FG000|Overall Study|Not treated, patient ineligible|3|||
19503096|NCT00559273|41882994|FG000|Correction Period (20 Weeks)|Death|3|||
19503097|NCT00559273|41882995|FG001|Correction Period (20 Weeks)|Death|4|||
19503098|NCT00559273|41882994|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
19503099|NCT00559273|41882995|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
19503100|NCT00559273|41882994|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
19503101|NCT00559273|41882995|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
19503102|NCT00559273|41882994|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
19503103|NCT00559273|41882995|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
19503104|NCT00559273|41882994|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
19503105|NCT00559273|41882995|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
19503106|NCT00559273|41882994|FG000|Evaluation Period (8 Weeks)|Death|1|||
19503107|NCT00559273|41882995|FG001|Evaluation Period (8 Weeks)|Death|3|||
19503108|NCT00559273|41882994|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
19503109|NCT00559273|41882995|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
19503110|NCT00559273|41882994|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
19503111|NCT00559273|41882995|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
19503112|NCT00559273|41882994|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
19503113|NCT00559273|41882995|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
19503114|NCT00558259|41883050|FG000|Overall Study|Adverse Event|50|||
19503115|NCT00558259|41883051|FG001|Overall Study|Adverse Event|81|||
19503116|NCT00558259|41883050|FG000|Overall Study|Protocol Violation|9|||
19503117|NCT00558259|41883051|FG001|Overall Study|Protocol Violation|5|||
19503118|NCT00558259|41883050|FG000|Overall Study|Withdrawal by Subject|12|||
19503119|NCT00558259|41883051|FG001|Overall Study|Withdrawal by Subject|13|||
19503120|NCT00558103|41883198|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
19503121|NCT00558103|41883199|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
19503122|NCT00558103|41883200|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
19503123|NCT00558103|41883201|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
19503124|NCT00558103|41883202|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
19503125|NCT00558103|41883203|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
19503126|NCT00558103|41883198|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
19503127|NCT00558103|41883199|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
19503128|NCT00558103|41883200|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
19503129|NCT00558103|41883201|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
19503130|NCT00558103|41883202|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
19503131|NCT00558103|41883203|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
19503132|NCT00558103|41883198|FG000|Randomized Treatment Phase|Disease Progression|1|||
19503133|NCT00558103|41883199|FG001|Randomized Treatment Phase|Disease Progression|0|||
19503134|NCT00558103|41883200|FG002|Randomized Treatment Phase|Disease Progression|1|||
19503135|NCT00558103|41883201|FG003|Randomized Treatment Phase|Disease Progression|0|||
19503136|NCT00558103|41883202|FG004|Randomized Treatment Phase|Disease Progression|0|||
19503137|NCT00558103|41883203|FG005|Randomized Treatment Phase|Disease Progression|0|||
19503138|NCT00558103|41883198|FG000|Randomized Treatment Phase|Adverse Event|0|||
19503139|NCT00558103|41883199|FG001|Randomized Treatment Phase|Adverse Event|0|||
19503140|NCT00558103|41883200|FG002|Randomized Treatment Phase|Adverse Event|0|||
19503141|NCT00558103|41883201|FG003|Randomized Treatment Phase|Adverse Event|1|||
19503142|NCT00558103|41883202|FG004|Randomized Treatment Phase|Adverse Event|1|||
19503143|NCT00558103|41883203|FG005|Randomized Treatment Phase|Adverse Event|0|||
19503144|NCT00558103|41883198|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
19503145|NCT00558103|41883199|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
19503146|NCT00558103|41883200|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
19503147|NCT00558103|41883201|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
19503148|NCT00558103|41883202|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
19503149|NCT00558103|41883203|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
19503150|NCT00558103|41883198|FG000|Monotherapy Extension Phase|Disease Progression|0|||
19503151|NCT00558103|41883199|FG001|Monotherapy Extension Phase|Disease Progression|0|||
19503152|NCT00558103|41883200|FG002|Monotherapy Extension Phase|Disease Progression|0|||
19503153|NCT00558103|41883201|FG003|Monotherapy Extension Phase|Disease Progression|0|||
19503154|NCT00558103|41883202|FG004|Monotherapy Extension Phase|Disease Progression|0|||
19503155|NCT00558103|41883203|FG005|Monotherapy Extension Phase|Disease Progression|8|||
19503156|NCT00558025|41883240|FG000|Overall Study|Adverse Event|1|||
19503157|NCT00558025|41883241|FG001|Overall Study|Adverse Event|1|||
19503158|NCT00558025|41883240|FG000|Overall Study|Withdrawal by Subject|2|||
19503159|NCT00558025|41883241|FG001|Overall Study|Withdrawal by Subject|2|||
19503160|NCT00558025|41883240|FG000|Overall Study|Protocol Violation|1|||
19503161|NCT00558025|41883241|FG001|Overall Study|Protocol Violation|0|||
19503162|NCT00557323|41883294|FG000|Overall Study|Death|3|||
19503163|NCT00557323|41883294|FG000|Overall Study|Withdrawal by Subject|2|||
19503164|NCT00557323|41883294|FG000|Overall Study|Administrative change|2|||
19503165|NCT00557245|41883328|FG000|Overall Study|Lost to Follow-up|7|||
19503166|NCT00557245|41883329|FG001|Overall Study|Lost to Follow-up|8|||
19503167|NCT00557245|41883330|FG002|Overall Study|Lost to Follow-up|10|||
19503168|NCT00557245|41883328|FG000|Overall Study|Ineligible|5|||
19503169|NCT00557245|41883329|FG001|Overall Study|Ineligible|4|||
19503170|NCT00557245|41883330|FG002|Overall Study|Ineligible|2|||
19503171|NCT00556075|41883391|FG000|Overall Study|Lost to Follow-up|3|||
19503172|NCT00556075|41883392|FG001|Overall Study|Lost to Follow-up|0|||
19503173|NCT00556075|41883393|FG002|Overall Study|Lost to Follow-up|3|||
19503174|NCT00556075|41883391|FG000|Overall Study|Withdrawal by Subject|3|||
19503175|NCT00556075|41883392|FG001|Overall Study|Withdrawal by Subject|3|||
19503176|NCT00556075|41883393|FG002|Overall Study|Withdrawal by Subject|0|||
19503177|NCT00556075|41883391|FG000|Overall Study|Protocol Violation|1|||
19503178|NCT00556075|41883392|FG001|Overall Study|Protocol Violation|1|||
19503179|NCT00556075|41883393|FG002|Overall Study|Protocol Violation|3|||
19503180|NCT00556075|41883391|FG000|Overall Study|Not eligible|1|||
19503181|NCT00556075|41883392|FG001|Overall Study|Not eligible|1|||
19503182|NCT00556075|41883393|FG002|Overall Study|Not eligible|2|||
19503183|NCT00556075|41883391|FG000|Overall Study|Adverse Event|1|||
19503184|NCT00556075|41883392|FG001|Overall Study|Adverse Event|2|||
19503185|NCT00556075|41883393|FG002|Overall Study|Adverse Event|0|||
19503186|NCT00556075|41883391|FG000|Overall Study|Personal issues|4|||
19503187|NCT00556075|41883392|FG001|Overall Study|Personal issues|1|||
19503188|NCT00556075|41883393|FG002|Overall Study|Personal issues|0|||
19503189|NCT00556075|41883391|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
19503190|NCT00556075|41883392|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
19503191|NCT00556075|41883393|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
19503192|NCT00555061|41883414|FG000|Overall Study|Adverse Event|3|||
19503193|NCT00555061|41883414|FG000|Overall Study|Protocol Violation|1|||
19503194|NCT00555061|41883414|FG000|Overall Study|Lost to Follow-up|2|||
19503195|NCT00555061|41883414|FG000|Overall Study|Withdrawal by Subject|2|||
19503196|NCT00555061|41883414|FG000|Overall Study|Participant enrolled, but never treated|1|||
19503197|NCT02289690|41883428|FG000|Overall Study|Adverse Event Related to Progression|0|||
19503198|NCT02289690|41883429|FG001|Overall Study|Adverse Event Related to Progression|1|||
19503199|NCT02289690|41883430|FG002|Overall Study|Adverse Event Related to Progression|1|||
19503200|NCT02289690|41883431|FG003|Overall Study|Adverse Event Related to Progression|0|||
19503201|NCT02289690|41883432|FG004|Overall Study|Adverse Event Related to Progression|1|||
19503202|NCT02289690|41883433|FG005|Overall Study|Adverse Event Related to Progression|0|||
19503203|NCT02289690|41883434|FG006|Overall Study|Adverse Event Related to Progression|1|||
19503204|NCT02289690|41883435|FG007|Overall Study|Adverse Event Related to Progression|0|||
19503205|NCT02289690|41883436|FG008|Overall Study|Adverse Event Related to Progression|0|||
19503206|NCT02289690|41883437|FG009|Overall Study|Adverse Event Related to Progression|0|||
19503207|NCT02289690|41883428|FG000|Overall Study|Withdrawal by Subject|1|||
19503208|NCT02289690|41883429|FG001|Overall Study|Withdrawal by Subject|0|||
19503209|NCT02289690|41883430|FG002|Overall Study|Withdrawal by Subject|0|||
19503210|NCT02289690|41883431|FG003|Overall Study|Withdrawal by Subject|0|||
19503211|NCT02289690|41883432|FG004|Overall Study|Withdrawal by Subject|1|||
19503212|NCT02289690|41883433|FG005|Overall Study|Withdrawal by Subject|1|||
19503213|NCT02289690|41883434|FG006|Overall Study|Withdrawal by Subject|0|||
19503214|NCT02289690|41883435|FG007|Overall Study|Withdrawal by Subject|0|||
19503215|NCT02289690|41883436|FG008|Overall Study|Withdrawal by Subject|4|||
19503216|NCT02289690|41883437|FG009|Overall Study|Withdrawal by Subject|2|||
19503217|NCT02289690|41883428|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
19503218|NCT02289690|41883429|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
19503219|NCT02289690|41883430|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
19503220|NCT02289690|41883431|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
19503221|NCT02289690|41883432|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
19503222|NCT02289690|41883433|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
19503223|NCT02289690|41883434|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
19503224|NCT02289690|41883435|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
19503225|NCT02289690|41883436|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
19503226|NCT02289690|41883437|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
19503227|NCT02289690|41883428|FG000|Overall Study|Lost to Follow-up|0|||
19503228|NCT02289690|41883429|FG001|Overall Study|Lost to Follow-up|0|||
19503229|NCT02289690|41883430|FG002|Overall Study|Lost to Follow-up|0|||
19503230|NCT02289690|41883431|FG003|Overall Study|Lost to Follow-up|0|||
19503231|NCT02289690|41883432|FG004|Overall Study|Lost to Follow-up|0|||
19503232|NCT02289690|41883433|FG005|Overall Study|Lost to Follow-up|0|||
19503233|NCT02289690|41883434|FG006|Overall Study|Lost to Follow-up|0|||
19503234|NCT02289690|41883435|FG007|Overall Study|Lost to Follow-up|1|||
19503235|NCT02289690|41883436|FG008|Overall Study|Lost to Follow-up|0|||
19503236|NCT02289690|41883437|FG009|Overall Study|Lost to Follow-up|2|||
19503237|NCT02289690|41883428|FG000|Overall Study|Death|0|||
19503238|NCT02289690|41883429|FG001|Overall Study|Death|0|||
19503239|NCT02289690|41883430|FG002|Overall Study|Death|0|||
19503240|NCT02289690|41883431|FG003|Overall Study|Death|0|||
19503241|NCT02289690|41883432|FG004|Overall Study|Death|0|||
19503242|NCT02289690|41883433|FG005|Overall Study|Death|0|||
19503243|NCT02289690|41883434|FG006|Overall Study|Death|0|||
19503244|NCT02289690|41883435|FG007|Overall Study|Death|49|||
19503245|NCT02289690|41883436|FG008|Overall Study|Death|45|||
19503246|NCT02289690|41883437|FG009|Overall Study|Death|41|||
19503247|NCT02289690|41883428|FG000|Overall Study|Sponsor Discontinued Study|0|||
19503248|NCT02289690|41883429|FG001|Overall Study|Sponsor Discontinued Study|0|||
19503249|NCT02289690|41883430|FG002|Overall Study|Sponsor Discontinued Study|0|||
19503250|NCT02289690|41883431|FG003|Overall Study|Sponsor Discontinued Study|0|||
19503251|NCT02289690|41883432|FG004|Overall Study|Sponsor Discontinued Study|0|||
19503252|NCT02289690|41883433|FG005|Overall Study|Sponsor Discontinued Study|0|||
19503253|NCT02289690|41883434|FG006|Overall Study|Sponsor Discontinued Study|0|||
19503254|NCT02289690|41883435|FG007|Overall Study|Sponsor Discontinued Study|9|||
19503255|NCT02289690|41883436|FG008|Overall Study|Sponsor Discontinued Study|7|||
19503256|NCT02289690|41883437|FG009|Overall Study|Sponsor Discontinued Study|15|||
19503257|NCT02289690|41883428|FG000|Overall Study|Other|0|||
19503258|NCT02289690|41883429|FG001|Overall Study|Other|0|||
19503259|NCT02289690|41883430|FG002|Overall Study|Other|0|||
19503260|NCT02289690|41883431|FG003|Overall Study|Other|1|||
19503261|NCT02289690|41883432|FG004|Overall Study|Other|1|||
19503262|NCT02289690|41883433|FG005|Overall Study|Other|0|||
19503263|NCT02289690|41883434|FG006|Overall Study|Other|1|||
19503264|NCT02289690|41883435|FG007|Overall Study|Other|2|||
19503265|NCT02289690|41883436|FG008|Overall Study|Other|3|||
19503266|NCT02289690|41883437|FG009|Overall Study|Other|1|||
19503267|NCT02289456|41883540|FG000|Induction Period|Death|2|||
19503268|NCT02289456|41883540|FG000|Induction Period|Adverse Event|11|||
19503269|NCT02289456|41883540|FG000|Induction Period|Progressive Disease (PD)|4|||
19503270|NCT02289456|41883540|FG000|Induction Period|Symptomatic Deterioration|4|||
19503271|NCT02289456|41883540|FG000|Induction Period|Withdrawal by Subject|2|||
19503272|NCT02289456|41883540|FG000|Induction Period|Miscellaneous|1|||
19503273|NCT02289456|41883540|FG000|Monotherapy Period|Death|1|||
19503274|NCT02289456|41883540|FG000|Monotherapy Period|Adverse Event|1|||
19503275|NCT02289456|41883540|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
19503276|NCT02289456|41883540|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
19503277|NCT02289456|41883540|FG000|Monotherapy Period|Withdrawal by Subject|2|||
19503278|NCT02289456|41883540|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
19503279|NCT02289456|41883540|FG000|Monotherapy Period|Miscellaneous|1|||
19503280|NCT02274948|41883589|FG000|Overall Study|Lost to Follow-up|28|||
19503281|NCT02274948|41883590|FG001|Overall Study|Lost to Follow-up|25|||
19503282|NCT02274948|41883589|FG000|Overall Study|Withdrawal by Subject|64|||
19503283|NCT02274948|41883590|FG001|Overall Study|Withdrawal by Subject|58|||
19503284|NCT02274948|41883589|FG000|Overall Study|Stopped on family Practitioner advice|2|||
19503285|NCT02274948|41883590|FG001|Overall Study|Stopped on family Practitioner advice|5|||
19503286|NCT02274948|41883589|FG000|Overall Study|Left the area|4|||
19503287|NCT02274948|41883590|FG001|Overall Study|Left the area|3|||
19503288|NCT02274792|41883606|FG000|Overall Study|Withdrawal by Subject|13|||
19503289|NCT02274792|41883606|FG000|Overall Study|Lost to Follow-up|8|||
19503290|NCT02274792|41883606|FG000|Overall Study|Protocol Specified Criteria|2|||
19503291|NCT02274792|41883606|FG000|Overall Study|Sponsor Decision|2|||
19503292|NCT02274558|41883636|FG000|Overall Study|Adverse Event|2|||
19503293|NCT02274558|41883637|FG001|Overall Study|Adverse Event|4|||
19503294|NCT02274558|41883638|FG002|Overall Study|Adverse Event|2|||
19503295|NCT02274558|41883636|FG000|Overall Study|Non-compliance|2|||
19503296|NCT02274558|41883637|FG001|Overall Study|Non-compliance|1|||
19503297|NCT02274558|41883638|FG002|Overall Study|Non-compliance|0|||
19503298|NCT02274558|41883636|FG000|Overall Study|Withdrawal by Subject|1|||
19503299|NCT02274558|41883637|FG001|Overall Study|Withdrawal by Subject|5|||
19503300|NCT02274558|41883638|FG002|Overall Study|Withdrawal by Subject|4|||
19503301|NCT02274558|41883636|FG000|Overall Study|Death|0|||
19503302|NCT02274558|41883637|FG001|Overall Study|Death|0|||
19503303|NCT02274558|41883638|FG002|Overall Study|Death|1|||
19503304|NCT02274558|41883636|FG000|Overall Study|Lost to Follow-up|2|||
19503305|NCT02274558|41883637|FG001|Overall Study|Lost to Follow-up|1|||
19503306|NCT02274558|41883638|FG002|Overall Study|Lost to Follow-up|1|||
19503307|NCT02274558|41883636|FG000|Overall Study|Physician Decision|0|||
19503308|NCT02274558|41883637|FG001|Overall Study|Physician Decision|2|||
19503309|NCT02274558|41883638|FG002|Overall Study|Physician Decision|1|||
19503310|NCT02287896|41883655|FG000|Second Injection Visit|Withdrawal by Subject|0|||
19503311|NCT02287896|41883656|FG001|Second Injection Visit|Withdrawal by Subject|1|||
19503312|NCT00553501|41883714|FG000|Overall Study|Adverse Event|2|||
19503313|NCT00553501|41883714|FG000|Overall Study|Death|1|||
19503314|NCT00553501|41883714|FG000|Overall Study|Progression|1|||
19503315|NCT02287584|41883742|FG000|the Double-blind Phase|Adverse Event|17|||
19503316|NCT02287584|41883743|FG001|the Double-blind Phase|Adverse Event|17|||
19503317|NCT02287584|41883744|FG002|the Double-blind Phase|Adverse Event|12|||
19503318|NCT02287584|41883745|FG003|the Double-blind Phase|Adverse Event|0|||
19503319|NCT02287584|41883746|FG004|the Double-blind Phase|Adverse Event|0|||
19503320|NCT02287584|41883747|FG005|the Double-blind Phase|Adverse Event|0|||
19503321|NCT02287584|41883742|FG000|the Double-blind Phase|Lack of Efficacy|18|||
19503322|NCT02287584|41883743|FG001|the Double-blind Phase|Lack of Efficacy|8|||
19503323|NCT02287584|41883744|FG002|the Double-blind Phase|Lack of Efficacy|8|||
19503324|NCT02287584|41883745|FG003|the Double-blind Phase|Lack of Efficacy|0|||
19503325|NCT02287584|41883746|FG004|the Double-blind Phase|Lack of Efficacy|0|||
19503326|NCT02287584|41883747|FG005|the Double-blind Phase|Lack of Efficacy|0|||
19503327|NCT02287584|41883742|FG000|the Double-blind Phase|Lost to Follow-up|0|||
19503328|NCT02287584|41883743|FG001|the Double-blind Phase|Lost to Follow-up|1|||
19503329|NCT02287584|41883744|FG002|the Double-blind Phase|Lost to Follow-up|1|||
19503330|NCT02287584|41883745|FG003|the Double-blind Phase|Lost to Follow-up|0|||
19503331|NCT02287584|41883746|FG004|the Double-blind Phase|Lost to Follow-up|0|||
19503332|NCT02287584|41883747|FG005|the Double-blind Phase|Lost to Follow-up|0|||
19503333|NCT02287584|41883742|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
19503334|NCT02287584|41883743|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
19503335|NCT02287584|41883744|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
19503336|NCT02287584|41883745|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
19503337|NCT02287584|41883746|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
19503338|NCT02287584|41883747|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
19503339|NCT02287584|41883742|FG000|the Double-blind Phase|Pregnancy|0|||
19503340|NCT02287584|41883743|FG001|the Double-blind Phase|Pregnancy|1|||
19503341|NCT02287584|41883744|FG002|the Double-blind Phase|Pregnancy|0|||
19503342|NCT02287584|41883745|FG003|the Double-blind Phase|Pregnancy|0|||
19503343|NCT02287584|41883746|FG004|the Double-blind Phase|Pregnancy|0|||
19503344|NCT02287584|41883747|FG005|the Double-blind Phase|Pregnancy|0|||
19503345|NCT02287584|41883742|FG000|the Double-blind Phase|Protocol Violation|0|||
19503346|NCT02287584|41883743|FG001|the Double-blind Phase|Protocol Violation|3|||
19503347|NCT02287584|41883744|FG002|the Double-blind Phase|Protocol Violation|0|||
19503348|NCT02287584|41883745|FG003|the Double-blind Phase|Protocol Violation|0|||
19503349|NCT02287584|41883746|FG004|the Double-blind Phase|Protocol Violation|0|||
19503350|NCT02287584|41883747|FG005|the Double-blind Phase|Protocol Violation|0|||
19503351|NCT02287584|41883742|FG000|the Double-blind Phase|other reasons|0|||
19503352|NCT02287584|41883743|FG001|the Double-blind Phase|other reasons|0|||
19503353|NCT02287584|41883744|FG002|the Double-blind Phase|other reasons|1|||
19503354|NCT02287584|41883745|FG003|the Double-blind Phase|other reasons|0|||
19503355|NCT02287584|41883746|FG004|the Double-blind Phase|other reasons|0|||
19503356|NCT02287584|41883747|FG005|the Double-blind Phase|other reasons|0|||
19503357|NCT02287584|41883742|FG000|the Open-label Phase|Did not receive drug|0|||
19503358|NCT02287584|41883743|FG001|the Open-label Phase|Did not receive drug|0|||
19503359|NCT02287584|41883744|FG002|the Open-label Phase|Did not receive drug|0|||
19503360|NCT02287584|41883745|FG003|the Open-label Phase|Did not receive drug|7|||
19503361|NCT02287584|41883746|FG004|the Open-label Phase|Did not receive drug|6|||
19503362|NCT02287584|41883747|FG005|the Open-label Phase|Did not receive drug|4|||
19503363|NCT02287584|41883742|FG000|the Open-label Phase|Adverse Event|0|||
19503364|NCT02287584|41883743|FG001|the Open-label Phase|Adverse Event|0|||
19503365|NCT02287584|41883744|FG002|the Open-label Phase|Adverse Event|0|||
19503366|NCT02287584|41883745|FG003|the Open-label Phase|Adverse Event|15|||
19503367|NCT02287584|41883746|FG004|the Open-label Phase|Adverse Event|12|||
19503368|NCT02287584|41883747|FG005|the Open-label Phase|Adverse Event|16|||
19503369|NCT02287584|41883742|FG000|the Open-label Phase|Lack of Efficacy|0|||
19503370|NCT02287584|41883743|FG001|the Open-label Phase|Lack of Efficacy|0|||
19503371|NCT02287584|41883744|FG002|the Open-label Phase|Lack of Efficacy|0|||
19503372|NCT02287584|41883745|FG003|the Open-label Phase|Lack of Efficacy|8|||
19503373|NCT02287584|41883746|FG004|the Open-label Phase|Lack of Efficacy|3|||
19503374|NCT02287584|41883747|FG005|the Open-label Phase|Lack of Efficacy|7|||
19503375|NCT02287584|41883742|FG000|the Open-label Phase|Lost to Follow-up|0|||
19503376|NCT02287584|41883743|FG001|the Open-label Phase|Lost to Follow-up|0|||
19503377|NCT02287584|41883744|FG002|the Open-label Phase|Lost to Follow-up|0|||
19503378|NCT02287584|41883745|FG003|the Open-label Phase|Lost to Follow-up|4|||
19503379|NCT02287584|41883746|FG004|the Open-label Phase|Lost to Follow-up|1|||
19503380|NCT02287584|41883747|FG005|the Open-label Phase|Lost to Follow-up|2|||
19503381|NCT02287584|41883742|FG000|the Open-label Phase|Withdrawal by Subject|0|||
19503382|NCT02287584|41883743|FG001|the Open-label Phase|Withdrawal by Subject|0|||
19503383|NCT02287584|41883744|FG002|the Open-label Phase|Withdrawal by Subject|0|||
19704455|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
19704456|NCT00159822|42148805|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
19503384|NCT02287584|41883745|FG003|the Open-label Phase|Withdrawal by Subject|18|||
19704457|NCT00159822|42148805|FG000|Post-treatment Follow-up Period|Death|1|||
19503385|NCT02287584|41883746|FG004|the Open-label Phase|Withdrawal by Subject|29|||
19503386|NCT02287584|41883747|FG005|the Open-label Phase|Withdrawal by Subject|21|||
19503387|NCT02287584|41883742|FG000|the Open-label Phase|non-compliance|0|||
19503388|NCT02287584|41883743|FG001|the Open-label Phase|non-compliance|0|||
19503389|NCT02287584|41883744|FG002|the Open-label Phase|non-compliance|0|||
19503390|NCT02287584|41883745|FG003|the Open-label Phase|non-compliance|2|||
19503391|NCT02287584|41883746|FG004|the Open-label Phase|non-compliance|5|||
19503392|NCT02287584|41883747|FG005|the Open-label Phase|non-compliance|1|||
19503393|NCT02287584|41883742|FG000|the Open-label Phase|other reasons|0|||
19614856|NCT04143594|42064053|FG000|Overall Study|Investigator's discretion|1|||
19614857|NCT04143594|42064054|FG001|Overall Study|Investigator's discretion|2|||
19614858|NCT04143594|42064055|FG002|Overall Study|Investigator's discretion|0|||
19614859|NCT04143594|42064056|FG003|Overall Study|Investigator's discretion|0|||
19614860|NCT04143594|42064053|FG000|Overall Study|Lack of Efficacy|0|||
19614861|NCT04143594|42064054|FG001|Overall Study|Lack of Efficacy|1|||
19614862|NCT04143594|42064055|FG002|Overall Study|Lack of Efficacy|0|||
19614863|NCT04143594|42064056|FG003|Overall Study|Lack of Efficacy|0|||
19503394|NCT02287584|41883743|FG001|the Open-label Phase|other reasons|0|||
19503395|NCT02287584|41883744|FG002|the Open-label Phase|other reasons|0|||
19503396|NCT02287584|41883745|FG003|the Open-label Phase|other reasons|3|||
19503397|NCT02287584|41883746|FG004|the Open-label Phase|other reasons|6|||
19503398|NCT02287584|41883747|FG005|the Open-label Phase|other reasons|6|||
19503399|NCT00553267|41883780|FG000|Overall Study|Adverse Event|8|||
19503400|NCT00553267|41883781|FG001|Overall Study|Adverse Event|10|||
19503401|NCT00553267|41883782|FG002|Overall Study|Adverse Event|5|||
19503402|NCT00553267|41883780|FG000|Overall Study|Non compliant with protocol|3|||
19503403|NCT00553267|41883781|FG001|Overall Study|Non compliant with protocol|3|||
19503404|NCT00553267|41883782|FG002|Overall Study|Non compliant with protocol|2|||
19503405|NCT00553267|41883780|FG000|Overall Study|Lost to Follow-up|0|||
19503406|NCT00553267|41883781|FG001|Overall Study|Lost to Follow-up|0|||
19503407|NCT00553267|41883782|FG002|Overall Study|Lost to Follow-up|1|||
19503408|NCT00553267|41883780|FG000|Overall Study|Consent withdrawn|2|||
19503409|NCT00553267|41883781|FG001|Overall Study|Consent withdrawn|3|||
19503410|NCT00553267|41883782|FG002|Overall Study|Consent withdrawn|1|||
19503411|NCT00553267|41883780|FG000|Overall Study|Specified category|1|||
19503412|NCT00553267|41883781|FG001|Overall Study|Specified category|2|||
19503413|NCT00553267|41883782|FG002|Overall Study|Specified category|1|||
19503414|NCT02271984|41883796|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503415|NCT02271984|41883797|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503416|NCT02271984|41883798|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503417|NCT02271984|41883799|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503418|NCT02271984|41883800|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503419|NCT02271984|41883801|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
19503420|NCT02271984|41883802|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503421|NCT02271984|41883803|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
19503422|NCT02271984|41883804|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503423|NCT02271984|41883805|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503424|NCT02271984|41883806|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503425|NCT02271984|41883807|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
19503426|NCT02287038|41883858|FG000|Overall Study|Stopped attending appointments|3|||
19503427|NCT02287038|41883859|FG001|Overall Study|Stopped attending appointments|2|||
19503428|NCT02287038|41883858|FG000|Overall Study|Anxiety after starting medication|0|||
19614864|NCT04143594|42064053|FG000|Overall Study|Protocol Violation|0|||
19614865|NCT04143594|42064054|FG001|Overall Study|Protocol Violation|0|||
19614866|NCT04143594|42064055|FG002|Overall Study|Protocol Violation|0|||
19614867|NCT04143594|42064056|FG003|Overall Study|Protocol Violation|1|||
19614868|NCT00560833|42064083|FG000|Overall Study|Adverse Event|16|||
19503429|NCT02287038|41883859|FG001|Overall Study|Anxiety after starting medication|1|||
19503430|NCT02287038|41883858|FG000|Overall Study|Nausea after starting medication|1|||
19503431|NCT02287038|41883859|FG001|Overall Study|Nausea after starting medication|0|||
19503432|NCT02287038|41883858|FG000|Overall Study|Abnormal ECG after starting medication|1|||
19503433|NCT02287038|41883859|FG001|Overall Study|Abnormal ECG after starting medication|0|||
19503434|NCT02286960|41883869|FG000|Overall Study|Lost to Follow-up|3|||
19503435|NCT02286960|41883870|FG001|Overall Study|Lost to Follow-up|3|||
19503436|NCT02286102|41883887|FG000|Overall Study|Screen Failure|1|||
19503437|NCT02286102|41883888|FG001|Overall Study|Screen Failure|1|||
19503438|NCT02285166|41883894|FG000|Overall Study|Case Report Forms Uncollected|564|||
19503439|NCT02285166|41883894|FG000|Overall Study|Protocol Deviation|402|||
19503440|NCT01642212|41883971|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
19503441|NCT01642212|41883972|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
19503442|NCT01642212|41883973|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
19503443|NCT01642212|41883974|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
19503444|NCT01642212|41883975|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
19503445|NCT01642212|41883971|FG000|Double-blind Treatment|Other|0|||
19503446|NCT01642212|41883972|FG001|Double-blind Treatment|Other|2|||
19503447|NCT01642212|41883973|FG002|Double-blind Treatment|Other|1|||
19503448|NCT01642212|41883974|FG003|Double-blind Treatment|Other|0|||
19614869|NCT00560833|42064084|FG001|Overall Study|Adverse Event|10|||
19614870|NCT00560833|42064085|FG002|Overall Study|Adverse Event|25|||
19614871|NCT00560833|42064086|FG003|Overall Study|Adverse Event|23|||
19503449|NCT01642212|41883975|FG004|Double-blind Treatment|Other|0|||
19503450|NCT01642212|41883971|FG000|Double-blind Treatment|Non-compliance|0|||
19503451|NCT01642212|41883972|FG001|Double-blind Treatment|Non-compliance|1|||
19503452|NCT01642212|41883973|FG002|Double-blind Treatment|Non-compliance|0|||
19503453|NCT01642212|41883974|FG003|Double-blind Treatment|Non-compliance|0|||
19503454|NCT01642212|41883975|FG004|Double-blind Treatment|Non-compliance|0|||
19503455|NCT01642212|41883971|FG000|Double-blind Treatment|Adverse Event|0|||
19503456|NCT01642212|41883972|FG001|Double-blind Treatment|Adverse Event|0|||
19503457|NCT01642212|41883973|FG002|Double-blind Treatment|Adverse Event|1|||
19503458|NCT01642212|41883974|FG003|Double-blind Treatment|Adverse Event|0|||
19503459|NCT01642212|41883975|FG004|Double-blind Treatment|Adverse Event|0|||
19503460|NCT01642212|41883971|FG000|Open-label Extension|Adverse Event|0|||
19503461|NCT01642212|41883972|FG001|Open-label Extension|Adverse Event|0|||
19503462|NCT01642212|41883973|FG002|Open-label Extension|Adverse Event|0|||
19503463|NCT01642212|41883974|FG003|Open-label Extension|Adverse Event|3|||
19503464|NCT01642212|41883975|FG004|Open-label Extension|Adverse Event|0|||
19503465|NCT01642212|41883971|FG000|Open-label Extension|Sponsor Decision|0|||
19503466|NCT01642212|41883972|FG001|Open-label Extension|Sponsor Decision|0|||
19503467|NCT01642212|41883973|FG002|Open-label Extension|Sponsor Decision|0|||
19503468|NCT01642212|41883974|FG003|Open-label Extension|Sponsor Decision|7|||
19503469|NCT01642212|41883975|FG004|Open-label Extension|Sponsor Decision|4|||
19503470|NCT01642212|41883971|FG000|Open-label Extension|Consent Withdrawn|0|||
19503471|NCT01642212|41883972|FG001|Open-label Extension|Consent Withdrawn|0|||
19503472|NCT01642212|41883973|FG002|Open-label Extension|Consent Withdrawn|0|||
19503473|NCT01642212|41883974|FG003|Open-label Extension|Consent Withdrawn|0|||
19503474|NCT01642212|41883975|FG004|Open-label Extension|Consent Withdrawn|2|||
19503475|NCT01642212|41883971|FG000|Open-label Extension|Lost to Follow-up|0|||
19503476|NCT01642212|41883972|FG001|Open-label Extension|Lost to Follow-up|0|||
19503477|NCT01642212|41883973|FG002|Open-label Extension|Lost to Follow-up|0|||
19503478|NCT01642212|41883974|FG003|Open-label Extension|Lost to Follow-up|0|||
19503479|NCT01642212|41883975|FG004|Open-label Extension|Lost to Follow-up|1|||
19503480|NCT01642212|41883971|FG000|Open-label Extension|Other|0|||
19503481|NCT01642212|41883972|FG001|Open-label Extension|Other|0|||
19503482|NCT01642212|41883973|FG002|Open-label Extension|Other|0|||
19503483|NCT01642212|41883974|FG003|Open-label Extension|Other|0|||
19503484|NCT01642212|41883975|FG004|Open-label Extension|Other|1|||
19503485|NCT00552175|41884000|FG000|Overall Study|Lack of Efficacy|2|||
19503486|NCT00552175|41884001|FG001|Overall Study|Lack of Efficacy|0|||
19503487|NCT00552175|41884002|FG002|Overall Study|Lack of Efficacy|1|||
19503488|NCT00552175|41884000|FG000|Overall Study|Adverse Event|9|||
19503489|NCT00552175|41884001|FG001|Overall Study|Adverse Event|9|||
19503490|NCT00552175|41884002|FG002|Overall Study|Adverse Event|10|||
19503491|NCT00552175|41884000|FG000|Overall Study|Withdrawal by Subject|2|||
19503492|NCT00552175|41884001|FG001|Overall Study|Withdrawal by Subject|2|||
19503493|NCT00552175|41884002|FG002|Overall Study|Withdrawal by Subject|1|||
19503494|NCT00552175|41884000|FG000|Overall Study|Lost to Follow-up|0|||
19503495|NCT00552175|41884001|FG001|Overall Study|Lost to Follow-up|0|||
19503496|NCT00552175|41884002|FG002|Overall Study|Lost to Follow-up|1|||
19503497|NCT00552175|41884000|FG000|Overall Study|Entry Criteria Not Met|1|||
19503498|NCT00552175|41884001|FG001|Overall Study|Entry Criteria Not Met|1|||
19503499|NCT00552175|41884002|FG002|Overall Study|Entry Criteria Not Met|0|||
19503500|NCT00552175|41884000|FG000|Overall Study|Reason Not Specified|3|||
19503501|NCT00552175|41884001|FG001|Overall Study|Reason Not Specified|1|||
19503502|NCT00552175|41884002|FG002|Overall Study|Reason Not Specified|1|||
19503503|NCT01644474|41884013|FG000|Overall Study|Poor compliance to protocol|1|||
19503504|NCT01644474|41884014|FG001|Overall Study|Poor compliance to protocol|0|||
19503505|NCT01644474|41884013|FG000|Overall Study|Consent withdrawn by participant|0|||
19503506|NCT01644474|41884014|FG001|Overall Study|Consent withdrawn by participant|1|||
19503507|NCT01644474|41884013|FG000|Overall Study|Participant moved|0|||
19503508|NCT01644474|41884014|FG001|Overall Study|Participant moved|1|||
19503509|NCT01644474|41884013|FG000|Overall Study|Adverse Event|4|||
19503510|NCT01644474|41884014|FG001|Overall Study|Adverse Event|5|||
19503511|NCT01644474|41884013|FG000|Overall Study|Site scheduling error|1|||
19503512|NCT01644474|41884014|FG001|Overall Study|Site scheduling error|1|||
19503513|NCT01644474|41884013|FG000|Overall Study|Protocol Violation|1|||
19503514|NCT01644474|41884014|FG001|Overall Study|Protocol Violation|0|||
19503515|NCT02285010|41884049|FG000|Overall Study|not abdominal hysterectomy|2|||
19503516|NCT02285010|41884050|FG001|Overall Study|not abdominal hysterectomy|0|||
19503517|NCT02285010|41884049|FG000|Overall Study|Not spinal anesthesia|3|||
19503518|NCT02285010|41884050|FG001|Overall Study|Not spinal anesthesia|1|||
19503519|NCT00551161|41884094|FG000|Overall Study|Withdrawal by Subject|1|||
19503520|NCT00550771|41884130|FG000|Overall Study|Adverse Event|11|||
19503521|NCT00550771|41884131|FG001|Overall Study|Adverse Event|3|||
19503522|NCT00550771|41884130|FG000|Overall Study|Discontinued for study-related reasons|0|||
19503523|NCT00550771|41884131|FG001|Overall Study|Discontinued for study-related reasons|1|||
19503524|NCT00550771|41884130|FG000|Overall Study|Physician Decision|2|||
19503525|NCT00550771|41884131|FG001|Overall Study|Physician Decision|0|||
19503526|NCT00550771|41884130|FG000|Overall Study|Withdrawal by Subject|0|||
19614872|NCT00560833|42064087|FG004|Overall Study|Adverse Event|35|||
19503527|NCT00550771|41884131|FG001|Overall Study|Withdrawal by Subject|1|||
19503528|NCT00550771|41884130|FG000|Overall Study|Protocol Violation|4|||
19503529|NCT00550771|41884131|FG001|Overall Study|Protocol Violation|5|||
19503530|NCT00550537|41884164|FG000|Overall Study|Death|18|||
19503531|NCT00550537|41884164|FG000|Overall Study|Adverse Event|20|||
19503532|NCT00550537|41884164|FG000|Overall Study|Disease progression before|46|||
19503533|NCT00550537|41884164|FG000|Overall Study|Withdrawal by Subject|7|||
19503534|NCT00550537|41884164|FG000|Overall Study|Change in treatment plan|4|||
19503535|NCT00550537|41884164|FG000|Overall Study|Other complicating ilness|3|||
19503536|NCT00550537|41884164|FG000|Overall Study|Declining performance status|2|||
19503537|NCT00550537|41884164|FG000|Overall Study|Treated closer to home|4|||
19503538|NCT00550147|41884182|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
19503539|NCT00550147|41884182|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
19503540|NCT00550147|41884182|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
19503541|NCT00550147|41884182|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
19503542|NCT00550147|41884182|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
19503543|NCT00550459|41884393|FG000|Overall Study|Adverse Event|0|||
19503544|NCT00550459|41884394|FG001|Overall Study|Adverse Event|2|||
19503545|NCT00550459|41884393|FG000|Overall Study|Withdrawal by Subject|1|||
19503546|NCT00550459|41884394|FG001|Overall Study|Withdrawal by Subject|1|||
19503547|NCT01643928|41884693|FG000|Overall Study|Lost to Follow-up|1|||
19503548|NCT01643928|41884694|FG001|Overall Study|Lost to Follow-up|0|||
19503549|NCT01643928|41884695|FG002|Overall Study|Lost to Follow-up|2|||
19503550|NCT01643928|41884696|FG003|Overall Study|Lost to Follow-up|0|||
19503551|NCT01643928|41884697|FG004|Overall Study|Lost to Follow-up|0|||
19503552|NCT01643928|41884693|FG000|Overall Study|Withdrawal by Subject|2|||
19503553|NCT01643928|41884694|FG001|Overall Study|Withdrawal by Subject|0|||
19503554|NCT01643928|41884695|FG002|Overall Study|Withdrawal by Subject|0|||
19503555|NCT01643928|41884696|FG003|Overall Study|Withdrawal by Subject|1|||
19503556|NCT01643928|41884697|FG004|Overall Study|Withdrawal by Subject|0|||
19503557|NCT01643928|41884693|FG000|Overall Study|Pregnancy|0|||
19503558|NCT01643928|41884694|FG001|Overall Study|Pregnancy|0|||
19503559|NCT01643928|41884695|FG002|Overall Study|Pregnancy|0|||
19503560|NCT01643928|41884696|FG003|Overall Study|Pregnancy|1|||
19503561|NCT01643928|41884697|FG004|Overall Study|Pregnancy|0|||
19503562|NCT01643928|41884693|FG000|Overall Study|Other|5|||
19503563|NCT01643928|41884694|FG001|Overall Study|Other|1|||
19503564|NCT01643928|41884695|FG002|Overall Study|Other|1|||
19503565|NCT01643928|41884696|FG003|Overall Study|Other|0|||
19503566|NCT01643928|41884697|FG004|Overall Study|Other|0|||
19503567|NCT01643928|41884693|FG000|Overall Study|Adverse Event|2|||
19503568|NCT01643928|41884694|FG001|Overall Study|Adverse Event|1|||
19503569|NCT01643928|41884695|FG002|Overall Study|Adverse Event|0|||
19503570|NCT01643928|41884696|FG003|Overall Study|Adverse Event|1|||
19503571|NCT01643928|41884697|FG004|Overall Study|Adverse Event|2|||
19503572|NCT03237845|41884908|FG000|Overall Study|Adverse Event|0|||
19503573|NCT03237845|41884909|FG001|Overall Study|Adverse Event|1|||
19503574|NCT03237845|41884908|FG000|Overall Study|Lost to Follow-up|13|||
19503575|NCT03237845|41884909|FG001|Overall Study|Lost to Follow-up|10|||
19614873|NCT00560833|42064083|FG000|Overall Study|Lost to Follow-up|0|||
19614874|NCT00560833|42064084|FG001|Overall Study|Lost to Follow-up|0|||
19614875|NCT00560833|42064085|FG002|Overall Study|Lost to Follow-up|1|||
19614876|NCT00560833|42064086|FG003|Overall Study|Lost to Follow-up|0|||
19614877|NCT00560833|42064087|FG004|Overall Study|Lost to Follow-up|0|||
19614878|NCT00560833|42064083|FG000|Overall Study|Lack of Efficacy|22|||
19614879|NCT00560833|42064084|FG001|Overall Study|Lack of Efficacy|9|||
19614880|NCT00560833|42064085|FG002|Overall Study|Lack of Efficacy|6|||
19614881|NCT00560833|42064086|FG003|Overall Study|Lack of Efficacy|4|||
19614882|NCT00560833|42064087|FG004|Overall Study|Lack of Efficacy|4|||
19614883|NCT00560833|42064083|FG000|Overall Study|Participant uncooperative|5|||
19614884|NCT00560833|42064084|FG001|Overall Study|Participant uncooperative|5|||
19614885|NCT00560833|42064085|FG002|Overall Study|Participant uncooperative|4|||
19614886|NCT00560833|42064086|FG003|Overall Study|Participant uncooperative|4|||
19614887|NCT00560833|42064087|FG004|Overall Study|Participant uncooperative|2|||
19614888|NCT00560833|42064083|FG000|Overall Study|Other|1|||
19503576|NCT03237845|41884908|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
19503577|NCT03237845|41884909|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
19503578|NCT03237845|41884908|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
19503579|NCT03237845|41884909|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
19503580|NCT03237845|41884908|FG000|Overall Study|Physician Decision|1|||
19503581|NCT03237845|41884909|FG001|Overall Study|Physician Decision|2|||
19503582|NCT03237845|41884908|FG000|Overall Study|Pregnancy|1|||
19503583|NCT03237845|41884909|FG001|Overall Study|Pregnancy|0|||
19503584|NCT03237845|41884908|FG000|Overall Study|Protocol Deviation|0|||
19503585|NCT03237845|41884909|FG001|Overall Study|Protocol Deviation|1|||
19503586|NCT03237845|41884908|FG000|Overall Study|Technical Problems|8|||
19614889|NCT00560833|42064084|FG001|Overall Study|Other|1|||
19614890|NCT00560833|42064085|FG002|Overall Study|Other|3|||
19614891|NCT00560833|42064086|FG003|Overall Study|Other|0|||
19503587|NCT03237845|41884909|FG001|Overall Study|Technical Problems|1|||
19503588|NCT03237845|41884908|FG000|Overall Study|Withdrawal by Subject|3|||
19503589|NCT03237845|41884909|FG001|Overall Study|Withdrawal by Subject|3|||
19503590|NCT03237845|41884908|FG000|Overall Study|Other Reasons|4|||
19503591|NCT03237845|41884909|FG001|Overall Study|Other Reasons|0|||
19503592|NCT01643850|41884996|FG000|Overall Study|Withdrawal by Subject|0|||
19503593|NCT01643850|41884997|FG001|Overall Study|Withdrawal by Subject|0|||
19503594|NCT01643850|41884998|FG002|Overall Study|Withdrawal by Subject|0|||
19503595|NCT01643850|41884999|FG003|Overall Study|Withdrawal by Subject|0|||
19503596|NCT01643850|41885000|FG004|Overall Study|Withdrawal by Subject|1|||
19503597|NCT01643850|41885001|FG005|Overall Study|Withdrawal by Subject|0|||
19503598|NCT01643850|41885002|FG006|Overall Study|Withdrawal by Subject|0|||
19503599|NCT01643850|41885003|FG007|Overall Study|Withdrawal by Subject|0|||
19503600|NCT01643850|41885004|FG008|Overall Study|Withdrawal by Subject|0|||
19503601|NCT01643850|41884996|FG000|Overall Study|Lost to Follow-up|0|||
19503602|NCT01643850|41884997|FG001|Overall Study|Lost to Follow-up|0|||
19503603|NCT01643850|41884998|FG002|Overall Study|Lost to Follow-up|0|||
19503604|NCT01643850|41884999|FG003|Overall Study|Lost to Follow-up|0|||
19503605|NCT01643850|41885000|FG004|Overall Study|Lost to Follow-up|0|||
19503606|NCT01643850|41885001|FG005|Overall Study|Lost to Follow-up|0|||
19503607|NCT01643850|41885002|FG006|Overall Study|Lost to Follow-up|1|||
19503608|NCT01643850|41885003|FG007|Overall Study|Lost to Follow-up|0|||
19503609|NCT01643850|41885004|FG008|Overall Study|Lost to Follow-up|1|||
19503610|NCT01643850|41884996|FG000|Overall Study|Adverse Event|0|||
19503611|NCT01643850|41884997|FG001|Overall Study|Adverse Event|0|||
19503612|NCT01643850|41884998|FG002|Overall Study|Adverse Event|0|||
19503613|NCT01643850|41884999|FG003|Overall Study|Adverse Event|0|||
19503614|NCT01643850|41885000|FG004|Overall Study|Adverse Event|1|||
19503615|NCT01643850|41885001|FG005|Overall Study|Adverse Event|0|||
19503616|NCT01643850|41885002|FG006|Overall Study|Adverse Event|0|||
19503617|NCT01643850|41885003|FG007|Overall Study|Adverse Event|0|||
19503618|NCT01643850|41885004|FG008|Overall Study|Adverse Event|0|||
19503619|NCT01643850|41884996|FG000|Overall Study|Administrative Problems|0|||
19503620|NCT01643850|41884997|FG001|Overall Study|Administrative Problems|0|||
19503621|NCT01643850|41884998|FG002|Overall Study|Administrative Problems|1|||
19503622|NCT01643850|41884999|FG003|Overall Study|Administrative Problems|0|||
19503623|NCT01643850|41885000|FG004|Overall Study|Administrative Problems|1|||
19503624|NCT01643850|41885001|FG005|Overall Study|Administrative Problems|0|||
19503625|NCT01643850|41885002|FG006|Overall Study|Administrative Problems|0|||
19503626|NCT01643850|41885003|FG007|Overall Study|Administrative Problems|0|||
19503627|NCT01643850|41885004|FG008|Overall Study|Administrative Problems|0|||
19503628|NCT02271594|41885072|FG000|Overall Study|Study closed; recruiting failure|19|||
19503629|NCT02271594|41885073|FG001|Overall Study|Study closed; recruiting failure|12|||
19503630|NCT02535923|41885092|FG000|Overall Study|Lost to Follow-up|5|||
19503631|NCT02535923|41885093|FG001|Overall Study|Lost to Follow-up|5|||
19503632|NCT02535923|41885092|FG000|Overall Study|Withdrawal by Subject|4|||
19503633|NCT02535923|41885093|FG001|Overall Study|Withdrawal by Subject|3|||
19503634|NCT02270736|41885102|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
19503635|NCT02270736|41885103|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
19503636|NCT02270736|41885104|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
19503637|NCT02270736|41885105|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
19503638|NCT02270736|41885106|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
19503639|NCT02270736|41885102|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
19503640|NCT02270736|41885103|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
19503641|NCT02270736|41885104|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
19503642|NCT02270736|41885105|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
19503643|NCT02270736|41885106|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
19503644|NCT02270736|41885102|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
19503645|NCT02270736|41885103|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
19503646|NCT02270736|41885104|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
19503647|NCT02270736|41885105|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
19503648|NCT02270736|41885106|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
19503649|NCT02270736|41885102|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
19503650|NCT02270736|41885103|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
19503651|NCT02270736|41885104|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
19503652|NCT02270736|41885105|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
19503653|NCT02270736|41885106|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
19503654|NCT02270736|41885102|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
19503655|NCT02270736|41885103|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
19503656|NCT02270736|41885104|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
19503657|NCT02270736|41885105|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
19503658|NCT02270736|41885106|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
19503659|NCT02270736|41885102|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
19503660|NCT02270736|41885103|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
19503661|NCT02270736|41885104|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
19503662|NCT02270736|41885105|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
19503663|NCT02270736|41885106|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
19503664|NCT02270736|41885102|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
19503665|NCT02270736|41885103|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
19503666|NCT02270736|41885104|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
19503667|NCT02270736|41885105|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
19503668|NCT02270736|41885106|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
19503669|NCT02270736|41885102|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
19503670|NCT02270736|41885103|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
19503671|NCT02270736|41885104|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
19503672|NCT02270736|41885105|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
19503673|NCT02270736|41885106|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
19503674|NCT02270736|41885102|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
19503675|NCT02270736|41885103|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
19503676|NCT02270736|41885104|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
19503677|NCT02270736|41885105|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
19503678|NCT02270736|41885106|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
19503679|NCT02269098|41885121|FG000|Overall Study|Lost to Follow-up|14|||
19503680|NCT02269098|41885122|FG001|Overall Study|Lost to Follow-up|9|||
19503681|NCT02283762|41885266|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
19503682|NCT02283762|41885267|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
19503683|NCT02283762|41885266|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
19503684|NCT02283762|41885267|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
19503685|NCT02283762|41885266|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
19503686|NCT02283762|41885267|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
19503687|NCT02283762|41885266|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
19503688|NCT02283762|41885267|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
19503689|NCT02283762|41885266|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
19503690|NCT02283762|41885267|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
19503691|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
19503692|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
19503693|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
19503694|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
19503695|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
19503696|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
19503697|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
19503698|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
19503699|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
19503700|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
19503701|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
19503702|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
19503703|NCT02283762|41885266|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
19503704|NCT02283762|41885267|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
19503705|NCT02283294|41885367|FG000|Overall Study|Lost to Follow-up|1|||
19503706|NCT02283294|41885368|FG001|Overall Study|Lost to Follow-up|1|||
19503707|NCT02283294|41885367|FG000|Overall Study|Withdrawal by Subject|1|||
19503708|NCT02283294|41885368|FG001|Overall Study|Withdrawal by Subject|6|||
19503709|NCT02283294|41885367|FG000|Overall Study|Protocol Violation|1|||
19503710|NCT02283294|41885368|FG001|Overall Study|Protocol Violation|0|||
19503711|NCT02283294|41885367|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
19503712|NCT02283294|41885368|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
19503713|NCT02282982|41885384|FG000|Overall Study|Lost to Follow-up|15|||
19503714|NCT02282982|41885384|FG000|Overall Study|Withdrew consent|2|||
19503715|NCT02282982|41885384|FG000|Overall Study|Death|4|||
19503716|NCT02282982|41885384|FG000|Overall Study|Lack of product|156|||
19503717|NCT02282982|41885384|FG000|Overall Study|Palivizumab is ended|11|||
19503718|NCT02282982|41885384|FG000|Overall Study|Other, not specified|18|||
19503719|NCT02268864|41885426|FG000|Overall Study|Withdrawal by Subject|2|||
19503720|NCT02268864|41885427|FG001|Overall Study|Withdrawal by Subject|0|||
19503721|NCT02268864|41885428|FG002|Overall Study|Withdrawal by Subject|0|||
19503722|NCT02268864|41885426|FG000|Overall Study|Death|0|||
19503723|NCT02268864|41885427|FG001|Overall Study|Death|1|||
19503724|NCT02268864|41885428|FG002|Overall Study|Death|0|||
19503725|NCT02268786|41885457|FG000|Overall Study|No Euploid Embryos available|42|||
19503726|NCT02268786|41885458|FG001|Overall Study|No Euploid Embryos available|0|||
19503727|NCT02268786|41885457|FG000|Overall Study|Withdrawal by Subject|7|||
19503728|NCT02268786|41885458|FG001|Overall Study|Withdrawal by Subject|14|||
19503729|NCT02268786|41885457|FG000|Overall Study|Thaw Failure|6|||
19503730|NCT02268786|41885458|FG001|Overall Study|Thaw Failure|4|||
19503731|NCT02268786|41885457|FG000|Overall Study|Protocol Violation|1|||
19503732|NCT02268786|41885458|FG001|Overall Study|Protocol Violation|0|||
19503733|NCT02268396|41885473|FG000|Overall Study|Adverse Event|3|||
19503734|NCT02268396|41885473|FG000|Overall Study|Administrative|2|||
19503735|NCT02268396|41885473|FG000|Overall Study|Withdrawal by Subject|1|||
19503736|NCT02268396|41885473|FG000|Overall Study|Lost to Follow-up|2|||
19503737|NCT02268396|41885473|FG000|Overall Study|Protocol-Specified Criteria|2|||
19503738|NCT02268396|41885473|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
19503739|NCT02268084|41885479|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
19503740|NCT02268084|41885480|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
19503741|NCT02268084|41885479|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
19503742|NCT02268084|41885480|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
19503743|NCT01643772|41885509|FG000|Overall Study|Protocol Violation|0|||
19503744|NCT01643772|41885510|FG001|Overall Study|Protocol Violation|0|||
19503745|NCT01643772|41885511|FG002|Overall Study|Protocol Violation|0|||
19503746|NCT01643772|41885512|FG003|Overall Study|Protocol Violation|1|||
19503747|NCT01643772|41885509|FG000|Overall Study|Adverse Event|0|||
19503748|NCT01643772|41885510|FG001|Overall Study|Adverse Event|0|||
19503749|NCT01643772|41885511|FG002|Overall Study|Adverse Event|0|||
19503750|NCT01643772|41885512|FG003|Overall Study|Adverse Event|1|||
19503751|NCT02265744|41885615|FG000|Overall Study|Poor/Non-compliance|1|||
19503752|NCT02265744|41885616|FG001|Overall Study|Poor/Non-compliance|1|||
19503753|NCT02265744|41885617|FG002|Overall Study|Poor/Non-compliance|0|||
19503754|NCT02265744|41885618|FG003|Overall Study|Poor/Non-compliance|0|||
19503755|NCT02265744|41885619|FG004|Overall Study|Poor/Non-compliance|2|||
19503756|NCT02265744|41885615|FG000|Overall Study|Lost to Follow-up|0|||
19503757|NCT02265744|41885616|FG001|Overall Study|Lost to Follow-up|0|||
19503758|NCT02265744|41885617|FG002|Overall Study|Lost to Follow-up|0|||
19503759|NCT02265744|41885618|FG003|Overall Study|Lost to Follow-up|1|||
19503760|NCT02265744|41885619|FG004|Overall Study|Lost to Follow-up|0|||
19503761|NCT02265744|41885615|FG000|Overall Study|Death|0|||
19503762|NCT02265744|41885616|FG001|Overall Study|Death|0|||
19503763|NCT02265744|41885617|FG002|Overall Study|Death|0|||
19503764|NCT02265744|41885618|FG003|Overall Study|Death|2|||
19503765|NCT02265744|41885619|FG004|Overall Study|Death|0|||
19503766|NCT02265744|41885615|FG000|Overall Study|Withdrawal by Subject|2|||
19503767|NCT02265744|41885616|FG001|Overall Study|Withdrawal by Subject|0|||
19503768|NCT02265744|41885617|FG002|Overall Study|Withdrawal by Subject|0|||
19614892|NCT00560833|42064087|FG004|Overall Study|Other|0|||
19503769|NCT02265744|41885618|FG003|Overall Study|Withdrawal by Subject|2|||
19503770|NCT02265744|41885619|FG004|Overall Study|Withdrawal by Subject|0|||
19503771|NCT02265744|41885615|FG000|Overall Study|Participant request to discontinue|2|||
19503772|NCT02265744|41885616|FG001|Overall Study|Participant request to discontinue|2|||
19503773|NCT02265744|41885617|FG002|Overall Study|Participant request to discontinue|2|||
19503774|NCT02265744|41885618|FG003|Overall Study|Participant request to discontinue|0|||
19503775|NCT02265744|41885619|FG004|Overall Study|Participant request to discontinue|0|||
19503776|NCT02265744|41885615|FG000|Overall Study|Adverse Event|8|||
19503777|NCT02265744|41885616|FG001|Overall Study|Adverse Event|4|||
19503778|NCT02265744|41885617|FG002|Overall Study|Adverse Event|9|||
19503779|NCT02265744|41885618|FG003|Overall Study|Adverse Event|8|||
19503780|NCT02265744|41885619|FG004|Overall Study|Adverse Event|2|||
19503781|NCT02265744|41885615|FG000|Overall Study|Lack of Efficacy|2|||
19503782|NCT02265744|41885616|FG001|Overall Study|Lack of Efficacy|4|||
19503783|NCT02265744|41885617|FG002|Overall Study|Lack of Efficacy|3|||
19503784|NCT02265744|41885618|FG003|Overall Study|Lack of Efficacy|4|||
19503785|NCT02265744|41885619|FG004|Overall Study|Lack of Efficacy|5|||
19503786|NCT02265744|41885615|FG000|Overall Study|Reason not provided by Investigator|1|||
19503787|NCT02265744|41885616|FG001|Overall Study|Reason not provided by Investigator|0|||
19503788|NCT02265744|41885617|FG002|Overall Study|Reason not provided by Investigator|0|||
19503789|NCT02265744|41885618|FG003|Overall Study|Reason not provided by Investigator|2|||
19503790|NCT02265744|41885619|FG004|Overall Study|Reason not provided by Investigator|0|||
19503791|NCT02265744|41885615|FG000|Overall Study|Administrative reason by sponsor|3|||
19503792|NCT02265744|41885616|FG001|Overall Study|Administrative reason by sponsor|2|||
19503793|NCT02265744|41885617|FG002|Overall Study|Administrative reason by sponsor|2|||
19503794|NCT02265744|41885618|FG003|Overall Study|Administrative reason by sponsor|3|||
19503795|NCT02265744|41885619|FG004|Overall Study|Administrative reason by sponsor|3|||
19503796|NCT02265744|41885615|FG000|Overall Study|Subject no longer meets study criteria|0|||
19503797|NCT02265744|41885616|FG001|Overall Study|Subject no longer meets study criteria|0|||
19503798|NCT02265744|41885617|FG002|Overall Study|Subject no longer meets study criteria|0|||
19503799|NCT02265744|41885618|FG003|Overall Study|Subject no longer meets study criteria|0|||
19503800|NCT02265744|41885619|FG004|Overall Study|Subject no longer meets study criteria|1|||
19503801|NCT02265744|41885615|FG000|Overall Study|Pregnancy|1|||
19503802|NCT02265744|41885616|FG001|Overall Study|Pregnancy|2|||
19503803|NCT02265744|41885617|FG002|Overall Study|Pregnancy|1|||
19503804|NCT02265744|41885618|FG003|Overall Study|Pregnancy|1|||
19503805|NCT02265744|41885619|FG004|Overall Study|Pregnancy|0|||
19503806|NCT00085735|41885648|FG000|Overall Study|Adverse Event|1|||
19503807|NCT00085735|41885649|FG001|Overall Study|Adverse Event|0|||
19503808|NCT00085735|41885650|FG002|Overall Study|Adverse Event|0|||
19503809|NCT00085735|41885651|FG003|Overall Study|Adverse Event|0|||
19503810|NCT00085735|41885652|FG004|Overall Study|Adverse Event|0|||
19503811|NCT00085735|41885653|FG005|Overall Study|Adverse Event|0|||
19614893|NCT00560833|42064083|FG000|Overall Study|Never received drug|0|||
19614894|NCT00560833|42064084|FG001|Overall Study|Never received drug|1|||
19614895|NCT00560833|42064085|FG002|Overall Study|Never received drug|0|||
19614896|NCT00560833|42064086|FG003|Overall Study|Never received drug|0|||
19614897|NCT00560833|42064087|FG004|Overall Study|Never received drug|1|||
19614898|NCT00771615|42064108|FG000|Overall Study|Withdrawal by Subject|0|||
19614899|NCT00771615|42064109|FG001|Overall Study|Withdrawal by Subject|1|||
19614900|NCT00771615|42064110|FG002|Overall Study|Withdrawal by Subject|0|||
19614901|NCT00771615|42064111|FG003|Overall Study|Withdrawal by Subject|0|||
19614902|NCT00771615|42064112|FG004|Overall Study|Withdrawal by Subject|0|||
19614903|NCT00771615|42064113|FG005|Overall Study|Withdrawal by Subject|0|||
19614904|NCT00771615|42064114|FG006|Overall Study|Withdrawal by Subject|0|||
19614905|NCT00771615|42064115|FG007|Overall Study|Withdrawal by Subject|1|||
19614906|NCT00771615|42064116|FG008|Overall Study|Withdrawal by Subject|0|||
19614907|NCT00771615|42064108|FG000|Overall Study|Lost to Follow-up|1|||
19614908|NCT00771615|42064109|FG001|Overall Study|Lost to Follow-up|1|||
19614909|NCT00771615|42064110|FG002|Overall Study|Lost to Follow-up|1|||
19614910|NCT00771615|42064111|FG003|Overall Study|Lost to Follow-up|1|||
19614911|NCT00771615|42064112|FG004|Overall Study|Lost to Follow-up|0|||
19614912|NCT00771615|42064113|FG005|Overall Study|Lost to Follow-up|1|||
19614913|NCT00771615|42064114|FG006|Overall Study|Lost to Follow-up|1|||
19614914|NCT00771615|42064115|FG007|Overall Study|Lost to Follow-up|0|||
19614915|NCT00771615|42064116|FG008|Overall Study|Lost to Follow-up|0|||
19614916|NCT02723604|42064145|FG000|Overall Study|ineligible|1|||
19503812|NCT00085735|41885648|FG000|Overall Study|Lack of Efficacy|2|||
19503813|NCT00085735|41885649|FG001|Overall Study|Lack of Efficacy|4|||
19503814|NCT00085735|41885650|FG002|Overall Study|Lack of Efficacy|6|||
19503815|NCT00085735|41885651|FG003|Overall Study|Lack of Efficacy|3|||
19503816|NCT00085735|41885652|FG004|Overall Study|Lack of Efficacy|4|||
19503817|NCT00085735|41885653|FG005|Overall Study|Lack of Efficacy|3|||
19614917|NCT02723604|42064145|FG000|Overall Study|never received treatment|1|||
19614918|NCT00560755|42064149|FG000|Overall Study|Protocol Violation|15|||
19614919|NCT00560755|42064149|FG000|Overall Study|Withdrawal by Subject|26|||
19614920|NCT00560755|42064149|FG000|Overall Study|Lost to Follow-up|9|||
19503818|NCT00085735|41885648|FG000|Overall Study|Lost to Follow-up|0|||
19503819|NCT00085735|41885649|FG001|Overall Study|Lost to Follow-up|1|||
19503820|NCT00085735|41885650|FG002|Overall Study|Lost to Follow-up|0|||
19503821|NCT00085735|41885651|FG003|Overall Study|Lost to Follow-up|0|||
19503822|NCT00085735|41885652|FG004|Overall Study|Lost to Follow-up|1|||
19503823|NCT00085735|41885653|FG005|Overall Study|Lost to Follow-up|0|||
19503824|NCT00085735|41885648|FG000|Overall Study|Physician Decision|2|||
19503825|NCT00085735|41885649|FG001|Overall Study|Physician Decision|3|||
19503826|NCT00085735|41885650|FG002|Overall Study|Physician Decision|2|||
19614921|NCT00560755|42064149|FG000|Overall Study|Adverse Event|8|||
19614922|NCT00560755|42064149|FG000|Overall Study|Physician Decision|2|||
19614923|NCT00770991|42064156|FG000|Overall Study|Physician Decision|2|||
19614924|NCT00770991|42064157|FG001|Overall Study|Physician Decision|0|||
19614925|NCT00770991|42064156|FG000|Overall Study|Withdrawal by Subject|1|||
19614926|NCT00770991|42064157|FG001|Overall Study|Withdrawal by Subject|0|||
19614927|NCT00770991|42064156|FG000|Overall Study|Adverse Event|1|||
19614928|NCT00770991|42064157|FG001|Overall Study|Adverse Event|5|||
19614929|NCT00770991|42064156|FG000|Overall Study|Pregnancy|1|||
19614930|NCT00770991|42064157|FG001|Overall Study|Pregnancy|0|||
19614931|NCT00925769|42064168|FG000|Overall Study|Major toxicity|1|||
19614932|NCT00925769|42064169|FG001|Overall Study|Major toxicity|0|||
19503827|NCT00085735|41885651|FG003|Overall Study|Physician Decision|3|||
19503828|NCT00085735|41885652|FG004|Overall Study|Physician Decision|11|||
19503829|NCT00085735|41885653|FG005|Overall Study|Physician Decision|8|||
19503830|NCT00085735|41885648|FG000|Overall Study|Protocol Violation|1|||
19614933|NCT00925769|42064170|FG002|Overall Study|Major toxicity|1|||
19614934|NCT00925769|42064171|FG003|Overall Study|Major toxicity|1|||
19614935|NCT00925769|42064172|FG004|Overall Study|Major toxicity|0|||
19614936|NCT00925769|42064173|FG005|Overall Study|Major toxicity|0|||
19614937|NCT00925769|42064168|FG000|Overall Study|Disease progression|4|||
19614938|NCT00925769|42064169|FG001|Overall Study|Disease progression|5|||
19614939|NCT00925769|42064170|FG002|Overall Study|Disease progression|3|||
19614940|NCT00925769|42064171|FG003|Overall Study|Disease progression|4|||
19614941|NCT00925769|42064172|FG004|Overall Study|Disease progression|2|||
19614942|NCT00925769|42064173|FG005|Overall Study|Disease progression|3|||
19614943|NCT00925769|42064168|FG000|Overall Study|Death|0|||
19614944|NCT00925769|42064169|FG001|Overall Study|Death|0|||
19614945|NCT00925769|42064170|FG002|Overall Study|Death|1|||
19614946|NCT00925769|42064171|FG003|Overall Study|Death|0|||
19614947|NCT00925769|42064172|FG004|Overall Study|Death|0|||
19614948|NCT00925769|42064173|FG005|Overall Study|Death|0|||
19614949|NCT00925769|42064168|FG000|Overall Study|Physician Decision|1|||
19614950|NCT00925769|42064169|FG001|Overall Study|Physician Decision|0|||
19614951|NCT00925769|42064170|FG002|Overall Study|Physician Decision|0|||
19614952|NCT00925769|42064171|FG003|Overall Study|Physician Decision|0|||
19614953|NCT00925769|42064172|FG004|Overall Study|Physician Decision|0|||
19614954|NCT00925769|42064173|FG005|Overall Study|Physician Decision|0|||
19614955|NCT00925769|42064168|FG000|Overall Study|Missing documentation|0|||
19614956|NCT00925769|42064169|FG001|Overall Study|Missing documentation|1|||
19614957|NCT00925769|42064170|FG002|Overall Study|Missing documentation|0|||
19614958|NCT00925769|42064171|FG003|Overall Study|Missing documentation|0|||
19704458|NCT00159822|42148805|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
19704459|NCT00159822|42148805|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
19704460|NCT00158262|42148811|FG000|Overall Study|Lost to Follow-up|1|||
19614959|NCT00925769|42064172|FG004|Overall Study|Missing documentation|0|||
19614960|NCT00925769|42064173|FG005|Overall Study|Missing documentation|0|||
19614961|NCT00925769|42064168|FG000|Overall Study|End of study visit not done|0|||
19614962|NCT00925769|42064169|FG001|Overall Study|End of study visit not done|0|||
19614963|NCT00925769|42064170|FG002|Overall Study|End of study visit not done|1|||
19704461|NCT00158262|42148812|FG001|Overall Study|Lost to Follow-up|1|||
19704462|NCT00157950|42148820|FG000|Overall Study|Death|1|||
19704463|NCT00157950|42148821|FG001|Overall Study|Death|0|||
19704464|NCT03745768|42148829|FG000|Overall Study|discontinued study|2|||
19503831|NCT00085735|41885649|FG001|Overall Study|Protocol Violation|0|||
19503832|NCT00085735|41885650|FG002|Overall Study|Protocol Violation|0|||
19503833|NCT00085735|41885651|FG003|Overall Study|Protocol Violation|0|||
19614964|NCT00925769|42064171|FG003|Overall Study|End of study visit not done|0|||
19614965|NCT00925769|42064172|FG004|Overall Study|End of study visit not done|0|||
19614966|NCT00925769|42064173|FG005|Overall Study|End of study visit not done|0|||
19614967|NCT00925769|42064168|FG000|Overall Study|Participant is unable to swallow drug|0|||
19614968|NCT00925769|42064169|FG001|Overall Study|Participant is unable to swallow drug|0|||
19503834|NCT00085735|41885652|FG004|Overall Study|Protocol Violation|0|||
19614969|NCT00925769|42064170|FG002|Overall Study|Participant is unable to swallow drug|0|||
19614970|NCT00925769|42064171|FG003|Overall Study|Participant is unable to swallow drug|1|||
19614971|NCT00925769|42064172|FG004|Overall Study|Participant is unable to swallow drug|0|||
19614972|NCT00925769|42064173|FG005|Overall Study|Participant is unable to swallow drug|0|||
19614973|NCT00925769|42064168|FG000|Overall Study|Adverse Event|0|||
19614974|NCT00925769|42064169|FG001|Overall Study|Adverse Event|0|||
19704465|NCT03745768|42148830|FG001|Overall Study|discontinued study|0|||
19614975|NCT00925769|42064170|FG002|Overall Study|Adverse Event|0|||
19614976|NCT00925769|42064171|FG003|Overall Study|Adverse Event|0|||
19614977|NCT00925769|42064172|FG004|Overall Study|Adverse Event|1|||
19614978|NCT00925769|42064173|FG005|Overall Study|Adverse Event|0|||
19503835|NCT00085735|41885653|FG005|Overall Study|Protocol Violation|0|||
19503836|NCT00085735|41885648|FG000|Overall Study|Withdrawal by Subject|1|||
19503837|NCT00085735|41885649|FG001|Overall Study|Withdrawal by Subject|0|||
19503838|NCT00085735|41885650|FG002|Overall Study|Withdrawal by Subject|4|||
19503839|NCT00085735|41885651|FG003|Overall Study|Withdrawal by Subject|5|||
19503840|NCT00085735|41885652|FG004|Overall Study|Withdrawal by Subject|7|||
19503841|NCT00085735|41885653|FG005|Overall Study|Withdrawal by Subject|8|||
19503842|NCT00085735|41885648|FG000|Overall Study|Patient ineligible|1|||
19503843|NCT00085735|41885649|FG001|Overall Study|Patient ineligible|0|||
19503844|NCT00085735|41885650|FG002|Overall Study|Patient ineligible|3|||
19503845|NCT00085735|41885651|FG003|Overall Study|Patient ineligible|7|||
19503846|NCT00085735|41885652|FG004|Overall Study|Patient ineligible|17|||
19503847|NCT00085735|41885653|FG005|Overall Study|Patient ineligible|8|||
19503848|NCT00085735|41885648|FG000|Overall Study|Excess residual disease|2|||
19503849|NCT00085735|41885649|FG001|Overall Study|Excess residual disease|2|||
19503850|NCT00085735|41885650|FG002|Overall Study|Excess residual disease|1|||
19503851|NCT00085735|41885651|FG003|Overall Study|Excess residual disease|1|||
19614979|NCT00770913|42064192|FG000|Overall Study|Adverse Event|1|||
19614980|NCT00770913|42064193|FG001|Overall Study|Adverse Event|3|||
19503852|NCT00085735|41885652|FG004|Overall Study|Excess residual disease|1|||
19503853|NCT00085735|41885653|FG005|Overall Study|Excess residual disease|4|||
19503854|NCT00085735|41885648|FG000|Overall Study|Reason not documented|1|||
19503855|NCT00085735|41885649|FG001|Overall Study|Reason not documented|0|||
19503856|NCT00085735|41885650|FG002|Overall Study|Reason not documented|1|||
19503857|NCT00085735|41885651|FG003|Overall Study|Reason not documented|0|||
19503858|NCT00085735|41885652|FG004|Overall Study|Reason not documented|1|||
19503859|NCT00085735|41885653|FG005|Overall Study|Reason not documented|0|||
19503860|NCT00085735|41885648|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
19503861|NCT00085735|41885649|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
19503862|NCT00085735|41885650|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
19503863|NCT00085735|41885651|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
19614981|NCT00770913|42064194|FG002|Overall Study|Adverse Event|6|||
19614982|NCT00770913|42064192|FG000|Overall Study|Refusal to continue participation|6|||
19614983|NCT00770913|42064193|FG001|Overall Study|Refusal to continue participation|4|||
19614984|NCT00770913|42064194|FG002|Overall Study|Refusal to continue participation|5|||
19614985|NCT00770913|42064192|FG000|Overall Study|Physician Decision|0|||
19614986|NCT00770913|42064193|FG001|Overall Study|Physician Decision|1|||
19614987|NCT00770913|42064194|FG002|Overall Study|Physician Decision|1|||
19614988|NCT00770913|42064192|FG000|Overall Study|Protocol Violation|3|||
19614989|NCT00770913|42064193|FG001|Overall Study|Protocol Violation|0|||
19614990|NCT00770913|42064194|FG002|Overall Study|Protocol Violation|1|||
19614991|NCT00770913|42064192|FG000|Overall Study|Incorrect drug was allocated|1|||
19503864|NCT00085735|41885652|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
19503865|NCT00085735|41885653|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
19503866|NCT01938001|41887233|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
19503867|NCT01938001|41887234|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
19503868|NCT01938001|41887233|FG000|Pre-Treatment|Death|1|||
19503869|NCT01938001|41887234|FG001|Pre-Treatment|Death|0|||
19503870|NCT01938001|41887233|FG000|Treatment|Death|2|||
19503871|NCT01938001|41887234|FG001|Treatment|Death|0|||
19503872|NCT01938001|41887233|FG000|Treatment|Adverse Event|14|||
19503873|NCT01938001|41887234|FG001|Treatment|Adverse Event|8|||
19503874|NCT01938001|41887233|FG000|Treatment|Progressive Disease|21|||
19503875|NCT01938001|41887234|FG001|Treatment|Progressive Disease|54|||
19503876|NCT01938001|41887233|FG000|Treatment|Withdrawal by Subject|13|||
19503877|NCT01938001|41887234|FG001|Treatment|Withdrawal by Subject|7|||
19503878|NCT01938001|41887233|FG000|Treatment|Other reasons|2|||
19503879|NCT01938001|41887234|FG001|Treatment|Other reasons|1|||
19614992|NCT00770913|42064193|FG001|Overall Study|Incorrect drug was allocated|0|||
19614993|NCT00770913|42064194|FG002|Overall Study|Incorrect drug was allocated|0|||
19614994|NCT00562861|42064204|FG000|Overall Study|Adverse Event|1|||
19614995|NCT00562861|42064205|FG001|Overall Study|Adverse Event|1|||
19614996|NCT00562861|42064204|FG000|Overall Study|Lack of Efficacy|5|||
19614997|NCT00562861|42064205|FG001|Overall Study|Lack of Efficacy|5|||
19614998|NCT00562861|42064204|FG000|Overall Study|noncompliance, moved|7|||
19614999|NCT00562861|42064205|FG001|Overall Study|noncompliance, moved|2|||
19615000|NCT00562861|42064204|FG000|Overall Study|Lost to Follow-up|7|||
19615001|NCT00562861|42064205|FG001|Overall Study|Lost to Follow-up|3|||
19615002|NCT00770679|42064211|FG000|Overall Study|Lost to Follow-up|3|||
19615003|NCT00770679|42064211|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
19615004|NCT00770601|42064215|FG000|Overall Study|Withdrawal by Subject|1|||
19615005|NCT00770367|42064221|FG000|First Intervention|Withdrawal by Subject|0|||
19615006|NCT00770367|42064222|FG001|First Intervention|Withdrawal by Subject|2|||
19615007|NCT00770367|42064221|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
19615008|NCT00770367|42064222|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
19615009|NCT00770367|42064221|FG000|Second Intervention|Lost to Follow-up|2|||
19615010|NCT00770367|42064222|FG001|Second Intervention|Lost to Follow-up|0|||
19615011|NCT00931307|42064230|FG000|Overall Study|Lack of Efficacy|12|||
19615012|NCT00931307|42064230|FG000|Overall Study|Biomicroscopy|1|||
19615013|NCT00930761|42064249|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
19615014|NCT00930761|42064250|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
19615015|NCT00930761|42064249|FG000|Overall Study|less than 3 music therapy sessions|0|||
19615016|NCT00930761|42064250|FG001|Overall Study|less than 3 music therapy sessions|3|||
19615017|NCT00770289|42064256|FG000|Overall Study|Other|6|||
19615018|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
19615019|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
19615020|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
19615021|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
19615022|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
19615023|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
19615024|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
19615025|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
19615026|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
19615027|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
19615028|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
19615029|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
19615030|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
19615031|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
19615032|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
19615033|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
19615034|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
19615035|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
19503928|NCT01081951|41887418|FG000|Overall Study|Death|54|||
19503929|NCT01081951|41887419|FG001|Overall Study|Death|47|||
19503930|NCT01081951|41887418|FG000|Overall Study|Withdrawal by Subject|2|||
19503931|NCT01081951|41887419|FG001|Overall Study|Withdrawal by Subject|6|||
19503932|NCT01081951|41887418|FG000|Overall Study|Allocated treatment but did not take it|0|||
19503933|NCT01081951|41887419|FG001|Overall Study|Allocated treatment but did not take it|1|||
19503934|NCT01081951|41887418|FG000|Overall Study|Lost to Follow-up|0|||
19503935|NCT01081951|41887419|FG001|Overall Study|Lost to Follow-up|1|||
19503936|NCT01066663|41887465|FG000|Overall Study|Adverse Event|0|||
19503937|NCT01066663|41887466|FG001|Overall Study|Adverse Event|0|||
19503938|NCT01066663|41887467|FG002|Overall Study|Adverse Event|1|||
19503939|NCT03930745|41889700|FG000|Overall Study|Lost to Follow-up|10|||
19503940|NCT03930745|41889701|FG001|Overall Study|Lost to Follow-up|5|||
19503941|NCT03930745|41889700|FG000|Overall Study|Withdrawal by Subject|1|||
19503942|NCT03930745|41889701|FG001|Overall Study|Withdrawal by Subject|2|||
19503943|NCT03930745|41889700|FG000|Overall Study|Protocol Violation|2|||
19503944|NCT03930745|41889701|FG001|Overall Study|Protocol Violation|2|||
19503945|NCT03930745|41889700|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
19503946|NCT03930745|41889701|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
19503947|NCT03930745|41889700|FG000|Overall Study|Adverse Event|0|||
19503948|NCT03930745|41889701|FG001|Overall Study|Adverse Event|1|||
19503949|NCT03930745|41889700|FG000|Overall Study|Pregnancy|0|||
19503950|NCT03930745|41889701|FG001|Overall Study|Pregnancy|1|||
19503951|NCT04473326|41892468|FG000|Overall Study|Death|0|||
19503952|NCT04473326|41892469|FG001|Overall Study|Death|1|||
19503953|NCT04473326|41892468|FG000|Overall Study|Withdrawal by Subject|1|||
19503954|NCT04473326|41892469|FG001|Overall Study|Withdrawal by Subject|2|||
19503955|NCT03838484|41893068|FG000|Overall Study|Lost to Follow-up|0|||
19503956|NCT03838484|41893069|FG001|Overall Study|Lost to Follow-up|1|||
19503957|NCT03838484|41893070|FG002|Overall Study|Lost to Follow-up|0|||
19503958|NCT03838484|41893071|FG003|Overall Study|Lost to Follow-up|0|||
19503959|NCT01349192|41893286|FG000|Overall Study|Protocol Violation|0|||
19503960|NCT01349192|41893287|FG001|Overall Study|Protocol Violation|1|||
19503961|NCT01349192|41893286|FG000|Overall Study|Withdrawal by Subject|0|||
19503962|NCT01349192|41893287|FG001|Overall Study|Withdrawal by Subject|2|||
19503963|NCT01349192|41893286|FG000|Overall Study|Lost to Follow-up|1|||
19503964|NCT01349192|41893287|FG001|Overall Study|Lost to Follow-up|3|||
19503965|NCT01349192|41893286|FG000|Overall Study|Failure to adhere to Protocol|2|||
19503966|NCT01349192|41893287|FG001|Overall Study|Failure to adhere to Protocol|0|||
19503967|NCT01721876|41893642|FG000|Overall Study|Not treated|1|||
19503968|NCT01721876|41893643|FG001|Overall Study|Not treated|4|||
19503969|NCT01721876|41893642|FG000|Overall Study|Disease progression / relapse|123|||
19503970|NCT01721876|41893643|FG001|Overall Study|Disease progression / relapse|156|||
19503971|NCT01721876|41893642|FG000|Overall Study|Death|6|||
19503972|NCT01721876|41893643|FG001|Overall Study|Death|13|||
19503973|NCT01721876|41893642|FG000|Overall Study|Adverse Event|41|||
19503974|NCT01721876|41893643|FG001|Overall Study|Adverse Event|165|||
19503975|NCT01721876|41893642|FG000|Overall Study|Protocol Violation|2|||
19503976|NCT01721876|41893643|FG001|Overall Study|Protocol Violation|1|||
19503977|NCT01721876|41893642|FG000|Overall Study|Withdrawal by Subject|15|||
19503978|NCT01721876|41893643|FG001|Overall Study|Withdrawal by Subject|38|||
19503979|NCT01721876|41893642|FG000|Overall Study|Reason not listed|34|||
19503980|NCT01721876|41893643|FG001|Overall Study|Reason not listed|63|||
19503981|NCT01721876|41893642|FG000|Overall Study|Sponsor terminated trial|0|||
19503982|NCT01721876|41893643|FG001|Overall Study|Sponsor terminated trial|4|||
19503983|NCT02029443|41893675|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
19503984|NCT02029443|41893676|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
19503985|NCT02029443|41893677|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
19503986|NCT02029443|41893678|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
19503987|NCT02029443|41893679|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
19503988|NCT02029443|41893675|FG000|Overall Study|Death|13|||
19503989|NCT02029443|41893676|FG001|Overall Study|Death|2|||
19503990|NCT02029443|41893677|FG002|Overall Study|Death|2|||
19503991|NCT02029443|41893678|FG003|Overall Study|Death|11|||
19503992|NCT02029443|41893679|FG004|Overall Study|Death|2|||
19503993|NCT02029443|41893675|FG000|Overall Study|Lost to Follow-up|1|||
19503994|NCT02029443|41893676|FG001|Overall Study|Lost to Follow-up|0|||
19503995|NCT02029443|41893677|FG002|Overall Study|Lost to Follow-up|1|||
19503996|NCT02029443|41893678|FG003|Overall Study|Lost to Follow-up|1|||
19503997|NCT02029443|41893679|FG004|Overall Study|Lost to Follow-up|0|||
19503998|NCT02029443|41893675|FG000|Overall Study|Started other anti-cancer therapy|17|||
19503999|NCT02029443|41893676|FG001|Overall Study|Started other anti-cancer therapy|4|||
19504000|NCT02029443|41893677|FG002|Overall Study|Started other anti-cancer therapy|7|||
19504001|NCT02029443|41893678|FG003|Overall Study|Started other anti-cancer therapy|9|||
19504002|NCT02029443|41893679|FG004|Overall Study|Started other anti-cancer therapy|3|||
19504003|NCT02029443|41893675|FG000|Overall Study|Withdrawal by Subject|3|||
19504004|NCT02029443|41893676|FG001|Overall Study|Withdrawal by Subject|1|||
19504005|NCT02029443|41893677|FG002|Overall Study|Withdrawal by Subject|1|||
19504006|NCT02029443|41893678|FG003|Overall Study|Withdrawal by Subject|1|||
19504007|NCT02029443|41893679|FG004|Overall Study|Withdrawal by Subject|0|||
19504008|NCT02029443|41893675|FG000|Overall Study|Other|6|||
19504009|NCT02029443|41893676|FG001|Overall Study|Other|6|||
19504010|NCT02029443|41893677|FG002|Overall Study|Other|4|||
19504011|NCT02029443|41893678|FG003|Overall Study|Other|2|||
19504012|NCT02029443|41893679|FG004|Overall Study|Other|0|||
19504013|NCT02265510|41893930|FG000|Overall Study|Withdrawal by Subject|1|||
19504014|NCT02265510|41893931|FG001|Overall Study|Withdrawal by Subject|1|||
19504015|NCT02265510|41893932|FG002|Overall Study|Withdrawal by Subject|2|||
19504016|NCT02265510|41893933|FG003|Overall Study|Withdrawal by Subject|1|||
19504017|NCT02265510|41893934|FG004|Overall Study|Withdrawal by Subject|0|||
19504018|NCT02265510|41893935|FG005|Overall Study|Withdrawal by Subject|2|||
19504019|NCT02265510|41893936|FG006|Overall Study|Withdrawal by Subject|0|||
19504020|NCT02265510|41893937|FG007|Overall Study|Withdrawal by Subject|2|||
19504021|NCT02265510|41893938|FG008|Overall Study|Withdrawal by Subject|0|||
19504022|NCT02265510|41893939|FG009|Overall Study|Withdrawal by Subject|0|||
19504023|NCT02265510|41893940|FG010|Overall Study|Withdrawal by Subject|0|||
19504024|NCT02265510|41893941|FG011|Overall Study|Withdrawal by Subject|0|||
19504025|NCT02265510|41893942|FG012|Overall Study|Withdrawal by Subject|1|||
19504026|NCT02265510|41893943|FG013|Overall Study|Withdrawal by Subject|0|||
19504027|NCT02265510|41893930|FG000|Overall Study|Disease Progression|0|||
19504028|NCT02265510|41893931|FG001|Overall Study|Disease Progression|1|||
19504029|NCT02265510|41893932|FG002|Overall Study|Disease Progression|2|||
19504030|NCT02265510|41893933|FG003|Overall Study|Disease Progression|1|||
19504031|NCT02265510|41893934|FG004|Overall Study|Disease Progression|1|||
19504032|NCT02265510|41893935|FG005|Overall Study|Disease Progression|0|||
19504033|NCT02265510|41893936|FG006|Overall Study|Disease Progression|0|||
19615036|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
19615037|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
19615038|NCT00556933|42064269|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
19615039|NCT00556933|42064270|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
19615040|NCT00556933|42064271|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
19504034|NCT02265510|41893937|FG007|Overall Study|Disease Progression|0|||
19504035|NCT02265510|41893938|FG008|Overall Study|Disease Progression|0|||
19504036|NCT02265510|41893939|FG009|Overall Study|Disease Progression|0|||
19504037|NCT02265510|41893940|FG010|Overall Study|Disease Progression|0|||
19504038|NCT02265510|41893941|FG011|Overall Study|Disease Progression|0|||
19504039|NCT02265510|41893942|FG012|Overall Study|Disease Progression|0|||
19504040|NCT02265510|41893943|FG013|Overall Study|Disease Progression|0|||
19504041|NCT02265510|41893930|FG000|Overall Study|Death|2|||
19504042|NCT02265510|41893931|FG001|Overall Study|Death|0|||
19504043|NCT02265510|41893932|FG002|Overall Study|Death|2|||
19615041|NCT00556933|42064272|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
19615042|NCT00556933|42064269|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
19615043|NCT00556933|42064270|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
19615044|NCT00556933|42064271|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
19615045|NCT00556933|42064272|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
19615046|NCT00556933|42064269|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
19615047|NCT00556933|42064270|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
19615048|NCT00556933|42064271|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
19615049|NCT00556933|42064272|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
19615050|NCT00556933|42064269|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
19615051|NCT00556933|42064270|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
19615052|NCT00556933|42064271|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
19393817|NCT02633293|41637733|FG000|Overall Study|Withdrawal by Subject|41|||
19504044|NCT02265510|41893933|FG003|Overall Study|Death|2|||
19504045|NCT02265510|41893934|FG004|Overall Study|Death|1|||
19504046|NCT02265510|41893935|FG005|Overall Study|Death|3|||
19615053|NCT00556933|42064272|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
19393818|NCT02633293|41637733|FG000|Overall Study|Protocol Violation|1|||
19393819|NCT02633293|41637733|FG000|Overall Study|Lost to Follow-up|1|||
19393820|NCT02633293|41637733|FG000|Overall Study|Study Terminated by Sponsor|24|||
19393821|NCT02633293|41637733|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
19393822|NCT02633293|41637733|FG000|Overall Study|Lung Transplant|5|||
19393823|NCT02633293|41637733|FG000|Overall Study|Lack of Efficacy|2|||
19393824|NCT02633293|41637733|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
19393825|NCT02623829|41637739|FG000|Overall Study|Lost to Follow-up|1|||
19393826|NCT02623829|41637740|FG001|Overall Study|Lost to Follow-up|1|||
19393827|NCT02655679|41637751|FG000|Overall Study|Adverse Event|0|||
19393828|NCT02655679|41637752|FG001|Overall Study|Adverse Event|1|||
19393829|NCT02655679|41637753|FG002|Overall Study|Adverse Event|0|||
19393830|NCT02655679|41637754|FG003|Overall Study|Adverse Event|0|||
19393831|NCT02655679|41637755|FG004|Overall Study|Adverse Event|0|||
19393832|NCT02655679|41637751|FG000|Overall Study|Withdrawal by Subject|1|||
19393833|NCT02655679|41637752|FG001|Overall Study|Withdrawal by Subject|1|||
19393834|NCT02655679|41637753|FG002|Overall Study|Withdrawal by Subject|0|||
19393835|NCT02655679|41637754|FG003|Overall Study|Withdrawal by Subject|3|||
19393836|NCT02655679|41637755|FG004|Overall Study|Withdrawal by Subject|1|||
19393837|NCT02655679|41637751|FG000|Overall Study|Inability to Comply with the Protocol|1|||
19393838|NCT02655679|41637752|FG001|Overall Study|Inability to Comply with the Protocol|0|||
19393839|NCT02655679|41637753|FG002|Overall Study|Inability to Comply with the Protocol|0|||
19393840|NCT02655679|41637754|FG003|Overall Study|Inability to Comply with the Protocol|0|||
19393841|NCT02655679|41637755|FG004|Overall Study|Inability to Comply with the Protocol|0|||
19393842|NCT02655679|41637751|FG000|Overall Study|Lost to Follow-up|0|||
19393843|NCT02655679|41637752|FG001|Overall Study|Lost to Follow-up|1|||
19393844|NCT02655679|41637753|FG002|Overall Study|Lost to Follow-up|1|||
19393845|NCT02655679|41637754|FG003|Overall Study|Lost to Follow-up|1|||
19393846|NCT02655679|41637755|FG004|Overall Study|Lost to Follow-up|0|||
19393847|NCT02655679|41637751|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19393848|NCT02655679|41637752|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19393849|NCT02655679|41637753|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19393850|NCT02655679|41637754|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19393851|NCT02655679|41637755|FG004|Overall Study|Other Miscellaneous Reasons|0|||
19393852|NCT02623361|41637770|FG000|Overall Study|Protocol Violation|0|||
19393853|NCT02623361|41637771|FG001|Overall Study|Protocol Violation|1|||
19393854|NCT02623361|41637770|FG000|Overall Study|Withdrawal by Subject|0|||
19393855|NCT02623361|41637771|FG001|Overall Study|Withdrawal by Subject|1|||
19393856|NCT01675531|41637799|FG000|Overall Study|Adverse Event|9|||
19393857|NCT01675531|41637799|FG000|Overall Study|Withdrawal by Subject|7|||
19393858|NCT01675531|41637799|FG000|Overall Study|Lack of Efficacy|1|||
19393859|NCT01675531|41637799|FG000|Overall Study|Protocol Violation|8|||
19393860|NCT02532543|41637808|FG000|Overall Study|Lost to Follow-up|0|||
19393861|NCT02532543|41637809|FG001|Overall Study|Lost to Follow-up|0|||
19393862|NCT02532543|41637810|FG002|Overall Study|Lost to Follow-up|1|||
19393863|NCT02532543|41637811|FG003|Overall Study|Lost to Follow-up|0|||
19393864|NCT02532465|41637823|FG000|Overall Study|Protocol Violation|1|||
19393865|NCT02532465|41637824|FG001|Overall Study|Protocol Violation|0|||
19393866|NCT02532465|41637823|FG000|Overall Study|Lack of Efficacy|0|||
19393867|NCT02532465|41637824|FG001|Overall Study|Lack of Efficacy|1|||
19393868|NCT02528331|41637830|FG000|Overall Study|Withdrawal by Subject|2|||
19393869|NCT02654977|41637834|FG000|Overall Study|Death|1|||
19393870|NCT02654977|41637834|FG000|Overall Study|Lost to Follow-up|1|||
19393871|NCT02654977|41637834|FG000|Overall Study|Adverse Event|1|||
19393872|NCT02654977|41637834|FG000|Overall Study|Withdrawal by Subject|1|||
19393873|NCT02654977|41637834|FG000|Overall Study|Lack of Efficacy|3|||
19393874|NCT01362517|41637838|FG000|Overall Study|Protocol Violation|1|||
19504047|NCT02265510|41893936|FG006|Overall Study|Death|2|||
19504048|NCT02265510|41893937|FG007|Overall Study|Death|1|||
19504049|NCT02265510|41893938|FG008|Overall Study|Death|3|||
19504050|NCT02265510|41893939|FG009|Overall Study|Death|3|||
19504051|NCT02265510|41893940|FG010|Overall Study|Death|4|||
19504052|NCT02265510|41893941|FG011|Overall Study|Death|12|||
19504053|NCT02265510|41893942|FG012|Overall Study|Death|7|||
19504054|NCT02265510|41893943|FG013|Overall Study|Death|6|||
19504055|NCT02265510|41893930|FG000|Overall Study|Lost to Follow-up|0|||
19504056|NCT02265510|41893931|FG001|Overall Study|Lost to Follow-up|0|||
19504057|NCT02265510|41893932|FG002|Overall Study|Lost to Follow-up|0|||
19504058|NCT02265510|41893933|FG003|Overall Study|Lost to Follow-up|0|||
19504059|NCT02265510|41893934|FG004|Overall Study|Lost to Follow-up|1|||
19504060|NCT02265510|41893935|FG005|Overall Study|Lost to Follow-up|0|||
19504061|NCT02265510|41893936|FG006|Overall Study|Lost to Follow-up|0|||
19504062|NCT02265510|41893937|FG007|Overall Study|Lost to Follow-up|0|||
19504063|NCT02265510|41893938|FG008|Overall Study|Lost to Follow-up|0|||
19504064|NCT02265510|41893939|FG009|Overall Study|Lost to Follow-up|2|||
19504065|NCT02265510|41893940|FG010|Overall Study|Lost to Follow-up|0|||
19504066|NCT02265510|41893941|FG011|Overall Study|Lost to Follow-up|0|||
19504067|NCT02265510|41893942|FG012|Overall Study|Lost to Follow-up|0|||
19504068|NCT02265510|41893943|FG013|Overall Study|Lost to Follow-up|2|||
19504069|NCT02265510|41893930|FG000|Overall Study|Other|0|||
19504070|NCT02265510|41893931|FG001|Overall Study|Other|1|||
19504071|NCT02265510|41893932|FG002|Overall Study|Other|0|||
19504072|NCT02265510|41893933|FG003|Overall Study|Other|0|||
19504073|NCT02265510|41893934|FG004|Overall Study|Other|0|||
19504074|NCT02265510|41893935|FG005|Overall Study|Other|0|||
19504075|NCT02265510|41893936|FG006|Overall Study|Other|0|||
19504076|NCT02265510|41893937|FG007|Overall Study|Other|0|||
19504077|NCT02265510|41893938|FG008|Overall Study|Other|0|||
19504078|NCT02265510|41893939|FG009|Overall Study|Other|0|||
19504079|NCT02265510|41893940|FG010|Overall Study|Other|0|||
19504080|NCT02265510|41893941|FG011|Overall Study|Other|0|||
19504081|NCT02265510|41893942|FG012|Overall Study|Other|0|||
19504082|NCT02265510|41893943|FG013|Overall Study|Other|0|||
19504083|NCT02265510|41893930|FG000|Overall Study|Study Terminated by Sponsor|0|||
19504084|NCT02265510|41893931|FG001|Overall Study|Study Terminated by Sponsor|0|||
19504085|NCT02265510|41893932|FG002|Overall Study|Study Terminated by Sponsor|0|||
19504086|NCT02265510|41893933|FG003|Overall Study|Study Terminated by Sponsor|0|||
19504087|NCT02265510|41893934|FG004|Overall Study|Study Terminated by Sponsor|0|||
19504088|NCT02265510|41893935|FG005|Overall Study|Study Terminated by Sponsor|1|||
19504089|NCT02265510|41893936|FG006|Overall Study|Study Terminated by Sponsor|1|||
19504090|NCT02265510|41893937|FG007|Overall Study|Study Terminated by Sponsor|1|||
19504091|NCT02265510|41893938|FG008|Overall Study|Study Terminated by Sponsor|1|||
19504092|NCT02265510|41893939|FG009|Overall Study|Study Terminated by Sponsor|2|||
19504093|NCT02265510|41893940|FG010|Overall Study|Study Terminated by Sponsor|1|||
19504094|NCT02265510|41893941|FG011|Overall Study|Study Terminated by Sponsor|4|||
19504095|NCT02265510|41893942|FG012|Overall Study|Study Terminated by Sponsor|1|||
19504096|NCT02265510|41893943|FG013|Overall Study|Study Terminated by Sponsor|2|||
19504097|NCT01238211|41894044|FG000|Overall Study|Continues active treatment|31|||
19504098|NCT01238211|41894044|FG000|Overall Study|Adverse Event|7|||
19504099|NCT01238211|41894044|FG000|Overall Study|Death|4|||
19504100|NCT01238211|41894044|FG000|Overall Study|Relapse/Progression|2|||
19504101|NCT01238211|41894044|FG000|Overall Study|Withdrawal by Subject|7|||
19504102|NCT01238211|41894044|FG000|Overall Study|Non-protocol treatment|4|||
19504103|NCT01238211|41894044|FG000|Overall Study|Investigator/Patient Decision|3|||
19504104|NCT02264574|41894220|FG000|Overall Study|Death|21|||
19504105|NCT02264574|41894221|FG001|Overall Study|Death|21|||
19504106|NCT02264574|41894220|FG000|Overall Study|Withdrawal by Subject|8|||
19504107|NCT02264574|41894221|FG001|Overall Study|Withdrawal by Subject|6|||
19504108|NCT02264574|41894220|FG000|Overall Study|Other, Not Specified|0|||
19504109|NCT02264574|41894221|FG001|Overall Study|Other, Not Specified|3|||
19504110|NCT01641900|41894261|FG000|Overall Study|Withdrawal by Subject|2|||
19504111|NCT01641900|41894262|FG001|Overall Study|Withdrawal by Subject|2|||
19504112|NCT01640808|41894335|FG000|Overall Study|Unable to continue dynamic CT|14|||
19504113|NCT01640808|41894336|FG001|Overall Study|Unable to continue dynamic CT|4|||
19504114|NCT01640808|41894335|FG000|Overall Study|Withdrawal by Subject|12|||
19504115|NCT01640808|41894336|FG001|Overall Study|Withdrawal by Subject|4|||
19504116|NCT01640808|41894335|FG000|Overall Study|Lost to Follow-up|4|||
19504117|NCT01640808|41894336|FG001|Overall Study|Lost to Follow-up|0|||
19504118|NCT01640808|41894335|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
19504119|NCT01640808|41894336|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
19504120|NCT01640808|41894335|FG000|Overall Study|Administration of anticancer drugs|2|||
19504121|NCT01640808|41894336|FG001|Overall Study|Administration of anticancer drugs|1|||
19504122|NCT01640808|41894335|FG000|Overall Study|Physician Decision|19|||
19504123|NCT01640808|41894336|FG001|Overall Study|Physician Decision|5|||
19504124|NCT01640808|41894335|FG000|Overall Study|Randomized but not treated|4|||
19504125|NCT01640808|41894336|FG001|Overall Study|Randomized but not treated|2|||
19504126|NCT02263326|41894357|FG000|Overall Study|Lost to Follow-up|1|||
19504127|NCT02263326|41894358|FG001|Overall Study|Lost to Follow-up|1|||
19504128|NCT02260986|41894469|FG000|Overall Study|Adverse Event|24|||
19504129|NCT02260986|41894470|FG001|Overall Study|Adverse Event|0|||
19504130|NCT02260986|41894471|FG002|Overall Study|Adverse Event|11|||
19504131|NCT02260986|41894469|FG000|Overall Study|Lack of Efficacy|27|||
19504132|NCT02260986|41894470|FG001|Overall Study|Lack of Efficacy|3|||
19504133|NCT02260986|41894471|FG002|Overall Study|Lack of Efficacy|0|||
19504134|NCT02260986|41894469|FG000|Overall Study|Protocol Violation|14|||
19615054|NCT00556933|42064269|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
19615055|NCT00556933|42064270|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
19615056|NCT00556933|42064271|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
19615057|NCT00556933|42064272|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
19615058|NCT00556933|42064269|FG000|CNI Withdrawal vs. Minimization|Death|0|||
19615059|NCT00556933|42064270|FG001|CNI Withdrawal vs. Minimization|Death|0|||
19615060|NCT00556933|42064271|FG002|CNI Withdrawal vs. Minimization|Death|0|||
19615061|NCT00556933|42064272|FG003|CNI Withdrawal vs. Minimization|Death|1|||
19615062|NCT00770211|42064293|FG000|Overall Study|Lost to Follow-up|1|||
19615063|NCT00770211|42064294|FG001|Overall Study|Lost to Follow-up|0|||
19504135|NCT02260986|41894470|FG001|Overall Study|Protocol Violation|5|||
19504136|NCT02260986|41894471|FG002|Overall Study|Protocol Violation|16|||
19504137|NCT02260986|41894469|FG000|Overall Study|Car accident|0|||
19504138|NCT02260986|41894470|FG001|Overall Study|Car accident|0|||
19504139|NCT02260986|41894471|FG002|Overall Study|Car accident|1|||
19504140|NCT02260986|41894469|FG000|Overall Study|Withdrawal by Subject|17|||
19504141|NCT02260986|41894470|FG001|Overall Study|Withdrawal by Subject|4|||
19504142|NCT02260986|41894471|FG002|Overall Study|Withdrawal by Subject|9|||
19504143|NCT02260986|41894469|FG000|Overall Study|Incorrect randomization|0|||
19504144|NCT02260986|41894470|FG001|Overall Study|Incorrect randomization|1|||
19504145|NCT02260986|41894471|FG002|Overall Study|Incorrect randomization|0|||
19504146|NCT02260986|41894469|FG000|Overall Study|Lack of investigation product supply|2|||
19504147|NCT02260986|41894470|FG001|Overall Study|Lack of investigation product supply|0|||
19504148|NCT02260986|41894471|FG002|Overall Study|Lack of investigation product supply|1|||
19504149|NCT02260986|41894469|FG000|Overall Study|Lost to Follow-up|4|||
19504150|NCT02260986|41894470|FG001|Overall Study|Lost to Follow-up|0|||
19504151|NCT02260986|41894471|FG002|Overall Study|Lost to Follow-up|3|||
19504152|NCT02260986|41894469|FG000|Overall Study|Pregnancy|2|||
19504153|NCT02260986|41894470|FG001|Overall Study|Pregnancy|0|||
19615064|NCT00770211|42064293|FG000|Overall Study|Withdrawal by Subject|0|||
19615065|NCT00770211|42064294|FG001|Overall Study|Withdrawal by Subject|2|||
19615066|NCT00928187|42064303|FG000|Overall Study|Death|1|||
19615067|NCT00928187|42064304|FG001|Overall Study|Death|2|||
19615068|NCT00928187|42064305|FG002|Overall Study|Death|3|||
19615069|NCT00928187|42064303|FG000|Overall Study|Lost to Follow-up|1|||
19704466|NCT03745222|42148839|FG000|Overall Study|Withdrawal by Subject|0|||
19504154|NCT02260986|41894471|FG002|Overall Study|Pregnancy|0|||
19504155|NCT02259582|41894487|FG000|Overall Study|Physician Decision|0|||
19504156|NCT02259582|41894488|FG001|Overall Study|Physician Decision|1|||
19504157|NCT02259582|41894489|FG002|Overall Study|Physician Decision|0|||
19504158|NCT02259582|41894487|FG000|Overall Study|Death|0|||
19504159|NCT02259582|41894488|FG001|Overall Study|Death|0|||
19504160|NCT02259582|41894489|FG002|Overall Study|Death|1|||
19504161|NCT02259582|41894487|FG000|Overall Study|Adverse Event|1|||
19504162|NCT02259582|41894488|FG001|Overall Study|Adverse Event|0|||
19504163|NCT02259582|41894489|FG002|Overall Study|Adverse Event|1|||
19504164|NCT02259582|41894487|FG000|Overall Study|Withdrawal by Subject|0|||
19504165|NCT02259582|41894488|FG001|Overall Study|Withdrawal by Subject|0|||
19504166|NCT02259582|41894489|FG002|Overall Study|Withdrawal by Subject|1|||
19504167|NCT02259582|41894487|FG000|Overall Study|Disease progression|14|||
19504168|NCT02259582|41894488|FG001|Overall Study|Disease progression|15|||
19504169|NCT02259582|41894489|FG002|Overall Study|Disease progression|17|||
19504170|NCT02259582|41894487|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
19504171|NCT02259582|41894488|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
19615070|NCT00928187|42064304|FG001|Overall Study|Lost to Follow-up|2|||
19615071|NCT00928187|42064305|FG002|Overall Study|Lost to Follow-up|1|||
19615072|NCT00928187|42064303|FG000|Overall Study|Withdrawal by Subject|0|||
19704467|NCT03745222|42148840|FG001|Overall Study|Withdrawal by Subject|1|||
19504172|NCT02259582|41894489|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
19504173|NCT03238651|41894502|FG000|Overall Study|Other|0|||
19504174|NCT03238651|41894503|FG001|Overall Study|Other|0|||
19504175|NCT03238651|41894504|FG002|Overall Study|Other|0|||
19615073|NCT00928187|42064304|FG001|Overall Study|Withdrawal by Subject|1|||
19615074|NCT00928187|42064305|FG002|Overall Study|Withdrawal by Subject|1|||
19615075|NCT00928187|42064303|FG000|Overall Study|Protocol Violation|0|||
19615076|NCT00928187|42064304|FG001|Overall Study|Protocol Violation|1|||
19504176|NCT03238651|41894505|FG003|Overall Study|Other|0|||
19504177|NCT03238651|41894506|FG004|Overall Study|Other|1|||
19504178|NCT03238651|41894502|FG000|Overall Study|Progressive Disease|2|||
19504179|NCT03238651|41894503|FG001|Overall Study|Progressive Disease|2|||
19504180|NCT03238651|41894504|FG002|Overall Study|Progressive Disease|2|||
19504181|NCT03238651|41894505|FG003|Overall Study|Progressive Disease|2|||
19504182|NCT03238651|41894506|FG004|Overall Study|Progressive Disease|0|||
19504183|NCT03238651|41894502|FG000|Overall Study|Withdrawal by Subject|0|||
19504184|NCT03238651|41894503|FG001|Overall Study|Withdrawal by Subject|1|||
19504185|NCT03238651|41894504|FG002|Overall Study|Withdrawal by Subject|0|||
19504186|NCT03238651|41894505|FG003|Overall Study|Withdrawal by Subject|1|||
19504187|NCT03238651|41894506|FG004|Overall Study|Withdrawal by Subject|0|||
19504188|NCT03238651|41894502|FG000|Overall Study|Adverse Event|1|||
19504189|NCT03238651|41894503|FG001|Overall Study|Adverse Event|3|||
19504190|NCT03238651|41894504|FG002|Overall Study|Adverse Event|2|||
19504191|NCT03238651|41894505|FG003|Overall Study|Adverse Event|0|||
19504192|NCT03238651|41894506|FG004|Overall Study|Adverse Event|0|||
19504193|NCT02259348|41894519|FG000|Overall Study|Donors|6|||
19504194|NCT02259348|41894519|FG000|Overall Study|Death|4|||
19504195|NCT02259114|41894780|FG000|Overall Study|Progressive Disease|14|||
19504196|NCT02259114|41894781|FG001|Overall Study|Progressive Disease|2|||
19504197|NCT02259114|41894782|FG002|Overall Study|Progressive Disease|10|||
19504198|NCT02259114|41894783|FG003|Overall Study|Progressive Disease|2|||
19504199|NCT02259114|41894784|FG004|Overall Study|Progressive Disease|5|||
19504200|NCT02259114|41894780|FG000|Overall Study|Adverse Event|2|||
19504201|NCT02259114|41894781|FG001|Overall Study|Adverse Event|1|||
19504202|NCT02259114|41894782|FG002|Overall Study|Adverse Event|0|||
19504203|NCT02259114|41894783|FG003|Overall Study|Adverse Event|0|||
19504204|NCT02259114|41894784|FG004|Overall Study|Adverse Event|1|||
19504205|NCT02259114|41894780|FG000|Overall Study|Death|3|||
19504206|NCT02259114|41894781|FG001|Overall Study|Death|0|||
19504207|NCT02259114|41894782|FG002|Overall Study|Death|1|||
19504208|NCT02259114|41894783|FG003|Overall Study|Death|0|||
19504209|NCT02259114|41894784|FG004|Overall Study|Death|0|||
19504210|NCT02259114|41894780|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
19504211|NCT02259114|41894781|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
19504212|NCT02259114|41894782|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
19504213|NCT02259114|41894783|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
19504214|NCT02259114|41894784|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
19504215|NCT02259114|41894780|FG000|Overall Study|Withdrawal by Subject|0|||
19504216|NCT02259114|41894781|FG001|Overall Study|Withdrawal by Subject|0|||
19504217|NCT02259114|41894782|FG002|Overall Study|Withdrawal by Subject|1|||
19504218|NCT02259114|41894783|FG003|Overall Study|Withdrawal by Subject|1|||
19504219|NCT02259114|41894784|FG004|Overall Study|Withdrawal by Subject|0|||
19504220|NCT02259114|41894780|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
19504221|NCT02259114|41894781|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
19504222|NCT02259114|41894782|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
19504223|NCT02259114|41894783|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
19504224|NCT02259114|41894784|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
19504225|NCT02259114|41894780|FG000|Overall Study|Not Treated|1|||
19504226|NCT02259114|41894781|FG001|Overall Study|Not Treated|0|||
19504227|NCT02259114|41894782|FG002|Overall Study|Not Treated|0|||
19504228|NCT02259114|41894783|FG003|Overall Study|Not Treated|0|||
19504229|NCT02259114|41894784|FG004|Overall Study|Not Treated|0|||
19504230|NCT03112603|41894798|FG000|End of Randomization Period|Lost to Follow-up|1|||
19504231|NCT03112603|41894799|FG001|End of Randomization Period|Lost to Follow-up|0|||
19504232|NCT03112603|41894800|FG002|End of Randomization Period|Lost to Follow-up|0|||
19504233|NCT03112603|41894798|FG000|End of Randomization Period|Subject/Guardian Decision|4|||
19504234|NCT03112603|41894799|FG001|End of Randomization Period|Subject/Guardian Decision|11|||
19504235|NCT03112603|41894800|FG002|End of Randomization Period|Subject/Guardian Decision|0|||
19504236|NCT03112603|41894798|FG000|End of Randomization Period|Physician Decision|4|||
19504237|NCT03112603|41894799|FG001|End of Randomization Period|Physician Decision|14|||
19504238|NCT03112603|41894800|FG002|End of Randomization Period|Physician Decision|0|||
19504239|NCT03112603|41894798|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4|||
19504240|NCT03112603|41894799|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5|||
19504241|NCT03112603|41894800|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0|||
19504242|NCT03112603|41894798|FG000|End of Randomization Period|Death|8|||
19504243|NCT03112603|41894799|FG001|End of Randomization Period|Death|7|||
19504244|NCT03112603|41894800|FG002|End of Randomization Period|Death|0|||
19504245|NCT03112603|41894798|FG000|End of Randomization Period|Disease Relapse|9|||
19504246|NCT03112603|41894799|FG001|End of Randomization Period|Disease Relapse|7|||
19504247|NCT03112603|41894800|FG002|End of Randomization Period|Disease Relapse|0|||
19504248|NCT03112603|41894798|FG000|End of Randomization Period|Lack of Efficacy|24|||
19504249|NCT03112603|41894799|FG001|End of Randomization Period|Lack of Efficacy|70|||
19504250|NCT03112603|41894800|FG002|End of Randomization Period|Lack of Efficacy|0|||
19504251|NCT03112603|41894798|FG000|End of Randomization Period|Adverse Event|28|||
19504252|NCT03112603|41894799|FG001|End of Randomization Period|Adverse Event|8|||
19504253|NCT03112603|41894800|FG002|End of Randomization Period|Adverse Event|0|||
19504254|NCT03112603|41894798|FG000|End of Randomization Period|Ongoing Treatment|83|||
19504255|NCT03112603|41894799|FG001|End of Randomization Period|Ongoing Treatment|42|||
19504256|NCT03112603|41894800|FG002|End of Randomization Period|Ongoing Treatment|0|||
19504257|NCT03112603|41894798|FG000|End of Cross Over Period|Death|0|||
19504258|NCT03112603|41894799|FG001|End of Cross Over Period|Death|0|||
19504259|NCT03112603|41894800|FG002|End of Cross Over Period|Death|1|||
19615077|NCT00928187|42064305|FG002|Overall Study|Protocol Violation|0|||
19615078|NCT00769119|42064315|FG000|Overall Study|Voluntary discontinuation|0|||
19615079|NCT00769119|42064316|FG001|Overall Study|Voluntary discontinuation|2|||
19615080|NCT00769119|42064315|FG000|Overall Study|Adverse Event|1|||
19615081|NCT00769119|42064316|FG001|Overall Study|Adverse Event|1|||
19615082|NCT00769119|42064315|FG000|Overall Study|Disallowed medication|1|||
19615083|NCT00769119|42064316|FG001|Overall Study|Disallowed medication|0|||
19615084|NCT00927953|42064324|FG000|Overall Study|Death|2|||
19615085|NCT00927953|42064325|FG001|Overall Study|Death|1|||
19615086|NCT00768651|42064332|FG000|Overall Study|Withdrawal by Subject|1|||
19615087|NCT00756717|42064337|FG000|Overall Study|Withdrawal by Subject|2|||
19615088|NCT03962101|42064341|FG000|Overall Study|Adverse Event|1|||
19615089|NCT03962101|42064341|FG000|Overall Study|Physician Decision|2|||
19615090|NCT03962101|42064341|FG000|Overall Study|Not related to medical events|1|||
19615091|NCT00923351|42064348|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
19615092|NCT00923351|42064349|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
19615093|NCT00923351|42064350|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
19704468|NCT03745222|42148841|FG002|Overall Study|Withdrawal by Subject|0|||
19704469|NCT03743038|42148849|FG000|Overall Study|Physician Decision|1|||
19504260|NCT03112603|41894798|FG000|End of Cross Over Period|Subject/Guardian Decision|0|||
19504261|NCT03112603|41894799|FG001|End of Cross Over Period|Subject/Guardian Decision|0|||
19504262|NCT03112603|41894800|FG002|End of Cross Over Period|Subject/Guardian Decision|3|||
19504263|NCT03112603|41894798|FG000|End of Cross Over Period|Physician Decision|0|||
19504264|NCT03112603|41894799|FG001|End of Cross Over Period|Physician Decision|0|||
19504265|NCT03112603|41894800|FG002|End of Cross Over Period|Physician Decision|3|||
19504266|NCT03112603|41894798|FG000|End of Cross Over Period|Lack of Efficacy|0|||
19504267|NCT03112603|41894799|FG001|End of Cross Over Period|Lack of Efficacy|0|||
19504268|NCT03112603|41894800|FG002|End of Cross Over Period|Lack of Efficacy|4|||
19504269|NCT03112603|41894798|FG000|End of Cross Over Period|Adverse Event|0|||
19504270|NCT03112603|41894799|FG001|End of Cross Over Period|Adverse Event|0|||
19504271|NCT03112603|41894800|FG002|End of Cross Over Period|Adverse Event|4|||
19504272|NCT03112603|41894798|FG000|End of Cross Over Period|Treatment Ongoing|0|||
19504273|NCT03112603|41894799|FG001|End of Cross Over Period|Treatment Ongoing|0|||
19504274|NCT03112603|41894800|FG002|End of Cross Over Period|Treatment Ongoing|46|||
19504275|NCT02258334|41894849|FG000|Overall Study|Adverse Event|1|||
19504276|NCT02258334|41894850|FG001|Overall Study|Adverse Event|0|||
19504277|NCT02258334|41894851|FG002|Overall Study|Adverse Event|0|||
19504278|NCT02258334|41894852|FG003|Overall Study|Adverse Event|0|||
19504279|NCT04960202|41894889|FG000|Overall Study|Other|12|||
19504280|NCT04960202|41894890|FG001|Overall Study|Other|10|||
19504281|NCT04960202|41894889|FG000|Overall Study|Withdrawal by Subject|43|||
19504282|NCT04960202|41894890|FG001|Overall Study|Withdrawal by Subject|45|||
19504283|NCT04960202|41894889|FG000|Overall Study|Lost to Follow-up|20|||
19504284|NCT04960202|41894890|FG001|Overall Study|Lost to Follow-up|17|||
19504285|NCT04960202|41894889|FG000|Overall Study|Death|0|||
19504286|NCT04960202|41894890|FG001|Overall Study|Death|15|||
19504287|NCT02257632|41894960|FG000|Overall Study|Withdrawal by Subject|0|||
19504288|NCT02257632|41894961|FG001|Overall Study|Withdrawal by Subject|1|||
19504289|NCT02257632|41894960|FG000|Overall Study|Adverse Event|1|||
19504290|NCT02257632|41894961|FG001|Overall Study|Adverse Event|2|||
19504291|NCT01642914|41895008|FG000|Overall Study|Adverse Event|11|||
19504292|NCT01642914|41895009|FG001|Overall Study|Adverse Event|7|||
19504293|NCT01642914|41895010|FG002|Overall Study|Adverse Event|15|||
19504294|NCT01642914|41895008|FG000|Overall Study|Lack of Efficacy|9|||
19504295|NCT01642914|41895009|FG001|Overall Study|Lack of Efficacy|4|||
19504296|NCT01642914|41895010|FG002|Overall Study|Lack of Efficacy|2|||
19504297|NCT01642914|41895008|FG000|Overall Study|Protocol Violation|15|||
19504298|NCT01642914|41895009|FG001|Overall Study|Protocol Violation|13|||
19504299|NCT01642914|41895010|FG002|Overall Study|Protocol Violation|6|||
19504300|NCT01642914|41895008|FG000|Overall Study|Withdrawal by Subject|5|||
19504301|NCT01642914|41895009|FG001|Overall Study|Withdrawal by Subject|5|||
19504302|NCT01642914|41895010|FG002|Overall Study|Withdrawal by Subject|10|||
19615094|NCT00755937|42064356|FG000|Recruitment|Unknown if infliximab received|164|||
19615095|NCT00755937|42064356|FG000|Observational Follow-up|Lost to Follow-up|148|||
19615096|NCT00755079|42064362|FG000|Overall Study|Lost to Follow-up|1|||
19504303|NCT01642914|41895008|FG000|Overall Study|Lost to Follow-up|5|||
19504304|NCT01642914|41895009|FG001|Overall Study|Lost to Follow-up|3|||
19504305|NCT01642914|41895010|FG002|Overall Study|Lost to Follow-up|7|||
19504306|NCT01642914|41895008|FG000|Overall Study|Other Reason|1|||
19504307|NCT01642914|41895009|FG001|Overall Study|Other Reason|0|||
19504308|NCT01642914|41895010|FG002|Overall Study|Other Reason|0|||
19504309|NCT01642602|41895069|FG000|Overall Study|Adverse Event|2|||
19504310|NCT02256540|41895122|FG000|Overall Study|Withdrawal by Subject|0|||
19504311|NCT02256540|41895123|FG001|Overall Study|Withdrawal by Subject|1|||
19504312|NCT02256540|41895124|FG002|Overall Study|Withdrawal by Subject|1|||
19504313|NCT02256540|41895122|FG000|Overall Study|Back pain preventing exercise|0|||
19504314|NCT02256540|41895123|FG001|Overall Study|Back pain preventing exercise|0|||
19504315|NCT02256540|41895124|FG002|Overall Study|Back pain preventing exercise|1|||
19504316|NCT01640184|41895148|FG000|Overall Study|Death|1|||
19504317|NCT01640184|41895149|FG001|Overall Study|Death|0|||
19504318|NCT01640184|41895150|FG002|Overall Study|Death|0|||
19504319|NCT01640184|41895148|FG000|Overall Study|Lost to Follow-up|4|||
19504320|NCT01640184|41895149|FG001|Overall Study|Lost to Follow-up|1|||
19504321|NCT01640184|41895150|FG002|Overall Study|Lost to Follow-up|0|||
19504322|NCT01640184|41895148|FG000|Overall Study|Physician Decision|3|||
19504323|NCT01640184|41895149|FG001|Overall Study|Physician Decision|0|||
19504324|NCT01640184|41895150|FG002|Overall Study|Physician Decision|0|||
19504325|NCT01640184|41895148|FG000|Overall Study|Withdrawal by Subject|0|||
19504326|NCT01640184|41895149|FG001|Overall Study|Withdrawal by Subject|1|||
19504327|NCT01640184|41895150|FG002|Overall Study|Withdrawal by Subject|1|||
19504328|NCT01640184|41895148|FG000|Overall Study|Protocol Violation|0|||
19504329|NCT01640184|41895149|FG001|Overall Study|Protocol Violation|0|||
19504330|NCT01640184|41895150|FG002|Overall Study|Protocol Violation|1|||
19504331|NCT02256384|41895170|FG000|Overall Study|Withdrawal by Subject|12|||
19504332|NCT02256384|41895170|FG000|Overall Study|Equipment not capturing data|2|||
19504333|NCT02255760|41895213|FG000|Overall Study|Lost to Follow-up|0|||
19504334|NCT02255760|41895214|FG001|Overall Study|Lost to Follow-up|1|||
19504335|NCT02255760|41895215|FG002|Overall Study|Lost to Follow-up|0|||
19504336|NCT02255760|41895216|FG003|Overall Study|Lost to Follow-up|0|||
19504337|NCT02255760|41895217|FG004|Overall Study|Lost to Follow-up|0|||
19504338|NCT01641822|41895313|FG000|Run-in Phase|Noncompliance with study drug|1|||
19504339|NCT01641822|41895314|FG001|Run-in Phase|Noncompliance with study drug|0|||
19504340|NCT01641822|41895315|FG002|Run-in Phase|Noncompliance with study drug|0|||
19504341|NCT01641822|41895313|FG000|Run-in Phase|Adverse Event|3|||
19504342|NCT01641822|41895314|FG001|Run-in Phase|Adverse Event|0|||
19504343|NCT01641822|41895315|FG002|Run-in Phase|Adverse Event|0|||
19504344|NCT01641822|41895313|FG000|Run-in Phase|Withdrew consent|1|||
19504345|NCT01641822|41895314|FG001|Run-in Phase|Withdrew consent|0|||
19504346|NCT01641822|41895315|FG002|Run-in Phase|Withdrew consent|0|||
19504347|NCT01641822|41895313|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
19504348|NCT01641822|41895314|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
19504349|NCT01641822|41895315|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
19504350|NCT01641822|41895313|FG000|Comparative Phase|Noncompliance with study drug|0|||
19504351|NCT01641822|41895314|FG001|Comparative Phase|Noncompliance with study drug|1|||
19504352|NCT01641822|41895315|FG002|Comparative Phase|Noncompliance with study drug|0|||
19504353|NCT01641822|41895313|FG000|Comparative Phase|Investigator's discretion|0|||
19504354|NCT01641822|41895314|FG001|Comparative Phase|Investigator's discretion|0|||
19504355|NCT01641822|41895315|FG002|Comparative Phase|Investigator's discretion|1|||
19504356|NCT01641822|41895313|FG000|Comparative Phase|Pregnancy|0|||
19504357|NCT01641822|41895314|FG001|Comparative Phase|Pregnancy|0|||
19504358|NCT01641822|41895315|FG002|Comparative Phase|Pregnancy|1|||
19504359|NCT01641822|41895313|FG000|Comparative Phase|Adverse event, serious fatal|0|||
19504360|NCT01641822|41895314|FG001|Comparative Phase|Adverse event, serious fatal|1|||
19504361|NCT01641822|41895315|FG002|Comparative Phase|Adverse event, serious fatal|0|||
19504362|NCT01641822|41895313|FG000|Comparative Phase|Withdrew consent|0|||
19615097|NCT00755079|42064363|FG001|Overall Study|Lost to Follow-up|3|||
19615098|NCT00755079|42064362|FG000|Overall Study|Adverse Event|0|||
19615099|NCT00755079|42064363|FG001|Overall Study|Adverse Event|1|||
19615100|NCT00755079|42064362|FG000|Overall Study|Withdrawal by Subject|0|||
19615101|NCT00755079|42064363|FG001|Overall Study|Withdrawal by Subject|2|||
19615102|NCT00925301|42064371|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
19504363|NCT01641822|41895314|FG001|Comparative Phase|Withdrew consent|3|||
19504364|NCT01641822|41895315|FG002|Comparative Phase|Withdrew consent|7|||
19504365|NCT01641822|41895313|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
19504366|NCT01641822|41895314|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
19504367|NCT01641822|41895315|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
19504368|NCT01641198|41895395|FG000|After 12 Months of Function|Lost to Follow-up|3|||
19504369|NCT01641198|41895396|FG001|After 12 Months of Function|Lost to Follow-up|2|||
19504370|NCT01641198|41895397|FG002|After 12 Months of Function|Lost to Follow-up|2|||
19504371|NCT01641198|41895395|FG000|After 12 Months of Function|Protocol Violation|1|||
19504372|NCT01641198|41895396|FG001|After 12 Months of Function|Protocol Violation|0|||
19504373|NCT01641198|41895397|FG002|After 12 Months of Function|Protocol Violation|0|||
19504374|NCT01641198|41895395|FG000|After 12 Months of Function|Adverse Event|0|||
19504375|NCT01641198|41895396|FG001|After 12 Months of Function|Adverse Event|1|||
19504376|NCT01641198|41895397|FG002|After 12 Months of Function|Adverse Event|0|||
19504377|NCT01641198|41895395|FG000|After 24 Months of Function|Lost to Follow-up|4|||
19504378|NCT01641198|41895396|FG001|After 24 Months of Function|Lost to Follow-up|9|||
19704470|NCT00153816|42148861|FG000|Overall Study|Death|6|||
19504379|NCT01641198|41895397|FG002|After 24 Months of Function|Lost to Follow-up|6|||
19504380|NCT01641198|41895395|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
19504381|NCT01641198|41895396|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
19504382|NCT01641198|41895397|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
19393875|NCT01362517|41637838|FG000|Overall Study|Lost to Follow-up|1|||
19393876|NCT01362439|41637845|FG000|Overall Study|Adverse Event|1|||
19393877|NCT01362439|41637845|FG000|Overall Study|Lack of Efficacy|3|||
19393878|NCT01362439|41637845|FG000|Overall Study|Lost to Follow-up|2|||
19393879|NCT01362439|41637845|FG000|Overall Study|Study medication non-compliant|1|||
19393880|NCT01362439|41637845|FG000|Overall Study|Participant who withdrew consent|8|||
19393881|NCT02653495|41637865|FG000|Overall Study|Lost to Follow-up|2|||
19393882|NCT02653495|41637866|FG001|Overall Study|Lost to Follow-up|0|||
19393883|NCT02653495|41637865|FG000|Overall Study|Screening Failure|10|||
19393884|NCT02653495|41637866|FG001|Overall Study|Screening Failure|0|||
19393885|NCT01675141|41637872|FG000|Overall Study|Lenalidomide outside NIH|3|||
19393886|NCT01675141|41637872|FG000|Overall Study|Withdrawal by Subject|3|||
19393887|NCT01675141|41637872|FG000|Overall Study|Physician Decision|4|||
19393888|NCT01675141|41637872|FG000|Overall Study|No treatment, per protocol|1|||
19393889|NCT03367819|41637907|FG000|Overall Study|Adverse Event|4|||
19393890|NCT03367819|41637908|FG001|Overall Study|Adverse Event|4|||
19393891|NCT03367819|41637907|FG000|Overall Study|Progressive Disease|15|||
19393892|NCT03367819|41637908|FG001|Overall Study|Progressive Disease|13|||
19393893|NCT03367819|41637907|FG000|Overall Study|Withdrawal by Subject|1|||
19393894|NCT03367819|41637908|FG001|Overall Study|Withdrawal by Subject|0|||
19393895|NCT03367819|41637907|FG000|Overall Study|Other|4|||
19393896|NCT03367819|41637908|FG001|Overall Study|Other|2|||
19393897|NCT01597193|41637951|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
19393898|NCT01597193|41637952|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
19393899|NCT01597193|41637953|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
19393900|NCT01597193|41637954|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
19393901|NCT01597193|41637955|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
19393902|NCT01597193|41637956|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
19393903|NCT01597193|41637957|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
19393904|NCT01597193|41637951|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
19393905|NCT01597193|41637952|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
19393906|NCT01597193|41637953|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
19393907|NCT01597193|41637954|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
19393908|NCT01597193|41637955|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
19393909|NCT01597193|41637956|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
19393910|NCT01597193|41637957|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
19393911|NCT01597193|41637951|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
19393912|NCT01597193|41637952|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
19393913|NCT01597193|41637953|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
19393914|NCT01597193|41637954|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
19393915|NCT01597193|41637955|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
19393916|NCT01597193|41637956|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
19393917|NCT01597193|41637957|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
19393918|NCT01597193|41637951|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19393919|NCT01597193|41637952|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19393920|NCT01597193|41637953|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19393921|NCT01597193|41637954|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19393922|NCT01597193|41637955|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19393923|NCT01597193|41637956|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
19393924|NCT01597193|41637957|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
19504383|NCT01641198|41895395|FG000|At 15-20 Years of Function|Death|1|||
19504384|NCT01641198|41895396|FG001|At 15-20 Years of Function|Death|0|||
19504385|NCT01641198|41895397|FG002|At 15-20 Years of Function|Death|1|||
19504386|NCT01639560|41895482|FG000|Overall Study|Withdrawal by Subject|9|||
19504387|NCT01639560|41895483|FG001|Overall Study|Withdrawal by Subject|14|||
19504388|NCT01639560|41895482|FG000|Overall Study|Lack of Efficacy|1|||
19615103|NCT00925301|42064372|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
19615104|NCT00925301|42064373|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
19615105|NCT00925301|42064374|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
19615106|NCT00925301|42064371|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
19615107|NCT00925301|42064372|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
19615108|NCT00925301|42064373|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
19615109|NCT00925301|42064374|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
19393925|NCT01597193|41637951|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
19615110|NCT00925301|42064371|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
19615111|NCT00925301|42064372|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
19393926|NCT01597193|41637952|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
19504389|NCT01639560|41895483|FG001|Overall Study|Lack of Efficacy|2|||
19615112|NCT00925301|42064373|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
19615113|NCT00925301|42064374|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
19615114|NCT00925301|42064371|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
19615115|NCT00925301|42064372|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
19615116|NCT00925301|42064373|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
19615117|NCT00925301|42064374|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
19615118|NCT00925301|42064371|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
19615119|NCT00925301|42064372|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
19615120|NCT00925301|42064373|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
19615121|NCT00925301|42064374|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
19615122|NCT00925301|42064371|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
19615123|NCT00925301|42064372|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
19504390|NCT01639560|41895482|FG000|Overall Study|Lost to Follow-up|9|||
19504391|NCT01639560|41895483|FG001|Overall Study|Lost to Follow-up|11|||
19504392|NCT01639560|41895482|FG000|Overall Study|Adverse Event|0|||
19504393|NCT01639560|41895483|FG001|Overall Study|Adverse Event|2|||
19504394|NCT01601652|41895505|FG000|Overall Study|Death|1|||
19504395|NCT03952130|41895543|FG000|Overall Study|Adverse Event|0|||
19504396|NCT03952130|41895544|FG001|Overall Study|Adverse Event|1|||
19504397|NCT03952130|41895543|FG000|Overall Study|Lost to Follow-up|1|||
19504398|NCT03952130|41895544|FG001|Overall Study|Lost to Follow-up|0|||
19504399|NCT03952130|41895543|FG000|Overall Study|Withdrawal by Subject|1|||
19504400|NCT03952130|41895544|FG001|Overall Study|Withdrawal by Subject|5|||
19504401|NCT01640964|41895588|FG000|Overall Study|Lost to Follow-up|0|||
19504402|NCT01640964|41895589|FG001|Overall Study|Lost to Follow-up|0|||
19504403|NCT01640964|41895590|FG002|Overall Study|Lost to Follow-up|1|||
19504404|NCT01640964|41895588|FG000|Overall Study|Protocol Deviation|1|||
19504405|NCT01640964|41895589|FG001|Overall Study|Protocol Deviation|1|||
19504406|NCT01640964|41895590|FG002|Overall Study|Protocol Deviation|2|||
19504407|NCT01638390|41895719|FG000|Overall Study|screening failures|21|||
19504408|NCT01600716|41895750|FG000|Overall Study|Other Reasons|3|||
19393927|NCT01597193|41637953|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
19393928|NCT01597193|41637954|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
19504409|NCT01600716|41895751|FG001|Overall Study|Other Reasons|1|||
19504410|NCT01600716|41895750|FG000|Overall Study|Personal Reasons|0|||
19504411|NCT01600716|41895751|FG001|Overall Study|Personal Reasons|2|||
19504412|NCT01600716|41895750|FG000|Overall Study|Lost to Follow-up|0|||
19504413|NCT01600716|41895751|FG001|Overall Study|Lost to Follow-up|2|||
19504414|NCT01600716|41895750|FG000|Overall Study|Pregnancy|1|||
19504415|NCT01600716|41895751|FG001|Overall Study|Pregnancy|0|||
19504416|NCT01600716|41895750|FG000|Overall Study|Lack of Efficacy|2|||
19504417|NCT01600716|41895751|FG001|Overall Study|Lack of Efficacy|1|||
19504418|NCT01600716|41895750|FG000|Overall Study|Adverse Event|1|||
19504419|NCT01600716|41895751|FG001|Overall Study|Adverse Event|1|||
19504420|NCT01600326|41895867|FG000|Overall Study|Lost to Follow-up|1|||
19615124|NCT00925301|42064373|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
19615125|NCT00925301|42064374|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
19615126|NCT00925301|42064371|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
19615127|NCT00925301|42064372|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
19615128|NCT00925301|42064373|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
19615129|NCT00925301|42064374|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
19615130|NCT00754065|42064387|FG000|Overall Study|Never received treatment|12|||
19615131|NCT00754065|42064388|FG001|Overall Study|Never received treatment|2|||
19615132|NCT00754065|42064387|FG000|Overall Study|Adverse Event|19|||
19615133|NCT00754065|42064388|FG001|Overall Study|Adverse Event|25|||
19615134|NCT00754065|42064387|FG000|Overall Study|Lost to Follow-up|7|||
19615135|NCT00754065|42064388|FG001|Overall Study|Lost to Follow-up|11|||
19615136|NCT00754065|42064387|FG000|Overall Study|Protocol Violation|12|||
19615137|NCT00754065|42064388|FG001|Overall Study|Protocol Violation|10|||
19615138|NCT00754065|42064387|FG000|Overall Study|Withdrawal by Subject|4|||
19615139|NCT00754065|42064388|FG001|Overall Study|Withdrawal by Subject|5|||
19615140|NCT00754065|42064387|FG000|Overall Study|Pregnancy|6|||
19615141|NCT00754065|42064388|FG001|Overall Study|Pregnancy|0|||
19615142|NCT00754065|42064387|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
19504421|NCT01600326|41895868|FG001|Overall Study|Lost to Follow-up|1|||
19504422|NCT01637142|41896004|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
19504423|NCT01636986|41896022|FG000|Overall Study|Withdrawal by Subject|0|||
19504424|NCT01636986|41896023|FG001|Overall Study|Withdrawal by Subject|1|||
19504425|NCT01636986|41896022|FG000|Overall Study|Corneal Staining|0|||
19615143|NCT00754065|42064388|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
19615144|NCT04138056|42064408|FG000|Primary Study|Lost to Follow-up|3|||
19504426|NCT01636986|41896023|FG001|Overall Study|Corneal Staining|1|||
19504427|NCT01601496|41896115|FG000|Overall Study|Physician Decision|1|||
19504428|NCT01601496|41896115|FG000|Overall Study|Withdrawal by Subject|1|||
19615145|NCT04138056|42064409|FG001|Primary Study|Lost to Follow-up|4|||
19615146|NCT04138056|42064410|FG002|Primary Study|Lost to Follow-up|1|||
19615147|NCT04138056|42064411|FG003|Primary Study|Lost to Follow-up|1|||
19615148|NCT04138056|42064412|FG004|Primary Study|Lost to Follow-up|4|||
19615149|NCT04138056|42064408|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
19504429|NCT01601496|41896115|FG000|Overall Study|Lost to Follow-up|6|||
19504430|NCT01601496|41896115|FG000|Overall Study|Death|4|||
19504431|NCT01601496|41896115|FG000|Overall Study|Other: patient refusal to continue|3|||
19504432|NCT03211832|41896121|FG000|Overall Study|No longer with agency|32|||
19615150|NCT04138056|42064409|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
19615151|NCT04138056|42064410|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
19615152|NCT04138056|42064411|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
19615153|NCT04138056|42064412|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
19615154|NCT04138056|42064408|FG000|Extension Study|Lost to Follow-up|1|||
19704471|NCT00153816|42148862|FG001|Overall Study|Death|5|||
19504433|NCT03211832|41896122|FG001|Overall Study|No longer with agency|49|||
19504434|NCT03211832|41896123|FG002|Overall Study|No longer with agency|30|||
19504435|NCT03211832|41896121|FG000|Overall Study|Declined survey|3|||
19504436|NCT03211832|41896122|FG001|Overall Study|Declined survey|3|||
19504437|NCT03211832|41896123|FG002|Overall Study|Declined survey|2|||
19504438|NCT03211832|41896121|FG000|Overall Study|Not available during data collection|1|||
19504439|NCT03211832|41896122|FG001|Overall Study|Not available during data collection|0|||
19504440|NCT03211832|41896123|FG002|Overall Study|Not available during data collection|2|||
19504441|NCT04887948|41896132|FG000|Overall Study|Death|1|||
19504442|NCT04887948|41896133|FG001|Overall Study|Death|0|||
19504443|NCT04887948|41896134|FG002|Overall Study|Death|0|||
19504444|NCT04887948|41896132|FG000|Overall Study|Lost to Follow-up|1|||
19504445|NCT04887948|41896133|FG001|Overall Study|Lost to Follow-up|0|||
19504446|NCT04887948|41896134|FG002|Overall Study|Lost to Follow-up|3|||
19504447|NCT04887948|41896132|FG000|Overall Study|Physician Decision|0|||
19504448|NCT04887948|41896133|FG001|Overall Study|Physician Decision|4|||
19504449|NCT04887948|41896134|FG002|Overall Study|Physician Decision|1|||
19504450|NCT04887948|41896132|FG000|Overall Study|Protocol Violation|1|||
19615155|NCT04138056|42064409|FG001|Extension Study|Lost to Follow-up|2|||
19504451|NCT04887948|41896133|FG001|Overall Study|Protocol Violation|1|||
19504452|NCT04887948|41896134|FG002|Overall Study|Protocol Violation|0|||
19504453|NCT04887948|41896132|FG000|Overall Study|Withdrawal by Subject|0|||
19504454|NCT04887948|41896133|FG001|Overall Study|Withdrawal by Subject|6|||
19504455|NCT04887948|41896134|FG002|Overall Study|Withdrawal by Subject|1|||
19504456|NCT04887948|41896132|FG000|Overall Study|No longer met eligibility criteria|1|||
19504457|NCT04887948|41896133|FG001|Overall Study|No longer met eligibility criteria|2|||
19504458|NCT04887948|41896134|FG002|Overall Study|No longer met eligibility criteria|1|||
19504459|NCT04887948|41896132|FG000|Overall Study|Other|2|||
19504460|NCT04887948|41896133|FG001|Overall Study|Other|1|||
19504461|NCT04887948|41896134|FG002|Overall Study|Other|1|||
19504462|NCT01638000|41896289|FG000|Overall Study|Randomized but Never Received Drug|7|||
19504463|NCT01638000|41896290|FG001|Overall Study|Randomized but Never Received Drug|10|||
19504464|NCT01638000|41896289|FG000|Overall Study|Adverse Event|14|||
19504465|NCT01638000|41896290|FG001|Overall Study|Adverse Event|16|||
19504466|NCT01638000|41896289|FG000|Overall Study|Lack of Efficacy|5|||
19504467|NCT01638000|41896290|FG001|Overall Study|Lack of Efficacy|6|||
19504468|NCT01638000|41896289|FG000|Overall Study|Protocol Violation|11|||
19504469|NCT01638000|41896290|FG001|Overall Study|Protocol Violation|13|||
19504470|NCT01638000|41896289|FG000|Overall Study|Withdrawal by Subject|21|||
19504471|NCT01638000|41896290|FG001|Overall Study|Withdrawal by Subject|24|||
19504472|NCT01638000|41896289|FG000|Overall Study|Miscellaneous|2|||
19504473|NCT01638000|41896290|FG001|Overall Study|Miscellaneous|2|||
19504474|NCT01637922|41896349|FG000|Overall Study|Adverse Event|0|||
19504475|NCT01637922|41896350|FG001|Overall Study|Adverse Event|1|||
19504476|NCT01637922|41896349|FG000|Overall Study|Protocol Violation|0|||
19504477|NCT01637922|41896350|FG001|Overall Study|Protocol Violation|1|||
19504478|NCT01637922|41896349|FG000|Overall Study|Withdrawal by Subject|0|||
19504479|NCT01637922|41896350|FG001|Overall Study|Withdrawal by Subject|3|||
19504480|NCT01637922|41896349|FG000|Overall Study|Lost to Follow-up|2|||
19504481|NCT01637922|41896350|FG001|Overall Study|Lost to Follow-up|0|||
19504482|NCT01920932|41896499|FG000|Overall Study|Death|1|||
19504483|NCT01920932|41896499|FG000|Overall Study|Withdrawal of consent|1|||
19504484|NCT03496662|41896576|FG000|Overall Study|Adverse Event|1|||
19504485|NCT03496662|41896577|FG001|Overall Study|Adverse Event|0|||
19504486|NCT03496662|41896578|FG002|Overall Study|Adverse Event|1|||
19504487|NCT03496662|41896576|FG000|Overall Study|Physician Decision|1|||
19504488|NCT03496662|41896577|FG001|Overall Study|Physician Decision|0|||
19504489|NCT03496662|41896578|FG002|Overall Study|Physician Decision|3|||
19504490|NCT03496662|41896576|FG000|Overall Study|Withdrawal by Subject|0|||
19504491|NCT03496662|41896577|FG001|Overall Study|Withdrawal by Subject|0|||
19504492|NCT03496662|41896578|FG002|Overall Study|Withdrawal by Subject|2|||
19504493|NCT03496662|41896576|FG000|Overall Study|Death|0|||
19504494|NCT03496662|41896577|FG001|Overall Study|Death|0|||
19504495|NCT03496662|41896578|FG002|Overall Study|Death|2|||
19504496|NCT03496662|41896576|FG000|Overall Study|Noncompliance|0|||
19504497|NCT03496662|41896577|FG001|Overall Study|Noncompliance|0|||
19504498|NCT03496662|41896578|FG002|Overall Study|Noncompliance|1|||
19504499|NCT01638546|41896588|FG000|Overall Study|Adverse Event|1|||
19504500|NCT01638546|41896589|FG001|Overall Study|Adverse Event|3|||
19504501|NCT01000051|41896599|FG000|Overall Study|Withdrawal by Subject|1|||
19504502|NCT01000051|41896600|FG001|Overall Study|Withdrawal by Subject|1|||
19504503|NCT01000051|41896599|FG000|Overall Study|Disease Progression|1|||
19504504|NCT01000051|41896600|FG001|Overall Study|Disease Progression|0|||
19504505|NCT01000051|41896599|FG000|Overall Study|Serious noncompliance|1|||
19504506|NCT01000051|41896600|FG001|Overall Study|Serious noncompliance|0|||
19504507|NCT01593254|41896608|FG000|Treatment Period|Treatment Failure|1|||
19504508|NCT01593254|41896609|FG001|Treatment Period|Treatment Failure|2|||
19504509|NCT01593254|41896608|FG000|Treatment Period|Pregnancy|0|||
19504510|NCT01593254|41896609|FG001|Treatment Period|Pregnancy|1|||
19704472|NCT00153816|42148863|FG002|Overall Study|Death|4|||
19504511|NCT01593254|41896608|FG000|Treatment Period|Poor/Non-Compliance|2|||
19504512|NCT01593254|41896609|FG001|Treatment Period|Poor/Non-Compliance|1|||
19504513|NCT01593254|41896608|FG000|Treatment Period|Maximum clinical benefit|1|||
19504514|NCT01593254|41896609|FG001|Treatment Period|Maximum clinical benefit|0|||
19504515|NCT01593254|41896608|FG000|Treatment Period|Subject withdrew consent|0|||
19504516|NCT01593254|41896609|FG001|Treatment Period|Subject withdrew consent|5|||
19504517|NCT01593254|41896608|FG000|Treatment Period|Subject Request to Discontinue|1|||
19504518|NCT01593254|41896609|FG001|Treatment Period|Subject Request to Discontinue|1|||
19504519|NCT01593254|41896608|FG000|Treatment Period|AE unrelated to Study Drug|0|||
19504520|NCT01593254|41896609|FG001|Treatment Period|AE unrelated to Study Drug|1|||
19504521|NCT01593254|41896608|FG000|Treatment Period|Death|2|||
19504522|NCT01593254|41896609|FG001|Treatment Period|Death|1|||
19504523|NCT01593254|41896608|FG000|Treatment Period|Study Drug Toxicity|3|||
19504524|NCT01593254|41896609|FG001|Treatment Period|Study Drug Toxicity|9|||
19504525|NCT01593254|41896608|FG000|Treatment Period|Disease Progression|1|||
19504526|NCT01593254|41896609|FG001|Treatment Period|Disease Progression|6|||
19504527|NCT01593254|41896608|FG000|Treatment Period|Did Not Achieve RCC|0|||
19504528|NCT01593254|41896609|FG001|Treatment Period|Did Not Achieve RCC|1|||
19504529|NCT01593254|41896608|FG000|Treatment Period|Patient Refused to Return|0|||
19504530|NCT01593254|41896609|FG001|Treatment Period|Patient Refused to Return|1|||
19504531|NCT01593254|41896608|FG000|Treatment Period|No Response|1|||
19504532|NCT01593254|41896609|FG001|Treatment Period|No Response|0|||
19504533|NCT01593254|41896608|FG000|Treatment Period|T315I MUTATION|0|||
19504534|NCT01593254|41896609|FG001|Treatment Period|T315I MUTATION|1|||
19504535|NCT01593254|41896608|FG000|Treatment Period|Investigator Decision|2|||
19504536|NCT01593254|41896609|FG001|Treatment Period|Investigator Decision|1|||
19504537|NCT01593254|41896608|FG000|Follow-Up Period|Withdrawal by Subject|0|||
19504538|NCT01593254|41896609|FG001|Follow-Up Period|Withdrawal by Subject|2|||
19504539|NCT01593254|41896608|FG000|Follow-Up Period|Non-Compliance|1|||
19504540|NCT01593254|41896609|FG001|Follow-Up Period|Non-Compliance|0|||
19504541|NCT01593254|41896608|FG000|Follow-Up Period|Death|2|||
19504542|NCT01593254|41896609|FG001|Follow-Up Period|Death|2|||
19504543|NCT01593254|41896608|FG000|Follow-Up Period|Subject request to Discontinue|0|||
19504544|NCT01593254|41896609|FG001|Follow-Up Period|Subject request to Discontinue|1|||
19504545|NCT01593254|41896608|FG000|Follow-Up Period|Pregnancy|0|||
19504546|NCT01593254|41896609|FG001|Follow-Up Period|Pregnancy|1|||
19504547|NCT01593254|41896608|FG000|Follow-Up Period|Study Drug Toxicity|0|||
19504548|NCT01593254|41896609|FG001|Follow-Up Period|Study Drug Toxicity|1|||
19504549|NCT01593254|41896608|FG000|Follow-Up Period|Patient refused to return|0|||
19504550|NCT01593254|41896609|FG001|Follow-Up Period|Patient refused to return|1|||
19504551|NCT01593254|41896608|FG000|Follow-Up Period|Fundus Hemorrhage|0|||
19504552|NCT01593254|41896609|FG001|Follow-Up Period|Fundus Hemorrhage|1|||
19504553|NCT01593254|41896608|FG000|Follow-Up Period|Disease Progression|0|||
19504554|NCT01593254|41896609|FG001|Follow-Up Period|Disease Progression|1|||
19504555|NCT01593254|41896608|FG000|Follow-Up Period|Study Drug Side Effects|0|||
19504556|NCT01593254|41896609|FG001|Follow-Up Period|Study Drug Side Effects|1|||
19504557|NCT03172494|41896628|FG000|Overall Study|Adverse Event|5|||
19504558|NCT03172494|41896629|FG001|Overall Study|Adverse Event|1|||
19504559|NCT03172494|41896630|FG002|Overall Study|Adverse Event|15|||
19504560|NCT03172494|41896628|FG000|Overall Study|Protocol Violation|3|||
19504561|NCT03172494|41896629|FG001|Overall Study|Protocol Violation|2|||
19504562|NCT03172494|41896630|FG002|Overall Study|Protocol Violation|1|||
19504563|NCT03172494|41896628|FG000|Overall Study|Lack of Efficacy|0|||
19504564|NCT03172494|41896629|FG001|Overall Study|Lack of Efficacy|0|||
19504565|NCT03172494|41896630|FG002|Overall Study|Lack of Efficacy|4|||
19504566|NCT03172494|41896628|FG000|Overall Study|Pregnancy|0|||
19504567|NCT03172494|41896629|FG001|Overall Study|Pregnancy|1|||
19504568|NCT03172494|41896630|FG002|Overall Study|Pregnancy|0|||
19504569|NCT03172494|41896628|FG000|Overall Study|Withdrawal by Subject|10|||
19504570|NCT03172494|41896629|FG001|Overall Study|Withdrawal by Subject|8|||
19504571|NCT03172494|41896630|FG002|Overall Study|Withdrawal by Subject|8|||
19504572|NCT03172494|41896628|FG000|Overall Study|Severe hypoglycaemic episode|0|||
19504573|NCT03172494|41896629|FG001|Overall Study|Severe hypoglycaemic episode|0|||
19504574|NCT03172494|41896630|FG002|Overall Study|Severe hypoglycaemic episode|1|||
19504575|NCT03172494|41896628|FG000|Overall Study|Non-compliance towards treatment|2|||
19504576|NCT03172494|41896629|FG001|Overall Study|Non-compliance towards treatment|0|||
19504577|NCT03172494|41896630|FG002|Overall Study|Non-compliance towards treatment|0|||
19504578|NCT01636362|41896731|FG000|Overall Study|Physician Decision|6|||
19504579|NCT01636362|41896731|FG000|Overall Study|Subject healed, not returning|1|||
19504580|NCT01636362|41896731|FG000|Overall Study|Withdrawal by Subject|1|||
19504581|NCT02797184|41896760|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
19504582|NCT02797184|41896761|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
19504583|NCT03042468|41896803|FG000|Overall Study|Death|0|||
19504584|NCT03042468|41896804|FG001|Overall Study|Death|1|||
19504585|NCT03042468|41896805|FG002|Overall Study|Death|1|||
19504586|NCT03042468|41896806|FG003|Overall Study|Death|0|||
19504587|NCT03042468|41896807|FG004|Overall Study|Death|0|||
19504588|NCT03042468|41896808|FG005|Overall Study|Death|0|||
19504589|NCT03042468|41896803|FG000|Overall Study|Withdrawal by Subject|0|||
19504590|NCT03042468|41896804|FG001|Overall Study|Withdrawal by Subject|0|||
19504591|NCT03042468|41896805|FG002|Overall Study|Withdrawal by Subject|0|||
19504592|NCT03042468|41896806|FG003|Overall Study|Withdrawal by Subject|0|||
19504593|NCT03042468|41896807|FG004|Overall Study|Withdrawal by Subject|0|||
19504594|NCT03042468|41896808|FG005|Overall Study|Withdrawal by Subject|1|||
19504595|NCT03042468|41896803|FG000|Overall Study|Lost to Follow-up|0|||
19504596|NCT03042468|41896804|FG001|Overall Study|Lost to Follow-up|0|||
19504597|NCT03042468|41896805|FG002|Overall Study|Lost to Follow-up|0|||
19504598|NCT03042468|41896806|FG003|Overall Study|Lost to Follow-up|0|||
19504599|NCT03042468|41896807|FG004|Overall Study|Lost to Follow-up|1|||
19504600|NCT03042468|41896808|FG005|Overall Study|Lost to Follow-up|1|||
19504601|NCT01634178|41896826|FG000|Treatment Period 1|Adverse Event|0|||
19504602|NCT01634178|41896827|FG001|Treatment Period 1|Adverse Event|1|||
19504603|NCT01634178|41896826|FG000|Treatment Period 2|Adverse Event|1|||
19504604|NCT01634178|41896827|FG001|Treatment Period 2|Adverse Event|0|||
19504605|NCT04158648|41896834|FG000|Overall Study|Ongoing in the Study|69|||
19504606|NCT04158648|41896834|FG000|Overall Study|Withdrawal by Subject|4|||
19504607|NCT04382911|41896875|FG000|Overall Study|unable to be imaged prior to surgery|2|||
19504608|NCT02412306|41896884|FG000|Overall Study|Lost to Follow-up|0|||
19504609|NCT02412306|41896885|FG001|Overall Study|Lost to Follow-up|1|||
19504610|NCT02412306|41896886|FG002|Overall Study|Lost to Follow-up|0|||
19504611|NCT02412306|41896887|FG003|Overall Study|Lost to Follow-up|0|||
19504612|NCT02412306|41896888|FG004|Overall Study|Lost to Follow-up|0|||
19504613|NCT02412306|41896884|FG000|Overall Study|Withdrawal by Subject|0|||
19504614|NCT02412306|41896885|FG001|Overall Study|Withdrawal by Subject|0|||
19504615|NCT02412306|41896886|FG002|Overall Study|Withdrawal by Subject|1|||
19504616|NCT02412306|41896887|FG003|Overall Study|Withdrawal by Subject|0|||
19504617|NCT02412306|41896888|FG004|Overall Study|Withdrawal by Subject|0|||
19504618|NCT02412306|41896884|FG000|Overall Study|Death|5|||
19504619|NCT02412306|41896885|FG001|Overall Study|Death|7|||
19504620|NCT02412306|41896886|FG002|Overall Study|Death|15|||
19504621|NCT02412306|41896887|FG003|Overall Study|Death|0|||
19504622|NCT02412306|41896888|FG004|Overall Study|Death|2|||
19504623|NCT04285723|41896911|FG000|Overall Study|Subject decision|1|||
19504624|NCT04285723|41896912|FG001|Overall Study|Subject decision|2|||
19504625|NCT04285723|41896911|FG000|Overall Study|Physician Decision|1|||
19504626|NCT04285723|41896912|FG001|Overall Study|Physician Decision|0|||
19504627|NCT04285723|41896911|FG000|Overall Study|No efficiency|1|||
19504628|NCT04285723|41896912|FG001|Overall Study|No efficiency|0|||
19504629|NCT03659136|41896926|FG000|Overall Study|COVID-19 related|1|||
19504630|NCT03659136|41896927|FG001|Overall Study|COVID-19 related|1|||
19504631|NCT03659136|41896926|FG000|Overall Study|Withdrawal by Subject|0|||
19504632|NCT03659136|41896927|FG001|Overall Study|Withdrawal by Subject|6|||
19504633|NCT03659136|41896926|FG000|Overall Study|Adverse Event|4|||
19504634|NCT03659136|41896927|FG001|Overall Study|Adverse Event|7|||
19504635|NCT03659136|41896926|FG000|Overall Study|Progressive disease|34|||
19504636|NCT03659136|41896927|FG001|Overall Study|Progressive disease|24|||
19504637|NCT03659136|41896926|FG000|Overall Study|Not treated|2|||
19504638|NCT03659136|41896927|FG001|Overall Study|Not treated|0|||
19504639|NCT03659136|41896926|FG000|Overall Study|Not specified above|2|||
19504640|NCT03659136|41896927|FG001|Overall Study|Not specified above|1|||
19504641|NCT01352221|41896936|FG000|Double-blind Phase|Adverse Event|6|||
19504642|NCT01352221|41896937|FG001|Double-blind Phase|Adverse Event|4|||
19504643|NCT01352221|41896938|FG002|Double-blind Phase|Adverse Event|0|||
19504644|NCT01352221|41896939|FG003|Double-blind Phase|Adverse Event|0|||
19504645|NCT01352221|41896936|FG000|Double-blind Phase|Withdrawal by Subject|3|||
19504646|NCT01352221|41896937|FG001|Double-blind Phase|Withdrawal by Subject|5|||
19504647|NCT01352221|41896938|FG002|Double-blind Phase|Withdrawal by Subject|0|||
19504648|NCT01352221|41896939|FG003|Double-blind Phase|Withdrawal by Subject|0|||
19504649|NCT01352221|41896936|FG000|Double-blind Phase|Lost to Follow-up|0|||
19504650|NCT01352221|41896937|FG001|Double-blind Phase|Lost to Follow-up|1|||
19504651|NCT01352221|41896938|FG002|Double-blind Phase|Lost to Follow-up|0|||
19504652|NCT01352221|41896939|FG003|Double-blind Phase|Lost to Follow-up|0|||
19504653|NCT01352221|41896936|FG000|Double-blind Phase|Protocol Violation|0|||
19504654|NCT01352221|41896937|FG001|Double-blind Phase|Protocol Violation|1|||
19504655|NCT01352221|41896938|FG002|Double-blind Phase|Protocol Violation|0|||
19504656|NCT01352221|41896939|FG003|Double-blind Phase|Protocol Violation|0|||
19504657|NCT01352221|41896936|FG000|Open-label Phase|Physician Decision|0|||
19504658|NCT01352221|41896937|FG001|Open-label Phase|Physician Decision|0|||
19504659|NCT01352221|41896938|FG002|Open-label Phase|Physician Decision|2|||
19504660|NCT01352221|41896939|FG003|Open-label Phase|Physician Decision|1|||
19504661|NCT01352221|41896936|FG000|Open-label Phase|Pregnancy|0|||
19504662|NCT01352221|41896937|FG001|Open-label Phase|Pregnancy|0|||
19504663|NCT01352221|41896938|FG002|Open-label Phase|Pregnancy|1|||
19504664|NCT01352221|41896939|FG003|Open-label Phase|Pregnancy|0|||
19504665|NCT01352221|41896936|FG000|Open-label Phase|Adverse Event|0|||
19504666|NCT01352221|41896937|FG001|Open-label Phase|Adverse Event|0|||
19504667|NCT01352221|41896938|FG002|Open-label Phase|Adverse Event|8|||
19504668|NCT01352221|41896939|FG003|Open-label Phase|Adverse Event|4|||
19504669|NCT01352221|41896936|FG000|Open-label Phase|Withdrawal by Subject|0|||
19504670|NCT01352221|41896937|FG001|Open-label Phase|Withdrawal by Subject|0|||
19504671|NCT01352221|41896938|FG002|Open-label Phase|Withdrawal by Subject|1|||
19504672|NCT01352221|41896939|FG003|Open-label Phase|Withdrawal by Subject|6|||
19504673|NCT01352221|41896936|FG000|Open-label Phase|Worsening of IBD|0|||
19504674|NCT01352221|41896937|FG001|Open-label Phase|Worsening of IBD|0|||
19504675|NCT01352221|41896938|FG002|Open-label Phase|Worsening of IBD|1|||
19504676|NCT01352221|41896939|FG003|Open-label Phase|Worsening of IBD|0|||
19504677|NCT01634100|41896965|FG000|Overall Study|Withdrawal by Subject|1|||
19504678|NCT01634100|41896966|FG001|Overall Study|Withdrawal by Subject|0|||
19504679|NCT01634100|41896967|FG002|Overall Study|Withdrawal by Subject|1|||
19504680|NCT01634100|41896968|FG003|Overall Study|Withdrawal by Subject|0|||
19504681|NCT01634100|41896969|FG004|Overall Study|Withdrawal by Subject|0|||
19504682|NCT01634100|41896970|FG005|Overall Study|Withdrawal by Subject|0|||
19504683|NCT03662659|41896980|FG000|Pre-treatment|Participant no longer met study criteria|1|||
19504684|NCT03662659|41896981|FG001|Pre-treatment|Participant no longer met study criteria|1|||
19504685|NCT03662659|41896980|FG000|Pre-treatment|Other reasons|1|||
19504686|NCT03662659|41896981|FG001|Pre-treatment|Other reasons|0|||
19504687|NCT03662659|41896980|FG000|Treatment|Completed Treatment|0|||
19504688|NCT03662659|41896981|FG001|Treatment|Completed Treatment|3|||
19504689|NCT03662659|41896980|FG000|Treatment|Disease Progression|69|||
19504690|NCT03662659|41896981|FG001|Treatment|Disease Progression|78|||
19504691|NCT03662659|41896980|FG000|Treatment|Study Drug Toxicity|18|||
19504692|NCT03662659|41896981|FG001|Treatment|Study Drug Toxicity|8|||
19504693|NCT03662659|41896980|FG000|Treatment|Death|12|||
19504694|NCT03662659|41896981|FG001|Treatment|Death|7|||
19504695|NCT03662659|41896980|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
19504696|NCT03662659|41896981|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
19504697|NCT03662659|41896980|FG000|Treatment|Withdrawal by Subject|1|||
19504698|NCT03662659|41896981|FG001|Treatment|Withdrawal by Subject|1|||
19504699|NCT03662659|41896980|FG000|Treatment|Poor/Non-compliance|1|||
19504700|NCT03662659|41896981|FG001|Treatment|Poor/Non-compliance|0|||
19504701|NCT03662659|41896980|FG000|Treatment|Participant no longer meets study criteria|1|||
19504702|NCT03662659|41896981|FG001|Treatment|Participant no longer meets study criteria|0|||
19504703|NCT03662659|41896980|FG000|Treatment|Other reasons|6|||
19504704|NCT03662659|41896981|FG001|Treatment|Other reasons|5|||
19504705|NCT01633944|41896989|FG000|Open-label Titration Phase|Adverse Event|109|||
19504706|NCT01633944|41896990|FG001|Open-label Titration Phase|Adverse Event|0|||
19504707|NCT01633944|41896991|FG002|Open-label Titration Phase|Adverse Event|0|||
19504708|NCT01633944|41896989|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
19504709|NCT01633944|41896990|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
19504710|NCT01633944|41896991|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
19504711|NCT01633944|41896989|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
19504712|NCT01633944|41896990|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
19504713|NCT01633944|41896991|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
19504714|NCT01633944|41896989|FG000|Open-label Titration Phase|Protocol Violation|24|||
19504715|NCT01633944|41896990|FG001|Open-label Titration Phase|Protocol Violation|0|||
19504716|NCT01633944|41896991|FG002|Open-label Titration Phase|Protocol Violation|0|||
19504717|NCT01633944|41896989|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
19504718|NCT01633944|41896990|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
19504719|NCT01633944|41896991|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
19504720|NCT01633944|41896989|FG000|Open-label Titration Phase|Other|68|||
19504721|NCT01633944|41896990|FG001|Open-label Titration Phase|Other|0|||
19504722|NCT01633944|41896991|FG002|Open-label Titration Phase|Other|0|||
19504723|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Adverse Event|0|||
19504724|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Adverse Event|13|||
19504725|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Adverse Event|7|||
19504726|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
19504727|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
19504728|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
19504729|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19504730|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
19504731|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
19504732|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
19504733|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
19504734|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
19504735|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
19504736|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
19504737|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
19504738|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
19504739|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
19504740|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
19504741|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
19504742|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
19504743|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
19504744|NCT01633944|41896989|FG000|Double-blind Treatment Phase|Other|0|||
19504745|NCT01633944|41896990|FG001|Double-blind Treatment Phase|Other|7|||
19504746|NCT01633944|41896991|FG002|Double-blind Treatment Phase|Other|0|||
19504747|NCT01633788|41897036|FG000|Overall Study|Adverse Event|1|||
19504748|NCT01633788|41897037|FG001|Overall Study|Adverse Event|3|||
19504749|NCT01633788|41897038|FG002|Overall Study|Adverse Event|3|||
19504750|NCT01633788|41897039|FG003|Overall Study|Adverse Event|3|||
19504751|NCT01633788|41897036|FG000|Overall Study|Lost to Follow-up|2|||
19504752|NCT01633788|41897037|FG001|Overall Study|Lost to Follow-up|2|||
19504753|NCT01633788|41897038|FG002|Overall Study|Lost to Follow-up|2|||
19504754|NCT01633788|41897039|FG003|Overall Study|Lost to Follow-up|0|||
19504755|NCT01633788|41897036|FG000|Overall Study|Personal Reasons|3|||
19504756|NCT01633788|41897037|FG001|Overall Study|Personal Reasons|1|||
19504757|NCT01633788|41897038|FG002|Overall Study|Personal Reasons|1|||
19504758|NCT01633788|41897039|FG003|Overall Study|Personal Reasons|3|||
19504759|NCT01633788|41897036|FG000|Overall Study|Protocol Violation|1|||
19504760|NCT01633788|41897037|FG001|Overall Study|Protocol Violation|0|||
19504761|NCT01633788|41897038|FG002|Overall Study|Protocol Violation|1|||
19504762|NCT01633788|41897039|FG003|Overall Study|Protocol Violation|0|||
19504763|NCT01633788|41897036|FG000|Overall Study|Other Reasons|0|||
19504764|NCT01633788|41897037|FG001|Overall Study|Other Reasons|2|||
19504765|NCT01633788|41897038|FG002|Overall Study|Other Reasons|3|||
19504766|NCT01633788|41897039|FG003|Overall Study|Other Reasons|7|||
19504767|NCT04154943|41897049|FG000|Overall Study|Study Ongoing|68|||
19504768|NCT04154943|41897049|FG000|Overall Study|Lost to Follow-up|1|||
19504769|NCT04154943|41897049|FG000|Overall Study|Decision by the Investigator|1|||
19504770|NCT04154943|41897049|FG000|Overall Study|Death|5|||
19504771|NCT04154943|41897049|FG000|Overall Study|Withdrawal by Subject|4|||
19504772|NCT03476239|41897070|FG000|Overall Study|Withdrawal by Subject|10|||
19504773|NCT03476239|41897070|FG000|Overall Study|Death|80|||
19504774|NCT03476239|41897070|FG000|Overall Study|Lost to Follow-up|8|||
19504775|NCT03468985|41897078|FG000|Overall Study|Adverse Event|0|||
19504776|NCT03468985|41897079|FG001|Overall Study|Adverse Event|2|||
19504777|NCT03468985|41897080|FG002|Overall Study|Adverse Event|0|||
19504778|NCT03468985|41897081|FG003|Overall Study|Adverse Event|0|||
19504779|NCT03468985|41897078|FG000|Overall Study|Withdrawal by Subject|0|||
19504780|NCT03468985|41897079|FG001|Overall Study|Withdrawal by Subject|0|||
19504781|NCT03468985|41897080|FG002|Overall Study|Withdrawal by Subject|0|||
19504782|NCT03468985|41897081|FG003|Overall Study|Withdrawal by Subject|1|||
19504783|NCT02678312|41897096|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
19504784|NCT02678312|41897097|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
19504785|NCT02678312|41897098|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
19504786|NCT02678312|41897099|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
19504787|NCT02678312|41897100|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
19504788|NCT02678312|41897096|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
19504789|NCT02678312|41897097|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
19504790|NCT02678312|41897098|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
19504791|NCT02678312|41897099|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
19504792|NCT02678312|41897100|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
19504793|NCT02678312|41897096|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
19504794|NCT02678312|41897097|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
19504795|NCT02678312|41897098|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
19504796|NCT02678312|41897099|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
19504797|NCT02678312|41897100|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
19504798|NCT02678312|41897096|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
19504799|NCT02678312|41897097|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
19504800|NCT02678312|41897098|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
19504801|NCT02678312|41897099|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
19504802|NCT02678312|41897100|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
19504803|NCT02678312|41897096|FG000|Part 2 Double Blind Epoch|Death|0|||
19504804|NCT02678312|41897097|FG001|Part 2 Double Blind Epoch|Death|0|||
19504805|NCT02678312|41897098|FG002|Part 2 Double Blind Epoch|Death|0|||
19504806|NCT02678312|41897099|FG003|Part 2 Double Blind Epoch|Death|8|||
19504807|NCT02678312|41897100|FG004|Part 2 Double Blind Epoch|Death|12|||
19504808|NCT02678312|41897096|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
19504809|NCT02678312|41897097|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
19504810|NCT02678312|41897098|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
19504811|NCT02678312|41897099|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
19504812|NCT02678312|41897100|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
19504813|NCT02678312|41897096|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
19504814|NCT02678312|41897097|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
19504815|NCT02678312|41897098|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
19504816|NCT02678312|41897099|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
19504817|NCT02678312|41897100|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
19504818|NCT02678312|41897096|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
19504819|NCT02678312|41897097|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
19504820|NCT02678312|41897098|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
19504821|NCT02678312|41897099|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
19504822|NCT02678312|41897100|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
19504823|NCT02256631|41897354|FG000|Overall Study|Lost to Follow-up|1|||
19504824|NCT02256631|41897355|FG001|Overall Study|Lost to Follow-up|1|||
19504825|NCT02256631|41897356|FG002|Overall Study|Lost to Follow-up|0|||
19504826|NCT02256631|41897357|FG003|Overall Study|Lost to Follow-up|2|||
19504827|NCT02256631|41897358|FG004|Overall Study|Lost to Follow-up|0|||
19504828|NCT02256631|41897359|FG005|Overall Study|Lost to Follow-up|4|||
19504829|NCT02256631|41897360|FG006|Overall Study|Lost to Follow-up|1|||
19504830|NCT02256631|41897354|FG000|Overall Study|Withdrawal by Subject|0|||
19504831|NCT02256631|41897355|FG001|Overall Study|Withdrawal by Subject|0|||
19504832|NCT02256631|41897356|FG002|Overall Study|Withdrawal by Subject|0|||
19504833|NCT02256631|41897357|FG003|Overall Study|Withdrawal by Subject|1|||
19504834|NCT02256631|41897358|FG004|Overall Study|Withdrawal by Subject|1|||
19504835|NCT02256631|41897359|FG005|Overall Study|Withdrawal by Subject|0|||
19504836|NCT02256631|41897360|FG006|Overall Study|Withdrawal by Subject|1|||
19504837|NCT02256631|41897354|FG000|Overall Study|Unable to get to clinic|0|||
19504838|NCT02256631|41897355|FG001|Overall Study|Unable to get to clinic|2|||
19504839|NCT02256631|41897356|FG002|Overall Study|Unable to get to clinic|0|||
19504840|NCT02256631|41897357|FG003|Overall Study|Unable to get to clinic|1|||
19704473|NCT00153816|42148864|FG003|Overall Study|Death|6|||
19504841|NCT02256631|41897358|FG004|Overall Study|Unable to get to clinic|0|||
19615156|NCT04138056|42064410|FG002|Extension Study|Lost to Follow-up|1|||
19615157|NCT04138056|42064411|FG003|Extension Study|Lost to Follow-up|0|||
19704474|NCT00153816|42148865|FG004|Overall Study|Death|0|||
19504842|NCT02256631|41897359|FG005|Overall Study|Unable to get to clinic|1|||
19504843|NCT02256631|41897360|FG006|Overall Study|Unable to get to clinic|2|||
19504844|NCT02163733|41897458|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
19504845|NCT02163733|41897459|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
19504846|NCT02163733|41897460|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
19504847|NCT02163733|41897458|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
19504848|NCT02163733|41897459|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
19504849|NCT02163733|41897460|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
19504850|NCT02279745|41897490|FG000|Overall Study|Adverse Event|7|||
19504851|NCT02279745|41897490|FG000|Overall Study|Death|6|||
19504852|NCT02279745|41897490|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
19504853|NCT02279745|41897490|FG000|Overall Study|Withdrawal by Subject|2|||
19504854|NCT02279745|41897490|FG000|Overall Study|Pregnancy|1|||
19504855|NCT02279745|41897490|FG000|Overall Study|Study Non-compliance|1|||
19504856|NCT02279745|41897490|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
19504857|NCT01761877|41897529|FG000|Overall Study|Adverse Event|7|||
19504858|NCT01761877|41897530|FG001|Overall Study|Adverse Event|0|||
19504859|NCT01761877|41897529|FG000|Overall Study|Withdrawal by Subject|6|||
19504860|NCT01761877|41897530|FG001|Overall Study|Withdrawal by Subject|4|||
19504861|NCT01761877|41897529|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
19504862|NCT01761877|41897530|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
19504863|NCT01761877|41897529|FG000|Overall Study|Death|0|||
19504864|NCT01761877|41897530|FG001|Overall Study|Death|1|||
19504865|NCT01761877|41897529|FG000|Overall Study|MRI intolerant|1|||
19504866|NCT01761877|41897530|FG001|Overall Study|MRI intolerant|6|||
19504867|NCT03093259|41897784|FG000|Overall Study|Adverse Event|1|||
19504868|NCT03093259|41897785|FG001|Overall Study|Adverse Event|0|||
19504869|NCT03093259|41897784|FG000|Overall Study|Withdrawal by Subject|1|||
19504870|NCT03093259|41897785|FG001|Overall Study|Withdrawal by Subject|0|||
19504871|NCT02997865|41898077|FG000|Overall Study|Death|2|||
19504872|NCT02997865|41898078|FG001|Overall Study|Death|1|||
19504873|NCT02997865|41898077|FG000|Overall Study|Lost to Follow-up|6|||
19504874|NCT02997865|41898078|FG001|Overall Study|Lost to Follow-up|3|||
19504875|NCT02997865|41898077|FG000|Overall Study|Withdrawal by Subject|5|||
19504876|NCT02997865|41898078|FG001|Overall Study|Withdrawal by Subject|0|||
19504877|NCT01575834|41899316|FG000|Overall Study|Withdrawal by Subject|352|||
19504878|NCT01575834|41899317|FG001|Overall Study|Withdrawal by Subject|390|||
19504879|NCT01575834|41899316|FG000|Overall Study|Death|81|||
19504880|NCT01575834|41899317|FG001|Overall Study|Death|74|||
19504881|NCT01575834|41899316|FG000|Overall Study|Other|70|||
19504882|NCT01575834|41899317|FG001|Overall Study|Other|70|||
19504883|NCT01575834|41899316|FG000|Overall Study|Adverse Event|63|||
19504884|NCT01575834|41899317|FG001|Overall Study|Adverse Event|61|||
19504885|NCT01575834|41899316|FG000|Overall Study|Lost to Follow-up|55|||
19504886|NCT01575834|41899317|FG001|Overall Study|Lost to Follow-up|68|||
19504887|NCT01575834|41899316|FG000|Overall Study|Noncompliance|52|||
19504888|NCT01575834|41899317|FG001|Overall Study|Noncompliance|27|||
19504889|NCT01575834|41899316|FG000|Overall Study|Administrative decision|15|||
19504890|NCT01575834|41899317|FG001|Overall Study|Administrative decision|33|||
19504891|NCT01575834|41899316|FG000|Overall Study|Ineligibility Determined|5|||
19504892|NCT01575834|41899317|FG001|Overall Study|Ineligibility Determined|8|||
19504893|NCT01575834|41899316|FG000|Overall Study|Protocol Deviation|4|||
19504894|NCT01575834|41899317|FG001|Overall Study|Protocol Deviation|3|||
19504895|NCT01575834|41899316|FG000|Overall Study|Requirement for Alternative Therapy|2|||
19504896|NCT01575834|41899317|FG001|Overall Study|Requirement for Alternative Therapy|4|||
19704475|NCT00153816|42148866|FG005|Overall Study|Death|2|||
19615158|NCT04138056|42064412|FG004|Extension Study|Lost to Follow-up|1|||
19504897|NCT02253654|41899429|FG000|Overall Study|Withdrawal by Subject|12|||
19504898|NCT02253654|41899430|FG001|Overall Study|Withdrawal by Subject|4|||
19704476|NCT00153816|42148861|FG000|Overall Study|Lost to Follow-up|7|||
19504899|NCT02253654|41899429|FG000|Overall Study|Decision by Sponsor|1|||
19704477|NCT00153816|42148862|FG001|Overall Study|Lost to Follow-up|8|||
19504900|NCT02253654|41899430|FG001|Overall Study|Decision by Sponsor|1|||
19504901|NCT02253654|41899429|FG000|Overall Study|Lost to Follow-up|2|||
19504902|NCT02253654|41899430|FG001|Overall Study|Lost to Follow-up|5|||
19504903|NCT02253654|41899429|FG000|Overall Study|Death|4|||
19504904|NCT02253654|41899430|FG001|Overall Study|Death|7|||
19504905|NCT02253654|41899429|FG000|Overall Study|Did Not Receive Study Treatment|4|||
19504906|NCT02253654|41899430|FG001|Overall Study|Did Not Receive Study Treatment|1|||
19504907|NCT02252406|41899438|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
19504908|NCT02252406|41899439|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
19504909|NCT02252406|41899438|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
19504910|NCT02252406|41899439|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
19504911|NCT02252406|41899438|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
19504912|NCT02252406|41899439|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
19504913|NCT02252406|41899438|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
19504914|NCT02252406|41899439|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
19504915|NCT02252406|41899438|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
19504916|NCT02252406|41899439|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
19504917|NCT02246478|41899449|FG000|Multiple-dose Phase|Protocol Violation|1|||
19504918|NCT02246478|41899450|FG001|Multiple-dose Phase|Protocol Violation|0|||
19504919|NCT02246478|41899451|FG002|Multiple-dose Phase|Protocol Violation|0|||
19504920|NCT02246478|41899452|FG003|Multiple-dose Phase|Protocol Violation|1|||
19504921|NCT02252016|41899471|FG000|Overall Study|Lost to Follow-up|2|||
19504922|NCT02252016|41899472|FG001|Overall Study|Lost to Follow-up|1|||
19504923|NCT02252016|41899471|FG000|Overall Study|Physician Decision|1|||
19504924|NCT02252016|41899472|FG001|Overall Study|Physician Decision|0|||
19504925|NCT02252016|41899471|FG000|Overall Study|Withdrawal by Subject|0|||
19504926|NCT02252016|41899472|FG001|Overall Study|Withdrawal by Subject|2|||
19504927|NCT02249832|41899478|FG000|Overall Study|Withdrawal by Subject|3|||
19504928|NCT02249832|41899478|FG000|Overall Study|Lost to Follow-up|10|||
19504929|NCT02248974|41899489|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
19504930|NCT02248974|41899490|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
19504931|NCT02248974|41899489|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
19504932|NCT02248974|41899490|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
19504933|NCT02248974|41899489|FG000|1-Day Follow-Up|Enrolled in another study|1|||
19504934|NCT02248974|41899490|FG001|1-Day Follow-Up|Enrolled in another study|0|||
19504935|NCT02248974|41899489|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
19504936|NCT02248974|41899490|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
19504937|NCT02248974|41899489|FG000|1-Week Follow-Up|Enrolled in another study|1|||
19504938|NCT02248974|41899490|FG001|1-Week Follow-Up|Enrolled in another study|1|||
19504939|NCT02248974|41899489|FG000|1-Week Follow-Up|Transferred to another facility|1|||
19504940|NCT02248974|41899490|FG001|1-Week Follow-Up|Transferred to another facility|0|||
19504941|NCT02248974|41899489|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
19504942|NCT02248974|41899490|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
19504943|NCT02248974|41899489|FG000|1-Week Follow-Up|Death|1|||
19504944|NCT02248974|41899490|FG001|1-Week Follow-Up|Death|1|||
19504945|NCT02248974|41899489|FG000|1-Week Follow-Up|Excluded because of age|0|||
19504946|NCT02248974|41899490|FG001|1-Week Follow-Up|Excluded because of age|1|||
19504947|NCT02248974|41899489|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
19504948|NCT02248974|41899490|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
19504949|NCT02248974|41899489|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
19504950|NCT02248974|41899490|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
19504951|NCT02248974|41899489|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
19504952|NCT02248974|41899490|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
19504953|NCT02248974|41899489|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
19504954|NCT02248974|41899490|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
19504955|NCT02248974|41899489|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
19504956|NCT02248974|41899490|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
19504957|NCT02246166|41899498|FG000|Overall Study|Protocol Violation|1|||
19504958|NCT02246166|41899499|FG001|Overall Study|Protocol Violation|0|||
19504959|NCT02706847|41899508|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
19504960|NCT02706847|41899509|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
19504961|NCT02706847|41899510|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
19393929|NCT01597193|41637955|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
19504962|NCT02706847|41899511|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
19504963|NCT02706847|41899508|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
19504964|NCT02706847|41899509|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
19504965|NCT02706847|41899510|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
19504966|NCT02706847|41899511|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
19504967|NCT02706847|41899508|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
19504968|NCT02706847|41899509|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
19504969|NCT02706847|41899510|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
19504970|NCT02706847|41899511|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
19504971|NCT02706847|41899508|FG000|Period 1: Day 1 to Week 12|Other|4|||
19504972|NCT02706847|41899509|FG001|Period 1: Day 1 to Week 12|Other|4|||
19504973|NCT02706847|41899510|FG002|Period 1: Day 1 to Week 12|Other|2|||
19504974|NCT02706847|41899511|FG003|Period 1: Day 1 to Week 12|Other|2|||
19504975|NCT02706847|41899508|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
19504976|NCT02706847|41899509|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
19504977|NCT02706847|41899510|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
19504978|NCT02706847|41899511|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
19504979|NCT02706847|41899508|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
19504980|NCT02706847|41899509|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
19504981|NCT02706847|41899510|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
19504982|NCT02706847|41899511|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
19504983|NCT02706847|41899508|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
19504984|NCT02706847|41899509|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
19504985|NCT02706847|41899510|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
19504986|NCT02706847|41899511|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
19504987|NCT02706847|41899508|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
19504988|NCT02706847|41899509|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
19504989|NCT02706847|41899510|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
19504990|NCT02706847|41899511|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
19393930|NCT01597193|41637956|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
19393931|NCT01597193|41637957|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
19393932|NCT02649439|41637980|FG000|Overall Study|Switched to alternative treatment|6|||
19393933|NCT02649439|41637981|FG001|Overall Study|Switched to alternative treatment|4|||
19393934|NCT02649439|41637980|FG000|Overall Study|Patient decision|1|||
19393935|NCT02649439|41637981|FG001|Overall Study|Patient decision|0|||
19393936|NCT02649439|41637980|FG000|Overall Study|Patient going out of country|1|||
19393937|NCT02649439|41637981|FG001|Overall Study|Patient going out of country|0|||
19393938|NCT02649439|41637980|FG000|Overall Study|To start finasteride|1|||
19393939|NCT02649439|41637981|FG001|Overall Study|To start finasteride|0|||
19393940|NCT02649439|41637980|FG000|Overall Study|Physician Decision|1|||
19393941|NCT02649439|41637981|FG001|Overall Study|Physician Decision|0|||
19393942|NCT02649439|41637980|FG000|Overall Study|Disease progression on study|12|||
19393943|NCT02649439|41637981|FG001|Overall Study|Disease progression on study|13|||
19393944|NCT02649439|41637980|FG000|Overall Study|Refused further treatment|1|||
19393945|NCT02649439|41637981|FG001|Overall Study|Refused further treatment|0|||
19393946|NCT02649439|41637980|FG000|Overall Study|Refused further follow up|2|||
19393947|NCT02649439|41637981|FG001|Overall Study|Refused further follow up|7|||
19393948|NCT02649439|41637980|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
19393949|NCT02649439|41637981|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
19393950|NCT02649439|41637980|FG000|Overall Study|No treatment, per protocol|1|||
19393951|NCT02649439|41637981|FG001|Overall Study|No treatment, per protocol|0|||
19393952|NCT02649439|41637980|FG000|Overall Study|PSA DT makes ineligible|0|||
19393953|NCT02649439|41637981|FG001|Overall Study|PSA DT makes ineligible|1|||
19393954|NCT02649439|41637980|FG000|Overall Study|Rising PSA No Mets|0|||
19393955|NCT02649439|41637981|FG001|Overall Study|Rising PSA No Mets|1|||
19393956|NCT02649439|41637980|FG000|Overall Study|Rising PSA|0|||
19393957|NCT02649439|41637981|FG001|Overall Study|Rising PSA|1|||
19393958|NCT02649439|41637980|FG000|Overall Study|Signed follow up protocol|0|||
19393959|NCT02649439|41637981|FG001|Overall Study|Signed follow up protocol|1|||
19393960|NCT02622113|41637996|FG000|Overall Study|Adverse Event|4|||
19393961|NCT02622113|41637997|FG001|Overall Study|Adverse Event|4|||
19393962|NCT02622113|41637996|FG000|Overall Study|Physician Decision|0|||
19393963|NCT02622113|41637997|FG001|Overall Study|Physician Decision|1|||
19393964|NCT02622113|41637996|FG000|Overall Study|Withdrawal by Subject|0|||
19393965|NCT02622113|41637997|FG001|Overall Study|Withdrawal by Subject|2|||
19393966|NCT02622113|41637996|FG000|Overall Study|Stopping Criteria|1|||
19393967|NCT02622113|41637997|FG001|Overall Study|Stopping Criteria|3|||
19393968|NCT02651467|41638006|FG000|Overall Study|Withdrawal by Subject|0|||
19393969|NCT02651467|41638007|FG001|Overall Study|Withdrawal by Subject|0|||
19393970|NCT02651467|41638008|FG002|Overall Study|Withdrawal by Subject|2|||
19393971|NCT02651467|41638006|FG000|Overall Study|Other (Not specified)|1|||
19393972|NCT02651467|41638007|FG001|Overall Study|Other (Not specified)|0|||
19393973|NCT02651467|41638008|FG002|Overall Study|Other (Not specified)|2|||
19393974|NCT02620787|41638037|FG000|Overall Study|Adverse Event|1|||
19393975|NCT02620787|41638038|FG001|Overall Study|Adverse Event|0|||
19393976|NCT02620787|41638037|FG000|Overall Study|Eligibility Criteria Not Met|1|||
19393977|NCT02620787|41638038|FG001|Overall Study|Eligibility Criteria Not Met|0|||
19393978|NCT02651155|41638046|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19504991|NCT02706847|41899508|FG000|Period 1: Week 12 to Week 24|Other|1|||
19393979|NCT02651155|41638047|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
19393980|NCT02651155|41638046|FG000|Overall Study|Voluntary Withdrawal|5|||
19393981|NCT02651155|41638047|FG001|Overall Study|Voluntary Withdrawal|0|||
19504992|NCT02706847|41899509|FG001|Period 1: Week 12 to Week 24|Other|0|||
19504993|NCT02706847|41899510|FG002|Period 1: Week 12 to Week 24|Other|1|||
19504994|NCT02706847|41899511|FG003|Period 1: Week 12 to Week 24|Other|4|||
19504995|NCT02706847|41899508|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
19504996|NCT02706847|41899509|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
19504997|NCT02706847|41899510|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
19504998|NCT02706847|41899511|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
19504999|NCT02706847|41899508|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
19505000|NCT02706847|41899509|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
19505001|NCT02706847|41899510|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
19505002|NCT02706847|41899511|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
19505003|NCT02706847|41899508|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
19505004|NCT02706847|41899509|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
19505005|NCT02706847|41899510|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
19505006|NCT02706847|41899511|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
19505007|NCT02706847|41899508|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
19505008|NCT02706847|41899509|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
19505009|NCT02706847|41899510|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
19505010|NCT02706847|41899511|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
19505011|NCT02706847|41899508|FG000|Period 2: Week 24 to Week 260|Other|8|||
19505012|NCT02706847|41899509|FG001|Period 2: Week 24 to Week 260|Other|5|||
19505013|NCT02706847|41899510|FG002|Period 2: Week 24 to Week 260|Other|15|||
19505014|NCT02706847|41899511|FG003|Period 2: Week 24 to Week 260|Other|15|||
19505015|NCT02245620|41899524|FG000|Overall Study|Physician Decision|1|||
19505016|NCT02245620|41899525|FG001|Overall Study|Physician Decision|1|||
19505017|NCT02244996|41899533|FG000|Overall Study|Lack of Efficacy|2|||
19505018|NCT02244996|41899534|FG001|Overall Study|Lack of Efficacy|6|||
19505019|NCT02243280|41899569|FG000|Treated|Adverse Event|1|||
19505020|NCT02243280|41899570|FG001|Treated|Adverse Event|0|||
19505021|NCT02243280|41899571|FG002|Treated|Adverse Event|0|||
19615159|NCT00753675|42064458|FG000|Overall Study|other reason|11|||
19615160|NCT00753675|42064459|FG001|Overall Study|other reason|12|||
19615161|NCT00753675|42064460|FG002|Overall Study|other reason|13|||
19615162|NCT00753675|42064458|FG000|Overall Study|Death|1|||
19615163|NCT00753675|42064459|FG001|Overall Study|Death|2|||
19615164|NCT00753675|42064460|FG002|Overall Study|Death|4|||
19615165|NCT00753675|42064458|FG000|Overall Study|Adverse Event|11|||
19615166|NCT00753675|42064459|FG001|Overall Study|Adverse Event|9|||
19615167|NCT00753675|42064460|FG002|Overall Study|Adverse Event|4|||
19615168|NCT00753675|42064458|FG000|Overall Study|Objective progression of disease|35|||
19615169|NCT00753675|42064459|FG001|Overall Study|Objective progression of disease|35|||
19615170|NCT00753675|42064460|FG002|Overall Study|Objective progression of disease|35|||
19615171|NCT00753675|42064458|FG000|Overall Study|Withdrawal by Subject|0|||
19615172|NCT00753675|42064459|FG001|Overall Study|Withdrawal by Subject|1|||
19615173|NCT00753675|42064460|FG002|Overall Study|Withdrawal by Subject|0|||
19615174|NCT00753675|42064458|FG000|Overall Study|Lost to Follow-up|1|||
19505022|NCT02243280|41899572|FG003|Treated|Adverse Event|0|||
19505023|NCT02243280|41899573|FG004|Treated|Adverse Event|0|||
19505024|NCT02243280|41899574|FG005|Treated|Adverse Event|0|||
19505025|NCT02243280|41899575|FG006|Treated|Adverse Event|0|||
19505026|NCT02243280|41899576|FG007|Treated|Adverse Event|0|||
19505027|NCT02243280|41899577|FG008|Treated|Adverse Event|0|||
19505028|NCT02243280|41899578|FG009|Treated|Adverse Event|0|||
19505029|NCT02243280|41899579|FG010|Treated|Adverse Event|1|||
19505030|NCT02243280|41899569|FG000|Treated|Lost to Follow-up|0|||
19505031|NCT02243280|41899570|FG001|Treated|Lost to Follow-up|0|||
19505032|NCT02243280|41899571|FG002|Treated|Lost to Follow-up|0|||
19505033|NCT02243280|41899572|FG003|Treated|Lost to Follow-up|0|||
19505034|NCT02243280|41899573|FG004|Treated|Lost to Follow-up|0|||
19505035|NCT02243280|41899574|FG005|Treated|Lost to Follow-up|0|||
19505036|NCT02243280|41899575|FG006|Treated|Lost to Follow-up|0|||
19505037|NCT02243280|41899576|FG007|Treated|Lost to Follow-up|0|||
19505038|NCT02243280|41899577|FG008|Treated|Lost to Follow-up|1|||
19505039|NCT02243280|41899578|FG009|Treated|Lost to Follow-up|0|||
19505040|NCT02243280|41899579|FG010|Treated|Lost to Follow-up|2|||
19505041|NCT02248818|41899637|FG000|Screening|Protocol Violation|0|||
19505042|NCT02248818|41899638|FG001|Screening|Protocol Violation|0|||
19505043|NCT02248818|41899639|FG002|Screening|Protocol Violation|0|||
19505044|NCT02248818|41899640|FG003|Screening|Protocol Violation|0|||
19505045|NCT02248818|41899641|FG004|Screening|Protocol Violation|0|||
19505046|NCT02248818|41899642|FG005|Screening|Protocol Violation|0|||
19505047|NCT02248818|41899643|FG006|Screening|Protocol Violation|0|||
19505048|NCT02248818|41899644|FG007|Screening|Protocol Violation|0|||
19505049|NCT02248818|41899645|FG008|Screening|Protocol Violation|7|||
19505050|NCT02248818|41899637|FG000|Screening|Study fully enrolled|0|||
19505051|NCT02248818|41899638|FG001|Screening|Study fully enrolled|0|||
19505052|NCT02248818|41899639|FG002|Screening|Study fully enrolled|0|||
19505053|NCT02248818|41899640|FG003|Screening|Study fully enrolled|0|||
19615175|NCT00753675|42064459|FG001|Overall Study|Lost to Follow-up|0|||
19615176|NCT00753675|42064460|FG002|Overall Study|Lost to Follow-up|0|||
19615177|NCT00586521|42064468|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
19505054|NCT02248818|41899641|FG004|Screening|Study fully enrolled|0|||
19505055|NCT02248818|41899642|FG005|Screening|Study fully enrolled|0|||
19505056|NCT02248818|41899643|FG006|Screening|Study fully enrolled|0|||
19505057|NCT02248818|41899644|FG007|Screening|Study fully enrolled|0|||
19505058|NCT02248818|41899645|FG008|Screening|Study fully enrolled|14|||
19505059|NCT02248818|41899637|FG000|Screening|Physician Decision|0|||
19505060|NCT02248818|41899638|FG001|Screening|Physician Decision|0|||
19505061|NCT02248818|41899639|FG002|Screening|Physician Decision|0|||
19505062|NCT02248818|41899640|FG003|Screening|Physician Decision|0|||
19505063|NCT02248818|41899641|FG004|Screening|Physician Decision|0|||
19505064|NCT02248818|41899642|FG005|Screening|Physician Decision|0|||
19505065|NCT02248818|41899643|FG006|Screening|Physician Decision|0|||
19505066|NCT02248818|41899644|FG007|Screening|Physician Decision|0|||
19505067|NCT02248818|41899645|FG008|Screening|Physician Decision|73|||
19505068|NCT02248818|41899637|FG000|Screening|Withdrawal by Subject|0|||
19505069|NCT02248818|41899638|FG001|Screening|Withdrawal by Subject|0|||
19505070|NCT02248818|41899639|FG002|Screening|Withdrawal by Subject|0|||
19505071|NCT02248818|41899640|FG003|Screening|Withdrawal by Subject|0|||
19505072|NCT02248818|41899641|FG004|Screening|Withdrawal by Subject|0|||
19505073|NCT02248818|41899642|FG005|Screening|Withdrawal by Subject|0|||
19505074|NCT02248818|41899643|FG006|Screening|Withdrawal by Subject|0|||
19505075|NCT02248818|41899644|FG007|Screening|Withdrawal by Subject|0|||
19505076|NCT02248818|41899645|FG008|Screening|Withdrawal by Subject|6|||
19505077|NCT02248818|41899637|FG000|Screening|Lost to Follow-up|0|||
19505078|NCT02248818|41899638|FG001|Screening|Lost to Follow-up|0|||
19505079|NCT02248818|41899639|FG002|Screening|Lost to Follow-up|0|||
19505080|NCT02248818|41899640|FG003|Screening|Lost to Follow-up|0|||
19505081|NCT02248818|41899641|FG004|Screening|Lost to Follow-up|0|||
19505082|NCT02248818|41899642|FG005|Screening|Lost to Follow-up|0|||
19505083|NCT02248818|41899643|FG006|Screening|Lost to Follow-up|0|||
19505084|NCT02248818|41899644|FG007|Screening|Lost to Follow-up|0|||
19505085|NCT02248818|41899645|FG008|Screening|Lost to Follow-up|7|||
19505086|NCT02248818|41899637|FG000|Randomised Study|Administrative - randomization error|0|||
19505087|NCT02248818|41899638|FG001|Randomised Study|Administrative - randomization error|0|||
19505088|NCT02248818|41899639|FG002|Randomised Study|Administrative - randomization error|0|||
19505089|NCT02248818|41899640|FG003|Randomised Study|Administrative - randomization error|0|||
19505090|NCT02248818|41899641|FG004|Randomised Study|Administrative - randomization error|0|||
19505091|NCT02248818|41899642|FG005|Randomised Study|Administrative - randomization error|8|||
19505092|NCT02248818|41899643|FG006|Randomised Study|Administrative - randomization error|0|||
19505093|NCT02248818|41899644|FG007|Randomised Study|Administrative - randomization error|0|||
19505094|NCT02248818|41899645|FG008|Randomised Study|Administrative - randomization error|0|||
19505095|NCT02247960|41899674|FG000|Patient Consent and Randomization|Physician Decision|2|||
19505096|NCT02247960|41899675|FG001|Patient Consent and Randomization|Physician Decision|2|||
19505097|NCT02247960|41899674|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
19505098|NCT02247960|41899675|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
19505099|NCT02247960|41899674|FG000|Catheter Removed|Lost to Follow-up|7|||
19505100|NCT02247960|41899675|FG001|Catheter Removed|Lost to Follow-up|10|||
19505101|NCT02247804|41899764|FG000|Treatment Period 1|Adverse Event|9|||
19505102|NCT02247804|41899765|FG001|Treatment Period 1|Adverse Event|2|||
19505103|NCT02247804|41899766|FG002|Treatment Period 1|Adverse Event|0|||
19505104|NCT02247804|41899764|FG000|Treatment Period 1|Lack of Efficacy|0|||
19505105|NCT02247804|41899765|FG001|Treatment Period 1|Lack of Efficacy|0|||
19505106|NCT02247804|41899766|FG002|Treatment Period 1|Lack of Efficacy|2|||
19505107|NCT02247804|41899764|FG000|Treatment Period 1|Lost to Follow-up|1|||
19505108|NCT02247804|41899765|FG001|Treatment Period 1|Lost to Follow-up|0|||
19505109|NCT02247804|41899766|FG002|Treatment Period 1|Lost to Follow-up|2|||
19505110|NCT02247804|41899764|FG000|Treatment Period 1|Personal Reasons|7|||
19505111|NCT02247804|41899765|FG001|Treatment Period 1|Personal Reasons|1|||
19505112|NCT02247804|41899766|FG002|Treatment Period 1|Personal Reasons|2|||
19505113|NCT02247804|41899764|FG000|Treatment Period 1|Protocol Deviation|0|||
19505114|NCT02247804|41899765|FG001|Treatment Period 1|Protocol Deviation|0|||
19505115|NCT02247804|41899766|FG002|Treatment Period 1|Protocol Deviation|1|||
19505116|NCT02247804|41899764|FG000|Treatment Period 1|Randomized but not Treated|5|||
19505117|NCT02247804|41899765|FG001|Treatment Period 1|Randomized but not Treated|1|||
19505118|NCT02247804|41899766|FG002|Treatment Period 1|Randomized but not Treated|1|||
19505119|NCT02247804|41899764|FG000|Treatment Period 2|Adverse Event|6|||
19505120|NCT02247804|41899765|FG001|Treatment Period 2|Adverse Event|3|||
19505121|NCT02247804|41899766|FG002|Treatment Period 2|Adverse Event|3|||
19505122|NCT02247804|41899764|FG000|Treatment Period 2|Lack of Efficacy|0|||
19505123|NCT02247804|41899765|FG001|Treatment Period 2|Lack of Efficacy|0|||
19505124|NCT02247804|41899766|FG002|Treatment Period 2|Lack of Efficacy|1|||
19505125|NCT02247804|41899764|FG000|Treatment Period 2|Lost to Follow-up|0|||
19505126|NCT02247804|41899765|FG001|Treatment Period 2|Lost to Follow-up|1|||
19505127|NCT02247804|41899766|FG002|Treatment Period 2|Lost to Follow-up|1|||
19505128|NCT02247804|41899764|FG000|Treatment Period 2|Personal Reasons|2|||
19505129|NCT02247804|41899765|FG001|Treatment Period 2|Personal Reasons|1|||
19505130|NCT02247804|41899766|FG002|Treatment Period 2|Personal Reasons|1|||
19505131|NCT02247804|41899764|FG000|Treatment Period 2|Reason not Specified|0|||
19505132|NCT02247804|41899765|FG001|Treatment Period 2|Reason not Specified|0|||
19505133|NCT02247804|41899766|FG002|Treatment Period 2|Reason not Specified|2|||
19505134|NCT02247804|41899764|FG000|Treatment Period 3|Adverse Event|4|||
19505135|NCT02247804|41899765|FG001|Treatment Period 3|Adverse Event|3|||
19505136|NCT02247804|41899766|FG002|Treatment Period 3|Adverse Event|3|||
19505137|NCT02247804|41899764|FG000|Treatment Period 3|Lack of Efficacy|0|||
19505138|NCT02247804|41899765|FG001|Treatment Period 3|Lack of Efficacy|1|||
19505139|NCT02247804|41899766|FG002|Treatment Period 3|Lack of Efficacy|0|||
19505140|NCT02247804|41899764|FG000|Treatment Period 3|Lost to Follow-up|1|||
19505141|NCT02247804|41899765|FG001|Treatment Period 3|Lost to Follow-up|2|||
19505142|NCT02247804|41899766|FG002|Treatment Period 3|Lost to Follow-up|2|||
19505143|NCT02247804|41899764|FG000|Treatment Period 3|Personal Reasons|4|||
19505144|NCT02247804|41899765|FG001|Treatment Period 3|Personal Reasons|3|||
19505145|NCT02247804|41899766|FG002|Treatment Period 3|Personal Reasons|2|||
19505146|NCT02247804|41899764|FG000|Treatment Period 3|Reason not Specified|2|||
19505147|NCT02247804|41899765|FG001|Treatment Period 3|Reason not Specified|1|||
19505148|NCT02247804|41899766|FG002|Treatment Period 3|Reason not Specified|3|||
19505149|NCT02243202|41899791|FG000|Overall Study|Adverse Event|5|||
19505150|NCT02243202|41899792|FG001|Overall Study|Adverse Event|6|||
19505151|NCT02243202|41899793|FG002|Overall Study|Adverse Event|10|||
19505152|NCT02243202|41899794|FG003|Overall Study|Adverse Event|4|||
19505153|NCT02243202|41899791|FG000|Overall Study|Lost to Follow-up|9|||
19505154|NCT02243202|41899792|FG001|Overall Study|Lost to Follow-up|9|||
19505155|NCT02243202|41899793|FG002|Overall Study|Lost to Follow-up|14|||
19505156|NCT02243202|41899794|FG003|Overall Study|Lost to Follow-up|11|||
19505157|NCT02243202|41899791|FG000|Overall Study|Protocol Violation|3|||
19505158|NCT02243202|41899792|FG001|Overall Study|Protocol Violation|1|||
19505159|NCT02243202|41899793|FG002|Overall Study|Protocol Violation|2|||
19505160|NCT02243202|41899794|FG003|Overall Study|Protocol Violation|1|||
19505161|NCT02243202|41899791|FG000|Overall Study|Withdrawal by Subject|7|||
19505162|NCT02243202|41899792|FG001|Overall Study|Withdrawal by Subject|6|||
19505163|NCT02243202|41899793|FG002|Overall Study|Withdrawal by Subject|4|||
19505164|NCT02243202|41899794|FG003|Overall Study|Withdrawal by Subject|4|||
19615178|NCT00923273|42064477|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
19615179|NCT00923273|42064478|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
19615180|NCT00923273|42064479|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
19615181|NCT00923273|42064480|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
19615182|NCT00923273|42064481|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
19505165|NCT02243202|41899791|FG000|Overall Study|Other|1|||
19505166|NCT02243202|41899792|FG001|Overall Study|Other|3|||
19505167|NCT02243202|41899793|FG002|Overall Study|Other|1|||
19505168|NCT02243202|41899794|FG003|Overall Study|Other|2|||
19505169|NCT02243202|41899791|FG000|Overall Study|Randomized but not received treatment|0|||
19505170|NCT02243202|41899792|FG001|Overall Study|Randomized but not received treatment|0|||
19505171|NCT02243202|41899793|FG002|Overall Study|Randomized but not received treatment|0|||
19505172|NCT02243202|41899794|FG003|Overall Study|Randomized but not received treatment|1|||
19505173|NCT02243046|41899807|FG000|Overall Study|Lost to Follow-up|1|||
19505174|NCT02243046|41899808|FG001|Overall Study|Lost to Follow-up|1|||
19505175|NCT02243046|41899809|FG002|Overall Study|Lost to Follow-up|4|||
19615183|NCT00923273|42064477|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
19615184|NCT00923273|42064478|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
19615185|NCT00923273|42064479|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
19704478|NCT00153816|42148863|FG002|Overall Study|Lost to Follow-up|5|||
19505176|NCT02207946|41899819|FG000|Overall Study|Lost to Follow-up|1|||
19505177|NCT02207946|41899820|FG001|Overall Study|Lost to Follow-up|0|||
19505178|NCT02207946|41899819|FG000|Overall Study|Adverse Event|0|||
19505179|NCT02207946|41899820|FG001|Overall Study|Adverse Event|1|||
19505180|NCT03976076|41899827|FG000|Overall Study|Withdrawal by Subject|2|||
19505181|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
19505182|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
19505183|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
19505184|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
19505185|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
19505186|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
19505187|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
19505188|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
19505189|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
19505190|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
19505191|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
19505192|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
19505193|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
19505194|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
19505195|NCT03732638|41899974|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
19505196|NCT03732638|41899975|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
19505197|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
19505198|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
19505199|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
19505200|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
19505201|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
19505202|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
19505203|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
19505204|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
19505205|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
19505206|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
19505207|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
19505208|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
19505209|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
19505210|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
19505211|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
19505212|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
19505213|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
19505214|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
19505215|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
19505216|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
19505217|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
19505218|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
19505219|NCT03732638|41899974|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
19505220|NCT03732638|41899975|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
19505221|NCT03732638|41899974|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
19505222|NCT03732638|41899975|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
19505223|NCT03732638|41899974|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
19505224|NCT03732638|41899975|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
19505225|NCT03732638|41899974|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
19505226|NCT03732638|41899975|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
19615186|NCT00923273|42064480|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
19615187|NCT00923273|42064481|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
19615188|NCT00923195|42064501|FG000|Overall Study|Death|0|||
19505227|NCT03732638|41899974|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
19505228|NCT03732638|41899975|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
19505229|NCT03551210|41900042|FG000|Overall Study|Adverse Event|5|||
19505230|NCT03551210|41900043|FG001|Overall Study|Adverse Event|6|||
19505231|NCT03551210|41900042|FG000|Overall Study|Withdrawal by Subject|1|||
19505232|NCT03551210|41900043|FG001|Overall Study|Withdrawal by Subject|7|||
19505233|NCT03551210|41900042|FG000|Overall Study|Needed in other antibiotic treatment|2|||
19505234|NCT03551210|41900043|FG001|Overall Study|Needed in other antibiotic treatment|5|||
19505235|NCT03551210|41900042|FG000|Overall Study|Lost to Follow-up|1|||
19505236|NCT03551210|41900043|FG001|Overall Study|Lost to Follow-up|1|||
19505237|NCT03551210|41900042|FG000|Overall Study|Absence of visit 4 and 5|1|||
19505238|NCT03551210|41900043|FG001|Overall Study|Absence of visit 4 and 5|0|||
19505239|NCT03551210|41900042|FG000|Overall Study|No drug for dispensing|0|||
19505240|NCT03551210|41900043|FG001|Overall Study|No drug for dispensing|1|||
19505241|NCT02207634|41900189|FG000|Overall Study|Withdrawal by Subject|21|||
19505242|NCT02207634|41900190|FG001|Overall Study|Withdrawal by Subject|31|||
19505243|NCT02207634|41900189|FG000|Overall Study|Lost to Follow-up|1|||
19505244|NCT02207634|41900190|FG001|Overall Study|Lost to Follow-up|0|||
19505245|NCT03452228|41900233|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
19505246|NCT03452228|41900234|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
19505247|NCT03452228|41900235|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
19505248|NCT03452228|41900233|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
19505249|NCT03452228|41900234|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
19505250|NCT03452228|41900235|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
19505251|NCT03452228|41900233|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
19505252|NCT03452228|41900234|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
19505253|NCT03452228|41900235|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
19505254|NCT03452228|41900233|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19505255|NCT03452228|41900234|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19505256|NCT03452228|41900235|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
19505257|NCT02207556|41900298|FG000|Overall Study|Physician Decision|1|||
19505258|NCT02207556|41900299|FG001|Overall Study|Physician Decision|0|||
19615189|NCT00923195|42064502|FG001|Overall Study|Death|1|||
19505259|NCT02207556|41900298|FG000|Overall Study|Withdrawal by Subject|1|||
19505260|NCT02207556|41900299|FG001|Overall Study|Withdrawal by Subject|0|||
19505261|NCT02207556|41900298|FG000|Overall Study|Death|0|||
19505262|NCT02207556|41900299|FG001|Overall Study|Death|5|||
19505263|NCT03266588|41900329|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
19505264|NCT03266588|41900330|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
19505265|NCT03266588|41900331|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
19505266|NCT03266588|41900329|FG000|Observational Period|Withdrawal by Subject|44|||
19505267|NCT03266588|41900330|FG001|Observational Period|Withdrawal by Subject|22|||
19505268|NCT03266588|41900331|FG002|Observational Period|Withdrawal by Subject|13|||
19505269|NCT03266588|41900329|FG000|Observational Period|Non-compliance|18|||
19505270|NCT03266588|41900330|FG001|Observational Period|Non-compliance|12|||
19505271|NCT03266588|41900331|FG002|Observational Period|Non-compliance|10|||
19505272|NCT03266588|41900329|FG000|Observational Period|Lost to Follow-up|8|||
19505273|NCT03266588|41900330|FG001|Observational Period|Lost to Follow-up|12|||
19505274|NCT03266588|41900331|FG002|Observational Period|Lost to Follow-up|4|||
19505275|NCT03266588|41900329|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
19505276|NCT03266588|41900330|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
19505277|NCT03266588|41900331|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
19505278|NCT03266588|41900329|FG000|Observational Period|Protocol Deviation|1|||
19505279|NCT03266588|41900330|FG001|Observational Period|Protocol Deviation|0|||
19505280|NCT03266588|41900331|FG002|Observational Period|Protocol Deviation|0|||
19505281|NCT03266588|41900329|FG000|Observational Period|Other Reasons|3|||
19505282|NCT03266588|41900330|FG001|Observational Period|Other Reasons|0|||
19505283|NCT03266588|41900331|FG002|Observational Period|Other Reasons|1|||
19505284|NCT03266588|41900329|FG000|Long-term Treatment Period|Adverse Event|33|||
19505285|NCT03266588|41900330|FG001|Long-term Treatment Period|Adverse Event|17|||
19505286|NCT03266588|41900331|FG002|Long-term Treatment Period|Adverse Event|8|||
19505287|NCT03266588|41900329|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
19505288|NCT03266588|41900330|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
19505289|NCT03266588|41900331|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
19505290|NCT03266588|41900329|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
19505291|NCT03266588|41900330|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
19505292|NCT03266588|41900331|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
19505293|NCT03266588|41900329|FG000|Long-term Treatment Period|Non-Compliance|126|||
19505294|NCT03266588|41900330|FG001|Long-term Treatment Period|Non-Compliance|57|||
19505295|NCT03266588|41900331|FG002|Long-term Treatment Period|Non-Compliance|7|||
19505296|NCT03266588|41900329|FG000|Long-term Treatment Period|Pregnancy|11|||
19505297|NCT03266588|41900330|FG001|Long-term Treatment Period|Pregnancy|5|||
19505298|NCT03266588|41900331|FG002|Long-term Treatment Period|Pregnancy|0|||
19505299|NCT03266588|41900329|FG000|Long-term Treatment Period|Protocol Deviation|17|||
19505300|NCT03266588|41900330|FG001|Long-term Treatment Period|Protocol Deviation|10|||
19505301|NCT03266588|41900331|FG002|Long-term Treatment Period|Protocol Deviation|4|||
19505302|NCT03266588|41900329|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
19505303|NCT03266588|41900330|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
19505304|NCT03266588|41900331|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
19505305|NCT03266588|41900329|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
19505306|NCT03266588|41900330|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
19505307|NCT03266588|41900331|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
19505308|NCT03266588|41900329|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
19505309|NCT03266588|41900330|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
19505310|NCT03266588|41900331|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
19505311|NCT03266588|41900329|FG000|Long-term Treatment Period|Other Reasons|5|||
19505312|NCT03266588|41900330|FG001|Long-term Treatment Period|Other Reasons|0|||
19615190|NCT00753519|42064510|FG000|Overall Study|Withdrawal by Subject|0|||
19615191|NCT00753519|42064511|FG001|Overall Study|Withdrawal by Subject|2|||
19615192|NCT00919061|42064519|FG000|Overall Study|Adverse Event|1|||
19615193|NCT00919061|42064519|FG000|Overall Study|Withdrawal by Subject|1|||
19505313|NCT03266588|41900331|FG002|Long-term Treatment Period|Other Reasons|0|||
19505314|NCT03266588|41900329|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
19505315|NCT03266588|41900330|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
19505316|NCT03266588|41900331|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
19505317|NCT03238196|41900395|FG000|Overall Study|Adverse Event|3|||
19505318|NCT03238196|41900396|FG001|Overall Study|Adverse Event|0|||
19505319|NCT03238196|41900397|FG002|Overall Study|Adverse Event|2|||
19505320|NCT03238196|41900398|FG003|Overall Study|Adverse Event|2|||
19505321|NCT03238196|41900395|FG000|Overall Study|Withdrawal by Subject|4|||
19505322|NCT03238196|41900396|FG001|Overall Study|Withdrawal by Subject|1|||
19505323|NCT03238196|41900397|FG002|Overall Study|Withdrawal by Subject|1|||
19615194|NCT00747435|42064523|FG000|Overall Study|Lost to Follow-up|2|||
19615195|NCT00747435|42064523|FG000|Overall Study|Withdrawal by Subject|3|||
19505324|NCT03238196|41900398|FG003|Overall Study|Withdrawal by Subject|0|||
19505325|NCT03238196|41900395|FG000|Overall Study|Disease progression|14|||
19505326|NCT03238196|41900396|FG001|Overall Study|Disease progression|2|||
19505327|NCT03238196|41900397|FG002|Overall Study|Disease progression|3|||
19505328|NCT03238196|41900398|FG003|Overall Study|Disease progression|2|||
19505329|NCT03238196|41900395|FG000|Overall Study|Still on treatment|1|||
19505330|NCT03238196|41900396|FG001|Overall Study|Still on treatment|0|||
19505331|NCT03238196|41900397|FG002|Overall Study|Still on treatment|0|||
19505332|NCT03238196|41900398|FG003|Overall Study|Still on treatment|0|||
19505333|NCT03019640|41900426|FG000|Overall Study|Screen Failures|4|||
19505334|NCT03019640|41900426|FG000|Overall Study|Adverse Event|3|||
19505335|NCT03019640|41900426|FG000|Overall Study|Participant Relapsed|1|||
19505336|NCT02240706|41900494|FG000|Overall Study|Lack of Efficacy|2|||
19505337|NCT02240706|41900495|FG001|Overall Study|Lack of Efficacy|2|||
19505338|NCT02240706|41900496|FG002|Overall Study|Lack of Efficacy|2|||
19505339|NCT02240706|41900497|FG003|Overall Study|Lack of Efficacy|2|||
19505340|NCT02240706|41900498|FG004|Overall Study|Lack of Efficacy|5|||
19505341|NCT02240706|41900499|FG005|Overall Study|Lack of Efficacy|0|||
19505342|NCT02240706|41900500|FG006|Overall Study|Lack of Efficacy|0|||
19505343|NCT02240706|41900494|FG000|Overall Study|Adverse Event|1|||
19505344|NCT02240706|41900495|FG001|Overall Study|Adverse Event|0|||
19505345|NCT02240706|41900496|FG002|Overall Study|Adverse Event|1|||
19505346|NCT02240706|41900497|FG003|Overall Study|Adverse Event|0|||
19505347|NCT02240706|41900498|FG004|Overall Study|Adverse Event|2|||
19505348|NCT02240706|41900499|FG005|Overall Study|Adverse Event|0|||
19505349|NCT02240706|41900500|FG006|Overall Study|Adverse Event|0|||
19505350|NCT02240706|41900494|FG000|Overall Study|Progressive disease|0|||
19505351|NCT02240706|41900495|FG001|Overall Study|Progressive disease|0|||
19505352|NCT02240706|41900496|FG002|Overall Study|Progressive disease|0|||
19505353|NCT02240706|41900497|FG003|Overall Study|Progressive disease|0|||
19505354|NCT02240706|41900498|FG004|Overall Study|Progressive disease|1|||
19505355|NCT02240706|41900499|FG005|Overall Study|Progressive disease|0|||
19505356|NCT02240706|41900500|FG006|Overall Study|Progressive disease|0|||
19505357|NCT02240706|41900494|FG000|Overall Study|Dose limiting toxicity|0|||
19505358|NCT02240706|41900495|FG001|Overall Study|Dose limiting toxicity|0|||
19704479|NCT00153816|42148864|FG003|Overall Study|Lost to Follow-up|8|||
19704480|NCT00153816|42148865|FG004|Overall Study|Lost to Follow-up|7|||
19704481|NCT00153816|42148866|FG005|Overall Study|Lost to Follow-up|9|||
19704482|NCT00153816|42148861|FG000|Overall Study|Withdrawal by Subject|9|||
19704483|NCT00153816|42148862|FG001|Overall Study|Withdrawal by Subject|9|||
19704484|NCT00153816|42148863|FG002|Overall Study|Withdrawal by Subject|9|||
19704485|NCT00153816|42148864|FG003|Overall Study|Withdrawal by Subject|4|||
19704486|NCT00153816|42148865|FG004|Overall Study|Withdrawal by Subject|1|||
19704487|NCT00153816|42148866|FG005|Overall Study|Withdrawal by Subject|5|||
19704488|NCT00153816|42148861|FG000|Overall Study|Follow-up exam not done|8|||
19704489|NCT00153816|42148862|FG001|Overall Study|Follow-up exam not done|7|||
19505359|NCT02240706|41900496|FG002|Overall Study|Dose limiting toxicity|0|||
19505360|NCT02240706|41900497|FG003|Overall Study|Dose limiting toxicity|0|||
19505361|NCT02240706|41900498|FG004|Overall Study|Dose limiting toxicity|1|||
19505362|NCT02240706|41900499|FG005|Overall Study|Dose limiting toxicity|0|||
19505363|NCT02240706|41900500|FG006|Overall Study|Dose limiting toxicity|0|||
19505364|NCT02240706|41900494|FG000|Overall Study|Refused to continue taking medication|0|||
19505365|NCT02240706|41900495|FG001|Overall Study|Refused to continue taking medication|1|||
19505366|NCT02240706|41900496|FG002|Overall Study|Refused to continue taking medication|3|||
19505367|NCT02240706|41900497|FG003|Overall Study|Refused to continue taking medication|1|||
19505368|NCT02240706|41900498|FG004|Overall Study|Refused to continue taking medication|2|||
19505369|NCT02240706|41900499|FG005|Overall Study|Refused to continue taking medication|0|||
19505370|NCT02240706|41900500|FG006|Overall Study|Refused to continue taking medication|0|||
19505371|NCT02240706|41900494|FG000|Overall Study|Insurance billing concerns|0|||
19505372|NCT02240706|41900495|FG001|Overall Study|Insurance billing concerns|0|||
19505373|NCT02240706|41900496|FG002|Overall Study|Insurance billing concerns|0|||
19505374|NCT02240706|41900497|FG003|Overall Study|Insurance billing concerns|1|||
19505375|NCT02240706|41900498|FG004|Overall Study|Insurance billing concerns|0|||
19505376|NCT02240706|41900499|FG005|Overall Study|Insurance billing concerns|0|||
19505377|NCT02240706|41900500|FG006|Overall Study|Insurance billing concerns|0|||
19505378|NCT01600092|41900525|FG000|Overall Study|Adverse Event|2|||
19505379|NCT01600092|41900526|FG001|Overall Study|Adverse Event|0|||
19505380|NCT01600092|41900525|FG000|Overall Study|Lost to Follow-up|4|||
19505381|NCT01600092|41900526|FG001|Overall Study|Lost to Follow-up|6|||
19505382|NCT01600092|41900525|FG000|Overall Study|Withdrawal by parent/guardian|8|||
19505383|NCT01600092|41900526|FG001|Overall Study|Withdrawal by parent/guardian|6|||
19505384|NCT01600092|41900525|FG000|Overall Study|Physician Decision|1|||
19505385|NCT01600092|41900526|FG001|Overall Study|Physician Decision|1|||
19505386|NCT01600092|41900525|FG000|Overall Study|Randomized but not vaccinated|3|||
19505387|NCT01600092|41900526|FG001|Overall Study|Randomized but not vaccinated|3|||
19505388|NCT02240628|41900538|FG000|Overall Study|Physician Decision|6|||
19505389|NCT02240628|41900539|FG001|Overall Study|Physician Decision|5|||
19505390|NCT02207400|41900561|FG000|Overall Study|Adverse Event|1|||
19505391|NCT02207400|41900562|FG001|Overall Study|Adverse Event|1|||
19505392|NCT02207400|41900561|FG000|Overall Study|Lost to Follow-up|6|||
19505393|NCT02207400|41900562|FG001|Overall Study|Lost to Follow-up|7|||
19505394|NCT02207400|41900561|FG000|Overall Study|Protocol Violation|1|||
19505395|NCT02207400|41900562|FG001|Overall Study|Protocol Violation|1|||
19505396|NCT02207400|41900561|FG000|Overall Study|Withdrawal by Subject|8|||
19505397|NCT02207400|41900562|FG001|Overall Study|Withdrawal by Subject|4|||
19505398|NCT02207400|41900561|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
19505399|NCT02207400|41900562|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
19505400|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
19505401|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
19505402|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
19505403|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505404|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505405|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505406|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505407|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505408|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505409|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505410|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
19505411|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
19505412|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505413|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
19505414|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505415|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505416|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505417|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505418|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505419|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505420|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505421|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
19505422|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
19505423|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
19505424|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
19505425|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505426|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505427|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505428|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505429|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505430|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505431|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505432|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
19505433|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
19505434|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
19505435|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505436|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505437|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505438|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505439|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505440|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505441|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505442|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505443|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
19505444|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
19505445|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
19505446|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
19505447|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505448|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505449|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505450|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505451|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505452|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505453|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505454|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
19505455|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505456|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
19505457|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
19505458|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505459|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505460|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505461|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505462|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505463|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505464|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505465|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
19505466|NCT02207244|41900955|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505467|NCT02207244|41900956|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
19505468|NCT02207244|41900957|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505469|NCT02207244|41900958|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505470|NCT02207244|41900959|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505471|NCT02207244|41900960|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505472|NCT02207244|41900961|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505473|NCT02207244|41900962|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505474|NCT02207244|41900963|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505475|NCT02207244|41900964|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505476|NCT02207244|41900965|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
19505477|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505478|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505479|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505480|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505481|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
19505482|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
19505483|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505484|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505485|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505486|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505487|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
19505488|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505489|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505490|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505491|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505492|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505493|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
19505494|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505495|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505496|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505497|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19505498|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
19615196|NCT00747435|42064523|FG000|Overall Study|Still undergoing follow up|1|||
19615197|NCT00918749|42064530|FG000|Overall Study|Adverse Event|1|||
19615198|NCT00918749|42064531|FG001|Overall Study|Adverse Event|0|||
19615199|NCT00918749|42064532|FG002|Overall Study|Adverse Event|1|||
19615200|NCT00918749|42064530|FG000|Overall Study|Lost to Follow-up|0|||
19615201|NCT00918749|42064531|FG001|Overall Study|Lost to Follow-up|0|||
19615202|NCT00918749|42064532|FG002|Overall Study|Lost to Follow-up|1|||
19615203|NCT00918749|42064530|FG000|Overall Study|Withdrawal by Subject|5|||
19615204|NCT00918749|42064531|FG001|Overall Study|Withdrawal by Subject|3|||
19615205|NCT00918749|42064532|FG002|Overall Study|Withdrawal by Subject|5|||
19373732|NCT02755649|41614936|FG000|Overall Study|Transitioned into OLE study|99|||
19373733|NCT02755649|41614937|FG001|Overall Study|Transitioned into OLE study|98|||
19373734|NCT02755649|41614938|FG002|Overall Study|Transitioned into OLE study|100|||
19373735|NCT02755649|41614936|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
19615206|NCT00918749|42064530|FG000|Overall Study|No Study Medication Taken|1|||
19615207|NCT00918749|42064531|FG001|Overall Study|No Study Medication Taken|0|||
19615208|NCT00918749|42064532|FG002|Overall Study|No Study Medication Taken|0|||
19615209|NCT00746733|42064540|FG000|Second Intervention|Adverse Event|1|||
19505499|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505500|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505501|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505502|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
19505503|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
19505504|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
19615210|NCT00746733|42064541|FG001|Second Intervention|Adverse Event|0|||
19615211|NCT00746733|42064540|FG000|Third Intervention|Withdrawal by Subject|1|||
19505505|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505506|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505507|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505508|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505509|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
19505510|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505511|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505512|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505513|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
19505514|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
19505515|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
19505516|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505517|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505518|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505519|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505520|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
19505521|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505522|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505523|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505524|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
19505525|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505526|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
19505527|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505528|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505529|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505530|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505531|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
19505532|NCT02207244|41900955|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505533|NCT02207244|41900956|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505534|NCT02207244|41900957|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505535|NCT02207244|41900958|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
19505536|NCT02207244|41900959|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505537|NCT02207244|41900960|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505538|NCT02207244|41900961|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505539|NCT02207244|41900962|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505540|NCT02207244|41900963|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505541|NCT02207244|41900964|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505542|NCT02207244|41900965|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
19505543|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505544|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505545|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505546|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505547|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505548|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19615212|NCT00746733|42064541|FG001|Third Intervention|Withdrawal by Subject|1|||
19615213|NCT00745875|42064556|FG000|Overall Study|Continuing study treatment|4|||
19615214|NCT00745875|42064557|FG001|Overall Study|Continuing study treatment|4|||
19615215|NCT00555217|42064565|FG000|Overall Study|Withdrawal by Subject|35|||
19615216|NCT00555217|42064566|FG001|Overall Study|Withdrawal by Subject|31|||
19615217|NCT00555217|42064565|FG000|Overall Study|Lost to Follow-up|19|||
19615218|NCT00555217|42064566|FG001|Overall Study|Lost to Follow-up|20|||
19615219|NCT00555217|42064565|FG000|Overall Study|close out sites|21|||
19615220|NCT00555217|42064566|FG001|Overall Study|close out sites|17|||
19615221|NCT00745251|42064574|FG000|Overall Study|Adverse Event|1|||
19615222|NCT00745251|42064575|FG001|Overall Study|Adverse Event|2|||
19615223|NCT00745251|42064574|FG000|Overall Study|Withdrawal by Subject|1|||
19615224|NCT00745251|42064575|FG001|Overall Study|Withdrawal by Subject|1|||
19505549|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
19505550|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
19505551|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
19505552|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
19505553|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
19505554|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19615225|NCT00745095|42064587|FG000|Overall Study|Declined to participate|1|||
19615226|NCT00745095|42064588|FG001|Overall Study|Declined to participate|0|||
19615227|NCT00745095|42064589|FG002|Overall Study|Declined to participate|0|||
19615228|NCT00745095|42064590|FG003|Overall Study|Declined to participate|0|||
19615229|NCT00745095|42064591|FG004|Overall Study|Declined to participate|92|||
19505555|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505556|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505557|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505558|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505559|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505560|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505561|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
19505562|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505563|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505564|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
19505565|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505566|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505567|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505568|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505569|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505570|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505571|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
19505572|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
19505573|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
19505574|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
19505575|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
19505576|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505577|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505578|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505579|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505580|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505581|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505582|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
19505583|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
19505584|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505585|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
19615230|NCT00745095|42064592|FG005|Overall Study|Declined to participate|95|||
19615231|NCT00745095|42064587|FG000|Overall Study|Ineligible due to GFR criteria|0|||
19704490|NCT00153816|42148863|FG002|Overall Study|Follow-up exam not done|11|||
19704491|NCT00153816|42148864|FG003|Overall Study|Follow-up exam not done|10|||
19704492|NCT00153816|42148865|FG004|Overall Study|Follow-up exam not done|8|||
19704493|NCT00153816|42148866|FG005|Overall Study|Follow-up exam not done|9|||
19704494|NCT00153816|42148861|FG000|Overall Study|Follow-up exam done, histology missing|2|||
19704495|NCT00153816|42148862|FG001|Overall Study|Follow-up exam done, histology missing|3|||
19704496|NCT00153816|42148863|FG002|Overall Study|Follow-up exam done, histology missing|3|||
19704497|NCT00153816|42148864|FG003|Overall Study|Follow-up exam done, histology missing|3|||
19505586|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
19505587|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505588|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505589|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505590|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505591|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505592|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505593|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
19505594|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
19505595|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
19505596|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
19505597|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
19505598|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505599|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505600|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505601|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505602|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505603|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505604|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505605|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
19505606|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
19505607|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19393982|NCT02619617|41638053|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
19505608|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
19505609|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505610|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505611|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505612|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505613|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505614|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505615|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19615232|NCT00745095|42064588|FG001|Overall Study|Ineligible due to GFR criteria|2|||
19615233|NCT00745095|42064589|FG002|Overall Study|Ineligible due to GFR criteria|3|||
19505616|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505617|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
19505618|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505619|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
19505620|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505621|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505622|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505623|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505624|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505625|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505626|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505627|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
19505628|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505629|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505630|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
19505631|NCT02207244|41900955|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505632|NCT02207244|41900956|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505633|NCT02207244|41900957|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505634|NCT02207244|41900958|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505635|NCT02207244|41900959|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505636|NCT02207244|41900960|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505637|NCT02207244|41900961|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
19505638|NCT02207244|41900962|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505639|NCT02207244|41900963|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19393983|NCT02619617|41638054|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
19505640|NCT02207244|41900964|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505641|NCT02207244|41900965|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
19505642|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505643|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505644|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505645|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505646|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505647|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505648|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505649|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505650|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
19505651|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
19505652|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
19505653|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505654|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505655|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505656|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505657|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505658|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19615234|NCT00745095|42064590|FG003|Overall Study|Ineligible due to GFR criteria|3|||
19615235|NCT00745095|42064591|FG004|Overall Study|Ineligible due to GFR criteria|30|||
19615236|NCT00745095|42064592|FG005|Overall Study|Ineligible due to GFR criteria|28|||
19615237|NCT00744939|42064613|FG000|Overall Study|Withdrawal by Subject|9|||
19615238|NCT00744939|42064613|FG000|Overall Study|Protocol Violation|13|||
19615239|NCT00744939|42064613|FG000|Overall Study|Death|24|||
19615240|NCT00744939|42064613|FG000|Overall Study|distance|4|||
19615241|NCT00744939|42064613|FG000|Overall Study|Lost to Follow-up|12|||
19615242|NCT00744939|42064613|FG000|Overall Study|Medical history exclusionary|1|||
19615243|NCT00744939|42064613|FG000|Overall Study|Did not receive Magnevist|7|||
19615244|NCT00744939|42064613|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
19704498|NCT00153816|42148865|FG004|Overall Study|Follow-up exam done, histology missing|1|||
19505659|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505660|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505661|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
19505662|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
19505663|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
19505664|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505665|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505666|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505667|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505668|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505669|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505670|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505671|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505672|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
19505673|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
19505674|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
19505675|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505676|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505677|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505678|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505679|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505680|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505681|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505682|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505683|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
19505684|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
19505685|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
19505686|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
19505687|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
19505688|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
19505689|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
19505690|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
19505691|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
19505692|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
19505693|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
19505694|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
19505695|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
19505696|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
19505697|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
19505698|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
19505699|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
19505700|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
19505701|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
19505702|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
19505703|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
19505704|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
19505705|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
19505706|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
19505707|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
19505708|NCT02207244|41900955|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505709|NCT02207244|41900956|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505710|NCT02207244|41900957|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505711|NCT02207244|41900958|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505712|NCT02207244|41900959|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505713|NCT02207244|41900960|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505714|NCT02207244|41900961|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505715|NCT02207244|41900962|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505716|NCT02207244|41900963|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505717|NCT02207244|41900964|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
19505718|NCT02207244|41900965|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
19505719|NCT02207088|41901018|FG000|Overall Study|Adverse Event|2|||
19505720|NCT02206620|41901033|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
19505721|NCT02206620|41901034|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
19505722|NCT02206620|41901033|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
19505723|NCT02206620|41901034|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
19505724|NCT02239926|41901048|FG000|Overall Study|Withdrawal by Subject|0|||
19505725|NCT02239926|41901049|FG001|Overall Study|Withdrawal by Subject|1|||
19505726|NCT02239692|41901057|FG000|Overall Study|Incomplete colonoscopy|1|||
19505727|NCT02239692|41901058|FG001|Overall Study|Incomplete colonoscopy|2|||
19505728|NCT02239692|41901057|FG000|Overall Study|Adverse Event|0|||
19505729|NCT02239692|41901058|FG001|Overall Study|Adverse Event|1|||
19505730|NCT02239692|41901057|FG000|Overall Study|Physician Decision|0|||
19505731|NCT02239692|41901058|FG001|Overall Study|Physician Decision|1|||
19505732|NCT02239692|41901057|FG000|Overall Study|Lost to Follow-up|1|||
19505733|NCT02239692|41901058|FG001|Overall Study|Lost to Follow-up|4|||
19505734|NCT02239692|41901057|FG000|Overall Study|Withdrawal by Subject|3|||
19505735|NCT02239692|41901058|FG001|Overall Study|Withdrawal by Subject|5|||
19505736|NCT02239692|41901057|FG000|Overall Study|Other reason|1|||
19505737|NCT02239692|41901058|FG001|Overall Study|Other reason|0|||
19505738|NCT02206152|41901086|FG000|Pre-Randomization|Withdrawal by Subject|2|||
19505739|NCT02204982|41901094|FG000|Overall Study|Patient ineligible-medical monitor|1|||
19505740|NCT02204982|41901095|FG001|Overall Study|Patient ineligible-medical monitor|0|||
19505741|NCT02204982|41901094|FG000|Overall Study|Withdrawal by Subject|1|||
19505742|NCT02204982|41901095|FG001|Overall Study|Withdrawal by Subject|0|||
19505743|NCT02204982|41901094|FG000|Overall Study|Adverse Event|1|||
19505744|NCT02204982|41901095|FG001|Overall Study|Adverse Event|0|||
19505745|NCT02204982|41901094|FG000|Overall Study|Adverse Event and Investigator decision|1|||
19505746|NCT02204982|41901095|FG001|Overall Study|Adverse Event and Investigator decision|0|||
19505747|NCT02204982|41901094|FG000|Overall Study|Physician Decision|0|||
19615245|NCT00744939|42064613|FG000|Overall Study|coma|1|||
19615246|NCT00744939|42064613|FG000|Overall Study|incorrect race|1|||
19615247|NCT00554515|42064625|FG000|Overall Study|Withdrawal by Subject|3|||
19615248|NCT00554515|42064625|FG000|Overall Study|Disease progression|52|||
19615249|NCT00554515|42064625|FG000|Overall Study|Physician Decision|18|||
19615250|NCT00554515|42064625|FG000|Overall Study|Withdrawal by Subject|11|||
19615251|NCT00554515|42064625|FG000|Overall Study|Adverse Event|9|||
19615252|NCT00554515|42064625|FG000|Overall Study|Death|2|||
19615253|NCT00554515|42064625|FG000|Overall Study|Achieved Stable Disease|7|||
19615254|NCT00554515|42064625|FG000|Overall Study|Other|1|||
19615255|NCT00554515|42064625|FG000|Overall Study|Misc|15|||
19615256|NCT00744861|42064654|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
19615257|NCT00744861|42064655|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
19615258|NCT00744861|42064656|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
19615259|NCT00744861|42064657|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
19615260|NCT00744861|42064654|FG000|Feasibility Stage 1|Pregnancy|0|||
19615261|NCT00744861|42064655|FG001|Feasibility Stage 1|Pregnancy|1|||
19615262|NCT00744861|42064656|FG002|Feasibility Stage 1|Pregnancy|0|||
19615263|NCT00744861|42064657|FG003|Feasibility Stage 1|Pregnancy|0|||
19615264|NCT00744861|42064654|FG000|Pivotal Stage 2|Adverse Event|0|||
19615265|NCT00744861|42064655|FG001|Pivotal Stage 2|Adverse Event|0|||
19615266|NCT00744861|42064656|FG002|Pivotal Stage 2|Adverse Event|6|||
19615267|NCT00744861|42064657|FG003|Pivotal Stage 2|Adverse Event|11|||
19373736|NCT02755649|41614937|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
19505748|NCT02204982|41901095|FG001|Overall Study|Physician Decision|2|||
19505749|NCT02204982|41901094|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
19505750|NCT02204982|41901095|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
19505751|NCT02204982|41901094|FG000|Overall Study|Termination of Study bySponsor|0|||
19505752|NCT02204982|41901095|FG001|Overall Study|Termination of Study bySponsor|1|||
19505753|NCT02239536|41901103|FG000|Overall Study|Non-neoplastic polyp|23|||
19505754|NCT02239536|41901104|FG001|Overall Study|Non-neoplastic polyp|17|||
19505755|NCT02239224|41901114|FG000|Overall Study|Administrative|0|||
19505756|NCT02239224|41901115|FG001|Overall Study|Administrative|0|||
19505757|NCT02239224|41901116|FG002|Overall Study|Administrative|3|||
19505758|NCT02239224|41901117|FG003|Overall Study|Administrative|1|||
19505759|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
19505760|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
19505761|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
19505762|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
19505763|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
19505764|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
19505765|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
19505766|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
19505767|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
19505768|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
19505769|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
19505770|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
19505771|NCT01600014|41901127|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
19505772|NCT01600014|41901128|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
19505773|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
19615268|NCT00744861|42064654|FG000|Pivotal Stage 2|Death|0|||
19615269|NCT00744861|42064655|FG001|Pivotal Stage 2|Death|0|||
19615270|NCT00744861|42064656|FG002|Pivotal Stage 2|Death|0|||
19615271|NCT00744861|42064657|FG003|Pivotal Stage 2|Death|1|||
19615272|NCT00744861|42064654|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
19615273|NCT00744861|42064655|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
19505774|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
19505775|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
19505776|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
19505777|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
19505778|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
19505779|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
19505780|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
19505781|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
19505782|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
19505783|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
19505784|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
19505785|NCT01600014|41901127|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
19505786|NCT01600014|41901128|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
19505787|NCT01600014|41901127|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
19505788|NCT01600014|41901128|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
19505789|NCT01600014|41901127|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
19505790|NCT01600014|41901128|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
19505791|NCT01600014|41901127|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
19505792|NCT01600014|41901128|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
19505793|NCT03330847|41901149|FG000|Overall Study|Patients ongoing study|62|||
19505794|NCT03330847|41901150|FG001|Overall Study|Patients ongoing study|65|||
19505795|NCT03330847|41901151|FG002|Overall Study|Patients ongoing study|15|||
19505796|NCT02237196|41901165|FG000|Overall Study|Adverse Event|0|||
19615274|NCT00744861|42064656|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
19615275|NCT00744861|42064657|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
19615276|NCT00744861|42064654|FG000|Pivotal Stage 2|Physician Decision|0|||
19615277|NCT00744861|42064655|FG001|Pivotal Stage 2|Physician Decision|0|||
19615278|NCT00744861|42064656|FG002|Pivotal Stage 2|Physician Decision|3|||
19615279|NCT00744861|42064657|FG003|Pivotal Stage 2|Physician Decision|1|||
19615280|NCT00744861|42064654|FG000|Pivotal Stage 2|Protocol Violation|0|||
19615281|NCT00744861|42064655|FG001|Pivotal Stage 2|Protocol Violation|0|||
19615282|NCT00744861|42064656|FG002|Pivotal Stage 2|Protocol Violation|0|||
19615283|NCT00744861|42064657|FG003|Pivotal Stage 2|Protocol Violation|1|||
19615284|NCT00744861|42064654|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
19615285|NCT00744861|42064655|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
19615286|NCT00744861|42064656|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
19615287|NCT00744861|42064657|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
19615288|NCT00744861|42064654|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
19704499|NCT00153816|42148866|FG005|Overall Study|Follow-up exam done, histology missing|2|||
19704500|NCT00151476|42148883|FG000|FAP Identified Subjects|Protocol Violation|0|||
19505797|NCT02237196|41901166|FG001|Overall Study|Adverse Event|1|||
19505798|NCT02237196|41901167|FG002|Overall Study|Adverse Event|1|||
19505799|NCT02237196|41901168|FG003|Overall Study|Adverse Event|0|||
19505800|NCT02237196|41901165|FG000|Overall Study|Lost to Follow-up|4|||
19505801|NCT02237196|41901166|FG001|Overall Study|Lost to Follow-up|2|||
19505802|NCT02237196|41901167|FG002|Overall Study|Lost to Follow-up|4|||
19505803|NCT02237196|41901168|FG003|Overall Study|Lost to Follow-up|6|||
19505804|NCT02237196|41901165|FG000|Overall Study|Physician Decision|2|||
19505805|NCT02237196|41901166|FG001|Overall Study|Physician Decision|0|||
19505806|NCT02237196|41901167|FG002|Overall Study|Physician Decision|0|||
19505807|NCT02237196|41901168|FG003|Overall Study|Physician Decision|1|||
19505808|NCT02237196|41901165|FG000|Overall Study|Pregnancy|0|||
19505809|NCT02237196|41901166|FG001|Overall Study|Pregnancy|0|||
19505810|NCT02237196|41901167|FG002|Overall Study|Pregnancy|1|||
19505811|NCT02237196|41901168|FG003|Overall Study|Pregnancy|1|||
19505812|NCT02237196|41901165|FG000|Overall Study|Withdrawal by Subject|1|||
19505813|NCT02237196|41901166|FG001|Overall Study|Withdrawal by Subject|1|||
19505814|NCT02237196|41901167|FG002|Overall Study|Withdrawal by Subject|4|||
19505815|NCT02237196|41901168|FG003|Overall Study|Withdrawal by Subject|1|||
19505816|NCT02237196|41901165|FG000|Overall Study|Site Error|1|||
19505817|NCT02237196|41901166|FG001|Overall Study|Site Error|2|||
19505818|NCT02237196|41901167|FG002|Overall Study|Site Error|0|||
19505819|NCT02237196|41901168|FG003|Overall Study|Site Error|2|||
19505820|NCT02237118|41901184|FG000|Overall Study|Protocol Violation|0|||
19505821|NCT02237118|41901185|FG001|Overall Study|Protocol Violation|1|||
19505822|NCT02237118|41901184|FG000|Overall Study|consent withdrawn|1|||
19505823|NCT02237118|41901185|FG001|Overall Study|consent withdrawn|0|||
19505824|NCT02234622|41901201|FG000|Overall Study|Withdrawal by Subject|16|||
19505825|NCT02234622|41901202|FG001|Overall Study|Withdrawal by Subject|22|||
19505826|NCT02234622|41901201|FG000|Overall Study|Lost to Follow-up|27|||
19505827|NCT02234622|41901202|FG001|Overall Study|Lost to Follow-up|14|||
19615289|NCT00744861|42064655|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
19615290|NCT00744861|42064656|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
19505828|NCT03250273|41901212|FG000|Overall Study|Disease Progression|2|||
19505829|NCT03250273|41901213|FG001|Overall Study|Disease Progression|11|||
19505830|NCT03250273|41901212|FG000|Overall Study|Death|0|||
19505831|NCT03250273|41901213|FG001|Overall Study|Death|1|||
19505832|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
19505833|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
19505834|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
19505835|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
19505836|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
19505837|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
19505838|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
19505839|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
19505840|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
19505841|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
19505842|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
19505843|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
19505844|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
19505845|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
19505846|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
19505847|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
19505848|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
19505849|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
19505850|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
19615291|NCT00744861|42064657|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
19615292|NCT03969589|42064667|FG000|Overall Study|Lost to Follow-up|3|||
19615293|NCT03969589|42064668|FG001|Overall Study|Lost to Follow-up|2|||
19615294|NCT03969589|42064667|FG000|Overall Study|Declined Follow-Up|0|||
19615295|NCT03969589|42064668|FG001|Overall Study|Declined Follow-Up|1|||
19615296|NCT00744627|42064676|FG000|Overall Study|Adverse Event|6|||
19615297|NCT00744627|42064677|FG001|Overall Study|Adverse Event|9|||
19615298|NCT00744627|42064676|FG000|Overall Study|Lack of Efficacy|7|||
19615299|NCT00744627|42064677|FG001|Overall Study|Lack of Efficacy|3|||
19615300|NCT00744627|42064676|FG000|Overall Study|Noncompliance|0|||
19615301|NCT00744627|42064677|FG001|Overall Study|Noncompliance|1|||
19615302|NCT00744627|42064676|FG000|Overall Study|Protocol Deviations|0|||
19615303|NCT00744627|42064677|FG001|Overall Study|Protocol Deviations|2|||
19615304|NCT00744627|42064676|FG000|Overall Study|Voluntary Withdrawal|9|||
19615305|NCT00744627|42064677|FG001|Overall Study|Voluntary Withdrawal|6|||
19615306|NCT00744627|42064676|FG000|Overall Study|Lost to Follow-up|2|||
19615307|NCT00744627|42064677|FG001|Overall Study|Lost to Follow-up|1|||
19615308|NCT00744627|42064676|FG000|Overall Study|Other|1|||
19615309|NCT00744627|42064677|FG001|Overall Study|Other|0|||
19615310|NCT03959137|42064683|FG000|Overall Study|Protocol Violation|6|||
19615311|NCT00562627|42064690|FG000|Overall Study|Protocol Violation|1|||
19615312|NCT00562627|42064691|FG001|Overall Study|Protocol Violation|1|||
19615313|NCT00562627|42064692|FG002|Overall Study|Protocol Violation|1|||
19615314|NCT00562159|42064702|FG000|Overall Study|Adverse Event|11|||
19615315|NCT00562159|42064703|FG001|Overall Study|Adverse Event|8|||
19505851|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
19505852|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
19505853|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
19505854|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
19505855|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
19505856|NCT02203032|41901219|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
19505857|NCT02203032|41901220|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
19505858|NCT02203032|41901221|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
19505859|NCT02203032|41901222|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
19505860|NCT02203032|41901219|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
19505861|NCT02203032|41901220|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
19505862|NCT02203032|41901221|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
19505863|NCT02203032|41901222|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
19505864|NCT02203032|41901219|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
19505865|NCT02203032|41901220|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
19505866|NCT02203032|41901221|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
19505867|NCT02203032|41901222|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
19505868|NCT02203032|41901219|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
19505869|NCT02203032|41901220|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
19505870|NCT02203032|41901221|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
19615316|NCT00562159|42064702|FG000|Overall Study|Lost to Follow-up|5|||
19615317|NCT00562159|42064703|FG001|Overall Study|Lost to Follow-up|4|||
19505871|NCT02203032|41901222|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
19505872|NCT02203032|41901219|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
19505873|NCT02203032|41901220|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
19505874|NCT02203032|41901221|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
19505875|NCT02203032|41901222|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
19505876|NCT02203032|41901219|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
19505877|NCT02203032|41901220|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
19505878|NCT02203032|41901221|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
19505879|NCT02203032|41901222|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
19505880|NCT02169414|41901234|FG000|Overall Study|Withdrawal by Subject|1|||
19505881|NCT02169414|41901235|FG001|Overall Study|Withdrawal by Subject|0|||
19505882|NCT02169414|41901236|FG002|Overall Study|Withdrawal by Subject|0|||
19505883|NCT02169414|41901237|FG003|Overall Study|Withdrawal by Subject|0|||
19393984|NCT02619617|41638053|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
19393985|NCT02619617|41638054|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
19393986|NCT02650921|41638075|FG000|Overall Study|Withdrawal by Subject|4|||
19393987|NCT02650921|41638075|FG000|Overall Study|Lost to Follow-up|2|||
19393988|NCT02650921|41638075|FG000|Overall Study|Adverse Event|1|||
19393989|NCT02650921|41638075|FG000|Overall Study|Due to Medical Condition|1|||
19393990|NCT01596335|41638083|FG000|Overall Study|exacerbation of primary disease|5|||
19393991|NCT01596335|41638084|FG001|Overall Study|exacerbation of primary disease|9|||
19393992|NCT02618759|41638092|FG000|Overall Study|Lost to Follow-up|0|||
19393993|NCT02618759|41638093|FG001|Overall Study|Lost to Follow-up|1|||
19393994|NCT02618759|41638092|FG000|Overall Study|Withdrawal by Subject|1|||
19393995|NCT02618759|41638093|FG001|Overall Study|Withdrawal by Subject|0|||
19393996|NCT02618759|41638092|FG000|Overall Study|Other Reasons|1|||
19393997|NCT02618759|41638093|FG001|Overall Study|Other Reasons|4|||
19393998|NCT02614079|41638108|FG000|Overall Study|Withdrawal by Subject|1|||
19393999|NCT02616029|41638114|FG000|Overall Study|Adverse Event|1|||
19394000|NCT02616029|41638115|FG001|Overall Study|Adverse Event|0|||
19394001|NCT02616029|41638114|FG000|Overall Study|Death|0|||
19394002|NCT02616029|41638115|FG001|Overall Study|Death|1|||
19505884|NCT02169414|41901234|FG000|Overall Study|Adverse Event|0|||
19505885|NCT02169414|41901235|FG001|Overall Study|Adverse Event|1|||
19505886|NCT02169414|41901236|FG002|Overall Study|Adverse Event|0|||
19505887|NCT02169414|41901237|FG003|Overall Study|Adverse Event|0|||
19505888|NCT03213457|41901254|FG000|Overall Study|Not Treated|1|||
19505889|NCT03213457|41901255|FG001|Overall Study|Not Treated|1|||
19505890|NCT03213457|41901256|FG002|Overall Study|Not Treated|0|||
19505891|NCT03213457|41901254|FG000|Overall Study|Adverse Event|16|||
19505892|NCT03213457|41901255|FG001|Overall Study|Adverse Event|9|||
19505893|NCT03213457|41901256|FG002|Overall Study|Adverse Event|41|||
19505894|NCT03213457|41901254|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19505895|NCT03213457|41901255|FG001|Overall Study|Non-Compliance With Study Drug|2|||
19505896|NCT03213457|41901256|FG002|Overall Study|Non-Compliance With Study Drug|7|||
19505897|NCT03213457|41901254|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
19505898|NCT03213457|41901255|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
19505899|NCT03213457|41901256|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
19505900|NCT03213457|41901254|FG000|Overall Study|Withdrawal by Subject|18|||
19505901|NCT03213457|41901255|FG001|Overall Study|Withdrawal by Subject|7|||
19505902|NCT03213457|41901256|FG002|Overall Study|Withdrawal by Subject|35|||
19505903|NCT03213457|41901254|FG000|Overall Study|Lost to Follow-up|12|||
19505904|NCT03213457|41901255|FG001|Overall Study|Lost to Follow-up|12|||
19505905|NCT03213457|41901256|FG002|Overall Study|Lost to Follow-up|33|||
19505906|NCT03213457|41901254|FG000|Overall Study|Pregnancy|11|||
19505907|NCT03213457|41901255|FG001|Overall Study|Pregnancy|0|||
19505908|NCT03213457|41901256|FG002|Overall Study|Pregnancy|7|||
19505909|NCT03213457|41901254|FG000|Overall Study|Protocol Violation|1|||
19505910|NCT03213457|41901255|FG001|Overall Study|Protocol Violation|1|||
19505911|NCT03213457|41901256|FG002|Overall Study|Protocol Violation|6|||
19505912|NCT03213457|41901254|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
19615318|NCT00562159|42064702|FG000|Overall Study|Withdrawal by Subject|9|||
19615319|NCT00562159|42064703|FG001|Overall Study|Withdrawal by Subject|8|||
19615320|NCT00562159|42064702|FG000|Overall Study|Protocol Violation|12|||
19615321|NCT00562159|42064703|FG001|Overall Study|Protocol Violation|12|||
19615322|NCT00562159|42064702|FG000|Overall Study|Did not meet protocol eligibility|1|||
19615323|NCT00562159|42064703|FG001|Overall Study|Did not meet protocol eligibility|1|||
19615324|NCT04223778|42064712|FG000|Overall Study|Ongoing|322|||
19505913|NCT03213457|41901255|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
19505914|NCT03213457|41901256|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
19505915|NCT03213457|41901254|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
19505916|NCT03213457|41901255|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
19615325|NCT04223778|42064713|FG001|Overall Study|Ongoing|326|||
19394003|NCT02616029|41638114|FG000|Overall Study|Protocol Violation|1|||
19394004|NCT02616029|41638115|FG001|Overall Study|Protocol Violation|0|||
19615326|NCT04223778|42064712|FG000|Overall Study|Death|0|||
19615327|NCT04223778|42064713|FG001|Overall Study|Death|1|||
19615328|NCT04223778|42064712|FG000|Overall Study|Lost to Follow-up|1|||
19615329|NCT04223778|42064713|FG001|Overall Study|Lost to Follow-up|5|||
19615330|NCT04223778|42064712|FG000|Overall Study|Physician Decision|3|||
19505917|NCT03213457|41901256|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
19505918|NCT03213457|41901254|FG000|Overall Study|Lack of Efficacy|12|||
19505919|NCT03213457|41901255|FG001|Overall Study|Lack of Efficacy|2|||
19505920|NCT03213457|41901256|FG002|Overall Study|Lack of Efficacy|9|||
19505921|NCT03213457|41901254|FG000|Overall Study|Other, Not Specified|11|||
19505922|NCT03213457|41901255|FG001|Overall Study|Other, Not Specified|3|||
19505923|NCT03213457|41901256|FG002|Overall Study|Other, Not Specified|26|||
19505924|NCT02201940|41901266|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
19505925|NCT02201940|41901267|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
19505926|NCT02201940|41901266|FG000|Overall Study|Lack of Efficacy|2|||
19505927|NCT02201940|41901267|FG001|Overall Study|Lack of Efficacy|113|||
19505928|NCT02201940|41901266|FG000|Overall Study|Lost to Follow-up|5|||
19505929|NCT02201940|41901267|FG001|Overall Study|Lost to Follow-up|0|||
19505930|NCT02201940|41901266|FG000|Overall Study|Withdrew Consent|2|||
19505931|NCT02201940|41901267|FG001|Overall Study|Withdrew Consent|1|||
19505932|NCT02201940|41901266|FG000|Overall Study|Investigator's Discretion|1|||
19505933|NCT02201940|41901267|FG001|Overall Study|Investigator's Discretion|1|||
19505934|NCT02201940|41901266|FG000|Overall Study|Death|1|||
19505935|NCT02201940|41901267|FG001|Overall Study|Death|0|||
19505936|NCT02201940|41901266|FG000|Overall Study|Adverse Event|0|||
19505937|NCT02201940|41901267|FG001|Overall Study|Adverse Event|1|||
19505938|NCT02232984|41901273|FG000|Overall Study|Withdrawal by Subject|5|||
19505939|NCT02232984|41901273|FG000|Overall Study|Death|1|||
19505940|NCT02232984|41901273|FG000|Overall Study|Investigator withdrawal|10|||
19505941|NCT02232984|41901273|FG000|Overall Study|Device implant unsuccessful|53|||
19505942|NCT02232984|41901273|FG000|Overall Study|not disclosed by site|7|||
19505943|NCT02232984|41901273|FG000|Overall Study|Protocol Violation|1|||
19505944|NCT02169336|41901283|FG000|Overall Study|Lack of Efficacy|1|||
19505945|NCT02169336|41901284|FG001|Overall Study|Lack of Efficacy|1|||
19505946|NCT02169336|41901285|FG002|Overall Study|Lack of Efficacy|0|||
19505947|NCT02169336|41901283|FG000|Overall Study|Adverse Event|2|||
19505948|NCT02169336|41901284|FG001|Overall Study|Adverse Event|3|||
19505949|NCT02169336|41901285|FG002|Overall Study|Adverse Event|1|||
19505950|NCT02169336|41901283|FG000|Overall Study|Withdrawal by Subject|1|||
19505951|NCT02169336|41901284|FG001|Overall Study|Withdrawal by Subject|0|||
19505952|NCT02169336|41901285|FG002|Overall Study|Withdrawal by Subject|0|||
19505953|NCT02169336|41901283|FG000|Overall Study|Physician Decision|0|||
19505954|NCT02169336|41901284|FG001|Overall Study|Physician Decision|0|||
19505955|NCT02169336|41901285|FG002|Overall Study|Physician Decision|1|||
19505956|NCT02169336|41901283|FG000|Overall Study|Subject declined to continue dosing|0|||
19505957|NCT02169336|41901284|FG001|Overall Study|Subject declined to continue dosing|0|||
19505958|NCT02169336|41901285|FG002|Overall Study|Subject declined to continue dosing|1|||
19505959|NCT02609828|41901301|FG000|Overall Study|Adverse Event|8|||
19505960|NCT02609828|41901302|FG001|Overall Study|Adverse Event|1|||
19505961|NCT02609828|41901303|FG002|Overall Study|Adverse Event|0|||
19505962|NCT02609828|41901304|FG003|Overall Study|Adverse Event|6|||
19615331|NCT04223778|42064713|FG001|Overall Study|Physician Decision|1|||
19505963|NCT02609828|41901301|FG000|Overall Study|Death|15|||
19505964|NCT02609828|41901302|FG001|Overall Study|Death|1|||
19505965|NCT02609828|41901303|FG002|Overall Study|Death|1|||
19615332|NCT04223778|42064712|FG000|Overall Study|Withdrawal by Subject|10|||
19615333|NCT04223778|42064713|FG001|Overall Study|Withdrawal by Subject|1|||
19615334|NCT04223778|42064712|FG000|Overall Study|Lack of Efficacy|0|||
19615335|NCT04223778|42064713|FG001|Overall Study|Lack of Efficacy|2|||
19615336|NCT00921557|42064722|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
19615337|NCT00921557|42064723|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
19615338|NCT00921557|42064724|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
19615339|NCT00921557|42064722|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
19704501|NCT00151476|42148884|FG001|FAP Identified Subjects|Protocol Violation|1|||
19615340|NCT00921557|42064723|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
19704502|NCT00151476|42148883|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
19505966|NCT02609828|41901304|FG003|Overall Study|Death|19|||
19505967|NCT02609828|41901301|FG000|Overall Study|Insufficient clinical response|2|||
19505968|NCT02609828|41901302|FG001|Overall Study|Insufficient clinical response|1|||
19505969|NCT02609828|41901303|FG002|Overall Study|Insufficient clinical response|0|||
19505970|NCT02609828|41901304|FG003|Overall Study|Insufficient clinical response|0|||
19505971|NCT02609828|41901301|FG000|Overall Study|Lost to Follow-up|0|||
19505972|NCT02609828|41901302|FG001|Overall Study|Lost to Follow-up|0|||
19505973|NCT02609828|41901303|FG002|Overall Study|Lost to Follow-up|0|||
19505974|NCT02609828|41901304|FG003|Overall Study|Lost to Follow-up|1|||
19505975|NCT02609828|41901301|FG000|Overall Study|Protocol Violation|2|||
19505976|NCT02609828|41901302|FG001|Overall Study|Protocol Violation|0|||
19505977|NCT02609828|41901303|FG002|Overall Study|Protocol Violation|0|||
19505978|NCT02609828|41901304|FG003|Overall Study|Protocol Violation|1|||
19505979|NCT02609828|41901301|FG000|Overall Study|Withdrawal by Subject|12|||
19505980|NCT02609828|41901302|FG001|Overall Study|Withdrawal by Subject|1|||
19505981|NCT02609828|41901303|FG002|Overall Study|Withdrawal by Subject|0|||
19505982|NCT02609828|41901304|FG003|Overall Study|Withdrawal by Subject|10|||
19505983|NCT02609828|41901301|FG000|Overall Study|Other|3|||
19505984|NCT02609828|41901302|FG001|Overall Study|Other|0|||
19505985|NCT02609828|41901303|FG002|Overall Study|Other|0|||
19505986|NCT02609828|41901304|FG003|Overall Study|Other|6|||
19505987|NCT02609828|41901301|FG000|Overall Study|Randomized but not treated|1|||
19505988|NCT02609828|41901302|FG001|Overall Study|Randomized but not treated|0|||
19505989|NCT02609828|41901303|FG002|Overall Study|Randomized but not treated|0|||
19505990|NCT02609828|41901304|FG003|Overall Study|Randomized but not treated|0|||
19505991|NCT01632306|41901320|FG000|Overall Study|Protocol Violation|1|||
19505992|NCT01632306|41901321|FG001|Overall Study|Protocol Violation|0|||
19505993|NCT01632306|41901322|FG002|Overall Study|Protocol Violation|0|||
19505994|NCT02201784|41901330|FG000|Overall Study|Failure to achieve adequate block|2|||
19505995|NCT02201784|41901331|FG001|Overall Study|Failure to achieve adequate block|0|||
19505996|NCT02201472|41901337|FG000|Overall Study|Lack of Efficacy|2|||
19505997|NCT02168946|41901382|FG000|Overall Study|Adverse Event|8|||
19505998|NCT02168946|41901383|FG001|Overall Study|Adverse Event|5|||
19505999|NCT02168946|41901382|FG000|Overall Study|Lost to Follow-up|3|||
19506000|NCT02168946|41901383|FG001|Overall Study|Lost to Follow-up|0|||
19506001|NCT02168946|41901382|FG000|Overall Study|Subject unable to come back for visits|1|||
19506002|NCT02168946|41901383|FG001|Overall Study|Subject unable to come back for visits|0|||
19506003|NCT02168478|41901404|FG000|Overall Study|Withdrawal by Subject|1|||
19506004|NCT02168478|41901404|FG000|Overall Study|Did Not Consent to Participation|2|||
19506005|NCT02168478|41901404|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
19506006|NCT02200614|41902594|FG000|Double Blind Treatment|Adverse Event|86|||
19506007|NCT02200614|41902595|FG001|Double Blind Treatment|Adverse Event|48|||
19506008|NCT02200614|41902594|FG000|Double Blind Treatment|Confirmed metastasis|120|||
19506009|NCT02200614|41902595|FG001|Double Blind Treatment|Confirmed metastasis|140|||
19506010|NCT02200614|41902594|FG000|Double Blind Treatment|Judgment of the investigator|59|||
19506011|NCT02200614|41902595|FG001|Double Blind Treatment|Judgment of the investigator|99|||
19506012|NCT02200614|41902594|FG000|Double Blind Treatment|Metastasis by local reading|1|||
19506013|NCT02200614|41902595|FG001|Double Blind Treatment|Metastasis by local reading|3|||
19506014|NCT02200614|41902594|FG000|Double Blind Treatment|Other reason|6|||
19506015|NCT02200614|41902595|FG001|Double Blind Treatment|Other reason|2|||
19506016|NCT02200614|41902594|FG000|Double Blind Treatment|Personal reason|77|||
19506017|NCT02200614|41902595|FG001|Double Blind Treatment|Personal reason|85|||
19506018|NCT02200614|41902594|FG000|Double Blind Treatment|Protocol deviation|14|||
19506019|NCT02200614|41902595|FG001|Double Blind Treatment|Protocol deviation|7|||
19506020|NCT02200614|41902594|FG000|Double Blind Treatment|Not treated|1|||
19506021|NCT02200614|41902595|FG001|Double Blind Treatment|Not treated|0|||
19506022|NCT02200614|41902594|FG000|Open Label|Adverse Event|41|||
19506023|NCT02200614|41902595|FG001|Open Label|Adverse Event|11|||
19506024|NCT02200614|41902594|FG000|Open Label|Confirmed metastasis|1|||
19506025|NCT02200614|41902595|FG001|Open Label|Confirmed metastasis|0|||
19506026|NCT02200614|41902594|FG000|Open Label|Judgment of the investigator|29|||
19506027|NCT02200614|41902595|FG001|Open Label|Judgment of the investigator|2|||
19506028|NCT02200614|41902594|FG000|Open Label|Metastasis by local reading|138|||
19506029|NCT02200614|41902595|FG001|Open Label|Metastasis by local reading|27|||
19506030|NCT02200614|41902594|FG000|Open Label|Other reason|22|||
19506031|NCT02200614|41902595|FG001|Open Label|Other reason|4|||
19506032|NCT02200614|41902594|FG000|Open Label|Personal reason|60|||
19506033|NCT02200614|41902595|FG001|Open Label|Personal reason|8|||
19506034|NCT02200614|41902594|FG000|Open Label|Protocol deviation|3|||
19506035|NCT02200614|41902595|FG001|Open Label|Protocol deviation|2|||
19506036|NCT02200614|41902594|FG000|Open Label|Missing|2|||
19506037|NCT02200614|41902595|FG001|Open Label|Missing|2|||
19506038|NCT02231892|41902606|FG000|Overall Study|Lost to Follow-up|1|||
19506039|NCT02231892|41902607|FG001|Overall Study|Lost to Follow-up|0|||
19506040|NCT02231892|41902608|FG002|Overall Study|Lost to Follow-up|3|||
19506041|NCT02231892|41902606|FG000|Overall Study|Withdrawal by Subject|4|||
19506042|NCT02231892|41902607|FG001|Overall Study|Withdrawal by Subject|3|||
19506043|NCT02231892|41902608|FG002|Overall Study|Withdrawal by Subject|15|||
19506044|NCT02231892|41902606|FG000|Overall Study|Physician Decision|0|||
19506045|NCT02231892|41902607|FG001|Overall Study|Physician Decision|2|||
19506046|NCT02231892|41902608|FG002|Overall Study|Physician Decision|4|||
19506047|NCT02231892|41902606|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
19506048|NCT02231892|41902607|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
19506049|NCT02231892|41902608|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
19506050|NCT02231892|41902606|FG000|Overall Study|Participant motor threshold was >83%|0|||
19506051|NCT02231892|41902607|FG001|Overall Study|Participant motor threshold was >83%|0|||
19506052|NCT02231892|41902608|FG002|Overall Study|Participant motor threshold was >83%|9|||
19506053|NCT02231892|41902606|FG000|Overall Study|Could not find motor threshold|2|||
19506054|NCT02231892|41902607|FG001|Overall Study|Could not find motor threshold|0|||
19506055|NCT02231892|41902608|FG002|Overall Study|Could not find motor threshold|1|||
19506056|NCT02231892|41902606|FG000|Overall Study|Could not find reliable motor hotspot|0|||
19506057|NCT02231892|41902607|FG001|Overall Study|Could not find reliable motor hotspot|0|||
19506058|NCT02231892|41902608|FG002|Overall Study|Could not find reliable motor hotspot|1|||
19506059|NCT02231580|41902624|FG000|Overall Study|Adverse Event|5|||
19506060|NCT02231580|41902625|FG001|Overall Study|Adverse Event|0|||
19506061|NCT02166606|41902633|FG000|Overall Study|Adverse Event|3|||
19506062|NCT02166606|41902633|FG000|Overall Study|Death|31|||
19506063|NCT02166606|41902633|FG000|Overall Study|Protocol Violation|7|||
19506064|NCT02166606|41902633|FG000|Overall Study|Lost to Follow-up|30|||
19506065|NCT02166606|41902633|FG000|Overall Study|Withdrawal by Subject|1|||
19506066|NCT02166606|41902633|FG000|Overall Study|Physician Decision|1|||
19506067|NCT02166606|41902633|FG000|Overall Study|Device upgrade|1|||
19506068|NCT02166606|41902633|FG000|Overall Study|Enrolled after End of Enrollment|4|||
19506069|NCT02230956|41902640|FG000|Overall Study|Adverse Event|1|||
19506070|NCT02230956|41902641|FG001|Overall Study|Adverse Event|1|||
19506071|NCT02230956|41902642|FG002|Overall Study|Adverse Event|0|||
19506072|NCT02230956|41902640|FG000|Overall Study|Lack of Efficacy|1|||
19506073|NCT02230956|41902641|FG001|Overall Study|Lack of Efficacy|1|||
19506074|NCT02230956|41902642|FG002|Overall Study|Lack of Efficacy|1|||
19506075|NCT02230956|41902640|FG000|Overall Study|Lost to Follow-up|1|||
19506076|NCT02230956|41902641|FG001|Overall Study|Lost to Follow-up|1|||
19506077|NCT02230956|41902642|FG002|Overall Study|Lost to Follow-up|2|||
19506078|NCT02230956|41902640|FG000|Overall Study|Personal Reasons|2|||
19506079|NCT02230956|41902641|FG001|Overall Study|Personal Reasons|1|||
19506080|NCT02230956|41902642|FG002|Overall Study|Personal Reasons|1|||
19506081|NCT02230956|41902640|FG000|Overall Study|Protocol Violation|0|||
19506082|NCT02230956|41902641|FG001|Overall Study|Protocol Violation|1|||
19506083|NCT02230956|41902642|FG002|Overall Study|Protocol Violation|1|||
19506084|NCT02230956|41902640|FG000|Overall Study|Other Miscellaneous Reason|0|||
19506085|NCT02230956|41902641|FG001|Overall Study|Other Miscellaneous Reason|1|||
19506086|NCT02230956|41902642|FG002|Overall Study|Other Miscellaneous Reason|2|||
19506087|NCT02230410|41902650|FG000|Overall Study|Screen Failure|3|||
19506088|NCT02230332|41902656|FG000|Overall Study|Adverse Event|2|||
19506089|NCT02230332|41902657|FG001|Overall Study|Adverse Event|1|||
19506090|NCT02230332|41902656|FG000|Overall Study|Lost to Follow-up|1|||
19506091|NCT02230332|41902657|FG001|Overall Study|Lost to Follow-up|0|||
19506092|NCT02230332|41902656|FG000|Overall Study|Protocol Violation|1|||
19506093|NCT02230332|41902657|FG001|Overall Study|Protocol Violation|0|||
19506094|NCT02230254|41902663|FG000|Overall Study|Lost to Follow-up|3|||
19506095|NCT02198664|41902669|FG000|Overall Study|Adverse Event|2|||
19506096|NCT02198664|41902670|FG001|Overall Study|Adverse Event|0|||
19506097|NCT02198664|41902669|FG000|Overall Study|Withdrawal by Subject|11|||
19506098|NCT02198664|41902670|FG001|Overall Study|Withdrawal by Subject|8|||
19506099|NCT02198664|41902669|FG000|Overall Study|Failure to tolerate|2|||
19506100|NCT02198664|41902670|FG001|Overall Study|Failure to tolerate|0|||
19506101|NCT02198664|41902669|FG000|Overall Study|Not stated|1|||
19506102|NCT02198664|41902670|FG001|Overall Study|Not stated|0|||
19506103|NCT02165826|41902681|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
19506104|NCT02165826|41902682|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
19506105|NCT02165826|41902683|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
19506106|NCT02165826|41902681|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
19506107|NCT02165826|41902682|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
19506108|NCT02165826|41902683|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
19506109|NCT02165826|41902681|FG000|Main Treatment Period|Lost to Follow-up|4|||
19506110|NCT02165826|41902682|FG001|Main Treatment Period|Lost to Follow-up|2|||
19506111|NCT02165826|41902683|FG002|Main Treatment Period|Lost to Follow-up|1|||
19506112|NCT02165826|41902681|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
19506113|NCT02165826|41902682|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
19506114|NCT02165826|41902683|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
19506115|NCT02165826|41902681|FG000|Main Treatment Period|Lack of Efficacy|2|||
19506116|NCT02165826|41902682|FG001|Main Treatment Period|Lack of Efficacy|0|||
19615341|NCT00921557|42064724|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
19506117|NCT02165826|41902683|FG002|Main Treatment Period|Lack of Efficacy|0|||
19506118|NCT02165826|41902681|FG000|Main Treatment Period|Reason Not Specified|8|||
19506119|NCT02165826|41902682|FG001|Main Treatment Period|Reason Not Specified|5|||
19506120|NCT02165826|41902683|FG002|Main Treatment Period|Reason Not Specified|16|||
19506121|NCT02165826|41902681|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
19506122|NCT02165826|41902682|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
19506123|NCT02165826|41902683|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
19506124|NCT02165826|41902681|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
19506125|NCT02165826|41902682|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
19615342|NCT00921557|42064722|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
19615343|NCT00921557|42064723|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
19615344|NCT00921557|42064724|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
19615345|NCT00921557|42064722|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
19615346|NCT00921557|42064723|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
19615347|NCT00921557|42064724|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
19615348|NCT00921557|42064722|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
19615349|NCT00921557|42064723|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
19615350|NCT00921557|42064724|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
19615351|NCT00550615|42064739|FG000|Overall Study|Withdrawal by Subject|0|||
19615352|NCT00550615|42064740|FG001|Overall Study|Withdrawal by Subject|0|||
19615353|NCT00550615|42064741|FG002|Overall Study|Withdrawal by Subject|2|||
19615354|NCT00550615|42064742|FG003|Overall Study|Withdrawal by Subject|3|||
19615355|NCT00550615|42064739|FG000|Overall Study|Not evaluable|0|||
19506126|NCT02165826|41902683|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
19506127|NCT02165826|41902681|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
19506128|NCT02165826|41902682|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
19506129|NCT02165826|41902683|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
19506130|NCT02165826|41902681|FG000|Down-Titration Period|Reason Not Specified|1|||
19506131|NCT02165826|41902682|FG001|Down-Titration Period|Reason Not Specified|0|||
19506132|NCT02165826|41902683|FG002|Down-Titration Period|Reason Not Specified|2|||
19506133|NCT02198040|41902720|FG000|Overall Study|Work reasons|0|||
19506134|NCT02198040|41902721|FG001|Overall Study|Work reasons|1|||
19506135|NCT02198040|41902722|FG002|Overall Study|Work reasons|0|||
19506136|NCT02198040|41902720|FG000|Overall Study|Withdrawal by Subject|0|||
19506137|NCT02198040|41902721|FG001|Overall Study|Withdrawal by Subject|0|||
19506138|NCT02198040|41902722|FG002|Overall Study|Withdrawal by Subject|1|||
19506139|NCT02197806|41902736|FG000|Overall Study|Adverse Event|0|||
19506140|NCT02197806|41902737|FG001|Overall Study|Adverse Event|1|||
19506141|NCT02197806|41902738|FG002|Overall Study|Adverse Event|0|||
19506142|NCT02197806|41902739|FG003|Overall Study|Adverse Event|1|||
19506143|NCT02229864|41902786|FG000|Overall Study|Death|2|||
19506144|NCT02229864|41902786|FG000|Overall Study|Lost to Follow-up|1|||
19506145|NCT02229552|41902790|FG000|Baseline|Withdrawal by Subject|6|||
19506146|NCT02229552|41902790|FG000|1-year Follow up|Withdrawal by Subject|7|||
19506147|NCT02229552|41902790|FG000|1-year Follow up|Lost to Follow-up|18|||
19506148|NCT02229552|41902790|FG000|2-Year Follow up|Withdrawal by Subject|9|||
19506149|NCT02229552|41902790|FG000|2-Year Follow up|Lost to Follow-up|17|||
19506150|NCT02229396|41902807|FG000|Overall Study|Adverse Event|6|||
19506151|NCT02229396|41902808|FG001|Overall Study|Adverse Event|12|||
19506152|NCT02229396|41902809|FG002|Overall Study|Adverse Event|12|||
19506153|NCT02229396|41902807|FG000|Overall Study|Death|2|||
19506154|NCT02229396|41902808|FG001|Overall Study|Death|3|||
19506155|NCT02229396|41902809|FG002|Overall Study|Death|1|||
19506156|NCT02229396|41902807|FG000|Overall Study|Lost to Follow-up|14|||
19506157|NCT02229396|41902808|FG001|Overall Study|Lost to Follow-up|14|||
19506158|NCT02229396|41902809|FG002|Overall Study|Lost to Follow-up|21|||
19506159|NCT02229396|41902807|FG000|Overall Study|Protocol Violation|2|||
19506160|NCT02229396|41902808|FG001|Overall Study|Protocol Violation|1|||
19506161|NCT02229396|41902809|FG002|Overall Study|Protocol Violation|0|||
19506162|NCT02229396|41902807|FG000|Overall Study|Patient Incorrectly Randomized|0|||
19506163|NCT02229396|41902808|FG001|Overall Study|Patient Incorrectly Randomized|0|||
19506164|NCT02229396|41902809|FG002|Overall Study|Patient Incorrectly Randomized|1|||
19506165|NCT02229396|41902807|FG000|Overall Study|Other|10|||
19506166|NCT02229396|41902808|FG001|Overall Study|Other|18|||
19506167|NCT02229396|41902809|FG002|Overall Study|Other|15|||
19506168|NCT02229396|41902807|FG000|Overall Study|Withdrawal by Subject|42|||
19506169|NCT02229396|41902808|FG001|Overall Study|Withdrawal by Subject|28|||
19506170|NCT02229396|41902809|FG002|Overall Study|Withdrawal by Subject|41|||
19506171|NCT02229396|41902807|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
19506172|NCT02229396|41902808|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
19506173|NCT02229396|41902809|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
19506174|NCT02229396|41902807|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
19506175|NCT02229396|41902808|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
19615356|NCT00550615|42064740|FG001|Overall Study|Not evaluable|0|||
19506176|NCT02229396|41902809|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
19506177|NCT02197416|41902824|FG000|Overall Study|Other reasons|0|||
19506178|NCT02197416|41902825|FG001|Overall Study|Other reasons|2|||
19506179|NCT02197416|41902826|FG002|Overall Study|Other reasons|5|||
19506180|NCT02197416|41902824|FG000|Overall Study|Withdrawal by Subject|0|||
19506181|NCT02197416|41902825|FG001|Overall Study|Withdrawal by Subject|2|||
19506182|NCT02197416|41902826|FG002|Overall Study|Withdrawal by Subject|1|||
19506183|NCT02197416|41902824|FG000|Overall Study|Protocol Violation|1|||
19506184|NCT02197416|41902825|FG001|Overall Study|Protocol Violation|0|||
19506185|NCT02197416|41902826|FG002|Overall Study|Protocol Violation|1|||
19506186|NCT02197416|41902824|FG000|Overall Study|Adverse Event|0|||
19506187|NCT02197416|41902825|FG001|Overall Study|Adverse Event|0|||
19506188|NCT02197416|41902826|FG002|Overall Study|Adverse Event|1|||
19506189|NCT02165202|41902834|FG000|Oral Phase|Refused further participation|5|||
19506190|NCT02165202|41902835|FG001|Oral Phase|Refused further participation|1|||
19506191|NCT02165202|41902834|FG000|Oral Phase|Study product Related Toxicity|1|||
19506192|NCT02165202|41902835|FG001|Oral Phase|Study product Related Toxicity|0|||
19506193|NCT02165202|41902834|FG000|Oral Phase|Unable to contact Participant|1|||
19506194|NCT02165202|41902835|FG001|Oral Phase|Unable to contact Participant|1|||
19506195|NCT02165202|41902834|FG000|Oral Phase|Clinical reasons|1|||
19506196|NCT02165202|41902835|FG001|Oral Phase|Clinical reasons|0|||
19506197|NCT02165202|41902834|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
19506198|NCT02165202|41902835|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
19506199|NCT02165202|41902834|FG000|Oral Phase|CMC advised termination|1|||
19506200|NCT02165202|41902835|FG001|Oral Phase|CMC advised termination|0|||
19506201|NCT02165202|41902834|FG000|Oral Phase|Relocated, no follow-up planned|1|||
19506202|NCT02165202|41902835|FG001|Oral Phase|Relocated, no follow-up planned|0|||
19506203|NCT02165202|41902834|FG000|Oral Phase|Abnormal EKG|0|||
19506204|NCT02165202|41902835|FG001|Oral Phase|Abnormal EKG|1|||
19506205|NCT02165202|41902834|FG000|Injection Phase|Abnormal Lab Value|5|||
19506206|NCT02165202|41902835|FG001|Injection Phase|Abnormal Lab Value|1|||
19506207|NCT02165202|41902834|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
19506208|NCT02165202|41902835|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
19506209|NCT02165202|41902834|FG000|Injection Phase|Unable to attend within Visit Window|1|||
19506210|NCT02165202|41902835|FG001|Injection Phase|Unable to attend within Visit Window|0|||
19506211|NCT02165202|41902834|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
19506212|NCT02165202|41902835|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
19506213|NCT02165202|41902834|FG000|Injection Phase|End of Study|2|||
19506214|NCT02165202|41902835|FG001|Injection Phase|End of Study|1|||
19506215|NCT02165202|41902834|FG000|Injection Phase|Study Product related Toxicity|1|||
19506216|NCT02165202|41902835|FG001|Injection Phase|Study Product related Toxicity|0|||
19506217|NCT02165202|41902834|FG000|Injection Phase|No longer interested|0|||
19506218|NCT02165202|41902835|FG001|Injection Phase|No longer interested|1|||
19506219|NCT02165202|41902834|FG000|Injection Phase|Participant unwilling to comply|1|||
19506220|NCT02165202|41902835|FG001|Injection Phase|Participant unwilling to comply|0|||
19506221|NCT01628874|41902843|FG000|Overall Study|Physician Decision|1|||
19506222|NCT01628874|41902844|FG001|Overall Study|Physician Decision|1|||
19506223|NCT01628874|41902843|FG000|Overall Study|Age >4 months|4|||
19506224|NCT01628874|41902844|FG001|Overall Study|Age >4 months|2|||
19506225|NCT02196714|41902869|FG000|Overall Study|Protocol Violation|0|||
19506226|NCT02196714|41902870|FG001|Overall Study|Protocol Violation|0|||
19506227|NCT02196714|41902871|FG002|Overall Study|Protocol Violation|1|||
19506228|NCT02196714|41902872|FG003|Overall Study|Protocol Violation|0|||
19506229|NCT02196558|41902896|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
19506230|NCT02196558|41902897|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
19506231|NCT02196558|41902898|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
19506232|NCT02196558|41902896|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
19506233|NCT02196558|41902897|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
19506234|NCT02196558|41902898|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
19506235|NCT02196558|41902896|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
19506236|NCT02196558|41902897|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
19506237|NCT02196558|41902898|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
19506238|NCT02196558|41902896|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
19506239|NCT02196558|41902897|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
19506240|NCT02196558|41902898|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
19506241|NCT02196558|41902896|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
19506242|NCT02196558|41902897|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
19506243|NCT02196558|41902898|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
19506244|NCT02196324|41902919|FG000|Overall Study|Withdrawal by Subject|8|||
19506245|NCT02196324|41902920|FG001|Overall Study|Withdrawal by Subject|4|||
19506246|NCT02196324|41902919|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
19506247|NCT02196324|41902920|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
19704503|NCT00151476|42148884|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
19506248|NCT02196324|41902919|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
19506249|NCT02196324|41902920|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
19506250|NCT02196324|41902919|FG000|Overall Study|Other|1|||
19506251|NCT02196324|41902920|FG001|Overall Study|Other|0|||
19506252|NCT02195700|41902928|FG000|Overall Study|Protocol Violation|0|||
19506253|NCT02195700|41902929|FG001|Overall Study|Protocol Violation|2|||
19506254|NCT02195700|41902928|FG000|Overall Study|Noncompliance|1|||
19506255|NCT02195700|41902929|FG001|Overall Study|Noncompliance|0|||
19506256|NCT02195700|41902928|FG000|Overall Study|Adverse Event|1|||
19506257|NCT02195700|41902929|FG001|Overall Study|Adverse Event|2|||
19506258|NCT02195700|41902928|FG000|Overall Study|Withdrawal by Subject|3|||
19506259|NCT02195700|41902929|FG001|Overall Study|Withdrawal by Subject|2|||
19506260|NCT02195700|41902928|FG000|Overall Study|Lost to Follow-up|1|||
19506261|NCT02195700|41902929|FG001|Overall Study|Lost to Follow-up|1|||
19506262|NCT02228460|41902944|FG000|Overall Study|Adverse Event|1|||
19506263|NCT02228460|41902944|FG000|Overall Study|Lost to Follow-up|1|||
19506264|NCT02227446|41902960|FG000|Overall Study|not eligible post randomization|18|||
19506265|NCT02227446|41902961|FG001|Overall Study|not eligible post randomization|29|||
19506266|NCT02227446|41902960|FG000|Overall Study|Withdrawal by Subject|4|||
19506267|NCT02227446|41902961|FG001|Overall Study|Withdrawal by Subject|5|||
19506268|NCT02227368|41902969|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
19506269|NCT02227368|41902970|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
19506270|NCT02227368|41902969|FG000|Overall Study|Lost to Follow-up|1|||
19506271|NCT02227368|41902970|FG001|Overall Study|Lost to Follow-up|0|||
19506272|NCT02227368|41902969|FG000|Overall Study|Adverse Event|1|||
19506273|NCT02227368|41902970|FG001|Overall Study|Adverse Event|0|||
19506274|NCT02162862|41902979|FG000|Overall Study|Lost to Follow-up|0|||
19506275|NCT02162862|41902980|FG001|Overall Study|Lost to Follow-up|11|||
19506276|NCT02162862|41902981|FG002|Overall Study|Lost to Follow-up|0|||
19506277|NCT02162862|41902979|FG000|Overall Study|Subject did not feel the med was needed|0|||
19506278|NCT02162862|41902980|FG001|Overall Study|Subject did not feel the med was needed|0|||
19506279|NCT02162862|41902981|FG002|Overall Study|Subject did not feel the med was needed|4|||
19506280|NCT02226198|41903019|FG000|Lead-in Phase|Protocol Violation|1|||
19506281|NCT02226198|41903020|FG001|Lead-in Phase|Protocol Violation|0|||
19506282|NCT02226198|41903021|FG002|Lead-in Phase|Protocol Violation|0|||
19506283|NCT02226198|41903019|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
19506284|NCT02226198|41903020|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
19506285|NCT02226198|41903021|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
19506286|NCT02226120|41903192|FG000|Overall Study|Adverse Event|60|||
19506287|NCT02226120|41903192|FG000|Overall Study|Death|172|||
19506288|NCT02226120|41903192|FG000|Overall Study|Study terminated by sponsor|1|||
19506289|NCT02226120|41903192|FG000|Overall Study|Technical problems|4|||
19506290|NCT02226120|41903192|FG000|Overall Study|Lost to Follow-up|13|||
19506291|NCT02226120|41903192|FG000|Overall Study|Physician Decision|21|||
19506292|NCT02226120|41903192|FG000|Overall Study|Withdrawal by parent/guardian|36|||
19615357|NCT00550615|42064741|FG002|Overall Study|Not evaluable|2|||
19615358|NCT00550615|42064742|FG003|Overall Study|Not evaluable|7|||
19615359|NCT00744471|42064752|FG000|Overall Study|Randomized but not treated|1|||
19615360|NCT00744471|42064753|FG001|Overall Study|Randomized but not treated|1|||
19615361|NCT00744471|42064754|FG002|Overall Study|Randomized but not treated|4|||
19506293|NCT02226120|41903192|FG000|Overall Study|Non-compliance with study drug|10|||
19506294|NCT02226120|41903192|FG000|Overall Study|Protocol deviation|1|||
19506295|NCT02226120|41903192|FG000|Overall Study|missing treatment disposition pages|2|||
19506296|NCT02194998|41903370|FG000|On-HCV Treatment|Did not pick up study medication|0|||
19506297|NCT02194998|41903371|FG001|On-HCV Treatment|Did not pick up study medication|1|||
19506298|NCT02194998|41903372|FG002|On-HCV Treatment|Did not pick up study medication|0|||
19506299|NCT02194998|41903373|FG003|On-HCV Treatment|Did not pick up study medication|0|||
19506300|NCT02194998|41903370|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
19506301|NCT02194998|41903371|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
19506302|NCT02194998|41903372|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
19506303|NCT02194998|41903373|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
19506304|NCT02194062|41903386|FG000|Overall Study|Lost to Follow-up|2|||
19506305|NCT02194062|41903387|FG001|Overall Study|Lost to Follow-up|2|||
19506306|NCT02194062|41903388|FG002|Overall Study|Lost to Follow-up|5|||
19615362|NCT00744471|42064755|FG003|Overall Study|Randomized but not treated|0|||
19394005|NCT02616029|41638114|FG000|Overall Study|Withdrew Consent|1|||
19506307|NCT02193828|41903409|FG000|Overall Study|Withdrawal by Subject|0|||
19615363|NCT00744471|42064752|FG000|Overall Study|Death|0|||
19394006|NCT02616029|41638115|FG001|Overall Study|Withdrew Consent|0|||
19394007|NCT02616029|41638114|FG000|Overall Study|Enrolled and Never Treated|1|||
19394008|NCT02616029|41638115|FG001|Overall Study|Enrolled and Never Treated|1|||
19394009|NCT02614859|41638123|FG000|Overall Study|Physician Decision|0|||
19394010|NCT02614859|41638124|FG001|Overall Study|Physician Decision|1|||
19394011|NCT02615249|41638132|FG000|Overall Study|Withdrawal by Subject|1|||
19394012|NCT02615171|41638139|FG000|Overall Study|Lost to Follow-up|2|||
19394013|NCT02615171|41638140|FG001|Overall Study|Lost to Follow-up|1|||
19394014|NCT02648347|41638148|FG000|Overall Study|Death|174|||
19394015|NCT02648347|41638149|FG001|Overall Study|Death|167|||
19394016|NCT02648347|41638148|FG000|Overall Study|Withdrawal by Subject|16|||
19506308|NCT02193828|41903410|FG001|Overall Study|Withdrawal by Subject|0|||
19506309|NCT02193828|41903411|FG002|Overall Study|Withdrawal by Subject|1|||
19615364|NCT00744471|42064753|FG001|Overall Study|Death|0|||
19394017|NCT02648347|41638149|FG001|Overall Study|Withdrawal by Subject|9|||
19394018|NCT02648347|41638148|FG000|Overall Study|Lost to Follow-up|18|||
19506310|NCT02193828|41903412|FG003|Overall Study|Withdrawal by Subject|1|||
19394019|NCT02648347|41638149|FG001|Overall Study|Lost to Follow-up|21|||
19394020|NCT02648347|41638148|FG000|Overall Study|Missing|1|||
19394021|NCT02648347|41638149|FG001|Overall Study|Missing|0|||
19394022|NCT02614703|41638157|FG000|Overall Study|Withdrawal by Subject|7|||
19394023|NCT02614703|41638158|FG001|Overall Study|Withdrawal by Subject|1|||
19394024|NCT01669343|41638164|FG000|Part A: All Patients|Withdrawal by Subject|7|||
19394025|NCT01669343|41638164|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
19394026|NCT01669343|41638164|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
19394027|NCT01669343|41638164|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
19394028|NCT01669343|41638164|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
19394029|NCT01594931|41638174|FG000|Overall Study|Adverse Event|3|||
19394030|NCT01594931|41638175|FG001|Overall Study|Adverse Event|1|||
19394031|NCT01594931|41638176|FG002|Overall Study|Adverse Event|1|||
19394032|NCT01594931|41638174|FG000|Overall Study|Withdrawal by Subject|2|||
19394033|NCT01594931|41638175|FG001|Overall Study|Withdrawal by Subject|1|||
19394034|NCT01594931|41638176|FG002|Overall Study|Withdrawal by Subject|1|||
19394035|NCT01594931|41638174|FG000|Overall Study|Lack of Efficacy|7|||
19394036|NCT01594931|41638175|FG001|Overall Study|Lack of Efficacy|2|||
19394037|NCT01594931|41638176|FG002|Overall Study|Lack of Efficacy|2|||
19394038|NCT01594931|41638174|FG000|Overall Study|Lost to Follow-up|4|||
19394039|NCT01594931|41638175|FG001|Overall Study|Lost to Follow-up|3|||
19394040|NCT01594931|41638176|FG002|Overall Study|Lost to Follow-up|3|||
19394041|NCT01594931|41638174|FG000|Overall Study|Protocol Violation|2|||
19394042|NCT01594931|41638175|FG001|Overall Study|Protocol Violation|1|||
19394043|NCT01594931|41638176|FG002|Overall Study|Protocol Violation|0|||
19394044|NCT01594931|41638174|FG000|Overall Study|No defiined|11|||
19394045|NCT01594931|41638175|FG001|Overall Study|No defiined|4|||
19394046|NCT01594931|41638176|FG002|Overall Study|No defiined|7|||
19394047|NCT01594853|41638186|FG000|Overall Study|Withdrawal by Subject|1|||
19394048|NCT01594853|41638187|FG001|Overall Study|Withdrawal by Subject|1|||
19394049|NCT01594853|41638186|FG000|Overall Study|Lost to Follow-up|1|||
19394050|NCT01594853|41638187|FG001|Overall Study|Lost to Follow-up|1|||
19394051|NCT01594853|41638186|FG000|Overall Study|noncompliance with exercise|0|||
19394052|NCT01594853|41638187|FG001|Overall Study|noncompliance with exercise|1|||
19394053|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
19394054|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
19394055|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
19394056|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
19394057|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
19506311|NCT02192970|41903433|FG000|Overall Study|Lost to Follow-up|6|||
19506312|NCT02192970|41903434|FG001|Overall Study|Lost to Follow-up|0|||
19506313|NCT02192190|41903618|FG000|Overall Study|Adverse Event|1|||
19506314|NCT02192190|41903619|FG001|Overall Study|Adverse Event|1|||
19506315|NCT02192190|41903620|FG002|Overall Study|Adverse Event|0|||
19506316|NCT02192190|41903621|FG003|Overall Study|Adverse Event|0|||
19704504|NCT00151476|42148883|FG000|FAP Analyzed Subjects|Other study participation|0|||
19506317|NCT02192190|41903622|FG004|Overall Study|Adverse Event|0|||
19506318|NCT02192190|41903623|FG005|Overall Study|Adverse Event|0|||
19506319|NCT02192190|41903618|FG000|Overall Study|Lost to Follow-up|3|||
19506320|NCT02192190|41903619|FG001|Overall Study|Lost to Follow-up|3|||
19506321|NCT02192190|41903620|FG002|Overall Study|Lost to Follow-up|2|||
19506322|NCT02192190|41903621|FG003|Overall Study|Lost to Follow-up|1|||
19506323|NCT02192190|41903622|FG004|Overall Study|Lost to Follow-up|4|||
19506324|NCT02192190|41903623|FG005|Overall Study|Lost to Follow-up|3|||
19506325|NCT02192190|41903618|FG000|Overall Study|Physician Decision|2|||
19506326|NCT02192190|41903619|FG001|Overall Study|Physician Decision|0|||
19506327|NCT02192190|41903620|FG002|Overall Study|Physician Decision|0|||
19506328|NCT02192190|41903621|FG003|Overall Study|Physician Decision|0|||
19506329|NCT02192190|41903622|FG004|Overall Study|Physician Decision|0|||
19506330|NCT02192190|41903623|FG005|Overall Study|Physician Decision|0|||
19394058|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
19394059|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
19394060|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
19394061|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
19394062|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
19394063|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
19394064|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
19394065|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
19394066|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
19506331|NCT02192190|41903618|FG000|Overall Study|Terminated by Sponsor|43|||
19506332|NCT02192190|41903619|FG001|Overall Study|Terminated by Sponsor|23|||
19506333|NCT02192190|41903620|FG002|Overall Study|Terminated by Sponsor|20|||
19506334|NCT02192190|41903621|FG003|Overall Study|Terminated by Sponsor|23|||
19506335|NCT02192190|41903622|FG004|Overall Study|Terminated by Sponsor|21|||
19506336|NCT02192190|41903623|FG005|Overall Study|Terminated by Sponsor|23|||
19506337|NCT02192190|41903618|FG000|Overall Study|Withdrawal by Subject|4|||
19506338|NCT02192190|41903619|FG001|Overall Study|Withdrawal by Subject|1|||
19506339|NCT02192190|41903620|FG002|Overall Study|Withdrawal by Subject|2|||
19506340|NCT02192190|41903621|FG003|Overall Study|Withdrawal by Subject|1|||
19506341|NCT02192190|41903622|FG004|Overall Study|Withdrawal by Subject|5|||
19506342|NCT02192190|41903623|FG005|Overall Study|Withdrawal by Subject|3|||
19506343|NCT02192190|41903618|FG000|Overall Study|Could not Keep Visit Schedule|1|||
19506344|NCT02192190|41903619|FG001|Overall Study|Could not Keep Visit Schedule|0|||
19506345|NCT02192190|41903620|FG002|Overall Study|Could not Keep Visit Schedule|0|||
19506346|NCT02192190|41903621|FG003|Overall Study|Could not Keep Visit Schedule|0|||
19506347|NCT02192190|41903622|FG004|Overall Study|Could not Keep Visit Schedule|0|||
19506348|NCT02192190|41903623|FG005|Overall Study|Could not Keep Visit Schedule|0|||
19506349|NCT02192190|41903618|FG000|Overall Study|Positive Drug Screen|0|||
19506350|NCT02192190|41903619|FG001|Overall Study|Positive Drug Screen|0|||
19506351|NCT02192190|41903620|FG002|Overall Study|Positive Drug Screen|0|||
19506352|NCT02192190|41903621|FG003|Overall Study|Positive Drug Screen|1|||
19506353|NCT02192190|41903622|FG004|Overall Study|Positive Drug Screen|0|||
19506354|NCT02192190|41903623|FG005|Overall Study|Positive Drug Screen|0|||
19506355|NCT02192190|41903618|FG000|Overall Study|Inadequate Pain Relief|0|||
19506356|NCT02192190|41903619|FG001|Overall Study|Inadequate Pain Relief|1|||
19506357|NCT02192190|41903620|FG002|Overall Study|Inadequate Pain Relief|1|||
19506358|NCT02192190|41903621|FG003|Overall Study|Inadequate Pain Relief|0|||
19506359|NCT02192190|41903622|FG004|Overall Study|Inadequate Pain Relief|0|||
19506360|NCT02192190|41903623|FG005|Overall Study|Inadequate Pain Relief|0|||
19506361|NCT02224638|41903651|FG000|Overall Study|Adverse Event|1|||
19506362|NCT02224638|41903652|FG001|Overall Study|Adverse Event|1|||
19506363|NCT02224560|41903667|FG000|Overall Study|Protocol Deviation|1|||
19506364|NCT02224560|41903668|FG001|Overall Study|Protocol Deviation|0|||
19506365|NCT02224560|41903669|FG002|Overall Study|Protocol Deviation|0|||
19506366|NCT02224560|41903667|FG000|Overall Study|Withdrawal by Subject|2|||
19506367|NCT02224560|41903668|FG001|Overall Study|Withdrawal by Subject|0|||
19506368|NCT02224560|41903669|FG002|Overall Study|Withdrawal by Subject|1|||
19506369|NCT02224560|41903667|FG000|Overall Study|Met Withdrawal Criteria|1|||
19506370|NCT02224560|41903668|FG001|Overall Study|Met Withdrawal Criteria|0|||
19506371|NCT02224560|41903669|FG002|Overall Study|Met Withdrawal Criteria|0|||
19506372|NCT02224560|41903667|FG000|Overall Study|Adverse Event|4|||
19506373|NCT02224560|41903668|FG001|Overall Study|Adverse Event|1|||
19506374|NCT02224560|41903669|FG002|Overall Study|Adverse Event|1|||
19506375|NCT02224560|41903667|FG000|Overall Study|Withdrawn by Investigator|1|||
19506376|NCT02224560|41903668|FG001|Overall Study|Withdrawn by Investigator|1|||
19506377|NCT02224560|41903669|FG002|Overall Study|Withdrawn by Investigator|0|||
19506378|NCT02161458|41903681|FG000|Overall Study|Withdrawal by Subject|0|||
19506379|NCT02161458|41903682|FG001|Overall Study|Withdrawal by Subject|4|||
19506380|NCT02161458|41903683|FG002|Overall Study|Withdrawal by Subject|4|||
19506381|NCT02161458|41903684|FG003|Overall Study|Withdrawal by Subject|0|||
19506382|NCT02161458|41903681|FG000|Overall Study|Lost to Follow-up|0|||
19506383|NCT02161458|41903682|FG001|Overall Study|Lost to Follow-up|2|||
19506384|NCT02161458|41903683|FG002|Overall Study|Lost to Follow-up|1|||
19506385|NCT02161458|41903684|FG003|Overall Study|Lost to Follow-up|0|||
19506386|NCT02223858|41903696|FG000|Overall Study|Death|1|||
19506387|NCT02223858|41903697|FG001|Overall Study|Death|1|||
19506388|NCT02223858|41903696|FG000|Overall Study|Lost to Follow-up|6|||
19506389|NCT02223858|41903697|FG001|Overall Study|Lost to Follow-up|11|||
19615365|NCT00744471|42064754|FG002|Overall Study|Death|0|||
19615366|NCT00744471|42064755|FG003|Overall Study|Death|1|||
19615367|NCT00744471|42064752|FG000|Overall Study|Adverse Event|6|||
19615368|NCT00744471|42064753|FG001|Overall Study|Adverse Event|7|||
19615369|NCT00744471|42064754|FG002|Overall Study|Adverse Event|5|||
19615370|NCT00744471|42064755|FG003|Overall Study|Adverse Event|9|||
19704505|NCT00151476|42148884|FG001|FAP Analyzed Subjects|Other study participation|1|||
19704506|NCT00149994|42148893|FG000|Overall Study|Administrative problems:|1|||
19704507|NCT00149994|42148894|FG001|Overall Study|Administrative problems:|0|||
19704508|NCT00149994|42148893|FG000|Overall Study|Protocol Violation|0|||
19704509|NCT00149994|42148894|FG001|Overall Study|Protocol Violation|1|||
19704510|NCT00149214|42148902|FG000|Overall Study|Adverse Event|12|||
19704511|NCT00149214|42148903|FG001|Overall Study|Adverse Event|9|||
19704512|NCT00149214|42148902|FG000|Overall Study|Withdrawal by Subject|4|||
19615371|NCT00744471|42064752|FG000|Overall Study|Withdrawal by Subject|9|||
19615372|NCT00744471|42064753|FG001|Overall Study|Withdrawal by Subject|9|||
19615373|NCT00744471|42064754|FG002|Overall Study|Withdrawal by Subject|15|||
19615374|NCT00744471|42064755|FG003|Overall Study|Withdrawal by Subject|12|||
19615375|NCT00744471|42064752|FG000|Overall Study|Protocol Violation|1|||
19615376|NCT00744471|42064753|FG001|Overall Study|Protocol Violation|4|||
19506390|NCT02223858|41903696|FG000|Overall Study|Withdrawal by Subject|8|||
19506391|NCT02223858|41903697|FG001|Overall Study|Withdrawal by Subject|5|||
19615377|NCT00744471|42064754|FG002|Overall Study|Protocol Violation|1|||
19615378|NCT00744471|42064755|FG003|Overall Study|Protocol Violation|2|||
19615379|NCT00744471|42064752|FG000|Overall Study|Entered extension study|41|||
19615380|NCT00744471|42064753|FG001|Overall Study|Entered extension study|84|||
19394067|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
19394068|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
19394069|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
19394070|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
19394071|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
19394072|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
19394073|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
19394074|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
19394075|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
19394076|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
19394077|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
19394078|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
19394079|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
19506392|NCT02223858|41903696|FG000|Overall Study|Refused|9|||
19506393|NCT02223858|41903697|FG001|Overall Study|Refused|9|||
19506394|NCT02223390|41903705|FG000|Overall Study|Lost to Follow-up|9|||
19506395|NCT02223390|41903706|FG001|Overall Study|Lost to Follow-up|4|||
19506396|NCT04914000|41905629|FG000|Overall Study|Lost to Follow-up|8|||
19506397|NCT04914000|41905629|FG000|Overall Study|Withdrawal by Subject|1|||
19506398|NCT04530825|41905646|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
19506399|NCT04530825|41905647|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
19506400|NCT04530825|41905648|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
19506401|NCT04530825|41905649|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
19506402|NCT04530825|41905646|FG000|Overall Study|Did not complete follow-up|3|||
19506403|NCT04530825|41905647|FG001|Overall Study|Did not complete follow-up|0|||
19506404|NCT04530825|41905648|FG002|Overall Study|Did not complete follow-up|0|||
19506405|NCT04530825|41905649|FG003|Overall Study|Did not complete follow-up|0|||
19506406|NCT04169373|41905663|FG000|Week 1 to Week 14|Adverse Event|1|||
19506407|NCT04169373|41905664|FG001|Week 1 to Week 14|Adverse Event|0|||
19506408|NCT04169373|41905665|FG002|Week 1 to Week 14|Adverse Event|1|||
19506409|NCT04169373|41905666|FG003|Week 1 to Week 14|Adverse Event|2|||
19506410|NCT04169373|41905663|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
19506411|NCT04169373|41905664|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
19506412|NCT04169373|41905665|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
19506413|NCT04169373|41905666|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
19506414|NCT04169373|41905663|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
19506415|NCT04169373|41905664|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
19506416|NCT04169373|41905665|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
19506417|NCT04169373|41905666|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
19506418|NCT04169373|41905663|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
19506419|NCT04169373|41905664|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
19506420|NCT04169373|41905665|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
19506421|NCT04169373|41905666|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
19506422|NCT04169373|41905663|FG000|Week 1 to Week 14|Other|1|||
19506423|NCT04169373|41905664|FG001|Week 1 to Week 14|Other|3|||
19506424|NCT04169373|41905665|FG002|Week 1 to Week 14|Other|3|||
19506425|NCT04169373|41905666|FG003|Week 1 to Week 14|Other|5|||
19506426|NCT04169373|41905663|FG000|Week 14 to Week 52|Adverse Event|1|||
19506427|NCT04169373|41905664|FG001|Week 14 to Week 52|Adverse Event|0|||
19506428|NCT04169373|41905665|FG002|Week 14 to Week 52|Adverse Event|0|||
19506429|NCT04169373|41905666|FG003|Week 14 to Week 52|Adverse Event|1|||
19506430|NCT04169373|41905663|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
19506431|NCT04169373|41905664|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
19506432|NCT04169373|41905665|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
19506433|NCT04169373|41905666|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
19506434|NCT04169373|41905663|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
19506435|NCT04169373|41905664|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
19615381|NCT00744471|42064754|FG002|Overall Study|Entered extension study|100|||
19615382|NCT00744471|42064755|FG003|Overall Study|Entered extension study|91|||
19506436|NCT04169373|41905665|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
19506437|NCT04169373|41905666|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
19506438|NCT04169373|41905663|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
19506439|NCT04169373|41905664|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
19506440|NCT04169373|41905665|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
19506441|NCT04169373|41905666|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
19506442|NCT04169373|41905663|FG000|Week 14 to Week 52|Other|4|||
19394080|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
19506443|NCT04169373|41905664|FG001|Week 14 to Week 52|Other|5|||
19506444|NCT04169373|41905665|FG002|Week 14 to Week 52|Other|4|||
19506445|NCT04169373|41905666|FG003|Week 14 to Week 52|Other|5|||
19506446|NCT04169373|41905663|FG000|Week 14 to Week 52|Ongoing|0|||
19506447|NCT04169373|41905664|FG001|Week 14 to Week 52|Ongoing|1|||
19506448|NCT04169373|41905665|FG002|Week 14 to Week 52|Ongoing|0|||
19506449|NCT04169373|41905666|FG003|Week 14 to Week 52|Ongoing|0|||
19506450|NCT04154930|41905681|FG000|Overall Study|Withdrawal by Subject|15|||
19506451|NCT04154930|41905682|FG001|Overall Study|Withdrawal by Subject|6|||
19506452|NCT04154930|41905681|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
19506453|NCT04154930|41905682|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
19506454|NCT04154930|41905681|FG000|Overall Study|Lost to Follow-up|14|||
19506455|NCT04154930|41905682|FG001|Overall Study|Lost to Follow-up|6|||
19506456|NCT04154930|41905681|FG000|Overall Study|Other|6|||
19506457|NCT04154930|41905682|FG001|Overall Study|Other|0|||
19506458|NCT04124471|41905688|FG000|Overall Study|screen failure|1|||
19506459|NCT04093024|41905694|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
19506460|NCT04093024|41905695|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
19506461|NCT04093024|41905694|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
19506462|NCT04093024|41905695|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
19506463|NCT04093024|41905694|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
19506464|NCT04093024|41905695|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
19506465|NCT04093024|41905694|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
19506466|NCT04093024|41905695|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
19506467|NCT03971474|41905731|FG000|Overall Study|Adverse Event|11|||
19506468|NCT03971474|41905732|FG001|Overall Study|Adverse Event|7|||
19506469|NCT03971474|41905731|FG000|Overall Study|Refusal unrelated to adverse event|5|||
19506470|NCT03971474|41905732|FG001|Overall Study|Refusal unrelated to adverse event|1|||
19506471|NCT03971474|41905731|FG000|Overall Study|Progression/relapse|40|||
19506472|NCT03971474|41905732|FG001|Overall Study|Progression/relapse|47|||
19506473|NCT03971474|41905731|FG000|Overall Study|Death|6|||
19506474|NCT03971474|41905732|FG001|Overall Study|Death|3|||
19506475|NCT03971474|41905731|FG000|Overall Study|Other - not protocol specified|5|||
19506476|NCT03971474|41905732|FG001|Overall Study|Other - not protocol specified|4|||
19506477|NCT03971474|41905731|FG000|Overall Study|On treatment|0|||
19506478|NCT03971474|41905732|FG001|Overall Study|On treatment|7|||
19506479|NCT03759379|41905742|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
19506480|NCT03759379|41905743|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
19506481|NCT03759379|41905742|FG000|Treatment Period|Death|2|||
19506482|NCT03759379|41905743|FG001|Treatment Period|Death|3|||
19506483|NCT03759379|41905742|FG000|Treatment Period|Lost to Follow-up|1|||
19506484|NCT03759379|41905743|FG001|Treatment Period|Lost to Follow-up|0|||
19506485|NCT03759379|41905742|FG000|Treatment Period|Physician Decision|0|||
19506486|NCT03759379|41905743|FG001|Treatment Period|Physician Decision|1|||
19506487|NCT03692052|41905749|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
19506488|NCT03692052|41905749|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
19506489|NCT03692052|41905749|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
19506490|NCT03692052|41905749|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
19506491|NCT03633929|41905753|FG000|Overall Study|Lost to Follow-up|1|||
19506492|NCT03633929|41905753|FG000|Overall Study|Did not login to software. Did not participate|3|||
19506493|NCT03625687|41905757|FG000|Overall Study|Death|1|||
19506494|NCT03062358|41905780|FG000|Overall Study|Death|220|||
19506495|NCT03062358|41905781|FG001|Overall Study|Death|127|||
19506496|NCT03062358|41905780|FG000|Overall Study|Withdrawal by Subject|2|||
19506497|NCT03062358|41905781|FG001|Overall Study|Withdrawal by Subject|1|||
19506498|NCT03062358|41905780|FG000|Overall Study|Ongoing in Trial|78|||
19506499|NCT03062358|41905781|FG001|Overall Study|Ongoing in Trial|25|||
19506500|NCT02998528|41905791|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
19506501|NCT02998528|41905792|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
19506502|NCT02998528|41905793|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
19506503|NCT02998528|41905791|FG000|Randomization Period|Participant withdrew consent|0|||
19506504|NCT02998528|41905792|FG001|Randomization Period|Participant withdrew consent|3|||
19506505|NCT02998528|41905793|FG002|Randomization Period|Participant withdrew consent|0|||
19506506|NCT02998528|41905791|FG000|Randomization Period|Participant no longer meets study criteria|1|||
19506507|NCT02998528|41905792|FG001|Randomization Period|Participant no longer meets study criteria|3|||
19615383|NCT00744471|42064752|FG000|Overall Study|Other|2|||
19615384|NCT00744471|42064753|FG001|Overall Study|Other|3|||
19615385|NCT00744471|42064754|FG002|Overall Study|Other|6|||
19615386|NCT00744471|42064755|FG003|Overall Study|Other|2|||
19615387|NCT00744471|42064752|FG000|Overall Study|Lack of Efficacy|83|||
19615388|NCT00744471|42064753|FG001|Overall Study|Lack of Efficacy|37|||
19615389|NCT00744471|42064754|FG002|Overall Study|Lack of Efficacy|19|||
19615390|NCT00744471|42064755|FG003|Overall Study|Lack of Efficacy|31|||
19615391|NCT00744471|42064752|FG000|Overall Study|Lost to Follow-up|0|||
19506508|NCT02998528|41905793|FG002|Randomization Period|Participant no longer meets study criteria|2|||
19615392|NCT00744471|42064753|FG001|Overall Study|Lost to Follow-up|0|||
19615393|NCT00744471|42064754|FG002|Overall Study|Lost to Follow-up|2|||
19506509|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
19506510|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
19506511|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
19506512|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
19506513|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
19506514|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
19506515|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
19506516|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
19506517|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
19506518|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
19506519|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
19506520|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
19506521|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
19506522|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
19506523|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
19506524|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Death|1|||
19506525|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Death|0|||
19506526|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Death|0|||
19506527|NCT02998528|41905791|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
19506528|NCT02998528|41905792|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
19506529|NCT02998528|41905793|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
19506530|NCT02998528|41905791|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
19506531|NCT02998528|41905792|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
19506532|NCT02998528|41905793|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
19506533|NCT02998528|41905791|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
19506534|NCT02998528|41905792|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
19506535|NCT02998528|41905793|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
19506536|NCT02998528|41905791|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
19506537|NCT02998528|41905792|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
19506538|NCT02998528|41905793|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
19506539|NCT02998528|41905791|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
19506540|NCT02998528|41905792|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
19506541|NCT02998528|41905793|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
19506542|NCT02998528|41905791|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
19506543|NCT02998528|41905792|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
19506544|NCT02998528|41905793|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
19506545|NCT02913482|41905812|FG000|Overall Study|Death|0|||
19506546|NCT02913482|41905813|FG001|Overall Study|Death|2|||
19506547|NCT02913482|41905814|FG002|Overall Study|Death|2|||
19506548|NCT02913482|41905812|FG000|Overall Study|Progressive Disease|1|||
19506549|NCT02913482|41905813|FG001|Overall Study|Progressive Disease|1|||
19506550|NCT02913482|41905814|FG002|Overall Study|Progressive Disease|1|||
19506551|NCT02869633|41905826|FG000|Overall Study|Death|2|||
19506552|NCT02869633|41905827|FG001|Overall Study|Death|1|||
19506553|NCT02869633|41905826|FG000|Overall Study|Patient refused follow-up|1|||
19506554|NCT02869633|41905827|FG001|Overall Study|Patient refused follow-up|0|||
19506555|NCT02869633|41905826|FG000|Overall Study|Provider discretion|1|||
19506556|NCT02869633|41905827|FG001|Overall Study|Provider discretion|0|||
19506557|NCT02869633|41905826|FG000|Overall Study|Investigator decision|1|||
19506558|NCT02869633|41905827|FG001|Overall Study|Investigator decision|0|||
19506559|NCT02869633|41905826|FG000|Overall Study|Lost to Follow-up|0|||
19506560|NCT02869633|41905827|FG001|Overall Study|Lost to Follow-up|1|||
19506561|NCT02869633|41905826|FG000|Overall Study|Not eligible|6|||
19506562|NCT02869633|41905827|FG001|Overall Study|Not eligible|1|||
19506563|NCT02869633|41905826|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
19506564|NCT02869633|41905827|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
19506565|NCT02869633|41905826|FG000|Overall Study|Withdrawal by Subject|0|||
19506566|NCT02869633|41905827|FG001|Overall Study|Withdrawal by Subject|1|||
19506567|NCT02785952|41905837|FG000|Overall Study|Adverse Event|31|||
19506568|NCT02785952|41905838|FG001|Overall Study|Adverse Event|19|||
19506569|NCT02785952|41905837|FG000|Overall Study|Refusal unrelated to adverse events|10|||
19506570|NCT02785952|41905838|FG001|Overall Study|Refusal unrelated to adverse events|5|||
19506571|NCT02785952|41905837|FG000|Overall Study|Disease progression/relapse|61|||
19506572|NCT02785952|41905838|FG001|Overall Study|Disease progression/relapse|89|||
19506573|NCT02785952|41905837|FG000|Overall Study|Death|11|||
19506574|NCT02785952|41905838|FG001|Overall Study|Death|7|||
19506575|NCT02785952|41905837|FG000|Overall Study|Other- not protocol specified|6|||
19506576|NCT02785952|41905838|FG001|Overall Study|Other- not protocol specified|4|||
19506577|NCT02785952|41905837|FG000|Overall Study|On protocol treatment|6|||
19506578|NCT02785952|41905838|FG001|Overall Study|On protocol treatment|3|||
19506579|NCT02674685|41905846|FG000|Overall Study|Withdrawal by Subject|4|||
19506580|NCT02654236|41905853|FG000|Overall Study|Withdrawal by Subject|0|||
19506581|NCT02654236|41905854|FG001|Overall Study|Withdrawal by Subject|0|||
19506582|NCT02654236|41905855|FG002|Overall Study|Withdrawal by Subject|2|||
19506583|NCT02372136|41905865|FG000|Overall Study|Death|3|||
19506584|NCT02372136|41905866|FG001|Overall Study|Death|1|||
19506585|NCT02278120|41905876|FG000|Overall Study|Progressive disease|122|||
19506586|NCT02278120|41905877|FG001|Overall Study|Progressive disease|174|||
19506587|NCT02278120|41905876|FG000|Overall Study|Patient/guardian decision|14|||
19506588|NCT02278120|41905877|FG001|Overall Study|Patient/guardian decision|8|||
19506589|NCT02278120|41905876|FG000|Overall Study|Adverse Event|12|||
19506590|NCT02278120|41905877|FG001|Overall Study|Adverse Event|10|||
19506591|NCT02278120|41905876|FG000|Overall Study|Physician Decision|8|||
19506592|NCT02278120|41905877|FG001|Overall Study|Physician Decision|19|||
19506593|NCT02278120|41905876|FG000|Overall Study|Death|3|||
19506594|NCT02278120|41905877|FG001|Overall Study|Death|3|||
19506595|NCT02278120|41905876|FG000|Overall Study|Lost to Follow-up|2|||
19506596|NCT02278120|41905877|FG001|Overall Study|Lost to Follow-up|0|||
19506597|NCT02278120|41905876|FG000|Overall Study|Protocol Violation|0|||
19506598|NCT02278120|41905877|FG001|Overall Study|Protocol Violation|2|||
19506599|NCT02194829|41905885|FG000|Overall Study|Adverse Event|2|||
19506600|NCT02194829|41905886|FG001|Overall Study|Adverse Event|2|||
19506601|NCT02194829|41905885|FG000|Overall Study|Death|0|||
19506602|NCT02194829|41905886|FG001|Overall Study|Death|1|||
19506603|NCT02194829|41905885|FG000|Overall Study|Disease progression|0|||
19506604|NCT02194829|41905886|FG001|Overall Study|Disease progression|1|||
19506605|NCT02194829|41905885|FG000|Overall Study|Withdrawal by Subject|0|||
19506606|NCT02194829|41905886|FG001|Overall Study|Withdrawal by Subject|1|||
19506607|NCT02194829|41905885|FG000|Overall Study|Never started protocol therapy|0|||
19506608|NCT02194829|41905886|FG001|Overall Study|Never started protocol therapy|1|||
19506609|NCT02087046|41905909|FG000|Overall Study|Adverse Event|4|||
19506610|NCT02087046|41905909|FG000|Overall Study|Death|1|||
19506611|NCT02087046|41905909|FG000|Overall Study|Lost to Follow-up|3|||
19506612|NCT02087046|41905909|FG000|Overall Study|Withdrawal by Subject|2|||
19506613|NCT02087046|41905909|FG000|Overall Study|Physician Decision|1|||
19506614|NCT01867242|41905921|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
19506615|NCT01867242|41905922|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
19506616|NCT01867242|41905923|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
19506617|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
19506618|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
19506619|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
19506620|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
19506621|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506622|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506623|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506624|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506625|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506626|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506627|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
19506628|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
19506629|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
19506630|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
19506631|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
19506632|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506633|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506634|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506635|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506636|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506637|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506638|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
19506639|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
19506640|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
19506641|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
19506642|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
19506643|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506644|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506645|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506646|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506647|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506648|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506649|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
19506650|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506651|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506652|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506653|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
19506654|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506655|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506656|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506657|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506658|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506659|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506660|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
19506661|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
19506662|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
19506663|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
19506664|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
19506665|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506666|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506667|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506668|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506669|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506670|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506671|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
19506672|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
19506673|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
19506674|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
19506675|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
19506676|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506677|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506678|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506679|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506680|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506681|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506682|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
19506683|NCT01847274|41905938|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
19506684|NCT01847274|41905939|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
19506685|NCT01847274|41905940|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
19506686|NCT01847274|41905941|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
19506687|NCT01847274|41905942|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506688|NCT01847274|41905943|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506689|NCT01847274|41905944|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506690|NCT01847274|41905945|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506691|NCT01847274|41905946|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506692|NCT01847274|41905947|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506693|NCT01847274|41905948|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
19506694|NCT01847274|41905938|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506695|NCT01847274|41905939|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506696|NCT01847274|41905940|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506697|NCT01847274|41905941|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506698|NCT01847274|41905942|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506699|NCT01847274|41905943|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
19506700|NCT01847274|41905944|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506701|NCT01847274|41905945|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506702|NCT01847274|41905946|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506703|NCT01847274|41905947|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506704|NCT01847274|41905948|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
19506705|NCT01847274|41905938|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506706|NCT01847274|41905939|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506707|NCT01847274|41905940|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506708|NCT01847274|41905941|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19704513|NCT00149214|42148903|FG001|Overall Study|Withdrawal by Subject|1|||
19506709|NCT01847274|41905942|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
19506710|NCT01847274|41905943|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506711|NCT01847274|41905944|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506712|NCT01847274|41905945|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506713|NCT01847274|41905946|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506714|NCT01847274|41905947|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506715|NCT01847274|41905948|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
19506716|NCT01847274|41905938|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506717|NCT01847274|41905939|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506718|NCT01847274|41905940|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506719|NCT01847274|41905941|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506720|NCT01847274|41905942|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506721|NCT01847274|41905943|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506722|NCT01847274|41905944|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
19506723|NCT01847274|41905945|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506724|NCT01847274|41905946|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506725|NCT01847274|41905947|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506726|NCT01847274|41905948|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
19506727|NCT01847274|41905938|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506728|NCT01847274|41905939|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506729|NCT01847274|41905940|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506730|NCT01847274|41905941|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506731|NCT01847274|41905942|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506732|NCT01847274|41905943|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506733|NCT01847274|41905944|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
19506734|NCT01847274|41905945|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506735|NCT01847274|41905946|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506736|NCT01847274|41905947|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506737|NCT01847274|41905948|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
19506738|NCT01847274|41905938|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506739|NCT01847274|41905939|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506740|NCT01847274|41905940|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506741|NCT01847274|41905941|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506742|NCT01847274|41905942|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506743|NCT01847274|41905943|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506744|NCT01847274|41905944|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
19506745|NCT01847274|41905945|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506746|NCT01847274|41905946|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506747|NCT01847274|41905947|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506748|NCT01847274|41905948|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
19506749|NCT01847274|41905938|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506750|NCT01847274|41905939|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506751|NCT01847274|41905940|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506752|NCT01847274|41905941|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506753|NCT01847274|41905942|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506754|NCT01847274|41905943|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506755|NCT01847274|41905944|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
19506756|NCT01847274|41905945|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
19506757|NCT01847274|41905946|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
19506758|NCT01847274|41905947|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
19506759|NCT01847274|41905948|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
19506760|NCT01847274|41905938|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506761|NCT01847274|41905939|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506762|NCT01847274|41905940|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19615394|NCT00744471|42064755|FG003|Overall Study|Lost to Follow-up|0|||
19615395|NCT00744237|42064768|FG000|Overall Study|Lack of Efficacy|1|||
19615396|NCT00744237|42064769|FG001|Overall Study|Lack of Efficacy|1|||
19615397|NCT00744237|42064770|FG002|Overall Study|Lack of Efficacy|0|||
19615398|NCT00744237|42064768|FG000|Overall Study|Withdrawal by Subject|9|||
19615399|NCT00744237|42064769|FG001|Overall Study|Withdrawal by Subject|5|||
19615400|NCT00744237|42064770|FG002|Overall Study|Withdrawal by Subject|3|||
19615401|NCT00744237|42064768|FG000|Overall Study|Lost to Follow-up|1|||
19615402|NCT00744237|42064769|FG001|Overall Study|Lost to Follow-up|1|||
19615403|NCT00744237|42064770|FG002|Overall Study|Lost to Follow-up|1|||
19615404|NCT00744237|42064768|FG000|Overall Study|Protocol Violation|3|||
19506763|NCT01847274|41905941|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506764|NCT01847274|41905942|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506765|NCT01847274|41905943|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506766|NCT01847274|41905944|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506767|NCT01847274|41905945|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
19506768|NCT01847274|41905946|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506769|NCT01847274|41905947|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
19506770|NCT01847274|41905948|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
19506771|NCT01847274|41905938|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506772|NCT01847274|41905939|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506773|NCT01847274|41905940|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506774|NCT01847274|41905941|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506775|NCT01847274|41905942|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506776|NCT01847274|41905943|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506777|NCT01847274|41905944|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506778|NCT01847274|41905945|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
19506779|NCT01847274|41905946|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
19506780|NCT01847274|41905947|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
19506781|NCT01847274|41905948|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
19506782|NCT01847274|41905938|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506783|NCT01847274|41905939|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506784|NCT01847274|41905940|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506785|NCT01847274|41905941|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506786|NCT01847274|41905942|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506787|NCT01847274|41905943|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506788|NCT01847274|41905944|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19615405|NCT00744237|42064769|FG001|Overall Study|Protocol Violation|4|||
19615406|NCT00744237|42064770|FG002|Overall Study|Protocol Violation|3|||
19615407|NCT00744237|42064768|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
19615408|NCT00744237|42064769|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
19506789|NCT01847274|41905945|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506790|NCT01847274|41905946|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506791|NCT01847274|41905947|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
19506792|NCT01847274|41905948|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
19506793|NCT01390038|41905978|FG000|Overall Study|Death|1|||
19506794|NCT01390038|41905978|FG000|Overall Study|Lost to Follow-up|1|||
19506795|NCT01390038|41905978|FG000|Overall Study|Withdrawal by Subject|4|||
19506796|NCT01390038|41905978|FG000|Overall Study|Simpliciti System Removal|2|||
19506797|NCT01169337|41905995|FG000|Overall Study|Lack of Efficacy|5|||
19506798|NCT01169337|41905996|FG001|Overall Study|Lack of Efficacy|7|||
19506799|NCT01169337|41905997|FG002|Overall Study|Lack of Efficacy|0|||
19506800|NCT01169337|41905995|FG000|Overall Study|Adverse Event|12|||
19506801|NCT01169337|41905996|FG001|Overall Study|Adverse Event|18|||
19506802|NCT01169337|41905997|FG002|Overall Study|Adverse Event|0|||
19506803|NCT01169337|41905995|FG000|Overall Study|Death|2|||
19506804|NCT01169337|41905996|FG001|Overall Study|Death|0|||
19506805|NCT01169337|41905997|FG002|Overall Study|Death|0|||
19506806|NCT01169337|41905995|FG000|Overall Study|Withdrawal by Subject|11|||
19506807|NCT01169337|41905996|FG001|Overall Study|Withdrawal by Subject|11|||
19506808|NCT01169337|41905997|FG002|Overall Study|Withdrawal by Subject|6|||
19506809|NCT01169337|41905995|FG000|Overall Study|Noncompliance|2|||
19506810|NCT01169337|41905996|FG001|Overall Study|Noncompliance|0|||
19506811|NCT01169337|41905997|FG002|Overall Study|Noncompliance|0|||
19506812|NCT01169337|41905995|FG000|Overall Study|Other complicating disease|1|||
19506813|NCT01169337|41905996|FG001|Overall Study|Other complicating disease|1|||
19506814|NCT01169337|41905997|FG002|Overall Study|Other complicating disease|0|||
19506815|NCT01169337|41905995|FG000|Overall Study|Physician Decision|1|||
19506816|NCT01169337|41905996|FG001|Overall Study|Physician Decision|5|||
19506817|NCT01169337|41905997|FG002|Overall Study|Physician Decision|0|||
19506818|NCT01169337|41905995|FG000|Overall Study|Alternative therapy|0|||
19506819|NCT01169337|41905996|FG001|Overall Study|Alternative therapy|2|||
19506820|NCT01169337|41905997|FG002|Overall Study|Alternative therapy|0|||
19506821|NCT01169337|41905995|FG000|Overall Study|Changed hospital|0|||
19615409|NCT00744237|42064770|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
19615410|NCT00744237|42064768|FG000|Overall Study|Dosing Error|1|||
19615411|NCT00744237|42064769|FG001|Overall Study|Dosing Error|0|||
19615412|NCT00744237|42064770|FG002|Overall Study|Dosing Error|1|||
19615413|NCT00744237|42064768|FG000|Overall Study|Study Drug Error|1|||
19615414|NCT00744237|42064769|FG001|Overall Study|Study Drug Error|0|||
19615415|NCT00744237|42064770|FG002|Overall Study|Study Drug Error|0|||
19615416|NCT00744237|42064768|FG000|Overall Study|Prohibited Concomitant Medication|0|||
19615417|NCT00744237|42064769|FG001|Overall Study|Prohibited Concomitant Medication|0|||
19615418|NCT00744237|42064770|FG002|Overall Study|Prohibited Concomitant Medication|1|||
19615419|NCT00744237|42064768|FG000|Overall Study|Poor Compliance|0|||
19615420|NCT00744237|42064769|FG001|Overall Study|Poor Compliance|2|||
19615421|NCT00744237|42064770|FG002|Overall Study|Poor Compliance|0|||
19615422|NCT00744237|42064768|FG000|Overall Study|Administrative. Site Closed|1|||
19615423|NCT00744237|42064769|FG001|Overall Study|Administrative. Site Closed|1|||
19615424|NCT00744237|42064770|FG002|Overall Study|Administrative. Site Closed|1|||
19394081|NCT01668797|41638204|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
19394082|NCT01668797|41638205|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
19506822|NCT01169337|41905996|FG001|Overall Study|Changed hospital|1|||
19506823|NCT01169337|41905997|FG002|Overall Study|Changed hospital|0|||
19506824|NCT01169337|41905995|FG000|Overall Study|Never started treatment|0|||
19506825|NCT01169337|41905996|FG001|Overall Study|Never started treatment|2|||
19506826|NCT01169337|41905997|FG002|Overall Study|Never started treatment|0|||
19506827|NCT01169337|41905995|FG000|Overall Study|Reason not reported|1|||
19506828|NCT01169337|41905996|FG001|Overall Study|Reason not reported|0|||
19506829|NCT01169337|41905997|FG002|Overall Study|Reason not reported|0|||
19506830|NCT01169337|41905995|FG000|Overall Study|Continuing lenalidomide|9|||
19506831|NCT01169337|41905996|FG001|Overall Study|Continuing lenalidomide|43|||
19506832|NCT01169337|41905997|FG002|Overall Study|Continuing lenalidomide|0|||
19506833|NCT00621192|41906009|FG000|Overall Study|Withdrawal by Subject|0|||
19506834|NCT00621192|41906010|FG001|Overall Study|Withdrawal by Subject|0|||
19506835|NCT00621192|41906011|FG002|Overall Study|Withdrawal by Subject|2|||
19506836|NCT00621192|41906012|FG003|Overall Study|Withdrawal by Subject|0|||
19506837|NCT00621192|41906009|FG000|Overall Study|Physician Decision|1|||
19506838|NCT00621192|41906010|FG001|Overall Study|Physician Decision|3|||
19506839|NCT00621192|41906011|FG002|Overall Study|Physician Decision|0|||
19394083|NCT01668797|41638206|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
19506840|NCT00621192|41906012|FG003|Overall Study|Physician Decision|0|||
19615425|NCT00744237|42064768|FG000|Overall Study|Adverse Event|9|||
19506841|NCT00621192|41906009|FG000|Overall Study|Protocol Violation|1|||
19394084|NCT01668797|41638207|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
19394085|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
19506842|NCT00621192|41906010|FG001|Overall Study|Protocol Violation|0|||
19506843|NCT00621192|41906011|FG002|Overall Study|Protocol Violation|0|||
19506844|NCT00621192|41906012|FG003|Overall Study|Protocol Violation|1|||
19506845|NCT00621192|41906009|FG000|Overall Study|Adverse Event|0|||
19506846|NCT00621192|41906010|FG001|Overall Study|Adverse Event|1|||
19506847|NCT00621192|41906011|FG002|Overall Study|Adverse Event|0|||
19506848|NCT00621192|41906012|FG003|Overall Study|Adverse Event|1|||
19506849|NCT00621192|41906009|FG000|Overall Study|Death|2|||
19506850|NCT00621192|41906010|FG001|Overall Study|Death|5|||
19506851|NCT00621192|41906011|FG002|Overall Study|Death|0|||
19506852|NCT00621192|41906012|FG003|Overall Study|Death|0|||
19506853|NCT00621192|41906009|FG000|Overall Study|Final Assessments not Completed|0|||
19506854|NCT00621192|41906010|FG001|Overall Study|Final Assessments not Completed|0|||
19506855|NCT00621192|41906011|FG002|Overall Study|Final Assessments not Completed|3|||
19506856|NCT00621192|41906012|FG003|Overall Study|Final Assessments not Completed|1|||
19506857|NCT00364286|41906022|FG000|Overall Study|Withdrawal by Subject|1|||
19506858|NCT00364286|41906022|FG000|Overall Study|Adverse Event|2|||
19506859|NCT00278200|41906028|FG000|Overall Study|Death|1|||
19506860|NCT00278200|41906029|FG001|Overall Study|Death|3|||
19506861|NCT00278200|41906028|FG000|Overall Study|Physician Decision|0|||
19506862|NCT00278200|41906029|FG001|Overall Study|Physician Decision|1|||
19506863|NCT00255346|41906040|FG000|Overall Study|Adverse Event|1|||
19506864|NCT00255346|41906041|FG001|Overall Study|Adverse Event|0|||
19506865|NCT00255346|41906042|FG002|Overall Study|Adverse Event|0|||
19506866|NCT00255346|41906043|FG003|Overall Study|Adverse Event|0|||
19506867|NCT00255346|41906044|FG004|Overall Study|Adverse Event|0|||
19615426|NCT00744237|42064769|FG001|Overall Study|Adverse Event|13|||
19615427|NCT00744237|42064770|FG002|Overall Study|Adverse Event|5|||
19615428|NCT00743145|42064778|FG000|Overall Study|Withdrawal by Subject|1|||
19615429|NCT00743145|42064778|FG000|Overall Study|Adverse Event|2|||
19615430|NCT00743145|42064778|FG000|Overall Study|Pregnancy|1|||
19615431|NCT00920855|42064795|FG000|Overall Study|Adverse Event|1|||
19615432|NCT00920855|42064796|FG001|Overall Study|Adverse Event|1|||
19615433|NCT00920855|42064797|FG002|Overall Study|Adverse Event|4|||
19615434|NCT00920855|42064795|FG000|Overall Study|Withdrawal by Subject|2|||
19615435|NCT00920855|42064796|FG001|Overall Study|Withdrawal by Subject|1|||
19615436|NCT00920855|42064797|FG002|Overall Study|Withdrawal by Subject|6|||
19615437|NCT00920855|42064795|FG000|Overall Study|Disease progression|2|||
19615438|NCT00920855|42064796|FG001|Overall Study|Disease progression|1|||
19615439|NCT00920855|42064797|FG002|Overall Study|Disease progression|10|||
19615440|NCT00920855|42064795|FG000|Overall Study|Noncompliance to study medication|0|||
19615441|NCT00920855|42064796|FG001|Overall Study|Noncompliance to study medication|0|||
19615442|NCT00920855|42064797|FG002|Overall Study|Noncompliance to study medication|1|||
19615443|NCT00920855|42064795|FG000|Overall Study|Response plateau; started maintenance|0|||
19615444|NCT00920855|42064796|FG001|Overall Study|Response plateau; started maintenance|0|||
19615445|NCT00920855|42064797|FG002|Overall Study|Response plateau; started maintenance|1|||
19615446|NCT00742209|42064811|FG000|Overall Study|Adverse Event|11|||
19615447|NCT00742209|42064812|FG001|Overall Study|Adverse Event|4|||
19615448|NCT00742209|42064813|FG002|Overall Study|Adverse Event|17|||
19615449|NCT00742209|42064814|FG003|Overall Study|Adverse Event|16|||
19615450|NCT00742209|42064815|FG004|Overall Study|Adverse Event|13|||
19615451|NCT00742209|42064811|FG000|Overall Study|Participant Withdrew Consent|8|||
19615452|NCT00742209|42064812|FG001|Overall Study|Participant Withdrew Consent|4|||
19615453|NCT00742209|42064813|FG002|Overall Study|Participant Withdrew Consent|14|||
19615454|NCT00742209|42064814|FG003|Overall Study|Participant Withdrew Consent|7|||
19615455|NCT00742209|42064815|FG004|Overall Study|Participant Withdrew Consent|4|||
19615456|NCT00742209|42064811|FG000|Overall Study|Protocol Violation|6|||
19615457|NCT00742209|42064812|FG001|Overall Study|Protocol Violation|5|||
19615458|NCT00742209|42064813|FG002|Overall Study|Protocol Violation|4|||
19615459|NCT00742209|42064814|FG003|Overall Study|Protocol Violation|5|||
19394086|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
19394087|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
19394088|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
19615460|NCT00742209|42064815|FG004|Overall Study|Protocol Violation|3|||
19615461|NCT00742209|42064811|FG000|Overall Study|Lost to Follow-up|3|||
19615462|NCT00742209|42064812|FG001|Overall Study|Lost to Follow-up|4|||
19394089|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
19615463|NCT00742209|42064813|FG002|Overall Study|Lost to Follow-up|5|||
19615464|NCT00742209|42064814|FG003|Overall Study|Lost to Follow-up|5|||
19615465|NCT00742209|42064815|FG004|Overall Study|Lost to Follow-up|3|||
19615466|NCT00742209|42064811|FG000|Overall Study|Lack of Efficacy|6|||
19615467|NCT00742209|42064812|FG001|Overall Study|Lack of Efficacy|1|||
19615468|NCT00742209|42064813|FG002|Overall Study|Lack of Efficacy|1|||
19615469|NCT00742209|42064814|FG003|Overall Study|Lack of Efficacy|3|||
19615470|NCT00742209|42064815|FG004|Overall Study|Lack of Efficacy|1|||
19615471|NCT00742209|42064811|FG000|Overall Study|Investigator Discretion|0|||
19615472|NCT00742209|42064812|FG001|Overall Study|Investigator Discretion|0|||
19615473|NCT00742209|42064813|FG002|Overall Study|Investigator Discretion|5|||
19615474|NCT00742209|42064814|FG003|Overall Study|Investigator Discretion|1|||
19615475|NCT00742209|42064815|FG004|Overall Study|Investigator Discretion|1|||
19615476|NCT00741819|42064828|FG000|Overall Study|Adverse Event|3|||
19615477|NCT00741819|42064828|FG000|Overall Study|Withdrawal by Subject|3|||
19704514|NCT00149214|42148902|FG000|Overall Study|Physician Decision|3|||
19704515|NCT00149214|42148903|FG001|Overall Study|Physician Decision|3|||
19506868|NCT02222922|41908221|FG000|Overall Study|Death|0|||
19506869|NCT02222922|41908222|FG001|Overall Study|Death|0|||
19506870|NCT02222922|41908223|FG002|Overall Study|Death|0|||
19506871|NCT02222922|41908224|FG003|Overall Study|Death|0|||
19506872|NCT02222922|41908225|FG004|Overall Study|Death|13|||
19506873|NCT02222922|41908226|FG005|Overall Study|Death|0|||
19506874|NCT02222922|41908227|FG006|Overall Study|Death|0|||
19506875|NCT02222922|41908228|FG007|Overall Study|Death|0|||
19506876|NCT02222922|41908229|FG008|Overall Study|Death|2|||
19506877|NCT02222922|41908221|FG000|Overall Study|Lost to Follow-up|0|||
19506878|NCT02222922|41908222|FG001|Overall Study|Lost to Follow-up|0|||
19506879|NCT02222922|41908223|FG002|Overall Study|Lost to Follow-up|1|||
19506880|NCT02222922|41908224|FG003|Overall Study|Lost to Follow-up|0|||
19506881|NCT02222922|41908225|FG004|Overall Study|Lost to Follow-up|9|||
19506882|NCT02222922|41908226|FG005|Overall Study|Lost to Follow-up|1|||
19506883|NCT02222922|41908227|FG006|Overall Study|Lost to Follow-up|0|||
19506884|NCT02222922|41908228|FG007|Overall Study|Lost to Follow-up|0|||
19506885|NCT02222922|41908229|FG008|Overall Study|Lost to Follow-up|0|||
19506886|NCT02222922|41908221|FG000|Overall Study|Other|0|||
19506887|NCT02222922|41908222|FG001|Overall Study|Other|0|||
19506888|NCT02222922|41908223|FG002|Overall Study|Other|0|||
19506889|NCT02222922|41908224|FG003|Overall Study|Other|2|||
19506890|NCT02222922|41908225|FG004|Overall Study|Other|10|||
19506891|NCT02222922|41908226|FG005|Overall Study|Other|2|||
19506892|NCT02222922|41908227|FG006|Overall Study|Other|2|||
19615478|NCT00741819|42064828|FG000|Overall Study|Death|1|||
19615479|NCT00741819|42064828|FG000|Overall Study|Disease progression|1|||
19704516|NCT00149214|42148902|FG000|Overall Study|Sponsor Decision|0|||
19506893|NCT02222922|41908228|FG007|Overall Study|Other|4|||
19506894|NCT02222922|41908229|FG008|Overall Study|Other|1|||
19506895|NCT02222922|41908221|FG000|Overall Study|Participant refused further follow-up|1|||
19506896|NCT02222922|41908222|FG001|Overall Study|Participant refused further follow-up|0|||
19506897|NCT02222922|41908223|FG002|Overall Study|Participant refused further follow-up|0|||
19506898|NCT02222922|41908224|FG003|Overall Study|Participant refused further follow-up|1|||
19506899|NCT02222922|41908225|FG004|Overall Study|Participant refused further follow-up|6|||
19615480|NCT00924443|42064834|FG000|Overall Study|Physician Decision|2|||
19615481|NCT00924443|42064834|FG000|Overall Study|Protocol Violation|1|||
19506900|NCT02222922|41908226|FG005|Overall Study|Participant refused further follow-up|0|||
19506901|NCT02222922|41908227|FG006|Overall Study|Participant refused further follow-up|0|||
19506902|NCT02222922|41908228|FG007|Overall Study|Participant refused further follow-up|0|||
19506903|NCT02222922|41908229|FG008|Overall Study|Participant refused further follow-up|3|||
19506904|NCT02161146|41908281|FG000|Overall Study|Adverse Event|1|||
19506905|NCT02161146|41908282|FG001|Overall Study|Adverse Event|1|||
19506906|NCT02161146|41908283|FG002|Overall Study|Adverse Event|0|||
19506907|NCT02161146|41908284|FG003|Overall Study|Adverse Event|1|||
19615482|NCT00924287|42064838|FG000|Overall Study|Death|1|||
19615483|NCT00923975|42064842|FG000|Overall Study|Did not meet inclusion criteria|1|||
19615484|NCT00918203|42064878|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
19615485|NCT00918203|42064879|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
19615486|NCT00918203|42064880|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
19615487|NCT00918203|42064878|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
19506908|NCT02161146|41908285|FG004|Overall Study|Adverse Event|0|||
19506909|NCT02161146|41908281|FG000|Overall Study|Lost to Follow-up|0|||
19506910|NCT02161146|41908282|FG001|Overall Study|Lost to Follow-up|1|||
19506911|NCT02161146|41908283|FG002|Overall Study|Lost to Follow-up|0|||
19506912|NCT02161146|41908284|FG003|Overall Study|Lost to Follow-up|0|||
19506913|NCT02161146|41908285|FG004|Overall Study|Lost to Follow-up|0|||
19615488|NCT00918203|42064879|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
19615489|NCT00918203|42064880|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
19615490|NCT00918203|42064878|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
19615491|NCT00918203|42064879|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
19615492|NCT00918203|42064880|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
19615493|NCT00918203|42064878|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
19615494|NCT00918203|42064879|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
19615495|NCT00918203|42064880|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
19615496|NCT00918281|42064892|FG000|Overall Study|Physician Decision|29|||
19615497|NCT02770716|42064901|FG000|Overall Study|Death|101|||
19615498|NCT02770716|42064902|FG001|Overall Study|Death|45|||
19615499|NCT02770716|42064901|FG000|Overall Study|Withdrawal by Subject|4|||
19615500|NCT02770716|42064902|FG001|Overall Study|Withdrawal by Subject|2|||
19615501|NCT02770716|42064901|FG000|Overall Study|Lost to Follow-up|1|||
19615502|NCT02770716|42064902|FG001|Overall Study|Lost to Follow-up|0|||
19615503|NCT02770716|42064901|FG000|Overall Study|Various reasons|6|||
19615504|NCT02770716|42064902|FG001|Overall Study|Various reasons|2|||
19615505|NCT00917579|42064908|FG000|Washout >= 2 Weeks|Adverse Event|1|||
19615506|NCT00917579|42064909|FG001|Washout >= 2 Weeks|Adverse Event|0|||
19615507|NCT00917579|42064908|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
19615508|NCT00917579|42064909|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
19615509|NCT00915551|42064917|FG000|Overall Study|Withdrawal by Subject|0|||
19615510|NCT00915551|42064918|FG001|Overall Study|Withdrawal by Subject|1|||
19615511|NCT00915473|42064926|FG000|Screening|Withdrawal by Subject|1|||
19615512|NCT00915473|42064927|FG001|Screening|Withdrawal by Subject|0|||
19615513|NCT00915473|42064926|FG000|4-week Follow Up|Lost to Follow-up|1|||
19615514|NCT00915473|42064927|FG001|4-week Follow Up|Lost to Follow-up|5|||
19615515|NCT00917501|42064935|FG000|Overall Study|Lost to Follow-up|4|||
19704517|NCT00149214|42148903|FG001|Overall Study|Sponsor Decision|1|||
19506914|NCT02161146|41908281|FG000|Overall Study|Personal Reasons|0|||
19506915|NCT02161146|41908282|FG001|Overall Study|Personal Reasons|1|||
19506916|NCT02161146|41908283|FG002|Overall Study|Personal Reasons|0|||
19506917|NCT02161146|41908284|FG003|Overall Study|Personal Reasons|2|||
19506918|NCT02161146|41908285|FG004|Overall Study|Personal Reasons|1|||
19506919|NCT02161146|41908281|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19506920|NCT02161146|41908282|FG001|Overall Study|Other Miscellaneous Reasons|1|||
19506921|NCT02161146|41908283|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19506922|NCT02161146|41908284|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19506923|NCT02161146|41908285|FG004|Overall Study|Other Miscellaneous Reasons|0|||
19506924|NCT02222688|41908516|FG000|Overall Study|Withdrawal by Subject|0|||
19506925|NCT02222688|41908517|FG001|Overall Study|Withdrawal by Subject|0|||
19506926|NCT02222688|41908518|FG002|Overall Study|Withdrawal by Subject|0|||
19506927|NCT02222688|41908519|FG003|Overall Study|Withdrawal by Subject|2|||
19506928|NCT02222688|41908520|FG004|Overall Study|Withdrawal by Subject|1|||
19506929|NCT02222688|41908521|FG005|Overall Study|Withdrawal by Subject|0|||
19615516|NCT00917501|42064936|FG001|Overall Study|Lost to Follow-up|1|||
19615517|NCT00917501|42064935|FG000|Overall Study|Withdrawal by Subject|3|||
19615518|NCT00917501|42064936|FG001|Overall Study|Withdrawal by Subject|1|||
19615519|NCT00917501|42064935|FG000|Overall Study|Lack of Efficacy|1|||
19615520|NCT00917501|42064936|FG001|Overall Study|Lack of Efficacy|2|||
19506930|NCT02222688|41908522|FG006|Overall Study|Withdrawal by Subject|1|||
19506931|NCT02222688|41908516|FG000|Overall Study|Disease progression|1|||
19506932|NCT02222688|41908517|FG001|Overall Study|Disease progression|0|||
19506933|NCT02222688|41908518|FG002|Overall Study|Disease progression|0|||
19506934|NCT02222688|41908519|FG003|Overall Study|Disease progression|0|||
19506935|NCT02222688|41908520|FG004|Overall Study|Disease progression|0|||
19506936|NCT02222688|41908521|FG005|Overall Study|Disease progression|0|||
19506937|NCT02222688|41908522|FG006|Overall Study|Disease progression|0|||
19506938|NCT02159352|41908574|FG000|Overall Study|Adverse Event|3|||
19506939|NCT02159352|41908575|FG001|Overall Study|Adverse Event|1|||
19506940|NCT02159352|41908574|FG000|Overall Study|Withdrawal by Subject|0|||
19506941|NCT02159352|41908575|FG001|Overall Study|Withdrawal by Subject|1|||
19506942|NCT02187744|41908612|FG000|Study|Participant refused further follow-up|1|||
19506943|NCT02187744|41908613|FG001|Study|Participant refused further follow-up|0|||
19506944|NCT02187744|41908612|FG000|Study|Other|2|||
19506945|NCT02187744|41908613|FG001|Study|Other|1|||
19506946|NCT02187744|41908612|FG000|Study|Lost to Follow-up|0|||
19506947|NCT02187744|41908613|FG001|Study|Lost to Follow-up|2|||
19506948|NCT02187744|41908612|FG000|Study|Related adverse event, not serious|0|||
19506949|NCT02187744|41908613|FG001|Study|Related adverse event, not serious|2|||
19506950|NCT02187744|41908612|FG000|Study|Death|1|||
19506951|NCT02187744|41908613|FG001|Study|Death|0|||
19506952|NCT02187744|41908612|FG000|Study|Related adverse event, serious non-fatal|0|||
19506953|NCT02187744|41908613|FG001|Study|Related adverse event, serious non-fatal|1|||
19506954|NCT02187744|41908612|FG000|Treatment|Death|1|||
19506955|NCT02187744|41908613|FG001|Treatment|Death|0|||
19506956|NCT02187744|41908612|FG000|Treatment|Related adverse event, serious non-fatal|0|||
19506957|NCT02187744|41908613|FG001|Treatment|Related adverse event, serious non-fatal|1|||
19506958|NCT02187744|41908612|FG000|Treatment|Related adverse event, not serious|0|||
19506959|NCT02187744|41908613|FG001|Treatment|Related adverse event, not serious|2|||
19506960|NCT02187744|41908612|FG000|Treatment|Lost to Follow-up|0|||
19506961|NCT02187744|41908613|FG001|Treatment|Lost to Follow-up|1|||
19506962|NCT02187744|41908612|FG000|Treatment|Other|2|||
19506963|NCT02187744|41908613|FG001|Treatment|Other|0|||
19506964|NCT02187744|41908612|FG000|Treatment|Participant refused continued treatment|1|||
19506965|NCT02187744|41908613|FG001|Treatment|Participant refused continued treatment|1|||
19615521|NCT00917501|42064935|FG000|Overall Study|trouble swollowing capsules|0|||
19615522|NCT00917501|42064936|FG001|Overall Study|trouble swollowing capsules|1|||
19615523|NCT00917267|42064955|FG000|Overall Study|Adverse Event|15|||
19615524|NCT00917267|42064956|FG001|Overall Study|Adverse Event|36|||
19615525|NCT00917267|42064955|FG000|Overall Study|Physician Decision|2|||
19615526|NCT00917267|42064956|FG001|Overall Study|Physician Decision|4|||
19615527|NCT00917267|42064955|FG000|Overall Study|Protocol Violation|9|||
19615528|NCT00917267|42064956|FG001|Overall Study|Protocol Violation|18|||
19615529|NCT00917267|42064955|FG000|Overall Study|Withdrawal by Subject|5|||
19615530|NCT00917267|42064956|FG001|Overall Study|Withdrawal by Subject|12|||
19615531|NCT00917267|42064955|FG000|Overall Study|Lost to follow up|0|||
19615532|NCT00917267|42064956|FG001|Overall Study|Lost to follow up|2|||
19615533|NCT00917267|42064955|FG000|Overall Study|Entry Criteria Not Met|1|||
19615534|NCT00917267|42064956|FG001|Overall Study|Entry Criteria Not Met|0|||
19615535|NCT00917267|42064955|FG000|Overall Study|Sponsor Decision|5|||
19615536|NCT00917267|42064956|FG001|Overall Study|Sponsor Decision|5|||
19615537|NCT00917267|42064955|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
19615538|NCT00917267|42064956|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
19615539|NCT00920699|42064969|FG000|Overall Study|Withdrawal by Subject|2|||
19615540|NCT00920699|42064970|FG001|Overall Study|Withdrawal by Subject|0|||
19615541|NCT00920699|42064971|FG002|Overall Study|Withdrawal by Subject|2|||
19615542|NCT00920699|42064969|FG000|Overall Study|no longer met eligibility|0|||
19615543|NCT00920699|42064970|FG001|Overall Study|no longer met eligibility|1|||
19615544|NCT00920699|42064971|FG002|Overall Study|no longer met eligibility|0|||
19615545|NCT00920699|42064969|FG000|Overall Study|Lost to Follow-up|0|||
19615546|NCT00920699|42064970|FG001|Overall Study|Lost to Follow-up|0|||
19615547|NCT00920699|42064971|FG002|Overall Study|Lost to Follow-up|2|||
19615548|NCT00920387|42064981|FG000|Stage 1|Adverse Event|1|||
19615549|NCT00920387|42064982|FG001|Stage 1|Adverse Event|0|||
19615550|NCT00920387|42064983|FG002|Stage 1|Adverse Event|0|||
19615551|NCT03462576|42064993|FG000|Overall Study|Protocol Violation|5|||
19615552|NCT03462576|42064994|FG001|Overall Study|Protocol Violation|11|||
19615553|NCT03462576|42064995|FG002|Overall Study|Protocol Violation|7|||
19506966|NCT02187042|41908775|FG000|Overall Study|Death|1|||
19506967|NCT02187042|41908776|FG001|Overall Study|Death|1|||
19506968|NCT02187042|41908775|FG000|Overall Study|Toxicity|6|||
19506969|NCT02187042|41908776|FG001|Overall Study|Toxicity|5|||
19506970|NCT02187042|41908775|FG000|Overall Study|Participant choice|1|||
19506971|NCT02187042|41908776|FG001|Overall Study|Participant choice|0|||
19506972|NCT02187042|41908775|FG000|Overall Study|Doctor choice|1|||
19506973|NCT02187042|41908776|FG001|Overall Study|Doctor choice|0|||
19506974|NCT02187042|41908775|FG000|Overall Study|Progressive disease|4|||
19506975|NCT02187042|41908776|FG001|Overall Study|Progressive disease|8|||
19506976|NCT02186652|41908785|FG000|Overall Study|Lost to Follow-up|2|||
19615554|NCT03462576|42064993|FG000|Overall Study|Device Malfunction|0|||
19615555|NCT03462576|42064994|FG001|Overall Study|Device Malfunction|0|||
19615556|NCT03462576|42064995|FG002|Overall Study|Device Malfunction|1|||
19506977|NCT02186652|41908786|FG001|Overall Study|Lost to Follow-up|0|||
19506978|NCT02185794|41908822|FG000|Overall Study|Enrolled but Never Dosed|1|||
19506979|NCT02185794|41908823|FG001|Overall Study|Enrolled but Never Dosed|6|||
19506980|NCT02185794|41908824|FG002|Overall Study|Enrolled but Never Dosed|3|||
19506981|NCT02185794|41908825|FG003|Overall Study|Enrolled but Never Dosed|1|||
19506982|NCT02185794|41908826|FG004|Overall Study|Enrolled but Never Dosed|1|||
19506983|NCT02185794|41908827|FG005|Overall Study|Enrolled but Never Dosed|0|||
19506984|NCT02185794|41908822|FG000|Overall Study|Investigator's Discretion|1|||
19506985|NCT02185794|41908823|FG001|Overall Study|Investigator's Discretion|0|||
19506986|NCT02185794|41908824|FG002|Overall Study|Investigator's Discretion|1|||
19506987|NCT02185794|41908825|FG003|Overall Study|Investigator's Discretion|2|||
19506988|NCT02185794|41908826|FG004|Overall Study|Investigator's Discretion|2|||
19506989|NCT02185794|41908827|FG005|Overall Study|Investigator's Discretion|15|||
19506990|NCT02185794|41908822|FG000|Overall Study|Withdrew Consent|2|||
19506991|NCT02185794|41908823|FG001|Overall Study|Withdrew Consent|5|||
19506992|NCT02185794|41908824|FG002|Overall Study|Withdrew Consent|10|||
19506993|NCT02185794|41908825|FG003|Overall Study|Withdrew Consent|2|||
19506994|NCT02185794|41908826|FG004|Overall Study|Withdrew Consent|0|||
19506995|NCT02185794|41908827|FG005|Overall Study|Withdrew Consent|0|||
19615557|NCT00916721|42065005|FG000|Overall Study|Lost to Follow-up|0|||
19615558|NCT00916721|42065006|FG001|Overall Study|Lost to Follow-up|1|||
19615559|NCT00916721|42065005|FG000|Overall Study|Adverse Event|6|||
19615560|NCT00916721|42065006|FG001|Overall Study|Adverse Event|3|||
19615561|NCT00916721|42065005|FG000|Overall Study|Withdrawal by Subject|2|||
19615562|NCT00916721|42065006|FG001|Overall Study|Withdrawal by Subject|2|||
19615563|NCT00916721|42065005|FG000|Overall Study|Protocol Violation|2|||
19615564|NCT00916721|42065006|FG001|Overall Study|Protocol Violation|4|||
19615565|NCT00915005|42065014|FG000|Overall Study|Withdrawal by Subject|4|||
19615566|NCT00915005|42065015|FG001|Overall Study|Withdrawal by Subject|4|||
19615567|NCT00915005|42065014|FG000|Overall Study|Patient preferred protons therapy|6|||
19615568|NCT00915005|42065015|FG001|Overall Study|Patient preferred protons therapy|0|||
19615569|NCT00915005|42065014|FG000|Overall Study|Insurance denial|3|||
19615570|NCT00915005|42065015|FG001|Overall Study|Insurance denial|15|||
19615571|NCT01143246|42065023|FG000|Overall Study|Adverse Event|24|||
19615572|NCT01143246|42065024|FG001|Overall Study|Adverse Event|28|||
19615573|NCT01143246|42065023|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
19615574|NCT01143246|42065024|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
19615575|NCT01143246|42065023|FG000|Overall Study|Lost to Follow-up|0|||
19615576|NCT01143246|42065024|FG001|Overall Study|Lost to Follow-up|1|||
19615577|NCT01143246|42065023|FG000|Overall Study|Death|16|||
19615578|NCT01143246|42065024|FG001|Overall Study|Death|15|||
19615579|NCT01143246|42065023|FG000|Overall Study|Reason not Specified|3|||
19615580|NCT01143246|42065024|FG001|Overall Study|Reason not Specified|5|||
19506996|NCT02185794|41908822|FG000|Overall Study|Lost to Follow-up|1|||
19506997|NCT02185794|41908823|FG001|Overall Study|Lost to Follow-up|2|||
19506998|NCT02185794|41908824|FG002|Overall Study|Lost to Follow-up|2|||
19506999|NCT02185794|41908825|FG003|Overall Study|Lost to Follow-up|3|||
19507000|NCT02185794|41908826|FG004|Overall Study|Lost to Follow-up|0|||
19507001|NCT02185794|41908827|FG005|Overall Study|Lost to Follow-up|1|||
19507002|NCT02221674|41908858|FG000|Overall Study|Lost to Follow-up|1|||
19507003|NCT02221674|41908859|FG001|Overall Study|Lost to Follow-up|0|||
19507004|NCT02221674|41908860|FG002|Overall Study|Lost to Follow-up|0|||
19507005|NCT02221284|41908875|FG000|Overall Study|Case Report Forms Uncollected|56|||
19507006|NCT02221284|41908875|FG000|Overall Study|Protocol Deviation|5|||
19507007|NCT02220894|41909201|FG000|Overall Study|Adverse Event|118|||
19507008|NCT02220894|41909202|FG001|Overall Study|Adverse Event|70|||
19507009|NCT02220894|41909201|FG000|Overall Study|Death|252|||
19507010|NCT02220894|41909202|FG001|Overall Study|Death|368|||
19507011|NCT02220894|41909201|FG000|Overall Study|Lost to Follow-up|0|||
19615581|NCT00561925|42065038|FG000|14 Day Lead-In Period|Adverse Event|38|||
19507012|NCT02220894|41909202|FG001|Overall Study|Lost to Follow-up|2|||
19507013|NCT02220894|41909201|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19507014|NCT02220894|41909202|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19507015|NCT02220894|41909201|FG000|Overall Study|Withdrawal by Subject|2|||
19507016|NCT02220894|41909202|FG001|Overall Study|Withdrawal by Subject|13|||
19507017|NCT02220894|41909201|FG000|Overall Study|Ongoing in Study|265|||
19507018|NCT02220894|41909202|FG001|Overall Study|Ongoing in Study|183|||
19507019|NCT02219334|41909219|FG000|Overall Study|Withdrawal by Subject|1|||
19507020|NCT02219334|41909220|FG001|Overall Study|Withdrawal by Subject|0|||
19615582|NCT00561925|42065039|FG001|14 Day Lead-In Period|Adverse Event|0|||
19615583|NCT00561925|42065040|FG002|14 Day Lead-In Period|Adverse Event|0|||
19615584|NCT00561925|42065041|FG003|14 Day Lead-In Period|Adverse Event|0|||
19615585|NCT00561925|42065042|FG004|14 Day Lead-In Period|Adverse Event|0|||
19615586|NCT00561925|42065038|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
19615587|NCT00561925|42065039|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
19507021|NCT02219334|41909219|FG000|Overall Study|Protocol Violation|7|||
19507022|NCT02219334|41909220|FG001|Overall Study|Protocol Violation|3|||
19615588|NCT00561925|42065040|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
19507023|NCT02159040|41909238|FG000|Overall Study|Death|1|||
19507024|NCT02218008|41909263|FG000|Stage 1 (S1)|Adverse Event|6|||
19507025|NCT02218008|41909264|FG001|Stage 1 (S1)|Adverse Event|5|||
19507026|NCT02218008|41909265|FG002|Stage 1 (S1)|Adverse Event|11|||
19507027|NCT02218008|41909266|FG003|Stage 1 (S1)|Adverse Event|0|||
19507028|NCT02218008|41909267|FG004|Stage 1 (S1)|Adverse Event|0|||
19507029|NCT02218008|41909268|FG005|Stage 1 (S1)|Adverse Event|0|||
19507030|NCT02218008|41909263|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
19507031|NCT02218008|41909264|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
19507032|NCT02218008|41909265|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
19507033|NCT02218008|41909266|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
19507034|NCT02218008|41909267|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
19507035|NCT02218008|41909268|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
19507036|NCT02218008|41909263|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
19507037|NCT02218008|41909264|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
19507038|NCT02218008|41909265|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
19507039|NCT02218008|41909266|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
19507040|NCT02218008|41909267|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
19507041|NCT02218008|41909268|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
19507042|NCT02218008|41909263|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
19507043|NCT02218008|41909264|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
19507044|NCT02218008|41909265|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
19507045|NCT02218008|41909266|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
19507046|NCT02218008|41909267|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
19507047|NCT02218008|41909268|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
19507048|NCT02218008|41909263|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
19507049|NCT02218008|41909264|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
19507050|NCT02218008|41909265|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
19507051|NCT02218008|41909266|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
19507052|NCT02218008|41909267|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
19507053|NCT02218008|41909268|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
19507054|NCT02218008|41909263|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
19507055|NCT02218008|41909264|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
19507056|NCT02218008|41909265|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
19507057|NCT02218008|41909266|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
19507058|NCT02218008|41909267|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
19507059|NCT02218008|41909268|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
19507060|NCT02218008|41909263|FG000|Stage 1 (S1)|Pregnancy|0|||
19507061|NCT02218008|41909264|FG001|Stage 1 (S1)|Pregnancy|0|||
19507062|NCT02218008|41909265|FG002|Stage 1 (S1)|Pregnancy|1|||
19507063|NCT02218008|41909266|FG003|Stage 1 (S1)|Pregnancy|0|||
19507064|NCT02218008|41909267|FG004|Stage 1 (S1)|Pregnancy|0|||
19507065|NCT02218008|41909268|FG005|Stage 1 (S1)|Pregnancy|0|||
19507066|NCT02218008|41909263|FG000|Stage 1 (S1)|Protocol Violation|0|||
19507067|NCT02218008|41909264|FG001|Stage 1 (S1)|Protocol Violation|0|||
19507068|NCT02218008|41909265|FG002|Stage 1 (S1)|Protocol Violation|1|||
19507069|NCT02218008|41909266|FG003|Stage 1 (S1)|Protocol Violation|0|||
19507070|NCT02218008|41909267|FG004|Stage 1 (S1)|Protocol Violation|0|||
19507071|NCT02218008|41909268|FG005|Stage 1 (S1)|Protocol Violation|0|||
19507072|NCT02218008|41909263|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
19507073|NCT02218008|41909264|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
19507074|NCT02218008|41909265|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
19507075|NCT02218008|41909266|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
19507076|NCT02218008|41909267|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
19507077|NCT02218008|41909268|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
19507078|NCT02218008|41909263|FG000|Stage 2 (S2)|Adverse Event|0|||
19507079|NCT02218008|41909264|FG001|Stage 2 (S2)|Adverse Event|0|||
19507080|NCT02218008|41909265|FG002|Stage 2 (S2)|Adverse Event|0|||
19507081|NCT02218008|41909266|FG003|Stage 2 (S2)|Adverse Event|2|||
19507082|NCT02218008|41909267|FG004|Stage 2 (S2)|Adverse Event|3|||
19507083|NCT02218008|41909268|FG005|Stage 2 (S2)|Adverse Event|3|||
19507084|NCT02218008|41909263|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
19507085|NCT02218008|41909264|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
19507086|NCT02218008|41909265|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
19507087|NCT02218008|41909266|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
19507088|NCT02218008|41909267|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
19507089|NCT02218008|41909268|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
19507090|NCT02218008|41909263|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
19507091|NCT02218008|41909264|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
19507092|NCT02218008|41909265|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
19507093|NCT02218008|41909266|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
19507094|NCT02218008|41909267|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
19507095|NCT02218008|41909268|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
19507096|NCT02218008|41909263|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
19507097|NCT02218008|41909264|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
19507098|NCT02218008|41909265|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
19507099|NCT02218008|41909266|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
19507100|NCT02218008|41909267|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
19507101|NCT02218008|41909268|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
19507102|NCT02218008|41909263|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
19507103|NCT02218008|41909264|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
19507104|NCT02218008|41909265|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
19507105|NCT02218008|41909266|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
19507106|NCT02218008|41909267|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
19507107|NCT02218008|41909268|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
19507108|NCT01632150|41909365|FG000|Overall Study|Disease progression|27|||
19507109|NCT01632150|41909365|FG000|Overall Study|Study drug toxicity|1|||
19507110|NCT01632150|41909365|FG000|Overall Study|Unrelated adverse event|7|||
19507111|NCT01632150|41909365|FG000|Overall Study|Withdrawal by Subject|2|||
19507112|NCT01632150|41909365|FG000|Overall Study|Patient underwent autologous transplant|1|||
19507113|NCT01632150|41909365|FG000|Overall Study|Moved to compassionate program|2|||
19507114|NCT02185014|41909390|FG000|Overall Study|Adverse Event|18|||
19507115|NCT02185014|41909390|FG000|Overall Study|Withdrew Consent|8|||
19507116|NCT02185014|41909390|FG000|Overall Study|Lost to Follow-up|4|||
19507117|NCT02185014|41909390|FG000|Overall Study|Lack of Efficacy|14|||
19507118|NCT02185014|41909390|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
19507119|NCT02185014|41909390|FG000|Overall Study|Subject Noncompliance|1|||
19507120|NCT02185014|41909390|FG000|Overall Study|Other|4|||
19507121|NCT02184156|41909440|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
19507122|NCT02184156|41909441|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
19507123|NCT02184156|41909440|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
19507124|NCT02184156|41909441|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
19507125|NCT02158884|41909464|FG000|Baseline Assessment|Missed performance assessment|3|||
19507126|NCT02158884|41909464|FG000|Baseline Assessment|Missed SMFA|1|||
19507127|NCT02158884|41909464|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
19507128|NCT02158884|41909464|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
19507129|NCT02158884|41909464|FG000|6 Month Assessment|Missed SMFA|20|||
19507130|NCT02158884|41909464|FG000|12 Month Assessment|Missed SMFA|17|||
19507131|NCT02158806|41909507|FG000|Overall Study|Death|2|||
19507132|NCT02158806|41909508|FG001|Overall Study|Death|0|||
19507133|NCT02158806|41909507|FG000|Overall Study|Withdrawal by Subject|2|||
19507134|NCT02158806|41909508|FG001|Overall Study|Withdrawal by Subject|0|||
19507135|NCT02158806|41909507|FG000|Overall Study|Lost to Follow-up|0|||
19507136|NCT02158806|41909508|FG001|Overall Study|Lost to Follow-up|3|||
19507137|NCT02158806|41909507|FG000|Overall Study|Moved out of area|0|||
19507138|NCT02158806|41909508|FG001|Overall Study|Moved out of area|1|||
19507139|NCT02158806|41909507|FG000|Overall Study|Transferred to palliative care|0|||
19507140|NCT02158806|41909508|FG001|Overall Study|Transferred to palliative care|1|||
19507141|NCT02158728|41909539|FG000|Overall Study|no procedure according to CIP done|3|||
19507142|NCT02158728|41909539|FG000|Overall Study|no qualified dataset|24|||
19507143|NCT02157948|41909584|FG000|Overall Study|Withdrawal by Subject|4|||
19507144|NCT02157948|41909585|FG001|Overall Study|Withdrawal by Subject|5|||
19507145|NCT02157948|41909584|FG000|Overall Study|Lost to Follow-up|3|||
19615589|NCT00561925|42065041|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
19615590|NCT00561925|42065042|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
19615591|NCT00561925|42065038|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
19615592|NCT00561925|42065039|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
19615593|NCT00561925|42065040|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
19615594|NCT00561925|42065041|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
19615595|NCT00561925|42065042|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
19507146|NCT02157948|41909585|FG001|Overall Study|Lost to Follow-up|2|||
19507147|NCT02157948|41909584|FG000|Overall Study|Protocol Specified Criteria|2|||
19507148|NCT02157948|41909585|FG001|Overall Study|Protocol Specified Criteria|1|||
19507149|NCT02157948|41909584|FG000|Overall Study|Decision by Sponsor|0|||
19507150|NCT02157948|41909585|FG001|Overall Study|Decision by Sponsor|1|||
19507151|NCT02182830|41909626|FG000|Overall Study|Not Treated|1|||
19507152|NCT02182830|41909627|FG001|Overall Study|Not Treated|1|||
19507153|NCT02182830|41909626|FG000|Overall Study|Trial stopped, reason missing|3|||
19507154|NCT02182830|41909627|FG001|Overall Study|Trial stopped, reason missing|3|||
19507155|NCT02182830|41909626|FG000|Overall Study|Consent withdrawn|8|||
19507156|NCT02182830|41909627|FG001|Overall Study|Consent withdrawn|8|||
19507157|NCT02182830|41909626|FG000|Overall Study|Lost to Follow-up|3|||
19507158|NCT02182830|41909627|FG001|Overall Study|Lost to Follow-up|3|||
19507159|NCT02182440|41910210|FG000|Overall Study|Adverse Event|0|||
19507160|NCT02182440|41910211|FG001|Overall Study|Adverse Event|1|||
19507161|NCT02182440|41910212|FG002|Overall Study|Adverse Event|0|||
19507162|NCT02182440|41910213|FG003|Overall Study|Adverse Event|0|||
19507163|NCT02182440|41910210|FG000|Overall Study|Death|31|||
19507164|NCT02182440|41910211|FG001|Overall Study|Death|8|||
19507165|NCT02182440|41910212|FG002|Overall Study|Death|5|||
19615596|NCT00561925|42065038|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
19507166|NCT02182440|41910213|FG003|Overall Study|Death|16|||
19507167|NCT02182440|41910210|FG000|Overall Study|Protocol Violation|0|||
19507168|NCT02182440|41910211|FG001|Overall Study|Protocol Violation|1|||
19507169|NCT02182440|41910212|FG002|Overall Study|Protocol Violation|0|||
19507170|NCT02182440|41910213|FG003|Overall Study|Protocol Violation|0|||
19507171|NCT02182440|41910210|FG000|Overall Study|Physician Decision|1|||
19507172|NCT02182440|41910211|FG001|Overall Study|Physician Decision|0|||
19507173|NCT02182440|41910212|FG002|Overall Study|Physician Decision|0|||
19507174|NCT02182440|41910213|FG003|Overall Study|Physician Decision|0|||
19507175|NCT02182440|41910210|FG000|Overall Study|Withdrawal by Subject|1|||
19507176|NCT02182440|41910211|FG001|Overall Study|Withdrawal by Subject|1|||
19507177|NCT02182440|41910212|FG002|Overall Study|Withdrawal by Subject|3|||
19507178|NCT02182440|41910213|FG003|Overall Study|Withdrawal by Subject|4|||
19507179|NCT02182440|41910210|FG000|Overall Study|different, e.g adm other hospital|12|||
19507180|NCT02182440|41910211|FG001|Overall Study|different, e.g adm other hospital|3|||
19507181|NCT02182440|41910212|FG002|Overall Study|different, e.g adm other hospital|3|||
19507182|NCT02182440|41910213|FG003|Overall Study|different, e.g adm other hospital|10|||
19507183|NCT02181816|41910255|FG000|Overall Study|Case Report Forms Uncollected|38|||
19507184|NCT02181816|41910255|FG000|Overall Study|Protocol Deviation|21|||
19507185|NCT02156466|41910411|FG000|Overall Study|Adverse Event|0|||
19507186|NCT02156466|41910412|FG001|Overall Study|Adverse Event|0|||
19507187|NCT02156466|41910413|FG002|Overall Study|Adverse Event|1|||
19507188|NCT02156466|41910414|FG003|Overall Study|Adverse Event|1|||
19507189|NCT02156466|41910415|FG004|Overall Study|Adverse Event|0|||
19507190|NCT02156466|41910411|FG000|Overall Study|Quantiferon Positivity|0|||
19507191|NCT02156466|41910412|FG001|Overall Study|Quantiferon Positivity|0|||
19507192|NCT02156466|41910413|FG002|Overall Study|Quantiferon Positivity|0|||
19507193|NCT02156466|41910414|FG003|Overall Study|Quantiferon Positivity|1|||
19507194|NCT02156466|41910415|FG004|Overall Study|Quantiferon Positivity|0|||
19507195|NCT02216526|41910454|FG000|Overall Study|Adverse Event|1|||
19507196|NCT02216526|41910455|FG001|Overall Study|Adverse Event|1|||
19507197|NCT02216526|41910456|FG002|Overall Study|Adverse Event|0|||
19507198|NCT02216526|41910454|FG000|Overall Study|Death|0|||
19507199|NCT02216526|41910455|FG001|Overall Study|Death|1|||
19507200|NCT02216526|41910456|FG002|Overall Study|Death|3|||
19507201|NCT02216526|41910454|FG000|Overall Study|Protocol Violation|2|||
19507202|NCT02216526|41910455|FG001|Overall Study|Protocol Violation|0|||
19507203|NCT02216526|41910456|FG002|Overall Study|Protocol Violation|2|||
19507204|NCT02216526|41910454|FG000|Overall Study|Hospitalization|2|||
19507205|NCT02216526|41910455|FG001|Overall Study|Hospitalization|1|||
19507206|NCT02216526|41910456|FG002|Overall Study|Hospitalization|3|||
19507207|NCT02216214|41910496|FG000|Overall Study|Randomized Never Received Study Drug|1|||
19507208|NCT02216214|41910497|FG001|Overall Study|Randomized Never Received Study Drug|0|||
19507209|NCT02216214|41910496|FG000|Overall Study|Adverse Event|10|||
19507210|NCT02216214|41910497|FG001|Overall Study|Adverse Event|8|||
19507211|NCT02216214|41910496|FG000|Overall Study|Lack of Efficacy|2|||
19507212|NCT02216214|41910497|FG001|Overall Study|Lack of Efficacy|2|||
19507213|NCT02216214|41910496|FG000|Overall Study|Lost to Follow-up|3|||
19615597|NCT00561925|42065039|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
19615598|NCT00561925|42065040|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
19615599|NCT00561925|42065041|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
19615600|NCT00561925|42065042|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
19615601|NCT00561925|42065038|FG000|14 Day Lead-In Period|Other|5|||
19507214|NCT02216214|41910497|FG001|Overall Study|Lost to Follow-up|2|||
19507215|NCT02216214|41910496|FG000|Overall Study|Protocol Violation|4|||
19507216|NCT02216214|41910497|FG001|Overall Study|Protocol Violation|2|||
19507217|NCT02216214|41910496|FG000|Overall Study|Withdrawal by Subject|22|||
19507218|NCT02216214|41910497|FG001|Overall Study|Withdrawal by Subject|20|||
19507219|NCT02216214|41910496|FG000|Overall Study|Study Terminated By Sponsor|0|||
19507220|NCT02216214|41910497|FG001|Overall Study|Study Terminated By Sponsor|1|||
19507221|NCT02216214|41910496|FG000|Overall Study|Miscellaneous|1|||
19507222|NCT02216214|41910497|FG001|Overall Study|Miscellaneous|1|||
19507223|NCT02214186|41910528|FG000|Overall Study|Lost to Follow-up|1|||
19507224|NCT02214186|41910529|FG001|Overall Study|Lost to Follow-up|1|||
19507225|NCT02214186|41910528|FG000|Overall Study|Protocol Violation|1|||
19507226|NCT02214186|41910529|FG001|Overall Study|Protocol Violation|1|||
19507227|NCT02181504|41910585|FG000|Overall Study|Adverse Event|1|||
19507228|NCT02181504|41910586|FG001|Overall Study|Adverse Event|1|||
19507229|NCT02181504|41910587|FG002|Overall Study|Adverse Event|1|||
19507230|NCT02179398|41910617|FG000|Overall Study|Lack of obligatory data|3|||
19507231|NCT02179398|41910618|FG001|Overall Study|Lack of obligatory data|3|||
19507232|NCT02179398|41910617|FG000|Overall Study|Lost to Follow-up|0|||
19507233|NCT02179398|41910618|FG001|Overall Study|Lost to Follow-up|1|||
19507234|NCT02156076|41910632|FG000|Treatment Period|no longer meets study criteria|0|||
19507235|NCT02156076|41910633|FG001|Treatment Period|no longer meets study criteria|0|||
19507236|NCT02156076|41910634|FG002|Treatment Period|no longer meets study criteria|1|||
19507237|NCT02156076|41910635|FG003|Treatment Period|no longer meets study criteria|0|||
19507238|NCT02156076|41910632|FG000|Treatment Period|Poor/non-compliance|0|||
19507239|NCT02156076|41910633|FG001|Treatment Period|Poor/non-compliance|1|||
19507240|NCT02156076|41910634|FG002|Treatment Period|Poor/non-compliance|0|||
19507241|NCT02156076|41910635|FG003|Treatment Period|Poor/non-compliance|0|||
19507242|NCT02156076|41910632|FG000|Treatment Period|Lost to Follow-up|0|||
19507243|NCT02156076|41910633|FG001|Treatment Period|Lost to Follow-up|0|||
19507244|NCT02156076|41910634|FG002|Treatment Period|Lost to Follow-up|0|||
19615602|NCT00561925|42065039|FG001|14 Day Lead-In Period|Other|0|||
19615603|NCT00561925|42065040|FG002|14 Day Lead-In Period|Other|0|||
19615604|NCT00561925|42065041|FG003|14 Day Lead-In Period|Other|0|||
19615605|NCT00561925|42065042|FG004|14 Day Lead-In Period|Other|0|||
19615606|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
19615607|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
19615608|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
19615609|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
19615610|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
19615611|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
19615612|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
19615613|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
19704518|NCT00149214|42148902|FG000|Overall Study|Progressive Disease|7|||
19704519|NCT00149214|42148903|FG001|Overall Study|Progressive Disease|3|||
19704520|NCT00114972|42148920|FG000|Overall Study|Withdrawal by Subject|40|||
19704521|NCT00114972|42148921|FG001|Overall Study|Withdrawal by Subject|7|||
19704522|NCT00114972|42148920|FG000|Overall Study|Lost to Follow-up|8|||
19704523|NCT00114972|42148921|FG001|Overall Study|Lost to Follow-up|5|||
19704524|NCT00129402|42148929|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
19704525|NCT00129402|42148930|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
19704526|NCT00129402|42148931|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
19704527|NCT00129402|42148932|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
19704528|NCT00129402|42148933|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
19507245|NCT02156076|41910635|FG003|Treatment Period|Lost to Follow-up|1|||
19507246|NCT02156076|41910632|FG000|Treatment Period|Withdrawal by Subject|0|||
19615614|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
19615615|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
19615616|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
19615617|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
19615618|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
19615619|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
19615620|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
19615621|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
19615622|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
19615623|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
19615624|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
19615625|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
19615626|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
19615627|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
19615628|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
19615629|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
19615630|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
19615631|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
19615632|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
19615633|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
19615634|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
19615635|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
19615636|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Death|0|||
19507247|NCT02156076|41910633|FG001|Treatment Period|Withdrawal by Subject|0|||
19507248|NCT02156076|41910634|FG002|Treatment Period|Withdrawal by Subject|1|||
19507249|NCT02156076|41910635|FG003|Treatment Period|Withdrawal by Subject|0|||
19507250|NCT02156076|41910632|FG000|Treatment Period|Subject request to discontinue treatment|0|||
19507251|NCT02156076|41910633|FG001|Treatment Period|Subject request to discontinue treatment|1|||
19507252|NCT02156076|41910634|FG002|Treatment Period|Subject request to discontinue treatment|0|||
19507253|NCT02156076|41910635|FG003|Treatment Period|Subject request to discontinue treatment|0|||
19507254|NCT02156076|41910632|FG000|Treatment Period|Adverse Event|0|||
19507255|NCT02156076|41910633|FG001|Treatment Period|Adverse Event|0|||
19507256|NCT02156076|41910634|FG002|Treatment Period|Adverse Event|0|||
19507257|NCT02156076|41910635|FG003|Treatment Period|Adverse Event|1|||
19507258|NCT02156076|41910632|FG000|Follow-up Period|Withdrawal by Subject|1|||
19507259|NCT02156076|41910633|FG001|Follow-up Period|Withdrawal by Subject|0|||
19507260|NCT02156076|41910634|FG002|Follow-up Period|Withdrawal by Subject|0|||
19507261|NCT02156076|41910635|FG003|Follow-up Period|Withdrawal by Subject|0|||
19615637|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Death|6|||
19615638|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Death|3|||
19615639|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Death|0|||
19507262|NCT02213094|41910647|FG000|Overall Study|Adverse Event|1|||
19507263|NCT02213094|41910648|FG001|Overall Study|Adverse Event|0|||
19507264|NCT02155608|41910656|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
19507265|NCT02155608|41910657|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
19507266|NCT02155608|41910656|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
19507267|NCT02155608|41910657|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
19507268|NCT01629966|41910672|FG000|Overall Study|Pregnancy|0|||
19507269|NCT01629966|41910673|FG001|Overall Study|Pregnancy|1|||
19507270|NCT01629966|41910674|FG002|Overall Study|Pregnancy|0|||
19507271|NCT01629966|41910672|FG000|Overall Study|Lost to Follow-up|10|||
19507272|NCT01629966|41910673|FG001|Overall Study|Lost to Follow-up|13|||
19507273|NCT01629966|41910674|FG002|Overall Study|Lost to Follow-up|9|||
19507274|NCT01629966|41910672|FG000|Overall Study|Withdrawal by Subject|8|||
19507275|NCT01629966|41910673|FG001|Overall Study|Withdrawal by Subject|9|||
19507276|NCT01629966|41910674|FG002|Overall Study|Withdrawal by Subject|16|||
19507277|NCT01629966|41910672|FG000|Overall Study|Protocol Violation|7|||
19507278|NCT01629966|41910673|FG001|Overall Study|Protocol Violation|9|||
19507279|NCT01629966|41910674|FG002|Overall Study|Protocol Violation|7|||
19507280|NCT01629966|41910672|FG000|Overall Study|Lack of Efficacy|5|||
19507281|NCT01629966|41910673|FG001|Overall Study|Lack of Efficacy|2|||
19507282|NCT01629966|41910674|FG002|Overall Study|Lack of Efficacy|4|||
19507283|NCT01629966|41910672|FG000|Overall Study|Adverse Event|11|||
19507284|NCT01629966|41910673|FG001|Overall Study|Adverse Event|18|||
19507285|NCT01629966|41910674|FG002|Overall Study|Adverse Event|30|||
19507286|NCT02177838|41910714|FG000|Overall Study|Withdrawal by Subject|1|||
19507287|NCT02177838|41910714|FG000|Overall Study|Physician Decision|1|||
19507288|NCT02177838|41910714|FG000|Overall Study|Death|1|||
19507289|NCT02177136|41910811|FG000|DB Phase|Withdrawal by Subject|2|||
19507290|NCT02177136|41910812|FG001|DB Phase|Withdrawal by Subject|0|||
19507291|NCT02177136|41910813|FG002|DB Phase|Withdrawal by Subject|0|||
19507292|NCT02177136|41910814|FG003|DB Phase|Withdrawal by Subject|0|||
19507293|NCT02177136|41910811|FG000|DB Phase|Discontinued Due to Pruritus|1|||
19507294|NCT02177136|41910812|FG001|DB Phase|Discontinued Due to Pruritus|3|||
19507295|NCT02177136|41910813|FG002|DB Phase|Discontinued Due to Pruritus|0|||
19507296|NCT02177136|41910814|FG003|DB Phase|Discontinued Due to Pruritus|0|||
19507297|NCT02177136|41910811|FG000|DB Phase|Adverse Event|3|||
19507298|NCT02177136|41910812|FG001|DB Phase|Adverse Event|2|||
19507299|NCT02177136|41910813|FG002|DB Phase|Adverse Event|3|||
19507300|NCT02177136|41910814|FG003|DB Phase|Adverse Event|0|||
19507301|NCT02177136|41910811|FG000|DB Phase|Protocol Violation|0|||
19507302|NCT02177136|41910812|FG001|DB Phase|Protocol Violation|0|||
19507303|NCT02177136|41910813|FG002|DB Phase|Protocol Violation|1|||
19507304|NCT02177136|41910814|FG003|DB Phase|Protocol Violation|0|||
19507305|NCT02177136|41910811|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
19507306|NCT02177136|41910812|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
19507307|NCT02177136|41910813|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
19507308|NCT02177136|41910814|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
19507309|NCT02177136|41910811|FG000|LTSE Phase|Withdrawal by Subject|0|||
19507310|NCT02177136|41910812|FG001|LTSE Phase|Withdrawal by Subject|0|||
19507311|NCT02177136|41910813|FG002|LTSE Phase|Withdrawal by Subject|0|||
19507312|NCT02177136|41910814|FG003|LTSE Phase|Withdrawal by Subject|6|||
19507313|NCT02177136|41910811|FG000|LTSE Phase|Adverse Event|0|||
19507314|NCT02177136|41910812|FG001|LTSE Phase|Adverse Event|0|||
19507315|NCT02177136|41910813|FG002|LTSE Phase|Adverse Event|0|||
19507316|NCT02177136|41910814|FG003|LTSE Phase|Adverse Event|10|||
19507317|NCT02177136|41910811|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
19507318|NCT02177136|41910812|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
19507319|NCT02177136|41910813|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
19507320|NCT02177136|41910814|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
19507321|NCT02177136|41910811|FG000|LTSE Phase|Physician Decision|0|||
19507322|NCT02177136|41910812|FG001|LTSE Phase|Physician Decision|0|||
19507323|NCT02177136|41910813|FG002|LTSE Phase|Physician Decision|0|||
19507324|NCT02177136|41910814|FG003|LTSE Phase|Physician Decision|2|||
19507325|NCT02177136|41910811|FG000|LTSE Phase|Lost to Follow-up|0|||
19507326|NCT02177136|41910812|FG001|LTSE Phase|Lost to Follow-up|0|||
19507327|NCT02177136|41910813|FG002|LTSE Phase|Lost to Follow-up|0|||
19507328|NCT02177136|41910814|FG003|LTSE Phase|Lost to Follow-up|1|||
19507329|NCT02177136|41910811|FG000|LTSE Phase|Participant Moved|0|||
19507330|NCT02177136|41910812|FG001|LTSE Phase|Participant Moved|0|||
19507331|NCT02177136|41910813|FG002|LTSE Phase|Participant Moved|0|||
19507332|NCT02177136|41910814|FG003|LTSE Phase|Participant Moved|1|||
19507333|NCT02176356|41910842|FG000|Overall Study|Screen Failure|14|||
19704529|NCT00129402|42148934|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
19704530|NCT00129402|42148935|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
19507334|NCT02176356|41910842|FG000|Overall Study|Lost to Follow-up|4|||
19507335|NCT02176356|41910842|FG000|Overall Study|Personal Reasons|3|||
19507336|NCT02176356|41910842|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19507337|NCT02210208|41910852|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
19507338|NCT02210208|41910852|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
19507339|NCT02210208|41910852|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
19507340|NCT02209506|41910872|FG000|Overall Study|Withdrawal by Subject|0|||
19507341|NCT02209506|41910873|FG001|Overall Study|Withdrawal by Subject|0|||
19507342|NCT02209506|41910874|FG002|Overall Study|Withdrawal by Subject|0|||
19507343|NCT02209506|41910875|FG003|Overall Study|Withdrawal by Subject|0|||
19507344|NCT02209506|41910876|FG004|Overall Study|Withdrawal by Subject|1|||
19507345|NCT02153736|41910893|FG000|Overall Study|Lost to Follow-up|1|||
19507346|NCT02153736|41910894|FG001|Overall Study|Lost to Follow-up|0|||
19507347|NCT02153736|41910893|FG000|Overall Study|Medical status change made ineligible|1|||
19507348|NCT02153736|41910894|FG001|Overall Study|Medical status change made ineligible|0|||
19507349|NCT02153736|41910893|FG000|Overall Study|Death|0|||
19507350|NCT02153736|41910894|FG001|Overall Study|Death|1|||
19507351|NCT02153736|41910893|FG000|Overall Study|Withdrawal by Subject|0|||
19507352|NCT02153736|41910894|FG001|Overall Study|Withdrawal by Subject|1|||
19507353|NCT02175966|41910902|FG000|Follow-up Period|Lack of Efficacy|10|||
19507354|NCT02175966|41910903|FG001|Follow-up Period|Lack of Efficacy|6|||
19507355|NCT02153346|41910909|FG000|Overall Study|Lost to Follow-up|11|||
19507356|NCT01599234|41910916|FG000|Overall Study|Adverse Event|9|||
19507357|NCT01599234|41910917|FG001|Overall Study|Adverse Event|5|||
19507358|NCT01599234|41910916|FG000|Overall Study|Withdrawal by Subject|2|||
19507359|NCT01599234|41910917|FG001|Overall Study|Withdrawal by Subject|1|||
19507360|NCT01599234|41910916|FG000|Overall Study|Lost to Follow-up|1|||
19507361|NCT01599234|41910917|FG001|Overall Study|Lost to Follow-up|2|||
19507362|NCT01599234|41910916|FG000|Overall Study|Lack of Efficacy|2|||
19507363|NCT01599234|41910917|FG001|Overall Study|Lack of Efficacy|4|||
19507364|NCT01599234|41910916|FG000|Overall Study|Unable to operate spray|1|||
19507365|NCT01599234|41910917|FG001|Overall Study|Unable to operate spray|0|||
19507366|NCT01599234|41910916|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
19507367|NCT01599234|41910917|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
19507368|NCT01599234|41910916|FG000|Overall Study|Death|1|||
19507369|NCT01599234|41910917|FG001|Overall Study|Death|0|||
19507370|NCT01599234|41910916|FG000|Overall Study|Patient would not stop driving|1|||
19507371|NCT01599234|41910917|FG001|Overall Study|Patient would not stop driving|0|||
19507372|NCT01599234|41910916|FG000|Overall Study|Contra-indication discovered|0|||
19507373|NCT01599234|41910917|FG001|Overall Study|Contra-indication discovered|1|||
19507374|NCT01599234|41910916|FG000|Overall Study|Pregnancy|0|||
19507375|NCT01599234|41910917|FG001|Overall Study|Pregnancy|1|||
19507376|NCT02174562|41910925|FG000|Overall Study|Withdrawal by Subject|7|||
19507377|NCT02174562|41910926|FG001|Overall Study|Withdrawal by Subject|2|||
19507378|NCT02174562|41910925|FG000|Overall Study|Death|2|||
19507379|NCT02174562|41910926|FG001|Overall Study|Death|0|||
19507380|NCT02174562|41910925|FG000|Overall Study|Lost to Follow-up|0|||
19507381|NCT02174562|41910926|FG001|Overall Study|Lost to Follow-up|3|||
19507382|NCT02136576|41910935|FG000|Overall Study|Lost to Follow-up|2|||
19507383|NCT02136576|41910936|FG001|Overall Study|Lost to Follow-up|0|||
19507384|NCT02136576|41910937|FG002|Overall Study|Lost to Follow-up|0|||
19507385|NCT02153112|41911209|FG000|Overall Study|Adverse Event|0|||
19507386|NCT02153112|41911210|FG001|Overall Study|Adverse Event|0|||
19507387|NCT02153112|41911211|FG002|Overall Study|Adverse Event|1|||
19507388|NCT02153112|41911212|FG003|Overall Study|Adverse Event|0|||
19507389|NCT02153112|41911213|FG004|Overall Study|Adverse Event|0|||
19615640|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Death|0|||
19615641|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
19615642|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
19615643|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
19615644|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
19615645|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
19615646|NCT00561925|42065038|FG000|144-week Double-blind, Double-dummy|Other|0|||
19615647|NCT00561925|42065039|FG001|144-week Double-blind, Double-dummy|Other|8|||
19615648|NCT00561925|42065040|FG002|144-week Double-blind, Double-dummy|Other|11|||
19615649|NCT00561925|42065041|FG003|144-week Double-blind, Double-dummy|Other|0|||
19615650|NCT00561925|42065042|FG004|144-week Double-blind, Double-dummy|Other|0|||
19615651|NCT00561925|42065038|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
19615652|NCT00561925|42065039|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
19615653|NCT00561925|42065040|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
19615654|NCT00561925|42065041|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
19615655|NCT00561925|42065042|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
19615656|NCT00549445|42065062|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
19615657|NCT00549445|42065063|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
19615658|NCT00601107|42065073|FG000|Overall Study|Adverse Event|0|||
19615659|NCT00601107|42065074|FG001|Overall Study|Adverse Event|1|||
19615660|NCT00601107|42065075|FG002|Overall Study|Adverse Event|3|||
19507390|NCT02153112|41911214|FG005|Overall Study|Adverse Event|0|||
19507391|NCT02153112|41911215|FG006|Overall Study|Adverse Event|0|||
19507392|NCT02153112|41911216|FG007|Overall Study|Adverse Event|0|||
19507393|NCT02153112|41911217|FG008|Overall Study|Adverse Event|0|||
19615661|NCT00601107|42065076|FG003|Overall Study|Adverse Event|0|||
19615662|NCT00601107|42065073|FG000|Overall Study|Withdrawal by Subject|5|||
19615663|NCT00601107|42065074|FG001|Overall Study|Withdrawal by Subject|4|||
19615664|NCT00601107|42065075|FG002|Overall Study|Withdrawal by Subject|7|||
19615665|NCT00601107|42065076|FG003|Overall Study|Withdrawal by Subject|4|||
19615666|NCT00601107|42065073|FG000|Overall Study|Lost to Follow-up|3|||
19615667|NCT00601107|42065074|FG001|Overall Study|Lost to Follow-up|3|||
19615668|NCT00601107|42065075|FG002|Overall Study|Lost to Follow-up|0|||
19615669|NCT00601107|42065076|FG003|Overall Study|Lost to Follow-up|3|||
19615670|NCT00601107|42065073|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
19615671|NCT00601107|42065074|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
19615672|NCT00601107|42065075|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
19615673|NCT00601107|42065076|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
19615674|NCT00601107|42065073|FG000|Overall Study|Worsening of Psoriasis|4|||
19615675|NCT00601107|42065074|FG001|Overall Study|Worsening of Psoriasis|1|||
19615676|NCT00601107|42065075|FG002|Overall Study|Worsening of Psoriasis|1|||
19615677|NCT00601107|42065076|FG003|Overall Study|Worsening of Psoriasis|4|||
19615678|NCT00601107|42065073|FG000|Overall Study|Undefined|1|||
19615679|NCT00601107|42065074|FG001|Overall Study|Undefined|0|||
19615680|NCT00601107|42065075|FG002|Overall Study|Undefined|1|||
19615681|NCT00601107|42065076|FG003|Overall Study|Undefined|0|||
19615682|NCT00914927|42065102|FG000|Overall Study|Adverse Event|0|||
19615683|NCT00914927|42065103|FG001|Overall Study|Adverse Event|0|||
19615684|NCT00914927|42065104|FG002|Overall Study|Adverse Event|0|||
19615685|NCT00914927|42065105|FG003|Overall Study|Adverse Event|0|||
19615686|NCT00914927|42065106|FG004|Overall Study|Adverse Event|1|||
19615687|NCT00914927|42065107|FG005|Overall Study|Adverse Event|0|||
19615688|NCT00914927|42065108|FG006|Overall Study|Adverse Event|0|||
19615689|NCT00914927|42065102|FG000|Overall Study|Withdrawal by Subject|0|||
19615690|NCT00914927|42065103|FG001|Overall Study|Withdrawal by Subject|1|||
19615691|NCT00914927|42065104|FG002|Overall Study|Withdrawal by Subject|0|||
19615692|NCT00914927|42065105|FG003|Overall Study|Withdrawal by Subject|1|||
19615693|NCT00914927|42065106|FG004|Overall Study|Withdrawal by Subject|0|||
19615694|NCT00914927|42065107|FG005|Overall Study|Withdrawal by Subject|0|||
19615695|NCT00914927|42065108|FG006|Overall Study|Withdrawal by Subject|0|||
19507394|NCT02153112|41911218|FG009|Overall Study|Adverse Event|0|||
19507395|NCT02153112|41911209|FG000|Overall Study|Lost to Follow-up|1|||
19507396|NCT02153112|41911210|FG001|Overall Study|Lost to Follow-up|1|||
19507397|NCT02153112|41911211|FG002|Overall Study|Lost to Follow-up|0|||
19507398|NCT02153112|41911212|FG003|Overall Study|Lost to Follow-up|0|||
19507399|NCT02153112|41911213|FG004|Overall Study|Lost to Follow-up|2|||
19507400|NCT02153112|41911214|FG005|Overall Study|Lost to Follow-up|1|||
19507401|NCT02153112|41911215|FG006|Overall Study|Lost to Follow-up|1|||
19507402|NCT02153112|41911216|FG007|Overall Study|Lost to Follow-up|0|||
19507403|NCT02153112|41911217|FG008|Overall Study|Lost to Follow-up|1|||
19507404|NCT02153112|41911218|FG009|Overall Study|Lost to Follow-up|1|||
19507405|NCT02153112|41911209|FG000|Overall Study|Withdrawal by Subject|3|||
19507406|NCT02153112|41911210|FG001|Overall Study|Withdrawal by Subject|1|||
19507407|NCT02153112|41911211|FG002|Overall Study|Withdrawal by Subject|2|||
19507408|NCT02153112|41911212|FG003|Overall Study|Withdrawal by Subject|2|||
19507409|NCT02153112|41911213|FG004|Overall Study|Withdrawal by Subject|1|||
19507410|NCT02153112|41911214|FG005|Overall Study|Withdrawal by Subject|1|||
19507411|NCT02153112|41911215|FG006|Overall Study|Withdrawal by Subject|7|||
19507412|NCT02153112|41911216|FG007|Overall Study|Withdrawal by Subject|2|||
19507413|NCT02153112|41911217|FG008|Overall Study|Withdrawal by Subject|13|||
19507414|NCT02153112|41911218|FG009|Overall Study|Withdrawal by Subject|12|||
19507415|NCT02153112|41911209|FG000|Overall Study|Reason not Specified|0|||
19507416|NCT02153112|41911210|FG001|Overall Study|Reason not Specified|0|||
19507417|NCT02153112|41911211|FG002|Overall Study|Reason not Specified|0|||
19507418|NCT02153112|41911212|FG003|Overall Study|Reason not Specified|0|||
19507419|NCT02153112|41911213|FG004|Overall Study|Reason not Specified|0|||
19507420|NCT02153112|41911214|FG005|Overall Study|Reason not Specified|0|||
19507421|NCT02153112|41911215|FG006|Overall Study|Reason not Specified|0|||
19507422|NCT02153112|41911216|FG007|Overall Study|Reason not Specified|0|||
19507423|NCT02153112|41911217|FG008|Overall Study|Reason not Specified|1|||
19507424|NCT02153112|41911218|FG009|Overall Study|Reason not Specified|1|||
19507425|NCT02133924|41911268|FG000|Overall Study|Death|38|||
19507426|NCT02133924|41911268|FG000|Overall Study|Physician Decision|1|||
19615696|NCT00914927|42065102|FG000|Overall Study|Lost to Follow-up|0|||
19615697|NCT00914927|42065103|FG001|Overall Study|Lost to Follow-up|0|||
19615698|NCT00914927|42065104|FG002|Overall Study|Lost to Follow-up|0|||
19615699|NCT00914927|42065105|FG003|Overall Study|Lost to Follow-up|1|||
19615700|NCT00914927|42065106|FG004|Overall Study|Lost to Follow-up|0|||
19615701|NCT00914927|42065107|FG005|Overall Study|Lost to Follow-up|0|||
19507427|NCT02133924|41911268|FG000|Overall Study|Withdrawal by Subject|3|||
19507428|NCT02173704|41911359|FG000|Overall Study|Adverse Event|1|||
19507429|NCT02173704|41911360|FG001|Overall Study|Adverse Event|0|||
19507430|NCT02173704|41911359|FG000|Overall Study|Lost to Follow-up|1|||
19507431|NCT02173704|41911360|FG001|Overall Study|Lost to Follow-up|0|||
19507432|NCT02173704|41911359|FG000|Overall Study|Other|1|||
19507433|NCT02173704|41911360|FG001|Overall Study|Other|0|||
19507434|NCT02173704|41911359|FG000|Overall Study|Protocol Violation|1|||
19507435|NCT02173704|41911360|FG001|Overall Study|Protocol Violation|0|||
19507436|NCT02173704|41911359|FG000|Overall Study|Withdrawal by Subject|9|||
19507437|NCT02173704|41911360|FG001|Overall Study|Withdrawal by Subject|4|||
19704531|NCT00129402|42148929|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19704532|NCT00129402|42148930|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19704533|NCT00129402|42148931|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19704534|NCT00129402|42148932|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19704535|NCT00129402|42148933|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19704536|NCT00129402|42148934|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
19704537|NCT00129402|42148935|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
19507438|NCT02173548|41911381|FG000|Overall Study|Lost to Follow-up|0|||
19507439|NCT02173548|41911382|FG001|Overall Study|Lost to Follow-up|2|||
19507440|NCT02173548|41911381|FG000|Overall Study|Withdrawal by Subject|1|||
19507441|NCT02173548|41911382|FG001|Overall Study|Withdrawal by Subject|0|||
19507442|NCT02173158|41911398|FG000|Efficacy Phase|Adverse Event|1|||
19507443|NCT02152566|41911420|FG000|Overall Study|Lost to Follow-up|1|||
19507444|NCT02152566|41911420|FG000|Overall Study|Withdrawal by Subject|2|||
19507445|NCT02171130|41911449|FG000|Overall Study|Death|1|||
19507446|NCT02171130|41911449|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
19507447|NCT02171130|41911449|FG000|Overall Study|Discontinued; Site Termination|5|||
19507448|NCT02171130|41911449|FG000|Overall Study|Withdrawal by Subject|3|||
19507449|NCT02171130|41911449|FG000|Overall Study|Physician Decision|1|||
19507450|NCT02171130|41911449|FG000|Overall Study|Lost to Follow-up|1|||
19507451|NCT02171130|41911449|FG000|Overall Study|Met Exclusion Criteria|1|||
19507452|NCT03603314|41917569|FG000|Overall Study|Lost to Follow-up|0|||
19507453|NCT03603314|41917570|FG001|Overall Study|Lost to Follow-up|3|||
19507454|NCT03603314|41917571|FG002|Overall Study|Lost to Follow-up|0|||
19507455|NCT03603314|41917569|FG000|Overall Study|Protocol Violation|0|||
19507456|NCT03603314|41917570|FG001|Overall Study|Protocol Violation|1|||
19507457|NCT03603314|41917571|FG002|Overall Study|Protocol Violation|0|||
19507458|NCT03603314|41917569|FG000|Overall Study|Adverse Event|2|||
19507459|NCT03603314|41917570|FG001|Overall Study|Adverse Event|0|||
19507460|NCT03603314|41917571|FG002|Overall Study|Adverse Event|0|||
19507461|NCT03603314|41917569|FG000|Overall Study|Physician Decision|1|||
19507462|NCT03603314|41917570|FG001|Overall Study|Physician Decision|1|||
19507463|NCT03603314|41917571|FG002|Overall Study|Physician Decision|0|||
19507464|NCT03603314|41917569|FG000|Overall Study|Withdrawal by Subject|4|||
19507465|NCT03603314|41917570|FG001|Overall Study|Withdrawal by Subject|5|||
19507466|NCT03603314|41917571|FG002|Overall Study|Withdrawal by Subject|3|||
19507467|NCT03603314|41917569|FG000|Overall Study|Other|0|||
19507468|NCT03603314|41917570|FG001|Overall Study|Other|1|||
19507469|NCT03603314|41917571|FG002|Overall Study|Other|0|||
19507470|NCT04302350|41917586|FG000|Overall Study|Physician Decision|1|||
19507471|NCT04302350|41917587|FG001|Overall Study|Physician Decision|1|||
19507472|NCT04302350|41917588|FG002|Overall Study|Physician Decision|2|||
19507473|NCT04302350|41917586|FG000|Overall Study|Lack of Efficacy|1|||
19507474|NCT04302350|41917587|FG001|Overall Study|Lack of Efficacy|1|||
19507475|NCT04302350|41917588|FG002|Overall Study|Lack of Efficacy|4|||
19507476|NCT04302350|41917586|FG000|Overall Study|Adverse Event|0|||
19507477|NCT04302350|41917587|FG001|Overall Study|Adverse Event|1|||
19507478|NCT04302350|41917588|FG002|Overall Study|Adverse Event|2|||
19507479|NCT02335424|41917619|FG000|Overall Study|Withdrawal by Subject|19|||
19507480|NCT02335424|41917619|FG000|Overall Study|Adverse Event|25|||
19507481|NCT02335424|41917619|FG000|Overall Study|Death|273|||
19507482|NCT02335424|41917619|FG000|Overall Study|Lost to Follow-up|3|||
19507483|NCT02335424|41917619|FG000|Overall Study|Physician Decision|13|||
19507484|NCT02335424|41917619|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
19507485|NCT02335424|41917619|FG000|Overall Study|Protocol Violation|1|||
19507486|NCT02335424|41917619|FG000|Overall Study|Screen failure|1|||
19507487|NCT03805412|41917626|FG000|Overall Study|Lost to Follow-up|0|||
19507488|NCT03805412|41917627|FG001|Overall Study|Lost to Follow-up|1|||
19507489|NCT04791319|41917647|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
19507490|NCT04791319|41917648|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
19507491|NCT04791319|41917649|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
19507492|NCT04791319|41917650|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
19615702|NCT00914927|42065108|FG006|Overall Study|Lost to Follow-up|0|||
19507493|NCT04791319|41917651|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507494|NCT04791319|41917652|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507495|NCT04791319|41917653|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507496|NCT04791319|41917654|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507497|NCT04791319|41917655|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507498|NCT04791319|41917656|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507499|NCT04791319|41917657|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
19507500|NCT04791319|41917647|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
19507501|NCT04791319|41917648|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507502|NCT04791319|41917649|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
19507503|NCT04791319|41917650|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
19507504|NCT04791319|41917651|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507505|NCT04791319|41917652|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507506|NCT04791319|41917653|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507507|NCT04791319|41917654|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507508|NCT04791319|41917655|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507509|NCT04791319|41917656|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507510|NCT04791319|41917657|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
19507511|NCT04791319|41917647|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
19507512|NCT04791319|41917648|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
19507513|NCT04791319|41917649|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
19507514|NCT04791319|41917650|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
19507515|NCT04791319|41917651|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507516|NCT04791319|41917652|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507517|NCT04791319|41917653|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507518|NCT04791319|41917654|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507519|NCT04791319|41917655|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507520|NCT04791319|41917656|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507521|NCT04791319|41917657|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
19507522|NCT04791319|41917647|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
19507523|NCT04791319|41917648|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
19507524|NCT04791319|41917649|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
19507525|NCT04791319|41917650|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
19507526|NCT04791319|41917651|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507527|NCT04791319|41917652|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507528|NCT04791319|41917653|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507529|NCT04791319|41917654|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507530|NCT04791319|41917655|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507531|NCT04791319|41917656|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507532|NCT04791319|41917657|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
19507533|NCT04791319|41917647|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507534|NCT04791319|41917648|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507535|NCT04791319|41917649|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507536|NCT04791319|41917650|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
19507537|NCT04791319|41917651|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507538|NCT04791319|41917652|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507539|NCT04791319|41917653|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507540|NCT04791319|41917654|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507541|NCT04791319|41917655|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19615703|NCT00914927|42065102|FG000|Overall Study|Administrative/Other|2|||
19615704|NCT00914927|42065103|FG001|Overall Study|Administrative/Other|1|||
19615705|NCT00914927|42065104|FG002|Overall Study|Administrative/Other|0|||
19615706|NCT00914927|42065105|FG003|Overall Study|Administrative/Other|0|||
19615707|NCT00914927|42065106|FG004|Overall Study|Administrative/Other|1|||
19615708|NCT00914927|42065107|FG005|Overall Study|Administrative/Other|0|||
19615709|NCT00914927|42065108|FG006|Overall Study|Administrative/Other|0|||
19615710|NCT00914849|42065135|FG000|Overall Study|Withdrawal by Subject|1|||
19615711|NCT00914849|42065136|FG001|Overall Study|Withdrawal by Subject|0|||
19615712|NCT00914849|42065135|FG000|Overall Study|Not eligible|0|||
19615713|NCT00914849|42065136|FG001|Overall Study|Not eligible|1|||
19615714|NCT00912743|42065144|FG000|Overall Study|Adverse Event|3|||
19615715|NCT00912743|42065145|FG001|Overall Study|Adverse Event|1|||
19615716|NCT00912743|42065144|FG000|Overall Study|Lack of Efficacy|9|||
19615717|NCT00912743|42065145|FG001|Overall Study|Lack of Efficacy|18|||
19615718|NCT00912743|42065144|FG000|Overall Study|Toxicity|0|||
19615719|NCT00912743|42065145|FG001|Overall Study|Toxicity|1|||
19615720|NCT00912743|42065144|FG000|Overall Study|End of treatment form was not collected|1|||
19507542|NCT04791319|41917656|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19615721|NCT00912743|42065145|FG001|Overall Study|End of treatment form was not collected|0|||
19615722|NCT00914459|42065153|FG000|Overall Study|Protocol Violation|0|||
19615723|NCT00914459|42065154|FG001|Overall Study|Protocol Violation|1|||
19507543|NCT04791319|41917657|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
19507544|NCT04791319|41917647|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507545|NCT04791319|41917648|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507546|NCT04791319|41917649|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507547|NCT04791319|41917650|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507548|NCT04791319|41917651|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
19507549|NCT04791319|41917652|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
19507550|NCT04791319|41917653|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
19507551|NCT04791319|41917654|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507552|NCT04791319|41917655|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507553|NCT04791319|41917656|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
19507554|NCT04791319|41917657|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
19507555|NCT04791319|41917647|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507556|NCT04791319|41917648|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507557|NCT04791319|41917649|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507558|NCT04791319|41917650|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507559|NCT04791319|41917651|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507560|NCT04791319|41917652|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507561|NCT04791319|41917653|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507562|NCT04791319|41917654|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507563|NCT04791319|41917655|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19615724|NCT00914459|42065153|FG000|Overall Study|Parent/Legal guardian request|1|||
19615725|NCT00914459|42065154|FG001|Overall Study|Parent/Legal guardian request|0|||
19615726|NCT00912509|42065164|FG000|Overall Study|Lost to Follow-up|1|||
19615727|NCT00912509|42065165|FG001|Overall Study|Lost to Follow-up|0|||
19615728|NCT00912509|42065164|FG000|Overall Study|Lack of Efficacy|4|||
19615729|NCT00912509|42065165|FG001|Overall Study|Lack of Efficacy|3|||
19615730|NCT00913835|42065185|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
19615731|NCT00913835|42065186|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
19615732|NCT00913835|42065185|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
19615733|NCT00913835|42065186|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
19615734|NCT00913835|42065185|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
19615735|NCT00913835|42065186|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
19615736|NCT00913835|42065185|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
19615737|NCT00913835|42065186|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
19615738|NCT00913835|42065185|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
19615739|NCT00913835|42065186|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
19615740|NCT00913523|42065211|FG000|Overall Study|Withdrawal by Subject|3|||
19615741|NCT00913523|42065212|FG001|Overall Study|Withdrawal by Subject|2|||
19615742|NCT00913523|42065213|FG002|Overall Study|Withdrawal by Subject|2|||
19615743|NCT00913523|42065211|FG000|Overall Study|Lost to Follow-up|1|||
19615744|NCT00913523|42065212|FG001|Overall Study|Lost to Follow-up|1|||
19615745|NCT00913523|42065213|FG002|Overall Study|Lost to Follow-up|1|||
19615746|NCT00913523|42065211|FG000|Overall Study|Adverse Event|1|||
19615747|NCT00913523|42065212|FG001|Overall Study|Adverse Event|0|||
19615748|NCT00913523|42065213|FG002|Overall Study|Adverse Event|0|||
19615749|NCT00913523|42065211|FG000|Overall Study|Protocol Violation|5|||
19507564|NCT04791319|41917656|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
19507565|NCT04791319|41917657|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
19507566|NCT04791319|41917647|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
19507567|NCT04791319|41917648|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
19507568|NCT04791319|41917649|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
19507569|NCT04791319|41917650|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
19507570|NCT04791319|41917651|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
19507571|NCT04791319|41917652|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
19507572|NCT04791319|41917653|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
19507573|NCT04791319|41917654|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
19507574|NCT04791319|41917655|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
19615750|NCT00913523|42065212|FG001|Overall Study|Protocol Violation|8|||
19615751|NCT00913523|42065213|FG002|Overall Study|Protocol Violation|8|||
19615752|NCT00913523|42065211|FG000|Overall Study|Pregnancy|1|||
19615753|NCT00913523|42065212|FG001|Overall Study|Pregnancy|3|||
19615754|NCT00913523|42065213|FG002|Overall Study|Pregnancy|0|||
19615755|NCT00913523|42065211|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
19615756|NCT00913523|42065212|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
19615757|NCT00913523|42065213|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
19615758|NCT00912197|42065223|FG000|Overall Study|Withdrawal by Subject|3|||
19507575|NCT04791319|41917656|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
19507576|NCT04791319|41917657|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
19507577|NCT04791319|41917647|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
19507578|NCT04791319|41917648|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
19507579|NCT04791319|41917649|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
19507580|NCT04791319|41917650|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
19507581|NCT04791319|41917651|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
19507582|NCT04791319|41917652|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
19507583|NCT04791319|41917653|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
19507584|NCT04791319|41917654|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
19507585|NCT04791319|41917655|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
19507586|NCT04791319|41917656|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
19507587|NCT04791319|41917657|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
19507588|NCT03472495|41917714|FG000|Overall Study|Treatment no longer indicated|1|||
19507589|NCT03472495|41917715|FG001|Overall Study|Treatment no longer indicated|2|||
19507590|NCT03472495|41917714|FG000|Overall Study|Physician Decision|0|||
19507591|NCT03472495|41917715|FG001|Overall Study|Physician Decision|2|||
19507592|NCT03234907|41917723|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
19507593|NCT03234907|41917724|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
19507594|NCT03234907|41917725|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
19507595|NCT03234907|41917726|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
19507596|NCT03234907|41917727|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
19507597|NCT03234907|41917728|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
19507598|NCT03234907|41917723|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
19507599|NCT03234907|41917724|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
19507600|NCT03234907|41917725|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
19507601|NCT03234907|41917726|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
19507602|NCT03234907|41917727|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
19507603|NCT03234907|41917728|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
19507604|NCT03234907|41917723|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
19507605|NCT03234907|41917724|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
19507606|NCT03234907|41917725|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
19507607|NCT03234907|41917726|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
19507608|NCT03234907|41917727|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
19507609|NCT03234907|41917728|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
19507610|NCT03234907|41917723|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
19507611|NCT03234907|41917724|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
19507612|NCT03234907|41917725|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
19507613|NCT03234907|41917726|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
19507614|NCT03234907|41917727|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
19507615|NCT03234907|41917728|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
19615759|NCT00912197|42065224|FG001|Overall Study|Withdrawal by Subject|3|||
19615760|NCT00910247|42065232|FG000|Overall Study|Adverse Event|15|||
19615761|NCT00910247|42065232|FG000|Overall Study|Death|2|||
19615762|NCT00910247|42065232|FG000|Overall Study|Lost to Follow-up|10|||
19615763|NCT00910247|42065232|FG000|Overall Study|Physician Decision|3|||
19507616|NCT03234907|41917723|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
19507617|NCT03234907|41917724|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
19507618|NCT03234907|41917725|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
19507619|NCT03234907|41917726|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
19507620|NCT03234907|41917727|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
19507621|NCT03234907|41917728|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
19507622|NCT03234907|41917723|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
19507623|NCT03234907|41917724|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
19507624|NCT03234907|41917725|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
19507625|NCT03234907|41917726|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
19507626|NCT03234907|41917727|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
19507627|NCT03234907|41917728|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
19507628|NCT03234907|41917723|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
19507629|NCT03234907|41917724|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
19507630|NCT03234907|41917725|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
19507631|NCT03234907|41917726|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
19615764|NCT00910247|42065232|FG000|Overall Study|Protocol Violation|10|||
19615765|NCT00910247|42065232|FG000|Overall Study|Withdrawal by Subject|25|||
19507632|NCT03234907|41917727|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
19507633|NCT03234907|41917728|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
19507634|NCT03818581|41917742|FG000|Overall Study|Adverse Event|1|||
19507635|NCT03818581|41917743|FG001|Overall Study|Adverse Event|0|||
19507636|NCT03818581|41917744|FG002|Overall Study|Adverse Event|0|||
19507637|NCT03818581|41917745|FG003|Overall Study|Adverse Event|0|||
19507638|NCT03818581|41917746|FG004|Overall Study|Adverse Event|0|||
19507639|NCT03818581|41917742|FG000|Overall Study|Covid-19|2|||
19507640|NCT03818581|41917743|FG001|Overall Study|Covid-19|0|||
19507641|NCT03818581|41917744|FG002|Overall Study|Covid-19|0|||
19507642|NCT03818581|41917745|FG003|Overall Study|Covid-19|0|||
19507643|NCT03818581|41917746|FG004|Overall Study|Covid-19|1|||
19507644|NCT03818581|41917742|FG000|Overall Study|Withdrawal by Subject|0|||
19507645|NCT03818581|41917743|FG001|Overall Study|Withdrawal by Subject|0|||
19507646|NCT03818581|41917744|FG002|Overall Study|Withdrawal by Subject|0|||
19507647|NCT03818581|41917745|FG003|Overall Study|Withdrawal by Subject|0|||
19507648|NCT03818581|41917746|FG004|Overall Study|Withdrawal by Subject|1|||
19507649|NCT03818581|41917742|FG000|Overall Study|No longer met study criteria|1|||
19507650|NCT03818581|41917743|FG001|Overall Study|No longer met study criteria|0|||
19507651|NCT03818581|41917744|FG002|Overall Study|No longer met study criteria|0|||
19507652|NCT03818581|41917745|FG003|Overall Study|No longer met study criteria|0|||
19507653|NCT03818581|41917746|FG004|Overall Study|No longer met study criteria|2|||
19507654|NCT03736447|41917760|FG000|Overall Study|Adverse Event|5|||
19507655|NCT03736447|41917761|FG001|Overall Study|Adverse Event|1|||
19507656|NCT03736447|41917760|FG000|Overall Study|Withdrawal by Subject|5|||
19507657|NCT03736447|41917761|FG001|Overall Study|Withdrawal by Subject|1|||
19507658|NCT03736447|41917760|FG000|Overall Study|Lost to Follow-up|1|||
19507659|NCT03736447|41917761|FG001|Overall Study|Lost to Follow-up|0|||
19507660|NCT03736447|41917760|FG000|Overall Study|Physician Decision|1|||
19507661|NCT03736447|41917761|FG001|Overall Study|Physician Decision|0|||
19507662|NCT03736447|41917760|FG000|Overall Study|Continued commitment to study treatment|3|||
19507663|NCT03736447|41917761|FG001|Overall Study|Continued commitment to study treatment|0|||
19507664|NCT03736447|41917760|FG000|Overall Study|Taste aversion to study product|0|||
19507665|NCT03736447|41917761|FG001|Overall Study|Taste aversion to study product|1|||
19507666|NCT01925131|41917773|FG000|Overall Study|Death|0|||
19507667|NCT01925131|41917774|FG001|Overall Study|Death|0|||
19507668|NCT01925131|41917775|FG002|Overall Study|Death|1|||
19507669|NCT01925131|41917776|FG003|Overall Study|Death|0|||
19507670|NCT01925131|41917777|FG004|Overall Study|Death|0|||
19507671|NCT01925131|41917778|FG005|Overall Study|Death|0|||
19507672|NCT01925131|41917773|FG000|Overall Study|Progression/Relapse|1|||
19507673|NCT01925131|41917774|FG001|Overall Study|Progression/Relapse|1|||
19507674|NCT01925131|41917775|FG002|Overall Study|Progression/Relapse|4|||
19507675|NCT01925131|41917776|FG003|Overall Study|Progression/Relapse|0|||
19507676|NCT01925131|41917777|FG004|Overall Study|Progression/Relapse|0|||
19507677|NCT01925131|41917778|FG005|Overall Study|Progression/Relapse|1|||
19507678|NCT01925131|41917773|FG000|Overall Study|Patient Refusal|1|||
19507679|NCT01925131|41917774|FG001|Overall Study|Patient Refusal|0|||
19507680|NCT01925131|41917775|FG002|Overall Study|Patient Refusal|0|||
19507681|NCT01925131|41917776|FG003|Overall Study|Patient Refusal|0|||
19507682|NCT01925131|41917777|FG004|Overall Study|Patient Refusal|0|||
19507683|NCT01925131|41917778|FG005|Overall Study|Patient Refusal|0|||
19507684|NCT01925131|41917773|FG000|Overall Study|Adverse Event|0|||
19507685|NCT01925131|41917774|FG001|Overall Study|Adverse Event|0|||
19507686|NCT01925131|41917775|FG002|Overall Study|Adverse Event|2|||
19507687|NCT01925131|41917776|FG003|Overall Study|Adverse Event|0|||
19507688|NCT01925131|41917777|FG004|Overall Study|Adverse Event|1|||
19507689|NCT01925131|41917778|FG005|Overall Study|Adverse Event|3|||
19507690|NCT01925131|41917773|FG000|Overall Study|Other - Not Protocol Specified|3|||
19507691|NCT01925131|41917774|FG001|Overall Study|Other - Not Protocol Specified|1|||
19507692|NCT01925131|41917775|FG002|Overall Study|Other - Not Protocol Specified|2|||
19507693|NCT01925131|41917776|FG003|Overall Study|Other - Not Protocol Specified|5|||
19507694|NCT01925131|41917777|FG004|Overall Study|Other - Not Protocol Specified|10|||
19507695|NCT01925131|41917778|FG005|Overall Study|Other - Not Protocol Specified|6|||
19507696|NCT00788125|41917803|FG000|Overall Study|Death|6|||
19507697|NCT02132754|41917841|FG000|Overall Study|Adverse Event|0|||
19507698|NCT02132754|41917842|FG001|Overall Study|Adverse Event|0|||
19507699|NCT02132754|41917843|FG002|Overall Study|Adverse Event|0|||
19507700|NCT02132754|41917844|FG003|Overall Study|Adverse Event|0|||
19507701|NCT02132754|41917845|FG004|Overall Study|Adverse Event|0|||
19507702|NCT02132754|41917846|FG005|Overall Study|Adverse Event|0|||
19507703|NCT02132754|41917847|FG006|Overall Study|Adverse Event|0|||
19507704|NCT02132754|41917848|FG007|Overall Study|Adverse Event|0|||
19507705|NCT02132754|41917849|FG008|Overall Study|Adverse Event|0|||
19507706|NCT02132754|41917850|FG009|Overall Study|Adverse Event|0|||
19507707|NCT02132754|41917851|FG010|Overall Study|Adverse Event|0|||
19507708|NCT02132754|41917852|FG011|Overall Study|Adverse Event|0|||
19507709|NCT02132754|41917853|FG012|Overall Study|Adverse Event|0|||
19507710|NCT02132754|41917854|FG013|Overall Study|Adverse Event|0|||
19507711|NCT02132754|41917855|FG014|Overall Study|Adverse Event|0|||
19507712|NCT02132754|41917856|FG015|Overall Study|Adverse Event|0|||
19507713|NCT02132754|41917857|FG016|Overall Study|Adverse Event|0|||
19507714|NCT02132754|41917858|FG017|Overall Study|Adverse Event|1|||
19507715|NCT02132754|41917859|FG018|Overall Study|Adverse Event|0|||
19507716|NCT02132754|41917860|FG019|Overall Study|Adverse Event|0|||
19507717|NCT02132754|41917861|FG020|Overall Study|Adverse Event|0|||
19615766|NCT00910247|42065232|FG000|Overall Study|Not collected|4|||
19615767|NCT00659334|42065243|FG000|Overall Study|Screen Failure|8|||
19615768|NCT00659334|42065244|FG001|Overall Study|Screen Failure|5|||
19615769|NCT00659334|42065245|FG002|Overall Study|Screen Failure|0|||
19615770|NCT00659334|42065246|FG003|Overall Study|Screen Failure|0|||
19615771|NCT00659334|42065247|FG004|Overall Study|Screen Failure|0|||
19615772|NCT00659334|42065248|FG005|Overall Study|Screen Failure|0|||
19615773|NCT00659334|42065249|FG006|Overall Study|Screen Failure|1|||
19615774|NCT00910091|42065271|FG000|Pre-assignment|Withdrawal by Subject|0|||
19615775|NCT00910091|42065272|FG001|Pre-assignment|Withdrawal by Subject|2|||
19615776|NCT00910091|42065271|FG000|Treatment and Survival|Withdrawal by Subject|3|||
19615777|NCT00910091|42065272|FG001|Treatment and Survival|Withdrawal by Subject|4|||
19615778|NCT00910091|42065271|FG000|Treatment and Survival|Adverse Event|1|||
19615779|NCT00910091|42065272|FG001|Treatment and Survival|Adverse Event|0|||
19615780|NCT00909857|42065281|FG000|Overall Study|Withdrawal by Subject|6|||
19615781|NCT00909857|42065282|FG001|Overall Study|Withdrawal by Subject|10|||
19615782|NCT00909857|42065281|FG000|Overall Study|Adverse Event|5|||
19615783|NCT00909857|42065282|FG001|Overall Study|Adverse Event|5|||
19615784|NCT00909857|42065281|FG000|Overall Study|Lost to Follow-up|2|||
19615785|NCT00909857|42065282|FG001|Overall Study|Lost to Follow-up|5|||
19615786|NCT00909857|42065281|FG000|Overall Study|Protocol Violation|2|||
19615787|NCT00909857|42065282|FG001|Overall Study|Protocol Violation|1|||
19615788|NCT00909857|42065281|FG000|Overall Study|Pregnancy|1|||
19615789|NCT00909857|42065282|FG001|Overall Study|Pregnancy|0|||
19615790|NCT00909857|42065281|FG000|Overall Study|Other|1|||
19615791|NCT00909857|42065282|FG001|Overall Study|Other|0|||
19615792|NCT00909857|42065281|FG000|Overall Study|Did not receive study medication|19|||
19615793|NCT00909857|42065282|FG001|Overall Study|Did not receive study medication|24|||
19615794|NCT00911807|42065291|FG000|Overall Study|Adverse Event|2|||
19615795|NCT00911807|42065292|FG001|Overall Study|Adverse Event|1|||
19615796|NCT00911807|42065293|FG002|Overall Study|Adverse Event|5|||
19615797|NCT00911807|42065291|FG000|Overall Study|Death|0|||
19615798|NCT00911807|42065292|FG001|Overall Study|Death|0|||
19615799|NCT00911807|42065293|FG002|Overall Study|Death|1|||
19615800|NCT00911807|42065291|FG000|Overall Study|Protocol Violation|6|||
19615801|NCT00911807|42065292|FG001|Overall Study|Protocol Violation|4|||
19615802|NCT00911807|42065293|FG002|Overall Study|Protocol Violation|9|||
19615803|NCT00911807|42065291|FG000|Overall Study|Withdrawal by Subject|8|||
19615804|NCT00911807|42065292|FG001|Overall Study|Withdrawal by Subject|10|||
19615805|NCT00911807|42065293|FG002|Overall Study|Withdrawal by Subject|7|||
19615806|NCT00911807|42065291|FG000|Overall Study|Organizational reasons|1|||
19615807|NCT00911807|42065292|FG001|Overall Study|Organizational reasons|3|||
19615808|NCT00911807|42065293|FG002|Overall Study|Organizational reasons|1|||
19615809|NCT04287920|42065320|FG000|Overall Study|Lost to Follow-up|1|||
19615810|NCT04287920|42065321|FG001|Overall Study|Lost to Follow-up|1|||
19615811|NCT04287920|42065320|FG000|Overall Study|Withdrawal by Subject|0|||
19615812|NCT04287920|42065321|FG001|Overall Study|Withdrawal by Subject|3|||
19615813|NCT00909779|42065329|FG000|Overall Study|Adverse Event|53|||
19615814|NCT00909779|42065330|FG001|Overall Study|Adverse Event|55|||
19615815|NCT00909779|42065329|FG000|Overall Study|Lack of Efficacy|7|||
19615816|NCT00909779|42065330|FG001|Overall Study|Lack of Efficacy|4|||
19507718|NCT02132754|41917862|FG021|Overall Study|Adverse Event|0|||
19507719|NCT02132754|41917863|FG022|Overall Study|Adverse Event|0|||
19615817|NCT00909779|42065329|FG000|Overall Study|Lost to Follow-up|19|||
19615818|NCT00909779|42065330|FG001|Overall Study|Lost to Follow-up|15|||
19615819|NCT00909779|42065329|FG000|Overall Study|Physician Decision|8|||
19615820|NCT00909779|42065330|FG001|Overall Study|Physician Decision|2|||
19615821|NCT00909779|42065329|FG000|Overall Study|Protocol Violation|2|||
19615822|NCT00909779|42065330|FG001|Overall Study|Protocol Violation|5|||
19615823|NCT00909779|42065329|FG000|Overall Study|Withdrawal by Subject|116|||
19615824|NCT00909779|42065330|FG001|Overall Study|Withdrawal by Subject|80|||
19615825|NCT00909779|42065329|FG000|Overall Study|Site Ceasing Operation|2|||
19615826|NCT00909779|42065330|FG001|Overall Study|Site Ceasing Operation|2|||
19615827|NCT00909779|42065329|FG000|Overall Study|Medical Monitor Decision|1|||
19507720|NCT02132754|41917864|FG023|Overall Study|Adverse Event|0|||
19615828|NCT00909779|42065330|FG001|Overall Study|Medical Monitor Decision|0|||
19615829|NCT00909779|42065329|FG000|Overall Study|Noncompliance|1|||
19615830|NCT00909779|42065330|FG001|Overall Study|Noncompliance|1|||
19615831|NCT00909779|42065329|FG000|Overall Study|Randomized in error|1|||
19615832|NCT00909779|42065330|FG001|Overall Study|Randomized in error|1|||
19615833|NCT00910871|42065338|FG000|Overall Study|Adverse Event|5|||
19615834|NCT00910871|42065338|FG000|Overall Study|Death|12|||
19615835|NCT00910871|42065338|FG000|Overall Study|Lost to Follow-up|8|||
19615836|NCT00910871|42065338|FG000|Overall Study|Protocol Violation|11|||
19615837|NCT00910871|42065338|FG000|Overall Study|Withdrawal by Subject|12|||
19615838|NCT00910871|42065338|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
19615839|NCT00910871|42065338|FG000|Overall Study|Undefined|1|||
19615840|NCT02631941|42065363|FG000|Overall Study|Physician Decision|0|||
19615841|NCT02631941|42065364|FG001|Overall Study|Physician Decision|1|||
19615842|NCT02631941|42065365|FG002|Overall Study|Physician Decision|0|||
19615843|NCT02631941|42065366|FG003|Overall Study|Physician Decision|0|||
19615844|NCT02631941|42065367|FG004|Overall Study|Physician Decision|0|||
19615845|NCT02631941|42065368|FG005|Overall Study|Physician Decision|0|||
19615846|NCT02631941|42065369|FG006|Overall Study|Physician Decision|0|||
19615847|NCT02631941|42065370|FG007|Overall Study|Physician Decision|0|||
19615848|NCT02631941|42065371|FG008|Overall Study|Physician Decision|0|||
19615849|NCT02631941|42065372|FG009|Overall Study|Physician Decision|0|||
19615850|NCT02631941|42065363|FG000|Overall Study|Adverse Event|0|||
19615851|NCT02631941|42065364|FG001|Overall Study|Adverse Event|1|||
19615852|NCT02631941|42065365|FG002|Overall Study|Adverse Event|0|||
19615853|NCT02631941|42065366|FG003|Overall Study|Adverse Event|0|||
19615854|NCT02631941|42065367|FG004|Overall Study|Adverse Event|0|||
19615855|NCT02631941|42065368|FG005|Overall Study|Adverse Event|0|||
19615856|NCT02631941|42065369|FG006|Overall Study|Adverse Event|0|||
19615857|NCT02631941|42065370|FG007|Overall Study|Adverse Event|0|||
19615858|NCT02631941|42065371|FG008|Overall Study|Adverse Event|0|||
19615859|NCT02631941|42065372|FG009|Overall Study|Adverse Event|0|||
19615860|NCT02631941|42065363|FG000|Overall Study|Withdrawal by Subject|0|||
19615861|NCT02631941|42065364|FG001|Overall Study|Withdrawal by Subject|0|||
19615862|NCT02631941|42065365|FG002|Overall Study|Withdrawal by Subject|0|||
19615863|NCT02631941|42065366|FG003|Overall Study|Withdrawal by Subject|0|||
19615864|NCT02631941|42065367|FG004|Overall Study|Withdrawal by Subject|1|||
19615865|NCT02631941|42065368|FG005|Overall Study|Withdrawal by Subject|0|||
19615866|NCT02631941|42065369|FG006|Overall Study|Withdrawal by Subject|0|||
19615867|NCT02631941|42065370|FG007|Overall Study|Withdrawal by Subject|1|||
19615868|NCT02631941|42065371|FG008|Overall Study|Withdrawal by Subject|0|||
19615869|NCT02631941|42065372|FG009|Overall Study|Withdrawal by Subject|0|||
19615870|NCT02631941|42065363|FG000|Overall Study|Lost to Follow-up|0|||
19615871|NCT02631941|42065364|FG001|Overall Study|Lost to Follow-up|0|||
19615872|NCT02631941|42065365|FG002|Overall Study|Lost to Follow-up|0|||
19615873|NCT02631941|42065366|FG003|Overall Study|Lost to Follow-up|0|||
19615874|NCT02631941|42065367|FG004|Overall Study|Lost to Follow-up|0|||
19615875|NCT02631941|42065368|FG005|Overall Study|Lost to Follow-up|0|||
19615876|NCT02631941|42065369|FG006|Overall Study|Lost to Follow-up|0|||
19615877|NCT02631941|42065370|FG007|Overall Study|Lost to Follow-up|0|||
19507721|NCT02132754|41917865|FG024|Overall Study|Adverse Event|0|||
19507722|NCT02132754|41917866|FG025|Overall Study|Adverse Event|1|||
19507723|NCT02132754|41917867|FG026|Overall Study|Adverse Event|1|||
19507724|NCT02132754|41917868|FG027|Overall Study|Adverse Event|0|||
19507725|NCT02132754|41917869|FG028|Overall Study|Adverse Event|0|||
19507726|NCT02132754|41917870|FG029|Overall Study|Adverse Event|0|||
19507727|NCT02132754|41917871|FG030|Overall Study|Adverse Event|1|||
19507728|NCT02132754|41917872|FG031|Overall Study|Adverse Event|0|||
19507729|NCT02132754|41917873|FG032|Overall Study|Adverse Event|1|||
19507730|NCT02132754|41917874|FG033|Overall Study|Adverse Event|1|||
19507731|NCT02132754|41917841|FG000|Overall Study|Clinical Progression|0|||
19507732|NCT02132754|41917842|FG001|Overall Study|Clinical Progression|0|||
19507733|NCT02132754|41917843|FG002|Overall Study|Clinical Progression|0|||
19507734|NCT02132754|41917844|FG003|Overall Study|Clinical Progression|0|||
19507735|NCT02132754|41917845|FG004|Overall Study|Clinical Progression|0|||
19507736|NCT02132754|41917846|FG005|Overall Study|Clinical Progression|0|||
19507737|NCT02132754|41917847|FG006|Overall Study|Clinical Progression|0|||
19507738|NCT02132754|41917848|FG007|Overall Study|Clinical Progression|0|||
19507739|NCT02132754|41917849|FG008|Overall Study|Clinical Progression|0|||
19615878|NCT02631941|42065371|FG008|Overall Study|Lost to Follow-up|1|||
19615879|NCT02631941|42065372|FG009|Overall Study|Lost to Follow-up|0|||
19615880|NCT00908375|42065384|FG000|Overall Study|Withdrawal by Subject|2|||
19373737|NCT02755649|41614938|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
19615881|NCT00908375|42065385|FG001|Overall Study|Withdrawal by Subject|4|||
19615882|NCT00908375|42065384|FG000|Overall Study|Lost to Follow-up|8|||
19615883|NCT00908375|42065385|FG001|Overall Study|Lost to Follow-up|6|||
19615884|NCT00909389|42065391|FG000|Overall Study|Adverse Event|6|||
19615885|NCT00909389|42065391|FG000|Overall Study|Death|4|||
19507740|NCT02132754|41917850|FG009|Overall Study|Clinical Progression|1|||
19507741|NCT02132754|41917851|FG010|Overall Study|Clinical Progression|0|||
19615886|NCT00909389|42065391|FG000|Overall Study|Poor Compliance|16|||
19507742|NCT02132754|41917852|FG011|Overall Study|Clinical Progression|0|||
19507743|NCT02132754|41917853|FG012|Overall Study|Clinical Progression|0|||
19507744|NCT02132754|41917854|FG013|Overall Study|Clinical Progression|0|||
19507745|NCT02132754|41917855|FG014|Overall Study|Clinical Progression|0|||
19507746|NCT02132754|41917856|FG015|Overall Study|Clinical Progression|0|||
19507747|NCT02132754|41917857|FG016|Overall Study|Clinical Progression|1|||
19507748|NCT02132754|41917858|FG017|Overall Study|Clinical Progression|1|||
19507749|NCT02132754|41917859|FG018|Overall Study|Clinical Progression|0|||
19507750|NCT02132754|41917860|FG019|Overall Study|Clinical Progression|1|||
19507751|NCT02132754|41917861|FG020|Overall Study|Clinical Progression|0|||
19507752|NCT02132754|41917862|FG021|Overall Study|Clinical Progression|0|||
19507753|NCT02132754|41917863|FG022|Overall Study|Clinical Progression|1|||
19507754|NCT02132754|41917864|FG023|Overall Study|Clinical Progression|0|||
19507755|NCT02132754|41917865|FG024|Overall Study|Clinical Progression|1|||
19507756|NCT02132754|41917866|FG025|Overall Study|Clinical Progression|1|||
19507757|NCT02132754|41917867|FG026|Overall Study|Clinical Progression|0|||
19507758|NCT02132754|41917868|FG027|Overall Study|Clinical Progression|1|||
19615887|NCT00909389|42065391|FG000|Overall Study|Lost to Follow-up|4|||
19615888|NCT00909389|42065391|FG000|Overall Study|No Information|103|||
19615889|NCT00910715|42065398|FG000|Overall Study|Lost to Follow-up|22|||
19615890|NCT00910715|42065399|FG001|Overall Study|Lost to Follow-up|26|||
19615891|NCT00910715|42065400|FG002|Overall Study|Lost to Follow-up|0|||
19615892|NCT00600483|42065480|FG000|Overall Study|Lost to Follow-up|26|||
19507759|NCT02132754|41917869|FG028|Overall Study|Clinical Progression|1|||
19507760|NCT02132754|41917870|FG029|Overall Study|Clinical Progression|0|||
19507761|NCT02132754|41917871|FG030|Overall Study|Clinical Progression|1|||
19507762|NCT02132754|41917872|FG031|Overall Study|Clinical Progression|0|||
19507763|NCT02132754|41917873|FG032|Overall Study|Clinical Progression|0|||
19507764|NCT02132754|41917874|FG033|Overall Study|Clinical Progression|2|||
19507765|NCT02132754|41917841|FG000|Overall Study|Death|0|||
19507766|NCT02132754|41917842|FG001|Overall Study|Death|0|||
19507767|NCT02132754|41917843|FG002|Overall Study|Death|0|||
19507768|NCT02132754|41917844|FG003|Overall Study|Death|0|||
19507769|NCT02132754|41917845|FG004|Overall Study|Death|0|||
19507770|NCT02132754|41917846|FG005|Overall Study|Death|0|||
19507771|NCT02132754|41917847|FG006|Overall Study|Death|0|||
19507772|NCT02132754|41917848|FG007|Overall Study|Death|0|||
19507773|NCT02132754|41917849|FG008|Overall Study|Death|0|||
19507774|NCT02132754|41917850|FG009|Overall Study|Death|0|||
19507775|NCT02132754|41917851|FG010|Overall Study|Death|0|||
19507776|NCT02132754|41917852|FG011|Overall Study|Death|0|||
19507777|NCT02132754|41917853|FG012|Overall Study|Death|0|||
19507778|NCT02132754|41917854|FG013|Overall Study|Death|0|||
19507779|NCT02132754|41917855|FG014|Overall Study|Death|0|||
19507780|NCT02132754|41917856|FG015|Overall Study|Death|1|||
19507781|NCT02132754|41917857|FG016|Overall Study|Death|0|||
19507782|NCT02132754|41917858|FG017|Overall Study|Death|0|||
19507783|NCT02132754|41917859|FG018|Overall Study|Death|0|||
19507784|NCT02132754|41917860|FG019|Overall Study|Death|1|||
19507785|NCT02132754|41917861|FG020|Overall Study|Death|0|||
19507786|NCT02132754|41917862|FG021|Overall Study|Death|1|||
19507787|NCT02132754|41917863|FG022|Overall Study|Death|0|||
19507788|NCT02132754|41917864|FG023|Overall Study|Death|0|||
19615893|NCT00600483|42065481|FG001|Overall Study|Lost to Follow-up|47|||
19507789|NCT02132754|41917865|FG024|Overall Study|Death|0|||
19507790|NCT02132754|41917866|FG025|Overall Study|Death|0|||
19507791|NCT02132754|41917867|FG026|Overall Study|Death|1|||
19507792|NCT02132754|41917868|FG027|Overall Study|Death|0|||
19507793|NCT02132754|41917869|FG028|Overall Study|Death|0|||
19507794|NCT02132754|41917870|FG029|Overall Study|Death|0|||
19507795|NCT02132754|41917871|FG030|Overall Study|Death|0|||
19507796|NCT02132754|41917872|FG031|Overall Study|Death|0|||
19507797|NCT02132754|41917873|FG032|Overall Study|Death|0|||
19507798|NCT02132754|41917874|FG033|Overall Study|Death|2|||
19507799|NCT02132754|41917841|FG000|Overall Study|Excluded Medication|0|||
19507800|NCT02132754|41917842|FG001|Overall Study|Excluded Medication|0|||
19507801|NCT02132754|41917843|FG002|Overall Study|Excluded Medication|0|||
19507802|NCT02132754|41917844|FG003|Overall Study|Excluded Medication|0|||
19507803|NCT02132754|41917845|FG004|Overall Study|Excluded Medication|0|||
19615894|NCT00600483|42065480|FG000|Overall Study|Randomized but not treated|10|||
19615895|NCT00600483|42065481|FG001|Overall Study|Randomized but not treated|0|||
19615896|NCT00600171|42065493|FG000|Overall Study|Adverse Event|0|||
19507804|NCT02132754|41917846|FG005|Overall Study|Excluded Medication|0|||
19507805|NCT02132754|41917847|FG006|Overall Study|Excluded Medication|0|||
19507806|NCT02132754|41917848|FG007|Overall Study|Excluded Medication|0|||
19507807|NCT02132754|41917849|FG008|Overall Study|Excluded Medication|0|||
19507808|NCT02132754|41917850|FG009|Overall Study|Excluded Medication|0|||
19507809|NCT02132754|41917851|FG010|Overall Study|Excluded Medication|0|||
19507810|NCT02132754|41917852|FG011|Overall Study|Excluded Medication|0|||
19507811|NCT02132754|41917853|FG012|Overall Study|Excluded Medication|0|||
19507812|NCT02132754|41917854|FG013|Overall Study|Excluded Medication|0|||
19507813|NCT02132754|41917855|FG014|Overall Study|Excluded Medication|0|||
19615897|NCT00600171|42065494|FG001|Overall Study|Adverse Event|1|||
19615898|NCT00600171|42065495|FG002|Overall Study|Adverse Event|0|||
19615899|NCT00600171|42065496|FG003|Overall Study|Adverse Event|0|||
19615900|NCT00600171|42065497|FG004|Overall Study|Adverse Event|1|||
19615901|NCT00600171|42065498|FG005|Overall Study|Adverse Event|0|||
19615902|NCT00600171|42065493|FG000|Overall Study|Lack of Efficacy|9|||
19507814|NCT02132754|41917856|FG015|Overall Study|Excluded Medication|0|||
19507815|NCT02132754|41917857|FG016|Overall Study|Excluded Medication|0|||
19507816|NCT02132754|41917858|FG017|Overall Study|Excluded Medication|0|||
19507817|NCT02132754|41917859|FG018|Overall Study|Excluded Medication|0|||
19507818|NCT02132754|41917860|FG019|Overall Study|Excluded Medication|0|||
19507819|NCT02132754|41917861|FG020|Overall Study|Excluded Medication|1|||
19507820|NCT02132754|41917862|FG021|Overall Study|Excluded Medication|0|||
19507821|NCT02132754|41917863|FG022|Overall Study|Excluded Medication|0|||
19507822|NCT02132754|41917864|FG023|Overall Study|Excluded Medication|0|||
19507823|NCT02132754|41917865|FG024|Overall Study|Excluded Medication|0|||
19507824|NCT02132754|41917866|FG025|Overall Study|Excluded Medication|0|||
19507825|NCT02132754|41917867|FG026|Overall Study|Excluded Medication|0|||
19507826|NCT02132754|41917868|FG027|Overall Study|Excluded Medication|0|||
19507827|NCT02132754|41917869|FG028|Overall Study|Excluded Medication|0|||
19507828|NCT02132754|41917870|FG029|Overall Study|Excluded Medication|0|||
19507829|NCT02132754|41917871|FG030|Overall Study|Excluded Medication|0|||
19507830|NCT02132754|41917872|FG031|Overall Study|Excluded Medication|0|||
19507831|NCT02132754|41917873|FG032|Overall Study|Excluded Medication|0|||
19507832|NCT02132754|41917874|FG033|Overall Study|Excluded Medication|1|||
19507833|NCT02132754|41917841|FG000|Overall Study|Physician Decision|0|||
19507834|NCT02132754|41917842|FG001|Overall Study|Physician Decision|0|||
19507835|NCT02132754|41917843|FG002|Overall Study|Physician Decision|0|||
19507836|NCT02132754|41917844|FG003|Overall Study|Physician Decision|0|||
19507837|NCT02132754|41917845|FG004|Overall Study|Physician Decision|0|||
19507838|NCT02132754|41917846|FG005|Overall Study|Physician Decision|0|||
19507839|NCT02132754|41917847|FG006|Overall Study|Physician Decision|0|||
19507840|NCT02132754|41917848|FG007|Overall Study|Physician Decision|0|||
19507841|NCT02132754|41917849|FG008|Overall Study|Physician Decision|0|||
19507842|NCT02132754|41917850|FG009|Overall Study|Physician Decision|1|||
19507843|NCT02132754|41917851|FG010|Overall Study|Physician Decision|0|||
19507844|NCT02132754|41917852|FG011|Overall Study|Physician Decision|1|||
19507845|NCT02132754|41917853|FG012|Overall Study|Physician Decision|1|||
19507846|NCT02132754|41917854|FG013|Overall Study|Physician Decision|0|||
19507847|NCT02132754|41917855|FG014|Overall Study|Physician Decision|0|||
19507848|NCT02132754|41917856|FG015|Overall Study|Physician Decision|1|||
19507849|NCT02132754|41917857|FG016|Overall Study|Physician Decision|0|||
19507850|NCT02132754|41917858|FG017|Overall Study|Physician Decision|0|||
19507851|NCT02132754|41917859|FG018|Overall Study|Physician Decision|0|||
19507852|NCT02132754|41917860|FG019|Overall Study|Physician Decision|0|||
19507853|NCT02132754|41917861|FG020|Overall Study|Physician Decision|0|||
19507854|NCT02132754|41917862|FG021|Overall Study|Physician Decision|0|||
19507855|NCT02132754|41917863|FG022|Overall Study|Physician Decision|0|||
19507856|NCT02132754|41917864|FG023|Overall Study|Physician Decision|0|||
19507857|NCT02132754|41917865|FG024|Overall Study|Physician Decision|1|||
19507858|NCT02132754|41917866|FG025|Overall Study|Physician Decision|0|||
19507859|NCT02132754|41917867|FG026|Overall Study|Physician Decision|0|||
19507860|NCT02132754|41917868|FG027|Overall Study|Physician Decision|0|||
19507861|NCT02132754|41917869|FG028|Overall Study|Physician Decision|0|||
19507862|NCT02132754|41917870|FG029|Overall Study|Physician Decision|0|||
19507863|NCT02132754|41917871|FG030|Overall Study|Physician Decision|0|||
19615903|NCT00600171|42065494|FG001|Overall Study|Lack of Efficacy|12|||
19615904|NCT00600171|42065495|FG002|Overall Study|Lack of Efficacy|3|||
19615905|NCT00600171|42065496|FG003|Overall Study|Lack of Efficacy|5|||
19615906|NCT00600171|42065497|FG004|Overall Study|Lack of Efficacy|4|||
19615907|NCT00600171|42065498|FG005|Overall Study|Lack of Efficacy|0|||
19615908|NCT00600171|42065493|FG000|Overall Study|Protocol Violation|1|||
19507864|NCT02132754|41917872|FG031|Overall Study|Physician Decision|1|||
19507865|NCT02132754|41917873|FG032|Overall Study|Physician Decision|0|||
19507866|NCT02132754|41917874|FG033|Overall Study|Physician Decision|3|||
19507867|NCT02132754|41917841|FG000|Overall Study|Progressive Disease|1|||
19507868|NCT02132754|41917842|FG001|Overall Study|Progressive Disease|1|||
19507869|NCT02132754|41917843|FG002|Overall Study|Progressive Disease|1|||
19507870|NCT02132754|41917844|FG003|Overall Study|Progressive Disease|1|||
19507871|NCT02132754|41917845|FG004|Overall Study|Progressive Disease|1|||
19615909|NCT00600171|42065494|FG001|Overall Study|Protocol Violation|2|||
19615910|NCT00600171|42065495|FG002|Overall Study|Protocol Violation|0|||
19615911|NCT00600171|42065496|FG003|Overall Study|Protocol Violation|1|||
19507872|NCT02132754|41917846|FG005|Overall Study|Progressive Disease|1|||
19507873|NCT02132754|41917847|FG006|Overall Study|Progressive Disease|1|||
19507874|NCT02132754|41917848|FG007|Overall Study|Progressive Disease|1|||
19507875|NCT02132754|41917849|FG008|Overall Study|Progressive Disease|1|||
19507876|NCT02132754|41917850|FG009|Overall Study|Progressive Disease|3|||
19615912|NCT00600171|42065497|FG004|Overall Study|Protocol Violation|0|||
19615913|NCT00600171|42065498|FG005|Overall Study|Protocol Violation|0|||
19615914|NCT00600171|42065493|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
19615915|NCT00600171|42065494|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19615916|NCT00600171|42065495|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
19615917|NCT00600171|42065496|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
19615918|NCT00600171|42065497|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
19615919|NCT00600171|42065498|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
19615920|NCT00600171|42065493|FG000|Overall Study|Withdrawal by Subject|3|||
19615921|NCT00600171|42065494|FG001|Overall Study|Withdrawal by Subject|0|||
19615922|NCT00600171|42065495|FG002|Overall Study|Withdrawal by Subject|0|||
19615923|NCT00600171|42065496|FG003|Overall Study|Withdrawal by Subject|1|||
19615924|NCT00600171|42065497|FG004|Overall Study|Withdrawal by Subject|1|||
19507877|NCT02132754|41917851|FG010|Overall Study|Progressive Disease|3|||
19507878|NCT02132754|41917852|FG011|Overall Study|Progressive Disease|2|||
19615925|NCT00600171|42065498|FG005|Overall Study|Withdrawal by Subject|1|||
19615926|NCT00600171|42065493|FG000|Overall Study|Physician Decision|0|||
19615927|NCT00600171|42065494|FG001|Overall Study|Physician Decision|1|||
19615928|NCT00600171|42065495|FG002|Overall Study|Physician Decision|0|||
19615929|NCT00600171|42065496|FG003|Overall Study|Physician Decision|1|||
19615930|NCT00600171|42065497|FG004|Overall Study|Physician Decision|0|||
19615931|NCT00600171|42065498|FG005|Overall Study|Physician Decision|2|||
19615932|NCT00600171|42065493|FG000|Overall Study|Lost to Follow-up|0|||
19615933|NCT00600171|42065494|FG001|Overall Study|Lost to Follow-up|0|||
19615934|NCT00600171|42065495|FG002|Overall Study|Lost to Follow-up|0|||
19507879|NCT02132754|41917853|FG012|Overall Study|Progressive Disease|2|||
19507880|NCT02132754|41917854|FG013|Overall Study|Progressive Disease|3|||
19507881|NCT02132754|41917855|FG014|Overall Study|Progressive Disease|2|||
19507882|NCT02132754|41917856|FG015|Overall Study|Progressive Disease|1|||
19507883|NCT02132754|41917857|FG016|Overall Study|Progressive Disease|2|||
19507884|NCT02132754|41917858|FG017|Overall Study|Progressive Disease|1|||
19507885|NCT02132754|41917859|FG018|Overall Study|Progressive Disease|3|||
19507886|NCT02132754|41917860|FG019|Overall Study|Progressive Disease|1|||
19615935|NCT00600171|42065496|FG003|Overall Study|Lost to Follow-up|1|||
19615936|NCT00600171|42065497|FG004|Overall Study|Lost to Follow-up|0|||
19615937|NCT00600171|42065498|FG005|Overall Study|Lost to Follow-up|0|||
19615938|NCT04035668|42065517|FG000|Overall Study|Adverse Event|3|||
19615939|NCT04035668|42065518|FG001|Overall Study|Adverse Event|4|||
19615940|NCT04035668|42065519|FG002|Overall Study|Adverse Event|2|||
19615941|NCT04035668|42065517|FG000|Overall Study|Lost to Follow-up|0|||
19615942|NCT04035668|42065518|FG001|Overall Study|Lost to Follow-up|1|||
19615943|NCT04035668|42065519|FG002|Overall Study|Lost to Follow-up|0|||
19615944|NCT04035668|42065517|FG000|Overall Study|Physician Decision|2|||
19615945|NCT04035668|42065518|FG001|Overall Study|Physician Decision|1|||
19615946|NCT04035668|42065519|FG002|Overall Study|Physician Decision|1|||
19615947|NCT04035668|42065517|FG000|Overall Study|Subject Decision|2|||
19615948|NCT04035668|42065518|FG001|Overall Study|Subject Decision|2|||
19615949|NCT04035668|42065519|FG002|Overall Study|Subject Decision|0|||
19615950|NCT00602667|42065540|FG000|Overall Study|Still on Therapy|0|||
19615951|NCT00602667|42065541|FG001|Overall Study|Still on Therapy|2|||
19615952|NCT00602667|42065542|FG002|Overall Study|Still on Therapy|2|||
19615953|NCT00602667|42065540|FG000|Overall Study|Death|0|||
19615954|NCT00602667|42065541|FG001|Overall Study|Death|1|||
19615955|NCT00602667|42065542|FG002|Overall Study|Death|1|||
19615956|NCT00602667|42065540|FG000|Overall Study|Family request|3|||
19615957|NCT00602667|42065541|FG001|Overall Study|Family request|25|||
19615958|NCT00602667|42065542|FG002|Overall Study|Family request|6|||
19615959|NCT00602667|42065540|FG000|Overall Study|Excessive toxicity|1|||
19615960|NCT00602667|42065541|FG001|Overall Study|Excessive toxicity|1|||
19615961|NCT00602667|42065542|FG002|Overall Study|Excessive toxicity|0|||
19615962|NCT00602667|42065540|FG000|Overall Study|Second malignancy|0|||
19615963|NCT00602667|42065541|FG001|Overall Study|Second malignancy|1|||
19615964|NCT00602667|42065542|FG002|Overall Study|Second malignancy|0|||
19615965|NCT00602667|42065540|FG000|Overall Study|Physician Decision|2|||
19615966|NCT00602667|42065541|FG001|Overall Study|Physician Decision|3|||
19704538|NCT00129402|42148929|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19507887|NCT02132754|41917861|FG020|Overall Study|Progressive Disease|1|||
19507888|NCT02132754|41917862|FG021|Overall Study|Progressive Disease|3|||
19507889|NCT02132754|41917863|FG022|Overall Study|Progressive Disease|2|||
19615967|NCT00602667|42065542|FG002|Overall Study|Physician Decision|8|||
19615968|NCT00602667|42065540|FG000|Overall Study|Progressive disease|13|||
19615969|NCT00602667|42065541|FG001|Overall Study|Progressive disease|48|||
19615970|NCT00602667|42065542|FG002|Overall Study|Progressive disease|45|||
19615971|NCT00602667|42065540|FG000|Overall Study|Progressive disease prior to therapy|0|||
19615972|NCT00602667|42065541|FG001|Overall Study|Progressive disease prior to therapy|0|||
19373738|NCT02755649|41614936|FG000|Overall Study|Physician Decision|0|||
19615973|NCT00602667|42065542|FG002|Overall Study|Progressive disease prior to therapy|1|||
19615974|NCT00885495|42065581|FG000|Overall Study|Adverse Event|1|||
19615975|NCT00885495|42065582|FG001|Overall Study|Adverse Event|2|||
19615976|NCT00885495|42065581|FG000|Overall Study|Protocol Violation|0|||
19615977|NCT00885495|42065582|FG001|Overall Study|Protocol Violation|1|||
19507890|NCT02132754|41917864|FG023|Overall Study|Progressive Disease|3|||
19507891|NCT02132754|41917865|FG024|Overall Study|Progressive Disease|0|||
19507892|NCT02132754|41917866|FG025|Overall Study|Progressive Disease|1|||
19507893|NCT02132754|41917867|FG026|Overall Study|Progressive Disease|2|||
19507894|NCT02132754|41917868|FG027|Overall Study|Progressive Disease|1|||
19507895|NCT02132754|41917869|FG028|Overall Study|Progressive Disease|2|||
19507896|NCT02132754|41917870|FG029|Overall Study|Progressive Disease|3|||
19507897|NCT02132754|41917871|FG030|Overall Study|Progressive Disease|1|||
19507898|NCT02132754|41917872|FG031|Overall Study|Progressive Disease|1|||
19507899|NCT02132754|41917873|FG032|Overall Study|Progressive Disease|3|||
19507900|NCT02132754|41917874|FG033|Overall Study|Progressive Disease|6|||
19507901|NCT02132754|41917841|FG000|Overall Study|Screen Failure|0|||
19507902|NCT02132754|41917842|FG001|Overall Study|Screen Failure|0|||
19507903|NCT02132754|41917843|FG002|Overall Study|Screen Failure|0|||
19507904|NCT02132754|41917844|FG003|Overall Study|Screen Failure|0|||
19507905|NCT02132754|41917845|FG004|Overall Study|Screen Failure|0|||
19507906|NCT02132754|41917846|FG005|Overall Study|Screen Failure|0|||
19507907|NCT02132754|41917847|FG006|Overall Study|Screen Failure|0|||
19507908|NCT02132754|41917848|FG007|Overall Study|Screen Failure|0|||
19507909|NCT02132754|41917849|FG008|Overall Study|Screen Failure|0|||
19507910|NCT02132754|41917850|FG009|Overall Study|Screen Failure|0|||
19507911|NCT02132754|41917851|FG010|Overall Study|Screen Failure|0|||
19507912|NCT02132754|41917852|FG011|Overall Study|Screen Failure|0|||
19507913|NCT02132754|41917853|FG012|Overall Study|Screen Failure|0|||
19507914|NCT02132754|41917854|FG013|Overall Study|Screen Failure|0|||
19507915|NCT02132754|41917855|FG014|Overall Study|Screen Failure|0|||
19507916|NCT02132754|41917856|FG015|Overall Study|Screen Failure|0|||
19507917|NCT02132754|41917857|FG016|Overall Study|Screen Failure|0|||
19507918|NCT02132754|41917858|FG017|Overall Study|Screen Failure|0|||
19507919|NCT02132754|41917859|FG018|Overall Study|Screen Failure|0|||
19507920|NCT02132754|41917860|FG019|Overall Study|Screen Failure|1|||
19507921|NCT02132754|41917861|FG020|Overall Study|Screen Failure|0|||
19507922|NCT02132754|41917862|FG021|Overall Study|Screen Failure|1|||
19507923|NCT02132754|41917863|FG022|Overall Study|Screen Failure|0|||
19507924|NCT02132754|41917864|FG023|Overall Study|Screen Failure|0|||
19507925|NCT02132754|41917865|FG024|Overall Study|Screen Failure|0|||
19507926|NCT02132754|41917866|FG025|Overall Study|Screen Failure|0|||
19507927|NCT02132754|41917867|FG026|Overall Study|Screen Failure|0|||
19507928|NCT02132754|41917868|FG027|Overall Study|Screen Failure|0|||
19507929|NCT02132754|41917869|FG028|Overall Study|Screen Failure|0|||
19507930|NCT02132754|41917870|FG029|Overall Study|Screen Failure|0|||
19507931|NCT02132754|41917871|FG030|Overall Study|Screen Failure|0|||
19507932|NCT02132754|41917872|FG031|Overall Study|Screen Failure|0|||
19507933|NCT02132754|41917873|FG032|Overall Study|Screen Failure|0|||
19507934|NCT02132754|41917874|FG033|Overall Study|Screen Failure|0|||
19507935|NCT02132754|41917841|FG000|Overall Study|Transferred to Extension Study|0|||
19507936|NCT02132754|41917842|FG001|Overall Study|Transferred to Extension Study|0|||
19507937|NCT02132754|41917843|FG002|Overall Study|Transferred to Extension Study|0|||
19507938|NCT02132754|41917844|FG003|Overall Study|Transferred to Extension Study|0|||
19507939|NCT02132754|41917845|FG004|Overall Study|Transferred to Extension Study|0|||
19507940|NCT02132754|41917846|FG005|Overall Study|Transferred to Extension Study|0|||
19615978|NCT00885495|42065581|FG000|Overall Study|Withdrawal by Subject|1|||
19507941|NCT02132754|41917847|FG006|Overall Study|Transferred to Extension Study|0|||
19507942|NCT02132754|41917848|FG007|Overall Study|Transferred to Extension Study|0|||
19507943|NCT02132754|41917849|FG008|Overall Study|Transferred to Extension Study|0|||
19507944|NCT02132754|41917850|FG009|Overall Study|Transferred to Extension Study|0|||
19507945|NCT02132754|41917851|FG010|Overall Study|Transferred to Extension Study|0|||
19507946|NCT02132754|41917852|FG011|Overall Study|Transferred to Extension Study|0|||
19507947|NCT02132754|41917853|FG012|Overall Study|Transferred to Extension Study|0|||
19507948|NCT02132754|41917854|FG013|Overall Study|Transferred to Extension Study|0|||
19507949|NCT02132754|41917855|FG014|Overall Study|Transferred to Extension Study|0|||
19507950|NCT02132754|41917856|FG015|Overall Study|Transferred to Extension Study|0|||
19507951|NCT02132754|41917857|FG016|Overall Study|Transferred to Extension Study|0|||
19507952|NCT02132754|41917858|FG017|Overall Study|Transferred to Extension Study|0|||
19507953|NCT02132754|41917859|FG018|Overall Study|Transferred to Extension Study|0|||
19507954|NCT02132754|41917860|FG019|Overall Study|Transferred to Extension Study|0|||
19507955|NCT02132754|41917861|FG020|Overall Study|Transferred to Extension Study|0|||
19507956|NCT02132754|41917862|FG021|Overall Study|Transferred to Extension Study|0|||
19507957|NCT02132754|41917863|FG022|Overall Study|Transferred to Extension Study|0|||
19507958|NCT02132754|41917864|FG023|Overall Study|Transferred to Extension Study|0|||
19507959|NCT02132754|41917865|FG024|Overall Study|Transferred to Extension Study|0|||
19507960|NCT02132754|41917866|FG025|Overall Study|Transferred to Extension Study|0|||
19507961|NCT02132754|41917867|FG026|Overall Study|Transferred to Extension Study|0|||
19615979|NCT00885495|42065582|FG001|Overall Study|Withdrawal by Subject|0|||
19507962|NCT02132754|41917868|FG027|Overall Study|Transferred to Extension Study|0|||
19507963|NCT02132754|41917869|FG028|Overall Study|Transferred to Extension Study|0|||
19507964|NCT02132754|41917870|FG029|Overall Study|Transferred to Extension Study|0|||
19507965|NCT02132754|41917871|FG030|Overall Study|Transferred to Extension Study|0|||
19507966|NCT02132754|41917872|FG031|Overall Study|Transferred to Extension Study|0|||
19507967|NCT02132754|41917873|FG032|Overall Study|Transferred to Extension Study|0|||
19507968|NCT02132754|41917874|FG033|Overall Study|Transferred to Extension Study|6|||
19507969|NCT02132754|41917841|FG000|Overall Study|Withdrawal by Subject|0|||
19507970|NCT02132754|41917842|FG001|Overall Study|Withdrawal by Subject|0|||
19507971|NCT02132754|41917843|FG002|Overall Study|Withdrawal by Subject|0|||
19507972|NCT02132754|41917844|FG003|Overall Study|Withdrawal by Subject|0|||
19507973|NCT02132754|41917845|FG004|Overall Study|Withdrawal by Subject|0|||
19507974|NCT02132754|41917846|FG005|Overall Study|Withdrawal by Subject|0|||
19507975|NCT02132754|41917847|FG006|Overall Study|Withdrawal by Subject|0|||
19507976|NCT02132754|41917848|FG007|Overall Study|Withdrawal by Subject|0|||
19507977|NCT02132754|41917849|FG008|Overall Study|Withdrawal by Subject|0|||
19507978|NCT02132754|41917850|FG009|Overall Study|Withdrawal by Subject|1|||
19507979|NCT02132754|41917851|FG010|Overall Study|Withdrawal by Subject|0|||
19507980|NCT02132754|41917852|FG011|Overall Study|Withdrawal by Subject|0|||
19507981|NCT02132754|41917853|FG012|Overall Study|Withdrawal by Subject|1|||
19507982|NCT02132754|41917854|FG013|Overall Study|Withdrawal by Subject|0|||
19507983|NCT02132754|41917855|FG014|Overall Study|Withdrawal by Subject|1|||
19507984|NCT02132754|41917856|FG015|Overall Study|Withdrawal by Subject|2|||
19507985|NCT02132754|41917857|FG016|Overall Study|Withdrawal by Subject|1|||
19507986|NCT02132754|41917858|FG017|Overall Study|Withdrawal by Subject|0|||
19507987|NCT02132754|41917859|FG018|Overall Study|Withdrawal by Subject|0|||
19507988|NCT02132754|41917860|FG019|Overall Study|Withdrawal by Subject|0|||
19507989|NCT02132754|41917861|FG020|Overall Study|Withdrawal by Subject|1|||
19507990|NCT02132754|41917862|FG021|Overall Study|Withdrawal by Subject|0|||
19507991|NCT02132754|41917863|FG022|Overall Study|Withdrawal by Subject|0|||
19507992|NCT02132754|41917864|FG023|Overall Study|Withdrawal by Subject|0|||
19507993|NCT02132754|41917865|FG024|Overall Study|Withdrawal by Subject|1|||
19615980|NCT00885105|42065595|FG000|Overall Study|Withdrawal by Subject|0|||
19615981|NCT00885105|42065596|FG001|Overall Study|Withdrawal by Subject|8|||
19615982|NCT00885105|42065595|FG000|Overall Study|Adverse Event|1|||
19615983|NCT00885105|42065596|FG001|Overall Study|Adverse Event|0|||
19507994|NCT02132754|41917866|FG025|Overall Study|Withdrawal by Subject|0|||
19507995|NCT02132754|41917867|FG026|Overall Study|Withdrawal by Subject|0|||
19615984|NCT00885105|42065595|FG000|Overall Study|Protocol Violation|0|||
19615985|NCT00885105|42065596|FG001|Overall Study|Protocol Violation|2|||
19615986|NCT03945188|42065604|FG000|Overall Study|Protocol Violation|1|||
19615987|NCT03945188|42065605|FG001|Overall Study|Protocol Violation|0|||
19615988|NCT03945188|42065604|FG000|Overall Study|Disease worsening|79|||
19507996|NCT02132754|41917868|FG027|Overall Study|Withdrawal by Subject|1|||
19507997|NCT02132754|41917869|FG028|Overall Study|Withdrawal by Subject|0|||
19507998|NCT02132754|41917870|FG029|Overall Study|Withdrawal by Subject|0|||
19507999|NCT02132754|41917871|FG030|Overall Study|Withdrawal by Subject|0|||
19508000|NCT02132754|41917872|FG031|Overall Study|Withdrawal by Subject|1|||
19508001|NCT02132754|41917873|FG032|Overall Study|Withdrawal by Subject|0|||
19508002|NCT02132754|41917874|FG033|Overall Study|Withdrawal by Subject|2|||
19508003|NCT02151786|41917984|FG000|Overall Study|Unavailability of Case Report Form|26|||
19508004|NCT02151786|41917984|FG000|Overall Study|Outside the Contract Period|1|||
19508005|NCT02151786|41917984|FG000|Overall Study|Randomized, not Treated|1|||
19508006|NCT02151786|41917984|FG000|Overall Study|Unavailability of Information|8|||
19508007|NCT02132130|41917992|FG000|Overall Study|Lost to Follow-up|0|||
19615989|NCT03945188|42065605|FG001|Overall Study|Disease worsening|73|||
19615990|NCT03945188|42065604|FG000|Overall Study|Physician Decision|2|||
19615991|NCT03945188|42065605|FG001|Overall Study|Physician Decision|2|||
19615992|NCT03945188|42065604|FG000|Overall Study|Lack of Efficacy|7|||
19615993|NCT03945188|42065605|FG001|Overall Study|Lack of Efficacy|4|||
19615994|NCT03945188|42065604|FG000|Overall Study|Pregnancy|2|||
19615995|NCT03945188|42065605|FG001|Overall Study|Pregnancy|0|||
19615996|NCT03945188|42065604|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
19615997|NCT03945188|42065605|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
19615998|NCT03945188|42065604|FG000|Overall Study|Adverse Event|10|||
19373739|NCT02755649|41614937|FG001|Overall Study|Physician Decision|0|||
19508008|NCT02132130|41917993|FG001|Overall Study|Lost to Follow-up|2|||
19508009|NCT02132130|41917994|FG002|Overall Study|Lost to Follow-up|0|||
19508010|NCT02132130|41917995|FG003|Overall Study|Lost to Follow-up|0|||
19508011|NCT02132130|41917992|FG000|Overall Study|Withdrawal by Subject|0|||
19508012|NCT02132130|41917993|FG001|Overall Study|Withdrawal by Subject|0|||
19508013|NCT02132130|41917994|FG002|Overall Study|Withdrawal by Subject|0|||
19615999|NCT03945188|42065605|FG001|Overall Study|Adverse Event|5|||
19616000|NCT03945188|42065604|FG000|Overall Study|Other|2|||
19616001|NCT03945188|42065605|FG001|Overall Study|Other|2|||
19616002|NCT03945188|42065604|FG000|Overall Study|Lost to Follow-up|1|||
19508014|NCT02132130|41917995|FG003|Overall Study|Withdrawal by Subject|1|||
19508015|NCT02131662|41918014|FG000|Overall Study|Protocol Violation|1|||
19508016|NCT02131662|41918015|FG001|Overall Study|Protocol Violation|0|||
19508017|NCT02131662|41918016|FG002|Overall Study|Protocol Violation|0|||
19508018|NCT02131662|41918017|FG003|Overall Study|Protocol Violation|0|||
19508019|NCT02131662|41918018|FG004|Overall Study|Protocol Violation|0|||
19508020|NCT02131662|41918014|FG000|Overall Study|Other|2|||
19508021|NCT02131662|41918015|FG001|Overall Study|Other|4|||
19508022|NCT02131662|41918016|FG002|Overall Study|Other|3|||
19508023|NCT02131662|41918017|FG003|Overall Study|Other|3|||
19508024|NCT02131662|41918018|FG004|Overall Study|Other|4|||
19508025|NCT02131662|41918014|FG000|Overall Study|Adverse Event|0|||
19508026|NCT02131662|41918015|FG001|Overall Study|Adverse Event|1|||
19508027|NCT02131662|41918016|FG002|Overall Study|Adverse Event|1|||
19508028|NCT02131662|41918017|FG003|Overall Study|Adverse Event|1|||
19508029|NCT02131662|41918018|FG004|Overall Study|Adverse Event|3|||
19508030|NCT02131662|41918014|FG000|Overall Study|Pregnancy|0|||
19508031|NCT02131662|41918015|FG001|Overall Study|Pregnancy|1|||
19508032|NCT02131662|41918016|FG002|Overall Study|Pregnancy|0|||
19508033|NCT02131662|41918017|FG003|Overall Study|Pregnancy|1|||
19508034|NCT02131662|41918018|FG004|Overall Study|Pregnancy|0|||
19508035|NCT02131662|41918014|FG000|Overall Study|Wish for pregnancy|0|||
19508036|NCT02131662|41918015|FG001|Overall Study|Wish for pregnancy|0|||
19508037|NCT02131662|41918016|FG002|Overall Study|Wish for pregnancy|0|||
19508038|NCT02131662|41918017|FG003|Overall Study|Wish for pregnancy|0|||
19508039|NCT02131662|41918018|FG004|Overall Study|Wish for pregnancy|1|||
19508040|NCT02131662|41918014|FG000|Overall Study|Lack of Efficacy|1|||
19508041|NCT02131662|41918015|FG001|Overall Study|Lack of Efficacy|0|||
19508042|NCT02131662|41918016|FG002|Overall Study|Lack of Efficacy|0|||
19508043|NCT02131662|41918017|FG003|Overall Study|Lack of Efficacy|0|||
19508044|NCT02131662|41918018|FG004|Overall Study|Lack of Efficacy|1|||
19508045|NCT02131662|41918014|FG000|Overall Study|Withdrawal by Subject|1|||
19508046|NCT02131662|41918015|FG001|Overall Study|Withdrawal by Subject|5|||
19508047|NCT02131662|41918016|FG002|Overall Study|Withdrawal by Subject|1|||
19508048|NCT02131662|41918017|FG003|Overall Study|Withdrawal by Subject|5|||
19508049|NCT02131662|41918018|FG004|Overall Study|Withdrawal by Subject|6|||
19508050|NCT02131662|41918014|FG000|Overall Study|Lost to Follow-up|1|||
19508051|NCT02131662|41918015|FG001|Overall Study|Lost to Follow-up|3|||
19508052|NCT02131662|41918016|FG002|Overall Study|Lost to Follow-up|0|||
19508053|NCT02131662|41918017|FG003|Overall Study|Lost to Follow-up|9|||
19508054|NCT02131662|41918018|FG004|Overall Study|Lost to Follow-up|0|||
19508055|NCT02131662|41918014|FG000|Overall Study|Not treated|2|||
19508056|NCT02131662|41918015|FG001|Overall Study|Not treated|0|||
19508057|NCT02131662|41918016|FG002|Overall Study|Not treated|2|||
19508058|NCT02131662|41918017|FG003|Overall Study|Not treated|2|||
19508059|NCT02131662|41918018|FG004|Overall Study|Not treated|3|||
19616003|NCT03945188|42065605|FG001|Overall Study|Lost to Follow-up|2|||
19616004|NCT00884949|42065611|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
19616005|NCT00884949|42065611|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
19616006|NCT00884793|42065624|FG000|Overall Study|Withdrawal by Subject|1|||
19616007|NCT00884325|42065630|FG000|Overall Study|Lost to Follow-up|1|||
19616008|NCT00884325|42065631|FG001|Overall Study|Lost to Follow-up|2|||
19616009|NCT00884325|42065630|FG000|Overall Study|Lack of Efficacy|0|||
19616010|NCT00884325|42065631|FG001|Overall Study|Lack of Efficacy|1|||
19616011|NCT00884325|42065630|FG000|Overall Study|Withdrawal by Subject|1|||
19616012|NCT00884325|42065631|FG001|Overall Study|Withdrawal by Subject|1|||
19616013|NCT00884325|42065630|FG000|Overall Study|Not provided|1|||
19616014|NCT00884325|42065631|FG001|Overall Study|Not provided|0|||
19616015|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
19616016|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
19616017|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Disease progression|75|||
19616018|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Disease progression|59|||
19616019|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Adverse Event|16|||
19616020|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Adverse Event|16|||
19616021|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Death|2|||
19616022|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Death|3|||
19616023|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
19508060|NCT02106156|41918037|FG000|Overall Study|Patient Died|19|||
19508061|NCT02106156|41918038|FG001|Overall Study|Patient Died|0|||
19508062|NCT02106156|41918039|FG002|Overall Study|Patient Died|0|||
19616024|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
19616025|NCT00883779|42065639|FG000|Primary Study Treatment Phase|Other|3|||
19616026|NCT00883779|42065640|FG001|Primary Study Treatment Phase|Other|0|||
19616027|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Adverse Event|2|||
19616028|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Adverse Event|3|||
19508063|NCT02106156|41918037|FG000|Overall Study|Lack of Tolerability|305|||
19508064|NCT02106156|41918038|FG001|Overall Study|Lack of Tolerability|3|||
19508065|NCT02106156|41918039|FG002|Overall Study|Lack of Tolerability|0|||
19508066|NCT02106156|41918037|FG000|Overall Study|Lack of Virological Response|1044|||
19508067|NCT02106156|41918038|FG001|Overall Study|Lack of Virological Response|8|||
19508068|NCT02106156|41918039|FG002|Overall Study|Lack of Virological Response|0|||
19508069|NCT02106156|41918037|FG000|Overall Study|Concomitant Disease|74|||
19508070|NCT02106156|41918038|FG001|Overall Study|Concomitant Disease|2|||
19508071|NCT02106156|41918039|FG002|Overall Study|Concomitant Disease|0|||
19508072|NCT02106156|41918037|FG000|Overall Study|Lack of Compliance|211|||
19508073|NCT02106156|41918038|FG001|Overall Study|Lack of Compliance|7|||
19508074|NCT02106156|41918039|FG002|Overall Study|Lack of Compliance|0|||
19508075|NCT02106156|41918037|FG000|Overall Study|Patients Request|307|||
19508076|NCT02106156|41918038|FG001|Overall Study|Patients Request|9|||
19508077|NCT02106156|41918039|FG002|Overall Study|Patients Request|0|||
19508078|NCT02106156|41918037|FG000|Overall Study|Lost to Follow-up|451|||
19508079|NCT02106156|41918038|FG001|Overall Study|Lost to Follow-up|8|||
19508080|NCT02106156|41918039|FG002|Overall Study|Lost to Follow-up|0|||
19508081|NCT02106156|41918037|FG000|Overall Study|Unplanned Event|82|||
19616029|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Death|1|||
19616030|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Death|3|||
19616031|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
19616032|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
19508082|NCT02106156|41918038|FG001|Overall Study|Unplanned Event|2|||
19508083|NCT02106156|41918039|FG002|Overall Study|Unplanned Event|0|||
19508084|NCT02106156|41918037|FG000|Overall Study|Change of Laboratory Parameter|10|||
19508085|NCT02106156|41918038|FG001|Overall Study|Change of Laboratory Parameter|0|||
19508086|NCT02106156|41918039|FG002|Overall Study|Change of Laboratory Parameter|0|||
19508087|NCT02106156|41918037|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
19508088|NCT02106156|41918038|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
19508089|NCT02106156|41918039|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
19508090|NCT02106156|41918037|FG000|Overall Study|Relocation/Change of Physician|40|||
19508091|NCT02106156|41918038|FG001|Overall Study|Relocation/Change of Physician|1|||
19508092|NCT02106156|41918039|FG002|Overall Study|Relocation/Change of Physician|0|||
19508093|NCT01598610|41918046|FG000|Overall Study|Adverse Event|1|||
19508094|NCT01625988|41918052|FG000|Overall Study|Lost to Follow-up|5|||
19508095|NCT01625988|41918053|FG001|Overall Study|Lost to Follow-up|6|||
19508096|NCT01625988|41918052|FG000|Overall Study|Withdrawal by Subject|8|||
19508097|NCT01625988|41918053|FG001|Overall Study|Withdrawal by Subject|3|||
19508098|NCT01625988|41918052|FG000|Overall Study|Adverse Event|0|||
19508099|NCT01625988|41918053|FG001|Overall Study|Adverse Event|1|||
19508100|NCT01625988|41918052|FG000|Overall Study|Lack of Efficacy|0|||
19508101|NCT01625988|41918053|FG001|Overall Study|Lack of Efficacy|1|||
19508102|NCT01625988|41918052|FG000|Overall Study|Randomized Inappropriately|1|||
19508103|NCT01625988|41918053|FG001|Overall Study|Randomized Inappropriately|0|||
19508104|NCT01625988|41918052|FG000|Overall Study|Protocol Violation|0|||
19508105|NCT01625988|41918053|FG001|Overall Study|Protocol Violation|2|||
19508106|NCT02131272|41918064|FG000|Overall Study|Withdrawal by parent|0|||
19508107|NCT02131272|41918065|FG001|Overall Study|Withdrawal by parent|1|||
19508108|NCT02131272|41918064|FG000|Overall Study|Withdrawal by Subject|0|||
19508109|NCT02131272|41918065|FG001|Overall Study|Withdrawal by Subject|1|||
19508110|NCT02131272|41918064|FG000|Overall Study|Withdrawal Criteria|1|||
19508111|NCT02131272|41918065|FG001|Overall Study|Withdrawal Criteria|0|||
19508112|NCT02130882|41918073|FG000|Overall Study|Withdrawal by Subject|0|||
19508113|NCT02130882|41918074|FG001|Overall Study|Withdrawal by Subject|1|||
19508114|NCT02130570|41918082|FG000|Overall Study|Death|3|||
19508115|NCT02130570|41918083|FG001|Overall Study|Death|5|||
19508116|NCT02130570|41918082|FG000|Overall Study|Withdrawal by Subject|6|||
19508117|NCT02130570|41918083|FG001|Overall Study|Withdrawal by Subject|3|||
19508118|NCT02130570|41918082|FG000|Overall Study|Part of practice that discontinued study|0|||
19616033|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
19616034|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
19616035|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Disease progression|103|||
19616036|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Disease progression|122|||
19616037|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Other|3|||
19616038|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Other|0|||
19616039|NCT00883779|42065639|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
19508119|NCT02130570|41918083|FG001|Overall Study|Part of practice that discontinued study|5|||
19508120|NCT02149836|41918090|FG000|Overall Study|Withdrawal by Subject|1|||
19508121|NCT02130024|41918096|FG000|Overall Study|Adverse Event|10|||
19508122|NCT02130024|41918097|FG001|Overall Study|Adverse Event|11|||
19508123|NCT02130024|41918096|FG000|Overall Study|Death|2|||
19508124|NCT02130024|41918097|FG001|Overall Study|Death|2|||
19508125|NCT02130024|41918096|FG000|Overall Study|Lost to Follow-up|1|||
19508126|NCT02130024|41918097|FG001|Overall Study|Lost to Follow-up|1|||
19616040|NCT00883779|42065640|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
19616041|NCT00883779|42065639|FG000|Off-study Phase|Death|185|||
19616042|NCT00883779|42065640|FG001|Off-study Phase|Death|174|||
19508127|NCT02130024|41918096|FG000|Overall Study|Physician Decision|1|||
19508128|NCT02130024|41918097|FG001|Overall Study|Physician Decision|3|||
19508129|NCT02130024|41918096|FG000|Overall Study|Protocol Deviation|4|||
19616043|NCT00883779|42065639|FG000|Off-study Phase|Refused treatment|1|||
19616044|NCT00883779|42065640|FG001|Off-study Phase|Refused treatment|1|||
19616045|NCT00883779|42065639|FG000|Off-study Phase|Failure to return|5|||
19616046|NCT00883779|42065640|FG001|Off-study Phase|Failure to return|6|||
19616047|NCT00883779|42065639|FG000|Off-study Phase|Other|18|||
19616048|NCT00883779|42065640|FG001|Off-study Phase|Other|21|||
19616049|NCT04159701|42065648|FG000|Period 1: Treatment Period|Pregnancy|1|||
19616050|NCT04159701|42065649|FG001|Period 1: Treatment Period|Pregnancy|0|||
19616051|NCT04159701|42065648|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
19616052|NCT04159701|42065649|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
19616053|NCT04159701|42065648|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
19616054|NCT04159701|42065649|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
19616055|NCT04159701|42065648|FG000|Washout Period|site terminated by sponsor|0|||
19616056|NCT04159701|42065649|FG001|Washout Period|site terminated by sponsor|1|||
19616057|NCT04159701|42065648|FG000|Washout Period|study terminated by sponsor|10|||
19508130|NCT02130024|41918097|FG001|Overall Study|Protocol Deviation|0|||
19508131|NCT02130024|41918096|FG000|Overall Study|Site Administration Problems|1|||
19508132|NCT02130024|41918097|FG001|Overall Study|Site Administration Problems|0|||
19508133|NCT02130024|41918096|FG000|Overall Study|Subject Withdrew Consent|6|||
19508134|NCT02130024|41918097|FG001|Overall Study|Subject Withdrew Consent|14|||
19508135|NCT02105688|41918105|FG000|Part A: Double-Blind|Adverse Event|1|||
19508136|NCT02105688|41918106|FG001|Part A: Double-Blind|Adverse Event|0|||
19508137|NCT02105688|41918105|FG000|Part A: Double-Blind|Death|0|||
19508138|NCT02105688|41918106|FG001|Part A: Double-Blind|Death|1|||
19508139|NCT02105688|41918105|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
19508140|NCT02105688|41918106|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
19508141|NCT02105688|41918105|FG000|Part A: Double-Blind|Physician Decision|0|||
19508142|NCT02105688|41918106|FG001|Part A: Double-Blind|Physician Decision|1|||
19508143|NCT02105688|41918105|FG000|Part A: Double-Blind|Status Unknown|0|||
19508144|NCT02105688|41918106|FG001|Part A: Double-Blind|Status Unknown|2|||
19508145|NCT02105688|41918105|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
19508146|NCT02105688|41918106|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
19508147|NCT02105688|41918105|FG000|Part B: Observational Follow-up|Death|2|||
19508148|NCT02105688|41918106|FG001|Part B: Observational Follow-up|Death|1|||
19508149|NCT02105688|41918105|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
19508150|NCT02105688|41918106|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
19508151|NCT02105688|41918105|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
19508152|NCT02105688|41918106|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
19508153|NCT02105688|41918105|FG000|Part B: Observational Follow-up|Physician Decision|3|||
19508154|NCT02105688|41918106|FG001|Part B: Observational Follow-up|Physician Decision|1|||
19508155|NCT02105454|41918113|FG000|Overall Study|Withdrawal by Subject|1|||
19508156|NCT01625910|41918119|FG000|Overall Study|Lost to Follow-up|3|||
19508157|NCT01625910|41918120|FG001|Overall Study|Lost to Follow-up|4|||
19508158|NCT02104752|41918130|FG000|Overall Study|Withdrawal by Subject|1|||
19508159|NCT02104752|41918131|FG001|Overall Study|Withdrawal by Subject|0|||
19508160|NCT02104752|41918130|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
19508161|NCT02104752|41918131|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
19508162|NCT02102724|41918139|FG000|Overall Study|Lost to Follow-up|1|||
19508163|NCT02102724|41918140|FG001|Overall Study|Lost to Follow-up|0|||
19508164|NCT02102724|41918139|FG000|Overall Study|surgery for brain aneurysm|1|||
19508165|NCT02102724|41918140|FG001|Overall Study|surgery for brain aneurysm|1|||
19508166|NCT02102490|41918146|FG000|Overall Study|Death|6|||
19508167|NCT02102490|41918146|FG000|Overall Study|Lost to Follow-up|1|||
19508168|NCT02101554|41918153|FG000|Overall Study|Protocol Violation|0|||
19508169|NCT02101554|41918154|FG001|Overall Study|Protocol Violation|1|||
19508170|NCT02101554|41918155|FG002|Overall Study|Protocol Violation|0|||
19508171|NCT02101554|41918153|FG000|Overall Study|Insufficient Clinical Response|0|||
19508172|NCT02101554|41918154|FG001|Overall Study|Insufficient Clinical Response|2|||
19508173|NCT02101554|41918155|FG002|Overall Study|Insufficient Clinical Response|0|||
19508174|NCT02101554|41918153|FG000|Overall Study|Adverse Event|2|||
19508175|NCT02101554|41918154|FG001|Overall Study|Adverse Event|1|||
19508176|NCT02101554|41918155|FG002|Overall Study|Adverse Event|1|||
19508177|NCT02101554|41918153|FG000|Overall Study|Lost to Follow-up|0|||
19616058|NCT04159701|42065649|FG001|Washout Period|study terminated by sponsor|3|||
19616059|NCT04159701|42065648|FG000|Washout Period|Withdrawal by Subject|1|||
19616060|NCT04159701|42065649|FG001|Washout Period|Withdrawal by Subject|0|||
19508178|NCT02101554|41918154|FG001|Overall Study|Lost to Follow-up|1|||
19508179|NCT02101554|41918155|FG002|Overall Study|Lost to Follow-up|0|||
19508180|NCT02101554|41918153|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
19508181|NCT02101554|41918154|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
19508182|NCT02101554|41918155|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
19508183|NCT02128932|41918166|FG000|Overall Study|Withdrawal by Subject|11|||
19508184|NCT02128932|41918167|FG001|Overall Study|Withdrawal by Subject|7|||
19508185|NCT02128932|41918168|FG002|Overall Study|Withdrawal by Subject|8|||
19508186|NCT02128932|41918166|FG000|Overall Study|Death|2|||
19508187|NCT02128932|41918167|FG001|Overall Study|Death|0|||
19508188|NCT02128932|41918168|FG002|Overall Study|Death|2|||
19508189|NCT02128932|41918166|FG000|Overall Study|Lost to Follow-up|2|||
19508190|NCT02128932|41918167|FG001|Overall Study|Lost to Follow-up|1|||
19508191|NCT02128932|41918168|FG002|Overall Study|Lost to Follow-up|1|||
19508192|NCT02128932|41918166|FG000|Overall Study|No reason for withdrawal|12|||
19508193|NCT02128932|41918167|FG001|Overall Study|No reason for withdrawal|11|||
19508194|NCT02128932|41918168|FG002|Overall Study|No reason for withdrawal|7|||
19508195|NCT02128542|41918178|FG000|Overall Study|Lost to Follow-up|3|||
19508196|NCT02128542|41918179|FG001|Overall Study|Lost to Follow-up|0|||
19508197|NCT02128542|41918178|FG000|Overall Study|Withdrew Consent|1|||
19508198|NCT02128542|41918179|FG001|Overall Study|Withdrew Consent|0|||
19508199|NCT02127372|41918189|FG000|Overall Study|Withdrawal by Subject|1|||
19508200|NCT02127372|41918190|FG001|Overall Study|Withdrawal by Subject|0|||
19508201|NCT02126826|41918204|FG000|Overall Study|Withdrawal by Subject|0|||
19508202|NCT02126826|41918205|FG001|Overall Study|Withdrawal by Subject|0|||
19508203|NCT02126826|41918206|FG002|Overall Study|Withdrawal by Subject|0|||
19508204|NCT02126826|41918207|FG003|Overall Study|Withdrawal by Subject|1|||
19508205|NCT02126826|41918208|FG004|Overall Study|Withdrawal by Subject|0|||
19508206|NCT02126826|41918209|FG005|Overall Study|Withdrawal by Subject|0|||
19508207|NCT02126826|41918210|FG006|Overall Study|Withdrawal by Subject|0|||
19508208|NCT02126670|41918235|FG000|Overall Study|Withdrawal by Subject|1|||
19508209|NCT02126670|41918236|FG001|Overall Study|Withdrawal by Subject|0|||
19508210|NCT02126670|41918237|FG002|Overall Study|Withdrawal by Subject|0|||
19508211|NCT02126670|41918238|FG003|Overall Study|Withdrawal by Subject|1|||
19508212|NCT02125734|41918250|FG000|Period 2|Adverse Event|0|||
19508213|NCT02125734|41918251|FG001|Period 2|Adverse Event|1|||
19508214|NCT02124798|41918257|FG000|Overall Study|Adverse Event|3|||
19508215|NCT02124798|41918257|FG000|Overall Study|Lost to Follow-up|1|||
19508216|NCT02146326|41918265|FG000|Overall Study|Lost to Follow-up|3|||
19508217|NCT02146326|41918266|FG001|Overall Study|Lost to Follow-up|3|||
19508218|NCT02146326|41918267|FG002|Overall Study|Lost to Follow-up|11|||
19508219|NCT02146326|41918268|FG003|Overall Study|Lost to Follow-up|19|||
19508220|NCT02146326|41918265|FG000|Overall Study|Withdrawal by Subject|2|||
19508221|NCT02146326|41918266|FG001|Overall Study|Withdrawal by Subject|1|||
19508222|NCT02146326|41918267|FG002|Overall Study|Withdrawal by Subject|15|||
19508223|NCT02146326|41918268|FG003|Overall Study|Withdrawal by Subject|11|||
19508224|NCT02146326|41918265|FG000|Overall Study|Separated from mental health center|23|||
19508225|NCT02146326|41918266|FG001|Overall Study|Separated from mental health center|33|||
19508226|NCT02146326|41918267|FG002|Overall Study|Separated from mental health center|0|||
19508227|NCT02146326|41918268|FG003|Overall Study|Separated from mental health center|0|||
19508228|NCT02146326|41918265|FG000|Overall Study|Incarcerated|0|||
19508229|NCT02146326|41918266|FG001|Overall Study|Incarcerated|0|||
19508230|NCT02146326|41918267|FG002|Overall Study|Incarcerated|3|||
19508231|NCT02146326|41918268|FG003|Overall Study|Incarcerated|8|||
19508232|NCT02146326|41918265|FG000|Overall Study|Death|0|||
19508233|NCT02146326|41918266|FG001|Overall Study|Death|0|||
19508234|NCT02146326|41918267|FG002|Overall Study|Death|4|||
19508235|NCT02146326|41918268|FG003|Overall Study|Death|4|||
19508236|NCT02146326|41918265|FG000|Overall Study|Unable to complete interview|0|||
19508237|NCT02146326|41918266|FG001|Overall Study|Unable to complete interview|0|||
19508238|NCT02146326|41918267|FG002|Overall Study|Unable to complete interview|10|||
19508239|NCT02146326|41918268|FG003|Overall Study|Unable to complete interview|6|||
19508240|NCT02146248|41918284|FG000|Overall Study|Withdrawal by Subject|2|||
19508241|NCT02145468|41918294|FG000|Overall Study|Withdrawal by Subject|5|||
19508242|NCT02145468|41918295|FG001|Overall Study|Withdrawal by Subject|8|||
19508243|NCT02124564|41918301|FG000|Treatment Period|Adverse Event|2|||
19508244|NCT02124564|41918301|FG000|Treatment Period|Lack of Efficacy|3|||
19508245|NCT02124564|41918301|FG000|Treatment Period|Withdrawal by Subject|2|||
19508246|NCT02145390|41918306|FG000|Overall Study|Withdrawal by Subject|1|||
19508247|NCT02100696|41918316|FG000|Induction Phase|Adverse Event|0|||
19508248|NCT02100696|41918317|FG001|Induction Phase|Adverse Event|0|||
19508249|NCT02100696|41918318|FG002|Induction Phase|Adverse Event|1|||
19508250|NCT02100696|41918319|FG003|Induction Phase|Adverse Event|0|||
19508251|NCT02100696|41918320|FG004|Induction Phase|Adverse Event|0|||
19616061|NCT04159701|42065648|FG000|Washout Period|Inadvertent Enrollment|1|||
19508252|NCT02100696|41918321|FG005|Induction Phase|Adverse Event|0|||
19508253|NCT02100696|41918316|FG000|Induction Phase|Lost to Follow-up|1|||
19508254|NCT02100696|41918317|FG001|Induction Phase|Lost to Follow-up|0|||
19508255|NCT02100696|41918318|FG002|Induction Phase|Lost to Follow-up|1|||
19508256|NCT02100696|41918319|FG003|Induction Phase|Lost to Follow-up|0|||
19508257|NCT02100696|41918320|FG004|Induction Phase|Lost to Follow-up|0|||
19508258|NCT02100696|41918321|FG005|Induction Phase|Lost to Follow-up|0|||
19508259|NCT02100696|41918316|FG000|Induction Phase|Protocol Violation|0|||
19508260|NCT02100696|41918317|FG001|Induction Phase|Protocol Violation|1|||
19508261|NCT02100696|41918318|FG002|Induction Phase|Protocol Violation|1|||
19508262|NCT02100696|41918319|FG003|Induction Phase|Protocol Violation|0|||
19508263|NCT02100696|41918320|FG004|Induction Phase|Protocol Violation|0|||
19508264|NCT02100696|41918321|FG005|Induction Phase|Protocol Violation|0|||
19508265|NCT02100696|41918316|FG000|Induction Phase|Withdrawal by Subject|8|||
19508266|NCT02100696|41918317|FG001|Induction Phase|Withdrawal by Subject|2|||
19508267|NCT02100696|41918318|FG002|Induction Phase|Withdrawal by Subject|13|||
19508268|NCT02100696|41918319|FG003|Induction Phase|Withdrawal by Subject|0|||
19508269|NCT02100696|41918320|FG004|Induction Phase|Withdrawal by Subject|0|||
19508270|NCT02100696|41918321|FG005|Induction Phase|Withdrawal by Subject|0|||
19508271|NCT02100696|41918316|FG000|Induction Phase|Physician Decision|1|||
19508272|NCT02100696|41918317|FG001|Induction Phase|Physician Decision|0|||
19508273|NCT02100696|41918318|FG002|Induction Phase|Physician Decision|2|||
19508274|NCT02100696|41918319|FG003|Induction Phase|Physician Decision|0|||
19508275|NCT02100696|41918320|FG004|Induction Phase|Physician Decision|0|||
19508276|NCT02100696|41918321|FG005|Induction Phase|Physician Decision|0|||
19508277|NCT02100696|41918316|FG000|Induction Phase|Multiple Reasons|5|||
19508278|NCT02100696|41918317|FG001|Induction Phase|Multiple Reasons|2|||
19508279|NCT02100696|41918318|FG002|Induction Phase|Multiple Reasons|8|||
19508280|NCT02100696|41918319|FG003|Induction Phase|Multiple Reasons|0|||
19508281|NCT02100696|41918320|FG004|Induction Phase|Multiple Reasons|0|||
19508282|NCT02100696|41918321|FG005|Induction Phase|Multiple Reasons|0|||
19508283|NCT02100696|41918316|FG000|Maintenance Phase|Adverse Event|0|||
19508284|NCT02100696|41918317|FG001|Maintenance Phase|Adverse Event|0|||
19508285|NCT02100696|41918318|FG002|Maintenance Phase|Adverse Event|0|||
19508286|NCT02100696|41918319|FG003|Maintenance Phase|Adverse Event|0|||
19508287|NCT02100696|41918320|FG004|Maintenance Phase|Adverse Event|0|||
19508288|NCT02100696|41918321|FG005|Maintenance Phase|Adverse Event|2|||
19508289|NCT02100696|41918316|FG000|Maintenance Phase|Lost to Follow-up|0|||
19508290|NCT02100696|41918317|FG001|Maintenance Phase|Lost to Follow-up|0|||
19508291|NCT02100696|41918318|FG002|Maintenance Phase|Lost to Follow-up|0|||
19508292|NCT02100696|41918319|FG003|Maintenance Phase|Lost to Follow-up|0|||
19508293|NCT02100696|41918320|FG004|Maintenance Phase|Lost to Follow-up|1|||
19616062|NCT04159701|42065649|FG001|Washout Period|Inadvertent Enrollment|0|||
19616063|NCT04159701|42065648|FG000|Washout Period|Miscellaneous|1|||
19616064|NCT04159701|42065649|FG001|Washout Period|Miscellaneous|0|||
19616065|NCT04159701|42065648|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
19616066|NCT04159701|42065649|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
19616067|NCT04159701|42065648|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
19616068|NCT04159701|42065649|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
19616069|NCT04159701|42065648|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
19616070|NCT04159701|42065649|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
19616071|NCT04159701|42065648|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
19616072|NCT04159701|42065649|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
19616073|NCT04159701|42065648|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
19616074|NCT04159701|42065649|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
19616075|NCT00880269|42065661|FG000|Overall Study|Protocol Violation|1|||
19616076|NCT00880269|42065662|FG001|Overall Study|Protocol Violation|0|||
19616077|NCT00880269|42065661|FG000|Overall Study|Disease Progression|13|||
19616078|NCT00880269|42065662|FG001|Overall Study|Disease Progression|11|||
19616079|NCT00880269|42065661|FG000|Overall Study|New Cancer Therapy|1|||
19616080|NCT00880269|42065662|FG001|Overall Study|New Cancer Therapy|0|||
19616081|NCT00880269|42065661|FG000|Overall Study|Death|4|||
19616082|NCT00880269|42065662|FG001|Overall Study|Death|2|||
19616083|NCT00880269|42065661|FG000|Overall Study|Lost to Follow-up|0|||
19616084|NCT00880269|42065662|FG001|Overall Study|Lost to Follow-up|1|||
19616085|NCT00880269|42065661|FG000|Overall Study|Withdrawal by Subject|3|||
19616086|NCT00880269|42065662|FG001|Overall Study|Withdrawal by Subject|4|||
19616087|NCT00880269|42065661|FG000|Overall Study|Adverse Event|10|||
19616088|NCT00880269|42065662|FG001|Overall Study|Adverse Event|9|||
19616089|NCT00880191|42065670|FG000|Overall Study|Refused further treatment|4|||
19616090|NCT00880191|42065671|FG001|Overall Study|Refused further treatment|1|||
19616091|NCT00880191|42065670|FG000|Overall Study|Adverse Event|8|||
19616092|NCT00880191|42065671|FG001|Overall Study|Adverse Event|6|||
19616093|NCT00880191|42065670|FG000|Overall Study|Hospitalization/efficacy|1|||
19616094|NCT00880191|42065671|FG001|Overall Study|Hospitalization/efficacy|1|||
19616095|NCT00597519|42065677|FG000|Overall Study|Death|1|||
19616096|NCT00879333|42065683|FG000|Overall Study|Adverse Event|94|||
19616097|NCT00879333|42065684|FG001|Overall Study|Adverse Event|34|||
19616098|NCT00879333|42065683|FG000|Overall Study|Abnormal Laboratory Value|1|||
19616099|NCT00879333|42065684|FG001|Overall Study|Abnormal Laboratory Value|0|||
19508294|NCT02100696|41918321|FG005|Maintenance Phase|Lost to Follow-up|0|||
19508295|NCT02100696|41918316|FG000|Maintenance Phase|Protocol Violation|0|||
19508296|NCT02100696|41918317|FG001|Maintenance Phase|Protocol Violation|0|||
19508297|NCT02100696|41918318|FG002|Maintenance Phase|Protocol Violation|0|||
19616100|NCT00879333|42065683|FG000|Overall Study|Withdrawal by Subject|20|||
19508298|NCT02100696|41918319|FG003|Maintenance Phase|Protocol Violation|0|||
19508299|NCT02100696|41918320|FG004|Maintenance Phase|Protocol Violation|1|||
19508300|NCT02100696|41918321|FG005|Maintenance Phase|Protocol Violation|0|||
19508301|NCT02100696|41918316|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19508302|NCT02100696|41918317|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19508303|NCT02100696|41918318|FG002|Maintenance Phase|Withdrawal by Subject|0|||
19508304|NCT02100696|41918319|FG003|Maintenance Phase|Withdrawal by Subject|1|||
19508305|NCT02100696|41918320|FG004|Maintenance Phase|Withdrawal by Subject|4|||
19508306|NCT02100696|41918321|FG005|Maintenance Phase|Withdrawal by Subject|2|||
19508307|NCT02100696|41918316|FG000|Maintenance Phase|Physician Decision|0|||
19508308|NCT02100696|41918317|FG001|Maintenance Phase|Physician Decision|0|||
19508309|NCT02100696|41918318|FG002|Maintenance Phase|Physician Decision|0|||
19508310|NCT02100696|41918319|FG003|Maintenance Phase|Physician Decision|0|||
19508311|NCT02100696|41918320|FG004|Maintenance Phase|Physician Decision|1|||
19508312|NCT02100696|41918321|FG005|Maintenance Phase|Physician Decision|0|||
19508313|NCT02100696|41918316|FG000|Maintenance Phase|Multiple Reasons|0|||
19508314|NCT02100696|41918317|FG001|Maintenance Phase|Multiple Reasons|0|||
19508315|NCT02100696|41918318|FG002|Maintenance Phase|Multiple Reasons|0|||
19508316|NCT02100696|41918319|FG003|Maintenance Phase|Multiple Reasons|0|||
19508317|NCT02100696|41918320|FG004|Maintenance Phase|Multiple Reasons|2|||
19508318|NCT02100696|41918321|FG005|Maintenance Phase|Multiple Reasons|1|||
19508319|NCT02145156|41918345|FG000|Overall Study|No match to vaccination records|60|||
19508320|NCT02145156|41918346|FG001|Overall Study|No match to vaccination records|52|||
19508321|NCT02145156|41918347|FG002|Overall Study|No match to vaccination records|41|||
19508322|NCT02123472|41918355|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
19508323|NCT02123472|41918356|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
19508324|NCT02145078|41918362|FG000|Overall Study|Death|1|||
19616101|NCT00879333|42065684|FG001|Overall Study|Withdrawal by Subject|7|||
19616102|NCT00879333|42065683|FG000|Overall Study|Lost to Follow-up|2|||
19616103|NCT00879333|42065684|FG001|Overall Study|Lost to Follow-up|1|||
19616104|NCT00879333|42065683|FG000|Overall Study|Administrative Problems|2|||
19616105|NCT00879333|42065684|FG001|Overall Study|Administrative Problems|0|||
19616106|NCT00879333|42065683|FG000|Overall Study|Death|16|||
19616107|NCT00879333|42065684|FG001|Overall Study|Death|5|||
19616108|NCT00879333|42065683|FG000|Overall Study|Disease Progression|292|||
19616109|NCT00879333|42065684|FG001|Overall Study|Disease Progression|169|||
19616110|NCT00879333|42065683|FG000|Overall Study|Protocol Violation|1|||
19616111|NCT00879333|42065684|FG001|Overall Study|Protocol Violation|1|||
19616112|NCT03481556|42065696|FG000|Overall Study|Adverse Event|1|||
19616113|NCT03481556|42065697|FG001|Overall Study|Adverse Event|0|||
19616114|NCT03481556|42065698|FG002|Overall Study|Adverse Event|0|||
19508325|NCT02145078|41918362|FG000|Overall Study|Reason not given|3|||
19508326|NCT02144610|41918368|FG000|Overall Study|Physician Decision|1|||
19616115|NCT03481556|42065699|FG003|Overall Study|Adverse Event|0|||
19616116|NCT03481556|42065696|FG000|Overall Study|Death|4|||
19616117|NCT03481556|42065697|FG001|Overall Study|Death|2|||
19616118|NCT03481556|42065698|FG002|Overall Study|Death|3|||
19616119|NCT03481556|42065699|FG003|Overall Study|Death|16|||
19616120|NCT03481556|42065696|FG000|Overall Study|Study Terminated by Sponsor|10|||
19616121|NCT03481556|42065697|FG001|Overall Study|Study Terminated by Sponsor|5|||
19616122|NCT03481556|42065698|FG002|Overall Study|Study Terminated by Sponsor|2|||
19616123|NCT03481556|42065699|FG003|Overall Study|Study Terminated by Sponsor|9|||
19616124|NCT00596427|42065717|FG000|Overall Study|Withdrawal by Subject|2|||
19616125|NCT00596427|42065718|FG001|Overall Study|Withdrawal by Subject|2|||
19616126|NCT00596427|42065717|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
19616127|NCT00596427|42065718|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
19616128|NCT00596427|42065717|FG000|Overall Study|Protocol Violation|1|||
19616129|NCT00596427|42065718|FG001|Overall Study|Protocol Violation|0|||
19508327|NCT02144610|41918369|FG001|Overall Study|Physician Decision|0|||
19508328|NCT02144610|41918368|FG000|Overall Study|Withdrawal by Subject|1|||
19616130|NCT02732210|42065727|FG000|Overall Study|Site Closed|0|||
19616131|NCT02732210|42065728|FG001|Overall Study|Site Closed|11|||
19616132|NCT02732210|42065727|FG000|Overall Study|Study Ended|13|||
19616133|NCT02732210|42065728|FG001|Overall Study|Study Ended|13|||
19616134|NCT02732210|42065727|FG000|Overall Study|Withdrawal by Subject|28|||
19616135|NCT02732210|42065728|FG001|Overall Study|Withdrawal by Subject|87|||
19616136|NCT02732210|42065727|FG000|Overall Study|Lost to Follow-up|5|||
19616137|NCT02732210|42065728|FG001|Overall Study|Lost to Follow-up|57|||
19616138|NCT02732210|42065727|FG000|Overall Study|Death|4|||
19616139|NCT02732210|42065728|FG001|Overall Study|Death|15|||
19616140|NCT02732210|42065727|FG000|Overall Study|Other|35|||
19616141|NCT02732210|42065728|FG001|Overall Study|Other|103|||
19616142|NCT02732210|42065727|FG000|Overall Study|Missing|0|||
19508329|NCT02144610|41918369|FG001|Overall Study|Withdrawal by Subject|5|||
19508330|NCT02144610|41918368|FG000|Overall Study|Death|2|||
19508331|NCT02144610|41918369|FG001|Overall Study|Death|2|||
19508332|NCT02144610|41918368|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
19616143|NCT02732210|42065728|FG001|Overall Study|Missing|8|||
19616144|NCT00595959|42065734|FG000|Overall Study|Withdrawal by Subject|1|||
19616145|NCT00595959|42065734|FG000|Overall Study|Lost to Follow-up|1|||
19616146|NCT00436748|42065772|FG000|Overall Study|Ineligibility Determined|1|||
19616147|NCT00436748|42065773|FG001|Overall Study|Ineligibility Determined|1|||
19616148|NCT00436748|42065772|FG000|Overall Study|Adverse Event|0|||
19616149|NCT00436748|42065773|FG001|Overall Study|Adverse Event|2|||
19616150|NCT00436748|42065772|FG000|Overall Study|Consent Withdrawn|1|||
19616151|NCT00436748|42065773|FG001|Overall Study|Consent Withdrawn|4|||
19616152|NCT00436748|42065772|FG000|Overall Study|Administrative Decision|1|||
19616153|NCT00436748|42065773|FG001|Overall Study|Administrative Decision|0|||
19616154|NCT00436748|42065772|FG000|Overall Study|Lost to Follow-up|0|||
19616155|NCT00436748|42065773|FG001|Overall Study|Lost to Follow-up|1|||
19616156|NCT00436748|42065772|FG000|Overall Study|Protocol-specified Criteria|5|||
19616157|NCT00436748|42065773|FG001|Overall Study|Protocol-specified Criteria|4|||
19616158|NCT00436748|42065772|FG000|Overall Study|Other|3|||
19616159|NCT00436748|42065773|FG001|Overall Study|Other|0|||
19616160|NCT03342404|42065781|FG000|Overall Study|Withdrawal by Subject|9|||
19616161|NCT03342404|42065782|FG001|Overall Study|Withdrawal by Subject|10|||
19616162|NCT03342404|42065781|FG000|Overall Study|Lack of Efficacy|1|||
19616163|NCT03342404|42065782|FG001|Overall Study|Lack of Efficacy|17|||
19616164|NCT03342404|42065781|FG000|Overall Study|Adverse Event|3|||
19616165|NCT03342404|42065782|FG001|Overall Study|Adverse Event|4|||
19616166|NCT03342404|42065781|FG000|Overall Study|Noncompliance with study drug|1|||
19616167|NCT03342404|42065782|FG001|Overall Study|Noncompliance with study drug|0|||
19616168|NCT03342404|42065781|FG000|Overall Study|Other reasons|1|||
19616169|NCT03342404|42065782|FG001|Overall Study|Other reasons|0|||
19616170|NCT02703272|42065792|FG000|Overall Study|Death|4|||
19616171|NCT02703272|42065793|FG001|Overall Study|Death|9|||
19616172|NCT02703272|42065794|FG002|Overall Study|Death|19|||
19616173|NCT02703272|42065795|FG003|Overall Study|Death|10|||
19616174|NCT02703272|42065792|FG000|Overall Study|Withdrawal by Subject|0|||
19616175|NCT02703272|42065793|FG001|Overall Study|Withdrawal by Subject|0|||
19616176|NCT02703272|42065794|FG002|Overall Study|Withdrawal by Subject|4|||
19394090|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
19394091|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
19394092|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
19394093|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
19508333|NCT02144610|41918369|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
19508334|NCT02144610|41918368|FG000|Overall Study|Other|0|||
19508335|NCT02144610|41918369|FG001|Overall Study|Other|1|||
19508336|NCT02100228|41918377|FG000|Overall Study|Other|19|||
19508337|NCT02100228|41918378|FG001|Overall Study|Other|19|||
19508338|NCT02100228|41918377|FG000|Overall Study|Administrative reason|0|||
19508339|NCT02100228|41918378|FG001|Overall Study|Administrative reason|1|||
19508340|NCT02100228|41918377|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
19508341|NCT02100228|41918378|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
19508342|NCT02100228|41918377|FG000|Overall Study|Non-compliance|0|||
19508343|NCT02100228|41918378|FG001|Overall Study|Non-compliance|3|||
19508344|NCT02100228|41918377|FG000|Overall Study|Lost to Follow-up|0|||
19508345|NCT02100228|41918378|FG001|Overall Study|Lost to Follow-up|1|||
19508346|NCT02100228|41918377|FG000|Overall Study|Withdrawal by Subject|27|||
19508347|NCT02100228|41918378|FG001|Overall Study|Withdrawal by Subject|37|||
19508348|NCT02100228|41918377|FG000|Overall Study|Adverse Event|16|||
19508349|NCT02100228|41918378|FG001|Overall Study|Adverse Event|12|||
19508350|NCT02100228|41918377|FG000|Overall Study|Death|1|||
19508351|NCT02100228|41918378|FG001|Overall Study|Death|1|||
19508352|NCT02099838|41918386|FG000|Overall Study|Death|1|||
19508353|NCT02099838|41918387|FG001|Overall Study|Death|0|||
19508354|NCT02099838|41918386|FG000|Overall Study|Lost to Follow-up|3|||
19508355|NCT02099838|41918387|FG001|Overall Study|Lost to Follow-up|1|||
19508356|NCT02099838|41918386|FG000|Overall Study|Withdrawal by Subject|0|||
19394094|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
19394095|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
19394096|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
19394097|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
19394098|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
19508357|NCT02099838|41918387|FG001|Overall Study|Withdrawal by Subject|1|||
19508358|NCT02144220|41918393|FG000|Overall Study|technology incompatibility|9|||
19616177|NCT02703272|42065795|FG003|Overall Study|Withdrawal by Subject|2|||
19508359|NCT02144220|41918393|FG000|Overall Study|Lack of Efficacy|4|||
19508360|NCT02144220|41918393|FG000|Overall Study|Physician Decision|3|||
19508361|NCT02144220|41918393|FG000|Overall Study|Withdrawal by Subject|2|||
19508362|NCT02144220|41918393|FG000|Overall Study|Protocol Violation|1|||
19508363|NCT02099682|41918397|FG000|Overall Study|Data Not Available|51|||
19508364|NCT02099682|41918397|FG000|Overall Study|Lost to Follow-up|31|||
19508365|NCT02099682|41918397|FG000|Overall Study|Other|29|||
19616178|NCT02703272|42065792|FG000|Overall Study|Study Terminated by Sponsor|6|||
19616179|NCT02703272|42065793|FG001|Overall Study|Study Terminated by Sponsor|1|||
19616180|NCT02703272|42065794|FG002|Overall Study|Study Terminated by Sponsor|12|||
19616181|NCT02703272|42065795|FG003|Overall Study|Study Terminated by Sponsor|4|||
19508366|NCT02142894|41918401|FG000|Overall Study|Protocol Violation|8|||
19508367|NCT02098746|41918405|FG000|Overall Study|Changes of Investigator|2|||
19508368|NCT02098746|41918405|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19508369|NCT02098746|41918405|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
19508370|NCT02098746|41918405|FG000|Overall Study|Data Not Available After Treatment|1|||
19508371|NCT02122770|41918413|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
19508372|NCT02122770|41918414|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
19508373|NCT02122770|41918415|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
19508374|NCT02122770|41918416|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
19508375|NCT02122770|41918417|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
19508376|NCT02122770|41918418|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
19508377|NCT02122770|41918413|FG000|Part A: Drug-drug Interaction 2|Other|0|||
19508378|NCT02122770|41918414|FG001|Part A: Drug-drug Interaction 2|Other|0|||
19616182|NCT02703272|42065792|FG000|Overall Study|Other|1|||
19616183|NCT02703272|42065793|FG001|Overall Study|Other|0|||
19616184|NCT02703272|42065794|FG002|Overall Study|Other|0|||
19616185|NCT02703272|42065795|FG003|Overall Study|Other|0|||
19616186|NCT02568215|42065835|FG000|Overall Study|Death|1|||
19616187|NCT02568215|42065836|FG001|Overall Study|Death|2|||
19616188|NCT02568215|42065837|FG002|Overall Study|Death|0|||
19616189|NCT02568215|42065835|FG000|Overall Study|Physician Decision|2|||
19616190|NCT02568215|42065836|FG001|Overall Study|Physician Decision|2|||
19616191|NCT02568215|42065837|FG002|Overall Study|Physician Decision|2|||
19616192|NCT02568215|42065835|FG000|Overall Study|Lost to Follow-up|29|||
19616193|NCT02568215|42065836|FG001|Overall Study|Lost to Follow-up|32|||
19616194|NCT02568215|42065837|FG002|Overall Study|Lost to Follow-up|41|||
19616195|NCT02568215|42065835|FG000|Overall Study|Withdrawal by Subject|21|||
19616196|NCT02568215|42065836|FG001|Overall Study|Withdrawal by Subject|19|||
19616197|NCT02568215|42065837|FG002|Overall Study|Withdrawal by Subject|22|||
19616198|NCT02568215|42065835|FG000|Overall Study|Protocol Violation|1|||
19616199|NCT02568215|42065836|FG001|Overall Study|Protocol Violation|1|||
19616200|NCT02568215|42065837|FG002|Overall Study|Protocol Violation|0|||
19616201|NCT02568215|42065835|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
19616202|NCT02568215|42065836|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
19616203|NCT02568215|42065837|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
19616204|NCT02568215|42065835|FG000|Overall Study|Other|0|||
19616205|NCT02568215|42065836|FG001|Overall Study|Other|1|||
19616206|NCT02568215|42065837|FG002|Overall Study|Other|4|||
19616207|NCT00908141|42065874|FG000|Overall Study|Withdrawal by Subject|0|||
19616208|NCT00908141|42065875|FG001|Overall Study|Withdrawal by Subject|1|||
19616209|NCT00906347|42065883|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
19616210|NCT00906347|42065884|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
19616211|NCT00906347|42065883|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
19616212|NCT00906347|42065884|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
19616213|NCT00906347|42065883|FG000|Received Study Drug|Refused study drug|1|||
19616214|NCT00906347|42065884|FG001|Received Study Drug|Refused study drug|0|||
19616215|NCT00906347|42065883|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
19616216|NCT00906347|42065884|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
19616217|NCT00906035|42065893|FG000|Overall Study|Withdrawal by Subject|2|||
19616218|NCT00906035|42065894|FG001|Overall Study|Withdrawal by Subject|3|||
19616219|NCT00906035|42065895|FG002|Overall Study|Withdrawal by Subject|0|||
19616220|NCT00905489|42065903|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
19616221|NCT00905489|42065903|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
19616222|NCT00905489|42065903|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
19616223|NCT02704754|42065914|FG000|Overall Study|Lost to Follow-up|1|||
19616224|NCT02704754|42065915|FG001|Overall Study|Lost to Follow-up|1|||
19616225|NCT02704754|42065914|FG000|Overall Study|Lack of Efficacy|1|||
19616226|NCT02704754|42065915|FG001|Overall Study|Lack of Efficacy|0|||
19508379|NCT02122770|41918415|FG002|Part A: Drug-drug Interaction 2|Other|1|||
19508380|NCT02122770|41918416|FG003|Part A: Drug-drug Interaction 2|Other|0|||
19508381|NCT02122770|41918417|FG004|Part A: Drug-drug Interaction 2|Other|0|||
19508382|NCT02122770|41918418|FG005|Part A: Drug-drug Interaction 2|Other|0|||
19508383|NCT02122770|41918413|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
19508384|NCT02122770|41918414|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
19616227|NCT02704754|42065914|FG000|Overall Study|Withdrawal by Subject|1|||
19616228|NCT02704754|42065915|FG001|Overall Study|Withdrawal by Subject|0|||
19616229|NCT03170882|42065923|FG000|Overall Study|Death|17|||
19616230|NCT03170882|42065924|FG001|Overall Study|Death|29|||
19616231|NCT03170882|42065923|FG000|Overall Study|Lost to Follow-up|0|||
19616232|NCT03170882|42065924|FG001|Overall Study|Lost to Follow-up|1|||
19616233|NCT03170882|42065923|FG000|Overall Study|Withdrawal by Subject|4|||
19616234|NCT03170882|42065924|FG001|Overall Study|Withdrawal by Subject|7|||
19616235|NCT03170882|42065923|FG000|Overall Study|Reason not Specified|28|||
19616236|NCT03170882|42065924|FG001|Overall Study|Reason not Specified|36|||
19508385|NCT02122770|41918415|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
19508386|NCT02122770|41918416|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
19508387|NCT02122770|41918417|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
19508388|NCT02122770|41918418|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
19508389|NCT02122770|41918413|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
19508390|NCT02122770|41918414|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
19508391|NCT02122770|41918415|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
19508392|NCT02122770|41918416|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
19508393|NCT02122770|41918417|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
19508394|NCT02122770|41918418|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
19508395|NCT02122770|41918413|FG000|Part B: Standard of Care|Adverse Event|0|||
19508396|NCT02122770|41918414|FG001|Part B: Standard of Care|Adverse Event|0|||
19508397|NCT02122770|41918415|FG002|Part B: Standard of Care|Adverse Event|0|||
19508398|NCT02122770|41918416|FG003|Part B: Standard of Care|Adverse Event|0|||
19508399|NCT02122770|41918417|FG004|Part B: Standard of Care|Adverse Event|4|||
19508400|NCT02122770|41918418|FG005|Part B: Standard of Care|Adverse Event|1|||
19508401|NCT02122770|41918413|FG000|Part B: Standard of Care|Other|0|||
19508402|NCT02122770|41918414|FG001|Part B: Standard of Care|Other|0|||
19508403|NCT02122770|41918415|FG002|Part B: Standard of Care|Other|0|||
19508404|NCT02122770|41918416|FG003|Part B: Standard of Care|Other|0|||
19508405|NCT02122770|41918417|FG004|Part B: Standard of Care|Other|0|||
19508406|NCT02122770|41918418|FG005|Part B: Standard of Care|Other|2|||
19508407|NCT02122770|41918413|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
19508408|NCT02122770|41918414|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
19508409|NCT02122770|41918415|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
19508410|NCT02122770|41918416|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
19508411|NCT02122770|41918417|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
19508412|NCT02122770|41918418|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
19508413|NCT02122770|41918413|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
19508414|NCT02122770|41918414|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
19508415|NCT02122770|41918415|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
19508416|NCT02122770|41918416|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
19508417|NCT02122770|41918417|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
19508418|NCT02122770|41918418|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
19616237|NCT00907517|42065935|FG000|Overall Study|Progressive Disease|3|||
19616238|NCT00907517|42065936|FG001|Overall Study|Progressive Disease|3|||
19616239|NCT00907517|42065937|FG002|Overall Study|Progressive Disease|4|||
19616240|NCT00907517|42065938|FG003|Overall Study|Progressive Disease|4|||
19616241|NCT00907517|42065939|FG004|Overall Study|Progressive Disease|4|||
19616242|NCT00907517|42065935|FG000|Overall Study|Symptomatic Deterioration|0|||
19616243|NCT00907517|42065936|FG001|Overall Study|Symptomatic Deterioration|0|||
19616244|NCT00907517|42065937|FG002|Overall Study|Symptomatic Deterioration|0|||
19616245|NCT00907517|42065938|FG003|Overall Study|Symptomatic Deterioration|0|||
19616246|NCT00907517|42065939|FG004|Overall Study|Symptomatic Deterioration|1|||
19616247|NCT00905255|42065953|FG000|Overall Study|Adverse Event|7|||
19616248|NCT00905255|42065954|FG001|Overall Study|Adverse Event|5|||
19616249|NCT00905255|42065953|FG000|Overall Study|Withdrawal by Subject|5|||
19616250|NCT00905255|42065954|FG001|Overall Study|Withdrawal by Subject|4|||
19616251|NCT00905255|42065953|FG000|Overall Study|Familial and Personal Reasons|1|||
19616252|NCT00905255|42065954|FG001|Overall Study|Familial and Personal Reasons|0|||
19616253|NCT00905021|42065961|FG000|Overall Study|Adverse Event|2|||
19616254|NCT00906971|42065968|FG000|Overall Study|Withdrawal by Subject|8|||
19616255|NCT00906971|42065969|FG001|Overall Study|Withdrawal by Subject|2|||
19508419|NCT02122770|41918413|FG000|Part B: Standard of Care|Progressive Disease|0|||
19508420|NCT02122770|41918414|FG001|Part B: Standard of Care|Progressive Disease|0|||
19508421|NCT02122770|41918415|FG002|Part B: Standard of Care|Progressive Disease|0|||
19508422|NCT02122770|41918416|FG003|Part B: Standard of Care|Progressive Disease|0|||
19508423|NCT02122770|41918417|FG004|Part B: Standard of Care|Progressive Disease|10|||
19508424|NCT02122770|41918418|FG005|Part B: Standard of Care|Progressive Disease|8|||
19508425|NCT02122380|41918443|FG000|First Intervention (30 Days)|Adverse Event|1|||
19508426|NCT02122380|41918444|FG001|First Intervention (30 Days)|Adverse Event|0|||
19508427|NCT02122380|41918443|FG000|First Intervention (30 Days)|Physician Decision|0|||
19508428|NCT02122380|41918444|FG001|First Intervention (30 Days)|Physician Decision|1|||
19508429|NCT02122380|41918443|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
19508430|NCT02122380|41918444|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
19508431|NCT02122380|41918443|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
19508432|NCT02122380|41918444|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
19616256|NCT00906971|42065968|FG000|Overall Study|Lost to Follow-up|0|||
19616257|NCT00906971|42065969|FG001|Overall Study|Lost to Follow-up|1|||
19616258|NCT00903929|42065975|FG000|Overall Study|Withdrawal by Subject|0|||
19616259|NCT00903929|42065976|FG001|Overall Study|Withdrawal by Subject|0|||
19616260|NCT00903929|42065977|FG002|Overall Study|Withdrawal by Subject|1|||
19616261|NCT00903929|42065978|FG003|Overall Study|Withdrawal by Subject|2|||
19508433|NCT02122380|41918443|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
19508434|NCT02122380|41918444|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
19508435|NCT02122146|41918459|FG000|Part 1: Dose Escalation|Death|0|||
19508436|NCT02122146|41918460|FG001|Part 1: Dose Escalation|Death|1|||
19508437|NCT02122146|41918461|FG002|Part 1: Dose Escalation|Death|1|||
19508438|NCT02122146|41918462|FG003|Part 1: Dose Escalation|Death|0|||
19508439|NCT02122146|41918463|FG004|Part 1: Dose Escalation|Death|0|||
19508440|NCT02122146|41918464|FG005|Part 1: Dose Escalation|Death|0|||
19508441|NCT02122146|41918465|FG006|Part 1: Dose Escalation|Death|0|||
19508442|NCT02122146|41918466|FG007|Part 1: Dose Escalation|Death|0|||
19508443|NCT02122146|41918459|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508444|NCT02122146|41918460|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508445|NCT02122146|41918461|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
19508446|NCT02122146|41918462|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508447|NCT02122146|41918463|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
19508448|NCT02122146|41918464|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508449|NCT02122146|41918465|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508450|NCT02122146|41918466|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
19508451|NCT02122146|41918459|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508452|NCT02122146|41918460|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508453|NCT02122146|41918461|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508454|NCT02122146|41918462|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
19508455|NCT02122146|41918463|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508456|NCT02122146|41918464|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508457|NCT02122146|41918465|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508458|NCT02122146|41918466|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
19508459|NCT02122146|41918459|FG000|Part 1: Dose Escalation|Other|1|||
19508460|NCT02122146|41918460|FG001|Part 1: Dose Escalation|Other|0|||
19508461|NCT02122146|41918461|FG002|Part 1: Dose Escalation|Other|0|||
19508462|NCT02122146|41918462|FG003|Part 1: Dose Escalation|Other|0|||
19508463|NCT02122146|41918463|FG004|Part 1: Dose Escalation|Other|0|||
19508464|NCT02122146|41918464|FG005|Part 1: Dose Escalation|Other|1|||
19508465|NCT02122146|41918465|FG006|Part 1: Dose Escalation|Other|1|||
19508466|NCT02122146|41918466|FG007|Part 1: Dose Escalation|Other|2|||
19508467|NCT02121834|41918492|FG000|Overall Study|Protocol Violation|0|||
19508468|NCT02121834|41918493|FG001|Overall Study|Protocol Violation|1|||
19508469|NCT02121834|41918494|FG002|Overall Study|Protocol Violation|0|||
19508470|NCT02121834|41918495|FG003|Overall Study|Protocol Violation|0|||
19508471|NCT02121834|41918496|FG004|Overall Study|Protocol Violation|0|||
19508472|NCT02121834|41918497|FG005|Overall Study|Protocol Violation|0|||
19508473|NCT02121834|41918498|FG006|Overall Study|Protocol Violation|0|||
19508474|NCT02121834|41918492|FG000|Overall Study|Withdrawal by Subject|0|||
19508475|NCT02121834|41918493|FG001|Overall Study|Withdrawal by Subject|1|||
19508476|NCT02121834|41918494|FG002|Overall Study|Withdrawal by Subject|1|||
19508477|NCT02121834|41918495|FG003|Overall Study|Withdrawal by Subject|0|||
19508478|NCT02121834|41918496|FG004|Overall Study|Withdrawal by Subject|0|||
19508479|NCT02121834|41918497|FG005|Overall Study|Withdrawal by Subject|0|||
19508480|NCT02121834|41918498|FG006|Overall Study|Withdrawal by Subject|0|||
19508481|NCT02121834|41918492|FG000|Overall Study|Lost to Follow-up|0|||
19508482|NCT02121834|41918493|FG001|Overall Study|Lost to Follow-up|0|||
19508483|NCT02121834|41918494|FG002|Overall Study|Lost to Follow-up|1|||
19508484|NCT02121834|41918495|FG003|Overall Study|Lost to Follow-up|0|||
19508485|NCT02121834|41918496|FG004|Overall Study|Lost to Follow-up|0|||
19508486|NCT02121834|41918497|FG005|Overall Study|Lost to Follow-up|0|||
19508487|NCT02121834|41918498|FG006|Overall Study|Lost to Follow-up|0|||
19508488|NCT02121756|41918526|FG000|Overall Study|Adverse Event|3|||
19508489|NCT02121756|41918527|FG001|Overall Study|Adverse Event|0|||
19508490|NCT02121756|41918526|FG000|Overall Study|Protocol Violation|1|||
19508491|NCT02121756|41918527|FG001|Overall Study|Protocol Violation|1|||
19508492|NCT02121756|41918526|FG000|Overall Study|Physician Decision|2|||
19508493|NCT02121756|41918527|FG001|Overall Study|Physician Decision|1|||
19508494|NCT02142504|41918539|FG000|Overall Study|Protocol Violation|2|||
19508495|NCT02142504|41918540|FG001|Overall Study|Protocol Violation|1|||
19508496|NCT02142504|41918541|FG002|Overall Study|Protocol Violation|2|||
19508497|NCT02142504|41918539|FG000|Overall Study|Adverse Event|2|||
19508498|NCT02142504|41918540|FG001|Overall Study|Adverse Event|3|||
19508499|NCT02142504|41918541|FG002|Overall Study|Adverse Event|4|||
19704539|NCT00129402|42148930|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19508500|NCT02142504|41918539|FG000|Overall Study|Lost to Follow-up|12|||
19508501|NCT02142504|41918540|FG001|Overall Study|Lost to Follow-up|19|||
19508502|NCT02142504|41918541|FG002|Overall Study|Lost to Follow-up|17|||
19508503|NCT02142504|41918539|FG000|Overall Study|Withdrawal by Subject|7|||
19508504|NCT02142504|41918540|FG001|Overall Study|Withdrawal by Subject|9|||
19508505|NCT02142504|41918541|FG002|Overall Study|Withdrawal by Subject|11|||
19508506|NCT02142504|41918539|FG000|Overall Study|Pregnancy|4|||
19508507|NCT02142504|41918540|FG001|Overall Study|Pregnancy|4|||
19508508|NCT02142504|41918541|FG002|Overall Study|Pregnancy|2|||
19508509|NCT02142504|41918539|FG000|Overall Study|Physician Decision|0|||
19508510|NCT02142504|41918540|FG001|Overall Study|Physician Decision|1|||
19508511|NCT02142504|41918541|FG002|Overall Study|Physician Decision|3|||
19508512|NCT02142504|41918539|FG000|Overall Study|Reason Not Specified|4|||
19508513|NCT02142504|41918540|FG001|Overall Study|Reason Not Specified|5|||
19508514|NCT02142504|41918541|FG002|Overall Study|Reason Not Specified|4|||
19508515|NCT02121522|41918549|FG000|Overall Study|Adverse Event|1|||
19508516|NCT02121210|41918555|FG000|Overall Study|Adverse Event|5|||
19508517|NCT02121210|41918556|FG001|Overall Study|Adverse Event|7|||
19508518|NCT02121210|41918555|FG000|Overall Study|Lack of Efficacy|2|||
19508519|NCT02121210|41918556|FG001|Overall Study|Lack of Efficacy|0|||
19508520|NCT02121210|41918555|FG000|Overall Study|Other than specified above|0|||
19508521|NCT02121210|41918556|FG001|Overall Study|Other than specified above|2|||
19508522|NCT02141490|41918565|FG000|Overall Study|Screening failures|4|||
19508523|NCT02141490|41918566|FG001|Overall Study|Screening failures|0|||
19508524|NCT02141490|41918567|FG002|Overall Study|Screening failures|0|||
19508525|NCT02097108|41918577|FG000|Overall Study|Adverse Event|1|||
19508526|NCT02097108|41918577|FG000|Overall Study|patient was abroad for 6 months|1|||
19508527|NCT02097030|41918583|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
19508528|NCT02097030|41918584|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
19508529|NCT02097030|41918583|FG000|First Intervention (3 Days)|Visual Acuity|0|||
19508530|NCT02097030|41918584|FG001|First Intervention (3 Days)|Visual Acuity|1|||
19508531|NCT02096952|41918594|FG000|Overall Study|Adverse Event|1|||
19508532|NCT02120898|41918601|FG000|Overall Study|Withdrawal by Subject|4|||
19508533|NCT02120898|41918602|FG001|Overall Study|Withdrawal by Subject|2|||
19508534|NCT02120898|41918603|FG002|Overall Study|Withdrawal by Subject|2|||
19508535|NCT02120898|41918601|FG000|Overall Study|Non-compliance with study drug|3|||
19508536|NCT02120898|41918602|FG001|Overall Study|Non-compliance with study drug|0|||
19508537|NCT02120898|41918603|FG002|Overall Study|Non-compliance with study drug|0|||
19508538|NCT02120898|41918601|FG000|Overall Study|Adverse Event|1|||
19508539|NCT02120898|41918602|FG001|Overall Study|Adverse Event|2|||
19616262|NCT00903929|42065975|FG000|Overall Study|Adverse Event|0|||
19616263|NCT00903929|42065976|FG001|Overall Study|Adverse Event|0|||
19616264|NCT00903929|42065977|FG002|Overall Study|Adverse Event|0|||
19616265|NCT00903929|42065978|FG003|Overall Study|Adverse Event|1|||
19616266|NCT00903695|42065985|FG000|Overall Study|medical exclusion after 1st testing|1|||
19616267|NCT00903695|42065986|FG001|Overall Study|medical exclusion after 1st testing|0|||
19616268|NCT00903695|42065985|FG000|Overall Study|lung cancer|1|||
19616269|NCT00903695|42065986|FG001|Overall Study|lung cancer|0|||
19394099|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
19508540|NCT02120898|41918603|FG002|Overall Study|Adverse Event|1|||
19508541|NCT02120898|41918601|FG000|Overall Study|Protocol Violation|1|||
19508542|NCT02120898|41918602|FG001|Overall Study|Protocol Violation|2|||
19508543|NCT02120898|41918603|FG002|Overall Study|Protocol Violation|0|||
19508544|NCT02120898|41918601|FG000|Overall Study|Lost to Follow-up|0|||
19508545|NCT02120898|41918602|FG001|Overall Study|Lost to Follow-up|0|||
19508546|NCT02120898|41918603|FG002|Overall Study|Lost to Follow-up|1|||
19508547|NCT02120664|41918616|FG000|Overall Study|Withdrawal by Subject|0|||
19508548|NCT02120664|41918617|FG001|Overall Study|Withdrawal by Subject|0|||
19508549|NCT02120664|41918618|FG002|Overall Study|Withdrawal by Subject|0|||
19508550|NCT02120664|41918619|FG003|Overall Study|Withdrawal by Subject|1|||
19508551|NCT02120664|41918620|FG004|Overall Study|Withdrawal by Subject|0|||
19508552|NCT01627860|41918635|FG000|Overall Study|Adverse Event|9|||
19508553|NCT01627860|41918636|FG001|Overall Study|Adverse Event|4|||
19508554|NCT01627860|41918635|FG000|Overall Study|Withdrawal by Subject|2|||
19508555|NCT01627860|41918636|FG001|Overall Study|Withdrawal by Subject|1|||
19508556|NCT01627860|41918635|FG000|Overall Study|Seizure frequency doubled|0|||
19508557|NCT01627860|41918636|FG001|Overall Study|Seizure frequency doubled|1|||
19508558|NCT01627860|41918635|FG000|Overall Study|Protocol Violation|1|||
19508559|NCT01627860|41918636|FG001|Overall Study|Protocol Violation|0|||
19508560|NCT01627782|41918646|FG000|Overall Study|Adverse Event|1|||
19508561|NCT01627782|41918647|FG001|Overall Study|Adverse Event|2|||
19508562|NCT01627782|41918648|FG002|Overall Study|Adverse Event|0|||
19508563|NCT01627782|41918649|FG003|Overall Study|Adverse Event|1|||
19508564|NCT01627782|41918646|FG000|Overall Study|Lack of Efficacy|11|||
19508565|NCT01627782|41918647|FG001|Overall Study|Lack of Efficacy|1|||
19394100|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
19508566|NCT01627782|41918648|FG002|Overall Study|Lack of Efficacy|15|||
19508567|NCT01627782|41918649|FG003|Overall Study|Lack of Efficacy|2|||
19508568|NCT01627782|41918646|FG000|Overall Study|Protocol Violation|1|||
19508569|NCT01627782|41918647|FG001|Overall Study|Protocol Violation|0|||
19508570|NCT01627782|41918648|FG002|Overall Study|Protocol Violation|0|||
19508571|NCT01627782|41918649|FG003|Overall Study|Protocol Violation|0|||
19508572|NCT01627782|41918646|FG000|Overall Study|Withdrawal by Subject|2|||
19508573|NCT01627782|41918647|FG001|Overall Study|Withdrawal by Subject|1|||
19508574|NCT01627782|41918648|FG002|Overall Study|Withdrawal by Subject|0|||
19508575|NCT01627782|41918649|FG003|Overall Study|Withdrawal by Subject|0|||
19508576|NCT01627782|41918646|FG000|Overall Study|Other|0|||
19616270|NCT02432274|42066002|FG000|Overall Study|Radiological Disease Progression|3|||
19508577|NCT01627782|41918647|FG001|Overall Study|Other|2|||
19508578|NCT01627782|41918648|FG002|Overall Study|Other|0|||
19508579|NCT01627782|41918649|FG003|Overall Study|Other|3|||
19508580|NCT01627782|41918646|FG000|Overall Study|Randomized But Not Treated|1|||
19508581|NCT01627782|41918647|FG001|Overall Study|Randomized But Not Treated|0|||
19508582|NCT01627782|41918648|FG002|Overall Study|Randomized But Not Treated|0|||
19508583|NCT01627782|41918649|FG003|Overall Study|Randomized But Not Treated|0|||
19508584|NCT01598532|41918661|FG000|Overall Study|Lost to Follow-up|3|||
19508585|NCT01598532|41918661|FG000|Overall Study|Did not meet inclusion criteria|8|||
19508586|NCT02119650|41918670|FG000|Overall Study|Adverse Event|3|||
19508587|NCT02119650|41918671|FG001|Overall Study|Adverse Event|4|||
19508588|NCT02119650|41918670|FG000|Overall Study|Subject decision|2|||
19508589|NCT02119650|41918671|FG001|Overall Study|Subject decision|3|||
19508590|NCT02119650|41918670|FG000|Overall Study|Disease progression|11|||
19508591|NCT02119650|41918671|FG001|Overall Study|Disease progression|14|||
19508592|NCT02119650|41918670|FG000|Overall Study|Death|5|||
19508593|NCT02119650|41918671|FG001|Overall Study|Death|1|||
19508594|NCT02119650|41918670|FG000|Overall Study|Noncompliance with study treatment|1|||
19508595|NCT02119650|41918671|FG001|Overall Study|Noncompliance with study treatment|1|||
19508596|NCT02119650|41918670|FG000|Overall Study|Study terminated by the sponsor|1|||
19508597|NCT02119650|41918671|FG001|Overall Study|Study terminated by the sponsor|0|||
19508598|NCT02119650|41918670|FG000|Overall Study|Physician Decision|0|||
19508599|NCT02119650|41918671|FG001|Overall Study|Physician Decision|2|||
19508600|NCT02119650|41918670|FG000|Overall Study|Multiple reasons for termination|2|||
19508601|NCT02119650|41918671|FG001|Overall Study|Multiple reasons for termination|1|||
19508602|NCT02119416|41918680|FG000|Overall Study|Protocol Violation|1|||
19508603|NCT02119416|41918681|FG001|Overall Study|Protocol Violation|1|||
19508604|NCT02119416|41918682|FG002|Overall Study|Protocol Violation|1|||
19508605|NCT02119416|41918680|FG000|Overall Study|wrong pubertal stage|1|||
19508606|NCT02119416|41918681|FG001|Overall Study|wrong pubertal stage|0|||
19508607|NCT02119416|41918682|FG002|Overall Study|wrong pubertal stage|1|||
19508608|NCT02140164|41918693|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
19508609|NCT02119260|41918704|FG000|Overall Study|Adverse Event|1|||
19508610|NCT02119260|41918705|FG001|Overall Study|Adverse Event|0|||
19508611|NCT02119260|41918706|FG002|Overall Study|Adverse Event|0|||
19508612|NCT02119260|41918707|FG003|Overall Study|Adverse Event|0|||
19508613|NCT02119260|41918708|FG004|Overall Study|Adverse Event|0|||
19508614|NCT02119260|41918709|FG005|Overall Study|Adverse Event|0|||
19508615|NCT02119260|41918710|FG006|Overall Study|Adverse Event|0|||
19508616|NCT02119260|41918704|FG000|Overall Study|Withdrew consent|0|||
19508617|NCT02119260|41918705|FG001|Overall Study|Withdrew consent|1|||
19508618|NCT02119260|41918706|FG002|Overall Study|Withdrew consent|1|||
19508619|NCT02119260|41918707|FG003|Overall Study|Withdrew consent|0|||
19508620|NCT02119260|41918708|FG004|Overall Study|Withdrew consent|0|||
19508621|NCT02119260|41918709|FG005|Overall Study|Withdrew consent|0|||
19508622|NCT02119260|41918710|FG006|Overall Study|Withdrew consent|0|||
19508623|NCT02119104|41918735|FG000|Overall Study|Protocol Violation|16|||
19508624|NCT02119026|41918741|FG000|1st-line Treatment|Adverse Event|9|||
19508625|NCT02119026|41918742|FG001|1st-line Treatment|Adverse Event|14|||
19508626|NCT02119026|41918741|FG000|1st-line Treatment|Physician Decision|3|||
19508627|NCT02119026|41918742|FG001|1st-line Treatment|Physician Decision|8|||
19508628|NCT02119026|41918741|FG000|1st-line Treatment|Withdrawal by Subject|4|||
19508629|NCT02119026|41918742|FG001|1st-line Treatment|Withdrawal by Subject|10|||
19508630|NCT02119026|41918741|FG000|1st-line Treatment|Patient condition or compliance|6|||
19508631|NCT02119026|41918742|FG001|1st-line Treatment|Patient condition or compliance|4|||
19508632|NCT02119026|41918741|FG000|1st-line Treatment|Surgery of metastases|2|||
19508633|NCT02119026|41918742|FG001|1st-line Treatment|Surgery of metastases|1|||
19508634|NCT02119026|41918741|FG000|1st-line Treatment|Death|2|||
19508635|NCT02119026|41918742|FG001|1st-line Treatment|Death|1|||
19508636|NCT02119026|41918741|FG000|2nd-line Treatment|Lost to Follow-up|2|||
19508637|NCT02119026|41918742|FG001|2nd-line Treatment|Lost to Follow-up|0|||
19508638|NCT02119026|41918741|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
19508639|NCT02119026|41918742|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
19508640|NCT02119026|41918741|FG000|2nd-line Treatment|Adverse Event|4|||
19508641|NCT02119026|41918742|FG001|2nd-line Treatment|Adverse Event|1|||
19508642|NCT02095158|41918748|FG000|Overall Study|Adverse Event|14|||
19508643|NCT02095158|41918748|FG000|Overall Study|Lack of Efficacy|3|||
19508644|NCT02095158|41918748|FG000|Overall Study|Pregnancy|1|||
19508645|NCT02095158|41918748|FG000|Overall Study|Lost to Follow-up|20|||
19508646|NCT02095158|41918748|FG000|Overall Study|Personal Reasons|35|||
19508647|NCT02095158|41918748|FG000|Overall Study|Protocol Violation|1|||
19508648|NCT02095158|41918748|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19508649|NCT02094612|41918754|FG000|Overall Study|Lost to Follow-up|47|||
19508650|NCT02094612|41918755|FG001|Overall Study|Lost to Follow-up|47|||
19508651|NCT02094612|41918754|FG000|Overall Study|Never started ADHD medication|32|||
19508652|NCT02094612|41918755|FG001|Overall Study|Never started ADHD medication|23|||
19508653|NCT02139306|41918763|FG000|Overall Study|Withdrawal by Subject|4|||
19508654|NCT02139306|41918764|FG001|Overall Study|Withdrawal by Subject|6|||
19508655|NCT02139306|41918763|FG000|Overall Study|Adverse Event|3|||
19508656|NCT02139306|41918764|FG001|Overall Study|Adverse Event|4|||
19508657|NCT02139306|41918763|FG000|Overall Study|Physician Decision|0|||
19508658|NCT02139306|41918764|FG001|Overall Study|Physician Decision|1|||
19508659|NCT02139306|41918763|FG000|Overall Study|Other Unspecified|2|||
19508660|NCT02139306|41918764|FG001|Overall Study|Other Unspecified|3|||
19508661|NCT02139306|41918763|FG000|Overall Study|Protocol Violation|4|||
19508662|NCT02139306|41918764|FG001|Overall Study|Protocol Violation|0|||
19508663|NCT02094300|41918771|FG000|Overall Study|Death|7|||
19508664|NCT02094300|41918771|FG000|Overall Study|Lost to Follow-up|10|||
19508665|NCT02094300|41918771|FG000|Overall Study|Still be eligible for follow-up|3|||
19508666|NCT02118792|41918777|FG000|Overall Study|Withdrawal by Subject|6|||
19508667|NCT02118792|41918778|FG001|Overall Study|Withdrawal by Subject|3|||
19508668|NCT02118792|41918777|FG000|Overall Study|Lost to Follow-up|4|||
19508669|NCT02118792|41918778|FG001|Overall Study|Lost to Follow-up|4|||
19508670|NCT02118792|41918777|FG000|Overall Study|Adverse Event|5|||
19508671|NCT02118792|41918778|FG001|Overall Study|Adverse Event|4|||
19508672|NCT02118792|41918777|FG000|Overall Study|Withdrawal by parent/guardian|14|||
19616271|NCT02432274|42066003|FG001|Overall Study|Radiological Disease Progression|4|||
19616272|NCT02432274|42066004|FG002|Overall Study|Radiological Disease Progression|7|||
19616273|NCT02432274|42066005|FG003|Overall Study|Radiological Disease Progression|0|||
19616274|NCT02432274|42066006|FG004|Overall Study|Radiological Disease Progression|24|||
19616275|NCT02432274|42066007|FG005|Overall Study|Radiological Disease Progression|6|||
19616276|NCT02432274|42066008|FG006|Overall Study|Radiological Disease Progression|11|||
19616277|NCT02432274|42066009|FG007|Overall Study|Radiological Disease Progression|9|||
19616278|NCT02432274|42066002|FG000|Overall Study|Clinical Disease Progression|0|||
19616279|NCT02432274|42066003|FG001|Overall Study|Clinical Disease Progression|4|||
19616280|NCT02432274|42066004|FG002|Overall Study|Clinical Disease Progression|1|||
19616281|NCT02432274|42066005|FG003|Overall Study|Clinical Disease Progression|0|||
19616282|NCT02432274|42066006|FG004|Overall Study|Clinical Disease Progression|1|||
19616283|NCT02432274|42066007|FG005|Overall Study|Clinical Disease Progression|0|||
19616284|NCT02432274|42066008|FG006|Overall Study|Clinical Disease Progression|0|||
19508673|NCT02118792|41918778|FG001|Overall Study|Withdrawal by parent/guardian|20|||
19508674|NCT02118792|41918777|FG000|Overall Study|Other|1|||
19508675|NCT02118792|41918778|FG001|Overall Study|Other|6|||
19508676|NCT02118792|41918777|FG000|Overall Study|Randomised but not treated|1|||
19508677|NCT02118792|41918778|FG001|Overall Study|Randomised but not treated|0|||
19508678|NCT02118714|41918786|FG000|Overall Study|Lost to Follow-up|2|||
19508679|NCT02118714|41918786|FG000|Overall Study|Protocol Violation|1|||
19508680|NCT02138916|41918793|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
19508681|NCT02138916|41918794|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
19508682|NCT02138916|41918795|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
19508683|NCT02138916|41918793|FG000|Overall Study|Death|14|||
19508684|NCT02138916|41918794|FG001|Overall Study|Death|11|||
19508685|NCT02138916|41918795|FG002|Overall Study|Death|12|||
19508686|NCT02138916|41918793|FG000|Overall Study|Withdrawal by Subject|27|||
19508687|NCT02138916|41918794|FG001|Overall Study|Withdrawal by Subject|31|||
19508688|NCT02138916|41918795|FG002|Overall Study|Withdrawal by Subject|32|||
19508689|NCT02138916|41918793|FG000|Overall Study|Study specific withdrawal criteria|0|||
19508690|NCT02138916|41918794|FG001|Overall Study|Study specific withdrawal criteria|0|||
19508691|NCT02138916|41918795|FG002|Overall Study|Study specific withdrawal criteria|1|||
19508692|NCT02138916|41918793|FG000|Overall Study|incorrect enrolment|1|||
19508693|NCT02138916|41918794|FG001|Overall Study|incorrect enrolment|1|||
19508694|NCT02138916|41918795|FG002|Overall Study|incorrect enrolment|0|||
19508695|NCT02138916|41918793|FG000|Overall Study|Severe non-compliance|1|||
19508696|NCT02138916|41918794|FG001|Overall Study|Severe non-compliance|2|||
19508697|NCT02138916|41918795|FG002|Overall Study|Severe non-compliance|1|||
19508698|NCT02138916|41918793|FG000|Overall Study|Lost to Follow-up|4|||
19508699|NCT02138916|41918794|FG001|Overall Study|Lost to Follow-up|2|||
19508700|NCT02138916|41918795|FG002|Overall Study|Lost to Follow-up|3|||
19508701|NCT02138916|41918793|FG000|Overall Study|Adverse Event|4|||
19508702|NCT02138916|41918794|FG001|Overall Study|Adverse Event|4|||
19508703|NCT02138916|41918795|FG002|Overall Study|Adverse Event|3|||
19508704|NCT02118012|41918805|FG000|Overall Study|Adverse Event|0|||
19508705|NCT02118012|41918806|FG001|Overall Study|Adverse Event|1|||
19508706|NCT02118012|41918805|FG000|Overall Study|Physician Decision|0|||
19508707|NCT02118012|41918806|FG001|Overall Study|Physician Decision|1|||
19508708|NCT02093520|41918814|FG000|Overall Study|Not treated|6|||
19508709|NCT02093520|41918815|FG001|Overall Study|Not treated|22|||
19508710|NCT02138838|41918823|FG000|Overall Study|Study Closure|7|||
19508711|NCT02138838|41918824|FG001|Overall Study|Study Closure|6|||
19508712|NCT02138838|41918823|FG000|Overall Study|Withdrawal by Subject|1|||
19508713|NCT02138838|41918824|FG001|Overall Study|Withdrawal by Subject|5|||
19508714|NCT02138214|41918833|FG000|Overall Study|Withdrawal by Subject|0|||
19616285|NCT02432274|42066009|FG007|Overall Study|Clinical Disease Progression|1|||
19616286|NCT02432274|42066002|FG000|Overall Study|Adverse Event|0|||
19508715|NCT02138214|41918834|FG001|Overall Study|Withdrawal by Subject|1|||
19508716|NCT02138214|41918835|FG002|Overall Study|Withdrawal by Subject|0|||
19508717|NCT02138214|41918833|FG000|Overall Study|Lost to Follow-up|0|||
19508718|NCT02138214|41918834|FG001|Overall Study|Lost to Follow-up|2|||
19508719|NCT02138214|41918835|FG002|Overall Study|Lost to Follow-up|4|||
19508720|NCT02138214|41918833|FG000|Overall Study|Screen Failure|0|||
19508721|NCT02138214|41918834|FG001|Overall Study|Screen Failure|1|||
19508722|NCT02138214|41918835|FG002|Overall Study|Screen Failure|0|||
19508723|NCT02092662|41918844|FG000|Overall Study|Lost to Follow-up|13|||
19508724|NCT02092662|41918845|FG001|Overall Study|Lost to Follow-up|0|||
19508725|NCT02092350|41918854|FG000|Overall Study|Adverse Event|0|||
19508726|NCT02092350|41918855|FG001|Overall Study|Adverse Event|3|||
19508727|NCT02092350|41918854|FG000|Overall Study|Death|2|||
19508728|NCT02092350|41918855|FG001|Overall Study|Death|5|||
19508729|NCT02092350|41918854|FG000|Overall Study|Lost to Follow-up|3|||
19508730|NCT02092350|41918855|FG001|Overall Study|Lost to Follow-up|1|||
19508731|NCT02092350|41918854|FG000|Overall Study|Protocol Violation|1|||
19508732|NCT02092350|41918855|FG001|Overall Study|Protocol Violation|0|||
19508733|NCT02092350|41918854|FG000|Overall Study|Physician Decision|1|||
19508734|NCT02092350|41918855|FG001|Overall Study|Physician Decision|1|||
19508735|NCT02092350|41918854|FG000|Overall Study|Screen Failure|1|||
19508736|NCT02092350|41918855|FG001|Overall Study|Screen Failure|0|||
19508737|NCT02092350|41918854|FG000|Overall Study|Withdrawal by Subject|2|||
19508738|NCT02092350|41918855|FG001|Overall Study|Withdrawal by Subject|2|||
19508739|NCT02117544|41918863|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
19508740|NCT02117544|41918864|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
19508741|NCT02138136|41918871|FG000|Overall Study|Protocol Violation|4|||
19508742|NCT02138136|41918871|FG000|Overall Study|Physician Decision|7|||
19508743|NCT02138136|41918871|FG000|Overall Study|Lack of Efficacy|35|||
19508744|NCT02138136|41918871|FG000|Overall Study|Pregnancy|2|||
19508745|NCT02138136|41918871|FG000|Overall Study|Adverse Event|18|||
19508746|NCT02138136|41918871|FG000|Overall Study|Withdrawal by Subject|36|||
19508747|NCT02138136|41918871|FG000|Overall Study|Lost to Follow-up|32|||
19508748|NCT02138136|41918871|FG000|Overall Study|Withdrawn by Sponsor|5|||
19508749|NCT01626690|41918878|FG000|Overall Study|Protocol Violation|1|||
19508750|NCT01626690|41918879|FG001|Overall Study|Protocol Violation|0|||
19508751|NCT01626690|41918878|FG000|Overall Study|Adverse Event|1|||
19508752|NCT01626690|41918879|FG001|Overall Study|Adverse Event|0|||
19508753|NCT01626456|41918889|FG000|Overall Study|Withdrawal by Subject|21|||
19616287|NCT02432274|42066003|FG001|Overall Study|Adverse Event|0|||
19616288|NCT02432274|42066004|FG002|Overall Study|Adverse Event|1|||
19616289|NCT02432274|42066005|FG003|Overall Study|Adverse Event|0|||
19616290|NCT02432274|42066006|FG004|Overall Study|Adverse Event|1|||
19616291|NCT02432274|42066007|FG005|Overall Study|Adverse Event|0|||
19616292|NCT02432274|42066008|FG006|Overall Study|Adverse Event|2|||
19616293|NCT02432274|42066009|FG007|Overall Study|Adverse Event|0|||
19616294|NCT02432274|42066002|FG000|Overall Study|Withdrawal by Subject|0|||
19616295|NCT02432274|42066003|FG001|Overall Study|Withdrawal by Subject|0|||
19508754|NCT01626456|41918890|FG001|Overall Study|Withdrawal by Subject|46|||
19508755|NCT01626456|41918889|FG000|Overall Study|Adverse Event|2|||
19508756|NCT01626456|41918890|FG001|Overall Study|Adverse Event|27|||
19508757|NCT01626456|41918889|FG000|Overall Study|Lost to Follow-up|2|||
19508758|NCT01626456|41918890|FG001|Overall Study|Lost to Follow-up|27|||
19508759|NCT01626456|41918889|FG000|Overall Study|Lack of Efficacy|6|||
19508760|NCT01626456|41918890|FG001|Overall Study|Lack of Efficacy|7|||
19508761|NCT01626456|41918889|FG000|Overall Study|Physician Decision|1|||
19508762|NCT01626456|41918890|FG001|Overall Study|Physician Decision|4|||
19508763|NCT01626456|41918889|FG000|Overall Study|Protocol Violation|1|||
19508764|NCT01626456|41918890|FG001|Overall Study|Protocol Violation|1|||
19508765|NCT01626456|41918889|FG000|Overall Study|Site Closure|2|||
19508766|NCT01626456|41918890|FG001|Overall Study|Site Closure|3|||
19508767|NCT01626456|41918889|FG000|Overall Study|Incarceration|0|||
19508768|NCT01626456|41918890|FG001|Overall Study|Incarceration|2|||
19508769|NCT02116608|41918908|FG000|Overall Study|Lost to Follow-up|0|||
19508770|NCT02116608|41918909|FG001|Overall Study|Lost to Follow-up|0|||
19508771|NCT02116608|41918910|FG002|Overall Study|Lost to Follow-up|1|||
19508772|NCT02116608|41918908|FG000|Overall Study|Physician Decision|0|||
19508773|NCT02116608|41918909|FG001|Overall Study|Physician Decision|1|||
19508774|NCT02116608|41918910|FG002|Overall Study|Physician Decision|0|||
19508775|NCT02116608|41918908|FG000|Overall Study|Death|0|||
19508776|NCT02116608|41918909|FG001|Overall Study|Death|1|||
19508777|NCT02116608|41918910|FG002|Overall Study|Death|0|||
19508778|NCT02092116|41918920|FG000|Overall Study|Withdrawal by Subject|0|||
19508779|NCT02092116|41918921|FG001|Overall Study|Withdrawal by Subject|3|||
19508780|NCT02092116|41918920|FG000|Overall Study|Adverse Event|0|||
19508781|NCT02092116|41918921|FG001|Overall Study|Adverse Event|1|||
19508782|NCT02091726|41918927|FG000|Overall Study|Lost to Follow-up|6|||
19508783|NCT02091414|41918931|FG000|Overall Study|Withdrawal by Subject|2|||
19508784|NCT02091414|41918931|FG000|Overall Study|Death|2|||
19508785|NCT02116530|41918937|FG000|Overall Study|Withdrawal by Subject|1|||
19508786|NCT02116530|41918938|FG001|Overall Study|Withdrawal by Subject|2|||
19508787|NCT02116530|41918937|FG000|Overall Study|Adverse Event|4|||
19508788|NCT02116530|41918938|FG001|Overall Study|Adverse Event|0|||
19508789|NCT02116530|41918937|FG000|Overall Study|Physician Decision|1|||
19508790|NCT02116530|41918938|FG001|Overall Study|Physician Decision|0|||
19508791|NCT02116530|41918937|FG000|Overall Study|Lost to Follow-up|1|||
19508792|NCT02116530|41918938|FG001|Overall Study|Lost to Follow-up|0|||
19508793|NCT02116530|41918937|FG000|Overall Study|Other Medical Problems|2|||
19508794|NCT02116530|41918938|FG001|Overall Study|Other Medical Problems|2|||
19508795|NCT02072226|41918946|FG000|Overall Study|Lost to Follow-up|11|||
19508796|NCT02072226|41918947|FG001|Overall Study|Lost to Follow-up|7|||
19508797|NCT02072226|41918946|FG000|Overall Study|Patient Non-compliance|2|||
19508798|NCT02072226|41918947|FG001|Overall Study|Patient Non-compliance|3|||
19508799|NCT02072226|41918946|FG000|Overall Study|Death|1|||
19508800|NCT02072226|41918947|FG001|Overall Study|Death|0|||
19508801|NCT02072226|41918946|FG000|Overall Study|Patient Withdrawal of Consent|1|||
19508802|NCT02072226|41918947|FG001|Overall Study|Patient Withdrawal of Consent|0|||
19508803|NCT02071290|41918955|FG000|Overall Study|Death|1|||
19508804|NCT02071290|41918956|FG001|Overall Study|Death|0|||
19508805|NCT02071290|41918955|FG000|Overall Study|Withdrawal by Subject|0|||
19508806|NCT02071290|41918956|FG001|Overall Study|Withdrawal by Subject|1|||
19508807|NCT02071290|41918955|FG000|Overall Study|Protocol Violation|3|||
19508808|NCT02071290|41918956|FG001|Overall Study|Protocol Violation|5|||
19508809|NCT02071290|41918955|FG000|Overall Study|Physician Decision|0|||
19508810|NCT02071290|41918956|FG001|Overall Study|Physician Decision|1|||
19508811|NCT02090634|41918964|FG000|Overall Study|Lost to Follow-up|0|||
19508812|NCT02090634|41918965|FG001|Overall Study|Lost to Follow-up|1|||
19508813|NCT02090634|41918964|FG000|Overall Study|Death|0|||
19508814|NCT02090634|41918965|FG001|Overall Study|Death|1|||
19508815|NCT02090634|41918964|FG000|Overall Study|Protocol Violation|3|||
19508816|NCT02090634|41918965|FG001|Overall Study|Protocol Violation|1|||
19508817|NCT02090634|41918964|FG000|Overall Study|Adverse Event|2|||
19508818|NCT02090634|41918965|FG001|Overall Study|Adverse Event|0|||
19616296|NCT02432274|42066004|FG002|Overall Study|Withdrawal by Subject|0|||
19616297|NCT02432274|42066005|FG003|Overall Study|Withdrawal by Subject|0|||
19508819|NCT02114892|41918973|FG000|Overall Study|Lost to Follow-up|1|||
19508820|NCT02114892|41918974|FG001|Overall Study|Lost to Follow-up|2|||
19508821|NCT02070978|41918983|FG000|Overall Study|Adverse Event|6|||
19508822|NCT02070978|41918984|FG001|Overall Study|Adverse Event|2|||
19616298|NCT02432274|42066006|FG004|Overall Study|Withdrawal by Subject|2|||
19616299|NCT02432274|42066007|FG005|Overall Study|Withdrawal by Subject|0|||
19508823|NCT02070978|41918985|FG002|Overall Study|Adverse Event|0|||
19508824|NCT02070978|41918983|FG000|Overall Study|Lost to Follow-up|1|||
19508825|NCT02070978|41918984|FG001|Overall Study|Lost to Follow-up|3|||
19508826|NCT02070978|41918985|FG002|Overall Study|Lost to Follow-up|4|||
19508827|NCT02070978|41918983|FG000|Overall Study|Withdrawal by Subject|3|||
19508828|NCT02070978|41918984|FG001|Overall Study|Withdrawal by Subject|5|||
19508829|NCT02070978|41918985|FG002|Overall Study|Withdrawal by Subject|3|||
19508830|NCT02070978|41918983|FG000|Overall Study|Protocol Violation|1|||
19508831|NCT02070978|41918984|FG001|Overall Study|Protocol Violation|0|||
19508832|NCT02070978|41918985|FG002|Overall Study|Protocol Violation|3|||
19508833|NCT02070978|41918983|FG000|Overall Study|Lack of Efficacy|0|||
19508834|NCT02070978|41918984|FG001|Overall Study|Lack of Efficacy|1|||
19508835|NCT02070978|41918985|FG002|Overall Study|Lack of Efficacy|0|||
19508836|NCT02070978|41918983|FG000|Overall Study|Death|0|||
19508837|NCT02070978|41918984|FG001|Overall Study|Death|0|||
19508838|NCT02070978|41918985|FG002|Overall Study|Death|2|||
19508839|NCT02070978|41918983|FG000|Overall Study|Un-specified|3|||
19508840|NCT02070978|41918984|FG001|Overall Study|Un-specified|2|||
19508841|NCT02070978|41918985|FG002|Overall Study|Un-specified|2|||
19508842|NCT02070978|41918983|FG000|Overall Study|Terminated by Sponsor|33|||
19508843|NCT02070978|41918984|FG001|Overall Study|Terminated by Sponsor|40|||
19508844|NCT02070978|41918985|FG002|Overall Study|Terminated by Sponsor|39|||
19508845|NCT02114268|41918999|FG000|Overall Study|Lost to Follow-up|4|||
19508846|NCT02114268|41919000|FG001|Overall Study|Lost to Follow-up|1|||
19508847|NCT02114268|41919001|FG002|Overall Study|Lost to Follow-up|1|||
19508848|NCT02114268|41919002|FG003|Overall Study|Lost to Follow-up|0|||
19508849|NCT02114268|41919003|FG004|Overall Study|Lost to Follow-up|0|||
19508850|NCT02114268|41919004|FG005|Overall Study|Lost to Follow-up|2|||
19508851|NCT02114268|41918999|FG000|Overall Study|Withdrawal by Subject|1|||
19508852|NCT02114268|41919000|FG001|Overall Study|Withdrawal by Subject|0|||
19508853|NCT02114268|41919001|FG002|Overall Study|Withdrawal by Subject|0|||
19508854|NCT02114268|41919002|FG003|Overall Study|Withdrawal by Subject|0|||
19508855|NCT02114268|41919003|FG004|Overall Study|Withdrawal by Subject|0|||
19508856|NCT02114268|41919004|FG005|Overall Study|Withdrawal by Subject|1|||
19508857|NCT02114268|41918999|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
19508858|NCT02114268|41919000|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
19508859|NCT02114268|41919001|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
19508860|NCT02114268|41919002|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
19508861|NCT02114268|41919003|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
19508862|NCT02114268|41919004|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
19508863|NCT02089230|41919026|FG000|Overall Study|Death|0|||
19508864|NCT02089230|41919027|FG001|Overall Study|Death|0|||
19508865|NCT02089230|41919028|FG002|Overall Study|Death|2|||
19508866|NCT02089230|41919026|FG000|Overall Study|Seeking Alternative Therapy|0|||
19508867|NCT02089230|41919027|FG001|Overall Study|Seeking Alternative Therapy|0|||
19508868|NCT02089230|41919028|FG002|Overall Study|Seeking Alternative Therapy|4|||
19508869|NCT02070744|41919040|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
19508870|NCT02070744|41919041|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
19508871|NCT02070744|41919042|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
19508872|NCT02070744|41919043|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
19508873|NCT02070744|41919044|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
19508874|NCT02070744|41919040|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
19508875|NCT02070744|41919041|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
19508876|NCT02070744|41919042|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
19508877|NCT02070744|41919043|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
19508878|NCT02070744|41919044|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
19508879|NCT02070744|41919040|FG000|OLE Phase (48 Weeks)|Other|0|||
19508880|NCT02070744|41919041|FG001|OLE Phase (48 Weeks)|Other|0|||
19508881|NCT02070744|41919042|FG002|OLE Phase (48 Weeks)|Other|0|||
19508882|NCT02070744|41919043|FG003|OLE Phase (48 Weeks)|Other|0|||
19508883|NCT02070744|41919044|FG004|OLE Phase (48 Weeks)|Other|1|||
19508884|NCT02113956|41919061|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
19508885|NCT02113956|41919062|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
19508886|NCT02113956|41919061|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
19508887|NCT02113956|41919062|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
19508888|NCT02113956|41919061|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
19508889|NCT02113956|41919062|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
19508890|NCT02070588|41919071|FG000|Overall Study|Withdrawal by Subject|29|||
19508891|NCT02070588|41919072|FG001|Overall Study|Withdrawal by Subject|1|||
19508892|NCT02070588|41919073|FG002|Overall Study|Withdrawal by Subject|0|||
19508893|NCT02070588|41919071|FG000|Overall Study|Writhdrawal due to early termination|9|||
19508894|NCT02070588|41919072|FG001|Overall Study|Writhdrawal due to early termination|0|||
19508895|NCT02070588|41919073|FG002|Overall Study|Writhdrawal due to early termination|0|||
19508896|NCT02070588|41919071|FG000|Overall Study|Adverse Event|1|||
19508897|NCT02070588|41919072|FG001|Overall Study|Adverse Event|0|||
19508898|NCT02070588|41919073|FG002|Overall Study|Adverse Event|0|||
19508899|NCT02111850|41919092|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508900|NCT02111850|41919093|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508901|NCT02111850|41919094|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508902|NCT02111850|41919095|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508903|NCT02111850|41919096|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
19508904|NCT02111850|41919097|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508905|NCT02111850|41919098|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508906|NCT02111850|41919099|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508907|NCT02111850|41919100|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508908|NCT02111850|41919101|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508909|NCT02111850|41919102|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
19508910|NCT02087904|41919132|FG000|Overall Study|Did Not Receive Study Drug|0|||
19616300|NCT02432274|42066008|FG006|Overall Study|Withdrawal by Subject|1|||
19616301|NCT02432274|42066009|FG007|Overall Study|Withdrawal by Subject|2|||
19616302|NCT02432274|42066002|FG000|Overall Study|Participant Choice|0|||
19616303|NCT02432274|42066003|FG001|Overall Study|Participant Choice|0|||
19616304|NCT02432274|42066004|FG002|Overall Study|Participant Choice|1|||
19616305|NCT02432274|42066005|FG003|Overall Study|Participant Choice|0|||
19616306|NCT02432274|42066006|FG004|Overall Study|Participant Choice|0|||
19616307|NCT02432274|42066007|FG005|Overall Study|Participant Choice|0|||
19616308|NCT02432274|42066008|FG006|Overall Study|Participant Choice|1|||
19616309|NCT02432274|42066009|FG007|Overall Study|Participant Choice|0|||
19616310|NCT02432274|42066002|FG000|Overall Study|Other than specified|0|||
19616311|NCT02432274|42066003|FG001|Overall Study|Other than specified|1|||
19616312|NCT02432274|42066004|FG002|Overall Study|Other than specified|0|||
19616313|NCT02432274|42066005|FG003|Overall Study|Other than specified|0|||
19616314|NCT02432274|42066006|FG004|Overall Study|Other than specified|0|||
19616315|NCT02432274|42066007|FG005|Overall Study|Other than specified|1|||
19616316|NCT02432274|42066008|FG006|Overall Study|Other than specified|0|||
19616317|NCT02432274|42066009|FG007|Overall Study|Other than specified|1|||
19616318|NCT02432274|42066002|FG000|Overall Study|Ongoing|0|||
19616319|NCT02432274|42066003|FG001|Overall Study|Ongoing|0|||
19616320|NCT02432274|42066004|FG002|Overall Study|Ongoing|1|||
19616321|NCT02432274|42066005|FG003|Overall Study|Ongoing|1|||
19616322|NCT02432274|42066006|FG004|Overall Study|Ongoing|3|||
19616323|NCT02432274|42066007|FG005|Overall Study|Ongoing|0|||
19508911|NCT02087904|41919133|FG001|Overall Study|Did Not Receive Study Drug|0|||
19508912|NCT02087904|41919134|FG002|Overall Study|Did Not Receive Study Drug|2|||
19508913|NCT02087904|41919135|FG003|Overall Study|Did Not Receive Study Drug|1|||
19508914|NCT02087904|41919132|FG000|Overall Study|Adverse Event|8|||
19508915|NCT02087904|41919133|FG001|Overall Study|Adverse Event|4|||
19508916|NCT02087904|41919134|FG002|Overall Study|Adverse Event|4|||
19508917|NCT02087904|41919135|FG003|Overall Study|Adverse Event|12|||
19508918|NCT02087904|41919132|FG000|Overall Study|Lack of Efficacy|3|||
19508919|NCT02087904|41919133|FG001|Overall Study|Lack of Efficacy|6|||
19508920|NCT02087904|41919134|FG002|Overall Study|Lack of Efficacy|3|||
19508921|NCT02087904|41919135|FG003|Overall Study|Lack of Efficacy|2|||
19508922|NCT02087904|41919132|FG000|Overall Study|Other|6|||
19508923|NCT02087904|41919133|FG001|Overall Study|Other|2|||
19508924|NCT02087904|41919134|FG002|Overall Study|Other|4|||
19508925|NCT02087904|41919135|FG003|Overall Study|Other|4|||
19508926|NCT02087904|41919132|FG000|Overall Study|Withdrawal by Subject|8|||
19508927|NCT02087904|41919133|FG001|Overall Study|Withdrawal by Subject|3|||
19508928|NCT02087904|41919134|FG002|Overall Study|Withdrawal by Subject|7|||
19508929|NCT02087904|41919135|FG003|Overall Study|Withdrawal by Subject|4|||
19508930|NCT02087904|41919132|FG000|Overall Study|Lost to Follow-up|0|||
19508931|NCT02087904|41919133|FG001|Overall Study|Lost to Follow-up|4|||
19508932|NCT02087904|41919134|FG002|Overall Study|Lost to Follow-up|2|||
19508933|NCT02087904|41919135|FG003|Overall Study|Lost to Follow-up|2|||
19508934|NCT02087670|41919147|FG000|Overall Study|Withdrawal by Subject|3|||
19508935|NCT02087670|41919148|FG001|Overall Study|Withdrawal by Subject|2|||
19508936|NCT02086968|41919156|FG000|Overall Study|Adverse Event|1|||
19508937|NCT02086968|41919157|FG001|Overall Study|Adverse Event|5|||
19508938|NCT02086968|41919156|FG000|Overall Study|Lost to Follow-up|2|||
19508939|NCT02086968|41919157|FG001|Overall Study|Lost to Follow-up|3|||
19508940|NCT02086968|41919156|FG000|Overall Study|Study drug received outside protocol|0|||
19508941|NCT02086968|41919157|FG001|Overall Study|Study drug received outside protocol|1|||
19508942|NCT02086968|41919156|FG000|Overall Study|Physician Decision|4|||
19508943|NCT02086968|41919157|FG001|Overall Study|Physician Decision|0|||
19616324|NCT02432274|42066008|FG006|Overall Study|Ongoing|0|||
19616325|NCT02432274|42066009|FG007|Overall Study|Ongoing|7|||
19616326|NCT00903617|42066043|FG000|Overall Study|Adverse Event|0|||
19616327|NCT00903617|42066044|FG001|Overall Study|Adverse Event|1|||
19616328|NCT00903617|42066045|FG002|Overall Study|Adverse Event|1|||
19508944|NCT02086968|41919156|FG000|Overall Study|Withdrawal by Subject|1|||
19508945|NCT02086968|41919157|FG001|Overall Study|Withdrawal by Subject|4|||
19508946|NCT02086110|41919165|FG000|Overall Study|Withdrawal by Subject|1|||
19508947|NCT02086110|41919166|FG001|Overall Study|Withdrawal by Subject|1|||
19508948|NCT02085252|41919175|FG000|Overall Study|Withdrawal of Consent|1|||
19508949|NCT02085252|41919176|FG001|Overall Study|Withdrawal of Consent|0|||
19508950|NCT02085252|41919175|FG000|Overall Study|Adverse Event|0|||
19508951|NCT02085252|41919176|FG001|Overall Study|Adverse Event|1|||
19508952|NCT02085252|41919175|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
19508953|NCT02085252|41919176|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
19508954|NCT02085252|41919175|FG000|Overall Study|Reason Not Specified|0|||
19508955|NCT02085252|41919176|FG001|Overall Study|Reason Not Specified|1|||
19508956|NCT02085252|41919175|FG000|Overall Study|Reason Unknown|0|||
19508957|NCT02085252|41919176|FG001|Overall Study|Reason Unknown|1|||
19508958|NCT02084238|41919182|FG000|Overall Study|Lost to Follow-up|2|||
19508959|NCT02084082|41919195|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
19508960|NCT02084082|41919196|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
19508961|NCT02084082|41919197|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
19508962|NCT02084082|41919198|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
19508963|NCT02084082|41919195|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19508964|NCT02084082|41919196|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19508965|NCT02084082|41919197|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
19508966|NCT02084082|41919198|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
19508967|NCT02083926|41919210|FG000|Overall Study|Withdrawal by Subject|1|||
19508968|NCT02083926|41919211|FG001|Overall Study|Withdrawal by Subject|0|||
19508969|NCT02083380|41919221|FG000|Overall Study|Lack of Efficacy|68|||
19508970|NCT02083380|41919222|FG001|Overall Study|Lack of Efficacy|79|||
19508971|NCT02083380|41919223|FG002|Overall Study|Lack of Efficacy|64|||
19508972|NCT02083380|41919221|FG000|Overall Study|Withdrawal by Subject|9|||
19508973|NCT02083380|41919222|FG001|Overall Study|Withdrawal by Subject|3|||
19508974|NCT02083380|41919223|FG002|Overall Study|Withdrawal by Subject|7|||
19508975|NCT02083380|41919221|FG000|Overall Study|Physician Decision|1|||
19508976|NCT02083380|41919222|FG001|Overall Study|Physician Decision|6|||
19508977|NCT02083380|41919223|FG002|Overall Study|Physician Decision|3|||
19508978|NCT02083380|41919221|FG000|Overall Study|Adverse Event|0|||
19508979|NCT02083380|41919222|FG001|Overall Study|Adverse Event|0|||
19508980|NCT02083380|41919223|FG002|Overall Study|Adverse Event|1|||
19508981|NCT02083380|41919221|FG000|Overall Study|Lost to Follow-up|5|||
19508982|NCT02083380|41919222|FG001|Overall Study|Lost to Follow-up|3|||
19508983|NCT02083380|41919223|FG002|Overall Study|Lost to Follow-up|3|||
19508984|NCT02083380|41919221|FG000|Overall Study|Other|8|||
19508985|NCT02083380|41919222|FG001|Overall Study|Other|4|||
19508986|NCT02083380|41919223|FG002|Overall Study|Other|6|||
19508987|NCT02109744|41919238|FG000|Overall Study|Death|1|||
19508988|NCT02109744|41919239|FG001|Overall Study|Death|1|||
19508989|NCT02109744|41919238|FG000|Overall Study|no marrow exam|1|||
19508990|NCT02109744|41919239|FG001|Overall Study|no marrow exam|0|||
19508991|NCT02109432|41919245|FG000|Overall Study|Withdrawal by Subject|1|||
19508992|NCT02109042|41919249|FG000|Overall Study|Sponsor Decision|15|||
19508993|NCT02066922|41919254|FG000|Overall Study|Adverse Event|1|||
19508994|NCT02108262|41919265|FG000|Overall Study|Non-compliance|0|||
19508995|NCT02108262|41919266|FG001|Overall Study|Non-compliance|2|||
19508996|NCT02108262|41919267|FG002|Overall Study|Non-compliance|1|||
19508997|NCT02108262|41919268|FG003|Overall Study|Non-compliance|1|||
19508998|NCT02108262|41919265|FG000|Overall Study|Randomized by error/screen failure|0|||
19508999|NCT02108262|41919266|FG001|Overall Study|Randomized by error/screen failure|0|||
19509000|NCT02108262|41919267|FG002|Overall Study|Randomized by error/screen failure|1|||
19509001|NCT02108262|41919268|FG003|Overall Study|Randomized by error/screen failure|0|||
19509002|NCT02108262|41919265|FG000|Overall Study|Distance to center|0|||
19509003|NCT02108262|41919266|FG001|Overall Study|Distance to center|1|||
19616329|NCT00903617|42066046|FG003|Overall Study|Adverse Event|0|||
19616330|NCT00903617|42066043|FG000|Overall Study|Protocol-defined stopping criteria|0|||
19616331|NCT00903617|42066044|FG001|Overall Study|Protocol-defined stopping criteria|2|||
19616332|NCT00903617|42066045|FG002|Overall Study|Protocol-defined stopping criteria|0|||
19616333|NCT00903617|42066046|FG003|Overall Study|Protocol-defined stopping criteria|0|||
19616334|NCT00903617|42066043|FG000|Overall Study|Lost to Follow-up|2|||
19616335|NCT00903617|42066044|FG001|Overall Study|Lost to Follow-up|0|||
19616336|NCT00903617|42066045|FG002|Overall Study|Lost to Follow-up|1|||
19616337|NCT00903617|42066046|FG003|Overall Study|Lost to Follow-up|1|||
19616338|NCT00903617|42066043|FG000|Overall Study|Withdrawal by Subject|1|||
19616339|NCT00903617|42066044|FG001|Overall Study|Withdrawal by Subject|2|||
19616340|NCT00903617|42066045|FG002|Overall Study|Withdrawal by Subject|3|||
19616341|NCT00903617|42066046|FG003|Overall Study|Withdrawal by Subject|0|||
19509004|NCT02108262|41919267|FG002|Overall Study|Distance to center|1|||
19509005|NCT02108262|41919268|FG003|Overall Study|Distance to center|0|||
19509006|NCT02108262|41919265|FG000|Overall Study|Adverse Event|0|||
19616342|NCT00903383|42066061|FG000|Overall Study|Adverse Event|1|||
19509007|NCT02108262|41919266|FG001|Overall Study|Adverse Event|11|||
19509008|NCT02108262|41919267|FG002|Overall Study|Adverse Event|6|||
19509009|NCT02108262|41919268|FG003|Overall Study|Adverse Event|12|||
19509010|NCT02108262|41919265|FG000|Overall Study|Death|0|||
19509011|NCT02108262|41919266|FG001|Overall Study|Death|2|||
19509012|NCT02108262|41919267|FG002|Overall Study|Death|2|||
19509013|NCT02108262|41919268|FG003|Overall Study|Death|1|||
19509014|NCT02108262|41919265|FG000|Overall Study|Lost to Follow-up|0|||
19509015|NCT02108262|41919266|FG001|Overall Study|Lost to Follow-up|0|||
19509016|NCT02108262|41919267|FG002|Overall Study|Lost to Follow-up|1|||
19509017|NCT02108262|41919268|FG003|Overall Study|Lost to Follow-up|0|||
19509018|NCT02108262|41919265|FG000|Overall Study|Physician Decision|0|||
19509019|NCT02108262|41919266|FG001|Overall Study|Physician Decision|0|||
19509020|NCT02108262|41919267|FG002|Overall Study|Physician Decision|2|||
19509021|NCT02108262|41919268|FG003|Overall Study|Physician Decision|0|||
19509022|NCT02108262|41919265|FG000|Overall Study|Withdrawal by Subject|0|||
19509023|NCT02108262|41919266|FG001|Overall Study|Withdrawal by Subject|7|||
19509024|NCT02108262|41919267|FG002|Overall Study|Withdrawal by Subject|3|||
19509025|NCT02108262|41919268|FG003|Overall Study|Withdrawal by Subject|4|||
19509026|NCT02108262|41919265|FG000|Overall Study|Due to key hepatic values|0|||
19509027|NCT02108262|41919266|FG001|Overall Study|Due to key hepatic values|1|||
19509028|NCT02108262|41919267|FG002|Overall Study|Due to key hepatic values|0|||
19509029|NCT02108262|41919268|FG003|Overall Study|Due to key hepatic values|0|||
19509030|NCT02108262|41919265|FG000|Overall Study|Unable to contact patient|0|||
19509031|NCT02108262|41919266|FG001|Overall Study|Unable to contact patient|3|||
19509032|NCT02108262|41919267|FG002|Overall Study|Unable to contact patient|1|||
19509033|NCT02108262|41919268|FG003|Overall Study|Unable to contact patient|2|||
19509034|NCT02108262|41919265|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
19509035|NCT02108262|41919266|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
19509036|NCT02108262|41919267|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
19509037|NCT02108262|41919268|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
19509038|NCT02108262|41919265|FG000|Overall Study|Patient did not want another infusion|0|||
19509039|NCT02108262|41919266|FG001|Overall Study|Patient did not want another infusion|3|||
19509040|NCT02108262|41919267|FG002|Overall Study|Patient did not want another infusion|3|||
19509041|NCT02108262|41919268|FG003|Overall Study|Patient did not want another infusion|2|||
19509042|NCT02108262|41919265|FG000|Overall Study|Vacation|0|||
19509043|NCT02108262|41919266|FG001|Overall Study|Vacation|1|||
19509044|NCT02108262|41919267|FG002|Overall Study|Vacation|0|||
19509045|NCT02108262|41919268|FG003|Overall Study|Vacation|0|||
19509046|NCT02108262|41919265|FG000|Overall Study|Patient decision|0|||
19509047|NCT02108262|41919266|FG001|Overall Study|Patient decision|7|||
19509048|NCT02108262|41919267|FG002|Overall Study|Patient decision|9|||
19509049|NCT02108262|41919268|FG003|Overall Study|Patient decision|14|||
19509050|NCT02108262|41919265|FG000|Overall Study|Missed IV due to pharmacy error|0|||
19509051|NCT02108262|41919266|FG001|Overall Study|Missed IV due to pharmacy error|0|||
19509052|NCT02108262|41919267|FG002|Overall Study|Missed IV due to pharmacy error|1|||
19509053|NCT02108262|41919268|FG003|Overall Study|Missed IV due to pharmacy error|0|||
19509054|NCT02107482|41919277|FG000|Overall Study|inconveinence|2|||
19509055|NCT02107482|41919277|FG000|Overall Study|Lost to Follow-up|1|||
19509056|NCT02107482|41919277|FG000|Overall Study|Lack of Efficacy|1|||
19509057|NCT02066298|41919287|FG000|Overall Study|Lost to Follow-up|3|||
19509058|NCT02066298|41919288|FG001|Overall Study|Lost to Follow-up|2|||
19509059|NCT02066298|41919289|FG002|Overall Study|Lost to Follow-up|3|||
19509060|NCT02066298|41919290|FG003|Overall Study|Lost to Follow-up|2|||
19509061|NCT02066298|41919291|FG004|Overall Study|Lost to Follow-up|3|||
19509062|NCT02066298|41919292|FG005|Overall Study|Lost to Follow-up|4|||
19509063|NCT02066298|41919287|FG000|Overall Study|Withdrawal by Subject|6|||
19509064|NCT02066298|41919288|FG001|Overall Study|Withdrawal by Subject|6|||
19509065|NCT02066298|41919289|FG002|Overall Study|Withdrawal by Subject|6|||
19509066|NCT02066298|41919290|FG003|Overall Study|Withdrawal by Subject|4|||
19509067|NCT02066298|41919291|FG004|Overall Study|Withdrawal by Subject|5|||
19509068|NCT02066298|41919292|FG005|Overall Study|Withdrawal by Subject|8|||
19509069|NCT02066298|41919287|FG000|Overall Study|Physician Decision|0|||
19509070|NCT02066298|41919288|FG001|Overall Study|Physician Decision|0|||
19509071|NCT02066298|41919289|FG002|Overall Study|Physician Decision|1|||
19509072|NCT02066298|41919290|FG003|Overall Study|Physician Decision|0|||
19509073|NCT02066298|41919291|FG004|Overall Study|Physician Decision|1|||
19509074|NCT02066298|41919292|FG005|Overall Study|Physician Decision|0|||
19509075|NCT02082912|41919306|FG000|Overall Study|Physician Decision|0|||
19509076|NCT02082912|41919307|FG001|Overall Study|Physician Decision|1|||
19509077|NCT02082522|41919315|FG000|Overall Study|Sponsor termination|5|||
19509078|NCT02082522|41919316|FG001|Overall Study|Sponsor termination|3|||
19509079|NCT02082522|41919315|FG000|Overall Study|Withdrawal by Subject|2|||
19509080|NCT02082522|41919316|FG001|Overall Study|Withdrawal by Subject|4|||
19509081|NCT02082522|41919315|FG000|Overall Study|Death|1|||
19509082|NCT02082522|41919316|FG001|Overall Study|Death|0|||
19509083|NCT02082522|41919315|FG000|Overall Study|Lost to Follow-up|1|||
19616343|NCT00903383|42066062|FG001|Overall Study|Adverse Event|2|||
19509084|NCT02082522|41919316|FG001|Overall Study|Lost to Follow-up|0|||
19509085|NCT02082522|41919315|FG000|Overall Study|Physician Decision|3|||
19509086|NCT02082522|41919316|FG001|Overall Study|Physician Decision|1|||
19509087|NCT02082522|41919315|FG000|Overall Study|Disease progression|2|||
19509088|NCT02082522|41919316|FG001|Overall Study|Disease progression|2|||
19509089|NCT02082522|41919315|FG000|Overall Study|Chemotherapy change|1|||
19509090|NCT02082522|41919316|FG001|Overall Study|Chemotherapy change|3|||
19509091|NCT02082210|41919328|FG000|Overall Study|Death|0|||
19616344|NCT00903383|42066063|FG002|Overall Study|Adverse Event|3|||
19616345|NCT00903383|42066064|FG003|Overall Study|Adverse Event|1|||
19616346|NCT00903383|42066061|FG000|Overall Study|Physician Decision|1|||
19616347|NCT00903383|42066062|FG001|Overall Study|Physician Decision|2|||
19616348|NCT00903383|42066063|FG002|Overall Study|Physician Decision|0|||
19616349|NCT00903383|42066064|FG003|Overall Study|Physician Decision|0|||
19616350|NCT00903383|42066061|FG000|Overall Study|Lost to Follow-up|0|||
19616351|NCT00903383|42066062|FG001|Overall Study|Lost to Follow-up|0|||
19616352|NCT00903383|42066063|FG002|Overall Study|Lost to Follow-up|0|||
19616353|NCT00903383|42066064|FG003|Overall Study|Lost to Follow-up|1|||
19616354|NCT00903383|42066061|FG000|Overall Study|Decision of Sponsor|1|||
19616355|NCT00903383|42066062|FG001|Overall Study|Decision of Sponsor|0|||
19616356|NCT00903383|42066063|FG002|Overall Study|Decision of Sponsor|0|||
19616357|NCT00903383|42066064|FG003|Overall Study|Decision of Sponsor|0|||
19616358|NCT00903383|42066061|FG000|Overall Study|Withdrawal by Subject|4|||
19616359|NCT00903383|42066062|FG001|Overall Study|Withdrawal by Subject|1|||
19509092|NCT02082210|41919329|FG001|Overall Study|Death|0|||
19509093|NCT02082210|41919330|FG002|Overall Study|Death|1|||
19509094|NCT02082210|41919331|FG003|Overall Study|Death|1|||
19509095|NCT02082210|41919332|FG004|Overall Study|Death|1|||
19509096|NCT02082210|41919333|FG005|Overall Study|Death|0|||
19509097|NCT02082210|41919328|FG000|Overall Study|Withdrawal by Subject|0|||
19509098|NCT02082210|41919329|FG001|Overall Study|Withdrawal by Subject|0|||
19509099|NCT02082210|41919330|FG002|Overall Study|Withdrawal by Subject|0|||
19509100|NCT02082210|41919331|FG003|Overall Study|Withdrawal by Subject|1|||
19509101|NCT02082210|41919332|FG004|Overall Study|Withdrawal by Subject|2|||
19509102|NCT02082210|41919333|FG005|Overall Study|Withdrawal by Subject|2|||
19509103|NCT02082210|41919328|FG000|Overall Study|Clinical Progression|0|||
19509104|NCT02082210|41919329|FG001|Overall Study|Clinical Progression|0|||
19509105|NCT02082210|41919330|FG002|Overall Study|Clinical Progression|0|||
19509106|NCT02082210|41919331|FG003|Overall Study|Clinical Progression|1|||
19509107|NCT02082210|41919332|FG004|Overall Study|Clinical Progression|0|||
19509108|NCT02082210|41919333|FG005|Overall Study|Clinical Progression|0|||
19509109|NCT02082210|41919328|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
19509110|NCT02082210|41919329|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
19509111|NCT02082210|41919330|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
19509112|NCT02082210|41919331|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
19509113|NCT02082210|41919332|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
19509114|NCT02082210|41919333|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
19509115|NCT02082210|41919328|FG000|Overall Study|Physician Decision|0|||
19509116|NCT02082210|41919329|FG001|Overall Study|Physician Decision|0|||
19509117|NCT02082210|41919330|FG002|Overall Study|Physician Decision|1|||
19509118|NCT02082210|41919331|FG003|Overall Study|Physician Decision|1|||
19509119|NCT02082210|41919332|FG004|Overall Study|Physician Decision|0|||
19616360|NCT00903383|42066063|FG002|Overall Study|Withdrawal by Subject|0|||
19616361|NCT00903383|42066064|FG003|Overall Study|Withdrawal by Subject|2|||
19616362|NCT00903383|42066061|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
19616363|NCT00903383|42066062|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
19616364|NCT00903383|42066063|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
19616365|NCT00903383|42066064|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
19616366|NCT00903383|42066061|FG000|Overall Study|Patient Decision|0|||
19616367|NCT00903383|42066062|FG001|Overall Study|Patient Decision|0|||
19616368|NCT00903383|42066063|FG002|Overall Study|Patient Decision|0|||
19616369|NCT00903383|42066064|FG003|Overall Study|Patient Decision|1|||
19616370|NCT02314026|42066074|FG000|Overall Study|Protocol Violation|28|||
19616371|NCT01617096|42066084|FG000|Overall Study|Withdrawal by Subject|96|||
19616372|NCT01617096|42066085|FG001|Overall Study|Withdrawal by Subject|81|||
19616373|NCT01617096|42066084|FG000|Overall Study|Lost to Follow-up|37|||
19616374|NCT01617096|42066085|FG001|Overall Study|Lost to Follow-up|32|||
19616375|NCT01617096|42066084|FG000|Overall Study|Physician Decision|10|||
19616376|NCT01617096|42066085|FG001|Overall Study|Physician Decision|18|||
19616377|NCT01617096|42066084|FG000|Overall Study|Death|4|||
19616378|NCT01617096|42066085|FG001|Overall Study|Death|3|||
19616379|NCT01617096|42066084|FG000|Overall Study|Other|1|||
19509120|NCT02082210|41919333|FG005|Overall Study|Physician Decision|0|||
19509121|NCT02107092|41919359|FG000|Overall Study|Miscellaneous|3|||
19509122|NCT02107092|41919359|FG000|Overall Study|Subject compliance|3|||
19509123|NCT02107092|41919359|FG000|Overall Study|Hypo-or hyperkalemia|2|||
19509124|NCT02107092|41919359|FG000|Overall Study|Met ECG withdrawal criteria|3|||
19616380|NCT01617096|42066085|FG001|Overall Study|Other|3|||
19616381|NCT00900731|42066114|FG000|Overall Study|Adverse Event|31|||
19509125|NCT02107092|41919359|FG000|Overall Study|Physician Decision|3|||
19509126|NCT02107092|41919359|FG000|Overall Study|Lost to Follow-up|2|||
19509127|NCT02107092|41919359|FG000|Overall Study|Withdrawal by Subject|9|||
19509128|NCT02107092|41919359|FG000|Overall Study|Adverse Event|7|||
19509129|NCT02107092|41919359|FG000|Overall Study|Expected progression of CKD|12|||
19509130|NCT02107014|41919363|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
19509131|NCT01624974|41919369|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
19509132|NCT01624974|41919370|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
19509133|NCT01624974|41919369|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
19509134|NCT01624974|41919370|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
19509135|NCT01624974|41919369|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
19509136|NCT01624974|41919370|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
19509137|NCT01624974|41919369|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
19509138|NCT01624974|41919370|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
19509139|NCT01624974|41919369|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
19509140|NCT01624974|41919370|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
19509141|NCT01624974|41919369|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
19509142|NCT01624974|41919370|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
19509143|NCT01624974|41919369|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
19509144|NCT01624974|41919370|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
19509145|NCT01624974|41919369|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
19509146|NCT01624974|41919370|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
19509147|NCT01624974|41919369|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
19509148|NCT01624974|41919370|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
19509149|NCT01624974|41919369|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
19509150|NCT01624974|41919370|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
19509151|NCT01624974|41919369|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
19509152|NCT01624974|41919370|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
19509153|NCT01624974|41919369|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
19509154|NCT01624974|41919370|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
19509155|NCT02065518|41919381|FG000|Overall Study|Lost to Follow-up|3|||
19509156|NCT02065518|41919382|FG001|Overall Study|Lost to Follow-up|4|||
19509157|NCT02065518|41919383|FG002|Overall Study|Lost to Follow-up|0|||
19509158|NCT02065518|41919384|FG003|Overall Study|Lost to Follow-up|3|||
19509159|NCT02065518|41919381|FG000|Overall Study|Withdrawal by Subject|3|||
19509160|NCT02065518|41919382|FG001|Overall Study|Withdrawal by Subject|4|||
19509161|NCT02065518|41919383|FG002|Overall Study|Withdrawal by Subject|9|||
19509162|NCT02065518|41919384|FG003|Overall Study|Withdrawal by Subject|2|||
19509163|NCT01624662|41919398|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
19509164|NCT01624662|41919399|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
19509165|NCT01624662|41919400|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
19509166|NCT01624662|41919401|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
19509167|NCT01624662|41919398|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
19509168|NCT01624662|41919399|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
19509169|NCT01624662|41919400|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
19509170|NCT01624662|41919401|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
19509171|NCT01624662|41919398|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
19509172|NCT01624662|41919399|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
19509173|NCT01624662|41919400|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
19509174|NCT01624662|41919401|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
19509175|NCT01624662|41919398|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
19509176|NCT01624662|41919399|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
19509177|NCT01624662|41919400|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
19509178|NCT01624662|41919401|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
19509179|NCT01624662|41919398|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
19509180|NCT01624662|41919399|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
19509181|NCT01624662|41919400|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
19509182|NCT01624662|41919401|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
19509183|NCT01624662|41919398|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19509184|NCT01624662|41919399|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
19509185|NCT01624662|41919400|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19509186|NCT01624662|41919401|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19509187|NCT01624662|41919398|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
19509188|NCT01624662|41919399|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
19509189|NCT01624662|41919400|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
19509190|NCT01624662|41919401|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
19509191|NCT01624506|41919424|FG000|Overall Study|Lost to Follow-up|29|||
19509192|NCT01624506|41919425|FG001|Overall Study|Lost to Follow-up|15|||
19509193|NCT01624506|41919424|FG000|Overall Study|Withdrawal by Subject|9|||
19509194|NCT01624506|41919425|FG001|Overall Study|Withdrawal by Subject|2|||
19509195|NCT01624506|41919424|FG000|Overall Study|Death|1|||
19509196|NCT01624506|41919425|FG001|Overall Study|Death|0|||
19509197|NCT01624506|41919424|FG000|Overall Study|LINX explants|23|||
19509198|NCT01624506|41919425|FG001|Overall Study|LINX explants|0|||
19509199|NCT01624506|41919424|FG000|Overall Study|Adverse Event|3|||
19509200|NCT01624506|41919425|FG001|Overall Study|Adverse Event|0|||
19509201|NCT02106390|41919434|FG000|Overall Study|Withdrawal by Subject|15|||
19509202|NCT02106390|41919435|FG001|Overall Study|Withdrawal by Subject|16|||
19509203|NCT02106390|41919436|FG002|Overall Study|Withdrawal by Subject|15|||
19509204|NCT02106390|41919434|FG000|Overall Study|Lost to Follow-up|25|||
19509205|NCT02106390|41919435|FG001|Overall Study|Lost to Follow-up|20|||
19509206|NCT02106390|41919436|FG002|Overall Study|Lost to Follow-up|13|||
19509207|NCT02106390|41919434|FG000|Overall Study|Other: Administrative Reason|8|||
19509208|NCT02106390|41919435|FG001|Overall Study|Other: Administrative Reason|5|||
19509209|NCT02106390|41919436|FG002|Overall Study|Other: Administrative Reason|12|||
19509210|NCT02106390|41919434|FG000|Overall Study|Other: Unspecified|1|||
19509211|NCT02106390|41919435|FG001|Overall Study|Other: Unspecified|4|||
19509212|NCT02106390|41919436|FG002|Overall Study|Other: Unspecified|2|||
19509213|NCT02106390|41919434|FG000|Overall Study|Adverse Event|0|||
19509214|NCT02106390|41919435|FG001|Overall Study|Adverse Event|2|||
19509215|NCT02106390|41919436|FG002|Overall Study|Adverse Event|1|||
19509216|NCT02106390|41919434|FG000|Overall Study|Protocol Violation|0|||
19509217|NCT02106390|41919435|FG001|Overall Study|Protocol Violation|1|||
19509218|NCT02106390|41919436|FG002|Overall Study|Protocol Violation|0|||
19509219|NCT02064894|41919450|FG000|Overall Study|Withdrawal by Subject|43|||
19509220|NCT02064894|41919451|FG001|Overall Study|Withdrawal by Subject|102|||
19509221|NCT02064894|41919452|FG002|Overall Study|Withdrawal by Subject|115|||
19509222|NCT02081586|41919464|FG000|Overall Study|Lost to Follow-up|0|||
19509223|NCT02081586|41919465|FG001|Overall Study|Lost to Follow-up|1|||
19509224|NCT02081586|41919466|FG002|Overall Study|Lost to Follow-up|0|||
19509225|NCT02081586|41919467|FG003|Overall Study|Lost to Follow-up|1|||
19509226|NCT02081586|41919464|FG000|Overall Study|Head injury not related to study|0|||
19509227|NCT02081586|41919465|FG001|Overall Study|Head injury not related to study|0|||
19509228|NCT02081586|41919466|FG002|Overall Study|Head injury not related to study|1|||
19509229|NCT02081586|41919467|FG003|Overall Study|Head injury not related to study|0|||
19509230|NCT02081196|41919479|FG000|Overall Study|Lost to Follow-up|1|||
19509231|NCT02064816|41919487|FG000|Overall Study|Adverse Event|3|||
19509232|NCT02064816|41919488|FG001|Overall Study|Adverse Event|2|||
19616382|NCT00900731|42066115|FG001|Overall Study|Adverse Event|27|||
19616383|NCT00900731|42066114|FG000|Overall Study|Withdrawal by Subject|8|||
19616384|NCT00900731|42066115|FG001|Overall Study|Withdrawal by Subject|7|||
19616385|NCT00900731|42066114|FG000|Overall Study|Protocol Deviation|8|||
19616386|NCT00900731|42066115|FG001|Overall Study|Protocol Deviation|11|||
19616387|NCT00900731|42066114|FG000|Overall Study|Administrative Problems|5|||
19616388|NCT00900731|42066115|FG001|Overall Study|Administrative Problems|4|||
19616389|NCT00900731|42066114|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
19616390|NCT00900731|42066115|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
19616391|NCT00900731|42066114|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
19616392|NCT00900731|42066115|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
19616393|NCT00900731|42066114|FG000|Overall Study|Lost to Follow-up|2|||
19616394|NCT00900731|42066115|FG001|Overall Study|Lost to Follow-up|3|||
19616395|NCT00900731|42066114|FG000|Overall Study|Lack of Efficacy|1|||
19616396|NCT00900731|42066115|FG001|Overall Study|Lack of Efficacy|3|||
19616397|NCT00900731|42066114|FG000|Overall Study|Death|0|||
19616398|NCT00900731|42066115|FG001|Overall Study|Death|2|||
19616399|NCT03635489|42066123|FG000|Overall Study|Death|6|||
19616400|NCT03635489|42066124|FG001|Overall Study|Death|3|||
19616401|NCT03635489|42066123|FG000|Overall Study|Lost to Follow-up|0|||
19616402|NCT03635489|42066124|FG001|Overall Study|Lost to Follow-up|1|||
19616403|NCT03635489|42066123|FG000|Overall Study|Withdrawal by Subject|1|||
19616404|NCT03635489|42066124|FG001|Overall Study|Withdrawal by Subject|2|||
19616405|NCT03842436|42066130|FG000|Overall Study|Lost to Follow-up|1|||
19616406|NCT02702414|42066162|FG000|Overall Study|Death|77|||
19616407|NCT02702414|42066163|FG001|Overall Study|Death|34|||
19616408|NCT02702414|42066162|FG000|Overall Study|Lost to Follow-up|0|||
19616409|NCT02702414|42066163|FG001|Overall Study|Lost to Follow-up|1|||
19616410|NCT02702414|42066162|FG000|Overall Study|Withdrawal by Subject|0|||
19616411|NCT02702414|42066163|FG001|Overall Study|Withdrawal by Subject|1|||
19704540|NCT00129402|42148931|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19704541|NCT00129402|42148932|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
19509233|NCT02064816|41919487|FG000|Overall Study|Withdrawal by Subject|2|||
19509234|NCT02064816|41919488|FG001|Overall Study|Withdrawal by Subject|1|||
19509235|NCT02064816|41919487|FG000|Overall Study|Lost to Follow-up|2|||
19509236|NCT02064816|41919488|FG001|Overall Study|Lost to Follow-up|1|||
19616412|NCT02702414|42066162|FG000|Overall Study|Participants Ongoing in Study|27|||
19509237|NCT02064816|41919487|FG000|Overall Study|Therapeutic failure|0|||
19616413|NCT02702414|42066163|FG001|Overall Study|Participants Ongoing in Study|15|||
19616414|NCT02702414|42066162|FG000|Overall Study|Not Treated|1|||
19616415|NCT02702414|42066163|FG001|Overall Study|Not Treated|0|||
19616416|NCT00602472|42066181|FG000|Overall Study|Adverse Event|5|||
19616417|NCT00602472|42066182|FG001|Overall Study|Adverse Event|23|||
19616418|NCT00602472|42066181|FG000|Overall Study|Protocol Violation|4|||
19616419|NCT00602472|42066182|FG001|Overall Study|Protocol Violation|19|||
19616420|NCT00602472|42066181|FG000|Overall Study|Withdrawal by Subject|8|||
19616421|NCT00602472|42066182|FG001|Overall Study|Withdrawal by Subject|14|||
19616422|NCT00602472|42066181|FG000|Overall Study|Other incl. lack of efficacy|4|||
19616423|NCT00602472|42066182|FG001|Overall Study|Other incl. lack of efficacy|2|||
19509238|NCT02064816|41919488|FG001|Overall Study|Therapeutic failure|1|||
19509239|NCT02064816|41919487|FG000|Overall Study|Other|1|||
19509240|NCT02064816|41919488|FG001|Overall Study|Other|3|||
19509241|NCT02080260|41919494|FG000|Overall Study|Death|18|||
19509242|NCT02080260|41919494|FG000|Overall Study|Withdrawal by Subject|1|||
19509243|NCT01624194|41919500|FG000|Overall Study|Lost to Follow-up|1|||
19509244|NCT01624194|41919501|FG001|Overall Study|Lost to Follow-up|0|||
19509245|NCT01624194|41919500|FG000|Overall Study|Withdrawal by Subject|1|||
19509246|NCT01624194|41919501|FG001|Overall Study|Withdrawal by Subject|0|||
19509247|NCT02079636|41919523|FG000|Overall Study|Death|2|||
19509248|NCT02079636|41919524|FG001|Overall Study|Death|1|||
19509249|NCT02079636|41919525|FG002|Overall Study|Death|0|||
19509250|NCT02079636|41919526|FG003|Overall Study|Death|5|||
19509251|NCT02079636|41919527|FG004|Overall Study|Death|1|||
19509252|NCT02079636|41919528|FG005|Overall Study|Death|2|||
19509253|NCT02079636|41919529|FG006|Overall Study|Death|1|||
19509254|NCT02079636|41919530|FG007|Overall Study|Death|0|||
19509255|NCT02079636|41919531|FG008|Overall Study|Death|0|||
19509256|NCT02079636|41919532|FG009|Overall Study|Death|0|||
19509257|NCT02079636|41919533|FG010|Overall Study|Death|0|||
19509258|NCT02079636|41919534|FG011|Overall Study|Death|1|||
19509259|NCT02079636|41919535|FG012|Overall Study|Death|1|||
19509260|NCT02079636|41919536|FG013|Overall Study|Death|0|||
19509261|NCT02079636|41919537|FG014|Overall Study|Death|2|||
19509262|NCT02079636|41919523|FG000|Overall Study|Adverse Event|1|||
19509263|NCT02079636|41919524|FG001|Overall Study|Adverse Event|1|||
19509264|NCT02079636|41919525|FG002|Overall Study|Adverse Event|0|||
19509265|NCT02079636|41919526|FG003|Overall Study|Adverse Event|1|||
19509266|NCT02079636|41919527|FG004|Overall Study|Adverse Event|1|||
19509267|NCT02079636|41919528|FG005|Overall Study|Adverse Event|2|||
19509268|NCT02079636|41919529|FG006|Overall Study|Adverse Event|0|||
19509269|NCT02079636|41919530|FG007|Overall Study|Adverse Event|0|||
19616424|NCT01832402|42066190|FG000|Overall Study|Lost to Follow-up|2|||
19616425|NCT01832402|42066191|FG001|Overall Study|Lost to Follow-up|0|||
19616426|NCT01832402|42066190|FG000|Overall Study|Withdrawal by Subject|3|||
19616427|NCT01832402|42066191|FG001|Overall Study|Withdrawal by Subject|3|||
19616428|NCT01832402|42066190|FG000|Overall Study|Declining Performance status|2|||
19616429|NCT01832402|42066191|FG001|Overall Study|Declining Performance status|1|||
19616430|NCT00901901|42066230|FG000|Treatment Period|Adverse Event|120|||
19616431|NCT00901901|42066231|FG001|Treatment Period|Adverse Event|128|||
19616432|NCT00901901|42066230|FG000|Treatment Period|Withdrawal by Subject|26|||
19616433|NCT00901901|42066231|FG001|Treatment Period|Withdrawal by Subject|24|||
19616434|NCT00901901|42066230|FG000|Treatment Period|Physician Decision|2|||
19616435|NCT00901901|42066231|FG001|Treatment Period|Physician Decision|2|||
19616436|NCT00901901|42066230|FG000|Treatment Period|Lost to Follow-up|3|||
19616437|NCT00901901|42066231|FG001|Treatment Period|Lost to Follow-up|5|||
19616438|NCT00901901|42066230|FG000|Treatment Period|Noncompliance with study medication|4|||
19616439|NCT00901901|42066231|FG001|Treatment Period|Noncompliance with study medication|1|||
19616440|NCT00901901|42066230|FG000|Treatment Period|Missing|1|||
19616441|NCT00901901|42066231|FG001|Treatment Period|Missing|0|||
19616442|NCT00901901|42066230|FG000|Treatment Period|Never treated|0|||
19616443|NCT00901901|42066231|FG001|Treatment Period|Never treated|3|||
19616444|NCT00901901|42066230|FG000|Treatment Period|Protocol driven decision point|0|||
19616445|NCT00901901|42066231|FG001|Treatment Period|Protocol driven decision point|2|||
19616446|NCT00901901|42066230|FG000|Treatment Period|Study terminated by sponsor|2|||
19616447|NCT00901901|42066231|FG001|Treatment Period|Study terminated by sponsor|0|||
19616448|NCT00901901|42066230|FG000|Treatment Period|Protocol Violation|5|||
19616449|NCT00901901|42066231|FG001|Treatment Period|Protocol Violation|9|||
19616450|NCT00901901|42066230|FG000|Treatment Period|Switch to commercial drug|1|||
19616451|NCT00901901|42066231|FG001|Treatment Period|Switch to commercial drug|1|||
19704542|NCT00129402|42148933|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19509270|NCT02079636|41919531|FG008|Overall Study|Adverse Event|0|||
19509271|NCT02079636|41919532|FG009|Overall Study|Adverse Event|0|||
19509272|NCT02079636|41919533|FG010|Overall Study|Adverse Event|0|||
19509273|NCT02079636|41919534|FG011|Overall Study|Adverse Event|0|||
19509274|NCT02079636|41919535|FG012|Overall Study|Adverse Event|0|||
19509275|NCT02079636|41919536|FG013|Overall Study|Adverse Event|0|||
19616452|NCT00901901|42066230|FG000|Treatment Period|Transfer to treatment continuation study|5|||
19509276|NCT02079636|41919537|FG014|Overall Study|Adverse Event|0|||
19509277|NCT02079636|41919523|FG000|Overall Study|Progressive disease|0|||
19509278|NCT02079636|41919524|FG001|Overall Study|Progressive disease|0|||
19509279|NCT02079636|41919525|FG002|Overall Study|Progressive disease|0|||
19509280|NCT02079636|41919526|FG003|Overall Study|Progressive disease|2|||
19509281|NCT02079636|41919527|FG004|Overall Study|Progressive disease|0|||
19509282|NCT02079636|41919528|FG005|Overall Study|Progressive disease|0|||
19509283|NCT02079636|41919529|FG006|Overall Study|Progressive disease|0|||
19509284|NCT02079636|41919530|FG007|Overall Study|Progressive disease|0|||
19509285|NCT02079636|41919531|FG008|Overall Study|Progressive disease|0|||
19509286|NCT02079636|41919532|FG009|Overall Study|Progressive disease|0|||
19509287|NCT02079636|41919533|FG010|Overall Study|Progressive disease|0|||
19509288|NCT02079636|41919534|FG011|Overall Study|Progressive disease|0|||
19509289|NCT02079636|41919535|FG012|Overall Study|Progressive disease|1|||
19509290|NCT02079636|41919536|FG013|Overall Study|Progressive disease|0|||
19509291|NCT02079636|41919537|FG014|Overall Study|Progressive disease|0|||
19509292|NCT02079636|41919523|FG000|Overall Study|Withdrawal by Subject|0|||
19509293|NCT02079636|41919524|FG001|Overall Study|Withdrawal by Subject|0|||
19509294|NCT02079636|41919525|FG002|Overall Study|Withdrawal by Subject|0|||
19509295|NCT02079636|41919526|FG003|Overall Study|Withdrawal by Subject|4|||
19509296|NCT02079636|41919527|FG004|Overall Study|Withdrawal by Subject|0|||
19509297|NCT02079636|41919528|FG005|Overall Study|Withdrawal by Subject|1|||
19509298|NCT02079636|41919529|FG006|Overall Study|Withdrawal by Subject|0|||
19509299|NCT02079636|41919530|FG007|Overall Study|Withdrawal by Subject|0|||
19509300|NCT02079636|41919531|FG008|Overall Study|Withdrawal by Subject|0|||
19509301|NCT02079636|41919532|FG009|Overall Study|Withdrawal by Subject|2|||
19509302|NCT02079636|41919533|FG010|Overall Study|Withdrawal by Subject|1|||
19509303|NCT02079636|41919534|FG011|Overall Study|Withdrawal by Subject|1|||
19509304|NCT02079636|41919535|FG012|Overall Study|Withdrawal by Subject|1|||
19509305|NCT02079636|41919536|FG013|Overall Study|Withdrawal by Subject|0|||
19509306|NCT02079636|41919537|FG014|Overall Study|Withdrawal by Subject|2|||
19509307|NCT02079636|41919523|FG000|Overall Study|Physician Decision|0|||
19509308|NCT02079636|41919524|FG001|Overall Study|Physician Decision|0|||
19509309|NCT02079636|41919525|FG002|Overall Study|Physician Decision|0|||
19509310|NCT02079636|41919526|FG003|Overall Study|Physician Decision|0|||
19509311|NCT02079636|41919527|FG004|Overall Study|Physician Decision|0|||
19509312|NCT02079636|41919528|FG005|Overall Study|Physician Decision|1|||
19509313|NCT02079636|41919529|FG006|Overall Study|Physician Decision|0|||
19509314|NCT02079636|41919530|FG007|Overall Study|Physician Decision|0|||
19509315|NCT02079636|41919531|FG008|Overall Study|Physician Decision|0|||
19509316|NCT02079636|41919532|FG009|Overall Study|Physician Decision|1|||
19509317|NCT02079636|41919533|FG010|Overall Study|Physician Decision|1|||
19509318|NCT02079636|41919534|FG011|Overall Study|Physician Decision|0|||
19509319|NCT02079636|41919535|FG012|Overall Study|Physician Decision|0|||
19509320|NCT02079636|41919536|FG013|Overall Study|Physician Decision|0|||
19509321|NCT02079636|41919537|FG014|Overall Study|Physician Decision|1|||
19509322|NCT02079636|41919523|FG000|Overall Study|Lost to Follow-up|0|||
19509323|NCT02079636|41919524|FG001|Overall Study|Lost to Follow-up|0|||
19509324|NCT02079636|41919525|FG002|Overall Study|Lost to Follow-up|0|||
19509325|NCT02079636|41919526|FG003|Overall Study|Lost to Follow-up|0|||
19509326|NCT02079636|41919527|FG004|Overall Study|Lost to Follow-up|0|||
19509327|NCT02079636|41919528|FG005|Overall Study|Lost to Follow-up|0|||
19509328|NCT02079636|41919529|FG006|Overall Study|Lost to Follow-up|0|||
19509329|NCT02079636|41919530|FG007|Overall Study|Lost to Follow-up|1|||
19509330|NCT02079636|41919531|FG008|Overall Study|Lost to Follow-up|0|||
19509331|NCT02079636|41919532|FG009|Overall Study|Lost to Follow-up|0|||
19509332|NCT02079636|41919533|FG010|Overall Study|Lost to Follow-up|0|||
19509333|NCT02079636|41919534|FG011|Overall Study|Lost to Follow-up|0|||
19509334|NCT02079636|41919535|FG012|Overall Study|Lost to Follow-up|0|||
19509335|NCT02079636|41919536|FG013|Overall Study|Lost to Follow-up|0|||
19509336|NCT02079636|41919537|FG014|Overall Study|Lost to Follow-up|0|||
19509337|NCT02079246|41919601|FG000|OLEX|Withdrawal before treatment|1|||
19704543|NCT00129402|42148934|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19373740|NCT02755649|41614938|FG002|Overall Study|Physician Decision|2|||
19509338|NCT02079246|41919602|FG001|OLEX|Withdrawal before treatment|0|||
19509339|NCT02079246|41919601|FG000|OLEX|Death|11|||
19509340|NCT02079246|41919602|FG001|OLEX|Death|0|||
19509341|NCT02079246|41919601|FG000|OLEX|Adverse Event|66|||
19509342|NCT02079246|41919602|FG001|OLEX|Adverse Event|0|||
19509343|NCT02079246|41919601|FG000|OLEX|Withdrawal by Subject|60|||
19509344|NCT02079246|41919602|FG001|OLEX|Withdrawal by Subject|0|||
19509345|NCT02079246|41919601|FG000|OLEX|Lost to Follow-up|6|||
19509346|NCT02079246|41919602|FG001|OLEX|Lost to Follow-up|0|||
19509347|NCT02079246|41919601|FG000|OLEX|Protocol Violation|6|||
19509348|NCT02079246|41919602|FG001|OLEX|Protocol Violation|0|||
19509349|NCT02079246|41919601|FG000|OLEX|Lack of Efficacy|3|||
19509350|NCT02079246|41919602|FG001|OLEX|Lack of Efficacy|0|||
19509351|NCT02079246|41919601|FG000|OLEX|Results of the lead-in studies|58|||
19509352|NCT02079246|41919602|FG001|OLEX|Results of the lead-in studies|0|||
19509353|NCT02079246|41919601|FG000|OLEX|Other: Disallowed medication|8|||
19509354|NCT02079246|41919602|FG001|OLEX|Other: Disallowed medication|0|||
19616453|NCT00901901|42066231|FG001|Treatment Period|Transfer to treatment continuation study|2|||
19616454|NCT00901901|42066230|FG000|Follow-up Period|Death|181|||
19616455|NCT00901901|42066231|FG001|Follow-up Period|Death|208|||
19616456|NCT00901901|42066230|FG000|Follow-up Period|Protocol driven decision point|47|||
19616457|NCT00901901|42066231|FG001|Follow-up Period|Protocol driven decision point|36|||
19616458|NCT00901901|42066230|FG000|Follow-up Period|Withdrawal by Subject|6|||
19616459|NCT00901901|42066231|FG001|Follow-up Period|Withdrawal by Subject|9|||
19616460|NCT00901901|42066230|FG000|Follow-up Period|Lost to Follow-up|12|||
19616461|NCT00901901|42066231|FG001|Follow-up Period|Lost to Follow-up|8|||
19616462|NCT00901901|42066230|FG000|Follow-up Period|Missing|94|||
19616463|NCT00901901|42066231|FG001|Follow-up Period|Missing|80|||
19616464|NCT02143778|42066239|FG000|Overall Study|Withdrawal by Subject|2|||
19616465|NCT02143778|42066239|FG000|Overall Study|Device malfunction|1|||
19616466|NCT00896363|42066283|FG000|Overall Study|Adverse Event|3|||
19616467|NCT00896363|42066284|FG001|Overall Study|Adverse Event|4|||
19616468|NCT00896363|42066285|FG002|Overall Study|Adverse Event|2|||
19616469|NCT00896363|42066283|FG000|Overall Study|Lack of Efficacy|0|||
19616470|NCT00896363|42066284|FG001|Overall Study|Lack of Efficacy|2|||
19616471|NCT00896363|42066285|FG002|Overall Study|Lack of Efficacy|1|||
19616472|NCT00896363|42066283|FG000|Overall Study|Withdrawal by Subject|3|||
19616473|NCT00896363|42066284|FG001|Overall Study|Withdrawal by Subject|5|||
19509355|NCT02079246|41919601|FG000|OLEX|Other: Insufficient compliance|2|||
19509356|NCT02079246|41919602|FG001|OLEX|Other: Insufficient compliance|0|||
19509357|NCT02079246|41919601|FG000|OLEX|Other: Caregiver unavailable|3|||
19509358|NCT02079246|41919602|FG001|OLEX|Other: Caregiver unavailable|0|||
19509359|NCT02079246|41919601|FG000|OLEX|Other: Coordinator decision|1|||
19509360|NCT02079246|41919602|FG001|OLEX|Other: Coordinator decision|0|||
19509361|NCT02079246|41919601|FG000|OLEX|Other: Worsening of condition|1|||
19509362|NCT02079246|41919602|FG001|OLEX|Other: Worsening of condition|0|||
19509363|NCT02079246|41919601|FG000|OLEX|Other: Moved to nursing home|1|||
19509364|NCT02079246|41919602|FG001|OLEX|Other: Moved to nursing home|0|||
19509365|NCT02079246|41919601|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
19509366|NCT02079246|41919602|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
19509367|NCT02079246|41919601|FG000|OLEX-MEM|Adverse Event|0|||
19509368|NCT02079246|41919602|FG001|OLEX-MEM|Adverse Event|6|||
19509369|NCT02079246|41919601|FG000|OLEX-MEM|Withdrawal by Subject|0|||
19509370|NCT02079246|41919602|FG001|OLEX-MEM|Withdrawal by Subject|7|||
19509371|NCT02079246|41919601|FG000|OLEX-MEM|Protocol Violation|0|||
19509372|NCT02079246|41919602|FG001|OLEX-MEM|Protocol Violation|2|||
19509373|NCT02079246|41919601|FG000|OLEX-MEM|Lost to Follow-up|0|||
19509374|NCT02079246|41919602|FG001|OLEX-MEM|Lost to Follow-up|1|||
19509375|NCT02079246|41919601|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
19509376|NCT02079246|41919602|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
19509377|NCT02077374|41919613|FG000|Overall Study|Withdrawal by Subject|0|||
19509378|NCT02077374|41919614|FG001|Overall Study|Withdrawal by Subject|1|||
19509379|NCT02077374|41919613|FG000|Overall Study|Protocol Violation|0|||
19509380|NCT02077374|41919614|FG001|Overall Study|Protocol Violation|1|||
19509381|NCT02077140|41919628|FG000|Overall Study|Lost to Follow-up|4|||
19509382|NCT02077140|41919629|FG001|Overall Study|Lost to Follow-up|1|||
19509383|NCT02077140|41919630|FG002|Overall Study|Lost to Follow-up|2|||
19509384|NCT02077140|41919631|FG003|Overall Study|Lost to Follow-up|2|||
19509385|NCT02077140|41919632|FG004|Overall Study|Lost to Follow-up|3|||
19509386|NCT02077140|41919628|FG000|Overall Study|Withdrawal by Subject|0|||
19509387|NCT02077140|41919629|FG001|Overall Study|Withdrawal by Subject|1|||
19509388|NCT02077140|41919630|FG002|Overall Study|Withdrawal by Subject|0|||
19509389|NCT02077140|41919631|FG003|Overall Study|Withdrawal by Subject|2|||
19509390|NCT02077140|41919632|FG004|Overall Study|Withdrawal by Subject|2|||
19509391|NCT02047110|41919651|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
19509392|NCT02047110|41919652|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
19509393|NCT02047110|41919653|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
19509394|NCT02047110|41919654|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
19509395|NCT02047110|41919651|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
19509396|NCT02047110|41919652|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
19509397|NCT02047110|41919653|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
19509398|NCT02047110|41919654|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
19509399|NCT02047110|41919651|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
19509400|NCT02047110|41919652|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
19509401|NCT02047110|41919653|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
19509402|NCT02047110|41919654|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
19509403|NCT02047110|41919651|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
19509404|NCT02047110|41919652|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
19509405|NCT02047110|41919653|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
19616474|NCT00896363|42066285|FG002|Overall Study|Withdrawal by Subject|5|||
19616475|NCT00900029|42066301|FG000|Overall Study|Lost to Follow-up|0|||
19509406|NCT02047110|41919654|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
19509407|NCT02047110|41919651|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
19509408|NCT02047110|41919652|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
19509409|NCT02047110|41919653|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
19509410|NCT02047110|41919654|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
19509411|NCT02047110|41919651|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
19509412|NCT02047110|41919652|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
19509413|NCT02047110|41919653|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
19509414|NCT02047110|41919654|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
19509415|NCT02047110|41919651|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
19509416|NCT02047110|41919652|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
19509417|NCT02047110|41919653|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
19509418|NCT02047110|41919654|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
19509419|NCT02047110|41919651|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
19509420|NCT02047110|41919652|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
19509421|NCT02047110|41919653|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
19509422|NCT02047110|41919654|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
19509423|NCT02047110|41919651|FG000|Escape Treatment Period|Adverse Event|1|||
19509424|NCT02047110|41919652|FG001|Escape Treatment Period|Adverse Event|2|||
19509425|NCT02047110|41919653|FG002|Escape Treatment Period|Adverse Event|2|||
19509426|NCT02047110|41919654|FG003|Escape Treatment Period|Adverse Event|0|||
19509427|NCT02047110|41919651|FG000|Escape Treatment Period|Other than specified|1|||
19509428|NCT02047110|41919652|FG001|Escape Treatment Period|Other than specified|2|||
19509429|NCT02047110|41919653|FG002|Escape Treatment Period|Other than specified|0|||
19509430|NCT02047110|41919654|FG003|Escape Treatment Period|Other than specified|1|||
19509431|NCT02047110|41919651|FG000|OLE Treatment Period|Other than specified|0|||
19509432|NCT02047110|41919652|FG001|OLE Treatment Period|Other than specified|0|||
19509433|NCT02047110|41919653|FG002|OLE Treatment Period|Other than specified|1|||
19509434|NCT02047110|41919654|FG003|OLE Treatment Period|Other than specified|0|||
19509435|NCT02046564|41919673|FG000|Overall Study|Adverse Event|6|||
19509436|NCT02046564|41919674|FG001|Overall Study|Adverse Event|3|||
19509437|NCT02046564|41919673|FG000|Overall Study|Physician Decision|0|||
19509438|NCT02046564|41919674|FG001|Overall Study|Physician Decision|1|||
19509439|NCT02046564|41919673|FG000|Overall Study|Protocol Violation|3|||
19509440|NCT02046564|41919674|FG001|Overall Study|Protocol Violation|1|||
19509441|NCT02046564|41919673|FG000|Overall Study|Withdrawal by Subject|4|||
19509442|NCT02046564|41919674|FG001|Overall Study|Withdrawal by Subject|10|||
19509443|NCT02046564|41919673|FG000|Overall Study|Subject met withdrawal criteria|2|||
19509444|NCT02046564|41919674|FG001|Overall Study|Subject met withdrawal criteria|5|||
19509445|NCT02046174|41919680|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
19509446|NCT02046174|41919681|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
19509447|NCT02045862|41919769|FG000|Overall Study|Death|0|||
19509448|NCT02045862|41919770|FG001|Overall Study|Death|0|||
19509449|NCT02045862|41919771|FG002|Overall Study|Death|1|||
19509450|NCT02045862|41919769|FG000|Overall Study|Miscellaneous|5|||
19509451|NCT02045862|41919770|FG001|Overall Study|Miscellaneous|0|||
19509452|NCT02045862|41919771|FG002|Overall Study|Miscellaneous|8|||
19509453|NCT02045862|41919769|FG000|Overall Study|Withdrawal by Patient|18|||
19509454|NCT02045862|41919770|FG001|Overall Study|Withdrawal by Patient|27|||
19509455|NCT02045862|41919771|FG002|Overall Study|Withdrawal by Patient|57|||
19509456|NCT02045862|41919769|FG000|Overall Study|Protocol Violation|0|||
19509457|NCT02045862|41919770|FG001|Overall Study|Protocol Violation|0|||
19509458|NCT02045862|41919771|FG002|Overall Study|Protocol Violation|6|||
19509459|NCT02045862|41919769|FG000|Overall Study|Lack of Efficacy|8|||
19509460|NCT02045862|41919770|FG001|Overall Study|Lack of Efficacy|4|||
19509461|NCT02045862|41919771|FG002|Overall Study|Lack of Efficacy|13|||
19509462|NCT02045862|41919769|FG000|Overall Study|Randomized but not Received Study Drug|0|||
19509463|NCT02045862|41919770|FG001|Overall Study|Randomized but not Received Study Drug|2|||
19509464|NCT02045862|41919771|FG002|Overall Study|Randomized but not Received Study Drug|8|||
19509465|NCT02045862|41919769|FG000|Overall Study|Adverse Event|7|||
19509466|NCT02045862|41919770|FG001|Overall Study|Adverse Event|5|||
19509467|NCT02045862|41919771|FG002|Overall Study|Adverse Event|27|||
19509468|NCT02045862|41919769|FG000|Overall Study|Lost to Follow-up|1|||
19509469|NCT02045862|41919770|FG001|Overall Study|Lost to Follow-up|2|||
19509470|NCT02045862|41919771|FG002|Overall Study|Lost to Follow-up|6|||
19509471|NCT02075658|41919781|FG000|Overall Study|Physician Decision|2|||
19509472|NCT02075658|41919782|FG001|Overall Study|Physician Decision|2|||
19509473|NCT02063880|41919790|FG000|Overall Study|Death|21|||
19509474|NCT02063880|41919791|FG001|Overall Study|Death|18|||
19509475|NCT02063880|41919790|FG000|Overall Study|Lost to Follow-up|7|||
19509476|NCT02063880|41919791|FG001|Overall Study|Lost to Follow-up|7|||
19509477|NCT02063880|41919790|FG000|Overall Study|Ineligible|0|||
19509478|NCT02063880|41919791|FG001|Overall Study|Ineligible|2|||
19509479|NCT02044848|41919799|FG000|Overall Study|Administrative Problems|2|||
19509480|NCT02044848|41919800|FG001|Overall Study|Administrative Problems|3|||
19509481|NCT02044458|41919808|FG000|Overall Study|Protocol Violation|3|||
19509482|NCT02044458|41919809|FG001|Overall Study|Protocol Violation|8|||
19509483|NCT02044302|41919817|FG000|Overall Study|study terminated|2|||
19509484|NCT02044302|41919818|FG001|Overall Study|study terminated|0|||
19509485|NCT02062944|41919822|FG000|Overall Study|Lost to Follow-up|1|||
19509486|NCT02062944|41919822|FG000|Overall Study|New hemotological disorder identified|1|||
19509487|NCT02062944|41919822|FG000|Overall Study|Uncontrolled Hypertension|1|||
19509488|NCT02062944|41919822|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
19509489|NCT02062632|41919827|FG000|Overall Study|No treatment data|1|||
19509490|NCT02062398|41919831|FG000|Overall Study|Implant removal|1|||
19509491|NCT02061540|41919835|FG000|Overall Study|Adverse Event|2|||
19509492|NCT02061540|41919835|FG000|Overall Study|Withdrawal by Subject|2|||
19509493|NCT02043366|41919850|FG000|Overall Study|Lost to Follow-up|2|||
19509494|NCT02043366|41919851|FG001|Overall Study|Lost to Follow-up|2|||
19509495|NCT02043366|41919852|FG002|Overall Study|Lost to Follow-up|2|||
19616476|NCT00900029|42066302|FG001|Overall Study|Lost to Follow-up|2|||
19616477|NCT00900029|42066303|FG002|Overall Study|Lost to Follow-up|1|||
19509496|NCT02043366|41919853|FG003|Overall Study|Lost to Follow-up|2|||
19509497|NCT02043366|41919854|FG004|Overall Study|Lost to Follow-up|2|||
19509498|NCT02043366|41919855|FG005|Overall Study|Lost to Follow-up|2|||
19509499|NCT02060370|41919871|FG000|Overall Study|Physician Decision|1|||
19616478|NCT00900029|42066304|FG003|Overall Study|Lost to Follow-up|4|||
19616479|NCT00900029|42066305|FG004|Overall Study|Lost to Follow-up|4|||
19616480|NCT00900029|42066301|FG000|Overall Study|Withdrawal by Subject|2|||
19616481|NCT00900029|42066302|FG001|Overall Study|Withdrawal by Subject|2|||
19616482|NCT00900029|42066303|FG002|Overall Study|Withdrawal by Subject|1|||
19616483|NCT00900029|42066304|FG003|Overall Study|Withdrawal by Subject|1|||
19616484|NCT00900029|42066305|FG004|Overall Study|Withdrawal by Subject|1|||
19616485|NCT00900029|42066301|FG000|Overall Study|Adverse Event|0|||
19616486|NCT00900029|42066302|FG001|Overall Study|Adverse Event|0|||
19616487|NCT00900029|42066303|FG002|Overall Study|Adverse Event|1|||
19616488|NCT00900029|42066304|FG003|Overall Study|Adverse Event|1|||
19616489|NCT00900029|42066305|FG004|Overall Study|Adverse Event|1|||
19616490|NCT00900029|42066301|FG000|Overall Study|Death|1|||
19616491|NCT00900029|42066302|FG001|Overall Study|Death|0|||
19616492|NCT00900029|42066303|FG002|Overall Study|Death|0|||
19616493|NCT00900029|42066304|FG003|Overall Study|Death|1|||
19616494|NCT00900029|42066305|FG004|Overall Study|Death|0|||
19616495|NCT00896051|42066323|FG000|Overall Study|Adverse Event|2|||
19616496|NCT00896051|42066324|FG001|Overall Study|Adverse Event|1|||
19616497|NCT00896051|42066323|FG000|Overall Study|Lost to Follow-up|3|||
19616498|NCT00896051|42066324|FG001|Overall Study|Lost to Follow-up|2|||
19616499|NCT00896051|42066323|FG000|Overall Study|Withdrawal by Subject|3|||
19616500|NCT00896051|42066324|FG001|Overall Study|Withdrawal by Subject|2|||
19394101|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
19394102|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
19394103|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
19394104|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
19394105|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
19394106|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
19394107|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
19394108|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
19394109|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
19394110|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
19394111|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
19394112|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
19509500|NCT01622088|41919875|FG000|Overall Study|Adverse Event|20|||
19509501|NCT01622088|41919875|FG000|Overall Study|Lost to Follow-up|1|||
19509502|NCT01622088|41919875|FG000|Overall Study|Withdrawal by Subject|20|||
19509503|NCT01622088|41919875|FG000|Overall Study|Investigator Decision|1|||
19509504|NCT01622088|41919875|FG000|Overall Study|Death|53|||
19616501|NCT00896051|42066323|FG000|Overall Study|Subject noncompliant|1|||
19616502|NCT00896051|42066324|FG001|Overall Study|Subject noncompliant|3|||
19616503|NCT00896051|42066323|FG000|Overall Study|Other|1|||
19616504|NCT00896051|42066324|FG001|Overall Study|Other|1|||
19509505|NCT01622088|41919875|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
19509506|NCT01621542|41919886|FG000|Overall Study|Adverse Event|0|||
19509507|NCT01621542|41919887|FG001|Overall Study|Adverse Event|0|||
19509508|NCT01621542|41919888|FG002|Overall Study|Adverse Event|1|||
19509509|NCT01621542|41919889|FG003|Overall Study|Adverse Event|3|||
19509510|NCT01621542|41919890|FG004|Overall Study|Adverse Event|0|||
19509511|NCT01621542|41919891|FG005|Overall Study|Adverse Event|0|||
19616505|NCT00894647|42066341|FG000|Overall Study|Adverse Event|5|||
19616506|NCT00894647|42066342|FG001|Overall Study|Adverse Event|4|||
19616507|NCT00894647|42066341|FG000|Overall Study|Withdrawal by Subject|4|||
19616508|NCT00894647|42066342|FG001|Overall Study|Withdrawal by Subject|4|||
19616509|NCT00894647|42066341|FG000|Overall Study|Lost to Follow-up|0|||
19616510|NCT00894647|42066342|FG001|Overall Study|Lost to Follow-up|2|||
19616511|NCT00894647|42066341|FG000|Overall Study|Non-compliance with study procedures|0|||
19616512|NCT00894647|42066342|FG001|Overall Study|Non-compliance with study procedures|2|||
19616513|NCT00894647|42066341|FG000|Overall Study|Other, not due to AE|1|||
19616514|NCT00894647|42066342|FG001|Overall Study|Other, not due to AE|2|||
19616515|NCT00892775|42066350|FG000|Overall Study|Protocol Violation|1|||
19616516|NCT00892775|42066351|FG001|Overall Study|Protocol Violation|0|||
19616517|NCT00892775|42066350|FG000|Overall Study|Subject difficulties with blood drawing|1|||
19616518|NCT00892775|42066351|FG001|Overall Study|Subject difficulties with blood drawing|0|||
19616519|NCT00892775|42066350|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
19616520|NCT00892775|42066351|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
19616521|NCT00892775|42066350|FG000|Overall Study|Migrated/ moved from study area|1|||
19616522|NCT00892775|42066351|FG001|Overall Study|Migrated/ moved from study area|0|||
19616523|NCT00892775|42066350|FG000|Overall Study|Withdrawal by Subject|0|||
19616524|NCT00892775|42066351|FG001|Overall Study|Withdrawal by Subject|1|||
19616525|NCT00892775|42066350|FG000|Overall Study|Lost to Follow-up|1|||
19616526|NCT00892775|42066351|FG001|Overall Study|Lost to Follow-up|0|||
19616527|NCT00895895|42066362|FG000|Period 1|Adverse Event|7|||
19616528|NCT00895895|42066363|FG001|Period 1|Adverse Event|6|||
19509512|NCT01621542|41919886|FG000|Overall Study|Death|0|||
19616529|NCT00895895|42066364|FG002|Period 1|Adverse Event|4|||
19616530|NCT00895895|42066365|FG003|Period 1|Adverse Event|6|||
19616531|NCT00895895|42066366|FG004|Period 1|Adverse Event|7|||
19616532|NCT00895895|42066362|FG000|Period 1|Death|0|||
19616533|NCT00895895|42066363|FG001|Period 1|Death|0|||
19616534|NCT00895895|42066364|FG002|Period 1|Death|0|||
19616535|NCT00895895|42066365|FG003|Period 1|Death|0|||
19616536|NCT00895895|42066366|FG004|Period 1|Death|1|||
19616537|NCT00895895|42066362|FG000|Period 1|discontinued by sponsor|2|||
19616538|NCT00895895|42066363|FG001|Period 1|discontinued by sponsor|1|||
19616539|NCT00895895|42066364|FG002|Period 1|discontinued by sponsor|2|||
19616540|NCT00895895|42066365|FG003|Period 1|discontinued by sponsor|1|||
19616541|NCT00895895|42066366|FG004|Period 1|discontinued by sponsor|1|||
19616542|NCT00895895|42066362|FG000|Period 1|failed to return|0|||
19616543|NCT00895895|42066363|FG001|Period 1|failed to return|0|||
19616544|NCT00895895|42066364|FG002|Period 1|failed to return|1|||
19704544|NCT00129402|42148935|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
19704545|NCT00129402|42148929|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
19704546|NCT00129402|42148930|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
19704547|NCT00129402|42148931|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
19704548|NCT00129402|42148932|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
19704549|NCT00129402|42148933|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
19704550|NCT00129402|42148934|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
19704551|NCT00129402|42148935|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
19704552|NCT00129402|42148929|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704553|NCT00129402|42148930|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704554|NCT00129402|42148931|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
19704555|NCT00129402|42148932|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704556|NCT00129402|42148933|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704557|NCT00129402|42148934|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704558|NCT00129402|42148935|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
19704559|NCT00129402|42148929|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
19704560|NCT00129402|42148930|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
19704561|NCT00129402|42148931|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
19509513|NCT01621542|41919887|FG001|Overall Study|Death|1|||
19509514|NCT01621542|41919888|FG002|Overall Study|Death|0|||
19509515|NCT01621542|41919889|FG003|Overall Study|Death|0|||
19509516|NCT01621542|41919890|FG004|Overall Study|Death|0|||
19509517|NCT01621542|41919891|FG005|Overall Study|Death|0|||
19616545|NCT00895895|42066365|FG003|Period 1|failed to return|0|||
19616546|NCT00895895|42066366|FG004|Period 1|failed to return|1|||
19616547|NCT00895895|42066362|FG000|Period 1|investigator request|0|||
19616548|NCT00895895|42066363|FG001|Period 1|investigator request|1|||
19704562|NCT00129402|42148932|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
19704563|NCT00129402|42148933|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
19704564|NCT00129402|42148934|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
19509518|NCT01621542|41919886|FG000|Overall Study|Physician Decision|1|||
19509519|NCT01621542|41919887|FG001|Overall Study|Physician Decision|0|||
19509520|NCT01621542|41919888|FG002|Overall Study|Physician Decision|1|||
19509521|NCT01621542|41919889|FG003|Overall Study|Physician Decision|13|||
19509522|NCT01621542|41919890|FG004|Overall Study|Physician Decision|3|||
19509523|NCT01621542|41919891|FG005|Overall Study|Physician Decision|1|||
19509524|NCT01621542|41919886|FG000|Overall Study|Withdrawal by Subject|2|||
19509525|NCT01621542|41919887|FG001|Overall Study|Withdrawal by Subject|0|||
19509526|NCT01621542|41919888|FG002|Overall Study|Withdrawal by Subject|1|||
19509527|NCT01621542|41919889|FG003|Overall Study|Withdrawal by Subject|3|||
19509528|NCT01621542|41919890|FG004|Overall Study|Withdrawal by Subject|3|||
19509529|NCT01621542|41919891|FG005|Overall Study|Withdrawal by Subject|3|||
19509530|NCT01621542|41919886|FG000|Overall Study|progression/treatment failure|2|||
19509531|NCT01621542|41919887|FG001|Overall Study|progression/treatment failure|4|||
19509532|NCT01621542|41919888|FG002|Overall Study|progression/treatment failure|3|||
19509533|NCT01621542|41919889|FG003|Overall Study|progression/treatment failure|7|||
19509534|NCT01621542|41919890|FG004|Overall Study|progression/treatment failure|3|||
19509535|NCT01621542|41919891|FG005|Overall Study|progression/treatment failure|5|||
19509536|NCT01621542|41919886|FG000|Overall Study|Protocol Violation|0|||
19509537|NCT01621542|41919887|FG001|Overall Study|Protocol Violation|0|||
19509538|NCT01621542|41919888|FG002|Overall Study|Protocol Violation|0|||
19704565|NCT00129402|42148935|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
19704566|NCT00129402|42148929|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19704567|NCT00129402|42148930|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19704568|NCT00129402|42148931|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
19704569|NCT00129402|42148932|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19509539|NCT01621542|41919889|FG003|Overall Study|Protocol Violation|1|||
19509540|NCT01621542|41919890|FG004|Overall Study|Protocol Violation|0|||
19509541|NCT01621542|41919891|FG005|Overall Study|Protocol Violation|0|||
19509542|NCT01621542|41919886|FG000|Overall Study|study stopped by sponsor|0|||
19509543|NCT01621542|41919887|FG001|Overall Study|study stopped by sponsor|0|||
19509544|NCT01621542|41919888|FG002|Overall Study|study stopped by sponsor|0|||
19509545|NCT01621542|41919889|FG003|Overall Study|study stopped by sponsor|1|||
19509546|NCT01621542|41919890|FG004|Overall Study|study stopped by sponsor|0|||
19509547|NCT01621542|41919891|FG005|Overall Study|study stopped by sponsor|0|||
19509548|NCT02021292|41919907|FG000|Overall Study|Physician Decision|0|||
19509549|NCT02021292|41919908|FG001|Overall Study|Physician Decision|1|||
19509550|NCT02021292|41919907|FG000|Overall Study|Lost to Follow-up|0|||
19509551|NCT02021292|41919908|FG001|Overall Study|Lost to Follow-up|1|||
19509552|NCT02021292|41919907|FG000|Overall Study|Death|0|||
19616549|NCT00895895|42066364|FG002|Period 1|investigator request|0|||
19616550|NCT00895895|42066365|FG003|Period 1|investigator request|0|||
19616551|NCT00895895|42066366|FG004|Period 1|investigator request|0|||
19616552|NCT00895895|42066362|FG000|Period 1|Lost to Follow-up|2|||
19616553|NCT00895895|42066363|FG001|Period 1|Lost to Follow-up|1|||
19616554|NCT00895895|42066364|FG002|Period 1|Lost to Follow-up|3|||
19616555|NCT00895895|42066365|FG003|Period 1|Lost to Follow-up|2|||
19616556|NCT00895895|42066366|FG004|Period 1|Lost to Follow-up|3|||
19616557|NCT00895895|42066362|FG000|Period 1|Other|1|||
19509553|NCT02021292|41919908|FG001|Overall Study|Death|1|||
19509554|NCT02059980|41919918|FG000|Overall Study|Lost to Follow-up|2|||
19616558|NCT00895895|42066363|FG001|Period 1|Other|2|||
19616559|NCT00895895|42066364|FG002|Period 1|Other|1|||
19616560|NCT00895895|42066365|FG003|Period 1|Other|1|||
19616561|NCT00895895|42066366|FG004|Period 1|Other|1|||
19616562|NCT00895895|42066362|FG000|Period 1|Protocol Violation|0|||
19616563|NCT00895895|42066363|FG001|Period 1|Protocol Violation|1|||
19616564|NCT00895895|42066364|FG002|Period 1|Protocol Violation|0|||
19616565|NCT00895895|42066365|FG003|Period 1|Protocol Violation|0|||
19509555|NCT02059980|41919919|FG001|Overall Study|Lost to Follow-up|1|||
19509556|NCT02043132|41919927|FG000|Overall Study|Lost to Follow-up|1|||
19616566|NCT00895895|42066366|FG004|Period 1|Protocol Violation|0|||
19509557|NCT02043132|41919928|FG001|Overall Study|Lost to Follow-up|1|||
19509558|NCT02043132|41919927|FG000|Overall Study|screen failures|4|||
19509559|NCT02043132|41919928|FG001|Overall Study|screen failures|8|||
19509560|NCT02059434|41919943|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
19509561|NCT02059434|41919944|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
19509562|NCT02059434|41919945|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
19509563|NCT02059434|41919946|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
19509564|NCT02059434|41919947|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
19616567|NCT00895895|42066362|FG000|Period 1|Withdrawal by Subject|6|||
19616568|NCT00895895|42066363|FG001|Period 1|Withdrawal by Subject|6|||
19616569|NCT00895895|42066364|FG002|Period 1|Withdrawal by Subject|8|||
19616570|NCT00895895|42066365|FG003|Period 1|Withdrawal by Subject|2|||
19616571|NCT00895895|42066366|FG004|Period 1|Withdrawal by Subject|4|||
19616572|NCT00895895|42066362|FG000|Period 1|unsatisfactory response-efficacy|2|||
19616573|NCT00895895|42066363|FG001|Period 1|unsatisfactory response-efficacy|0|||
19616574|NCT00895895|42066364|FG002|Period 1|unsatisfactory response-efficacy|0|||
19616575|NCT00895895|42066365|FG003|Period 1|unsatisfactory response-efficacy|0|||
19616576|NCT00895895|42066366|FG004|Period 1|unsatisfactory response-efficacy|0|||
19616577|NCT00895895|42066362|FG000|Period 1|randomized and not treated|1|||
19616578|NCT00895895|42066363|FG001|Period 1|randomized and not treated|3|||
19616579|NCT00895895|42066364|FG002|Period 1|randomized and not treated|1|||
19616580|NCT00895895|42066365|FG003|Period 1|randomized and not treated|1|||
19616581|NCT00895895|42066366|FG004|Period 1|randomized and not treated|2|||
19616582|NCT00895895|42066362|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
19616583|NCT00895895|42066363|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
19616584|NCT00895895|42066364|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
19616585|NCT00895895|42066365|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
19616586|NCT00895895|42066366|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
19616587|NCT00895895|42066362|FG000|After Period 1, Prior to Period 2|Other|0|||
19616588|NCT00895895|42066363|FG001|After Period 1, Prior to Period 2|Other|0|||
19616589|NCT00895895|42066364|FG002|After Period 1, Prior to Period 2|Other|1|||
19616590|NCT00895895|42066365|FG003|After Period 1, Prior to Period 2|Other|0|||
19616591|NCT00895895|42066366|FG004|After Period 1, Prior to Period 2|Other|0|||
19616592|NCT00895895|42066362|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
19616593|NCT00895895|42066363|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
19616594|NCT00895895|42066364|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
19616595|NCT00895895|42066365|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
19509565|NCT02059434|41919948|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
19509566|NCT02059434|41919949|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
19509567|NCT02059434|41919950|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
19509568|NCT02059434|41919951|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
19509569|NCT02059434|41919943|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
19509570|NCT02059434|41919944|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
19509571|NCT02059434|41919945|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
19509572|NCT02059434|41919946|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
19509573|NCT02059434|41919947|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
19509574|NCT02059434|41919948|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
19509575|NCT02059434|41919949|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
19509576|NCT02059434|41919950|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
19509577|NCT02059434|41919951|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
19509578|NCT02059434|41919943|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
19509579|NCT02059434|41919944|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
19509580|NCT02059434|41919945|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
19509581|NCT02059434|41919946|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
19509582|NCT02059434|41919947|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
19509583|NCT02059434|41919948|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
19509584|NCT02059434|41919949|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
19616596|NCT00895895|42066366|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
19616597|NCT00895895|42066362|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
19616598|NCT00895895|42066363|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
19616599|NCT00895895|42066364|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
19616600|NCT00895895|42066365|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
19616601|NCT00895895|42066366|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
19616602|NCT00895895|42066362|FG000|Period 2|Adverse Event|3|||
19616603|NCT00895895|42066363|FG001|Period 2|Adverse Event|3|||
19616604|NCT00895895|42066364|FG002|Period 2|Adverse Event|5|||
19616605|NCT00895895|42066365|FG003|Period 2|Adverse Event|2|||
19616606|NCT00895895|42066366|FG004|Period 2|Adverse Event|5|||
19616607|NCT00895895|42066362|FG000|Period 2|Death|0|||
19616608|NCT00895895|42066363|FG001|Period 2|Death|0|||
19616609|NCT00895895|42066364|FG002|Period 2|Death|1|||
19616610|NCT00895895|42066365|FG003|Period 2|Death|0|||
19616611|NCT00895895|42066366|FG004|Period 2|Death|0|||
19616612|NCT00895895|42066362|FG000|Period 2|discontinued by sponsor|44|||
19616613|NCT00895895|42066363|FG001|Period 2|discontinued by sponsor|44|||
19616614|NCT00895895|42066364|FG002|Period 2|discontinued by sponsor|38|||
19616615|NCT00895895|42066365|FG003|Period 2|discontinued by sponsor|46|||
19616616|NCT00895895|42066366|FG004|Period 2|discontinued by sponsor|37|||
19616617|NCT00895895|42066362|FG000|Period 2|failed to return|2|||
19616618|NCT00895895|42066363|FG001|Period 2|failed to return|0|||
19616619|NCT00895895|42066364|FG002|Period 2|failed to return|0|||
19616620|NCT00895895|42066365|FG003|Period 2|failed to return|0|||
19509585|NCT02059434|41919950|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
19616621|NCT00895895|42066366|FG004|Period 2|failed to return|0|||
19616622|NCT00895895|42066362|FG000|Period 2|investigator request|2|||
19509586|NCT02059434|41919951|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
19509587|NCT02059434|41919943|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
19509588|NCT02059434|41919944|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
19509589|NCT02059434|41919945|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
19509590|NCT02059434|41919946|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
19509591|NCT02059434|41919947|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
19509592|NCT02059434|41919948|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
19509593|NCT02059434|41919949|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
19509594|NCT02059434|41919950|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
19509595|NCT02059434|41919951|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
19509596|NCT02059434|41919943|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509597|NCT02059434|41919944|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509598|NCT02059434|41919945|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509599|NCT02059434|41919946|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509600|NCT02059434|41919947|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509601|NCT02059434|41919948|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509602|NCT02059434|41919949|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509603|NCT02059434|41919950|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
19509604|NCT02059434|41919951|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
19509605|NCT02059278|41919981|FG000|Overall Study|Adverse Event|1|||
19509606|NCT02059278|41919982|FG001|Overall Study|Adverse Event|1|||
19509607|NCT02059278|41919981|FG000|Overall Study|Lost to Follow-up|1|||
19509608|NCT02059278|41919982|FG001|Overall Study|Lost to Follow-up|0|||
19509609|NCT02059278|41919981|FG000|Overall Study|Withdrawal by Subject|0|||
19509610|NCT02059278|41919982|FG001|Overall Study|Withdrawal by Subject|3|||
19509611|NCT02059278|41919981|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
19509612|NCT02059278|41919982|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
19509613|NCT02020512|41919988|FG000|Overall Study|Adverse Event|1|||
19509614|NCT02020512|41919988|FG000|Overall Study|Lost to Follow-up|3|||
19509615|NCT02020512|41919988|FG000|Overall Study|Protocol Violation|4|||
19509616|NCT02041962|41919994|FG000|Overall Study|Lost Aetna Coverage|43|||
19509617|NCT02041962|41919995|FG001|Overall Study|Lost Aetna Coverage|40|||
19509618|NCT02041962|41919994|FG000|Overall Study|Death|1|||
19509619|NCT02041962|41919995|FG001|Overall Study|Death|1|||
19509620|NCT02041962|41919994|FG000|Overall Study|Lost to Follow-up|37|||
19509621|NCT02041962|41919995|FG001|Overall Study|Lost to Follow-up|32|||
19509622|NCT02041962|41919994|FG000|Overall Study|Withdrawal by Subject|0|||
19509623|NCT02041962|41919995|FG001|Overall Study|Withdrawal by Subject|11|||
19509624|NCT02041494|41920003|FG000|Overall Study|Death|1|||
19509625|NCT02041494|41920004|FG001|Overall Study|Death|3|||
19509626|NCT02041494|41920003|FG000|Overall Study|Lost to Follow-up|2|||
19509627|NCT02041494|41920004|FG001|Overall Study|Lost to Follow-up|6|||
19509628|NCT02041494|41920003|FG000|Overall Study|study terminated|16|||
19509629|NCT02041494|41920004|FG001|Overall Study|study terminated|11|||
19509630|NCT02041104|41920035|FG000|Overall Study|Lost to Follow-up|1|||
19509631|NCT02041104|41920036|FG001|Overall Study|Lost to Follow-up|4|||
19509632|NCT02041104|41920035|FG000|Overall Study|discomfort during OGTT|0|||
19509633|NCT02041104|41920036|FG001|Overall Study|discomfort during OGTT|3|||
19509634|NCT02019420|41920046|FG000|Overall Study|Did not receive study drug|2|||
19509635|NCT02019420|41920047|FG001|Overall Study|Did not receive study drug|2|||
19509636|NCT02019420|41920046|FG000|Overall Study|Withdrawal by Subject|1|||
19509637|NCT02019420|41920047|FG001|Overall Study|Withdrawal by Subject|3|||
19509638|NCT02019420|41920046|FG000|Overall Study|At request of sponsor or investigator|0|||
19509639|NCT02019420|41920047|FG001|Overall Study|At request of sponsor or investigator|1|||
19509640|NCT02019420|41920046|FG000|Overall Study|Death|104|||
19509641|NCT02019420|41920047|FG001|Overall Study|Death|99|||
19509642|NCT02019420|41920046|FG000|Overall Study|Transferred to other care facility|1|||
19509643|NCT02019420|41920047|FG001|Overall Study|Transferred to other care facility|1|||
19509644|NCT02019264|41920055|FG000|Overall Study|Not treated|6|||
19509645|NCT02019264|41920056|FG001|Overall Study|Not treated|4|||
19509646|NCT02019264|41920055|FG000|Overall Study|Lost to Follow-up|50|||
19509647|NCT02019264|41920056|FG001|Overall Study|Lost to Follow-up|47|||
19509648|NCT02019264|41920055|FG000|Overall Study|Withdrawal by Subject|142|||
19509649|NCT02019264|41920056|FG001|Overall Study|Withdrawal by Subject|117|||
19616623|NCT00895895|42066363|FG001|Period 2|investigator request|0|||
19616624|NCT00895895|42066364|FG002|Period 2|investigator request|0|||
19509650|NCT02019264|41920055|FG000|Overall Study|Administrative reason|36|||
19509651|NCT02019264|41920056|FG001|Overall Study|Administrative reason|28|||
19509652|NCT02019264|41920055|FG000|Overall Study|Missing|14|||
19509653|NCT02019264|41920056|FG001|Overall Study|Missing|11|||
19509654|NCT02019108|41920064|FG000|Overall Study|Lost to Follow-up|5|||
19509655|NCT02019108|41920065|FG001|Overall Study|Lost to Follow-up|7|||
19509656|NCT02018562|41920073|FG000|Overall Study|Withdrawal by Subject|2|||
19509657|NCT02018562|41920074|FG001|Overall Study|Withdrawal by Subject|0|||
19509658|NCT02018562|41920073|FG000|Overall Study|Discharged prior to study completion|1|||
19509659|NCT02018562|41920074|FG001|Overall Study|Discharged prior to study completion|0|||
19509660|NCT02058966|41920080|FG000|Open-Label Methamphetamine|Adverse Event|1|||
19509661|NCT02058966|41920080|FG000|First Intervention|Withdrawal by Subject|1|||
19509662|NCT02017860|41920092|FG000|Overall Study|Adverse Event|1|||
19509663|NCT02017860|41920092|FG000|Overall Study|Withdrawal by Subject|1|||
19509664|NCT02040870|41920096|FG000|Overall Study|Completed treatment phase|6|||
19509665|NCT02040870|41920096|FG000|Overall Study|Adverse Event|7|||
19509666|NCT02040870|41920096|FG000|Overall Study|Progressive disease|58|||
19509667|NCT02040870|41920096|FG000|Overall Study|Physician Decision|6|||
19509668|NCT02040870|41920096|FG000|Overall Study|Subject/guardian decision|10|||
19509669|NCT02040870|41920096|FG000|Overall Study|Lost to Follow-up|3|||
19509670|NCT02040870|41920096|FG000|Overall Study|Death|13|||
19509671|NCT02016690|41920100|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
19509672|NCT02016690|41920100|FG000|Overall Study|Excluded from SAS: Duplication|2|||
19509673|NCT02016690|41920100|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
19509674|NCT02016690|41920100|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
19509675|NCT02016690|41920100|FG000|Overall Study|Did not meet inclusion criteria|13|||
19509676|NCT02016690|41920100|FG000|Overall Study|Hospitalized for RSV at study start|3|||
19509677|NCT02016300|41920106|FG000|Overall Study|Lost to Follow-up|0|||
19509678|NCT02016300|41920107|FG001|Overall Study|Lost to Follow-up|3|||
19509679|NCT02040090|41920115|FG000|Overall Study|Adverse Event|2|||
19509680|NCT02040090|41920116|FG001|Overall Study|Adverse Event|0|||
19509681|NCT02040090|41920115|FG000|Overall Study|Physician Decision|1|||
19509682|NCT02040090|41920116|FG001|Overall Study|Physician Decision|0|||
19509683|NCT02040090|41920115|FG000|Overall Study|Withdrawal by Subject|0|||
19509684|NCT02040090|41920116|FG001|Overall Study|Withdrawal by Subject|1|||
19509685|NCT02040090|41920115|FG000|Overall Study|Lost to Follow-up|0|||
19509686|NCT02040090|41920116|FG001|Overall Study|Lost to Follow-up|1|||
19509687|NCT02058498|41920122|FG000|Overall Study|Withdrawal by Subject|4|||
19509688|NCT02039856|41920128|FG000|Overall Study|Death|5|||
19509689|NCT02039856|41920129|FG001|Overall Study|Death|3|||
19509690|NCT02039856|41920128|FG000|Overall Study|Partial survey completion|61|||
19509691|NCT02039856|41920129|FG001|Overall Study|Partial survey completion|26|||
19509692|NCT02039856|41920128|FG000|Overall Study|Lost to Follow-up|388|||
19509693|NCT02039856|41920129|FG001|Overall Study|Lost to Follow-up|206|||
19509694|NCT02039856|41920128|FG000|Overall Study|Withdrawal by Subject|1573|||
19509695|NCT02039856|41920129|FG001|Overall Study|Withdrawal by Subject|618|||
19509696|NCT02039778|41920137|FG000|Overall Study|Death|2|||
19509697|NCT02039778|41920137|FG000|Overall Study|Withdrawal by Subject|1|||
19509698|NCT02039778|41920137|FG000|Overall Study|Never started the protocol treatment|1|||
19509699|NCT02015754|41920141|FG000|Overall Study|Disease progression|5|||
19509700|NCT02015754|41920141|FG000|Overall Study|Change in treatment modality|5|||
19509701|NCT02015754|41920141|FG000|Overall Study|Lost to Follow-up|1|||
19509702|NCT02015676|41920148|FG000|Overall Study|Adverse Event|2|||
19509703|NCT02015676|41920149|FG001|Overall Study|Adverse Event|18|||
19509704|NCT02015676|41920150|FG002|Overall Study|Adverse Event|0|||
19509705|NCT02015676|41920148|FG000|Overall Study|Lack of Efficacy|2|||
19509706|NCT02015676|41920149|FG001|Overall Study|Lack of Efficacy|4|||
19509707|NCT02015676|41920150|FG002|Overall Study|Lack of Efficacy|0|||
19509708|NCT02015676|41920148|FG000|Overall Study|Protocol Violation|1|||
19509709|NCT02015676|41920149|FG001|Overall Study|Protocol Violation|0|||
19509710|NCT02015676|41920150|FG002|Overall Study|Protocol Violation|0|||
19509711|NCT02015676|41920148|FG000|Overall Study|Withdrawal by Subject|1|||
19509712|NCT02015676|41920149|FG001|Overall Study|Withdrawal by Subject|7|||
19509713|NCT02015676|41920150|FG002|Overall Study|Withdrawal by Subject|1|||
19509714|NCT02015676|41920148|FG000|Overall Study|Administrative reasons|0|||
19509715|NCT02015676|41920149|FG001|Overall Study|Administrative reasons|3|||
19509716|NCT02015676|41920150|FG002|Overall Study|Administrative reasons|1|||
19509717|NCT02015676|41920148|FG000|Overall Study|Death|0|||
19509718|NCT02015676|41920149|FG001|Overall Study|Death|1|||
19509719|NCT02015676|41920150|FG002|Overall Study|Death|0|||
19509720|NCT02015676|41920148|FG000|Overall Study|Disease progression|3|||
19509721|NCT02015676|41920149|FG001|Overall Study|Disease progression|1|||
19509722|NCT02015676|41920150|FG002|Overall Study|Disease progression|1|||
19509723|NCT02015520|41920158|FG000|Overall Study|Lack of Efficacy|1|||
19509724|NCT02015520|41920159|FG001|Overall Study|Lack of Efficacy|0|||
19509725|NCT02015520|41920160|FG002|Overall Study|Lack of Efficacy|3|||
19509726|NCT02015520|41920161|FG003|Overall Study|Lack of Efficacy|2|||
19509727|NCT02015520|41920158|FG000|Overall Study|Adverse Event|0|||
19616625|NCT00895895|42066365|FG003|Period 2|investigator request|0|||
19616626|NCT00895895|42066366|FG004|Period 2|investigator request|0|||
19616627|NCT00895895|42066362|FG000|Period 2|Lost to Follow-up|1|||
19616628|NCT00895895|42066363|FG001|Period 2|Lost to Follow-up|2|||
19509728|NCT02015520|41920159|FG001|Overall Study|Adverse Event|0|||
19509729|NCT02015520|41920160|FG002|Overall Study|Adverse Event|0|||
19509730|NCT02015520|41920161|FG003|Overall Study|Adverse Event|1|||
19616629|NCT00895895|42066364|FG002|Period 2|Lost to Follow-up|1|||
19509731|NCT02015520|41920158|FG000|Overall Study|Withdrawal by Subject|2|||
19509732|NCT02015520|41920159|FG001|Overall Study|Withdrawal by Subject|2|||
19509733|NCT02015520|41920160|FG002|Overall Study|Withdrawal by Subject|1|||
19509734|NCT02015520|41920161|FG003|Overall Study|Withdrawal by Subject|0|||
19509735|NCT02015520|41920158|FG000|Overall Study|Death|1|||
19509736|NCT02015520|41920159|FG001|Overall Study|Death|0|||
19509737|NCT02015520|41920160|FG002|Overall Study|Death|0|||
19509738|NCT02015520|41920161|FG003|Overall Study|Death|0|||
19509739|NCT02015520|41920158|FG000|Overall Study|Lost to Follow-up|0|||
19509740|NCT02015520|41920159|FG001|Overall Study|Lost to Follow-up|0|||
19509741|NCT02015520|41920160|FG002|Overall Study|Lost to Follow-up|1|||
19509742|NCT02015520|41920161|FG003|Overall Study|Lost to Follow-up|0|||
19509743|NCT02015520|41920158|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
19509744|NCT02015520|41920159|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
19509745|NCT02015520|41920160|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
19509746|NCT02015520|41920161|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
19509747|NCT02015520|41920158|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
19509748|NCT02015520|41920159|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
19509749|NCT02015520|41920160|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
19509750|NCT02015520|41920161|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
19509751|NCT02058108|41920173|FG000|Overall Study|Abnormal Laboratory Values|0|||
19509752|NCT02058108|41920174|FG001|Overall Study|Abnormal Laboratory Values|1|||
19509753|NCT02058108|41920173|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
19509754|NCT02058108|41920174|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19509755|NCT02058108|41920173|FG000|Overall Study|No longer requires study drug|0|||
19509756|NCT02058108|41920174|FG001|Overall Study|No longer requires study drug|1|||
19509757|NCT02058108|41920173|FG000|Overall Study|Withdrawal by Subject|1|||
19509758|NCT02058108|41920174|FG001|Overall Study|Withdrawal by Subject|0|||
19616630|NCT00895895|42066365|FG003|Period 2|Lost to Follow-up|1|||
19616631|NCT00895895|42066366|FG004|Period 2|Lost to Follow-up|0|||
19616632|NCT00895895|42066362|FG000|Period 2|Other|1|||
19509759|NCT02058108|41920173|FG000|Overall Study|Administrative problems|3|||
19509760|NCT02058108|41920174|FG001|Overall Study|Administrative problems|3|||
19509761|NCT02058108|41920173|FG000|Overall Study|Protocol Violation|0|||
19509762|NCT02058108|41920174|FG001|Overall Study|Protocol Violation|1|||
19509763|NCT02057874|41920182|FG000|Overall Study|participant did not return for scan|1|||
19509764|NCT02038920|41920189|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
19509765|NCT02038920|41920190|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
19509766|NCT02038920|41920191|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
19509767|NCT02038920|41920192|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
19509768|NCT02038920|41920193|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
19509769|NCT02038920|41920194|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
19509770|NCT02038920|41920189|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
19509771|NCT02038920|41920190|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
19509772|NCT02038920|41920191|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
19509773|NCT02038920|41920192|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
19509774|NCT02038920|41920193|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
19509775|NCT02038920|41920194|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
19509776|NCT02038920|41920189|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
19509777|NCT02038920|41920190|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
19509778|NCT02038920|41920191|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
19509779|NCT02038920|41920192|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
19509780|NCT02038920|41920193|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
19509781|NCT02038920|41920194|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
19509782|NCT02038920|41920189|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
19509783|NCT02038920|41920190|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
19509784|NCT02038920|41920191|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
19509785|NCT02038920|41920192|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
19509786|NCT02038920|41920193|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
19509787|NCT02038920|41920194|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
19509788|NCT02038920|41920189|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
19509789|NCT02038920|41920190|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
19509790|NCT02038920|41920191|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
19509791|NCT02038920|41920192|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
19509792|NCT02038920|41920193|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
19509793|NCT02038920|41920194|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
19509794|NCT02038920|41920189|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
19509795|NCT02038920|41920190|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
19509796|NCT02038920|41920191|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
19509797|NCT02038920|41920192|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
19509798|NCT02038920|41920193|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
19509799|NCT02038920|41920194|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
19509800|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
19509801|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
19509802|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
19509803|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
19509804|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
19509805|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
19509806|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
19509807|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
19509808|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
19509809|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
19509810|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
19509811|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
19509812|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
19509813|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
19509814|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
19509815|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
19509816|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
19509817|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
19509818|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
19509819|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
19509820|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
19509821|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
19509822|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
19509823|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
19509824|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
19509825|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
19509826|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
19509827|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
19509828|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
19509829|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
19509830|NCT02038920|41920189|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
19616633|NCT00895895|42066363|FG001|Period 2|Other|1|||
19616634|NCT00895895|42066364|FG002|Period 2|Other|3|||
19616635|NCT00895895|42066365|FG003|Period 2|Other|1|||
19616636|NCT00895895|42066366|FG004|Period 2|Other|1|||
19616637|NCT00895895|42066362|FG000|Period 2|Protocol Violation|1|||
19616638|NCT00895895|42066363|FG001|Period 2|Protocol Violation|0|||
19616639|NCT00895895|42066364|FG002|Period 2|Protocol Violation|1|||
19616640|NCT00895895|42066365|FG003|Period 2|Protocol Violation|1|||
19616641|NCT00895895|42066366|FG004|Period 2|Protocol Violation|1|||
19616642|NCT00895895|42066362|FG000|Period 2|Withdrawal by Subject|0|||
19616643|NCT00895895|42066363|FG001|Period 2|Withdrawal by Subject|2|||
19616644|NCT00895895|42066364|FG002|Period 2|Withdrawal by Subject|0|||
19616645|NCT00895895|42066365|FG003|Period 2|Withdrawal by Subject|3|||
19616646|NCT00895895|42066366|FG004|Period 2|Withdrawal by Subject|5|||
19616647|NCT00895895|42066362|FG000|Period 2|unsatisfactory response-efficacy|2|||
19616648|NCT00895895|42066363|FG001|Period 2|unsatisfactory response-efficacy|1|||
19616649|NCT00895895|42066364|FG002|Period 2|unsatisfactory response-efficacy|0|||
19616650|NCT00895895|42066365|FG003|Period 2|unsatisfactory response-efficacy|0|||
19616651|NCT00895895|42066366|FG004|Period 2|unsatisfactory response-efficacy|0|||
19616652|NCT00895661|42066384|FG000|Overall Study|Death|1|||
19616653|NCT00895661|42066384|FG000|Overall Study|reason unknown|2|||
19616654|NCT00895583|42066390|FG000|Overall Study|Adverse Event|28|||
19616655|NCT00895583|42066391|FG001|Overall Study|Adverse Event|4|||
19616656|NCT00895583|42066390|FG000|Overall Study|Death|2|||
19616657|NCT00895583|42066391|FG001|Overall Study|Death|1|||
19616658|NCT00895583|42066390|FG000|Overall Study|Physician Decision|3|||
19616659|NCT00895583|42066391|FG001|Overall Study|Physician Decision|1|||
19616660|NCT00895583|42066390|FG000|Overall Study|Lost to Follow-up|1|||
19616661|NCT00895583|42066391|FG001|Overall Study|Lost to Follow-up|3|||
19616662|NCT00895583|42066390|FG000|Overall Study|Protocol Violation|1|||
19616663|NCT00895583|42066391|FG001|Overall Study|Protocol Violation|0|||
19616664|NCT00895583|42066390|FG000|Overall Study|Withdrawal by Subject|4|||
19616665|NCT00895583|42066391|FG001|Overall Study|Withdrawal by Subject|2|||
19616666|NCT00895583|42066390|FG000|Overall Study|Lack of Efficacy|5|||
19616667|NCT00895583|42066391|FG001|Overall Study|Lack of Efficacy|0|||
19616668|NCT00895583|42066390|FG000|Overall Study|Other|0|||
19616669|NCT00895583|42066391|FG001|Overall Study|Other|1|||
19616670|NCT00894413|42066408|FG000|Overall Study|Physician Decision|0|||
19616671|NCT00894413|42066409|FG001|Overall Study|Physician Decision|2|||
19616672|NCT00894413|42066408|FG000|Overall Study|Adverse Event|0|||
19616673|NCT00894413|42066409|FG001|Overall Study|Adverse Event|2|||
19616674|NCT00894413|42066408|FG000|Overall Study|Withdrawal by Subject|0|||
19616675|NCT00894413|42066409|FG001|Overall Study|Withdrawal by Subject|4|||
19616676|NCT00895037|42066418|FG000|Overall Study|Death|0|||
19616677|NCT00895037|42066419|FG001|Overall Study|Death|2|||
19616678|NCT00895037|42066420|FG002|Overall Study|Death|1|||
19616679|NCT00892151|42066428|FG000|Overall Study|Protocol Violation|1|||
19616680|NCT01706705|42066432|FG000|Overall Study|Death|1|||
19616681|NCT01706705|42066432|FG000|Overall Study|Lack of Efficacy|13|||
19509831|NCT02038920|41920190|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
19509832|NCT02038920|41920191|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
19509833|NCT02038920|41920192|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
19616682|NCT01706705|42066432|FG000|Overall Study|Non-clinical|6|||
19616683|NCT00894803|42066448|FG000|Overall Study|Death|20|||
19616684|NCT00894803|42066449|FG001|Overall Study|Death|4|||
19616685|NCT00894803|42066448|FG000|Overall Study|Lost to Follow-up|0|||
19616686|NCT00894803|42066449|FG001|Overall Study|Lost to Follow-up|1|||
19616687|NCT00601458|42066458|FG000|Overall Study|Dosing Error|1|||
19616688|NCT00601458|42066459|FG001|Overall Study|Dosing Error|0|||
19616689|NCT00601458|42066460|FG002|Overall Study|Dosing Error|0|||
19616690|NCT00601458|42066458|FG000|Overall Study|Incomplete Data|0|||
19616691|NCT00601458|42066459|FG001|Overall Study|Incomplete Data|2|||
19616692|NCT00601458|42066460|FG002|Overall Study|Incomplete Data|0|||
19616693|NCT00601458|42066458|FG000|Overall Study|Protocol Violation|3|||
19616694|NCT00601458|42066459|FG001|Overall Study|Protocol Violation|2|||
19616695|NCT00601458|42066460|FG002|Overall Study|Protocol Violation|1|||
19616696|NCT00601458|42066458|FG000|Overall Study|Early Termination|0|||
19509834|NCT02038920|41920193|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
19509835|NCT02038920|41920194|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
19509836|NCT02038764|41920216|FG000|Overall Study|Adverse Event|0|||
19509837|NCT02038764|41920217|FG001|Overall Study|Adverse Event|0|||
19509838|NCT02038764|41920218|FG002|Overall Study|Adverse Event|1|||
19509839|NCT02038764|41920219|FG003|Overall Study|Adverse Event|0|||
19509840|NCT02038764|41920220|FG004|Overall Study|Adverse Event|0|||
19509841|NCT02038764|41920216|FG000|Overall Study|Lost to Follow-up|0|||
19509842|NCT02038764|41920217|FG001|Overall Study|Lost to Follow-up|1|||
19509843|NCT02038764|41920218|FG002|Overall Study|Lost to Follow-up|0|||
19509844|NCT02038764|41920219|FG003|Overall Study|Lost to Follow-up|0|||
19509845|NCT02038764|41920220|FG004|Overall Study|Lost to Follow-up|0|||
19509846|NCT02038764|41920216|FG000|Overall Study|Withdrawal by Subject|0|||
19509847|NCT02038764|41920217|FG001|Overall Study|Withdrawal by Subject|0|||
19509848|NCT02038764|41920218|FG002|Overall Study|Withdrawal by Subject|0|||
19509849|NCT02038764|41920219|FG003|Overall Study|Withdrawal by Subject|0|||
19509850|NCT02038764|41920220|FG004|Overall Study|Withdrawal by Subject|1|||
19509851|NCT02038764|41920216|FG000|Overall Study|Other|1|||
19509852|NCT02038764|41920217|FG001|Overall Study|Other|0|||
19509853|NCT02038764|41920218|FG002|Overall Study|Other|1|||
19509854|NCT02038764|41920219|FG003|Overall Study|Other|0|||
19509855|NCT02038764|41920220|FG004|Overall Study|Other|0|||
19509856|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
19509857|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
19509858|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
19509859|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
19509860|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
19509861|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
19509862|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
19509863|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
19509864|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
19509865|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
19509866|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
19509867|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
19616697|NCT00601458|42066459|FG001|Overall Study|Early Termination|1|||
19509868|NCT02057718|41920238|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
19509869|NCT02057718|41920239|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
19616698|NCT00601458|42066460|FG002|Overall Study|Early Termination|1|||
19616699|NCT02141282|42066472|FG000|Overall Study|Adverse event, not related to progression|8|||
19509870|NCT02057718|41920238|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
19509871|NCT02057718|41920239|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
19509872|NCT02057718|41920238|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
19509873|NCT02057718|41920239|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
19509874|NCT02057718|41920238|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
19509875|NCT02057718|41920239|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
19509876|NCT02057718|41920238|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
19509877|NCT02057718|41920239|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
19509878|NCT01622868|41920247|FG000|Overall Study|Protocol Violation|7|||
19509879|NCT01622868|41920248|FG001|Overall Study|Protocol Violation|0|||
19509880|NCT02014740|41920256|FG000|Overall Study|Lost to Follow-up|4|||
19509881|NCT02014740|41920257|FG001|Overall Study|Lost to Follow-up|4|||
19509882|NCT02014740|41920256|FG000|Overall Study|Withdrawal by Subject|2|||
19509883|NCT02014740|41920257|FG001|Overall Study|Withdrawal by Subject|1|||
19509884|NCT02014584|41920265|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
19509885|NCT02014584|41920266|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
19509886|NCT02014584|41920267|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
19509887|NCT02014584|41920268|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
19509888|NCT02014584|41920269|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
19509889|NCT02014584|41920270|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
19509890|NCT02014584|41920265|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
19509891|NCT02014584|41920266|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
19509892|NCT02014584|41920267|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
19509893|NCT02014584|41920268|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
19509894|NCT02014584|41920269|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
19509895|NCT02014584|41920270|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
19509896|NCT02014584|41920265|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
19509897|NCT02014584|41920266|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
19509898|NCT02014584|41920267|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
19509899|NCT02014584|41920268|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
19509900|NCT02014584|41920269|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
19509901|NCT02014584|41920270|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
19509902|NCT02014584|41920265|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
19509903|NCT02014584|41920266|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
19509904|NCT02014584|41920267|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
19509905|NCT02014584|41920268|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
19509906|NCT02014584|41920269|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
19509907|NCT02014584|41920270|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
19509908|NCT02014584|41920265|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
19509909|NCT02014584|41920266|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
19509910|NCT02014584|41920267|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
19509911|NCT02014584|41920268|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
19509912|NCT02014584|41920269|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
19509913|NCT02014584|41920270|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
19509914|NCT02014272|41920282|FG000|Intervention Period 1|Withdrawal by Subject|1|||
19509915|NCT02014272|41920283|FG001|Intervention Period 1|Withdrawal by Subject|0|||
19509916|NCT02014272|41920282|FG000|Intervention Period 1|Adverse Event|0|||
19509917|NCT02014272|41920283|FG001|Intervention Period 1|Adverse Event|1|||
19509918|NCT02037984|41920297|FG000|Overall Study|Lack of Efficacy|0|||
19509919|NCT02037984|41920298|FG001|Overall Study|Lack of Efficacy|0|||
19509920|NCT02037984|41920299|FG002|Overall Study|Lack of Efficacy|3|||
19509921|NCT02037984|41920300|FG003|Overall Study|Lack of Efficacy|10|||
19509922|NCT02037984|41920301|FG004|Overall Study|Lack of Efficacy|2|||
19509923|NCT02037984|41920302|FG005|Overall Study|Lack of Efficacy|2|||
19509924|NCT02037984|41920303|FG006|Overall Study|Lack of Efficacy|4|||
19509925|NCT02037984|41920304|FG007|Overall Study|Lack of Efficacy|3|||
19509926|NCT02037984|41920297|FG000|Overall Study|Lost to Follow-up|1|||
19509927|NCT02037984|41920298|FG001|Overall Study|Lost to Follow-up|0|||
19509928|NCT02037984|41920299|FG002|Overall Study|Lost to Follow-up|3|||
19509929|NCT02037984|41920300|FG003|Overall Study|Lost to Follow-up|5|||
19509930|NCT02037984|41920301|FG004|Overall Study|Lost to Follow-up|2|||
19509931|NCT02037984|41920302|FG005|Overall Study|Lost to Follow-up|2|||
19509932|NCT02037984|41920303|FG006|Overall Study|Lost to Follow-up|2|||
19509933|NCT02037984|41920304|FG007|Overall Study|Lost to Follow-up|4|||
19509934|NCT02037984|41920297|FG000|Overall Study|Physician Decision|0|||
19509935|NCT02037984|41920298|FG001|Overall Study|Physician Decision|0|||
19509936|NCT02037984|41920299|FG002|Overall Study|Physician Decision|0|||
19509937|NCT02037984|41920300|FG003|Overall Study|Physician Decision|0|||
19509938|NCT02037984|41920301|FG004|Overall Study|Physician Decision|0|||
19509939|NCT02037984|41920302|FG005|Overall Study|Physician Decision|0|||
19509940|NCT02037984|41920303|FG006|Overall Study|Physician Decision|1|||
19509941|NCT02037984|41920304|FG007|Overall Study|Physician Decision|0|||
19509942|NCT02037984|41920297|FG000|Overall Study|Protocol Violation|0|||
19509943|NCT02037984|41920298|FG001|Overall Study|Protocol Violation|0|||
19509944|NCT02037984|41920299|FG002|Overall Study|Protocol Violation|0|||
19509945|NCT02037984|41920300|FG003|Overall Study|Protocol Violation|0|||
19509946|NCT02037984|41920301|FG004|Overall Study|Protocol Violation|0|||
19509947|NCT02037984|41920302|FG005|Overall Study|Protocol Violation|1|||
19509948|NCT02037984|41920303|FG006|Overall Study|Protocol Violation|2|||
19509949|NCT02037984|41920304|FG007|Overall Study|Protocol Violation|0|||
19509950|NCT02037984|41920297|FG000|Overall Study|Technical Problems|0|||
19509951|NCT02037984|41920298|FG001|Overall Study|Technical Problems|0|||
19509952|NCT02037984|41920299|FG002|Overall Study|Technical Problems|3|||
19509953|NCT02037984|41920300|FG003|Overall Study|Technical Problems|3|||
19509954|NCT02037984|41920301|FG004|Overall Study|Technical Problems|2|||
19509955|NCT02037984|41920302|FG005|Overall Study|Technical Problems|3|||
19509956|NCT02037984|41920303|FG006|Overall Study|Technical Problems|4|||
19509957|NCT02037984|41920304|FG007|Overall Study|Technical Problems|2|||
19509958|NCT02037984|41920297|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19509959|NCT02037984|41920298|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19509960|NCT02037984|41920299|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
19509961|NCT02037984|41920300|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
19509962|NCT02037984|41920301|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
19509963|NCT02037984|41920302|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
19509964|NCT02037984|41920303|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
19509965|NCT02037984|41920304|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
19509966|NCT02037984|41920297|FG000|Overall Study|Withdrawal by Subject|0|||
19509967|NCT02037984|41920298|FG001|Overall Study|Withdrawal by Subject|0|||
19509968|NCT02037984|41920299|FG002|Overall Study|Withdrawal by Subject|0|||
19509969|NCT02037984|41920300|FG003|Overall Study|Withdrawal by Subject|1|||
19509970|NCT02037984|41920301|FG004|Overall Study|Withdrawal by Subject|1|||
19509971|NCT02037984|41920302|FG005|Overall Study|Withdrawal by Subject|3|||
19509972|NCT02037984|41920303|FG006|Overall Study|Withdrawal by Subject|0|||
19509973|NCT02037984|41920304|FG007|Overall Study|Withdrawal by Subject|1|||
19509974|NCT02057406|41920335|FG000|Overall Study|Physician Decision|0|||
19509975|NCT02057406|41920336|FG001|Overall Study|Physician Decision|0|||
19509976|NCT02057406|41920337|FG002|Overall Study|Physician Decision|2|||
19509977|NCT02057406|41920335|FG000|Overall Study|Withdrawal by Subject|0|||
19509978|NCT02057406|41920336|FG001|Overall Study|Withdrawal by Subject|2|||
19509979|NCT02057406|41920337|FG002|Overall Study|Withdrawal by Subject|0|||
19509980|NCT02057406|41920335|FG000|Overall Study|Lost to Follow-up|0|||
19509981|NCT02057406|41920336|FG001|Overall Study|Lost to Follow-up|0|||
19509982|NCT02057406|41920337|FG002|Overall Study|Lost to Follow-up|1|||
19509983|NCT02057406|41920335|FG000|Overall Study|Death|1|||
19509984|NCT02057406|41920336|FG001|Overall Study|Death|0|||
19509985|NCT02057406|41920337|FG002|Overall Study|Death|0|||
19509986|NCT02057406|41920335|FG000|Overall Study|Protocol Violation|0|||
19394113|NCT01668797|41638204|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
19394114|NCT01668797|41638205|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
19394115|NCT01668797|41638206|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
19394116|NCT01668797|41638207|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
19394117|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
19394118|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
19394119|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
19394120|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
19394121|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
19394122|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
19394123|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
19394124|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
19394125|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
19394126|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
19394127|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
19394128|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
19509987|NCT02057406|41920336|FG001|Overall Study|Protocol Violation|1|||
19509988|NCT02057406|41920337|FG002|Overall Study|Protocol Violation|0|||
19509989|NCT02057406|41920335|FG000|Overall Study|Patient transportation issues|0|||
19509990|NCT02057406|41920336|FG001|Overall Study|Patient transportation issues|0|||
19509991|NCT02057406|41920337|FG002|Overall Study|Patient transportation issues|1|||
19509992|NCT02036580|41920348|FG000|Overall Study|Withdrawal by Subject|0|||
19509993|NCT02036580|41920349|FG001|Overall Study|Withdrawal by Subject|1|||
19509994|NCT02036580|41920350|FG002|Overall Study|Withdrawal by Subject|0|||
19509995|NCT02036580|41920348|FG000|Overall Study|Adverse Event|1|||
19509996|NCT02036580|41920349|FG001|Overall Study|Adverse Event|0|||
19509997|NCT02036580|41920350|FG002|Overall Study|Adverse Event|0|||
19509998|NCT02014116|41920367|FG000|Overall Study|Progressive Disease|3|||
19509999|NCT02014116|41920368|FG001|Overall Study|Progressive Disease|4|||
19510000|NCT02014116|41920369|FG002|Overall Study|Progressive Disease|2|||
19510001|NCT02014116|41920370|FG003|Overall Study|Progressive Disease|6|||
19510002|NCT02014116|41920371|FG004|Overall Study|Progressive Disease|1|||
19510003|NCT02014116|41920372|FG005|Overall Study|Progressive Disease|13|||
19510004|NCT02014116|41920373|FG006|Overall Study|Progressive Disease|1|||
19510005|NCT02014116|41920374|FG007|Overall Study|Progressive Disease|3|||
19510006|NCT02014116|41920375|FG008|Overall Study|Progressive Disease|7|||
19510007|NCT02014116|41920367|FG000|Overall Study|Adverse Event|0|||
19510008|NCT02014116|41920368|FG001|Overall Study|Adverse Event|0|||
19510009|NCT02014116|41920369|FG002|Overall Study|Adverse Event|0|||
19510010|NCT02014116|41920370|FG003|Overall Study|Adverse Event|0|||
19510011|NCT02014116|41920371|FG004|Overall Study|Adverse Event|1|||
19510012|NCT02014116|41920372|FG005|Overall Study|Adverse Event|0|||
19510013|NCT02014116|41920373|FG006|Overall Study|Adverse Event|0|||
19510014|NCT02014116|41920374|FG007|Overall Study|Adverse Event|1|||
19510015|NCT02014116|41920375|FG008|Overall Study|Adverse Event|0|||
19510016|NCT02014116|41920367|FG000|Overall Study|Lost to Follow-up|0|||
19510017|NCT02014116|41920368|FG001|Overall Study|Lost to Follow-up|0|||
19510018|NCT02014116|41920369|FG002|Overall Study|Lost to Follow-up|0|||
19510019|NCT02014116|41920370|FG003|Overall Study|Lost to Follow-up|0|||
19510020|NCT02014116|41920371|FG004|Overall Study|Lost to Follow-up|0|||
19510021|NCT02014116|41920372|FG005|Overall Study|Lost to Follow-up|1|||
19510022|NCT02014116|41920373|FG006|Overall Study|Lost to Follow-up|0|||
19510023|NCT02014116|41920374|FG007|Overall Study|Lost to Follow-up|0|||
19510024|NCT02014116|41920375|FG008|Overall Study|Lost to Follow-up|1|||
19510025|NCT02014116|41920367|FG000|Overall Study|Death|0|||
19510026|NCT02014116|41920368|FG001|Overall Study|Death|0|||
19510027|NCT02014116|41920369|FG002|Overall Study|Death|0|||
19510028|NCT02014116|41920370|FG003|Overall Study|Death|0|||
19510029|NCT02014116|41920371|FG004|Overall Study|Death|0|||
19510030|NCT02014116|41920372|FG005|Overall Study|Death|0|||
19510031|NCT02014116|41920373|FG006|Overall Study|Death|0|||
19510032|NCT02014116|41920374|FG007|Overall Study|Death|1|||
19510033|NCT02014116|41920375|FG008|Overall Study|Death|1|||
19510034|NCT02014116|41920367|FG000|Overall Study|Withdrawal by Subject|0|||
19510035|NCT02014116|41920368|FG001|Overall Study|Withdrawal by Subject|0|||
19510036|NCT02014116|41920369|FG002|Overall Study|Withdrawal by Subject|1|||
19510037|NCT02014116|41920370|FG003|Overall Study|Withdrawal by Subject|1|||
19510038|NCT02014116|41920371|FG004|Overall Study|Withdrawal by Subject|0|||
19510039|NCT02014116|41920372|FG005|Overall Study|Withdrawal by Subject|1|||
19510040|NCT02014116|41920373|FG006|Overall Study|Withdrawal by Subject|0|||
19510041|NCT02014116|41920374|FG007|Overall Study|Withdrawal by Subject|0|||
19510042|NCT02014116|41920375|FG008|Overall Study|Withdrawal by Subject|0|||
19510043|NCT02014116|41920367|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
19510044|NCT02014116|41920368|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
19510045|NCT02014116|41920369|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
19510046|NCT02014116|41920370|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
19510047|NCT02014116|41920371|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
19510048|NCT02014116|41920372|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
19510049|NCT02014116|41920373|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
19510050|NCT02014116|41920374|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
19510051|NCT02014116|41920375|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
19510052|NCT02014116|41920367|FG000|Overall Study|Physician Decision|0|||
19510053|NCT02014116|41920368|FG001|Overall Study|Physician Decision|0|||
19510054|NCT02014116|41920369|FG002|Overall Study|Physician Decision|0|||
19510055|NCT02014116|41920370|FG003|Overall Study|Physician Decision|0|||
19510056|NCT02014116|41920371|FG004|Overall Study|Physician Decision|0|||
19510057|NCT02014116|41920372|FG005|Overall Study|Physician Decision|0|||
19510058|NCT02014116|41920373|FG006|Overall Study|Physician Decision|0|||
19510059|NCT02014116|41920374|FG007|Overall Study|Physician Decision|0|||
19510060|NCT02014116|41920375|FG008|Overall Study|Physician Decision|1|||
19510061|NCT02057250|41920402|FG000|AID Assessment Phase|Adverse Event|3|||
19510062|NCT02057250|41920403|FG001|AID Assessment Phase|Adverse Event|2|||
19510063|NCT02057250|41920404|FG002|AID Assessment Phase|Adverse Event|6|||
19510064|NCT02057250|41920405|FG003|AID Assessment Phase|Adverse Event|1|||
19510065|NCT02057250|41920406|FG004|AID Assessment Phase|Adverse Event|0|||
19510066|NCT02057250|41920402|FG000|AID Assessment Phase|Other than specified above|1|||
19510067|NCT02057250|41920403|FG001|AID Assessment Phase|Other than specified above|1|||
19510068|NCT02057250|41920404|FG002|AID Assessment Phase|Other than specified above|1|||
19510069|NCT02057250|41920405|FG003|AID Assessment Phase|Other than specified above|1|||
19510070|NCT02057250|41920406|FG004|AID Assessment Phase|Other than specified above|0|||
19510071|NCT02057250|41920402|FG000|Extension Phase|Adverse Event|0|||
19510072|NCT02057250|41920403|FG001|Extension Phase|Adverse Event|0|||
19510073|NCT02057250|41920404|FG002|Extension Phase|Adverse Event|0|||
19510074|NCT02057250|41920405|FG003|Extension Phase|Adverse Event|0|||
19510075|NCT02057250|41920406|FG004|Extension Phase|Adverse Event|15|||
19510076|NCT02057250|41920402|FG000|Extension Phase|Lack of Efficacy|0|||
19510077|NCT02057250|41920403|FG001|Extension Phase|Lack of Efficacy|0|||
19510078|NCT02057250|41920404|FG002|Extension Phase|Lack of Efficacy|0|||
19510079|NCT02057250|41920405|FG003|Extension Phase|Lack of Efficacy|0|||
19510080|NCT02057250|41920406|FG004|Extension Phase|Lack of Efficacy|10|||
19510081|NCT02057250|41920402|FG000|Extension Phase|Entered in this period but not treated|0|||
19510082|NCT02057250|41920403|FG001|Extension Phase|Entered in this period but not treated|0|||
19510083|NCT02057250|41920404|FG002|Extension Phase|Entered in this period but not treated|0|||
19510084|NCT02057250|41920405|FG003|Extension Phase|Entered in this period but not treated|0|||
19616700|NCT02141282|42066473|FG001|Overall Study|Adverse event, not related to progression|1|||
19616701|NCT02141282|42066474|FG002|Overall Study|Adverse event, not related to progression|3|||
19616702|NCT02141282|42066475|FG003|Overall Study|Adverse event, not related to progression|1|||
19616703|NCT02141282|42066472|FG000|Overall Study|Adverse event, related to progression|1|||
19616704|NCT02141282|42066473|FG001|Overall Study|Adverse event, related to progression|0|||
19616705|NCT02141282|42066474|FG002|Overall Study|Adverse event, related to progression|2|||
19616706|NCT02141282|42066475|FG003|Overall Study|Adverse event, related to progression|0|||
19616707|NCT02141282|42066472|FG000|Overall Study|COVID-19 infection|1|||
19616708|NCT02141282|42066473|FG001|Overall Study|COVID-19 infection|0|||
19616709|NCT02141282|42066474|FG002|Overall Study|COVID-19 infection|0|||
19616710|NCT02141282|42066475|FG003|Overall Study|COVID-19 infection|0|||
19616711|NCT02141282|42066472|FG000|Overall Study|Lost to Follow-up|0|||
19616712|NCT02141282|42066473|FG001|Overall Study|Lost to Follow-up|0|||
19616713|NCT02141282|42066474|FG002|Overall Study|Lost to Follow-up|4|||
19616714|NCT02141282|42066475|FG003|Overall Study|Lost to Follow-up|2|||
19616715|NCT02141282|42066472|FG000|Overall Study|Other, not specified|14|||
19616716|NCT02141282|42066473|FG001|Overall Study|Other, not specified|11|||
19616717|NCT02141282|42066474|FG002|Overall Study|Other, not specified|23|||
19616718|NCT02141282|42066475|FG003|Overall Study|Other, not specified|9|||
19616719|NCT02141282|42066472|FG000|Overall Study|Progressive disease, Richter's|4|||
19616720|NCT02141282|42066473|FG001|Overall Study|Progressive disease, Richter's|1|||
19616721|NCT02141282|42066474|FG002|Overall Study|Progressive disease, Richter's|1|||
19616722|NCT02141282|42066475|FG003|Overall Study|Progressive disease, Richter's|1|||
19616723|NCT02141282|42066472|FG000|Overall Study|Progressive disease per protocol|12|||
19616724|NCT02141282|42066473|FG001|Overall Study|Progressive disease per protocol|7|||
19616725|NCT02141282|42066474|FG002|Overall Study|Progressive disease per protocol|9|||
19616726|NCT02141282|42066475|FG003|Overall Study|Progressive disease per protocol|2|||
19616727|NCT02141282|42066472|FG000|Overall Study|Stem cell transplant|1|||
19616728|NCT02141282|42066473|FG001|Overall Study|Stem cell transplant|0|||
19616729|NCT02141282|42066474|FG002|Overall Study|Stem cell transplant|1|||
19616730|NCT02141282|42066475|FG003|Overall Study|Stem cell transplant|0|||
19616731|NCT02141282|42066472|FG000|Overall Study|Study terminated by Sponsor|0|||
19616732|NCT02141282|42066473|FG001|Overall Study|Study terminated by Sponsor|1|||
19616733|NCT02141282|42066474|FG002|Overall Study|Study terminated by Sponsor|0|||
19616734|NCT02141282|42066475|FG003|Overall Study|Study terminated by Sponsor|0|||
19616735|NCT02141282|42066472|FG000|Overall Study|Subject non-compliance|0|||
19616736|NCT02141282|42066473|FG001|Overall Study|Subject non-compliance|0|||
19510085|NCT02057250|41920406|FG004|Extension Phase|Entered in this period but not treated|4|||
19510086|NCT02057250|41920402|FG000|Extension Phase|Other than specified above|0|||
19616737|NCT02141282|42066474|FG002|Overall Study|Subject non-compliance|1|||
19616738|NCT02141282|42066475|FG003|Overall Study|Subject non-compliance|0|||
19616739|NCT02141282|42066472|FG000|Overall Study|Withdrew consent|2|||
19616740|NCT02141282|42066473|FG001|Overall Study|Withdrew consent|0|||
19616741|NCT02141282|42066474|FG002|Overall Study|Withdrew consent|4|||
19616742|NCT02141282|42066475|FG003|Overall Study|Withdrew consent|0|||
19616743|NCT00003479|42066488|FG000|Overall Study|Not evaluable|3|||
19616744|NCT00891839|42066492|FG000|Overall Study|Adverse Event|2|||
19510087|NCT02057250|41920403|FG001|Extension Phase|Other than specified above|0|||
19510088|NCT02057250|41920404|FG002|Extension Phase|Other than specified above|0|||
19510089|NCT02057250|41920405|FG003|Extension Phase|Other than specified above|0|||
19510090|NCT02057250|41920406|FG004|Extension Phase|Other than specified above|7|||
19510091|NCT02036502|41920426|FG000|Part 1:Dose Determination/Escalation|Death|3|||
19510092|NCT02036502|41920427|FG001|Part 1:Dose Determination/Escalation|Death|2|||
19510093|NCT02036502|41920428|FG002|Part 1:Dose Determination/Escalation|Death|0|||
19510094|NCT02036502|41920429|FG003|Part 1:Dose Determination/Escalation|Death|0|||
19510095|NCT02036502|41920430|FG004|Part 1:Dose Determination/Escalation|Death|0|||
19510096|NCT02036502|41920431|FG005|Part 1:Dose Determination/Escalation|Death|0|||
19510097|NCT02036502|41920432|FG006|Part 1:Dose Determination/Escalation|Death|0|||
19510098|NCT02036502|41920433|FG007|Part 1:Dose Determination/Escalation|Death|0|||
19510099|NCT02036502|41920426|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
19510100|NCT02036502|41920427|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510101|NCT02036502|41920428|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510102|NCT02036502|41920429|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510103|NCT02036502|41920430|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510104|NCT02036502|41920431|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510105|NCT02036502|41920432|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510106|NCT02036502|41920433|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
19510107|NCT02036502|41920426|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510108|NCT02036502|41920427|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
19510109|NCT02036502|41920428|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510110|NCT02036502|41920429|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510111|NCT02036502|41920430|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510112|NCT02036502|41920431|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510113|NCT02036502|41920432|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510114|NCT02036502|41920433|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
19510115|NCT02036502|41920426|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
19510116|NCT02036502|41920427|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
19510117|NCT02036502|41920428|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
19510118|NCT02036502|41920429|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
19510119|NCT02036502|41920430|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
19510120|NCT02036502|41920431|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
19510121|NCT02036502|41920432|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
19510122|NCT02036502|41920433|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
19510123|NCT02036502|41920426|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
19510124|NCT02036502|41920427|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
19510125|NCT02036502|41920428|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
19510126|NCT02036502|41920429|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
19510127|NCT02036502|41920430|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
19510128|NCT02036502|41920431|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
19510129|NCT02036502|41920432|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
19510130|NCT02036502|41920433|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
19510131|NCT02036502|41920426|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510132|NCT02036502|41920427|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510133|NCT02036502|41920428|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
19510134|NCT02036502|41920429|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510135|NCT02036502|41920430|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510136|NCT02036502|41920431|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510137|NCT02036502|41920432|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510138|NCT02036502|41920433|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
19510139|NCT02036502|41920426|FG000|Part 2:Dose Confirmation|Death|0|||
19510140|NCT02036502|41920427|FG001|Part 2:Dose Confirmation|Death|0|||
19510141|NCT02036502|41920428|FG002|Part 2:Dose Confirmation|Death|1|||
19510142|NCT02036502|41920429|FG003|Part 2:Dose Confirmation|Death|0|||
19510143|NCT02036502|41920430|FG004|Part 2:Dose Confirmation|Death|0|||
19510144|NCT02036502|41920431|FG005|Part 2:Dose Confirmation|Death|0|||
19510145|NCT02036502|41920432|FG006|Part 2:Dose Confirmation|Death|0|||
19510146|NCT02036502|41920433|FG007|Part 2:Dose Confirmation|Death|0|||
19510147|NCT02036502|41920426|FG000|Part 2:Dose Confirmation|Not treated|0|||
19510148|NCT02036502|41920427|FG001|Part 2:Dose Confirmation|Not treated|0|||
19510149|NCT02036502|41920428|FG002|Part 2:Dose Confirmation|Not treated|0|||
19510150|NCT02036502|41920429|FG003|Part 2:Dose Confirmation|Not treated|1|||
19510151|NCT02036502|41920430|FG004|Part 2:Dose Confirmation|Not treated|0|||
19510152|NCT02036502|41920431|FG005|Part 2:Dose Confirmation|Not treated|0|||
19510153|NCT02036502|41920432|FG006|Part 2:Dose Confirmation|Not treated|0|||
19616745|NCT00891839|42066492|FG000|Overall Study|Withdrawal by Subject|2|||
19704570|NCT00129402|42148933|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19510154|NCT02036502|41920433|FG007|Part 2:Dose Confirmation|Not treated|0|||
19510155|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Adverse Event|0|||
19510156|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Adverse Event|0|||
19510157|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Adverse Event|0|||
19510158|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Adverse Event|0|||
19510159|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Adverse Event|0|||
19510160|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Adverse Event|4|||
19510161|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Adverse Event|0|||
19510162|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Adverse Event|2|||
19510163|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Death|0|||
19510164|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Death|0|||
19510165|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Death|0|||
19510166|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Death|0|||
19510167|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Death|0|||
19510168|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Death|24|||
19510169|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Death|0|||
19510170|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Death|3|||
19510171|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510172|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510173|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510174|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510175|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510176|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510177|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
19510178|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
19510179|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Physician Decision|0|||
19510180|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Physician Decision|0|||
19510181|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Physician Decision|0|||
19510182|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Physician Decision|0|||
19510183|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Physician Decision|0|||
19510184|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Physician Decision|1|||
19510185|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Physician Decision|0|||
19510186|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Physician Decision|0|||
19510187|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
19510188|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
19510189|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
19510190|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
19510191|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
19510192|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
19510193|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
19510194|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
19510195|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510196|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510197|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510198|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510199|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510200|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
19616746|NCT00891839|42066492|FG000|Overall Study|Disease progression|3|||
19616747|NCT00600756|42066498|FG000|Analysis After 6 Months|Adverse Event|43|||
19616748|NCT00600756|42066499|FG001|Analysis After 6 Months|Adverse Event|33|||
19616749|NCT00600756|42066498|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
19616750|NCT00600756|42066499|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
19616751|NCT00600756|42066498|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
19616752|NCT00600756|42066499|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
19616753|NCT00600756|42066498|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
19616754|NCT00600756|42066499|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
19616755|NCT00600756|42066498|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
19616756|NCT00600756|42066499|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
19616757|NCT00600756|42066498|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
19616758|NCT00600756|42066499|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
19616759|NCT00600756|42066498|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
19616760|NCT00600756|42066499|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
19616761|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
19616762|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
19616763|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
19616764|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
19616765|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
19616766|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
19510201|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
19510202|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
19616767|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
19616768|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
19510203|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
19510204|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
19510205|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
19510206|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
19510207|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
19510208|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
19510209|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
19510210|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
19510211|NCT02036502|41920426|FG000|Part 3:Dose Expansion|Not Treated|0|||
19510212|NCT02036502|41920427|FG001|Part 3:Dose Expansion|Not Treated|0|||
19510213|NCT02036502|41920428|FG002|Part 3:Dose Expansion|Not Treated|0|||
19510214|NCT02036502|41920429|FG003|Part 3:Dose Expansion|Not Treated|0|||
19510215|NCT02036502|41920430|FG004|Part 3:Dose Expansion|Not Treated|0|||
19510216|NCT02036502|41920431|FG005|Part 3:Dose Expansion|Not Treated|2|||
19510217|NCT02036502|41920432|FG006|Part 3:Dose Expansion|Not Treated|0|||
19510218|NCT02036502|41920433|FG007|Part 3:Dose Expansion|Not Treated|0|||
19510219|NCT02056626|41920457|FG000|Overall Study|patient did not follow directions|3|||
19510220|NCT02056626|41920458|FG001|Overall Study|patient did not follow directions|1|||
19510221|NCT02056626|41920459|FG002|Overall Study|patient did not follow directions|0|||
19510222|NCT02056626|41920460|FG003|Overall Study|patient did not follow directions|0|||
19510223|NCT02035332|41920470|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
19510224|NCT02056392|41920480|FG000|Overall Study|Lost to Follow-up|0|||
19510225|NCT02056392|41920481|FG001|Overall Study|Lost to Follow-up|1|||
19510226|NCT02056392|41920482|FG002|Overall Study|Lost to Follow-up|2|||
19510227|NCT02056392|41920483|FG003|Overall Study|Lost to Follow-up|0|||
19510228|NCT02056392|41920484|FG004|Overall Study|Lost to Follow-up|0|||
19510229|NCT02056392|41920485|FG005|Overall Study|Lost to Follow-up|0|||
19510230|NCT02056392|41920480|FG000|Overall Study|Protocol Violation|1|||
19510231|NCT02056392|41920481|FG001|Overall Study|Protocol Violation|0|||
19510232|NCT02056392|41920482|FG002|Overall Study|Protocol Violation|1|||
19510233|NCT02056392|41920483|FG003|Overall Study|Protocol Violation|0|||
19510234|NCT02056392|41920484|FG004|Overall Study|Protocol Violation|0|||
19510235|NCT02056392|41920485|FG005|Overall Study|Protocol Violation|0|||
19510236|NCT02056392|41920480|FG000|Overall Study|Withdrawal by Subject|1|||
19510237|NCT02056392|41920481|FG001|Overall Study|Withdrawal by Subject|0|||
19510238|NCT02056392|41920482|FG002|Overall Study|Withdrawal by Subject|0|||
19510239|NCT02056392|41920483|FG003|Overall Study|Withdrawal by Subject|0|||
19510240|NCT02056392|41920484|FG004|Overall Study|Withdrawal by Subject|1|||
19510241|NCT02056392|41920485|FG005|Overall Study|Withdrawal by Subject|0|||
19510242|NCT02034708|41920495|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
19510243|NCT02034708|41920496|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
19510244|NCT02034708|41920495|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
19510245|NCT02034708|41920496|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
19510246|NCT02034708|41920495|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
19510247|NCT02034708|41920496|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
19510248|NCT02034708|41920495|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
19510249|NCT02034708|41920496|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
19510250|NCT02034552|41920510|FG000|Overall Study|Never treated|3|||
19510251|NCT02034552|41920511|FG001|Overall Study|Never treated|2|||
19510252|NCT02034552|41920512|FG002|Overall Study|Never treated|0|||
19510253|NCT02034552|41920510|FG000|Overall Study|Radiological progression|3|||
19510254|NCT02034552|41920511|FG001|Overall Study|Radiological progression|5|||
19510255|NCT02034552|41920512|FG002|Overall Study|Radiological progression|4|||
19510256|NCT02034552|41920510|FG000|Overall Study|AE not assoc. with disease progression|1|||
19510257|NCT02034552|41920511|FG001|Overall Study|AE not assoc. with disease progression|4|||
19510258|NCT02034552|41920512|FG002|Overall Study|AE not assoc. with disease progression|2|||
19510259|NCT02034552|41920510|FG000|Overall Study|AE associated with disease progression|0|||
19510260|NCT02034552|41920511|FG001|Overall Study|AE associated with disease progression|1|||
19510261|NCT02034552|41920512|FG002|Overall Study|AE associated with disease progression|0|||
19510262|NCT02034552|41920510|FG000|Overall Study|Withdrawal by Subject|2|||
19510263|NCT02034552|41920511|FG001|Overall Study|Withdrawal by Subject|1|||
19510264|NCT02034552|41920512|FG002|Overall Study|Withdrawal by Subject|1|||
19510265|NCT02034552|41920510|FG000|Overall Study|Non-compliance with study drug|0|||
19510266|NCT02034552|41920511|FG001|Overall Study|Non-compliance with study drug|0|||
19510267|NCT02034552|41920512|FG002|Overall Study|Non-compliance with study drug|1|||
19510268|NCT02034552|41920510|FG000|Overall Study|Clinical progression|5|||
19510269|NCT02034552|41920511|FG001|Overall Study|Clinical progression|7|||
19510270|NCT02034552|41920512|FG002|Overall Study|Clinical progression|9|||
19510271|NCT02034474|41920522|FG000|Overall Study|Adverse Event|3|||
19510272|NCT02034474|41920523|FG001|Overall Study|Adverse Event|2|||
19510273|NCT02034474|41920522|FG000|Overall Study|Withdrawal by Subject|1|||
19510274|NCT02034474|41920523|FG001|Overall Study|Withdrawal by Subject|2|||
19510275|NCT02011542|41920531|FG000|Overall Study|Physician Decision|1|||
19510276|NCT02011386|41920535|FG000|Overall Study|Non-compliance|2|||
19510277|NCT02011386|41920535|FG000|Overall Study|Lack of Efficacy|3|||
19510278|NCT02010684|41920541|FG000|Overall Study|Lost to Follow-up|8|||
19510279|NCT02010684|41920542|FG001|Overall Study|Lost to Follow-up|18|||
19510280|NCT02010684|41920541|FG000|Overall Study|Withdrawal by Subject|4|||
19510281|NCT02010684|41920542|FG001|Overall Study|Withdrawal by Subject|5|||
19510282|NCT02034162|41920550|FG000|Double-blind|Lost to Follow-up|3|||
19510283|NCT02034162|41920551|FG001|Double-blind|Lost to Follow-up|0|||
19510284|NCT02034162|41920552|FG002|Double-blind|Lost to Follow-up|0|||
19510285|NCT02034162|41920550|FG000|Double-blind|Physician Decision|1|||
19510286|NCT02034162|41920551|FG001|Double-blind|Physician Decision|0|||
19510287|NCT02034162|41920552|FG002|Double-blind|Physician Decision|0|||
19510288|NCT02034162|41920550|FG000|Double-blind|Protocol Violation|0|||
19510289|NCT02034162|41920551|FG001|Double-blind|Protocol Violation|1|||
19510290|NCT02034162|41920552|FG002|Double-blind|Protocol Violation|0|||
19510291|NCT02034162|41920550|FG000|Double-blind|Withdrawal by Subject|5|||
19510292|NCT02034162|41920551|FG001|Double-blind|Withdrawal by Subject|7|||
19510293|NCT02034162|41920552|FG002|Double-blind|Withdrawal by Subject|0|||
19510294|NCT02034006|41920565|FG000|Overall Study|Withdrawal by Subject|7|||
19510295|NCT02034006|41920565|FG000|Overall Study|Lost to Follow-up|5|||
19510296|NCT02034006|41920565|FG000|Overall Study|Death|1|||
19510297|NCT02034006|41920565|FG000|Overall Study|Pregnancy|1|||
19510298|NCT02054910|41920574|FG000|Overall Study|Lost to Follow-up|4|||
19510299|NCT02054910|41920575|FG001|Overall Study|Lost to Follow-up|1|||
19510300|NCT02033850|41920585|FG000|Overall Study|Death|1|||
19510301|NCT02033850|41920586|FG001|Overall Study|Death|0|||
19510302|NCT02033850|41920585|FG000|Overall Study|unrelated medical reason|1|||
19510303|NCT02033850|41920586|FG001|Overall Study|unrelated medical reason|1|||
19510304|NCT02054130|41920596|FG000|Overall Study|Withdrawal by Subject|4|||
19510305|NCT02054130|41920597|FG001|Overall Study|Withdrawal by Subject|4|||
19510306|NCT02054130|41920598|FG002|Overall Study|Withdrawal by Subject|7|||
19510307|NCT02054130|41920599|FG003|Overall Study|Withdrawal by Subject|10|||
19510308|NCT02054130|41920596|FG000|Overall Study|Death|0|||
19510309|NCT02054130|41920597|FG001|Overall Study|Death|1|||
19510310|NCT02054130|41920598|FG002|Overall Study|Death|0|||
19510311|NCT02054130|41920599|FG003|Overall Study|Death|0|||
19510312|NCT02054130|41920596|FG000|Overall Study|Lost to Follow-up|0|||
19510313|NCT02054130|41920597|FG001|Overall Study|Lost to Follow-up|0|||
19510314|NCT02054130|41920598|FG002|Overall Study|Lost to Follow-up|1|||
19510315|NCT02054130|41920599|FG003|Overall Study|Lost to Follow-up|2|||
19510316|NCT02054130|41920596|FG000|Overall Study|Missed dose|4|||
19510317|NCT02054130|41920597|FG001|Overall Study|Missed dose|6|||
19510318|NCT02054130|41920598|FG002|Overall Study|Missed dose|7|||
19510319|NCT02054130|41920599|FG003|Overall Study|Missed dose|10|||
19510320|NCT02053350|41920612|FG000|Overall Study|Withdrawal by Subject|1|||
19510321|NCT02053350|41920612|FG000|Overall Study|Adverse Event|4|||
19510322|NCT02009046|41920618|FG000|Overall Study|Lost to Follow-up|256|||
19510323|NCT02009046|41920619|FG001|Overall Study|Lost to Follow-up|206|||
19510324|NCT02052960|41920635|FG000|Overall Study|Adverse Event|19|||
19510325|NCT02052960|41920636|FG001|Overall Study|Adverse Event|17|||
19510326|NCT02052960|41920635|FG000|Overall Study|Protocol Violation|4|||
19510327|NCT02052960|41920636|FG001|Overall Study|Protocol Violation|3|||
19510328|NCT02052960|41920635|FG000|Overall Study|Withdrawal by Subject|6|||
19510329|NCT02052960|41920636|FG001|Overall Study|Withdrawal by Subject|11|||
19510330|NCT02052960|41920635|FG000|Overall Study|Other|25|||
19510331|NCT02052960|41920636|FG001|Overall Study|Other|15|||
19510332|NCT02008890|41920648|FG000|Period 1|Withdrawal by Subject|7|||
19510333|NCT02008890|41920649|FG001|Period 1|Withdrawal by Subject|7|||
19510334|NCT02008890|41920650|FG002|Period 1|Withdrawal by Subject|5|||
19510335|NCT02008890|41920651|FG003|Period 1|Withdrawal by Subject|0|||
19510336|NCT02008890|41920652|FG004|Period 1|Withdrawal by Subject|0|||
19510337|NCT02008890|41920648|FG000|Period 1|Pregnancy|1|||
19510338|NCT02008890|41920649|FG001|Period 1|Pregnancy|0|||
19510339|NCT02008890|41920650|FG002|Period 1|Pregnancy|0|||
19510340|NCT02008890|41920651|FG003|Period 1|Pregnancy|0|||
19510341|NCT02008890|41920652|FG004|Period 1|Pregnancy|0|||
19510342|NCT02008890|41920648|FG000|Period 1|Physician Decision|1|||
19510343|NCT02008890|41920649|FG001|Period 1|Physician Decision|0|||
19510344|NCT02008890|41920650|FG002|Period 1|Physician Decision|1|||
19510345|NCT02008890|41920651|FG003|Period 1|Physician Decision|0|||
19510346|NCT02008890|41920652|FG004|Period 1|Physician Decision|0|||
19510347|NCT02008890|41920648|FG000|Period 1|Adverse Event|6|||
19510348|NCT02008890|41920649|FG001|Period 1|Adverse Event|8|||
19510349|NCT02008890|41920650|FG002|Period 1|Adverse Event|6|||
19510350|NCT02008890|41920651|FG003|Period 1|Adverse Event|0|||
19510351|NCT02008890|41920652|FG004|Period 1|Adverse Event|0|||
19510352|NCT02008890|41920648|FG000|Period 2|Adverse Event|12|||
19510353|NCT02008890|41920649|FG001|Period 2|Adverse Event|7|||
19510354|NCT02008890|41920650|FG002|Period 2|Adverse Event|0|||
19510355|NCT02008890|41920651|FG003|Period 2|Adverse Event|5|||
19510356|NCT02008890|41920652|FG004|Period 2|Adverse Event|5|||
19510357|NCT02008890|41920648|FG000|Period 2|Withdrawal by Subject|11|||
19510358|NCT02008890|41920649|FG001|Period 2|Withdrawal by Subject|8|||
19510359|NCT02008890|41920650|FG002|Period 2|Withdrawal by Subject|0|||
19510360|NCT02008890|41920651|FG003|Period 2|Withdrawal by Subject|7|||
19510361|NCT02008890|41920652|FG004|Period 2|Withdrawal by Subject|2|||
19510362|NCT02008890|41920648|FG000|Period 2|Physician Decision|4|||
19510363|NCT02008890|41920649|FG001|Period 2|Physician Decision|0|||
19510364|NCT02008890|41920650|FG002|Period 2|Physician Decision|0|||
19510365|NCT02008890|41920651|FG003|Period 2|Physician Decision|2|||
19510366|NCT02008890|41920652|FG004|Period 2|Physician Decision|1|||
19510367|NCT02008890|41920648|FG000|Period 2|Lost to Follow-up|0|||
19510368|NCT02008890|41920649|FG001|Period 2|Lost to Follow-up|0|||
19510369|NCT02008890|41920650|FG002|Period 2|Lost to Follow-up|1|||
19510370|NCT02008890|41920651|FG003|Period 2|Lost to Follow-up|0|||
19510371|NCT02008890|41920652|FG004|Period 2|Lost to Follow-up|0|||
19510372|NCT02008890|41920648|FG000|Extension Period|Withdrawal by Subject|3|||
19510373|NCT02008890|41920649|FG001|Extension Period|Withdrawal by Subject|2|||
19510374|NCT02008890|41920650|FG002|Extension Period|Withdrawal by Subject|0|||
19510375|NCT02008890|41920651|FG003|Extension Period|Withdrawal by Subject|4|||
19510376|NCT02008890|41920652|FG004|Extension Period|Withdrawal by Subject|2|||
19510377|NCT02008890|41920648|FG000|Extension Period|Lost to Follow-up|1|||
19510378|NCT02008890|41920649|FG001|Extension Period|Lost to Follow-up|0|||
19510379|NCT02008890|41920650|FG002|Extension Period|Lost to Follow-up|0|||
19510380|NCT02008890|41920651|FG003|Extension Period|Lost to Follow-up|0|||
19510381|NCT02008890|41920652|FG004|Extension Period|Lost to Follow-up|0|||
19510382|NCT02008890|41920648|FG000|Extension Period|Adverse Event|1|||
19616769|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
19616770|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
19616771|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
19616772|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
19616773|NCT00600756|42066498|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
19616774|NCT00600756|42066499|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
19616775|NCT00890825|42066511|FG000|Overall Study|Withdrawal by Subject|1|||
19616776|NCT00890825|42066512|FG001|Overall Study|Withdrawal by Subject|0|||
19616777|NCT00890825|42066511|FG000|Overall Study|Alive at data cut off (DCO)|13|||
19616778|NCT00890825|42066512|FG001|Overall Study|Alive at data cut off (DCO)|14|||
19616779|NCT00890201|42066520|FG000|Overall Study|Protocol Violation|5|||
19616780|NCT00890201|42066521|FG001|Overall Study|Protocol Violation|56|||
19616781|NCT00891527|42066527|FG000|Overall Study|Withdrawal by Subject|2|||
19616782|NCT03861078|42066532|FG000|Overall Study|COVID-19 shut down|4|||
19616783|NCT03861078|42066532|FG000|Overall Study|Lost to Follow-up|1|||
19616784|NCT03861078|42066532|FG000|Overall Study|Protocol Violation|2|||
19616785|NCT03861078|42066532|FG000|Overall Study|lack of venous access|1|||
19616786|NCT00891371|42066540|FG000|Pre-assignment|Inclusion/exclusion|5|||
19616787|NCT00891371|42066540|FG000|Pre-assignment|Consent withdrawal|1|||
19616788|NCT00891371|42066540|FG000|Treatment|Lack of Efficacy|5|||
19616789|NCT00891371|42066540|FG000|Treatment|Adverse Event|2|||
19616790|NCT00891371|42066540|FG000|Treatment|Death|1|||
19616791|NCT00891371|42066540|FG000|Treatment|Lost to Follow-up|1|||
19616792|NCT00890045|42066546|FG000|Overall Study|Death|0|||
19616793|NCT00890045|42066547|FG001|Overall Study|Death|1|||
19616794|NCT00890045|42066546|FG000|Overall Study|Did not receive HeRO Graft|0|||
19616795|NCT00890045|42066547|FG001|Overall Study|Did not receive HeRO Graft|2|||
19616796|NCT00890045|42066546|FG000|Overall Study|Lost to Follow-up|5|||
19616797|NCT00890045|42066547|FG001|Overall Study|Lost to Follow-up|7|||
19616798|NCT00891293|42066553|FG000|Overall Study|Adverse Event|2|||
19616799|NCT00891293|42066553|FG000|Overall Study|Protocol Violation|2|||
19616800|NCT00891293|42066553|FG000|Overall Study|Laboratory abnormality|4|||
19616801|NCT00891293|42066553|FG000|Overall Study|Lost to Follow-up|7|||
19616802|NCT00891293|42066553|FG000|Overall Study|Subject withdrew consent|7|||
19616803|NCT00891293|42066553|FG000|Overall Study|Sponsor termination|62|||
19616804|NCT00889421|42066577|FG000|Overall Study|Lack of Efficacy|3|||
19616805|NCT00889265|42066581|FG000|Overall Study|Adverse Event|1|||
19616806|NCT00889265|42066581|FG000|Overall Study|Lost to Follow-up|5|||
19616807|NCT00889265|42066581|FG000|Overall Study|Protocol Violation|1|||
19616808|NCT00603746|42066591|FG000|Overall Study|Adverse Event|2|||
19616809|NCT00603746|42066592|FG001|Overall Study|Adverse Event|3|||
19616810|NCT00603746|42066593|FG002|Overall Study|Adverse Event|0|||
19616811|NCT00603746|42066594|FG003|Overall Study|Adverse Event|1|||
19616812|NCT00603746|42066595|FG004|Overall Study|Adverse Event|0|||
19510383|NCT02008890|41920649|FG001|Extension Period|Adverse Event|3|||
19510384|NCT02008890|41920650|FG002|Extension Period|Adverse Event|0|||
19510385|NCT02008890|41920651|FG003|Extension Period|Adverse Event|0|||
19510386|NCT02008890|41920652|FG004|Extension Period|Adverse Event|2|||
19616813|NCT00603746|42066596|FG005|Overall Study|Adverse Event|4|||
19616814|NCT00603746|42066591|FG000|Overall Study|Lack of Efficacy|34|||
19616815|NCT00603746|42066592|FG001|Overall Study|Lack of Efficacy|11|||
19616816|NCT00603746|42066593|FG002|Overall Study|Lack of Efficacy|6|||
19616817|NCT00603746|42066594|FG003|Overall Study|Lack of Efficacy|11|||
19616818|NCT00603746|42066595|FG004|Overall Study|Lack of Efficacy|12|||
19510387|NCT02052414|41920667|FG000|Overall Study|Adverse Event|12|||
19510388|NCT02052414|41920667|FG000|Overall Study|Lack of Efficacy|2|||
19510389|NCT02052414|41920667|FG000|Overall Study|Withdrawal by Subject|3|||
19510390|NCT02007954|41920672|FG000|Overall Study|Received liver transplant|3|||
19510391|NCT02007954|41920672|FG000|Overall Study|Switch in treatment modality|2|||
19510392|NCT02007954|41920672|FG000|Overall Study|Disease progression and unrelated AE|1|||
19616819|NCT00603746|42066596|FG005|Overall Study|Lack of Efficacy|8|||
19616820|NCT00603746|42066591|FG000|Overall Study|Protocol Violation|0|||
19616821|NCT00603746|42066592|FG001|Overall Study|Protocol Violation|3|||
19616822|NCT00603746|42066593|FG002|Overall Study|Protocol Violation|1|||
19616823|NCT00603746|42066594|FG003|Overall Study|Protocol Violation|0|||
19616824|NCT00603746|42066595|FG004|Overall Study|Protocol Violation|1|||
19616825|NCT00603746|42066596|FG005|Overall Study|Protocol Violation|0|||
19616826|NCT00603746|42066591|FG000|Overall Study|Lost to Follow-up|0|||
19616827|NCT00603746|42066592|FG001|Overall Study|Lost to Follow-up|1|||
19616828|NCT00603746|42066593|FG002|Overall Study|Lost to Follow-up|1|||
19616829|NCT00603746|42066594|FG003|Overall Study|Lost to Follow-up|0|||
19616830|NCT00603746|42066595|FG004|Overall Study|Lost to Follow-up|0|||
19616831|NCT00603746|42066596|FG005|Overall Study|Lost to Follow-up|0|||
19616832|NCT00603746|42066591|FG000|Overall Study|Physician Decision|1|||
19616833|NCT00603746|42066592|FG001|Overall Study|Physician Decision|0|||
19616834|NCT00603746|42066593|FG002|Overall Study|Physician Decision|0|||
19616835|NCT00603746|42066594|FG003|Overall Study|Physician Decision|0|||
19616836|NCT00603746|42066595|FG004|Overall Study|Physician Decision|1|||
19616837|NCT00603746|42066596|FG005|Overall Study|Physician Decision|0|||
19616838|NCT00603746|42066591|FG000|Overall Study|Withdrawal by Subject|1|||
19616839|NCT00603746|42066592|FG001|Overall Study|Withdrawal by Subject|0|||
19616840|NCT00603746|42066593|FG002|Overall Study|Withdrawal by Subject|0|||
19616841|NCT00603746|42066594|FG003|Overall Study|Withdrawal by Subject|1|||
19616842|NCT00603746|42066595|FG004|Overall Study|Withdrawal by Subject|3|||
19616843|NCT00603746|42066596|FG005|Overall Study|Withdrawal by Subject|1|||
19616844|NCT00888329|42066612|FG000|Overall Study|Physician Decision|6|||
19616845|NCT00888329|42066613|FG001|Overall Study|Physician Decision|9|||
19616846|NCT00603590|42066621|FG000|Overall Study|Did not attend study clinic|39|||
19616847|NCT00603590|42066622|FG001|Overall Study|Did not attend study clinic|30|||
19616848|NCT00603590|42066621|FG000|Overall Study|Refused blood test|5|||
19616849|NCT00603590|42066622|FG001|Overall Study|Refused blood test|1|||
19616850|NCT00603590|42066621|FG000|Overall Study|Patient discontinued study drug|22|||
19616851|NCT00603590|42066622|FG001|Overall Study|Patient discontinued study drug|15|||
19616852|NCT00603590|42066621|FG000|Overall Study|Adverse Event|2|||
19616853|NCT00603590|42066622|FG001|Overall Study|Adverse Event|0|||
19616854|NCT00603590|42066621|FG000|Overall Study|Lost to Follow-up|8|||
19616855|NCT00603590|42066622|FG001|Overall Study|Lost to Follow-up|4|||
19616856|NCT00603590|42066621|FG000|Overall Study|Cardiovascular event|0|||
19616857|NCT00603590|42066622|FG001|Overall Study|Cardiovascular event|1|||
19616858|NCT00888173|42066628|FG000|Overall Study|Wrong Primary|1|||
19616859|NCT00888173|42066628|FG000|Overall Study|Ineligible: required test not done|1|||
19616860|NCT00887549|42066641|FG000|Induction Therapy|Adverse Event|8|||
19616861|NCT00887549|42066641|FG000|Induction Therapy|Physician Decision|1|||
19616862|NCT00887549|42066641|FG000|Induction Therapy|Progressive Disease|13|||
19616863|NCT00887549|42066641|FG000|Induction Therapy|Death due to Study Disease|4|||
19616864|NCT00887549|42066641|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
19616865|NCT00887549|42066641|FG000|Maintenance Therapy|Adverse Event|16|||
19616866|NCT00887549|42066641|FG000|Maintenance Therapy|Physician Decision|1|||
19616867|NCT00887549|42066641|FG000|Maintenance Therapy|Progressive Disease|25|||
19616868|NCT00887549|42066641|FG000|Maintenance Therapy|Death due to adverse event|1|||
19616869|NCT00887315|42066651|FG000|Overall Study|Study termination|7|||
19616870|NCT00887315|42066652|FG001|Overall Study|Study termination|4|||
19616871|NCT03608826|42066658|FG000|Overall Study|Death|3|||
19616872|NCT03608826|42066658|FG000|Overall Study|Heart Transplant|3|||
19616873|NCT03608826|42066658|FG000|Overall Study|Physician Decision|4|||
19616874|NCT00887159|42066665|FG000|Overall Study|Disease progression|6|||
19616875|NCT00887159|42066666|FG001|Overall Study|Disease progression|39|||
19616876|NCT00887159|42066667|FG002|Overall Study|Disease progression|33|||
19616877|NCT00887159|42066665|FG000|Overall Study|Adverse Event|3|||
19616878|NCT00887159|42066666|FG001|Overall Study|Adverse Event|4|||
19616879|NCT00887159|42066667|FG002|Overall Study|Adverse Event|17|||
19616880|NCT00887159|42066665|FG000|Overall Study|Death|2|||
19616881|NCT00887159|42066666|FG001|Overall Study|Death|2|||
19616882|NCT00887159|42066667|FG002|Overall Study|Death|0|||
19616883|NCT00887159|42066665|FG000|Overall Study|Withdrawal by Subject|4|||
19616884|NCT00887159|42066666|FG001|Overall Study|Withdrawal by Subject|4|||
19616885|NCT00887159|42066667|FG002|Overall Study|Withdrawal by Subject|2|||
19616886|NCT00887159|42066665|FG000|Overall Study|Alternative therapy|2|||
19616887|NCT00887159|42066666|FG001|Overall Study|Alternative therapy|0|||
19616888|NCT00887159|42066667|FG002|Overall Study|Alternative therapy|0|||
19616889|NCT00887159|42066665|FG000|Overall Study|Physician Decision|1|||
19616890|NCT00887159|42066666|FG001|Overall Study|Physician Decision|1|||
19616891|NCT00887159|42066667|FG002|Overall Study|Physician Decision|0|||
19510393|NCT02007954|41920672|FG000|Overall Study|Death|1|||
19510394|NCT02049450|41920676|FG000|Overall Study|Adverse Event|2|||
19510395|NCT02049450|41920676|FG000|Overall Study|Withdrawal by Subject|1|||
19510396|NCT02049450|41920676|FG000|Overall Study|Patients/guardian decision|1|||
19510397|NCT02031432|41920687|FG000|Overall Study|Protocol Violation|1|||
19510398|NCT02031432|41920687|FG000|Overall Study|Lack of Efficacy|5|||
19510399|NCT02031432|41920687|FG000|Overall Study|Cancer Progression|2|||
19510400|NCT02031432|41920687|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
19510401|NCT02031432|41920687|FG000|Overall Study|Adverse Event|8|||
19510402|NCT02031432|41920687|FG000|Overall Study|Withdrawal by Subject|5|||
19510403|NCT02031432|41920687|FG000|Overall Study|Lost to Follow-up|1|||
19510404|NCT02031432|41920687|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
19510405|NCT02031432|41920687|FG000|Overall Study|Death|10|||
19510406|NCT02031276|41920694|FG000|Period 1 Double-blind IV|Adverse Event|6|||
19510407|NCT02031276|41920695|FG001|Period 1 Double-blind IV|Adverse Event|5|||
19510408|NCT02031276|41920696|FG002|Period 1 Double-blind IV|Adverse Event|1|||
19510409|NCT02031276|41920694|FG000|Period 1 Double-blind IV|Other|0|||
19510410|NCT02031276|41920695|FG001|Period 1 Double-blind IV|Other|1|||
19510411|NCT02031276|41920696|FG002|Period 1 Double-blind IV|Other|0|||
19510412|NCT02031276|41920694|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
19510413|NCT02031276|41920695|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
19510414|NCT02031276|41920696|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
19510415|NCT02031276|41920694|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
19510416|NCT02031276|41920695|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
19510417|NCT02031276|41920696|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
19510418|NCT02031276|41920694|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
19510419|NCT02031276|41920695|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
19510420|NCT02031276|41920696|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
19510421|NCT02031276|41920694|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
19510422|NCT02031276|41920695|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
19510423|NCT02031276|41920696|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
19510424|NCT02031276|41920694|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
19510425|NCT02031276|41920695|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
19510426|NCT02031276|41920696|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
19510427|NCT02031276|41920694|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
19510428|NCT02031276|41920695|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
19510429|NCT02031276|41920696|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
19616892|NCT00887159|42066665|FG000|Overall Study|Sympomatic deterioration|1|||
19616893|NCT00887159|42066666|FG001|Overall Study|Sympomatic deterioration|0|||
19616894|NCT00887159|42066667|FG002|Overall Study|Sympomatic deterioration|0|||
19616895|NCT00887159|42066665|FG000|Overall Study|Treatment delayed|1|||
19616896|NCT00887159|42066666|FG001|Overall Study|Treatment delayed|1|||
19616897|NCT00887159|42066667|FG002|Overall Study|Treatment delayed|0|||
19616898|NCT00887159|42066665|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
19616899|NCT00887159|42066666|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
19616900|NCT00887159|42066667|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
19616901|NCT00887159|42066665|FG000|Overall Study|Received more tx instead of observation|1|||
19616902|NCT00887159|42066666|FG001|Overall Study|Received more tx instead of observation|0|||
19616903|NCT00887159|42066667|FG002|Overall Study|Received more tx instead of observation|0|||
19616904|NCT00887159|42066665|FG000|Overall Study|Ineligible|5|||
19616905|NCT00887159|42066666|FG001|Overall Study|Ineligible|1|||
19510430|NCT02031276|41920694|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
19510431|NCT02031276|41920695|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
19510432|NCT02031276|41920696|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
19510433|NCT02007720|41920710|FG000|Overall Study|Withdrawal by Subject|9|||
19510434|NCT02007720|41920711|FG001|Overall Study|Withdrawal by Subject|11|||
19510435|NCT02007720|41920710|FG000|Overall Study|study terminated by sponsor|58|||
19616906|NCT00887159|42066667|FG002|Overall Study|Ineligible|0|||
19616907|NCT00887159|42066665|FG000|Overall Study|Never started assigned therapy|3|||
19616908|NCT00887159|42066666|FG001|Overall Study|Never started assigned therapy|3|||
19616909|NCT00887159|42066667|FG002|Overall Study|Never started assigned therapy|4|||
19616910|NCT00886769|42066679|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
19616911|NCT00886769|42066680|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
19616912|NCT00886613|42066689|FG000|Overall Study|Protocol deviation (Part B)|1|||
19616913|NCT00886613|42066690|FG001|Overall Study|Protocol deviation (Part B)|0|||
19616914|NCT00886613|42066691|FG002|Overall Study|Protocol deviation (Part B)|0|||
19616915|NCT00886613|42066689|FG000|Overall Study|Lost to follow-up (Part B)|1|||
19616916|NCT00886613|42066690|FG001|Overall Study|Lost to follow-up (Part B)|0|||
19616917|NCT00886613|42066691|FG002|Overall Study|Lost to follow-up (Part B)|1|||
19704571|NCT00129402|42148934|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19510436|NCT02007720|41920711|FG001|Overall Study|study terminated by sponsor|54|||
19616918|NCT00886613|42066689|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
19704572|NCT00129402|42148935|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
19616919|NCT00886613|42066690|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
19616920|NCT00886613|42066691|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
19616921|NCT00886379|42066707|FG000|Overall Study|Transferred Schools|0|||
19616922|NCT00886379|42066708|FG001|Overall Study|Transferred Schools|0|||
19616923|NCT00886379|42066709|FG002|Overall Study|Transferred Schools|2|||
19616924|NCT00886379|42066710|FG003|Overall Study|Transferred Schools|1|||
19616925|NCT00886379|42066711|FG004|Overall Study|Transferred Schools|1|||
19616926|NCT00886379|42066707|FG000|Overall Study|Final blood draw not obtained|3|||
19616927|NCT00886379|42066708|FG001|Overall Study|Final blood draw not obtained|3|||
19616928|NCT00886379|42066709|FG002|Overall Study|Final blood draw not obtained|4|||
19616929|NCT00886379|42066710|FG003|Overall Study|Final blood draw not obtained|2|||
19616930|NCT00886379|42066711|FG004|Overall Study|Final blood draw not obtained|2|||
19616931|NCT00599196|42066723|FG000|Overall Study|Lack of Efficacy|22|||
19616932|NCT00599196|42066723|FG000|Overall Study|Adverse Event|93|||
19616933|NCT00599196|42066723|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
19616934|NCT00599196|42066723|FG000|Overall Study|Subject withdrew consent|43|||
19616935|NCT00599196|42066723|FG000|Overall Study|Study ended per sponsor|197|||
19616936|NCT00599196|42066723|FG000|Overall Study|Lost to Follow-up|17|||
19616937|NCT00599196|42066723|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
19616938|NCT00599196|42066723|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
19616939|NCT00599196|42066723|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
19616940|NCT00599196|42066723|FG000|Overall Study|Other: Pt Moved To Australia|1|||
19616941|NCT00599196|42066723|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
19616942|NCT00599196|42066723|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
19616943|NCT00603512|42066732|FG000|Overall Study|Adverse Event|0|||
19616944|NCT00603512|42066733|FG001|Overall Study|Adverse Event|2|||
19616945|NCT00603512|42066734|FG002|Overall Study|Adverse Event|4|||
19616946|NCT00603512|42066735|FG003|Overall Study|Adverse Event|4|||
19616947|NCT00603512|42066736|FG004|Overall Study|Adverse Event|2|||
19616948|NCT00603512|42066732|FG000|Overall Study|Lack of Efficacy|0|||
19616949|NCT00603512|42066733|FG001|Overall Study|Lack of Efficacy|1|||
19616950|NCT00603512|42066734|FG002|Overall Study|Lack of Efficacy|0|||
19616951|NCT00603512|42066735|FG003|Overall Study|Lack of Efficacy|0|||
19616952|NCT00603512|42066736|FG004|Overall Study|Lack of Efficacy|1|||
19616953|NCT00603512|42066732|FG000|Overall Study|Other|2|||
19616954|NCT00603512|42066733|FG001|Overall Study|Other|1|||
19616955|NCT00603512|42066734|FG002|Overall Study|Other|0|||
19616956|NCT00603512|42066735|FG003|Overall Study|Other|1|||
19616957|NCT00603512|42066736|FG004|Overall Study|Other|1|||
19616958|NCT00603512|42066732|FG000|Overall Study|Withdrawal by Subject|0|||
19616959|NCT00603512|42066733|FG001|Overall Study|Withdrawal by Subject|0|||
19616960|NCT00603512|42066734|FG002|Overall Study|Withdrawal by Subject|0|||
19616961|NCT00603512|42066735|FG003|Overall Study|Withdrawal by Subject|0|||
19616962|NCT00603512|42066736|FG004|Overall Study|Withdrawal by Subject|1|||
19616963|NCT00603512|42066732|FG000|Overall Study|Randomized but not treated|0|||
19616964|NCT00603512|42066733|FG001|Overall Study|Randomized but not treated|1|||
19616965|NCT00603512|42066734|FG002|Overall Study|Randomized but not treated|1|||
19704573|NCT00129402|42148929|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
19704574|NCT00129402|42148930|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
19704575|NCT00129402|42148931|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
19704576|NCT00129402|42148932|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
19704577|NCT00129402|42148933|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
19704578|NCT00129402|42148934|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
19704579|NCT00129402|42148935|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
19704580|NCT00129402|42148929|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
19616966|NCT00603512|42066735|FG003|Overall Study|Randomized but not treated|2|||
19616967|NCT00603512|42066736|FG004|Overall Study|Randomized but not treated|0|||
19616968|NCT04242875|42066748|FG000|Overall Study|Adverse Event|2|||
19704581|NCT00129402|42148930|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
19704582|NCT00129402|42148931|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
19704583|NCT00129402|42148932|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
19704584|NCT00129402|42148933|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
19704585|NCT00129402|42148934|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
19616969|NCT00603278|42066762|FG000|Overall Study|Lack of Efficacy|35|||
19616970|NCT00603278|42066763|FG001|Overall Study|Lack of Efficacy|10|||
19616971|NCT00603278|42066764|FG002|Overall Study|Lack of Efficacy|11|||
19616972|NCT00603278|42066765|FG003|Overall Study|Lack of Efficacy|8|||
19616973|NCT00603278|42066766|FG004|Overall Study|Lack of Efficacy|7|||
19510437|NCT02007720|41920710|FG000|Overall Study|technical problem|4|||
19616974|NCT00603278|42066767|FG005|Overall Study|Lack of Efficacy|14|||
19616975|NCT00603278|42066762|FG000|Overall Study|Adverse Event|0|||
19616976|NCT00603278|42066763|FG001|Overall Study|Adverse Event|3|||
19616977|NCT00603278|42066764|FG002|Overall Study|Adverse Event|1|||
19704586|NCT00129402|42148935|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
19704587|NCT00129402|42148929|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704588|NCT00129402|42148930|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704589|NCT00129402|42148931|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704590|NCT00129402|42148932|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704591|NCT00129402|42148933|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704592|NCT00129402|42148934|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
19704593|NCT00129402|42148935|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
19704594|NCT00129402|42148929|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19704595|NCT00129402|42148930|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19704596|NCT00129402|42148931|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19704597|NCT00129402|42148932|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19704598|NCT00129402|42148933|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19704599|NCT00129402|42148934|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
19510438|NCT02007720|41920711|FG001|Overall Study|technical problem|2|||
19510439|NCT02007720|41920710|FG000|Overall Study|patient followd less than 165 days|11|||
19510440|NCT02007720|41920711|FG001|Overall Study|patient followd less than 165 days|5|||
19510441|NCT01363440|41920721|FG000|Overall Study|Adverse Event|5|||
19510442|NCT01363440|41920722|FG001|Overall Study|Adverse Event|4|||
19510443|NCT01363440|41920723|FG002|Overall Study|Adverse Event|4|||
19510444|NCT01363440|41920721|FG000|Overall Study|Death|3|||
19510445|NCT01363440|41920722|FG001|Overall Study|Death|7|||
19510446|NCT01363440|41920723|FG002|Overall Study|Death|5|||
19510447|NCT01363440|41920721|FG000|Overall Study|Withdrawal by Subject|9|||
19510448|NCT01363440|41920722|FG001|Overall Study|Withdrawal by Subject|11|||
19510449|NCT01363440|41920723|FG002|Overall Study|Withdrawal by Subject|11|||
19510450|NCT01363440|41920721|FG000|Overall Study|Lost to Follow-up|2|||
19510451|NCT01363440|41920722|FG001|Overall Study|Lost to Follow-up|4|||
19510452|NCT01363440|41920723|FG002|Overall Study|Lost to Follow-up|5|||
19510453|NCT01363440|41920721|FG000|Overall Study|Other|4|||
19510454|NCT01363440|41920722|FG001|Overall Study|Other|5|||
19510455|NCT01363440|41920723|FG002|Overall Study|Other|2|||
19510456|NCT02007252|41920736|FG000|Overall Study|Administrative problems|3|||
19510457|NCT02007252|41920737|FG001|Overall Study|Administrative problems|7|||
19510458|NCT02007252|41920736|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19510459|NCT02007252|41920737|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19510460|NCT02007252|41920736|FG000|Overall Study|Adverse Event|7|||
19510461|NCT02007252|41920737|FG001|Overall Study|Adverse Event|4|||
19510462|NCT02007096|41920745|FG000|Overall Study|medication not available|2|||
19510463|NCT02007096|41920746|FG001|Overall Study|medication not available|0|||
19510464|NCT02007096|41920745|FG000|Overall Study|did not inject saline|0|||
19510465|NCT02007096|41920746|FG001|Overall Study|did not inject saline|3|||
19510466|NCT02007096|41920745|FG000|Overall Study|did not follow postoperative protocol|8|||
19510467|NCT02007096|41920746|FG001|Overall Study|did not follow postoperative protocol|11|||
19510468|NCT02007096|41920745|FG000|Overall Study|converted to open surgery|1|||
19510469|NCT02007096|41920746|FG001|Overall Study|converted to open surgery|1|||
19510470|NCT02007096|41920745|FG000|Overall Study|no mesh placed|0|||
19510471|NCT02007096|41920746|FG001|Overall Study|no mesh placed|1|||
19510472|NCT02006706|41920752|FG000|Overall Study|Lost to Follow-up|1|||
19510473|NCT02049138|41920759|FG000|Overall Study|Adverse Event|46|||
19510474|NCT02049138|41920760|FG001|Overall Study|Adverse Event|25|||
19510475|NCT02049138|41920761|FG002|Overall Study|Adverse Event|1|||
19510476|NCT02049138|41920759|FG000|Overall Study|Withdrawal by Subject|57|||
19510477|NCT02049138|41920760|FG001|Overall Study|Withdrawal by Subject|21|||
19510478|NCT02049138|41920761|FG002|Overall Study|Withdrawal by Subject|5|||
19510479|NCT02049138|41920759|FG000|Overall Study|Lost to Follow-up|18|||
19510480|NCT02049138|41920760|FG001|Overall Study|Lost to Follow-up|5|||
19510481|NCT02049138|41920761|FG002|Overall Study|Lost to Follow-up|1|||
19510482|NCT02049138|41920759|FG000|Overall Study|Lack of Efficacy|10|||
19510483|NCT02049138|41920760|FG001|Overall Study|Lack of Efficacy|26|||
19510484|NCT02049138|41920761|FG002|Overall Study|Lack of Efficacy|1|||
19510485|NCT02049138|41920759|FG000|Overall Study|Non-Compliance|15|||
19510486|NCT02049138|41920760|FG001|Overall Study|Non-Compliance|6|||
19510487|NCT02049138|41920761|FG002|Overall Study|Non-Compliance|0|||
19510488|NCT02049138|41920759|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
19510489|NCT02049138|41920760|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
19510490|NCT02049138|41920761|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
19510491|NCT02049138|41920759|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
19510492|NCT02049138|41920760|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
19510493|NCT02049138|41920761|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
19510494|NCT02049138|41920759|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
19510495|NCT02049138|41920760|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
19510496|NCT02049138|41920761|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
19510497|NCT02049138|41920759|FG000|Overall Study|Other|15|||
19510498|NCT02049138|41920760|FG001|Overall Study|Other|13|||
19510499|NCT02049138|41920761|FG002|Overall Study|Other|0|||
19510500|NCT02049138|41920759|FG000|Overall Study|Missing|0|||
19510501|NCT02049138|41920760|FG001|Overall Study|Missing|1|||
19510502|NCT02049138|41920761|FG002|Overall Study|Missing|0|||
19510503|NCT02048904|41920772|FG000|Overall Study|Withdrawal by Subject|7|||
19510504|NCT02048904|41920772|FG000|Overall Study|Physician Decision|70|||
19510505|NCT02006628|41920778|FG000|Overall Study|Adverse Event|1|||
19510506|NCT02006628|41920779|FG001|Overall Study|Adverse Event|1|||
19616978|NCT00603278|42066765|FG003|Overall Study|Adverse Event|0|||
19616979|NCT00603278|42066766|FG004|Overall Study|Adverse Event|2|||
19616980|NCT00603278|42066767|FG005|Overall Study|Adverse Event|1|||
19616981|NCT00603278|42066762|FG000|Overall Study|Withdrawal by Subject|2|||
19616982|NCT00603278|42066763|FG001|Overall Study|Withdrawal by Subject|3|||
19616983|NCT00603278|42066764|FG002|Overall Study|Withdrawal by Subject|1|||
19616984|NCT00603278|42066765|FG003|Overall Study|Withdrawal by Subject|2|||
19616985|NCT00603278|42066766|FG004|Overall Study|Withdrawal by Subject|1|||
19616986|NCT00603278|42066767|FG005|Overall Study|Withdrawal by Subject|2|||
19510507|NCT02006628|41920778|FG000|Overall Study|Withdrawal by Subject|2|||
19510508|NCT02006628|41920779|FG001|Overall Study|Withdrawal by Subject|1|||
19510509|NCT02048826|41920787|FG000|Overall Study|Withdrawal by Subject|1|||
19510510|NCT02048826|41920788|FG001|Overall Study|Withdrawal by Subject|0|||
19510511|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
19510512|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
19510513|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
19510514|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
19510515|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
19510516|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
19510517|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
19510518|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
19510519|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
19510520|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
19510521|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
19510522|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
19510523|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
19510524|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
19510525|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
19510526|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Other|1|||
19510527|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Other|5|||
19510528|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Other|0|||
19510529|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Other|2|||
19510530|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Other|3|||
19510531|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
19510532|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
19510533|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
19510534|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
19510535|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
19510536|NCT02006472|41920799|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
19510537|NCT02006472|41920800|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
19510538|NCT02006472|41920801|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
19510539|NCT02006472|41920802|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
19510540|NCT02006472|41920803|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
19510541|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
19510542|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
19510543|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
19510544|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
19510545|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
19510546|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
19510547|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
19510548|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
19510549|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
19510550|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
19510551|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
19510552|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
19510553|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
19510554|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
19510555|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
19510556|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Other|0|||
19510557|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Other|1|||
19510558|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Other|0|||
19510559|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Other|1|||
19510560|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Other|0|||
19510561|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Not treated|0|||
19510562|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Not treated|0|||
19616987|NCT00603278|42066762|FG000|Overall Study|Protocol Violation|3|||
19510563|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Not treated|2|||
19510564|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Not treated|0|||
19510565|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Not treated|0|||
19510566|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
19510567|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
19510568|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
19510569|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
19510570|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
19510571|NCT02006472|41920799|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
19510572|NCT02006472|41920800|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
19510573|NCT02006472|41920801|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
19510574|NCT02006472|41920802|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
19510575|NCT02006472|41920803|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
19510576|NCT02005692|41920820|FG000|Overall Study|Protocol Violation|1|||
19510577|NCT02005692|41920820|FG000|Overall Study|Withdrawal by Subject|1|||
19510578|NCT02005692|41920820|FG000|Overall Study|Discharged earlier than anticipated|5|||
19510579|NCT02029638|41920828|FG000|Overall Study|Death|0|||
19510580|NCT02029638|41920829|FG001|Overall Study|Death|0|||
19510581|NCT02029638|41920830|FG002|Overall Study|Death|1|||
19510582|NCT02029638|41920828|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
19510583|NCT02029638|41920829|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
19510584|NCT02029638|41920830|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
19510585|NCT02047734|41920841|FG000|Overall Study|Adverse Event|18|||
19510586|NCT02047734|41920842|FG001|Overall Study|Adverse Event|13|||
19510587|NCT02047734|41920843|FG002|Overall Study|Adverse Event|13|||
19510588|NCT02047734|41920841|FG000|Overall Study|Lack of Efficacy|4|||
19510589|NCT02047734|41920842|FG001|Overall Study|Lack of Efficacy|5|||
19510590|NCT02047734|41920843|FG002|Overall Study|Lack of Efficacy|1|||
19510591|NCT02047734|41920841|FG000|Overall Study|Protocol Violation|3|||
19510592|NCT02047734|41920842|FG001|Overall Study|Protocol Violation|1|||
19510593|NCT02047734|41920843|FG002|Overall Study|Protocol Violation|1|||
19510594|NCT02047734|41920841|FG000|Overall Study|Lost to Follow-up|1|||
19510595|NCT02047734|41920842|FG001|Overall Study|Lost to Follow-up|4|||
19510596|NCT02047734|41920843|FG002|Overall Study|Lost to Follow-up|0|||
19510597|NCT02047734|41920841|FG000|Overall Study|Death|0|||
19510598|NCT02047734|41920842|FG001|Overall Study|Death|1|||
19510599|NCT02047734|41920843|FG002|Overall Study|Death|0|||
19510600|NCT02047734|41920841|FG000|Overall Study|Withdrawal by Subject|30|||
19510601|NCT02047734|41920842|FG001|Overall Study|Withdrawal by Subject|31|||
19510602|NCT02047734|41920843|FG002|Overall Study|Withdrawal by Subject|19|||
19510603|NCT02047734|41920841|FG000|Overall Study|Physician Decision|7|||
19510604|NCT02047734|41920842|FG001|Overall Study|Physician Decision|6|||
19510605|NCT02047734|41920843|FG002|Overall Study|Physician Decision|5|||
19510606|NCT02047734|41920841|FG000|Overall Study|Miscellaneous|2|||
19510607|NCT02047734|41920842|FG001|Overall Study|Miscellaneous|4|||
19510608|NCT02047734|41920843|FG002|Overall Study|Miscellaneous|6|||
19510609|NCT02047734|41920841|FG000|Overall Study|Did Not Receive Study Drug|2|||
19510610|NCT02047734|41920842|FG001|Overall Study|Did Not Receive Study Drug|4|||
19510611|NCT02047734|41920843|FG002|Overall Study|Did Not Receive Study Drug|1|||
19510612|NCT01994850|41920851|FG000|Overall Study|Physician Decision|1|||
19510613|NCT01994850|41920851|FG000|Overall Study|Withdrawal by Subject|1|||
19510614|NCT02027844|41920858|FG000|Overall Study|Withdrawal by Subject|3|||
19510615|NCT02027844|41920859|FG001|Overall Study|Withdrawal by Subject|2|||
19510616|NCT02027844|41920860|FG002|Overall Study|Withdrawal by Subject|1|||
19510617|NCT02027844|41920858|FG000|Overall Study|Lost to Follow-up|0|||
19510618|NCT02027844|41920859|FG001|Overall Study|Lost to Follow-up|2|||
19510619|NCT02027844|41920860|FG002|Overall Study|Lost to Follow-up|1|||
19510620|NCT02027844|41920858|FG000|Overall Study|Protocol Violation|0|||
19510621|NCT02027844|41920859|FG001|Overall Study|Protocol Violation|2|||
19510622|NCT02027844|41920860|FG002|Overall Study|Protocol Violation|0|||
19510623|NCT02027844|41920858|FG000|Overall Study|Incomlete data|2|||
19510624|NCT02027844|41920859|FG001|Overall Study|Incomlete data|0|||
19510625|NCT02027844|41920860|FG002|Overall Study|Incomlete data|0|||
19510626|NCT01994382|41920885|FG000|Overall Study|Informed consent withdrawn|0|||
19510627|NCT01994382|41920886|FG001|Overall Study|Informed consent withdrawn|0|||
19510628|NCT01994382|41920887|FG002|Overall Study|Informed consent withdrawn|0|||
19510629|NCT01994382|41920888|FG003|Overall Study|Informed consent withdrawn|0|||
19510630|NCT01994382|41920889|FG004|Overall Study|Informed consent withdrawn|0|||
19510631|NCT01994382|41920890|FG005|Overall Study|Informed consent withdrawn|0|||
19510632|NCT01994382|41920891|FG006|Overall Study|Informed consent withdrawn|1|||
19510633|NCT01994382|41920892|FG007|Overall Study|Informed consent withdrawn|0|||
19510634|NCT01994382|41920893|FG008|Overall Study|Informed consent withdrawn|0|||
19704600|NCT00129402|42148935|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
19510635|NCT01994382|41920894|FG009|Overall Study|Informed consent withdrawn|0|||
19510636|NCT01994382|41920895|FG010|Overall Study|Informed consent withdrawn|0|||
19510637|NCT01994382|41920896|FG011|Overall Study|Informed consent withdrawn|0|||
19510638|NCT01994382|41920897|FG012|Overall Study|Informed consent withdrawn|0|||
19510639|NCT01994382|41920898|FG013|Overall Study|Informed consent withdrawn|0|||
19510640|NCT01994382|41920899|FG014|Overall Study|Informed consent withdrawn|0|||
19510641|NCT01994382|41920900|FG015|Overall Study|Informed consent withdrawn|0|||
19510642|NCT01994382|41920901|FG016|Overall Study|Informed consent withdrawn|0|||
19510643|NCT01994382|41920885|FG000|Overall Study|Progressive disease|3|||
19510644|NCT01994382|41920886|FG001|Overall Study|Progressive disease|4|||
19510645|NCT01994382|41920887|FG002|Overall Study|Progressive disease|4|||
19510646|NCT01994382|41920888|FG003|Overall Study|Progressive disease|3|||
19510647|NCT01994382|41920889|FG004|Overall Study|Progressive disease|2|||
19510648|NCT01994382|41920890|FG005|Overall Study|Progressive disease|3|||
19510649|NCT01994382|41920891|FG006|Overall Study|Progressive disease|3|||
19510650|NCT01994382|41920892|FG007|Overall Study|Progressive disease|6|||
19510651|NCT01994382|41920893|FG008|Overall Study|Progressive disease|2|||
19510652|NCT01994382|41920894|FG009|Overall Study|Progressive disease|2|||
19510653|NCT01994382|41920895|FG010|Overall Study|Progressive disease|13|||
19510654|NCT01994382|41920896|FG011|Overall Study|Progressive disease|8|||
19510655|NCT01994382|41920897|FG012|Overall Study|Progressive disease|7|||
19510656|NCT01994382|41920898|FG013|Overall Study|Progressive disease|3|||
19510657|NCT01994382|41920899|FG014|Overall Study|Progressive disease|6|||
19510658|NCT01994382|41920900|FG015|Overall Study|Progressive disease|44|||
19510659|NCT01994382|41920901|FG016|Overall Study|Progressive disease|28|||
19510660|NCT01994382|41920885|FG000|Overall Study|Physician Decision|0|||
19510661|NCT01994382|41920886|FG001|Overall Study|Physician Decision|1|||
19510662|NCT01994382|41920887|FG002|Overall Study|Physician Decision|0|||
19510663|NCT01994382|41920888|FG003|Overall Study|Physician Decision|0|||
19510664|NCT01994382|41920889|FG004|Overall Study|Physician Decision|0|||
19510665|NCT01994382|41920890|FG005|Overall Study|Physician Decision|0|||
19510666|NCT01994382|41920891|FG006|Overall Study|Physician Decision|0|||
19510667|NCT01994382|41920892|FG007|Overall Study|Physician Decision|0|||
19510668|NCT01994382|41920893|FG008|Overall Study|Physician Decision|0|||
19510669|NCT01994382|41920894|FG009|Overall Study|Physician Decision|0|||
19510670|NCT01994382|41920895|FG010|Overall Study|Physician Decision|3|||
19510671|NCT01994382|41920896|FG011|Overall Study|Physician Decision|1|||
19510672|NCT01994382|41920897|FG012|Overall Study|Physician Decision|1|||
19510673|NCT01994382|41920898|FG013|Overall Study|Physician Decision|0|||
19510674|NCT01994382|41920899|FG014|Overall Study|Physician Decision|1|||
19510675|NCT01994382|41920900|FG015|Overall Study|Physician Decision|4|||
19510676|NCT01994382|41920901|FG016|Overall Study|Physician Decision|2|||
19510677|NCT01994382|41920885|FG000|Overall Study|Death|0|||
19510678|NCT01994382|41920886|FG001|Overall Study|Death|0|||
19510679|NCT01994382|41920887|FG002|Overall Study|Death|0|||
19510680|NCT01994382|41920888|FG003|Overall Study|Death|0|||
19510681|NCT01994382|41920889|FG004|Overall Study|Death|1|||
19510682|NCT01994382|41920890|FG005|Overall Study|Death|0|||
19510683|NCT01994382|41920891|FG006|Overall Study|Death|0|||
19616988|NCT00603278|42066763|FG001|Overall Study|Protocol Violation|0|||
19616989|NCT00603278|42066764|FG002|Overall Study|Protocol Violation|1|||
19616990|NCT00603278|42066765|FG003|Overall Study|Protocol Violation|1|||
19616991|NCT00603278|42066766|FG004|Overall Study|Protocol Violation|0|||
19616992|NCT00603278|42066767|FG005|Overall Study|Protocol Violation|1|||
19616993|NCT00603278|42066762|FG000|Overall Study|Physician Decision|0|||
19616994|NCT00603278|42066763|FG001|Overall Study|Physician Decision|1|||
19616995|NCT00603278|42066764|FG002|Overall Study|Physician Decision|0|||
19616996|NCT00603278|42066765|FG003|Overall Study|Physician Decision|0|||
19616997|NCT00603278|42066766|FG004|Overall Study|Physician Decision|2|||
19616998|NCT00603278|42066767|FG005|Overall Study|Physician Decision|1|||
19616999|NCT00603278|42066762|FG000|Overall Study|Lost to Follow-up|1|||
19394129|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
19394130|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
19394131|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
19394132|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
19394133|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
19394134|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
19394135|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
19394136|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
19394137|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
19510684|NCT01994382|41920892|FG007|Overall Study|Death|0|||
19510685|NCT01994382|41920893|FG008|Overall Study|Death|1|||
19510686|NCT01994382|41920894|FG009|Overall Study|Death|1|||
19510687|NCT01994382|41920895|FG010|Overall Study|Death|0|||
19510688|NCT01994382|41920896|FG011|Overall Study|Death|0|||
19510689|NCT01994382|41920897|FG012|Overall Study|Death|0|||
19510690|NCT01994382|41920898|FG013|Overall Study|Death|0|||
19510691|NCT01994382|41920899|FG014|Overall Study|Death|0|||
19510692|NCT01994382|41920900|FG015|Overall Study|Death|1|||
19510693|NCT01994382|41920901|FG016|Overall Study|Death|0|||
19510694|NCT01994382|41920885|FG000|Overall Study|Adverse Event|0|||
19510695|NCT01994382|41920886|FG001|Overall Study|Adverse Event|1|||
19510696|NCT01994382|41920887|FG002|Overall Study|Adverse Event|2|||
19617000|NCT00603278|42066763|FG001|Overall Study|Lost to Follow-up|0|||
19617001|NCT00603278|42066764|FG002|Overall Study|Lost to Follow-up|0|||
19617002|NCT00603278|42066765|FG003|Overall Study|Lost to Follow-up|0|||
19617003|NCT00603278|42066766|FG004|Overall Study|Lost to Follow-up|1|||
19510697|NCT01994382|41920888|FG003|Overall Study|Adverse Event|0|||
19510698|NCT01994382|41920889|FG004|Overall Study|Adverse Event|0|||
19510699|NCT01994382|41920890|FG005|Overall Study|Adverse Event|0|||
19510700|NCT01994382|41920891|FG006|Overall Study|Adverse Event|0|||
19510701|NCT01994382|41920892|FG007|Overall Study|Adverse Event|0|||
19510702|NCT01994382|41920893|FG008|Overall Study|Adverse Event|0|||
19510703|NCT01994382|41920894|FG009|Overall Study|Adverse Event|0|||
19510704|NCT01994382|41920895|FG010|Overall Study|Adverse Event|15|||
19510705|NCT01994382|41920896|FG011|Overall Study|Adverse Event|2|||
19510706|NCT01994382|41920897|FG012|Overall Study|Adverse Event|7|||
19510707|NCT01994382|41920898|FG013|Overall Study|Adverse Event|3|||
19510708|NCT01994382|41920899|FG014|Overall Study|Adverse Event|17|||
19510709|NCT01994382|41920900|FG015|Overall Study|Adverse Event|6|||
19510710|NCT01994382|41920901|FG016|Overall Study|Adverse Event|3|||
19510711|NCT01994382|41920885|FG000|Overall Study|Other than specified|0|||
19510712|NCT01994382|41920886|FG001|Overall Study|Other than specified|0|||
19510713|NCT01994382|41920887|FG002|Overall Study|Other than specified|0|||
19510714|NCT01994382|41920888|FG003|Overall Study|Other than specified|0|||
19510715|NCT01994382|41920889|FG004|Overall Study|Other than specified|0|||
19510716|NCT01994382|41920890|FG005|Overall Study|Other than specified|0|||
19510717|NCT01994382|41920891|FG006|Overall Study|Other than specified|0|||
19510718|NCT01994382|41920892|FG007|Overall Study|Other than specified|0|||
19510719|NCT01994382|41920893|FG008|Overall Study|Other than specified|0|||
19510720|NCT01994382|41920894|FG009|Overall Study|Other than specified|0|||
19510721|NCT01994382|41920895|FG010|Overall Study|Other than specified|2|||
19510722|NCT01994382|41920896|FG011|Overall Study|Other than specified|0|||
19510723|NCT01994382|41920897|FG012|Overall Study|Other than specified|2|||
19510724|NCT01994382|41920898|FG013|Overall Study|Other than specified|0|||
19510725|NCT01994382|41920899|FG014|Overall Study|Other than specified|0|||
19510726|NCT01994382|41920900|FG015|Overall Study|Other than specified|4|||
19510727|NCT01994382|41920901|FG016|Overall Study|Other than specified|4|||
19510728|NCT01994382|41920885|FG000|Overall Study|Withdrawal by Subject|0|||
19510729|NCT01994382|41920886|FG001|Overall Study|Withdrawal by Subject|0|||
19510730|NCT01994382|41920887|FG002|Overall Study|Withdrawal by Subject|0|||
19510731|NCT01994382|41920888|FG003|Overall Study|Withdrawal by Subject|0|||
19510732|NCT01994382|41920889|FG004|Overall Study|Withdrawal by Subject|0|||
19510733|NCT01994382|41920890|FG005|Overall Study|Withdrawal by Subject|0|||
19510734|NCT01994382|41920891|FG006|Overall Study|Withdrawal by Subject|0|||
19510735|NCT01994382|41920892|FG007|Overall Study|Withdrawal by Subject|0|||
19510736|NCT01994382|41920893|FG008|Overall Study|Withdrawal by Subject|0|||
19510737|NCT01994382|41920894|FG009|Overall Study|Withdrawal by Subject|0|||
19510738|NCT01994382|41920895|FG010|Overall Study|Withdrawal by Subject|6|||
19510739|NCT01994382|41920896|FG011|Overall Study|Withdrawal by Subject|0|||
19510740|NCT01994382|41920897|FG012|Overall Study|Withdrawal by Subject|2|||
19510741|NCT01994382|41920898|FG013|Overall Study|Withdrawal by Subject|0|||
19617004|NCT00603278|42066767|FG005|Overall Study|Lost to Follow-up|0|||
19510742|NCT01994382|41920899|FG014|Overall Study|Withdrawal by Subject|4|||
19510743|NCT01994382|41920900|FG015|Overall Study|Withdrawal by Subject|3|||
19510744|NCT01994382|41920901|FG016|Overall Study|Withdrawal by Subject|0|||
19510745|NCT01994382|41920885|FG000|Overall Study|Lost to Follow-up|0|||
19510746|NCT01994382|41920886|FG001|Overall Study|Lost to Follow-up|0|||
19510747|NCT01994382|41920887|FG002|Overall Study|Lost to Follow-up|0|||
19510748|NCT01994382|41920888|FG003|Overall Study|Lost to Follow-up|0|||
19510749|NCT01994382|41920889|FG004|Overall Study|Lost to Follow-up|0|||
19510750|NCT01994382|41920890|FG005|Overall Study|Lost to Follow-up|0|||
19510751|NCT01994382|41920891|FG006|Overall Study|Lost to Follow-up|0|||
19510752|NCT01994382|41920892|FG007|Overall Study|Lost to Follow-up|0|||
19510753|NCT01994382|41920893|FG008|Overall Study|Lost to Follow-up|0|||
19510754|NCT01994382|41920894|FG009|Overall Study|Lost to Follow-up|0|||
19617005|NCT00876447|42066783|FG000|Overall Study|Other miscellaneous reasons|3|||
19510755|NCT01994382|41920895|FG010|Overall Study|Lost to Follow-up|1|||
19510756|NCT01994382|41920896|FG011|Overall Study|Lost to Follow-up|0|||
19510757|NCT01994382|41920897|FG012|Overall Study|Lost to Follow-up|0|||
19510758|NCT01994382|41920898|FG013|Overall Study|Lost to Follow-up|0|||
19510759|NCT01994382|41920899|FG014|Overall Study|Lost to Follow-up|0|||
19510760|NCT01994382|41920900|FG015|Overall Study|Lost to Follow-up|0|||
19510761|NCT01994382|41920901|FG016|Overall Study|Lost to Follow-up|0|||
19617006|NCT00876447|42066784|FG001|Overall Study|Other miscellaneous reasons|8|||
19617007|NCT00876447|42066783|FG000|Overall Study|Site closure|19|||
19510762|NCT01994382|41920885|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510763|NCT01994382|41920886|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510764|NCT01994382|41920887|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19617008|NCT00876447|42066784|FG001|Overall Study|Site closure|14|||
19510765|NCT01994382|41920888|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510766|NCT01994382|41920889|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510767|NCT01994382|41920890|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510768|NCT01994382|41920891|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510769|NCT01994382|41920892|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510770|NCT01994382|41920893|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510771|NCT01994382|41920894|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510772|NCT01994382|41920895|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
19510773|NCT01994382|41920896|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510774|NCT01994382|41920897|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
19510775|NCT01994382|41920898|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510776|NCT01994382|41920899|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
19510777|NCT01994382|41920900|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
19510778|NCT01994382|41920901|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
19510779|NCT01994382|41920885|FG000|Overall Study|Protocol violation/noncompliance|0|||
19510780|NCT01994382|41920886|FG001|Overall Study|Protocol violation/noncompliance|0|||
19510781|NCT01994382|41920887|FG002|Overall Study|Protocol violation/noncompliance|0|||
19510782|NCT01994382|41920888|FG003|Overall Study|Protocol violation/noncompliance|0|||
19510783|NCT01994382|41920889|FG004|Overall Study|Protocol violation/noncompliance|0|||
19510784|NCT01994382|41920890|FG005|Overall Study|Protocol violation/noncompliance|0|||
19510785|NCT01994382|41920891|FG006|Overall Study|Protocol violation/noncompliance|0|||
19510786|NCT01994382|41920892|FG007|Overall Study|Protocol violation/noncompliance|0|||
19510787|NCT01994382|41920893|FG008|Overall Study|Protocol violation/noncompliance|0|||
19510788|NCT01994382|41920894|FG009|Overall Study|Protocol violation/noncompliance|0|||
19510789|NCT01994382|41920895|FG010|Overall Study|Protocol violation/noncompliance|0|||
19510790|NCT01994382|41920896|FG011|Overall Study|Protocol violation/noncompliance|1|||
19510791|NCT01994382|41920897|FG012|Overall Study|Protocol violation/noncompliance|0|||
19510792|NCT01994382|41920898|FG013|Overall Study|Protocol violation/noncompliance|0|||
19510793|NCT01994382|41920899|FG014|Overall Study|Protocol violation/noncompliance|0|||
19510794|NCT01994382|41920900|FG015|Overall Study|Protocol violation/noncompliance|0|||
19510795|NCT01994382|41920901|FG016|Overall Study|Protocol violation/noncompliance|2|||
19510796|NCT01994382|41920885|FG000|Overall Study|Rolled over to Phase 2a|0|||
19510797|NCT01994382|41920886|FG001|Overall Study|Rolled over to Phase 2a|0|||
19510798|NCT01994382|41920887|FG002|Overall Study|Rolled over to Phase 2a|1|||
19510799|NCT01994382|41920888|FG003|Overall Study|Rolled over to Phase 2a|0|||
19510800|NCT01994382|41920889|FG004|Overall Study|Rolled over to Phase 2a|0|||
19510801|NCT01994382|41920890|FG005|Overall Study|Rolled over to Phase 2a|0|||
19510802|NCT01994382|41920891|FG006|Overall Study|Rolled over to Phase 2a|0|||
19510803|NCT01994382|41920892|FG007|Overall Study|Rolled over to Phase 2a|0|||
19510804|NCT01994382|41920893|FG008|Overall Study|Rolled over to Phase 2a|0|||
19617009|NCT00876447|42066783|FG000|Overall Study|Protocol Violation|9|||
19617010|NCT00876447|42066784|FG001|Overall Study|Protocol Violation|3|||
19617011|NCT00876447|42066783|FG000|Overall Study|Personal reasons|30|||
19617012|NCT00876447|42066784|FG001|Overall Study|Personal reasons|28|||
19617013|NCT00876447|42066783|FG000|Overall Study|Lost to Follow-up|6|||
19617014|NCT00876447|42066784|FG001|Overall Study|Lost to Follow-up|15|||
19617015|NCT00876447|42066783|FG000|Overall Study|Pregnancy|4|||
19617016|NCT00876447|42066784|FG001|Overall Study|Pregnancy|2|||
19617017|NCT00876447|42066783|FG000|Overall Study|Lack of Efficacy|5|||
19617018|NCT00876447|42066784|FG001|Overall Study|Lack of Efficacy|3|||
19617019|NCT00876447|42066783|FG000|Overall Study|Adverse Event|4|||
19617020|NCT00876447|42066784|FG001|Overall Study|Adverse Event|8|||
19617021|NCT00598650|42066814|FG000|Overall Study|Withdrawal by Subject|3|||
19510805|NCT01994382|41920894|FG009|Overall Study|Rolled over to Phase 2a|2|||
19510806|NCT01994382|41920895|FG010|Overall Study|Rolled over to Phase 2a|0|||
19510807|NCT01994382|41920896|FG011|Overall Study|Rolled over to Phase 2a|0|||
19510808|NCT01994382|41920897|FG012|Overall Study|Rolled over to Phase 2a|0|||
19510809|NCT01994382|41920898|FG013|Overall Study|Rolled over to Phase 2a|0|||
19510810|NCT01994382|41920899|FG014|Overall Study|Rolled over to Phase 2a|0|||
19510811|NCT01994382|41920900|FG015|Overall Study|Rolled over to Phase 2a|0|||
19510812|NCT01994382|41920901|FG016|Overall Study|Rolled over to Phase 2a|0|||
19510813|NCT02003898|41920944|FG000|Overall Study|Death|3|||
19510814|NCT02003898|41920944|FG000|Overall Study|Lost to Follow-up|12|||
19510815|NCT02003898|41920944|FG000|Overall Study|Withdrawal by Subject|52|||
19510816|NCT01994226|41920950|FG000|Overall Study|Protocol Violation|13|||
19510817|NCT01994226|41920951|FG001|Overall Study|Protocol Violation|10|||
19510818|NCT01994226|41920950|FG000|Overall Study|Early Cessation of treatment|6|||
19617022|NCT00598650|42066814|FG000|Overall Study|Adverse Event|18|||
19617023|NCT00598650|42066814|FG000|Overall Study|No treatment for 3 weeks|1|||
19617024|NCT00598650|42066814|FG000|Overall Study|Not eligible|1|||
19617025|NCT00598650|42066814|FG000|Overall Study|Prohibited Concomitant Medication|2|||
19617026|NCT00598650|42066814|FG000|Overall Study|Physician Decision|2|||
19617027|NCT04249076|42066821|FG000|Overall Study|Adverse Event|1|||
19617028|NCT04249076|42066822|FG001|Overall Study|Adverse Event|1|||
19617029|NCT04249076|42066821|FG000|Overall Study|Protocol Violation|1|||
19617030|NCT04249076|42066822|FG001|Overall Study|Protocol Violation|2|||
19617031|NCT04249076|42066821|FG000|Overall Study|Lack of Efficacy|0|||
19617032|NCT04249076|42066822|FG001|Overall Study|Lack of Efficacy|1|||
19617033|NCT04249076|42066821|FG000|Overall Study|Withdrawal by Subject|0|||
19617034|NCT04249076|42066822|FG001|Overall Study|Withdrawal by Subject|1|||
19617035|NCT04150107|42066830|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
19617036|NCT04150107|42066831|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
19617037|NCT04150107|42066830|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
19617038|NCT04150107|42066831|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
19617039|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
19617040|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
19617041|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
19617042|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
19617043|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
19617044|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
19617045|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Death|4|||
19617046|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Death|3|||
19617047|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
19617048|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
19617049|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
19617050|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
19617051|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
19617052|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
19617053|NCT04173494|42066841|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
19617054|NCT04173494|42066842|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
19617055|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
19617056|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
19617057|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
19617058|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
19617059|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
19617060|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
19617061|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
19617062|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
19617063|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Death|3|||
19617064|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Death|1|||
19617065|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
19617066|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
19617067|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
19617068|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
19617069|NCT04173494|42066841|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
19617070|NCT04173494|42066842|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
19617071|NCT00875979|42066850|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
19617072|NCT00875979|42066851|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
19617073|NCT00875979|42066850|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
19617074|NCT00875979|42066851|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
19617075|NCT00875979|42066850|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
19617076|NCT00875979|42066851|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
19617077|NCT00875979|42066850|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
19617078|NCT00875979|42066851|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
19617079|NCT00875979|42066850|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
19617080|NCT00875979|42066851|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
19617081|NCT00875979|42066850|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
19617082|NCT00875979|42066851|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
19617083|NCT00875979|42066850|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
19617084|NCT00875979|42066851|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
19617085|NCT00875979|42066850|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
19617086|NCT00875979|42066851|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
19617087|NCT00875979|42066850|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
19617088|NCT00875979|42066851|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
19617089|NCT00602420|42066859|FG000|Overall Study|Death|1|||
19617090|NCT00602420|42066860|FG001|Overall Study|Death|4|||
19617091|NCT00602420|42066859|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
19617092|NCT00602420|42066860|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
19617093|NCT00602420|42066859|FG000|Overall Study|Withdrawal by Subject|18|||
19617094|NCT00602420|42066860|FG001|Overall Study|Withdrawal by Subject|17|||
19617095|NCT00602420|42066859|FG000|Overall Study|Adverse Event|1|||
19617096|NCT00602420|42066860|FG001|Overall Study|Adverse Event|0|||
19617097|NCT00875667|42066874|FG000|Overall Study|Adverse Event|29|||
19617098|NCT00875667|42066875|FG001|Overall Study|Adverse Event|10|||
19617099|NCT00875667|42066874|FG000|Overall Study|Withdrawal by Subject|17|||
19617100|NCT00875667|42066875|FG001|Overall Study|Withdrawal by Subject|5|||
19617101|NCT00875667|42066874|FG000|Overall Study|Death|7|||
19617102|NCT00875667|42066875|FG001|Overall Study|Death|2|||
19617103|NCT00875667|42066874|FG000|Overall Study|Protocol Violation|2|||
19617104|NCT00875667|42066875|FG001|Overall Study|Protocol Violation|0|||
19617105|NCT00875667|42066874|FG000|Overall Study|Disease Progression|100|||
19617106|NCT00875667|42066875|FG001|Overall Study|Disease Progression|49|||
19617107|NCT00875667|42066874|FG000|Overall Study|Miscellaneous|12|||
19617108|NCT00875667|42066875|FG001|Overall Study|Miscellaneous|6|||
19617109|NCT00875667|42066874|FG000|Overall Study|Randomized but no Study Drug Given|3|||
19617110|NCT00875667|42066875|FG001|Overall Study|Randomized but no Study Drug Given|1|||
19617111|NCT00602030|42066885|FG000|Lead-in Phase|Disease Progression|2|||
19617112|NCT00602030|42066886|FG001|Lead-in Phase|Disease Progression|3|||
19617113|NCT00602030|42066887|FG002|Lead-in Phase|Disease Progression|0|||
19617114|NCT00602030|42066888|FG003|Lead-in Phase|Disease Progression|0|||
19617115|NCT00602030|42066889|FG004|Lead-in Phase|Disease Progression|0|||
19617116|NCT00602030|42066885|FG000|Lead-in Phase|Adverse Event|0|||
19617117|NCT00602030|42066886|FG001|Lead-in Phase|Adverse Event|2|||
19617118|NCT00602030|42066887|FG002|Lead-in Phase|Adverse Event|0|||
19617119|NCT00602030|42066888|FG003|Lead-in Phase|Adverse Event|0|||
19617120|NCT00602030|42066889|FG004|Lead-in Phase|Adverse Event|0|||
19617121|NCT00602030|42066885|FG000|Double-blind Phase|Disease progression|0|||
19617122|NCT00602030|42066886|FG001|Double-blind Phase|Disease progression|0|||
19617123|NCT00602030|42066887|FG002|Double-blind Phase|Disease progression|33|||
19617124|NCT00602030|42066888|FG003|Double-blind Phase|Disease progression|30|||
19617125|NCT00602030|42066889|FG004|Double-blind Phase|Disease progression|0|||
19617126|NCT00602030|42066885|FG000|Double-blind Phase|Adverse Event|0|||
19617127|NCT00602030|42066886|FG001|Double-blind Phase|Adverse Event|0|||
19617128|NCT00602030|42066887|FG002|Double-blind Phase|Adverse Event|9|||
19617129|NCT00602030|42066888|FG003|Double-blind Phase|Adverse Event|18|||
19617130|NCT00602030|42066889|FG004|Double-blind Phase|Adverse Event|0|||
19617131|NCT00602030|42066885|FG000|Double-blind Phase|Consent withdrawal|0|||
19617132|NCT00602030|42066886|FG001|Double-blind Phase|Consent withdrawal|0|||
19617133|NCT00602030|42066887|FG002|Double-blind Phase|Consent withdrawal|4|||
19617134|NCT00602030|42066888|FG003|Double-blind Phase|Consent withdrawal|3|||
19617135|NCT00602030|42066889|FG004|Double-blind Phase|Consent withdrawal|0|||
19617136|NCT00602030|42066885|FG000|Double-blind Phase|Death|0|||
19617137|NCT00602030|42066886|FG001|Double-blind Phase|Death|0|||
19617138|NCT00602030|42066887|FG002|Double-blind Phase|Death|3|||
19617139|NCT00602030|42066888|FG003|Double-blind Phase|Death|3|||
19617140|NCT00602030|42066889|FG004|Double-blind Phase|Death|0|||
19617141|NCT00602030|42066885|FG000|Double-blind Phase|Administrative decision|0|||
19617142|NCT00602030|42066886|FG001|Double-blind Phase|Administrative decision|0|||
19617143|NCT00602030|42066887|FG002|Double-blind Phase|Administrative decision|0|||
19617144|NCT00602030|42066888|FG003|Double-blind Phase|Administrative decision|2|||
19617145|NCT00602030|42066889|FG004|Double-blind Phase|Administrative decision|0|||
19617146|NCT00602030|42066885|FG000|Double-blind Phase|Ineligibility|0|||
19617147|NCT00602030|42066886|FG001|Double-blind Phase|Ineligibility|0|||
19617148|NCT00602030|42066887|FG002|Double-blind Phase|Ineligibility|0|||
19617149|NCT00602030|42066888|FG003|Double-blind Phase|Ineligibility|1|||
19617150|NCT00602030|42066889|FG004|Double-blind Phase|Ineligibility|0|||
19617151|NCT00602030|42066885|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
19617152|NCT00602030|42066886|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
19617153|NCT00602030|42066887|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
19617154|NCT00602030|42066888|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
19617155|NCT00602030|42066889|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
19617156|NCT00602030|42066885|FG000|Double-blind Phase|Reason not specified|0|||
19617157|NCT00602030|42066886|FG001|Double-blind Phase|Reason not specified|0|||
19617158|NCT00602030|42066887|FG002|Double-blind Phase|Reason not specified|4|||
19617159|NCT00602030|42066888|FG003|Double-blind Phase|Reason not specified|2|||
19617160|NCT00602030|42066889|FG004|Double-blind Phase|Reason not specified|0|||
19617161|NCT00602030|42066885|FG000|Crossover Phase|Disease Progression|0|||
19617162|NCT00602030|42066886|FG001|Crossover Phase|Disease Progression|0|||
19617163|NCT00602030|42066887|FG002|Crossover Phase|Disease Progression|0|||
19617164|NCT00602030|42066888|FG003|Crossover Phase|Disease Progression|0|||
19617165|NCT00602030|42066889|FG004|Crossover Phase|Disease Progression|11|||
19617166|NCT00602030|42066885|FG000|Crossover Phase|Adverse Event|0|||
19617167|NCT00602030|42066886|FG001|Crossover Phase|Adverse Event|0|||
19617168|NCT00602030|42066887|FG002|Crossover Phase|Adverse Event|0|||
19617169|NCT00602030|42066888|FG003|Crossover Phase|Adverse Event|0|||
19617170|NCT00602030|42066889|FG004|Crossover Phase|Adverse Event|3|||
19617171|NCT00602030|42066885|FG000|Crossover Phase|Consent withdrawal|0|||
19617172|NCT00602030|42066886|FG001|Crossover Phase|Consent withdrawal|0|||
19617173|NCT00602030|42066887|FG002|Crossover Phase|Consent withdrawal|0|||
19617174|NCT00602030|42066888|FG003|Crossover Phase|Consent withdrawal|0|||
19617175|NCT00602030|42066889|FG004|Crossover Phase|Consent withdrawal|2|||
19617176|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
19617177|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
19617178|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
19617179|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
19617180|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
19617181|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
19617182|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
19617183|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
19617184|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
19617185|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
19617186|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
19617187|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
19617188|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
19617189|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
19617190|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
19617191|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
19617192|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
19617193|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
19617194|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
19704601|NCT00129402|42148929|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19510819|NCT01994226|41920951|FG001|Overall Study|Early Cessation of treatment|11|||
19510820|NCT02002884|41920960|FG000|Main Period (MP)|Other|0|||
19510821|NCT02002884|41920961|FG001|Main Period (MP)|Other|3|||
19510822|NCT02002884|41920962|FG002|Main Period (MP)|Other|3|||
19510823|NCT02002884|41920963|FG003|Main Period (MP)|Other|0|||
19510824|NCT02002884|41920960|FG000|Main Period (MP)|Adverse Event|0|||
19510825|NCT02002884|41920961|FG001|Main Period (MP)|Adverse Event|1|||
19510826|NCT02002884|41920962|FG002|Main Period (MP)|Adverse Event|1|||
19510827|NCT02002884|41920963|FG003|Main Period (MP)|Adverse Event|0|||
19510828|NCT02002884|41920960|FG000|Main Period (MP)|Withdrawal by Subject|6|||
19510829|NCT02002884|41920961|FG001|Main Period (MP)|Withdrawal by Subject|2|||
19510830|NCT02002884|41920962|FG002|Main Period (MP)|Withdrawal by Subject|2|||
19510831|NCT02002884|41920963|FG003|Main Period (MP)|Withdrawal by Subject|0|||
19510832|NCT02002884|41920960|FG000|Main Period (MP)|Lost to Follow-up|0|||
19510833|NCT02002884|41920961|FG001|Main Period (MP)|Lost to Follow-up|0|||
19510834|NCT02002884|41920962|FG002|Main Period (MP)|Lost to Follow-up|2|||
19510835|NCT02002884|41920963|FG003|Main Period (MP)|Lost to Follow-up|0|||
19510836|NCT02002884|41920960|FG000|Open-Label Extension Period (OLEX)|Other|0|||
19510837|NCT02002884|41920961|FG001|Open-Label Extension Period (OLEX)|Other|0|||
19510838|NCT02002884|41920962|FG002|Open-Label Extension Period (OLEX)|Other|0|||
19510839|NCT02002884|41920963|FG003|Open-Label Extension Period (OLEX)|Other|24|||
19510840|NCT02002884|41920960|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
19510841|NCT02002884|41920961|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
19510842|NCT02002884|41920962|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
19510843|NCT02002884|41920963|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
19510844|NCT02002884|41920960|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
19510845|NCT02002884|41920961|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
19510846|NCT02002884|41920962|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
19510847|NCT02002884|41920963|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
19510848|NCT02002884|41920960|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
19510849|NCT02002884|41920961|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
19510850|NCT02002884|41920962|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
19510851|NCT02002884|41920963|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
19510852|NCT02002884|41920960|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
19510853|NCT02002884|41920961|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
19510854|NCT02002884|41920962|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
19510855|NCT02002884|41920963|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
19510856|NCT02002182|41920975|FG000|Overall Study|Withdraw from study|3|||
19617195|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
19617196|NCT00549757|42066903|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
19617197|NCT00549757|42066904|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
19617198|NCT00549757|42066903|FG000|Extension Period (in Average 9 Months)|Death|143|||
19510857|NCT02002182|41920976|FG001|Overall Study|Withdraw from study|1|||
19510858|NCT02002182|41920975|FG000|Overall Study|Health Reasons|1|||
19510859|NCT02002182|41920976|FG001|Overall Study|Health Reasons|0|||
19510860|NCT02002182|41920975|FG000|Overall Study|Death|1|||
19510861|NCT02002182|41920976|FG001|Overall Study|Death|0|||
19510862|NCT01990950|41920982|FG000|Overall Study|Death|3|||
19510863|NCT01990950|41920982|FG000|Overall Study|Lost to Follow-up|2|||
19510864|NCT01990950|41920982|FG000|Overall Study|Withdrawal by Subject|6|||
19510865|NCT02001558|41920988|FG000|Overall Study|Lost to Follow-up|8|||
19510866|NCT02001558|41920989|FG001|Overall Study|Lost to Follow-up|14|||
19510867|NCT02023866|41920995|FG000|Overall Study|Non-compliance|2|||
19510868|NCT02023866|41920995|FG000|Overall Study|Adverse Event|3|||
19510869|NCT02023866|41920995|FG000|Overall Study|Withdrawal by Subject|1|||
19510870|NCT02023242|41921001|FG000|Overall Study|Lost to Follow-up|3|||
19510871|NCT02023242|41921002|FG001|Overall Study|Lost to Follow-up|1|||
19510872|NCT02023242|41921001|FG000|Overall Study|Death|0|||
19510873|NCT02023242|41921002|FG001|Overall Study|Death|1|||
19510874|NCT01967940|41921011|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
19510875|NCT01967940|41921012|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
19510876|NCT01967940|41921013|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
19510877|NCT01967940|41921014|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
19394138|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
19394139|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
19394140|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
19394141|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
19510878|NCT01967940|41921011|FG000|Part 2|Adverse Event|0|||
19510879|NCT01967940|41921012|FG001|Part 2|Adverse Event|0|||
19510880|NCT01967940|41921013|FG002|Part 2|Adverse Event|0|||
19510881|NCT01967940|41921014|FG003|Part 2|Adverse Event|1|||
19510882|NCT01967940|41921011|FG000|Part 2|Unknown Reason|0|||
19510883|NCT01967940|41921012|FG001|Part 2|Unknown Reason|0|||
19510884|NCT01967940|41921013|FG002|Part 2|Unknown Reason|0|||
19510885|NCT01967940|41921014|FG003|Part 2|Unknown Reason|1|||
19510886|NCT01990560|41921024|FG000|Overall Study|Withdrawal by Subject|1|||
19510887|NCT01999218|41921031|FG000|Overall Study|Hyperglycemia|18|||
19510888|NCT01999218|41921032|FG001|Overall Study|Hyperglycemia|17|||
19510889|NCT01999218|41921033|FG002|Overall Study|Hyperglycemia|17|||
19510890|NCT01999218|41921031|FG000|Overall Study|Lack of Efficacy|1|||
19510891|NCT01999218|41921032|FG001|Overall Study|Lack of Efficacy|0|||
19510892|NCT01999218|41921033|FG002|Overall Study|Lack of Efficacy|1|||
19510893|NCT01999218|41921031|FG000|Overall Study|Lost to Follow-up|22|||
19510894|NCT01999218|41921032|FG001|Overall Study|Lost to Follow-up|17|||
19510895|NCT01999218|41921033|FG002|Overall Study|Lost to Follow-up|18|||
19510896|NCT01999218|41921031|FG000|Overall Study|Non-Compliance With Study Drug|6|||
19510897|NCT01999218|41921032|FG001|Overall Study|Non-Compliance With Study Drug|4|||
19510898|NCT01999218|41921033|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19510899|NCT01999218|41921031|FG000|Overall Study|Physician Decision|1|||
19510900|NCT01999218|41921032|FG001|Overall Study|Physician Decision|4|||
19510901|NCT01999218|41921033|FG002|Overall Study|Physician Decision|6|||
19510902|NCT01999218|41921031|FG000|Overall Study|Protocol Violation|4|||
19510903|NCT01999218|41921032|FG001|Overall Study|Protocol Violation|5|||
19510904|NCT01999218|41921033|FG002|Overall Study|Protocol Violation|4|||
19510905|NCT01999218|41921031|FG000|Overall Study|Screen failure|0|||
19510906|NCT01999218|41921032|FG001|Overall Study|Screen failure|1|||
19510907|NCT01999218|41921033|FG002|Overall Study|Screen failure|0|||
19510908|NCT01999218|41921031|FG000|Overall Study|Study Terminated By Sponsor|7|||
19510909|NCT01999218|41921032|FG001|Overall Study|Study Terminated By Sponsor|5|||
19510910|NCT01999218|41921033|FG002|Overall Study|Study Terminated By Sponsor|12|||
19510911|NCT01999218|41921031|FG000|Overall Study|Participant moves|2|||
19510912|NCT01999218|41921032|FG001|Overall Study|Participant moves|5|||
19510913|NCT01999218|41921033|FG002|Overall Study|Participant moves|3|||
19510914|NCT01999218|41921031|FG000|Overall Study|Withdrawal by Subject|28|||
19510915|NCT01999218|41921032|FG001|Overall Study|Withdrawal by Subject|29|||
19510916|NCT01999218|41921033|FG002|Overall Study|Withdrawal by Subject|34|||
19510917|NCT01999218|41921031|FG000|Overall Study|Creatinine/eGFR|0|||
19510918|NCT01999218|41921032|FG001|Overall Study|Creatinine/eGFR|0|||
19510919|NCT01999218|41921033|FG002|Overall Study|Creatinine/eGFR|1|||
19510920|NCT01999218|41921031|FG000|Overall Study|Death|7|||
19510921|NCT01999218|41921032|FG001|Overall Study|Death|1|||
19510922|NCT01999218|41921033|FG002|Overall Study|Death|2|||
19510923|NCT01999218|41921031|FG000|Overall Study|Excluded Medication|1|||
19510924|NCT01999218|41921032|FG001|Overall Study|Excluded Medication|1|||
19510925|NCT01999218|41921033|FG002|Overall Study|Excluded Medication|2|||
19510926|NCT01999218|41921031|FG000|Overall Study|Adverse Event|9|||
19510927|NCT01999218|41921032|FG001|Overall Study|Adverse Event|7|||
19510928|NCT01999218|41921033|FG002|Overall Study|Adverse Event|7|||
19617199|NCT00549757|42066904|FG001|Extension Period (in Average 9 Months)|Death|136|||
19617200|NCT00549757|42066903|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
19617201|NCT00549757|42066904|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
19617202|NCT00549757|42066903|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
19617203|NCT00549757|42066904|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
19617204|NCT00549757|42066903|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
19617205|NCT00549757|42066904|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
19617206|NCT00549601|42066919|FG000|Randomized|Protocol Violation|0|||
19617207|NCT00549601|42066920|FG001|Randomized|Protocol Violation|0|||
19617208|NCT00549601|42066921|FG002|Randomized|Protocol Violation|1|||
19617209|NCT00549601|42066919|FG000|Randomized|Withdrawal by Subject|0|||
19617210|NCT00549601|42066920|FG001|Randomized|Withdrawal by Subject|1|||
19617211|NCT00549601|42066921|FG002|Randomized|Withdrawal by Subject|1|||
19617212|NCT00549601|42066919|FG000|Received Study Drug|Adverse Event|2|||
19617213|NCT00549601|42066920|FG001|Received Study Drug|Adverse Event|5|||
19617214|NCT00549601|42066921|FG002|Received Study Drug|Adverse Event|1|||
19617215|NCT00549601|42066919|FG000|Received Study Drug|Death|0|||
19617216|NCT00549601|42066920|FG001|Received Study Drug|Death|1|||
19510929|NCT01999218|41921031|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
19510930|NCT01999218|41921032|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
19510931|NCT01999218|41921033|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
19510932|NCT01998984|41921045|FG000|Overall Study|Adverse Event|0|||
19510933|NCT01998984|41921046|FG001|Overall Study|Adverse Event|0|||
19510934|NCT01998984|41921047|FG002|Overall Study|Adverse Event|0|||
19510935|NCT01998984|41921048|FG003|Overall Study|Adverse Event|1|||
19510936|NCT01998984|41921045|FG000|Overall Study|Lost to Follow-up|0|||
19510937|NCT01998984|41921046|FG001|Overall Study|Lost to Follow-up|1|||
19617217|NCT00549601|42066921|FG002|Received Study Drug|Death|0|||
19617218|NCT00549601|42066919|FG000|Received Study Drug|Lost to Follow-up|0|||
19617219|NCT00549601|42066920|FG001|Received Study Drug|Lost to Follow-up|1|||
19617220|NCT00549601|42066921|FG002|Received Study Drug|Lost to Follow-up|1|||
19617221|NCT00549601|42066919|FG000|Received Study Drug|Protocol Violation|3|||
19510938|NCT01998984|41921047|FG002|Overall Study|Lost to Follow-up|0|||
19510939|NCT01998984|41921048|FG003|Overall Study|Lost to Follow-up|1|||
19510940|NCT01998984|41921045|FG000|Overall Study|Withdrawal by Subject|0|||
19510941|NCT01998984|41921046|FG001|Overall Study|Withdrawal by Subject|0|||
19510942|NCT01998984|41921047|FG002|Overall Study|Withdrawal by Subject|1|||
19510943|NCT01998984|41921048|FG003|Overall Study|Withdrawal by Subject|0|||
19510944|NCT01998984|41921045|FG000|Overall Study|Other|0|||
19510945|NCT01998984|41921046|FG001|Overall Study|Other|0|||
19510946|NCT01998984|41921047|FG002|Overall Study|Other|0|||
19510947|NCT01998984|41921048|FG003|Overall Study|Other|1|||
19510948|NCT01967706|41921060|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
19510949|NCT01967706|41921061|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
19617222|NCT00549601|42066920|FG001|Received Study Drug|Protocol Violation|4|||
19617223|NCT00549601|42066921|FG002|Received Study Drug|Protocol Violation|1|||
19617224|NCT00549601|42066919|FG000|Received Study Drug|Withdrawal by Subject|2|||
19617225|NCT00549601|42066920|FG001|Received Study Drug|Withdrawal by Subject|0|||
19617226|NCT00549601|42066921|FG002|Received Study Drug|Withdrawal by Subject|1|||
19617227|NCT00601640|42066947|FG000|Overall Study|Withdrawal by Subject|3|||
19617228|NCT00601640|42066948|FG001|Overall Study|Withdrawal by Subject|0|||
19617229|NCT00601640|42066949|FG002|Overall Study|Withdrawal by Subject|7|||
19617230|NCT00601640|42066947|FG000|Overall Study|Death|1|||
19617231|NCT00601640|42066948|FG001|Overall Study|Death|0|||
19510950|NCT01967706|41921062|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
19510951|NCT01967706|41921063|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
19510952|NCT01967628|41921074|FG000|Overall Study|Withdrawal by Subject|2|||
19510953|NCT01967628|41921075|FG001|Overall Study|Withdrawal by Subject|0|||
19510954|NCT01967628|41921074|FG000|Overall Study|Unable to complete bronchoscopy|4|||
19510955|NCT01967628|41921075|FG001|Overall Study|Unable to complete bronchoscopy|6|||
19510956|NCT01967628|41921074|FG000|Overall Study|Lost to Follow-up|1|||
19510957|NCT01967628|41921075|FG001|Overall Study|Lost to Follow-up|0|||
19510958|NCT01967628|41921074|FG000|Overall Study|Low protein concentration in sample|20|||
19510959|NCT01967628|41921075|FG001|Overall Study|Low protein concentration in sample|25|||
19510960|NCT01998906|41921084|FG000|Overall Study|Participants ongoing in follow-up|77|||
19510961|NCT01998906|41921085|FG001|Overall Study|Participants ongoing in follow-up|60|||
19510962|NCT01998906|41921086|FG002|Overall Study|Participants ongoing in follow-up|58|||
19510963|NCT01998906|41921084|FG000|Overall Study|Death|21|||
19510964|NCT01998906|41921085|FG001|Overall Study|Death|30|||
19510965|NCT01998906|41921086|FG002|Overall Study|Death|17|||
19510966|NCT01998906|41921084|FG000|Overall Study|Lack of Efficacy|10|||
19510967|NCT01998906|41921085|FG001|Overall Study|Lack of Efficacy|9|||
19510968|NCT01998906|41921086|FG002|Overall Study|Lack of Efficacy|8|||
19510969|NCT01998906|41921084|FG000|Overall Study|Failure to return|0|||
19510970|NCT01998906|41921085|FG001|Overall Study|Failure to return|2|||
19510971|NCT01998906|41921086|FG002|Overall Study|Failure to return|4|||
19510972|NCT01998906|41921084|FG000|Overall Study|Violation of Selection Criteria|0|||
19510973|NCT01998906|41921085|FG001|Overall Study|Violation of Selection Criteria|0|||
19510974|NCT01998906|41921086|FG002|Overall Study|Violation of Selection Criteria|1|||
19617232|NCT00601640|42066949|FG002|Overall Study|Death|0|||
19617233|NCT00601640|42066947|FG000|Overall Study|Adverse Event|0|||
19617234|NCT00601640|42066948|FG001|Overall Study|Adverse Event|4|||
19617235|NCT00601640|42066949|FG002|Overall Study|Adverse Event|2|||
19617236|NCT00601640|42066947|FG000|Overall Study|intercurrent illness|1|||
19510975|NCT01998906|41921084|FG000|Overall Study|Withdrawal by Subject|1|||
19510976|NCT01998906|41921085|FG001|Overall Study|Withdrawal by Subject|4|||
19510977|NCT01998906|41921086|FG002|Overall Study|Withdrawal by Subject|3|||
19510978|NCT01998906|41921084|FG000|Overall Study|Administrative/Other|2|||
19510979|NCT01998906|41921085|FG001|Overall Study|Administrative/Other|1|||
19510980|NCT01998906|41921086|FG002|Overall Study|Administrative/Other|3|||
19510981|NCT01998906|41921084|FG000|Overall Study|Other|3|||
19510982|NCT01998906|41921085|FG001|Overall Study|Other|8|||
19510983|NCT01998906|41921086|FG002|Overall Study|Other|4|||
19510984|NCT01967550|41921099|FG000|Overall Study|Withdrawal by Subject|1|||
19510985|NCT01967550|41921100|FG001|Overall Study|Withdrawal by Subject|0|||
19510986|NCT01967550|41921099|FG000|Overall Study|Adverse Event|2|||
19510987|NCT01967550|41921100|FG001|Overall Study|Adverse Event|0|||
19510988|NCT01967550|41921099|FG000|Overall Study|Protocol Violation|2|||
19510989|NCT01967550|41921100|FG001|Overall Study|Protocol Violation|1|||
19510990|NCT01967550|41921099|FG000|Overall Study|Non Compliance|0|||
19510991|NCT01967550|41921100|FG001|Overall Study|Non Compliance|1|||
19510992|NCT01989546|41921106|FG000|Overall Study|Clinical Progression|1|||
19510993|NCT01989546|41921106|FG000|Overall Study|Disease progression on study|8|||
19510994|NCT01997892|41921110|FG000|Overall Study|Physician Decision|2|||
19617237|NCT00601640|42066948|FG001|Overall Study|intercurrent illness|0|||
19617238|NCT00601640|42066949|FG002|Overall Study|intercurrent illness|0|||
19617239|NCT00601640|42066947|FG000|Overall Study|change in eligibility status|0|||
19617240|NCT00601640|42066948|FG001|Overall Study|change in eligibility status|1|||
19617241|NCT00601640|42066949|FG002|Overall Study|change in eligibility status|1|||
19617242|NCT02805725|42066964|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
19617243|NCT02805725|42066965|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
19617244|NCT02805725|42066966|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
19617245|NCT02805725|42066967|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
19617246|NCT02805725|42066968|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
19617247|NCT02805725|42066964|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
19617248|NCT02805725|42066965|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
19617249|NCT02805725|42066966|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
19617250|NCT02805725|42066967|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
19617251|NCT02805725|42066968|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
19617252|NCT02805725|42066964|FG000|Phase II|Protocol Violation|0|||
19617253|NCT02805725|42066965|FG001|Phase II|Protocol Violation|0|||
19617254|NCT02805725|42066966|FG002|Phase II|Protocol Violation|0|||
19617255|NCT02805725|42066967|FG003|Phase II|Protocol Violation|0|||
19617256|NCT02805725|42066968|FG004|Phase II|Protocol Violation|6|||
19617257|NCT00546871|42066985|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
19510995|NCT01997892|41921110|FG000|Overall Study|Lost to Follow-up|6|||
19510996|NCT01997892|41921110|FG000|Overall Study|Death|14|||
19510997|NCT01997892|41921110|FG000|Overall Study|Renal transplant|8|||
19510998|NCT01997892|41921110|FG000|Overall Study|Other|3|||
19510999|NCT01997892|41921110|FG000|Overall Study|Study completion data not recorded|35|||
19511000|NCT01989468|41921122|FG000|Overall Study|Adverse Event|10|||
19511001|NCT01989468|41921123|FG001|Overall Study|Adverse Event|15|||
19511002|NCT01989468|41921124|FG002|Overall Study|Adverse Event|4|||
19511003|NCT01989468|41921125|FG003|Overall Study|Adverse Event|5|||
19511004|NCT01989468|41921126|FG004|Overall Study|Adverse Event|4|||
19511005|NCT01989468|41921122|FG000|Overall Study|Lack of Efficacy|11|||
19511006|NCT01989468|41921123|FG001|Overall Study|Lack of Efficacy|11|||
19511007|NCT01989468|41921124|FG002|Overall Study|Lack of Efficacy|7|||
19511008|NCT01989468|41921125|FG003|Overall Study|Lack of Efficacy|4|||
19511009|NCT01989468|41921126|FG004|Overall Study|Lack of Efficacy|2|||
19511010|NCT01989468|41921122|FG000|Overall Study|Lost to Follow-up|5|||
19511011|NCT01989468|41921123|FG001|Overall Study|Lost to Follow-up|2|||
19511012|NCT01989468|41921124|FG002|Overall Study|Lost to Follow-up|0|||
19511013|NCT01989468|41921125|FG003|Overall Study|Lost to Follow-up|1|||
19511014|NCT01989468|41921126|FG004|Overall Study|Lost to Follow-up|1|||
19511015|NCT01989468|41921122|FG000|Overall Study|Physician Decision|4|||
19511016|NCT01989468|41921123|FG001|Overall Study|Physician Decision|1|||
19511017|NCT01989468|41921124|FG002|Overall Study|Physician Decision|0|||
19511018|NCT01989468|41921125|FG003|Overall Study|Physician Decision|1|||
19511019|NCT01989468|41921126|FG004|Overall Study|Physician Decision|0|||
19511020|NCT01989468|41921122|FG000|Overall Study|Pregnancy|0|||
19511021|NCT01989468|41921123|FG001|Overall Study|Pregnancy|1|||
19511022|NCT01989468|41921124|FG002|Overall Study|Pregnancy|0|||
19511023|NCT01989468|41921125|FG003|Overall Study|Pregnancy|0|||
19511024|NCT01989468|41921126|FG004|Overall Study|Pregnancy|0|||
19511025|NCT01989468|41921122|FG000|Overall Study|Technical Problems|3|||
19511026|NCT01989468|41921123|FG001|Overall Study|Technical Problems|1|||
19511027|NCT01989468|41921124|FG002|Overall Study|Technical Problems|3|||
19511028|NCT01989468|41921125|FG003|Overall Study|Technical Problems|1|||
19511029|NCT01989468|41921126|FG004|Overall Study|Technical Problems|0|||
19617258|NCT00546871|42066986|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
19617259|NCT00546871|42066985|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
19511030|NCT01989468|41921122|FG000|Overall Study|Subject Guardian Decision|11|||
19511031|NCT01989468|41921123|FG001|Overall Study|Subject Guardian Decision|6|||
19511032|NCT01989468|41921124|FG002|Overall Study|Subject Guardian Decision|4|||
19511033|NCT01989468|41921125|FG003|Overall Study|Subject Guardian Decision|4|||
19511034|NCT01989468|41921126|FG004|Overall Study|Subject Guardian Decision|1|||
19511035|NCT01989468|41921122|FG000|Overall Study|Death|3|||
19511036|NCT01989468|41921123|FG001|Overall Study|Death|0|||
19511037|NCT01989468|41921124|FG002|Overall Study|Death|1|||
19511038|NCT01989468|41921125|FG003|Overall Study|Death|0|||
19511039|NCT01989468|41921126|FG004|Overall Study|Death|0|||
19511040|NCT01989156|41921142|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
19511041|NCT01989156|41921143|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
19511042|NCT01989156|41921144|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
19511043|NCT01989156|41921142|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
19511044|NCT01989156|41921143|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
19617260|NCT00546871|42066986|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
19617261|NCT00546871|42066985|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
19617262|NCT00546871|42066986|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
19617263|NCT00546871|42066985|FG000|Study Extension Period|Protocol Violation|1|||
19617264|NCT00546871|42066986|FG001|Study Extension Period|Protocol Violation|0|||
19617265|NCT00546871|42066985|FG000|Study Extension Period|Withdrawal by Subject|0|||
19617266|NCT00546871|42066986|FG001|Study Extension Period|Withdrawal by Subject|1|||
19617267|NCT03951805|42067019|FG000|Overall Study|Adverse Event|1|||
19617268|NCT03951805|42067020|FG001|Overall Study|Adverse Event|0|||
19617269|NCT03951805|42067021|FG002|Overall Study|Adverse Event|0|||
19617270|NCT03951805|42067022|FG003|Overall Study|Adverse Event|0|||
19617271|NCT03944707|42067034|FG000|Overall Study|Adverse Event|0|||
19617272|NCT03944707|42067035|FG001|Overall Study|Adverse Event|2|||
19617273|NCT03944707|42067034|FG000|Overall Study|Study terminated by sponsor|12|||
19617274|NCT03944707|42067035|FG001|Overall Study|Study terminated by sponsor|7|||
19617275|NCT03944707|42067034|FG000|Overall Study|Subject decision|0|||
19617276|NCT03944707|42067035|FG001|Overall Study|Subject decision|1|||
19617277|NCT00549055|42067041|FG000|Overall Study|Adverse Event|4|||
19617278|NCT00549055|42067041|FG000|Overall Study|Lack of Efficacy|18|||
19617279|NCT00549055|42067041|FG000|Overall Study|Stabilization|5|||
19617280|NCT00549055|42067041|FG000|Overall Study|Progression to fibrosis|2|||
19617281|NCT00549055|42067041|FG000|Overall Study|Decrease of size|1|||
19617282|NCT00549055|42067041|FG000|Overall Study|Active choroidal neovascula increased|1|||
19617283|NCT00549055|42067041|FG000|Overall Study|Vitreous hemorrhage|1|||
19617284|NCT00549055|42067041|FG000|Overall Study|Growth choroidal neovascularisation|1|||
19617285|NCT00549055|42067041|FG000|Overall Study|Choroidal neovascularization|1|||
19617286|NCT00549055|42067041|FG000|Overall Study|Very low visual acuity (VA)|1|||
19617287|NCT00883116|42067047|FG000|Overall Study|Adverse event unrelated to study drug|5|||
19617288|NCT00883116|42067048|FG001|Overall Study|Adverse event unrelated to study drug|10|||
19617289|NCT00883116|42067047|FG000|Overall Study|Death|6|||
19617290|NCT00883116|42067048|FG001|Overall Study|Death|2|||
19617291|NCT00883116|42067047|FG000|Overall Study|Disease progression|130|||
19617292|NCT00883116|42067048|FG001|Overall Study|Disease progression|128|||
19617293|NCT00883116|42067047|FG000|Overall Study|Lost to Follow-up|0|||
19617294|NCT00883116|42067048|FG001|Overall Study|Lost to Follow-up|1|||
19617295|NCT00883116|42067047|FG000|Overall Study|Maximum clinical benefit|13|||
19617296|NCT00883116|42067048|FG001|Overall Study|Maximum clinical benefit|46|||
19617297|NCT00883116|42067047|FG000|Overall Study|Not identified|3|||
19617298|NCT00883116|42067048|FG001|Overall Study|Not identified|6|||
19617299|NCT00883116|42067047|FG000|Overall Study|Study drug toxicity|36|||
19617300|NCT00883116|42067048|FG001|Overall Study|Study drug toxicity|16|||
19617301|NCT00883116|42067047|FG000|Overall Study|Withdrawal by Subject|14|||
19617302|NCT00883116|42067048|FG001|Overall Study|Withdrawal by Subject|8|||
19617303|NCT00883116|42067047|FG000|Overall Study|No longer meets study criteria|2|||
19617304|NCT00883116|42067048|FG001|Overall Study|No longer meets study criteria|2|||
19617305|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
19617306|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
19617307|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
19617308|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
19617309|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
19617310|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
19617311|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Personal issues|2|||
19617312|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Personal issues|0|||
19617313|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Personal issues|0|||
19617314|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Too busy|7|||
19617315|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Too busy|1|||
19617316|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Too busy|0|||
19617317|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Pain|2|||
19617318|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Pain|0|||
19511045|NCT01989156|41921144|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
19511046|NCT01989156|41921142|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
19511047|NCT01989156|41921143|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
19511048|NCT01989156|41921144|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
19511049|NCT01989156|41921142|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
19511050|NCT01989156|41921143|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
19511051|NCT01989156|41921144|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
19511052|NCT01989156|41921142|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
19511053|NCT01989156|41921143|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
19511054|NCT01989156|41921144|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
19511055|NCT01989156|41921142|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
19511056|NCT01989156|41921143|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
19511057|NCT01989156|41921144|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
19511058|NCT01989156|41921142|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
19511059|NCT01989156|41921143|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
19511060|NCT01989156|41921144|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
19511061|NCT01989156|41921142|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
19511062|NCT01989156|41921143|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
19511063|NCT01989156|41921144|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
19511064|NCT01620762|41921155|FG000|Overall Study|Protocol Violation|1|||
19511065|NCT01620762|41921156|FG001|Overall Study|Protocol Violation|1|||
19511066|NCT01620762|41921157|FG002|Overall Study|Protocol Violation|1|||
19511067|NCT01620762|41921155|FG000|Overall Study|Adverse Event|9|||
19511068|NCT01620762|41921156|FG001|Overall Study|Adverse Event|5|||
19511069|NCT01620762|41921157|FG002|Overall Study|Adverse Event|2|||
19511070|NCT01620762|41921155|FG000|Overall Study|Withdrawal by Subject|23|||
19511071|NCT01620762|41921156|FG001|Overall Study|Withdrawal by Subject|26|||
19511072|NCT01620762|41921157|FG002|Overall Study|Withdrawal by Subject|27|||
19511073|NCT01620762|41921155|FG000|Overall Study|Lost to Follow-up|11|||
19511074|NCT01620762|41921156|FG001|Overall Study|Lost to Follow-up|17|||
19511075|NCT01620762|41921157|FG002|Overall Study|Lost to Follow-up|10|||
19511076|NCT01620762|41921155|FG000|Overall Study|Protocol deviation|1|||
19511077|NCT01620762|41921156|FG001|Overall Study|Protocol deviation|1|||
19511078|NCT01620762|41921157|FG002|Overall Study|Protocol deviation|6|||
19511079|NCT01620762|41921155|FG000|Overall Study|Subject deterioration|0|||
19511080|NCT01620762|41921156|FG001|Overall Study|Subject deterioration|1|||
19511081|NCT01620762|41921157|FG002|Overall Study|Subject deterioration|1|||
19511082|NCT01620762|41921155|FG000|Overall Study|Non-specified|3|||
19511083|NCT01620762|41921156|FG001|Overall Study|Non-specified|6|||
19511084|NCT01620762|41921157|FG002|Overall Study|Non-specified|5|||
19511085|NCT01620762|41921155|FG000|Overall Study|Use of prohibted therapies|0|||
19511086|NCT01620762|41921156|FG001|Overall Study|Use of prohibted therapies|1|||
19511087|NCT01620762|41921157|FG002|Overall Study|Use of prohibted therapies|1|||
19511088|NCT01966068|41921167|FG000|Overall Study|Withdrawal by Subject|57|||
19511089|NCT01966068|41921167|FG000|Overall Study|Lost to Follow-up|81|||
19511090|NCT01620528|41921175|FG000|Treatment Period|Did Not Receive Study Drug|0|||
19511091|NCT01620528|41921176|FG001|Treatment Period|Did Not Receive Study Drug|0|||
19511092|NCT01620528|41921177|FG002|Treatment Period|Did Not Receive Study Drug|1|||
19511093|NCT01620528|41921175|FG000|Treatment Period|Withdrawal by Subject|35|||
19511094|NCT01620528|41921176|FG001|Treatment Period|Withdrawal by Subject|21|||
19511095|NCT01620528|41921177|FG002|Treatment Period|Withdrawal by Subject|16|||
19511096|NCT01620528|41921175|FG000|Treatment Period|Adverse Event|17|||
19511097|NCT01620528|41921176|FG001|Treatment Period|Adverse Event|13|||
19511098|NCT01620528|41921177|FG002|Treatment Period|Adverse Event|21|||
19511099|NCT01620528|41921175|FG000|Treatment Period|Lost to Follow-up|16|||
19511100|NCT01620528|41921176|FG001|Treatment Period|Lost to Follow-up|8|||
19511101|NCT01620528|41921177|FG002|Treatment Period|Lost to Follow-up|14|||
19511102|NCT01620528|41921175|FG000|Treatment Period|Other|9|||
19511103|NCT01620528|41921176|FG001|Treatment Period|Other|5|||
19511104|NCT01620528|41921177|FG002|Treatment Period|Other|7|||
19511105|NCT01620528|41921175|FG000|Treatment Period|Subject Noncompliant|11|||
19511106|NCT01620528|41921176|FG001|Treatment Period|Subject Noncompliant|2|||
19511107|NCT01620528|41921177|FG002|Treatment Period|Subject Noncompliant|2|||
19511108|NCT01620528|41921175|FG000|Treatment Period|Pregnancy|7|||
19511109|NCT01620528|41921176|FG001|Treatment Period|Pregnancy|2|||
19511110|NCT01620528|41921177|FG002|Treatment Period|Pregnancy|2|||
19511111|NCT01620528|41921175|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
19511112|NCT01620528|41921176|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
19511113|NCT01620528|41921177|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
19511114|NCT01620528|41921175|FG000|Treatment Period|Exclusionary Medication Received|0|||
19511115|NCT01620528|41921176|FG001|Treatment Period|Exclusionary Medication Received|1|||
19511116|NCT01620528|41921177|FG002|Treatment Period|Exclusionary Medication Received|0|||
19511117|NCT01620528|41921175|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
19511118|NCT01620528|41921176|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
19617319|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Pain|0|||
19511119|NCT01620528|41921177|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
19511120|NCT01620528|41921175|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
19511121|NCT01620528|41921176|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
19511122|NCT01620528|41921177|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
19511123|NCT01620528|41921175|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
19511124|NCT01620528|41921176|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
19511125|NCT01620528|41921177|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
19511126|NCT01620528|41921175|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
19511127|NCT01620528|41921176|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
19511128|NCT01620528|41921177|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
19511129|NCT01620528|41921175|FG000|Post-Treatment Follow-Up Period|Other|6|||
19511130|NCT01620528|41921176|FG001|Post-Treatment Follow-Up Period|Other|4|||
19511131|NCT01620528|41921177|FG002|Post-Treatment Follow-Up Period|Other|2|||
19511132|NCT01965834|41921185|FG000|Overall Study|Lack of Efficacy|4|||
19511133|NCT01965600|41921189|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
19511134|NCT01965600|41921190|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
19511135|NCT01965600|41921191|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
19511136|NCT01965600|41921192|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
19511137|NCT01965600|41921189|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
19511138|NCT01965600|41921190|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
19511139|NCT01965600|41921191|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
19511140|NCT01965600|41921192|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
19511141|NCT01965600|41921189|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
19511142|NCT01965600|41921190|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
19511143|NCT01965600|41921191|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
19511144|NCT01965600|41921192|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
19511145|NCT01965600|41921189|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
19511146|NCT01965600|41921190|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
19511147|NCT01965600|41921191|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
19511148|NCT01965600|41921192|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
19511149|NCT01965600|41921189|FG000|Second Intervention|Study terminated by Sponsor|0|||
19511150|NCT01965600|41921190|FG001|Second Intervention|Study terminated by Sponsor|0|||
19511151|NCT01965600|41921191|FG002|Second Intervention|Study terminated by Sponsor|2|||
19511152|NCT01965600|41921192|FG003|Second Intervention|Study terminated by Sponsor|2|||
19511153|NCT01996332|41921200|FG000|Overall Study|Adverse Event|117|||
19511154|NCT01996332|41921200|FG000|Overall Study|Lack of Efficacy|1245|||
19511155|NCT01996332|41921200|FG000|Overall Study|Death|264|||
19511156|NCT01996332|41921200|FG000|Overall Study|Protocol Violation|9|||
19511157|NCT01996332|41921200|FG000|Overall Study|Withdrawal by Subject|71|||
19511158|NCT01996332|41921200|FG000|Overall Study|Other|20|||
19511159|NCT01996332|41921200|FG000|Overall Study|Clinical Deterioration|28|||
19511160|NCT01996332|41921200|FG000|Overall Study|Physician Decision|17|||
19511161|NCT01996332|41921200|FG000|Overall Study|Lost to Follow-up|34|||
19511162|NCT01996254|41921206|FG000|Overall Study|Change in Eligibility|0|||
19511163|NCT01996254|41921207|FG001|Overall Study|Change in Eligibility|2|||
19511164|NCT01996254|41921208|FG002|Overall Study|Change in Eligibility|0|||
19511165|NCT01996254|41921206|FG000|Overall Study|Withdrawal by Subject|0|||
19511166|NCT01996254|41921207|FG001|Overall Study|Withdrawal by Subject|3|||
19511167|NCT01996254|41921208|FG002|Overall Study|Withdrawal by Subject|4|||
19511168|NCT01996254|41921206|FG000|Overall Study|Lost to Follow-up|1|||
19511169|NCT01996254|41921207|FG001|Overall Study|Lost to Follow-up|0|||
19511170|NCT01996254|41921208|FG002|Overall Study|Lost to Follow-up|4|||
19511171|NCT01987986|41921222|FG000|Overall Study|Lost to Follow-up|1|||
19511172|NCT01987986|41921223|FG001|Overall Study|Lost to Follow-up|0|||
19511173|NCT01987986|41921224|FG002|Overall Study|Lost to Follow-up|0|||
19511174|NCT01987986|41921225|FG003|Overall Study|Lost to Follow-up|0|||
19511175|NCT01987986|41921222|FG000|Overall Study|Adverse Event|1|||
19617320|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Moved|1|||
19617321|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Moved|0|||
19617322|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Moved|0|||
19617323|NCT00594399|42067067|FG000|Initial 3 Month Counseling|Family illness|1|||
19617324|NCT00594399|42067068|FG001|Initial 3 Month Counseling|Family illness|0|||
19617325|NCT00594399|42067069|FG002|Initial 3 Month Counseling|Family illness|0|||
19617326|NCT00594399|42067067|FG000|Rerandomization Arm 1 Only|Death|2|||
19617327|NCT00594399|42067068|FG001|Rerandomization Arm 1 Only|Death|1|||
19617328|NCT00594399|42067069|FG002|Rerandomization Arm 1 Only|Death|0|||
19617329|NCT00594399|42067067|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
19617330|NCT00594399|42067068|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
19617331|NCT00594399|42067069|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
19704602|NCT00129402|42148930|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19617332|NCT00546715|42067079|FG000|Overall Study|Withdrawal by Subject|0|||
19617333|NCT00546715|42067080|FG001|Overall Study|Withdrawal by Subject|1|||
19617334|NCT00546715|42067081|FG002|Overall Study|Withdrawal by Subject|0|||
19617335|NCT00546715|42067082|FG003|Overall Study|Withdrawal by Subject|0|||
19617336|NCT00874029|42067092|FG000|Overall Study|Withdrawal by Subject|10|||
19617337|NCT00874029|42067092|FG000|Overall Study|Pregnancy|4|||
19617338|NCT00874029|42067092|FG000|Overall Study|Physician Decision|1|||
19617339|NCT00874029|42067092|FG000|Overall Study|Adverse Event|1|||
19617340|NCT00874029|42067092|FG000|Overall Study|Lost to Follow-up|5|||
19617341|NCT00546637|42067108|FG000|Overall Study|Adverse Event|46|||
19617342|NCT00546637|42067109|FG001|Overall Study|Adverse Event|20|||
19617343|NCT00546637|42067108|FG000|Overall Study|Lack of Efficacy|5|||
19617344|NCT00546637|42067109|FG001|Overall Study|Lack of Efficacy|5|||
19617345|NCT00546637|42067108|FG000|Overall Study|Lost to Follow-up|2|||
19617346|NCT00546637|42067109|FG001|Overall Study|Lost to Follow-up|2|||
19617347|NCT00546637|42067108|FG000|Overall Study|Other|10|||
19617348|NCT00546637|42067109|FG001|Overall Study|Other|12|||
19617349|NCT00546637|42067108|FG000|Overall Study|Withdrawal by Subject|7|||
19617350|NCT00546637|42067109|FG001|Overall Study|Withdrawal by Subject|9|||
19617351|NCT00546637|42067108|FG000|Overall Study|Randomized, but not treated|3|||
19617352|NCT00546637|42067109|FG001|Overall Study|Randomized, but not treated|1|||
19617353|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
19617354|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
19617355|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
19617356|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
19617357|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
19617358|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
19617359|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
19617360|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
19617361|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
19617362|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
19617363|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
19617364|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
19617365|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
19511176|NCT01987986|41921223|FG001|Overall Study|Adverse Event|0|||
19511177|NCT01987986|41921224|FG002|Overall Study|Adverse Event|2|||
19511178|NCT01987986|41921225|FG003|Overall Study|Adverse Event|0|||
19511179|NCT01987908|41921235|FG000|Placebo Lead-in Period|Adverse Event|2|||
19511180|NCT01987908|41921236|FG001|Placebo Lead-in Period|Adverse Event|0|||
19511181|NCT01987908|41921237|FG002|Placebo Lead-in Period|Adverse Event|0|||
19511182|NCT01987908|41921235|FG000|Placebo Lead-in Period|Physician Decision|2|||
19511183|NCT01987908|41921236|FG001|Placebo Lead-in Period|Physician Decision|0|||
19511184|NCT01987908|41921237|FG002|Placebo Lead-in Period|Physician Decision|0|||
19511185|NCT01987908|41921235|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
19511186|NCT01987908|41921236|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
19511187|NCT01987908|41921237|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
19511188|NCT01987908|41921235|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
19511189|NCT01987908|41921236|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
19511190|NCT01987908|41921237|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
19511191|NCT01987908|41921235|FG000|Treatment Period|Adverse Event|0|||
19511192|NCT01987908|41921236|FG001|Treatment Period|Adverse Event|1|||
19511193|NCT01987908|41921237|FG002|Treatment Period|Adverse Event|1|||
19511194|NCT01987908|41921235|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
19511195|NCT01987908|41921236|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
19617366|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
19617367|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
19617368|NCT00546481|42067117|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
19617369|NCT00546481|42067118|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
19617370|NCT00546481|42067119|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
19617371|NCT00546481|42067117|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
19617372|NCT00546481|42067118|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
19617373|NCT00546481|42067119|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
19617374|NCT00546481|42067117|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
19617375|NCT00546481|42067118|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
19617376|NCT00546481|42067119|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
19617377|NCT00546481|42067117|FG000|Maintenance Phase (CERA)|Other Reason|0|||
19617378|NCT00546481|42067118|FG001|Maintenance Phase (CERA)|Other Reason|0|||
19617379|NCT00546481|42067119|FG002|Maintenance Phase (CERA)|Other Reason|1|||
19617380|NCT00880698|42067131|FG000|Overall Study|Death|0|||
19617381|NCT00880698|42067132|FG001|Overall Study|Death|0|||
19617382|NCT00880698|42067133|FG002|Overall Study|Death|1|||
19617383|NCT00880698|42067134|FG003|Overall Study|Death|2|||
19617384|NCT00880698|42067131|FG000|Overall Study|Lost to Follow-up|1|||
19617385|NCT00880698|42067132|FG001|Overall Study|Lost to Follow-up|3|||
19617386|NCT00880698|42067133|FG002|Overall Study|Lost to Follow-up|0|||
19617387|NCT00880698|42067134|FG003|Overall Study|Lost to Follow-up|1|||
19617388|NCT00880620|42067150|FG000|Overall Study|Adverse Event|4|||
19617389|NCT00880620|42067151|FG001|Overall Study|Adverse Event|5|||
19617390|NCT00880620|42067152|FG002|Overall Study|Adverse Event|15|||
19617391|NCT00880620|42067153|FG003|Overall Study|Adverse Event|15|||
19617392|NCT00880620|42067150|FG000|Overall Study|Death|0|||
19617393|NCT00880620|42067151|FG001|Overall Study|Death|0|||
19617394|NCT00880620|42067152|FG002|Overall Study|Death|1|||
19617395|NCT00880620|42067153|FG003|Overall Study|Death|0|||
19617396|NCT00880620|42067150|FG000|Overall Study|Lack of Efficacy|12|||
19617397|NCT00880620|42067151|FG001|Overall Study|Lack of Efficacy|4|||
19617398|NCT00880620|42067152|FG002|Overall Study|Lack of Efficacy|0|||
19617399|NCT00880620|42067153|FG003|Overall Study|Lack of Efficacy|1|||
19617400|NCT00880620|42067150|FG000|Overall Study|Lost to Follow-up|0|||
19617401|NCT00880620|42067151|FG001|Overall Study|Lost to Follow-up|1|||
19617402|NCT00880620|42067152|FG002|Overall Study|Lost to Follow-up|1|||
19617403|NCT00880620|42067153|FG003|Overall Study|Lost to Follow-up|0|||
19617404|NCT00880620|42067150|FG000|Overall Study|Protocol Violation|0|||
19617405|NCT00880620|42067151|FG001|Overall Study|Protocol Violation|1|||
19617406|NCT00880620|42067152|FG002|Overall Study|Protocol Violation|0|||
19617407|NCT00880620|42067153|FG003|Overall Study|Protocol Violation|2|||
19617408|NCT00880620|42067150|FG000|Overall Study|Withdrawal by Subject|4|||
19617409|NCT00880620|42067151|FG001|Overall Study|Withdrawal by Subject|3|||
19617410|NCT00880620|42067152|FG002|Overall Study|Withdrawal by Subject|1|||
19617411|NCT00880620|42067153|FG003|Overall Study|Withdrawal by Subject|3|||
19617412|NCT00880620|42067150|FG000|Overall Study|Noncompliance|0|||
19617413|NCT00880620|42067151|FG001|Overall Study|Noncompliance|0|||
19617414|NCT00880620|42067152|FG002|Overall Study|Noncompliance|1|||
19617415|NCT00880620|42067153|FG003|Overall Study|Noncompliance|1|||
19617416|NCT00880620|42067150|FG000|Overall Study|Other|1|||
19617417|NCT00880620|42067151|FG001|Overall Study|Other|1|||
19617418|NCT00880620|42067152|FG002|Overall Study|Other|2|||
19617419|NCT00880620|42067153|FG003|Overall Study|Other|2|||
19617420|NCT00881868|42067179|FG000|Overall Study|Adverse Event|0|||
19617421|NCT00881868|42067180|FG001|Overall Study|Adverse Event|1|||
19617422|NCT00881868|42067179|FG000|Overall Study|Lost to Follow-up|2|||
19617423|NCT00881868|42067180|FG001|Overall Study|Lost to Follow-up|1|||
19617424|NCT00881868|42067179|FG000|Overall Study|Physician Decision|4|||
19617425|NCT00881868|42067180|FG001|Overall Study|Physician Decision|0|||
19617426|NCT00881868|42067179|FG000|Overall Study|Protocol Violation|2|||
19617427|NCT00881868|42067180|FG001|Overall Study|Protocol Violation|0|||
19617428|NCT00881712|42067189|FG000|Overall Study|Death|1|||
19617429|NCT00881712|42067190|FG001|Overall Study|Death|0|||
19617430|NCT00881712|42067191|FG002|Overall Study|Death|0|||
19617431|NCT00881712|42067189|FG000|Overall Study|Withdrawal by Subject|1|||
19617432|NCT00881712|42067190|FG001|Overall Study|Withdrawal by Subject|0|||
19617433|NCT00881712|42067191|FG002|Overall Study|Withdrawal by Subject|0|||
19617434|NCT03955471|42067199|FG000|Overall Study|Death|22|||
19617435|NCT03955471|42067199|FG000|Overall Study|Lost to Follow-up|1|||
19617436|NCT03955471|42067199|FG000|Overall Study|Withdrawal by Subject|6|||
19617437|NCT03955471|42067199|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
19617438|NCT00880542|42067203|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
19617439|NCT00880542|42067203|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
19617440|NCT00880542|42067203|FG000|REP: Surgical Resection|progressive disease|1|||
19704603|NCT00129402|42148931|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19511196|NCT01987908|41921237|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
19511197|NCT01987908|41921235|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
19511198|NCT01987908|41921236|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
19511199|NCT01987908|41921237|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
19511200|NCT01995552|41921261|FG000|Overall Study|Protocol Violation|1|||
19511201|NCT01995552|41921261|FG000|Overall Study|Lack of Efficacy|15|||
19511202|NCT01995552|41921261|FG000|Overall Study|Death|1|||
19511203|NCT01987830|41921267|FG000|Overall Study|Never received baseline scan|1|||
19511204|NCT01987596|41921273|FG000|Overall Study|Physician Decision|1|||
19511205|NCT01987596|41921274|FG001|Overall Study|Physician Decision|0|||
19617441|NCT00885534|42067207|FG000|Overall Study|Patient deemed ineligible|1|||
19617442|NCT00885378|42067213|FG000|Overall Study|Lack of Efficacy|2|||
19617443|NCT00885378|42067214|FG001|Overall Study|Lack of Efficacy|2|||
19617444|NCT00885378|42067213|FG000|Overall Study|Withdrawal by Subject|1|||
19617445|NCT00885378|42067214|FG001|Overall Study|Withdrawal by Subject|2|||
19617446|NCT00885378|42067213|FG000|Overall Study|Lost to Follow-up|1|||
19617447|NCT00885378|42067214|FG001|Overall Study|Lost to Follow-up|2|||
19617448|NCT00885378|42067213|FG000|Overall Study|Poor/Noncompliance|2|||
19617449|NCT00885378|42067214|FG001|Overall Study|Poor/Noncompliance|2|||
19617450|NCT00885378|42067213|FG000|Overall Study|Protocol Violation|2|||
19704604|NCT00129402|42148932|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19617451|NCT00885378|42067214|FG001|Overall Study|Protocol Violation|0|||
19511206|NCT01987596|41921273|FG000|Overall Study|Progressive Disease; missing all period|0|||
19511207|NCT01987596|41921274|FG001|Overall Study|Progressive Disease; missing all period|1|||
19511208|NCT01964976|41921288|FG000|Overall Study|Protocol Violation|31|||
19511209|NCT01964898|41921297|FG000|Overall Study|ineligible post-randomization|1|||
19511210|NCT01964898|41921298|FG001|Overall Study|ineligible post-randomization|1|||
19511211|NCT01964898|41921297|FG000|Overall Study|did not receive the allocated interventi|2|||
19511212|NCT01964898|41921298|FG001|Overall Study|did not receive the allocated interventi|1|||
19511213|NCT01964898|41921297|FG000|Overall Study|Lost to Follow-up|3|||
19511214|NCT01964898|41921298|FG001|Overall Study|Lost to Follow-up|5|||
19511215|NCT01964898|41921297|FG000|Overall Study|Withdrawal by Subject|1|||
19511216|NCT01964898|41921298|FG001|Overall Study|Withdrawal by Subject|0|||
19511217|NCT01964352|41921308|FG000|Overall Study|Adverse Event|13|||
19511218|NCT01964352|41921309|FG001|Overall Study|Adverse Event|3|||
19511219|NCT01964352|41921310|FG002|Overall Study|Adverse Event|4|||
19511220|NCT01964352|41921311|FG003|Overall Study|Adverse Event|3|||
19511221|NCT01964352|41921308|FG000|Overall Study|Lack of Efficacy|6|||
19511222|NCT01964352|41921309|FG001|Overall Study|Lack of Efficacy|0|||
19511223|NCT01964352|41921310|FG002|Overall Study|Lack of Efficacy|0|||
19511224|NCT01964352|41921311|FG003|Overall Study|Lack of Efficacy|0|||
19511225|NCT01964352|41921308|FG000|Overall Study|Protocol Violation|2|||
19511226|NCT01964352|41921309|FG001|Overall Study|Protocol Violation|4|||
19511227|NCT01964352|41921310|FG002|Overall Study|Protocol Violation|0|||
19511228|NCT01964352|41921311|FG003|Overall Study|Protocol Violation|2|||
19511229|NCT01964352|41921308|FG000|Overall Study|Lost to Follow-up|1|||
19617452|NCT00545779|42067220|FG000|Overall Study|Violation of selection criteria at entry|8|||
19617453|NCT00545779|42067220|FG000|Overall Study|Other protocol violation|1|||
19617454|NCT00545779|42067220|FG000|Overall Study|Did not cooperate|7|||
19617455|NCT00545779|42067220|FG000|Overall Study|Withdrawal by Subject|20|||
19617456|NCT00545779|42067220|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
19617457|NCT00545779|42067220|FG000|Overall Study|Failure to return|3|||
19511230|NCT01964352|41921309|FG001|Overall Study|Lost to Follow-up|0|||
19511231|NCT01964352|41921310|FG002|Overall Study|Lost to Follow-up|0|||
19511232|NCT01964352|41921311|FG003|Overall Study|Lost to Follow-up|1|||
19511233|NCT01964352|41921308|FG000|Overall Study|Withdrawal by Subject|4|||
19511234|NCT01964352|41921309|FG001|Overall Study|Withdrawal by Subject|2|||
19511235|NCT01964352|41921310|FG002|Overall Study|Withdrawal by Subject|1|||
19511236|NCT01964352|41921311|FG003|Overall Study|Withdrawal by Subject|0|||
19511237|NCT01964352|41921308|FG000|Overall Study|Other than stated above|0|||
19511238|NCT01964352|41921309|FG001|Overall Study|Other than stated above|2|||
19511239|NCT01964352|41921310|FG002|Overall Study|Other than stated above|1|||
19511240|NCT01964352|41921311|FG003|Overall Study|Other than stated above|2|||
19511241|NCT01946412|41921321|FG000|Overall Study|Adverse Event|1|||
19511242|NCT01946412|41921321|FG000|Overall Study|Non-Compliance|1|||
19511243|NCT01946412|41921321|FG000|Overall Study|Continued with commercial Kalydeco|2|||
19511244|NCT01946412|41921321|FG000|Overall Study|Difficulty in swallowing|1|||
19511245|NCT01946178|41921327|FG000|Overall Study|Pregnancy|1|||
19511246|NCT01946178|41921327|FG000|Overall Study|Lost to Follow-up|1|||
19511247|NCT01945944|41921337|FG000|Overall Study|Adverse Event|0|||
19511248|NCT01945944|41921338|FG001|Overall Study|Adverse Event|2|||
19511249|NCT01945944|41921337|FG000|Overall Study|Physician Decision|1|||
19511250|NCT01945944|41921338|FG001|Overall Study|Physician Decision|0|||
19511251|NCT01945944|41921337|FG000|Overall Study|Withdrawal by Subject|0|||
19511252|NCT01945944|41921338|FG001|Overall Study|Withdrawal by Subject|1|||
19511253|NCT01945866|41921348|FG000|Overall Study|Eyes did not complete or were dropped|2|||
19511254|NCT01945866|41921349|FG001|Overall Study|Eyes did not complete or were dropped|0|||
19511255|NCT01986114|41921356|FG000|Overall Study|Adverse Event|59|||
19511256|NCT01986114|41921356|FG000|Overall Study|Lack of Efficacy|23|||
19511257|NCT01986114|41921356|FG000|Overall Study|Withdrawal by Subject|58|||
19511258|NCT01986114|41921356|FG000|Overall Study|Noncompliance|3|||
19511259|NCT01986114|41921356|FG000|Overall Study|Protocol Violation|1|||
19511260|NCT01986114|41921356|FG000|Overall Study|Lost to Follow-up|5|||
19511261|NCT01986114|41921356|FG000|Overall Study|Other reason|7|||
19511262|NCT01945710|41921369|FG000|Overall Study|Progressive Disease|5|||
19511263|NCT01945710|41921370|FG001|Overall Study|Progressive Disease|4|||
19511264|NCT01945710|41921371|FG002|Overall Study|Progressive Disease|3|||
19511265|NCT01945710|41921372|FG003|Overall Study|Progressive Disease|2|||
19511266|NCT01945710|41921373|FG004|Overall Study|Progressive Disease|7|||
19511267|NCT01945710|41921374|FG005|Overall Study|Progressive Disease|3|||
19511268|NCT01945710|41921375|FG006|Overall Study|Progressive Disease|19|||
19511269|NCT01945710|41921369|FG000|Overall Study|Adverse Event|0|||
19511270|NCT01945710|41921370|FG001|Overall Study|Adverse Event|1|||
19511271|NCT01945710|41921371|FG002|Overall Study|Adverse Event|0|||
19617458|NCT00597714|42067230|FG000|Overall Study|Death|56|||
19511272|NCT01945710|41921372|FG003|Overall Study|Adverse Event|0|||
19511273|NCT01945710|41921373|FG004|Overall Study|Adverse Event|0|||
19511274|NCT01945710|41921374|FG005|Overall Study|Adverse Event|0|||
19511275|NCT01945710|41921375|FG006|Overall Study|Adverse Event|0|||
19511276|NCT01945710|41921369|FG000|Overall Study|Other|2|||
19511277|NCT01945710|41921370|FG001|Overall Study|Other|0|||
19511278|NCT01945710|41921371|FG002|Overall Study|Other|3|||
19511279|NCT01945710|41921372|FG003|Overall Study|Other|1|||
19511280|NCT01945710|41921373|FG004|Overall Study|Other|1|||
19511281|NCT01945710|41921374|FG005|Overall Study|Other|0|||
19511282|NCT01945710|41921375|FG006|Overall Study|Other|4|||
19511283|NCT01945710|41921369|FG000|Overall Study|Withdrawal by Subject|0|||
19511284|NCT01945710|41921370|FG001|Overall Study|Withdrawal by Subject|1|||
19511285|NCT01945710|41921371|FG002|Overall Study|Withdrawal by Subject|1|||
19511286|NCT01945710|41921372|FG003|Overall Study|Withdrawal by Subject|0|||
19511287|NCT01945710|41921373|FG004|Overall Study|Withdrawal by Subject|1|||
19511288|NCT01945710|41921374|FG005|Overall Study|Withdrawal by Subject|0|||
19511289|NCT01945710|41921375|FG006|Overall Study|Withdrawal by Subject|0|||
19511290|NCT01945242|41921395|FG000|Overall Study|Physician Decision|3|||
19511291|NCT01945242|41921396|FG001|Overall Study|Physician Decision|3|||
19511292|NCT01945086|41921406|FG000|Overall Study|Withdrawal by Subject|1|||
19511293|NCT01945086|41921407|FG001|Overall Study|Withdrawal by Subject|0|||
19511294|NCT01945086|41921408|FG002|Overall Study|Withdrawal by Subject|1|||
19511295|NCT01945086|41921406|FG000|Overall Study|Adverse Event|0|||
19511296|NCT01945086|41921407|FG001|Overall Study|Adverse Event|0|||
19511297|NCT01945086|41921408|FG002|Overall Study|Adverse Event|1|||
19511298|NCT01963728|41921418|FG000|Overall Study|Study terminated early|0|||
19511299|NCT01963728|41921419|FG001|Overall Study|Study terminated early|1|||
19511300|NCT01963260|41921435|FG000|Overall Study|Withdrawal by Subject|2|||
19511301|NCT01963260|41921436|FG001|Overall Study|Withdrawal by Subject|0|||
19511302|NCT01963260|41921437|FG002|Overall Study|Withdrawal by Subject|0|||
19511303|NCT01963260|41921438|FG003|Overall Study|Withdrawal by Subject|1|||
19511304|NCT01963260|41921439|FG004|Overall Study|Withdrawal by Subject|2|||
19511305|NCT01963260|41921440|FG005|Overall Study|Withdrawal by Subject|0|||
19511306|NCT01963260|41921441|FG006|Overall Study|Withdrawal by Subject|0|||
19511307|NCT01963260|41921442|FG007|Overall Study|Withdrawal by Subject|0|||
19511308|NCT01963260|41921443|FG008|Overall Study|Withdrawal by Subject|0|||
19511309|NCT01963260|41921444|FG009|Overall Study|Withdrawal by Subject|0|||
19511310|NCT01962948|41921477|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
19511311|NCT01962948|41921478|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
19511312|NCT01962948|41921479|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
19511313|NCT01962948|41921480|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
19511314|NCT01985334|41921495|FG000|Overall Study|Administrative problems|1|||
19511315|NCT01985334|41921496|FG001|Overall Study|Administrative problems|1|||
19511316|NCT01985334|41921497|FG002|Overall Study|Administrative problems|0|||
19511317|NCT01985334|41921498|FG003|Overall Study|Administrative problems|2|||
19511318|NCT01985334|41921499|FG004|Overall Study|Administrative problems|0|||
19511319|NCT01985334|41921500|FG005|Overall Study|Administrative problems|1|||
19511320|NCT01985334|41921501|FG006|Overall Study|Administrative problems|1|||
19511321|NCT01985334|41921502|FG007|Overall Study|Administrative problems|3|||
19617459|NCT00597714|42067231|FG001|Overall Study|Death|46|||
19617460|NCT00597714|42067232|FG002|Overall Study|Death|0|||
19617461|NCT00597714|42067230|FG000|Overall Study|Recipient death|0|||
19617462|NCT00597714|42067231|FG001|Overall Study|Recipient death|0|||
19617463|NCT00597714|42067232|FG002|Overall Study|Recipient death|10|||
19617464|NCT03938857|42067245|FG000|Overall Study|Physician Decision|1|||
19617465|NCT03938857|42067246|FG001|Overall Study|Physician Decision|0|||
19617466|NCT03938857|42067247|FG002|Overall Study|Physician Decision|0|||
19617467|NCT03938857|42067248|FG003|Overall Study|Physician Decision|0|||
19617468|NCT00884832|42067260|FG000|Overall Study|Withdrawal by Subject|0|||
19617469|NCT00884832|42067261|FG001|Overall Study|Withdrawal by Subject|1|||
19617470|NCT03938545|42067271|FG000|Overall Study|Lost to Follow-up|0|||
19617471|NCT03938545|42067272|FG001|Overall Study|Lost to Follow-up|0|||
19617472|NCT03938545|42067273|FG002|Overall Study|Lost to Follow-up|0|||
19617473|NCT03938545|42067274|FG003|Overall Study|Lost to Follow-up|1|||
19617474|NCT03938545|42067271|FG000|Overall Study|Non-compliance with study drug|0|||
19617475|NCT03938545|42067272|FG001|Overall Study|Non-compliance with study drug|0|||
19617476|NCT03938545|42067273|FG002|Overall Study|Non-compliance with study drug|1|||
19617477|NCT03938545|42067274|FG003|Overall Study|Non-compliance with study drug|0|||
19617478|NCT03938545|42067271|FG000|Overall Study|Pregnancy|1|||
19617479|NCT03938545|42067272|FG001|Overall Study|Pregnancy|0|||
19617480|NCT03938545|42067273|FG002|Overall Study|Pregnancy|0|||
19617481|NCT03938545|42067274|FG003|Overall Study|Pregnancy|0|||
19617482|NCT03938545|42067271|FG000|Overall Study|Study terminated by sponsor|6|||
19617483|NCT03938545|42067272|FG001|Overall Study|Study terminated by sponsor|4|||
19617484|NCT03938545|42067273|FG002|Overall Study|Study terminated by sponsor|2|||
19617485|NCT03938545|42067274|FG003|Overall Study|Study terminated by sponsor|4|||
19617486|NCT03938545|42067271|FG000|Overall Study|Withdrawal by Subject|0|||
19617487|NCT03938545|42067272|FG001|Overall Study|Withdrawal by Subject|1|||
19617488|NCT03938545|42067273|FG002|Overall Study|Withdrawal by Subject|0|||
19617489|NCT03938545|42067274|FG003|Overall Study|Withdrawal by Subject|0|||
19511322|NCT01985334|41921495|FG000|Overall Study|Death|1|||
19511323|NCT01985334|41921496|FG001|Overall Study|Death|0|||
19511324|NCT01985334|41921497|FG002|Overall Study|Death|0|||
19511325|NCT01985334|41921498|FG003|Overall Study|Death|3|||
19511326|NCT01985334|41921499|FG004|Overall Study|Death|0|||
19511327|NCT01985334|41921500|FG005|Overall Study|Death|0|||
19511328|NCT01985334|41921501|FG006|Overall Study|Death|1|||
19511329|NCT01985334|41921502|FG007|Overall Study|Death|2|||
19511330|NCT01985334|41921495|FG000|Overall Study|Worsening of disease|0|||
19511331|NCT01985334|41921496|FG001|Overall Study|Worsening of disease|0|||
19511332|NCT01985334|41921497|FG002|Overall Study|Worsening of disease|0|||
19511333|NCT01985334|41921498|FG003|Overall Study|Worsening of disease|1|||
19511334|NCT01985334|41921499|FG004|Overall Study|Worsening of disease|0|||
19511335|NCT01985334|41921500|FG005|Overall Study|Worsening of disease|3|||
19511336|NCT01985334|41921501|FG006|Overall Study|Worsening of disease|0|||
19511337|NCT01985334|41921502|FG007|Overall Study|Worsening of disease|1|||
19511338|NCT01985334|41921495|FG000|Overall Study|Other|2|||
19511339|NCT01985334|41921496|FG001|Overall Study|Other|9|||
19511340|NCT01985334|41921497|FG002|Overall Study|Other|7|||
19511341|NCT01985334|41921498|FG003|Overall Study|Other|17|||
19511342|NCT01985334|41921499|FG004|Overall Study|Other|4|||
19511343|NCT01985334|41921500|FG005|Overall Study|Other|8|||
19511344|NCT01985334|41921501|FG006|Overall Study|Other|4|||
19511345|NCT01985334|41921502|FG007|Overall Study|Other|7|||
19511346|NCT01985334|41921495|FG000|Overall Study|Protocol deviation|6|||
19511347|NCT01985334|41921496|FG001|Overall Study|Protocol deviation|31|||
19511348|NCT01985334|41921497|FG002|Overall Study|Protocol deviation|25|||
19511349|NCT01985334|41921498|FG003|Overall Study|Protocol deviation|84|||
19511350|NCT01985334|41921499|FG004|Overall Study|Protocol deviation|17|||
19511351|NCT01985334|41921500|FG005|Overall Study|Protocol deviation|47|||
19511352|NCT01985334|41921501|FG006|Overall Study|Protocol deviation|15|||
19511353|NCT01985334|41921502|FG007|Overall Study|Protocol deviation|42|||
19511354|NCT01985334|41921495|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
19511355|NCT01985334|41921496|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
19511356|NCT01985334|41921497|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
19511357|NCT01985334|41921498|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
19511358|NCT01985334|41921499|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
19511359|NCT01985334|41921500|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
19511360|NCT01985334|41921501|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
19511361|NCT01985334|41921502|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
19511362|NCT01985334|41921495|FG000|Overall Study|Subject withdrawal of consent|3|||
19511363|NCT01985334|41921496|FG001|Overall Study|Subject withdrawal of consent|6|||
19511364|NCT01985334|41921497|FG002|Overall Study|Subject withdrawal of consent|2|||
19511365|NCT01985334|41921498|FG003|Overall Study|Subject withdrawal of consent|28|||
19511366|NCT01985334|41921499|FG004|Overall Study|Subject withdrawal of consent|4|||
19511367|NCT01985334|41921500|FG005|Overall Study|Subject withdrawal of consent|19|||
19511368|NCT01985334|41921501|FG006|Overall Study|Subject withdrawal of consent|0|||
19511369|NCT01985334|41921502|FG007|Overall Study|Subject withdrawal of consent|20|||
19511370|NCT01985334|41921495|FG000|Overall Study|Adverse Event|0|||
19511371|NCT01985334|41921496|FG001|Overall Study|Adverse Event|8|||
19511372|NCT01985334|41921497|FG002|Overall Study|Adverse Event|2|||
19511373|NCT01985334|41921498|FG003|Overall Study|Adverse Event|26|||
19617490|NCT03938545|42067271|FG000|Overall Study|Adverse Event|1|||
19617491|NCT03938545|42067272|FG001|Overall Study|Adverse Event|0|||
19617492|NCT03938545|42067273|FG002|Overall Study|Adverse Event|0|||
19617493|NCT03938545|42067274|FG003|Overall Study|Adverse Event|0|||
19617494|NCT00879996|42067286|FG000|Overall Study|Lost to Follow-up|7|||
19617495|NCT00879996|42067287|FG001|Overall Study|Lost to Follow-up|6|||
19617496|NCT00879996|42067286|FG000|Overall Study|non-compliance|6|||
19617497|NCT00879996|42067287|FG001|Overall Study|non-compliance|4|||
19617498|NCT00879996|42067286|FG000|Overall Study|Physician Decision|1|||
19617499|NCT00879996|42067287|FG001|Overall Study|Physician Decision|2|||
19511374|NCT01985334|41921499|FG004|Overall Study|Adverse Event|3|||
19511375|NCT01985334|41921500|FG005|Overall Study|Adverse Event|18|||
19511376|NCT01985334|41921501|FG006|Overall Study|Adverse Event|3|||
19511377|NCT01985334|41921502|FG007|Overall Study|Adverse Event|15|||
19617500|NCT00879996|42067286|FG000|Overall Study|psychiatric problem|0|||
19617501|NCT00879996|42067287|FG001|Overall Study|psychiatric problem|1|||
19617502|NCT00879996|42067286|FG000|Overall Study|put on parole|1|||
19617503|NCT00879996|42067287|FG001|Overall Study|put on parole|0|||
19617504|NCT00873093|42067300|FG000|Overall Study|Adverse Event|0|||
19617505|NCT00873093|42067301|FG001|Overall Study|Adverse Event|2|||
19617506|NCT00873093|42067302|FG002|Overall Study|Adverse Event|0|||
19617507|NCT00873093|42067303|FG003|Overall Study|Adverse Event|0|||
19617508|NCT00873093|42067304|FG004|Overall Study|Adverse Event|0|||
19617509|NCT00873093|42067300|FG000|Overall Study|Death|0|||
19617510|NCT00873093|42067301|FG001|Overall Study|Death|3|||
19617511|NCT00873093|42067302|FG002|Overall Study|Death|2|||
19511378|NCT01985334|41921495|FG000|Overall Study|Other|4|||
19511379|NCT01985334|41921496|FG001|Overall Study|Other|2|||
19511380|NCT01985334|41921497|FG002|Overall Study|Other|3|||
19511381|NCT01985334|41921498|FG003|Overall Study|Other|10|||
19511382|NCT01985334|41921499|FG004|Overall Study|Other|1|||
19511383|NCT01985334|41921500|FG005|Overall Study|Other|6|||
19511384|NCT01985334|41921501|FG006|Overall Study|Other|2|||
19511385|NCT01985334|41921502|FG007|Overall Study|Other|2|||
19511386|NCT01985334|41921495|FG000|Overall Study|Medication non-compliance|0|||
19511387|NCT01985334|41921496|FG001|Overall Study|Medication non-compliance|4|||
19511388|NCT01985334|41921497|FG002|Overall Study|Medication non-compliance|1|||
19511389|NCT01985334|41921498|FG003|Overall Study|Medication non-compliance|6|||
19511390|NCT01985334|41921499|FG004|Overall Study|Medication non-compliance|2|||
19511391|NCT01985334|41921500|FG005|Overall Study|Medication non-compliance|3|||
19511392|NCT01985334|41921501|FG006|Overall Study|Medication non-compliance|1|||
19511393|NCT01985334|41921502|FG007|Overall Study|Medication non-compliance|3|||
19511394|NCT01985334|41921495|FG000|Overall Study|Use of prohibited treatment|1|||
19511395|NCT01985334|41921496|FG001|Overall Study|Use of prohibited treatment|4|||
19511396|NCT01985334|41921497|FG002|Overall Study|Use of prohibited treatment|1|||
19511397|NCT01985334|41921498|FG003|Overall Study|Use of prohibited treatment|2|||
19511398|NCT01985334|41921499|FG004|Overall Study|Use of prohibited treatment|1|||
19511399|NCT01985334|41921500|FG005|Overall Study|Use of prohibited treatment|6|||
19511400|NCT01985334|41921501|FG006|Overall Study|Use of prohibited treatment|2|||
19511401|NCT01985334|41921502|FG007|Overall Study|Use of prohibited treatment|0|||
19511402|NCT01985334|41921495|FG000|Overall Study|Investigator decision|0|||
19511403|NCT01985334|41921496|FG001|Overall Study|Investigator decision|3|||
19511404|NCT01985334|41921497|FG002|Overall Study|Investigator decision|0|||
19511405|NCT01985334|41921498|FG003|Overall Study|Investigator decision|7|||
19511406|NCT01985334|41921499|FG004|Overall Study|Investigator decision|1|||
19511407|NCT01985334|41921500|FG005|Overall Study|Investigator decision|1|||
19511408|NCT01985334|41921501|FG006|Overall Study|Investigator decision|0|||
19511409|NCT01985334|41921502|FG007|Overall Study|Investigator decision|4|||
19511410|NCT01985334|41921495|FG000|Overall Study|Lost to Follow-up|0|||
19511411|NCT01985334|41921496|FG001|Overall Study|Lost to Follow-up|2|||
19511412|NCT01985334|41921497|FG002|Overall Study|Lost to Follow-up|0|||
19511413|NCT01985334|41921498|FG003|Overall Study|Lost to Follow-up|3|||
19511414|NCT01985334|41921499|FG004|Overall Study|Lost to Follow-up|1|||
19511415|NCT01985334|41921500|FG005|Overall Study|Lost to Follow-up|4|||
19511416|NCT01985334|41921501|FG006|Overall Study|Lost to Follow-up|0|||
19511417|NCT01985334|41921502|FG007|Overall Study|Lost to Follow-up|3|||
19511418|NCT01944774|41921537|FG000|Overall Study|Withdrawal by Subject|2|||
19511419|NCT01944774|41921538|FG001|Overall Study|Withdrawal by Subject|3|||
19511420|NCT01944774|41921539|FG002|Overall Study|Withdrawal by Subject|3|||
19511421|NCT01944774|41921537|FG000|Overall Study|Adverse Event|3|||
19511422|NCT01944774|41921538|FG001|Overall Study|Adverse Event|2|||
19511423|NCT01944774|41921539|FG002|Overall Study|Adverse Event|3|||
19511424|NCT01944774|41921537|FG000|Overall Study|Lack of Efficacy|1|||
19511425|NCT01944774|41921538|FG001|Overall Study|Lack of Efficacy|2|||
19511426|NCT01944774|41921539|FG002|Overall Study|Lack of Efficacy|2|||
19511427|NCT01944774|41921537|FG000|Overall Study|Lost to Follow-up|0|||
19511428|NCT01944774|41921538|FG001|Overall Study|Lost to Follow-up|1|||
19511429|NCT01944774|41921539|FG002|Overall Study|Lost to Follow-up|0|||
19511430|NCT01944462|41921550|FG000|PPPP Educational Program|Lost to Follow-up|60|||
19511431|NCT01943292|41921558|FG000|Overall Study|Withdrawal by Subject|1|||
19511432|NCT01943292|41921559|FG001|Overall Study|Withdrawal by Subject|0|||
19511433|NCT01943292|41921560|FG002|Overall Study|Withdrawal by Subject|0|||
19511434|NCT01961544|41921568|FG000|Overall Study|Protocol Violation|1|||
19617512|NCT00873093|42067303|FG003|Overall Study|Death|0|||
19617513|NCT00873093|42067304|FG004|Overall Study|Death|0|||
19617514|NCT00873093|42067300|FG000|Overall Study|Physician Decision|0|||
19617515|NCT00873093|42067301|FG001|Overall Study|Physician Decision|17|||
19511435|NCT01961544|41921568|FG000|Overall Study|Withdrawal by Subject|7|||
19511436|NCT01961544|41921568|FG000|Overall Study|Adverse Event|1|||
19511437|NCT01961544|41921568|FG000|Overall Study|Physician Decision|2|||
19511438|NCT01961544|41921568|FG000|Overall Study|Poor Tolerance|1|||
19511439|NCT01961544|41921568|FG000|Overall Study|Aggravation of Steral Pain|1|||
19511440|NCT01942590|41921574|FG000|Overall Study|Withdrawal by Subject|0|||
19617516|NCT00873093|42067302|FG002|Overall Study|Physician Decision|10|||
19617517|NCT00873093|42067303|FG003|Overall Study|Physician Decision|10|||
19617518|NCT00873093|42067304|FG004|Overall Study|Physician Decision|2|||
19617519|NCT00873093|42067300|FG000|Overall Study|Withdrawal by Subject|1|||
19617520|NCT00873093|42067301|FG001|Overall Study|Withdrawal by Subject|4|||
19617521|NCT00873093|42067302|FG002|Overall Study|Withdrawal by Subject|4|||
19617522|NCT00873093|42067303|FG003|Overall Study|Withdrawal by Subject|0|||
19617523|NCT00873093|42067304|FG004|Overall Study|Withdrawal by Subject|0|||
19617524|NCT00873093|42067300|FG000|Overall Study|Ineligible|0|||
19617525|NCT00873093|42067301|FG001|Overall Study|Ineligible|1|||
19617526|NCT00873093|42067302|FG002|Overall Study|Ineligible|0|||
19617527|NCT00873093|42067303|FG003|Overall Study|Ineligible|1|||
19617528|NCT00873093|42067304|FG004|Overall Study|Ineligible|0|||
19617529|NCT00884286|42067328|FG000|Overall Study|Progressive disease|21|||
19617530|NCT00884286|42067329|FG001|Overall Study|Progressive disease|28|||
19617531|NCT00884286|42067328|FG000|Overall Study|Toxicity|4|||
19617532|NCT00884286|42067329|FG001|Overall Study|Toxicity|1|||
19617533|NCT00884286|42067328|FG000|Overall Study|Death|2|||
19617534|NCT00884286|42067329|FG001|Overall Study|Death|2|||
19511441|NCT01942590|41921575|FG001|Overall Study|Withdrawal by Subject|1|||
19511442|NCT01942590|41921574|FG000|Overall Study|Adverse Event|1|||
19511443|NCT01942590|41921575|FG001|Overall Study|Adverse Event|0|||
19511444|NCT01984242|41921585|FG000|Overall Study|Death|52|||
19511445|NCT01984242|41921586|FG001|Overall Study|Death|50|||
19511446|NCT01984242|41921587|FG002|Overall Study|Death|52|||
19511447|NCT01984242|41921585|FG000|Overall Study|Withdrawal by Subject|5|||
19511448|NCT01984242|41921586|FG001|Overall Study|Withdrawal by Subject|3|||
19511449|NCT01984242|41921587|FG002|Overall Study|Withdrawal by Subject|10|||
19511450|NCT01984242|41921585|FG000|Overall Study|Physician Decision|0|||
19511451|NCT01984242|41921586|FG001|Overall Study|Physician Decision|0|||
19511452|NCT01984242|41921587|FG002|Overall Study|Physician Decision|1|||
19511453|NCT01984242|41921585|FG000|Overall Study|Lost to Follow-up|4|||
19511454|NCT01984242|41921586|FG001|Overall Study|Lost to Follow-up|0|||
19617535|NCT00884286|42067328|FG000|Overall Study|Physician Decision|1|||
19617536|NCT00884286|42067329|FG001|Overall Study|Physician Decision|0|||
19617537|NCT00884286|42067328|FG000|Overall Study|Septic shock|1|||
19617538|NCT00884286|42067329|FG001|Overall Study|Septic shock|0|||
19617539|NCT00884286|42067328|FG000|Overall Study|Thrombus in right auricle|1|||
19704605|NCT00129402|42148933|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19511455|NCT01984242|41921587|FG002|Overall Study|Lost to Follow-up|3|||
19511456|NCT01984242|41921585|FG000|Overall Study|Sponsor Decision|1|||
19511457|NCT01984242|41921586|FG001|Overall Study|Sponsor Decision|0|||
19511458|NCT01984242|41921587|FG002|Overall Study|Sponsor Decision|0|||
19511459|NCT01984242|41921585|FG000|Overall Study|Non-Compliance|1|||
19511460|NCT01984242|41921586|FG001|Overall Study|Non-Compliance|0|||
19511461|NCT01984242|41921587|FG002|Overall Study|Non-Compliance|0|||
19511462|NCT01984242|41921585|FG000|Overall Study|Study terminated by Sponsor|38|||
19511463|NCT01984242|41921586|FG001|Overall Study|Study terminated by Sponsor|50|||
19511464|NCT01984242|41921587|FG002|Overall Study|Study terminated by Sponsor|34|||
19511465|NCT01984242|41921585|FG000|Overall Study|Disease Progression|0|||
19511466|NCT01984242|41921586|FG001|Overall Study|Disease Progression|0|||
19511467|NCT01984242|41921587|FG002|Overall Study|Disease Progression|1|||
19511468|NCT01941498|41921603|FG000|Overall Study|Relocated out of state|1|||
19511469|NCT01960998|41921624|FG000|Overall Study|Lost to Follow-up|3|||
19511470|NCT01960998|41921625|FG001|Overall Study|Lost to Follow-up|7|||
19511471|NCT01960998|41921624|FG000|Overall Study|Death|0|||
19511472|NCT01960998|41921625|FG001|Overall Study|Death|1|||
19511473|NCT01960998|41921624|FG000|Overall Study|Withdrawal by Subject|8|||
19511474|NCT01960998|41921625|FG001|Overall Study|Withdrawal by Subject|2|||
19511475|NCT01960998|41921624|FG000|Overall Study|lost computer access|0|||
19511476|NCT01960998|41921625|FG001|Overall Study|lost computer access|1|||
19511477|NCT01941186|41921635|FG000|Follow-up|Lost to Follow-up|1|||
19511478|NCT01941186|41921636|FG001|Follow-up|Lost to Follow-up|0|||
19511479|NCT01960842|41921655|FG000|Overall Study|Adverse Event|1|||
19511480|NCT01960842|41921655|FG000|Overall Study|Withdrawal by Subject|2|||
19511481|NCT01984164|41921661|FG000|Overall Study|Withdrawal by Subject|4|||
19511482|NCT01984164|41921662|FG001|Overall Study|Withdrawal by Subject|3|||
19511483|NCT01984164|41921661|FG000|Overall Study|Adverse Event|5|||
19511484|NCT01984164|41921662|FG001|Overall Study|Adverse Event|19|||
19511485|NCT01984164|41921661|FG000|Overall Study|Lost to Follow-up|1|||
19511486|NCT01984164|41921662|FG001|Overall Study|Lost to Follow-up|3|||
19511487|NCT01941030|41921670|FG000|Overall Study|Death|3|||
19511488|NCT01941030|41921671|FG001|Overall Study|Death|2|||
19511489|NCT01941030|41921670|FG000|Overall Study|Lost to Follow-up|6|||
19511490|NCT01941030|41921671|FG001|Overall Study|Lost to Follow-up|5|||
19511491|NCT01941030|41921670|FG000|Overall Study|Withdrawal by Subject|4|||
19511492|NCT01941030|41921671|FG001|Overall Study|Withdrawal by Subject|6|||
19617540|NCT00884286|42067329|FG001|Overall Study|Thrombus in right auricle|0|||
19617541|NCT00884286|42067328|FG000|Overall Study|Not treated|2|||
19617542|NCT00884286|42067329|FG001|Overall Study|Not treated|1|||
19617543|NCT00884286|42067328|FG000|Overall Study|Comprised lung carcinoma|0|||
19617544|NCT00884286|42067329|FG001|Overall Study|Comprised lung carcinoma|1|||
19511493|NCT01983930|41921679|FG000|Overall Study|Withdrawal by Subject|9|||
19511494|NCT01983930|41921680|FG001|Overall Study|Withdrawal by Subject|8|||
19511495|NCT01983930|41921679|FG000|Overall Study|Adverse Event|0|||
19511496|NCT01983930|41921680|FG001|Overall Study|Adverse Event|1|||
19511497|NCT01983774|41921693|FG000|Overall Study|Lung Transplant|0|||
19511498|NCT01983774|41921694|FG001|Overall Study|Lung Transplant|1|||
19511499|NCT01983774|41921693|FG000|Overall Study|Lost to Follow-up|1|||
19511500|NCT01983774|41921694|FG001|Overall Study|Lost to Follow-up|0|||
19511501|NCT01982682|41921702|FG000|Overall Study|Physician Decision|1|||
19511502|NCT01940484|41921707|FG000|Overall Study|Withdrawal by Subject|3|||
19511503|NCT01940484|41921707|FG000|Overall Study|Underwent transplantation|4|||
19511504|NCT01940484|41921707|FG000|Overall Study|Death|2|||
19511505|NCT01940484|41921707|FG000|Overall Study|Adverse Event|1|||
19511506|NCT01939548|41921714|FG000|Overall Study|Non compliance|0|||
19511507|NCT01939548|41921715|FG001|Overall Study|Non compliance|2|||
19511508|NCT01939548|41921716|FG002|Overall Study|Non compliance|0|||
19511509|NCT01939548|41921714|FG000|Overall Study|Study Terminated by Sponsor|17|||
19511510|NCT01939548|41921715|FG001|Overall Study|Study Terminated by Sponsor|19|||
19511511|NCT01939548|41921716|FG002|Overall Study|Study Terminated by Sponsor|12|||
19617545|NCT00873015|42067340|FG000|Overall Study|Withdrawal by Subject|0|||
19617546|NCT00873015|42067341|FG001|Overall Study|Withdrawal by Subject|1|||
19617547|NCT00873015|42067342|FG002|Overall Study|Withdrawal by Subject|0|||
19511512|NCT01939548|41921714|FG000|Overall Study|Insufficient Clinical Response|1|||
19511513|NCT01939548|41921715|FG001|Overall Study|Insufficient Clinical Response|0|||
19511514|NCT01939548|41921716|FG002|Overall Study|Insufficient Clinical Response|0|||
19511515|NCT01939548|41921714|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
19511516|NCT01939548|41921715|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
19511517|NCT01939548|41921716|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
19617548|NCT00873015|42067343|FG003|Overall Study|Withdrawal by Subject|0|||
19617549|NCT03921151|42067358|FG000|Overall Study|Withdrawal by Subject|11|||
19617550|NCT03921151|42067359|FG001|Overall Study|Withdrawal by Subject|16|||
19617551|NCT00872001|42067371|FG000|Overall Study|Adverse Event|34|||
19617552|NCT00872001|42067372|FG001|Overall Study|Adverse Event|23|||
19617553|NCT00872001|42067371|FG000|Overall Study|Protocol Defined Clinical Event|5|||
19617554|NCT00872001|42067372|FG001|Overall Study|Protocol Defined Clinical Event|7|||
19617555|NCT00872001|42067371|FG000|Overall Study|Lost to Follow-up|13|||
19617556|NCT00872001|42067372|FG001|Overall Study|Lost to Follow-up|12|||
19617557|NCT00872001|42067371|FG000|Overall Study|Withdrawal by Subject|18|||
19617558|NCT00872001|42067372|FG001|Overall Study|Withdrawal by Subject|30|||
19617559|NCT00872001|42067371|FG000|Overall Study|Protocol Violation|5|||
19617560|NCT00872001|42067372|FG001|Overall Study|Protocol Violation|8|||
19617561|NCT00872001|42067371|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
19511518|NCT01939548|41921714|FG000|Overall Study|Withdrawal by Subject|4|||
19511519|NCT01939548|41921715|FG001|Overall Study|Withdrawal by Subject|4|||
19511520|NCT01939548|41921716|FG002|Overall Study|Withdrawal by Subject|1|||
19511521|NCT01939548|41921714|FG000|Overall Study|Protocol Violation|7|||
19511522|NCT01939548|41921715|FG001|Overall Study|Protocol Violation|6|||
19511523|NCT01939548|41921716|FG002|Overall Study|Protocol Violation|5|||
19511524|NCT01939548|41921714|FG000|Overall Study|Lost to Follow-up|5|||
19511525|NCT01939548|41921715|FG001|Overall Study|Lost to Follow-up|5|||
19511526|NCT01939548|41921716|FG002|Overall Study|Lost to Follow-up|3|||
19511527|NCT01939548|41921714|FG000|Overall Study|Adverse Event|2|||
19511528|NCT01939548|41921715|FG001|Overall Study|Adverse Event|9|||
19511529|NCT01939548|41921716|FG002|Overall Study|Adverse Event|7|||
19511530|NCT01939548|41921714|FG000|Overall Study|Death|0|||
19511531|NCT01939548|41921715|FG001|Overall Study|Death|0|||
19511532|NCT01939548|41921716|FG002|Overall Study|Death|1|||
19511533|NCT01939548|41921714|FG000|Overall Study|Participant dropped|0|||
19511534|NCT01939548|41921715|FG001|Overall Study|Participant dropped|0|||
19511535|NCT01939548|41921716|FG002|Overall Study|Participant dropped|1|||
19511536|NCT01939548|41921714|FG000|Overall Study|Participant unwilling to continue|0|||
19511537|NCT01939548|41921715|FG001|Overall Study|Participant unwilling to continue|1|||
19511538|NCT01939548|41921716|FG002|Overall Study|Participant unwilling to continue|0|||
19511539|NCT01939548|41921714|FG000|Overall Study|Participant withdrew consent|0|||
19511540|NCT01939548|41921715|FG001|Overall Study|Participant withdrew consent|2|||
19511541|NCT01939548|41921716|FG002|Overall Study|Participant withdrew consent|0|||
19511542|NCT01939548|41921714|FG000|Overall Study|Did not complete follow-up|0|||
19511543|NCT01939548|41921715|FG001|Overall Study|Did not complete follow-up|1|||
19511544|NCT01939548|41921716|FG002|Overall Study|Did not complete follow-up|0|||
19511545|NCT01960296|41921726|FG000|Overall Study|Postponed surgery|1|||
19511546|NCT01960296|41921727|FG001|Overall Study|Postponed surgery|0|||
19617562|NCT00872001|42067372|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
19511547|NCT01960296|41921726|FG000|Overall Study|Received different procedure|1|||
19511548|NCT01960296|41921727|FG001|Overall Study|Received different procedure|3|||
19511549|NCT01982292|41921735|FG000|Overall Study|Adverse Event|2|||
19511550|NCT01982292|41921736|FG001|Overall Study|Adverse Event|0|||
19617563|NCT00872001|42067371|FG000|Overall Study|Administrative|23|||
19511551|NCT01982292|41921735|FG000|Overall Study|Death|1|||
19511552|NCT01982292|41921736|FG001|Overall Study|Death|0|||
19511553|NCT01982292|41921735|FG000|Overall Study|Lost to Follow-up|2|||
19511554|NCT01982292|41921736|FG001|Overall Study|Lost to Follow-up|0|||
19511555|NCT01982292|41921735|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
19511556|NCT01982292|41921736|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
19511557|NCT01982292|41921735|FG000|Overall Study|Protocol Deviation|1|||
19511558|NCT01982292|41921736|FG001|Overall Study|Protocol Deviation|0|||
19511559|NCT01982292|41921735|FG000|Overall Study|Patient/Guardian Decision|3|||
19511560|NCT01982292|41921736|FG001|Overall Study|Patient/Guardian Decision|1|||
19511561|NCT01982292|41921735|FG000|Overall Study|Technical Problems|2|||
19511562|NCT01982292|41921736|FG001|Overall Study|Technical Problems|0|||
19511563|NCT01939314|41921744|FG000|Overall Study|Withdrawal by Subject|3|||
19511564|NCT01939314|41921745|FG001|Overall Study|Withdrawal by Subject|1|||
19511565|NCT01939314|41921744|FG000|Overall Study|Protocol Violation|1|||
19511566|NCT01939314|41921745|FG001|Overall Study|Protocol Violation|0|||
19511567|NCT01939314|41921744|FG000|Overall Study|Pregnancy|0|||
19511568|NCT01939314|41921745|FG001|Overall Study|Pregnancy|1|||
19511569|NCT01939314|41921744|FG000|Overall Study|Lost to Follow-up|5|||
19511570|NCT01939314|41921745|FG001|Overall Study|Lost to Follow-up|6|||
19511571|NCT01939158|41921757|FG000|Overall Study|Adverse Event|1|||
19511572|NCT01939158|41921758|FG001|Overall Study|Adverse Event|0|||
19511573|NCT01939158|41921759|FG002|Overall Study|Adverse Event|0|||
19511574|NCT01939158|41921760|FG003|Overall Study|Adverse Event|0|||
19511575|NCT01939158|41921757|FG000|Overall Study|Withdrawal by Subject|22|||
19511576|NCT01939158|41921758|FG001|Overall Study|Withdrawal by Subject|25|||
19511577|NCT01939158|41921759|FG002|Overall Study|Withdrawal by Subject|15|||
19511578|NCT01939158|41921760|FG003|Overall Study|Withdrawal by Subject|17|||
19511579|NCT01939158|41921757|FG000|Overall Study|Migrated/moved from study area|5|||
19511580|NCT01939158|41921758|FG001|Overall Study|Migrated/moved from study area|7|||
19511581|NCT01939158|41921759|FG002|Overall Study|Migrated/moved from study area|3|||
19511582|NCT01939158|41921760|FG003|Overall Study|Migrated/moved from study area|6|||
19511583|NCT01939158|41921757|FG000|Overall Study|Lost to Follow-up|18|||
19511584|NCT01939158|41921758|FG001|Overall Study|Lost to Follow-up|17|||
19511585|NCT01939158|41921759|FG002|Overall Study|Lost to Follow-up|17|||
19511586|NCT01939158|41921760|FG003|Overall Study|Lost to Follow-up|17|||
19511587|NCT01939158|41921757|FG000|Overall Study|Death|0|||
19511588|NCT01939158|41921758|FG001|Overall Study|Death|0|||
19511589|NCT01939158|41921759|FG002|Overall Study|Death|1|||
19511590|NCT01939158|41921760|FG003|Overall Study|Death|1|||
19511591|NCT01939158|41921757|FG000|Overall Study|No longer meets eligibility criteria|0|||
19511592|NCT01939158|41921758|FG001|Overall Study|No longer meets eligibility criteria|0|||
19511593|NCT01939158|41921759|FG002|Overall Study|No longer meets eligibility criteria|1|||
19511594|NCT01939158|41921760|FG003|Overall Study|No longer meets eligibility criteria|0|||
19511595|NCT01939158|41921757|FG000|Overall Study|Other|1|||
19511596|NCT01939158|41921758|FG001|Overall Study|Other|3|||
19511597|NCT01939158|41921759|FG002|Overall Study|Other|4|||
19511598|NCT01939158|41921760|FG003|Overall Study|Other|3|||
19511599|NCT01939002|41921776|FG000|Overall Study|Adverse Event|13|||
19511600|NCT01939002|41921777|FG001|Overall Study|Adverse Event|13|||
19511601|NCT01939002|41921776|FG000|Overall Study|Withdrawal by Subject|5|||
19511602|NCT01939002|41921777|FG001|Overall Study|Withdrawal by Subject|3|||
19511603|NCT01939002|41921776|FG000|Overall Study|Other|1|||
19511604|NCT01939002|41921777|FG001|Overall Study|Other|2|||
19511605|NCT01938846|41921791|FG000|Overall Study|Progressive disease|26|||
19511606|NCT01938846|41921792|FG001|Overall Study|Progressive disease|18|||
19511607|NCT01938846|41921793|FG002|Overall Study|Progressive disease|16|||
19511608|NCT01938846|41921791|FG000|Overall Study|Adverse Event|8|||
19511609|NCT01938846|41921792|FG001|Overall Study|Adverse Event|4|||
19511610|NCT01938846|41921793|FG002|Overall Study|Adverse Event|3|||
19511611|NCT01938846|41921791|FG000|Overall Study|Withdrawal by Subject|2|||
19511612|NCT01938846|41921792|FG001|Overall Study|Withdrawal by Subject|2|||
19511613|NCT01938846|41921793|FG002|Overall Study|Withdrawal by Subject|1|||
19511614|NCT01938846|41921791|FG000|Overall Study|Other than listed|5|||
19511615|NCT01938846|41921792|FG001|Overall Study|Other than listed|1|||
19511616|NCT01938846|41921793|FG002|Overall Study|Other than listed|4|||
19617564|NCT00872001|42067372|FG001|Overall Study|Administrative|15|||
19511617|NCT01960140|41921834|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
19511618|NCT01981356|41921844|FG000|Overall Study|Lost to Follow-up|4|||
19704606|NCT00129402|42148934|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
19511619|NCT01981356|41921845|FG001|Overall Study|Lost to Follow-up|1|||
19511620|NCT01981356|41921844|FG000|Overall Study|Withdrawal by Subject|1|||
19511621|NCT01981356|41921845|FG001|Overall Study|Withdrawal by Subject|1|||
19511622|NCT01981356|41921844|FG000|Overall Study|Protocol Violation|2|||
19511623|NCT01981356|41921845|FG001|Overall Study|Protocol Violation|0|||
19511624|NCT01981122|41921854|FG000|Overall Study|Withdrawal by Subject|0|||
19511625|NCT01981122|41921855|FG001|Overall Study|Withdrawal by Subject|2|||
19511626|NCT01981122|41921854|FG000|Overall Study|Protocol Violation|0|||
19511627|NCT01981122|41921855|FG001|Overall Study|Protocol Violation|1|||
19511628|NCT01981122|41921854|FG000|Overall Study|Lost to Follow-up|0|||
19511629|NCT01981122|41921855|FG001|Overall Study|Lost to Follow-up|1|||
19511630|NCT01981122|41921854|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
19511631|NCT01981122|41921855|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
19511632|NCT01981122|41921854|FG000|Overall Study|Death|14|||
19511633|NCT01981122|41921855|FG001|Overall Study|Death|15|||
19511634|NCT01959672|41921861|FG000|Overall Study|Death|1|||
19511635|NCT01980888|41921870|FG000|Overall Study|Study Terminated by Sponsor|116|||
19511636|NCT01980888|41921871|FG001|Overall Study|Study Terminated by Sponsor|122|||
19511637|NCT01980888|41921870|FG000|Overall Study|Withdrew Consent|17|||
19511638|NCT01980888|41921871|FG001|Overall Study|Withdrew Consent|6|||
19511639|NCT01980888|41921870|FG000|Overall Study|Investigator's Discretion|8|||
19511640|NCT01980888|41921871|FG001|Overall Study|Investigator's Discretion|3|||
19511641|NCT01980888|41921870|FG000|Overall Study|Non-Compliance with Study Drug|3|||
19511642|NCT01980888|41921871|FG001|Overall Study|Non-Compliance with Study Drug|2|||
19511643|NCT01937364|41921888|FG000|Overall Study|Adverse Event|2|||
19511644|NCT01937364|41921889|FG001|Overall Study|Adverse Event|1|||
19511645|NCT01979952|41921897|FG000|Overall Study|Adverse Event|4|||
19511646|NCT01979952|41921898|FG001|Overall Study|Adverse Event|5|||
19511647|NCT01979952|41921897|FG000|Overall Study|Protocol Violation|1|||
19511648|NCT01979952|41921898|FG001|Overall Study|Protocol Violation|0|||
19511649|NCT01979952|41921897|FG000|Overall Study|Withdrawal by Subject|2|||
19511650|NCT01979952|41921898|FG001|Overall Study|Withdrawal by Subject|1|||
19511651|NCT01979952|41921897|FG000|Overall Study|Other than specified above|1|||
19511652|NCT01979952|41921898|FG001|Overall Study|Other than specified above|0|||
19511653|NCT01937130|41921908|FG000|Overall Study|Withdrawal by Subject|0|||
19511654|NCT01937130|41921909|FG001|Overall Study|Withdrawal by Subject|0|||
19511655|NCT01937130|41921910|FG002|Overall Study|Withdrawal by Subject|0|||
19511656|NCT01937130|41921911|FG003|Overall Study|Withdrawal by Subject|1|||
19511657|NCT01937130|41921908|FG000|Overall Study|Adverse Event|0|||
19511658|NCT01937130|41921909|FG001|Overall Study|Adverse Event|1|||
19511659|NCT01937130|41921910|FG002|Overall Study|Adverse Event|0|||
19511660|NCT01937130|41921911|FG003|Overall Study|Adverse Event|1|||
19511661|NCT01937130|41921908|FG000|Overall Study|Death|1|||
19511662|NCT01937130|41921909|FG001|Overall Study|Death|1|||
19511663|NCT01937130|41921910|FG002|Overall Study|Death|1|||
19511664|NCT01937130|41921911|FG003|Overall Study|Death|0|||
19511665|NCT01937130|41921908|FG000|Overall Study|Lost to Follow-up|2|||
19511666|NCT01937130|41921909|FG001|Overall Study|Lost to Follow-up|0|||
19511667|NCT01937130|41921910|FG002|Overall Study|Lost to Follow-up|2|||
19511668|NCT01937130|41921911|FG003|Overall Study|Lost to Follow-up|0|||
19511669|NCT01937130|41921908|FG000|Overall Study|Physician Decision|0|||
19511670|NCT01937130|41921909|FG001|Overall Study|Physician Decision|1|||
19511671|NCT01937130|41921910|FG002|Overall Study|Physician Decision|0|||
19511672|NCT01937130|41921911|FG003|Overall Study|Physician Decision|0|||
19511673|NCT01937130|41921908|FG000|Overall Study|Patients unable to swallow|0|||
19617565|NCT00871923|42067380|FG000|Overall Study|Death|1|||
19617566|NCT00871923|42067380|FG000|Overall Study|Withdrawal by Subject|1|||
19617567|NCT03922945|42067387|FG000|Overall Study|Adverse Event|1|||
19617568|NCT03922945|42067388|FG001|Overall Study|Adverse Event|1|||
19617569|NCT03922945|42067389|FG002|Overall Study|Adverse Event|2|||
19617570|NCT03922945|42067387|FG000|Overall Study|Lost to Follow-up|13|||
19617571|NCT03922945|42067388|FG001|Overall Study|Lost to Follow-up|9|||
19617572|NCT03922945|42067389|FG002|Overall Study|Lost to Follow-up|20|||
19511674|NCT01937130|41921909|FG001|Overall Study|Patients unable to swallow|1|||
19511675|NCT01937130|41921910|FG002|Overall Study|Patients unable to swallow|0|||
19511676|NCT01937130|41921911|FG003|Overall Study|Patients unable to swallow|0|||
19511677|NCT01937130|41921908|FG000|Overall Study|Patient lost to FU due to death|2|||
19511678|NCT01937130|41921909|FG001|Overall Study|Patient lost to FU due to death|0|||
19511679|NCT01937130|41921910|FG002|Overall Study|Patient lost to FU due to death|0|||
19511680|NCT01937130|41921911|FG003|Overall Study|Patient lost to FU due to death|0|||
19511681|NCT01936974|41921923|FG000|Overall Study|Physician Decision|2|||
19511682|NCT01936974|41921924|FG001|Overall Study|Physician Decision|5|||
19511683|NCT01959516|41921930|FG000|Epoch 1|Adverse Event|4|||
19511684|NCT01959516|41921931|FG001|Epoch 1|Adverse Event|1|||
19511685|NCT01959516|41921930|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
19511686|NCT01959516|41921931|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
19511687|NCT01959516|41921930|FG000|Epoch 1|Subject withdrew consent|3|||
19511688|NCT01959516|41921931|FG001|Epoch 1|Subject withdrew consent|2|||
19511689|NCT01959516|41921930|FG000|Epoch 1|Administrative problems|1|||
19511690|NCT01959516|41921931|FG001|Epoch 1|Administrative problems|0|||
19511691|NCT01959516|41921930|FG000|Epoch 1|Use of prohibited treatment|1|||
19511692|NCT01959516|41921931|FG001|Epoch 1|Use of prohibited treatment|0|||
19617573|NCT03922945|42067387|FG000|Overall Study|Lack of Efficacy|2|||
19511693|NCT01959516|41921930|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
19511694|NCT01959516|41921931|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
19511695|NCT01959516|41921930|FG000|Epoch 1|Protocol deviation|0|||
19511696|NCT01959516|41921931|FG001|Epoch 1|Protocol deviation|1|||
19511697|NCT01959516|41921930|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
19511698|NCT01959516|41921931|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
19511699|NCT01959516|41921930|FG000|Epoch 2|Subject withdrew consent|1|||
19704607|NCT00129402|42148935|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
19704608|NCT00129402|42148929|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704609|NCT00129402|42148930|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704610|NCT00129402|42148931|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704611|NCT00129402|42148932|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704612|NCT00129402|42148933|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704613|NCT00129402|42148934|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
19704614|NCT00129402|42148935|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
19704615|NCT03739528|42148945|FG000|Overall Study|Not treated|8|||
19704616|NCT03739528|42148946|FG001|Overall Study|Not treated|12|||
19511700|NCT01959516|41921931|FG001|Epoch 2|Subject withdrew consent|0|||
19511701|NCT01959516|41921930|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
19511702|NCT01959516|41921931|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
19511703|NCT01979016|41921939|FG000|Overall Study|Withdrawal by Subject|2|||
19511704|NCT01979016|41921940|FG001|Overall Study|Withdrawal by Subject|0|||
19511705|NCT01979016|41921939|FG000|Overall Study|Adverse Event|0|||
19511706|NCT01979016|41921940|FG001|Overall Study|Adverse Event|1|||
19511707|NCT01935336|41921950|FG000|Overall Study|Adverse Event|1|||
19511708|NCT01935336|41921951|FG001|Overall Study|Adverse Event|0|||
19511709|NCT01935336|41921952|FG002|Overall Study|Adverse Event|0|||
19511710|NCT01935336|41921953|FG003|Overall Study|Adverse Event|0|||
19511711|NCT01935336|41921950|FG000|Overall Study|Progressive disease|5|||
19511712|NCT01935336|41921951|FG001|Overall Study|Progressive disease|3|||
19511713|NCT01935336|41921952|FG002|Overall Study|Progressive disease|47|||
19511714|NCT01935336|41921953|FG003|Overall Study|Progressive disease|66|||
19511715|NCT01978236|41921969|FG000|Overall Study|Discontinued due to study close|2|||
19511716|NCT01977846|41921975|FG000|Total Study - Prospective|Death|0|||
19511717|NCT01977846|41921976|FG001|Total Study - Prospective|Death|1|||
19511718|NCT01977846|41921975|FG000|Total Study - Prospective|Lost to Follow-up|0|||
19511719|NCT01977846|41921976|FG001|Total Study - Prospective|Lost to Follow-up|8|||
19511720|NCT01977846|41921975|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
19511721|NCT01977846|41921976|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
19511722|NCT01977846|41921975|FG000|Total Study - Prospective|Not available at time of visit|0|||
19511723|NCT01977846|41921976|FG001|Total Study - Prospective|Not available at time of visit|5|||
19511724|NCT01977846|41921975|FG000|Total Study - Prospective|No show|0|||
19511725|NCT01977846|41921976|FG001|Total Study - Prospective|No show|1|||
19511726|NCT01977846|41921975|FG000|Total Study - Prospective|Protocol Violation|0|||
19511727|NCT01977846|41921976|FG001|Total Study - Prospective|Protocol Violation|1|||
19511728|NCT01934790|41921983|FG000|Treatment|Adverse Event|3|||
19511729|NCT01934790|41921983|FG000|Treatment|Clinical progression|6|||
19511730|NCT01934790|41921983|FG000|Treatment|Radiological progression|4|||
19511731|NCT01934790|41921983|FG000|Treatment|Withdrawal by Subject|2|||
19511732|NCT01934790|41921983|FG000|Treatment|Study drug never administered|1|||
19511733|NCT01934790|41921983|FG000|Active Follow up|Death|20|||
19511734|NCT01934790|41921983|FG000|Active Follow up|Physician Decision|2|||
19511735|NCT01934790|41921983|FG000|Active Follow up|Progressive disease|1|||
19511736|NCT01934790|41921983|FG000|Active Follow up|Other reason|1|||
19511737|NCT01934556|41921990|FG000|Overall Study|Withdrawal by Subject|0|||
19511738|NCT01934556|41921991|FG001|Overall Study|Withdrawal by Subject|1|||
19511739|NCT01934556|41921992|FG002|Overall Study|Withdrawal by Subject|1|||
19511740|NCT01934556|41921990|FG000|Overall Study|Lost to Follow-up|4|||
19511741|NCT01934556|41921991|FG001|Overall Study|Lost to Follow-up|10|||
19511742|NCT01934556|41921992|FG002|Overall Study|Lost to Follow-up|7|||
19511743|NCT01934556|41921990|FG000|Overall Study|Death|1|||
19511744|NCT01934556|41921991|FG001|Overall Study|Death|5|||
19511745|NCT01934556|41921992|FG002|Overall Study|Death|2|||
19511746|NCT01977690|41922002|FG000|Overall Study|Withdrawal by Subject|0|||
19511747|NCT01977690|41922003|FG001|Overall Study|Withdrawal by Subject|4|||
19511748|NCT01934010|41922078|FG000|Overall Study|Adverse Event|1|||
19511749|NCT01934010|41922079|FG001|Overall Study|Adverse Event|1|||
19511750|NCT01934010|41922080|FG002|Overall Study|Adverse Event|0|||
19511751|NCT01934010|41922078|FG000|Overall Study|Withdrawal by Subject|15|||
19511752|NCT01934010|41922079|FG001|Overall Study|Withdrawal by Subject|6|||
19511753|NCT01934010|41922080|FG002|Overall Study|Withdrawal by Subject|2|||
19511754|NCT01934010|41922078|FG000|Overall Study|Lost to Follow-up|7|||
19511755|NCT01934010|41922079|FG001|Overall Study|Lost to Follow-up|4|||
19511756|NCT01934010|41922080|FG002|Overall Study|Lost to Follow-up|0|||
19511757|NCT01620138|41922099|FG000|Overall Study|Withdrawal by Subject|3|||
19704617|NCT03739528|42148945|FG000|Overall Study|Treatment and study discontinued|6|||
19704618|NCT03739528|42148946|FG001|Overall Study|Treatment and study discontinued|2|||
19704619|NCT03739528|42148945|FG000|Overall Study|Treatment discontinued + study completed|1|||
19704620|NCT03739528|42148946|FG001|Overall Study|Treatment discontinued + study completed|3|||
19704621|NCT00114738|42148955|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
19704622|NCT00114738|42148956|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
19704623|NCT00114738|42148957|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
19704624|NCT00114738|42148955|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
19704625|NCT00114738|42148956|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
19704626|NCT00114738|42148957|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
19704627|NCT00114738|42148955|FG000|Screening for Randomization|Neuropathy|17|||
19704628|NCT00114738|42148956|FG001|Screening for Randomization|Neuropathy|0|||
19704629|NCT00114738|42148957|FG002|Screening for Randomization|Neuropathy|0|||
19511758|NCT01620138|41922100|FG001|Overall Study|Withdrawal by Subject|0|||
19511759|NCT01620138|41922099|FG000|Overall Study|Lack of Efficacy|1|||
19511760|NCT01620138|41922100|FG001|Overall Study|Lack of Efficacy|0|||
19511761|NCT01620138|41922099|FG000|Overall Study|Adverse Event|2|||
19511762|NCT01620138|41922100|FG001|Overall Study|Adverse Event|0|||
19511763|NCT01977612|41922108|FG000|Overall Study|Lost to Follow-up|1|||
19511764|NCT01977612|41922109|FG001|Overall Study|Lost to Follow-up|1|||
19511765|NCT01932996|41922117|FG000|Overall Study|Protocol Violation|2|||
19511766|NCT01932996|41922118|FG001|Overall Study|Protocol Violation|0|||
19511767|NCT01932762|41922128|FG000|Overall Study|Withdrawal by Subject|1|||
19511768|NCT01932762|41922129|FG001|Overall Study|Withdrawal by Subject|2|||
19511769|NCT01932762|41922130|FG002|Overall Study|Withdrawal by Subject|0|||
19511770|NCT01932762|41922131|FG003|Overall Study|Withdrawal by Subject|0|||
19511771|NCT01932762|41922128|FG000|Overall Study|Lost to Follow-up|4|||
19511772|NCT01932762|41922129|FG001|Overall Study|Lost to Follow-up|0|||
19511773|NCT01932762|41922130|FG002|Overall Study|Lost to Follow-up|0|||
19511774|NCT01932762|41922131|FG003|Overall Study|Lost to Follow-up|1|||
19511775|NCT01932762|41922128|FG000|Overall Study|Physician Decision|1|||
19511776|NCT01932762|41922129|FG001|Overall Study|Physician Decision|0|||
19511777|NCT01932762|41922130|FG002|Overall Study|Physician Decision|0|||
19511778|NCT01932762|41922131|FG003|Overall Study|Physician Decision|0|||
19511779|NCT01618968|41922145|FG000|Overall Study|Adverse Event|1|||
19511780|NCT01618968|41922146|FG001|Overall Study|Adverse Event|0|||
19511781|NCT01618968|41922147|FG002|Overall Study|Adverse Event|0|||
19511782|NCT01618968|41922148|FG003|Overall Study|Adverse Event|0|||
19511783|NCT01618968|41922145|FG000|Overall Study|Death|0|||
19511784|NCT01618968|41922146|FG001|Overall Study|Death|0|||
19511785|NCT01618968|41922147|FG002|Overall Study|Death|0|||
19511786|NCT01618968|41922148|FG003|Overall Study|Death|1|||
19511787|NCT01932294|41922157|FG000|Overall Study|Death|43|||
19511788|NCT01932294|41922157|FG000|Overall Study|Lost to Follow-up|8|||
19511789|NCT01932294|41922157|FG000|Overall Study|VAD Implantation|20|||
19511790|NCT01932294|41922157|FG000|Overall Study|Heart Transplantation|16|||
19511791|NCT01932294|41922157|FG000|Overall Study|Transferred to other hospitals|12|||
19511792|NCT01931670|41922165|FG000|Treatment Period|Exclusionary Medication Received|1|||
19511793|NCT01931670|41922166|FG001|Treatment Period|Exclusionary Medication Received|1|||
19511794|NCT01931670|41922167|FG002|Treatment Period|Exclusionary Medication Received|1|||
19511795|NCT01931670|41922165|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
19511796|NCT01931670|41922166|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
19511797|NCT01931670|41922167|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
19511798|NCT01931670|41922165|FG000|Treatment Period|Subject Noncompliant|4|||
19511799|NCT01931670|41922166|FG001|Treatment Period|Subject Noncompliant|9|||
19511800|NCT01931670|41922167|FG002|Treatment Period|Subject Noncompliant|5|||
19511801|NCT01931670|41922165|FG000|Treatment Period|Adverse Event|19|||
19511802|NCT01931670|41922166|FG001|Treatment Period|Adverse Event|8|||
19617574|NCT03922945|42067388|FG001|Overall Study|Lack of Efficacy|0|||
19617575|NCT03922945|42067389|FG002|Overall Study|Lack of Efficacy|1|||
19617576|NCT03922945|42067387|FG000|Overall Study|Protocol Non-Compliance|0|||
19617577|NCT03922945|42067388|FG001|Overall Study|Protocol Non-Compliance|0|||
19617578|NCT03922945|42067389|FG002|Overall Study|Protocol Non-Compliance|1|||
19617579|NCT03922945|42067387|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
19617580|NCT03922945|42067388|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
19617581|NCT03922945|42067389|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
19617582|NCT03922945|42067387|FG000|Overall Study|All Other Personal Reasons|1|||
19617583|NCT03922945|42067388|FG001|Overall Study|All Other Personal Reasons|1|||
19617584|NCT03922945|42067389|FG002|Overall Study|All Other Personal Reasons|2|||
19617585|NCT03922477|42067400|FG000|Overall Study|Death|9|||
19617586|NCT03922477|42067400|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
19617587|NCT03922477|42067400|FG000|Overall Study|Physician Decision|1|||
19617588|NCT03922477|42067400|FG000|Overall Study|Withdrawal by Subject|2|||
19511803|NCT01931670|41922167|FG002|Treatment Period|Adverse Event|21|||
19511804|NCT01931670|41922165|FG000|Treatment Period|Lack of Efficacy|11|||
19511805|NCT01931670|41922166|FG001|Treatment Period|Lack of Efficacy|2|||
19511806|NCT01931670|41922167|FG002|Treatment Period|Lack of Efficacy|2|||
19511807|NCT01931670|41922165|FG000|Treatment Period|Pregnancy|7|||
19511808|NCT01931670|41922166|FG001|Treatment Period|Pregnancy|2|||
19511809|NCT01931670|41922167|FG002|Treatment Period|Pregnancy|0|||
19511810|NCT01931670|41922165|FG000|Treatment Period|Other|8|||
19511811|NCT01931670|41922166|FG001|Treatment Period|Other|7|||
19511812|NCT01931670|41922167|FG002|Treatment Period|Other|2|||
19511813|NCT01931670|41922165|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
19511814|NCT01931670|41922166|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
19511815|NCT01931670|41922167|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
19511816|NCT01931670|41922165|FG000|Treatment Period|Lost to Follow-up|19|||
19511817|NCT01931670|41922166|FG001|Treatment Period|Lost to Follow-up|5|||
19511818|NCT01931670|41922167|FG002|Treatment Period|Lost to Follow-up|7|||
19511819|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
19511820|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
19511821|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
19511822|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
19617589|NCT00867165|42067406|FG000|Overall Study|Adverse Event|3|||
19617590|NCT00867165|42067407|FG001|Overall Study|Adverse Event|0|||
19617591|NCT00867165|42067406|FG000|Overall Study|Withdrawal by Subject|1|||
19617592|NCT00867165|42067407|FG001|Overall Study|Withdrawal by Subject|0|||
19617593|NCT00867087|42067413|FG000|Overall Study|Other|1|||
19617594|NCT00867087|42067413|FG000|Overall Study|Withdrawal by Subject|4|||
19617595|NCT00867087|42067413|FG000|Overall Study|Death|37|||
19617596|NCT00545233|42067419|FG000|Overall Study|Adverse Event|10|||
19617597|NCT00545233|42067420|FG001|Overall Study|Adverse Event|5|||
19617598|NCT00545233|42067419|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
19617599|NCT00545233|42067420|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
19511823|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
19511824|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
19511825|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
19511826|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
19511827|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
19511828|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
19511829|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
19511830|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
19511831|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
19511832|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
19511833|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
19511834|NCT01931670|41922165|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
19511835|NCT01931670|41922166|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
19511836|NCT01931670|41922167|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
19511837|NCT01977456|41922175|FG000|Overall Study|Death|5|||
19511838|NCT01957644|41922184|FG000|Overall Study|Adverse Event|4|||
19511839|NCT01957644|41922185|FG001|Overall Study|Adverse Event|2|||
19511840|NCT01957644|41922186|FG002|Overall Study|Adverse Event|0|||
19511841|NCT01957644|41922187|FG003|Overall Study|Adverse Event|0|||
19511842|NCT01957644|41922188|FG004|Overall Study|Adverse Event|1|||
19511843|NCT01957644|41922184|FG000|Overall Study|Progressive disease / relapse|0|||
19511844|NCT01957644|41922185|FG001|Overall Study|Progressive disease / relapse|1|||
19511845|NCT01957644|41922186|FG002|Overall Study|Progressive disease / relapse|0|||
19511846|NCT01957644|41922187|FG003|Overall Study|Progressive disease / relapse|1|||
19511847|NCT01957644|41922188|FG004|Overall Study|Progressive disease / relapse|0|||
19511848|NCT01957644|41922184|FG000|Overall Study|Other reason|1|||
19511849|NCT01957644|41922185|FG001|Overall Study|Other reason|2|||
19511850|NCT01957644|41922186|FG002|Overall Study|Other reason|1|||
19511851|NCT01957644|41922187|FG003|Overall Study|Other reason|1|||
19511852|NCT01957644|41922188|FG004|Overall Study|Other reason|0|||
19511853|NCT01957644|41922184|FG000|Overall Study|Withdrawal by Subject|1|||
19511854|NCT01957644|41922185|FG001|Overall Study|Withdrawal by Subject|0|||
19511855|NCT01957644|41922186|FG002|Overall Study|Withdrawal by Subject|0|||
19511856|NCT01957644|41922187|FG003|Overall Study|Withdrawal by Subject|0|||
19511857|NCT01957644|41922188|FG004|Overall Study|Withdrawal by Subject|0|||
19511858|NCT01957644|41922184|FG000|Overall Study|Protocol Violation|0|||
19511859|NCT01957644|41922185|FG001|Overall Study|Protocol Violation|1|||
19511860|NCT01957644|41922186|FG002|Overall Study|Protocol Violation|0|||
19511861|NCT01957644|41922187|FG003|Overall Study|Protocol Violation|0|||
19511862|NCT01957644|41922188|FG004|Overall Study|Protocol Violation|0|||
19511863|NCT01931202|41922205|FG000|Overall Study|Withdrawal by Subject|0|||
19511864|NCT01931202|41922206|FG001|Overall Study|Withdrawal by Subject|0|||
19511865|NCT01931202|41922207|FG002|Overall Study|Withdrawal by Subject|2|||
19511866|NCT01931202|41922205|FG000|Overall Study|Lost to Follow-up|0|||
19511867|NCT01931202|41922206|FG001|Overall Study|Lost to Follow-up|5|||
19511868|NCT01931202|41922207|FG002|Overall Study|Lost to Follow-up|2|||
19511869|NCT01930890|41922222|FG000|Overall Study|Study Termination|14|||
19511870|NCT01930890|41922223|FG001|Overall Study|Study Termination|28|||
19511871|NCT01930890|41922224|FG002|Overall Study|Study Termination|13|||
19511872|NCT01930890|41922225|FG003|Overall Study|Study Termination|25|||
19511873|NCT01930890|41922222|FG000|Overall Study|Death|0|||
19511874|NCT01930890|41922223|FG001|Overall Study|Death|0|||
19511875|NCT01930890|41922224|FG002|Overall Study|Death|0|||
19511876|NCT01930890|41922225|FG003|Overall Study|Death|1|||
19511877|NCT01930890|41922222|FG000|Overall Study|Investigator Decision|0|||
19511878|NCT01930890|41922223|FG001|Overall Study|Investigator Decision|1|||
19511879|NCT01930890|41922224|FG002|Overall Study|Investigator Decision|0|||
19511880|NCT01930890|41922225|FG003|Overall Study|Investigator Decision|0|||
19511881|NCT01930890|41922222|FG000|Overall Study|Consent Withdrawn|0|||
19511882|NCT01930890|41922223|FG001|Overall Study|Consent Withdrawn|3|||
19511883|NCT01930890|41922224|FG002|Overall Study|Consent Withdrawn|0|||
19511884|NCT01930890|41922225|FG003|Overall Study|Consent Withdrawn|1|||
19511885|NCT01930890|41922222|FG000|Overall Study|Adverse Event|0|||
19511886|NCT01930890|41922223|FG001|Overall Study|Adverse Event|1|||
19511887|NCT01930890|41922224|FG002|Overall Study|Adverse Event|0|||
19511888|NCT01930890|41922225|FG003|Overall Study|Adverse Event|0|||
19511889|NCT01930188|41922238|FG000|Overall Study|unclassified|4|||
19511890|NCT01930188|41922239|FG001|Overall Study|unclassified|5|||
19511891|NCT01930188|41922240|FG002|Overall Study|unclassified|3|||
19511892|NCT01930188|41922238|FG000|Overall Study|Missing follow-up information|2|||
19511893|NCT01930188|41922239|FG001|Overall Study|Missing follow-up information|2|||
19511894|NCT01930188|41922240|FG002|Overall Study|Missing follow-up information|3|||
19511895|NCT01930188|41922238|FG000|Overall Study|Lost to Follow-up|5|||
19617600|NCT00545233|42067419|FG000|Overall Study|Protocol Violation|2|||
19511896|NCT01930188|41922239|FG001|Overall Study|Lost to Follow-up|2|||
19511897|NCT01930188|41922240|FG002|Overall Study|Lost to Follow-up|2|||
19511898|NCT01930188|41922238|FG000|Overall Study|Death|2|||
19511899|NCT01930188|41922239|FG001|Overall Study|Death|1|||
19511900|NCT01930188|41922240|FG002|Overall Study|Death|3|||
19511901|NCT01930188|41922238|FG000|Overall Study|Withdrawal by Subject|9|||
19511902|NCT01930188|41922239|FG001|Overall Study|Withdrawal by Subject|11|||
19511903|NCT01930188|41922240|FG002|Overall Study|Withdrawal by Subject|8|||
19511904|NCT01977222|41922249|FG000|Overall Study|Withdrawal by Subject|1|||
19511905|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
19511906|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
19511907|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
19511908|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
19511909|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
19511910|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
19511911|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
19511912|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
19511913|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
19511914|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
19511915|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
19511916|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
19511917|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
19511918|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
19511919|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
19511920|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
19511921|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
19511922|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
19511923|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19511924|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19511925|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
19511926|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
19511927|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
19511928|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
19511929|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
19511930|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
19511931|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
19511932|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
19511933|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
19511934|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
19511935|NCT01957488|41922253|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
19511936|NCT01957488|41922254|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
19511937|NCT01957488|41922255|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
19394142|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
19394143|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
19511938|NCT01957488|41922256|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
19511939|NCT01957488|41922257|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
19511940|NCT01957488|41922258|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
19511941|NCT01957488|41922253|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
19511942|NCT01957488|41922254|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
19511943|NCT01957488|41922255|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
19511944|NCT01957488|41922256|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
19511945|NCT01957488|41922257|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
19511946|NCT01957488|41922258|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
19511947|NCT01957488|41922253|FG000|Test Period 2 (2 Weeks)|Other|1|||
19511948|NCT01957488|41922254|FG001|Test Period 2 (2 Weeks)|Other|0|||
19511949|NCT01957488|41922255|FG002|Test Period 2 (2 Weeks)|Other|0|||
19511950|NCT01957488|41922256|FG003|Test Period 2 (2 Weeks)|Other|0|||
19511951|NCT01957488|41922257|FG004|Test Period 2 (2 Weeks)|Other|0|||
19511952|NCT01957488|41922258|FG005|Test Period 2 (2 Weeks)|Other|0|||
19511953|NCT01957488|41922253|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
19511954|NCT01957488|41922254|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
19511955|NCT01957488|41922255|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
19511956|NCT01957488|41922256|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
19511957|NCT01957488|41922257|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
19511958|NCT01957488|41922258|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
19511959|NCT01957488|41922253|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
19511960|NCT01957488|41922254|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
19511961|NCT01957488|41922255|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
19511962|NCT01957488|41922256|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
19511963|NCT01957488|41922257|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
19511964|NCT01957488|41922258|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
19511965|NCT01957488|41922253|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
19511966|NCT01957488|41922254|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
19511967|NCT01957488|41922255|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
19511968|NCT01957488|41922256|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
19511969|NCT01957488|41922257|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
19511970|NCT01957488|41922258|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
19511971|NCT01957488|41922253|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
19511972|NCT01957488|41922254|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
19511973|NCT01957488|41922255|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
19511974|NCT01957488|41922256|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
19511975|NCT01957488|41922257|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
19511976|NCT01957488|41922258|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
19511977|NCT01957488|41922253|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
19511978|NCT01957488|41922254|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
19511979|NCT01957488|41922255|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
19511980|NCT01957488|41922256|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
19511981|NCT01957488|41922257|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
19511982|NCT01957488|41922258|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
19511983|NCT01976364|41922266|FG000|Main Study (36 Months)|Adverse Event|63|||
19511984|NCT01976364|41922267|FG001|Main Study (36 Months)|Adverse Event|0|||
19511985|NCT01976364|41922268|FG002|Main Study (36 Months)|Adverse Event|0|||
19617601|NCT00545233|42067420|FG001|Overall Study|Protocol Violation|0|||
19617602|NCT00545233|42067419|FG000|Overall Study|Refused Treatment|9|||
19617603|NCT00545233|42067420|FG001|Overall Study|Refused Treatment|7|||
19617604|NCT00545233|42067419|FG000|Overall Study|Failure to Return|4|||
19617605|NCT00545233|42067420|FG001|Overall Study|Failure to Return|6|||
19511986|NCT01976364|41922266|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
19511987|NCT01976364|41922267|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
19511988|NCT01976364|41922268|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
19511989|NCT01976364|41922266|FG000|Main Study (36 Months)|Other|13|||
19511990|NCT01976364|41922267|FG001|Main Study (36 Months)|Other|0|||
19511991|NCT01976364|41922268|FG002|Main Study (36 Months)|Other|0|||
19511992|NCT01976364|41922266|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
19511993|NCT01976364|41922267|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
19511994|NCT01976364|41922268|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
19511995|NCT01976364|41922266|FG000|Main Study (36 Months)|Medication error|1|||
19511996|NCT01976364|41922267|FG001|Main Study (36 Months)|Medication error|0|||
19511997|NCT01976364|41922268|FG002|Main Study (36 Months)|Medication error|0|||
19511998|NCT01976364|41922266|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
19511999|NCT01976364|41922267|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
19512000|NCT01976364|41922268|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
19512001|NCT01976364|41922266|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
19512002|NCT01976364|41922267|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
19512003|NCT01976364|41922268|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
19512004|NCT01976364|41922266|FG000|Main Study (36 Months)|Protocol Violation|13|||
19512005|NCT01976364|41922267|FG001|Main Study (36 Months)|Protocol Violation|0|||
19512006|NCT01976364|41922268|FG002|Main Study (36 Months)|Protocol Violation|0|||
19512007|NCT01976364|41922266|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
19512008|NCT01976364|41922267|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
19512009|NCT01976364|41922268|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
19617606|NCT00545233|42067419|FG000|Overall Study|Insufficient response|14|||
19617607|NCT00545233|42067420|FG001|Overall Study|Insufficient response|15|||
19617608|NCT00545233|42067419|FG000|Overall Study|Physician Decision|2|||
19617609|NCT00545233|42067420|FG001|Overall Study|Physician Decision|1|||
19617610|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617611|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
19704630|NCT00114738|42148955|FG000|Screening for Randomization|Progressive disease|2|||
19704631|NCT00114738|42148956|FG001|Screening for Randomization|Progressive disease|0|||
19704632|NCT00114738|42148957|FG002|Screening for Randomization|Progressive disease|0|||
19704633|NCT00114738|42148955|FG000|Screening for Randomization|CNS Hemorrhage|1|||
19704634|NCT00114738|42148956|FG001|Screening for Randomization|CNS Hemorrhage|0|||
19704635|NCT00114738|42148957|FG002|Screening for Randomization|CNS Hemorrhage|0|||
19704636|NCT00114738|42148955|FG000|Screening for Randomization|Other|1|||
19704637|NCT00114738|42148956|FG001|Screening for Randomization|Other|0|||
19704638|NCT00114738|42148957|FG002|Screening for Randomization|Other|0|||
19704639|NCT00148122|42148964|FG000|Overall Study|Withdrawal by Subject|2|||
19704640|NCT00147498|42148972|FG000|Overall Study|Adverse Event|1|||
19704641|NCT00147498|42148973|FG001|Overall Study|Adverse Event|6|||
19704642|NCT00147498|42148974|FG002|Overall Study|Adverse Event|7|||
19512010|NCT01976364|41922266|FG000|Main Study (36 Months)|Death|5|||
19512011|NCT01976364|41922267|FG001|Main Study (36 Months)|Death|0|||
19512012|NCT01976364|41922268|FG002|Main Study (36 Months)|Death|0|||
19512013|NCT01976364|41922266|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
19512014|NCT01976364|41922267|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
19617612|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617613|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617614|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617615|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
19617616|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
19617617|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617618|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19512015|NCT01976364|41922268|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
19512016|NCT01976364|41922266|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
19512017|NCT01976364|41922267|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
19512018|NCT01976364|41922268|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
19512019|NCT01976364|41922266|FG000|Sub-study (12 Months)|Protocol Violation|0|||
19512020|NCT01976364|41922267|FG001|Sub-study (12 Months)|Protocol Violation|1|||
19512021|NCT01976364|41922268|FG002|Sub-study (12 Months)|Protocol Violation|1|||
19512022|NCT01976364|41922266|FG000|Sub-study (12 Months)|Adverse Event|0|||
19512023|NCT01976364|41922267|FG001|Sub-study (12 Months)|Adverse Event|4|||
19512024|NCT01976364|41922268|FG002|Sub-study (12 Months)|Adverse Event|3|||
19512025|NCT01956240|41922279|FG000|Overall Study|Lost to Follow-up|6|||
19512026|NCT01956240|41922280|FG001|Overall Study|Lost to Follow-up|20|||
19512027|NCT01956240|41922279|FG000|Overall Study|Adverse Event|17|||
19512028|NCT01956240|41922280|FG001|Overall Study|Adverse Event|4|||
19512029|NCT01929876|41922286|FG000|Period 2|Non-Compliance|1|||
19512030|NCT01929408|41922290|FG000|Overall Study|received HCT as initial treatment|8|||
19512031|NCT01929018|41922296|FG000|Overall Study|Lost to Follow-up|1|||
19512032|NCT01929018|41922297|FG001|Overall Study|Lost to Follow-up|0|||
19512033|NCT01929018|41922296|FG000|Overall Study|Hospitalization|0|||
19512034|NCT01929018|41922297|FG001|Overall Study|Hospitalization|1|||
19512035|NCT01928940|41922305|FG000|Overall Study|Adverse Event|0|||
19512036|NCT01928940|41922306|FG001|Overall Study|Adverse Event|1|||
19512037|NCT01928862|41922318|FG000|Overall Study|Lost to Follow-up|1|||
19512038|NCT01928862|41922319|FG001|Overall Study|Lost to Follow-up|0|||
19512039|NCT01928862|41922320|FG002|Overall Study|Lost to Follow-up|0|||
19512040|NCT01928862|41922321|FG003|Overall Study|Lost to Follow-up|0|||
19512041|NCT01928862|41922322|FG004|Overall Study|Lost to Follow-up|1|||
19512042|NCT01954056|41922337|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
19512043|NCT01954056|41922338|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
19512044|NCT01953354|41922346|FG000|Overall Study|Withdrawal by Subject|0|||
19512045|NCT01953354|41922347|FG001|Overall Study|Withdrawal by Subject|1|||
19512046|NCT01953354|41922346|FG000|Overall Study|Decision of Sponsor|0|||
19512047|NCT01953354|41922347|FG001|Overall Study|Decision of Sponsor|1|||
19512048|NCT01953354|41922346|FG000|Overall Study|Disease Exacerbation|1|||
19512049|NCT01953354|41922347|FG001|Overall Study|Disease Exacerbation|0|||
19512050|NCT01975272|41922356|FG000|Overall Study|Excluded after protocol amendment|1|||
19512051|NCT01975272|41922357|FG001|Overall Study|Excluded after protocol amendment|1|||
19512052|NCT01975272|41922358|FG002|Overall Study|Excluded after protocol amendment|2|||
19512053|NCT01951638|41922371|FG000|Treatment Period|Protocol Violation|0|||
19512054|NCT01951638|41922372|FG001|Treatment Period|Protocol Violation|0|||
19512055|NCT01951638|41922373|FG002|Treatment Period|Protocol Violation|0|||
19512056|NCT01951638|41922374|FG003|Treatment Period|Protocol Violation|2|||
19512057|NCT01951638|41922375|FG004|Treatment Period|Protocol Violation|0|||
19512058|NCT01951638|41922371|FG000|Treatment Period|Protocol-driven decision point|1|||
19512059|NCT01951638|41922372|FG001|Treatment Period|Protocol-driven decision point|3|||
19617619|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617620|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617621|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617622|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617623|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617624|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617625|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19704643|NCT00147498|42148975|FG003|Overall Study|Adverse Event|3|||
19704644|NCT00147498|42148972|FG000|Overall Study|Lack of Efficacy|1|||
19704645|NCT00147498|42148973|FG001|Overall Study|Lack of Efficacy|1|||
19704646|NCT00147498|42148974|FG002|Overall Study|Lack of Efficacy|1|||
19704647|NCT00147498|42148975|FG003|Overall Study|Lack of Efficacy|8|||
19704648|NCT00147498|42148972|FG000|Overall Study|Laboratory abnormality|0|||
19704649|NCT00147498|42148973|FG001|Overall Study|Laboratory abnormality|0|||
19704650|NCT00147498|42148974|FG002|Overall Study|Laboratory abnormality|2|||
19704651|NCT00147498|42148975|FG003|Overall Study|Laboratory abnormality|0|||
19512060|NCT01951638|41922373|FG002|Treatment Period|Protocol-driven decision point|0|||
19512061|NCT01951638|41922374|FG003|Treatment Period|Protocol-driven decision point|0|||
19512062|NCT01951638|41922375|FG004|Treatment Period|Protocol-driven decision point|0|||
19512063|NCT01951638|41922371|FG000|Treatment Period|Logistical difficulties|0|||
19512064|NCT01951638|41922372|FG001|Treatment Period|Logistical difficulties|1|||
19512065|NCT01951638|41922373|FG002|Treatment Period|Logistical difficulties|1|||
19512066|NCT01951638|41922374|FG003|Treatment Period|Logistical difficulties|0|||
19512067|NCT01951638|41922375|FG004|Treatment Period|Logistical difficulties|0|||
19512068|NCT01951638|41922371|FG000|Treatment Period|Withdrawal by Subject|9|||
19512069|NCT01951638|41922372|FG001|Treatment Period|Withdrawal by Subject|6|||
19512070|NCT01951638|41922373|FG002|Treatment Period|Withdrawal by Subject|4|||
19512071|NCT01951638|41922374|FG003|Treatment Period|Withdrawal by Subject|5|||
19512072|NCT01951638|41922375|FG004|Treatment Period|Withdrawal by Subject|4|||
19512073|NCT01951638|41922371|FG000|Treatment Period|Death|0|||
19512074|NCT01951638|41922372|FG001|Treatment Period|Death|0|||
19512075|NCT01951638|41922373|FG002|Treatment Period|Death|0|||
19512076|NCT01951638|41922374|FG003|Treatment Period|Death|3|||
19512077|NCT01951638|41922375|FG004|Treatment Period|Death|1|||
19512078|NCT01951638|41922371|FG000|Treatment Period|Adverse Event|3|||
19512079|NCT01951638|41922372|FG001|Treatment Period|Adverse Event|4|||
19512080|NCT01951638|41922373|FG002|Treatment Period|Adverse Event|8|||
19512081|NCT01951638|41922374|FG003|Treatment Period|Adverse Event|6|||
19512082|NCT01951638|41922375|FG004|Treatment Period|Adverse Event|5|||
19512083|NCT01951638|41922371|FG000|Follow-up Period|Protocol Violation|0|||
19512084|NCT01951638|41922372|FG001|Follow-up Period|Protocol Violation|0|||
19512085|NCT01951638|41922373|FG002|Follow-up Period|Protocol Violation|0|||
19512086|NCT01951638|41922374|FG003|Follow-up Period|Protocol Violation|1|||
19512087|NCT01951638|41922375|FG004|Follow-up Period|Protocol Violation|0|||
19512088|NCT01951638|41922371|FG000|Follow-up Period|Logistical difficulties|0|||
19512089|NCT01951638|41922372|FG001|Follow-up Period|Logistical difficulties|2|||
19512090|NCT01951638|41922373|FG002|Follow-up Period|Logistical difficulties|0|||
19512091|NCT01951638|41922374|FG003|Follow-up Period|Logistical difficulties|0|||
19512092|NCT01951638|41922375|FG004|Follow-up Period|Logistical difficulties|1|||
19512093|NCT01951638|41922371|FG000|Follow-up Period|Withdrawal by Subject|1|||
19512094|NCT01951638|41922372|FG001|Follow-up Period|Withdrawal by Subject|5|||
19512095|NCT01951638|41922373|FG002|Follow-up Period|Withdrawal by Subject|2|||
19512096|NCT01951638|41922374|FG003|Follow-up Period|Withdrawal by Subject|1|||
19512097|NCT01951638|41922375|FG004|Follow-up Period|Withdrawal by Subject|2|||
19617626|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617627|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617628|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19704652|NCT00147498|42148972|FG000|Overall Study|Participant defaulted|0|||
19617629|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617630|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617631|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617632|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617633|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617634|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
19617635|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617636|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
19617637|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617638|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617639|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617640|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617641|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617642|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617643|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617644|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617645|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617646|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617647|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617648|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617649|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617650|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617651|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617652|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617653|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19704653|NCT00147498|42148973|FG001|Overall Study|Participant defaulted|1|||
19704654|NCT00147498|42148974|FG002|Overall Study|Participant defaulted|4|||
19704655|NCT00147498|42148975|FG003|Overall Study|Participant defaulted|3|||
19704656|NCT00147498|42148972|FG000|Overall Study|Other|1|||
19704657|NCT00147498|42148973|FG001|Overall Study|Other|1|||
19704658|NCT00147498|42148974|FG002|Overall Study|Other|3|||
19617654|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617655|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617656|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19704659|NCT00147498|42148975|FG003|Overall Study|Other|3|||
19704660|NCT00113568|42148985|FG000|Overall Study|Adverse Event|97|||
19512098|NCT01951638|41922371|FG000|Follow-up Period|Lost to Follow-up|0|||
19704661|NCT00113568|42148985|FG000|Overall Study|Death|1|||
19704662|NCT00113568|42148985|FG000|Overall Study|Lack of Efficacy|30|||
19512099|NCT01951638|41922372|FG001|Follow-up Period|Lost to Follow-up|1|||
19512100|NCT01951638|41922373|FG002|Follow-up Period|Lost to Follow-up|0|||
19512101|NCT01951638|41922374|FG003|Follow-up Period|Lost to Follow-up|1|||
19704663|NCT00113568|42148985|FG000|Overall Study|Lost to Follow-up|156|||
19704664|NCT00113568|42148985|FG000|Overall Study|Protocol Violation|32|||
19704665|NCT00113568|42148985|FG000|Overall Study|Withdrawal by Subject|117|||
19704666|NCT00113568|42148985|FG000|Overall Study|Other|112|||
19704667|NCT00113490|42148991|FG000|Overall Study|Withdrawal by Subject|1|||
19704668|NCT00113490|42148992|FG001|Overall Study|Withdrawal by Subject|3|||
19704669|NCT00113490|42148991|FG000|Overall Study|Lost to Follow-up|1|||
19704670|NCT00113490|42148992|FG001|Overall Study|Lost to Follow-up|0|||
19704671|NCT00146640|42149000|FG000|Overall Study|Adverse Event|12|||
19704672|NCT00146640|42149001|FG001|Overall Study|Adverse Event|10|||
19704673|NCT00146640|42149000|FG000|Overall Study|Medical Reasons|3|||
19704674|NCT00146640|42149001|FG001|Overall Study|Medical Reasons|0|||
19704675|NCT00146640|42149000|FG000|Overall Study|Non-Medical Reasons|8|||
19704676|NCT00146640|42149001|FG001|Overall Study|Non-Medical Reasons|4|||
19704677|NCT03737110|42149018|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
19704678|NCT03737110|42149019|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
19704679|NCT03737110|42149020|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
19704680|NCT03737110|42149018|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
19704681|NCT03737110|42149019|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
19704682|NCT03737110|42149020|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
19704683|NCT03737110|42149018|FG000|Run-in (RI) Period|Adverse Event|4|||
19704684|NCT03737110|42149019|FG001|Run-in (RI) Period|Adverse Event|0|||
19704685|NCT03737110|42149020|FG002|Run-in (RI) Period|Adverse Event|0|||
19704686|NCT03737110|42149018|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
19704687|NCT03737110|42149019|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
19704688|NCT03737110|42149020|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
19704689|NCT03737110|42149018|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
19704690|NCT03737110|42149019|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
19704691|NCT03737110|42149020|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
19704692|NCT00146328|42149041|FG000|Overall Study|Adverse Event|39|||
19704693|NCT00146328|42149042|FG001|Overall Study|Adverse Event|48|||
19704694|NCT00146328|42149043|FG002|Overall Study|Adverse Event|79|||
19704695|NCT00146328|42149041|FG000|Overall Study|Protocol Violation|11|||
19704696|NCT00146328|42149042|FG001|Overall Study|Protocol Violation|6|||
19704697|NCT00146328|42149043|FG002|Overall Study|Protocol Violation|12|||
19704698|NCT00146328|42149041|FG000|Overall Study|Lost to Follow-up|7|||
19704699|NCT00146328|42149042|FG001|Overall Study|Lost to Follow-up|4|||
19704700|NCT00146328|42149043|FG002|Overall Study|Lost to Follow-up|7|||
19704701|NCT00146328|42149041|FG000|Overall Study|Withdrawal by Subject|16|||
19704702|NCT00146328|42149042|FG001|Overall Study|Withdrawal by Subject|16|||
19704703|NCT00146328|42149043|FG002|Overall Study|Withdrawal by Subject|22|||
19704704|NCT00146328|42149041|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
19704705|NCT00146328|42149042|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
19704706|NCT00146328|42149043|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
19704707|NCT00146328|42149041|FG000|Overall Study|Trial ended/site closed|8|||
19704708|NCT00146328|42149042|FG001|Overall Study|Trial ended/site closed|2|||
19704709|NCT00146328|42149043|FG002|Overall Study|Trial ended/site closed|19|||
19704710|NCT00146328|42149041|FG000|Overall Study|Patient decision to end|0|||
19704711|NCT00146328|42149042|FG001|Overall Study|Patient decision to end|1|||
19704712|NCT00146328|42149043|FG002|Overall Study|Patient decision to end|6|||
19704713|NCT00146328|42149041|FG000|Overall Study|Enroll into other trial|2|||
19704714|NCT00146328|42149042|FG001|Overall Study|Enroll into other trial|4|||
19704715|NCT00146328|42149043|FG002|Overall Study|Enroll into other trial|2|||
19704716|NCT00146328|42149041|FG000|Overall Study|Death|0|||
19704717|NCT00146328|42149042|FG001|Overall Study|Death|1|||
19704718|NCT00146328|42149043|FG002|Overall Study|Death|1|||
19704719|NCT00146328|42149041|FG000|Overall Study|Moved|2|||
19704720|NCT00146328|42149042|FG001|Overall Study|Moved|0|||
19704721|NCT00146328|42149043|FG002|Overall Study|Moved|0|||
19704722|NCT00146328|42149041|FG000|Overall Study|Interaction with other medication|2|||
19704723|NCT00146328|42149042|FG001|Overall Study|Interaction with other medication|0|||
19704724|NCT00146328|42149043|FG002|Overall Study|Interaction with other medication|1|||
19704725|NCT03733444|42149054|FG000|Overall Study|Adverse Event|8|||
19704726|NCT03733444|42149055|FG001|Overall Study|Adverse Event|10|||
19704727|NCT03733444|42149056|FG002|Overall Study|Adverse Event|5|||
19704728|NCT03733444|42149054|FG000|Overall Study|Death|20|||
19704729|NCT03733444|42149055|FG001|Overall Study|Death|19|||
19704730|NCT03733444|42149056|FG002|Overall Study|Death|11|||
19704731|NCT03733444|42149054|FG000|Overall Study|Lost to Follow-up|3|||
19704732|NCT03733444|42149055|FG001|Overall Study|Lost to Follow-up|0|||
19704733|NCT03733444|42149056|FG002|Overall Study|Lost to Follow-up|1|||
19704734|NCT03733444|42149054|FG000|Overall Study|Lack of Efficacy|0|||
19512102|NCT01951638|41922375|FG004|Follow-up Period|Lost to Follow-up|0|||
19512103|NCT01951638|41922371|FG000|Follow-up Period|Death|1|||
19512104|NCT01951638|41922372|FG001|Follow-up Period|Death|0|||
19512105|NCT01951638|41922373|FG002|Follow-up Period|Death|1|||
19512106|NCT01951638|41922374|FG003|Follow-up Period|Death|4|||
19512107|NCT01951638|41922375|FG004|Follow-up Period|Death|1|||
19512108|NCT01951638|41922371|FG000|Follow-up Period|Adverse Event|0|||
19512109|NCT01951638|41922372|FG001|Follow-up Period|Adverse Event|1|||
19512110|NCT01951638|41922373|FG002|Follow-up Period|Adverse Event|2|||
19512111|NCT01951638|41922374|FG003|Follow-up Period|Adverse Event|1|||
19512112|NCT01951638|41922375|FG004|Follow-up Period|Adverse Event|1|||
19512113|NCT01928472|41922391|FG000|Overall Study|Death|0|||
19512114|NCT01928472|41922392|FG001|Overall Study|Death|0|||
19512115|NCT01928472|41922393|FG002|Overall Study|Death|1|||
19512116|NCT01928472|41922394|FG003|Overall Study|Death|0|||
19512117|NCT01928472|41922391|FG000|Overall Study|Withdrawal by Subject|4|||
19512118|NCT01928472|41922392|FG001|Overall Study|Withdrawal by Subject|4|||
19512119|NCT01928472|41922393|FG002|Overall Study|Withdrawal by Subject|1|||
19512120|NCT01928472|41922394|FG003|Overall Study|Withdrawal by Subject|2|||
19512121|NCT01928472|41922391|FG000|Overall Study|Lost to Follow-up|2|||
19512122|NCT01928472|41922392|FG001|Overall Study|Lost to Follow-up|3|||
19512123|NCT01928472|41922393|FG002|Overall Study|Lost to Follow-up|4|||
19512124|NCT01928472|41922394|FG003|Overall Study|Lost to Follow-up|0|||
19512125|NCT01928472|41922391|FG000|Overall Study|Administrative Reason|2|||
19512126|NCT01928472|41922392|FG001|Overall Study|Administrative Reason|1|||
19512127|NCT01928472|41922393|FG002|Overall Study|Administrative Reason|0|||
19512128|NCT01928472|41922394|FG003|Overall Study|Administrative Reason|0|||
19512129|NCT01928472|41922391|FG000|Overall Study|Unclassified|0|||
19512130|NCT01928472|41922392|FG001|Overall Study|Unclassified|0|||
19512131|NCT01928472|41922393|FG002|Overall Study|Unclassified|1|||
19512132|NCT01928472|41922394|FG003|Overall Study|Unclassified|0|||
19512133|NCT01351415|41924264|FG000|Overall Study|Withdrawal by Subject|15|||
19512134|NCT01351415|41924265|FG001|Overall Study|Withdrawal by Subject|17|||
19512135|NCT01351415|41924264|FG000|Overall Study|Trial termination by the Sponsor|28|||
19617657|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617658|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617659|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
19617660|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
19617661|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
19617662|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
19617663|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
19617664|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
19512136|NCT01351415|41924265|FG001|Overall Study|Trial termination by the Sponsor|19|||
19512137|NCT01351415|41924264|FG000|Overall Study|Lost to Follow-up|5|||
19512138|NCT01351415|41924265|FG001|Overall Study|Lost to Follow-up|7|||
19512139|NCT01351415|41924264|FG000|Overall Study|Death|190|||
19512140|NCT01351415|41924265|FG001|Overall Study|Death|187|||
19512141|NCT01351415|41924264|FG000|Overall Study|Physician Decision|2|||
19512142|NCT01351415|41924265|FG001|Overall Study|Physician Decision|3|||
19512143|NCT01351415|41924264|FG000|Overall Study|Reason unknown|0|||
19512144|NCT01351415|41924265|FG001|Overall Study|Reason unknown|2|||
19512145|NCT01351415|41924264|FG000|Overall Study|Never Started|5|||
19512146|NCT01351415|41924265|FG001|Overall Study|Never Started|5|||
19512147|NCT04811339|41924373|FG000|Overall Study|lack of transportation not wanting to return|4|||
19512148|NCT04811339|41924374|FG001|Overall Study|lack of transportation not wanting to return|8|||
19512149|NCT04811339|41924375|FG002|Overall Study|lack of transportation not wanting to return|0|||
19512150|NCT04811339|41924373|FG000|Overall Study|Adverse Event|3|||
19512151|NCT04811339|41924374|FG001|Overall Study|Adverse Event|0|||
19512152|NCT04811339|41924375|FG002|Overall Study|Adverse Event|0|||
19512153|NCT04811339|41924373|FG000|Overall Study|Lost to Follow-up|1|||
19512154|NCT04811339|41924374|FG001|Overall Study|Lost to Follow-up|0|||
19512155|NCT04811339|41924375|FG002|Overall Study|Lost to Follow-up|0|||
19512156|NCT04811339|41924373|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
19512157|NCT04811339|41924374|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
19512158|NCT04811339|41924375|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
19617665|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
19512159|NCT04811339|41924373|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
19512160|NCT04811339|41924374|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
19512161|NCT04811339|41924375|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
19512162|NCT04811339|41924373|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
19512163|NCT04811339|41924374|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
19512164|NCT04811339|41924375|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
19512165|NCT04811339|41924373|FG000|Overall Study|Withdrawal by Subject|0|||
19512166|NCT04811339|41924374|FG001|Overall Study|Withdrawal by Subject|3|||
19512167|NCT04811339|41924375|FG002|Overall Study|Withdrawal by Subject|0|||
19512168|NCT04811339|41924373|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
19512169|NCT04811339|41924374|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
19512170|NCT04811339|41924375|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
19512171|NCT04811339|41924373|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
19512172|NCT04811339|41924374|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
19512173|NCT04811339|41924375|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
19512174|NCT04652453|41924388|FG000|Overall Study|Death|8|||
19512175|NCT04652453|41924389|FG001|Overall Study|Death|2|||
19512176|NCT04652453|41924390|FG002|Overall Study|Death|0|||
19512177|NCT04652453|41924388|FG000|Overall Study|Hospice|5|||
19512178|NCT04652453|41924389|FG001|Overall Study|Hospice|5|||
19512179|NCT04652453|41924390|FG002|Overall Study|Hospice|0|||
19512180|NCT04652453|41924388|FG000|Overall Study|Withdrawal by Subject|2|||
19512181|NCT04652453|41924389|FG001|Overall Study|Withdrawal by Subject|0|||
19512182|NCT04652453|41924390|FG002|Overall Study|Withdrawal by Subject|0|||
19512183|NCT04332107|41924398|FG000|Day 3|Lost to Follow-up|23|||
19512184|NCT04332107|41924399|FG001|Day 3|Lost to Follow-up|14|||
19512185|NCT04332107|41924398|FG000|Day 3|Missing outcome data|3|||
19512186|NCT04332107|41924399|FG001|Day 3|Missing outcome data|6|||
19512187|NCT04332107|41924398|FG000|Day 14|Lost to Follow-up|13|||
19512188|NCT04332107|41924399|FG001|Day 14|Lost to Follow-up|4|||
19512189|NCT04332107|41924398|FG000|Day 14|Missing outcome data|4|||
19512190|NCT04332107|41924399|FG001|Day 14|Missing outcome data|4|||
19512191|NCT04332107|41924398|FG000|Day 21|Lost to Follow-up|10|||
19512192|NCT04332107|41924399|FG001|Day 21|Lost to Follow-up|2|||
19512193|NCT03375203|41924414|FG000|Overall Study|Protocol Violation|0|||
19512194|NCT03375203|41924415|FG001|Overall Study|Protocol Violation|0|||
19512195|NCT03375203|41924416|FG002|Overall Study|Protocol Violation|1|||
19512196|NCT03375203|41924417|FG003|Overall Study|Protocol Violation|0|||
19512197|NCT03375203|41924418|FG004|Overall Study|Protocol Violation|0|||
19512198|NCT03375203|41924414|FG000|Overall Study|Adverse Event|2|||
19512199|NCT03375203|41924415|FG001|Overall Study|Adverse Event|3|||
19512200|NCT03375203|41924416|FG002|Overall Study|Adverse Event|0|||
19512201|NCT03375203|41924417|FG003|Overall Study|Adverse Event|2|||
19512202|NCT03375203|41924418|FG004|Overall Study|Adverse Event|2|||
19512203|NCT03375203|41924414|FG000|Overall Study|Withdrawal by Subject|3|||
19512204|NCT03375203|41924415|FG001|Overall Study|Withdrawal by Subject|0|||
19512205|NCT03375203|41924416|FG002|Overall Study|Withdrawal by Subject|1|||
19512206|NCT03375203|41924417|FG003|Overall Study|Withdrawal by Subject|0|||
19512207|NCT03375203|41924418|FG004|Overall Study|Withdrawal by Subject|2|||
19512208|NCT03375203|41924414|FG000|Overall Study|Non-compliance with study drug|1|||
19512209|NCT03375203|41924415|FG001|Overall Study|Non-compliance with study drug|0|||
19512210|NCT03375203|41924416|FG002|Overall Study|Non-compliance with study drug|0|||
19512211|NCT03375203|41924417|FG003|Overall Study|Non-compliance with study drug|0|||
19512212|NCT03375203|41924418|FG004|Overall Study|Non-compliance with study drug|0|||
19512213|NCT03375203|41924414|FG000|Overall Study|Randomized, not treated.|0|||
19512214|NCT03375203|41924415|FG001|Overall Study|Randomized, not treated.|1|||
19512215|NCT03375203|41924416|FG002|Overall Study|Randomized, not treated.|0|||
19512216|NCT03375203|41924417|FG003|Overall Study|Randomized, not treated.|0|||
19512217|NCT03375203|41924418|FG004|Overall Study|Randomized, not treated.|0|||
19512218|NCT03075839|41924440|FG000|Overall Study|Lost to Follow-up|4|||
19512219|NCT02919683|41924446|FG000|Post-Surgery Follow-Up|Death|2|||
19512220|NCT02919683|41924447|FG001|Post-Surgery Follow-Up|Death|2|||
19512221|NCT02919683|41924446|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
19512222|NCT02919683|41924447|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
19512223|NCT01928082|41924454|FG000|Overall Study|Study terminated.|1|||
19512224|NCT01972776|41924464|FG000|Part 1|Withdrawal by Subject|0|||
19512225|NCT01972776|41924465|FG001|Part 1|Withdrawal by Subject|0|||
19512226|NCT01972776|41924466|FG002|Part 1|Withdrawal by Subject|1|||
19512227|NCT01972776|41924467|FG003|Part 1|Withdrawal by Subject|0|||
19512228|NCT01972776|41924468|FG004|Part 1|Withdrawal by Subject|0|||
19512229|NCT01972776|41924469|FG005|Part 1|Withdrawal by Subject|0|||
19512230|NCT01972776|41924464|FG000|Part 1|Adverse Event|0|||
19512231|NCT01972776|41924465|FG001|Part 1|Adverse Event|0|||
19512232|NCT01972776|41924466|FG002|Part 1|Adverse Event|1|||
19512233|NCT01972776|41924467|FG003|Part 1|Adverse Event|1|||
19512234|NCT01972776|41924468|FG004|Part 1|Adverse Event|0|||
19512235|NCT01972776|41924469|FG005|Part 1|Adverse Event|0|||
19512236|NCT01972776|41924464|FG000|Part 2|Adverse Event|0|||
19512237|NCT01972776|41924465|FG001|Part 2|Adverse Event|0|||
19617666|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
19617667|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
19394144|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
19512238|NCT01972776|41924466|FG002|Part 2|Adverse Event|0|||
19512239|NCT01972776|41924467|FG003|Part 2|Adverse Event|0|||
19512240|NCT01972776|41924468|FG004|Part 2|Adverse Event|3|||
19512241|NCT01972776|41924469|FG005|Part 2|Adverse Event|0|||
19512242|NCT01972776|41924464|FG000|Part 2|Administrative problems|0|||
19512243|NCT01972776|41924465|FG001|Part 2|Administrative problems|0|||
19512244|NCT01972776|41924466|FG002|Part 2|Administrative problems|0|||
19512245|NCT01972776|41924467|FG003|Part 2|Administrative problems|0|||
19512246|NCT01972776|41924468|FG004|Part 2|Administrative problems|10|||
19512247|NCT01972776|41924469|FG005|Part 2|Administrative problems|7|||
19512248|NCT02908685|41924495|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
19512249|NCT02908685|41924496|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
19512250|NCT02908685|41924497|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
19512251|NCT02908685|41924498|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
19512252|NCT02908685|41924499|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
19512253|NCT02908685|41924500|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
19512254|NCT02908685|41924501|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
19512255|NCT02908685|41924502|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
19512256|NCT02908685|41924503|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
19512257|NCT02908685|41924504|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
19512258|NCT02908685|41924505|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
19512259|NCT02908685|41924506|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
19512260|NCT02908685|41924495|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
19512261|NCT02908685|41924496|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
19512262|NCT02908685|41924497|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
19512263|NCT02908685|41924498|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
19512264|NCT02908685|41924499|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
19512265|NCT02908685|41924500|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
19512266|NCT02908685|41924501|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
19512267|NCT02908685|41924502|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
19512268|NCT02908685|41924503|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
19512269|NCT02908685|41924504|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
19512270|NCT02908685|41924505|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
19512271|NCT02908685|41924506|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
19512272|NCT02908685|41924495|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
19512273|NCT02908685|41924496|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
19512274|NCT02908685|41924497|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
19512275|NCT02908685|41924498|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
19512276|NCT02908685|41924499|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
19512277|NCT02908685|41924500|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
19512278|NCT02908685|41924501|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
19512279|NCT02908685|41924502|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
19512280|NCT02908685|41924503|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
19512281|NCT02908685|41924504|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
19512282|NCT02908685|41924505|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
19512283|NCT02908685|41924506|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
19512284|NCT03763331|41924525|FG000|Overall Study|Lost to Follow-up|1|||
19512285|NCT03763331|41924526|FG001|Overall Study|Lost to Follow-up|0|||
19512286|NCT03763331|41924525|FG000|Overall Study|Withdrawal by Subject|1|||
19512287|NCT03763331|41924526|FG001|Overall Study|Withdrawal by Subject|0|||
19512288|NCT03763331|41924525|FG000|Overall Study|Non-compliance|0|||
19512289|NCT03763331|41924526|FG001|Overall Study|Non-compliance|3|||
19617668|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
19617669|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
19617670|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
19617671|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
19617672|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
19617673|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
19617674|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
19617675|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
19617676|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
19617677|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
19617678|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
19512302|NCT00001259|41924562|FG000|Study 2|Adverse Event|0|||
19512303|NCT00001259|41924563|FG001|Study 2|Adverse Event|0|||
19512304|NCT00001259|41924564|FG002|Study 2|Adverse Event|0|||
19512305|NCT00001259|41924565|FG003|Study 2|Adverse Event|0|||
19512306|NCT00001259|41924566|FG004|Study 2|Adverse Event|2|||
19512307|NCT00001259|41924567|FG005|Study 2|Adverse Event|0|||
19512308|NCT00001259|41924568|FG006|Study 2|Adverse Event|0|||
19512309|NCT01926444|41924582|FG000|Overall Study|Colonoscopy not performed|0|||
19512310|NCT01926444|41924583|FG001|Overall Study|Colonoscopy not performed|0|||
19512311|NCT01926444|41924584|FG002|Overall Study|Colonoscopy not performed|4|||
19512312|NCT01926444|41924585|FG003|Overall Study|Colonoscopy not performed|2|||
19512313|NCT01597908|41924601|FG000|Randomized Phase|Death|217|||
19512314|NCT01597908|41924602|FG001|Randomized Phase|Death|238|||
19512315|NCT01597908|41924603|FG002|Randomized Phase|Death|0|||
19512316|NCT01597908|41924601|FG000|Randomized Phase|Sponsor Decision|93|||
19512317|NCT01597908|41924602|FG001|Randomized Phase|Sponsor Decision|39|||
19512318|NCT01597908|41924603|FG002|Randomized Phase|Sponsor Decision|0|||
19512319|NCT01597908|41924601|FG000|Randomized Phase|Lost to Follow-up|9|||
19512320|NCT01597908|41924602|FG001|Randomized Phase|Lost to Follow-up|16|||
19512321|NCT01597908|41924603|FG002|Randomized Phase|Lost to Follow-up|0|||
19512322|NCT01597908|41924601|FG000|Randomized Phase|Physician Decision|6|||
19617679|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
19617680|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
19617681|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
19617682|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
19617683|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
19617684|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
19617685|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
19617686|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19512323|NCT01597908|41924602|FG001|Randomized Phase|Physician Decision|3|||
19512324|NCT01597908|41924603|FG002|Randomized Phase|Physician Decision|0|||
19617687|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617688|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617689|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617690|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617691|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617692|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617693|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617694|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617695|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617696|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617697|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617698|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617699|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617700|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617701|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617702|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617703|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617704|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617705|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617706|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617707|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617708|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617709|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
19617710|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617711|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19512325|NCT01597908|41924601|FG000|Randomized Phase|Withdrawal by Subject|26|||
19512326|NCT01597908|41924602|FG001|Randomized Phase|Withdrawal by Subject|22|||
19512327|NCT01597908|41924603|FG002|Randomized Phase|Withdrawal by Subject|0|||
19512328|NCT01597908|41924601|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
19512329|NCT01597908|41924602|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
19512330|NCT01597908|41924603|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
19512331|NCT01597908|41924601|FG000|Crossover Phase|Death|0|||
19512332|NCT01597908|41924602|FG001|Crossover Phase|Death|0|||
19512333|NCT01597908|41924603|FG002|Crossover Phase|Death|11|||
19512334|NCT01597908|41924601|FG000|Crossover Phase|Withdrawal by Subject|0|||
19512335|NCT01597908|41924602|FG001|Crossover Phase|Withdrawal by Subject|0|||
19512336|NCT01597908|41924603|FG002|Crossover Phase|Withdrawal by Subject|3|||
19512337|NCT01597908|41924601|FG000|Crossover Phase|Sponsor Decision|0|||
19512338|NCT01597908|41924602|FG001|Crossover Phase|Sponsor Decision|0|||
19512339|NCT01597908|41924603|FG002|Crossover Phase|Sponsor Decision|20|||
19512340|NCT01951170|41924612|FG000|Overall Study|Investigator decision|1|||
19512341|NCT01951092|41924616|FG000|Overall Study|Lost to Follow-up|10|||
19512342|NCT01951092|41924616|FG000|Overall Study|Incarceration|1|||
19512343|NCT01951092|41924616|FG000|Overall Study|Transfer of Care|1|||
19512344|NCT01949532|41924622|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
19617712|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617713|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617714|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617715|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
19617716|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
19617717|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617718|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617719|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
19512345|NCT01949532|41924623|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
19512346|NCT01949142|41924631|FG000|Overall Study|Withdrawal of consent|1|||
19512347|NCT01949142|41924632|FG001|Overall Study|Withdrawal of consent|0|||
19617720|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617721|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617722|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617723|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617724|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617725|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617726|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617727|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617728|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617729|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617730|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19512348|NCT01949142|41924631|FG000|Overall Study|Lost to Follow-up|1|||
19512349|NCT01949142|41924632|FG001|Overall Study|Lost to Follow-up|1|||
19512350|NCT01949142|41924631|FG000|Overall Study|Parent changed their mind|1|||
19512351|NCT01949142|41924632|FG001|Overall Study|Parent changed their mind|0|||
19512352|NCT01948908|41924642|FG000|Overall Study|Protocol Violation|1|||
19512353|NCT01948908|41924643|FG001|Overall Study|Protocol Violation|0|||
19512354|NCT01948908|41924644|FG002|Overall Study|Protocol Violation|2|||
19512355|NCT01925274|41924655|FG000|Overall Study|Death|1|||
19512356|NCT01925274|41924656|FG001|Overall Study|Death|0|||
19512357|NCT01925274|41924657|FG002|Overall Study|Death|0|||
19512358|NCT01925274|41924655|FG000|Overall Study|Lost to Follow-up|0|||
19512359|NCT01925274|41924656|FG001|Overall Study|Lost to Follow-up|1|||
19512360|NCT01925274|41924657|FG002|Overall Study|Lost to Follow-up|0|||
19512361|NCT01925274|41924655|FG000|Overall Study|Withdrawal by Subject|1|||
19512362|NCT01925274|41924656|FG001|Overall Study|Withdrawal by Subject|2|||
19512363|NCT01925274|41924657|FG002|Overall Study|Withdrawal by Subject|0|||
19512364|NCT01925274|41924655|FG000|Overall Study|Study terminated by sponsor|4|||
19512365|NCT01925274|41924656|FG001|Overall Study|Study terminated by sponsor|0|||
19512366|NCT01925274|41924657|FG002|Overall Study|Study terminated by sponsor|0|||
19512367|NCT01925274|41924655|FG000|Overall Study|Protocol amendment|1|||
19512368|NCT01925274|41924656|FG001|Overall Study|Protocol amendment|3|||
19512369|NCT01925274|41924657|FG002|Overall Study|Protocol amendment|6|||
19512370|NCT01948830|41924669|FG000|Overall Study|Physician Decision|1|||
19512371|NCT01948830|41924670|FG001|Overall Study|Physician Decision|3|||
19512372|NCT01948830|41924669|FG000|Overall Study|Protocol deviation|1|||
19512373|NCT01948830|41924670|FG001|Overall Study|Protocol deviation|2|||
19512374|NCT01948830|41924669|FG000|Overall Study|Lost to Follow-up|5|||
19512375|NCT01948830|41924670|FG001|Overall Study|Lost to Follow-up|4|||
19512376|NCT01948830|41924669|FG000|Overall Study|Withdrawal by Subject|14|||
19512377|NCT01948830|41924670|FG001|Overall Study|Withdrawal by Subject|17|||
19512378|NCT01948830|41924669|FG000|Overall Study|Adverse Event|9|||
19512379|NCT01948830|41924670|FG001|Overall Study|Adverse Event|2|||
19512380|NCT01948830|41924669|FG000|Overall Study|Death|3|||
19512381|NCT01948830|41924670|FG001|Overall Study|Death|4|||
19512382|NCT01972464|41924678|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
19512383|NCT01972464|41924679|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
19512384|NCT01972464|41924678|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
19512385|NCT01972464|41924679|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
19512386|NCT01972464|41924678|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
19512387|NCT01972464|41924679|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
19512388|NCT01972464|41924678|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
19512389|NCT01972464|41924679|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
19512390|NCT01948050|41924688|FG000|Overall Study|Withdrawal by Subject|0|||
19512391|NCT01948050|41924689|FG001|Overall Study|Withdrawal by Subject|1|||
19512392|NCT01947894|41924698|FG000|Overall Study|Other|3|||
19512393|NCT01947894|41924699|FG001|Overall Study|Other|4|||
19512394|NCT01947894|41924700|FG002|Overall Study|Other|3|||
19512395|NCT01947894|41924698|FG000|Overall Study|Withdrawal by Subject|12|||
19512396|NCT01947894|41924699|FG001|Overall Study|Withdrawal by Subject|4|||
19512397|NCT01947894|41924700|FG002|Overall Study|Withdrawal by Subject|1|||
19512398|NCT01947894|41924698|FG000|Overall Study|Death|12|||
19512399|NCT01947894|41924699|FG001|Overall Study|Death|1|||
19512400|NCT01947894|41924700|FG002|Overall Study|Death|0|||
19512401|NCT01947894|41924698|FG000|Overall Study|Physician Decision|2|||
19512402|NCT01947894|41924699|FG001|Overall Study|Physician Decision|0|||
19512403|NCT01947894|41924700|FG002|Overall Study|Physician Decision|0|||
19512404|NCT01947894|41924698|FG000|Overall Study|Adverse Event|5|||
19512405|NCT01947894|41924699|FG001|Overall Study|Adverse Event|1|||
19512406|NCT01947894|41924700|FG002|Overall Study|Adverse Event|0|||
19512407|NCT01947894|41924698|FG000|Overall Study|Switched to other growth hormone brand|53|||
19512408|NCT01947894|41924699|FG001|Overall Study|Switched to other growth hormone brand|8|||
19512409|NCT01947894|41924700|FG002|Overall Study|Switched to other growth hormone brand|23|||
19512410|NCT01947582|41924708|FG000|Overall Study|Withdrawal by Subject|1|||
19512411|NCT01924806|41924714|FG000|Overall Study|Physician Decision|2|||
19512412|NCT01924806|41924715|FG001|Overall Study|Physician Decision|1|||
19512413|NCT01924182|41924723|FG000|Overall Study|Withdrawal by Subject|1|||
19512414|NCT01924182|41924724|FG001|Overall Study|Withdrawal by Subject|0|||
19512415|NCT01972308|41924732|FG000|Overall Study|Withdrawal by Subject|0|||
19512416|NCT01972308|41924733|FG001|Overall Study|Withdrawal by Subject|1|||
19512417|NCT01972308|41924732|FG000|Overall Study|Lost to Follow-up|4|||
19512418|NCT01972308|41924733|FG001|Overall Study|Lost to Follow-up|6|||
19512419|NCT01972308|41924732|FG000|Overall Study|Death|4|||
19512420|NCT01972308|41924733|FG001|Overall Study|Death|1|||
19512421|NCT01946880|41924743|FG000|Overall Study|Lost to Follow-up|1|||
19512422|NCT01946880|41924744|FG001|Overall Study|Lost to Follow-up|0|||
19512423|NCT01946880|41924743|FG000|Overall Study|Physician Decision|1|||
19512424|NCT01946880|41924744|FG001|Overall Study|Physician Decision|1|||
19512425|NCT01946880|41924743|FG000|Overall Study|Withdrawal by Subject|3|||
19512426|NCT01946880|41924744|FG001|Overall Study|Withdrawal by Subject|2|||
19512427|NCT01946880|41924743|FG000|Overall Study|Met Primary Endpoint|1|||
19512428|NCT01946880|41924744|FG001|Overall Study|Met Primary Endpoint|0|||
19512429|NCT01946880|41924743|FG000|Overall Study|Personal and Family Issues|1|||
19512430|NCT01946880|41924744|FG001|Overall Study|Personal and Family Issues|0|||
19512431|NCT01972152|41924750|FG000|First Treatment Visit|Lost to Follow-up|0|||
19512432|NCT01972152|41924751|FG001|First Treatment Visit|Lost to Follow-up|1|||
19512433|NCT01972152|41924752|FG002|First Treatment Visit|Lost to Follow-up|0|||
19512434|NCT01972152|41924753|FG003|First Treatment Visit|Lost to Follow-up|0|||
19512435|NCT01972152|41924754|FG004|First Treatment Visit|Lost to Follow-up|0|||
19512436|NCT01972152|41924755|FG005|First Treatment Visit|Lost to Follow-up|0|||
19512437|NCT01972152|41924750|FG000|Second Treatment Visit|Protocol Violation|0|||
19512438|NCT01972152|41924751|FG001|Second Treatment Visit|Protocol Violation|1|||
19512439|NCT01972152|41924752|FG002|Second Treatment Visit|Protocol Violation|0|||
19512440|NCT01972152|41924753|FG003|Second Treatment Visit|Protocol Violation|0|||
19512441|NCT01972152|41924754|FG004|Second Treatment Visit|Protocol Violation|0|||
19512442|NCT01972152|41924755|FG005|Second Treatment Visit|Protocol Violation|0|||
19512443|NCT01972074|41924769|FG000|Overall Study|Adverse Event|4|||
19512444|NCT01972074|41924770|FG001|Overall Study|Adverse Event|1|||
19512445|NCT01972074|41924771|FG002|Overall Study|Adverse Event|0|||
19512446|NCT01972074|41924769|FG000|Overall Study|Lack of Efficacy|1|||
19512447|NCT01972074|41924770|FG001|Overall Study|Lack of Efficacy|1|||
19512448|NCT01972074|41924771|FG002|Overall Study|Lack of Efficacy|0|||
19512449|NCT01972074|41924769|FG000|Overall Study|Lost to Follow-up|0|||
19512450|NCT01972074|41924770|FG001|Overall Study|Lost to Follow-up|1|||
19512451|NCT01972074|41924771|FG002|Overall Study|Lost to Follow-up|1|||
19512452|NCT01972074|41924769|FG000|Overall Study|Withdrawal by Subject|1|||
19512453|NCT01972074|41924770|FG001|Overall Study|Withdrawal by Subject|1|||
19512454|NCT01972074|41924771|FG002|Overall Study|Withdrawal by Subject|1|||
19512455|NCT01972074|41924769|FG000|Overall Study|Scanner Unavailable|0|||
19512456|NCT01972074|41924770|FG001|Overall Study|Scanner Unavailable|0|||
19512457|NCT01972074|41924771|FG002|Overall Study|Scanner Unavailable|1|||
19512458|NCT01970982|41924781|FG000|Overall Study|Withdrawal by Subject|0|||
19512459|NCT01970982|41924782|FG001|Overall Study|Withdrawal by Subject|0|||
19512460|NCT01970982|41924783|FG002|Overall Study|Withdrawal by Subject|2|||
19512461|NCT01946802|41924792|FG000|Overall Study|Death|1|||
19512462|NCT01946802|41924792|FG000|Overall Study|Withdrawal by Subject|2|||
19512463|NCT01946802|41924792|FG000|Overall Study|Combined septic shock|1|||
19512464|NCT01946802|41924792|FG000|Overall Study|Protocol Violation|1|||
19512465|NCT01618266|41924796|FG000|Overall Study|Lost to Follow-up|9|||
19512466|NCT01618266|41924796|FG000|Overall Study|Treatment satisfaction|10|||
19512467|NCT01618266|41924796|FG000|Overall Study|Other reasons|11|||
19512468|NCT01618266|41924796|FG000|Overall Study|Lack of Efficacy|23|||
19512469|NCT01618266|41924796|FG000|Overall Study|Protocol Violation|43|||
19512470|NCT01919112|41924803|FG000|Secondary Analysis-day 30|Death|1|||
19512471|NCT01919112|41924804|FG001|Secondary Analysis-day 30|Death|1|||
19512472|NCT01919112|41924805|FG002|Secondary Analysis-day 30|Death|1|||
19512473|NCT01919112|41924803|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
19512474|NCT01919112|41924804|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
19512475|NCT01919112|41924805|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
19512476|NCT01918332|41924817|FG000|Overall Study|Adverse Event|0|||
19512477|NCT01918332|41924818|FG001|Overall Study|Adverse Event|0|||
19512478|NCT01918332|41924819|FG002|Overall Study|Adverse Event|0|||
19512479|NCT01918332|41924820|FG003|Overall Study|Adverse Event|1|||
19512480|NCT01918332|41924817|FG000|Overall Study|Withdrawal by Subject|2|||
19512481|NCT01918332|41924818|FG001|Overall Study|Withdrawal by Subject|3|||
19512482|NCT01918332|41924819|FG002|Overall Study|Withdrawal by Subject|2|||
19512483|NCT01918332|41924820|FG003|Overall Study|Withdrawal by Subject|3|||
19512484|NCT01918332|41924817|FG000|Overall Study|Protocol Violation|6|||
19512485|NCT01918332|41924818|FG001|Overall Study|Protocol Violation|2|||
19512486|NCT01918332|41924819|FG002|Overall Study|Protocol Violation|6|||
19512487|NCT01918332|41924820|FG003|Overall Study|Protocol Violation|3|||
19512488|NCT01918332|41924817|FG000|Overall Study|lipid result by central lab did not meet|0|||
19512489|NCT01918332|41924818|FG001|Overall Study|lipid result by central lab did not meet|0|||
19512490|NCT01918332|41924819|FG002|Overall Study|lipid result by central lab did not meet|1|||
19512491|NCT01918332|41924820|FG003|Overall Study|lipid result by central lab did not meet|0|||
19512492|NCT01922934|41924832|FG000|Eligible Patients|Death|0|||
19512493|NCT01922934|41924833|FG001|Eligible Patients|Death|7|||
19512494|NCT01922934|41924832|FG000|Eligible Patients|Physician Decision|17|||
19512495|NCT01922934|41924833|FG001|Eligible Patients|Physician Decision|0|||
19512496|NCT01922934|41924832|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
19512497|NCT01922934|41924833|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
19512498|NCT01922934|41924832|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
19512499|NCT01922934|41924833|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
19512500|NCT01922934|41924832|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
19512501|NCT01922934|41924833|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
19512502|NCT01922934|41924832|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
19512503|NCT01922934|41924833|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
19512504|NCT01970592|41924841|FG000|Overall Study|Withdrawal by Subject|4|||
19512505|NCT01970592|41924841|FG000|Overall Study|Physician Decision|1|||
19704735|NCT03733444|42149055|FG001|Overall Study|Lack of Efficacy|1|||
19704736|NCT03733444|42149056|FG002|Overall Study|Lack of Efficacy|1|||
19512506|NCT01970592|41924841|FG000|Overall Study|Adverse Event|1|||
19512507|NCT01920594|41924847|FG000|Overall Study|Adverse Event|4|||
19512508|NCT01920594|41924848|FG001|Overall Study|Adverse Event|2|||
19512509|NCT01920594|41924847|FG000|Overall Study|Lost to Follow-up|1|||
19512510|NCT01920594|41924848|FG001|Overall Study|Lost to Follow-up|0|||
19512511|NCT01920594|41924847|FG000|Overall Study|Recovery|2|||
19512512|NCT01920594|41924848|FG001|Overall Study|Recovery|0|||
19512513|NCT01920594|41924847|FG000|Overall Study|Investigator discretion|0|||
19512514|NCT01920594|41924848|FG001|Overall Study|Investigator discretion|1|||
19512515|NCT01917084|41924854|FG000|Overall Study|Withdrawal by Subject|1|||
19512516|NCT01917006|41924865|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
19512517|NCT01917006|41924866|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
19512518|NCT01917006|41924867|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
19512519|NCT01917006|41924868|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
19512520|NCT01917006|41924869|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
19512521|NCT01917006|41924870|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
19512522|NCT01917006|41924871|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
19512523|NCT01917006|41924872|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
19512524|NCT01917006|41924865|FG000|Randomized-treatment Period|Personal Reasons|0|||
19512525|NCT01917006|41924866|FG001|Randomized-treatment Period|Personal Reasons|0|||
19512526|NCT01917006|41924867|FG002|Randomized-treatment Period|Personal Reasons|0|||
19512527|NCT01917006|41924868|FG003|Randomized-treatment Period|Personal Reasons|0|||
19512528|NCT01917006|41924869|FG004|Randomized-treatment Period|Personal Reasons|0|||
19512529|NCT01917006|41924870|FG005|Randomized-treatment Period|Personal Reasons|1|||
19512530|NCT01917006|41924871|FG006|Randomized-treatment Period|Personal Reasons|0|||
19512531|NCT01917006|41924872|FG007|Randomized-treatment Period|Personal Reasons|0|||
19512532|NCT01917006|41924865|FG000|Randomized-treatment Period|Protocol Violation|1|||
19512533|NCT01917006|41924866|FG001|Randomized-treatment Period|Protocol Violation|0|||
19512534|NCT01917006|41924867|FG002|Randomized-treatment Period|Protocol Violation|0|||
19512535|NCT01917006|41924868|FG003|Randomized-treatment Period|Protocol Violation|0|||
19512536|NCT01917006|41924869|FG004|Randomized-treatment Period|Protocol Violation|0|||
19512537|NCT01917006|41924870|FG005|Randomized-treatment Period|Protocol Violation|0|||
19512538|NCT01917006|41924871|FG006|Randomized-treatment Period|Protocol Violation|0|||
19512539|NCT01917006|41924872|FG007|Randomized-treatment Period|Protocol Violation|0|||
19512540|NCT01917006|41924865|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512541|NCT01917006|41924866|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512542|NCT01917006|41924867|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512543|NCT01917006|41924868|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512544|NCT01917006|41924869|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512545|NCT01917006|41924870|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512546|NCT01917006|41924871|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
19512547|NCT01917006|41924872|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
19512548|NCT01917006|41924865|FG000|Open-label Period|Adverse Event|0|||
19512549|NCT01917006|41924866|FG001|Open-label Period|Adverse Event|0|||
19512550|NCT01917006|41924867|FG002|Open-label Period|Adverse Event|0|||
19512551|NCT01917006|41924868|FG003|Open-label Period|Adverse Event|0|||
19512552|NCT01917006|41924869|FG004|Open-label Period|Adverse Event|0|||
19512553|NCT01917006|41924870|FG005|Open-label Period|Adverse Event|0|||
19512554|NCT01917006|41924871|FG006|Open-label Period|Adverse Event|0|||
19512555|NCT01917006|41924872|FG007|Open-label Period|Adverse Event|1|||
19512556|NCT01917006|41924865|FG000|Open-label Period|Lost to Follow-up|0|||
19512557|NCT01917006|41924866|FG001|Open-label Period|Lost to Follow-up|0|||
19512558|NCT01917006|41924867|FG002|Open-label Period|Lost to Follow-up|0|||
19512559|NCT01917006|41924868|FG003|Open-label Period|Lost to Follow-up|0|||
19512560|NCT01917006|41924869|FG004|Open-label Period|Lost to Follow-up|0|||
19512561|NCT01917006|41924870|FG005|Open-label Period|Lost to Follow-up|0|||
19512562|NCT01917006|41924871|FG006|Open-label Period|Lost to Follow-up|0|||
19617731|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617732|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19512563|NCT01917006|41924872|FG007|Open-label Period|Lost to Follow-up|1|||
19512564|NCT01916304|41924889|FG000|Overall Study|Screening failure|17|||
19512565|NCT01916226|41924897|FG000|Overall Study|Adverse Event|1|||
19512566|NCT01916226|41924898|FG001|Overall Study|Adverse Event|0|||
19512567|NCT01916226|41924899|FG002|Overall Study|Adverse Event|1|||
19512568|NCT01916226|41924900|FG003|Overall Study|Adverse Event|1|||
19512569|NCT01916226|41924897|FG000|Overall Study|Lack of Efficacy|0|||
19512570|NCT01916226|41924898|FG001|Overall Study|Lack of Efficacy|0|||
19512571|NCT01916226|41924899|FG002|Overall Study|Lack of Efficacy|2|||
19512572|NCT01916226|41924900|FG003|Overall Study|Lack of Efficacy|1|||
19512573|NCT01916226|41924897|FG000|Overall Study|Protocol Violation|0|||
19512574|NCT01916226|41924898|FG001|Overall Study|Protocol Violation|1|||
19617733|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617734|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
19617735|NCT02393248|42067452|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617736|NCT02393248|42067453|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617737|NCT02393248|42067454|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617738|NCT02393248|42067455|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617739|NCT02393248|42067456|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617740|NCT02393248|42067457|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617741|NCT02393248|42067458|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
19617742|NCT02393248|42067459|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617743|NCT02393248|42067460|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617744|NCT02393248|42067461|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617745|NCT02393248|42067462|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617746|NCT02393248|42067463|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617747|NCT02393248|42067464|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617748|NCT02393248|42067465|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617749|NCT02393248|42067466|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617750|NCT02393248|42067467|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617751|NCT02393248|42067468|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617752|NCT02393248|42067469|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617753|NCT02393248|42067470|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617754|NCT02393248|42067471|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19512575|NCT01916226|41924899|FG002|Overall Study|Protocol Violation|0|||
19512576|NCT01916226|41924900|FG003|Overall Study|Protocol Violation|1|||
19512577|NCT01916226|41924897|FG000|Overall Study|Physician Decision|0|||
19512578|NCT01916226|41924898|FG001|Overall Study|Physician Decision|0|||
19512579|NCT01916226|41924899|FG002|Overall Study|Physician Decision|0|||
19512580|NCT01916226|41924900|FG003|Overall Study|Physician Decision|1|||
19512581|NCT01969500|41924913|FG000|Overall Study|Death|0|||
19512582|NCT01969500|41924914|FG001|Overall Study|Death|1|||
19512583|NCT01969500|41924913|FG000|Overall Study|extended hospitalization|1|||
19512584|NCT01969500|41924914|FG001|Overall Study|extended hospitalization|1|||
19512585|NCT01915914|41924920|FG000|Acute Phase|Withdrawal by Subject|4|||
19512586|NCT01915914|41924921|FG001|Acute Phase|Withdrawal by Subject|0|||
19617755|NCT02393248|42067472|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19704737|NCT03733444|42149054|FG000|Overall Study|Physician Decision|2|||
19704738|NCT03733444|42149055|FG001|Overall Study|Physician Decision|1|||
19704739|NCT03733444|42149056|FG002|Overall Study|Physician Decision|0|||
19704740|NCT03733444|42149054|FG000|Overall Study|Protocol Violation|2|||
19704741|NCT03733444|42149055|FG001|Overall Study|Protocol Violation|1|||
19704742|NCT03733444|42149056|FG002|Overall Study|Protocol Violation|0|||
19704743|NCT03733444|42149054|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
19704744|NCT03733444|42149055|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
19512587|NCT01915914|41924922|FG002|Acute Phase|Withdrawal by Subject|0|||
19512588|NCT01915914|41924923|FG003|Acute Phase|Withdrawal by Subject|0|||
19512589|NCT01915914|41924920|FG000|Acute Phase|Lost to Follow-up|4|||
19512590|NCT01915914|41924921|FG001|Acute Phase|Lost to Follow-up|0|||
19512591|NCT01915914|41924922|FG002|Acute Phase|Lost to Follow-up|0|||
19512592|NCT01915914|41924923|FG003|Acute Phase|Lost to Follow-up|0|||
19512593|NCT01915914|41924920|FG000|Acute Phase|Physician Decision|1|||
19512594|NCT01915914|41924921|FG001|Acute Phase|Physician Decision|0|||
19512595|NCT01915914|41924922|FG002|Acute Phase|Physician Decision|0|||
19512596|NCT01915914|41924923|FG003|Acute Phase|Physician Decision|0|||
19512597|NCT01915914|41924920|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
19512598|NCT01915914|41924921|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
19617756|NCT02393248|42067473|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617757|NCT02393248|42067474|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19617758|NCT02393248|42067475|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19512599|NCT01915914|41924922|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
19512600|NCT01915914|41924923|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
19512601|NCT01915914|41924920|FG000|Acute Phase|"Not Achieved treatment success"|1|||
19512602|NCT01915914|41924921|FG001|Acute Phase|"Not Achieved treatment success"|0|||
19512603|NCT01915914|41924922|FG002|Acute Phase|"Not Achieved treatment success"|0|||
19512604|NCT01915914|41924923|FG003|Acute Phase|"Not Achieved treatment success"|0|||
19512605|NCT01915914|41924920|FG000|Acute Phase|Missing|1|||
19512606|NCT01915914|41924921|FG001|Acute Phase|Missing|0|||
19512607|NCT01915914|41924922|FG002|Acute Phase|Missing|0|||
19512608|NCT01915914|41924923|FG003|Acute Phase|Missing|0|||
19512609|NCT01915914|41924920|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19512610|NCT01915914|41924921|FG001|Maintenance Phase|Withdrawal by Subject|1|||
19512611|NCT01915914|41924922|FG002|Maintenance Phase|Withdrawal by Subject|1|||
19512612|NCT01915914|41924923|FG003|Maintenance Phase|Withdrawal by Subject|0|||
19512613|NCT01915914|41924920|FG000|Maintenance Phase|Lost to Follow-up|0|||
19512614|NCT01915914|41924921|FG001|Maintenance Phase|Lost to Follow-up|4|||
19512615|NCT01915914|41924922|FG002|Maintenance Phase|Lost to Follow-up|1|||
19512616|NCT01915914|41924923|FG003|Maintenance Phase|Lost to Follow-up|0|||
19512617|NCT01915914|41924920|FG000|Maintenance Phase|Missing|0|||
19512618|NCT01915914|41924921|FG001|Maintenance Phase|Missing|1|||
19512619|NCT01915914|41924922|FG002|Maintenance Phase|Missing|0|||
19512620|NCT01915914|41924923|FG003|Maintenance Phase|Missing|0|||
19512621|NCT01915914|41924920|FG000|Follow-up Phase|Withdrawal by Subject|0|||
19512622|NCT01915914|41924921|FG001|Follow-up Phase|Withdrawal by Subject|0|||
19512623|NCT01915914|41924922|FG002|Follow-up Phase|Withdrawal by Subject|0|||
19512624|NCT01915914|41924923|FG003|Follow-up Phase|Withdrawal by Subject|1|||
19512625|NCT01915914|41924920|FG000|Follow-up Phase|Physician Decision|0|||
19512626|NCT01915914|41924921|FG001|Follow-up Phase|Physician Decision|0|||
19512627|NCT01915914|41924922|FG002|Follow-up Phase|Physician Decision|0|||
19512628|NCT01915914|41924923|FG003|Follow-up Phase|Physician Decision|1|||
19512629|NCT01919970|41924943|FG000|Overall Study|Withdrawal by Subject|3|||
19512630|NCT01919970|41924944|FG001|Overall Study|Withdrawal by Subject|0|||
19512631|NCT01919814|41924950|FG000|Overall Study|Adverse Event|1|||
19512632|NCT01919814|41924951|FG001|Overall Study|Adverse Event|0|||
19512633|NCT01919814|41924950|FG000|Overall Study|Protocol Violation|1|||
19512634|NCT01919814|41924951|FG001|Overall Study|Protocol Violation|0|||
19512635|NCT01919814|41924950|FG000|Overall Study|Withdrawal by Subject|1|||
19512636|NCT01919814|41924951|FG001|Overall Study|Withdrawal by Subject|0|||
19512637|NCT01968954|41924959|FG000|Overall Study|Adverse Event|6|||
19512638|NCT01968954|41924960|FG001|Overall Study|Adverse Event|3|||
19512639|NCT01968954|41924959|FG000|Overall Study|Death|1|||
19512640|NCT01968954|41924960|FG001|Overall Study|Death|2|||
19512641|NCT01968954|41924959|FG000|Overall Study|Lost to Follow-up|6|||
19512642|NCT01968954|41924960|FG001|Overall Study|Lost to Follow-up|4|||
19512643|NCT01968954|41924959|FG000|Overall Study|Withdrawal by Subject|20|||
19512644|NCT01968954|41924960|FG001|Overall Study|Withdrawal by Subject|23|||
19512645|NCT01968954|41924959|FG000|Overall Study|Other|7|||
19512646|NCT01968954|41924960|FG001|Overall Study|Other|8|||
19512647|NCT01968954|41924959|FG000|Overall Study|Protocol Violation|0|||
19512648|NCT01968954|41924960|FG001|Overall Study|Protocol Violation|1|||
19512649|NCT01968954|41924959|FG000|Overall Study|Did not met inclusion criteria|0|||
19512650|NCT01968954|41924960|FG001|Overall Study|Did not met inclusion criteria|2|||
19512651|NCT01919190|41924969|FG000|Overall Study|Intra-op findings, etc.|3|||
19512652|NCT01919190|41924970|FG001|Overall Study|Intra-op findings, etc.|0|||
19617759|NCT02393248|42067476|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
19512653|NCT01620060|41924977|FG000|Overall Study|Adverse Event|9|||
19512654|NCT01620060|41924977|FG000|Overall Study|Protocol Violation|1|||
19512655|NCT01620060|41924977|FG000|Overall Study|Withdrawal by Subject|1|||
19512656|NCT01620060|41924977|FG000|Overall Study|Did not comply with Study Produre|1|||
19512657|NCT01620060|41924977|FG000|Overall Study|Family emergency|1|||
19512658|NCT01620060|41924977|FG000|Overall Study|Per Sponsor Decision|2|||
19512659|NCT01914666|41924984|FG000|Treatment Period|Lack of Efficacy|0|||
19512660|NCT01914666|41924985|FG001|Treatment Period|Lack of Efficacy|0|||
19512661|NCT01914666|41924986|FG002|Treatment Period|Lack of Efficacy|2|||
19512662|NCT01914666|41924984|FG000|Treatment Period|Adverse Event|10|||
19512663|NCT01914666|41924985|FG001|Treatment Period|Adverse Event|4|||
19512664|NCT01914666|41924986|FG002|Treatment Period|Adverse Event|2|||
19512665|NCT01914666|41924984|FG000|Treatment Period|Withdrawal by Subject|3|||
19512666|NCT01914666|41924985|FG001|Treatment Period|Withdrawal by Subject|2|||
19512667|NCT01914666|41924986|FG002|Treatment Period|Withdrawal by Subject|2|||
19512668|NCT01914666|41924984|FG000|Treatment Period|Physician Decision|0|||
19512669|NCT01914666|41924985|FG001|Treatment Period|Physician Decision|0|||
19512670|NCT01914666|41924986|FG002|Treatment Period|Physician Decision|2|||
19512671|NCT01913340|41924994|FG000|Overall Study|Death|2|||
19512672|NCT01913340|41924995|FG001|Overall Study|Death|5|||
19512673|NCT01913340|41924994|FG000|Overall Study|Lost to Follow-up|1|||
19512674|NCT01913340|41924995|FG001|Overall Study|Lost to Follow-up|1|||
19512675|NCT01864200|41925003|FG000|Overall Study|Lost to Follow-up|1|||
19512676|NCT01864200|41925004|FG001|Overall Study|Lost to Follow-up|3|||
19512677|NCT01864200|41925003|FG000|Overall Study|Protocol Violation|1|||
19512678|NCT01864200|41925004|FG001|Overall Study|Protocol Violation|0|||
19512679|NCT01912872|41925014|FG000|Overall Study|Lost to Follow-up|2|||
19512680|NCT01912872|41925015|FG001|Overall Study|Lost to Follow-up|3|||
19512681|NCT01912872|41925016|FG002|Overall Study|Lost to Follow-up|5|||
19512682|NCT01912872|41925017|FG003|Overall Study|Lost to Follow-up|5|||
19512683|NCT01912872|41925014|FG000|Overall Study|Other unspecified|3|||
19512684|NCT01912872|41925015|FG001|Overall Study|Other unspecified|1|||
19512685|NCT01912872|41925016|FG002|Overall Study|Other unspecified|3|||
19512686|NCT01912872|41925017|FG003|Overall Study|Other unspecified|0|||
19512687|NCT01912872|41925014|FG000|Overall Study|Informed consent withdrawn|0|||
19512688|NCT01912872|41925015|FG001|Overall Study|Informed consent withdrawn|0|||
19512689|NCT01912872|41925016|FG002|Overall Study|Informed consent withdrawn|1|||
19512690|NCT01912872|41925017|FG003|Overall Study|Informed consent withdrawn|1|||
19512691|NCT01912872|41925014|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
19512692|NCT01912872|41925015|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
19512693|NCT01912872|41925016|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
19512694|NCT01912872|41925017|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
19512695|NCT01912872|41925014|FG000|Overall Study|Protocol Violation|0|||
19512696|NCT01912872|41925015|FG001|Overall Study|Protocol Violation|0|||
19512697|NCT01912872|41925016|FG002|Overall Study|Protocol Violation|1|||
19512698|NCT01912872|41925017|FG003|Overall Study|Protocol Violation|0|||
19512699|NCT01912872|41925014|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19512700|NCT01912872|41925015|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19512701|NCT01912872|41925016|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19512702|NCT01912872|41925017|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
19512703|NCT01912872|41925014|FG000|Overall Study|Withdrawal of study medication|0|||
19512704|NCT01912872|41925015|FG001|Overall Study|Withdrawal of study medication|0|||
19512705|NCT01912872|41925016|FG002|Overall Study|Withdrawal of study medication|0|||
19512706|NCT01912872|41925017|FG003|Overall Study|Withdrawal of study medication|2|||
19512707|NCT01912872|41925014|FG000|Overall Study|Missing|0|||
19512708|NCT01912872|41925015|FG001|Overall Study|Missing|0|||
19512709|NCT01912872|41925016|FG002|Overall Study|Missing|0|||
19512710|NCT01912872|41925017|FG003|Overall Study|Missing|1|||
19512711|NCT01912404|41925030|FG000|Overall Study|Due to personal reasons|1|||
19512712|NCT01912404|41925031|FG001|Overall Study|Due to personal reasons|0|||
19512713|NCT01911780|41925039|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
19512714|NCT01911780|41925040|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
19512715|NCT01911780|41925039|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
19512716|NCT01911780|41925040|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
19512717|NCT01911780|41925039|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
19512718|NCT01911780|41925040|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
19512719|NCT01911780|41925039|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
19512720|NCT01911780|41925040|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
19512721|NCT01911780|41925039|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
19512722|NCT01911780|41925040|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
19512723|NCT01911780|41925039|FG000|Extension Period (52 Weeks)|Personal reason|1|||
19512724|NCT01911780|41925040|FG001|Extension Period (52 Weeks)|Personal reason|1|||
19512725|NCT01911546|41925050|FG000|Overall Study|Lost to Follow-up|1|||
19512726|NCT01911546|41925050|FG000|Overall Study|Everolimus was discontinued|5|||
19512727|NCT01910298|41925056|FG000|Overall Study|Adverse Event|1|||
19512728|NCT01910298|41925057|FG001|Overall Study|Adverse Event|0|||
19617760|NCT02393248|42067452|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19512729|NCT01910298|41925056|FG000|Overall Study|Withdrawal by Subject|2|||
19512730|NCT01910298|41925057|FG001|Overall Study|Withdrawal by Subject|7|||
19617761|NCT02393248|42067453|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19512731|NCT01910298|41925056|FG000|Overall Study|Protocol Deviation|0|||
19512732|NCT01910298|41925057|FG001|Overall Study|Protocol Deviation|5|||
19512733|NCT01910298|41925056|FG000|Overall Study|Lost to Follow-up|1|||
19512734|NCT01910298|41925057|FG001|Overall Study|Lost to Follow-up|1|||
19512735|NCT01910298|41925056|FG000|Overall Study|Study Terminated by Sponsor|1|||
19512736|NCT01910298|41925057|FG001|Overall Study|Study Terminated by Sponsor|17|||
19512737|NCT01910298|41925056|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19512738|NCT01910298|41925057|FG001|Overall Study|Other Miscellaneous Reasons|2|||
19512739|NCT01909674|41925065|FG000|Overall Study|Withdrawal by Subject|5|||
19512740|NCT01909674|41925066|FG001|Overall Study|Withdrawal by Subject|2|||
19512741|NCT01908816|41925076|FG000|Overall Study|Subject's no longer requires study drug|0|||
19512742|NCT01908816|41925077|FG001|Overall Study|Subject's no longer requires study drug|0|||
19512743|NCT01908816|41925078|FG002|Overall Study|Subject's no longer requires study drug|0|||
19512744|NCT01908816|41925079|FG003|Overall Study|Subject's no longer requires study drug|1|||
19512745|NCT01908816|41925076|FG000|Overall Study|Protocol deviation|1|||
19512746|NCT01908816|41925077|FG001|Overall Study|Protocol deviation|2|||
19512747|NCT01908816|41925078|FG002|Overall Study|Protocol deviation|1|||
19512748|NCT01908816|41925079|FG003|Overall Study|Protocol deviation|1|||
19512749|NCT01908816|41925076|FG000|Overall Study|Withdrawal by Subject|0|||
19512750|NCT01908816|41925077|FG001|Overall Study|Withdrawal by Subject|4|||
19512751|NCT01908816|41925078|FG002|Overall Study|Withdrawal by Subject|2|||
19512752|NCT01908816|41925079|FG003|Overall Study|Withdrawal by Subject|2|||
19512753|NCT01908816|41925076|FG000|Overall Study|Lost to Follow-up|3|||
19512754|NCT01908816|41925077|FG001|Overall Study|Lost to Follow-up|5|||
19512755|NCT01908816|41925078|FG002|Overall Study|Lost to Follow-up|4|||
19512756|NCT01908816|41925079|FG003|Overall Study|Lost to Follow-up|2|||
19512757|NCT01908816|41925076|FG000|Overall Study|Death|1|||
19512758|NCT01908816|41925077|FG001|Overall Study|Death|0|||
19512759|NCT01908816|41925078|FG002|Overall Study|Death|7|||
19512760|NCT01908816|41925079|FG003|Overall Study|Death|1|||
19512761|NCT01908816|41925076|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19512762|NCT01908816|41925077|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
19512763|NCT01908816|41925078|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
19512764|NCT01908816|41925079|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
19512765|NCT01908816|41925076|FG000|Overall Study|Early termination|87|||
19512766|NCT01908816|41925077|FG001|Overall Study|Early termination|60|||
19512767|NCT01908816|41925078|FG002|Overall Study|Early termination|43|||
19512768|NCT01908816|41925079|FG003|Overall Study|Early termination|28|||
19512769|NCT01908582|41925092|FG000|Period 2|Physician Decision|1|||
19512770|NCT01908582|41925092|FG000|Period 2|Withdrawal by Subject|1|||
19512771|NCT01908426|41925101|FG000|Overall Study|Adverse Event|98|||
19512772|NCT01908426|41925102|FG001|Overall Study|Adverse Event|11|||
19512773|NCT01908426|41925101|FG000|Overall Study|Clinical Deterioration|72|||
19512774|NCT01908426|41925102|FG001|Overall Study|Clinical Deterioration|38|||
19512775|NCT01908426|41925101|FG000|Overall Study|Lack of Efficacy|3|||
19512776|NCT01908426|41925102|FG001|Overall Study|Lack of Efficacy|0|||
19512777|NCT01908426|41925101|FG000|Overall Study|Lost to Follow-up|0|||
19512778|NCT01908426|41925102|FG001|Overall Study|Lost to Follow-up|1|||
19512779|NCT01908426|41925101|FG000|Overall Study|Physician Decision|3|||
19512780|NCT01908426|41925102|FG001|Overall Study|Physician Decision|3|||
19512781|NCT01908426|41925101|FG000|Overall Study|Withdrawal by Subject|11|||
19512782|NCT01908426|41925102|FG001|Overall Study|Withdrawal by Subject|6|||
19512783|NCT01908426|41925101|FG000|Overall Study|Progressive Disease|206|||
19512784|NCT01908426|41925102|FG001|Overall Study|Progressive Disease|152|||
19512785|NCT01908426|41925101|FG000|Overall Study|Protocol Violation|1|||
19512786|NCT01908426|41925102|FG001|Overall Study|Protocol Violation|0|||
19512787|NCT01908426|41925101|FG000|Overall Study|No Study Treatment Given|3|||
19512788|NCT01908426|41925102|FG001|Overall Study|No Study Treatment Given|0|||
19512789|NCT01907100|41925112|FG000|Overall Study|PD based on modified RECIST criteria|31|||
19512790|NCT01907100|41925113|FG001|Overall Study|PD based on modified RECIST criteria|32|||
19512791|NCT01907100|41925114|FG002|Overall Study|PD based on modified RECIST criteria|95|||
19512792|NCT01907100|41925115|FG003|Overall Study|PD based on modified RECIST criteria|92|||
19512793|NCT01907100|41925112|FG000|Overall Study|Withdrawal by Subject|2|||
19512794|NCT01907100|41925113|FG001|Overall Study|Withdrawal by Subject|5|||
19512795|NCT01907100|41925114|FG002|Overall Study|Withdrawal by Subject|10|||
19512796|NCT01907100|41925115|FG003|Overall Study|Withdrawal by Subject|13|||
19512797|NCT01907100|41925112|FG000|Overall Study|Protocol Violation|0|||
19512798|NCT01907100|41925113|FG001|Overall Study|Protocol Violation|0|||
19512799|NCT01907100|41925114|FG002|Overall Study|Protocol Violation|1|||
19512800|NCT01907100|41925115|FG003|Overall Study|Protocol Violation|1|||
19512801|NCT01907100|41925112|FG000|Overall Study|Lost to Follow-up|0|||
19512802|NCT01907100|41925113|FG001|Overall Study|Lost to Follow-up|0|||
19512803|NCT01907100|41925114|FG002|Overall Study|Lost to Follow-up|0|||
19512804|NCT01907100|41925115|FG003|Overall Study|Lost to Follow-up|1|||
19512805|NCT01907100|41925112|FG000|Overall Study|Not treated|2|||
19512806|NCT01907100|41925113|FG001|Overall Study|Not treated|0|||
19512807|NCT01907100|41925114|FG002|Overall Study|Not treated|1|||
19512808|NCT01907100|41925115|FG003|Overall Study|Not treated|2|||
19512809|NCT01907100|41925112|FG000|Overall Study|Other than reasons specified|1|||
19512810|NCT01907100|41925113|FG001|Overall Study|Other than reasons specified|0|||
19512811|NCT01907100|41925114|FG002|Overall Study|Other than reasons specified|10|||
19512812|NCT01907100|41925115|FG003|Overall Study|Other than reasons specified|6|||
19512813|NCT01907100|41925112|FG000|Overall Study|Adverse event (AE)|6|||
19512814|NCT01907100|41925113|FG001|Overall Study|Adverse event (AE)|3|||
19512815|NCT01907100|41925114|FG002|Overall Study|Adverse event (AE)|22|||
19512816|NCT01907100|41925115|FG003|Overall Study|Adverse event (AE)|23|||
19512817|NCT01907100|41925112|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
19512818|NCT01907100|41925113|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
19512819|NCT01907100|41925114|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
19512820|NCT01907100|41925115|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
19512821|NCT01889862|41925123|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
19512822|NCT01889862|41925124|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
19512823|NCT01889862|41925125|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
19512824|NCT01889862|41925126|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
19512825|NCT01889862|41925127|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
19512826|NCT01889862|41925123|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
19512827|NCT01889862|41925124|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
19512828|NCT01889862|41925125|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
19512829|NCT01889862|41925126|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
19512830|NCT01889862|41925127|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
19512831|NCT01889862|41925123|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
19512832|NCT01889862|41925124|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
19512833|NCT01889862|41925125|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
19512834|NCT01889862|41925126|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
19512835|NCT01889862|41925127|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
19512836|NCT01889862|41925123|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
19512837|NCT01889862|41925124|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
19512838|NCT01889862|41925125|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
19512839|NCT01889862|41925126|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
19512840|NCT01889862|41925127|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
19512841|NCT01889862|41925123|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
19512842|NCT01889862|41925124|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
19512843|NCT01889862|41925125|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
19512844|NCT01889862|41925126|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
19512845|NCT01889862|41925127|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
19512846|NCT01889862|41925123|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
19512847|NCT01889862|41925124|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
19512848|NCT01889862|41925125|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
19512849|NCT01889862|41925126|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
19512850|NCT01889862|41925127|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
19512851|NCT01889862|41925123|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
19512852|NCT01889862|41925124|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
19512853|NCT01889862|41925125|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
19512854|NCT01889862|41925126|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
19512855|NCT01889862|41925127|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
19512856|NCT01889862|41925123|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
19512857|NCT01889862|41925124|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
19512858|NCT01889862|41925125|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
19512859|NCT01889862|41925126|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
19512860|NCT01889862|41925127|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
19512861|NCT01889862|41925123|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
19512862|NCT01889862|41925124|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
19512863|NCT01889862|41925125|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
19512864|NCT01889862|41925126|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
19512865|NCT01889862|41925127|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
19512866|NCT01889862|41925123|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
19512867|NCT01889862|41925124|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
19512868|NCT01889862|41925125|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
19512869|NCT01889862|41925126|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
19512870|NCT01889862|41925127|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
19512871|NCT01887912|41925154|FG000|Overall Study|Serious adverse event|400|||
19512872|NCT01887912|41925155|FG001|Overall Study|Serious adverse event|198|||
19512873|NCT01887912|41925154|FG000|Overall Study|Other Adverse Event|34|||
19512874|NCT01887912|41925155|FG001|Overall Study|Other Adverse Event|15|||
19512875|NCT01887912|41925154|FG000|Overall Study|Protocol Violation|67|||
19512876|NCT01887912|41925155|FG001|Overall Study|Protocol Violation|37|||
19512877|NCT01887912|41925154|FG000|Overall Study|Lost to Follow-up|163|||
19512878|NCT01887912|41925155|FG001|Overall Study|Lost to Follow-up|74|||
19512879|NCT01887912|41925154|FG000|Overall Study|Withdrawal by Subject|606|||
19512880|NCT01887912|41925155|FG001|Overall Study|Withdrawal by Subject|349|||
19512881|NCT01887912|41925154|FG000|Overall Study|Other|122|||
19512882|NCT01887912|41925155|FG001|Overall Study|Other|58|||
19512883|NCT01887678|41925163|FG000|Overall Study|Adverse Event|4|||
19512884|NCT01887678|41925164|FG001|Overall Study|Adverse Event|6|||
19394145|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
19512885|NCT01887678|41925163|FG000|Overall Study|Exceeded rescue medication dosage|4|||
19512886|NCT01887678|41925164|FG001|Overall Study|Exceeded rescue medication dosage|5|||
19512887|NCT01887678|41925163|FG000|Overall Study|Withdrawal of consent|3|||
19512888|NCT01887678|41925164|FG001|Overall Study|Withdrawal of consent|4|||
19512889|NCT01887678|41925163|FG000|Overall Study|Lost to Follow-up|4|||
19512890|NCT01887678|41925164|FG001|Overall Study|Lost to Follow-up|2|||
19512891|NCT01887678|41925163|FG000|Overall Study|Deterioration of clinical condition|0|||
19512892|NCT01887678|41925164|FG001|Overall Study|Deterioration of clinical condition|4|||
19512893|NCT01887678|41925163|FG000|Overall Study|Lack of Efficacy|1|||
19512894|NCT01887678|41925164|FG001|Overall Study|Lack of Efficacy|2|||
19512895|NCT01887678|41925163|FG000|Overall Study|Non-compliance|0|||
19512896|NCT01887678|41925164|FG001|Overall Study|Non-compliance|3|||
19512897|NCT01887678|41925163|FG000|Overall Study|Specified|1|||
19512898|NCT01887678|41925164|FG001|Overall Study|Specified|2|||
19512899|NCT01887600|41925172|FG000|Overall Study|Death|39|||
19512900|NCT01887600|41925173|FG001|Overall Study|Death|16|||
19512901|NCT01887600|41925172|FG000|Overall Study|Lack of Efficacy|3|||
19512902|NCT01887600|41925173|FG001|Overall Study|Lack of Efficacy|26|||
19512903|NCT01887600|41925172|FG000|Overall Study|Lost to Follow-up|5|||
19512904|NCT01887600|41925173|FG001|Overall Study|Lost to Follow-up|1|||
19512905|NCT01887600|41925172|FG000|Overall Study|Physician Decision|7|||
19512906|NCT01887600|41925173|FG001|Overall Study|Physician Decision|8|||
19512907|NCT01887600|41925172|FG000|Overall Study|Protocol Deviation|3|||
19512908|NCT01887600|41925173|FG001|Overall Study|Protocol Deviation|0|||
19512909|NCT01887600|41925172|FG000|Overall Study|Withdrawal by Subject|58|||
19512910|NCT01887600|41925173|FG001|Overall Study|Withdrawal by Subject|52|||
19512911|NCT01887600|41925172|FG000|Overall Study|Adverse Event|21|||
19512912|NCT01887600|41925173|FG001|Overall Study|Adverse Event|9|||
19512913|NCT01887600|41925172|FG000|Overall Study|Non-compliance with study drug|3|||
19512914|NCT01887600|41925173|FG001|Overall Study|Non-compliance with study drug|0|||
19512915|NCT01887600|41925172|FG000|Overall Study|Miscellaneous|6|||
19512916|NCT01887600|41925173|FG001|Overall Study|Miscellaneous|2|||
19512917|NCT01887600|41925172|FG000|Overall Study|Progressive Disease|1|||
19512918|NCT01887600|41925173|FG001|Overall Study|Progressive Disease|0|||
19512919|NCT01887288|41925180|FG000|Overall Study|The study was terminated and the PI has|16|||
19512920|NCT01887210|41925186|FG000|Overall Study|Withdrawal by Subject|1|||
19512921|NCT01887210|41925187|FG001|Overall Study|Withdrawal by Subject|3|||
19512922|NCT01887210|41925186|FG000|Overall Study|Lost to Follow-up|0|||
19512923|NCT01887210|41925187|FG001|Overall Study|Lost to Follow-up|1|||
19512924|NCT01885182|41925218|FG000|Overall Study|Adverse Event|11|||
19512925|NCT01885182|41925219|FG001|Overall Study|Adverse Event|13|||
19512926|NCT01885182|41925218|FG000|Overall Study|Withdrawal by Subject|13|||
19512927|NCT01885182|41925219|FG001|Overall Study|Withdrawal by Subject|6|||
19512928|NCT01885182|41925218|FG000|Overall Study|Lost to Follow-up|2|||
19512929|NCT01885182|41925219|FG001|Overall Study|Lost to Follow-up|2|||
19512930|NCT01885182|41925218|FG000|Overall Study|Lack of Efficacy|8|||
19512931|NCT01885182|41925219|FG001|Overall Study|Lack of Efficacy|1|||
19512932|NCT01885104|41925229|FG000|Overall Study|Withdrawal of Consent|1|||
19512933|NCT01885104|41925230|FG001|Overall Study|Withdrawal of Consent|0|||
19512934|NCT01885104|41925229|FG000|Overall Study|Lost to Follow-up|0|||
19512935|NCT01885104|41925230|FG001|Overall Study|Lost to Follow-up|1|||
19512936|NCT01885104|41925229|FG000|Overall Study|Physician Decision|1|||
19512937|NCT01885104|41925230|FG001|Overall Study|Physician Decision|0|||
19512938|NCT01881750|41925238|FG000|Overall Study|Changes in concomitant therapies|2|||
19512939|NCT01881750|41925239|FG001|Overall Study|Changes in concomitant therapies|3|||
19512940|NCT01881750|41925238|FG000|Overall Study|Lost to Follow-up|0|||
19512941|NCT01881750|41925239|FG001|Overall Study|Lost to Follow-up|1|||
19512942|NCT01906008|41925249|FG000|Overall Study|Lost to Follow-up|2|||
19512943|NCT01906008|41925250|FG001|Overall Study|Lost to Follow-up|0|||
19512944|NCT01906008|41925249|FG000|Overall Study|Oxaliplatin toxicity|2|||
19512945|NCT01906008|41925250|FG001|Overall Study|Oxaliplatin toxicity|0|||
19512946|NCT01906008|41925249|FG000|Overall Study|Protocol Violation|0|||
19512947|NCT01906008|41925250|FG001|Overall Study|Protocol Violation|1|||
19512948|NCT01906008|41925249|FG000|Overall Study|Withdrawal by Subject|1|||
19512949|NCT01906008|41925250|FG001|Overall Study|Withdrawal by Subject|5|||
19512950|NCT01906008|41925249|FG000|Overall Study|Did not start study med|3|||
19512951|NCT01906008|41925250|FG001|Overall Study|Did not start study med|4|||
19512952|NCT01906008|41925249|FG000|Overall Study|Oxaliplatin stops|10|||
19512953|NCT01906008|41925250|FG001|Overall Study|Oxaliplatin stops|8|||
19512954|NCT01906008|41925249|FG000|Overall Study|Hospice|1|||
19512955|NCT01906008|41925250|FG001|Overall Study|Hospice|0|||
19512956|NCT01906008|41925249|FG000|Overall Study|Physician Decision|3|||
19512957|NCT01906008|41925250|FG001|Overall Study|Physician Decision|3|||
19512958|NCT01906008|41925249|FG000|Overall Study|Lack of compliance of study med|5|||
19394146|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
19512959|NCT01906008|41925250|FG001|Overall Study|Lack of compliance of study med|3|||
19512960|NCT01906008|41925249|FG000|Overall Study|Adverse Event|0|||
19512961|NCT01906008|41925250|FG001|Overall Study|Adverse Event|3|||
19512962|NCT01863732|41925260|FG000|Overall Study|Adverse Event|2|||
19512963|NCT01863732|41925261|FG001|Overall Study|Adverse Event|0|||
19512964|NCT01863732|41925262|FG002|Overall Study|Adverse Event|3|||
19512965|NCT01863732|41925263|FG003|Overall Study|Adverse Event|3|||
19512966|NCT01863732|41925260|FG000|Overall Study|Lack of Efficacy|1|||
19512967|NCT01863732|41925261|FG001|Overall Study|Lack of Efficacy|0|||
19512968|NCT01863732|41925262|FG002|Overall Study|Lack of Efficacy|2|||
19512969|NCT01863732|41925263|FG003|Overall Study|Lack of Efficacy|1|||
19512970|NCT01863732|41925260|FG000|Overall Study|Lost to Follow-up|2|||
19512971|NCT01863732|41925261|FG001|Overall Study|Lost to Follow-up|2|||
19512972|NCT01863732|41925262|FG002|Overall Study|Lost to Follow-up|1|||
19512973|NCT01863732|41925263|FG003|Overall Study|Lost to Follow-up|1|||
19617762|NCT02393248|42067454|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617763|NCT02393248|42067455|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617764|NCT02393248|42067456|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617765|NCT02393248|42067457|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19512974|NCT01863732|41925260|FG000|Overall Study|Physician Decision|1|||
19512975|NCT01863732|41925261|FG001|Overall Study|Physician Decision|0|||
19512976|NCT01863732|41925262|FG002|Overall Study|Physician Decision|1|||
19512977|NCT01863732|41925263|FG003|Overall Study|Physician Decision|0|||
19512978|NCT01863732|41925260|FG000|Overall Study|Pregnancy|0|||
19512979|NCT01863732|41925261|FG001|Overall Study|Pregnancy|0|||
19512980|NCT01863732|41925262|FG002|Overall Study|Pregnancy|0|||
19512981|NCT01863732|41925263|FG003|Overall Study|Pregnancy|1|||
19512982|NCT01863732|41925260|FG000|Overall Study|Technical problems|0|||
19512983|NCT01863732|41925261|FG001|Overall Study|Technical problems|1|||
19512984|NCT01863732|41925262|FG002|Overall Study|Technical problems|1|||
19617766|NCT02393248|42067458|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617767|NCT02393248|42067459|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617768|NCT02393248|42067460|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19704745|NCT03733444|42149056|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
19704746|NCT03733444|42149054|FG000|Overall Study|Study Terminated by Sponsor|203|||
19704747|NCT03733444|42149055|FG001|Overall Study|Study Terminated by Sponsor|209|||
19704748|NCT03733444|42149056|FG002|Overall Study|Study Terminated by Sponsor|221|||
19704749|NCT03733444|42149054|FG000|Overall Study|Withdrawal by Subject|19|||
19704750|NCT03733444|42149055|FG001|Overall Study|Withdrawal by Subject|18|||
19704751|NCT03733444|42149056|FG002|Overall Study|Withdrawal by Subject|16|||
19704752|NCT03733444|42149054|FG000|Overall Study|Miscellaneous|1|||
19704753|NCT03733444|42149055|FG001|Overall Study|Miscellaneous|0|||
19704754|NCT03733444|42149056|FG002|Overall Study|Miscellaneous|1|||
19704755|NCT03733444|42149054|FG000|Overall Study|Not Treated|1|||
19704756|NCT03733444|42149055|FG001|Overall Study|Not Treated|2|||
19704757|NCT03733444|42149056|FG002|Overall Study|Not Treated|1|||
19704758|NCT03731182|42149076|FG000|Overall Study|Lost to Follow-up|2|||
19704759|NCT03731182|42149077|FG001|Overall Study|Lost to Follow-up|0|||
19704760|NCT03731182|42149076|FG000|Overall Study|Physician Decision|1|||
19704761|NCT03731182|42149077|FG001|Overall Study|Physician Decision|0|||
19704762|NCT03731182|42149076|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
19704763|NCT03731182|42149077|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
19704764|NCT03730012|42149086|FG000|Overall Study|Adverse Event|0|||
19512985|NCT01863732|41925263|FG003|Overall Study|Technical problems|0|||
19512986|NCT01863732|41925260|FG000|Overall Study|Subject/guardian decision|6|||
19512987|NCT01863732|41925261|FG001|Overall Study|Subject/guardian decision|9|||
19704765|NCT03730012|42149087|FG001|Overall Study|Adverse Event|1|||
19512988|NCT01863732|41925262|FG002|Overall Study|Subject/guardian decision|3|||
19512989|NCT01863732|41925263|FG003|Overall Study|Subject/guardian decision|1|||
19512990|NCT01863732|41925260|FG000|Overall Study|Death|1|||
19512991|NCT01863732|41925261|FG001|Overall Study|Death|0|||
19512992|NCT01863732|41925262|FG002|Overall Study|Death|0|||
19512993|NCT01863732|41925263|FG003|Overall Study|Death|1|||
19512994|NCT01905540|41925276|FG000|Period 3|Other|1|||
19512995|NCT01905540|41925277|FG001|Period 3|Other|0|||
19512996|NCT01905540|41925278|FG002|Period 3|Other|1|||
19512997|NCT01905540|41925279|FG003|Period 3|Other|1|||
19512998|NCT01904760|41925291|FG000|Overall Study|Protocol Violation|1|||
19512999|NCT01904760|41925292|FG001|Overall Study|Protocol Violation|0|||
19513000|NCT01904604|41925301|FG000|Overall Study|Withdrew before receiving dosing|0|||
19513001|NCT01904604|41925302|FG001|Overall Study|Withdrew before receiving dosing|1|||
19513002|NCT01904604|41925303|FG002|Overall Study|Withdrew before receiving dosing|0|||
19513003|NCT01904604|41925301|FG000|Overall Study|Non-compliance|1|||
19513004|NCT01904604|41925302|FG001|Overall Study|Non-compliance|0|||
19513005|NCT01904604|41925303|FG002|Overall Study|Non-compliance|0|||
19513006|NCT01904604|41925301|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
19513007|NCT01904604|41925302|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
19513008|NCT01904604|41925303|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
19513009|NCT01904604|41925301|FG000|Overall Study|Patch site reactions|1|||
19513010|NCT01904604|41925302|FG001|Overall Study|Patch site reactions|1|||
19513011|NCT01904604|41925303|FG002|Overall Study|Patch site reactions|0|||
19513012|NCT01904604|41925301|FG000|Overall Study|Increased syncope|0|||
19513013|NCT01904604|41925302|FG001|Overall Study|Increased syncope|1|||
19513014|NCT01904604|41925303|FG002|Overall Study|Increased syncope|0|||
19513015|NCT01904604|41925301|FG000|Overall Study|Unrelated illness|0|||
19513016|NCT01904604|41925302|FG001|Overall Study|Unrelated illness|1|||
19513017|NCT01904604|41925303|FG002|Overall Study|Unrelated illness|0|||
19513018|NCT01904604|41925301|FG000|Overall Study|Passed Week 52 OFC|1|||
19513019|NCT01904604|41925302|FG001|Overall Study|Passed Week 52 OFC|0|||
19513020|NCT01904604|41925303|FG002|Overall Study|Passed Week 52 OFC|0|||
19513021|NCT01904604|41925301|FG000|Overall Study|Withdrawal by Subject|1|||
19513022|NCT01904604|41925302|FG001|Overall Study|Withdrawal by Subject|2|||
19513023|NCT01904604|41925303|FG002|Overall Study|Withdrawal by Subject|0|||
19513024|NCT01904604|41925301|FG000|Overall Study|Participant Relocated|1|||
19513025|NCT01904604|41925302|FG001|Overall Study|Participant Relocated|1|||
19513026|NCT01904604|41925303|FG002|Overall Study|Participant Relocated|1|||
19513027|NCT01904604|41925301|FG000|Overall Study|Lost to Follow-up|0|||
19513028|NCT01904604|41925302|FG001|Overall Study|Lost to Follow-up|0|||
19513029|NCT01904604|41925303|FG002|Overall Study|Lost to Follow-up|1|||
19513030|NCT01904058|41925318|FG000|Overall Study|Adverse Event|2|||
19513031|NCT01904058|41925319|FG001|Overall Study|Adverse Event|0|||
19513032|NCT01904058|41925320|FG002|Overall Study|Adverse Event|0|||
19513033|NCT01904058|41925321|FG003|Overall Study|Adverse Event|0|||
19513034|NCT01904058|41925318|FG000|Overall Study|Withdrawal by Subject|1|||
19513035|NCT01904058|41925319|FG001|Overall Study|Withdrawal by Subject|0|||
19513036|NCT01904058|41925320|FG002|Overall Study|Withdrawal by Subject|1|||
19513037|NCT01904058|41925321|FG003|Overall Study|Withdrawal by Subject|0|||
19513038|NCT01904058|41925318|FG000|Overall Study|Pregnancy|0|||
19513039|NCT01904058|41925319|FG001|Overall Study|Pregnancy|0|||
19513040|NCT01904058|41925320|FG002|Overall Study|Pregnancy|0|||
19513041|NCT01904058|41925321|FG003|Overall Study|Pregnancy|1|||
19513042|NCT01881126|41925339|FG000|Overall Study|Non-compliance|1|||
19513043|NCT01881126|41925340|FG001|Overall Study|Non-compliance|1|||
19513044|NCT01881126|41925339|FG000|Overall Study|Adverse Event|0|||
19513045|NCT01881126|41925340|FG001|Overall Study|Adverse Event|1|||
19513046|NCT01614600|41925346|FG000|Overall Study|Unacceptable fit|1|||
19513047|NCT01614600|41925346|FG000|Overall Study|Discomfort|1|||
19513048|NCT01614600|41925346|FG000|Overall Study|Unable to remove lens at the end of day|1|||
19513049|NCT01614600|41925346|FG000|Overall Study|Protocol deviation|1|||
19513050|NCT01880736|41925354|FG000|Overall Study|Adverse Event|0|||
19513051|NCT01880736|41925355|FG001|Overall Study|Adverse Event|0|||
19513052|NCT01880736|41925356|FG002|Overall Study|Adverse Event|0|||
19513053|NCT01880736|41925357|FG003|Overall Study|Adverse Event|1|||
19513054|NCT01880736|41925354|FG000|Overall Study|Withdrawal Criteria|1|||
19704766|NCT03730012|42149086|FG000|Overall Study|Lack of Efficacy|1|||
19513055|NCT01880736|41925355|FG001|Overall Study|Withdrawal Criteria|2|||
19513056|NCT01880736|41925356|FG002|Overall Study|Withdrawal Criteria|1|||
19513057|NCT01880736|41925357|FG003|Overall Study|Withdrawal Criteria|5|||
19513058|NCT01880424|41925369|FG000|Overall Study|Adverse Event|7|||
19513059|NCT01880424|41925370|FG001|Overall Study|Adverse Event|6|||
19513060|NCT01880424|41925369|FG000|Overall Study|Lack of Efficacy|1|||
19513061|NCT01880424|41925370|FG001|Overall Study|Lack of Efficacy|4|||
19513062|NCT01880424|41925369|FG000|Overall Study|Lost to Follow-up|3|||
19513063|NCT01880424|41925370|FG001|Overall Study|Lost to Follow-up|2|||
19513064|NCT01880424|41925369|FG000|Overall Study|Protocol Violation|11|||
19513065|NCT01880424|41925370|FG001|Overall Study|Protocol Violation|13|||
19513066|NCT01880424|41925369|FG000|Overall Study|Withdrawal by Subject|10|||
19513067|NCT01880424|41925370|FG001|Overall Study|Withdrawal by Subject|30|||
19513068|NCT01880424|41925369|FG000|Overall Study|Other|1|||
19513069|NCT01880424|41925370|FG001|Overall Study|Other|0|||
19513070|NCT01862874|41925378|FG000|Overall Study|Randomized not treated|1|||
19513071|NCT01862874|41925379|FG001|Overall Study|Randomized not treated|0|||
19513072|NCT01862874|41925378|FG000|Overall Study|Adverse Event|0|||
19513073|NCT01862874|41925379|FG001|Overall Study|Adverse Event|3|||
19513074|NCT01862874|41925378|FG000|Overall Study|Lost to Follow-up|26|||
19513075|NCT01862874|41925379|FG001|Overall Study|Lost to Follow-up|29|||
19513076|NCT01862874|41925378|FG000|Overall Study|Physician Decision|5|||
19513077|NCT01862874|41925379|FG001|Overall Study|Physician Decision|3|||
19513078|NCT01862874|41925378|FG000|Overall Study|Withdrawn by parent/guardian|1|||
19513079|NCT01862874|41925379|FG001|Overall Study|Withdrawn by parent/guardian|1|||
19513080|NCT01862874|41925378|FG000|Overall Study|Withdrawal by Subject|46|||
19513081|NCT01862874|41925379|FG001|Overall Study|Withdrawal by Subject|40|||
19513082|NCT01862874|41925378|FG000|Overall Study|Death|0|||
19513083|NCT01862874|41925379|FG001|Overall Study|Death|1|||
19513084|NCT01879722|41925395|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19513085|NCT01879722|41925396|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
19513086|NCT01879722|41925397|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19513087|NCT01879722|41925398|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
19513088|NCT01879722|41925399|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
19513089|NCT01879722|41925400|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
19513090|NCT01879722|41925401|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
19513091|NCT01879722|41925402|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
19513092|NCT01879722|41925403|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
19513093|NCT01879722|41925404|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
19513094|NCT01879722|41925395|FG000|Overall Study|Voluntary Withdrawal|0|||
19513095|NCT01879722|41925396|FG001|Overall Study|Voluntary Withdrawal|0|||
19513096|NCT01879722|41925397|FG002|Overall Study|Voluntary Withdrawal|0|||
19513097|NCT01879722|41925398|FG003|Overall Study|Voluntary Withdrawal|0|||
19513098|NCT01879722|41925399|FG004|Overall Study|Voluntary Withdrawal|0|||
19513099|NCT01879722|41925400|FG005|Overall Study|Voluntary Withdrawal|0|||
19513100|NCT01879722|41925401|FG006|Overall Study|Voluntary Withdrawal|0|||
19513101|NCT01879722|41925402|FG007|Overall Study|Voluntary Withdrawal|0|||
19513102|NCT01879722|41925403|FG008|Overall Study|Voluntary Withdrawal|1|||
19513103|NCT01879722|41925404|FG009|Overall Study|Voluntary Withdrawal|0|||
19513104|NCT01879410|41925431|FG000|Overall Study|Adverse Event|9|||
19513105|NCT01879410|41925432|FG001|Overall Study|Adverse Event|14|||
19513106|NCT01879410|41925431|FG000|Overall Study|Lack of Efficacy|4|||
19513107|NCT01879410|41925432|FG001|Overall Study|Lack of Efficacy|6|||
19513108|NCT01879410|41925431|FG000|Overall Study|Protocol Violation|1|||
19513109|NCT01879410|41925432|FG001|Overall Study|Protocol Violation|7|||
19513110|NCT01879410|41925431|FG000|Overall Study|Lost to Follow-up|2|||
19513111|NCT01879410|41925432|FG001|Overall Study|Lost to Follow-up|1|||
19513112|NCT01879410|41925431|FG000|Overall Study|Withdrawal by Subject|7|||
19513113|NCT01879410|41925432|FG001|Overall Study|Withdrawal by Subject|8|||
19513114|NCT01879410|41925431|FG000|Overall Study|Randomised in Error|1|||
19513115|NCT01879410|41925432|FG001|Overall Study|Randomised in Error|2|||
19513116|NCT01903434|41925438|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
19513117|NCT01903434|41925439|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
19513118|NCT01903434|41925438|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
19513119|NCT01903434|41925439|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
19513120|NCT01903356|41925445|FG000|Overall Study|Lost to Follow-up|7|||
19513121|NCT01903356|41925445|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
19513122|NCT01903356|41925445|FG000|Overall Study|Violated the dosage and administration|3|||
19513123|NCT01862796|41925452|FG000|Overall Study|Prohibited medications|0|||
19513124|NCT01862796|41925453|FG001|Overall Study|Prohibited medications|0|||
19513125|NCT01862796|41925454|FG002|Overall Study|Prohibited medications|1|||
19513126|NCT01878084|41925462|FG000|Overall Study|Physician Decision|2|||
19513127|NCT01862640|41925471|FG000|Overall Study|Adverse Event|4|||
19513128|NCT01862640|41925472|FG001|Overall Study|Adverse Event|10|||
19513129|NCT01862640|41925473|FG002|Overall Study|Adverse Event|6|||
19513130|NCT01862640|41925474|FG003|Overall Study|Adverse Event|8|||
19617769|NCT02393248|42067461|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617770|NCT02393248|42067462|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617771|NCT02393248|42067463|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
19617772|NCT02393248|42067464|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
19617773|NCT02393248|42067465|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
19513131|NCT01862640|41925471|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
19513132|NCT01862640|41925472|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
19513133|NCT01862640|41925473|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
19513134|NCT01862640|41925474|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
19513135|NCT01862640|41925471|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
19513136|NCT01862640|41925472|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
19617774|NCT02393248|42067466|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
19513137|NCT01862640|41925473|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
19513138|NCT01862640|41925474|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
19513139|NCT01862640|41925471|FG000|Overall Study|Withdrawal by Subject|2|||
19513140|NCT01862640|41925472|FG001|Overall Study|Withdrawal by Subject|4|||
19513141|NCT01862640|41925473|FG002|Overall Study|Withdrawal by Subject|8|||
19513142|NCT01862640|41925474|FG003|Overall Study|Withdrawal by Subject|5|||
19513143|NCT01862640|41925471|FG000|Overall Study|Protocol Deviation|0|||
19513144|NCT01862640|41925472|FG001|Overall Study|Protocol Deviation|0|||
19513145|NCT01862640|41925473|FG002|Overall Study|Protocol Deviation|1|||
19513146|NCT01862640|41925474|FG003|Overall Study|Protocol Deviation|0|||
19513147|NCT01902966|41925483|FG000|Overall Study|Death|1|||
19513148|NCT01902966|41925483|FG000|Overall Study|Physician Decision|1|||
19513149|NCT01902966|41925483|FG000|Overall Study|Withdrawal by Subject|1|||
19513150|NCT01862484|41925489|FG000|Overall Study|Lack of Efficacy|1|||
19513151|NCT01862484|41925490|FG001|Overall Study|Lack of Efficacy|1|||
19513152|NCT01862484|41925489|FG000|Overall Study|Lost to Follow-up|1|||
19513153|NCT01862484|41925490|FG001|Overall Study|Lost to Follow-up|2|||
19513154|NCT01862484|41925489|FG000|Overall Study|Protocol Violation|0|||
19513155|NCT01862484|41925490|FG001|Overall Study|Protocol Violation|2|||
19513156|NCT01862484|41925489|FG000|Overall Study|Withdrawal by Subject|0|||
19513157|NCT01862484|41925490|FG001|Overall Study|Withdrawal by Subject|3|||
19513158|NCT01902888|41925496|FG000|Overall Study|Study Terminated|3|||
19513159|NCT01862328|41925507|FG000|Overall Study|Progressive Disease|3|||
19513160|NCT01862328|41925508|FG001|Overall Study|Progressive Disease|11|||
19513161|NCT01862328|41925509|FG002|Overall Study|Progressive Disease|5|||
19513162|NCT01862328|41925510|FG003|Overall Study|Progressive Disease|6|||
19513163|NCT01862328|41925511|FG004|Overall Study|Progressive Disease|7|||
19513164|NCT01862328|41925512|FG005|Overall Study|Progressive Disease|4|||
19513165|NCT01862328|41925513|FG006|Overall Study|Progressive Disease|3|||
19513166|NCT01862328|41925507|FG000|Overall Study|Adverse Event|0|||
19513167|NCT01862328|41925508|FG001|Overall Study|Adverse Event|4|||
19513168|NCT01862328|41925509|FG002|Overall Study|Adverse Event|0|||
19513169|NCT01862328|41925510|FG003|Overall Study|Adverse Event|1|||
19513170|NCT01862328|41925511|FG004|Overall Study|Adverse Event|0|||
19513171|NCT01862328|41925512|FG005|Overall Study|Adverse Event|2|||
19513172|NCT01862328|41925513|FG006|Overall Study|Adverse Event|4|||
19513173|NCT01862328|41925507|FG000|Overall Study|Other|0|||
19513174|NCT01862328|41925508|FG001|Overall Study|Other|2|||
19513175|NCT01862328|41925509|FG002|Overall Study|Other|1|||
19513176|NCT01862328|41925510|FG003|Overall Study|Other|0|||
19513177|NCT01862328|41925511|FG004|Overall Study|Other|4|||
19513178|NCT01862328|41925512|FG005|Overall Study|Other|0|||
19513179|NCT01862328|41925513|FG006|Overall Study|Other|1|||
19617775|NCT02393248|42067467|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617776|NCT02393248|42067468|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617777|NCT02393248|42067469|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617778|NCT02393248|42067470|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617779|NCT02393248|42067471|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617780|NCT02393248|42067472|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19513180|NCT01862328|41925507|FG000|Overall Study|Withdrawal by Subject|1|||
19394147|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
19513181|NCT01862328|41925508|FG001|Overall Study|Withdrawal by Subject|1|||
19513182|NCT01862328|41925509|FG002|Overall Study|Withdrawal by Subject|0|||
19513183|NCT01862328|41925510|FG003|Overall Study|Withdrawal by Subject|0|||
19513184|NCT01862328|41925511|FG004|Overall Study|Withdrawal by Subject|1|||
19513185|NCT01862328|41925512|FG005|Overall Study|Withdrawal by Subject|1|||
19513186|NCT01862328|41925513|FG006|Overall Study|Withdrawal by Subject|1|||
19513187|NCT01862328|41925507|FG000|Overall Study|Symptomatic Deterioration|0|||
19513188|NCT01862328|41925508|FG001|Overall Study|Symptomatic Deterioration|0|||
19513189|NCT01862328|41925509|FG002|Overall Study|Symptomatic Deterioration|0|||
19513190|NCT01862328|41925510|FG003|Overall Study|Symptomatic Deterioration|0|||
19513191|NCT01862328|41925511|FG004|Overall Study|Symptomatic Deterioration|0|||
19513192|NCT01862328|41925512|FG005|Overall Study|Symptomatic Deterioration|0|||
19513193|NCT01862328|41925513|FG006|Overall Study|Symptomatic Deterioration|1|||
19513194|NCT01862250|41925535|FG000|Overall Study|Adverse Event|4|||
19617781|NCT02393248|42067473|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617782|NCT02393248|42067474|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617783|NCT02393248|42067475|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617784|NCT02393248|42067476|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
19617785|NCT02393248|42067452|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617786|NCT02393248|42067453|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617787|NCT02393248|42067454|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617788|NCT02393248|42067455|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617789|NCT02393248|42067456|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617790|NCT02393248|42067457|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617791|NCT02393248|42067458|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19513195|NCT01860846|41925539|FG000|Overall Study|Lost to Follow-up|33|||
19513196|NCT01901874|41925543|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
19513197|NCT01901874|41925543|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
19513198|NCT01901874|41925543|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
19513199|NCT01901874|41925543|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
19513200|NCT01901874|41925543|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
19513201|NCT01901874|41925543|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
19513202|NCT01860534|41925549|FG000|ROP #1|Needed treatment for ROP|0|||
19513203|NCT01860534|41925550|FG001|ROP #1|Needed treatment for ROP|1|||
19513204|NCT01860534|41925549|FG000|ROP #2|discharged prior to ROP #2|1|||
19513205|NCT01860534|41925550|FG001|ROP #2|discharged prior to ROP #2|0|||
19513206|NCT01901328|41925560|FG000|Overall Study|Lost to Follow-up|1|||
19513207|NCT01901328|41925561|FG001|Overall Study|Lost to Follow-up|0|||
19513208|NCT01901328|41925560|FG000|Overall Study|Physician Decision|0|||
19513209|NCT01901328|41925561|FG001|Overall Study|Physician Decision|1|||
19513210|NCT01901328|41925560|FG000|Overall Study|Protocol Violation|1|||
19513211|NCT01901328|41925561|FG001|Overall Study|Protocol Violation|1|||
19513212|NCT01901328|41925560|FG000|Overall Study|Study Terminated by Sponsor|19|||
19513213|NCT01901328|41925561|FG001|Overall Study|Study Terminated by Sponsor|16|||
19513214|NCT01901328|41925560|FG000|Overall Study|Withdrawal by Subject|1|||
19513215|NCT01901328|41925561|FG001|Overall Study|Withdrawal by Subject|2|||
19513216|NCT01901328|41925560|FG000|Overall Study|Lack of Efficacy|0|||
19513217|NCT01901328|41925561|FG001|Overall Study|Lack of Efficacy|1|||
19513218|NCT01859988|41925574|FG000|Overall Study|Withdrawal by Subject|6|||
19513219|NCT01859988|41925575|FG001|Overall Study|Withdrawal by Subject|3|||
19513220|NCT01859988|41925576|FG002|Overall Study|Withdrawal by Subject|4|||
19513221|NCT01859988|41925577|FG003|Overall Study|Withdrawal by Subject|3|||
19513222|NCT01859988|41925578|FG004|Overall Study|Withdrawal by Subject|2|||
19513223|NCT01859988|41925579|FG005|Overall Study|Withdrawal by Subject|2|||
19513224|NCT01859988|41925574|FG000|Overall Study|Lack of Efficacy|1|||
19513225|NCT01859988|41925575|FG001|Overall Study|Lack of Efficacy|1|||
19513226|NCT01859988|41925576|FG002|Overall Study|Lack of Efficacy|5|||
19513227|NCT01859988|41925577|FG003|Overall Study|Lack of Efficacy|0|||
19513228|NCT01859988|41925578|FG004|Overall Study|Lack of Efficacy|7|||
19513229|NCT01859988|41925579|FG005|Overall Study|Lack of Efficacy|9|||
19513230|NCT01859988|41925574|FG000|Overall Study|Physician Decision|1|||
19513231|NCT01859988|41925575|FG001|Overall Study|Physician Decision|3|||
19513232|NCT01859988|41925576|FG002|Overall Study|Physician Decision|1|||
19513233|NCT01859988|41925577|FG003|Overall Study|Physician Decision|3|||
19513234|NCT01859988|41925578|FG004|Overall Study|Physician Decision|4|||
19513235|NCT01859988|41925579|FG005|Overall Study|Physician Decision|1|||
19513236|NCT01859988|41925574|FG000|Overall Study|Adverse Event|2|||
19513237|NCT01859988|41925575|FG001|Overall Study|Adverse Event|1|||
19513238|NCT01859988|41925576|FG002|Overall Study|Adverse Event|3|||
19513239|NCT01859988|41925577|FG003|Overall Study|Adverse Event|1|||
19513240|NCT01859988|41925578|FG004|Overall Study|Adverse Event|2|||
19513241|NCT01859988|41925579|FG005|Overall Study|Adverse Event|2|||
19513242|NCT01859988|41925574|FG000|Overall Study|Lost to Follow-up|1|||
19513243|NCT01859988|41925575|FG001|Overall Study|Lost to Follow-up|2|||
19513244|NCT01859988|41925576|FG002|Overall Study|Lost to Follow-up|3|||
19513245|NCT01859988|41925577|FG003|Overall Study|Lost to Follow-up|0|||
19513246|NCT01859988|41925578|FG004|Overall Study|Lost to Follow-up|3|||
19513247|NCT01859988|41925579|FG005|Overall Study|Lost to Follow-up|2|||
19513248|NCT01859988|41925574|FG000|Overall Study|Protocol Violation|0|||
19513249|NCT01859988|41925575|FG001|Overall Study|Protocol Violation|0|||
19513250|NCT01859988|41925576|FG002|Overall Study|Protocol Violation|1|||
19513251|NCT01859988|41925577|FG003|Overall Study|Protocol Violation|0|||
19513252|NCT01859988|41925578|FG004|Overall Study|Protocol Violation|0|||
19513253|NCT01859988|41925579|FG005|Overall Study|Protocol Violation|0|||
19513254|NCT01859988|41925574|FG000|Overall Study|Other than specified above|0|||
19513255|NCT01859988|41925575|FG001|Overall Study|Other than specified above|2|||
19513256|NCT01859988|41925576|FG002|Overall Study|Other than specified above|11|||
19513257|NCT01859988|41925577|FG003|Overall Study|Other than specified above|3|||
19513258|NCT01859988|41925578|FG004|Overall Study|Other than specified above|5|||
19513259|NCT01859988|41925579|FG005|Overall Study|Other than specified above|3|||
19513260|NCT01859598|41925593|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
19513261|NCT01876446|41925601|FG000|Overall Study|Death|0|||
19394148|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
19513262|NCT01876446|41925602|FG001|Overall Study|Death|1|||
19513263|NCT01876446|41925601|FG000|Overall Study|Withdrawal by Subject|1|||
19513264|NCT01876446|41925602|FG001|Overall Study|Withdrawal by Subject|2|||
19513265|NCT01876446|41925601|FG000|Overall Study|Physician Decision|1|||
19513266|NCT01876446|41925602|FG001|Overall Study|Physician Decision|3|||
19513267|NCT01900626|41925610|FG000|Overall Study|study was closed due to low enrollment|1|||
19513268|NCT01900626|41925611|FG001|Overall Study|study was closed due to low enrollment|1|||
19513269|NCT01900314|41925621|FG000|Overall Study|Lost to Follow-up|1|||
19513270|NCT01900314|41925622|FG001|Overall Study|Lost to Follow-up|0|||
19513271|NCT01900314|41925621|FG000|Overall Study|Protocol Violation|0|||
19513272|NCT01900314|41925622|FG001|Overall Study|Protocol Violation|1|||
19513273|NCT01900314|41925621|FG000|Overall Study|Withdrawal by Subject|3|||
19513274|NCT01900314|41925622|FG001|Overall Study|Withdrawal by Subject|3|||
19513275|NCT01899768|41925629|FG000|Part A|Adverse Event|2|||
19513276|NCT01899768|41925629|FG000|Part A|Withdrawal by Subject|1|||
19513277|NCT01899768|41925629|FG000|Part B|Adverse Event|1|||
19513278|NCT01899768|41925629|FG000|Part B|Withdrawal by Subject|1|||
19513279|NCT01898598|41925639|FG000|Overall Study|Adverse Event|1|||
19513280|NCT01898598|41925640|FG001|Overall Study|Adverse Event|0|||
19513281|NCT01898598|41925639|FG000|Overall Study|Withdrawal by Subject|3|||
19513282|NCT01898598|41925640|FG001|Overall Study|Withdrawal by Subject|0|||
19513283|NCT01898598|41925639|FG000|Overall Study|Lost to Follow-up|0|||
19513284|NCT01898598|41925640|FG001|Overall Study|Lost to Follow-up|1|||
19513285|NCT01898598|41925639|FG000|Overall Study|Other|0|||
19513286|NCT01898598|41925640|FG001|Overall Study|Other|1|||
19513287|NCT01898442|41925649|FG000|Overall Study|Hemolysis/technical problems|1|||
19617792|NCT02393248|42067459|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617793|NCT02393248|42067460|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19513288|NCT01898442|41925650|FG001|Overall Study|Hemolysis/technical problems|2|||
19513289|NCT01898442|41925651|FG002|Overall Study|Hemolysis/technical problems|2|||
19513290|NCT01898442|41925649|FG000|Overall Study|Patient vomited pills|0|||
19513291|NCT01898442|41925650|FG001|Overall Study|Patient vomited pills|0|||
19513292|NCT01898442|41925651|FG002|Overall Study|Patient vomited pills|1|||
19513293|NCT01898286|41925659|FG000|Overall Study|Withdrawal by Subject|1|||
19513294|NCT01898286|41925659|FG000|Overall Study|Protocol Violation|1|||
19513295|NCT01898286|41925659|FG000|Overall Study|Lost to Follow-up|1|||
19513296|NCT01898208|41925666|FG000|Overall Study|Positive blood culture|17|||
19513297|NCT01898208|41925667|FG001|Overall Study|Positive blood culture|23|||
19513298|NCT01898208|41925668|FG002|Overall Study|Positive blood culture|15|||
19513299|NCT01898208|41925666|FG000|Overall Study|Death/comfort care within 24 hours|10|||
19513300|NCT01898208|41925667|FG001|Overall Study|Death/comfort care within 24 hours|9|||
19513301|NCT01898208|41925668|FG002|Overall Study|Death/comfort care within 24 hours|8|||
19513302|NCT01898208|41925666|FG000|Overall Study|Negative Gram Stain|6|||
19513303|NCT01898208|41925667|FG001|Overall Study|Negative Gram Stain|9|||
19513304|NCT01898208|41925668|FG002|Overall Study|Negative Gram Stain|6|||
19513305|NCT01898208|41925666|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
19513306|NCT01898208|41925667|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
19513307|NCT01898208|41925668|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
19513308|NCT01898208|41925666|FG000|Overall Study|System/Technical Error|1|||
19513309|NCT01898208|41925667|FG001|Overall Study|System/Technical Error|2|||
19513310|NCT01898208|41925668|FG002|Overall Study|System/Technical Error|3|||
19513311|NCT01898208|41925666|FG000|Overall Study|Lost to Follow-up|3|||
19513312|NCT01898208|41925667|FG001|Overall Study|Lost to Follow-up|1|||
19513313|NCT01898208|41925668|FG002|Overall Study|Lost to Follow-up|1|||
19513314|NCT01898130|41925676|FG000|Treatment|Withdrawal by Subject|2|||
19617794|NCT02393248|42067461|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617795|NCT02393248|42067462|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
19617796|NCT02393248|42067463|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
19704767|NCT03730012|42149087|FG001|Overall Study|Lack of Efficacy|5|||
19513315|NCT01898130|41925676|FG000|Treatment|Progressive Disease|4|||
19513316|NCT01898130|41925676|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
19513317|NCT01876368|41925682|FG000|Overall Study|Adverse Event|2|||
19513318|NCT01876368|41925683|FG001|Overall Study|Adverse Event|5|||
19513319|NCT01876368|41925682|FG000|Overall Study|Lack of Efficacy|1|||
19513320|NCT01876368|41925683|FG001|Overall Study|Lack of Efficacy|0|||
19513321|NCT01876368|41925682|FG000|Overall Study|Lost to Follow-up|0|||
19513322|NCT01876368|41925683|FG001|Overall Study|Lost to Follow-up|1|||
19513323|NCT01876368|41925682|FG000|Overall Study|Non-compliance with study treatment|0|||
19513324|NCT01876368|41925683|FG001|Overall Study|Non-compliance with study treatment|1|||
19513325|NCT01876368|41925682|FG000|Overall Study|Physician Decision|0|||
19513326|NCT01876368|41925683|FG001|Overall Study|Physician Decision|2|||
19513327|NCT01876368|41925682|FG000|Overall Study|Protocol deviation|3|||
19513328|NCT01876368|41925683|FG001|Overall Study|Protocol deviation|3|||
19513329|NCT01876368|41925682|FG000|Overall Study|Subject/guardian decision|3|||
19513330|NCT01876368|41925683|FG001|Overall Study|Subject/guardian decision|1|||
19513331|NCT01874340|41925693|FG000|Overall Study|Study terminated by Sponsor|6|||
19513332|NCT01874340|41925694|FG001|Overall Study|Study terminated by Sponsor|8|||
19513333|NCT01874340|41925695|FG002|Overall Study|Study terminated by Sponsor|8|||
19513334|NCT01874340|41925696|FG003|Overall Study|Study terminated by Sponsor|4|||
19513335|NCT01874340|41925693|FG000|Overall Study|Withdrawal by Subject|0|||
19513336|NCT01874340|41925694|FG001|Overall Study|Withdrawal by Subject|0|||
19513337|NCT01874340|41925695|FG002|Overall Study|Withdrawal by Subject|0|||
19513338|NCT01874340|41925696|FG003|Overall Study|Withdrawal by Subject|1|||
19513339|NCT01897896|41925708|FG000|Overall Study|Death|1|||
19513340|NCT01897896|41925709|FG001|Overall Study|Death|0|||
19513341|NCT01897896|41925708|FG000|Overall Study|Adverse Event|11|||
19513342|NCT01897896|41925709|FG001|Overall Study|Adverse Event|1|||
19513343|NCT01897896|41925708|FG000|Overall Study|Lost to Follow-up|1|||
19513344|NCT01897896|41925709|FG001|Overall Study|Lost to Follow-up|0|||
19513345|NCT01897896|41925708|FG000|Overall Study|Non-compliance with study drug dosing|1|||
19513346|NCT01897896|41925709|FG001|Overall Study|Non-compliance with study drug dosing|1|||
19513347|NCT01897896|41925708|FG000|Overall Study|Withdrawal by Subject|7|||
19513348|NCT01897896|41925709|FG001|Overall Study|Withdrawal by Subject|1|||
19513349|NCT01897896|41925708|FG000|Overall Study|Require drug that interfere with study|1|||
19513350|NCT01897896|41925709|FG001|Overall Study|Require drug that interfere with study|4|||
19513351|NCT01897896|41925708|FG000|Overall Study|Protocol Violation|1|||
19513352|NCT01897896|41925709|FG001|Overall Study|Protocol Violation|1|||
19513353|NCT01897896|41925708|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
19617797|NCT02393248|42067464|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617798|NCT02393248|42067465|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617799|NCT02393248|42067466|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617800|NCT02393248|42067467|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617801|NCT02393248|42067468|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617802|NCT02393248|42067469|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617803|NCT02393248|42067470|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617804|NCT02393248|42067471|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617805|NCT02393248|42067472|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617806|NCT02393248|42067473|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617807|NCT02393248|42067474|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617808|NCT02393248|42067475|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19617809|NCT02393248|42067476|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
19513354|NCT01897896|41925709|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
19513355|NCT01897896|41925708|FG000|Overall Study|Caregiver can no longer participate|0|||
19513356|NCT01897896|41925709|FG001|Overall Study|Caregiver can no longer participate|2|||
19513357|NCT01897896|41925708|FG000|Overall Study|Other than specified|2|||
19513358|NCT01897896|41925709|FG001|Overall Study|Other than specified|1|||
19513359|NCT01858194|41925719|FG000|Overall Study|Total Artificial Heart Implant|0|||
19513360|NCT01858194|41925720|FG001|Overall Study|Total Artificial Heart Implant|1|||
19513361|NCT01858194|41925719|FG000|Overall Study|Lost to Follow-up|0|||
19513362|NCT01858194|41925720|FG001|Overall Study|Lost to Follow-up|1|||
19513363|NCT01873950|41925728|FG000|Period 5|Withdrawal by Subject|0|||
19513364|NCT01873950|41925729|FG001|Period 5|Withdrawal by Subject|0|||
19513365|NCT01873950|41925730|FG002|Period 5|Withdrawal by Subject|0|||
19513366|NCT01873950|41925731|FG003|Period 5|Withdrawal by Subject|1|||
19513367|NCT01873950|41925732|FG004|Period 5|Withdrawal by Subject|0|||
19513368|NCT01857102|41925746|FG000|Period 1|No longer meets Eligibility Criteria|0|||
19513369|NCT01857102|41925747|FG001|Period 1|No longer meets Eligibility Criteria|2|||
19513370|NCT01857102|41925746|FG000|Period 1|Lost to Follow-up|0|||
19513371|NCT01857102|41925747|FG001|Period 1|Lost to Follow-up|3|||
19513372|NCT01857102|41925746|FG000|Period 1|Unsatisfactory Lens Fit|1|||
19513373|NCT01857102|41925747|FG001|Period 1|Unsatisfactory Lens Fit|0|||
19513374|NCT01857102|41925746|FG000|Period 1|Unsatisfactory Visual Response|1|||
19513375|NCT01857102|41925747|FG001|Period 1|Unsatisfactory Visual Response|0|||
19513376|NCT01857102|41925746|FG000|Period 1|Physician Decision|1|||
19513377|NCT01857102|41925747|FG001|Period 1|Physician Decision|0|||
19513378|NCT01857102|41925746|FG000|Period 2|Lens Discomfort|1|||
19513379|NCT01857102|41925747|FG001|Period 2|Lens Discomfort|0|||
19513380|NCT01857102|41925746|FG000|Period 2|Unsatisfactory Lens Fit|1|||
19513381|NCT01857102|41925747|FG001|Period 2|Unsatisfactory Lens Fit|0|||
19513382|NCT01872078|41925759|FG000|Overall Study|Adverse Event|0|||
19513383|NCT01872078|41925760|FG001|Overall Study|Adverse Event|0|||
19513384|NCT01872078|41925761|FG002|Overall Study|Adverse Event|1|||
19513385|NCT01872078|41925762|FG003|Overall Study|Adverse Event|0|||
19513386|NCT01872078|41925759|FG000|Overall Study|Dose administration non-compliance|0|||
19513387|NCT01872078|41925760|FG001|Overall Study|Dose administration non-compliance|0|||
19513388|NCT01872078|41925761|FG002|Overall Study|Dose administration non-compliance|0|||
19513389|NCT01872078|41925762|FG003|Overall Study|Dose administration non-compliance|1|||
19513390|NCT01872078|41925759|FG000|Overall Study|Protocol Violation|0|||
19513391|NCT01872078|41925760|FG001|Overall Study|Protocol Violation|0|||
19513392|NCT01872078|41925761|FG002|Overall Study|Protocol Violation|1|||
19513393|NCT01872078|41925762|FG003|Overall Study|Protocol Violation|0|||
19513394|NCT01872078|41925759|FG000|Overall Study|Withdrawal by Subject|0|||
19513395|NCT01872078|41925760|FG001|Overall Study|Withdrawal by Subject|0|||
19513396|NCT01872078|41925761|FG002|Overall Study|Withdrawal by Subject|1|||
19513397|NCT01872078|41925762|FG003|Overall Study|Withdrawal by Subject|0|||
19513398|NCT01872078|41925759|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
19513399|NCT01872078|41925760|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
19513400|NCT01872078|41925761|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
19513401|NCT01872078|41925762|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
19513402|NCT01896726|41925772|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
19513403|NCT01896726|41925772|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
19513404|NCT01856790|41925779|FG000|Closed Loop Control|Withdrawal by Subject|2|||
19513405|NCT01856790|41925779|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
19513406|NCT01856322|41925793|FG000|Overall Study|off study due to lack of accrual|0|||
19513407|NCT01856322|41925794|FG001|Overall Study|off study due to lack of accrual|0|||
19513408|NCT01856322|41925795|FG002|Overall Study|off study due to lack of accrual|3|||
19513409|NCT01896102|41925802|FG000|Overall Study|Death|1|||
19513410|NCT01896102|41925802|FG000|Overall Study|Participant to receive allogenic transplant|2|||
19513411|NCT01871532|41925809|FG000|Overall Study|Withdrawal by Subject|1|||
19513412|NCT01871532|41925810|FG001|Overall Study|Withdrawal by Subject|2|||
19513413|NCT01855074|41925816|FG000|Overall Study|Adverse Event|1|||
19513414|NCT01855074|41925816|FG000|Overall Study|Lost to Follow-up|4|||
19513415|NCT01855074|41925816|FG000|Overall Study|Withdrawal by Subject|8|||
19513416|NCT01855074|41925816|FG000|Overall Study|Started but not treated|1|||
19513417|NCT01871142|41925820|FG000|Overall Study|Adverse Event|1|||
19513418|NCT01895322|41925834|FG000|Overall Study|Adverse Event|1|||
19513419|NCT01895322|41925834|FG000|Overall Study|Withdrawal by Subject|2|||
19513420|NCT01895322|41925834|FG000|Overall Study|Protocol Violation|10|||
19513421|NCT01894776|41925839|FG000|Overall Study|Withdrawal by Subject|1|||
19513422|NCT01894620|41925845|FG000|Overall Study|Withdrawal by Subject|0|||
19513423|NCT01894620|41925846|FG001|Overall Study|Withdrawal by Subject|1|||
19513424|NCT01854918|41925856|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
19513425|NCT01854918|41925857|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
19513426|NCT01854918|41925856|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
19513427|NCT01854918|41925857|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
19513428|NCT01854918|41925856|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
19513429|NCT01854918|41925857|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
19513430|NCT01854918|41925856|FG000|SOC-controlled Period (Year 1)|Death|5|||
19513431|NCT01854918|41925857|FG001|SOC-controlled Period (Year 1)|Death|5|||
19513432|NCT01854918|41925856|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
19513433|NCT01854918|41925857|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
19513434|NCT01854918|41925856|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
19513435|NCT01854918|41925857|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
19513436|NCT01854918|41925856|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
19513437|NCT01854918|41925857|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
19513438|NCT01854918|41925856|FG000|All-IP Period (Years 2 and 3)|Death|5|||
19513439|NCT01854918|41925857|FG001|All-IP Period (Years 2 and 3)|Death|16|||
19513440|NCT01894230|41925872|FG000|Overall Study|Lost to Follow-up|2|||
19513441|NCT01894230|41925873|FG001|Overall Study|Lost to Follow-up|2|||
19513442|NCT01894230|41925872|FG000|Overall Study|Withdrawal by Subject|4|||
19513443|NCT01894230|41925873|FG001|Overall Study|Withdrawal by Subject|4|||
19513444|NCT01894230|41925872|FG000|Overall Study|Non-adherent|0|||
19513445|NCT01894230|41925873|FG001|Overall Study|Non-adherent|1|||
19513446|NCT01894230|41925872|FG000|Overall Study|Death|1|||
19513447|NCT01894230|41925873|FG001|Overall Study|Death|0|||
19513448|NCT01894152|41925879|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
19513449|NCT01854528|41925885|FG000|Overall Study|Adverse Event|0|||
19513450|NCT01854528|41925886|FG001|Overall Study|Adverse Event|4|||
19513451|NCT01854528|41925885|FG000|Overall Study|Withdrawal by Subject|0|||
19513452|NCT01854528|41925886|FG001|Overall Study|Withdrawal by Subject|2|||
19513453|NCT01854528|41925885|FG000|Overall Study|Virologic Failure|0|||
19513454|NCT01854528|41925886|FG001|Overall Study|Virologic Failure|9|||
19513455|NCT01853982|41925894|FG000|Overall Study|Withdrawal by Subject|1|||
19513456|NCT01853982|41925895|FG001|Overall Study|Withdrawal by Subject|0|||
19513457|NCT01853982|41925894|FG000|Overall Study|Death|1|||
19513458|NCT01853982|41925895|FG001|Overall Study|Death|0|||
19513459|NCT01853982|41925894|FG000|Overall Study|Lost to Follow-up|0|||
19513460|NCT01853982|41925895|FG001|Overall Study|Lost to Follow-up|1|||
19513461|NCT01853280|41925903|FG000|Overall Study|Lack of Efficacy|2|||
19513462|NCT01853280|41925904|FG001|Overall Study|Lack of Efficacy|2|||
19513463|NCT01853280|41925903|FG000|Overall Study|Lost to Follow-up|0|||
19513464|NCT01853280|41925904|FG001|Overall Study|Lost to Follow-up|1|||
19513465|NCT01853280|41925903|FG000|Overall Study|Physician Decision|0|||
19513466|NCT01853280|41925904|FG001|Overall Study|Physician Decision|1|||
19513467|NCT01853280|41925903|FG000|Overall Study|Withdrawal by Subject|0|||
19513468|NCT01853280|41925904|FG001|Overall Study|Withdrawal by Subject|1|||
19513469|NCT01853280|41925903|FG000|Overall Study|Ineligible|0|||
19513470|NCT01853280|41925904|FG001|Overall Study|Ineligible|1|||
19513471|NCT01892436|41925914|FG000|Overall Study|Withdrawal by Subject|8|||
19513472|NCT01892436|41925915|FG001|Overall Study|Withdrawal by Subject|15|||
19513473|NCT01892436|41925916|FG002|Overall Study|Withdrawal by Subject|4|||
19513474|NCT01892436|41925917|FG003|Overall Study|Withdrawal by Subject|4|||
19513475|NCT01892436|41925914|FG000|Overall Study|Death|1|||
19513476|NCT01892436|41925915|FG001|Overall Study|Death|1|||
19513477|NCT01892436|41925916|FG002|Overall Study|Death|0|||
19513478|NCT01892436|41925917|FG003|Overall Study|Death|0|||
19513479|NCT01892436|41925914|FG000|Overall Study|Physician Decision|2|||
19513480|NCT01892436|41925915|FG001|Overall Study|Physician Decision|1|||
19513481|NCT01892436|41925916|FG002|Overall Study|Physician Decision|0|||
19513482|NCT01892436|41925917|FG003|Overall Study|Physician Decision|1|||
19513483|NCT01892436|41925914|FG000|Overall Study|Pregnancy|0|||
19513484|NCT01892436|41925915|FG001|Overall Study|Pregnancy|2|||
19513485|NCT01892436|41925916|FG002|Overall Study|Pregnancy|1|||
19513486|NCT01892436|41925917|FG003|Overall Study|Pregnancy|0|||
19513487|NCT01892436|41925914|FG000|Overall Study|Technical problems|2|||
19513488|NCT01892436|41925915|FG001|Overall Study|Technical problems|1|||
19513489|NCT01892436|41925916|FG002|Overall Study|Technical problems|1|||
19513490|NCT01892436|41925917|FG003|Overall Study|Technical problems|1|||
19513491|NCT01892436|41925914|FG000|Overall Study|Lack of Efficacy|1|||
19513492|NCT01892436|41925915|FG001|Overall Study|Lack of Efficacy|2|||
19513493|NCT01892436|41925916|FG002|Overall Study|Lack of Efficacy|2|||
19513494|NCT01892436|41925917|FG003|Overall Study|Lack of Efficacy|2|||
19513495|NCT01892436|41925914|FG000|Overall Study|Lost to Follow-up|1|||
19513496|NCT01892436|41925915|FG001|Overall Study|Lost to Follow-up|1|||
19513497|NCT01892436|41925916|FG002|Overall Study|Lost to Follow-up|1|||
19513498|NCT01892436|41925917|FG003|Overall Study|Lost to Follow-up|3|||
19513499|NCT01892436|41925914|FG000|Overall Study|non-compliance with treatment|1|||
19513500|NCT01892436|41925915|FG001|Overall Study|non-compliance with treatment|0|||
19513501|NCT01892436|41925916|FG002|Overall Study|non-compliance with treatment|0|||
19513502|NCT01892436|41925917|FG003|Overall Study|non-compliance with treatment|0|||
19513503|NCT01892436|41925914|FG000|Overall Study|Adverse Event|7|||
19513504|NCT01892436|41925915|FG001|Overall Study|Adverse Event|6|||
19513505|NCT01892436|41925916|FG002|Overall Study|Adverse Event|2|||
19513506|NCT01892436|41925917|FG003|Overall Study|Adverse Event|3|||
19513507|NCT01853046|41925929|FG000|Overall Study|Withdrawal by Subject|1|||
19513508|NCT01853046|41925930|FG001|Overall Study|Withdrawal by Subject|1|||
19513509|NCT01853046|41925929|FG000|Overall Study|Adverse Event|4|||
19513510|NCT01853046|41925930|FG001|Overall Study|Adverse Event|2|||
19513511|NCT01853046|41925929|FG000|Overall Study|Disease progression|13|||
19513512|NCT01853046|41925930|FG001|Overall Study|Disease progression|3|||
19513513|NCT01891890|41925940|FG000|Overall Study|Lost to Follow-up|0|||
19513514|NCT01891890|41925941|FG001|Overall Study|Lost to Follow-up|0|||
19513515|NCT01891890|41925942|FG002|Overall Study|Lost to Follow-up|1|||
19513516|NCT01891890|41925940|FG000|Overall Study|Study ended before endpoint reached|7|||
19513517|NCT01891890|41925941|FG001|Overall Study|Study ended before endpoint reached|3|||
19513518|NCT01891890|41925942|FG002|Overall Study|Study ended before endpoint reached|6|||
19513519|NCT01852812|41925953|FG000|Overall Study|Adverse Event|0|||
19513520|NCT01852812|41925954|FG001|Overall Study|Adverse Event|0|||
19513521|NCT01852812|41925955|FG002|Overall Study|Adverse Event|1|||
19513522|NCT01852812|41925953|FG000|Overall Study|Non-compliance With Study Drug|0|||
19513523|NCT01852812|41925954|FG001|Overall Study|Non-compliance With Study Drug|1|||
19513524|NCT01852812|41925955|FG002|Overall Study|Non-compliance With Study Drug|0|||
19513525|NCT01869348|41925965|FG000|Overall Study|Withdrawal by Subject|1|||
19513526|NCT01869348|41925966|FG001|Overall Study|Withdrawal by Subject|1|||
19513527|NCT01869192|41925974|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
19513528|NCT01869192|41925975|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
19513529|NCT01869192|41925974|FG000|Postoperative Chemotherapy|Physician Decision|0|||
19513530|NCT01869192|41925975|FG001|Postoperative Chemotherapy|Physician Decision|2|||
19513531|NCT01868646|41925983|FG000|Overall Study|Do not meet inclusion criteria|3|||
19513532|NCT01868646|41925984|FG001|Overall Study|Do not meet inclusion criteria|5|||
19513533|NCT01852110|41925992|FG000|Overall Study|Adverse Event|12|||
19513534|NCT01852110|41925993|FG001|Overall Study|Adverse Event|5|||
19513535|NCT01852110|41925994|FG002|Overall Study|Adverse Event|0|||
19513536|NCT01852110|41925995|FG003|Overall Study|Adverse Event|0|||
19513537|NCT01852110|41925996|FG004|Overall Study|Adverse Event|0|||
19513538|NCT01852110|41925997|FG005|Overall Study|Adverse Event|0|||
19513539|NCT01852110|41925992|FG000|Overall Study|Lost to Follow-up|1|||
19513540|NCT01852110|41925993|FG001|Overall Study|Lost to Follow-up|3|||
19513541|NCT01852110|41925994|FG002|Overall Study|Lost to Follow-up|0|||
19513542|NCT01852110|41925995|FG003|Overall Study|Lost to Follow-up|0|||
19513543|NCT01852110|41925996|FG004|Overall Study|Lost to Follow-up|0|||
19513544|NCT01852110|41925997|FG005|Overall Study|Lost to Follow-up|0|||
19513545|NCT01852110|41925992|FG000|Overall Study|Non-compliance with Study Drug|2|||
19513546|NCT01852110|41925993|FG001|Overall Study|Non-compliance with Study Drug|1|||
19513547|NCT01852110|41925994|FG002|Overall Study|Non-compliance with Study Drug|0|||
19513548|NCT01852110|41925995|FG003|Overall Study|Non-compliance with Study Drug|0|||
19513549|NCT01852110|41925996|FG004|Overall Study|Non-compliance with Study Drug|0|||
19513550|NCT01852110|41925997|FG005|Overall Study|Non-compliance with Study Drug|0|||
19513551|NCT01852110|41925992|FG000|Overall Study|Physician Decision|1|||
19394149|NCT01668797|41638204|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
19513552|NCT01852110|41925993|FG001|Overall Study|Physician Decision|0|||
19513553|NCT01852110|41925994|FG002|Overall Study|Physician Decision|0|||
19513554|NCT01852110|41925995|FG003|Overall Study|Physician Decision|0|||
19513555|NCT01852110|41925996|FG004|Overall Study|Physician Decision|0|||
19513556|NCT01852110|41925997|FG005|Overall Study|Physician Decision|0|||
19513557|NCT01852110|41925992|FG000|Overall Study|Protocol Violation|0|||
19513558|NCT01852110|41925993|FG001|Overall Study|Protocol Violation|1|||
19513559|NCT01852110|41925994|FG002|Overall Study|Protocol Violation|0|||
19513560|NCT01852110|41925995|FG003|Overall Study|Protocol Violation|0|||
19513561|NCT01852110|41925996|FG004|Overall Study|Protocol Violation|0|||
19513562|NCT01852110|41925997|FG005|Overall Study|Protocol Violation|0|||
19513563|NCT01852110|41925992|FG000|Overall Study|Study Terminated by Sponsor|30|||
19513564|NCT01852110|41925993|FG001|Overall Study|Study Terminated by Sponsor|32|||
19513565|NCT01852110|41925994|FG002|Overall Study|Study Terminated by Sponsor|0|||
19513566|NCT01852110|41925995|FG003|Overall Study|Study Terminated by Sponsor|0|||
19513567|NCT01852110|41925996|FG004|Overall Study|Study Terminated by Sponsor|0|||
19513568|NCT01852110|41925997|FG005|Overall Study|Study Terminated by Sponsor|0|||
19513569|NCT01852110|41925992|FG000|Overall Study|Withdrawal by Subject|4|||
19513570|NCT01852110|41925993|FG001|Overall Study|Withdrawal by Subject|4|||
19513571|NCT01852110|41925994|FG002|Overall Study|Withdrawal by Subject|0|||
19513572|NCT01852110|41925995|FG003|Overall Study|Withdrawal by Subject|0|||
19513573|NCT01852110|41925996|FG004|Overall Study|Withdrawal by Subject|0|||
19513574|NCT01852110|41925997|FG005|Overall Study|Withdrawal by Subject|0|||
19513575|NCT01851720|41926013|FG000|Overall Study|Lost to Follow-up|0|||
19513576|NCT01851720|41926014|FG001|Overall Study|Lost to Follow-up|1|||
19513577|NCT01851330|41926023|FG000|Overall Study|Lack of Efficacy|10|||
19513578|NCT01851330|41926024|FG001|Overall Study|Lack of Efficacy|9|||
19513579|NCT01851330|41926025|FG002|Overall Study|Lack of Efficacy|2|||
19513580|NCT01851330|41926023|FG000|Overall Study|Lost to Follow-up|1|||
19513581|NCT01851330|41926024|FG001|Overall Study|Lost to Follow-up|6|||
19513582|NCT01851330|41926025|FG002|Overall Study|Lost to Follow-up|9|||
19513583|NCT01851330|41926023|FG000|Overall Study|Withdrew Consent|2|||
19513584|NCT01851330|41926024|FG001|Overall Study|Withdrew Consent|1|||
19513585|NCT01851330|41926025|FG002|Overall Study|Withdrew Consent|0|||
19513586|NCT01851330|41926023|FG000|Overall Study|Investigator's Discretion|0|||
19513587|NCT01851330|41926024|FG001|Overall Study|Investigator's Discretion|0|||
19513588|NCT01851330|41926025|FG002|Overall Study|Investigator's Discretion|1|||
19513589|NCT01868022|41926042|FG000|Overall Study|Withdrawal by Subject|0|||
19513590|NCT01868022|41926043|FG001|Overall Study|Withdrawal by Subject|0|||
19513591|NCT01868022|41926044|FG002|Overall Study|Withdrawal by Subject|1|||
19513592|NCT01868022|41926045|FG003|Overall Study|Withdrawal by Subject|1|||
19513593|NCT01868022|41926046|FG004|Overall Study|Withdrawal by Subject|0|||
19513594|NCT01868022|41926047|FG005|Overall Study|Withdrawal by Subject|0|||
19513595|NCT01868022|41926048|FG006|Overall Study|Withdrawal by Subject|0|||
19513596|NCT01868022|41926049|FG007|Overall Study|Withdrawal by Subject|1|||
19513597|NCT01868022|41926050|FG008|Overall Study|Withdrawal by Subject|0|||
19513598|NCT01868022|41926042|FG000|Overall Study|Adverse Event|0|||
19513599|NCT01868022|41926043|FG001|Overall Study|Adverse Event|0|||
19513600|NCT01868022|41926044|FG002|Overall Study|Adverse Event|0|||
19513601|NCT01868022|41926045|FG003|Overall Study|Adverse Event|0|||
19513602|NCT01868022|41926046|FG004|Overall Study|Adverse Event|2|||
19513603|NCT01868022|41926047|FG005|Overall Study|Adverse Event|0|||
19513604|NCT01868022|41926048|FG006|Overall Study|Adverse Event|0|||
19513605|NCT01868022|41926049|FG007|Overall Study|Adverse Event|2|||
19513606|NCT01868022|41926050|FG008|Overall Study|Adverse Event|2|||
19513607|NCT01868022|41926042|FG000|Overall Study|Physician Decision|0|||
19513608|NCT01868022|41926043|FG001|Overall Study|Physician Decision|0|||
19513609|NCT01868022|41926044|FG002|Overall Study|Physician Decision|0|||
19513610|NCT01868022|41926045|FG003|Overall Study|Physician Decision|0|||
19513611|NCT01868022|41926046|FG004|Overall Study|Physician Decision|0|||
19513612|NCT01868022|41926047|FG005|Overall Study|Physician Decision|1|||
19513613|NCT01868022|41926048|FG006|Overall Study|Physician Decision|0|||
19513614|NCT01868022|41926049|FG007|Overall Study|Physician Decision|2|||
19513615|NCT01868022|41926050|FG008|Overall Study|Physician Decision|0|||
19513616|NCT01868022|41926042|FG000|Overall Study|Study closed/terminated|0|||
19513617|NCT01868022|41926043|FG001|Overall Study|Study closed/terminated|0|||
19513618|NCT01868022|41926044|FG002|Overall Study|Study closed/terminated|0|||
19513619|NCT01868022|41926045|FG003|Overall Study|Study closed/terminated|0|||
19513620|NCT01868022|41926046|FG004|Overall Study|Study closed/terminated|0|||
19513621|NCT01868022|41926047|FG005|Overall Study|Study closed/terminated|0|||
19513622|NCT01868022|41926048|FG006|Overall Study|Study closed/terminated|0|||
19513623|NCT01868022|41926049|FG007|Overall Study|Study closed/terminated|1|||
19513624|NCT01868022|41926050|FG008|Overall Study|Study closed/terminated|0|||
19513625|NCT01868022|41926042|FG000|Overall Study|Ongoing|0|||
19513626|NCT01868022|41926043|FG001|Overall Study|Ongoing|0|||
19513627|NCT01868022|41926044|FG002|Overall Study|Ongoing|0|||
19513628|NCT01868022|41926045|FG003|Overall Study|Ongoing|0|||
19513629|NCT01868022|41926046|FG004|Overall Study|Ongoing|0|||
19513630|NCT01868022|41926047|FG005|Overall Study|Ongoing|0|||
19513631|NCT01868022|41926048|FG006|Overall Study|Ongoing|0|||
19513632|NCT01868022|41926049|FG007|Overall Study|Ongoing|3|||
19513633|NCT01868022|41926050|FG008|Overall Study|Ongoing|0|||
19513634|NCT01850004|41926076|FG000|Overall Study|Poor/Non-compliance|1|||
19513635|NCT01850004|41926076|FG000|Overall Study|Participant Withdrew Consent|9|||
19513636|NCT01850004|41926076|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
19513637|NCT01850004|41926076|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
19617810|NCT02393248|42067452|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
19617811|NCT02393248|42067453|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
19617812|NCT02393248|42067454|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
19617813|NCT02393248|42067455|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
19617814|NCT02393248|42067456|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
19513638|NCT01850004|41926076|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
19513639|NCT01850004|41926076|FG000|Overall Study|Other Reasons|2|||
19513640|NCT01850004|41926076|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
19617815|NCT02393248|42067457|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
19617816|NCT02393248|42067458|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
19617817|NCT02393248|42067459|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
19617818|NCT02393248|42067460|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
19617819|NCT02393248|42067461|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
19617820|NCT02393248|42067462|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
19617821|NCT02393248|42067463|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
19617822|NCT02393248|42067464|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
19617823|NCT02393248|42067465|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
19617824|NCT02393248|42067466|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
19617825|NCT02393248|42067467|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
19617826|NCT02393248|42067468|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
19617827|NCT02393248|42067469|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
19617828|NCT02393248|42067470|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
19617829|NCT02393248|42067471|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
19617830|NCT02393248|42067472|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
19617831|NCT02393248|42067473|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
19617832|NCT02393248|42067474|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
19513641|NCT01850004|41926076|FG000|Overall Study|Maximum Clinical Benefit|4|||
19513642|NCT01867710|41926084|FG000|Overall Study|Death|25|||
19513643|NCT01867710|41926085|FG001|Overall Study|Death|15|||
19513644|NCT01867710|41926086|FG002|Overall Study|Death|27|||
19513645|NCT01867710|41926087|FG003|Overall Study|Death|20|||
19513646|NCT01867710|41926084|FG000|Overall Study|Lost to Follow-up|3|||
19513647|NCT01867710|41926085|FG001|Overall Study|Lost to Follow-up|4|||
19513648|NCT01867710|41926086|FG002|Overall Study|Lost to Follow-up|3|||
19513649|NCT01867710|41926087|FG003|Overall Study|Lost to Follow-up|2|||
19513650|NCT01867710|41926084|FG000|Overall Study|Withdrawal of consent|2|||
19513651|NCT01867710|41926085|FG001|Overall Study|Withdrawal of consent|5|||
19513652|NCT01867710|41926086|FG002|Overall Study|Withdrawal of consent|1|||
19513653|NCT01867710|41926087|FG003|Overall Study|Withdrawal of consent|2|||
19513654|NCT01867710|41926084|FG000|Overall Study|Study Terminated by Sponsor|9|||
19513655|NCT01867710|41926085|FG001|Overall Study|Study Terminated by Sponsor|13|||
19513656|NCT01867710|41926086|FG002|Overall Study|Study Terminated by Sponsor|8|||
19513657|NCT01867710|41926087|FG003|Overall Study|Study Terminated by Sponsor|16|||
19513658|NCT01867710|41926084|FG000|Overall Study|Biochemical progression|0|||
19513659|NCT01867710|41926085|FG001|Overall Study|Biochemical progression|1|||
19513660|NCT01867710|41926086|FG002|Overall Study|Biochemical progression|0|||
19513661|NCT01867710|41926087|FG003|Overall Study|Biochemical progression|0|||
19513662|NCT01867710|41926084|FG000|Overall Study|Clinical progression|0|||
19513663|NCT01867710|41926085|FG001|Overall Study|Clinical progression|0|||
19513664|NCT01867710|41926086|FG002|Overall Study|Clinical progression|1|||
19513665|NCT01867710|41926087|FG003|Overall Study|Clinical progression|0|||
19513666|NCT01867710|41926084|FG000|Overall Study|Disease progression|1|||
19513667|NCT01867710|41926085|FG001|Overall Study|Disease progression|0|||
19513668|NCT01867710|41926086|FG002|Overall Study|Disease progression|0|||
19513669|NCT01867710|41926087|FG003|Overall Study|Disease progression|0|||
19513670|NCT01867710|41926084|FG000|Overall Study|Patient decision|0|||
19513671|NCT01867710|41926085|FG001|Overall Study|Patient decision|0|||
19513672|NCT01867710|41926086|FG002|Overall Study|Patient decision|0|||
19513673|NCT01867710|41926087|FG003|Overall Study|Patient decision|1|||
19513674|NCT01867710|41926084|FG000|Overall Study|Patient to follow subsequent treatment|0|||
19513675|NCT01867710|41926085|FG001|Overall Study|Patient to follow subsequent treatment|1|||
19513676|NCT01867710|41926086|FG002|Overall Study|Patient to follow subsequent treatment|0|||
19513677|NCT01867710|41926087|FG003|Overall Study|Patient to follow subsequent treatment|0|||
19513678|NCT01867710|41926084|FG000|Overall Study|Progressive disease|1|||
19513679|NCT01867710|41926085|FG001|Overall Study|Progressive disease|0|||
19513680|NCT01867710|41926086|FG002|Overall Study|Progressive disease|0|||
19513681|NCT01867710|41926087|FG003|Overall Study|Progressive disease|0|||
19513682|NCT01867710|41926084|FG000|Overall Study|Protocol Violation|0|||
19513683|NCT01867710|41926085|FG001|Overall Study|Protocol Violation|0|||
19513684|NCT01867710|41926086|FG002|Overall Study|Protocol Violation|0|||
19513685|NCT01867710|41926087|FG003|Overall Study|Protocol Violation|1|||
19617833|NCT02393248|42067475|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
19513686|NCT01867710|41926084|FG000|Overall Study|PSA-progression|0|||
19513687|NCT01867710|41926085|FG001|Overall Study|PSA-progression|1|||
19513688|NCT01867710|41926086|FG002|Overall Study|PSA-progression|0|||
19513689|NCT01867710|41926087|FG003|Overall Study|PSA-progression|0|||
19513690|NCT01867710|41926084|FG000|Overall Study|Study medication no longer effective|0|||
19513691|NCT01867710|41926085|FG001|Overall Study|Study medication no longer effective|1|||
19513692|NCT01867710|41926086|FG002|Overall Study|Study medication no longer effective|0|||
19513693|NCT01867710|41926087|FG003|Overall Study|Study medication no longer effective|0|||
19513694|NCT01849848|41926097|FG000|Overall Study|Physician Decision|1|||
19513695|NCT01849848|41926097|FG000|Overall Study|Progression of the primary disease|3|||
19513696|NCT01849458|41926101|FG000|Overall Study|Lost to Follow-up|4|||
19513697|NCT01832766|41926105|FG000|Washout|Lost to Follow-up|0|||
19513698|NCT01832766|41926106|FG001|Washout|Lost to Follow-up|1|||
19513699|NCT01832532|41926114|FG000|Overall Study|Withdrawal by Subject|5|||
19513700|NCT01832532|41926115|FG001|Overall Study|Withdrawal by Subject|2|||
19513701|NCT01848990|41926124|FG000|Overall Study|Adverse Event|6|||
19513702|NCT01848990|41926125|FG001|Overall Study|Adverse Event|2|||
19513703|NCT01848990|41926126|FG002|Overall Study|Adverse Event|0|||
19513704|NCT01848990|41926124|FG000|Overall Study|Lost to Follow-up|6|||
19513705|NCT01848990|41926125|FG001|Overall Study|Lost to Follow-up|2|||
19513706|NCT01848990|41926126|FG002|Overall Study|Lost to Follow-up|2|||
19513707|NCT01848990|41926124|FG000|Overall Study|Protocol Violation|1|||
19513708|NCT01848990|41926125|FG001|Overall Study|Protocol Violation|1|||
19513709|NCT01848990|41926126|FG002|Overall Study|Protocol Violation|0|||
19513710|NCT01848990|41926124|FG000|Overall Study|Withdrawal by Subject|29|||
19513711|NCT01848990|41926125|FG001|Overall Study|Withdrawal by Subject|10|||
19513712|NCT01848990|41926126|FG002|Overall Study|Withdrawal by Subject|11|||
19513713|NCT01848990|41926124|FG000|Overall Study|Physician Decision|1|||
19513714|NCT01848990|41926125|FG001|Overall Study|Physician Decision|1|||
19513715|NCT01848990|41926126|FG002|Overall Study|Physician Decision|0|||
19513716|NCT01848990|41926124|FG000|Overall Study|Non Compliance|1|||
19513717|NCT01848990|41926125|FG001|Overall Study|Non Compliance|0|||
19513718|NCT01848990|41926126|FG002|Overall Study|Non Compliance|0|||
19513719|NCT01848990|41926124|FG000|Overall Study|Death|1|||
19513720|NCT01848990|41926125|FG001|Overall Study|Death|0|||
19513721|NCT01848990|41926126|FG002|Overall Study|Death|1|||
19513722|NCT01848990|41926124|FG000|Overall Study|Other|1|||
19513723|NCT01848990|41926125|FG001|Overall Study|Other|4|||
19513724|NCT01848990|41926126|FG002|Overall Study|Other|2|||
19513725|NCT01867086|41926138|FG000|Overall Study|Disease Progression|1|||
19513726|NCT01831596|41926142|FG000|Overall Study|Other|8|||
19513727|NCT01848834|41926151|FG000|Overall Study|Adverse Event|3|||
19513728|NCT01848834|41926152|FG001|Overall Study|Adverse Event|11|||
19513729|NCT01848834|41926153|FG002|Overall Study|Adverse Event|3|||
19513730|NCT01848834|41926154|FG003|Overall Study|Adverse Event|5|||
19513731|NCT01848834|41926155|FG004|Overall Study|Adverse Event|9|||
19513732|NCT01848834|41926151|FG000|Overall Study|Death|2|||
19513733|NCT01848834|41926152|FG001|Overall Study|Death|11|||
19513734|NCT01848834|41926153|FG002|Overall Study|Death|1|||
19513735|NCT01848834|41926154|FG003|Overall Study|Death|8|||
19513736|NCT01848834|41926155|FG004|Overall Study|Death|27|||
19513737|NCT01848834|41926151|FG000|Overall Study|Excluded Medication|5|||
19513738|NCT01848834|41926152|FG001|Overall Study|Excluded Medication|4|||
19513739|NCT01848834|41926153|FG002|Overall Study|Excluded Medication|3|||
19513740|NCT01848834|41926154|FG003|Overall Study|Excluded Medication|6|||
19513741|NCT01848834|41926155|FG004|Overall Study|Excluded Medication|6|||
19513742|NCT01848834|41926151|FG000|Overall Study|Lost to Follow-up|5|||
19513743|NCT01848834|41926152|FG001|Overall Study|Lost to Follow-up|5|||
19513744|NCT01848834|41926153|FG002|Overall Study|Lost to Follow-up|3|||
19513745|NCT01848834|41926154|FG003|Overall Study|Lost to Follow-up|0|||
19513746|NCT01848834|41926155|FG004|Overall Study|Lost to Follow-up|3|||
19513747|NCT01848834|41926151|FG000|Overall Study|Physician Decision|1|||
19513748|NCT01848834|41926152|FG001|Overall Study|Physician Decision|3|||
19513749|NCT01848834|41926153|FG002|Overall Study|Physician Decision|4|||
19513750|NCT01848834|41926154|FG003|Overall Study|Physician Decision|0|||
19513751|NCT01848834|41926155|FG004|Overall Study|Physician Decision|11|||
19513752|NCT01848834|41926151|FG000|Overall Study|Protocol Violation|0|||
19513753|NCT01848834|41926152|FG001|Overall Study|Protocol Violation|0|||
19513754|NCT01848834|41926153|FG002|Overall Study|Protocol Violation|0|||
19513755|NCT01848834|41926154|FG003|Overall Study|Protocol Violation|0|||
19513756|NCT01848834|41926155|FG004|Overall Study|Protocol Violation|1|||
19513757|NCT01848834|41926151|FG000|Overall Study|Sponsor Decision|1|||
19513758|NCT01848834|41926152|FG001|Overall Study|Sponsor Decision|1|||
19513759|NCT01848834|41926153|FG002|Overall Study|Sponsor Decision|0|||
19513760|NCT01848834|41926154|FG003|Overall Study|Sponsor Decision|1|||
19513761|NCT01848834|41926155|FG004|Overall Study|Sponsor Decision|1|||
19617834|NCT02393248|42067476|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
19513762|NCT01848834|41926151|FG000|Overall Study|Withdrawal by Subject|2|||
19513763|NCT01848834|41926152|FG001|Overall Study|Withdrawal by Subject|13|||
19513764|NCT01848834|41926153|FG002|Overall Study|Withdrawal by Subject|10|||
19617835|NCT02393248|42067452|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617836|NCT02393248|42067453|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617837|NCT02393248|42067454|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617838|NCT02393248|42067455|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617839|NCT02393248|42067456|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617840|NCT02393248|42067457|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617841|NCT02393248|42067458|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617842|NCT02393248|42067459|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617843|NCT02393248|42067460|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617844|NCT02393248|42067461|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617845|NCT02393248|42067462|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617846|NCT02393248|42067463|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
19617847|NCT02393248|42067464|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617848|NCT02393248|42067465|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
19617849|NCT02393248|42067466|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617850|NCT02393248|42067467|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19513765|NCT01848834|41926154|FG003|Overall Study|Withdrawal by Subject|6|||
19513766|NCT01848834|41926155|FG004|Overall Study|Withdrawal by Subject|36|||
19513767|NCT01867008|41926171|FG000|Overall Study|Withdrawal by Subject|1|||
19513768|NCT01848756|41926175|FG000|Overall Study|Adverse Event|1|||
19513769|NCT01848756|41926175|FG000|Overall Study|Withdrawal by Subject|1|||
19513770|NCT01848756|41926175|FG000|Overall Study|Enrolled in Error|1|||
19513771|NCT01830972|41926182|FG000|Part II|Withdrawal by Subject|2|||
19513772|NCT01830972|41926183|FG001|Part II|Withdrawal by Subject|2|||
19513773|NCT01830972|41926182|FG000|Part III|Withdrawal by Subject|1|||
19513774|NCT01830972|41926183|FG001|Part III|Withdrawal by Subject|0|||
19513775|NCT01830972|41926182|FG000|Part III|Noncompliance|1|||
19513776|NCT01830972|41926183|FG001|Part III|Noncompliance|0|||
19513777|NCT01830972|41926182|FG000|Part IV|Withdrawal by Subject|2|||
19513778|NCT01830972|41926183|FG001|Part IV|Withdrawal by Subject|1|||
19513779|NCT01830972|41926182|FG000|Part IV|Non-Compliance|1|||
19513780|NCT01830972|41926183|FG001|Part IV|Non-Compliance|0|||
19513781|NCT01848288|41926199|FG000|Overall Study|Death|1|||
19513782|NCT01848288|41926199|FG000|Overall Study|Protocol Violation|1|||
19513783|NCT01848288|41926199|FG000|Overall Study|Withdrawal by Subject|1|||
19513784|NCT01848210|41926206|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
19513785|NCT01848210|41926207|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
19513786|NCT01848210|41926206|FG000|Overall Study|Lost to Follow-up|24|||
19513787|NCT01848210|41926207|FG001|Overall Study|Lost to Follow-up|12|||
19513788|NCT01848210|41926206|FG000|Overall Study|Protocol Violation|3|||
19617851|NCT02393248|42067468|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617852|NCT02393248|42067469|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617853|NCT02393248|42067470|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617854|NCT02393248|42067471|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617855|NCT02393248|42067472|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617856|NCT02393248|42067473|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617857|NCT02393248|42067474|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617858|NCT02393248|42067475|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617859|NCT02393248|42067476|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
19617860|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617861|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617862|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617863|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617864|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617865|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617866|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617867|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617868|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617869|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617870|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617871|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617872|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617873|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617874|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617875|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19704768|NCT03730012|42149086|FG000|Overall Study|Withdrawal by Subject|0|||
19704769|NCT03730012|42149087|FG001|Overall Study|Withdrawal by Subject|1|||
19513789|NCT01848210|41926207|FG001|Overall Study|Protocol Violation|5|||
19513790|NCT01848210|41926206|FG000|Overall Study|Use of Forbidden Drugs|9|||
19617876|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617877|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19513791|NCT01848210|41926207|FG001|Overall Study|Use of Forbidden Drugs|10|||
19513792|NCT01848210|41926206|FG000|Overall Study|Impedition Condition|5|||
19513793|NCT01848210|41926207|FG001|Overall Study|Impedition Condition|9|||
19617878|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
19617879|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617880|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
19617881|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
19617882|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617883|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
19617884|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
19617885|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Death|0|||
19617886|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Death|0|||
19617887|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Death|0|||
19617888|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Death|0|||
19617889|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Death|0|||
19617890|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Death|0|||
19617891|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Death|0|||
19617892|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Death|0|||
19617893|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Death|0|||
19617894|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Death|0|||
19617895|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Death|0|||
19617896|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Death|0|||
19617897|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Death|0|||
19617898|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Death|0|||
19617899|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Death|0|||
19617900|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Death|1|||
19617901|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Death|7|||
19617902|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Death|5|||
19617903|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Death|5|||
19617904|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Death|3|||
19617905|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Death|7|||
19617906|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Death|5|||
19617907|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Death|6|||
19617908|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Death|3|||
19617909|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Death|0|||
19617910|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617911|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617912|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617913|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617914|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617915|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617916|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617917|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617918|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617919|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617920|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617921|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617922|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617923|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617924|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617925|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617926|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617927|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617928|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617929|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
19617930|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617931|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617932|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617933|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
19617934|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
19617935|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Disease Progression|0|||
19617936|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Disease Progression|0|||
19617937|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Disease Progression|0|||
19617938|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Disease Progression|0|||
19513794|NCT01848210|41926206|FG000|Overall Study|Adverse Event|7|||
19513795|NCT01848210|41926207|FG001|Overall Study|Adverse Event|9|||
19513796|NCT01848210|41926206|FG000|Overall Study|Discontinuation Criterion|5|||
19513797|NCT01848210|41926207|FG001|Overall Study|Discontinuation Criterion|7|||
19513798|NCT01848210|41926206|FG000|Overall Study|Hypesensitivity|1|||
19513799|NCT01848210|41926207|FG001|Overall Study|Hypesensitivity|0|||
19513800|NCT01848210|41926206|FG000|Overall Study|Hepatic Function Alteration|4|||
19513801|NCT01848210|41926207|FG001|Overall Study|Hepatic Function Alteration|0|||
19513802|NCT01848210|41926206|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
19513803|NCT01848210|41926207|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
19513804|NCT01848210|41926206|FG000|Overall Study|Administrative|1|||
19513805|NCT01848210|41926207|FG001|Overall Study|Administrative|0|||
19513806|NCT01830816|41926216|FG000|Overall Study|Progressive Disease|12|||
19513807|NCT01830816|41926217|FG001|Overall Study|Progressive Disease|7|||
19513808|NCT01830816|41926218|FG002|Overall Study|Progressive Disease|7|||
19513809|NCT01830816|41926216|FG000|Overall Study|Adverse Event|3|||
19513810|NCT01830816|41926217|FG001|Overall Study|Adverse Event|4|||
19513811|NCT01830816|41926218|FG002|Overall Study|Adverse Event|0|||
19513812|NCT01830816|41926216|FG000|Overall Study|Study Terminated by Sponsor|1|||
19513813|NCT01830816|41926217|FG001|Overall Study|Study Terminated by Sponsor|1|||
19513814|NCT01830816|41926218|FG002|Overall Study|Study Terminated by Sponsor|0|||
19513815|NCT01830816|41926216|FG000|Overall Study|Withdrawal by Subject|1|||
19513816|NCT01830816|41926217|FG001|Overall Study|Withdrawal by Subject|1|||
19513817|NCT01830816|41926218|FG002|Overall Study|Withdrawal by Subject|0|||
19513818|NCT01830816|41926216|FG000|Overall Study|Lost to Follow-up|0|||
19513819|NCT01830816|41926217|FG001|Overall Study|Lost to Follow-up|1|||
19513820|NCT01830816|41926218|FG002|Overall Study|Lost to Follow-up|0|||
19513821|NCT01830816|41926216|FG000|Overall Study|Symptomatic Deterioration|1|||
19513822|NCT01830816|41926217|FG001|Overall Study|Symptomatic Deterioration|0|||
19513823|NCT01830816|41926218|FG002|Overall Study|Symptomatic Deterioration|0|||
19513824|NCT01830816|41926216|FG000|Overall Study|Reason not Specified|2|||
19513825|NCT01830816|41926217|FG001|Overall Study|Reason not Specified|0|||
19513826|NCT01830816|41926218|FG002|Overall Study|Reason not Specified|0|||
19513827|NCT01846416|41926232|FG000|Treatment Phase|Death|2|||
19513828|NCT01846416|41926233|FG001|Treatment Phase|Death|9|||
19513829|NCT01846416|41926234|FG002|Treatment Phase|Death|1|||
19513830|NCT01846416|41926232|FG000|Treatment Phase|Withdrawal by Subject|2|||
19513831|NCT01846416|41926233|FG001|Treatment Phase|Withdrawal by Subject|4|||
19513832|NCT01846416|41926234|FG002|Treatment Phase|Withdrawal by Subject|2|||
19513833|NCT01846416|41926232|FG000|Treatment Phase|Other|1|||
19513834|NCT01846416|41926233|FG001|Treatment Phase|Other|5|||
19513835|NCT01846416|41926234|FG002|Treatment Phase|Other|1|||
19513836|NCT01846416|41926232|FG000|Treatment Phase|Physician Decision|1|||
19513837|NCT01846416|41926233|FG001|Treatment Phase|Physician Decision|2|||
19513838|NCT01846416|41926234|FG002|Treatment Phase|Physician Decision|0|||
19513839|NCT01846416|41926232|FG000|Treatment Phase|Adverse Event|3|||
19513840|NCT01846416|41926233|FG001|Treatment Phase|Adverse Event|4|||
19513841|NCT01846416|41926234|FG002|Treatment Phase|Adverse Event|0|||
19513842|NCT01846416|41926232|FG000|Treatment Phase|Non-compliance|0|||
19513843|NCT01846416|41926233|FG001|Treatment Phase|Non-compliance|2|||
19513844|NCT01846416|41926234|FG002|Treatment Phase|Non-compliance|0|||
19513845|NCT01846416|41926232|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
19513846|NCT01846416|41926233|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
19513847|NCT01846416|41926234|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
19513848|NCT01846416|41926232|FG000|Treatment Phase|Progressive Disease|21|||
19513849|NCT01846416|41926233|FG001|Treatment Phase|Progressive Disease|63|||
19513850|NCT01846416|41926234|FG002|Treatment Phase|Progressive Disease|9|||
19513851|NCT01846416|41926232|FG000|Survival Follow-up|Death|21|||
19513852|NCT01846416|41926233|FG001|Survival Follow-up|Death|62|||
19513853|NCT01846416|41926234|FG002|Survival Follow-up|Death|9|||
19513854|NCT01846416|41926232|FG000|Survival Follow-up|Lost to Follow-up|0|||
19394150|NCT01668797|41638205|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
19394151|NCT01668797|41638206|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
19394152|NCT01668797|41638207|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
19394153|NCT02613221|41638214|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
19394154|NCT02613221|41638214|FG000|Overall Study|Adverse Event|2|||
19394155|NCT02613221|41638214|FG000|Overall Study|Voluntary Discontinuation|1|||
19394156|NCT02613221|41638214|FG000|Overall Study|Delayed Treatment|1|||
19394157|NCT02613221|41638214|FG000|Overall Study|Enrolled but Not Treated|1|||
19394158|NCT01362049|41638222|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
19513855|NCT01846416|41926233|FG001|Survival Follow-up|Lost to Follow-up|2|||
19513856|NCT01846416|41926234|FG002|Survival Follow-up|Lost to Follow-up|2|||
19513857|NCT01846416|41926232|FG000|Survival Follow-up|Withdrawal by Subject|2|||
19513858|NCT01846416|41926233|FG001|Survival Follow-up|Withdrawal by Subject|7|||
19513859|NCT01846416|41926234|FG002|Survival Follow-up|Withdrawal by Subject|0|||
19513860|NCT01846416|41926232|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
19513861|NCT01846416|41926233|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
19513862|NCT01846416|41926234|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
19513863|NCT01846416|41926232|FG000|Survival Follow-up|Other|3|||
19513864|NCT01846416|41926233|FG001|Survival Follow-up|Other|1|||
19513865|NCT01846416|41926234|FG002|Survival Follow-up|Other|1|||
19513866|NCT01865448|41926245|FG000|Overall Study|Adverse Event|1|||
19513867|NCT01865448|41926246|FG001|Overall Study|Adverse Event|1|||
19513868|NCT01865448|41926245|FG000|Overall Study|Pregnancy|0|||
19513869|NCT01865448|41926246|FG001|Overall Study|Pregnancy|1|||
19513870|NCT01865448|41926245|FG000|Overall Study|dropout unrelated to study|1|||
19513871|NCT01865448|41926246|FG001|Overall Study|dropout unrelated to study|1|||
19513872|NCT01804140|41926253|FG000|Overall Study|No sampling or biopsy procedures done|114|||
19513873|NCT01846104|41926257|FG000|Overall Study|Withdrawal by Subject|1|||
19513874|NCT01803282|41926273|FG000|Overall Study|Progressive Disease|4|||
19513875|NCT01803282|41926274|FG001|Overall Study|Progressive Disease|3|||
19513876|NCT01803282|41926275|FG002|Overall Study|Progressive Disease|6|||
19513877|NCT01803282|41926276|FG003|Overall Study|Progressive Disease|22|||
19513878|NCT01803282|41926277|FG004|Overall Study|Progressive Disease|5|||
19513879|NCT01803282|41926278|FG005|Overall Study|Progressive Disease|8|||
19513880|NCT01803282|41926279|FG006|Overall Study|Progressive Disease|23|||
19513881|NCT01803282|41926280|FG007|Overall Study|Progressive Disease|24|||
19513882|NCT01803282|41926281|FG008|Overall Study|Progressive Disease|3|||
19513883|NCT01803282|41926282|FG009|Overall Study|Progressive Disease|29|||
19513884|NCT01803282|41926283|FG010|Overall Study|Progressive Disease|6|||
19513885|NCT01803282|41926284|FG011|Overall Study|Progressive Disease|11|||
19513886|NCT01803282|41926273|FG000|Overall Study|Death|0|||
19513887|NCT01803282|41926274|FG001|Overall Study|Death|0|||
19513888|NCT01803282|41926275|FG002|Overall Study|Death|0|||
19513889|NCT01803282|41926276|FG003|Overall Study|Death|0|||
19513890|NCT01803282|41926277|FG004|Overall Study|Death|2|||
19513891|NCT01803282|41926278|FG005|Overall Study|Death|1|||
19513892|NCT01803282|41926279|FG006|Overall Study|Death|1|||
19513893|NCT01803282|41926280|FG007|Overall Study|Death|5|||
19513894|NCT01803282|41926281|FG008|Overall Study|Death|1|||
19513895|NCT01803282|41926282|FG009|Overall Study|Death|1|||
19513896|NCT01803282|41926283|FG010|Overall Study|Death|0|||
19513897|NCT01803282|41926284|FG011|Overall Study|Death|0|||
19513898|NCT01803282|41926273|FG000|Overall Study|Withdrew Consent|0|||
19513899|NCT01803282|41926274|FG001|Overall Study|Withdrew Consent|0|||
19513900|NCT01803282|41926275|FG002|Overall Study|Withdrew Consent|0|||
19513901|NCT01803282|41926276|FG003|Overall Study|Withdrew Consent|6|||
19513902|NCT01803282|41926277|FG004|Overall Study|Withdrew Consent|1|||
19513903|NCT01803282|41926278|FG005|Overall Study|Withdrew Consent|0|||
19513904|NCT01803282|41926279|FG006|Overall Study|Withdrew Consent|8|||
19513905|NCT01803282|41926280|FG007|Overall Study|Withdrew Consent|3|||
19513906|NCT01803282|41926281|FG008|Overall Study|Withdrew Consent|1|||
19513907|NCT01803282|41926282|FG009|Overall Study|Withdrew Consent|5|||
19513908|NCT01803282|41926283|FG010|Overall Study|Withdrew Consent|0|||
19513909|NCT01803282|41926284|FG011|Overall Study|Withdrew Consent|1|||
19513910|NCT01803282|41926273|FG000|Overall Study|Investigator's Discretion|0|||
19513911|NCT01803282|41926274|FG001|Overall Study|Investigator's Discretion|0|||
19513912|NCT01803282|41926275|FG002|Overall Study|Investigator's Discretion|0|||
19513913|NCT01803282|41926276|FG003|Overall Study|Investigator's Discretion|7|||
19513914|NCT01803282|41926277|FG004|Overall Study|Investigator's Discretion|2|||
19513915|NCT01803282|41926278|FG005|Overall Study|Investigator's Discretion|1|||
19513916|NCT01803282|41926279|FG006|Overall Study|Investigator's Discretion|7|||
19513917|NCT01803282|41926280|FG007|Overall Study|Investigator's Discretion|10|||
19513918|NCT01803282|41926281|FG008|Overall Study|Investigator's Discretion|6|||
19513919|NCT01803282|41926282|FG009|Overall Study|Investigator's Discretion|7|||
19513920|NCT01803282|41926283|FG010|Overall Study|Investigator's Discretion|1|||
19513921|NCT01803282|41926284|FG011|Overall Study|Investigator's Discretion|0|||
19513922|NCT01803282|41926273|FG000|Overall Study|Adverse Event|0|||
19513923|NCT01803282|41926274|FG001|Overall Study|Adverse Event|0|||
19513924|NCT01803282|41926275|FG002|Overall Study|Adverse Event|0|||
19513925|NCT01803282|41926276|FG003|Overall Study|Adverse Event|0|||
19513926|NCT01803282|41926277|FG004|Overall Study|Adverse Event|0|||
19513927|NCT01803282|41926278|FG005|Overall Study|Adverse Event|0|||
19513928|NCT01803282|41926279|FG006|Overall Study|Adverse Event|1|||
19513929|NCT01803282|41926280|FG007|Overall Study|Adverse Event|2|||
19513930|NCT01803282|41926281|FG008|Overall Study|Adverse Event|0|||
19513931|NCT01803282|41926282|FG009|Overall Study|Adverse Event|1|||
19513932|NCT01803282|41926283|FG010|Overall Study|Adverse Event|0|||
19513933|NCT01803282|41926284|FG011|Overall Study|Adverse Event|3|||
19513934|NCT01803282|41926273|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19513935|NCT01803282|41926274|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19513936|NCT01803282|41926275|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19513937|NCT01803282|41926276|FG003|Overall Study|Non-Compliance with Study Drug|1|||
19513938|NCT01803282|41926277|FG004|Overall Study|Non-Compliance with Study Drug|0|||
19513939|NCT01803282|41926278|FG005|Overall Study|Non-Compliance with Study Drug|0|||
19513940|NCT01803282|41926279|FG006|Overall Study|Non-Compliance with Study Drug|0|||
19513941|NCT01803282|41926280|FG007|Overall Study|Non-Compliance with Study Drug|0|||
19513942|NCT01803282|41926281|FG008|Overall Study|Non-Compliance with Study Drug|0|||
19513943|NCT01803282|41926282|FG009|Overall Study|Non-Compliance with Study Drug|0|||
19513944|NCT01803282|41926283|FG010|Overall Study|Non-Compliance with Study Drug|0|||
19513945|NCT01803282|41926284|FG011|Overall Study|Non-Compliance with Study Drug|0|||
19513946|NCT01803282|41926273|FG000|Overall Study|Unknown Reason|0|||
19513947|NCT01803282|41926274|FG001|Overall Study|Unknown Reason|0|||
19513948|NCT01803282|41926275|FG002|Overall Study|Unknown Reason|0|||
19513949|NCT01803282|41926276|FG003|Overall Study|Unknown Reason|0|||
19513950|NCT01803282|41926277|FG004|Overall Study|Unknown Reason|0|||
19513951|NCT01803282|41926278|FG005|Overall Study|Unknown Reason|0|||
19513952|NCT01803282|41926279|FG006|Overall Study|Unknown Reason|0|||
19513953|NCT01803282|41926280|FG007|Overall Study|Unknown Reason|1|||
19513954|NCT01803282|41926281|FG008|Overall Study|Unknown Reason|0|||
19513955|NCT01803282|41926282|FG009|Overall Study|Unknown Reason|0|||
19513956|NCT01803282|41926283|FG010|Overall Study|Unknown Reason|0|||
19513957|NCT01803282|41926284|FG011|Overall Study|Unknown Reason|0|||
19513958|NCT01803282|41926273|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
19513959|NCT01803282|41926274|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
19513960|NCT01803282|41926275|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
19513961|NCT01803282|41926276|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
19513962|NCT01803282|41926277|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
19513963|NCT01803282|41926278|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
19513964|NCT01803282|41926279|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
19513965|NCT01803282|41926280|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
19513966|NCT01803282|41926281|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
19513967|NCT01803282|41926282|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
19513968|NCT01803282|41926283|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
19513969|NCT01803282|41926284|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
19513970|NCT01803282|41926273|FG000|Overall Study|Enrolled but Never Treated|0|||
19513971|NCT01803282|41926274|FG001|Overall Study|Enrolled but Never Treated|0|||
19513972|NCT01803282|41926275|FG002|Overall Study|Enrolled but Never Treated|0|||
19513973|NCT01803282|41926276|FG003|Overall Study|Enrolled but Never Treated|0|||
19513974|NCT01803282|41926277|FG004|Overall Study|Enrolled but Never Treated|1|||
19513975|NCT01803282|41926278|FG005|Overall Study|Enrolled but Never Treated|0|||
19513976|NCT01803282|41926279|FG006|Overall Study|Enrolled but Never Treated|1|||
19513977|NCT01803282|41926280|FG007|Overall Study|Enrolled but Never Treated|1|||
19513978|NCT01803282|41926281|FG008|Overall Study|Enrolled but Never Treated|0|||
19513979|NCT01803282|41926282|FG009|Overall Study|Enrolled but Never Treated|1|||
19513980|NCT01803282|41926283|FG010|Overall Study|Enrolled but Never Treated|0|||
19513981|NCT01803282|41926284|FG011|Overall Study|Enrolled but Never Treated|0|||
19513982|NCT01844778|41926313|FG000|Overall Study|Protocol deviation|0|||
19513983|NCT01844778|41926314|FG001|Overall Study|Protocol deviation|1|||
19513984|NCT01844778|41926315|FG002|Overall Study|Protocol deviation|2|||
19513985|NCT01844778|41926313|FG000|Overall Study|Withdrawal by Subject|2|||
19513986|NCT01844778|41926314|FG001|Overall Study|Withdrawal by Subject|0|||
19513987|NCT01844778|41926315|FG002|Overall Study|Withdrawal by Subject|0|||
19513988|NCT01844778|41926313|FG000|Overall Study|Adverse Event|0|||
19513989|NCT01844778|41926314|FG001|Overall Study|Adverse Event|2|||
19513990|NCT01844778|41926315|FG002|Overall Study|Adverse Event|2|||
19617939|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Disease Progression|0|||
19617940|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Disease Progression|0|||
19617941|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Disease Progression|0|||
19617942|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Disease Progression|0|||
19617943|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Disease Progression|0|||
19617944|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Disease Progression|0|||
19617945|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Disease Progression|0|||
19617946|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Disease Progression|0|||
19617947|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Disease Progression|0|||
19617948|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Disease Progression|0|||
19617949|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Disease Progression|0|||
19617950|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Disease Progression|0|||
19617951|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Disease Progression|0|||
19617952|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Disease Progression|0|||
19704770|NCT03730012|42149086|FG000|Overall Study|Miscellaneous|2|||
19513991|NCT01802580|41926329|FG000|Overall Study|Physician Decision|1|||
19513992|NCT01802580|41926330|FG001|Overall Study|Physician Decision|0|||
19513993|NCT01802580|41926329|FG000|Overall Study|Protocol Violation|2|||
19513994|NCT01802580|41926330|FG001|Overall Study|Protocol Violation|0|||
19513995|NCT01802580|41926329|FG000|Overall Study|Withdrawal by Subject|5|||
19513996|NCT01802580|41926330|FG001|Overall Study|Withdrawal by Subject|6|||
19513997|NCT01802580|41926329|FG000|Overall Study|Other|1|||
19513998|NCT01802580|41926330|FG001|Overall Study|Other|3|||
19513999|NCT01802580|41926329|FG000|Overall Study|Lack of Efficacy|0|||
19514000|NCT01802580|41926330|FG001|Overall Study|Lack of Efficacy|2|||
19514001|NCT01611090|41926338|FG000|Randomized Period|Lost to Follow-up|8|||
19514002|NCT01611090|41926339|FG001|Randomized Period|Lost to Follow-up|3|||
19514003|NCT01611090|41926340|FG002|Randomized Period|Lost to Follow-up|0|||
19514004|NCT01611090|41926338|FG000|Randomized Period|Withdrawal by Subject|22|||
19514005|NCT01611090|41926339|FG001|Randomized Period|Withdrawal by Subject|26|||
19514006|NCT01611090|41926340|FG002|Randomized Period|Withdrawal by Subject|0|||
19514007|NCT01611090|41926338|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
19514008|NCT01611090|41926339|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
19514009|NCT01611090|41926340|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
19514010|NCT01611090|41926338|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
19514011|NCT01611090|41926339|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
19514012|NCT01611090|41926340|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
19514013|NCT01844700|41926349|FG000|Overall Study|Lack of Efficacy|1|||
19514014|NCT01844700|41926350|FG001|Overall Study|Lack of Efficacy|0|||
19514015|NCT01844700|41926349|FG000|Overall Study|refused medication switch|1|||
19514016|NCT01844700|41926350|FG001|Overall Study|refused medication switch|0|||
19514017|NCT01844700|41926349|FG000|Overall Study|Withdrawal by Subject|1|||
19514018|NCT01844700|41926350|FG001|Overall Study|Withdrawal by Subject|0|||
19514019|NCT01844700|41926349|FG000|Overall Study|stopped taking meds|0|||
19514020|NCT01844700|41926350|FG001|Overall Study|stopped taking meds|1|||
19514021|NCT01827384|41926370|FG000|Overall Study|Switched to alternative treatment|0|||
19514022|NCT01827384|41926371|FG001|Overall Study|Switched to alternative treatment|0|||
19514023|NCT01827384|41926372|FG002|Overall Study|Switched to alternative treatment|0|||
19514024|NCT01827384|41926373|FG003|Overall Study|Switched to alternative treatment|0|||
19514025|NCT01827384|41926374|FG004|Overall Study|Switched to alternative treatment|0|||
19514026|NCT01827384|41926375|FG005|Overall Study|Switched to alternative treatment|0|||
19514027|NCT01827384|41926376|FG006|Overall Study|Switched to alternative treatment|0|||
19514028|NCT01827384|41926377|FG007|Overall Study|Switched to alternative treatment|0|||
19514029|NCT01827384|41926378|FG008|Overall Study|Switched to alternative treatment|0|||
19514030|NCT01827384|41926379|FG009|Overall Study|Switched to alternative treatment|0|||
19514031|NCT01827384|41926380|FG010|Overall Study|Switched to alternative treatment|0|||
19514032|NCT01827384|41926381|FG011|Overall Study|Switched to alternative treatment|0|||
19514033|NCT01827384|41926382|FG012|Overall Study|Switched to alternative treatment|0|||
19514034|NCT01827384|41926383|FG013|Overall Study|Switched to alternative treatment|2|||
19514035|NCT01827384|41926370|FG000|Overall Study|Disease progression before treatment|0|||
19617953|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Disease Progression|0|||
19617954|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Disease Progression|0|||
19617955|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Disease Progression|2|||
19617956|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Disease Progression|1|||
19617957|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Disease Progression|0|||
19617958|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Disease Progression|0|||
19617959|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Disease Progression|0|||
19617960|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617961|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617962|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617963|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617964|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617965|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617966|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617967|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617968|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617969|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617970|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617971|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617972|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617973|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617974|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617975|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617976|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617977|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617978|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617979|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617980|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
19617981|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
19617982|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617983|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617984|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
19617985|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617986|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617987|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617988|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19514036|NCT01827384|41926371|FG001|Overall Study|Disease progression before treatment|0|||
19514037|NCT01827384|41926372|FG002|Overall Study|Disease progression before treatment|0|||
19514038|NCT01827384|41926373|FG003|Overall Study|Disease progression before treatment|0|||
19617989|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617990|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617991|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617992|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617993|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617994|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617995|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617996|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617997|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617998|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19617999|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618000|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618001|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618002|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618003|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618004|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618005|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
19618006|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618007|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618008|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618009|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
19618010|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Adverse Event|0|||
19618011|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Adverse Event|0|||
19618012|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Adverse Event|0|||
19618013|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Adverse Event|0|||
19618014|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Adverse Event|0|||
19618015|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Adverse Event|0|||
19618016|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Adverse Event|0|||
19618017|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Adverse Event|0|||
19618018|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Adverse Event|0|||
19618019|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Adverse Event|0|||
19618020|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Adverse Event|0|||
19618021|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Adverse Event|0|||
19618022|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Adverse Event|0|||
19618023|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Adverse Event|0|||
19618024|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Adverse Event|0|||
19618025|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Adverse Event|0|||
19618026|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Adverse Event|0|||
19618027|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Adverse Event|0|||
19618028|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Adverse Event|0|||
19618029|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Adverse Event|0|||
19618030|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Adverse Event|0|||
19618031|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Adverse Event|0|||
19618032|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Adverse Event|0|||
19704771|NCT03730012|42149087|FG001|Overall Study|Miscellaneous|1|||
19704772|NCT03728140|42149098|FG000|Overall Study|Abnormal embryo transfer operation|10|||
19704773|NCT03728140|42149099|FG001|Overall Study|Abnormal embryo transfer operation|7|||
19704774|NCT03725722|42149124|FG000|Overall Study|Lack of Efficacy|2|||
19704775|NCT03725722|42149125|FG001|Overall Study|Lack of Efficacy|1|||
19704776|NCT03725722|42149126|FG002|Overall Study|Lack of Efficacy|2|||
19704777|NCT03725722|42149127|FG003|Overall Study|Lack of Efficacy|0|||
19704778|NCT03725722|42149128|FG004|Overall Study|Lack of Efficacy|2|||
19514039|NCT01827384|41926374|FG004|Overall Study|Disease progression before treatment|0|||
19514040|NCT01827384|41926375|FG005|Overall Study|Disease progression before treatment|0|||
19514041|NCT01827384|41926376|FG006|Overall Study|Disease progression before treatment|0|||
19514042|NCT01827384|41926377|FG007|Overall Study|Disease progression before treatment|0|||
19514043|NCT01827384|41926378|FG008|Overall Study|Disease progression before treatment|0|||
19514044|NCT01827384|41926379|FG009|Overall Study|Disease progression before treatment|0|||
19514045|NCT01827384|41926380|FG010|Overall Study|Disease progression before treatment|0|||
19514046|NCT01827384|41926381|FG011|Overall Study|Disease progression before treatment|0|||
19514047|NCT01827384|41926382|FG012|Overall Study|Disease progression before treatment|0|||
19514048|NCT01827384|41926383|FG013|Overall Study|Disease progression before treatment|4|||
19514049|NCT01827384|41926370|FG000|Overall Study|Ineligible|0|||
19618033|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Adverse Event|1|||
19514050|NCT01827384|41926371|FG001|Overall Study|Ineligible|0|||
19514051|NCT01827384|41926372|FG002|Overall Study|Ineligible|0|||
19514052|NCT01827384|41926373|FG003|Overall Study|Ineligible|0|||
19514053|NCT01827384|41926374|FG004|Overall Study|Ineligible|0|||
19514054|NCT01827384|41926375|FG005|Overall Study|Ineligible|0|||
19514055|NCT01827384|41926376|FG006|Overall Study|Ineligible|0|||
19514056|NCT01827384|41926377|FG007|Overall Study|Ineligible|0|||
19514057|NCT01827384|41926378|FG008|Overall Study|Ineligible|0|||
19514058|NCT01827384|41926379|FG009|Overall Study|Ineligible|0|||
19514059|NCT01827384|41926380|FG010|Overall Study|Ineligible|0|||
19514060|NCT01827384|41926381|FG011|Overall Study|Ineligible|0|||
19514061|NCT01827384|41926382|FG012|Overall Study|Ineligible|0|||
19514062|NCT01827384|41926383|FG013|Overall Study|Ineligible|19|||
19514063|NCT01827384|41926370|FG000|Overall Study|Participant died before treatment|0|||
19514064|NCT01827384|41926371|FG001|Overall Study|Participant died before treatment|0|||
19514065|NCT01827384|41926372|FG002|Overall Study|Participant died before treatment|0|||
19514066|NCT01827384|41926373|FG003|Overall Study|Participant died before treatment|0|||
19514067|NCT01827384|41926374|FG004|Overall Study|Participant died before treatment|0|||
19514068|NCT01827384|41926375|FG005|Overall Study|Participant died before treatment|0|||
19514069|NCT01827384|41926376|FG006|Overall Study|Participant died before treatment|0|||
19514070|NCT01827384|41926377|FG007|Overall Study|Participant died before treatment|0|||
19514071|NCT01827384|41926378|FG008|Overall Study|Participant died before treatment|0|||
19514072|NCT01827384|41926379|FG009|Overall Study|Participant died before treatment|0|||
19514073|NCT01827384|41926380|FG010|Overall Study|Participant died before treatment|0|||
19514074|NCT01827384|41926381|FG011|Overall Study|Participant died before treatment|0|||
19514075|NCT01827384|41926382|FG012|Overall Study|Participant died before treatment|0|||
19514076|NCT01827384|41926383|FG013|Overall Study|Participant died before treatment|5|||
19514077|NCT01827384|41926370|FG000|Overall Study|Insufficient tumor cells|0|||
19514078|NCT01827384|41926371|FG001|Overall Study|Insufficient tumor cells|0|||
19514079|NCT01827384|41926372|FG002|Overall Study|Insufficient tumor cells|0|||
19514080|NCT01827384|41926373|FG003|Overall Study|Insufficient tumor cells|0|||
19514081|NCT01827384|41926374|FG004|Overall Study|Insufficient tumor cells|0|||
19514082|NCT01827384|41926375|FG005|Overall Study|Insufficient tumor cells|0|||
19514083|NCT01827384|41926376|FG006|Overall Study|Insufficient tumor cells|0|||
19514084|NCT01827384|41926377|FG007|Overall Study|Insufficient tumor cells|0|||
19618034|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Adverse Event|0|||
19514085|NCT01827384|41926378|FG008|Overall Study|Insufficient tumor cells|0|||
19514086|NCT01827384|41926379|FG009|Overall Study|Insufficient tumor cells|0|||
19514087|NCT01827384|41926380|FG010|Overall Study|Insufficient tumor cells|0|||
19514088|NCT01827384|41926381|FG011|Overall Study|Insufficient tumor cells|0|||
19514089|NCT01827384|41926382|FG012|Overall Study|Insufficient tumor cells|0|||
19514090|NCT01827384|41926383|FG013|Overall Study|Insufficient tumor cells|13|||
19514091|NCT01827384|41926370|FG000|Overall Study|No actionable mutation|0|||
19514092|NCT01827384|41926371|FG001|Overall Study|No actionable mutation|0|||
19514093|NCT01827384|41926372|FG002|Overall Study|No actionable mutation|0|||
19514094|NCT01827384|41926373|FG003|Overall Study|No actionable mutation|0|||
19514095|NCT01827384|41926374|FG004|Overall Study|No actionable mutation|0|||
19514096|NCT01827384|41926375|FG005|Overall Study|No actionable mutation|0|||
19514097|NCT01827384|41926376|FG006|Overall Study|No actionable mutation|0|||
19514098|NCT01827384|41926377|FG007|Overall Study|No actionable mutation|0|||
19514099|NCT01827384|41926378|FG008|Overall Study|No actionable mutation|0|||
19514100|NCT01827384|41926379|FG009|Overall Study|No actionable mutation|0|||
19514101|NCT01827384|41926380|FG010|Overall Study|No actionable mutation|0|||
19514102|NCT01827384|41926381|FG011|Overall Study|No actionable mutation|0|||
19514103|NCT01827384|41926382|FG012|Overall Study|No actionable mutation|0|||
19514104|NCT01827384|41926383|FG013|Overall Study|No actionable mutation|73|||
19514105|NCT01827384|41926370|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
19514106|NCT01827384|41926371|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
19514107|NCT01827384|41926372|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
19514108|NCT01827384|41926373|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
19514109|NCT01827384|41926374|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
19514110|NCT01827384|41926375|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
19514111|NCT01827384|41926376|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
19514112|NCT01827384|41926377|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
19514113|NCT01827384|41926378|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
19514114|NCT01827384|41926379|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
19514115|NCT01827384|41926380|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
19514116|NCT01827384|41926381|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
19514117|NCT01827384|41926382|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
19618035|NCT02393248|42067452|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19514118|NCT01827384|41926383|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
19514119|NCT01844076|41926417|FG000|Overall Study|Adverse Event|1|||
19514120|NCT01844076|41926418|FG001|Overall Study|Adverse Event|0|||
19514121|NCT01844076|41926419|FG002|Overall Study|Adverse Event|0|||
19514122|NCT01844076|41926420|FG003|Overall Study|Adverse Event|0|||
19514123|NCT01844076|41926417|FG000|Overall Study|Withdrawal by Subject|1|||
19514124|NCT01844076|41926418|FG001|Overall Study|Withdrawal by Subject|0|||
19514125|NCT01844076|41926419|FG002|Overall Study|Withdrawal by Subject|0|||
19514126|NCT01844076|41926420|FG003|Overall Study|Withdrawal by Subject|0|||
19514127|NCT01826604|41926432|FG000|Overall Study|Lost to Follow-up|8|||
19514128|NCT01826604|41926433|FG001|Overall Study|Lost to Follow-up|9|||
19514129|NCT01843842|41926441|FG000|Overall Study|Do not meet inclusion criteria|1|||
19514130|NCT01843842|41926442|FG001|Overall Study|Do not meet inclusion criteria|1|||
19514131|NCT01826448|41926450|FG000|Overall Study|Adverse Event|1|||
19514132|NCT01826448|41926451|FG001|Overall Study|Adverse Event|3|||
19514133|NCT01826448|41926450|FG000|Overall Study|Disease progression|2|||
19514134|NCT01826448|41926451|FG001|Overall Study|Disease progression|4|||
19514135|NCT01826448|41926450|FG000|Overall Study|Withdrawal by Subject|1|||
19514136|NCT01826448|41926451|FG001|Overall Study|Withdrawal by Subject|0|||
19514137|NCT01826448|41926450|FG000|Overall Study|Physician Decision|0|||
19514138|NCT01826448|41926451|FG001|Overall Study|Physician Decision|1|||
19514139|NCT01826448|41926450|FG000|Overall Study|2 active cancers|0|||
19514140|NCT01826448|41926451|FG001|Overall Study|2 active cancers|1|||
19514141|NCT01826370|41926457|FG000|Overall Study|Protocol Violation|6|||
19514142|NCT01826370|41926457|FG000|Overall Study|Lost to Follow-up|12|||
19514143|NCT01826370|41926457|FG000|Overall Study|Other reason not defined above|2|||
19514144|NCT01826214|41926463|FG000|Overall Study|Adverse Event|7|||
19514145|NCT01826214|41926464|FG001|Overall Study|Adverse Event|6|||
19514146|NCT01826214|41926463|FG000|Overall Study|Death|3|||
19514147|NCT01826214|41926464|FG001|Overall Study|Death|1|||
19514148|NCT01826214|41926463|FG000|Overall Study|Lost to Follow-up|1|||
19514149|NCT01826214|41926464|FG001|Overall Study|Lost to Follow-up|0|||
19514150|NCT01826214|41926463|FG000|Overall Study|Physician Decision|0|||
19514151|NCT01826214|41926464|FG001|Overall Study|Physician Decision|2|||
19514152|NCT01826214|41926463|FG000|Overall Study|Progressive disease|22|||
19514153|NCT01826214|41926464|FG001|Overall Study|Progressive disease|21|||
19514154|NCT01826214|41926463|FG000|Overall Study|Study terminated by Sponsor|0|||
19514155|NCT01826214|41926464|FG001|Overall Study|Study terminated by Sponsor|1|||
19514156|NCT01826214|41926463|FG000|Overall Study|Subject/guardian decision|2|||
19514157|NCT01826214|41926464|FG001|Overall Study|Subject/guardian decision|3|||
19514158|NCT01843062|41926472|FG000|Overall Study|Protocol Violation|1|||
19514159|NCT01843062|41926473|FG001|Overall Study|Protocol Violation|0|||
19514160|NCT01843062|41926472|FG000|Overall Study|New treatment following progression|2|||
19514161|NCT01843062|41926473|FG001|Overall Study|New treatment following progression|0|||
19514162|NCT01843062|41926472|FG000|Overall Study|Pregnancy|1|||
19514163|NCT01843062|41926473|FG001|Overall Study|Pregnancy|0|||
19514164|NCT01843062|41926472|FG000|Overall Study|Adverse Event|2|||
19514165|NCT01843062|41926473|FG001|Overall Study|Adverse Event|0|||
19514166|NCT01843062|41926472|FG000|Overall Study|Incorrect randomisation|1|||
19514167|NCT01843062|41926473|FG001|Overall Study|Incorrect randomisation|0|||
19514168|NCT01843062|41926472|FG000|Overall Study|Withdrawal by Subject|12|||
19514169|NCT01843062|41926473|FG001|Overall Study|Withdrawal by Subject|3|||
19514170|NCT01843062|41926472|FG000|Overall Study|Death|1|||
19514171|NCT01843062|41926473|FG001|Overall Study|Death|2|||
19514172|NCT01843062|41926472|FG000|Overall Study|Lost to Follow-up|2|||
19514173|NCT01843062|41926473|FG001|Overall Study|Lost to Follow-up|4|||
19514174|NCT01842438|41926481|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
19514175|NCT01842438|41926482|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
19514176|NCT01842438|41926481|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
19514177|NCT01842438|41926482|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
19514178|NCT01842438|41926481|FG000|T2: 6month Follow-up|Death|0|||
19514179|NCT01842438|41926482|FG001|T2: 6month Follow-up|Death|1|||
19514180|NCT01799226|41926494|FG000|Overall Study|Withdrawal by Subject|1|||
19514181|NCT01799226|41926495|FG001|Overall Study|Withdrawal by Subject|0|||
19514182|NCT01799226|41926494|FG000|Overall Study|Disqualified at Day 14|1|||
19514183|NCT01799226|41926495|FG001|Overall Study|Disqualified at Day 14|0|||
19514184|NCT01798992|41926505|FG000|Overall Study|Administrative withdrawal|0|||
19514185|NCT01798992|41926506|FG001|Overall Study|Administrative withdrawal|1|||
19514186|NCT01798992|41926507|FG002|Overall Study|Administrative withdrawal|0|||
19704779|NCT03725722|42149124|FG000|Overall Study|Adverse Event|2|||
19514187|NCT01798992|41926508|FG003|Overall Study|Administrative withdrawal|1|||
19514188|NCT01798992|41926505|FG000|Overall Study|Lost to Follow-up|0|||
19514189|NCT01798992|41926506|FG001|Overall Study|Lost to Follow-up|1|||
19514190|NCT01798992|41926507|FG002|Overall Study|Lost to Follow-up|1|||
19514191|NCT01798992|41926508|FG003|Overall Study|Lost to Follow-up|0|||
19514192|NCT01798992|41926505|FG000|Overall Study|Insufficient biopsy tissue|0|||
19514193|NCT01798992|41926506|FG001|Overall Study|Insufficient biopsy tissue|0|||
19704780|NCT03725722|42149125|FG001|Overall Study|Adverse Event|2|||
19514194|NCT01798992|41926507|FG002|Overall Study|Insufficient biopsy tissue|1|||
19514195|NCT01798992|41926508|FG003|Overall Study|Insufficient biopsy tissue|0|||
19514196|NCT01825200|41926519|FG000|Overall Study|Lost to Follow-up|5|||
19514197|NCT01825200|41926520|FG001|Overall Study|Lost to Follow-up|6|||
19514198|NCT01825200|41926519|FG000|Overall Study|Withdrawal by Subject|0|||
19514199|NCT01825200|41926520|FG001|Overall Study|Withdrawal by Subject|1|||
19514200|NCT01824576|41926526|FG000|Overall Study|Device deficiency|2|||
19514201|NCT01824498|41926536|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
19514202|NCT01824498|41926537|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
19514203|NCT01824498|41926538|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
19514204|NCT01824498|41926539|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
19514205|NCT01824498|41926540|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
19514206|NCT01824498|41926541|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
19514207|NCT01798134|41926549|FG000|Overall Study|Lost to Follow-up|1|||
19514208|NCT01798134|41926549|FG000|Overall Study|Withdrawal by Subject|3|||
19514209|NCT01798134|41926549|FG000|Overall Study|Death|2|||
19514210|NCT01798134|41926549|FG000|Overall Study|Adverse Event|3|||
19514211|NCT01798134|41926549|FG000|Overall Study|Physician Decision|3|||
19514212|NCT01798134|41926549|FG000|Overall Study|Liver transplant/surgery|4|||
19514213|NCT01798056|41926555|FG000|Overall Study|Serious Adverse Event|13|||
19514214|NCT01798056|41926556|FG001|Overall Study|Serious Adverse Event|12|||
19514215|NCT01798056|41926555|FG000|Overall Study|Withdrawal by Subject|12|||
19514216|NCT01798056|41926556|FG001|Overall Study|Withdrawal by Subject|9|||
19514217|NCT01798056|41926555|FG000|Overall Study|Migrated/moved from study area|1|||
19514218|NCT01798056|41926556|FG001|Overall Study|Migrated/moved from study area|1|||
19514219|NCT01798056|41926555|FG000|Overall Study|Lost to Follow-up|1|||
19514220|NCT01798056|41926556|FG001|Overall Study|Lost to Follow-up|1|||
19514221|NCT01798056|41926555|FG000|Overall Study|Other|0|||
19514222|NCT01798056|41926556|FG001|Overall Study|Other|2|||
19514223|NCT01824342|41926566|FG000|Overall Study|Withdrawal by Subject|0|||
19514224|NCT01824342|41926567|FG001|Overall Study|Withdrawal by Subject|3|||
19514225|NCT01824342|41926566|FG000|Overall Study|Adverse Event|1|||
19514226|NCT01824342|41926567|FG001|Overall Study|Adverse Event|1|||
19514227|NCT01824342|41926566|FG000|Overall Study|Disease Progression|1|||
19514228|NCT01824342|41926567|FG001|Overall Study|Disease Progression|1|||
19514229|NCT01824342|41926566|FG000|Overall Study|Physician Decision|5|||
19514230|NCT01824342|41926567|FG001|Overall Study|Physician Decision|0|||
19514231|NCT01824342|41926566|FG000|Overall Study|Death|2|||
19514232|NCT01824342|41926567|FG001|Overall Study|Death|0|||
19514233|NCT01841970|41926573|FG000|Overall Study|Withdrawal by Subject|1|||
19514234|NCT01841970|41926573|FG000|Overall Study|Physician Decision|2|||
19514235|NCT01841970|41926573|FG000|Overall Study|Lost to Follow-up|8|||
19514236|NCT01823328|41926582|FG000|Overall Study|Withdrawal by Subject|8|||
19514237|NCT01823328|41926583|FG001|Overall Study|Withdrawal by Subject|6|||
19514238|NCT01840410|41926591|FG000|Overall Study|Physician Decision|1|||
19514239|NCT01840410|41926592|FG001|Overall Study|Physician Decision|2|||
19514240|NCT01840410|41926591|FG000|Overall Study|Pregnancy|1|||
19514241|NCT01840410|41926592|FG001|Overall Study|Pregnancy|0|||
19514242|NCT01840410|41926591|FG000|Overall Study|Protocol deviation|1|||
19514243|NCT01840410|41926592|FG001|Overall Study|Protocol deviation|0|||
19514244|NCT01840410|41926591|FG000|Overall Study|Lost to Follow-up|1|||
19514245|NCT01840410|41926592|FG001|Overall Study|Lost to Follow-up|0|||
19514246|NCT01840410|41926591|FG000|Overall Study|Withdrawal by Subject|2|||
19514247|NCT01840410|41926592|FG001|Overall Study|Withdrawal by Subject|1|||
19514248|NCT01840410|41926591|FG000|Overall Study|Adverse Event|1|||
19514249|NCT01840410|41926592|FG001|Overall Study|Adverse Event|1|||
19514250|NCT01797432|41926600|FG000|Overall Study|Lost to Follow-up|1|||
19514251|NCT01797432|41926600|FG000|Overall Study|Adverse Event|1|||
19514252|NCT01797432|41926600|FG000|Overall Study|Withdrawal by Subject|1|||
19514253|NCT01797432|41926600|FG000|Overall Study|lived too far from study site|1|||
19514254|NCT01797120|41926606|FG000|Overall Study|Disesae progression|37|||
19514255|NCT01797120|41926607|FG001|Overall Study|Disesae progression|49|||
19514256|NCT01797120|41926606|FG000|Overall Study|Adverse Event|13|||
19514257|NCT01797120|41926607|FG001|Overall Study|Adverse Event|5|||
19514258|NCT01797120|41926606|FG000|Overall Study|Withdrawal by Subject|6|||
19514259|NCT01797120|41926607|FG001|Overall Study|Withdrawal by Subject|6|||
19514260|NCT01797120|41926606|FG000|Overall Study|Symptomatic progression|2|||
19514261|NCT01797120|41926607|FG001|Overall Study|Symptomatic progression|1|||
19514262|NCT01797120|41926606|FG000|Overall Study|Non-compliance|1|||
19514263|NCT01797120|41926607|FG001|Overall Study|Non-compliance|0|||
19514264|NCT01797120|41926606|FG000|Overall Study|Physician Decision|3|||
19514265|NCT01797120|41926607|FG001|Overall Study|Physician Decision|0|||
19514266|NCT01797120|41926606|FG000|Overall Study|still on treatment|2|||
19514267|NCT01797120|41926607|FG001|Overall Study|still on treatment|4|||
19514268|NCT01797120|41926606|FG000|Overall Study|never start protocol therapy|2|||
19514269|NCT01797120|41926607|FG001|Overall Study|never start protocol therapy|0|||
19514270|NCT01796964|41926615|FG000|Overall Study|Adverse Event|1|||
19514271|NCT01796964|41926616|FG001|Overall Study|Adverse Event|1|||
19514272|NCT01796964|41926615|FG000|Overall Study|Death|1|||
19514273|NCT01796964|41926616|FG001|Overall Study|Death|0|||
19514274|NCT01796964|41926615|FG000|Overall Study|Protocol Violation|0|||
19514275|NCT01796964|41926616|FG001|Overall Study|Protocol Violation|1|||
19514276|NCT01796964|41926615|FG000|Overall Study|Withdrawal by Subject|1|||
19514277|NCT01796964|41926616|FG001|Overall Study|Withdrawal by Subject|1|||
19514278|NCT01838694|41926625|FG000|Overall Study|Adverse Event|0|||
19514279|NCT01838694|41926626|FG001|Overall Study|Adverse Event|1|||
19514280|NCT01795638|41926637|FG000|Overall Study|Death|0|||
19514281|NCT01795638|41926638|FG001|Overall Study|Death|3|||
19514282|NCT01795638|41926637|FG000|Overall Study|transferred to quaternary hospital|2|||
19514283|NCT01795638|41926638|FG001|Overall Study|transferred to quaternary hospital|3|||
19514284|NCT01795638|41926637|FG000|Overall Study|Protocol Violation|3|||
19514285|NCT01795638|41926638|FG001|Overall Study|Protocol Violation|0|||
19514286|NCT01795638|41926637|FG000|Overall Study|discharged from hospital|7|||
19514287|NCT01795638|41926638|FG001|Overall Study|discharged from hospital|5|||
19514288|NCT01795638|41926637|FG000|Overall Study|Withdrawal by Subject|1|||
19514289|NCT01795638|41926638|FG001|Overall Study|Withdrawal by Subject|0|||
19514290|NCT01794780|41926652|FG000|Overall Study|Adverse Event|0|||
19514291|NCT01794780|41926653|FG001|Overall Study|Adverse Event|1|||
19514292|NCT01794780|41926654|FG002|Overall Study|Adverse Event|2|||
19514293|NCT01794780|41926655|FG003|Overall Study|Adverse Event|0|||
19514294|NCT01794780|41926656|FG004|Overall Study|Adverse Event|0|||
19618036|NCT02393248|42067453|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618037|NCT02393248|42067454|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618038|NCT02393248|42067455|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618039|NCT02393248|42067456|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618040|NCT02393248|42067457|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618041|NCT02393248|42067458|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618042|NCT02393248|42067459|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618043|NCT02393248|42067460|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618044|NCT02393248|42067461|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618045|NCT02393248|42067462|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618046|NCT02393248|42067463|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618047|NCT02393248|42067464|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618048|NCT02393248|42067465|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618049|NCT02393248|42067466|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618050|NCT02393248|42067467|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618051|NCT02393248|42067468|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19514295|NCT01794780|41926657|FG005|Overall Study|Adverse Event|0|||
19514296|NCT01794780|41926658|FG006|Overall Study|Adverse Event|0|||
19514297|NCT01794780|41926659|FG007|Overall Study|Adverse Event|0|||
19514298|NCT01794780|41926652|FG000|Overall Study|Death|0|||
19514299|NCT01794780|41926653|FG001|Overall Study|Death|2|||
19514300|NCT01794780|41926654|FG002|Overall Study|Death|14|||
19514301|NCT01794780|41926655|FG003|Overall Study|Death|1|||
19514302|NCT01794780|41926656|FG004|Overall Study|Death|0|||
19514303|NCT01794780|41926657|FG005|Overall Study|Death|9|||
19514304|NCT01794780|41926658|FG006|Overall Study|Death|4|||
19514305|NCT01794780|41926659|FG007|Overall Study|Death|0|||
19514306|NCT01794780|41926652|FG000|Overall Study|Lost to Follow-up|10|||
19514307|NCT01794780|41926653|FG001|Overall Study|Lost to Follow-up|64|||
19514308|NCT01794780|41926654|FG002|Overall Study|Lost to Follow-up|165|||
19514309|NCT01794780|41926655|FG003|Overall Study|Lost to Follow-up|53|||
19514310|NCT01794780|41926656|FG004|Overall Study|Lost to Follow-up|2|||
19514311|NCT01794780|41926657|FG005|Overall Study|Lost to Follow-up|99|||
19514312|NCT01794780|41926658|FG006|Overall Study|Lost to Follow-up|30|||
19514313|NCT01794780|41926659|FG007|Overall Study|Lost to Follow-up|5|||
19514314|NCT01794780|41926652|FG000|Overall Study|Withdrew informed consent|7|||
19514315|NCT01794780|41926653|FG001|Overall Study|Withdrew informed consent|17|||
19514316|NCT01794780|41926654|FG002|Overall Study|Withdrew informed consent|36|||
19514317|NCT01794780|41926655|FG003|Overall Study|Withdrew informed consent|9|||
19514318|NCT01794780|41926656|FG004|Overall Study|Withdrew informed consent|0|||
19514319|NCT01794780|41926657|FG005|Overall Study|Withdrew informed consent|48|||
19514320|NCT01794780|41926658|FG006|Overall Study|Withdrew informed consent|4|||
19514321|NCT01794780|41926659|FG007|Overall Study|Withdrew informed consent|3|||
19514322|NCT01794780|41926652|FG000|Overall Study|Other|0|||
19514323|NCT01794780|41926653|FG001|Overall Study|Other|12|||
19514324|NCT01794780|41926654|FG002|Overall Study|Other|25|||
19514325|NCT01794780|41926655|FG003|Overall Study|Other|20|||
19514326|NCT01794780|41926656|FG004|Overall Study|Other|1|||
19514327|NCT01794780|41926657|FG005|Overall Study|Other|24|||
19514328|NCT01794780|41926658|FG006|Overall Study|Other|4|||
19514329|NCT01794780|41926659|FG007|Overall Study|Other|1|||
19514330|NCT01838616|41926686|FG000|Titration Period|Adverse Event|18|||
19514331|NCT01838616|41926687|FG001|Titration Period|Adverse Event|48|||
19514332|NCT01838616|41926686|FG000|Titration Period|Lack of Efficacy|5|||
19514333|NCT01838616|41926687|FG001|Titration Period|Lack of Efficacy|12|||
19514334|NCT01838616|41926686|FG000|Titration Period|Withdrawal by Subject|5|||
19514335|NCT01838616|41926687|FG001|Titration Period|Withdrawal by Subject|5|||
19514336|NCT01838616|41926686|FG000|Titration Period|Technical problems|1|||
19514337|NCT01838616|41926687|FG001|Titration Period|Technical problems|0|||
19514338|NCT01838616|41926686|FG000|Titration Period|Other|1|||
19514339|NCT01838616|41926687|FG001|Titration Period|Other|0|||
19514340|NCT01838616|41926686|FG000|Titration Period|Protocol Violation|0|||
19514341|NCT01838616|41926687|FG001|Titration Period|Protocol Violation|1|||
19514342|NCT01838616|41926686|FG000|Continuation Period|Lack of Efficacy|3|||
19514343|NCT01838616|41926687|FG001|Continuation Period|Lack of Efficacy|5|||
19514344|NCT01838616|41926686|FG000|Continuation Period|Adverse Event|8|||
19514345|NCT01838616|41926687|FG001|Continuation Period|Adverse Event|4|||
19514346|NCT01838616|41926686|FG000|Continuation Period|Protocol Violation|2|||
19514347|NCT01838616|41926687|FG001|Continuation Period|Protocol Violation|0|||
19514348|NCT01838616|41926686|FG000|Continuation Period|Lost to Follow-up|1|||
19514349|NCT01838616|41926687|FG001|Continuation Period|Lost to Follow-up|0|||
19514350|NCT01838616|41926686|FG000|Continuation Period|Withdrawal by Subject|0|||
19514351|NCT01838616|41926687|FG001|Continuation Period|Withdrawal by Subject|4|||
19514352|NCT01838616|41926686|FG000|Continuation Period|Technical problems|0|||
19514353|NCT01838616|41926687|FG001|Continuation Period|Technical problems|1|||
19514354|NCT01838616|41926686|FG000|Pick-up Arm|Lack of Efficacy|4|||
19514355|NCT01838616|41926687|FG001|Pick-up Arm|Lack of Efficacy|0|||
19514356|NCT01838616|41926686|FG000|Pick-up Arm|Adverse Event|9|||
19514357|NCT01838616|41926687|FG001|Pick-up Arm|Adverse Event|0|||
19514358|NCT01838616|41926686|FG000|Pick-up Arm|Withdrawal by Subject|1|||
19514359|NCT01838616|41926687|FG001|Pick-up Arm|Withdrawal by Subject|0|||
19514360|NCT01838616|41926686|FG000|Pick-up Arm|Technical problems|1|||
19514361|NCT01838616|41926687|FG001|Pick-up Arm|Technical problems|0|||
19514362|NCT01611792|41926700|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
19514363|NCT01611792|41926701|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
19514364|NCT01611792|41926700|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
19514365|NCT01611792|41926701|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
19514366|NCT01820364|41926708|FG000|Part I: LGX818|Death|1|||
19514367|NCT01820364|41926709|FG001|Part I: LGX818|Death|0|||
19514368|NCT01820364|41926708|FG000|Part I: LGX818|Administrative Problems|3|||
19514369|NCT01820364|41926709|FG001|Part I: LGX818|Administrative Problems|0|||
19514370|NCT01820364|41926708|FG000|Part I: LGX818|Adverse Event|6|||
19514371|NCT01820364|41926709|FG001|Part I: LGX818|Adverse Event|0|||
19514372|NCT01820364|41926708|FG000|Part I: LGX818|Disease Progression|4|||
19514373|NCT01820364|41926709|FG001|Part I: LGX818|Disease Progression|0|||
19514374|NCT01820364|41926708|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
19514375|NCT01820364|41926709|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
19514376|NCT01819506|41926717|FG000|Overall Study|Physician Decision|5|||
19514377|NCT01819506|41926718|FG001|Overall Study|Physician Decision|2|||
19514378|NCT01819506|41926717|FG000|Overall Study|Withdrawal by Subject|3|||
19514379|NCT01819506|41926718|FG001|Overall Study|Withdrawal by Subject|3|||
19514380|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
19514381|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
19514382|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Death|1|||
19514383|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Death|2|||
19514384|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
19514385|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
19514386|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
19514387|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
19514388|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
19514389|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
19514390|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
19514391|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
19514392|NCT01794000|41926726|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
19514393|NCT01794000|41926727|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
19514394|NCT01794000|41926726|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
19514395|NCT01794000|41926727|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
19514396|NCT01609296|41926734|FG000|Overall Study|Death|253|||
19514397|NCT01609296|41926734|FG000|Overall Study|Withdrawal by Subject|151|||
19514398|NCT01609296|41926734|FG000|Overall Study|Lost to Follow-up|21|||
19514399|NCT01609296|41926734|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
19514400|NCT01609296|41926734|FG000|Overall Study|missed visit but known to be alive|28|||
19514401|NCT01609218|41926742|FG000|Period 1|Adverse Event|3|||
19514402|NCT01609218|41926743|FG001|Period 1|Adverse Event|5|||
19514403|NCT01609218|41926742|FG000|Period 1|Sponsor Decision|0|||
19514404|NCT01609218|41926743|FG001|Period 1|Sponsor Decision|1|||
19514405|NCT01609218|41926742|FG000|Period 2|Adverse Event|1|||
19514406|NCT01609218|41926743|FG001|Period 2|Adverse Event|0|||
19514407|NCT01609062|41926751|FG000|Extension Phase|Terminated by Sponsor|14|||
19514408|NCT01609062|41926752|FG001|Extension Phase|Terminated by Sponsor|9|||
19514409|NCT01609062|41926751|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
19514410|NCT01609062|41926752|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
19514411|NCT01609062|41926751|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
19514412|NCT01609062|41926752|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
19514413|NCT01819272|41926765|FG000|Overall Study|Adverse Event|1|||
19514414|NCT01819272|41926766|FG001|Overall Study|Adverse Event|0|||
19514415|NCT01819272|41926767|FG002|Overall Study|Adverse Event|0|||
19514416|NCT01819272|41926768|FG003|Overall Study|Adverse Event|2|||
19514417|NCT01819272|41926769|FG004|Overall Study|Adverse Event|0|||
19514418|NCT01819272|41926770|FG005|Overall Study|Adverse Event|0|||
19514419|NCT01819272|41926765|FG000|Overall Study|Lost to Follow-up|3|||
19514420|NCT01819272|41926766|FG001|Overall Study|Lost to Follow-up|0|||
19514421|NCT01819272|41926767|FG002|Overall Study|Lost to Follow-up|1|||
19514422|NCT01819272|41926768|FG003|Overall Study|Lost to Follow-up|0|||
19514423|NCT01819272|41926769|FG004|Overall Study|Lost to Follow-up|0|||
19514424|NCT01819272|41926770|FG005|Overall Study|Lost to Follow-up|3|||
19514425|NCT01819272|41926765|FG000|Overall Study|Protocol Violation|0|||
19514426|NCT01819272|41926766|FG001|Overall Study|Protocol Violation|0|||
19514427|NCT01819272|41926767|FG002|Overall Study|Protocol Violation|0|||
19514428|NCT01819272|41926768|FG003|Overall Study|Protocol Violation|1|||
19514429|NCT01819272|41926769|FG004|Overall Study|Protocol Violation|2|||
19514430|NCT01819272|41926770|FG005|Overall Study|Protocol Violation|3|||
19514431|NCT01819272|41926765|FG000|Overall Study|Physician Decision|0|||
19514432|NCT01819272|41926766|FG001|Overall Study|Physician Decision|1|||
19514433|NCT01819272|41926767|FG002|Overall Study|Physician Decision|0|||
19514434|NCT01819272|41926768|FG003|Overall Study|Physician Decision|0|||
19514435|NCT01819272|41926769|FG004|Overall Study|Physician Decision|0|||
19514436|NCT01819272|41926770|FG005|Overall Study|Physician Decision|0|||
19514437|NCT01819272|41926765|FG000|Overall Study|Withdrawal of Consent|0|||
19514438|NCT01819272|41926766|FG001|Overall Study|Withdrawal of Consent|1|||
19514439|NCT01819272|41926767|FG002|Overall Study|Withdrawal of Consent|2|||
19514440|NCT01819272|41926768|FG003|Overall Study|Withdrawal of Consent|1|||
19514441|NCT01819272|41926769|FG004|Overall Study|Withdrawal of Consent|0|||
19514442|NCT01819272|41926770|FG005|Overall Study|Withdrawal of Consent|1|||
19514443|NCT01819272|41926765|FG000|Overall Study|Loss of Glucose Control|2|||
19514444|NCT01819272|41926766|FG001|Overall Study|Loss of Glucose Control|1|||
19514445|NCT01819272|41926767|FG002|Overall Study|Loss of Glucose Control|0|||
19514446|NCT01819272|41926768|FG003|Overall Study|Loss of Glucose Control|1|||
19514447|NCT01819272|41926769|FG004|Overall Study|Loss of Glucose Control|2|||
19514448|NCT01819272|41926770|FG005|Overall Study|Loss of Glucose Control|0|||
19514449|NCT01819194|41926784|FG000|Overall Study|Loss of study articles|2|||
19514450|NCT01611558|41926788|FG000|Induction Phase|Study drug toxicity|15|||
19514451|NCT01611558|41926788|FG000|Induction Phase|Disease progression|18|||
19514452|NCT01611558|41926788|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
19514453|NCT01611558|41926788|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
19514454|NCT01611558|41926788|FG000|Induction Phase|Death|1|||
19514455|NCT01611558|41926788|FG000|Maintenance Phase|Withdrawal by Subject|1|||
19514456|NCT01611558|41926788|FG000|Maintenance Phase|Elevated Uric acid|1|||
19514457|NCT01818726|41926795|FG000|Overall Study|Administrative reasons|5|||
19514458|NCT01818726|41926796|FG001|Overall Study|Administrative reasons|1|||
19514459|NCT01818726|41926795|FG000|Overall Study|Withdrawal by Subject|0|||
19514460|NCT01818726|41926796|FG001|Overall Study|Withdrawal by Subject|1|||
19514461|NCT01818726|41926795|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
19514462|NCT01818726|41926796|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
19514463|NCT01818336|41926802|FG000|Overall Study|Declined retest visit|0|||
19514464|NCT01818336|41926803|FG001|Overall Study|Declined retest visit|11|||
19514465|NCT01818336|41926802|FG000|Overall Study|Lost to Follow-up|0|||
19514466|NCT01818336|41926803|FG001|Overall Study|Lost to Follow-up|1|||
19514467|NCT01818258|41926811|FG000|Overall Study|Death|3|||
19514468|NCT01818258|41926812|FG001|Overall Study|Death|0|||
19704781|NCT03725722|42149126|FG002|Overall Study|Adverse Event|1|||
19514469|NCT01818258|41926811|FG000|Overall Study|Withdrawal by Subject|0|||
19514470|NCT01818258|41926812|FG001|Overall Study|Withdrawal by Subject|1|||
19514471|NCT01818258|41926811|FG000|Overall Study|Lost to Follow-up|0|||
19514472|NCT01818258|41926812|FG001|Overall Study|Lost to Follow-up|1|||
19514473|NCT01818258|41926811|FG000|Overall Study|Unable to Travel to Clinic|0|||
19514474|NCT01818258|41926812|FG001|Overall Study|Unable to Travel to Clinic|1|||
19514475|NCT01817790|41926821|FG000|Overall Study|Adverse Event|0|||
19514476|NCT01817790|41926822|FG001|Overall Study|Adverse Event|2|||
19514477|NCT01817790|41926821|FG000|Overall Study|Lost to Follow-up|0|||
19514478|NCT01817790|41926822|FG001|Overall Study|Lost to Follow-up|1|||
19514479|NCT01817790|41926821|FG000|Overall Study|Protocol Violation|2|||
19514480|NCT01817790|41926822|FG001|Overall Study|Protocol Violation|1|||
19514481|NCT01817790|41926821|FG000|Overall Study|Withdrawal by Subject|1|||
19514482|NCT01817790|41926822|FG001|Overall Study|Withdrawal by Subject|3|||
19514483|NCT01817790|41926821|FG000|Overall Study|Other: Could not attend appointment|1|||
19514484|NCT01817790|41926822|FG001|Overall Study|Other: Could not attend appointment|1|||
19514485|NCT01793688|41926830|FG000|Overall Study|Protocol Violation|2|||
19514489|NCT01793142|41926851|FG000|Overall Study|Randomized not treated|7|||
19514490|NCT01792830|41926866|FG000|Overall Study|Withdrawal by Subject|22|||
19514491|NCT01792830|41926867|FG001|Overall Study|Withdrawal by Subject|0|||
19514492|NCT01792830|41926868|FG002|Overall Study|Withdrawal by Subject|0|||
19514493|NCT01792830|41926869|FG003|Overall Study|Withdrawal by Subject|2|||
19514494|NCT01792830|41926870|FG004|Overall Study|Withdrawal by Subject|1|||
19514495|NCT01792830|41926871|FG005|Overall Study|Withdrawal by Subject|1|||
19514496|NCT01792830|41926872|FG006|Overall Study|Withdrawal by Subject|1|||
19514497|NCT01792830|41926873|FG007|Overall Study|Withdrawal by Subject|1|||
19514498|NCT01792830|41926874|FG008|Overall Study|Withdrawal by Subject|7|||
19514499|NCT01792830|41926875|FG009|Overall Study|Withdrawal by Subject|0|||
19514500|NCT01792830|41926876|FG010|Overall Study|Withdrawal by Subject|2|||
19514501|NCT01792830|41926866|FG000|Overall Study|Death|3|||
19514502|NCT01792830|41926867|FG001|Overall Study|Death|0|||
19514503|NCT01792830|41926868|FG002|Overall Study|Death|0|||
19514504|NCT01792830|41926869|FG003|Overall Study|Death|1|||
19514505|NCT01792830|41926870|FG004|Overall Study|Death|0|||
19514506|NCT01792830|41926871|FG005|Overall Study|Death|0|||
19514507|NCT01792830|41926872|FG006|Overall Study|Death|1|||
19514508|NCT01792830|41926873|FG007|Overall Study|Death|0|||
19514509|NCT01792830|41926874|FG008|Overall Study|Death|1|||
19514510|NCT01792830|41926875|FG009|Overall Study|Death|0|||
19514511|NCT01792830|41926876|FG010|Overall Study|Death|1|||
19514512|NCT01792830|41926866|FG000|Overall Study|Adverse Event|0|||
19514513|NCT01792830|41926867|FG001|Overall Study|Adverse Event|0|||
19514514|NCT01792830|41926868|FG002|Overall Study|Adverse Event|0|||
19514515|NCT01792830|41926869|FG003|Overall Study|Adverse Event|0|||
19514516|NCT01792830|41926870|FG004|Overall Study|Adverse Event|0|||
19514517|NCT01792830|41926871|FG005|Overall Study|Adverse Event|0|||
19514518|NCT01792830|41926872|FG006|Overall Study|Adverse Event|0|||
19514519|NCT01792830|41926873|FG007|Overall Study|Adverse Event|0|||
19514520|NCT01792830|41926874|FG008|Overall Study|Adverse Event|1|||
19514521|NCT01792830|41926875|FG009|Overall Study|Adverse Event|0|||
19514522|NCT01792830|41926876|FG010|Overall Study|Adverse Event|0|||
19514523|NCT01792518|41926908|FG000|Overall Study|Adverse Event|3|||
19514524|NCT01792518|41926909|FG001|Overall Study|Adverse Event|4|||
19514525|NCT01792518|41926908|FG000|Overall Study|Protocol Violation|0|||
19514526|NCT01792518|41926909|FG001|Overall Study|Protocol Violation|1|||
19514527|NCT01792518|41926908|FG000|Overall Study|Lost to Follow-up|3|||
19514528|NCT01792518|41926909|FG001|Overall Study|Lost to Follow-up|1|||
19514529|NCT01792518|41926908|FG000|Overall Study|Withdrawal by Subject|2|||
19514530|NCT01792518|41926909|FG001|Overall Study|Withdrawal by Subject|0|||
19514531|NCT01792518|41926908|FG000|Overall Study|Other Reason|0|||
19514532|NCT01792518|41926909|FG001|Overall Study|Other Reason|1|||
19514533|NCT01792284|41926915|FG000|Lead-in Period|Adverse Event|15|||
19514534|NCT01792284|41926916|FG001|Lead-in Period|Adverse Event|0|||
19514535|NCT01792284|41926917|FG002|Lead-in Period|Adverse Event|0|||
19514536|NCT01792284|41926915|FG000|Lead-in Period|Lost to Follow-up|2|||
19514537|NCT01792284|41926916|FG001|Lead-in Period|Lost to Follow-up|0|||
19514538|NCT01792284|41926917|FG002|Lead-in Period|Lost to Follow-up|0|||
19514539|NCT01792284|41926915|FG000|Lead-in Period|Protocol Violation|1|||
19514540|NCT01792284|41926916|FG001|Lead-in Period|Protocol Violation|0|||
19514541|NCT01792284|41926917|FG002|Lead-in Period|Protocol Violation|0|||
19514542|NCT01792284|41926915|FG000|Lead-in Period|Withdrawal by Subject|10|||
19514543|NCT01792284|41926916|FG001|Lead-in Period|Withdrawal by Subject|0|||
19514544|NCT01792284|41926917|FG002|Lead-in Period|Withdrawal by Subject|0|||
19618052|NCT02393248|42067469|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618053|NCT02393248|42067470|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19514545|NCT01792284|41926915|FG000|Lead-in Period|Physician Decision|1|||
19514546|NCT01792284|41926916|FG001|Lead-in Period|Physician Decision|0|||
19514547|NCT01792284|41926917|FG002|Lead-in Period|Physician Decision|0|||
19514548|NCT01792284|41926915|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
19514549|NCT01792284|41926916|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
19514550|NCT01792284|41926917|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
19514551|NCT01792284|41926915|FG000|Randomization Period 1|Withdrawal by Subject|0|||
19514552|NCT01792284|41926916|FG001|Randomization Period 1|Withdrawal by Subject|1|||
19514553|NCT01792284|41926917|FG002|Randomization Period 1|Withdrawal by Subject|1|||
19514554|NCT01792284|41926915|FG000|Randomization Period 1|Physician Decision|0|||
19514555|NCT01792284|41926916|FG001|Randomization Period 1|Physician Decision|1|||
19514556|NCT01792284|41926917|FG002|Randomization Period 1|Physician Decision|1|||
19514557|NCT01792284|41926915|FG000|Randomization Period 1|Adverse Event|0|||
19514558|NCT01792284|41926916|FG001|Randomization Period 1|Adverse Event|0|||
19514559|NCT01792284|41926917|FG002|Randomization Period 1|Adverse Event|2|||
19514560|NCT01792284|41926915|FG000|Randomization Period 1|Lost to Follow-up|0|||
19514561|NCT01792284|41926916|FG001|Randomization Period 1|Lost to Follow-up|0|||
19514562|NCT01792284|41926917|FG002|Randomization Period 1|Lost to Follow-up|1|||
19514563|NCT01792284|41926915|FG000|Randomization Period 2|Protocol Violation|0|||
19514564|NCT01792284|41926916|FG001|Randomization Period 2|Protocol Violation|1|||
19514565|NCT01792284|41926917|FG002|Randomization Period 2|Protocol Violation|0|||
19514566|NCT01792284|41926915|FG000|Randomization Period 2|Withdrawal by Subject|0|||
19514567|NCT01792284|41926916|FG001|Randomization Period 2|Withdrawal by Subject|2|||
19514568|NCT01792284|41926917|FG002|Randomization Period 2|Withdrawal by Subject|0|||
19514569|NCT01791894|41926925|FG000|Overall Study|Adverse Event|1|||
19514570|NCT01837680|41926932|FG000|Overall Study|Lost to Follow-up|2|||
19514571|NCT01837680|41926933|FG001|Overall Study|Lost to Follow-up|2|||
19514572|NCT01837680|41926932|FG000|Overall Study|lack of insurance|0|||
19514573|NCT01837680|41926933|FG001|Overall Study|lack of insurance|2|||
19514574|NCT01837680|41926932|FG000|Overall Study|allergic reaction|6|||
19514575|NCT01837680|41926933|FG001|Overall Study|allergic reaction|0|||
19514576|NCT01837680|41926932|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
19514577|NCT01837680|41926933|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
19514578|NCT01836276|41926941|FG000|Overall Study|Lost to Follow-up|28|||
19514579|NCT01836276|41926942|FG001|Overall Study|Lost to Follow-up|51|||
19514580|NCT01790568|41926948|FG000|Overall Study|Progression prior to transplant|0|||
19514581|NCT01790568|41926949|FG001|Overall Study|Progression prior to transplant|1|||
19514582|NCT01610076|41926955|FG000|Overall Study|Technical issue with video|0|||
19514583|NCT01610076|41926956|FG001|Overall Study|Technical issue with video|1|||
19514584|NCT01610076|41926955|FG000|Overall Study|Lost to Follow-up|3|||
19514585|NCT01610076|41926956|FG001|Overall Study|Lost to Follow-up|4|||
19514586|NCT01836198|41926965|FG000|Part A, Period 2|Protocol Violation|0|||
19514587|NCT01836198|41926966|FG001|Part A, Period 2|Protocol Violation|1|||
19514588|NCT01836198|41926967|FG002|Part A, Period 2|Protocol Violation|0|||
19514589|NCT01816074|41926987|FG000|Phase 1|Time commitment issues|0|||
19514590|NCT01816074|41926988|FG001|Phase 1|Time commitment issues|0|||
19514591|NCT01816074|41926989|FG002|Phase 1|Time commitment issues|1|||
19514592|NCT01816074|41926990|FG003|Phase 1|Time commitment issues|0|||
19514593|NCT01816074|41926987|FG000|Phase 2|Time commitment Issues|0|||
19514594|NCT01816074|41926988|FG001|Phase 2|Time commitment Issues|2|||
19514595|NCT01816074|41926989|FG002|Phase 2|Time commitment Issues|0|||
19514596|NCT01816074|41926990|FG003|Phase 2|Time commitment Issues|0|||
19514597|NCT01816074|41926987|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
19514598|NCT01816074|41926988|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
19514599|NCT01816074|41926989|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
19514600|NCT01816074|41926990|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
19514601|NCT01816074|41926987|FG000|Phase 2|Physician Decision|0|||
19514602|NCT01816074|41926988|FG001|Phase 2|Physician Decision|0|||
19514603|NCT01816074|41926989|FG002|Phase 2|Physician Decision|0|||
19514604|NCT01816074|41926990|FG003|Phase 2|Physician Decision|1|||
19514605|NCT01816074|41926987|FG000|Phase 2|Withdrawal by Subject|1|||
19514606|NCT01816074|41926988|FG001|Phase 2|Withdrawal by Subject|0|||
19514607|NCT01816074|41926989|FG002|Phase 2|Withdrawal by Subject|0|||
19514608|NCT01816074|41926990|FG003|Phase 2|Withdrawal by Subject|0|||
19514609|NCT01815918|41927016|FG000|Overall Study|Patient samples not analyzable|3|||
19514610|NCT01815918|41927017|FG001|Overall Study|Patient samples not analyzable|4|||
19514611|NCT01815918|41927016|FG000|Overall Study|Lack of Efficacy|15|||
19514612|NCT01815918|41927017|FG001|Overall Study|Lack of Efficacy|15|||
19514613|NCT01789476|41927029|FG000|Overall Study|Lack of Efficacy|6|||
19514614|NCT01789476|41927030|FG001|Overall Study|Lack of Efficacy|2|||
19618054|NCT02393248|42067471|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19514615|NCT01789476|41927029|FG000|Overall Study|Adverse Event|1|||
19514616|NCT01789476|41927030|FG001|Overall Study|Adverse Event|0|||
19514617|NCT01789476|41927029|FG000|Overall Study|Unable to get IV access|1|||
19514618|NCT01789476|41927030|FG001|Overall Study|Unable to get IV access|0|||
19514619|NCT01789320|41927036|FG000|Overall Study|Re-enrolled into study|1|||
19514620|NCT01789320|41927036|FG000|Overall Study|Lost to Follow-up|1|||
19514621|NCT01815840|41927042|FG000|Overall Study|Missing|1|||
19514622|NCT01815840|41927043|FG001|Overall Study|Missing|0|||
19514623|NCT01815840|41927042|FG000|Overall Study|Withdrew Consent|31|||
19514624|NCT01815840|41927043|FG001|Overall Study|Withdrew Consent|30|||
19514625|NCT01815840|41927042|FG000|Overall Study|Administrative/Other|1|||
19514626|NCT01815840|41927043|FG001|Overall Study|Administrative/Other|3|||
19514627|NCT01815840|41927042|FG000|Overall Study|Adverse Event|10|||
19514628|NCT01815840|41927043|FG001|Overall Study|Adverse Event|16|||
19514629|NCT01815840|41927042|FG000|Overall Study|Death|2|||
19514630|NCT01815840|41927043|FG001|Overall Study|Death|2|||
19514631|NCT01815840|41927042|FG000|Overall Study|Disease progression|3|||
19514632|NCT01815840|41927043|FG001|Overall Study|Disease progression|2|||
19514633|NCT01815840|41927042|FG000|Overall Study|Investigators Decision|2|||
19514634|NCT01815840|41927043|FG001|Overall Study|Investigators Decision|3|||
19514635|NCT01815840|41927042|FG000|Overall Study|Lost to Follow-up|3|||
19514636|NCT01815840|41927043|FG001|Overall Study|Lost to Follow-up|6|||
19514637|NCT01815840|41927042|FG000|Overall Study|Refused Treatment|5|||
19514638|NCT01815840|41927043|FG001|Overall Study|Refused Treatment|1|||
19514639|NCT01815840|41927042|FG000|Overall Study|Sponsor Termination Treatment|1|||
19514640|NCT01815840|41927043|FG001|Overall Study|Sponsor Termination Treatment|0|||
19514641|NCT01774110|41927049|FG000|Overall Study|Lost to Follow-up|7|||
19514642|NCT01788228|41927056|FG000|Overall Study|Migrated/moved from study area|1|||
19514643|NCT01788228|41927057|FG001|Overall Study|Migrated/moved from study area|0|||
19514644|NCT01607346|41927066|FG000|Overall Study|Adverse Event|3|||
19514645|NCT01787838|41927070|FG000|Overall Study|refused|1413|||
19514646|NCT01787760|41927077|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
19514647|NCT01787760|41927078|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
19514648|NCT01787760|41927079|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
19514649|NCT01787760|41927077|FG000|Overall Study|Decompensated on left exotropia|0|||
19514650|NCT01787760|41927078|FG001|Overall Study|Decompensated on left exotropia|0|||
19514651|NCT01787760|41927079|FG002|Overall Study|Decompensated on left exotropia|1|||
19514652|NCT01787760|41927077|FG000|Overall Study|Dryness|0|||
19514653|NCT01787760|41927078|FG001|Overall Study|Dryness|1|||
19514654|NCT01787760|41927079|FG002|Overall Study|Dryness|0|||
19514655|NCT01787760|41927077|FG000|Overall Study|Relocation|1|||
19514656|NCT01787760|41927078|FG001|Overall Study|Relocation|1|||
19514657|NCT01787760|41927079|FG002|Overall Study|Relocation|0|||
19514658|NCT01787760|41927077|FG000|Overall Study|Lens discomfort|3|||
19514659|NCT01787760|41927078|FG001|Overall Study|Lens discomfort|0|||
19514660|NCT01787760|41927079|FG002|Overall Study|Lens discomfort|0|||
19514661|NCT01787760|41927077|FG000|Overall Study|Lens handling difficulty|1|||
19514662|NCT01787760|41927078|FG001|Overall Study|Lens handling difficulty|2|||
19514663|NCT01787760|41927079|FG002|Overall Study|Lens handling difficulty|0|||
19514664|NCT01787760|41927077|FG000|Overall Study|Protocol Violation|6|||
19514665|NCT01787760|41927078|FG001|Overall Study|Protocol Violation|0|||
19514666|NCT01787760|41927079|FG002|Overall Study|Protocol Violation|1|||
19514667|NCT01787760|41927077|FG000|Overall Study|Withdrawal by Subject|5|||
19618055|NCT02393248|42067472|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618056|NCT02393248|42067473|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618057|NCT02393248|42067474|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618058|NCT02393248|42067475|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
19618059|NCT02393248|42067476|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
19618060|NCT00601484|42067539|FG000|Overall Study|Adverse Event|0|||
19618061|NCT00601484|42067540|FG001|Overall Study|Adverse Event|1|||
19618062|NCT00601484|42067539|FG000|Overall Study|Lost to Follow-up|4|||
19618063|NCT00601484|42067540|FG001|Overall Study|Lost to Follow-up|3|||
19618064|NCT00601484|42067539|FG000|Overall Study|Lack of Efficacy|0|||
19618065|NCT00601484|42067540|FG001|Overall Study|Lack of Efficacy|2|||
19618066|NCT00601484|42067539|FG000|Overall Study|Withdrawal by Subject|1|||
19618067|NCT00601484|42067540|FG001|Overall Study|Withdrawal by Subject|1|||
19618068|NCT00601484|42067539|FG000|Overall Study|Randomized, but not treated|0|||
19618069|NCT00601484|42067540|FG001|Overall Study|Randomized, but not treated|1|||
19618070|NCT00883896|42067550|FG000|Overall Study|Lost to Follow-up|0|||
19618071|NCT00883896|42067551|FG001|Overall Study|Lost to Follow-up|0|||
19618072|NCT00883896|42067552|FG002|Overall Study|Lost to Follow-up|0|||
19514668|NCT01787760|41927078|FG001|Overall Study|Withdrawal by Subject|1|||
19514669|NCT01787760|41927079|FG002|Overall Study|Withdrawal by Subject|2|||
19514670|NCT01787760|41927077|FG000|Overall Study|Lost to Follow-up|1|||
19514671|NCT01787760|41927078|FG001|Overall Study|Lost to Follow-up|0|||
19514672|NCT01787760|41927079|FG002|Overall Study|Lost to Follow-up|1|||
19514673|NCT01787760|41927077|FG000|Overall Study|Stroke|1|||
19514674|NCT01787760|41927078|FG001|Overall Study|Stroke|0|||
19514675|NCT01787760|41927079|FG002|Overall Study|Stroke|0|||
19514676|NCT01787760|41927077|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
19514677|NCT01787760|41927078|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
19514678|NCT01787760|41927079|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
19514679|NCT01787760|41927077|FG000|Overall Study|Unsatisfactory physiological response|2|||
19514680|NCT01787760|41927078|FG001|Overall Study|Unsatisfactory physiological response|4|||
19514681|NCT01787760|41927079|FG002|Overall Study|Unsatisfactory physiological response|0|||
19514682|NCT01787760|41927077|FG000|Overall Study|Unsatisfactory visual response|1|||
19514683|NCT01787760|41927078|FG001|Overall Study|Unsatisfactory visual response|1|||
19514684|NCT01787760|41927079|FG002|Overall Study|Unsatisfactory visual response|0|||
19514685|NCT01787760|41927077|FG000|Overall Study|Near vision blur|1|||
19514686|NCT01787760|41927078|FG001|Overall Study|Near vision blur|0|||
19514687|NCT01787760|41927079|FG002|Overall Study|Near vision blur|0|||
19514688|NCT01815138|41927090|FG000|Overall Study|Withdrawal by Subject|0|||
19514689|NCT01815138|41927091|FG001|Overall Study|Withdrawal by Subject|1|||
19514690|NCT01815138|41927090|FG000|Overall Study|Physician Decision|8|||
19514691|NCT01815138|41927091|FG001|Overall Study|Physician Decision|5|||
19514692|NCT01606800|41927099|FG000|Overall Study|Adverse Event|3|||
19514693|NCT01606800|41927100|FG001|Overall Study|Adverse Event|1|||
19514694|NCT01606800|41927099|FG000|Overall Study|Participant withdrew consent|0|||
19514695|NCT01606800|41927100|FG001|Overall Study|Participant withdrew consent|1|||
19514696|NCT01606800|41927099|FG000|Overall Study|Missing completion status|2|||
19514697|NCT01606800|41927100|FG001|Overall Study|Missing completion status|0|||
19514698|NCT01772550|41927109|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
19514699|NCT01772550|41927110|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
19514700|NCT01772550|41927111|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
19514701|NCT01772550|41927109|FG000|Overall Study|Adverse Event|0|||
19514702|NCT01772550|41927110|FG001|Overall Study|Adverse Event|0|||
19514703|NCT01772550|41927111|FG002|Overall Study|Adverse Event|1|||
19514704|NCT01787292|41927119|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
19514705|NCT01787292|41927120|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
19514706|NCT01787292|41927119|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
19514707|NCT01787292|41927120|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
19514708|NCT01814748|41927133|FG000|Overall Study|Lost to Follow-up|1|||
19514709|NCT01814748|41927134|FG001|Overall Study|Lost to Follow-up|2|||
19514710|NCT01814748|41927133|FG000|Overall Study|Study site terminated by sponsor|1|||
19514711|NCT01814748|41927134|FG001|Overall Study|Study site terminated by sponsor|1|||
19514712|NCT01814748|41927133|FG000|Overall Study|Withdrawal by Subject|6|||
19514713|NCT01814748|41927134|FG001|Overall Study|Withdrawal by Subject|4|||
19514714|NCT01814670|41927140|FG000|Overall Study|Protocol Violation|12|||
19514715|NCT01814046|41927146|FG000|Drug Administration|Death due to complications of RSV|1|||
19514716|NCT01814046|41927147|FG001|Drug Administration|Death due to complications of RSV|0|||
19514717|NCT01814046|41927148|FG002|Drug Administration|Death due to complications of RSV|0|||
19514718|NCT01813890|41927158|FG000|Overall Study|Adverse Event|0|||
19514719|NCT01813890|41927159|FG001|Overall Study|Adverse Event|3|||
19514720|NCT01813890|41927160|FG002|Overall Study|Adverse Event|4|||
19514721|NCT01813890|41927158|FG000|Overall Study|Lack of Efficacy|9|||
19514722|NCT01813890|41927159|FG001|Overall Study|Lack of Efficacy|1|||
19514723|NCT01813890|41927160|FG002|Overall Study|Lack of Efficacy|2|||
19514724|NCT01772316|41927168|FG000|Overall Study|Serious adverse event|1|||
19514725|NCT01772316|41927168|FG000|Overall Study|Inform consent withdrawn|1|||
19514726|NCT01772316|41927168|FG000|Overall Study|Withdrawn by sponsor decision|5|||
19514727|NCT01813422|41927174|FG000|Overall Study|Withdrawal by Subject|14|||
19514728|NCT01813422|41927175|FG001|Overall Study|Withdrawal by Subject|8|||
19514729|NCT01813422|41927174|FG000|Overall Study|Death|2|||
19514730|NCT01813422|41927175|FG001|Overall Study|Death|3|||
19514731|NCT01813422|41927174|FG000|Overall Study|Sponsor Decision|2|||
19514732|NCT01813422|41927175|FG001|Overall Study|Sponsor Decision|1|||
19514733|NCT01813422|41927174|FG000|Overall Study|Lost to Follow-up|2|||
19514734|NCT01813422|41927175|FG001|Overall Study|Lost to Follow-up|4|||
19514735|NCT01786668|41927185|FG000|Overall Study|Adverse Event|0|||
19514736|NCT01786668|41927186|FG001|Overall Study|Adverse Event|1|||
19514737|NCT01786668|41927187|FG002|Overall Study|Adverse Event|1|||
19514738|NCT01786668|41927188|FG003|Overall Study|Adverse Event|2|||
19514739|NCT01786668|41927185|FG000|Overall Study|Withdrawal by Subject|0|||
19514740|NCT01786668|41927186|FG001|Overall Study|Withdrawal by Subject|0|||
19514741|NCT01786668|41927187|FG002|Overall Study|Withdrawal by Subject|3|||
19618073|NCT00883896|42067553|FG003|Overall Study|Lost to Follow-up|2|||
19618074|NCT00883896|42067550|FG000|Overall Study|Withdrawal by Subject|5|||
19618075|NCT00883896|42067551|FG001|Overall Study|Withdrawal by Subject|0|||
19618076|NCT00883896|42067552|FG002|Overall Study|Withdrawal by Subject|1|||
19618077|NCT00883896|42067553|FG003|Overall Study|Withdrawal by Subject|3|||
19618078|NCT00883896|42067550|FG000|Overall Study|Lack of Efficacy|0|||
19618079|NCT00883896|42067551|FG001|Overall Study|Lack of Efficacy|0|||
19618080|NCT00883896|42067552|FG002|Overall Study|Lack of Efficacy|0|||
19618081|NCT00883896|42067553|FG003|Overall Study|Lack of Efficacy|2|||
19514742|NCT01786668|41927188|FG003|Overall Study|Withdrawal by Subject|1|||
19514743|NCT01786668|41927185|FG000|Overall Study|Pregnancy|0|||
19514744|NCT01786668|41927186|FG001|Overall Study|Pregnancy|0|||
19514745|NCT01786668|41927187|FG002|Overall Study|Pregnancy|0|||
19514746|NCT01786668|41927188|FG003|Overall Study|Pregnancy|1|||
19514747|NCT01786668|41927185|FG000|Overall Study|Lost to Follow-up|1|||
19514748|NCT01786668|41927186|FG001|Overall Study|Lost to Follow-up|0|||
19514749|NCT01786668|41927187|FG002|Overall Study|Lost to Follow-up|1|||
19514750|NCT01786668|41927188|FG003|Overall Study|Lost to Follow-up|0|||
19514751|NCT01786512|41927209|FG000|Overall Study|Lost to Follow-up|0|||
19514752|NCT01786512|41927210|FG001|Overall Study|Lost to Follow-up|0|||
19514753|NCT01786512|41927211|FG002|Overall Study|Lost to Follow-up|0|||
19514754|NCT01786512|41927212|FG003|Overall Study|Lost to Follow-up|0|||
19514755|NCT01786512|41927213|FG004|Overall Study|Lost to Follow-up|0|||
19514756|NCT01786512|41927214|FG005|Overall Study|Lost to Follow-up|0|||
19514757|NCT01786512|41927215|FG006|Overall Study|Lost to Follow-up|0|||
19514758|NCT01786512|41927216|FG007|Overall Study|Lost to Follow-up|0|||
19514759|NCT01786512|41927217|FG008|Overall Study|Lost to Follow-up|0|||
19514760|NCT01786512|41927218|FG009|Overall Study|Lost to Follow-up|1|||
19514761|NCT01786512|41927219|FG010|Overall Study|Lost to Follow-up|0|||
19514762|NCT01786512|41927209|FG000|Overall Study|Decision by sponsor|0|||
19514763|NCT01786512|41927210|FG001|Overall Study|Decision by sponsor|0|||
19514764|NCT01786512|41927211|FG002|Overall Study|Decision by sponsor|0|||
19514765|NCT01786512|41927212|FG003|Overall Study|Decision by sponsor|0|||
19514766|NCT01786512|41927213|FG004|Overall Study|Decision by sponsor|0|||
19514767|NCT01786512|41927214|FG005|Overall Study|Decision by sponsor|0|||
19514768|NCT01786512|41927215|FG006|Overall Study|Decision by sponsor|0|||
19514769|NCT01786512|41927216|FG007|Overall Study|Decision by sponsor|0|||
19514770|NCT01786512|41927217|FG008|Overall Study|Decision by sponsor|0|||
19514771|NCT01786512|41927218|FG009|Overall Study|Decision by sponsor|0|||
19514772|NCT01786512|41927219|FG010|Overall Study|Decision by sponsor|2|||
19514773|NCT01786512|41927209|FG000|Overall Study|Withdrawal by Subject|0|||
19514774|NCT01786512|41927210|FG001|Overall Study|Withdrawal by Subject|1|||
19514775|NCT01786512|41927211|FG002|Overall Study|Withdrawal by Subject|0|||
19514776|NCT01786512|41927212|FG003|Overall Study|Withdrawal by Subject|0|||
19514777|NCT01786512|41927213|FG004|Overall Study|Withdrawal by Subject|0|||
19514778|NCT01786512|41927214|FG005|Overall Study|Withdrawal by Subject|0|||
19514779|NCT01786512|41927215|FG006|Overall Study|Withdrawal by Subject|1|||
19514780|NCT01786512|41927216|FG007|Overall Study|Withdrawal by Subject|0|||
19514781|NCT01786512|41927217|FG008|Overall Study|Withdrawal by Subject|0|||
19514782|NCT01786512|41927218|FG009|Overall Study|Withdrawal by Subject|3|||
19514783|NCT01786512|41927219|FG010|Overall Study|Withdrawal by Subject|7|||
19514784|NCT01786512|41927209|FG000|Overall Study|Death|0|||
19514785|NCT01786512|41927210|FG001|Overall Study|Death|0|||
19514786|NCT01786512|41927211|FG002|Overall Study|Death|0|||
19514787|NCT01786512|41927212|FG003|Overall Study|Death|0|||
19514788|NCT01786512|41927213|FG004|Overall Study|Death|0|||
19514789|NCT01786512|41927214|FG005|Overall Study|Death|0|||
19514790|NCT01786512|41927215|FG006|Overall Study|Death|0|||
19514791|NCT01786512|41927216|FG007|Overall Study|Death|0|||
19514792|NCT01786512|41927217|FG008|Overall Study|Death|4|||
19514793|NCT01786512|41927218|FG009|Overall Study|Death|1|||
19514794|NCT01786512|41927219|FG010|Overall Study|Death|3|||
19514795|NCT01772160|41927251|FG000|Overall Study|Death|3|||
19514796|NCT01772160|41927251|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
19514797|NCT01772160|41927251|FG000|Overall Study|Consent withdrawal|3|||
19514798|NCT01772160|41927251|FG000|Overall Study|Migrated / moved from the study area|4|||
19514799|NCT01772160|41927251|FG000|Overall Study|Lost to Follow-up|30|||
19514800|NCT01772160|41927251|FG000|Overall Study|Other|5|||
19514801|NCT01770912|41927257|FG000|Overall Study|Lost to Follow-up|2|||
19514802|NCT01770912|41927258|FG001|Overall Study|Lost to Follow-up|0|||
19618082|NCT00883896|42067550|FG000|Overall Study|Other|1|||
19618083|NCT00883896|42067551|FG001|Overall Study|Other|0|||
19618084|NCT00883896|42067552|FG002|Overall Study|Other|0|||
19618085|NCT00883896|42067553|FG003|Overall Study|Other|0|||
19618086|NCT03920293|42067565|FG000|Overall Study|Withdrawal by Subject|2|||
19618087|NCT03920293|42067566|FG001|Overall Study|Withdrawal by Subject|1|||
19514803|NCT01811706|41927264|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
19618088|NCT03920293|42067565|FG000|Overall Study|Physician Decision|1|||
19514804|NCT01811706|41927265|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
19514805|NCT01811472|41927276|FG000|Overall Study|Adverse Event|1|||
19514806|NCT01811472|41927277|FG001|Overall Study|Adverse Event|0|||
19514807|NCT01811472|41927278|FG002|Overall Study|Adverse Event|4|||
19514808|NCT01811472|41927276|FG000|Overall Study|Lost to Follow-up|0|||
19514809|NCT01811472|41927277|FG001|Overall Study|Lost to Follow-up|0|||
19514810|NCT01811472|41927278|FG002|Overall Study|Lost to Follow-up|1|||
19514811|NCT01811472|41927276|FG000|Overall Study|Subject/guardian decision|1|||
19514812|NCT01811472|41927277|FG001|Overall Study|Subject/guardian decision|0|||
19514813|NCT01811472|41927278|FG002|Overall Study|Subject/guardian decision|0|||
19618089|NCT03920293|42067566|FG001|Overall Study|Physician Decision|2|||
19514814|NCT01811238|41927287|FG000|Overall Study|Withdrawal by Subject|42|||
19514815|NCT01811238|41927287|FG000|Overall Study|Adverse Event|25|||
19514816|NCT01811238|41927287|FG000|Overall Study|Protocol Violation|4|||
19514817|NCT01811238|41927287|FG000|Overall Study|Lack of Efficacy|4|||
19514818|NCT01811238|41927287|FG000|Overall Study|subject refused study medication|6|||
19514819|NCT01769508|41927292|FG000|Overall Study|Death|3|||
19514820|NCT01769508|41927292|FG000|Overall Study|Withdrawal by Subject|1|||
19514821|NCT01769508|41927292|FG000|Overall Study|Adverse Event|1|||
19514822|NCT01769508|41927292|FG000|Overall Study|Lost to Follow-up|1|||
19514823|NCT01810380|41927299|FG000|Overall Study|Randomised not treated|2|||
19514824|NCT01810380|41927300|FG001|Overall Study|Randomised not treated|1|||
19514825|NCT01810380|41927301|FG002|Overall Study|Randomised not treated|1|||
19514826|NCT01810380|41927299|FG000|Overall Study|Adverse Event|11|||
19514827|NCT01810380|41927300|FG001|Overall Study|Adverse Event|14|||
19514828|NCT01810380|41927301|FG002|Overall Study|Adverse Event|4|||
19514829|NCT01810380|41927299|FG000|Overall Study|Lack of Efficacy|24|||
19514830|NCT01810380|41927300|FG001|Overall Study|Lack of Efficacy|10|||
19514831|NCT01810380|41927301|FG002|Overall Study|Lack of Efficacy|11|||
19514832|NCT01810380|41927299|FG000|Overall Study|Protocol Violation|1|||
19514833|NCT01810380|41927300|FG001|Overall Study|Protocol Violation|0|||
19514834|NCT01810380|41927301|FG002|Overall Study|Protocol Violation|1|||
19514835|NCT01810380|41927299|FG000|Overall Study|Withdrawal by Subject|6|||
19514836|NCT01810380|41927300|FG001|Overall Study|Withdrawal by Subject|0|||
19514837|NCT01810380|41927301|FG002|Overall Study|Withdrawal by Subject|6|||
19514838|NCT01810380|41927299|FG000|Overall Study|Administrative or other reasons|11|||
19514839|NCT01810380|41927300|FG001|Overall Study|Administrative or other reasons|13|||
19514840|NCT01810380|41927301|FG002|Overall Study|Administrative or other reasons|9|||
19514841|NCT01769196|41927311|FG000|Overall Study|Adverse Event|24|||
19514842|NCT01769196|41927312|FG001|Overall Study|Adverse Event|20|||
19514843|NCT01769196|41927311|FG000|Overall Study|Death|21|||
19514844|NCT01769196|41927312|FG001|Overall Study|Death|26|||
19514845|NCT01769196|41927311|FG000|Overall Study|Investigator Discretion|7|||
19514846|NCT01769196|41927312|FG001|Overall Study|Investigator Discretion|3|||
19514847|NCT01769196|41927311|FG000|Overall Study|Lack of Efficacy|3|||
19514848|NCT01769196|41927312|FG001|Overall Study|Lack of Efficacy|2|||
19514849|NCT01769196|41927311|FG000|Overall Study|Progressive disease|11|||
19514850|NCT01769196|41927312|FG001|Overall Study|Progressive disease|6|||
19514851|NCT01769196|41927311|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
19514852|NCT01769196|41927312|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
19514853|NCT01769196|41927311|FG000|Overall Study|Protocol Violation|0|||
19514854|NCT01769196|41927312|FG001|Overall Study|Protocol Violation|3|||
19514855|NCT01769196|41927311|FG000|Overall Study|Study terminated by sponsor|160|||
19514856|NCT01769196|41927312|FG001|Overall Study|Study terminated by sponsor|161|||
19514857|NCT01769196|41927311|FG000|Overall Study|Participant never dosed with study drug|1|||
19514858|NCT01769196|41927312|FG001|Overall Study|Participant never dosed with study drug|0|||
19514859|NCT01769196|41927311|FG000|Overall Study|Withdrew consent|36|||
19514860|NCT01769196|41927312|FG001|Overall Study|Withdrew consent|40|||
19514861|NCT01810302|41927320|FG000|Overall Study|Death|1|||
19514862|NCT01810302|41927321|FG001|Overall Study|Death|0|||
19514863|NCT01810302|41927320|FG000|Overall Study|Physician Decision|0|||
19514864|NCT01810302|41927321|FG001|Overall Study|Physician Decision|1|||
19514865|NCT01783938|41927329|FG000|Overall Study|Disease Progression|18|||
19514866|NCT01783938|41927330|FG001|Overall Study|Disease Progression|41|||
19514867|NCT01783938|41927329|FG000|Overall Study|Study Drug Toxicity|27|||
19514868|NCT01783938|41927330|FG001|Overall Study|Study Drug Toxicity|14|||
19514869|NCT01783938|41927329|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
19514870|NCT01783938|41927330|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
19514871|NCT01783938|41927329|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
19514872|NCT01783938|41927330|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
19514873|NCT01783938|41927329|FG000|Overall Study|Participant Withdrew Consent|2|||
19514874|NCT01783938|41927330|FG001|Overall Study|Participant Withdrew Consent|0|||
19514875|NCT01783938|41927329|FG000|Overall Study|Maximum Clinical Benefit|1|||
19514876|NCT01783938|41927330|FG001|Overall Study|Maximum Clinical Benefit|0|||
19514877|NCT01783938|41927329|FG000|Overall Study|Other Reasons|3|||
19514878|NCT01783938|41927330|FG001|Overall Study|Other Reasons|1|||
19514879|NCT01768572|41927339|FG000|Overall Study|Adverse Event|7|||
19514880|NCT01768572|41927340|FG001|Overall Study|Adverse Event|8|||
19514881|NCT01768572|41927341|FG002|Overall Study|Adverse Event|4|||
19514882|NCT01768572|41927339|FG000|Overall Study|Lack of Efficacy|1|||
19514883|NCT01768572|41927340|FG001|Overall Study|Lack of Efficacy|3|||
19514884|NCT01768572|41927341|FG002|Overall Study|Lack of Efficacy|1|||
19514885|NCT01768572|41927339|FG000|Overall Study|Other, Not due to an adverse event|1|||
19514886|NCT01768572|41927340|FG001|Overall Study|Other, Not due to an adverse event|1|||
19514887|NCT01768572|41927341|FG002|Overall Study|Other, Not due to an adverse event|1|||
19514888|NCT01783548|41927351|FG000|Overall Study|Adverse Event|8|||
19514889|NCT01783548|41927352|FG001|Overall Study|Adverse Event|4|||
19514890|NCT01783548|41927351|FG000|Overall Study|Withdrawal by Subject|11|||
19514891|NCT01783548|41927352|FG001|Overall Study|Withdrawal by Subject|8|||
19514892|NCT01783548|41927351|FG000|Overall Study|Non-compliance|4|||
19514893|NCT01783548|41927352|FG001|Overall Study|Non-compliance|0|||
19514894|NCT01783548|41927351|FG000|Overall Study|Protocol Violation|2|||
19514895|NCT01783548|41927352|FG001|Overall Study|Protocol Violation|2|||
19514896|NCT01783548|41927351|FG000|Overall Study|Lost to Follow-up|8|||
19514897|NCT01783548|41927352|FG001|Overall Study|Lost to Follow-up|3|||
19514898|NCT01783548|41927351|FG000|Overall Study|Lack of Efficacy|1|||
19514899|NCT01783548|41927352|FG001|Overall Study|Lack of Efficacy|1|||
19514900|NCT01809210|41927365|FG000|Overall Study|Withdrawal by Subject|0|||
19514901|NCT01809210|41927366|FG001|Overall Study|Withdrawal by Subject|0|||
19514902|NCT01809210|41927367|FG002|Overall Study|Withdrawal by Subject|1|||
19514903|NCT01809210|41927368|FG003|Overall Study|Withdrawal by Subject|1|||
19514904|NCT01809210|41927369|FG004|Overall Study|Withdrawal by Subject|1|||
19514905|NCT01809210|41927370|FG005|Overall Study|Withdrawal by Subject|0|||
19618090|NCT03920293|42067565|FG000|Overall Study|Adverse Event|0|||
19618091|NCT03920293|42067566|FG001|Overall Study|Adverse Event|2|||
19618092|NCT03920293|42067565|FG000|Overall Study|Sponsor Decision|0|||
19618093|NCT03920293|42067566|FG001|Overall Study|Sponsor Decision|1|||
19618094|NCT03920293|42067565|FG000|Overall Study|Death|2|||
19618095|NCT03920293|42067566|FG001|Overall Study|Death|0|||
19618096|NCT03920293|42067565|FG000|Overall Study|Protocol Violation|1|||
19618097|NCT03920293|42067566|FG001|Overall Study|Protocol Violation|0|||
19514906|NCT01809210|41927371|FG006|Overall Study|Withdrawal by Subject|4|||
19514907|NCT01809210|41927365|FG000|Overall Study|Death|1|||
19514908|NCT01809210|41927366|FG001|Overall Study|Death|1|||
19514909|NCT01809210|41927367|FG002|Overall Study|Death|2|||
19514910|NCT01809210|41927368|FG003|Overall Study|Death|0|||
19514911|NCT01809210|41927369|FG004|Overall Study|Death|1|||
19514912|NCT01809210|41927370|FG005|Overall Study|Death|3|||
19514913|NCT01809210|41927371|FG006|Overall Study|Death|1|||
19514914|NCT01809132|41927390|FG000|Overall Study|Withdrawal by Subject|0|||
19514915|NCT01809132|41927391|FG001|Overall Study|Withdrawal by Subject|0|||
19514916|NCT01809132|41927392|FG002|Overall Study|Withdrawal by Subject|1|||
19514917|NCT01808508|41927403|FG000|Overall Study|Lost to Follow-up|1|||
19514918|NCT01808508|41927404|FG001|Overall Study|Lost to Follow-up|0|||
19514919|NCT01808508|41927405|FG002|Overall Study|Lost to Follow-up|0|||
19514920|NCT01766778|41927415|FG000|Overall Study|Adverse Event|4|||
19514921|NCT01766778|41927416|FG001|Overall Study|Adverse Event|4|||
19514922|NCT01766778|41927415|FG000|Overall Study|Withdrawal by Subject|1|||
19514923|NCT01766778|41927416|FG001|Overall Study|Withdrawal by Subject|0|||
19514924|NCT01808196|41927422|FG000|Overall Study|Lost to Follow-up|1|||
19514925|NCT01808118|41927426|FG000|Period 1|Adverse Event|15|||
19514926|NCT01808118|41927427|FG001|Period 1|Adverse Event|0|||
19514927|NCT01808118|41927428|FG002|Period 1|Adverse Event|0|||
19514928|NCT01808118|41927426|FG000|Period 1|Withdrew consent|24|||
19514929|NCT01808118|41927427|FG001|Period 1|Withdrew consent|0|||
19514930|NCT01808118|41927428|FG002|Period 1|Withdrew consent|0|||
19514931|NCT01808118|41927426|FG000|Period 1|Lost to Follow-up|9|||
19514932|NCT01808118|41927427|FG001|Period 1|Lost to Follow-up|0|||
19514933|NCT01808118|41927428|FG002|Period 1|Lost to Follow-up|0|||
19514934|NCT01808118|41927426|FG000|Period 1|Did not meet criteria for remission|303|||
19514935|NCT01808118|41927427|FG001|Period 1|Did not meet criteria for remission|0|||
19514936|NCT01808118|41927428|FG002|Period 1|Did not meet criteria for remission|0|||
19514937|NCT01808118|41927426|FG000|Period 1|Enrolled in error|7|||
19514938|NCT01808118|41927427|FG001|Period 1|Enrolled in error|0|||
19514939|NCT01808118|41927428|FG002|Period 1|Enrolled in error|0|||
19514940|NCT01808118|41927426|FG000|Period 1|Did not meet inclusion criteria|3|||
19514941|NCT01808118|41927427|FG001|Period 1|Did not meet inclusion criteria|0|||
19514942|NCT01808118|41927428|FG002|Period 1|Did not meet inclusion criteria|0|||
19514943|NCT01808118|41927426|FG000|Period 1|Non-conformance with inclusion criteria|3|||
19514944|NCT01808118|41927427|FG001|Period 1|Non-conformance with inclusion criteria|0|||
19514945|NCT01808118|41927428|FG002|Period 1|Non-conformance with inclusion criteria|0|||
19514946|NCT01808118|41927426|FG000|Period 1|Investigator decision: site closure|2|||
19514947|NCT01808118|41927427|FG001|Period 1|Investigator decision: site closure|0|||
19514948|NCT01808118|41927428|FG002|Period 1|Investigator decision: site closure|0|||
19514949|NCT01808118|41927426|FG000|Period 1|Non-compliance per sponsor|1|||
19514950|NCT01808118|41927427|FG001|Period 1|Non-compliance per sponsor|0|||
19514951|NCT01808118|41927428|FG002|Period 1|Non-compliance per sponsor|0|||
19514952|NCT01808118|41927426|FG000|Period 1|Lack of Efficacy|1|||
19618098|NCT03920293|42067565|FG000|Overall Study|Noncompliance|1|||
19618099|NCT03920293|42067566|FG001|Overall Study|Noncompliance|0|||
19618100|NCT00867009|42067572|FG000|Induction Period|Nonserious Adverse Event|5|||
19514953|NCT01808118|41927427|FG001|Period 1|Lack of Efficacy|0|||
19514954|NCT01808118|41927428|FG002|Period 1|Lack of Efficacy|0|||
19514955|NCT01808118|41927426|FG000|Period 2|Adverse Event|0|||
19514956|NCT01808118|41927427|FG001|Period 2|Adverse Event|4|||
19514957|NCT01808118|41927428|FG002|Period 2|Adverse Event|0|||
19514958|NCT01808118|41927426|FG000|Period 2|Withdrew consent|0|||
19618101|NCT00867009|42067572|FG000|Induction Period|Serious Adverse Event|10|||
19618102|NCT00867009|42067572|FG000|Induction Period|Death due to serious adverse event|6|||
19618103|NCT00867009|42067572|FG000|Induction Period|Death due to Study Disease|4|||
19618104|NCT00867009|42067572|FG000|Induction Period|Protocol Violation|1|||
19618105|NCT00867009|42067572|FG000|Induction Period|Withdrawal by Subject|8|||
19618106|NCT00867009|42067572|FG000|Induction Period|Physician Decision|3|||
19514959|NCT01808118|41927427|FG001|Period 2|Withdrew consent|7|||
19514960|NCT01808118|41927428|FG002|Period 2|Withdrew consent|6|||
19514961|NCT01808118|41927426|FG000|Period 2|Lost to Follow-up|0|||
19514962|NCT01808118|41927427|FG001|Period 2|Lost to Follow-up|0|||
19514963|NCT01808118|41927428|FG002|Period 2|Lost to Follow-up|2|||
19514964|NCT01808118|41927426|FG000|Period 2|Investigator no longer conducting trials|0|||
19514965|NCT01808118|41927427|FG001|Period 2|Investigator no longer conducting trials|1|||
19514966|NCT01808118|41927428|FG002|Period 2|Investigator no longer conducting trials|0|||
19514967|NCT01808118|41927426|FG000|Period 2|Switched to other therapy|0|||
19514968|NCT01808118|41927427|FG001|Period 2|Switched to other therapy|1|||
19514969|NCT01808118|41927428|FG002|Period 2|Switched to other therapy|0|||
19514970|NCT01807650|41927442|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
19514971|NCT01807650|41927442|FG000|Overall Study|Adverse Event|5|||
19514972|NCT01807650|41927442|FG000|Overall Study|Other|2|||
19514973|NCT01782690|41927483|FG000|Overall Study|Not reported|7|||
19514974|NCT01782690|41927483|FG000|Overall Study|Toxicity of gemcitabine|1|||
19514975|NCT01782690|41927483|FG000|Overall Study|Toxicity of erlotinib|1|||
19514976|NCT01782690|41927483|FG000|Overall Study|Lost to Follow-up|31|||
19514977|NCT01782690|41927483|FG000|Overall Study|Withdrawal of informed consent|2|||
19514978|NCT01782690|41927483|FG000|Overall Study|Absent rash|9|||
19514979|NCT01782690|41927483|FG000|Overall Study|Physician Decision|13|||
19514980|NCT01782690|41927483|FG000|Overall Study|Patient's wish|21|||
19514981|NCT01782690|41927483|FG000|Overall Study|Tumor progression|74|||
19618107|NCT00867009|42067572|FG000|Induction Period|Progressive Disease (PD)|25|||
19618108|NCT00867009|42067572|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
19618109|NCT00601250|42067578|FG000|Overall Study|Adverse Event|3|||
19618110|NCT00601250|42067579|FG001|Overall Study|Adverse Event|9|||
19618111|NCT00601250|42067578|FG000|Overall Study|Protocol Violation|3|||
19618112|NCT00601250|42067579|FG001|Overall Study|Protocol Violation|2|||
19618113|NCT00601250|42067578|FG000|Overall Study|Lost to Follow-up|2|||
19618114|NCT00601250|42067579|FG001|Overall Study|Lost to Follow-up|6|||
19618115|NCT00601250|42067578|FG000|Overall Study|Withdrawal by Subject|4|||
19618116|NCT00601250|42067579|FG001|Overall Study|Withdrawal by Subject|13|||
19618117|NCT00601250|42067578|FG000|Overall Study|Other incl. lack of efficacy|2|||
19618118|NCT00601250|42067579|FG001|Overall Study|Other incl. lack of efficacy|9|||
19618119|NCT00866775|42067587|FG000|Overall Study|Adverse Event|5|||
19514982|NCT01782690|41927483|FG000|Overall Study|Death|133|||
19514983|NCT01782690|41927483|FG000|Overall Study|Study completion unknown|7|||
19514984|NCT01782378|41927489|FG000|First Series|Lost to Follow-up|7|||
19514985|NCT01782378|41927490|FG001|First Series|Lost to Follow-up|8|||
19514986|NCT01782378|41927489|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
19514987|NCT01782378|41927490|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
19514988|NCT01782378|41927489|FG000|Second Series|Lost to Follow-up|8|||
19514989|NCT01782378|41927490|FG001|Second Series|Lost to Follow-up|7|||
19514990|NCT01782378|41927489|FG000|Second Series|Did not choose to complete S2 Optional|18|||
19514991|NCT01782378|41927490|FG001|Second Series|Did not choose to complete S2 Optional|0|||
19514992|NCT01766310|41927498|FG000|Overall Study|Lost to Follow-up|1|||
19514993|NCT01766310|41927499|FG001|Overall Study|Lost to Follow-up|3|||
19514994|NCT01765920|41927507|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
19514995|NCT01765920|41927508|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
19514996|NCT01765920|41927507|FG000|Overall Study|Patient code disclosure|0|||
19514997|NCT01765920|41927508|FG001|Overall Study|Patient code disclosure|1|||
19514998|NCT01782222|41927517|FG000|Overall Study|Adverse Event|4|||
19514999|NCT01782222|41927518|FG001|Overall Study|Adverse Event|5|||
19515000|NCT01782222|41927519|FG002|Overall Study|Adverse Event|3|||
19515001|NCT01782222|41927517|FG000|Overall Study|Lack of Efficacy|2|||
19515002|NCT01782222|41927518|FG001|Overall Study|Lack of Efficacy|1|||
19515003|NCT01782222|41927519|FG002|Overall Study|Lack of Efficacy|0|||
19515004|NCT01782222|41927517|FG000|Overall Study|Protocol Violation|1|||
19515005|NCT01782222|41927518|FG001|Overall Study|Protocol Violation|0|||
19515006|NCT01782222|41927519|FG002|Overall Study|Protocol Violation|0|||
19515007|NCT01782222|41927517|FG000|Overall Study|Withdrawal by Subject|1|||
19515008|NCT01782222|41927518|FG001|Overall Study|Withdrawal by Subject|4|||
19515009|NCT01782222|41927519|FG002|Overall Study|Withdrawal by Subject|1|||
19515010|NCT01782222|41927517|FG000|Overall Study|Moved to other state|0|||
19515011|NCT01782222|41927518|FG001|Overall Study|Moved to other state|1|||
19515012|NCT01782222|41927519|FG002|Overall Study|Moved to other state|0|||
19618120|NCT00866775|42067588|FG001|Overall Study|Adverse Event|19|||
19618121|NCT00866775|42067587|FG000|Overall Study|Death|1|||
19618122|NCT00866775|42067588|FG001|Overall Study|Death|0|||
19515013|NCT01781832|41927527|FG000|Overall Study|Withdrawal by Subject|1|||
19618123|NCT00866775|42067587|FG000|Overall Study|Lost to Follow-up|0|||
19515014|NCT01807182|41927531|FG000|Overall Study|Death|1|||
19515015|NCT01807182|41927531|FG000|Overall Study|New therapy|1|||
19515016|NCT01807182|41927531|FG000|Overall Study|Moved to hospice care|1|||
19515017|NCT01806714|41927537|FG000|Overall Study|No functioning phone number|200|||
19515018|NCT01806714|41927538|FG001|Overall Study|No functioning phone number|170|||
19515019|NCT01765764|41927547|FG000|Treatment Period|Adverse Event|1|||
19515020|NCT01765764|41927548|FG001|Treatment Period|Adverse Event|2|||
19515021|NCT01765764|41927549|FG002|Treatment Period|Adverse Event|1|||
19515022|NCT01765764|41927547|FG000|Treatment Period|Lost to Follow-up|0|||
19515023|NCT01765764|41927548|FG001|Treatment Period|Lost to Follow-up|3|||
19515024|NCT01765764|41927549|FG002|Treatment Period|Lost to Follow-up|2|||
19515025|NCT01765764|41927547|FG000|Treatment Period|Personal Reasons|1|||
19515026|NCT01765764|41927548|FG001|Treatment Period|Personal Reasons|2|||
19515027|NCT01765764|41927549|FG002|Treatment Period|Personal Reasons|1|||
19515028|NCT01765764|41927547|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
19515029|NCT01765764|41927548|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
19515030|NCT01765764|41927549|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
19515031|NCT01806168|41927560|FG000|Overall Study|Adverse Event|1|||
19515032|NCT01806168|41927561|FG001|Overall Study|Adverse Event|0|||
19515033|NCT01806168|41927562|FG002|Overall Study|Adverse Event|0|||
19515034|NCT01806168|41927560|FG000|Overall Study|Withdrawal by Subject|0|||
19515035|NCT01806168|41927561|FG001|Overall Study|Withdrawal by Subject|1|||
19515036|NCT01806168|41927562|FG002|Overall Study|Withdrawal by Subject|2|||
19515037|NCT01806168|41927560|FG000|Overall Study|Protocol Violation|0|||
19515038|NCT01806168|41927561|FG001|Overall Study|Protocol Violation|0|||
19515039|NCT01806168|41927562|FG002|Overall Study|Protocol Violation|1|||
19515040|NCT01804842|41927576|FG000|Overall Study|Adverse Event|1|||
19515041|NCT01804842|41927577|FG001|Overall Study|Adverse Event|1|||
19515042|NCT01804842|41927578|FG002|Overall Study|Adverse Event|0|||
19515043|NCT01804842|41927576|FG000|Overall Study|Lost to Follow-up|1|||
19515044|NCT01804842|41927577|FG001|Overall Study|Lost to Follow-up|0|||
19515045|NCT01804842|41927578|FG002|Overall Study|Lost to Follow-up|0|||
19515046|NCT01804842|41927576|FG000|Overall Study|Non-Compliance|1|||
19515047|NCT01804842|41927577|FG001|Overall Study|Non-Compliance|1|||
19515048|NCT01804842|41927578|FG002|Overall Study|Non-Compliance|0|||
19515049|NCT01804842|41927576|FG000|Overall Study|Personal Reason|0|||
19515050|NCT01804842|41927577|FG001|Overall Study|Personal Reason|0|||
19515051|NCT01804842|41927578|FG002|Overall Study|Personal Reason|1|||
19515052|NCT01781286|41927586|FG000|Overall Study|Lost to Follow-up|0|||
19515053|NCT01781286|41927587|FG001|Overall Study|Lost to Follow-up|0|||
19515054|NCT01781286|41927588|FG002|Overall Study|Lost to Follow-up|0|||
19515055|NCT01781286|41927589|FG003|Overall Study|Lost to Follow-up|0|||
19515056|NCT01781286|41927590|FG004|Overall Study|Lost to Follow-up|0|||
19618124|NCT00866775|42067588|FG001|Overall Study|Lost to Follow-up|4|||
19618125|NCT00866775|42067587|FG000|Overall Study|Physician Decision|0|||
19618126|NCT00866775|42067588|FG001|Overall Study|Physician Decision|3|||
19618127|NCT00866775|42067587|FG000|Overall Study|Protocol Violation|3|||
19618128|NCT00866775|42067588|FG001|Overall Study|Protocol Violation|4|||
19618129|NCT00866775|42067587|FG000|Overall Study|Withdrawal by Subject|4|||
19618130|NCT00866775|42067588|FG001|Overall Study|Withdrawal by Subject|4|||
19618131|NCT00866775|42067587|FG000|Overall Study|met exit criteria|23|||
19618132|NCT00866775|42067588|FG001|Overall Study|met exit criteria|17|||
19618133|NCT00866775|42067587|FG000|Overall Study|discontinued due to communication error|0|||
19618134|NCT00866775|42067588|FG001|Overall Study|discontinued due to communication error|1|||
19618135|NCT03265210|42067598|FG000|Overall Study|Withdrawal by Subject|7|||
19618136|NCT03265210|42067599|FG001|Overall Study|Withdrawal by Subject|9|||
19618137|NCT03265210|42067598|FG000|Overall Study|Lost to Follow-up|2|||
19618138|NCT03265210|42067599|FG001|Overall Study|Lost to Follow-up|0|||
19618139|NCT03265210|42067598|FG000|Overall Study|Physician Decision|2|||
19618140|NCT03265210|42067599|FG001|Overall Study|Physician Decision|0|||
19618141|NCT03265210|42067598|FG000|Overall Study|Adverse Event|1|||
19618142|NCT03265210|42067599|FG001|Overall Study|Adverse Event|0|||
19618143|NCT00543985|42067605|FG000|Overall Study|Withdrawal by Subject|4|||
19618144|NCT00582556|42067620|FG000|Overall Study|Withdrawal by Subject|0|||
19618145|NCT00582556|42067621|FG001|Overall Study|Withdrawal by Subject|1|||
19618146|NCT00582556|42067622|FG002|Overall Study|Withdrawal by Subject|1|||
19618147|NCT00582556|42067620|FG000|Overall Study|Physician Decision|0|||
19618148|NCT00582556|42067621|FG001|Overall Study|Physician Decision|0|||
19618149|NCT00582556|42067622|FG002|Overall Study|Physician Decision|1|||
19618150|NCT00542269|42067634|FG000|Overall Study|Adverse Event|10|||
19618151|NCT00542269|42067635|FG001|Overall Study|Adverse Event|4|||
19704782|NCT03725722|42149127|FG003|Overall Study|Adverse Event|0|||
19618152|NCT00542269|42067636|FG002|Overall Study|Adverse Event|5|||
19618153|NCT00542269|42067634|FG000|Overall Study|Protocol Violation|1|||
19515057|NCT01781286|41927591|FG005|Overall Study|Lost to Follow-up|1|||
19515058|NCT01781286|41927586|FG000|Overall Study|Time Constraints|2|||
19515059|NCT01781286|41927587|FG001|Overall Study|Time Constraints|0|||
19618154|NCT00542269|42067635|FG001|Overall Study|Protocol Violation|1|||
19515060|NCT01781286|41927588|FG002|Overall Study|Time Constraints|2|||
19515061|NCT01781286|41927589|FG003|Overall Study|Time Constraints|0|||
19515062|NCT01781286|41927590|FG004|Overall Study|Time Constraints|0|||
19515063|NCT01781286|41927591|FG005|Overall Study|Time Constraints|0|||
19515064|NCT01781286|41927586|FG000|Overall Study|Noncompliance|0|||
19515065|NCT01781286|41927587|FG001|Overall Study|Noncompliance|0|||
19515066|NCT01781286|41927588|FG002|Overall Study|Noncompliance|0|||
19515067|NCT01781286|41927589|FG003|Overall Study|Noncompliance|1|||
19515068|NCT01781286|41927590|FG004|Overall Study|Noncompliance|0|||
19515069|NCT01781286|41927591|FG005|Overall Study|Noncompliance|0|||
19515070|NCT01780974|41927603|FG000|Overall Study|Death|1|||
19515071|NCT01780974|41927604|FG001|Overall Study|Death|0|||
19515072|NCT01780974|41927603|FG000|Overall Study|Adverse Event|1|||
19515073|NCT01780974|41927604|FG001|Overall Study|Adverse Event|3|||
19515074|NCT01780662|41927613|FG000|Overall Study|Adverse Event|1|||
19515075|NCT01780662|41927614|FG001|Overall Study|Adverse Event|0|||
19515076|NCT01780662|41927615|FG002|Overall Study|Adverse Event|2|||
19515077|NCT01780662|41927613|FG000|Overall Study|Physician Decision|0|||
19515078|NCT01780662|41927614|FG001|Overall Study|Physician Decision|5|||
19515079|NCT01780662|41927615|FG002|Overall Study|Physician Decision|7|||
19515080|NCT01780662|41927613|FG000|Overall Study|Protocol Violation|0|||
19515081|NCT01780662|41927614|FG001|Overall Study|Protocol Violation|1|||
19515082|NCT01780662|41927615|FG002|Overall Study|Protocol Violation|0|||
19515083|NCT01780662|41927613|FG000|Overall Study|Ineligible|0|||
19515084|NCT01780662|41927614|FG001|Overall Study|Ineligible|0|||
19515085|NCT01780662|41927615|FG002|Overall Study|Ineligible|1|||
19515086|NCT01780584|41927627|FG000|Overall Study|Death|1|||
19515087|NCT01780584|41927628|FG001|Overall Study|Death|0|||
19515088|NCT01780584|41927629|FG002|Overall Study|Death|1|||
19515089|NCT01780584|41927627|FG000|Overall Study|Adverse Event|0|||
19515090|NCT01780584|41927628|FG001|Overall Study|Adverse Event|1|||
19515091|NCT01780584|41927629|FG002|Overall Study|Adverse Event|0|||
19515092|NCT01780584|41927627|FG000|Overall Study|Protocol Violation|0|||
19515093|NCT01780584|41927628|FG001|Overall Study|Protocol Violation|0|||
19515094|NCT01780584|41927629|FG002|Overall Study|Protocol Violation|1|||
19515095|NCT01780506|41927639|FG000|Double-Blind Phase|Randomized but not Treated|3|||
19515096|NCT01780506|41927640|FG001|Double-Blind Phase|Randomized but not Treated|2|||
19515097|NCT01780506|41927639|FG000|Double-Blind Phase|Adverse Event|4|||
19515098|NCT01780506|41927640|FG001|Double-Blind Phase|Adverse Event|14|||
19515099|NCT01780506|41927639|FG000|Double-Blind Phase|Death|1|||
19515100|NCT01780506|41927640|FG001|Double-Blind Phase|Death|2|||
19515101|NCT01780506|41927639|FG000|Double-Blind Phase|Pregnancy|2|||
19618155|NCT00542269|42067636|FG002|Overall Study|Protocol Violation|0|||
19618156|NCT00542269|42067634|FG000|Overall Study|Withdrawal by Subject|1|||
19618157|NCT00542269|42067635|FG001|Overall Study|Withdrawal by Subject|0|||
19618158|NCT00542269|42067636|FG002|Overall Study|Withdrawal by Subject|0|||
19618159|NCT00542269|42067634|FG000|Overall Study|Administrative problems|1|||
19618160|NCT00542269|42067635|FG001|Overall Study|Administrative problems|1|||
19618161|NCT00542269|42067636|FG002|Overall Study|Administrative problems|1|||
19618162|NCT00866697|42067648|FG000|Overall Study|Study closed/terminated|156|||
19618163|NCT00866697|42067649|FG001|Overall Study|Study closed/terminated|138|||
19618164|NCT00866697|42067648|FG000|Overall Study|Lost to Follow-up|22|||
19618165|NCT00866697|42067649|FG001|Overall Study|Lost to Follow-up|28|||
19618166|NCT00866697|42067648|FG000|Overall Study|Physician Decision|3|||
19618167|NCT00866697|42067649|FG001|Overall Study|Physician Decision|5|||
19618168|NCT00866697|42067648|FG000|Overall Study|Withdrawal by Subject|33|||
19618169|NCT00866697|42067649|FG001|Overall Study|Withdrawal by Subject|57|||
19618170|NCT00542191|42067655|FG000|Overall Study|Death|3|||
19618171|NCT00600938|42067661|FG000|Core Study|Abnormal test procedure result(s)|3|||
19618172|NCT00600938|42067662|FG001|Core Study|Abnormal test procedure result(s)|2|||
19618173|NCT00600938|42067663|FG002|Core Study|Abnormal test procedure result(s)|0|||
19618174|NCT00600938|42067664|FG003|Core Study|Abnormal test procedure result(s)|0|||
19618175|NCT00600938|42067661|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
19618176|NCT00600938|42067662|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
19618177|NCT00600938|42067663|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
19618178|NCT00600938|42067664|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
19618179|NCT00600938|42067661|FG000|Core Study|Patient withdrew consent|7|||
19618180|NCT00600938|42067662|FG001|Core Study|Patient withdrew consent|12|||
19618181|NCT00600938|42067663|FG002|Core Study|Patient withdrew consent|0|||
19618182|NCT00600938|42067664|FG003|Core Study|Patient withdrew consent|0|||
19618183|NCT00600938|42067661|FG000|Core Study|Lost to Follow-up|3|||
19704783|NCT03725722|42149128|FG004|Overall Study|Adverse Event|6|||
19704784|NCT03725722|42149124|FG000|Overall Study|Withdrawal by Subject|4|||
19515102|NCT01780506|41927640|FG001|Double-Blind Phase|Pregnancy|1|||
19515103|NCT01780506|41927639|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19515104|NCT01780506|41927640|FG001|Double-Blind Phase|Lack of Efficacy|1|||
19515105|NCT01780506|41927639|FG000|Double-Blind Phase|Investigator's Discretion|5|||
19515106|NCT01780506|41927640|FG001|Double-Blind Phase|Investigator's Discretion|2|||
19618184|NCT00600938|42067662|FG001|Core Study|Lost to Follow-up|2|||
19515107|NCT01780506|41927639|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
19515108|NCT01780506|41927640|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
19515109|NCT01780506|41927639|FG000|Double-Blind Phase|Protocol Violation|4|||
19515110|NCT01780506|41927640|FG001|Double-Blind Phase|Protocol Violation|3|||
19515111|NCT01780506|41927639|FG000|Double-Blind Phase|Withdrew Consent|23|||
19515112|NCT01780506|41927640|FG001|Double-Blind Phase|Withdrew Consent|24|||
19515113|NCT01780506|41927639|FG000|Double-Blind Phase|Lost to Follow-up|23|||
19515114|NCT01780506|41927640|FG001|Double-Blind Phase|Lost to Follow-up|26|||
19515115|NCT01780506|41927639|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
19515116|NCT01780506|41927640|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
19515117|NCT01779648|41927650|FG000|Overall Study|Protocol Violation|1|||
19515118|NCT01779648|41927651|FG001|Overall Study|Protocol Violation|0|||
19515119|NCT01762800|41927659|FG000|Overall Study|Adverse Event|8|||
19515120|NCT01762800|41927660|FG001|Overall Study|Adverse Event|13|||
19515121|NCT01762800|41927659|FG000|Overall Study|Lack of Efficacy|3|||
19515122|NCT01762800|41927660|FG001|Overall Study|Lack of Efficacy|2|||
19515123|NCT01762800|41927659|FG000|Overall Study|Study Closed/Terminated|0|||
19704785|NCT03725722|42149125|FG001|Overall Study|Withdrawal by Subject|1|||
19704786|NCT03725722|42149126|FG002|Overall Study|Withdrawal by Subject|0|||
19704787|NCT03725722|42149127|FG003|Overall Study|Withdrawal by Subject|4|||
19704788|NCT03725722|42149128|FG004|Overall Study|Withdrawal by Subject|4|||
19704789|NCT03725722|42149124|FG000|Overall Study|Lost to Follow-up|3|||
19704790|NCT03725722|42149125|FG001|Overall Study|Lost to Follow-up|1|||
19704791|NCT03725722|42149126|FG002|Overall Study|Lost to Follow-up|2|||
19704792|NCT03725722|42149127|FG003|Overall Study|Lost to Follow-up|2|||
19704793|NCT03725722|42149128|FG004|Overall Study|Lost to Follow-up|1|||
19704794|NCT03725722|42149124|FG000|Overall Study|Personal reasons|0|||
19515124|NCT01762800|41927660|FG001|Overall Study|Study Closed/Terminated|1|||
19515125|NCT01762800|41927659|FG000|Overall Study|Physician Decision|1|||
19515126|NCT01762800|41927660|FG001|Overall Study|Physician Decision|1|||
19515127|NCT01762800|41927659|FG000|Overall Study|Withdrawal by Subject|7|||
19515128|NCT01762800|41927660|FG001|Overall Study|Withdrawal by Subject|4|||
19515129|NCT01597596|41927674|FG000|Overall Study|Study terminated by sponsor|1|||
19515130|NCT01597596|41927675|FG001|Overall Study|Study terminated by sponsor|0|||
19515131|NCT01597596|41927674|FG000|Overall Study|Physician Decision|0|||
19515132|NCT01597596|41927675|FG001|Overall Study|Physician Decision|1|||
19515133|NCT01778556|41927683|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
19515134|NCT01778556|41927684|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
19515135|NCT01778556|41927683|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19515136|NCT01778556|41927684|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
19515137|NCT01778556|41927683|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
19515138|NCT01778556|41927684|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
19515139|NCT01778556|41927683|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
19515140|NCT01778556|41927684|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
19515141|NCT01761162|41927693|FG000|Overall Study|Withdrawal by Subject|3|||
19515142|NCT01778010|41927697|FG000|Overall Study|Withdrawal by Subject|2|||
19515143|NCT01778010|41927697|FG000|Overall Study|abnormal ECG before meds|1|||
19515144|NCT01778010|41927697|FG000|Overall Study|Arrested|1|||
19515145|NCT01778010|41927697|FG000|Overall Study|rash while on placebo|1|||
19515146|NCT01777932|41927714|FG000|Overall Study|Disease progression|136|||
19515147|NCT01777932|41927714|FG000|Overall Study|Death|3|||
19515148|NCT01777932|41927714|FG000|Overall Study|Adverse Event|34|||
19515149|NCT01777932|41927714|FG000|Overall Study|Lost to Follow-up|3|||
19515150|NCT01777932|41927714|FG000|Overall Study|Investigator decision|10|||
19515151|NCT01777932|41927714|FG000|Overall Study|Reimbursement limit|9|||
19515152|NCT01777932|41927714|FG000|Overall Study|Patient refused further treatment|10|||
19515153|NCT01777854|41927718|FG000|Overall Study|Physician Decision|3|||
19515154|NCT01777854|41927719|FG001|Overall Study|Physician Decision|3|||
19515155|NCT01777776|41927727|FG000|Overall Study|Adverse Event|2|||
19515156|NCT01777776|41927728|FG001|Overall Study|Adverse Event|4|||
19515157|NCT01777776|41927729|FG002|Overall Study|Adverse Event|0|||
19515158|NCT01777776|41927730|FG003|Overall Study|Adverse Event|0|||
19515159|NCT01777776|41927727|FG000|Overall Study|Disease Progression|4|||
19515160|NCT01777776|41927728|FG001|Overall Study|Disease Progression|8|||
19515161|NCT01777776|41927729|FG002|Overall Study|Disease Progression|6|||
19515162|NCT01777776|41927730|FG003|Overall Study|Disease Progression|3|||
19515163|NCT01777776|41927727|FG000|Overall Study|Withdrawal by Subject|0|||
19515164|NCT01777776|41927728|FG001|Overall Study|Withdrawal by Subject|0|||
19515165|NCT01777776|41927729|FG002|Overall Study|Withdrawal by Subject|0|||
19515166|NCT01777776|41927730|FG003|Overall Study|Withdrawal by Subject|1|||
19515167|NCT01777620|41927751|FG000|Overall Study|Subject Withdrawal|1|||
19704795|NCT03725722|42149125|FG001|Overall Study|Personal reasons|0|||
19704796|NCT03725722|42149126|FG002|Overall Study|Personal reasons|1|||
19515168|NCT01777620|41927752|FG001|Overall Study|Subject Withdrawal|0|||
19515169|NCT01777542|41927758|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
19515170|NCT01777542|41927759|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
19515171|NCT01736124|41927768|FG000|Post-intervention Assessment|Death|2|||
19704797|NCT03725722|42149127|FG003|Overall Study|Personal reasons|0|||
19515172|NCT01736124|41927769|FG001|Post-intervention Assessment|Death|2|||
19515173|NCT01736124|41927768|FG000|Post-intervention Assessment|lost computer access|1|||
19515174|NCT01736124|41927769|FG001|Post-intervention Assessment|lost computer access|1|||
19515175|NCT01736124|41927768|FG000|Post-intervention Assessment|Moved away|3|||
19515176|NCT01736124|41927769|FG001|Post-intervention Assessment|Moved away|1|||
19515177|NCT01736124|41927768|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
19515178|NCT01736124|41927769|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
19515179|NCT01736124|41927768|FG000|Post-intervention Assessment|Illness|3|||
19515180|NCT01736124|41927769|FG001|Post-intervention Assessment|Illness|2|||
19515181|NCT01736124|41927768|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
19515182|NCT01736124|41927769|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
19515183|NCT01736124|41927768|FG000|Post-intervention Assessment|Temporarily away|3|||
19515184|NCT01736124|41927769|FG001|Post-intervention Assessment|Temporarily away|1|||
19515185|NCT01736124|41927768|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
19515186|NCT01736124|41927769|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
19515187|NCT01736124|41927768|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
19515188|NCT01736124|41927769|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
19515189|NCT01736124|41927768|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
19515190|NCT01736124|41927769|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
19515191|NCT01736124|41927768|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
19515192|NCT01736124|41927769|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
19515193|NCT01736124|41927768|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
19515194|NCT01736124|41927769|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
19515195|NCT01736124|41927768|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
19515196|NCT01736124|41927769|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
19515197|NCT01736124|41927768|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
19515198|NCT01736124|41927769|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
19515199|NCT01736124|41927768|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
19515200|NCT01736124|41927769|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
19515201|NCT01736124|41927768|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
19515202|NCT01736124|41927769|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
19515203|NCT01759446|41927782|FG000|Overall Study|Protocol Violation|1|||
19515204|NCT01759446|41927783|FG001|Overall Study|Protocol Violation|0|||
19515205|NCT01759446|41927784|FG002|Overall Study|Protocol Violation|1|||
19515206|NCT01759446|41927785|FG003|Overall Study|Protocol Violation|0|||
19515207|NCT01759446|41927786|FG004|Overall Study|Protocol Violation|0|||
19515208|NCT01759446|41927782|FG000|Overall Study|Withdrawal by Subject|0|||
19515209|NCT01759446|41927783|FG001|Overall Study|Withdrawal by Subject|1|||
19515210|NCT01759446|41927784|FG002|Overall Study|Withdrawal by Subject|0|||
19515211|NCT01759446|41927785|FG003|Overall Study|Withdrawal by Subject|1|||
19515212|NCT01759446|41927786|FG004|Overall Study|Withdrawal by Subject|0|||
19515213|NCT01777308|41927800|FG000|Overall Study|Withdrawal by Subject|5|||
19515214|NCT01777308|41927801|FG001|Overall Study|Withdrawal by Subject|1|||
19515215|NCT01777308|41927800|FG000|Overall Study|Migrated/moved from study area|1|||
19515216|NCT01777308|41927801|FG001|Overall Study|Migrated/moved from study area|0|||
19515217|NCT01777308|41927800|FG000|Overall Study|Lost to Follow-up|7|||
19515218|NCT01777308|41927801|FG001|Overall Study|Lost to Follow-up|2|||
19515219|NCT01777308|41927800|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
19515220|NCT01777308|41927801|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
19515221|NCT01759368|41927810|FG000|Overall Study|Lost to Follow-up|1|||
19515222|NCT01759368|41927811|FG001|Overall Study|Lost to Follow-up|0|||
19515223|NCT01777152|41927821|FG000|Overall Study|Withdrawal by Subject|22|||
19515224|NCT01777152|41927822|FG001|Overall Study|Withdrawal by Subject|16|||
19515225|NCT01777152|41927821|FG000|Overall Study|Lost to Follow-up|3|||
19515226|NCT01777152|41927822|FG001|Overall Study|Lost to Follow-up|5|||
19515227|NCT01777152|41927821|FG000|Overall Study|Death|68|||
19515228|NCT01777152|41927822|FG001|Overall Study|Death|89|||
19515229|NCT01777152|41927821|FG000|Overall Study|Not eligible, no study drug received|1|||
19515230|NCT01777152|41927822|FG001|Overall Study|Not eligible, no study drug received|0|||
19515231|NCT01777152|41927821|FG000|Overall Study|Change of diagnosis|1|||
19515232|NCT01777152|41927822|FG001|Overall Study|Change of diagnosis|0|||
19515233|NCT01759290|41927829|FG000|Overall Study|Subjects withdrawn consent|5|||
19515234|NCT01759290|41927829|FG000|Overall Study|Physician Decision|2|||
19515235|NCT01759290|41927829|FG000|Overall Study|Death|17|||
19515236|NCT01759290|41927829|FG000|Overall Study|Lost to Follow-up|53|||
19515237|NCT01759290|41927829|FG000|Overall Study|Unknown reason|4|||
19515238|NCT01758900|41927835|FG000|Overall Study|difficulty for further intubation|7|||
19515239|NCT01758900|41927836|FG001|Overall Study|difficulty for further intubation|8|||
19515240|NCT01757184|41927844|FG000|Double-blind Period|Adverse Event|1|||
19515241|NCT01757184|41927845|FG001|Double-blind Period|Adverse Event|0|||
19515242|NCT01757184|41927846|FG002|Double-blind Period|Adverse Event|0|||
19515243|NCT01757184|41927847|FG003|Double-blind Period|Adverse Event|0|||
19704798|NCT03725722|42149128|FG004|Overall Study|Personal reasons|1|||
19394159|NCT01362049|41638223|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
19515244|NCT01757184|41927844|FG000|Open-label Period|Lost to Follow-up|0|||
19515245|NCT01757184|41927845|FG001|Open-label Period|Lost to Follow-up|0|||
19515246|NCT01757184|41927846|FG002|Open-label Period|Lost to Follow-up|2|||
19515247|NCT01757184|41927847|FG003|Open-label Period|Lost to Follow-up|0|||
19515248|NCT01757184|41927844|FG000|Open-label Period|Withdrawal by Subject|0|||
19515249|NCT01757184|41927845|FG001|Open-label Period|Withdrawal by Subject|0|||
19515250|NCT01757184|41927846|FG002|Open-label Period|Withdrawal by Subject|1|||
19515251|NCT01757184|41927847|FG003|Open-label Period|Withdrawal by Subject|1|||
19515252|NCT01757184|41927844|FG000|Open-label Period|Discontinued by Sponsor|0|||
19515253|NCT01757184|41927845|FG001|Open-label Period|Discontinued by Sponsor|0|||
19515254|NCT01757184|41927846|FG002|Open-label Period|Discontinued by Sponsor|1|||
19515255|NCT01757184|41927847|FG003|Open-label Period|Discontinued by Sponsor|2|||
19515256|NCT01775904|41927861|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
19515257|NCT01775904|41927861|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
19515258|NCT01775670|41927873|FG000|Overall Study|Lost to Follow-up|1|||
19515259|NCT01775670|41927874|FG001|Overall Study|Lost to Follow-up|1|||
19515260|NCT01775124|41927882|FG000|Core Period|Disease Progression|0|||
19515261|NCT01775124|41927883|FG001|Core Period|Disease Progression|1|||
19515262|NCT01775124|41927882|FG000|Core Period|Physician Decision|1|||
19515263|NCT01775124|41927883|FG001|Core Period|Physician Decision|1|||
19515264|NCT01775124|41927882|FG000|Core Period|Death|0|||
19515265|NCT01775124|41927883|FG001|Core Period|Death|1|||
19515266|NCT01775124|41927882|FG000|Core Period|Administrative problems|1|||
19515267|NCT01775124|41927883|FG001|Core Period|Administrative problems|0|||
19515268|NCT01775124|41927882|FG000|Core Period|Withdrawal by Subject|4|||
19515269|NCT01775124|41927883|FG001|Core Period|Withdrawal by Subject|2|||
19515270|NCT01775124|41927882|FG000|Core Period|Adverse Event|5|||
19515271|NCT01775124|41927883|FG001|Core Period|Adverse Event|5|||
19515272|NCT01775124|41927882|FG000|Extension Period|Adverse Event|3|||
19515273|NCT01775124|41927883|FG001|Extension Period|Adverse Event|2|||
19515274|NCT01775124|41927882|FG000|Extension Period|Physician Decision|0|||
19515275|NCT01775124|41927883|FG001|Extension Period|Physician Decision|2|||
19515276|NCT01775124|41927882|FG000|Extension Period|Administrative problems|0|||
19515277|NCT01775124|41927883|FG001|Extension Period|Administrative problems|1|||
19515278|NCT01775124|41927882|FG000|Extension Period|Lost to Follow-up|0|||
19515279|NCT01775124|41927883|FG001|Extension Period|Lost to Follow-up|1|||
19515280|NCT01775124|41927882|FG000|Extension Period|Withdrawal by Subject|9|||
19515281|NCT01775124|41927883|FG001|Extension Period|Withdrawal by Subject|12|||
19515282|NCT01733316|41927890|FG000|RP103 Phase|Non-compliance|1|||
19515283|NCT01733316|41927890|FG000|Long Term Extension Phase|Adverse Event|1|||
19515284|NCT01733316|41927890|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
19515285|NCT01733316|41927890|FG000|Long Term Extension Phase|Sponsor Decision|2|||
19515286|NCT01732926|41927903|FG000|Overall Study|Study Terminated by Sponsor|168|||
19515287|NCT01732926|41927904|FG001|Overall Study|Study Terminated by Sponsor|80|||
19515288|NCT01732926|41927903|FG000|Overall Study|Withdrawal by Subject|46|||
19515289|NCT01732926|41927904|FG001|Overall Study|Withdrawal by Subject|8|||
19515290|NCT01732926|41927903|FG000|Overall Study|Physician Decision|24|||
19515291|NCT01732926|41927904|FG001|Overall Study|Physician Decision|11|||
19515292|NCT01732926|41927903|FG000|Overall Study|Other Reason|21|||
19515293|NCT01732926|41927904|FG001|Overall Study|Other Reason|4|||
19515294|NCT01732926|41927903|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
19515295|NCT01732926|41927904|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
19704799|NCT03725722|42149124|FG000|Overall Study|COVID-19 situation|0|||
19704800|NCT03725722|42149125|FG001|Overall Study|COVID-19 situation|1|||
19704801|NCT03725722|42149126|FG002|Overall Study|COVID-19 situation|0|||
19704802|NCT03725722|42149127|FG003|Overall Study|COVID-19 situation|0|||
19704803|NCT03725722|42149128|FG004|Overall Study|COVID-19 situation|0|||
19704804|NCT02966314|42149142|FG000|Overall Study|Lost to Follow-up|1|||
19704805|NCT02966314|42149143|FG001|Overall Study|Lost to Follow-up|0|||
19704806|NCT03723070|42149149|FG000|Overall Study|Lost to Follow-up|2|||
19704807|NCT03723070|42149149|FG000|Overall Study|Physician Decision|1|||
19704808|NCT03723070|42149149|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
19704809|NCT03722524|42149157|FG000|Overall Study|Protocol Violation|86|||
19704810|NCT03722524|42149157|FG000|Overall Study|Adverse Event|7|||
19704811|NCT03722524|42149157|FG000|Overall Study|Lost to Follow-up|1|||
19704812|NCT03722524|42149157|FG000|Overall Study|Reason is not stated|1|||
19704813|NCT03722524|42149157|FG000|Overall Study|Physician Decision|1|||
19704814|NCT03722524|42149157|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
19515296|NCT01732926|41927903|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
19515297|NCT01732926|41927904|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
19515298|NCT01755858|41927912|FG000|Overall Study|Adverse Event|1|||
19515299|NCT01755858|41927913|FG001|Overall Study|Adverse Event|1|||
19515300|NCT01732770|41927923|FG000|Overall Study|Lost to Follow-up|2|||
19515301|NCT01732770|41927924|FG001|Overall Study|Lost to Follow-up|3|||
19515302|NCT01732770|41927923|FG000|Overall Study|Withdrawal by Subject|5|||
19515303|NCT01732770|41927924|FG001|Overall Study|Withdrawal by Subject|3|||
19515304|NCT01732770|41927923|FG000|Overall Study|Decision by Sponsor|2|||
19704815|NCT03722446|42149163|FG000|Overall Study|Protocol Violation|15|||
19704816|NCT03722446|42149164|FG001|Overall Study|Protocol Violation|2|||
19618185|NCT00600938|42067663|FG002|Core Study|Lost to Follow-up|0|||
19618186|NCT00600938|42067664|FG003|Core Study|Lost to Follow-up|0|||
19618187|NCT00600938|42067661|FG000|Core Study|Death|1|||
19618188|NCT00600938|42067662|FG001|Core Study|Death|1|||
19704817|NCT00146172|42149178|FG000|Overall Study|Adverse Event|0|||
19618189|NCT00600938|42067663|FG002|Core Study|Death|0|||
19618190|NCT00600938|42067664|FG003|Core Study|Death|0|||
19618191|NCT00600938|42067661|FG000|Core Study|Protocol Violation|1|||
19618192|NCT00600938|42067662|FG001|Core Study|Protocol Violation|2|||
19618193|NCT00600938|42067663|FG002|Core Study|Protocol Violation|0|||
19618194|NCT00600938|42067664|FG003|Core Study|Protocol Violation|0|||
19618195|NCT00600938|42067661|FG000|Extension Study|Adverse Event|1|||
19618196|NCT00600938|42067662|FG001|Extension Study|Adverse Event|0|||
19618197|NCT00600938|42067663|FG002|Extension Study|Adverse Event|2|||
19618198|NCT00600938|42067664|FG003|Extension Study|Adverse Event|0|||
19618199|NCT00600938|42067661|FG000|Extension Study|Abnormal test procedure results|0|||
19618200|NCT00600938|42067662|FG001|Extension Study|Abnormal test procedure results|1|||
19618201|NCT00600938|42067663|FG002|Extension Study|Abnormal test procedure results|1|||
19618202|NCT00600938|42067664|FG003|Extension Study|Abnormal test procedure results|1|||
19618203|NCT00600938|42067661|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
19618204|NCT00600938|42067662|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
19618205|NCT00600938|42067663|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
19618206|NCT00600938|42067664|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
19618207|NCT00600938|42067661|FG000|Extension Study|Withdrawal by Subject|2|||
19618208|NCT00600938|42067662|FG001|Extension Study|Withdrawal by Subject|2|||
19618209|NCT00600938|42067663|FG002|Extension Study|Withdrawal by Subject|3|||
19618210|NCT00600938|42067664|FG003|Extension Study|Withdrawal by Subject|0|||
19618211|NCT00600938|42067661|FG000|Extension Study|Lost to Follow-up|1|||
19618212|NCT00600938|42067662|FG001|Extension Study|Lost to Follow-up|1|||
19618213|NCT00600938|42067663|FG002|Extension Study|Lost to Follow-up|2|||
19618214|NCT00600938|42067664|FG003|Extension Study|Lost to Follow-up|0|||
19618215|NCT00600938|42067661|FG000|Extension Study|Death|1|||
19618216|NCT00600938|42067662|FG001|Extension Study|Death|0|||
19618217|NCT00600938|42067663|FG002|Extension Study|Death|0|||
19618218|NCT00600938|42067664|FG003|Extension Study|Death|0|||
19618219|NCT00543439|42067705|FG000|Period 1|Adverse Event|0|||
19618220|NCT00543439|42067706|FG001|Period 1|Adverse Event|2|||
19618221|NCT00543439|42067707|FG002|Period 1|Adverse Event|1|||
19618222|NCT00543439|42067705|FG000|Period 1|Withdrawal by Subject|1|||
19618223|NCT00543439|42067706|FG001|Period 1|Withdrawal by Subject|1|||
19618224|NCT00543439|42067707|FG002|Period 1|Withdrawal by Subject|0|||
19618225|NCT00543439|42067705|FG000|Period 1|Physician Decision|0|||
19618226|NCT00543439|42067706|FG001|Period 1|Physician Decision|0|||
19618227|NCT00543439|42067707|FG002|Period 1|Physician Decision|1|||
19618228|NCT00543439|42067705|FG000|Period 2|Protocol Violation|1|||
19618229|NCT00543439|42067706|FG001|Period 2|Protocol Violation|0|||
19618230|NCT00543439|42067707|FG002|Period 2|Protocol Violation|1|||
19618231|NCT00543439|42067705|FG000|Period 2|Adverse Event|0|||
19618232|NCT00543439|42067706|FG001|Period 2|Adverse Event|1|||
19618233|NCT00543439|42067707|FG002|Period 2|Adverse Event|1|||
19618234|NCT00582166|42067724|FG000|Overall Study|Death|1|||
19618235|NCT00582166|42067724|FG000|Overall Study|Ineligible pathology|1|||
19618236|NCT00601172|42067730|FG000|Overall Study|Adverse Event|43|||
19618237|NCT00601172|42067731|FG001|Overall Study|Adverse Event|32|||
19618238|NCT00601172|42067730|FG000|Overall Study|Lack of Efficacy|11|||
19618239|NCT00601172|42067731|FG001|Overall Study|Lack of Efficacy|12|||
19618240|NCT00601172|42067730|FG000|Overall Study|Protocol Violation|2|||
19618241|NCT00601172|42067731|FG001|Overall Study|Protocol Violation|5|||
19618242|NCT00601172|42067730|FG000|Overall Study|Lost to Follow-up|4|||
19618243|NCT00601172|42067731|FG001|Overall Study|Lost to Follow-up|3|||
19618244|NCT00601172|42067730|FG000|Overall Study|Physician Decision|27|||
19618245|NCT00601172|42067731|FG001|Overall Study|Physician Decision|28|||
19618246|NCT00601172|42067730|FG000|Overall Study|Withdrawal by Subject|35|||
19618247|NCT00601172|42067731|FG001|Overall Study|Withdrawal by Subject|27|||
19618248|NCT00601172|42067730|FG000|Overall Study|Did not meet continuation criteria|19|||
19618249|NCT00601172|42067731|FG001|Overall Study|Did not meet continuation criteria|20|||
19618250|NCT00582010|42067740|FG000|Overall Study|Death|0|||
19618251|NCT00582010|42067741|FG001|Overall Study|Death|1|||
19618252|NCT03920215|42067755|FG000|Overall Study|Lost to Follow-up|1|||
19618253|NCT03920215|42067756|FG001|Overall Study|Lost to Follow-up|2|||
19618254|NCT03920215|42067757|FG002|Overall Study|Lost to Follow-up|0|||
19618255|NCT03920215|42067758|FG003|Overall Study|Lost to Follow-up|0|||
19618256|NCT03920215|42067755|FG000|Overall Study|Death|0|||
19618257|NCT03920215|42067756|FG001|Overall Study|Death|0|||
19618258|NCT03920215|42067757|FG002|Overall Study|Death|0|||
19618259|NCT03920215|42067758|FG003|Overall Study|Death|1|||
19618260|NCT00580840|42067768|FG000|Run-in|Adverse Event|17|||
19618261|NCT00580840|42067769|FG001|Run-in|Adverse Event|0|||
19618262|NCT00580840|42067770|FG002|Run-in|Adverse Event|0|||
19515305|NCT01732770|41927924|FG001|Overall Study|Decision by Sponsor|2|||
19515306|NCT01732770|41927923|FG000|Overall Study|Death|1|||
19515307|NCT01732770|41927924|FG001|Overall Study|Death|0|||
19515308|NCT01732692|41927932|FG000|Overall Study|Adverse Event|0|||
19515309|NCT01732692|41927933|FG001|Overall Study|Adverse Event|1|||
19515310|NCT01774968|41927941|FG000|Overall Study|Adverse Event|4|||
19515311|NCT01774968|41927942|FG001|Overall Study|Adverse Event|4|||
19515312|NCT01774968|41927941|FG000|Overall Study|Death|0|||
19515313|NCT01774968|41927942|FG001|Overall Study|Death|1|||
19515314|NCT01774968|41927941|FG000|Overall Study|Lost to Follow-up|1|||
19515315|NCT01774968|41927942|FG001|Overall Study|Lost to Follow-up|3|||
19515316|NCT01774968|41927941|FG000|Overall Study|Physician Decision|5|||
19515317|NCT01774968|41927942|FG001|Overall Study|Physician Decision|1|||
19515318|NCT01774968|41927941|FG000|Overall Study|Protocol Violation|14|||
19515319|NCT01774968|41927942|FG001|Overall Study|Protocol Violation|13|||
19515320|NCT01774968|41927941|FG000|Overall Study|Sponsor Decision|0|||
19515321|NCT01774968|41927942|FG001|Overall Study|Sponsor Decision|2|||
19515322|NCT01774968|41927941|FG000|Overall Study|Withdrawal by Subject|6|||
19515323|NCT01774968|41927942|FG001|Overall Study|Withdrawal by Subject|11|||
19515324|NCT01774344|41927950|FG000|Overall Study|Withdrawal by Subject|3|||
19515325|NCT01774344|41927951|FG001|Overall Study|Withdrawal by Subject|10|||
19515326|NCT01774344|41927950|FG000|Overall Study|Protocol Violation|0|||
19515327|NCT01774344|41927951|FG001|Overall Study|Protocol Violation|1|||
19515328|NCT01774344|41927950|FG000|Overall Study|Lost to Follow-up|4|||
19515329|NCT01774344|41927951|FG001|Overall Study|Lost to Follow-up|10|||
19515330|NCT01774344|41927950|FG000|Overall Study|End of survival follow-up not available|2|||
19515331|NCT01774344|41927951|FG001|Overall Study|End of survival follow-up not available|2|||
19515332|NCT01774344|41927950|FG000|Overall Study|Data collection finished|4|||
19515333|NCT01774344|41927951|FG001|Overall Study|Data collection finished|14|||
19515334|NCT01774344|41927950|FG000|Overall Study|Other|0|||
19515335|NCT01774344|41927951|FG001|Overall Study|Other|1|||
19515336|NCT01774344|41927950|FG000|Overall Study|Did not enter Survival Follow up|49|||
19515337|NCT01774344|41927951|FG001|Overall Study|Did not enter Survival Follow up|83|||
19515338|NCT01732536|41927959|FG000|Overall Study|Withdrawal by Subject|1|||
19515339|NCT01732536|41927960|FG001|Overall Study|Withdrawal by Subject|1|||
19515340|NCT01755702|41927969|FG000|Wash Out Period I|Other Reason|3|||
19515341|NCT01755702|41927969|FG000|Washout Period II|Other Reason|5|||
19515342|NCT01732458|41927983|FG000|Overall Study|Lost to Follow-up|0|||
19618263|NCT00580840|42067771|FG003|Run-in|Adverse Event|0|||
19618264|NCT00580840|42067768|FG000|Run-in|Lack of Efficacy|93|||
19515343|NCT01732458|41927984|FG001|Overall Study|Lost to Follow-up|2|||
19515344|NCT01732458|41927985|FG002|Overall Study|Lost to Follow-up|0|||
19515345|NCT01732458|41927986|FG003|Overall Study|Lost to Follow-up|0|||
19515346|NCT01732458|41927983|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19618265|NCT00580840|42067769|FG001|Run-in|Lack of Efficacy|0|||
19618266|NCT00580840|42067770|FG002|Run-in|Lack of Efficacy|0|||
19618267|NCT00580840|42067771|FG003|Run-in|Lack of Efficacy|0|||
19618268|NCT00580840|42067768|FG000|Run-in|Loss of Efficacy|1|||
19618269|NCT00580840|42067769|FG001|Run-in|Loss of Efficacy|0|||
19618270|NCT00580840|42067770|FG002|Run-in|Loss of Efficacy|0|||
19618271|NCT00580840|42067771|FG003|Run-in|Loss of Efficacy|0|||
19618272|NCT00580840|42067768|FG000|Run-in|Lost to Follow-up|4|||
19618273|NCT00580840|42067769|FG001|Run-in|Lost to Follow-up|0|||
19618274|NCT00580840|42067770|FG002|Run-in|Lost to Follow-up|0|||
19515347|NCT01732458|41927984|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19515348|NCT01732458|41927985|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19515349|NCT01732458|41927986|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19515350|NCT01732458|41927983|FG000|Overall Study|Physician Decision|1|||
19515351|NCT01732458|41927984|FG001|Overall Study|Physician Decision|2|||
19515352|NCT01732458|41927985|FG002|Overall Study|Physician Decision|2|||
19515353|NCT01732458|41927986|FG003|Overall Study|Physician Decision|0|||
19515354|NCT01732458|41927983|FG000|Overall Study|Protocol Violation|2|||
19515355|NCT01732458|41927984|FG001|Overall Study|Protocol Violation|0|||
19515356|NCT01732458|41927985|FG002|Overall Study|Protocol Violation|0|||
19515357|NCT01732458|41927986|FG003|Overall Study|Protocol Violation|2|||
19515358|NCT01732458|41927983|FG000|Overall Study|Screen Failure|0|||
19515359|NCT01732458|41927984|FG001|Overall Study|Screen Failure|1|||
19515360|NCT01732458|41927985|FG002|Overall Study|Screen Failure|0|||
19515361|NCT01732458|41927986|FG003|Overall Study|Screen Failure|0|||
19515362|NCT01731990|41928010|FG000|Overall Study|Adverse Event|1|||
19515363|NCT01731990|41928011|FG001|Overall Study|Adverse Event|5|||
19515364|NCT01731990|41928010|FG000|Overall Study|Withdrawal by Subject|1|||
19704818|NCT00146172|42149179|FG001|Overall Study|Adverse Event|0|||
19515365|NCT01731990|41928011|FG001|Overall Study|Withdrawal by Subject|1|||
19515366|NCT01731990|41928010|FG000|Overall Study|Protocol deviation|1|||
19515367|NCT01731990|41928011|FG001|Overall Study|Protocol deviation|2|||
19515368|NCT01731990|41928010|FG000|Overall Study|Death|1|||
19515369|NCT01731990|41928011|FG001|Overall Study|Death|0|||
19618275|NCT00580840|42067771|FG003|Run-in|Lost to Follow-up|0|||
19618276|NCT00580840|42067768|FG000|Run-in|Withdrawal by Subject|5|||
19618277|NCT00580840|42067769|FG001|Run-in|Withdrawal by Subject|0|||
19515370|NCT01708902|41928024|FG000|Overall Study|Adverse Event|3|||
19515371|NCT01708902|41928025|FG001|Overall Study|Adverse Event|4|||
19515372|NCT01708902|41928026|FG002|Overall Study|Adverse Event|9|||
19515373|NCT01708902|41928027|FG003|Overall Study|Adverse Event|2|||
19515374|NCT01708902|41928028|FG004|Overall Study|Adverse Event|7|||
19515375|NCT01708902|41928029|FG005|Overall Study|Adverse Event|3|||
19515376|NCT01708902|41928030|FG006|Overall Study|Adverse Event|5|||
19515377|NCT01708902|41928024|FG000|Overall Study|Lack of Efficacy|3|||
19515378|NCT01708902|41928025|FG001|Overall Study|Lack of Efficacy|1|||
19515379|NCT01708902|41928026|FG002|Overall Study|Lack of Efficacy|0|||
19515380|NCT01708902|41928027|FG003|Overall Study|Lack of Efficacy|0|||
19515381|NCT01708902|41928028|FG004|Overall Study|Lack of Efficacy|0|||
19515382|NCT01708902|41928029|FG005|Overall Study|Lack of Efficacy|1|||
19515383|NCT01708902|41928030|FG006|Overall Study|Lack of Efficacy|0|||
19515384|NCT01708902|41928024|FG000|Overall Study|Non compliance with protocol|0|||
19515385|NCT01708902|41928025|FG001|Overall Study|Non compliance with protocol|2|||
19515386|NCT01708902|41928026|FG002|Overall Study|Non compliance with protocol|1|||
19515387|NCT01708902|41928027|FG003|Overall Study|Non compliance with protocol|3|||
19515388|NCT01708902|41928028|FG004|Overall Study|Non compliance with protocol|0|||
19515389|NCT01708902|41928029|FG005|Overall Study|Non compliance with protocol|0|||
19515390|NCT01708902|41928030|FG006|Overall Study|Non compliance with protocol|0|||
19515391|NCT01708902|41928024|FG000|Overall Study|Lost to Follow-up|2|||
19515392|NCT01708902|41928025|FG001|Overall Study|Lost to Follow-up|1|||
19515393|NCT01708902|41928026|FG002|Overall Study|Lost to Follow-up|2|||
19515394|NCT01708902|41928027|FG003|Overall Study|Lost to Follow-up|2|||
19515395|NCT01708902|41928028|FG004|Overall Study|Lost to Follow-up|0|||
19515396|NCT01708902|41928029|FG005|Overall Study|Lost to Follow-up|0|||
19515397|NCT01708902|41928030|FG006|Overall Study|Lost to Follow-up|1|||
19515398|NCT01708902|41928024|FG000|Overall Study|Refused to continue trial medication|8|||
19515399|NCT01708902|41928025|FG001|Overall Study|Refused to continue trial medication|0|||
19515400|NCT01708902|41928026|FG002|Overall Study|Refused to continue trial medication|4|||
19618278|NCT00580840|42067770|FG002|Run-in|Withdrawal by Subject|0|||
19618279|NCT00580840|42067771|FG003|Run-in|Withdrawal by Subject|0|||
19618280|NCT00580840|42067768|FG000|Run-in|Other: Per Sponsor Request|2|||
19515401|NCT01708902|41928027|FG003|Overall Study|Refused to continue trial medication|2|||
19515402|NCT01708902|41928028|FG004|Overall Study|Refused to continue trial medication|8|||
19515403|NCT01708902|41928029|FG005|Overall Study|Refused to continue trial medication|1|||
19515404|NCT01708902|41928030|FG006|Overall Study|Refused to continue trial medication|1|||
19515405|NCT01708902|41928024|FG000|Overall Study|Other Reason|1|||
19515406|NCT01708902|41928025|FG001|Overall Study|Other Reason|0|||
19515407|NCT01708902|41928026|FG002|Overall Study|Other Reason|1|||
19515408|NCT01708902|41928027|FG003|Overall Study|Other Reason|1|||
19515409|NCT01708902|41928028|FG004|Overall Study|Other Reason|1|||
19515410|NCT01708902|41928029|FG005|Overall Study|Other Reason|2|||
19515411|NCT01708902|41928030|FG006|Overall Study|Other Reason|0|||
19515412|NCT01755546|41928049|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
19515413|NCT01755546|41928049|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
19515414|NCT01755546|41928049|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
19515415|NCT01755546|41928049|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
19515416|NCT01755546|41928049|FG000|Titration Phase|Adverse Event|11|||
19515417|NCT01755546|41928049|FG000|Titration Phase|Lack of Efficacy|18|||
19515418|NCT01755546|41928049|FG000|Titration Phase|Protocol Violation|9|||
19515419|NCT01755546|41928049|FG000|Titration Phase|Lost to Follow-up|2|||
19515420|NCT01755546|41928049|FG000|Titration Phase|Other and Continuing|22|||
19515421|NCT01755546|41928049|FG000|Titration Phase|Withdrawal by Subject|8|||
19515422|NCT01755546|41928049|FG000|Long Term Treatment|Adverse Event|12|||
19618281|NCT00580840|42067769|FG001|Run-in|Other: Per Sponsor Request|0|||
19618282|NCT00580840|42067770|FG002|Run-in|Other: Per Sponsor Request|0|||
19618283|NCT00580840|42067771|FG003|Run-in|Other: Per Sponsor Request|0|||
19618284|NCT00580840|42067768|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
19618285|NCT00580840|42067769|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
19618286|NCT00580840|42067770|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
19515423|NCT01755546|41928049|FG000|Long Term Treatment|Lack of Efficacy|6|||
19515424|NCT01755546|41928049|FG000|Long Term Treatment|Protocol Violation|10|||
19515425|NCT01755546|41928049|FG000|Long Term Treatment|Withdrawal by Subject|35|||
19515426|NCT01755546|41928049|FG000|Long Term Treatment|Lost to Follow-up|17|||
19515427|NCT01755546|41928049|FG000|Long Term Treatment|other and ongoing|41|||
19515428|NCT01755234|41928055|FG000|Overall Study|Lost to Follow-up|11|||
19515429|NCT01755234|41928056|FG001|Overall Study|Lost to Follow-up|6|||
19515430|NCT01755234|41928055|FG000|Overall Study|Change in surgical case|2|||
19515431|NCT01755234|41928056|FG001|Overall Study|Change in surgical case|1|||
19515432|NCT01755234|41928055|FG000|Overall Study|case cancelled|1|||
19618287|NCT00580840|42067771|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
19618288|NCT00580840|42067768|FG000|Run-in|Other: Exclusionary Lab Value|1|||
19515433|NCT01755234|41928056|FG001|Overall Study|case cancelled|0|||
19515434|NCT01755234|41928055|FG000|Overall Study|Withdrawal by Subject|0|||
19515435|NCT01755234|41928056|FG001|Overall Study|Withdrawal by Subject|1|||
19515436|NCT01755234|41928055|FG000|Overall Study|unblinded|1|||
19515437|NCT01755234|41928056|FG001|Overall Study|unblinded|0|||
19515438|NCT01731912|41928062|FG000|Overall Study|noncompliance|2|||
19515439|NCT01731678|41928066|FG000|Overall Study|Withdrawal by Subject|3|||
19515440|NCT01731678|41928066|FG000|Overall Study|Did not meet inclusion criteria|1|||
19515441|NCT01731678|41928066|FG000|Overall Study|RMT too high, making TMS difficult|3|||
19515442|NCT01731600|41928072|FG000|Overall Study|Adverse Event|2|||
19618289|NCT00580840|42067769|FG001|Run-in|Other: Exclusionary Lab Value|0|||
19618290|NCT00580840|42067770|FG002|Run-in|Other: Exclusionary Lab Value|0|||
19618291|NCT00580840|42067771|FG003|Run-in|Other: Exclusionary Lab Value|0|||
19618292|NCT00580840|42067768|FG000|Double-Blind|Adverse Event|0|||
19618293|NCT00580840|42067769|FG001|Double-Blind|Adverse Event|3|||
19618294|NCT00580840|42067770|FG002|Double-Blind|Adverse Event|4|||
19618295|NCT00580840|42067771|FG003|Double-Blind|Adverse Event|1|||
19618296|NCT00580840|42067768|FG000|Double-Blind|Loss of Efficacy|0|||
19618297|NCT00580840|42067769|FG001|Double-Blind|Loss of Efficacy|1|||
19618298|NCT00580840|42067770|FG002|Double-Blind|Loss of Efficacy|2|||
19618299|NCT00580840|42067771|FG003|Double-Blind|Loss of Efficacy|10|||
19618300|NCT00580840|42067768|FG000|Double-Blind|Lost to Follow-up|0|||
19618301|NCT00580840|42067769|FG001|Double-Blind|Lost to Follow-up|1|||
19618302|NCT00580840|42067770|FG002|Double-Blind|Lost to Follow-up|0|||
19618303|NCT00580840|42067771|FG003|Double-Blind|Lost to Follow-up|2|||
19618304|NCT00580840|42067768|FG000|Double-Blind|Withdrawal by Subject|0|||
19618305|NCT00580840|42067769|FG001|Double-Blind|Withdrawal by Subject|1|||
19618306|NCT00580840|42067770|FG002|Double-Blind|Withdrawal by Subject|2|||
19618307|NCT00580840|42067771|FG003|Double-Blind|Withdrawal by Subject|2|||
19618308|NCT00580840|42067768|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
19618309|NCT00580840|42067769|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
19618310|NCT00580840|42067770|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
19618311|NCT00580840|42067771|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
19618312|NCT00580840|42067768|FG000|Double-Blind|Other: Forbidden Medication|0|||
19618313|NCT00580840|42067769|FG001|Double-Blind|Other: Forbidden Medication|0|||
19618314|NCT00580840|42067770|FG002|Double-Blind|Other: Forbidden Medication|1|||
19618315|NCT00580840|42067771|FG003|Double-Blind|Other: Forbidden Medication|0|||
19618316|NCT00879684|42067781|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
19515443|NCT01731600|41928073|FG001|Overall Study|Adverse Event|0|||
19515444|NCT01731600|41928072|FG000|Overall Study|Withdrawal criteria|1|||
19515445|NCT01731600|41928073|FG001|Overall Study|Withdrawal criteria|0|||
19515446|NCT01731600|41928072|FG000|Overall Study|Other reasons|3|||
19515447|NCT01731600|41928073|FG001|Overall Study|Other reasons|0|||
19515448|NCT01730586|41928083|FG000|Overall Study|Progressive Disease|2|||
19515449|NCT01730586|41928083|FG000|Overall Study|Inadequate Trial|8|||
19515450|NCT01730586|41928083|FG000|Overall Study|Adverse Event|2|||
19515451|NCT01730586|41928083|FG000|Overall Study|Hospice|1|||
19515452|NCT01707030|41928091|FG000|Overall Study|Death|1|||
19515453|NCT01707030|41928092|FG001|Overall Study|Death|1|||
19515454|NCT01707030|41928091|FG000|Overall Study|Withdrawal by Subject|2|||
19515455|NCT01707030|41928092|FG001|Overall Study|Withdrawal by Subject|3|||
19515456|NCT01707030|41928091|FG000|Overall Study|Lost to Follow-up|8|||
19515457|NCT01707030|41928092|FG001|Overall Study|Lost to Follow-up|13|||
19515458|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
19515459|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
19515460|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
19515461|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
19515462|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
19515463|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
19515464|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
19515465|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
19515466|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
19515467|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
19515468|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
19515469|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
19515470|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
19515471|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
19515472|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
19515473|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
19515474|NCT01755156|41928104|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
19515475|NCT01755156|41928105|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
19515476|NCT01755156|41928104|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
19618317|NCT00879684|42067782|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
19618318|NCT00879684|42067783|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
19618319|NCT00879684|42067784|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
19618320|NCT00879684|42067785|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
19515477|NCT01755156|41928105|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
19515478|NCT01755156|41928104|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
19515479|NCT01755156|41928105|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
19515480|NCT01754922|41928117|FG000|Overall Study|Adverse Event|0|||
19515481|NCT01754922|41928118|FG001|Overall Study|Adverse Event|1|||
19515482|NCT01754766|41928128|FG000|Overall Study|Personal reasons|1|||
19515483|NCT01754766|41928129|FG001|Overall Study|Personal reasons|1|||
19515484|NCT01754766|41928130|FG002|Overall Study|Personal reasons|0|||
19515485|NCT01754376|41928138|FG000|Overall Study|Adverse Event|1|||
19515486|NCT01754376|41928138|FG000|Overall Study|Lack of Efficacy|2|||
19515487|NCT01605396|41928145|FG000|Overall Study|Adverse Event|5|||
19515488|NCT01605396|41928146|FG001|Overall Study|Adverse Event|3|||
19515489|NCT01605396|41928145|FG000|Overall Study|Lost to Follow-up|1|||
19515490|NCT01605396|41928146|FG001|Overall Study|Lost to Follow-up|0|||
19515491|NCT01605396|41928145|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19515492|NCT01605396|41928146|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19515493|NCT01605396|41928145|FG000|Overall Study|Physician Decision|2|||
19515494|NCT01605396|41928146|FG001|Overall Study|Physician Decision|2|||
19515495|NCT01605396|41928145|FG000|Overall Study|Progressive Disease|23|||
19515496|NCT01605396|41928146|FG001|Overall Study|Progressive Disease|27|||
19515497|NCT01605396|41928145|FG000|Overall Study|Withdrawal by Subject|4|||
19515498|NCT01605396|41928146|FG001|Overall Study|Withdrawal by Subject|2|||
19515499|NCT01605396|41928145|FG000|Overall Study|Transfer Off Study|4|||
19515500|NCT01605396|41928146|FG001|Overall Study|Transfer Off Study|5|||
19515501|NCT01730118|41928159|FG000|Dose Escalation|Death on study|5|||
19515502|NCT01730118|41928160|FG001|Dose Escalation|Death on study|7|||
19515503|NCT01730118|41928161|FG002|Dose Escalation|Death on study|2|||
19515504|NCT01730118|41928162|FG003|Dose Escalation|Death on study|6|||
19515505|NCT01730118|41928163|FG004|Dose Escalation|Death on study|0|||
19515506|NCT01730118|41928164|FG005|Dose Escalation|Death on study|0|||
19515507|NCT01730118|41928165|FG006|Dose Escalation|Death on study|0|||
19515508|NCT01730118|41928159|FG000|Dose Escalation|Died before treatment|0|||
19515509|NCT01730118|41928160|FG001|Dose Escalation|Died before treatment|0|||
19515510|NCT01730118|41928161|FG002|Dose Escalation|Died before treatment|0|||
19515511|NCT01730118|41928162|FG003|Dose Escalation|Died before treatment|0|||
19515512|NCT01730118|41928163|FG004|Dose Escalation|Died before treatment|0|||
19515513|NCT01730118|41928164|FG005|Dose Escalation|Died before treatment|0|||
19515514|NCT01730118|41928165|FG006|Dose Escalation|Died before treatment|1|||
19515515|NCT01730118|41928159|FG000|Dose Escalation|Chose to start a different treatment|1|||
19515516|NCT01730118|41928160|FG001|Dose Escalation|Chose to start a different treatment|0|||
19515517|NCT01730118|41928161|FG002|Dose Escalation|Chose to start a different treatment|0|||
19618321|NCT00879684|42067786|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
19618322|NCT00879684|42067787|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
19704819|NCT00146172|42149180|FG002|Overall Study|Adverse Event|1|||
19704820|NCT00146172|42149181|FG003|Overall Study|Adverse Event|1|||
19618323|NCT00879684|42067781|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
19618324|NCT00879684|42067782|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
19618325|NCT00879684|42067783|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
19618326|NCT00879684|42067784|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
19618327|NCT00879684|42067785|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
19618328|NCT00879684|42067786|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
19618329|NCT00879684|42067787|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
19618330|NCT00879684|42067781|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
19618331|NCT00879684|42067782|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
19618332|NCT00879684|42067783|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
19618333|NCT00879684|42067784|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
19618334|NCT00879684|42067785|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
19618335|NCT00879684|42067786|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
19618336|NCT00879684|42067787|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
19618337|NCT00879684|42067781|FG000|Stage 1: Dose Escalation|Death|0|||
19618338|NCT00879684|42067782|FG001|Stage 1: Dose Escalation|Death|0|||
19618339|NCT00879684|42067783|FG002|Stage 1: Dose Escalation|Death|1|||
19618340|NCT00879684|42067784|FG003|Stage 1: Dose Escalation|Death|0|||
19618341|NCT00879684|42067785|FG004|Stage 1: Dose Escalation|Death|0|||
19618342|NCT00879684|42067786|FG005|Stage 1: Dose Escalation|Death|0|||
19618343|NCT00879684|42067787|FG006|Stage 1: Dose Escalation|Death|0|||
19618344|NCT00879684|42067781|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19618345|NCT00879684|42067782|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19618346|NCT00879684|42067783|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19618347|NCT00879684|42067784|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19618348|NCT00879684|42067785|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19515518|NCT01730118|41928162|FG003|Dose Escalation|Chose to start a different treatment|0|||
19515519|NCT01730118|41928163|FG004|Dose Escalation|Chose to start a different treatment|0|||
19515520|NCT01730118|41928164|FG005|Dose Escalation|Chose to start a different treatment|0|||
19515521|NCT01730118|41928165|FG006|Dose Escalation|Chose to start a different treatment|0|||
19515522|NCT01730118|41928159|FG000|Dose Escalation|Withdrawal by Subject|0|||
19515523|NCT01730118|41928160|FG001|Dose Escalation|Withdrawal by Subject|0|||
19515524|NCT01730118|41928161|FG002|Dose Escalation|Withdrawal by Subject|1|||
19515525|NCT01730118|41928162|FG003|Dose Escalation|Withdrawal by Subject|0|||
19515526|NCT01730118|41928163|FG004|Dose Escalation|Withdrawal by Subject|0|||
19515527|NCT01730118|41928164|FG005|Dose Escalation|Withdrawal by Subject|0|||
19515528|NCT01730118|41928165|FG006|Dose Escalation|Withdrawal by Subject|0|||
19515529|NCT01730118|41928159|FG000|Dose Escalation|Disease progression prior to treatment|0|||
19515530|NCT01730118|41928160|FG001|Dose Escalation|Disease progression prior to treatment|0|||
19515531|NCT01730118|41928161|FG002|Dose Escalation|Disease progression prior to treatment|0|||
19515532|NCT01730118|41928162|FG003|Dose Escalation|Disease progression prior to treatment|0|||
19515533|NCT01730118|41928163|FG004|Dose Escalation|Disease progression prior to treatment|0|||
19515534|NCT01730118|41928164|FG005|Dose Escalation|Disease progression prior to treatment|0|||
19515535|NCT01730118|41928165|FG006|Dose Escalation|Disease progression prior to treatment|1|||
19515536|NCT01730118|41928159|FG000|Dose Expansion|Death|0|||
19515537|NCT01730118|41928160|FG001|Dose Expansion|Death|0|||
19515538|NCT01730118|41928161|FG002|Dose Expansion|Death|0|||
19515539|NCT01730118|41928162|FG003|Dose Expansion|Death|0|||
19515540|NCT01730118|41928163|FG004|Dose Expansion|Death|1|||
19515541|NCT01730118|41928164|FG005|Dose Expansion|Death|0|||
19515542|NCT01730118|41928165|FG006|Dose Expansion|Death|0|||
19515543|NCT01730118|41928159|FG000|Dose Expansion|Other medical condition|0|||
19515544|NCT01730118|41928160|FG001|Dose Expansion|Other medical condition|0|||
19515545|NCT01730118|41928161|FG002|Dose Expansion|Other medical condition|0|||
19515546|NCT01730118|41928162|FG003|Dose Expansion|Other medical condition|0|||
19515547|NCT01730118|41928163|FG004|Dose Expansion|Other medical condition|1|||
19515548|NCT01730118|41928164|FG005|Dose Expansion|Other medical condition|0|||
19515549|NCT01730118|41928165|FG006|Dose Expansion|Other medical condition|0|||
19515550|NCT01730118|41928159|FG000|Dose Expansion|Withdrawal by Subject|0|||
19515551|NCT01730118|41928160|FG001|Dose Expansion|Withdrawal by Subject|0|||
19515552|NCT01730118|41928161|FG002|Dose Expansion|Withdrawal by Subject|0|||
19515553|NCT01730118|41928162|FG003|Dose Expansion|Withdrawal by Subject|0|||
19515554|NCT01730118|41928163|FG004|Dose Expansion|Withdrawal by Subject|1|||
19515555|NCT01730118|41928164|FG005|Dose Expansion|Withdrawal by Subject|0|||
19515556|NCT01730118|41928165|FG006|Dose Expansion|Withdrawal by Subject|0|||
19515557|NCT01730118|41928159|FG000|Dose Expansion|Disease progression|0|||
19515558|NCT01730118|41928160|FG001|Dose Expansion|Disease progression|0|||
19515559|NCT01730118|41928161|FG002|Dose Expansion|Disease progression|0|||
19515560|NCT01730118|41928162|FG003|Dose Expansion|Disease progression|0|||
19515561|NCT01730118|41928163|FG004|Dose Expansion|Disease progression|0|||
19515562|NCT01730118|41928164|FG005|Dose Expansion|Disease progression|1|||
19515563|NCT01730118|41928165|FG006|Dose Expansion|Disease progression|0|||
19515564|NCT01730118|41928159|FG000|Dose Expansion|Inability to return|0|||
19515565|NCT01730118|41928160|FG001|Dose Expansion|Inability to return|0|||
19515566|NCT01730118|41928161|FG002|Dose Expansion|Inability to return|0|||
19515567|NCT01730118|41928162|FG003|Dose Expansion|Inability to return|0|||
19515568|NCT01730118|41928163|FG004|Dose Expansion|Inability to return|0|||
19515569|NCT01730118|41928164|FG005|Dose Expansion|Inability to return|1|||
19515570|NCT01730118|41928165|FG006|Dose Expansion|Inability to return|0|||
19515571|NCT01730118|41928159|FG000|Dose Expansion|Physician Decision|0|||
19515572|NCT01730118|41928160|FG001|Dose Expansion|Physician Decision|0|||
19515573|NCT01730118|41928161|FG002|Dose Expansion|Physician Decision|0|||
19515574|NCT01730118|41928162|FG003|Dose Expansion|Physician Decision|0|||
19515575|NCT01730118|41928163|FG004|Dose Expansion|Physician Decision|0|||
19515576|NCT01730118|41928164|FG005|Dose Expansion|Physician Decision|1|||
19515577|NCT01730118|41928165|FG006|Dose Expansion|Physician Decision|0|||
19515578|NCT01730040|41928189|FG000|Overall Study|Randomized but not treated|0|||
19515579|NCT01730040|41928190|FG001|Overall Study|Randomized but not treated|0|||
19515580|NCT01730040|41928191|FG002|Overall Study|Randomized but not treated|0|||
19515581|NCT01730040|41928192|FG003|Overall Study|Randomized but not treated|0|||
19515582|NCT01730040|41928193|FG004|Overall Study|Randomized but not treated|0|||
19515583|NCT01730040|41928194|FG005|Overall Study|Randomized but not treated|1|||
19515584|NCT01730040|41928195|FG006|Overall Study|Randomized but not treated|0|||
19515585|NCT01730040|41928189|FG000|Overall Study|Subject moved|0|||
19515586|NCT01730040|41928190|FG001|Overall Study|Subject moved|0|||
19515587|NCT01730040|41928191|FG002|Overall Study|Subject moved|1|||
19515588|NCT01730040|41928192|FG003|Overall Study|Subject moved|0|||
19515589|NCT01730040|41928193|FG004|Overall Study|Subject moved|0|||
19515590|NCT01730040|41928194|FG005|Overall Study|Subject moved|0|||
19515591|NCT01730040|41928195|FG006|Overall Study|Subject moved|1|||
19515592|NCT01730040|41928189|FG000|Overall Study|Physician Decision|0|||
19515593|NCT01730040|41928190|FG001|Overall Study|Physician Decision|0|||
19515594|NCT01730040|41928191|FG002|Overall Study|Physician Decision|0|||
19515595|NCT01730040|41928192|FG003|Overall Study|Physician Decision|0|||
19515596|NCT01730040|41928193|FG004|Overall Study|Physician Decision|0|||
19515597|NCT01730040|41928194|FG005|Overall Study|Physician Decision|1|||
19515598|NCT01730040|41928195|FG006|Overall Study|Physician Decision|1|||
19515599|NCT01730040|41928189|FG000|Overall Study|Other than specified|7|||
19515600|NCT01730040|41928190|FG001|Overall Study|Other than specified|8|||
19515601|NCT01730040|41928191|FG002|Overall Study|Other than specified|5|||
19515602|NCT01730040|41928192|FG003|Overall Study|Other than specified|5|||
19515603|NCT01730040|41928193|FG004|Overall Study|Other than specified|5|||
19515604|NCT01730040|41928194|FG005|Overall Study|Other than specified|4|||
19515605|NCT01730040|41928195|FG006|Overall Study|Other than specified|4|||
19515606|NCT01730040|41928189|FG000|Overall Study|Adverse Event|4|||
19515607|NCT01730040|41928190|FG001|Overall Study|Adverse Event|3|||
19515608|NCT01730040|41928191|FG002|Overall Study|Adverse Event|5|||
19515609|NCT01730040|41928192|FG003|Overall Study|Adverse Event|3|||
19515610|NCT01730040|41928193|FG004|Overall Study|Adverse Event|1|||
19515611|NCT01730040|41928194|FG005|Overall Study|Adverse Event|1|||
19515612|NCT01730040|41928195|FG006|Overall Study|Adverse Event|2|||
19515613|NCT01730040|41928189|FG000|Overall Study|Poor compliance to protocol|2|||
19515614|NCT01730040|41928190|FG001|Overall Study|Poor compliance to protocol|4|||
19515615|NCT01730040|41928191|FG002|Overall Study|Poor compliance to protocol|0|||
19515616|NCT01730040|41928192|FG003|Overall Study|Poor compliance to protocol|0|||
19515617|NCT01730040|41928193|FG004|Overall Study|Poor compliance to protocol|0|||
19515618|NCT01730040|41928194|FG005|Overall Study|Poor compliance to protocol|0|||
19515619|NCT01730040|41928195|FG006|Overall Study|Poor compliance to protocol|1|||
19515620|NCT01706328|41928213|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
19515621|NCT01706328|41928214|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19515622|NCT01706328|41928215|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19515623|NCT01706328|41928213|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
19515624|NCT01706328|41928214|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19515625|NCT01706328|41928215|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19515626|NCT01706328|41928213|FG000|2-week Run-in Period|Physician Decision|4|||
19515627|NCT01706328|41928214|FG001|2-week Run-in Period|Physician Decision|0|||
19515628|NCT01706328|41928215|FG002|2-week Run-in Period|Physician Decision|0|||
19515629|NCT01706328|41928213|FG000|2-week Run-in Period|Adverse Event|4|||
19515630|NCT01706328|41928214|FG001|2-week Run-in Period|Adverse Event|0|||
19515631|NCT01706328|41928215|FG002|2-week Run-in Period|Adverse Event|0|||
19515632|NCT01706328|41928213|FG000|2-week Run-in Period|Lost to Follow-up|2|||
19515633|NCT01706328|41928214|FG001|2-week Run-in Period|Lost to Follow-up|0|||
19515634|NCT01706328|41928215|FG002|2-week Run-in Period|Lost to Follow-up|0|||
19515635|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
19515636|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
19515637|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
19515638|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
19515639|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
19515640|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
19515641|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
19515642|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
19515643|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
19515644|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
19515645|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
19515646|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
19515647|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
19515648|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
19515649|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
19515650|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
19515651|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
19515652|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
19515653|NCT01706328|41928213|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19515654|NCT01706328|41928214|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
19515655|NCT01706328|41928215|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
19515656|NCT01753518|41928223|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
19515657|NCT01753518|41928224|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
19515658|NCT01753518|41928223|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
19515659|NCT01753518|41928224|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
19515660|NCT01753518|41928223|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
19515661|NCT01753518|41928224|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
19515662|NCT01753518|41928223|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
19515663|NCT01753518|41928224|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
19515664|NCT01706250|41928230|FG000|Overall Study|Lost to Follow-up|2|||
19515665|NCT01729728|41928242|FG000|Overall Study|Adverse Event|0|||
19515666|NCT01729728|41928243|FG001|Overall Study|Adverse Event|6|||
19515667|NCT01729728|41928244|FG002|Overall Study|Adverse Event|0|||
19515668|NCT01729728|41928242|FG000|Overall Study|Protocol Violation|1|||
19515669|NCT01729728|41928243|FG001|Overall Study|Protocol Violation|0|||
19515670|NCT01729728|41928244|FG002|Overall Study|Protocol Violation|1|||
19515671|NCT01729026|41928377|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
19515672|NCT01729026|41928378|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
19515673|NCT01729026|41928377|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
19515674|NCT01729026|41928378|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
19515675|NCT01728792|41928392|FG000|Overall Study|Withdrawal of Consent|1|||
19515676|NCT01728792|41928393|FG001|Overall Study|Withdrawal of Consent|1|||
19515677|NCT01728792|41928394|FG002|Overall Study|Withdrawal of Consent|0|||
19515678|NCT01728792|41928395|FG003|Overall Study|Withdrawal of Consent|1|||
19515679|NCT01728792|41928396|FG004|Overall Study|Withdrawal of Consent|0|||
19515680|NCT01728792|41928392|FG000|Overall Study|Lost to Follow-up|2|||
19515681|NCT01728792|41928393|FG001|Overall Study|Lost to Follow-up|1|||
19515682|NCT01728792|41928394|FG002|Overall Study|Lost to Follow-up|4|||
19515683|NCT01728792|41928395|FG003|Overall Study|Lost to Follow-up|2|||
19515684|NCT01728792|41928396|FG004|Overall Study|Lost to Follow-up|0|||
19515685|NCT01752036|41928408|FG000|Overall Study|Death|2|||
19618349|NCT00879684|42067786|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
19618350|NCT00879684|42067787|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
19618351|NCT00879684|42067781|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618352|NCT00879684|42067782|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618353|NCT00879684|42067783|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618354|NCT00879684|42067784|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618355|NCT00879684|42067785|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618356|NCT00879684|42067786|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
19618357|NCT00879684|42067787|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
19618358|NCT00879684|42067781|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618359|NCT00879684|42067782|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618360|NCT00879684|42067783|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618361|NCT00879684|42067784|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618362|NCT00879684|42067785|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618363|NCT00879684|42067786|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
19618364|NCT00879684|42067787|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
19618365|NCT00581776|42067806|FG000|Overall Study|Disease progression or no response|3|||
19618366|NCT00883740|42067810|FG000|First Intervention|Lost to Follow-up|1|||
19618367|NCT00883740|42067811|FG001|First Intervention|Lost to Follow-up|0|||
19618368|NCT00883740|42067810|FG000|First Intervention|No longer willing to participate|2|||
19618369|NCT00883740|42067811|FG001|First Intervention|No longer willing to participate|0|||
19618370|NCT00883740|42067810|FG000|First Intervention|Protocol Violation|3|||
19618371|NCT00883740|42067811|FG001|First Intervention|Protocol Violation|6|||
19618372|NCT00883740|42067810|FG000|First Intervention|Adverse Event|1|||
19618373|NCT00883740|42067811|FG001|First Intervention|Adverse Event|2|||
19618374|NCT00883740|42067810|FG000|Second Intervention|Protocol Violation|1|||
19618375|NCT00883740|42067811|FG001|Second Intervention|Protocol Violation|0|||
19618376|NCT00883740|42067810|FG000|Second Intervention|No longer willing to participate|0|||
19618377|NCT00883740|42067811|FG001|Second Intervention|No longer willing to participate|1|||
19618378|NCT00597012|42067819|FG000|Overall Study|Death|1|||
19618379|NCT00597012|42067820|FG001|Overall Study|Death|1|||
19618380|NCT00597012|42067819|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
19618381|NCT00597012|42067820|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
19618382|NCT00597012|42067819|FG000|Overall Study|Withdrawal by Subject|7|||
19618383|NCT00597012|42067820|FG001|Overall Study|Withdrawal by Subject|4|||
19618384|NCT00597012|42067819|FG000|Overall Study|Ineligible|2|||
19618385|NCT00597012|42067820|FG001|Overall Study|Ineligible|0|||
19618386|NCT00597012|42067819|FG000|Overall Study|Lost to Follow-up|0|||
19618387|NCT00597012|42067820|FG001|Overall Study|Lost to Follow-up|2|||
19618388|NCT00542815|42067831|FG000|Overall Study|Adverse Event|19|||
19618389|NCT00542815|42067832|FG001|Overall Study|Adverse Event|6|||
19618390|NCT00542815|42067833|FG002|Overall Study|Adverse Event|9|||
19618391|NCT00542815|42067831|FG000|Overall Study|Death|10|||
19618392|NCT00542815|42067832|FG001|Overall Study|Death|7|||
19618393|NCT00542815|42067833|FG002|Overall Study|Death|3|||
19618394|NCT00542815|42067831|FG000|Overall Study|Lack of Efficacy|9|||
19515686|NCT01728324|41928416|FG000|Termination of DBV|Adverse Event|14|||
19515687|NCT01728324|41928417|FG001|Termination of DBV|Adverse Event|13|||
19515688|NCT01728324|41928418|FG002|Termination of DBV|Adverse Event|4|||
19515689|NCT01728324|41928416|FG000|Termination of DBV|Lack of Efficacy|14|||
19515690|NCT01728324|41928417|FG001|Termination of DBV|Lack of Efficacy|12|||
19618395|NCT00542815|42067832|FG001|Overall Study|Lack of Efficacy|2|||
19618396|NCT00542815|42067833|FG002|Overall Study|Lack of Efficacy|0|||
19618397|NCT00542815|42067831|FG000|Overall Study|Physician Decision|2|||
19618398|NCT00542815|42067832|FG001|Overall Study|Physician Decision|1|||
19618399|NCT00542815|42067833|FG002|Overall Study|Physician Decision|0|||
19618400|NCT00542815|42067831|FG000|Overall Study|Protocol Violation|1|||
19394160|NCT01362049|41638224|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
19618401|NCT00542815|42067832|FG001|Overall Study|Protocol Violation|1|||
19618402|NCT00542815|42067833|FG002|Overall Study|Protocol Violation|2|||
19618403|NCT00542815|42067831|FG000|Overall Study|Withdrawal by Subject|41|||
19704821|NCT00146172|42149182|FG004|Overall Study|Adverse Event|0|||
19704822|NCT00146172|42149183|FG005|Overall Study|Adverse Event|2|||
19704823|NCT00146172|42149184|FG006|Overall Study|Adverse Event|3|||
19704824|NCT00146172|42149185|FG007|Overall Study|Adverse Event|10|||
19704825|NCT00146172|42149178|FG000|Overall Study|Lost to Follow-up|0|||
19704826|NCT00146172|42149179|FG001|Overall Study|Lost to Follow-up|0|||
19704827|NCT00146172|42149180|FG002|Overall Study|Lost to Follow-up|0|||
19704828|NCT00146172|42149181|FG003|Overall Study|Lost to Follow-up|0|||
19704829|NCT00146172|42149182|FG004|Overall Study|Lost to Follow-up|0|||
19704830|NCT00146172|42149183|FG005|Overall Study|Lost to Follow-up|0|||
19515691|NCT01728324|41928418|FG002|Termination of DBV|Lack of Efficacy|8|||
19515692|NCT01728324|41928416|FG000|Termination of DBV|Withdrawal by Subject|9|||
19515693|NCT01728324|41928417|FG001|Termination of DBV|Withdrawal by Subject|6|||
19618404|NCT00542815|42067832|FG001|Overall Study|Withdrawal by Subject|5|||
19618405|NCT00542815|42067833|FG002|Overall Study|Withdrawal by Subject|8|||
19618406|NCT00542815|42067831|FG000|Overall Study|Other reasons|24|||
19618407|NCT00542815|42067832|FG001|Overall Study|Other reasons|10|||
19618408|NCT00542815|42067833|FG002|Overall Study|Other reasons|10|||
19618409|NCT00542425|42067846|FG000|Initial 24 Weeks|Administrative reasons|0|||
19618410|NCT00542425|42067847|FG001|Initial 24 Weeks|Administrative reasons|0|||
19618411|NCT00542425|42067848|FG002|Initial 24 Weeks|Administrative reasons|1|||
19515694|NCT01728324|41928418|FG002|Termination of DBV|Withdrawal by Subject|2|||
19515695|NCT01728324|41928416|FG000|Termination of DBV|Other than stated|1|||
19515696|NCT01728324|41928417|FG001|Termination of DBV|Other than stated|3|||
19515697|NCT01728324|41928418|FG002|Termination of DBV|Other than stated|0|||
19515698|NCT01728324|41928416|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
19515699|NCT01728324|41928417|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
19515700|NCT01728324|41928418|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
19515701|NCT01728324|41928416|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
19515702|NCT01728324|41928417|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
19515703|NCT01728324|41928418|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
19515704|NCT01728324|41928416|FG000|Termination of FDV|Adverse Event|14|||
19515705|NCT01728324|41928417|FG001|Termination of FDV|Adverse Event|13|||
19618412|NCT00542425|42067849|FG003|Initial 24 Weeks|Administrative reasons|1|||
19618413|NCT00542425|42067850|FG004|Initial 24 Weeks|Administrative reasons|0|||
19618414|NCT00542425|42067846|FG000|Initial 24 Weeks|Adverse Event|0|||
19618415|NCT00542425|42067847|FG001|Initial 24 Weeks|Adverse Event|1|||
19618416|NCT00542425|42067848|FG002|Initial 24 Weeks|Adverse Event|1|||
19618417|NCT00542425|42067849|FG003|Initial 24 Weeks|Adverse Event|3|||
19515706|NCT01728324|41928418|FG002|Termination of FDV|Adverse Event|4|||
19515707|NCT01728324|41928416|FG000|Termination of FDV|Lack of Efficacy|14|||
19515708|NCT01728324|41928417|FG001|Termination of FDV|Lack of Efficacy|12|||
19515709|NCT01728324|41928418|FG002|Termination of FDV|Lack of Efficacy|8|||
19515710|NCT01728324|41928416|FG000|Termination of FDV|Withdrawal by Subject|9|||
19515711|NCT01728324|41928417|FG001|Termination of FDV|Withdrawal by Subject|6|||
19515712|NCT01728324|41928418|FG002|Termination of FDV|Withdrawal by Subject|2|||
19515713|NCT01728324|41928416|FG000|Termination of FDV|Other than stated|1|||
19515714|NCT01728324|41928417|FG001|Termination of FDV|Other than stated|3|||
19515715|NCT01728324|41928418|FG002|Termination of FDV|Other than stated|0|||
19515716|NCT01728324|41928416|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
19515717|NCT01728324|41928417|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
19515718|NCT01728324|41928418|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
19515719|NCT01728324|41928416|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
19515720|NCT01728324|41928417|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
19515721|NCT01728324|41928418|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
19515722|NCT01728324|41928416|FG000|Termination of RBV|Adverse Event|15|||
19515723|NCT01728324|41928417|FG001|Termination of RBV|Adverse Event|16|||
19515724|NCT01728324|41928418|FG002|Termination of RBV|Adverse Event|5|||
19515725|NCT01728324|41928416|FG000|Termination of RBV|Lack of Efficacy|14|||
19618418|NCT00542425|42067850|FG004|Initial 24 Weeks|Adverse Event|2|||
19618419|NCT00542425|42067846|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
19618420|NCT00542425|42067847|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
19618421|NCT00542425|42067848|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
19618422|NCT00542425|42067849|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
19618423|NCT00542425|42067850|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
19704831|NCT00146172|42149184|FG006|Overall Study|Lost to Follow-up|0|||
19704832|NCT00146172|42149185|FG007|Overall Study|Lost to Follow-up|1|||
19515726|NCT01728324|41928417|FG001|Termination of RBV|Lack of Efficacy|11|||
19515727|NCT01728324|41928418|FG002|Termination of RBV|Lack of Efficacy|7|||
19515728|NCT01728324|41928416|FG000|Termination of RBV|Withdrawal by Subject|9|||
19515729|NCT01728324|41928417|FG001|Termination of RBV|Withdrawal by Subject|5|||
19618424|NCT00542425|42067846|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
19704833|NCT00146172|42149178|FG000|Overall Study|Disease Progression|2|||
19515730|NCT01728324|41928418|FG002|Termination of RBV|Withdrawal by Subject|2|||
19515731|NCT01728324|41928416|FG000|Termination of RBV|Other than stated|1|||
19515732|NCT01728324|41928417|FG001|Termination of RBV|Other than stated|3|||
19515733|NCT01728324|41928418|FG002|Termination of RBV|Other than stated|1|||
19515734|NCT01728324|41928416|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
19515735|NCT01728324|41928417|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
19515736|NCT01728324|41928418|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
19515737|NCT01728324|41928416|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
19515738|NCT01728324|41928417|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
19515739|NCT01728324|41928418|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
19515740|NCT01728246|41928430|FG000|Overall Study|Participant needed rescue medication|1|||
19515741|NCT01728246|41928431|FG001|Overall Study|Participant needed rescue medication|5|||
19515742|NCT01728246|41928430|FG000|Overall Study|Protocol Violation|1|||
19515743|NCT01728246|41928431|FG001|Overall Study|Protocol Violation|0|||
19515744|NCT01728246|41928430|FG000|Overall Study|Withdrawal by Subject|2|||
19515745|NCT01728246|41928431|FG001|Overall Study|Withdrawal by Subject|3|||
19515746|NCT01728246|41928430|FG000|Overall Study|Lost to Follow-up|23|||
19515747|NCT01728246|41928431|FG001|Overall Study|Lost to Follow-up|22|||
19515748|NCT01728246|41928430|FG000|Overall Study|Lack of Efficacy|1|||
19515749|NCT01728246|41928431|FG001|Overall Study|Lack of Efficacy|1|||
19515750|NCT01728246|41928430|FG000|Overall Study|Adverse Event|8|||
19515751|NCT01728246|41928431|FG001|Overall Study|Adverse Event|5|||
19515752|NCT01705236|41928437|FG000|Overall Study|Lost to Follow-up|1|||
19515753|NCT01705236|41928437|FG000|Overall Study|Administrative problems|2|||
19515754|NCT01705236|41928437|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
19515755|NCT01705236|41928437|FG000|Overall Study|Protocol Violation|3|||
19515756|NCT01705236|41928437|FG000|Overall Study|Abnormal test procedure result(s)|4|||
19515757|NCT01705236|41928437|FG000|Overall Study|Abnormal laboratory value(s)|4|||
19515758|NCT01705236|41928437|FG000|Overall Study|Withdrawal by Subject|5|||
19515759|NCT01705236|41928437|FG000|Overall Study|Adverse Event|5|||
19515760|NCT01705080|41928444|FG000|Overall Study|Missed visit|10|||
19515761|NCT01705080|41928445|FG001|Overall Study|Missed visit|4|||
19515762|NCT01705080|41928446|FG002|Overall Study|Missed visit|1|||
19515763|NCT01705080|41928444|FG000|Overall Study|Death|4|||
19515764|NCT01705080|41928445|FG001|Overall Study|Death|4|||
19515765|NCT01705080|41928446|FG002|Overall Study|Death|6|||
19515766|NCT01705080|41928444|FG000|Overall Study|Withdrawal by Subject|61|||
19515767|NCT01705080|41928445|FG001|Overall Study|Withdrawal by Subject|44|||
19515768|NCT01705080|41928446|FG002|Overall Study|Withdrawal by Subject|9|||
19515769|NCT01704846|41928456|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19515770|NCT01704846|41928457|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19515771|NCT01751802|41928465|FG000|Overall Study|Adverse Event|4|||
19515772|NCT01751802|41928466|FG001|Overall Study|Adverse Event|2|||
19515773|NCT01704456|41928480|FG000|Overall Study|Lost to Follow-up|8|||
19515774|NCT01704456|41928481|FG001|Overall Study|Lost to Follow-up|14|||
19515775|NCT01703988|41928491|FG000|Overall Study|Investigator Judgment|0|||
19515776|NCT01703988|41928492|FG001|Overall Study|Investigator Judgment|0|||
19515777|NCT01703988|41928493|FG002|Overall Study|Investigator Judgment|0|||
19515778|NCT01703988|41928494|FG003|Overall Study|Investigator Judgment|1|||
19515779|NCT01703832|41928507|FG000|Overall Study|Withdrawal by Subject|1|||
19515780|NCT01703832|41928508|FG001|Overall Study|Withdrawal by Subject|0|||
19515781|NCT01703286|41928514|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
19515782|NCT01703286|41928515|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
19515783|NCT01703286|41928516|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
19515784|NCT01703286|41928517|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
19515785|NCT01703286|41928518|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
19515786|NCT01703286|41928519|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
19515787|NCT01703286|41928514|FG000|Period 2 Including Washout|Adverse Event|0|||
19515788|NCT01703286|41928515|FG001|Period 2 Including Washout|Adverse Event|0|||
19515789|NCT01703286|41928516|FG002|Period 2 Including Washout|Adverse Event|0|||
19515790|NCT01703286|41928517|FG003|Period 2 Including Washout|Adverse Event|1|||
19515791|NCT01703286|41928518|FG004|Period 2 Including Washout|Adverse Event|0|||
19515792|NCT01703286|41928519|FG005|Period 2 Including Washout|Adverse Event|0|||
19515793|NCT01703208|41928532|FG000|Overall Study|Death|61|||
19515794|NCT01703208|41928533|FG001|Overall Study|Death|48|||
19515795|NCT01703208|41928532|FG000|Overall Study|Lack of Efficacy|1|||
19515796|NCT01703208|41928533|FG001|Overall Study|Lack of Efficacy|2|||
19515797|NCT01703208|41928532|FG000|Overall Study|Lost to Follow-up|68|||
19515798|NCT01703208|41928533|FG001|Overall Study|Lost to Follow-up|62|||
19515799|NCT01703208|41928532|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19515800|NCT01703208|41928533|FG001|Overall Study|Non-Compliance with Study Drug|0|||
19515801|NCT01703208|41928532|FG000|Overall Study|Excluded Medication|1|||
19515802|NCT01703208|41928533|FG001|Overall Study|Excluded Medication|2|||
19515803|NCT01703208|41928532|FG000|Overall Study|Site Discontinued Study Participation|23|||
19515804|NCT01703208|41928533|FG001|Overall Study|Site Discontinued Study Participation|27|||
19394161|NCT01362049|41638225|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
19515805|NCT01703208|41928532|FG000|Overall Study|Physician Decision|11|||
19515806|NCT01703208|41928533|FG001|Overall Study|Physician Decision|13|||
19515807|NCT01703208|41928532|FG000|Overall Study|Progressive disease|2|||
19515808|NCT01703208|41928533|FG001|Overall Study|Progressive disease|2|||
19515809|NCT01703208|41928532|FG000|Overall Study|Protocol Violation|1|||
19515810|NCT01703208|41928533|FG001|Overall Study|Protocol Violation|1|||
19515811|NCT01703208|41928532|FG000|Overall Study|Study Terminated by Sponsor|1710|||
19515812|NCT01703208|41928533|FG001|Overall Study|Study Terminated by Sponsor|1716|||
19515813|NCT01703208|41928532|FG000|Overall Study|Withdrawal by Subject|205|||
19515814|NCT01703208|41928533|FG001|Overall Study|Withdrawal by Subject|209|||
19515815|NCT01703208|41928532|FG000|Overall Study|Adverse Event|14|||
19515816|NCT01703208|41928533|FG001|Overall Study|Adverse Event|19|||
19515817|NCT01703208|41928532|FG000|Overall Study|Technical Problems|0|||
19515818|NCT01703208|41928533|FG001|Overall Study|Technical Problems|1|||
19515819|NCT01703208|41928532|FG000|Overall Study|Protocol Deviation|2|||
19515820|NCT01703208|41928533|FG001|Overall Study|Protocol Deviation|0|||
19515821|NCT01727700|41928542|FG000|Overall Study|Adverse Event|0|||
19515822|NCT01727700|41928543|FG001|Overall Study|Adverse Event|7|||
19515823|NCT01727700|41928544|FG002|Overall Study|Adverse Event|1|||
19515824|NCT01727700|41928542|FG000|Overall Study|Particpant withdrew consent|0|||
19515825|NCT01727700|41928543|FG001|Overall Study|Particpant withdrew consent|3|||
19515826|NCT01727700|41928544|FG002|Overall Study|Particpant withdrew consent|1|||
19515827|NCT01727700|41928542|FG000|Overall Study|Protocol Violation|2|||
19515828|NCT01727700|41928543|FG001|Overall Study|Protocol Violation|0|||
19515829|NCT01727700|41928544|FG002|Overall Study|Protocol Violation|0|||
19515830|NCT01727154|41928552|FG000|Overall Study|Death|17|||
19515831|NCT01727154|41928552|FG000|Overall Study|Withdrawal by Subject|14|||
19515832|NCT01727154|41928552|FG000|Overall Study|Subject Withdrew Consent|18|||
19515833|NCT01727154|41928552|FG000|Overall Study|Study Terminated|6|||
19515834|NCT01727154|41928552|FG000|Overall Study|No Discontinuation Documentation|4|||
19515835|NCT01725750|41928558|FG000|Overall Study|Adverse Event|1|||
19515836|NCT01725750|41928559|FG001|Overall Study|Adverse Event|0|||
19515837|NCT01725750|41928558|FG000|Overall Study|Lost to Follow-up|1|||
19515838|NCT01725750|41928559|FG001|Overall Study|Lost to Follow-up|1|||
19515839|NCT01725750|41928558|FG000|Overall Study|Withdrawal by Subject|0|||
19515840|NCT01725750|41928559|FG001|Overall Study|Withdrawal by Subject|9|||
19515841|NCT01725282|41928571|FG000|Overall Study|Adverse Event|1|||
19515842|NCT01725282|41928572|FG001|Overall Study|Adverse Event|3|||
19515843|NCT01725282|41928573|FG002|Overall Study|Adverse Event|6|||
19515844|NCT01725282|41928574|FG003|Overall Study|Adverse Event|4|||
19515845|NCT01725282|41928571|FG000|Overall Study|Exacerbation of Target Disease|1|||
19515846|NCT01725282|41928572|FG001|Overall Study|Exacerbation of Target Disease|0|||
19515847|NCT01725282|41928573|FG002|Overall Study|Exacerbation of Target Disease|0|||
19618425|NCT00542425|42067847|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
19618426|NCT00542425|42067848|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
19618427|NCT00542425|42067849|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
19618428|NCT00542425|42067850|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
19618429|NCT00542425|42067846|FG000|Initial 24 Weeks|Non-compliance|0|||
19618430|NCT00542425|42067847|FG001|Initial 24 Weeks|Non-compliance|0|||
19618431|NCT00542425|42067848|FG002|Initial 24 Weeks|Non-compliance|0|||
19618432|NCT00542425|42067849|FG003|Initial 24 Weeks|Non-compliance|1|||
19618433|NCT00542425|42067850|FG004|Initial 24 Weeks|Non-compliance|1|||
19618434|NCT00542425|42067846|FG000|Initial 24 Weeks|Protocol Violation|0|||
19618435|NCT00542425|42067847|FG001|Initial 24 Weeks|Protocol Violation|0|||
19618436|NCT00542425|42067848|FG002|Initial 24 Weeks|Protocol Violation|0|||
19618437|NCT00542425|42067849|FG003|Initial 24 Weeks|Protocol Violation|1|||
19618438|NCT00542425|42067850|FG004|Initial 24 Weeks|Protocol Violation|0|||
19618439|NCT00542425|42067846|FG000|Initial 24 Weeks|Refusal of treatment|2|||
19618440|NCT00542425|42067847|FG001|Initial 24 Weeks|Refusal of treatment|2|||
19618441|NCT00542425|42067848|FG002|Initial 24 Weeks|Refusal of treatment|1|||
19618442|NCT00542425|42067849|FG003|Initial 24 Weeks|Refusal of treatment|4|||
19618443|NCT00542425|42067850|FG004|Initial 24 Weeks|Refusal of treatment|1|||
19515848|NCT01725282|41928574|FG003|Overall Study|Exacerbation of Target Disease|1|||
19515849|NCT01725282|41928571|FG000|Overall Study|Met Exclusion Criteria|0|||
19515850|NCT01725282|41928572|FG001|Overall Study|Met Exclusion Criteria|0|||
19515851|NCT01725282|41928573|FG002|Overall Study|Met Exclusion Criteria|1|||
19515852|NCT01725282|41928574|FG003|Overall Study|Met Exclusion Criteria|0|||
19515853|NCT01725282|41928571|FG000|Overall Study|Study Site Withdrawal|0|||
19515854|NCT01725282|41928572|FG001|Overall Study|Study Site Withdrawal|1|||
19515855|NCT01725282|41928573|FG002|Overall Study|Study Site Withdrawal|0|||
19515856|NCT01725282|41928574|FG003|Overall Study|Study Site Withdrawal|0|||
19515857|NCT01725282|41928571|FG000|Overall Study|Withdrawal by Subject|0|||
19515858|NCT01725282|41928572|FG001|Overall Study|Withdrawal by Subject|0|||
19515859|NCT01725282|41928573|FG002|Overall Study|Withdrawal by Subject|1|||
19515860|NCT01725282|41928574|FG003|Overall Study|Withdrawal by Subject|1|||
19515861|NCT01725282|41928571|FG000|Overall Study|Lack of Efficacy|0|||
19618444|NCT00542425|42067846|FG000|Initial 24 Weeks|Other|0|||
19618445|NCT00542425|42067847|FG001|Initial 24 Weeks|Other|2|||
19618446|NCT00542425|42067848|FG002|Initial 24 Weeks|Other|1|||
19618447|NCT00542425|42067849|FG003|Initial 24 Weeks|Other|0|||
19618448|NCT00542425|42067850|FG004|Initial 24 Weeks|Other|0|||
19618449|NCT00542425|42067846|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
19618450|NCT00542425|42067847|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
19618451|NCT00542425|42067848|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
19618452|NCT00542425|42067849|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
19618453|NCT00542425|42067850|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
19618454|NCT00542425|42067846|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
19618455|NCT00542425|42067847|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
19618456|NCT00542425|42067848|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
19618457|NCT00542425|42067849|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
19618458|NCT00542425|42067850|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
19618459|NCT00542425|42067846|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
19618460|NCT00542425|42067847|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
19618461|NCT00542425|42067848|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
19618462|NCT00542425|42067849|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
19618463|NCT00542425|42067850|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
19515862|NCT01725282|41928572|FG001|Overall Study|Lack of Efficacy|1|||
19515863|NCT01725282|41928573|FG002|Overall Study|Lack of Efficacy|0|||
19515864|NCT01725282|41928574|FG003|Overall Study|Lack of Efficacy|1|||
19515865|NCT01725126|41928590|FG000|Overall Study|Protocol Violation|0|||
19515866|NCT01725126|41928591|FG001|Overall Study|Protocol Violation|1|||
19515867|NCT01725126|41928592|FG002|Overall Study|Protocol Violation|0|||
19515868|NCT01725126|41928593|FG003|Overall Study|Protocol Violation|0|||
19515869|NCT01725126|41928594|FG004|Overall Study|Protocol Violation|0|||
19515870|NCT01725126|41928595|FG005|Overall Study|Protocol Violation|0|||
19515871|NCT01725126|41928590|FG000|Overall Study|Withdrawal by Subject|0|||
19515872|NCT01725126|41928591|FG001|Overall Study|Withdrawal by Subject|0|||
19515873|NCT01725126|41928592|FG002|Overall Study|Withdrawal by Subject|0|||
19515874|NCT01725126|41928593|FG003|Overall Study|Withdrawal by Subject|1|||
19515875|NCT01725126|41928594|FG004|Overall Study|Withdrawal by Subject|0|||
19515876|NCT01725126|41928595|FG005|Overall Study|Withdrawal by Subject|0|||
19515877|NCT01751724|41928620|FG000|Overall Study|extubated bef.start assigned treatment|1|||
19515878|NCT01751724|41928621|FG001|Overall Study|extubated bef.start assigned treatment|0|||
19515879|NCT01751724|41928620|FG000|Overall Study|withdrawn by parent|0|||
19515880|NCT01751724|41928621|FG001|Overall Study|withdrawn by parent|2|||
19515881|NCT01751646|41928629|FG000|Overall Study|Lost to Follow-up|5|||
19515882|NCT01751646|41928630|FG001|Overall Study|Lost to Follow-up|1|||
19515883|NCT01751646|41928629|FG000|Overall Study|Withdrawal by Subject|0|||
19515884|NCT01751646|41928630|FG001|Overall Study|Withdrawal by Subject|4|||
19515885|NCT01751646|41928629|FG000|Overall Study|Starting hormone therapy|1|||
19515886|NCT01751646|41928630|FG001|Overall Study|Starting hormone therapy|0|||
19515887|NCT01751646|41928629|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
19515888|NCT01751646|41928630|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
19515889|NCT01751646|41928629|FG000|Overall Study|Inadvertent enrollment|1|||
19515890|NCT01751646|41928630|FG001|Overall Study|Inadvertent enrollment|1|||
19515891|NCT01751646|41928629|FG000|Overall Study|Moved out of the area|1|||
19515892|NCT01751646|41928630|FG001|Overall Study|Moved out of the area|5|||
19515893|NCT01751646|41928629|FG000|Overall Study|Inability to attend required visits|0|||
19515894|NCT01751646|41928630|FG001|Overall Study|Inability to attend required visits|1|||
19515895|NCT01751646|41928629|FG000|Overall Study|Off study due to multiple obligations|0|||
19515896|NCT01751646|41928630|FG001|Overall Study|Off study due to multiple obligations|1|||
19515897|NCT01751646|41928629|FG000|Overall Study|Fails to comply with study requirements|0|||
19515898|NCT01751646|41928630|FG001|Overall Study|Fails to comply with study requirements|1|||
19515899|NCT01751646|41928629|FG000|Overall Study|Childcare issues|1|||
19515900|NCT01751646|41928630|FG001|Overall Study|Childcare issues|1|||
19515901|NCT01751568|41928643|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
19515902|NCT01751568|41928644|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
19515903|NCT01751568|41928645|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
19618464|NCT00542425|42067846|FG000|Extended 24 Weeks of Treatment|Other|1|||
19515904|NCT01751412|41928653|FG000|Overall Study|Disease Progression Before Treatment|1|||
19515905|NCT01751178|41928660|FG000|Overall Study|Adverse Event|2|||
19515906|NCT01751178|41928661|FG001|Overall Study|Adverse Event|0|||
19515907|NCT01751178|41928662|FG002|Overall Study|Adverse Event|0|||
19515908|NCT01751178|41928660|FG000|Overall Study|Other Reason (unknown)|1|||
19515909|NCT01751178|41928661|FG001|Overall Study|Other Reason (unknown)|0|||
19515910|NCT01751178|41928662|FG002|Overall Study|Other Reason (unknown)|2|||
19515911|NCT01606254|41928678|FG000|Overall Study|Withdrawal by Subject|1|||
19515912|NCT01606254|41928679|FG001|Overall Study|Withdrawal by Subject|3|||
19515913|NCT01606254|41928680|FG002|Overall Study|Withdrawal by Subject|0|||
19515914|NCT01606254|41928681|FG003|Overall Study|Withdrawal by Subject|2|||
19618465|NCT00542425|42067847|FG001|Extended 24 Weeks of Treatment|Other|1|||
19515915|NCT01606254|41928678|FG000|Overall Study|Adverse Event|1|||
19515916|NCT01606254|41928679|FG001|Overall Study|Adverse Event|1|||
19515917|NCT01606254|41928680|FG002|Overall Study|Adverse Event|0|||
19515918|NCT01606254|41928681|FG003|Overall Study|Adverse Event|1|||
19515919|NCT01750242|41928691|FG000|Overall Study|Unreadable Images|3|||
19515920|NCT01723254|41928704|FG000|Overall Study|Conflict with work schedule|0|||
19515921|NCT01723254|41928705|FG001|Overall Study|Conflict with work schedule|0|||
19515922|NCT01723254|41928706|FG002|Overall Study|Conflict with work schedule|0|||
19515923|NCT01723254|41928707|FG003|Overall Study|Conflict with work schedule|0|||
19515924|NCT01723254|41928708|FG004|Overall Study|Conflict with work schedule|0|||
19515925|NCT01723254|41928709|FG005|Overall Study|Conflict with work schedule|0|||
19515926|NCT01723254|41928710|FG006|Overall Study|Conflict with work schedule|0|||
19515927|NCT01723254|41928711|FG007|Overall Study|Conflict with work schedule|1|||
19515928|NCT01723254|41928704|FG000|Overall Study|Personal issues|0|||
19515929|NCT01723254|41928705|FG001|Overall Study|Personal issues|0|||
19515930|NCT01723254|41928706|FG002|Overall Study|Personal issues|0|||
19515931|NCT01723254|41928707|FG003|Overall Study|Personal issues|0|||
19515932|NCT01723254|41928708|FG004|Overall Study|Personal issues|0|||
19515933|NCT01723254|41928709|FG005|Overall Study|Personal issues|1|||
19515934|NCT01723254|41928710|FG006|Overall Study|Personal issues|0|||
19515935|NCT01723254|41928711|FG007|Overall Study|Personal issues|0|||
19515936|NCT01723254|41928704|FG000|Overall Study|No longer have time to participate|0|||
19515937|NCT01723254|41928705|FG001|Overall Study|No longer have time to participate|0|||
19515938|NCT01723254|41928706|FG002|Overall Study|No longer have time to participate|0|||
19515939|NCT01723254|41928707|FG003|Overall Study|No longer have time to participate|1|||
19515940|NCT01723254|41928708|FG004|Overall Study|No longer have time to participate|0|||
19515941|NCT01723254|41928709|FG005|Overall Study|No longer have time to participate|0|||
19515942|NCT01723254|41928710|FG006|Overall Study|No longer have time to participate|0|||
19515943|NCT01723254|41928711|FG007|Overall Study|No longer have time to participate|0|||
19515944|NCT01723254|41928704|FG000|Overall Study|Move/Left to another country/city|0|||
19515945|NCT01723254|41928705|FG001|Overall Study|Move/Left to another country/city|0|||
19515946|NCT01723254|41928706|FG002|Overall Study|Move/Left to another country/city|2|||
19515947|NCT01723254|41928707|FG003|Overall Study|Move/Left to another country/city|1|||
19515948|NCT01723254|41928708|FG004|Overall Study|Move/Left to another country/city|1|||
19515949|NCT01723254|41928709|FG005|Overall Study|Move/Left to another country/city|0|||
19515950|NCT01723254|41928710|FG006|Overall Study|Move/Left to another country/city|0|||
19515951|NCT01723254|41928711|FG007|Overall Study|Move/Left to another country/city|0|||
19515952|NCT01723254|41928704|FG000|Overall Study|Protocol Violation|0|||
19515953|NCT01723254|41928705|FG001|Overall Study|Protocol Violation|1|||
19515954|NCT01723254|41928706|FG002|Overall Study|Protocol Violation|0|||
19515955|NCT01723254|41928707|FG003|Overall Study|Protocol Violation|0|||
19515956|NCT01723254|41928708|FG004|Overall Study|Protocol Violation|0|||
19515957|NCT01723254|41928709|FG005|Overall Study|Protocol Violation|0|||
19515958|NCT01723254|41928710|FG006|Overall Study|Protocol Violation|0|||
19515959|NCT01723254|41928711|FG007|Overall Study|Protocol Violation|0|||
19515960|NCT01723254|41928704|FG000|Overall Study|Withdrawal by Subject|1|||
19515961|NCT01723254|41928705|FG001|Overall Study|Withdrawal by Subject|2|||
19515962|NCT01723254|41928706|FG002|Overall Study|Withdrawal by Subject|1|||
19515963|NCT01723254|41928707|FG003|Overall Study|Withdrawal by Subject|0|||
19515964|NCT01723254|41928708|FG004|Overall Study|Withdrawal by Subject|1|||
19515965|NCT01723254|41928709|FG005|Overall Study|Withdrawal by Subject|1|||
19515966|NCT01723254|41928710|FG006|Overall Study|Withdrawal by Subject|1|||
19515967|NCT01723254|41928711|FG007|Overall Study|Withdrawal by Subject|2|||
19515968|NCT01722162|41928731|FG000|Overall Study|Withdrawal by Subject|1|||
19515969|NCT01722162|41928732|FG001|Overall Study|Withdrawal by Subject|1|||
19515970|NCT01722162|41928731|FG000|Overall Study|Found ineligible|1|||
19515971|NCT01722162|41928732|FG001|Overall Study|Found ineligible|0|||
19515972|NCT01722162|41928731|FG000|Overall Study|Unrelated to study adverse event|2|||
19515973|NCT01722162|41928732|FG001|Overall Study|Unrelated to study adverse event|2|||
19515974|NCT01722162|41928731|FG000|Overall Study|Adverse Event|1|||
19515975|NCT01722162|41928732|FG001|Overall Study|Adverse Event|1|||
19515976|NCT01722162|41928731|FG000|Overall Study|Insurance denial post enrollment|0|||
19515977|NCT01722162|41928732|FG001|Overall Study|Insurance denial post enrollment|1|||
19515978|NCT01722162|41928731|FG000|Overall Study|Noncompliance|0|||
19515979|NCT01722162|41928732|FG001|Overall Study|Noncompliance|1|||
19515980|NCT01721772|41928740|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
19515981|NCT01721772|41928741|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
19515982|NCT01721772|41928740|FG000|Pre-Treatment|Poor/non-compliance|0|||
19515983|NCT01721772|41928741|FG001|Pre-Treatment|Poor/non-compliance|1|||
19515984|NCT01721772|41928740|FG000|Pre-Treatment|Participant withdrew consent|0|||
19515985|NCT01721772|41928741|FG001|Pre-Treatment|Participant withdrew consent|1|||
19515986|NCT01721772|41928740|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
19515987|NCT01721772|41928741|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
19515988|NCT01721772|41928740|FG000|Treatment|Disease progression|119|||
19515989|NCT01721772|41928741|FG001|Treatment|Disease progression|168|||
19515990|NCT01721772|41928740|FG000|Treatment|Study drug toxicity|19|||
19515991|NCT01721772|41928741|FG001|Treatment|Study drug toxicity|10|||
19515992|NCT01721772|41928740|FG000|Treatment|Adverse event unrelated to study drug|7|||
19515993|NCT01721772|41928741|FG001|Treatment|Adverse event unrelated to study drug|7|||
19515994|NCT01721772|41928740|FG000|Treatment|Maximum clinical benefit|16|||
19515995|NCT01721772|41928741|FG001|Treatment|Maximum clinical benefit|4|||
19515996|NCT01721772|41928740|FG000|Treatment|Other|19|||
19515997|NCT01721772|41928741|FG001|Treatment|Other|2|||
19515998|NCT01721772|41928740|FG000|Treatment|Participant withdrew consent|2|||
19515999|NCT01721772|41928741|FG001|Treatment|Participant withdrew consent|5|||
19516000|NCT01721772|41928740|FG000|Treatment|Participant request to discontinue study treatment|21|||
19516001|NCT01721772|41928741|FG001|Treatment|Participant request to discontinue study treatment|8|||
19516002|NCT01721772|41928740|FG000|Treatment|Death|1|||
19516003|NCT01721772|41928741|FG001|Treatment|Death|0|||
19516004|NCT01721772|41928740|FG000|Treatment|Not reported|1|||
19516005|NCT01721772|41928741|FG001|Treatment|Not reported|0|||
19516006|NCT01721772|41928740|FG000|Treatment|Poor/non-compliance|1|||
19516007|NCT01721772|41928741|FG001|Treatment|Poor/non-compliance|0|||
19516008|NCT01721772|41928740|FG000|Treatment|Lost to Follow-up|0|||
19516009|NCT01721772|41928741|FG001|Treatment|Lost to Follow-up|1|||
19516010|NCT01702428|41928751|FG000|Overall Study|Adverse Event|2|||
19516011|NCT01702428|41928752|FG001|Overall Study|Adverse Event|0|||
19516012|NCT01702428|41928753|FG002|Overall Study|Adverse Event|0|||
19516013|NCT01702428|41928754|FG003|Overall Study|Adverse Event|0|||
19516014|NCT01702428|41928751|FG000|Overall Study|Lost to Follow-up|33|||
19516015|NCT01702428|41928752|FG001|Overall Study|Lost to Follow-up|41|||
19516016|NCT01702428|41928753|FG002|Overall Study|Lost to Follow-up|37|||
19516017|NCT01702428|41928754|FG003|Overall Study|Lost to Follow-up|44|||
19516018|NCT01702428|41928751|FG000|Overall Study|Parents cannot assist to site|1|||
19516019|NCT01702428|41928752|FG001|Overall Study|Parents cannot assist to site|0|||
19516020|NCT01702428|41928753|FG002|Overall Study|Parents cannot assist to site|1|||
19516021|NCT01702428|41928754|FG003|Overall Study|Parents cannot assist to site|0|||
19516022|NCT01702428|41928751|FG000|Overall Study|Lost Coverage|0|||
19618466|NCT00542425|42067848|FG002|Extended 24 Weeks of Treatment|Other|0|||
19618467|NCT00542425|42067849|FG003|Extended 24 Weeks of Treatment|Other|0|||
19618468|NCT00542425|42067850|FG004|Extended 24 Weeks of Treatment|Other|1|||
19618469|NCT00541099|42067862|FG000|Overall Study|Ineligible|3|||
19618470|NCT00580606|42067868|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
19618471|NCT00580606|42067869|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
19618472|NCT00580606|42067868|FG000|Open Label (OL)|Withdrawal by Subject|4|||
19618473|NCT00580606|42067869|FG001|Open Label (OL)|Withdrawal by Subject|6|||
19618474|NCT00580606|42067868|FG000|Open Label (OL)|Dosing Symptoms|0|||
19618475|NCT00580606|42067869|FG001|Open Label (OL)|Dosing Symptoms|1|||
19618476|NCT00580606|42067868|FG000|Open Label (OL)|Lost to Follow-up|0|||
19618477|NCT00580606|42067869|FG001|Open Label (OL)|Lost to Follow-up|1|||
19618478|NCT00580606|42067868|FG000|Open Label (OL)|Pregnancy|0|||
19618479|NCT00580606|42067869|FG001|Open Label (OL)|Pregnancy|1|||
19618480|NCT00580606|42067868|FG000|Open Label (OL)|Non-compliance|2|||
19516023|NCT01702428|41928752|FG001|Overall Study|Lost Coverage|0|||
19516024|NCT01702428|41928753|FG002|Overall Study|Lost Coverage|0|||
19516025|NCT01702428|41928754|FG003|Overall Study|Lost Coverage|1|||
19516026|NCT01702428|41928751|FG000|Overall Study|Lost Health Plan|3|||
19516027|NCT01702428|41928752|FG001|Overall Study|Lost Health Plan|5|||
19516028|NCT01702428|41928753|FG002|Overall Study|Lost Health Plan|0|||
19516029|NCT01702428|41928754|FG003|Overall Study|Lost Health Plan|2|||
19516030|NCT01702428|41928751|FG000|Overall Study|Mother transferred care|0|||
19516031|NCT01702428|41928752|FG001|Overall Study|Mother transferred care|1|||
19516032|NCT01702428|41928753|FG002|Overall Study|Mother transferred care|0|||
19516033|NCT01702428|41928754|FG003|Overall Study|Mother transferred care|0|||
19516034|NCT01702428|41928751|FG000|Overall Study|Parents too busy|1|||
19516035|NCT01702428|41928752|FG001|Overall Study|Parents too busy|0|||
19516036|NCT01702428|41928753|FG002|Overall Study|Parents too busy|0|||
19516037|NCT01702428|41928754|FG003|Overall Study|Parents too busy|0|||
19516038|NCT01702428|41928751|FG000|Overall Study|Protocol Violation|3|||
19516039|NCT01702428|41928752|FG001|Overall Study|Protocol Violation|0|||
19618481|NCT00580606|42067869|FG001|Open Label (OL)|Non-compliance|0|||
19618482|NCT00580606|42067868|FG000|Open Label (OL)|Physician Decision|1|||
19516040|NCT01702428|41928753|FG002|Overall Study|Protocol Violation|1|||
19516041|NCT01702428|41928754|FG003|Overall Study|Protocol Violation|0|||
19516042|NCT01702428|41928751|FG000|Overall Study|Withdrawal by Subject|21|||
19516043|NCT01702428|41928752|FG001|Overall Study|Withdrawal by Subject|23|||
19516044|NCT01702428|41928753|FG002|Overall Study|Withdrawal by Subject|14|||
19516045|NCT01702428|41928754|FG003|Overall Study|Withdrawal by Subject|10|||
19516046|NCT01701258|41928775|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
19516047|NCT01701258|41928776|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
19516048|NCT01701258|41928777|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
19516049|NCT01701258|41928778|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
19516050|NCT01701258|41928779|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
19516051|NCT01701258|41928780|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
19516052|NCT01701258|41928781|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
19516053|NCT01701258|41928782|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
19618483|NCT00580606|42067869|FG001|Open Label (OL)|Physician Decision|1|||
19618484|NCT00580606|42067868|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
19618485|NCT00580606|42067869|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
19618486|NCT00579982|42067883|FG000|Overall Study|Adverse Event|4|||
19618487|NCT00579982|42067883|FG000|Overall Study|Protocol Violation|4|||
19618488|NCT00596466|42067887|FG000|Overall Study|Lack of Efficacy|5|||
19516054|NCT01701258|41928783|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
19516055|NCT01701258|41928784|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
19516056|NCT01701258|41928785|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
19516057|NCT01701258|41928786|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
19516058|NCT01701258|41928787|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
19516059|NCT01701258|41928775|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
19516060|NCT01701258|41928776|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
19516061|NCT01701258|41928777|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
19516062|NCT01701258|41928778|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
19516063|NCT01701258|41928779|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
19516064|NCT01701258|41928780|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
19516065|NCT01701258|41928781|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
19516066|NCT01701258|41928782|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
19516067|NCT01701258|41928783|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
19516068|NCT01701258|41928784|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
19516069|NCT01701258|41928785|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
19516070|NCT01701258|41928786|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
19516071|NCT01701258|41928787|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
19516072|NCT01701258|41928775|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
19516073|NCT01701258|41928776|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
19516074|NCT01701258|41928777|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
19516075|NCT01701258|41928778|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
19516076|NCT01701258|41928779|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
19516077|NCT01701258|41928780|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
19516078|NCT01701258|41928781|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
19516079|NCT01701258|41928782|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
19516080|NCT01701258|41928783|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
19516081|NCT01701258|41928784|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
19516082|NCT01701258|41928785|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
19516083|NCT01701258|41928786|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
19516084|NCT01701258|41928787|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
19516085|NCT01701258|41928775|FG000|Assessment and Scheduling|Investigator Terminated|2|||
19516086|NCT01701258|41928776|FG001|Assessment and Scheduling|Investigator Terminated|0|||
19516087|NCT01701258|41928777|FG002|Assessment and Scheduling|Investigator Terminated|0|||
19516088|NCT01701258|41928778|FG003|Assessment and Scheduling|Investigator Terminated|0|||
19516089|NCT01701258|41928779|FG004|Assessment and Scheduling|Investigator Terminated|0|||
19516090|NCT01701258|41928780|FG005|Assessment and Scheduling|Investigator Terminated|0|||
19516091|NCT01701258|41928781|FG006|Assessment and Scheduling|Investigator Terminated|0|||
19516092|NCT01701258|41928782|FG007|Assessment and Scheduling|Investigator Terminated|0|||
19516093|NCT01701258|41928783|FG008|Assessment and Scheduling|Investigator Terminated|0|||
19516094|NCT01701258|41928784|FG009|Assessment and Scheduling|Investigator Terminated|0|||
19516095|NCT01701258|41928785|FG010|Assessment and Scheduling|Investigator Terminated|0|||
19516096|NCT01701258|41928786|FG011|Assessment and Scheduling|Investigator Terminated|0|||
19516097|NCT01701258|41928787|FG012|Assessment and Scheduling|Investigator Terminated|0|||
19516098|NCT01700946|41928817|FG000|Overall Study|Lost to Follow-up|1|||
19516099|NCT01700946|41928818|FG001|Overall Study|Lost to Follow-up|0|||
19516100|NCT01700946|41928817|FG000|Overall Study|Physician Decision|7|||
19516101|NCT01700946|41928818|FG001|Overall Study|Physician Decision|12|||
19516102|NCT01700946|41928817|FG000|Overall Study|Withdrawal by Subject|0|||
19516103|NCT01700946|41928818|FG001|Overall Study|Withdrawal by Subject|2|||
19516104|NCT01700946|41928817|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
19516105|NCT01700946|41928818|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
19516106|NCT01700946|41928817|FG000|Overall Study|Relapse|2|||
19516107|NCT01700946|41928818|FG001|Overall Study|Relapse|1|||
19516108|NCT01700946|41928817|FG000|Overall Study|Unacceptable toxicity|1|||
19516109|NCT01700946|41928818|FG001|Overall Study|Unacceptable toxicity|0|||
19516110|NCT01748994|41928830|FG000|Overall Study|Lost to Follow-up|8|||
19516111|NCT01748994|41928831|FG001|Overall Study|Lost to Follow-up|6|||
19516112|NCT01721070|41928837|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
19516113|NCT01748760|41928846|FG000|Overall Study|Withdrawal by Subject|1|||
19618489|NCT00596466|42067887|FG000|Overall Study|Adverse Event|4|||
19516114|NCT01748760|41928847|FG001|Overall Study|Withdrawal by Subject|1|||
19618490|NCT00596466|42067887|FG000|Overall Study|Withdrawal by Subject|2|||
19618491|NCT00596466|42067887|FG000|Overall Study|Protocol Violation|2|||
19618492|NCT00596466|42067887|FG000|Overall Study|Unpecified|2|||
19618493|NCT00596466|42067887|FG000|Overall Study|Enrolled, not treated|2|||
19618494|NCT00596934|42067891|FG000|Overall Study|Protocol Violation|1|||
19618495|NCT00596934|42067891|FG000|Overall Study|Withdrawal by Subject|1|||
19618496|NCT03911401|42067900|FG000|Overall Study|Adverse Event|1|||
19618497|NCT03911401|42067901|FG001|Overall Study|Adverse Event|2|||
19618498|NCT03911401|42067902|FG002|Overall Study|Adverse Event|5|||
19618499|NCT03911401|42067900|FG000|Overall Study|Lack of Efficacy|1|||
19618500|NCT03911401|42067901|FG001|Overall Study|Lack of Efficacy|1|||
19618501|NCT03911401|42067902|FG002|Overall Study|Lack of Efficacy|8|||
19618502|NCT03911401|42067900|FG000|Overall Study|Physician Decision|0|||
19618503|NCT03911401|42067901|FG001|Overall Study|Physician Decision|0|||
19618504|NCT03911401|42067902|FG002|Overall Study|Physician Decision|1|||
19516115|NCT01748760|41928846|FG000|Overall Study|Lost to Follow-up|5|||
19516116|NCT01748760|41928847|FG001|Overall Study|Lost to Follow-up|1|||
19516117|NCT01748292|41928855|FG000|Overall Study|Adverse Event|2|||
19516118|NCT01748292|41928856|FG001|Overall Study|Adverse Event|4|||
19516119|NCT01748292|41928855|FG000|Overall Study|Lost to Follow-up|0|||
19516120|NCT01748292|41928856|FG001|Overall Study|Lost to Follow-up|3|||
19516121|NCT01748292|41928855|FG000|Overall Study|Death|0|||
19516122|NCT01748292|41928856|FG001|Overall Study|Death|3|||
19516123|NCT01748292|41928855|FG000|Overall Study|Withdrawal by Subject|0|||
19516124|NCT01748292|41928856|FG001|Overall Study|Withdrawal by Subject|2|||
19516125|NCT01720602|41928862|FG000|Overall Study|Adverse Event|3|||
19516126|NCT01720602|41928862|FG000|Overall Study|Progressive disease on therapy|2|||
19516127|NCT01746732|41928866|FG000|Lead-In Period|Withdrawal by Subject|1|||
19516128|NCT01746732|41928867|FG001|Lead-In Period|Withdrawal by Subject|0|||
19516129|NCT01746732|41928868|FG002|Lead-In Period|Withdrawal by Subject|0|||
19516130|NCT01746732|41928866|FG000|Period 1|Physician Decision|0|||
19516131|NCT01746732|41928867|FG001|Period 1|Physician Decision|1|||
19516132|NCT01746732|41928868|FG002|Period 1|Physician Decision|0|||
19516133|NCT01746732|41928866|FG000|Period 2|Withdrawal by Subject|0|||
19516134|NCT01746732|41928867|FG001|Period 2|Withdrawal by Subject|0|||
19516135|NCT01746732|41928868|FG002|Period 2|Withdrawal by Subject|2|||
19516136|NCT01746732|41928866|FG000|Period 2|Adverse Event|0|||
19516137|NCT01746732|41928867|FG001|Period 2|Adverse Event|0|||
19516138|NCT01746732|41928868|FG002|Period 2|Adverse Event|1|||
19516139|NCT01746732|41928866|FG000|Period 2|Lost to Follow-up|0|||
19516140|NCT01746732|41928867|FG001|Period 2|Lost to Follow-up|0|||
19516141|NCT01746732|41928868|FG002|Period 2|Lost to Follow-up|1|||
19516142|NCT01720524|41928878|FG000|Part A|Insufficient Clinical Response|2|||
19516143|NCT01720524|41928879|FG001|Part A|Insufficient Clinical Response|4|||
19516144|NCT01720524|41928878|FG000|Part A|Adverse Event|2|||
19516145|NCT01720524|41928879|FG001|Part A|Adverse Event|2|||
19516146|NCT01720524|41928878|FG000|Part A|Death|2|||
19516147|NCT01720524|41928879|FG001|Part A|Death|1|||
19516148|NCT01720524|41928878|FG000|Part A|Lost to Follow-up|0|||
19516149|NCT01720524|41928879|FG001|Part A|Lost to Follow-up|1|||
19516150|NCT01720524|41928878|FG000|Part A|Missed 28 day follow-up visit|1|||
19516151|NCT01720524|41928879|FG001|Part A|Missed 28 day follow-up visit|1|||
19516152|NCT01720524|41928878|FG000|Part A|Withdrawal by Subject|0|||
19516153|NCT01720524|41928879|FG001|Part A|Withdrawal by Subject|1|||
19516154|NCT01720524|41928878|FG000|Part A|Other|0|||
19516155|NCT01720524|41928879|FG001|Part A|Other|1|||
19516156|NCT01720524|41928878|FG000|Part A|Lost to Follow-up|0|||
19516157|NCT01720524|41928879|FG001|Part A|Lost to Follow-up|1|||
19516158|NCT01720524|41928878|FG000|Part B|No longer willing to participate in study|1|||
19516159|NCT01720524|41928879|FG001|Part B|No longer willing to participate in study|4|||
19516160|NCT01720524|41928878|FG000|Part B|Other|2|||
19516161|NCT01720524|41928879|FG001|Part B|Other|0|||
19516162|NCT01720524|41928878|FG000|Part B|Lost to Follow-up|2|||
19516163|NCT01720524|41928879|FG001|Part B|Lost to Follow-up|3|||
19516164|NCT01720524|41928878|FG000|Part B|Death|0|||
19618505|NCT03911401|42067900|FG000|Overall Study|Withdrawal by Subject|1|||
19516165|NCT01720524|41928879|FG001|Part B|Death|2|||
19516166|NCT01720446|41928891|FG000|Overall Study|Lost to Follow-up|12|||
19516167|NCT01720446|41928892|FG001|Overall Study|Lost to Follow-up|6|||
19516168|NCT01720446|41928893|FG002|Overall Study|Lost to Follow-up|16|||
19516169|NCT01720446|41928894|FG003|Overall Study|Lost to Follow-up|16|||
19516170|NCT01720446|41928891|FG000|Overall Study|Withdrawal by Subject|2|||
19516171|NCT01720446|41928892|FG001|Overall Study|Withdrawal by Subject|5|||
19516172|NCT01720446|41928893|FG002|Overall Study|Withdrawal by Subject|4|||
19516173|NCT01720446|41928894|FG003|Overall Study|Withdrawal by Subject|4|||
19516174|NCT01698918|41928907|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
19516175|NCT01698918|41928907|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
19516176|NCT01698918|41928907|FG000|First Line Treatment (Core+Extension)|Death|2|||
19516177|NCT01698918|41928907|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
19618506|NCT03911401|42067901|FG001|Overall Study|Withdrawal by Subject|2|||
19516178|NCT01698918|41928907|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
19516179|NCT01698918|41928907|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
19516180|NCT01698918|41928907|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
19516181|NCT01698918|41928907|FG000|Second Line Treatment (Core+Extension)|Death|1|||
19516182|NCT01698918|41928907|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
19516183|NCT01698918|41928907|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
19516184|NCT01746108|41928922|FG000|Overall Study|Migrated /moved from study area|0|||
19516185|NCT01746108|41928923|FG001|Overall Study|Migrated /moved from study area|1|||
19516186|NCT01746108|41928924|FG002|Overall Study|Migrated /moved from study area|0|||
19516187|NCT01746108|41928922|FG000|Overall Study|Adverse event, non-fatal|0|||
19516188|NCT01746108|41928923|FG001|Overall Study|Adverse event, non-fatal|1|||
19516189|NCT01746108|41928924|FG002|Overall Study|Adverse event, non-fatal|0|||
19516190|NCT01746108|41928922|FG000|Overall Study|Withdrawal by Subject|0|||
19516191|NCT01746108|41928923|FG001|Overall Study|Withdrawal by Subject|1|||
19516192|NCT01746108|41928924|FG002|Overall Study|Withdrawal by Subject|0|||
19516193|NCT01746108|41928922|FG000|Overall Study|Lost to Follow-up|0|||
19516194|NCT01746108|41928923|FG001|Overall Study|Lost to Follow-up|1|||
19516195|NCT01746108|41928924|FG002|Overall Study|Lost to Follow-up|0|||
19516196|NCT01717638|41928953|FG000|Overall Study|Lost to Follow-up|0|||
19516197|NCT01717638|41928954|FG001|Overall Study|Lost to Follow-up|0|||
19516198|NCT01717638|41928955|FG002|Overall Study|Lost to Follow-up|0|||
19516199|NCT01717638|41928956|FG003|Overall Study|Lost to Follow-up|0|||
19516200|NCT01717638|41928957|FG004|Overall Study|Lost to Follow-up|0|||
19516201|NCT01717638|41928958|FG005|Overall Study|Lost to Follow-up|1|||
19516202|NCT01717638|41928959|FG006|Overall Study|Lost to Follow-up|0|||
19516203|NCT01717638|41928960|FG007|Overall Study|Lost to Follow-up|0|||
19516204|NCT01717638|41928961|FG008|Overall Study|Lost to Follow-up|0|||
19516205|NCT01717638|41928962|FG009|Overall Study|Lost to Follow-up|0|||
19516206|NCT01717638|41928963|FG010|Overall Study|Lost to Follow-up|0|||
19516207|NCT01717638|41928964|FG011|Overall Study|Lost to Follow-up|0|||
19516208|NCT01717638|41928965|FG012|Overall Study|Lost to Follow-up|0|||
19516209|NCT01717638|41928953|FG000|Overall Study|Father in hospital|0|||
19516210|NCT01717638|41928954|FG001|Overall Study|Father in hospital|0|||
19516211|NCT01717638|41928955|FG002|Overall Study|Father in hospital|0|||
19516212|NCT01717638|41928956|FG003|Overall Study|Father in hospital|0|||
19516213|NCT01717638|41928957|FG004|Overall Study|Father in hospital|0|||
19516214|NCT01717638|41928958|FG005|Overall Study|Father in hospital|0|||
19516215|NCT01717638|41928959|FG006|Overall Study|Father in hospital|0|||
19516216|NCT01717638|41928960|FG007|Overall Study|Father in hospital|0|||
19516217|NCT01717638|41928961|FG008|Overall Study|Father in hospital|0|||
19516218|NCT01717638|41928962|FG009|Overall Study|Father in hospital|0|||
19516219|NCT01717638|41928963|FG010|Overall Study|Father in hospital|0|||
19516220|NCT01717638|41928964|FG011|Overall Study|Father in hospital|0|||
19618507|NCT03911401|42067902|FG002|Overall Study|Withdrawal by Subject|0|||
19618508|NCT03911401|42067900|FG000|Overall Study|Withdrawal by parent/guardian|4|||
19618509|NCT03911401|42067901|FG001|Overall Study|Withdrawal by parent/guardian|4|||
19618510|NCT03911401|42067902|FG002|Overall Study|Withdrawal by parent/guardian|11|||
19618511|NCT00579670|42067915|FG000|Overall Study|Death|1|||
19618512|NCT00579670|42067916|FG001|Overall Study|Death|0|||
19618513|NCT00579670|42067917|FG002|Overall Study|Death|0|||
19618514|NCT00579670|42067918|FG003|Overall Study|Death|0|||
19618515|NCT00579670|42067919|FG004|Overall Study|Death|0|||
19618516|NCT00579670|42067915|FG000|Overall Study|Adverse Event|1|||
19618517|NCT00579670|42067916|FG001|Overall Study|Adverse Event|0|||
19618518|NCT00579670|42067917|FG002|Overall Study|Adverse Event|1|||
19618519|NCT00579670|42067918|FG003|Overall Study|Adverse Event|2|||
19618520|NCT00579670|42067919|FG004|Overall Study|Adverse Event|0|||
19618521|NCT00579670|42067915|FG000|Overall Study|Lack of Efficacy|0|||
19618522|NCT00579670|42067916|FG001|Overall Study|Lack of Efficacy|0|||
19618523|NCT00579670|42067917|FG002|Overall Study|Lack of Efficacy|1|||
19618524|NCT00579670|42067918|FG003|Overall Study|Lack of Efficacy|14|||
19704834|NCT00146172|42149179|FG001|Overall Study|Disease Progression|4|||
19704835|NCT00146172|42149180|FG002|Overall Study|Disease Progression|2|||
19704836|NCT00146172|42149181|FG003|Overall Study|Disease Progression|5|||
19704837|NCT00146172|42149182|FG004|Overall Study|Disease Progression|2|||
19704838|NCT00146172|42149183|FG005|Overall Study|Disease Progression|2|||
19704839|NCT00146172|42149184|FG006|Overall Study|Disease Progression|1|||
19704840|NCT00146172|42149185|FG007|Overall Study|Disease Progression|22|||
19704841|NCT00146172|42149178|FG000|Overall Study|Death|0|||
19516221|NCT01717638|41928965|FG012|Overall Study|Father in hospital|1|||
19516222|NCT01717638|41928953|FG000|Overall Study|Withdrawal by Subject|0|||
19516223|NCT01717638|41928954|FG001|Overall Study|Withdrawal by Subject|1|||
19516224|NCT01717638|41928955|FG002|Overall Study|Withdrawal by Subject|1|||
19516225|NCT01717638|41928956|FG003|Overall Study|Withdrawal by Subject|0|||
19516226|NCT01717638|41928957|FG004|Overall Study|Withdrawal by Subject|1|||
19516227|NCT01717638|41928958|FG005|Overall Study|Withdrawal by Subject|0|||
19516228|NCT01717638|41928959|FG006|Overall Study|Withdrawal by Subject|2|||
19704842|NCT00146172|42149179|FG001|Overall Study|Death|0|||
19516229|NCT01717638|41928960|FG007|Overall Study|Withdrawal by Subject|1|||
19516230|NCT01717638|41928961|FG008|Overall Study|Withdrawal by Subject|2|||
19516231|NCT01717638|41928962|FG009|Overall Study|Withdrawal by Subject|1|||
19516232|NCT01717638|41928963|FG010|Overall Study|Withdrawal by Subject|0|||
19516233|NCT01717638|41928964|FG011|Overall Study|Withdrawal by Subject|0|||
19516234|NCT01717638|41928965|FG012|Overall Study|Withdrawal by Subject|18|||
19516235|NCT01745094|41929003|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
19516236|NCT01745094|41929004|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
19516237|NCT01745094|41929005|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
19516238|NCT01745094|41929006|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
19516239|NCT01745094|41929003|FG000|Overall Study|Adverse Event|0|||
19516240|NCT01745094|41929004|FG001|Overall Study|Adverse Event|0|||
19516241|NCT01745094|41929005|FG002|Overall Study|Adverse Event|3|||
19516242|NCT01745094|41929006|FG003|Overall Study|Adverse Event|0|||
19516243|NCT01745094|41929003|FG000|Overall Study|Withdrawal by Subject|2|||
19516244|NCT01745094|41929004|FG001|Overall Study|Withdrawal by Subject|0|||
19394162|NCT01362049|41638222|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
19394163|NCT01362049|41638223|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
19394164|NCT01362049|41638224|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
19394165|NCT01362049|41638225|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
19394166|NCT02612909|41638257|FG000|Phase 2|Withdrawal by Subject|2|||
19394167|NCT02612909|41638258|FG001|Phase 2|Withdrawal by Subject|5|||
19394168|NCT02612909|41638259|FG002|Phase 2|Withdrawal by Subject|0|||
19394169|NCT02612909|41638260|FG003|Phase 2|Withdrawal by Subject|0|||
19394170|NCT02612909|41638261|FG004|Phase 2|Withdrawal by Subject|0|||
19394171|NCT02612909|41638257|FG000|Phase 2|Pregnancy|0|||
19394172|NCT02612909|41638258|FG001|Phase 2|Pregnancy|0|||
19394173|NCT02612909|41638259|FG002|Phase 2|Pregnancy|1|||
19394174|NCT02612909|41638260|FG003|Phase 2|Pregnancy|0|||
19394175|NCT02612909|41638261|FG004|Phase 2|Pregnancy|0|||
19394176|NCT02612909|41638257|FG000|Phase 3|Withdrawal by Subject|0|||
19394177|NCT02612909|41638258|FG001|Phase 3|Withdrawal by Subject|0|||
19394178|NCT02612909|41638259|FG002|Phase 3|Withdrawal by Subject|0|||
19394179|NCT02612909|41638260|FG003|Phase 3|Withdrawal by Subject|1|||
19394180|NCT02612909|41638261|FG004|Phase 3|Withdrawal by Subject|0|||
19394181|NCT02612285|41638275|FG000|Overall Study|Withdrawal by Subject|1|||
19394182|NCT02609633|41638281|FG000|Overall Study|Consent Withdrawn|0|||
19394183|NCT02609633|41638282|FG001|Overall Study|Consent Withdrawn|1|||
19394184|NCT02609633|41638281|FG000|Overall Study|Protocol Deviation|1|||
19516245|NCT01745094|41929005|FG002|Overall Study|Withdrawal by Subject|1|||
19516246|NCT01745094|41929006|FG003|Overall Study|Withdrawal by Subject|2|||
19516247|NCT01745094|41929003|FG000|Overall Study|Protocol Violation|1|||
19516248|NCT01745094|41929004|FG001|Overall Study|Protocol Violation|0|||
19516249|NCT01745094|41929005|FG002|Overall Study|Protocol Violation|3|||
19516250|NCT01745094|41929006|FG003|Overall Study|Protocol Violation|1|||
19516251|NCT01745094|41929003|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
19516252|NCT01745094|41929004|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
19516253|NCT01745094|41929005|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
19516254|NCT01745094|41929006|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
19516255|NCT01745094|41929003|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
19516256|NCT01745094|41929004|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
19516257|NCT01745094|41929005|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
19516258|NCT01745094|41929006|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
19516259|NCT01745094|41929003|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
19516260|NCT01745094|41929004|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
19516261|NCT01745094|41929005|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
19516262|NCT01745094|41929006|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
19516263|NCT01697748|41929021|FG000|Overall Study|ineligible skin incision|1|||
19516264|NCT01697748|41929022|FG001|Overall Study|ineligible skin incision|2|||
19516265|NCT01697748|41929021|FG000|Overall Study|ineligible uterine incision|4|||
19516266|NCT01697748|41929022|FG001|Overall Study|ineligible uterine incision|1|||
19516267|NCT01697748|41929021|FG000|Overall Study|Lost to Follow-up|53|||
19516268|NCT01697748|41929022|FG001|Overall Study|Lost to Follow-up|65|||
19516269|NCT01717326|41929048|FG000|Overall Study|Death|0|||
19704843|NCT00146172|42149180|FG002|Overall Study|Death|0|||
19394185|NCT02609633|41638282|FG001|Overall Study|Protocol Deviation|0|||
19394186|NCT02609633|41638281|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
19394187|NCT02609633|41638282|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
19394188|NCT02609633|41638281|FG000|Overall Study|Reason not Specified|2|||
19394189|NCT02609633|41638282|FG001|Overall Study|Reason not Specified|1|||
19394190|NCT01371981|41638301|FG000|Overall Study|Adverse Event|12|||
19516270|NCT01717326|41929049|FG001|Overall Study|Death|0|||
19516271|NCT01717326|41929050|FG002|Overall Study|Death|0|||
19516272|NCT01717326|41929051|FG003|Overall Study|Death|0|||
19516273|NCT01717326|41929052|FG004|Overall Study|Death|0|||
19516274|NCT01717326|41929053|FG005|Overall Study|Death|0|||
19704844|NCT00146172|42149181|FG003|Overall Study|Death|0|||
19516275|NCT01717326|41929054|FG006|Overall Study|Death|0|||
19516276|NCT01717326|41929055|FG007|Overall Study|Death|0|||
19516277|NCT01717326|41929056|FG008|Overall Study|Death|0|||
19516278|NCT01717326|41929057|FG009|Overall Study|Death|0|||
19516279|NCT01717326|41929058|FG010|Overall Study|Death|1|||
19516280|NCT01717326|41929059|FG011|Overall Study|Death|0|||
19516281|NCT01717326|41929060|FG012|Overall Study|Death|0|||
19516282|NCT01717326|41929061|FG013|Overall Study|Death|0|||
19516283|NCT01717326|41929062|FG014|Overall Study|Death|0|||
19516284|NCT01717326|41929063|FG015|Overall Study|Death|0|||
19516285|NCT01717326|41929064|FG016|Overall Study|Death|0|||
19516286|NCT01717326|41929065|FG017|Overall Study|Death|0|||
19516287|NCT01717326|41929066|FG018|Overall Study|Death|0|||
19516288|NCT01717326|41929067|FG019|Overall Study|Death|0|||
19516289|NCT01717326|41929048|FG000|Overall Study|Lost to Follow-up|3|||
19516290|NCT01717326|41929049|FG001|Overall Study|Lost to Follow-up|0|||
19516291|NCT01717326|41929050|FG002|Overall Study|Lost to Follow-up|0|||
19516292|NCT01717326|41929051|FG003|Overall Study|Lost to Follow-up|2|||
19516293|NCT01717326|41929052|FG004|Overall Study|Lost to Follow-up|1|||
19516294|NCT01717326|41929053|FG005|Overall Study|Lost to Follow-up|0|||
19516295|NCT01717326|41929054|FG006|Overall Study|Lost to Follow-up|1|||
19516296|NCT01717326|41929055|FG007|Overall Study|Lost to Follow-up|0|||
19516297|NCT01717326|41929056|FG008|Overall Study|Lost to Follow-up|0|||
19516298|NCT01717326|41929057|FG009|Overall Study|Lost to Follow-up|0|||
19516299|NCT01717326|41929058|FG010|Overall Study|Lost to Follow-up|1|||
19618525|NCT00579670|42067919|FG004|Overall Study|Lack of Efficacy|0|||
19618526|NCT00579670|42067915|FG000|Overall Study|Lost to Follow-up|0|||
19618527|NCT00579670|42067916|FG001|Overall Study|Lost to Follow-up|1|||
19618528|NCT00579670|42067917|FG002|Overall Study|Lost to Follow-up|0|||
19618529|NCT00579670|42067918|FG003|Overall Study|Lost to Follow-up|4|||
19618530|NCT00579670|42067919|FG004|Overall Study|Lost to Follow-up|0|||
19618531|NCT00579670|42067915|FG000|Overall Study|Other|0|||
19618532|NCT00579670|42067916|FG001|Overall Study|Other|0|||
19618533|NCT00579670|42067917|FG002|Overall Study|Other|1|||
19618534|NCT00579670|42067918|FG003|Overall Study|Other|2|||
19516300|NCT01717326|41929059|FG011|Overall Study|Lost to Follow-up|0|||
19516301|NCT01717326|41929060|FG012|Overall Study|Lost to Follow-up|0|||
19516302|NCT01717326|41929061|FG013|Overall Study|Lost to Follow-up|0|||
19618535|NCT00579670|42067919|FG004|Overall Study|Other|0|||
19618536|NCT00579670|42067915|FG000|Overall Study|Withdrawal by Subject|0|||
19618537|NCT00579670|42067916|FG001|Overall Study|Withdrawal by Subject|0|||
19618538|NCT00579670|42067917|FG002|Overall Study|Withdrawal by Subject|1|||
19704845|NCT00146172|42149182|FG004|Overall Study|Death|0|||
19704846|NCT00146172|42149183|FG005|Overall Study|Death|0|||
19704847|NCT00146172|42149184|FG006|Overall Study|Death|1|||
19704848|NCT00146172|42149185|FG007|Overall Study|Death|0|||
19704849|NCT00146172|42149178|FG000|Overall Study|Physician Decision|0|||
19704850|NCT00146172|42149179|FG001|Overall Study|Physician Decision|0|||
19704851|NCT00146172|42149180|FG002|Overall Study|Physician Decision|0|||
19704852|NCT00146172|42149181|FG003|Overall Study|Physician Decision|0|||
19704853|NCT00146172|42149182|FG004|Overall Study|Physician Decision|0|||
19704854|NCT00146172|42149183|FG005|Overall Study|Physician Decision|0|||
19704855|NCT00146172|42149184|FG006|Overall Study|Physician Decision|0|||
19704856|NCT00146172|42149185|FG007|Overall Study|Physician Decision|1|||
19704857|NCT00146172|42149178|FG000|Overall Study|Withdrawal by Subject|0|||
19704858|NCT00146172|42149179|FG001|Overall Study|Withdrawal by Subject|0|||
19704859|NCT00146172|42149180|FG002|Overall Study|Withdrawal by Subject|0|||
19704860|NCT00146172|42149181|FG003|Overall Study|Withdrawal by Subject|0|||
19704861|NCT00146172|42149182|FG004|Overall Study|Withdrawal by Subject|0|||
19704862|NCT00146172|42149183|FG005|Overall Study|Withdrawal by Subject|1|||
19704863|NCT00146172|42149184|FG006|Overall Study|Withdrawal by Subject|1|||
19704864|NCT00146172|42149185|FG007|Overall Study|Withdrawal by Subject|4|||
19704865|NCT00146172|42149178|FG000|Overall Study|Symptomatic Deterioration|1|||
19704866|NCT00146172|42149179|FG001|Overall Study|Symptomatic Deterioration|0|||
19704867|NCT00146172|42149180|FG002|Overall Study|Symptomatic Deterioration|1|||
19704868|NCT00146172|42149181|FG003|Overall Study|Symptomatic Deterioration|0|||
19516303|NCT01717326|41929062|FG014|Overall Study|Lost to Follow-up|0|||
19516304|NCT01717326|41929063|FG015|Overall Study|Lost to Follow-up|2|||
19516305|NCT01717326|41929064|FG016|Overall Study|Lost to Follow-up|1|||
19516306|NCT01717326|41929065|FG017|Overall Study|Lost to Follow-up|0|||
19516307|NCT01717326|41929066|FG018|Overall Study|Lost to Follow-up|2|||
19516308|NCT01717326|41929067|FG019|Overall Study|Lost to Follow-up|3|||
19516309|NCT01717326|41929048|FG000|Overall Study|Physician Decision|0|||
19516310|NCT01717326|41929049|FG001|Overall Study|Physician Decision|0|||
19516311|NCT01717326|41929050|FG002|Overall Study|Physician Decision|0|||
19618539|NCT00579670|42067918|FG003|Overall Study|Withdrawal by Subject|0|||
19704869|NCT00146172|42149182|FG004|Overall Study|Symptomatic Deterioration|1|||
19704870|NCT00146172|42149183|FG005|Overall Study|Symptomatic Deterioration|2|||
19704871|NCT00146172|42149184|FG006|Overall Study|Symptomatic Deterioration|0|||
19704872|NCT00146172|42149185|FG007|Overall Study|Symptomatic Deterioration|2|||
19704873|NCT00145626|42149213|FG000|Overall Study|Did not have NK infusions|2|||
19618540|NCT00579670|42067919|FG004|Overall Study|Withdrawal by Subject|0|||
19618541|NCT03909295|42067943|FG000|Overall Study|Adverse Event|2|||
19618542|NCT03909295|42067943|FG000|Overall Study|Study terminated by sponsor|50|||
19516312|NCT01717326|41929051|FG003|Overall Study|Physician Decision|0|||
19516313|NCT01717326|41929052|FG004|Overall Study|Physician Decision|0|||
19516314|NCT01717326|41929053|FG005|Overall Study|Physician Decision|0|||
19516315|NCT01717326|41929054|FG006|Overall Study|Physician Decision|0|||
19516316|NCT01717326|41929055|FG007|Overall Study|Physician Decision|0|||
19516317|NCT01717326|41929056|FG008|Overall Study|Physician Decision|0|||
19516318|NCT01717326|41929057|FG009|Overall Study|Physician Decision|1|||
19516319|NCT01717326|41929058|FG010|Overall Study|Physician Decision|0|||
19516320|NCT01717326|41929059|FG011|Overall Study|Physician Decision|0|||
19516321|NCT01717326|41929060|FG012|Overall Study|Physician Decision|0|||
19516322|NCT01717326|41929061|FG013|Overall Study|Physician Decision|0|||
19516323|NCT01717326|41929062|FG014|Overall Study|Physician Decision|0|||
19516324|NCT01717326|41929063|FG015|Overall Study|Physician Decision|0|||
19516325|NCT01717326|41929064|FG016|Overall Study|Physician Decision|0|||
19516326|NCT01717326|41929065|FG017|Overall Study|Physician Decision|0|||
19516327|NCT01717326|41929066|FG018|Overall Study|Physician Decision|0|||
19516328|NCT01717326|41929067|FG019|Overall Study|Physician Decision|0|||
19516329|NCT01717326|41929048|FG000|Overall Study|Protocol Violation|0|||
19516330|NCT01717326|41929049|FG001|Overall Study|Protocol Violation|0|||
19516331|NCT01717326|41929050|FG002|Overall Study|Protocol Violation|0|||
19516332|NCT01717326|41929051|FG003|Overall Study|Protocol Violation|0|||
19516333|NCT01717326|41929052|FG004|Overall Study|Protocol Violation|1|||
19516334|NCT01717326|41929053|FG005|Overall Study|Protocol Violation|0|||
19516335|NCT01717326|41929054|FG006|Overall Study|Protocol Violation|0|||
19516336|NCT01717326|41929055|FG007|Overall Study|Protocol Violation|0|||
19516337|NCT01717326|41929056|FG008|Overall Study|Protocol Violation|0|||
19516338|NCT01717326|41929057|FG009|Overall Study|Protocol Violation|0|||
19516339|NCT01717326|41929058|FG010|Overall Study|Protocol Violation|0|||
19618543|NCT00599924|42067954|FG000|Overall Study|Lack of Efficacy|3|||
19618544|NCT00599924|42067955|FG001|Overall Study|Lack of Efficacy|5|||
19516340|NCT01717326|41929059|FG011|Overall Study|Protocol Violation|0|||
19516341|NCT01717326|41929060|FG012|Overall Study|Protocol Violation|0|||
19516342|NCT01717326|41929061|FG013|Overall Study|Protocol Violation|0|||
19618545|NCT00599924|42067956|FG002|Overall Study|Lack of Efficacy|1|||
19618546|NCT00599924|42067957|FG003|Overall Study|Lack of Efficacy|2|||
19618547|NCT00599924|42067958|FG004|Overall Study|Lack of Efficacy|3|||
19618548|NCT00599924|42067959|FG005|Overall Study|Lack of Efficacy|2|||
19618549|NCT00599924|42067960|FG006|Overall Study|Lack of Efficacy|0|||
19618550|NCT00599924|42067954|FG000|Overall Study|Adverse Event|0|||
19618551|NCT00599924|42067955|FG001|Overall Study|Adverse Event|0|||
19618552|NCT00599924|42067956|FG002|Overall Study|Adverse Event|0|||
19618553|NCT00599924|42067957|FG003|Overall Study|Adverse Event|2|||
19618554|NCT00599924|42067958|FG004|Overall Study|Adverse Event|0|||
19618555|NCT00599924|42067959|FG005|Overall Study|Adverse Event|0|||
19618556|NCT00599924|42067960|FG006|Overall Study|Adverse Event|2|||
19618557|NCT00599924|42067954|FG000|Overall Study|Death|0|||
19618558|NCT00599924|42067955|FG001|Overall Study|Death|0|||
19618559|NCT00599924|42067956|FG002|Overall Study|Death|0|||
19618560|NCT00599924|42067957|FG003|Overall Study|Death|2|||
19618561|NCT00599924|42067958|FG004|Overall Study|Death|0|||
19618562|NCT00599924|42067959|FG005|Overall Study|Death|2|||
19618563|NCT00599924|42067960|FG006|Overall Study|Death|1|||
19618564|NCT00599924|42067954|FG000|Overall Study|Protocol Violation|0|||
19618565|NCT00599924|42067955|FG001|Overall Study|Protocol Violation|0|||
19618566|NCT00599924|42067956|FG002|Overall Study|Protocol Violation|0|||
19618567|NCT00599924|42067957|FG003|Overall Study|Protocol Violation|1|||
19618568|NCT00599924|42067958|FG004|Overall Study|Protocol Violation|0|||
19618569|NCT00599924|42067959|FG005|Overall Study|Protocol Violation|0|||
19618570|NCT00599924|42067960|FG006|Overall Study|Protocol Violation|0|||
19516343|NCT01717326|41929062|FG014|Overall Study|Protocol Violation|0|||
19516344|NCT01717326|41929063|FG015|Overall Study|Protocol Violation|0|||
19516345|NCT01717326|41929064|FG016|Overall Study|Protocol Violation|0|||
19516346|NCT01717326|41929065|FG017|Overall Study|Protocol Violation|0|||
19516347|NCT01717326|41929066|FG018|Overall Study|Protocol Violation|0|||
19516348|NCT01717326|41929067|FG019|Overall Study|Protocol Violation|0|||
19618571|NCT00599924|42067954|FG000|Overall Study|Withdrawal by Subject|0|||
19618572|NCT00599924|42067955|FG001|Overall Study|Withdrawal by Subject|0|||
19516349|NCT01717326|41929048|FG000|Overall Study|Withdrawal by Subject|0|||
19516350|NCT01717326|41929049|FG001|Overall Study|Withdrawal by Subject|1|||
19516351|NCT01717326|41929050|FG002|Overall Study|Withdrawal by Subject|0|||
19516352|NCT01717326|41929051|FG003|Overall Study|Withdrawal by Subject|0|||
19516353|NCT01717326|41929052|FG004|Overall Study|Withdrawal by Subject|0|||
19516354|NCT01717326|41929053|FG005|Overall Study|Withdrawal by Subject|0|||
19516355|NCT01717326|41929054|FG006|Overall Study|Withdrawal by Subject|0|||
19516356|NCT01717326|41929055|FG007|Overall Study|Withdrawal by Subject|0|||
19618573|NCT00599924|42067956|FG002|Overall Study|Withdrawal by Subject|1|||
19618574|NCT00599924|42067957|FG003|Overall Study|Withdrawal by Subject|0|||
19618575|NCT00599924|42067958|FG004|Overall Study|Withdrawal by Subject|1|||
19516357|NCT01717326|41929056|FG008|Overall Study|Withdrawal by Subject|0|||
19516358|NCT01717326|41929057|FG009|Overall Study|Withdrawal by Subject|1|||
19516359|NCT01717326|41929058|FG010|Overall Study|Withdrawal by Subject|0|||
19516360|NCT01717326|41929059|FG011|Overall Study|Withdrawal by Subject|0|||
19516361|NCT01717326|41929060|FG012|Overall Study|Withdrawal by Subject|1|||
19516362|NCT01717326|41929061|FG013|Overall Study|Withdrawal by Subject|0|||
19516363|NCT01717326|41929062|FG014|Overall Study|Withdrawal by Subject|0|||
19516364|NCT01717326|41929063|FG015|Overall Study|Withdrawal by Subject|1|||
19516365|NCT01717326|41929064|FG016|Overall Study|Withdrawal by Subject|0|||
19516366|NCT01717326|41929065|FG017|Overall Study|Withdrawal by Subject|0|||
19516367|NCT01717326|41929066|FG018|Overall Study|Withdrawal by Subject|2|||
19516368|NCT01717326|41929067|FG019|Overall Study|Withdrawal by Subject|3|||
19516369|NCT01697592|41929119|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
19516370|NCT01697592|41929120|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516371|NCT01697592|41929121|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516372|NCT01697592|41929122|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516373|NCT01697592|41929123|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516374|NCT01697592|41929124|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516375|NCT01697592|41929125|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516376|NCT01697592|41929126|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516377|NCT01697592|41929127|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516378|NCT01697592|41929128|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
19516379|NCT01697592|41929119|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516380|NCT01697592|41929120|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516381|NCT01697592|41929121|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516382|NCT01697592|41929122|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516383|NCT01697592|41929123|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516384|NCT01697592|41929124|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
19516385|NCT01697592|41929125|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516386|NCT01697592|41929126|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516387|NCT01697592|41929127|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516388|NCT01697592|41929128|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19516389|NCT01697592|41929119|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
19516390|NCT01697592|41929120|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516391|NCT01697592|41929121|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516392|NCT01697592|41929122|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516393|NCT01697592|41929123|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516394|NCT01697592|41929124|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516395|NCT01697592|41929125|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516396|NCT01697592|41929126|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516397|NCT01697592|41929127|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516398|NCT01697592|41929128|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19516399|NCT01697592|41929119|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
19516400|NCT01697592|41929120|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
19516401|NCT01697592|41929121|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516402|NCT01697592|41929122|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516403|NCT01697592|41929123|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516404|NCT01697592|41929124|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516405|NCT01697592|41929125|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
19618576|NCT00599924|42067959|FG005|Overall Study|Withdrawal by Subject|0|||
19618577|NCT00599924|42067960|FG006|Overall Study|Withdrawal by Subject|0|||
19618578|NCT00599924|42067954|FG000|Overall Study|Other|0|||
19618579|NCT00599924|42067955|FG001|Overall Study|Other|0|||
19618580|NCT00599924|42067956|FG002|Overall Study|Other|0|||
19618581|NCT00599924|42067957|FG003|Overall Study|Other|1|||
19618582|NCT00599924|42067958|FG004|Overall Study|Other|2|||
19618583|NCT00599924|42067959|FG005|Overall Study|Other|0|||
19618584|NCT00599924|42067960|FG006|Overall Study|Other|2|||
19618585|NCT00581542|42067983|FG000|Overall Study|they met an exclusion criteria|2|||
19516406|NCT01697592|41929126|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516407|NCT01697592|41929127|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19516408|NCT01697592|41929128|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
19516409|NCT01697592|41929119|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19516410|NCT01697592|41929120|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
19516411|NCT01697592|41929121|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
19516412|NCT01697592|41929122|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
19516413|NCT01697592|41929123|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19618586|NCT00581542|42067984|FG001|Overall Study|they met an exclusion criteria|2|||
19618587|NCT00581542|42067983|FG000|Overall Study|Lost to Follow-up|9|||
19618588|NCT00581542|42067984|FG001|Overall Study|Lost to Follow-up|21|||
19516414|NCT01697592|41929124|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19516415|NCT01697592|41929125|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
19516416|NCT01697592|41929126|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19516417|NCT01697592|41929127|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19516418|NCT01697592|41929128|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
19516419|NCT01697592|41929119|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
19516420|NCT01697592|41929120|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516421|NCT01697592|41929121|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19618589|NCT03912337|42067994|FG000|Overall Study|Withdrawal of Consent From Study|1|||
19618590|NCT03912337|42067995|FG001|Overall Study|Withdrawal of Consent From Study|0|||
19516422|NCT01697592|41929122|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
19516423|NCT01697592|41929123|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516424|NCT01697592|41929124|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516425|NCT01697592|41929125|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516426|NCT01697592|41929126|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516427|NCT01697592|41929127|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516428|NCT01697592|41929128|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
19516429|NCT01697592|41929119|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
19618591|NCT03912337|42067994|FG000|Overall Study|Lost to Follow-up|1|||
19618592|NCT03912337|42067995|FG001|Overall Study|Lost to Follow-up|1|||
19618593|NCT03912259|42068003|FG000|Overall Study|Adverse Event (AE)|2|||
19618594|NCT03912259|42068004|FG001|Overall Study|Adverse Event (AE)|4|||
19618595|NCT03912259|42068003|FG000|Overall Study|Lack of Efficacy|4|||
19618596|NCT03912259|42068004|FG001|Overall Study|Lack of Efficacy|1|||
19618597|NCT03912259|42068003|FG000|Overall Study|Withdrawal by Subject|11|||
19618598|NCT03912259|42068004|FG001|Overall Study|Withdrawal by Subject|1|||
19618599|NCT02121652|42068013|FG000|Overall Study|Lost to Follow-up|2|||
19618600|NCT02121652|42068014|FG001|Overall Study|Lost to Follow-up|1|||
19618601|NCT02121652|42068013|FG000|Overall Study|Death|1|||
19618602|NCT02121652|42068014|FG001|Overall Study|Death|0|||
19618603|NCT02121652|42068013|FG000|Overall Study|Withdrawal by Subject|3|||
19618604|NCT02121652|42068014|FG001|Overall Study|Withdrawal by Subject|3|||
19618605|NCT00595920|42068033|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
19618606|NCT00595764|42068039|FG000|Overall Study|Protocol Violation|24|||
19618607|NCT00595764|42068040|FG001|Overall Study|Protocol Violation|19|||
19618608|NCT00595764|42068039|FG000|Overall Study|Missed Medication >1 week|10|||
19618609|NCT00595764|42068040|FG001|Overall Study|Missed Medication >1 week|17|||
19618610|NCT00595764|42068039|FG000|Overall Study|Missed 3 PM visits|1|||
19618611|NCT00595764|42068040|FG001|Overall Study|Missed 3 PM visits|7|||
19618612|NCT00595764|42068039|FG000|Overall Study|Withdrawal by Subject|4|||
19618613|NCT00595764|42068040|FG001|Overall Study|Withdrawal by Subject|0|||
19618614|NCT00581308|42068060|FG000|Pre Discharge|Lost to Follow-up|1|||
19618615|NCT00581308|42068060|FG000|Pre Discharge|Device Removed|1|||
19618616|NCT00581308|42068060|FG000|Month 1|Lost to Follow-up|3|||
19618617|NCT00581308|42068060|FG000|Month 1|Withdrawal by Subject|2|||
19516430|NCT01697592|41929120|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516431|NCT01697592|41929121|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516432|NCT01697592|41929122|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516433|NCT01697592|41929123|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516434|NCT01697592|41929124|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
19516435|NCT01697592|41929125|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516436|NCT01697592|41929126|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
19516437|NCT01697592|41929127|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516438|NCT01697592|41929128|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
19516439|NCT01697592|41929119|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
19516440|NCT01697592|41929120|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
19516441|NCT01697592|41929121|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
19516442|NCT01697592|41929122|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
19516443|NCT01697592|41929123|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
19516444|NCT01697592|41929124|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
19516445|NCT01697592|41929125|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
19516446|NCT01697592|41929126|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
19516447|NCT01697592|41929127|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
19516448|NCT01697592|41929128|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
19516449|NCT01744782|41929164|FG000|Overall Study|Death|1|||
19516450|NCT01744392|41929168|FG000|Overall Study|Physician Decision|1|||
19516451|NCT01604850|41929175|FG000|Overall Study|Enrolled but never treated|0|||
19516452|NCT01604850|41929176|FG001|Overall Study|Enrolled but never treated|1|||
19618618|NCT00581308|42068060|FG000|Month 1|Device Removed|2|||
19618619|NCT00581308|42068060|FG000|Month 1|Uknown|1|||
19618620|NCT00581308|42068060|FG000|Month 6|Lost to Follow-up|1|||
19618621|NCT00581308|42068060|FG000|Month 6|Withdrawal by Subject|2|||
19618622|NCT00581308|42068060|FG000|Month 12|Death|1|||
19516453|NCT01604850|41929175|FG000|Overall Study|Efficacy Failure|50|||
19516454|NCT01604850|41929176|FG001|Overall Study|Efficacy Failure|29|||
19516455|NCT01604850|41929175|FG000|Overall Study|Lost to Follow-up|1|||
19516456|NCT01604850|41929176|FG001|Overall Study|Lost to Follow-up|0|||
19516457|NCT01604850|41929175|FG000|Overall Study|Subject withdrew consent|1|||
19516458|NCT01604850|41929176|FG001|Overall Study|Subject withdrew consent|0|||
19516459|NCT01742286|41929189|FG000|Escalation Phase|Administrative problems|1|||
19516460|NCT01742286|41929190|FG001|Escalation Phase|Administrative problems|1|||
19516461|NCT01742286|41929191|FG002|Escalation Phase|Administrative problems|0|||
19516462|NCT01742286|41929192|FG003|Escalation Phase|Administrative problems|0|||
19516463|NCT01742286|41929193|FG004|Escalation Phase|Administrative problems|0|||
19516464|NCT01742286|41929194|FG005|Escalation Phase|Administrative problems|0|||
19516465|NCT01742286|41929195|FG006|Escalation Phase|Administrative problems|2|||
19516466|NCT01742286|41929189|FG000|Escalation Phase|Adverse Event|0|||
19516467|NCT01742286|41929190|FG001|Escalation Phase|Adverse Event|1|||
19516468|NCT01742286|41929191|FG002|Escalation Phase|Adverse Event|2|||
19516469|NCT01742286|41929192|FG003|Escalation Phase|Adverse Event|0|||
19516470|NCT01742286|41929193|FG004|Escalation Phase|Adverse Event|0|||
19516471|NCT01742286|41929194|FG005|Escalation Phase|Adverse Event|1|||
19516472|NCT01742286|41929195|FG006|Escalation Phase|Adverse Event|0|||
19516473|NCT01742286|41929189|FG000|Escalation Phase|Disease progression|3|||
19516474|NCT01742286|41929190|FG001|Escalation Phase|Disease progression|7|||
19516475|NCT01742286|41929191|FG002|Escalation Phase|Disease progression|4|||
19516476|NCT01742286|41929192|FG003|Escalation Phase|Disease progression|1|||
19516477|NCT01742286|41929193|FG004|Escalation Phase|Disease progression|4|||
19516478|NCT01742286|41929194|FG005|Escalation Phase|Disease progression|3|||
19516479|NCT01742286|41929195|FG006|Escalation Phase|Disease progression|2|||
19516480|NCT01742286|41929189|FG000|Escalation Phase|Death|0|||
19516481|NCT01742286|41929190|FG001|Escalation Phase|Death|0|||
19516482|NCT01742286|41929191|FG002|Escalation Phase|Death|0|||
19516483|NCT01742286|41929192|FG003|Escalation Phase|Death|0|||
19516484|NCT01742286|41929193|FG004|Escalation Phase|Death|0|||
19516485|NCT01742286|41929194|FG005|Escalation Phase|Death|1|||
19516486|NCT01742286|41929195|FG006|Escalation Phase|Death|0|||
19516487|NCT01742286|41929189|FG000|Escalation Phase|Physician Decision|0|||
19516488|NCT01742286|41929190|FG001|Escalation Phase|Physician Decision|3|||
19516489|NCT01742286|41929191|FG002|Escalation Phase|Physician Decision|0|||
19516490|NCT01742286|41929192|FG003|Escalation Phase|Physician Decision|1|||
19516491|NCT01742286|41929193|FG004|Escalation Phase|Physician Decision|0|||
19516492|NCT01742286|41929194|FG005|Escalation Phase|Physician Decision|0|||
19516493|NCT01742286|41929195|FG006|Escalation Phase|Physician Decision|2|||
19516494|NCT01742286|41929189|FG000|Escalation Phase|Subject/guardian decision|1|||
19516495|NCT01742286|41929190|FG001|Escalation Phase|Subject/guardian decision|0|||
19516496|NCT01742286|41929191|FG002|Escalation Phase|Subject/guardian decision|0|||
19516497|NCT01742286|41929192|FG003|Escalation Phase|Subject/guardian decision|0|||
19516498|NCT01742286|41929193|FG004|Escalation Phase|Subject/guardian decision|0|||
19516499|NCT01742286|41929194|FG005|Escalation Phase|Subject/guardian decision|0|||
19516500|NCT01742286|41929195|FG006|Escalation Phase|Subject/guardian decision|0|||
19516501|NCT01742286|41929189|FG000|Expansion Phase|Administrative problems|0|||
19516502|NCT01742286|41929190|FG001|Expansion Phase|Administrative problems|0|||
19516503|NCT01742286|41929191|FG002|Expansion Phase|Administrative problems|0|||
19516504|NCT01742286|41929192|FG003|Expansion Phase|Administrative problems|0|||
19516505|NCT01742286|41929193|FG004|Expansion Phase|Administrative problems|0|||
19516506|NCT01742286|41929194|FG005|Expansion Phase|Administrative problems|0|||
19516507|NCT01742286|41929195|FG006|Expansion Phase|Administrative problems|5|||
19516508|NCT01742286|41929189|FG000|Expansion Phase|Physician Decision|0|||
19516509|NCT01742286|41929190|FG001|Expansion Phase|Physician Decision|0|||
19516510|NCT01742286|41929191|FG002|Expansion Phase|Physician Decision|4|||
19516511|NCT01742286|41929192|FG003|Expansion Phase|Physician Decision|0|||
19516512|NCT01742286|41929193|FG004|Expansion Phase|Physician Decision|0|||
19516513|NCT01742286|41929194|FG005|Expansion Phase|Physician Decision|0|||
19516514|NCT01742286|41929195|FG006|Expansion Phase|Physician Decision|9|||
19516515|NCT01742286|41929189|FG000|Expansion Phase|Adverse Event|0|||
19516516|NCT01742286|41929190|FG001|Expansion Phase|Adverse Event|0|||
19516517|NCT01742286|41929191|FG002|Expansion Phase|Adverse Event|0|||
19516518|NCT01742286|41929192|FG003|Expansion Phase|Adverse Event|0|||
19516519|NCT01742286|41929193|FG004|Expansion Phase|Adverse Event|0|||
19516520|NCT01742286|41929194|FG005|Expansion Phase|Adverse Event|0|||
19516521|NCT01742286|41929195|FG006|Expansion Phase|Adverse Event|6|||
19516522|NCT01742286|41929189|FG000|Expansion Phase|Disease progression|0|||
19516523|NCT01742286|41929190|FG001|Expansion Phase|Disease progression|0|||
19516524|NCT01742286|41929191|FG002|Expansion Phase|Disease progression|3|||
19516525|NCT01742286|41929192|FG003|Expansion Phase|Disease progression|0|||
19516526|NCT01742286|41929193|FG004|Expansion Phase|Disease progression|0|||
19516527|NCT01742286|41929194|FG005|Expansion Phase|Disease progression|0|||
19516528|NCT01742286|41929195|FG006|Expansion Phase|Disease progression|15|||
19516529|NCT01742286|41929189|FG000|Expansion Phase|Withdrawal by Subject|0|||
19516530|NCT01742286|41929190|FG001|Expansion Phase|Withdrawal by Subject|0|||
19516531|NCT01742286|41929191|FG002|Expansion Phase|Withdrawal by Subject|0|||
19516532|NCT01742286|41929192|FG003|Expansion Phase|Withdrawal by Subject|0|||
19516533|NCT01742286|41929193|FG004|Expansion Phase|Withdrawal by Subject|0|||
19516534|NCT01742286|41929194|FG005|Expansion Phase|Withdrawal by Subject|0|||
19516535|NCT01742286|41929195|FG006|Expansion Phase|Withdrawal by Subject|1|||
19516536|NCT01697358|41929220|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
19516537|NCT01697358|41929221|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
19516538|NCT01697358|41929220|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
19516539|NCT01697358|41929221|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
19516540|NCT01697358|41929220|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
19516541|NCT01697358|41929221|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
19516542|NCT01697358|41929220|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
19516543|NCT01697358|41929221|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
19516544|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
19516545|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
19516546|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
19516547|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
19516548|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
19516549|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
19516550|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
19516551|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
19516552|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
19516553|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
19516554|NCT01697358|41929220|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
19516555|NCT01697358|41929221|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
19516556|NCT01716234|41929234|FG000|Overall Study|Protocol Violation|0|||
19516557|NCT01716234|41929235|FG001|Overall Study|Protocol Violation|0|||
19516558|NCT01716234|41929236|FG002|Overall Study|Protocol Violation|0|||
19516559|NCT01716234|41929237|FG003|Overall Study|Protocol Violation|1|||
19516560|NCT01716234|41929238|FG004|Overall Study|Protocol Violation|1|||
19516561|NCT01716234|41929239|FG005|Overall Study|Protocol Violation|1|||
19516562|NCT01716234|41929240|FG006|Overall Study|Protocol Violation|0|||
19516563|NCT01716234|41929234|FG000|Overall Study|Lack of Efficacy|0|||
19516564|NCT01716234|41929235|FG001|Overall Study|Lack of Efficacy|0|||
19516565|NCT01716234|41929236|FG002|Overall Study|Lack of Efficacy|0|||
19516566|NCT01716234|41929237|FG003|Overall Study|Lack of Efficacy|1|||
19516567|NCT01716234|41929238|FG004|Overall Study|Lack of Efficacy|0|||
19516568|NCT01716234|41929239|FG005|Overall Study|Lack of Efficacy|0|||
19516569|NCT01716234|41929240|FG006|Overall Study|Lack of Efficacy|0|||
19516570|NCT01716234|41929234|FG000|Overall Study|Did not meet protocol eligibility|0|||
19516571|NCT01716234|41929235|FG001|Overall Study|Did not meet protocol eligibility|0|||
19516572|NCT01716234|41929236|FG002|Overall Study|Did not meet protocol eligibility|1|||
19516573|NCT01716234|41929237|FG003|Overall Study|Did not meet protocol eligibility|0|||
19516574|NCT01716234|41929238|FG004|Overall Study|Did not meet protocol eligibility|0|||
19516575|NCT01716234|41929239|FG005|Overall Study|Did not meet protocol eligibility|4|||
19516576|NCT01716234|41929240|FG006|Overall Study|Did not meet protocol eligibility|0|||
19516577|NCT01716234|41929234|FG000|Overall Study|Adverse Event|7|||
19516578|NCT01716234|41929235|FG001|Overall Study|Adverse Event|10|||
19516579|NCT01716234|41929236|FG002|Overall Study|Adverse Event|2|||
19618623|NCT00581308|42068060|FG000|Month 12|Lost to Follow-up|14|||
19618624|NCT00581308|42068060|FG000|Month 12|Withdrawal by Subject|3|||
19618625|NCT00581308|42068060|FG000|Month 12|Device Removed|1|||
19618626|NCT00581308|42068060|FG000|Month 12|Other|1|||
19618627|NCT00877890|42068069|FG000|Overall Study|Adverse Event|6|||
19618628|NCT00877890|42068070|FG001|Overall Study|Adverse Event|6|||
19618629|NCT00877890|42068069|FG000|Overall Study|Lost to Follow-up|5|||
19394191|NCT01371981|41638302|FG001|Overall Study|Adverse Event|17|||
19516580|NCT01716234|41929237|FG003|Overall Study|Adverse Event|8|||
19516581|NCT01716234|41929238|FG004|Overall Study|Adverse Event|3|||
19516582|NCT01716234|41929239|FG005|Overall Study|Adverse Event|6|||
19516583|NCT01716234|41929240|FG006|Overall Study|Adverse Event|0|||
19516584|NCT01716234|41929234|FG000|Overall Study|Withdrawal by Subject|3|||
19516585|NCT01716234|41929235|FG001|Overall Study|Withdrawal by Subject|0|||
19516586|NCT01716234|41929236|FG002|Overall Study|Withdrawal by Subject|2|||
19516587|NCT01716234|41929237|FG003|Overall Study|Withdrawal by Subject|2|||
19516588|NCT01716234|41929238|FG004|Overall Study|Withdrawal by Subject|1|||
19516589|NCT01716234|41929239|FG005|Overall Study|Withdrawal by Subject|3|||
19516590|NCT01716234|41929240|FG006|Overall Study|Withdrawal by Subject|0|||
19516591|NCT01716156|41929259|FG000|Overall Study|Protocol Violation|1|||
19516592|NCT01716156|41929260|FG001|Overall Study|Protocol Violation|0|||
19618630|NCT00877890|42068070|FG001|Overall Study|Lost to Follow-up|5|||
19618631|NCT00877890|42068069|FG000|Overall Study|Protocol Violation|0|||
19516593|NCT01716156|41929261|FG002|Overall Study|Protocol Violation|0|||
19516594|NCT01716156|41929259|FG000|Overall Study|Withdrawal by Subject|0|||
19516595|NCT01716156|41929260|FG001|Overall Study|Withdrawal by Subject|1|||
19516596|NCT01716156|41929261|FG002|Overall Study|Withdrawal by Subject|2|||
19516597|NCT01716156|41929259|FG000|Overall Study|Lost to Follow-up|1|||
19516598|NCT01716156|41929260|FG001|Overall Study|Lost to Follow-up|0|||
19516599|NCT01716156|41929261|FG002|Overall Study|Lost to Follow-up|0|||
19516600|NCT01696188|41929275|FG000|Overall Study|Protocol Violation|1|||
19516601|NCT01696188|41929276|FG001|Overall Study|Protocol Violation|1|||
19516602|NCT01739790|41929284|FG000|Overall Study|Early Trial Termination|2|||
19516603|NCT01739790|41929285|FG001|Overall Study|Early Trial Termination|4|||
19516604|NCT01696032|41929295|FG000|Overall Study|Withdrawal by Subject|0|||
19516605|NCT01696032|41929296|FG001|Overall Study|Withdrawal by Subject|0|||
19516606|NCT01696032|41929297|FG002|Overall Study|Withdrawal by Subject|1|||
19516607|NCT01696032|41929298|FG003|Overall Study|Withdrawal by Subject|2|||
19516608|NCT01696032|41929295|FG000|Overall Study|Death|14|||
19516609|NCT01696032|41929296|FG001|Overall Study|Death|4|||
19516610|NCT01696032|41929297|FG002|Overall Study|Death|43|||
19516611|NCT01696032|41929298|FG003|Overall Study|Death|18|||
19516612|NCT01696032|41929295|FG000|Overall Study|Lost to Follow-up|0|||
19516613|NCT01696032|41929296|FG001|Overall Study|Lost to Follow-up|1|||
19516614|NCT01696032|41929297|FG002|Overall Study|Lost to Follow-up|0|||
19516615|NCT01696032|41929298|FG003|Overall Study|Lost to Follow-up|0|||
19516616|NCT01696032|41929295|FG000|Overall Study|Database lock|0|||
19516617|NCT01696032|41929296|FG001|Overall Study|Database lock|1|||
19516618|NCT01696032|41929297|FG002|Overall Study|Database lock|7|||
19516619|NCT01696032|41929298|FG003|Overall Study|Database lock|2|||
19516620|NCT01695954|41929314|FG000|Overall Study|Withdrawal by Subject|4|||
19516621|NCT01695954|41929315|FG001|Overall Study|Withdrawal by Subject|0|||
19516622|NCT01695954|41929314|FG000|Overall Study|Adverse Event|0|||
19516623|NCT01695954|41929315|FG001|Overall Study|Adverse Event|2|||
19516624|NCT01694706|41929323|FG000|Overall Study|Adverse Event|0|||
19516625|NCT01694706|41929324|FG001|Overall Study|Adverse Event|1|||
19516626|NCT01694706|41929325|FG002|Overall Study|Adverse Event|0|||
19516627|NCT01694706|41929323|FG000|Overall Study|other reason not defined above|1|||
19516628|NCT01694706|41929324|FG001|Overall Study|other reason not defined above|0|||
19516629|NCT01694706|41929325|FG002|Overall Study|other reason not defined above|0|||
19516630|NCT01693692|41929337|FG000|Overall Study|Withdrawal by Subject|12|||
19516631|NCT01693692|41929338|FG001|Overall Study|Withdrawal by Subject|10|||
19516632|NCT01693692|41929339|FG002|Overall Study|Withdrawal by Subject|11|||
19516633|NCT01693692|41929337|FG000|Overall Study|Adverse Event|7|||
19516634|NCT01693692|41929338|FG001|Overall Study|Adverse Event|14|||
19516635|NCT01693692|41929339|FG002|Overall Study|Adverse Event|9|||
19516636|NCT01693692|41929337|FG000|Overall Study|Physician Decision|0|||
19516637|NCT01693692|41929338|FG001|Overall Study|Physician Decision|0|||
19516638|NCT01693692|41929339|FG002|Overall Study|Physician Decision|1|||
19516639|NCT01693692|41929337|FG000|Overall Study|Protocol Violation|5|||
19516640|NCT01693692|41929338|FG001|Overall Study|Protocol Violation|4|||
19516641|NCT01693692|41929339|FG002|Overall Study|Protocol Violation|6|||
19516642|NCT01693692|41929337|FG000|Overall Study|Lost to Follow-up|2|||
19516643|NCT01693692|41929338|FG001|Overall Study|Lost to Follow-up|2|||
19516644|NCT01693692|41929339|FG002|Overall Study|Lost to Follow-up|3|||
19516645|NCT01693692|41929337|FG000|Overall Study|Other|4|||
19516646|NCT01693692|41929338|FG001|Overall Study|Other|4|||
19516647|NCT01693692|41929339|FG002|Overall Study|Other|6|||
19516648|NCT01693614|41929350|FG000|Overall Study|Adverse Event|7|||
19516649|NCT01693614|41929351|FG001|Overall Study|Adverse Event|11|||
19516650|NCT01693614|41929352|FG002|Overall Study|Adverse Event|5|||
19516651|NCT01693614|41929350|FG000|Overall Study|Disease progression|11|||
19516652|NCT01693614|41929351|FG001|Overall Study|Disease progression|8|||
19516653|NCT01693614|41929352|FG002|Overall Study|Disease progression|7|||
19516654|NCT01693614|41929350|FG000|Overall Study|Protocol Violation|5|||
19516655|NCT01693614|41929351|FG001|Overall Study|Protocol Violation|2|||
19516656|NCT01693614|41929352|FG002|Overall Study|Protocol Violation|1|||
19516657|NCT01693614|41929350|FG000|Overall Study|Death|1|||
19704874|NCT00145626|42149213|FG000|Overall Study|Turned 2 years old before treatment|1|||
19516658|NCT01693614|41929351|FG001|Overall Study|Death|0|||
19516659|NCT01693614|41929352|FG002|Overall Study|Death|0|||
19516660|NCT01693614|41929350|FG000|Overall Study|Physician Decision|1|||
19516661|NCT01693614|41929351|FG001|Overall Study|Physician Decision|1|||
19516662|NCT01693614|41929352|FG002|Overall Study|Physician Decision|4|||
19516663|NCT01693614|41929350|FG000|Overall Study|Withdrawal by subject/guardian|0|||
19516664|NCT01693614|41929351|FG001|Overall Study|Withdrawal by subject/guardian|0|||
19516665|NCT01693614|41929352|FG002|Overall Study|Withdrawal by subject/guardian|2|||
19516666|NCT01693614|41929350|FG000|Overall Study|Withdrawal by Subject|1|||
19516667|NCT01693614|41929351|FG001|Overall Study|Withdrawal by Subject|0|||
19516668|NCT01693614|41929352|FG002|Overall Study|Withdrawal by Subject|5|||
19516669|NCT01715298|41929363|FG000|Overall Study|Lost to Follow-up|0|||
19516670|NCT01715298|41929364|FG001|Overall Study|Lost to Follow-up|2|||
19704875|NCT00145626|42149213|FG000|Overall Study|Death|1|||
19516671|NCT01715298|41929363|FG000|Overall Study|Patient/guardian decision|7|||
19516672|NCT01715298|41929364|FG001|Overall Study|Patient/guardian decision|9|||
19516673|NCT01713582|41929391|FG000|Overall Study|Disease progression|3|||
19516674|NCT01713582|41929392|FG001|Overall Study|Disease progression|3|||
19516675|NCT01713582|41929393|FG002|Overall Study|Disease progression|3|||
19516676|NCT01713582|41929394|FG003|Overall Study|Disease progression|2|||
19516677|NCT01713582|41929395|FG004|Overall Study|Disease progression|3|||
19516678|NCT01713582|41929396|FG005|Overall Study|Disease progression|3|||
19516679|NCT01713582|41929397|FG006|Overall Study|Disease progression|3|||
19516680|NCT01713582|41929398|FG007|Overall Study|Disease progression|3|||
19516681|NCT01713582|41929399|FG008|Overall Study|Disease progression|3|||
19516682|NCT01713582|41929400|FG009|Overall Study|Disease progression|11|||
19516683|NCT01713582|41929401|FG010|Overall Study|Disease progression|10|||
19516684|NCT01713582|41929402|FG011|Overall Study|Disease progression|5|||
19516685|NCT01713582|41929403|FG012|Overall Study|Disease progression|3|||
19516686|NCT01713582|41929404|FG013|Overall Study|Disease progression|3|||
19516687|NCT01713582|41929405|FG014|Overall Study|Disease progression|6|||
19516688|NCT01713582|41929406|FG015|Overall Study|Disease progression|6|||
19516689|NCT01713582|41929407|FG016|Overall Study|Disease progression|5|||
19516690|NCT01713582|41929408|FG017|Overall Study|Disease progression|2|||
19516691|NCT01713582|41929409|FG018|Overall Study|Disease progression|3|||
19516692|NCT01713582|41929410|FG019|Overall Study|Disease progression|5|||
19516693|NCT01713582|41929411|FG020|Overall Study|Disease progression|15|||
19516694|NCT01713582|41929391|FG000|Overall Study|Death|0|||
19516695|NCT01713582|41929392|FG001|Overall Study|Death|0|||
19516696|NCT01713582|41929393|FG002|Overall Study|Death|0|||
19516697|NCT01713582|41929394|FG003|Overall Study|Death|1|||
19516698|NCT01713582|41929395|FG004|Overall Study|Death|1|||
19516699|NCT01713582|41929396|FG005|Overall Study|Death|3|||
19516700|NCT01713582|41929397|FG006|Overall Study|Death|3|||
19516701|NCT01713582|41929398|FG007|Overall Study|Death|2|||
19516702|NCT01713582|41929399|FG008|Overall Study|Death|3|||
19516703|NCT01713582|41929400|FG009|Overall Study|Death|4|||
19516704|NCT01713582|41929401|FG010|Overall Study|Death|3|||
19516705|NCT01713582|41929402|FG011|Overall Study|Death|0|||
19516706|NCT01713582|41929403|FG012|Overall Study|Death|0|||
19516707|NCT01713582|41929404|FG013|Overall Study|Death|0|||
19516708|NCT01713582|41929405|FG014|Overall Study|Death|0|||
19516709|NCT01713582|41929406|FG015|Overall Study|Death|0|||
19516710|NCT01713582|41929407|FG016|Overall Study|Death|0|||
19516711|NCT01713582|41929408|FG017|Overall Study|Death|0|||
19516712|NCT01713582|41929409|FG018|Overall Study|Death|0|||
19516713|NCT01713582|41929410|FG019|Overall Study|Death|0|||
19516714|NCT01713582|41929411|FG020|Overall Study|Death|0|||
19516715|NCT01713582|41929391|FG000|Overall Study|Adverse event-related|0|||
19516716|NCT01713582|41929392|FG001|Overall Study|Adverse event-related|0|||
19516717|NCT01713582|41929393|FG002|Overall Study|Adverse event-related|0|||
19516718|NCT01713582|41929394|FG003|Overall Study|Adverse event-related|0|||
19516719|NCT01713582|41929395|FG004|Overall Study|Adverse event-related|0|||
19516720|NCT01713582|41929396|FG005|Overall Study|Adverse event-related|0|||
19516721|NCT01713582|41929397|FG006|Overall Study|Adverse event-related|0|||
19516722|NCT01713582|41929398|FG007|Overall Study|Adverse event-related|0|||
19516723|NCT01713582|41929399|FG008|Overall Study|Adverse event-related|0|||
19516724|NCT01713582|41929400|FG009|Overall Study|Adverse event-related|1|||
19516725|NCT01713582|41929401|FG010|Overall Study|Adverse event-related|1|||
19516726|NCT01713582|41929402|FG011|Overall Study|Adverse event-related|0|||
19516727|NCT01713582|41929403|FG012|Overall Study|Adverse event-related|0|||
19516728|NCT01713582|41929404|FG013|Overall Study|Adverse event-related|0|||
19516729|NCT01713582|41929405|FG014|Overall Study|Adverse event-related|0|||
19516730|NCT01713582|41929406|FG015|Overall Study|Adverse event-related|0|||
19516731|NCT01713582|41929407|FG016|Overall Study|Adverse event-related|0|||
19516732|NCT01713582|41929408|FG017|Overall Study|Adverse event-related|0|||
19516733|NCT01713582|41929409|FG018|Overall Study|Adverse event-related|1|||
19516734|NCT01713582|41929410|FG019|Overall Study|Adverse event-related|0|||
19516735|NCT01713582|41929411|FG020|Overall Study|Adverse event-related|0|||
19516736|NCT01713582|41929391|FG000|Overall Study|Adverse event-unrelated|0|||
19516737|NCT01713582|41929392|FG001|Overall Study|Adverse event-unrelated|0|||
19704876|NCT00145626|42149213|FG000|Overall Study|Withdrawal by Subject|1|||
19516738|NCT01713582|41929393|FG002|Overall Study|Adverse event-unrelated|0|||
19516739|NCT01713582|41929394|FG003|Overall Study|Adverse event-unrelated|0|||
19516740|NCT01713582|41929395|FG004|Overall Study|Adverse event-unrelated|0|||
19516741|NCT01713582|41929396|FG005|Overall Study|Adverse event-unrelated|1|||
19516742|NCT01713582|41929397|FG006|Overall Study|Adverse event-unrelated|1|||
19516743|NCT01713582|41929398|FG007|Overall Study|Adverse event-unrelated|1|||
19516744|NCT01713582|41929399|FG008|Overall Study|Adverse event-unrelated|0|||
19704877|NCT00153062|42149237|FG000|Overall Study|Death|360|||
19516745|NCT01713582|41929400|FG009|Overall Study|Adverse event-unrelated|0|||
19516746|NCT01713582|41929401|FG010|Overall Study|Adverse event-unrelated|0|||
19516747|NCT01713582|41929402|FG011|Overall Study|Adverse event-unrelated|0|||
19516748|NCT01713582|41929403|FG012|Overall Study|Adverse event-unrelated|0|||
19516749|NCT01713582|41929404|FG013|Overall Study|Adverse event-unrelated|1|||
19516750|NCT01713582|41929405|FG014|Overall Study|Adverse event-unrelated|1|||
19516751|NCT01713582|41929406|FG015|Overall Study|Adverse event-unrelated|0|||
19516752|NCT01713582|41929407|FG016|Overall Study|Adverse event-unrelated|0|||
19516753|NCT01713582|41929408|FG017|Overall Study|Adverse event-unrelated|0|||
19516754|NCT01713582|41929409|FG018|Overall Study|Adverse event-unrelated|0|||
19516755|NCT01713582|41929410|FG019|Overall Study|Adverse event-unrelated|0|||
19516756|NCT01713582|41929411|FG020|Overall Study|Adverse event-unrelated|0|||
19516757|NCT01713582|41929391|FG000|Overall Study|Withdrawal of consent|0|||
19516758|NCT01713582|41929392|FG001|Overall Study|Withdrawal of consent|0|||
19516759|NCT01713582|41929393|FG002|Overall Study|Withdrawal of consent|1|||
19516760|NCT01713582|41929394|FG003|Overall Study|Withdrawal of consent|0|||
19516761|NCT01713582|41929395|FG004|Overall Study|Withdrawal of consent|0|||
19516762|NCT01713582|41929396|FG005|Overall Study|Withdrawal of consent|1|||
19516763|NCT01713582|41929397|FG006|Overall Study|Withdrawal of consent|0|||
19516764|NCT01713582|41929398|FG007|Overall Study|Withdrawal of consent|0|||
19516765|NCT01713582|41929399|FG008|Overall Study|Withdrawal of consent|0|||
19516766|NCT01713582|41929400|FG009|Overall Study|Withdrawal of consent|1|||
19516767|NCT01713582|41929401|FG010|Overall Study|Withdrawal of consent|0|||
19516768|NCT01713582|41929402|FG011|Overall Study|Withdrawal of consent|0|||
19516769|NCT01713582|41929403|FG012|Overall Study|Withdrawal of consent|0|||
19516770|NCT01713582|41929404|FG013|Overall Study|Withdrawal of consent|0|||
19516771|NCT01713582|41929405|FG014|Overall Study|Withdrawal of consent|0|||
19516772|NCT01713582|41929406|FG015|Overall Study|Withdrawal of consent|0|||
19516773|NCT01713582|41929407|FG016|Overall Study|Withdrawal of consent|0|||
19516774|NCT01713582|41929408|FG017|Overall Study|Withdrawal of consent|0|||
19516775|NCT01713582|41929409|FG018|Overall Study|Withdrawal of consent|1|||
19516776|NCT01713582|41929410|FG019|Overall Study|Withdrawal of consent|0|||
19516777|NCT01713582|41929411|FG020|Overall Study|Withdrawal of consent|0|||
19516778|NCT01713582|41929391|FG000|Overall Study|Lack of Efficacy|0|||
19516779|NCT01713582|41929392|FG001|Overall Study|Lack of Efficacy|0|||
19516780|NCT01713582|41929393|FG002|Overall Study|Lack of Efficacy|0|||
19516781|NCT01713582|41929394|FG003|Overall Study|Lack of Efficacy|0|||
19516782|NCT01713582|41929395|FG004|Overall Study|Lack of Efficacy|0|||
19516783|NCT01713582|41929396|FG005|Overall Study|Lack of Efficacy|0|||
19516784|NCT01713582|41929397|FG006|Overall Study|Lack of Efficacy|0|||
19516785|NCT01713582|41929398|FG007|Overall Study|Lack of Efficacy|0|||
19516786|NCT01713582|41929399|FG008|Overall Study|Lack of Efficacy|0|||
19516787|NCT01713582|41929400|FG009|Overall Study|Lack of Efficacy|1|||
19516788|NCT01713582|41929401|FG010|Overall Study|Lack of Efficacy|2|||
19516789|NCT01713582|41929402|FG011|Overall Study|Lack of Efficacy|0|||
19516790|NCT01713582|41929403|FG012|Overall Study|Lack of Efficacy|0|||
19516791|NCT01713582|41929404|FG013|Overall Study|Lack of Efficacy|0|||
19516792|NCT01713582|41929405|FG014|Overall Study|Lack of Efficacy|0|||
19516793|NCT01713582|41929406|FG015|Overall Study|Lack of Efficacy|0|||
19516794|NCT01713582|41929407|FG016|Overall Study|Lack of Efficacy|0|||
19516795|NCT01713582|41929408|FG017|Overall Study|Lack of Efficacy|0|||
19516796|NCT01713582|41929409|FG018|Overall Study|Lack of Efficacy|0|||
19516797|NCT01713582|41929410|FG019|Overall Study|Lack of Efficacy|0|||
19516798|NCT01713582|41929411|FG020|Overall Study|Lack of Efficacy|0|||
19516799|NCT01713582|41929391|FG000|Overall Study|Withdrawal by Subject|0|||
19516800|NCT01713582|41929392|FG001|Overall Study|Withdrawal by Subject|0|||
19516801|NCT01713582|41929393|FG002|Overall Study|Withdrawal by Subject|0|||
19516802|NCT01713582|41929394|FG003|Overall Study|Withdrawal by Subject|0|||
19516803|NCT01713582|41929395|FG004|Overall Study|Withdrawal by Subject|0|||
19516804|NCT01713582|41929396|FG005|Overall Study|Withdrawal by Subject|0|||
19516805|NCT01713582|41929397|FG006|Overall Study|Withdrawal by Subject|0|||
19516806|NCT01713582|41929398|FG007|Overall Study|Withdrawal by Subject|0|||
19516807|NCT01713582|41929399|FG008|Overall Study|Withdrawal by Subject|0|||
19516808|NCT01713582|41929400|FG009|Overall Study|Withdrawal by Subject|0|||
19516809|NCT01713582|41929401|FG010|Overall Study|Withdrawal by Subject|0|||
19516810|NCT01713582|41929402|FG011|Overall Study|Withdrawal by Subject|0|||
19516811|NCT01713582|41929403|FG012|Overall Study|Withdrawal by Subject|0|||
19516812|NCT01713582|41929404|FG013|Overall Study|Withdrawal by Subject|0|||
19516813|NCT01713582|41929405|FG014|Overall Study|Withdrawal by Subject|0|||
19516814|NCT01713582|41929406|FG015|Overall Study|Withdrawal by Subject|0|||
19516815|NCT01713582|41929407|FG016|Overall Study|Withdrawal by Subject|0|||
19516816|NCT01713582|41929408|FG017|Overall Study|Withdrawal by Subject|1|||
19516817|NCT01713582|41929409|FG018|Overall Study|Withdrawal by Subject|0|||
19516818|NCT01713582|41929410|FG019|Overall Study|Withdrawal by Subject|0|||
19516819|NCT01713582|41929411|FG020|Overall Study|Withdrawal by Subject|0|||
19516820|NCT01713582|41929391|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
19516821|NCT01713582|41929392|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
19516822|NCT01713582|41929393|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
19516823|NCT01713582|41929394|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
19516824|NCT01713582|41929395|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
19516825|NCT01713582|41929396|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
19516826|NCT01713582|41929397|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
19516827|NCT01713582|41929398|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
19516828|NCT01713582|41929399|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
19516829|NCT01713582|41929400|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
19516830|NCT01713582|41929401|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
19516831|NCT01713582|41929402|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
19516832|NCT01713582|41929403|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
19516833|NCT01713582|41929404|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
19516834|NCT01713582|41929405|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
19516835|NCT01713582|41929406|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
19516836|NCT01713582|41929407|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
19516837|NCT01713582|41929408|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
19516838|NCT01713582|41929409|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
19516839|NCT01713582|41929410|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
19516840|NCT01713582|41929411|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
19516841|NCT01713582|41929391|FG000|Overall Study|Disease progression and adverse event|0|||
19516842|NCT01713582|41929392|FG001|Overall Study|Disease progression and adverse event|0|||
19516843|NCT01713582|41929393|FG002|Overall Study|Disease progression and adverse event|0|||
19516844|NCT01713582|41929394|FG003|Overall Study|Disease progression and adverse event|0|||
19516845|NCT01713582|41929395|FG004|Overall Study|Disease progression and adverse event|0|||
19516846|NCT01713582|41929396|FG005|Overall Study|Disease progression and adverse event|0|||
19516847|NCT01713582|41929397|FG006|Overall Study|Disease progression and adverse event|0|||
19516848|NCT01713582|41929398|FG007|Overall Study|Disease progression and adverse event|0|||
19516849|NCT01713582|41929399|FG008|Overall Study|Disease progression and adverse event|0|||
19516850|NCT01713582|41929400|FG009|Overall Study|Disease progression and adverse event|0|||
19516851|NCT01713582|41929401|FG010|Overall Study|Disease progression and adverse event|0|||
19516852|NCT01713582|41929402|FG011|Overall Study|Disease progression and adverse event|0|||
19516853|NCT01713582|41929403|FG012|Overall Study|Disease progression and adverse event|0|||
19516854|NCT01713582|41929404|FG013|Overall Study|Disease progression and adverse event|0|||
19516855|NCT01713582|41929405|FG014|Overall Study|Disease progression and adverse event|0|||
19516856|NCT01713582|41929406|FG015|Overall Study|Disease progression and adverse event|0|||
19516857|NCT01713582|41929407|FG016|Overall Study|Disease progression and adverse event|1|||
19516858|NCT01713582|41929408|FG017|Overall Study|Disease progression and adverse event|0|||
19516859|NCT01713582|41929409|FG018|Overall Study|Disease progression and adverse event|0|||
19516860|NCT01713582|41929410|FG019|Overall Study|Disease progression and adverse event|0|||
19516861|NCT01713582|41929411|FG020|Overall Study|Disease progression and adverse event|0|||
19516862|NCT01739400|41929471|FG000|Overall Study|Physician Decision|3|||
19516863|NCT01739400|41929472|FG001|Overall Study|Physician Decision|0|||
19516864|NCT01739400|41929471|FG000|Overall Study|Lost to Follow-up|2|||
19516865|NCT01739400|41929472|FG001|Overall Study|Lost to Follow-up|0|||
19516866|NCT01739400|41929471|FG000|Overall Study|Death|5|||
19516867|NCT01739400|41929472|FG001|Overall Study|Death|2|||
19516868|NCT01739400|41929471|FG000|Overall Study|Withdrawal by Subject|7|||
19516869|NCT01739400|41929472|FG001|Overall Study|Withdrawal by Subject|7|||
19516870|NCT01713348|41929481|FG000|Overall Study|Withdrawal by Subject|3|||
19516871|NCT01713348|41929482|FG001|Overall Study|Withdrawal by Subject|2|||
19516872|NCT01713348|41929483|FG002|Overall Study|Withdrawal by Subject|2|||
19516873|NCT01713348|41929484|FG003|Overall Study|Withdrawal by Subject|0|||
19516874|NCT01713348|41929481|FG000|Overall Study|Lost to Follow-up|1|||
19516875|NCT01713348|41929482|FG001|Overall Study|Lost to Follow-up|0|||
19516876|NCT01713348|41929483|FG002|Overall Study|Lost to Follow-up|0|||
19516877|NCT01713348|41929484|FG003|Overall Study|Lost to Follow-up|0|||
19516878|NCT01737996|41929497|FG000|Overall Study|Adverse Event|0|||
19516879|NCT01737996|41929498|FG001|Overall Study|Adverse Event|1|||
19516880|NCT01737996|41929499|FG002|Overall Study|Adverse Event|1|||
19516881|NCT01737996|41929497|FG000|Overall Study|Withdrawal by Subject|0|||
19516882|NCT01737996|41929498|FG001|Overall Study|Withdrawal by Subject|0|||
19516883|NCT01737996|41929499|FG002|Overall Study|Withdrawal by Subject|1|||
19516884|NCT01713036|41929507|FG000|Overall Study|Death|1|||
19516885|NCT01712334|41929517|FG000|Treatment Period 1|Randomized in Error|0|||
19516886|NCT01712334|41929518|FG001|Treatment Period 1|Randomized in Error|2|||
19516887|NCT01712256|41929524|FG000|Overall Study|Lost to Follow-up|1|||
19516888|NCT01712178|41929530|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
19516889|NCT01712178|41929531|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
19516890|NCT01712178|41929530|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
19516891|NCT01712178|41929531|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
19516892|NCT01712178|41929530|FG000|Overall Study|Lost to Follow-up|0|||
19618632|NCT00877890|42068070|FG001|Overall Study|Protocol Violation|1|||
19618633|NCT00877890|42068069|FG000|Overall Study|Withdrawal of Consent|6|||
19704878|NCT00153062|42149238|FG001|Overall Study|Death|352|||
19516893|NCT01712178|41929531|FG001|Overall Study|Lost to Follow-up|1|||
19516894|NCT01693068|41929539|FG000|Randomization Period|On-study|2|||
19516895|NCT01693068|41929540|FG001|Randomization Period|On-study|5|||
19516896|NCT01693068|41929541|FG002|Randomization Period|On-study|0|||
19516897|NCT01693068|41929539|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
19516898|NCT01693068|41929540|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
19516899|NCT01693068|41929541|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
19516900|NCT01691898|41929555|FG000|Overall Study|Death|34|||
19516901|NCT01691898|41929556|FG001|Overall Study|Death|32|||
19516902|NCT01691898|41929557|FG002|Overall Study|Death|6|||
19516903|NCT01691898|41929558|FG003|Overall Study|Death|3|||
19516904|NCT01691898|41929559|FG004|Overall Study|Death|8|||
19516905|NCT01691898|41929560|FG005|Overall Study|Death|31|||
19516906|NCT01691898|41929555|FG000|Overall Study|Adverse Event|0|||
19516907|NCT01691898|41929556|FG001|Overall Study|Adverse Event|1|||
19516908|NCT01691898|41929557|FG002|Overall Study|Adverse Event|0|||
19516909|NCT01691898|41929558|FG003|Overall Study|Adverse Event|1|||
19516910|NCT01691898|41929559|FG004|Overall Study|Adverse Event|1|||
19516911|NCT01691898|41929560|FG005|Overall Study|Adverse Event|0|||
19516912|NCT01691898|41929555|FG000|Overall Study|Progression of Disease|1|||
19516913|NCT01691898|41929556|FG001|Overall Study|Progression of Disease|2|||
19516914|NCT01691898|41929557|FG002|Overall Study|Progression of Disease|1|||
19618634|NCT00877890|42068070|FG001|Overall Study|Withdrawal of Consent|12|||
19618635|NCT00877890|42068069|FG000|Overall Study|Investigator Decision|0|||
19618636|NCT00877890|42068070|FG001|Overall Study|Investigator Decision|2|||
19618637|NCT00877890|42068069|FG000|Overall Study|Loss of Glucose Control|3|||
19618638|NCT00877890|42068070|FG001|Overall Study|Loss of Glucose Control|4|||
19618639|NCT03474679|42068080|FG000|Overall Study|Death|7|||
19618640|NCT03474679|42068080|FG000|Overall Study|Withdrawal by Subject|1|||
19618641|NCT03472885|42068084|FG000|Overall Study|Adverse Event|1|||
19618642|NCT03905863|42068090|FG000|Overall Study|Adverse Event|2|||
19618643|NCT03905863|42068091|FG001|Overall Study|Adverse Event|4|||
19516915|NCT01691898|41929558|FG003|Overall Study|Progression of Disease|0|||
19516916|NCT01691898|41929559|FG004|Overall Study|Progression of Disease|0|||
19516917|NCT01691898|41929560|FG005|Overall Study|Progression of Disease|1|||
19516918|NCT01691898|41929555|FG000|Overall Study|Lost to Follow-up|3|||
19516919|NCT01691898|41929556|FG001|Overall Study|Lost to Follow-up|1|||
19516920|NCT01691898|41929557|FG002|Overall Study|Lost to Follow-up|0|||
19516921|NCT01691898|41929558|FG003|Overall Study|Lost to Follow-up|0|||
19516922|NCT01691898|41929559|FG004|Overall Study|Lost to Follow-up|1|||
19516923|NCT01691898|41929560|FG005|Overall Study|Lost to Follow-up|0|||
19516924|NCT01691898|41929555|FG000|Overall Study|Withdrawal by Subject|9|||
19516925|NCT01691898|41929556|FG001|Overall Study|Withdrawal by Subject|8|||
19516926|NCT01691898|41929557|FG002|Overall Study|Withdrawal by Subject|2|||
19516927|NCT01691898|41929558|FG003|Overall Study|Withdrawal by Subject|1|||
19516928|NCT01691898|41929559|FG004|Overall Study|Withdrawal by Subject|3|||
19516929|NCT01691898|41929560|FG005|Overall Study|Withdrawal by Subject|3|||
19516930|NCT01691898|41929555|FG000|Overall Study|Non-Compliance|0|||
19516931|NCT01691898|41929556|FG001|Overall Study|Non-Compliance|0|||
19516932|NCT01691898|41929557|FG002|Overall Study|Non-Compliance|0|||
19516933|NCT01691898|41929558|FG003|Overall Study|Non-Compliance|0|||
19516934|NCT01691898|41929559|FG004|Overall Study|Non-Compliance|1|||
19516935|NCT01691898|41929560|FG005|Overall Study|Non-Compliance|0|||
19516936|NCT01737840|41929594|FG000|Overall Study|Diagnosed with an other pathology|2|||
19516937|NCT01737840|41929595|FG001|Overall Study|Diagnosed with an other pathology|2|||
19516938|NCT01691820|41929605|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
19516939|NCT01691820|41929606|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
19516940|NCT01691820|41929605|FG000|Overall Study|Migrated/moved from study area|7|||
19516941|NCT01691820|41929606|FG001|Overall Study|Migrated/moved from study area|4|||
19516942|NCT01691820|41929605|FG000|Overall Study|Lost to Follow-up|6|||
19618644|NCT03905863|42068090|FG000|Overall Study|Withdrawal by Subject|2|||
19618645|NCT03905863|42068091|FG001|Overall Study|Withdrawal by Subject|2|||
19618646|NCT03905863|42068090|FG000|Overall Study|Physician Decision|0|||
19618647|NCT03905863|42068091|FG001|Overall Study|Physician Decision|3|||
19704879|NCT00153062|42149239|FG002|Overall Study|Death|369|||
19618648|NCT03905863|42068090|FG000|Overall Study|Lost to Follow-up|1|||
19618649|NCT03905863|42068091|FG001|Overall Study|Lost to Follow-up|0|||
19516943|NCT01691820|41929606|FG001|Overall Study|Lost to Follow-up|17|||
19516944|NCT01691820|41929605|FG000|Overall Study|Other (unspecified)|4|||
19516945|NCT01691820|41929606|FG001|Overall Study|Other (unspecified)|1|||
19516946|NCT01711866|41929616|FG000|Overall Study|Noncompliant|3|||
19516947|NCT01711866|41929616|FG000|Overall Study|Withdrawal by Subject|3|||
19516948|NCT01711866|41929616|FG000|Overall Study|Adverse Event|2|||
19516949|NCT01737762|41929622|FG000|Overall Study|Adverse Event|2|||
19516950|NCT01737762|41929623|FG001|Overall Study|Adverse Event|2|||
19516951|NCT01737762|41929622|FG000|Overall Study|Lost to Follow-up|1|||
19516952|NCT01737762|41929623|FG001|Overall Study|Lost to Follow-up|0|||
19516953|NCT01737762|41929622|FG000|Overall Study|Withdrawal by Subject|2|||
19704880|NCT00153062|42149240|FG003|Overall Study|Death|365|||
19516954|NCT01737762|41929623|FG001|Overall Study|Withdrawal by Subject|2|||
19516955|NCT01737762|41929622|FG000|Overall Study|Progressive disease|1|||
19516956|NCT01737762|41929623|FG001|Overall Study|Progressive disease|2|||
19516957|NCT01737762|41929622|FG000|Overall Study|Physician Decision|1|||
19516958|NCT01737762|41929623|FG001|Overall Study|Physician Decision|1|||
19516959|NCT01737762|41929622|FG000|Overall Study|Moved from area|2|||
19516960|NCT01737762|41929623|FG001|Overall Study|Moved from area|1|||
19516961|NCT01737762|41929622|FG000|Overall Study|Trial termination|11|||
19516962|NCT01737762|41929623|FG001|Overall Study|Trial termination|9|||
19516963|NCT01691508|41929631|FG000|Overall Study|Adverse Event|3|||
19516964|NCT01691508|41929632|FG001|Overall Study|Adverse Event|3|||
19516965|NCT01691508|41929631|FG000|Overall Study|Withdrawal by Subject|1|||
19516966|NCT01691508|41929632|FG001|Overall Study|Withdrawal by Subject|0|||
19516967|NCT01682460|41929638|FG000|Overall Study|Withdrawal by Subject|2|||
19516968|NCT01682460|41929638|FG000|Overall Study|Did not meet inclusion criteria|2|||
19516969|NCT01691430|41929644|FG000|Overall Study|Death|17|||
19516970|NCT01691430|41929645|FG001|Overall Study|Death|16|||
19516971|NCT01691430|41929644|FG000|Overall Study|Withdrawal by Subject|5|||
19516972|NCT01691430|41929645|FG001|Overall Study|Withdrawal by Subject|1|||
19516973|NCT01691430|41929644|FG000|Overall Study|Lost to Follow-up|0|||
19516974|NCT01691430|41929645|FG001|Overall Study|Lost to Follow-up|3|||
19516975|NCT01709838|41929651|FG000|Overall Study|Withdrawal by Subject|21|||
19516976|NCT01709838|41929651|FG000|Overall Study|Lost to Follow-up|16|||
19516977|NCT01709838|41929651|FG000|Overall Study|Pregnancy|10|||
19516978|NCT01709838|41929651|FG000|Overall Study|Subject/guardian decision|8|||
19516979|NCT01709838|41929651|FG000|Overall Study|Adverse Event|4|||
19516980|NCT01709838|41929651|FG000|Overall Study|Physician Decision|4|||
19516981|NCT01709838|41929651|FG000|Overall Study|Death|3|||
19516982|NCT01709838|41929651|FG000|Overall Study|Protocol Violation|1|||
19516983|NCT01682226|41929657|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
19516984|NCT01682226|41929657|FG000|Overall Study|Participants did not receive treatment|2|||
19516985|NCT01682226|41929657|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
19516986|NCT01688466|41929663|FG000|Overall Study|Withdrawal by Subject|2|||
19516987|NCT01688466|41929664|FG001|Overall Study|Withdrawal by Subject|1|||
19516988|NCT01688466|41929663|FG000|Overall Study|Death|0|||
19516989|NCT01688466|41929664|FG001|Overall Study|Death|1|||
19516990|NCT01688466|41929663|FG000|Overall Study|Adverse Event|0|||
19618650|NCT03905863|42068090|FG000|Overall Study|Protocol Violation|0|||
19618651|NCT03905863|42068091|FG001|Overall Study|Protocol Violation|2|||
19618652|NCT03905863|42068090|FG000|Overall Study|Death|0|||
19618653|NCT03905863|42068091|FG001|Overall Study|Death|1|||
19618654|NCT04067011|42068100|FG000|Overall Study|Not Treated|8|||
19618655|NCT04067011|42068101|FG001|Overall Study|Not Treated|7|||
19516991|NCT01688466|41929664|FG001|Overall Study|Adverse Event|4|||
19516992|NCT01688466|41929663|FG000|Overall Study|Not evaluable|0|||
19516993|NCT01688466|41929664|FG001|Overall Study|Not evaluable|1|||
19516994|NCT01682148|41929672|FG000|Overall Study|Withdrawal by Subject|2|||
19516995|NCT01682148|41929673|FG001|Overall Study|Withdrawal by Subject|0|||
19516996|NCT01682148|41929672|FG000|Overall Study|Lost to Follow-up|1|||
19516997|NCT01682148|41929673|FG001|Overall Study|Lost to Follow-up|2|||
19516998|NCT01682148|41929672|FG000|Overall Study|Protocol Violation|1|||
19516999|NCT01682148|41929673|FG001|Overall Study|Protocol Violation|1|||
19517000|NCT01681992|41929687|FG000|Overall Study|Adverse Event|3|||
19618656|NCT04067011|42068102|FG002|Overall Study|Not Treated|5|||
19618657|NCT04067011|42068100|FG000|Overall Study|Adverse Event|2|||
19618658|NCT04067011|42068101|FG001|Overall Study|Adverse Event|1|||
19618659|NCT04067011|42068102|FG002|Overall Study|Adverse Event|0|||
19618660|NCT04067011|42068100|FG000|Overall Study|Withdrawal by Subject|6|||
19618661|NCT04067011|42068101|FG001|Overall Study|Withdrawal by Subject|2|||
19618662|NCT04067011|42068102|FG002|Overall Study|Withdrawal by Subject|1|||
19618663|NCT04067011|42068100|FG000|Overall Study|Lost to Follow-up|0|||
19618664|NCT04067011|42068101|FG001|Overall Study|Lost to Follow-up|0|||
19618665|NCT04067011|42068102|FG002|Overall Study|Lost to Follow-up|1|||
19618666|NCT04067011|42068100|FG000|Overall Study|Physician Decision|1|||
19618667|NCT04067011|42068101|FG001|Overall Study|Physician Decision|1|||
19618668|NCT04067011|42068102|FG002|Overall Study|Physician Decision|0|||
19517001|NCT01681992|41929688|FG001|Overall Study|Adverse Event|2|||
19517002|NCT01681992|41929689|FG002|Overall Study|Adverse Event|3|||
19517003|NCT01681992|41929687|FG000|Overall Study|Lost to Follow-up|36|||
19517004|NCT01681992|41929688|FG001|Overall Study|Lost to Follow-up|38|||
19517005|NCT01681992|41929689|FG002|Overall Study|Lost to Follow-up|53|||
19517006|NCT01681992|41929687|FG000|Overall Study|As Per Sponsor Decision|0|||
19517007|NCT01681992|41929688|FG001|Overall Study|As Per Sponsor Decision|0|||
19517008|NCT01681992|41929689|FG002|Overall Study|As Per Sponsor Decision|1|||
19517009|NCT01681992|41929687|FG000|Overall Study|Protocol Violation|0|||
19517010|NCT01681992|41929688|FG001|Overall Study|Protocol Violation|0|||
19517011|NCT01681992|41929689|FG002|Overall Study|Protocol Violation|1|||
19618669|NCT04067011|42068100|FG000|Overall Study|Other Reasons|2|||
19618670|NCT04067011|42068101|FG001|Overall Study|Other Reasons|0|||
19517012|NCT01681992|41929687|FG000|Overall Study|Withdrawal by Subject|27|||
19517013|NCT01681992|41929688|FG001|Overall Study|Withdrawal by Subject|30|||
19517014|NCT01681992|41929689|FG002|Overall Study|Withdrawal by Subject|25|||
19517015|NCT01687998|41929699|FG000|Overall Study|Withdrawal by Subject|49|||
19517016|NCT01687998|41929700|FG001|Overall Study|Withdrawal by Subject|51|||
19517017|NCT01687998|41929699|FG000|Overall Study|Known to be Alive at Study End|54|||
19517018|NCT01687998|41929700|FG001|Overall Study|Known to be Alive at Study End|62|||
19517019|NCT01687998|41929699|FG000|Overall Study|Lost to Follow-up|9|||
19517020|NCT01687998|41929700|FG001|Overall Study|Lost to Follow-up|7|||
19517021|NCT01681836|41929706|FG000|Second Intervention|Withdrawal by Subject|0|||
19517022|NCT01681836|41929707|FG001|Second Intervention|Withdrawal by Subject|1|||
19517023|NCT01681368|41929713|FG000|Overall Study|Refused further treatment|1|||
19517024|NCT01681368|41929713|FG000|Overall Study|Refused further follow up|1|||
19517025|NCT01681212|41929717|FG000|Overall Study|No longer met study criteria|5|||
19517026|NCT01681212|41929717|FG000|Overall Study|Administrative reason by sponsor|1|||
19517027|NCT01687296|41929723|FG000|Overall Study|Lack of Efficacy|1|||
19517028|NCT01687296|41929724|FG001|Overall Study|Lack of Efficacy|1|||
19517029|NCT01687296|41929723|FG000|Overall Study|Protocol Violation|0|||
19517030|NCT01687296|41929724|FG001|Overall Study|Protocol Violation|1|||
19517031|NCT01687296|41929723|FG000|Overall Study|Withdrawal by Subject|6|||
19517032|NCT01687296|41929724|FG001|Overall Study|Withdrawal by Subject|3|||
19517033|NCT01568892|41929745|FG000|Open-label Phase|Adverse Event|2|||
19517034|NCT01568892|41929746|FG001|Open-label Phase|Adverse Event|0|||
19517035|NCT01568892|41929745|FG000|Open-label Phase|Lack of Efficacy|4|||
19517036|NCT01568892|41929746|FG001|Open-label Phase|Lack of Efficacy|2|||
19517037|NCT01568892|41929745|FG000|Open-label Phase|Lost to Follow-up|0|||
19517038|NCT01568892|41929746|FG001|Open-label Phase|Lost to Follow-up|1|||
19517039|NCT01568112|41929757|FG000|Overall Study|Randomized But Not Treated|0|||
19517040|NCT01568112|41929758|FG001|Overall Study|Randomized But Not Treated|1|||
19517041|NCT01568112|41929759|FG002|Overall Study|Randomized But Not Treated|0|||
19517042|NCT01568112|41929760|FG003|Overall Study|Randomized But Not Treated|0|||
19517043|NCT01568112|41929757|FG000|Overall Study|Withdrew due to Adverse Event|2|||
19517044|NCT01568112|41929758|FG001|Overall Study|Withdrew due to Adverse Event|4|||
19517045|NCT01568112|41929759|FG002|Overall Study|Withdrew due to Adverse Event|6|||
19517046|NCT01568112|41929760|FG003|Overall Study|Withdrew due to Adverse Event|3|||
19517047|NCT01568112|41929757|FG000|Overall Study|Lost to Follow-up|0|||
19517048|NCT01568112|41929758|FG001|Overall Study|Lost to Follow-up|0|||
19517049|NCT01568112|41929759|FG002|Overall Study|Lost to Follow-up|0|||
19517050|NCT01568112|41929760|FG003|Overall Study|Lost to Follow-up|1|||
19517051|NCT01568112|41929757|FG000|Overall Study|Withdrawal by Subject|2|||
19517052|NCT01568112|41929758|FG001|Overall Study|Withdrawal by Subject|3|||
19517053|NCT01568112|41929759|FG002|Overall Study|Withdrawal by Subject|0|||
19517054|NCT01568112|41929760|FG003|Overall Study|Withdrawal by Subject|7|||
19517055|NCT01568112|41929757|FG000|Overall Study|Withdrawal by Physician|1|||
19517056|NCT01568112|41929758|FG001|Overall Study|Withdrawal by Physician|0|||
19517057|NCT01568112|41929759|FG002|Overall Study|Withdrawal by Physician|1|||
19517058|NCT01568112|41929760|FG003|Overall Study|Withdrawal by Physician|1|||
19517059|NCT01568034|41929771|FG000|Overall Study|Withdrawal by Subject|1|||
19517060|NCT01568034|41929772|FG001|Overall Study|Withdrawal by Subject|0|||
19517061|NCT01568034|41929773|FG002|Overall Study|Withdrawal by Subject|0|||
19517062|NCT01568034|41929774|FG003|Overall Study|Withdrawal by Subject|0|||
19517063|NCT01687218|41929790|FG000|Overall Study|Withdrawal by Subject|2|||
19517064|NCT01687218|41929791|FG001|Overall Study|Withdrawal by Subject|3|||
19517065|NCT01687218|41929792|FG002|Overall Study|Withdrawal by Subject|0|||
19517066|NCT01687218|41929793|FG003|Overall Study|Withdrawal by Subject|1|||
19517067|NCT01687218|41929794|FG004|Overall Study|Withdrawal by Subject|1|||
19517068|NCT01687218|41929795|FG005|Overall Study|Withdrawal by Subject|0|||
19517069|NCT01687218|41929790|FG000|Overall Study|Relocated, no follow-up planned|1|||
19517070|NCT01687218|41929791|FG001|Overall Study|Relocated, no follow-up planned|0|||
19517071|NCT01687218|41929792|FG002|Overall Study|Relocated, no follow-up planned|1|||
19517072|NCT01687218|41929793|FG003|Overall Study|Relocated, no follow-up planned|1|||
19517073|NCT01687218|41929794|FG004|Overall Study|Relocated, no follow-up planned|0|||
19517074|NCT01687218|41929795|FG005|Overall Study|Relocated, no follow-up planned|0|||
19517075|NCT01686828|41929807|FG000|Overall Study|Physician Decision|1|||
19517076|NCT01686828|41929808|FG001|Overall Study|Physician Decision|0|||
19517077|NCT01686828|41929809|FG002|Overall Study|Physician Decision|0|||
19517078|NCT01686828|41929810|FG003|Overall Study|Physician Decision|0|||
19517079|NCT01686828|41929807|FG000|Overall Study|New Job|0|||
19517080|NCT01686828|41929808|FG001|Overall Study|New Job|1|||
19517081|NCT01686828|41929809|FG002|Overall Study|New Job|0|||
19517082|NCT01686828|41929810|FG003|Overall Study|New Job|0|||
19517083|NCT01686828|41929807|FG000|Overall Study|Weight Loss|0|||
19517084|NCT01686828|41929808|FG001|Overall Study|Weight Loss|0|||
19517085|NCT01686828|41929809|FG002|Overall Study|Weight Loss|1|||
19517086|NCT01686828|41929810|FG003|Overall Study|Weight Loss|0|||
19517087|NCT01686438|41929827|FG000|Overall Study|Lost to Follow-up|8|||
19517088|NCT01686438|41929828|FG001|Overall Study|Lost to Follow-up|9|||
19517089|NCT01686438|41929829|FG002|Overall Study|Lost to Follow-up|10|||
19517090|NCT01686438|41929827|FG000|Overall Study|Adverse Event|0|||
19517091|NCT01686438|41929828|FG001|Overall Study|Adverse Event|0|||
19517092|NCT01686438|41929829|FG002|Overall Study|Adverse Event|1|||
19517093|NCT01686438|41929827|FG000|Overall Study|Protocol Violation|0|||
19517094|NCT01686438|41929828|FG001|Overall Study|Protocol Violation|0|||
19517095|NCT01686438|41929829|FG002|Overall Study|Protocol Violation|1|||
19517096|NCT01686438|41929827|FG000|Overall Study|Withdrawal by Subject|0|||
19517097|NCT01686438|41929828|FG001|Overall Study|Withdrawal by Subject|0|||
19517098|NCT01686438|41929829|FG002|Overall Study|Withdrawal by Subject|1|||
19517099|NCT01593696|41929843|FG000|Dose Escalation|Progressive Disease|2|||
19517100|NCT01593696|41929844|FG001|Dose Escalation|Progressive Disease|0|||
19517101|NCT01593696|41929845|FG002|Dose Escalation|Progressive Disease|0|||
19517102|NCT01593696|41929846|FG003|Dose Escalation|Progressive Disease|0|||
19517103|NCT01593696|41929843|FG000|Dose Expansion|Fungal infection|0|||
19517104|NCT01593696|41929844|FG001|Dose Expansion|Fungal infection|0|||
19517105|NCT01593696|41929845|FG002|Dose Expansion|Fungal infection|1|||
19517106|NCT01593696|41929846|FG003|Dose Expansion|Fungal infection|0|||
19517107|NCT01592760|41929859|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
19517108|NCT01592760|41929860|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
19517109|NCT01592760|41929861|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
19517110|NCT01603602|41929875|FG000|Overall Study|Adverse Event|1|||
19517111|NCT01603602|41929876|FG001|Overall Study|Adverse Event|0|||
19517112|NCT01603602|41929877|FG002|Overall Study|Adverse Event|0|||
19517113|NCT01603602|41929875|FG000|Overall Study|Personal Reasons|1|||
19517114|NCT01603602|41929876|FG001|Overall Study|Personal Reasons|0|||
19517115|NCT01603602|41929877|FG002|Overall Study|Personal Reasons|1|||
19517116|NCT01684878|41929889|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
19517117|NCT01684878|41929890|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
19517118|NCT01684878|41929891|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
19517119|NCT01684878|41929892|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
19517120|NCT01684878|41929889|FG000|Part 1: Safety Run in Phase|Death|15|||
19517121|NCT01684878|41929890|FG001|Part 1: Safety Run in Phase|Death|20|||
19517122|NCT01684878|41929891|FG002|Part 1: Safety Run in Phase|Death|0|||
19517123|NCT01684878|41929892|FG003|Part 1: Safety Run in Phase|Death|0|||
19517124|NCT01684878|41929889|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
19517125|NCT01684878|41929890|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
19517126|NCT01684878|41929891|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
19618671|NCT04067011|42068102|FG002|Overall Study|Other Reasons|1|||
19618672|NCT04067011|42068100|FG000|Overall Study|Missing|0|||
19618673|NCT04067011|42068101|FG001|Overall Study|Missing|2|||
19618674|NCT04067011|42068102|FG002|Overall Study|Missing|0|||
19618675|NCT00539305|42068146|FG000|Overall Study|Adverse Event|1|||
19618676|NCT00539305|42068147|FG001|Overall Study|Adverse Event|0|||
19618677|NCT00539305|42068146|FG000|Overall Study|Substance Use|0|||
19618678|NCT00539305|42068147|FG001|Overall Study|Substance Use|1|||
19618679|NCT00539305|42068146|FG000|Overall Study|Withdrawal by Subject|0|||
19618680|NCT00539305|42068147|FG001|Overall Study|Withdrawal by Subject|1|||
19618681|NCT00877032|42068179|FG000|Overall Study|Did not meet entrance criteria|0|||
19618682|NCT00877032|42068180|FG001|Overall Study|Did not meet entrance criteria|0|||
19618683|NCT00877032|42068181|FG002|Overall Study|Did not meet entrance criteria|0|||
19618684|NCT00877032|42068182|FG003|Overall Study|Did not meet entrance criteria|1|||
19618685|NCT00877032|42068183|FG004|Overall Study|Did not meet entrance criteria|0|||
19618686|NCT00877032|42068184|FG005|Overall Study|Did not meet entrance criteria|0|||
19618687|NCT00877032|42068185|FG006|Overall Study|Did not meet entrance criteria|2|||
19618688|NCT00538681|42068224|FG000|Overall Study|Progressive Disease|7|||
19618689|NCT00538681|42068225|FG001|Overall Study|Progressive Disease|0|||
19618690|NCT00538681|42068226|FG002|Overall Study|Progressive Disease|1|||
19618691|NCT00538681|42068227|FG003|Overall Study|Progressive Disease|0|||
19618692|NCT00538681|42068224|FG000|Overall Study|Sponsor Decision|1|||
19618693|NCT00538681|42068225|FG001|Overall Study|Sponsor Decision|3|||
19618694|NCT00538681|42068226|FG002|Overall Study|Sponsor Decision|8|||
19618695|NCT00538681|42068227|FG003|Overall Study|Sponsor Decision|9|||
19618696|NCT00538681|42068224|FG000|Overall Study|Adverse Event|1|||
19618697|NCT00538681|42068225|FG001|Overall Study|Adverse Event|1|||
19618698|NCT00538681|42068226|FG002|Overall Study|Adverse Event|1|||
19517127|NCT01684878|41929892|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
19517128|NCT01684878|41929889|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
19517129|NCT01684878|41929890|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
19517130|NCT01684878|41929891|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
19517131|NCT01684878|41929892|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
19517132|NCT01684878|41929889|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
19517133|NCT01684878|41929890|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
19517134|NCT01684878|41929891|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
19618699|NCT00538681|42068227|FG003|Overall Study|Adverse Event|0|||
19618700|NCT00538681|42068224|FG000|Overall Study|Death|0|||
19618701|NCT00538681|42068225|FG001|Overall Study|Death|0|||
19618702|NCT00538681|42068226|FG002|Overall Study|Death|1|||
19618703|NCT00538681|42068227|FG003|Overall Study|Death|1|||
19517135|NCT01684878|41929892|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
19517136|NCT01684878|41929889|FG000|Part 2: Randomized Phase|Death|0|||
19517137|NCT01684878|41929890|FG001|Part 2: Randomized Phase|Death|0|||
19517138|NCT01684878|41929891|FG002|Part 2: Randomized Phase|Death|62|||
19517139|NCT01684878|41929892|FG003|Part 2: Randomized Phase|Death|68|||
19517140|NCT01684878|41929889|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
19517141|NCT01684878|41929890|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
19517142|NCT01684878|41929891|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
19517143|NCT01684878|41929892|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
19517144|NCT01684878|41929889|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
19517145|NCT01684878|41929890|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
19517146|NCT01684878|41929891|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
19517147|NCT01684878|41929892|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
19517148|NCT01684722|41929906|FG000|Overall Study|Lost to Follow-up|78|||
19517149|NCT01684722|41929907|FG001|Overall Study|Lost to Follow-up|56|||
19517150|NCT01684722|41929908|FG002|Overall Study|Lost to Follow-up|75|||
19517151|NCT01684722|41929909|FG003|Overall Study|Lost to Follow-up|89|||
19517152|NCT01684722|41929906|FG000|Overall Study|Death|19|||
19517153|NCT01684722|41929907|FG001|Overall Study|Death|21|||
19517154|NCT01684722|41929908|FG002|Overall Study|Death|19|||
19517155|NCT01684722|41929909|FG003|Overall Study|Death|21|||
19517156|NCT01592292|41929926|FG000|Overall Study|Follow-up loss|3|||
19517157|NCT01592292|41929927|FG001|Overall Study|Follow-up loss|3|||
19517158|NCT01592292|41929928|FG002|Overall Study|Follow-up loss|1|||
19517159|NCT01592292|41929929|FG003|Overall Study|Follow-up loss|0|||
19517160|NCT01592292|41929926|FG000|Overall Study|Withdrew consent|2|||
19517161|NCT01592292|41929927|FG001|Overall Study|Withdrew consent|1|||
19517162|NCT01592292|41929928|FG002|Overall Study|Withdrew consent|0|||
19517163|NCT01592292|41929929|FG003|Overall Study|Withdrew consent|0|||
19517164|NCT01592292|41929926|FG000|Overall Study|Other|1|||
19517165|NCT01592292|41929927|FG001|Overall Study|Other|1|||
19517166|NCT01592292|41929928|FG002|Overall Study|Other|2|||
19517167|NCT01592292|41929929|FG003|Overall Study|Other|1|||
19517168|NCT01590888|41929938|FG000|Overall Study|Adverse Event|3|||
19517169|NCT01590888|41929939|FG001|Overall Study|Adverse Event|0|||
19517170|NCT01590888|41929940|FG002|Overall Study|Adverse Event|1|||
19517171|NCT01590888|41929938|FG000|Overall Study|Lost to Follow-up|1|||
19517172|NCT01590888|41929939|FG001|Overall Study|Lost to Follow-up|0|||
19517173|NCT01590888|41929940|FG002|Overall Study|Lost to Follow-up|0|||
19517174|NCT01565928|41929948|FG000|Overall Study|Adverse Event|3|||
19517175|NCT01565928|41929948|FG000|Overall Study|Other|3|||
19517176|NCT01565928|41929948|FG000|Overall Study|Progressive Disease|13|||
19517177|NCT01565928|41929948|FG000|Overall Study|Withdrawal by Subject|1|||
19517178|NCT01565928|41929948|FG000|Overall Study|Death|2|||
19517179|NCT01565850|41929957|FG000|Overall Study|Adverse Event|0|||
19517180|NCT01565850|41929958|FG001|Overall Study|Adverse Event|1|||
19517181|NCT01565850|41929957|FG000|Overall Study|Lost to Follow-up|12|||
19517182|NCT01565850|41929958|FG001|Overall Study|Lost to Follow-up|4|||
19517183|NCT01565850|41929957|FG000|Overall Study|Investigator's Discretion|2|||
19517184|NCT01565850|41929958|FG001|Overall Study|Investigator's Discretion|1|||
19517185|NCT01565850|41929957|FG000|Overall Study|Participant noncompliance|2|||
19517186|NCT01565850|41929958|FG001|Overall Study|Participant noncompliance|0|||
19517187|NCT01565850|41929957|FG000|Overall Study|Withdrew Consent|4|||
19517188|NCT01565850|41929958|FG001|Overall Study|Withdrew Consent|2|||
19517189|NCT01565694|41929964|FG000|Dose-Titration Period|Adverse Event|4|||
19517190|NCT01565694|41929964|FG000|Dose-Titration Period|Protocol Violation|10|||
19517191|NCT01565694|41929964|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
19618704|NCT00538681|42068224|FG000|Overall Study|Investigator Decision|0|||
19618705|NCT00538681|42068225|FG001|Overall Study|Investigator Decision|0|||
19618706|NCT00538681|42068226|FG002|Overall Study|Investigator Decision|0|||
19517192|NCT01543152|41929973|FG000|Overall Study|Withdrawal by Subject|0|||
19517193|NCT01543152|41929974|FG001|Overall Study|Withdrawal by Subject|2|||
19517194|NCT01543152|41929975|FG002|Overall Study|Withdrawal by Subject|0|||
19517195|NCT01543152|41929976|FG003|Overall Study|Withdrawal by Subject|0|||
19517196|NCT01543152|41929977|FG004|Overall Study|Withdrawal by Subject|0|||
19517197|NCT01590810|41929994|FG000|Overall Study|Physician Decision|0|||
19517198|NCT01590810|41929995|FG001|Overall Study|Physician Decision|1|||
19517199|NCT01590810|41929996|FG002|Overall Study|Physician Decision|1|||
19517200|NCT01590810|41929997|FG003|Overall Study|Physician Decision|0|||
19517201|NCT01590810|41929998|FG004|Overall Study|Physician Decision|0|||
19517202|NCT01542528|41930033|FG000|Overall Study|Lost to Follow-up|2|||
19517203|NCT01542528|41930034|FG001|Overall Study|Lost to Follow-up|1|||
19517204|NCT01542528|41930033|FG000|Overall Study|Physician Decision|1|||
19517205|NCT01542528|41930034|FG001|Overall Study|Physician Decision|0|||
19517206|NCT01542528|41930033|FG000|Overall Study|Withdrawal by Subject|9|||
19517207|NCT01542528|41930034|FG001|Overall Study|Withdrawal by Subject|6|||
19517208|NCT01565148|41930044|FG000|Overall Study|Withdrawal by Subject|1|||
19517209|NCT01565148|41930045|FG001|Overall Study|Withdrawal by Subject|1|||
19517210|NCT01565148|41930046|FG002|Overall Study|Withdrawal by Subject|1|||
19517211|NCT01565148|41930047|FG003|Overall Study|Withdrawal by Subject|2|||
19517212|NCT01565148|41930044|FG000|Overall Study|Lost to Follow-up|4|||
19517213|NCT01565148|41930045|FG001|Overall Study|Lost to Follow-up|4|||
19517214|NCT01565148|41930046|FG002|Overall Study|Lost to Follow-up|0|||
19517215|NCT01565148|41930047|FG003|Overall Study|Lost to Follow-up|3|||
19517216|NCT01565148|41930044|FG000|Overall Study|Rescue Therapy|8|||
19618707|NCT00538681|42068227|FG003|Overall Study|Investigator Decision|1|||
19618708|NCT00876018|42068241|FG000|Overall Study|Lost to Follow-up|0|||
19517217|NCT01565148|41930045|FG001|Overall Study|Rescue Therapy|5|||
19517218|NCT01565148|41930046|FG002|Overall Study|Rescue Therapy|5|||
19517219|NCT01565148|41930047|FG003|Overall Study|Rescue Therapy|8|||
19517220|NCT01565148|41930044|FG000|Overall Study|Death|0|||
19517221|NCT01565148|41930045|FG001|Overall Study|Death|0|||
19517222|NCT01565148|41930046|FG002|Overall Study|Death|1|||
19517223|NCT01565148|41930047|FG003|Overall Study|Death|0|||
19517224|NCT01565148|41930044|FG000|Overall Study|Physician Decision|2|||
19517225|NCT01565148|41930045|FG001|Overall Study|Physician Decision|5|||
19517226|NCT01565148|41930046|FG002|Overall Study|Physician Decision|0|||
19517227|NCT01565148|41930047|FG003|Overall Study|Physician Decision|0|||
19517228|NCT01564758|41930061|FG000|Overall Study|Death|8|||
19517229|NCT01564758|41930061|FG000|Overall Study|Adverse Event|3|||
19517230|NCT01564758|41930061|FG000|Overall Study|Other|3|||
19517231|NCT01541826|41930068|FG000|Overall Study|Lost to Follow-up|2|||
19517232|NCT01541826|41930069|FG001|Overall Study|Lost to Follow-up|3|||
19517233|NCT01541826|41930070|FG002|Overall Study|Lost to Follow-up|0|||
19517234|NCT01541826|41930068|FG000|Overall Study|Withdrawal by Subject|2|||
19517235|NCT01541826|41930069|FG001|Overall Study|Withdrawal by Subject|0|||
19517236|NCT01541826|41930070|FG002|Overall Study|Withdrawal by Subject|0|||
19517237|NCT01541748|41930078|FG000|Overall Study|Lost to Follow-up|17|||
19517238|NCT01541748|41930078|FG000|Overall Study|Moved out of state|1|||
19517239|NCT01541748|41930078|FG000|Overall Study|Withdrawal by Subject|7|||
19517240|NCT01541748|41930078|FG000|Overall Study|Screen failure|5|||
19517241|NCT01541748|41930078|FG000|Overall Study|Did not receive study device|1|||
19517242|NCT01589094|41930091|FG000|Overall Study|Did not receive treatment|2|||
19517243|NCT01563978|41930097|FG000|Overall Study|Physician Decision|1|||
19517244|NCT01563978|41930098|FG001|Overall Study|Physician Decision|0|||
19517245|NCT01563978|41930097|FG000|Overall Study|Lost to Follow-up|1|||
19517246|NCT01563978|41930098|FG001|Overall Study|Lost to Follow-up|0|||
19517247|NCT01563978|41930097|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
19517248|NCT01563978|41930098|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
19517249|NCT01563978|41930097|FG000|Overall Study|Adverse Event|1|||
19517250|NCT01563978|41930098|FG001|Overall Study|Adverse Event|2|||
19517251|NCT01563354|41930107|FG000|Core Phase|Adverse Event|5|||
19517252|NCT01563354|41930108|FG001|Core Phase|Adverse Event|15|||
19517253|NCT01563354|41930109|FG002|Core Phase|Adverse Event|13|||
19517254|NCT01563354|41930107|FG000|Core Phase|Withdrawal by Subject|1|||
19517255|NCT01563354|41930108|FG001|Core Phase|Withdrawal by Subject|0|||
19517256|NCT01563354|41930109|FG002|Core Phase|Withdrawal by Subject|3|||
19517257|NCT01563354|41930107|FG000|Core Phase|Lost to Follow-up|1|||
19517258|NCT01563354|41930108|FG001|Core Phase|Lost to Follow-up|0|||
19517259|NCT01563354|41930109|FG002|Core Phase|Lost to Follow-up|0|||
19517260|NCT01563354|41930107|FG000|Core Phase|Death|1|||
19517261|NCT01563354|41930108|FG001|Core Phase|Death|5|||
19517262|NCT01563354|41930109|FG002|Core Phase|Death|2|||
19517263|NCT01563354|41930107|FG000|Core Phase|Diseasse progression|18|||
19517264|NCT01563354|41930108|FG001|Core Phase|Diseasse progression|7|||
19517265|NCT01563354|41930109|FG002|Core Phase|Diseasse progression|8|||
19517266|NCT01563354|41930107|FG000|Core Phase|Protocol deviation|2|||
19517267|NCT01563354|41930108|FG001|Core Phase|Protocol deviation|0|||
19517268|NCT01563354|41930109|FG002|Core Phase|Protocol deviation|0|||
19517269|NCT01563354|41930107|FG000|Core Phase|PI decision - did not enter extension|0|||
19517270|NCT01563354|41930108|FG001|Core Phase|PI decision - did not enter extension|1|||
19517271|NCT01563354|41930109|FG002|Core Phase|PI decision - did not enter extension|0|||
19517272|NCT01563354|41930107|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
19517273|NCT01563354|41930108|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
19517274|NCT01563354|41930109|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
19517275|NCT01563354|41930107|FG000|Extension Phase|Adverse Event|0|||
19517276|NCT01563354|41930108|FG001|Extension Phase|Adverse Event|3|||
19517277|NCT01563354|41930109|FG002|Extension Phase|Adverse Event|2|||
19517278|NCT01563354|41930107|FG000|Extension Phase|Withdrawal by Subject|0|||
19517279|NCT01563354|41930108|FG001|Extension Phase|Withdrawal by Subject|1|||
19517280|NCT01563354|41930109|FG002|Extension Phase|Withdrawal by Subject|0|||
19517281|NCT01563354|41930107|FG000|Extension Phase|Administration problems|3|||
19517282|NCT01563354|41930108|FG001|Extension Phase|Administration problems|2|||
19517283|NCT01563354|41930109|FG002|Extension Phase|Administration problems|3|||
19517284|NCT01563354|41930107|FG000|Extension Phase|Disease progression|9|||
19517285|NCT01563354|41930108|FG001|Extension Phase|Disease progression|8|||
19517286|NCT01563354|41930109|FG002|Extension Phase|Disease progression|10|||
19517287|NCT01588548|41930123|FG000|Overall Study|Withdrawal by Subject|0|||
19517288|NCT01588548|41930124|FG001|Overall Study|Withdrawal by Subject|1|||
19517289|NCT01588548|41930125|FG002|Overall Study|Withdrawal by Subject|1|||
19517290|NCT01588548|41930126|FG003|Overall Study|Withdrawal by Subject|1|||
19517291|NCT01588548|41930127|FG004|Overall Study|Withdrawal by Subject|2|||
19517292|NCT01588548|41930128|FG005|Overall Study|Withdrawal by Subject|3|||
19517293|NCT01588548|41930123|FG000|Overall Study|Adverse Event|0|||
19517294|NCT01588548|41930124|FG001|Overall Study|Adverse Event|0|||
19517295|NCT01588548|41930125|FG002|Overall Study|Adverse Event|1|||
19517296|NCT01588548|41930126|FG003|Overall Study|Adverse Event|2|||
19618709|NCT00876018|42068242|FG001|Overall Study|Lost to Follow-up|1|||
19618710|NCT00876018|42068243|FG002|Overall Study|Lost to Follow-up|1|||
19618711|NCT00876018|42068241|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
19618712|NCT00876018|42068242|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
19618713|NCT00876018|42068243|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
19618714|NCT03885934|42068268|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
19618715|NCT03885934|42068269|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
19618716|NCT03885934|42068270|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
19618717|NCT03885934|42068271|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
19618718|NCT03885934|42068272|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
19618719|NCT03885934|42068273|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
19618720|NCT00875706|42068290|FG000|Overall Study|Withdrawal by Subject|1|||
19618721|NCT00875706|42068291|FG001|Overall Study|Withdrawal by Subject|0|||
19618722|NCT00875706|42068292|FG002|Overall Study|Withdrawal by Subject|0|||
19618723|NCT04399889|42068303|FG000|Overall Study|Death|5|||
19618724|NCT04399889|42068304|FG001|Overall Study|Death|1|||
19618725|NCT04399889|42068305|FG002|Overall Study|Death|1|||
19704881|NCT00153062|42149237|FG000|Overall Study|Withdrawal by Subject|14|||
19704882|NCT00153062|42149238|FG001|Overall Study|Withdrawal by Subject|30|||
19704883|NCT00153062|42149239|FG002|Overall Study|Withdrawal by Subject|27|||
19704884|NCT00153062|42149240|FG003|Overall Study|Withdrawal by Subject|28|||
19704885|NCT00153062|42149237|FG000|Overall Study|Lost to Follow-up|12|||
19704886|NCT00153062|42149238|FG001|Overall Study|Lost to Follow-up|20|||
19618726|NCT00837265|42068320|FG000|Pilot Phase|Withdrawal by Subject|0|||
19618727|NCT00837265|42068321|FG001|Pilot Phase|Withdrawal by Subject|2|||
19618728|NCT00837265|42068322|FG002|Pilot Phase|Withdrawal by Subject|3|||
19618729|NCT00837265|42068323|FG003|Pilot Phase|Withdrawal by Subject|2|||
19618730|NCT00837265|42068324|FG004|Pilot Phase|Withdrawal by Subject|0|||
19704887|NCT00153062|42149239|FG002|Overall Study|Lost to Follow-up|15|||
19704888|NCT00153062|42149240|FG003|Overall Study|Lost to Follow-up|16|||
19704889|NCT00153062|42149237|FG000|Overall Study|Adverse Event|0|||
19704890|NCT00153062|42149238|FG001|Overall Study|Adverse Event|1|||
19704891|NCT00153062|42149239|FG002|Overall Study|Adverse Event|1|||
19704892|NCT00153062|42149240|FG003|Overall Study|Adverse Event|0|||
19704893|NCT00153062|42149237|FG000|Overall Study|Protocol Violation|0|||
19704894|NCT00153062|42149238|FG001|Overall Study|Protocol Violation|2|||
19704895|NCT00153062|42149239|FG002|Overall Study|Protocol Violation|1|||
19704896|NCT00153062|42149240|FG003|Overall Study|Protocol Violation|1|||
19704897|NCT00153062|42149237|FG000|Overall Study|No disposition data available|1|||
19704898|NCT00153062|42149238|FG001|Overall Study|No disposition data available|1|||
19704899|NCT00153062|42149239|FG002|Overall Study|No disposition data available|1|||
19704900|NCT00153062|42149240|FG003|Overall Study|No disposition data available|1|||
19704901|NCT00153062|42149237|FG000|Overall Study|Other|0|||
19704902|NCT00153062|42149238|FG001|Overall Study|Other|0|||
19704903|NCT00153062|42149239|FG002|Overall Study|Other|1|||
19704904|NCT00153062|42149240|FG003|Overall Study|Other|0|||
19704905|NCT00145470|42149252|FG000|Overall Study|Adverse Event|19|||
19704906|NCT00145470|42149253|FG001|Overall Study|Adverse Event|25|||
19704907|NCT00145470|42149252|FG000|Overall Study|Lack of Efficacy|27|||
19704908|NCT00145470|42149253|FG001|Overall Study|Lack of Efficacy|13|||
19704909|NCT00145470|42149252|FG000|Overall Study|Withdrawal by Subject|36|||
19704910|NCT00145470|42149253|FG001|Overall Study|Withdrawal by Subject|34|||
19704911|NCT00145470|42149252|FG000|Overall Study|Lost to Follow-up|21|||
19704912|NCT00145470|42149253|FG001|Overall Study|Lost to Follow-up|17|||
19704913|NCT00145470|42149252|FG000|Overall Study|Reason Not Reported|9|||
19704914|NCT00145470|42149253|FG001|Overall Study|Reason Not Reported|9|||
19618731|NCT00837265|42068325|FG005|Pilot Phase|Withdrawal by Subject|0|||
19618732|NCT00837265|42068326|FG006|Pilot Phase|Withdrawal by Subject|0|||
19618733|NCT00837265|42068320|FG000|Pilot Phase|Decision of the investigator|2|||
19618734|NCT00837265|42068321|FG001|Pilot Phase|Decision of the investigator|1|||
19618735|NCT00837265|42068322|FG002|Pilot Phase|Decision of the investigator|0|||
19704915|NCT00152516|42149259|FG000|Overall Study|Adverse Event|18|||
19517297|NCT01588548|41930127|FG004|Overall Study|Adverse Event|1|||
19517298|NCT01588548|41930128|FG005|Overall Study|Adverse Event|0|||
19517299|NCT01588548|41930123|FG000|Overall Study|Condition Under Investigation Worsened|3|||
19517300|NCT01588548|41930124|FG001|Overall Study|Condition Under Investigation Worsened|6|||
19517301|NCT01588548|41930125|FG002|Overall Study|Condition Under Investigation Worsened|4|||
19517302|NCT01588548|41930126|FG003|Overall Study|Condition Under Investigation Worsened|4|||
19517303|NCT01588548|41930127|FG004|Overall Study|Condition Under Investigation Worsened|3|||
19618736|NCT00837265|42068323|FG003|Pilot Phase|Decision of the investigator|0|||
19517304|NCT01588548|41930128|FG005|Overall Study|Condition Under Investigation Worsened|3|||
19517305|NCT01587924|41930146|FG000|Overall Study|Adverse Event|0|||
19517306|NCT01587924|41930147|FG001|Overall Study|Adverse Event|2|||
19517307|NCT01587924|41930148|FG002|Overall Study|Adverse Event|0|||
19517308|NCT01587924|41930149|FG003|Overall Study|Adverse Event|0|||
19517309|NCT01587924|41930146|FG000|Overall Study|Protocol Violation|2|||
19517310|NCT01587924|41930147|FG001|Overall Study|Protocol Violation|1|||
19517311|NCT01587924|41930148|FG002|Overall Study|Protocol Violation|2|||
19517312|NCT01587924|41930149|FG003|Overall Study|Protocol Violation|1|||
19517313|NCT01587924|41930146|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
19517314|NCT01587924|41930147|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
19517315|NCT01587924|41930148|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
19517316|NCT01587924|41930149|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
19517317|NCT01587924|41930146|FG000|Overall Study|Withdrawal by Subject|0|||
19517318|NCT01587924|41930147|FG001|Overall Study|Withdrawal by Subject|1|||
19517319|NCT01587924|41930148|FG002|Overall Study|Withdrawal by Subject|1|||
19517320|NCT01587924|41930149|FG003|Overall Study|Withdrawal by Subject|0|||
19517321|NCT01539642|41930161|FG000|Overall Study|Lack of Efficacy|20|||
19517322|NCT01539642|41930162|FG001|Overall Study|Lack of Efficacy|18|||
19517323|NCT01539642|41930161|FG000|Overall Study|Patient ready for early discharge|8|||
19517324|NCT01539642|41930162|FG001|Overall Study|Patient ready for early discharge|7|||
19517325|NCT01539642|41930161|FG000|Overall Study|Adverse Event|6|||
19517326|NCT01539642|41930162|FG001|Overall Study|Adverse Event|4|||
19517327|NCT01539642|41930161|FG000|Overall Study|Withdrawal by Subject|2|||
19517328|NCT01539642|41930162|FG001|Overall Study|Withdrawal by Subject|2|||
19517329|NCT01586364|41930168|FG000|Overall Study|Withdrawal by Subject|40|||
19517330|NCT01586364|41930168|FG000|Overall Study|Adverse Event|37|||
19517331|NCT01586364|41930168|FG000|Overall Study|Lost to Follow-up|17|||
19517332|NCT01586364|41930168|FG000|Overall Study|Protocol Violation|16|||
19517333|NCT01586364|41930168|FG000|Overall Study|Lack of Efficacy|1|||
19517334|NCT01586364|41930168|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
19517335|NCT01586364|41930168|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
19517336|NCT01586364|41930168|FG000|Overall Study|Other-Site closure due to PI illness|1|||
19517337|NCT01586364|41930168|FG000|Overall Study|Other-PI discretion, site closing|2|||
19517338|NCT01586364|41930168|FG000|Overall Study|Other-Not specified|1|||
19517339|NCT01538628|41930174|FG000|Overall Study|Withdrawal by Subject|1|||
19517340|NCT01538628|41930175|FG001|Overall Study|Withdrawal by Subject|1|||
19517341|NCT01538628|41930174|FG000|Overall Study|Lost to Follow-up|0|||
19517342|NCT01538628|41930175|FG001|Overall Study|Lost to Follow-up|1|||
19517343|NCT01538472|41930182|FG000|Overall Study|Disease Progression|3|||
19517344|NCT01538472|41930182|FG000|Overall Study|Death|1|||
19517345|NCT01562028|41930188|FG000|Overall Study|Withdrawal by Subject|1|||
19517346|NCT01562028|41930189|FG001|Overall Study|Withdrawal by Subject|1|||
19517347|NCT01562028|41930188|FG000|Overall Study|Lost to Follow-up|2|||
19517348|NCT01562028|41930189|FG001|Overall Study|Lost to Follow-up|1|||
19517349|NCT01585584|41930195|FG000|Overall Study|Lack of Efficacy|1|||
19517350|NCT01585584|41930195|FG000|Overall Study|Withdrawal by Subject|1|||
19517351|NCT01585584|41930195|FG000|Overall Study|Physician Decision|2|||
19517352|NCT01561560|41930199|FG000|First Two Weeks of Wear|Time/job conflict|0|||
19517353|NCT01561560|41930200|FG001|First Two Weeks of Wear|Time/job conflict|1|||
19517354|NCT01561560|41930199|FG000|First Two Weeks of Wear|Adverse Event|0|||
19517355|NCT01561560|41930200|FG001|First Two Weeks of Wear|Adverse Event|1|||
19517356|NCT01561560|41930199|FG000|Second Two Weeks of Wear|Adverse Event|0|||
19517357|NCT01561560|41930200|FG001|Second Two Weeks of Wear|Adverse Event|1|||
19517358|NCT01537068|41930208|FG000|Overall Study|Lost to Follow-up|2|||
19517359|NCT01537068|41930209|FG001|Overall Study|Lost to Follow-up|1|||
19517360|NCT01537068|41930208|FG000|Overall Study|Adverse Event|0|||
19517361|NCT01537068|41930209|FG001|Overall Study|Adverse Event|1|||
19517362|NCT01537068|41930208|FG000|Overall Study|Withdrawal by Subject|1|||
19517363|NCT01537068|41930209|FG001|Overall Study|Withdrawal by Subject|1|||
19517364|NCT01537068|41930208|FG000|Overall Study|Lack of Efficacy|1|||
19517365|NCT01537068|41930209|FG001|Overall Study|Lack of Efficacy|0|||
19618737|NCT00837265|42068324|FG004|Pilot Phase|Decision of the investigator|0|||
19517366|NCT01585428|41930217|FG000|Overall Study|Death during treatment|1|||
19517367|NCT01585428|41930218|FG001|Overall Study|Death during treatment|0|||
19517368|NCT01585272|41930225|FG000|Overall Study|Adverse Event|22|||
19517369|NCT01585272|41930225|FG000|Overall Study|Protocol Violation|7|||
19517370|NCT01585272|41930225|FG000|Overall Study|Withdrawal by Subject|10|||
19517371|NCT01585194|41930229|FG000|Overall Study|Withdrawal by Subject|1|||
19517372|NCT01585194|41930229|FG000|Overall Study|Physician Decision|2|||
19517373|NCT01585194|41930229|FG000|Overall Study|Lack of insurance|1|||
19517374|NCT01560780|41930235|FG000|Overall Study|Death|2|||
19517375|NCT01560780|41930236|FG001|Overall Study|Death|1|||
19517376|NCT01560780|41930235|FG000|Overall Study|Patient Preference|11|||
19517377|NCT01560780|41930236|FG001|Overall Study|Patient Preference|11|||
19517378|NCT01585038|41930244|FG000|Overall Study|Adverse Event|2|||
19517379|NCT01585038|41930245|FG001|Overall Study|Adverse Event|2|||
19517380|NCT01560234|41930259|FG000|Overall Study|Lost to Follow-up|3|||
19517381|NCT01560234|41930260|FG001|Overall Study|Lost to Follow-up|0|||
19517382|NCT01560234|41930261|FG002|Overall Study|Lost to Follow-up|1|||
19517383|NCT01560234|41930262|FG003|Overall Study|Lost to Follow-up|0|||
19517384|NCT01560234|41930263|FG004|Overall Study|Lost to Follow-up|0|||
19517385|NCT01560234|41930264|FG005|Overall Study|Lost to Follow-up|2|||
19517386|NCT01560234|41930265|FG006|Overall Study|Lost to Follow-up|0|||
19517387|NCT01560234|41930266|FG007|Overall Study|Lost to Follow-up|2|||
19517388|NCT01559844|41930284|FG000|Overall Study|Consent Withdrawn|7|||
19517389|NCT01559844|41930284|FG000|Overall Study|Death|5|||
19517390|NCT01559844|41930284|FG000|Overall Study|Efficacy Failure|10|||
19517391|NCT01559844|41930284|FG000|Overall Study|No Longer A Transplant Candidate|3|||
19517392|NCT01584648|41930290|FG000|Overall Study|Death|136|||
19517393|NCT01584648|41930291|FG001|Overall Study|Death|146|||
19517394|NCT01584648|41930290|FG000|Overall Study|Lost to Follow-up|9|||
19517395|NCT01584648|41930291|FG001|Overall Study|Lost to Follow-up|9|||
19517396|NCT01584648|41930290|FG000|Overall Study|Investigator discretion|3|||
19517397|NCT01584648|41930291|FG001|Overall Study|Investigator discretion|2|||
19517398|NCT01584648|41930290|FG000|Overall Study|Withdrew consent|13|||
19517399|NCT01584648|41930291|FG001|Overall Study|Withdrew consent|4|||
19517400|NCT01584648|41930290|FG000|Overall Study|Study closed/terminated|50|||
19517401|NCT01584648|41930291|FG001|Overall Study|Study closed/terminated|23|||
19517402|NCT01584648|41930290|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
19517403|NCT01584648|41930291|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
19517404|NCT01559454|41930302|FG000|Overall Study|Lost to Follow-up|3|||
19517405|NCT01559454|41930303|FG001|Overall Study|Lost to Follow-up|2|||
19517406|NCT01559454|41930302|FG000|Overall Study|Withdrawal by Subject|0|||
19517407|NCT01559454|41930303|FG001|Overall Study|Withdrawal by Subject|1|||
19517408|NCT01559454|41930302|FG000|Overall Study|Physician Decision|0|||
19517409|NCT01559454|41930303|FG001|Overall Study|Physician Decision|1|||
19517410|NCT01559454|41930302|FG000|Overall Study|Protocol Violation|0|||
19517411|NCT01559454|41930303|FG001|Overall Study|Protocol Violation|1|||
19517412|NCT01559454|41930302|FG000|Overall Study|Lack of Efficacy|0|||
19517413|NCT01559454|41930303|FG001|Overall Study|Lack of Efficacy|1|||
19517414|NCT01584024|41930309|FG000|Overall Study|Lost to Follow-up|10|||
19517415|NCT01584024|41930309|FG000|Overall Study|Withdrawal by Subject|3|||
19517416|NCT01583166|41930316|FG000|Overall Study|Withdrawal by Subject|4|||
19517417|NCT01583166|41930317|FG001|Overall Study|Withdrawal by Subject|6|||
19517418|NCT01535274|41930325|FG000|Overall Study|Determined to be ineligible|0|||
19517419|NCT01535274|41930326|FG001|Overall Study|Determined to be ineligible|1|||
19517420|NCT01535274|41930325|FG000|Overall Study|Misallocated to propofol intervention|0|||
19517421|NCT01535274|41930326|FG001|Overall Study|Misallocated to propofol intervention|1|||
19517422|NCT01558752|41930336|FG000|Overall Study|Physician Decision|2|||
19517423|NCT01558752|41930337|FG001|Overall Study|Physician Decision|0|||
19517424|NCT01582854|41930345|FG000|Overall Study|Death|8|||
19517425|NCT01582854|41930346|FG001|Overall Study|Death|5|||
19517426|NCT01582854|41930345|FG000|Overall Study|Adverse Event|2|||
19517427|NCT01582854|41930346|FG001|Overall Study|Adverse Event|3|||
19517428|NCT01582854|41930345|FG000|Overall Study|Withdrawal by Participant|8|||
19517429|NCT01582854|41930346|FG001|Overall Study|Withdrawal by Participant|11|||
19517430|NCT01582854|41930345|FG000|Overall Study|Lost to Follow-up|1|||
19517431|NCT01582854|41930346|FG001|Overall Study|Lost to Follow-up|2|||
19517432|NCT01582854|41930345|FG000|Overall Study|Physician Decision|0|||
19517433|NCT01582854|41930346|FG001|Overall Study|Physician Decision|1|||
19517434|NCT01582854|41930345|FG000|Overall Study|Recurrent Stroke|13|||
19517435|NCT01582854|41930346|FG001|Overall Study|Recurrent Stroke|8|||
19517436|NCT01582854|41930345|FG000|Overall Study|Disallowed Concomitant Medication|3|||
19517437|NCT01582854|41930346|FG001|Overall Study|Disallowed Concomitant Medication|2|||
19517438|NCT01582854|41930345|FG000|Overall Study|Carotid or Neurosurgery|0|||
19517439|NCT01582854|41930346|FG001|Overall Study|Carotid or Neurosurgery|1|||
19517440|NCT01582854|41930345|FG000|Overall Study|General Anaesthesia|0|||
19517441|NCT01582854|41930346|FG001|Overall Study|General Anaesthesia|1|||
19517442|NCT01582854|41930345|FG000|Overall Study|Other Miscellaneous Reason|1|||
19517443|NCT01582854|41930346|FG001|Overall Study|Other Miscellaneous Reason|0|||
19517444|NCT01582308|41930352|FG000|Period 1|Withdrawal by Subject|0|||
19517445|NCT01582308|41930353|FG001|Period 1|Withdrawal by Subject|0|||
19517446|NCT01582308|41930354|FG002|Period 1|Withdrawal by Subject|0|||
19517447|NCT01582308|41930355|FG003|Period 1|Withdrawal by Subject|0|||
19517448|NCT01582308|41930356|FG004|Period 1|Withdrawal by Subject|0|||
19517449|NCT01582308|41930357|FG005|Period 1|Withdrawal by Subject|0|||
19517450|NCT01582308|41930358|FG006|Period 1|Withdrawal by Subject|1|||
19517451|NCT01582308|41930359|FG007|Period 1|Withdrawal by Subject|0|||
19517452|NCT01582308|41930360|FG008|Period 1|Withdrawal by Subject|0|||
19517453|NCT01582308|41930361|FG009|Period 1|Withdrawal by Subject|0|||
19517454|NCT01582308|41930352|FG000|10-day Washout Following Period 1|Physician Decision|0|||
19517455|NCT01582308|41930353|FG001|10-day Washout Following Period 1|Physician Decision|0|||
19517456|NCT01582308|41930354|FG002|10-day Washout Following Period 1|Physician Decision|0|||
19517457|NCT01582308|41930355|FG003|10-day Washout Following Period 1|Physician Decision|0|||
19517458|NCT01582308|41930356|FG004|10-day Washout Following Period 1|Physician Decision|1|||
19517459|NCT01582308|41930357|FG005|10-day Washout Following Period 1|Physician Decision|0|||
19517460|NCT01582308|41930358|FG006|10-day Washout Following Period 1|Physician Decision|0|||
19517461|NCT01582308|41930359|FG007|10-day Washout Following Period 1|Physician Decision|0|||
19517462|NCT01582308|41930360|FG008|10-day Washout Following Period 1|Physician Decision|0|||
19517463|NCT01582308|41930361|FG009|10-day Washout Following Period 1|Physician Decision|0|||
19517464|NCT01582308|41930352|FG000|Period 4|Physician Decision|1|||
19517465|NCT01582308|41930353|FG001|Period 4|Physician Decision|0|||
19517466|NCT01582308|41930354|FG002|Period 4|Physician Decision|0|||
19517467|NCT01582308|41930355|FG003|Period 4|Physician Decision|0|||
19517468|NCT01582308|41930356|FG004|Period 4|Physician Decision|0|||
19517469|NCT01582308|41930357|FG005|Period 4|Physician Decision|1|||
19517470|NCT01582308|41930358|FG006|Period 4|Physician Decision|0|||
19517471|NCT01582308|41930359|FG007|Period 4|Physician Decision|0|||
19517472|NCT01582308|41930360|FG008|Period 4|Physician Decision|0|||
19517473|NCT01582308|41930361|FG009|Period 4|Physician Decision|1|||
19517474|NCT01558674|41930376|FG000|Part 1|Study Terminated by Sponsor|10|||
19517475|NCT01558674|41930377|FG001|Part 1|Study Terminated by Sponsor|0|||
19517476|NCT01558674|41930376|FG000|Part 1|Withdrawal by Subject|1|||
19517477|NCT01558674|41930377|FG001|Part 1|Withdrawal by Subject|0|||
19517478|NCT01558596|41930398|FG000|Overall Study|Withdrawal by Subject|1|||
19517479|NCT01558596|41930399|FG001|Overall Study|Withdrawal by Subject|0|||
19517480|NCT01558596|41930398|FG000|Overall Study|surgery elsewhere or cancelled|1|||
19517481|NCT01558596|41930399|FG001|Overall Study|surgery elsewhere or cancelled|1|||
19517482|NCT01558596|41930398|FG000|Overall Study|Protocol Violation|1|||
19517483|NCT01558596|41930399|FG001|Overall Study|Protocol Violation|0|||
19517484|NCT01535040|41930407|FG000|Overall Study|Physician Decision|0|||
19517485|NCT01535040|41930408|FG001|Overall Study|Physician Decision|1|||
19517486|NCT01535040|41930407|FG000|Overall Study|Withdrawal by Subject|13|||
19517487|NCT01535040|41930408|FG001|Overall Study|Withdrawal by Subject|10|||
19517488|NCT01535040|41930407|FG000|Overall Study|Never Started|9|||
19517489|NCT01535040|41930408|FG001|Overall Study|Never Started|4|||
19618738|NCT00837265|42068325|FG005|Pilot Phase|Decision of the investigator|0|||
19618739|NCT00837265|42068326|FG006|Pilot Phase|Decision of the investigator|0|||
19618740|NCT00837265|42068320|FG000|Pilot Phase|Adverse Event|1|||
19618741|NCT00837265|42068321|FG001|Pilot Phase|Adverse Event|0|||
19618742|NCT00837265|42068322|FG002|Pilot Phase|Adverse Event|0|||
19618743|NCT00837265|42068323|FG003|Pilot Phase|Adverse Event|0|||
19618744|NCT00837265|42068324|FG004|Pilot Phase|Adverse Event|0|||
19618745|NCT00837265|42068325|FG005|Pilot Phase|Adverse Event|0|||
19618746|NCT00837265|42068326|FG006|Pilot Phase|Adverse Event|0|||
19618747|NCT00837265|42068320|FG000|Pilot Phase|Disease progression|0|||
19618748|NCT00837265|42068321|FG001|Pilot Phase|Disease progression|0|||
19618749|NCT00837265|42068322|FG002|Pilot Phase|Disease progression|0|||
19618750|NCT00837265|42068323|FG003|Pilot Phase|Disease progression|1|||
19618751|NCT00837265|42068324|FG004|Pilot Phase|Disease progression|0|||
19618752|NCT00837265|42068325|FG005|Pilot Phase|Disease progression|0|||
19704916|NCT00152516|42149259|FG000|Overall Study|Lack and Loss of Efficacy|30|||
19704917|NCT00152516|42149259|FG000|Overall Study|Lost to Follow-up|5|||
19618753|NCT00837265|42068326|FG006|Pilot Phase|Disease progression|0|||
19618754|NCT00837265|42068320|FG000|Pilot Phase|Participant left the city|0|||
19618755|NCT00837265|42068321|FG001|Pilot Phase|Participant left the city|0|||
19618756|NCT00837265|42068322|FG002|Pilot Phase|Participant left the city|0|||
19618757|NCT00837265|42068323|FG003|Pilot Phase|Participant left the city|1|||
19618758|NCT00837265|42068324|FG004|Pilot Phase|Participant left the city|0|||
19618759|NCT00837265|42068325|FG005|Pilot Phase|Participant left the city|0|||
19618760|NCT00837265|42068326|FG006|Pilot Phase|Participant left the city|0|||
19618761|NCT00837265|42068320|FG000|Main Phase|Withdrawal by Subject|0|||
19704918|NCT00152516|42149259|FG000|Overall Study|Withdrawal by Subject|8|||
19394192|NCT01371981|41638303|FG002|Overall Study|Adverse Event|0|||
19517490|NCT01535040|41930407|FG000|Overall Study|Toxicity|7|||
19517491|NCT01535040|41930408|FG001|Overall Study|Toxicity|5|||
19517492|NCT01535040|41930407|FG000|Overall Study|Multiple Reasons|1|||
19517493|NCT01535040|41930408|FG001|Overall Study|Multiple Reasons|1|||
19517494|NCT01534962|41930418|FG000|Overall Study|Randomized but did not start treatment|2|||
19618762|NCT00837265|42068321|FG001|Main Phase|Withdrawal by Subject|0|||
19618763|NCT00837265|42068322|FG002|Main Phase|Withdrawal by Subject|0|||
19618764|NCT00837265|42068323|FG003|Main Phase|Withdrawal by Subject|0|||
19618765|NCT00837265|42068324|FG004|Main Phase|Withdrawal by Subject|4|||
19704919|NCT00152516|42149259|FG000|Overall Study|Protocol Violation|3|||
19618766|NCT00837265|42068325|FG005|Main Phase|Withdrawal by Subject|2|||
19618767|NCT00837265|42068326|FG006|Main Phase|Withdrawal by Subject|1|||
19618768|NCT00837265|42068320|FG000|Main Phase|Decision of the investigator|0|||
19618769|NCT00837265|42068321|FG001|Main Phase|Decision of the investigator|0|||
19618770|NCT00837265|42068322|FG002|Main Phase|Decision of the investigator|0|||
19618771|NCT00837265|42068323|FG003|Main Phase|Decision of the investigator|0|||
19618772|NCT00837265|42068324|FG004|Main Phase|Decision of the investigator|0|||
19618773|NCT00837265|42068325|FG005|Main Phase|Decision of the investigator|2|||
19618774|NCT00837265|42068326|FG006|Main Phase|Decision of the investigator|1|||
19618775|NCT00837265|42068320|FG000|Main Phase|Adverse Event|0|||
19618776|NCT00837265|42068321|FG001|Main Phase|Adverse Event|0|||
19618777|NCT00837265|42068322|FG002|Main Phase|Adverse Event|0|||
19618778|NCT00837265|42068323|FG003|Main Phase|Adverse Event|0|||
19618779|NCT00837265|42068324|FG004|Main Phase|Adverse Event|0|||
19704920|NCT00152516|42149259|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
19704921|NCT00152516|42149259|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
19618780|NCT00837265|42068325|FG005|Main Phase|Adverse Event|1|||
19618781|NCT00837265|42068326|FG006|Main Phase|Adverse Event|0|||
19618782|NCT00837265|42068320|FG000|Main Phase|Death|0|||
19618783|NCT00837265|42068321|FG001|Main Phase|Death|0|||
19618784|NCT00837265|42068322|FG002|Main Phase|Death|0|||
19618785|NCT00837265|42068323|FG003|Main Phase|Death|0|||
19618786|NCT00837265|42068324|FG004|Main Phase|Death|2|||
19618787|NCT00837265|42068325|FG005|Main Phase|Death|0|||
19618788|NCT00837265|42068326|FG006|Main Phase|Death|1|||
19618789|NCT00837265|42068320|FG000|Main Phase|Lost to Follow-up|0|||
19618790|NCT00837265|42068321|FG001|Main Phase|Lost to Follow-up|0|||
19618791|NCT00837265|42068322|FG002|Main Phase|Lost to Follow-up|0|||
19618792|NCT00837265|42068323|FG003|Main Phase|Lost to Follow-up|0|||
19618793|NCT00837265|42068324|FG004|Main Phase|Lost to Follow-up|1|||
19618794|NCT00837265|42068325|FG005|Main Phase|Lost to Follow-up|0|||
19618795|NCT00837265|42068326|FG006|Main Phase|Lost to Follow-up|0|||
19618796|NCT00837265|42068320|FG000|Main Phase|Principal investigator resignation|0|||
19618797|NCT00837265|42068321|FG001|Main Phase|Principal investigator resignation|0|||
19618798|NCT00837265|42068322|FG002|Main Phase|Principal investigator resignation|0|||
19618799|NCT00837265|42068323|FG003|Main Phase|Principal investigator resignation|0|||
19618800|NCT00837265|42068324|FG004|Main Phase|Principal investigator resignation|2|||
19618801|NCT00837265|42068325|FG005|Main Phase|Principal investigator resignation|0|||
19618802|NCT00837265|42068326|FG006|Main Phase|Principal investigator resignation|0|||
19618803|NCT00837265|42068320|FG000|Main Phase|Participant's personal reason|0|||
19618804|NCT00837265|42068321|FG001|Main Phase|Participant's personal reason|0|||
19618805|NCT00837265|42068322|FG002|Main Phase|Participant's personal reason|0|||
19618806|NCT00837265|42068323|FG003|Main Phase|Participant's personal reason|0|||
19618807|NCT00837265|42068324|FG004|Main Phase|Participant's personal reason|1|||
19618808|NCT00837265|42068325|FG005|Main Phase|Participant's personal reason|0|||
19618809|NCT00837265|42068326|FG006|Main Phase|Participant's personal reason|0|||
19618810|NCT00594516|42068339|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
19618811|NCT00594516|42068340|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
19618812|NCT00594516|42068341|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
19618813|NCT00594516|42068339|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
19618814|NCT00594516|42068340|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
19618815|NCT00594516|42068341|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
19618816|NCT00594516|42068339|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
19618817|NCT00594516|42068340|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
19704922|NCT00152516|42149259|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
19704923|NCT00152516|42149259|FG000|Overall Study|Other: Non-Compliance|2|||
19704924|NCT00152516|42149259|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
19704925|NCT00152516|42149259|FG000|Overall Study|Other: Moved Out Of State|1|||
19704926|NCT00152516|42149259|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
19704927|NCT00152516|42149259|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
19704928|NCT00145158|42149265|FG000|Overall Study|premature withdrawal|2|||
19704929|NCT00145158|42149266|FG001|Overall Study|premature withdrawal|3|||
19704930|NCT00150800|42149273|FG000|Overall Study|Adverse Event|89|||
19704931|NCT00150800|42149273|FG000|Overall Study|Death|18|||
19704932|NCT00150800|42149273|FG000|Overall Study|Lack of Efficacy|166|||
19704933|NCT00150800|42149273|FG000|Overall Study|Lost to Follow-up|58|||
19704934|NCT00150800|42149273|FG000|Overall Study|Subject's choice|90|||
19704935|NCT00150800|42149273|FG000|Overall Study|No compliance|18|||
19704936|NCT00150800|42149273|FG000|Overall Study|IP misshandling|1|||
19704937|NCT00150800|42149273|FG000|Overall Study|Site closure|24|||
19704938|NCT00150800|42149273|FG000|Overall Study|Protocol non-adherence|2|||
19704939|NCT00150800|42149273|FG000|Overall Study|Nobody to accompany patient|1|||
19618818|NCT00594516|42068341|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
19618819|NCT00594516|42068339|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
19618820|NCT00594516|42068340|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
19704940|NCT00150800|42149273|FG000|Overall Study|Distance too long for patient|1|||
19618821|NCT00594516|42068341|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
19618822|NCT00594516|42068339|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
19618823|NCT00594516|42068340|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
19618824|NCT00594516|42068341|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
19618825|NCT00594516|42068339|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
19704941|NCT00150800|42149273|FG000|Overall Study|Neurosurgery|2|||
19704942|NCT00150800|42149273|FG000|Overall Study|BRV monotherapy|1|||
19704943|NCT00150800|42149273|FG000|Overall Study|Visit refusal|3|||
19704944|NCT00150800|42149273|FG000|Overall Study|Sponsor's request|2|||
19704945|NCT00150800|42149273|FG000|Overall Study|Generalized Epilepsy|1|||
19704946|NCT00150800|42149273|FG000|Overall Study|Moved from area/country|8|||
19704947|NCT00150800|42149273|FG000|Overall Study|PI retiring|2|||
19704948|NCT00150800|42149273|FG000|Overall Study|PI leaving site|2|||
19704949|NCT00150800|42149273|FG000|Overall Study|Patient insurance|1|||
19704950|NCT00150800|42149273|FG000|Overall Study|Surgical intervention|4|||
19618826|NCT00594516|42068340|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
19618827|NCT00594516|42068341|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
19618828|NCT00594516|42068339|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
19618829|NCT00594516|42068340|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
19618830|NCT00594516|42068341|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
19704951|NCT00150800|42149273|FG000|Overall Study|Pregnancy planned|1|||
19704952|NCT00150800|42149273|FG000|Overall Study|PI discontinuation request|1|||
19704953|NCT00144300|42149280|FG000|Overall Study|Adverse Event|18|||
19704954|NCT00144300|42149281|FG001|Overall Study|Adverse Event|16|||
19618831|NCT00594516|42068339|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
19618832|NCT00594516|42068340|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
19618833|NCT00594516|42068341|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
19618834|NCT00594516|42068339|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
19618835|NCT00594516|42068340|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
19618836|NCT00594516|42068341|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
19618837|NCT00538291|42068345|FG000|Overall Study|Adverse Event|2|||
19618838|NCT00538291|42068345|FG000|Overall Study|Withdrawal by Subject|1|||
19618839|NCT00594906|42068351|FG000|Overall Study|Physician Decision|1|||
19618840|NCT00594906|42068352|FG001|Overall Study|Physician Decision|0|||
19618841|NCT00594906|42068351|FG000|Overall Study|Physician Decision|0|||
19618842|NCT00594906|42068352|FG001|Overall Study|Physician Decision|1|||
19618843|NCT00594906|42068351|FG000|Overall Study|Death|0|||
19618844|NCT00594906|42068352|FG001|Overall Study|Death|1|||
19704955|NCT00144300|42149280|FG000|Overall Study|Protocol Violation|1|||
19704956|NCT00144300|42149281|FG001|Overall Study|Protocol Violation|3|||
19704957|NCT00144300|42149280|FG000|Overall Study|Lost to Follow-up|3|||
19704958|NCT00144300|42149281|FG001|Overall Study|Lost to Follow-up|0|||
19704959|NCT00144300|42149280|FG000|Overall Study|Withdrawal by Subject|6|||
19704960|NCT00144300|42149281|FG001|Overall Study|Withdrawal by Subject|6|||
19704961|NCT00144300|42149280|FG000|Overall Study|Other reason (not specified)|1|||
19704962|NCT00144300|42149281|FG001|Overall Study|Other reason (not specified)|3|||
19704963|NCT00149630|42149289|FG000|Overall Study|Incarceration|2|||
19618845|NCT00537979|42068360|FG000|Overall Study|Adverse Event|2|||
19618846|NCT00537979|42068361|FG001|Overall Study|Adverse Event|2|||
19618847|NCT00537979|42068360|FG000|Overall Study|Withdrawal by Subject|1|||
19618848|NCT00537979|42068361|FG001|Overall Study|Withdrawal by Subject|4|||
19618849|NCT00537979|42068360|FG000|Overall Study|Lost to Follow-up|1|||
19618850|NCT00537979|42068361|FG001|Overall Study|Lost to Follow-up|4|||
19618851|NCT00537979|42068360|FG000|Overall Study|Lack of Efficacy|0|||
19618852|NCT00537979|42068361|FG001|Overall Study|Lack of Efficacy|1|||
19618853|NCT00537979|42068360|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
19618854|NCT00537979|42068361|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
19618855|NCT00537979|42068360|FG000|Overall Study|Death|0|||
19618856|NCT00537979|42068361|FG001|Overall Study|Death|3|||
19618857|NCT00537979|42068360|FG000|Overall Study|Kidney transplant|0|||
19618858|NCT00537979|42068361|FG001|Overall Study|Kidney transplant|3|||
19618859|NCT00537979|42068360|FG000|Overall Study|Heart failure|0|||
19618860|NCT00537979|42068361|FG001|Overall Study|Heart failure|1|||
19618861|NCT00537823|42068370|FG000|Overall Study|Adverse Event|2|||
19618862|NCT00537823|42068371|FG001|Overall Study|Adverse Event|0|||
19618863|NCT00537277|42068378|FG000|Overall Study|Adverse Event|1|||
19618864|NCT00537277|42068378|FG000|Overall Study|Lack of Efficacy|2|||
19618865|NCT00537277|42068378|FG000|Overall Study|Lost to Follow-up|12|||
19618866|NCT00537277|42068378|FG000|Overall Study|Protocol Violation|11|||
19618867|NCT00537277|42068378|FG000|Overall Study|Unclassified|4|||
19618868|NCT00537277|42068378|FG000|Overall Study|Inability to tolerate trial medication|4|||
19704964|NCT00149630|42149290|FG001|Overall Study|Incarceration|0|||
19704965|NCT00149630|42149289|FG000|Overall Study|Treatment Programs|4|||
19618869|NCT00537277|42068378|FG000|Overall Study|Non-compliance with trial procedures|15|||
19618870|NCT00537199|42068382|FG000|Overall Study|Study Terminated|1|||
19704966|NCT00149630|42149290|FG001|Overall Study|Treatment Programs|5|||
19618871|NCT03898063|42068388|FG000|Overall Study|Withdrawal by Subject|10|||
19618872|NCT03898063|42068389|FG001|Overall Study|Withdrawal by Subject|8|||
19618873|NCT00873912|42068397|FG000|Overall Study|Withdrawal by Subject|1|||
19618874|NCT00873912|42068398|FG001|Overall Study|Withdrawal by Subject|0|||
19618875|NCT00873912|42068397|FG000|Overall Study|Lost to Follow-up|2|||
19618876|NCT00873912|42068398|FG001|Overall Study|Lost to Follow-up|0|||
19618877|NCT03823300|42068410|FG000|Overall Study|Withdrawal by Subject|16|||
19618878|NCT03823300|42068411|FG001|Overall Study|Withdrawal by Subject|22|||
19618879|NCT03823300|42068410|FG000|Overall Study|Death|10|||
19618880|NCT03823300|42068411|FG001|Overall Study|Death|14|||
19618881|NCT03823300|42068410|FG000|Overall Study|Adverse Event|3|||
19618882|NCT03823300|42068411|FG001|Overall Study|Adverse Event|5|||
19618883|NCT03823300|42068410|FG000|Overall Study|Physician Decision|1|||
19618884|NCT03823300|42068411|FG001|Overall Study|Physician Decision|7|||
19618885|NCT03823300|42068410|FG000|Overall Study|Lost to Follow-up|1|||
19618886|NCT03823300|42068411|FG001|Overall Study|Lost to Follow-up|3|||
19618887|NCT03823300|42068410|FG000|Overall Study|Protocol Violation|1|||
19618888|NCT03823300|42068411|FG001|Overall Study|Protocol Violation|1|||
19618889|NCT03823300|42068410|FG000|Overall Study|Lack of Efficacy|1|||
19618890|NCT03823300|42068411|FG001|Overall Study|Lack of Efficacy|1|||
19618891|NCT03823300|42068410|FG000|Overall Study|Not Eligible|0|||
19618892|NCT03823300|42068411|FG001|Overall Study|Not Eligible|1|||
19618893|NCT03823300|42068410|FG000|Overall Study|Other|1|||
19618894|NCT03823300|42068411|FG001|Overall Study|Other|0|||
19618895|NCT00537745|42068417|FG000|Overall Study|Did not meet eligibility criteria|2|||
19618896|NCT00537745|42068417|FG000|Overall Study|Withdrawal by Subject|2|||
19618897|NCT00537745|42068417|FG000|Overall Study|Subject unable to provide Interlock info|1|||
19618898|NCT00874848|42068424|FG000|Overall Study|Adverse Event|13|||
19618899|NCT00874848|42068425|FG001|Overall Study|Adverse Event|2|||
19618900|NCT00874848|42068424|FG000|Overall Study|Progressive neoplastic disease|38|||
19618901|NCT00874848|42068425|FG001|Overall Study|Progressive neoplastic disease|18|||
19618902|NCT00874848|42068424|FG000|Overall Study|Withdrawal by Subject|7|||
19618903|NCT00874848|42068425|FG001|Overall Study|Withdrawal by Subject|4|||
19618904|NCT00874848|42068424|FG000|Overall Study|Noncompliance|1|||
19618905|NCT00874848|42068425|FG001|Overall Study|Noncompliance|1|||
19618906|NCT00874848|42068424|FG000|Overall Study|Failure to comply with protocol|0|||
19618907|NCT00874848|42068425|FG001|Overall Study|Failure to comply with protocol|1|||
19618908|NCT00874848|42068424|FG000|Overall Study|Physician Decision|0|||
19618909|NCT00874848|42068425|FG001|Overall Study|Physician Decision|2|||
19618910|NCT00578812|42068433|FG000|Overall Study|Not treated|6|||
19618911|NCT00578812|42068434|FG001|Overall Study|Not treated|7|||
19618912|NCT00536809|42068441|FG000|Phase II|Adverse Event|1|||
19618913|NCT00536809|42068441|FG000|Phase II|Referred for surgical resection|1|||
19618914|NCT00536731|42068452|FG000|Overall Study|Adverse Event|3|||
19618915|NCT00536731|42068453|FG001|Overall Study|Adverse Event|2|||
19618916|NCT00536731|42068454|FG002|Overall Study|Adverse Event|3|||
19618917|NCT00536731|42068452|FG000|Overall Study|Withdrawal by Subject|0|||
19618918|NCT00536731|42068453|FG001|Overall Study|Withdrawal by Subject|2|||
19618919|NCT00536731|42068454|FG002|Overall Study|Withdrawal by Subject|0|||
19618920|NCT00536731|42068452|FG000|Overall Study|Intake of prohibited conc. medication|0|||
19618921|NCT00536731|42068453|FG001|Overall Study|Intake of prohibited conc. medication|0|||
19618922|NCT00536731|42068454|FG002|Overall Study|Intake of prohibited conc. medication|1|||
19618923|NCT00536731|42068452|FG000|Overall Study|Safety reasons|0|||
19618924|NCT00536731|42068453|FG001|Overall Study|Safety reasons|0|||
19618925|NCT00536731|42068454|FG002|Overall Study|Safety reasons|1|||
19618926|NCT00536731|42068452|FG000|Overall Study|Other|1|||
19618927|NCT00536731|42068453|FG001|Overall Study|Other|1|||
19618928|NCT00536731|42068454|FG002|Overall Study|Other|0|||
19618929|NCT00536575|42068462|FG000|Overall Study|Withdrawal by Subject|1|||
19618930|NCT00536575|42068462|FG000|Overall Study|Death|1|||
19618931|NCT03214250|42068473|FG000|Overall Study|Death|5|||
19618932|NCT03214250|42068474|FG001|Overall Study|Death|5|||
19618933|NCT03214250|42068475|FG002|Overall Study|Death|7|||
19618934|NCT03214250|42068476|FG003|Overall Study|Death|4|||
19618935|NCT03214250|42068477|FG004|Overall Study|Death|23|||
19618936|NCT03214250|42068478|FG005|Overall Study|Death|23|||
19618937|NCT03214250|42068479|FG006|Overall Study|Death|24|||
19618938|NCT03214250|42068473|FG000|Overall Study|Lost to Follow-up|0|||
19618939|NCT03214250|42068474|FG001|Overall Study|Lost to Follow-up|0|||
19618940|NCT03214250|42068475|FG002|Overall Study|Lost to Follow-up|0|||
19618941|NCT03214250|42068476|FG003|Overall Study|Lost to Follow-up|1|||
19618942|NCT03214250|42068477|FG004|Overall Study|Lost to Follow-up|1|||
19618943|NCT03214250|42068478|FG005|Overall Study|Lost to Follow-up|2|||
19618944|NCT03214250|42068479|FG006|Overall Study|Lost to Follow-up|0|||
19618945|NCT03214250|42068473|FG000|Overall Study|Other|0|||
19618946|NCT03214250|42068474|FG001|Overall Study|Other|0|||
19618947|NCT03214250|42068475|FG002|Overall Study|Other|0|||
19618948|NCT03214250|42068476|FG003|Overall Study|Other|0|||
19618949|NCT03214250|42068477|FG004|Overall Study|Other|1|||
19618950|NCT03214250|42068478|FG005|Overall Study|Other|1|||
19618951|NCT03214250|42068479|FG006|Overall Study|Other|2|||
19618952|NCT03214250|42068473|FG000|Overall Study|Remains on Study|2|||
19618953|NCT03214250|42068474|FG001|Overall Study|Remains on Study|2|||
19618954|NCT03214250|42068475|FG002|Overall Study|Remains on Study|0|||
19618955|NCT03214250|42068476|FG003|Overall Study|Remains on Study|1|||
19618956|NCT03214250|42068477|FG004|Overall Study|Remains on Study|7|||
19618957|NCT03214250|42068478|FG005|Overall Study|Remains on Study|5|||
19618958|NCT03214250|42068479|FG006|Overall Study|Remains on Study|3|||
19618959|NCT03214250|42068473|FG000|Overall Study|Withdrawal by Subject|0|||
19618960|NCT03214250|42068474|FG001|Overall Study|Withdrawal by Subject|0|||
19618961|NCT03214250|42068475|FG002|Overall Study|Withdrawal by Subject|1|||
19618962|NCT03214250|42068476|FG003|Overall Study|Withdrawal by Subject|2|||
19618963|NCT03214250|42068477|FG004|Overall Study|Withdrawal by Subject|5|||
19618964|NCT03214250|42068478|FG005|Overall Study|Withdrawal by Subject|0|||
19618965|NCT03214250|42068479|FG006|Overall Study|Withdrawal by Subject|2|||
19618966|NCT00874770|42068503|FG000|Overall Study|Lack of Efficacy|2|||
19618967|NCT00874770|42068504|FG001|Overall Study|Lack of Efficacy|0|||
19618968|NCT00874770|42068505|FG002|Overall Study|Lack of Efficacy|0|||
19618969|NCT00874770|42068506|FG003|Overall Study|Lack of Efficacy|2|||
19618970|NCT00874770|42068503|FG000|Overall Study|Adverse Event|1|||
19618971|NCT00874770|42068504|FG001|Overall Study|Adverse Event|1|||
19618972|NCT00874770|42068505|FG002|Overall Study|Adverse Event|4|||
19618973|NCT00874770|42068506|FG003|Overall Study|Adverse Event|2|||
19618974|NCT00874770|42068503|FG000|Overall Study|Lost to Follow-up|1|||
19618975|NCT00874770|42068504|FG001|Overall Study|Lost to Follow-up|0|||
19618976|NCT00874770|42068505|FG002|Overall Study|Lost to Follow-up|0|||
19618977|NCT00874770|42068506|FG003|Overall Study|Lost to Follow-up|1|||
19618978|NCT00874770|42068503|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
19618979|NCT00874770|42068504|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
19618980|NCT00874770|42068505|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
19618981|NCT00874770|42068506|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
19618982|NCT00536263|42068529|FG000|Overall Study|Adverse Event|5|||
19618983|NCT00536263|42068530|FG001|Overall Study|Adverse Event|5|||
19618984|NCT00536263|42068531|FG002|Overall Study|Adverse Event|7|||
19618985|NCT00536263|42068529|FG000|Overall Study|Lost to Follow-up|3|||
19618986|NCT00536263|42068530|FG001|Overall Study|Lost to Follow-up|4|||
19618987|NCT00536263|42068531|FG002|Overall Study|Lost to Follow-up|4|||
19618988|NCT00536263|42068529|FG000|Overall Study|Subject withdrew - not treatment related|2|||
19618989|NCT00536263|42068530|FG001|Overall Study|Subject withdrew - not treatment related|0|||
19618990|NCT00536263|42068531|FG002|Overall Study|Subject withdrew - not treatment related|5|||
19618991|NCT00536263|42068529|FG000|Overall Study|Subject withdrew - treatment related|0|||
19618992|NCT00536263|42068530|FG001|Overall Study|Subject withdrew - treatment related|3|||
19618993|NCT00536263|42068531|FG002|Overall Study|Subject withdrew - treatment related|2|||
19618994|NCT00536263|42068529|FG000|Overall Study|Noncompliance with protocol|0|||
19618995|NCT00536263|42068530|FG001|Overall Study|Noncompliance with protocol|0|||
19618996|NCT00536263|42068531|FG002|Overall Study|Noncompliance with protocol|1|||
19618997|NCT00536263|42068529|FG000|Overall Study|Did not meet protocol eligibility|1|||
19618998|NCT00536263|42068530|FG001|Overall Study|Did not meet protocol eligibility|2|||
19618999|NCT00536263|42068531|FG002|Overall Study|Did not meet protocol eligibility|2|||
19619000|NCT00578344|42068539|FG000|Overall Study|Insurance problems|1|||
19704967|NCT00149630|42149289|FG000|Overall Study|Adverse Event|2|||
19704968|NCT00149630|42149290|FG001|Overall Study|Adverse Event|0|||
19619001|NCT00578344|42068539|FG000|Overall Study|Graft failure|1|||
19619002|NCT00873366|42068543|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
19619003|NCT00873366|42068543|FG000|Overall Study|Off tamoxifen due to side effects|2|||
19619004|NCT00873366|42068543|FG000|Overall Study|Refused to continue DM-BT testing|3|||
19619005|NCT00536107|42068549|FG000|Overall Study|Death|5|||
19619006|NCT00536107|42068550|FG001|Overall Study|Death|1|||
19619007|NCT00536107|42068549|FG000|Overall Study|Incorrect enrolment|1|||
19619008|NCT00536107|42068550|FG001|Overall Study|Incorrect enrolment|0|||
19619009|NCT00536107|42068549|FG000|Overall Study|Withdrawal by Subject|0|||
19619010|NCT00536107|42068550|FG001|Overall Study|Withdrawal by Subject|1|||
19619011|NCT00536107|42068549|FG000|Overall Study|Study Termination|2|||
19619012|NCT00536107|42068550|FG001|Overall Study|Study Termination|4|||
19619013|NCT00885482|42068579|FG000|Overall Study|Pregnancy|1|||
19619014|NCT00885482|42068579|FG000|Overall Study|Lack of Efficacy|1|||
19619015|NCT00885482|42068579|FG000|Overall Study|Death|1|||
19619016|NCT00885482|42068579|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
19619017|NCT00885170|42068603|FG000|Overall Study|Adverse Event|12|||
19619018|NCT00885170|42068604|FG001|Overall Study|Adverse Event|4|||
19619019|NCT00885170|42068603|FG000|Overall Study|Excessive bone loss|6|||
19619020|NCT00885170|42068604|FG001|Overall Study|Excessive bone loss|3|||
19619021|NCT00885170|42068603|FG000|Overall Study|Lost to Follow-up|2|||
19619022|NCT00885170|42068604|FG001|Overall Study|Lost to Follow-up|1|||
19619023|NCT00885170|42068603|FG000|Overall Study|Physician Decision|2|||
19619024|NCT00885170|42068604|FG001|Overall Study|Physician Decision|1|||
19619025|NCT00885170|42068603|FG000|Overall Study|Protocol Violation|3|||
19619026|NCT00885170|42068604|FG001|Overall Study|Protocol Violation|1|||
19619027|NCT00885170|42068603|FG000|Overall Study|Withdrawal by Subject|13|||
19619028|NCT00885170|42068604|FG001|Overall Study|Withdrawal by Subject|13|||
19619029|NCT00866619|42068631|FG000|Overall Study|Adverse Event|112|||
19619030|NCT00866619|42068632|FG001|Overall Study|Adverse Event|106|||
19619031|NCT00866619|42068633|FG002|Overall Study|Adverse Event|47|||
19619032|NCT00866619|42068634|FG003|Overall Study|Adverse Event|44|||
19619033|NCT00866619|42068631|FG000|Overall Study|Protocol Violation|2|||
19619034|NCT00866619|42068632|FG001|Overall Study|Protocol Violation|39|||
19619035|NCT00866619|42068633|FG002|Overall Study|Protocol Violation|2|||
19619036|NCT00866619|42068634|FG003|Overall Study|Protocol Violation|17|||
19704969|NCT00127842|42149300|FG000|Overall Study|Adverse Event|15|||
19704970|NCT00127842|42149300|FG000|Overall Study|Withdrawal by Subject|3|||
19704971|NCT00127842|42149300|FG000|Overall Study|Lost to Follow-up|1|||
19704972|NCT00127842|42149300|FG000|Overall Study|Lack of Efficacy|12|||
19704973|NCT00127842|42149300|FG000|Overall Study|Noncompliance|2|||
19619037|NCT00866619|42068631|FG000|Overall Study|Withdrawal by Subject|587|||
19619038|NCT00866619|42068632|FG001|Overall Study|Withdrawal by Subject|295|||
19619039|NCT00866619|42068633|FG002|Overall Study|Withdrawal by Subject|272|||
19619040|NCT00866619|42068634|FG003|Overall Study|Withdrawal by Subject|144|||
19619041|NCT00866619|42068631|FG000|Overall Study|Lost to Follow-up|1145|||
19619042|NCT00866619|42068632|FG001|Overall Study|Lost to Follow-up|830|||
19619043|NCT00866619|42068633|FG002|Overall Study|Lost to Follow-up|568|||
19619044|NCT00866619|42068634|FG003|Overall Study|Lost to Follow-up|425|||
19619045|NCT00884390|42068681|FG000|Overall Study|Adverse Event|0|||
19619046|NCT00884390|42068682|FG001|Overall Study|Adverse Event|1|||
19619047|NCT00884390|42068681|FG000|Overall Study|Lost to Follow-up|0|||
19619048|NCT00884390|42068682|FG001|Overall Study|Lost to Follow-up|1|||
19619049|NCT00884390|42068681|FG000|Overall Study|Physician Decision|2|||
19619050|NCT00884390|42068682|FG001|Overall Study|Physician Decision|1|||
19619051|NCT00884390|42068681|FG000|Overall Study|Protocol Violation|4|||
19619052|NCT00884390|42068682|FG001|Overall Study|Protocol Violation|1|||
19619053|NCT00884390|42068681|FG000|Overall Study|Withdrawal by Subject|4|||
19619054|NCT00884390|42068682|FG001|Overall Study|Withdrawal by Subject|1|||
19619055|NCT00884390|42068681|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
19704974|NCT00127842|42149300|FG000|Overall Study|Protocol Violation|1|||
19704975|NCT00127842|42149300|FG000|Overall Study|Other|5|||
19704976|NCT03720652|42149306|FG000|Overall Study|Withdrawal by Subject|2|||
19704977|NCT03720652|42149307|FG001|Overall Study|Withdrawal by Subject|7|||
19704978|NCT03720652|42149306|FG000|Overall Study|Lost to Follow-up|0|||
19704979|NCT03720652|42149307|FG001|Overall Study|Lost to Follow-up|4|||
19704980|NCT00112866|42149317|FG000|Overall Study|Protocol Violation|1|||
19704981|NCT00112866|42149318|FG001|Overall Study|Protocol Violation|0|||
19704982|NCT00112866|42149317|FG000|Overall Study|did not start treatment post-op|1|||
19704983|NCT00112866|42149318|FG001|Overall Study|did not start treatment post-op|2|||
19704984|NCT00127608|42149332|FG000|Overall Study|VZV DNA negative|1|||
19704985|NCT00149396|42149336|FG000|Overall Study|Death|15|||
19704986|NCT00149396|42149336|FG000|Overall Study|Withdrawal by Subject|1|||
19704987|NCT00149396|42149336|FG000|Overall Study|Subject noncompliance|2|||
19394193|NCT01371981|41638304|FG003|Overall Study|Adverse Event|4|||
19619056|NCT00884390|42068682|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
19619057|NCT00884390|42068681|FG000|Overall Study|Other|11|||
19619058|NCT00884390|42068682|FG001|Overall Study|Other|1|||
19619059|NCT00872898|42068719|FG000|Part Two - Double Blind|Adverse Event|4|||
19619060|NCT00872898|42068720|FG001|Part Two - Double Blind|Adverse Event|3|||
19619061|NCT00872898|42068719|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
19619062|NCT00872898|42068720|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
19619063|NCT00872898|42068719|FG000|Part Two - Double Blind|Protocol Violation|1|||
19619064|NCT00872898|42068720|FG001|Part Two - Double Blind|Protocol Violation|0|||
19619065|NCT00872898|42068719|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
19619066|NCT00872898|42068720|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
19619067|NCT00872898|42068719|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
19619068|NCT00872898|42068720|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
19619069|NCT00872898|42068719|FG000|Part Two - Double Blind|Other reasons|2|||
19619070|NCT00872898|42068720|FG001|Part Two - Double Blind|Other reasons|0|||
19619071|NCT00884312|42068731|FG000|Overall Study|Non-fatal Progressive Disease|0|||
19619072|NCT00884312|42068732|FG001|Overall Study|Non-fatal Progressive Disease|8|||
19704988|NCT00149396|42149336|FG000|Overall Study|other treatment|5|||
19704989|NCT00223496|42149347|FG000|Overall Study|screen failure|9|||
19619073|NCT00884312|42068731|FG000|Overall Study|Fatal Progressive Disease|0|||
19619074|NCT00884312|42068732|FG001|Overall Study|Fatal Progressive Disease|1|||
19619075|NCT00884312|42068731|FG000|Overall Study|Non-fatal Adverse Event|1|||
19619076|NCT00884312|42068732|FG001|Overall Study|Non-fatal Adverse Event|0|||
19619077|NCT00884312|42068731|FG000|Overall Study|Fatal Adverse Event|1|||
19619078|NCT00884312|42068732|FG001|Overall Study|Fatal Adverse Event|4|||
19704990|NCT00223496|42149347|FG000|Overall Study|Lost to Follow-up|4|||
19704991|NCT00223496|42149347|FG000|Overall Study|Lack of Efficacy|6|||
19619079|NCT00884312|42068731|FG000|Overall Study|Withdrawal by Subject|0|||
19704992|NCT00223496|42149347|FG000|Overall Study|Withdrawal by Subject|1|||
19704993|NCT00223496|42149347|FG000|Overall Study|Physician Decision|2|||
19704994|NCT00255944|42149353|FG000|Overall Study|Lost to Follow-up|797|||
19704995|NCT00255944|42149354|FG001|Overall Study|Lost to Follow-up|834|||
19704996|NCT00143598|42149362|FG000|Overall Study|Lost to Follow-up|23|||
19704997|NCT00143598|42149363|FG001|Overall Study|Lost to Follow-up|21|||
19704998|NCT00143598|42149362|FG000|Overall Study|Withdrawal by Subject|33|||
19704999|NCT00143598|42149363|FG001|Overall Study|Withdrawal by Subject|37|||
19705000|NCT00143598|42149362|FG000|Overall Study|Death|36|||
19705001|NCT00143598|42149363|FG001|Overall Study|Death|36|||
19705002|NCT00126672|42149369|FG000|Overall Study|Adverse Event|4|||
19705003|NCT00126672|42149369|FG000|Overall Study|Lost to Follow-up|4|||
19705004|NCT00145574|42149376|FG000|Double Blind|Adverse Event|0|||
19705005|NCT00145574|42149377|FG001|Double Blind|Adverse Event|3|||
19705006|NCT00145574|42149378|FG002|Double Blind|Adverse Event|1|||
19705007|NCT00145574|42149376|FG000|Double Blind|Withdrawal by Subject|1|||
19705008|NCT00145574|42149377|FG001|Double Blind|Withdrawal by Subject|1|||
19705009|NCT00145574|42149378|FG002|Double Blind|Withdrawal by Subject|1|||
19705010|NCT00145574|42149376|FG000|Double Blind|required restricted medicine|0|||
19705011|NCT00145574|42149377|FG001|Double Blind|required restricted medicine|1|||
19705012|NCT00145574|42149378|FG002|Double Blind|required restricted medicine|0|||
19705013|NCT00145574|42149376|FG000|Open Label Long-term Extension|Adverse Event|0|||
19705014|NCT00145574|42149377|FG001|Open Label Long-term Extension|Adverse Event|0|||
19705015|NCT00145574|42149378|FG002|Open Label Long-term Extension|Adverse Event|5|||
19705016|NCT00145574|42149376|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
19705017|NCT00145574|42149377|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
19705018|NCT00145574|42149378|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
19705019|NCT00145574|42149376|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
19705020|NCT00145574|42149377|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
19619080|NCT00884312|42068732|FG001|Overall Study|Withdrawal by Subject|6|||
19619081|NCT00884312|42068731|FG000|Overall Study|Physician Decision|0|||
19619082|NCT00884312|42068732|FG001|Overall Study|Physician Decision|1|||
19619083|NCT00884312|42068731|FG000|Overall Study|Other|0|||
19619084|NCT00884312|42068732|FG001|Overall Study|Other|4|||
19619085|NCT00884312|42068731|FG000|Overall Study|Did Not Receive Study Drug|0|||
19619086|NCT00884312|42068732|FG001|Overall Study|Did Not Receive Study Drug|1|||
19619087|NCT00534313|42068742|FG000|Short-term Period|Adverse Event|1|||
19619088|NCT00534313|42068743|FG001|Short-term Period|Adverse Event|2|||
19619089|NCT00534313|42068744|FG002|Short-term Period|Adverse Event|1|||
19619090|NCT00534313|42068745|FG003|Short-term Period|Adverse Event|3|||
19619091|NCT00534313|42068742|FG000|Short-term Period|Lack of Efficacy|3|||
19619092|NCT00534313|42068743|FG001|Short-term Period|Lack of Efficacy|4|||
19619093|NCT00534313|42068744|FG002|Short-term Period|Lack of Efficacy|0|||
19619094|NCT00534313|42068745|FG003|Short-term Period|Lack of Efficacy|3|||
19619095|NCT00534313|42068742|FG000|Short-term Period|Participant not meeting study criteria|0|||
19619096|NCT00534313|42068743|FG001|Short-term Period|Participant not meeting study criteria|0|||
19619097|NCT00534313|42068744|FG002|Short-term Period|Participant not meeting study criteria|0|||
19619098|NCT00534313|42068745|FG003|Short-term Period|Participant not meeting study criteria|1|||
19619099|NCT00534313|42068742|FG000|Short-term Period|Participant withdrew consent|2|||
19619100|NCT00534313|42068743|FG001|Short-term Period|Participant withdrew consent|0|||
19619101|NCT00534313|42068744|FG002|Short-term Period|Participant withdrew consent|0|||
19619102|NCT00534313|42068745|FG003|Short-term Period|Participant withdrew consent|2|||
19619103|NCT00534313|42068742|FG000|Short-term Period|Pregnancy|0|||
19619104|NCT00534313|42068743|FG001|Short-term Period|Pregnancy|0|||
19619105|NCT00534313|42068744|FG002|Short-term Period|Pregnancy|1|||
19619106|NCT00534313|42068745|FG003|Short-term Period|Pregnancy|0|||
19619107|NCT00534313|42068742|FG000|Long-term Period|Adverse Event|2|||
19619108|NCT00534313|42068743|FG001|Long-term Period|Adverse Event|1|||
19619109|NCT00534313|42068744|FG002|Long-term Period|Adverse Event|0|||
19619110|NCT00534313|42068745|FG003|Long-term Period|Adverse Event|1|||
19619111|NCT00534313|42068742|FG000|Long-term Period|Lack of Efficacy|14|||
19619112|NCT00534313|42068743|FG001|Long-term Period|Lack of Efficacy|10|||
19619113|NCT00534313|42068744|FG002|Long-term Period|Lack of Efficacy|14|||
19619114|NCT00534313|42068745|FG003|Long-term Period|Lack of Efficacy|12|||
19619115|NCT00534313|42068742|FG000|Long-term Period|Lost to Follow-up|1|||
19619116|NCT00534313|42068743|FG001|Long-term Period|Lost to Follow-up|2|||
19619117|NCT00534313|42068744|FG002|Long-term Period|Lost to Follow-up|0|||
19619118|NCT00534313|42068745|FG003|Long-term Period|Lost to Follow-up|0|||
19619119|NCT00534313|42068742|FG000|Long-term Period|Withdrawal by Subject|2|||
19619120|NCT00534313|42068743|FG001|Long-term Period|Withdrawal by Subject|2|||
19619121|NCT00534313|42068744|FG002|Long-term Period|Withdrawal by Subject|0|||
19619122|NCT00534313|42068745|FG003|Long-term Period|Withdrawal by Subject|0|||
19619123|NCT00534313|42068742|FG000|Long-term Period|No longer meets study criteria|0|||
19619124|NCT00534313|42068743|FG001|Long-term Period|No longer meets study criteria|1|||
19619125|NCT00534313|42068744|FG002|Long-term Period|No longer meets study criteria|0|||
19619126|NCT00534313|42068745|FG003|Long-term Period|No longer meets study criteria|0|||
19619127|NCT00534313|42068742|FG000|Long-term Period|Poor compliance/noncompliance|0|||
19619128|NCT00534313|42068743|FG001|Long-term Period|Poor compliance/noncompliance|1|||
19619129|NCT00534313|42068744|FG002|Long-term Period|Poor compliance/noncompliance|1|||
19619130|NCT00534313|42068745|FG003|Long-term Period|Poor compliance/noncompliance|0|||
19619131|NCT00534313|42068742|FG000|Long-term Period|Administrative reason by sponsor|17|||
19619132|NCT00534313|42068743|FG001|Long-term Period|Administrative reason by sponsor|15|||
19619133|NCT00534313|42068744|FG002|Long-term Period|Administrative reason by sponsor|26|||
19619134|NCT00534313|42068745|FG003|Long-term Period|Administrative reason by sponsor|18|||
19619135|NCT00534313|42068742|FG000|Long-term Period|Other|1|||
19619136|NCT00534313|42068743|FG001|Long-term Period|Other|2|||
19619137|NCT00534313|42068744|FG002|Long-term Period|Other|2|||
19619138|NCT00534313|42068745|FG003|Long-term Period|Other|2|||
19619139|NCT02611960|42068792|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7|||
19619140|NCT02611960|42068793|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8|||
19619141|NCT02611960|42068792|FG000|Overall Study|Death|87|||
19619142|NCT02611960|42068793|FG001|Overall Study|Death|85|||
19619143|NCT02611960|42068792|FG000|Overall Study|Withdrawal by Subject|0|||
19619144|NCT02611960|42068793|FG001|Overall Study|Withdrawal by Subject|1|||
19619145|NCT02611960|42068792|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1|||
19619146|NCT02611960|42068793|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4|||
19619147|NCT02611960|42068792|FG000|Overall Study|Participants Ongoing|22|||
19619148|NCT02611960|42068793|FG001|Overall Study|Participants Ongoing|18|||
19619149|NCT03888391|42068800|FG000|Overall Study|Lost to Follow-up|15|||
19619150|NCT00594204|42068806|FG000|Overall Study|Adverse Event|15|||
19619151|NCT00594204|42068807|FG001|Overall Study|Adverse Event|3|||
19619152|NCT00594204|42068806|FG000|Overall Study|Lost to Follow-up|9|||
19619153|NCT00594204|42068807|FG001|Overall Study|Lost to Follow-up|5|||
19619154|NCT00594204|42068806|FG000|Overall Study|Withdrawal by Subject|23|||
19619155|NCT00594204|42068807|FG001|Overall Study|Withdrawal by Subject|29|||
19619156|NCT00594204|42068806|FG000|Overall Study|Other|4|||
19619157|NCT00594204|42068807|FG001|Overall Study|Other|3|||
19619158|NCT00594204|42068806|FG000|Overall Study|Lack of Efficacy|3|||
19619159|NCT00594204|42068807|FG001|Overall Study|Lack of Efficacy|4|||
19619160|NCT00594204|42068806|FG000|Overall Study|Randomized but not treated|4|||
19619161|NCT00594204|42068807|FG001|Overall Study|Randomized but not treated|1|||
19619162|NCT03888235|42068825|FG000|Overall Study|Lost to Follow-up|1|||
19619163|NCT03888235|42068826|FG001|Overall Study|Lost to Follow-up|1|||
19619164|NCT03888235|42068827|FG002|Overall Study|Lost to Follow-up|0|||
19619165|NCT00866307|42068858|FG000|Induction|Adverse Event|5|||
19619166|NCT00866307|42068859|FG001|Induction|Adverse Event|0|||
19619167|NCT00866307|42068860|FG002|Induction|Adverse Event|0|||
19619168|NCT00866307|42068858|FG000|Induction|Death|2|||
19619169|NCT00866307|42068859|FG001|Induction|Death|0|||
19619170|NCT00866307|42068860|FG002|Induction|Death|0|||
19619171|NCT00866307|42068858|FG000|Induction|Physician Decision|5|||
19619172|NCT00866307|42068859|FG001|Induction|Physician Decision|0|||
19619173|NCT00866307|42068860|FG002|Induction|Physician Decision|0|||
19619174|NCT00866307|42068858|FG000|Induction|Progressive Disease|1|||
19619175|NCT00866307|42068859|FG001|Induction|Progressive Disease|0|||
19619176|NCT00866307|42068860|FG002|Induction|Progressive Disease|0|||
19619177|NCT00866307|42068858|FG000|Induction|Identification of Patients with Day 29 M|3|||
19619178|NCT00866307|42068859|FG001|Induction|Identification of Patients with Day 29 M|0|||
19619179|NCT00866307|42068860|FG002|Induction|Identification of Patients with Day 29 M|0|||
19619180|NCT00866307|42068858|FG000|Induction|Inadequate cytognetic samples th|1|||
19619181|NCT00866307|42068859|FG001|Induction|Inadequate cytognetic samples th|0|||
19619182|NCT00866307|42068860|FG002|Induction|Inadequate cytognetic samples th|0|||
19619183|NCT00866307|42068858|FG000|Induction|Improper post-induction consent|2|||
19619184|NCT00866307|42068859|FG001|Induction|Improper post-induction consent|0|||
19619185|NCT00866307|42068860|FG002|Induction|Improper post-induction consent|0|||
19619186|NCT00866307|42068858|FG000|Induction|Study was closed at the time|1|||
19619187|NCT00866307|42068859|FG001|Induction|Study was closed at the time|0|||
19619188|NCT00866307|42068860|FG002|Induction|Study was closed at the time|0|||
19619189|NCT00866307|42068858|FG000|Consolidation/Maintenance|Adverse Event|0|||
19619190|NCT00866307|42068859|FG001|Consolidation/Maintenance|Adverse Event|0|||
19619191|NCT00866307|42068860|FG002|Consolidation/Maintenance|Adverse Event|8|||
19619192|NCT00866307|42068858|FG000|Consolidation/Maintenance|Death|0|||
19619193|NCT00866307|42068859|FG001|Consolidation/Maintenance|Death|0|||
19619194|NCT00866307|42068860|FG002|Consolidation/Maintenance|Death|1|||
19619195|NCT00866307|42068858|FG000|Consolidation/Maintenance|Physician Decision|0|||
19619196|NCT00866307|42068859|FG001|Consolidation/Maintenance|Physician Decision|3|||
19619197|NCT00866307|42068860|FG002|Consolidation/Maintenance|Physician Decision|2|||
19619198|NCT00866307|42068858|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
19619199|NCT00866307|42068859|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
19619200|NCT00866307|42068860|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
19619201|NCT00866307|42068858|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
19619202|NCT00866307|42068859|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
19619203|NCT00866307|42068860|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
19619204|NCT00866307|42068858|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
19619205|NCT00866307|42068859|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
19619206|NCT00866307|42068860|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
19619207|NCT00866307|42068858|FG000|Consolidation/Maintenance|Therapy error|0|||
19619208|NCT00866307|42068859|FG001|Consolidation/Maintenance|Therapy error|1|||
19619209|NCT00866307|42068860|FG002|Consolidation/Maintenance|Therapy error|0|||
19619210|NCT00866307|42068858|FG000|Consolidation/Maintenance|Non-compliance|0|||
19619211|NCT00866307|42068859|FG001|Consolidation/Maintenance|Non-compliance|0|||
19619212|NCT00866307|42068860|FG002|Consolidation/Maintenance|Non-compliance|1|||
19619213|NCT00866307|42068858|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
19619214|NCT00866307|42068859|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
19619215|NCT00866307|42068860|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
19619216|NCT00531427|42068868|FG000|Overall Study|Withdrawal by Subject|7|||
19619217|NCT00531427|42068869|FG001|Overall Study|Withdrawal by Subject|13|||
19619218|NCT00531427|42068868|FG000|Overall Study|Adverse Event|44|||
19619219|NCT00531427|42068869|FG001|Overall Study|Adverse Event|30|||
19619220|NCT00531427|42068868|FG000|Overall Study|Lost to Follow-up|4|||
19619221|NCT00531427|42068869|FG001|Overall Study|Lost to Follow-up|3|||
19619222|NCT00531427|42068868|FG000|Overall Study|Lack of Efficacy|14|||
19619223|NCT00531427|42068869|FG001|Overall Study|Lack of Efficacy|39|||
19619224|NCT00531427|42068868|FG000|Overall Study|Administrative|4|||
19619225|NCT00531427|42068869|FG001|Overall Study|Administrative|9|||
19619226|NCT00871728|42068876|FG000|Overall Study|Adverse Event|1|||
19619227|NCT00871728|42068876|FG000|Overall Study|Protocol Violation|7|||
19619228|NCT00871728|42068876|FG000|Overall Study|Lost to Follow-up|2|||
19619229|NCT00871728|42068876|FG000|Overall Study|Failed to Visit Hospital|4|||
19619230|NCT00871728|42068876|FG000|Overall Study|Participant Non-compliance|1|||
19619231|NCT00871728|42068876|FG000|Overall Study|Withdrawal of Informed Consent|5|||
19619232|NCT00868998|42068880|FG000|Overall Study|Screen Failure|1|||
19619233|NCT00868998|42068880|FG000|Overall Study|Withdrawal by Subject|1|||
19619234|NCT00868998|42068880|FG000|Overall Study|Progression of disease|2|||
19619235|NCT00868998|42068880|FG000|Overall Study|Death|1|||
19619236|NCT00533845|42068895|FG000|Overall Study|Physician Decision|1|||
19619237|NCT00533845|42068896|FG001|Overall Study|Physician Decision|0|||
19619238|NCT00857649|42068904|FG000|Overall Study|Adverse Event|15|||
19619239|NCT00857649|42068905|FG001|Overall Study|Adverse Event|10|||
19619240|NCT00857649|42068904|FG000|Overall Study|Non-compliance|1|||
19619241|NCT00857649|42068905|FG001|Overall Study|Non-compliance|1|||
19619242|NCT00857649|42068904|FG000|Overall Study|Protocol Violation|2|||
19619243|NCT00857649|42068905|FG001|Overall Study|Protocol Violation|2|||
19619244|NCT00857649|42068904|FG000|Overall Study|Withdrawal of Consent|10|||
19619245|NCT00857649|42068905|FG001|Overall Study|Withdrawal of Consent|7|||
19619246|NCT00857649|42068904|FG000|Overall Study|Nursing Home Placement|2|||
19619247|NCT00857649|42068905|FG001|Overall Study|Nursing Home Placement|9|||
19619248|NCT00857649|42068904|FG000|Overall Study|Other Reasons|1|||
19619249|NCT00857649|42068905|FG001|Overall Study|Other Reasons|3|||
19619250|NCT00857415|42068913|FG000|Overall Study|Image acquisition failure|2|||
19619251|NCT00857415|42068914|FG001|Overall Study|Image acquisition failure|0|||
19619252|NCT00857415|42068913|FG000|Overall Study|Invalid image or not imaged|3|||
19619253|NCT00857415|42068914|FG001|Overall Study|Invalid image or not imaged|0|||
19619254|NCT00857415|42068913|FG000|Overall Study|Subject still living at end of study|110|||
19619255|NCT00857415|42068914|FG001|Overall Study|Subject still living at end of study|0|||
19619256|NCT00857415|42068913|FG000|Overall Study|Deceased with no autopsy|2|||
19619257|NCT00857415|42068914|FG001|Overall Study|Deceased with no autopsy|0|||
19619258|NCT00532441|42068920|FG000|Overall Study|Death|1|||
19619259|NCT00532441|42068921|FG001|Overall Study|Death|0|||
19619260|NCT00857259|42068942|FG000|Overall Study|Protocol Violation|1|||
19619261|NCT00857259|42068943|FG001|Overall Study|Protocol Violation|0|||
19619262|NCT00857259|42068944|FG002|Overall Study|Protocol Violation|1|||
19619263|NCT00868608|42068957|FG000|Overall Study|Withdrawal by Subject|3|||
19619264|NCT00868608|42068958|FG001|Overall Study|Withdrawal by Subject|1|||
19619265|NCT00868608|42068959|FG002|Overall Study|Withdrawal by Subject|0|||
19619266|NCT00868608|42068957|FG000|Overall Study|Lost to Follow-up|3|||
19619267|NCT00868608|42068958|FG001|Overall Study|Lost to Follow-up|0|||
19619268|NCT00868608|42068959|FG002|Overall Study|Lost to Follow-up|1|||
19619269|NCT00868608|42068957|FG000|Overall Study|Death|16|||
19619270|NCT00868608|42068958|FG001|Overall Study|Death|2|||
19705021|NCT00145574|42149378|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
19619271|NCT00868608|42068959|FG002|Overall Study|Death|4|||
19619272|NCT00868608|42068957|FG000|Overall Study|Other - Unspecified|1|||
19619273|NCT00868608|42068958|FG001|Overall Study|Other - Unspecified|0|||
19619274|NCT00868608|42068959|FG002|Overall Study|Other - Unspecified|0|||
19619275|NCT00856635|42068969|FG000|Overall Study|Lost to Follow-up|2|||
19619276|NCT00856635|42068970|FG001|Overall Study|Lost to Follow-up|5|||
19619277|NCT00856635|42068969|FG000|Overall Study|Pregnancy|1|||
19619278|NCT00856635|42068970|FG001|Overall Study|Pregnancy|0|||
19619279|NCT00856635|42068969|FG000|Overall Study|Withdrawal by Subject|3|||
19619280|NCT00856635|42068970|FG001|Overall Study|Withdrawal by Subject|1|||
19619281|NCT00856635|42068969|FG000|Overall Study|Serious Adverse Event|1|||
19619282|NCT00856635|42068970|FG001|Overall Study|Serious Adverse Event|0|||
19619283|NCT00856635|42068969|FG000|Overall Study|Other|1|||
19705022|NCT00145574|42149376|FG000|Open Label Long-term Extension|required restricted medicine|0|||
19705023|NCT00145574|42149377|FG001|Open Label Long-term Extension|required restricted medicine|0|||
19705024|NCT00145574|42149378|FG002|Open Label Long-term Extension|required restricted medicine|1|||
19705025|NCT00145496|42149393|FG000|Overall Study|Adverse Event|42|||
19705026|NCT00145496|42149394|FG001|Overall Study|Adverse Event|30|||
19705027|NCT00145496|42149393|FG000|Overall Study|Lack of Efficacy|12|||
19705028|NCT00145496|42149394|FG001|Overall Study|Lack of Efficacy|7|||
19705029|NCT00145496|42149393|FG000|Overall Study|Withdrawal by Subject|32|||
19705030|NCT00145496|42149394|FG001|Overall Study|Withdrawal by Subject|26|||
19705031|NCT00145496|42149393|FG000|Overall Study|Lost to Follow-up|12|||
19705032|NCT00145496|42149394|FG001|Overall Study|Lost to Follow-up|5|||
19705033|NCT00145496|42149393|FG000|Overall Study|Other|25|||
19394194|NCT01371981|41638305|FG004|Overall Study|Adverse Event|1|||
19394195|NCT01371981|41638306|FG005|Overall Study|Adverse Event|0|||
19705034|NCT00145496|42149394|FG001|Overall Study|Other|13|||
19705035|NCT00255164|42149403|FG000|Overall Study|Adverse Event|10|||
19619284|NCT00856635|42068970|FG001|Overall Study|Other|0|||
19619285|NCT00856635|42068969|FG000|Overall Study|Discontinued at Randomization|2|||
19705036|NCT00255164|42149404|FG001|Overall Study|Adverse Event|6|||
19705037|NCT00255164|42149405|FG002|Overall Study|Adverse Event|9|||
19705038|NCT00255164|42149403|FG000|Overall Study|Lost to Follow-up|4|||
19705039|NCT00255164|42149404|FG001|Overall Study|Lost to Follow-up|3|||
19619286|NCT00856635|42068970|FG001|Overall Study|Discontinued at Randomization|2|||
19619287|NCT00856557|42068980|FG000|Overall Study|No patients with contextual flags|12|||
19619288|NCT00856557|42068981|FG001|Overall Study|No patients with contextual flags|16|||
19619289|NCT00856323|42068987|FG000|Overall Study|Withdrawal by Subject|2|||
19619290|NCT00856245|42068995|FG000|Overall Study|Was not transplanted|5|||
19619291|NCT00855933|42069001|FG000|Overall Study|Withdrawal by Subject|0|||
19619292|NCT00855933|42069002|FG001|Overall Study|Withdrawal by Subject|1|||
19619293|NCT00871572|42069012|FG000|Overall Study|Adverse Event|0|||
19619294|NCT00871572|42069013|FG001|Overall Study|Adverse Event|2|||
19619295|NCT00871572|42069014|FG002|Overall Study|Adverse Event|0|||
19619296|NCT00871572|42069015|FG003|Overall Study|Adverse Event|3|||
19619297|NCT00871572|42069012|FG000|Overall Study|Investigator Decision|0|||
19619298|NCT00871572|42069013|FG001|Overall Study|Investigator Decision|1|||
19619299|NCT00871572|42069014|FG002|Overall Study|Investigator Decision|0|||
19619300|NCT00871572|42069015|FG003|Overall Study|Investigator Decision|1|||
19619301|NCT00871572|42069012|FG000|Overall Study|Lost to Follow-up|0|||
19619302|NCT00871572|42069013|FG001|Overall Study|Lost to Follow-up|1|||
19619303|NCT00871572|42069014|FG002|Overall Study|Lost to Follow-up|0|||
19619304|NCT00871572|42069015|FG003|Overall Study|Lost to Follow-up|1|||
19619305|NCT00871572|42069012|FG000|Overall Study|Protocol Violation|0|||
19619306|NCT00871572|42069013|FG001|Overall Study|Protocol Violation|0|||
19619307|NCT00871572|42069014|FG002|Overall Study|Protocol Violation|1|||
19619308|NCT00871572|42069015|FG003|Overall Study|Protocol Violation|1|||
19619309|NCT00871572|42069012|FG000|Overall Study|Sponsor Decision|1|||
19619310|NCT00871572|42069013|FG001|Overall Study|Sponsor Decision|0|||
19619311|NCT00871572|42069014|FG002|Overall Study|Sponsor Decision|0|||
19619312|NCT00871572|42069015|FG003|Overall Study|Sponsor Decision|0|||
19619313|NCT00871572|42069012|FG000|Overall Study|Withdrawal by Subject|1|||
19619314|NCT00871572|42069013|FG001|Overall Study|Withdrawal by Subject|2|||
19619315|NCT00871572|42069014|FG002|Overall Study|Withdrawal by Subject|3|||
19619316|NCT00871572|42069015|FG003|Overall Study|Withdrawal by Subject|1|||
19619317|NCT03885661|42069027|FG000|Overall Study|Withdrawal by Subject|0|||
19619318|NCT03885661|42069028|FG001|Overall Study|Withdrawal by Subject|1|||
19619319|NCT03885661|42069027|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
19619320|NCT03885661|42069028|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
19619321|NCT00868530|42069034|FG000|Overall Study|Adverse Event|3|||
19619322|NCT00868530|42069034|FG000|Overall Study|Lost to Follow-up|1|||
19619323|NCT00855465|42069040|FG000|Treatment Period|Adverse Event|4|||
19619324|NCT00855465|42069041|FG001|Treatment Period|Adverse Event|2|||
19619325|NCT00855465|42069040|FG000|Treatment Period|Death|2|||
19619326|NCT00855465|42069041|FG001|Treatment Period|Death|2|||
19619327|NCT00855465|42069040|FG000|Treatment Period|Lack of Efficacy|2|||
19619328|NCT00855465|42069041|FG001|Treatment Period|Lack of Efficacy|1|||
19619329|NCT00855465|42069040|FG000|Treatment Period|Non-compliance|1|||
19619330|NCT00855465|42069041|FG001|Treatment Period|Non-compliance|0|||
19619331|NCT00855465|42069040|FG000|Treatment Period|Protocol Violation|2|||
19619332|NCT00855465|42069041|FG001|Treatment Period|Protocol Violation|0|||
19619333|NCT00855465|42069040|FG000|Treatment Period|Withdrawal by Subject|2|||
19619334|NCT00855465|42069041|FG001|Treatment Period|Withdrawal by Subject|0|||
19619335|NCT00855465|42069040|FG000|Treatment Period|Not treated|1|||
19619336|NCT00855465|42069041|FG001|Treatment Period|Not treated|0|||
19619337|NCT00855465|42069040|FG000|Follow-up Period (FUP)|Adverse Event|0|||
19619338|NCT00855465|42069041|FG001|Follow-up Period (FUP)|Adverse Event|1|||
19619339|NCT00855465|42069040|FG000|Follow-up Period (FUP)|Death|0|||
19619340|NCT00855465|42069041|FG001|Follow-up Period (FUP)|Death|1|||
19619341|NCT00855465|42069040|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
19619342|NCT00855465|42069041|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
19619343|NCT00855465|42069040|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
19619344|NCT00855465|42069041|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
19619345|NCT00855465|42069040|FG000|Follow-up Period (FUP)|Missing|1|||
19619346|NCT00855465|42069041|FG001|Follow-up Period (FUP)|Missing|0|||
19619347|NCT00598442|42069050|FG000|Overall Study|Adverse Event|3|||
19619348|NCT00598442|42069051|FG001|Overall Study|Adverse Event|0|||
19619349|NCT00598442|42069052|FG002|Overall Study|Adverse Event|0|||
19619350|NCT00598442|42069050|FG000|Overall Study|Death|19|||
19619351|NCT00598442|42069051|FG001|Overall Study|Death|11|||
19619352|NCT00598442|42069052|FG002|Overall Study|Death|11|||
19619353|NCT00598442|42069050|FG000|Overall Study|Lost to Follow-up|4|||
19619354|NCT00598442|42069051|FG001|Overall Study|Lost to Follow-up|3|||
19619355|NCT00598442|42069052|FG002|Overall Study|Lost to Follow-up|3|||
19619356|NCT00598442|42069050|FG000|Overall Study|Physician Decision|2|||
19619357|NCT00598442|42069051|FG001|Overall Study|Physician Decision|1|||
19619358|NCT00598442|42069052|FG002|Overall Study|Physician Decision|1|||
19619359|NCT00598442|42069050|FG000|Overall Study|Withdrawal by Subject|8|||
19619360|NCT00598442|42069051|FG001|Overall Study|Withdrawal by Subject|16|||
19619361|NCT00598442|42069052|FG002|Overall Study|Withdrawal by Subject|6|||
19619362|NCT00598442|42069050|FG000|Overall Study|Noncompliance|0|||
19619363|NCT00598442|42069051|FG001|Overall Study|Noncompliance|2|||
19619364|NCT00598442|42069052|FG002|Overall Study|Noncompliance|1|||
19619365|NCT00598442|42069050|FG000|Overall Study|Relocation|1|||
19619366|NCT00598442|42069051|FG001|Overall Study|Relocation|4|||
19619367|NCT00598442|42069052|FG002|Overall Study|Relocation|0|||
19619368|NCT00598442|42069050|FG000|Overall Study|Renal transplant|0|||
19619369|NCT00598442|42069051|FG001|Overall Study|Renal transplant|0|||
19619370|NCT00598442|42069052|FG002|Overall Study|Renal transplant|1|||
19619371|NCT00598442|42069050|FG000|Overall Study|Site closed by sponsor|5|||
19619372|NCT00598442|42069051|FG001|Overall Study|Site closed by sponsor|2|||
19619373|NCT00598442|42069052|FG002|Overall Study|Site closed by sponsor|1|||
19619374|NCT00598442|42069050|FG000|Overall Study|Started dialysis|1|||
19619375|NCT00598442|42069051|FG001|Overall Study|Started dialysis|0|||
19619376|NCT00598442|42069052|FG002|Overall Study|Started dialysis|0|||
19619377|NCT00593814|42069062|FG000|Overall Study|Death|7|||
19619378|NCT00593814|42069063|FG001|Overall Study|Death|0|||
19619379|NCT00593814|42069062|FG000|Overall Study|Withdrawal by Subject|7|||
19619380|NCT00593814|42069063|FG001|Overall Study|Withdrawal by Subject|0|||
19619381|NCT00593814|42069062|FG000|Overall Study|Lost to Follow-up|7|||
19619382|NCT00593814|42069063|FG001|Overall Study|Lost to Follow-up|0|||
19619383|NCT00593814|42069062|FG000|Overall Study|Physician Decision|3|||
19619384|NCT00593814|42069063|FG001|Overall Study|Physician Decision|0|||
19619385|NCT00855309|42069071|FG000|Overall Study|patient never recieved drug|1|||
19619386|NCT00855309|42069072|FG001|Overall Study|patient never recieved drug|0|||
19619387|NCT00532129|42069078|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
19619388|NCT00532129|42069078|FG000|Treatment Period|Physician Decision|15|||
19619389|NCT00532129|42069078|FG000|Treatment Period|Disease progression|3|||
19619390|NCT00532129|42069078|FG000|Treatment Period|Protocol Violation|1|||
19619391|NCT00532129|42069078|FG000|Treatment Period|Other|5|||
19619392|NCT00532129|42069078|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
19619393|NCT00532129|42069078|FG000|Follow-up Period|Disease progression|57|||
19619394|NCT00532129|42069078|FG000|Follow-up Period|Lost to Follow-up|1|||
19619395|NCT00532129|42069078|FG000|Follow-up Period|Other|6|||
19619396|NCT00854607|42069082|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
19619397|NCT00854373|42069095|FG000|Overall Study|Withdrawal by Subject|1|||
19619398|NCT00854373|42069096|FG001|Overall Study|Withdrawal by Subject|3|||
19619399|NCT00854373|42069095|FG000|Overall Study|Forgot to take study drug|1|||
19619400|NCT00854373|42069096|FG001|Overall Study|Forgot to take study drug|1|||
19619401|NCT00853905|42069104|FG000|Overall Study|Lost to Follow-up|1|||
19619402|NCT00853905|42069105|FG001|Overall Study|Lost to Follow-up|3|||
19619403|NCT00853905|42069104|FG000|Overall Study|Withdrawal by Subject|0|||
19619404|NCT00853905|42069105|FG001|Overall Study|Withdrawal by Subject|1|||
19705040|NCT00255164|42149405|FG002|Overall Study|Lost to Follow-up|4|||
19705041|NCT00255164|42149403|FG000|Overall Study|Withdrawal by Subject|18|||
19705042|NCT00255164|42149404|FG001|Overall Study|Withdrawal by Subject|17|||
19705043|NCT00255164|42149405|FG002|Overall Study|Withdrawal by Subject|8|||
19705044|NCT00255164|42149403|FG000|Overall Study|Noncompliance|0|||
19705045|NCT00255164|42149404|FG001|Overall Study|Noncompliance|1|||
19705046|NCT00255164|42149405|FG002|Overall Study|Noncompliance|2|||
19705047|NCT00255164|42149403|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
19705048|NCT00255164|42149404|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
19705049|NCT00255164|42149405|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
19705050|NCT00255164|42149403|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
19705051|NCT00255164|42149404|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
19705052|NCT00255164|42149405|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
19705053|NCT00255164|42149403|FG000|Overall Study|Possible Barrett's Esophagus|1|||
19705054|NCT00255164|42149404|FG001|Overall Study|Possible Barrett's Esophagus|3|||
19705055|NCT00255164|42149405|FG002|Overall Study|Possible Barrett's Esophagus|8|||
19705056|NCT00255164|42149403|FG000|Overall Study|Esophageal Stricture|0|||
19705057|NCT00255164|42149404|FG001|Overall Study|Esophageal Stricture|0|||
19705058|NCT00255164|42149405|FG002|Overall Study|Esophageal Stricture|1|||
19705059|NCT00255164|42149403|FG000|Overall Study|Therapeutic Failure|11|||
19705060|NCT00255164|42149404|FG001|Overall Study|Therapeutic Failure|2|||
19705061|NCT00255164|42149405|FG002|Overall Study|Therapeutic Failure|3|||
19705062|NCT00126594|42149415|FG000|Overall Study|Ineligible|2|||
19705063|NCT00126594|42149416|FG001|Overall Study|Ineligible|0|||
19705064|NCT00126594|42149415|FG000|Overall Study|Withdrawal by Subject|0|||
19705065|NCT00126594|42149416|FG001|Overall Study|Withdrawal by Subject|4|||
19705066|NCT00126594|42149415|FG000|Overall Study|Physician Decision|1|||
19705067|NCT00126594|42149416|FG001|Overall Study|Physician Decision|3|||
19619405|NCT00853905|42069104|FG000|Overall Study|never had surgery|1|||
19619406|NCT00853905|42069105|FG001|Overall Study|never had surgery|0|||
19619407|NCT00868296|42069116|FG000|Overall Study|Adverse Event|0|||
19619408|NCT00868296|42069117|FG001|Overall Study|Adverse Event|2|||
19619409|NCT00868296|42069116|FG000|Overall Study|Withdrawal by Subject|0|||
19619410|NCT00868296|42069117|FG001|Overall Study|Withdrawal by Subject|1|||
19619411|NCT00867360|42069125|FG000|Overall Study|Withdrawal by Subject|1|||
19705068|NCT00126594|42149415|FG000|Overall Study|Adverse Event|7|||
19705069|NCT00126594|42149416|FG001|Overall Study|Adverse Event|5|||
19705070|NCT00126594|42149415|FG000|Overall Study|Non-compliance|0|||
19705071|NCT00126594|42149416|FG001|Overall Study|Non-compliance|1|||
19705072|NCT00126594|42149415|FG000|Overall Study|Disease Progression|29|||
19705073|NCT00126594|42149416|FG001|Overall Study|Disease Progression|24|||
19705074|NCT00126438|42149425|FG000|Overall Study|Withdrawal due to adverse event|1|||
19705075|NCT00126438|42149426|FG001|Overall Study|Withdrawal due to adverse event|0|||
19705076|NCT00126438|42149425|FG000|Overall Study|Lost to Follow-up|22|||
19705077|NCT00126438|42149426|FG001|Overall Study|Lost to Follow-up|0|||
19705078|NCT00126438|42149425|FG000|Overall Study|Protocol Violation|8|||
19705079|NCT00126438|42149426|FG001|Overall Study|Protocol Violation|8|||
19705080|NCT00126438|42149425|FG000|Overall Study|Withdrawal by Subject|3|||
19705081|NCT00126438|42149426|FG001|Overall Study|Withdrawal by Subject|2|||
19705082|NCT00142584|42149434|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
19705083|NCT00142584|42149435|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
19705084|NCT00142584|42149434|FG000|Overall Study|Withdrawal by Subject|30|||
19705085|NCT00142584|42149435|FG001|Overall Study|Withdrawal by Subject|16|||
19705086|NCT00142584|42149434|FG000|Overall Study|Lost to Follow-up|22|||
19705087|NCT00142584|42149435|FG001|Overall Study|Lost to Follow-up|12|||
19705088|NCT00142584|42149434|FG000|Overall Study|Adverse Event|14|||
19705089|NCT00142584|42149435|FG001|Overall Study|Adverse Event|5|||
19705090|NCT00142584|42149434|FG000|Overall Study|Protocol Violation|4|||
19705091|NCT00142584|42149435|FG001|Overall Study|Protocol Violation|7|||
19705092|NCT00142584|42149434|FG000|Overall Study|Treatment Failure|2|||
19705093|NCT00142584|42149435|FG001|Overall Study|Treatment Failure|0|||
19705094|NCT00126126|42149445|FG000|Overall Study|Lost to Follow-up|0|||
19705095|NCT00126126|42149446|FG001|Overall Study|Lost to Follow-up|2|||
19705096|NCT00125268|42149454|FG000|Overall Study|Withdrawal by Subject|1|||
19705097|NCT00125268|42149455|FG001|Overall Study|Withdrawal by Subject|1|||
19705098|NCT00125190|42149461|FG000|Overall Study|Subject/Parent Decision|7|||
19705099|NCT00125190|42149461|FG000|Overall Study|Non-compliance|2|||
19705100|NCT00125190|42149461|FG000|Overall Study|Adverse Event|1|||
19705101|NCT00125190|42149461|FG000|Overall Study|Other|1|||
19705102|NCT00125190|42149461|FG000|Overall Study|Lost to Follow-up|4|||
19705103|NCT00141726|42149466|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
19705104|NCT00111228|42149473|FG000|Overall Study|Withdrawal by Subject|5|||
19705105|NCT00111228|42149474|FG001|Overall Study|Withdrawal by Subject|1|||
19705106|NCT00111228|42149475|FG002|Overall Study|Withdrawal by Subject|0|||
19705107|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
19705108|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
19705109|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|Death|1|||
19705110|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|Death|0|||
19705111|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
19394196|NCT01371981|41638301|FG000|Overall Study|Death|22|||
19394197|NCT01371981|41638302|FG001|Overall Study|Death|16|||
19394198|NCT01371981|41638303|FG002|Overall Study|Death|0|||
19394199|NCT01371981|41638304|FG003|Overall Study|Death|0|||
19394200|NCT01371981|41638305|FG004|Overall Study|Death|2|||
19394201|NCT01371981|41638306|FG005|Overall Study|Death|2|||
19394202|NCT01371981|41638301|FG000|Overall Study|Lack of Efficacy|69|||
19394203|NCT01371981|41638302|FG001|Overall Study|Lack of Efficacy|61|||
19619412|NCT00867360|42069126|FG001|Overall Study|Withdrawal by Subject|0|||
19619413|NCT00867360|42069125|FG000|Overall Study|Physician Decision|0|||
19619414|NCT00867360|42069126|FG001|Overall Study|Physician Decision|1|||
19619415|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
19619416|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
19619417|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
19619418|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
19619419|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
19619420|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
19619421|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
19619422|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
19619423|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
19619424|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
19619425|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
19619426|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
19619427|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
19619428|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
19619429|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
19619430|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
19619431|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
19619432|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
19619433|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
19394204|NCT01371981|41638303|FG002|Overall Study|Lack of Efficacy|4|||
19394205|NCT01371981|41638304|FG003|Overall Study|Lack of Efficacy|8|||
19705112|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
19705113|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
19705114|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
19705115|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
19705116|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
19705117|NCT00110994|42149485|FG000|Double-blind (DB) Treatment|other reasons|2|||
19705118|NCT00110994|42149486|FG001|Double-blind (DB) Treatment|other reasons|3|||
19705119|NCT00110994|42149485|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
19705120|NCT00110994|42149486|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
19705121|NCT00110994|42149485|FG000|Active Follow-up|Other reasons|0|||
19705122|NCT00110994|42149486|FG001|Active Follow-up|Other reasons|2|||
19705123|NCT00110994|42149485|FG000|Long Term Follow-up|Death|19|||
19705124|NCT00110994|42149486|FG001|Long Term Follow-up|Death|17|||
19705125|NCT00144170|42149494|FG000|Overall Study|Adverse Event|84|||
19705126|NCT00144170|42149495|FG001|Overall Study|Adverse Event|41|||
19705127|NCT00144170|42149494|FG000|Overall Study|Protocol Violation|23|||
19705128|NCT00144170|42149495|FG001|Overall Study|Protocol Violation|16|||
19705129|NCT00144170|42149494|FG000|Overall Study|Lost to Follow-up|5|||
19705130|NCT00144170|42149495|FG001|Overall Study|Lost to Follow-up|10|||
19705131|NCT00144170|42149494|FG000|Overall Study|Withdrawal by Subject|29|||
19705132|NCT00144170|42149495|FG001|Overall Study|Withdrawal by Subject|13|||
19705133|NCT00144170|42149494|FG000|Overall Study|Other reason not defined above|211|||
19705134|NCT00144170|42149495|FG001|Overall Study|Other reason not defined above|316|||
19705135|NCT00255086|42149503|FG000|Overall Study|Adverse Event|1|||
19705136|NCT00255086|42149504|FG001|Overall Study|Adverse Event|1|||
19705137|NCT00255086|42149503|FG000|Overall Study|Protocol Violation|1|||
19705138|NCT00255086|42149504|FG001|Overall Study|Protocol Violation|1|||
19705139|NCT00110214|42149513|FG000|Overall Study|Never started treatment|21|||
19705140|NCT00110214|42149514|FG001|Overall Study|Never started treatment|20|||
19705141|NCT00110214|42149513|FG000|Overall Study|Disease progression or death|260|||
19705142|NCT00110214|42149514|FG001|Overall Study|Disease progression or death|151|||
19705143|NCT00110214|42149513|FG000|Overall Study|Adverse Event|115|||
19705144|NCT00110214|42149514|FG001|Overall Study|Adverse Event|192|||
19705145|NCT00110214|42149513|FG000|Overall Study|Refused further treatment|52|||
19705146|NCT00110214|42149514|FG001|Overall Study|Refused further treatment|65|||
19705147|NCT00110214|42149513|FG000|Overall Study|Other (not specified)|61|||
19705148|NCT00110214|42149514|FG001|Overall Study|Other (not specified)|75|||
19705149|NCT00124020|42149522|FG000|Overall Study|Death|67|||
19705150|NCT00124020|42149523|FG001|Overall Study|Death|71|||
19705151|NCT00124020|42149522|FG000|Overall Study|Withdrawal by Subject|13|||
19705152|NCT00124020|42149523|FG001|Overall Study|Withdrawal by Subject|11|||
19705153|NCT00124020|42149522|FG000|Overall Study|Lost to Follow-up|5|||
19705154|NCT00124020|42149523|FG001|Overall Study|Lost to Follow-up|8|||
19705155|NCT00124020|42149522|FG000|Overall Study|Other|1|||
19705156|NCT00124020|42149523|FG001|Overall Study|Other|1|||
19705157|NCT00124020|42149522|FG000|Overall Study|Transfer to another hospital|2|||
19705158|NCT00124020|42149523|FG001|Overall Study|Transfer to another hospital|0|||
19705159|NCT00215540|42149532|FG000|Overall Study|Withdrew from study medication|1|||
19705160|NCT00215540|42149533|FG001|Overall Study|Withdrew from study medication|0|||
19705161|NCT00215540|42149534|FG002|Overall Study|Withdrew from study medication|0|||
19705162|NCT00143390|42149544|FG000|Overall Study|Death|2|||
19705163|NCT00143390|42149545|FG001|Overall Study|Death|0|||
19705164|NCT00143390|42149544|FG000|Overall Study|Not meeting entry criteria|2|||
19705165|NCT00143390|42149545|FG001|Overall Study|Not meeting entry criteria|5|||
19705166|NCT00143390|42149544|FG000|Overall Study|Withdrawal by Subject|4|||
19705167|NCT00143390|42149545|FG001|Overall Study|Withdrawal by Subject|4|||
19394206|NCT01371981|41638305|FG004|Overall Study|Lack of Efficacy|5|||
19619434|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
19619435|NCT00593736|42069137|FG000|Screening Period and Placebo Run-in|Various|0|||
19619436|NCT00593736|42069138|FG001|Screening Period and Placebo Run-in|Various|0|||
19619437|NCT00593736|42069139|FG002|Screening Period and Placebo Run-in|Various|0|||
19619438|NCT00593736|42069140|FG003|Screening Period and Placebo Run-in|Various|25|||
19619439|NCT00593736|42069137|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
19619440|NCT00593736|42069138|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
19619441|NCT00593736|42069139|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
19619442|NCT00593736|42069140|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
19619443|NCT00593736|42069137|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
19619444|NCT00593736|42069138|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
19619445|NCT00593736|42069139|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
19619446|NCT00593736|42069140|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
19619447|NCT00593736|42069137|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
19619448|NCT00593736|42069138|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
19394207|NCT01371981|41638306|FG005|Overall Study|Lack of Efficacy|0|||
19705168|NCT00143390|42149544|FG000|Overall Study|Progressive disease|119|||
19705169|NCT00143390|42149545|FG001|Overall Study|Progressive disease|115|||
19705170|NCT00143390|42149544|FG000|Overall Study|Protocol Violation|2|||
19705171|NCT00143390|42149545|FG001|Overall Study|Protocol Violation|0|||
19705172|NCT00143390|42149544|FG000|Overall Study|Study termination|10|||
19705173|NCT00143390|42149545|FG001|Overall Study|Study termination|15|||
19705174|NCT00143390|42149544|FG000|Overall Study|Adverse Event|9|||
19705175|NCT00143390|42149545|FG001|Overall Study|Adverse Event|8|||
19705176|NCT00143390|42149544|FG000|Overall Study|Other|1|||
19705177|NCT00143390|42149545|FG001|Overall Study|Other|2|||
19705178|NCT00141102|42149553|FG000|Overall Study|Adverse Event|233|||
19705179|NCT00141102|42149554|FG001|Overall Study|Adverse Event|305|||
19705180|NCT00141102|42149553|FG000|Overall Study|Laboratory Abnormality|9|||
19705181|NCT00141102|42149554|FG001|Overall Study|Laboratory Abnormality|33|||
19705182|NCT00141102|42149553|FG000|Overall Study|Lack of Efficacy|21|||
19705183|NCT00141102|42149554|FG001|Overall Study|Lack of Efficacy|26|||
19705184|NCT00141102|42149553|FG000|Overall Study|Lost to Follow-up|29|||
19705185|NCT00141102|42149554|FG001|Overall Study|Lost to Follow-up|32|||
19705186|NCT00141102|42149553|FG000|Overall Study|Other|87|||
19705187|NCT00141102|42149554|FG001|Overall Study|Other|76|||
19705188|NCT00141102|42149553|FG000|Overall Study|Withdrawal by Subject|112|||
19705189|NCT00141102|42149554|FG001|Overall Study|Withdrawal by Subject|142|||
19705190|NCT00141102|42149553|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
19705191|NCT00141102|42149554|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
19705192|NCT00141102|42149553|FG000|Overall Study|Death|2|||
19705193|NCT00141102|42149554|FG001|Overall Study|Death|2|||
19705194|NCT00255008|42149565|FG000|Overall Study|Adverse Event|1|||
19705195|NCT00255008|42149566|FG001|Overall Study|Adverse Event|1|||
19705196|NCT00255008|42149567|FG002|Overall Study|Adverse Event|2|||
19705197|NCT00255008|42149568|FG003|Overall Study|Adverse Event|0|||
19705198|NCT00255008|42149565|FG000|Overall Study|Lost to Follow-up|1|||
19705199|NCT00255008|42149566|FG001|Overall Study|Lost to Follow-up|0|||
19705200|NCT00255008|42149567|FG002|Overall Study|Lost to Follow-up|1|||
19705201|NCT00255008|42149568|FG003|Overall Study|Lost to Follow-up|2|||
19705202|NCT00255008|42149565|FG000|Overall Study|Did not meet viral reduction criteria|4|||
19705203|NCT00255008|42149566|FG001|Overall Study|Did not meet viral reduction criteria|5|||
19705204|NCT00255008|42149567|FG002|Overall Study|Did not meet viral reduction criteria|0|||
19705205|NCT00255008|42149568|FG003|Overall Study|Did not meet viral reduction criteria|1|||
19705206|NCT00255008|42149565|FG000|Overall Study|Withdrew consent|0|||
19705207|NCT00255008|42149566|FG001|Overall Study|Withdrew consent|0|||
19705208|NCT00255008|42149567|FG002|Overall Study|Withdrew consent|2|||
19705209|NCT00255008|42149568|FG003|Overall Study|Withdrew consent|0|||
19705210|NCT00255008|42149565|FG000|Overall Study|Sponsor request|18|||
19705211|NCT00255008|42149566|FG001|Overall Study|Sponsor request|3|||
19705212|NCT00255008|42149567|FG002|Overall Study|Sponsor request|8|||
19705213|NCT00255008|42149568|FG003|Overall Study|Sponsor request|17|||
19705214|NCT00255008|42149565|FG000|Overall Study|Adverse lab experience|1|||
19705215|NCT00255008|42149566|FG001|Overall Study|Adverse lab experience|0|||
19705216|NCT00255008|42149567|FG002|Overall Study|Adverse lab experience|0|||
19705217|NCT00255008|42149568|FG003|Overall Study|Adverse lab experience|0|||
19705218|NCT00255008|42149565|FG000|Overall Study|Other|7|||
19705219|NCT00255008|42149566|FG001|Overall Study|Other|0|||
19705220|NCT00255008|42149567|FG002|Overall Study|Other|3|||
19705221|NCT00255008|42149568|FG003|Overall Study|Other|2|||
19705222|NCT03714022|42149580|FG000|Overall Study|Adverse Event|1|||
19705223|NCT03714022|42149581|FG001|Overall Study|Adverse Event|0|||
19705224|NCT03714022|42149580|FG000|Overall Study|Consent withdrawal|0|||
19705225|NCT03714022|42149581|FG001|Overall Study|Consent withdrawal|1|||
19705226|NCT03714022|42149580|FG000|Overall Study|Lost to Follow-up|3|||
19705227|NCT03714022|42149581|FG001|Overall Study|Lost to Follow-up|2|||
19705228|NCT00143312|42149587|FG000|Overall Study|Death|11|||
19705229|NCT00143312|42149587|FG000|Overall Study|Adverse Event|2|||
19705230|NCT00143312|42149587|FG000|Overall Study|Lost to Follow-up|1|||
19705231|NCT00143312|42149587|FG000|Overall Study|Other|1|||
19705232|NCT00143312|42149587|FG000|Overall Study|Withdrawal by Subject|1|||
19705233|NCT00254540|42149593|FG000|Overall Study|Adverse Event|6|||
19705234|NCT00254540|42149594|FG001|Overall Study|Adverse Event|7|||
19705235|NCT00254540|42149593|FG000|Overall Study|Lack of Efficacy|13|||
19705236|NCT00254540|42149594|FG001|Overall Study|Lack of Efficacy|13|||
19705237|NCT00254540|42149593|FG000|Overall Study|Death|0|||
19705238|NCT00254540|42149594|FG001|Overall Study|Death|1|||
19705239|NCT00254540|42149593|FG000|Overall Study|Laboratory Test Abnormality|0|||
19705240|NCT00254540|42149594|FG001|Overall Study|Laboratory Test Abnormality|1|||
19705241|NCT00139776|42149603|FG000|Period I|Did not enter Period II|575|||
19705242|NCT00139776|42149604|FG001|Period I|Did not enter Period II|0|||
19705243|NCT00139776|42149605|FG002|Period I|Did not enter Period II|0|||
19705244|NCT00139776|42149606|FG003|Period I|Did not enter Period II|0|||
19705245|NCT00139776|42149603|FG000|Period II|Not Randomized into Period III|0|||
19705246|NCT00139776|42149604|FG001|Period II|Not Randomized into Period III|322|||
19705247|NCT00139776|42149605|FG002|Period II|Not Randomized into Period III|0|||
19705248|NCT00139776|42149606|FG003|Period II|Not Randomized into Period III|0|||
19705249|NCT00139776|42149603|FG000|Period III|Adverse Event|0|||
19705250|NCT00139776|42149604|FG001|Period III|Adverse Event|0|||
19705251|NCT00139776|42149605|FG002|Period III|Adverse Event|22|||
19705252|NCT00139776|42149606|FG003|Period III|Adverse Event|23|||
19705253|NCT00139776|42149603|FG000|Period III|Other|0|||
19705254|NCT00139776|42149604|FG001|Period III|Other|0|||
19705255|NCT00139776|42149605|FG002|Period III|Other|23|||
19705256|NCT00139776|42149606|FG003|Period III|Other|34|||
19705257|NCT00139776|42149603|FG000|Period III|Lack of Efficacy|0|||
19705258|NCT00139776|42149604|FG001|Period III|Lack of Efficacy|0|||
19705259|NCT00139776|42149605|FG002|Period III|Lack of Efficacy|10|||
19705260|NCT00139776|42149606|FG003|Period III|Lack of Efficacy|24|||
19705261|NCT00139776|42149603|FG000|Period III|Lost to Follow-up|0|||
19705262|NCT00139776|42149604|FG001|Period III|Lost to Follow-up|0|||
19705263|NCT00139776|42149605|FG002|Period III|Lost to Follow-up|5|||
19705264|NCT00139776|42149606|FG003|Period III|Lost to Follow-up|4|||
19705265|NCT00139776|42149603|FG000|Period III|Withdrawal by Subject|0|||
19705266|NCT00139776|42149604|FG001|Period III|Withdrawal by Subject|0|||
19705267|NCT00139776|42149605|FG002|Period III|Withdrawal by Subject|16|||
19705268|NCT00139776|42149606|FG003|Period III|Withdrawal by Subject|21|||
19705269|NCT00413699|42149615|FG000|Initial Period|Death|25|||
19705270|NCT00413699|42149616|FG001|Initial Period|Death|30|||
19705271|NCT00413699|42149617|FG002|Initial Period|Death|0|||
19705272|NCT00413699|42149615|FG000|Initial Period|Lack of Efficacy|59|||
19705273|NCT00413699|42149616|FG001|Initial Period|Lack of Efficacy|115|||
19705274|NCT00413699|42149617|FG002|Initial Period|Lack of Efficacy|0|||
19705275|NCT00413699|42149615|FG000|Initial Period|Lost to Follow-up|31|||
19705276|NCT00413699|42149616|FG001|Initial Period|Lost to Follow-up|101|||
19705277|NCT00413699|42149617|FG002|Initial Period|Lost to Follow-up|0|||
19705278|NCT00413699|42149615|FG000|Initial Period|Protocol Violation|38|||
19705279|NCT00413699|42149616|FG001|Initial Period|Protocol Violation|89|||
19705280|NCT00413699|42149617|FG002|Initial Period|Protocol Violation|0|||
19705281|NCT00413699|42149615|FG000|Initial Period|Pregnancy|10|||
19705282|NCT00413699|42149616|FG001|Initial Period|Pregnancy|8|||
19705283|NCT00413699|42149617|FG002|Initial Period|Pregnancy|0|||
19705284|NCT00413699|42149615|FG000|Initial Period|Did not meet entrance criteria|2|||
19705285|NCT00413699|42149616|FG001|Initial Period|Did not meet entrance criteria|2|||
19705286|NCT00413699|42149617|FG002|Initial Period|Did not meet entrance criteria|0|||
19705287|NCT00413699|42149615|FG000|Initial Period|Medication error without adverse event|0|||
19705288|NCT00413699|42149616|FG001|Initial Period|Medication error without adverse event|1|||
19705289|NCT00413699|42149617|FG002|Initial Period|Medication error without adverse event|0|||
19705290|NCT00413699|42149615|FG000|Initial Period|Study terminated by Sponsor|0|||
19705291|NCT00413699|42149616|FG001|Initial Period|Study terminated by Sponsor|1|||
19705292|NCT00413699|42149617|FG002|Initial Period|Study terminated by Sponsor|0|||
19705293|NCT00413699|42149615|FG000|Initial Period|Other|67|||
19705294|NCT00413699|42149616|FG001|Initial Period|Other|211|||
19705295|NCT00413699|42149617|FG002|Initial Period|Other|0|||
19705296|NCT00413699|42149615|FG000|Initial Period|Adverse event related to study drug|178|||
19705297|NCT00413699|42149616|FG001|Initial Period|Adverse event related to study drug|527|||
19705298|NCT00413699|42149617|FG002|Initial Period|Adverse event related to study drug|0|||
19705299|NCT00413699|42149615|FG000|Initial Period|Adverse event not related to study drug|113|||
19705300|NCT00413699|42149616|FG001|Initial Period|Adverse event not related to study drug|248|||
19705301|NCT00413699|42149617|FG002|Initial Period|Adverse event not related to study drug|0|||
19705302|NCT00413699|42149615|FG000|Initial Period|Missing end of study page|0|||
19705303|NCT00413699|42149616|FG001|Initial Period|Missing end of study page|4|||
19705304|NCT00413699|42149617|FG002|Initial Period|Missing end of study page|0|||
19705305|NCT00413699|42149615|FG000|Initial Period|No longer willing to participate|116|||
19705306|NCT00413699|42149616|FG001|Initial Period|No longer willing to participate|368|||
19705307|NCT00413699|42149617|FG002|Initial Period|No longer willing to participate|0|||
19705308|NCT00413699|42149615|FG000|Extension Period|No Longer Willing to Participate|0|||
19705309|NCT00413699|42149616|FG001|Extension Period|No Longer Willing to Participate|0|||
19705310|NCT00413699|42149617|FG002|Extension Period|No Longer Willing to Participate|2|||
19705311|NCT00413699|42149615|FG000|Extension Period|Protocol Violation|0|||
19705312|NCT00413699|42149616|FG001|Extension Period|Protocol Violation|0|||
19705313|NCT00413699|42149617|FG002|Extension Period|Protocol Violation|1|||
19705314|NCT00413699|42149615|FG000|Extension Period|Adverse Event|0|||
19705315|NCT00413699|42149616|FG001|Extension Period|Adverse Event|0|||
19705316|NCT00413699|42149617|FG002|Extension Period|Adverse Event|2|||
19705317|NCT03713320|42149645|FG000|Randomized Period|Adverse Event|1|||
19705318|NCT03713320|42149646|FG001|Randomized Period|Adverse Event|5|||
19705319|NCT03713320|42149647|FG002|Randomized Period|Adverse Event|0|||
19705320|NCT03713320|42149645|FG000|Randomized Period|Physician Decision|1|||
19705321|NCT03713320|42149646|FG001|Randomized Period|Physician Decision|1|||
19705322|NCT03713320|42149647|FG002|Randomized Period|Physician Decision|0|||
19705323|NCT03713320|42149645|FG000|Randomized Period|Withdrawal by Subject|4|||
19705324|NCT03713320|42149646|FG001|Randomized Period|Withdrawal by Subject|0|||
19705325|NCT03713320|42149647|FG002|Randomized Period|Withdrawal by Subject|0|||
19705326|NCT03713320|42149645|FG000|Randomized Period|Participant decision|3|||
19705327|NCT03713320|42149646|FG001|Randomized Period|Participant decision|1|||
19705328|NCT03713320|42149647|FG002|Randomized Period|Participant decision|0|||
19705329|NCT03713320|42149645|FG000|Randomized Period|Study terminated by sponsor|6|||
19705330|NCT03713320|42149646|FG001|Randomized Period|Study terminated by sponsor|3|||
19705331|NCT03713320|42149647|FG002|Randomized Period|Study terminated by sponsor|0|||
19705332|NCT03713320|42149645|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
19705333|NCT03713320|42149646|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
19705334|NCT03713320|42149647|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
19705335|NCT03713320|42149645|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
19705336|NCT03713320|42149646|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
19705337|NCT03713320|42149647|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
19705338|NCT03712930|42149654|FG000|Overall Study|Death|7|||
19705339|NCT03712930|42149654|FG000|Overall Study|Physician Decision|1|||
19619449|NCT00593736|42069139|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
19619450|NCT00593736|42069140|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
19619451|NCT00593736|42069137|FG000|Treatment Period and Placebo Run-out|Various|1|||
19619452|NCT00593736|42069138|FG001|Treatment Period and Placebo Run-out|Various|1|||
19619453|NCT00593736|42069139|FG002|Treatment Period and Placebo Run-out|Various|1|||
19619454|NCT00593736|42069140|FG003|Treatment Period and Placebo Run-out|Various|0|||
19619455|NCT00883688|42069150|FG000|Overall Study|Ineligible|2|||
19619456|NCT03883477|42069156|FG000|Overall Study|Death|1|||
19619457|NCT03883477|42069157|FG001|Overall Study|Death|0|||
19619458|NCT03883477|42069156|FG000|Overall Study|Protocol Violation|0|||
19705340|NCT03712930|42149654|FG000|Overall Study|Study Terminated by Sponsor|3|||
19705341|NCT03712930|42149654|FG000|Overall Study|Progressive Disease|2|||
19705342|NCT00420407|42149660|FG000|Overall Study|Lost to Follow-up|0|||
19705343|NCT00420407|42149661|FG001|Overall Study|Lost to Follow-up|3|||
19619459|NCT03883477|42069157|FG001|Overall Study|Protocol Violation|1|||
19619460|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Other|4|||
19619461|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Other|0|||
19619462|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
19619463|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
19619464|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
19619465|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
19619466|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
19619467|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
19619468|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
19619469|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
19705344|NCT00420407|42149660|FG000|Overall Study|Physician Decision|2|||
19705345|NCT00420407|42149661|FG001|Overall Study|Physician Decision|1|||
19394208|NCT01371981|41638301|FG000|Overall Study|Physician Decision|48|||
19394209|NCT01371981|41638302|FG001|Overall Study|Physician Decision|63|||
19394210|NCT01371981|41638303|FG002|Overall Study|Physician Decision|1|||
19619470|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
19619471|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
19619472|NCT00853827|42069165|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
19705346|NCT00420407|42149660|FG000|Overall Study|subject identified as detainee|1|||
19705347|NCT00420407|42149661|FG001|Overall Study|subject identified as detainee|0|||
19619473|NCT00853827|42069166|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
19619474|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
19619475|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
19619476|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
19619477|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
19619478|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
19619479|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
19619480|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
19619481|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
19705348|NCT00420407|42149660|FG000|Overall Study|subject identified as Jehovah's witness|1|||
19705349|NCT00420407|42149661|FG001|Overall Study|subject identified as Jehovah's witness|0|||
19705350|NCT00420407|42149660|FG000|Overall Study|Withdrawal by Subject|0|||
19705351|NCT00420407|42149661|FG001|Overall Study|Withdrawal by Subject|2|||
19705352|NCT00420095|42149670|FG000|Overall Study|Adverse Event|1|||
19705353|NCT00420095|42149671|FG001|Overall Study|Adverse Event|0|||
19705354|NCT00420095|42149670|FG000|Overall Study|Protocol Violation|1|||
19705355|NCT00420095|42149671|FG001|Overall Study|Protocol Violation|1|||
19705356|NCT00420095|42149670|FG000|Overall Study|Lost to Follow-up|1|||
19705357|NCT00420095|42149671|FG001|Overall Study|Lost to Follow-up|0|||
19705358|NCT00419393|42149677|FG000|Overall Study|Adverse Event|5|||
19705359|NCT00419393|42149677|FG000|Overall Study|Protocol Violation|5|||
19705360|NCT00419393|42149677|FG000|Overall Study|Withdrawal by Subject|7|||
19705361|NCT00419393|42149677|FG000|Overall Study|Other: Sponsor request|3|||
19619482|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
19619483|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
19619484|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
19619485|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
19619486|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
19619487|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
19619488|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
19619489|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
19619490|NCT00853827|42069165|FG000|Double Blind Period (103 Weeks)|Death|1|||
19619491|NCT00853827|42069166|FG001|Double Blind Period (103 Weeks)|Death|6|||
19619492|NCT00853749|42069174|FG000|Overall Study|Lost to Follow-up|0|||
19619493|NCT00853749|42069175|FG001|Overall Study|Lost to Follow-up|1|||
19619494|NCT00592839|42069184|FG000|Overall Study|Withdrawal by Subject|1|||
19619495|NCT00592839|42069185|FG001|Overall Study|Withdrawal by Subject|1|||
19619496|NCT00592839|42069186|FG002|Overall Study|Withdrawal by Subject|3|||
19619497|NCT00592839|42069184|FG000|Overall Study|Protocol Violation|1|||
19619498|NCT00592839|42069185|FG001|Overall Study|Protocol Violation|1|||
19619499|NCT00592839|42069186|FG002|Overall Study|Protocol Violation|2|||
19619500|NCT00592839|42069184|FG000|Overall Study|Adverse Event|0|||
19619501|NCT00592839|42069185|FG001|Overall Study|Adverse Event|1|||
19619502|NCT00592839|42069186|FG002|Overall Study|Adverse Event|0|||
19619503|NCT00592839|42069184|FG000|Overall Study|Lost to Follow-up|0|||
19619504|NCT00592839|42069185|FG001|Overall Study|Lost to Follow-up|1|||
19619505|NCT00592839|42069186|FG002|Overall Study|Lost to Follow-up|1|||
19619506|NCT00598832|42069196|FG000|Overall Study|Lack of Efficacy|3|||
19619507|NCT00598832|42069197|FG001|Overall Study|Lack of Efficacy|7|||
19619508|NCT00598832|42069196|FG000|Overall Study|Adverse Event|6|||
19619509|NCT00598832|42069197|FG001|Overall Study|Adverse Event|2|||
19619510|NCT00598832|42069196|FG000|Overall Study|Withdrawal by Subject|25|||
19619511|NCT00598832|42069197|FG001|Overall Study|Withdrawal by Subject|36|||
19619512|NCT00598832|42069196|FG000|Overall Study|Protocol Violation|0|||
19619513|NCT00598832|42069197|FG001|Overall Study|Protocol Violation|2|||
19619514|NCT00598832|42069196|FG000|Overall Study|Lost to Follow-up|24|||
19619515|NCT00598832|42069197|FG001|Overall Study|Lost to Follow-up|29|||
19619516|NCT00598832|42069196|FG000|Overall Study|Pregnancy|2|||
19619517|NCT00598832|42069197|FG001|Overall Study|Pregnancy|2|||
19619518|NCT00598832|42069196|FG000|Overall Study|Physician Decision|1|||
19619519|NCT00598832|42069197|FG001|Overall Study|Physician Decision|4|||
19619520|NCT00598832|42069196|FG000|Overall Study|Non compliance|1|||
19619521|NCT00598832|42069197|FG001|Overall Study|Non compliance|0|||
19705362|NCT00419393|42149677|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
19705363|NCT00419393|42149677|FG000|Overall Study|Other: Site closure|1|||
19705364|NCT00419393|42149677|FG000|Overall Study|Other: Other health problems|1|||
19619522|NCT00853593|42069203|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
19619523|NCT00853593|42069203|FG000|Overall Study|Model 4396 lead not attempted|29|||
19619524|NCT00853593|42069203|FG000|Overall Study|Implant not attempted|4|||
19619525|NCT00853125|42069224|FG000|Overall Study|Study participant's donor was CMV +|1|||
19619526|NCT00530023|42069231|FG000|Overall Study|Withdrawal by Subject|0|||
19619527|NCT00530023|42069232|FG001|Overall Study|Withdrawal by Subject|1|||
19619528|NCT00529087|42069241|FG000|Overall Study|Adverse Event|10|||
19705365|NCT00419393|42149677|FG000|Overall Study|Other: Investigator decision|1|||
19705366|NCT00419159|42149683|FG000|Overall Study|Adverse Event|7|||
19619529|NCT00529087|42069242|FG001|Overall Study|Adverse Event|13|||
19619530|NCT00529087|42069243|FG002|Overall Study|Adverse Event|4|||
19619531|NCT00529087|42069241|FG000|Overall Study|Lost to Follow-up|6|||
19619532|NCT00529087|42069242|FG001|Overall Study|Lost to Follow-up|4|||
19619533|NCT00529087|42069243|FG002|Overall Study|Lost to Follow-up|1|||
19619534|NCT00529087|42069241|FG000|Overall Study|Protocol Violation|8|||
19619535|NCT00529087|42069242|FG001|Overall Study|Protocol Violation|7|||
19619536|NCT00529087|42069243|FG002|Overall Study|Protocol Violation|6|||
19619537|NCT00529087|42069241|FG000|Overall Study|Withdrawal by Subject|3|||
19619538|NCT00529087|42069242|FG001|Overall Study|Withdrawal by Subject|3|||
19619539|NCT00529087|42069243|FG002|Overall Study|Withdrawal by Subject|3|||
19619540|NCT00529087|42069241|FG000|Overall Study|Protocol deviation|1|||
19619541|NCT00529087|42069242|FG001|Overall Study|Protocol deviation|1|||
19619542|NCT00529087|42069243|FG002|Overall Study|Protocol deviation|2|||
19619543|NCT00870870|42069278|FG000|Overall Study|Withdrawal by Subject|0|||
19619544|NCT00870870|42069279|FG001|Overall Study|Withdrawal by Subject|1|||
19619545|NCT00870870|42069280|FG002|Overall Study|Withdrawal by Subject|1|||
19619546|NCT00870870|42069281|FG003|Overall Study|Withdrawal by Subject|3|||
19619547|NCT00870870|42069278|FG000|Overall Study|Adverse Event|0|||
19619548|NCT00870870|42069279|FG001|Overall Study|Adverse Event|0|||
19619549|NCT00870870|42069280|FG002|Overall Study|Adverse Event|2|||
19619550|NCT00870870|42069281|FG003|Overall Study|Adverse Event|2|||
19619551|NCT03877237|42069298|FG000|Overall Study|Adverse Event|1|||
19619552|NCT03877237|42069299|FG001|Overall Study|Adverse Event|2|||
19619553|NCT03877237|42069298|FG000|Overall Study|Death|3|||
19619554|NCT03877237|42069299|FG001|Overall Study|Death|2|||
19619555|NCT03877237|42069298|FG000|Overall Study|Physician Decision|1|||
19619556|NCT03877237|42069299|FG001|Overall Study|Physician Decision|0|||
19619557|NCT03877237|42069298|FG000|Overall Study|Withdrawal by Subject|0|||
19619558|NCT03877237|42069299|FG001|Overall Study|Withdrawal by Subject|2|||
19619559|NCT00528931|42069305|FG000|Overall Study|Lost to Follow-up|1|||
19619560|NCT00866814|42069310|FG000|Overall Study|Lost to Follow-up|12|||
19619561|NCT00866814|42069310|FG000|Overall Study|Adverse Event|2|||
19619562|NCT00866814|42069310|FG000|Overall Study|Physician Decision|1|||
19619563|NCT00866814|42069310|FG000|Overall Study|Death|1|||
19619564|NCT00866814|42069310|FG000|Overall Study|No longer wished to participate|1|||
19619565|NCT00866814|42069310|FG000|Overall Study|Unable to meet follow-up requirements|2|||
19619566|NCT00866814|42069310|FG000|Overall Study|Moved to area without study site|1|||
19619567|NCT00871494|42069314|FG000|Overall Study|Protocol Violation|5|||
19619568|NCT00871494|42069314|FG000|Overall Study|Lack of Efficacy|4|||
19619569|NCT00871494|42069314|FG000|Overall Study|Adverse Event|4|||
19619570|NCT00871494|42069314|FG000|Overall Study|Lost to Follow-up|1|||
19619571|NCT00529789|42069318|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
19619572|NCT00529789|42069318|FG000|Study Period II/III|Adverse Event|3|||
19619573|NCT00529789|42069318|FG000|Study Period II/III|Lack of Efficacy|2|||
19619574|NCT00529789|42069318|FG000|Study Period II/III|Withdrawal by Subject|1|||
19619575|NCT00529789|42069318|FG000|Study Period II/III|Protocol Violation|3|||
19619576|NCT00529789|42069318|FG000|Study Period II/III|Physician Decision|3|||
19619577|NCT00529789|42069318|FG000|Study Period II/III|Lost to Follow-up|3|||
19619578|NCT00529789|42069318|FG000|Study Period IV|Parent/Caregiver Decision|1|||
19619579|NCT00529789|42069318|FG000|Study Period IV|Adverse Event|1|||
19619580|NCT00529789|42069318|FG000|Study Period IV|Lack of Efficacy|1|||
19619581|NCT00529789|42069318|FG000|Study Period IV|Lost to Follow-up|3|||
19619582|NCT00577642|42069328|FG000|Overall Study|Clinical Disease Progression|1|||
19619583|NCT00866658|42069334|FG000|Overall Study|Adverse Event|5|||
19619584|NCT00866658|42069335|FG001|Overall Study|Adverse Event|14|||
19619585|NCT00866658|42069334|FG000|Overall Study|Lack of Efficacy|2|||
19619586|NCT00866658|42069335|FG001|Overall Study|Lack of Efficacy|1|||
19619587|NCT00866658|42069334|FG000|Overall Study|Withdrawal by Subject|1|||
19619588|NCT00866658|42069335|FG001|Overall Study|Withdrawal by Subject|0|||
19619589|NCT00866658|42069334|FG000|Overall Study|Protocol Violation|1|||
19619590|NCT00866658|42069335|FG001|Overall Study|Protocol Violation|1|||
19619591|NCT00866658|42069334|FG000|Overall Study|Familial and Personal Reasons|4|||
19619592|NCT00866658|42069335|FG001|Overall Study|Familial and Personal Reasons|5|||
19619593|NCT03872453|42069345|FG000|Overall Study|Adverse Event|1|||
19619594|NCT03872453|42069346|FG001|Overall Study|Adverse Event|1|||
19619595|NCT03872453|42069347|FG002|Overall Study|Adverse Event|0|||
19619596|NCT03872453|42069348|FG003|Overall Study|Adverse Event|0|||
19619597|NCT03872453|42069345|FG000|Overall Study|Lost to Follow-up|8|||
19619598|NCT03872453|42069346|FG001|Overall Study|Lost to Follow-up|7|||
19619599|NCT03872453|42069347|FG002|Overall Study|Lost to Follow-up|4|||
19619600|NCT03872453|42069348|FG003|Overall Study|Lost to Follow-up|4|||
19619601|NCT03872453|42069345|FG000|Overall Study|Never Treated Migraine|19|||
19619602|NCT03872453|42069346|FG001|Overall Study|Never Treated Migraine|17|||
19619603|NCT03872453|42069347|FG002|Overall Study|Never Treated Migraine|13|||
19619604|NCT03872453|42069348|FG003|Overall Study|Never Treated Migraine|12|||
19619605|NCT03872453|42069345|FG000|Overall Study|Pregnancy|1|||
19619606|NCT03872453|42069346|FG001|Overall Study|Pregnancy|0|||
19619607|NCT03872453|42069347|FG002|Overall Study|Pregnancy|0|||
19619608|NCT03872453|42069348|FG003|Overall Study|Pregnancy|0|||
19619609|NCT03872453|42069345|FG000|Overall Study|Protocol Deviation|2|||
19619610|NCT03872453|42069346|FG001|Overall Study|Protocol Deviation|0|||
19619611|NCT03872453|42069347|FG002|Overall Study|Protocol Deviation|0|||
19619612|NCT03872453|42069348|FG003|Overall Study|Protocol Deviation|2|||
19619613|NCT03872453|42069345|FG000|Overall Study|Withdrawal by Subject|0|||
19619614|NCT03872453|42069346|FG001|Overall Study|Withdrawal by Subject|1|||
19619615|NCT03872453|42069347|FG002|Overall Study|Withdrawal by Subject|2|||
19619616|NCT03872453|42069348|FG003|Overall Study|Withdrawal by Subject|0|||
19619617|NCT03872453|42069345|FG000|Overall Study|Other Than Specified|1|||
19619618|NCT03872453|42069346|FG001|Overall Study|Other Than Specified|0|||
19619619|NCT03872453|42069347|FG002|Overall Study|Other Than Specified|0|||
19619620|NCT03872453|42069348|FG003|Overall Study|Other Than Specified|0|||
19619621|NCT00597584|42069360|FG000|Overall Study|Adverse Event|4|||
19619622|NCT00597584|42069361|FG001|Overall Study|Adverse Event|2|||
19619623|NCT00597584|42069360|FG000|Overall Study|Death|53|||
19619624|NCT00597584|42069361|FG001|Overall Study|Death|30|||
19619625|NCT00597584|42069360|FG000|Overall Study|Lack of Efficacy|1|||
19619626|NCT00597584|42069361|FG001|Overall Study|Lack of Efficacy|0|||
19619627|NCT00597584|42069360|FG000|Overall Study|Lost to Follow-up|2|||
19619628|NCT00597584|42069361|FG001|Overall Study|Lost to Follow-up|4|||
19619629|NCT00597584|42069360|FG000|Overall Study|Physician Decision|3|||
19619630|NCT00597584|42069361|FG001|Overall Study|Physician Decision|0|||
19619631|NCT00597584|42069360|FG000|Overall Study|Pregnancy|2|||
19619632|NCT00597584|42069361|FG001|Overall Study|Pregnancy|0|||
19619633|NCT00597584|42069360|FG000|Overall Study|Withdrawal by Subject|44|||
19619634|NCT00597584|42069361|FG001|Overall Study|Withdrawal by Subject|12|||
19394211|NCT01371981|41638304|FG003|Overall Study|Physician Decision|7|||
19394212|NCT01371981|41638305|FG004|Overall Study|Physician Decision|14|||
19517495|NCT01534962|41930419|FG001|Overall Study|Randomized but did not start treatment|0|||
19705367|NCT00419159|42149684|FG001|Overall Study|Adverse Event|15|||
19705368|NCT00419159|42149683|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19705369|NCT00419159|42149684|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19619635|NCT00597584|42069360|FG000|Overall Study|Discontinued Dialysis|0|||
19619636|NCT00597584|42069361|FG001|Overall Study|Discontinued Dialysis|1|||
19705370|NCT00419159|42149683|FG000|Overall Study|Subject's no longer requires study drug|0|||
19705371|NCT00419159|42149684|FG001|Overall Study|Subject's no longer requires study drug|1|||
19705372|NCT00419159|42149683|FG000|Overall Study|Protocol Violation|1|||
19705373|NCT00419159|42149684|FG001|Overall Study|Protocol Violation|0|||
19705374|NCT00419159|42149683|FG000|Overall Study|Withdrawal by Subject|10|||
19705375|NCT00419159|42149684|FG001|Overall Study|Withdrawal by Subject|3|||
19705376|NCT00419159|42149683|FG000|Overall Study|Lost to Follow-up|0|||
19705377|NCT00419159|42149684|FG001|Overall Study|Lost to Follow-up|1|||
19705378|NCT00419159|42149683|FG000|Overall Study|Death|2|||
19705379|NCT00419159|42149684|FG001|Overall Study|Death|2|||
19705380|NCT00419159|42149683|FG000|Overall Study|Disease progression|79|||
19705381|NCT00419159|42149684|FG001|Overall Study|Disease progression|76|||
19705382|NCT03717064|42149698|FG000|Period 2|Adverse Event|1|||
19705383|NCT03716050|42149710|FG000|Overall Study|Lost to Follow-up|0|||
19705384|NCT03716050|42149711|FG001|Overall Study|Lost to Follow-up|0|||
19705385|NCT03716050|42149712|FG002|Overall Study|Lost to Follow-up|1|||
19705386|NCT03716050|42149713|FG003|Overall Study|Lost to Follow-up|0|||
19394213|NCT01371981|41638306|FG005|Overall Study|Physician Decision|3|||
19619637|NCT00597584|42069360|FG000|Overall Study|Lost ability to consent|1|||
19619638|NCT00597584|42069361|FG001|Overall Study|Lost ability to consent|1|||
19619639|NCT00597584|42069360|FG000|Overall Study|Never dosed|1|||
19619640|NCT00597584|42069361|FG001|Overall Study|Never dosed|0|||
19619641|NCT00597584|42069360|FG000|Overall Study|Relocation|8|||
19705387|NCT03716050|42149714|FG004|Overall Study|Lost to Follow-up|0|||
19705388|NCT03716050|42149715|FG005|Overall Study|Lost to Follow-up|0|||
19705389|NCT03716050|42149716|FG006|Overall Study|Lost to Follow-up|0|||
19705390|NCT03716050|42149717|FG007|Overall Study|Lost to Follow-up|0|||
19394214|NCT01371981|41638301|FG000|Overall Study|Withdrawal by Subject|12|||
19394215|NCT01371981|41638302|FG001|Overall Study|Withdrawal by Subject|19|||
19394216|NCT01371981|41638303|FG002|Overall Study|Withdrawal by Subject|1|||
19394217|NCT01371981|41638304|FG003|Overall Study|Withdrawal by Subject|2|||
19394218|NCT01371981|41638305|FG004|Overall Study|Withdrawal by Subject|10|||
19394219|NCT01371981|41638306|FG005|Overall Study|Withdrawal by Subject|3|||
19394220|NCT01371981|41638301|FG000|Overall Study|Ineligible|19|||
19394221|NCT01371981|41638302|FG001|Overall Study|Ineligible|13|||
19394222|NCT01371981|41638303|FG002|Overall Study|Ineligible|0|||
19394223|NCT01371981|41638304|FG003|Overall Study|Ineligible|0|||
19394224|NCT01371981|41638305|FG004|Overall Study|Ineligible|0|||
19394225|NCT01371981|41638306|FG005|Overall Study|Ineligible|4|||
19619642|NCT00597584|42069361|FG001|Overall Study|Relocation|6|||
19619643|NCT00597584|42069360|FG000|Overall Study|Renal transplant|9|||
19619644|NCT00597584|42069361|FG001|Overall Study|Renal transplant|7|||
19619645|NCT00529633|42069369|FG000|Overall Study|Withdrawal by Subject|1|||
19619646|NCT00529633|42069370|FG001|Overall Study|Withdrawal by Subject|1|||
19619647|NCT00530335|42069376|FG000|Overall Study|Adverse Event|3|||
19619648|NCT00530335|42069376|FG000|Overall Study|Protocol Violation|1|||
19619649|NCT00530335|42069376|FG000|Overall Study|Withdrawal by Subject|1|||
19619650|NCT00530335|42069376|FG000|Overall Study|Physician Decision|1|||
19619651|NCT00712270|42069383|FG000|Overall Study|Withdrawal by Subject|11|||
19619652|NCT00712270|42069383|FG000|Overall Study|Screen Failure|3|||
19619653|NCT00530257|42069409|FG000|Overall Study|Lost to Follow-up|1|||
19619654|NCT00869778|42069419|FG000|Overall Study|Adverse Event|2|||
19619655|NCT00869778|42069420|FG001|Overall Study|Adverse Event|0|||
19619656|NCT00869778|42069421|FG002|Overall Study|Adverse Event|0|||
19619657|NCT00869778|42069419|FG000|Overall Study|Withdrawal by Subject|3|||
19619658|NCT00869778|42069420|FG001|Overall Study|Withdrawal by Subject|4|||
19619659|NCT00869778|42069421|FG002|Overall Study|Withdrawal by Subject|5|||
19619660|NCT00869778|42069419|FG000|Overall Study|Pregnancy|1|||
19619661|NCT00869778|42069420|FG001|Overall Study|Pregnancy|0|||
19619662|NCT00869778|42069421|FG002|Overall Study|Pregnancy|0|||
19619663|NCT00869778|42069419|FG000|Overall Study|Protocol Violation|5|||
19619664|NCT00869778|42069420|FG001|Overall Study|Protocol Violation|3|||
19619665|NCT00869778|42069421|FG002|Overall Study|Protocol Violation|5|||
19619666|NCT00869778|42069419|FG000|Overall Study|Unblinding|1|||
19619667|NCT00869778|42069420|FG001|Overall Study|Unblinding|0|||
19619668|NCT00869778|42069421|FG002|Overall Study|Unblinding|0|||
19619669|NCT00711958|42069452|FG000|Overall Study|Withdrawal by Subject|6|||
19619670|NCT00711958|42069453|FG001|Overall Study|Withdrawal by Subject|8|||
19619671|NCT00711958|42069452|FG000|Overall Study|Lack of Efficacy|3|||
19619672|NCT00711958|42069453|FG001|Overall Study|Lack of Efficacy|1|||
19619673|NCT00711958|42069452|FG000|Overall Study|Clinical deterioration|1|||
19619674|NCT00711958|42069453|FG001|Overall Study|Clinical deterioration|0|||
19619675|NCT00711958|42069452|FG000|Overall Study|Adverse Event|9|||
19619676|NCT00711958|42069453|FG001|Overall Study|Adverse Event|7|||
19619677|NCT00711958|42069452|FG000|Overall Study|Protocol Violation|1|||
19619678|NCT00711958|42069453|FG001|Overall Study|Protocol Violation|0|||
19619679|NCT00711958|42069452|FG000|Overall Study|Lost to Follow-up|2|||
19619680|NCT00711958|42069453|FG001|Overall Study|Lost to Follow-up|2|||
19619681|NCT00711958|42069452|FG000|Overall Study|Death|10|||
19619682|NCT00711958|42069453|FG001|Overall Study|Death|5|||
19619683|NCT00711958|42069452|FG000|Overall Study|Progression of disease|1|||
19619684|NCT00711958|42069453|FG001|Overall Study|Progression of disease|0|||
19619685|NCT00711880|42069461|FG000|Overall Study|Adverse Event|11|||
19619686|NCT00711880|42069462|FG001|Overall Study|Adverse Event|2|||
19619687|NCT00711880|42069461|FG000|Overall Study|Patient non-compliance|1|||
19619688|NCT00711880|42069462|FG001|Overall Study|Patient non-compliance|0|||
19619689|NCT00711880|42069461|FG000|Overall Study|Lack of Efficacy|1|||
19619690|NCT00711880|42069462|FG001|Overall Study|Lack of Efficacy|5|||
19619691|NCT00528775|42069468|FG000|Overall Study|Other not specified|1|||
19619692|NCT00853047|42069477|FG000|Core Phase|Participant Request|0|||
19619693|NCT00853047|42069478|FG001|Core Phase|Participant Request|0|||
19619694|NCT00853047|42069479|FG002|Core Phase|Participant Request|0|||
19619695|NCT00853047|42069480|FG003|Core Phase|Participant Request|1|||
19619696|NCT00853047|42069481|FG004|Core Phase|Participant Request|0|||
19619697|NCT00853047|42069482|FG005|Core Phase|Participant Request|0|||
19619698|NCT00853047|42069477|FG000|Open-Label Extension Phase|Participant Request|0|||
19619699|NCT00853047|42069478|FG001|Open-Label Extension Phase|Participant Request|0|||
19619700|NCT00853047|42069479|FG002|Open-Label Extension Phase|Participant Request|0|||
19619701|NCT00853047|42069480|FG003|Open-Label Extension Phase|Participant Request|0|||
19619702|NCT00853047|42069481|FG004|Open-Label Extension Phase|Participant Request|0|||
19619703|NCT00853047|42069482|FG005|Open-Label Extension Phase|Participant Request|7|||
19619704|NCT00853047|42069477|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
19619705|NCT00853047|42069478|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
19705391|NCT03716050|42149710|FG000|Overall Study|Physician Decision|0|||
19619706|NCT00853047|42069479|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
19619707|NCT00853047|42069480|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
19619708|NCT00853047|42069481|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
19619709|NCT00853047|42069482|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
19619710|NCT00853047|42069477|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
19619711|NCT00853047|42069478|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
19619712|NCT00853047|42069479|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
19619713|NCT00853047|42069480|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
19619714|NCT00853047|42069481|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
19619715|NCT00853047|42069482|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
19619716|NCT00853047|42069477|FG000|Open-Label Extension Phase|Investigator Decision|0|||
19619717|NCT00853047|42069478|FG001|Open-Label Extension Phase|Investigator Decision|0|||
19619718|NCT00853047|42069479|FG002|Open-Label Extension Phase|Investigator Decision|0|||
19619719|NCT00853047|42069480|FG003|Open-Label Extension Phase|Investigator Decision|0|||
19619720|NCT00853047|42069481|FG004|Open-Label Extension Phase|Investigator Decision|0|||
19619721|NCT00853047|42069482|FG005|Open-Label Extension Phase|Investigator Decision|1|||
19619722|NCT00853047|42069477|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
19619723|NCT00853047|42069478|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
19619724|NCT00853047|42069479|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
19619725|NCT00853047|42069480|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
19619726|NCT00853047|42069481|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
19619727|NCT00853047|42069482|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
19619728|NCT00529399|42069500|FG000|Overall Study|Lost to Follow-up|1|||
19619729|NCT00529399|42069501|FG001|Overall Study|Lost to Follow-up|0|||
19619730|NCT00529399|42069502|FG002|Overall Study|Lost to Follow-up|1|||
19619731|NCT00529399|42069500|FG000|Overall Study|Withdrawal by Subject|1|||
19619732|NCT00529399|42069501|FG001|Overall Study|Withdrawal by Subject|0|||
19619733|NCT00529399|42069502|FG002|Overall Study|Withdrawal by Subject|1|||
19619734|NCT00529399|42069500|FG000|Overall Study|Non-compliant|0|||
19619735|NCT00529399|42069501|FG001|Overall Study|Non-compliant|1|||
19619736|NCT00529399|42069502|FG002|Overall Study|Non-compliant|0|||
19619737|NCT00852969|42069512|FG000|Overall Study|Adverse Event|0|||
19619738|NCT00852969|42069513|FG001|Overall Study|Adverse Event|1|||
19619739|NCT00852969|42069512|FG000|Overall Study|Lost to Follow-up|0|||
19619740|NCT00852969|42069513|FG001|Overall Study|Lost to Follow-up|1|||
19619741|NCT03870997|42069525|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
19619742|NCT03870997|42069526|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
19619743|NCT03870997|42069527|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
19619744|NCT03870997|42069528|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
19619745|NCT03870997|42069529|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
19619746|NCT03870997|42069530|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
19619747|NCT00521365|42069539|FG000|Overall Study|Adverse Event|3|||
19619748|NCT00521365|42069539|FG000|Overall Study|Lost to Follow-up|6|||
19619749|NCT00521365|42069539|FG000|Overall Study|Protocol deviation|2|||
19619750|NCT00521365|42069539|FG000|Overall Study|Drug compliance|3|||
19619751|NCT00521365|42069539|FG000|Overall Study|Usage of not allowed drugs|6|||
19619752|NCT00711802|42069551|FG000|Overall Study|Not treated (no further detail)|2|||
19619753|NCT00711802|42069552|FG001|Overall Study|Not treated (no further detail)|1|||
19619754|NCT00711802|42069553|FG002|Overall Study|Not treated (no further detail)|2|||
19619755|NCT00711802|42069554|FG003|Overall Study|Not treated (no further detail)|0|||
19619756|NCT00711802|42069555|FG004|Overall Study|Not treated (no further detail)|2|||
19619757|NCT00711802|42069556|FG005|Overall Study|Not treated (no further detail)|0|||
19619758|NCT00711802|42069557|FG006|Overall Study|Not treated (no further detail)|0|||
19619759|NCT00711802|42069558|FG007|Overall Study|Not treated (no further detail)|0|||
19619760|NCT00711802|42069551|FG000|Overall Study|Adverse Event|0|||
19619761|NCT00711802|42069552|FG001|Overall Study|Adverse Event|0|||
19619762|NCT00711802|42069553|FG002|Overall Study|Adverse Event|0|||
19619763|NCT00711802|42069554|FG003|Overall Study|Adverse Event|0|||
19619764|NCT00711802|42069555|FG004|Overall Study|Adverse Event|1|||
19619765|NCT00711802|42069556|FG005|Overall Study|Adverse Event|1|||
19619766|NCT00711802|42069557|FG006|Overall Study|Adverse Event|0|||
19619767|NCT00711802|42069558|FG007|Overall Study|Adverse Event|0|||
19619768|NCT00711802|42069551|FG000|Overall Study|Microbiological failure|0|||
19619769|NCT00711802|42069552|FG001|Overall Study|Microbiological failure|1|||
19619770|NCT00711802|42069553|FG002|Overall Study|Microbiological failure|0|||
19619771|NCT00711802|42069554|FG003|Overall Study|Microbiological failure|0|||
19619772|NCT00711802|42069555|FG004|Overall Study|Microbiological failure|0|||
19619773|NCT00711802|42069556|FG005|Overall Study|Microbiological failure|1|||
19619774|NCT00711802|42069557|FG006|Overall Study|Microbiological failure|0|||
19619775|NCT00711802|42069558|FG007|Overall Study|Microbiological failure|0|||
19619776|NCT00711802|42069551|FG000|Overall Study|Protocol Violation|0|||
19619777|NCT00711802|42069552|FG001|Overall Study|Protocol Violation|0|||
19619778|NCT00711802|42069553|FG002|Overall Study|Protocol Violation|0|||
19619779|NCT00711802|42069554|FG003|Overall Study|Protocol Violation|1|||
19619780|NCT00711802|42069555|FG004|Overall Study|Protocol Violation|0|||
19619781|NCT00711802|42069556|FG005|Overall Study|Protocol Violation|0|||
19619782|NCT00711802|42069557|FG006|Overall Study|Protocol Violation|0|||
19619783|NCT00711802|42069558|FG007|Overall Study|Protocol Violation|0|||
19619784|NCT00711802|42069551|FG000|Overall Study|Physician Decision|0|||
19619785|NCT00711802|42069552|FG001|Overall Study|Physician Decision|2|||
19517496|NCT01534962|41930420|FG002|Overall Study|Randomized but did not start treatment|0|||
19517497|NCT01534962|41930421|FG003|Overall Study|Randomized but did not start treatment|1|||
19619786|NCT00711802|42069553|FG002|Overall Study|Physician Decision|0|||
19619787|NCT00711802|42069554|FG003|Overall Study|Physician Decision|0|||
19619788|NCT00711802|42069555|FG004|Overall Study|Physician Decision|0|||
19619789|NCT00711802|42069556|FG005|Overall Study|Physician Decision|0|||
19619790|NCT00711802|42069557|FG006|Overall Study|Physician Decision|0|||
19619791|NCT00711802|42069558|FG007|Overall Study|Physician Decision|0|||
19619792|NCT00711802|42069551|FG000|Overall Study|Withdrawal by Subject|0|||
19619793|NCT00711802|42069552|FG001|Overall Study|Withdrawal by Subject|1|||
19619794|NCT00711802|42069553|FG002|Overall Study|Withdrawal by Subject|0|||
19619795|NCT00711802|42069554|FG003|Overall Study|Withdrawal by Subject|1|||
19619796|NCT00711802|42069555|FG004|Overall Study|Withdrawal by Subject|0|||
19619797|NCT00711802|42069556|FG005|Overall Study|Withdrawal by Subject|0|||
19619798|NCT00711802|42069557|FG006|Overall Study|Withdrawal by Subject|0|||
19619799|NCT00711802|42069558|FG007|Overall Study|Withdrawal by Subject|0|||
19619800|NCT00711802|42069551|FG000|Overall Study|Lost to Follow-up|0|||
19619801|NCT00711802|42069552|FG001|Overall Study|Lost to Follow-up|0|||
19619802|NCT00711802|42069553|FG002|Overall Study|Lost to Follow-up|3|||
19619803|NCT00711802|42069554|FG003|Overall Study|Lost to Follow-up|1|||
19619804|NCT00711802|42069555|FG004|Overall Study|Lost to Follow-up|10|||
19619805|NCT00711802|42069556|FG005|Overall Study|Lost to Follow-up|6|||
19619806|NCT00711802|42069557|FG006|Overall Study|Lost to Follow-up|4|||
19619807|NCT00711802|42069558|FG007|Overall Study|Lost to Follow-up|2|||
19619808|NCT00711802|42069551|FG000|Overall Study|Reason not reported|0|||
19619809|NCT00711802|42069552|FG001|Overall Study|Reason not reported|1|||
19619810|NCT00711802|42069553|FG002|Overall Study|Reason not reported|1|||
19619811|NCT00711802|42069554|FG003|Overall Study|Reason not reported|0|||
19619812|NCT00711802|42069555|FG004|Overall Study|Reason not reported|1|||
19619813|NCT00711802|42069556|FG005|Overall Study|Reason not reported|0|||
19619814|NCT00711802|42069557|FG006|Overall Study|Reason not reported|1|||
19619815|NCT00711802|42069558|FG007|Overall Study|Reason not reported|0|||
19619816|NCT00851877|42069579|FG000|Phase I-1|Death|1|||
19619817|NCT00851877|42069580|FG001|Phase I-1|Death|0|||
19619818|NCT00851877|42069581|FG002|Phase I-1|Death|0|||
19619819|NCT00851877|42069579|FG000|Phase II|Withdrawal by Subject|0|||
19619820|NCT00851877|42069580|FG001|Phase II|Withdrawal by Subject|0|||
19619821|NCT00851877|42069581|FG002|Phase II|Withdrawal by Subject|3|||
19619822|NCT00882908|42069592|FG000|Overall Study|Adverse Event|0|||
19619823|NCT00882908|42069593|FG001|Overall Study|Adverse Event|0|||
19619824|NCT00882908|42069594|FG002|Overall Study|Adverse Event|1|||
19619825|NCT00882908|42069595|FG003|Overall Study|Adverse Event|0|||
19619826|NCT00882908|42069596|FG004|Overall Study|Adverse Event|1|||
19517498|NCT01534962|41930418|FG000|Overall Study|Discontinued at AF recurrence|35|||
19517499|NCT01534962|41930419|FG001|Overall Study|Discontinued at AF recurrence|26|||
19517500|NCT01534962|41930420|FG002|Overall Study|Discontinued at AF recurrence|24|||
19517501|NCT01534962|41930421|FG003|Overall Study|Discontinued at AF recurrence|31|||
19517502|NCT01582152|41930433|FG000|Overall Study|Disease Progression|4|||
19517503|NCT01582152|41930434|FG001|Overall Study|Disease Progression|5|||
19517504|NCT01582152|41930433|FG000|Overall Study|Adverse Event|2|||
19517505|NCT01582152|41930434|FG001|Overall Study|Adverse Event|1|||
19517506|NCT01581684|41930450|FG000|Overall Study|Other reason not defined|0|||
19517507|NCT01581684|41930451|FG001|Overall Study|Other reason not defined|0|||
19517508|NCT01581684|41930452|FG002|Overall Study|Other reason not defined|0|||
19517509|NCT01581684|41930453|FG003|Overall Study|Other reason not defined|0|||
19517510|NCT01581684|41930454|FG004|Overall Study|Other reason not defined|0|||
19517511|NCT01581684|41930455|FG005|Overall Study|Other reason not defined|0|||
19517512|NCT01581684|41930456|FG006|Overall Study|Other reason not defined|0|||
19517513|NCT01581684|41930457|FG007|Overall Study|Other reason not defined|0|||
19517514|NCT01581684|41930458|FG008|Overall Study|Other reason not defined|1|||
19517515|NCT01581684|41930459|FG009|Overall Study|Other reason not defined|0|||
19619827|NCT00882908|42069592|FG000|Overall Study|Lost to Follow-up|3|||
19619828|NCT00882908|42069593|FG001|Overall Study|Lost to Follow-up|5|||
19619829|NCT00882908|42069594|FG002|Overall Study|Lost to Follow-up|3|||
19619830|NCT00882908|42069595|FG003|Overall Study|Lost to Follow-up|1|||
19619831|NCT00882908|42069596|FG004|Overall Study|Lost to Follow-up|2|||
19619832|NCT00882908|42069592|FG000|Overall Study|Protocol Violation|0|||
19619833|NCT00882908|42069593|FG001|Overall Study|Protocol Violation|1|||
19619834|NCT00882908|42069594|FG002|Overall Study|Protocol Violation|0|||
19619835|NCT00882908|42069595|FG003|Overall Study|Protocol Violation|0|||
19619836|NCT00882908|42069596|FG004|Overall Study|Protocol Violation|0|||
19619837|NCT00882908|42069592|FG000|Overall Study|Withdrawal by Subject|0|||
19619838|NCT00882908|42069593|FG001|Overall Study|Withdrawal by Subject|0|||
19619839|NCT00882908|42069594|FG002|Overall Study|Withdrawal by Subject|3|||
19619840|NCT00882908|42069595|FG003|Overall Study|Withdrawal by Subject|5|||
19619841|NCT00882908|42069596|FG004|Overall Study|Withdrawal by Subject|2|||
19619842|NCT00882908|42069592|FG000|Overall Study|Subject reached a virologic endpoint|0|||
19619843|NCT00882908|42069593|FG001|Overall Study|Subject reached a virologic endpoint|0|||
19619844|NCT00882908|42069594|FG002|Overall Study|Subject reached a virologic endpoint|0|||
19619845|NCT00882908|42069595|FG003|Overall Study|Subject reached a virologic endpoint|0|||
19619846|NCT00882908|42069596|FG004|Overall Study|Subject reached a virologic endpoint|1|||
19619847|NCT00882908|42069592|FG000|Overall Study|Study terminated in error|0|||
19619848|NCT00882908|42069593|FG001|Overall Study|Study terminated in error|0|||
19619849|NCT00882908|42069594|FG002|Overall Study|Study terminated in error|0|||
19619850|NCT00882908|42069595|FG003|Overall Study|Study terminated in error|1|||
19619851|NCT00882908|42069596|FG004|Overall Study|Study terminated in error|0|||
19619852|NCT00851799|42069612|FG000|Overall Study|Death|1|||
19619853|NCT00851799|42069613|FG001|Overall Study|Death|0|||
19619854|NCT00851799|42069614|FG002|Overall Study|Death|1|||
19619855|NCT00851799|42069612|FG000|Overall Study|Lost to Follow-up|5|||
19619856|NCT00851799|42069613|FG001|Overall Study|Lost to Follow-up|3|||
19619857|NCT00851799|42069614|FG002|Overall Study|Lost to Follow-up|10|||
19619858|NCT00851799|42069612|FG000|Overall Study|Not able to get to clinic|8|||
19619859|NCT00851799|42069613|FG001|Overall Study|Not able to get to clinic|5|||
19619860|NCT00851799|42069614|FG002|Overall Study|Not able to get to clinic|9|||
19619861|NCT00851799|42069612|FG000|Overall Study|Not willing to adhere to requirements|1|||
19619862|NCT00851799|42069613|FG001|Overall Study|Not willing to adhere to requirements|2|||
19619863|NCT00851799|42069614|FG002|Overall Study|Not willing to adhere to requirements|2|||
19619864|NCT00851799|42069612|FG000|Overall Study|Withdrew consent prior study completion|1|||
19619865|NCT00851799|42069613|FG001|Overall Study|Withdrew consent prior study completion|2|||
19619866|NCT00851799|42069614|FG002|Overall Study|Withdrew consent prior study completion|1|||
19619867|NCT00851799|42069612|FG000|Overall Study|Severe Debilitation|0|||
19619868|NCT00851799|42069613|FG001|Overall Study|Severe Debilitation|1|||
19619869|NCT00851799|42069614|FG002|Overall Study|Severe Debilitation|0|||
19619870|NCT00851799|42069612|FG000|Overall Study|Completed protocol due to pregnancy|0|||
19619871|NCT00851799|42069613|FG001|Overall Study|Completed protocol due to pregnancy|0|||
19619872|NCT00851799|42069614|FG002|Overall Study|Completed protocol due to pregnancy|1|||
19619873|NCT00521053|42069622|FG000|Observation Phase|Disease Progression|55|||
19619874|NCT00521053|42069622|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
19619875|NCT00521053|42069622|FG000|Observation Phase|Death|2|||
19619876|NCT00521053|42069622|FG000|Observation Phase|Adverse Event|1|||
19619877|NCT00521053|42069622|FG000|Observation Phase|Other non-study melanoma treatment|1|||
19619878|NCT00521053|42069622|FG000|Observation Phase|Physician Decision|1|||
19619879|NCT00711646|42069631|FG000|Overall Study|Adverse Event|6|||
19619880|NCT00711646|42069632|FG001|Overall Study|Adverse Event|1|||
19619881|NCT00711646|42069631|FG000|Overall Study|Withdrawal by Subject|4|||
19619882|NCT00711646|42069632|FG001|Overall Study|Withdrawal by Subject|0|||
19619883|NCT00711646|42069631|FG000|Overall Study|Protocol Violation|0|||
19619884|NCT00711646|42069632|FG001|Overall Study|Protocol Violation|1|||
19619885|NCT00711646|42069631|FG000|Overall Study|Lost to Follow-up|1|||
19619886|NCT00711646|42069632|FG001|Overall Study|Lost to Follow-up|0|||
19619887|NCT00711646|42069631|FG000|Overall Study|administrative decision|0|||
19619888|NCT00711646|42069632|FG001|Overall Study|administrative decision|1|||
19619889|NCT00711646|42069631|FG000|Overall Study|patient non-compliance|1|||
19619890|NCT00711646|42069632|FG001|Overall Study|patient non-compliance|0|||
19619891|NCT00520975|42069640|FG000|Overall Study|Disease progression|31|||
19619892|NCT00520975|42069641|FG001|Overall Study|Disease progression|23|||
19619893|NCT00520975|42069640|FG000|Overall Study|Adverse Event|7|||
19619894|NCT00520975|42069641|FG001|Overall Study|Adverse Event|10|||
19619895|NCT00520975|42069640|FG000|Overall Study|Death|0|||
19619896|NCT00520975|42069641|FG001|Overall Study|Death|2|||
19619897|NCT00520975|42069640|FG000|Overall Study|Withdrawal by Subject|3|||
19619898|NCT00520975|42069641|FG001|Overall Study|Withdrawal by Subject|5|||
19619899|NCT00520975|42069640|FG000|Overall Study|Other therapy|2|||
19619900|NCT00520975|42069641|FG001|Overall Study|Other therapy|4|||
19619901|NCT00520975|42069640|FG000|Overall Study|Other reasons|4|||
19619902|NCT00520975|42069641|FG001|Overall Study|Other reasons|2|||
19619903|NCT00520975|42069640|FG000|Overall Study|Not start protocol therapy|1|||
19619904|NCT00520975|42069641|FG001|Overall Study|Not start protocol therapy|2|||
19619905|NCT00851721|42069649|FG000|Overall Study|planned surgery|1|||
19619906|NCT00851721|42069650|FG001|Overall Study|planned surgery|0|||
19619907|NCT00851721|42069649|FG000|Overall Study|Death|1|||
19619908|NCT00851721|42069650|FG001|Overall Study|Death|0|||
19619909|NCT00851721|42069649|FG000|Overall Study|Adverse Event|0|||
19619910|NCT00851721|42069650|FG001|Overall Study|Adverse Event|1|||
19619911|NCT00520741|42069664|FG000|Overall Study|Adverse Event|16|||
19619912|NCT00520741|42069665|FG001|Overall Study|Adverse Event|56|||
19619913|NCT00520741|42069664|FG000|Overall Study|Lack of Efficacy|11|||
19619914|NCT00520741|42069665|FG001|Overall Study|Lack of Efficacy|30|||
19619915|NCT00520741|42069664|FG000|Overall Study|Withdrawal by Subject|0|||
19619916|NCT00520741|42069665|FG001|Overall Study|Withdrawal by Subject|11|||
19619917|NCT00520741|42069664|FG000|Overall Study|Protocol Violation|2|||
19619918|NCT00520741|42069665|FG001|Overall Study|Protocol Violation|15|||
19619919|NCT00520741|42069664|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
19619920|NCT00520741|42069665|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
19619921|NCT00520741|42069664|FG000|Overall Study|Lost to Follow-up|4|||
19619922|NCT00520741|42069665|FG001|Overall Study|Lost to Follow-up|4|||
19619923|NCT00520741|42069664|FG000|Overall Study|Other reasons for premature termination|0|||
19619924|NCT00520741|42069665|FG001|Overall Study|Other reasons for premature termination|6|||
19619925|NCT00882518|42069675|FG000|Overall Study|Adverse Event|9|||
19619926|NCT00882518|42069676|FG001|Overall Study|Adverse Event|18|||
19619927|NCT00882518|42069675|FG000|Overall Study|Withdrawal by Subject|9|||
19619928|NCT00882518|42069676|FG001|Overall Study|Withdrawal by Subject|13|||
19619929|NCT00882518|42069675|FG000|Overall Study|Lack of Efficacy|12|||
19619930|NCT00882518|42069676|FG001|Overall Study|Lack of Efficacy|9|||
19619931|NCT00882518|42069675|FG000|Overall Study|Severe non-compliance to protocol|3|||
19619932|NCT00882518|42069676|FG001|Overall Study|Severe non-compliance to protocol|1|||
19619933|NCT00882518|42069675|FG000|Overall Study|Incorrect enrolment|4|||
19619934|NCT00882518|42069676|FG001|Overall Study|Incorrect enrolment|2|||
19619935|NCT00882518|42069675|FG000|Overall Study|Central lab closure for National day|1|||
19619936|NCT00882518|42069676|FG001|Overall Study|Central lab closure for National day|0|||
19619937|NCT00882518|42069675|FG000|Overall Study|Allocating random number by mistake|0|||
19619938|NCT00882518|42069676|FG001|Overall Study|Allocating random number by mistake|1|||
19619939|NCT00882362|42069693|FG000|Overall Study|Adverse Event|13|||
19619940|NCT00882362|42069694|FG001|Overall Study|Adverse Event|10|||
19619941|NCT00882362|42069693|FG000|Overall Study|Withdrawal by Subject|13|||
19619942|NCT00882362|42069694|FG001|Overall Study|Withdrawal by Subject|10|||
19619943|NCT00882362|42069693|FG000|Overall Study|Lack of Efficacy|3|||
19619944|NCT00882362|42069694|FG001|Overall Study|Lack of Efficacy|0|||
19619945|NCT00882362|42069693|FG000|Overall Study|Protocol Violation|7|||
19619946|NCT00882362|42069694|FG001|Overall Study|Protocol Violation|2|||
19619947|NCT00882362|42069693|FG000|Overall Study|Pregnancy|1|||
19619948|NCT00882362|42069694|FG001|Overall Study|Pregnancy|0|||
19619949|NCT00882362|42069693|FG000|Overall Study|Physician Decision|5|||
19619950|NCT00882362|42069694|FG001|Overall Study|Physician Decision|1|||
19619951|NCT00882362|42069693|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
19619952|NCT00882362|42069694|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
19619953|NCT00882362|42069693|FG000|Overall Study|change of residence or other commitments|5|||
19619954|NCT00882362|42069694|FG001|Overall Study|change of residence or other commitments|0|||
19619955|NCT00851643|42069706|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
19619956|NCT00851643|42069707|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
19619957|NCT00851643|42069708|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
19619958|NCT00851643|42069709|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
19619959|NCT00851643|42069710|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
19619960|NCT00851643|42069711|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
19619961|NCT00851643|42069706|FG000|Base Study (Up to 12 Months)|Other|0|||
19619962|NCT00851643|42069707|FG001|Base Study (Up to 12 Months)|Other|0|||
19619963|NCT00851643|42069708|FG002|Base Study (Up to 12 Months)|Other|0|||
19619964|NCT00851643|42069709|FG003|Base Study (Up to 12 Months)|Other|0|||
19619965|NCT00851643|42069710|FG004|Base Study (Up to 12 Months)|Other|0|||
19619966|NCT00851643|42069711|FG005|Base Study (Up to 12 Months)|Other|1|||
19619967|NCT00851643|42069706|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
19619968|NCT00851643|42069707|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
19619969|NCT00851643|42069708|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
19619970|NCT00851643|42069709|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
19619971|NCT00851643|42069710|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
19619972|NCT00851643|42069711|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
19619973|NCT00851643|42069706|FG000|Extension Study (Up to 36 Months)|Moved|0|||
19619974|NCT00851643|42069707|FG001|Extension Study (Up to 36 Months)|Moved|2|||
19619975|NCT00851643|42069708|FG002|Extension Study (Up to 36 Months)|Moved|1|||
19619976|NCT00851643|42069709|FG003|Extension Study (Up to 36 Months)|Moved|1|||
19619977|NCT00851643|42069710|FG004|Extension Study (Up to 36 Months)|Moved|0|||
19619978|NCT00851643|42069711|FG005|Extension Study (Up to 36 Months)|Moved|1|||
19619979|NCT00529243|42069724|FG000|Overall Study|Adverse Event|1|||
19619980|NCT00529243|42069724|FG000|Overall Study|Death|1|||
19619981|NCT00529243|42069724|FG000|Overall Study|Relocated|1|||
19619982|NCT03728309|42069730|FG000|Overall Study|Randomized but not Treated|0|||
19619983|NCT03728309|42069731|FG001|Overall Study|Randomized but not Treated|1|||
19619984|NCT03728309|42069730|FG000|Overall Study|Adverse Event|0|||
19619985|NCT03728309|42069731|FG001|Overall Study|Adverse Event|1|||
19619986|NCT03728309|42069730|FG000|Overall Study|Withdrawal by Subject|2|||
19619987|NCT03728309|42069731|FG001|Overall Study|Withdrawal by Subject|8|||
19619988|NCT03728309|42069730|FG000|Overall Study|Lost to Follow-up|9|||
19619989|NCT03728309|42069731|FG001|Overall Study|Lost to Follow-up|10|||
19619990|NCT03728309|42069730|FG000|Overall Study|Protocol Deviation|0|||
19619991|NCT03728309|42069731|FG001|Overall Study|Protocol Deviation|1|||
19619992|NCT03728309|42069730|FG000|Overall Study|Due to COVID|1|||
19619993|NCT03728309|42069731|FG001|Overall Study|Due to COVID|3|||
19619994|NCT03683719|42069748|FG000|Overall Study|Lack of Efficacy|1|||
19619995|NCT03683719|42069749|FG001|Overall Study|Lack of Efficacy|3|||
19619996|NCT03683719|42069750|FG002|Overall Study|Lack of Efficacy|4|||
19619997|NCT03683719|42069751|FG003|Overall Study|Lack of Efficacy|0|||
19619998|NCT03683719|42069752|FG004|Overall Study|Lack of Efficacy|4|||
19619999|NCT03683719|42069748|FG000|Overall Study|Adverse Event|6|||
19620000|NCT03683719|42069749|FG001|Overall Study|Adverse Event|6|||
19620001|NCT03683719|42069750|FG002|Overall Study|Adverse Event|0|||
19620002|NCT03683719|42069751|FG003|Overall Study|Adverse Event|1|||
19620003|NCT03683719|42069752|FG004|Overall Study|Adverse Event|3|||
19620004|NCT03683719|42069748|FG000|Overall Study|Withdrawal by Subject|4|||
19620005|NCT03683719|42069749|FG001|Overall Study|Withdrawal by Subject|4|||
19620006|NCT03683719|42069750|FG002|Overall Study|Withdrawal by Subject|3|||
19620007|NCT03683719|42069751|FG003|Overall Study|Withdrawal by Subject|5|||
19620008|NCT03683719|42069752|FG004|Overall Study|Withdrawal by Subject|5|||
19620009|NCT03683719|42069748|FG000|Overall Study|Lost to Follow-up|1|||
19620010|NCT03683719|42069749|FG001|Overall Study|Lost to Follow-up|0|||
19620011|NCT03683719|42069750|FG002|Overall Study|Lost to Follow-up|0|||
19620012|NCT03683719|42069751|FG003|Overall Study|Lost to Follow-up|1|||
19620013|NCT03683719|42069752|FG004|Overall Study|Lost to Follow-up|1|||
19620014|NCT03683719|42069748|FG000|Overall Study|Other personal reasons|0|||
19620015|NCT03683719|42069749|FG001|Overall Study|Other personal reasons|0|||
19620016|NCT03683719|42069750|FG002|Overall Study|Other personal reasons|1|||
19620017|NCT03683719|42069751|FG003|Overall Study|Other personal reasons|0|||
19620018|NCT03683719|42069752|FG004|Overall Study|Other personal reasons|1|||
19620019|NCT00851253|42069766|FG000|Overall Study|Disease Progression|1|||
19620020|NCT00851253|42069767|FG001|Overall Study|Disease Progression|0|||
19620021|NCT00520351|42069775|FG000|First Intervention|Withdrawal by Subject|1|||
19620022|NCT00520351|42069776|FG001|First Intervention|Withdrawal by Subject|1|||
19620023|NCT00850395|42069786|FG000|Overall Study|Death|1|||
19620024|NCT00850395|42069786|FG000|Overall Study|Adverse Event|1|||
19620025|NCT00850395|42069786|FG000|Overall Study|Insufficient clinical response|3|||
19620026|NCT00850395|42069786|FG000|Overall Study|Other|5|||
19620027|NCT00520039|42069792|FG000|Overall Study|Exclusion criteria met at first visit|7|||
19620028|NCT00520039|42069793|FG001|Overall Study|Exclusion criteria met at first visit|5|||
19620029|NCT00577720|42069805|FG000|Overall Study|Adverse Event|2|||
19620030|NCT00577720|42069806|FG001|Overall Study|Adverse Event|1|||
19620031|NCT00577720|42069807|FG002|Overall Study|Adverse Event|0|||
19620032|NCT00577720|42069808|FG003|Overall Study|Adverse Event|4|||
19620033|NCT00577720|42069805|FG000|Overall Study|Lost to Follow-up|0|||
19620034|NCT00577720|42069806|FG001|Overall Study|Lost to Follow-up|0|||
19620035|NCT00577720|42069807|FG002|Overall Study|Lost to Follow-up|1|||
19620036|NCT00577720|42069808|FG003|Overall Study|Lost to Follow-up|0|||
19620037|NCT00577720|42069805|FG000|Overall Study|Protocol Violation|0|||
19620038|NCT00577720|42069806|FG001|Overall Study|Protocol Violation|0|||
19620039|NCT00577720|42069807|FG002|Overall Study|Protocol Violation|0|||
19620040|NCT00577720|42069808|FG003|Overall Study|Protocol Violation|1|||
19620041|NCT00577720|42069805|FG000|Overall Study|Withdrawal by Subject|2|||
19620042|NCT00577720|42069806|FG001|Overall Study|Withdrawal by Subject|0|||
19620043|NCT00577720|42069807|FG002|Overall Study|Withdrawal by Subject|0|||
19620044|NCT00577720|42069808|FG003|Overall Study|Withdrawal by Subject|2|||
19620045|NCT00519649|42069818|FG000|Overall Study|Withdrawal by Subject|1|||
19620046|NCT00512707|42069836|FG000|Overall Study|Lost to Follow-up|5|||
19620047|NCT00512707|42069837|FG001|Overall Study|Lost to Follow-up|11|||
19620048|NCT00512707|42069836|FG000|Overall Study|Developed skin irritation|2|||
19620049|NCT00512707|42069837|FG001|Overall Study|Developed skin irritation|1|||
19620050|NCT00512707|42069836|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
19620051|NCT00512707|42069837|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
19620052|NCT00512707|42069836|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
19620053|NCT00512707|42069837|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
19620054|NCT03471767|42069845|FG000|Overall Study|Withdrawal by Subject|3|||
19620055|NCT03471767|42069846|FG001|Overall Study|Withdrawal by Subject|1|||
19620056|NCT03471767|42069845|FG000|Overall Study|Adverse Event|1|||
19620057|NCT03471767|42069846|FG001|Overall Study|Adverse Event|0|||
19517516|NCT01557582|41930492|FG000|Overall Study|Protocol Violation|4|||
19620058|NCT03471767|42069845|FG000|Overall Study|Lost to Follow-up|1|||
19620059|NCT03471767|42069846|FG001|Overall Study|Lost to Follow-up|0|||
19620060|NCT03471767|42069845|FG000|Overall Study|PI Withdrawal|1|||
19620061|NCT03471767|42069846|FG001|Overall Study|PI Withdrawal|3|||
19620062|NCT00849693|42069856|FG000|Acute Treatment Phase|Adverse Event|12|||
19620063|NCT00849693|42069857|FG001|Acute Treatment Phase|Adverse Event|7|||
19620064|NCT00849693|42069858|FG002|Acute Treatment Phase|Adverse Event|6|||
19620065|NCT00849693|42069859|FG003|Acute Treatment Phase|Adverse Event|4|||
19620066|NCT00849693|42069856|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
19620067|NCT00849693|42069857|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
19620068|NCT00849693|42069858|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
19620069|NCT00849693|42069859|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
19620070|NCT00849693|42069856|FG000|Acute Treatment Phase|Protocol Violation|1|||
19620071|NCT00849693|42069857|FG001|Acute Treatment Phase|Protocol Violation|5|||
19620072|NCT00849693|42069858|FG002|Acute Treatment Phase|Protocol Violation|2|||
19620073|NCT00849693|42069859|FG003|Acute Treatment Phase|Protocol Violation|6|||
19620074|NCT00849693|42069856|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
19620075|NCT00849693|42069857|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
19620076|NCT00849693|42069858|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
19620077|NCT00849693|42069859|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
19620078|NCT00849693|42069856|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
19620079|NCT00849693|42069857|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
19620080|NCT00849693|42069858|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
19517517|NCT01557582|41930492|FG000|Overall Study|Operator error|2|||
19517518|NCT01557504|41930498|FG000|Overall Study|Physician Decision|1|||
19517519|NCT01557504|41930499|FG001|Overall Study|Physician Decision|0|||
19517520|NCT01557348|41930513|FG000|Overall Study|Adverse Event|6|||
19517521|NCT01557348|41930514|FG001|Overall Study|Adverse Event|16|||
19517522|NCT01557348|41930513|FG000|Overall Study|Infusion reaction event|5|||
19517523|NCT01557348|41930514|FG001|Overall Study|Infusion reaction event|5|||
19517524|NCT01557348|41930513|FG000|Overall Study|Death|7|||
19517525|NCT01557348|41930514|FG001|Overall Study|Death|4|||
19517526|NCT01557348|41930513|FG000|Overall Study|Insufficient Therapeutic Response|13|||
19517527|NCT01557348|41930514|FG001|Overall Study|Insufficient Therapeutic Response|28|||
19517528|NCT01557348|41930513|FG000|Overall Study|Withdrawal by Subject|5|||
19517529|NCT01557348|41930514|FG001|Overall Study|Withdrawal by Subject|4|||
19517530|NCT01557348|41930513|FG000|Overall Study|Lost to Follow-up|26|||
19517531|NCT01557348|41930514|FG001|Overall Study|Lost to Follow-up|22|||
19517532|NCT01557348|41930513|FG000|Overall Study|Administrative|18|||
19517533|NCT01557348|41930514|FG001|Overall Study|Administrative|11|||
19517534|NCT01580670|41930521|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
19517535|NCT01580670|41930521|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
19517536|NCT01534260|41930527|FG000|Overall Study|Adverse Event|1|||
19517537|NCT01534260|41930528|FG001|Overall Study|Adverse Event|8|||
19517538|NCT01534260|41930527|FG000|Overall Study|Death|2|||
19517539|NCT01534260|41930528|FG001|Overall Study|Death|0|||
19517540|NCT01534260|41930527|FG000|Overall Study|Lack of Efficacy|1|||
19517541|NCT01534260|41930528|FG001|Overall Study|Lack of Efficacy|1|||
19517542|NCT01534260|41930527|FG000|Overall Study|Withdrawal by Subject|1|||
19517543|NCT01534260|41930528|FG001|Overall Study|Withdrawal by Subject|3|||
19517544|NCT01534260|41930527|FG000|Overall Study|Disease Progression|8|||
19517545|NCT01534260|41930528|FG001|Overall Study|Disease Progression|6|||
19517546|NCT01534260|41930527|FG000|Overall Study|Physician Decision|3|||
19517547|NCT01534260|41930528|FG001|Overall Study|Physician Decision|1|||
19517548|NCT01534260|41930527|FG000|Overall Study|No treatment, per protocol|0|||
19517549|NCT01534260|41930528|FG001|Overall Study|No treatment, per protocol|1|||
19517550|NCT01534182|41930536|FG000|Overall Study|Administrative problems|1|||
19517551|NCT01534182|41930537|FG001|Overall Study|Administrative problems|0|||
19517552|NCT01534182|41930536|FG000|Overall Study|Withdrawal by Subject|4|||
19517553|NCT01534182|41930537|FG001|Overall Study|Withdrawal by Subject|7|||
19517554|NCT01534182|41930536|FG000|Overall Study|Adverse Event|7|||
19517555|NCT01534182|41930537|FG001|Overall Study|Adverse Event|3|||
19517556|NCT01579812|41930544|FG000|Overall Study|Ineligible after treatment start|40|||
19517557|NCT01579812|41930544|FG000|Overall Study|Patient choice|3|||
19517558|NCT01579812|41930544|FG000|Overall Study|Noncompliance|3|||
19517559|NCT01579812|41930544|FG000|Overall Study|Withdrawal by Subject|6|||
19517560|NCT01533714|41930557|FG000|Overall Study|Adverse Event|0|||
19517561|NCT01533714|41930558|FG001|Overall Study|Adverse Event|1|||
19517562|NCT01533714|41930559|FG002|Overall Study|Adverse Event|2|||
19517563|NCT01533714|41930560|FG003|Overall Study|Adverse Event|2|||
19517564|NCT01533714|41930561|FG004|Overall Study|Adverse Event|2|||
19620081|NCT00849693|42069859|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
19620082|NCT00849693|42069856|FG000|Acute Treatment Phase|Physician Decision|2|||
19620083|NCT00849693|42069857|FG001|Acute Treatment Phase|Physician Decision|1|||
19620084|NCT00849693|42069858|FG002|Acute Treatment Phase|Physician Decision|2|||
19620085|NCT00849693|42069859|FG003|Acute Treatment Phase|Physician Decision|1|||
19620086|NCT00849693|42069856|FG000|Acute Treatment Phase|Sponsor decision|0|||
19620087|NCT00849693|42069857|FG001|Acute Treatment Phase|Sponsor decision|0|||
19620088|NCT00849693|42069858|FG002|Acute Treatment Phase|Sponsor decision|1|||
19620089|NCT00849693|42069859|FG003|Acute Treatment Phase|Sponsor decision|0|||
19620090|NCT00849693|42069856|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
19620091|NCT00849693|42069857|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
19620092|NCT00849693|42069858|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
19620093|NCT00849693|42069859|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
19620094|NCT00849693|42069856|FG000|Extension Phase|Adverse Event|4|||
19620095|NCT00849693|42069857|FG001|Extension Phase|Adverse Event|6|||
19620096|NCT00849693|42069858|FG002|Extension Phase|Adverse Event|3|||
19620097|NCT00849693|42069859|FG003|Extension Phase|Adverse Event|7|||
19620098|NCT00849693|42069856|FG000|Extension Phase|Lost to Follow-up|7|||
19620099|NCT00849693|42069857|FG001|Extension Phase|Lost to Follow-up|5|||
19620100|NCT00849693|42069858|FG002|Extension Phase|Lost to Follow-up|6|||
19620101|NCT00849693|42069859|FG003|Extension Phase|Lost to Follow-up|6|||
19620102|NCT00849693|42069856|FG000|Extension Phase|Protocol Violation|0|||
19620103|NCT00849693|42069857|FG001|Extension Phase|Protocol Violation|3|||
19620104|NCT00849693|42069858|FG002|Extension Phase|Protocol Violation|2|||
19620105|NCT00849693|42069859|FG003|Extension Phase|Protocol Violation|3|||
19620106|NCT00849693|42069856|FG000|Extension Phase|Withdrawal by Subject|6|||
19620107|NCT00849693|42069857|FG001|Extension Phase|Withdrawal by Subject|9|||
19620108|NCT00849693|42069858|FG002|Extension Phase|Withdrawal by Subject|10|||
19620109|NCT00849693|42069859|FG003|Extension Phase|Withdrawal by Subject|15|||
19620110|NCT00849693|42069856|FG000|Extension Phase|Parent or caregiver decision|9|||
19620111|NCT00849693|42069857|FG001|Extension Phase|Parent or caregiver decision|4|||
19620112|NCT00849693|42069858|FG002|Extension Phase|Parent or caregiver decision|10|||
19620113|NCT00849693|42069859|FG003|Extension Phase|Parent or caregiver decision|5|||
19620114|NCT00849693|42069856|FG000|Extension Phase|Physician Decision|1|||
19620115|NCT00849693|42069857|FG001|Extension Phase|Physician Decision|1|||
19620116|NCT00849693|42069858|FG002|Extension Phase|Physician Decision|2|||
19620117|NCT00849693|42069859|FG003|Extension Phase|Physician Decision|0|||
19620118|NCT00849693|42069856|FG000|Extension Phase|Sponsor decision|1|||
19620119|NCT00849693|42069857|FG001|Extension Phase|Sponsor decision|0|||
19620120|NCT00849693|42069858|FG002|Extension Phase|Sponsor decision|0|||
19620121|NCT00849693|42069859|FG003|Extension Phase|Sponsor decision|1|||
19620122|NCT00849693|42069856|FG000|Extension Phase|Lack of Efficacy|2|||
19620123|NCT00849693|42069857|FG001|Extension Phase|Lack of Efficacy|2|||
19620124|NCT00849693|42069858|FG002|Extension Phase|Lack of Efficacy|2|||
19620125|NCT00849693|42069859|FG003|Extension Phase|Lack of Efficacy|1|||
19620126|NCT00527605|42069883|FG000|Overall Study|Adverse Event|3|||
19620127|NCT00527605|42069884|FG001|Overall Study|Adverse Event|0|||
19620128|NCT00527605|42069883|FG000|Overall Study|Withdrawal by Subject|3|||
19620129|NCT00527605|42069884|FG001|Overall Study|Withdrawal by Subject|7|||
19620130|NCT00527605|42069883|FG000|Overall Study|Lost to Follow-up|6|||
19620131|NCT00527605|42069884|FG001|Overall Study|Lost to Follow-up|2|||
19620132|NCT00527605|42069883|FG000|Overall Study|Protocol Violation|1|||
19620133|NCT00527605|42069884|FG001|Overall Study|Protocol Violation|2|||
19620134|NCT00849381|42069890|FG000|Overall Study|Adverse Event|1|||
19620135|NCT00849381|42069890|FG000|Overall Study|Lost to Follow-up|129|||
19620136|NCT00849381|42069890|FG000|Overall Study|Protocol Violation|5|||
19620137|NCT00849381|42069890|FG000|Overall Study|Withdrawal by Subject|6|||
19517565|NCT01533714|41930562|FG005|Overall Study|Adverse Event|1|||
19517566|NCT01533714|41930557|FG000|Overall Study|Lack of Efficacy|0|||
19620138|NCT00849381|42069890|FG000|Overall Study|Other|4|||
19620139|NCT00711412|42069894|FG000|Induction Treatment|Death|2|||
19620140|NCT00711412|42069894|FG000|Induction Treatment|Adverse Event|1|||
19620141|NCT00711412|42069894|FG000|Induction Treatment|Other|1|||
19620142|NCT00711412|42069894|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
19620143|NCT00711412|42069894|FG000|Evaluated for Combination Treatment|Death|1|||
19620144|NCT00711412|42069894|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
19620145|NCT00711412|42069894|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
19620146|NCT00711412|42069894|FG000|Combination Treatment|Progressive Disease|1|||
19620147|NCT00711412|42069894|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
19620148|NCT00711412|42069894|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
19620149|NCT00711412|42069894|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
19620150|NCT00711412|42069894|FG000|Evaluation for Response and Surgery|Death|1|||
19620151|NCT00711412|42069894|FG000|Survival Follow up Until Death|Other|12|||
19620152|NCT00577408|42069910|FG000|Overall Study|Stopped attending study visits|9|||
19620153|NCT00577408|42069911|FG001|Overall Study|Stopped attending study visits|11|||
19620154|NCT00577408|42069910|FG000|Overall Study|Continued opioid use|3|||
19620155|NCT00577408|42069911|FG001|Overall Study|Continued opioid use|2|||
19620156|NCT00577408|42069910|FG000|Overall Study|Non-compliance with study meds|0|||
19620157|NCT00577408|42069911|FG001|Overall Study|Non-compliance with study meds|3|||
19620158|NCT00577408|42069910|FG000|Overall Study|Refused Oral Naltrexone|0|||
19620159|NCT00577408|42069911|FG001|Overall Study|Refused Oral Naltrexone|1|||
19620160|NCT00577408|42069910|FG000|Overall Study|Moved out of state|0|||
19620161|NCT00577408|42069911|FG001|Overall Study|Moved out of state|1|||
19620162|NCT00577408|42069910|FG000|Overall Study|Scheduling Issues|0|||
19620163|NCT00577408|42069911|FG001|Overall Study|Scheduling Issues|3|||
19620164|NCT00577408|42069910|FG000|Overall Study|Death|0|||
19620165|NCT00577408|42069911|FG001|Overall Study|Death|1|||
19620166|NCT00577408|42069910|FG000|Overall Study|Psychiatric hospitalization|0|||
19620167|NCT00577408|42069911|FG001|Overall Study|Psychiatric hospitalization|1|||
19620168|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
19620169|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
19620170|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
19620171|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
19620172|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
19620173|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
19620174|NCT00828009|42069917|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
19620175|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
19620176|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
19620177|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Death|1|||
19620178|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
19620179|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
19620180|NCT00828009|42069917|FG000|Step 2 - Maintenance Therapy|Other|1|||
19620181|NCT00713596|42069925|FG000|Overall Study|Study was terminated|2|||
19620182|NCT00713596|42069926|FG001|Overall Study|Study was terminated|3|||
19620183|NCT00713596|42069927|FG002|Overall Study|Study was terminated|2|||
19620184|NCT00880568|42069944|FG000|Overall Study|Disease progression|3|||
19620185|NCT00880568|42069945|FG001|Overall Study|Disease progression|3|||
19620186|NCT00880568|42069946|FG002|Overall Study|Disease progression|3|||
19620187|NCT00880568|42069947|FG003|Overall Study|Disease progression|1|||
19620188|NCT00880568|42069948|FG004|Overall Study|Disease progression|3|||
19620189|NCT00880568|42069949|FG005|Overall Study|Disease progression|3|||
19620190|NCT00880568|42069950|FG006|Overall Study|Disease progression|5|||
19620191|NCT00880568|42069951|FG007|Overall Study|Disease progression|0|||
19620192|NCT00880568|42069952|FG008|Overall Study|Disease progression|3|||
19620193|NCT00880568|42069944|FG000|Overall Study|Adverse Event|0|||
19620194|NCT00880568|42069945|FG001|Overall Study|Adverse Event|0|||
19620195|NCT00880568|42069946|FG002|Overall Study|Adverse Event|0|||
19517567|NCT01533714|41930558|FG001|Overall Study|Lack of Efficacy|0|||
19517568|NCT01533714|41930559|FG002|Overall Study|Lack of Efficacy|0|||
19517569|NCT01533714|41930560|FG003|Overall Study|Lack of Efficacy|0|||
19517570|NCT01533714|41930561|FG004|Overall Study|Lack of Efficacy|0|||
19517571|NCT01533714|41930562|FG005|Overall Study|Lack of Efficacy|1|||
19517572|NCT01533714|41930557|FG000|Overall Study|Withdrawal by Subject|0|||
19517573|NCT01533714|41930558|FG001|Overall Study|Withdrawal by Subject|1|||
19517574|NCT01533714|41930559|FG002|Overall Study|Withdrawal by Subject|0|||
19517575|NCT01533714|41930560|FG003|Overall Study|Withdrawal by Subject|1|||
19517576|NCT01533714|41930561|FG004|Overall Study|Withdrawal by Subject|1|||
19517577|NCT01533714|41930562|FG005|Overall Study|Withdrawal by Subject|0|||
19517578|NCT01533714|41930557|FG000|Overall Study|Exclusion criteria|0|||
19517579|NCT01533714|41930558|FG001|Overall Study|Exclusion criteria|1|||
19517580|NCT01533714|41930559|FG002|Overall Study|Exclusion criteria|0|||
19517581|NCT01533714|41930560|FG003|Overall Study|Exclusion criteria|0|||
19517582|NCT01533714|41930561|FG004|Overall Study|Exclusion criteria|0|||
19517583|NCT01533714|41930562|FG005|Overall Study|Exclusion criteria|0|||
19517584|NCT01533714|41930557|FG000|Overall Study|Positive for purified protein derivative|0|||
19517585|NCT01533714|41930558|FG001|Overall Study|Positive for purified protein derivative|0|||
19517586|NCT01533714|41930559|FG002|Overall Study|Positive for purified protein derivative|1|||
19517587|NCT01533714|41930560|FG003|Overall Study|Positive for purified protein derivative|0|||
19517588|NCT01533714|41930561|FG004|Overall Study|Positive for purified protein derivative|1|||
19517589|NCT01533714|41930562|FG005|Overall Study|Positive for purified protein derivative|0|||
19517590|NCT01533714|41930557|FG000|Overall Study|Withdrawal criteria|0|||
19620196|NCT00880568|42069947|FG003|Overall Study|Adverse Event|0|||
19620197|NCT00880568|42069948|FG004|Overall Study|Adverse Event|0|||
19620198|NCT00880568|42069949|FG005|Overall Study|Adverse Event|0|||
19620199|NCT00880568|42069950|FG006|Overall Study|Adverse Event|1|||
19620200|NCT00880568|42069951|FG007|Overall Study|Adverse Event|1|||
19620201|NCT00880568|42069952|FG008|Overall Study|Adverse Event|0|||
19620202|NCT00880568|42069944|FG000|Overall Study|Withdrawal by Subject|0|||
19620203|NCT00880568|42069945|FG001|Overall Study|Withdrawal by Subject|0|||
19620204|NCT00880568|42069946|FG002|Overall Study|Withdrawal by Subject|0|||
19620205|NCT00880568|42069947|FG003|Overall Study|Withdrawal by Subject|0|||
19620206|NCT00880568|42069948|FG004|Overall Study|Withdrawal by Subject|0|||
19620207|NCT00880568|42069949|FG005|Overall Study|Withdrawal by Subject|0|||
19620208|NCT00880568|42069950|FG006|Overall Study|Withdrawal by Subject|0|||
19620209|NCT00880568|42069951|FG007|Overall Study|Withdrawal by Subject|1|||
19620210|NCT00880568|42069952|FG008|Overall Study|Withdrawal by Subject|0|||
19620211|NCT00881894|42069979|FG000|Overall Study|Consent withdrawn|0|||
19620212|NCT00881894|42069980|FG001|Overall Study|Consent withdrawn|1|||
19620213|NCT00881894|42069979|FG000|Overall Study|Other reasons for premature termination|1|||
19620214|NCT00881894|42069980|FG001|Overall Study|Other reasons for premature termination|2|||
19620215|NCT00711100|42069986|FG000|Overall Study|Lack of Efficacy|5|||
19620216|NCT00711100|42069986|FG000|Overall Study|Withdrawal by Subject|8|||
19620217|NCT00827931|42070004|FG000|Overall Study|Death|3|||
19620218|NCT00827931|42070005|FG001|Overall Study|Death|5|||
19620219|NCT00827931|42070004|FG000|Overall Study|Adverse Event|1|||
19620220|NCT00827931|42070005|FG001|Overall Study|Adverse Event|0|||
19620221|NCT00827931|42070004|FG000|Overall Study|Lost to Follow-up|1|||
19620222|NCT00827931|42070005|FG001|Overall Study|Lost to Follow-up|0|||
19620223|NCT00827931|42070004|FG000|Overall Study|Withdrawal by Subject|0|||
19620224|NCT00827931|42070005|FG001|Overall Study|Withdrawal by Subject|1|||
19620225|NCT00827931|42070004|FG000|Overall Study|Other|1|||
19620226|NCT00827931|42070005|FG001|Overall Study|Other|0|||
19620227|NCT00526669|42070011|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
19620228|NCT00526669|42070012|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
19620229|NCT00526669|42070011|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
19620230|NCT00526669|42070012|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
19620231|NCT00526669|42070011|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
19620232|NCT00526669|42070012|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
19620233|NCT00526669|42070011|FG000|Combined Treatment Phase|Death|0|||
19620234|NCT00526669|42070012|FG001|Combined Treatment Phase|Death|2|||
19620235|NCT00710866|42070024|FG000|Overall Study|Protocol Violation|5|||
19620236|NCT00710866|42070025|FG001|Overall Study|Protocol Violation|4|||
19620237|NCT00710866|42070024|FG000|Overall Study|Withdrawal by Subject|2|||
19620238|NCT00710866|42070025|FG001|Overall Study|Withdrawal by Subject|1|||
19620239|NCT00710866|42070024|FG000|Overall Study|Lost to Follow-up|1|||
19620240|NCT00710866|42070025|FG001|Overall Study|Lost to Follow-up|0|||
19620241|NCT00710866|42070024|FG000|Overall Study|Failed to meet eligibility|1|||
19620242|NCT00710866|42070025|FG001|Overall Study|Failed to meet eligibility|1|||
19620243|NCT00827775|42070042|FG000|Overall Study|Withdrawal by Subject|0|||
19620244|NCT00827775|42070043|FG001|Overall Study|Withdrawal by Subject|5|||
19620245|NCT00827541|42070051|FG000|Overall Study|Exitus|1|||
19620246|NCT00827541|42070052|FG001|Overall Study|Exitus|8|||
19620247|NCT00827541|42070051|FG000|Overall Study|Other|1|||
19620248|NCT00827541|42070052|FG001|Overall Study|Other|3|||
19620249|NCT00827541|42070051|FG000|Overall Study|Pathogen not susceptible|1|||
19620250|NCT00827541|42070052|FG001|Overall Study|Pathogen not susceptible|0|||
19620251|NCT00827541|42070051|FG000|Overall Study|Lack of effectiveness|1|||
19620252|NCT00827541|42070052|FG001|Overall Study|Lack of effectiveness|0|||
19620253|NCT00518323|42070062|FG000|Overall Study|Lack of Efficacy|14|||
19620254|NCT00518323|42070063|FG001|Overall Study|Lack of Efficacy|2|||
19620255|NCT00518323|42070064|FG002|Overall Study|Lack of Efficacy|4|||
19620256|NCT00518323|42070065|FG003|Overall Study|Lack of Efficacy|20|||
19620257|NCT00518323|42070062|FG000|Overall Study|Withdrawal by Subject|1|||
19620258|NCT00518323|42070063|FG001|Overall Study|Withdrawal by Subject|2|||
19620259|NCT00518323|42070064|FG002|Overall Study|Withdrawal by Subject|4|||
19620260|NCT00518323|42070065|FG003|Overall Study|Withdrawal by Subject|2|||
19620261|NCT00518323|42070062|FG000|Overall Study|Lost to Follow-up|0|||
19620262|NCT00518323|42070063|FG001|Overall Study|Lost to Follow-up|2|||
19620263|NCT00518323|42070064|FG002|Overall Study|Lost to Follow-up|1|||
19620264|NCT00518323|42070065|FG003|Overall Study|Lost to Follow-up|3|||
19620265|NCT00518323|42070062|FG000|Overall Study|Adverse Event|1|||
19620266|NCT00518323|42070063|FG001|Overall Study|Adverse Event|1|||
19620267|NCT00518323|42070064|FG002|Overall Study|Adverse Event|1|||
19620268|NCT00518323|42070065|FG003|Overall Study|Adverse Event|0|||
19620269|NCT00518323|42070062|FG000|Overall Study|Prohibited medication and others|3|||
19620270|NCT00518323|42070063|FG001|Overall Study|Prohibited medication and others|1|||
19620271|NCT00518323|42070064|FG002|Overall Study|Prohibited medication and others|1|||
19620272|NCT00518323|42070065|FG003|Overall Study|Prohibited medication and others|0|||
19620273|NCT00826449|42070077|FG000|Overall Study|Disease Progression|4|||
19620274|NCT00826449|42070077|FG000|Overall Study|Withdrawal by Subject|1|||
19620275|NCT00825825|42070082|FG000|First Medication Period (14 Days)|Adverse Event|1|||
19620276|NCT00825825|42070083|FG001|First Medication Period (14 Days)|Adverse Event|0|||
19620277|NCT00825825|42070084|FG002|First Medication Period (14 Days)|Adverse Event|0|||
19620278|NCT00825825|42070085|FG003|First Medication Period (14 Days)|Adverse Event|0|||
19620279|NCT00825825|42070086|FG004|First Medication Period (14 Days)|Adverse Event|0|||
19620280|NCT00825825|42070087|FG005|First Medication Period (14 Days)|Adverse Event|1|||
19620281|NCT00825825|42070082|FG000|First Medication Period (14 Days)|Physician Decision|2|||
19620282|NCT00825825|42070083|FG001|First Medication Period (14 Days)|Physician Decision|0|||
19620283|NCT00825825|42070084|FG002|First Medication Period (14 Days)|Physician Decision|1|||
19620284|NCT00825825|42070085|FG003|First Medication Period (14 Days)|Physician Decision|0|||
19620285|NCT00825825|42070086|FG004|First Medication Period (14 Days)|Physician Decision|0|||
19620286|NCT00825825|42070087|FG005|First Medication Period (14 Days)|Physician Decision|1|||
19620287|NCT00825825|42070082|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
19620288|NCT00825825|42070083|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
19620289|NCT00825825|42070084|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
19620290|NCT00825825|42070085|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
19620291|NCT00825825|42070086|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
19620292|NCT00825825|42070087|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
19620293|NCT00825825|42070082|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
19620294|NCT00825825|42070083|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
19620295|NCT00825825|42070084|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
19620296|NCT00825825|42070085|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
19620297|NCT00825825|42070086|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
19620298|NCT00825825|42070087|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
19620299|NCT00825825|42070082|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
19620300|NCT00825825|42070083|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
19620301|NCT00825825|42070084|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
19620302|NCT00825825|42070085|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
19620303|NCT00825825|42070086|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
19620304|NCT00825825|42070087|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
19620305|NCT00825825|42070082|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
19620306|NCT00825825|42070083|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
19620307|NCT00825825|42070084|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
19620308|NCT00825825|42070085|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
19620309|NCT00825825|42070086|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
19620310|NCT00825825|42070087|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
19620311|NCT00825825|42070082|FG000|Third Medication Period (14 Days)|poor data quality|0|||
19620312|NCT00825825|42070083|FG001|Third Medication Period (14 Days)|poor data quality|1|||
19620313|NCT00825825|42070084|FG002|Third Medication Period (14 Days)|poor data quality|0|||
19620314|NCT00825825|42070085|FG003|Third Medication Period (14 Days)|poor data quality|0|||
19620315|NCT00825825|42070086|FG004|Third Medication Period (14 Days)|poor data quality|0|||
19620316|NCT00825825|42070087|FG005|Third Medication Period (14 Days)|poor data quality|0|||
19620317|NCT00710710|42070096|FG000|Overall Study|Consent withdrawn|2|||
19620318|NCT00710710|42070097|FG001|Overall Study|Consent withdrawn|2|||
19620319|NCT00710710|42070096|FG000|Overall Study|Protocol Violation|0|||
19620320|NCT00710710|42070097|FG001|Overall Study|Protocol Violation|1|||
19620321|NCT00710710|42070096|FG000|Overall Study|Adverse Event|3|||
19620322|NCT00710710|42070097|FG001|Overall Study|Adverse Event|3|||
19620323|NCT00710710|42070096|FG000|Overall Study|Progressive disease|40|||
19620324|NCT00710710|42070097|FG001|Overall Study|Progressive disease|38|||
19620325|NCT00880334|42070105|FG000|Randomized Phase|Physician Decision|1|||
19620326|NCT00880334|42070106|FG001|Randomized Phase|Physician Decision|0|||
19620327|NCT00880334|42070105|FG000|Randomized Phase|Withdrawal by Subject|2|||
19620328|NCT00880334|42070106|FG001|Randomized Phase|Withdrawal by Subject|1|||
19620329|NCT00880334|42070105|FG000|Randomized Phase|Inadequate Labs|1|||
19620330|NCT00880334|42070106|FG001|Randomized Phase|Inadequate Labs|1|||
19620331|NCT00880334|42070105|FG000|Randomized Phase|Brain Metastasis|0|||
19620332|NCT00880334|42070106|FG001|Randomized Phase|Brain Metastasis|1|||
19620333|NCT00880334|42070105|FG000|Randomized Phase|Crossover Participants|0|||
19620334|NCT00880334|42070106|FG001|Randomized Phase|Crossover Participants|37|||
19620335|NCT00865566|42070122|FG000|Overall Study|Death|1|||
19620336|NCT00865566|42070123|FG001|Overall Study|Death|11|||
19620337|NCT00865566|42070122|FG000|Overall Study|Lost to Follow-up|314|||
19620338|NCT00865566|42070123|FG001|Overall Study|Lost to Follow-up|315|||
19620339|NCT00865566|42070122|FG000|Overall Study|Withdrawal by Subject|45|||
19620340|NCT00865566|42070123|FG001|Overall Study|Withdrawal by Subject|65|||
19620341|NCT00865566|42070122|FG000|Overall Study|Physician Decision|0|||
19394226|NCT01371981|41638301|FG000|Overall Study|Did not start treatment|2|||
19517591|NCT01533714|41930558|FG001|Overall Study|Withdrawal criteria|0|||
19620342|NCT00865566|42070123|FG001|Overall Study|Physician Decision|1|||
19620343|NCT00865566|42070122|FG000|Overall Study|Participant relocated|78|||
19620344|NCT00865566|42070123|FG001|Overall Study|Participant relocated|107|||
19620345|NCT00865566|42070122|FG000|Overall Study|Participant unable to adhere|27|||
19620346|NCT00865566|42070123|FG001|Overall Study|Participant unable to adhere|42|||
19620347|NCT00865566|42070122|FG000|Overall Study|Other; N=245 due to early study closure|154|||
19620348|NCT00865566|42070123|FG001|Overall Study|Other; N=245 due to early study closure|139|||
19620349|NCT00865566|42070122|FG000|Overall Study|HIV infection|5|||
19620350|NCT00865566|42070123|FG001|Overall Study|HIV infection|7|||
19620351|NCT03866473|42070131|FG000|Phase 1|Death|1|||
19620352|NCT03866473|42070132|FG001|Phase 1|Death|0|||
19620353|NCT03866473|42070131|FG000|Phase 2|Death|0|||
19620354|NCT03866473|42070132|FG001|Phase 2|Death|2|||
19620355|NCT03866473|42070131|FG000|Phase 2|Dropped|1|||
19620356|NCT03866473|42070132|FG001|Phase 2|Dropped|1|||
19620357|NCT03866473|42070131|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
19620358|NCT03866473|42070132|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
19705392|NCT03716050|42149711|FG001|Overall Study|Physician Decision|0|||
19705393|NCT03716050|42149712|FG002|Overall Study|Physician Decision|0|||
19705394|NCT03716050|42149713|FG003|Overall Study|Physician Decision|1|||
19620359|NCT00710554|42070144|FG000|Overall Study|Adverse Event|24|||
19620360|NCT00710554|42070145|FG001|Overall Study|Adverse Event|7|||
19620361|NCT00710554|42070144|FG000|Overall Study|Withdrawal by Subject|7|||
19620362|NCT00710554|42070145|FG001|Overall Study|Withdrawal by Subject|3|||
19705395|NCT03716050|42149714|FG004|Overall Study|Physician Decision|0|||
19705396|NCT03716050|42149715|FG005|Overall Study|Physician Decision|0|||
19705397|NCT03716050|42149716|FG006|Overall Study|Physician Decision|0|||
19705398|NCT03716050|42149717|FG007|Overall Study|Physician Decision|0|||
19705399|NCT03716050|42149710|FG000|Overall Study|Protocol Violation|0|||
19705400|NCT03716050|42149711|FG001|Overall Study|Protocol Violation|0|||
19620363|NCT00710554|42070144|FG000|Overall Study|Lost to Follow-up|7|||
19705401|NCT03716050|42149712|FG002|Overall Study|Protocol Violation|0|||
19705402|NCT03716050|42149713|FG003|Overall Study|Protocol Violation|1|||
19620364|NCT00710554|42070145|FG001|Overall Study|Lost to Follow-up|1|||
19620365|NCT00710554|42070144|FG000|Overall Study|Lack of Efficacy|11|||
19620366|NCT00710554|42070145|FG001|Overall Study|Lack of Efficacy|12|||
19620367|NCT00710554|42070144|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
19620368|NCT00710554|42070145|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
19620369|NCT00525499|42070155|FG000|Overall Study|Lost to Follow-up|2|||
19620370|NCT00525499|42070156|FG001|Overall Study|Lost to Follow-up|4|||
19620371|NCT00525499|42070157|FG002|Overall Study|Lost to Follow-up|1|||
19620372|NCT00525499|42070158|FG003|Overall Study|Lost to Follow-up|4|||
19620373|NCT00525499|42070155|FG000|Overall Study|Adverse Event|0|||
19620374|NCT00525499|42070156|FG001|Overall Study|Adverse Event|1|||
19620375|NCT00525499|42070157|FG002|Overall Study|Adverse Event|0|||
19620376|NCT00525499|42070158|FG003|Overall Study|Adverse Event|1|||
19620377|NCT00525499|42070155|FG000|Overall Study|Withdrawal by Subject|5|||
19620378|NCT00525499|42070156|FG001|Overall Study|Withdrawal by Subject|1|||
19620379|NCT00525499|42070157|FG002|Overall Study|Withdrawal by Subject|5|||
19620380|NCT00525499|42070158|FG003|Overall Study|Withdrawal by Subject|2|||
19620381|NCT00525499|42070155|FG000|Overall Study|Protocol Violation|0|||
19620382|NCT00525499|42070156|FG001|Overall Study|Protocol Violation|1|||
19620383|NCT00525499|42070157|FG002|Overall Study|Protocol Violation|1|||
19620384|NCT00525499|42070158|FG003|Overall Study|Protocol Violation|0|||
19620385|NCT00824655|42070170|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
19620386|NCT00824655|42070171|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
19620387|NCT00824655|42070170|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
19620388|NCT00824655|42070171|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
19620389|NCT00525265|42070181|FG000|Overall Study|Protocol Violation|1|||
19620390|NCT00525265|42070182|FG001|Overall Study|Protocol Violation|0|||
19620391|NCT00880256|42070188|FG000|Overall Study|Lost to Follow-up|28|||
19620392|NCT03865381|42070197|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
19620393|NCT03865381|42070197|FG000|Overall Study|Withdrawal by Subject|2|||
19620394|NCT00713206|42070203|FG000|Overall Study|Lost to Follow-up|4|||
19620395|NCT00713206|42070204|FG001|Overall Study|Lost to Follow-up|4|||
19620396|NCT00713206|42070203|FG000|Overall Study|Death|1|||
19620397|NCT00713206|42070204|FG001|Overall Study|Death|0|||
19620398|NCT00865098|42070210|FG000|Overall Study|Progressive disease|1|||
19620399|NCT00880100|42070214|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
19620400|NCT00880100|42070214|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
19620401|NCT00880100|42070214|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
19620402|NCT00518011|42070220|FG000|Overall Study|Death|1|||
19620403|NCT00518011|42070221|FG001|Overall Study|Death|1|||
19620404|NCT00518011|42070220|FG000|Overall Study|Adverse Event|2|||
19620405|NCT00518011|42070221|FG001|Overall Study|Adverse Event|3|||
19620406|NCT00518011|42070220|FG000|Overall Study|Disease Progression|2|||
19620407|NCT00518011|42070221|FG001|Overall Study|Disease Progression|2|||
19620408|NCT00518011|42070220|FG000|Overall Study|Other Reasons|3|||
19620409|NCT00518011|42070221|FG001|Overall Study|Other Reasons|2|||
19620410|NCT00518011|42070220|FG000|Overall Study|Withdrawal by Subject|1|||
19620411|NCT00518011|42070221|FG001|Overall Study|Withdrawal by Subject|0|||
19620412|NCT00865020|42070230|FG000|Overall Study|Withdrawal by Subject|22|||
19620413|NCT00865020|42070231|FG001|Overall Study|Withdrawal by Subject|16|||
19620414|NCT00865020|42070230|FG000|Overall Study|Adverse Event|9|||
19620415|NCT00865020|42070231|FG001|Overall Study|Adverse Event|14|||
19620416|NCT00865020|42070230|FG000|Overall Study|Abnormal test procedure result(s)|6|||
19705403|NCT03716050|42149714|FG004|Overall Study|Protocol Violation|0|||
19705404|NCT03716050|42149715|FG005|Overall Study|Protocol Violation|0|||
19705405|NCT03716050|42149716|FG006|Overall Study|Protocol Violation|0|||
19705406|NCT03716050|42149717|FG007|Overall Study|Protocol Violation|2|||
19705407|NCT00413231|42149734|FG000|0 to 30-day Post Treatment|Death|5|||
19705408|NCT00413231|42149734|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
19705409|NCT00413231|42149734|FG000|30-day to 365-day Post Treatment|Death|13|||
19705410|NCT00413231|42149734|FG000|365-day to 60-month Post Treatment|Death|36|||
19705411|NCT00413231|42149734|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
19705412|NCT00413231|42149734|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
19620417|NCT00865020|42070231|FG001|Overall Study|Abnormal test procedure result(s)|8|||
19620418|NCT00865020|42070230|FG000|Overall Study|Lost to Follow-up|6|||
19620419|NCT00865020|42070231|FG001|Overall Study|Lost to Follow-up|4|||
19620420|NCT00865020|42070230|FG000|Overall Study|Protocol deviation|4|||
19620421|NCT00865020|42070231|FG001|Overall Study|Protocol deviation|1|||
19620422|NCT00865020|42070230|FG000|Overall Study|Administrative problems|0|||
19620423|NCT00865020|42070231|FG001|Overall Study|Administrative problems|2|||
19705413|NCT00413231|42149734|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
19620424|NCT00865020|42070230|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19620425|NCT00865020|42070231|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19620426|NCT00865020|42070230|FG000|Overall Study|Death|0|||
19620427|NCT00865020|42070231|FG001|Overall Study|Death|1|||
19620428|NCT00865020|42070230|FG000|Overall Study|Randomized but discontinued|2|||
19620429|NCT00865020|42070231|FG001|Overall Study|Randomized but discontinued|4|||
19620430|NCT00517933|42070239|FG000|Period 1|Death|2|||
19620431|NCT00517933|42070240|FG001|Period 1|Death|1|||
19620432|NCT00517933|42070239|FG000|Period 1|Adverse Event|4|||
19620433|NCT00517933|42070240|FG001|Period 1|Adverse Event|4|||
19620434|NCT00517933|42070239|FG000|Period 1|Lost to Follow-up|2|||
19620435|NCT00517933|42070240|FG001|Period 1|Lost to Follow-up|0|||
19620436|NCT00517933|42070239|FG000|Period 1|Underwent lung transplant|0|||
19620437|NCT00517933|42070240|FG001|Period 1|Underwent lung transplant|1|||
19620438|NCT00517933|42070239|FG000|Period 2|Death|2|||
19620439|NCT00517933|42070240|FG001|Period 2|Death|4|||
19620440|NCT00517933|42070239|FG000|Period 2|Adverse Event|2|||
19620441|NCT00517933|42070240|FG001|Period 2|Adverse Event|4|||
19620442|NCT00517933|42070239|FG000|Period 2|Physician Decision|1|||
19620443|NCT00517933|42070240|FG001|Period 2|Physician Decision|0|||
19620444|NCT00517933|42070239|FG000|Period 2|Withdrawal by Subject|1|||
19620445|NCT00517933|42070240|FG001|Period 2|Withdrawal by Subject|3|||
19620446|NCT00517933|42070239|FG000|Period 2|Underwent lung transplant|0|||
19620447|NCT00517933|42070240|FG001|Period 2|Underwent lung transplant|2|||
19620448|NCT00701038|42070251|FG000|Overall Study|study amended pilot group of patients|4|||
19620449|NCT00701038|42070252|FG001|Overall Study|study amended pilot group of patients|4|||
19620450|NCT00857766|42070271|FG000|Overall Study|Adverse Event|13|||
19517592|NCT01533714|41930559|FG002|Overall Study|Withdrawal criteria|1|||
19620451|NCT00857766|42070272|FG001|Overall Study|Adverse Event|12|||
19620452|NCT00857766|42070271|FG000|Overall Study|Protocol Violation|11|||
19705414|NCT00413153|42149754|FG000|Overall Study|Withdrawal by Subject|1|||
19705415|NCT00413153|42149755|FG001|Overall Study|Withdrawal by Subject|1|||
19705416|NCT00413153|42149754|FG000|Overall Study|Adverse Event|1|||
19705417|NCT00413153|42149755|FG001|Overall Study|Adverse Event|0|||
19620453|NCT00857766|42070272|FG001|Overall Study|Protocol Violation|11|||
19620454|NCT00857766|42070271|FG000|Overall Study|Lost to Follow-up|1|||
19620455|NCT00857766|42070272|FG001|Overall Study|Lost to Follow-up|0|||
19620456|NCT00857766|42070271|FG000|Overall Study|Investigator Discretion|2|||
19620457|NCT00857766|42070272|FG001|Overall Study|Investigator Discretion|3|||
19620458|NCT00857766|42070271|FG000|Overall Study|Participant Withdrew Consent|4|||
19620459|NCT00857766|42070272|FG001|Overall Study|Participant Withdrew Consent|4|||
19620460|NCT00517699|42070278|FG000|Overall Study|Withdrawal by Subject|1|||
19620461|NCT00517699|42070278|FG000|Overall Study|Lack of Efficacy|1|||
19620462|NCT00517699|42070278|FG000|Overall Study|Administrative error|1|||
19620463|NCT00517699|42070278|FG000|Overall Study|Study terminated by Sponsor|2|||
19620464|NCT00857454|42070282|FG000|Overall Study|Withdrawal by Subject|2|||
19620465|NCT00857454|42070282|FG000|Overall Study|Lost to Follow-up|1|||
19620466|NCT00857454|42070282|FG000|Overall Study|Adverse Event|2|||
19620467|NCT00857454|42070282|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
19620468|NCT00857454|42070282|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
19620469|NCT00857454|42070282|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
19620470|NCT00525031|42070288|FG000|Overall Study|Disease Progression|1|||
19620471|NCT00525031|42070289|FG001|Overall Study|Disease Progression|1|||
19620472|NCT00524485|42070296|FG000|Overall Study|Withdrawal by Subject|5|||
19620473|NCT00857220|42070300|FG000|Overall Study|Adverse Event|35|||
19620474|NCT00857220|42070300|FG000|Overall Study|Death|1|||
19620475|NCT00857220|42070300|FG000|Overall Study|Lack of Efficacy|11|||
19620476|NCT00857220|42070300|FG000|Overall Study|Lost to Follow-up|30|||
19620477|NCT00857220|42070300|FG000|Overall Study|Physician Decision|4|||
19620478|NCT00857220|42070300|FG000|Overall Study|Protocol Violation|16|||
19620479|NCT00857220|42070300|FG000|Overall Study|Withdrawal by Subject|67|||
19620480|NCT00857220|42070300|FG000|Overall Study|Clinical Hold|6|||
19620481|NCT00857220|42070300|FG000|Overall Study|Site Closed|5|||
19620482|NCT00857220|42070300|FG000|Overall Study|Miscellaneous|8|||
19620483|NCT00524173|42070306|FG000|Overall Study|Lost to Follow-up|0|||
19620484|NCT00524173|42070307|FG001|Overall Study|Lost to Follow-up|1|||
19620485|NCT00524173|42070306|FG000|Overall Study|Death|1|||
19620486|NCT00524173|42070307|FG001|Overall Study|Death|0|||
19620487|NCT00524173|42070306|FG000|Overall Study|Had not reached endpoint at study close|4|||
19620488|NCT00524173|42070307|FG001|Overall Study|Had not reached endpoint at study close|1|||
19620489|NCT00879710|42070315|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
19705418|NCT00412607|42149761|FG000|Overall Study|Withdrawal by Subject|9|||
19705419|NCT00412607|42149761|FG000|Overall Study|Lost to Follow-up|19|||
19517593|NCT01533714|41930560|FG003|Overall Study|Withdrawal criteria|0|||
19620490|NCT00879710|42070316|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
19620491|NCT00879710|42070317|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
19705420|NCT00412607|42149761|FG000|Overall Study|Death|61|||
19705421|NCT00412607|42149761|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
19620492|NCT00879710|42070318|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
19620493|NCT00879710|42070315|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
19620494|NCT00879710|42070316|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
19620495|NCT00879710|42070317|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
19620496|NCT00879710|42070318|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
19620497|NCT00597506|42070326|FG000|Overall Study|Subject is being followed for survival|1|||
19620498|NCT00708682|42070339|FG000|Infant Series|Adverse Event|1|||
19620499|NCT00708682|42070339|FG000|Infant Series|Lost to Follow-up|4|||
19620500|NCT00708682|42070339|FG000|Infant Series|Protocol Violation|1|||
19620501|NCT00708682|42070339|FG000|Infant Series|Parent/legal guardian request|6|||
19620502|NCT00708682|42070339|FG000|Infant Series|Failed to return|2|||
19620503|NCT00708682|42070339|FG000|Infant Series|Other|19|||
19620504|NCT00708682|42070339|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
19620505|NCT00708682|42070339|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
19620506|NCT00708682|42070339|FG000|Toddler Dose|Lost to Follow-up|3|||
19620507|NCT00708682|42070339|FG000|Toddler Dose|Failed to Return|4|||
19620508|NCT00712348|42070345|FG000|Overall Study|Withdrawal by Subject|1|||
19620509|NCT00881504|42070349|FG000|Overall Study|Withdrawal by Subject|1|||
19620510|NCT01936831|42070366|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620511|NCT01936831|42070367|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620512|NCT01936831|42070368|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620513|NCT01936831|42070369|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620514|NCT01936831|42070370|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620515|NCT01936831|42070371|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
19620516|NCT01936831|42070372|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620517|NCT01936831|42070373|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620518|NCT01936831|42070374|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
19620519|NCT03863353|42070391|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
19620520|NCT03863353|42070392|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
19620521|NCT00523705|42070400|FG000|Overall Study|No time for study.|0|||
19620522|NCT00523705|42070401|FG001|Overall Study|No time for study.|1|||
19620523|NCT00523549|42070414|FG000|Overall Study|Adverse Event|6|||
19620524|NCT00523549|42070415|FG001|Overall Study|Adverse Event|3|||
19620525|NCT00523549|42070414|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19620526|NCT00523549|42070415|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19620527|NCT00523549|42070414|FG000|Overall Study|Protocol Deviation|3|||
19620528|NCT00523549|42070415|FG001|Overall Study|Protocol Deviation|1|||
19620529|NCT00523549|42070414|FG000|Overall Study|Patient withdrew consent|7|||
19620530|NCT00523549|42070415|FG001|Overall Study|Patient withdrew consent|6|||
19620531|NCT00523549|42070414|FG000|Overall Study|Lost to Follow-up|3|||
19620532|NCT00523549|42070415|FG001|Overall Study|Lost to Follow-up|5|||
19620533|NCT03504085|42070423|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
19620534|NCT03504085|42070424|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
19620535|NCT03504085|42070423|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
19620536|NCT03504085|42070424|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
19620537|NCT00700102|42070432|FG000|Overall Study|Died|394|||
19620538|NCT00700102|42070433|FG001|Overall Study|Died|385|||
19620539|NCT00700102|42070432|FG000|Overall Study|Lost to Follow-up|8|||
19620540|NCT00700102|42070433|FG001|Overall Study|Lost to Follow-up|10|||
19620541|NCT00595478|42070441|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
19620542|NCT00595478|42070442|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
19620543|NCT00595478|42070441|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
19620544|NCT00595478|42070442|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
19620545|NCT00516295|42070451|FG000|Overall Study|Lack of Efficacy|2|||
19620546|NCT00516295|42070452|FG001|Overall Study|Lack of Efficacy|0|||
19620547|NCT00516295|42070453|FG002|Overall Study|Lack of Efficacy|0|||
19620548|NCT00516295|42070451|FG000|Overall Study|Ineligible|1|||
19620549|NCT00516295|42070452|FG001|Overall Study|Ineligible|0|||
19620550|NCT00516295|42070453|FG002|Overall Study|Ineligible|0|||
19620551|NCT03861559|42070463|FG000|Overall Study|Adverse Event|0|||
19620552|NCT03861559|42070464|FG001|Overall Study|Adverse Event|2|||
19620553|NCT03861559|42070463|FG000|Overall Study|Treatment failure|0|||
19620554|NCT03861559|42070464|FG001|Overall Study|Treatment failure|2|||
19620555|NCT03861559|42070463|FG000|Overall Study|Noncompliance|1|||
19620556|NCT03861559|42070464|FG001|Overall Study|Noncompliance|1|||
19620557|NCT03861559|42070463|FG000|Overall Study|Did not meet eligibility requirements|1|||
19620558|NCT03861559|42070464|FG001|Overall Study|Did not meet eligibility requirements|0|||
19620559|NCT00516139|42070470|FG000|Overall Study|Adverse Event|27|||
19620560|NCT00516139|42070470|FG000|Overall Study|Lost to Follow-up|1|||
19620561|NCT00516139|42070470|FG000|Overall Study|Protocol Violation|1|||
19620562|NCT00516139|42070470|FG000|Overall Study|Withdrawal by Subject|8|||
19620563|NCT00516139|42070470|FG000|Overall Study|Lack of Efficacy|1|||
19620564|NCT00879086|42070480|FG000|Overall Study|Adverse Event|3|||
19620565|NCT00879086|42070481|FG001|Overall Study|Adverse Event|15|||
19620566|NCT00879086|42070480|FG000|Overall Study|Participant choice|2|||
19620567|NCT00879086|42070481|FG001|Overall Study|Participant choice|2|||
19620568|NCT00879086|42070480|FG000|Overall Study|Progression of disease|40|||
19620569|NCT00879086|42070481|FG001|Overall Study|Progression of disease|26|||
19620570|NCT00879086|42070480|FG000|Overall Study|Withdrawal of consent|2|||
19620571|NCT00879086|42070481|FG001|Overall Study|Withdrawal of consent|1|||
19620572|NCT00879086|42070480|FG000|Overall Study|Other|4|||
19620573|NCT00879086|42070481|FG001|Overall Study|Other|6|||
19620574|NCT00879086|42070480|FG000|Overall Study|Death|1|||
19620575|NCT00879086|42070481|FG001|Overall Study|Death|2|||
19620576|NCT00515827|42070489|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
19620577|NCT00515827|42070490|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
19620578|NCT00515827|42070489|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
19620579|NCT00515827|42070490|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
19620580|NCT00522457|42070498|FG000|Overall Study|Due to disease progression|16|||
19620581|NCT00522457|42070498|FG000|Overall Study|Adverse Event|2|||
19620582|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
19620583|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
19620584|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
19620585|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
19620586|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
19620587|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
19620588|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
19620589|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
19620590|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
19620591|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
19620592|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
19620593|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
19620594|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
19620595|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
19620596|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
19620597|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
19620598|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
19620599|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
19620600|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
19620601|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
19620602|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
19620603|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
19620604|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
19620605|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
19620606|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
19620607|NCT00856986|42070507|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
19620608|NCT00856986|42070508|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
19620609|NCT00856986|42070509|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
19620610|NCT00856986|42070510|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
19620611|NCT00856986|42070511|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
19620612|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
19620613|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
19620614|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
19620615|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
19620616|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
19620617|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
19620618|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
19620619|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
19620620|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
19620621|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
19620622|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
19620623|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
19620624|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
19620625|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
19620626|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
19620627|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
19620628|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
19620629|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
19620630|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
19620631|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
19620632|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
19620633|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
19373741|NCT02755649|41614936|FG000|Overall Study|Withdrawal by Subject|0|||
19620634|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
19620635|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
19620636|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
19620637|NCT00856986|42070507|FG000|Main Period, Weeks 0-26|Unclassified|7|||
19620638|NCT00856986|42070508|FG001|Main Period, Weeks 0-26|Unclassified|6|||
19620639|NCT00856986|42070509|FG002|Main Period, Weeks 0-26|Unclassified|7|||
19620640|NCT00856986|42070510|FG003|Main Period, Weeks 0-26|Unclassified|0|||
19620641|NCT00856986|42070511|FG004|Main Period, Weeks 0-26|Unclassified|0|||
19620642|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
19620643|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
19620644|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
19620645|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
19620646|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
19620647|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
19620648|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
19620649|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
19620650|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
19620651|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
19620652|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
19620653|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
19620654|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
19620655|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
19620656|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
19620657|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
19620658|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
19620659|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
19620660|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
19620661|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
19620662|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
19620663|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
19620664|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
19620665|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
19620666|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
19620667|NCT00856986|42070507|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
19620668|NCT00856986|42070508|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
19620669|NCT00856986|42070509|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
19620670|NCT00856986|42070510|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
19620671|NCT00856986|42070511|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
19620672|NCT00707746|42070525|FG000|Treatment Period|Adverse Event|2|||
19620673|NCT00707746|42070526|FG001|Treatment Period|Adverse Event|4|||
19620674|NCT00707746|42070525|FG000|Treatment Period|Ineligibility|0|||
19620675|NCT00707746|42070526|FG001|Treatment Period|Ineligibility|1|||
19620676|NCT00856908|42070534|FG000|Overall Study|Lost to Follow-up|1|||
19620677|NCT00856908|42070535|FG001|Overall Study|Lost to Follow-up|0|||
19620678|NCT00522379|42070546|FG000|Overall Study|Adverse Event|12|||
19620679|NCT00522379|42070547|FG001|Overall Study|Adverse Event|15|||
19620680|NCT00522379|42070548|FG002|Overall Study|Adverse Event|12|||
19620681|NCT00522379|42070549|FG003|Overall Study|Adverse Event|5|||
19620682|NCT00522379|42070550|FG004|Overall Study|Adverse Event|17|||
19620683|NCT00522379|42070546|FG000|Overall Study|Lack of Efficacy|3|||
19620684|NCT00522379|42070547|FG001|Overall Study|Lack of Efficacy|0|||
19620685|NCT00522379|42070548|FG002|Overall Study|Lack of Efficacy|2|||
19620686|NCT00522379|42070549|FG003|Overall Study|Lack of Efficacy|2|||
19620687|NCT00522379|42070550|FG004|Overall Study|Lack of Efficacy|7|||
19620688|NCT00522379|42070546|FG000|Overall Study|Withdrawal by Subject|2|||
19620689|NCT00522379|42070547|FG001|Overall Study|Withdrawal by Subject|3|||
19620690|NCT00522379|42070548|FG002|Overall Study|Withdrawal by Subject|1|||
19620691|NCT00522379|42070549|FG003|Overall Study|Withdrawal by Subject|2|||
19620692|NCT00522379|42070550|FG004|Overall Study|Withdrawal by Subject|0|||
19620693|NCT00522379|42070546|FG000|Overall Study|Protocol Violation|1|||
19620694|NCT00522379|42070547|FG001|Overall Study|Protocol Violation|1|||
19620695|NCT00522379|42070548|FG002|Overall Study|Protocol Violation|2|||
19620696|NCT00522379|42070549|FG003|Overall Study|Protocol Violation|0|||
19620697|NCT00522379|42070550|FG004|Overall Study|Protocol Violation|0|||
19620698|NCT00522379|42070546|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
19620699|NCT00522379|42070547|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
19620700|NCT00522379|42070548|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
19620701|NCT00522379|42070549|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
19620702|NCT00522379|42070550|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
19620703|NCT00522379|42070546|FG000|Overall Study|Lost to Follow-up|1|||
19620704|NCT00522379|42070547|FG001|Overall Study|Lost to Follow-up|0|||
19620705|NCT00522379|42070548|FG002|Overall Study|Lost to Follow-up|4|||
19620706|NCT00522379|42070549|FG003|Overall Study|Lost to Follow-up|2|||
19620707|NCT00522379|42070550|FG004|Overall Study|Lost to Follow-up|2|||
19620708|NCT00522379|42070546|FG000|Overall Study|Randomization error|0|||
19620709|NCT00522379|42070547|FG001|Overall Study|Randomization error|0|||
19620710|NCT00522379|42070548|FG002|Overall Study|Randomization error|0|||
19620711|NCT00522379|42070549|FG003|Overall Study|Randomization error|0|||
19620712|NCT00522379|42070550|FG004|Overall Study|Randomization error|1|||
19620713|NCT00522379|42070546|FG000|Overall Study|Dispensing error|1|||
19620714|NCT00522379|42070547|FG001|Overall Study|Dispensing error|0|||
19620715|NCT00522379|42070548|FG002|Overall Study|Dispensing error|0|||
19620716|NCT00522379|42070549|FG003|Overall Study|Dispensing error|1|||
19620717|NCT00522379|42070550|FG004|Overall Study|Dispensing error|0|||
19620718|NCT00522379|42070546|FG000|Overall Study|Subject Moved|1|||
19620719|NCT00522379|42070547|FG001|Overall Study|Subject Moved|1|||
19620720|NCT00522379|42070548|FG002|Overall Study|Subject Moved|0|||
19620721|NCT00522379|42070549|FG003|Overall Study|Subject Moved|0|||
19620722|NCT00522379|42070550|FG004|Overall Study|Subject Moved|0|||
19620723|NCT00522379|42070546|FG000|Overall Study|Sponsor Request|0|||
19620724|NCT00522379|42070547|FG001|Overall Study|Sponsor Request|1|||
19620725|NCT00522379|42070548|FG002|Overall Study|Sponsor Request|0|||
19620726|NCT00522379|42070549|FG003|Overall Study|Sponsor Request|0|||
19620727|NCT00522379|42070550|FG004|Overall Study|Sponsor Request|0|||
19620728|NCT00522379|42070546|FG000|Overall Study|Family Problem|0|||
19620729|NCT00522379|42070547|FG001|Overall Study|Family Problem|0|||
19620730|NCT00522379|42070548|FG002|Overall Study|Family Problem|1|||
19620731|NCT00522379|42070549|FG003|Overall Study|Family Problem|0|||
19620732|NCT00522379|42070550|FG004|Overall Study|Family Problem|0|||
19620733|NCT00522379|42070546|FG000|Overall Study|Site Closed|0|||
19620734|NCT00522379|42070547|FG001|Overall Study|Site Closed|0|||
19620735|NCT00522379|42070548|FG002|Overall Study|Site Closed|0|||
19620736|NCT00522379|42070549|FG003|Overall Study|Site Closed|1|||
19620737|NCT00522379|42070550|FG004|Overall Study|Site Closed|0|||
19620738|NCT00522379|42070546|FG000|Overall Study|Subject Withdrawal|0|||
19620739|NCT00522379|42070547|FG001|Overall Study|Subject Withdrawal|0|||
19620740|NCT00522379|42070548|FG002|Overall Study|Subject Withdrawal|0|||
19620741|NCT00522379|42070549|FG003|Overall Study|Subject Withdrawal|1|||
19620742|NCT00522379|42070550|FG004|Overall Study|Subject Withdrawal|0|||
19620743|NCT00856830|42070566|FG000|Irinotecan & Bendamustine|Death|0|||
19620744|NCT00856830|42070567|FG001|Irinotecan & Bendamustine|Death|0|||
19620745|NCT00856830|42070568|FG002|Irinotecan & Bendamustine|Death|0|||
19620746|NCT00856830|42070569|FG003|Irinotecan & Bendamustine|Death|2|||
19620747|NCT00856830|42070566|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
19620748|NCT00856830|42070567|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
19620749|NCT00856830|42070568|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
19620750|NCT00856830|42070569|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
19620751|NCT00522301|42070574|FG000|Overall Study|Withdrawal by Subject|1|||
19620752|NCT00522301|42070574|FG000|Overall Study|Adverse Event|5|||
19620753|NCT00863928|42070580|FG000|Overall Study|Protocol Violation|26|||
19620754|NCT00863928|42070581|FG001|Overall Study|Protocol Violation|0|||
19620755|NCT00863928|42070580|FG000|Overall Study|Withdrawal by Subject|3|||
19620756|NCT00863928|42070581|FG001|Overall Study|Withdrawal by Subject|0|||
19620757|NCT00863928|42070580|FG000|Overall Study|surgery cancellation|4|||
19620758|NCT00863928|42070581|FG001|Overall Study|surgery cancellation|0|||
19620759|NCT00863928|42070580|FG000|Overall Study|medication allergy|3|||
19705422|NCT00419003|42149770|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
19705423|NCT00419003|42149771|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
19705424|NCT00419003|42149770|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
19705425|NCT00419003|42149771|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
19705426|NCT00418691|42149783|FG000|Overall Study|Lost to Follow-up|1|||
19705427|NCT00418691|42149784|FG001|Overall Study|Lost to Follow-up|2|||
19705428|NCT00418691|42149785|FG002|Overall Study|Lost to Follow-up|3|||
19705429|NCT00418691|42149783|FG000|Overall Study|Started new medication voiding entry|0|||
19705430|NCT00418691|42149784|FG001|Overall Study|Started new medication voiding entry|0|||
19705431|NCT00418691|42149785|FG002|Overall Study|Started new medication voiding entry|1|||
19705432|NCT00418691|42149783|FG000|Overall Study|Progressive Disease|1|||
19705433|NCT00418691|42149784|FG001|Overall Study|Progressive Disease|0|||
19705434|NCT00418691|42149785|FG002|Overall Study|Progressive Disease|1|||
19705435|NCT00412373|42149795|FG000|Overall Study|Adverse Event|8|||
19620760|NCT00863928|42070581|FG001|Overall Study|medication allergy|0|||
19620761|NCT00856518|42070589|FG000|Overall Study|Lost to Follow-up|4|||
19620762|NCT00856518|42070590|FG001|Overall Study|Lost to Follow-up|2|||
19620763|NCT00506389|42070601|FG000|In-treatment Period|Other|3|||
19620764|NCT00506389|42070602|FG001|In-treatment Period|Other|3|||
19620765|NCT00506389|42070603|FG002|In-treatment Period|Other|4|||
19620766|NCT00506389|42070601|FG000|In-treatment Period|Lost to Follow-up|0|||
19620767|NCT00506389|42070602|FG001|In-treatment Period|Lost to Follow-up|0|||
19620768|NCT00506389|42070603|FG002|In-treatment Period|Lost to Follow-up|1|||
19620769|NCT00506389|42070601|FG000|In-treatment Period|Lack of compliance|1|||
19620770|NCT00506389|42070602|FG001|In-treatment Period|Lack of compliance|0|||
19620771|NCT00506389|42070603|FG002|In-treatment Period|Lack of compliance|0|||
19620772|NCT00506389|42070601|FG000|In-treatment Period|Reasons not related to trial|4|||
19620773|NCT00506389|42070602|FG001|In-treatment Period|Reasons not related to trial|1|||
19705436|NCT00412373|42149796|FG001|Overall Study|Adverse Event|13|||
19705437|NCT00412373|42149795|FG000|Overall Study|Lack of Efficacy|16|||
19705438|NCT00412373|42149796|FG001|Overall Study|Lack of Efficacy|22|||
19705439|NCT00412373|42149795|FG000|Overall Study|Lost to Follow-up|7|||
19620774|NCT00506389|42070603|FG002|In-treatment Period|Reasons not related to trial|0|||
19620775|NCT00506389|42070601|FG000|In-treatment Period|Withdrawal by Subject|3|||
19620776|NCT00506389|42070602|FG001|In-treatment Period|Withdrawal by Subject|3|||
19620777|NCT00506389|42070603|FG002|In-treatment Period|Withdrawal by Subject|4|||
19620778|NCT00506389|42070601|FG000|In-treatment Period|Lack of Efficacy|0|||
19620779|NCT00506389|42070602|FG001|In-treatment Period|Lack of Efficacy|2|||
19620780|NCT00506389|42070603|FG002|In-treatment Period|Lack of Efficacy|0|||
19620781|NCT00506389|42070601|FG000|In-treatment Period|Adverse Event|11|||
19620782|NCT00506389|42070602|FG001|In-treatment Period|Adverse Event|5|||
19620783|NCT00506389|42070603|FG002|In-treatment Period|Adverse Event|2|||
19620784|NCT00506389|42070601|FG000|In-treatment Period|Randomized but not treated|4|||
19620785|NCT00506389|42070602|FG001|In-treatment Period|Randomized but not treated|1|||
19620786|NCT00506389|42070603|FG002|In-treatment Period|Randomized but not treated|1|||
19620787|NCT00871338|42070616|FG000|Prior to Booster|Withdrawal by Subject|1|||
19620788|NCT00871338|42070617|FG001|Prior to Booster|Withdrawal by Subject|3|||
19620789|NCT00871338|42070616|FG000|Prior to Booster|Lost to Follow-up|1|||
19620790|NCT00871338|42070617|FG001|Prior to Booster|Lost to Follow-up|0|||
19620791|NCT00824421|42070626|FG000|Overall Study|Adverse Event|6|||
19620792|NCT00824421|42070627|FG001|Overall Study|Adverse Event|6|||
19620793|NCT00824421|42070628|FG002|Overall Study|Adverse Event|6|||
19620794|NCT00824421|42070626|FG000|Overall Study|Death|0|||
19620795|NCT00824421|42070627|FG001|Overall Study|Death|1|||
19620796|NCT00824421|42070628|FG002|Overall Study|Death|0|||
19620797|NCT00824421|42070626|FG000|Overall Study|Lack of Efficacy|5|||
19620798|NCT00824421|42070627|FG001|Overall Study|Lack of Efficacy|7|||
19620799|NCT00824421|42070628|FG002|Overall Study|Lack of Efficacy|4|||
19620800|NCT00824421|42070626|FG000|Overall Study|Lost to Follow-up|2|||
19620801|NCT00824421|42070627|FG001|Overall Study|Lost to Follow-up|3|||
19620802|NCT00824421|42070628|FG002|Overall Study|Lost to Follow-up|0|||
19620803|NCT00824421|42070626|FG000|Overall Study|Pregnancy|1|||
19620804|NCT00824421|42070627|FG001|Overall Study|Pregnancy|0|||
19620805|NCT00824421|42070628|FG002|Overall Study|Pregnancy|1|||
19620806|NCT00824421|42070626|FG000|Overall Study|Withdrawal by Subject|2|||
19620807|NCT00824421|42070627|FG001|Overall Study|Withdrawal by Subject|3|||
19620808|NCT00824421|42070628|FG002|Overall Study|Withdrawal by Subject|3|||
19620809|NCT00824421|42070626|FG000|Overall Study|Randomized but not Treated|1|||
19620810|NCT00824421|42070627|FG001|Overall Study|Randomized but not Treated|1|||
19620811|NCT00824421|42070628|FG002|Overall Study|Randomized but not Treated|0|||
19620812|NCT00824421|42070626|FG000|Overall Study|Other|0|||
19620813|NCT00824421|42070627|FG001|Overall Study|Other|1|||
19620814|NCT00824421|42070628|FG002|Overall Study|Other|0|||
19620815|NCT00514813|42070642|FG000|Overall Study|Study terminated|14|||
19620816|NCT00514813|42070643|FG001|Overall Study|Study terminated|74|||
19620817|NCT00514813|42070644|FG002|Overall Study|Study terminated|40|||
19620818|NCT00514813|42070645|FG003|Overall Study|Study terminated|2|||
19620819|NCT00514813|42070642|FG000|Overall Study|Adverse Event|0|||
19620820|NCT00514813|42070643|FG001|Overall Study|Adverse Event|2|||
19620821|NCT00514813|42070644|FG002|Overall Study|Adverse Event|2|||
19620822|NCT00514813|42070645|FG003|Overall Study|Adverse Event|0|||
19620823|NCT00514813|42070642|FG000|Overall Study|Protocol Violation|1|||
19620824|NCT00514813|42070643|FG001|Overall Study|Protocol Violation|0|||
19620825|NCT00514813|42070644|FG002|Overall Study|Protocol Violation|0|||
19620826|NCT00514813|42070645|FG003|Overall Study|Protocol Violation|0|||
19620827|NCT00514813|42070642|FG000|Overall Study|Withdrawal by Subject|0|||
19620828|NCT00514813|42070643|FG001|Overall Study|Withdrawal by Subject|1|||
19620829|NCT00514813|42070644|FG002|Overall Study|Withdrawal by Subject|0|||
19620830|NCT00514813|42070645|FG003|Overall Study|Withdrawal by Subject|0|||
19620831|NCT00514813|42070642|FG000|Overall Study|Lack of Efficacy|0|||
19620832|NCT00514813|42070643|FG001|Overall Study|Lack of Efficacy|1|||
19620833|NCT00514813|42070644|FG002|Overall Study|Lack of Efficacy|0|||
19620834|NCT00514813|42070645|FG003|Overall Study|Lack of Efficacy|0|||
19620835|NCT00514813|42070642|FG000|Overall Study|Kidney transplant|0|||
19620836|NCT00514813|42070643|FG001|Overall Study|Kidney transplant|6|||
19620837|NCT00514813|42070644|FG002|Overall Study|Kidney transplant|2|||
19620838|NCT00514813|42070645|FG003|Overall Study|Kidney transplant|0|||
19620839|NCT00514813|42070642|FG000|Overall Study|Death|0|||
19620840|NCT00514813|42070643|FG001|Overall Study|Death|2|||
19620841|NCT00514813|42070644|FG002|Overall Study|Death|3|||
19620842|NCT00514813|42070645|FG003|Overall Study|Death|2|||
19620843|NCT00597116|42070657|FG000|Overall Study|Adverse Event|2|||
19620844|NCT00597116|42070658|FG001|Overall Study|Adverse Event|1|||
19620845|NCT00597116|42070657|FG000|Overall Study|Withdrawal by Subject|0|||
19620846|NCT00597116|42070658|FG001|Overall Study|Withdrawal by Subject|2|||
19620847|NCT00597116|42070657|FG000|Overall Study|Physician Decision|0|||
19620848|NCT00597116|42070658|FG001|Overall Study|Physician Decision|1|||
19620849|NCT00597116|42070657|FG000|Overall Study|Death|0|||
19620850|NCT00597116|42070658|FG001|Overall Study|Death|1|||
19620851|NCT00597116|42070657|FG000|Overall Study|Lost to Follow-up|1|||
19620852|NCT00597116|42070658|FG001|Overall Study|Lost to Follow-up|0|||
19620853|NCT00597116|42070657|FG000|Overall Study|Progressive disease|11|||
19620854|NCT00597116|42070658|FG001|Overall Study|Progressive disease|6|||
19620855|NCT00514735|42070666|FG000|Overall Study|Withdrawal by Subject|13|||
19620856|NCT00514735|42070667|FG001|Overall Study|Withdrawal by Subject|5|||
19620857|NCT00514735|42070666|FG000|Overall Study|Death|1|||
19620858|NCT00514735|42070667|FG001|Overall Study|Death|0|||
19620859|NCT00514735|42070666|FG000|Overall Study|Lost to Follow-up|0|||
19620860|NCT00514735|42070667|FG001|Overall Study|Lost to Follow-up|1|||
19620861|NCT03252587|42070679|FG000|Overall Study|Adverse Event|3|||
19705440|NCT00412373|42149796|FG001|Overall Study|Lost to Follow-up|13|||
19705441|NCT00412373|42149795|FG000|Overall Study|Withdrawal by Subject|8|||
19705442|NCT00412373|42149796|FG001|Overall Study|Withdrawal by Subject|27|||
19705443|NCT00412373|42149795|FG000|Overall Study|Other|2|||
19705444|NCT00412373|42149796|FG001|Overall Study|Other|2|||
19705445|NCT00418379|42149805|FG000|Year 1|Adverse Event|9|||
19705446|NCT00418379|42149806|FG001|Year 1|Adverse Event|15|||
19705447|NCT00418379|42149807|FG002|Year 1|Adverse Event|3|||
19705448|NCT00418379|42149805|FG000|Year 1|Withdrawal by Subject|7|||
19705449|NCT00418379|42149806|FG001|Year 1|Withdrawal by Subject|8|||
19705450|NCT00418379|42149807|FG002|Year 1|Withdrawal by Subject|5|||
19705451|NCT00418379|42149805|FG000|Year 1|Any other reason not above-mentioned|2|||
19705452|NCT00418379|42149806|FG001|Year 1|Any other reason not above-mentioned|5|||
19705453|NCT00418379|42149807|FG002|Year 1|Any other reason not above-mentioned|7|||
19705454|NCT00418379|42149805|FG000|Year 2|Adverse Event|5|||
19705455|NCT00418379|42149806|FG001|Year 2|Adverse Event|2|||
19705456|NCT00418379|42149807|FG002|Year 2|Adverse Event|1|||
19705457|NCT00418379|42149805|FG000|Year 2|Withdrawal by Subject|1|||
19705458|NCT00418379|42149806|FG001|Year 2|Withdrawal by Subject|1|||
19705459|NCT00418379|42149807|FG002|Year 2|Withdrawal by Subject|3|||
19705460|NCT00418379|42149805|FG000|Year 2|Any other reason not above-mentioned|2|||
19705461|NCT00418379|42149806|FG001|Year 2|Any other reason not above-mentioned|1|||
19705462|NCT00418379|42149807|FG002|Year 2|Any other reason not above-mentioned|6|||
19705463|NCT00418379|42149805|FG000|Year 3|Withdrawal by Subject|1|||
19705464|NCT00418379|42149806|FG001|Year 3|Withdrawal by Subject|1|||
19705465|NCT00418379|42149807|FG002|Year 3|Withdrawal by Subject|2|||
19705466|NCT00418379|42149805|FG000|Year 3|Any other reason not above-mentioned|2|||
19705467|NCT00418379|42149806|FG001|Year 3|Any other reason not above-mentioned|1|||
19705468|NCT00418379|42149807|FG002|Year 3|Any other reason not above-mentioned|1|||
19705469|NCT00418379|42149805|FG000|Year 4|Adverse Event|0|||
19705470|NCT00418379|42149806|FG001|Year 4|Adverse Event|1|||
19705471|NCT00418379|42149807|FG002|Year 4|Adverse Event|0|||
19705472|NCT00418379|42149805|FG000|Year 4|Withdrawal by Subject|2|||
19705473|NCT00418379|42149806|FG001|Year 4|Withdrawal by Subject|3|||
19705474|NCT00418379|42149807|FG002|Year 4|Withdrawal by Subject|2|||
19705475|NCT00418379|42149805|FG000|Year 4|Any other reason not above-mentioned|1|||
19705476|NCT00418379|42149806|FG001|Year 4|Any other reason not above-mentioned|1|||
19705477|NCT00418379|42149807|FG002|Year 4|Any other reason not above-mentioned|0|||
19705478|NCT00418379|42149805|FG000|Year 5|Adverse Event|0|||
19517594|NCT01533714|41930561|FG004|Overall Study|Withdrawal criteria|3|||
19517595|NCT01533714|41930562|FG005|Overall Study|Withdrawal criteria|1|||
19517596|NCT01533714|41930557|FG000|Overall Study|Ineligibility reason|0|||
19517597|NCT01533714|41930558|FG001|Overall Study|Ineligibility reason|0|||
19517598|NCT01533714|41930559|FG002|Overall Study|Ineligibility reason|0|||
19517599|NCT01533714|41930560|FG003|Overall Study|Ineligibility reason|1|||
19705479|NCT00418379|42149806|FG001|Year 5|Adverse Event|1|||
19705480|NCT00418379|42149807|FG002|Year 5|Adverse Event|0|||
19705481|NCT00418379|42149805|FG000|Year 5|Any other reason not above-mentioned|2|||
19705482|NCT00418379|42149806|FG001|Year 5|Any other reason not above-mentioned|4|||
19705483|NCT00418379|42149807|FG002|Year 5|Any other reason not above-mentioned|3|||
19705484|NCT00418145|42149815|FG000|Overall Study|study terminated|6|||
19705485|NCT00417989|42149823|FG000|Overall Study|Withdrawal by Subject|13|||
19705486|NCT00417989|42149824|FG001|Overall Study|Withdrawal by Subject|13|||
19705487|NCT00417989|42149823|FG000|Overall Study|Lost to Follow-up|1|||
19517600|NCT01533714|41930561|FG004|Overall Study|Ineligibility reason|0|||
19517601|NCT01533714|41930562|FG005|Overall Study|Ineligibility reason|0|||
19620862|NCT03252587|42070680|FG001|Overall Study|Adverse Event|8|||
19705488|NCT00417989|42149824|FG001|Overall Study|Lost to Follow-up|6|||
19705489|NCT00417989|42149823|FG000|Overall Study|Protocol Violation|1|||
19705490|NCT00417989|42149824|FG001|Overall Study|Protocol Violation|0|||
19705491|NCT00417989|42149823|FG000|Overall Study|Death|0|||
19705492|NCT00417989|42149824|FG001|Overall Study|Death|1|||
19705493|NCT00417989|42149823|FG000|Overall Study|Physician Decision|5|||
19705494|NCT00417989|42149824|FG001|Overall Study|Physician Decision|2|||
19705495|NCT00412217|42149834|FG000|Overall Study|Insufficient Data Available|8|||
19705496|NCT00412217|42149835|FG001|Overall Study|Insufficient Data Available|3|||
19705497|NCT00412217|42149834|FG000|Overall Study|Death|5|||
19705498|NCT00412217|42149835|FG001|Overall Study|Death|4|||
19705499|NCT00412217|42149834|FG000|Overall Study|Disease Progression|2|||
19705500|NCT00412217|42149835|FG001|Overall Study|Disease Progression|3|||
19705501|NCT00412217|42149834|FG000|Overall Study|Investigator Decision|1|||
19620863|NCT03252587|42070681|FG002|Overall Study|Adverse Event|6|||
19620864|NCT03252587|42070682|FG003|Overall Study|Adverse Event|12|||
19620865|NCT03252587|42070679|FG000|Overall Study|Lack of Efficacy|7|||
19620866|NCT03252587|42070680|FG001|Overall Study|Lack of Efficacy|2|||
19620867|NCT03252587|42070681|FG002|Overall Study|Lack of Efficacy|2|||
19620868|NCT03252587|42070682|FG003|Overall Study|Lack of Efficacy|4|||
19620869|NCT03252587|42070679|FG000|Overall Study|Lost to Follow-up|2|||
19620870|NCT03252587|42070680|FG001|Overall Study|Lost to Follow-up|0|||
19620871|NCT03252587|42070681|FG002|Overall Study|Lost to Follow-up|0|||
19620872|NCT03252587|42070682|FG003|Overall Study|Lost to Follow-up|2|||
19620873|NCT03252587|42070679|FG000|Overall Study|Pregnancy|2|||
19620874|NCT03252587|42070680|FG001|Overall Study|Pregnancy|1|||
19620875|NCT03252587|42070681|FG002|Overall Study|Pregnancy|0|||
19620876|NCT03252587|42070682|FG003|Overall Study|Pregnancy|1|||
19620877|NCT03252587|42070679|FG000|Overall Study|Withdrawal by Subject|8|||
19620878|NCT03252587|42070680|FG001|Overall Study|Withdrawal by Subject|4|||
19620879|NCT03252587|42070681|FG002|Overall Study|Withdrawal by Subject|4|||
19620880|NCT03252587|42070682|FG003|Overall Study|Withdrawal by Subject|4|||
19620881|NCT03252587|42070679|FG000|Overall Study|Other Reasons|2|||
19620882|NCT03252587|42070680|FG001|Overall Study|Other Reasons|5|||
19620883|NCT03252587|42070681|FG002|Overall Study|Other Reasons|5|||
19620884|NCT03252587|42070682|FG003|Overall Study|Other Reasons|4|||
19620885|NCT00511147|42070695|FG000|Overall Study|Withdrawal by Subject|1|||
19620886|NCT00511147|42070695|FG000|Overall Study|Disease progression|5|||
19620887|NCT00511147|42070695|FG000|Overall Study|Required platelet transfusion|1|||
19620888|NCT00510835|42070702|FG000|Overall Study|Withdrawal by Subject|6|||
19620889|NCT00510835|42070703|FG001|Overall Study|Withdrawal by Subject|2|||
19620890|NCT00510835|42070704|FG002|Overall Study|Withdrawal by Subject|2|||
19620891|NCT00506077|42070714|FG000|Treatment Period 1|Adverse Event|2|||
19620892|NCT00506077|42070715|FG001|Treatment Period 1|Adverse Event|1|||
19620893|NCT00506077|42070714|FG000|Treatment Period 1|Lost to Follow-up|0|||
19620894|NCT00506077|42070715|FG001|Treatment Period 1|Lost to Follow-up|2|||
19620895|NCT00506077|42070714|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19620896|NCT00506077|42070715|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19620897|NCT00506077|42070714|FG000|Treatment Period 2|Adverse Event|0|||
19620898|NCT00506077|42070715|FG001|Treatment Period 2|Adverse Event|1|||
19620899|NCT00506077|42070714|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19620900|NCT00506077|42070715|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19620901|NCT00505921|42070721|FG000|Overall Study|Ineligible|1|||
19620902|NCT00505921|42070721|FG000|Overall Study|Failed to Mobilize|8|||
19620903|NCT00596960|42070727|FG000|Overall Study|Death|1|||
19620904|NCT00596960|42070728|FG001|Overall Study|Death|2|||
19620905|NCT00596960|42070727|FG000|Overall Study|Lost to Follow-up|6|||
19620906|NCT00596960|42070728|FG001|Overall Study|Lost to Follow-up|5|||
19620907|NCT00596960|42070727|FG000|Overall Study|Withdrawal by Subject|1|||
19620908|NCT00596960|42070728|FG001|Overall Study|Withdrawal by Subject|0|||
19620909|NCT00596960|42070727|FG000|Overall Study|Incarcerated|2|||
19620910|NCT00596960|42070728|FG001|Overall Study|Incarcerated|0|||
19705502|NCT00412217|42149835|FG001|Overall Study|Investigator Decision|0|||
19394227|NCT01371981|41638302|FG001|Overall Study|Did not start treatment|3|||
19394228|NCT01371981|41638303|FG002|Overall Study|Did not start treatment|0|||
19517602|NCT01533246|41930576|FG000|Overall Study|Adverse Event|1|||
19517603|NCT01533246|41930576|FG000|Overall Study|Withdrawal by Subject|1|||
19517604|NCT01579578|41930582|FG000|Overall Study|Death|4|||
19517605|NCT01579578|41930583|FG001|Overall Study|Death|1|||
19517606|NCT01579578|41930582|FG000|Overall Study|Lost to Follow-up|1|||
19517607|NCT01579578|41930583|FG001|Overall Study|Lost to Follow-up|1|||
19517608|NCT01579578|41930582|FG000|Overall Study|Withdrawal by Subject|2|||
19517609|NCT01579578|41930583|FG001|Overall Study|Withdrawal by Subject|1|||
19517610|NCT01579578|41930582|FG000|Overall Study|Eligibility criteria|3|||
19517611|NCT01579578|41930583|FG001|Overall Study|Eligibility criteria|9|||
19517612|NCT01579578|41930582|FG000|Overall Study|Ongoing|3|||
19517613|NCT01579578|41930583|FG001|Overall Study|Ongoing|0|||
19517614|NCT01578486|41930589|FG000|Overall Study|Physician Decision|3|||
19620911|NCT00596960|42070727|FG000|Overall Study|Physician Decision|1|||
19620912|NCT00596960|42070728|FG001|Overall Study|Physician Decision|0|||
19620913|NCT00596960|42070727|FG000|Overall Study|Protocol Violation|0|||
19620914|NCT00596960|42070728|FG001|Overall Study|Protocol Violation|1|||
19620915|NCT00596960|42070727|FG000|Overall Study|No alcohol use data|0|||
19620916|NCT00596960|42070728|FG001|Overall Study|No alcohol use data|1|||
19620917|NCT00505765|42070737|FG000|Overall Study|Withdrawal by Subject|1|||
19620918|NCT00505765|42070738|FG001|Overall Study|Withdrawal by Subject|0|||
19517615|NCT01578486|41930589|FG000|Overall Study|Withdrawal by Subject|2|||
19620919|NCT00505765|42070739|FG002|Overall Study|Withdrawal by Subject|0|||
19620920|NCT00505765|42070737|FG000|Overall Study|Adverse Event|1|||
19620921|NCT00505765|42070738|FG001|Overall Study|Adverse Event|2|||
19620922|NCT00505765|42070739|FG002|Overall Study|Adverse Event|0|||
19705503|NCT00412217|42149834|FG000|Overall Study|Withdrawal by Subject|2|||
19517616|NCT01532934|41930595|FG000|Overall Study|Lost to Follow-up|11|||
19517617|NCT01532934|41930596|FG001|Overall Study|Lost to Follow-up|11|||
19620923|NCT00505765|42070737|FG000|Overall Study|Noncompliance|0|||
19620924|NCT00505765|42070738|FG001|Overall Study|Noncompliance|1|||
19620925|NCT00505765|42070739|FG002|Overall Study|Noncompliance|3|||
19620926|NCT00505687|42070747|FG000|Overall Study|Important protocol violation|2|||
19620927|NCT00505687|42070747|FG000|Overall Study|Lack of Efficacy|15|||
19620928|NCT00505687|42070747|FG000|Overall Study|Adverse Event|48|||
19620929|NCT00505687|42070747|FG000|Overall Study|Subject withdrew consent|15|||
19620930|NCT00505687|42070747|FG000|Overall Study|Lost to Follow-up|1|||
19620931|NCT00505687|42070747|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
19620932|NCT00505687|42070747|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
19620933|NCT00505687|42070747|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
19620934|NCT00505687|42070747|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
19620935|NCT00505687|42070747|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
19620936|NCT00505687|42070747|FG000|Overall Study|Other: Disease Progression|1|||
19620937|NCT00505687|42070747|FG000|Overall Study|Other: As Per Sponsor|8|||
19620938|NCT00505375|42070753|FG000|Overall Study|Death|1|||
19620939|NCT00505375|42070754|FG001|Overall Study|Death|0|||
19620940|NCT00505375|42070753|FG000|Overall Study|Withdrawal by Subject|2|||
19620941|NCT00505375|42070754|FG001|Overall Study|Withdrawal by Subject|2|||
19620942|NCT00505375|42070753|FG000|Overall Study|Lost to Follow-up|0|||
19620943|NCT00505375|42070754|FG001|Overall Study|Lost to Follow-up|2|||
19620944|NCT00505375|42070753|FG000|Overall Study|Pregnancy|1|||
19620945|NCT00505375|42070754|FG001|Overall Study|Pregnancy|0|||
19517618|NCT01532934|41930595|FG000|Overall Study|In controlled environment|3|||
19517619|NCT01532934|41930596|FG001|Overall Study|In controlled environment|2|||
19517620|NCT01532388|41930606|FG000|3-month Follow-up|Lost to Follow-up|68|||
19517621|NCT01532388|41930607|FG001|3-month Follow-up|Lost to Follow-up|68|||
19517622|NCT01532388|41930606|FG000|6-month Follow-up|Lost to Follow-up|74|||
19517623|NCT01532388|41930607|FG001|6-month Follow-up|Lost to Follow-up|66|||
19517624|NCT01532388|41930606|FG000|12-month Follow-up|Lost to Follow-up|69|||
19517625|NCT01532388|41930607|FG001|12-month Follow-up|Lost to Follow-up|67|||
19517626|NCT01555164|41930615|FG000|Overall Study|Adverse Event|5|||
19517627|NCT01555164|41930616|FG001|Overall Study|Adverse Event|7|||
19517628|NCT01555164|41930615|FG000|Overall Study|Hyperglycemia|0|||
19517629|NCT01555164|41930616|FG001|Overall Study|Hyperglycemia|1|||
19517630|NCT01555164|41930615|FG000|Overall Study|Investigator's Discretion|2|||
19517631|NCT01555164|41930616|FG001|Overall Study|Investigator's Discretion|2|||
19517632|NCT01555164|41930615|FG000|Overall Study|Lost to Follow-up|4|||
19517633|NCT01555164|41930616|FG001|Overall Study|Lost to Follow-up|3|||
19517634|NCT01555164|41930615|FG000|Overall Study|Protocol Violation|9|||
19517635|NCT01555164|41930616|FG001|Overall Study|Protocol Violation|5|||
19517636|NCT01555164|41930615|FG000|Overall Study|Subject Non-compliance|14|||
19517637|NCT01555164|41930616|FG001|Overall Study|Subject Non-compliance|6|||
19517638|NCT01555164|41930615|FG000|Overall Study|Subject Withdrew Consent|6|||
19517639|NCT01555164|41930616|FG001|Overall Study|Subject Withdrew Consent|11|||
19517640|NCT01578330|41930622|FG000|Overall Study|Adverse Event|2|||
19517641|NCT01578330|41930622|FG000|Overall Study|Protocol Violation|5|||
19620946|NCT00505375|42070753|FG000|Overall Study|Travel issues|0|||
19620947|NCT00505375|42070754|FG001|Overall Study|Travel issues|1|||
19620948|NCT00594932|42070762|FG000|First 3 Months|Withdrawal by Subject|1|||
19620949|NCT00594932|42070763|FG001|First 3 Months|Withdrawal by Subject|3|||
19620950|NCT00594932|42070762|FG000|Final 3 Months|Withdrawal by Subject|4|||
19620951|NCT00594932|42070763|FG001|Final 3 Months|Withdrawal by Subject|3|||
19620952|NCT00504829|42070772|FG000|Overall Study|Protocol Violation|6|||
19620953|NCT00504829|42070773|FG001|Overall Study|Protocol Violation|4|||
19620954|NCT00504829|42070774|FG002|Overall Study|Protocol Violation|10|||
19620955|NCT00504595|42070786|FG000|Overall Study|Lack of Efficacy|1|||
19620956|NCT00504595|42070787|FG001|Overall Study|Lack of Efficacy|0|||
19620957|NCT00504595|42070788|FG002|Overall Study|Lack of Efficacy|0|||
19620958|NCT00504595|42070789|FG003|Overall Study|Lack of Efficacy|0|||
19620959|NCT00504595|42070786|FG000|Overall Study|Other|0|||
19620960|NCT00504595|42070787|FG001|Overall Study|Other|0|||
19620961|NCT00504595|42070788|FG002|Overall Study|Other|2|||
19620962|NCT00504595|42070789|FG003|Overall Study|Other|0|||
19620963|NCT00513409|42070801|FG000|Overall Study|Adverse Event|0|||
19620964|NCT00513409|42070802|FG001|Overall Study|Adverse Event|1|||
19620965|NCT00513409|42070801|FG000|Overall Study|Withdrawal by Subject|0|||
19620966|NCT00513409|42070802|FG001|Overall Study|Withdrawal by Subject|2|||
19620967|NCT00513409|42070801|FG000|Overall Study|Lost to Follow-up|0|||
19620968|NCT00513409|42070802|FG001|Overall Study|Lost to Follow-up|1|||
19620969|NCT00513409|42070801|FG000|Overall Study|Physician Decision|1|||
19620970|NCT00513409|42070802|FG001|Overall Study|Physician Decision|0|||
19620971|NCT00513409|42070801|FG000|Overall Study|Visit 3 not done|1|||
19620972|NCT00513409|42070802|FG001|Overall Study|Visit 3 not done|2|||
19620973|NCT03150095|42070810|FG000|Overall Study|Death|0|||
19620974|NCT03150095|42070811|FG001|Overall Study|Death|1|||
19620975|NCT03150095|42070810|FG000|Overall Study|Lost to Follow-up|1|||
19620976|NCT03150095|42070811|FG001|Overall Study|Lost to Follow-up|1|||
19620977|NCT03150095|42070810|FG000|Overall Study|Withdrawal by Subject|4|||
19620978|NCT03150095|42070811|FG001|Overall Study|Withdrawal by Subject|0|||
19620979|NCT03150095|42070810|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
19620980|NCT03150095|42070811|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
19620981|NCT00705016|42070820|FG000|Overall Study|Adverse Event|6|||
19620982|NCT00705016|42070821|FG001|Overall Study|Adverse Event|11|||
19620983|NCT00705016|42070822|FG002|Overall Study|Adverse Event|10|||
19620984|NCT00705016|42070820|FG000|Overall Study|Death|5|||
19620985|NCT00705016|42070821|FG001|Overall Study|Death|7|||
19620986|NCT00705016|42070822|FG002|Overall Study|Death|5|||
19620987|NCT00705016|42070820|FG000|Overall Study|Protocol Violation|0|||
19620988|NCT00705016|42070821|FG001|Overall Study|Protocol Violation|1|||
19620989|NCT00705016|42070822|FG002|Overall Study|Protocol Violation|1|||
19620990|NCT00705016|42070820|FG000|Overall Study|Withdrawal by Subject|4|||
19620991|NCT00705016|42070821|FG001|Overall Study|Withdrawal by Subject|3|||
19620992|NCT00705016|42070822|FG002|Overall Study|Withdrawal by Subject|2|||
19620993|NCT00705016|42070820|FG000|Overall Study|Progressive Disease|33|||
19620994|NCT00705016|42070821|FG001|Overall Study|Progressive Disease|29|||
19620995|NCT00705016|42070822|FG002|Overall Study|Progressive Disease|33|||
19620996|NCT00705016|42070820|FG000|Overall Study|Symptomatic Deterioration|3|||
19620997|NCT00705016|42070821|FG001|Overall Study|Symptomatic Deterioration|1|||
19705504|NCT00412217|42149835|FG001|Overall Study|Withdrawal by Subject|0|||
19705505|NCT00412217|42149834|FG000|Overall Study|Lost to Follow-up|1|||
19705506|NCT00412217|42149835|FG001|Overall Study|Lost to Follow-up|4|||
19705507|NCT00412217|42149834|FG000|Overall Study|Study Terminated by Sponsor|26|||
19705508|NCT00412217|42149835|FG001|Overall Study|Study Terminated by Sponsor|33|||
19705509|NCT00412217|42149834|FG000|Overall Study|Other|1|||
19705510|NCT00412217|42149835|FG001|Overall Study|Other|1|||
19705511|NCT05000164|42149841|FG000|Overall Study|Adverse Event|1|||
19705512|NCT05000164|42149841|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
19705513|NCT05000164|42149841|FG000|Overall Study|Lens Discomfort|3|||
19620998|NCT00705016|42070822|FG002|Overall Study|Symptomatic Deterioration|1|||
19620999|NCT00705016|42070820|FG000|Overall Study|Other|9|||
19621000|NCT00705016|42070821|FG001|Overall Study|Other|6|||
19621001|NCT00705016|42070822|FG002|Overall Study|Other|6|||
19621002|NCT00595868|42070832|FG000|Overall Study|Lost to Follow-up|45|||
19705514|NCT05000164|42149841|FG000|Overall Study|Withdrew Consent during Study|2|||
19621003|NCT00595868|42070833|FG001|Overall Study|Lost to Follow-up|50|||
19621004|NCT00856284|42070863|FG000|Overall Study|Hyperglycemic rescue|231|||
19621005|NCT00856284|42070864|FG001|Overall Study|Hyperglycemic rescue|201|||
19621006|NCT00856284|42070865|FG002|Overall Study|Hyperglycemic rescue|235|||
19621007|NCT00856284|42070863|FG000|Overall Study|Adverse Event|60|||
19621008|NCT00856284|42070864|FG001|Overall Study|Adverse Event|74|||
19621009|NCT00856284|42070865|FG002|Overall Study|Adverse Event|82|||
19621010|NCT00856284|42070863|FG000|Overall Study|Major protocol deviation|24|||
19621011|NCT00856284|42070864|FG001|Overall Study|Major protocol deviation|16|||
19621012|NCT00856284|42070865|FG002|Overall Study|Major protocol deviation|15|||
19621013|NCT00856284|42070863|FG000|Overall Study|Lost to Follow-up|20|||
19621014|NCT00856284|42070864|FG001|Overall Study|Lost to Follow-up|22|||
19621015|NCT00856284|42070865|FG002|Overall Study|Lost to Follow-up|28|||
19621016|NCT00856284|42070863|FG000|Overall Study|Voluntary withdrawal|48|||
19621017|NCT00856284|42070864|FG001|Overall Study|Voluntary withdrawal|52|||
19621018|NCT00856284|42070865|FG002|Overall Study|Voluntary withdrawal|62|||
19621019|NCT00856284|42070863|FG000|Overall Study|Pregnancy|1|||
19621020|NCT00856284|42070864|FG001|Overall Study|Pregnancy|2|||
19621021|NCT00856284|42070865|FG002|Overall Study|Pregnancy|0|||
19621022|NCT00856284|42070863|FG000|Overall Study|Investigator discretion|9|||
19621023|NCT00856284|42070864|FG001|Overall Study|Investigator discretion|8|||
19621024|NCT00856284|42070865|FG002|Overall Study|Investigator discretion|10|||
19621025|NCT00856284|42070863|FG000|Overall Study|Other|15|||
19621026|NCT00856284|42070864|FG001|Overall Study|Other|17|||
19705515|NCT05000164|42149841|FG000|Overall Study|Subject Withdrawn by PI|2|||
19705516|NCT05000164|42149841|FG000|Overall Study|Other Fractured Test Article|1|||
19705517|NCT00123474|42149849|FG000|Randomized to Treatment|Randomized, never treated|1|||
19705518|NCT00123474|42149850|FG001|Randomized to Treatment|Randomized, never treated|4|||
19705519|NCT00123474|42149851|FG002|Randomized to Treatment|Randomized, never treated|2|||
19705520|NCT00123474|42149852|FG003|Randomized to Treatment|Randomized, never treated|1|||
19705521|NCT00123474|42149849|FG000|As Treated at Study Closure|not reported when site closed|1|||
19705522|NCT00123474|42149850|FG001|As Treated at Study Closure|not reported when site closed|0|||
19705523|NCT00123474|42149851|FG002|As Treated at Study Closure|not reported when site closed|1|||
19705524|NCT00123474|42149852|FG003|As Treated at Study Closure|not reported when site closed|0|||
19705525|NCT00123474|42149849|FG000|As Treated at Study Closure|Adverse Event|10|||
19705526|NCT00123474|42149850|FG001|As Treated at Study Closure|Adverse Event|4|||
19705527|NCT00123474|42149851|FG002|As Treated at Study Closure|Adverse Event|10|||
19705528|NCT00123474|42149852|FG003|As Treated at Study Closure|Adverse Event|8|||
19705529|NCT00123474|42149849|FG000|As Treated at Study Closure|Disease Progression|35|||
19705530|NCT00123474|42149850|FG001|As Treated at Study Closure|Disease Progression|42|||
19705531|NCT00123474|42149851|FG002|As Treated at Study Closure|Disease Progression|29|||
19705532|NCT00123474|42149852|FG003|As Treated at Study Closure|Disease Progression|27|||
19705533|NCT00123474|42149849|FG000|As Treated at Study Closure|Investigator Request|12|||
19705534|NCT00123474|42149850|FG001|As Treated at Study Closure|Investigator Request|6|||
19705535|NCT00123474|42149851|FG002|As Treated at Study Closure|Investigator Request|7|||
19705536|NCT00123474|42149852|FG003|As Treated at Study Closure|Investigator Request|5|||
19705537|NCT00123474|42149849|FG000|As Treated at Study Closure|non-specified|54|||
19705538|NCT00123474|42149850|FG001|As Treated at Study Closure|non-specified|47|||
19705539|NCT00123474|42149851|FG002|As Treated at Study Closure|non-specified|57|||
19705540|NCT00123474|42149852|FG003|As Treated at Study Closure|non-specified|60|||
19705541|NCT00123474|42149849|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
19705542|NCT00123474|42149850|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
19705543|NCT00123474|42149851|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
19621027|NCT00856284|42070865|FG002|Overall Study|Other|14|||
19621028|NCT00856284|42070863|FG000|Overall Study|Randomized in error|0|||
19621029|NCT00856284|42070864|FG001|Overall Study|Randomized in error|0|||
19621030|NCT00856284|42070865|FG002|Overall Study|Randomized in error|1|||
19621031|NCT00510289|42070873|FG000|Overall Study|Withdrawal by Subject|7|||
19621032|NCT00510289|42070873|FG000|Overall Study|Refused bone marrow biopsy|2|||
19621033|NCT00510289|42070873|FG000|Overall Study|Lost to Follow-up|1|||
19621034|NCT00510289|42070873|FG000|Overall Study|Progressed prior to starting drug|2|||
19621035|NCT00492115|42070880|FG000|Overall Study|Withdrawal by Subject|3|||
19621036|NCT00492115|42070881|FG001|Overall Study|Withdrawal by Subject|4|||
19621037|NCT00856206|42070889|FG000|Overall Study|Protocol Violation|6|||
19621038|NCT00856206|42070890|FG001|Overall Study|Protocol Violation|18|||
19705544|NCT00123474|42149852|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
19705545|NCT00123474|42149849|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
19705546|NCT00123474|42149850|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
19705547|NCT00123474|42149851|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
19705548|NCT00123474|42149852|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
19517642|NCT01577160|41930626|FG000|Overall Study|Adverse Event|9|||
19621039|NCT00856206|42070889|FG000|Overall Study|Adverse Event|10|||
19621040|NCT00856206|42070890|FG001|Overall Study|Adverse Event|46|||
19621041|NCT00856206|42070889|FG000|Overall Study|Lack of Efficacy|1|||
19621042|NCT00856206|42070890|FG001|Overall Study|Lack of Efficacy|2|||
19621043|NCT00856206|42070889|FG000|Overall Study|Withdrawal by Subject|15|||
19621044|NCT00856206|42070890|FG001|Overall Study|Withdrawal by Subject|36|||
19621045|NCT00856206|42070889|FG000|Overall Study|Lost to Follow-up|13|||
19621046|NCT00856206|42070890|FG001|Overall Study|Lost to Follow-up|39|||
19621047|NCT00856206|42070889|FG000|Overall Study|Death|2|||
19621048|NCT00856206|42070890|FG001|Overall Study|Death|2|||
19621049|NCT00856206|42070889|FG000|Overall Study|Decision by the Sponsor|4|||
19621050|NCT00856206|42070890|FG001|Overall Study|Decision by the Sponsor|8|||
19621051|NCT00856206|42070889|FG000|Overall Study|Other than specified above|3|||
19621052|NCT00856206|42070890|FG001|Overall Study|Other than specified above|10|||
19621053|NCT00593112|42070898|FG000|Overall Study|Scan Anxiety|3|||
19621054|NCT00593112|42070899|FG001|Overall Study|Scan Anxiety|0|||
19621055|NCT00593112|42070898|FG000|Overall Study|Abnormal Scan|1|||
19621056|NCT00593112|42070899|FG001|Overall Study|Abnormal Scan|0|||
19621057|NCT00593112|42070898|FG000|Overall Study|Unreadable Scan|1|||
19621058|NCT00593112|42070899|FG001|Overall Study|Unreadable Scan|0|||
19621059|NCT00593112|42070898|FG000|Overall Study|Withdrawal by Subject|5|||
19621060|NCT00593112|42070899|FG001|Overall Study|Withdrawal by Subject|0|||
19621061|NCT00491179|42070907|FG000|Overall Study|Adverse Event|5|||
19621062|NCT00491179|42070908|FG001|Overall Study|Adverse Event|1|||
19621063|NCT00491179|42070907|FG000|Overall Study|Withdrawal by Subject|2|||
19621064|NCT00491179|42070908|FG001|Overall Study|Withdrawal by Subject|1|||
19621065|NCT00503581|42070917|FG000|Overall Study|Study closed|3|||
19621066|NCT00503581|42070918|FG001|Overall Study|Study closed|4|||
19621067|NCT00503581|42070919|FG002|Overall Study|Study closed|2|||
19621068|NCT00703534|42070929|FG000|Overall Study|Adverse Event|14|||
19621069|NCT00703534|42070930|FG001|Overall Study|Adverse Event|3|||
19621070|NCT00703534|42070929|FG000|Overall Study|Withdrawal by Subject|8|||
19621071|NCT00703534|42070930|FG001|Overall Study|Withdrawal by Subject|7|||
19621072|NCT00703534|42070929|FG000|Overall Study|Incorrect Enrollment|6|||
19621073|NCT00703534|42070930|FG001|Overall Study|Incorrect Enrollment|6|||
19621074|NCT00703534|42070929|FG000|Overall Study|Lost to Follow-up|1|||
19621075|NCT00703534|42070930|FG001|Overall Study|Lost to Follow-up|4|||
19621076|NCT00703534|42070929|FG000|Overall Study|Severe Non Compliance|1|||
19621077|NCT00703534|42070930|FG001|Overall Study|Severe Non Compliance|5|||
19621078|NCT00503425|42070936|FG000|Overall Study|Participant files lost|6|||
19621079|NCT00503425|42070936|FG000|Overall Study|Adverse Event|5|||
19621080|NCT00503425|42070936|FG000|Overall Study|Lack of Efficacy|25|||
19621081|NCT00503425|42070936|FG000|Overall Study|Withdrawal by Subject|8|||
19621082|NCT00503425|42070936|FG000|Overall Study|Lost to Follow-up|3|||
19621083|NCT00503425|42070936|FG000|Overall Study|Death|3|||
19621084|NCT00503425|42070936|FG000|Overall Study|Missing Data/Unknown|4|||
19621085|NCT00863772|42070944|FG000|Overall Study|Adverse Event|1|||
19621086|NCT00863772|42070945|FG001|Overall Study|Adverse Event|4|||
19621087|NCT00863772|42070946|FG002|Overall Study|Adverse Event|0|||
19621088|NCT00863772|42070944|FG000|Overall Study|Lack of Efficacy|4|||
19621089|NCT00863772|42070945|FG001|Overall Study|Lack of Efficacy|2|||
19621090|NCT00863772|42070946|FG002|Overall Study|Lack of Efficacy|4|||
19621091|NCT00863772|42070944|FG000|Overall Study|Lost to Follow-up|5|||
19621092|NCT00863772|42070945|FG001|Overall Study|Lost to Follow-up|1|||
19621093|NCT00863772|42070946|FG002|Overall Study|Lost to Follow-up|1|||
19621094|NCT00863772|42070944|FG000|Overall Study|Protocol Violation|2|||
19621095|NCT00863772|42070945|FG001|Overall Study|Protocol Violation|0|||
19621096|NCT00863772|42070946|FG002|Overall Study|Protocol Violation|2|||
19621097|NCT00863772|42070944|FG000|Overall Study|Withdrawal by Subject|4|||
19621098|NCT00863772|42070945|FG001|Overall Study|Withdrawal by Subject|7|||
19621099|NCT00863772|42070946|FG002|Overall Study|Withdrawal by Subject|5|||
19621100|NCT00863772|42070944|FG000|Overall Study|Study terminated by sponsor|44|||
19621101|NCT00863772|42070945|FG001|Overall Study|Study terminated by sponsor|45|||
19621102|NCT00863772|42070946|FG002|Overall Study|Study terminated by sponsor|36|||
19517643|NCT01577160|41930626|FG000|Overall Study|Lack of Efficacy|15|||
19517644|NCT01577160|41930626|FG000|Overall Study|Lost to Follow-up|40|||
19517645|NCT01577160|41930626|FG000|Overall Study|Withdrawal by Subject|18|||
19517646|NCT01577160|41930626|FG000|Overall Study|Subject Uncooperative|7|||
19517647|NCT01577160|41930626|FG000|Overall Study|Other|9|||
19517648|NCT01554618|41930632|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
19517649|NCT01554618|41930633|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
19517650|NCT01554618|41930632|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
19517651|NCT01554618|41930633|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
19517652|NCT01554618|41930632|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
19517653|NCT01554618|41930633|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
19517654|NCT01554618|41930632|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
19621103|NCT00863772|42070944|FG000|Overall Study|Entered extension study|6|||
19621104|NCT00863772|42070945|FG001|Overall Study|Entered extension study|4|||
19621105|NCT00863772|42070946|FG002|Overall Study|Entered extension study|9|||
19621106|NCT00863772|42070944|FG000|Overall Study|Other|1|||
19621107|NCT00863772|42070945|FG001|Overall Study|Other|2|||
19621108|NCT00863772|42070946|FG002|Overall Study|Other|4|||
19621109|NCT00863772|42070944|FG000|Overall Study|Randomized but not Treated|1|||
19621110|NCT00863772|42070945|FG001|Overall Study|Randomized but not Treated|0|||
19621111|NCT00863772|42070946|FG002|Overall Study|Randomized but not Treated|0|||
19621112|NCT00502801|42070954|FG000|Treatment Period|Withdrawal by Subject|3|||
19621113|NCT00502801|42070954|FG000|Treatment Period|Adverse Event|7|||
19621114|NCT00502801|42070954|FG000|Treatment Period|Death|14|||
19621115|NCT00502801|42070954|FG000|Treatment Period|OTHER|30|||
19621116|NCT00502801|42070954|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
19621117|NCT00502801|42070954|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
19621118|NCT00502801|42070954|FG000|End of Therapy to Test of Cure|Death|3|||
19621119|NCT00502801|42070954|FG000|End of Therapy to Test of Cure|OTHER|2|||
19621120|NCT00824265|42070960|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
19621121|NCT00824265|42070961|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
19621122|NCT00824265|42070960|FG000|Treatment Phase|Protocol Violation|1|||
19621123|NCT00824265|42070961|FG001|Treatment Phase|Protocol Violation|0|||
19621124|NCT00824265|42070960|FG000|Treatment Phase|Lost to Follow-up|1|||
19621125|NCT00824265|42070961|FG001|Treatment Phase|Lost to Follow-up|1|||
19621126|NCT00824265|42070960|FG000|Treatment Phase|Physician Decision|6|||
19621127|NCT00824265|42070961|FG001|Treatment Phase|Physician Decision|12|||
19621128|NCT00824265|42070960|FG000|Treatment Phase|Withdrawal by Subject|6|||
19621129|NCT00824265|42070961|FG001|Treatment Phase|Withdrawal by Subject|15|||
19621130|NCT00824265|42070960|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
19621131|NCT00824265|42070961|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
19621132|NCT00824265|42070960|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
19621133|NCT00824265|42070961|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
19621134|NCT00855894|42070971|FG000|Overall Study|Death|31|||
19621135|NCT00855894|42070971|FG000|Overall Study|Patient's decision|1|||
19621136|NCT00855894|42070971|FG000|Overall Study|Disease progression|1|||
19621137|NCT00855816|42070977|FG000|Overall Study|Withdrawal by Subject|22|||
19621138|NCT00855816|42070978|FG001|Overall Study|Withdrawal by Subject|15|||
19621139|NCT00855816|42070977|FG000|Overall Study|Lost to Follow-up|3|||
19621140|NCT00855816|42070978|FG001|Overall Study|Lost to Follow-up|5|||
19621141|NCT00855816|42070977|FG000|Overall Study|Death|1|||
19621142|NCT00855816|42070978|FG001|Overall Study|Death|0|||
19621143|NCT00855816|42070977|FG000|Overall Study|Became ineligible|0|||
19621144|NCT00855816|42070978|FG001|Overall Study|Became ineligible|1|||
19621145|NCT00855738|42070984|FG000|Overall Study|Lost to Follow-up|2|||
19621146|NCT00855738|42070984|FG000|Overall Study|Adverse Event|1|||
19621147|NCT00855738|42070984|FG000|Overall Study|Subject Defaulted|1|||
19621148|NCT00855738|42070984|FG000|Overall Study|Death|1|||
19621149|NCT00490945|42070995|FG000|Overall Study|Adverse Event|0|||
19621150|NCT00490945|42070996|FG001|Overall Study|Adverse Event|1|||
19621151|NCT00490945|42070997|FG002|Overall Study|Adverse Event|0|||
19621152|NCT00490945|42070998|FG003|Overall Study|Adverse Event|0|||
19621153|NCT00490945|42070999|FG004|Overall Study|Adverse Event|0|||
19621154|NCT00879398|42071017|FG000|Overall Study|Visit Stop|399|||
19621155|NCT00879398|42071017|FG000|Overall Study|Lack of Efficacy|64|||
19621156|NCT00879398|42071017|FG000|Overall Study|Adverse Event|41|||
19621157|NCT00879398|42071017|FG000|Overall Study|Other Reasons|171|||
19621158|NCT00696436|42071026|FG000|Overall Study|Adverse Event|7|||
19621159|NCT00696436|42071027|FG001|Overall Study|Adverse Event|9|||
19621160|NCT00696436|42071028|FG002|Overall Study|Adverse Event|8|||
19621161|NCT00696436|42071029|FG003|Overall Study|Adverse Event|6|||
19621162|NCT00696436|42071030|FG004|Overall Study|Adverse Event|4|||
19621163|NCT00696436|42071026|FG000|Overall Study|Protocol Violation|3|||
19621164|NCT00696436|42071027|FG001|Overall Study|Protocol Violation|2|||
19621165|NCT00696436|42071028|FG002|Overall Study|Protocol Violation|2|||
19621166|NCT00696436|42071029|FG003|Overall Study|Protocol Violation|0|||
19621167|NCT00696436|42071030|FG004|Overall Study|Protocol Violation|1|||
19621168|NCT00696436|42071026|FG000|Overall Study|Lost to Follow-up|1|||
19621169|NCT00696436|42071027|FG001|Overall Study|Lost to Follow-up|6|||
19621170|NCT00696436|42071028|FG002|Overall Study|Lost to Follow-up|2|||
19621171|NCT00696436|42071029|FG003|Overall Study|Lost to Follow-up|4|||
19621172|NCT00696436|42071030|FG004|Overall Study|Lost to Follow-up|3|||
19621173|NCT00696436|42071026|FG000|Overall Study|Withdrawal by Subject|4|||
19621174|NCT00696436|42071027|FG001|Overall Study|Withdrawal by Subject|11|||
19621175|NCT00696436|42071028|FG002|Overall Study|Withdrawal by Subject|5|||
19705549|NCT00142298|42149893|FG000|Overall Study|Adverse Event|10|||
19705550|NCT00142298|42149894|FG001|Overall Study|Adverse Event|10|||
19621176|NCT00696436|42071029|FG003|Overall Study|Withdrawal by Subject|7|||
19621177|NCT00696436|42071030|FG004|Overall Study|Withdrawal by Subject|1|||
19621178|NCT00696436|42071026|FG000|Overall Study|Lack of Efficacy|3|||
19621179|NCT00696436|42071027|FG001|Overall Study|Lack of Efficacy|1|||
19621180|NCT00696436|42071028|FG002|Overall Study|Lack of Efficacy|5|||
19621181|NCT00696436|42071029|FG003|Overall Study|Lack of Efficacy|2|||
19621182|NCT00696436|42071030|FG004|Overall Study|Lack of Efficacy|4|||
19621183|NCT00696436|42071026|FG000|Overall Study|Participant Unavailability|2|||
19621184|NCT00696436|42071027|FG001|Overall Study|Participant Unavailability|0|||
19621185|NCT00696436|42071028|FG002|Overall Study|Participant Unavailability|2|||
19621186|NCT00696436|42071029|FG003|Overall Study|Participant Unavailability|1|||
19621187|NCT00696436|42071030|FG004|Overall Study|Participant Unavailability|0|||
19621188|NCT00696436|42071026|FG000|Overall Study|Administrative Error|2|||
19621189|NCT00696436|42071027|FG001|Overall Study|Administrative Error|0|||
19621190|NCT00696436|42071028|FG002|Overall Study|Administrative Error|2|||
19621191|NCT00696436|42071029|FG003|Overall Study|Administrative Error|0|||
19621192|NCT00696436|42071030|FG004|Overall Study|Administrative Error|0|||
19621193|NCT00696436|42071026|FG000|Overall Study|Participant Non-compliance|0|||
19621194|NCT00696436|42071027|FG001|Overall Study|Participant Non-compliance|0|||
19621195|NCT00696436|42071028|FG002|Overall Study|Participant Non-compliance|1|||
19621196|NCT00696436|42071029|FG003|Overall Study|Participant Non-compliance|2|||
19621197|NCT00696436|42071030|FG004|Overall Study|Participant Non-compliance|0|||
19621198|NCT00696436|42071026|FG000|Overall Study|Administrative Decision|1|||
19621199|NCT00696436|42071027|FG001|Overall Study|Administrative Decision|0|||
19621200|NCT00696436|42071028|FG002|Overall Study|Administrative Decision|0|||
19621201|NCT00696436|42071029|FG003|Overall Study|Administrative Decision|0|||
19373742|NCT02755649|41614937|FG001|Overall Study|Withdrawal by Subject|1|||
19373743|NCT02755649|41614938|FG002|Overall Study|Withdrawal by Subject|0|||
19373744|NCT02755649|41614936|FG000|Overall Study|Undecided|1|||
19373745|NCT02755649|41614937|FG001|Overall Study|Undecided|0|||
19373746|NCT02755649|41614938|FG002|Overall Study|Undecided|0|||
19621202|NCT00696436|42071030|FG004|Overall Study|Administrative Decision|0|||
19621203|NCT00696436|42071026|FG000|Overall Study|Missing|0|||
19621204|NCT00696436|42071027|FG001|Overall Study|Missing|1|||
19621205|NCT00696436|42071028|FG002|Overall Study|Missing|1|||
19621206|NCT00696436|42071029|FG003|Overall Study|Missing|0|||
19621207|NCT00696436|42071030|FG004|Overall Study|Missing|0|||
19621208|NCT00878072|42071042|FG000|Overall Study|Withdrew consent|2|||
19621209|NCT00594854|42071070|FG000|Overall Study|Study terminated|7|||
19621210|NCT00594854|42071071|FG001|Overall Study|Study terminated|10|||
19621211|NCT00855582|42071080|FG000|Overall Study|Adverse Event|2|||
19621212|NCT00855582|42071081|FG001|Overall Study|Adverse Event|6|||
19621213|NCT00855582|42071082|FG002|Overall Study|Adverse Event|3|||
19621214|NCT00855582|42071080|FG000|Overall Study|Death|1|||
19621215|NCT00855582|42071081|FG001|Overall Study|Death|0|||
19621216|NCT00855582|42071082|FG002|Overall Study|Death|0|||
19621217|NCT00855582|42071080|FG000|Overall Study|Lack of Efficacy|1|||
19621218|NCT00855582|42071081|FG001|Overall Study|Lack of Efficacy|3|||
19621219|NCT00855582|42071082|FG002|Overall Study|Lack of Efficacy|8|||
19705551|NCT00142298|42149895|FG002|Overall Study|Adverse Event|1|||
19705552|NCT00142298|42149896|FG003|Overall Study|Adverse Event|5|||
19705553|NCT00142298|42149897|FG004|Overall Study|Adverse Event|2|||
19705554|NCT00142298|42149898|FG005|Overall Study|Adverse Event|2|||
19705555|NCT00142298|42149899|FG006|Overall Study|Adverse Event|0|||
19705556|NCT00142298|42149900|FG007|Overall Study|Adverse Event|0|||
19705557|NCT00142298|42149901|FG008|Overall Study|Adverse Event|0|||
19705558|NCT00142298|42149902|FG009|Overall Study|Adverse Event|0|||
19705559|NCT00142298|42149893|FG000|Overall Study|Clinical disease progression|1|||
19705560|NCT00142298|42149894|FG001|Overall Study|Clinical disease progression|0|||
19705561|NCT00142298|42149895|FG002|Overall Study|Clinical disease progression|0|||
19705562|NCT00142298|42149896|FG003|Overall Study|Clinical disease progression|0|||
19705563|NCT00142298|42149897|FG004|Overall Study|Clinical disease progression|0|||
19705564|NCT00142298|42149898|FG005|Overall Study|Clinical disease progression|0|||
19705565|NCT00142298|42149899|FG006|Overall Study|Clinical disease progression|0|||
19705566|NCT00142298|42149900|FG007|Overall Study|Clinical disease progression|0|||
19705567|NCT00142298|42149901|FG008|Overall Study|Clinical disease progression|0|||
19705568|NCT00142298|42149902|FG009|Overall Study|Clinical disease progression|0|||
19705569|NCT00142298|42149893|FG000|Overall Study|Death|1|||
19705570|NCT00142298|42149894|FG001|Overall Study|Death|1|||
19373747|NCT00151411|41614948|FG000|Overall Study|Lost to Follow-up|15|||
19621220|NCT00855582|42071080|FG000|Overall Study|Lost to Follow-up|1|||
19621221|NCT00855582|42071081|FG001|Overall Study|Lost to Follow-up|3|||
19621222|NCT00855582|42071082|FG002|Overall Study|Lost to Follow-up|1|||
19621223|NCT00855582|42071080|FG000|Overall Study|Physician Decision|0|||
19621224|NCT00855582|42071081|FG001|Overall Study|Physician Decision|0|||
19621225|NCT00855582|42071082|FG002|Overall Study|Physician Decision|1|||
19621226|NCT00855582|42071080|FG000|Overall Study|Protocol Violation|6|||
19621227|NCT00855582|42071081|FG001|Overall Study|Protocol Violation|2|||
19621228|NCT00855582|42071082|FG002|Overall Study|Protocol Violation|6|||
19621229|NCT00855582|42071080|FG000|Overall Study|Entry Criteria Not Met|8|||
19621230|NCT00855582|42071081|FG001|Overall Study|Entry Criteria Not Met|6|||
19621231|NCT00855582|42071082|FG002|Overall Study|Entry Criteria Not Met|3|||
19705571|NCT00142298|42149895|FG002|Overall Study|Death|1|||
19705572|NCT00142298|42149896|FG003|Overall Study|Death|0|||
19705573|NCT00142298|42149897|FG004|Overall Study|Death|0|||
19705574|NCT00142298|42149898|FG005|Overall Study|Death|6|||
19705575|NCT00142298|42149899|FG006|Overall Study|Death|0|||
19621232|NCT00855582|42071080|FG000|Overall Study|Withdrawal by Subject|7|||
19621233|NCT00855582|42071081|FG001|Overall Study|Withdrawal by Subject|4|||
19621234|NCT00855582|42071082|FG002|Overall Study|Withdrawal by Subject|8|||
19621235|NCT00854724|42071095|FG000|First Intervention|Withdrawal by Subject|1|||
19621236|NCT00854724|42071096|FG001|First Intervention|Withdrawal by Subject|1|||
19621237|NCT00854724|42071095|FG000|Washout|Protocol Violation|1|||
19621238|NCT00854724|42071096|FG001|Washout|Protocol Violation|0|||
19621239|NCT00854724|42071095|FG000|Washout|Withdrawal by Subject|0|||
19621240|NCT00854724|42071096|FG001|Washout|Withdrawal by Subject|1|||
19621241|NCT00854724|42071095|FG000|Second Intervention|Protocol Violation|1|||
19621242|NCT00854724|42071096|FG001|Second Intervention|Protocol Violation|0|||
19621243|NCT00854724|42071095|FG000|Second Intervention|Physician Decision|0|||
19621244|NCT00854724|42071096|FG001|Second Intervention|Physician Decision|1|||
19621245|NCT00698932|42071134|FG000|Overall Study|Adverse Event|0|||
19621246|NCT00698932|42071135|FG001|Overall Study|Adverse Event|2|||
19621247|NCT00698932|42071134|FG000|Overall Study|Incorrect enrollment|0|||
19621248|NCT00698932|42071135|FG001|Overall Study|Incorrect enrollment|2|||
19621249|NCT00698932|42071134|FG000|Overall Study|Study specific discontinuation criteria|3|||
19621250|NCT00698932|42071135|FG001|Overall Study|Study specific discontinuation criteria|4|||
19621251|NCT00698932|42071134|FG000|Overall Study|Withdrawal by Subject|11|||
19621252|NCT00698932|42071135|FG001|Overall Study|Withdrawal by Subject|23|||
19621253|NCT00698932|42071134|FG000|Overall Study|Lost to Follow-up|6|||
19621254|NCT00698932|42071135|FG001|Overall Study|Lost to Follow-up|1|||
19621255|NCT00698932|42071134|FG000|Overall Study|Severe non-compliance to protocol|1|||
19621256|NCT00698932|42071135|FG001|Overall Study|Severe non-compliance to protocol|2|||
19621257|NCT00698932|42071134|FG000|Overall Study|Safety reasons|0|||
19621258|NCT00698932|42071135|FG001|Overall Study|Safety reasons|2|||
19621259|NCT00698932|42071134|FG000|Overall Study|Death|1|||
19621260|NCT00698932|42071135|FG001|Overall Study|Death|0|||
19621261|NCT00823719|42071143|FG000|Overall Study|Adverse Event|1|||
19621262|NCT00823719|42071144|FG001|Overall Study|Adverse Event|2|||
19621263|NCT00823719|42071143|FG000|Overall Study|Physician Decision|1|||
19621264|NCT00823719|42071144|FG001|Overall Study|Physician Decision|4|||
19621265|NCT00823719|42071143|FG000|Overall Study|Withdrawal by Subject|0|||
19621266|NCT00823719|42071144|FG001|Overall Study|Withdrawal by Subject|1|||
19621267|NCT00823719|42071143|FG000|Overall Study|Disease Progression|4|||
19621268|NCT00823719|42071144|FG001|Overall Study|Disease Progression|4|||
19621269|NCT00875420|42071157|FG000|Overall Study|Adverse Event|0|||
19621270|NCT00875420|42071158|FG001|Overall Study|Adverse Event|1|||
19621271|NCT00875420|42071159|FG002|Overall Study|Adverse Event|1|||
19621272|NCT00875420|42071160|FG003|Overall Study|Adverse Event|0|||
19621273|NCT00875420|42071161|FG004|Overall Study|Adverse Event|0|||
19621274|NCT00875420|42071157|FG000|Overall Study|Inability to complete study procedures|1|||
19621275|NCT00875420|42071158|FG001|Overall Study|Inability to complete study procedures|0|||
19621276|NCT00875420|42071159|FG002|Overall Study|Inability to complete study procedures|1|||
19621277|NCT00875420|42071160|FG003|Overall Study|Inability to complete study procedures|1|||
19621278|NCT00875420|42071161|FG004|Overall Study|Inability to complete study procedures|1|||
19621279|NCT00875420|42071157|FG000|Overall Study|Lost to Follow-up|1|||
19621280|NCT00875420|42071158|FG001|Overall Study|Lost to Follow-up|0|||
19621281|NCT00875420|42071159|FG002|Overall Study|Lost to Follow-up|0|||
19621282|NCT00875420|42071160|FG003|Overall Study|Lost to Follow-up|0|||
19621283|NCT00875420|42071161|FG004|Overall Study|Lost to Follow-up|0|||
19621284|NCT00875420|42071157|FG000|Overall Study|Personal reason|0|||
19621285|NCT00875420|42071158|FG001|Overall Study|Personal reason|0|||
19621286|NCT00875420|42071159|FG002|Overall Study|Personal reason|0|||
19621287|NCT00875420|42071160|FG003|Overall Study|Personal reason|0|||
19621288|NCT00875420|42071161|FG004|Overall Study|Personal reason|1|||
19621289|NCT00875420|42071157|FG000|Overall Study|Prohibited medication|0|||
19621290|NCT00875420|42071158|FG001|Overall Study|Prohibited medication|0|||
19621291|NCT00875420|42071159|FG002|Overall Study|Prohibited medication|0|||
19621292|NCT00875420|42071160|FG003|Overall Study|Prohibited medication|1|||
19621293|NCT00875420|42071161|FG004|Overall Study|Prohibited medication|0|||
19621294|NCT00875420|42071157|FG000|Overall Study|Sponsor decision|0|||
19621295|NCT00875420|42071158|FG001|Overall Study|Sponsor decision|1|||
19621296|NCT00875420|42071159|FG002|Overall Study|Sponsor decision|0|||
19621297|NCT00875420|42071160|FG003|Overall Study|Sponsor decision|0|||
19705576|NCT00142298|42149900|FG007|Overall Study|Death|0|||
19621298|NCT00875420|42071161|FG004|Overall Study|Sponsor decision|0|||
19621299|NCT00875420|42071157|FG000|Overall Study|Withdrawal by Subject|0|||
19621300|NCT00875420|42071158|FG001|Overall Study|Withdrawal by Subject|0|||
19621301|NCT00875420|42071159|FG002|Overall Study|Withdrawal by Subject|1|||
19705577|NCT00142298|42149901|FG008|Overall Study|Death|0|||
19705578|NCT00142298|42149902|FG009|Overall Study|Death|0|||
19705579|NCT00142298|42149893|FG000|Overall Study|Lack of Efficacy|44|||
19621302|NCT00875420|42071160|FG003|Overall Study|Withdrawal by Subject|0|||
19621303|NCT00875420|42071161|FG004|Overall Study|Withdrawal by Subject|0|||
19621304|NCT00822237|42071175|FG000|Dose 1 Vaccination|Not vaccinated|3|||
19705580|NCT00142298|42149894|FG001|Overall Study|Lack of Efficacy|62|||
19621305|NCT00822237|42071176|FG001|Dose 1 Vaccination|Not vaccinated|0|||
19621306|NCT00822237|42071175|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
19621307|NCT00822237|42071176|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
19621308|NCT00822237|42071175|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
19621309|NCT00822237|42071176|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
19621310|NCT00822237|42071175|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
19621311|NCT00822237|42071176|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
19621312|NCT00822237|42071175|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
19621313|NCT00822237|42071176|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
19621314|NCT00577096|42071183|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
19621315|NCT00577096|42071184|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
19621316|NCT00577096|42071183|FG000|Short Term Participation|Withdrawal by Subject|3|||
19621317|NCT00577096|42071184|FG001|Short Term Participation|Withdrawal by Subject|5|||
19621318|NCT00577096|42071183|FG000|Short Term Participation|Death|1|||
19621319|NCT00577096|42071184|FG001|Short Term Participation|Death|1|||
19621320|NCT00863304|42071194|FG000|Overall Study|Adverse Event|10|||
19621321|NCT00863304|42071195|FG001|Overall Study|Adverse Event|4|||
19621322|NCT00863304|42071196|FG002|Overall Study|Adverse Event|14|||
19621323|NCT00863304|42071197|FG003|Overall Study|Adverse Event|16|||
19621324|NCT00863304|42071194|FG000|Overall Study|Lost to Follow-up|1|||
19621325|NCT00863304|42071195|FG001|Overall Study|Lost to Follow-up|5|||
19621326|NCT00863304|42071196|FG002|Overall Study|Lost to Follow-up|4|||
19621327|NCT00863304|42071197|FG003|Overall Study|Lost to Follow-up|2|||
19621328|NCT00863304|42071194|FG000|Overall Study|Lack of Efficacy|57|||
19621329|NCT00863304|42071195|FG001|Overall Study|Lack of Efficacy|26|||
19621330|NCT00863304|42071196|FG002|Overall Study|Lack of Efficacy|30|||
19621331|NCT00863304|42071197|FG003|Overall Study|Lack of Efficacy|28|||
19621332|NCT00863304|42071194|FG000|Overall Study|Withdrawal by Subject|19|||
19621333|NCT00863304|42071195|FG001|Overall Study|Withdrawal by Subject|14|||
19621334|NCT00863304|42071196|FG002|Overall Study|Withdrawal by Subject|20|||
19621335|NCT00863304|42071197|FG003|Overall Study|Withdrawal by Subject|18|||
19621336|NCT00863304|42071194|FG000|Overall Study|Other|1|||
19621337|NCT00863304|42071195|FG001|Overall Study|Other|0|||
19621338|NCT00863304|42071196|FG002|Overall Study|Other|0|||
19621339|NCT00863304|42071197|FG003|Overall Study|Other|1|||
19621340|NCT00863304|42071194|FG000|Overall Study|Protocol Violation|2|||
19621341|NCT00863304|42071195|FG001|Overall Study|Protocol Violation|6|||
19621342|NCT00863304|42071196|FG002|Overall Study|Protocol Violation|2|||
19621343|NCT00863304|42071197|FG003|Overall Study|Protocol Violation|0|||
19621344|NCT00863304|42071194|FG000|Overall Study|Randomized, but not Treated|3|||
19621345|NCT00863304|42071195|FG001|Overall Study|Randomized, but not Treated|1|||
19621346|NCT00863304|42071196|FG002|Overall Study|Randomized, but not Treated|4|||
19621347|NCT00863304|42071197|FG003|Overall Study|Randomized, but not Treated|1|||
19621348|NCT00863304|42071194|FG000|Overall Study|Entered extension study|101|||
19621349|NCT00863304|42071195|FG001|Overall Study|Entered extension study|129|||
19621350|NCT00863304|42071196|FG002|Overall Study|Entered extension study|113|||
19621351|NCT00863304|42071197|FG003|Overall Study|Entered extension study|125|||
19621352|NCT00695110|42071209|FG000|Treatment Period 1|Adverse Event|1|||
19621353|NCT00695110|42071209|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19621354|NCT00695110|42071209|FG000|Treatment Period 3|Withdrawal by Subject|1|||
19621355|NCT00695110|42071209|FG000|Treatment Period 4|Adverse Event|1|||
19621356|NCT00594386|42071216|FG000|Overall Study|Major protocol violation|2|||
19621357|NCT00594386|42071216|FG000|Overall Study|Lack of Efficacy|12|||
19621358|NCT00594386|42071216|FG000|Overall Study|Adverse Event|68|||
19621359|NCT00594386|42071216|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
19621360|NCT00594386|42071216|FG000|Overall Study|Subject withdrew consent|35|||
19621361|NCT00594386|42071216|FG000|Overall Study|Study ended per sponsor|115|||
19621362|NCT00594386|42071216|FG000|Overall Study|Lost to Follow-up|6|||
19621363|NCT00594386|42071216|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
19621364|NCT00594386|42071216|FG000|Overall Study|Other: Subject moved to Seattle|1|||
19621365|NCT00594386|42071216|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
19621366|NCT00594386|42071216|FG000|Overall Study|Other: Study terminated per investigator|2|||
19621367|NCT00594386|42071216|FG000|Overall Study|Other: Sponsor closure of study|1|||
19621368|NCT00594386|42071216|FG000|Overall Study|Other: Site terminated participation|1|||
19621369|NCT00594386|42071216|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
19621370|NCT00594386|42071216|FG000|Overall Study|Other: Loss of drivers license|1|||
19621371|NCT00862992|42071223|FG000|Overall Study|Adverse Event|2|||
19621372|NCT00862992|42071224|FG001|Overall Study|Adverse Event|1|||
19621373|NCT00862992|42071225|FG002|Overall Study|Adverse Event|1|||
19621374|NCT00862992|42071223|FG000|Overall Study|Physician Decision|1|||
19373748|NCT00151411|41614949|FG001|Overall Study|Lost to Follow-up|19|||
19621375|NCT00862992|42071224|FG001|Overall Study|Physician Decision|0|||
19621376|NCT00862992|42071225|FG002|Overall Study|Physician Decision|0|||
19621377|NCT00862992|42071223|FG000|Overall Study|Withdrawal by Subject|0|||
19621378|NCT00862992|42071224|FG001|Overall Study|Withdrawal by Subject|0|||
19621379|NCT00862992|42071225|FG002|Overall Study|Withdrawal by Subject|2|||
19621380|NCT00694096|42071233|FG000|Overall Study|Withdrawal by Subject|5|||
19621381|NCT00854100|42071240|FG000|Overall Study|Inability to complete the study visits|0|||
19621382|NCT00854100|42071241|FG001|Overall Study|Inability to complete the study visits|0|||
19621383|NCT00854100|42071242|FG002|Overall Study|Inability to complete the study visits|1|||
19621384|NCT00854100|42071240|FG000|Overall Study|Lost to Follow-up|2|||
19621385|NCT00854100|42071241|FG001|Overall Study|Lost to Follow-up|0|||
19621386|NCT00854100|42071242|FG002|Overall Study|Lost to Follow-up|3|||
19621387|NCT00854100|42071240|FG000|Overall Study|Withdrawal by Subject|3|||
19621388|NCT00854100|42071241|FG001|Overall Study|Withdrawal by Subject|1|||
19621389|NCT00854100|42071242|FG002|Overall Study|Withdrawal by Subject|2|||
19621390|NCT00854100|42071240|FG000|Overall Study|Protocol Violation|2|||
19621391|NCT00854100|42071241|FG001|Overall Study|Protocol Violation|4|||
19621392|NCT00854100|42071242|FG002|Overall Study|Protocol Violation|3|||
19621393|NCT00854100|42071240|FG000|Overall Study|Adverse Event|2|||
19621394|NCT00854100|42071241|FG001|Overall Study|Adverse Event|1|||
19621395|NCT00854100|42071242|FG002|Overall Study|Adverse Event|2|||
19621396|NCT00509899|42071259|FG000|Overall Study|Progressive disease|1|||
19621397|NCT00509899|42071260|FG001|Overall Study|Progressive disease|3|||
19621398|NCT00509899|42071261|FG002|Overall Study|Progressive disease|5|||
19621399|NCT00509899|42071262|FG003|Overall Study|Progressive disease|1|||
19621400|NCT00509899|42071263|FG004|Overall Study|Progressive disease|0|||
19621401|NCT00509899|42071264|FG005|Overall Study|Progressive disease|1|||
19621402|NCT00509899|42071265|FG006|Overall Study|Progressive disease|0|||
19621403|NCT00509899|42071266|FG007|Overall Study|Progressive disease|0|||
19621404|NCT00509899|42071259|FG000|Overall Study|Unacceptable Toxicity|1|||
19621405|NCT00509899|42071260|FG001|Overall Study|Unacceptable Toxicity|0|||
19621406|NCT00509899|42071261|FG002|Overall Study|Unacceptable Toxicity|0|||
19621407|NCT00509899|42071262|FG003|Overall Study|Unacceptable Toxicity|2|||
19621408|NCT00509899|42071263|FG004|Overall Study|Unacceptable Toxicity|0|||
19621409|NCT00509899|42071264|FG005|Overall Study|Unacceptable Toxicity|0|||
19621410|NCT00509899|42071265|FG006|Overall Study|Unacceptable Toxicity|0|||
19621411|NCT00509899|42071266|FG007|Overall Study|Unacceptable Toxicity|0|||
19621412|NCT00509899|42071259|FG000|Overall Study|Withdrawal by Subject|6|||
19621413|NCT00509899|42071260|FG001|Overall Study|Withdrawal by Subject|2|||
19621414|NCT00509899|42071261|FG002|Overall Study|Withdrawal by Subject|3|||
19621415|NCT00509899|42071262|FG003|Overall Study|Withdrawal by Subject|0|||
19621416|NCT00509899|42071263|FG004|Overall Study|Withdrawal by Subject|3|||
19621417|NCT00509899|42071264|FG005|Overall Study|Withdrawal by Subject|2|||
19621418|NCT00509899|42071265|FG006|Overall Study|Withdrawal by Subject|0|||
19621419|NCT00509899|42071266|FG007|Overall Study|Withdrawal by Subject|0|||
19621420|NCT00509899|42071259|FG000|Overall Study|Physician Decision|4|||
19621421|NCT00509899|42071260|FG001|Overall Study|Physician Decision|2|||
19621422|NCT00509899|42071261|FG002|Overall Study|Physician Decision|7|||
19621423|NCT00509899|42071262|FG003|Overall Study|Physician Decision|0|||
19621424|NCT00509899|42071263|FG004|Overall Study|Physician Decision|1|||
19621425|NCT00509899|42071264|FG005|Overall Study|Physician Decision|4|||
19621426|NCT00509899|42071265|FG006|Overall Study|Physician Decision|0|||
19621427|NCT00509899|42071266|FG007|Overall Study|Physician Decision|0|||
19621428|NCT00509899|42071259|FG000|Overall Study|Intercurrent Illness|1|||
19621429|NCT00509899|42071260|FG001|Overall Study|Intercurrent Illness|0|||
19621430|NCT00509899|42071261|FG002|Overall Study|Intercurrent Illness|0|||
19621431|NCT00509899|42071262|FG003|Overall Study|Intercurrent Illness|1|||
19621432|NCT00509899|42071263|FG004|Overall Study|Intercurrent Illness|0|||
19621433|NCT00509899|42071264|FG005|Overall Study|Intercurrent Illness|1|||
19621434|NCT00509899|42071265|FG006|Overall Study|Intercurrent Illness|0|||
19621435|NCT00509899|42071266|FG007|Overall Study|Intercurrent Illness|0|||
19621436|NCT00509899|42071259|FG000|Overall Study|Death|2|||
19621437|NCT00509899|42071260|FG001|Overall Study|Death|2|||
19621438|NCT00509899|42071261|FG002|Overall Study|Death|3|||
19621439|NCT00509899|42071262|FG003|Overall Study|Death|0|||
19621440|NCT00509899|42071263|FG004|Overall Study|Death|1|||
19621441|NCT00509899|42071264|FG005|Overall Study|Death|1|||
19621442|NCT00509899|42071265|FG006|Overall Study|Death|1|||
19621443|NCT00509899|42071266|FG007|Overall Study|Death|1|||
19621444|NCT00509899|42071259|FG000|Overall Study|Lack of Efficacy|1|||
19621445|NCT00509899|42071260|FG001|Overall Study|Lack of Efficacy|0|||
19621446|NCT00509899|42071261|FG002|Overall Study|Lack of Efficacy|2|||
19621447|NCT00509899|42071262|FG003|Overall Study|Lack of Efficacy|0|||
19621448|NCT00509899|42071263|FG004|Overall Study|Lack of Efficacy|0|||
19621449|NCT00509899|42071264|FG005|Overall Study|Lack of Efficacy|1|||
19621450|NCT00509899|42071265|FG006|Overall Study|Lack of Efficacy|0|||
19517655|NCT01554618|41930633|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
19621451|NCT00509899|42071266|FG007|Overall Study|Lack of Efficacy|0|||
19621452|NCT00862836|42071280|FG000|Overall Study|Withdrawal by Subject|1|||
19621453|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
19621454|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
19621455|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
19621456|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Death|28|||
19621457|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Death|0|||
19621458|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Death|0|||
19621459|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
19621460|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
19621461|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
19621462|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
19621463|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
19621464|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
19621465|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
19621466|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
19621467|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
19621468|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
19621469|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
19621470|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
19621471|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
19705581|NCT00142298|42149895|FG002|Overall Study|Lack of Efficacy|9|||
19705582|NCT00142298|42149896|FG003|Overall Study|Lack of Efficacy|12|||
19705583|NCT00142298|42149897|FG004|Overall Study|Lack of Efficacy|1|||
19705584|NCT00142298|42149898|FG005|Overall Study|Lack of Efficacy|0|||
19705585|NCT00142298|42149899|FG006|Overall Study|Lack of Efficacy|0|||
19705586|NCT00142298|42149900|FG007|Overall Study|Lack of Efficacy|1|||
19705587|NCT00142298|42149901|FG008|Overall Study|Lack of Efficacy|0|||
19705588|NCT00142298|42149902|FG009|Overall Study|Lack of Efficacy|0|||
19705589|NCT00142298|42149893|FG000|Overall Study|Non-compliance|15|||
19705590|NCT00142298|42149894|FG001|Overall Study|Non-compliance|13|||
19705591|NCT00142298|42149895|FG002|Overall Study|Non-compliance|0|||
19705592|NCT00142298|42149896|FG003|Overall Study|Non-compliance|6|||
19705593|NCT00142298|42149897|FG004|Overall Study|Non-compliance|1|||
19705594|NCT00142298|42149898|FG005|Overall Study|Non-compliance|0|||
19705595|NCT00142298|42149899|FG006|Overall Study|Non-compliance|0|||
19705596|NCT00142298|42149900|FG007|Overall Study|Non-compliance|3|||
19705597|NCT00142298|42149901|FG008|Overall Study|Non-compliance|3|||
19705598|NCT00142298|42149902|FG009|Overall Study|Non-compliance|0|||
19705599|NCT00142298|42149893|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
19705600|NCT00142298|42149894|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
19705601|NCT00142298|42149895|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
19705602|NCT00142298|42149896|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
19705603|NCT00142298|42149897|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
19705604|NCT00142298|42149898|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
19705605|NCT00142298|42149899|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
19705606|NCT00142298|42149900|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
19705607|NCT00142298|42149901|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
19705608|NCT00142298|42149902|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
19705609|NCT00142298|42149893|FG000|Overall Study|Pregnancy|4|||
19705610|NCT00142298|42149894|FG001|Overall Study|Pregnancy|4|||
19621472|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
19705611|NCT00142298|42149895|FG002|Overall Study|Pregnancy|2|||
19705612|NCT00142298|42149896|FG003|Overall Study|Pregnancy|3|||
19705613|NCT00142298|42149897|FG004|Overall Study|Pregnancy|0|||
19705614|NCT00142298|42149898|FG005|Overall Study|Pregnancy|0|||
19705615|NCT00142298|42149899|FG006|Overall Study|Pregnancy|0|||
19705616|NCT00142298|42149900|FG007|Overall Study|Pregnancy|0|||
19705617|NCT00142298|42149901|FG008|Overall Study|Pregnancy|1|||
19705618|NCT00142298|42149902|FG009|Overall Study|Pregnancy|0|||
19705619|NCT00142298|42149893|FG000|Overall Study|Virologic breakthrough|19|||
19705620|NCT00142298|42149894|FG001|Overall Study|Virologic breakthrough|23|||
19705621|NCT00142298|42149895|FG002|Overall Study|Virologic breakthrough|9|||
19705622|NCT00142298|42149896|FG003|Overall Study|Virologic breakthrough|7|||
19705623|NCT00142298|42149897|FG004|Overall Study|Virologic breakthrough|2|||
19705624|NCT00142298|42149898|FG005|Overall Study|Virologic breakthrough|3|||
19705625|NCT00142298|42149899|FG006|Overall Study|Virologic breakthrough|3|||
19705626|NCT00142298|42149900|FG007|Overall Study|Virologic breakthrough|0|||
19705627|NCT00142298|42149901|FG008|Overall Study|Virologic breakthrough|0|||
19705628|NCT00142298|42149902|FG009|Overall Study|Virologic breakthrough|0|||
19705629|NCT00142298|42149893|FG000|Overall Study|Other- not specified|0|||
19705630|NCT00142298|42149894|FG001|Overall Study|Other- not specified|3|||
19705631|NCT00142298|42149895|FG002|Overall Study|Other- not specified|0|||
19705632|NCT00142298|42149896|FG003|Overall Study|Other- not specified|1|||
19705633|NCT00142298|42149897|FG004|Overall Study|Other- not specified|0|||
19705634|NCT00142298|42149898|FG005|Overall Study|Other- not specified|0|||
19621473|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
19621474|NCT00820755|42071284|FG000|Period 1: Combination Therapy Phase|Other|11|||
19621475|NCT00820755|42071285|FG001|Period 1: Combination Therapy Phase|Other|0|||
19621476|NCT00820755|42071286|FG002|Period 1: Combination Therapy Phase|Other|0|||
19621477|NCT00820755|42071284|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
19621478|NCT00820755|42071285|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
19621479|NCT00820755|42071286|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
19621480|NCT00820599|42071294|FG000|Overall Study|Death|129|||
19621481|NCT00820599|42071294|FG000|Overall Study|Withdrawal by Subject|2|||
19621482|NCT00819741|42071300|FG000|Overall Study|Adverse Event|5|||
19621483|NCT00819741|42071301|FG001|Overall Study|Adverse Event|2|||
19621484|NCT00819741|42071300|FG000|Overall Study|Lack of Efficacy|0|||
19621485|NCT00819741|42071301|FG001|Overall Study|Lack of Efficacy|2|||
19621486|NCT00819741|42071300|FG000|Overall Study|Lost to Follow-up|3|||
19621487|NCT00819741|42071301|FG001|Overall Study|Lost to Follow-up|1|||
19621488|NCT00819741|42071300|FG000|Overall Study|Protocol Violation|3|||
19621489|NCT00819741|42071301|FG001|Overall Study|Protocol Violation|4|||
19621490|NCT00819741|42071300|FG000|Overall Study|Withdrawal by Subject|2|||
19705635|NCT00142298|42149899|FG006|Overall Study|Other- not specified|0|||
19705636|NCT00142298|42149900|FG007|Overall Study|Other- not specified|0|||
19705637|NCT00142298|42149901|FG008|Overall Study|Other- not specified|0|||
19705638|NCT00142298|42149902|FG009|Overall Study|Other- not specified|0|||
19705639|NCT00142298|42149893|FG000|Overall Study|Lost to Follow-up|0|||
19705640|NCT00142298|42149894|FG001|Overall Study|Lost to Follow-up|0|||
19705641|NCT00142298|42149895|FG002|Overall Study|Lost to Follow-up|0|||
19705642|NCT00142298|42149896|FG003|Overall Study|Lost to Follow-up|0|||
19705643|NCT00142298|42149897|FG004|Overall Study|Lost to Follow-up|0|||
19705644|NCT00142298|42149898|FG005|Overall Study|Lost to Follow-up|0|||
19705645|NCT00142298|42149899|FG006|Overall Study|Lost to Follow-up|2|||
19705646|NCT00142298|42149900|FG007|Overall Study|Lost to Follow-up|0|||
19705647|NCT00142298|42149901|FG008|Overall Study|Lost to Follow-up|0|||
19705648|NCT00142298|42149902|FG009|Overall Study|Lost to Follow-up|0|||
19705649|NCT00142298|42149893|FG000|Overall Study|Treatment Failure|0|||
19705650|NCT00142298|42149894|FG001|Overall Study|Treatment Failure|0|||
19705651|NCT00142298|42149895|FG002|Overall Study|Treatment Failure|0|||
19705652|NCT00142298|42149896|FG003|Overall Study|Treatment Failure|0|||
19705653|NCT00142298|42149897|FG004|Overall Study|Treatment Failure|0|||
19705654|NCT00142298|42149898|FG005|Overall Study|Treatment Failure|2|||
19705655|NCT00142298|42149899|FG006|Overall Study|Treatment Failure|2|||
19705656|NCT00142298|42149900|FG007|Overall Study|Treatment Failure|0|||
19705657|NCT00142298|42149901|FG008|Overall Study|Treatment Failure|0|||
19705658|NCT00142298|42149902|FG009|Overall Study|Treatment Failure|0|||
19705659|NCT03709654|42149926|FG000|Overall Study|Lost to Follow-up|1|||
19705660|NCT03709654|42149927|FG001|Overall Study|Lost to Follow-up|1|||
19705661|NCT03709654|42149926|FG000|Overall Study|Withdrawal by Subject|1|||
19705662|NCT03709654|42149927|FG001|Overall Study|Withdrawal by Subject|1|||
19705663|NCT03709654|42149926|FG000|Overall Study|Adverse Event|1|||
19705664|NCT03709654|42149927|FG001|Overall Study|Adverse Event|0|||
19705665|NCT00412061|42149935|FG000|Double Blind Phase|Disease Progression|101|||
19705666|NCT00412061|42149936|FG001|Double Blind Phase|Disease Progression|154|||
19705667|NCT00412061|42149935|FG000|Double Blind Phase|Adverse Event|61|||
19705668|NCT00412061|42149936|FG001|Double Blind Phase|Adverse Event|16|||
19705669|NCT00412061|42149935|FG000|Double Blind Phase|Final Primary Analysis|26|||
19705670|NCT00412061|42149936|FG001|Double Blind Phase|Final Primary Analysis|14|||
19705671|NCT00412061|42149935|FG000|Double Blind Phase|Withdrawal by Subject|18|||
19705672|NCT00412061|42149936|FG001|Double Blind Phase|Withdrawal by Subject|20|||
19705673|NCT00412061|42149935|FG000|Double Blind Phase|Death|6|||
19705674|NCT00412061|42149936|FG001|Double Blind Phase|Death|3|||
19705675|NCT00412061|42149935|FG000|Double Blind Phase|Protocol Violation|3|||
19705676|NCT00412061|42149936|FG001|Double Blind Phase|Protocol Violation|4|||
19705677|NCT00412061|42149935|FG000|Double Blind Phase|New Cander Therapy|1|||
19705678|NCT00412061|42149936|FG001|Double Blind Phase|New Cander Therapy|1|||
19705679|NCT00412061|42149935|FG000|Double Blind Phase|Lost to Follow-up|0|||
19705680|NCT00412061|42149936|FG001|Double Blind Phase|Lost to Follow-up|1|||
19705681|NCT00412061|42149935|FG000|Open Label Phase|Disease Progression|0|||
19705682|NCT00412061|42149936|FG001|Open Label Phase|Disease Progression|86|||
19621491|NCT00819741|42071301|FG001|Overall Study|Withdrawal by Subject|2|||
19621492|NCT00819741|42071300|FG000|Overall Study|Unclassified|6|||
19621493|NCT00819741|42071301|FG001|Overall Study|Unclassified|0|||
19705683|NCT00412061|42149935|FG000|Open Label Phase|Adverse Event|0|||
19705684|NCT00412061|42149936|FG001|Open Label Phase|Adverse Event|46|||
19705685|NCT00412061|42149935|FG000|Open Label Phase|Withdrawal by Subject|0|||
19705686|NCT00412061|42149936|FG001|Open Label Phase|Withdrawal by Subject|15|||
19705687|NCT00412061|42149935|FG000|Open Label Phase|Administrative Problems|0|||
19705688|NCT00412061|42149936|FG001|Open Label Phase|Administrative Problems|13|||
19705689|NCT00412061|42149935|FG000|Open Label Phase|Death|0|||
19705690|NCT00412061|42149936|FG001|Open Label Phase|Death|7|||
19621494|NCT00819741|42071300|FG000|Overall Study|Reasons unknown|3|||
19621495|NCT00819741|42071301|FG001|Overall Study|Reasons unknown|3|||
19621496|NCT00862134|42071309|FG000|Overall Study|Death|1|||
19621497|NCT00862134|42071310|FG001|Overall Study|Death|0|||
19621498|NCT00862134|42071309|FG000|Overall Study|Physician Decision|0|||
19621499|NCT00862134|42071310|FG001|Overall Study|Physician Decision|1|||
19621500|NCT00862134|42071309|FG000|Overall Study|Withdrawal by Subject|1|||
19621501|NCT00862134|42071310|FG001|Overall Study|Withdrawal by Subject|2|||
19621502|NCT00862134|42071309|FG000|Overall Study|Sponsor terminated study|5|||
19621503|NCT00862134|42071310|FG001|Overall Study|Sponsor terminated study|7|||
19621504|NCT00862134|42071309|FG000|Overall Study|Adverse Event|2|||
19621505|NCT00862134|42071310|FG001|Overall Study|Adverse Event|2|||
19621506|NCT00862134|42071309|FG000|Overall Study|Withdrew prior to dosing|2|||
19621507|NCT00862134|42071310|FG001|Overall Study|Withdrew prior to dosing|0|||
19621508|NCT00848484|42071318|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
19621509|NCT00848484|42071319|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
19621510|NCT00848484|42071318|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
19621511|NCT00848484|42071319|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
19621512|NCT00848484|42071318|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
19621513|NCT00848484|42071319|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
19621514|NCT00848484|42071318|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
19621515|NCT00848484|42071319|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
19621516|NCT00848484|42071318|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
19621517|NCT00848484|42071319|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
19621518|NCT00509821|42071327|FG000|Study Period 1 (Induction)|Death|0|||
19621519|NCT00509821|42071328|FG001|Study Period 1 (Induction)|Death|1|||
19621520|NCT00509821|42071327|FG000|Study Period 1 (Induction)|Adverse Event|0|||
19621521|NCT00509821|42071328|FG001|Study Period 1 (Induction)|Adverse Event|2|||
19621522|NCT00509821|42071327|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
19621523|NCT00509821|42071328|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
19621524|NCT00508651|42071341|FG000|Overall Study|Lost to Follow-up|3|||
19621525|NCT00508651|42071342|FG001|Overall Study|Lost to Follow-up|1|||
19621526|NCT00508651|42071341|FG000|Overall Study|Withdrawal by Subject|1|||
19621527|NCT00508651|42071342|FG001|Overall Study|Withdrawal by Subject|1|||
19621528|NCT00490555|42071352|FG000|Overall Study|noncompliant with drug administration|0|||
19621529|NCT00490555|42071353|FG001|Overall Study|noncompliant with drug administration|0|||
19621530|NCT00490555|42071354|FG002|Overall Study|noncompliant with drug administration|2|||
19621531|NCT00490555|42071355|FG003|Overall Study|noncompliant with drug administration|0|||
19621532|NCT00501085|42071365|FG000|Overall Study|Lost to Follow-up|195|||
19621533|NCT00501085|42071365|FG000|Overall Study|Withdrawal by Subject|34|||
19621534|NCT00501085|42071365|FG000|Overall Study|Subject Decision|1|||
19621535|NCT00501085|42071365|FG000|Overall Study|Revision Surgery|7|||
19621536|NCT00501085|42071365|FG000|Overall Study|Explantation Surgery|26|||
19621537|NCT00501085|42071365|FG000|Overall Study|Adverse Event|4|||
19621538|NCT00501085|42071365|FG000|Overall Study|Non-Compliance|24|||
19621539|NCT00501085|42071365|FG000|Overall Study|Study closed by sponsor|109|||
19621540|NCT00501085|42071365|FG000|Overall Study|Other loss to follow-up|32|||
19621541|NCT00501007|42071369|FG000|Overall Study|Inclusion criteria not met.|29|||
19621542|NCT00501007|42071370|FG001|Overall Study|Inclusion criteria not met.|25|||
19621543|NCT00873860|42071380|FG000|Overall Study|Lost to Follow-up|1|||
19621544|NCT00873860|42071381|FG001|Overall Study|Lost to Follow-up|0|||
19621545|NCT00873860|42071382|FG002|Overall Study|Lost to Follow-up|0|||
19621546|NCT00873860|42071383|FG003|Overall Study|Lost to Follow-up|1|||
19621547|NCT00873860|42071380|FG000|Overall Study|Withdrawal by Subject|1|||
19621548|NCT00873860|42071381|FG001|Overall Study|Withdrawal by Subject|0|||
19621549|NCT00873860|42071382|FG002|Overall Study|Withdrawal by Subject|2|||
19621550|NCT00873860|42071383|FG003|Overall Study|Withdrawal by Subject|0|||
19621551|NCT00873860|42071380|FG000|Overall Study|Death|1|||
19621552|NCT00873860|42071381|FG001|Overall Study|Death|0|||
19621553|NCT00873860|42071382|FG002|Overall Study|Death|0|||
19621554|NCT00873860|42071383|FG003|Overall Study|Death|0|||
19621555|NCT00873860|42071380|FG000|Overall Study|Other|1|||
19621556|NCT00873860|42071381|FG001|Overall Study|Other|0|||
19621557|NCT00873860|42071382|FG002|Overall Study|Other|1|||
19621558|NCT00873860|42071383|FG003|Overall Study|Other|0|||
19621559|NCT03853291|42071406|FG000|Overall Study|Lost to Follow-up|1|||
19621560|NCT03853291|42071407|FG001|Overall Study|Lost to Follow-up|2|||
19621561|NCT03853291|42071408|FG002|Overall Study|Lost to Follow-up|0|||
19621562|NCT03853291|42071409|FG003|Overall Study|Lost to Follow-up|0|||
19621563|NCT03853291|42071410|FG004|Overall Study|Lost to Follow-up|0|||
19621564|NCT03853291|42071411|FG005|Overall Study|Lost to Follow-up|0|||
19621565|NCT03853291|42071406|FG000|Overall Study|Determined to be ineligible|1|||
19705691|NCT00412061|42149935|FG000|Open Label Phase|Lost to Follow-up|0|||
19621566|NCT03853291|42071407|FG001|Overall Study|Determined to be ineligible|1|||
19621567|NCT03853291|42071408|FG002|Overall Study|Determined to be ineligible|0|||
19621568|NCT03853291|42071409|FG003|Overall Study|Determined to be ineligible|0|||
19621569|NCT03853291|42071410|FG004|Overall Study|Determined to be ineligible|0|||
19621570|NCT03853291|42071411|FG005|Overall Study|Determined to be ineligible|0|||
19621571|NCT03853213|42071424|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
19621572|NCT03853213|42071425|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
19621573|NCT03853213|42071424|FG000|Overall Study|Other (e.g., too busy)|0|||
19621574|NCT03853213|42071425|FG001|Overall Study|Other (e.g., too busy)|2|||
19621575|NCT00819585|42071458|FG000|Core Study|Adverse Event|2|||
19621576|NCT00819585|42071459|FG001|Core Study|Adverse Event|1|||
19621577|NCT00819585|42071460|FG002|Core Study|Adverse Event|1|||
19621578|NCT00819585|42071461|FG003|Core Study|Adverse Event|4|||
19621579|NCT00819585|42071462|FG004|Core Study|Adverse Event|1|||
19621580|NCT00819585|42071463|FG005|Core Study|Adverse Event|0|||
19621581|NCT00819585|42071464|FG006|Core Study|Adverse Event|2|||
19621582|NCT00819585|42071465|FG007|Core Study|Adverse Event|0|||
19621583|NCT00819585|42071466|FG008|Core Study|Adverse Event|0|||
19621584|NCT00819585|42071467|FG009|Core Study|Adverse Event|0|||
19621585|NCT00819585|42071468|FG010|Core Study|Adverse Event|0|||
19621586|NCT00819585|42071458|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
19621587|NCT00819585|42071459|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
19621588|NCT00819585|42071460|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
19621589|NCT00819585|42071461|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
19621590|NCT00819585|42071462|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
19621591|NCT00819585|42071463|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
19621592|NCT00819585|42071464|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
19621593|NCT00819585|42071465|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
19621594|NCT00819585|42071466|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
19621595|NCT00819585|42071467|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
19621596|NCT00819585|42071468|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
19621597|NCT00819585|42071458|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621598|NCT00819585|42071459|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
19621599|NCT00819585|42071460|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621600|NCT00819585|42071461|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621601|NCT00819585|42071462|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621602|NCT00819585|42071463|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621603|NCT00819585|42071464|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
19621604|NCT00819585|42071465|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621605|NCT00819585|42071466|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621606|NCT00819585|42071467|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621607|NCT00819585|42071468|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
19621608|NCT00819585|42071458|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
19621609|NCT00819585|42071459|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
19621610|NCT00819585|42071460|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
19621611|NCT00819585|42071461|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
19621612|NCT00819585|42071462|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
19621613|NCT00819585|42071463|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
19621614|NCT00819585|42071464|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
19621615|NCT00819585|42071465|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
19621616|NCT00819585|42071466|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
19621617|NCT00819585|42071467|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
19621618|NCT00819585|42071468|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
19621619|NCT00819585|42071458|FG000|Core Study|Subject Withdrew Consent|0|||
19621620|NCT00819585|42071459|FG001|Core Study|Subject Withdrew Consent|3|||
19621621|NCT00819585|42071460|FG002|Core Study|Subject Withdrew Consent|2|||
19621622|NCT00819585|42071461|FG003|Core Study|Subject Withdrew Consent|1|||
19621623|NCT00819585|42071462|FG004|Core Study|Subject Withdrew Consent|0|||
19621624|NCT00819585|42071463|FG005|Core Study|Subject Withdrew Consent|0|||
19621625|NCT00819585|42071464|FG006|Core Study|Subject Withdrew Consent|3|||
19621626|NCT00819585|42071465|FG007|Core Study|Subject Withdrew Consent|0|||
19621627|NCT00819585|42071466|FG008|Core Study|Subject Withdrew Consent|0|||
19621628|NCT00819585|42071467|FG009|Core Study|Subject Withdrew Consent|0|||
19621629|NCT00819585|42071468|FG010|Core Study|Subject Withdrew Consent|0|||
19621630|NCT00819585|42071458|FG000|Core Study|Lost to Follow-up|2|||
19621631|NCT00819585|42071459|FG001|Core Study|Lost to Follow-up|1|||
19621632|NCT00819585|42071460|FG002|Core Study|Lost to Follow-up|2|||
19621633|NCT00819585|42071461|FG003|Core Study|Lost to Follow-up|0|||
19621634|NCT00819585|42071462|FG004|Core Study|Lost to Follow-up|1|||
19621635|NCT00819585|42071463|FG005|Core Study|Lost to Follow-up|1|||
19621636|NCT00819585|42071464|FG006|Core Study|Lost to Follow-up|1|||
19621637|NCT00819585|42071465|FG007|Core Study|Lost to Follow-up|0|||
19621638|NCT00819585|42071466|FG008|Core Study|Lost to Follow-up|0|||
19621639|NCT00819585|42071467|FG009|Core Study|Lost to Follow-up|0|||
19621640|NCT00819585|42071468|FG010|Core Study|Lost to Follow-up|0|||
19621641|NCT00819585|42071458|FG000|Core Study|Administrative Problems|0|||
19621642|NCT00819585|42071459|FG001|Core Study|Administrative Problems|0|||
19621643|NCT00819585|42071460|FG002|Core Study|Administrative Problems|0|||
19621644|NCT00819585|42071461|FG003|Core Study|Administrative Problems|0|||
19621645|NCT00819585|42071462|FG004|Core Study|Administrative Problems|0|||
19621646|NCT00819585|42071463|FG005|Core Study|Administrative Problems|0|||
19621647|NCT00819585|42071464|FG006|Core Study|Administrative Problems|2|||
19621648|NCT00819585|42071465|FG007|Core Study|Administrative Problems|0|||
19621649|NCT00819585|42071466|FG008|Core Study|Administrative Problems|0|||
19621650|NCT00819585|42071467|FG009|Core Study|Administrative Problems|0|||
19621651|NCT00819585|42071468|FG010|Core Study|Administrative Problems|0|||
19705692|NCT00412061|42149936|FG001|Open Label Phase|Lost to Follow-up|2|||
19705693|NCT00412061|42149935|FG000|Open Label Phase|New Cancer Therapy|0|||
19705694|NCT00412061|42149936|FG001|Open Label Phase|New Cancer Therapy|1|||
19705695|NCT00411671|42149954|FG000|Overall Study|Adverse Event|15|||
19705696|NCT00411671|42149954|FG000|Overall Study|Death|2|||
19705697|NCT00411671|42149954|FG000|Overall Study|Lost to Follow-up|3|||
19705698|NCT03835481|42149963|FG000|Double-blind Period|Other not stated below|0|||
19394229|NCT01371981|41638304|FG003|Overall Study|Did not start treatment|0|||
19394230|NCT01371981|41638305|FG004|Overall Study|Did not start treatment|0|||
19394231|NCT01371981|41638306|FG005|Overall Study|Did not start treatment|2|||
19394232|NCT01597375|41638334|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
19394233|NCT01597375|41638335|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
19394234|NCT01597375|41638334|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
19394235|NCT01597375|41638335|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
19621652|NCT00819585|42071458|FG000|Core Study|Death|0|||
19621653|NCT00819585|42071459|FG001|Core Study|Death|0|||
19621654|NCT00819585|42071460|FG002|Core Study|Death|0|||
19621655|NCT00819585|42071461|FG003|Core Study|Death|0|||
19621656|NCT00819585|42071462|FG004|Core Study|Death|0|||
19621657|NCT00819585|42071463|FG005|Core Study|Death|0|||
19621658|NCT00819585|42071464|FG006|Core Study|Death|1|||
19621659|NCT00819585|42071465|FG007|Core Study|Death|0|||
19621660|NCT00819585|42071466|FG008|Core Study|Death|0|||
19621661|NCT00819585|42071467|FG009|Core Study|Death|0|||
19621662|NCT00819585|42071468|FG010|Core Study|Death|0|||
19621663|NCT00819585|42071458|FG000|Core Study|Protocol Violation|0|||
19621664|NCT00819585|42071459|FG001|Core Study|Protocol Violation|0|||
19621665|NCT00819585|42071460|FG002|Core Study|Protocol Violation|1|||
19621666|NCT00819585|42071461|FG003|Core Study|Protocol Violation|0|||
19621667|NCT00819585|42071462|FG004|Core Study|Protocol Violation|0|||
19621668|NCT00819585|42071463|FG005|Core Study|Protocol Violation|1|||
19621669|NCT00819585|42071464|FG006|Core Study|Protocol Violation|3|||
19621670|NCT00819585|42071465|FG007|Core Study|Protocol Violation|0|||
19621671|NCT00819585|42071466|FG008|Core Study|Protocol Violation|0|||
19621672|NCT00819585|42071467|FG009|Core Study|Protocol Violation|0|||
19621673|NCT00819585|42071468|FG010|Core Study|Protocol Violation|0|||
19621674|NCT00819585|42071458|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
19621675|NCT00819585|42071459|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
19621676|NCT00819585|42071460|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
19621677|NCT00819585|42071461|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
19621678|NCT00819585|42071462|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
19621679|NCT00819585|42071463|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
19621680|NCT00819585|42071464|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
19621681|NCT00819585|42071465|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
19621682|NCT00819585|42071466|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
19621683|NCT00819585|42071467|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
19621684|NCT00819585|42071468|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
19621685|NCT00819585|42071458|FG000|Extension Study|Subject Withdrew Consent|0|||
19621686|NCT00819585|42071459|FG001|Extension Study|Subject Withdrew Consent|0|||
19621687|NCT00819585|42071460|FG002|Extension Study|Subject Withdrew Consent|0|||
19621688|NCT00819585|42071461|FG003|Extension Study|Subject Withdrew Consent|0|||
19621689|NCT00819585|42071462|FG004|Extension Study|Subject Withdrew Consent|0|||
19621690|NCT00819585|42071463|FG005|Extension Study|Subject Withdrew Consent|0|||
19621691|NCT00819585|42071464|FG006|Extension Study|Subject Withdrew Consent|0|||
19621692|NCT00819585|42071465|FG007|Extension Study|Subject Withdrew Consent|0|||
19621693|NCT00819585|42071466|FG008|Extension Study|Subject Withdrew Consent|3|||
19621694|NCT00819585|42071467|FG009|Extension Study|Subject Withdrew Consent|0|||
19621695|NCT00819585|42071468|FG010|Extension Study|Subject Withdrew Consent|1|||
19394236|NCT01597375|41638334|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
19394237|NCT01597375|41638335|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
19394238|NCT01597375|41638334|FG000|Washout (2 Weeks)|Adverse Event|1|||
19621696|NCT00819585|42071458|FG000|Extension Study|Lost to Follow-up|0|||
19621697|NCT00819585|42071459|FG001|Extension Study|Lost to Follow-up|0|||
19621698|NCT00819585|42071460|FG002|Extension Study|Lost to Follow-up|0|||
19621699|NCT00819585|42071461|FG003|Extension Study|Lost to Follow-up|0|||
19621700|NCT00819585|42071462|FG004|Extension Study|Lost to Follow-up|0|||
19621701|NCT00819585|42071463|FG005|Extension Study|Lost to Follow-up|0|||
19621702|NCT00819585|42071464|FG006|Extension Study|Lost to Follow-up|0|||
19621703|NCT00819585|42071465|FG007|Extension Study|Lost to Follow-up|0|||
19705699|NCT03835481|42149964|FG001|Double-blind Period|Other not stated below|0|||
19621704|NCT00819585|42071466|FG008|Extension Study|Lost to Follow-up|2|||
19621705|NCT00819585|42071467|FG009|Extension Study|Lost to Follow-up|1|||
19621706|NCT00819585|42071468|FG010|Extension Study|Lost to Follow-up|1|||
19621707|NCT00819585|42071458|FG000|Extension Study|Death|0|||
19621708|NCT00819585|42071459|FG001|Extension Study|Death|0|||
19621709|NCT00819585|42071460|FG002|Extension Study|Death|0|||
19621710|NCT00819585|42071461|FG003|Extension Study|Death|0|||
19621711|NCT00819585|42071462|FG004|Extension Study|Death|0|||
19621712|NCT00819585|42071463|FG005|Extension Study|Death|0|||
19621713|NCT00819585|42071464|FG006|Extension Study|Death|0|||
19621714|NCT00819585|42071465|FG007|Extension Study|Death|0|||
19621715|NCT00819585|42071466|FG008|Extension Study|Death|2|||
19621716|NCT00819585|42071467|FG009|Extension Study|Death|0|||
19621717|NCT00819585|42071468|FG010|Extension Study|Death|0|||
19621718|NCT00508261|42071500|FG000|Overall Study|Other|0|||
19621719|NCT00508261|42071501|FG001|Overall Study|Other|1|||
19621720|NCT00508261|42071502|FG002|Overall Study|Other|1|||
19621721|NCT00508261|42071503|FG003|Overall Study|Other|0|||
19621722|NCT00508261|42071500|FG000|Overall Study|Serious Adverse Event|0|||
19621723|NCT00508261|42071501|FG001|Overall Study|Serious Adverse Event|1|||
19621724|NCT00508261|42071502|FG002|Overall Study|Serious Adverse Event|0|||
19621725|NCT00508261|42071503|FG003|Overall Study|Serious Adverse Event|0|||
19621726|NCT00508261|42071500|FG000|Overall Study|Withdrawal by Subject|3|||
19621727|NCT00508261|42071501|FG001|Overall Study|Withdrawal by Subject|4|||
19621728|NCT00508261|42071502|FG002|Overall Study|Withdrawal by Subject|4|||
19621729|NCT00508261|42071503|FG003|Overall Study|Withdrawal by Subject|0|||
19394239|NCT01597375|41638335|FG001|Washout (2 Weeks)|Adverse Event|0|||
19394240|NCT01597375|41638334|FG000|Second Intervention|Failed to react at both Aspirin|1|||
19621730|NCT00508261|42071500|FG000|Overall Study|Migrated/ moved from study area|0|||
19621731|NCT00508261|42071501|FG001|Overall Study|Migrated/ moved from study area|1|||
19621732|NCT00508261|42071502|FG002|Overall Study|Migrated/ moved from study area|0|||
19621733|NCT00508261|42071503|FG003|Overall Study|Migrated/ moved from study area|0|||
19621734|NCT00508261|42071500|FG000|Overall Study|Lost to Follow-up|0|||
19621735|NCT00508261|42071501|FG001|Overall Study|Lost to Follow-up|1|||
19621736|NCT00508261|42071502|FG002|Overall Study|Lost to Follow-up|1|||
19621737|NCT00508261|42071503|FG003|Overall Study|Lost to Follow-up|1|||
19621738|NCT00819039|42071542|FG000|Overall Study|Physician Decision|1|||
19621739|NCT00819039|42071543|FG001|Overall Study|Physician Decision|0|||
19621740|NCT00819039|42071544|FG002|Overall Study|Physician Decision|1|||
19621741|NCT00819039|42071542|FG000|Overall Study|Protocol Violation|1|||
19621742|NCT00819039|42071543|FG001|Overall Study|Protocol Violation|0|||
19621743|NCT00819039|42071544|FG002|Overall Study|Protocol Violation|0|||
19621744|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
19621745|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
19621746|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
19621747|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
19621748|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
19621749|NCT00500539|42071554|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
19621750|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
19621751|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
19621752|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
19621753|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
19394241|NCT01597375|41638335|FG001|Second Intervention|Failed to react at both Aspirin|1|||
19394242|NCT02527161|41638342|FG000|Overall Study|Failed MRI|52|||
19621754|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Death|1|||
19705700|NCT03835481|42149965|FG002|Double-blind Period|Other not stated below|0|||
19705701|NCT03835481|42149966|FG003|Double-blind Period|Other not stated below|1|||
19705702|NCT03835481|42149967|FG004|Double-blind Period|Other not stated below|1|||
19705703|NCT03835481|42149963|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
19705704|NCT03835481|42149964|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
19705705|NCT03835481|42149965|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
19705706|NCT03835481|42149966|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
19705707|NCT03835481|42149967|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
19705708|NCT03835481|42149963|FG000|Double-blind Period|Withdrawal by Subject|0|||
19705709|NCT03835481|42149964|FG001|Double-blind Period|Withdrawal by Subject|0|||
19394243|NCT02527161|41638342|FG000|Overall Study|Withdrawal by Subject|19|||
19621755|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
19621756|NCT00500539|42071554|FG000|Follow-up Period (16 Weeks)|Missing|3|||
19621757|NCT00818883|42071563|FG000|Overall Study|Adverse Event|28|||
19621758|NCT00818883|42071564|FG001|Overall Study|Adverse Event|19|||
19621759|NCT00818883|42071563|FG000|Overall Study|Protocol Violation|2|||
19621760|NCT00818883|42071564|FG001|Overall Study|Protocol Violation|2|||
19621761|NCT00818883|42071563|FG000|Overall Study|Lost to Follow-up|3|||
19621762|NCT00818883|42071564|FG001|Overall Study|Lost to Follow-up|2|||
19621763|NCT00818883|42071563|FG000|Overall Study|Withdrawal by Subject|16|||
19705710|NCT03835481|42149965|FG002|Double-blind Period|Withdrawal by Subject|1|||
19621764|NCT00818883|42071564|FG001|Overall Study|Withdrawal by Subject|14|||
19621765|NCT00818883|42071563|FG000|Overall Study|Lack of Efficacy|0|||
19621766|NCT00818883|42071564|FG001|Overall Study|Lack of Efficacy|2|||
19621767|NCT00818883|42071563|FG000|Overall Study|Other|2|||
19621768|NCT00818883|42071564|FG001|Overall Study|Other|7|||
19705711|NCT03835481|42149966|FG003|Double-blind Period|Withdrawal by Subject|0|||
19373749|NCT00151411|41614948|FG000|Overall Study|Withdrawal by Subject|12|||
19373750|NCT00151411|41614949|FG001|Overall Study|Withdrawal by Subject|20|||
19373751|NCT00151411|41614948|FG000|Overall Study|Adverse Event|6|||
19373752|NCT00151411|41614949|FG001|Overall Study|Adverse Event|0|||
19373753|NCT00151411|41614948|FG000|Overall Study|Pregnancy|0|||
19705712|NCT03835481|42149967|FG004|Double-blind Period|Withdrawal by Subject|5|||
19705713|NCT03835481|42149963|FG000|Double-blind Period|Lost to Follow-up|0|||
19705714|NCT03835481|42149964|FG001|Double-blind Period|Lost to Follow-up|0|||
19705715|NCT03835481|42149965|FG002|Double-blind Period|Lost to Follow-up|0|||
19705716|NCT03835481|42149966|FG003|Double-blind Period|Lost to Follow-up|1|||
19705717|NCT03835481|42149967|FG004|Double-blind Period|Lost to Follow-up|0|||
19705718|NCT03835481|42149963|FG000|Double-blind Period|Protocol Violation|0|||
19705719|NCT03835481|42149964|FG001|Double-blind Period|Protocol Violation|2|||
19705720|NCT03835481|42149965|FG002|Double-blind Period|Protocol Violation|0|||
19705721|NCT03835481|42149966|FG003|Double-blind Period|Protocol Violation|1|||
19705722|NCT03835481|42149967|FG004|Double-blind Period|Protocol Violation|0|||
19705723|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
19705724|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
19705725|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
19705726|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
19705727|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
19373754|NCT00151411|41614949|FG001|Overall Study|Pregnancy|4|||
19621769|NCT00508027|42071570|FG000|Dose Level 1|Lost to Follow-up|4|||
19621770|NCT00508027|42071570|FG000|Dose Level 1|Withdrawal by Subject|2|||
19621771|NCT00508027|42071570|FG000|Dose Level 1|Physician Decision|2|||
19621772|NCT00508027|42071570|FG000|Dose Level 2|Lost to Follow-up|2|||
19621773|NCT00508027|42071570|FG000|Dose Level 2|Withdrawal by Subject|2|||
19621774|NCT00500149|42071599|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
19621775|NCT00500149|42071600|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
19621776|NCT00500149|42071599|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
19621777|NCT00500149|42071600|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
19621778|NCT00500149|42071599|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
19621779|NCT00500149|42071600|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
19621780|NCT00500149|42071599|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
19621781|NCT00500149|42071600|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
19621782|NCT00500149|42071599|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
19705728|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
19705729|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
19705730|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
19705731|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
19705732|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
19705733|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
19705734|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
19705735|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
19705736|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
19705737|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
19705738|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
19705739|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
19705740|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
19705741|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
19705742|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
19705743|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
19705744|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
19705745|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
19705746|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
19705747|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
19621783|NCT00500149|42071600|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
19517656|NCT01554618|41930632|FG000|Open-Label Extension Period|Physician Decision|0|||
19517657|NCT01554618|41930633|FG001|Open-Label Extension Period|Physician Decision|1|||
19517658|NCT01554618|41930632|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
19517659|NCT01554618|41930633|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
19517660|NCT01531998|41930643|FG000|Overall Study|Withdrawal by Subject|3|||
19621784|NCT00500149|42071599|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
19621785|NCT00500149|42071600|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
19621786|NCT00500149|42071599|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
19621787|NCT00500149|42071600|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
19621788|NCT00489853|42071606|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
19621789|NCT00489853|42071607|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
19621790|NCT00489853|42071608|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
19621791|NCT00489853|42071606|FG000|Wash-out Period 1|Adverse Event|0|||
19621792|NCT00489853|42071607|FG001|Wash-out Period 1|Adverse Event|1|||
19621793|NCT00489853|42071608|FG002|Wash-out Period 1|Adverse Event|1|||
19621794|NCT00489853|42071606|FG000|Wash-out Period 1|Protocol Violation|0|||
19621795|NCT00489853|42071607|FG001|Wash-out Period 1|Protocol Violation|1|||
19621796|NCT00489853|42071608|FG002|Wash-out Period 1|Protocol Violation|1|||
19621797|NCT00489853|42071606|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
19621798|NCT00489853|42071607|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
19621799|NCT00489853|42071608|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
19621800|NCT00489853|42071606|FG000|Wash-out Period 2|Adverse Event|1|||
19621801|NCT00489853|42071607|FG001|Wash-out Period 2|Adverse Event|1|||
19621802|NCT00489853|42071608|FG002|Wash-out Period 2|Adverse Event|0|||
19621803|NCT00489853|42071606|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
19621804|NCT00489853|42071607|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
19621805|NCT00489853|42071608|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
19621806|NCT00489853|42071606|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
19621807|NCT00489853|42071607|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
19621808|NCT00489853|42071608|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
19621809|NCT00499681|42071618|FG000|Overall Study|toxicity|0|||
19621810|NCT00499681|42071619|FG001|Overall Study|toxicity|1|||
19621811|NCT00499681|42071618|FG000|Overall Study|disease progression|0|||
19621812|NCT00499681|42071619|FG001|Overall Study|disease progression|1|||
19621813|NCT00875810|42071630|FG000|Overall Study|Withdrawal by Subject|1|||
19621814|NCT00875810|42071630|FG000|Overall Study|Physician Decision|3|||
19621815|NCT00875810|42071630|FG000|Overall Study|Lost to Follow-up|39|||
19621816|NCT00875810|42071630|FG000|Overall Study|Patient enroled but not implanted|2|||
19621817|NCT00875810|42071630|FG000|Overall Study|Device explanted|1|||
19621818|NCT00499603|42071636|FG000|Overall Study|Adverse Event|0|||
19621819|NCT00499603|42071637|FG001|Overall Study|Adverse Event|1|||
19621820|NCT00810069|42071656|FG000|Lead-in Period I|Adverse Event|43|||
19621821|NCT00810069|42071657|FG001|Lead-in Period I|Adverse Event|0|||
19621822|NCT00810069|42071658|FG002|Lead-in Period I|Adverse Event|0|||
19621823|NCT00810069|42071656|FG000|Lead-in Period I|Lack of Efficacy|1|||
19621824|NCT00810069|42071657|FG001|Lead-in Period I|Lack of Efficacy|0|||
19621825|NCT00810069|42071658|FG002|Lead-in Period I|Lack of Efficacy|0|||
19621826|NCT00810069|42071656|FG000|Lead-in Period I|Lost to Follow-up|19|||
19621827|NCT00810069|42071657|FG001|Lead-in Period I|Lost to Follow-up|0|||
19621828|NCT00810069|42071658|FG002|Lead-in Period I|Lost to Follow-up|0|||
19621829|NCT00810069|42071656|FG000|Lead-in Period I|Physician Decision|1|||
19621830|NCT00810069|42071657|FG001|Lead-in Period I|Physician Decision|0|||
19705748|NCT03835481|42149963|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
19705749|NCT03835481|42149964|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
19705750|NCT03835481|42149965|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
19621831|NCT00810069|42071658|FG002|Lead-in Period I|Physician Decision|0|||
19621832|NCT00810069|42071656|FG000|Lead-in Period I|Protocol Violation|1|||
19621833|NCT00810069|42071657|FG001|Lead-in Period I|Protocol Violation|0|||
19621834|NCT00810069|42071658|FG002|Lead-in Period I|Protocol Violation|0|||
19621835|NCT00810069|42071656|FG000|Lead-in Period I|Withdrawal by Subject|46|||
19621836|NCT00810069|42071657|FG001|Lead-in Period I|Withdrawal by Subject|0|||
19621837|NCT00810069|42071658|FG002|Lead-in Period I|Withdrawal by Subject|0|||
19621838|NCT00810069|42071656|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
19621839|NCT00810069|42071657|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
19621840|NCT00810069|42071658|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
19621841|NCT00810069|42071656|FG000|Lead-in Period I|Randomization criteria not met|158|||
19621842|NCT00810069|42071657|FG001|Lead-in Period I|Randomization criteria not met|0|||
19621843|NCT00810069|42071658|FG002|Lead-in Period I|Randomization criteria not met|0|||
19705751|NCT03835481|42149966|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
19705752|NCT03835481|42149967|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
19705753|NCT03709576|42150014|FG000|Overall Study|progression prior to enrollment|1|||
19705754|NCT00122460|42150021|FG000|Overall Study|investigational study phase ongoing|7|||
19705755|NCT00122460|42150022|FG001|Overall Study|investigational study phase ongoing|1|||
19705756|NCT00137436|42150028|FG000|Overall Study|Adverse Event|13|||
19705757|NCT00137436|42150028|FG000|Overall Study|Death|2|||
19705758|NCT00137436|42150028|FG000|Overall Study|Lack of Efficacy|17|||
19705759|NCT00137436|42150028|FG000|Overall Study|Withdrawal by Subject|6|||
19705760|NCT00137436|42150028|FG000|Overall Study|Other|5|||
19705761|NCT03834623|42150034|FG000|Overall Study|Progression|0|||
19705762|NCT03834623|42150035|FG001|Overall Study|Progression|1|||
19705763|NCT00410813|42150043|FG000|Overall Study|Adverse Event|6|||
19705764|NCT00410813|42150044|FG001|Overall Study|Adverse Event|11|||
19705765|NCT00410813|42150043|FG000|Overall Study|Progression|32|||
19705766|NCT00410813|42150044|FG001|Overall Study|Progression|21|||
19705767|NCT00410813|42150043|FG000|Overall Study|Not protocol specified|3|||
19705768|NCT00410813|42150044|FG001|Overall Study|Not protocol specified|4|||
19705769|NCT00410813|42150043|FG000|Overall Study|Ineligible|2|||
19705770|NCT00410813|42150044|FG001|Overall Study|Ineligible|4|||
19705771|NCT00410813|42150043|FG000|Overall Study|Death|0|||
19705772|NCT00410813|42150044|FG001|Overall Study|Death|2|||
19705773|NCT03704194|42150075|FG000|Overall Study|Withdrawal by Subject|0|||
19705774|NCT03704194|42150076|FG001|Overall Study|Withdrawal by Subject|1|||
19705775|NCT00405821|42150086|FG000|Overall Study|Death|5|||
19705776|NCT00405821|42150087|FG001|Overall Study|Death|7|||
19705777|NCT00405821|42150086|FG000|Overall Study|Lost to Follow-up|7|||
19705778|NCT00405821|42150087|FG001|Overall Study|Lost to Follow-up|7|||
19705779|NCT00405821|42150086|FG000|Overall Study|Protocol Violation|1|||
19705780|NCT00405821|42150087|FG001|Overall Study|Protocol Violation|0|||
19705781|NCT00405821|42150086|FG000|Overall Study|initiated ART|9|||
19705782|NCT00405821|42150087|FG001|Overall Study|initiated ART|8|||
19705783|NCT01446016|42150093|FG000|Overall Study|Lost to Follow-up|3|||
19705784|NCT01446016|42150093|FG000|Overall Study|Withdrawal by Subject|1|||
19705785|NCT01446016|42150093|FG000|Overall Study|Toxicity|3|||
19705786|NCT00137046|42150099|FG000|Overall Study|Death|2|||
19705787|NCT00137046|42150100|FG001|Overall Study|Death|1|||
19705788|NCT00137046|42150099|FG000|Overall Study|Adverse Event|16|||
19705789|NCT00137046|42150100|FG001|Overall Study|Adverse Event|5|||
19705790|NCT00137046|42150099|FG000|Overall Study|Laboratory Abnormality|2|||
19705791|NCT00137046|42150100|FG001|Overall Study|Laboratory Abnormality|0|||
19705792|NCT00137046|42150099|FG000|Overall Study|Lack of Efficacy|13|||
19705793|NCT00137046|42150100|FG001|Overall Study|Lack of Efficacy|1|||
19705794|NCT00137046|42150099|FG000|Overall Study|Lost to Follow-up|8|||
19705795|NCT00137046|42150100|FG001|Overall Study|Lost to Follow-up|24|||
19705796|NCT00137046|42150099|FG000|Overall Study|Other|23|||
19705797|NCT00137046|42150100|FG001|Overall Study|Other|19|||
19705798|NCT00137046|42150099|FG000|Overall Study|Withdrawal by Subject|33|||
19705799|NCT00137046|42150100|FG001|Overall Study|Withdrawal by Subject|42|||
19705800|NCT00137046|42150099|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
19705801|NCT00137046|42150100|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
19705802|NCT00137046|42150099|FG000|Overall Study|Withdrew prior to study treatment|1|||
19705803|NCT00137046|42150100|FG001|Overall Study|Withdrew prior to study treatment|1|||
19517661|NCT01576146|41930647|FG000|Extension Period 1|Adverse Event|2|||
19621844|NCT00810069|42071656|FG000|Double-Blind Period II|Adverse Event|0|||
19705804|NCT00122382|42150112|FG000|Double-Blind Study|Adverse Event|9|||
19705805|NCT00122382|42150113|FG001|Double-Blind Study|Adverse Event|11|||
19705806|NCT00122382|42150114|FG002|Double-Blind Study|Adverse Event|0|||
19705807|NCT00122382|42150112|FG000|Double-Blind Study|Death|2|||
19705808|NCT00122382|42150113|FG001|Double-Blind Study|Death|2|||
19705809|NCT00122382|42150114|FG002|Double-Blind Study|Death|0|||
19705810|NCT00122382|42150112|FG000|Double-Blind Study|Lack of Efficacy|0|||
19705811|NCT00122382|42150113|FG001|Double-Blind Study|Lack of Efficacy|8|||
19705812|NCT00122382|42150114|FG002|Double-Blind Study|Lack of Efficacy|0|||
19705813|NCT00122382|42150112|FG000|Double-Blind Study|Lost to Follow-up|2|||
19621845|NCT00810069|42071657|FG001|Double-Blind Period II|Adverse Event|9|||
19621846|NCT00810069|42071658|FG002|Double-Blind Period II|Adverse Event|8|||
19621847|NCT00810069|42071656|FG000|Double-Blind Period II|Lack of Efficacy|0|||
19621848|NCT00810069|42071657|FG001|Double-Blind Period II|Lack of Efficacy|7|||
19621849|NCT00810069|42071658|FG002|Double-Blind Period II|Lack of Efficacy|12|||
19621850|NCT00810069|42071656|FG000|Double-Blind Period II|Lost to Follow-up|0|||
19621851|NCT00810069|42071657|FG001|Double-Blind Period II|Lost to Follow-up|9|||
19621852|NCT00810069|42071658|FG002|Double-Blind Period II|Lost to Follow-up|9|||
19621853|NCT00810069|42071656|FG000|Double-Blind Period II|Physician Decision|0|||
19621854|NCT00810069|42071657|FG001|Double-Blind Period II|Physician Decision|0|||
19621855|NCT00810069|42071658|FG002|Double-Blind Period II|Physician Decision|1|||
19621856|NCT00810069|42071656|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
19621857|NCT00810069|42071657|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
19621858|NCT00810069|42071658|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
19705814|NCT00122382|42150113|FG001|Double-Blind Study|Lost to Follow-up|1|||
19705815|NCT00122382|42150114|FG002|Double-Blind Study|Lost to Follow-up|0|||
19705816|NCT00122382|42150112|FG000|Double-Blind Study|Pregnancy|2|||
19705817|NCT00122382|42150113|FG001|Double-Blind Study|Pregnancy|0|||
19705818|NCT00122382|42150114|FG002|Double-Blind Study|Pregnancy|0|||
19705819|NCT00122382|42150112|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
19705820|NCT00122382|42150113|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
19705821|NCT00122382|42150114|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
19621859|NCT00810069|42071656|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
19621860|NCT00810069|42071657|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
19621861|NCT00810069|42071658|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
19621862|NCT00810069|42071656|FG000|Double-Blind Period II|Clinical relapse|0|||
19621863|NCT00810069|42071657|FG001|Double-Blind Period II|Clinical relapse|3|||
19621864|NCT00810069|42071658|FG002|Double-Blind Period II|Clinical relapse|0|||
19621865|NCT00810069|42071656|FG000|Double-Blind Period II|Protocol Violation|0|||
19621866|NCT00810069|42071657|FG001|Double-Blind Period II|Protocol Violation|7|||
19621867|NCT00810069|42071658|FG002|Double-Blind Period II|Protocol Violation|6|||
19621868|NCT00489541|42071669|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
19621869|NCT00489541|42071670|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
19705822|NCT00122382|42150112|FG000|Double-Blind Study|Withdrawal of Consent|7|||
19705823|NCT00122382|42150113|FG001|Double-Blind Study|Withdrawal of Consent|3|||
19621870|NCT00489541|42071669|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
19621871|NCT00489541|42071670|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
19621872|NCT00489541|42071669|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
19621873|NCT00489541|42071670|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
19621874|NCT00489541|42071669|FG000|12-Month Clinical Follow-up|Death|3|||
19621875|NCT00489541|42071670|FG001|12-Month Clinical Follow-up|Death|2|||
19621876|NCT00489541|42071669|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
19621877|NCT00489541|42071670|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
19621878|NCT00489541|42071669|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
19621879|NCT00489541|42071670|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
19621880|NCT00809835|42071680|FG000|Overall Study|Lost to Follow-up|7|||
19621881|NCT00809835|42071681|FG001|Overall Study|Lost to Follow-up|6|||
19621882|NCT00809835|42071682|FG002|Overall Study|Lost to Follow-up|10|||
19621883|NCT00809835|42071683|FG003|Overall Study|Lost to Follow-up|2|||
19621884|NCT00809835|42071680|FG000|Overall Study|Withdrawal by Subject|1|||
19705824|NCT00122382|42150114|FG002|Double-Blind Study|Withdrawal of Consent|0|||
19705825|NCT00122382|42150112|FG000|Double-Blind Study|Protocol Violation|1|||
19705826|NCT00122382|42150113|FG001|Double-Blind Study|Protocol Violation|0|||
19705827|NCT00122382|42150114|FG002|Double-Blind Study|Protocol Violation|0|||
19705828|NCT00122382|42150112|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
19705829|NCT00122382|42150113|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
19705830|NCT00122382|42150114|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
19705831|NCT00122382|42150112|FG000|Double-Blind Study|Randomized but not treated|0|||
19705832|NCT00122382|42150113|FG001|Double-Blind Study|Randomized but not treated|2|||
19705833|NCT00122382|42150114|FG002|Double-Blind Study|Randomized but not treated|0|||
19705834|NCT00122382|42150112|FG000|Open-Label Study|Adverse Event|0|||
19517662|NCT01576146|41930647|FG000|Extension Period 1|Death|2|||
19517663|NCT01576146|41930647|FG000|Extension Period 1|Physician Decision|2|||
19517664|NCT01576146|41930647|FG000|Extension Period 1|Withdrawal by Subject|1|||
19517665|NCT01576146|41930647|FG000|Extension Period 1|Lost to Follow-up|1|||
19517666|NCT01576146|41930647|FG000|Extension Period 1|Parathyroidectomy|1|||
19621885|NCT00809835|42071681|FG001|Overall Study|Withdrawal by Subject|1|||
19621886|NCT00809835|42071682|FG002|Overall Study|Withdrawal by Subject|1|||
19621887|NCT00809835|42071683|FG003|Overall Study|Withdrawal by Subject|0|||
19621888|NCT00853242|42071700|FG000|Overall Study|Adverse Event|0|||
19517667|NCT01576146|41930647|FG000|Extension Period 1|Renal Transplant|1|||
19517668|NCT01576146|41930647|FG000|Extension Period 2|Sponsor Decision|13|||
19517669|NCT01576146|41930647|FG000|Extension Period 2|Death|1|||
19517670|NCT01576146|41930647|FG000|Extension Period 2|Adverse Event|1|||
19517671|NCT01576146|41930647|FG000|Extension Period 2|Renal Transplant|1|||
19517672|NCT01576146|41930647|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
19517673|NCT01553916|41930651|FG000|Overall Study|Withdrawal by Subject|2|||
19517674|NCT01553916|41930651|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
19517675|NCT01553136|41930657|FG000|Overall Study|Adverse Event|3|||
19517676|NCT01553136|41930658|FG001|Overall Study|Adverse Event|2|||
19621889|NCT00853242|42071701|FG001|Overall Study|Adverse Event|1|||
19621890|NCT00853242|42071702|FG002|Overall Study|Adverse Event|1|||
19621891|NCT00853242|42071703|FG003|Overall Study|Adverse Event|0|||
19621892|NCT00853242|42071704|FG004|Overall Study|Adverse Event|3|||
19621893|NCT00853242|42071705|FG005|Overall Study|Adverse Event|1|||
19705835|NCT00122382|42150113|FG001|Open-Label Study|Adverse Event|0|||
19705836|NCT00122382|42150114|FG002|Open-Label Study|Adverse Event|11|||
19705837|NCT00122382|42150112|FG000|Open-Label Study|Death|0|||
19705838|NCT00122382|42150113|FG001|Open-Label Study|Death|0|||
19705839|NCT00122382|42150114|FG002|Open-Label Study|Death|2|||
19705840|NCT00122382|42150112|FG000|Open-Label Study|Lack of Efficacy|0|||
19705841|NCT00122382|42150113|FG001|Open-Label Study|Lack of Efficacy|0|||
19705842|NCT00122382|42150114|FG002|Open-Label Study|Lack of Efficacy|3|||
19705843|NCT00122382|42150112|FG000|Open-Label Study|Lost to Follow-up|0|||
19705844|NCT00122382|42150113|FG001|Open-Label Study|Lost to Follow-up|0|||
19705845|NCT00122382|42150114|FG002|Open-Label Study|Lost to Follow-up|3|||
19705846|NCT00122382|42150112|FG000|Open-Label Study|Pregnancy|0|||
19705847|NCT00122382|42150113|FG001|Open-Label Study|Pregnancy|0|||
19705848|NCT00122382|42150114|FG002|Open-Label Study|Pregnancy|2|||
19705849|NCT00122382|42150112|FG000|Open-Label Study|Poor/Non-Compliance|0|||
19705850|NCT00122382|42150113|FG001|Open-Label Study|Poor/Non-Compliance|0|||
19705851|NCT00122382|42150114|FG002|Open-Label Study|Poor/Non-Compliance|1|||
19705852|NCT00122382|42150112|FG000|Open-Label Study|Withdrawal of Consent|0|||
19705853|NCT00122382|42150113|FG001|Open-Label Study|Withdrawal of Consent|0|||
19705854|NCT00122382|42150114|FG002|Open-Label Study|Withdrawal of Consent|4|||
19705855|NCT01028716|42150132|FG000|Overall Study|Physician Decision|1|||
19705856|NCT00106704|42150139|FG000|Overall Study|Adverse Event|10|||
19705857|NCT00106704|42150140|FG001|Overall Study|Adverse Event|7|||
19705858|NCT00106704|42150139|FG000|Overall Study|Death|2|||
19621894|NCT00853242|42071706|FG006|Overall Study|Adverse Event|1|||
19621895|NCT00853242|42071700|FG000|Overall Study|Noncompliant|0|||
19705859|NCT00106704|42150140|FG001|Overall Study|Death|1|||
19705860|NCT00106704|42150139|FG000|Overall Study|Lack of Efficacy|67|||
19705861|NCT00106704|42150140|FG001|Overall Study|Lack of Efficacy|69|||
19705862|NCT00106704|42150139|FG000|Overall Study|Lost to Follow-up|7|||
19705863|NCT00106704|42150140|FG001|Overall Study|Lost to Follow-up|3|||
19705864|NCT00106704|42150139|FG000|Overall Study|Pregnancy|1|||
19705865|NCT00106704|42150140|FG001|Overall Study|Pregnancy|0|||
19705866|NCT00106704|42150139|FG000|Overall Study|Protocol Violation|4|||
19705867|NCT00106704|42150140|FG001|Overall Study|Protocol Violation|7|||
19705868|NCT00106704|42150139|FG000|Overall Study|Withdrawal by Subject|14|||
19705869|NCT00106704|42150140|FG001|Overall Study|Withdrawal by Subject|21|||
19705870|NCT00106704|42150139|FG000|Overall Study|Patient moved|1|||
19705871|NCT00106704|42150140|FG001|Overall Study|Patient moved|0|||
19705872|NCT00106704|42150139|FG000|Overall Study|Site terminated|0|||
19705873|NCT00106704|42150140|FG001|Overall Study|Site terminated|1|||
19705874|NCT00106704|42150139|FG000|Overall Study|Planned major surgery|1|||
19705875|NCT00106704|42150140|FG001|Overall Study|Planned major surgery|0|||
19705876|NCT00106704|42150139|FG000|Overall Study|Patient Received Glycemic Medication|22|||
19705877|NCT00106704|42150140|FG001|Overall Study|Patient Received Glycemic Medication|41|||
19705878|NCT00106704|42150139|FG000|Overall Study|Unable to re-enter US|1|||
19705879|NCT00106704|42150140|FG001|Overall Study|Unable to re-enter US|0|||
19705880|NCT00106704|42150139|FG000|Overall Study|Laboratory test|1|||
19705881|NCT00106704|42150140|FG001|Overall Study|Laboratory test|1|||
19705882|NCT00105066|42150148|FG000|Overall Study|Adverse Event|2|||
19705883|NCT00105066|42150149|FG001|Overall Study|Adverse Event|5|||
19705884|NCT00104520|42150157|FG000|Overall Study|Unrelated adverse event|34|||
19517677|NCT01553136|41930657|FG000|Overall Study|Withdrawal by Subject|2|||
19517678|NCT01553136|41930658|FG001|Overall Study|Withdrawal by Subject|3|||
19621896|NCT00853242|42071701|FG001|Overall Study|Noncompliant|0|||
19621897|NCT00853242|42071702|FG002|Overall Study|Noncompliant|0|||
19621898|NCT00853242|42071703|FG003|Overall Study|Noncompliant|0|||
19621899|NCT00853242|42071704|FG004|Overall Study|Noncompliant|1|||
19621900|NCT00853242|42071705|FG005|Overall Study|Noncompliant|0|||
19621901|NCT00853242|42071706|FG006|Overall Study|Noncompliant|0|||
19621902|NCT00853242|42071700|FG000|Overall Study|Withdrawal by Subject|1|||
19621903|NCT00853242|42071701|FG001|Overall Study|Withdrawal by Subject|2|||
19621904|NCT00853242|42071702|FG002|Overall Study|Withdrawal by Subject|0|||
19621905|NCT00853242|42071703|FG003|Overall Study|Withdrawal by Subject|4|||
19394244|NCT02527161|41638342|FG000|Overall Study|Delay in or unfit for surgery|16|||
19621906|NCT00853242|42071704|FG004|Overall Study|Withdrawal by Subject|0|||
19621907|NCT00853242|42071705|FG005|Overall Study|Withdrawal by Subject|0|||
19621908|NCT00853242|42071706|FG006|Overall Study|Withdrawal by Subject|2|||
19621909|NCT00853242|42071700|FG000|Overall Study|Other|2|||
19621910|NCT00853242|42071701|FG001|Overall Study|Other|0|||
19621911|NCT00853242|42071702|FG002|Overall Study|Other|2|||
19621912|NCT00853242|42071703|FG003|Overall Study|Other|0|||
19621913|NCT00853242|42071704|FG004|Overall Study|Other|0|||
19621914|NCT00853242|42071705|FG005|Overall Study|Other|1|||
19621915|NCT00853242|42071706|FG006|Overall Study|Other|2|||
19621916|NCT00848250|42071730|FG000|Overall Study|surgery was completed without cardiopulm|0|||
19621917|NCT00848250|42071731|FG001|Overall Study|surgery was completed without cardiopulm|1|||
19621918|NCT00809757|42071741|FG000|Overall Study|Adverse Event|2|||
19621919|NCT00809757|42071742|FG001|Overall Study|Adverse Event|3|||
19621920|NCT00809757|42071743|FG002|Overall Study|Adverse Event|3|||
19621921|NCT00809757|42071741|FG000|Overall Study|Lost to Follow-up|0|||
19621922|NCT00809757|42071742|FG001|Overall Study|Lost to Follow-up|0|||
19621923|NCT00809757|42071743|FG002|Overall Study|Lost to Follow-up|1|||
19621924|NCT00809757|42071741|FG000|Overall Study|Protocol Violation|1|||
19621925|NCT00809757|42071742|FG001|Overall Study|Protocol Violation|1|||
19621926|NCT00809757|42071743|FG002|Overall Study|Protocol Violation|1|||
19621927|NCT00809757|42071741|FG000|Overall Study|Withdrawal by Subject|2|||
19621928|NCT00809757|42071742|FG001|Overall Study|Withdrawal by Subject|1|||
19621929|NCT00809757|42071743|FG002|Overall Study|Withdrawal by Subject|3|||
19621930|NCT00809757|42071741|FG000|Overall Study|Subject Uncooperative|1|||
19621931|NCT00809757|42071742|FG001|Overall Study|Subject Uncooperative|0|||
19621932|NCT00809757|42071743|FG002|Overall Study|Subject Uncooperative|2|||
19621933|NCT00809757|42071741|FG000|Overall Study|Noncompliance with Medication|0|||
19621934|NCT00809757|42071742|FG001|Overall Study|Noncompliance with Medication|0|||
19621935|NCT00809757|42071743|FG002|Overall Study|Noncompliance with Medication|1|||
19621936|NCT00594464|42071757|FG000|Overall Study|Withdrawal by Subject|1|||
19621937|NCT00594464|42071757|FG000|Overall Study|Delay in operation|2|||
19621938|NCT00809445|42071770|FG000|1 Month Follow-up|Lost contact|1|||
19621939|NCT00809445|42071771|FG001|1 Month Follow-up|Lost contact|2|||
19621940|NCT00809445|42071772|FG002|1 Month Follow-up|Lost contact|1|||
19621941|NCT00809445|42071770|FG000|1 Month Follow-up|Withdrew consent|1|||
19621942|NCT00809445|42071771|FG001|1 Month Follow-up|Withdrew consent|1|||
19621943|NCT00809445|42071772|FG002|1 Month Follow-up|Withdrew consent|1|||
19621944|NCT00809445|42071770|FG000|1 Month Follow-up|Death|0|||
19621945|NCT00809445|42071771|FG001|1 Month Follow-up|Death|1|||
19621946|NCT00809445|42071772|FG002|1 Month Follow-up|Death|1|||
19621947|NCT00809445|42071770|FG000|1 Month Follow-up|Incarcerated|0|||
19621948|NCT00809445|42071771|FG001|1 Month Follow-up|Incarcerated|0|||
19621949|NCT00809445|42071772|FG002|1 Month Follow-up|Incarcerated|1|||
19621950|NCT00809445|42071770|FG000|6 Month Follow-up|Lost contact|16|||
19621951|NCT00809445|42071771|FG001|6 Month Follow-up|Lost contact|14|||
19621952|NCT00809445|42071772|FG002|6 Month Follow-up|Lost contact|14|||
19621953|NCT00809445|42071770|FG000|6 Month Follow-up|Death|2|||
19621954|NCT00809445|42071771|FG001|6 Month Follow-up|Death|1|||
19621955|NCT00809445|42071772|FG002|6 Month Follow-up|Death|1|||
19621956|NCT00809445|42071770|FG000|6 Month Follow-up|Incarcerated|6|||
19621957|NCT00809445|42071771|FG001|6 Month Follow-up|Incarcerated|8|||
19621958|NCT00809445|42071772|FG002|6 Month Follow-up|Incarcerated|8|||
19621959|NCT00809445|42071770|FG000|6 Month Follow-up|Withdrew consent|0|||
19621960|NCT00809445|42071771|FG001|6 Month Follow-up|Withdrew consent|0|||
19621961|NCT00809445|42071772|FG002|6 Month Follow-up|Withdrew consent|1|||
19621962|NCT00593918|42071795|FG000|Overall Study|Withdrawal by Subject|5|||
19621963|NCT00593918|42071796|FG001|Overall Study|Withdrawal by Subject|24|||
19621964|NCT00593840|42071802|FG000|Overall Study|Withdrawal by Subject|1|||
19621965|NCT00499369|42071811|FG000|Overall Study|Adverse Event|2|||
19621966|NCT00499369|42071812|FG001|Overall Study|Adverse Event|2|||
19621967|NCT00499369|42071813|FG002|Overall Study|Adverse Event|3|||
19621968|NCT00499369|42071814|FG003|Overall Study|Adverse Event|1|||
19621969|NCT00499369|42071815|FG004|Overall Study|Adverse Event|2|||
19621970|NCT00499369|42071811|FG000|Overall Study|Withdrawal by Subject|0|||
19621971|NCT00499369|42071812|FG001|Overall Study|Withdrawal by Subject|1|||
19621972|NCT00499369|42071813|FG002|Overall Study|Withdrawal by Subject|1|||
19621973|NCT00499369|42071814|FG003|Overall Study|Withdrawal by Subject|0|||
19621974|NCT00499369|42071815|FG004|Overall Study|Withdrawal by Subject|0|||
19621975|NCT00499369|42071811|FG000|Overall Study|Progression|10|||
19394245|NCT02527161|41638342|FG000|Overall Study|MRI contraindication|6|||
19621976|NCT00499369|42071812|FG001|Overall Study|Progression|12|||
19621977|NCT00499369|42071813|FG002|Overall Study|Progression|9|||
19621978|NCT00499369|42071814|FG003|Overall Study|Progression|6|||
19621979|NCT00499369|42071815|FG004|Overall Study|Progression|10|||
19621980|NCT00499369|42071811|FG000|Overall Study|Death|0|||
19621981|NCT00499369|42071812|FG001|Overall Study|Death|1|||
19621982|NCT00499369|42071813|FG002|Overall Study|Death|0|||
19621983|NCT00499369|42071814|FG003|Overall Study|Death|0|||
19621984|NCT00499369|42071815|FG004|Overall Study|Death|0|||
19621985|NCT00499369|42071811|FG000|Overall Study|Not protocol specified|2|||
19621986|NCT00499369|42071812|FG001|Overall Study|Not protocol specified|0|||
19621987|NCT00499369|42071813|FG002|Overall Study|Not protocol specified|3|||
19621988|NCT00499369|42071814|FG003|Overall Study|Not protocol specified|1|||
19621989|NCT00499369|42071815|FG004|Overall Study|Not protocol specified|0|||
19621990|NCT00499369|42071811|FG000|Overall Study|Ineligible|2|||
19621991|NCT00499369|42071812|FG001|Overall Study|Ineligible|2|||
19621992|NCT00499369|42071813|FG002|Overall Study|Ineligible|1|||
19621993|NCT00499369|42071814|FG003|Overall Study|Ineligible|1|||
19621994|NCT00499369|42071815|FG004|Overall Study|Ineligible|0|||
19705885|NCT00104520|42150158|FG001|Overall Study|Unrelated adverse event|47|||
19705886|NCT00104520|42150157|FG000|Overall Study|Study drug intolerance|0|||
19705887|NCT00104520|42150158|FG001|Overall Study|Study drug intolerance|1|||
19705888|NCT00104520|42150157|FG000|Overall Study|Related adverse event|13|||
19705889|NCT00104520|42150158|FG001|Overall Study|Related adverse event|15|||
19705890|NCT00104520|42150157|FG000|Overall Study|Lost to Follow-up|1|||
19705891|NCT00104520|42150158|FG001|Overall Study|Lost to Follow-up|0|||
19705892|NCT00104520|42150157|FG000|Overall Study|Noncompliance|0|||
19705893|NCT00104520|42150158|FG001|Overall Study|Noncompliance|2|||
19705894|NCT00104520|42150157|FG000|Overall Study|Personal/administrative|1|||
19705895|NCT00104520|42150158|FG001|Overall Study|Personal/administrative|1|||
19705896|NCT00104520|42150157|FG000|Overall Study|Other|1|||
19705897|NCT00104520|42150158|FG001|Overall Study|Other|5|||
19705898|NCT00135330|42150167|FG000|Overall Study|Adverse Event|2|||
19705899|NCT00135330|42150168|FG001|Overall Study|Adverse Event|5|||
19705900|NCT00135330|42150169|FG002|Overall Study|Adverse Event|1|||
19705901|NCT00135330|42150167|FG000|Overall Study|Lost to Follow-up|0|||
19705902|NCT00135330|42150168|FG001|Overall Study|Lost to Follow-up|2|||
19705903|NCT00135330|42150169|FG002|Overall Study|Lost to Follow-up|3|||
19705904|NCT00135330|42150167|FG000|Overall Study|Physician Decision|1|||
19705905|NCT00135330|42150168|FG001|Overall Study|Physician Decision|1|||
19621995|NCT00869258|42071827|FG000|Overall Study|Physician Decision|1|||
19621996|NCT00693784|42071831|FG000|Overall Study|Lost to Follow-up|2|||
19705906|NCT00135330|42150169|FG002|Overall Study|Physician Decision|0|||
19705907|NCT00135330|42150167|FG000|Overall Study|Protocol Violation|4|||
19621997|NCT00693784|42071831|FG000|Overall Study|Withdrawal by Subject|2|||
19705908|NCT00135330|42150168|FG001|Overall Study|Protocol Violation|3|||
19705909|NCT00135330|42150169|FG002|Overall Study|Protocol Violation|3|||
19705910|NCT00135330|42150167|FG000|Overall Study|Patient Decision|5|||
19705911|NCT00135330|42150168|FG001|Overall Study|Patient Decision|1|||
19394246|NCT02527161|41638342|FG000|Overall Study|Consent violation|4|||
19621998|NCT00693706|42071837|FG000|Overall Study|Protocol Violation|0|||
19705912|NCT00135330|42150169|FG002|Overall Study|Patient Decision|4|||
19621999|NCT00693706|42071838|FG001|Overall Study|Protocol Violation|1|||
19622000|NCT00488683|42071847|FG000|Overall Study|Withdrawal by Subject|1|||
19622001|NCT00488683|42071848|FG001|Overall Study|Withdrawal by Subject|2|||
19622002|NCT00488683|42071849|FG002|Overall Study|Withdrawal by Subject|2|||
19622003|NCT00488683|42071847|FG000|Overall Study|Lost to Follow-up|5|||
19622004|NCT00488683|42071848|FG001|Overall Study|Lost to Follow-up|3|||
19622005|NCT00488683|42071849|FG002|Overall Study|Lost to Follow-up|0|||
19622006|NCT00488683|42071847|FG000|Overall Study|Protocol Violation|5|||
19622007|NCT00488683|42071848|FG001|Overall Study|Protocol Violation|1|||
19622008|NCT00488683|42071849|FG002|Overall Study|Protocol Violation|0|||
19622009|NCT00488683|42071847|FG000|Overall Study|Unable to Classify|1|||
19622010|NCT00488683|42071848|FG001|Overall Study|Unable to Classify|0|||
19622011|NCT00488683|42071849|FG002|Overall Study|Unable to Classify|0|||
19622012|NCT00693472|42071883|FG000|Part 1|Adverse Event|1|||
19622013|NCT00693472|42071884|FG001|Part 1|Adverse Event|1|||
19622014|NCT00693472|42071885|FG002|Part 1|Adverse Event|0|||
19622015|NCT00693472|42071886|FG003|Part 1|Adverse Event|0|||
19622016|NCT00693472|42071883|FG000|Part 1|Lost to Follow-up|0|||
19622017|NCT00693472|42071884|FG001|Part 1|Lost to Follow-up|1|||
19622018|NCT00693472|42071885|FG002|Part 1|Lost to Follow-up|0|||
19622019|NCT00693472|42071886|FG003|Part 1|Lost to Follow-up|0|||
19622020|NCT00693472|42071883|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
19622021|NCT00693472|42071884|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
19622022|NCT00693472|42071885|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
19622023|NCT00693472|42071886|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
19622024|NCT00693472|42071883|FG000|Part 2|Adverse Event|0|||
19622025|NCT00693472|42071884|FG001|Part 2|Adverse Event|0|||
19622026|NCT00693472|42071885|FG002|Part 2|Adverse Event|1|||
19622027|NCT00693472|42071886|FG003|Part 2|Adverse Event|0|||
19622028|NCT00693472|42071883|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
19622029|NCT00693472|42071884|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
19622030|NCT00693472|42071885|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
19622031|NCT00693472|42071886|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
19622032|NCT00498433|42071899|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
19622033|NCT00498433|42071900|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
19622034|NCT00498433|42071901|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
19622035|NCT00498433|42071899|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
19622036|NCT00498433|42071900|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
19622037|NCT00498433|42071901|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
19622038|NCT00498433|42071899|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
19622039|NCT00498433|42071900|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
19622040|NCT00498433|42071901|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
19622041|NCT00498433|42071899|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
19622042|NCT00498433|42071900|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
19622043|NCT00498433|42071901|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
19622044|NCT00498355|42071918|FG000|Overall Study|Lost to Follow-up|1|||
19622045|NCT04327271|42071925|FG000|Overall Study|Death|1|||
19622046|NCT04327271|42071926|FG001|Overall Study|Death|0|||
19622047|NCT04327271|42071925|FG000|Overall Study|Withdrawal by Subject|1|||
19622048|NCT04327271|42071926|FG001|Overall Study|Withdrawal by Subject|0|||
19622049|NCT04327271|42071925|FG000|Overall Study|randomization error (data capture)|4|||
19622050|NCT04327271|42071926|FG001|Overall Study|randomization error (data capture)|3|||
19622051|NCT00688636|42071943|FG000|Overall Study|Adverse Event|2|||
19622052|NCT00688636|42071944|FG001|Overall Study|Adverse Event|1|||
19622053|NCT00870740|42071956|FG000|Overall Study|Adverse Event|2|||
19622054|NCT00870740|42071957|FG001|Overall Study|Adverse Event|1|||
19622055|NCT00870740|42071958|FG002|Overall Study|Adverse Event|3|||
19622056|NCT00870740|42071959|FG003|Overall Study|Adverse Event|2|||
19622057|NCT00870740|42071960|FG004|Overall Study|Adverse Event|1|||
19622058|NCT00870740|42071961|FG005|Overall Study|Adverse Event|6|||
19622059|NCT00870740|42071956|FG000|Overall Study|Consent Withdrawn|6|||
19622060|NCT00870740|42071957|FG001|Overall Study|Consent Withdrawn|3|||
19622061|NCT00870740|42071958|FG002|Overall Study|Consent Withdrawn|4|||
19622062|NCT00870740|42071959|FG003|Overall Study|Consent Withdrawn|6|||
19622063|NCT00870740|42071960|FG004|Overall Study|Consent Withdrawn|6|||
19622064|NCT00870740|42071961|FG005|Overall Study|Consent Withdrawn|5|||
19622065|NCT00870740|42071956|FG000|Overall Study|Investigator Decision|2|||
19622066|NCT00870740|42071957|FG001|Overall Study|Investigator Decision|0|||
19622067|NCT00870740|42071958|FG002|Overall Study|Investigator Decision|1|||
19622068|NCT00870740|42071959|FG003|Overall Study|Investigator Decision|0|||
19622069|NCT00870740|42071960|FG004|Overall Study|Investigator Decision|0|||
19622070|NCT00870740|42071961|FG005|Overall Study|Investigator Decision|0|||
19622071|NCT00870740|42071956|FG000|Overall Study|Subject Non-compliance|0|||
19622072|NCT00870740|42071957|FG001|Overall Study|Subject Non-compliance|0|||
19622073|NCT00870740|42071958|FG002|Overall Study|Subject Non-compliance|0|||
19622074|NCT00870740|42071959|FG003|Overall Study|Subject Non-compliance|0|||
19622075|NCT00870740|42071960|FG004|Overall Study|Subject Non-compliance|0|||
19622076|NCT00870740|42071961|FG005|Overall Study|Subject Non-compliance|1|||
19622077|NCT00870740|42071956|FG000|Overall Study|Death|0|||
19622078|NCT00870740|42071957|FG001|Overall Study|Death|0|||
19622079|NCT00870740|42071958|FG002|Overall Study|Death|0|||
19622080|NCT00870740|42071959|FG003|Overall Study|Death|0|||
19622081|NCT00870740|42071960|FG004|Overall Study|Death|1|||
19622082|NCT00870740|42071961|FG005|Overall Study|Death|0|||
19622083|NCT00870740|42071956|FG000|Overall Study|Other|2|||
19622084|NCT00870740|42071957|FG001|Overall Study|Other|5|||
19622085|NCT00870740|42071958|FG002|Overall Study|Other|2|||
19622086|NCT00870740|42071959|FG003|Overall Study|Other|4|||
19622087|NCT00870740|42071960|FG004|Overall Study|Other|3|||
19622088|NCT00870740|42071961|FG005|Overall Study|Other|5|||
19622089|NCT00869024|42071988|FG000|Overall Study|Death|2|||
19622090|NCT00869024|42071989|FG001|Overall Study|Death|3|||
19622091|NCT00869024|42071988|FG000|Overall Study|Lost to Follow-up|0|||
19622092|NCT00869024|42071989|FG001|Overall Study|Lost to Follow-up|1|||
19622093|NCT00869024|42071988|FG000|Overall Study|Protocol Violation|0|||
19622094|NCT00869024|42071989|FG001|Overall Study|Protocol Violation|1|||
19622095|NCT00506779|42071997|FG000|Overall Study|Withdrawal by Subject|1|||
19622096|NCT00506779|42071998|FG001|Overall Study|Withdrawal by Subject|0|||
19622097|NCT00506779|42071999|FG002|Overall Study|Withdrawal by Subject|1|||
19622098|NCT00506779|42072000|FG003|Overall Study|Withdrawal by Subject|0|||
19622099|NCT00506779|42071997|FG000|Overall Study|Adverse Event|0|||
19622100|NCT00506779|42071998|FG001|Overall Study|Adverse Event|1|||
19622101|NCT00506779|42071999|FG002|Overall Study|Adverse Event|1|||
19622102|NCT00506779|42072000|FG003|Overall Study|Adverse Event|1|||
19622103|NCT00488293|42072013|FG000|Overall Study|Lost to Follow-up|28|||
19622104|NCT00488293|42072014|FG001|Overall Study|Lost to Follow-up|25|||
19622105|NCT00488293|42072013|FG000|Overall Study|Withdrawal by Subject|5|||
19622106|NCT00488293|42072014|FG001|Overall Study|Withdrawal by Subject|3|||
19622107|NCT00488293|42072013|FG000|Overall Study|Death|2|||
19622108|NCT00488293|42072014|FG001|Overall Study|Death|1|||
19622109|NCT00488293|42072013|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
19622110|NCT00488293|42072014|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
19622111|NCT00868790|42072020|FG000|Period 1|Adverse Event|1|||
19622112|NCT00868790|42072021|FG001|Period 1|Adverse Event|0|||
19622113|NCT00868790|42072022|FG002|Period 1|Adverse Event|0|||
19622114|NCT00868790|42072023|FG003|Period 1|Adverse Event|0|||
19622115|NCT00868790|42072024|FG004|Period 1|Adverse Event|0|||
19622116|NCT00868790|42072025|FG005|Period 1|Adverse Event|0|||
19622117|NCT00868790|42072026|FG006|Period 1|Adverse Event|0|||
19622118|NCT00868790|42072027|FG007|Period 1|Adverse Event|3|||
19622119|NCT00868790|42072028|FG008|Period 1|Adverse Event|1|||
19622120|NCT00868790|42072029|FG009|Period 1|Adverse Event|0|||
19622121|NCT00868790|42072030|FG010|Period 1|Adverse Event|0|||
19622122|NCT00868790|42072031|FG011|Period 1|Adverse Event|0|||
19622123|NCT00868790|42072032|FG012|Period 1|Adverse Event|0|||
19622124|NCT00868790|42072033|FG013|Period 1|Adverse Event|1|||
19622125|NCT00868790|42072020|FG000|Period 1|Protocol Violation|1|||
19622126|NCT00868790|42072021|FG001|Period 1|Protocol Violation|0|||
19622127|NCT00868790|42072022|FG002|Period 1|Protocol Violation|0|||
19622128|NCT00868790|42072023|FG003|Period 1|Protocol Violation|0|||
19622129|NCT00868790|42072024|FG004|Period 1|Protocol Violation|0|||
19622130|NCT00868790|42072025|FG005|Period 1|Protocol Violation|0|||
19622131|NCT00868790|42072026|FG006|Period 1|Protocol Violation|0|||
19622132|NCT00868790|42072027|FG007|Period 1|Protocol Violation|0|||
19394247|NCT02527161|41638342|FG000|Overall Study|Only Recruited to Part A|27|||
19394248|NCT02527161|41638342|FG000|Overall Study|Physician Decision|1|||
19394249|NCT02527161|41638342|FG000|Overall Study|Adverse Event|1|||
19622133|NCT00868790|42072028|FG008|Period 1|Protocol Violation|0|||
19622134|NCT00868790|42072029|FG009|Period 1|Protocol Violation|0|||
19622135|NCT00868790|42072030|FG010|Period 1|Protocol Violation|0|||
19622136|NCT00868790|42072031|FG011|Period 1|Protocol Violation|0|||
19622137|NCT00868790|42072032|FG012|Period 1|Protocol Violation|0|||
19705913|NCT00135330|42150167|FG000|Overall Study|Sponsor Decision|0|||
19622138|NCT00868790|42072033|FG013|Period 1|Protocol Violation|0|||
19622139|NCT00868790|42072020|FG000|Period 1|Withdrawal by Subject|0|||
19622140|NCT00868790|42072021|FG001|Period 1|Withdrawal by Subject|1|||
19622141|NCT00868790|42072022|FG002|Period 1|Withdrawal by Subject|0|||
19622142|NCT00868790|42072023|FG003|Period 1|Withdrawal by Subject|0|||
19622143|NCT00868790|42072024|FG004|Period 1|Withdrawal by Subject|0|||
19622144|NCT00868790|42072025|FG005|Period 1|Withdrawal by Subject|0|||
19622145|NCT00868790|42072026|FG006|Period 1|Withdrawal by Subject|0|||
19622146|NCT00868790|42072027|FG007|Period 1|Withdrawal by Subject|0|||
19622147|NCT00868790|42072028|FG008|Period 1|Withdrawal by Subject|0|||
19622148|NCT00868790|42072029|FG009|Period 1|Withdrawal by Subject|0|||
19622149|NCT00868790|42072030|FG010|Period 1|Withdrawal by Subject|0|||
19622150|NCT00868790|42072031|FG011|Period 1|Withdrawal by Subject|0|||
19622151|NCT00868790|42072032|FG012|Period 1|Withdrawal by Subject|0|||
19622152|NCT00868790|42072033|FG013|Period 1|Withdrawal by Subject|1|||
19622153|NCT00868790|42072020|FG000|Period 1|Abnormal Triglycerides|0|||
19705914|NCT00135330|42150168|FG001|Overall Study|Sponsor Decision|1|||
19622154|NCT00868790|42072021|FG001|Period 1|Abnormal Triglycerides|0|||
19622155|NCT00868790|42072022|FG002|Period 1|Abnormal Triglycerides|0|||
19622156|NCT00868790|42072023|FG003|Period 1|Abnormal Triglycerides|0|||
19622157|NCT00868790|42072024|FG004|Period 1|Abnormal Triglycerides|1|||
19622158|NCT00868790|42072025|FG005|Period 1|Abnormal Triglycerides|0|||
19622159|NCT00868790|42072026|FG006|Period 1|Abnormal Triglycerides|0|||
19622160|NCT00868790|42072027|FG007|Period 1|Abnormal Triglycerides|0|||
19622161|NCT00868790|42072028|FG008|Period 1|Abnormal Triglycerides|0|||
19622162|NCT00868790|42072029|FG009|Period 1|Abnormal Triglycerides|0|||
19622163|NCT00868790|42072030|FG010|Period 1|Abnormal Triglycerides|0|||
19622164|NCT00868790|42072031|FG011|Period 1|Abnormal Triglycerides|0|||
19622165|NCT00868790|42072032|FG012|Period 1|Abnormal Triglycerides|0|||
19622166|NCT00868790|42072033|FG013|Period 1|Abnormal Triglycerides|0|||
19622167|NCT00868790|42072020|FG000|Period 1|Lost to Follow-up|0|||
19622168|NCT00868790|42072021|FG001|Period 1|Lost to Follow-up|0|||
19622169|NCT00868790|42072022|FG002|Period 1|Lost to Follow-up|0|||
19622170|NCT00868790|42072023|FG003|Period 1|Lost to Follow-up|0|||
19622171|NCT00868790|42072024|FG004|Period 1|Lost to Follow-up|0|||
19622172|NCT00868790|42072025|FG005|Period 1|Lost to Follow-up|1|||
19622173|NCT00868790|42072026|FG006|Period 1|Lost to Follow-up|0|||
19622174|NCT00868790|42072027|FG007|Period 1|Lost to Follow-up|0|||
19622175|NCT00868790|42072028|FG008|Period 1|Lost to Follow-up|0|||
19622176|NCT00868790|42072029|FG009|Period 1|Lost to Follow-up|0|||
19622177|NCT00868790|42072030|FG010|Period 1|Lost to Follow-up|0|||
19622178|NCT00868790|42072031|FG011|Period 1|Lost to Follow-up|0|||
19622179|NCT00868790|42072032|FG012|Period 1|Lost to Follow-up|0|||
19622180|NCT00868790|42072033|FG013|Period 1|Lost to Follow-up|0|||
19622181|NCT00868790|42072020|FG000|Period 2|Adverse Event|0|||
19622182|NCT00868790|42072021|FG001|Period 2|Adverse Event|0|||
19622183|NCT00868790|42072022|FG002|Period 2|Adverse Event|0|||
19622184|NCT00868790|42072023|FG003|Period 2|Adverse Event|0|||
19622185|NCT00868790|42072024|FG004|Period 2|Adverse Event|0|||
19622186|NCT00868790|42072025|FG005|Period 2|Adverse Event|0|||
19622187|NCT00868790|42072026|FG006|Period 2|Adverse Event|0|||
19622188|NCT00868790|42072027|FG007|Period 2|Adverse Event|0|||
19622189|NCT00868790|42072028|FG008|Period 2|Adverse Event|1|||
19622190|NCT00868790|42072029|FG009|Period 2|Adverse Event|0|||
19622191|NCT00868790|42072030|FG010|Period 2|Adverse Event|0|||
19622192|NCT00868790|42072031|FG011|Period 2|Adverse Event|0|||
19622193|NCT00868790|42072032|FG012|Period 2|Adverse Event|0|||
19622194|NCT00868790|42072033|FG013|Period 2|Adverse Event|0|||
19622195|NCT00868790|42072020|FG000|Period 2|Lost to Follow-up|0|||
19622196|NCT00868790|42072021|FG001|Period 2|Lost to Follow-up|1|||
19622197|NCT00868790|42072022|FG002|Period 2|Lost to Follow-up|0|||
19622198|NCT00868790|42072023|FG003|Period 2|Lost to Follow-up|0|||
19622199|NCT00868790|42072024|FG004|Period 2|Lost to Follow-up|0|||
19622200|NCT00868790|42072025|FG005|Period 2|Lost to Follow-up|1|||
19622201|NCT00868790|42072026|FG006|Period 2|Lost to Follow-up|0|||
19622202|NCT00868790|42072027|FG007|Period 2|Lost to Follow-up|0|||
19622203|NCT00868790|42072028|FG008|Period 2|Lost to Follow-up|0|||
19622204|NCT00868790|42072029|FG009|Period 2|Lost to Follow-up|0|||
19622205|NCT00868790|42072030|FG010|Period 2|Lost to Follow-up|0|||
19622206|NCT00868790|42072031|FG011|Period 2|Lost to Follow-up|0|||
19622207|NCT00868790|42072032|FG012|Period 2|Lost to Follow-up|0|||
19622208|NCT00868790|42072033|FG013|Period 2|Lost to Follow-up|0|||
19622209|NCT00868790|42072020|FG000|Period 2|Withdrawal by Subject|0|||
19622210|NCT00868790|42072021|FG001|Period 2|Withdrawal by Subject|0|||
19622211|NCT00868790|42072022|FG002|Period 2|Withdrawal by Subject|0|||
19622212|NCT00868790|42072023|FG003|Period 2|Withdrawal by Subject|0|||
19622213|NCT00868790|42072024|FG004|Period 2|Withdrawal by Subject|0|||
19622214|NCT00868790|42072025|FG005|Period 2|Withdrawal by Subject|0|||
19622215|NCT00868790|42072026|FG006|Period 2|Withdrawal by Subject|0|||
19622216|NCT00868790|42072027|FG007|Period 2|Withdrawal by Subject|0|||
19622217|NCT00868790|42072028|FG008|Period 2|Withdrawal by Subject|1|||
19622218|NCT00868790|42072029|FG009|Period 2|Withdrawal by Subject|0|||
19622219|NCT00868790|42072030|FG010|Period 2|Withdrawal by Subject|0|||
19622220|NCT00868790|42072031|FG011|Period 2|Withdrawal by Subject|0|||
19622221|NCT00868790|42072032|FG012|Period 2|Withdrawal by Subject|0|||
19622222|NCT00868790|42072033|FG013|Period 2|Withdrawal by Subject|1|||
19622223|NCT00868790|42072020|FG000|Period 3|Adverse Event|0|||
19622224|NCT00868790|42072021|FG001|Period 3|Adverse Event|0|||
19622225|NCT00868790|42072022|FG002|Period 3|Adverse Event|0|||
19622226|NCT00868790|42072023|FG003|Period 3|Adverse Event|0|||
19622227|NCT00868790|42072024|FG004|Period 3|Adverse Event|0|||
19622228|NCT00868790|42072025|FG005|Period 3|Adverse Event|0|||
19622229|NCT00868790|42072026|FG006|Period 3|Adverse Event|0|||
19622230|NCT00868790|42072027|FG007|Period 3|Adverse Event|0|||
19622231|NCT00868790|42072028|FG008|Period 3|Adverse Event|0|||
19622232|NCT00868790|42072029|FG009|Period 3|Adverse Event|1|||
19622233|NCT00868790|42072030|FG010|Period 3|Adverse Event|0|||
19622234|NCT00868790|42072031|FG011|Period 3|Adverse Event|0|||
19622235|NCT00868790|42072032|FG012|Period 3|Adverse Event|0|||
19622236|NCT00868790|42072033|FG013|Period 3|Adverse Event|0|||
19622237|NCT00868790|42072020|FG000|Period 3|Protocol Violation|0|||
19622238|NCT00868790|42072021|FG001|Period 3|Protocol Violation|0|||
19622239|NCT00868790|42072022|FG002|Period 3|Protocol Violation|0|||
19622240|NCT00868790|42072023|FG003|Period 3|Protocol Violation|0|||
19622241|NCT00868790|42072024|FG004|Period 3|Protocol Violation|0|||
19622242|NCT00868790|42072025|FG005|Period 3|Protocol Violation|0|||
19622243|NCT00868790|42072026|FG006|Period 3|Protocol Violation|0|||
19622244|NCT00868790|42072027|FG007|Period 3|Protocol Violation|0|||
19622245|NCT00868790|42072028|FG008|Period 3|Protocol Violation|0|||
19622246|NCT00868790|42072029|FG009|Period 3|Protocol Violation|0|||
19622247|NCT00868790|42072030|FG010|Period 3|Protocol Violation|1|||
19622248|NCT00868790|42072031|FG011|Period 3|Protocol Violation|0|||
19622249|NCT00868790|42072032|FG012|Period 3|Protocol Violation|0|||
19622250|NCT00868790|42072033|FG013|Period 3|Protocol Violation|0|||
19622251|NCT00868790|42072020|FG000|Period 3|Study Terminated by Sponsor|0|||
19622252|NCT00868790|42072021|FG001|Period 3|Study Terminated by Sponsor|0|||
19622253|NCT00868790|42072022|FG002|Period 3|Study Terminated by Sponsor|0|||
19622254|NCT00868790|42072023|FG003|Period 3|Study Terminated by Sponsor|1|||
19622255|NCT00868790|42072024|FG004|Period 3|Study Terminated by Sponsor|0|||
19622256|NCT00868790|42072025|FG005|Period 3|Study Terminated by Sponsor|0|||
19622257|NCT00868790|42072026|FG006|Period 3|Study Terminated by Sponsor|0|||
19622258|NCT00868790|42072027|FG007|Period 3|Study Terminated by Sponsor|0|||
19622259|NCT00868790|42072028|FG008|Period 3|Study Terminated by Sponsor|0|||
19622260|NCT00868790|42072029|FG009|Period 3|Study Terminated by Sponsor|0|||
19622261|NCT00868790|42072030|FG010|Period 3|Study Terminated by Sponsor|0|||
19622262|NCT00868790|42072031|FG011|Period 3|Study Terminated by Sponsor|0|||
19622263|NCT00868790|42072032|FG012|Period 3|Study Terminated by Sponsor|0|||
19622264|NCT00868790|42072033|FG013|Period 3|Study Terminated by Sponsor|0|||
19622265|NCT00868790|42072020|FG000|Period 4|Adverse Event|0|||
19622266|NCT00868790|42072021|FG001|Period 4|Adverse Event|0|||
19622267|NCT00868790|42072022|FG002|Period 4|Adverse Event|0|||
19622268|NCT00868790|42072023|FG003|Period 4|Adverse Event|0|||
19622269|NCT00868790|42072024|FG004|Period 4|Adverse Event|0|||
19622270|NCT00868790|42072025|FG005|Period 4|Adverse Event|0|||
19622271|NCT00868790|42072026|FG006|Period 4|Adverse Event|0|||
19622272|NCT00868790|42072027|FG007|Period 4|Adverse Event|1|||
19622273|NCT00868790|42072028|FG008|Period 4|Adverse Event|0|||
19622274|NCT00868790|42072029|FG009|Period 4|Adverse Event|0|||
19622275|NCT00868790|42072030|FG010|Period 4|Adverse Event|1|||
19622276|NCT00868790|42072031|FG011|Period 4|Adverse Event|0|||
19622277|NCT00868790|42072032|FG012|Period 4|Adverse Event|1|||
19622278|NCT00868790|42072033|FG013|Period 4|Adverse Event|0|||
19622279|NCT00868790|42072020|FG000|Period 4|Lost to Follow-up|0|||
19622280|NCT00868790|42072021|FG001|Period 4|Lost to Follow-up|0|||
19622281|NCT00868790|42072022|FG002|Period 4|Lost to Follow-up|0|||
19622282|NCT00868790|42072023|FG003|Period 4|Lost to Follow-up|0|||
19622283|NCT00868790|42072024|FG004|Period 4|Lost to Follow-up|0|||
19622284|NCT00868790|42072025|FG005|Period 4|Lost to Follow-up|0|||
19622285|NCT00868790|42072026|FG006|Period 4|Lost to Follow-up|0|||
19622286|NCT00868790|42072027|FG007|Period 4|Lost to Follow-up|1|||
19622287|NCT00868790|42072028|FG008|Period 4|Lost to Follow-up|0|||
19622288|NCT00868790|42072029|FG009|Period 4|Lost to Follow-up|0|||
19622289|NCT00868790|42072030|FG010|Period 4|Lost to Follow-up|0|||
19622290|NCT00868790|42072031|FG011|Period 4|Lost to Follow-up|0|||
19622291|NCT00868790|42072032|FG012|Period 4|Lost to Follow-up|0|||
19622292|NCT00868790|42072033|FG013|Period 4|Lost to Follow-up|0|||
19622293|NCT00868790|42072020|FG000|Period 4|Study Terminated by Sponsor|2|||
19622294|NCT00868790|42072021|FG001|Period 4|Study Terminated by Sponsor|0|||
19622295|NCT00868790|42072022|FG002|Period 4|Study Terminated by Sponsor|0|||
19622296|NCT00868790|42072023|FG003|Period 4|Study Terminated by Sponsor|0|||
19622297|NCT00868790|42072024|FG004|Period 4|Study Terminated by Sponsor|0|||
19705915|NCT00135330|42150169|FG002|Overall Study|Sponsor Decision|0|||
19705916|NCT00134784|42150181|FG000|Overall Study|Withdrawal by Subject|2|||
19705917|NCT00134784|42150182|FG001|Overall Study|Withdrawal by Subject|2|||
19705918|NCT00134784|42150183|FG002|Overall Study|Withdrawal by Subject|2|||
19705919|NCT00134784|42150184|FG003|Overall Study|Withdrawal by Subject|1|||
19705920|NCT00134082|42150191|FG000|Overall Study|Adverse Event|2|||
19705921|NCT00134082|42150191|FG000|Overall Study|Death|1|||
19622298|NCT00868790|42072025|FG005|Period 4|Study Terminated by Sponsor|0|||
19622299|NCT00868790|42072026|FG006|Period 4|Study Terminated by Sponsor|0|||
19622300|NCT00868790|42072027|FG007|Period 4|Study Terminated by Sponsor|1|||
19622301|NCT00868790|42072028|FG008|Period 4|Study Terminated by Sponsor|2|||
19622302|NCT00868790|42072029|FG009|Period 4|Study Terminated by Sponsor|0|||
19622303|NCT00868790|42072030|FG010|Period 4|Study Terminated by Sponsor|2|||
19622304|NCT00868790|42072031|FG011|Period 4|Study Terminated by Sponsor|1|||
19622305|NCT00868790|42072032|FG012|Period 4|Study Terminated by Sponsor|0|||
19622306|NCT00868790|42072033|FG013|Period 4|Study Terminated by Sponsor|1|||
19622307|NCT00868790|42072020|FG000|Period 4|Abnormal ALT/AST|0|||
19622308|NCT00868790|42072021|FG001|Period 4|Abnormal ALT/AST|0|||
19622309|NCT00868790|42072022|FG002|Period 4|Abnormal ALT/AST|1|||
19705922|NCT03703336|42150197|FG000|Overall Study|Parent withdrew consent|29|||
19622310|NCT00868790|42072023|FG003|Period 4|Abnormal ALT/AST|0|||
19622311|NCT00868790|42072024|FG004|Period 4|Abnormal ALT/AST|0|||
19622312|NCT00868790|42072025|FG005|Period 4|Abnormal ALT/AST|0|||
19622313|NCT00868790|42072026|FG006|Period 4|Abnormal ALT/AST|0|||
19622314|NCT00868790|42072027|FG007|Period 4|Abnormal ALT/AST|0|||
19622315|NCT00868790|42072028|FG008|Period 4|Abnormal ALT/AST|0|||
19622316|NCT00868790|42072029|FG009|Period 4|Abnormal ALT/AST|0|||
19622317|NCT00868790|42072030|FG010|Period 4|Abnormal ALT/AST|0|||
19622318|NCT00868790|42072031|FG011|Period 4|Abnormal ALT/AST|0|||
19622319|NCT00868790|42072032|FG012|Period 4|Abnormal ALT/AST|0|||
19622320|NCT00868790|42072033|FG013|Period 4|Abnormal ALT/AST|0|||
19705923|NCT03703336|42150198|FG001|Overall Study|Parent withdrew consent|8|||
19622321|NCT00868790|42072020|FG000|Post-study|Withdrawal by Subject|0|||
19622322|NCT00868790|42072021|FG001|Post-study|Withdrawal by Subject|0|||
19622323|NCT00868790|42072022|FG002|Post-study|Withdrawal by Subject|0|||
19622324|NCT00868790|42072023|FG003|Post-study|Withdrawal by Subject|0|||
19622325|NCT00868790|42072024|FG004|Post-study|Withdrawal by Subject|1|||
19622326|NCT00868790|42072025|FG005|Post-study|Withdrawal by Subject|0|||
19622327|NCT00868790|42072026|FG006|Post-study|Withdrawal by Subject|0|||
19622328|NCT00868790|42072027|FG007|Post-study|Withdrawal by Subject|0|||
19705924|NCT03703336|42150197|FG000|Overall Study|Migration|3|||
19705925|NCT03703336|42150198|FG001|Overall Study|Migration|3|||
19705926|NCT03703336|42150197|FG000|Overall Study|Protocol Violation|3|||
19705927|NCT03703336|42150198|FG001|Overall Study|Protocol Violation|1|||
19705928|NCT03703336|42150197|FG000|Overall Study|Physician Decision|2|||
19622329|NCT00868790|42072028|FG008|Post-study|Withdrawal by Subject|0|||
19622330|NCT00868790|42072029|FG009|Post-study|Withdrawal by Subject|0|||
19622331|NCT00868790|42072030|FG010|Post-study|Withdrawal by Subject|0|||
19622332|NCT00868790|42072031|FG011|Post-study|Withdrawal by Subject|0|||
19622333|NCT00868790|42072032|FG012|Post-study|Withdrawal by Subject|0|||
19622334|NCT00868790|42072033|FG013|Post-study|Withdrawal by Subject|0|||
19705929|NCT03703336|42150198|FG001|Overall Study|Physician Decision|0|||
19705930|NCT03703336|42150197|FG000|Overall Study|Adverse Event|0|||
19705931|NCT03703336|42150198|FG001|Overall Study|Adverse Event|2|||
19622335|NCT00868790|42072020|FG000|Post-study|Excluded Medication|0|||
19622336|NCT00868790|42072021|FG001|Post-study|Excluded Medication|0|||
19622337|NCT00868790|42072022|FG002|Post-study|Excluded Medication|0|||
19622338|NCT00868790|42072023|FG003|Post-study|Excluded Medication|0|||
19622339|NCT00868790|42072024|FG004|Post-study|Excluded Medication|0|||
19622340|NCT00868790|42072025|FG005|Post-study|Excluded Medication|0|||
19622341|NCT00868790|42072026|FG006|Post-study|Excluded Medication|0|||
19622342|NCT00868790|42072027|FG007|Post-study|Excluded Medication|2|||
19622343|NCT00868790|42072028|FG008|Post-study|Excluded Medication|0|||
19622344|NCT00868790|42072029|FG009|Post-study|Excluded Medication|1|||
19622345|NCT00868790|42072030|FG010|Post-study|Excluded Medication|0|||
19622346|NCT00868790|42072031|FG011|Post-study|Excluded Medication|0|||
19622347|NCT00868790|42072032|FG012|Post-study|Excluded Medication|0|||
19622348|NCT00868790|42072033|FG013|Post-study|Excluded Medication|0|||
19622349|NCT00496483|42072049|FG000|Overall Study|Not dosed|9|||
19622350|NCT00496483|42072049|FG000|Overall Study|Adverse Event|2|||
19622351|NCT00496483|42072049|FG000|Overall Study|Lack of Efficacy|1|||
19622352|NCT03528551|42072059|FG000|Overall Study|Lost to Follow-up|0|||
19622353|NCT03528551|42072060|FG001|Overall Study|Lost to Follow-up|1|||
19622354|NCT03528551|42072061|FG002|Overall Study|Lost to Follow-up|0|||
19622355|NCT03528551|42072059|FG000|Overall Study|Transferred to other arm/group|2|||
19622356|NCT03528551|42072060|FG001|Overall Study|Transferred to other arm/group|3|||
19622357|NCT03528551|42072061|FG002|Overall Study|Transferred to other arm/group|0|||
19622358|NCT03528551|42072059|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19622359|NCT03528551|42072060|FG001|Overall Study|Withdrawal by parent/guardian|5|||
19622360|NCT03528551|42072061|FG002|Overall Study|Withdrawal by parent/guardian|0|||
19705932|NCT03703336|42150197|FG000|Overall Study|Lost to Follow-up|1|||
19622361|NCT03528551|42072059|FG000|Overall Study|Protocol Violation|0|||
19622362|NCT03528551|42072060|FG001|Overall Study|Protocol Violation|3|||
19622363|NCT03528551|42072061|FG002|Overall Study|Protocol Violation|0|||
19705933|NCT03703336|42150198|FG001|Overall Study|Lost to Follow-up|0|||
19622364|NCT03528551|42072059|FG000|Overall Study|Withdrawal by Subject|0|||
19622365|NCT03528551|42072060|FG001|Overall Study|Withdrawal by Subject|7|||
19622366|NCT03528551|42072061|FG002|Overall Study|Withdrawal by Subject|0|||
19622367|NCT00487981|42072070|FG000|Overall Study|Hypothyroidism diagnosis|1|||
19622368|NCT00861744|42072078|FG000|Overall Study|Adverse Event|0|||
19622369|NCT00861744|42072079|FG001|Overall Study|Adverse Event|0|||
19622370|NCT00861744|42072080|FG002|Overall Study|Adverse Event|0|||
19622371|NCT00861744|42072081|FG003|Overall Study|Adverse Event|1|||
19622372|NCT00861744|42072078|FG000|Overall Study|Lost to Follow-up|7|||
19622373|NCT00861744|42072079|FG001|Overall Study|Lost to Follow-up|19|||
19622374|NCT00861744|42072080|FG002|Overall Study|Lost to Follow-up|17|||
19622375|NCT00861744|42072081|FG003|Overall Study|Lost to Follow-up|12|||
19622376|NCT00861744|42072078|FG000|Overall Study|Withdrawal by Subject|10|||
19622377|NCT00861744|42072079|FG001|Overall Study|Withdrawal by Subject|6|||
19622378|NCT00861744|42072080|FG002|Overall Study|Withdrawal by Subject|6|||
19622379|NCT00861744|42072081|FG003|Overall Study|Withdrawal by Subject|19|||
19622380|NCT00861744|42072078|FG000|Overall Study|Protocol Violation|0|||
19622381|NCT00861744|42072079|FG001|Overall Study|Protocol Violation|1|||
19622382|NCT00861744|42072080|FG002|Overall Study|Protocol Violation|0|||
19622383|NCT00861744|42072081|FG003|Overall Study|Protocol Violation|0|||
19622384|NCT00861744|42072078|FG000|Overall Study|Migration from study area|0|||
19622385|NCT00861744|42072079|FG001|Overall Study|Migration from study area|3|||
19622386|NCT00861744|42072080|FG002|Overall Study|Migration from study area|1|||
19622387|NCT00861744|42072081|FG003|Overall Study|Migration from study area|0|||
19705934|NCT03702166|42150204|FG000|Overall Study|Lost to Follow-up|1|||
19705935|NCT03702166|42150204|FG000|Overall Study|Withdrawal by Subject|1|||
19705936|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
19705937|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
19705938|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
19705939|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
19705940|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
19622388|NCT00861744|42072078|FG000|Overall Study|Blood draws|0|||
19622389|NCT00861744|42072079|FG001|Overall Study|Blood draws|0|||
19622390|NCT00861744|42072080|FG002|Overall Study|Blood draws|0|||
19622391|NCT00861744|42072081|FG003|Overall Study|Blood draws|1|||
19622392|NCT00603239|42072093|FG000|Overall Study|Adverse Event|4|||
19622393|NCT00603239|42072094|FG001|Overall Study|Adverse Event|1|||
19622394|NCT00603239|42072093|FG000|Overall Study|Entry criteria not met|0|||
19622395|NCT00603239|42072094|FG001|Overall Study|Entry criteria not met|1|||
19622396|NCT00603239|42072093|FG000|Overall Study|Loss of glucose control|3|||
19622397|NCT00603239|42072094|FG001|Overall Study|Loss of glucose control|0|||
19622398|NCT00603239|42072093|FG000|Overall Study|Lost to Follow-up|2|||
19622399|NCT00603239|42072094|FG001|Overall Study|Lost to Follow-up|1|||
19622400|NCT00603239|42072093|FG000|Overall Study|Physician Decision|2|||
19622401|NCT00603239|42072094|FG001|Overall Study|Physician Decision|0|||
19622402|NCT00603239|42072093|FG000|Overall Study|Protocol Violation|2|||
19622403|NCT00603239|42072094|FG001|Overall Study|Protocol Violation|0|||
19622404|NCT00603239|42072093|FG000|Overall Study|Subject decision|2|||
19622405|NCT00603239|42072094|FG001|Overall Study|Subject decision|1|||
19622406|NCT00852930|42072103|FG000|Overall Study|Withdrawal by Subject|1|||
19622407|NCT00852930|42072104|FG001|Overall Study|Withdrawal by Subject|1|||
19622408|NCT00852930|42072105|FG002|Overall Study|Withdrawal by Subject|1|||
19622409|NCT00852930|42072103|FG000|Overall Study|Physician Decision|0|||
19622410|NCT00852930|42072104|FG001|Overall Study|Physician Decision|0|||
19622411|NCT00852930|42072105|FG002|Overall Study|Physician Decision|1|||
19705941|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
19705942|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
19705943|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
19705944|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
19705945|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
19705946|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
19705947|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
19705948|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
19705949|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
19705950|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
19705951|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
19705952|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
19705953|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
19705954|NCT00132678|42150211|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
19622412|NCT00852540|42072116|FG000|Overall Study|Adverse Event|10|||
19622413|NCT00852540|42072117|FG001|Overall Study|Adverse Event|3|||
19622414|NCT00852540|42072116|FG000|Overall Study|Lack of Efficacy|15|||
19622415|NCT00852540|42072117|FG001|Overall Study|Lack of Efficacy|3|||
19622416|NCT00852540|42072116|FG000|Overall Study|Protocol Violation|1|||
19622417|NCT00852540|42072117|FG001|Overall Study|Protocol Violation|2|||
19622418|NCT00852540|42072116|FG000|Overall Study|Lost to Follow-up|2|||
19622419|NCT00852540|42072117|FG001|Overall Study|Lost to Follow-up|3|||
19622420|NCT00852540|42072116|FG000|Overall Study|Investigator Discretion|2|||
19622421|NCT00852540|42072117|FG001|Overall Study|Investigator Discretion|3|||
19622422|NCT00852540|42072116|FG000|Overall Study|Withdrawal by Subject|3|||
19622423|NCT00852540|42072117|FG001|Overall Study|Withdrawal by Subject|1|||
19622424|NCT00852540|42072116|FG000|Overall Study|Did Not Receive Study Drug|3|||
19622425|NCT00852540|42072117|FG001|Overall Study|Did Not Receive Study Drug|3|||
19622426|NCT00861198|42072124|FG000|Overall Study|SpyGlass Failed|5|||
19622427|NCT00847704|42072128|FG000|Overall Study|Withdrawal by Subject|1|||
19622428|NCT00860574|42072132|FG000|Overall Study|Death|2|||
19622429|NCT00860574|42072132|FG000|Overall Study|Relapse|1|||
19622430|NCT00496015|42072141|FG000|Overall Study|Other|1|||
19622431|NCT00496015|42072142|FG001|Overall Study|Other|0|||
19622432|NCT00496015|42072143|FG002|Overall Study|Other|0|||
19622433|NCT00496015|42072144|FG003|Overall Study|Other|1|||
19622434|NCT00496015|42072145|FG004|Overall Study|Other|0|||
19622435|NCT00487825|42072167|FG000|Overall Study|Adverse Event|2|||
19622436|NCT00487825|42072168|FG001|Overall Study|Adverse Event|2|||
19622437|NCT00487825|42072167|FG000|Overall Study|Lack of Efficacy|1|||
19622438|NCT00487825|42072168|FG001|Overall Study|Lack of Efficacy|1|||
19622439|NCT00487825|42072167|FG000|Overall Study|Other|3|||
19622440|NCT00487825|42072168|FG001|Overall Study|Other|2|||
19622441|NCT00487747|42072174|FG000|Overall Study|Adverse Event|1|||
19622442|NCT00487747|42072174|FG000|Overall Study|Lost to Follow-up|9|||
19622443|NCT00487747|42072174|FG000|Overall Study|Lack of Efficacy|1|||
19622444|NCT00487435|42072178|FG000|Overall Study|Adverse Event|146|||
19622445|NCT00487435|42072178|FG000|Overall Study|Death|2|||
19622446|NCT00487435|42072178|FG000|Overall Study|Lack of Efficacy|33|||
19622447|NCT00487435|42072178|FG000|Overall Study|Lost to Follow-up|54|||
19622448|NCT00487435|42072178|FG000|Overall Study|Pregnancy|2|||
19622449|NCT00487435|42072178|FG000|Overall Study|Withdrawal by Subject|132|||
19622450|NCT00487435|42072178|FG000|Overall Study|Resolution Of Pain|1|||
19622451|NCT00487435|42072178|FG000|Overall Study|Study Medication Non-Compliant|32|||
19622452|NCT00487435|42072178|FG000|Overall Study|Other|83|||
19622453|NCT00487279|42072184|FG000|Overall Study|Death|1|||
19622454|NCT00487279|42072185|FG001|Overall Study|Death|0|||
19622455|NCT00487279|42072184|FG000|Overall Study|Withdrawal by Subject|0|||
19622456|NCT00487279|42072185|FG001|Overall Study|Withdrawal by Subject|2|||
19622457|NCT00495625|42072191|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
19622458|NCT00847626|42072206|FG000|Overall Study|Adverse Event|10|||
19622459|NCT00847626|42072207|FG001|Overall Study|Adverse Event|10|||
19622460|NCT00847626|42072208|FG002|Overall Study|Adverse Event|6|||
19622461|NCT00847626|42072209|FG003|Overall Study|Adverse Event|19|||
19622462|NCT00847626|42072210|FG004|Overall Study|Adverse Event|11|||
19622463|NCT00847626|42072211|FG005|Overall Study|Adverse Event|22|||
19622464|NCT00847626|42072212|FG006|Overall Study|Adverse Event|4|||
19622465|NCT00847626|42072213|FG007|Overall Study|Adverse Event|6|||
19622466|NCT00847626|42072214|FG008|Overall Study|Adverse Event|3|||
19622467|NCT00847626|42072215|FG009|Overall Study|Adverse Event|6|||
19622468|NCT00847626|42072216|FG010|Overall Study|Adverse Event|6|||
19622469|NCT00847626|42072206|FG000|Overall Study|Protocol Violation|2|||
19622470|NCT00847626|42072207|FG001|Overall Study|Protocol Violation|1|||
19622471|NCT00847626|42072208|FG002|Overall Study|Protocol Violation|2|||
19622472|NCT00847626|42072209|FG003|Overall Study|Protocol Violation|1|||
19622473|NCT00847626|42072210|FG004|Overall Study|Protocol Violation|1|||
19622474|NCT00847626|42072211|FG005|Overall Study|Protocol Violation|1|||
19622475|NCT00847626|42072212|FG006|Overall Study|Protocol Violation|1|||
19622476|NCT00847626|42072213|FG007|Overall Study|Protocol Violation|1|||
19622477|NCT00847626|42072214|FG008|Overall Study|Protocol Violation|0|||
19622478|NCT00847626|42072215|FG009|Overall Study|Protocol Violation|1|||
19622479|NCT00847626|42072216|FG010|Overall Study|Protocol Violation|1|||
19622480|NCT00847626|42072206|FG000|Overall Study|Lost to Follow-up|0|||
19622481|NCT00847626|42072207|FG001|Overall Study|Lost to Follow-up|1|||
19622482|NCT00847626|42072208|FG002|Overall Study|Lost to Follow-up|1|||
19622483|NCT00847626|42072209|FG003|Overall Study|Lost to Follow-up|1|||
19622484|NCT00847626|42072210|FG004|Overall Study|Lost to Follow-up|0|||
19622485|NCT00847626|42072211|FG005|Overall Study|Lost to Follow-up|3|||
19622486|NCT00847626|42072212|FG006|Overall Study|Lost to Follow-up|1|||
19622487|NCT00847626|42072213|FG007|Overall Study|Lost to Follow-up|3|||
19622488|NCT00847626|42072214|FG008|Overall Study|Lost to Follow-up|1|||
19622489|NCT00847626|42072215|FG009|Overall Study|Lost to Follow-up|0|||
19622490|NCT00847626|42072216|FG010|Overall Study|Lost to Follow-up|1|||
19622491|NCT00847626|42072206|FG000|Overall Study|Withdrawal by Subject|5|||
19622492|NCT00847626|42072207|FG001|Overall Study|Withdrawal by Subject|5|||
19622493|NCT00847626|42072208|FG002|Overall Study|Withdrawal by Subject|3|||
19622494|NCT00847626|42072209|FG003|Overall Study|Withdrawal by Subject|8|||
19622495|NCT00847626|42072210|FG004|Overall Study|Withdrawal by Subject|12|||
19622496|NCT00847626|42072211|FG005|Overall Study|Withdrawal by Subject|9|||
19622497|NCT00847626|42072212|FG006|Overall Study|Withdrawal by Subject|8|||
19622498|NCT00847626|42072213|FG007|Overall Study|Withdrawal by Subject|4|||
19622499|NCT00847626|42072214|FG008|Overall Study|Withdrawal by Subject|4|||
19622500|NCT00847626|42072215|FG009|Overall Study|Withdrawal by Subject|5|||
19622501|NCT00847626|42072216|FG010|Overall Study|Withdrawal by Subject|2|||
19622502|NCT00847626|42072206|FG000|Overall Study|Lack of Efficacy|3|||
19622503|NCT00847626|42072207|FG001|Overall Study|Lack of Efficacy|1|||
19622504|NCT00847626|42072208|FG002|Overall Study|Lack of Efficacy|0|||
19622505|NCT00847626|42072209|FG003|Overall Study|Lack of Efficacy|1|||
19622506|NCT00847626|42072210|FG004|Overall Study|Lack of Efficacy|2|||
19622507|NCT00847626|42072211|FG005|Overall Study|Lack of Efficacy|0|||
19622508|NCT00847626|42072212|FG006|Overall Study|Lack of Efficacy|6|||
19622509|NCT00847626|42072213|FG007|Overall Study|Lack of Efficacy|2|||
19622510|NCT00847626|42072214|FG008|Overall Study|Lack of Efficacy|5|||
19622511|NCT00847626|42072215|FG009|Overall Study|Lack of Efficacy|1|||
19622512|NCT00847626|42072216|FG010|Overall Study|Lack of Efficacy|7|||
19622513|NCT00847626|42072206|FG000|Overall Study|Other|1|||
19622514|NCT00847626|42072207|FG001|Overall Study|Other|5|||
19622515|NCT00847626|42072208|FG002|Overall Study|Other|4|||
19622516|NCT00847626|42072209|FG003|Overall Study|Other|1|||
19622517|NCT00847626|42072210|FG004|Overall Study|Other|2|||
19622518|NCT00847626|42072211|FG005|Overall Study|Other|2|||
19622519|NCT00847626|42072212|FG006|Overall Study|Other|2|||
19622520|NCT00847626|42072213|FG007|Overall Study|Other|3|||
19622521|NCT00847626|42072214|FG008|Overall Study|Other|1|||
19622522|NCT00847626|42072215|FG009|Overall Study|Other|1|||
19622523|NCT00847626|42072216|FG010|Overall Study|Other|3|||
19622524|NCT00851682|42072245|FG000|Overall Study|screen failure|5|||
19622525|NCT00851682|42072246|FG001|Overall Study|screen failure|0|||
19622526|NCT00860262|42072255|FG000|Overall Study|Adverse Event|9|||
19622527|NCT00860262|42072256|FG001|Overall Study|Adverse Event|6|||
19622528|NCT00860262|42072257|FG002|Overall Study|Adverse Event|7|||
19622529|NCT00860262|42072255|FG000|Overall Study|Protocol Violation|0|||
19622530|NCT00860262|42072256|FG001|Overall Study|Protocol Violation|1|||
19622531|NCT00860262|42072257|FG002|Overall Study|Protocol Violation|0|||
19622532|NCT00860262|42072255|FG000|Overall Study|Lost to Follow-up|2|||
19622533|NCT00860262|42072256|FG001|Overall Study|Lost to Follow-up|0|||
19622534|NCT00860262|42072257|FG002|Overall Study|Lost to Follow-up|1|||
19622535|NCT00860262|42072255|FG000|Overall Study|Withdrawal by Subject|4|||
19622536|NCT00860262|42072256|FG001|Overall Study|Withdrawal by Subject|8|||
19622537|NCT00860262|42072257|FG002|Overall Study|Withdrawal by Subject|6|||
19622538|NCT00860262|42072255|FG000|Overall Study|Lack of Efficacy|0|||
19622539|NCT00860262|42072256|FG001|Overall Study|Lack of Efficacy|4|||
19622540|NCT00860262|42072257|FG002|Overall Study|Lack of Efficacy|3|||
19622541|NCT00860262|42072255|FG000|Overall Study|Other|5|||
19622542|NCT00860262|42072256|FG001|Overall Study|Other|3|||
19622543|NCT00860262|42072257|FG002|Overall Study|Other|1|||
19622544|NCT00860028|42072269|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
19622545|NCT00860028|42072270|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
19622546|NCT00859638|42072280|FG000|Overall Study|Lost to Follow-up|6|||
19622547|NCT00859638|42072281|FG001|Overall Study|Lost to Follow-up|1|||
19622548|NCT00859638|42072280|FG000|Overall Study|Withdrawal by Subject|3|||
19622549|NCT00859638|42072281|FG001|Overall Study|Withdrawal by Subject|2|||
19622550|NCT00859638|42072280|FG000|Overall Study|Ill health|1|||
19622551|NCT00859638|42072281|FG001|Overall Study|Ill health|1|||
19622552|NCT00846846|42072287|FG000|Overall Study|Death|56|||
19622553|NCT00846846|42072287|FG000|Overall Study|Withdrawal by Subject|19|||
19622554|NCT00846768|42072291|FG000|Overall Study|Adverse Event|0|||
19622555|NCT00846768|42072292|FG001|Overall Study|Adverse Event|1|||
19622556|NCT00846768|42072293|FG002|Overall Study|Adverse Event|0|||
19622557|NCT00846768|42072294|FG003|Overall Study|Adverse Event|0|||
19622558|NCT00863798|42072307|FG000|Overall Study|Adverse Event|5|||
19622559|NCT00863798|42072308|FG001|Overall Study|Adverse Event|2|||
19622560|NCT00863798|42072309|FG002|Overall Study|Adverse Event|4|||
19622561|NCT00863798|42072307|FG000|Overall Study|Participant failed to return|2|||
19622562|NCT00863798|42072308|FG001|Overall Study|Participant failed to return|1|||
19622563|NCT00863798|42072309|FG002|Overall Study|Participant failed to return|0|||
19622564|NCT00863798|42072307|FG000|Overall Study|Investigator request|1|||
19622565|NCT00863798|42072308|FG001|Overall Study|Investigator request|2|||
19622566|NCT00863798|42072309|FG002|Overall Study|Investigator request|1|||
19622567|NCT00863798|42072307|FG000|Overall Study|Lack of Efficacy|4|||
19622568|NCT00863798|42072308|FG001|Overall Study|Lack of Efficacy|3|||
19622569|NCT00863798|42072309|FG002|Overall Study|Lack of Efficacy|6|||
19622570|NCT00863798|42072307|FG000|Overall Study|Lost to Follow-up|6|||
19622571|NCT00863798|42072308|FG001|Overall Study|Lost to Follow-up|9|||
19622572|NCT00863798|42072309|FG002|Overall Study|Lost to Follow-up|5|||
19622573|NCT00863798|42072307|FG000|Overall Study|Other|2|||
19622574|NCT00863798|42072308|FG001|Overall Study|Other|3|||
19622575|NCT00863798|42072309|FG002|Overall Study|Other|1|||
19622576|NCT00863798|42072307|FG000|Overall Study|Protocol Violation|0|||
19622577|NCT00863798|42072308|FG001|Overall Study|Protocol Violation|1|||
19622578|NCT00863798|42072309|FG002|Overall Study|Protocol Violation|1|||
19622579|NCT00863798|42072307|FG000|Overall Study|Withdrawal by Subject|8|||
19622580|NCT00863798|42072308|FG001|Overall Study|Withdrawal by Subject|7|||
19622581|NCT00863798|42072309|FG002|Overall Study|Withdrawal by Subject|4|||
19622582|NCT00863798|42072307|FG000|Overall Study|Randomized not treated|4|||
19622583|NCT00863798|42072308|FG001|Overall Study|Randomized not treated|2|||
19622584|NCT00863798|42072309|FG002|Overall Study|Randomized not treated|3|||
19622585|NCT00859014|42072317|FG000|Overall Study|Death|4|||
19622586|NCT00859014|42072317|FG000|Overall Study|Lost to Follow-up|1|||
19622587|NCT00593606|42072321|FG000|Overall Study|Adverse Event|13|||
19622588|NCT00593606|42072321|FG000|Overall Study|Withdrawal by Subject|1|||
19622589|NCT00593606|42072321|FG000|Overall Study|Protocol Violation|3|||
19622590|NCT00593606|42072321|FG000|Overall Study|Lost to Follow-up|2|||
19622591|NCT00593606|42072321|FG000|Overall Study|Run-In Failure|5|||
19622592|NCT00593606|42072321|FG000|Overall Study|Screen Failure|3|||
19622593|NCT00870584|42072327|FG000|Overall Study|Adverse Event|3|||
19622594|NCT00870584|42072328|FG001|Overall Study|Adverse Event|3|||
19622595|NCT00870584|42072327|FG000|Overall Study|Withdrawal by Subject|6|||
19622596|NCT00870584|42072328|FG001|Overall Study|Withdrawal by Subject|7|||
19622597|NCT00870584|42072327|FG000|Overall Study|Lost to Follow-up|5|||
19622598|NCT00870584|42072328|FG001|Overall Study|Lost to Follow-up|1|||
19622599|NCT00870584|42072327|FG000|Overall Study|Protocol Deviation|2|||
19622600|NCT00870584|42072328|FG001|Overall Study|Protocol Deviation|2|||
19622601|NCT00870194|42072336|FG000|Overall Study|Adverse Event|10|||
19622602|NCT00870194|42072337|FG001|Overall Study|Adverse Event|5|||
19622603|NCT00870194|42072336|FG000|Overall Study|Lack of Efficacy|0|||
19622604|NCT00870194|42072337|FG001|Overall Study|Lack of Efficacy|1|||
19622605|NCT00870194|42072336|FG000|Overall Study|Lost to Follow-up|2|||
19622606|NCT00870194|42072337|FG001|Overall Study|Lost to Follow-up|0|||
19622607|NCT00870194|42072336|FG000|Overall Study|Physician Decision|3|||
19622608|NCT00870194|42072337|FG001|Overall Study|Physician Decision|1|||
19622609|NCT00870194|42072336|FG000|Overall Study|Protocol Violation|3|||
19622610|NCT00870194|42072337|FG001|Overall Study|Protocol Violation|3|||
19622611|NCT00870194|42072336|FG000|Overall Study|Entry Criteria Not Met|1|||
19622612|NCT00870194|42072337|FG001|Overall Study|Entry Criteria Not Met|2|||
19622613|NCT00870194|42072336|FG000|Overall Study|Subject Decision|7|||
19622614|NCT00870194|42072337|FG001|Overall Study|Subject Decision|2|||
19622615|NCT00690430|42072345|FG000|Core Phase|Abnormal Laboratory value|0|||
19622616|NCT00690430|42072346|FG001|Core Phase|Abnormal Laboratory value|1|||
19622617|NCT00690430|42072347|FG002|Core Phase|Abnormal Laboratory value|0|||
19622618|NCT00690430|42072345|FG000|Core Phase|Adverse Event|5|||
19622619|NCT00690430|42072346|FG001|Core Phase|Adverse Event|1|||
19705955|NCT00132678|42150212|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
19705956|NCT00132678|42150213|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
19622620|NCT00690430|42072347|FG002|Core Phase|Adverse Event|0|||
19622621|NCT00690430|42072345|FG000|Core Phase|Death|0|||
19622622|NCT00690430|42072346|FG001|Core Phase|Death|2|||
19622623|NCT00690430|42072347|FG002|Core Phase|Death|0|||
19622624|NCT00690430|42072345|FG000|Core Phase|Protocol Violation|1|||
19622625|NCT00690430|42072346|FG001|Core Phase|Protocol Violation|0|||
19622626|NCT00690430|42072347|FG002|Core Phase|Protocol Violation|0|||
19622627|NCT00690430|42072345|FG000|Core Phase|Withdrawal by Subject|3|||
19622628|NCT00690430|42072346|FG001|Core Phase|Withdrawal by Subject|3|||
19622629|NCT00690430|42072347|FG002|Core Phase|Withdrawal by Subject|0|||
19622630|NCT00690430|42072345|FG000|Core Phase|Subject no longer requires study drug|1|||
19622631|NCT00690430|42072346|FG001|Core Phase|Subject no longer requires study drug|0|||
19622632|NCT00690430|42072347|FG002|Core Phase|Subject no longer requires study drug|0|||
19622633|NCT00690430|42072345|FG000|Core Phase|Lack of Efficacy|8|||
19622634|NCT00690430|42072346|FG001|Core Phase|Lack of Efficacy|10|||
19622635|NCT00690430|42072347|FG002|Core Phase|Lack of Efficacy|0|||
19622636|NCT00690430|42072345|FG000|Core Phase|Administrative Problems|0|||
19622637|NCT00690430|42072346|FG001|Core Phase|Administrative Problems|1|||
19622638|NCT00690430|42072347|FG002|Core Phase|Administrative Problems|0|||
19622639|NCT00690430|42072345|FG000|Core Phase|Early Termination|0|||
19622640|NCT00690430|42072346|FG001|Core Phase|Early Termination|5|||
19705957|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Death|2|||
19622641|NCT00690430|42072347|FG002|Core Phase|Early Termination|0|||
19622642|NCT00690430|42072345|FG000|Extension Phase|Lack of Efficacy|3|||
19622643|NCT00690430|42072346|FG001|Extension Phase|Lack of Efficacy|1|||
19622644|NCT00690430|42072347|FG002|Extension Phase|Lack of Efficacy|4|||
19705958|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Death|0|||
19705959|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Death|0|||
19705960|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
19705961|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
19705962|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
19705963|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
19705964|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
19705965|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
19705966|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
19705967|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
19622645|NCT00690430|42072345|FG000|Extension Phase|Abnormal Lab Values|1|||
19622646|NCT00690430|42072346|FG001|Extension Phase|Abnormal Lab Values|0|||
19622647|NCT00690430|42072347|FG002|Extension Phase|Abnormal Lab Values|0|||
19622648|NCT00690430|42072345|FG000|Extension Phase|Abnormal test procedure results|1|||
19622649|NCT00690430|42072346|FG001|Extension Phase|Abnormal test procedure results|0|||
19622650|NCT00690430|42072347|FG002|Extension Phase|Abnormal test procedure results|0|||
19622651|NCT00690430|42072345|FG000|Extension Phase|Administrative Problems|0|||
19622652|NCT00690430|42072346|FG001|Extension Phase|Administrative Problems|1|||
19622653|NCT00690430|42072347|FG002|Extension Phase|Administrative Problems|1|||
19622654|NCT00690430|42072345|FG000|Extension Phase|Adverse Event|2|||
19622655|NCT00690430|42072346|FG001|Extension Phase|Adverse Event|1|||
19622656|NCT00690430|42072347|FG002|Extension Phase|Adverse Event|2|||
19622657|NCT00690430|42072345|FG000|Extension Phase|Death|1|||
19622658|NCT00690430|42072346|FG001|Extension Phase|Death|1|||
19622659|NCT00690430|42072347|FG002|Extension Phase|Death|1|||
19622660|NCT00690430|42072345|FG000|Extension Phase|Withdrawal by Subject|0|||
19622661|NCT00690430|42072346|FG001|Extension Phase|Withdrawal by Subject|0|||
19622662|NCT00690430|42072347|FG002|Extension Phase|Withdrawal by Subject|2|||
19622663|NCT00690430|42072345|FG000|Extension Phase|Early Termination|10|||
19622664|NCT00690430|42072346|FG001|Extension Phase|Early Termination|1|||
19622665|NCT00690430|42072347|FG002|Extension Phase|Early Termination|3|||
19622666|NCT00863330|42072356|FG000|Overall Study|study terminated early due to administra|6|||
19622667|NCT00688324|42072360|FG000|Overall Study|Withdrawal by Subject|2|||
19622668|NCT00688324|42072360|FG000|Overall Study|Physician Decision|5|||
19622669|NCT00688324|42072360|FG000|Overall Study|Lost to Follow-up|1|||
19622670|NCT00862940|42072367|FG000|Overall Study|Adverse Event|15|||
19622671|NCT00862940|42072368|FG001|Overall Study|Adverse Event|12|||
19622672|NCT00862940|42072367|FG000|Overall Study|Lack of Efficacy|1|||
19622673|NCT00862940|42072368|FG001|Overall Study|Lack of Efficacy|3|||
19622674|NCT00862940|42072367|FG000|Overall Study|Protocol Violation|2|||
19622675|NCT00862940|42072368|FG001|Overall Study|Protocol Violation|5|||
19622676|NCT00862940|42072367|FG000|Overall Study|Withdrawal by Subject|4|||
19622677|NCT00862940|42072368|FG001|Overall Study|Withdrawal by Subject|6|||
19622678|NCT00862940|42072367|FG000|Overall Study|Non-compliance|4|||
19622679|NCT00862940|42072368|FG001|Overall Study|Non-compliance|0|||
19622680|NCT00862940|42072367|FG000|Overall Study|Lost to Follow-up|0|||
19622681|NCT00862940|42072368|FG001|Overall Study|Lost to Follow-up|1|||
19622682|NCT00862940|42072367|FG000|Overall Study|Administrative or other reason(s)|4|||
19622683|NCT00862940|42072368|FG001|Overall Study|Administrative or other reason(s)|3|||
19705968|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
19705969|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
19705970|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
19705971|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
19705972|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
19705973|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
19705974|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
19705975|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
19705976|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
19705977|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
19705978|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
19705979|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
19705980|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
19705981|NCT00132678|42150211|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
19705982|NCT00132678|42150212|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
19705983|NCT00132678|42150213|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
19705984|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
19705985|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
19705986|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
19705987|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
19705988|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
19705989|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
19622684|NCT00868166|42072376|FG000|Overall Study|Death|58|||
19622685|NCT00868166|42072377|FG001|Overall Study|Death|65|||
19622686|NCT00868166|42072376|FG000|Overall Study|Withdrawal by Subject|33|||
19622687|NCT00868166|42072377|FG001|Overall Study|Withdrawal by Subject|25|||
19622688|NCT00868166|42072376|FG000|Overall Study|Protocol Violation|1|||
19622689|NCT00868166|42072377|FG001|Overall Study|Protocol Violation|0|||
19622690|NCT00868166|42072376|FG000|Overall Study|Lost to Follow-up|1|||
19622691|NCT00868166|42072377|FG001|Overall Study|Lost to Follow-up|3|||
19622692|NCT00868166|42072376|FG000|Overall Study|Adverse Event|9|||
19622693|NCT00868166|42072377|FG001|Overall Study|Adverse Event|10|||
19622694|NCT00868166|42072376|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
19622695|NCT00868166|42072377|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
19622696|NCT00868166|42072376|FG000|Overall Study|Non-compliance with IMP|1|||
19622697|NCT00868166|42072377|FG001|Overall Study|Non-compliance with IMP|1|||
19622698|NCT00858780|42072383|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
19622699|NCT00858780|42072384|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
19622700|NCT00858780|42072385|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
19622701|NCT00858780|42072386|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
19622702|NCT00858780|42072387|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
19622703|NCT00858780|42072383|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
19622704|NCT00858780|42072384|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
19622705|NCT00858780|42072385|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
19622706|NCT00858780|42072386|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
19622707|NCT00858780|42072387|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
19622708|NCT00858780|42072383|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
19622709|NCT00858780|42072384|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
19622710|NCT00858780|42072385|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
19622711|NCT00858780|42072386|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
19622712|NCT00858780|42072387|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
19622713|NCT00858780|42072383|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
19622714|NCT00858780|42072384|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
19622715|NCT00858780|42072385|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
19622716|NCT00858780|42072386|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
19622717|NCT00858780|42072387|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
19622718|NCT00858780|42072383|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
19622719|NCT00858780|42072384|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
19622720|NCT00858780|42072385|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
19705990|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
19705991|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
19622721|NCT00858780|42072386|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
19622722|NCT00858780|42072387|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
19622723|NCT00858780|42072383|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
19622724|NCT00858780|42072384|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
19622725|NCT00858780|42072385|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
19622726|NCT00858780|42072386|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
19622727|NCT00858780|42072387|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
19622728|NCT00850200|42072397|FG000|Overall Study|Physician Decision|2|||
19622729|NCT00850200|42072397|FG000|Overall Study|Did not recieve treatment|2|||
19622730|NCT00850200|42072397|FG000|Overall Study|Withdrawal by Subject|1|||
19622731|NCT00858234|42072404|FG000|Overall Study|Adverse Event|6|||
19622732|NCT00858234|42072404|FG000|Overall Study|Progressive disease|2|||
19622733|NCT00858234|42072404|FG000|Overall Study|Status unknown|1|||
19622734|NCT00862082|42072410|FG000|Overall Study|Sponsor decision to terminate the study|5|||
19622735|NCT00862082|42072411|FG001|Overall Study|Sponsor decision to terminate the study|0|||
19622736|NCT00862082|42072410|FG000|Overall Study|Withdrawal by Subject|0|||
19622737|NCT00862082|42072411|FG001|Overall Study|Withdrawal by Subject|1|||
19622738|NCT00849186|42072424|FG000|Overall Study|Adverse Event|2|||
19622739|NCT00849186|42072424|FG000|Overall Study|Withdrawal by Subject|1|||
19622740|NCT00849186|42072424|FG000|Overall Study|not treated|6|||
19622741|NCT00849186|42072424|FG000|Overall Study|Other|1|||
19622742|NCT00692770|42072431|FG000|Overall Study|Protocol Violation|2|||
19622743|NCT00692770|42072432|FG001|Overall Study|Protocol Violation|7|||
19622744|NCT00692770|42072431|FG000|Overall Study|Withdrawal by Subject|97|||
19622745|NCT00692770|42072432|FG001|Overall Study|Withdrawal by Subject|36|||
19622746|NCT00692770|42072431|FG000|Overall Study|Adverse Event|136|||
19622747|NCT00692770|42072432|FG001|Overall Study|Adverse Event|41|||
19622748|NCT00692770|42072431|FG000|Overall Study|Death|10|||
19622749|NCT00692770|42072432|FG001|Overall Study|Death|5|||
19705992|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
19622750|NCT00692770|42072431|FG000|Overall Study|Lost to Follow-up|7|||
19622751|NCT00692770|42072432|FG001|Overall Study|Lost to Follow-up|3|||
19622752|NCT00692770|42072431|FG000|Overall Study|Non-compliant with study medication|11|||
19622753|NCT00692770|42072432|FG001|Overall Study|Non-compliant with study medication|5|||
19622754|NCT00692770|42072431|FG000|Overall Study|Progression by clinical judgment|2|||
19622755|NCT00692770|42072432|FG001|Overall Study|Progression by clinical judgment|3|||
19622756|NCT00692770|42072431|FG000|Overall Study|Physician decision not protocol driven|10|||
19622757|NCT00692770|42072432|FG001|Overall Study|Physician decision not protocol driven|14|||
19622758|NCT00692770|42072431|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
19622759|NCT00692770|42072432|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
19622760|NCT00692770|42072431|FG000|Overall Study|Protocol driven decision point|3|||
19622761|NCT00692770|42072432|FG001|Overall Study|Protocol driven decision point|7|||
19622762|NCT00692770|42072431|FG000|Overall Study|Completed all planned assessments|79|||
19622763|NCT00692770|42072432|FG001|Overall Study|Completed all planned assessments|101|||
19622764|NCT00692770|42072431|FG000|Overall Study|Radiological and clinical progression|8|||
19622765|NCT00692770|42072432|FG001|Overall Study|Radiological and clinical progression|8|||
19622766|NCT00692770|42072431|FG000|Overall Study|Clinical endpoint reached|16|||
19622767|NCT00692770|42072432|FG001|Overall Study|Clinical endpoint reached|43|||
19622768|NCT00692770|42072431|FG000|Overall Study|Study terminated by sponsor|2|||
19622769|NCT00692770|42072432|FG001|Overall Study|Study terminated by sponsor|2|||
19622770|NCT00692770|42072431|FG000|Overall Study|Randomized but not treated|3|||
19622771|NCT00692770|42072432|FG001|Overall Study|Randomized but not treated|4|||
19622772|NCT00849108|42072447|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
19622773|NCT00849108|42072448|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
19622774|NCT00849108|42072447|FG000|Cohort 2 Efficacy|Adverse Event|0|||
19622775|NCT00849108|42072448|FG001|Cohort 2 Efficacy|Adverse Event|1|||
19622776|NCT00849108|42072447|FG000|Cohort 2 Efficacy|Other|0|||
19622777|NCT00849108|42072448|FG001|Cohort 2 Efficacy|Other|9|||
19622778|NCT00867308|42072458|FG000|Overall Study|Death|1|||
19622779|NCT00867308|42072459|FG001|Overall Study|Death|0|||
19622780|NCT00867308|42072458|FG000|Overall Study|Adverse Event|1|||
19622781|NCT00867308|42072459|FG001|Overall Study|Adverse Event|4|||
19622782|NCT00867308|42072458|FG000|Overall Study|Lack of Efficacy|6|||
19622783|NCT00867308|42072459|FG001|Overall Study|Lack of Efficacy|12|||
19622784|NCT00867308|42072458|FG000|Overall Study|Withdrawal by Subject|1|||
19622785|NCT00867308|42072459|FG001|Overall Study|Withdrawal by Subject|2|||
19622786|NCT00866918|42072467|FG000|Overall Study|Death|1|||
19622787|NCT00866918|42072468|FG001|Overall Study|Death|5|||
19622788|NCT00866918|42072467|FG000|Overall Study|Lack of Efficacy|1|||
19622789|NCT00866918|42072468|FG001|Overall Study|Lack of Efficacy|1|||
19622790|NCT00866918|42072467|FG000|Overall Study|Physician Decision|10|||
19622791|NCT00866918|42072468|FG001|Overall Study|Physician Decision|2|||
19622792|NCT00866918|42072467|FG000|Overall Study|Ineligible|2|||
19622793|NCT00866918|42072468|FG001|Overall Study|Ineligible|4|||
19622794|NCT00866918|42072467|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
19622795|NCT00866918|42072468|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
19622796|NCT00866918|42072467|FG000|Overall Study|Secondary malignancy|1|||
19622797|NCT00866918|42072468|FG001|Overall Study|Secondary malignancy|0|||
19622798|NCT03158285|42072477|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
19622799|NCT03158285|42072478|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
19705993|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
19705994|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
19705995|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
19705996|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
19705997|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
19705998|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
19705999|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
19706000|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
19706001|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
19622800|NCT03158285|42072479|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
19622801|NCT03158285|42072477|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
19622802|NCT03158285|42072478|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
19622803|NCT03158285|42072479|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
19622804|NCT03158285|42072477|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
19622805|NCT03158285|42072478|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
19622806|NCT03158285|42072479|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
19517679|NCT01553136|41930657|FG000|Overall Study|Lost to Follow-up|4|||
19517680|NCT01553136|41930658|FG001|Overall Study|Lost to Follow-up|10|||
19517681|NCT01553136|41930657|FG000|Overall Study|Physician Decision|2|||
19517682|NCT01553136|41930658|FG001|Overall Study|Physician Decision|3|||
19517683|NCT01553136|41930657|FG000|Overall Study|Scheduling Difficulties|5|||
19517684|NCT01553136|41930658|FG001|Overall Study|Scheduling Difficulties|4|||
19706002|NCT00132678|42150211|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
19706003|NCT00132678|42150212|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
19706004|NCT00132678|42150213|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
19706005|NCT00101868|42150223|FG000|Overall Study|Death|10|||
19706006|NCT00101868|42150224|FG001|Overall Study|Death|10|||
19706007|NCT00101868|42150223|FG000|Overall Study|Withdrawal by Subject|8|||
19706008|NCT00101868|42150224|FG001|Overall Study|Withdrawal by Subject|9|||
19706009|NCT00101868|42150223|FG000|Overall Study|Protocol Violation|3|||
19706010|NCT00101868|42150224|FG001|Overall Study|Protocol Violation|0|||
19706011|NCT00101868|42150223|FG000|Overall Study|Lost to Follow-up|8|||
19706012|NCT00101868|42150224|FG001|Overall Study|Lost to Follow-up|13|||
19706013|NCT00101400|42150232|FG000|Survival Follow-Up|Alive|7|||
19706014|NCT03821064|42150236|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
19706015|NCT00141518|42150243|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
19706016|NCT00141518|42150244|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
19706017|NCT00141518|42150245|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
19706018|NCT00141518|42150243|FG000|Overall Study|Adverse Event|7|||
19706019|NCT00141518|42150244|FG001|Overall Study|Adverse Event|5|||
19706020|NCT00141518|42150245|FG002|Overall Study|Adverse Event|2|||
19706021|NCT00141518|42150243|FG000|Overall Study|Withdrawal by Subject|2|||
19706022|NCT00141518|42150244|FG001|Overall Study|Withdrawal by Subject|0|||
19706023|NCT00141518|42150245|FG002|Overall Study|Withdrawal by Subject|2|||
19706024|NCT00141518|42150243|FG000|Overall Study|Protocol Violation|1|||
19706025|NCT00141518|42150244|FG001|Overall Study|Protocol Violation|1|||
19622807|NCT03158285|42072477|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
19622808|NCT03158285|42072478|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
19622809|NCT03158285|42072479|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
19622810|NCT03158285|42072477|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
19622811|NCT03158285|42072478|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
19622812|NCT03158285|42072479|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
19706026|NCT00141518|42150245|FG002|Overall Study|Protocol Violation|2|||
19706027|NCT00141518|42150243|FG000|Overall Study|Lack of Efficacy|5|||
19622813|NCT03158285|42072477|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
19706028|NCT00141518|42150244|FG001|Overall Study|Lack of Efficacy|0|||
19706029|NCT00141518|42150245|FG002|Overall Study|Lack of Efficacy|0|||
19706030|NCT00253448|42150255|FG000|Overall Study|Withdrawal by Subject|1|||
19706031|NCT00098748|42150262|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
19706032|NCT00098748|42150263|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
19706033|NCT00098748|42150264|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
19706034|NCT00098748|42150262|FG000|Received Study Treatment|Death|2|||
19706035|NCT00098748|42150263|FG001|Received Study Treatment|Death|1|||
19706036|NCT00098748|42150264|FG002|Received Study Treatment|Death|2|||
19706037|NCT00098748|42150262|FG000|Received Study Treatment|Adverse Event|1|||
19706038|NCT00098748|42150263|FG001|Received Study Treatment|Adverse Event|2|||
19706039|NCT00098748|42150264|FG002|Received Study Treatment|Adverse Event|5|||
19706040|NCT00098748|42150262|FG000|Received Study Treatment|Lack of Efficacy|40|||
19706041|NCT00098748|42150263|FG001|Received Study Treatment|Lack of Efficacy|27|||
19706042|NCT00098748|42150264|FG002|Received Study Treatment|Lack of Efficacy|27|||
19706043|NCT00098748|42150262|FG000|Received Study Treatment|Other|2|||
19706044|NCT00098748|42150263|FG001|Received Study Treatment|Other|2|||
19706045|NCT00098748|42150264|FG002|Received Study Treatment|Other|6|||
19706046|NCT00098748|42150262|FG000|Received Study Treatment|Subject defaulted|3|||
19706047|NCT00098748|42150263|FG001|Received Study Treatment|Subject defaulted|4|||
19706048|NCT00098748|42150264|FG002|Received Study Treatment|Subject defaulted|4|||
19706049|NCT00098748|42150262|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
19706050|NCT00098748|42150263|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
19706051|NCT00098748|42150264|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
19706052|NCT00098748|42150262|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
19706053|NCT00098748|42150263|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
19706054|NCT00098748|42150264|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
19706055|NCT00098748|42150262|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
19517685|NCT01552902|41930667|FG000|Overall Study|Adverse Event|1|||
19706056|NCT00098748|42150263|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
19706057|NCT00098748|42150264|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
19706058|NCT00098748|42150262|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
19706059|NCT00098748|42150263|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
19706060|NCT00098748|42150264|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
19706061|NCT00098748|42150262|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
19706062|NCT00098748|42150263|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
19706063|NCT00098748|42150264|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
19706064|NCT00130520|42150272|FG000|Overall Study|Adverse Event|11|||
19706065|NCT00130520|42150272|FG000|Overall Study|Death|1|||
19706066|NCT00130520|42150272|FG000|Overall Study|Physician Decision|1|||
19706067|NCT00130520|42150272|FG000|Overall Study|Withdrawal by Subject|1|||
19706068|NCT00130520|42150272|FG000|Overall Study|Disease Progression|23|||
19706069|NCT00130520|42150272|FG000|Overall Study|Protocol non-compliance|1|||
19706070|NCT00130520|42150272|FG000|Overall Study|Did not meet re-treatment criteria|1|||
19706071|NCT00132132|42150278|FG000|Overall Study|Lost to Follow-up|7|||
19706072|NCT00132132|42150279|FG001|Overall Study|Lost to Follow-up|2|||
19706073|NCT00130442|42150287|FG000|Overall Study|Withdrawal by Subject|0|||
19706074|NCT00130442|42150288|FG001|Overall Study|Withdrawal by Subject|1|||
19706075|NCT00130442|42150287|FG000|Overall Study|did not meet criteria|1|||
19706076|NCT00130442|42150288|FG001|Overall Study|did not meet criteria|1|||
19706077|NCT00130208|42150298|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
19706078|NCT00130208|42150299|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
19706079|NCT00130208|42150298|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
19706080|NCT00130208|42150299|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
19706081|NCT00130208|42150298|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
19706082|NCT00130208|42150299|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
19706083|NCT00130208|42150298|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
19706084|NCT00130208|42150299|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
19706085|NCT00130208|42150298|FG000|Maintenance Period (26 Weeks)|Other|1|||
19706086|NCT00130208|42150299|FG001|Maintenance Period (26 Weeks)|Other|1|||
19706087|NCT00130208|42150298|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
19706088|NCT00130208|42150299|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
19706089|NCT00130208|42150298|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
19706090|NCT00130208|42150299|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
19706091|NCT00130208|42150298|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
19706092|NCT00130208|42150299|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
19706093|NCT00130208|42150298|FG000|Washout Period (8 Weeks)|Other|1|||
19706094|NCT00130208|42150299|FG001|Washout Period (8 Weeks)|Other|1|||
19706095|NCT00253370|42150305|FG000|Overall Study|Adverse Event|18|||
19706096|NCT00253370|42150305|FG000|Overall Study|Disease progression|13|||
19706097|NCT00253370|42150305|FG000|Overall Study|Death|2|||
19706098|NCT00253370|42150305|FG000|Overall Study|Withdrawal by Subject|6|||
19706099|NCT00253370|42150305|FG000|Overall Study|Non-protocol therapy|1|||
19706100|NCT00253370|42150305|FG000|Overall Study|Physician Decision|1|||
19706101|NCT00253370|42150305|FG000|Overall Study|Protocol Violation|1|||
19706102|NCT00253370|42150305|FG000|Overall Study|Abdominal pain due to disease|1|||
19706103|NCT00140426|42150312|FG000|Overall Study|Withdrawal by Subject|0|||
19706104|NCT00140426|42150313|FG001|Overall Study|Withdrawal by Subject|3|||
19706105|NCT00121134|42150328|FG000|Overall Study|Progression of Disease|5|||
19706106|NCT00121134|42150329|FG001|Overall Study|Progression of Disease|3|||
19706107|NCT00121134|42150330|FG002|Overall Study|Progression of Disease|4|||
19706108|NCT00121134|42150331|FG003|Overall Study|Progression of Disease|2|||
19706109|NCT00121134|42150328|FG000|Overall Study|Toxicity|4|||
19706110|NCT00121134|42150329|FG001|Overall Study|Toxicity|7|||
19706111|NCT00121134|42150330|FG002|Overall Study|Toxicity|13|||
19706112|NCT00121134|42150331|FG003|Overall Study|Toxicity|5|||
19706113|NCT00121134|42150328|FG000|Overall Study|Physician Decision|6|||
19706114|NCT00121134|42150329|FG001|Overall Study|Physician Decision|4|||
19706115|NCT00121134|42150330|FG002|Overall Study|Physician Decision|4|||
19706116|NCT00121134|42150331|FG003|Overall Study|Physician Decision|1|||
19706117|NCT00121134|42150328|FG000|Overall Study|Treatment Delay|1|||
19706118|NCT00121134|42150329|FG001|Overall Study|Treatment Delay|0|||
19706119|NCT00121134|42150330|FG002|Overall Study|Treatment Delay|0|||
19706120|NCT00121134|42150331|FG003|Overall Study|Treatment Delay|0|||
19706121|NCT00121134|42150328|FG000|Overall Study|Intercurrent Illness|0|||
19706122|NCT00121134|42150329|FG001|Overall Study|Intercurrent Illness|0|||
19706123|NCT00121134|42150330|FG002|Overall Study|Intercurrent Illness|0|||
19706124|NCT00121134|42150331|FG003|Overall Study|Intercurrent Illness|1|||
19706125|NCT00121134|42150328|FG000|Overall Study|Patient Personal Reasons|0|||
19706126|NCT00121134|42150329|FG001|Overall Study|Patient Personal Reasons|1|||
19706127|NCT00121134|42150330|FG002|Overall Study|Patient Personal Reasons|0|||
19706128|NCT00121134|42150331|FG003|Overall Study|Patient Personal Reasons|0|||
19706129|NCT02657434|42150343|FG000|Overall Study|On-Going in Study|77|||
19706130|NCT02657434|42150344|FG001|Overall Study|On-Going in Study|91|||
19706131|NCT02657434|42150343|FG000|Overall Study|Death|177|||
19706132|NCT02657434|42150344|FG001|Overall Study|Death|183|||
19706133|NCT02657434|42150343|FG000|Overall Study|Lost to Follow-up|2|||
19706134|NCT02657434|42150344|FG001|Overall Study|Lost to Follow-up|2|||
19706135|NCT02657434|42150343|FG000|Overall Study|Randomization by Error|2|||
19706136|NCT02657434|42150344|FG001|Overall Study|Randomization by Error|0|||
19706137|NCT02657434|42150343|FG000|Overall Study|Withdrawal by Subject|27|||
19706138|NCT02657434|42150344|FG001|Overall Study|Withdrawal by Subject|16|||
19706139|NCT02657434|42150343|FG000|Overall Study|Protocol Violation|1|||
19706140|NCT02657434|42150344|FG001|Overall Study|Protocol Violation|0|||
19706141|NCT00119262|42150353|FG000|Overall Study|Lack of Efficacy|0|||
19706142|NCT00119262|42150354|FG001|Overall Study|Lack of Efficacy|3|||
19706143|NCT00119262|42150353|FG000|Overall Study|Withdrawal by Subject|12|||
19706144|NCT00119262|42150354|FG001|Overall Study|Withdrawal by Subject|11|||
19706145|NCT00119262|42150353|FG000|Overall Study|Adverse Event|33|||
19706146|NCT00119262|42150354|FG001|Overall Study|Adverse Event|35|||
19706147|NCT00119262|42150353|FG000|Overall Study|other disease|0|||
19706148|NCT00119262|42150354|FG001|Overall Study|other disease|2|||
19706149|NCT00119262|42150353|FG000|Overall Study|ineligble|1|||
19706150|NCT00119262|42150354|FG001|Overall Study|ineligble|2|||
19706151|NCT00119262|42150353|FG000|Overall Study|others|0|||
19706152|NCT00119262|42150354|FG001|Overall Study|others|5|||
19706153|NCT03703882|42150362|FG000|Overall Study|Adverse Event|1|||
19706154|NCT03703882|42150363|FG001|Overall Study|Adverse Event|0|||
19706155|NCT03703882|42150362|FG000|Overall Study|Lost to Follow-up|0|||
19706156|NCT03703882|42150363|FG001|Overall Study|Lost to Follow-up|2|||
19706157|NCT03703882|42150362|FG000|Overall Study|Non-compliance with study drug|0|||
19706158|NCT03703882|42150363|FG001|Overall Study|Non-compliance with study drug|1|||
19706159|NCT03703882|42150362|FG000|Overall Study|Physician Decision|0|||
19706160|NCT03703882|42150363|FG001|Overall Study|Physician Decision|1|||
19706161|NCT03703882|42150362|FG000|Overall Study|Progressive disease|1|||
19706162|NCT03703882|42150363|FG001|Overall Study|Progressive disease|0|||
19706163|NCT03703882|42150362|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19706164|NCT03703882|42150363|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19706165|NCT03703882|42150362|FG000|Overall Study|Starting another treatment|0|||
19706166|NCT03703882|42150363|FG001|Overall Study|Starting another treatment|1|||
19706167|NCT03703882|42150362|FG000|Overall Study|noncompliance with study procedures|0|||
19706168|NCT03703882|42150363|FG001|Overall Study|noncompliance with study procedures|1|||
19706169|NCT00131664|42150372|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
19706170|NCT00131664|42150373|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
19706171|NCT00131664|42150374|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
19706172|NCT00131664|42150375|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
19706173|NCT00131664|42150376|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
19706174|NCT00131664|42150377|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
19706175|NCT00131664|42150372|FG000|First Period (First 6 Months)|Death|0|||
19706176|NCT00131664|42150373|FG001|First Period (First 6 Months)|Death|1|||
19706177|NCT00131664|42150374|FG002|First Period (First 6 Months)|Death|0|||
19706178|NCT00131664|42150375|FG003|First Period (First 6 Months)|Death|0|||
19706179|NCT00131664|42150376|FG004|First Period (First 6 Months)|Death|0|||
19706180|NCT00131664|42150377|FG005|First Period (First 6 Months)|Death|0|||
19706181|NCT00131664|42150372|FG000|First Period (First 6 Months)|Protocol Violation|2|||
19706182|NCT00131664|42150373|FG001|First Period (First 6 Months)|Protocol Violation|2|||
19706183|NCT00131664|42150374|FG002|First Period (First 6 Months)|Protocol Violation|1|||
19706184|NCT00131664|42150375|FG003|First Period (First 6 Months)|Protocol Violation|0|||
19706185|NCT00131664|42150376|FG004|First Period (First 6 Months)|Protocol Violation|0|||
19706186|NCT00131664|42150377|FG005|First Period (First 6 Months)|Protocol Violation|0|||
19706187|NCT00131664|42150372|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
19706188|NCT00131664|42150373|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
19706189|NCT00131664|42150374|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
19706190|NCT00131664|42150375|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
19706191|NCT00131664|42150376|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
19706192|NCT00131664|42150377|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
19706193|NCT00131664|42150372|FG000|First Period (First 6 Months)|Adverse Event|9|||
19706194|NCT00131664|42150373|FG001|First Period (First 6 Months)|Adverse Event|4|||
19706195|NCT00131664|42150374|FG002|First Period (First 6 Months)|Adverse Event|5|||
19706196|NCT00131664|42150375|FG003|First Period (First 6 Months)|Adverse Event|0|||
19706197|NCT00131664|42150376|FG004|First Period (First 6 Months)|Adverse Event|0|||
19706198|NCT00131664|42150377|FG005|First Period (First 6 Months)|Adverse Event|0|||
19706199|NCT00131664|42150372|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
19706200|NCT00131664|42150373|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
19706201|NCT00131664|42150374|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
19706202|NCT00131664|42150375|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
19706203|NCT00131664|42150376|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
19706204|NCT00131664|42150377|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
19706205|NCT00131664|42150372|FG000|First Period (First 6 Months)|Administrative reasons|2|||
19706206|NCT00131664|42150373|FG001|First Period (First 6 Months)|Administrative reasons|0|||
19706207|NCT00131664|42150374|FG002|First Period (First 6 Months)|Administrative reasons|5|||
19706208|NCT00131664|42150375|FG003|First Period (First 6 Months)|Administrative reasons|0|||
19706209|NCT00131664|42150376|FG004|First Period (First 6 Months)|Administrative reasons|0|||
19706210|NCT00131664|42150377|FG005|First Period (First 6 Months)|Administrative reasons|0|||
19706211|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
19706212|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
19706213|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
19706214|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
19706215|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
19706216|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
19706217|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
19706218|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
19706219|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
19706220|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
19706221|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
19706222|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
19706223|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
19706224|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
19706225|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
19706226|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
19706227|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
19706228|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
19706229|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
19706230|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
19706231|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
19706232|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
19706233|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
19706234|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
19706235|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
19706236|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
19706237|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
19706238|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
19706239|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
19706240|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
19706241|NCT00131664|42150372|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
19706242|NCT00131664|42150373|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
19706243|NCT00131664|42150374|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
19706244|NCT00131664|42150375|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
19706245|NCT00131664|42150376|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
19706246|NCT00131664|42150377|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
19706247|NCT00131508|42150390|FG000|Overall Study|Disease progression|0|||
19706248|NCT00131508|42150391|FG001|Overall Study|Disease progression|2|||
19706249|NCT00131508|42150390|FG000|Overall Study|Non-Compliance|2|||
19706250|NCT00131508|42150391|FG001|Overall Study|Non-Compliance|4|||
19706251|NCT00131508|42150390|FG000|Overall Study|Withdrawal by Subject|1|||
19706252|NCT00131508|42150391|FG001|Overall Study|Withdrawal by Subject|2|||
19706253|NCT05050318|42150400|FG000|Overall Study|Protocol Deviation|1|||
19706254|NCT05050318|42150401|FG001|Overall Study|Protocol Deviation|0|||
19706255|NCT05050318|42150402|FG002|Overall Study|Protocol Deviation|0|||
19706256|NCT03699124|42150413|FG000|Overall Study|Adverse Event|6|||
19706257|NCT03699124|42150414|FG001|Overall Study|Adverse Event|5|||
19706258|NCT03699124|42150415|FG002|Overall Study|Adverse Event|2|||
19706259|NCT03699124|42150413|FG000|Overall Study|Death|0|||
19706260|NCT03699124|42150414|FG001|Overall Study|Death|2|||
19706261|NCT03699124|42150415|FG002|Overall Study|Death|0|||
19706262|NCT03699124|42150413|FG000|Overall Study|Lost to Follow-up|20|||
19706263|NCT03699124|42150414|FG001|Overall Study|Lost to Follow-up|16|||
19706264|NCT03699124|42150415|FG002|Overall Study|Lost to Follow-up|15|||
19706265|NCT03699124|42150413|FG000|Overall Study|Protocol Violation|1|||
19706266|NCT03699124|42150414|FG001|Overall Study|Protocol Violation|0|||
19706267|NCT03699124|42150415|FG002|Overall Study|Protocol Violation|0|||
19706268|NCT03699124|42150413|FG000|Overall Study|Withdrawal by Subject|13|||
19706269|NCT03699124|42150414|FG001|Overall Study|Withdrawal by Subject|14|||
19706270|NCT03699124|42150415|FG002|Overall Study|Withdrawal by Subject|13|||
19394250|NCT02527161|41638342|FG000|Overall Study|Lost to Follow-up|6|||
19706271|NCT03699124|42150413|FG000|Overall Study|Other reasons|5|||
19706272|NCT03699124|42150414|FG001|Overall Study|Other reasons|3|||
19706273|NCT03699124|42150415|FG002|Overall Study|Other reasons|10|||
19706274|NCT05002972|42150423|FG000|Overall Study|Withdrawal by Subject|2|||
19706275|NCT04651114|42150427|FG000|Overall Study|Withdrawal by Subject|8|||
19706276|NCT04980040|42150431|FG000|Overall Study|Violated the Inclusion Criteria|260|||
19706277|NCT04980040|42150431|FG000|Overall Study|Violated the Administration & Dosage|225|||
19706278|NCT04980040|42150431|FG000|Overall Study|Lost to Safety-Follow-up|4|||
19706279|NCT04980040|42150431|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
19706280|NCT00131352|42150437|FG000|Initial Treatment Period|Adverse Event|1|||
19706281|NCT00131352|42150438|FG001|Initial Treatment Period|Adverse Event|3|||
19706282|NCT00131352|42150437|FG000|Initial Treatment Period|Non-compliant|1|||
19706283|NCT00131352|42150438|FG001|Initial Treatment Period|Non-compliant|2|||
19706284|NCT00131352|42150437|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
19706285|NCT00131352|42150438|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
19706286|NCT00131352|42150437|FG000|Initial Treatment Period|Lack of Efficacy|6|||
19706287|NCT00131352|42150438|FG001|Initial Treatment Period|Lack of Efficacy|4|||
19706288|NCT00131352|42150437|FG000|Initial Treatment Period|Other|0|||
19706289|NCT00131352|42150438|FG001|Initial Treatment Period|Other|2|||
19706290|NCT00131352|42150437|FG000|Repeat Treatment Period|Adverse Event|1|||
19706291|NCT00131352|42150438|FG001|Repeat Treatment Period|Adverse Event|0|||
19706292|NCT00131352|42150437|FG000|Repeat Treatment Period|Other|1|||
19706293|NCT00131352|42150438|FG001|Repeat Treatment Period|Other|0|||
19706294|NCT04633642|42150448|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
19706295|NCT04633642|42150449|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
19622814|NCT03158285|42072478|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
19622815|NCT03158285|42072479|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
19622816|NCT03158285|42072477|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
19622817|NCT03158285|42072478|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
19622818|NCT03158285|42072479|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
19622819|NCT03158285|42072477|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
19622820|NCT03158285|42072478|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
19622821|NCT03158285|42072479|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
19622822|NCT03158285|42072477|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
19622823|NCT03158285|42072478|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
19622824|NCT03158285|42072479|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
19622825|NCT03158285|42072477|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
19622826|NCT03158285|42072478|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
19622827|NCT03158285|42072479|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
19622828|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
19622829|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
19622830|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
19622831|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
19622832|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
19622833|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
19622834|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
19622835|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
19622836|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
19622837|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
19622838|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
19622839|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
19622840|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Death|1|||
19622841|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Death|0|||
19622842|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Death|0|||
19622843|NCT03158285|42072477|FG000|Active Treatment Period: Week 52-100|Other|4|||
19622844|NCT03158285|42072478|FG001|Active Treatment Period: Week 52-100|Other|1|||
19622845|NCT03158285|42072479|FG002|Active Treatment Period: Week 52-100|Other|0|||
19622846|NCT00861692|42072492|FG000|Overall Study|Death|6|||
19622847|NCT00602927|42072498|FG000|Period 1: 13 Days|Protocol Violation|2|||
19622848|NCT00602927|42072499|FG001|Period 1: 13 Days|Protocol Violation|4|||
19622849|NCT00602927|42072498|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
19622850|NCT00602927|42072499|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
19622851|NCT00602927|42072498|FG000|Period 1: 13 Days|Time|1|||
19706296|NCT00136916|42150457|FG000|Overall Study|Never received study treatment|3|||
19622852|NCT00602927|42072499|FG001|Period 1: 13 Days|Time|0|||
19622853|NCT00602927|42072498|FG000|Period 1: 13 Days|Claustrophobia|0|||
19622854|NCT00602927|42072499|FG001|Period 1: 13 Days|Claustrophobia|1|||
19706297|NCT00136916|42150458|FG001|Overall Study|Never received study treatment|5|||
19706298|NCT00136916|42150457|FG000|Overall Study|Death|1|||
19706299|NCT00136916|42150458|FG001|Overall Study|Death|3|||
19706300|NCT00136916|42150457|FG000|Overall Study|Adverse Event|27|||
19622855|NCT00602927|42072498|FG000|Period 2: 14 Days|Protocol Violation|0|||
19622856|NCT00602927|42072499|FG001|Period 2: 14 Days|Protocol Violation|2|||
19622857|NCT00602927|42072498|FG000|Period 3: 13 Days|Protocol Violation|0|||
19622858|NCT00602927|42072499|FG001|Period 3: 13 Days|Protocol Violation|1|||
19622859|NCT00602927|42072498|FG000|Period 3: 13 Days|MRI data quality|2|||
19622860|NCT00602927|42072499|FG001|Period 3: 13 Days|MRI data quality|2|||
19622861|NCT00602537|42072507|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
19622862|NCT00602537|42072508|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
19622863|NCT00602537|42072507|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
19622864|NCT00602537|42072508|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
19622865|NCT00602537|42072507|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
19622866|NCT00602537|42072508|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
19622867|NCT00602537|42072507|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
19622868|NCT00602537|42072508|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
19622869|NCT00602537|42072507|FG000|Follow Up Study Comparison|Adverse Event|1|||
19622870|NCT00602537|42072508|FG001|Follow Up Study Comparison|Adverse Event|0|||
19622871|NCT00602537|42072507|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
19622872|NCT00602537|42072508|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
19622873|NCT00602537|42072507|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
19622874|NCT00602537|42072508|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
19622875|NCT00861614|42072516|FG000|Overall Study|Disease Progression|182|||
19622876|NCT00861614|42072517|FG001|Overall Study|Disease Progression|263|||
19622877|NCT00861614|42072516|FG000|Overall Study|Study Drug Toxicity|79|||
19622878|NCT00861614|42072517|FG001|Overall Study|Study Drug Toxicity|6|||
19622879|NCT00861614|42072516|FG000|Overall Study|Death|32|||
19622880|NCT00861614|42072517|FG001|Overall Study|Death|19|||
19622881|NCT00861614|42072516|FG000|Overall Study|Adverse Event|27|||
19622882|NCT00861614|42072517|FG001|Overall Study|Adverse Event|23|||
19622883|NCT00861614|42072516|FG000|Overall Study|Withdrawal by Subject|34|||
19622884|NCT00861614|42072517|FG001|Overall Study|Withdrawal by Subject|35|||
19622885|NCT00861614|42072516|FG000|Overall Study|Other|17|||
19622886|NCT00861614|42072517|FG001|Overall Study|Other|22|||
19622887|NCT00485173|42072525|FG000|Overall Study|Death|4|||
19622888|NCT00485173|42072526|FG001|Overall Study|Death|3|||
19622889|NCT00485173|42072525|FG000|Overall Study|Lost to Follow-up|32|||
19622890|NCT00485173|42072526|FG001|Overall Study|Lost to Follow-up|61|||
19622891|NCT00495469|42072539|FG000|Overall Study|Adverse Event|0|||
19622892|NCT00495469|42072540|FG001|Overall Study|Adverse Event|1|||
19622893|NCT00495469|42072541|FG002|Overall Study|Adverse Event|3|||
19622894|NCT00495469|42072542|FG003|Overall Study|Adverse Event|0|||
19517686|NCT01552902|41930668|FG001|Overall Study|Adverse Event|15|||
19517687|NCT01552902|41930669|FG002|Overall Study|Adverse Event|14|||
19517688|NCT01552902|41930667|FG000|Overall Study|Protocol Violation|3|||
19517689|NCT01552902|41930668|FG001|Overall Study|Protocol Violation|3|||
19517690|NCT01552902|41930669|FG002|Overall Study|Protocol Violation|3|||
19517691|NCT01552902|41930667|FG000|Overall Study|Lack of Efficacy|4|||
19517692|NCT01552902|41930668|FG001|Overall Study|Lack of Efficacy|3|||
19517693|NCT01552902|41930669|FG002|Overall Study|Lack of Efficacy|1|||
19517694|NCT01552902|41930667|FG000|Overall Study|Withdrawal by Subject|1|||
19517695|NCT01552902|41930668|FG001|Overall Study|Withdrawal by Subject|9|||
19517696|NCT01552902|41930669|FG002|Overall Study|Withdrawal by Subject|6|||
19517697|NCT01552902|41930667|FG000|Overall Study|Lost to Follow-up|1|||
19517698|NCT01552902|41930668|FG001|Overall Study|Lost to Follow-up|3|||
19517699|NCT01552902|41930669|FG002|Overall Study|Lost to Follow-up|6|||
19517700|NCT01552902|41930667|FG000|Overall Study|Other|3|||
19517701|NCT01552902|41930668|FG001|Overall Study|Other|4|||
19622895|NCT00495469|42072543|FG004|Overall Study|Adverse Event|1|||
19622896|NCT00495469|42072544|FG005|Overall Study|Adverse Event|1|||
19622897|NCT00495469|42072545|FG006|Overall Study|Adverse Event|1|||
19622898|NCT00495469|42072539|FG000|Overall Study|Lost to Follow-up|1|||
19622899|NCT00495469|42072540|FG001|Overall Study|Lost to Follow-up|1|||
19622900|NCT00495469|42072541|FG002|Overall Study|Lost to Follow-up|3|||
19622901|NCT00495469|42072542|FG003|Overall Study|Lost to Follow-up|1|||
19622902|NCT00495469|42072543|FG004|Overall Study|Lost to Follow-up|0|||
19622903|NCT00495469|42072544|FG005|Overall Study|Lost to Follow-up|0|||
19622904|NCT00495469|42072545|FG006|Overall Study|Lost to Follow-up|0|||
19622905|NCT00495469|42072539|FG000|Overall Study|Protocol Violation|0|||
19517702|NCT01552902|41930669|FG002|Overall Study|Other|3|||
19517703|NCT01529346|41930695|FG000|Overall Study|Lost to Follow-up|2|||
19517704|NCT01529346|41930696|FG001|Overall Study|Lost to Follow-up|0|||
19517705|NCT01529346|41930697|FG002|Overall Study|Lost to Follow-up|1|||
19517706|NCT01529346|41930698|FG003|Overall Study|Lost to Follow-up|0|||
19622906|NCT00495469|42072540|FG001|Overall Study|Protocol Violation|0|||
19622907|NCT00495469|42072541|FG002|Overall Study|Protocol Violation|0|||
19622908|NCT00495469|42072542|FG003|Overall Study|Protocol Violation|0|||
19622909|NCT00495469|42072543|FG004|Overall Study|Protocol Violation|1|||
19622910|NCT00495469|42072544|FG005|Overall Study|Protocol Violation|2|||
19622911|NCT00495469|42072545|FG006|Overall Study|Protocol Violation|0|||
19622912|NCT00495469|42072539|FG000|Overall Study|Withdrawal by Subject|5|||
19622913|NCT00495469|42072540|FG001|Overall Study|Withdrawal by Subject|3|||
19622914|NCT00495469|42072541|FG002|Overall Study|Withdrawal by Subject|1|||
19622915|NCT00495469|42072542|FG003|Overall Study|Withdrawal by Subject|3|||
19622916|NCT00495469|42072543|FG004|Overall Study|Withdrawal by Subject|3|||
19622917|NCT00495469|42072544|FG005|Overall Study|Withdrawal by Subject|2|||
19622918|NCT00495469|42072545|FG006|Overall Study|Withdrawal by Subject|3|||
19622919|NCT00495469|42072539|FG000|Overall Study|Lack of Efficacy|0|||
19622920|NCT00495469|42072540|FG001|Overall Study|Lack of Efficacy|0|||
19622921|NCT00495469|42072541|FG002|Overall Study|Lack of Efficacy|0|||
19622922|NCT00495469|42072542|FG003|Overall Study|Lack of Efficacy|0|||
19622923|NCT00495469|42072543|FG004|Overall Study|Lack of Efficacy|0|||
19706301|NCT00136916|42150458|FG001|Overall Study|Adverse Event|8|||
19706302|NCT00136916|42150457|FG000|Overall Study|Laboratory abnormality|0|||
19706303|NCT00136916|42150458|FG001|Overall Study|Laboratory abnormality|1|||
19706304|NCT00136916|42150457|FG000|Overall Study|Lack of Efficacy|13|||
19706305|NCT00136916|42150458|FG001|Overall Study|Lack of Efficacy|3|||
19706306|NCT00136916|42150457|FG000|Overall Study|Lost to Follow-up|12|||
19706307|NCT00136916|42150458|FG001|Overall Study|Lost to Follow-up|14|||
19706308|NCT00136916|42150457|FG000|Overall Study|Withdrawal by Subject|44|||
19622924|NCT00495469|42072544|FG005|Overall Study|Lack of Efficacy|0|||
19622925|NCT00495469|42072545|FG006|Overall Study|Lack of Efficacy|1|||
19622926|NCT00495469|42072539|FG000|Overall Study|Liver function test abnormality|0|||
19622927|NCT00495469|42072540|FG001|Overall Study|Liver function test abnormality|1|||
19622928|NCT00495469|42072541|FG002|Overall Study|Liver function test abnormality|0|||
19622929|NCT00495469|42072542|FG003|Overall Study|Liver function test abnormality|0|||
19622930|NCT00495469|42072543|FG004|Overall Study|Liver function test abnormality|0|||
19622931|NCT00495469|42072544|FG005|Overall Study|Liver function test abnormality|0|||
19622932|NCT00495469|42072545|FG006|Overall Study|Liver function test abnormality|0|||
19622933|NCT00495469|42072539|FG000|Overall Study|ST depression at randomisation in ECG|0|||
19622934|NCT00495469|42072540|FG001|Overall Study|ST depression at randomisation in ECG|1|||
19622935|NCT00495469|42072541|FG002|Overall Study|ST depression at randomisation in ECG|0|||
19622936|NCT00495469|42072542|FG003|Overall Study|ST depression at randomisation in ECG|0|||
19622937|NCT00495469|42072543|FG004|Overall Study|ST depression at randomisation in ECG|0|||
19622938|NCT00495469|42072544|FG005|Overall Study|ST depression at randomisation in ECG|0|||
19622939|NCT00495469|42072545|FG006|Overall Study|ST depression at randomisation in ECG|0|||
19622940|NCT00861380|42072575|FG000|Overall Study|Withdrawal Information not recorded|8427|||
19622941|NCT00861380|42072576|FG001|Overall Study|Withdrawal Information not recorded|9112|||
19622942|NCT00861380|42072577|FG002|Overall Study|Withdrawal Information not recorded|8872|||
19622943|NCT00861380|42072578|FG003|Overall Study|Withdrawal Information not recorded|3689|||
19622944|NCT00861380|42072579|FG004|Overall Study|Withdrawal Information not recorded|1812|||
19622945|NCT00861380|42072580|FG005|Overall Study|Withdrawal Information not recorded|6249|||
19622946|NCT00861380|42072581|FG006|Overall Study|Withdrawal Information not recorded|3020|||
19622947|NCT00495391|42072616|FG000|Overall Study|Lack of Efficacy|34|||
19622948|NCT00495391|42072617|FG001|Overall Study|Lack of Efficacy|18|||
19622949|NCT00495391|42072616|FG000|Overall Study|Withdrawal by Subject|2|||
19622950|NCT00495391|42072617|FG001|Overall Study|Withdrawal by Subject|3|||
19622951|NCT00869960|42072623|FG000|Overall Study|Lost to Follow-up|2|||
19622952|NCT00494299|42072629|FG000|Overall Study|Adverse Event|93|||
19622953|NCT00494299|42072630|FG001|Overall Study|Adverse Event|13|||
19622954|NCT00494299|42072629|FG000|Overall Study|Lost to Follow-up|1|||
19622955|NCT00494299|42072630|FG001|Overall Study|Lost to Follow-up|0|||
19622956|NCT00494299|42072629|FG000|Overall Study|Physician Decision|0|||
19622957|NCT00494299|42072630|FG001|Overall Study|Physician Decision|2|||
19622958|NCT00494299|42072629|FG000|Overall Study|Protocol Violation|1|||
19706309|NCT00136916|42150458|FG001|Overall Study|Withdrawal by Subject|46|||
19706310|NCT00136916|42150457|FG000|Overall Study|Other|22|||
19706311|NCT00136916|42150458|FG001|Overall Study|Other|24|||
19706312|NCT00136916|42150457|FG000|Overall Study|Discontinued in follow up period|3|||
19706313|NCT00136916|42150458|FG001|Overall Study|Discontinued in follow up period|0|||
19706314|NCT04633564|42150468|FG000|Period 1|Adverse Event|28|||
19706315|NCT04633564|42150469|FG001|Period 1|Adverse Event|19|||
19706316|NCT04633564|42150468|FG000|Period 1|Death|8|||
19706317|NCT04633564|42150469|FG001|Period 1|Death|7|||
19706318|NCT04633564|42150468|FG000|Period 1|Lost to Follow-up|3|||
19706319|NCT04633564|42150469|FG001|Period 1|Lost to Follow-up|5|||
19706320|NCT04633564|42150468|FG000|Period 1|Physician Decision|4|||
19706321|NCT04633564|42150469|FG001|Period 1|Physician Decision|12|||
19706322|NCT04633564|42150468|FG000|Period 1|Protocol Violation|0|||
19706323|NCT04633564|42150469|FG001|Period 1|Protocol Violation|1|||
19706324|NCT04633564|42150468|FG000|Period 1|Withdrawal by Subject|10|||
19706325|NCT04633564|42150469|FG001|Period 1|Withdrawal by Subject|8|||
19706326|NCT04633564|42150468|FG000|Period 1|Progressive disease|47|||
19622959|NCT00494299|42072630|FG001|Overall Study|Protocol Violation|2|||
19622960|NCT00494299|42072629|FG000|Overall Study|Withdrawal by Subject|8|||
19622961|NCT00494299|42072630|FG001|Overall Study|Withdrawal by Subject|3|||
19706327|NCT04633564|42150469|FG001|Period 1|Progressive disease|51|||
19706328|NCT04633564|42150468|FG000|Period 1|Terminated by Sponsor|8|||
19706329|NCT04633564|42150469|FG001|Period 1|Terminated by Sponsor|6|||
19622962|NCT00494299|42072629|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
19622963|NCT00494299|42072630|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
19622964|NCT00494299|42072629|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
19622965|NCT00494299|42072630|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
19622966|NCT00494299|42072629|FG000|Overall Study|Site Closed by Sponsor|6|||
19706330|NCT04633564|42150468|FG000|Period 2|Adverse Event|3|||
19706331|NCT04633564|42150469|FG001|Period 2|Adverse Event|4|||
19706332|NCT04633564|42150468|FG000|Period 2|Death|0|||
19706333|NCT04633564|42150469|FG001|Period 2|Death|2|||
19706334|NCT04633564|42150468|FG000|Period 2|Lost to Follow-up|0|||
19706335|NCT04633564|42150469|FG001|Period 2|Lost to Follow-up|1|||
19706336|NCT04633564|42150468|FG000|Period 2|Physician Decision|2|||
19706337|NCT04633564|42150469|FG001|Period 2|Physician Decision|4|||
19706338|NCT04633564|42150468|FG000|Period 2|Withdrawal by Subject|5|||
19706339|NCT04633564|42150469|FG001|Period 2|Withdrawal by Subject|1|||
19706340|NCT04633564|42150468|FG000|Period 2|Progressive Disease|74|||
19706341|NCT04633564|42150469|FG001|Period 2|Progressive Disease|82|||
19706342|NCT04633564|42150468|FG000|Period 2|Terminated by Sponsor|9|||
19706343|NCT04633564|42150469|FG001|Period 2|Terminated by Sponsor|3|||
19706344|NCT04960228|42150477|FG000|Overall Study|Withdrawal by Subject|216|||
19706345|NCT04960228|42150478|FG001|Overall Study|Withdrawal by Subject|35|||
19706346|NCT04960228|42150477|FG000|Overall Study|Failed attention check|69|||
19706347|NCT04960228|42150478|FG001|Overall Study|Failed attention check|148|||
19706348|NCT04960228|42150477|FG000|Overall Study|Flagged for response quality by Dynata|3|||
19706349|NCT04960228|42150478|FG001|Overall Study|Flagged for response quality by Dynata|3|||
19706350|NCT04619992|42150486|FG000|Overall Study|Withdrawal by Subject|1|||
19706351|NCT04619992|42150487|FG001|Overall Study|Withdrawal by Subject|0|||
19706352|NCT00136604|42150498|FG000|Overall Study|Lost to Follow-up|1|||
19706353|NCT00136604|42150499|FG001|Overall Study|Lost to Follow-up|0|||
19706354|NCT00136604|42150500|FG002|Overall Study|Lost to Follow-up|0|||
19706355|NCT00136604|42150501|FG003|Overall Study|Lost to Follow-up|0|||
19706356|NCT00136604|42150502|FG004|Overall Study|Lost to Follow-up|1|||
19706357|NCT00136604|42150498|FG000|Overall Study|Migrated/moved from study area|0|||
19706358|NCT00136604|42150499|FG001|Overall Study|Migrated/moved from study area|1|||
19706359|NCT00136604|42150500|FG002|Overall Study|Migrated/moved from study area|0|||
19706360|NCT00136604|42150501|FG003|Overall Study|Migrated/moved from study area|0|||
19706361|NCT00136604|42150502|FG004|Overall Study|Migrated/moved from study area|0|||
19706362|NCT00135512|42150518|FG000|Overall Study|Adverse Event|56|||
19706363|NCT00135512|42150518|FG000|Overall Study|Lack of Efficacy|25|||
19706364|NCT00135512|42150518|FG000|Overall Study|Other|42|||
19706365|NCT00130728|42150524|FG000|Overall Study|Death|258|||
19706366|NCT00130728|42150525|FG001|Overall Study|Death|258|||
19706367|NCT00130728|42150524|FG000|Overall Study|Lost to Follow-up|4|||
19706368|NCT00130728|42150525|FG001|Overall Study|Lost to Follow-up|0|||
19706369|NCT00130728|42150524|FG000|Overall Study|Withdrawal by Subject|0|||
19706370|NCT00130728|42150525|FG001|Overall Study|Withdrawal by Subject|2|||
19706371|NCT00129974|42150531|FG000|Overall Study|Other|1|||
19706372|NCT04947436|42150538|FG000|Overall Study|Lost to Follow-up|3|||
19706373|NCT04947436|42150539|FG001|Overall Study|Lost to Follow-up|7|||
19706374|NCT04947436|42150540|FG002|Overall Study|Lost to Follow-up|5|||
19622967|NCT00494299|42072630|FG001|Overall Study|Site Closed by Sponsor|0|||
19622968|NCT00494299|42072629|FG000|Overall Study|Protocol Driven Decision Point|11|||
19622969|NCT00494299|42072630|FG001|Overall Study|Protocol Driven Decision Point|22|||
19622970|NCT00593684|42072638|FG000|Overall Study|Death|2|||
19622971|NCT00593684|42072639|FG001|Overall Study|Death|1|||
19622972|NCT02963831|42072649|FG000|Overall Study|Progressive Disease|3|||
19622973|NCT02963831|42072650|FG001|Overall Study|Progressive Disease|3|||
19622974|NCT02963831|42072651|FG002|Overall Study|Progressive Disease|16|||
19622975|NCT02963831|42072652|FG003|Overall Study|Progressive Disease|27|||
19622976|NCT02963831|42072649|FG000|Overall Study|Withdrawal by Subject|1|||
19622977|NCT02963831|42072650|FG001|Overall Study|Withdrawal by Subject|0|||
19622978|NCT02963831|42072651|FG002|Overall Study|Withdrawal by Subject|2|||
19622979|NCT02963831|42072652|FG003|Overall Study|Withdrawal by Subject|4|||
19622980|NCT02963831|42072649|FG000|Overall Study|Adverse Event|0|||
19706375|NCT04947436|42150538|FG000|Overall Study|Death|1|||
19706376|NCT04947436|42150539|FG001|Overall Study|Death|1|||
19706377|NCT04947436|42150540|FG002|Overall Study|Death|1|||
19706378|NCT00119106|42150550|FG000|Overall Study|HIV infected at baseline|179|||
19706379|NCT00119106|42150551|FG001|Overall Study|HIV infected at baseline|178|||
19706380|NCT00135356|42150567|FG000|Overall Study|Adverse Event|6|||
19706381|NCT00135356|42150568|FG001|Overall Study|Adverse Event|2|||
19706382|NCT00135356|42150567|FG000|Overall Study|Lack of Efficacy|2|||
19706383|NCT00135356|42150568|FG001|Overall Study|Lack of Efficacy|0|||
19706384|NCT00135356|42150567|FG000|Overall Study|Lost to Follow-up|3|||
19622981|NCT02963831|42072650|FG001|Overall Study|Adverse Event|1|||
19622982|NCT02963831|42072651|FG002|Overall Study|Adverse Event|1|||
19706385|NCT00135356|42150568|FG001|Overall Study|Lost to Follow-up|1|||
19622983|NCT02963831|42072652|FG003|Overall Study|Adverse Event|2|||
19622984|NCT02963831|42072649|FG000|Overall Study|Death|0|||
19622985|NCT02963831|42072650|FG001|Overall Study|Death|0|||
19622986|NCT02963831|42072651|FG002|Overall Study|Death|0|||
19622987|NCT02963831|42072652|FG003|Overall Study|Death|2|||
19622988|NCT00859898|42072667|FG000|Overall Study|Lack of Efficacy|0|||
19622989|NCT00859898|42072668|FG001|Overall Study|Lack of Efficacy|1|||
19622990|NCT00859898|42072669|FG002|Overall Study|Lack of Efficacy|1|||
19622991|NCT00859898|42072667|FG000|Overall Study|Adverse Event|4|||
19622992|NCT00859898|42072668|FG001|Overall Study|Adverse Event|9|||
19622993|NCT00859898|42072669|FG002|Overall Study|Adverse Event|8|||
19622994|NCT00859898|42072667|FG000|Overall Study|Withdrawal by Subject|11|||
19622995|NCT00859898|42072668|FG001|Overall Study|Withdrawal by Subject|8|||
19622996|NCT00859898|42072669|FG002|Overall Study|Withdrawal by Subject|11|||
19622997|NCT00859898|42072667|FG000|Overall Study|Death|0|||
19622998|NCT00859898|42072668|FG001|Overall Study|Death|0|||
19622999|NCT00859898|42072669|FG002|Overall Study|Death|1|||
19623000|NCT00859898|42072667|FG000|Overall Study|Lost to Follow-up|10|||
19623001|NCT00859898|42072668|FG001|Overall Study|Lost to Follow-up|11|||
19623002|NCT00859898|42072669|FG002|Overall Study|Lost to Follow-up|5|||
19623003|NCT00859898|42072667|FG000|Overall Study|poor/non-compliance|2|||
19623004|NCT00859898|42072668|FG001|Overall Study|poor/non-compliance|0|||
19623005|NCT00859898|42072669|FG002|Overall Study|poor/non-compliance|0|||
19623006|NCT00859898|42072667|FG000|Overall Study|No longer meets criteria|0|||
19623007|NCT00859898|42072668|FG001|Overall Study|No longer meets criteria|1|||
19623008|NCT00859898|42072669|FG002|Overall Study|No longer meets criteria|0|||
19623009|NCT00859898|42072667|FG000|Overall Study|non-specified|1|||
19623010|NCT00859898|42072668|FG001|Overall Study|non-specified|1|||
19623011|NCT00859898|42072669|FG002|Overall Study|non-specified|1|||
19623012|NCT00859586|42072678|FG000|Overall Study|Donors|4|||
19623013|NCT00494221|42072685|FG000|Overall Study|Death|15|||
19623014|NCT00494221|42072686|FG001|Overall Study|Death|9|||
19623015|NCT00494221|42072687|FG002|Overall Study|Death|14|||
19623016|NCT00494221|42072685|FG000|Overall Study|Withdrawal by Subject|1|||
19623017|NCT00494221|42072686|FG001|Overall Study|Withdrawal by Subject|2|||
19623018|NCT00494221|42072687|FG002|Overall Study|Withdrawal by Subject|0|||
19623019|NCT00857948|42072699|FG000|Overall Study|Withdrawal by Subject|2|||
19623020|NCT00857948|42072700|FG001|Overall Study|Withdrawal by Subject|0|||
19623021|NCT00857948|42072701|FG002|Overall Study|Withdrawal by Subject|0|||
19623022|NCT00857948|42072702|FG003|Overall Study|Withdrawal by Subject|0|||
19623023|NCT00857948|42072699|FG000|Overall Study|Protocol Violation|1|||
19623024|NCT00857948|42072700|FG001|Overall Study|Protocol Violation|0|||
19623025|NCT00857948|42072701|FG002|Overall Study|Protocol Violation|1|||
19623026|NCT00857948|42072702|FG003|Overall Study|Protocol Violation|0|||
19623027|NCT00866606|42072712|FG000|Overall Study|Lost to Follow-up|3|||
19623028|NCT00866606|42072712|FG000|Overall Study|Adverse Event|1|||
19623029|NCT00857792|42072716|FG000|Overall Study|inadequate image quality for analysis|12|||
19623030|NCT00601835|42072722|FG000|Overall Study|Withdrawal by Subject|9|||
19623031|NCT00601835|42072723|FG001|Overall Study|Withdrawal by Subject|6|||
19623032|NCT00601835|42072722|FG000|Overall Study|Physician Decision|1|||
19623033|NCT00601835|42072723|FG001|Overall Study|Physician Decision|0|||
19623034|NCT00601835|42072722|FG000|Overall Study|Lost to Follow-up|37|||
19623035|NCT00601835|42072723|FG001|Overall Study|Lost to Follow-up|5|||
19623036|NCT00601835|42072722|FG000|Overall Study|Adverse Event|1|||
19623037|NCT00601835|42072723|FG001|Overall Study|Adverse Event|1|||
19623038|NCT00601835|42072722|FG000|Overall Study|Relocate|12|||
19623039|NCT00601835|42072723|FG001|Overall Study|Relocate|2|||
19623040|NCT00857246|42072729|FG000|Induction Regimen|Adverse Event|1|||
19623041|NCT00857246|42072729|FG000|Induction Regimen|disease-related complications|1|||
19623042|NCT00857246|42072729|FG000|Induction Regimen|Withdrawal by Subject|1|||
19623043|NCT00857246|42072729|FG000|Surgery (Curative)|disease progression|6|||
19623044|NCT00857246|42072729|FG000|ChemoRT|Withdrawal by Subject|1|||
19623045|NCT00857246|42072729|FG000|ChemoRT|Adverse Event|2|||
19623046|NCT00856856|42072736|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
19623047|NCT00856856|42072736|FG000|4-year Clinical Follow-up|Missed visit|1|||
19623048|NCT00493285|42072751|FG000|Overall Study|Lost to Follow-up|0|||
19623049|NCT00493285|42072752|FG001|Overall Study|Lost to Follow-up|0|||
19623050|NCT00493285|42072753|FG002|Overall Study|Lost to Follow-up|0|||
19623051|NCT00493285|42072754|FG003|Overall Study|Lost to Follow-up|0|||
19623052|NCT00493285|42072755|FG004|Overall Study|Lost to Follow-up|1|||
19623053|NCT00493285|42072756|FG005|Overall Study|Lost to Follow-up|0|||
19623054|NCT00856778|42072770|FG000|Overall Study|Adverse Event|7|||
19623055|NCT00856778|42072770|FG000|Overall Study|Withdrawal by Subject|10|||
19623056|NCT00856778|42072770|FG000|Overall Study|Study deviation|2|||
19706386|NCT00135356|42150567|FG000|Overall Study|Surgery for abdominal fat|1|||
19623057|NCT00856778|42072770|FG000|Overall Study|Lost to Follow-up|5|||
19623058|NCT00603473|42072774|FG000|Overall Study|Adverse Event|4|||
19623059|NCT00603473|42072774|FG000|Overall Study|Lack of Efficacy|4|||
19623060|NCT00603473|42072774|FG000|Overall Study|Protocol Violation|1|||
19623061|NCT00486889|42072778|FG000|Overall Study|Death|3|||
19623062|NCT00486889|42072778|FG000|Overall Study|Non-compliant|2|||
19623063|NCT00486889|42072778|FG000|Overall Study|Withdrawal by Subject|6|||
19623064|NCT00486811|42072785|FG000|Overall Study|Adverse Event|28|||
19623065|NCT00486811|42072786|FG001|Overall Study|Adverse Event|60|||
19623066|NCT00486811|42072787|FG002|Overall Study|Adverse Event|135|||
19623067|NCT00486811|42072785|FG000|Overall Study|Lack of Efficacy|34|||
19623068|NCT00486811|42072786|FG001|Overall Study|Lack of Efficacy|14|||
19623069|NCT00486811|42072787|FG002|Overall Study|Lack of Efficacy|7|||
19623070|NCT00486811|42072785|FG000|Overall Study|Lost to Follow-up|4|||
19623071|NCT00486811|42072786|FG001|Overall Study|Lost to Follow-up|6|||
19623072|NCT00486811|42072787|FG002|Overall Study|Lost to Follow-up|4|||
19623073|NCT00486811|42072785|FG000|Overall Study|Withdrawal by Subject|33|||
19623074|NCT00486811|42072786|FG001|Overall Study|Withdrawal by Subject|44|||
19623075|NCT00486811|42072787|FG002|Overall Study|Withdrawal by Subject|58|||
19623076|NCT00486811|42072785|FG000|Overall Study|Study drug non-compliant|5|||
19706387|NCT00135356|42150568|FG001|Overall Study|Surgery for abdominal fat|0|||
19706388|NCT00135356|42150567|FG000|Overall Study|Change in antiviral regimen|0|||
19706389|NCT00135356|42150568|FG001|Overall Study|Change in antiviral regimen|1|||
19706390|NCT00135356|42150567|FG000|Overall Study|Poor/noncompliance|1|||
19706391|NCT00135356|42150568|FG001|Overall Study|Poor/noncompliance|1|||
19706392|NCT00135356|42150567|FG000|Overall Study|No longer meets study criteria|2|||
19623077|NCT00486811|42072786|FG001|Overall Study|Study drug non-compliant|6|||
19623078|NCT00486811|42072787|FG002|Overall Study|Study drug non-compliant|3|||
19394251|NCT02609399|41638349|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
19623079|NCT00486811|42072785|FG000|Overall Study|All other|18|||
19623080|NCT00486811|42072786|FG001|Overall Study|All other|11|||
19623081|NCT00486811|42072787|FG002|Overall Study|All other|7|||
19623082|NCT00486265|42072795|FG000|Overall Study|Adverse Event|1|||
19623083|NCT00486265|42072795|FG000|Overall Study|Lack of Efficacy|8|||
19623084|NCT02151604|42072799|FG000|Overall Study|Lost to Follow-up|3|||
19623085|NCT02151604|42072799|FG000|Overall Study|Withdrawal by Subject|2|||
19623086|NCT02151604|42072799|FG000|Overall Study|Physician Decision|3|||
19623087|NCT02151604|42072799|FG000|Overall Study|Death|1|||
19623088|NCT00466921|42072804|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
19706393|NCT00135356|42150568|FG001|Overall Study|No longer meets study criteria|0|||
19706394|NCT00135356|42150567|FG000|Overall Study|Withdrawal by Subject|2|||
19706395|NCT00135356|42150568|FG001|Overall Study|Withdrawal by Subject|4|||
19706396|NCT00118716|42150576|FG000|Overall Study|Adverse Event|2|||
19706397|NCT00118716|42150577|FG001|Overall Study|Adverse Event|7|||
19706398|NCT00118716|42150576|FG000|Overall Study|Protocol Violation|5|||
19706399|NCT00118716|42150577|FG001|Overall Study|Protocol Violation|4|||
19706400|NCT00118716|42150576|FG000|Overall Study|Withdrawal by Subject|0|||
19706401|NCT00118716|42150577|FG001|Overall Study|Withdrawal by Subject|1|||
19706402|NCT00118716|42150576|FG000|Overall Study|Exacerbation|2|||
19623089|NCT00466921|42072804|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
19623090|NCT00466921|42072804|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
19623091|NCT00466921|42072804|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
19623092|NCT00466921|42072804|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
19623093|NCT00466921|42072804|FG000|Follow up for a Minimum of 1 Year|Death|6|||
19623094|NCT00601523|42072810|FG000|Overall Study|Adverse Event|42|||
19623095|NCT00601523|42072811|FG001|Overall Study|Adverse Event|14|||
19623096|NCT00601523|42072810|FG000|Overall Study|Lack of Efficacy|3|||
19623097|NCT00601523|42072811|FG001|Overall Study|Lack of Efficacy|0|||
19623098|NCT00601523|42072810|FG000|Overall Study|Protocol Violation|5|||
19623099|NCT00601523|42072811|FG001|Overall Study|Protocol Violation|1|||
19623100|NCT00601523|42072810|FG000|Overall Study|Lost to Follow-up|0|||
19623101|NCT00601523|42072811|FG001|Overall Study|Lost to Follow-up|1|||
19623102|NCT00601523|42072810|FG000|Overall Study|Withdrawal by Subject|18|||
19623103|NCT00601523|42072811|FG001|Overall Study|Withdrawal by Subject|9|||
19623104|NCT00601523|42072810|FG000|Overall Study|Other|9|||
19623105|NCT00601523|42072811|FG001|Overall Study|Other|1|||
19623106|NCT00466687|42072817|FG000|Overall Study|Adverse Event|1|||
19623107|NCT00466687|42072817|FG000|Overall Study|Other complicating illness|3|||
19623108|NCT00466687|42072817|FG000|Overall Study|Withdrawal by Subject|1|||
19623109|NCT00466687|42072817|FG000|Overall Study|Disease progression|29|||
19623110|NCT00465985|42072839|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
19623111|NCT00465985|42072840|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
19623112|NCT00465985|42072839|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
19706403|NCT00118716|42150577|FG001|Overall Study|Exacerbation|2|||
19706404|NCT00118716|42150576|FG000|Overall Study|Discontinued by sponsor|1|||
19706405|NCT00118716|42150577|FG001|Overall Study|Discontinued by sponsor|1|||
19706406|NCT00118716|42150576|FG000|Overall Study|Non-compliance|1|||
19394252|NCT02609399|41638350|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
19706407|NCT00118716|42150577|FG001|Overall Study|Non-compliance|3|||
19623113|NCT00465985|42072840|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
19623114|NCT00465985|42072839|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
19623115|NCT00465985|42072840|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
19623116|NCT00465985|42072839|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
19623117|NCT00465985|42072840|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
19623118|NCT00454051|42072851|FG000|Overall Study|Adverse Event|1|||
19623119|NCT00454051|42072852|FG001|Overall Study|Adverse Event|2|||
19623120|NCT00454051|42072851|FG000|Overall Study|Withdrawal by Subject|1|||
19623121|NCT00454051|42072852|FG001|Overall Study|Withdrawal by Subject|0|||
19623122|NCT00454051|42072851|FG000|Overall Study|Protocol Violation|1|||
19623123|NCT00454051|42072852|FG001|Overall Study|Protocol Violation|1|||
19623124|NCT00484939|42072860|FG000|Overall Study|Death|9|||
19623125|NCT00484939|42072861|FG001|Overall Study|Death|13|||
19623126|NCT00484939|42072860|FG000|Overall Study|Adverse Event|22|||
19623127|NCT00484939|42072861|FG001|Overall Study|Adverse Event|12|||
19623128|NCT00484939|42072860|FG000|Overall Study|Patient Withdrew Consent|19|||
19623129|NCT00484939|42072861|FG001|Overall Study|Patient Withdrew Consent|10|||
19623130|NCT00484939|42072860|FG000|Overall Study|Protocol Violation|3|||
19623131|NCT00484939|42072861|FG001|Overall Study|Protocol Violation|3|||
19623132|NCT00484939|42072860|FG000|Overall Study|Lost to Follow-up|0|||
19623133|NCT00484939|42072861|FG001|Overall Study|Lost to Follow-up|3|||
19623134|NCT00484939|42072860|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
19706408|NCT00118716|42150576|FG000|Overall Study|misrandomized|1|||
19706409|NCT00118716|42150577|FG001|Overall Study|misrandomized|1|||
19706410|NCT00118716|42150576|FG000|Overall Study|Expired drug use|1|||
19706411|NCT00118716|42150577|FG001|Overall Study|Expired drug use|2|||
19706412|NCT00118716|42150576|FG000|Overall Study|Investigator discretion|0|||
19706413|NCT00118716|42150577|FG001|Overall Study|Investigator discretion|1|||
19706414|NCT04584346|42150585|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
19706415|NCT04584346|42150586|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
19706416|NCT00118482|42150596|FG000|Overall Study|Lost to Follow-up|7|||
19706417|NCT00118482|42150597|FG001|Overall Study|Lost to Follow-up|7|||
19706418|NCT00118482|42150596|FG000|Overall Study|Withdrawal by Subject|23|||
19706419|NCT00118482|42150597|FG001|Overall Study|Withdrawal by Subject|22|||
19706420|NCT00129272|42150605|FG000|Overall Study|Lost to Follow-up|12|||
19706421|NCT00129272|42150606|FG001|Overall Study|Lost to Follow-up|11|||
19706422|NCT00129272|42150605|FG000|Overall Study|Withdrawal by Subject|5|||
19706423|NCT00129272|42150606|FG001|Overall Study|Withdrawal by Subject|11|||
19706424|NCT04899232|42150615|FG000|Screening Period|Physician Decision|1|||
19706425|NCT04899232|42150616|FG001|Screening Period|Physician Decision|0|||
19706426|NCT04899232|42150617|FG002|Screening Period|Physician Decision|0|||
19706427|NCT04899232|42150615|FG000|Screening Period|Withdrawal by Subject|1|||
19706428|NCT04899232|42150616|FG001|Screening Period|Withdrawal by Subject|0|||
19706429|NCT04899232|42150617|FG002|Screening Period|Withdrawal by Subject|0|||
19706430|NCT04899232|42150615|FG000|Screening Period|Participant discharged before receiving intervention|3|||
19706431|NCT04899232|42150616|FG001|Screening Period|Participant discharged before receiving intervention|0|||
19706432|NCT04899232|42150617|FG002|Screening Period|Participant discharged before receiving intervention|0|||
19706433|NCT00096174|42150634|FG000|Overall Study|Lack of Efficacy|9|||
19706434|NCT00096174|42150634|FG000|Overall Study|Adverse Event|15|||
19706435|NCT00096174|42150634|FG000|Overall Study|Death|6|||
19706436|NCT00096174|42150634|FG000|Overall Study|Withdrawal by Subject|15|||
19706437|NCT00096174|42150634|FG000|Overall Study|Not started protocol therapy|3|||
19706438|NCT00096174|42150634|FG000|Overall Study|Ineligible|6|||
19706439|NCT00096174|42150634|FG000|Overall Study|other reason|8|||
19706440|NCT04559698|42150640|FG000|Overall Study|Lost to Follow-up|14|||
19706441|NCT04559698|42150641|FG001|Overall Study|Lost to Follow-up|15|||
19706442|NCT04559698|42150640|FG000|Overall Study|Withdrawal by Subject|0|||
19706443|NCT04559698|42150641|FG001|Overall Study|Withdrawal by Subject|1|||
19706444|NCT00133952|42150649|FG000|Overall Study|Adverse Event|1|||
19706445|NCT00133952|42150650|FG001|Overall Study|Adverse Event|2|||
19706446|NCT00133952|42150649|FG000|Overall Study|Death|3|||
19706447|NCT00133952|42150650|FG001|Overall Study|Death|2|||
19706448|NCT00133952|42150649|FG000|Overall Study|Lost to Follow-up|9|||
19706449|NCT00133952|42150650|FG001|Overall Study|Lost to Follow-up|14|||
19706450|NCT00133952|42150649|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
19706451|NCT00133952|42150650|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
19706452|NCT00133952|42150649|FG000|Overall Study|Protocol Violation|1|||
19623135|NCT00484939|42072861|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
19706453|NCT00133952|42150650|FG001|Overall Study|Protocol Violation|1|||
19706454|NCT00133952|42150649|FG000|Overall Study|Withdrawal by Subject|20|||
19706455|NCT00133952|42150650|FG001|Overall Study|Withdrawal by Subject|4|||
19706456|NCT00133952|42150649|FG000|Overall Study|Physician Decision|4|||
19706457|NCT00133952|42150650|FG001|Overall Study|Physician Decision|3|||
19706458|NCT00133952|42150649|FG000|Overall Study|Sponsor Decision|0|||
19706459|NCT00133952|42150650|FG001|Overall Study|Sponsor Decision|1|||
19623136|NCT00484939|42072860|FG000|Overall Study|Disease progression|67|||
19623137|NCT00484939|42072861|FG001|Overall Study|Disease progression|88|||
19623138|NCT00484939|42072860|FG000|Overall Study|Screen Failure|2|||
19623139|NCT00484939|42072861|FG001|Overall Study|Screen Failure|2|||
19623140|NCT00484939|42072860|FG000|Overall Study|Reason Not Specified|11|||
19623141|NCT00484939|42072861|FG001|Overall Study|Reason Not Specified|6|||
19623142|NCT00453973|42072869|FG000|Overall Study|Adverse Event|4|||
19623143|NCT00453973|42072870|FG001|Overall Study|Adverse Event|9|||
19623144|NCT00453973|42072869|FG000|Overall Study|Withdrawal by Subject|7|||
19623145|NCT00453973|42072870|FG001|Overall Study|Withdrawal by Subject|6|||
19623146|NCT00453973|42072869|FG000|Overall Study|PI Decision|0|||
19623147|NCT00453973|42072870|FG001|Overall Study|PI Decision|2|||
19623148|NCT00453973|42072869|FG000|Overall Study|Relocation|1|||
19623149|NCT00453973|42072870|FG001|Overall Study|Relocation|0|||
19623150|NCT00453973|42072869|FG000|Overall Study|Renal transplant|1|||
19623151|NCT00453973|42072870|FG001|Overall Study|Renal transplant|1|||
19623152|NCT00453973|42072869|FG000|Overall Study|Site closed by sponsor|3|||
19623153|NCT00453973|42072870|FG001|Overall Study|Site closed by sponsor|0|||
19623154|NCT00453973|42072869|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
19623155|NCT00453973|42072870|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
19623156|NCT00465361|42072876|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
19623157|NCT00464815|42072882|FG000|Overall Study|Withdrawal by Subject|6|||
19623158|NCT00464815|42072883|FG001|Overall Study|Withdrawal by Subject|3|||
19623159|NCT00464737|42072892|FG000|Overall Study|Adverse Event|12|||
19623160|NCT00464737|42072893|FG001|Overall Study|Adverse Event|17|||
19623161|NCT00464737|42072894|FG002|Overall Study|Adverse Event|33|||
19623162|NCT00464737|42072892|FG000|Overall Study|Lack of Efficacy|7|||
19623163|NCT00464737|42072893|FG001|Overall Study|Lack of Efficacy|7|||
19623164|NCT00464737|42072894|FG002|Overall Study|Lack of Efficacy|4|||
19623165|NCT00464737|42072892|FG000|Overall Study|Withdrawal by Subject|5|||
19623166|NCT00464737|42072893|FG001|Overall Study|Withdrawal by Subject|3|||
19623167|NCT00464737|42072894|FG002|Overall Study|Withdrawal by Subject|5|||
19623168|NCT00464737|42072892|FG000|Overall Study|Protocol Violation|1|||
19623169|NCT00464737|42072893|FG001|Overall Study|Protocol Violation|1|||
19623170|NCT00464737|42072894|FG002|Overall Study|Protocol Violation|5|||
19623171|NCT00464737|42072892|FG000|Overall Study|Non-compliance|0|||
19623172|NCT00464737|42072893|FG001|Overall Study|Non-compliance|1|||
19623173|NCT00464737|42072894|FG002|Overall Study|Non-compliance|1|||
19623174|NCT00464737|42072892|FG000|Overall Study|Lost to Follow-up|5|||
19623175|NCT00464737|42072893|FG001|Overall Study|Lost to Follow-up|2|||
19623176|NCT00464737|42072894|FG002|Overall Study|Lost to Follow-up|5|||
19623177|NCT00464737|42072892|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
19623178|NCT00464737|42072893|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
19623179|NCT00464737|42072894|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
19623180|NCT00464737|42072892|FG000|Overall Study|Other: Subject left town; family illness|1|||
19623181|NCT00464737|42072893|FG001|Overall Study|Other: Subject left town; family illness|0|||
19623182|NCT00464737|42072894|FG002|Overall Study|Other: Subject left town; family illness|0|||
19623183|NCT00464737|42072892|FG000|Overall Study|Other: Study demands too great|0|||
19623184|NCT00464737|42072893|FG001|Overall Study|Other: Study demands too great|1|||
19623185|NCT00464737|42072894|FG002|Overall Study|Other: Study demands too great|0|||
19623186|NCT00464737|42072892|FG000|Overall Study|Other: Personal family reasons|0|||
19623187|NCT00464737|42072893|FG001|Overall Study|Other: Personal family reasons|0|||
19623188|NCT00464737|42072894|FG002|Overall Study|Other: Personal family reasons|1|||
19623189|NCT00464737|42072892|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
19623190|NCT00464737|42072893|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
19623191|NCT00464737|42072894|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
19623192|NCT00453349|42072904|FG000|Randomized|Adverse Event|12|||
19623193|NCT00453349|42072905|FG001|Randomized|Adverse Event|11|||
19623194|NCT00453349|42072904|FG000|Randomized|Lack of Efficacy|2|||
19623195|NCT00453349|42072905|FG001|Randomized|Lack of Efficacy|1|||
19623196|NCT00453349|42072904|FG000|Randomized|Lost to Follow-up|7|||
19623197|NCT00453349|42072905|FG001|Randomized|Lost to Follow-up|5|||
19623198|NCT00453349|42072904|FG000|Randomized|Protocol Violation|1|||
19623199|NCT00453349|42072905|FG001|Randomized|Protocol Violation|1|||
19623200|NCT00453349|42072904|FG000|Randomized|Withdrawal by Subject|3|||
19623201|NCT00453349|42072905|FG001|Randomized|Withdrawal by Subject|5|||
19623202|NCT00453349|42072904|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
19623203|NCT00453349|42072905|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
19623204|NCT00453349|42072904|FG000|Completed Study|Adverse Event|12|||
19623205|NCT00453349|42072905|FG001|Completed Study|Adverse Event|11|||
19623206|NCT00453349|42072904|FG000|Completed Study|Lack of Efficacy|2|||
19623207|NCT00453349|42072905|FG001|Completed Study|Lack of Efficacy|1|||
19623208|NCT00453349|42072904|FG000|Completed Study|Lost to Follow-up|7|||
19623209|NCT00453349|42072905|FG001|Completed Study|Lost to Follow-up|5|||
19623210|NCT00453349|42072904|FG000|Completed Study|Protocol Violation|1|||
19623211|NCT00453349|42072905|FG001|Completed Study|Protocol Violation|1|||
19623212|NCT00453349|42072904|FG000|Completed Study|Withdrawal by Subject|3|||
19623213|NCT00453349|42072905|FG001|Completed Study|Withdrawal by Subject|5|||
19623214|NCT00453349|42072904|FG000|Completed Study|Lost to follow up after study treatment|2|||
19623215|NCT00453349|42072905|FG001|Completed Study|Lost to follow up after study treatment|11|||
19623216|NCT00464269|42072915|FG000|Overall Study|Lack of Efficacy|1|||
19623217|NCT00464269|42072916|FG001|Overall Study|Lack of Efficacy|0|||
19623218|NCT00464269|42072917|FG002|Overall Study|Lack of Efficacy|0|||
19517707|NCT01529346|41930699|FG004|Overall Study|Lost to Follow-up|0|||
19517708|NCT01529346|41930695|FG000|Overall Study|Other|0|||
19517709|NCT01529346|41930696|FG001|Overall Study|Other|1|||
19517710|NCT01529346|41930697|FG002|Overall Study|Other|1|||
19517711|NCT01529346|41930698|FG003|Overall Study|Other|0|||
19517712|NCT01529346|41930699|FG004|Overall Study|Other|0|||
19517713|NCT01529268|41930723|FG000|Overall Study|Lost to Follow-up|9|||
19517714|NCT01529268|41930724|FG001|Overall Study|Lost to Follow-up|3|||
19517715|NCT01529268|41930723|FG000|Overall Study|Moved|3|||
19517716|NCT01529268|41930724|FG001|Overall Study|Moved|0|||
19623219|NCT00464269|42072918|FG003|Overall Study|Lack of Efficacy|0|||
19623220|NCT00464269|42072915|FG000|Overall Study|Lost to Follow-up|0|||
19623221|NCT00464269|42072916|FG001|Overall Study|Lost to Follow-up|4|||
19623222|NCT00464269|42072917|FG002|Overall Study|Lost to Follow-up|0|||
19373755|NCT02662569|41614959|FG000|Overall Study|Withdrawal by Subject|6|||
19373756|NCT02662569|41614960|FG001|Overall Study|Withdrawal by Subject|1|||
19623223|NCT00464269|42072918|FG003|Overall Study|Lost to Follow-up|1|||
19623224|NCT00464269|42072915|FG000|Overall Study|Withdrawal by Subject|0|||
19623225|NCT00464269|42072916|FG001|Overall Study|Withdrawal by Subject|2|||
19623226|NCT00464269|42072917|FG002|Overall Study|Withdrawal by Subject|1|||
19623227|NCT00464269|42072918|FG003|Overall Study|Withdrawal by Subject|1|||
19623228|NCT00464269|42072915|FG000|Overall Study|Other reason|3|||
19373757|NCT02662569|41614961|FG002|Overall Study|Withdrawal by Subject|6|||
19373758|NCT02662569|41614962|FG003|Overall Study|Withdrawal by Subject|4|||
19373759|NCT02662569|41614959|FG000|Overall Study|Lost to Follow-up|1|||
19373760|NCT02662569|41614960|FG001|Overall Study|Lost to Follow-up|0|||
19373761|NCT02662569|41614961|FG002|Overall Study|Lost to Follow-up|0|||
19373762|NCT02662569|41614962|FG003|Overall Study|Lost to Follow-up|0|||
19373763|NCT02741635|41614972|FG000|Overall Study|Withdrawal by Subject|1|||
19373764|NCT02753075|41614980|FG000|Overall Study|Adverse Event|2|||
19517717|NCT01529112|41930732|FG000|Overall Study|Adverse Event|2|||
19517718|NCT01529112|41930733|FG001|Overall Study|Adverse Event|0|||
19623229|NCT00464269|42072916|FG001|Overall Study|Other reason|3|||
19623230|NCT00464269|42072917|FG002|Overall Study|Other reason|1|||
19623231|NCT00464269|42072918|FG003|Overall Study|Other reason|1|||
19623232|NCT00464269|42072915|FG000|Overall Study|AE, serious fatal|0|||
19623233|NCT00464269|42072916|FG001|Overall Study|AE, serious fatal|0|||
19623234|NCT00464269|42072917|FG002|Overall Study|AE, serious fatal|1|||
19623235|NCT00464269|42072918|FG003|Overall Study|AE, serious fatal|1|||
19623236|NCT00464269|42072915|FG000|Overall Study|SAE, non-fatal|0|||
19623237|NCT00464269|42072916|FG001|Overall Study|SAE, non-fatal|0|||
19623238|NCT00464269|42072917|FG002|Overall Study|SAE, non-fatal|0|||
19623239|NCT00464269|42072918|FG003|Overall Study|SAE, non-fatal|1|||
19623240|NCT00464269|42072915|FG000|Overall Study|AE, non-serious non-fatal|2|||
19623241|NCT00464269|42072916|FG001|Overall Study|AE, non-serious non-fatal|8|||
19623242|NCT00464269|42072917|FG002|Overall Study|AE, non-serious non-fatal|3|||
19706460|NCT00118092|42150656|FG000|Overall Study|Withdrawal by Subject|1|||
19706461|NCT00118092|42150656|FG000|Overall Study|Protocol Violation|1|||
19706462|NCT04555096|42150663|FG000|Overall Study|Death|4|||
19706463|NCT04555096|42150664|FG001|Overall Study|Death|4|||
19706464|NCT04555096|42150663|FG000|Overall Study|Withdrawal by Subject|1|||
19706465|NCT04555096|42150664|FG001|Overall Study|Withdrawal by Subject|0|||
19706466|NCT04555096|42150663|FG000|Overall Study|Other|0|||
19373765|NCT02753075|41614981|FG001|Overall Study|Adverse Event|1|||
19373766|NCT02753075|41614982|FG002|Overall Study|Adverse Event|0|||
19517719|NCT01529112|41930732|FG000|Overall Study|Death|59|||
19517720|NCT01529112|41930733|FG001|Overall Study|Death|38|||
19623243|NCT00464269|42072918|FG003|Overall Study|AE, non-serious non-fatal|4|||
19623244|NCT00464269|42072915|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19623245|NCT00464269|42072916|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19706467|NCT04555096|42150664|FG001|Overall Study|Other|1|||
19623246|NCT00464269|42072917|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
19623247|NCT00464269|42072918|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19623248|NCT00484315|42072932|FG000|12-Month Clinical Follow-up|Death|6|||
19623249|NCT00484315|42072933|FG001|12-Month Clinical Follow-up|Death|2|||
19623250|NCT00484315|42072932|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
19623251|NCT00484315|42072933|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
19623252|NCT00484315|42072932|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
19623253|NCT00484315|42072933|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
19623254|NCT00484315|42072932|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
19623255|NCT00484315|42072933|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
19623256|NCT00484315|42072932|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
19623257|NCT00484315|42072933|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
19623258|NCT00484315|42072932|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
19623259|NCT00484315|42072933|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
19623260|NCT00484315|42072932|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
19623261|NCT00484315|42072933|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
19623262|NCT00463801|42072939|FG000|Overall Study|Protocol Violation|1|||
19623263|NCT00463801|42072939|FG000|Overall Study|Lack of Efficacy|2|||
19623264|NCT00463801|42072939|FG000|Overall Study|Adverse Event|4|||
19623265|NCT00463801|42072939|FG000|Overall Study|Lost to Follow-up|5|||
19623266|NCT00463801|42072939|FG000|Overall Study|No longer require therapy|1|||
19623267|NCT00463567|42072950|FG000|Overall Study|Adverse Event|29|||
19623268|NCT00463567|42072951|FG001|Overall Study|Adverse Event|26|||
19623269|NCT00463567|42072952|FG002|Overall Study|Adverse Event|17|||
19623270|NCT00463567|42072953|FG003|Overall Study|Adverse Event|46|||
19706468|NCT00097500|42150672|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
19706469|NCT00097500|42150673|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
19706470|NCT00097500|42150672|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
19706471|NCT00097500|42150673|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
19706472|NCT00097500|42150672|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
19706473|NCT00097500|42150673|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
19706474|NCT00097500|42150672|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
19706475|NCT00097500|42150673|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
19706476|NCT00097500|42150672|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
19706477|NCT00097500|42150673|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
19706478|NCT00097500|42150672|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
19706479|NCT00097500|42150673|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
19706480|NCT00097500|42150672|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
19706481|NCT00097500|42150673|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
19706482|NCT04551898|42150683|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
19706483|NCT04551898|42150684|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
19706484|NCT04551898|42150685|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
19706485|NCT04551898|42150686|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
19706486|NCT04551898|42150683|FG000|Overall Study|Withdrawal by Subject|5|||
19706487|NCT04551898|42150684|FG001|Overall Study|Withdrawal by Subject|1|||
19706488|NCT04551898|42150685|FG002|Overall Study|Withdrawal by Subject|2|||
19706489|NCT04551898|42150686|FG003|Overall Study|Withdrawal by Subject|2|||
19706490|NCT04551898|42150683|FG000|Overall Study|Lost to Follow-up|2|||
19706491|NCT04551898|42150684|FG001|Overall Study|Lost to Follow-up|1|||
19706492|NCT04551898|42150685|FG002|Overall Study|Lost to Follow-up|2|||
19706493|NCT04551898|42150686|FG003|Overall Study|Lost to Follow-up|2|||
19706494|NCT04551898|42150683|FG000|Overall Study|Death|1|||
19706495|NCT04551898|42150684|FG001|Overall Study|Death|0|||
19706496|NCT04551898|42150685|FG002|Overall Study|Death|0|||
19706497|NCT04551898|42150686|FG003|Overall Study|Death|0|||
19706498|NCT04551898|42150683|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
19706499|NCT04551898|42150684|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
19706500|NCT04551898|42150685|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
19706501|NCT04551898|42150686|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
19706502|NCT04849780|42150704|FG000|Period 1|Covid-19 Related|1|||
19706503|NCT04849780|42150705|FG001|Period 1|Covid-19 Related|0|||
19706504|NCT04849780|42150704|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
19706505|NCT04849780|42150705|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
19706506|NCT04849780|42150704|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
19706507|NCT04849780|42150705|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
19706508|NCT04823494|42150719|FG000|Overall Study|Programming software malfunction.|1|||
19706509|NCT04823494|42150720|FG001|Overall Study|Programming software malfunction.|0|||
19706510|NCT04823494|42150719|FG000|Overall Study|Withdrawal by Subject|1|||
19517721|NCT01529112|41930732|FG000|Overall Study|Protocol Violation|1|||
19623271|NCT00463567|42072954|FG004|Overall Study|Adverse Event|10|||
19623272|NCT00463567|42072955|FG005|Overall Study|Adverse Event|10|||
19623273|NCT00463567|42072956|FG006|Overall Study|Adverse Event|4|||
19623274|NCT00463567|42072950|FG000|Overall Study|Withdrawal by Subject|29|||
19623275|NCT00463567|42072951|FG001|Overall Study|Withdrawal by Subject|22|||
19623276|NCT00463567|42072952|FG002|Overall Study|Withdrawal by Subject|20|||
19623277|NCT00463567|42072953|FG003|Overall Study|Withdrawal by Subject|37|||
19623278|NCT00463567|42072954|FG004|Overall Study|Withdrawal by Subject|6|||
19623279|NCT00463567|42072955|FG005|Overall Study|Withdrawal by Subject|5|||
19623280|NCT00463567|42072956|FG006|Overall Study|Withdrawal by Subject|1|||
19623281|NCT00463567|42072950|FG000|Overall Study|Protocol Deviation|13|||
19623282|NCT00463567|42072951|FG001|Overall Study|Protocol Deviation|9|||
19623283|NCT00463567|42072952|FG002|Overall Study|Protocol Deviation|14|||
19623284|NCT00463567|42072953|FG003|Overall Study|Protocol Deviation|11|||
19623285|NCT00463567|42072954|FG004|Overall Study|Protocol Deviation|1|||
19623286|NCT00463567|42072955|FG005|Overall Study|Protocol Deviation|1|||
19623287|NCT00463567|42072956|FG006|Overall Study|Protocol Deviation|2|||
19623288|NCT00463567|42072950|FG000|Overall Study|Lost to Follow-up|12|||
19623289|NCT00463567|42072951|FG001|Overall Study|Lost to Follow-up|6|||
19623290|NCT00463567|42072952|FG002|Overall Study|Lost to Follow-up|13|||
19623291|NCT00463567|42072953|FG003|Overall Study|Lost to Follow-up|8|||
19623292|NCT00463567|42072954|FG004|Overall Study|Lost to Follow-up|1|||
19623293|NCT00463567|42072955|FG005|Overall Study|Lost to Follow-up|1|||
19623294|NCT00463567|42072956|FG006|Overall Study|Lost to Follow-up|1|||
19623295|NCT00463567|42072950|FG000|Overall Study|Administrative problems|5|||
19623296|NCT00463567|42072951|FG001|Overall Study|Administrative problems|3|||
19623297|NCT00463567|42072952|FG002|Overall Study|Administrative problems|6|||
19623298|NCT00463567|42072953|FG003|Overall Study|Administrative problems|9|||
19623299|NCT00463567|42072954|FG004|Overall Study|Administrative problems|3|||
19623300|NCT00463567|42072955|FG005|Overall Study|Administrative problems|2|||
19623301|NCT00463567|42072956|FG006|Overall Study|Administrative problems|2|||
19623302|NCT00463567|42072950|FG000|Overall Study|Lack of Efficacy|4|||
19623303|NCT00463567|42072951|FG001|Overall Study|Lack of Efficacy|9|||
19623304|NCT00463567|42072952|FG002|Overall Study|Lack of Efficacy|9|||
19623305|NCT00463567|42072953|FG003|Overall Study|Lack of Efficacy|17|||
19623306|NCT00463567|42072954|FG004|Overall Study|Lack of Efficacy|1|||
19623307|NCT00463567|42072955|FG005|Overall Study|Lack of Efficacy|0|||
19623308|NCT00463567|42072956|FG006|Overall Study|Lack of Efficacy|1|||
19623309|NCT00463567|42072950|FG000|Overall Study|Abnormal lab value(s)|1|||
19623310|NCT00463567|42072951|FG001|Overall Study|Abnormal lab value(s)|1|||
19623311|NCT00463567|42072952|FG002|Overall Study|Abnormal lab value(s)|2|||
19623312|NCT00463567|42072953|FG003|Overall Study|Abnormal lab value(s)|1|||
19623313|NCT00463567|42072954|FG004|Overall Study|Abnormal lab value(s)|1|||
19623314|NCT00463567|42072955|FG005|Overall Study|Abnormal lab value(s)|0|||
19623315|NCT00463567|42072956|FG006|Overall Study|Abnormal lab value(s)|0|||
19623316|NCT00463567|42072950|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19623317|NCT00463567|42072951|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19623318|NCT00463567|42072952|FG002|Overall Study|Abnormal test procedure result(s)|6|||
19623319|NCT00463567|42072953|FG003|Overall Study|Abnormal test procedure result(s)|2|||
19623320|NCT00463567|42072954|FG004|Overall Study|Abnormal test procedure result(s)|0|||
19623321|NCT00463567|42072955|FG005|Overall Study|Abnormal test procedure result(s)|2|||
19623322|NCT00463567|42072956|FG006|Overall Study|Abnormal test procedure result(s)|0|||
19623323|NCT00463567|42072950|FG000|Overall Study|Death|1|||
19623324|NCT00463567|42072951|FG001|Overall Study|Death|0|||
19623325|NCT00463567|42072952|FG002|Overall Study|Death|2|||
19623326|NCT00463567|42072953|FG003|Overall Study|Death|0|||
19623327|NCT00463567|42072954|FG004|Overall Study|Death|0|||
19623328|NCT00463567|42072955|FG005|Overall Study|Death|0|||
19623329|NCT00463567|42072956|FG006|Overall Study|Death|0|||
19623330|NCT00484159|42072981|FG000|Overall Study|Lost to Follow-up|1|||
19623331|NCT00484159|42072982|FG001|Overall Study|Lost to Follow-up|1|||
19623332|NCT00484159|42072983|FG002|Overall Study|Lost to Follow-up|0|||
19623333|NCT00462865|42072991|FG000|Overall Study|Adverse Event|1|||
19623334|NCT03839641|42072997|FG000|Overall Study|Withdrawal by Subject|1|||
19623335|NCT03839641|42072998|FG001|Overall Study|Withdrawal by Subject|1|||
19623336|NCT00462709|42073006|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
19623337|NCT00462709|42073006|FG000|Overall Study|Lost to Follow-up|10|||
19623338|NCT00462709|42073006|FG000|Overall Study|Withdrawal by Subject|8|||
19623339|NCT00462709|42073006|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
19623340|NCT00462709|42073006|FG000|Overall Study|Death|2|||
19623341|NCT00462709|42073006|FG000|Overall Study|Logistical reasons|2|||
19623342|NCT00462709|42073006|FG000|Overall Study|Physician Decision|1|||
19623343|NCT00462709|42073006|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
19623344|NCT00461305|42073012|FG000|Treatment|Adverse Event|26|||
19623345|NCT00461305|42073013|FG001|Treatment|Adverse Event|3|||
19623346|NCT00461305|42073012|FG000|Treatment|Lost to Follow-up|4|||
19623347|NCT00461305|42073013|FG001|Treatment|Lost to Follow-up|2|||
19623348|NCT00461305|42073012|FG000|Treatment|Protocol Violation|13|||
19623349|NCT00461305|42073013|FG001|Treatment|Protocol Violation|2|||
19623350|NCT00461305|42073012|FG000|Treatment|Withdrawal by Subject|48|||
19623351|NCT00461305|42073013|FG001|Treatment|Withdrawal by Subject|2|||
19623352|NCT00461305|42073012|FG000|Treatment|Never dispensed|5|||
19623353|NCT00461305|42073013|FG001|Treatment|Never dispensed|0|||
19623354|NCT00461305|42073012|FG000|Treatment|Study drug not taken|1|||
19623355|NCT00461305|42073013|FG001|Treatment|Study drug not taken|0|||
19623356|NCT00461305|42073012|FG000|Treatment|Partially missing diary|2|||
19623357|NCT00461305|42073013|FG001|Treatment|Partially missing diary|0|||
19623358|NCT00461305|42073012|FG000|Treatment|Other (missing drug etc)|2|||
19623359|NCT00461305|42073013|FG001|Treatment|Other (missing drug etc)|0|||
19623360|NCT00461305|42073012|FG000|Continued Treatment|Adverse Event|26|||
19623361|NCT00461305|42073013|FG001|Continued Treatment|Adverse Event|0|||
19623362|NCT00461305|42073012|FG000|Continued Treatment|Lost to Follow-up|4|||
19623363|NCT00461305|42073013|FG001|Continued Treatment|Lost to Follow-up|0|||
19623364|NCT00461305|42073012|FG000|Continued Treatment|Protocol Violation|13|||
19623365|NCT00461305|42073013|FG001|Continued Treatment|Protocol Violation|0|||
19623366|NCT00461305|42073012|FG000|Continued Treatment|Withdrawal by Subject|48|||
19623367|NCT00461305|42073013|FG001|Continued Treatment|Withdrawal by Subject|0|||
19623368|NCT00461305|42073012|FG000|Continued Treatment|Partially missing diary|2|||
19623369|NCT00461305|42073013|FG001|Continued Treatment|Partially missing diary|0|||
19623370|NCT00461305|42073012|FG000|Continued Treatment|Other (missing drug etc)|2|||
19623371|NCT00461305|42073013|FG001|Continued Treatment|Other (missing drug etc)|0|||
19623372|NCT00856544|42073024|FG000|Overall Study|Randomized but not treated|3|||
19623373|NCT00856544|42073025|FG001|Overall Study|Randomized but not treated|0|||
19623374|NCT00856544|42073026|FG002|Overall Study|Randomized but not treated|0|||
19623375|NCT00856544|42073027|FG003|Overall Study|Randomized but not treated|0|||
19623376|NCT00856544|42073024|FG000|Overall Study|Death|0|||
19623377|NCT00856544|42073025|FG001|Overall Study|Death|2|||
19623378|NCT00856544|42073026|FG002|Overall Study|Death|0|||
19623379|NCT00856544|42073027|FG003|Overall Study|Death|0|||
19623380|NCT00856544|42073024|FG000|Overall Study|Adverse Event|20|||
19623381|NCT00856544|42073025|FG001|Overall Study|Adverse Event|29|||
19623382|NCT00856544|42073026|FG002|Overall Study|Adverse Event|2|||
19623383|NCT00856544|42073027|FG003|Overall Study|Adverse Event|3|||
19623384|NCT00856544|42073024|FG000|Overall Study|Lack of Efficacy|16|||
19623385|NCT00856544|42073025|FG001|Overall Study|Lack of Efficacy|12|||
19706511|NCT04823494|42150720|FG001|Overall Study|Withdrawal by Subject|0|||
19706512|NCT04823494|42150719|FG000|Overall Study|Devices lost|0|||
19706513|NCT04823494|42150720|FG001|Overall Study|Devices lost|1|||
19706514|NCT04542694|42150730|FG000|Overall Study|The need for prohibited therapy|2|||
19706515|NCT04542694|42150731|FG001|Overall Study|The need for prohibited therapy|0|||
19706516|NCT04542694|42150730|FG000|Overall Study|Adverse Event|1|||
19706517|NCT04542694|42150731|FG001|Overall Study|Adverse Event|0|||
19706518|NCT04542694|42150730|FG000|Overall Study|Protocol Violation|1|||
19706519|NCT04542694|42150731|FG001|Overall Study|Protocol Violation|0|||
19706520|NCT00117312|42150741|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
19706521|NCT00117312|42150742|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
19706522|NCT00117312|42150743|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
19706523|NCT00117312|42150744|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
19706524|NCT00117312|42150741|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
19706525|NCT00117312|42150742|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
19706526|NCT00117312|42150743|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
19706527|NCT00117312|42150744|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
19706528|NCT00117312|42150741|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
19706529|NCT00117312|42150742|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
19706530|NCT00117312|42150743|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
19706531|NCT00117312|42150744|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
19706532|NCT00117312|42150741|FG000|Overall Study|Other|0|||
19706533|NCT00117312|42150742|FG001|Overall Study|Other|1|||
19706534|NCT00117312|42150743|FG002|Overall Study|Other|3|||
19623386|NCT00856544|42073026|FG002|Overall Study|Lack of Efficacy|3|||
19623387|NCT00856544|42073027|FG003|Overall Study|Lack of Efficacy|3|||
19623388|NCT00856544|42073024|FG000|Overall Study|Other|9|||
19623389|NCT00856544|42073025|FG001|Overall Study|Other|16|||
19623390|NCT00856544|42073026|FG002|Overall Study|Other|1|||
19623391|NCT00856544|42073027|FG003|Overall Study|Other|6|||
19623392|NCT00856544|42073024|FG000|Overall Study|Lost to Follow-up|1|||
19623393|NCT00856544|42073025|FG001|Overall Study|Lost to Follow-up|2|||
19623394|NCT00856544|42073026|FG002|Overall Study|Lost to Follow-up|2|||
19706535|NCT00117312|42150744|FG003|Overall Study|Other|1|||
19706536|NCT00117312|42150741|FG000|Overall Study|Patient choice|0|||
19706537|NCT00117312|42150742|FG001|Overall Study|Patient choice|0|||
19623395|NCT00856544|42073027|FG003|Overall Study|Lost to Follow-up|0|||
19706538|NCT00117312|42150743|FG002|Overall Study|Patient choice|2|||
19706539|NCT00117312|42150744|FG003|Overall Study|Patient choice|1|||
19706540|NCT00117312|42150741|FG000|Overall Study|Adverse Event|0|||
19623396|NCT00856544|42073024|FG000|Overall Study|Withdrawal by Subject|8|||
19623397|NCT00856544|42073025|FG001|Overall Study|Withdrawal by Subject|5|||
19623398|NCT00856544|42073026|FG002|Overall Study|Withdrawal by Subject|0|||
19623399|NCT00856544|42073027|FG003|Overall Study|Withdrawal by Subject|1|||
19623400|NCT00856388|42073049|FG000|Overall Study|Other|1|||
19623401|NCT00848354|42073056|FG000|Phase 1|Adverse Event|5|||
19623402|NCT00848354|42073057|FG001|Phase 1|Adverse Event|4|||
19623403|NCT00848354|42073056|FG000|Phase 1|Discontinuation of study by sponsor|2|||
19623404|NCT00848354|42073057|FG001|Phase 1|Discontinuation of study by sponsor|1|||
19623405|NCT00848354|42073056|FG000|Phase 1|Failed to return|0|||
19623406|NCT00848354|42073057|FG001|Phase 1|Failed to return|1|||
19623407|NCT00848354|42073056|FG000|Phase 1|Lost to Follow-up|1|||
19623408|NCT00848354|42073057|FG001|Phase 1|Lost to Follow-up|1|||
19623409|NCT00848354|42073056|FG000|Phase 1|Unspecified Reason|1|||
19623410|NCT00848354|42073057|FG001|Phase 1|Unspecified Reason|1|||
19623411|NCT00848354|42073056|FG000|Phase 1|Protocol Violation|1|||
19623412|NCT00848354|42073057|FG001|Phase 1|Protocol Violation|1|||
19623413|NCT00848354|42073056|FG000|Phase 1|Withdrawal by Subject|2|||
19623414|NCT00848354|42073057|FG001|Phase 1|Withdrawal by Subject|4|||
19623415|NCT00848354|42073056|FG000|Phase 1|Lack of Efficacy|0|||
19623416|NCT00848354|42073057|FG001|Phase 1|Lack of Efficacy|1|||
19623417|NCT00848354|42073056|FG000|Phase 2 Year 1|Adverse Event|7|||
19623418|NCT00848354|42073057|FG001|Phase 2 Year 1|Adverse Event|2|||
19623419|NCT00848354|42073056|FG000|Phase 2 Year 1|Death|1|||
19623420|NCT00848354|42073057|FG001|Phase 2 Year 1|Death|0|||
19623421|NCT00848354|42073056|FG000|Phase 2 Year 1|Failed to Return|1|||
19623422|NCT00848354|42073057|FG001|Phase 2 Year 1|Failed to Return|1|||
19623423|NCT00848354|42073056|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
19623424|NCT00848354|42073057|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
19623425|NCT00848354|42073056|FG000|Phase 2 Year 1|Unspecified Reason|3|||
19623426|NCT00848354|42073057|FG001|Phase 2 Year 1|Unspecified Reason|0|||
19623427|NCT00848354|42073056|FG000|Phase 2 Year 1|Protocol Violation|4|||
19623428|NCT00848354|42073057|FG001|Phase 2 Year 1|Protocol Violation|1|||
19623429|NCT00848354|42073056|FG000|Phase 2 Year 1|Subject Request|1|||
19623430|NCT00848354|42073057|FG001|Phase 2 Year 1|Subject Request|2|||
19623431|NCT00848354|42073056|FG000|Phase 2 Year 2|Adverse Event|12|||
19623432|NCT00848354|42073057|FG001|Phase 2 Year 2|Adverse Event|2|||
19623433|NCT00848354|42073056|FG000|Phase 2 Year 2|Death|2|||
19623434|NCT00848354|42073057|FG001|Phase 2 Year 2|Death|0|||
19623435|NCT00848354|42073056|FG000|Phase 2 Year 2|Failed to return|3|||
19623436|NCT00848354|42073057|FG001|Phase 2 Year 2|Failed to return|0|||
19623437|NCT00848354|42073056|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
19623438|NCT00848354|42073057|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
19623439|NCT00848354|42073056|FG000|Phase 2 Year 2|Unspecified Reason|1|||
19623440|NCT00848354|42073057|FG001|Phase 2 Year 2|Unspecified Reason|0|||
19623441|NCT00848354|42073056|FG000|Phase 2 Year 2|Protocol Violation|1|||
19623442|NCT00848354|42073057|FG001|Phase 2 Year 2|Protocol Violation|1|||
19623443|NCT00848354|42073056|FG000|Phase 2 Year 2|Subject Request|1|||
19623444|NCT00848354|42073057|FG001|Phase 2 Year 2|Subject Request|1|||
19623445|NCT00848354|42073056|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
19623446|NCT00848354|42073057|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
19623447|NCT00848198|42073067|FG000|Overall Study|Incomplete Case Report Forms|15|||
19623448|NCT00848120|42073075|FG000|Overall Study|Adverse Event|1|||
19623449|NCT00600821|42073081|FG000|Overall Study|Death|45|||
19623450|NCT00600821|42073082|FG001|Overall Study|Death|46|||
19623451|NCT00600821|42073081|FG000|Overall Study|Lost to Follow-up|2|||
19623452|NCT00600821|42073082|FG001|Overall Study|Lost to Follow-up|2|||
19623453|NCT00600821|42073081|FG000|Overall Study|Withdrawal by Subject|1|||
19623454|NCT00600821|42073082|FG001|Overall Study|Withdrawal by Subject|1|||
19623455|NCT00600821|42073081|FG000|Overall Study|Terminated by sponsor|8|||
19623456|NCT00600821|42073082|FG001|Overall Study|Terminated by sponsor|6|||
19623457|NCT00600821|42073081|FG000|Overall Study|Objective progression or relapse|0|||
19623458|NCT00600821|42073082|FG001|Overall Study|Objective progression or relapse|1|||
19623459|NCT00600821|42073081|FG000|Overall Study|Randomized but not treated|0|||
19623460|NCT00600821|42073082|FG001|Overall Study|Randomized but not treated|1|||
19623461|NCT00600821|42073081|FG000|Overall Study|Other|2|||
19623462|NCT00600821|42073082|FG001|Overall Study|Other|3|||
19623463|NCT00592904|42073094|FG000|Overall Study|Adverse Event|15|||
19623464|NCT00592904|42073095|FG001|Overall Study|Adverse Event|25|||
19623465|NCT00592904|42073096|FG002|Overall Study|Adverse Event|13|||
19623466|NCT00592904|42073097|FG003|Overall Study|Adverse Event|5|||
19623467|NCT00592904|42073094|FG000|Overall Study|Protocol Violation|1|||
19623468|NCT00592904|42073095|FG001|Overall Study|Protocol Violation|1|||
19623469|NCT00592904|42073096|FG002|Overall Study|Protocol Violation|0|||
19623470|NCT00592904|42073097|FG003|Overall Study|Protocol Violation|1|||
19623471|NCT00592904|42073094|FG000|Overall Study|Withdrawal by Subject|4|||
19623472|NCT00592904|42073095|FG001|Overall Study|Withdrawal by Subject|16|||
19623473|NCT00592904|42073096|FG002|Overall Study|Withdrawal by Subject|1|||
19623474|NCT00592904|42073097|FG003|Overall Study|Withdrawal by Subject|2|||
19623475|NCT00592904|42073094|FG000|Overall Study|Lack of Efficacy|2|||
19623476|NCT00592904|42073095|FG001|Overall Study|Lack of Efficacy|7|||
19623477|NCT00592904|42073096|FG002|Overall Study|Lack of Efficacy|2|||
19623478|NCT00592904|42073097|FG003|Overall Study|Lack of Efficacy|3|||
19623479|NCT00592904|42073094|FG000|Overall Study|Physician Decision|0|||
19623480|NCT00592904|42073095|FG001|Overall Study|Physician Decision|3|||
19623481|NCT00592904|42073096|FG002|Overall Study|Physician Decision|1|||
19623482|NCT00592904|42073097|FG003|Overall Study|Physician Decision|0|||
19623483|NCT00592904|42073094|FG000|Overall Study|Other|3|||
19623484|NCT00592904|42073095|FG001|Overall Study|Other|3|||
19623485|NCT00592904|42073096|FG002|Overall Study|Other|0|||
19623486|NCT00592904|42073097|FG003|Overall Study|Other|0|||
19623487|NCT00855920|42073110|FG000|Overall Study|Protocol Violation|0|||
19623488|NCT00855920|42073111|FG001|Overall Study|Protocol Violation|0|||
19623489|NCT00855920|42073112|FG002|Overall Study|Protocol Violation|2|||
19623490|NCT00855920|42073110|FG000|Overall Study|Adverse Event|2|||
19623491|NCT00855920|42073111|FG001|Overall Study|Adverse Event|1|||
19623492|NCT00855920|42073112|FG002|Overall Study|Adverse Event|1|||
19623493|NCT00855920|42073110|FG000|Overall Study|Lack of Efficacy|2|||
19623494|NCT00855920|42073111|FG001|Overall Study|Lack of Efficacy|2|||
19623495|NCT00855920|42073112|FG002|Overall Study|Lack of Efficacy|2|||
19623496|NCT00855920|42073110|FG000|Overall Study|Withdrawal by Subject|2|||
19623497|NCT00855920|42073111|FG001|Overall Study|Withdrawal by Subject|3|||
19623498|NCT00855920|42073112|FG002|Overall Study|Withdrawal by Subject|2|||
19623499|NCT00855920|42073110|FG000|Overall Study|Lost to Follow-up|1|||
19623500|NCT00855920|42073111|FG001|Overall Study|Lost to Follow-up|0|||
19623501|NCT00855920|42073112|FG002|Overall Study|Lost to Follow-up|2|||
19623502|NCT00855920|42073110|FG000|Overall Study|Death|0|||
19623503|NCT00855920|42073111|FG001|Overall Study|Death|1|||
19623504|NCT00855920|42073112|FG002|Overall Study|Death|0|||
19623505|NCT00855920|42073110|FG000|Overall Study|Decision by the sponsor|0|||
19623506|NCT00855920|42073111|FG001|Overall Study|Decision by the sponsor|1|||
19623507|NCT00855920|42073112|FG002|Overall Study|Decision by the sponsor|1|||
19623508|NCT00855920|42073110|FG000|Overall Study|Other than specified above|1|||
19623509|NCT00855920|42073111|FG001|Overall Study|Other than specified above|1|||
19623510|NCT00855920|42073112|FG002|Overall Study|Other than specified above|1|||
19623511|NCT00848042|42073123|FG000|Overall Study|Death|1|||
19623512|NCT00848042|42073124|FG001|Overall Study|Death|2|||
19623513|NCT00848042|42073125|FG002|Overall Study|Death|0|||
19623514|NCT00848042|42073123|FG000|Overall Study|Other Therapy|3|||
19623515|NCT00848042|42073124|FG001|Overall Study|Other Therapy|0|||
19623516|NCT00848042|42073125|FG002|Overall Study|Other Therapy|0|||
19623517|NCT00847886|42073135|FG000|Overall Study|Adverse Event|0|||
19623518|NCT00847886|42073136|FG001|Overall Study|Adverse Event|1|||
19623519|NCT00847808|42073142|FG000|Overall Study|Adverse Event|7|||
19623520|NCT00847808|42073142|FG000|Overall Study|Protocol Violation|1|||
19623521|NCT00847808|42073142|FG000|Overall Study|Lost to Follow-up|1|||
19623522|NCT00847808|42073142|FG000|Overall Study|Withdrawal by Subject|4|||
19623523|NCT00847808|42073142|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
19623524|NCT00847808|42073142|FG000|Overall Study|Participant Took Excluded Medication|1|||
19623525|NCT00600353|42073148|FG000|Overall Study|history of malignancy within 5 years|1|||
19623526|NCT00600353|42073149|FG001|Overall Study|history of malignancy within 5 years|0|||
19623527|NCT00600353|42073148|FG000|Overall Study|History of prepartive regimen|0|||
19623528|NCT00600353|42073149|FG001|Overall Study|History of prepartive regimen|1|||
19623529|NCT00691210|42073163|FG000|Overall Study|Progression of Disease|0|||
19623530|NCT00691210|42073164|FG001|Overall Study|Progression of Disease|0|||
19623531|NCT00691210|42073165|FG002|Overall Study|Progression of Disease|0|||
19623532|NCT00691210|42073166|FG003|Overall Study|Progression of Disease|2|||
19623533|NCT00691210|42073167|FG004|Overall Study|Progression of Disease|0|||
19623534|NCT00691210|42073168|FG005|Overall Study|Progression of Disease|0|||
19623535|NCT00691210|42073169|FG006|Overall Study|Progression of Disease|0|||
19623536|NCT00691210|42073170|FG007|Overall Study|Progression of Disease|0|||
19623537|NCT00691210|42073163|FG000|Overall Study|Lack of Efficacy|0|||
19623538|NCT00691210|42073164|FG001|Overall Study|Lack of Efficacy|0|||
19706541|NCT00117312|42150742|FG001|Overall Study|Adverse Event|2|||
19706542|NCT00117312|42150743|FG002|Overall Study|Adverse Event|0|||
19706543|NCT00117312|42150744|FG003|Overall Study|Adverse Event|0|||
19706544|NCT00117312|42150741|FG000|Overall Study|Protocol Violation|0|||
19706545|NCT00117312|42150742|FG001|Overall Study|Protocol Violation|1|||
19517722|NCT01529112|41930733|FG001|Overall Study|Protocol Violation|0|||
19623539|NCT00691210|42073165|FG002|Overall Study|Lack of Efficacy|0|||
19623540|NCT00691210|42073166|FG003|Overall Study|Lack of Efficacy|1|||
19623541|NCT00691210|42073167|FG004|Overall Study|Lack of Efficacy|0|||
19623542|NCT00691210|42073168|FG005|Overall Study|Lack of Efficacy|1|||
19623543|NCT00691210|42073169|FG006|Overall Study|Lack of Efficacy|0|||
19623544|NCT00691210|42073170|FG007|Overall Study|Lack of Efficacy|0|||
19623545|NCT00691132|42073190|FG000|Overall Study|Adverse Event|2|||
19623546|NCT00691132|42073191|FG001|Overall Study|Adverse Event|3|||
19623547|NCT00691132|42073190|FG000|Overall Study|Withdrawal by Subject|10|||
19706546|NCT00117312|42150743|FG002|Overall Study|Protocol Violation|3|||
19623548|NCT00691132|42073191|FG001|Overall Study|Withdrawal by Subject|10|||
19623549|NCT00855218|42073213|FG000|Overall Study|Adverse Event|43|||
19623550|NCT00855218|42073214|FG001|Overall Study|Adverse Event|27|||
19623551|NCT00855218|42073213|FG000|Overall Study|Withdrawal by Subject|10|||
19623552|NCT00855218|42073214|FG001|Overall Study|Withdrawal by Subject|6|||
19623553|NCT00855218|42073213|FG000|Overall Study|Physician Decision|18|||
19623554|NCT00855218|42073214|FG001|Overall Study|Physician Decision|11|||
19623555|NCT00855218|42073213|FG000|Overall Study|Lost to Follow-up|0|||
19623556|NCT00855218|42073214|FG001|Overall Study|Lost to Follow-up|1|||
19623557|NCT00855218|42073213|FG000|Overall Study|Protocol Violation|5|||
19623558|NCT00855218|42073214|FG001|Overall Study|Protocol Violation|9|||
19623559|NCT00855218|42073213|FG000|Overall Study|non-compliant with study drug|3|||
19623560|NCT00855218|42073214|FG001|Overall Study|non-compliant with study drug|1|||
19623561|NCT00855218|42073213|FG000|Overall Study|patient convenience|2|||
19623562|NCT00855218|42073214|FG001|Overall Study|patient convenience|0|||
19623563|NCT00855218|42073213|FG000|Overall Study|technical problems|2|||
19623564|NCT00855218|42073214|FG001|Overall Study|technical problems|1|||
19623565|NCT00855218|42073213|FG000|Overall Study|Still treated with study medication|0|||
19623566|NCT00855218|42073214|FG001|Overall Study|Still treated with study medication|1|||
19623567|NCT00855218|42073213|FG000|Overall Study|Untreatable disease progression|54|||
19623568|NCT00855218|42073214|FG001|Overall Study|Untreatable disease progression|67|||
19623569|NCT00855218|42073213|FG000|Overall Study|Second malignancy|0|||
19623570|NCT00855218|42073214|FG001|Overall Study|Second malignancy|1|||
19623571|NCT00855218|42073213|FG000|Overall Study|Progression measurement proven|7|||
19623572|NCT00855218|42073214|FG001|Overall Study|Progression measurement proven|15|||
19623573|NCT00855218|42073213|FG000|Overall Study|Clinical endpoint reached|10|||
19623574|NCT00855218|42073214|FG001|Overall Study|Clinical endpoint reached|13|||
19623575|NCT01063348|42073222|FG000|Overall Study|Lost to Follow-up|3|||
19623576|NCT01063348|42073223|FG001|Overall Study|Lost to Follow-up|10|||
19623577|NCT00855062|42073231|FG000|Step1|Early Study Closure|5|||
19623578|NCT00855062|42073232|FG001|Step1|Early Study Closure|7|||
19623579|NCT00855062|42073231|FG000|Step1|Adverse Event|1|||
19623580|NCT00855062|42073232|FG001|Step1|Adverse Event|1|||
19623581|NCT00855062|42073231|FG000|Step1|Protocol Violation|1|||
19623582|NCT00855062|42073232|FG001|Step1|Protocol Violation|0|||
19623583|NCT00855062|42073231|FG000|Step1|Pregnancy|1|||
19623584|NCT00855062|42073232|FG001|Step1|Pregnancy|0|||
19623585|NCT00855062|42073231|FG000|Step1|Withdrawal by Subject|2|||
19623586|NCT00855062|42073232|FG001|Step1|Withdrawal by Subject|3|||
19623587|NCT00855062|42073231|FG000|Step2|Early Study Closure|6|||
19623588|NCT00855062|42073232|FG001|Step2|Early Study Closure|2|||
19623589|NCT00855062|42073231|FG000|Step2|Adverse Event|0|||
19623590|NCT00855062|42073232|FG001|Step2|Adverse Event|3|||
19623591|NCT00855062|42073231|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
19623592|NCT00855062|42073232|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
19623593|NCT00854906|42073238|FG000|Overall Study|One person had no ocular history|1|||
19623594|NCT00854828|42073249|FG000|Overall Study|Death|1|||
19623595|NCT00854828|42073250|FG001|Overall Study|Death|0|||
19623596|NCT00854828|42073251|FG002|Overall Study|Death|0|||
19623597|NCT00854828|42073252|FG003|Overall Study|Death|0|||
19623598|NCT00854828|42073249|FG000|Overall Study|Withdrawal by Subject|1|||
19623599|NCT00854828|42073250|FG001|Overall Study|Withdrawal by Subject|1|||
19623600|NCT00854828|42073251|FG002|Overall Study|Withdrawal by Subject|0|||
19623601|NCT00854828|42073252|FG003|Overall Study|Withdrawal by Subject|9|||
19623602|NCT00854828|42073249|FG000|Overall Study|Missed 24mo visit|1|||
19623603|NCT00854828|42073250|FG001|Overall Study|Missed 24mo visit|1|||
19623604|NCT00854828|42073251|FG002|Overall Study|Missed 24mo visit|8|||
19623605|NCT00854828|42073252|FG003|Overall Study|Missed 24mo visit|8|||
19623606|NCT00847730|42073262|FG000|Overall Study|Multiple interruptions in therapy|8|||
19623607|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
19623608|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
19623609|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
19623610|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
19623611|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
19623612|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
19623613|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19623614|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
19623615|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
19623616|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19623617|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19623618|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
19623619|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
19623620|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
19623621|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
19623622|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
19623623|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
19623624|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
19623625|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
19623626|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
19623627|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
19623628|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
19623629|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
19623630|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
19623631|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
19623632|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
19623633|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
19623634|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
19623635|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
19623636|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
19623637|NCT00600119|42073272|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
19623638|NCT00600119|42073273|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
19623639|NCT00600119|42073274|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
19623640|NCT00600119|42073275|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
19623641|NCT00600119|42073276|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
19623642|NCT00600119|42073277|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
19623643|NCT00600119|42073272|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
19623644|NCT00600119|42073273|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
19623645|NCT00600119|42073274|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19623646|NCT00600119|42073275|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
19623647|NCT00600119|42073276|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
19623648|NCT00600119|42073277|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
19623649|NCT00600119|42073272|FG000|Double-blind Treatment Period|Other|0|||
19623650|NCT00600119|42073273|FG001|Double-blind Treatment Period|Other|0|||
19623651|NCT00600119|42073274|FG002|Double-blind Treatment Period|Other|0|||
19623652|NCT00600119|42073275|FG003|Double-blind Treatment Period|Other|0|||
19623653|NCT00600119|42073276|FG004|Double-blind Treatment Period|Other|2|||
19623654|NCT00600119|42073277|FG005|Double-blind Treatment Period|Other|1|||
19623655|NCT00600119|42073272|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
19623656|NCT00600119|42073273|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
19623657|NCT00600119|42073274|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
19623658|NCT00600119|42073275|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
19623659|NCT00600119|42073276|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
19623660|NCT00600119|42073277|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
19623661|NCT00600119|42073272|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
19623662|NCT00600119|42073273|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
19623663|NCT00600119|42073274|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
19623664|NCT00600119|42073275|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
19623665|NCT00600119|42073276|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
19623666|NCT00600119|42073277|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
19623667|NCT00600119|42073272|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
19623668|NCT00600119|42073273|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
19623669|NCT00600119|42073274|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
19623670|NCT00600119|42073275|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
19623671|NCT00600119|42073276|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
19623672|NCT00600119|42073277|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
19623673|NCT00600119|42073272|FG000|Double-blind Treatment Period|Physician Decision|2|||
19623674|NCT00600119|42073273|FG001|Double-blind Treatment Period|Physician Decision|0|||
19623675|NCT00600119|42073274|FG002|Double-blind Treatment Period|Physician Decision|0|||
19623676|NCT00600119|42073275|FG003|Double-blind Treatment Period|Physician Decision|0|||
19623677|NCT00600119|42073276|FG004|Double-blind Treatment Period|Physician Decision|0|||
19623678|NCT00600119|42073277|FG005|Double-blind Treatment Period|Physician Decision|0|||
19623679|NCT00600119|42073272|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19623680|NCT00600119|42073273|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
19623681|NCT00600119|42073274|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
19623682|NCT00600119|42073275|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
19623683|NCT00600119|42073276|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
19623684|NCT00600119|42073277|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
19623685|NCT00600119|42073272|FG000|Double-blind Treatment Period|Adverse Event|1|||
19623686|NCT00600119|42073273|FG001|Double-blind Treatment Period|Adverse Event|1|||
19706547|NCT00117312|42150744|FG003|Overall Study|Protocol Violation|0|||
19623687|NCT00600119|42073274|FG002|Double-blind Treatment Period|Adverse Event|0|||
19623688|NCT00600119|42073275|FG003|Double-blind Treatment Period|Adverse Event|1|||
19623689|NCT00600119|42073276|FG004|Double-blind Treatment Period|Adverse Event|2|||
19623690|NCT00600119|42073277|FG005|Double-blind Treatment Period|Adverse Event|10|||
19623691|NCT00600119|42073272|FG000|Follow-up Period|Adverse Event|0|||
19623692|NCT00600119|42073273|FG001|Follow-up Period|Adverse Event|0|||
19623693|NCT00600119|42073274|FG002|Follow-up Period|Adverse Event|0|||
19623694|NCT00600119|42073275|FG003|Follow-up Period|Adverse Event|0|||
19623695|NCT00600119|42073276|FG004|Follow-up Period|Adverse Event|0|||
19623696|NCT00600119|42073277|FG005|Follow-up Period|Adverse Event|1|||
19623697|NCT00600119|42073272|FG000|Follow-up Period|Other|1|||
19623698|NCT00600119|42073273|FG001|Follow-up Period|Other|0|||
19623699|NCT00600119|42073274|FG002|Follow-up Period|Other|0|||
19623700|NCT00600119|42073275|FG003|Follow-up Period|Other|0|||
19623701|NCT00600119|42073276|FG004|Follow-up Period|Other|0|||
19623702|NCT00600119|42073277|FG005|Follow-up Period|Other|0|||
19623703|NCT00866294|42073294|FG000|Overall Study|Adverse Event|12|||
19623704|NCT00866294|42073295|FG001|Overall Study|Adverse Event|13|||
19623705|NCT00866294|42073296|FG002|Overall Study|Adverse Event|9|||
19623706|NCT00866294|42073294|FG000|Overall Study|Lack of Efficacy|7|||
19623707|NCT00866294|42073295|FG001|Overall Study|Lack of Efficacy|1|||
19623708|NCT00866294|42073296|FG002|Overall Study|Lack of Efficacy|0|||
19623709|NCT00866294|42073294|FG000|Overall Study|Protocol Violation|2|||
19623710|NCT00866294|42073295|FG001|Overall Study|Protocol Violation|0|||
19623711|NCT00866294|42073296|FG002|Overall Study|Protocol Violation|0|||
19623712|NCT00866294|42073294|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
19623713|NCT00866294|42073295|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19623714|NCT00866294|42073296|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19623715|NCT00866294|42073294|FG000|Overall Study|Lost to Follow-up|1|||
19623716|NCT00866294|42073295|FG001|Overall Study|Lost to Follow-up|3|||
19623717|NCT00866294|42073296|FG002|Overall Study|Lost to Follow-up|0|||
19623718|NCT00866294|42073294|FG000|Overall Study|Physician Decision|6|||
19623719|NCT00866294|42073295|FG001|Overall Study|Physician Decision|2|||
19623720|NCT00866294|42073296|FG002|Overall Study|Physician Decision|1|||
19623721|NCT00854360|42073316|FG000|Overall Study|Adverse Event|0|||
19623722|NCT00854360|42073317|FG001|Overall Study|Adverse Event|1|||
19623723|NCT00854360|42073318|FG002|Overall Study|Adverse Event|2|||
19623724|NCT00854360|42073319|FG003|Overall Study|Adverse Event|6|||
19623725|NCT00854360|42073316|FG000|Overall Study|Withdrawal by Subject|0|||
19623726|NCT00854360|42073317|FG001|Overall Study|Withdrawal by Subject|0|||
19623727|NCT00854360|42073318|FG002|Overall Study|Withdrawal by Subject|0|||
19623728|NCT00854360|42073319|FG003|Overall Study|Withdrawal by Subject|1|||
19623729|NCT00854360|42073316|FG000|Overall Study|Pregnancy|0|||
19623730|NCT00854360|42073317|FG001|Overall Study|Pregnancy|1|||
19623731|NCT00854360|42073318|FG002|Overall Study|Pregnancy|0|||
19623732|NCT00854360|42073319|FG003|Overall Study|Pregnancy|0|||
19623733|NCT00854360|42073316|FG000|Overall Study|Lack of Efficacy|2|||
19623734|NCT00854360|42073317|FG001|Overall Study|Lack of Efficacy|1|||
19623735|NCT00854360|42073318|FG002|Overall Study|Lack of Efficacy|0|||
19706548|NCT00117312|42150741|FG000|Overall Study|PSA decrease <=50%|0|||
19706549|NCT00117312|42150742|FG001|Overall Study|PSA decrease <=50%|2|||
19706550|NCT00117312|42150743|FG002|Overall Study|PSA decrease <=50%|2|||
19623736|NCT00854360|42073319|FG003|Overall Study|Lack of Efficacy|0|||
19623737|NCT00854360|42073316|FG000|Overall Study|Other|0|||
19623738|NCT00854360|42073317|FG001|Overall Study|Other|0|||
19623739|NCT00854360|42073318|FG002|Overall Study|Other|0|||
19623740|NCT00854360|42073319|FG003|Overall Study|Other|3|||
19623741|NCT00853970|42073331|FG000|Overall Study|Withdrawal by Subject|2|||
19623742|NCT00853970|42073332|FG001|Overall Study|Withdrawal by Subject|1|||
19623743|NCT00853970|42073331|FG000|Overall Study|Cancelled surgery|4|||
19623744|NCT00853970|42073332|FG001|Overall Study|Cancelled surgery|2|||
19623745|NCT00865904|42073360|FG000|Overall Study|Randomized but not Treated|2|||
19623746|NCT00865904|42073361|FG001|Overall Study|Randomized but not Treated|0|||
19706551|NCT00117312|42150744|FG003|Overall Study|PSA decrease <=50%|4|||
19706552|NCT00117312|42150741|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
19706553|NCT00117312|42150742|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
19706554|NCT00117312|42150743|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
19706555|NCT00117312|42150744|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
19706556|NCT00117312|42150741|FG000|Overall Study|Hepatic abnormality|0|||
19706557|NCT00117312|42150742|FG001|Overall Study|Hepatic abnormality|1|||
19623747|NCT00865904|42073362|FG002|Overall Study|Randomized but not Treated|0|||
19623748|NCT00865904|42073363|FG003|Overall Study|Randomized but not Treated|1|||
19623749|NCT00865904|42073364|FG004|Overall Study|Randomized but not Treated|1|||
19623750|NCT00599339|42073380|FG000|Overall Study|Adverse Event|79|||
19623751|NCT00599339|42073380|FG000|Overall Study|Withdrawal by Subject|137|||
19623752|NCT00599339|42073380|FG000|Overall Study|Other Reason|179|||
19623753|NCT00599339|42073380|FG000|Overall Study|Lost to Follow-up|221|||
19623754|NCT00599339|42073380|FG000|Overall Study|No valid data consent|36|||
19706558|NCT00117312|42150743|FG002|Overall Study|Hepatic abnormality|0|||
19706559|NCT00117312|42150744|FG003|Overall Study|Hepatic abnormality|1|||
19623755|NCT00599339|42073380|FG000|Overall Study|Study Termination Status Unknown|12|||
19623756|NCT00599027|42073404|FG000|Overall Study|Withdrawal by Subject|1|||
19623757|NCT00599027|42073405|FG001|Overall Study|Withdrawal by Subject|1|||
19623758|NCT00599027|42073404|FG000|Overall Study|Adverse Event|0|||
19623759|NCT00599027|42073405|FG001|Overall Study|Adverse Event|1|||
19623760|NCT00599027|42073404|FG000|Overall Study|Treatment Failure|0|||
19623761|NCT00599027|42073405|FG001|Overall Study|Treatment Failure|1|||
19623762|NCT02881151|42073411|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
19623763|NCT00689728|42073419|FG000|Double-Blind Treatment|Adverse Event|1|||
19706560|NCT00117312|42150741|FG000|Overall Study|Withdrawal by Subject|0|||
19706561|NCT00117312|42150742|FG001|Overall Study|Withdrawal by Subject|2|||
19706562|NCT00117312|42150743|FG002|Overall Study|Withdrawal by Subject|0|||
19706563|NCT00117312|42150744|FG003|Overall Study|Withdrawal by Subject|0|||
19706564|NCT00129116|42150759|FG000|Primary Phase|Lost to Follow-up|1|||
19706565|NCT00129116|42150760|FG001|Primary Phase|Lost to Follow-up|1|||
19706566|NCT00129116|42150761|FG002|Primary Phase|Lost to Follow-up|0|||
19706567|NCT00129116|42150762|FG003|Primary Phase|Lost to Follow-up|1|||
19706568|NCT00129116|42150763|FG004|Primary Phase|Lost to Follow-up|1|||
19706569|NCT00129116|42150759|FG000|Primary Phase|Protocol Violation|0|||
19706570|NCT00129116|42150760|FG001|Primary Phase|Protocol Violation|1|||
19706571|NCT00129116|42150761|FG002|Primary Phase|Protocol Violation|0|||
19706572|NCT00129116|42150762|FG003|Primary Phase|Protocol Violation|0|||
19706573|NCT00129116|42150763|FG004|Primary Phase|Protocol Violation|0|||
19706574|NCT00129116|42150759|FG000|Primary Phase|Adverse Event|1|||
19706575|NCT00129116|42150760|FG001|Primary Phase|Adverse Event|1|||
19706576|NCT00129116|42150761|FG002|Primary Phase|Adverse Event|0|||
19706577|NCT00129116|42150762|FG003|Primary Phase|Adverse Event|0|||
19623764|NCT00689728|42073420|FG001|Double-Blind Treatment|Adverse Event|0|||
19706578|NCT00129116|42150763|FG004|Primary Phase|Adverse Event|0|||
19706579|NCT00129116|42150759|FG000|Primary Phase|Withdrawal by Subject|0|||
19706580|NCT00129116|42150760|FG001|Primary Phase|Withdrawal by Subject|1|||
19623765|NCT00689728|42073421|FG002|Double-Blind Treatment|Adverse Event|0|||
19623766|NCT00689728|42073419|FG000|Double-Blind Treatment|Protocol Violation|0|||
19623767|NCT00689728|42073420|FG001|Double-Blind Treatment|Protocol Violation|0|||
19623768|NCT00689728|42073421|FG002|Double-Blind Treatment|Protocol Violation|1|||
19623769|NCT00689728|42073419|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
19623770|NCT00689728|42073420|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
19623771|NCT00689728|42073421|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
19623772|NCT00689728|42073419|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
19623773|NCT00689728|42073420|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
19623774|NCT00689728|42073421|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
19623775|NCT00689728|42073419|FG000|Rescue|Adverse Event|0|||
19623776|NCT00689728|42073420|FG001|Rescue|Adverse Event|1|||
19623777|NCT00689728|42073421|FG002|Rescue|Adverse Event|0|||
19623778|NCT00689728|42073419|FG000|Rescue|Withdrawal by Subject|1|||
19623779|NCT00689728|42073420|FG001|Rescue|Withdrawal by Subject|1|||
19623780|NCT00689728|42073421|FG002|Rescue|Withdrawal by Subject|1|||
19623781|NCT00689728|42073419|FG000|Optional Follow-Up|Adverse Event|1|||
19623782|NCT00689728|42073420|FG001|Optional Follow-Up|Adverse Event|0|||
19623783|NCT00689728|42073421|FG002|Optional Follow-Up|Adverse Event|0|||
19623784|NCT00689728|42073419|FG000|Optional Follow-Up|Lack of Efficacy|0|||
19623785|NCT00689728|42073420|FG001|Optional Follow-Up|Lack of Efficacy|1|||
19623786|NCT00689728|42073421|FG002|Optional Follow-Up|Lack of Efficacy|1|||
19623787|NCT00689728|42073419|FG000|Optional Follow-Up|Lost to Follow-up|0|||
19623788|NCT00689728|42073420|FG001|Optional Follow-Up|Lost to Follow-up|1|||
19623789|NCT00689728|42073421|FG002|Optional Follow-Up|Lost to Follow-up|1|||
19623790|NCT00689728|42073419|FG000|Optional Follow-Up|Protocol Violation|0|||
19623791|NCT00689728|42073420|FG001|Optional Follow-Up|Protocol Violation|0|||
19623792|NCT00689728|42073421|FG002|Optional Follow-Up|Protocol Violation|1|||
19623793|NCT00689728|42073419|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
19623794|NCT00689728|42073420|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
19623795|NCT00689728|42073421|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
19623796|NCT00691054|42073450|FG000|Overall Study|Withdrawal by Subject|1|||
19623797|NCT00598871|42073458|FG000|Overall Study|Adverse Event|0|||
19623798|NCT00598871|42073459|FG001|Overall Study|Adverse Event|1|||
19623799|NCT00690820|42073467|FG000|Period 1|Withdrawal by Subject|0|||
19623800|NCT00690820|42073468|FG001|Period 1|Withdrawal by Subject|1|||
19623801|NCT00689338|42073474|FG000|Overall Study|Death|65|||
19623802|NCT00689338|42073474|FG000|Overall Study|Adverse Event|13|||
19623803|NCT00689338|42073474|FG000|Overall Study|Insufficient Clinical Response|1|||
19623804|NCT00689338|42073474|FG000|Overall Study|Lack of Efficacy|6|||
19623805|NCT00689338|42073474|FG000|Overall Study|Other|8|||
19623806|NCT00689338|42073474|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
19623807|NCT00689338|42073474|FG000|Overall Study|Lost to Follow-up|5|||
19623808|NCT00689338|42073474|FG000|Overall Study|Withdrawal by Subject|3|||
19623809|NCT00689338|42073474|FG000|Overall Study|Protocol Violation|15|||
19623810|NCT00686998|42073481|FG000|Overall Study|Adverse Event|3|||
19623811|NCT00686998|42073482|FG001|Overall Study|Adverse Event|2|||
19623812|NCT00686998|42073483|FG002|Overall Study|Adverse Event|1|||
19623813|NCT00686998|42073481|FG000|Overall Study|Withdrawal by Subject|2|||
19623814|NCT00686998|42073482|FG001|Overall Study|Withdrawal by Subject|1|||
19623815|NCT00686998|42073483|FG002|Overall Study|Withdrawal by Subject|2|||
19623816|NCT00686998|42073481|FG000|Overall Study|Lack of Efficacy|7|||
19623817|NCT00686998|42073482|FG001|Overall Study|Lack of Efficacy|5|||
19623818|NCT00686998|42073483|FG002|Overall Study|Lack of Efficacy|0|||
19623819|NCT00686998|42073481|FG000|Overall Study|Other|0|||
19623820|NCT00686998|42073482|FG001|Overall Study|Other|0|||
19623821|NCT00686998|42073483|FG002|Overall Study|Other|1|||
19623822|NCT00686998|42073481|FG000|Overall Study|Safety Reasons|1|||
19623823|NCT00686998|42073482|FG001|Overall Study|Safety Reasons|0|||
19623824|NCT00686998|42073483|FG002|Overall Study|Safety Reasons|0|||
19623825|NCT00848718|42073504|FG000|Overall Study|Adverse Event|2|||
19623826|NCT00848718|42073505|FG001|Overall Study|Adverse Event|2|||
19623827|NCT00848718|42073506|FG002|Overall Study|Adverse Event|1|||
19623828|NCT00848718|42073507|FG003|Overall Study|Adverse Event|1|||
19623829|NCT00848718|42073508|FG004|Overall Study|Adverse Event|1|||
19623830|NCT00848718|42073509|FG005|Overall Study|Adverse Event|0|||
19623831|NCT00848718|42073510|FG006|Overall Study|Adverse Event|0|||
19623832|NCT00848718|42073511|FG007|Overall Study|Adverse Event|1|||
19623833|NCT00848718|42073512|FG008|Overall Study|Adverse Event|1|||
19623834|NCT00848718|42073513|FG009|Overall Study|Adverse Event|0|||
19623835|NCT00848718|42073514|FG010|Overall Study|Adverse Event|0|||
19623836|NCT00848718|42073515|FG011|Overall Study|Adverse Event|0|||
19623837|NCT00848718|42073516|FG012|Overall Study|Adverse Event|2|||
19623838|NCT00848718|42073504|FG000|Overall Study|Lack of Efficacy|0|||
19623839|NCT00848718|42073505|FG001|Overall Study|Lack of Efficacy|0|||
19623840|NCT00848718|42073506|FG002|Overall Study|Lack of Efficacy|1|||
19623841|NCT00848718|42073507|FG003|Overall Study|Lack of Efficacy|0|||
19623842|NCT00848718|42073508|FG004|Overall Study|Lack of Efficacy|0|||
19623843|NCT00848718|42073509|FG005|Overall Study|Lack of Efficacy|0|||
19623844|NCT00848718|42073510|FG006|Overall Study|Lack of Efficacy|1|||
19623845|NCT00848718|42073511|FG007|Overall Study|Lack of Efficacy|0|||
19623846|NCT00848718|42073512|FG008|Overall Study|Lack of Efficacy|0|||
19623847|NCT00848718|42073513|FG009|Overall Study|Lack of Efficacy|0|||
19623848|NCT00848718|42073514|FG010|Overall Study|Lack of Efficacy|0|||
19623849|NCT00848718|42073515|FG011|Overall Study|Lack of Efficacy|0|||
19623850|NCT00848718|42073516|FG012|Overall Study|Lack of Efficacy|0|||
19623851|NCT00848718|42073504|FG000|Overall Study|Physician Decision|0|||
19623852|NCT00848718|42073505|FG001|Overall Study|Physician Decision|1|||
19623853|NCT00848718|42073506|FG002|Overall Study|Physician Decision|0|||
19623854|NCT00848718|42073507|FG003|Overall Study|Physician Decision|0|||
19623855|NCT00848718|42073508|FG004|Overall Study|Physician Decision|1|||
19623856|NCT00848718|42073509|FG005|Overall Study|Physician Decision|1|||
19623857|NCT00848718|42073510|FG006|Overall Study|Physician Decision|0|||
19623858|NCT00848718|42073511|FG007|Overall Study|Physician Decision|0|||
19623859|NCT00848718|42073512|FG008|Overall Study|Physician Decision|1|||
19623860|NCT00848718|42073513|FG009|Overall Study|Physician Decision|2|||
19623861|NCT00848718|42073514|FG010|Overall Study|Physician Decision|0|||
19623862|NCT00848718|42073515|FG011|Overall Study|Physician Decision|0|||
19623863|NCT00848718|42073516|FG012|Overall Study|Physician Decision|1|||
19623864|NCT00848718|42073504|FG000|Overall Study|Progressive disease before treatment|1|||
19623865|NCT00848718|42073505|FG001|Overall Study|Progressive disease before treatment|5|||
19623866|NCT00848718|42073506|FG002|Overall Study|Progressive disease before treatment|1|||
19623867|NCT00848718|42073507|FG003|Overall Study|Progressive disease before treatment|3|||
19623868|NCT00848718|42073508|FG004|Overall Study|Progressive disease before treatment|4|||
19623869|NCT00848718|42073509|FG005|Overall Study|Progressive disease before treatment|4|||
19623870|NCT00848718|42073510|FG006|Overall Study|Progressive disease before treatment|2|||
19623871|NCT00848718|42073511|FG007|Overall Study|Progressive disease before treatment|1|||
19623872|NCT00848718|42073512|FG008|Overall Study|Progressive disease before treatment|2|||
19623873|NCT00848718|42073513|FG009|Overall Study|Progressive disease before treatment|7|||
19623874|NCT00848718|42073514|FG010|Overall Study|Progressive disease before treatment|3|||
19623875|NCT00848718|42073515|FG011|Overall Study|Progressive disease before treatment|6|||
19623876|NCT00848718|42073516|FG012|Overall Study|Progressive disease before treatment|2|||
19623877|NCT00848718|42073504|FG000|Overall Study|Protocol Violation|0|||
19623878|NCT00848718|42073505|FG001|Overall Study|Protocol Violation|1|||
19623879|NCT00848718|42073506|FG002|Overall Study|Protocol Violation|0|||
19623880|NCT00848718|42073507|FG003|Overall Study|Protocol Violation|0|||
19623881|NCT00848718|42073508|FG004|Overall Study|Protocol Violation|0|||
19623882|NCT00848718|42073509|FG005|Overall Study|Protocol Violation|0|||
19623883|NCT00848718|42073510|FG006|Overall Study|Protocol Violation|0|||
19623884|NCT00848718|42073511|FG007|Overall Study|Protocol Violation|1|||
19623885|NCT00848718|42073512|FG008|Overall Study|Protocol Violation|0|||
19623886|NCT00848718|42073513|FG009|Overall Study|Protocol Violation|0|||
19623887|NCT00848718|42073514|FG010|Overall Study|Protocol Violation|0|||
19623888|NCT00848718|42073515|FG011|Overall Study|Protocol Violation|0|||
19623889|NCT00848718|42073516|FG012|Overall Study|Protocol Violation|1|||
19623890|NCT00848718|42073504|FG000|Overall Study|Withdrawal by Subject|1|||
19623891|NCT00848718|42073505|FG001|Overall Study|Withdrawal by Subject|0|||
19623892|NCT00848718|42073506|FG002|Overall Study|Withdrawal by Subject|0|||
19623893|NCT00848718|42073507|FG003|Overall Study|Withdrawal by Subject|1|||
19706581|NCT00129116|42150761|FG002|Primary Phase|Withdrawal by Subject|0|||
19706582|NCT00129116|42150762|FG003|Primary Phase|Withdrawal by Subject|0|||
19706583|NCT00129116|42150763|FG004|Primary Phase|Withdrawal by Subject|0|||
19706584|NCT00129116|42150759|FG000|Primary Phase|Other|0|||
19706585|NCT00129116|42150760|FG001|Primary Phase|Other|0|||
19706586|NCT00129116|42150761|FG002|Primary Phase|Other|1|||
19706587|NCT00129116|42150762|FG003|Primary Phase|Other|0|||
19706588|NCT00129116|42150763|FG004|Primary Phase|Other|0|||
19706589|NCT00129116|42150759|FG000|Booster Phase|Lost to Follow-up|2|||
19706590|NCT00129116|42150760|FG001|Booster Phase|Lost to Follow-up|0|||
19706591|NCT00129116|42150761|FG002|Booster Phase|Lost to Follow-up|0|||
19706592|NCT00129116|42150762|FG003|Booster Phase|Lost to Follow-up|0|||
19706593|NCT00129116|42150763|FG004|Booster Phase|Lost to Follow-up|1|||
19706594|NCT00117156|42150775|FG000|Overall Study|Adverse Event|9|||
19706595|NCT00117156|42150775|FG000|Overall Study|Physician Decision|1|||
19706596|NCT00117156|42150775|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
19706597|NCT00096954|42150781|FG000|Overall Study|Adverse Event|3|||
19623894|NCT00848718|42073508|FG004|Overall Study|Withdrawal by Subject|0|||
19623895|NCT00848718|42073509|FG005|Overall Study|Withdrawal by Subject|0|||
19623896|NCT00848718|42073510|FG006|Overall Study|Withdrawal by Subject|0|||
19623897|NCT00848718|42073511|FG007|Overall Study|Withdrawal by Subject|0|||
19623898|NCT00848718|42073512|FG008|Overall Study|Withdrawal by Subject|0|||
19706598|NCT00096954|42150782|FG001|Overall Study|Adverse Event|1|||
19623899|NCT00848718|42073513|FG009|Overall Study|Withdrawal by Subject|0|||
19623900|NCT00848718|42073514|FG010|Overall Study|Withdrawal by Subject|1|||
19623901|NCT00848718|42073515|FG011|Overall Study|Withdrawal by Subject|0|||
19706599|NCT00096954|42150781|FG000|Overall Study|Withdrawal by Subject|9|||
19623902|NCT00848718|42073516|FG012|Overall Study|Withdrawal by Subject|0|||
19623903|NCT00848718|42073504|FG000|Overall Study|Progressive disease during treatment|3|||
19623904|NCT00848718|42073505|FG001|Overall Study|Progressive disease during treatment|0|||
19623905|NCT00848718|42073506|FG002|Overall Study|Progressive disease during treatment|3|||
19623906|NCT00848718|42073507|FG003|Overall Study|Progressive disease during treatment|0|||
19623907|NCT00848718|42073508|FG004|Overall Study|Progressive disease during treatment|0|||
19623908|NCT00848718|42073509|FG005|Overall Study|Progressive disease during treatment|0|||
19623909|NCT00848718|42073510|FG006|Overall Study|Progressive disease during treatment|0|||
19623910|NCT00848718|42073511|FG007|Overall Study|Progressive disease during treatment|2|||
19623911|NCT00848718|42073512|FG008|Overall Study|Progressive disease during treatment|0|||
19623912|NCT00848718|42073513|FG009|Overall Study|Progressive disease during treatment|0|||
19623913|NCT00848718|42073514|FG010|Overall Study|Progressive disease during treatment|0|||
19623914|NCT00848718|42073515|FG011|Overall Study|Progressive disease during treatment|0|||
19623915|NCT00848718|42073516|FG012|Overall Study|Progressive disease during treatment|2|||
19623916|NCT00883337|42073553|FG000|Core Treatment Period|Adverse Event|9|||
19623917|NCT00883337|42073554|FG001|Core Treatment Period|Adverse Event|12|||
19623918|NCT00883337|42073555|FG002|Core Treatment Period|Adverse Event|22|||
19623919|NCT00883337|42073553|FG000|Core Treatment Period|Lack of Efficacy|7|||
19623920|NCT00883337|42073554|FG001|Core Treatment Period|Lack of Efficacy|4|||
19623921|NCT00883337|42073555|FG002|Core Treatment Period|Lack of Efficacy|2|||
19623922|NCT00883337|42073553|FG000|Core Treatment Period|Lost to Follow-up|1|||
19623923|NCT00883337|42073554|FG001|Core Treatment Period|Lost to Follow-up|1|||
19623924|NCT00883337|42073555|FG002|Core Treatment Period|Lost to Follow-up|0|||
19623925|NCT00883337|42073553|FG000|Core Treatment Period|Withdrawal by Subject|2|||
19623926|NCT00883337|42073554|FG001|Core Treatment Period|Withdrawal by Subject|2|||
19623927|NCT00883337|42073555|FG002|Core Treatment Period|Withdrawal by Subject|6|||
19623928|NCT00883337|42073553|FG000|Core Treatment Period|Wish to be pregnant|1|||
19623929|NCT00883337|42073554|FG001|Core Treatment Period|Wish to be pregnant|2|||
19623930|NCT00883337|42073555|FG002|Core Treatment Period|Wish to be pregnant|1|||
19623931|NCT00883337|42073553|FG000|Core Treatment Period|Poor compliance to protocol|0|||
19623932|NCT00883337|42073554|FG001|Core Treatment Period|Poor compliance to protocol|0|||
19623933|NCT00883337|42073555|FG002|Core Treatment Period|Poor compliance to protocol|1|||
19623934|NCT00883337|42073553|FG000|Core Treatment Period|Other than above|0|||
19623935|NCT00883337|42073554|FG001|Core Treatment Period|Other than above|1|||
19623936|NCT00883337|42073555|FG002|Core Treatment Period|Other than above|1|||
19623937|NCT00883337|42073553|FG000|Extension Treatment Period|Adverse Event|8|||
19623938|NCT00883337|42073554|FG001|Extension Treatment Period|Adverse Event|5|||
19623939|NCT00883337|42073555|FG002|Extension Treatment Period|Adverse Event|5|||
19623940|NCT00883337|42073553|FG000|Extension Treatment Period|Lack of Efficacy|8|||
19623941|NCT00883337|42073554|FG001|Extension Treatment Period|Lack of Efficacy|8|||
19623942|NCT00883337|42073555|FG002|Extension Treatment Period|Lack of Efficacy|8|||
19623943|NCT00883337|42073553|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
19623944|NCT00883337|42073554|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
19623945|NCT00883337|42073555|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
19623946|NCT00883337|42073553|FG000|Extension Treatment Period|Lost to Follow-up|1|||
19623947|NCT00883337|42073554|FG001|Extension Treatment Period|Lost to Follow-up|0|||
19623948|NCT00883337|42073555|FG002|Extension Treatment Period|Lost to Follow-up|0|||
19623949|NCT00883337|42073553|FG000|Extension Treatment Period|Other than above|10|||
19623950|NCT00883337|42073554|FG001|Extension Treatment Period|Other than above|9|||
19623951|NCT00883337|42073555|FG002|Extension Treatment Period|Other than above|5|||
19623952|NCT00838110|42073571|FG000|Overall Study|Death|0|||
19623953|NCT00838110|42073572|FG001|Overall Study|Death|0|||
19623954|NCT00838110|42073573|FG002|Overall Study|Death|1|||
19623955|NCT00838110|42073574|FG003|Overall Study|Death|2|||
19623956|NCT00838110|42073571|FG000|Overall Study|Adverse Event|11|||
19623957|NCT00838110|42073572|FG001|Overall Study|Adverse Event|10|||
19623958|NCT00838110|42073573|FG002|Overall Study|Adverse Event|8|||
19623959|NCT00838110|42073574|FG003|Overall Study|Adverse Event|7|||
19623960|NCT00838110|42073571|FG000|Overall Study|Withdrawal by Subject|5|||
19623961|NCT00838110|42073572|FG001|Overall Study|Withdrawal by Subject|6|||
19706600|NCT00096954|42150782|FG001|Overall Study|Withdrawal by Subject|8|||
19706601|NCT00096954|42150781|FG000|Overall Study|Physician Decision|1|||
19623962|NCT00838110|42073573|FG002|Overall Study|Withdrawal by Subject|3|||
19623963|NCT00838110|42073574|FG003|Overall Study|Withdrawal by Subject|4|||
19623964|NCT00838110|42073571|FG000|Overall Study|Other|3|||
19623965|NCT00838110|42073572|FG001|Overall Study|Other|3|||
19623966|NCT00838110|42073573|FG002|Overall Study|Other|3|||
19623967|NCT00838110|42073574|FG003|Overall Study|Other|2|||
19623968|NCT00838110|42073571|FG000|Overall Study|Protocol Violation|0|||
19623969|NCT00838110|42073572|FG001|Overall Study|Protocol Violation|2|||
19623970|NCT00838110|42073573|FG002|Overall Study|Protocol Violation|1|||
19623971|NCT00838110|42073574|FG003|Overall Study|Protocol Violation|1|||
19623972|NCT00838110|42073571|FG000|Overall Study|Lost to Follow-up|3|||
19623973|NCT00838110|42073572|FG001|Overall Study|Lost to Follow-up|0|||
19623974|NCT00838110|42073573|FG002|Overall Study|Lost to Follow-up|0|||
19623975|NCT00838110|42073574|FG003|Overall Study|Lost to Follow-up|0|||
19623976|NCT00838110|42073571|FG000|Overall Study|Did not meet eligibility criteria|0|||
19623977|NCT00838110|42073572|FG001|Overall Study|Did not meet eligibility criteria|0|||
19623978|NCT00838110|42073573|FG002|Overall Study|Did not meet eligibility criteria|1|||
19623979|NCT00838110|42073574|FG003|Overall Study|Did not meet eligibility criteria|2|||
19623980|NCT00838110|42073571|FG000|Overall Study|Randomized but not treated|0|||
19706602|NCT00096954|42150782|FG001|Overall Study|Physician Decision|1|||
19706603|NCT00096954|42150781|FG000|Overall Study|Sponsors Decision|1|||
19706604|NCT00096954|42150782|FG001|Overall Study|Sponsors Decision|1|||
19706605|NCT00096954|42150781|FG000|Overall Study|Pregnancy|1|||
19706606|NCT00096954|42150782|FG001|Overall Study|Pregnancy|1|||
19706607|NCT00096954|42150781|FG000|Overall Study|Initiation of immunotherapy|1|||
19706608|NCT00096954|42150782|FG001|Overall Study|Initiation of immunotherapy|0|||
19706609|NCT00096954|42150781|FG000|Overall Study|Non-compliance|0|||
19706610|NCT00096954|42150782|FG001|Overall Study|Non-compliance|3|||
19706611|NCT00096954|42150781|FG000|Overall Study|Lost to Follow-up|8|||
19706612|NCT00096954|42150782|FG001|Overall Study|Lost to Follow-up|5|||
19706613|NCT00096486|42150792|FG000|Overall Study|Withdrawal by Subject|0|||
19706614|NCT00096486|42150793|FG001|Overall Study|Withdrawal by Subject|0|||
19706615|NCT00096486|42150794|FG002|Overall Study|Withdrawal by Subject|1|||
19706616|NCT00096486|42150795|FG003|Overall Study|Withdrawal by Subject|1|||
19706617|NCT00096486|42150792|FG000|Overall Study|Not Treated|0|||
19706618|NCT00096486|42150793|FG001|Overall Study|Not Treated|0|||
19706619|NCT00096486|42150794|FG002|Overall Study|Not Treated|1|||
19394253|NCT02609399|41638349|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
19623981|NCT00838110|42073572|FG001|Overall Study|Randomized but not treated|1|||
19623982|NCT00838110|42073573|FG002|Overall Study|Randomized but not treated|0|||
19706620|NCT00096486|42150795|FG003|Overall Study|Not Treated|1|||
19706621|NCT00116844|42150807|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
19706622|NCT00116844|42150808|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
19706623|NCT00116844|42150807|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
19706624|NCT00116844|42150808|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
19623983|NCT00838110|42073574|FG003|Overall Study|Randomized but not treated|0|||
19623984|NCT00837876|42073584|FG000|Overall Study|Death|2|||
19623985|NCT00837876|42073584|FG000|Overall Study|Adverse Event|7|||
19623986|NCT00837876|42073584|FG000|Overall Study|Physician Decision|1|||
19623987|NCT00837876|42073584|FG000|Overall Study|Withdrawal by Subject|3|||
19623988|NCT00837876|42073584|FG000|Overall Study|disease progression|24|||
19706625|NCT00116844|42150807|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
19706626|NCT00116844|42150808|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
19706627|NCT00116844|42150807|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
19706628|NCT00116844|42150808|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
19706629|NCT00116844|42150807|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
19706630|NCT00116844|42150808|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
19706631|NCT00116844|42150807|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
19706632|NCT00116844|42150808|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
19706633|NCT00116844|42150807|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
19706634|NCT00116844|42150808|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
19706635|NCT00116844|42150807|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
19706636|NCT00116844|42150808|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
19706637|NCT00116844|42150807|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
19706638|NCT00116844|42150808|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
19706639|NCT00128492|42150816|FG000|Overall Study|AE unrelated to study|2|||
19706640|NCT00128492|42150817|FG001|Overall Study|AE unrelated to study|9|||
19706641|NCT00128492|42150816|FG000|Overall Study|Study drug intolerance (AE)|2|||
19706642|NCT00128492|42150817|FG001|Overall Study|Study drug intolerance (AE)|8|||
19706643|NCT00128492|42150816|FG000|Overall Study|AE related to study|1|||
19706644|NCT00128492|42150817|FG001|Overall Study|AE related to study|4|||
19706645|NCT00128492|42150816|FG000|Overall Study|Death|1|||
19706646|NCT00128492|42150817|FG001|Overall Study|Death|0|||
19623989|NCT00686920|42073590|FG000|Overall Study|Death|45|||
19623990|NCT00686920|42073591|FG001|Overall Study|Death|14|||
19623991|NCT00686920|42073590|FG000|Overall Study|Liver Transplant|23|||
19623992|NCT00686920|42073591|FG001|Overall Study|Liver Transplant|8|||
19623993|NCT00686920|42073590|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
19623994|NCT00686920|42073591|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
19623995|NCT00686920|42073590|FG000|Overall Study|Withdrawal by Subject|23|||
19623996|NCT00686920|42073591|FG001|Overall Study|Withdrawal by Subject|5|||
19623997|NCT00686920|42073590|FG000|Overall Study|Protocol Violation|2|||
19623998|NCT00686920|42073591|FG001|Overall Study|Protocol Violation|1|||
19623999|NCT00686920|42073590|FG000|Overall Study|Adverse Event|10|||
19624000|NCT00686920|42073591|FG001|Overall Study|Adverse Event|2|||
19624001|NCT00686920|42073590|FG000|Overall Study|Personal Reason|0|||
19624002|NCT00686920|42073591|FG001|Overall Study|Personal Reason|1|||
19624003|NCT00686920|42073590|FG000|Overall Study|Lost to Follow-up|15|||
19624004|NCT00686920|42073591|FG001|Overall Study|Lost to Follow-up|3|||
19624005|NCT00686920|42073590|FG000|Overall Study|Moved to Another State|1|||
19624006|NCT00686920|42073591|FG001|Overall Study|Moved to Another State|0|||
19624007|NCT00686920|42073590|FG000|Overall Study|Transferred to Nursing Home|1|||
19624008|NCT00686920|42073591|FG001|Overall Study|Transferred to Nursing Home|0|||
19624009|NCT00686920|42073590|FG000|Overall Study|Noncompliance|9|||
19624010|NCT00686920|42073591|FG001|Overall Study|Noncompliance|0|||
19706647|NCT00128492|42150816|FG000|Overall Study|Lost to Follow-up|1|||
19706648|NCT00128492|42150817|FG001|Overall Study|Lost to Follow-up|5|||
19706649|NCT00128492|42150816|FG000|Overall Study|Noncompliance|0|||
19706650|NCT00128492|42150817|FG001|Overall Study|Noncompliance|5|||
19706651|NCT00128492|42150816|FG000|Overall Study|Personal or administrative|10|||
19706652|NCT00128492|42150817|FG001|Overall Study|Personal or administrative|22|||
19706653|NCT00128492|42150816|FG000|Overall Study|Withdrawal by Subject|3|||
19706654|NCT00128492|42150817|FG001|Overall Study|Withdrawal by Subject|5|||
19706655|NCT00128492|42150816|FG000|Overall Study|Pregnancy|0|||
19706656|NCT00128492|42150817|FG001|Overall Study|Pregnancy|1|||
19706657|NCT00132314|42150825|FG000|Overall Study|Lost to Follow-up|70|||
19706658|NCT00132314|42150826|FG001|Overall Study|Lost to Follow-up|62|||
19706659|NCT00132314|42150825|FG000|Overall Study|Lacked SSN|1|||
19706660|NCT00132314|42150826|FG001|Overall Study|Lacked SSN|3|||
19706661|NCT00132314|42150825|FG000|Overall Study|Refused intervention at baseline|2|||
19706662|NCT00132314|42150826|FG001|Overall Study|Refused intervention at baseline|7|||
19706663|NCT04539262|42150840|FG000|Overall Study|Adverse Event|0|||
19706664|NCT04539262|42150841|FG001|Overall Study|Adverse Event|0|||
19706665|NCT04539262|42150842|FG002|Overall Study|Adverse Event|1|||
19706666|NCT04539262|42150843|FG003|Overall Study|Adverse Event|0|||
19706667|NCT04539262|42150844|FG004|Overall Study|Adverse Event|0|||
19706668|NCT04539262|42150845|FG005|Overall Study|Adverse Event|0|||
19706669|NCT04539262|42150846|FG006|Overall Study|Adverse Event|0|||
19706670|NCT04539262|42150847|FG007|Overall Study|Adverse Event|0|||
19706671|NCT04539262|42150840|FG000|Overall Study|Withdrew Consent|0|||
19706672|NCT04539262|42150841|FG001|Overall Study|Withdrew Consent|0|||
19706673|NCT04539262|42150842|FG002|Overall Study|Withdrew Consent|0|||
19706674|NCT04539262|42150843|FG003|Overall Study|Withdrew Consent|1|||
19706675|NCT04539262|42150844|FG004|Overall Study|Withdrew Consent|0|||
19706676|NCT04539262|42150845|FG005|Overall Study|Withdrew Consent|0|||
19706677|NCT04539262|42150846|FG006|Overall Study|Withdrew Consent|0|||
19706678|NCT04539262|42150847|FG007|Overall Study|Withdrew Consent|0|||
19706679|NCT04539262|42150840|FG000|Overall Study|Randomized, Not treated|0|||
19706680|NCT04539262|42150841|FG001|Overall Study|Randomized, Not treated|1|||
19706681|NCT04539262|42150842|FG002|Overall Study|Randomized, Not treated|0|||
19706682|NCT04539262|42150843|FG003|Overall Study|Randomized, Not treated|0|||
19706683|NCT04539262|42150844|FG004|Overall Study|Randomized, Not treated|0|||
19706684|NCT04539262|42150845|FG005|Overall Study|Randomized, Not treated|0|||
19706685|NCT04539262|42150846|FG006|Overall Study|Randomized, Not treated|1|||
19706686|NCT04539262|42150847|FG007|Overall Study|Randomized, Not treated|0|||
19706687|NCT03702010|42150870|FG000|Follow-up (30days)|Lack of Efficacy|2|||
19706688|NCT03702010|42150871|FG001|Follow-up (30days)|Lack of Efficacy|2|||
19706689|NCT04538170|42150885|FG000|Overall Study|Withdrawal by Subject|104|||
19706690|NCT04538170|42150886|FG001|Overall Study|Withdrawal by Subject|210|||
19706691|NCT04537234|42150898|FG000|Overall Study|Withdrawal by Subject|2|||
19706692|NCT04537234|42150899|FG001|Overall Study|Withdrawal by Subject|0|||
19706693|NCT04537078|42150907|FG000|Overall Study|Protocol Violation|3|||
19706694|NCT04537078|42150908|FG001|Overall Study|Protocol Violation|2|||
19706695|NCT04537078|42150907|FG000|Overall Study|Lost to Follow-up|1|||
19706696|NCT04537078|42150908|FG001|Overall Study|Lost to Follow-up|0|||
19706697|NCT04537078|42150907|FG000|Overall Study|Withdrawal by Subject|0|||
19706698|NCT04537078|42150908|FG001|Overall Study|Withdrawal by Subject|1|||
19706699|NCT04532164|42150921|FG000|Overall Study|Adverse Event|1|||
19706700|NCT04532164|42150921|FG000|Overall Study|Protocol Violation|5|||
19706701|NCT04532164|42150921|FG000|Overall Study|Lost to Follow-up|1|||
19706702|NCT04532164|42150921|FG000|Overall Study|Found to be Ineligible|3|||
19624011|NCT00686920|42073590|FG000|Overall Study|Principal Investigator Decision|2|||
19706703|NCT04532164|42150921|FG000|Overall Study|Withdrawal by Subject|14|||
19706704|NCT00116688|42150928|FG000|Overall Study|Protocol deviation|1|||
19706705|NCT00116688|42150929|FG001|Overall Study|Protocol deviation|0|||
19706706|NCT00116688|42150928|FG000|Overall Study|Noncompliance|3|||
19706707|NCT00116688|42150929|FG001|Overall Study|Noncompliance|1|||
19706708|NCT00116688|42150928|FG000|Overall Study|Adverse Event|11|||
19624012|NCT00686920|42073591|FG001|Overall Study|Principal Investigator Decision|0|||
19624013|NCT00845832|42073600|FG000|Treatment Period|Adverse Event|0|||
19706709|NCT00116688|42150929|FG001|Overall Study|Adverse Event|0|||
19706710|NCT00116688|42150928|FG000|Overall Study|Withdrawal by Subject|26|||
19706711|NCT00116688|42150929|FG001|Overall Study|Withdrawal by Subject|2|||
19624014|NCT00845832|42073601|FG001|Treatment Period|Adverse Event|2|||
19624015|NCT00845832|42073602|FG002|Treatment Period|Adverse Event|0|||
19624016|NCT00845832|42073600|FG000|Treatment Period|Protocol Violation|1|||
19624017|NCT00845832|42073601|FG001|Treatment Period|Protocol Violation|1|||
19624018|NCT00845832|42073602|FG002|Treatment Period|Protocol Violation|0|||
19624019|NCT00845832|42073600|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
19624020|NCT00845832|42073601|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
19624021|NCT00845832|42073602|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
19624022|NCT00845832|42073600|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
19624023|NCT00845832|42073601|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
19624024|NCT00845832|42073602|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
19624025|NCT00591864|42073610|FG000|Overall Study|Incomplete Imaging|5|||
19624026|NCT00885755|42073618|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
19624027|NCT00885755|42073619|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
19624028|NCT00885755|42073620|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
19624029|NCT00885755|42073618|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
19624030|NCT00885755|42073619|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
19624031|NCT00885755|42073620|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
19624032|NCT00885755|42073618|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
19624033|NCT00885755|42073619|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
19624034|NCT00885755|42073620|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
19624035|NCT00885755|42073618|FG000|Part I: Trastuzumab+Taxane|Death|0|||
19624036|NCT00885755|42073619|FG001|Part I: Trastuzumab+Taxane|Death|0|||
19624037|NCT00885755|42073620|FG002|Part I: Trastuzumab+Taxane|Death|1|||
19624038|NCT00885755|42073618|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
19624039|NCT00885755|42073619|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
19624040|NCT00885755|42073620|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
19624041|NCT00837486|42073630|FG000|Blinded-treatment Phase|Physician Decision|1|||
19624042|NCT00837486|42073631|FG001|Blinded-treatment Phase|Physician Decision|0|||
19624043|NCT00837486|42073630|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
19624044|NCT00837486|42073631|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
19624045|NCT00837486|42073630|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
19624046|NCT00837486|42073631|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
19624047|NCT00837486|42073630|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
19624048|NCT00837486|42073631|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
19624049|NCT00845676|42073639|FG000|Overall Study|Virologic breakthrough at week 20|1|||
19624050|NCT00845676|42073639|FG000|Overall Study|Adverse Event|1|||
19373767|NCT02753075|41614980|FG000|Overall Study|Lost to Follow-up|2|||
19373768|NCT02753075|41614981|FG001|Overall Study|Lost to Follow-up|0|||
19373769|NCT02753075|41614982|FG002|Overall Study|Lost to Follow-up|0|||
19624051|NCT00883181|42073644|FG000|Overall Study|Hematological Adverse Event|26|||
19624052|NCT00883181|42073644|FG000|Overall Study|Non-hematological Adverse Event|55|||
19624053|NCT00883181|42073644|FG000|Overall Study|Disease Progression|94|||
19624054|NCT00883181|42073644|FG000|Overall Study|Administrative Reason|24|||
19624055|NCT00883181|42073644|FG000|Overall Study|Withdrawal by Subject|4|||
19624056|NCT00883181|42073644|FG000|Overall Study|Death|31|||
19624057|NCT00883181|42073644|FG000|Overall Study|Other|38|||
19624058|NCT00883181|42073644|FG000|Overall Study|Protocol Deviation|3|||
19624059|NCT00883181|42073644|FG000|Overall Study|Noncompliance|3|||
19624060|NCT00845520|42073664|FG000|Overall Study|Death|1|||
19624061|NCT00845520|42073665|FG001|Overall Study|Death|2|||
19624062|NCT00845520|42073666|FG002|Overall Study|Death|0|||
19624063|NCT00845520|42073664|FG000|Overall Study|Lost to Follow-up|1|||
19624064|NCT00845520|42073665|FG001|Overall Study|Lost to Follow-up|0|||
19624065|NCT00845520|42073666|FG002|Overall Study|Lost to Follow-up|0|||
19624066|NCT00845520|42073664|FG000|Overall Study|Adverse Event|0|||
19624067|NCT00845520|42073665|FG001|Overall Study|Adverse Event|0|||
19624068|NCT00845520|42073666|FG002|Overall Study|Adverse Event|1|||
19624069|NCT00844896|42073682|FG000|Overall Study|Lost to Follow-up|12|||
19624070|NCT00844896|42073683|FG001|Overall Study|Lost to Follow-up|16|||
19624071|NCT00844896|42073682|FG000|Overall Study|Parents did not have time to complete|0|||
19624072|NCT00844896|42073683|FG001|Overall Study|Parents did not have time to complete|1|||
19624073|NCT00827502|42073690|FG000|Overall Study|randomized but not treated|11|||
19624074|NCT00827502|42073690|FG000|Overall Study|Adverse Event|1|||
19624075|NCT00827502|42073690|FG000|Overall Study|Lost to Follow-up|4|||
19624076|NCT00827502|42073690|FG000|Overall Study|Withdrawal by Subject|5|||
19624077|NCT00837330|42073696|FG000|Overall Study|Lost to Follow-up|1|||
19624078|NCT00837330|42073697|FG001|Overall Study|Lost to Follow-up|3|||
19706712|NCT00116688|42150928|FG000|Overall Study|Requirement for alternative therapy|11|||
19624079|NCT00837096|42073705|FG000|Overall Study|Physician Decision|1|||
19624080|NCT00837096|42073706|FG001|Overall Study|Physician Decision|1|||
19624081|NCT00837096|42073705|FG000|Overall Study|Not reported|9|||
19624082|NCT00837096|42073706|FG001|Overall Study|Not reported|8|||
19624083|NCT00885677|42073714|FG000|Overall Study|Death|40|||
19624084|NCT00885677|42073715|FG001|Overall Study|Death|34|||
19624085|NCT00885677|42073714|FG000|Overall Study|Lost to Follow-up|15|||
19624086|NCT00885677|42073715|FG001|Overall Study|Lost to Follow-up|13|||
19624087|NCT00885677|42073714|FG000|Overall Study|Protocol Violation|54|||
19624088|NCT00885677|42073715|FG001|Overall Study|Protocol Violation|54|||
19624089|NCT00885677|42073714|FG000|Overall Study|premature study closure|41|||
19624090|NCT00885677|42073715|FG001|Overall Study|premature study closure|44|||
19624091|NCT00885677|42073714|FG000|Overall Study|device/lead revision or replacement|7|||
19624092|NCT00885677|42073715|FG001|Overall Study|device/lead revision or replacement|6|||
19624093|NCT00885677|42073714|FG000|Overall Study|Heart transplantation|1|||
19624094|NCT00885677|42073715|FG001|Overall Study|Heart transplantation|0|||
19624095|NCT00885677|42073714|FG000|Overall Study|Inclusion/exclusion not met|25|||
19624096|NCT00885677|42073715|FG001|Overall Study|Inclusion/exclusion not met|27|||
19624097|NCT00885365|42073723|FG000|4 Weeks ON Treatment|Adverse Event|2|||
19624098|NCT00885365|42073724|FG001|4 Weeks ON Treatment|Adverse Event|4|||
19624099|NCT00885365|42073723|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
19624100|NCT00885365|42073724|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
19624101|NCT00885365|42073723|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
19624102|NCT00885365|42073724|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
19624103|NCT00827112|42073732|FG000|Overall Study|Adverse Event|2|||
19624104|NCT00827112|42073733|FG001|Overall Study|Adverse Event|0|||
19624105|NCT00827112|42073732|FG000|Overall Study|Lack of Efficacy|2|||
19624106|NCT00827112|42073733|FG001|Overall Study|Lack of Efficacy|0|||
19624107|NCT00827112|42073732|FG000|Overall Study|Lost to Follow-up|3|||
19624108|NCT00827112|42073733|FG001|Overall Study|Lost to Follow-up|2|||
19624109|NCT00827112|42073732|FG000|Overall Study|Pregnancy|0|||
19624110|NCT00827112|42073733|FG001|Overall Study|Pregnancy|1|||
19624111|NCT00827112|42073732|FG000|Overall Study|Protocol Violation|0|||
19624112|NCT00827112|42073733|FG001|Overall Study|Protocol Violation|2|||
19624113|NCT00827112|42073732|FG000|Overall Study|Withdrawal by Subject|2|||
19624114|NCT00827112|42073733|FG001|Overall Study|Withdrawal by Subject|1|||
19624115|NCT00827112|42073732|FG000|Overall Study|Randomized but not treated|5|||
19624116|NCT00827112|42073733|FG001|Overall Study|Randomized but not treated|3|||
19624117|NCT00827112|42073732|FG000|Overall Study|Other|1|||
19624118|NCT00827112|42073733|FG001|Overall Study|Other|3|||
19624119|NCT00689104|42073743|FG000|Overall Study|Eligibility criterion not met|5|||
19624120|NCT00689104|42073744|FG001|Overall Study|Eligibility criterion not met|8|||
19624121|NCT00689104|42073745|FG002|Overall Study|Eligibility criterion not met|0|||
19624122|NCT00689104|42073746|FG003|Overall Study|Eligibility criterion not met|4|||
19624123|NCT00689104|42073743|FG000|Overall Study|Adverse Event|13|||
19624124|NCT00689104|42073744|FG001|Overall Study|Adverse Event|25|||
19624125|NCT00689104|42073745|FG002|Overall Study|Adverse Event|16|||
19624126|NCT00689104|42073746|FG003|Overall Study|Adverse Event|24|||
19624127|NCT00689104|42073743|FG000|Overall Study|Lack of Efficacy|5|||
19624128|NCT00689104|42073744|FG001|Overall Study|Lack of Efficacy|6|||
19624129|NCT00689104|42073745|FG002|Overall Study|Lack of Efficacy|2|||
19624130|NCT00689104|42073746|FG003|Overall Study|Lack of Efficacy|3|||
19624131|NCT00689104|42073743|FG000|Overall Study|Withdrawal by Subject|12|||
19624132|NCT00689104|42073744|FG001|Overall Study|Withdrawal by Subject|11|||
19624133|NCT00689104|42073745|FG002|Overall Study|Withdrawal by Subject|18|||
19394254|NCT02609399|41638350|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
19394255|NCT02609399|41638349|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
19394256|NCT02609399|41638350|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
19394257|NCT02720185|41638358|FG000|Overall Study|Lost to Follow-up|1|||
19394258|NCT02526693|41638381|FG000|Overall Study|Physician Decision|3|||
19394259|NCT02526693|41638382|FG001|Overall Study|Physician Decision|1|||
19394260|NCT02710669|41638400|FG000|Overall Study|Physician Decision|2|||
19394261|NCT02710669|41638401|FG001|Overall Study|Physician Decision|1|||
19394262|NCT02710669|41638402|FG002|Overall Study|Physician Decision|0|||
19394263|NCT02710669|41638400|FG000|Overall Study|Institutional delays (including COVID)|2|||
19394264|NCT02710669|41638401|FG001|Overall Study|Institutional delays (including COVID)|2|||
19394265|NCT02710669|41638402|FG002|Overall Study|Institutional delays (including COVID)|0|||
19624134|NCT00689104|42073746|FG003|Overall Study|Withdrawal by Subject|11|||
19624135|NCT00689104|42073743|FG000|Overall Study|Lost to Follow-up|4|||
19624136|NCT00689104|42073744|FG001|Overall Study|Lost to Follow-up|3|||
19624137|NCT00689104|42073745|FG002|Overall Study|Lost to Follow-up|2|||
19624138|NCT00689104|42073746|FG003|Overall Study|Lost to Follow-up|5|||
19394266|NCT02710669|41638400|FG000|Overall Study|arrived in afib/aflutter|10|||
19624139|NCT00689104|42073743|FG000|Overall Study|Protocol Violation|2|||
19624140|NCT00689104|42073744|FG001|Overall Study|Protocol Violation|3|||
19624141|NCT00689104|42073745|FG002|Overall Study|Protocol Violation|5|||
19624142|NCT00689104|42073746|FG003|Overall Study|Protocol Violation|3|||
19624143|NCT00689104|42073743|FG000|Overall Study|Randomized but never received study drug|2|||
19624144|NCT00689104|42073744|FG001|Overall Study|Randomized but never received study drug|1|||
19624145|NCT00689104|42073745|FG002|Overall Study|Randomized but never received study drug|1|||
19624146|NCT00689104|42073746|FG003|Overall Study|Randomized but never received study drug|0|||
19624147|NCT00689104|42073743|FG000|Overall Study|Physician Decision|1|||
19624148|NCT00689104|42073744|FG001|Overall Study|Physician Decision|0|||
19624149|NCT00689104|42073745|FG002|Overall Study|Physician Decision|0|||
19624150|NCT00689104|42073746|FG003|Overall Study|Physician Decision|0|||
19624151|NCT00689104|42073743|FG000|Overall Study|Non-compliance with study procedures|0|||
19624152|NCT00689104|42073744|FG001|Overall Study|Non-compliance with study procedures|0|||
19624153|NCT00689104|42073745|FG002|Overall Study|Non-compliance with study procedures|1|||
19624154|NCT00689104|42073746|FG003|Overall Study|Non-compliance with study procedures|0|||
19624155|NCT00689026|42073758|FG000|Overall Study|Withdrawal by Subject|13|||
19624156|NCT00689026|42073759|FG001|Overall Study|Withdrawal by Subject|6|||
19624157|NCT00598559|42073768|FG000|Overall Study|Adverse Event|11|||
19624158|NCT00598559|42073769|FG001|Overall Study|Adverse Event|7|||
19624159|NCT00598559|42073770|FG002|Overall Study|Adverse Event|0|||
19624160|NCT00598559|42073768|FG000|Overall Study|Withdrawal by Subject|2|||
19624161|NCT00598559|42073769|FG001|Overall Study|Withdrawal by Subject|2|||
19624162|NCT00598559|42073770|FG002|Overall Study|Withdrawal by Subject|0|||
19624163|NCT00598559|42073768|FG000|Overall Study|Protocol Non-compliance|1|||
19624164|NCT00598559|42073769|FG001|Overall Study|Protocol Non-compliance|0|||
19624165|NCT00598559|42073770|FG002|Overall Study|Protocol Non-compliance|0|||
19624166|NCT00598559|42073768|FG000|Overall Study|Early discharge from hospital|9|||
19624167|NCT00598559|42073769|FG001|Overall Study|Early discharge from hospital|12|||
19624168|NCT00598559|42073770|FG002|Overall Study|Early discharge from hospital|3|||
19624169|NCT00598559|42073768|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
19624170|NCT00598559|42073769|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
19624171|NCT00598559|42073770|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
19624172|NCT00686686|42073778|FG000|Overall Study|Non-compliance|1|||
19624173|NCT00686686|42073778|FG000|Overall Study|Adverse Event|2|||
19624174|NCT00686686|42073778|FG000|Overall Study|Lost to Follow-up|3|||
19624175|NCT04160195|42073784|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
19624176|NCT04160195|42073785|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
19624177|NCT00686374|42073793|FG000|Overall Study|Lack of Efficacy|10|||
19624178|NCT00686374|42073793|FG000|Overall Study|Adverse Event|8|||
19624179|NCT00686374|42073793|FG000|Overall Study|Withdrew consent|5|||
19624180|NCT00686374|42073793|FG000|Overall Study|Lost to Follow-up|1|||
19624181|NCT00686374|42073793|FG000|Overall Study|Missing reason|33|||
19624182|NCT00686374|42073793|FG000|Overall Study|Other, not specified|4|||
19624183|NCT00571948|42073799|FG000|Overall Study|Lost to Follow-up|2|||
19624184|NCT00571948|42073800|FG001|Overall Study|Lost to Follow-up|0|||
19624185|NCT00571948|42073799|FG000|Overall Study|Withdrawal by Subject|1|||
19624186|NCT00571948|42073800|FG001|Overall Study|Withdrawal by Subject|2|||
19624187|NCT00571948|42073799|FG000|Overall Study|Protocol Violation|3|||
19624188|NCT00571948|42073800|FG001|Overall Study|Protocol Violation|3|||
19624189|NCT00571948|42073799|FG000|Overall Study|infant refused study meal|3|||
19624190|NCT00571948|42073800|FG001|Overall Study|infant refused study meal|4|||
19624191|NCT00571948|42073799|FG000|Overall Study|Parent were afraid of blood colection|2|||
19624192|NCT00571948|42073800|FG001|Overall Study|Parent were afraid of blood colection|5|||
19624193|NCT00684424|42073806|FG000|Overall Study|Adverse Event|1|||
19624194|NCT00684424|42073806|FG000|Overall Study|Lost to Follow-up|2|||
19624195|NCT00684424|42073806|FG000|Overall Study|Other|2|||
19624196|NCT00685750|42073818|FG000|Overall Study|Tumor sampling failure|0|||
19624197|NCT00685750|42073819|FG001|Overall Study|Tumor sampling failure|0|||
19624198|NCT00685750|42073820|FG002|Overall Study|Tumor sampling failure|1|||
19624199|NCT00685750|42073821|FG003|Overall Study|Tumor sampling failure|0|||
19624200|NCT00685750|42073822|FG004|Overall Study|Tumor sampling failure|0|||
19624201|NCT00685750|42073823|FG005|Overall Study|Tumor sampling failure|0|||
19624202|NCT00685750|42073824|FG006|Overall Study|Tumor sampling failure|0|||
19624203|NCT00685750|42073818|FG000|Overall Study|Patient didn't receive the treatment|0|||
19624204|NCT00685750|42073819|FG001|Overall Study|Patient didn't receive the treatment|0|||
19624205|NCT00685750|42073820|FG002|Overall Study|Patient didn't receive the treatment|0|||
19624206|NCT00685750|42073821|FG003|Overall Study|Patient didn't receive the treatment|0|||
19706713|NCT00116688|42150929|FG001|Overall Study|Requirement for alternative therapy|1|||
19706714|NCT00116688|42150928|FG000|Overall Study|Physician Decision|7|||
19706715|NCT00116688|42150929|FG001|Overall Study|Physician Decision|0|||
19624207|NCT00685750|42073822|FG004|Overall Study|Patient didn't receive the treatment|0|||
19624208|NCT00685750|42073823|FG005|Overall Study|Patient didn't receive the treatment|0|||
19624209|NCT00685750|42073824|FG006|Overall Study|Patient didn't receive the treatment|1|||
19624210|NCT00685750|42073818|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19624211|NCT00685750|42073819|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19624212|NCT00685750|42073820|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
19624213|NCT00685750|42073821|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
19624214|NCT00685750|42073822|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
19624215|NCT00685750|42073823|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
19706716|NCT00116688|42150928|FG000|Overall Study|Lost to Follow-up|3|||
19706717|NCT00116688|42150929|FG001|Overall Study|Lost to Follow-up|0|||
19624216|NCT00685750|42073824|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
19624217|NCT00576628|42073844|FG000|Overall Study|Adverse Event|11|||
19624218|NCT00576628|42073844|FG000|Overall Study|Death|2|||
19624219|NCT00576628|42073844|FG000|Overall Study|Failure to return|1|||
19624220|NCT00576628|42073844|FG000|Overall Study|Refused Treatment|8|||
19624221|NCT00576628|42073844|FG000|Overall Study|Pregnancy|1|||
19624222|NCT00576628|42073844|FG000|Overall Study|RBC transfusion|1|||
19624223|NCT00576628|42073844|FG000|Overall Study|Progression of Kidney Disease|1|||
19624224|NCT00576628|42073844|FG000|Overall Study|Progression of Renal Failure|1|||
19624225|NCT00576628|42073844|FG000|Overall Study|The patient move into other town|1|||
19624226|NCT00576628|42073844|FG000|Overall Study|Transplantation|1|||
19624227|NCT00576628|42073844|FG000|Overall Study|Dialysis|15|||
19624228|NCT00683878|42073852|FG000|Overall Study|Lack of Efficacy|3|||
19624229|NCT00683878|42073853|FG001|Overall Study|Lack of Efficacy|0|||
19624230|NCT00683878|42073854|FG002|Overall Study|Lack of Efficacy|1|||
19624231|NCT00683878|42073852|FG000|Overall Study|Adverse Event|4|||
19624232|NCT00683878|42073853|FG001|Overall Study|Adverse Event|3|||
19624233|NCT00683878|42073854|FG002|Overall Study|Adverse Event|3|||
19624234|NCT00683878|42073852|FG000|Overall Study|Withdrawal by Subject|9|||
19624235|NCT00683878|42073853|FG001|Overall Study|Withdrawal by Subject|8|||
19624236|NCT00683878|42073854|FG002|Overall Study|Withdrawal by Subject|6|||
19624237|NCT00683878|42073852|FG000|Overall Study|Death|0|||
19624238|NCT00683878|42073853|FG001|Overall Study|Death|1|||
19624239|NCT00683878|42073854|FG002|Overall Study|Death|0|||
19624240|NCT00683878|42073852|FG000|Overall Study|Lost to Follow-up|4|||
19624241|NCT00683878|42073853|FG001|Overall Study|Lost to Follow-up|2|||
19624242|NCT00683878|42073854|FG002|Overall Study|Lost to Follow-up|4|||
19624243|NCT00683878|42073852|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
19624244|NCT00683878|42073853|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
19624245|NCT00683878|42073854|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
19624246|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
19624247|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
19624248|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
19624249|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
19624250|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Death|3|||
19624251|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Death|0|||
19624252|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Death|0|||
19624253|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Death|0|||
19624254|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
19624255|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
19624256|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
19624257|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
19624258|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
19624259|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
19624260|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
19624261|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
19624262|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
19624263|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
19624264|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
19624265|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
19624266|NCT00884741|42073865|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
19624267|NCT00884741|42073866|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
19624268|NCT00884741|42073867|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
19624269|NCT00884741|42073868|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
19624270|NCT00884741|42073865|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
19624271|NCT00884741|42073866|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
19706718|NCT00116688|42150928|FG000|Overall Study|Death|15|||
19706719|NCT00116688|42150929|FG001|Overall Study|Death|0|||
19706720|NCT00116688|42150928|FG000|Overall Study|Protocol-specified criteria|3|||
19706721|NCT00116688|42150929|FG001|Overall Study|Protocol-specified criteria|0|||
19706722|NCT00116688|42150928|FG000|Overall Study|Pregnancy|1|||
19706723|NCT00116688|42150929|FG001|Overall Study|Pregnancy|0|||
19706724|NCT00116688|42150928|FG000|Overall Study|Other|11|||
19706725|NCT00116688|42150929|FG001|Overall Study|Other|0|||
19706726|NCT04531540|42150935|FG000|Overall Study|Adverse Event|1|||
19706727|NCT04531540|42150935|FG000|Overall Study|Protocol Violation|3|||
19624272|NCT00884741|42073867|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
19624273|NCT00884741|42073868|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
19624274|NCT00884741|42073865|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
19624275|NCT00884741|42073866|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
19624276|NCT00884741|42073867|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
19624277|NCT00884741|42073868|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
19706728|NCT04531540|42150935|FG000|Overall Study|Withdrawal by Subject|4|||
19624278|NCT00884741|42073865|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
19624279|NCT00884741|42073866|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
19624280|NCT00884741|42073867|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
19624281|NCT00884741|42073868|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
19624282|NCT00884741|42073865|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
19624283|NCT00884741|42073866|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
19624284|NCT00884741|42073867|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
19624285|NCT00884741|42073868|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
19624286|NCT00884741|42073865|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
19624287|NCT00884741|42073866|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
19624288|NCT00884741|42073867|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
19624289|NCT00884741|42073868|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
19624290|NCT00884741|42073865|FG000|Randomization|Protocol Violation|0|||
19624291|NCT00884741|42073866|FG001|Randomization|Protocol Violation|0|||
19624292|NCT00884741|42073867|FG002|Randomization|Protocol Violation|8|||
19624293|NCT00884741|42073868|FG003|Randomization|Protocol Violation|8|||
19624294|NCT00598481|42073875|FG000|Treatment|Physician Decision|1|||
19624295|NCT00880763|42073886|FG000|Extension Period (Part 2)|Adverse Event|0|||
19624296|NCT00880763|42073887|FG001|Extension Period (Part 2)|Adverse Event|0|||
19624297|NCT00880763|42073888|FG002|Extension Period (Part 2)|Adverse Event|1|||
19624298|NCT00880763|42073889|FG003|Extension Period (Part 2)|Adverse Event|1|||
19624299|NCT00880763|42073886|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
19706729|NCT04531540|42150935|FG000|Overall Study|Found to be Ineligible|1|||
19706730|NCT04799782|42150939|FG000|Washout|Physician Decision|2|||
19706731|NCT04799782|42150940|FG001|Washout|Physician Decision|0|||
19706732|NCT04799782|42150939|FG000|Washout|Withdrawal by Subject|0|||
19706733|NCT04799782|42150940|FG001|Washout|Withdrawal by Subject|2|||
19706734|NCT04799782|42150939|FG000|Washout|Lost to Follow-up|0|||
19706735|NCT04799782|42150940|FG001|Washout|Lost to Follow-up|1|||
19706736|NCT03697252|42150948|FG000|Overall Study|Adverse Event|3|||
19706737|NCT03697252|42150949|FG001|Overall Study|Adverse Event|2|||
19706738|NCT03697252|42150948|FG000|Overall Study|Withdrawal by Subject|14|||
19706739|NCT03697252|42150949|FG001|Overall Study|Withdrawal by Subject|14|||
19706740|NCT03697252|42150948|FG000|Overall Study|Lost to Follow-up|0|||
19706741|NCT03697252|42150949|FG001|Overall Study|Lost to Follow-up|1|||
19706742|NCT03697252|42150948|FG000|Overall Study|Physician Decision|1|||
19706743|NCT03697252|42150949|FG001|Overall Study|Physician Decision|1|||
19706744|NCT03697252|42150948|FG000|Overall Study|Other|0|||
19706745|NCT03697252|42150949|FG001|Overall Study|Other|1|||
19706746|NCT03701074|42150957|FG000|Overall Study|Physician Decision|1|||
19706747|NCT03701074|42150958|FG001|Overall Study|Physician Decision|0|||
19706748|NCT04728802|42150966|FG000|Overall Study|Withdrawal by Subject|4|||
19624300|NCT00880763|42073887|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
19624301|NCT00880763|42073888|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
19624302|NCT00880763|42073889|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
19624303|NCT00880763|42073886|FG000|Extension Period (Part 2)|Physician Decision|0|||
19624304|NCT00880763|42073887|FG001|Extension Period (Part 2)|Physician Decision|1|||
19624305|NCT00880763|42073888|FG002|Extension Period (Part 2)|Physician Decision|1|||
19624306|NCT00880763|42073889|FG003|Extension Period (Part 2)|Physician Decision|0|||
19624307|NCT00880763|42073886|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
19624308|NCT00880763|42073887|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
19624309|NCT00880763|42073888|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
19624310|NCT00880763|42073889|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
19706749|NCT04728802|42150967|FG001|Overall Study|Withdrawal by Subject|20|||
19706750|NCT04728802|42150966|FG000|Overall Study|Physician Decision|7|||
19706751|NCT04728802|42150967|FG001|Overall Study|Physician Decision|7|||
19706752|NCT04728802|42150966|FG000|Overall Study|Protocol Violation|10|||
19706753|NCT04728802|42150967|FG001|Overall Study|Protocol Violation|4|||
19706754|NCT04728802|42150966|FG000|Overall Study|Transfer|1|||
19706755|NCT04728802|42150967|FG001|Overall Study|Transfer|0|||
19706756|NCT04728802|42150966|FG000|Overall Study|Death|4|||
19706757|NCT04728802|42150967|FG001|Overall Study|Death|5|||
19706758|NCT04728802|42150966|FG000|Overall Study|Other|3|||
19706759|NCT04728802|42150967|FG001|Overall Study|Other|0|||
19706760|NCT04715932|42150975|FG000|Overall Study|Lost to Follow-up|1|||
19706761|NCT04715932|42150976|FG001|Overall Study|Lost to Follow-up|0|||
19706762|NCT00130832|42150984|FG000|Overall Study|Adverse Event|1|||
19706763|NCT00130832|42150985|FG001|Overall Study|Adverse Event|1|||
19373770|NCT02753075|41614980|FG000|Overall Study|Withdrawal of Consent|1|||
19624311|NCT00884273|42073901|FG000|Overall Study|Adverse Event|0|||
19706764|NCT00130832|42150984|FG000|Overall Study|Lost to Follow-up|1|||
19706765|NCT00130832|42150985|FG001|Overall Study|Lost to Follow-up|2|||
19706766|NCT00130832|42150984|FG000|Overall Study|Protocol Violation|6|||
19706767|NCT00130832|42150985|FG001|Overall Study|Protocol Violation|8|||
19706768|NCT00130832|42150984|FG000|Overall Study|Withdrawal by Subject|6|||
19373771|NCT02753075|41614981|FG001|Overall Study|Withdrawal of Consent|1|||
19706769|NCT00130832|42150985|FG001|Overall Study|Withdrawal by Subject|1|||
19706770|NCT00130832|42150984|FG000|Overall Study|Moved|2|||
19706771|NCT00130832|42150985|FG001|Overall Study|Moved|2|||
19706772|NCT00130832|42150984|FG000|Overall Study|Other|0|||
19706773|NCT00130832|42150985|FG001|Overall Study|Other|3|||
19706774|NCT00096018|42150993|FG000|Overall Study|Became Ineligible (not treated)|0|||
19706775|NCT00096018|42150994|FG001|Overall Study|Became Ineligible (not treated)|3|||
19706776|NCT00096018|42150993|FG000|Overall Study|Miscellaneous (not treated)|0|||
19706777|NCT00096018|42150994|FG001|Overall Study|Miscellaneous (not treated)|2|||
19706778|NCT00096018|42150993|FG000|Overall Study|Adverse Event|0|||
19706779|NCT00096018|42150994|FG001|Overall Study|Adverse Event|5|||
19706780|NCT00096018|42150993|FG000|Overall Study|Death|0|||
19706781|NCT00096018|42150994|FG001|Overall Study|Death|1|||
19706782|NCT00096018|42150993|FG000|Overall Study|Withdrawal by Subject|0|||
19706783|NCT00096018|42150994|FG001|Overall Study|Withdrawal by Subject|2|||
19706784|NCT00096018|42150993|FG000|Overall Study|Miscellaneous|2|||
19706785|NCT00096018|42150994|FG001|Overall Study|Miscellaneous|1|||
19706786|NCT04713748|42151000|FG000|Overall Study|Not enough kits allocated|35|||
19706787|NCT04702984|42151004|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
19706788|NCT04701658|42151010|FG000|Overall Study|Lost to Follow-up|6|||
19706789|NCT00128102|42151016|FG000|Overall Study|Site Discontinued|3|||
19706790|NCT00128102|42151017|FG001|Overall Study|Site Discontinued|6|||
19624312|NCT00884273|42073902|FG001|Overall Study|Adverse Event|2|||
19624313|NCT00884273|42073901|FG000|Overall Study|Protocol Violation|1|||
19624314|NCT00884273|42073902|FG001|Overall Study|Protocol Violation|3|||
19624315|NCT00884273|42073901|FG000|Overall Study|Practical reasons|1|||
19624316|NCT00884273|42073902|FG001|Overall Study|Practical reasons|0|||
19624317|NCT00884117|42073908|FG000|Overall Study|Adverse Event|2|||
19624318|NCT00884117|42073908|FG000|Overall Study|Withdrawal by Subject|89|||
19624319|NCT00884117|42073908|FG000|Overall Study|Death|3|||
19624320|NCT00884117|42073908|FG000|Overall Study|Lost to Follow-up|143|||
19624321|NCT00884117|42073908|FG000|Overall Study|Other|12|||
19624322|NCT00884039|42073927|FG000|Overall Study|Withdrawal by Subject|0|||
19624323|NCT00884039|42073928|FG001|Overall Study|Withdrawal by Subject|1|||
19624324|NCT00884039|42073927|FG000|Overall Study|Lack of Efficacy|2|||
19624325|NCT00884039|42073928|FG001|Overall Study|Lack of Efficacy|0|||
19624326|NCT00835770|42073936|FG000|Overall Study|MS Relapse|17|||
19624327|NCT00835770|42073937|FG001|Overall Study|MS Relapse|23|||
19624328|NCT00835770|42073936|FG000|Overall Study|MS Progression|14|||
19624329|NCT00835770|42073937|FG001|Overall Study|MS Progression|9|||
19624330|NCT00835770|42073936|FG000|Overall Study|Adverse Event|113|||
19624331|NCT00835770|42073937|FG001|Overall Study|Adverse Event|124|||
19624332|NCT00835770|42073936|FG000|Overall Study|Lost to Follow-up|22|||
19624333|NCT00835770|42073937|FG001|Overall Study|Lost to Follow-up|19|||
19624334|NCT00835770|42073936|FG000|Overall Study|Consent Withdrawn|144|||
19624335|NCT00835770|42073937|FG001|Overall Study|Consent Withdrawn|156|||
19624336|NCT00835770|42073936|FG000|Overall Study|Investigator Decision|42|||
19624337|NCT00835770|42073937|FG001|Overall Study|Investigator Decision|42|||
19706791|NCT00128102|42151016|FG000|Overall Study|Other|0|||
19706792|NCT00128102|42151017|FG001|Overall Study|Other|1|||
19706793|NCT00128102|42151016|FG000|Overall Study|Progressive Disease|255|||
19706794|NCT00128102|42151017|FG001|Overall Study|Progressive Disease|285|||
19706795|NCT00128102|42151016|FG000|Overall Study|Adverse Event|34|||
19706796|NCT00128102|42151017|FG001|Overall Study|Adverse Event|11|||
19706797|NCT00128102|42151016|FG000|Overall Study|Death|12|||
19706798|NCT00128102|42151017|FG001|Overall Study|Death|13|||
19706799|NCT00128102|42151016|FG000|Overall Study|Physician Decision|3|||
19706800|NCT00128102|42151017|FG001|Overall Study|Physician Decision|3|||
19706801|NCT00128102|42151016|FG000|Overall Study|Withdrawal by Subject|19|||
19706802|NCT00128102|42151017|FG001|Overall Study|Withdrawal by Subject|11|||
19706803|NCT00128102|42151016|FG000|Overall Study|Protocol Violation|2|||
19706804|NCT00128102|42151017|FG001|Overall Study|Protocol Violation|2|||
19517723|NCT01529112|41930732|FG000|Overall Study|Withdrawal by Subject|7|||
19624338|NCT00835770|42073936|FG000|Overall Study|Participant Non-Compliance|11|||
19624339|NCT00835770|42073937|FG001|Overall Study|Participant Non-Compliance|9|||
19624340|NCT00835770|42073936|FG000|Overall Study|Death|4|||
19624341|NCT00835770|42073937|FG001|Overall Study|Death|6|||
19624342|NCT00835770|42073936|FG000|Overall Study|Other|115|||
19624343|NCT00835770|42073937|FG001|Overall Study|Other|104|||
19624344|NCT00835770|42073936|FG000|Overall Study|Other|2|||
19706805|NCT04668274|42151023|FG000|Part 1 Study Period 1|Adverse Event|3|||
19706806|NCT04668274|42151024|FG001|Part 1 Study Period 1|Adverse Event|0|||
19706807|NCT04668274|42151025|FG002|Part 1 Study Period 1|Adverse Event|0|||
19706808|NCT04668274|42151026|FG003|Part 1 Study Period 1|Adverse Event|0|||
19706809|NCT04668274|42151023|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
19706810|NCT04668274|42151024|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
19706811|NCT04668274|42151025|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
19706812|NCT04668274|42151026|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
19706813|NCT04668274|42151023|FG000|Part 1 Study Period 2|Other|0|||
19706814|NCT04668274|42151024|FG001|Part 1 Study Period 2|Other|1|||
19706815|NCT04668274|42151025|FG002|Part 1 Study Period 2|Other|0|||
19706816|NCT04668274|42151026|FG003|Part 1 Study Period 2|Other|0|||
19706817|NCT04668274|42151023|FG000|Part 1 Study Period 3|Adverse Event|0|||
19706818|NCT04668274|42151024|FG001|Part 1 Study Period 3|Adverse Event|0|||
19706819|NCT04668274|42151025|FG002|Part 1 Study Period 3|Adverse Event|1|||
19706820|NCT04668274|42151026|FG003|Part 1 Study Period 3|Adverse Event|0|||
19706821|NCT04668274|42151023|FG000|Part 1 Study Period 3|Other|0|||
19706822|NCT04668274|42151024|FG001|Part 1 Study Period 3|Other|0|||
19706823|NCT04668274|42151025|FG002|Part 1 Study Period 3|Other|2|||
19706824|NCT04668274|42151026|FG003|Part 1 Study Period 3|Other|0|||
19706825|NCT04668274|42151023|FG000|Part 2 Study Period 4|Other|0|||
19706826|NCT04668274|42151024|FG001|Part 2 Study Period 4|Other|0|||
19706827|NCT04668274|42151025|FG002|Part 2 Study Period 4|Other|0|||
19624345|NCT00835770|42073937|FG001|Overall Study|Other|1|||
19624346|NCT00880685|42073949|FG000|Memantine 10mg|Lost to Follow-up|2|||
19624347|NCT00880685|42073949|FG000|Memantine 20mg|Withdrawal by Subject|1|||
19624348|NCT00835380|42073956|FG000|Overall Study|Withdrawal by Subject|2|||
19624349|NCT00880607|42073962|FG000|Overall Study|Physician Decision|2|||
19624350|NCT00880607|42073963|FG001|Overall Study|Physician Decision|2|||
19624351|NCT00880607|42073962|FG000|Overall Study|Protocol Violation|2|||
19624352|NCT00880607|42073963|FG001|Overall Study|Protocol Violation|1|||
19624353|NCT00880607|42073962|FG000|Overall Study|surgery did not extend past L1 level|3|||
19624354|NCT00880607|42073963|FG001|Overall Study|surgery did not extend past L1 level|0|||
19624355|NCT00835068|42073973|FG000|Overall Study|Death|1|||
19624356|NCT00835068|42073974|FG001|Overall Study|Death|0|||
19624357|NCT00835068|42073973|FG000|Overall Study|Adverse Event|0|||
19624358|NCT00835068|42073974|FG001|Overall Study|Adverse Event|1|||
19624359|NCT00835068|42073973|FG000|Overall Study|Other|8|||
19624360|NCT00835068|42073974|FG001|Overall Study|Other|0|||
19624361|NCT00835068|42073973|FG000|Overall Study|Withdrawal by Subject|1|||
19706828|NCT04668274|42151026|FG003|Part 2 Study Period 4|Other|1|||
19706829|NCT04406194|42151041|FG000|Period 1|Withdrawal by Subject|0|||
19706830|NCT04406194|42151042|FG001|Period 1|Withdrawal by Subject|1|||
19706831|NCT03822884|42151057|FG000|Overall Study|Withdrawal by Subject|0|||
19706832|NCT03822884|42151058|FG001|Overall Study|Withdrawal by Subject|0|||
19706833|NCT03822884|42151059|FG002|Overall Study|Withdrawal by Subject|0|||
19706834|NCT03822884|42151060|FG003|Overall Study|Withdrawal by Subject|0|||
19706835|NCT03822884|42151061|FG004|Overall Study|Withdrawal by Subject|1|||
19706836|NCT03822884|42151062|FG005|Overall Study|Withdrawal by Subject|0|||
19706837|NCT03822416|42151072|FG000|Overall Study|Lost to Follow-up|1|||
19706838|NCT03822416|42151073|FG001|Overall Study|Lost to Follow-up|0|||
19706839|NCT03822416|42151072|FG000|Overall Study|Withdrawal by Subject|0|||
19706840|NCT03822416|42151073|FG001|Overall Study|Withdrawal by Subject|1|||
19706841|NCT04405570|42151083|FG000|Overall Study|Adverse Event|0|||
19706842|NCT04405570|42151084|FG001|Overall Study|Adverse Event|1|||
19706843|NCT04405570|42151085|FG002|Overall Study|Adverse Event|1|||
19706844|NCT04405570|42151086|FG003|Overall Study|Adverse Event|1|||
19706845|NCT04405570|42151083|FG000|Overall Study|Lost to Follow-up|0|||
19706846|NCT04405570|42151084|FG001|Overall Study|Lost to Follow-up|1|||
19706847|NCT04405570|42151085|FG002|Overall Study|Lost to Follow-up|0|||
19706848|NCT04405570|42151086|FG003|Overall Study|Lost to Follow-up|0|||
19706849|NCT04405570|42151083|FG000|Overall Study|Physician Decision|0|||
19706850|NCT04405570|42151084|FG001|Overall Study|Physician Decision|0|||
19706851|NCT04405570|42151085|FG002|Overall Study|Physician Decision|1|||
19706852|NCT04405570|42151086|FG003|Overall Study|Physician Decision|0|||
19706853|NCT04405570|42151083|FG000|Overall Study|Withdrawal by Subject|0|||
19706854|NCT04405570|42151084|FG001|Overall Study|Withdrawal by Subject|1|||
19706855|NCT04405570|42151085|FG002|Overall Study|Withdrawal by Subject|1|||
19706856|NCT04405570|42151086|FG003|Overall Study|Withdrawal by Subject|0|||
19706857|NCT04405570|42151083|FG000|Overall Study|Randomized not dosed|0|||
19624362|NCT00835068|42073974|FG001|Overall Study|Withdrawal by Subject|0|||
19624363|NCT00834912|42073986|FG000|Treatment Period 1|Adverse Event|0|||
19624364|NCT00834912|42073987|FG001|Treatment Period 1|Adverse Event|1|||
19624365|NCT00834912|42073988|FG002|Treatment Period 1|Adverse Event|0|||
19706858|NCT04405570|42151084|FG001|Overall Study|Randomized not dosed|2|||
19706859|NCT04405570|42151085|FG002|Overall Study|Randomized not dosed|0|||
19624366|NCT00834912|42073989|FG003|Treatment Period 1|Adverse Event|1|||
19624367|NCT00834912|42073990|FG004|Treatment Period 1|Adverse Event|0|||
19624368|NCT00834912|42073991|FG005|Treatment Period 1|Adverse Event|0|||
19624369|NCT00834912|42073986|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19624370|NCT00834912|42073987|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19706860|NCT04405570|42151086|FG003|Overall Study|Randomized not dosed|0|||
19706861|NCT00127712|42151101|FG000|Overall Study|Adverse Event|3|||
19706862|NCT00127712|42151102|FG001|Overall Study|Adverse Event|0|||
19706863|NCT00127712|42151101|FG000|Overall Study|Lack of GI access to continue|2|||
19624371|NCT00834912|42073988|FG002|Treatment Period 2|Withdrawal by Subject|1|||
19624372|NCT00834912|42073989|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19624373|NCT00834912|42073990|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19624374|NCT00834912|42073991|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19624375|NCT00883493|42074001|FG000|Overall Study|Adverse Event|11|||
19624376|NCT00883493|42074002|FG001|Overall Study|Adverse Event|12|||
19624377|NCT00883493|42074001|FG000|Overall Study|Lack of Efficacy|4|||
19624378|NCT00883493|42074002|FG001|Overall Study|Lack of Efficacy|3|||
19624379|NCT00883493|42074001|FG000|Overall Study|Lost to Follow-up|7|||
19624380|NCT00883493|42074002|FG001|Overall Study|Lost to Follow-up|6|||
19624381|NCT00883493|42074001|FG000|Overall Study|Withdrawal by Subject|11|||
19624382|NCT00883493|42074002|FG001|Overall Study|Withdrawal by Subject|20|||
19624383|NCT00883493|42074001|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
19706864|NCT00127712|42151102|FG001|Overall Study|Lack of GI access to continue|0|||
19706865|NCT04404010|42151110|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
19706866|NCT04404010|42151111|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
19706867|NCT04401202|42151121|FG000|Overall Study|Lost to Follow-up|2|||
19706868|NCT04401202|42151122|FG001|Overall Study|Lost to Follow-up|2|||
19706869|NCT04401202|42151121|FG000|Overall Study|Adverse Event|0|||
19706870|NCT04401202|42151122|FG001|Overall Study|Adverse Event|1|||
19706871|NCT04401202|42151121|FG000|Overall Study|Hospitalized|4|||
19706872|NCT04401202|42151122|FG001|Overall Study|Hospitalized|1|||
19706873|NCT00096356|42151131|FG000|Overall Study|Adverse Event|11|||
19706874|NCT00096356|42151132|FG001|Overall Study|Adverse Event|9|||
19706875|NCT00096356|42151131|FG000|Overall Study|Physician Decision|5|||
19706876|NCT00096356|42151132|FG001|Overall Study|Physician Decision|3|||
19706877|NCT00096356|42151131|FG000|Overall Study|Withdrawal by Subject|17|||
19706878|NCT00096356|42151132|FG001|Overall Study|Withdrawal by Subject|23|||
19706879|NCT00096356|42151131|FG000|Overall Study|Lack of Efficacy|1|||
19706880|NCT00096356|42151132|FG001|Overall Study|Lack of Efficacy|0|||
19706881|NCT00096356|42151131|FG000|Overall Study|multiple reasons|10|||
19706882|NCT00096356|42151132|FG001|Overall Study|multiple reasons|18|||
19706883|NCT04391842|42151139|FG000|Overall Study|Withdrawal by Subject|2|||
19706884|NCT04358068|42151145|FG000|Overall Study|Did not initiate study treatment|2|||
19706885|NCT04358068|42151146|FG001|Overall Study|Did not initiate study treatment|2|||
19706886|NCT03694210|42151152|FG000|Overall Study|Death|1|||
19706887|NCT03694210|42151152|FG000|Overall Study|Screen Failure|7|||
19706888|NCT04339972|42151160|FG000|Overall Study|Scheduling Issues|3|||
19706889|NCT04339972|42151161|FG001|Overall Study|Scheduling Issues|3|||
19706890|NCT04339972|42151160|FG000|Overall Study|dropout|1|||
19706891|NCT04339972|42151161|FG001|Overall Study|dropout|1|||
19624384|NCT00883493|42074002|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
19624385|NCT00883493|42074001|FG000|Overall Study|Study specific disc. criteria|2|||
19624386|NCT00883493|42074002|FG001|Overall Study|Study specific disc. criteria|0|||
19624387|NCT00883493|42074001|FG000|Overall Study|Other|5|||
19624388|NCT00883493|42074002|FG001|Overall Study|Other|3|||
19624389|NCT00844428|42074008|FG000|Screening Period|Screen Failure|3|||
19624390|NCT00844428|42074008|FG000|Extension Treatment Period|Death|1|||
19624391|NCT00844428|42074008|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
19624392|NCT00834834|42074014|FG000|Overall Study|Withdrawal by Subject|4|||
19706892|NCT04339972|42151160|FG000|Overall Study|Technical issues|1|||
19706893|NCT04339972|42151161|FG001|Overall Study|Technical issues|0|||
19706894|NCT04339972|42151160|FG000|Overall Study|Claustraphobia|0|||
19706895|NCT04339972|42151161|FG001|Overall Study|Claustraphobia|1|||
19706896|NCT00096278|42151169|FG000|Overall Study|No follow-up data|15|||
19706897|NCT00096278|42151170|FG001|Overall Study|No follow-up data|18|||
19706898|NCT00096278|42151169|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
19624393|NCT00834834|42074015|FG001|Overall Study|Withdrawal by Subject|3|||
19624394|NCT00834366|42074023|FG000|Treatment Period 1|Adverse Event|1|||
19624395|NCT00834366|42074024|FG001|Treatment Period 1|Adverse Event|1|||
19624396|NCT00844194|42074032|FG000|Overall Study|Adverse Event|17|||
19624397|NCT00844194|42074033|FG001|Overall Study|Adverse Event|5|||
19624398|NCT00844194|42074032|FG000|Overall Study|Protocol Violation|1|||
19624399|NCT00844194|42074033|FG001|Overall Study|Protocol Violation|1|||
19624400|NCT00844194|42074032|FG000|Overall Study|Lost to Follow-up|1|||
19624401|NCT00844194|42074033|FG001|Overall Study|Lost to Follow-up|1|||
19624402|NCT00844194|42074032|FG000|Overall Study|Withdrawal by Subject|2|||
19624403|NCT00844194|42074033|FG001|Overall Study|Withdrawal by Subject|1|||
19624404|NCT00844194|42074032|FG000|Overall Study|Lack of Efficacy|3|||
19624405|NCT00844194|42074033|FG001|Overall Study|Lack of Efficacy|0|||
19706899|NCT00096278|42151170|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
19706900|NCT00095940|42151185|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
19706901|NCT00095940|42151186|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
19706902|NCT00095940|42151187|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
19706903|NCT00095940|42151188|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
19706904|NCT00095940|42151189|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
19624406|NCT00844194|42074032|FG000|Overall Study|Other reason (not specified)|1|||
19624407|NCT00844194|42074033|FG001|Overall Study|Other reason (not specified)|0|||
19624408|NCT00826176|42074045|FG000|Overall Study|Lost to Follow-up|1|||
19624409|NCT00826176|42074046|FG001|Overall Study|Lost to Follow-up|0|||
19624410|NCT00826176|42074045|FG000|Overall Study|Subject Withdrew Consent|3|||
19706905|NCT00095940|42151190|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
19706906|NCT00095940|42151191|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
19706907|NCT00095940|42151192|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
19706908|NCT00095940|42151193|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
19624411|NCT00826176|42074046|FG001|Overall Study|Subject Withdrew Consent|0|||
19624412|NCT00826176|42074045|FG000|Overall Study|Administrative|9|||
19624413|NCT00826176|42074046|FG001|Overall Study|Administrative|0|||
19624414|NCT00878969|42074055|FG000|Overall Study|Physician Decision|5|||
19624415|NCT00878969|42074056|FG001|Overall Study|Physician Decision|3|||
19624416|NCT00878969|42074057|FG002|Overall Study|Physician Decision|2|||
19624417|NCT00878969|42074055|FG000|Overall Study|Withdrawal by Subject|1|||
19624418|NCT00878969|42074056|FG001|Overall Study|Withdrawal by Subject|6|||
19624419|NCT00878969|42074057|FG002|Overall Study|Withdrawal by Subject|3|||
19624420|NCT00878969|42074055|FG000|Overall Study|kidney transplant|2|||
19706909|NCT00095940|42151185|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
19706910|NCT00095940|42151186|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
19706911|NCT00095940|42151187|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
19706912|NCT00095940|42151188|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
19706913|NCT00095940|42151189|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
19706914|NCT00095940|42151190|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
19706915|NCT00095940|42151191|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
19706916|NCT00095940|42151192|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
19706917|NCT00095940|42151193|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
19706918|NCT00095940|42151185|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706919|NCT00095940|42151186|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706920|NCT00095940|42151187|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706921|NCT00095940|42151188|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706922|NCT00095940|42151189|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706923|NCT00095940|42151190|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706924|NCT00095940|42151191|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
19706925|NCT00095940|42151192|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
19706926|NCT00095940|42151193|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
19624421|NCT00878969|42074056|FG001|Overall Study|kidney transplant|3|||
19624422|NCT00878969|42074057|FG002|Overall Study|kidney transplant|2|||
19624423|NCT00878969|42074055|FG000|Overall Study|Adverse Event|3|||
19624424|NCT00878969|42074056|FG001|Overall Study|Adverse Event|1|||
19624425|NCT00878969|42074057|FG002|Overall Study|Adverse Event|2|||
19624426|NCT00878969|42074055|FG000|Overall Study|Lost to Follow-up|2|||
19624427|NCT00878969|42074056|FG001|Overall Study|Lost to Follow-up|1|||
19624428|NCT00878969|42074057|FG002|Overall Study|Lost to Follow-up|0|||
19624429|NCT00878969|42074055|FG000|Overall Study|Protocol Violation|2|||
19624430|NCT00878969|42074056|FG001|Overall Study|Protocol Violation|0|||
19624431|NCT00878969|42074057|FG002|Overall Study|Protocol Violation|0|||
19624432|NCT00878969|42074055|FG000|Overall Study|Death|0|||
19624433|NCT00878969|42074056|FG001|Overall Study|Death|0|||
19624434|NCT00878969|42074057|FG002|Overall Study|Death|2|||
19624435|NCT00878969|42074055|FG000|Overall Study|Pregnancy|0|||
19624436|NCT00878969|42074056|FG001|Overall Study|Pregnancy|1|||
19624437|NCT00878969|42074057|FG002|Overall Study|Pregnancy|0|||
19624438|NCT00843726|42074071|FG000|Overall Study|Death|1|||
19624439|NCT00843726|42074072|FG001|Overall Study|Death|0|||
19624440|NCT00843726|42074071|FG000|Overall Study|Withdrawal by Subject|0|||
19624441|NCT00843726|42074072|FG001|Overall Study|Withdrawal by Subject|1|||
19624442|NCT00843492|42074081|FG000|Overall Study|Adverse Event|0|||
19624443|NCT00843492|42074082|FG001|Overall Study|Adverse Event|3|||
19624444|NCT00843492|42074081|FG000|Overall Study|Lost to Follow-up|4|||
19706927|NCT00114218|42151211|FG000|Overall Study|Wrong Cell Type|2|||
19706928|NCT00114218|42151211|FG000|Overall Study|Wrong Primary|1|||
19706929|NCT00114218|42151211|FG000|Overall Study|Never Treated|1|||
19624445|NCT00843492|42074082|FG001|Overall Study|Lost to Follow-up|4|||
19624446|NCT00843492|42074081|FG000|Overall Study|Withdrawal by Subject|0|||
19624447|NCT00843492|42074082|FG001|Overall Study|Withdrawal by Subject|4|||
19624448|NCT00843492|42074081|FG000|Overall Study|Immobilization Stopped|1|||
19624449|NCT00843492|42074082|FG001|Overall Study|Immobilization Stopped|0|||
19624450|NCT00843492|42074081|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
19624451|NCT00843492|42074082|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
19624452|NCT00843492|42074081|FG000|Overall Study|Orthopedic Surgery|0|||
19624453|NCT00843492|42074082|FG001|Overall Study|Orthopedic Surgery|2|||
19624454|NCT00843492|42074081|FG000|Overall Study|Visit Not Performed|1|||
19624455|NCT00843492|42074082|FG001|Overall Study|Visit Not Performed|0|||
19624456|NCT00843492|42074081|FG000|Overall Study|Deep-vein Thrombosis|1|||
19624457|NCT00843492|42074082|FG001|Overall Study|Deep-vein Thrombosis|0|||
19624458|NCT00833976|42074088|FG000|Overall Study|Withdrawal by Subject|5|||
19624459|NCT00833976|42074088|FG000|Overall Study|Lost to Follow-up|4|||
19624460|NCT00833976|42074088|FG000|Overall Study|Did not meet eligibility criteria|41|||
19624461|NCT00833976|42074088|FG000|Overall Study|Physician Decision|1|||
19624462|NCT00833898|42074094|FG000|Overall Study|Withdrawal by Subject|33|||
19624463|NCT00833898|42074095|FG001|Overall Study|Withdrawal by Subject|27|||
19624464|NCT00833898|42074094|FG000|Overall Study|Lost to Follow-up|7|||
19624465|NCT00833898|42074095|FG001|Overall Study|Lost to Follow-up|7|||
19624466|NCT00833898|42074094|FG000|Overall Study|Patient did not receive transplant|0|||
19624467|NCT00833898|42074095|FG001|Overall Study|Patient did not receive transplant|2|||
19624468|NCT00825162|42074104|FG000|Overall Study|Withdrawal by Subject|11|||
19624469|NCT00825162|42074105|FG001|Overall Study|Withdrawal by Subject|13|||
19624470|NCT00825162|42074106|FG002|Overall Study|Withdrawal by Subject|3|||
19624471|NCT00825162|42074104|FG000|Overall Study|Lost to Follow-up|9|||
19624472|NCT00825162|42074105|FG001|Overall Study|Lost to Follow-up|6|||
19624473|NCT00825162|42074106|FG002|Overall Study|Lost to Follow-up|3|||
19624474|NCT00825162|42074104|FG000|Overall Study|Physician Decision|2|||
19706930|NCT04380688|42151217|FG000|Overall Study|Death|2|||
19706931|NCT04380688|42151218|FG001|Overall Study|Death|2|||
19706932|NCT04380688|42151217|FG000|Overall Study|Lost to Follow-up|2|||
19706933|NCT04380688|42151218|FG001|Overall Study|Lost to Follow-up|4|||
19706934|NCT04380688|42151217|FG000|Overall Study|Withdrawal by Subject|3|||
19706935|NCT04380688|42151218|FG001|Overall Study|Withdrawal by Subject|3|||
19706936|NCT00095628|42151224|FG000|Overall Study|Disease progression prior to treatment|1|||
19706937|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Adverse Event|3|||
19706938|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Adverse Event|0|||
19706939|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Adverse Event|0|||
19706940|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
19706941|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
19706942|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
19706943|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
19706944|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
19706945|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
19706946|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
19624475|NCT00825162|42074105|FG001|Overall Study|Physician Decision|0|||
19624476|NCT00825162|42074106|FG002|Overall Study|Physician Decision|0|||
19624477|NCT00825162|42074104|FG000|Overall Study|Move away from the study area|1|||
19394267|NCT02710669|41638401|FG001|Overall Study|arrived in afib/aflutter|8|||
19517724|NCT01529112|41930733|FG001|Overall Study|Withdrawal by Subject|3|||
19517725|NCT01551420|41930741|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
19706947|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
19706948|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
19706949|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
19706950|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
19706951|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
19706952|NCT04380142|42151230|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
19706953|NCT04380142|42151231|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
19706954|NCT04380142|42151232|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
19517726|NCT01551420|41930742|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
19517727|NCT01551420|41930741|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
19624478|NCT00825162|42074105|FG001|Overall Study|Move away from the study area|0|||
19706955|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19706956|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19706957|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Adverse Event|14|||
19706958|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
19706959|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
19624479|NCT00825162|42074106|FG002|Overall Study|Move away from the study area|0|||
19706960|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
19706961|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
19706962|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
19624480|NCT00825162|42074104|FG000|Overall Study|Unable to attend the study visit|5|||
19624481|NCT00825162|42074105|FG001|Overall Study|Unable to attend the study visit|2|||
19624482|NCT00825162|42074106|FG002|Overall Study|Unable to attend the study visit|0|||
19624483|NCT00824850|42074121|FG000|Overall Study|Withdrawal by Subject|0|||
19624484|NCT00824850|42074122|FG001|Overall Study|Withdrawal by Subject|1|||
19624485|NCT00596687|42074136|FG000|Overall Study|< 24 hours of insulin treatment|8|||
19624486|NCT00596687|42074137|FG001|Overall Study|< 24 hours of insulin treatment|6|||
19706963|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
19706964|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
19706965|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
19706966|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
19706967|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
19706968|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
19706969|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
19706970|NCT04380142|42151230|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
19706971|NCT04380142|42151231|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
19706972|NCT04380142|42151232|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
19706973|NCT04045132|42151242|FG000|Overall Study|Lost to Follow-up|3|||
19706974|NCT04045132|42151243|FG001|Overall Study|Lost to Follow-up|6|||
19706975|NCT04335136|42151253|FG000|Overall Study|Death|8|||
19706976|NCT04335136|42151254|FG001|Overall Study|Death|4|||
19706977|NCT04335136|42151253|FG000|Overall Study|Lost to Follow-up|2|||
19706978|NCT04335136|42151254|FG001|Overall Study|Lost to Follow-up|0|||
19706979|NCT04335136|42151253|FG000|Overall Study|Protocol Violation|1|||
19706980|NCT04335136|42151254|FG001|Overall Study|Protocol Violation|0|||
19706981|NCT04335136|42151253|FG000|Overall Study|Withdrawal by Subject|1|||
19706982|NCT04335136|42151254|FG001|Overall Study|Withdrawal by Subject|1|||
19624487|NCT00596687|42074136|FG000|Overall Study|continuous insulin infusion during TPN|2|||
19706983|NCT04335136|42151253|FG000|Overall Study|Health-threatening condition|0|||
19706984|NCT04335136|42151254|FG001|Overall Study|Health-threatening condition|1|||
19706985|NCT04335136|42151253|FG000|Overall Study|Adverse Event|0|||
19706986|NCT04335136|42151254|FG001|Overall Study|Adverse Event|1|||
19706987|NCT04335136|42151253|FG000|Overall Study|Erroneously randomized|2|||
19706988|NCT04335136|42151254|FG001|Overall Study|Erroneously randomized|0|||
19706989|NCT04171414|42151260|FG000|Overall Study|Death|1|||
19706990|NCT04171414|42151260|FG000|Overall Study|Withdrawal by Subject|1|||
19706991|NCT04167670|42151267|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
19706992|NCT04167670|42151268|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
19706993|NCT04167670|42151269|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
19706994|NCT04167670|42151267|FG000|Overall Study|Significant protocol deviation|3|||
19706995|NCT04167670|42151268|FG001|Overall Study|Significant protocol deviation|1|||
19624488|NCT00596687|42074137|FG001|Overall Study|continuous insulin infusion during TPN|1|||
19624489|NCT00596687|42074136|FG000|Overall Study|Withdrawal by Subject|3|||
19624490|NCT00596687|42074137|FG001|Overall Study|Withdrawal by Subject|1|||
19624491|NCT00596687|42074136|FG000|Overall Study|cancelled surgery|1|||
19624492|NCT00596687|42074137|FG001|Overall Study|cancelled surgery|1|||
19624493|NCT00824772|42074143|FG000|Overall Study|Withdrawal by Subject|8|||
19624494|NCT00824616|42074149|FG000|Overall Study|Adverse Event|2|||
19624495|NCT00824616|42074150|FG001|Overall Study|Adverse Event|1|||
19624496|NCT00824616|42074149|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
19624497|NCT00824616|42074150|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
19624498|NCT00824616|42074149|FG000|Overall Study|Hyperglycemia|1|||
19624499|NCT00824616|42074150|FG001|Overall Study|Hyperglycemia|1|||
19624500|NCT00824616|42074149|FG000|Overall Study|Lack of Efficacy|2|||
19624501|NCT00824616|42074150|FG001|Overall Study|Lack of Efficacy|1|||
19624502|NCT00824616|42074149|FG000|Overall Study|Lost to Follow-up|0|||
19624503|NCT00824616|42074150|FG001|Overall Study|Lost to Follow-up|1|||
19624504|NCT00824616|42074149|FG000|Overall Study|Withdrawal by Subject|1|||
19624505|NCT00824616|42074150|FG001|Overall Study|Withdrawal by Subject|1|||
19624506|NCT00824382|42074160|FG000|Overall Study|Adverse Event|4|||
19624507|NCT00824382|42074161|FG001|Overall Study|Adverse Event|1|||
19624508|NCT00824382|42074162|FG002|Overall Study|Adverse Event|1|||
19624509|NCT00824382|42074163|FG003|Overall Study|Adverse Event|4|||
19624510|NCT00824382|42074160|FG000|Overall Study|Protocol Violation|1|||
19624511|NCT00824382|42074161|FG001|Overall Study|Protocol Violation|0|||
19624512|NCT00824382|42074162|FG002|Overall Study|Protocol Violation|0|||
19624513|NCT00824382|42074163|FG003|Overall Study|Protocol Violation|1|||
19624514|NCT00824382|42074160|FG000|Overall Study|Investigator's decision|0|||
19624515|NCT00824382|42074161|FG001|Overall Study|Investigator's decision|1|||
19624516|NCT00824382|42074162|FG002|Overall Study|Investigator's decision|2|||
19624517|NCT00824382|42074163|FG003|Overall Study|Investigator's decision|0|||
19624518|NCT00833040|42074175|FG000|Overall Study|Adverse Event|0|||
19624519|NCT00833040|42074176|FG001|Overall Study|Adverse Event|0|||
19624520|NCT00833040|42074177|FG002|Overall Study|Adverse Event|0|||
19624521|NCT00833040|42074178|FG003|Overall Study|Adverse Event|0|||
19624522|NCT00833040|42074179|FG004|Overall Study|Adverse Event|0|||
19624523|NCT00833040|42074180|FG005|Overall Study|Adverse Event|1|||
19624524|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
19624525|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
19624526|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
19624527|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
19624528|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
19624529|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
19624530|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
19624531|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
19624532|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
19624533|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
19624534|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
19624535|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
19624536|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
19624537|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
19624538|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
19624539|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
19624540|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
19624541|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
19624542|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
19624543|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
19624544|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
19624545|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
19624546|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
19624547|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
19624548|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
19624549|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
19624550|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
19624551|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
19624552|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
19624553|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
19624554|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
19624555|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
19624556|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
19624557|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
19624558|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
19624559|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
19624560|NCT00843024|42074189|FG000|Single-blind Placebo Run-In Phase|Other|0|||
19624561|NCT00843024|42074190|FG001|Single-blind Placebo Run-In Phase|Other|1|||
19624562|NCT00843024|42074191|FG002|Single-blind Placebo Run-In Phase|Other|0|||
19624563|NCT00843024|42074192|FG003|Single-blind Placebo Run-In Phase|Other|0|||
19624564|NCT00843024|42074193|FG004|Single-blind Placebo Run-In Phase|Other|0|||
19624565|NCT00843024|42074194|FG005|Single-blind Placebo Run-In Phase|Other|0|||
19624566|NCT00843024|42074189|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
19624567|NCT00843024|42074190|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
19624568|NCT00843024|42074191|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
19624569|NCT00843024|42074192|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
19624570|NCT00843024|42074193|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
19624571|NCT00843024|42074194|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
19624572|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
19624573|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
19706996|NCT04167670|42151269|FG002|Overall Study|Significant protocol deviation|0|||
19706997|NCT04167670|42151267|FG000|Overall Study|Lost to Follow-up|0|||
19706998|NCT04167670|42151268|FG001|Overall Study|Lost to Follow-up|3|||
19706999|NCT04167670|42151269|FG002|Overall Study|Lost to Follow-up|3|||
19707000|NCT04167670|42151267|FG000|Overall Study|Voluntary Withdrawal|0|||
19707001|NCT04167670|42151268|FG001|Overall Study|Voluntary Withdrawal|1|||
19707002|NCT04167670|42151269|FG002|Overall Study|Voluntary Withdrawal|1|||
19707003|NCT04167670|42151267|FG000|Overall Study|Withdrawal of Consent|4|||
19707004|NCT04167670|42151268|FG001|Overall Study|Withdrawal of Consent|1|||
19707005|NCT04167670|42151269|FG002|Overall Study|Withdrawal of Consent|3|||
19707006|NCT04167670|42151267|FG000|Overall Study|Miscellaneous|7|||
19707007|NCT04167670|42151268|FG001|Overall Study|Miscellaneous|5|||
19707008|NCT04167670|42151269|FG002|Overall Study|Miscellaneous|3|||
19707009|NCT00113516|42151277|FG000|Part 1|Adverse Event|6|||
19707010|NCT00113516|42151278|FG001|Part 1|Adverse Event|0|||
19707011|NCT00113516|42151277|FG000|Part 1|Death|3|||
19707012|NCT00113516|42151278|FG001|Part 1|Death|0|||
19707013|NCT00113516|42151277|FG000|Part 1|Other|3|||
19707014|NCT00113516|42151278|FG001|Part 1|Other|0|||
19707015|NCT00113516|42151277|FG000|Part 1|Withdrawal by Subject|2|||
19707016|NCT00113516|42151278|FG001|Part 1|Withdrawal by Subject|0|||
19707017|NCT00113516|42151277|FG000|Part 1|Lack of Efficacy|2|||
19707018|NCT00113516|42151278|FG001|Part 1|Lack of Efficacy|0|||
19707019|NCT00113516|42151277|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
19707020|NCT00113516|42151278|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
19707021|NCT00113516|42151277|FG000|Part 1|Laboratory Abnormality|1|||
19707022|NCT00113516|42151278|FG001|Part 1|Laboratory Abnormality|0|||
19707023|NCT00113516|42151277|FG000|Part 1|Ongoing|1|||
19707024|NCT00113516|42151278|FG001|Part 1|Ongoing|0|||
19707025|NCT00113516|42151277|FG000|Part 1|Missing|65|||
19624574|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
19624575|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
19624576|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
19624577|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
19624578|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19624579|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19624580|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19624581|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
19624582|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19624583|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
19624584|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
19624585|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
19624586|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
19624587|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
19624588|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
19624589|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
19624590|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Physician Decision|0|||
19624591|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Physician Decision|0|||
19624592|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Physician Decision|0|||
19624593|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Physician Decision|3|||
19624594|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Physician Decision|1|||
19624595|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Physician Decision|1|||
19624596|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Adverse Event|0|||
19624597|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Adverse Event|0|||
19707026|NCT00113516|42151278|FG001|Part 1|Missing|0|||
19707027|NCT00113516|42151277|FG000|Part 2|Adverse Event|0|||
19707028|NCT00113516|42151278|FG001|Part 2|Adverse Event|16|||
19707029|NCT00113516|42151277|FG000|Part 2|Death|0|||
19707030|NCT00113516|42151278|FG001|Part 2|Death|5|||
19624598|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Adverse Event|0|||
19707031|NCT00113516|42151277|FG000|Part 2|Lack of Efficacy|0|||
19707032|NCT00113516|42151278|FG001|Part 2|Lack of Efficacy|37|||
19707033|NCT00113516|42151277|FG000|Part 2|Withdrawal by Subject|0|||
19624599|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Adverse Event|0|||
19624600|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Adverse Event|1|||
19624601|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Adverse Event|1|||
19624602|NCT00843024|42074189|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
19624603|NCT00843024|42074190|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
19707034|NCT00113516|42151278|FG001|Part 2|Withdrawal by Subject|3|||
19707035|NCT00113516|42151277|FG000|Part 2|Other|0|||
19707036|NCT00113516|42151278|FG001|Part 2|Other|3|||
19707037|NCT00113516|42151277|FG000|Part 2|Laboratory Abnormality|0|||
19707038|NCT00113516|42151278|FG001|Part 2|Laboratory Abnormality|1|||
19707039|NCT00113516|42151277|FG000|Part 2|Ongoing|0|||
19707040|NCT00113516|42151278|FG001|Part 2|Ongoing|1|||
19707041|NCT04142242|42151290|FG000|Overall Study|Non-compliance with the protocol|1|||
19707042|NCT04142242|42151291|FG001|Overall Study|Non-compliance with the protocol|0|||
19707043|NCT04142242|42151292|FG002|Overall Study|Non-compliance with the protocol|0|||
19707044|NCT04142242|42151293|FG003|Overall Study|Non-compliance with the protocol|0|||
19707045|NCT04142242|42151294|FG004|Overall Study|Non-compliance with the protocol|0|||
19707046|NCT04142242|42151295|FG005|Overall Study|Non-compliance with the protocol|1|||
19707047|NCT04142242|42151290|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
19707048|NCT04142242|42151291|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
19707049|NCT04142242|42151292|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
19707050|NCT04142242|42151293|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
19707051|NCT04142242|42151294|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
19707052|NCT04142242|42151295|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
19707053|NCT04142242|42151290|FG000|Overall Study|Ongoing|0|||
19707054|NCT04142242|42151291|FG001|Overall Study|Ongoing|0|||
19707055|NCT04142242|42151292|FG002|Overall Study|Ongoing|31|||
19624604|NCT00843024|42074191|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
19624605|NCT00843024|42074192|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
19624606|NCT00843024|42074193|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
19707056|NCT04142242|42151293|FG003|Overall Study|Ongoing|39|||
19707057|NCT04142242|42151294|FG004|Overall Study|Ongoing|0|||
19707058|NCT04142242|42151295|FG005|Overall Study|Ongoing|0|||
19624607|NCT00843024|42074194|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
19624608|NCT00832650|42074210|FG000|Overall Study|Randomized but not treated|0|||
19624609|NCT00832650|42074211|FG001|Overall Study|Randomized but not treated|0|||
19624610|NCT00832650|42074212|FG002|Overall Study|Randomized but not treated|1|||
19624611|NCT00595517|42074220|FG000|Overall Study|Adverse Event|6|||
19624612|NCT00595517|42074220|FG000|Overall Study|Withdrawal by Subject|4|||
19624613|NCT00595517|42074220|FG000|Overall Study|Protocol Violation|2|||
19624614|NCT00595517|42074220|FG000|Overall Study|Recurrence of ulcer|5|||
19624615|NCT00595517|42074220|FG000|Overall Study|usage of prohibited treatment|1|||
19624616|NCT00595517|42074220|FG000|Overall Study|No intention to attend regularly|1|||
19624617|NCT00823836|42074226|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
19624618|NCT00823836|42074227|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
19624619|NCT00823836|42074226|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
19624620|NCT00823836|42074227|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
19624621|NCT00823836|42074226|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
19707059|NCT04140292|42151323|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
19707060|NCT04140292|42151324|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
19707061|NCT04138810|42151333|FG000|Overall Study|Withdrawal by Subject|0|||
19707062|NCT04138810|42151334|FG001|Overall Study|Withdrawal by Subject|1|||
19707063|NCT04138810|42151333|FG000|Overall Study|Subject cancelled surgery|1|||
19707064|NCT04138810|42151334|FG001|Overall Study|Subject cancelled surgery|0|||
19707065|NCT00127166|42151342|FG000|Period I|Protocol Violation|0|||
19624622|NCT00823836|42074227|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
19624623|NCT00823836|42074226|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
19624624|NCT00823836|42074227|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
19624625|NCT00823836|42074226|FG000|Long-term Phase|Adverse Event|3|||
19624626|NCT00823836|42074227|FG001|Long-term Phase|Adverse Event|2|||
19624627|NCT00823836|42074226|FG000|Long-term Phase|Physician Decision|1|||
19624628|NCT00823836|42074227|FG001|Long-term Phase|Physician Decision|2|||
19624629|NCT00823836|42074226|FG000|Long-term Phase|Withdrawal by Subject|1|||
19624630|NCT00823836|42074227|FG001|Long-term Phase|Withdrawal by Subject|1|||
19624631|NCT00879437|42074236|FG000|Overall Study|Protocol Violation|0|||
19624632|NCT00879437|42074237|FG001|Overall Study|Protocol Violation|1|||
19707066|NCT00127166|42151343|FG001|Period I|Protocol Violation|2|||
19707067|NCT00127166|42151342|FG000|Period I|Withdrawal by Subject|2|||
19624633|NCT00879437|42074236|FG000|Overall Study|Death|1|||
19624634|NCT00879437|42074237|FG001|Overall Study|Death|0|||
19624635|NCT00877799|42074250|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
19624636|NCT00877799|42074251|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
19624637|NCT00877799|42074252|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
19624638|NCT00877799|42074253|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
19624639|NCT00877799|42074254|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
19624640|NCT00877799|42074250|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
19624641|NCT00877799|42074251|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
19624642|NCT00877799|42074252|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
19624643|NCT00877799|42074253|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
19624644|NCT00877799|42074254|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
19624645|NCT00877799|42074250|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
19624646|NCT00877799|42074251|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
19624647|NCT00877799|42074252|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
19624648|NCT00877799|42074253|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
19624649|NCT00877799|42074254|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
19624650|NCT00877799|42074250|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
19624651|NCT00877799|42074251|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
19624652|NCT00877799|42074252|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
19624653|NCT00877799|42074253|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
19624654|NCT00877799|42074254|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
19624655|NCT00877799|42074250|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
19624656|NCT00877799|42074251|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
19624657|NCT00877799|42074252|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
19624658|NCT00877799|42074253|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
19624659|NCT00877799|42074254|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
19624660|NCT00595127|42074265|FG000|Overall Study|Death|6|||
19624661|NCT00595127|42074265|FG000|Overall Study|Relapsed|3|||
19624662|NCT00595127|42074265|FG000|Overall Study|joined another trial|1|||
19624663|NCT00877487|42074269|FG000|Open-label Treatment Phase|Adverse Event|1|||
19624664|NCT00877487|42074270|FG001|Open-label Treatment Phase|Adverse Event|0|||
19707068|NCT00127166|42151343|FG001|Period I|Withdrawal by Subject|0|||
19707069|NCT00127166|42151342|FG000|Period I|Patient did not meet inclusion criteria|1|||
19624665|NCT00877487|42074269|FG000|Open-label Treatment Phase|Protocol Violation|3|||
19624666|NCT00877487|42074270|FG001|Open-label Treatment Phase|Protocol Violation|0|||
19624667|NCT00877487|42074269|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
19624668|NCT00877487|42074270|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
19624669|NCT00877487|42074269|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
19624670|NCT00877487|42074270|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
19624671|NCT00877487|42074269|FG000|Open-label Treatment Phase|Out of country for business|1|||
19624672|NCT00877487|42074270|FG001|Open-label Treatment Phase|Out of country for business|0|||
19624673|NCT00877487|42074269|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
19624674|NCT00877487|42074270|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
19624675|NCT00877487|42074269|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
19624676|NCT00877487|42074270|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
19624677|NCT00877487|42074269|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
19624678|NCT00877487|42074270|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
19624679|NCT00877487|42074269|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
19624680|NCT00877487|42074270|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
19624681|NCT00878501|42074279|FG000|Overall Study|Adverse Event|11|||
19624682|NCT00878501|42074280|FG001|Overall Study|Adverse Event|3|||
19624683|NCT00878501|42074281|FG002|Overall Study|Adverse Event|3|||
19624684|NCT00878501|42074279|FG000|Overall Study|Lack of Efficacy|2|||
19624685|NCT00878501|42074280|FG001|Overall Study|Lack of Efficacy|1|||
19624686|NCT00878501|42074281|FG002|Overall Study|Lack of Efficacy|0|||
19624687|NCT00878501|42074279|FG000|Overall Study|Withdrawal by Subject|2|||
19624688|NCT00878501|42074280|FG001|Overall Study|Withdrawal by Subject|1|||
19624689|NCT00878501|42074281|FG002|Overall Study|Withdrawal by Subject|2|||
19707070|NCT00127166|42151343|FG001|Period I|Patient did not meet inclusion criteria|0|||
19707071|NCT00127166|42151342|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
19707072|NCT00127166|42151343|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
19707073|NCT00127166|42151342|FG000|Period II|Withdrawal by Subject|2|||
19707074|NCT00127166|42151343|FG001|Period II|Withdrawal by Subject|0|||
19707075|NCT00127166|42151342|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
19707076|NCT00127166|42151343|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
19707077|NCT00125138|42151353|FG000|Overall Study|Adverse Event|1|||
19707078|NCT00125138|42151354|FG001|Overall Study|Adverse Event|0|||
19707079|NCT00125138|42151355|FG002|Overall Study|Adverse Event|3|||
19707080|NCT00125138|42151356|FG003|Overall Study|Adverse Event|2|||
19707081|NCT00125138|42151353|FG000|Overall Study|Withdrawal by Subject|2|||
19707082|NCT00125138|42151354|FG001|Overall Study|Withdrawal by Subject|3|||
19624690|NCT00878501|42074279|FG000|Overall Study|Protocol Violation|0|||
19624691|NCT00878501|42074280|FG001|Overall Study|Protocol Violation|0|||
19624692|NCT00878501|42074281|FG002|Overall Study|Protocol Violation|1|||
19624693|NCT00878501|42074279|FG000|Overall Study|Incorrect enrolment|1|||
19624694|NCT00878501|42074280|FG001|Overall Study|Incorrect enrolment|2|||
19624695|NCT00878501|42074281|FG002|Overall Study|Incorrect enrolment|0|||
19624696|NCT00878501|42074279|FG000|Overall Study|Intake of prohibited concom. medication|0|||
19624697|NCT00878501|42074280|FG001|Overall Study|Intake of prohibited concom. medication|0|||
19624698|NCT00878501|42074281|FG002|Overall Study|Intake of prohibited concom. medication|1|||
19624699|NCT00878501|42074279|FG000|Overall Study|Mis-randomisation of patient|1|||
19624700|NCT00878501|42074280|FG001|Overall Study|Mis-randomisation of patient|0|||
19624701|NCT00878501|42074281|FG002|Overall Study|Mis-randomisation of patient|0|||
19624702|NCT00878501|42074279|FG000|Overall Study|Administrative|0|||
19624703|NCT00878501|42074280|FG001|Overall Study|Administrative|0|||
19624704|NCT00878501|42074281|FG002|Overall Study|Administrative|1|||
19624705|NCT00882713|42074289|FG000|Overall Study|Adverse Event|2|||
19624706|NCT00882713|42074289|FG000|Overall Study|Death|3|||
19624707|NCT00882713|42074289|FG000|Overall Study|Administrative reasons|4|||
19624708|NCT00882713|42074289|FG000|Overall Study|refused treatment/withdrew consent|4|||
19624709|NCT00882713|42074289|FG000|Overall Study|Blood transfusion|2|||
19624710|NCT00882713|42074289|FG000|Overall Study|Insufficient therapeutic response|3|||
19624711|NCT00882713|42074289|FG000|Overall Study|Failure to return|2|||
19624712|NCT00882713|42074289|FG000|Overall Study|Other - Reasons|2|||
19624713|NCT00809133|42074308|FG000|Overall Study|Progressive disease|2|||
19624714|NCT00809133|42074309|FG001|Overall Study|Progressive disease|5|||
19624715|NCT00809133|42074310|FG002|Overall Study|Progressive disease|5|||
19624716|NCT00809133|42074311|FG003|Overall Study|Progressive disease|3|||
19624717|NCT00809133|42074312|FG004|Overall Study|Progressive disease|4|||
19624718|NCT00809133|42074313|FG005|Overall Study|Progressive disease|1|||
19624719|NCT00809133|42074314|FG006|Overall Study|Progressive disease|3|||
19707083|NCT00125138|42151355|FG002|Overall Study|Withdrawal by Subject|1|||
19707084|NCT00125138|42151356|FG003|Overall Study|Withdrawal by Subject|1|||
19707085|NCT00125138|42151353|FG000|Overall Study|Lack of Efficacy|0|||
19707086|NCT00125138|42151354|FG001|Overall Study|Lack of Efficacy|0|||
19624720|NCT00809133|42074315|FG007|Overall Study|Progressive disease|3|||
19624721|NCT00809133|42074316|FG008|Overall Study|Progressive disease|3|||
19624722|NCT00809133|42074317|FG009|Overall Study|Progressive disease|9|||
19624723|NCT00809133|42074318|FG010|Overall Study|Progressive disease|5|||
19624724|NCT00809133|42074319|FG011|Overall Study|Progressive disease|7|||
19624725|NCT00809133|42074320|FG012|Overall Study|Progressive disease|5|||
19624726|NCT00809133|42074321|FG013|Overall Study|Progressive disease|4|||
19624727|NCT00809133|42074308|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624728|NCT00809133|42074309|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624729|NCT00809133|42074310|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624730|NCT00809133|42074311|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624731|NCT00809133|42074312|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624732|NCT00809133|42074313|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
19624733|NCT00809133|42074314|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
19624734|NCT00809133|42074315|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
19624735|NCT00809133|42074316|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624736|NCT00809133|42074317|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624737|NCT00809133|42074318|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624738|NCT00809133|42074319|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624739|NCT00809133|42074320|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19624740|NCT00809133|42074321|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19624741|NCT00809133|42074308|FG000|Overall Study|Other adverse event|1|||
19624742|NCT00809133|42074309|FG001|Overall Study|Other adverse event|1|||
19707087|NCT00125138|42151355|FG002|Overall Study|Lack of Efficacy|0|||
19707088|NCT00125138|42151356|FG003|Overall Study|Lack of Efficacy|1|||
19707089|NCT00125138|42151353|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
19707090|NCT00125138|42151354|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
19707091|NCT00125138|42151355|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
19707092|NCT00125138|42151356|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
19707093|NCT04132336|42151373|FG000|Overall Study|Investigator Decision|0|||
19707094|NCT04132336|42151374|FG001|Overall Study|Investigator Decision|1|||
19707095|NCT04132336|42151375|FG002|Overall Study|Investigator Decision|0|||
19707096|NCT04132336|42151376|FG003|Overall Study|Investigator Decision|0|||
19707097|NCT04132336|42151377|FG004|Overall Study|Investigator Decision|0|||
19707098|NCT04132336|42151378|FG005|Overall Study|Investigator Decision|0|||
19707099|NCT04132336|42151379|FG006|Overall Study|Investigator Decision|0|||
19707100|NCT04131556|42151395|FG000|Overall Study|Adverse Event|1|||
19707101|NCT04131556|42151395|FG000|Overall Study|Withdrawal by Subject|1|||
19707102|NCT04295356|42151404|FG000|Overall Study|Physician Decision|1|||
19624743|NCT00809133|42074310|FG002|Overall Study|Other adverse event|1|||
19624744|NCT00809133|42074311|FG003|Overall Study|Other adverse event|0|||
19624745|NCT00809133|42074312|FG004|Overall Study|Other adverse event|0|||
19624746|NCT00809133|42074313|FG005|Overall Study|Other adverse event|3|||
19624747|NCT00809133|42074314|FG006|Overall Study|Other adverse event|2|||
19624748|NCT00809133|42074315|FG007|Overall Study|Other adverse event|4|||
19624749|NCT00809133|42074316|FG008|Overall Study|Other adverse event|0|||
19624750|NCT00809133|42074317|FG009|Overall Study|Other adverse event|0|||
19624751|NCT00809133|42074318|FG010|Overall Study|Other adverse event|1|||
19624752|NCT00809133|42074319|FG011|Overall Study|Other adverse event|1|||
19624753|NCT00809133|42074320|FG012|Overall Study|Other adverse event|0|||
19624754|NCT00809133|42074321|FG013|Overall Study|Other adverse event|1|||
19707103|NCT04295356|42151405|FG001|Overall Study|Physician Decision|0|||
19707104|NCT04295356|42151404|FG000|Overall Study|Lost to Follow-up|0|||
19707105|NCT04295356|42151405|FG001|Overall Study|Lost to Follow-up|3|||
19707106|NCT04295356|42151404|FG000|Overall Study|Protocol Violation|0|||
19707107|NCT04295356|42151405|FG001|Overall Study|Protocol Violation|1|||
19707108|NCT03691948|42151413|FG000|Overall Study|Lost to Follow-up|1|||
19624755|NCT00809133|42074308|FG000|Overall Study|Lost to Follow-up|0|||
19624756|NCT00809133|42074309|FG001|Overall Study|Lost to Follow-up|0|||
19624757|NCT00809133|42074310|FG002|Overall Study|Lost to Follow-up|0|||
19624758|NCT00809133|42074311|FG003|Overall Study|Lost to Follow-up|0|||
19624759|NCT00809133|42074312|FG004|Overall Study|Lost to Follow-up|0|||
19624760|NCT00809133|42074313|FG005|Overall Study|Lost to Follow-up|1|||
19624761|NCT00809133|42074314|FG006|Overall Study|Lost to Follow-up|0|||
19624762|NCT00809133|42074315|FG007|Overall Study|Lost to Follow-up|0|||
19624763|NCT00809133|42074316|FG008|Overall Study|Lost to Follow-up|0|||
19624764|NCT00809133|42074317|FG009|Overall Study|Lost to Follow-up|0|||
19707109|NCT03691948|42151414|FG001|Overall Study|Lost to Follow-up|3|||
19707110|NCT04126174|42151421|FG000|Overall Study|Lost to Follow-up|3|||
19707111|NCT04126174|42151422|FG001|Overall Study|Lost to Follow-up|3|||
19707112|NCT04124926|42151430|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
19707113|NCT04124926|42151431|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
19624765|NCT00809133|42074318|FG010|Overall Study|Lost to Follow-up|0|||
19624766|NCT00809133|42074319|FG011|Overall Study|Lost to Follow-up|0|||
19624767|NCT00809133|42074320|FG012|Overall Study|Lost to Follow-up|0|||
19624768|NCT00809133|42074321|FG013|Overall Study|Lost to Follow-up|0|||
19624769|NCT00809133|42074308|FG000|Overall Study|Consent withdrawn|0|||
19624770|NCT00809133|42074309|FG001|Overall Study|Consent withdrawn|0|||
19624771|NCT00809133|42074310|FG002|Overall Study|Consent withdrawn|0|||
19624772|NCT00809133|42074311|FG003|Overall Study|Consent withdrawn|0|||
19624773|NCT00809133|42074312|FG004|Overall Study|Consent withdrawn|1|||
19624774|NCT00809133|42074313|FG005|Overall Study|Consent withdrawn|0|||
19624775|NCT00809133|42074314|FG006|Overall Study|Consent withdrawn|0|||
19624776|NCT00809133|42074315|FG007|Overall Study|Consent withdrawn|0|||
19624777|NCT00809133|42074316|FG008|Overall Study|Consent withdrawn|0|||
19624778|NCT00809133|42074317|FG009|Overall Study|Consent withdrawn|0|||
19624779|NCT00809133|42074318|FG010|Overall Study|Consent withdrawn|0|||
19624780|NCT00809133|42074319|FG011|Overall Study|Consent withdrawn|0|||
19624781|NCT00809133|42074320|FG012|Overall Study|Consent withdrawn|0|||
19624782|NCT00809133|42074321|FG013|Overall Study|Consent withdrawn|0|||
19707114|NCT04124926|42151432|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
19707115|NCT04124926|42151433|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
19707116|NCT04124926|42151434|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
19707117|NCT04124926|42151430|FG000|Healing Phase|Protocol Violation|0|||
19707118|NCT04124926|42151431|FG001|Healing Phase|Protocol Violation|1|||
19707119|NCT04124926|42151432|FG002|Healing Phase|Protocol Violation|0|||
19707120|NCT04124926|42151433|FG003|Healing Phase|Protocol Violation|0|||
19707121|NCT04124926|42151434|FG004|Healing Phase|Protocol Violation|0|||
19707122|NCT04124926|42151430|FG000|Healing Phase|Lost to Follow-up|5|||
19707123|NCT04124926|42151431|FG001|Healing Phase|Lost to Follow-up|4|||
19707124|NCT04124926|42151432|FG002|Healing Phase|Lost to Follow-up|0|||
19707125|NCT04124926|42151433|FG003|Healing Phase|Lost to Follow-up|0|||
19707126|NCT04124926|42151434|FG004|Healing Phase|Lost to Follow-up|0|||
19707127|NCT04124926|42151430|FG000|Healing Phase|Voluntary Withdrawal|10|||
19707128|NCT04124926|42151431|FG001|Healing Phase|Voluntary Withdrawal|7|||
19707129|NCT04124926|42151432|FG002|Healing Phase|Voluntary Withdrawal|0|||
19707130|NCT04124926|42151433|FG003|Healing Phase|Voluntary Withdrawal|0|||
19707131|NCT04124926|42151434|FG004|Healing Phase|Voluntary Withdrawal|0|||
19707132|NCT04124926|42151430|FG000|Healing Phase|Withdrawal of Consent|5|||
19707133|NCT04124926|42151431|FG001|Healing Phase|Withdrawal of Consent|3|||
19707134|NCT04124926|42151432|FG002|Healing Phase|Withdrawal of Consent|0|||
19707135|NCT04124926|42151433|FG003|Healing Phase|Withdrawal of Consent|0|||
19707136|NCT04124926|42151434|FG004|Healing Phase|Withdrawal of Consent|0|||
19707137|NCT04124926|42151430|FG000|Healing Phase|Miscellaneous|8|||
19707138|NCT04124926|42151431|FG001|Healing Phase|Miscellaneous|7|||
19707139|NCT04124926|42151432|FG002|Healing Phase|Miscellaneous|0|||
19707140|NCT04124926|42151433|FG003|Healing Phase|Miscellaneous|0|||
19707141|NCT04124926|42151434|FG004|Healing Phase|Miscellaneous|0|||
19707142|NCT04124926|42151430|FG000|Healing Phase|Randomized but not Treated|0|||
19707143|NCT04124926|42151431|FG001|Healing Phase|Randomized but not Treated|3|||
19707144|NCT04124926|42151432|FG002|Healing Phase|Randomized but not Treated|0|||
19707145|NCT04124926|42151433|FG003|Healing Phase|Randomized but not Treated|0|||
19707146|NCT04124926|42151434|FG004|Healing Phase|Randomized but not Treated|0|||
19707147|NCT04124926|42151430|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
19707148|NCT04124926|42151431|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
19707149|NCT04124926|42151432|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
19707150|NCT04124926|42151433|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
19707151|NCT04124926|42151434|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
19707152|NCT04124926|42151430|FG000|Maintenance Phase|Protocol Violation|0|||
19707153|NCT04124926|42151431|FG001|Maintenance Phase|Protocol Violation|0|||
19707154|NCT04124926|42151432|FG002|Maintenance Phase|Protocol Violation|3|||
19707155|NCT04124926|42151433|FG003|Maintenance Phase|Protocol Violation|0|||
19707156|NCT04124926|42151434|FG004|Maintenance Phase|Protocol Violation|0|||
19707157|NCT04124926|42151430|FG000|Maintenance Phase|Lost to Follow-up|0|||
19707158|NCT04124926|42151431|FG001|Maintenance Phase|Lost to Follow-up|0|||
19707159|NCT04124926|42151432|FG002|Maintenance Phase|Lost to Follow-up|7|||
19707160|NCT04124926|42151433|FG003|Maintenance Phase|Lost to Follow-up|8|||
19707161|NCT04124926|42151434|FG004|Maintenance Phase|Lost to Follow-up|9|||
19707162|NCT04124926|42151430|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
19624783|NCT00809133|42074308|FG000|Overall Study|Other not mentioned above|0|||
19624784|NCT00809133|42074309|FG001|Overall Study|Other not mentioned above|1|||
19707163|NCT04124926|42151431|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
19707164|NCT04124926|42151432|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
19707165|NCT04124926|42151433|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
19707166|NCT04124926|42151434|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
19707167|NCT04124926|42151430|FG000|Maintenance Phase|Pregnancy|0|||
19707168|NCT04124926|42151431|FG001|Maintenance Phase|Pregnancy|0|||
19624785|NCT00809133|42074310|FG002|Overall Study|Other not mentioned above|0|||
19624786|NCT00809133|42074311|FG003|Overall Study|Other not mentioned above|0|||
19707169|NCT04124926|42151432|FG002|Maintenance Phase|Pregnancy|0|||
19707170|NCT04124926|42151433|FG003|Maintenance Phase|Pregnancy|1|||
19707171|NCT04124926|42151434|FG004|Maintenance Phase|Pregnancy|0|||
19707172|NCT04124926|42151430|FG000|Maintenance Phase|Lack of Efficacy|0|||
19707173|NCT04124926|42151431|FG001|Maintenance Phase|Lack of Efficacy|0|||
19624787|NCT00809133|42074312|FG004|Overall Study|Other not mentioned above|0|||
19624788|NCT00809133|42074313|FG005|Overall Study|Other not mentioned above|1|||
19624789|NCT00809133|42074314|FG006|Overall Study|Other not mentioned above|0|||
19624790|NCT00809133|42074315|FG007|Overall Study|Other not mentioned above|0|||
19624791|NCT00809133|42074316|FG008|Overall Study|Other not mentioned above|0|||
19624792|NCT00809133|42074317|FG009|Overall Study|Other not mentioned above|0|||
19624793|NCT00809133|42074318|FG010|Overall Study|Other not mentioned above|0|||
19624794|NCT00809133|42074319|FG011|Overall Study|Other not mentioned above|0|||
19624795|NCT00809133|42074320|FG012|Overall Study|Other not mentioned above|0|||
19624796|NCT00809133|42074321|FG013|Overall Study|Other not mentioned above|0|||
19624797|NCT00882557|42074366|FG000|Overall Study|Withdrawal by Subject|1|||
19624798|NCT00882557|42074367|FG001|Overall Study|Withdrawal by Subject|0|||
19624799|NCT00882557|42074366|FG000|Overall Study|Trouble with Vein Access|1|||
19624800|NCT00882557|42074367|FG001|Overall Study|Trouble with Vein Access|0|||
19624801|NCT00882557|42074366|FG000|Overall Study|Randomized Not Treated|0|||
19624802|NCT00882557|42074367|FG001|Overall Study|Randomized Not Treated|1|||
19624803|NCT00808899|42074373|FG000|Overall Study|Death|1|||
19624804|NCT00808899|42074373|FG000|Overall Study|Physician Decision|3|||
19624805|NCT00808665|42074379|FG000|Overall Study|Withdrawal by Subject|1|||
19624806|NCT00808665|42074380|FG001|Overall Study|Withdrawal by Subject|0|||
19624807|NCT00808665|42074379|FG000|Overall Study|only required minimally invasive surgery|1|||
19624808|NCT00808665|42074380|FG001|Overall Study|only required minimally invasive surgery|0|||
19624809|NCT00808665|42074379|FG000|Overall Study|surgery cancelled|1|||
19624810|NCT00808665|42074380|FG001|Overall Study|surgery cancelled|0|||
19624811|NCT00808665|42074379|FG000|Overall Study|required an additional procedure|0|||
19624812|NCT00808665|42074380|FG001|Overall Study|required an additional procedure|1|||
19624813|NCT00808665|42074379|FG000|Overall Study|Physician Decision|3|||
19624814|NCT00808665|42074380|FG001|Overall Study|Physician Decision|1|||
19624815|NCT00808665|42074379|FG000|Overall Study|Medication stopped by resident|0|||
19624816|NCT00808665|42074380|FG001|Overall Study|Medication stopped by resident|1|||
19624817|NCT00808509|42074388|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
19624818|NCT00808509|42074389|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
19624819|NCT00808509|42074388|FG000|Randomized Phase|Reduced methotrexate dose|1|||
19624820|NCT00808509|42074389|FG001|Randomized Phase|Reduced methotrexate dose|2|||
19707174|NCT04124926|42151432|FG002|Maintenance Phase|Lack of Efficacy|0|||
19707175|NCT04124926|42151433|FG003|Maintenance Phase|Lack of Efficacy|0|||
19707176|NCT04124926|42151434|FG004|Maintenance Phase|Lack of Efficacy|1|||
19707177|NCT04124926|42151430|FG000|Maintenance Phase|Withdrawal of Consent|0|||
19707178|NCT04124926|42151431|FG001|Maintenance Phase|Withdrawal of Consent|0|||
19707179|NCT04124926|42151432|FG002|Maintenance Phase|Withdrawal of Consent|5|||
19707180|NCT04124926|42151433|FG003|Maintenance Phase|Withdrawal of Consent|5|||
19707181|NCT04124926|42151434|FG004|Maintenance Phase|Withdrawal of Consent|5|||
19707182|NCT04124926|42151430|FG000|Maintenance Phase|Miscellaneous|0|||
19707183|NCT04124926|42151431|FG001|Maintenance Phase|Miscellaneous|0|||
19707184|NCT04124926|42151432|FG002|Maintenance Phase|Miscellaneous|1|||
19707185|NCT04124926|42151433|FG003|Maintenance Phase|Miscellaneous|2|||
19707186|NCT04124926|42151434|FG004|Maintenance Phase|Miscellaneous|4|||
19624821|NCT00808509|42074388|FG000|Randomized Phase|Patient refused rescue therapy|0|||
19624822|NCT00808509|42074389|FG001|Randomized Phase|Patient refused rescue therapy|3|||
19624823|NCT00807885|42074406|FG000|Overall Study|Lost to Follow-up|0|||
19624824|NCT00807885|42074407|FG001|Overall Study|Lost to Follow-up|0|||
19624825|NCT00807885|42074408|FG002|Overall Study|Lost to Follow-up|0|||
19624826|NCT00807885|42074409|FG003|Overall Study|Lost to Follow-up|0|||
19624827|NCT00807885|42074410|FG004|Overall Study|Lost to Follow-up|0|||
19624828|NCT00807885|42074411|FG005|Overall Study|Lost to Follow-up|1|||
19624829|NCT00807885|42074412|FG006|Overall Study|Lost to Follow-up|0|||
19624830|NCT00807885|42074413|FG007|Overall Study|Lost to Follow-up|0|||
19624831|NCT00807885|42074414|FG008|Overall Study|Lost to Follow-up|0|||
19624832|NCT00807573|42074434|FG000|Overall Study|Withdrawal by Subject|1|||
19624833|NCT00807573|42074434|FG000|Overall Study|Adverse Event|1|||
19624834|NCT00842712|42074445|FG000|Safety Run-in Part|Adverse Event|0|||
19624835|NCT00842712|42074446|FG001|Safety Run-in Part|Adverse Event|1|||
19624836|NCT00842712|42074447|FG002|Safety Run-in Part|Adverse Event|0|||
19624837|NCT00842712|42074448|FG003|Safety Run-in Part|Adverse Event|0|||
19707187|NCT04124926|42151430|FG000|Maintenance Phase|Randomized but not Treated|0|||
19624838|NCT00842712|42074449|FG004|Safety Run-in Part|Adverse Event|0|||
19624839|NCT00842712|42074450|FG005|Safety Run-in Part|Adverse Event|0|||
19624840|NCT00842712|42074451|FG006|Safety Run-in Part|Adverse Event|0|||
19624841|NCT00842712|42074445|FG000|Safety Run-in Part|Progressive disease|3|||
19624842|NCT00842712|42074446|FG001|Safety Run-in Part|Progressive disease|1|||
19624843|NCT00842712|42074447|FG002|Safety Run-in Part|Progressive disease|0|||
19707188|NCT04124926|42151431|FG001|Maintenance Phase|Randomized but not Treated|0|||
19707189|NCT04124926|42151432|FG002|Maintenance Phase|Randomized but not Treated|2|||
19624844|NCT00842712|42074448|FG003|Safety Run-in Part|Progressive disease|1|||
19624845|NCT00842712|42074449|FG004|Safety Run-in Part|Progressive disease|0|||
19707190|NCT04124926|42151433|FG003|Maintenance Phase|Randomized but not Treated|2|||
19624846|NCT00842712|42074450|FG005|Safety Run-in Part|Progressive disease|0|||
19624847|NCT00842712|42074451|FG006|Safety Run-in Part|Progressive disease|0|||
19624848|NCT00842712|42074445|FG000|Randomized Part|Randomized but not treated|0|||
19624849|NCT00842712|42074446|FG001|Randomized Part|Randomized but not treated|0|||
19624850|NCT00842712|42074447|FG002|Randomized Part|Randomized but not treated|0|||
19624851|NCT00842712|42074448|FG003|Randomized Part|Randomized but not treated|0|||
19624852|NCT00842712|42074449|FG004|Randomized Part|Randomized but not treated|0|||
19624853|NCT00842712|42074450|FG005|Randomized Part|Randomized but not treated|1|||
19624854|NCT00842712|42074451|FG006|Randomized Part|Randomized but not treated|4|||
19624855|NCT00842712|42074445|FG000|Randomized Part|Ongoing at cut-off date|0|||
19707191|NCT04124926|42151434|FG004|Maintenance Phase|Randomized but not Treated|0|||
19707192|NCT04274686|42151446|FG000|Overall Study|Physician Decision|1|||
19707193|NCT04274686|42151447|FG001|Overall Study|Physician Decision|0|||
19707194|NCT04113694|42151455|FG000|Overall Study|Adverse Event|2|||
19707195|NCT04113694|42151455|FG000|Overall Study|Lost to Follow-up|2|||
19707196|NCT04113694|42151455|FG000|Overall Study|Withdrawal by Subject|6|||
19624856|NCT00842712|42074446|FG001|Randomized Part|Ongoing at cut-off date|0|||
19624857|NCT00842712|42074447|FG002|Randomized Part|Ongoing at cut-off date|0|||
19624858|NCT00842712|42074448|FG003|Randomized Part|Ongoing at cut-off date|0|||
19624859|NCT00842712|42074449|FG004|Randomized Part|Ongoing at cut-off date|0|||
19624860|NCT00842712|42074450|FG005|Randomized Part|Ongoing at cut-off date|0|||
19624861|NCT00842712|42074451|FG006|Randomized Part|Ongoing at cut-off date|2|||
19624862|NCT00842244|42074467|FG000|Overall Study|Death|3|||
19624863|NCT00842244|42074467|FG000|Overall Study|Withdrawal by Subject|1|||
19624864|NCT00842244|42074467|FG000|Overall Study|Other|17|||
19624865|NCT00832416|42074478|FG000|Overall Study|Lack of Efficacy|17|||
19624866|NCT00832416|42074479|FG001|Overall Study|Lack of Efficacy|15|||
19624867|NCT00832416|42074480|FG002|Overall Study|Lack of Efficacy|13|||
19624868|NCT00832416|42074481|FG003|Overall Study|Lack of Efficacy|52|||
19624869|NCT00832416|42074478|FG000|Overall Study|Withdrawal by Subject|5|||
19624870|NCT00832416|42074479|FG001|Overall Study|Withdrawal by Subject|7|||
19624871|NCT00832416|42074480|FG002|Overall Study|Withdrawal by Subject|2|||
19624872|NCT00832416|42074481|FG003|Overall Study|Withdrawal by Subject|10|||
19624873|NCT00832416|42074478|FG000|Overall Study|Physician Decision|2|||
19707197|NCT04113694|42151455|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
19707198|NCT04105972|42151464|FG000|Overall Study|Adverse Event|2|||
19707199|NCT04105972|42151465|FG001|Overall Study|Adverse Event|1|||
19707200|NCT04102540|42151471|FG000|Overall Study|Withdrawn by PI|2|||
19707201|NCT04102540|42151471|FG000|Overall Study|Lost to Follow-up|6|||
19707202|NCT00124982|42151477|FG000|Short-term Period|Death|1|||
19624874|NCT00832416|42074479|FG001|Overall Study|Physician Decision|12|||
19707203|NCT00124982|42151478|FG001|Short-term Period|Death|1|||
19707204|NCT00124982|42151479|FG002|Short-term Period|Death|0|||
19707205|NCT00124982|42151477|FG000|Short-term Period|Adverse Event|17|||
19707206|NCT00124982|42151478|FG001|Short-term Period|Adverse Event|22|||
19707207|NCT00124982|42151479|FG002|Short-term Period|Adverse Event|0|||
19624875|NCT00832416|42074480|FG002|Overall Study|Physician Decision|5|||
19624876|NCT00832416|42074481|FG003|Overall Study|Physician Decision|10|||
19624877|NCT00832416|42074478|FG000|Overall Study|Administrative|0|||
19624878|NCT00832416|42074479|FG001|Overall Study|Administrative|0|||
19624879|NCT00832416|42074480|FG002|Overall Study|Administrative|0|||
19624880|NCT00832416|42074481|FG003|Overall Study|Administrative|1|||
19624881|NCT00832416|42074478|FG000|Overall Study|Adverse Event|21|||
19624882|NCT00832416|42074479|FG001|Overall Study|Adverse Event|19|||
19624883|NCT00832416|42074480|FG002|Overall Study|Adverse Event|41|||
19624884|NCT00832416|42074481|FG003|Overall Study|Adverse Event|10|||
19624885|NCT00832416|42074478|FG000|Overall Study|Death|1|||
19624886|NCT00832416|42074479|FG001|Overall Study|Death|0|||
19624887|NCT00832416|42074480|FG002|Overall Study|Death|0|||
19624888|NCT00832416|42074481|FG003|Overall Study|Death|0|||
19624889|NCT00841776|42074493|FG000|Overall Study|Lack of Efficacy|0|||
19624890|NCT00841776|42074494|FG001|Overall Study|Lack of Efficacy|1|||
19624891|NCT00841776|42074493|FG000|Overall Study|Lost to Follow-up|2|||
19624892|NCT00841776|42074494|FG001|Overall Study|Lost to Follow-up|1|||
19624893|NCT00841776|42074493|FG000|Overall Study|Withdrawal by Subject|0|||
19624894|NCT00841776|42074494|FG001|Overall Study|Withdrawal by Subject|1|||
19624895|NCT00683800|42074502|FG000|Overall Study|Adverse Event|195|||
19624896|NCT00683800|42074503|FG001|Overall Study|Adverse Event|102|||
19624897|NCT00683800|42074502|FG000|Overall Study|Death|0|||
19624898|NCT00683800|42074503|FG001|Overall Study|Death|1|||
19624899|NCT00683800|42074502|FG000|Overall Study|Lost to Follow-up|57|||
19624900|NCT00683800|42074503|FG001|Overall Study|Lost to Follow-up|44|||
19624901|NCT00683800|42074502|FG000|Overall Study|Other|5|||
19624902|NCT00683800|42074503|FG001|Overall Study|Other|2|||
19624903|NCT00683800|42074502|FG000|Overall Study|Protocol Violation|13|||
19624904|NCT00683800|42074503|FG001|Overall Study|Protocol Violation|16|||
19707208|NCT00124982|42151477|FG000|Short-term Period|Lack of Efficacy|32|||
19707209|NCT00124982|42151478|FG001|Short-term Period|Lack of Efficacy|73|||
19707210|NCT00124982|42151479|FG002|Short-term Period|Lack of Efficacy|0|||
19624905|NCT00683800|42074502|FG000|Overall Study|Withdrawal by Subject|66|||
19624906|NCT00683800|42074503|FG001|Overall Study|Withdrawal by Subject|64|||
19624907|NCT00683800|42074502|FG000|Overall Study|Lack of Efficacy|61|||
19624908|NCT00683800|42074503|FG001|Overall Study|Lack of Efficacy|104|||
19624909|NCT00683800|42074502|FG000|Overall Study|Randomized, not treated|35|||
19624910|NCT00683800|42074503|FG001|Overall Study|Randomized, not treated|33|||
19624911|NCT00683644|42074511|FG000|Overall Study|Withdrawal by Subject|4|||
19624912|NCT00683644|42074512|FG001|Overall Study|Withdrawal by Subject|2|||
19624913|NCT00683644|42074511|FG000|Overall Study|Lost to Follow-up|1|||
19624914|NCT00683644|42074512|FG001|Overall Study|Lost to Follow-up|4|||
19624915|NCT00683644|42074511|FG000|Overall Study|Adverse Event|1|||
19624916|NCT00683644|42074512|FG001|Overall Study|Adverse Event|2|||
19624917|NCT00683644|42074511|FG000|Overall Study|Low copper, other health problems,|7|||
19624918|NCT00683644|42074512|FG001|Overall Study|Low copper, other health problems,|6|||
19624919|NCT00685360|42074525|FG000|Overall Study|Lost to Follow-up|0|||
19624920|NCT00685360|42074526|FG001|Overall Study|Lost to Follow-up|1|||
19624921|NCT00685360|42074527|FG002|Overall Study|Lost to Follow-up|2|||
19624922|NCT00685360|42074525|FG000|Overall Study|Adverse Event|4|||
19624923|NCT00685360|42074526|FG001|Overall Study|Adverse Event|6|||
19624924|NCT00685360|42074527|FG002|Overall Study|Adverse Event|4|||
19624925|NCT00685360|42074525|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
19624926|NCT00685360|42074526|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
19624927|NCT00685360|42074527|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
19624928|NCT00685360|42074525|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
19624929|NCT00685360|42074526|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
19624930|NCT00685360|42074527|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
19624931|NCT00685360|42074525|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
19624932|NCT00685360|42074526|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
19624933|NCT00685360|42074527|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
19624934|NCT00685360|42074525|FG000|Overall Study|Protocol Deviation|0|||
19624935|NCT00685360|42074526|FG001|Overall Study|Protocol Deviation|1|||
19624936|NCT00685360|42074527|FG002|Overall Study|Protocol Deviation|1|||
19624937|NCT00684814|42074535|FG000|Washout Period of 7 Days|Adverse Event|1|||
19624938|NCT00684814|42074536|FG001|Washout Period of 7 Days|Adverse Event|2|||
19624939|NCT00684814|42074535|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
19624940|NCT00684814|42074536|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
19624941|NCT00684814|42074535|FG000|Second Intervention|Adverse Event|1|||
19624942|NCT00684814|42074536|FG001|Second Intervention|Adverse Event|0|||
19624943|NCT00576472|42074557|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624944|NCT00576472|42074558|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624945|NCT00576472|42074559|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624946|NCT00576472|42074560|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
19624947|NCT00576472|42074561|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624948|NCT00576472|42074562|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624949|NCT00576472|42074563|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
19707211|NCT00124982|42151477|FG000|Short-term Period|Lost to Follow-up|8|||
19707212|NCT00124982|42151478|FG001|Short-term Period|Lost to Follow-up|5|||
19707213|NCT00124982|42151479|FG002|Short-term Period|Lost to Follow-up|0|||
19707214|NCT00124982|42151477|FG000|Short-term Period|Withdrawal of Consent|7|||
19707215|NCT00124982|42151478|FG001|Short-term Period|Withdrawal of Consent|9|||
19707216|NCT00124982|42151479|FG002|Short-term Period|Withdrawal of Consent|0|||
19707217|NCT00124982|42151477|FG000|Short-term Period|Poor/Non-compliance|3|||
19707218|NCT00124982|42151478|FG001|Short-term Period|Poor/Non-compliance|1|||
19707219|NCT00124982|42151479|FG002|Short-term Period|Poor/Non-compliance|0|||
19707220|NCT00124982|42151477|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
19707221|NCT00124982|42151478|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
19707222|NCT00124982|42151479|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
19707223|NCT00124982|42151477|FG000|Short-term Period|Participant Decision|1|||
19707224|NCT00124982|42151478|FG001|Short-term Period|Participant Decision|0|||
19707225|NCT00124982|42151479|FG002|Short-term Period|Participant Decision|0|||
19624950|NCT00576472|42074564|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624951|NCT00576472|42074565|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624952|NCT00576472|42074566|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624953|NCT00576472|42074567|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624954|NCT00576472|42074568|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624955|NCT00576472|42074569|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624956|NCT00576472|42074570|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624957|NCT00576472|42074571|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
19624958|NCT00576472|42074557|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
19624959|NCT00576472|42074558|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
19624960|NCT00576472|42074559|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
19624961|NCT00576472|42074560|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
19624962|NCT00576472|42074561|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
19624963|NCT00576472|42074562|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
19624964|NCT00576472|42074563|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
19624965|NCT00576472|42074564|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
19624966|NCT00576472|42074565|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
19624967|NCT00576472|42074566|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
19624968|NCT00576472|42074567|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
19624969|NCT00576472|42074568|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
19624970|NCT00576472|42074569|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
19707226|NCT00124982|42151477|FG000|Short-term Period|Participant Chose Own Doctor|0|||
19707227|NCT00124982|42151478|FG001|Short-term Period|Participant Chose Own Doctor|1|||
19624971|NCT00576472|42074570|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
19624972|NCT00576472|42074571|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
19624973|NCT00576472|42074557|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624974|NCT00576472|42074558|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624975|NCT00576472|42074559|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624976|NCT00576472|42074560|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
19624977|NCT00576472|42074561|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19707228|NCT00124982|42151479|FG002|Short-term Period|Participant Chose Own Doctor|0|||
19707229|NCT00124982|42151477|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
19707230|NCT00124982|42151478|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
19707231|NCT00124982|42151479|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
19707232|NCT00124982|42151477|FG000|Short-term Period|Participant Had Lymphopenia|1|||
19707233|NCT00124982|42151478|FG001|Short-term Period|Participant Had Lymphopenia|0|||
19707234|NCT00124982|42151479|FG002|Short-term Period|Participant Had Lymphopenia|0|||
19707235|NCT00124982|42151477|FG000|Long-term Period|Death|0|||
19707236|NCT00124982|42151478|FG001|Long-term Period|Death|0|||
19707237|NCT00124982|42151479|FG002|Long-term Period|Death|1|||
19707238|NCT00124982|42151477|FG000|Long-term Period|Adverse Event|0|||
19707239|NCT00124982|42151478|FG001|Long-term Period|Adverse Event|0|||
19707240|NCT00124982|42151479|FG002|Long-term Period|Adverse Event|17|||
19707241|NCT00124982|42151477|FG000|Long-term Period|Lack of Efficacy|0|||
19707242|NCT00124982|42151478|FG001|Long-term Period|Lack of Efficacy|0|||
19707243|NCT00124982|42151479|FG002|Long-term Period|Lack of Efficacy|46|||
19624978|NCT00576472|42074562|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624979|NCT00576472|42074563|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624980|NCT00576472|42074564|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624981|NCT00576472|42074565|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624982|NCT00576472|42074566|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624983|NCT00576472|42074567|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19707244|NCT00124982|42151477|FG000|Long-term Period|Lost to Follow-up|0|||
19707245|NCT00124982|42151478|FG001|Long-term Period|Lost to Follow-up|0|||
19707246|NCT00124982|42151479|FG002|Long-term Period|Lost to Follow-up|4|||
19707247|NCT00124982|42151477|FG000|Long-term Period|Withdrawal by Subject|0|||
19624984|NCT00576472|42074568|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624985|NCT00576472|42074569|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624986|NCT00576472|42074570|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624987|NCT00576472|42074571|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
19624988|NCT00576472|42074557|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
19624989|NCT00576472|42074558|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
19624990|NCT00576472|42074559|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
19624991|NCT00576472|42074560|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
19707248|NCT00124982|42151478|FG001|Long-term Period|Withdrawal by Subject|0|||
19707249|NCT00124982|42151479|FG002|Long-term Period|Withdrawal by Subject|16|||
19624992|NCT00576472|42074561|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
19624993|NCT00576472|42074562|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
19624994|NCT00576472|42074563|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
19624995|NCT00576472|42074564|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
19624996|NCT00576472|42074565|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
19624997|NCT00576472|42074566|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
19624998|NCT00576472|42074567|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
19624999|NCT00576472|42074568|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
19707250|NCT00124982|42151477|FG000|Long-term Period|Pregnancy|0|||
19707251|NCT00124982|42151478|FG001|Long-term Period|Pregnancy|0|||
19707252|NCT00124982|42151479|FG002|Long-term Period|Pregnancy|1|||
19707253|NCT00124982|42151477|FG000|Long-term Period|Poor/Non-compliance|0|||
19707254|NCT00124982|42151478|FG001|Long-term Period|Poor/Non-compliance|0|||
19707255|NCT00124982|42151479|FG002|Long-term Period|Poor/Non-compliance|2|||
19707256|NCT00124982|42151477|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
19707257|NCT00124982|42151478|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
19707258|NCT00124982|42151479|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
19707259|NCT00124982|42151477|FG000|Long-term Period|Neurologist Recommendation|0|||
19707260|NCT00124982|42151478|FG001|Long-term Period|Neurologist Recommendation|0|||
19707261|NCT00124982|42151479|FG002|Long-term Period|Neurologist Recommendation|1|||
19707262|NCT04263142|42151493|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
19707263|NCT04263142|42151494|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
19707264|NCT04263142|42151495|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
19625000|NCT00576472|42074569|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
19625001|NCT00576472|42074570|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
19625002|NCT00576472|42074571|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
19625003|NCT00576472|42074557|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625004|NCT00576472|42074558|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625005|NCT00576472|42074559|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625006|NCT00576472|42074560|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
19625007|NCT00576472|42074561|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625008|NCT00576472|42074562|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625009|NCT00576472|42074563|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625010|NCT00576472|42074564|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625011|NCT00576472|42074565|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625012|NCT00576472|42074566|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625013|NCT00576472|42074567|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625014|NCT00576472|42074568|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625015|NCT00576472|42074569|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625016|NCT00576472|42074570|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625017|NCT00576472|42074571|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
19625018|NCT00576472|42074557|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625019|NCT00576472|42074558|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625020|NCT00576472|42074559|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625021|NCT00576472|42074560|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625022|NCT00576472|42074561|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625023|NCT00576472|42074562|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
19707265|NCT04263142|42151496|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
19707266|NCT04263142|42151497|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
19707267|NCT04263142|42151493|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
19625024|NCT00576472|42074563|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
19625025|NCT00576472|42074564|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625026|NCT00576472|42074565|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625027|NCT00576472|42074566|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625028|NCT00576472|42074567|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625029|NCT00576472|42074568|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625030|NCT00576472|42074569|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625031|NCT00576472|42074570|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625032|NCT00576472|42074571|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
19625033|NCT00576472|42074557|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
19625034|NCT00576472|42074558|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
19625035|NCT00576472|42074559|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
19625036|NCT00576472|42074560|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
19625037|NCT00576472|42074561|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
19625038|NCT00576472|42074562|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
19625039|NCT00576472|42074563|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
19625040|NCT00576472|42074564|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
19625041|NCT00576472|42074565|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
19625042|NCT00576472|42074566|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
19625043|NCT00576472|42074567|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
19625044|NCT00576472|42074568|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
19625045|NCT00576472|42074569|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
19625046|NCT00576472|42074570|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
19625047|NCT00576472|42074571|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
19625048|NCT00576472|42074557|FG000|MPH Cross Over Phase|Physician Decision|0|||
19707268|NCT04263142|42151494|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
19707269|NCT04263142|42151495|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
19707270|NCT04263142|42151496|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
19707271|NCT04263142|42151497|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
19625049|NCT00576472|42074558|FG001|MPH Cross Over Phase|Physician Decision|0|||
19625050|NCT00576472|42074559|FG002|MPH Cross Over Phase|Physician Decision|0|||
19625051|NCT00576472|42074560|FG003|MPH Cross Over Phase|Physician Decision|0|||
19707272|NCT04095286|42151510|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707273|NCT04095286|42151511|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
19707274|NCT04095286|42151512|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707275|NCT04095286|42151513|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707276|NCT04095286|42151514|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19625052|NCT00576472|42074561|FG004|MPH Cross Over Phase|Physician Decision|0|||
19625053|NCT00576472|42074562|FG005|MPH Cross Over Phase|Physician Decision|0|||
19625054|NCT00576472|42074563|FG006|MPH Cross Over Phase|Physician Decision|4|||
19625055|NCT00576472|42074564|FG007|MPH Cross Over Phase|Physician Decision|0|||
19625056|NCT00576472|42074565|FG008|MPH Cross Over Phase|Physician Decision|0|||
19625057|NCT00576472|42074566|FG009|MPH Cross Over Phase|Physician Decision|0|||
19625058|NCT00576472|42074567|FG010|MPH Cross Over Phase|Physician Decision|0|||
19625059|NCT00576472|42074568|FG011|MPH Cross Over Phase|Physician Decision|0|||
19625060|NCT00576472|42074569|FG012|MPH Cross Over Phase|Physician Decision|0|||
19625061|NCT00576472|42074570|FG013|MPH Cross Over Phase|Physician Decision|0|||
19625062|NCT00576472|42074571|FG014|MPH Cross Over Phase|Physician Decision|0|||
19625063|NCT00576472|42074557|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625064|NCT00576472|42074558|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625065|NCT00576472|42074559|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625066|NCT00576472|42074560|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625067|NCT00576472|42074561|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625068|NCT00576472|42074562|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625069|NCT00576472|42074563|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625070|NCT00576472|42074564|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
19707277|NCT04095286|42151515|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707278|NCT04095286|42151510|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
19707279|NCT04095286|42151511|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
19625071|NCT00576472|42074565|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
19625072|NCT00576472|42074566|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625073|NCT00576472|42074567|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
19625074|NCT00576472|42074568|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
19625075|NCT00576472|42074569|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625076|NCT00576472|42074570|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
19707280|NCT04095286|42151512|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
19707281|NCT04095286|42151513|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
19707282|NCT04095286|42151514|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
19707283|NCT04095286|42151515|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
19707284|NCT04095286|42151510|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
19707285|NCT04095286|42151511|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
19707286|NCT04095286|42151512|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
19625077|NCT00576472|42074571|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
19625078|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625079|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625080|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625081|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625082|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625083|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625084|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625085|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625086|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625087|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625088|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625089|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625090|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625091|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
19625092|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
19625093|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
19625094|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
19625095|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
19625096|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
19625097|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
19707287|NCT04095286|42151513|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
19707288|NCT04095286|42151514|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
19707289|NCT04095286|42151515|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
19707290|NCT04095286|42151510|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707291|NCT04095286|42151511|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707292|NCT04095286|42151512|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
19707293|NCT04095286|42151513|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707294|NCT04095286|42151514|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19625098|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
19625099|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
19625100|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
19625101|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
19625102|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
19625103|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
19625104|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
19625105|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
19625106|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
19625107|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
19625108|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
19625109|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
19625110|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
19625111|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
19625112|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
19625113|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
19625114|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
19625115|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
19707295|NCT04095286|42151515|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
19707296|NCT04095286|42151510|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
19707297|NCT04095286|42151511|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
19707298|NCT04095286|42151512|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
19625116|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
19625117|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
19625118|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
19625119|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
19625120|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
19625121|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
19625122|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
19625123|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Side effects|0|||
19625124|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Side effects|0|||
19625125|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Side effects|0|||
19625126|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Side effects|0|||
19625127|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Side effects|0|||
19625128|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Side effects|0|||
19625129|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Side effects|0|||
19625130|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Side effects|0|||
19625131|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Side effects|0|||
19625132|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Side effects|0|||
19625133|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Side effects|0|||
19625134|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Side effects|0|||
19625135|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Side effects|0|||
19625136|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Side effects|0|||
19707299|NCT04095286|42151513|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
19707300|NCT04095286|42151514|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
19707301|NCT04095286|42151515|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
19625137|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Side effects|8|||
19625138|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625139|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625140|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625141|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625142|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625143|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625144|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625145|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19707302|NCT04093414|42151525|FG000|3 Month Follow up|Physician Decision|0|||
19707303|NCT04093414|42151526|FG001|3 Month Follow up|Physician Decision|1|||
19707304|NCT04093414|42151525|FG000|6month Follow up|Physician Decision|1|||
19707305|NCT04093414|42151526|FG001|6month Follow up|Physician Decision|3|||
19707306|NCT04093258|42151532|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
19707307|NCT04093258|42151533|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
19707308|NCT04253236|42151541|FG000|Overall Study|Adverse Event|1|||
19707309|NCT04253236|42151542|FG001|Overall Study|Adverse Event|0|||
19707310|NCT04253236|42151541|FG000|Overall Study|Safety Concerns|1|||
19707311|NCT04253236|42151542|FG001|Overall Study|Safety Concerns|0|||
19707312|NCT04253236|42151541|FG000|Overall Study|Study Terminated by Sponsor|1|||
19707313|NCT04253236|42151542|FG001|Overall Study|Study Terminated by Sponsor|0|||
19707314|NCT04087720|42151548|FG000|Overall Study|Withdrawal by Subject|2|||
19707315|NCT04087720|42151548|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
19625146|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625147|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625148|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625149|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625150|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625151|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
19625152|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
19625153|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
19625154|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
19625155|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
19625156|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
19707316|NCT04086472|42151557|FG000|Overall Study|Lost to Follow-up|1|||
19707317|NCT04086472|42151558|FG001|Overall Study|Lost to Follow-up|0|||
19707318|NCT04086472|42151559|FG002|Overall Study|Lost to Follow-up|0|||
19625157|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
19625158|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
19707319|NCT04086472|42151560|FG003|Overall Study|Lost to Follow-up|0|||
19707320|NCT04086472|42151561|FG004|Overall Study|Lost to Follow-up|1|||
19707321|NCT04086472|42151557|FG000|Overall Study|Physician Decision|0|||
19707322|NCT04086472|42151558|FG001|Overall Study|Physician Decision|1|||
19707323|NCT04086472|42151559|FG002|Overall Study|Physician Decision|1|||
19707324|NCT04086472|42151560|FG003|Overall Study|Physician Decision|0|||
19707325|NCT04086472|42151561|FG004|Overall Study|Physician Decision|0|||
19707326|NCT04086472|42151557|FG000|Overall Study|Withdrawal by Subject|1|||
19707327|NCT04086472|42151558|FG001|Overall Study|Withdrawal by Subject|1|||
19707328|NCT04086472|42151559|FG002|Overall Study|Withdrawal by Subject|1|||
19707329|NCT04086472|42151560|FG003|Overall Study|Withdrawal by Subject|0|||
19707330|NCT04086472|42151561|FG004|Overall Study|Withdrawal by Subject|0|||
19625159|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
19625160|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
19625161|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
19625162|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
19625163|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
19625164|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
19625165|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
19707331|NCT04086472|42151557|FG000|Overall Study|Various reasons|2|||
19707332|NCT04086472|42151558|FG001|Overall Study|Various reasons|0|||
19707333|NCT04086472|42151559|FG002|Overall Study|Various reasons|0|||
19707334|NCT04086472|42151560|FG003|Overall Study|Various reasons|3|||
19707335|NCT04086472|42151561|FG004|Overall Study|Various reasons|1|||
19707336|NCT04249336|42151577|FG000|Overall Study|Lost to Follow-up|3|||
19707337|NCT04249336|42151578|FG001|Overall Study|Lost to Follow-up|3|||
19707338|NCT04249336|42151579|FG002|Overall Study|Lost to Follow-up|3|||
19707339|NCT04249336|42151580|FG003|Overall Study|Lost to Follow-up|3|||
19707340|NCT04245202|42151592|FG000|Overall Study|Lack of Efficacy|10|||
19707341|NCT04245202|42151593|FG001|Overall Study|Lack of Efficacy|1|||
19707342|NCT04079842|42151600|FG000|Overall Study|Request of subject|2|||
19707343|NCT04079842|42151600|FG000|Overall Study|Unable to draw Arterial samples|1|||
19707344|NCT04078126|42151604|FG000|Washout|Study put on hold due to COVID-19|0|||
19707345|NCT04078126|42151605|FG001|Washout|Study put on hold due to COVID-19|2|||
19707346|NCT04078126|42151604|FG000|Period 2|Study put on hold due to COVID-19|1|||
19707347|NCT04078126|42151605|FG001|Period 2|Study put on hold due to COVID-19|1|||
19625166|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
19625167|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
19625168|NCT00576472|42074557|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625169|NCT00576472|42074558|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625170|NCT00576472|42074559|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19707348|NCT04073368|42151615|FG000|Overall Study|Adverse Event|2|||
19707349|NCT04073368|42151616|FG001|Overall Study|Adverse Event|0|||
19625171|NCT00576472|42074560|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625172|NCT00576472|42074561|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19707350|NCT04073368|42151617|FG002|Overall Study|Adverse Event|1|||
19707351|NCT04073368|42151618|FG003|Overall Study|Adverse Event|1|||
19707352|NCT04073368|42151615|FG000|Overall Study|Withdrawal by Subject|2|||
19707353|NCT04073368|42151616|FG001|Overall Study|Withdrawal by Subject|2|||
19707354|NCT04073368|42151617|FG002|Overall Study|Withdrawal by Subject|1|||
19707355|NCT04073368|42151618|FG003|Overall Study|Withdrawal by Subject|1|||
19707356|NCT04073368|42151615|FG000|Overall Study|Lost to Follow-up|1|||
19625173|NCT00576472|42074562|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625174|NCT00576472|42074563|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625175|NCT00576472|42074564|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625176|NCT00576472|42074565|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625177|NCT00576472|42074566|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625178|NCT00576472|42074567|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625179|NCT00576472|42074568|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625180|NCT00576472|42074569|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19707357|NCT04073368|42151616|FG001|Overall Study|Lost to Follow-up|1|||
19707358|NCT04073368|42151617|FG002|Overall Study|Lost to Follow-up|1|||
19707359|NCT04073368|42151618|FG003|Overall Study|Lost to Follow-up|0|||
19707360|NCT04073368|42151615|FG000|Overall Study|Protocol Violation|0|||
19707361|NCT04073368|42151616|FG001|Overall Study|Protocol Violation|1|||
19707362|NCT04073368|42151617|FG002|Overall Study|Protocol Violation|0|||
19707363|NCT04073368|42151618|FG003|Overall Study|Protocol Violation|0|||
19707364|NCT04073368|42151615|FG000|Overall Study|Subject noncompliance|7|||
19707365|NCT04073368|42151616|FG001|Overall Study|Subject noncompliance|4|||
19707366|NCT04073368|42151617|FG002|Overall Study|Subject noncompliance|0|||
19707367|NCT04073368|42151618|FG003|Overall Study|Subject noncompliance|0|||
19707368|NCT00124748|42151630|FG000|Overall Study|Adverse Event|8|||
19707369|NCT00124748|42151631|FG001|Overall Study|Adverse Event|39|||
19707370|NCT00124748|42151630|FG000|Overall Study|Abnormal laboratory Value|2|||
19707371|NCT00124748|42151631|FG001|Overall Study|Abnormal laboratory Value|2|||
19707372|NCT00124748|42151630|FG000|Overall Study|Abnormal Procedure|0|||
19707373|NCT00124748|42151631|FG001|Overall Study|Abnormal Procedure|1|||
19707374|NCT00124748|42151630|FG000|Overall Study|Lack of Efficacy|20|||
19707375|NCT00124748|42151631|FG001|Overall Study|Lack of Efficacy|41|||
19707376|NCT00124748|42151630|FG000|Overall Study|No longer requires study drug|1|||
19625181|NCT00576472|42074570|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
19625182|NCT00576472|42074571|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
19625183|NCT00823212|42074604|FG000|Overall Study|Death|8|||
19625184|NCT00823212|42074605|FG001|Overall Study|Death|10|||
19625185|NCT00823212|42074604|FG000|Overall Study|Withdrawal by Subject|6|||
19707377|NCT00124748|42151631|FG001|Overall Study|No longer requires study drug|1|||
19625186|NCT00823212|42074605|FG001|Overall Study|Withdrawal by Subject|1|||
19625187|NCT00823212|42074604|FG000|Overall Study|Incarcerated|0|||
19625188|NCT00823212|42074605|FG001|Overall Study|Incarcerated|1|||
19625189|NCT00823212|42074604|FG000|Overall Study|Missed 12-month visit|21|||
19625190|NCT00823212|42074605|FG001|Overall Study|Missed 12-month visit|21|||
19625191|NCT00807495|42074618|FG000|Overall Study|Adverse Event|6|||
19625192|NCT00807495|42074619|FG001|Overall Study|Adverse Event|3|||
19625193|NCT00807495|42074620|FG002|Overall Study|Adverse Event|1|||
19625194|NCT00807495|42074621|FG003|Overall Study|Adverse Event|1|||
19625195|NCT00807495|42074622|FG004|Overall Study|Adverse Event|2|||
19625196|NCT00807495|42074618|FG000|Overall Study|Withdrawal by Patient|2|||
19625197|NCT00807495|42074619|FG001|Overall Study|Withdrawal by Patient|0|||
19625198|NCT00807495|42074620|FG002|Overall Study|Withdrawal by Patient|1|||
19625199|NCT00807495|42074621|FG003|Overall Study|Withdrawal by Patient|0|||
19625200|NCT00807495|42074622|FG004|Overall Study|Withdrawal by Patient|0|||
19625201|NCT00807495|42074618|FG000|Overall Study|Reason Not Specified|0|||
19625202|NCT00807495|42074619|FG001|Overall Study|Reason Not Specified|3|||
19625203|NCT00807495|42074620|FG002|Overall Study|Reason Not Specified|2|||
19707378|NCT00124748|42151630|FG000|Overall Study|Protocol Violation|3|||
19707379|NCT00124748|42151631|FG001|Overall Study|Protocol Violation|1|||
19707380|NCT00124748|42151630|FG000|Overall Study|Withdrawal by Subject|5|||
19625204|NCT00807495|42074621|FG003|Overall Study|Reason Not Specified|0|||
19707381|NCT00124748|42151631|FG001|Overall Study|Withdrawal by Subject|15|||
19707382|NCT00124748|42151630|FG000|Overall Study|Lost to Follow-up|2|||
19707383|NCT00124748|42151631|FG001|Overall Study|Lost to Follow-up|7|||
19707384|NCT00124748|42151630|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
19707385|NCT00124748|42151631|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
19707386|NCT00124748|42151630|FG000|Overall Study|Death|1|||
19625205|NCT00807495|42074622|FG004|Overall Study|Reason Not Specified|3|||
19625206|NCT00576316|42074634|FG000|Overall Study|Adverse Event|9|||
19625207|NCT00576316|42074634|FG000|Overall Study|Withdrawal by Subject|2|||
19625208|NCT00576316|42074634|FG000|Overall Study|Protocol Violation|9|||
19625209|NCT00823134|42074638|FG000|Overall Study|Invalid measurement|1|||
19625210|NCT00831792|42074643|FG000|Overall Study|Not Eligible|3|||
19625211|NCT00831792|42074643|FG000|Overall Study|Adverse Event|1|||
19625212|NCT00831792|42074643|FG000|Overall Study|Death|1|||
19625213|NCT00831792|42074643|FG000|Overall Study|Lack of Efficacy|1|||
19625214|NCT00575380|42074649|FG000|Overall Study|Withdrawal by Subject|1|||
19625215|NCT00575380|42074650|FG001|Overall Study|Withdrawal by Subject|0|||
19625216|NCT00575380|42074649|FG000|Overall Study|Adverse Event|0|||
19625217|NCT00575380|42074650|FG001|Overall Study|Adverse Event|1|||
19625218|NCT00575380|42074649|FG000|Overall Study|Various|0|||
19625219|NCT00575380|42074650|FG001|Overall Study|Various|2|||
19625220|NCT00840996|42074658|FG000|Overall Study|Withdrawal by Subject|1|||
19625221|NCT00840996|42074659|FG001|Overall Study|Withdrawal by Subject|0|||
19625222|NCT00680914|42074667|FG000|Overall Study|Consent withdrawal|6|||
19625223|NCT00680914|42074668|FG001|Overall Study|Consent withdrawal|3|||
19625224|NCT00680914|42074667|FG000|Overall Study|Lost to Follow-up|4|||
19625225|NCT00680914|42074668|FG001|Overall Study|Lost to Follow-up|0|||
19625226|NCT00680914|42074667|FG000|Overall Study|serious adverse event (SAE)|0|||
19625227|NCT00680914|42074668|FG001|Overall Study|serious adverse event (SAE)|1|||
19625228|NCT00680836|42074676|FG000|Overall Study|Withdrawal by Subject|3|||
19625229|NCT00680836|42074677|FG001|Overall Study|Withdrawal by Subject|0|||
19625230|NCT00680836|42074676|FG000|Overall Study|Lost to Follow-up|3|||
19625231|NCT00680836|42074677|FG001|Overall Study|Lost to Follow-up|1|||
19625232|NCT00680836|42074676|FG000|Overall Study|Physician Decision|2|||
19625233|NCT00680836|42074677|FG001|Overall Study|Physician Decision|1|||
19625234|NCT00679432|42074688|FG000|Overall Study|Adverse Event|5|||
19625235|NCT00679432|42074689|FG001|Overall Study|Adverse Event|6|||
19707387|NCT00124748|42151631|FG001|Overall Study|Death|3|||
19707388|NCT04070326|42151639|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
19707389|NCT04070326|42151640|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
19707390|NCT03689452|42151650|FG000|Overall Study|Lost to Follow-up|1|||
19625236|NCT00679432|42074690|FG002|Overall Study|Adverse Event|10|||
19625237|NCT00679432|42074691|FG003|Overall Study|Adverse Event|7|||
19625238|NCT00679432|42074688|FG000|Overall Study|Protocol Violation|1|||
19625239|NCT00679432|42074689|FG001|Overall Study|Protocol Violation|1|||
19625240|NCT00679432|42074690|FG002|Overall Study|Protocol Violation|2|||
19625241|NCT00679432|42074691|FG003|Overall Study|Protocol Violation|1|||
19625242|NCT00679432|42074688|FG000|Overall Study|Withdrawal by Subject|8|||
19625243|NCT00679432|42074689|FG001|Overall Study|Withdrawal by Subject|11|||
19625244|NCT00679432|42074690|FG002|Overall Study|Withdrawal by Subject|10|||
19625245|NCT00679432|42074691|FG003|Overall Study|Withdrawal by Subject|9|||
19625246|NCT00679432|42074688|FG000|Overall Study|Lost to Follow-up|1|||
19625247|NCT00679432|42074689|FG001|Overall Study|Lost to Follow-up|5|||
19625248|NCT00679432|42074690|FG002|Overall Study|Lost to Follow-up|4|||
19625249|NCT00679432|42074691|FG003|Overall Study|Lost to Follow-up|2|||
19625250|NCT00679432|42074688|FG000|Overall Study|Physician Decision|3|||
19625251|NCT00679432|42074689|FG001|Overall Study|Physician Decision|2|||
19625252|NCT00679432|42074690|FG002|Overall Study|Physician Decision|2|||
19625253|NCT00679432|42074691|FG003|Overall Study|Physician Decision|2|||
19625254|NCT00679432|42074688|FG000|Overall Study|Sponsor decision|1|||
19625255|NCT00679432|42074689|FG001|Overall Study|Sponsor decision|0|||
19707391|NCT03689452|42151651|FG001|Overall Study|Lost to Follow-up|1|||
19707392|NCT04067050|42151659|FG000|One Month|Lost to Follow-up|4|||
19707393|NCT04067050|42151660|FG001|One Month|Lost to Follow-up|0|||
19707394|NCT04067050|42151659|FG000|Two Month|Lost to Follow-up|1|||
19707395|NCT04067050|42151660|FG001|Two Month|Lost to Follow-up|0|||
19707396|NCT04067050|42151659|FG000|Two Month|Adverse Event|1|||
19707397|NCT04067050|42151660|FG001|Two Month|Adverse Event|0|||
19707398|NCT04060654|42151666|FG000|Overall Study|Withdrawal by Subject|1|||
19707399|NCT04060654|42151666|FG000|Overall Study|Lost to Follow-up|5|||
19707400|NCT00096200|42151673|FG000|Overall Study|Adverse Event|0|||
19707401|NCT00096200|42151674|FG001|Overall Study|Adverse Event|4|||
19707402|NCT00096200|42151675|FG002|Overall Study|Adverse Event|0|||
19707403|NCT00096200|42151673|FG000|Overall Study|Withdrawal by Subject|1|||
19707404|NCT00096200|42151674|FG001|Overall Study|Withdrawal by Subject|2|||
19625256|NCT00679432|42074690|FG002|Overall Study|Sponsor decision|0|||
19625257|NCT00679432|42074691|FG003|Overall Study|Sponsor decision|0|||
19625258|NCT00679432|42074688|FG000|Overall Study|Lack of Efficacy|13|||
19625259|NCT00679432|42074689|FG001|Overall Study|Lack of Efficacy|9|||
19625260|NCT00679432|42074690|FG002|Overall Study|Lack of Efficacy|14|||
19625261|NCT00679432|42074691|FG003|Overall Study|Lack of Efficacy|8|||
19625262|NCT00679432|42074688|FG000|Overall Study|Infectious colitis, normal histology|5|||
19707405|NCT00096200|42151675|FG002|Overall Study|Withdrawal by Subject|0|||
19707406|NCT00096200|42151673|FG000|Overall Study|Ineligible pathology|0|||
19625263|NCT00679432|42074689|FG001|Overall Study|Infectious colitis, normal histology|4|||
19707407|NCT00096200|42151674|FG001|Overall Study|Ineligible pathology|1|||
19707408|NCT00096200|42151675|FG002|Overall Study|Ineligible pathology|0|||
19707409|NCT04059094|42151688|FG000|Overall Study|Adverse Event|0|||
19707410|NCT04059094|42151689|FG001|Overall Study|Adverse Event|0|||
19707411|NCT04059094|42151690|FG002|Overall Study|Adverse Event|0|||
19625264|NCT00679432|42074690|FG002|Overall Study|Infectious colitis, normal histology|8|||
19707412|NCT04059094|42151691|FG003|Overall Study|Adverse Event|0|||
19707413|NCT04059094|42151692|FG004|Overall Study|Adverse Event|1|||
19707414|NCT04059094|42151688|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
19707415|NCT04059094|42151689|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
19707416|NCT04059094|42151690|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
19707417|NCT04059094|42151691|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
19707418|NCT04059094|42151692|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
19707419|NCT00096044|42151708|FG000|Overall Study|Withdrawal by Subject|9|||
19707420|NCT00096044|42151708|FG000|Overall Study|Adverse Event|21|||
19707421|NCT00096044|42151708|FG000|Overall Study|Disease Progression|4|||
19707422|NCT03689374|42151714|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
19707423|NCT03689374|42151715|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
19707424|NCT03689374|42151716|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
19707425|NCT03689374|42151714|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
19625265|NCT00679432|42074691|FG003|Overall Study|Infectious colitis, normal histology|3|||
19625266|NCT00679432|42074688|FG000|Overall Study|Randomization error, return to prior Rx|0|||
19373772|NCT02753075|41614982|FG002|Overall Study|Withdrawal of Consent|3|||
19517728|NCT01551420|41930742|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
19625267|NCT00679432|42074689|FG001|Overall Study|Randomization error, return to prior Rx|0|||
19625268|NCT00679432|42074690|FG002|Overall Study|Randomization error, return to prior Rx|3|||
19625269|NCT00679432|42074691|FG003|Overall Study|Randomization error, return to prior Rx|0|||
19625270|NCT00679354|42074701|FG000|Overall Study|Death|3|||
19625271|NCT00679354|42074701|FG000|Overall Study|Lack of Efficacy|22|||
19625272|NCT00679354|42074701|FG000|Overall Study|Physician Decision|4|||
19625273|NCT00679354|42074701|FG000|Overall Study|Ineligible|1|||
19707426|NCT03689374|42151715|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
19625274|NCT00822900|42074708|FG000|Overall Study|Withdrawal by Subject|14|||
19625275|NCT00822900|42074709|FG001|Overall Study|Withdrawal by Subject|14|||
19625276|NCT00822900|42074708|FG000|Overall Study|Lost to Follow-up|9|||
19707427|NCT03689374|42151716|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
19707428|NCT03689374|42151714|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
19707429|NCT03689374|42151715|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
19707430|NCT03689374|42151716|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
19707431|NCT03689374|42151714|FG000|Treatment Period (Week 0 to 52)|Death|0|||
19707432|NCT03689374|42151715|FG001|Treatment Period (Week 0 to 52)|Death|11|||
19625277|NCT00822900|42074709|FG001|Overall Study|Lost to Follow-up|9|||
19625278|NCT00822900|42074708|FG000|Overall Study|Death|83|||
19625279|NCT00822900|42074709|FG001|Overall Study|Death|69|||
19625280|NCT00822900|42074708|FG000|Overall Study|Became a ward of the state|2|||
19707433|NCT03689374|42151716|FG002|Treatment Period (Week 0 to 52)|Death|1|||
19707434|NCT00113360|42151722|FG000|Overall Study|Adverse Event|3|||
19707435|NCT00113360|42151722|FG000|Overall Study|Subject required surgery|1|||
19707436|NCT00113360|42151722|FG000|Overall Study|Did not meet eligibility criteria|3|||
19707437|NCT00123734|42151726|FG000|Overall Study|Death|3|||
19707438|NCT00123734|42151726|FG000|Overall Study|Lost to Follow-up|3|||
19707439|NCT00123734|42151726|FG000|Overall Study|Dropout|1|||
19707440|NCT00123734|42151726|FG000|Overall Study|Withdrawal by Subject|1|||
19707441|NCT00112736|42151736|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
19707442|NCT00112736|42151737|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
19625281|NCT00822900|42074709|FG001|Overall Study|Became a ward of the state|1|||
19625282|NCT00682786|42074717|FG000|Overall Study|Withdrawal by Subject|2|||
19625283|NCT00682786|42074718|FG001|Overall Study|Withdrawal by Subject|2|||
19625284|NCT00682786|42074717|FG000|Overall Study|Did not receive irinotecan|0|||
19707443|NCT00123422|42151752|FG000|Overall Study|Physician Decision|2|||
19707444|NCT00123422|42151753|FG001|Overall Study|Physician Decision|2|||
19707445|NCT00123422|42151754|FG002|Overall Study|Physician Decision|6|||
19707446|NCT00123422|42151752|FG000|Overall Study|Withdrawal by Subject|1|||
19707447|NCT00123422|42151753|FG001|Overall Study|Withdrawal by Subject|2|||
19707448|NCT00123422|42151754|FG002|Overall Study|Withdrawal by Subject|2|||
19707449|NCT00123422|42151752|FG000|Overall Study|Lost to Follow-up|1|||
19707450|NCT00123422|42151753|FG001|Overall Study|Lost to Follow-up|2|||
19707451|NCT00123422|42151754|FG002|Overall Study|Lost to Follow-up|2|||
19707452|NCT04052620|42151764|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
19707453|NCT04052620|42151765|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
19707454|NCT04052620|42151764|FG000|Overall Study|Withdrawal by Subject|1|||
19707455|NCT04052620|42151765|FG001|Overall Study|Withdrawal by Subject|0|||
19707456|NCT04052620|42151764|FG000|Overall Study|Lost to Follow-up|1|||
19707457|NCT04052620|42151765|FG001|Overall Study|Lost to Follow-up|1|||
19707458|NCT04052620|42151764|FG000|Overall Study|Adverse Event|1|||
19707459|NCT04052620|42151765|FG001|Overall Study|Adverse Event|0|||
19707460|NCT04052620|42151764|FG000|Overall Study|Subject did not meet study Criteria|0|||
19707461|NCT04052620|42151765|FG001|Overall Study|Subject did not meet study Criteria|1|||
19707462|NCT04052620|42151764|FG000|Overall Study|Screened failure, randomized by mistake|0|||
19625285|NCT00682786|42074718|FG001|Overall Study|Did not receive irinotecan|1|||
19625286|NCT00840450|42074730|FG000|Overall Study|Adverse Event|1|||
19625287|NCT00840450|42074730|FG000|Overall Study|Lack of Efficacy|2|||
19625288|NCT00840294|42074736|FG000|Overall Study|Withdrawal by Subject|2|||
19625289|NCT00840294|42074737|FG001|Overall Study|Withdrawal by Subject|1|||
19625290|NCT00840294|42074736|FG000|Overall Study|Protocol Violation|1|||
19625291|NCT00840294|42074737|FG001|Overall Study|Protocol Violation|3|||
19625292|NCT00840294|42074736|FG000|Overall Study|Illness|0|||
19625293|NCT00840294|42074737|FG001|Overall Study|Illness|1|||
19625294|NCT00679042|42074743|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
19625295|NCT00679042|42074743|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
19625296|NCT00679042|42074743|FG000|5-Year Follow Up|Death|1|||
19373773|NCT02753075|41614980|FG000|Overall Study|Physician Decision|3|||
19373774|NCT02753075|41614981|FG001|Overall Study|Physician Decision|1|||
19625297|NCT00679042|42074743|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
19625298|NCT00679042|42074743|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
19625299|NCT00680368|42074747|FG000|Overall Study|not supervised, not eligible|15|||
19625300|NCT00680056|42074755|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
19625301|NCT00680056|42074756|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
19625302|NCT00680056|42074755|FG000|Second Intervention|Protocol Violation|3|||
19625303|NCT00680056|42074756|FG001|Second Intervention|Protocol Violation|1|||
19625304|NCT00680992|42074766|FG000|Overall Study|Complete Resection (as per protocol)|25|||
19625305|NCT00680992|42074767|FG001|Overall Study|Complete Resection (as per protocol)|121|||
19625306|NCT00680992|42074768|FG002|Overall Study|Complete Resection (as per protocol)|0|||
19625307|NCT00680992|42074766|FG000|Overall Study|Administrative Decision|83|||
19625308|NCT00680992|42074767|FG001|Overall Study|Administrative Decision|42|||
19707463|NCT04052620|42151765|FG001|Overall Study|Screened failure, randomized by mistake|1|||
19707464|NCT04052620|42151764|FG000|Overall Study|Personal reasons|2|||
19625309|NCT00680992|42074768|FG002|Overall Study|Administrative Decision|5|||
19625310|NCT00680992|42074766|FG000|Overall Study|End of Trial|32|||
19625311|NCT00680992|42074767|FG001|Overall Study|End of Trial|12|||
19625312|NCT00680992|42074768|FG002|Overall Study|End of Trial|3|||
19625313|NCT00680992|42074766|FG000|Overall Study|Withdrawal by Subject|33|||
19625314|NCT00680992|42074767|FG001|Overall Study|Withdrawal by Subject|11|||
19625315|NCT00680992|42074768|FG002|Overall Study|Withdrawal by Subject|1|||
19625316|NCT00680992|42074766|FG000|Overall Study|Adverse Event|21|||
19707465|NCT04052620|42151765|FG001|Overall Study|Personal reasons|4|||
19707466|NCT04052620|42151764|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
19707467|NCT04052620|42151765|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
19707468|NCT00112580|42151773|FG000|Overall Study|Adverse Event|1|||
19707469|NCT00112580|42151774|FG001|Overall Study|Adverse Event|2|||
19707470|NCT00112580|42151773|FG000|Overall Study|Disease progression|5|||
19707471|NCT00112580|42151774|FG001|Overall Study|Disease progression|16|||
19707472|NCT00112580|42151773|FG000|Overall Study|Participant withdrew consent|2|||
19625317|NCT00680992|42074767|FG001|Overall Study|Adverse Event|19|||
19625318|NCT00680992|42074768|FG002|Overall Study|Adverse Event|1|||
19625319|NCT00680992|42074766|FG000|Overall Study|Other|19|||
19625320|NCT00680992|42074767|FG001|Overall Study|Other|14|||
19625321|NCT00680992|42074768|FG002|Overall Study|Other|1|||
19625322|NCT00680992|42074766|FG000|Overall Study|Disease Progression|21|||
19625323|NCT00680992|42074767|FG001|Overall Study|Disease Progression|9|||
19625324|NCT00680992|42074768|FG002|Overall Study|Disease Progression|0|||
19707473|NCT00112580|42151774|FG001|Overall Study|Participant withdrew consent|1|||
19707474|NCT04238650|42151781|FG000|Overall Study|Withdrawal by Subject|0|||
19707475|NCT04238650|42151782|FG001|Overall Study|Withdrawal by Subject|1|||
19707476|NCT00095576|42151790|FG000|Overall Study|Adverse Event|5|||
19707477|NCT00095576|42151791|FG001|Overall Study|Adverse Event|3|||
19707478|NCT00095576|42151790|FG000|Overall Study|Lost to Follow-up|233|||
19707479|NCT00095576|42151791|FG001|Overall Study|Lost to Follow-up|229|||
19707480|NCT00095576|42151790|FG000|Overall Study|Protocol Violation|1|||
19625325|NCT00680992|42074766|FG000|Overall Study|Lost to Follow-up|12|||
19625326|NCT00680992|42074767|FG001|Overall Study|Lost to Follow-up|14|||
19625327|NCT00680992|42074768|FG002|Overall Study|Lost to Follow-up|0|||
19625328|NCT00680992|42074766|FG000|Overall Study|Noncompliance|4|||
19625329|NCT00680992|42074767|FG001|Overall Study|Noncompliance|6|||
19625330|NCT00680992|42074768|FG002|Overall Study|Noncompliance|0|||
19625331|NCT00680992|42074766|FG000|Overall Study|Requirement for Alternative Therapy|8|||
19625332|NCT00680992|42074767|FG001|Overall Study|Requirement for Alternative Therapy|2|||
19625333|NCT00680992|42074768|FG002|Overall Study|Requirement for Alternative Therapy|0|||
19625334|NCT00680992|42074766|FG000|Overall Study|Pregnancy|5|||
19625335|NCT00680992|42074767|FG001|Overall Study|Pregnancy|0|||
19625336|NCT00680992|42074768|FG002|Overall Study|Pregnancy|1|||
19707481|NCT00095576|42151791|FG001|Overall Study|Protocol Violation|0|||
19625337|NCT00680992|42074766|FG000|Overall Study|Death|5|||
19625338|NCT00680992|42074767|FG001|Overall Study|Death|1|||
19625339|NCT00680992|42074768|FG002|Overall Study|Death|0|||
19625340|NCT00680992|42074766|FG000|Overall Study|Ineligibility Determined|0|||
19625341|NCT00680992|42074767|FG001|Overall Study|Ineligibility Determined|1|||
19625342|NCT00680992|42074768|FG002|Overall Study|Ineligibility Determined|0|||
19625343|NCT00805389|42074782|FG000|Overall Study|Adverse Event|0|||
19625344|NCT00805389|42074783|FG001|Overall Study|Adverse Event|0|||
19625345|NCT00805389|42074784|FG002|Overall Study|Adverse Event|1|||
19625346|NCT00805389|42074785|FG003|Overall Study|Adverse Event|2|||
19625347|NCT00805389|42074786|FG004|Overall Study|Adverse Event|0|||
19625348|NCT00805389|42074782|FG000|Overall Study|Lost to Follow-up|4|||
19625349|NCT00805389|42074783|FG001|Overall Study|Lost to Follow-up|3|||
19625350|NCT00805389|42074784|FG002|Overall Study|Lost to Follow-up|6|||
19625351|NCT00805389|42074785|FG003|Overall Study|Lost to Follow-up|10|||
19625352|NCT00805389|42074786|FG004|Overall Study|Lost to Follow-up|9|||
19625353|NCT00805389|42074782|FG000|Overall Study|Protocol Violation|0|||
19625354|NCT00805389|42074783|FG001|Overall Study|Protocol Violation|0|||
19625355|NCT00805389|42074784|FG002|Overall Study|Protocol Violation|1|||
19625356|NCT00805389|42074785|FG003|Overall Study|Protocol Violation|0|||
19625357|NCT00805389|42074786|FG004|Overall Study|Protocol Violation|0|||
19625358|NCT00805389|42074782|FG000|Overall Study|Withdrawal by Subject|3|||
19625359|NCT00805389|42074783|FG001|Overall Study|Withdrawal by Subject|2|||
19625360|NCT00805389|42074784|FG002|Overall Study|Withdrawal by Subject|4|||
19625361|NCT00805389|42074785|FG003|Overall Study|Withdrawal by Subject|5|||
19625362|NCT00805389|42074786|FG004|Overall Study|Withdrawal by Subject|4|||
19625363|NCT00678886|42074810|FG000|Overall Study|Withdrawal by Subject|0|||
19625364|NCT00678886|42074811|FG001|Overall Study|Withdrawal by Subject|0|||
19625365|NCT00678886|42074812|FG002|Overall Study|Withdrawal by Subject|4|||
19625366|NCT00678886|42074813|FG003|Overall Study|Withdrawal by Subject|6|||
19625367|NCT00678886|42074810|FG000|Overall Study|Physician Decision|0|||
19625368|NCT00678886|42074811|FG001|Overall Study|Physician Decision|0|||
19625369|NCT00678886|42074812|FG002|Overall Study|Physician Decision|1|||
19625370|NCT00678886|42074813|FG003|Overall Study|Physician Decision|1|||
19625371|NCT00678886|42074810|FG000|Overall Study|Lost to Follow-up|0|||
19625372|NCT00678886|42074811|FG001|Overall Study|Lost to Follow-up|0|||
19625373|NCT00678886|42074812|FG002|Overall Study|Lost to Follow-up|3|||
19625374|NCT00678886|42074813|FG003|Overall Study|Lost to Follow-up|2|||
19625375|NCT00678886|42074810|FG000|Overall Study|Other|0|||
19625376|NCT00678886|42074811|FG001|Overall Study|Other|0|||
19625377|NCT00678886|42074812|FG002|Overall Study|Other|1|||
19707482|NCT00095576|42151790|FG000|Overall Study|Withdrawal by Subject|34|||
19373775|NCT02753075|41614982|FG002|Overall Study|Physician Decision|0|||
19373776|NCT02332720|41615014|FG000|Part A and Part B|Lost to Follow-up|1|||
19625378|NCT00678886|42074813|FG003|Overall Study|Other|0|||
19625379|NCT00804843|42074824|FG000|Overall Study|Protocol Violation|1|||
19625380|NCT00804843|42074825|FG001|Overall Study|Protocol Violation|0|||
19625381|NCT00804843|42074824|FG000|Overall Study|Adverse Event|8|||
19625382|NCT00804843|42074825|FG001|Overall Study|Adverse Event|5|||
19625383|NCT00804843|42074824|FG000|Overall Study|Withdrawal by Subject|1|||
19625384|NCT00804843|42074825|FG001|Overall Study|Withdrawal by Subject|2|||
19625385|NCT00822120|42074834|FG000|Initial Registration|Adverse Event|1|||
19625386|NCT00822120|42074835|FG001|Initial Registration|Adverse Event|0|||
19625387|NCT00822120|42074836|FG002|Initial Registration|Adverse Event|0|||
19625388|NCT00822120|42074837|FG003|Initial Registration|Adverse Event|0|||
19625389|NCT00822120|42074838|FG004|Initial Registration|Adverse Event|0|||
19625390|NCT00822120|42074839|FG005|Initial Registration|Adverse Event|0|||
19625391|NCT00822120|42074834|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
19625392|NCT00822120|42074835|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19625393|NCT00822120|42074836|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19625394|NCT00822120|42074837|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19625395|NCT00822120|42074838|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19625396|NCT00822120|42074839|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19625397|NCT00822120|42074834|FG000|Initial Registration|Reasons not Protocol Specified|2|||
19625398|NCT00822120|42074835|FG001|Initial Registration|Reasons not Protocol Specified|0|||
19625399|NCT00822120|42074836|FG002|Initial Registration|Reasons not Protocol Specified|0|||
19625400|NCT00822120|42074837|FG003|Initial Registration|Reasons not Protocol Specified|0|||
19625401|NCT00822120|42074838|FG004|Initial Registration|Reasons not Protocol Specified|0|||
19625402|NCT00822120|42074839|FG005|Initial Registration|Reasons not Protocol Specified|0|||
19625403|NCT00822120|42074834|FG000|Initial Registration|Ineligible|22|||
19625404|NCT00822120|42074835|FG001|Initial Registration|Ineligible|1|||
19625405|NCT00822120|42074836|FG002|Initial Registration|Ineligible|0|||
19625406|NCT00822120|42074837|FG003|Initial Registration|Ineligible|0|||
19625407|NCT00822120|42074838|FG004|Initial Registration|Ineligible|0|||
19625408|NCT00822120|42074839|FG005|Initial Registration|Ineligible|0|||
19625409|NCT00822120|42074834|FG000|PET-directed Therapy|Adverse Event|0|||
19625410|NCT00822120|42074835|FG001|PET-directed Therapy|Adverse Event|0|||
19625411|NCT00822120|42074836|FG002|PET-directed Therapy|Adverse Event|0|||
19625412|NCT00822120|42074837|FG003|PET-directed Therapy|Adverse Event|1|||
19625413|NCT00822120|42074838|FG004|PET-directed Therapy|Adverse Event|0|||
19625414|NCT00822120|42074839|FG005|PET-directed Therapy|Adverse Event|0|||
19625415|NCT00822120|42074834|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
19625416|NCT00822120|42074835|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
19625417|NCT00822120|42074836|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
19625418|NCT00822120|42074837|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
19707483|NCT00095576|42151791|FG001|Overall Study|Withdrawal by Subject|47|||
19707484|NCT00095576|42151790|FG000|Overall Study|Option to switch to a rollover study|1097|||
19707485|NCT00095576|42151791|FG001|Overall Study|Option to switch to a rollover study|1099|||
19707486|NCT00095576|42151790|FG000|Overall Study|Site terminated|75|||
19707487|NCT00095576|42151791|FG001|Overall Study|Site terminated|67|||
19707488|NCT00095576|42151790|FG000|Overall Study|Subject moved|30|||
19707489|NCT00095576|42151791|FG001|Overall Study|Subject moved|36|||
19707490|NCT04049578|42151797|FG000|Overall Study|Physician Decision|1|||
19707491|NCT04044352|42151801|FG000|Overall Study|Lost to Follow-up|9|||
19707492|NCT04044352|42151801|FG000|Overall Study|Withdrawal by Subject|2|||
19707493|NCT04043962|42151806|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
19707494|NCT04043962|42151806|FG000|Post-Treatment|Withdrawal by Subject|5|||
19625419|NCT00822120|42074838|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
19625420|NCT00822120|42074839|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
19625421|NCT00822120|42074834|FG000|PET-directed Therapy|Death|0|||
19625422|NCT00822120|42074835|FG001|PET-directed Therapy|Death|0|||
19625423|NCT00822120|42074836|FG002|PET-directed Therapy|Death|0|||
19625424|NCT00822120|42074837|FG003|PET-directed Therapy|Death|2|||
19707495|NCT04043962|42151806|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
19707496|NCT04043728|42151813|FG000|Overall Study|Lost to Follow-up|1|||
19707497|NCT04043728|42151814|FG001|Overall Study|Lost to Follow-up|2|||
19707498|NCT04043728|42151815|FG002|Overall Study|Lost to Follow-up|0|||
19625425|NCT00822120|42074838|FG004|PET-directed Therapy|Death|0|||
19625426|NCT00822120|42074839|FG005|PET-directed Therapy|Death|0|||
19625427|NCT00822120|42074834|FG000|PET-directed Therapy|Protocol Violation|0|||
19625428|NCT00822120|42074835|FG001|PET-directed Therapy|Protocol Violation|0|||
19625429|NCT00822120|42074836|FG002|PET-directed Therapy|Protocol Violation|0|||
19625430|NCT00822120|42074837|FG003|PET-directed Therapy|Protocol Violation|6|||
19625431|NCT00822120|42074838|FG004|PET-directed Therapy|Protocol Violation|0|||
19625432|NCT00822120|42074839|FG005|PET-directed Therapy|Protocol Violation|0|||
19625433|NCT00804687|42074860|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
19625434|NCT00804687|42074861|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
19625435|NCT00804687|42074862|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
19707499|NCT04043416|42151825|FG000|Washout|Change in health condition|0|||
19707500|NCT04043416|42151826|FG001|Washout|Change in health condition|1|||
19707501|NCT00095498|42151838|FG000|Overall Study|Physician Decision|9|||
19707502|NCT00095498|42151839|FG001|Overall Study|Physician Decision|10|||
19707503|NCT00095498|42151840|FG002|Overall Study|Physician Decision|8|||
19707504|NCT00095498|42151838|FG000|Overall Study|Adverse Event|1|||
19707505|NCT00095498|42151839|FG001|Overall Study|Adverse Event|0|||
19707506|NCT00095498|42151840|FG002|Overall Study|Adverse Event|1|||
19707507|NCT00095498|42151838|FG000|Overall Study|Withdrawal by Subject|15|||
19707508|NCT00095498|42151839|FG001|Overall Study|Withdrawal by Subject|16|||
19707509|NCT00095498|42151840|FG002|Overall Study|Withdrawal by Subject|15|||
19707510|NCT00095498|42151838|FG000|Overall Study|Disease progression|0|||
19707511|NCT00095498|42151839|FG001|Overall Study|Disease progression|1|||
19707512|NCT00095498|42151840|FG002|Overall Study|Disease progression|1|||
19707513|NCT00095498|42151838|FG000|Overall Study|Ineligibility determined|3|||
19707514|NCT00095498|42151839|FG001|Overall Study|Ineligibility determined|0|||
19707515|NCT00095498|42151840|FG002|Overall Study|Ineligibility determined|2|||
19707516|NCT00095498|42151838|FG000|Overall Study|Lost to Follow-up|1|||
19707517|NCT00095498|42151839|FG001|Overall Study|Lost to Follow-up|1|||
19707518|NCT00095498|42151840|FG002|Overall Study|Lost to Follow-up|2|||
19707519|NCT00095498|42151838|FG000|Overall Study|Noncompliance|1|||
19707520|NCT00095498|42151839|FG001|Overall Study|Noncompliance|0|||
19707521|NCT00095498|42151840|FG002|Overall Study|Noncompliance|1|||
19707522|NCT00095498|42151838|FG000|Overall Study|Other|6|||
19707523|NCT00095498|42151839|FG001|Overall Study|Other|7|||
19707524|NCT00095498|42151840|FG002|Overall Study|Other|6|||
19707525|NCT00095498|42151838|FG000|Overall Study|Protocol Violation|0|||
19707526|NCT00095498|42151839|FG001|Overall Study|Protocol Violation|0|||
19707527|NCT00095498|42151840|FG002|Overall Study|Protocol Violation|1|||
19707528|NCT00095498|42151838|FG000|Overall Study|Requirement for alternative therapy|1|||
19707529|NCT00095498|42151839|FG001|Overall Study|Requirement for alternative therapy|0|||
19707530|NCT00095498|42151840|FG002|Overall Study|Requirement for alternative therapy|2|||
19707531|NCT04237792|42151854|FG000|Treatment (Day 1)|Adverse Event|1|||
19707532|NCT04237792|42151855|FG001|Treatment (Day 1)|Adverse Event|0|||
19707533|NCT04237792|42151856|FG002|Treatment (Day 1)|Adverse Event|0|||
19707534|NCT04237792|42151857|FG003|Treatment (Day 1)|Adverse Event|0|||
19707535|NCT04237792|42151858|FG004|Treatment (Day 1)|Adverse Event|1|||
19707536|NCT04237792|42151859|FG005|Treatment (Day 1)|Adverse Event|1|||
19707537|NCT04237792|42151854|FG000|Treatment (Day 1)|Other|0|||
19707538|NCT04237792|42151855|FG001|Treatment (Day 1)|Other|0|||
19707539|NCT04237792|42151856|FG002|Treatment (Day 1)|Other|1|||
19707540|NCT04237792|42151857|FG003|Treatment (Day 1)|Other|0|||
19707541|NCT04237792|42151858|FG004|Treatment (Day 1)|Other|0|||
19707542|NCT04237792|42151859|FG005|Treatment (Day 1)|Other|1|||
19707543|NCT04237792|42151854|FG000|Treatment (Day 1)|Not treated|1|||
19707544|NCT04237792|42151855|FG001|Treatment (Day 1)|Not treated|1|||
19707545|NCT04237792|42151856|FG002|Treatment (Day 1)|Not treated|2|||
19707546|NCT04237792|42151857|FG003|Treatment (Day 1)|Not treated|1|||
19707547|NCT04237792|42151858|FG004|Treatment (Day 1)|Not treated|0|||
19707548|NCT04237792|42151859|FG005|Treatment (Day 1)|Not treated|1|||
19707549|NCT04233580|42151890|FG000|Overall Study|Adverse Event|3|||
19707550|NCT04233580|42151891|FG001|Overall Study|Adverse Event|3|||
19707551|NCT04233580|42151890|FG000|Overall Study|Withdrawal by Subject|2|||
19707552|NCT04233580|42151891|FG001|Overall Study|Withdrawal by Subject|1|||
19707553|NCT00122954|42151899|FG000|Overall Study|Withdrawal by Subject|2|||
19707554|NCT00122954|42151900|FG001|Overall Study|Withdrawal by Subject|2|||
19707555|NCT00122954|42151899|FG000|Overall Study|Protocol Violation|0|||
19707556|NCT00122954|42151900|FG001|Overall Study|Protocol Violation|1|||
19707557|NCT04491994|42151908|FG000|Overall Study|Withdrawal by Subject|10|||
19707558|NCT04491994|42151909|FG001|Overall Study|Withdrawal by Subject|5|||
19707559|NCT04491994|42151908|FG000|Overall Study|developed fever > 3 days|4|||
19707560|NCT04491994|42151909|FG001|Overall Study|developed fever > 3 days|1|||
19707561|NCT04491994|42151908|FG000|Overall Study|Protocol Violation|11|||
19707562|NCT04491994|42151909|FG001|Overall Study|Protocol Violation|2|||
19707563|NCT04491994|42151908|FG000|Overall Study|Lost to Follow-up|4|||
19707564|NCT04491994|42151909|FG001|Overall Study|Lost to Follow-up|3|||
19707565|NCT04041700|42151915|FG000|Overall Study|Pregnancy|1|||
19707566|NCT04041700|42151915|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
19707567|NCT04227340|42151921|FG000|Overall Study|Withdrawal by Subject|3|||
19707568|NCT04033432|42151928|FG000|Overall Study|Progressive Disease|8|||
19707569|NCT04033432|42151928|FG000|Overall Study|Adverse Event|4|||
19707570|NCT04033432|42151928|FG000|Overall Study|Death|1|||
19707571|NCT04223830|42151933|FG000|Overall Study|Lost to Follow-up|9|||
19707572|NCT04223830|42151933|FG000|Overall Study|Adverse Event|1|||
19707573|NCT04032652|42151940|FG000|Overall Study|The study was terminated and the PI has|1|||
19707574|NCT04032652|42151941|FG001|Overall Study|The study was terminated and the PI has|1|||
19707575|NCT04031404|42151947|FG000|Baseline|Lost to Follow-up|0|||
19707576|NCT04031404|42151948|FG001|Baseline|Lost to Follow-up|1|||
19707577|NCT04031404|42151947|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
19707578|NCT04031404|42151948|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
19707579|NCT04031404|42151947|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
19707580|NCT04031404|42151948|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
19707581|NCT04031404|42151947|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
19707582|NCT04031404|42151948|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
19707583|NCT04031404|42151947|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
19707584|NCT04031404|42151948|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
19707585|NCT04476784|42151964|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
19707586|NCT04476784|42151965|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
19707587|NCT04026568|42151976|FG000|Overall Study|study terminated|0|||
19707588|NCT04026568|42151977|FG001|Overall Study|study terminated|1|||
19707589|NCT04025632|42151985|FG000|Overall Study|Adverse Event|1|||
19707590|NCT04025632|42151986|FG001|Overall Study|Adverse Event|1|||
19707591|NCT04025632|42151985|FG000|Overall Study|Withdrawal by Subject|1|||
19707592|NCT04025632|42151986|FG001|Overall Study|Withdrawal by Subject|1|||
19707593|NCT04025632|42151985|FG000|Overall Study|Study Terminated by Sponsor|10|||
19707594|NCT04025632|42151986|FG001|Overall Study|Study Terminated by Sponsor|9|||
19707595|NCT04025632|42151985|FG000|Overall Study|Physician Decision|3|||
19707596|NCT04025632|42151986|FG001|Overall Study|Physician Decision|1|||
19707597|NCT04024228|42151997|FG000|Overall Study|Adverse Event|1|||
19707598|NCT04024228|42151998|FG001|Overall Study|Adverse Event|0|||
19707599|NCT04024228|42151997|FG000|Overall Study|Protocol Deviation|0|||
19707600|NCT04024228|42151998|FG001|Overall Study|Protocol Deviation|2|||
19707601|NCT04024228|42151997|FG000|Overall Study|Withdrawal by Subject|3|||
19707602|NCT04024228|42151998|FG001|Overall Study|Withdrawal by Subject|4|||
19707603|NCT04023994|42152012|FG000|Overall Study|Lost to Follow-up|0|||
19707604|NCT04023994|42152013|FG001|Overall Study|Lost to Follow-up|1|||
19707605|NCT04023994|42152014|FG002|Overall Study|Lost to Follow-up|2|||
19707606|NCT04023994|42152015|FG003|Overall Study|Lost to Follow-up|0|||
19707607|NCT04023994|42152016|FG004|Overall Study|Lost to Follow-up|0|||
19707608|NCT04023994|42152017|FG005|Overall Study|Lost to Follow-up|0|||
19707609|NCT04023994|42152012|FG000|Overall Study|Withdrawal by Subject|0|||
19625436|NCT00804687|42074863|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
19625437|NCT00804687|42074864|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
19625438|NCT00804687|42074865|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
19625439|NCT00804687|42074860|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
19625440|NCT00804687|42074861|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
19625441|NCT00804687|42074862|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
19625442|NCT00804687|42074863|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
19625443|NCT00804687|42074864|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
19625444|NCT00804687|42074865|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
19625445|NCT00804687|42074860|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
19625446|NCT00804687|42074861|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
19625447|NCT00804687|42074862|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
19625448|NCT00804687|42074863|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
19625449|NCT00804687|42074864|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
19625450|NCT00804687|42074865|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
19625451|NCT00804687|42074860|FG000|Period 5: Treatment Period|Positive drug test|1|||
19625452|NCT00804687|42074861|FG001|Period 5: Treatment Period|Positive drug test|0|||
19625453|NCT00804687|42074862|FG002|Period 5: Treatment Period|Positive drug test|0|||
19625454|NCT00804687|42074863|FG003|Period 5: Treatment Period|Positive drug test|0|||
19707610|NCT04023994|42152013|FG001|Overall Study|Withdrawal by Subject|0|||
19707611|NCT04023994|42152014|FG002|Overall Study|Withdrawal by Subject|0|||
19707612|NCT04023994|42152015|FG003|Overall Study|Withdrawal by Subject|1|||
19707613|NCT04023994|42152016|FG004|Overall Study|Withdrawal by Subject|0|||
19707614|NCT04023994|42152017|FG005|Overall Study|Withdrawal by Subject|0|||
19707615|NCT04023682|42152036|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
19707616|NCT04018612|42152047|FG000|Overall Study|Withdrawal by Subject|1|||
19707617|NCT04018612|42152048|FG001|Overall Study|Withdrawal by Subject|0|||
19707618|NCT04018612|42152049|FG002|Overall Study|Withdrawal by Subject|1|||
19707619|NCT04018066|42152057|FG000|Overall Study|participants started taking medications during the study period|3|||
19707620|NCT04018066|42152057|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
19707621|NCT04209400|42152064|FG000|Overall Study|Withdrawal by Subject|0|||
19707622|NCT04209400|42152065|FG001|Overall Study|Withdrawal by Subject|1|||
19707623|NCT04207840|42152071|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
19707624|NCT04207840|42152072|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
19707625|NCT04207840|42152073|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
19707626|NCT04207840|42152071|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
19707627|NCT04207840|42152072|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
19707628|NCT04207840|42152073|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
19707629|NCT04006366|42152081|FG000|Overall Study|Withdrawal by Subject|1|||
19707630|NCT04191148|42152087|FG000|Overall Study|Withdrawal by Subject|1|||
19707631|NCT04191148|42152088|FG001|Overall Study|Withdrawal by Subject|0|||
19707632|NCT04191148|42152087|FG000|Overall Study|Adverse Event|1|||
19707633|NCT04191148|42152088|FG001|Overall Study|Adverse Event|0|||
19707634|NCT04004260|42152098|FG000|Overall Study|Withdrawal by Subject|7|||
19707635|NCT04004260|42152099|FG001|Overall Study|Withdrawal by Subject|3|||
19394268|NCT02710669|41638402|FG002|Overall Study|arrived in afib/aflutter|2|||
19625455|NCT00804687|42074864|FG004|Period 5: Treatment Period|Positive drug test|0|||
19625456|NCT00804687|42074865|FG005|Period 5: Treatment Period|Positive drug test|0|||
19625457|NCT00678652|42074877|FG000|Overall Study|Protocol Violation|2|||
19625458|NCT00678652|42074878|FG001|Overall Study|Protocol Violation|0|||
19625459|NCT00678652|42074879|FG002|Overall Study|Protocol Violation|0|||
19625460|NCT00678652|42074880|FG003|Overall Study|Protocol Violation|0|||
19625461|NCT00678652|42074877|FG000|Overall Study|Pregnancy|0|||
19625462|NCT00678652|42074878|FG001|Overall Study|Pregnancy|0|||
19625463|NCT00678652|42074879|FG002|Overall Study|Pregnancy|1|||
19625464|NCT00678652|42074880|FG003|Overall Study|Pregnancy|0|||
19707636|NCT04004260|42152098|FG000|Overall Study|Lost to Follow-up|22|||
19707637|NCT04004260|42152099|FG001|Overall Study|Lost to Follow-up|12|||
19707638|NCT04004260|42152098|FG000|Overall Study|Did not engage in intervention|13|||
19707639|NCT04004260|42152099|FG001|Overall Study|Did not engage in intervention|17|||
19625465|NCT00678652|42074877|FG000|Overall Study|Relocation|1|||
19625466|NCT00678652|42074878|FG001|Overall Study|Relocation|0|||
19625467|NCT00678652|42074879|FG002|Overall Study|Relocation|0|||
19625468|NCT00678652|42074880|FG003|Overall Study|Relocation|0|||
19625469|NCT00840060|42074901|FG000|Overall Study|Withdrawal by Subject|1|||
19625470|NCT00840060|42074902|FG001|Overall Study|Withdrawal by Subject|0|||
19625471|NCT00840060|42074901|FG000|Overall Study|Change in emotional/behavioral status|0|||
19625472|NCT00840060|42074902|FG001|Overall Study|Change in emotional/behavioral status|1|||
19625473|NCT00574912|42074908|FG000|Overall Study|Could not place IV lines.|3|||
19625474|NCT00574912|42074908|FG000|Overall Study|scheduling conflicts|3|||
19707640|NCT04470622|42152107|FG000|Overall Study|Withdrawal by Subject|0|||
19707641|NCT04470622|42152108|FG001|Overall Study|Withdrawal by Subject|1|||
19707642|NCT04470622|42152107|FG000|Overall Study|Screen Failure|0|||
19707643|NCT04470622|42152108|FG001|Overall Study|Screen Failure|1|||
19707644|NCT04470622|42152107|FG000|Overall Study|Death|0|||
19707645|NCT04470622|42152108|FG001|Overall Study|Death|1|||
19625475|NCT00574912|42074908|FG000|Overall Study|Physician Decision|2|||
19625476|NCT00674128|42074922|FG000|Overall Study|Withdrawal by Subject|25|||
19625477|NCT00674128|42074923|FG001|Overall Study|Withdrawal by Subject|23|||
19625478|NCT00804141|42074929|FG000|Overall Study|Adverse Event|157|||
19625479|NCT00804141|42074929|FG000|Overall Study|Death|4|||
19625480|NCT00804141|42074929|FG000|Overall Study|Failed to return|96|||
19707646|NCT04465630|42152114|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
19707647|NCT04465630|42152114|FG000|Overall Study|Screen failure|8|||
19707648|NCT04465630|42152114|FG000|Overall Study|Baseline failure|16|||
19707649|NCT04182880|42152121|FG000|Overall Study|Pregnancy|1|||
19707650|NCT04182880|42152122|FG001|Overall Study|Pregnancy|0|||
19707651|NCT04465396|42152132|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
19707652|NCT04465396|42152133|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
19625481|NCT00804141|42074929|FG000|Overall Study|Investigator request|8|||
19625482|NCT00804141|42074929|FG000|Overall Study|Protocol Violation|85|||
19625483|NCT00804141|42074929|FG000|Overall Study|Withdrawal by Subject|131|||
19625484|NCT00804141|42074929|FG000|Overall Study|Lack of Efficacy|46|||
19625485|NCT00804141|42074929|FG000|Overall Study|Other than specified|30|||
19625486|NCT00804141|42074929|FG000|Overall Study|Enrolled but not treated|6|||
19625487|NCT00677092|42074933|FG000|Overall Study|Adverse Event|1|||
19625488|NCT00677092|42074933|FG000|Overall Study|Lost to Follow-up|1|||
19625489|NCT00677092|42074933|FG000|Overall Study|Withdrawal by Subject|3|||
19625490|NCT00677092|42074933|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
19625491|NCT00677014|42074941|FG000|Overall Study|Lost to Follow-up|20|||
19625492|NCT00677014|42074942|FG001|Overall Study|Lost to Follow-up|12|||
19625493|NCT00677014|42074943|FG002|Overall Study|Lost to Follow-up|24|||
19625494|NCT00677014|42074941|FG000|Overall Study|Death|6|||
19625495|NCT00677014|42074942|FG001|Overall Study|Death|15|||
19707653|NCT04465396|42152134|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
19707654|NCT04465396|42152135|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
19707655|NCT03999892|42152160|FG000|Overall Study|Lost to Follow-up|1|||
19625496|NCT00677014|42074943|FG002|Overall Study|Death|7|||
19625497|NCT00677014|42074941|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
19625498|NCT00677014|42074942|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
19625499|NCT00677014|42074943|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
19625500|NCT00839436|42074954|FG000|Overall Study|Developed exclusionary condition|1|||
19625501|NCT00839436|42074955|FG001|Overall Study|Developed exclusionary condition|0|||
19625502|NCT00839436|42074956|FG002|Overall Study|Developed exclusionary condition|0|||
19625503|NCT00839436|42074954|FG000|Overall Study|Withdrawal by Subject|0|||
19625504|NCT00839436|42074955|FG001|Overall Study|Withdrawal by Subject|1|||
19625505|NCT00839436|42074956|FG002|Overall Study|Withdrawal by Subject|0|||
19625506|NCT00839436|42074954|FG000|Overall Study|Study drug no longer available|0|||
19625507|NCT00839436|42074955|FG001|Overall Study|Study drug no longer available|0|||
19625508|NCT00839436|42074956|FG002|Overall Study|Study drug no longer available|1|||
19625509|NCT00675766|42074977|FG000|Overall Study|Lost to Follow-up|6|||
19625510|NCT00675766|42074978|FG001|Overall Study|Lost to Follow-up|5|||
19625511|NCT00675766|42074979|FG002|Overall Study|Lost to Follow-up|21|||
19625512|NCT00675766|42074980|FG003|Overall Study|Lost to Follow-up|26|||
19625513|NCT00673894|42074992|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
19625514|NCT00673894|42074993|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
19625515|NCT00673894|42074992|FG000|First Intervention 4 Weeks|Adverse Event|1|||
19625516|NCT00673894|42074993|FG001|First Intervention 4 Weeks|Adverse Event|0|||
19625517|NCT00674986|42075001|FG000|Overall Study|Adverse Event|2|||
19707656|NCT03996694|42152164|FG000|First Washout (7 Days)|positive urine drug screen|0|||
19707657|NCT03996694|42152165|FG001|First Washout (7 Days)|positive urine drug screen|0|||
19707658|NCT03996694|42152166|FG002|First Washout (7 Days)|positive urine drug screen|1|||
19707659|NCT03996694|42152167|FG003|First Washout (7 Days)|positive urine drug screen|0|||
19707660|NCT03996694|42152168|FG004|First Washout (7 Days)|positive urine drug screen|0|||
19707661|NCT03996694|42152169|FG005|First Washout (7 Days)|positive urine drug screen|0|||
19707662|NCT03996694|42152164|FG000|First Washout (7 Days)|Adverse Event|0|||
19707663|NCT03996694|42152165|FG001|First Washout (7 Days)|Adverse Event|1|||
19707664|NCT03996694|42152166|FG002|First Washout (7 Days)|Adverse Event|0|||
19625518|NCT00674986|42075002|FG001|Overall Study|Adverse Event|1|||
19625519|NCT00674986|42075001|FG000|Overall Study|Subject withdrew consent|12|||
19625520|NCT00674986|42075002|FG001|Overall Study|Subject withdrew consent|19|||
19625521|NCT00674986|42075001|FG000|Overall Study|Lost to Follow-up|25|||
19625522|NCT00674986|42075002|FG001|Overall Study|Lost to Follow-up|53|||
19625523|NCT00674986|42075001|FG000|Overall Study|Other reasons|4|||
19625524|NCT00674986|42075002|FG001|Overall Study|Other reasons|8|||
19394269|NCT02610725|41638410|FG000|Overall Study|Lost to Follow-up|197|||
19625525|NCT00673816|42075009|FG000|Overall Study|Adverse Event|1|||
19625526|NCT00673816|42075009|FG000|Overall Study|Withdrawal by Subject|1|||
19625527|NCT00673660|42075014|FG000|Overall Study|Lost to Follow-up|107|||
19625528|NCT00672958|42075025|FG000|Overall Study|Adverse Event|11|||
19707665|NCT03996694|42152167|FG003|First Washout (7 Days)|Adverse Event|0|||
19707666|NCT03996694|42152168|FG004|First Washout (7 Days)|Adverse Event|0|||
19707667|NCT03996694|42152169|FG005|First Washout (7 Days)|Adverse Event|0|||
19707668|NCT03996694|42152164|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
19707669|NCT03996694|42152165|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
19707670|NCT03996694|42152166|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
19707671|NCT03996694|42152167|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
19707672|NCT03996694|42152168|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
19707673|NCT03996694|42152169|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
19625529|NCT00672958|42075026|FG001|Overall Study|Adverse Event|9|||
19625530|NCT00672958|42075025|FG000|Overall Study|Lack of Efficacy|6|||
19625531|NCT00672958|42075026|FG001|Overall Study|Lack of Efficacy|11|||
19625532|NCT00672958|42075025|FG000|Overall Study|Non-compliance with study drug|2|||
19625533|NCT00672958|42075026|FG001|Overall Study|Non-compliance with study drug|3|||
19625534|NCT00672958|42075025|FG000|Overall Study|Protocol deviations|11|||
19625535|NCT00672958|42075026|FG001|Overall Study|Protocol deviations|5|||
19625536|NCT00672958|42075025|FG000|Overall Study|Voluntary withdrawal|12|||
19625537|NCT00672958|42075026|FG001|Overall Study|Voluntary withdrawal|8|||
19625538|NCT00672958|42075025|FG000|Overall Study|Lost to Follow-up|22|||
19625539|NCT00672958|42075026|FG001|Overall Study|Lost to Follow-up|17|||
19625540|NCT00672958|42075025|FG000|Overall Study|Reason not specified|0|||
19625541|NCT00672958|42075026|FG001|Overall Study|Reason not specified|3|||
19625542|NCT00672646|42075035|FG000|Overall Study|Lost to Follow-up|0|||
19707674|NCT03996694|42152164|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
19625543|NCT00672646|42075036|FG001|Overall Study|Lost to Follow-up|1|||
19625544|NCT00672646|42075037|FG002|Overall Study|Lost to Follow-up|2|||
19625545|NCT00672646|42075035|FG000|Overall Study|Withdrawal by Subject|0|||
19625546|NCT00672646|42075036|FG001|Overall Study|Withdrawal by Subject|0|||
19625547|NCT00672646|42075037|FG002|Overall Study|Withdrawal by Subject|1|||
19625548|NCT00672490|42075047|FG000|Overall Study|Withdrawal by Subject|8|||
19625549|NCT00672490|42075048|FG001|Overall Study|Withdrawal by Subject|8|||
19625550|NCT00672490|42075047|FG000|Overall Study|Lack of Compliance|2|||
19625551|NCT00672490|42075048|FG001|Overall Study|Lack of Compliance|7|||
19625552|NCT00672490|42075047|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
19625553|NCT00672490|42075048|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
19625554|NCT00672490|42075047|FG000|Overall Study|Adverse Event|5|||
19625555|NCT00672490|42075048|FG001|Overall Study|Adverse Event|8|||
19625556|NCT00672490|42075047|FG000|Overall Study|Violation of Concomitant Medicine|1|||
19625557|NCT00672490|42075048|FG001|Overall Study|Violation of Concomitant Medicine|0|||
19625558|NCT00672490|42075047|FG000|Overall Study|Intolerance|0|||
19625559|NCT00672490|42075048|FG001|Overall Study|Intolerance|2|||
19625560|NCT00672490|42075047|FG000|Overall Study|Lost to Follow-up|1|||
19625561|NCT00672490|42075048|FG001|Overall Study|Lost to Follow-up|5|||
19625562|NCT00672490|42075047|FG000|Overall Study|No reason was provided|6|||
19625563|NCT00672490|42075048|FG001|Overall Study|No reason was provided|2|||
19625564|NCT00670930|42075056|FG000|Overall Study|Adminstrative Problem|0|||
19625565|NCT00670930|42075057|FG001|Overall Study|Adminstrative Problem|1|||
19625566|NCT00670930|42075056|FG000|Overall Study|Lost to Follow-up|1|||
19625567|NCT00670930|42075057|FG001|Overall Study|Lost to Follow-up|0|||
19625568|NCT00670540|42075063|FG000|Overall Study|ineligible|17|||
19625569|NCT00670540|42075063|FG000|Overall Study|not living in France|348|||
19625570|NCT00670540|42075063|FG000|Overall Study|refused to participate|189|||
19625571|NCT00670540|42075063|FG000|Overall Study|controls randomised for no follow up|2770|||
19625572|NCT00670540|42075063|FG000|Overall Study|missing information inclusion criteria|1|||
19625573|NCT00591786|42075077|FG000|Overall Study|Withdrawal of Informed Consent|0|||
19625574|NCT00591786|42075078|FG001|Overall Study|Withdrawal of Informed Consent|0|||
19625575|NCT00591786|42075079|FG002|Overall Study|Withdrawal of Informed Consent|1|||
19625576|NCT00591786|42075080|FG003|Overall Study|Withdrawal of Informed Consent|0|||
19625577|NCT00591786|42075081|FG004|Overall Study|Withdrawal of Informed Consent|0|||
19625578|NCT00591786|42075082|FG005|Overall Study|Withdrawal of Informed Consent|0|||
19625579|NCT00591786|42075083|FG006|Overall Study|Withdrawal of Informed Consent|0|||
19625580|NCT00591786|42075084|FG007|Overall Study|Withdrawal of Informed Consent|0|||
19625581|NCT00591786|42075085|FG008|Overall Study|Withdrawal of Informed Consent|0|||
19625582|NCT00591786|42075086|FG009|Overall Study|Withdrawal of Informed Consent|0|||
19625583|NCT00674362|42075110|FG000|Double Blind|Adverse Event|6|||
19625584|NCT00674362|42075111|FG001|Double Blind|Adverse Event|6|||
19625585|NCT00674362|42075110|FG000|Double Blind|Lack of Efficacy|2|||
19625586|NCT00674362|42075111|FG001|Double Blind|Lack of Efficacy|6|||
19625587|NCT00674362|42075110|FG000|Double Blind|Loss of efficacy|0|||
19625588|NCT00674362|42075111|FG001|Double Blind|Loss of efficacy|1|||
19625589|NCT00674362|42075110|FG000|Double Blind|Withdrawal by Subject|4|||
19625590|NCT00674362|42075111|FG001|Double Blind|Withdrawal by Subject|3|||
19625591|NCT00674362|42075110|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
19625592|NCT00674362|42075111|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
19625593|NCT00674362|42075110|FG000|Double Blind|Other: Surgery|0|||
19625594|NCT00674362|42075111|FG001|Double Blind|Other: Surgery|1|||
19625595|NCT00674362|42075110|FG000|Open Label|Adverse Event|1|||
19625596|NCT00674362|42075111|FG001|Open Label|Adverse Event|0|||
19625597|NCT00674362|42075110|FG000|Open Label|Other: Subject moved to extension study|1|||
19625598|NCT00674362|42075111|FG001|Open Label|Other: Subject moved to extension study|0|||
19707675|NCT03996694|42152165|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
19707676|NCT03996694|42152166|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
19707677|NCT03996694|42152167|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
19707678|NCT03996694|42152168|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
19707679|NCT03996694|42152169|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
19707680|NCT04179838|42152185|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
19707681|NCT04179838|42152186|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
19707682|NCT04179838|42152185|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
19707683|NCT04179838|42152186|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
19707684|NCT03994120|42152194|FG000|Overall Study|Lost to Follow-up|3|||
19625599|NCT00820950|42075123|FG000|Overall Study|Scheduling Conflict|0|||
19625600|NCT00820950|42075124|FG001|Overall Study|Scheduling Conflict|0|||
19625601|NCT00820950|42075125|FG002|Overall Study|Scheduling Conflict|0|||
19625602|NCT00820950|42075126|FG003|Overall Study|Scheduling Conflict|0|||
19625603|NCT00820950|42075127|FG004|Overall Study|Scheduling Conflict|0|||
19625604|NCT00820950|42075128|FG005|Overall Study|Scheduling Conflict|0|||
19625605|NCT00820950|42075129|FG006|Overall Study|Scheduling Conflict|1|||
19625606|NCT00820950|42075130|FG007|Overall Study|Scheduling Conflict|1|||
19625607|NCT00820950|42075131|FG008|Overall Study|Scheduling Conflict|0|||
19707685|NCT03994120|42152195|FG001|Overall Study|Lost to Follow-up|1|||
19625608|NCT00820950|42075132|FG009|Overall Study|Scheduling Conflict|0|||
19625609|NCT00820950|42075123|FG000|Overall Study|Protocol Violation|1|||
19625610|NCT00820950|42075124|FG001|Overall Study|Protocol Violation|1|||
19625611|NCT00820950|42075125|FG002|Overall Study|Protocol Violation|0|||
19625612|NCT00820950|42075126|FG003|Overall Study|Protocol Violation|0|||
19625613|NCT00820950|42075127|FG004|Overall Study|Protocol Violation|0|||
19625614|NCT00820950|42075128|FG005|Overall Study|Protocol Violation|0|||
19625615|NCT00820950|42075129|FG006|Overall Study|Protocol Violation|0|||
19625616|NCT00820950|42075130|FG007|Overall Study|Protocol Violation|0|||
19625617|NCT00820950|42075131|FG008|Overall Study|Protocol Violation|0|||
19625618|NCT00820950|42075132|FG009|Overall Study|Protocol Violation|0|||
19625619|NCT00670306|42075172|FG000|Overall Study|Adverse Event|8|||
19625620|NCT00670306|42075172|FG000|Overall Study|Lack of Efficacy|10|||
19707686|NCT04178590|42152201|FG000|Overall Study|Pregnancy|1|||
19707687|NCT04178590|42152201|FG000|Overall Study|Lost to Follow-up|1|||
19625621|NCT00670306|42075172|FG000|Overall Study|Withdrawal by Subject|9|||
19707688|NCT04175392|42152229|FG000|Overall Study|Withdrawal by Subject|3|||
19625622|NCT00670306|42075172|FG000|Overall Study|Physician Decision|1|||
19625623|NCT00670306|42075172|FG000|Overall Study|Lost to Follow-up|8|||
19707689|NCT04175392|42152230|FG001|Overall Study|Withdrawal by Subject|2|||
19707690|NCT03986866|42152238|FG000|Overall Study|Withdrawal by Subject|0|||
19707691|NCT03986866|42152239|FG001|Overall Study|Withdrawal by Subject|3|||
19707692|NCT03986866|42152238|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
19707693|NCT03986866|42152239|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
19707694|NCT03980938|42152247|FG000|Treatment Period 1|Study Terminated|1|||
19707695|NCT03980938|42152248|FG001|Treatment Period 1|Study Terminated|1|||
19707696|NCT03980938|42152247|FG000|Treatment Period 2|Study Terminated|2|||
19625624|NCT00670306|42075172|FG000|Overall Study|incl/excl criterias did not meet|19|||
19707697|NCT03980938|42152248|FG001|Treatment Period 2|Study Terminated|2|||
19707698|NCT03656692|42152254|FG000|Overall Study|Worsening of disease activity|2|||
19707699|NCT03656692|42152254|FG000|Overall Study|Physician Decision|1|||
19707700|NCT04439266|42152258|FG000|Overall Study|Ineligible|1|||
19625625|NCT00672256|42075176|FG000|Overall Study|PI dropped, bad data|44|||
19625626|NCT00591630|42075184|FG000|Overall Study|Death|0|||
19625627|NCT00591630|42075185|FG001|Overall Study|Death|0|||
19625628|NCT00591630|42075186|FG002|Overall Study|Death|1|||
19625629|NCT00591630|42075187|FG003|Overall Study|Death|0|||
19625630|NCT00670228|42075199|FG000|Overall Study|Adverse Event|1|||
19625631|NCT00670228|42075200|FG001|Overall Study|Adverse Event|0|||
19625632|NCT00670228|42075199|FG000|Overall Study|Death or MACE|0|||
19625633|NCT00670228|42075200|FG001|Overall Study|Death or MACE|1|||
19625634|NCT00670228|42075199|FG000|Overall Study|Not treated|2|||
19625635|NCT00670228|42075200|FG001|Overall Study|Not treated|2|||
19625636|NCT00670228|42075199|FG000|Overall Study|Not meeting the selection criteria|2|||
19625637|NCT00670228|42075200|FG001|Overall Study|Not meeting the selection criteria|0|||
19625638|NCT00570778|42075206|FG000|Overall Study|Protocol deviation|2|||
19625639|NCT00570778|42075207|FG001|Overall Study|Protocol deviation|1|||
19625640|NCT00570778|42075208|FG002|Overall Study|Protocol deviation|2|||
19625641|NCT00570778|42075209|FG003|Overall Study|Protocol deviation|2|||
19625642|NCT00570778|42075206|FG000|Overall Study|Adverse Event|0|||
19625643|NCT00570778|42075207|FG001|Overall Study|Adverse Event|1|||
19625644|NCT00570778|42075208|FG002|Overall Study|Adverse Event|4|||
19625645|NCT00570778|42075209|FG003|Overall Study|Adverse Event|1|||
19625646|NCT00570778|42075206|FG000|Overall Study|Subject withdrew consent|0|||
19625647|NCT00570778|42075207|FG001|Overall Study|Subject withdrew consent|1|||
19625648|NCT00570778|42075208|FG002|Overall Study|Subject withdrew consent|0|||
19625649|NCT00570778|42075209|FG003|Overall Study|Subject withdrew consent|1|||
19625650|NCT00570778|42075206|FG000|Overall Study|Abnormal test procedure|1|||
19625651|NCT00570778|42075207|FG001|Overall Study|Abnormal test procedure|0|||
19625652|NCT00570778|42075208|FG002|Overall Study|Abnormal test procedure|0|||
19625653|NCT00570778|42075209|FG003|Overall Study|Abnormal test procedure|0|||
19625654|NCT00570778|42075206|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19625655|NCT00570778|42075207|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19625656|NCT00570778|42075208|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
19625657|NCT00570778|42075209|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
19625658|NCT00570778|42075206|FG000|Overall Study|Lost to Follow-up|0|||
19625659|NCT00570778|42075207|FG001|Overall Study|Lost to Follow-up|0|||
19707701|NCT04439266|42152258|FG000|Overall Study|Adverse Event|1|||
19707702|NCT04439266|42152258|FG000|Overall Study|Death|1|||
19707703|NCT04439266|42152258|FG000|Overall Study|Disease progression|1|||
19707704|NCT04439266|42152258|FG000|Overall Study|Still on treatment|1|||
19707705|NCT03682120|42152266|FG000|Overall Study|Lost to Follow-up|11|||
19707706|NCT03682120|42152267|FG001|Overall Study|Lost to Follow-up|4|||
19707707|NCT03682120|42152268|FG002|Overall Study|Lost to Follow-up|5|||
19625660|NCT00570778|42075208|FG002|Overall Study|Lost to Follow-up|1|||
19625661|NCT00570778|42075209|FG003|Overall Study|Lost to Follow-up|0|||
19707708|NCT03682120|42152269|FG003|Overall Study|Lost to Follow-up|2|||
19707709|NCT03682120|42152266|FG000|Overall Study|Physician Decision|1|||
19707710|NCT03682120|42152267|FG001|Overall Study|Physician Decision|0|||
19707711|NCT03682120|42152268|FG002|Overall Study|Physician Decision|0|||
19625662|NCT00570778|42075206|FG000|Overall Study|Subject no longer requires study drug|0|||
19625663|NCT00570778|42075207|FG001|Overall Study|Subject no longer requires study drug|1|||
19625664|NCT00570778|42075208|FG002|Overall Study|Subject no longer requires study drug|0|||
19625665|NCT00570778|42075209|FG003|Overall Study|Subject no longer requires study drug|0|||
19625666|NCT00668746|42075221|FG000|Overall Study|Lost to Follow-up|2|||
19625667|NCT00668746|42075222|FG001|Overall Study|Lost to Follow-up|1|||
19625668|NCT00878189|42075240|FG000|Overall Study|Death|0|||
19625669|NCT00878189|42075241|FG001|Overall Study|Death|1|||
19625670|NCT00878189|42075242|FG002|Overall Study|Death|0|||
19625671|NCT00878189|42075243|FG003|Overall Study|Death|1|||
19625672|NCT00878189|42075244|FG004|Overall Study|Death|0|||
19625673|NCT00878189|42075245|FG005|Overall Study|Death|0|||
19625674|NCT00878189|42075246|FG006|Overall Study|Death|0|||
19625675|NCT00878189|42075247|FG007|Overall Study|Death|0|||
19625676|NCT00878189|42075248|FG008|Overall Study|Death|1|||
19625677|NCT00878189|42075240|FG000|Overall Study|Participant Refused to Follow-up|0|||
19625678|NCT00878189|42075241|FG001|Overall Study|Participant Refused to Follow-up|0|||
19625679|NCT00878189|42075242|FG002|Overall Study|Participant Refused to Follow-up|0|||
19625680|NCT00878189|42075243|FG003|Overall Study|Participant Refused to Follow-up|0|||
19625681|NCT00878189|42075244|FG004|Overall Study|Participant Refused to Follow-up|0|||
19625682|NCT00878189|42075245|FG005|Overall Study|Participant Refused to Follow-up|4|||
19625683|NCT00878189|42075246|FG006|Overall Study|Participant Refused to Follow-up|0|||
19625684|NCT00878189|42075247|FG007|Overall Study|Participant Refused to Follow-up|0|||
19625685|NCT00878189|42075248|FG008|Overall Study|Participant Refused to Follow-up|0|||
19625686|NCT00878189|42075240|FG000|Overall Study|Other|3|||
19625687|NCT00878189|42075241|FG001|Overall Study|Other|2|||
19625688|NCT00878189|42075242|FG002|Overall Study|Other|4|||
19625689|NCT00878189|42075243|FG003|Overall Study|Other|7|||
19625690|NCT00878189|42075244|FG004|Overall Study|Other|4|||
19625691|NCT00878189|42075245|FG005|Overall Study|Other|18|||
19625692|NCT00878189|42075246|FG006|Overall Study|Other|15|||
19625693|NCT00878189|42075247|FG007|Overall Study|Other|3|||
19625694|NCT00878189|42075248|FG008|Overall Study|Other|4|||
19625695|NCT00878189|42075240|FG000|Overall Study|Lost to Follow-up|0|||
19625696|NCT00878189|42075241|FG001|Overall Study|Lost to Follow-up|0|||
19625697|NCT00878189|42075242|FG002|Overall Study|Lost to Follow-up|0|||
19625698|NCT00878189|42075243|FG003|Overall Study|Lost to Follow-up|0|||
19625699|NCT00878189|42075244|FG004|Overall Study|Lost to Follow-up|0|||
19625700|NCT00878189|42075245|FG005|Overall Study|Lost to Follow-up|1|||
19625701|NCT00878189|42075246|FG006|Overall Study|Lost to Follow-up|1|||
19625702|NCT00878189|42075247|FG007|Overall Study|Lost to Follow-up|0|||
19625703|NCT00878189|42075248|FG008|Overall Study|Lost to Follow-up|0|||
19625704|NCT00878189|42075240|FG000|Overall Study|Objection Progression or Relapse|0|||
19625705|NCT00878189|42075241|FG001|Overall Study|Objection Progression or Relapse|0|||
19625706|NCT00878189|42075242|FG002|Overall Study|Objection Progression or Relapse|0|||
19625707|NCT00878189|42075243|FG003|Overall Study|Objection Progression or Relapse|0|||
19625708|NCT00878189|42075244|FG004|Overall Study|Objection Progression or Relapse|0|||
19625709|NCT00878189|42075245|FG005|Overall Study|Objection Progression or Relapse|0|||
19625710|NCT00878189|42075246|FG006|Overall Study|Objection Progression or Relapse|0|||
19625711|NCT00878189|42075247|FG007|Overall Study|Objection Progression or Relapse|0|||
19625712|NCT00878189|42075248|FG008|Overall Study|Objection Progression or Relapse|3|||
19625713|NCT00668200|42075282|FG000|Overall Study|Withdrawal by Subject|2|||
19625714|NCT00668200|42075282|FG000|Overall Study|Lost to Follow-up|1|||
19625715|NCT00838578|42075286|FG000|Overall Study|Protocol Violation|2|||
19625716|NCT00829296|42075296|FG000|Overall Study|Adverse Event|5|||
19625717|NCT00829296|42075297|FG001|Overall Study|Adverse Event|4|||
19625718|NCT00881621|42075303|FG000|Overall Study|Physician Decision|34|||
19625719|NCT00818766|42075309|FG000|Overall Study|Could not be Contacted on Day 28|11|||
19625720|NCT00818766|42075310|FG001|Overall Study|Could not be Contacted on Day 28|10|||
19625721|NCT00818766|42075309|FG000|Overall Study|Death|1|||
19625722|NCT00818766|42075310|FG001|Overall Study|Death|0|||
19625723|NCT00818766|42075309|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
19707712|NCT03682120|42152269|FG003|Overall Study|Physician Decision|0|||
19707713|NCT03682120|42152266|FG000|Overall Study|Withdrawal by Subject|1|||
19707714|NCT03682120|42152267|FG001|Overall Study|Withdrawal by Subject|2|||
19707715|NCT03682120|42152268|FG002|Overall Study|Withdrawal by Subject|3|||
19707716|NCT03682120|42152269|FG003|Overall Study|Withdrawal by Subject|0|||
19707717|NCT03682120|42152266|FG000|Overall Study|Death|0|||
19707718|NCT03682120|42152267|FG001|Overall Study|Death|1|||
19707719|NCT03682120|42152268|FG002|Overall Study|Death|0|||
19625724|NCT00818766|42075310|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
19625725|NCT00667888|42075318|FG000|Overall Study|Death|1|||
19625726|NCT00667888|42075319|FG001|Overall Study|Death|1|||
19625727|NCT00667888|42075318|FG000|Overall Study|Withdrawal by Subject|6|||
19625728|NCT00667888|42075319|FG001|Overall Study|Withdrawal by Subject|3|||
19625729|NCT00667888|42075318|FG000|Overall Study|Proceed with other treatment|3|||
19625730|NCT00667888|42075319|FG001|Overall Study|Proceed with other treatment|3|||
19625731|NCT00667888|42075318|FG000|Overall Study|Ineligible after SIM|0|||
19625732|NCT00667888|42075319|FG001|Overall Study|Ineligible after SIM|2|||
19625733|NCT00594815|42075325|FG000|Overall Study|Never Treated|3|||
19625734|NCT00594815|42075325|FG000|Overall Study|Withdrawal by Subject|2|||
19625735|NCT00594815|42075325|FG000|Overall Study|Toxicity|4|||
19707720|NCT03682120|42152269|FG003|Overall Study|Death|0|||
19625736|NCT00820248|42075331|FG000|Overall Study|No treated|4|||
19625737|NCT00820248|42075332|FG001|Overall Study|No treated|1|||
19625738|NCT00820170|42075343|FG000|Overall Study|Adverse Event|0|||
19625739|NCT00820170|42075344|FG001|Overall Study|Adverse Event|0|||
19625740|NCT00820170|42075345|FG002|Overall Study|Adverse Event|0|||
19625741|NCT00820170|42075346|FG003|Overall Study|Adverse Event|0|||
19625742|NCT00820170|42075347|FG004|Overall Study|Adverse Event|2|||
19625743|NCT00820170|42075343|FG000|Overall Study|Progressive Disease|0|||
19625744|NCT00820170|42075344|FG001|Overall Study|Progressive Disease|0|||
19625745|NCT00820170|42075345|FG002|Overall Study|Progressive Disease|0|||
19625746|NCT00820170|42075346|FG003|Overall Study|Progressive Disease|0|||
19625747|NCT00820170|42075347|FG004|Overall Study|Progressive Disease|2|||
19625748|NCT00818454|42075364|FG000|Treatment Period 1|Adverse Event|0|||
19625749|NCT00818454|42075365|FG001|Treatment Period 1|Adverse Event|1|||
19625750|NCT00818454|42075366|FG002|Treatment Period 1|Adverse Event|0|||
19625751|NCT00818454|42075367|FG003|Treatment Period 1|Adverse Event|0|||
19625752|NCT00818454|42075364|FG000|Treatment Period 1|Other|3|||
19625753|NCT00818454|42075365|FG001|Treatment Period 1|Other|0|||
19625754|NCT00818454|42075366|FG002|Treatment Period 1|Other|0|||
19625755|NCT00818454|42075367|FG003|Treatment Period 1|Other|0|||
19625756|NCT00818454|42075364|FG000|Washout Period of 1 Week|Adverse Event|1|||
19625757|NCT00818454|42075365|FG001|Washout Period of 1 Week|Adverse Event|1|||
19707721|NCT03682120|42152266|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
19707722|NCT03682120|42152267|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
19707723|NCT03682120|42152268|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
19707724|NCT03682120|42152269|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
19707725|NCT04428502|42152281|FG000|Overall Study|Did not meet entrance criteria|14|||
19707726|NCT04428424|42152286|FG000|Overall Study|Does not meet entrance criteria|132|||
19707727|NCT04428424|42152286|FG000|Overall Study|Lost to Follow-up|115|||
19707728|NCT03655756|42152290|FG000|Overall Study|Death|1|||
19707729|NCT00095238|42152296|FG000|Overall Study|Lack of Efficacy|9|||
19707730|NCT00095238|42152297|FG001|Overall Study|Lack of Efficacy|9|||
19707731|NCT00095238|42152296|FG000|Overall Study|Adverse Event|331|||
19707732|NCT00095238|42152297|FG001|Overall Study|Adverse Event|287|||
19707733|NCT00095238|42152296|FG000|Overall Study|Subject Withdrew Consent|208|||
19707734|NCT00095238|42152297|FG001|Overall Study|Subject Withdrew Consent|223|||
19707735|NCT00095238|42152296|FG000|Overall Study|Death|154|||
19707736|NCT00095238|42152297|FG001|Overall Study|Death|170|||
19707737|NCT00095238|42152296|FG000|Overall Study|Lost to Follow-up|19|||
19707738|NCT00095238|42152297|FG001|Overall Study|Lost to Follow-up|24|||
19707739|NCT00095238|42152296|FG000|Overall Study|Noncompliance|44|||
19707740|NCT00095238|42152297|FG001|Overall Study|Noncompliance|45|||
19707741|NCT00095238|42152296|FG000|Overall Study|No longer met study criteria|4|||
19394270|NCT02610725|41638410|FG000|Overall Study|self-reported contraindication|9|||
19625758|NCT00818454|42075366|FG002|Washout Period of 1 Week|Adverse Event|0|||
19625759|NCT00818454|42075367|FG003|Washout Period of 1 Week|Adverse Event|0|||
19625760|NCT00818454|42075364|FG000|Washout Period of 1 Week|Protocol Violation|2|||
19625761|NCT00818454|42075365|FG001|Washout Period of 1 Week|Protocol Violation|0|||
19625762|NCT00818454|42075366|FG002|Washout Period of 1 Week|Protocol Violation|0|||
19625763|NCT00818454|42075367|FG003|Washout Period of 1 Week|Protocol Violation|0|||
19625764|NCT00818454|42075364|FG000|Washout Period of 1 Week|Other|1|||
19707742|NCT00095238|42152297|FG001|Overall Study|No longer met study criteria|5|||
19707743|NCT00095238|42152296|FG000|Overall Study|Study terminated by sponsor|0|||
19625765|NCT00818454|42075365|FG001|Washout Period of 1 Week|Other|2|||
19625766|NCT00818454|42075366|FG002|Washout Period of 1 Week|Other|0|||
19625767|NCT00818454|42075367|FG003|Washout Period of 1 Week|Other|0|||
19625768|NCT00818454|42075364|FG000|Treatment Period 2|Other|2|||
19625769|NCT00818454|42075365|FG001|Treatment Period 2|Other|1|||
19625770|NCT00818454|42075366|FG002|Treatment Period 2|Other|0|||
19625771|NCT00818454|42075367|FG003|Treatment Period 2|Other|0|||
19625772|NCT00818454|42075364|FG000|Treatment Period 3|Adverse Event|0|||
19625773|NCT00818454|42075365|FG001|Treatment Period 3|Adverse Event|0|||
19625774|NCT00818454|42075366|FG002|Treatment Period 3|Adverse Event|0|||
19625775|NCT00818454|42075367|FG003|Treatment Period 3|Adverse Event|1|||
19625776|NCT00828984|42075380|FG000|Overall Study|Adverse Event|2|||
19625777|NCT00828984|42075381|FG001|Overall Study|Adverse Event|3|||
19625778|NCT00828984|42075382|FG002|Overall Study|Adverse Event|0|||
19625779|NCT00828984|42075380|FG000|Overall Study|Lost to Follow-up|5|||
19625780|NCT00828984|42075381|FG001|Overall Study|Lost to Follow-up|3|||
19625781|NCT00828984|42075382|FG002|Overall Study|Lost to Follow-up|1|||
19625782|NCT00828984|42075380|FG000|Overall Study|Withdrawal by Subject|4|||
19625783|NCT00828984|42075381|FG001|Overall Study|Withdrawal by Subject|4|||
19625784|NCT00828984|42075382|FG002|Overall Study|Withdrawal by Subject|4|||
19625785|NCT00828984|42075380|FG000|Overall Study|Ineligable|1|||
19625786|NCT00828984|42075381|FG001|Overall Study|Ineligable|2|||
19625787|NCT00828984|42075382|FG002|Overall Study|Ineligable|0|||
19625788|NCT00828984|42075380|FG000|Overall Study|Medical Contraindication|0|||
19625789|NCT00828984|42075381|FG001|Overall Study|Medical Contraindication|1|||
19625790|NCT00828984|42075382|FG002|Overall Study|Medical Contraindication|0|||
19625791|NCT00828984|42075380|FG000|Overall Study|Noncompliant|1|||
19625792|NCT00828984|42075381|FG001|Overall Study|Noncompliant|2|||
19625793|NCT00828984|42075382|FG002|Overall Study|Noncompliant|3|||
19625794|NCT00828984|42075380|FG000|Overall Study|ConMed|1|||
19625795|NCT00828984|42075381|FG001|Overall Study|ConMed|1|||
19625796|NCT00828984|42075382|FG002|Overall Study|ConMed|1|||
19625797|NCT00828750|42075390|FG000|Overall Study|Lack of Efficacy|3|||
19625798|NCT00828750|42075390|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
19625799|NCT00667810|42075399|FG000|Overall Study|Adverse Event|13|||
19625800|NCT00667810|42075400|FG001|Overall Study|Adverse Event|14|||
19625801|NCT00667810|42075401|FG002|Overall Study|Adverse Event|19|||
19625802|NCT00667810|42075402|FG003|Overall Study|Adverse Event|1|||
19625803|NCT00667810|42075399|FG000|Overall Study|Death|1|||
19625804|NCT00667810|42075400|FG001|Overall Study|Death|1|||
19625805|NCT00667810|42075401|FG002|Overall Study|Death|3|||
19625806|NCT00667810|42075402|FG003|Overall Study|Death|0|||
19625807|NCT00667810|42075399|FG000|Overall Study|Lack of Efficacy|1|||
19625808|NCT00667810|42075400|FG001|Overall Study|Lack of Efficacy|0|||
19625809|NCT00667810|42075401|FG002|Overall Study|Lack of Efficacy|2|||
19625810|NCT00667810|42075402|FG003|Overall Study|Lack of Efficacy|0|||
19625811|NCT00667810|42075399|FG000|Overall Study|Lost to Follow-up|1|||
19625812|NCT00667810|42075400|FG001|Overall Study|Lost to Follow-up|4|||
19625813|NCT00667810|42075401|FG002|Overall Study|Lost to Follow-up|2|||
19625814|NCT00667810|42075402|FG003|Overall Study|Lost to Follow-up|0|||
19625815|NCT00667810|42075399|FG000|Overall Study|Physician Decision|1|||
19625816|NCT00667810|42075400|FG001|Overall Study|Physician Decision|1|||
19625817|NCT00667810|42075401|FG002|Overall Study|Physician Decision|2|||
19625818|NCT00667810|42075402|FG003|Overall Study|Physician Decision|0|||
19625819|NCT00667810|42075399|FG000|Overall Study|Protocol Violation|0|||
19625820|NCT00667810|42075400|FG001|Overall Study|Protocol Violation|2|||
19625821|NCT00667810|42075401|FG002|Overall Study|Protocol Violation|0|||
19625822|NCT00667810|42075402|FG003|Overall Study|Protocol Violation|0|||
19625823|NCT00667810|42075399|FG000|Overall Study|Withdrawal by Subject|14|||
19625824|NCT00667810|42075400|FG001|Overall Study|Withdrawal by Subject|20|||
19625825|NCT00667810|42075401|FG002|Overall Study|Withdrawal by Subject|29|||
19625826|NCT00667810|42075402|FG003|Overall Study|Withdrawal by Subject|1|||
19625827|NCT00667810|42075399|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
19625828|NCT00667810|42075400|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
19625829|NCT00667810|42075401|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
19625830|NCT00667810|42075402|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
19625831|NCT00667810|42075399|FG000|Overall Study|Failed to Return|0|||
19625832|NCT00667810|42075400|FG001|Overall Study|Failed to Return|0|||
19625833|NCT00667810|42075401|FG002|Overall Study|Failed to Return|2|||
19625834|NCT00667810|42075402|FG003|Overall Study|Failed to Return|0|||
19625835|NCT00667810|42075399|FG000|Overall Study|Loss of Caregiver|0|||
19625836|NCT00667810|42075400|FG001|Overall Study|Loss of Caregiver|1|||
19625837|NCT00667810|42075401|FG002|Overall Study|Loss of Caregiver|3|||
19625838|NCT00667810|42075402|FG003|Overall Study|Loss of Caregiver|0|||
19625839|NCT00667810|42075399|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
19625840|NCT00667810|42075400|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
19625841|NCT00667810|42075401|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
19625842|NCT00667810|42075402|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
19625843|NCT00667810|42075399|FG000|Overall Study|Other|6|||
19625844|NCT00667810|42075400|FG001|Overall Study|Other|6|||
19625845|NCT00667810|42075401|FG002|Overall Study|Other|5|||
19625846|NCT00667810|42075402|FG003|Overall Study|Other|0|||
19625847|NCT00819390|42075421|FG000|Overall Study|Lost to Follow-up|1|||
19625848|NCT00819390|42075422|FG001|Overall Study|Lost to Follow-up|1|||
19625849|NCT00819390|42075423|FG002|Overall Study|Lost to Follow-up|0|||
19625850|NCT00819390|42075424|FG003|Overall Study|Lost to Follow-up|0|||
19625851|NCT00819390|42075421|FG000|Overall Study|Withdrawal by Subject|2|||
19625852|NCT00819390|42075422|FG001|Overall Study|Withdrawal by Subject|0|||
19625853|NCT00819390|42075423|FG002|Overall Study|Withdrawal by Subject|0|||
19373777|NCT02332720|41615015|FG001|Part A and Part B|Lost to Follow-up|0|||
19707744|NCT00095238|42152297|FG001|Overall Study|Study terminated by sponsor|1|||
19707745|NCT00095238|42152296|FG000|Overall Study|Missing|1|||
19707746|NCT00095238|42152297|FG001|Overall Study|Missing|0|||
19707747|NCT00095238|42152296|FG000|Overall Study|Other Reasons|87|||
19707748|NCT00095238|42152297|FG001|Overall Study|Other Reasons|88|||
19707749|NCT00082368|42152335|FG000|Overall Study|Not treated-pt had poor IV access|1|||
19707750|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
19707751|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
19707752|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
19707753|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
19707754|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
19707755|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
19707756|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
19707757|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
19707758|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
19707759|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
19707760|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
19707761|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
19707762|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
19707763|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
19707764|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
19707765|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
19707766|NCT00094770|42152341|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
19707767|NCT00094770|42152342|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
19707768|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
19707769|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
19707770|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
19707771|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
19707772|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
19707773|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
19707774|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
19707775|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
19707776|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
19707777|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
19707778|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
19707779|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
19707780|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
19707781|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
19373778|NCT02332720|41615016|FG002|Part A and Part B|Lost to Follow-up|0|||
19373779|NCT02332720|41615017|FG003|Part A and Part B|Lost to Follow-up|0|||
19625854|NCT00819390|42075424|FG003|Overall Study|Withdrawal by Subject|0|||
19625855|NCT00819390|42075421|FG000|Overall Study|Adverse Event|0|||
19625856|NCT00819390|42075422|FG001|Overall Study|Adverse Event|0|||
19625857|NCT00819390|42075423|FG002|Overall Study|Adverse Event|1|||
19625858|NCT00819390|42075424|FG003|Overall Study|Adverse Event|0|||
19625859|NCT00876395|42075439|FG000|Overall Study|Untreated|8|||
19373780|NCT02332720|41615018|FG004|Part A and Part B|Lost to Follow-up|0|||
19373781|NCT02332720|41615019|FG005|Part A and Part B|Lost to Follow-up|2|||
19373782|NCT02332720|41615020|FG006|Part A and Part B|Lost to Follow-up|1|||
19373783|NCT02332720|41615021|FG007|Part A and Part B|Lost to Follow-up|1|||
19373784|NCT02332720|41615022|FG008|Part A and Part B|Lost to Follow-up|0|||
19373785|NCT02332720|41615023|FG009|Part A and Part B|Lost to Follow-up|0|||
19373786|NCT02332720|41615024|FG010|Part A and Part B|Lost to Follow-up|0|||
19373787|NCT02332720|41615025|FG011|Part A and Part B|Lost to Follow-up|0|||
19373788|NCT02332720|41615026|FG012|Part A and Part B|Lost to Follow-up|0|||
19373789|NCT02332720|41615027|FG013|Part A and Part B|Lost to Follow-up|0|||
19373790|NCT02332720|41615028|FG014|Part A and Part B|Lost to Follow-up|0|||
19373791|NCT02332720|41615029|FG015|Part A and Part B|Lost to Follow-up|1|||
19373792|NCT02332720|41615030|FG016|Part A and Part B|Lost to Follow-up|0|||
19373793|NCT02332720|41615031|FG017|Part A and Part B|Lost to Follow-up|0|||
19373794|NCT02332720|41615032|FG018|Part A and Part B|Lost to Follow-up|0|||
19373795|NCT02332720|41615033|FG019|Part A and Part B|Lost to Follow-up|0|||
19373796|NCT02332720|41615034|FG020|Part A and Part B|Lost to Follow-up|0|||
19373797|NCT02332720|41615035|FG021|Part A and Part B|Lost to Follow-up|0|||
19625860|NCT00876395|42075440|FG001|Overall Study|Untreated|1|||
19625861|NCT00876395|42075439|FG000|Overall Study|Adverse Event|63|||
19625862|NCT00876395|42075440|FG001|Overall Study|Adverse Event|11|||
19625863|NCT00876395|42075439|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19625864|NCT00876395|42075440|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19625865|NCT00876395|42075439|FG000|Overall Study|Disease progression|259|||
19625866|NCT00876395|42075440|FG001|Overall Study|Disease progression|162|||
19707782|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
19707783|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
19707784|NCT00094770|42152341|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
19707785|NCT00094770|42152342|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
19707786|NCT00069576|42152350|FG000|Original Trial|Lost to Follow-up|25|||
19707787|NCT00069576|42152351|FG001|Original Trial|Lost to Follow-up|33|||
19707788|NCT00069576|42152350|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
19707789|NCT00069576|42152351|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
19707790|NCT00069264|42152357|FG000|Overall Study|Adverse Event|3|||
19707791|NCT00069264|42152357|FG000|Overall Study|Progressive Disease|23|||
19707792|NCT00069264|42152357|FG000|Overall Study|Withdrawal by Subject|3|||
19707793|NCT00069264|42152357|FG000|Overall Study|Discon Therapy|3|||
19625867|NCT00876395|42075439|FG000|Overall Study|New cancer therapy|25|||
19625868|NCT00876395|42075440|FG001|Overall Study|New cancer therapy|7|||
19625869|NCT00876395|42075439|FG000|Overall Study|Protocol Violation|5|||
19625870|NCT00876395|42075440|FG001|Overall Study|Protocol Violation|2|||
19625871|NCT00876395|42075439|FG000|Overall Study|Withdrawal by Subject|66|||
19625872|NCT00876395|42075440|FG001|Overall Study|Withdrawal by Subject|33|||
19625873|NCT00876395|42075439|FG000|Overall Study|Lost to Follow-up|2|||
19625874|NCT00876395|42075440|FG001|Overall Study|Lost to Follow-up|0|||
19625875|NCT00876395|42075439|FG000|Overall Study|Administrative problems|39|||
19625876|NCT00876395|42075440|FG001|Overall Study|Administrative problems|23|||
19625877|NCT00876395|42075439|FG000|Overall Study|Death|12|||
19625878|NCT00876395|42075440|FG001|Overall Study|Death|0|||
19625879|NCT00594659|42075454|FG000|Overall Study|Lost to Follow-up|13|||
19625880|NCT00594659|42075455|FG001|Overall Study|Lost to Follow-up|9|||
19625881|NCT00594659|42075456|FG002|Overall Study|Lost to Follow-up|7|||
19625882|NCT00667732|42075466|FG000|Run -In (8 Weeks)|Adverse Event|4|||
19625883|NCT00667732|42075467|FG001|Run -In (8 Weeks)|Adverse Event|0|||
19625884|NCT00667732|42075468|FG002|Run -In (8 Weeks)|Adverse Event|0|||
19625885|NCT00667732|42075466|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
19625886|NCT00667732|42075467|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
19625887|NCT00667732|42075468|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
19625888|NCT00667732|42075466|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
19625889|NCT00667732|42075467|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
19625890|NCT00667732|42075468|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
19625891|NCT00671788|42075478|FG000|Overall Study|Adverse Event|8|||
19625892|NCT00671788|42075478|FG000|Overall Study|Refused further treatment|3|||
19625893|NCT00671788|42075478|FG000|Overall Study|Ineligible|1|||
19625894|NCT00671788|42075478|FG000|Overall Study|MD Decision|1|||
19625895|NCT00671788|42075478|FG000|Overall Study|Other|1|||
19625896|NCT00875615|42075482|FG000|Overall Study|Withdrawal by Subject|1|||
19625897|NCT00597701|42075488|FG000|Overall Study|Withdrawal by Subject|5|||
19625898|NCT00597701|42075489|FG001|Overall Study|Withdrawal by Subject|5|||
19625899|NCT00597701|42075488|FG000|Overall Study|Death|0|||
19625900|NCT00597701|42075489|FG001|Overall Study|Death|1|||
19625901|NCT00597701|42075488|FG000|Overall Study|Physician Decision|2|||
19707794|NCT00069108|42152363|FG000|Overall Study|Withdrawal by Subject|5|||
19373798|NCT02332720|41615036|FG022|Part A and Part B|Lost to Follow-up|0|||
19373799|NCT02332720|41615014|FG000|Part A and Part B|Adverse Event|0|||
19373800|NCT02332720|41615015|FG001|Part A and Part B|Adverse Event|0|||
19373801|NCT02332720|41615016|FG002|Part A and Part B|Adverse Event|0|||
19707795|NCT00069108|42152364|FG001|Overall Study|Withdrawal by Subject|9|||
19707796|NCT00069108|42152363|FG000|Overall Study|Adverse Event|64|||
19707797|NCT00069108|42152364|FG001|Overall Study|Adverse Event|42|||
19707798|NCT00069108|42152363|FG000|Overall Study|Death|6|||
19707799|NCT00069108|42152364|FG001|Overall Study|Death|6|||
19707800|NCT00069108|42152363|FG000|Overall Study|Administration|15|||
19707801|NCT00069108|42152364|FG001|Overall Study|Administration|4|||
19625902|NCT00597701|42075489|FG001|Overall Study|Physician Decision|0|||
19625903|NCT00597701|42075488|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
19625904|NCT00597701|42075489|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
19625905|NCT00671554|42075495|FG000|Overall Study|Disease progression|3|||
19625906|NCT00667576|42075505|FG000|Overall Study|Withdrawal by Subject|1|||
19625907|NCT00667576|42075506|FG001|Overall Study|Withdrawal by Subject|0|||
19625908|NCT00667576|42075507|FG002|Overall Study|Withdrawal by Subject|1|||
19625909|NCT00667576|42075508|FG003|Overall Study|Withdrawal by Subject|1|||
19625910|NCT00667576|42075509|FG004|Overall Study|Withdrawal by Subject|1|||
19625911|NCT00667576|42075505|FG000|Overall Study|Adverse Event|1|||
19625912|NCT00667576|42075506|FG001|Overall Study|Adverse Event|1|||
19625913|NCT00667576|42075507|FG002|Overall Study|Adverse Event|0|||
19625914|NCT00667576|42075508|FG003|Overall Study|Adverse Event|0|||
19625915|NCT00667576|42075509|FG004|Overall Study|Adverse Event|0|||
19625916|NCT00667576|42075505|FG000|Overall Study|Lost to Follow-up|0|||
19625917|NCT00667576|42075506|FG001|Overall Study|Lost to Follow-up|0|||
19625918|NCT00667576|42075507|FG002|Overall Study|Lost to Follow-up|1|||
19625919|NCT00667576|42075508|FG003|Overall Study|Lost to Follow-up|0|||
19625920|NCT00667576|42075509|FG004|Overall Study|Lost to Follow-up|0|||
19625921|NCT00667576|42075505|FG000|Overall Study|Protocol Violation|0|||
19625922|NCT00667576|42075506|FG001|Overall Study|Protocol Violation|0|||
19625923|NCT00667576|42075507|FG002|Overall Study|Protocol Violation|0|||
19625924|NCT00667576|42075508|FG003|Overall Study|Protocol Violation|1|||
19625925|NCT00667576|42075509|FG004|Overall Study|Protocol Violation|0|||
19625926|NCT00667576|42075505|FG000|Overall Study|Physician Decision|0|||
19625927|NCT00667576|42075506|FG001|Overall Study|Physician Decision|0|||
19707802|NCT00069108|42152363|FG000|Overall Study|Insufficient therapy|117|||
19707803|NCT00069108|42152364|FG001|Overall Study|Insufficient therapy|144|||
19707804|NCT00069108|42152363|FG000|Overall Study|Violation criteria|1|||
19707805|NCT00069108|42152364|FG001|Overall Study|Violation criteria|4|||
19394271|NCT02684461|41638417|FG000|Overall Study|Adverse Event|1|||
19394272|NCT02684461|41638418|FG001|Overall Study|Adverse Event|0|||
19625928|NCT00667576|42075507|FG002|Overall Study|Physician Decision|0|||
19625929|NCT00667576|42075508|FG003|Overall Study|Physician Decision|1|||
19707806|NCT00069108|42152363|FG000|Overall Study|Refused treatment|5|||
19707807|NCT00069108|42152364|FG001|Overall Study|Refused treatment|10|||
19707808|NCT00094536|42152371|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
19707809|NCT00094536|42152371|FG000|Treatment and Follow-up|Adverse Event|4|||
19625930|NCT00667576|42075509|FG004|Overall Study|Physician Decision|0|||
19625931|NCT00667576|42075505|FG000|Overall Study|Missed Visit|0|||
19625932|NCT00667576|42075506|FG001|Overall Study|Missed Visit|0|||
19707810|NCT00094536|42152371|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
19707811|NCT00094536|42152371|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
19707812|NCT00094536|42152371|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
19707813|NCT00094536|42152371|FG000|Treatment and Follow-up|Subject non-compliance|9|||
19707814|NCT00094536|42152371|FG000|Treatment and Follow-up|Unable to attend visits|1|||
19707815|NCT00405587|42152379|FG000|Overall Study|Death|0|||
19707816|NCT00405587|42152380|FG001|Overall Study|Death|0|||
19707817|NCT00405587|42152381|FG002|Overall Study|Death|0|||
19625933|NCT00667576|42075507|FG002|Overall Study|Missed Visit|0|||
19625934|NCT00667576|42075508|FG003|Overall Study|Missed Visit|1|||
19707818|NCT00405587|42152382|FG003|Overall Study|Death|1|||
19625935|NCT00667576|42075509|FG004|Overall Study|Missed Visit|0|||
19625936|NCT00666718|42075523|FG000|Overall Study|Adverse Event|0|||
19625937|NCT00666718|42075524|FG001|Overall Study|Adverse Event|1|||
19625938|NCT00666718|42075523|FG000|Overall Study|Death|1|||
19625939|NCT00666718|42075524|FG001|Overall Study|Death|0|||
19625940|NCT00666718|42075523|FG000|Overall Study|Lost to Follow-up|1|||
19625941|NCT00666718|42075524|FG001|Overall Study|Lost to Follow-up|0|||
19625942|NCT00666718|42075523|FG000|Overall Study|Entry Criteria Not Met|2|||
19625943|NCT00666718|42075524|FG001|Overall Study|Entry Criteria Not Met|0|||
19625944|NCT00666718|42075523|FG000|Overall Study|Protocol Violation|1|||
19707819|NCT00405587|42152379|FG000|Overall Study|Disease Progression|22|||
19707820|NCT00405587|42152380|FG001|Overall Study|Disease Progression|23|||
19707821|NCT00405587|42152381|FG002|Overall Study|Disease Progression|21|||
19707822|NCT00405587|42152382|FG003|Overall Study|Disease Progression|17|||
19707823|NCT00405587|42152379|FG000|Overall Study|Physician Decision|3|||
19707824|NCT00405587|42152380|FG001|Overall Study|Physician Decision|2|||
19707825|NCT00405587|42152381|FG002|Overall Study|Physician Decision|0|||
19707826|NCT00405587|42152382|FG003|Overall Study|Physician Decision|0|||
19707827|NCT00405587|42152379|FG000|Overall Study|Adverse Event|1|||
19707828|NCT00405587|42152380|FG001|Overall Study|Adverse Event|0|||
19707829|NCT00405587|42152381|FG002|Overall Study|Adverse Event|0|||
19707830|NCT00405587|42152382|FG003|Overall Study|Adverse Event|0|||
19707831|NCT00405587|42152379|FG000|Overall Study|Lost to Follow-up|0|||
19707832|NCT00405587|42152380|FG001|Overall Study|Lost to Follow-up|1|||
19707833|NCT00405587|42152381|FG002|Overall Study|Lost to Follow-up|1|||
19707834|NCT00405587|42152382|FG003|Overall Study|Lost to Follow-up|0|||
19707835|NCT00405587|42152379|FG000|Overall Study|Radiation induced necrosis|0|||
19707836|NCT00405587|42152380|FG001|Overall Study|Radiation induced necrosis|1|||
19707837|NCT00405587|42152381|FG002|Overall Study|Radiation induced necrosis|0|||
19707838|NCT00405587|42152382|FG003|Overall Study|Radiation induced necrosis|0|||
19707839|NCT00405587|42152379|FG000|Overall Study|Withdrawal by Subject|0|||
19707840|NCT00405587|42152380|FG001|Overall Study|Withdrawal by Subject|0|||
19707841|NCT00405587|42152381|FG002|Overall Study|Withdrawal by Subject|0|||
19707842|NCT00405587|42152382|FG003|Overall Study|Withdrawal by Subject|2|||
19707843|NCT00405587|42152379|FG000|Overall Study|Participant not dosed|0|||
19707844|NCT00405587|42152380|FG001|Overall Study|Participant not dosed|1|||
19707845|NCT00405587|42152381|FG002|Overall Study|Participant not dosed|0|||
19707846|NCT00405587|42152382|FG003|Overall Study|Participant not dosed|0|||
19707847|NCT00405275|42152420|FG000|Overall Study|Death|1|||
19707848|NCT00405275|42152421|FG001|Overall Study|Death|0|||
19707849|NCT00405275|42152420|FG000|Overall Study|Lost to Follow-up|5|||
19707850|NCT00405275|42152421|FG001|Overall Study|Lost to Follow-up|1|||
19707851|NCT00405275|42152420|FG000|Overall Study|Withdrawal by Subject|7|||
19707852|NCT00405275|42152421|FG001|Overall Study|Withdrawal by Subject|9|||
19707853|NCT00405275|42152420|FG000|Overall Study|Unwilling to continue|10|||
19707854|NCT00405275|42152421|FG001|Overall Study|Unwilling to continue|9|||
19707855|NCT00404651|42152431|FG000|Overall Study|Serious Adverse Event|0|||
19707856|NCT00404651|42152432|FG001|Overall Study|Serious Adverse Event|0|||
19707857|NCT00404651|42152433|FG002|Overall Study|Serious Adverse Event|2|||
19707858|NCT00404651|42152434|FG003|Overall Study|Serious Adverse Event|0|||
19707859|NCT00404651|42152431|FG000|Overall Study|Protocol Violation|10|||
19707860|NCT00404651|42152432|FG001|Overall Study|Protocol Violation|5|||
19707861|NCT00404651|42152433|FG002|Overall Study|Protocol Violation|14|||
19707862|NCT00404651|42152434|FG003|Overall Study|Protocol Violation|5|||
19707863|NCT00404651|42152431|FG000|Overall Study|Lost to Follow-up|15|||
19707864|NCT00404651|42152432|FG001|Overall Study|Lost to Follow-up|11|||
19707865|NCT00404651|42152433|FG002|Overall Study|Lost to Follow-up|13|||
19707866|NCT00404651|42152434|FG003|Overall Study|Lost to Follow-up|10|||
19707867|NCT00404651|42152431|FG000|Overall Study|Withdrawal by Subject|14|||
19707868|NCT00404651|42152432|FG001|Overall Study|Withdrawal by Subject|12|||
19373802|NCT02332720|41615017|FG003|Part A and Part B|Adverse Event|0|||
19625945|NCT00666718|42075524|FG001|Overall Study|Protocol Violation|3|||
19625946|NCT00666718|42075523|FG000|Overall Study|Withdrawal by Subject|7|||
19625947|NCT00666718|42075524|FG001|Overall Study|Withdrawal by Subject|12|||
19625948|NCT00666718|42075523|FG000|Overall Study|Physician Decision|0|||
19707869|NCT00404651|42152433|FG002|Overall Study|Withdrawal by Subject|16|||
19707870|NCT00404651|42152434|FG003|Overall Study|Withdrawal by Subject|6|||
19625949|NCT00666718|42075524|FG001|Overall Study|Physician Decision|2|||
19625950|NCT00667420|42075530|FG000|Overall Study|Adverse Event|2|||
19625951|NCT00667420|42075530|FG000|Overall Study|Lack of Efficacy|5|||
19625952|NCT00667420|42075530|FG000|Overall Study|Physician Decision|1|||
19625953|NCT00667420|42075530|FG000|Overall Study|Withdrawal by Subject|2|||
19625954|NCT00853658|42075538|FG000|Overall Study|Death|713|||
19625955|NCT00853658|42075539|FG001|Overall Study|Death|768|||
19625956|NCT00853658|42075540|FG002|Overall Study|Death|753|||
19707871|NCT00404495|42152446|FG000|Overall Study|Death|37|||
19625957|NCT00853658|42075538|FG000|Overall Study|Lost to Follow-up|11|||
19625958|NCT00853658|42075539|FG001|Overall Study|Lost to Follow-up|6|||
19625959|NCT00853658|42075540|FG002|Overall Study|Lost to Follow-up|11|||
19625960|NCT00853658|42075538|FG000|Overall Study|H.A. Request|26|||
19707872|NCT00404495|42152447|FG001|Overall Study|Death|11|||
19707873|NCT00404495|42152446|FG000|Overall Study|Lost to Follow-up|5|||
19707874|NCT00404495|42152447|FG001|Overall Study|Lost to Follow-up|0|||
19707875|NCT00404495|42152446|FG000|Overall Study|Other|1|||
19707876|NCT00404495|42152447|FG001|Overall Study|Other|0|||
19707877|NCT00404495|42152446|FG000|Overall Study|Withdrawal by Subject|1|||
19625961|NCT00853658|42075539|FG001|Overall Study|H.A. Request|23|||
19625962|NCT00853658|42075540|FG002|Overall Study|H.A. Request|19|||
19625963|NCT00853658|42075538|FG000|Overall Study|IRB request|0|||
19625964|NCT00853658|42075539|FG001|Overall Study|IRB request|0|||
19625965|NCT00853658|42075540|FG002|Overall Study|IRB request|2|||
19625966|NCT00853658|42075538|FG000|Overall Study|Vital Status known (alive) at study end|2|||
19625967|NCT00853658|42075539|FG001|Overall Study|Vital Status known (alive) at study end|3|||
19625968|NCT00853658|42075540|FG002|Overall Study|Vital Status known (alive) at study end|3|||
19625969|NCT00853658|42075538|FG000|Overall Study|Vital Status unknown at study end|1|||
19625970|NCT00853658|42075539|FG001|Overall Study|Vital Status unknown at study end|1|||
19625971|NCT00853658|42075540|FG002|Overall Study|Vital Status unknown at study end|0|||
19625972|NCT00853658|42075538|FG000|Overall Study|Vital Status at study end N/A|8|||
19625973|NCT00853658|42075539|FG001|Overall Study|Vital Status at study end N/A|10|||
19625974|NCT00853658|42075540|FG002|Overall Study|Vital Status at study end N/A|10|||
19625975|NCT00853658|42075538|FG000|Overall Study|Patient's request|21|||
19625976|NCT00853658|42075539|FG001|Overall Study|Patient's request|17|||
19707878|NCT00404495|42152447|FG001|Overall Study|Withdrawal by Subject|0|||
19707879|NCT00409409|42152455|FG000|Overall Study|Adverse Event|7|||
19707880|NCT00409409|42152456|FG001|Overall Study|Adverse Event|2|||
19707881|NCT00409409|42152455|FG000|Overall Study|Withdrawal by Subject|1|||
19707882|NCT00409409|42152456|FG001|Overall Study|Withdrawal by Subject|1|||
19707883|NCT00409409|42152455|FG000|Overall Study|Any other reason not above-mentioned|0|||
19707884|NCT00409409|42152456|FG001|Overall Study|Any other reason not above-mentioned|1|||
19707885|NCT00409331|42152462|FG000|Overall Study|Physician Decision|1|||
19707886|NCT00409175|42152468|FG000|Overall Study|Adverse Event|4|||
19707887|NCT00409175|42152469|FG001|Overall Study|Adverse Event|3|||
19707888|NCT00409175|42152468|FG000|Overall Study|Withdrawal by Subject|1|||
19707889|NCT00409175|42152469|FG001|Overall Study|Withdrawal by Subject|2|||
19625977|NCT00853658|42075540|FG002|Overall Study|Patient's request|11|||
19625978|NCT00853658|42075538|FG000|Overall Study|Missing study completion information|5|||
19625979|NCT00853658|42075539|FG001|Overall Study|Missing study completion information|4|||
19707890|NCT00409175|42152468|FG000|Overall Study|Negative genotype|0|||
19707891|NCT00409175|42152469|FG001|Overall Study|Negative genotype|1|||
19625980|NCT00853658|42075540|FG002|Overall Study|Missing study completion information|6|||
19625981|NCT00666562|42075551|FG000|Overall Study|Withdrawal by Subject|0|||
19625982|NCT00666562|42075552|FG001|Overall Study|Withdrawal by Subject|1|||
19625983|NCT00666562|42075553|FG002|Overall Study|Withdrawal by Subject|0|||
19625984|NCT00666562|42075551|FG000|Overall Study|Concomitant Medication|0|||
19707892|NCT00409175|42152468|FG000|Overall Study|Liver transplantation|13|||
19707893|NCT00409175|42152469|FG001|Overall Study|Liver transplantation|13|||
19707894|NCT00408629|42152477|FG000|Overall Study|Adverse Event|13|||
19625985|NCT00666562|42075552|FG001|Overall Study|Concomitant Medication|1|||
19625986|NCT00666562|42075553|FG002|Overall Study|Concomitant Medication|0|||
19707895|NCT00408629|42152478|FG001|Overall Study|Adverse Event|27|||
19625987|NCT00666328|42075568|FG000|Overall Study|Death|2|||
19625988|NCT00666328|42075568|FG000|Overall Study|Lost to Follow-up|2|||
19625989|NCT00666328|42075568|FG000|Overall Study|No longer met eligibility criteria|1|||
19625990|NCT00853580|42075576|FG000|Overall Study|Lost to Follow-up|3|||
19625991|NCT00853580|42075577|FG001|Overall Study|Lost to Follow-up|5|||
19707896|NCT00408629|42152477|FG000|Overall Study|Withdrawal by Subject|8|||
19707897|NCT00408629|42152478|FG001|Overall Study|Withdrawal by Subject|4|||
19707898|NCT00408629|42152477|FG000|Overall Study|Lost to Follow-up|1|||
19707899|NCT00408629|42152478|FG001|Overall Study|Lost to Follow-up|1|||
19707900|NCT00408629|42152477|FG000|Overall Study|Lack of Efficacy|63|||
19707901|NCT00408629|42152478|FG001|Overall Study|Lack of Efficacy|73|||
19707902|NCT00408629|42152477|FG000|Overall Study|Protocol Violation|1|||
19707903|NCT00408629|42152478|FG001|Overall Study|Protocol Violation|5|||
19707904|NCT00408629|42152477|FG000|Overall Study|Miscellaneous|11|||
19707905|NCT00408629|42152478|FG001|Overall Study|Miscellaneous|15|||
19707906|NCT00408317|42152485|FG000|First Intervention Period|Adverse Event|0|||
19707907|NCT00408317|42152486|FG001|First Intervention Period|Adverse Event|1|||
19707908|NCT00408317|42152485|FG000|Second Intervention Period|Adverse Event|2|||
19625992|NCT00853580|42075576|FG000|Overall Study|Protocol Violation|2|||
19625993|NCT00853580|42075577|FG001|Overall Study|Protocol Violation|1|||
19707909|NCT00408317|42152486|FG001|Second Intervention Period|Adverse Event|0|||
19707910|NCT00408317|42152485|FG000|Second Intervention Period|Protocol Violation|0|||
19625994|NCT00853580|42075576|FG000|Overall Study|Withdrawal by Subject|2|||
19625995|NCT00853580|42075577|FG001|Overall Study|Withdrawal by Subject|8|||
19625996|NCT00853580|42075576|FG000|Overall Study|Commenced contraindicated therapy|0|||
19625997|NCT00853580|42075577|FG001|Overall Study|Commenced contraindicated therapy|2|||
19625998|NCT00865514|42075583|FG000|Overall Study|Infusion cost exceeded funding|2|||
19625999|NCT00865280|42075590|FG000|Overall Study|Withdrawal by Subject|4|||
19626000|NCT00865280|42075591|FG001|Overall Study|Withdrawal by Subject|1|||
19626001|NCT00865280|42075590|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
19626002|NCT00865280|42075591|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
19626003|NCT00865280|42075590|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
19626004|NCT00865280|42075591|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
19626005|NCT00865280|42075590|FG000|Overall Study|Exclusion Condition|1|||
19626006|NCT00865280|42075591|FG001|Overall Study|Exclusion Condition|0|||
19626007|NCT00865280|42075590|FG000|Overall Study|Adverse Event|0|||
19626008|NCT00865280|42075591|FG001|Overall Study|Adverse Event|1|||
19626009|NCT00865124|42075600|FG000|Overall Study|Physician Decision|2|||
19626010|NCT00865124|42075601|FG001|Overall Study|Physician Decision|1|||
19626011|NCT00865124|42075602|FG002|Overall Study|Physician Decision|0|||
19626012|NCT00865124|42075600|FG000|Overall Study|Withdrawn consent|2|||
19626013|NCT00865124|42075601|FG001|Overall Study|Withdrawn consent|0|||
19707911|NCT00408317|42152486|FG001|Second Intervention Period|Protocol Violation|1|||
19707912|NCT00408317|42152485|FG000|Second Intervention Period|Withdrawal of consent|0|||
19707913|NCT00408317|42152486|FG001|Second Intervention Period|Withdrawal of consent|1|||
19707914|NCT00112502|42152500|FG000|Overall Study|Withdrawal by Subject|0|||
19707915|NCT00112502|42152501|FG001|Overall Study|Withdrawal by Subject|1|||
19707916|NCT00112502|42152502|FG002|Overall Study|Withdrawal by Subject|1|||
19707917|NCT00112502|42152503|FG003|Overall Study|Withdrawal by Subject|4|||
19707918|NCT00112502|42152504|FG004|Overall Study|Withdrawal by Subject|2|||
19707919|NCT00112502|42152505|FG005|Overall Study|Withdrawal by Subject|5|||
19707920|NCT00112502|42152506|FG006|Overall Study|Withdrawal by Subject|3|||
19707921|NCT00112502|42152507|FG007|Overall Study|Withdrawal by Subject|7|||
19707922|NCT03822182|42152538|FG000|Overall Study|Protocol Violation|0|||
19707923|NCT03822182|42152539|FG001|Overall Study|Protocol Violation|1|||
19707924|NCT03822182|42152540|FG002|Overall Study|Protocol Violation|1|||
19707925|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
19707926|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
19707927|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
19707928|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
19707929|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
19707930|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
19707931|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
19707932|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
19707933|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
19707934|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
19707935|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
19707936|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
19707937|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
19707938|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
19707939|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
19707940|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
19707941|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
19707942|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
19707943|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
19707944|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
19707945|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
19373803|NCT02332720|41615018|FG004|Part A and Part B|Adverse Event|0|||
19707946|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
19626014|NCT00865124|42075602|FG002|Overall Study|Withdrawn consent|0|||
19626015|NCT00871715|42075613|FG000|Overall Study|Withdrawal by Subject|6|||
19626016|NCT00871715|42075614|FG001|Overall Study|Withdrawal by Subject|10|||
19626017|NCT00871715|42075615|FG002|Overall Study|Withdrawal by Subject|15|||
19626018|NCT00871715|42075613|FG000|Overall Study|Physician Decision|6|||
19626019|NCT00871715|42075614|FG001|Overall Study|Physician Decision|0|||
19626020|NCT00871715|42075615|FG002|Overall Study|Physician Decision|2|||
19626021|NCT00871715|42075613|FG000|Overall Study|Lost to Follow-up|3|||
19626022|NCT00871715|42075614|FG001|Overall Study|Lost to Follow-up|6|||
19626023|NCT00871715|42075615|FG002|Overall Study|Lost to Follow-up|9|||
19626024|NCT00819234|42075624|FG000|Overall Study|Withdrawal by Subject|8|||
19626025|NCT00819234|42075625|FG001|Overall Study|Withdrawal by Subject|13|||
19626026|NCT00819234|42075626|FG002|Overall Study|Withdrawal by Subject|6|||
19626027|NCT00819234|42075627|FG003|Overall Study|Withdrawal by Subject|3|||
19626028|NCT00819234|42075628|FG004|Overall Study|Withdrawal by Subject|0|||
19626029|NCT00819234|42075629|FG005|Overall Study|Withdrawal by Subject|4|||
19626030|NCT00819234|42075630|FG006|Overall Study|Withdrawal by Subject|4|||
19626031|NCT00819234|42075631|FG007|Overall Study|Withdrawal by Subject|8|||
19626032|NCT00819234|42075632|FG008|Overall Study|Withdrawal by Subject|5|||
19626033|NCT00819234|42075633|FG009|Overall Study|Withdrawal by Subject|3|||
19626034|NCT00819234|42075624|FG000|Overall Study|Adverse Event|0|||
19626035|NCT00819234|42075625|FG001|Overall Study|Adverse Event|0|||
19626036|NCT00819234|42075626|FG002|Overall Study|Adverse Event|1|||
19626037|NCT00819234|42075627|FG003|Overall Study|Adverse Event|0|||
19626038|NCT00819234|42075628|FG004|Overall Study|Adverse Event|0|||
19626039|NCT00819234|42075629|FG005|Overall Study|Adverse Event|2|||
19626040|NCT00819234|42075630|FG006|Overall Study|Adverse Event|0|||
19626041|NCT00819234|42075631|FG007|Overall Study|Adverse Event|0|||
19626042|NCT00819234|42075632|FG008|Overall Study|Adverse Event|0|||
19626043|NCT00819234|42075633|FG009|Overall Study|Adverse Event|0|||
19626044|NCT00819234|42075624|FG000|Overall Study|Physician Decision|0|||
19626045|NCT00819234|42075625|FG001|Overall Study|Physician Decision|0|||
19626046|NCT00819234|42075626|FG002|Overall Study|Physician Decision|0|||
19626047|NCT00819234|42075627|FG003|Overall Study|Physician Decision|1|||
19626048|NCT00819234|42075628|FG004|Overall Study|Physician Decision|0|||
19626049|NCT00819234|42075629|FG005|Overall Study|Physician Decision|0|||
19626050|NCT00819234|42075630|FG006|Overall Study|Physician Decision|0|||
19626051|NCT00819234|42075631|FG007|Overall Study|Physician Decision|0|||
19626052|NCT00819234|42075632|FG008|Overall Study|Physician Decision|0|||
19626053|NCT00819234|42075633|FG009|Overall Study|Physician Decision|2|||
19626054|NCT00819234|42075624|FG000|Overall Study|Protocol Violation|0|||
19626055|NCT00819234|42075625|FG001|Overall Study|Protocol Violation|0|||
19626056|NCT00819234|42075626|FG002|Overall Study|Protocol Violation|1|||
19626057|NCT00819234|42075627|FG003|Overall Study|Protocol Violation|0|||
19626058|NCT00819234|42075628|FG004|Overall Study|Protocol Violation|0|||
19626059|NCT00819234|42075629|FG005|Overall Study|Protocol Violation|0|||
19626060|NCT00819234|42075630|FG006|Overall Study|Protocol Violation|0|||
19626061|NCT00819234|42075631|FG007|Overall Study|Protocol Violation|0|||
19626062|NCT00819234|42075632|FG008|Overall Study|Protocol Violation|0|||
19626063|NCT00819234|42075633|FG009|Overall Study|Protocol Violation|0|||
19626064|NCT00819234|42075624|FG000|Overall Study|Lost to Follow-up|2|||
19626065|NCT00819234|42075625|FG001|Overall Study|Lost to Follow-up|2|||
19626066|NCT00819234|42075626|FG002|Overall Study|Lost to Follow-up|0|||
19626067|NCT00819234|42075627|FG003|Overall Study|Lost to Follow-up|2|||
19626068|NCT00819234|42075628|FG004|Overall Study|Lost to Follow-up|1|||
19626069|NCT00819234|42075629|FG005|Overall Study|Lost to Follow-up|1|||
19626070|NCT00819234|42075630|FG006|Overall Study|Lost to Follow-up|1|||
19626071|NCT00819234|42075631|FG007|Overall Study|Lost to Follow-up|1|||
19626072|NCT00819234|42075632|FG008|Overall Study|Lost to Follow-up|1|||
19626073|NCT00819234|42075633|FG009|Overall Study|Lost to Follow-up|2|||
19626074|NCT00667342|42075691|FG000|Overall Study|Protocol Violation|1|||
19626075|NCT00667342|42075692|FG001|Overall Study|Protocol Violation|0|||
19626076|NCT00667342|42075693|FG002|Overall Study|Protocol Violation|0|||
19626077|NCT00667342|42075691|FG000|Overall Study|Withdrawal by Subject|1|||
19626078|NCT00667342|42075692|FG001|Overall Study|Withdrawal by Subject|0|||
19626079|NCT00667342|42075693|FG002|Overall Study|Withdrawal by Subject|0|||
19626080|NCT00667342|42075691|FG000|Overall Study|Physician Decision|3|||
19626081|NCT00667342|42075692|FG001|Overall Study|Physician Decision|0|||
19626082|NCT00667342|42075693|FG002|Overall Study|Physician Decision|0|||
19626083|NCT00667342|42075691|FG000|Overall Study|Relapse or tumor progression|9|||
19626084|NCT00667342|42075692|FG001|Overall Study|Relapse or tumor progression|0|||
19626085|NCT00667342|42075693|FG002|Overall Study|Relapse or tumor progression|7|||
19626086|NCT00667342|42075691|FG000|Overall Study|Adverse Event|0|||
19626087|NCT00667342|42075692|FG001|Overall Study|Adverse Event|0|||
19626088|NCT00667342|42075693|FG002|Overall Study|Adverse Event|1|||
19626089|NCT00667342|42075691|FG000|Overall Study|Ineligible|0|||
19626090|NCT00667342|42075692|FG001|Overall Study|Ineligible|0|||
19626091|NCT00667342|42075693|FG002|Overall Study|Ineligible|1|||
19626092|NCT00871403|42075710|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
19626093|NCT00871403|42075711|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
19626094|NCT00871403|42075712|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
19626095|NCT00871403|42075710|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
19626096|NCT00871403|42075711|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
19626097|NCT00871403|42075712|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
19626098|NCT00871403|42075710|FG000|Combination Treatment Phase|Adverse Event|0|||
19707947|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
19707948|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
19707949|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
19707950|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
19707951|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
19626099|NCT00871403|42075711|FG001|Combination Treatment Phase|Adverse Event|17|||
19626100|NCT00871403|42075712|FG002|Combination Treatment Phase|Adverse Event|2|||
19626101|NCT00871403|42075710|FG000|Combination Treatment Phase|Disease Progression|0|||
19626102|NCT00871403|42075711|FG001|Combination Treatment Phase|Disease Progression|8|||
19626103|NCT00871403|42075712|FG002|Combination Treatment Phase|Disease Progression|5|||
19626104|NCT00871403|42075710|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
19626105|NCT00871403|42075711|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
19626106|NCT00871403|42075712|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
19626107|NCT00871403|42075710|FG000|Combination Treatment Phase|Physician Decision|0|||
19626108|NCT00871403|42075711|FG001|Combination Treatment Phase|Physician Decision|1|||
19626109|NCT00871403|42075712|FG002|Combination Treatment Phase|Physician Decision|3|||
19626110|NCT00871403|42075710|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
19626111|NCT00871403|42075711|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
19626112|NCT00871403|42075712|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
19626113|NCT00871403|42075710|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
19626114|NCT00871403|42075711|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
19626115|NCT00871403|42075712|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
19626116|NCT00853112|42075726|FG000|Overall Study|Randomized but not treated|0|||
19626117|NCT00853112|42075727|FG001|Overall Study|Randomized but not treated|1|||
19626118|NCT00853112|42075728|FG002|Overall Study|Randomized but not treated|0|||
19626119|NCT00853112|42075729|FG003|Overall Study|Randomized but not treated|2|||
19626120|NCT00853112|42075730|FG004|Overall Study|Randomized but not treated|0|||
19626121|NCT00853112|42075731|FG005|Overall Study|Randomized but not treated|0|||
19626122|NCT00853112|42075732|FG006|Overall Study|Randomized but not treated|1|||
19626123|NCT00460603|42075760|FG000|Phase 1|Death|1|||
19626124|NCT00460603|42075761|FG001|Phase 1|Death|0|||
19626125|NCT00460603|42075762|FG002|Phase 1|Death|0|||
19626126|NCT00460603|42075763|FG003|Phase 1|Death|2|||
19626127|NCT00460603|42075764|FG004|Phase 1|Death|0|||
19707952|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
19707953|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
19707954|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
19707955|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19707956|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
19707957|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
19707958|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
19707959|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19707960|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
19707961|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
19707962|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
19707963|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
19626128|NCT00460603|42075765|FG005|Phase 1|Death|0|||
19626129|NCT00460603|42075766|FG006|Phase 1|Death|0|||
19707964|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
19707965|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
19707966|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
19707967|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
19707968|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
19707969|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
19707970|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
19626130|NCT00460603|42075767|FG007|Phase 1|Death|0|||
19626131|NCT00460603|42075768|FG008|Phase 1|Death|1|||
19626132|NCT00460603|42075769|FG009|Phase 1|Death|0|||
19626133|NCT00460603|42075770|FG010|Phase 1|Death|0|||
19626134|NCT00460603|42075771|FG011|Phase 1|Death|0|||
19626135|NCT00460603|42075760|FG000|Phase 1|Adverse Event|3|||
19626136|NCT00460603|42075761|FG001|Phase 1|Adverse Event|1|||
19626137|NCT00460603|42075762|FG002|Phase 1|Adverse Event|1|||
19626138|NCT00460603|42075763|FG003|Phase 1|Adverse Event|2|||
19626139|NCT00460603|42075764|FG004|Phase 1|Adverse Event|0|||
19626140|NCT00460603|42075765|FG005|Phase 1|Adverse Event|0|||
19626141|NCT00460603|42075766|FG006|Phase 1|Adverse Event|3|||
19626142|NCT00460603|42075767|FG007|Phase 1|Adverse Event|0|||
19626143|NCT00460603|42075768|FG008|Phase 1|Adverse Event|4|||
19626144|NCT00460603|42075769|FG009|Phase 1|Adverse Event|0|||
19626145|NCT00460603|42075770|FG010|Phase 1|Adverse Event|0|||
19626146|NCT00460603|42075771|FG011|Phase 1|Adverse Event|0|||
19626147|NCT00460603|42075760|FG000|Phase 1|Lack of Efficacy|1|||
19626148|NCT00460603|42075761|FG001|Phase 1|Lack of Efficacy|0|||
19626149|NCT00460603|42075762|FG002|Phase 1|Lack of Efficacy|1|||
19626150|NCT00460603|42075763|FG003|Phase 1|Lack of Efficacy|2|||
19626151|NCT00460603|42075764|FG004|Phase 1|Lack of Efficacy|2|||
19626152|NCT00460603|42075765|FG005|Phase 1|Lack of Efficacy|2|||
19626153|NCT00460603|42075766|FG006|Phase 1|Lack of Efficacy|2|||
19626154|NCT00460603|42075767|FG007|Phase 1|Lack of Efficacy|2|||
19626155|NCT00460603|42075768|FG008|Phase 1|Lack of Efficacy|11|||
19626156|NCT00460603|42075769|FG009|Phase 1|Lack of Efficacy|0|||
19626157|NCT00460603|42075770|FG010|Phase 1|Lack of Efficacy|0|||
19626158|NCT00460603|42075771|FG011|Phase 1|Lack of Efficacy|0|||
19626159|NCT00460603|42075760|FG000|Phase 1|Withdrawal by Subject|1|||
19626160|NCT00460603|42075761|FG001|Phase 1|Withdrawal by Subject|2|||
19626161|NCT00460603|42075762|FG002|Phase 1|Withdrawal by Subject|1|||
19626162|NCT00460603|42075763|FG003|Phase 1|Withdrawal by Subject|1|||
19626163|NCT00460603|42075764|FG004|Phase 1|Withdrawal by Subject|3|||
19626164|NCT00460603|42075765|FG005|Phase 1|Withdrawal by Subject|0|||
19626165|NCT00460603|42075766|FG006|Phase 1|Withdrawal by Subject|1|||
19626166|NCT00460603|42075767|FG007|Phase 1|Withdrawal by Subject|0|||
19626167|NCT00460603|42075768|FG008|Phase 1|Withdrawal by Subject|2|||
19626168|NCT00460603|42075769|FG009|Phase 1|Withdrawal by Subject|0|||
19626169|NCT00460603|42075770|FG010|Phase 1|Withdrawal by Subject|0|||
19626170|NCT00460603|42075771|FG011|Phase 1|Withdrawal by Subject|0|||
19626171|NCT00460603|42075760|FG000|Phase 1|Other|0|||
19626172|NCT00460603|42075761|FG001|Phase 1|Other|3|||
19626173|NCT00460603|42075762|FG002|Phase 1|Other|1|||
19626174|NCT00460603|42075763|FG003|Phase 1|Other|1|||
19626175|NCT00460603|42075764|FG004|Phase 1|Other|1|||
19626176|NCT00460603|42075765|FG005|Phase 1|Other|2|||
19707971|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
19707972|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
19707973|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
19707974|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
19707975|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
19707976|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
19707977|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
19707978|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
19707979|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
19707980|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
19707981|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
19707982|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
19626177|NCT00460603|42075766|FG006|Phase 1|Other|0|||
19626178|NCT00460603|42075767|FG007|Phase 1|Other|1|||
19626179|NCT00460603|42075768|FG008|Phase 1|Other|0|||
19373804|NCT02332720|41615019|FG005|Part A and Part B|Adverse Event|0|||
19626180|NCT00460603|42075769|FG009|Phase 1|Other|0|||
19626181|NCT00460603|42075770|FG010|Phase 1|Other|0|||
19626182|NCT00460603|42075771|FG011|Phase 1|Other|0|||
19626183|NCT00460603|42075760|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626184|NCT00460603|42075761|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19707983|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
19707984|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
19707985|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
19707986|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
19707987|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
19707988|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
19707989|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
19707990|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
19707991|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
19626185|NCT00460603|42075762|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626186|NCT00460603|42075763|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626187|NCT00460603|42075764|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626188|NCT00460603|42075765|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626189|NCT00460603|42075766|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626190|NCT00460603|42075767|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626191|NCT00460603|42075768|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626192|NCT00460603|42075769|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
19626193|NCT00460603|42075770|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626194|NCT00460603|42075771|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
19626195|NCT00460603|42075760|FG000|Phase 2|Adverse Event|0|||
19626196|NCT00460603|42075761|FG001|Phase 2|Adverse Event|0|||
19626197|NCT00460603|42075762|FG002|Phase 2|Adverse Event|0|||
19707992|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
19707993|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
19707994|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
19707995|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
19707996|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
19707997|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
19707998|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
19707999|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
19708000|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
19708001|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
19708002|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
19708003|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
19708004|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
19708005|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
19708006|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
19708007|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
19708008|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
19708009|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
19708010|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
19708011|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
19708012|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
19708013|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
19708014|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
19708015|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
19708016|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
19708017|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
19708018|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
19708019|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
19708020|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
19708021|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
19708022|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
19708023|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
19626198|NCT00460603|42075763|FG003|Phase 2|Adverse Event|0|||
19626199|NCT00460603|42075764|FG004|Phase 2|Adverse Event|0|||
19626200|NCT00460603|42075765|FG005|Phase 2|Adverse Event|0|||
19626201|NCT00460603|42075766|FG006|Phase 2|Adverse Event|0|||
19626202|NCT00460603|42075767|FG007|Phase 2|Adverse Event|0|||
19626203|NCT00460603|42075768|FG008|Phase 2|Adverse Event|0|||
19626204|NCT00460603|42075769|FG009|Phase 2|Adverse Event|12|||
19626205|NCT00460603|42075770|FG010|Phase 2|Adverse Event|9|||
19373805|NCT02332720|41615020|FG006|Part A and Part B|Adverse Event|0|||
19626206|NCT00460603|42075771|FG011|Phase 2|Adverse Event|10|||
19626207|NCT00460603|42075760|FG000|Phase 2|Death|0|||
19517729|NCT01551420|41930741|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
19626208|NCT00460603|42075761|FG001|Phase 2|Death|0|||
19708024|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
19708025|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
19708026|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
19708027|NCT00111800|42152555|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
19708028|NCT00111800|42152556|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
19708029|NCT00111800|42152557|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
19708030|NCT00111800|42152558|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
19708031|NCT00111800|42152559|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
19708032|NCT00111800|42152560|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
19708033|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
19708034|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
19708035|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
19708036|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
19708037|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
19708038|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
19708039|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
19708040|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
19708041|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
19708042|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
19708043|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
19708044|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
19708045|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
19708046|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
19708047|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
19708048|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
19708049|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
19708050|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
19708051|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
19708052|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
19708053|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
19708054|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
19708055|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
19708056|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
19708057|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19708058|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19708059|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
19708060|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19708061|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19708062|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
19708063|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
19708064|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
19708065|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
19708066|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
19708067|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
19708068|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
19708069|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
19708070|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
19708071|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
19708072|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
19708073|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
19708074|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
19517730|NCT01551420|41930742|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
19708075|NCT00111800|42152555|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
19708076|NCT00111800|42152556|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
19708077|NCT00111800|42152557|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
19708078|NCT00111800|42152558|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
19708079|NCT00111800|42152559|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
19708080|NCT00111800|42152560|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
19708081|NCT00094328|42152583|FG000|Overall Study|Lost to Follow-up|1|||
19708082|NCT00094172|42152589|FG000|Overall Study|Adverse Event|0|||
19708083|NCT00094172|42152590|FG001|Overall Study|Adverse Event|1|||
19708084|NCT00094172|42152589|FG000|Overall Study|Lost to Follow-up|2|||
19708085|NCT00094172|42152590|FG001|Overall Study|Lost to Follow-up|0|||
19708086|NCT00094172|42152589|FG000|Overall Study|Protocol Violation|0|||
19708087|NCT00094172|42152590|FG001|Overall Study|Protocol Violation|1|||
19708088|NCT00094172|42152589|FG000|Overall Study|Withdrawal by Subject|10|||
19708089|NCT00094172|42152590|FG001|Overall Study|Withdrawal by Subject|5|||
19708090|NCT00094172|42152589|FG000|Overall Study|Primary endpoint met.|1|||
19708091|NCT00094172|42152590|FG001|Overall Study|Primary endpoint met.|0|||
19708092|NCT00094172|42152589|FG000|Overall Study|Started other MS therapy due to disease|1|||
19708093|NCT00094172|42152590|FG001|Overall Study|Started other MS therapy due to disease|0|||
19708094|NCT00094094|42152596|FG000|Overall Study|Death|2|||
19708095|NCT00094094|42152596|FG000|Overall Study|Lack of Efficacy|23|||
19708096|NCT00094094|42152596|FG000|Overall Study|Adverse Event|7|||
19708097|NCT00110396|42152600|FG000|Overall Study|Adverse Event|15|||
19708098|NCT00110396|42152600|FG000|Overall Study|Lost to Follow-up|1|||
19708099|NCT00110396|42152600|FG000|Overall Study|Administration of plasmapheresis|1|||
19708100|NCT00110396|42152600|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
19708101|NCT00110396|42152600|FG000|Overall Study|Lack of Efficacy|1|||
19708102|NCT00110396|42152600|FG000|Overall Study|Decided not to continue treatment|1|||
19708103|NCT00110396|42152600|FG000|Overall Study|Patient non-compliance|1|||
19708104|NCT00110396|42152600|FG000|Overall Study|Patient refused to continue|1|||
19708105|NCT00110396|42152600|FG000|Overall Study|Patient refused to participate|1|||
19708106|NCT00110396|42152600|FG000|Overall Study|Patient will|1|||
19708107|NCT00110396|42152600|FG000|Overall Study|Patient's decision|1|||
19708108|NCT00110396|42152600|FG000|Overall Study|Participation in MS vaccine study|1|||
19708109|NCT00110396|42152600|FG000|Overall Study|Pregnancy|1|||
19708110|NCT00110396|42152600|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
19708111|NCT00110396|42152600|FG000|Overall Study|Protocol Violation|2|||
19708112|NCT00110396|42152600|FG000|Overall Study|Patient refused to come back|1|||
19708113|NCT00110396|42152600|FG000|Overall Study|The patient has refused|2|||
19708114|NCT00110396|42152600|FG000|Overall Study|The patient has refused to visit site|1|||
19708115|NCT00110396|42152600|FG000|Overall Study|Patient is to be administered copaxone|1|||
19708116|NCT03819218|42152604|FG000|Overall Study|Protocol Violation|1|||
19708117|NCT00093470|42152610|FG000|Overall Study|Disease progression|39|||
19708118|NCT00093470|42152611|FG001|Overall Study|Disease progression|0|||
19708119|NCT00093470|42152610|FG000|Overall Study|Adverse Event|15|||
19708120|NCT00093470|42152611|FG001|Overall Study|Adverse Event|0|||
19708121|NCT00093470|42152610|FG000|Overall Study|Death|2|||
19708122|NCT00093470|42152611|FG001|Overall Study|Death|0|||
19626209|NCT00460603|42075762|FG002|Phase 2|Death|0|||
19626210|NCT00460603|42075763|FG003|Phase 2|Death|0|||
19626211|NCT00460603|42075764|FG004|Phase 2|Death|0|||
19626212|NCT00460603|42075765|FG005|Phase 2|Death|0|||
19626213|NCT00460603|42075766|FG006|Phase 2|Death|0|||
19626214|NCT00460603|42075767|FG007|Phase 2|Death|0|||
19626215|NCT00460603|42075768|FG008|Phase 2|Death|0|||
19626216|NCT00460603|42075769|FG009|Phase 2|Death|4|||
19626217|NCT00460603|42075770|FG010|Phase 2|Death|2|||
19626218|NCT00460603|42075771|FG011|Phase 2|Death|2|||
19626219|NCT00460603|42075760|FG000|Phase 2|Protocol Violation|0|||
19626220|NCT00460603|42075761|FG001|Phase 2|Protocol Violation|0|||
19626221|NCT00460603|42075762|FG002|Phase 2|Protocol Violation|0|||
19626222|NCT00460603|42075763|FG003|Phase 2|Protocol Violation|0|||
19626223|NCT00460603|42075764|FG004|Phase 2|Protocol Violation|0|||
19626224|NCT00460603|42075765|FG005|Phase 2|Protocol Violation|0|||
19626225|NCT00460603|42075766|FG006|Phase 2|Protocol Violation|0|||
19708123|NCT00093470|42152610|FG000|Overall Study|Withdrawal by Subject|8|||
19708124|NCT00093470|42152611|FG001|Overall Study|Withdrawal by Subject|0|||
19708125|NCT00093470|42152610|FG000|Overall Study|Alternative therapy|2|||
19708126|NCT00093470|42152611|FG001|Overall Study|Alternative therapy|0|||
19708127|NCT00093470|42152610|FG000|Overall Study|Other complicating disease|3|||
19708128|NCT00093470|42152611|FG001|Overall Study|Other complicating disease|0|||
19708129|NCT00093470|42152610|FG000|Overall Study|Physician Decision|2|||
19708130|NCT00093470|42152611|FG001|Overall Study|Physician Decision|0|||
19708131|NCT00093470|42152610|FG000|Overall Study|Never started treatment|1|||
19708132|NCT00093470|42152611|FG001|Overall Study|Never started treatment|0|||
19708133|NCT00093470|42152610|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
19708134|NCT00093470|42152611|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
19708135|NCT00407537|42152619|FG000|Overall Study|Death|5|||
19708136|NCT00407537|42152620|FG001|Overall Study|Death|2|||
19708137|NCT00407537|42152619|FG000|Overall Study|Adverse Event|36|||
19708138|NCT00407537|42152620|FG001|Overall Study|Adverse Event|0|||
19708139|NCT00407537|42152619|FG000|Overall Study|Lost to Follow-up|12|||
19708140|NCT00407537|42152620|FG001|Overall Study|Lost to Follow-up|19|||
19708141|NCT00407537|42152619|FG000|Overall Study|Other|6|||
19708142|NCT00407537|42152620|FG001|Overall Study|Other|7|||
19708143|NCT00407537|42152619|FG000|Overall Study|Withdrawal by Subject|34|||
19708144|NCT00407537|42152620|FG001|Overall Study|Withdrawal by Subject|16|||
19708145|NCT00094458|42152629|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
19708146|NCT00094458|42152630|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
19708147|NCT00094458|42152631|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
19708148|NCT00094458|42152632|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
19626226|NCT00460603|42075767|FG007|Phase 2|Protocol Violation|0|||
19626227|NCT00460603|42075768|FG008|Phase 2|Protocol Violation|0|||
19626228|NCT00460603|42075769|FG009|Phase 2|Protocol Violation|1|||
19626229|NCT00460603|42075770|FG010|Phase 2|Protocol Violation|1|||
19626230|NCT00460603|42075771|FG011|Phase 2|Protocol Violation|0|||
19626231|NCT00460603|42075760|FG000|Phase 2|Lost to Follow-up|0|||
19626232|NCT00460603|42075761|FG001|Phase 2|Lost to Follow-up|0|||
19626233|NCT00460603|42075762|FG002|Phase 2|Lost to Follow-up|0|||
19626234|NCT00460603|42075763|FG003|Phase 2|Lost to Follow-up|0|||
19626235|NCT00460603|42075764|FG004|Phase 2|Lost to Follow-up|0|||
19626236|NCT00460603|42075765|FG005|Phase 2|Lost to Follow-up|0|||
19626237|NCT00460603|42075766|FG006|Phase 2|Lost to Follow-up|0|||
19708149|NCT00094458|42152633|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
19708150|NCT00094458|42152634|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
19708151|NCT00094458|42152629|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
19708152|NCT00094458|42152630|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
19708153|NCT00094458|42152631|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
19708154|NCT00094458|42152632|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
19708155|NCT00094458|42152633|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
19708156|NCT00094458|42152634|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
19708157|NCT00094458|42152629|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
19708158|NCT00094458|42152630|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
19708159|NCT00094458|42152631|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
19708160|NCT00094458|42152632|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
19708161|NCT00094458|42152633|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
19626238|NCT00460603|42075767|FG007|Phase 2|Lost to Follow-up|0|||
19626239|NCT00460603|42075768|FG008|Phase 2|Lost to Follow-up|0|||
19708162|NCT00094458|42152634|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
19708163|NCT00094458|42152629|FG000|Main Study: Through Week 30|Adverse Event|38|||
19708164|NCT00094458|42152630|FG001|Main Study: Through Week 30|Adverse Event|20|||
19708165|NCT00094458|42152631|FG002|Main Study: Through Week 30|Adverse Event|28|||
19708166|NCT00094458|42152632|FG003|Main Study: Through Week 30|Adverse Event|0|||
19708167|NCT00094458|42152633|FG004|Main Study: Through Week 30|Adverse Event|0|||
19708168|NCT00094458|42152634|FG005|Main Study: Through Week 30|Adverse Event|0|||
19708169|NCT00094458|42152629|FG000|Main Study: Through Week 30|Death|1|||
19708170|NCT00094458|42152630|FG001|Main Study: Through Week 30|Death|0|||
19708171|NCT00094458|42152631|FG002|Main Study: Through Week 30|Death|0|||
19708172|NCT00094458|42152632|FG003|Main Study: Through Week 30|Death|0|||
19708173|NCT00094458|42152633|FG004|Main Study: Through Week 30|Death|0|||
19708174|NCT00094458|42152634|FG005|Main Study: Through Week 30|Death|0|||
19708175|NCT00094458|42152629|FG000|Main Study: Through Week 30|Other|19|||
19708176|NCT00094458|42152630|FG001|Main Study: Through Week 30|Other|16|||
19708177|NCT00094458|42152631|FG002|Main Study: Through Week 30|Other|9|||
19708178|NCT00094458|42152632|FG003|Main Study: Through Week 30|Other|0|||
19708179|NCT00094458|42152633|FG004|Main Study: Through Week 30|Other|0|||
19708180|NCT00094458|42152634|FG005|Main Study: Through Week 30|Other|0|||
19708181|NCT00094458|42152629|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
19708182|NCT00094458|42152630|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
19708183|NCT00094458|42152631|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
19708184|NCT00094458|42152632|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
19708185|NCT00094458|42152633|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
19708186|NCT00094458|42152634|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
19708187|NCT00094458|42152629|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
19708188|NCT00094458|42152630|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
19708189|NCT00094458|42152631|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
19708190|NCT00094458|42152632|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
19708191|NCT00094458|42152633|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
19708192|NCT00094458|42152634|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
19708193|NCT00094458|42152629|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
19708194|NCT00094458|42152630|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
19708195|NCT00094458|42152631|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
19708196|NCT00094458|42152632|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
19708197|NCT00094458|42152633|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
19708198|NCT00094458|42152634|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
19708199|NCT00094458|42152629|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
19708200|NCT00094458|42152630|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
19626240|NCT00460603|42075769|FG009|Phase 2|Lost to Follow-up|1|||
19626241|NCT00460603|42075770|FG010|Phase 2|Lost to Follow-up|0|||
19626242|NCT00460603|42075771|FG011|Phase 2|Lost to Follow-up|0|||
19626243|NCT00460603|42075760|FG000|Phase 2|Other|0|||
19626244|NCT00460603|42075761|FG001|Phase 2|Other|0|||
19626245|NCT00460603|42075762|FG002|Phase 2|Other|0|||
19626246|NCT00460603|42075763|FG003|Phase 2|Other|0|||
19708201|NCT00094458|42152631|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
19708202|NCT00094458|42152632|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
19708203|NCT00094458|42152633|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
19708204|NCT00094458|42152634|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
19708205|NCT00094458|42152629|FG000|OLE: Open-Label Extension|Adverse Event|0|||
19708206|NCT00094458|42152630|FG001|OLE: Open-Label Extension|Adverse Event|0|||
19708207|NCT00094458|42152631|FG002|OLE: Open-Label Extension|Adverse Event|0|||
19708208|NCT00094458|42152632|FG003|OLE: Open-Label Extension|Adverse Event|0|||
19708209|NCT00094458|42152633|FG004|OLE: Open-Label Extension|Adverse Event|3|||
19708210|NCT00094458|42152634|FG005|OLE: Open-Label Extension|Adverse Event|4|||
19708211|NCT00094458|42152629|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
19517731|NCT01551420|41930741|FG000|Screened for Part B Eligibility|Declined participation|8|||
19626247|NCT00460603|42075764|FG004|Phase 2|Other|0|||
19626248|NCT00460603|42075765|FG005|Phase 2|Other|0|||
19626249|NCT00460603|42075766|FG006|Phase 2|Other|0|||
19626250|NCT00460603|42075767|FG007|Phase 2|Other|0|||
19708212|NCT00094458|42152630|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
19708213|NCT00094458|42152631|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
19708214|NCT00094458|42152632|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
19708215|NCT00094458|42152633|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
19708216|NCT00094458|42152634|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
19708217|NCT00094458|42152629|FG000|OLE: Open-Label Extension|Patient decision|0|||
19708218|NCT00094458|42152630|FG001|OLE: Open-Label Extension|Patient decision|0|||
19708219|NCT00094458|42152631|FG002|OLE: Open-Label Extension|Patient decision|0|||
19708220|NCT00094458|42152632|FG003|OLE: Open-Label Extension|Patient decision|0|||
19708221|NCT00094458|42152633|FG004|OLE: Open-Label Extension|Patient decision|1|||
19708222|NCT00094458|42152634|FG005|OLE: Open-Label Extension|Patient decision|0|||
19708223|NCT00406367|42152650|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
19708224|NCT00406367|42152651|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
19708225|NCT00406367|42152650|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
19708226|NCT00406367|42152651|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
19708227|NCT00406367|42152650|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
19708228|NCT00406367|42152651|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
19708229|NCT00406367|42152650|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
19708230|NCT00406367|42152651|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
19708231|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
19708232|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
19708233|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
19708234|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
19708235|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
19708236|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
19708237|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
19708238|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
19708239|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
19708240|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
19708241|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
19708242|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
19708243|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
19708244|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
19708245|NCT00406367|42152650|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
19708246|NCT00406367|42152651|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
19708247|NCT00394589|42152660|FG000|Overall Study|Adverse Event|2|||
19708248|NCT00394589|42152661|FG001|Overall Study|Adverse Event|1|||
19708249|NCT00394589|42152662|FG002|Overall Study|Adverse Event|2|||
19708250|NCT00394589|42152660|FG000|Overall Study|Lack of Efficacy|2|||
19708251|NCT00394589|42152661|FG001|Overall Study|Lack of Efficacy|2|||
19708252|NCT00394589|42152662|FG002|Overall Study|Lack of Efficacy|3|||
19708253|NCT00394589|42152660|FG000|Overall Study|Protocol Violation|4|||
19708254|NCT00394589|42152661|FG001|Overall Study|Protocol Violation|0|||
19394273|NCT02684461|41638419|FG002|Overall Study|Adverse Event|0|||
19394274|NCT02684461|41638417|FG000|Overall Study|Lack of Efficacy|1|||
19394275|NCT02684461|41638418|FG001|Overall Study|Lack of Efficacy|2|||
19394276|NCT02684461|41638419|FG002|Overall Study|Lack of Efficacy|0|||
19708255|NCT00394589|42152662|FG002|Overall Study|Protocol Violation|2|||
19708256|NCT00068406|42152670|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
19708257|NCT00068406|42152670|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
19708258|NCT00403559|42152676|FG000|Overall Study|Adverse Event|0|||
19708259|NCT00403559|42152677|FG001|Overall Study|Adverse Event|1|||
19708260|NCT00403559|42152676|FG000|Overall Study|Lost to Follow-up|3|||
19708261|NCT00403559|42152677|FG001|Overall Study|Lost to Follow-up|3|||
19708262|NCT00403559|42152676|FG000|Overall Study|Withdrawal by Subject|1|||
19708263|NCT00403559|42152677|FG001|Overall Study|Withdrawal by Subject|0|||
19708264|NCT00403481|42152685|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
19708265|NCT00403481|42152685|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
19708266|NCT00403481|42152685|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
19708267|NCT00403481|42152685|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
19708268|NCT00403481|42152685|FG000|Olm 40 mg|Adverse Event|2|||
19708269|NCT00403481|42152685|FG000|Olm 40 mg|Protocol Violation|1|||
19708270|NCT00403481|42152685|FG000|Olm 40 mg|Withdrawal by Subject|1|||
19708271|NCT00403481|42152685|FG000|Olm 40 mg|Other|1|||
19708272|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
19708273|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
19708274|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
19708275|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
19708276|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
19708277|NCT00403481|42152685|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
19708278|NCT00402779|42152694|FG000|Overall Study|Screen Failure|77|||
19708279|NCT00402779|42152695|FG001|Overall Study|Screen Failure|76|||
19708280|NCT00394433|42152701|FG000|Overall Study|Adverse Event|2|||
19708281|NCT00394433|42152701|FG000|Overall Study|Alternative Therapy|1|||
19708282|NCT00092534|42152707|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
19708283|NCT00092534|42152708|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
19708284|NCT00092534|42152709|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19708285|NCT00092534|42152710|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19708286|NCT00092534|42152711|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
19708287|NCT00092534|42152707|FG000|Base Study Vaccination Period|Adverse Event|3|||
19708288|NCT00092534|42152708|FG001|Base Study Vaccination Period|Adverse Event|1|||
19708289|NCT00092534|42152709|FG002|Base Study Vaccination Period|Adverse Event|0|||
19708290|NCT00092534|42152710|FG003|Base Study Vaccination Period|Adverse Event|0|||
19708291|NCT00092534|42152711|FG004|Base Study Vaccination Period|Adverse Event|0|||
19708292|NCT00092534|42152707|FG000|Base Study Vaccination Period|Death|5|||
19708293|NCT00092534|42152708|FG001|Base Study Vaccination Period|Death|4|||
19708294|NCT00092534|42152709|FG002|Base Study Vaccination Period|Death|0|||
19708295|NCT00092534|42152710|FG003|Base Study Vaccination Period|Death|0|||
19708296|NCT00092534|42152711|FG004|Base Study Vaccination Period|Death|0|||
19708297|NCT00092534|42152707|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
19708298|NCT00092534|42152708|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
19708299|NCT00092534|42152709|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
19708300|NCT00092534|42152710|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
19708301|NCT00092534|42152711|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
19708302|NCT00092534|42152707|FG000|Base Study Vaccination Period|Physician Decision|1|||
19708303|NCT00092534|42152708|FG001|Base Study Vaccination Period|Physician Decision|0|||
19708304|NCT00092534|42152709|FG002|Base Study Vaccination Period|Physician Decision|0|||
19708305|NCT00092534|42152710|FG003|Base Study Vaccination Period|Physician Decision|0|||
19708306|NCT00092534|42152711|FG004|Base Study Vaccination Period|Physician Decision|0|||
19708307|NCT00092534|42152707|FG000|Base Study Vaccination Period|Pregnancy|9|||
19708308|NCT00092534|42152708|FG001|Base Study Vaccination Period|Pregnancy|7|||
19708309|NCT00092534|42152709|FG002|Base Study Vaccination Period|Pregnancy|0|||
19708310|NCT00092534|42152710|FG003|Base Study Vaccination Period|Pregnancy|0|||
19708311|NCT00092534|42152711|FG004|Base Study Vaccination Period|Pregnancy|0|||
19708312|NCT00092534|42152707|FG000|Base Study Vaccination Period|Protocol Violation|2|||
19708313|NCT00092534|42152708|FG001|Base Study Vaccination Period|Protocol Violation|1|||
19708314|NCT00092534|42152709|FG002|Base Study Vaccination Period|Protocol Violation|0|||
19708315|NCT00092534|42152710|FG003|Base Study Vaccination Period|Protocol Violation|0|||
19708316|NCT00092534|42152711|FG004|Base Study Vaccination Period|Protocol Violation|0|||
19708317|NCT00092534|42152707|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
19708318|NCT00092534|42152708|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
19708319|NCT00092534|42152709|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
19708320|NCT00092534|42152710|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
19708321|NCT00092534|42152711|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
19708322|NCT00092534|42152707|FG000|Base Study Vaccination Period|Moved|14|||
19708323|NCT00092534|42152708|FG001|Base Study Vaccination Period|Moved|12|||
19708324|NCT00092534|42152709|FG002|Base Study Vaccination Period|Moved|0|||
19708325|NCT00092534|42152710|FG003|Base Study Vaccination Period|Moved|0|||
19708326|NCT00092534|42152711|FG004|Base Study Vaccination Period|Moved|0|||
19708327|NCT00092534|42152707|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
19708328|NCT00092534|42152708|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
19708329|NCT00092534|42152709|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
19708330|NCT00092534|42152710|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
19373806|NCT02332720|41615021|FG007|Part A and Part B|Adverse Event|0|||
19373807|NCT02332720|41615022|FG008|Part A and Part B|Adverse Event|0|||
19708331|NCT00092534|42152711|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
19708332|NCT00092534|42152707|FG000|Base Study Vaccination Period|Travel|1|||
19708333|NCT00092534|42152708|FG001|Base Study Vaccination Period|Travel|0|||
19708334|NCT00092534|42152709|FG002|Base Study Vaccination Period|Travel|0|||
19708335|NCT00092534|42152710|FG003|Base Study Vaccination Period|Travel|0|||
19708336|NCT00092534|42152711|FG004|Base Study Vaccination Period|Travel|0|||
19708337|NCT00092534|42152707|FG000|Base Study Vaccination Period|Site Closed|0|||
19708338|NCT00092534|42152708|FG001|Base Study Vaccination Period|Site Closed|1|||
19708339|NCT00092534|42152709|FG002|Base Study Vaccination Period|Site Closed|0|||
19708340|NCT00092534|42152710|FG003|Base Study Vaccination Period|Site Closed|0|||
19708341|NCT00092534|42152711|FG004|Base Study Vaccination Period|Site Closed|0|||
19708342|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Adverse Event|2|||
19708343|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Adverse Event|4|||
19708344|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Adverse Event|0|||
19708345|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Adverse Event|0|||
19708346|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Adverse Event|0|||
19708347|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Death|2|||
19394277|NCT02647645|41638444|FG000|Overall Study|Lost to Follow-up|2|||
19394278|NCT02647645|41638445|FG001|Overall Study|Lost to Follow-up|1|||
19394279|NCT02531373|41638460|FG000|Overall Study|Lack of Efficacy|0|||
19394280|NCT02531373|41638461|FG001|Overall Study|Lack of Efficacy|0|||
19394281|NCT02531373|41638462|FG002|Overall Study|Lack of Efficacy|0|||
19394282|NCT02531373|41638463|FG003|Overall Study|Lack of Efficacy|0|||
19394283|NCT02531373|41638464|FG004|Overall Study|Lack of Efficacy|3|||
19394284|NCT02531373|41638465|FG005|Overall Study|Lack of Efficacy|2|||
19394285|NCT02531373|41638466|FG006|Overall Study|Lack of Efficacy|4|||
19394286|NCT02531373|41638467|FG007|Overall Study|Lack of Efficacy|8|||
19394287|NCT02531373|41638468|FG008|Overall Study|Lack of Efficacy|5|||
19394288|NCT02531373|41638460|FG000|Overall Study|Lost to Follow-up|0|||
19394289|NCT02531373|41638461|FG001|Overall Study|Lost to Follow-up|0|||
19394290|NCT02531373|41638462|FG002|Overall Study|Lost to Follow-up|0|||
19394291|NCT02531373|41638463|FG003|Overall Study|Lost to Follow-up|0|||
19394292|NCT02531373|41638464|FG004|Overall Study|Lost to Follow-up|0|||
19394293|NCT02531373|41638465|FG005|Overall Study|Lost to Follow-up|2|||
19394294|NCT02531373|41638466|FG006|Overall Study|Lost to Follow-up|2|||
19394295|NCT02531373|41638467|FG007|Overall Study|Lost to Follow-up|0|||
19394296|NCT02531373|41638468|FG008|Overall Study|Lost to Follow-up|0|||
19394297|NCT02531373|41638460|FG000|Overall Study|Physician Decision|0|||
19394298|NCT02531373|41638461|FG001|Overall Study|Physician Decision|0|||
19708348|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Death|1|||
19708349|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Death|0|||
19708350|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Death|0|||
19708351|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Death|0|||
19708352|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
19708353|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
19708354|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
19708355|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
19708356|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
19708357|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Pregnancy|6|||
19708358|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Pregnancy|10|||
19708359|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Pregnancy|0|||
19708360|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Pregnancy|0|||
19708361|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Pregnancy|0|||
19708362|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
19708363|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
19708364|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
19708365|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
19708366|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
19708367|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
19708368|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
19708369|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
19708370|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
19708371|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
19708372|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Moved|62|||
19708373|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Moved|58|||
19708374|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Moved|0|||
19708375|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Moved|0|||
19708376|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Moved|0|||
19708377|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Travel|10|||
19708378|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Travel|7|||
19394299|NCT02531373|41638462|FG002|Overall Study|Physician Decision|0|||
19708379|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Travel|0|||
19708380|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Travel|0|||
19708381|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Travel|0|||
19708382|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Site Closed|0|||
19708383|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Site Closed|2|||
19708384|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Site Closed|0|||
19708385|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Site Closed|0|||
19394300|NCT02531373|41638463|FG003|Overall Study|Physician Decision|0|||
19394301|NCT02531373|41638464|FG004|Overall Study|Physician Decision|2|||
19394302|NCT02531373|41638465|FG005|Overall Study|Physician Decision|1|||
19394303|NCT02531373|41638466|FG006|Overall Study|Physician Decision|0|||
19394304|NCT02531373|41638467|FG007|Overall Study|Physician Decision|0|||
19394305|NCT02531373|41638468|FG008|Overall Study|Physician Decision|0|||
19394306|NCT02531373|41638460|FG000|Overall Study|Protocol Violation|0|||
19394307|NCT02531373|41638461|FG001|Overall Study|Protocol Violation|0|||
19394308|NCT02531373|41638462|FG002|Overall Study|Protocol Violation|0|||
19394309|NCT02531373|41638463|FG003|Overall Study|Protocol Violation|0|||
19394310|NCT02531373|41638464|FG004|Overall Study|Protocol Violation|0|||
19394311|NCT02531373|41638465|FG005|Overall Study|Protocol Violation|1|||
19394312|NCT02531373|41638466|FG006|Overall Study|Protocol Violation|1|||
19394313|NCT02531373|41638467|FG007|Overall Study|Protocol Violation|0|||
19394314|NCT02531373|41638468|FG008|Overall Study|Protocol Violation|1|||
19394315|NCT02531373|41638460|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19394316|NCT02531373|41638461|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19394317|NCT02531373|41638462|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
19394318|NCT02531373|41638463|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
19394319|NCT02531373|41638464|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
19394320|NCT02531373|41638465|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
19394321|NCT02531373|41638466|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
19394322|NCT02531373|41638467|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
19394323|NCT02531373|41638468|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
19394324|NCT02531373|41638460|FG000|Overall Study|Withdrawal by Subject|0|||
19394325|NCT02531373|41638461|FG001|Overall Study|Withdrawal by Subject|0|||
19394326|NCT02531373|41638462|FG002|Overall Study|Withdrawal by Subject|0|||
19394327|NCT02531373|41638463|FG003|Overall Study|Withdrawal by Subject|0|||
19394328|NCT02531373|41638464|FG004|Overall Study|Withdrawal by Subject|3|||
19394329|NCT02531373|41638465|FG005|Overall Study|Withdrawal by Subject|0|||
19394330|NCT02531373|41638466|FG006|Overall Study|Withdrawal by Subject|0|||
19394331|NCT02531373|41638467|FG007|Overall Study|Withdrawal by Subject|0|||
19394332|NCT02531373|41638468|FG008|Overall Study|Withdrawal by Subject|0|||
19394333|NCT02606279|41638491|FG000|Overall Study|Lost to Follow-up|0|||
19394334|NCT02606279|41638492|FG001|Overall Study|Lost to Follow-up|1|||
19394335|NCT02643355|41638506|FG000|Overall Study|Withdrawal by Subject|1|||
19394336|NCT02643355|41638507|FG001|Overall Study|Withdrawal by Subject|3|||
19394337|NCT02643355|41638506|FG000|Overall Study|Protocol Violation|0|||
19394338|NCT02643355|41638507|FG001|Overall Study|Protocol Violation|2|||
19394339|NCT02604017|41638515|FG000|Overall Study|Withdrew Consent|0|||
19394340|NCT02604017|41638516|FG001|Overall Study|Withdrew Consent|2|||
19394341|NCT02604017|41638515|FG000|Overall Study|Lost to Follow-up|5|||
19394342|NCT02604017|41638516|FG001|Overall Study|Lost to Follow-up|6|||
19394343|NCT02604017|41638515|FG000|Overall Study|Other|1|||
19394344|NCT02604017|41638516|FG001|Overall Study|Other|0|||
19394345|NCT02640547|41638522|FG000|Overall Study|Failure to Return|1|||
19394346|NCT02640547|41638522|FG000|Overall Study|Withdrawal by Subject|1|||
19708386|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Site Closed|0|||
19708387|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
19708388|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
19373808|NCT02332720|41615023|FG009|Part A and Part B|Adverse Event|0|||
19373809|NCT02332720|41615024|FG010|Part A and Part B|Adverse Event|0|||
19373810|NCT02332720|41615025|FG011|Part A and Part B|Adverse Event|0|||
19373811|NCT02332720|41615026|FG012|Part A and Part B|Adverse Event|0|||
19373812|NCT02332720|41615027|FG013|Part A and Part B|Adverse Event|0|||
19373813|NCT02332720|41615028|FG014|Part A and Part B|Adverse Event|0|||
19373814|NCT02332720|41615029|FG015|Part A and Part B|Adverse Event|0|||
19373815|NCT02332720|41615030|FG016|Part A and Part B|Adverse Event|0|||
19394347|NCT02640547|41638522|FG000|Overall Study|Death|6|||
19708389|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
19708390|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
19708391|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
19708392|NCT00092534|42152707|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
19708393|NCT00092534|42152708|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
19708394|NCT00092534|42152709|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
19708395|NCT00092534|42152710|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
19708396|NCT00092534|42152711|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
19708397|NCT00092534|42152707|FG000|Base Study EXT|Lost to Follow-up|0|||
19708398|NCT00092534|42152708|FG001|Base Study EXT|Lost to Follow-up|0|||
19708399|NCT00092534|42152709|FG002|Base Study EXT|Lost to Follow-up|41|||
19708400|NCT00092534|42152710|FG003|Base Study EXT|Lost to Follow-up|0|||
19708401|NCT00092534|42152711|FG004|Base Study EXT|Lost to Follow-up|0|||
19708402|NCT00092534|42152707|FG000|Base Study EXT|Physician Decision|0|||
19708403|NCT00092534|42152708|FG001|Base Study EXT|Physician Decision|0|||
19708404|NCT00092534|42152709|FG002|Base Study EXT|Physician Decision|1|||
19708405|NCT00092534|42152710|FG003|Base Study EXT|Physician Decision|0|||
19708406|NCT00092534|42152711|FG004|Base Study EXT|Physician Decision|0|||
19708407|NCT00092534|42152707|FG000|Base Study EXT|Pregnancy|0|||
19708408|NCT00092534|42152708|FG001|Base Study EXT|Pregnancy|0|||
19708409|NCT00092534|42152709|FG002|Base Study EXT|Pregnancy|12|||
19708410|NCT00092534|42152710|FG003|Base Study EXT|Pregnancy|0|||
19708411|NCT00092534|42152711|FG004|Base Study EXT|Pregnancy|0|||
19708412|NCT00092534|42152707|FG000|Base Study EXT|Withdrawal by Subject|0|||
19394348|NCT02640547|41638522|FG000|Overall Study|Miscellaneous|3|||
19394349|NCT02530905|41638536|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
19394350|NCT02530905|41638537|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
19394351|NCT02530905|41638538|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
19394352|NCT02530671|41638562|FG000|Overall Study|Lost to Follow-up|2|||
19394353|NCT02530671|41638563|FG001|Overall Study|Lost to Follow-up|0|||
19394354|NCT02530671|41638562|FG000|Overall Study|Withdrawal by Subject|1|||
19394355|NCT02530671|41638563|FG001|Overall Study|Withdrawal by Subject|0|||
19708413|NCT00092534|42152708|FG001|Base Study EXT|Withdrawal by Subject|0|||
19708414|NCT00092534|42152709|FG002|Base Study EXT|Withdrawal by Subject|18|||
19708415|NCT00092534|42152710|FG003|Base Study EXT|Withdrawal by Subject|0|||
19708416|NCT00092534|42152711|FG004|Base Study EXT|Withdrawal by Subject|0|||
19708417|NCT00092534|42152707|FG000|Base Study EXT|Participant moved|0|||
19394356|NCT02603393|41638571|FG000|Overall Study|Patient/guardian decision|32|||
19394357|NCT02603393|41638572|FG001|Overall Study|Patient/guardian decision|18|||
19394358|NCT02603393|41638571|FG000|Overall Study|Adverse Event|17|||
19708418|NCT00092534|42152708|FG001|Base Study EXT|Participant moved|0|||
19708419|NCT00092534|42152709|FG002|Base Study EXT|Participant moved|6|||
19708420|NCT00092534|42152710|FG003|Base Study EXT|Participant moved|0|||
19708421|NCT00092534|42152711|FG004|Base Study EXT|Participant moved|0|||
19708422|NCT00092534|42152707|FG000|Base Study EXT|Travel|0|||
19708423|NCT00092534|42152708|FG001|Base Study EXT|Travel|0|||
19394359|NCT02603393|41638572|FG001|Overall Study|Adverse Event|15|||
19394360|NCT02603393|41638571|FG000|Overall Study|Technical problems|4|||
19394361|NCT02603393|41638572|FG001|Overall Study|Technical problems|7|||
19394362|NCT02603393|41638571|FG000|Overall Study|Lack of Efficacy|7|||
19394363|NCT02603393|41638572|FG001|Overall Study|Lack of Efficacy|2|||
19394364|NCT02603393|41638571|FG000|Overall Study|Death|3|||
19394365|NCT02603393|41638572|FG001|Overall Study|Death|4|||
19394366|NCT02603393|41638571|FG000|Overall Study|Physician Decision|3|||
19394367|NCT02603393|41638572|FG001|Overall Study|Physician Decision|3|||
19394368|NCT02603393|41638571|FG000|Overall Study|Protocol deviation|2|||
19394369|NCT02603393|41638572|FG001|Overall Study|Protocol deviation|3|||
19394370|NCT02603393|41638571|FG000|Overall Study|Lost to Follow-up|1|||
19394371|NCT02603393|41638572|FG001|Overall Study|Lost to Follow-up|2|||
19394372|NCT02603393|41638571|FG000|Overall Study|Non-compliance with study treatment|1|||
19394373|NCT02603393|41638572|FG001|Overall Study|Non-compliance with study treatment|0|||
19394374|NCT02603393|41638571|FG000|Overall Study|Sponsor decision|1|||
19394375|NCT02603393|41638572|FG001|Overall Study|Sponsor decision|0|||
19394376|NCT02642653|41638580|FG000|Overall Study|Adverse Event|2|||
19394377|NCT02642653|41638581|FG001|Overall Study|Adverse Event|0|||
19394378|NCT01659567|41638587|FG000|Overall Study|Lack of Efficacy|22|||
19394379|NCT01659567|41638587|FG000|Overall Study|Switched to Pegferon|6|||
19394380|NCT01659567|41638587|FG000|Overall Study|Adverse Event|12|||
19394381|NCT01659567|41638587|FG000|Overall Study|Good result at early stage of treatment|5|||
19394382|NCT01659567|41638587|FG000|Overall Study|Withdrawal by Subject|64|||
19394383|NCT01659567|41638587|FG000|Overall Study|Progression of the main disease|1|||
19394384|NCT01659567|41638587|FG000|Overall Study|Other|13|||
19394385|NCT02605967|41638603|FG000|Overall Study|subject / guardian decision|1|||
19394386|NCT02605967|41638604|FG001|Overall Study|subject / guardian decision|2|||
19394387|NCT02605967|41638603|FG000|Overall Study|Physician Decision|10|||
19394388|NCT02605967|41638604|FG001|Overall Study|Physician Decision|1|||
19394389|NCT02605967|41638603|FG000|Overall Study|Death|4|||
19394390|NCT02605967|41638604|FG001|Overall Study|Death|2|||
19394391|NCT02605967|41638603|FG000|Overall Study|Adverse Event|1|||
19394392|NCT02605967|41638604|FG001|Overall Study|Adverse Event|0|||
19394393|NCT02605967|41638603|FG000|Overall Study|progressive disease|66|||
19394394|NCT02605967|41638604|FG001|Overall Study|progressive disease|35|||
19394395|NCT01668173|41638614|FG000|Overall Study|Adverse Event|3|||
19394396|NCT01668173|41638614|FG000|Overall Study|Trial suspension|4|||
19394397|NCT02600351|41638631|FG000|Overall Study|Lack of Efficacy|3|||
19394398|NCT02600351|41638632|FG001|Overall Study|Lack of Efficacy|0|||
19394399|NCT02600351|41638633|FG002|Overall Study|Lack of Efficacy|5|||
19394400|NCT02600351|41638634|FG003|Overall Study|Lack of Efficacy|2|||
19394401|NCT02600351|41638631|FG000|Overall Study|Lost to Follow-up|1|||
19708424|NCT00092534|42152709|FG002|Base Study EXT|Travel|2|||
19708425|NCT00092534|42152710|FG003|Base Study EXT|Travel|0|||
19708426|NCT00092534|42152711|FG004|Base Study EXT|Travel|0|||
19708427|NCT00092534|42152707|FG000|Base Study EXT|Site closed|0|||
19708428|NCT00092534|42152708|FG001|Base Study EXT|Site closed|0|||
19708429|NCT00092534|42152709|FG002|Base Study EXT|Site closed|21|||
19708430|NCT00092534|42152710|FG003|Base Study EXT|Site closed|0|||
19708431|NCT00092534|42152711|FG004|Base Study EXT|Site closed|0|||
19708432|NCT00092534|42152707|FG000|Base Study EXT|Study ended|0|||
19708433|NCT00092534|42152708|FG001|Base Study EXT|Study ended|0|||
19708434|NCT00092534|42152709|FG002|Base Study EXT|Study ended|29|||
19708435|NCT00092534|42152710|FG003|Base Study EXT|Study ended|0|||
19708436|NCT00092534|42152711|FG004|Base Study EXT|Study ended|0|||
19708437|NCT00092534|42152707|FG000|Base Study EXT|Protocol Violation|0|||
19708438|NCT00092534|42152708|FG001|Base Study EXT|Protocol Violation|0|||
19708439|NCT00092534|42152709|FG002|Base Study EXT|Protocol Violation|15|||
19394402|NCT02600351|41638632|FG001|Overall Study|Lost to Follow-up|0|||
19394403|NCT02600351|41638633|FG002|Overall Study|Lost to Follow-up|0|||
19394404|NCT02600351|41638634|FG003|Overall Study|Lost to Follow-up|0|||
19394405|NCT02600351|41638631|FG000|Overall Study|Randomized but Not Treated|1|||
19394406|NCT02600351|41638632|FG001|Overall Study|Randomized but Not Treated|0|||
19394407|NCT02600351|41638633|FG002|Overall Study|Randomized but Not Treated|1|||
19394408|NCT02600351|41638634|FG003|Overall Study|Randomized but Not Treated|3|||
19394409|NCT02640235|41638648|FG000|Overall Study|Withdrawal by Subject|7|||
19394410|NCT02640235|41638649|FG001|Overall Study|Withdrawal by Subject|6|||
19394411|NCT02640235|41638648|FG000|Overall Study|Lost to Follow-up|4|||
19708440|NCT00092534|42152710|FG003|Base Study EXT|Protocol Violation|0|||
19708441|NCT00092534|42152711|FG004|Base Study EXT|Protocol Violation|0|||
19708442|NCT00092534|42152707|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
19708443|NCT00092534|42152708|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
19394412|NCT02640235|41638649|FG001|Overall Study|Lost to Follow-up|3|||
19394413|NCT02640235|41638648|FG000|Overall Study|Death|2|||
19394414|NCT02640235|41638649|FG001|Overall Study|Death|3|||
19394415|NCT02640235|41638648|FG000|Overall Study|Other|1|||
19394416|NCT02640235|41638649|FG001|Overall Study|Other|2|||
19394417|NCT02599961|41638655|FG000|Overall Study|Withdrawal by Subject|1|||
19394418|NCT02599961|41638655|FG000|Overall Study|Subject Non-Compliance|2|||
19394419|NCT02599961|41638655|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
19394420|NCT02599961|41638655|FG000|Overall Study|Other, Not Specified|3|||
19394421|NCT02640157|41638680|FG000|Overall Study|Adverse Event|2|||
19394422|NCT02640157|41638681|FG001|Overall Study|Adverse Event|2|||
19394423|NCT02640157|41638682|FG002|Overall Study|Adverse Event|1|||
19394424|NCT02640157|41638680|FG000|Overall Study|Withdrew consent|2|||
19394425|NCT02640157|41638681|FG001|Overall Study|Withdrew consent|0|||
19394426|NCT02640157|41638682|FG002|Overall Study|Withdrew consent|2|||
19394427|NCT02640157|41638680|FG000|Overall Study|Lost to Follow-up|9|||
19394428|NCT02640157|41638681|FG001|Overall Study|Lost to Follow-up|2|||
19394429|NCT02640157|41638682|FG002|Overall Study|Lost to Follow-up|7|||
19394430|NCT02640157|41638680|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
19394431|NCT02640157|41638681|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
19394432|NCT02640157|41638682|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
19708444|NCT00092534|42152709|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
19708445|NCT00092534|42152710|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
19708446|NCT00092534|42152711|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
19708447|NCT00068250|42152724|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
19708448|NCT00068250|42152725|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
19708449|NCT00068250|42152726|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
19708450|NCT00068250|42152727|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
19394433|NCT01673347|41638691|FG000|Overall Study|failure of allograft|7|||
19394434|NCT02528253|41638700|FG000|Overall Study|Adverse Event|3|||
19394435|NCT02528253|41638701|FG001|Overall Study|Adverse Event|4|||
19626251|NCT00460603|42075768|FG008|Phase 2|Other|0|||
19626252|NCT00460603|42075769|FG009|Phase 2|Other|6|||
19626253|NCT00460603|42075770|FG010|Phase 2|Other|16|||
19626254|NCT00460603|42075771|FG011|Phase 2|Other|7|||
19626255|NCT00460603|42075760|FG000|Phase 2|Objective Progression or Relapse|0|||
19626256|NCT00460603|42075761|FG001|Phase 2|Objective Progression or Relapse|0|||
19626257|NCT00460603|42075762|FG002|Phase 2|Objective Progression or Relapse|0|||
19626258|NCT00460603|42075763|FG003|Phase 2|Objective Progression or Relapse|0|||
19626259|NCT00460603|42075764|FG004|Phase 2|Objective Progression or Relapse|0|||
19708451|NCT00393887|42152737|FG000|Overall Study|Physician Decision|5|||
19708452|NCT00393887|42152738|FG001|Overall Study|Physician Decision|0|||
19708453|NCT00393887|42152737|FG000|Overall Study|Lost to Follow-up|11|||
19708454|NCT00393887|42152738|FG001|Overall Study|Lost to Follow-up|9|||
19708455|NCT00393029|42152746|FG000|Overall Study|Not treated|0|||
19708456|NCT00393029|42152747|FG001|Overall Study|Not treated|1|||
19708457|NCT00402233|42152758|FG000|Overall Study|Adverse Event|1|||
19708458|NCT00402233|42152759|FG001|Overall Study|Adverse Event|7|||
19708459|NCT00402233|42152760|FG002|Overall Study|Adverse Event|9|||
19708460|NCT00402233|42152761|FG003|Overall Study|Adverse Event|9|||
19708461|NCT00402233|42152758|FG000|Overall Study|Protocol Violation|0|||
19708462|NCT00402233|42152759|FG001|Overall Study|Protocol Violation|1|||
19708463|NCT00402233|42152760|FG002|Overall Study|Protocol Violation|0|||
19708464|NCT00402233|42152761|FG003|Overall Study|Protocol Violation|0|||
19708465|NCT00402233|42152758|FG000|Overall Study|Withdrawal by Subject|2|||
19708466|NCT00402233|42152759|FG001|Overall Study|Withdrawal by Subject|1|||
19708467|NCT00402233|42152760|FG002|Overall Study|Withdrawal by Subject|2|||
19708468|NCT00402233|42152761|FG003|Overall Study|Withdrawal by Subject|2|||
19708469|NCT00402233|42152758|FG000|Overall Study|Worsening of disease under study|2|||
19708470|NCT00402233|42152759|FG001|Overall Study|Worsening of disease under study|0|||
19708471|NCT00402233|42152760|FG002|Overall Study|Worsening of disease under study|0|||
19708472|NCT00402233|42152761|FG003|Overall Study|Worsening of disease under study|0|||
19708473|NCT00402233|42152758|FG000|Overall Study|Worsening of other pre-existing disease|0|||
19708474|NCT00402233|42152759|FG001|Overall Study|Worsening of other pre-existing disease|1|||
19708475|NCT00402233|42152760|FG002|Overall Study|Worsening of other pre-existing disease|0|||
19708476|NCT00402233|42152761|FG003|Overall Study|Worsening of other pre-existing disease|0|||
19708477|NCT00092456|42152775|FG000|Overall Study|Adverse Event|0|||
19708478|NCT00092456|42152776|FG001|Overall Study|Adverse Event|0|||
19708479|NCT00092456|42152777|FG002|Overall Study|Adverse Event|1|||
19708480|NCT00092456|42152778|FG003|Overall Study|Adverse Event|1|||
19708481|NCT00092456|42152775|FG000|Overall Study|Lost to Follow-up|2|||
19708482|NCT00092456|42152776|FG001|Overall Study|Lost to Follow-up|2|||
19708483|NCT00092456|42152777|FG002|Overall Study|Lost to Follow-up|1|||
19708484|NCT00092456|42152778|FG003|Overall Study|Lost to Follow-up|2|||
19708485|NCT00092456|42152775|FG000|Overall Study|Protocol Violation|5|||
19708486|NCT00092456|42152776|FG001|Overall Study|Protocol Violation|7|||
19708487|NCT00092456|42152777|FG002|Overall Study|Protocol Violation|8|||
19708488|NCT00092456|42152778|FG003|Overall Study|Protocol Violation|6|||
19708489|NCT00092456|42152775|FG000|Overall Study|Withdrawal by Subject|13|||
19708490|NCT00092456|42152776|FG001|Overall Study|Withdrawal by Subject|5|||
19708491|NCT00092456|42152777|FG002|Overall Study|Withdrawal by Subject|16|||
19708492|NCT00092456|42152778|FG003|Overall Study|Withdrawal by Subject|6|||
19708493|NCT00092456|42152775|FG000|Overall Study|Moved|1|||
19708494|NCT00092456|42152776|FG001|Overall Study|Moved|1|||
19708495|NCT00092456|42152777|FG002|Overall Study|Moved|0|||
19708496|NCT00092456|42152778|FG003|Overall Study|Moved|1|||
19708497|NCT00092456|42152775|FG000|Overall Study|Other|4|||
19708498|NCT00092456|42152776|FG001|Overall Study|Other|2|||
19708499|NCT00092456|42152777|FG002|Overall Study|Other|3|||
19708500|NCT00092456|42152778|FG003|Overall Study|Other|0|||
19708501|NCT00067470|42152790|FG000|Overall Study|Withdrawal by Subject|0|||
19708502|NCT00067470|42152791|FG001|Overall Study|Withdrawal by Subject|1|||
19708503|NCT00401843|42152800|FG000|Overall Study|Achieved Complete Response|1|||
19708504|NCT00401843|42152801|FG001|Overall Study|Achieved Complete Response|5|||
19708505|NCT00401843|42152802|FG002|Overall Study|Achieved Complete Response|11|||
19708506|NCT00401843|42152800|FG000|Overall Study|Adverse Event|7|||
19708507|NCT00401843|42152801|FG001|Overall Study|Adverse Event|26|||
19708508|NCT00401843|42152802|FG002|Overall Study|Adverse Event|27|||
19708509|NCT00401843|42152800|FG000|Overall Study|Death|0|||
19708510|NCT00401843|42152801|FG001|Overall Study|Death|8|||
19708511|NCT00401843|42152802|FG002|Overall Study|Death|10|||
19708512|NCT00401843|42152800|FG000|Overall Study|Disease progression|10|||
19626260|NCT00460603|42075765|FG005|Phase 2|Objective Progression or Relapse|0|||
19708513|NCT00401843|42152801|FG001|Overall Study|Disease progression|60|||
19708514|NCT00401843|42152802|FG002|Overall Study|Disease progression|49|||
19708515|NCT00401843|42152800|FG000|Overall Study|End of Study|1|||
19708516|NCT00401843|42152801|FG001|Overall Study|End of Study|1|||
19708517|NCT00401843|42152802|FG002|Overall Study|End of Study|2|||
19708518|NCT00401843|42152800|FG000|Overall Study|Lost to Follow-up|0|||
19708519|NCT00401843|42152801|FG001|Overall Study|Lost to Follow-up|0|||
19626261|NCT00460603|42075766|FG006|Phase 2|Objective Progression or Relapse|0|||
19373816|NCT02332720|41615031|FG017|Part A and Part B|Adverse Event|1|||
19373817|NCT02332720|41615032|FG018|Part A and Part B|Adverse Event|0|||
19373818|NCT02332720|41615033|FG019|Part A and Part B|Adverse Event|0|||
19373819|NCT02332720|41615034|FG020|Part A and Part B|Adverse Event|0|||
19373820|NCT02332720|41615035|FG021|Part A and Part B|Adverse Event|0|||
19373821|NCT02332720|41615036|FG022|Part A and Part B|Adverse Event|0|||
19373822|NCT02332720|41615014|FG000|Part A and Part B|Physician Decision|0|||
19373823|NCT02332720|41615015|FG001|Part A and Part B|Physician Decision|0|||
19373824|NCT02332720|41615016|FG002|Part A and Part B|Physician Decision|0|||
19373825|NCT02332720|41615017|FG003|Part A and Part B|Physician Decision|0|||
19373826|NCT02332720|41615018|FG004|Part A and Part B|Physician Decision|0|||
19373827|NCT02332720|41615019|FG005|Part A and Part B|Physician Decision|0|||
19373828|NCT02332720|41615020|FG006|Part A and Part B|Physician Decision|0|||
19373829|NCT02332720|41615021|FG007|Part A and Part B|Physician Decision|0|||
19373830|NCT02332720|41615022|FG008|Part A and Part B|Physician Decision|0|||
19373831|NCT02332720|41615023|FG009|Part A and Part B|Physician Decision|0|||
19373832|NCT02332720|41615024|FG010|Part A and Part B|Physician Decision|0|||
19373833|NCT02332720|41615025|FG011|Part A and Part B|Physician Decision|0|||
19373834|NCT02332720|41615026|FG012|Part A and Part B|Physician Decision|0|||
19373835|NCT02332720|41615027|FG013|Part A and Part B|Physician Decision|0|||
19373836|NCT02332720|41615028|FG014|Part A and Part B|Physician Decision|0|||
19373837|NCT02332720|41615029|FG015|Part A and Part B|Physician Decision|0|||
19373838|NCT02332720|41615030|FG016|Part A and Part B|Physician Decision|0|||
19373839|NCT02332720|41615031|FG017|Part A and Part B|Physician Decision|0|||
19373840|NCT02332720|41615032|FG018|Part A and Part B|Physician Decision|1|||
19373841|NCT02332720|41615033|FG019|Part A and Part B|Physician Decision|0|||
19373842|NCT02332720|41615034|FG020|Part A and Part B|Physician Decision|0|||
19373843|NCT02332720|41615035|FG021|Part A and Part B|Physician Decision|0|||
19373844|NCT02332720|41615036|FG022|Part A and Part B|Physician Decision|0|||
19373845|NCT02332720|41615014|FG000|Part A and Part B|Withdrawal by Subject|0|||
19373846|NCT02332720|41615015|FG001|Part A and Part B|Withdrawal by Subject|0|||
19373847|NCT02332720|41615016|FG002|Part A and Part B|Withdrawal by Subject|0|||
19373848|NCT02332720|41615017|FG003|Part A and Part B|Withdrawal by Subject|0|||
19373849|NCT02332720|41615018|FG004|Part A and Part B|Withdrawal by Subject|0|||
19373850|NCT02332720|41615019|FG005|Part A and Part B|Withdrawal by Subject|1|||
19373851|NCT02332720|41615020|FG006|Part A and Part B|Withdrawal by Subject|0|||
19373852|NCT02332720|41615021|FG007|Part A and Part B|Withdrawal by Subject|0|||
19373853|NCT02332720|41615022|FG008|Part A and Part B|Withdrawal by Subject|0|||
19373854|NCT02332720|41615023|FG009|Part A and Part B|Withdrawal by Subject|0|||
19373855|NCT02332720|41615024|FG010|Part A and Part B|Withdrawal by Subject|0|||
19373856|NCT02332720|41615025|FG011|Part A and Part B|Withdrawal by Subject|0|||
19373857|NCT02332720|41615026|FG012|Part A and Part B|Withdrawal by Subject|0|||
19373858|NCT02332720|41615027|FG013|Part A and Part B|Withdrawal by Subject|0|||
19373859|NCT02332720|41615028|FG014|Part A and Part B|Withdrawal by Subject|0|||
19373860|NCT02332720|41615029|FG015|Part A and Part B|Withdrawal by Subject|0|||
19373861|NCT02332720|41615030|FG016|Part A and Part B|Withdrawal by Subject|0|||
19373862|NCT02332720|41615031|FG017|Part A and Part B|Withdrawal by Subject|0|||
19373863|NCT02332720|41615032|FG018|Part A and Part B|Withdrawal by Subject|0|||
19373864|NCT02332720|41615033|FG019|Part A and Part B|Withdrawal by Subject|1|||
19394436|NCT02528253|41638702|FG002|Overall Study|Adverse Event|4|||
19394437|NCT02528253|41638703|FG003|Overall Study|Adverse Event|8|||
19394438|NCT02528253|41638704|FG004|Overall Study|Adverse Event|18|||
19394439|NCT02528253|41638700|FG000|Overall Study|Death|2|||
19394440|NCT02528253|41638701|FG001|Overall Study|Death|2|||
19708520|NCT00401843|42152802|FG002|Overall Study|Lost to Follow-up|2|||
19708521|NCT00401843|42152800|FG000|Overall Study|Other Unspecified|0|||
19708522|NCT00401843|42152801|FG001|Overall Study|Other Unspecified|3|||
19708523|NCT00401843|42152802|FG002|Overall Study|Other Unspecified|5|||
19708524|NCT00401843|42152800|FG000|Overall Study|Physician Decision|0|||
19708525|NCT00401843|42152801|FG001|Overall Study|Physician Decision|16|||
19708526|NCT00401843|42152802|FG002|Overall Study|Physician Decision|10|||
19708527|NCT00401843|42152800|FG000|Overall Study|Protocol Violation|0|||
19708528|NCT00401843|42152801|FG001|Overall Study|Protocol Violation|0|||
19708529|NCT00401843|42152802|FG002|Overall Study|Protocol Violation|1|||
19708530|NCT00401843|42152800|FG000|Overall Study|Withdrawal by Subject|1|||
19708531|NCT00401843|42152801|FG001|Overall Study|Withdrawal by Subject|5|||
19708532|NCT00401843|42152802|FG002|Overall Study|Withdrawal by Subject|5|||
19708533|NCT00401843|42152800|FG000|Overall Study|Withdrawal of consent to study agent|1|||
19708534|NCT00401843|42152801|FG001|Overall Study|Withdrawal of consent to study agent|15|||
19708535|NCT00401843|42152802|FG002|Overall Study|Withdrawal of consent to study agent|17|||
19708536|NCT00401843|42152800|FG000|Overall Study|Randomized but not Treated|0|||
19708537|NCT00401843|42152801|FG001|Overall Study|Randomized but not Treated|2|||
19394441|NCT02528253|41638702|FG002|Overall Study|Death|1|||
19394442|NCT02528253|41638703|FG003|Overall Study|Death|0|||
19708538|NCT00401843|42152802|FG002|Overall Study|Randomized but not Treated|3|||
19373865|NCT02332720|41615034|FG020|Part A and Part B|Withdrawal by Subject|0|||
19708539|NCT00401843|42152800|FG000|Overall Study|Received incorrect treatment|0|||
19708540|NCT00401843|42152801|FG001|Overall Study|Received incorrect treatment|3|||
19708541|NCT00401843|42152802|FG002|Overall Study|Received incorrect treatment|0|||
19708542|NCT00401531|42152814|FG000|Overall Study|Adverse Event|2|||
19708543|NCT00401531|42152815|FG001|Overall Study|Adverse Event|0|||
19708544|NCT00401531|42152814|FG000|Overall Study|Protocol Violation|3|||
19626262|NCT00460603|42075767|FG007|Phase 2|Objective Progression or Relapse|0|||
19626263|NCT00460603|42075768|FG008|Phase 2|Objective Progression or Relapse|0|||
19626264|NCT00460603|42075769|FG009|Phase 2|Objective Progression or Relapse|9|||
19626265|NCT00460603|42075770|FG010|Phase 2|Objective Progression or Relapse|10|||
19626266|NCT00460603|42075771|FG011|Phase 2|Objective Progression or Relapse|17|||
19626267|NCT00460603|42075760|FG000|Phase 2|Global Deterioration of Health Status|0|||
19626268|NCT00460603|42075761|FG001|Phase 2|Global Deterioration of Health Status|0|||
19626269|NCT00460603|42075762|FG002|Phase 2|Global Deterioration of Health Status|0|||
19626270|NCT00460603|42075763|FG003|Phase 2|Global Deterioration of Health Status|0|||
19626271|NCT00460603|42075764|FG004|Phase 2|Global Deterioration of Health Status|0|||
19708545|NCT00401531|42152815|FG001|Overall Study|Protocol Violation|7|||
19708546|NCT00401531|42152814|FG000|Overall Study|Lost to Follow-up|1|||
19708547|NCT00401531|42152815|FG001|Overall Study|Lost to Follow-up|1|||
19708548|NCT00401531|42152814|FG000|Overall Study|Withdrawal by Subject|3|||
19708549|NCT00401531|42152815|FG001|Overall Study|Withdrawal by Subject|2|||
19373866|NCT02332720|41615035|FG021|Part A and Part B|Withdrawal by Subject|0|||
19373867|NCT02332720|41615036|FG022|Part A and Part B|Withdrawal by Subject|0|||
19708550|NCT00401375|42152824|FG000|Overall Study|Protocol Violation|2|||
19708551|NCT00401375|42152825|FG001|Overall Study|Protocol Violation|2|||
19708552|NCT00401375|42152826|FG002|Overall Study|Protocol Violation|1|||
19708553|NCT00401375|42152824|FG000|Overall Study|Adverse Event|6|||
19708554|NCT00401375|42152825|FG001|Overall Study|Adverse Event|11|||
19708555|NCT00401375|42152826|FG002|Overall Study|Adverse Event|10|||
19708556|NCT00401375|42152824|FG000|Overall Study|Withdrawal by Subject|9|||
19708557|NCT00401375|42152825|FG001|Overall Study|Withdrawal by Subject|7|||
19708558|NCT00401375|42152826|FG002|Overall Study|Withdrawal by Subject|7|||
19708559|NCT00401375|42152824|FG000|Overall Study|Lost to Follow-up|0|||
19708560|NCT00401375|42152825|FG001|Overall Study|Lost to Follow-up|1|||
19708561|NCT00401375|42152826|FG002|Overall Study|Lost to Follow-up|1|||
19708562|NCT00401375|42152824|FG000|Overall Study|Other than specified|2|||
19708563|NCT00401375|42152825|FG001|Overall Study|Other than specified|1|||
19708564|NCT00401375|42152826|FG002|Overall Study|Other than specified|3|||
19708565|NCT00401375|42152824|FG000|Overall Study|Randomized but not treated|3|||
19708566|NCT00401375|42152825|FG001|Overall Study|Randomized but not treated|3|||
19708567|NCT00401375|42152826|FG002|Overall Study|Randomized but not treated|3|||
19708568|NCT00400985|42152834|FG000|Overall Study|Withdrawal by Subject|5|||
19708569|NCT00400985|42152834|FG000|Overall Study|system modification|8|||
19708570|NCT00400985|42152834|FG000|Overall Study|Death|30|||
19708571|NCT00400985|42152834|FG000|Overall Study|Lost to Follow-up|9|||
19708572|NCT00400517|42152838|FG000|Overall Study|Withdrawal by Subject|1|||
19708573|NCT00400517|42152838|FG000|Overall Study|Physician Decision|1|||
19708574|NCT00392171|42152842|FG000|Overall Study|Did not meet inclusion criteria|4|||
19708575|NCT00392171|42152842|FG000|Overall Study|Disease progression|101|||
19708576|NCT00392015|42152852|FG000|Overall Study|Lost to Follow-up|2|||
19708577|NCT00392015|42152853|FG001|Overall Study|Lost to Follow-up|0|||
19708578|NCT00392015|42152854|FG002|Overall Study|Lost to Follow-up|2|||
19708579|NCT00392015|42152855|FG003|Overall Study|Lost to Follow-up|1|||
19708580|NCT00392015|42152856|FG004|Overall Study|Lost to Follow-up|1|||
19708581|NCT00392015|42152857|FG005|Overall Study|Lost to Follow-up|0|||
19708582|NCT00392015|42152852|FG000|Overall Study|Withdrawal by Subject|0|||
19708583|NCT00392015|42152853|FG001|Overall Study|Withdrawal by Subject|0|||
19708584|NCT00392015|42152854|FG002|Overall Study|Withdrawal by Subject|2|||
19708585|NCT00392015|42152855|FG003|Overall Study|Withdrawal by Subject|0|||
19708586|NCT00392015|42152856|FG004|Overall Study|Withdrawal by Subject|0|||
19708587|NCT00392015|42152857|FG005|Overall Study|Withdrawal by Subject|0|||
19373868|NCT02331394|41615108|FG000|Overall Study|Disease progression|1|||
19373869|NCT01645930|41615119|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
19373870|NCT01645930|41615119|FG000|Overall Study|Progressive Disease|12|||
19373871|NCT01645930|41615119|FG000|Overall Study|Adverse Event|4|||
19373872|NCT01645930|41615119|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
19373873|NCT01645930|41615119|FG000|Overall Study|Withdrawal by Participant|2|||
19373874|NCT01645930|41615119|FG000|Overall Study|Reason not Defined|1|||
19373875|NCT02299336|41615123|FG000|Overall Study|Withdrawal by Subject|11|||
19373876|NCT02299336|41615123|FG000|Overall Study|Adverse Event|1|||
19373877|NCT02299336|41615123|FG000|Overall Study|Death|1|||
19373878|NCT02299336|41615123|FG000|Overall Study|Lost to Follow-up|1|||
19373879|NCT02664441|41615129|FG000|Randomization|Withdrawal by Subject|0|||
19373880|NCT02664441|41615130|FG001|Randomization|Withdrawal by Subject|1|||
19708588|NCT00392015|42152852|FG000|Overall Study|Adverse Event|0|||
19708589|NCT00392015|42152853|FG001|Overall Study|Adverse Event|0|||
19708590|NCT00392015|42152854|FG002|Overall Study|Adverse Event|0|||
19708591|NCT00392015|42152855|FG003|Overall Study|Adverse Event|0|||
19708592|NCT00392015|42152856|FG004|Overall Study|Adverse Event|1|||
19373881|NCT02664441|41615129|FG000|36-week Randomized Trial|Adverse Event|2|||
19373882|NCT02664441|41615130|FG001|36-week Randomized Trial|Adverse Event|0|||
19373883|NCT02664441|41615129|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
19394443|NCT02528253|41638704|FG004|Overall Study|Death|1|||
19708593|NCT00392015|42152857|FG005|Overall Study|Adverse Event|0|||
19708594|NCT00392015|42152852|FG000|Overall Study|Previous trial recipient|0|||
19708595|NCT00392015|42152853|FG001|Overall Study|Previous trial recipient|0|||
19708596|NCT00392015|42152854|FG002|Overall Study|Previous trial recipient|0|||
19708597|NCT00392015|42152855|FG003|Overall Study|Previous trial recipient|0|||
19708598|NCT00392015|42152856|FG004|Overall Study|Previous trial recipient|1|||
19708599|NCT00392015|42152857|FG005|Overall Study|Previous trial recipient|0|||
19708600|NCT00391625|42152876|FG000|Month 14|Withdrawal by Subject|1|||
19708601|NCT00391625|42152876|FG000|Month 50|Physician Decision|1|||
19708602|NCT00091832|42152909|FG000|Overall Study|Physician Decision|1|||
19708603|NCT00091832|42152910|FG001|Overall Study|Physician Decision|0|||
19708604|NCT00091832|42152911|FG002|Overall Study|Physician Decision|0|||
19708605|NCT00091832|42152912|FG003|Overall Study|Physician Decision|0|||
19708606|NCT00091832|42152913|FG004|Overall Study|Physician Decision|0|||
19708607|NCT00091832|42152914|FG005|Overall Study|Physician Decision|0|||
19708608|NCT00091832|42152909|FG000|Overall Study|Adverse Event|0|||
19708609|NCT00091832|42152910|FG001|Overall Study|Adverse Event|0|||
19708610|NCT00091832|42152911|FG002|Overall Study|Adverse Event|0|||
19708611|NCT00091832|42152912|FG003|Overall Study|Adverse Event|1|||
19708612|NCT00091832|42152913|FG004|Overall Study|Adverse Event|3|||
19708613|NCT00091832|42152914|FG005|Overall Study|Adverse Event|0|||
19708614|NCT00091832|42152909|FG000|Overall Study|Withdrawal by Subject|4|||
19708615|NCT00091832|42152910|FG001|Overall Study|Withdrawal by Subject|5|||
19708616|NCT00091832|42152911|FG002|Overall Study|Withdrawal by Subject|0|||
19708617|NCT00091832|42152912|FG003|Overall Study|Withdrawal by Subject|1|||
19708618|NCT00091832|42152913|FG004|Overall Study|Withdrawal by Subject|3|||
19708619|NCT00091832|42152914|FG005|Overall Study|Withdrawal by Subject|1|||
19708620|NCT00091832|42152909|FG000|Overall Study|Death|6|||
19708621|NCT00091832|42152910|FG001|Overall Study|Death|4|||
19708622|NCT00091832|42152911|FG002|Overall Study|Death|5|||
19708623|NCT00091832|42152912|FG003|Overall Study|Death|8|||
19708624|NCT00091832|42152913|FG004|Overall Study|Death|5|||
19708625|NCT00091832|42152914|FG005|Overall Study|Death|6|||
19708626|NCT00091832|42152909|FG000|Overall Study|Disease Progression|2|||
19708627|NCT00091832|42152910|FG001|Overall Study|Disease Progression|0|||
19708628|NCT00091832|42152911|FG002|Overall Study|Disease Progression|0|||
19708629|NCT00091832|42152912|FG003|Overall Study|Disease Progression|1|||
19708630|NCT00091832|42152913|FG004|Overall Study|Disease Progression|1|||
19708631|NCT00091832|42152914|FG005|Overall Study|Disease Progression|2|||
19708632|NCT00091832|42152909|FG000|Overall Study|Ineligibility Determined|0|||
19708633|NCT00091832|42152910|FG001|Overall Study|Ineligibility Determined|0|||
19708634|NCT00091832|42152911|FG002|Overall Study|Ineligibility Determined|1|||
19708635|NCT00091832|42152912|FG003|Overall Study|Ineligibility Determined|0|||
19708636|NCT00091832|42152913|FG004|Overall Study|Ineligibility Determined|1|||
19708637|NCT00091832|42152914|FG005|Overall Study|Ineligibility Determined|0|||
19708638|NCT00091832|42152909|FG000|Overall Study|Lost to Follow-up|1|||
19708639|NCT00091832|42152910|FG001|Overall Study|Lost to Follow-up|0|||
19708640|NCT00091832|42152911|FG002|Overall Study|Lost to Follow-up|3|||
19708641|NCT00091832|42152912|FG003|Overall Study|Lost to Follow-up|3|||
19708642|NCT00091832|42152913|FG004|Overall Study|Lost to Follow-up|2|||
19708643|NCT00091832|42152914|FG005|Overall Study|Lost to Follow-up|1|||
19708644|NCT00091832|42152909|FG000|Overall Study|Noncompliance|0|||
19708645|NCT00091832|42152910|FG001|Overall Study|Noncompliance|1|||
19708646|NCT00091832|42152911|FG002|Overall Study|Noncompliance|0|||
19708647|NCT00091832|42152912|FG003|Overall Study|Noncompliance|0|||
19708648|NCT00091832|42152913|FG004|Overall Study|Noncompliance|0|||
19708649|NCT00091832|42152914|FG005|Overall Study|Noncompliance|0|||
19708650|NCT00091832|42152909|FG000|Overall Study|Other|0|||
19708651|NCT00091832|42152910|FG001|Overall Study|Other|1|||
19708652|NCT00091832|42152911|FG002|Overall Study|Other|2|||
19708653|NCT00091832|42152912|FG003|Overall Study|Other|0|||
19708654|NCT00091832|42152913|FG004|Overall Study|Other|0|||
19708655|NCT00091832|42152914|FG005|Overall Study|Other|0|||
19708656|NCT00091832|42152909|FG000|Overall Study|Protocol Violation|0|||
19708657|NCT00091832|42152910|FG001|Overall Study|Protocol Violation|0|||
19708658|NCT00091832|42152911|FG002|Overall Study|Protocol Violation|1|||
19708659|NCT00091832|42152912|FG003|Overall Study|Protocol Violation|0|||
19708660|NCT00091832|42152913|FG004|Overall Study|Protocol Violation|0|||
19708661|NCT00091832|42152914|FG005|Overall Study|Protocol Violation|1|||
19708662|NCT00391391|42152932|FG000|Overall Study|Adverse Event|0|||
19708663|NCT00391391|42152933|FG001|Overall Study|Adverse Event|0|||
19708664|NCT00391391|42152934|FG002|Overall Study|Adverse Event|0|||
19708665|NCT00391391|42152935|FG003|Overall Study|Adverse Event|1|||
19708666|NCT00391391|42152932|FG000|Overall Study|Lost to Follow-up|1|||
19708667|NCT00391391|42152933|FG001|Overall Study|Lost to Follow-up|3|||
19708668|NCT00391391|42152934|FG002|Overall Study|Lost to Follow-up|7|||
19708669|NCT00391391|42152935|FG003|Overall Study|Lost to Follow-up|4|||
19708670|NCT00391391|42152932|FG000|Overall Study|Protocol Violation|2|||
19708671|NCT00391391|42152933|FG001|Overall Study|Protocol Violation|3|||
19708672|NCT00391391|42152934|FG002|Overall Study|Protocol Violation|6|||
19708673|NCT00391391|42152935|FG003|Overall Study|Protocol Violation|7|||
19708674|NCT00391391|42152932|FG000|Overall Study|Withdrawal by Subject|6|||
19708675|NCT00391391|42152933|FG001|Overall Study|Withdrawal by Subject|4|||
19708676|NCT00391391|42152934|FG002|Overall Study|Withdrawal by Subject|10|||
19708677|NCT00391391|42152935|FG003|Overall Study|Withdrawal by Subject|7|||
19708678|NCT00091442|42152947|FG000|Overall Study|Progressive Disease|220|||
19708679|NCT00091442|42152948|FG001|Overall Study|Progressive Disease|189|||
19708680|NCT00091442|42152947|FG000|Overall Study|Physician Decision|61|||
19708681|NCT00091442|42152948|FG001|Overall Study|Physician Decision|58|||
19708682|NCT00091442|42152947|FG000|Overall Study|Withdrawal by Subject|38|||
19708683|NCT00091442|42152948|FG001|Overall Study|Withdrawal by Subject|46|||
19708684|NCT00091442|42152947|FG000|Overall Study|Adverse Event|29|||
19708685|NCT00091442|42152948|FG001|Overall Study|Adverse Event|48|||
19708686|NCT00091442|42152947|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
19708687|NCT00091442|42152948|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
19708688|NCT00091442|42152947|FG000|Overall Study|Death|9|||
19708689|NCT00091442|42152948|FG001|Overall Study|Death|7|||
19708690|NCT00091442|42152947|FG000|Overall Study|Lost to Follow-up|1|||
19708691|NCT00091442|42152948|FG001|Overall Study|Lost to Follow-up|3|||
19708692|NCT00091442|42152947|FG000|Overall Study|Other|2|||
19708693|NCT00091442|42152948|FG001|Overall Study|Other|6|||
19708694|NCT00390689|42152957|FG000|Overall Study|Adverse Event|2|||
19708695|NCT00390689|42152958|FG001|Overall Study|Adverse Event|5|||
19708696|NCT00390689|42152959|FG002|Overall Study|Adverse Event|2|||
19708697|NCT00390689|42152957|FG000|Overall Study|Lack of Efficacy|0|||
19708698|NCT00390689|42152958|FG001|Overall Study|Lack of Efficacy|0|||
19708699|NCT00390689|42152959|FG002|Overall Study|Lack of Efficacy|1|||
19708700|NCT00390689|42152957|FG000|Overall Study|Protocol Violation|1|||
19708701|NCT00390689|42152958|FG001|Overall Study|Protocol Violation|0|||
19708702|NCT00390689|42152959|FG002|Overall Study|Protocol Violation|0|||
19708703|NCT00390689|42152957|FG000|Overall Study|Investigator's judgement|2|||
19708704|NCT00390689|42152958|FG001|Overall Study|Investigator's judgement|0|||
19708705|NCT00390689|42152959|FG002|Overall Study|Investigator's judgement|0|||
19708706|NCT00121238|42152976|FG000|Overall Study|disease progression before intervention|1|||
19708707|NCT00121238|42152976|FG000|Overall Study|Protocol Violation|2|||
19708708|NCT00390455|42152982|FG000|Overall Study|Adverse Event|17|||
19708709|NCT00390455|42152983|FG001|Overall Study|Adverse Event|3|||
19708710|NCT00390455|42152982|FG000|Overall Study|Withdrawal by Subject|8|||
19708711|NCT00390455|42152983|FG001|Overall Study|Withdrawal by Subject|8|||
19708712|NCT00390455|42152982|FG000|Overall Study|Alternate Treatment|0|||
19708713|NCT00390455|42152983|FG001|Overall Study|Alternate Treatment|1|||
19708714|NCT00390455|42152982|FG000|Overall Study|Other Medical Reasons|7|||
19708715|NCT00390455|42152983|FG001|Overall Study|Other Medical Reasons|11|||
19708716|NCT03812510|42152989|FG000|Overall Study|Lost to Follow-up|39|||
19708717|NCT03812510|42152989|FG000|Overall Study|Withdrawal by Subject|42|||
19708718|NCT03812510|42152989|FG000|Overall Study|Physician Decision|2|||
19708719|NCT03812510|42152989|FG000|Overall Study|Study Terminated by Sponsor|9|||
19708720|NCT03812510|42152989|FG000|Overall Study|Did Not Start Study Medication|55|||
19708721|NCT03812510|42152989|FG000|Overall Study|Adverse Event|5|||
19708722|NCT00390299|42152999|FG000|Overall Study|Cancellation|1|||
19708723|NCT00390299|42153000|FG001|Overall Study|Cancellation|0|||
19708724|NCT00390299|42153001|FG002|Overall Study|Cancellation|0|||
19708725|NCT00390299|42153002|FG003|Overall Study|Cancellation|0|||
19626272|NCT00460603|42075765|FG005|Phase 2|Global Deterioration of Health Status|0|||
19626273|NCT00460603|42075766|FG006|Phase 2|Global Deterioration of Health Status|0|||
19626274|NCT00460603|42075767|FG007|Phase 2|Global Deterioration of Health Status|0|||
19626275|NCT00460603|42075768|FG008|Phase 2|Global Deterioration of Health Status|0|||
19626276|NCT00460603|42075769|FG009|Phase 2|Global Deterioration of Health Status|0|||
19626277|NCT00460603|42075770|FG010|Phase 2|Global Deterioration of Health Status|1|||
19708726|NCT00390299|42153003|FG004|Overall Study|Cancellation|0|||
19708727|NCT00119678|42153019|FG000|Double-blind Treatment Period|Death|1|||
19708728|NCT00119678|42153020|FG001|Double-blind Treatment Period|Death|0|||
19708729|NCT00119678|42153019|FG000|Double-blind Treatment Period|Adverse Event|7|||
19708730|NCT00119678|42153020|FG001|Double-blind Treatment Period|Adverse Event|1|||
19708731|NCT00119678|42153019|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
19708732|NCT00119678|42153020|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
19708733|NCT00119678|42153019|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
19708734|NCT00119678|42153020|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
19708735|NCT00119678|42153019|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
19708736|NCT00119678|42153020|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
19708737|NCT00119678|42153019|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
19708738|NCT00119678|42153020|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
19708739|NCT00119678|42153019|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
19708740|NCT00119678|42153020|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
19708741|NCT00119678|42153019|FG000|Double-blind Treatment Period|Pregnancy|0|||
19626278|NCT00460603|42075771|FG011|Phase 2|Global Deterioration of Health Status|0|||
19626279|NCT00460603|42075760|FG000|Phase 2|Withdrawal by Subject|0|||
19626280|NCT00460603|42075761|FG001|Phase 2|Withdrawal by Subject|0|||
19626281|NCT00460603|42075762|FG002|Phase 2|Withdrawal by Subject|0|||
19626282|NCT00460603|42075763|FG003|Phase 2|Withdrawal by Subject|0|||
19626283|NCT00460603|42075764|FG004|Phase 2|Withdrawal by Subject|0|||
19626284|NCT00460603|42075765|FG005|Phase 2|Withdrawal by Subject|0|||
19626285|NCT00460603|42075766|FG006|Phase 2|Withdrawal by Subject|0|||
19626286|NCT00460603|42075767|FG007|Phase 2|Withdrawal by Subject|0|||
19626287|NCT00460603|42075768|FG008|Phase 2|Withdrawal by Subject|0|||
19708742|NCT00119678|42153020|FG001|Double-blind Treatment Period|Pregnancy|2|||
19708743|NCT00119678|42153019|FG000|Double-blind Treatment Period|Not treated|1|||
19708744|NCT00119678|42153020|FG001|Double-blind Treatment Period|Not treated|2|||
19373884|NCT02664441|41615130|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
19708745|NCT00119678|42153019|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
19626288|NCT00460603|42075769|FG009|Phase 2|Withdrawal by Subject|5|||
19626289|NCT00460603|42075770|FG010|Phase 2|Withdrawal by Subject|4|||
19708746|NCT00119678|42153020|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
19708747|NCT00119678|42153019|FG000|Open-label Treatment Period|Death|1|||
19708748|NCT00119678|42153020|FG001|Open-label Treatment Period|Death|0|||
19708749|NCT00119678|42153019|FG000|Open-label Treatment Period|Adverse Event|3|||
19708750|NCT00119678|42153020|FG001|Open-label Treatment Period|Adverse Event|0|||
19708751|NCT00119678|42153019|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
19708752|NCT00119678|42153020|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
19708753|NCT00119678|42153019|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
19708754|NCT00119678|42153020|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
19708755|NCT00119678|42153019|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
19708756|NCT00119678|42153020|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
19708757|NCT00119678|42153019|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
19708758|NCT00119678|42153020|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
19708759|NCT00119678|42153019|FG000|Open-label Treatment Period|Pregnancy|1|||
19373885|NCT02664441|41615129|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
19373886|NCT02664441|41615130|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
19708760|NCT00119678|42153020|FG001|Open-label Treatment Period|Pregnancy|0|||
19708761|NCT00119678|42153019|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
19708762|NCT00119678|42153020|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
19708763|NCT00110084|42153028|FG000|Overall Study|Adverse Event|9|||
19708764|NCT00110084|42153028|FG000|Overall Study|Death|1|||
19708765|NCT00110084|42153028|FG000|Overall Study|Patient Refusal|10|||
19373887|NCT02664441|41615129|FG000|18-week Open Label Extension|Adverse Event|1|||
19708766|NCT00110084|42153028|FG000|Overall Study|Alternate Therapy|5|||
19708767|NCT00110084|42153028|FG000|Overall Study|Intercurrent Illness|1|||
19708768|NCT00110084|42153028|FG000|Overall Study|Other|2|||
19708769|NCT00390221|42153035|FG000|Overall Study|Lost to Follow-up|0|||
19373888|NCT02664441|41615130|FG001|18-week Open Label Extension|Adverse Event|0|||
19373889|NCT02664441|41615129|FG000|18-week Open Label Extension|Physician Decision|1|||
19373890|NCT02664441|41615130|FG001|18-week Open Label Extension|Physician Decision|0|||
19373891|NCT02664441|41615129|FG000|18-week Open Label Extension|Death|1|||
19373892|NCT02664441|41615130|FG001|18-week Open Label Extension|Death|0|||
19373893|NCT02664441|41615129|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
19373894|NCT02664441|41615130|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
19373895|NCT02298946|41615139|FG000|Overall Study|Did not receive treatment|2|||
19373896|NCT02298946|41615140|FG001|Overall Study|Did not receive treatment|0|||
19373897|NCT02298946|41615139|FG000|Overall Study|Unevaluable|2|||
19373898|NCT02298946|41615140|FG001|Overall Study|Unevaluable|1|||
19373899|NCT02328040|41615147|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
19373900|NCT02328040|41615148|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
19626290|NCT00460603|42075771|FG011|Phase 2|Withdrawal by Subject|5|||
19626291|NCT00460603|42075760|FG000|Phase 2|Randomized, but not treated|0|||
19626292|NCT00460603|42075761|FG001|Phase 2|Randomized, but not treated|0|||
19626293|NCT00460603|42075762|FG002|Phase 2|Randomized, but not treated|0|||
19626294|NCT00460603|42075763|FG003|Phase 2|Randomized, but not treated|0|||
19626295|NCT00460603|42075764|FG004|Phase 2|Randomized, but not treated|0|||
19626296|NCT00460603|42075765|FG005|Phase 2|Randomized, but not treated|0|||
19626297|NCT00460603|42075766|FG006|Phase 2|Randomized, but not treated|0|||
19626298|NCT00460603|42075767|FG007|Phase 2|Randomized, but not treated|0|||
19626299|NCT00460603|42075768|FG008|Phase 2|Randomized, but not treated|0|||
19626300|NCT00460603|42075769|FG009|Phase 2|Randomized, but not treated|3|||
19626301|NCT00460603|42075770|FG010|Phase 2|Randomized, but not treated|0|||
19626302|NCT00460603|42075771|FG011|Phase 2|Randomized, but not treated|0|||
19626303|NCT00662038|42075797|FG000|Overall Study|Reason not specified|3|||
19626304|NCT00662038|42075797|FG000|Overall Study|Withdrawn consent|22|||
19626305|NCT00662038|42075797|FG000|Overall Study|Withdrawal by Subject|83|||
19626306|NCT00662038|42075797|FG000|Overall Study|Sponsor decision|1|||
19626307|NCT00662038|42075797|FG000|Overall Study|Physician Decision|19|||
19626308|NCT00662038|42075797|FG000|Overall Study|Lung transplantation|44|||
19708770|NCT00390221|42153036|FG001|Overall Study|Lost to Follow-up|3|||
19708771|NCT00390221|42153037|FG002|Overall Study|Lost to Follow-up|0|||
19708772|NCT00390221|42153035|FG000|Overall Study|Adverse Event|1|||
19708773|NCT00390221|42153036|FG001|Overall Study|Adverse Event|4|||
19708774|NCT00390221|42153037|FG002|Overall Study|Adverse Event|3|||
19708775|NCT00390221|42153035|FG000|Overall Study|Investigator Decision|0|||
19708776|NCT00390221|42153036|FG001|Overall Study|Investigator Decision|0|||
19708777|NCT00390221|42153037|FG002|Overall Study|Investigator Decision|1|||
19708778|NCT00390221|42153035|FG000|Overall Study|Withdrawal by Subject|13|||
19708779|NCT00390221|42153036|FG001|Overall Study|Withdrawal by Subject|9|||
19708780|NCT00390221|42153037|FG002|Overall Study|Withdrawal by Subject|7|||
19708781|NCT00390221|42153035|FG000|Overall Study|Subject Non-compliance|1|||
19708782|NCT00390221|42153036|FG001|Overall Study|Subject Non-compliance|0|||
19708783|NCT00390221|42153037|FG002|Overall Study|Subject Non-compliance|2|||
19708784|NCT00390221|42153035|FG000|Overall Study|Other|3|||
19708785|NCT00390221|42153036|FG001|Overall Study|Other|4|||
19708786|NCT00390221|42153037|FG002|Overall Study|Other|2|||
19708787|NCT00389831|42153048|FG000|Overall Study|Lack of Efficacy|0|||
19708788|NCT00389831|42153049|FG001|Overall Study|Lack of Efficacy|2|||
19708789|NCT00389831|42153048|FG000|Overall Study|Did not receive treatment.|0|||
19708790|NCT00389831|42153049|FG001|Overall Study|Did not receive treatment.|2|||
19708791|NCT00389831|42153048|FG000|Overall Study|Other reasons|0|||
19708792|NCT00389831|42153049|FG001|Overall Study|Other reasons|2|||
19708793|NCT00389831|42153048|FG000|Overall Study|Lost to Follow-up|0|||
19708794|NCT00389831|42153049|FG001|Overall Study|Lost to Follow-up|1|||
19708795|NCT00389597|42153071|FG000|Overall Study|Lost to Follow-up|8|||
19708796|NCT00389597|42153072|FG001|Overall Study|Lost to Follow-up|6|||
19708797|NCT00389597|42153073|FG002|Overall Study|Lost to Follow-up|4|||
19708798|NCT00389597|42153074|FG003|Overall Study|Lost to Follow-up|6|||
19708799|NCT00389519|42153088|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
19708800|NCT00389519|42153089|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
19708801|NCT00389519|42153090|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
19708802|NCT00389519|42153091|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
19708803|NCT00389519|42153088|FG000|Placebo Run-In|Withdrawal by Subject|19|||
19708804|NCT00389519|42153089|FG001|Placebo Run-In|Withdrawal by Subject|0|||
19708805|NCT00389519|42153090|FG002|Placebo Run-In|Withdrawal by Subject|0|||
19708806|NCT00389519|42153091|FG003|Placebo Run-In|Withdrawal by Subject|0|||
19373901|NCT01647958|41615156|FG000|Initial Study|Lost to Follow-up|2|||
19373902|NCT01647958|41615157|FG001|Initial Study|Lost to Follow-up|3|||
19626309|NCT00662038|42075797|FG000|Overall Study|Lost to Follow-up|1|||
19626310|NCT00662038|42075797|FG000|Overall Study|Death|95|||
19708807|NCT00389519|42153088|FG000|Placebo Run-In|Reason not specified|40|||
19708808|NCT00389519|42153089|FG001|Placebo Run-In|Reason not specified|0|||
19708809|NCT00389519|42153090|FG002|Placebo Run-In|Reason not specified|0|||
19708810|NCT00389519|42153091|FG003|Placebo Run-In|Reason not specified|0|||
19394444|NCT02528253|41638700|FG000|Overall Study|Insufficient clinical response|7|||
19394445|NCT02528253|41638701|FG001|Overall Study|Insufficient clinical response|10|||
19626311|NCT00662038|42075797|FG000|Overall Study|Adverse Event|358|||
19626312|NCT00662038|42075797|FG000|Overall Study|Continued treatment|5|||
19626313|NCT00819156|42075807|FG000|Overall Study|Adverse Event|1|||
19626314|NCT00819156|42075808|FG001|Overall Study|Adverse Event|4|||
19626315|NCT00819156|42075809|FG002|Overall Study|Adverse Event|2|||
19626316|NCT00819156|42075810|FG003|Overall Study|Adverse Event|1|||
19626317|NCT00819156|42075811|FG004|Overall Study|Adverse Event|2|||
19626318|NCT00819156|42075812|FG005|Overall Study|Adverse Event|3|||
19626319|NCT00819156|42075807|FG000|Overall Study|Withdrawal by Subject|0|||
19626320|NCT00819156|42075808|FG001|Overall Study|Withdrawal by Subject|3|||
19626321|NCT00819156|42075809|FG002|Overall Study|Withdrawal by Subject|2|||
19394446|NCT02528253|41638702|FG002|Overall Study|Insufficient clinical response|13|||
19394447|NCT02528253|41638703|FG003|Overall Study|Insufficient clinical response|12|||
19394448|NCT02528253|41638704|FG004|Overall Study|Insufficient clinical response|16|||
19394449|NCT02528253|41638700|FG000|Overall Study|Lost to Follow-up|16|||
19394450|NCT02528253|41638701|FG001|Overall Study|Lost to Follow-up|9|||
19394451|NCT02528253|41638702|FG002|Overall Study|Lost to Follow-up|31|||
19394452|NCT02528253|41638703|FG003|Overall Study|Lost to Follow-up|16|||
19394453|NCT02528253|41638704|FG004|Overall Study|Lost to Follow-up|34|||
19394454|NCT02528253|41638700|FG000|Overall Study|Other|21|||
19394455|NCT02528253|41638701|FG001|Overall Study|Other|22|||
19708811|NCT00389519|42153088|FG000|Randomized|Did not receive study drug|2|||
19708812|NCT00389519|42153089|FG001|Randomized|Did not receive study drug|0|||
19708813|NCT00389519|42153090|FG002|Randomized|Did not receive study drug|0|||
19708814|NCT00389519|42153091|FG003|Randomized|Did not receive study drug|0|||
19708815|NCT00389519|42153088|FG000|Treated|Adverse Event|1|||
19708816|NCT00389519|42153089|FG001|Treated|Adverse Event|0|||
19708817|NCT00389519|42153090|FG002|Treated|Adverse Event|0|||
19708818|NCT00389519|42153091|FG003|Treated|Adverse Event|2|||
19708819|NCT00389519|42153088|FG000|Treated|Reason not specified|1|||
19708820|NCT00389519|42153089|FG001|Treated|Reason not specified|1|||
19708821|NCT00389519|42153090|FG002|Treated|Reason not specified|0|||
19708822|NCT00389519|42153091|FG003|Treated|Reason not specified|2|||
19708823|NCT00389441|42153101|FG000|Overall Study|Adverse Event|7|||
19708824|NCT00389441|42153101|FG000|Overall Study|Death|4|||
19708825|NCT00389441|42153101|FG000|Overall Study|Lost to Follow-up|2|||
19708826|NCT00389441|42153101|FG000|Overall Study|Withdrawal by Subject|4|||
19708827|NCT00389441|42153101|FG000|Overall Study|Physician Decision|1|||
19708828|NCT00389441|42153101|FG000|Overall Study|Protocol Violation|1|||
19708829|NCT00389441|42153101|FG000|Overall Study|Global deterioration of health status|4|||
19708830|NCT00389441|42153101|FG000|Overall Study|Objective progression or relapse|26|||
19708831|NCT00389441|42153101|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
19708832|NCT00389441|42153101|FG000|Overall Study|Clinical progression|1|||
19708833|NCT00118898|42153109|FG000|Overall Study|Death|6|||
19708834|NCT00118898|42153110|FG001|Overall Study|Death|11|||
19708835|NCT00118898|42153111|FG002|Overall Study|Death|6|||
19708836|NCT00118898|42153112|FG003|Overall Study|Death|8|||
19708837|NCT00118898|42153109|FG000|Overall Study|Lost to Follow-up|26|||
19708838|NCT00118898|42153110|FG001|Overall Study|Lost to Follow-up|34|||
19708839|NCT00118898|42153111|FG002|Overall Study|Lost to Follow-up|33|||
19708840|NCT00118898|42153112|FG003|Overall Study|Lost to Follow-up|33|||
19708841|NCT00118898|42153109|FG000|Overall Study|Withdrawal by Subject|10|||
19708842|NCT00118898|42153110|FG001|Overall Study|Withdrawal by Subject|5|||
19708843|NCT00118898|42153111|FG002|Overall Study|Withdrawal by Subject|8|||
19708844|NCT00118898|42153112|FG003|Overall Study|Withdrawal by Subject|8|||
19708845|NCT00118898|42153109|FG000|Overall Study|Site Closure|33|||
19708846|NCT00118898|42153110|FG001|Overall Study|Site Closure|31|||
19708847|NCT00118898|42153111|FG002|Overall Study|Site Closure|28|||
19708848|NCT00118898|42153112|FG003|Overall Study|Site Closure|37|||
19708849|NCT00118898|42153109|FG000|Overall Study|Severe debilitation|1|||
19708850|NCT00118898|42153110|FG001|Overall Study|Severe debilitation|4|||
19708851|NCT00118898|42153111|FG002|Overall Study|Severe debilitation|6|||
19708852|NCT00118898|42153112|FG003|Overall Study|Severe debilitation|4|||
19708853|NCT00118898|42153109|FG000|Overall Study|Not compliant with requirements|11|||
19708854|NCT00118898|42153110|FG001|Overall Study|Not compliant with requirements|13|||
19708855|NCT00118898|42153111|FG002|Overall Study|Not compliant with requirements|11|||
19708856|NCT00118898|42153112|FG003|Overall Study|Not compliant with requirements|11|||
19708857|NCT00118898|42153109|FG000|Overall Study|Not able to get to clinic|34|||
19708858|NCT00118898|42153110|FG001|Overall Study|Not able to get to clinic|43|||
19708859|NCT00118898|42153111|FG002|Overall Study|Not able to get to clinic|31|||
19708860|NCT00118898|42153112|FG003|Overall Study|Not able to get to clinic|40|||
19708861|NCT00118430|42153125|FG000|Overall Study|Withdrawal by Subject|6|||
19394456|NCT02528253|41638702|FG002|Overall Study|Other|58|||
19626322|NCT00819156|42075810|FG003|Overall Study|Withdrawal by Subject|0|||
19626323|NCT00819156|42075811|FG004|Overall Study|Withdrawal by Subject|1|||
19626324|NCT00819156|42075812|FG005|Overall Study|Withdrawal by Subject|0|||
19626325|NCT00819156|42075807|FG000|Overall Study|Protocol Violation|1|||
19626326|NCT00819156|42075808|FG001|Overall Study|Protocol Violation|0|||
19626327|NCT00819156|42075809|FG002|Overall Study|Protocol Violation|1|||
19626328|NCT00819156|42075810|FG003|Overall Study|Protocol Violation|0|||
19626329|NCT00819156|42075811|FG004|Overall Study|Protocol Violation|0|||
19708862|NCT00118430|42153126|FG001|Overall Study|Withdrawal by Subject|2|||
19708863|NCT00118430|42153127|FG002|Overall Study|Withdrawal by Subject|0|||
19708864|NCT00118430|42153125|FG000|Overall Study|Lost to Follow-up|15|||
19708865|NCT00118430|42153126|FG001|Overall Study|Lost to Follow-up|22|||
19708866|NCT00118430|42153127|FG002|Overall Study|Lost to Follow-up|28|||
19394457|NCT02528253|41638703|FG003|Overall Study|Other|52|||
19394458|NCT02528253|41638704|FG004|Overall Study|Other|76|||
19626330|NCT00819156|42075812|FG005|Overall Study|Protocol Violation|1|||
19626331|NCT00819156|42075807|FG000|Overall Study|Lost to Follow-up|0|||
19708867|NCT00090584|42153136|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
19708868|NCT00090584|42153137|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
19708869|NCT00090584|42153136|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
19708870|NCT00090584|42153137|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
19708871|NCT03670810|42153157|FG000|Main Study|Adverse Event|37|||
19708872|NCT03670810|42153158|FG001|Main Study|Adverse Event|38|||
19708873|NCT03670810|42153159|FG002|Main Study|Adverse Event|3|||
19708874|NCT03670810|42153160|FG003|Main Study|Adverse Event|4|||
19394459|NCT02528253|41638700|FG000|Overall Study|Withdrawal by Subject|25|||
19394460|NCT02528253|41638701|FG001|Overall Study|Withdrawal by Subject|20|||
19394461|NCT02528253|41638702|FG002|Overall Study|Withdrawal by Subject|29|||
19394462|NCT02528253|41638703|FG003|Overall Study|Withdrawal by Subject|48|||
19394463|NCT02528253|41638704|FG004|Overall Study|Withdrawal by Subject|73|||
19394464|NCT02528253|41638700|FG000|Overall Study|Protocol Violation|1|||
19394465|NCT02528253|41638701|FG001|Overall Study|Protocol Violation|2|||
19394466|NCT02528253|41638702|FG002|Overall Study|Protocol Violation|4|||
19394467|NCT02528253|41638703|FG003|Overall Study|Protocol Violation|0|||
19394468|NCT02528253|41638704|FG004|Overall Study|Protocol Violation|4|||
19394469|NCT02528253|41638700|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
19394470|NCT02528253|41638701|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
19394471|NCT02528253|41638702|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
19394472|NCT02528253|41638703|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
19394473|NCT02528253|41638704|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
19394474|NCT01672957|41638735|FG000|Overall Study|Protocol Violation|48|||
19394475|NCT01672957|41638735|FG000|Overall Study|Death|2|||
19394476|NCT01672957|41638735|FG000|Overall Study|ICF Signed After Transplantation|5|||
19394477|NCT02525133|41638741|FG000|Overall Study|Adverse Event|0|||
19394478|NCT02525133|41638742|FG001|Overall Study|Adverse Event|1|||
19394479|NCT02525133|41638741|FG000|Overall Study|Death|0|||
19394480|NCT02525133|41638742|FG001|Overall Study|Death|1|||
19394481|NCT02525133|41638741|FG000|Overall Study|did not meet randomization criteria|1|||
19394482|NCT02525133|41638742|FG001|Overall Study|did not meet randomization criteria|0|||
19708875|NCT03670810|42153161|FG004|Main Study|Adverse Event|4|||
19708876|NCT03670810|42153162|FG005|Main Study|Adverse Event|5|||
19394483|NCT02525133|41638741|FG000|Overall Study|Lost to Follow-up|5|||
19626332|NCT00819156|42075808|FG001|Overall Study|Lost to Follow-up|1|||
19626333|NCT00819156|42075809|FG002|Overall Study|Lost to Follow-up|0|||
19626334|NCT00819156|42075810|FG003|Overall Study|Lost to Follow-up|0|||
19626335|NCT00819156|42075811|FG004|Overall Study|Lost to Follow-up|0|||
19626336|NCT00819156|42075812|FG005|Overall Study|Lost to Follow-up|2|||
19626337|NCT00819156|42075807|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
19626338|NCT00819156|42075808|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
19626339|NCT00819156|42075809|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
19708877|NCT03670810|42153163|FG006|Main Study|Adverse Event|0|||
19708878|NCT03670810|42153164|FG007|Main Study|Adverse Event|0|||
19708879|NCT03670810|42153165|FG008|Main Study|Adverse Event|0|||
19708880|NCT03670810|42153157|FG000|Main Study|Lack of Efficacy|8|||
19708881|NCT03670810|42153158|FG001|Main Study|Lack of Efficacy|9|||
19394484|NCT02525133|41638742|FG001|Overall Study|Lost to Follow-up|1|||
19394485|NCT02525133|41638741|FG000|Overall Study|randomized not enrolled|3|||
19394486|NCT02525133|41638742|FG001|Overall Study|randomized not enrolled|0|||
19394487|NCT02525133|41638741|FG000|Overall Study|Withdrawal by Subject|1|||
19394488|NCT02525133|41638742|FG001|Overall Study|Withdrawal by Subject|0|||
19394489|NCT01659255|41638765|FG000|Overall Study|Adverse Event|0|||
19394490|NCT01659255|41638766|FG001|Overall Study|Adverse Event|0|||
19394491|NCT01659255|41638767|FG002|Overall Study|Adverse Event|0|||
19394492|NCT01659255|41638768|FG003|Overall Study|Adverse Event|0|||
19394493|NCT01659255|41638769|FG004|Overall Study|Adverse Event|0|||
19394494|NCT01659255|41638770|FG005|Overall Study|Adverse Event|1|||
19394495|NCT01659255|41638771|FG006|Overall Study|Adverse Event|1|||
19394496|NCT01659255|41638772|FG007|Overall Study|Adverse Event|0|||
19394497|NCT01659255|41638773|FG008|Overall Study|Adverse Event|0|||
19394498|NCT01659255|41638774|FG009|Overall Study|Adverse Event|1|||
19394499|NCT01659255|41638775|FG010|Overall Study|Adverse Event|0|||
19394500|NCT01659255|41638776|FG011|Overall Study|Adverse Event|1|||
19394501|NCT01659255|41638777|FG012|Overall Study|Adverse Event|0|||
19394502|NCT01659255|41638778|FG013|Overall Study|Adverse Event|2|||
19394503|NCT01659255|41638779|FG014|Overall Study|Adverse Event|0|||
19394504|NCT01659255|41638780|FG015|Overall Study|Adverse Event|1|||
19394505|NCT01659255|41638781|FG016|Overall Study|Adverse Event|0|||
19394506|NCT01659255|41638765|FG000|Overall Study|Death|0|||
19394507|NCT01659255|41638766|FG001|Overall Study|Death|1|||
19394508|NCT01659255|41638767|FG002|Overall Study|Death|0|||
19394509|NCT01659255|41638768|FG003|Overall Study|Death|0|||
19394510|NCT01659255|41638769|FG004|Overall Study|Death|0|||
19394511|NCT01659255|41638770|FG005|Overall Study|Death|0|||
19394512|NCT01659255|41638771|FG006|Overall Study|Death|0|||
19394513|NCT01659255|41638772|FG007|Overall Study|Death|1|||
19394514|NCT01659255|41638773|FG008|Overall Study|Death|1|||
19394515|NCT01659255|41638774|FG009|Overall Study|Death|0|||
19394516|NCT01659255|41638775|FG010|Overall Study|Death|0|||
19394517|NCT01659255|41638776|FG011|Overall Study|Death|0|||
19394518|NCT01659255|41638777|FG012|Overall Study|Death|1|||
19394519|NCT01659255|41638778|FG013|Overall Study|Death|1|||
19394520|NCT01659255|41638779|FG014|Overall Study|Death|2|||
19394521|NCT01659255|41638780|FG015|Overall Study|Death|1|||
19394522|NCT01659255|41638781|FG016|Overall Study|Death|0|||
19394523|NCT01659255|41638765|FG000|Overall Study|Progressive Disease|2|||
19394524|NCT01659255|41638766|FG001|Overall Study|Progressive Disease|0|||
19394525|NCT01659255|41638767|FG002|Overall Study|Progressive Disease|0|||
19394526|NCT01659255|41638768|FG003|Overall Study|Progressive Disease|0|||
19394527|NCT01659255|41638769|FG004|Overall Study|Progressive Disease|0|||
19394528|NCT01659255|41638770|FG005|Overall Study|Progressive Disease|0|||
19394529|NCT01659255|41638771|FG006|Overall Study|Progressive Disease|0|||
19394530|NCT01659255|41638772|FG007|Overall Study|Progressive Disease|1|||
19394531|NCT01659255|41638773|FG008|Overall Study|Progressive Disease|0|||
19394532|NCT01659255|41638774|FG009|Overall Study|Progressive Disease|2|||
19394533|NCT01659255|41638775|FG010|Overall Study|Progressive Disease|2|||
19394534|NCT01659255|41638776|FG011|Overall Study|Progressive Disease|3|||
19394535|NCT01659255|41638777|FG012|Overall Study|Progressive Disease|5|||
19394536|NCT01659255|41638778|FG013|Overall Study|Progressive Disease|13|||
19394537|NCT01659255|41638779|FG014|Overall Study|Progressive Disease|6|||
19394538|NCT01659255|41638780|FG015|Overall Study|Progressive Disease|2|||
19394539|NCT01659255|41638781|FG016|Overall Study|Progressive Disease|3|||
19394540|NCT01659255|41638765|FG000|Overall Study|Withdrew Consent|0|||
19626340|NCT00819156|42075810|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
19626341|NCT00819156|42075811|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
19626342|NCT00819156|42075812|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
19394541|NCT01659255|41638766|FG001|Overall Study|Withdrew Consent|0|||
19394542|NCT01659255|41638767|FG002|Overall Study|Withdrew Consent|0|||
19394543|NCT01659255|41638768|FG003|Overall Study|Withdrew Consent|0|||
19626343|NCT00819156|42075807|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
19626344|NCT00819156|42075808|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
19626345|NCT00819156|42075809|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
19626346|NCT00819156|42075810|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
19626347|NCT00819156|42075811|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
19394544|NCT01659255|41638769|FG004|Overall Study|Withdrew Consent|0|||
19394545|NCT01659255|41638770|FG005|Overall Study|Withdrew Consent|0|||
19394546|NCT01659255|41638771|FG006|Overall Study|Withdrew Consent|0|||
19394547|NCT01659255|41638772|FG007|Overall Study|Withdrew Consent|0|||
19394548|NCT01659255|41638773|FG008|Overall Study|Withdrew Consent|0|||
19394549|NCT01659255|41638774|FG009|Overall Study|Withdrew Consent|0|||
19394550|NCT01659255|41638775|FG010|Overall Study|Withdrew Consent|1|||
19708882|NCT03670810|42153159|FG002|Main Study|Lack of Efficacy|3|||
19708883|NCT03670810|42153160|FG003|Main Study|Lack of Efficacy|4|||
19708884|NCT03670810|42153161|FG004|Main Study|Lack of Efficacy|0|||
19708885|NCT03670810|42153162|FG005|Main Study|Lack of Efficacy|0|||
19708886|NCT03670810|42153163|FG006|Main Study|Lack of Efficacy|0|||
19708887|NCT03670810|42153164|FG007|Main Study|Lack of Efficacy|0|||
19708888|NCT03670810|42153165|FG008|Main Study|Lack of Efficacy|0|||
19708889|NCT03670810|42153157|FG000|Main Study|Lost to Follow-up|9|||
19708890|NCT03670810|42153158|FG001|Main Study|Lost to Follow-up|7|||
19708891|NCT03670810|42153159|FG002|Main Study|Lost to Follow-up|4|||
19708892|NCT03670810|42153160|FG003|Main Study|Lost to Follow-up|6|||
19708893|NCT03670810|42153161|FG004|Main Study|Lost to Follow-up|1|||
19708894|NCT03670810|42153162|FG005|Main Study|Lost to Follow-up|0|||
19708895|NCT03670810|42153163|FG006|Main Study|Lost to Follow-up|0|||
19708896|NCT03670810|42153164|FG007|Main Study|Lost to Follow-up|0|||
19708897|NCT03670810|42153165|FG008|Main Study|Lost to Follow-up|0|||
19708898|NCT03670810|42153157|FG000|Main Study|Non-compliance with Study Drug|0|||
19708899|NCT03670810|42153158|FG001|Main Study|Non-compliance with Study Drug|2|||
19708900|NCT03670810|42153159|FG002|Main Study|Non-compliance with Study Drug|3|||
19708901|NCT03670810|42153160|FG003|Main Study|Non-compliance with Study Drug|0|||
19708902|NCT03670810|42153161|FG004|Main Study|Non-compliance with Study Drug|0|||
19708903|NCT03670810|42153162|FG005|Main Study|Non-compliance with Study Drug|0|||
19708904|NCT03670810|42153163|FG006|Main Study|Non-compliance with Study Drug|0|||
19708905|NCT03670810|42153164|FG007|Main Study|Non-compliance with Study Drug|1|||
19708906|NCT03670810|42153165|FG008|Main Study|Non-compliance with Study Drug|0|||
19708907|NCT03670810|42153157|FG000|Main Study|Physician Decision|3|||
19708908|NCT03670810|42153158|FG001|Main Study|Physician Decision|0|||
19708909|NCT03670810|42153159|FG002|Main Study|Physician Decision|1|||
19708910|NCT03670810|42153160|FG003|Main Study|Physician Decision|0|||
19708911|NCT03670810|42153161|FG004|Main Study|Physician Decision|0|||
19708912|NCT03670810|42153162|FG005|Main Study|Physician Decision|0|||
19708913|NCT03670810|42153163|FG006|Main Study|Physician Decision|1|||
19708914|NCT03670810|42153164|FG007|Main Study|Physician Decision|1|||
19708915|NCT03670810|42153165|FG008|Main Study|Physician Decision|0|||
19708916|NCT03670810|42153157|FG000|Main Study|Pregnancy|1|||
19708917|NCT03670810|42153158|FG001|Main Study|Pregnancy|2|||
19708918|NCT03670810|42153159|FG002|Main Study|Pregnancy|0|||
19708919|NCT03670810|42153160|FG003|Main Study|Pregnancy|0|||
19708920|NCT03670810|42153161|FG004|Main Study|Pregnancy|0|||
19708921|NCT03670810|42153162|FG005|Main Study|Pregnancy|0|||
19708922|NCT03670810|42153163|FG006|Main Study|Pregnancy|0|||
19708923|NCT03670810|42153164|FG007|Main Study|Pregnancy|0|||
19708924|NCT03670810|42153165|FG008|Main Study|Pregnancy|0|||
19708925|NCT03670810|42153157|FG000|Main Study|Protocol Deviation|2|||
19708926|NCT03670810|42153158|FG001|Main Study|Protocol Deviation|12|||
19708927|NCT03670810|42153159|FG002|Main Study|Protocol Deviation|8|||
19708928|NCT03670810|42153160|FG003|Main Study|Protocol Deviation|4|||
19708929|NCT03670810|42153161|FG004|Main Study|Protocol Deviation|0|||
19708930|NCT03670810|42153162|FG005|Main Study|Protocol Deviation|0|||
19708931|NCT03670810|42153163|FG006|Main Study|Protocol Deviation|0|||
19708932|NCT03670810|42153164|FG007|Main Study|Protocol Deviation|0|||
19626348|NCT00819156|42075812|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
19626349|NCT00819156|42075807|FG000|Overall Study|Prostate-specific antigen progression|0|||
19626350|NCT00819156|42075808|FG001|Overall Study|Prostate-specific antigen progression|0|||
19626351|NCT00819156|42075809|FG002|Overall Study|Prostate-specific antigen progression|0|||
19626352|NCT00819156|42075810|FG003|Overall Study|Prostate-specific antigen progression|0|||
19626353|NCT00819156|42075811|FG004|Overall Study|Prostate-specific antigen progression|1|||
19626354|NCT00819156|42075812|FG005|Overall Study|Prostate-specific antigen progression|0|||
19626355|NCT00459979|42075834|FG000|Overall Study|Withdrawal by Subject|1|||
19626356|NCT00459979|42075834|FG000|Overall Study|Protocol Violation|1|||
19626357|NCT00851786|42075840|FG000|Overall Study|Withdrawal by Subject|0|||
19626358|NCT00851786|42075841|FG001|Overall Study|Withdrawal by Subject|1|||
19708933|NCT03670810|42153165|FG008|Main Study|Protocol Deviation|0|||
19708934|NCT03670810|42153157|FG000|Main Study|Withdrawal by Subject|21|||
19708935|NCT03670810|42153158|FG001|Main Study|Withdrawal by Subject|21|||
19708936|NCT03670810|42153159|FG002|Main Study|Withdrawal by Subject|8|||
19708937|NCT03670810|42153160|FG003|Main Study|Withdrawal by Subject|9|||
19708938|NCT03670810|42153161|FG004|Main Study|Withdrawal by Subject|5|||
19708939|NCT03670810|42153162|FG005|Main Study|Withdrawal by Subject|2|||
19708940|NCT03670810|42153163|FG006|Main Study|Withdrawal by Subject|1|||
19708941|NCT03670810|42153164|FG007|Main Study|Withdrawal by Subject|1|||
19708942|NCT03670810|42153165|FG008|Main Study|Withdrawal by Subject|0|||
19708943|NCT03670810|42153157|FG000|Main Study|Participant did not want to take the three other treatments|1|||
19708944|NCT03670810|42153158|FG001|Main Study|Participant did not want to take the three other treatments|0|||
19708945|NCT03670810|42153159|FG002|Main Study|Participant did not want to take the three other treatments|0|||
19708946|NCT03670810|42153160|FG003|Main Study|Participant did not want to take the three other treatments|0|||
19708947|NCT03670810|42153161|FG004|Main Study|Participant did not want to take the three other treatments|0|||
19708948|NCT03670810|42153162|FG005|Main Study|Participant did not want to take the three other treatments|0|||
19708949|NCT03670810|42153163|FG006|Main Study|Participant did not want to take the three other treatments|0|||
19708950|NCT03670810|42153164|FG007|Main Study|Participant did not want to take the three other treatments|0|||
19708951|NCT03670810|42153165|FG008|Main Study|Participant did not want to take the three other treatments|0|||
19708952|NCT03670810|42153157|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708953|NCT03670810|42153158|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
19708954|NCT03670810|42153159|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708955|NCT03670810|42153160|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708956|NCT03670810|42153161|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19626359|NCT00851786|42075840|FG000|Overall Study|Protocol Violation|0|||
19626360|NCT00851786|42075841|FG001|Overall Study|Protocol Violation|1|||
19626361|NCT00851786|42075840|FG000|Overall Study|Lost to Follow-up|1|||
19626362|NCT00851786|42075841|FG001|Overall Study|Lost to Follow-up|0|||
19626363|NCT00851786|42075840|FG000|Overall Study|Incarceration|1|||
19626364|NCT00851786|42075841|FG001|Overall Study|Incarceration|0|||
19626365|NCT00851786|42075840|FG000|Overall Study|Site Closure|1|||
19626366|NCT00851786|42075841|FG001|Overall Study|Site Closure|0|||
19626367|NCT00851786|42075840|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
19626368|NCT00851786|42075841|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
19626369|NCT00665626|42075849|FG000|Overall Study|Lack of Efficacy|8|||
19626370|NCT00665626|42075850|FG001|Overall Study|Lack of Efficacy|5|||
19708957|NCT03670810|42153162|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708958|NCT03670810|42153163|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708959|NCT03670810|42153164|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708960|NCT03670810|42153165|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
19708961|NCT03670810|42153157|FG000|Main Study|Travel and Coronavirus issues|0|||
19708962|NCT03670810|42153158|FG001|Main Study|Travel and Coronavirus issues|0|||
19708963|NCT03670810|42153159|FG002|Main Study|Travel and Coronavirus issues|0|||
19708964|NCT03670810|42153160|FG003|Main Study|Travel and Coronavirus issues|1|||
19708965|NCT03670810|42153161|FG004|Main Study|Travel and Coronavirus issues|0|||
19708966|NCT03670810|42153162|FG005|Main Study|Travel and Coronavirus issues|0|||
19708967|NCT03670810|42153163|FG006|Main Study|Travel and Coronavirus issues|0|||
19708968|NCT03670810|42153164|FG007|Main Study|Travel and Coronavirus issues|0|||
19708969|NCT03670810|42153165|FG008|Main Study|Travel and Coronavirus issues|0|||
19626371|NCT00665626|42075849|FG000|Overall Study|Lost to Follow-up|0|||
19626372|NCT00665626|42075850|FG001|Overall Study|Lost to Follow-up|2|||
19626373|NCT00665626|42075849|FG000|Overall Study|Withdrawal by Subject|0|||
19626374|NCT00665626|42075850|FG001|Overall Study|Withdrawal by Subject|1|||
19626375|NCT00665626|42075849|FG000|Overall Study|Protocol Violation|0|||
19626376|NCT00665626|42075850|FG001|Overall Study|Protocol Violation|2|||
19626377|NCT00665626|42075849|FG000|Overall Study|Adverse Event|1|||
19626378|NCT00665626|42075850|FG001|Overall Study|Adverse Event|9|||
19708970|NCT03670810|42153157|FG000|Open Label Extension|Protocol Deviation|0|||
19626379|NCT00665626|42075849|FG000|Overall Study|Due to exclusion criteria|0|||
19626380|NCT00665626|42075850|FG001|Overall Study|Due to exclusion criteria|1|||
19708971|NCT03670810|42153158|FG001|Open Label Extension|Protocol Deviation|0|||
19708972|NCT03670810|42153159|FG002|Open Label Extension|Protocol Deviation|0|||
19708973|NCT03670810|42153160|FG003|Open Label Extension|Protocol Deviation|0|||
19708974|NCT03670810|42153161|FG004|Open Label Extension|Protocol Deviation|0|||
19708975|NCT03670810|42153162|FG005|Open Label Extension|Protocol Deviation|0|||
19708976|NCT03670810|42153163|FG006|Open Label Extension|Protocol Deviation|0|||
19708977|NCT03670810|42153164|FG007|Open Label Extension|Protocol Deviation|0|||
19708978|NCT03670810|42153165|FG008|Open Label Extension|Protocol Deviation|5|||
19708979|NCT03670810|42153157|FG000|Open Label Extension|Death|0|||
19708980|NCT03670810|42153158|FG001|Open Label Extension|Death|0|||
19708981|NCT03670810|42153159|FG002|Open Label Extension|Death|0|||
19708982|NCT03670810|42153160|FG003|Open Label Extension|Death|0|||
19708983|NCT03670810|42153161|FG004|Open Label Extension|Death|0|||
19708984|NCT03670810|42153162|FG005|Open Label Extension|Death|0|||
19708985|NCT03670810|42153163|FG006|Open Label Extension|Death|0|||
19708986|NCT03670810|42153164|FG007|Open Label Extension|Death|0|||
19708987|NCT03670810|42153165|FG008|Open Label Extension|Death|1|||
19708988|NCT03670810|42153157|FG000|Open Label Extension|COVID-19|0|||
19626381|NCT00665626|42075849|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
19626382|NCT00665626|42075850|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
19626383|NCT00665626|42075849|FG000|Overall Study|Unably to comply with dosing regimen|0|||
19626384|NCT00665626|42075850|FG001|Overall Study|Unably to comply with dosing regimen|1|||
19626385|NCT00665626|42075849|FG000|Overall Study|Death|1|||
19626386|NCT00665626|42075850|FG001|Overall Study|Death|0|||
19626387|NCT00828672|42075858|FG000|Study Treatment|Lost to Follow-up|1|||
19626388|NCT00828672|42075859|FG001|Study Treatment|Lost to Follow-up|0|||
19626389|NCT00828672|42075858|FG000|Study Treatment|Adverse Event|0|||
19626390|NCT00828672|42075859|FG001|Study Treatment|Adverse Event|1|||
19708989|NCT03670810|42153158|FG001|Open Label Extension|COVID-19|0|||
19708990|NCT03670810|42153159|FG002|Open Label Extension|COVID-19|0|||
19708991|NCT03670810|42153160|FG003|Open Label Extension|COVID-19|0|||
19708992|NCT03670810|42153161|FG004|Open Label Extension|COVID-19|0|||
19708993|NCT03670810|42153162|FG005|Open Label Extension|COVID-19|0|||
19708994|NCT03670810|42153163|FG006|Open Label Extension|COVID-19|0|||
19626391|NCT00828672|42075858|FG000|Study Treatment|Complete response, no surgery|1|||
19626392|NCT00828672|42075859|FG001|Study Treatment|Complete response, no surgery|1|||
19373903|NCT01647958|41615156|FG000|Continuation Phase|treatment received during Overall Study|39|||
19626393|NCT00828672|42075858|FG000|Post-surgery (<30 Days)|No central review materials|0|||
19626394|NCT00828672|42075859|FG001|Post-surgery (<30 Days)|No central review materials|1|||
19626395|NCT00873119|42075867|FG000|Overall Study|Patient request|4|||
19626396|NCT00873119|42075868|FG001|Overall Study|Patient request|2|||
19626397|NCT00873119|42075867|FG000|Overall Study|Adverse Event|8|||
19626398|NCT00873119|42075868|FG001|Overall Study|Adverse Event|0|||
19626399|NCT00873119|42075867|FG000|Overall Study|Progressive disease|26|||
19626400|NCT00873119|42075868|FG001|Overall Study|Progressive disease|18|||
19626401|NCT00873119|42075867|FG000|Overall Study|Death|2|||
19626402|NCT00873119|42075868|FG001|Overall Study|Death|1|||
19626403|NCT00873119|42075867|FG000|Overall Study|Other|2|||
19626404|NCT00873119|42075868|FG001|Overall Study|Other|5|||
19626405|NCT00873119|42075867|FG000|Overall Study|Not treated|2|||
19626406|NCT00873119|42075868|FG001|Overall Study|Not treated|0|||
19626407|NCT00661726|42075874|FG000|Overall Study|Adverse Event|1|||
19626408|NCT00865046|42075881|FG000|Overall Study|Lost to Follow-up|1|||
19626409|NCT00865046|42075882|FG001|Overall Study|Lost to Follow-up|4|||
19626410|NCT00865046|42075883|FG002|Overall Study|Lost to Follow-up|0|||
19626411|NCT00865046|42075881|FG000|Overall Study|Death|0|||
19626412|NCT00865046|42075882|FG001|Overall Study|Death|1|||
19626413|NCT00865046|42075883|FG002|Overall Study|Death|1|||
19626414|NCT00865046|42075881|FG000|Overall Study|Withdrawal by Subject|5|||
19626415|NCT00865046|42075882|FG001|Overall Study|Withdrawal by Subject|0|||
19626416|NCT00865046|42075883|FG002|Overall Study|Withdrawal by Subject|0|||
19626417|NCT00828516|42075891|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
19626418|NCT00665392|42075895|FG000|Overall Study|not treated|1|||
19626419|NCT00851630|42075902|FG000|Overall Study|Death|2|||
19626420|NCT00851630|42075903|FG001|Overall Study|Death|1|||
19626421|NCT00851630|42075902|FG000|Overall Study|Clinical failure|0|||
19626422|NCT00851630|42075903|FG001|Overall Study|Clinical failure|1|||
19626423|NCT00459667|42075912|FG000|Overall Study|Adverse Event|9|||
19626424|NCT00459667|42075913|FG001|Overall Study|Adverse Event|12|||
19626425|NCT00459667|42075914|FG002|Overall Study|Adverse Event|8|||
19626426|NCT00459667|42075912|FG000|Overall Study|Lost to Follow-up|5|||
19626427|NCT00459667|42075913|FG001|Overall Study|Lost to Follow-up|9|||
19626428|NCT00459667|42075914|FG002|Overall Study|Lost to Follow-up|3|||
19626429|NCT00459667|42075912|FG000|Overall Study|Pregnancy|1|||
19708995|NCT03670810|42153164|FG007|Open Label Extension|COVID-19|0|||
19708996|NCT03670810|42153165|FG008|Open Label Extension|COVID-19|1|||
19708997|NCT03670810|42153157|FG000|Open Label Extension|Lack of Efficacy|0|||
19708998|NCT03670810|42153158|FG001|Open Label Extension|Lack of Efficacy|0|||
19708999|NCT03670810|42153159|FG002|Open Label Extension|Lack of Efficacy|0|||
19709000|NCT03670810|42153160|FG003|Open Label Extension|Lack of Efficacy|0|||
19709001|NCT03670810|42153161|FG004|Open Label Extension|Lack of Efficacy|0|||
19394551|NCT01659255|41638776|FG011|Overall Study|Withdrew Consent|0|||
19709002|NCT03670810|42153162|FG005|Open Label Extension|Lack of Efficacy|0|||
19709003|NCT03670810|42153163|FG006|Open Label Extension|Lack of Efficacy|0|||
19709004|NCT03670810|42153164|FG007|Open Label Extension|Lack of Efficacy|0|||
19709005|NCT03670810|42153165|FG008|Open Label Extension|Lack of Efficacy|39|||
19709006|NCT03670810|42153157|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
19709007|NCT03670810|42153158|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
19709008|NCT03670810|42153159|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
19709009|NCT03670810|42153160|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
19709010|NCT03670810|42153161|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
19709011|NCT03670810|42153162|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
19709012|NCT03670810|42153163|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
19709013|NCT03670810|42153164|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
19709014|NCT03670810|42153165|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
19709015|NCT03670810|42153157|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709016|NCT03670810|42153158|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709017|NCT03670810|42153159|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709018|NCT03670810|42153160|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709019|NCT03670810|42153161|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709020|NCT03670810|42153162|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709021|NCT03670810|42153163|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709022|NCT03670810|42153164|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
19709023|NCT03670810|42153165|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
19709024|NCT03670810|42153157|FG000|Open Label Extension|Withdrawal by Subject|0|||
19709025|NCT03670810|42153158|FG001|Open Label Extension|Withdrawal by Subject|0|||
19709026|NCT03670810|42153159|FG002|Open Label Extension|Withdrawal by Subject|0|||
19709027|NCT03670810|42153160|FG003|Open Label Extension|Withdrawal by Subject|0|||
19709028|NCT03670810|42153161|FG004|Open Label Extension|Withdrawal by Subject|0|||
19709029|NCT03670810|42153162|FG005|Open Label Extension|Withdrawal by Subject|0|||
19709030|NCT03670810|42153163|FG006|Open Label Extension|Withdrawal by Subject|0|||
19709031|NCT03670810|42153164|FG007|Open Label Extension|Withdrawal by Subject|0|||
19709032|NCT03670810|42153165|FG008|Open Label Extension|Withdrawal by Subject|46|||
19709033|NCT03670810|42153157|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709034|NCT03670810|42153158|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709035|NCT03670810|42153159|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709036|NCT03670810|42153160|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709037|NCT03670810|42153161|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709038|NCT03670810|42153162|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709039|NCT03670810|42153163|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709040|NCT03670810|42153164|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
19709041|NCT03670810|42153165|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
19626430|NCT00459667|42075913|FG001|Overall Study|Pregnancy|1|||
19626431|NCT00459667|42075914|FG002|Overall Study|Pregnancy|1|||
19626432|NCT00459667|42075912|FG000|Overall Study|Protocol Violation|1|||
19626433|NCT00459667|42075913|FG001|Overall Study|Protocol Violation|0|||
19626434|NCT00459667|42075914|FG002|Overall Study|Protocol Violation|0|||
19626435|NCT00459667|42075912|FG000|Overall Study|Withdrawal by Subject|3|||
19626436|NCT00459667|42075913|FG001|Overall Study|Withdrawal by Subject|5|||
19626437|NCT00459667|42075914|FG002|Overall Study|Withdrawal by Subject|5|||
19626438|NCT00459667|42075912|FG000|Overall Study|Other disease modifying treatment|1|||
19626439|NCT00459667|42075913|FG001|Overall Study|Other disease modifying treatment|2|||
19626440|NCT00459667|42075914|FG002|Overall Study|Other disease modifying treatment|1|||
19626441|NCT00459667|42075912|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
19709042|NCT03670810|42153157|FG000|Open Label Extension|Physician Decision|0|||
19709043|NCT03670810|42153158|FG001|Open Label Extension|Physician Decision|0|||
19709044|NCT03670810|42153159|FG002|Open Label Extension|Physician Decision|0|||
19709045|NCT03670810|42153160|FG003|Open Label Extension|Physician Decision|0|||
19709046|NCT03670810|42153161|FG004|Open Label Extension|Physician Decision|0|||
19709047|NCT03670810|42153162|FG005|Open Label Extension|Physician Decision|0|||
19709048|NCT03670810|42153163|FG006|Open Label Extension|Physician Decision|0|||
19709049|NCT03670810|42153164|FG007|Open Label Extension|Physician Decision|0|||
19709050|NCT03670810|42153165|FG008|Open Label Extension|Physician Decision|2|||
19709051|NCT03670810|42153157|FG000|Open Label Extension|Non-compliance with study drug|0|||
19709052|NCT03670810|42153158|FG001|Open Label Extension|Non-compliance with study drug|0|||
19709053|NCT03670810|42153159|FG002|Open Label Extension|Non-compliance with study drug|0|||
19709054|NCT03670810|42153160|FG003|Open Label Extension|Non-compliance with study drug|0|||
19709055|NCT03670810|42153161|FG004|Open Label Extension|Non-compliance with study drug|0|||
19709056|NCT03670810|42153162|FG005|Open Label Extension|Non-compliance with study drug|0|||
19709057|NCT03670810|42153163|FG006|Open Label Extension|Non-compliance with study drug|0|||
19709058|NCT03670810|42153164|FG007|Open Label Extension|Non-compliance with study drug|0|||
19709059|NCT03670810|42153165|FG008|Open Label Extension|Non-compliance with study drug|5|||
19709060|NCT03670810|42153157|FG000|Open Label Extension|Pregnancy|0|||
19709061|NCT03670810|42153158|FG001|Open Label Extension|Pregnancy|0|||
19709062|NCT03670810|42153159|FG002|Open Label Extension|Pregnancy|0|||
19709063|NCT03670810|42153160|FG003|Open Label Extension|Pregnancy|0|||
19709064|NCT03670810|42153161|FG004|Open Label Extension|Pregnancy|0|||
19709065|NCT03670810|42153162|FG005|Open Label Extension|Pregnancy|0|||
19709066|NCT03670810|42153163|FG006|Open Label Extension|Pregnancy|0|||
19709067|NCT03670810|42153164|FG007|Open Label Extension|Pregnancy|0|||
19709068|NCT03670810|42153165|FG008|Open Label Extension|Pregnancy|3|||
19709069|NCT03670810|42153157|FG000|Open Label Extension|Adverse Event|0|||
19709070|NCT03670810|42153158|FG001|Open Label Extension|Adverse Event|0|||
19709071|NCT03670810|42153159|FG002|Open Label Extension|Adverse Event|0|||
19709072|NCT03670810|42153160|FG003|Open Label Extension|Adverse Event|0|||
19709073|NCT03670810|42153161|FG004|Open Label Extension|Adverse Event|0|||
19709074|NCT03670810|42153162|FG005|Open Label Extension|Adverse Event|0|||
19709075|NCT03670810|42153163|FG006|Open Label Extension|Adverse Event|0|||
19709076|NCT03670810|42153164|FG007|Open Label Extension|Adverse Event|0|||
19709077|NCT03670810|42153165|FG008|Open Label Extension|Adverse Event|24|||
19709078|NCT03670810|42153157|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
19709079|NCT03670810|42153158|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
19709080|NCT03670810|42153159|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
19709081|NCT03670810|42153160|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
19709082|NCT03670810|42153161|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
19709083|NCT03670810|42153162|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
19709084|NCT03670810|42153163|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
19709085|NCT03670810|42153164|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
19709086|NCT03670810|42153165|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
19709087|NCT03670810|42153157|FG000|Open Label Extension|Lost to Follow-up|0|||
19709088|NCT03670810|42153158|FG001|Open Label Extension|Lost to Follow-up|0|||
19709089|NCT03670810|42153159|FG002|Open Label Extension|Lost to Follow-up|0|||
19709090|NCT03670810|42153160|FG003|Open Label Extension|Lost to Follow-up|0|||
19709091|NCT03670810|42153161|FG004|Open Label Extension|Lost to Follow-up|0|||
19709092|NCT03670810|42153162|FG005|Open Label Extension|Lost to Follow-up|0|||
19709093|NCT03670810|42153163|FG006|Open Label Extension|Lost to Follow-up|0|||
19709094|NCT03670810|42153164|FG007|Open Label Extension|Lost to Follow-up|0|||
19709095|NCT03670810|42153165|FG008|Open Label Extension|Lost to Follow-up|23|||
19709096|NCT00089648|42153179|FG000|Overall Study|Adverse Event|7|||
19709097|NCT00089648|42153179|FG000|Overall Study|Withdrawal by Subject|1|||
19709098|NCT00089648|42153179|FG000|Overall Study|Lack of Efficacy|33|||
19709099|NCT00118040|42153186|FG000|Overall Study|Adverse Event|0|||
19709100|NCT00118040|42153187|FG001|Overall Study|Adverse Event|1|||
19709101|NCT00118040|42153188|FG002|Overall Study|Adverse Event|0|||
19709102|NCT00118040|42153186|FG000|Overall Study|Withdrawal by Subject|0|||
19709103|NCT00118040|42153187|FG001|Overall Study|Withdrawal by Subject|0|||
19709104|NCT00118040|42153188|FG002|Overall Study|Withdrawal by Subject|2|||
19709105|NCT00118040|42153186|FG000|Overall Study|Medical Contraindication|0|||
19709106|NCT00118040|42153187|FG001|Overall Study|Medical Contraindication|0|||
19709107|NCT00118040|42153188|FG002|Overall Study|Medical Contraindication|1|||
19709108|NCT00118040|42153186|FG000|Overall Study|Non-Compliant Participant|1|||
19709109|NCT00118040|42153187|FG001|Overall Study|Non-Compliant Participant|1|||
19709110|NCT00118040|42153188|FG002|Overall Study|Non-Compliant Participant|2|||
19709111|NCT00118040|42153186|FG000|Overall Study|Other|0|||
19709112|NCT00118040|42153187|FG001|Overall Study|Other|0|||
19709113|NCT00118040|42153188|FG002|Overall Study|Other|1|||
19626442|NCT00459667|42075913|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
19373904|NCT01647958|41615157|FG001|Continuation Phase|treatment received during Overall Study|0|||
19373905|NCT01647958|41615156|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
19373906|NCT01647958|41615157|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
19626443|NCT00459667|42075914|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
19626444|NCT00459667|42075912|FG000|Overall Study|No treatment administered|6|||
19626445|NCT00459667|42075913|FG001|Overall Study|No treatment administered|3|||
19626446|NCT00459667|42075914|FG002|Overall Study|No treatment administered|1|||
19626447|NCT00828204|42075924|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
19626448|NCT00828204|42075925|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
19626449|NCT00828204|42075924|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
19626450|NCT00828204|42075925|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
19626451|NCT00828204|42075924|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
19626452|NCT00828204|42075925|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
19626453|NCT00828204|42075924|FG000|Main Study: After Study Restart|Adverse Event|0|||
19709114|NCT00389207|42153204|FG000|Overall Study|Adverse Event|26|||
19709115|NCT00389207|42153205|FG001|Overall Study|Adverse Event|32|||
19709116|NCT00389207|42153206|FG002|Overall Study|Adverse Event|10|||
19373907|NCT02298868|41615172|FG000|Overall Study|Adverse Event|1|||
19626454|NCT00828204|42075925|FG001|Main Study: After Study Restart|Adverse Event|2|||
19626455|NCT00828204|42075924|FG000|Main Study: After Study Restart|Noncompliance|0|||
19626456|NCT00828204|42075925|FG001|Main Study: After Study Restart|Noncompliance|1|||
19626457|NCT00828204|42075924|FG000|Extension Study|Lost to Follow-up|0|||
19626458|NCT00828204|42075925|FG001|Extension Study|Lost to Follow-up|1|||
19626459|NCT00828204|42075924|FG000|Extension Study|Physician Decision|0|||
19626460|NCT00828204|42075925|FG001|Extension Study|Physician Decision|2|||
19626461|NCT00851552|42075932|FG000|Overall Study|Death|2|||
19626462|NCT00851552|42075932|FG000|Overall Study|Adverse Event|1|||
19626463|NCT00851552|42075932|FG000|Overall Study|Disease Progression|4|||
19626464|NCT00459355|42075938|FG000|Overall Study|Subject no longer met inc criteria|20|||
19626465|NCT00459355|42075939|FG001|Overall Study|Subject no longer met inc criteria|18|||
19709117|NCT00389207|42153204|FG000|Overall Study|Protocol Violation|3|||
19517732|NCT01551420|41930742|FG001|Screened for Part B Eligibility|Declined participation|1|||
19517733|NCT01551420|41930741|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
19517734|NCT01551420|41930742|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
19517735|NCT01551420|41930741|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
19517736|NCT01551420|41930742|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
19517737|NCT01551420|41930741|FG000|Home Use (Part B)|Withdrawal by staff|0|||
19517738|NCT01551420|41930742|FG001|Home Use (Part B)|Withdrawal by staff|1|||
19517739|NCT01575054|41930750|FG000|Overall Study|Other Reasons|5|||
19517740|NCT01575054|41930751|FG001|Overall Study|Other Reasons|3|||
19517741|NCT01575054|41930750|FG000|Overall Study|Protocol Violation|2|||
19517742|NCT01575054|41930751|FG001|Overall Study|Protocol Violation|1|||
19517743|NCT01575054|41930750|FG000|Overall Study|Personal Reasons|10|||
19517744|NCT01575054|41930751|FG001|Overall Study|Personal Reasons|11|||
19517745|NCT01575054|41930750|FG000|Overall Study|Lost to Follow-up|3|||
19517746|NCT01575054|41930751|FG001|Overall Study|Lost to Follow-up|3|||
19517747|NCT01575054|41930750|FG000|Overall Study|Adverse Event|9|||
19517748|NCT01575054|41930751|FG001|Overall Study|Adverse Event|8|||
19517749|NCT01528254|41930759|FG000|Overall Study|Administrative problems|96|||
19517750|NCT01528254|41930760|FG001|Overall Study|Administrative problems|94|||
19517751|NCT01528254|41930759|FG000|Overall Study|Adverse Event|28|||
19517752|NCT01528254|41930760|FG001|Overall Study|Adverse Event|44|||
19517753|NCT01528254|41930759|FG000|Overall Study|Lost to Follow-up|17|||
19517754|NCT01528254|41930760|FG001|Overall Study|Lost to Follow-up|24|||
19517755|NCT01528254|41930759|FG000|Overall Study|Death|13|||
19517756|NCT01528254|41930760|FG001|Overall Study|Death|9|||
19517757|NCT01528254|41930759|FG000|Overall Study|Protocol deviation|9|||
19517758|NCT01528254|41930760|FG001|Overall Study|Protocol deviation|19|||
19517759|NCT01528254|41930759|FG000|Overall Study|New therapy for study indication|8|||
19517760|NCT01528254|41930760|FG001|Overall Study|New therapy for study indication|6|||
19517761|NCT01528254|41930759|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
19517762|NCT01528254|41930760|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
19517763|NCT01528254|41930759|FG000|Overall Study|Withdrawal by Subject|5|||
19517764|NCT01528254|41930760|FG001|Overall Study|Withdrawal by Subject|4|||
19517765|NCT01528254|41930759|FG000|Overall Study|Abnormal laboratory value(s)|3|||
19517766|NCT01528254|41930760|FG001|Overall Study|Abnormal laboratory value(s)|7|||
19517767|NCT01528254|41930759|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19517768|NCT01528254|41930760|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19517769|NCT01528254|41930759|FG000|Overall Study|No longer requires study drug|1|||
19517770|NCT01528254|41930760|FG001|Overall Study|No longer requires study drug|1|||
19517771|NCT01574352|41930769|FG000|Overall Study|Withdrawal by Subject|6|||
19517772|NCT01574352|41930770|FG001|Overall Study|Withdrawal by Subject|13|||
19626466|NCT00459043|42075951|FG000|Overall Study|Withdrawal by Subject|1|||
19626467|NCT00459043|42075952|FG001|Overall Study|Withdrawal by Subject|0|||
19709118|NCT00389207|42153205|FG001|Overall Study|Protocol Violation|1|||
19517773|NCT01574352|41930769|FG000|Overall Study|Injury in non-camp related sport|1|||
19517774|NCT01574352|41930770|FG001|Overall Study|Injury in non-camp related sport|0|||
19517775|NCT01527006|41930778|FG000|Core Study|Adverse Event|0|||
19517776|NCT01527006|41930779|FG001|Core Study|Adverse Event|2|||
19517777|NCT01527006|41930778|FG000|Core Study|Lost to Follow-up|0|||
19517778|NCT01527006|41930779|FG001|Core Study|Lost to Follow-up|1|||
19517779|NCT01527006|41930778|FG000|Core Study|Subject Choice|1|||
19517780|NCT01527006|41930779|FG001|Core Study|Subject Choice|0|||
19517781|NCT01527006|41930778|FG000|Core Study|Inadequate Therapeutic Effect|1|||
19517782|NCT01527006|41930779|FG001|Core Study|Inadequate Therapeutic Effect|0|||
19517783|NCT01527006|41930778|FG000|Core Study|Withdrawal by Subject|0|||
19517784|NCT01527006|41930779|FG001|Core Study|Withdrawal by Subject|1|||
19373908|NCT02298868|41615172|FG000|Overall Study|Death|1|||
19626468|NCT00817206|42075960|FG000|Overall Study|Adverse Event|10|||
19626469|NCT00817206|42075961|FG001|Overall Study|Adverse Event|3|||
19626470|NCT00817206|42075960|FG000|Overall Study|Protocol Violation|0|||
19709119|NCT00389207|42153206|FG002|Overall Study|Protocol Violation|4|||
19709120|NCT00389207|42153204|FG000|Overall Study|Lost to Follow-up|12|||
19709121|NCT00389207|42153205|FG001|Overall Study|Lost to Follow-up|9|||
19709122|NCT00389207|42153206|FG002|Overall Study|Lost to Follow-up|7|||
19709123|NCT00389207|42153204|FG000|Overall Study|Withdrawal by Subject|5|||
19709124|NCT00389207|42153205|FG001|Overall Study|Withdrawal by Subject|7|||
19709125|NCT00389207|42153206|FG002|Overall Study|Withdrawal by Subject|11|||
19709126|NCT00389207|42153204|FG000|Overall Study|Other|17|||
19709127|NCT00389207|42153205|FG001|Overall Study|Other|23|||
19709128|NCT00389207|42153206|FG002|Overall Study|Other|9|||
19709129|NCT00388973|42153221|FG000|Overall Study|Adverse Event|16|||
19709130|NCT00388973|42153222|FG001|Overall Study|Adverse Event|6|||
19709131|NCT00388973|42153221|FG000|Overall Study|Lack of Efficacy|1|||
19709132|NCT00388973|42153222|FG001|Overall Study|Lack of Efficacy|12|||
19709133|NCT00388973|42153221|FG000|Overall Study|Protocol Violation|3|||
19709134|NCT00388973|42153222|FG001|Overall Study|Protocol Violation|0|||
19709135|NCT00388973|42153221|FG000|Overall Study|Withdrawal by Subject|14|||
19709136|NCT00388973|42153222|FG001|Overall Study|Withdrawal by Subject|17|||
19709137|NCT00388973|42153221|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
19709138|NCT00388973|42153222|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
19709139|NCT00388973|42153221|FG000|Overall Study|Did not complete 61 days of treatment|5|||
19709140|NCT00388973|42153222|FG001|Overall Study|Did not complete 61 days of treatment|4|||
19709141|NCT00388973|42153221|FG000|Overall Study|Left region|0|||
19709142|NCT00388973|42153222|FG001|Overall Study|Left region|1|||
19709143|NCT00388973|42153221|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
19709144|NCT00388973|42153222|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
19709145|NCT00085202|42153230|FG000|Overall Study|Still on therapy|2|||
19709146|NCT00085202|42153231|FG001|Overall Study|Still on therapy|0|||
19709147|NCT00085202|42153230|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
19709148|NCT00085202|42153231|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
19709149|NCT00085202|42153230|FG000|Overall Study|Excessive toxicity|6|||
19709150|NCT00085202|42153231|FG001|Overall Study|Excessive toxicity|5|||
19709151|NCT00085202|42153230|FG000|Overall Study|Non-specified|3|||
19709152|NCT00085202|42153231|FG001|Overall Study|Non-specified|5|||
19709153|NCT00085202|42153230|FG000|Overall Study|Withdrawal by Subject|2|||
19709154|NCT00085202|42153231|FG001|Overall Study|Withdrawal by Subject|1|||
19709155|NCT00085202|42153230|FG000|Overall Study|Physician Decision|4|||
19709156|NCT00085202|42153231|FG001|Overall Study|Physician Decision|1|||
19709157|NCT00085202|42153230|FG000|Overall Study|Progressive disease|1|||
19709158|NCT00085202|42153231|FG001|Overall Study|Progressive disease|11|||
19626471|NCT00817206|42075961|FG001|Overall Study|Protocol Violation|2|||
19626472|NCT00817206|42075960|FG000|Overall Study|Lost to Follow-up|0|||
19626473|NCT00817206|42075961|FG001|Overall Study|Lost to Follow-up|1|||
19626474|NCT00817206|42075960|FG000|Overall Study|Death|2|||
19626475|NCT00817206|42075961|FG001|Overall Study|Death|0|||
19626476|NCT00817206|42075960|FG000|Overall Study|Withdrawal by Subject|7|||
19626477|NCT00817206|42075961|FG001|Overall Study|Withdrawal by Subject|3|||
19626478|NCT00817206|42075960|FG000|Overall Study|Physician Decision|2|||
19626479|NCT00817206|42075961|FG001|Overall Study|Physician Decision|0|||
19709159|NCT00388583|42153257|FG000|Overall Study|Protocol Violation|1|||
19709160|NCT00388583|42153258|FG001|Overall Study|Protocol Violation|0|||
19709161|NCT00388583|42153257|FG000|Overall Study|Withdrawal by Subject|3|||
19709162|NCT00388583|42153258|FG001|Overall Study|Withdrawal by Subject|3|||
19709163|NCT00388583|42153257|FG000|Overall Study|Serious Adverse Event|2|||
19709164|NCT00388583|42153258|FG001|Overall Study|Serious Adverse Event|0|||
19709165|NCT00388583|42153257|FG000|Overall Study|Did not receive vaccine|0|||
19709166|NCT00388583|42153258|FG001|Overall Study|Did not receive vaccine|1|||
19709167|NCT00117572|42153266|FG000|Overall Study|Site withdrew before starting treatment|2|||
19709168|NCT00117572|42153267|FG001|Overall Study|Site withdrew before starting treatment|3|||
19709169|NCT00117572|42153266|FG000|Overall Study|Withdrawal by Subject|3|||
19709170|NCT00117572|42153267|FG001|Overall Study|Withdrawal by Subject|3|||
19709171|NCT00117572|42153266|FG000|Overall Study|Protocol Violation|1|||
19709172|NCT00117572|42153267|FG001|Overall Study|Protocol Violation|0|||
19709173|NCT00388505|42153275|FG000|Overall Study|Adverse Event or Death|43|||
19709174|NCT00388505|42153276|FG001|Overall Study|Adverse Event or Death|17|||
19709175|NCT00388505|42153275|FG000|Overall Study|Withdrawal by Subject|24|||
19709176|NCT00388505|42153276|FG001|Overall Study|Withdrawal by Subject|9|||
19709177|NCT00388505|42153275|FG000|Overall Study|Lost to Follow-up|5|||
19709178|NCT00388505|42153276|FG001|Overall Study|Lost to Follow-up|3|||
19709179|NCT00388505|42153275|FG000|Overall Study|Inappropriate Enrollment|0|||
19709180|NCT00388505|42153276|FG001|Overall Study|Inappropriate Enrollment|1|||
19709181|NCT00388505|42153275|FG000|Overall Study|Administrative Reason|1|||
19709182|NCT00388505|42153276|FG001|Overall Study|Administrative Reason|0|||
19709183|NCT00388505|42153275|FG000|Overall Study|Protocol Violation|6|||
19709184|NCT00388505|42153276|FG001|Overall Study|Protocol Violation|5|||
19709185|NCT00388505|42153275|FG000|Overall Study|Unable to classify|4|||
19709186|NCT00388505|42153276|FG001|Overall Study|Unable to classify|3|||
19709187|NCT00388349|42153282|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
19709188|NCT00388349|42153283|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
19709189|NCT00117338|42153293|FG000|Overall Study|Adverse Event|0|||
19709190|NCT00117338|42153294|FG001|Overall Study|Adverse Event|1|||
19709191|NCT00117338|42153293|FG000|Overall Study|Protocol Violation|3|||
19709192|NCT00117338|42153294|FG001|Overall Study|Protocol Violation|2|||
19709193|NCT00117338|42153293|FG000|Overall Study|Withdrawal by Subject|1|||
19709194|NCT00117338|42153294|FG001|Overall Study|Withdrawal by Subject|0|||
19709195|NCT00117338|42153293|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
19709196|NCT00117338|42153294|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
19709197|NCT00117338|42153293|FG000|Overall Study|Lack of Efficacy|0|||
19709198|NCT00117338|42153294|FG001|Overall Study|Lack of Efficacy|1|||
19709199|NCT00388037|42153300|FG000|Overall Study|Protocol Violation|1|||
19709200|NCT00387881|42153306|FG000|Overall Study|Lost to Follow-up|23|||
19709201|NCT00387881|42153307|FG001|Overall Study|Lost to Follow-up|23|||
19709202|NCT00387881|42153306|FG000|Overall Study|Protocol Violation|2|||
19709203|NCT00387881|42153307|FG001|Overall Study|Protocol Violation|12|||
19709204|NCT00387881|42153306|FG000|Overall Study|Withdrawal by Subject|15|||
19709205|NCT00387881|42153307|FG001|Overall Study|Withdrawal by Subject|18|||
19709206|NCT00387881|42153306|FG000|Overall Study|Sponsor terminated Study|0|||
19709207|NCT00387881|42153307|FG001|Overall Study|Sponsor terminated Study|1|||
19709208|NCT00387881|42153306|FG000|Overall Study|Not eligible|6|||
19709209|NCT00387881|42153307|FG001|Overall Study|Not eligible|7|||
19709210|NCT00387881|42153306|FG000|Overall Study|No opportunity to treat headache|32|||
19709211|NCT00387881|42153307|FG001|Overall Study|No opportunity to treat headache|34|||
19709212|NCT00387881|42153306|FG000|Overall Study|Not otherwise specified|11|||
19709213|NCT00387881|42153307|FG001|Overall Study|Not otherwise specified|7|||
19709214|NCT00084656|42153316|FG000|Overall Study|Other reasons|0|||
19709215|NCT00084656|42153317|FG001|Overall Study|Other reasons|12|||
19709216|NCT00084656|42153318|FG002|Overall Study|Other reasons|11|||
19709217|NCT00084656|42153316|FG000|Overall Study|Withdrawal by Subject|15|||
19709218|NCT00084656|42153317|FG001|Overall Study|Withdrawal by Subject|4|||
19709219|NCT00084656|42153318|FG002|Overall Study|Withdrawal by Subject|4|||
19709220|NCT00084656|42153316|FG000|Overall Study|Disease relapse|0|||
19709221|NCT00084656|42153317|FG001|Overall Study|Disease relapse|9|||
19709222|NCT00084656|42153318|FG002|Overall Study|Disease relapse|10|||
19709223|NCT00084656|42153316|FG000|Overall Study|Disease progression|9|||
19709224|NCT00084656|42153317|FG001|Overall Study|Disease progression|0|||
19709225|NCT00084656|42153318|FG002|Overall Study|Disease progression|0|||
19709226|NCT00084656|42153316|FG000|Overall Study|Lost to Follow-up|1|||
19709227|NCT00084656|42153317|FG001|Overall Study|Lost to Follow-up|0|||
19709228|NCT00084656|42153318|FG002|Overall Study|Lost to Follow-up|1|||
19709229|NCT00387725|42153332|FG000|Overall Study|Adverse Event|0|||
19709230|NCT00387725|42153333|FG001|Overall Study|Adverse Event|0|||
19709231|NCT00387725|42153334|FG002|Overall Study|Adverse Event|0|||
19709232|NCT00387725|42153335|FG003|Overall Study|Adverse Event|1|||
19709233|NCT00387725|42153332|FG000|Overall Study|Protocol Violation|0|||
19709234|NCT00387725|42153333|FG001|Overall Study|Protocol Violation|1|||
19709235|NCT00387725|42153334|FG002|Overall Study|Protocol Violation|0|||
19709236|NCT00387725|42153335|FG003|Overall Study|Protocol Violation|0|||
19709237|NCT00387725|42153332|FG000|Overall Study|Withdrawal by Subject|1|||
19394552|NCT01659255|41638777|FG012|Overall Study|Withdrew Consent|0|||
19394553|NCT01659255|41638778|FG013|Overall Study|Withdrew Consent|1|||
19394554|NCT01659255|41638779|FG014|Overall Study|Withdrew Consent|0|||
19626480|NCT00665002|42075967|FG000|Overall Study|Progression/relapse during treatment|11|||
19626481|NCT00665002|42075967|FG000|Overall Study|Cytogenetic resistance|1|||
19626482|NCT03847987|42075973|FG000|Overall Study|Lost to Follow-up|1|||
19626483|NCT03847987|42075974|FG001|Overall Study|Lost to Follow-up|0|||
19626484|NCT03847987|42075973|FG000|Overall Study|Adverse Event|2|||
19626485|NCT03847987|42075974|FG001|Overall Study|Adverse Event|0|||
19626486|NCT00660010|42075991|FG000|Overall Study|Withdrawal by Subject|2|||
19626487|NCT00660010|42075991|FG000|Overall Study|Lost to Follow-up|3|||
19626488|NCT00660010|42075991|FG000|Overall Study|Adverse Event|1|||
19626489|NCT00660010|42075991|FG000|Overall Study|Noncompliance with visit schedule|3|||
19626490|NCT00873041|42075998|FG000|Core Study|Adverse Event|2|||
19626491|NCT00873041|42075999|FG001|Core Study|Adverse Event|3|||
19626492|NCT00873041|42076000|FG002|Core Study|Adverse Event|1|||
19626493|NCT00873041|42075998|FG000|Core Study|Withdrawal by Subject|1|||
19626494|NCT00873041|42075999|FG001|Core Study|Withdrawal by Subject|2|||
19626495|NCT00873041|42076000|FG002|Core Study|Withdrawal by Subject|2|||
19626496|NCT00873041|42075998|FG000|Core Study|Lost to Follow-up|3|||
19626497|NCT00873041|42075999|FG001|Core Study|Lost to Follow-up|1|||
19626498|NCT00873041|42076000|FG002|Core Study|Lost to Follow-up|0|||
19626499|NCT00873041|42075998|FG000|Core Study|Abnormal laboratory value|0|||
19626500|NCT00873041|42075999|FG001|Core Study|Abnormal laboratory value|0|||
19626501|NCT00873041|42076000|FG002|Core Study|Abnormal laboratory value|1|||
19626502|NCT00873041|42075998|FG000|Core Study|Protocol deviation|1|||
19626503|NCT00873041|42075999|FG001|Core Study|Protocol deviation|0|||
19626504|NCT00873041|42076000|FG002|Core Study|Protocol deviation|1|||
19626505|NCT00873041|42075998|FG000|Extension Study|Adverse Event|1|||
19626506|NCT00873041|42075999|FG001|Extension Study|Adverse Event|0|||
19626507|NCT00873041|42076000|FG002|Extension Study|Adverse Event|1|||
19626508|NCT00873041|42075998|FG000|Extension Study|Administrative reasons|0|||
19626509|NCT00873041|42075999|FG001|Extension Study|Administrative reasons|0|||
19626510|NCT00873041|42076000|FG002|Extension Study|Administrative reasons|1|||
19626511|NCT00458341|42076017|FG000|Cycle 1|Adverse Event|1|||
19626512|NCT00458341|42076018|FG001|Cycle 1|Adverse Event|0|||
19626513|NCT00816036|42076026|FG000|Overall Study|Death|47|||
19626514|NCT00816036|42076027|FG001|Overall Study|Death|28|||
19626515|NCT00816036|42076026|FG000|Overall Study|Lost to Follow-up|75|||
19626516|NCT00816036|42076027|FG001|Overall Study|Lost to Follow-up|57|||
19626517|NCT00816036|42076026|FG000|Overall Study|Withdrawal by Subject|54|||
19626518|NCT00816036|42076027|FG001|Overall Study|Withdrawal by Subject|23|||
19626519|NCT00664534|42076035|FG000|Overall Study|Adverse Event|2|||
19626520|NCT00664534|42076036|FG001|Overall Study|Adverse Event|3|||
19394555|NCT01659255|41638780|FG015|Overall Study|Withdrew Consent|0|||
19394556|NCT01659255|41638781|FG016|Overall Study|Withdrew Consent|0|||
19394557|NCT01659255|41638765|FG000|Overall Study|Investigator Decision|0|||
19394558|NCT01659255|41638766|FG001|Overall Study|Investigator Decision|0|||
19394559|NCT01659255|41638767|FG002|Overall Study|Investigator Decision|0|||
19394560|NCT01659255|41638768|FG003|Overall Study|Investigator Decision|0|||
19394561|NCT01659255|41638769|FG004|Overall Study|Investigator Decision|0|||
19394562|NCT01659255|41638770|FG005|Overall Study|Investigator Decision|0|||
19626521|NCT00664534|42076035|FG000|Overall Study|Lost to Follow-up|6|||
19626522|NCT00664534|42076036|FG001|Overall Study|Lost to Follow-up|10|||
19626523|NCT00664534|42076035|FG000|Overall Study|Protocol Violation|10|||
19626524|NCT00664534|42076036|FG001|Overall Study|Protocol Violation|8|||
19626525|NCT00664534|42076035|FG000|Overall Study|Withdrawal by Subject|7|||
19626526|NCT00664534|42076036|FG001|Overall Study|Withdrawal by Subject|6|||
19626527|NCT00664534|42076035|FG000|Overall Study|Physician Decision|8|||
19626528|NCT00664534|42076036|FG001|Overall Study|Physician Decision|0|||
19626529|NCT00664534|42076035|FG000|Overall Study|Sponsor decision|8|||
19626530|NCT00664534|42076036|FG001|Overall Study|Sponsor decision|6|||
19709238|NCT00387725|42153333|FG001|Overall Study|Withdrawal by Subject|0|||
19709239|NCT00387725|42153334|FG002|Overall Study|Withdrawal by Subject|1|||
19709240|NCT00387725|42153335|FG003|Overall Study|Withdrawal by Subject|0|||
19709241|NCT00387725|42153332|FG000|Overall Study|Parent/legal guardian request|0|||
19709242|NCT00387725|42153333|FG001|Overall Study|Parent/legal guardian request|0|||
19709243|NCT00387725|42153334|FG002|Overall Study|Parent/legal guardian request|1|||
19709244|NCT00387725|42153335|FG003|Overall Study|Parent/legal guardian request|1|||
19709245|NCT00102596|42153345|FG000|Part A|Screen failures|6|||
19709246|NCT00102596|42153346|FG001|Part A|Screen failures|0|||
19709247|NCT00102596|42153345|FG000|Part A|Adverse Event|1|||
19709248|NCT00102596|42153346|FG001|Part A|Adverse Event|0|||
19709249|NCT00387647|42153353|FG000|Overall Study|Death|18|||
19709250|NCT00386009|42153359|FG000|Overall Study|Adverse Event|0|||
19709251|NCT00386009|42153360|FG001|Overall Study|Adverse Event|2|||
19709252|NCT00386009|42153359|FG000|Overall Study|Death|1|||
19709253|NCT00386009|42153360|FG001|Overall Study|Death|0|||
19709254|NCT00386009|42153359|FG000|Overall Study|Entry Criteria Not Met|0|||
19709255|NCT00386009|42153360|FG001|Overall Study|Entry Criteria Not Met|2|||
19709256|NCT00386009|42153359|FG000|Overall Study|Lost to Follow-up|1|||
19709257|NCT00386009|42153360|FG001|Overall Study|Lost to Follow-up|1|||
19709258|NCT00386009|42153359|FG000|Overall Study|Protocol Violation|1|||
19709259|NCT00386009|42153360|FG001|Overall Study|Protocol Violation|0|||
19709260|NCT00386009|42153359|FG000|Overall Study|Sponsor Decision|1|||
19709261|NCT00386009|42153360|FG001|Overall Study|Sponsor Decision|1|||
19709262|NCT00386009|42153359|FG000|Overall Study|Withdrawal by Subject|5|||
19709263|NCT00386009|42153360|FG001|Overall Study|Withdrawal by Subject|4|||
19709264|NCT00373685|42153368|FG000|Overall Study|Death|2|||
19709265|NCT00373685|42153369|FG001|Overall Study|Death|1|||
19709266|NCT00373685|42153368|FG000|Overall Study|Adverse Event|278|||
19709267|NCT00373685|42153369|FG001|Overall Study|Adverse Event|253|||
19709268|NCT00373685|42153368|FG000|Overall Study|Insufficient clinical response|169|||
19709269|NCT00373685|42153369|FG001|Overall Study|Insufficient clinical response|119|||
19709270|NCT00373685|42153368|FG000|Overall Study|Did not meet entrance criteria|167|||
19373909|NCT02298868|41615172|FG000|Overall Study|Patient underwent transplant|1|||
19373910|NCT02327260|41615179|FG000|Overall Study|Lost to Follow-up|2|||
19373911|NCT02327260|41615180|FG001|Overall Study|Lost to Follow-up|3|||
19373912|NCT02327260|41615181|FG002|Overall Study|Lost to Follow-up|2|||
19373913|NCT02327260|41615179|FG000|Overall Study|invalid phone number|1|||
19373914|NCT02327260|41615180|FG001|Overall Study|invalid phone number|1|||
19394563|NCT01659255|41638771|FG006|Overall Study|Investigator Decision|0|||
19394564|NCT01659255|41638772|FG007|Overall Study|Investigator Decision|0|||
19394565|NCT01659255|41638773|FG008|Overall Study|Investigator Decision|0|||
19394566|NCT01659255|41638774|FG009|Overall Study|Investigator Decision|0|||
19394567|NCT01659255|41638775|FG010|Overall Study|Investigator Decision|0|||
19394568|NCT01659255|41638776|FG011|Overall Study|Investigator Decision|0|||
19394569|NCT01659255|41638777|FG012|Overall Study|Investigator Decision|1|||
19394570|NCT01659255|41638778|FG013|Overall Study|Investigator Decision|1|||
19394571|NCT01659255|41638779|FG014|Overall Study|Investigator Decision|0|||
19517785|NCT01527006|41930778|FG000|Core Study|Other|0|||
19517786|NCT01527006|41930779|FG001|Core Study|Other|2|||
19709271|NCT00373685|42153369|FG001|Overall Study|Did not meet entrance criteria|184|||
19373915|NCT02327260|41615181|FG002|Overall Study|invalid phone number|0|||
19373916|NCT02327260|41615179|FG000|Overall Study|non-adherence to protocol|2|||
19373917|NCT02327260|41615180|FG001|Overall Study|non-adherence to protocol|0|||
19373918|NCT02327260|41615181|FG002|Overall Study|non-adherence to protocol|0|||
19373919|NCT02327260|41615179|FG000|Overall Study|cognitive concerns|1|||
19373920|NCT02327260|41615180|FG001|Overall Study|cognitive concerns|0|||
19373921|NCT02327260|41615181|FG002|Overall Study|cognitive concerns|0|||
19373922|NCT02296840|41615192|FG000|Overall Study|Adverse Event|1|||
19517787|NCT01527006|41930778|FG000|Extension Phase|Adverse Event|4|||
19709272|NCT00373685|42153368|FG000|Overall Study|Lost to follow up|83|||
19709273|NCT00373685|42153369|FG001|Overall Study|Lost to follow up|103|||
19709274|NCT00373685|42153368|FG000|Overall Study|No longer willing to participate|337|||
19709275|NCT00373685|42153369|FG001|Overall Study|No longer willing to participate|352|||
19709276|NCT00373685|42153368|FG000|Overall Study|Other|149|||
19709277|NCT00373685|42153369|FG001|Overall Study|Other|146|||
19709278|NCT00373685|42153368|FG000|Overall Study|Protocol Violation|191|||
19709279|NCT00373685|42153369|FG001|Overall Study|Protocol Violation|182|||
19709280|NCT00373685|42153368|FG000|Overall Study|Final Status Unknown|12|||
19709281|NCT00373685|42153369|FG001|Overall Study|Final Status Unknown|4|||
19709282|NCT00373685|42153368|FG000|Overall Study|Randomized, not treated|51|||
19709283|NCT00373685|42153369|FG001|Overall Study|Randomized, not treated|77|||
19709284|NCT00373529|42153375|FG000|Overall Study|Physician Decision|19|||
19709285|NCT00373529|42153375|FG000|Overall Study|Withdrawal by Subject|7|||
19709286|NCT00373529|42153375|FG000|Overall Study|Adverse Event|7|||
19709287|NCT00373529|42153375|FG000|Overall Study|Treatment failure|36|||
19709288|NCT00373529|42153375|FG000|Overall Study|Disease recurrence|10|||
19709289|NCT00373529|42153375|FG000|Overall Study|Death|16|||
19709290|NCT00373529|42153375|FG000|Overall Study|Need for treatment prohibited by study|1|||
19709291|NCT00373529|42153375|FG000|Overall Study|Other|8|||
19709292|NCT00373529|42153375|FG000|Overall Study|Failed independent confirmation of AML|3|||
19709293|NCT00373529|42153375|FG000|Overall Study|Consent violation|1|||
19709294|NCT00373295|42153379|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
19709295|NCT00373295|42153380|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
19709296|NCT00373295|42153381|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
19709297|NCT00373295|42153382|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
19709298|NCT00373295|42153383|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
19709299|NCT00373295|42153384|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
19709300|NCT00385541|42153394|FG000|Overall Study|severe pain, clinician requested unblind|0|||
19709301|NCT00385541|42153395|FG001|Overall Study|severe pain, clinician requested unblind|1|||
19709302|NCT00094302|42153403|FG000|Overall Study|Lost to Follow-up|43|||
19709303|NCT00094302|42153404|FG001|Overall Study|Lost to Follow-up|41|||
19709304|NCT00094302|42153403|FG000|Overall Study|Physician Decision|5|||
19709305|NCT00094302|42153404|FG001|Overall Study|Physician Decision|8|||
19709306|NCT00094302|42153403|FG000|Overall Study|Withdrawal by Subject|103|||
19373923|NCT02296840|41615193|FG001|Overall Study|Adverse Event|1|||
19373924|NCT02296840|41615192|FG000|Overall Study|Protocol Violation|2|||
19373925|NCT02296840|41615193|FG001|Overall Study|Protocol Violation|1|||
19709307|NCT00094302|42153404|FG001|Overall Study|Withdrawal by Subject|111|||
19709308|NCT00094302|42153403|FG000|Overall Study|Death|266|||
19709309|NCT00094302|42153404|FG001|Overall Study|Death|246|||
19709310|NCT00372905|42153410|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
19709311|NCT00372905|42153411|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
19709312|NCT00372905|42153412|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
19709313|NCT00372905|42153413|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
19709314|NCT00372905|42153410|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
19709315|NCT00372905|42153411|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
19709316|NCT00372905|42153412|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
19709317|NCT00372905|42153413|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
19709318|NCT00372905|42153410|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
19709319|NCT00372905|42153411|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
19709320|NCT00372905|42153412|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
19709321|NCT00372905|42153413|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
19709322|NCT00372905|42153410|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
19709323|NCT00372905|42153411|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
19709324|NCT00372905|42153412|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
19709325|NCT00372905|42153413|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
19709326|NCT00372905|42153410|FG000|Follow up Until Relapse or Progression|Study closed|0|||
19709327|NCT00372905|42153411|FG001|Follow up Until Relapse or Progression|Study closed|0|||
19709328|NCT00372905|42153412|FG002|Follow up Until Relapse or Progression|Study closed|0|||
19709329|NCT00372905|42153413|FG003|Follow up Until Relapse or Progression|Study closed|3|||
19709330|NCT00372905|42153410|FG000|Follow up Until Relapse or Progression|Other|0|||
19709331|NCT00372905|42153411|FG001|Follow up Until Relapse or Progression|Other|1|||
19709332|NCT00372905|42153412|FG002|Follow up Until Relapse or Progression|Other|0|||
19709333|NCT00372905|42153413|FG003|Follow up Until Relapse or Progression|Other|0|||
19709334|NCT00384839|42153423|FG000|Overall Study|Adverse Event|4|||
19709335|NCT00384839|42153423|FG000|Overall Study|Investigator Request|1|||
19709336|NCT00384839|42153423|FG000|Overall Study|Patient Request|1|||
19709337|NCT00384839|42153423|FG000|Overall Study|Ineligible|2|||
19709338|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
19709339|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
19709340|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
19709341|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
19709342|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
19709343|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
19709344|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
19709345|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
19709346|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
19709347|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
19709348|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
19709349|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
19709350|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
19709351|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
19709352|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
19709353|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
19709354|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
19709355|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
19709356|NCT00384293|42153429|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
19709357|NCT00384293|42153430|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
19709358|NCT00384293|42153431|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
19709359|NCT00384293|42153429|FG000|Post-randomization Period|Adverse Event|0|||
19709360|NCT00384293|42153430|FG001|Post-randomization Period|Adverse Event|23|||
19709361|NCT00384293|42153431|FG002|Post-randomization Period|Adverse Event|7|||
19709362|NCT00384293|42153429|FG000|Post-randomization Period|Lost to Follow-up|0|||
19709363|NCT00384293|42153430|FG001|Post-randomization Period|Lost to Follow-up|2|||
19709364|NCT00384293|42153431|FG002|Post-randomization Period|Lost to Follow-up|1|||
19709365|NCT00384293|42153429|FG000|Post-randomization Period|Protocol Violation|0|||
19709366|NCT00384293|42153430|FG001|Post-randomization Period|Protocol Violation|1|||
19709367|NCT00384293|42153431|FG002|Post-randomization Period|Protocol Violation|0|||
19709368|NCT00384293|42153429|FG000|Post-randomization Period|Withdrawal by Subject|0|||
19709369|NCT00384293|42153430|FG001|Post-randomization Period|Withdrawal by Subject|8|||
19709370|NCT00384293|42153431|FG002|Post-randomization Period|Withdrawal by Subject|6|||
19709371|NCT00384293|42153429|FG000|Post-randomization Period|Trial Termination|0|||
19709372|NCT00384293|42153430|FG001|Post-randomization Period|Trial Termination|180|||
19709373|NCT00384293|42153431|FG002|Post-randomization Period|Trial Termination|204|||
19709374|NCT00384293|42153429|FG000|Post-randomization Period|Patient Randomized in Error|0|||
19709375|NCT00384293|42153430|FG001|Post-randomization Period|Patient Randomized in Error|0|||
19709376|NCT00384293|42153431|FG002|Post-randomization Period|Patient Randomized in Error|1|||
19709377|NCT00067002|42153441|FG000|Overall Study|Early Death|1|||
19709378|NCT00067002|42153442|FG001|Overall Study|Early Death|2|||
19709379|NCT00067002|42153441|FG000|Overall Study|Delayed|1|||
19709380|NCT00067002|42153442|FG001|Overall Study|Delayed|1|||
19709381|NCT00067002|42153441|FG000|Overall Study|Graft Failure|5|||
19709382|NCT00067002|42153442|FG001|Overall Study|Graft Failure|6|||
19709383|NCT00091572|42153450|FG000|Overall Study|Lost to Follow-up|1|||
19709384|NCT00091572|42153451|FG001|Overall Study|Lost to Follow-up|1|||
19709385|NCT00091572|42153450|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
19709386|NCT00091572|42153451|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
19709387|NCT00091572|42153450|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
19709388|NCT00091572|42153451|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
19709389|NCT00091572|42153450|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
19709390|NCT00091572|42153451|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
19709391|NCT00091572|42153450|FG000|Overall Study|Other Reason|6|||
19709392|NCT00091572|42153451|FG001|Overall Study|Other Reason|13|||
19709393|NCT00091572|42153450|FG000|Overall Study|Ongoing (still on treatment)|8|||
19394572|NCT01659255|41638780|FG015|Overall Study|Investigator Decision|0|||
19394573|NCT01659255|41638781|FG016|Overall Study|Investigator Decision|0|||
19373926|NCT02296840|41615192|FG000|Overall Study|Lost to Follow-up|6|||
19373927|NCT02296840|41615193|FG001|Overall Study|Lost to Follow-up|17|||
19626531|NCT00594035|42076044|FG000|Overall Study|Lost to Follow-up|1|||
19626532|NCT00594035|42076045|FG001|Overall Study|Lost to Follow-up|1|||
19709394|NCT00091572|42153451|FG001|Overall Study|Ongoing (still on treatment)|12|||
19709395|NCT00091572|42153450|FG000|Overall Study|Major Protocol Violation|2|||
19709396|NCT00091572|42153451|FG001|Overall Study|Major Protocol Violation|0|||
19709397|NCT00091572|42153450|FG000|Overall Study|Toxicity (Related AE)|53|||
19709398|NCT00091572|42153451|FG001|Overall Study|Toxicity (Related AE)|9|||
19626533|NCT00594035|42076044|FG000|Overall Study|Withdrawal by Subject|1|||
19626534|NCT00594035|42076045|FG001|Overall Study|Withdrawal by Subject|0|||
19626535|NCT00594035|42076044|FG000|Overall Study|Subject transferred to nursing home|0|||
19626536|NCT00594035|42076045|FG001|Overall Study|Subject transferred to nursing home|1|||
19626537|NCT00594035|42076044|FG000|Overall Study|Subject couldn't return due to job|0|||
19626538|NCT00594035|42076045|FG001|Overall Study|Subject couldn't return due to job|1|||
19626539|NCT00570310|42076053|FG000|Overall Study|Adverse Event|1|||
19626540|NCT00570310|42076054|FG001|Overall Study|Adverse Event|2|||
19626541|NCT00570310|42076053|FG000|Overall Study|Lack of Efficacy|1|||
19626542|NCT00570310|42076054|FG001|Overall Study|Lack of Efficacy|4|||
19709399|NCT00084266|42153459|FG000|Overall Study|Death|42|||
19394574|NCT01659255|41638765|FG000|Overall Study|Sponsor's Decision|0|||
19394575|NCT01659255|41638766|FG001|Overall Study|Sponsor's Decision|0|||
19394576|NCT01659255|41638767|FG002|Overall Study|Sponsor's Decision|0|||
19394577|NCT01659255|41638768|FG003|Overall Study|Sponsor's Decision|0|||
19394578|NCT01659255|41638769|FG004|Overall Study|Sponsor's Decision|0|||
19394579|NCT01659255|41638770|FG005|Overall Study|Sponsor's Decision|0|||
19394580|NCT01659255|41638771|FG006|Overall Study|Sponsor's Decision|1|||
19394581|NCT01659255|41638772|FG007|Overall Study|Sponsor's Decision|0|||
19394582|NCT01659255|41638773|FG008|Overall Study|Sponsor's Decision|0|||
19394583|NCT01659255|41638774|FG009|Overall Study|Sponsor's Decision|0|||
19394584|NCT01659255|41638775|FG010|Overall Study|Sponsor's Decision|0|||
19394585|NCT01659255|41638776|FG011|Overall Study|Sponsor's Decision|0|||
19394586|NCT01659255|41638777|FG012|Overall Study|Sponsor's Decision|0|||
19394587|NCT01659255|41638778|FG013|Overall Study|Sponsor's Decision|0|||
19394588|NCT01659255|41638779|FG014|Overall Study|Sponsor's Decision|0|||
19394589|NCT01659255|41638780|FG015|Overall Study|Sponsor's Decision|0|||
19394590|NCT01659255|41638781|FG016|Overall Study|Sponsor's Decision|0|||
19394591|NCT01659255|41638765|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394592|NCT01659255|41638766|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394593|NCT01659255|41638767|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394594|NCT01659255|41638768|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394595|NCT01659255|41638769|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394596|NCT01659255|41638770|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394597|NCT01659255|41638771|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394598|NCT01659255|41638772|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394599|NCT01659255|41638773|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394600|NCT01659255|41638774|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394601|NCT01659255|41638775|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394602|NCT01659255|41638776|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394603|NCT01659255|41638777|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394604|NCT01659255|41638778|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394605|NCT01659255|41638779|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394606|NCT01659255|41638780|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
19394607|NCT01659255|41638781|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
19394608|NCT01659255|41638765|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
19394609|NCT01659255|41638766|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
19394610|NCT01659255|41638767|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
19394611|NCT01659255|41638768|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
19394612|NCT01659255|41638769|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
19394613|NCT01659255|41638770|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
19394614|NCT01659255|41638771|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
19394615|NCT01659255|41638772|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
19394616|NCT01659255|41638773|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
19394617|NCT01659255|41638774|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
19394618|NCT01659255|41638775|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
19394619|NCT01659255|41638776|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
19394620|NCT01659255|41638777|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
19394621|NCT01659255|41638778|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
19394622|NCT01659255|41638779|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
19394623|NCT01659255|41638780|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
19626543|NCT00664066|42076060|FG000|Overall Study|Study terminated|3|||
19626544|NCT00814710|42076066|FG000|Overall Study|Adverse Event|1|||
19626545|NCT00814710|42076067|FG001|Overall Study|Adverse Event|0|||
19626546|NCT00814710|42076066|FG000|Overall Study|Lost to Follow-up|7|||
19626547|NCT00814710|42076067|FG001|Overall Study|Lost to Follow-up|3|||
19626548|NCT00871169|42076073|FG000|Overall Study|Protocol Violation|1|||
19626549|NCT00871169|42076073|FG000|Overall Study|Patient did not receive study treatment|2|||
19626550|NCT00814632|42076077|FG000|Overall Study|Lack of Efficacy|2|||
19626551|NCT00851318|42076085|FG000|Overall Study|Withdrawal by Subject|7|||
19626552|NCT00851318|42076086|FG001|Overall Study|Withdrawal by Subject|1|||
19626553|NCT00851318|42076087|FG002|Overall Study|Withdrawal by Subject|5|||
19626554|NCT00851318|42076088|FG003|Overall Study|Withdrawal by Subject|3|||
19626555|NCT00851318|42076085|FG000|Overall Study|Adverse Event|13|||
19626556|NCT00851318|42076086|FG001|Overall Study|Adverse Event|2|||
19626557|NCT00851318|42076087|FG002|Overall Study|Adverse Event|9|||
19626558|NCT00851318|42076088|FG003|Overall Study|Adverse Event|12|||
19626559|NCT00851318|42076085|FG000|Overall Study|Pregnancy|0|||
19626560|NCT00851318|42076086|FG001|Overall Study|Pregnancy|0|||
19626561|NCT00851318|42076087|FG002|Overall Study|Pregnancy|1|||
19626562|NCT00851318|42076088|FG003|Overall Study|Pregnancy|1|||
19626563|NCT00851318|42076085|FG000|Overall Study|Lack of Efficacy|8|||
19626564|NCT00851318|42076086|FG001|Overall Study|Lack of Efficacy|2|||
19626565|NCT00851318|42076087|FG002|Overall Study|Lack of Efficacy|4|||
19626566|NCT00851318|42076088|FG003|Overall Study|Lack of Efficacy|2|||
19626567|NCT00851318|42076085|FG000|Overall Study|Non-compliance with Study Procedures|2|||
19626568|NCT00851318|42076086|FG001|Overall Study|Non-compliance with Study Procedures|0|||
19626569|NCT00851318|42076087|FG002|Overall Study|Non-compliance with Study Procedures|1|||
19626570|NCT00851318|42076088|FG003|Overall Study|Non-compliance with Study Procedures|0|||
19626571|NCT00851318|42076085|FG000|Overall Study|Physician Decision|0|||
19626572|NCT00851318|42076086|FG001|Overall Study|Physician Decision|0|||
19626573|NCT00851318|42076087|FG002|Overall Study|Physician Decision|1|||
19626574|NCT00851318|42076088|FG003|Overall Study|Physician Decision|1|||
19626575|NCT00593957|42076101|FG000|Overall Study|Physician Decision|0|||
19626576|NCT00593957|42076102|FG001|Overall Study|Physician Decision|1|||
19626577|NCT00593957|42076103|FG002|Overall Study|Physician Decision|2|||
19626578|NCT00870233|42076125|FG000|Overall Study|Withdrawal by Subject|18|||
19626579|NCT00870233|42076125|FG000|Overall Study|Did not undergo laparotomy|3|||
19626580|NCT00870233|42076125|FG000|Overall Study|Incompatible internet browser|2|||
19626581|NCT00870233|42076125|FG000|Overall Study|Death|1|||
19626582|NCT00851084|42076132|FG000|Overall Study|Randomized but not treated|1|||
19626583|NCT00851084|42076133|FG001|Overall Study|Randomized but not treated|0|||
19626584|NCT00851084|42076132|FG000|Overall Study|Adverse Event|26|||
19626585|NCT00851084|42076133|FG001|Overall Study|Adverse Event|36|||
19626586|NCT00851084|42076132|FG000|Overall Study|Disease progression|52|||
19626587|NCT00851084|42076133|FG001|Overall Study|Disease progression|47|||
19626588|NCT00851084|42076132|FG000|Overall Study|Poor compliance to protocol|1|||
19626589|NCT00851084|42076133|FG001|Overall Study|Poor compliance to protocol|1|||
19626590|NCT00851084|42076132|FG000|Overall Study|Physician Decision|13|||
19626591|NCT00851084|42076133|FG001|Overall Study|Physician Decision|14|||
19626592|NCT00851084|42076132|FG000|Overall Study|Consent withdrawn|0|||
19626593|NCT00851084|42076133|FG001|Overall Study|Consent withdrawn|2|||
19626594|NCT00851084|42076132|FG000|Overall Study|Withdrawal by Subject|11|||
19709400|NCT00084266|42153460|FG001|Overall Study|Death|39|||
19373928|NCT02663895|41615202|FG000|Overall Study|Adverse Event|3|||
19373929|NCT02663895|41615202|FG000|Overall Study|Physician Decision|2|||
19626595|NCT00851084|42076133|FG001|Overall Study|Withdrawal by Subject|12|||
19626596|NCT00851084|42076132|FG000|Overall Study|Metastatic surgery|6|||
19626597|NCT00851084|42076133|FG001|Overall Study|Metastatic surgery|6|||
19626598|NCT00851084|42076132|FG000|Overall Study|Other|7|||
19626599|NCT00851084|42076133|FG001|Overall Study|Other|1|||
19626600|NCT00845858|42076144|FG000|Overall Study|Withdrawal by Subject|5|||
19626601|NCT00845858|42076145|FG001|Overall Study|Withdrawal by Subject|1|||
19626602|NCT00845858|42076146|FG002|Overall Study|Withdrawal by Subject|1|||
19626603|NCT00845858|42076144|FG000|Overall Study|Adverse Event|3|||
19626604|NCT00845858|42076145|FG001|Overall Study|Adverse Event|8|||
19626605|NCT00845858|42076146|FG002|Overall Study|Adverse Event|4|||
19626606|NCT00845858|42076144|FG000|Overall Study|Protocol Violation|0|||
19709401|NCT00084266|42153459|FG000|Overall Study|Adverse Event|8|||
19626607|NCT00845858|42076145|FG001|Overall Study|Protocol Violation|0|||
19626608|NCT00845858|42076146|FG002|Overall Study|Protocol Violation|1|||
19626609|NCT00845858|42076144|FG000|Overall Study|not eligible|0|||
19626610|NCT00845858|42076145|FG001|Overall Study|not eligible|3|||
19626611|NCT00845858|42076146|FG002|Overall Study|not eligible|2|||
19626612|NCT00850538|42076157|FG000|Overall Study|unable/unwilling to complete MRI|13|||
19626613|NCT00850538|42076157|FG000|Overall Study|specimen missed due to scheduling error|14|||
19626614|NCT00850538|42076157|FG000|Overall Study|specimen unusable|7|||
19626615|NCT00850538|42076157|FG000|Overall Study|Withdrawal by Subject|3|||
19626616|NCT00850538|42076157|FG000|Overall Study|radiology error|2|||
19626617|NCT00850538|42076157|FG000|Overall Study|Protocol Violation|2|||
19626618|NCT00850460|42076163|FG000|Overall Study|Lost to Follow-up|4|||
19626619|NCT00850460|42076164|FG001|Overall Study|Lost to Follow-up|4|||
19626620|NCT00661492|42076172|FG000|Overall Study|Adverse Event|16|||
19626621|NCT00661492|42076173|FG001|Overall Study|Adverse Event|13|||
19626622|NCT00661492|42076172|FG000|Overall Study|Disease Progression|44|||
19626623|NCT00661492|42076173|FG001|Overall Study|Disease Progression|14|||
19626624|NCT00661492|42076172|FG000|Overall Study|Patient Request|6|||
19626625|NCT00661492|42076173|FG001|Overall Study|Patient Request|1|||
19626626|NCT00661492|42076172|FG000|Overall Study|Investigator Request|1|||
19626627|NCT00661492|42076173|FG001|Overall Study|Investigator Request|0|||
19626628|NCT00661492|42076172|FG000|Overall Study|Lost to Follow-up|0|||
19626629|NCT00661492|42076173|FG001|Overall Study|Lost to Follow-up|1|||
19626630|NCT00661492|42076172|FG000|Overall Study|Other|1|||
19626631|NCT00661492|42076173|FG001|Overall Study|Other|0|||
19626632|NCT00850070|42076181|FG000|Overall Study|Lack of Efficacy|1|||
19626633|NCT00850070|42076182|FG001|Overall Study|Lack of Efficacy|1|||
19626634|NCT00850070|42076181|FG000|Overall Study|Adverse Event|2|||
19626635|NCT00850070|42076182|FG001|Overall Study|Adverse Event|0|||
19626636|NCT00592358|42076193|FG000|Overall Study|Withdrawal by Subject|2|||
19626637|NCT00592358|42076193|FG000|Overall Study|Adverse Event|1|||
19626638|NCT00592358|42076193|FG000|Overall Study|Lack of Efficacy|2|||
19626639|NCT00592358|42076193|FG000|Overall Study|Inability to swallow pills|1|||
19626640|NCT00814320|42076199|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
19626641|NCT00814320|42076200|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
19709402|NCT00084266|42153460|FG001|Overall Study|Adverse Event|5|||
19709403|NCT00084266|42153459|FG000|Overall Study|Lack of Efficacy|2|||
19709404|NCT00084266|42153460|FG001|Overall Study|Lack of Efficacy|4|||
19709405|NCT00084266|42153459|FG000|Overall Study|Lost to Follow-up|5|||
19626642|NCT00814320|42076199|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
19626643|NCT00814320|42076200|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
19626644|NCT00814320|42076199|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
19626645|NCT00814320|42076200|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
19626646|NCT00814320|42076199|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
19626647|NCT00814320|42076200|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
19626648|NCT00814320|42076199|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
19626649|NCT00814320|42076200|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
19626650|NCT00814320|42076199|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
19626651|NCT00814320|42076200|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
19626652|NCT00814320|42076199|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
19626653|NCT00814320|42076200|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
19626654|NCT00814320|42076199|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
19626655|NCT00814320|42076200|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
19626656|NCT00814320|42076199|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
19626657|NCT00814320|42076200|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
19626658|NCT00814320|42076199|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
19626659|NCT00814320|42076200|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
19626660|NCT00869999|42076223|FG000|Overall Study|Withdrawal by Subject|1|||
19626661|NCT00869999|42076223|FG000|Overall Study|removed prior to starting therapy|1|||
19626662|NCT00570232|42076227|FG000|Overall Study|Adverse Event|10|||
19626663|NCT00570232|42076227|FG000|Overall Study|discontinued due to medical condition|3|||
19626664|NCT00570232|42076227|FG000|Overall Study|discontinued due to recurrence|8|||
19626665|NCT00570232|42076227|FG000|Overall Study|discontinued due to noncompliance|2|||
19626666|NCT00809328|42076231|FG000|Overall Study|Lack of Efficacy|18|||
19626667|NCT00809328|42076231|FG000|Overall Study|Adverse Event|6|||
19626668|NCT00809328|42076231|FG000|Overall Study|Protocol Violation|3|||
19626669|NCT00809328|42076231|FG000|Overall Study|Withdrawal by Subject|2|||
19626670|NCT00868517|42076238|FG000|Overall Study|Withdrawal by Subject|3|||
19626671|NCT00868517|42076239|FG001|Overall Study|Withdrawal by Subject|3|||
19626672|NCT00868517|42076240|FG002|Overall Study|Withdrawal by Subject|2|||
19626673|NCT00868517|42076238|FG000|Overall Study|Protocol Violation|1|||
19626674|NCT00868517|42076239|FG001|Overall Study|Protocol Violation|1|||
19626675|NCT00868517|42076240|FG002|Overall Study|Protocol Violation|0|||
19626676|NCT00868439|42076250|FG000|Overall Study|Adverse Event|4|||
19626677|NCT00868439|42076251|FG001|Overall Study|Adverse Event|3|||
19626678|NCT00868439|42076250|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
19626679|NCT00868439|42076251|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
19626680|NCT00868439|42076250|FG000|Overall Study|Death|0|||
19626681|NCT00868439|42076251|FG001|Overall Study|Death|1|||
19626682|NCT00868439|42076250|FG000|Overall Study|Protocol Violation|1|||
19626683|NCT00868439|42076251|FG001|Overall Study|Protocol Violation|1|||
19626684|NCT00868439|42076250|FG000|Overall Study|Physician Decision|1|||
19626685|NCT00868439|42076251|FG001|Overall Study|Physician Decision|0|||
19626686|NCT00868439|42076250|FG000|Overall Study|Withdrawal by Subject|0|||
19626687|NCT00868439|42076251|FG001|Overall Study|Withdrawal by Subject|1|||
19709406|NCT00084266|42153460|FG001|Overall Study|Lost to Follow-up|3|||
19626688|NCT00814164|42076257|FG000|Overall Study|Progression|7|||
19626689|NCT00814164|42076257|FG000|Overall Study|not stated|7|||
19626690|NCT00814164|42076257|FG000|Overall Study|Death|5|||
19626691|NCT00659230|42076263|FG000|Overall Study|Lost to Follow-up|2|||
19626692|NCT00659230|42076264|FG001|Overall Study|Lost to Follow-up|5|||
19626693|NCT00659230|42076263|FG000|Overall Study|Lost source documentation|5|||
19709407|NCT00084266|42153459|FG000|Overall Study|Participant not willing to participate|3|||
19709408|NCT00084266|42153460|FG001|Overall Study|Participant not willing to participate|8|||
19709409|NCT00084266|42153459|FG000|Overall Study|Other|360|||
19709410|NCT00084266|42153460|FG001|Overall Study|Other|344|||
19709411|NCT00084266|42153459|FG000|Overall Study|Randomized not treated|21|||
19709412|NCT00084266|42153460|FG001|Overall Study|Randomized not treated|20|||
19709413|NCT00091026|42153468|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
19709414|NCT00091026|42153469|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
19709415|NCT00091026|42153468|FG000|Overall Study|Patient withdrew and never received trea|0|||
19709416|NCT00091026|42153469|FG001|Overall Study|Patient withdrew and never received trea|2|||
19626694|NCT00659230|42076264|FG001|Overall Study|Lost source documentation|4|||
19709417|NCT00091026|42153468|FG000|Overall Study|Unknown-never received treatment|0|||
19709418|NCT00091026|42153469|FG001|Overall Study|Unknown-never received treatment|1|||
19709419|NCT00116558|42153478|FG000|Overall Study|Death|11|||
19709420|NCT00116558|42153479|FG001|Overall Study|Death|5|||
19709421|NCT00116558|42153480|FG002|Overall Study|Death|3|||
19709422|NCT00116558|42153478|FG000|Overall Study|Withdrawal by Subject|17|||
19709423|NCT00116558|42153479|FG001|Overall Study|Withdrawal by Subject|3|||
19709424|NCT00116558|42153480|FG002|Overall Study|Withdrawal by Subject|12|||
19709425|NCT00116558|42153478|FG000|Overall Study|disease progression|3|||
19709426|NCT00116558|42153479|FG001|Overall Study|disease progression|7|||
19709427|NCT00116558|42153480|FG002|Overall Study|disease progression|18|||
19709428|NCT00116168|42153491|FG000|Overall Study|Lost to Follow-up|6|||
19709429|NCT00116168|42153492|FG001|Overall Study|Lost to Follow-up|5|||
19709430|NCT00116168|42153493|FG002|Overall Study|Lost to Follow-up|0|||
19709431|NCT00116168|42153494|FG003|Overall Study|Lost to Follow-up|0|||
19709432|NCT00115934|42153506|FG000|Overall Study|Lost to Follow-up|1|||
19709433|NCT00115934|42153507|FG001|Overall Study|Lost to Follow-up|0|||
19709434|NCT00115934|42153506|FG000|Overall Study|Did not receive intervention|3|||
19709435|NCT00115934|42153507|FG001|Overall Study|Did not receive intervention|2|||
19709436|NCT00115778|42153513|FG000|Overall Study|Withdrawal by Subject|0|||
19709437|NCT00115778|42153514|FG001|Overall Study|Withdrawal by Subject|1|||
19709438|NCT00100178|42153523|FG000|Overall Study|Lost to Follow-up|0|||
19709439|NCT00100178|42153524|FG001|Overall Study|Lost to Follow-up|6|||
19709440|NCT00100178|42153525|FG002|Overall Study|Lost to Follow-up|5|||
19709441|NCT00100178|42153523|FG000|Overall Study|Adverse Event|2|||
19709442|NCT00100178|42153524|FG001|Overall Study|Adverse Event|2|||
19709443|NCT00100178|42153525|FG002|Overall Study|Adverse Event|1|||
19709444|NCT00100178|42153523|FG000|Overall Study|Withdrawal by Subject|1|||
19709445|NCT00100178|42153524|FG001|Overall Study|Withdrawal by Subject|1|||
19709446|NCT00100178|42153525|FG002|Overall Study|Withdrawal by Subject|1|||
19709447|NCT00100178|42153523|FG000|Overall Study|Physician Decision|6|||
19709448|NCT00100178|42153524|FG001|Overall Study|Physician Decision|1|||
19709449|NCT00100178|42153525|FG002|Overall Study|Physician Decision|3|||
19709450|NCT00099632|42153539|FG000|Overall Study|Lost to Follow-up|1|||
19709451|NCT00099632|42153540|FG001|Overall Study|Lost to Follow-up|0|||
19709452|NCT00099632|42153541|FG002|Overall Study|Lost to Follow-up|3|||
19709453|NCT00099632|42153542|FG003|Overall Study|Lost to Follow-up|1|||
19709454|NCT00099632|42153543|FG004|Overall Study|Lost to Follow-up|1|||
19709455|NCT00099632|42153544|FG005|Overall Study|Lost to Follow-up|0|||
19709456|NCT00099632|42153539|FG000|Overall Study|Withdrawal by Subject|0|||
19709457|NCT00099632|42153540|FG001|Overall Study|Withdrawal by Subject|1|||
19626695|NCT00659230|42076263|FG000|Overall Study|Did not return post-randomization|2|||
19626696|NCT00659230|42076264|FG001|Overall Study|Did not return post-randomization|3|||
19626697|NCT00809094|42076272|FG000|Overall Study|Lost to Follow-up|0|||
19626698|NCT00809094|42076273|FG001|Overall Study|Lost to Follow-up|1|||
19709458|NCT00099632|42153541|FG002|Overall Study|Withdrawal by Subject|0|||
19626699|NCT00658996|42076279|FG000|First Intervention|Positive slit lamp finding|1|||
19626700|NCT00658996|42076280|FG001|First Intervention|Positive slit lamp finding|0|||
19626701|NCT00658996|42076279|FG000|First Intervention|Lack of lenses|0|||
19626702|NCT00658996|42076280|FG001|First Intervention|Lack of lenses|1|||
19626703|NCT00658996|42076279|FG000|Crossover Period|Physician Decision|1|||
19626704|NCT00658996|42076280|FG001|Crossover Period|Physician Decision|0|||
19626705|NCT00658996|42076279|FG000|Crossover Period|Ineligible|1|||
19626706|NCT00658996|42076280|FG001|Crossover Period|Ineligible|1|||
19626707|NCT00658996|42076279|FG000|Second Intervention|Developed a stye on upper lid|1|||
19626708|NCT00658996|42076280|FG001|Second Intervention|Developed a stye on upper lid|0|||
19709459|NCT00099632|42153542|FG003|Overall Study|Withdrawal by Subject|0|||
19709460|NCT00099632|42153543|FG004|Overall Study|Withdrawal by Subject|0|||
19709461|NCT00099632|42153544|FG005|Overall Study|Withdrawal by Subject|1|||
19709462|NCT00099632|42153539|FG000|Overall Study|Protocol Violation|0|||
19709463|NCT00099632|42153540|FG001|Overall Study|Protocol Violation|0|||
19709464|NCT00099632|42153541|FG002|Overall Study|Protocol Violation|0|||
19709465|NCT00099632|42153542|FG003|Overall Study|Protocol Violation|0|||
19709466|NCT00099632|42153543|FG004|Overall Study|Protocol Violation|0|||
19709467|NCT00099632|42153544|FG005|Overall Study|Protocol Violation|1|||
19709468|NCT00098774|42153558|FG000|Overall Study|Adverse Event|2|||
19709469|NCT00098774|42153558|FG000|Overall Study|Disease Progression|9|||
19709470|NCT00098774|42153558|FG000|Overall Study|Withdrawal by Subject|1|||
19709471|NCT00098774|42153558|FG000|Overall Study|Failed (to respond) during induction|4|||
19709472|NCT00098774|42153558|FG000|Overall Study|Physician Decision|2|||
19709473|NCT00384059|42153564|FG000|Infant Series|Not consented|2|||
19709474|NCT00384059|42153565|FG001|Infant Series|Not consented|6|||
19709475|NCT00384059|42153564|FG000|Infant Series|Withdrawal by Subject|2|||
19709476|NCT00384059|42153565|FG001|Infant Series|Withdrawal by Subject|2|||
19709477|NCT00384059|42153564|FG000|Infant Series|Adverse Event|1|||
19709478|NCT00384059|42153565|FG001|Infant Series|Adverse Event|2|||
19709479|NCT00384059|42153564|FG000|Infant Series|Protocol Violation|1|||
19709480|NCT00384059|42153565|FG001|Infant Series|Protocol Violation|2|||
19709481|NCT00384059|42153564|FG000|Infant Series|Lost to Follow-up|0|||
19709482|NCT00384059|42153565|FG001|Infant Series|Lost to Follow-up|1|||
19709483|NCT00384059|42153564|FG000|After Infant Series|Protocol Violation|2|||
19709484|NCT00384059|42153565|FG001|After Infant Series|Protocol Violation|3|||
19709485|NCT00384059|42153564|FG000|After Infant Series|Withdrawal by Subject|2|||
19709486|NCT00384059|42153565|FG001|After Infant Series|Withdrawal by Subject|2|||
19709487|NCT00384059|42153564|FG000|After Infant Series|Failed to Return|0|||
19709488|NCT00384059|42153565|FG001|After Infant Series|Failed to Return|2|||
19709489|NCT00384059|42153564|FG000|After Infant Series|Adverse Event|0|||
19709490|NCT00384059|42153565|FG001|After Infant Series|Adverse Event|1|||
19709491|NCT00384059|42153564|FG000|After Infant Series|Physician Decision|0|||
19709492|NCT00384059|42153565|FG001|After Infant Series|Physician Decision|1|||
19709493|NCT00384059|42153564|FG000|After Infant Series|Lost to Follow-up|0|||
19709494|NCT00384059|42153565|FG001|After Infant Series|Lost to Follow-up|1|||
19709495|NCT00384059|42153564|FG000|Toddler Dose|Lost to Follow-up|1|||
19709496|NCT00384059|42153565|FG001|Toddler Dose|Lost to Follow-up|1|||
19709497|NCT00384059|42153564|FG000|Toddler Dose|Failed to return|0|||
19709498|NCT00384059|42153565|FG001|Toddler Dose|Failed to return|1|||
19709499|NCT00383123|42153594|FG000|Overall Study|Adverse Event|1|||
19709500|NCT00383123|42153595|FG001|Overall Study|Adverse Event|0|||
19709501|NCT00383123|42153594|FG000|Overall Study|Lost to Follow-up|68|||
19709502|NCT00383123|42153595|FG001|Overall Study|Lost to Follow-up|61|||
19709503|NCT00383123|42153594|FG000|Overall Study|Protocol Violation|5|||
19709504|NCT00383123|42153595|FG001|Overall Study|Protocol Violation|1|||
19709505|NCT00383123|42153594|FG000|Overall Study|Withdrawal by Subject|27|||
19709506|NCT00383123|42153595|FG001|Overall Study|Withdrawal by Subject|18|||
19709507|NCT00383123|42153594|FG000|Overall Study|Other reason|10|||
19709508|NCT00383123|42153595|FG001|Overall Study|Other reason|6|||
19709509|NCT00382967|42153603|FG000|Overall Study|Protocol Violation|1|||
19709510|NCT00382967|42153604|FG001|Overall Study|Protocol Violation|1|||
19709511|NCT00858364|42153612|FG000|Overall Study|Administrative Decision|3|||
19709512|NCT00858364|42153613|FG001|Overall Study|Administrative Decision|2|||
19626709|NCT00658996|42076279|FG000|Second Intervention|Positive slit lamp finding|0|||
19709513|NCT00858364|42153612|FG000|Overall Study|Adverse Event|5|||
19709514|NCT00858364|42153613|FG001|Overall Study|Adverse Event|2|||
19709515|NCT00858364|42153612|FG000|Overall Study|Withdrawal by Subject|44|||
19709516|NCT00858364|42153613|FG001|Overall Study|Withdrawal by Subject|118|||
19709517|NCT00858364|42153612|FG000|Overall Study|Ineligibility Determined|1|||
19709518|NCT00858364|42153613|FG001|Overall Study|Ineligibility Determined|10|||
19709519|NCT00858364|42153612|FG000|Overall Study|Lost to Follow-up|24|||
19709520|NCT00858364|42153613|FG001|Overall Study|Lost to Follow-up|54|||
19709521|NCT00858364|42153612|FG000|Overall Study|Noncompliance|3|||
19709522|NCT00858364|42153613|FG001|Overall Study|Noncompliance|4|||
19709523|NCT00858364|42153612|FG000|Overall Study|Protocol Deviation|0|||
19626710|NCT00658996|42076280|FG001|Second Intervention|Positive slit lamp finding|1|||
19626711|NCT00867815|42076286|FG000|Overall Study|Lost to Follow-up|1|||
19626712|NCT00452413|42076293|FG000|Overall Study|Progressive Disease|4|||
19626713|NCT00452413|42076294|FG001|Overall Study|Progressive Disease|11|||
19709524|NCT00858364|42153613|FG001|Overall Study|Protocol Deviation|2|||
19709525|NCT00858364|42153612|FG000|Overall Study|Other|9|||
19709526|NCT00858364|42153613|FG001|Overall Study|Other|17|||
19626714|NCT00452413|42076295|FG002|Overall Study|Progressive Disease|30|||
19626715|NCT00452413|42076293|FG000|Overall Study|Withdrawal by Subject|0|||
19626716|NCT00452413|42076294|FG001|Overall Study|Withdrawal by Subject|1|||
19626717|NCT00452413|42076295|FG002|Overall Study|Withdrawal by Subject|4|||
19626718|NCT00452413|42076293|FG000|Overall Study|Adverse Event|0|||
19626719|NCT00452413|42076294|FG001|Overall Study|Adverse Event|0|||
19626720|NCT00452413|42076295|FG002|Overall Study|Adverse Event|5|||
19626721|NCT00452413|42076293|FG000|Overall Study|Physician Decision|0|||
19626722|NCT00452413|42076294|FG001|Overall Study|Physician Decision|0|||
19626723|NCT00452413|42076295|FG002|Overall Study|Physician Decision|4|||
19626724|NCT00452413|42076293|FG000|Overall Study|Death due to study disease|0|||
19626725|NCT00452413|42076294|FG001|Overall Study|Death due to study disease|0|||
19626726|NCT00452413|42076295|FG002|Overall Study|Death due to study disease|2|||
19626727|NCT00452413|42076293|FG000|Overall Study|Death due to adverse event (AE)|0|||
19626728|NCT00452413|42076294|FG001|Overall Study|Death due to adverse event (AE)|0|||
19626729|NCT00452413|42076295|FG002|Overall Study|Death due to adverse event (AE)|1|||
19626730|NCT00452413|42076293|FG000|Overall Study|On treatment|0|||
19626731|NCT00452413|42076294|FG001|Overall Study|On treatment|0|||
19626732|NCT00452413|42076295|FG002|Overall Study|On treatment|3|||
19626733|NCT00867503|42076304|FG000|Overall Study|Withdrawal by Subject|1|||
19626734|NCT00867113|42076310|FG000|Treatment Period|Adverse Event|15|||
19626735|NCT00867113|42076310|FG000|Treatment Period|Death|2|||
19626736|NCT00867113|42076310|FG000|Treatment Period|Withdrawal by Subject|19|||
19626737|NCT00867113|42076310|FG000|Treatment Period|Lost to Follow-up|3|||
19626738|NCT00867113|42076310|FG000|Treatment Period|Administrative problems|1|||
19626739|NCT00867113|42076310|FG000|Treatment Period|Disease progression/relapse|1|||
19626740|NCT00867113|42076310|FG000|Treatment Period|Protocol Violation|4|||
19626741|NCT00867113|42076310|FG000|Post Treatment After Survival Follow-up|Death|1|||
19626742|NCT00867113|42076310|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
19626743|NCT00867113|42076310|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
19626744|NCT00867113|42076310|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
19709527|NCT00858364|42153612|FG000|Overall Study|Missing|1|||
19709528|NCT00858364|42153613|FG001|Overall Study|Missing|1|||
19709529|NCT00858364|42153612|FG000|Overall Study|Still on-study|114|||
19709530|NCT00858364|42153613|FG001|Overall Study|Still on-study|247|||
19709531|NCT00382733|42153619|FG000|Overall Study|Withdrawal by Subject|0|||
19709532|NCT00382733|42153620|FG001|Overall Study|Withdrawal by Subject|1|||
19709533|NCT00382733|42153621|FG002|Overall Study|Withdrawal by Subject|0|||
19626745|NCT00451555|42076317|FG000|Overall Study|Protocol Violation|2|||
19709534|NCT00382733|42153622|FG003|Overall Study|Withdrawal by Subject|0|||
19709535|NCT00382733|42153623|FG004|Overall Study|Withdrawal by Subject|0|||
19709536|NCT03631732|42153638|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
19709537|NCT03631732|42153639|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
19709538|NCT03631732|42153638|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
19709539|NCT03631732|42153639|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
19709540|NCT03631732|42153638|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
19709541|NCT03631732|42153639|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
19709542|NCT03631732|42153638|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
19709543|NCT03631732|42153639|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
19709544|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
19709545|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
19517788|NCT01527006|41930779|FG001|Extension Phase|Adverse Event|2|||
19709546|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
19709547|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
19709548|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
19709549|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
19709550|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
19709551|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
19709552|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
19709553|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
19709554|NCT03631732|42153638|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
19709555|NCT03631732|42153639|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
19709556|NCT03630016|42153649|FG000|Overall Study|Poor Sensor Placement|1|||
19709557|NCT03628924|42153656|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
19709558|NCT03628924|42153657|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709559|NCT03628924|42153658|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709560|NCT03628924|42153659|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709561|NCT03628924|42153660|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709562|NCT03628924|42153661|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709563|NCT03628924|42153662|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
19709564|NCT03628924|42153656|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709565|NCT03628924|42153657|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709566|NCT03628924|42153658|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
19709567|NCT03628924|42153659|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709568|NCT03628924|42153660|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709569|NCT03628924|42153661|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709570|NCT03628924|42153662|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19709571|NCT03628924|42153656|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
19709572|NCT03628924|42153657|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
19709573|NCT03628924|42153658|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
19709574|NCT03628924|42153659|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
19709575|NCT03628924|42153660|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
19709576|NCT03628924|42153661|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
19709577|NCT03628924|42153662|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
19709578|NCT03628924|42153656|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19709579|NCT03628924|42153657|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
19709580|NCT03628924|42153658|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19373930|NCT02663895|41615202|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
19709581|NCT03628924|42153659|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19709582|NCT03628924|42153660|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19709583|NCT03628924|42153661|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19709584|NCT03628924|42153662|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
19709585|NCT03628924|42153656|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
19709586|NCT03628924|42153657|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
19709587|NCT03628924|42153658|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
19709588|NCT03628924|42153659|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
19709589|NCT03628924|42153660|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
19709590|NCT03628924|42153661|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
19709591|NCT03628924|42153662|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
19709592|NCT03628924|42153656|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
19709593|NCT03628924|42153657|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
19709594|NCT03628924|42153658|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
19709595|NCT03628924|42153659|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
19709596|NCT03628924|42153660|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
19709597|NCT03628924|42153661|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
19709598|NCT03628924|42153662|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
19709599|NCT03628924|42153656|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
19709600|NCT03628924|42153657|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
19709601|NCT03628924|42153658|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
19709602|NCT03628924|42153659|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
19709603|NCT03628924|42153660|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
19709604|NCT03628924|42153661|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
19709605|NCT03628924|42153662|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
19709606|NCT03628924|42153656|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
19709607|NCT03628924|42153657|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
19709608|NCT03628924|42153658|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
19709609|NCT03628924|42153659|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
19709610|NCT03628924|42153660|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
19709611|NCT03628924|42153661|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
19709612|NCT03628924|42153662|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
19709613|NCT03628924|42153656|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
19709614|NCT03628924|42153657|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
19709615|NCT03628924|42153658|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
19709616|NCT03628924|42153659|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
19709617|NCT03628924|42153660|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
19709618|NCT03628924|42153661|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
19709619|NCT03628924|42153662|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
19709620|NCT03628924|42153656|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
19709621|NCT03628924|42153657|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
19709622|NCT03628924|42153658|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
19709623|NCT03628924|42153659|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
19709624|NCT03628924|42153660|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
19709625|NCT03628924|42153661|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
19709626|NCT03628924|42153662|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
19709627|NCT03627832|42153676|FG000|Overall Study|Withdrawal by Subject|10|||
19709628|NCT03627832|42153677|FG001|Overall Study|Withdrawal by Subject|1|||
19709629|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
19709630|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
19709631|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
19709632|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
19626746|NCT00451555|42076318|FG001|Overall Study|Protocol Violation|2|||
19626747|NCT00451555|42076317|FG000|Overall Study|Adverse Event|3|||
19626748|NCT00451555|42076318|FG001|Overall Study|Adverse Event|1|||
19626749|NCT00451555|42076317|FG000|Overall Study|Withdrawal by Subject|6|||
19626750|NCT00451555|42076318|FG001|Overall Study|Withdrawal by Subject|0|||
19626751|NCT00451555|42076317|FG000|Overall Study|Physician Decision|2|||
19626752|NCT00451555|42076318|FG001|Overall Study|Physician Decision|1|||
19626753|NCT00808236|42076335|FG000|Overall Study|Was not resuscitated|50|||
19626754|NCT00808236|42076336|FG001|Overall Study|Was not resuscitated|56|||
19626755|NCT00808236|42076335|FG000|Overall Study|Pre-defined exclusion|13|||
19709633|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
19709634|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709635|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709636|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709637|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709638|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709639|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709640|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709641|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709642|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709643|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709644|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709645|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709646|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709647|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709648|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709649|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709650|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709651|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709652|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
19517789|NCT01527006|41930778|FG000|Extension Phase|Lost to Follow-up|0|||
19517790|NCT01527006|41930779|FG001|Extension Phase|Lost to Follow-up|1|||
19517791|NCT01527006|41930778|FG000|Extension Phase|Subject Choice|1|||
19626756|NCT00808236|42076336|FG001|Overall Study|Pre-defined exclusion|3|||
19709653|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709654|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
19709655|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709656|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
19709657|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709658|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709659|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709660|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709661|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709662|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709663|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709664|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709665|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709666|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709667|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19626757|NCT00808236|42076335|FG000|Overall Study|Lost to Follow-up|1|||
19626758|NCT00808236|42076336|FG001|Overall Study|Lost to Follow-up|1|||
19626759|NCT00808236|42076335|FG000|Overall Study|Physician Decision|0|||
19626760|NCT00808236|42076336|FG001|Overall Study|Physician Decision|1|||
19626761|NCT00808236|42076335|FG000|Overall Study|Death|18|||
19626762|NCT00808236|42076336|FG001|Overall Study|Death|30|||
19626763|NCT00867035|42076344|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
19626764|NCT00867035|42076345|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
19626765|NCT00867035|42076344|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
19626766|NCT00867035|42076345|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
19626767|NCT00663208|42076358|FG000|Treatment Period|Lost to Follow-up|0|||
19626768|NCT00663208|42076359|FG001|Treatment Period|Lost to Follow-up|1|||
19517792|NCT01527006|41930779|FG001|Extension Phase|Subject Choice|1|||
19517793|NCT01527006|41930778|FG000|Extension Phase|Inadequate therapeutic effect|1|||
19709668|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709669|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709670|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709671|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709672|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709673|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709674|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709675|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709676|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709677|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709678|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709679|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709680|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
19709681|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709682|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
19709683|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709684|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709685|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709686|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19626769|NCT00663208|42076360|FG002|Treatment Period|Lost to Follow-up|0|||
19626770|NCT00663208|42076361|FG003|Treatment Period|Lost to Follow-up|0|||
19626771|NCT00663208|42076362|FG004|Treatment Period|Lost to Follow-up|0|||
19626772|NCT00663208|42076363|FG005|Treatment Period|Lost to Follow-up|0|||
19626773|NCT00663208|42076364|FG006|Treatment Period|Lost to Follow-up|0|||
19626774|NCT00663208|42076358|FG000|Follow-up Period|Lost to Follow-up|2|||
19626775|NCT00663208|42076359|FG001|Follow-up Period|Lost to Follow-up|0|||
19626776|NCT00663208|42076360|FG002|Follow-up Period|Lost to Follow-up|3|||
19626777|NCT00663208|42076361|FG003|Follow-up Period|Lost to Follow-up|2|||
19626778|NCT00663208|42076362|FG004|Follow-up Period|Lost to Follow-up|0|||
19626779|NCT00663208|42076363|FG005|Follow-up Period|Lost to Follow-up|0|||
19709687|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709688|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709689|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19626780|NCT00663208|42076364|FG006|Follow-up Period|Lost to Follow-up|0|||
19626781|NCT00663208|42076358|FG000|Follow-up Period|Other reason|1|||
19626782|NCT00663208|42076359|FG001|Follow-up Period|Other reason|0|||
19626783|NCT00663208|42076360|FG002|Follow-up Period|Other reason|0|||
19626784|NCT00663208|42076361|FG003|Follow-up Period|Other reason|0|||
19626785|NCT00663208|42076362|FG004|Follow-up Period|Other reason|0|||
19626786|NCT00663208|42076363|FG005|Follow-up Period|Other reason|0|||
19626787|NCT00663208|42076364|FG006|Follow-up Period|Other reason|1|||
19626788|NCT00810810|42076386|FG000|Overall Study|Withdrawal by Subject|0|||
19626789|NCT00810810|42076387|FG001|Overall Study|Withdrawal by Subject|8|||
19626790|NCT00810810|42076388|FG002|Overall Study|Withdrawal by Subject|10|||
19626791|NCT00810810|42076389|FG003|Overall Study|Withdrawal by Subject|8|||
19626792|NCT00810810|42076386|FG000|Overall Study|Physician Decision|0|||
19626793|NCT00810810|42076387|FG001|Overall Study|Physician Decision|3|||
19626794|NCT00810810|42076388|FG002|Overall Study|Physician Decision|1|||
19626795|NCT00810810|42076389|FG003|Overall Study|Physician Decision|5|||
19626796|NCT00661258|42076401|FG000|Overall Study|Death|1|||
19626797|NCT00661258|42076402|FG001|Overall Study|Death|0|||
19626798|NCT00661258|42076401|FG000|Overall Study|caught by police and in detox center|2|||
19626799|NCT00661258|42076402|FG001|Overall Study|caught by police and in detox center|1|||
19626800|NCT00871871|42076410|FG000|Part I|Adverse Event|0|||
19626801|NCT00871871|42076411|FG001|Part I|Adverse Event|2|||
19626802|NCT00871871|42076412|FG002|Part I|Adverse Event|0|||
19626803|NCT00871871|42076413|FG003|Part I|Adverse Event|0|||
19626804|NCT00871871|42076410|FG000|Part I|Withdrawal by Subject|3|||
19626805|NCT00871871|42076411|FG001|Part I|Withdrawal by Subject|0|||
19626806|NCT00871871|42076412|FG002|Part I|Withdrawal by Subject|0|||
19626807|NCT00871871|42076413|FG003|Part I|Withdrawal by Subject|0|||
19626808|NCT00871871|42076410|FG000|Part I|Laboratory abnormality|0|||
19626809|NCT00871871|42076411|FG001|Part I|Laboratory abnormality|1|||
19626810|NCT00871871|42076412|FG002|Part I|Laboratory abnormality|0|||
19626811|NCT00871871|42076413|FG003|Part I|Laboratory abnormality|0|||
19626812|NCT00871871|42076410|FG000|Part II|Lack of Efficacy|0|||
19626813|NCT00871871|42076411|FG001|Part II|Lack of Efficacy|0|||
19626814|NCT00871871|42076412|FG002|Part II|Lack of Efficacy|1|||
19626815|NCT00871871|42076413|FG003|Part II|Lack of Efficacy|0|||
19626816|NCT00871871|42076410|FG000|Part II|Withdrawal by Subject|0|||
19626817|NCT00871871|42076411|FG001|Part II|Withdrawal by Subject|0|||
19709690|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19626818|NCT00871871|42076412|FG002|Part II|Withdrawal by Subject|2|||
19626819|NCT00871871|42076413|FG003|Part II|Withdrawal by Subject|1|||
19626820|NCT00871871|42076410|FG000|Part II|Adverse Event|0|||
19626821|NCT00871871|42076411|FG001|Part II|Adverse Event|0|||
19709691|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709692|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709693|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709694|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709695|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709696|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709697|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709698|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709699|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709700|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709701|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709702|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709703|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709704|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709705|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709706|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
19709707|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
19709708|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709709|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
19709710|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
19709711|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
19709712|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709713|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709714|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709715|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709716|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709717|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709718|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709719|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709720|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709721|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709722|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709723|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709724|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709725|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709726|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709727|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709728|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709729|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709730|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19709731|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19626822|NCT00871871|42076412|FG002|Part II|Adverse Event|1|||
19626823|NCT00871871|42076413|FG003|Part II|Adverse Event|2|||
19626824|NCT00871871|42076410|FG000|Part II|Protocol Violation|0|||
19626825|NCT00871871|42076411|FG001|Part II|Protocol Violation|0|||
19626826|NCT00871871|42076412|FG002|Part II|Protocol Violation|0|||
19626827|NCT00871871|42076413|FG003|Part II|Protocol Violation|1|||
19626828|NCT00849680|42076431|FG000|Overall Study|Adverse Event|0|||
19626829|NCT00849680|42076432|FG001|Overall Study|Adverse Event|0|||
19626830|NCT00849680|42076433|FG002|Overall Study|Adverse Event|0|||
19626831|NCT00849680|42076434|FG003|Overall Study|Adverse Event|0|||
19626832|NCT00849680|42076435|FG004|Overall Study|Adverse Event|0|||
19626833|NCT00849680|42076436|FG005|Overall Study|Adverse Event|0|||
19709732|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
19626834|NCT00849680|42076437|FG006|Overall Study|Adverse Event|2|||
19709733|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
19626835|NCT00849680|42076438|FG007|Overall Study|Adverse Event|0|||
19626836|NCT00849680|42076431|FG000|Overall Study|Lost to Follow-up|7|||
19626837|NCT00849680|42076432|FG001|Overall Study|Lost to Follow-up|3|||
19626838|NCT00849680|42076433|FG002|Overall Study|Lost to Follow-up|12|||
19626839|NCT00849680|42076434|FG003|Overall Study|Lost to Follow-up|11|||
19626840|NCT00849680|42076435|FG004|Overall Study|Lost to Follow-up|8|||
19626841|NCT00849680|42076436|FG005|Overall Study|Lost to Follow-up|11|||
19626842|NCT00849680|42076437|FG006|Overall Study|Lost to Follow-up|12|||
19626843|NCT00849680|42076438|FG007|Overall Study|Lost to Follow-up|5|||
19626844|NCT00849680|42076431|FG000|Overall Study|Subject moved|1|||
19626845|NCT00849680|42076432|FG001|Overall Study|Subject moved|0|||
19626846|NCT00849680|42076433|FG002|Overall Study|Subject moved|3|||
19626847|NCT00849680|42076434|FG003|Overall Study|Subject moved|1|||
19626848|NCT00849680|42076435|FG004|Overall Study|Subject moved|0|||
19626849|NCT00849680|42076436|FG005|Overall Study|Subject moved|2|||
19626850|NCT00849680|42076437|FG006|Overall Study|Subject moved|2|||
19626851|NCT00849680|42076438|FG007|Overall Study|Subject moved|2|||
19709734|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
19709735|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
19709736|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
19709737|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
19709738|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709739|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709740|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709741|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709742|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709743|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709744|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709745|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709746|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709747|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709748|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709749|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709750|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709751|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709752|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709753|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709754|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709755|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709756|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709757|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709758|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
19709759|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|moved|0|||
19709760|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|moved|1|||
19709761|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|moved|1|||
19709762|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|moved|0|||
19709763|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|moved|0|||
19709764|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|moved|0|||
19626852|NCT00849680|42076431|FG000|Overall Study|Withdrawal by Subject|2|||
19709765|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|moved|0|||
19709766|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|moved|0|||
19709767|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|moved|0|||
19709768|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|moved|0|||
19709769|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|moved|0|||
19709770|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|moved|0|||
19709771|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|moved|0|||
19709772|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|moved|0|||
19709773|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|moved|0|||
19709774|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|moved|0|||
19709775|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|moved|0|||
19709776|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|moved|0|||
19709777|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|moved|0|||
19709778|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|moved|0|||
19709779|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|moved|0|||
19709780|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|moved|0|||
19709781|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|moved|0|||
19709782|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|moved|0|||
19709783|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|moved|0|||
19626853|NCT00849680|42076432|FG001|Overall Study|Withdrawal by Subject|0|||
19626854|NCT00849680|42076433|FG002|Overall Study|Withdrawal by Subject|0|||
19626855|NCT00849680|42076434|FG003|Overall Study|Withdrawal by Subject|2|||
19626856|NCT00849680|42076435|FG004|Overall Study|Withdrawal by Subject|2|||
19626857|NCT00849680|42076436|FG005|Overall Study|Withdrawal by Subject|2|||
19626858|NCT00849680|42076437|FG006|Overall Study|Withdrawal by Subject|1|||
19626859|NCT00849680|42076438|FG007|Overall Study|Withdrawal by Subject|1|||
19626860|NCT00849680|42076431|FG000|Overall Study|Subject unable to comply with protocol|1|||
19626861|NCT00849680|42076432|FG001|Overall Study|Subject unable to comply with protocol|0|||
19626862|NCT00849680|42076433|FG002|Overall Study|Subject unable to comply with protocol|0|||
19709784|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|moved|0|||
19626863|NCT00849680|42076434|FG003|Overall Study|Subject unable to comply with protocol|0|||
19626864|NCT00849680|42076435|FG004|Overall Study|Subject unable to comply with protocol|0|||
19626865|NCT00849680|42076436|FG005|Overall Study|Subject unable to comply with protocol|0|||
19626866|NCT00849680|42076437|FG006|Overall Study|Subject unable to comply with protocol|0|||
19626867|NCT00849680|42076438|FG007|Overall Study|Subject unable to comply with protocol|0|||
19626868|NCT00810342|42076458|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
19626869|NCT00810342|42076459|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
19626870|NCT00810342|42076458|FG000|Month 1 Follow-up|Pregnancy|1|||
19626871|NCT00810342|42076459|FG001|Month 1 Follow-up|Pregnancy|0|||
19626872|NCT00810342|42076458|FG000|6-month Follow-up|Lost to Follow-up|18|||
19626873|NCT00810342|42076459|FG001|6-month Follow-up|Lost to Follow-up|6|||
19626874|NCT00810342|42076458|FG000|6-month Follow-up|Pregnancy|6|||
19626875|NCT00810342|42076459|FG001|6-month Follow-up|Pregnancy|2|||
19626876|NCT00810342|42076458|FG000|12-month Followup|Pregnancy|9|||
19626877|NCT00810342|42076459|FG001|12-month Followup|Pregnancy|10|||
19626878|NCT00810342|42076458|FG000|12-month Followup|Lost to Follow-up|3|||
19626879|NCT00810342|42076459|FG001|12-month Followup|Lost to Follow-up|1|||
19626880|NCT00849524|42076467|FG000|Overall Study|Lack of Efficacy|3|||
19626881|NCT00808080|42076471|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
19626882|NCT00866723|42076476|FG000|Overall Study|Withdrawal by Subject|1|||
19626883|NCT00866723|42076476|FG000|Overall Study|Disease Progression|4|||
19626884|NCT00849290|42076480|FG000|Overall Study|Adverse Event|3|||
19626885|NCT00849290|42076480|FG000|Overall Study|Death|14|||
19626886|NCT00849290|42076480|FG000|Overall Study|Withdrawal by Subject|11|||
19626887|NCT00849290|42076480|FG000|Overall Study|Lost to Follow-up|2|||
19626888|NCT00849290|42076480|FG000|Overall Study|Protocol Violation|5|||
19626889|NCT00849290|42076480|FG000|Overall Study|Disease Progression|20|||
19626890|NCT00849212|42076484|FG000|Overall Study|Lack of Efficacy|1|||
19626891|NCT00849212|42076484|FG000|Overall Study|Withdrawal by Subject|3|||
19626892|NCT00849212|42076484|FG000|Overall Study|Adverse Event|2|||
19626893|NCT00849212|42076484|FG000|Overall Study|Miscellaneous|1|||
19626894|NCT00810264|42076488|FG000|Overall Study|Lost to Follow-up|191|||
19626895|NCT00810264|42076488|FG000|Overall Study|Withdrawal by subject or physician|721|||
19626896|NCT00810264|42076488|FG000|Overall Study|Death|641|||
19626897|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
19626898|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
19626899|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
19626900|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
19626901|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
19626902|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
19626903|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
19626904|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
19626905|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
19626906|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
19626907|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
19709785|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709786|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709787|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709788|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
19709789|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709790|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709791|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709792|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709793|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709794|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709795|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709796|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709797|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709798|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19626908|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
19626909|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
19626910|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
19626911|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
19709799|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709800|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709801|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709802|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709803|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709804|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709805|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709806|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709807|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709808|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709809|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709810|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
19709811|NCT00112437|42153688|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709812|NCT00112437|42153689|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394624|NCT01659255|41638781|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
19394625|NCT02637037|41638821|FG000|Overall Study|Positive drug screen at admission|1|||
19394626|NCT02637037|41638822|FG001|Overall Study|Positive drug screen at admission|0|||
19626912|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
19626913|NCT00849056|42076498|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
19626914|NCT00849056|42076499|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
19626915|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
19626916|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
19626917|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
19626918|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
19626919|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
19626920|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
19626921|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
19626922|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
19626923|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
19626924|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
19626925|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
19626926|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
19626927|NCT00849056|42076498|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
19626928|NCT00849056|42076499|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
19626929|NCT00837434|42076507|FG000|Overall Study|Physician Decision|3|||
19626930|NCT00837434|42076508|FG001|Overall Study|Physician Decision|0|||
19626931|NCT00837434|42076507|FG000|Overall Study|Lost to Follow-up|1|||
19626932|NCT00837434|42076508|FG001|Overall Study|Lost to Follow-up|1|||
19626933|NCT00837434|42076507|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
19626934|NCT00837434|42076508|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
19626935|NCT00837434|42076507|FG000|Overall Study|Noncompliant|2|||
19709813|NCT00112437|42153690|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709814|NCT00112437|42153691|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709815|NCT00112437|42153692|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
19709816|NCT00112437|42153693|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709817|NCT00112437|42153694|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709818|NCT00112437|42153695|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394627|NCT02637037|41638821|FG000|Overall Study|Withdrawal by Subject|2|||
19394628|NCT02637037|41638822|FG001|Overall Study|Withdrawal by Subject|1|||
19394629|NCT02637037|41638821|FG000|Overall Study|Adverse Event|1|||
19394630|NCT02637037|41638822|FG001|Overall Study|Adverse Event|0|||
19394631|NCT02637895|41638842|FG000|Overall Study|Lost to Follow-up|4|||
19394632|NCT02637895|41638843|FG001|Overall Study|Lost to Follow-up|0|||
19394633|NCT02637895|41638842|FG000|Overall Study|Protocol Violation|0|||
19394634|NCT02637895|41638843|FG001|Overall Study|Protocol Violation|1|||
19394635|NCT02637895|41638842|FG000|Overall Study|Lack of Efficacy|1|||
19394636|NCT02637895|41638843|FG001|Overall Study|Lack of Efficacy|0|||
19394637|NCT02637895|41638842|FG000|Overall Study|Withdrawal by Subject|1|||
19394638|NCT02637895|41638843|FG001|Overall Study|Withdrawal by Subject|1|||
19394639|NCT02637895|41638842|FG000|Overall Study|Abnormal baseline lab|0|||
19394640|NCT02637895|41638843|FG001|Overall Study|Abnormal baseline lab|1|||
19394641|NCT02522481|41638850|FG000|Overall Study|discontinued|1|||
19394642|NCT02522481|41638850|FG000|Overall Study|Not dosed|2|||
19394643|NCT02522403|41638863|FG000|Overall Study|Lost to Follow-up|2|||
19394644|NCT02522403|41638864|FG001|Overall Study|Lost to Follow-up|2|||
19394645|NCT02522403|41638863|FG000|Overall Study|Withdrawal by Subject|2|||
19394646|NCT02522403|41638864|FG001|Overall Study|Withdrawal by Subject|4|||
19394647|NCT02522325|41638870|FG000|Overall Study|Adverse Event|0|||
19394648|NCT02522325|41638871|FG001|Overall Study|Adverse Event|1|||
19394649|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
19394650|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
19394651|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
19709819|NCT00112437|42153696|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394652|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
19394653|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
19394654|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
19709820|NCT00112437|42153697|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394655|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
19394656|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
19394657|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
19394658|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
19394659|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
19394660|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
19394661|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
19394662|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
19394663|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
19394664|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
19394665|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
19394666|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
19394667|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
19394668|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
19394669|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
19394670|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
19394671|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
19394672|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
19394673|NCT01672879|41638880|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
19394674|NCT01672879|41638881|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
19394675|NCT01672879|41638882|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
19517794|NCT01527006|41930779|FG001|Extension Phase|Inadequate therapeutic effect|1|||
19517795|NCT01527006|41930778|FG000|Extension Phase|Other|0|||
19517796|NCT01527006|41930779|FG001|Extension Phase|Other|3|||
19517797|NCT01526928|41930797|FG000|Overall Study|Progressive Disease|35|||
19517798|NCT01526928|41930798|FG001|Overall Study|Progressive Disease|17|||
19517799|NCT01526928|41930799|FG002|Overall Study|Progressive Disease|150|||
19626936|NCT00837434|42076508|FG001|Overall Study|Noncompliant|0|||
19626937|NCT00837434|42076507|FG000|Overall Study|Baseline assessments not done in time|1|||
19394676|NCT01672879|41638880|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
19394677|NCT01672879|41638881|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
19394678|NCT01672879|41638882|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
19394679|NCT01672879|41638880|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
19394680|NCT01672879|41638881|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
19394681|NCT01672879|41638882|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
19394682|NCT01672879|41638880|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
19394683|NCT01672879|41638881|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
19394684|NCT01672879|41638882|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
19394685|NCT01672879|41638880|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
19394686|NCT01672879|41638881|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
19394687|NCT01672879|41638882|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
19394688|NCT02601209|41638898|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
19394689|NCT02601209|41638899|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
19394690|NCT02601209|41638900|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
19394691|NCT02601209|41638901|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394692|NCT02601209|41638902|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394693|NCT02601209|41638903|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394694|NCT02601209|41638904|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394695|NCT02601209|41638905|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394696|NCT02601209|41638906|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
19394697|NCT02601209|41638898|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394698|NCT02601209|41638899|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394699|NCT02601209|41638900|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394700|NCT02601209|41638901|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394701|NCT02601209|41638902|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
19517800|NCT01526928|41930800|FG003|Overall Study|Progressive Disease|182|||
19517801|NCT01526928|41930801|FG004|Overall Study|Progressive Disease|76|||
19626938|NCT00837434|42076508|FG001|Overall Study|Baseline assessments not done in time|0|||
19626939|NCT00837434|42076507|FG000|Overall Study|Unable to obtain study drug|1|||
19626940|NCT00837434|42076508|FG001|Overall Study|Unable to obtain study drug|0|||
19626941|NCT00827918|42076517|FG000|Overall Study|Adverse Event|4|||
19626942|NCT00827918|42076518|FG001|Overall Study|Adverse Event|0|||
19626943|NCT00827918|42076519|FG002|Overall Study|Adverse Event|0|||
19626944|NCT00827918|42076517|FG000|Overall Study|Lack of Efficacy|16|||
19626945|NCT00827918|42076518|FG001|Overall Study|Lack of Efficacy|4|||
19626946|NCT00827918|42076519|FG002|Overall Study|Lack of Efficacy|15|||
19626947|NCT00827918|42076517|FG000|Overall Study|Physician Decision|1|||
19709821|NCT00112437|42153698|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709822|NCT00112437|42153699|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709823|NCT00112437|42153700|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709824|NCT00112437|42153701|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709825|NCT00112437|42153702|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709826|NCT00112437|42153703|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709827|NCT00112437|42153704|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394702|NCT02601209|41638903|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
19394703|NCT02601209|41638904|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
19394704|NCT02601209|41638905|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394705|NCT02601209|41638906|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
19394706|NCT01659021|41638922|FG000|Main Study|Adverse Event|2|||
19394707|NCT01659021|41638923|FG001|Main Study|Adverse Event|3|||
19394708|NCT01659021|41638922|FG000|Main Study|Lost to Follow-up|1|||
19394709|NCT01659021|41638923|FG001|Main Study|Lost to Follow-up|0|||
19394710|NCT01659021|41638922|FG000|Main Study|Unknown Reasons|2|||
19709828|NCT00112437|42153705|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709829|NCT00112437|42153706|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709830|NCT00112437|42153707|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709831|NCT00112437|42153708|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709832|NCT00112437|42153709|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709833|NCT00112437|42153710|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709834|NCT00112437|42153711|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19709835|NCT00112437|42153712|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19394711|NCT01659021|41638923|FG001|Main Study|Unknown Reasons|1|||
19626948|NCT00827918|42076518|FG001|Overall Study|Physician Decision|0|||
19626949|NCT00827918|42076519|FG002|Overall Study|Physician Decision|0|||
19626950|NCT00827918|42076517|FG000|Overall Study|Pregnancy|0|||
19626951|NCT00827918|42076518|FG001|Overall Study|Pregnancy|1|||
19626952|NCT00827918|42076519|FG002|Overall Study|Pregnancy|0|||
19626953|NCT00827918|42076517|FG000|Overall Study|Progressive Disease|1|||
19626954|NCT00827918|42076518|FG001|Overall Study|Progressive Disease|1|||
19626955|NCT00827918|42076519|FG002|Overall Study|Progressive Disease|0|||
19626956|NCT00827918|42076517|FG000|Overall Study|Protocol Violation|0|||
19626957|NCT00827918|42076518|FG001|Overall Study|Protocol Violation|1|||
19626958|NCT00827918|42076519|FG002|Overall Study|Protocol Violation|0|||
19626959|NCT00827918|42076517|FG000|Overall Study|Withdrawal by Subject|6|||
19626960|NCT00827918|42076518|FG001|Overall Study|Withdrawal by Subject|2|||
19626961|NCT00827918|42076519|FG002|Overall Study|Withdrawal by Subject|6|||
19626962|NCT00813150|42076529|FG000|Treatment Period|Adverse Event|16|||
19626963|NCT00813150|42076530|FG001|Treatment Period|Adverse Event|15|||
19626964|NCT00813150|42076529|FG000|Treatment Period|Death|2|||
19626965|NCT00813150|42076530|FG001|Treatment Period|Death|0|||
19626966|NCT00813150|42076529|FG000|Treatment Period|Progressive disease|1|||
19626967|NCT00813150|42076530|FG001|Treatment Period|Progressive disease|0|||
19626968|NCT00813150|42076529|FG000|Treatment Period|Complete response|0|||
19626969|NCT00813150|42076530|FG001|Treatment Period|Complete response|1|||
19626970|NCT00813150|42076529|FG000|Treatment Period|Stable disease|1|||
19626971|NCT00813150|42076530|FG001|Treatment Period|Stable disease|2|||
19626972|NCT00813150|42076529|FG000|Treatment Period|Protocol Violation|3|||
19626973|NCT00813150|42076530|FG001|Treatment Period|Protocol Violation|4|||
19626974|NCT00813150|42076529|FG000|Treatment Period|Withdrawal by Subject|5|||
19626975|NCT00813150|42076530|FG001|Treatment Period|Withdrawal by Subject|3|||
19626976|NCT00813150|42076529|FG000|Treatment Period|Non compliance|0|||
19626977|NCT00813150|42076530|FG001|Treatment Period|Non compliance|1|||
19626978|NCT00813150|42076529|FG000|Treatment Period|Reason not specified|3|||
19626979|NCT00813150|42076530|FG001|Treatment Period|Reason not specified|4|||
19626980|NCT00813150|42076529|FG000|Treatment Period|Data not available|1|||
19626981|NCT00813150|42076530|FG001|Treatment Period|Data not available|2|||
19626982|NCT00813150|42076529|FG000|Long Term Follow-up|Death|0|||
19626983|NCT00813150|42076530|FG001|Long Term Follow-up|Death|4|||
19626984|NCT00813150|42076529|FG000|Long Term Follow-up|Other|0|||
19626985|NCT00813150|42076530|FG001|Long Term Follow-up|Other|3|||
19709836|NCT00112437|42153713|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
19626986|NCT00813150|42076529|FG000|Long Term Follow-up|Lost to Follow-up|2|||
19626987|NCT00813150|42076530|FG001|Long Term Follow-up|Lost to Follow-up|0|||
19626988|NCT00813150|42076529|FG000|Long Term Follow-up|Progression/Relapse|22|||
19626989|NCT00813150|42076530|FG001|Long Term Follow-up|Progression/Relapse|24|||
19709837|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
19709838|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
19709839|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
19709840|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
19709841|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
19709842|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
19709843|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
19709844|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
19709845|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
19709846|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
19709847|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
19709848|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
19709849|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
19709850|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
19709851|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
19709852|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
19709853|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
19709854|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
19709855|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
19709856|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
19709857|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
19709858|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
19709859|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
19709860|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
19709861|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
19709862|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
19709863|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709864|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709865|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709866|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709867|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709868|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
19709869|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
19709870|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709871|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709872|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
19709873|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709874|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709875|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709876|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709877|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709878|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19394712|NCT01659021|41638922|FG000|Main Study|Physician Decision|34|||
19626990|NCT00807846|42076538|FG000|Overall Study|Adverse Event|5|||
19626991|NCT00807846|42076539|FG001|Overall Study|Adverse Event|0|||
19626992|NCT00807846|42076538|FG000|Overall Study|Lack of Efficacy|2|||
19626993|NCT00807846|42076539|FG001|Overall Study|Lack of Efficacy|0|||
19626994|NCT00807846|42076538|FG000|Overall Study|Protocol Violation|2|||
19626995|NCT00807846|42076539|FG001|Overall Study|Protocol Violation|1|||
19626996|NCT00807846|42076538|FG000|Overall Study|Withdrawal by Subject|2|||
19626997|NCT00807846|42076539|FG001|Overall Study|Withdrawal by Subject|1|||
19626998|NCT00807846|42076538|FG000|Overall Study|Other|1|||
19626999|NCT00807846|42076539|FG001|Overall Study|Other|2|||
19627000|NCT00810108|42076547|FG000|Overall Study|Withdrawal by Subject|1|||
19709879|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709880|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709881|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709882|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709883|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709884|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709885|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709886|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19394713|NCT01659021|41638923|FG001|Main Study|Physician Decision|16|||
19627001|NCT00810108|42076548|FG001|Overall Study|Withdrawal by Subject|0|||
19627002|NCT00827606|42076555|FG000|Overall Study|Protocol Violation|4|||
19627003|NCT00827606|42076556|FG001|Overall Study|Protocol Violation|3|||
19709887|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709888|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
19709889|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709890|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709891|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709892|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709893|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709894|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709895|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709896|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709897|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
19709898|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709899|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709900|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709901|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709902|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19627004|NCT00827606|42076555|FG000|Overall Study|Lost to Follow-up|3|||
19627005|NCT00827606|42076556|FG001|Overall Study|Lost to Follow-up|1|||
19627006|NCT00827606|42076555|FG000|Overall Study|Withdrawal by Subject|7|||
19627007|NCT00827606|42076556|FG001|Overall Study|Withdrawal by Subject|6|||
19627008|NCT00827606|42076555|FG000|Overall Study|Pregnancy|0|||
19627009|NCT00827606|42076556|FG001|Overall Study|Pregnancy|1|||
19627010|NCT00827606|42076555|FG000|Overall Study|Other|5|||
19627011|NCT00827606|42076556|FG001|Overall Study|Other|13|||
19627012|NCT00827606|42076555|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
19709903|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709904|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709905|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709906|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709907|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19627013|NCT00827606|42076556|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
19627014|NCT00827606|42076555|FG000|Overall Study|Adverse Event|4|||
19627015|NCT00827606|42076556|FG001|Overall Study|Adverse Event|2|||
19709908|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709909|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709910|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709911|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709912|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709913|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709914|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
19709915|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709916|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709917|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
19627016|NCT00663052|42076570|FG000|Overall Study|Adverse Event|6|||
19627017|NCT00663052|42076571|FG001|Overall Study|Adverse Event|3|||
19627018|NCT00663052|42076570|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
19627019|NCT00663052|42076571|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19627020|NCT00663052|42076570|FG000|Overall Study|Protocol Violation|1|||
19627021|NCT00663052|42076571|FG001|Overall Study|Protocol Violation|0|||
19627022|NCT00663052|42076570|FG000|Overall Study|Withdrawal by Subject|2|||
19627023|NCT00663052|42076571|FG001|Overall Study|Withdrawal by Subject|5|||
19709918|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709919|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709920|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709921|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709922|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709923|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
19709924|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709925|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709926|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709927|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709928|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709929|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709930|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709931|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709932|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709933|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709934|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709935|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709936|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709937|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709938|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709939|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709940|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
19709941|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709942|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709943|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19627024|NCT00663052|42076570|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
19627025|NCT00663052|42076571|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
19627026|NCT00663052|42076570|FG000|Overall Study|Other|0|||
19627027|NCT00663052|42076571|FG001|Overall Study|Other|1|||
19627028|NCT00827372|42076577|FG000|Overall Study|Adverse Event|5|||
19709944|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709945|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19627029|NCT00827372|42076577|FG000|Overall Study|Lack of Efficacy|3|||
19627030|NCT00826748|42076585|FG000|Overall Study|Withdrawal by Subject|0|||
19627031|NCT00826748|42076586|FG001|Overall Study|Withdrawal by Subject|0|||
19627032|NCT00826748|42076587|FG002|Overall Study|Withdrawal by Subject|2|||
19627033|NCT00826748|42076585|FG000|Overall Study|Physician Decision|0|||
19627034|NCT00826748|42076586|FG001|Overall Study|Physician Decision|0|||
19627035|NCT00826748|42076587|FG002|Overall Study|Physician Decision|1|||
19627036|NCT00826748|42076585|FG000|Overall Study|Samples Did Not pass QC|0|||
19627037|NCT00826748|42076586|FG001|Overall Study|Samples Did Not pass QC|0|||
19627038|NCT00826748|42076587|FG002|Overall Study|Samples Did Not pass QC|1|||
19627039|NCT00806988|42076597|FG000|Overall Study|Death|15|||
19627040|NCT00806988|42076598|FG001|Overall Study|Death|16|||
19627041|NCT00806988|42076597|FG000|Overall Study|Withdrawal by Subject|8|||
19627042|NCT00806988|42076598|FG001|Overall Study|Withdrawal by Subject|8|||
19627043|NCT00806988|42076597|FG000|Overall Study|Lost to Follow-up|4|||
19627044|NCT00806988|42076598|FG001|Overall Study|Lost to Follow-up|19|||
19627045|NCT00807144|42076606|FG000|Overall Study|Lost to Follow-up|0|||
19627046|NCT00807144|42076607|FG001|Overall Study|Lost to Follow-up|1|||
19627047|NCT00591006|42076613|FG000|Overall Study|Withdrawal by Subject|0|||
19627048|NCT00591006|42076614|FG001|Overall Study|Withdrawal by Subject|0|||
19627049|NCT00591006|42076615|FG002|Overall Study|Withdrawal by Subject|0|||
19627050|NCT00591006|42076616|FG003|Overall Study|Withdrawal by Subject|0|||
19627051|NCT00591006|42076617|FG004|Overall Study|Withdrawal by Subject|0|||
19627052|NCT00591006|42076618|FG005|Overall Study|Withdrawal by Subject|0|||
19627053|NCT00591006|42076619|FG006|Overall Study|Withdrawal by Subject|0|||
19627054|NCT00591006|42076620|FG007|Overall Study|Withdrawal by Subject|0|||
19627055|NCT00591006|42076621|FG008|Overall Study|Withdrawal by Subject|0|||
19627056|NCT00591006|42076622|FG009|Overall Study|Withdrawal by Subject|0|||
19627057|NCT00591006|42076623|FG010|Overall Study|Withdrawal by Subject|0|||
19627058|NCT00591006|42076624|FG011|Overall Study|Withdrawal by Subject|0|||
19627059|NCT00591006|42076625|FG012|Overall Study|Withdrawal by Subject|0|||
19627060|NCT00591006|42076626|FG013|Overall Study|Withdrawal by Subject|0|||
19627061|NCT00591006|42076627|FG014|Overall Study|Withdrawal by Subject|0|||
19627062|NCT00591006|42076628|FG015|Overall Study|Withdrawal by Subject|1|||
19627063|NCT00591006|42076629|FG016|Overall Study|Withdrawal by Subject|0|||
19627064|NCT00591006|42076630|FG017|Overall Study|Withdrawal by Subject|0|||
19627065|NCT00591006|42076631|FG018|Overall Study|Withdrawal by Subject|0|||
19627066|NCT00591006|42076632|FG019|Overall Study|Withdrawal by Subject|0|||
19627067|NCT00591006|42076633|FG020|Overall Study|Withdrawal by Subject|0|||
19627068|NCT00591006|42076634|FG021|Overall Study|Withdrawal by Subject|0|||
19627069|NCT00591006|42076635|FG022|Overall Study|Withdrawal by Subject|0|||
19709946|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
19709947|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
19709948|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
19709949|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
19709950|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
19709951|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19627070|NCT00591006|42076636|FG023|Overall Study|Withdrawal by Subject|1|||
19627071|NCT00591006|42076613|FG000|Overall Study|Adverse Event|0|||
19627072|NCT00591006|42076614|FG001|Overall Study|Adverse Event|0|||
19627073|NCT00591006|42076615|FG002|Overall Study|Adverse Event|0|||
19627074|NCT00591006|42076616|FG003|Overall Study|Adverse Event|0|||
19627075|NCT00591006|42076617|FG004|Overall Study|Adverse Event|0|||
19627076|NCT00591006|42076618|FG005|Overall Study|Adverse Event|0|||
19627077|NCT00591006|42076619|FG006|Overall Study|Adverse Event|0|||
19627078|NCT00591006|42076620|FG007|Overall Study|Adverse Event|0|||
19627079|NCT00591006|42076621|FG008|Overall Study|Adverse Event|0|||
19627080|NCT00591006|42076622|FG009|Overall Study|Adverse Event|0|||
19627081|NCT00591006|42076623|FG010|Overall Study|Adverse Event|0|||
19627082|NCT00591006|42076624|FG011|Overall Study|Adverse Event|0|||
19627083|NCT00591006|42076625|FG012|Overall Study|Adverse Event|0|||
19627084|NCT00591006|42076626|FG013|Overall Study|Adverse Event|0|||
19627085|NCT00591006|42076627|FG014|Overall Study|Adverse Event|0|||
19627086|NCT00591006|42076628|FG015|Overall Study|Adverse Event|0|||
19627087|NCT00591006|42076629|FG016|Overall Study|Adverse Event|0|||
19627088|NCT00591006|42076630|FG017|Overall Study|Adverse Event|0|||
19627089|NCT00591006|42076631|FG018|Overall Study|Adverse Event|0|||
19627090|NCT00591006|42076632|FG019|Overall Study|Adverse Event|0|||
19627091|NCT00591006|42076633|FG020|Overall Study|Adverse Event|0|||
19627092|NCT00591006|42076634|FG021|Overall Study|Adverse Event|0|||
19627093|NCT00591006|42076635|FG022|Overall Study|Adverse Event|1|||
19627094|NCT00591006|42076636|FG023|Overall Study|Adverse Event|0|||
19627095|NCT00844844|42076653|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
19627096|NCT00844844|42076653|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
19627097|NCT00844844|42076653|FG000|Extension Treatment Period|Adverse Event|2|||
19627098|NCT00844844|42076653|FG000|Post Treatment Period|Withdrawal by Subject|1|||
19627099|NCT00660790|42076657|FG000|Baseline to 3 Months|Death|1|||
19627100|NCT00660790|42076657|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
19627101|NCT00660790|42076657|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
19627102|NCT00836810|42076663|FG000|Overall Study|New diagnosis|1|||
19627103|NCT00836810|42076664|FG001|Overall Study|New diagnosis|0|||
19627104|NCT00658684|42076673|FG000|Overall Study|Adverse Event|10|||
19627105|NCT00658684|42076674|FG001|Overall Study|Adverse Event|8|||
19627106|NCT00658684|42076675|FG002|Overall Study|Adverse Event|2|||
19627107|NCT00658684|42076676|FG003|Overall Study|Adverse Event|0|||
19627108|NCT00658684|42076673|FG000|Overall Study|Withdrawal by Subject|6|||
19627109|NCT00658684|42076674|FG001|Overall Study|Withdrawal by Subject|4|||
19627110|NCT00658684|42076675|FG002|Overall Study|Withdrawal by Subject|1|||
19627111|NCT00658684|42076676|FG003|Overall Study|Withdrawal by Subject|1|||
19627112|NCT00658684|42076673|FG000|Overall Study|Lack of Efficacy|1|||
19627113|NCT00658684|42076674|FG001|Overall Study|Lack of Efficacy|1|||
19627114|NCT00658684|42076675|FG002|Overall Study|Lack of Efficacy|0|||
19627115|NCT00658684|42076676|FG003|Overall Study|Lack of Efficacy|0|||
19627116|NCT00658684|42076673|FG000|Overall Study|Protocol Violation|1|||
19627117|NCT00658684|42076674|FG001|Overall Study|Protocol Violation|1|||
19627118|NCT00658684|42076675|FG002|Overall Study|Protocol Violation|0|||
19627119|NCT00658684|42076676|FG003|Overall Study|Protocol Violation|0|||
19627120|NCT00658684|42076673|FG000|Overall Study|Pregnancy|1|||
19627121|NCT00658684|42076674|FG001|Overall Study|Pregnancy|1|||
19627122|NCT00658684|42076675|FG002|Overall Study|Pregnancy|0|||
19627123|NCT00658684|42076676|FG003|Overall Study|Pregnancy|0|||
19627124|NCT00660400|42076686|FG000|Overall Study|Lack of insurance approval|1|||
19627125|NCT00660400|42076686|FG000|Overall Study|Suboptimal organ function|1|||
19709952|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709953|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19627126|NCT00660400|42076686|FG000|Overall Study|Intracranial hemorrhage|1|||
19627127|NCT00660400|42076686|FG000|Overall Study|Withdrawal by Subject|1|||
19627128|NCT00826514|42076692|FG000|Overall Study|Adverse Event|1|||
19627129|NCT00826514|42076693|FG001|Overall Study|Adverse Event|1|||
19627130|NCT00826514|42076692|FG000|Overall Study|Lack of Efficacy|0|||
19627131|NCT00826514|42076693|FG001|Overall Study|Lack of Efficacy|1|||
19627132|NCT00826514|42076692|FG000|Overall Study|Withdrawal by Subject|2|||
19627133|NCT00826514|42076693|FG001|Overall Study|Withdrawal by Subject|3|||
19627134|NCT00826280|42076702|FG000|Overall Study|Randomized but drug not received|1|||
19627135|NCT00826280|42076703|FG001|Overall Study|Randomized but drug not received|0|||
19627136|NCT00826280|42076704|FG002|Overall Study|Randomized but drug not received|1|||
19627137|NCT00826280|42076702|FG000|Overall Study|Adverse Event|1|||
19627138|NCT00826280|42076703|FG001|Overall Study|Adverse Event|3|||
19627139|NCT00826280|42076704|FG002|Overall Study|Adverse Event|0|||
19709954|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709955|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709956|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709957|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709958|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709959|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709960|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709961|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709962|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709963|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709964|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709965|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709966|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
19709967|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709968|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709969|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709970|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709971|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709972|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709973|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709974|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709975|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709976|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
19709977|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709978|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709979|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709980|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709981|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709982|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709983|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709984|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709985|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709986|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709987|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709988|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709989|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709990|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709991|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709992|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
19709993|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709994|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709995|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709996|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709997|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709998|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
19709999|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710000|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710001|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710002|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
19710003|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710004|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710005|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710006|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710007|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710008|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710009|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710010|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710011|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710012|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710013|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710014|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710015|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
19373931|NCT02663895|41615202|FG000|Overall Study|Withdrawal by Subject|1|||
19373932|NCT02663817|41615207|FG000|Overall Study|Screen failure|2|||
19373933|NCT01372605|41615215|FG000|Overall Study|Death|1|||
19710016|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710017|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710018|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
19710019|NCT00112437|42153688|FG000|Year 2 (12-Month Extension)|Moved|0|||
19710020|NCT00112437|42153689|FG001|Year 2 (12-Month Extension)|Moved|0|||
19710021|NCT00112437|42153690|FG002|Year 2 (12-Month Extension)|Moved|0|||
19710022|NCT00112437|42153691|FG003|Year 2 (12-Month Extension)|Moved|0|||
19710023|NCT00112437|42153692|FG004|Year 2 (12-Month Extension)|Moved|0|||
19710024|NCT00112437|42153693|FG005|Year 2 (12-Month Extension)|Moved|0|||
19710025|NCT00112437|42153694|FG006|Year 2 (12-Month Extension)|Moved|0|||
19710026|NCT00112437|42153695|FG007|Year 2 (12-Month Extension)|Moved|0|||
19710027|NCT00112437|42153696|FG008|Year 2 (12-Month Extension)|Moved|0|||
19710028|NCT00112437|42153697|FG009|Year 2 (12-Month Extension)|Moved|1|||
19710029|NCT00112437|42153698|FG010|Year 2 (12-Month Extension)|Moved|0|||
19710030|NCT00112437|42153699|FG011|Year 2 (12-Month Extension)|Moved|0|||
19710031|NCT00112437|42153700|FG012|Year 2 (12-Month Extension)|Moved|0|||
19710032|NCT00112437|42153701|FG013|Year 2 (12-Month Extension)|Moved|0|||
19710033|NCT00112437|42153702|FG014|Year 2 (12-Month Extension)|Moved|0|||
19710034|NCT00112437|42153703|FG015|Year 2 (12-Month Extension)|Moved|0|||
19710035|NCT00112437|42153704|FG016|Year 2 (12-Month Extension)|Moved|0|||
19710036|NCT00112437|42153705|FG017|Year 2 (12-Month Extension)|Moved|0|||
19710037|NCT00112437|42153706|FG018|Year 2 (12-Month Extension)|Moved|0|||
19710038|NCT00112437|42153707|FG019|Year 2 (12-Month Extension)|Moved|0|||
19710039|NCT00112437|42153708|FG020|Year 2 (12-Month Extension)|Moved|0|||
19710040|NCT00112437|42153709|FG021|Year 2 (12-Month Extension)|Moved|0|||
19710041|NCT00112437|42153710|FG022|Year 2 (12-Month Extension)|Moved|0|||
19710042|NCT00112437|42153711|FG023|Year 2 (12-Month Extension)|Moved|0|||
19710043|NCT00112437|42153712|FG024|Year 2 (12-Month Extension)|Moved|0|||
19710044|NCT00112437|42153713|FG025|Year 2 (12-Month Extension)|Moved|0|||
19710045|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
19710046|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
19710047|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
19710048|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
19710049|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
19710050|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
19710051|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
19710052|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
19710053|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
19710054|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
19710055|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
19710056|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
19710057|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
19710058|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
19710059|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
19710060|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
19710061|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
19710062|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
19710063|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
19710064|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
19710065|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
19710066|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
19710067|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
19710068|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
19710069|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
19710070|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
19710071|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710072|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710073|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710074|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710075|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710076|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710077|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710078|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710079|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710080|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710081|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710082|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
19710083|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710084|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
19710085|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710086|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
19710087|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710088|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710089|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
19710090|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710091|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710092|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710093|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710094|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710095|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710096|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
19710097|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710098|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710099|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710100|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710101|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710102|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19394714|NCT01659021|41638922|FG000|Main Study|Withdrawal by Subject|19|||
19710103|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710104|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19627140|NCT00826280|42076702|FG000|Overall Study|Lost to Follow-up|0|||
19627141|NCT00826280|42076703|FG001|Overall Study|Lost to Follow-up|1|||
19627142|NCT00826280|42076704|FG002|Overall Study|Lost to Follow-up|0|||
19627143|NCT00826280|42076702|FG000|Overall Study|Sponsor discontinued subject or study|1|||
19373934|NCT01372605|41615216|FG001|Overall Study|Death|2|||
19373935|NCT01372605|41615215|FG000|Overall Study|Lost to Follow-up|2|||
19373936|NCT01372605|41615216|FG001|Overall Study|Lost to Follow-up|1|||
19373937|NCT01372605|41615215|FG000|Overall Study|Withdrawal by Subject|4|||
19373938|NCT01372605|41615216|FG001|Overall Study|Withdrawal by Subject|7|||
19373939|NCT01372605|41615215|FG000|Overall Study|Moved|3|||
19627144|NCT00826280|42076703|FG001|Overall Study|Sponsor discontinued subject or study|0|||
19627145|NCT00826280|42076704|FG002|Overall Study|Sponsor discontinued subject or study|0|||
19627146|NCT00826280|42076702|FG000|Overall Study|Reversible ischemic defect not present|43|||
19627147|NCT00826280|42076703|FG001|Overall Study|Reversible ischemic defect not present|40|||
19627148|NCT00826280|42076704|FG002|Overall Study|Reversible ischemic defect not present|44|||
19627149|NCT00826280|42076702|FG000|Overall Study|Interpretation Failure|1|||
19627150|NCT00826280|42076703|FG001|Overall Study|Interpretation Failure|0|||
19627151|NCT00826280|42076704|FG002|Overall Study|Interpretation Failure|0|||
19627152|NCT00826280|42076702|FG000|Overall Study|Machine Failure|1|||
19627153|NCT00826280|42076703|FG001|Overall Study|Machine Failure|1|||
19627154|NCT00826280|42076704|FG002|Overall Study|Machine Failure|0|||
19627155|NCT00826280|42076702|FG000|Overall Study|One or more non-interpretable scan|0|||
19710105|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710106|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710107|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710108|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710109|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710110|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710111|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710112|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
19710113|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710114|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710115|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710116|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19373940|NCT01372605|41615216|FG001|Overall Study|Moved|0|||
19373941|NCT01372605|41615215|FG000|Overall Study|Changed medical home|2|||
19373942|NCT01372605|41615216|FG001|Overall Study|Changed medical home|0|||
19373943|NCT02751983|41615224|FG000|Treatment|Stopped ACT, but Remained in study|2|||
19373944|NCT02751983|41615225|FG001|Treatment|Stopped ACT, but Remained in study|0|||
19373945|NCT02751983|41615224|FG000|Treatment|Discharged prior to beginning ACT|2|||
19373946|NCT02751983|41615225|FG001|Treatment|Discharged prior to beginning ACT|0|||
19373947|NCT02751983|41615224|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
19373948|NCT02751983|41615225|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
19627156|NCT00826280|42076703|FG001|Overall Study|One or more non-interpretable scan|1|||
19627157|NCT00826280|42076704|FG002|Overall Study|One or more non-interpretable scan|1|||
19710117|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710118|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710119|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710120|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710121|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710122|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
19710123|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710124|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710125|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
19627158|NCT00864851|42076715|FG000|Overall Study|Withdrawal by Subject|0|||
19627159|NCT00864851|42076716|FG001|Overall Study|Withdrawal by Subject|1|||
19627160|NCT00864851|42076717|FG002|Overall Study|Withdrawal by Subject|0|||
19627161|NCT00864851|42076715|FG000|Overall Study|Physician Decision|1|||
19394715|NCT01659021|41638923|FG001|Main Study|Withdrawal by Subject|16|||
19394716|NCT01659021|41638922|FG000|Main Study|Study Terminated by Sponsor|16|||
19394717|NCT01659021|41638923|FG001|Main Study|Study Terminated by Sponsor|1|||
19394718|NCT01659021|41638922|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
19394719|NCT01659021|41638923|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
19394720|NCT01659021|41638922|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
19394721|NCT01659021|41638923|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
19394722|NCT02524665|41638933|FG000|Overall Study|Lost to Follow-up|1|||
19394723|NCT02638129|41638940|FG000|Overall Study|Study terminated|28|||
19394724|NCT02638129|41638941|FG001|Overall Study|Study terminated|30|||
19394725|NCT02524275|41638947|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
19394726|NCT01658943|41638953|FG000|Overall Study|Adverse Event|6|||
19394727|NCT01658943|41638954|FG001|Overall Study|Adverse Event|13|||
19394728|NCT01658943|41638953|FG000|Overall Study|Withdrawal by Subject|9|||
19394729|NCT01658943|41638954|FG001|Overall Study|Withdrawal by Subject|2|||
19394730|NCT01658943|41638953|FG000|Overall Study|Progression/Relapse|39|||
19394731|NCT01658943|41638954|FG001|Overall Study|Progression/Relapse|40|||
19394732|NCT01658943|41638953|FG000|Overall Study|Death|4|||
19394733|NCT01658943|41638954|FG001|Overall Study|Death|2|||
19394734|NCT01658943|41638953|FG000|Overall Study|not protocol specified|4|||
19394735|NCT01658943|41638954|FG001|Overall Study|not protocol specified|1|||
19394736|NCT01658943|41638953|FG000|Overall Study|Not eligible|7|||
19394737|NCT01658943|41638954|FG001|Overall Study|Not eligible|9|||
19394738|NCT01658943|41638953|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
19394739|NCT01658943|41638954|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
19394740|NCT02600819|41638960|FG000|GEN Phase|Adverse Event|2|||
19394741|NCT02600819|41638961|FG001|GEN Phase|Adverse Event|0|||
19394742|NCT02600819|41638960|FG000|GEN Phase|Death|2|||
19394743|NCT02600819|41638961|FG001|GEN Phase|Death|0|||
19394744|NCT02600819|41638960|FG000|GEN Phase|Investigator's Discretion|4|||
19394745|NCT02600819|41638961|FG001|GEN Phase|Investigator's Discretion|0|||
19394746|NCT02600819|41638960|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
19394747|NCT02600819|41638961|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
19394748|NCT02600819|41638960|FG000|GEN Phase|Withdrew Consent|5|||
19394749|NCT02600819|41638961|FG001|GEN Phase|Withdrew Consent|0|||
19394750|NCT02600819|41638960|FG000|GEN Phase|Lost to Follow-up|2|||
19394751|NCT02600819|41638961|FG001|GEN Phase|Lost to Follow-up|0|||
19394752|NCT02597933|41638969|FG000|Overall Study|Withdrawal by Subject|7|||
19394753|NCT02597933|41638970|FG001|Overall Study|Withdrawal by Subject|5|||
19394754|NCT02597933|41638969|FG000|Overall Study|Protocol Violation|2|||
19394755|NCT02597933|41638970|FG001|Overall Study|Protocol Violation|2|||
19394756|NCT02597933|41638969|FG000|Overall Study|Adverse Event|20|||
19394757|NCT02597933|41638970|FG001|Overall Study|Adverse Event|28|||
19394758|NCT02597933|41638969|FG000|Overall Study|Not treated|2|||
19394759|NCT02597933|41638970|FG001|Overall Study|Not treated|2|||
19394760|NCT02597933|41638969|FG000|Overall Study|Other than stated above|7|||
19394761|NCT02597933|41638970|FG001|Overall Study|Other than stated above|14|||
19394762|NCT02597855|41638978|FG000|Overall Study|Lost to Follow-up|2|||
19394763|NCT02597855|41638979|FG001|Overall Study|Lost to Follow-up|1|||
19627162|NCT00864851|42076716|FG001|Overall Study|Physician Decision|0|||
19710126|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710127|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710128|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710129|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710130|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710131|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710132|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710133|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
19373949|NCT02751983|41615224|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
19373950|NCT02751983|41615225|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
19373951|NCT02751983|41615224|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
19373952|NCT02751983|41615225|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
19373953|NCT00232141|41615245|FG000|Overall Study|Adverse Event|9|||
19373954|NCT00232141|41615246|FG001|Overall Study|Adverse Event|4|||
19373955|NCT00232141|41615245|FG000|Overall Study|Lack of Efficacy|0|||
19373956|NCT00232141|41615246|FG001|Overall Study|Lack of Efficacy|3|||
19373957|NCT00232141|41615245|FG000|Overall Study|Lost to Follow-up|9|||
19373958|NCT00232141|41615246|FG001|Overall Study|Lost to Follow-up|6|||
19373959|NCT00232141|41615245|FG000|Overall Study|Other|8|||
19373960|NCT00232141|41615246|FG001|Overall Study|Other|10|||
19373961|NCT00232141|41615245|FG000|Overall Study|Withdrawal by Subject|5|||
19373962|NCT00232141|41615246|FG001|Overall Study|Withdrawal by Subject|3|||
19373963|NCT02741245|41615275|FG000|Overall Study|Adverse Event|0|||
19373964|NCT02741245|41615276|FG001|Overall Study|Adverse Event|0|||
19373965|NCT02741245|41615277|FG002|Overall Study|Adverse Event|0|||
19373966|NCT02741245|41615278|FG003|Overall Study|Adverse Event|2|||
19373967|NCT02741245|41615279|FG004|Overall Study|Adverse Event|2|||
19373968|NCT02741245|41615275|FG000|Overall Study|Protocol Violation|0|||
19373969|NCT02741245|41615276|FG001|Overall Study|Protocol Violation|1|||
19373970|NCT02741245|41615277|FG002|Overall Study|Protocol Violation|0|||
19373971|NCT02741245|41615278|FG003|Overall Study|Protocol Violation|1|||
19373972|NCT02741245|41615279|FG004|Overall Study|Protocol Violation|0|||
19373973|NCT02741245|41615275|FG000|Overall Study|Withdrawal by Subject|0|||
19373974|NCT02741245|41615276|FG001|Overall Study|Withdrawal by Subject|0|||
19373975|NCT02741245|41615277|FG002|Overall Study|Withdrawal by Subject|0|||
19373976|NCT02741245|41615278|FG003|Overall Study|Withdrawal by Subject|1|||
19373977|NCT02741245|41615279|FG004|Overall Study|Withdrawal by Subject|0|||
19373978|NCT03227757|41615291|FG000|Overall Study|Death|7|||
19373979|NCT03227757|41615291|FG000|Overall Study|Withdrawal|5|||
19373980|NCT03227757|41615291|FG000|Overall Study|Missed visits|4|||
19373981|NCT02751827|41615302|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
19373982|NCT02751827|41615303|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
19373983|NCT02751827|41615304|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
19373984|NCT04896593|41615321|FG000|Overall Study|Withdrawal by Subject|2|||
19373985|NCT04896593|41615321|FG000|Overall Study|Lost to Follow-up|1|||
19373986|NCT04896593|41615321|FG000|Overall Study|Did not complete onboarding|2|||
19373987|NCT04601272|41615337|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
19373988|NCT04601272|41615338|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
19373989|NCT04601272|41615339|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
19373990|NCT04059484|41615358|FG000|Overall Study|Adverse Event|2|||
19373991|NCT04059484|41615359|FG001|Overall Study|Adverse Event|5|||
19373992|NCT04059484|41615358|FG000|Overall Study|Withdrawal by Subject|5|||
19373993|NCT04059484|41615359|FG001|Overall Study|Withdrawal by Subject|3|||
19710134|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
19373994|NCT04059484|41615358|FG000|Overall Study|Progressive disease|112|||
19710135|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710136|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710137|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710138|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
19710139|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710140|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710141|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710142|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710143|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710144|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710145|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710146|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710147|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710148|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
19710149|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710150|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710151|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710152|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710153|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710154|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710155|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710156|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710157|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710158|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710159|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710160|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
19710161|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710162|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710163|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
19710164|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710165|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710166|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710167|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710168|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710169|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710170|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710171|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710172|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710173|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710174|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
19710175|NCT00112437|42153688|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710176|NCT00112437|42153689|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710177|NCT00112437|42153690|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710178|NCT00112437|42153691|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710179|NCT00112437|42153692|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710180|NCT00112437|42153693|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710181|NCT00112437|42153694|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710182|NCT00112437|42153695|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710183|NCT00112437|42153696|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710184|NCT00112437|42153697|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710185|NCT00112437|42153698|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
19710186|NCT00112437|42153699|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
19710187|NCT00112437|42153700|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710188|NCT00112437|42153701|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19394764|NCT02604407|41638988|FG000|Overall Study|Adverse Event|0|||
19394765|NCT02604407|41638989|FG001|Overall Study|Adverse Event|7|||
19710189|NCT00112437|42153702|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710190|NCT00112437|42153703|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710191|NCT00112437|42153704|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710192|NCT00112437|42153705|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710193|NCT00112437|42153706|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710194|NCT00112437|42153707|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710195|NCT00112437|42153708|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710196|NCT00112437|42153709|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710197|NCT00112437|42153710|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710198|NCT00112437|42153711|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710199|NCT00112437|42153712|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710200|NCT00112437|42153713|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
19710201|NCT00112437|42153688|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710202|NCT00112437|42153689|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710203|NCT00112437|42153690|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710204|NCT00112437|42153691|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710205|NCT00112437|42153692|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710206|NCT00112437|42153693|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710207|NCT00112437|42153694|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710208|NCT00112437|42153695|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710209|NCT00112437|42153696|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19394766|NCT02604407|41638990|FG002|Overall Study|Adverse Event|5|||
19394767|NCT02604407|41638988|FG000|Overall Study|Protocol Violation|2|||
19394768|NCT02604407|41638989|FG001|Overall Study|Protocol Violation|0|||
19394769|NCT02604407|41638990|FG002|Overall Study|Protocol Violation|0|||
19394770|NCT02604407|41638988|FG000|Overall Study|Withdrawal by Subject|3|||
19394771|NCT02604407|41638989|FG001|Overall Study|Withdrawal by Subject|3|||
19394772|NCT02604407|41638990|FG002|Overall Study|Withdrawal by Subject|5|||
19394773|NCT02604407|41638988|FG000|Overall Study|Lost to Follow-up|2|||
19394774|NCT02604407|41638989|FG001|Overall Study|Lost to Follow-up|1|||
19394775|NCT02604407|41638990|FG002|Overall Study|Lost to Follow-up|2|||
19394776|NCT02604407|41638988|FG000|Overall Study|Lack of Efficacy|1|||
19394777|NCT02604407|41638989|FG001|Overall Study|Lack of Efficacy|0|||
19394778|NCT02604407|41638990|FG002|Overall Study|Lack of Efficacy|0|||
19394779|NCT02604407|41638988|FG000|Overall Study|Other|3|||
19710210|NCT00112437|42153697|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710211|NCT00112437|42153698|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710212|NCT00112437|42153699|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710213|NCT00112437|42153700|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710214|NCT00112437|42153701|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710215|NCT00112437|42153702|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19394780|NCT02604407|41638989|FG001|Overall Study|Other|1|||
19394781|NCT02604407|41638990|FG002|Overall Study|Other|4|||
19710216|NCT00112437|42153703|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19394782|NCT02593097|41639000|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
19394783|NCT02593097|41639001|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
19394784|NCT02593097|41639000|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
19394785|NCT02593097|41639001|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
19394786|NCT02593097|41639000|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
19394787|NCT02593097|41639001|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
19394788|NCT02593097|41639000|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
19394789|NCT02593097|41639001|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
19394790|NCT02593097|41639000|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
19394791|NCT02593097|41639001|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
19394792|NCT01657461|41639009|FG000|Overall Study|Death|9|||
19394793|NCT01657461|41639010|FG001|Overall Study|Death|12|||
19394794|NCT01657461|41639009|FG000|Overall Study|Lost to Follow-up|0|||
19394795|NCT01657461|41639010|FG001|Overall Study|Lost to Follow-up|3|||
19394796|NCT01657461|41639009|FG000|Overall Study|Physician Decision|0|||
19394797|NCT01657461|41639010|FG001|Overall Study|Physician Decision|2|||
19394798|NCT01657461|41639009|FG000|Overall Study|Withdrawal by Subject|1|||
19394799|NCT01657461|41639010|FG001|Overall Study|Withdrawal by Subject|3|||
19394800|NCT02592551|41639019|FG000|Overall Study|Not evaluable|1|||
19394801|NCT02592551|41639020|FG001|Overall Study|Not evaluable|3|||
19394802|NCT02592551|41639021|FG002|Overall Study|Not evaluable|0|||
19394803|NCT02595749|41639032|FG000|Overall Study|Withdrawal by Subject|12|||
19394804|NCT02595749|41639033|FG001|Overall Study|Withdrawal by Subject|7|||
19394805|NCT01657305|41639039|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
19394806|NCT01657305|41639039|FG000|Overall Study|Withdrawal by Subject|4|||
19394807|NCT01657305|41639039|FG000|Overall Study|Adverse Event|1|||
19394808|NCT01657305|41639039|FG000|Overall Study|Lost to Follow-up|1|||
19394809|NCT01657305|41639039|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
19394810|NCT02634307|41639082|FG000|Overall Study|Adverse Event|50|||
19394811|NCT02634307|41639083|FG001|Overall Study|Adverse Event|24|||
19394812|NCT02634307|41639084|FG002|Overall Study|Adverse Event|14|||
19394813|NCT02634307|41639082|FG000|Overall Study|Lost to Follow-up|21|||
19394814|NCT02634307|41639083|FG001|Overall Study|Lost to Follow-up|5|||
19394815|NCT02634307|41639084|FG002|Overall Study|Lost to Follow-up|6|||
19394816|NCT02634307|41639082|FG000|Overall Study|Pregnancy|5|||
19394817|NCT02634307|41639083|FG001|Overall Study|Pregnancy|1|||
19394818|NCT02634307|41639084|FG002|Overall Study|Pregnancy|3|||
19394819|NCT02634307|41639082|FG000|Overall Study|Withdrawal by Subject|38|||
19394820|NCT02634307|41639083|FG001|Overall Study|Withdrawal by Subject|24|||
19394821|NCT02634307|41639084|FG002|Overall Study|Withdrawal by Subject|18|||
19394822|NCT02634307|41639082|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19394823|NCT02634307|41639083|FG001|Overall Study|Non-Compliance with Study Drug|2|||
19394824|NCT02634307|41639084|FG002|Overall Study|Non-Compliance with Study Drug|2|||
19394825|NCT02634307|41639082|FG000|Overall Study|Lack of Efficacy|1|||
19394826|NCT02634307|41639083|FG001|Overall Study|Lack of Efficacy|5|||
19394827|NCT02634307|41639084|FG002|Overall Study|Lack of Efficacy|3|||
19394828|NCT02634307|41639082|FG000|Overall Study|Physician Decision|7|||
19394829|NCT02634307|41639083|FG001|Overall Study|Physician Decision|5|||
19394830|NCT02634307|41639084|FG002|Overall Study|Physician Decision|5|||
19394831|NCT02634307|41639082|FG000|Overall Study|Reason not Specified|3|||
19394832|NCT02634307|41639083|FG001|Overall Study|Reason not Specified|5|||
19394833|NCT02634307|41639084|FG002|Overall Study|Reason not Specified|10|||
19394834|NCT01365273|41639094|FG000|Overall Study|Lost to Follow-up|1|||
19394835|NCT01365273|41639095|FG001|Overall Study|Lost to Follow-up|0|||
19394836|NCT01365273|41639094|FG000|Overall Study|Protocol Violation|0|||
19394837|NCT01365273|41639095|FG001|Overall Study|Protocol Violation|1|||
19394838|NCT01365273|41639094|FG000|Overall Study|Physician Decision|1|||
19394839|NCT01365273|41639095|FG001|Overall Study|Physician Decision|0|||
19394840|NCT02595437|41639101|FG000|Triferic Via IV|Withdrawal by Subject|1|||
19394841|NCT02594735|41639122|FG000|Overall Study|Adverse Event|1|||
19394842|NCT02634151|41639130|FG000|Overall Study|Withdrawal by Subject|1|||
19394843|NCT02634151|41639131|FG001|Overall Study|Withdrawal by Subject|0|||
19394844|NCT02634151|41639130|FG000|Overall Study|Non-Compliance|0|||
19394845|NCT02634151|41639131|FG001|Overall Study|Non-Compliance|1|||
19394846|NCT02634151|41639130|FG000|Overall Study|Other|0|||
19394847|NCT02634151|41639131|FG001|Overall Study|Other|1|||
19394848|NCT01655823|41639142|FG000|Overall Study|Lost to Follow-up|0|||
19394849|NCT01655823|41639143|FG001|Overall Study|Lost to Follow-up|1|||
19394850|NCT01655823|41639144|FG002|Overall Study|Lost to Follow-up|0|||
19394851|NCT01655823|41639145|FG003|Overall Study|Lost to Follow-up|0|||
19394852|NCT01655823|41639146|FG004|Overall Study|Lost to Follow-up|1|||
19394853|NCT01655823|41639142|FG000|Overall Study|Withdrawal by Subject|0|||
19394854|NCT01655823|41639143|FG001|Overall Study|Withdrawal by Subject|1|||
19394855|NCT01655823|41639144|FG002|Overall Study|Withdrawal by Subject|0|||
19394856|NCT01655823|41639145|FG003|Overall Study|Withdrawal by Subject|1|||
19394857|NCT01655823|41639146|FG004|Overall Study|Withdrawal by Subject|0|||
19394858|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
19394859|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
19394860|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
19394861|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
19394862|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
19394863|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
19394864|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
19394865|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
19394866|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
19627163|NCT00864851|42076717|FG002|Overall Study|Physician Decision|0|||
19627164|NCT00864851|42076715|FG000|Overall Study|Death|1|||
19627165|NCT00864851|42076716|FG001|Overall Study|Death|0|||
19627166|NCT00864851|42076717|FG002|Overall Study|Death|0|||
19627167|NCT00864851|42076715|FG000|Overall Study|Patient uncooperative|1|||
19627168|NCT00864851|42076716|FG001|Overall Study|Patient uncooperative|0|||
19394867|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
19394868|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
19394869|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
19394870|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
19517802|NCT01526928|41930802|FG005|Overall Study|Progressive Disease|4|||
19627169|NCT00864851|42076717|FG002|Overall Study|Patient uncooperative|0|||
19394871|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
19710217|NCT00112437|42153704|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710218|NCT00112437|42153705|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710219|NCT00112437|42153706|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710220|NCT00112437|42153707|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710221|NCT00112437|42153708|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
19710222|NCT00112437|42153709|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
19710223|NCT00112437|42153710|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710224|NCT00112437|42153711|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710225|NCT00112437|42153712|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710226|NCT00112437|42153713|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
19710227|NCT00112437|42153688|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710228|NCT00112437|42153689|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19394872|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
19710229|NCT00112437|42153690|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19373995|NCT04059484|41615359|FG001|Overall Study|Progressive disease|112|||
19373996|NCT04059484|41615358|FG000|Overall Study|Other|8|||
19373997|NCT04059484|41615359|FG001|Overall Study|Other|3|||
19373998|NCT04059484|41615358|FG000|Overall Study|Ongoing|20|||
19373999|NCT04059484|41615359|FG001|Overall Study|Ongoing|20|||
19374000|NCT03965091|41615371|FG000|Overall Study|Adverse Event|0|||
19394873|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
19394874|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
19394875|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
19394876|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
19394877|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
19394878|NCT01360645|41639160|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
19394879|NCT01360645|41639161|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
19394880|NCT01360645|41639162|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
19394881|NCT01360645|41639163|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
19394882|NCT01360645|41639160|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
19394883|NCT01360645|41639161|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
19394884|NCT01360645|41639162|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
19394885|NCT01360645|41639163|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
19394886|NCT01360645|41639160|FG000|Phase B (6 Weeks)|Adverse Event|0|||
19394887|NCT01360645|41639161|FG001|Phase B (6 Weeks)|Adverse Event|6|||
19394888|NCT01360645|41639162|FG002|Phase B (6 Weeks)|Adverse Event|0|||
19394889|NCT01360645|41639163|FG003|Phase B (6 Weeks)|Adverse Event|0|||
19394890|NCT01360645|41639160|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
19394891|NCT01360645|41639161|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
19394892|NCT01360645|41639162|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
19374001|NCT03965091|41615372|FG001|Overall Study|Adverse Event|2|||
19374002|NCT03965091|41615373|FG002|Overall Study|Adverse Event|3|||
19374003|NCT03965091|41615371|FG000|Overall Study|Withdrawal by Subject|11|||
19374004|NCT03965091|41615372|FG001|Overall Study|Withdrawal by Subject|3|||
19374005|NCT03965091|41615373|FG002|Overall Study|Withdrawal by Subject|5|||
19374006|NCT03965091|41615371|FG000|Overall Study|Non-compliance with study drug|0|||
19374007|NCT03965091|41615372|FG001|Overall Study|Non-compliance with study drug|0|||
19374008|NCT03965091|41615373|FG002|Overall Study|Non-compliance with study drug|1|||
19374009|NCT03965091|41615371|FG000|Overall Study|Lost to Follow-up|1|||
19374010|NCT03965091|41615372|FG001|Overall Study|Lost to Follow-up|1|||
19374011|NCT03965091|41615373|FG002|Overall Study|Lost to Follow-up|1|||
19374012|NCT03965091|41615371|FG000|Overall Study|Lack of Efficacy|2|||
19374013|NCT03965091|41615372|FG001|Overall Study|Lack of Efficacy|0|||
19374014|NCT03965091|41615373|FG002|Overall Study|Lack of Efficacy|0|||
19394893|NCT01360645|41639163|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
19394894|NCT01360645|41639160|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
19394895|NCT01360645|41639161|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
19394896|NCT01360645|41639162|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
19394897|NCT01360645|41639163|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
19394898|NCT01360645|41639160|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
19394899|NCT01360645|41639161|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
19394900|NCT01360645|41639162|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
19394901|NCT01360645|41639163|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
19394902|NCT01360645|41639160|FG000|Phase A+|Lost to Follow-up|0|||
19394903|NCT01360645|41639161|FG001|Phase A+|Lost to Follow-up|0|||
19394904|NCT01360645|41639162|FG002|Phase A+|Lost to Follow-up|0|||
19394905|NCT01360645|41639163|FG003|Phase A+|Lost to Follow-up|7|||
19394906|NCT01360645|41639160|FG000|Phase A+|Adverse Event|0|||
19394907|NCT01360645|41639161|FG001|Phase A+|Adverse Event|0|||
19394908|NCT01360645|41639162|FG002|Phase A+|Adverse Event|0|||
19394909|NCT01360645|41639163|FG003|Phase A+|Adverse Event|2|||
19394910|NCT01360645|41639160|FG000|Phase A+|Met Withdrawal Criteria|0|||
19394911|NCT01360645|41639161|FG001|Phase A+|Met Withdrawal Criteria|0|||
19374015|NCT03965091|41615371|FG000|Overall Study|Other than specified|9|||
19374016|NCT03965091|41615372|FG001|Overall Study|Other than specified|11|||
19374017|NCT03965091|41615373|FG002|Overall Study|Other than specified|8|||
19374018|NCT03359096|41615400|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
19394912|NCT01360645|41639162|FG002|Phase A+|Met Withdrawal Criteria|0|||
19394913|NCT01360645|41639163|FG003|Phase A+|Met Withdrawal Criteria|4|||
19394914|NCT01360645|41639160|FG000|Phase A+|Physician Decision|0|||
19394915|NCT01360645|41639161|FG001|Phase A+|Physician Decision|0|||
19394916|NCT01360645|41639162|FG002|Phase A+|Physician Decision|0|||
19394917|NCT01360645|41639163|FG003|Phase A+|Physician Decision|2|||
19394918|NCT01360645|41639160|FG000|Phase A+|Withdrawal by Subject|0|||
19394919|NCT01360645|41639161|FG001|Phase A+|Withdrawal by Subject|0|||
19394920|NCT01360645|41639162|FG002|Phase A+|Withdrawal by Subject|0|||
19394921|NCT01360645|41639163|FG003|Phase A+|Withdrawal by Subject|5|||
19394922|NCT01360645|41639160|FG000|Phase A+|Protocol Deviation|0|||
19394923|NCT01360645|41639161|FG001|Phase A+|Protocol Deviation|0|||
19394924|NCT01360645|41639162|FG002|Phase A+|Protocol Deviation|0|||
19394925|NCT01360645|41639163|FG003|Phase A+|Protocol Deviation|4|||
19394926|NCT02633527|41639178|FG000|Overall Study|Failed to meet eligibility|0|||
19394927|NCT02633527|41639179|FG001|Overall Study|Failed to meet eligibility|1|||
19374019|NCT03359096|41615401|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
19374020|NCT03359096|41615400|FG000|First Intervention (4 Weeks)|Death|1|||
19374021|NCT03359096|41615401|FG001|First Intervention (4 Weeks)|Death|0|||
19374022|NCT03359096|41615400|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
19374023|NCT03359096|41615401|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
19374024|NCT03261700|41615409|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
19394928|NCT02633527|41639180|FG002|Overall Study|Failed to meet eligibility|1|||
19394929|NCT02633527|41639181|FG003|Overall Study|Failed to meet eligibility|0|||
19394930|NCT02633527|41639182|FG004|Overall Study|Failed to meet eligibility|1|||
19627170|NCT00857207|42076729|FG000|Overall Study|Withdrawal by Subject|13|||
19627171|NCT00857207|42076730|FG001|Overall Study|Withdrawal by Subject|0|||
19627172|NCT00857207|42076729|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
19627173|NCT00857207|42076730|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
19394931|NCT02633527|41639178|FG000|Overall Study|Adverse Event|0|||
19394932|NCT02633527|41639179|FG001|Overall Study|Adverse Event|4|||
19394933|NCT02633527|41639180|FG002|Overall Study|Adverse Event|3|||
19394934|NCT02633527|41639181|FG003|Overall Study|Adverse Event|1|||
19394935|NCT02633527|41639182|FG004|Overall Study|Adverse Event|5|||
19710230|NCT00112437|42153691|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710231|NCT00112437|42153692|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710232|NCT00112437|42153693|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710233|NCT00112437|42153694|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710234|NCT00112437|42153695|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710235|NCT00112437|42153696|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710236|NCT00112437|42153697|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710237|NCT00112437|42153698|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710238|NCT00112437|42153699|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710239|NCT00112437|42153700|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710240|NCT00112437|42153701|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710241|NCT00112437|42153702|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710242|NCT00112437|42153703|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710243|NCT00112437|42153704|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710244|NCT00112437|42153705|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710245|NCT00112437|42153706|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710246|NCT00112437|42153707|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710247|NCT00112437|42153708|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
19710248|NCT00112437|42153709|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710249|NCT00112437|42153710|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710250|NCT00112437|42153711|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710251|NCT00112437|42153712|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710252|NCT00112437|42153713|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
19710253|NCT00112437|42153688|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710254|NCT00112437|42153689|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710255|NCT00112437|42153690|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710256|NCT00112437|42153691|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710257|NCT00112437|42153692|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710258|NCT00112437|42153693|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710259|NCT00112437|42153694|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710260|NCT00112437|42153695|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710261|NCT00112437|42153696|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710262|NCT00112437|42153697|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710263|NCT00112437|42153698|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710264|NCT00112437|42153699|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710265|NCT00112437|42153700|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710266|NCT00112437|42153701|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710267|NCT00112437|42153702|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710268|NCT00112437|42153703|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710269|NCT00112437|42153704|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710270|NCT00112437|42153705|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710271|NCT00112437|42153706|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710272|NCT00112437|42153707|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710273|NCT00112437|42153708|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710274|NCT00112437|42153709|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
19710275|NCT00112437|42153710|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710276|NCT00112437|42153711|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710277|NCT00112437|42153712|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710278|NCT00112437|42153713|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
19710279|NCT00112437|42153688|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710280|NCT00112437|42153689|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710281|NCT00112437|42153690|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710282|NCT00112437|42153691|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710283|NCT00112437|42153692|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710284|NCT00112437|42153693|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710285|NCT00112437|42153694|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710286|NCT00112437|42153695|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710287|NCT00112437|42153696|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
19627174|NCT00857207|42076729|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
19627175|NCT00857207|42076730|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
19627176|NCT00836498|42076739|FG000|Overall Study|Adverse Event|1|||
19627177|NCT00836498|42076740|FG001|Overall Study|Adverse Event|0|||
19627178|NCT00836498|42076739|FG000|Overall Study|Lost to Follow-up|1|||
19627179|NCT00836498|42076740|FG001|Overall Study|Lost to Follow-up|0|||
19627180|NCT00836498|42076739|FG000|Overall Study|Withdrawal by Subject|2|||
19627181|NCT00836498|42076740|FG001|Overall Study|Withdrawal by Subject|1|||
19627182|NCT00856973|42076750|FG000|Overall Study|Adverse Event|5|||
19627183|NCT00856973|42076751|FG001|Overall Study|Adverse Event|5|||
19627184|NCT00856973|42076752|FG002|Overall Study|Adverse Event|3|||
19627185|NCT00856973|42076750|FG000|Overall Study|Lost to Follow-up|6|||
19627186|NCT00856973|42076751|FG001|Overall Study|Lost to Follow-up|3|||
19627187|NCT00856973|42076752|FG002|Overall Study|Lost to Follow-up|5|||
19627188|NCT00856973|42076750|FG000|Overall Study|Physician Decision|0|||
19627189|NCT00856973|42076751|FG001|Overall Study|Physician Decision|3|||
19627190|NCT00856973|42076752|FG002|Overall Study|Physician Decision|1|||
19627191|NCT00856973|42076750|FG000|Overall Study|Protocol Violation|1|||
19627192|NCT00856973|42076751|FG001|Overall Study|Protocol Violation|2|||
19627193|NCT00856973|42076752|FG002|Overall Study|Protocol Violation|1|||
19627194|NCT00856973|42076750|FG000|Overall Study|Withdrawal by Subject|13|||
19627195|NCT00856973|42076751|FG001|Overall Study|Withdrawal by Subject|16|||
19627196|NCT00856973|42076752|FG002|Overall Study|Withdrawal by Subject|15|||
19627197|NCT00856973|42076750|FG000|Overall Study|Other|11|||
19627198|NCT00856973|42076751|FG001|Overall Study|Other|12|||
19627199|NCT00856973|42076752|FG002|Overall Study|Other|13|||
19627200|NCT00844532|42076764|FG000|Overall Study|Death|16|||
19627201|NCT00844532|42076764|FG000|Overall Study|Withdrawal by Subject|16|||
19627202|NCT00844532|42076764|FG000|Overall Study|Lost to Follow-up|7|||
19627203|NCT00805194|42076770|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
19627204|NCT00805194|42076771|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
19627205|NCT00805194|42076770|FG000|Overall Study|Worsening or AE of underlying disease|64|||
19627206|NCT00805194|42076771|FG001|Overall Study|Worsening or AE of underlying disease|70|||
19627207|NCT00805194|42076770|FG000|Overall Study|Other AE|84|||
19627208|NCT00805194|42076771|FG001|Overall Study|Other AE|73|||
19627209|NCT00805194|42076770|FG000|Overall Study|Protocol Violation|9|||
19627210|NCT00805194|42076771|FG001|Overall Study|Protocol Violation|9|||
19627211|NCT00805194|42076770|FG000|Overall Study|Lost to Follow-up|5|||
19627212|NCT00805194|42076771|FG001|Overall Study|Lost to Follow-up|5|||
19627213|NCT00805194|42076770|FG000|Overall Study|Withdrawal by Subject|60|||
19627214|NCT00805194|42076771|FG001|Overall Study|Withdrawal by Subject|42|||
19627215|NCT00805194|42076770|FG000|Overall Study|Not treated|3|||
19627216|NCT00805194|42076771|FG001|Overall Study|Not treated|4|||
19627217|NCT00805194|42076770|FG000|Overall Study|Reasons other than stated above|20|||
19710288|NCT00112437|42153697|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710289|NCT00112437|42153698|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
19627218|NCT00805194|42076771|FG001|Overall Study|Reasons other than stated above|16|||
19627219|NCT00836186|42076782|FG000|Overall Study|Blood could not be drawn|1|||
19627220|NCT00657046|42076790|FG000|Overall Study|Adverse Event|1|||
19627221|NCT00657046|42076791|FG001|Overall Study|Adverse Event|1|||
19710290|NCT00112437|42153699|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710291|NCT00112437|42153700|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710292|NCT00112437|42153701|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710293|NCT00112437|42153702|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710294|NCT00112437|42153703|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710295|NCT00112437|42153704|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710296|NCT00112437|42153705|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710297|NCT00112437|42153706|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710298|NCT00112437|42153707|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710299|NCT00112437|42153708|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710300|NCT00112437|42153709|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
19710301|NCT00112437|42153710|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710302|NCT00112437|42153711|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710303|NCT00112437|42153712|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710304|NCT00112437|42153713|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
19710305|NCT00112437|42153688|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710306|NCT00112437|42153689|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710307|NCT00112437|42153690|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710308|NCT00112437|42153691|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710309|NCT00112437|42153692|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710310|NCT00112437|42153693|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710311|NCT00112437|42153694|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710312|NCT00112437|42153695|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710313|NCT00112437|42153696|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710314|NCT00112437|42153697|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710315|NCT00112437|42153698|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710316|NCT00112437|42153699|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710317|NCT00112437|42153700|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710318|NCT00112437|42153701|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710319|NCT00112437|42153702|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710320|NCT00112437|42153703|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710321|NCT00112437|42153704|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710322|NCT00112437|42153705|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710323|NCT00112437|42153706|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710324|NCT00112437|42153707|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710325|NCT00112437|42153708|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
19710326|NCT00112437|42153709|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
19710327|NCT00112437|42153710|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710328|NCT00112437|42153711|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710329|NCT00112437|42153712|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19710330|NCT00112437|42153713|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
19627222|NCT00657046|42076792|FG002|Overall Study|Adverse Event|0|||
19627223|NCT00657046|42076790|FG000|Overall Study|Protocol Violation|2|||
19627224|NCT00657046|42076791|FG001|Overall Study|Protocol Violation|2|||
19627225|NCT00657046|42076792|FG002|Overall Study|Protocol Violation|0|||
19627226|NCT00657046|42076790|FG000|Overall Study|Withdrawal by Subject|1|||
19627227|NCT00657046|42076791|FG001|Overall Study|Withdrawal by Subject|0|||
19627228|NCT00657046|42076792|FG002|Overall Study|Withdrawal by Subject|0|||
19627229|NCT00657046|42076790|FG000|Overall Study|Death|0|||
19627230|NCT00657046|42076791|FG001|Overall Study|Death|0|||
19627231|NCT00657046|42076792|FG002|Overall Study|Death|1|||
19627232|NCT00657046|42076790|FG000|Overall Study|Surgery|0|||
19710331|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710332|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710333|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710334|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710335|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710336|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710337|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710338|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710339|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710340|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710341|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710342|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710343|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710344|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710345|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710346|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710347|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710348|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710349|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710350|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710351|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710352|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710353|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
19710354|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
19710355|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
19710356|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
19710357|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Death|0|||
19710358|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Death|0|||
19710359|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Death|0|||
19710360|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Death|0|||
19710361|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Death|0|||
19627233|NCT00657046|42076791|FG001|Overall Study|Surgery|0|||
19627234|NCT00657046|42076792|FG002|Overall Study|Surgery|1|||
19627235|NCT00856661|42076802|FG000|Overall Study|Death|15|||
19627236|NCT00856661|42076803|FG001|Overall Study|Death|18|||
19627237|NCT00856661|42076802|FG000|Overall Study|Protocol Violation|2|||
19627238|NCT00856661|42076803|FG001|Overall Study|Protocol Violation|1|||
19627239|NCT00856661|42076802|FG000|Overall Study|Withdrawal by Subject|1|||
19627240|NCT00856661|42076803|FG001|Overall Study|Withdrawal by Subject|2|||
19627241|NCT00856661|42076802|FG000|Overall Study|Lost to Follow-up|1|||
19627242|NCT00856661|42076803|FG001|Overall Study|Lost to Follow-up|3|||
19627243|NCT00856661|42076802|FG000|Overall Study|Physician Judgement|8|||
19627244|NCT00856661|42076803|FG001|Overall Study|Physician Judgement|5|||
19710362|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Death|0|||
19394936|NCT02633527|41639178|FG000|Overall Study|Lost to Follow-up|1|||
19394937|NCT02633527|41639179|FG001|Overall Study|Lost to Follow-up|2|||
19394938|NCT02633527|41639180|FG002|Overall Study|Lost to Follow-up|5|||
19710363|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Death|0|||
19710364|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Death|0|||
19627245|NCT00844376|42076809|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
19627246|NCT00844376|42076810|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
19627247|NCT00658606|42076818|FG000|Overall Study|Adverse Event|2|||
19627248|NCT00658606|42076819|FG001|Overall Study|Adverse Event|1|||
19627249|NCT00658606|42076818|FG000|Overall Study|Lack of Efficacy|6|||
19627250|NCT00658606|42076819|FG001|Overall Study|Lack of Efficacy|3|||
19710365|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Death|0|||
19710366|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Death|0|||
19710367|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Death|0|||
19710368|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Death|0|||
19710369|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Death|0|||
19710370|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Death|0|||
19710371|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Death|0|||
19710372|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Death|0|||
19710373|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Death|0|||
19710374|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Death|0|||
19710375|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Death|0|||
19710376|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Death|0|||
19710377|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Death|0|||
19710378|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Death|0|||
19710379|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Death|0|||
19710380|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Death|2|||
19710381|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Death|0|||
19710382|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Death|0|||
19710383|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710384|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710385|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710386|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710387|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19517803|NCT01526928|41930797|FG000|Overall Study|Adverse Event|2|||
19517804|NCT01526928|41930798|FG001|Overall Study|Adverse Event|1|||
19517805|NCT01526928|41930799|FG002|Overall Study|Adverse Event|29|||
19517806|NCT01526928|41930800|FG003|Overall Study|Adverse Event|40|||
19517807|NCT01526928|41930801|FG004|Overall Study|Adverse Event|13|||
19517808|NCT01526928|41930802|FG005|Overall Study|Adverse Event|2|||
19517809|NCT01526928|41930797|FG000|Overall Study|Death|0|||
19517810|NCT01526928|41930798|FG001|Overall Study|Death|0|||
19517811|NCT01526928|41930799|FG002|Overall Study|Death|3|||
19517812|NCT01526928|41930800|FG003|Overall Study|Death|0|||
19517813|NCT01526928|41930801|FG004|Overall Study|Death|0|||
19517814|NCT01526928|41930802|FG005|Overall Study|Death|0|||
19517815|NCT01526928|41930797|FG000|Overall Study|Withdrawal by Subject|1|||
19517816|NCT01526928|41930798|FG001|Overall Study|Withdrawal by Subject|0|||
19394939|NCT02633527|41639181|FG003|Overall Study|Lost to Follow-up|5|||
19394940|NCT02633527|41639182|FG004|Overall Study|Lost to Follow-up|4|||
19394941|NCT02633527|41639178|FG000|Overall Study|Withdrawal by Subject|0|||
19394942|NCT02633527|41639179|FG001|Overall Study|Withdrawal by Subject|3|||
19394943|NCT02633527|41639180|FG002|Overall Study|Withdrawal by Subject|5|||
19394944|NCT02633527|41639181|FG003|Overall Study|Withdrawal by Subject|4|||
19394945|NCT02633527|41639182|FG004|Overall Study|Withdrawal by Subject|4|||
19394946|NCT02633527|41639178|FG000|Overall Study|Protocol Violation|0|||
19394947|NCT02633527|41639179|FG001|Overall Study|Protocol Violation|1|||
19394948|NCT02633527|41639180|FG002|Overall Study|Protocol Violation|1|||
19394949|NCT02633527|41639181|FG003|Overall Study|Protocol Violation|1|||
19394950|NCT02633527|41639182|FG004|Overall Study|Protocol Violation|1|||
19394951|NCT02633527|41639178|FG000|Overall Study|Physician Decision|0|||
19394952|NCT02633527|41639179|FG001|Overall Study|Physician Decision|0|||
19394953|NCT02633527|41639180|FG002|Overall Study|Physician Decision|0|||
19627251|NCT00658606|42076818|FG000|Overall Study|Lost to Follow-up|1|||
19627252|NCT00658606|42076819|FG001|Overall Study|Lost to Follow-up|0|||
19627253|NCT00658606|42076818|FG000|Overall Study|Withdrawal by Subject|7|||
19627254|NCT00658606|42076819|FG001|Overall Study|Withdrawal by Subject|16|||
19627255|NCT00658606|42076818|FG000|Overall Study|Lack of Compliance|0|||
19627256|NCT00658606|42076819|FG001|Overall Study|Lack of Compliance|3|||
19627257|NCT00589290|42076825|FG000|Overall Study|Withdrawal by Subject|1|||
19627258|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
19627259|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
19627260|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Death|0|||
19710388|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19517817|NCT01526928|41930799|FG002|Overall Study|Withdrawal by Subject|13|||
19517818|NCT01526928|41930800|FG003|Overall Study|Withdrawal by Subject|11|||
19517819|NCT01526928|41930801|FG004|Overall Study|Withdrawal by Subject|3|||
19517820|NCT01526928|41930802|FG005|Overall Study|Withdrawal by Subject|0|||
19517821|NCT01526928|41930797|FG000|Overall Study|Physician Decision|0|||
19517822|NCT01526928|41930798|FG001|Overall Study|Physician Decision|0|||
19394954|NCT02633527|41639181|FG003|Overall Study|Physician Decision|0|||
19394955|NCT02633527|41639182|FG004|Overall Study|Physician Decision|1|||
19394956|NCT02633527|41639178|FG000|Overall Study|Administrative reason|1|||
19394957|NCT02633527|41639179|FG001|Overall Study|Administrative reason|0|||
19517823|NCT01526928|41930799|FG002|Overall Study|Physician Decision|2|||
19517824|NCT01526928|41930800|FG003|Overall Study|Physician Decision|5|||
19517825|NCT01526928|41930801|FG004|Overall Study|Physician Decision|0|||
19517826|NCT01526928|41930802|FG005|Overall Study|Physician Decision|0|||
19517827|NCT01526928|41930797|FG000|Overall Study|Other Reason|0|||
19517828|NCT01526928|41930798|FG001|Overall Study|Other Reason|1|||
19517829|NCT01526928|41930799|FG002|Overall Study|Other Reason|11|||
19517830|NCT01526928|41930800|FG003|Overall Study|Other Reason|4|||
19517831|NCT01526928|41930801|FG004|Overall Study|Other Reason|1|||
19517832|NCT01526928|41930802|FG005|Overall Study|Other Reason|0|||
19517833|NCT01526928|41930797|FG000|Overall Study|Lost to Follow-up|0|||
19517834|NCT01526928|41930798|FG001|Overall Study|Lost to Follow-up|0|||
19627261|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Death|1|||
19627262|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
19710389|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19627263|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
19627264|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
19627265|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
19710390|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710391|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710392|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710393|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710394|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710395|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710396|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710397|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710398|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710399|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19627266|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
19627267|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
19627268|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
19627269|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
19627270|NCT00843518|42076833|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
19627271|NCT00843518|42076834|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
19627272|NCT00843284|42076844|FG000|Overall Study|Adverse Event|39|||
19627273|NCT00843284|42076844|FG000|Overall Study|Lack of Efficacy|5|||
19627274|NCT00843284|42076844|FG000|Overall Study|Lost to Follow-up|11|||
19627275|NCT00843284|42076844|FG000|Overall Study|Other|10|||
19627276|NCT00843284|42076844|FG000|Overall Study|Withdrawal by Subject|4|||
19627277|NCT00843284|42076844|FG000|Overall Study|Death|3|||
19627278|NCT00652834|42076861|FG000|Overall Study|Withdrawal by Subject|3|||
19627279|NCT00652834|42076861|FG000|Overall Study|Lost to Follow-up|2|||
19627280|NCT00825812|42076869|FG000|Overall Study|Never entered follow up|0|||
19627281|NCT00825812|42076870|FG001|Overall Study|Never entered follow up|0|||
19627282|NCT00825812|42076871|FG002|Overall Study|Never entered follow up|0|||
19627283|NCT00825812|42076872|FG003|Overall Study|Never entered follow up|1|||
19627284|NCT00825812|42076869|FG000|Overall Study|Adverse Event|0|||
19627285|NCT00825812|42076870|FG001|Overall Study|Adverse Event|0|||
19627286|NCT00825812|42076871|FG002|Overall Study|Adverse Event|0|||
19627287|NCT00825812|42076872|FG003|Overall Study|Adverse Event|1|||
19627288|NCT00825812|42076869|FG000|Overall Study|Subject withdrew consent|0|||
19627289|NCT00825812|42076870|FG001|Overall Study|Subject withdrew consent|0|||
19710400|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710401|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19627290|NCT00825812|42076871|FG002|Overall Study|Subject withdrew consent|3|||
19627291|NCT00825812|42076872|FG003|Overall Study|Subject withdrew consent|2|||
19627292|NCT00825812|42076869|FG000|Overall Study|Non-compliance with protocol|0|||
19627293|NCT00825812|42076870|FG001|Overall Study|Non-compliance with protocol|0|||
19627294|NCT00825812|42076871|FG002|Overall Study|Non-compliance with protocol|0|||
19710402|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710403|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710404|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710405|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710406|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710407|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
19710408|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
19710409|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Other|0|||
19710410|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Other|0|||
19710411|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Other|0|||
19710412|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Other|0|||
19710413|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Other|0|||
19710414|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Other|0|||
19710415|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Other|0|||
19627295|NCT00825812|42076872|FG003|Overall Study|Non-compliance with protocol|1|||
19627296|NCT00825812|42076869|FG000|Overall Study|Administrative|0|||
19627297|NCT00825812|42076870|FG001|Overall Study|Administrative|1|||
19517835|NCT01526928|41930799|FG002|Overall Study|Lost to Follow-up|0|||
19517836|NCT01526928|41930800|FG003|Overall Study|Lost to Follow-up|1|||
19710416|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Other|0|||
19710417|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Other|0|||
19710418|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Other|0|||
19710419|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Other|0|||
19710420|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Other|0|||
19710421|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Other|0|||
19710422|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Other|0|||
19710423|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Other|0|||
19710424|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Other|0|||
19710425|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Other|0|||
19710426|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Other|0|||
19710427|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Other|0|||
19710428|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Other|0|||
19710429|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Other|0|||
19710430|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Other|0|||
19710431|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Other|0|||
19710432|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Other|0|||
19710433|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Other|1|||
19710434|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Other|0|||
19710435|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710436|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710437|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710438|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710439|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710440|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710441|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710442|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710443|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710444|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710445|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710446|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710447|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710448|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19627298|NCT00825812|42076871|FG002|Overall Study|Administrative|3|||
19627299|NCT00825812|42076872|FG003|Overall Study|Administrative|5|||
19710449|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710450|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710451|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710452|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19627300|NCT00824720|42076885|FG000|Overall Study|failed plug insertion|3|||
19627301|NCT00824720|42076886|FG001|Overall Study|failed plug insertion|1|||
19627302|NCT00824720|42076887|FG002|Overall Study|failed plug insertion|0|||
19627303|NCT00824720|42076885|FG000|Overall Study|Protocol Violation|0|||
19627304|NCT00824720|42076886|FG001|Overall Study|Protocol Violation|0|||
19627305|NCT00824720|42076887|FG002|Overall Study|Protocol Violation|1|||
19627306|NCT03704064|42076897|FG000|Overall Study|Lost to Follow-up|8|||
19627307|NCT03704064|42076898|FG001|Overall Study|Lost to Follow-up|4|||
19627308|NCT03704064|42076897|FG000|Overall Study|Withdrawal by Subject|1|||
19627309|NCT03704064|42076898|FG001|Overall Study|Withdrawal by Subject|1|||
19627310|NCT03704064|42076897|FG000|Overall Study|No longer available for study visits|0|||
19627311|NCT03704064|42076898|FG001|Overall Study|No longer available for study visits|1|||
19627312|NCT03704064|42076897|FG000|Overall Study|Censoring event|1|||
19627313|NCT03704064|42076898|FG001|Overall Study|Censoring event|0|||
19627314|NCT00824564|42076906|FG000|Overall Study|Lost to Follow-up|5|||
19627315|NCT00824564|42076907|FG001|Overall Study|Lost to Follow-up|7|||
19627316|NCT00824564|42076906|FG000|Overall Study|Withdrawal by Subject|1|||
19627317|NCT00824564|42076907|FG001|Overall Study|Withdrawal by Subject|1|||
19627318|NCT00824564|42076906|FG000|Overall Study|Other|1|||
19627319|NCT00824564|42076907|FG001|Overall Study|Other|2|||
19627320|NCT00824564|42076906|FG000|Overall Study|Randomized, but not treated|1|||
19627321|NCT00824564|42076907|FG001|Overall Study|Randomized, but not treated|0|||
19627322|NCT00658528|42076915|FG000|Overall Study|Adverse Event|5|||
19627323|NCT00658528|42076916|FG001|Overall Study|Adverse Event|7|||
19627324|NCT00658528|42076915|FG000|Overall Study|Lost to Follow-up|14|||
19627325|NCT00658528|42076916|FG001|Overall Study|Lost to Follow-up|22|||
19627326|NCT00658528|42076915|FG000|Overall Study|Withdrawal by Subject|8|||
19627327|NCT00658528|42076916|FG001|Overall Study|Withdrawal by Subject|6|||
19627328|NCT00658528|42076915|FG000|Overall Study|Withdrawal of consent|5|||
19627329|NCT00658528|42076916|FG001|Overall Study|Withdrawal of consent|6|||
19627330|NCT00658528|42076915|FG000|Overall Study|Other|8|||
19627331|NCT00658528|42076916|FG001|Overall Study|Other|4|||
19627332|NCT02864394|42076924|FG000|Overall Study|Death|135|||
19627333|NCT02864394|42076925|FG001|Overall Study|Death|150|||
19627334|NCT02864394|42076924|FG000|Overall Study|Withdrawal by Subject|1|||
19710453|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19394958|NCT02633527|41639180|FG002|Overall Study|Administrative reason|0|||
19627335|NCT02864394|42076925|FG001|Overall Study|Withdrawal by Subject|9|||
19627336|NCT02864394|42076924|FG000|Overall Study|Ongoing In Study|77|||
19627337|NCT02864394|42076925|FG001|Overall Study|Ongoing In Study|53|||
19627338|NCT00856583|42076933|FG000|Overall Study|Lack of Efficacy|389|||
19627339|NCT00856583|42076934|FG001|Overall Study|Lack of Efficacy|377|||
19627340|NCT00856583|42076933|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
19627341|NCT00856583|42076934|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
19627342|NCT00856583|42076933|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
19627343|NCT00856583|42076934|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
19627344|NCT00856583|42076933|FG000|Overall Study|Non-compliance|305|||
19627345|NCT00856583|42076934|FG001|Overall Study|Non-compliance|262|||
19627346|NCT00856583|42076933|FG000|Overall Study|Withdrawal by Subject|1092|||
19627347|NCT00856583|42076934|FG001|Overall Study|Withdrawal by Subject|919|||
19627348|NCT00856583|42076933|FG000|Overall Study|Physician Decision|59|||
19627349|NCT00856583|42076934|FG001|Overall Study|Physician Decision|82|||
19627350|NCT00856583|42076933|FG000|Overall Study|Pregnancy|14|||
19627351|NCT00856583|42076934|FG001|Overall Study|Pregnancy|5|||
19627352|NCT00856583|42076933|FG000|Overall Study|Other|92|||
19627353|NCT00856583|42076934|FG001|Overall Study|Other|104|||
19627354|NCT00856583|42076933|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
19627355|NCT00856583|42076934|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
19627356|NCT00856349|42076940|FG000|Overall Study|Death|418|||
19627357|NCT00856349|42076940|FG000|Overall Study|Withdrawal by Subject|116|||
19627358|NCT00856349|42076940|FG000|Overall Study|Lost to Follow-up|91|||
19627359|NCT00856349|42076940|FG000|Overall Study|Protocol Violation|38|||
19627360|NCT00856349|42076940|FG000|Overall Study|Physician Decision|13|||
19627361|NCT00856349|42076940|FG000|Overall Study|Subject relocation|104|||
19627362|NCT00856349|42076940|FG000|Overall Study|Device explant|33|||
19627363|NCT00856349|42076940|FG000|Overall Study|Site closure|78|||
19627364|NCT00856349|42076940|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
19627365|NCT00803244|42076948|FG000|Overall Study|Adverse Event|1|||
19627366|NCT00803244|42076949|FG001|Overall Study|Adverse Event|2|||
19627367|NCT00803244|42076948|FG000|Overall Study|Withdrawal by Subject|2|||
19627368|NCT00803244|42076949|FG001|Overall Study|Withdrawal by Subject|3|||
19627369|NCT00803244|42076948|FG000|Overall Study|Any other reason not above-mentioned|4|||
19627370|NCT00803244|42076949|FG001|Overall Study|Any other reason not above-mentioned|10|||
19627371|NCT04060212|42076955|FG000|Overall Study|Withdrawal by Subject|7|||
19627372|NCT00804570|42076961|FG000|Overall Study|Adverse Event|14|||
19627373|NCT00804570|42076962|FG001|Overall Study|Adverse Event|7|||
19627374|NCT00804570|42076961|FG000|Overall Study|Lack of Efficacy|0|||
19627375|NCT00804570|42076962|FG001|Overall Study|Lack of Efficacy|1|||
19627376|NCT00804570|42076961|FG000|Overall Study|Lost to Follow-up|18|||
19627377|NCT00804570|42076962|FG001|Overall Study|Lost to Follow-up|21|||
19627378|NCT00804570|42076961|FG000|Overall Study|Entry criteria not met|5|||
19627379|NCT00804570|42076962|FG001|Overall Study|Entry criteria not met|5|||
19627380|NCT00804570|42076961|FG000|Overall Study|Protocol Violation|12|||
19627381|NCT00804570|42076962|FG001|Overall Study|Protocol Violation|16|||
19627382|NCT00804570|42076961|FG000|Overall Study|Physician Decision|1|||
19627383|NCT00804570|42076962|FG001|Overall Study|Physician Decision|2|||
19710454|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710455|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710456|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710457|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710458|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
19710459|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710460|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
19710461|NCT00112437|42153688|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710462|NCT00112437|42153689|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710463|NCT00112437|42153690|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710464|NCT00112437|42153691|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19627384|NCT00804570|42076961|FG000|Overall Study|Sponsor decision|1|||
19627385|NCT00804570|42076962|FG001|Overall Study|Sponsor decision|4|||
19627386|NCT00804570|42076961|FG000|Overall Study|Withdrawal by Subject|21|||
19627387|NCT00804570|42076962|FG001|Overall Study|Withdrawal by Subject|38|||
19627388|NCT00824408|42076974|FG000|Run-in Phase|Progressive disease|4|||
19627389|NCT00824408|42076975|FG001|Run-in Phase|Progressive disease|4|||
19627390|NCT00824408|42076976|FG002|Run-in Phase|Progressive disease|0|||
19710465|NCT00112437|42153692|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710466|NCT00112437|42153693|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710467|NCT00112437|42153694|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710468|NCT00112437|42153695|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710469|NCT00112437|42153696|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710470|NCT00112437|42153697|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710471|NCT00112437|42153698|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710472|NCT00112437|42153699|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710473|NCT00112437|42153700|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710474|NCT00112437|42153701|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710475|NCT00112437|42153702|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710476|NCT00112437|42153703|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710477|NCT00112437|42153704|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710478|NCT00112437|42153705|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710479|NCT00112437|42153706|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710480|NCT00112437|42153707|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710481|NCT00112437|42153708|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710482|NCT00112437|42153709|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19710483|NCT00112437|42153710|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
19710484|NCT00112437|42153711|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
19710485|NCT00112437|42153712|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
19627391|NCT00824408|42076977|FG003|Run-in Phase|Progressive disease|0|||
19627392|NCT00824408|42076978|FG004|Run-in Phase|Progressive disease|0|||
19627393|NCT00824408|42076974|FG000|Run-in Phase|Adverse Event|1|||
19627394|NCT00824408|42076975|FG001|Run-in Phase|Adverse Event|1|||
19627395|NCT00824408|42076976|FG002|Run-in Phase|Adverse Event|0|||
19627396|NCT00824408|42076977|FG003|Run-in Phase|Adverse Event|0|||
19627397|NCT00824408|42076978|FG004|Run-in Phase|Adverse Event|0|||
19627398|NCT00824408|42076974|FG000|Run-in Phase|Refused to continue medication|1|||
19627399|NCT00824408|42076975|FG001|Run-in Phase|Refused to continue medication|0|||
19627400|NCT00824408|42076976|FG002|Run-in Phase|Refused to continue medication|0|||
19710486|NCT00112437|42153713|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
19627401|NCT00824408|42076977|FG003|Run-in Phase|Refused to continue medication|0|||
19627402|NCT00824408|42076978|FG004|Run-in Phase|Refused to continue medication|0|||
19627403|NCT00824408|42076974|FG000|Run-in Phase|Other reason not defined above|0|||
19627404|NCT00824408|42076975|FG001|Run-in Phase|Other reason not defined above|1|||
19627405|NCT00824408|42076976|FG002|Run-in Phase|Other reason not defined above|0|||
19627406|NCT00824408|42076977|FG003|Run-in Phase|Other reason not defined above|0|||
19627407|NCT00824408|42076978|FG004|Run-in Phase|Other reason not defined above|0|||
19627408|NCT00824408|42076974|FG000|Randomized Phase|Not treated|0|||
19627409|NCT00824408|42076975|FG001|Randomized Phase|Not treated|0|||
19627410|NCT00824408|42076976|FG002|Randomized Phase|Not treated|1|||
19627411|NCT00824408|42076977|FG003|Randomized Phase|Not treated|1|||
19627412|NCT00824408|42076978|FG004|Randomized Phase|Not treated|1|||
19627413|NCT00824408|42076974|FG000|Randomized Phase|Progressive disease|0|||
19627414|NCT00824408|42076975|FG001|Randomized Phase|Progressive disease|0|||
19627415|NCT00824408|42076976|FG002|Randomized Phase|Progressive disease|25|||
19627416|NCT00824408|42076977|FG003|Randomized Phase|Progressive disease|36|||
19627417|NCT00824408|42076978|FG004|Randomized Phase|Progressive disease|34|||
19627418|NCT00824408|42076974|FG000|Randomized Phase|Adverse Event|0|||
19627419|NCT00824408|42076975|FG001|Randomized Phase|Adverse Event|0|||
19627420|NCT00824408|42076976|FG002|Randomized Phase|Adverse Event|4|||
19627421|NCT00824408|42076977|FG003|Randomized Phase|Adverse Event|5|||
19710487|NCT03653416|42153769|FG000|Overall Study|Protocol Violation|6|||
19710488|NCT03653416|42153770|FG001|Overall Study|Protocol Violation|1|||
19710489|NCT00112359|42153778|FG000|Overall Study|Unrelated adverse event|16|||
19710490|NCT00112359|42153779|FG001|Overall Study|Unrelated adverse event|8|||
19710491|NCT00112359|42153778|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
19710492|NCT00112359|42153779|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
19710493|NCT00112359|42153778|FG000|Overall Study|Related adverse event|5|||
19710494|NCT00112359|42153779|FG001|Overall Study|Related adverse event|3|||
19710495|NCT00112359|42153778|FG000|Overall Study|Lost to Follow-up|0|||
19710496|NCT00112359|42153779|FG001|Overall Study|Lost to Follow-up|1|||
19710497|NCT00112359|42153778|FG000|Overall Study|Personal/administrative|1|||
19710498|NCT00112359|42153779|FG001|Overall Study|Personal/administrative|1|||
19710499|NCT00112359|42153778|FG000|Overall Study|Other|3|||
19710500|NCT00112359|42153779|FG001|Overall Study|Other|0|||
19710501|NCT00119379|42153787|FG000|Overall Study|Adverse Event|4|||
19710502|NCT00119379|42153788|FG001|Overall Study|Adverse Event|1|||
19710503|NCT00118911|42153796|FG000|Overall Study|Withdrawal by Subject|2|||
19710504|NCT00118911|42153797|FG001|Overall Study|Withdrawal by Subject|5|||
19710505|NCT00131937|42153803|FG000|Overall Study|Adverse Event|3|||
19710506|NCT00131937|42153803|FG000|Overall Study|Withdrawal by Subject|2|||
19627422|NCT00824408|42076978|FG004|Randomized Phase|Adverse Event|5|||
19627423|NCT00824408|42076974|FG000|Randomized Phase|Refused to continue medication|0|||
19627424|NCT00824408|42076975|FG001|Randomized Phase|Refused to continue medication|0|||
19627425|NCT00824408|42076976|FG002|Randomized Phase|Refused to continue medication|2|||
19627426|NCT00824408|42076977|FG003|Randomized Phase|Refused to continue medication|2|||
19627427|NCT00824408|42076978|FG004|Randomized Phase|Refused to continue medication|2|||
19627428|NCT00824408|42076974|FG000|Randomized Phase|Other reason not defined above|0|||
19627429|NCT00824408|42076975|FG001|Randomized Phase|Other reason not defined above|0|||
19627430|NCT00824408|42076976|FG002|Randomized Phase|Other reason not defined above|4|||
19627431|NCT00824408|42076977|FG003|Randomized Phase|Other reason not defined above|2|||
19627432|NCT00824408|42076978|FG004|Randomized Phase|Other reason not defined above|4|||
19627433|NCT00866333|42076999|FG000|Overall Study|Withdrawal of consent|0|||
19710507|NCT00131937|42153803|FG000|Overall Study|Physician Decision|1|||
19710508|NCT00131937|42153803|FG000|Overall Study|Disease Progression|7|||
19710509|NCT00131937|42153803|FG000|Overall Study|Alternative therapy|1|||
19627434|NCT00866333|42077000|FG001|Overall Study|Withdrawal of consent|1|||
19627435|NCT00866333|42077001|FG002|Overall Study|Withdrawal of consent|2|||
19627436|NCT00866333|42076999|FG000|Overall Study|Reason not Specified|3|||
19627437|NCT00866333|42077000|FG001|Overall Study|Reason not Specified|1|||
19710510|NCT00131469|42153809|FG000|Overall Study|Withdrawal by Subject|3|||
19710511|NCT00131469|42153810|FG001|Overall Study|Withdrawal by Subject|4|||
19710512|NCT00131469|42153809|FG000|Overall Study|Protocol Violation|3|||
19710513|NCT00131469|42153810|FG001|Overall Study|Protocol Violation|1|||
19710514|NCT00131469|42153809|FG000|Overall Study|Death|0|||
19710515|NCT00131469|42153810|FG001|Overall Study|Death|1|||
19710516|NCT00131469|42153809|FG000|Overall Study|Lost to Follow-up|0|||
19710517|NCT00131469|42153810|FG001|Overall Study|Lost to Follow-up|1|||
19710518|NCT00131469|42153809|FG000|Overall Study|scan not analyzable|3|||
19710519|NCT00131469|42153810|FG001|Overall Study|scan not analyzable|6|||
19710520|NCT00372593|42153819|FG000|Overall Study|Adverse Event|43|||
19710521|NCT00372593|42153820|FG001|Overall Study|Adverse Event|45|||
19710522|NCT00372593|42153821|FG002|Overall Study|Adverse Event|0|||
19710523|NCT00372593|42153819|FG000|Overall Study|Death|16|||
19710524|NCT00372593|42153820|FG001|Overall Study|Death|20|||
19710525|NCT00372593|42153821|FG002|Overall Study|Death|1|||
19710526|NCT00372593|42153819|FG000|Overall Study|Lack of Efficacy|82|||
19710527|NCT00372593|42153820|FG001|Overall Study|Lack of Efficacy|71|||
19710528|NCT00372593|42153821|FG002|Overall Study|Lack of Efficacy|2|||
19710529|NCT00372593|42153819|FG000|Overall Study|Lost to Follow-up|1|||
19710530|NCT00372593|42153820|FG001|Overall Study|Lost to Follow-up|0|||
19710531|NCT00372593|42153821|FG002|Overall Study|Lost to Follow-up|0|||
19710532|NCT00372593|42153819|FG000|Overall Study|Physician Decision|42|||
19710533|NCT00372593|42153820|FG001|Overall Study|Physician Decision|41|||
19710534|NCT00372593|42153821|FG002|Overall Study|Physician Decision|0|||
19710535|NCT00372593|42153819|FG000|Overall Study|Ineligible|20|||
19710536|NCT00372593|42153820|FG001|Overall Study|Ineligible|21|||
19710537|NCT00372593|42153821|FG002|Overall Study|Ineligible|1|||
19710538|NCT03666988|42153836|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
19710539|NCT03666988|42153837|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
19710540|NCT03666988|42153838|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
19627438|NCT00866333|42077001|FG002|Overall Study|Reason not Specified|1|||
19627439|NCT00866333|42076999|FG000|Overall Study|Study Terminated by Sponsor|2|||
19627440|NCT00866333|42077000|FG001|Overall Study|Study Terminated by Sponsor|5|||
19627441|NCT00866333|42077001|FG002|Overall Study|Study Terminated by Sponsor|9|||
19627442|NCT00834080|42077009|FG000|Overall Study|Adverse Event|7|||
19627443|NCT00834080|42077009|FG000|Overall Study|Lost to Follow-up|7|||
19627444|NCT00834080|42077009|FG000|Overall Study|Withdrawal by Subject|5|||
19627445|NCT00834080|42077009|FG000|Overall Study|Other - Pregnancy|1|||
19627446|NCT00834080|42077009|FG000|Overall Study|Other - False positive tests of the UDS|1|||
19627447|NCT00834080|42077009|FG000|Overall Study|Physician Decision|1|||
19627448|NCT00834080|42077009|FG000|Overall Study|Subject Relocated|1|||
19627449|NCT00823472|42077015|FG000|Overall Study|Physician Decision|24|||
19627450|NCT00823472|42077016|FG001|Overall Study|Physician Decision|28|||
19710541|NCT03666988|42153839|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
19710542|NCT03666988|42153840|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
19710543|NCT03666988|42153841|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
19710544|NCT03666988|42153836|FG000|Part 1 (Up to 28 Months)|Other|0|||
19710545|NCT03666988|42153837|FG001|Part 1 (Up to 28 Months)|Other|1|||
19710546|NCT03666988|42153838|FG002|Part 1 (Up to 28 Months)|Other|1|||
19710547|NCT03666988|42153839|FG003|Part 1 (Up to 28 Months)|Other|0|||
19710548|NCT03666988|42153840|FG004|Part 1 (Up to 28 Months)|Other|0|||
19710549|NCT03666988|42153841|FG005|Part 1 (Up to 28 Months)|Other|0|||
19710550|NCT03666988|42153836|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
19710551|NCT03666988|42153837|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
19710552|NCT03666988|42153838|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
19710553|NCT03666988|42153839|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
19710554|NCT03666988|42153840|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
19710555|NCT03666988|42153841|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
19710556|NCT03666988|42153836|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
19710557|NCT03666988|42153837|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
19710558|NCT03666988|42153838|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
19710559|NCT03666988|42153839|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
19710560|NCT03666988|42153840|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
19710561|NCT03666988|42153841|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
19394959|NCT02633527|41639181|FG003|Overall Study|Administrative reason|1|||
19394960|NCT02633527|41639182|FG004|Overall Study|Administrative reason|0|||
19394961|NCT02633527|41639178|FG000|Overall Study|Multiple reasons|1|||
19394962|NCT02633527|41639179|FG001|Overall Study|Multiple reasons|0|||
19394963|NCT02633527|41639180|FG002|Overall Study|Multiple reasons|2|||
19394964|NCT02633527|41639181|FG003|Overall Study|Multiple reasons|2|||
19394965|NCT02633527|41639182|FG004|Overall Study|Multiple reasons|1|||
19394966|NCT01667549|41639199|FG000|Overall Study|Withdrawal by Subject|3|||
19627451|NCT00856193|42077022|FG000|Period 2|Abnormal test procedure results|0|||
19627452|NCT00856193|42077023|FG001|Period 2|Abnormal test procedure results|1|||
19627453|NCT00856193|42077022|FG000|Period 2|Lost to Follow-up|0|||
19627454|NCT00856193|42077023|FG001|Period 2|Lost to Follow-up|1|||
19627455|NCT00652366|42077034|FG000|Overall Study|Adverse Event|8|||
19627456|NCT00652366|42077035|FG001|Overall Study|Adverse Event|4|||
19627457|NCT00652366|42077036|FG002|Overall Study|Adverse Event|7|||
19627458|NCT00652366|42077037|FG003|Overall Study|Adverse Event|17|||
19394967|NCT01667549|41639200|FG001|Overall Study|Withdrawal by Subject|5|||
19394968|NCT01667549|41639201|FG002|Overall Study|Withdrawal by Subject|7|||
19627459|NCT00652366|42077038|FG004|Overall Study|Adverse Event|13|||
19627460|NCT00652366|42077034|FG000|Overall Study|Death|5|||
19627461|NCT00652366|42077035|FG001|Overall Study|Death|4|||
19394969|NCT01667549|41639202|FG003|Overall Study|Withdrawal by Subject|6|||
19394970|NCT01667549|41639203|FG004|Overall Study|Withdrawal by Subject|1|||
19394971|NCT01672801|41639261|FG000|Overall Study|Screen Failure|0|||
19394972|NCT01672801|41639262|FG001|Overall Study|Screen Failure|1|||
19394973|NCT01655901|41639268|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
19394974|NCT01655901|41639269|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
19394975|NCT01655901|41639270|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
19394976|NCT01655901|41639271|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
19394977|NCT01655901|41639272|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
19394978|NCT01655901|41639273|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
19394979|NCT01656759|41639284|FG000|Overall Study|Protocol Violation|2|||
19394980|NCT01656759|41639285|FG001|Overall Study|Protocol Violation|3|||
19394981|NCT02631577|41639293|FG000|Overall Study|Death|1|||
19394982|NCT02631577|41639294|FG001|Overall Study|Death|7|||
19394983|NCT02631577|41639293|FG000|Overall Study|Withdrawal by Subject|0|||
19394984|NCT02631577|41639294|FG001|Overall Study|Withdrawal by Subject|3|||
19394985|NCT01667081|41639302|FG000|Overall Study|Death|43|||
19394986|NCT01667081|41639303|FG001|Overall Study|Death|3|||
19394987|NCT01667081|41639302|FG000|Overall Study|Lost to Follow-up|99|||
19394988|NCT01667081|41639303|FG001|Overall Study|Lost to Follow-up|48|||
19394989|NCT01667081|41639302|FG000|Overall Study|Physician Decision|16|||
19394990|NCT01667081|41639303|FG001|Overall Study|Physician Decision|2|||
19394991|NCT01667081|41639302|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
19394992|NCT01667081|41639303|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
19394993|NCT01667081|41639302|FG000|Overall Study|Withdrawal by Subject|90|||
19394994|NCT01667081|41639303|FG001|Overall Study|Withdrawal by Subject|35|||
19394995|NCT04545619|41639320|FG000|Overall Study|due to equipment challenges|1|||
19394996|NCT02518971|41639326|FG000|Overall Study|Lost to Follow-up|0|||
19394997|NCT02518971|41639327|FG001|Overall Study|Lost to Follow-up|1|||
19394998|NCT02518971|41639326|FG000|Overall Study|Physician Decision|6|||
19394999|NCT02518971|41639327|FG001|Overall Study|Physician Decision|6|||
19395000|NCT02518971|41639326|FG000|Overall Study|Protocol Violation|6|||
19395001|NCT02518971|41639327|FG001|Overall Study|Protocol Violation|4|||
19395002|NCT02518971|41639326|FG000|Overall Study|Withdrawal by Subject|4|||
19395003|NCT02518971|41639327|FG001|Overall Study|Withdrawal by Subject|5|||
19395004|NCT02518971|41639326|FG000|Overall Study|Side effects|1|||
19395005|NCT02518971|41639327|FG001|Overall Study|Side effects|0|||
19395006|NCT02518971|41639326|FG000|Overall Study|medication lost in mail|0|||
19395007|NCT02518971|41639327|FG001|Overall Study|medication lost in mail|1|||
19395008|NCT02518971|41639326|FG000|Overall Study|eligibility criteria no longer met|6|||
19395009|NCT02518971|41639327|FG001|Overall Study|eligibility criteria no longer met|3|||
19395010|NCT01365039|41639336|FG000|Overall Study|Study related symptoms and complaints|1|||
19395011|NCT01365039|41639337|FG001|Overall Study|Study related symptoms and complaints|0|||
19395012|NCT01364727|41639344|FG000|Overall Study|Not Eligible|2|||
19395013|NCT02633215|41639352|FG000|Overall Study|Lost to Follow-up|2|||
19395014|NCT02633215|41639353|FG001|Overall Study|Lost to Follow-up|3|||
19395015|NCT01364649|41639361|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
19395016|NCT01364649|41639362|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
19395017|NCT01364649|41639361|FG000|Overall Study|Lack of Efficacy|6|||
19395018|NCT01364649|41639362|FG001|Overall Study|Lack of Efficacy|0|||
19395019|NCT01364649|41639361|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
19395020|NCT01364649|41639362|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
19395021|NCT01364649|41639361|FG000|Overall Study|Protocol Deviations|4|||
19395022|NCT01364649|41639362|FG001|Overall Study|Protocol Deviations|8|||
19395023|NCT01364649|41639361|FG000|Overall Study|Withdrawal of Consent|9|||
19395024|NCT01364649|41639362|FG001|Overall Study|Withdrawal of Consent|7|||
19395025|NCT01364649|41639361|FG000|Overall Study|Lost to Follow-up|12|||
19395026|NCT01364649|41639362|FG001|Overall Study|Lost to Follow-up|13|||
19395027|NCT01364649|41639361|FG000|Overall Study|Other|4|||
19395028|NCT01364649|41639362|FG001|Overall Study|Other|1|||
19395029|NCT02588261|41639370|FG000|Overall Study|Study Terminated by Sponsor|157|||
19395030|NCT02588261|41639371|FG001|Overall Study|Study Terminated by Sponsor|142|||
19395031|NCT02588261|41639370|FG000|Overall Study|Protocol Deviation|1|||
19395032|NCT02588261|41639371|FG001|Overall Study|Protocol Deviation|0|||
19395033|NCT02588261|41639370|FG000|Overall Study|Death|1|||
19395034|NCT02588261|41639371|FG001|Overall Study|Death|2|||
19395035|NCT02588261|41639370|FG000|Overall Study|Withdrawal by Subject|12|||
19395036|NCT02588261|41639371|FG001|Overall Study|Withdrawal by Subject|8|||
19395037|NCT02588261|41639370|FG000|Overall Study|Noncompliance with Study Drug|0|||
19395038|NCT02588261|41639371|FG001|Overall Study|Noncompliance with Study Drug|1|||
19395039|NCT02588261|41639370|FG000|Overall Study|Miscellaneous|5|||
19395040|NCT02588261|41639371|FG001|Overall Study|Miscellaneous|4|||
19395041|NCT02588261|41639370|FG000|Overall Study|Progressive Disease|61|||
19395042|NCT02588261|41639371|FG001|Overall Study|Progressive Disease|82|||
19395043|NCT02588261|41639370|FG000|Overall Study|Adverse Event|29|||
19395044|NCT02588261|41639371|FG001|Overall Study|Adverse Event|24|||
19395045|NCT02588261|41639370|FG000|Overall Study|Lost to Follow-up|1|||
19395046|NCT02588261|41639371|FG001|Overall Study|Lost to Follow-up|0|||
19710562|NCT03666988|42153836|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
19710563|NCT03666988|42153837|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
19710564|NCT03666988|42153838|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
19710565|NCT03666988|42153839|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
19710566|NCT03666988|42153840|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
19710567|NCT03666988|42153841|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
19710568|NCT00382109|42153861|FG000|Overall Study|Adverse Event|3|||
19710569|NCT00382109|42153862|FG001|Overall Study|Adverse Event|0|||
19710570|NCT00382109|42153861|FG000|Overall Study|Physician Decision|6|||
19395047|NCT01359449|41639379|FG000|Overall Study|Lost to Follow-up|1|||
19395048|NCT01359449|41639380|FG001|Overall Study|Lost to Follow-up|0|||
19395049|NCT01359449|41639379|FG000|Overall Study|Protocol Violation|0|||
19710571|NCT00382109|42153862|FG001|Overall Study|Physician Decision|1|||
19710572|NCT00382109|42153861|FG000|Overall Study|Withdrawal by Subject|1|||
19710573|NCT00382109|42153862|FG001|Overall Study|Withdrawal by Subject|0|||
19710574|NCT00382109|42153861|FG000|Overall Study|ineligible|2|||
19710575|NCT00382109|42153862|FG001|Overall Study|ineligible|0|||
19710576|NCT00382109|42153861|FG000|Overall Study|Other|0|||
19710577|NCT00382109|42153862|FG001|Overall Study|Other|2|||
19710578|NCT00382109|42153861|FG000|Overall Study|consent withdrawal|0|||
19395050|NCT01359449|41639380|FG001|Overall Study|Protocol Violation|2|||
19395051|NCT01359449|41639379|FG000|Overall Study|Withdrawal by Subject|3|||
19395052|NCT01359449|41639380|FG001|Overall Study|Withdrawal by Subject|2|||
19395053|NCT01672723|41639386|FG000|First Intervention|Adverse Event|3|||
19395054|NCT01672723|41639387|FG001|First Intervention|Adverse Event|0|||
19395055|NCT02632747|41639395|FG000|Wash-out Period|Adverse Event|1|||
19395056|NCT02632747|41639396|FG001|Wash-out Period|Adverse Event|0|||
19395057|NCT02520531|41639415|FG000|Overall Study|Revision of study device components|2|||
19395058|NCT02520531|41639416|FG001|Overall Study|Revision of study device components|2|||
19395059|NCT02520531|41639415|FG000|Overall Study|Death|1|||
19395060|NCT02520531|41639416|FG001|Overall Study|Death|2|||
19395061|NCT02520531|41639415|FG000|Overall Study|Lost to Follow-up|1|||
19395062|NCT02520531|41639416|FG001|Overall Study|Lost to Follow-up|1|||
19395063|NCT02520531|41639415|FG000|Overall Study|Meet exclusion criterion|0|||
19395064|NCT02520531|41639416|FG001|Overall Study|Meet exclusion criterion|1|||
19395065|NCT02520531|41639415|FG000|Overall Study|Withdrawal by Subject|1|||
19395066|NCT02520531|41639416|FG001|Overall Study|Withdrawal by Subject|0|||
19395067|NCT02520531|41639415|FG000|Overall Study|Not study device|1|||
19395068|NCT02520531|41639416|FG001|Overall Study|Not study device|0|||
19395069|NCT01671319|41639422|FG000|Overall Study|Withdrawal by Subject|1|||
19395070|NCT01670539|41639426|FG000|Overall Study|Death|3|||
19395071|NCT01670539|41639427|FG001|Overall Study|Death|5|||
19395072|NCT01670539|41639426|FG000|Overall Study|Withdrawal by Subject|3|||
19395073|NCT01670539|41639427|FG001|Overall Study|Withdrawal by Subject|0|||
19395074|NCT02516163|41639434|FG000|Overall Study|Withdrawal by Subject|1|||
19395075|NCT02516163|41639434|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
19395076|NCT02516163|41639434|FG000|Overall Study|Unfit/delay in surgery|3|||
19395077|NCT02516163|41639434|FG000|Overall Study|Use of incorrect measurement technique|5|||
19395078|NCT02516163|41639434|FG000|Overall Study|Data not recorded|2|||
19395079|NCT02516163|41639434|FG000|Overall Study|MRI contraindication exclusion|6|||
19395080|NCT02589665|41639442|FG000|Induction Period|Did not receive drug|0|||
19395081|NCT02589665|41639443|FG001|Induction Period|Did not receive drug|0|||
19395082|NCT02589665|41639444|FG002|Induction Period|Did not receive drug|0|||
19395083|NCT02589665|41639445|FG003|Induction Period|Did not receive drug|1|||
19395084|NCT02589665|41639446|FG004|Induction Period|Did not receive drug|0|||
19395085|NCT02589665|41639447|FG005|Induction Period|Did not receive drug|0|||
19395086|NCT02589665|41639448|FG006|Induction Period|Did not receive drug|0|||
19395087|NCT02589665|41639449|FG007|Induction Period|Did not receive drug|0|||
19395088|NCT02589665|41639450|FG008|Induction Period|Did not receive drug|0|||
19395089|NCT02589665|41639451|FG009|Induction Period|Did not receive drug|0|||
19395090|NCT02589665|41639442|FG000|Induction Period|Adverse Event|3|||
19395091|NCT02589665|41639443|FG001|Induction Period|Adverse Event|0|||
19395092|NCT02589665|41639444|FG002|Induction Period|Adverse Event|2|||
19395093|NCT02589665|41639445|FG003|Induction Period|Adverse Event|2|||
19395094|NCT02589665|41639446|FG004|Induction Period|Adverse Event|0|||
19395095|NCT02589665|41639447|FG005|Induction Period|Adverse Event|0|||
19395096|NCT02589665|41639448|FG006|Induction Period|Adverse Event|0|||
19395097|NCT02589665|41639449|FG007|Induction Period|Adverse Event|0|||
19395098|NCT02589665|41639450|FG008|Induction Period|Adverse Event|0|||
19395099|NCT02589665|41639451|FG009|Induction Period|Adverse Event|0|||
19395100|NCT02589665|41639442|FG000|Induction Period|Withdrawal by Subject|0|||
19395101|NCT02589665|41639443|FG001|Induction Period|Withdrawal by Subject|1|||
19710579|NCT00382109|42153862|FG001|Overall Study|consent withdrawal|1|||
19710580|NCT03651622|42153874|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
19710581|NCT03651622|42153875|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
19710582|NCT03651622|42153876|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
19710583|NCT03651622|42153874|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
19710584|NCT03651622|42153875|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
19710585|NCT03651622|42153876|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
19710586|NCT03651622|42153874|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
19710587|NCT03651622|42153875|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
19710588|NCT03651622|42153876|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
19710589|NCT03651622|42153874|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
19710590|NCT03651622|42153875|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
19710591|NCT03651622|42153876|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
19710592|NCT03651622|42153874|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
19710593|NCT03651622|42153875|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
19710594|NCT03651622|42153876|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
19710595|NCT00381797|42153889|FG000|Overall Study|Withdrawal by Subject|1|||
19710596|NCT00381797|42153890|FG001|Overall Study|Withdrawal by Subject|1|||
19710597|NCT00381797|42153891|FG002|Overall Study|Withdrawal by Subject|0|||
19710598|NCT00381797|42153892|FG003|Overall Study|Withdrawal by Subject|0|||
19710599|NCT00381797|42153893|FG004|Overall Study|Withdrawal by Subject|2|||
19710600|NCT00381797|42153889|FG000|Overall Study|Ineligible|0|||
19710601|NCT00381797|42153890|FG001|Overall Study|Ineligible|0|||
19710602|NCT00381797|42153891|FG002|Overall Study|Ineligible|0|||
19710603|NCT00381797|42153892|FG003|Overall Study|Ineligible|1|||
19710604|NCT00381797|42153893|FG004|Overall Study|Ineligible|0|||
19517837|NCT01526928|41930801|FG004|Overall Study|Lost to Follow-up|0|||
19710605|NCT03665038|42153929|FG000|Overall Study|Lost to Follow-up|0|||
19710606|NCT03665038|42153930|FG001|Overall Study|Lost to Follow-up|0|||
19710607|NCT03665038|42153931|FG002|Overall Study|Lost to Follow-up|1|||
19710608|NCT03664024|42153941|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
19710609|NCT03664024|42153941|FG000|Overall Study|Lost to Follow-up|2|||
19395102|NCT02589665|41639444|FG002|Induction Period|Withdrawal by Subject|0|||
19395103|NCT02589665|41639445|FG003|Induction Period|Withdrawal by Subject|1|||
19395104|NCT02589665|41639446|FG004|Induction Period|Withdrawal by Subject|0|||
19395105|NCT02589665|41639447|FG005|Induction Period|Withdrawal by Subject|0|||
19395106|NCT02589665|41639448|FG006|Induction Period|Withdrawal by Subject|0|||
19395107|NCT02589665|41639449|FG007|Induction Period|Withdrawal by Subject|0|||
19395108|NCT02589665|41639450|FG008|Induction Period|Withdrawal by Subject|0|||
19395109|NCT02589665|41639451|FG009|Induction Period|Withdrawal by Subject|0|||
19395110|NCT02589665|41639442|FG000|Induction Period|Protocol Violation|0|||
19395111|NCT02589665|41639443|FG001|Induction Period|Protocol Violation|1|||
19395112|NCT02589665|41639444|FG002|Induction Period|Protocol Violation|0|||
19395113|NCT02589665|41639445|FG003|Induction Period|Protocol Violation|0|||
19395114|NCT02589665|41639446|FG004|Induction Period|Protocol Violation|0|||
19395115|NCT02589665|41639447|FG005|Induction Period|Protocol Violation|0|||
19395116|NCT02589665|41639448|FG006|Induction Period|Protocol Violation|0|||
19395117|NCT02589665|41639449|FG007|Induction Period|Protocol Violation|0|||
19395118|NCT02589665|41639450|FG008|Induction Period|Protocol Violation|0|||
19395119|NCT02589665|41639451|FG009|Induction Period|Protocol Violation|0|||
19395120|NCT02589665|41639442|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395121|NCT02589665|41639443|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395122|NCT02589665|41639444|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395123|NCT02589665|41639445|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395124|NCT02589665|41639446|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
19395125|NCT02589665|41639447|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
19395126|NCT02589665|41639448|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
19395127|NCT02589665|41639449|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395128|NCT02589665|41639450|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395129|NCT02589665|41639451|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395130|NCT02589665|41639442|FG000|Maintenance Period|Withdrawal by Subject|0|||
19395131|NCT02589665|41639443|FG001|Maintenance Period|Withdrawal by Subject|0|||
19395132|NCT02589665|41639444|FG002|Maintenance Period|Withdrawal by Subject|0|||
19395133|NCT02589665|41639445|FG003|Maintenance Period|Withdrawal by Subject|0|||
19395134|NCT02589665|41639446|FG004|Maintenance Period|Withdrawal by Subject|4|||
19395135|NCT02589665|41639447|FG005|Maintenance Period|Withdrawal by Subject|2|||
19395136|NCT02589665|41639448|FG006|Maintenance Period|Withdrawal by Subject|4|||
19395137|NCT02589665|41639449|FG007|Maintenance Period|Withdrawal by Subject|0|||
19395138|NCT02589665|41639450|FG008|Maintenance Period|Withdrawal by Subject|0|||
19395139|NCT02589665|41639451|FG009|Maintenance Period|Withdrawal by Subject|0|||
19395140|NCT02589665|41639442|FG000|Maintenance Period|Lack of Efficacy|0|||
19395141|NCT02589665|41639443|FG001|Maintenance Period|Lack of Efficacy|0|||
19395142|NCT02589665|41639444|FG002|Maintenance Period|Lack of Efficacy|0|||
19395143|NCT02589665|41639445|FG003|Maintenance Period|Lack of Efficacy|0|||
19627462|NCT00652366|42077036|FG002|Overall Study|Death|1|||
19710610|NCT03664024|42153941|FG000|Overall Study|Withdrawal by Subject|2|||
19374025|NCT03261700|41615410|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
19374026|NCT03019588|41615439|FG000|Overall Study|Death|44|||
19374027|NCT03019588|41615440|FG001|Overall Study|Death|46|||
19374028|NCT03019588|41615439|FG000|Overall Study|Study terminated by Sponsor|3|||
19374029|NCT03019588|41615440|FG001|Overall Study|Study terminated by Sponsor|1|||
19627463|NCT00652366|42077037|FG003|Overall Study|Death|8|||
19627464|NCT00652366|42077038|FG004|Overall Study|Death|5|||
19627465|NCT00652366|42077034|FG000|Overall Study|Lack of Efficacy|84|||
19627466|NCT00652366|42077035|FG001|Overall Study|Lack of Efficacy|58|||
19627467|NCT00652366|42077036|FG002|Overall Study|Lack of Efficacy|53|||
19627468|NCT00652366|42077037|FG003|Overall Study|Lack of Efficacy|133|||
19627469|NCT00652366|42077038|FG004|Overall Study|Lack of Efficacy|13|||
19627470|NCT00652366|42077034|FG000|Overall Study|Violation of Selection Criteria|0|||
19627471|NCT00652366|42077035|FG001|Overall Study|Violation of Selection Criteria|0|||
19627472|NCT00652366|42077036|FG002|Overall Study|Violation of Selection Criteria|1|||
19627473|NCT00652366|42077037|FG003|Overall Study|Violation of Selection Criteria|0|||
19710611|NCT03664024|42153941|FG000|Overall Study|Death|80|||
19710612|NCT00381641|42153950|FG000|Overall Study|Withdrawal by Subject|0|||
19627474|NCT00652366|42077038|FG004|Overall Study|Violation of Selection Criteria|0|||
19627475|NCT00652366|42077034|FG000|Overall Study|Protocol Violation|1|||
19627476|NCT00652366|42077035|FG001|Overall Study|Protocol Violation|0|||
19627477|NCT00652366|42077036|FG002|Overall Study|Protocol Violation|0|||
19627478|NCT00652366|42077037|FG003|Overall Study|Protocol Violation|0|||
19627479|NCT00652366|42077038|FG004|Overall Study|Protocol Violation|0|||
19627480|NCT00652366|42077034|FG000|Overall Study|Refused treatment|3|||
19627481|NCT00652366|42077035|FG001|Overall Study|Refused treatment|7|||
19627482|NCT00652366|42077036|FG002|Overall Study|Refused treatment|6|||
19627483|NCT00652366|42077037|FG003|Overall Study|Refused treatment|17|||
19627484|NCT00652366|42077038|FG004|Overall Study|Refused treatment|5|||
19710613|NCT00381641|42153951|FG001|Overall Study|Withdrawal by Subject|2|||
19710614|NCT00381563|42153959|FG000|Overall Study|Withdrawal by Subject|5|||
19710615|NCT00381563|42153960|FG001|Overall Study|Withdrawal by Subject|5|||
19710616|NCT00381563|42153959|FG000|Overall Study|Lost to Follow-up|2|||
19710617|NCT00381563|42153960|FG001|Overall Study|Lost to Follow-up|0|||
19710618|NCT00381563|42153959|FG000|Overall Study|Protocol Violation|0|||
19710619|NCT00381563|42153960|FG001|Overall Study|Protocol Violation|1|||
19710620|NCT03624946|42153967|FG000|Overall Study|Lost to Follow-up|0|||
19710621|NCT03624946|42153968|FG001|Overall Study|Lost to Follow-up|1|||
19627485|NCT00652366|42077034|FG000|Overall Study|Other|5|||
19627486|NCT00652366|42077035|FG001|Overall Study|Other|2|||
19627487|NCT00652366|42077036|FG002|Overall Study|Other|3|||
19627488|NCT00652366|42077037|FG003|Overall Study|Other|4|||
19627489|NCT00652366|42077038|FG004|Overall Study|Other|0|||
19627490|NCT00841568|42077052|FG000|Overall Study|Adverse Event|1|||
19627491|NCT00841568|42077052|FG000|Overall Study|Death|1|||
19627492|NCT00841568|42077052|FG000|Overall Study|Withdrawal by Subject|2|||
19627493|NCT00841568|42077052|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
19627494|NCT00855959|42077060|FG000|Overall Study|Adverse Event|2|||
19627495|NCT00855959|42077060|FG000|Overall Study|Lost to Follow-up|2|||
19627496|NCT00855959|42077060|FG000|Overall Study|Withdrawal by Subject|3|||
19710622|NCT00381095|42153980|FG000|Overall Study|Death|3|||
19627497|NCT00855959|42077060|FG000|Overall Study|Pregnancy|1|||
19710623|NCT00381095|42153981|FG001|Overall Study|Death|4|||
19710624|NCT00381095|42153980|FG000|Overall Study|Lack of Efficacy|2|||
19710625|NCT00381095|42153981|FG001|Overall Study|Lack of Efficacy|4|||
19710626|NCT00381095|42153980|FG000|Overall Study|Other|2|||
19627498|NCT00855959|42077060|FG000|Overall Study|Incorrect enrolment|1|||
19627499|NCT00841100|42077064|FG000|Phase 1 (28 Days)|Adverse Event|1|||
19710627|NCT00381095|42153981|FG001|Overall Study|Other|2|||
19395144|NCT02589665|41639446|FG004|Maintenance Period|Lack of Efficacy|2|||
19395145|NCT02589665|41639447|FG005|Maintenance Period|Lack of Efficacy|1|||
19395146|NCT02589665|41639448|FG006|Maintenance Period|Lack of Efficacy|0|||
19395147|NCT02589665|41639449|FG007|Maintenance Period|Lack of Efficacy|0|||
19395148|NCT02589665|41639450|FG008|Maintenance Period|Lack of Efficacy|0|||
19395149|NCT02589665|41639451|FG009|Maintenance Period|Lack of Efficacy|0|||
19395150|NCT02589665|41639442|FG000|Maintenance Period|Adverse Event|0|||
19395151|NCT02589665|41639443|FG001|Maintenance Period|Adverse Event|0|||
19395152|NCT02589665|41639444|FG002|Maintenance Period|Adverse Event|0|||
19395153|NCT02589665|41639445|FG003|Maintenance Period|Adverse Event|0|||
19395154|NCT02589665|41639446|FG004|Maintenance Period|Adverse Event|0|||
19395155|NCT02589665|41639447|FG005|Maintenance Period|Adverse Event|0|||
19395156|NCT02589665|41639448|FG006|Maintenance Period|Adverse Event|2|||
19395157|NCT02589665|41639449|FG007|Maintenance Period|Adverse Event|0|||
19395158|NCT02589665|41639450|FG008|Maintenance Period|Adverse Event|0|||
19395159|NCT02589665|41639451|FG009|Maintenance Period|Adverse Event|0|||
19395160|NCT02589665|41639442|FG000|Maintenance Period|Lost to Follow-up|0|||
19395161|NCT02589665|41639443|FG001|Maintenance Period|Lost to Follow-up|0|||
19395162|NCT02589665|41639444|FG002|Maintenance Period|Lost to Follow-up|0|||
19395163|NCT02589665|41639445|FG003|Maintenance Period|Lost to Follow-up|0|||
19395164|NCT02589665|41639446|FG004|Maintenance Period|Lost to Follow-up|0|||
19395165|NCT02589665|41639447|FG005|Maintenance Period|Lost to Follow-up|1|||
19395166|NCT02589665|41639448|FG006|Maintenance Period|Lost to Follow-up|0|||
19395167|NCT02589665|41639449|FG007|Maintenance Period|Lost to Follow-up|0|||
19710628|NCT00381095|42153980|FG000|Overall Study|Protocol Violation|1|||
19710629|NCT00381095|42153981|FG001|Overall Study|Protocol Violation|1|||
19710630|NCT00381095|42153980|FG000|Overall Study|Withdrawal by Subject|3|||
19710631|NCT00381095|42153981|FG001|Overall Study|Withdrawal by Subject|3|||
19710632|NCT00381095|42153980|FG000|Overall Study|Adverse Event|2|||
19710633|NCT00381095|42153981|FG001|Overall Study|Adverse Event|7|||
19710634|NCT03619174|42153989|FG000|Overall Study|Lost to Follow-up|3|||
19710635|NCT03619174|42153990|FG001|Overall Study|Lost to Follow-up|0|||
19710636|NCT03619174|42153989|FG000|Overall Study|Withdrawal by Subject|4|||
19710637|NCT03619174|42153990|FG001|Overall Study|Withdrawal by Subject|3|||
19710638|NCT03619174|42153989|FG000|Overall Study|Pregnancy|1|||
19710639|NCT03619174|42153990|FG001|Overall Study|Pregnancy|1|||
19710640|NCT03619174|42153989|FG000|Overall Study|Discomfort during treatment|1|||
19710641|NCT03619174|42153990|FG001|Overall Study|Discomfort during treatment|0|||
19710642|NCT00112047|42153998|FG000|Randomized Phase|Lost to Follow-up|26|||
19710643|NCT00112047|42153999|FG001|Randomized Phase|Lost to Follow-up|33|||
19710644|NCT00112047|42153998|FG000|Randomized Phase|Adverse Event|10|||
19710645|NCT00112047|42153999|FG001|Randomized Phase|Adverse Event|10|||
19710646|NCT00112047|42153998|FG000|Randomized Phase|Withrawal of consent|10|||
19710647|NCT00112047|42153999|FG001|Randomized Phase|Withrawal of consent|18|||
19710648|NCT00112047|42153998|FG000|Randomized Phase|Sub-optimal virological response|3|||
19395168|NCT02589665|41639450|FG008|Maintenance Period|Lost to Follow-up|0|||
19395169|NCT02589665|41639451|FG009|Maintenance Period|Lost to Follow-up|0|||
19710649|NCT00112047|42153999|FG001|Randomized Phase|Sub-optimal virological response|13|||
19710650|NCT00112047|42153998|FG000|Randomized Phase|Noncompliance|8|||
19710651|NCT00112047|42153999|FG001|Randomized Phase|Noncompliance|4|||
19710652|NCT00112047|42153998|FG000|Randomized Phase|Protocol Violation|2|||
19395170|NCT02589665|41639442|FG000|Maintenance Period|Physician Decision|0|||
19395171|NCT02589665|41639443|FG001|Maintenance Period|Physician Decision|0|||
19395172|NCT02589665|41639444|FG002|Maintenance Period|Physician Decision|0|||
19395173|NCT02589665|41639445|FG003|Maintenance Period|Physician Decision|0|||
19395174|NCT02589665|41639446|FG004|Maintenance Period|Physician Decision|0|||
19395175|NCT02589665|41639447|FG005|Maintenance Period|Physician Decision|1|||
19395176|NCT02589665|41639448|FG006|Maintenance Period|Physician Decision|0|||
19395177|NCT02589665|41639449|FG007|Maintenance Period|Physician Decision|0|||
19395178|NCT02589665|41639450|FG008|Maintenance Period|Physician Decision|0|||
19627500|NCT00841100|42077064|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
19627501|NCT00651820|42077068|FG000|Overall Study|Lost to Follow-up|2|||
19710653|NCT00112047|42153999|FG001|Randomized Phase|Protocol Violation|0|||
19710654|NCT00112047|42153998|FG000|Randomized Phase|Pregnancy|3|||
19710655|NCT00112047|42153999|FG001|Randomized Phase|Pregnancy|1|||
19710656|NCT00112047|42153998|FG000|Randomized Phase|Death|1|||
19710657|NCT00112047|42153999|FG001|Randomized Phase|Death|3|||
19710658|NCT00112047|42153998|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
19710659|NCT00112047|42153999|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
19395179|NCT02589665|41639451|FG009|Maintenance Period|Physician Decision|0|||
19627502|NCT03307785|42077085|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
19627503|NCT03307785|42077086|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
19627504|NCT03307785|42077087|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
19627505|NCT03307785|42077088|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
19627506|NCT03307785|42077089|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
19627507|NCT03307785|42077090|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
19627508|NCT03307785|42077091|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
19627509|NCT03307785|42077092|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
19627510|NCT03307785|42077093|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
19627511|NCT03307785|42077094|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
19627512|NCT03307785|42077095|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
19627513|NCT03307785|42077085|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
19710660|NCT00112047|42153998|FG000|Randomized Phase|Inability to swallow pills|0|||
19710661|NCT00112047|42153999|FG001|Randomized Phase|Inability to swallow pills|1|||
19710662|NCT00112047|42153998|FG000|Randomized Phase|Incarceration|3|||
19710663|NCT00112047|42153999|FG001|Randomized Phase|Incarceration|2|||
19710664|NCT00112047|42153998|FG000|Randomized Phase|Moved out of State|0|||
19710665|NCT00112047|42153999|FG001|Randomized Phase|Moved out of State|1|||
19710666|NCT00112047|42153998|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
19710667|NCT00112047|42153999|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
19710668|NCT00112047|42153998|FG000|Randomized Phase|High Hepatitis B DNA|0|||
19710669|NCT00112047|42153999|FG001|Randomized Phase|High Hepatitis B DNA|1|||
19710670|NCT00112047|42153998|FG000|Atripla Phase|Adverse Event|2|||
19710671|NCT00112047|42153999|FG001|Atripla Phase|Adverse Event|1|||
19710672|NCT00112047|42153998|FG000|Atripla Phase|Lost to Follow-up|5|||
19710673|NCT00112047|42153999|FG001|Atripla Phase|Lost to Follow-up|7|||
19710674|NCT00112047|42153998|FG000|Atripla Phase|Pregnancy|0|||
19710675|NCT00112047|42153999|FG001|Atripla Phase|Pregnancy|1|||
19710676|NCT00112047|42153998|FG000|Atripla Phase|Death|0|||
19710677|NCT00112047|42153999|FG001|Atripla Phase|Death|2|||
19710678|NCT00112047|42153998|FG000|Atripla Phase|Withdrew consent|7|||
19710679|NCT00112047|42153999|FG001|Atripla Phase|Withdrew consent|7|||
19710680|NCT00112047|42153998|FG000|Atripla Phase|Sub-optimal virological response|0|||
19710681|NCT00112047|42153999|FG001|Atripla Phase|Sub-optimal virological response|1|||
19710682|NCT00112047|42153998|FG000|Atripla Phase|Non-compliance|1|||
19710683|NCT00112047|42153999|FG001|Atripla Phase|Non-compliance|0|||
19710684|NCT00112047|42153998|FG000|Atripla Phase|Other|3|||
19710685|NCT00112047|42153999|FG001|Atripla Phase|Other|1|||
19710686|NCT03658876|42154012|FG000|Overall Study|Protocol Violation|3|||
19710687|NCT03658876|42154013|FG001|Overall Study|Protocol Violation|2|||
19710688|NCT03658876|42154012|FG000|Overall Study|Withdrawal by Subject|2|||
19710689|NCT03658876|42154013|FG001|Overall Study|Withdrawal by Subject|0|||
19710690|NCT03658876|42154012|FG000|Overall Study|Death|0|||
19710691|NCT03658876|42154013|FG001|Overall Study|Death|1|||
19710692|NCT03658876|42154012|FG000|Overall Study|Intercurrent illness|6|||
19710693|NCT03658876|42154013|FG001|Overall Study|Intercurrent illness|4|||
19710694|NCT03658876|42154012|FG000|Overall Study|Transplantation/other operation|1|||
19710695|NCT03658876|42154013|FG001|Overall Study|Transplantation/other operation|5|||
19710696|NCT03618628|42154019|FG000|Overall Study|Death|1|||
19710697|NCT03618628|42154019|FG000|Overall Study|Lost to Follow-up|1|||
19710698|NCT03617770|42154025|FG000|Overall Study|Lost to Follow-up|1|||
19710699|NCT03617770|42154026|FG001|Overall Study|Lost to Follow-up|0|||
19710700|NCT03616600|42154034|FG000|Overall Study|Withdrawal by Subject|1|||
19710701|NCT03616600|42154035|FG001|Overall Study|Withdrawal by Subject|0|||
19710702|NCT00380393|42154044|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
19710703|NCT00380393|42154045|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
19710704|NCT00380393|42154044|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
19710705|NCT00380393|42154045|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
19710706|NCT00380393|42154044|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
19627514|NCT03307785|42077086|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
19627515|NCT03307785|42077087|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627516|NCT03307785|42077088|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627517|NCT03307785|42077089|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627518|NCT03307785|42077090|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627519|NCT03307785|42077091|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627520|NCT03307785|42077092|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19710707|NCT00380393|42154045|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
19710708|NCT00380393|42154044|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
19710709|NCT00380393|42154045|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
19710710|NCT00380393|42154044|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
19710711|NCT00380393|42154045|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
19710712|NCT00380393|42154044|FG000|Month 14|Withdrawal by Subject|9|||
19710713|NCT00380393|42154045|FG001|Month 14|Withdrawal by Subject|7|||
19710714|NCT00380393|42154044|FG000|Month 14|Death|1|||
19710715|NCT00380393|42154045|FG001|Month 14|Death|0|||
19710716|NCT00380393|42154044|FG000|Month 14|Lost to Follow-up|0|||
19710717|NCT00380393|42154045|FG001|Month 14|Lost to Follow-up|1|||
19710718|NCT00380393|42154044|FG000|Month 14|Migrated/moved from study area|39|||
19710719|NCT00380393|42154045|FG001|Month 14|Migrated/moved from study area|42|||
19710720|NCT00380393|42154044|FG000|Month 14|Protocol Violation|2|||
19710721|NCT00380393|42154045|FG001|Month 14|Protocol Violation|0|||
19710722|NCT00380393|42154044|FG000|Month 14|Others|6|||
19710723|NCT00380393|42154045|FG001|Month 14|Others|6|||
19710724|NCT00380081|42154057|FG000|Overall Study|Withdrawal by Subject|0|||
19710725|NCT00380081|42154058|FG001|Overall Study|Withdrawal by Subject|0|||
19710726|NCT00380081|42154059|FG002|Overall Study|Withdrawal by Subject|0|||
19710727|NCT00380081|42154060|FG003|Overall Study|Withdrawal by Subject|0|||
19627521|NCT03307785|42077093|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19710728|NCT00380081|42154061|FG004|Overall Study|Withdrawal by Subject|1|||
19710729|NCT00380081|42154062|FG005|Overall Study|Withdrawal by Subject|0|||
19710730|NCT00380081|42154057|FG000|Overall Study|Family Emergency|0|||
19710731|NCT00380081|42154058|FG001|Overall Study|Family Emergency|0|||
19710732|NCT00380081|42154059|FG002|Overall Study|Family Emergency|0|||
19710733|NCT00380081|42154060|FG003|Overall Study|Family Emergency|0|||
19710734|NCT00380081|42154061|FG004|Overall Study|Family Emergency|0|||
19710735|NCT00380081|42154062|FG005|Overall Study|Family Emergency|1|||
19710736|NCT03579940|42154081|FG000|Period 2|Withdrawal by Subject|0|||
19710737|NCT03579940|42154082|FG001|Period 2|Withdrawal by Subject|0|||
19710738|NCT03579940|42154083|FG002|Period 2|Withdrawal by Subject|1|||
19710739|NCT03579940|42154084|FG003|Period 2|Withdrawal by Subject|0|||
19710740|NCT03579940|42154085|FG004|Period 2|Withdrawal by Subject|0|||
19710741|NCT03579940|42154086|FG005|Period 2|Withdrawal by Subject|0|||
19710742|NCT03579940|42154087|FG006|Period 2|Withdrawal by Subject|0|||
19710743|NCT03579940|42154088|FG007|Period 2|Withdrawal by Subject|0|||
19710744|NCT03579940|42154089|FG008|Period 2|Withdrawal by Subject|0|||
19710745|NCT03579940|42154090|FG009|Period 2|Withdrawal by Subject|0|||
19710746|NCT03579940|42154091|FG010|Period 2|Withdrawal by Subject|0|||
19710747|NCT00098306|42154126|FG000|Double Blind|Randomized, not treated|9|||
19710748|NCT00098306|42154127|FG001|Double Blind|Randomized, not treated|5|||
19710749|NCT00098306|42154128|FG002|Double Blind|Randomized, not treated|2|||
19710750|NCT00098306|42154129|FG003|Double Blind|Randomized, not treated|0|||
19710751|NCT00098306|42154130|FG004|Double Blind|Randomized, not treated|0|||
19710752|NCT00098306|42154131|FG005|Double Blind|Randomized, not treated|0|||
19710753|NCT00098306|42154132|FG006|Double Blind|Randomized, not treated|0|||
19710754|NCT00098306|42154126|FG000|Double Blind|Ongoing at cut-off date|151|||
19710755|NCT00098306|42154127|FG001|Double Blind|Ongoing at cut-off date|166|||
19710756|NCT00098306|42154128|FG002|Double Blind|Ongoing at cut-off date|72|||
19710757|NCT00098306|42154129|FG003|Double Blind|Ongoing at cut-off date|0|||
19710758|NCT00098306|42154130|FG004|Double Blind|Ongoing at cut-off date|0|||
19710759|NCT00098306|42154131|FG005|Double Blind|Ongoing at cut-off date|0|||
19710760|NCT00098306|42154132|FG006|Double Blind|Ongoing at cut-off date|0|||
19710761|NCT00098306|42154126|FG000|Double Blind|Adverse Event|11|||
19710762|NCT00098306|42154127|FG001|Double Blind|Adverse Event|10|||
19710763|NCT00098306|42154128|FG002|Double Blind|Adverse Event|6|||
19710764|NCT00098306|42154129|FG003|Double Blind|Adverse Event|0|||
19710765|NCT00098306|42154130|FG004|Double Blind|Adverse Event|0|||
19710766|NCT00098306|42154131|FG005|Double Blind|Adverse Event|0|||
19395180|NCT02589665|41639442|FG000|Maintenance Period|Reason Not Collected|0|||
19395181|NCT02589665|41639443|FG001|Maintenance Period|Reason Not Collected|0|||
19395182|NCT02589665|41639444|FG002|Maintenance Period|Reason Not Collected|0|||
19395183|NCT02589665|41639445|FG003|Maintenance Period|Reason Not Collected|0|||
19395184|NCT02589665|41639446|FG004|Maintenance Period|Reason Not Collected|0|||
19395185|NCT02589665|41639447|FG005|Maintenance Period|Reason Not Collected|1|||
19395186|NCT02589665|41639448|FG006|Maintenance Period|Reason Not Collected|1|||
19395187|NCT02589665|41639449|FG007|Maintenance Period|Reason Not Collected|0|||
19395188|NCT02589665|41639450|FG008|Maintenance Period|Reason Not Collected|0|||
19395189|NCT02589665|41639451|FG009|Maintenance Period|Reason Not Collected|0|||
19395190|NCT02589665|41639442|FG000|Induction Extension Period|Adverse Event|0|||
19395191|NCT02589665|41639443|FG001|Induction Extension Period|Adverse Event|0|||
19627522|NCT03307785|42077094|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627523|NCT03307785|42077095|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
19627524|NCT03307785|42077085|FG000|Part A: Up to 28.5 Months|Death|4|||
19627525|NCT03307785|42077086|FG001|Part A: Up to 28.5 Months|Death|4|||
19627526|NCT03307785|42077087|FG002|Part A: Up to 28.5 Months|Death|0|||
19627527|NCT03307785|42077088|FG003|Part A: Up to 28.5 Months|Death|0|||
19627528|NCT03307785|42077089|FG004|Part A: Up to 28.5 Months|Death|0|||
19627529|NCT03307785|42077090|FG005|Part A: Up to 28.5 Months|Death|0|||
19395192|NCT02589665|41639444|FG002|Induction Extension Period|Adverse Event|0|||
19395193|NCT02589665|41639445|FG003|Induction Extension Period|Adverse Event|0|||
19395194|NCT02589665|41639446|FG004|Induction Extension Period|Adverse Event|0|||
19395195|NCT02589665|41639447|FG005|Induction Extension Period|Adverse Event|0|||
19395196|NCT02589665|41639448|FG006|Induction Extension Period|Adverse Event|0|||
19395197|NCT02589665|41639449|FG007|Induction Extension Period|Adverse Event|0|||
19395198|NCT02589665|41639450|FG008|Induction Extension Period|Adverse Event|4|||
19395199|NCT02589665|41639451|FG009|Induction Extension Period|Adverse Event|0|||
19627530|NCT03307785|42077091|FG006|Part A: Up to 28.5 Months|Death|0|||
19627531|NCT03307785|42077092|FG007|Part A: Up to 28.5 Months|Death|0|||
19710767|NCT00098306|42154132|FG006|Double Blind|Adverse Event|0|||
19710768|NCT00098306|42154126|FG000|Double Blind|Lack of Efficacy|43|||
19710769|NCT00098306|42154127|FG001|Double Blind|Lack of Efficacy|34|||
19710770|NCT00098306|42154128|FG002|Double Blind|Lack of Efficacy|17|||
19710771|NCT00098306|42154129|FG003|Double Blind|Lack of Efficacy|0|||
19710772|NCT00098306|42154130|FG004|Double Blind|Lack of Efficacy|0|||
19710773|NCT00098306|42154131|FG005|Double Blind|Lack of Efficacy|0|||
19710774|NCT00098306|42154132|FG006|Double Blind|Lack of Efficacy|0|||
19710775|NCT00098306|42154126|FG000|Double Blind|Death|1|||
19710776|NCT00098306|42154127|FG001|Double Blind|Death|4|||
19710777|NCT00098306|42154128|FG002|Double Blind|Death|1|||
19627532|NCT03307785|42077093|FG008|Part A: Up to 28.5 Months|Death|0|||
19395200|NCT02589665|41639442|FG000|Induction Extension Period|Lack of Efficacy|0|||
19395201|NCT02589665|41639443|FG001|Induction Extension Period|Lack of Efficacy|0|||
19395202|NCT02589665|41639444|FG002|Induction Extension Period|Lack of Efficacy|0|||
19395203|NCT02589665|41639445|FG003|Induction Extension Period|Lack of Efficacy|0|||
19395204|NCT02589665|41639446|FG004|Induction Extension Period|Lack of Efficacy|0|||
19395205|NCT02589665|41639447|FG005|Induction Extension Period|Lack of Efficacy|0|||
19395206|NCT02589665|41639448|FG006|Induction Extension Period|Lack of Efficacy|0|||
19395207|NCT02589665|41639449|FG007|Induction Extension Period|Lack of Efficacy|0|||
19395208|NCT02589665|41639450|FG008|Induction Extension Period|Lack of Efficacy|3|||
19395209|NCT02589665|41639451|FG009|Induction Extension Period|Lack of Efficacy|0|||
19395210|NCT02589665|41639442|FG000|Induction Extension Period|Withdrawal by Subject|0|||
19395211|NCT02589665|41639443|FG001|Induction Extension Period|Withdrawal by Subject|0|||
19395212|NCT02589665|41639444|FG002|Induction Extension Period|Withdrawal by Subject|0|||
19395213|NCT02589665|41639445|FG003|Induction Extension Period|Withdrawal by Subject|0|||
19395214|NCT02589665|41639446|FG004|Induction Extension Period|Withdrawal by Subject|0|||
19395215|NCT02589665|41639447|FG005|Induction Extension Period|Withdrawal by Subject|0|||
19395216|NCT02589665|41639448|FG006|Induction Extension Period|Withdrawal by Subject|0|||
19395217|NCT02589665|41639449|FG007|Induction Extension Period|Withdrawal by Subject|2|||
19395218|NCT02589665|41639450|FG008|Induction Extension Period|Withdrawal by Subject|3|||
19395219|NCT02589665|41639451|FG009|Induction Extension Period|Withdrawal by Subject|0|||
19395220|NCT02589665|41639442|FG000|Induction Extension Period|Physician Decision|0|||
19395221|NCT02589665|41639443|FG001|Induction Extension Period|Physician Decision|0|||
19395222|NCT02589665|41639444|FG002|Induction Extension Period|Physician Decision|0|||
19395223|NCT02589665|41639445|FG003|Induction Extension Period|Physician Decision|0|||
19395224|NCT02589665|41639446|FG004|Induction Extension Period|Physician Decision|0|||
19395225|NCT02589665|41639447|FG005|Induction Extension Period|Physician Decision|0|||
19395226|NCT02589665|41639448|FG006|Induction Extension Period|Physician Decision|0|||
19395227|NCT02589665|41639449|FG007|Induction Extension Period|Physician Decision|0|||
19395228|NCT02589665|41639450|FG008|Induction Extension Period|Physician Decision|1|||
19395229|NCT02589665|41639451|FG009|Induction Extension Period|Physician Decision|0|||
19395230|NCT02589665|41639442|FG000|Induction Extension Period|Reason Not Collected|0|||
19395231|NCT02589665|41639443|FG001|Induction Extension Period|Reason Not Collected|0|||
19395232|NCT02589665|41639444|FG002|Induction Extension Period|Reason Not Collected|0|||
19395233|NCT02589665|41639445|FG003|Induction Extension Period|Reason Not Collected|0|||
19395234|NCT02589665|41639446|FG004|Induction Extension Period|Reason Not Collected|0|||
19395235|NCT02589665|41639447|FG005|Induction Extension Period|Reason Not Collected|0|||
19395236|NCT02589665|41639448|FG006|Induction Extension Period|Reason Not Collected|0|||
19395237|NCT02589665|41639449|FG007|Induction Extension Period|Reason Not Collected|0|||
19395238|NCT02589665|41639450|FG008|Induction Extension Period|Reason Not Collected|1|||
19395239|NCT02589665|41639451|FG009|Induction Extension Period|Reason Not Collected|0|||
19395240|NCT02589665|41639442|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395241|NCT02589665|41639443|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395242|NCT02589665|41639444|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19627533|NCT03307785|42077094|FG009|Part A: Up to 28.5 Months|Death|0|||
19627534|NCT03307785|42077095|FG010|Part A: Up to 28.5 Months|Death|0|||
19627535|NCT03307785|42077085|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
19627536|NCT03307785|42077086|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
19627537|NCT03307785|42077087|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
19627538|NCT03307785|42077088|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
19627539|NCT03307785|42077089|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
19627540|NCT03307785|42077090|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
19627541|NCT03307785|42077091|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
19627542|NCT03307785|42077092|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
19627543|NCT03307785|42077093|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
19627544|NCT03307785|42077094|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
19627545|NCT03307785|42077095|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
19627546|NCT03307785|42077085|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
19710778|NCT00098306|42154129|FG003|Double Blind|Death|0|||
19374050|NCT02890355|41615474|FG000|Overall Study|Adverse Event|5|||
19374051|NCT02890355|41615475|FG001|Overall Study|Adverse Event|5|||
19374052|NCT02890355|41615474|FG000|Overall Study|Refusal unrelated to adverse event|5|||
19374053|NCT02890355|41615475|FG001|Overall Study|Refusal unrelated to adverse event|10|||
19374054|NCT02890355|41615474|FG000|Overall Study|Progression/relapse|46|||
19374055|NCT02890355|41615475|FG001|Overall Study|Progression/relapse|39|||
19374056|NCT02890355|41615474|FG000|Overall Study|Not protocol specified|3|||
19374057|NCT02890355|41615475|FG001|Overall Study|Not protocol specified|4|||
19374058|NCT02841280|41615485|FG000|Overall Study|Adverse Event|2|||
19374059|NCT02841280|41615486|FG001|Overall Study|Adverse Event|1|||
19374060|NCT02841280|41615485|FG000|Overall Study|Death|1|||
19710779|NCT00098306|42154130|FG004|Double Blind|Death|0|||
19710780|NCT00098306|42154131|FG005|Double Blind|Death|0|||
19710781|NCT00098306|42154132|FG006|Double Blind|Death|0|||
19710782|NCT00098306|42154126|FG000|Double Blind|Participant defaulted|19|||
19710783|NCT00098306|42154127|FG001|Double Blind|Participant defaulted|18|||
19710784|NCT00098306|42154128|FG002|Double Blind|Participant defaulted|11|||
19710785|NCT00098306|42154129|FG003|Double Blind|Participant defaulted|0|||
19710786|NCT00098306|42154130|FG004|Double Blind|Participant defaulted|0|||
19710787|NCT00098306|42154131|FG005|Double Blind|Participant defaulted|0|||
19710788|NCT00098306|42154132|FG006|Double Blind|Participant defaulted|0|||
19710789|NCT00098306|42154126|FG000|Double Blind|Un-specified|7|||
19710790|NCT00098306|42154127|FG001|Double Blind|Un-specified|3|||
19710791|NCT00098306|42154128|FG002|Double Blind|Un-specified|11|||
19710792|NCT00098306|42154129|FG003|Double Blind|Un-specified|0|||
19710793|NCT00098306|42154130|FG004|Double Blind|Un-specified|0|||
19710794|NCT00098306|42154131|FG005|Double Blind|Un-specified|0|||
19710795|NCT00098306|42154132|FG006|Double Blind|Un-specified|0|||
19710796|NCT00098306|42154126|FG000|Open Label|Lack of Efficacy|0|||
19710797|NCT00098306|42154127|FG001|Open Label|Lack of Efficacy|0|||
19710798|NCT00098306|42154128|FG002|Open Label|Lack of Efficacy|0|||
19710799|NCT00098306|42154129|FG003|Open Label|Lack of Efficacy|13|||
19710800|NCT00098306|42154130|FG004|Open Label|Lack of Efficacy|0|||
19710801|NCT00098306|42154131|FG005|Open Label|Lack of Efficacy|0|||
19710802|NCT00098306|42154132|FG006|Open Label|Lack of Efficacy|0|||
19710803|NCT00098306|42154126|FG000|Open Label|Adverse Event|0|||
19710804|NCT00098306|42154127|FG001|Open Label|Adverse Event|0|||
19710805|NCT00098306|42154128|FG002|Open Label|Adverse Event|0|||
19710806|NCT00098306|42154129|FG003|Open Label|Adverse Event|2|||
19710807|NCT00098306|42154130|FG004|Open Label|Adverse Event|0|||
19710808|NCT00098306|42154131|FG005|Open Label|Adverse Event|0|||
19710809|NCT00098306|42154132|FG006|Open Label|Adverse Event|0|||
19710810|NCT00098306|42154126|FG000|Open Label|Death|0|||
19710811|NCT00098306|42154127|FG001|Open Label|Death|0|||
19710812|NCT00098306|42154128|FG002|Open Label|Death|0|||
19710813|NCT00098306|42154129|FG003|Open Label|Death|4|||
19710814|NCT00098306|42154130|FG004|Open Label|Death|0|||
19710815|NCT00098306|42154131|FG005|Open Label|Death|0|||
19710816|NCT00098306|42154132|FG006|Open Label|Death|0|||
19710817|NCT00098306|42154126|FG000|Open Label|Participant defaulted|0|||
19710818|NCT00098306|42154127|FG001|Open Label|Participant defaulted|0|||
19710819|NCT00098306|42154128|FG002|Open Label|Participant defaulted|0|||
19710820|NCT00098306|42154129|FG003|Open Label|Participant defaulted|24|||
19710821|NCT00098306|42154130|FG004|Open Label|Participant defaulted|0|||
19710822|NCT00098306|42154131|FG005|Open Label|Participant defaulted|0|||
19710823|NCT00098306|42154132|FG006|Open Label|Participant defaulted|0|||
19710824|NCT00098306|42154126|FG000|Open Label|Un-specified|0|||
19710825|NCT00098306|42154127|FG001|Open Label|Un-specified|0|||
19710826|NCT00098306|42154128|FG002|Open Label|Un-specified|0|||
19374061|NCT02841280|41615486|FG001|Overall Study|Death|0|||
19710827|NCT00098306|42154129|FG003|Open Label|Un-specified|15|||
19710828|NCT00098306|42154130|FG004|Open Label|Un-specified|0|||
19710829|NCT00098306|42154131|FG005|Open Label|Un-specified|0|||
19710830|NCT00098306|42154132|FG006|Open Label|Un-specified|0|||
19710831|NCT00098306|42154126|FG000|Open Label|Ongoing at cut-off date|0|||
19710832|NCT00098306|42154127|FG001|Open Label|Ongoing at cut-off date|0|||
19710833|NCT00098306|42154128|FG002|Open Label|Ongoing at cut-off date|0|||
19710834|NCT00098306|42154129|FG003|Open Label|Ongoing at cut-off date|269|||
19710835|NCT00098306|42154130|FG004|Open Label|Ongoing at cut-off date|62|||
19710836|NCT00098306|42154131|FG005|Open Label|Ongoing at cut-off date|0|||
19710837|NCT00098306|42154132|FG006|Open Label|Ongoing at cut-off date|0|||
19710838|NCT00098306|42154126|FG000|Observational Phase|Death|0|||
19710839|NCT00098306|42154127|FG001|Observational Phase|Death|0|||
19710840|NCT00098306|42154128|FG002|Observational Phase|Death|0|||
19710841|NCT00098306|42154129|FG003|Observational Phase|Death|0|||
19710842|NCT00098306|42154130|FG004|Observational Phase|Death|0|||
19710843|NCT00098306|42154131|FG005|Observational Phase|Death|5|||
19710844|NCT00098306|42154132|FG006|Observational Phase|Death|4|||
19710845|NCT00098306|42154126|FG000|Observational Phase|Participant defaulted|0|||
19710846|NCT00098306|42154127|FG001|Observational Phase|Participant defaulted|0|||
19710847|NCT00098306|42154128|FG002|Observational Phase|Participant defaulted|0|||
19710848|NCT00098306|42154129|FG003|Observational Phase|Participant defaulted|0|||
19710849|NCT00098306|42154130|FG004|Observational Phase|Participant defaulted|0|||
19710850|NCT00098306|42154131|FG005|Observational Phase|Participant defaulted|34|||
19710851|NCT00098306|42154132|FG006|Observational Phase|Participant defaulted|18|||
19710852|NCT00098306|42154126|FG000|Observational Phase|Un-specified|0|||
19710853|NCT00098306|42154127|FG001|Observational Phase|Un-specified|0|||
19710854|NCT00098306|42154128|FG002|Observational Phase|Un-specified|0|||
19374062|NCT02841280|41615485|FG000|Overall Study|Lost to Follow-up|2|||
19374063|NCT02841280|41615486|FG001|Overall Study|Lost to Follow-up|2|||
19374064|NCT02841280|41615485|FG000|Overall Study|Withdrawal by Subject|7|||
19374065|NCT02841280|41615486|FG001|Overall Study|Withdrawal by Subject|3|||
19395243|NCT02589665|41639445|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395244|NCT02589665|41639446|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395245|NCT02589665|41639447|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395246|NCT02589665|41639448|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395247|NCT02589665|41639449|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395248|NCT02589665|41639450|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
19395249|NCT02589665|41639451|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
19395250|NCT02589665|41639442|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
19395251|NCT02589665|41639443|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
19395252|NCT02589665|41639444|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
19395253|NCT02589665|41639445|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
19395254|NCT02589665|41639446|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
19395255|NCT02589665|41639447|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
19395256|NCT02589665|41639448|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
19395257|NCT02589665|41639449|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
19395258|NCT02589665|41639450|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
19395259|NCT02589665|41639451|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
19395260|NCT02589665|41639442|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
19395261|NCT02589665|41639443|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
19395262|NCT02589665|41639444|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
19395263|NCT02589665|41639445|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
19395264|NCT02589665|41639446|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
19395265|NCT02589665|41639447|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
19395266|NCT02589665|41639448|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
19395267|NCT02589665|41639449|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
19395268|NCT02589665|41639450|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
19395269|NCT02589665|41639451|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
19395270|NCT02589665|41639442|FG000|Maintenance Extension Period|Adverse Event|0|||
19395271|NCT02589665|41639443|FG001|Maintenance Extension Period|Adverse Event|0|||
19395272|NCT02589665|41639444|FG002|Maintenance Extension Period|Adverse Event|0|||
19395273|NCT02589665|41639445|FG003|Maintenance Extension Period|Adverse Event|0|||
19395274|NCT02589665|41639446|FG004|Maintenance Extension Period|Adverse Event|0|||
19395275|NCT02589665|41639447|FG005|Maintenance Extension Period|Adverse Event|0|||
19395276|NCT02589665|41639448|FG006|Maintenance Extension Period|Adverse Event|0|||
19395277|NCT02589665|41639449|FG007|Maintenance Extension Period|Adverse Event|0|||
19395278|NCT02589665|41639450|FG008|Maintenance Extension Period|Adverse Event|0|||
19395279|NCT02589665|41639451|FG009|Maintenance Extension Period|Adverse Event|2|||
19395280|NCT02589665|41639442|FG000|Maintenance Extension Period|Non-responder|0|||
19395281|NCT02589665|41639443|FG001|Maintenance Extension Period|Non-responder|0|||
19627547|NCT03307785|42077086|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
19627548|NCT03307785|42077087|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
19627549|NCT03307785|42077088|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
19627550|NCT03307785|42077089|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
19627551|NCT03307785|42077090|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
19627552|NCT03307785|42077091|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
19374066|NCT02841280|41615485|FG000|Overall Study|Stop Point: BP above threshold|2|||
19374067|NCT02841280|41615486|FG001|Overall Study|Stop Point: BP above threshold|0|||
19374068|NCT02455557|41615509|FG000|Overall Study|Withdrawal by Subject|2|||
19374069|NCT02270450|41615517|FG000|Overall Study|Refusal unrelated to adverse event|3|||
19374070|NCT02270450|41615518|FG001|Overall Study|Refusal unrelated to adverse event|1|||
19374071|NCT02270450|41615519|FG002|Overall Study|Refusal unrelated to adverse event|5|||
19374072|NCT02270450|41615520|FG003|Overall Study|Refusal unrelated to adverse event|14|||
19374073|NCT02270450|41615517|FG000|Overall Study|Progression/relapse|1|||
19374074|NCT02270450|41615518|FG001|Overall Study|Progression/relapse|2|||
19374075|NCT02270450|41615519|FG002|Overall Study|Progression/relapse|4|||
19374076|NCT02270450|41615520|FG003|Overall Study|Progression/relapse|9|||
19374077|NCT02270450|41615517|FG000|Overall Study|Death|19|||
19374078|NCT02270450|41615518|FG001|Overall Study|Death|19|||
19374079|NCT02270450|41615519|FG002|Overall Study|Death|31|||
19374080|NCT02270450|41615520|FG003|Overall Study|Death|59|||
19374081|NCT01570868|41615543|FG000|Overall Study|Adverse Event|8|||
19374082|NCT01570868|41615544|FG001|Overall Study|Adverse Event|1|||
19374083|NCT01570868|41615543|FG000|Overall Study|FDA Recommendation|23|||
19395282|NCT02589665|41639444|FG002|Maintenance Extension Period|Non-responder|0|||
19395283|NCT02589665|41639445|FG003|Maintenance Extension Period|Non-responder|0|||
19395284|NCT02589665|41639446|FG004|Maintenance Extension Period|Non-responder|0|||
19395285|NCT02589665|41639447|FG005|Maintenance Extension Period|Non-responder|0|||
19395286|NCT02589665|41639448|FG006|Maintenance Extension Period|Non-responder|0|||
19395287|NCT02589665|41639449|FG007|Maintenance Extension Period|Non-responder|0|||
19395288|NCT02589665|41639450|FG008|Maintenance Extension Period|Non-responder|0|||
19395289|NCT02589665|41639451|FG009|Maintenance Extension Period|Non-responder|1|||
19395290|NCT01905397|41639477|FG000|Overall Study|Death|0|||
19395291|NCT01905397|41639478|FG001|Overall Study|Death|1|||
19395292|NCT01905397|41639477|FG000|Overall Study|Withdrawal by Subject|2|||
19395293|NCT01905397|41639478|FG001|Overall Study|Withdrawal by Subject|0|||
19517838|NCT01526928|41930802|FG005|Overall Study|Lost to Follow-up|0|||
19517839|NCT01526928|41930797|FG000|Overall Study|Protocol Deviation|0|||
19627553|NCT03307785|42077092|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
19395294|NCT01905397|41639477|FG000|Overall Study|Surgery canceled/aborted|9|||
19395295|NCT01905397|41639478|FG001|Overall Study|Surgery canceled/aborted|5|||
19395296|NCT01905397|41639477|FG000|Overall Study|Incision < 7 cm|2|||
19395297|NCT01905397|41639478|FG001|Overall Study|Incision < 7 cm|0|||
19395298|NCT01905397|41639477|FG000|Overall Study|Wrong treatment|1|||
19395299|NCT01905397|41639478|FG001|Overall Study|Wrong treatment|1|||
19395300|NCT01905397|41639477|FG000|Overall Study|Device not applied|3|||
19395301|NCT01905397|41639478|FG001|Overall Study|Device not applied|0|||
19395302|NCT01905397|41639477|FG000|Overall Study|Dressing not applied in operating room|1|||
19395303|NCT01905397|41639478|FG001|Overall Study|Dressing not applied in operating room|0|||
19395304|NCT01905397|41639477|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
19395305|NCT01905397|41639478|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
19395306|NCT01362595|41639484|FG000|Overall Study|Screen failure|10|||
19395307|NCT01362595|41639484|FG000|Overall Study|Withdrawal by Subject|2|||
19395308|NCT02519595|41639491|FG000|Overall Study|Protocol Violation|8|||
19395309|NCT02519595|41639492|FG001|Overall Study|Protocol Violation|22|||
19395310|NCT02519595|41639493|FG002|Overall Study|Protocol Violation|16|||
19395311|NCT00660673|41639505|FG000|Overall Study|Adverse Event|84|||
19395312|NCT00660673|41639505|FG000|Overall Study|Lack of Efficacy|7|||
19395313|NCT00660673|41639505|FG000|Overall Study|Withdrawal by Subject|22|||
19395314|NCT00660673|41639505|FG000|Overall Study|Administrative|2|||
19627554|NCT03307785|42077093|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
19627555|NCT03307785|42077094|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
19627556|NCT03307785|42077095|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
19627557|NCT03307785|42077085|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
19627558|NCT03307785|42077086|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
19395315|NCT00660673|41639505|FG000|Overall Study|Protocol Violation|2|||
19627559|NCT03307785|42077087|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
19627560|NCT03307785|42077088|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
19627561|NCT03307785|42077089|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
19627562|NCT03307785|42077090|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
19517840|NCT01526928|41930798|FG001|Overall Study|Protocol Deviation|0|||
19710855|NCT00098306|42154129|FG003|Observational Phase|Un-specified|0|||
19710856|NCT00098306|42154130|FG004|Observational Phase|Un-specified|0|||
19710857|NCT00098306|42154131|FG005|Observational Phase|Un-specified|7|||
19710858|NCT00098306|42154132|FG006|Observational Phase|Un-specified|4|||
19710859|NCT03615040|42154147|FG000|Overall Study|Withdrawal by Subject|2|||
19710860|NCT03615040|42154148|FG001|Overall Study|Withdrawal by Subject|1|||
19710861|NCT03615040|42154147|FG000|Overall Study|Physician Decision|2|||
19710862|NCT03615040|42154148|FG001|Overall Study|Physician Decision|2|||
19374084|NCT01570868|41615544|FG001|Overall Study|FDA Recommendation|3|||
19374085|NCT01570868|41615543|FG000|Overall Study|Physician Decision|10|||
19374086|NCT01570868|41615544|FG001|Overall Study|Physician Decision|4|||
19374087|NCT01570868|41615543|FG000|Overall Study|Lost to Follow-up|1|||
19374088|NCT01570868|41615544|FG001|Overall Study|Lost to Follow-up|0|||
19374089|NCT01570868|41615543|FG000|Overall Study|Withdrawal by Subject|1|||
19374090|NCT01570868|41615544|FG001|Overall Study|Withdrawal by Subject|0|||
19374091|NCT01565499|41615554|FG000|Overall Study|Physician Decision|1|||
19374092|NCT01565499|41615554|FG000|Overall Study|Adverse Event|5|||
19374093|NCT01565499|41615554|FG000|Overall Study|Withdrawal by Subject|2|||
19374094|NCT01306942|41615561|FG000|Phase I|Adverse Event|2|||
19374095|NCT01306942|41615562|FG001|Phase I|Adverse Event|2|||
19374096|NCT01306942|41615563|FG002|Phase I|Adverse Event|0|||
19374097|NCT01306942|41615564|FG003|Phase I|Adverse Event|0|||
19374098|NCT01306942|41615561|FG000|Phase I|Physician Decision|3|||
19374099|NCT01306942|41615562|FG001|Phase I|Physician Decision|1|||
19374100|NCT01306942|41615563|FG002|Phase I|Physician Decision|0|||
19374101|NCT01306942|41615564|FG003|Phase I|Physician Decision|0|||
19374102|NCT01306942|41615561|FG000|Phase II|Adverse Event|0|||
19374103|NCT01306942|41615562|FG001|Phase II|Adverse Event|0|||
19374104|NCT01306942|41615563|FG002|Phase II|Adverse Event|0|||
19374105|NCT01306942|41615564|FG003|Phase II|Adverse Event|6|||
19374106|NCT01306942|41615561|FG000|Phase II|Physician Decision|2|||
19374107|NCT01306942|41615562|FG001|Phase II|Physician Decision|0|||
19374108|NCT01306942|41615563|FG002|Phase II|Physician Decision|0|||
19374109|NCT01306942|41615564|FG003|Phase II|Physician Decision|5|||
19374110|NCT01306942|41615561|FG000|Phase II|Withdrawal by Subject|0|||
19374111|NCT01306942|41615562|FG001|Phase II|Withdrawal by Subject|0|||
19374112|NCT01306942|41615563|FG002|Phase II|Withdrawal by Subject|0|||
19374113|NCT01306942|41615564|FG003|Phase II|Withdrawal by Subject|2|||
19374114|NCT01306942|41615561|FG000|Phase II|Death|0|||
19374115|NCT01306942|41615562|FG001|Phase II|Death|0|||
19374116|NCT01306942|41615563|FG002|Phase II|Death|0|||
19374117|NCT01306942|41615564|FG003|Phase II|Death|1|||
19374118|NCT01306942|41615561|FG000|Phase II|Not finished treatment|0|||
19374119|NCT01306942|41615562|FG001|Phase II|Not finished treatment|0|||
19374120|NCT01306942|41615563|FG002|Phase II|Not finished treatment|0|||
19374121|NCT01306942|41615564|FG003|Phase II|Not finished treatment|1|||
19374122|NCT01306942|41615561|FG000|Phase II|Protocol Violation|0|||
19374123|NCT01306942|41615562|FG001|Phase II|Protocol Violation|0|||
19374124|NCT01306942|41615563|FG002|Phase II|Protocol Violation|0|||
19374125|NCT01306942|41615564|FG003|Phase II|Protocol Violation|1|||
19374126|NCT01036087|41615576|FG000|Overall Study|Adverse Event|2|||
19374127|NCT01036087|41615576|FG000|Overall Study|Lack of Efficacy|1|||
19374128|NCT00572156|41615593|FG000|Overall Study|Adverse Event|3|||
19374129|NCT00572156|41615594|FG001|Overall Study|Adverse Event|1|||
19374130|NCT00572156|41615595|FG002|Overall Study|Adverse Event|5|||
19374131|NCT00572156|41615596|FG003|Overall Study|Adverse Event|1|||
19374132|NCT00572156|41615593|FG000|Overall Study|Lost to Follow-up|1|||
19374133|NCT00572156|41615594|FG001|Overall Study|Lost to Follow-up|1|||
19374134|NCT00572156|41615595|FG002|Overall Study|Lost to Follow-up|1|||
19374135|NCT00572156|41615596|FG003|Overall Study|Lost to Follow-up|0|||
19374136|NCT00572156|41615593|FG000|Overall Study|Protocol Violation|1|||
19374137|NCT00572156|41615594|FG001|Overall Study|Protocol Violation|2|||
19374138|NCT00572156|41615595|FG002|Overall Study|Protocol Violation|0|||
19374139|NCT00572156|41615596|FG003|Overall Study|Protocol Violation|2|||
19374140|NCT00572156|41615593|FG000|Overall Study|Patient/Parent Decision|1|||
19710863|NCT03615040|42154147|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
19710864|NCT03615040|42154148|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
19374141|NCT00572156|41615594|FG001|Overall Study|Patient/Parent Decision|6|||
19374142|NCT00572156|41615595|FG002|Overall Study|Patient/Parent Decision|4|||
19374143|NCT00572156|41615596|FG003|Overall Study|Patient/Parent Decision|3|||
19374144|NCT00572156|41615593|FG000|Overall Study|Sponsor Decision|20|||
19374145|NCT00572156|41615594|FG001|Overall Study|Sponsor Decision|16|||
19374146|NCT00572156|41615595|FG002|Overall Study|Sponsor Decision|17|||
19374147|NCT00572156|41615596|FG003|Overall Study|Sponsor Decision|19|||
19374148|NCT00447772|41615606|FG000|Overall Study|Lack of Efficacy|3|||
19374149|NCT00447772|41615606|FG000|Overall Study|Insufficient compliance|6|||
19374150|NCT00447772|41615606|FG000|Overall Study|Discontinuation of drug therapy|1|||
19374151|NCT00447772|41615606|FG000|Overall Study|Lost to Follow-up|9|||
19374152|NCT00447772|41615606|FG000|Overall Study|Withdrawal by Subject|1|||
19374153|NCT00447772|41615606|FG000|Overall Study|Unable to attend all study visits|2|||
19374154|NCT00447772|41615606|FG000|Overall Study|Adverse Event|1|||
19395316|NCT02630563|41639520|FG000|Overall Study|Administrative|1|||
19395317|NCT02588339|41639534|FG000|Overall Study|Withdrawal by Subject|1|||
19395318|NCT02588339|41639534|FG000|Overall Study|GVHD Progression prior to treatment|2|||
19395319|NCT02629159|41639541|FG000|Overall Study|Adverse Event|17|||
19395320|NCT02629159|41639542|FG001|Overall Study|Adverse Event|20|||
19395321|NCT02629159|41639543|FG002|Overall Study|Adverse Event|22|||
19395322|NCT02629159|41639541|FG000|Overall Study|Withdrawal by Subject|22|||
19395323|NCT02629159|41639542|FG001|Overall Study|Withdrawal by Subject|11|||
19395324|NCT02629159|41639543|FG002|Overall Study|Withdrawal by Subject|15|||
19395325|NCT02629159|41639541|FG000|Overall Study|Lost to Follow-up|7|||
19395326|NCT02629159|41639542|FG001|Overall Study|Lost to Follow-up|4|||
19395327|NCT02629159|41639543|FG002|Overall Study|Lost to Follow-up|5|||
19395328|NCT02629159|41639541|FG000|Overall Study|Lack of Efficacy|4|||
19395329|NCT02629159|41639542|FG001|Overall Study|Lack of Efficacy|0|||
19395330|NCT02629159|41639543|FG002|Overall Study|Lack of Efficacy|1|||
19395331|NCT02629159|41639541|FG000|Overall Study|Other|6|||
19395332|NCT02629159|41639542|FG001|Overall Study|Other|4|||
19395333|NCT02629159|41639543|FG002|Overall Study|Other|8|||
19395334|NCT02628769|41639554|FG000|First Intervention|Adverse Event|1|||
19395335|NCT02628769|41639555|FG001|First Intervention|Adverse Event|0|||
19395336|NCT02628769|41639554|FG000|First Intervention|Withdrawal by Subject|0|||
19395337|NCT02628769|41639555|FG001|First Intervention|Withdrawal by Subject|1|||
19395338|NCT02628769|41639554|FG000|Second Intervention|Adverse Event|2|||
19395339|NCT02628769|41639555|FG001|Second Intervention|Adverse Event|0|||
19395340|NCT02628769|41639554|FG000|Second Intervention|Physician Decision|0|||
19395341|NCT02628769|41639555|FG001|Second Intervention|Physician Decision|1|||
19395342|NCT02626819|41639563|FG000|Overall Study|Lost to Follow-up|3|||
19395343|NCT02626819|41639564|FG001|Overall Study|Lost to Follow-up|2|||
19395344|NCT02626819|41639563|FG000|Overall Study|Withdrawal by Subject|1|||
19395345|NCT02626819|41639564|FG001|Overall Study|Withdrawal by Subject|0|||
19374155|NCT00447772|41615606|FG000|Overall Study|Patient relocated|1|||
19374156|NCT00447772|41615606|FG000|Overall Study|Incomplete documentation at visit 1|1|||
19374157|NCT00447772|41615606|FG000|Overall Study|Chemotherapy for lung cancer|1|||
19374158|NCT00447772|41615606|FG000|Overall Study|Premature re-injection required|1|||
19374159|NCT02296138|41615615|FG000|Overall Study|Adverse Event|348|||
19374160|NCT02296138|41615616|FG001|Overall Study|Adverse Event|259|||
19395346|NCT02626819|41639563|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
19395347|NCT02626819|41639564|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
19395348|NCT02630251|41639574|FG000|Overall Study|Physician Decision|0|||
19395349|NCT02630251|41639575|FG001|Overall Study|Physician Decision|0|||
19395350|NCT02630251|41639576|FG002|Overall Study|Physician Decision|1|||
19395351|NCT02630251|41639577|FG003|Overall Study|Physician Decision|0|||
19395352|NCT02518113|41639591|FG000|Overall Study|Adverse Event|1|||
19395353|NCT02518113|41639592|FG001|Overall Study|Adverse Event|0|||
19395354|NCT02518113|41639593|FG002|Overall Study|Adverse Event|1|||
19395355|NCT02518113|41639594|FG003|Overall Study|Adverse Event|0|||
19395356|NCT02518113|41639591|FG000|Overall Study|Death|1|||
19395357|NCT02518113|41639592|FG001|Overall Study|Death|2|||
19395358|NCT02518113|41639593|FG002|Overall Study|Death|0|||
19395359|NCT02518113|41639594|FG003|Overall Study|Death|0|||
19395360|NCT02518113|41639591|FG000|Overall Study|Physician Decision|0|||
19395361|NCT02518113|41639592|FG001|Overall Study|Physician Decision|1|||
19395362|NCT02518113|41639593|FG002|Overall Study|Physician Decision|0|||
19395363|NCT02518113|41639594|FG003|Overall Study|Physician Decision|0|||
19395364|NCT02518113|41639591|FG000|Overall Study|Progressive Disease|1|||
19395365|NCT02518113|41639592|FG001|Overall Study|Progressive Disease|2|||
19395366|NCT02518113|41639593|FG002|Overall Study|Progressive Disease|3|||
19395367|NCT02518113|41639594|FG003|Overall Study|Progressive Disease|0|||
19395368|NCT02629861|41639610|FG000|Overall Study|Adverse Event|7|||
19395369|NCT02629861|41639611|FG001|Overall Study|Adverse Event|5|||
19395370|NCT02629861|41639612|FG002|Overall Study|Adverse Event|4|||
19395371|NCT02629861|41639610|FG000|Overall Study|Withdrawal by Subject|5|||
19395372|NCT02629861|41639611|FG001|Overall Study|Withdrawal by Subject|8|||
19395373|NCT02629861|41639612|FG002|Overall Study|Withdrawal by Subject|13|||
19395374|NCT02629861|41639610|FG000|Overall Study|Protocol Violation|2|||
19395375|NCT02629861|41639611|FG001|Overall Study|Protocol Violation|3|||
19374161|NCT02296138|41615615|FG000|Overall Study|Lack of Efficacy|59|||
19374162|NCT02296138|41615616|FG001|Overall Study|Lack of Efficacy|37|||
19374163|NCT02296138|41615615|FG000|Overall Study|Protocol Violation|35|||
19395376|NCT02629861|41639612|FG002|Overall Study|Protocol Violation|7|||
19395377|NCT02629861|41639610|FG000|Overall Study|Lost to Follow-up|12|||
19374164|NCT02296138|41615616|FG001|Overall Study|Protocol Violation|36|||
19374165|NCT02296138|41615615|FG000|Overall Study|Lost to Follow-up|9|||
19374166|NCT02296138|41615616|FG001|Overall Study|Lost to Follow-up|12|||
19374167|NCT02296138|41615615|FG000|Overall Study|Withdrawal by Subject|184|||
19395378|NCT02629861|41639611|FG001|Overall Study|Lost to Follow-up|9|||
19395379|NCT02629861|41639612|FG002|Overall Study|Lost to Follow-up|4|||
19395380|NCT02629861|41639610|FG000|Overall Study|Other|1|||
19395381|NCT02629861|41639611|FG001|Overall Study|Other|1|||
19395382|NCT02629861|41639612|FG002|Overall Study|Other|0|||
19374168|NCT02296138|41615616|FG001|Overall Study|Withdrawal by Subject|131|||
19374169|NCT02296138|41615615|FG000|Overall Study|Not Treated|1|||
19374170|NCT02296138|41615616|FG001|Overall Study|Not Treated|1|||
19374171|NCT02296138|41615615|FG000|Overall Study|Patients with data irregularities|10|||
19374172|NCT02296138|41615616|FG001|Overall Study|Patients with data irregularities|11|||
19374173|NCT02296138|41615615|FG000|Overall Study|Other than specified|15|||
19374174|NCT02296138|41615616|FG001|Overall Study|Other than specified|13|||
19710865|NCT03615040|42154147|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
19710866|NCT03615040|42154148|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
19710867|NCT03615040|42154147|FG000|Overall Study|Death|0|||
19710868|NCT03615040|42154148|FG001|Overall Study|Death|2|||
19710869|NCT00068822|42154156|FG000|First Randomized Intervention|Lost to Follow-up|1|||
19710870|NCT00068822|42154157|FG001|First Randomized Intervention|Lost to Follow-up|2|||
19710871|NCT00068588|42154166|FG000|Overall Study|Adverse Event|0|||
19710872|NCT00068588|42154167|FG001|Overall Study|Adverse Event|0|||
19627563|NCT03307785|42077091|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
19627564|NCT03307785|42077092|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
19627565|NCT03307785|42077093|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
19627566|NCT03307785|42077094|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
19710873|NCT00068588|42154168|FG002|Overall Study|Adverse Event|2|||
19710874|NCT00068588|42154166|FG000|Overall Study|Withdrawal by Subject|0|||
19710875|NCT00068588|42154167|FG001|Overall Study|Withdrawal by Subject|0|||
19710876|NCT00068588|42154168|FG002|Overall Study|Withdrawal by Subject|1|||
19710877|NCT00068588|42154166|FG000|Overall Study|Poor KPS|0|||
19710878|NCT00068588|42154167|FG001|Overall Study|Poor KPS|0|||
19710879|NCT00068588|42154168|FG002|Overall Study|Poor KPS|1|||
19710880|NCT03650452|42154177|FG000|Overall Study|Physician Decision|1|||
19710881|NCT03650452|42154178|FG001|Overall Study|Physician Decision|0|||
19710882|NCT03650452|42154177|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
19710883|NCT03650452|42154178|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
19710884|NCT03650452|42154177|FG000|Overall Study|Adverse Event|3|||
19710885|NCT03650452|42154178|FG001|Overall Study|Adverse Event|4|||
19710886|NCT03650452|42154177|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
19710887|NCT03650452|42154178|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
19710888|NCT03575806|42154186|FG000|Overall Study|Withdrawal by Subject|0|||
19710889|NCT03575806|42154187|FG001|Overall Study|Withdrawal by Subject|2|||
19710890|NCT03575806|42154186|FG000|Overall Study|Protocol Violation|0|||
19710891|NCT03575806|42154187|FG001|Overall Study|Protocol Violation|2|||
19710892|NCT03610048|42154193|FG000|Overall Study|Study terminated by sponsor|84|||
19710893|NCT03610048|42154193|FG000|Overall Study|Adverse Event|32|||
19710894|NCT03610048|42154193|FG000|Overall Study|Withdrawal by Subject|31|||
19710895|NCT03610048|42154193|FG000|Overall Study|Lost to Follow-up|8|||
19710896|NCT03610048|42154193|FG000|Overall Study|Other|4|||
19710897|NCT03610048|42154193|FG000|Overall Study|Physician Decision|1|||
19710898|NCT03610048|42154193|FG000|Overall Study|Pregnancy|1|||
19710899|NCT03608254|42154197|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
19710900|NCT03608254|42154197|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
19374175|NCT02324842|41615625|FG000|Overall Study|Lost to Follow-up|1|||
19627567|NCT03307785|42077095|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
19627568|NCT03307785|42077085|FG000|Part B: Up to 28.5 Months|Death|0|||
19627569|NCT03307785|42077086|FG001|Part B: Up to 28.5 Months|Death|0|||
19627570|NCT03307785|42077087|FG002|Part B: Up to 28.5 Months|Death|7|||
19627571|NCT03307785|42077088|FG003|Part B: Up to 28.5 Months|Death|0|||
19627572|NCT03307785|42077089|FG004|Part B: Up to 28.5 Months|Death|0|||
19710901|NCT03606460|42154203|FG000|Overall Study|Lost to Follow-up|1|||
19710902|NCT03606460|42154204|FG001|Overall Study|Lost to Follow-up|8|||
19374176|NCT02324842|41615626|FG001|Overall Study|Lost to Follow-up|1|||
19374177|NCT02324842|41615627|FG002|Overall Study|Lost to Follow-up|2|||
19374178|NCT02295280|41615637|FG000|Overall Study|Adverse Event|0|||
19374179|NCT02295280|41615638|FG001|Overall Study|Adverse Event|1|||
19374180|NCT02294734|41615646|FG000|Overall Study|Adverse Event|5|||
19374181|NCT02294734|41615647|FG001|Overall Study|Adverse Event|5|||
19374182|NCT02294734|41615646|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
19374183|NCT02294734|41615647|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
19374184|NCT02294734|41615646|FG000|Overall Study|Lost to Follow-up|2|||
19374185|NCT02294734|41615647|FG001|Overall Study|Lost to Follow-up|0|||
19374186|NCT02294734|41615646|FG000|Overall Study|Physician Decision|2|||
19374187|NCT02294734|41615647|FG001|Overall Study|Physician Decision|1|||
19374188|NCT02294734|41615646|FG000|Overall Study|Withdrawal by Subject|4|||
19374189|NCT02294734|41615647|FG001|Overall Study|Withdrawal by Subject|2|||
19374190|NCT02323204|41615668|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
19374191|NCT02323204|41615669|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
19374192|NCT02323204|41615670|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
19374193|NCT02323204|41615671|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
19374194|NCT02323204|41615668|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
19374195|NCT02323204|41615669|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
19374196|NCT02323204|41615670|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
19374197|NCT02323204|41615671|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
19374198|NCT02323204|41615668|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
19374199|NCT02323204|41615669|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
19395383|NCT02629861|41639610|FG000|Overall Study|Pregnancy|2|||
19395384|NCT02629861|41639611|FG001|Overall Study|Pregnancy|1|||
19395385|NCT02629861|41639612|FG002|Overall Study|Pregnancy|0|||
19395386|NCT02482935|41639620|FG000|Period 1|Withdrawal by Subject|1|||
19395387|NCT02482935|41639621|FG001|Period 1|Withdrawal by Subject|0|||
19395388|NCT02513823|41639627|FG000|Overall Study|Lost to Follow-up|4|||
19374200|NCT02323204|41615670|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
19374201|NCT02323204|41615671|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
19374202|NCT02323204|41615668|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
19374203|NCT02323204|41615669|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
19395389|NCT02513823|41639627|FG000|Overall Study|Physician Decision|1|||
19395390|NCT02513745|41639633|FG000|Overall Study|Criteria at time of surgery not met.|3|||
19395391|NCT02513745|41639634|FG001|Overall Study|Criteria at time of surgery not met.|3|||
19395392|NCT02512965|41639642|FG000|Overall Study|Withdrawal by Subject|0|||
19395393|NCT02512965|41639643|FG001|Overall Study|Withdrawal by Subject|4|||
19395394|NCT02477553|41639651|FG000|Overall Study|Screening up-to-date|12|||
19395395|NCT02477553|41639652|FG001|Overall Study|Screening up-to-date|13|||
19395396|NCT02477553|41639651|FG000|Overall Study|No MD visit|1|||
19395397|NCT02477553|41639652|FG001|Overall Study|No MD visit|1|||
19395398|NCT02477553|41639651|FG000|Overall Study|Workup consistent w/CRC|1|||
19395399|NCT02477553|41639652|FG001|Overall Study|Workup consistent w/CRC|1|||
19395400|NCT02477553|41639651|FG000|Overall Study|Technical issues with intervention|2|||
19374204|NCT02323204|41615670|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
19374205|NCT02323204|41615671|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
19395401|NCT02477553|41639652|FG001|Overall Study|Technical issues with intervention|0|||
19395402|NCT02477553|41639651|FG000|Overall Study|Elevated risk for CRC|2|||
19395403|NCT02477553|41639652|FG001|Overall Study|Elevated risk for CRC|2|||
19395404|NCT02477553|41639651|FG000|Overall Study|MD advised against screening|1|||
19395405|NCT02477553|41639652|FG001|Overall Study|MD advised against screening|3|||
19395406|NCT02477553|41639651|FG000|Overall Study|patient deceased|1|||
19395407|NCT02477553|41639652|FG001|Overall Study|patient deceased|0|||
19395408|NCT01665911|41639658|FG000|Overall Study|Protocol Violation|4|||
19395409|NCT01665911|41639658|FG000|Overall Study|Withdrawal by Subject|1|||
19395410|NCT01665911|41639658|FG000|Overall Study|Adverse Event|1|||
19395411|NCT02452359|41639663|FG000|Overall Study|Adverse Event|1|||
19395412|NCT02452359|41639663|FG000|Overall Study|Lost to Follow-up|15|||
19627573|NCT03307785|42077090|FG005|Part B: Up to 28.5 Months|Death|0|||
19627574|NCT03307785|42077091|FG006|Part B: Up to 28.5 Months|Death|0|||
19374206|NCT02323204|41615668|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
19374207|NCT02323204|41615669|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
19374208|NCT02323204|41615670|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
19374209|NCT02323204|41615671|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
19374210|NCT02323204|41615668|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
19395413|NCT02452359|41639663|FG000|Overall Study|Pregnancy|1|||
19395414|NCT02452359|41639663|FG000|Overall Study|Withdrawal by Subject|4|||
19395415|NCT02476617|41639667|FG000|Overall Study|Adverse Event|1|||
19395416|NCT02476617|41639667|FG000|Overall Study|Lost to Follow-up|1|||
19627575|NCT03307785|42077092|FG007|Part B: Up to 28.5 Months|Death|0|||
19627576|NCT03307785|42077093|FG008|Part B: Up to 28.5 Months|Death|0|||
19395417|NCT01665599|41639684|FG000|Overall Study|Adverse Event|1|||
19395418|NCT01665599|41639684|FG000|Overall Study|Consent Withdrawn|1|||
19374211|NCT02323204|41615669|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
19374212|NCT02323204|41615670|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
19374213|NCT02323204|41615671|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
19374214|NCT02323204|41615668|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
19374215|NCT02323204|41615669|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
19374216|NCT02323204|41615670|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
19374217|NCT02323204|41615671|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
19374218|NCT02323204|41615668|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
19374219|NCT02323204|41615669|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
19374220|NCT02323204|41615670|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
19374221|NCT02323204|41615671|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
19374222|NCT02323204|41615668|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
19374223|NCT02323204|41615669|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
19395419|NCT01665599|41639684|FG000|Overall Study|Investigator/Sponsor decision|1|||
19395420|NCT01665599|41639684|FG000|Overall Study|Death|1|||
19395421|NCT01665599|41639684|FG000|Overall Study|Lost to Follow-up|2|||
19395422|NCT01665599|41639684|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
19395423|NCT01665599|41639684|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
19395424|NCT01671085|41639690|FG000|Overall Study|Withdrawal by Subject|1|||
19395425|NCT01671085|41639691|FG001|Overall Study|Withdrawal by Subject|0|||
19395426|NCT02510001|41639706|FG000|Overall Study|Early disease progression|0|||
19395427|NCT02510001|41639707|FG001|Overall Study|Early disease progression|0|||
19395428|NCT02510001|41639708|FG002|Overall Study|Early disease progression|0|||
19395429|NCT02510001|41639709|FG003|Overall Study|Early disease progression|1|||
19395430|NCT02510001|41639710|FG004|Overall Study|Early disease progression|1|||
19395431|NCT02510001|41639711|FG005|Overall Study|Early disease progression|1|||
19395432|NCT02510001|41639712|FG006|Overall Study|Early disease progression|0|||
19395433|NCT02510001|41639713|FG007|Overall Study|Early disease progression|0|||
19395434|NCT02510001|41639706|FG000|Overall Study|Adverse Event|0|||
19395435|NCT02510001|41639707|FG001|Overall Study|Adverse Event|0|||
19395436|NCT02510001|41639708|FG002|Overall Study|Adverse Event|0|||
19395437|NCT02510001|41639709|FG003|Overall Study|Adverse Event|1|||
19395438|NCT02510001|41639710|FG004|Overall Study|Adverse Event|2|||
19395439|NCT02510001|41639711|FG005|Overall Study|Adverse Event|1|||
19395440|NCT02510001|41639712|FG006|Overall Study|Adverse Event|2|||
19627577|NCT03307785|42077094|FG009|Part B: Up to 28.5 Months|Death|0|||
19627578|NCT03307785|42077095|FG010|Part B: Up to 28.5 Months|Death|0|||
19627579|NCT03307785|42077085|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627580|NCT03307785|42077086|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627581|NCT03307785|42077087|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
19627582|NCT03307785|42077088|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627583|NCT03307785|42077089|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627584|NCT03307785|42077090|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627585|NCT03307785|42077091|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627586|NCT03307785|42077092|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627587|NCT03307785|42077093|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627588|NCT03307785|42077094|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627589|NCT03307785|42077095|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
19627590|NCT03307785|42077085|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627591|NCT03307785|42077086|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627592|NCT03307785|42077087|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
19627593|NCT03307785|42077088|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627594|NCT03307785|42077089|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627595|NCT03307785|42077090|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627596|NCT03307785|42077091|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627597|NCT03307785|42077092|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627598|NCT03307785|42077093|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627599|NCT03307785|42077094|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627600|NCT03307785|42077095|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
19627601|NCT03307785|42077085|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
19627602|NCT03307785|42077086|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
19627603|NCT03307785|42077087|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
19627604|NCT03307785|42077088|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
19627605|NCT03307785|42077089|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
19627606|NCT03307785|42077090|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
19395441|NCT02510001|41639713|FG007|Overall Study|Adverse Event|5|||
19395442|NCT02510001|41639706|FG000|Overall Study|Physician Decision|0|||
19395443|NCT02510001|41639707|FG001|Overall Study|Physician Decision|0|||
19395444|NCT02510001|41639708|FG002|Overall Study|Physician Decision|0|||
19395445|NCT02510001|41639709|FG003|Overall Study|Physician Decision|0|||
19627607|NCT03307785|42077091|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
19627608|NCT03307785|42077092|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
19627609|NCT03307785|42077093|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
19627610|NCT03307785|42077094|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
19627611|NCT03307785|42077095|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
19627612|NCT03307785|42077085|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
19627613|NCT03307785|42077086|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
19627614|NCT03307785|42077087|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
19627615|NCT03307785|42077088|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
19627616|NCT03307785|42077089|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
19627617|NCT03307785|42077090|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
19627618|NCT03307785|42077091|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
19627619|NCT03307785|42077092|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
19627620|NCT03307785|42077093|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
19627621|NCT03307785|42077094|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
19627622|NCT03307785|42077095|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
19627623|NCT03307785|42077085|FG000|Part C: Up to 22.5 Months|Death|0|||
19627624|NCT03307785|42077086|FG001|Part C: Up to 22.5 Months|Death|0|||
19627625|NCT03307785|42077087|FG002|Part C: Up to 22.5 Months|Death|0|||
19627626|NCT03307785|42077088|FG003|Part C: Up to 22.5 Months|Death|1|||
19627627|NCT03307785|42077089|FG004|Part C: Up to 22.5 Months|Death|4|||
19627628|NCT03307785|42077090|FG005|Part C: Up to 22.5 Months|Death|0|||
19627629|NCT03307785|42077091|FG006|Part C: Up to 22.5 Months|Death|0|||
19627630|NCT03307785|42077092|FG007|Part C: Up to 22.5 Months|Death|0|||
19627631|NCT03307785|42077093|FG008|Part C: Up to 22.5 Months|Death|0|||
19627632|NCT03307785|42077094|FG009|Part C: Up to 22.5 Months|Death|0|||
19627633|NCT03307785|42077095|FG010|Part C: Up to 22.5 Months|Death|0|||
19627634|NCT03307785|42077085|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627635|NCT03307785|42077086|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627636|NCT03307785|42077087|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627637|NCT03307785|42077088|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
19627638|NCT03307785|42077089|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627639|NCT03307785|42077090|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627640|NCT03307785|42077091|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627641|NCT03307785|42077092|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627642|NCT03307785|42077093|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627643|NCT03307785|42077094|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627644|NCT03307785|42077095|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
19627645|NCT03307785|42077085|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627646|NCT03307785|42077086|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627647|NCT03307785|42077087|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627648|NCT03307785|42077088|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
19627649|NCT03307785|42077089|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
19627650|NCT03307785|42077090|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627651|NCT03307785|42077091|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627652|NCT03307785|42077092|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627653|NCT03307785|42077093|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627654|NCT03307785|42077094|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627655|NCT03307785|42077095|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
19627656|NCT03307785|42077085|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
19710903|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
19710904|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
19627657|NCT03307785|42077086|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
19627658|NCT03307785|42077087|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
19627659|NCT03307785|42077088|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
19710905|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
19710906|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
19710907|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
19710908|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
19710909|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
19710910|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
19710911|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
19710912|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
19710913|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
19710914|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
19710915|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
19710916|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
19710917|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
19627660|NCT03307785|42077089|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
19710918|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
19710919|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
19710920|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
19710921|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
19710922|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
19710923|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
19710924|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
19710925|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
19710926|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
19710927|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
19710928|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
19710929|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
19710930|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
19710931|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
19627661|NCT03307785|42077090|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
19627662|NCT03307785|42077091|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
19627663|NCT03307785|42077092|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
19627664|NCT03307785|42077093|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
19627665|NCT03307785|42077094|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
19627666|NCT03307785|42077095|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
19627667|NCT03307785|42077085|FG000|Part D: Up to 9.5 Months|Death|0|||
19627668|NCT03307785|42077086|FG001|Part D: Up to 9.5 Months|Death|0|||
19627669|NCT03307785|42077087|FG002|Part D: Up to 9.5 Months|Death|0|||
19627670|NCT03307785|42077088|FG003|Part D: Up to 9.5 Months|Death|0|||
19627671|NCT03307785|42077089|FG004|Part D: Up to 9.5 Months|Death|0|||
19627672|NCT03307785|42077090|FG005|Part D: Up to 9.5 Months|Death|1|||
19627673|NCT03307785|42077091|FG006|Part D: Up to 9.5 Months|Death|0|||
19627674|NCT03307785|42077092|FG007|Part D: Up to 9.5 Months|Death|0|||
19627675|NCT03307785|42077093|FG008|Part D: Up to 9.5 Months|Death|0|||
19627676|NCT03307785|42077094|FG009|Part D: Up to 9.5 Months|Death|0|||
19627677|NCT03307785|42077095|FG010|Part D: Up to 9.5 Months|Death|0|||
19627678|NCT03307785|42077085|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627679|NCT03307785|42077086|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627680|NCT03307785|42077087|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627681|NCT03307785|42077088|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627682|NCT03307785|42077089|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627683|NCT03307785|42077090|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
19627684|NCT03307785|42077091|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627685|NCT03307785|42077092|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627686|NCT03307785|42077093|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627687|NCT03307785|42077094|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627688|NCT03307785|42077095|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
19627689|NCT03307785|42077085|FG000|Part E: Up to 4.4 Months|Death|0|||
19627690|NCT03307785|42077086|FG001|Part E: Up to 4.4 Months|Death|0|||
19627691|NCT03307785|42077087|FG002|Part E: Up to 4.4 Months|Death|0|||
19627692|NCT03307785|42077088|FG003|Part E: Up to 4.4 Months|Death|0|||
19627693|NCT03307785|42077089|FG004|Part E: Up to 4.4 Months|Death|0|||
19627694|NCT03307785|42077090|FG005|Part E: Up to 4.4 Months|Death|0|||
19627695|NCT03307785|42077091|FG006|Part E: Up to 4.4 Months|Death|1|||
19627696|NCT03307785|42077092|FG007|Part E: Up to 4.4 Months|Death|0|||
19627697|NCT03307785|42077093|FG008|Part E: Up to 4.4 Months|Death|0|||
19627698|NCT03307785|42077094|FG009|Part E: Up to 4.4 Months|Death|0|||
19627699|NCT03307785|42077095|FG010|Part E: Up to 4.4 Months|Death|0|||
19627700|NCT03307785|42077085|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
19627701|NCT03307785|42077086|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
19627702|NCT03307785|42077087|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
19627703|NCT03307785|42077088|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
19627704|NCT03307785|42077089|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
19627705|NCT03307785|42077090|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
19627706|NCT03307785|42077091|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
19627707|NCT03307785|42077092|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
19627708|NCT03307785|42077093|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
19627709|NCT03307785|42077094|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
19627710|NCT03307785|42077095|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
19627711|NCT03307785|42077085|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
19627712|NCT03307785|42077086|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
19627713|NCT03307785|42077087|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
19627714|NCT03307785|42077088|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
19627715|NCT03307785|42077089|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
19627716|NCT03307785|42077090|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
19627717|NCT03307785|42077091|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
19627718|NCT03307785|42077092|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
19627719|NCT03307785|42077093|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
19627720|NCT03307785|42077094|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
19627721|NCT03307785|42077095|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
19627722|NCT00866177|42077116|FG000|Overall Study|Withdrawal by Subject|1|||
19627723|NCT00866177|42077116|FG000|Overall Study|Not Treated|151|||
19627724|NCT00833924|42077120|FG000|Overall Study|Death|21|||
19627725|NCT00833924|42077120|FG000|Overall Study|Conversion|2|||
19627726|NCT00833924|42077120|FG000|Overall Study|Lost to Follow-up|2|||
19627727|NCT00833924|42077120|FG000|Overall Study|Withdrawal by Subject|13|||
19627728|NCT00833924|42077120|FG000|Overall Study|In study follow-up|71|||
19627729|NCT00840086|42077124|FG000|Overall Study|Adverse Event|1|||
19627730|NCT00840086|42077124|FG000|Overall Study|Protocol Violation|2|||
19627731|NCT00840086|42077124|FG000|Overall Study|Lost to Follow-up|1|||
19627732|NCT00822926|42077133|FG000|Second Injection Visit|Lost to Follow-up|1|||
19627733|NCT00822926|42077134|FG001|Second Injection Visit|Lost to Follow-up|0|||
19627734|NCT00822926|42077133|FG000|Second Injection Visit|Withdrawal by Subject|0|||
19627735|NCT00822926|42077134|FG001|Second Injection Visit|Withdrawal by Subject|1|||
19627736|NCT00822770|42077145|FG000|Overall Study|Not treated|1|||
19627737|NCT00822770|42077146|FG001|Overall Study|Not treated|0|||
19627738|NCT00822770|42077145|FG000|Overall Study|Complication/Incomplete treatment|1|||
19627739|NCT00822770|42077146|FG001|Overall Study|Complication/Incomplete treatment|0|||
19627740|NCT00822770|42077145|FG000|Overall Study|Death|1|||
19627741|NCT00822770|42077146|FG001|Overall Study|Death|1|||
19627742|NCT02842086|42077154|FG000|Overall Study|Randomized but Never Treated|6|||
19627743|NCT02842086|42077155|FG001|Overall Study|Randomized but Never Treated|6|||
19627744|NCT02842086|42077154|FG000|Overall Study|Still in Double-Blind Phase|7|||
19627745|NCT02842086|42077155|FG001|Overall Study|Still in Double-Blind Phase|3|||
19627746|NCT02842086|42077154|FG000|Overall Study|Adverse Event|18|||
19627747|NCT02842086|42077155|FG001|Overall Study|Adverse Event|20|||
19627748|NCT02842086|42077154|FG000|Overall Study|Death|3|||
19627749|NCT02842086|42077155|FG001|Overall Study|Death|3|||
19627750|NCT02842086|42077154|FG000|Overall Study|Investigator's Discretion|9|||
19627751|NCT02842086|42077155|FG001|Overall Study|Investigator's Discretion|13|||
19627752|NCT02842086|42077154|FG000|Overall Study|Non-Compliance with Study Drug|9|||
19627753|NCT02842086|42077155|FG001|Overall Study|Non-Compliance with Study Drug|8|||
19627754|NCT02842086|42077154|FG000|Overall Study|Protocol Violation|8|||
19627755|NCT02842086|42077155|FG001|Overall Study|Protocol Violation|4|||
19627756|NCT02842086|42077154|FG000|Overall Study|Withdrew Consent|205|||
19627757|NCT02842086|42077155|FG001|Overall Study|Withdrew Consent|194|||
19627758|NCT02842086|42077154|FG000|Overall Study|Lost to Follow-up|274|||
19627759|NCT02842086|42077155|FG001|Overall Study|Lost to Follow-up|236|||
19627760|NCT02842086|42077154|FG000|Overall Study|HIV-1 Infection|5|||
19627761|NCT02842086|42077155|FG001|Overall Study|HIV-1 Infection|6|||
19627762|NCT00822692|42077163|FG000|Overall Study|Lost to Follow-up|17|||
19710932|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
19710933|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
19710934|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
19710935|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
19710936|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
19710937|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
19710938|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
19710939|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
19710940|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
19710941|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
19710942|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
19710943|NCT03605836|42154215|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
19627763|NCT00822692|42077164|FG001|Overall Study|Lost to Follow-up|25|||
19627764|NCT00806442|42077170|FG000|Overall Study|Lost to Follow-up|3|||
19627765|NCT00806442|42077171|FG001|Overall Study|Lost to Follow-up|2|||
19710944|NCT03605836|42154216|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
19710945|NCT03605836|42154217|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
19710946|NCT03605836|42154218|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
19627766|NCT00806442|42077170|FG000|Overall Study|Withdrawal by Subject|1|||
19627767|NCT00806442|42077171|FG001|Overall Study|Withdrawal by Subject|5|||
19627768|NCT00821678|42077181|FG000|Overall Study|Withdrawal by Subject|8|||
19627769|NCT00821678|42077182|FG001|Overall Study|Withdrawal by Subject|0|||
19627770|NCT00821678|42077181|FG000|Overall Study|Lost to Follow-up|13|||
19627771|NCT00821678|42077182|FG001|Overall Study|Lost to Follow-up|12|||
19710947|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
19710948|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
19710949|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
19710950|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
19710951|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
19710952|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
19710953|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
19710954|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
19710955|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
19710956|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
19710957|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
19710958|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
19710959|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
19710960|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
19710961|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
19710962|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
19710963|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
19710964|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
19710965|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
19710966|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
19710967|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
19710968|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
19710969|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
19710970|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
19710971|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
19710972|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
19710973|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
19710974|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
19710975|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
19710976|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
19710977|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
19395446|NCT02510001|41639710|FG004|Overall Study|Physician Decision|1|||
19395447|NCT02510001|41639711|FG005|Overall Study|Physician Decision|0|||
19395448|NCT02510001|41639712|FG006|Overall Study|Physician Decision|0|||
19395449|NCT02510001|41639713|FG007|Overall Study|Physician Decision|0|||
19627772|NCT00821678|42077181|FG000|Overall Study|Death|0|||
19627773|NCT00821678|42077182|FG001|Overall Study|Death|2|||
19627774|NCT00839852|42077190|FG000|Overall Study|Adverse Event|10|||
19627775|NCT00839852|42077190|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19395450|NCT02510001|41639706|FG000|Overall Study|Withdrawal by Subject|0|||
19395451|NCT02510001|41639707|FG001|Overall Study|Withdrawal by Subject|0|||
19395452|NCT02510001|41639708|FG002|Overall Study|Withdrawal by Subject|0|||
19395453|NCT02510001|41639709|FG003|Overall Study|Withdrawal by Subject|0|||
19395454|NCT02510001|41639710|FG004|Overall Study|Withdrawal by Subject|0|||
19395455|NCT02510001|41639711|FG005|Overall Study|Withdrawal by Subject|0|||
19395456|NCT02510001|41639712|FG006|Overall Study|Withdrawal by Subject|0|||
19395457|NCT02510001|41639713|FG007|Overall Study|Withdrawal by Subject|2|||
19395458|NCT02452047|41639752|FG000|Overall Study|Adverse Event|0|||
19395459|NCT02452047|41639753|FG001|Overall Study|Adverse Event|1|||
19395460|NCT02452047|41639754|FG002|Overall Study|Adverse Event|1|||
19395461|NCT02452047|41639752|FG000|Overall Study|Death|1|||
19395462|NCT02452047|41639753|FG001|Overall Study|Death|3|||
19395463|NCT02452047|41639754|FG002|Overall Study|Death|1|||
19395464|NCT02452047|41639752|FG000|Overall Study|Physician Decision|1|||
19395465|NCT02452047|41639753|FG001|Overall Study|Physician Decision|0|||
19395466|NCT02452047|41639754|FG002|Overall Study|Physician Decision|0|||
19395467|NCT02452047|41639752|FG000|Overall Study|Lost to Follow-up|1|||
19627776|NCT00839852|42077190|FG000|Overall Study|Protocol Violation|9|||
19627777|NCT00839852|42077190|FG000|Overall Study|Withdrawal of Consent|16|||
19627778|NCT00839852|42077190|FG000|Overall Study|Lost to Follow-up|7|||
19627779|NCT00839852|42077190|FG000|Overall Study|Lack of Compliance While in Jail|1|||
19395468|NCT02452047|41639753|FG001|Overall Study|Lost to Follow-up|1|||
19395469|NCT02452047|41639754|FG002|Overall Study|Lost to Follow-up|0|||
19395470|NCT02452047|41639752|FG000|Overall Study|Withdrawal by Subject|1|||
19395471|NCT02452047|41639753|FG001|Overall Study|Withdrawal by Subject|0|||
19395472|NCT02452047|41639754|FG002|Overall Study|Withdrawal by Subject|0|||
19395473|NCT02475369|41639762|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
19395474|NCT02475369|41639763|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
19627780|NCT00839852|42077190|FG000|Overall Study|Pregnancy|1|||
19627781|NCT00833690|42077197|FG000|Overall Study|Withdrawal by Subject|1|||
19627782|NCT00833690|42077198|FG001|Overall Study|Withdrawal by Subject|0|||
19395475|NCT02474589|41639776|FG000|Overall Study|Adverse Event|6|||
19395476|NCT02474589|41639777|FG001|Overall Study|Adverse Event|2|||
19395477|NCT02474589|41639776|FG000|Overall Study|Lost to Follow-up|6|||
19395478|NCT02474589|41639777|FG001|Overall Study|Lost to Follow-up|1|||
19395479|NCT02474589|41639776|FG000|Overall Study|Protocol Violation|4|||
19395480|NCT02474589|41639777|FG001|Overall Study|Protocol Violation|1|||
19395481|NCT02474589|41639776|FG000|Overall Study|Withdrawal by Subject|4|||
19395482|NCT02474589|41639777|FG001|Overall Study|Withdrawal by Subject|0|||
19395483|NCT02474589|41639776|FG000|Overall Study|Inability to complete study procedures|5|||
19395484|NCT02474589|41639777|FG001|Overall Study|Inability to complete study procedures|1|||
19395485|NCT02586233|41639790|FG000|Overall Study|Randomized but did not receive treatment|0|||
19395486|NCT02586233|41639791|FG001|Overall Study|Randomized but did not receive treatment|1|||
19395487|NCT02586233|41639792|FG002|Overall Study|Randomized but did not receive treatment|0|||
19395488|NCT02586233|41639793|FG003|Overall Study|Randomized but did not receive treatment|0|||
19395489|NCT02586233|41639794|FG004|Overall Study|Randomized but did not receive treatment|0|||
19395490|NCT02586233|41639795|FG005|Overall Study|Randomized but did not receive treatment|2|||
19395491|NCT02586233|41639796|FG006|Overall Study|Randomized but did not receive treatment|2|||
19395492|NCT02586233|41639790|FG000|Overall Study|Death|0|||
19395493|NCT02586233|41639791|FG001|Overall Study|Death|1|||
19395494|NCT02586233|41639792|FG002|Overall Study|Death|0|||
19395495|NCT02586233|41639793|FG003|Overall Study|Death|0|||
19395496|NCT02586233|41639794|FG004|Overall Study|Death|2|||
19395497|NCT02586233|41639795|FG005|Overall Study|Death|0|||
19395498|NCT02586233|41639796|FG006|Overall Study|Death|0|||
19395499|NCT02474355|41639816|FG000|Overall Study|Other|43|||
19395500|NCT02474355|41639816|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
19395501|NCT02474355|41639816|FG000|Overall Study|Lost to Follow-up|98|||
19395502|NCT02474355|41639816|FG000|Overall Study|Withdrawal by Subject|124|||
19395503|NCT02474355|41639816|FG000|Overall Study|Death|1361|||
19395504|NCT02474199|41639822|FG000|Overall Study|Lost to Follow-up|1|||
19395505|NCT02474199|41639823|FG001|Overall Study|Lost to Follow-up|0|||
19395506|NCT02474199|41639824|FG002|Overall Study|Lost to Follow-up|0|||
19395507|NCT02474199|41639825|FG003|Overall Study|Lost to Follow-up|0|||
19395508|NCT02474199|41639822|FG000|Overall Study|Withdrawal by Subject|1|||
19395509|NCT02474199|41639823|FG001|Overall Study|Withdrawal by Subject|2|||
19395510|NCT02474199|41639824|FG002|Overall Study|Withdrawal by Subject|0|||
19395511|NCT02474199|41639825|FG003|Overall Study|Withdrawal by Subject|1|||
19395512|NCT02474199|41639822|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
19395513|NCT02474199|41639823|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
19395514|NCT02474199|41639824|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
19395515|NCT02474199|41639825|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
19395516|NCT02474199|41639822|FG000|Overall Study|Did not meet eligibility criteria|0|||
19395517|NCT02474199|41639823|FG001|Overall Study|Did not meet eligibility criteria|0|||
19395518|NCT02474199|41639824|FG002|Overall Study|Did not meet eligibility criteria|2|||
19395519|NCT02474199|41639825|FG003|Overall Study|Did not meet eligibility criteria|2|||
19395520|NCT02450487|41639832|FG000|Overall Study|Lost to Follow-up|3|||
19395521|NCT02473965|41639839|FG000|Overall Study|Adverse Event|6|||
19395522|NCT02473965|41639840|FG001|Overall Study|Adverse Event|4|||
19395523|NCT02473965|41639839|FG000|Overall Study|MG worsening|4|||
19395524|NCT02473965|41639840|FG001|Overall Study|MG worsening|1|||
19395525|NCT02473965|41639839|FG000|Overall Study|Withdrawal by Subject|2|||
19395526|NCT02473965|41639840|FG001|Overall Study|Withdrawal by Subject|3|||
19395527|NCT02473965|41639839|FG000|Overall Study|Physician Decision|0|||
19395528|NCT02473965|41639840|FG001|Overall Study|Physician Decision|2|||
19395529|NCT02472795|41639851|FG000|Overall Study|Adverse Event|0|||
19395530|NCT02472795|41639852|FG001|Overall Study|Adverse Event|1|||
19395531|NCT02472795|41639853|FG002|Overall Study|Adverse Event|0|||
19395532|NCT02472795|41639854|FG003|Overall Study|Adverse Event|0|||
19395533|NCT02472795|41639855|FG004|Overall Study|Adverse Event|2|||
19395534|NCT02472795|41639851|FG000|Overall Study|Withdrawal by Subject|0|||
19395535|NCT02472795|41639852|FG001|Overall Study|Withdrawal by Subject|0|||
19395536|NCT02472795|41639853|FG002|Overall Study|Withdrawal by Subject|0|||
19395537|NCT02472795|41639854|FG003|Overall Study|Withdrawal by Subject|0|||
19395538|NCT02472795|41639855|FG004|Overall Study|Withdrawal by Subject|1|||
19395539|NCT02507349|41639869|FG000|Overall Study|Death|12|||
19395540|NCT02507349|41639870|FG001|Overall Study|Death|16|||
19395541|NCT02507349|41639869|FG000|Overall Study|Withdrawal by Subject|1|||
19395542|NCT02507349|41639870|FG001|Overall Study|Withdrawal by Subject|1|||
19395543|NCT02507349|41639869|FG000|Overall Study|Lost to Follow-up|174|||
19395544|NCT02507349|41639870|FG001|Overall Study|Lost to Follow-up|144|||
19395545|NCT02506881|41639880|FG000|First Intervention (Day 1)|Protocol Violation|0|||
19395546|NCT02506881|41639881|FG001|First Intervention (Day 1)|Protocol Violation|0|||
19710978|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
19710979|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
19710980|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
19710981|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
19710982|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
19710983|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
19627783|NCT00833690|42077199|FG002|Overall Study|Withdrawal by Subject|0|||
19627784|NCT00833690|42077197|FG000|Overall Study|Discontinued study drug|3|||
19627785|NCT00833690|42077198|FG001|Overall Study|Discontinued study drug|2|||
19627786|NCT00833690|42077199|FG002|Overall Study|Discontinued study drug|0|||
19627787|NCT00820898|42077207|FG000|Overall Study|Inelgible - wrong primary site|1|||
19627788|NCT00865709|42077219|FG000|Treatment|Adverse Event|9|||
19627789|NCT00865709|42077220|FG001|Treatment|Adverse Event|6|||
19627790|NCT00865709|42077219|FG000|Treatment|Withdrawal by Subject|10|||
19627791|NCT00865709|42077220|FG001|Treatment|Withdrawal by Subject|7|||
19627792|NCT00865709|42077219|FG000|Treatment|Physician Decision|3|||
19627793|NCT00865709|42077220|FG001|Treatment|Physician Decision|2|||
19627794|NCT00865709|42077219|FG000|Treatment|Surgery|8|||
19627795|NCT00865709|42077220|FG001|Treatment|Surgery|3|||
19627796|NCT00839306|42077230|FG000|Overall Study|Adverse Event|3|||
19627797|NCT00839306|42077231|FG001|Overall Study|Adverse Event|5|||
19627798|NCT00839306|42077230|FG000|Overall Study|Lost to Follow-up|6|||
19627799|NCT00839306|42077231|FG001|Overall Study|Lost to Follow-up|9|||
19710984|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
19710985|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
19710986|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
19710987|NCT03605836|42154215|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
19710988|NCT03605836|42154216|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
19710989|NCT03605836|42154217|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
19710990|NCT03605836|42154218|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
19710991|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
19710992|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
19710993|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
19710994|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
19374224|NCT02323204|41615670|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
19374225|NCT02323204|41615671|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
19374226|NCT02322892|41615683|FG000|Overall Study|Surgery cancelled|1|||
19374227|NCT02322892|41615684|FG001|Overall Study|Surgery cancelled|2|||
19374228|NCT02322892|41615683|FG000|Overall Study|Met exclusion criteria|0|||
19374229|NCT02322892|41615684|FG001|Overall Study|Met exclusion criteria|1|||
19374230|NCT02322892|41615683|FG000|Overall Study|Protocol Violation|1|||
19374231|NCT02322892|41615684|FG001|Overall Study|Protocol Violation|0|||
19374232|NCT03916081|41615693|FG000|Overall Study|Adverse Event|1|||
19374233|NCT03916081|41615694|FG001|Overall Study|Adverse Event|0|||
19374234|NCT03916081|41615695|FG002|Overall Study|Adverse Event|0|||
19374235|NCT03916081|41615693|FG000|Overall Study|Physician Decision|0|||
19374236|NCT03916081|41615694|FG001|Overall Study|Physician Decision|0|||
19374237|NCT03916081|41615695|FG002|Overall Study|Physician Decision|1|||
19374238|NCT03916081|41615693|FG000|Overall Study|Lost to Follow-up|0|||
19374239|NCT03916081|41615694|FG001|Overall Study|Lost to Follow-up|1|||
19374240|NCT03916081|41615695|FG002|Overall Study|Lost to Follow-up|0|||
19374241|NCT03916081|41615693|FG000|Overall Study|Withdrawal by Subject|3|||
19374242|NCT03916081|41615694|FG001|Overall Study|Withdrawal by Subject|0|||
19374243|NCT03916081|41615695|FG002|Overall Study|Withdrawal by Subject|1|||
19374244|NCT03916081|41615693|FG000|Overall Study|Worsening of AD|0|||
19374245|NCT03916081|41615694|FG001|Overall Study|Worsening of AD|0|||
19374246|NCT03916081|41615695|FG002|Overall Study|Worsening of AD|1|||
19374247|NCT02739997|41615703|FG000|Overall Study|Death|1|||
19374248|NCT02739997|41615703|FG000|Overall Study|Withdrawal by Subject|1|||
19374249|NCT02221037|41615720|FG000|Overall Study|Physician Decision|0|||
19374250|NCT02221037|41615721|FG001|Overall Study|Physician Decision|0|||
19374251|NCT02221037|41615722|FG002|Overall Study|Physician Decision|1|||
19374252|NCT02221037|41615723|FG003|Overall Study|Physician Decision|0|||
19374253|NCT02704429|41615739|FG000|Part A: 24 Weeks|Adverse Event|3|||
19374254|NCT02704429|41615740|FG001|Part A: 24 Weeks|Adverse Event|0|||
19627800|NCT00839306|42077230|FG000|Overall Study|Withdrawal by Subject|5|||
19627801|NCT00839306|42077231|FG001|Overall Study|Withdrawal by Subject|7|||
19710995|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
19374255|NCT02704429|41615739|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
19374256|NCT02704429|41615740|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
19374257|NCT02751359|41615747|FG000|Overall Study|Lost to Follow-up|1|||
19374258|NCT02750813|41615766|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
19374259|NCT02750813|41615767|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
19627802|NCT00839306|42077230|FG000|Overall Study|Lack of Efficacy|5|||
19627803|NCT00839306|42077231|FG001|Overall Study|Lack of Efficacy|4|||
19374260|NCT02750813|41615766|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
19395547|NCT02506881|41639882|FG002|First Intervention (Day 1)|Protocol Violation|1|||
19395548|NCT02506881|41639883|FG003|First Intervention (Day 1)|Protocol Violation|0|||
19395549|NCT02506881|41639880|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
19395550|NCT02506881|41639881|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395551|NCT02506881|41639882|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395552|NCT02506881|41639883|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395553|NCT02506881|41639880|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
19395554|NCT02506881|41639881|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
19395555|NCT02506881|41639882|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
19395556|NCT02506881|41639883|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
19395557|NCT02506257|41639907|FG000|Overall Study|Adverse Event|0|||
19395558|NCT02506257|41639908|FG001|Overall Study|Adverse Event|2|||
19395559|NCT02506257|41639909|FG002|Overall Study|Adverse Event|3|||
19395560|NCT02506257|41639910|FG003|Overall Study|Adverse Event|0|||
19395561|NCT02506257|41639907|FG000|Overall Study|Protocol Violation|0|||
19395562|NCT02506257|41639908|FG001|Overall Study|Protocol Violation|0|||
19395563|NCT02506257|41639909|FG002|Overall Study|Protocol Violation|1|||
19395564|NCT02506257|41639910|FG003|Overall Study|Protocol Violation|0|||
19395565|NCT02506101|41639922|FG000|Overall Study|Transportation issues|1|||
19395566|NCT02506101|41639923|FG001|Overall Study|Transportation issues|0|||
19395567|NCT02506101|41639922|FG000|Overall Study|No enrollment and staff unavailability|1|||
19395568|NCT02506101|41639923|FG001|Overall Study|No enrollment and staff unavailability|0|||
19395569|NCT01671007|41639938|FG000|Overall Study|Other reasons than listed|166|||
19395570|NCT01671007|41639939|FG001|Overall Study|Other reasons than listed|373|||
19395571|NCT01671007|41639940|FG002|Overall Study|Other reasons than listed|197|||
19395572|NCT01671007|41639941|FG003|Overall Study|Other reasons than listed|228|||
19395573|NCT01671007|41639942|FG004|Overall Study|Other reasons than listed|14|||
19395574|NCT01671007|41639943|FG005|Overall Study|Other reasons than listed|71|||
19627804|NCT00839306|42077230|FG000|Overall Study|Other|6|||
19374261|NCT02750813|41615767|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
19374262|NCT00503035|41615783|FG000|Overall Study|Lost to Follow-up|2|||
19374263|NCT00503035|41615783|FG000|Overall Study|Physician Decision|3|||
19374264|NCT00503035|41615783|FG000|Overall Study|Ineligible|15|||
19374265|NCT03137381|41615792|FG000|Overall Study|Adverse Event|3|||
19374266|NCT03137381|41615793|FG001|Overall Study|Adverse Event|0|||
19374267|NCT03137381|41615794|FG002|Overall Study|Adverse Event|2|||
19374268|NCT03137381|41615795|FG003|Overall Study|Adverse Event|0|||
19374269|NCT03137381|41615792|FG000|Overall Study|Lost to Follow-up|2|||
19374270|NCT03137381|41615793|FG001|Overall Study|Lost to Follow-up|1|||
19374271|NCT03137381|41615794|FG002|Overall Study|Lost to Follow-up|1|||
19374272|NCT03137381|41615795|FG003|Overall Study|Lost to Follow-up|0|||
19374273|NCT03137381|41615792|FG000|Overall Study|Protocol deviation|1|||
19374274|NCT03137381|41615793|FG001|Overall Study|Protocol deviation|1|||
19374275|NCT03137381|41615794|FG002|Overall Study|Protocol deviation|0|||
19374276|NCT03137381|41615795|FG003|Overall Study|Protocol deviation|1|||
19374277|NCT03137381|41615792|FG000|Overall Study|Withdrawal by Investigator|0|||
19374278|NCT03137381|41615793|FG001|Overall Study|Withdrawal by Investigator|1|||
19374279|NCT03137381|41615794|FG002|Overall Study|Withdrawal by Investigator|1|||
19374280|NCT03137381|41615795|FG003|Overall Study|Withdrawal by Investigator|0|||
19374281|NCT03137381|41615792|FG000|Overall Study|Withdrawal by Subject|3|||
19374282|NCT03137381|41615793|FG001|Overall Study|Withdrawal by Subject|4|||
19374283|NCT03137381|41615794|FG002|Overall Study|Withdrawal by Subject|3|||
19374284|NCT03137381|41615795|FG003|Overall Study|Withdrawal by Subject|0|||
19374285|NCT03137381|41615792|FG000|Overall Study|Pregnancy|0|||
19374286|NCT03137381|41615793|FG001|Overall Study|Pregnancy|0|||
19374287|NCT03137381|41615794|FG002|Overall Study|Pregnancy|1|||
19374288|NCT03137381|41615795|FG003|Overall Study|Pregnancy|0|||
19374289|NCT02750501|41615822|FG000|Overall Study|Adverse Event|4|||
19374290|NCT02750501|41615822|FG000|Overall Study|Physician Decision|1|||
19374291|NCT02750501|41615822|FG000|Overall Study|Protocol Violation|1|||
19374292|NCT02750501|41615822|FG000|Overall Study|G-tube came out|1|||
19374293|NCT02750501|41615822|FG000|Overall Study|Non-compliant use of PERT|1|||
19374294|NCT01337297|41615836|FG000|Overall Study|They entered to single anodal tDCS|4|||
19374295|NCT01337297|41615837|FG001|Overall Study|They entered to single anodal tDCS|3|||
19374296|NCT01337297|41615836|FG000|Overall Study|Lost to Follow-up|1|||
19374297|NCT01337297|41615837|FG001|Overall Study|Lost to Follow-up|3|||
19374298|NCT02302963|41615845|FG000|Overall Study|Withdrawal by Subject|2|||
19374299|NCT02302963|41615846|FG001|Overall Study|Withdrawal by Subject|1|||
19374300|NCT02302963|41615845|FG000|Overall Study|Steroid injection|0|||
19374301|NCT02302963|41615846|FG001|Overall Study|Steroid injection|1|||
19374302|NCT02302963|41615845|FG000|Overall Study|Physician Decision|1|||
19395575|NCT01671007|41639944|FG006|Overall Study|Other reasons than listed|17|||
19395576|NCT01671007|41639945|FG007|Overall Study|Other reasons than listed|66|||
19395577|NCT01671007|41639946|FG008|Overall Study|Other reasons than listed|0|||
19395578|NCT01671007|41639938|FG000|Overall Study|Withdrawal by Subject|36|||
19627805|NCT00839306|42077231|FG001|Overall Study|Other|18|||
19395579|NCT01671007|41639939|FG001|Overall Study|Withdrawal by Subject|59|||
19395580|NCT01671007|41639940|FG002|Overall Study|Withdrawal by Subject|53|||
19395581|NCT01671007|41639941|FG003|Overall Study|Withdrawal by Subject|58|||
19395582|NCT01671007|41639942|FG004|Overall Study|Withdrawal by Subject|4|||
19395583|NCT01671007|41639943|FG005|Overall Study|Withdrawal by Subject|15|||
19395584|NCT01671007|41639944|FG006|Overall Study|Withdrawal by Subject|1|||
19395585|NCT01671007|41639945|FG007|Overall Study|Withdrawal by Subject|19|||
19395586|NCT01671007|41639946|FG008|Overall Study|Withdrawal by Subject|0|||
19395587|NCT01671007|41639938|FG000|Overall Study|Lost to Follow-up|93|||
19395588|NCT01671007|41639939|FG001|Overall Study|Lost to Follow-up|142|||
19395589|NCT01671007|41639940|FG002|Overall Study|Lost to Follow-up|91|||
19395590|NCT01671007|41639941|FG003|Overall Study|Lost to Follow-up|63|||
19395591|NCT01671007|41639942|FG004|Overall Study|Lost to Follow-up|7|||
19395592|NCT01671007|41639943|FG005|Overall Study|Lost to Follow-up|20|||
19395593|NCT01671007|41639944|FG006|Overall Study|Lost to Follow-up|2|||
19395594|NCT01671007|41639945|FG007|Overall Study|Lost to Follow-up|28|||
19395595|NCT01671007|41639946|FG008|Overall Study|Lost to Follow-up|0|||
19395596|NCT01671007|41639938|FG000|Overall Study|No end of study case report form|3|||
19395597|NCT01671007|41639939|FG001|Overall Study|No end of study case report form|1|||
19395598|NCT01671007|41639940|FG002|Overall Study|No end of study case report form|0|||
19395599|NCT01671007|41639941|FG003|Overall Study|No end of study case report form|2|||
19395600|NCT01671007|41639942|FG004|Overall Study|No end of study case report form|0|||
19395601|NCT01671007|41639943|FG005|Overall Study|No end of study case report form|0|||
19395602|NCT01671007|41639944|FG006|Overall Study|No end of study case report form|0|||
19395603|NCT01671007|41639945|FG007|Overall Study|No end of study case report form|0|||
19395604|NCT01671007|41639946|FG008|Overall Study|No end of study case report form|0|||
19395605|NCT01671007|41639938|FG000|Overall Study|Not eligible|23|||
19395606|NCT01671007|41639939|FG001|Overall Study|Not eligible|76|||
19395607|NCT01671007|41639940|FG002|Overall Study|Not eligible|25|||
19395608|NCT01671007|41639941|FG003|Overall Study|Not eligible|17|||
19395609|NCT01671007|41639942|FG004|Overall Study|Not eligible|0|||
19395610|NCT01671007|41639943|FG005|Overall Study|Not eligible|6|||
19395611|NCT01671007|41639944|FG006|Overall Study|Not eligible|1|||
19395612|NCT01671007|41639945|FG007|Overall Study|Not eligible|19|||
19395613|NCT01671007|41639946|FG008|Overall Study|Not eligible|0|||
19395614|NCT02505945|41639959|FG000|Overall Study|Withdrawal by Subject|13|||
19395615|NCT02505945|41639960|FG001|Overall Study|Withdrawal by Subject|2|||
19395616|NCT02505945|41639959|FG000|Overall Study|Adverse Event|1|||
19395617|NCT02505945|41639960|FG001|Overall Study|Adverse Event|0|||
19395618|NCT02505945|41639959|FG000|Overall Study|Physician Decision|2|||
19395619|NCT02505945|41639960|FG001|Overall Study|Physician Decision|1|||
19395620|NCT02505945|41639959|FG000|Overall Study|Lost to Follow-up|6|||
19395621|NCT02505945|41639960|FG001|Overall Study|Lost to Follow-up|1|||
19395622|NCT02505867|41639968|FG000|Overall Study|Lack of Efficacy|6|||
19395623|NCT02505867|41639969|FG001|Overall Study|Lack of Efficacy|6|||
19395624|NCT02472639|41639977|FG000|Overall Study|Physician Decision|4|||
19395625|NCT02472639|41639978|FG001|Overall Study|Physician Decision|3|||
19395626|NCT02472405|41639984|FG000|Overall Study|Lost to Follow-up|9|||
19395627|NCT02472405|41639984|FG000|Overall Study|Adverse Event|1|||
19395628|NCT02448771|41639990|FG000|Overall Study|Disease Progression|30|||
19395629|NCT02448771|41639990|FG000|Overall Study|Unacceptable Toxicity|1|||
19395630|NCT02448771|41639990|FG000|Overall Study|Physician Decision|3|||
19395631|NCT02448771|41639990|FG000|Overall Study|Started new therapy|2|||
19395632|NCT02504541|41639995|FG000|Overall Study|Adverse Event|4|||
19395633|NCT02504541|41639995|FG000|Overall Study|Withdrawal by Subject|4|||
19395634|NCT02504541|41639995|FG000|Overall Study|Lost to Follow-up|1|||
19395635|NCT02504541|41639995|FG000|Overall Study|Met Stopping Criteria|1|||
19395636|NCT02504541|41639995|FG000|Overall Study|Protocol Violation|2|||
19395637|NCT02504541|41639995|FG000|Overall Study|Termination by Sponsor|1|||
19395638|NCT02504541|41639995|FG000|Overall Study|Other|2|||
19395639|NCT02504541|41639995|FG000|Overall Study|Multiple|5|||
19395640|NCT02725177|41639999|FG000|Overall Study|Physician Decision|4|||
19395641|NCT02725177|41639999|FG000|Overall Study|Adverse Event|1|||
19395642|NCT02448537|41640006|FG000|Overall Study|Withdrawal by Subject|1|||
19395643|NCT02448537|41640007|FG001|Overall Study|Withdrawal by Subject|1|||
19374303|NCT02302963|41615846|FG001|Overall Study|Physician Decision|0|||
19374304|NCT04702997|41615854|FG000|Overall Study|Withdrawal by Subject|1|||
19374305|NCT04702997|41615855|FG001|Overall Study|Withdrawal by Subject|1|||
19374306|NCT03507127|41615876|FG000|Overall Study|Withdrawal by Subject|1|||
19374307|NCT03507127|41615877|FG001|Overall Study|Withdrawal by Subject|0|||
19374308|NCT03507127|41615876|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
19374309|NCT03507127|41615877|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
19374310|NCT02322190|41615900|FG000|Overall Study|Death on study|1|||
19395644|NCT02448537|41640008|FG002|Overall Study|Withdrawal by Subject|1|||
19395645|NCT02504151|41640018|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
19395646|NCT02504151|41640019|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
19395647|NCT02504151|41640018|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
19395648|NCT02504151|41640019|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
19395649|NCT02504151|41640018|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
19395650|NCT02504151|41640019|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19395651|NCT02504151|41640018|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
19395652|NCT02504151|41640019|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
19395653|NCT02448381|41640027|FG000|Overall Study|Adverse Event|2|||
19395654|NCT02448381|41640028|FG001|Overall Study|Adverse Event|0|||
19395655|NCT02448381|41640027|FG000|Overall Study|Lost to Follow-up|16|||
19395656|NCT02448381|41640028|FG001|Overall Study|Lost to Follow-up|9|||
19395657|NCT02448381|41640027|FG000|Overall Study|Physician Decision|1|||
19395658|NCT02448381|41640028|FG001|Overall Study|Physician Decision|1|||
19395659|NCT02448381|41640027|FG000|Overall Study|Pregnancy|1|||
19395660|NCT02448381|41640028|FG001|Overall Study|Pregnancy|0|||
19395661|NCT02448381|41640027|FG000|Overall Study|Withdrawal by Subject|13|||
19395662|NCT02448381|41640028|FG001|Overall Study|Withdrawal by Subject|9|||
19395663|NCT02448381|41640027|FG000|Overall Study|Noncompliance with Study Procedures|2|||
19395664|NCT02448381|41640028|FG001|Overall Study|Noncompliance with Study Procedures|0|||
19395665|NCT02448225|41640040|FG000|Overall Study|Withdrawal by Subject|1|||
19395666|NCT02448225|41640040|FG000|Overall Study|Did not get FSPG scan|18|||
19395667|NCT02448225|41640040|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
19395668|NCT02503215|41640047|FG000|Overall Study|Unable to wear compression stockings|1|||
19395669|NCT02503215|41640047|FG000|Overall Study|Unable to use positive airway pressure|2|||
19395670|NCT02447991|41640053|FG000|Overall Study|Withdrawn by subject - no data|0|||
19395671|NCT02447991|41640054|FG001|Overall Study|Withdrawn by subject - no data|2|||
19395672|NCT02447991|41640053|FG000|Overall Study|Withdrawn by Subject - with data|4|||
19395673|NCT02447991|41640054|FG001|Overall Study|Withdrawn by Subject - with data|4|||
19395674|NCT02447991|41640053|FG000|Overall Study|Lost to Follow-up - no data|3|||
19395675|NCT02447991|41640054|FG001|Overall Study|Lost to Follow-up - no data|6|||
19395676|NCT02447991|41640053|FG000|Overall Study|Lost to follow-up - with data|0|||
19395677|NCT02447991|41640054|FG001|Overall Study|Lost to follow-up - with data|3|||
19395678|NCT02447991|41640053|FG000|Overall Study|End of study - no treatment results|3|||
19395679|NCT02447991|41640054|FG001|Overall Study|End of study - no treatment results|6|||
19395680|NCT02447991|41640053|FG000|Overall Study|End of study - partial treatment results|0|||
19395681|NCT02447991|41640054|FG001|Overall Study|End of study - partial treatment results|9|||
19395682|NCT02586155|41640066|FG000|Overall Study|Adverse Event|2|||
19395683|NCT02586155|41640067|FG001|Overall Study|Adverse Event|3|||
19395684|NCT02586155|41640066|FG000|Overall Study|Withdrawal by Subject|31|||
19395685|NCT02586155|41640067|FG001|Overall Study|Withdrawal by Subject|24|||
19395686|NCT02586155|41640066|FG000|Overall Study|Lost to Follow-up|7|||
19395687|NCT02586155|41640067|FG001|Overall Study|Lost to Follow-up|13|||
19395688|NCT02586155|41640066|FG000|Overall Study|Death|61|||
19395689|NCT02586155|41640067|FG001|Overall Study|Death|72|||
19395690|NCT02586155|41640066|FG000|Overall Study|Other reasons|26|||
19395691|NCT02586155|41640067|FG001|Overall Study|Other reasons|15|||
19395692|NCT02446743|41640075|FG000|Overall Study|Withdrawal by Subject|1|||
19395693|NCT02446743|41640076|FG001|Overall Study|Withdrawal by Subject|1|||
19395694|NCT02446743|41640075|FG000|Overall Study|Lost to Follow-up|1|||
19395695|NCT02446743|41640076|FG001|Overall Study|Lost to Follow-up|0|||
19395696|NCT02446743|41640075|FG000|Overall Study|Adverse Event|1|||
19395697|NCT02446743|41640076|FG001|Overall Study|Adverse Event|1|||
19395698|NCT02446743|41640075|FG000|Overall Study|Other|2|||
19395699|NCT02446743|41640076|FG001|Overall Study|Other|3|||
19395700|NCT02586077|41640091|FG000|Overall Study|Withdrawal by Subject|1|||
19395701|NCT02586077|41640091|FG000|Overall Study|Physician Decision|4|||
19395702|NCT02586077|41640091|FG000|Overall Study|Lost to Follow-up|3|||
19395703|NCT02583425|41640096|FG000|Screening|Did not meet entry criteria|12|||
19395704|NCT02583425|41640096|FG000|Baseline|Did not meet continued criteria|5|||
19395705|NCT02583425|41640096|FG000|Treatment Period|Adverse Event|1|||
19395706|NCT02581163|41640101|FG000|Overall Study|Failure to return|15|||
19395707|NCT02581163|41640101|FG000|Overall Study|Insufficient virological response|3|||
19395708|NCT02581163|41640101|FG000|Overall Study|Withdrew consent|1|||
19395709|NCT02581163|41640101|FG000|Overall Study|Death|1|||
19395710|NCT02581163|41640101|FG000|Overall Study|Other, not specified|9|||
19395711|NCT02627677|41640111|FG000|Overall Study|Adverse event (not progressive disease)|1|||
19395712|NCT02627677|41640112|FG001|Overall Study|Adverse event (not progressive disease)|4|||
19395713|NCT02627677|41640113|FG002|Overall Study|Adverse event (not progressive disease)|1|||
19395714|NCT02627677|41640111|FG000|Overall Study|Progressive disease|1|||
19710996|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
19710997|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
19710998|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
19395715|NCT02627677|41640112|FG001|Overall Study|Progressive disease|3|||
19395716|NCT02627677|41640113|FG002|Overall Study|Progressive disease|0|||
19395717|NCT02627677|41640111|FG000|Overall Study|Lack of Efficacy|1|||
19395718|NCT02627677|41640112|FG001|Overall Study|Lack of Efficacy|2|||
19395719|NCT02627677|41640113|FG002|Overall Study|Lack of Efficacy|0|||
19395720|NCT02627677|41640111|FG000|Overall Study|Lost to Follow-up|0|||
19395721|NCT02627677|41640112|FG001|Overall Study|Lost to Follow-up|0|||
19395722|NCT02627677|41640113|FG002|Overall Study|Lost to Follow-up|1|||
19395723|NCT02627677|41640111|FG000|Overall Study|Pregnancy|0|||
19395724|NCT02627677|41640112|FG001|Overall Study|Pregnancy|1|||
19395725|NCT02627677|41640113|FG002|Overall Study|Pregnancy|0|||
19395726|NCT02627677|41640111|FG000|Overall Study|Study Terminated by Sponsor|5|||
19395727|NCT02627677|41640112|FG001|Overall Study|Study Terminated by Sponsor|10|||
19395728|NCT02627677|41640113|FG002|Overall Study|Study Terminated by Sponsor|6|||
19395729|NCT02627677|41640111|FG000|Overall Study|Physician Decision|0|||
19395730|NCT02627677|41640112|FG001|Overall Study|Physician Decision|0|||
19395731|NCT02627677|41640113|FG002|Overall Study|Physician Decision|2|||
19395732|NCT02627677|41640111|FG000|Overall Study|Withdrawal by Subject|2|||
19395733|NCT02627677|41640112|FG001|Overall Study|Withdrawal by Subject|1|||
19395734|NCT02627677|41640113|FG002|Overall Study|Withdrawal by Subject|1|||
19395735|NCT02627677|41640111|FG000|Overall Study|Reason not Specified|0|||
19395736|NCT02627677|41640112|FG001|Overall Study|Reason not Specified|0|||
19395737|NCT02627677|41640113|FG002|Overall Study|Reason not Specified|1|||
19395738|NCT02627677|41640111|FG000|Overall Study|Randomized but not Treated|1|||
19395739|NCT02627677|41640112|FG001|Overall Study|Randomized but not Treated|0|||
19395740|NCT02627677|41640113|FG002|Overall Study|Randomized but not Treated|0|||
19395741|NCT02501811|41640126|FG000|Overall Study|Death|1|||
19395742|NCT02501811|41640127|FG001|Overall Study|Death|3|||
19395743|NCT02501811|41640128|FG002|Overall Study|Death|2|||
19395744|NCT02501811|41640129|FG003|Overall Study|Death|3|||
19395745|NCT02501811|41640126|FG000|Overall Study|Withdrawal by Subject|3|||
19395746|NCT02501811|41640127|FG001|Overall Study|Withdrawal by Subject|3|||
19395747|NCT02501811|41640128|FG002|Overall Study|Withdrawal by Subject|2|||
19395748|NCT02501811|41640129|FG003|Overall Study|Withdrawal by Subject|3|||
19395749|NCT02501811|41640126|FG000|Overall Study|Lost to Follow-up|0|||
19395750|NCT02501811|41640127|FG001|Overall Study|Lost to Follow-up|0|||
19395751|NCT02501811|41640128|FG002|Overall Study|Lost to Follow-up|2|||
19395752|NCT02501811|41640129|FG003|Overall Study|Lost to Follow-up|1|||
19395753|NCT02585999|41640139|FG000|Overall Study|Lost to Follow-up|1|||
19395754|NCT02585999|41640139|FG000|Overall Study|Protocol Violation|1|||
19395755|NCT02582255|41640146|FG000|Overall Study|Protocol Violation|0|||
19395756|NCT02582255|41640147|FG001|Overall Study|Protocol Violation|3|||
19395757|NCT02500719|41640156|FG000|Overall Study|Lost to Follow-up|2|||
19395758|NCT02500719|41640157|FG001|Overall Study|Lost to Follow-up|3|||
19395759|NCT02500719|41640156|FG000|Overall Study|Trauma history|1|||
19395760|NCT02500719|41640157|FG001|Overall Study|Trauma history|0|||
19395761|NCT02500719|41640156|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
19395762|NCT02500719|41640157|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
19395763|NCT02500719|41640156|FG000|Overall Study|Did not meet criteria for PTSD|0|||
19395764|NCT02500719|41640157|FG001|Overall Study|Did not meet criteria for PTSD|1|||
19395765|NCT02500719|41640156|FG000|Overall Study|Claustrophobia|0|||
19395766|NCT02500719|41640157|FG001|Overall Study|Claustrophobia|1|||
19395767|NCT02500719|41640156|FG000|Overall Study|History of head trauma|0|||
19395768|NCT02500719|41640157|FG001|Overall Study|History of head trauma|1|||
19395769|NCT02500641|41640165|FG000|Overall Study|Adverse Event|0|||
19395770|NCT02500641|41640166|FG001|Overall Study|Adverse Event|2|||
19395771|NCT02500641|41640165|FG000|Overall Study|Withdrawal by Subject|4|||
19395772|NCT02500641|41640166|FG001|Overall Study|Withdrawal by Subject|5|||
19395773|NCT02500641|41640165|FG000|Overall Study|Unable to follow study procedures|3|||
19395774|NCT02500641|41640166|FG001|Overall Study|Unable to follow study procedures|2|||
19395775|NCT02500641|41640165|FG000|Overall Study|Protocol Violation|1|||
19395776|NCT02500641|41640166|FG001|Overall Study|Protocol Violation|2|||
19395777|NCT02500641|41640165|FG000|Overall Study|Lost to Follow-up|1|||
19395778|NCT02500641|41640166|FG001|Overall Study|Lost to Follow-up|0|||
19395779|NCT02500641|41640165|FG000|Overall Study|Sponsor decision|1|||
19395780|NCT02500641|41640166|FG001|Overall Study|Sponsor decision|0|||
19395781|NCT02500641|41640165|FG000|Overall Study|Non compliance to study drug|0|||
19395782|NCT02500641|41640166|FG001|Overall Study|Non compliance to study drug|1|||
19395783|NCT02499783|41640174|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
19395784|NCT02499783|41640175|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
19395785|NCT02499783|41640176|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
19395786|NCT02499783|41640174|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
19395787|NCT02499783|41640175|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
19395788|NCT02499783|41640176|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
19395789|NCT02499783|41640174|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
19395790|NCT02499783|41640175|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
19395791|NCT02499783|41640176|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
19395792|NCT02499783|41640174|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
19395793|NCT02499783|41640175|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
19395794|NCT02499783|41640176|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
19395795|NCT02499783|41640174|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
19395796|NCT02499783|41640175|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
19395797|NCT02499783|41640176|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
19395798|NCT02499783|41640174|FG000|DB Period: Weeks 0-8|Other|1|||
19395799|NCT02499783|41640175|FG001|DB Period: Weeks 0-8|Other|1|||
19395800|NCT02499783|41640176|FG002|DB Period: Weeks 0-8|Other|0|||
19395801|NCT02499783|41640174|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
19395802|NCT02499783|41640175|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
19395803|NCT02499783|41640176|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
19395804|NCT02499783|41640174|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
19395805|NCT02499783|41640175|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
19395806|NCT02499783|41640176|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
19395807|NCT02499783|41640174|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
19395808|NCT02499783|41640175|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
19374311|NCT02322190|41615901|FG001|Overall Study|Death on study|0|||
19374312|NCT02321800|41615917|FG000|Overall Study|Withdrawal by Subject|3|||
19374313|NCT02321800|41615918|FG001|Overall Study|Withdrawal by Subject|3|||
19374314|NCT02321800|41615917|FG000|Overall Study|Death|1|||
19374315|NCT02321800|41615918|FG001|Overall Study|Death|0|||
19374316|NCT02321800|41615917|FG000|Overall Study|Protocol Violation|1|||
19374317|NCT02321800|41615918|FG001|Overall Study|Protocol Violation|0|||
19374318|NCT02321800|41615917|FG000|Overall Study|Lost to Follow-up|10|||
19374319|NCT02321800|41615918|FG001|Overall Study|Lost to Follow-up|4|||
19374320|NCT02321800|41615917|FG000|Overall Study|Adverse Event|2|||
19374321|NCT02321800|41615918|FG001|Overall Study|Adverse Event|3|||
19374322|NCT02321800|41615917|FG000|Overall Study|Other, Miscellaneous|3|||
19374323|NCT02321800|41615918|FG001|Overall Study|Other, Miscellaneous|1|||
19374324|NCT02292784|41615964|FG000|Overall Study|Lost to Follow-up|1|||
19374325|NCT02292784|41615965|FG001|Overall Study|Lost to Follow-up|17|||
19374326|NCT02292784|41615966|FG002|Overall Study|Lost to Follow-up|18|||
19374327|NCT02292784|41615964|FG000|Overall Study|Withdrawal by Subject|0|||
19374328|NCT02292784|41615965|FG001|Overall Study|Withdrawal by Subject|3|||
19374329|NCT02292784|41615966|FG002|Overall Study|Withdrawal by Subject|3|||
19374330|NCT02320396|41615976|FG000|Overall Study|Adverse Event|2|||
19374331|NCT02320396|41615977|FG001|Overall Study|Adverse Event|2|||
19374332|NCT02320396|41615976|FG000|Overall Study|Pregnancy|0|||
19374333|NCT02320396|41615977|FG001|Overall Study|Pregnancy|1|||
19374334|NCT02320396|41615976|FG000|Overall Study|Protocol Violation|0|||
19374335|NCT02320396|41615977|FG001|Overall Study|Protocol Violation|1|||
19374336|NCT02320396|41615976|FG000|Overall Study|Withdrawal by Subject|2|||
19374337|NCT02320396|41615977|FG001|Overall Study|Withdrawal by Subject|0|||
19374338|NCT02292238|41615985|FG000|Overall Study|Protocol Violation|1|||
19374339|NCT02292238|41615986|FG001|Overall Study|Protocol Violation|2|||
19374340|NCT02292238|41615985|FG000|Overall Study|Withdrawal by Subject|2|||
19374341|NCT02292238|41615986|FG001|Overall Study|Withdrawal by Subject|1|||
19374342|NCT02292238|41615985|FG000|Overall Study|Lost to Follow-up|1|||
19374343|NCT02292238|41615986|FG001|Overall Study|Lost to Follow-up|0|||
19374344|NCT02292238|41615985|FG000|Overall Study|Physician Decision|0|||
19374345|NCT02292238|41615986|FG001|Overall Study|Physician Decision|1|||
19374346|NCT02234843|41616023|FG000|Overall Study|Death|1|||
19374347|NCT02234843|41616024|FG001|Overall Study|Death|0|||
19374348|NCT02234843|41616025|FG002|Overall Study|Death|0|||
19374349|NCT02234843|41616026|FG003|Overall Study|Death|0|||
19374350|NCT02234843|41616027|FG004|Overall Study|Death|0|||
19374351|NCT02234843|41616028|FG005|Overall Study|Death|0|||
19374352|NCT02234843|41616029|FG006|Overall Study|Death|0|||
19374353|NCT02234843|41616030|FG007|Overall Study|Death|0|||
19374354|NCT02234843|41616031|FG008|Overall Study|Death|0|||
19374355|NCT02234843|41616032|FG009|Overall Study|Death|0|||
19374356|NCT02234843|41616023|FG000|Overall Study|Protocol Violation|1|||
19374357|NCT02234843|41616024|FG001|Overall Study|Protocol Violation|0|||
19374358|NCT02234843|41616025|FG002|Overall Study|Protocol Violation|1|||
19374359|NCT02234843|41616026|FG003|Overall Study|Protocol Violation|0|||
19374360|NCT02234843|41616027|FG004|Overall Study|Protocol Violation|0|||
19374361|NCT02234843|41616028|FG005|Overall Study|Protocol Violation|0|||
19374362|NCT02234843|41616029|FG006|Overall Study|Protocol Violation|0|||
19374363|NCT02234843|41616030|FG007|Overall Study|Protocol Violation|0|||
19374364|NCT02234843|41616031|FG008|Overall Study|Protocol Violation|0|||
19374365|NCT02234843|41616032|FG009|Overall Study|Protocol Violation|0|||
19395809|NCT02499783|41640176|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
19395810|NCT02499783|41640174|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
19395811|NCT02499783|41640175|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
19395812|NCT02499783|41640176|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
19395813|NCT02468193|41640186|FG000|Overall Study|Adverse Event|4|||
19395814|NCT02468193|41640186|FG000|Overall Study|Subject/ Guardian decision|2|||
19395815|NCT02466555|41640206|FG000|Overall Study|Lost to Follow-up|2|||
19395816|NCT02466399|41640213|FG000|Overall Study|Adverse Event|1|||
19395817|NCT02466399|41640214|FG001|Overall Study|Adverse Event|0|||
19395818|NCT02466399|41640213|FG000|Overall Study|Early exit due to family emergency|1|||
19395819|NCT02466399|41640214|FG001|Overall Study|Early exit due to family emergency|0|||
19395820|NCT02465931|41640222|FG000|Overall Study|Lost to Follow-up|9|||
19395821|NCT02465931|41640223|FG001|Overall Study|Lost to Follow-up|11|||
19395822|NCT02465931|41640222|FG000|Overall Study|Protocol Violation|1|||
19395823|NCT02465931|41640223|FG001|Overall Study|Protocol Violation|0|||
19395824|NCT02465931|41640222|FG000|Overall Study|Withdrawal by Subject|1|||
19395825|NCT02465931|41640223|FG001|Overall Study|Withdrawal by Subject|0|||
19395826|NCT02465463|41640231|FG000|Overall Study|Lost to Follow-up|2|||
19395827|NCT02465463|41640232|FG001|Overall Study|Lost to Follow-up|1|||
19395828|NCT02465463|41640231|FG000|Overall Study|Death|1|||
19395829|NCT02465463|41640232|FG001|Overall Study|Death|0|||
19395830|NCT02465463|41640231|FG000|Overall Study|Protocol Violation|1|||
19395831|NCT02465463|41640232|FG001|Overall Study|Protocol Violation|0|||
19395832|NCT02464059|41640239|FG000|Overall Study|Lost to Follow-up|6|||
19395833|NCT02463357|41640248|FG000|Overall Study|Withdrawal by Subject|1|||
19395834|NCT02463357|41640249|FG001|Overall Study|Withdrawal by Subject|0|||
19395835|NCT02463357|41640250|FG002|Overall Study|Withdrawal by Subject|0|||
19395836|NCT02463357|41640251|FG003|Overall Study|Withdrawal by Subject|0|||
19395837|NCT02463357|41640252|FG004|Overall Study|Withdrawal by Subject|0|||
19395838|NCT02463357|41640248|FG000|Overall Study|Withdrawal by Subject|0|||
19395839|NCT02463357|41640249|FG001|Overall Study|Withdrawal by Subject|0|||
19395840|NCT02463357|41640250|FG002|Overall Study|Withdrawal by Subject|0|||
19395841|NCT02463357|41640251|FG003|Overall Study|Withdrawal by Subject|0|||
19395842|NCT02463357|41640252|FG004|Overall Study|Withdrawal by Subject|1|||
19395843|NCT02579759|41640267|FG000|Overall Study|Protocol Violation|2|||
19395844|NCT02579759|41640268|FG001|Overall Study|Protocol Violation|0|||
19395845|NCT02579759|41640269|FG002|Overall Study|Protocol Violation|0|||
19395846|NCT02579759|41640267|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
19395847|NCT02579759|41640268|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
19395848|NCT02579759|41640269|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
19395849|NCT02579759|41640267|FG000|Overall Study|BfArM hold|13|||
19395850|NCT02579759|41640268|FG001|Overall Study|BfArM hold|12|||
19395851|NCT02579759|41640269|FG002|Overall Study|BfArM hold|12|||
19395852|NCT02579759|41640267|FG000|Overall Study|Sponsor stopped Dose 2|0|||
19395853|NCT02579759|41640268|FG001|Overall Study|Sponsor stopped Dose 2|41|||
19395854|NCT02579759|41640269|FG002|Overall Study|Sponsor stopped Dose 2|0|||
19395855|NCT02579759|41640267|FG000|Overall Study|Non compliance|0|||
19395856|NCT02579759|41640268|FG001|Overall Study|Non compliance|1|||
19395857|NCT02579759|41640269|FG002|Overall Study|Non compliance|0|||
19395858|NCT02579759|41640267|FG000|Overall Study|Pregnancy|0|||
19395859|NCT02579759|41640268|FG001|Overall Study|Pregnancy|1|||
19395860|NCT02579759|41640269|FG002|Overall Study|Pregnancy|0|||
19395861|NCT02579759|41640267|FG000|Overall Study|Inclusion/exclusion criteria|0|||
19395862|NCT02579759|41640268|FG001|Overall Study|Inclusion/exclusion criteria|0|||
19395863|NCT02579759|41640269|FG002|Overall Study|Inclusion/exclusion criteria|1|||
19395864|NCT02579759|41640267|FG000|Overall Study|Adverse Event|4|||
19395865|NCT02579759|41640268|FG001|Overall Study|Adverse Event|3|||
19395866|NCT02579759|41640269|FG002|Overall Study|Adverse Event|1|||
19395867|NCT02579759|41640267|FG000|Overall Study|Withdrawal by Subject|3|||
19395868|NCT02579759|41640268|FG001|Overall Study|Withdrawal by Subject|3|||
19395869|NCT02579759|41640269|FG002|Overall Study|Withdrawal by Subject|5|||
19395870|NCT02579759|41640267|FG000|Overall Study|Lost to Follow-up|2|||
19395871|NCT02579759|41640268|FG001|Overall Study|Lost to Follow-up|2|||
19395872|NCT02579759|41640269|FG002|Overall Study|Lost to Follow-up|2|||
19395873|NCT02445963|41640283|FG000|Overall Study|Lost to Follow-up|1|||
19395874|NCT02445963|41640284|FG001|Overall Study|Lost to Follow-up|0|||
19395875|NCT02445963|41640285|FG002|Overall Study|Lost to Follow-up|0|||
19395876|NCT02445963|41640286|FG003|Overall Study|Lost to Follow-up|0|||
19395877|NCT02445963|41640283|FG000|Overall Study|Change in employment|1|||
19395878|NCT02445963|41640284|FG001|Overall Study|Change in employment|0|||
19395879|NCT02445963|41640285|FG002|Overall Study|Change in employment|0|||
19395880|NCT02445963|41640286|FG003|Overall Study|Change in employment|0|||
19395881|NCT02445963|41640283|FG000|Overall Study|Symptoms post-vaccination|0|||
19395882|NCT02445963|41640284|FG001|Overall Study|Symptoms post-vaccination|0|||
19395883|NCT02445963|41640285|FG002|Overall Study|Symptoms post-vaccination|1|||
19395884|NCT02445963|41640286|FG003|Overall Study|Symptoms post-vaccination|0|||
19395885|NCT02499159|41640300|FG000|Randomization|Protocol Violation|1|||
19395886|NCT02499159|41640301|FG001|Randomization|Protocol Violation|1|||
19395887|NCT02499159|41640300|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
19395888|NCT02499159|41640301|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
19395889|NCT02499159|41640300|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
19395890|NCT02499159|41640301|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
19395891|NCT02499159|41640300|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
19395892|NCT02499159|41640301|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
19395893|NCT02499159|41640300|FG000|30-Day Follow-Up Phone Call|Other|1|||
19395894|NCT02499159|41640301|FG001|30-Day Follow-Up Phone Call|Other|0|||
19395895|NCT01664039|41640309|FG000|Overall Study|Adverse Event|3|||
19395896|NCT01664039|41640310|FG001|Overall Study|Adverse Event|4|||
19395897|NCT01664039|41640309|FG000|Overall Study|Lost to Follow-up|1|||
19395898|NCT01664039|41640310|FG001|Overall Study|Lost to Follow-up|1|||
19395899|NCT01664039|41640309|FG000|Overall Study|Withdrawal by Subject|1|||
19395900|NCT01664039|41640310|FG001|Overall Study|Withdrawal by Subject|3|||
19395901|NCT01664039|41640309|FG000|Overall Study|Noncompliance|1|||
19395902|NCT01664039|41640310|FG001|Overall Study|Noncompliance|1|||
19395903|NCT02445573|41640318|FG000|Overall Study|Withdrawal by Subject|1|||
19395904|NCT02445573|41640319|FG001|Overall Study|Withdrawal by Subject|1|||
19395905|NCT02445573|41640318|FG000|Overall Study|Lost to Follow-up|0|||
19395906|NCT02445573|41640319|FG001|Overall Study|Lost to Follow-up|1|||
19395907|NCT02445339|41640327|FG000|Overall Study|Physician Decision|1|||
19395908|NCT02445339|41640328|FG001|Overall Study|Physician Decision|0|||
19395909|NCT02445339|41640327|FG000|Overall Study|Lost to Follow-up|11|||
19395910|NCT02445339|41640328|FG001|Overall Study|Lost to Follow-up|15|||
19395911|NCT02579603|41640336|FG000|Overall Study|Not treated|1|||
19395912|NCT02579603|41640337|FG001|Overall Study|Not treated|0|||
19395913|NCT02579603|41640336|FG000|Overall Study|Adverse Event|2|||
19395914|NCT02579603|41640337|FG001|Overall Study|Adverse Event|2|||
19395915|NCT02579603|41640336|FG000|Overall Study|Other than stated|1|||
19395916|NCT02579603|41640337|FG001|Overall Study|Other than stated|0|||
19395917|NCT02625259|41640349|FG000|First Intervention (Day 1)|Other|0|||
19395918|NCT02625259|41640350|FG001|First Intervention (Day 1)|Other|0|||
19395919|NCT02625259|41640351|FG002|First Intervention (Day 1)|Other|1|||
19395920|NCT02625259|41640352|FG003|First Intervention (Day 1)|Other|0|||
19395921|NCT02625259|41640353|FG004|First Intervention (Day 1)|Other|0|||
19395922|NCT02625259|41640349|FG000|First Intervention (Day 1)|Adverse Event|2|||
19395923|NCT02625259|41640350|FG001|First Intervention (Day 1)|Adverse Event|1|||
19395924|NCT02625259|41640351|FG002|First Intervention (Day 1)|Adverse Event|0|||
19395925|NCT02625259|41640352|FG003|First Intervention (Day 1)|Adverse Event|0|||
19395926|NCT02625259|41640353|FG004|First Intervention (Day 1)|Adverse Event|0|||
19395927|NCT02625259|41640349|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395928|NCT02625259|41640350|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395929|NCT02625259|41640351|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395930|NCT02625259|41640352|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
19395931|NCT02625259|41640353|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
19395932|NCT02577107|41640370|FG000|Overall Study|Protocol deviation|0|||
19395933|NCT02577107|41640371|FG001|Overall Study|Protocol deviation|1|||
19395934|NCT02444793|41640381|FG000|Overall Study|Lost to Follow-up|2|||
19395935|NCT02444793|41640382|FG001|Overall Study|Lost to Follow-up|2|||
19395936|NCT02444793|41640383|FG002|Overall Study|Lost to Follow-up|0|||
19395937|NCT02444793|41640384|FG003|Overall Study|Lost to Follow-up|0|||
19395938|NCT02444793|41640381|FG000|Overall Study|Death|0|||
19395939|NCT02444793|41640382|FG001|Overall Study|Death|3|||
19395940|NCT02444793|41640383|FG002|Overall Study|Death|0|||
19395941|NCT02444793|41640384|FG003|Overall Study|Death|0|||
19395942|NCT02444793|41640381|FG000|Overall Study|Other|0|||
19395943|NCT02444793|41640382|FG001|Overall Study|Other|0|||
19395944|NCT02444793|41640383|FG002|Overall Study|Other|2|||
19395945|NCT02444793|41640384|FG003|Overall Study|Other|0|||
19395946|NCT02444793|41640381|FG000|Overall Study|Objective progression or relapse|9|||
19395947|NCT02444793|41640382|FG001|Overall Study|Objective progression or relapse|1|||
19395948|NCT02444793|41640383|FG002|Overall Study|Objective progression or relapse|2|||
19395949|NCT02444793|41640384|FG003|Overall Study|Objective progression or relapse|3|||
19395950|NCT02624713|41640397|FG000|Overall Study|Lost to Follow-up|14|||
19395951|NCT02624713|41640398|FG001|Overall Study|Lost to Follow-up|0|||
19395952|NCT02624791|41640405|FG000|Overall Study|Withdrawal by Subject|2|||
19395953|NCT02624791|41640406|FG001|Overall Study|Withdrawal by Subject|0|||
19395954|NCT02624791|41640407|FG002|Overall Study|Withdrawal by Subject|0|||
19395955|NCT02624791|41640408|FG003|Overall Study|Withdrawal by Subject|0|||
19395956|NCT02624791|41640409|FG004|Overall Study|Withdrawal by Subject|0|||
19395957|NCT02624791|41640410|FG005|Overall Study|Withdrawal by Subject|0|||
19395958|NCT02577029|41640422|FG000|Overall Study|Adverse Event|1|||
19395959|NCT02577029|41640423|FG001|Overall Study|Adverse Event|0|||
19395960|NCT02577029|41640424|FG002|Overall Study|Adverse Event|2|||
19710999|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
19395961|NCT02577029|41640425|FG003|Overall Study|Adverse Event|0|||
19395962|NCT02577029|41640426|FG004|Overall Study|Adverse Event|1|||
19395963|NCT02577029|41640427|FG005|Overall Study|Adverse Event|0|||
19395964|NCT02577029|41640428|FG006|Overall Study|Adverse Event|0|||
19395965|NCT02577029|41640429|FG007|Overall Study|Adverse Event|0|||
19395966|NCT02577029|41640422|FG000|Overall Study|Withdrawal by Subject|0|||
19395967|NCT02577029|41640423|FG001|Overall Study|Withdrawal by Subject|0|||
19395968|NCT02577029|41640424|FG002|Overall Study|Withdrawal by Subject|0|||
19395969|NCT02577029|41640425|FG003|Overall Study|Withdrawal by Subject|0|||
19395970|NCT02577029|41640426|FG004|Overall Study|Withdrawal by Subject|0|||
19395971|NCT02577029|41640427|FG005|Overall Study|Withdrawal by Subject|1|||
19395972|NCT02577029|41640428|FG006|Overall Study|Withdrawal by Subject|0|||
19395973|NCT02577029|41640429|FG007|Overall Study|Withdrawal by Subject|0|||
19395974|NCT02577029|41640422|FG000|Overall Study|Sponsor Termination of the Study|9|||
19395975|NCT02577029|41640423|FG001|Overall Study|Sponsor Termination of the Study|2|||
19395976|NCT02577029|41640424|FG002|Overall Study|Sponsor Termination of the Study|5|||
19395977|NCT02577029|41640425|FG003|Overall Study|Sponsor Termination of the Study|12|||
19395978|NCT02577029|41640426|FG004|Overall Study|Sponsor Termination of the Study|10|||
19395979|NCT02577029|41640427|FG005|Overall Study|Sponsor Termination of the Study|12|||
19395980|NCT02577029|41640428|FG006|Overall Study|Sponsor Termination of the Study|12|||
19395981|NCT02577029|41640429|FG007|Overall Study|Sponsor Termination of the Study|12|||
19395982|NCT02577887|41640447|FG000|Overall Study|Death|93|||
19395983|NCT02577887|41640447|FG000|Overall Study|Protocol Violation|125|||
19395984|NCT02577887|41640447|FG000|Overall Study|Withdrawal by Subject|80|||
19395985|NCT03597347|41640454|FG000|Overall Study|Withdrawal by Subject|1|||
19395986|NCT03597347|41640455|FG001|Overall Study|Withdrawal by Subject|1|||
19395987|NCT03597347|41640456|FG002|Overall Study|Withdrawal by Subject|0|||
19395988|NCT03597347|41640454|FG000|Overall Study|Withdrawal due to Covid-19|3|||
19395989|NCT03597347|41640455|FG001|Overall Study|Withdrawal due to Covid-19|0|||
19395990|NCT03597347|41640456|FG002|Overall Study|Withdrawal due to Covid-19|0|||
19395991|NCT03597347|41640454|FG000|Overall Study|Sponsor decision to terminate study|3|||
19395992|NCT03597347|41640455|FG001|Overall Study|Sponsor decision to terminate study|2|||
19395993|NCT03597347|41640456|FG002|Overall Study|Sponsor decision to terminate study|4|||
19395994|NCT02576951|41640468|FG000|Overall Study|Lost to Follow-up|0|||
19395995|NCT02576951|41640469|FG001|Overall Study|Lost to Follow-up|0|||
19395996|NCT02576951|41640470|FG002|Overall Study|Lost to Follow-up|2|||
19395997|NCT02576951|41640471|FG003|Overall Study|Lost to Follow-up|2|||
19395998|NCT02576951|41640468|FG000|Overall Study|Withdrawal by Subject|1|||
19395999|NCT02576951|41640469|FG001|Overall Study|Withdrawal by Subject|0|||
19396000|NCT02576951|41640470|FG002|Overall Study|Withdrawal by Subject|0|||
19396001|NCT02576951|41640471|FG003|Overall Study|Withdrawal by Subject|2|||
19396002|NCT02576951|41640468|FG000|Overall Study|Protocol Violation|0|||
19396003|NCT02576951|41640469|FG001|Overall Study|Protocol Violation|0|||
19396004|NCT02576951|41640470|FG002|Overall Study|Protocol Violation|0|||
19396005|NCT02576951|41640471|FG003|Overall Study|Protocol Violation|1|||
19396006|NCT02621047|41640486|FG000|Overall Study|Adverse Event|0|||
19396007|NCT02621047|41640487|FG001|Overall Study|Adverse Event|0|||
19396008|NCT02621047|41640488|FG002|Overall Study|Adverse Event|1|||
19396009|NCT02443155|41640501|FG000|Overall Study|Adverse Event|3|||
19396010|NCT02443155|41640502|FG001|Overall Study|Adverse Event|4|||
19396011|NCT02443155|41640503|FG002|Overall Study|Adverse Event|1|||
19396012|NCT02443155|41640504|FG003|Overall Study|Adverse Event|2|||
19396013|NCT02443155|41640501|FG000|Overall Study|Unclassified|0|||
19396014|NCT02443155|41640502|FG001|Overall Study|Unclassified|0|||
19396015|NCT02443155|41640503|FG002|Overall Study|Unclassified|2|||
19396016|NCT02443155|41640504|FG003|Overall Study|Unclassified|1|||
19396017|NCT02443155|41640501|FG000|Overall Study|Withdrawal by Subject|4|||
19396018|NCT02443155|41640502|FG001|Overall Study|Withdrawal by Subject|7|||
19396019|NCT02443155|41640503|FG002|Overall Study|Withdrawal by Subject|3|||
19396020|NCT02443155|41640504|FG003|Overall Study|Withdrawal by Subject|9|||
19396021|NCT02443155|41640501|FG000|Overall Study|Pregnancy|3|||
19396022|NCT02443155|41640502|FG001|Overall Study|Pregnancy|1|||
19396023|NCT02443155|41640503|FG002|Overall Study|Pregnancy|1|||
19396024|NCT02443155|41640504|FG003|Overall Study|Pregnancy|2|||
19396025|NCT02443155|41640501|FG000|Overall Study|Lost to Follow-up|1|||
19396026|NCT02443155|41640502|FG001|Overall Study|Lost to Follow-up|2|||
19396027|NCT02443155|41640503|FG002|Overall Study|Lost to Follow-up|0|||
19396028|NCT02443155|41640504|FG003|Overall Study|Lost to Follow-up|1|||
19396029|NCT02443155|41640501|FG000|Overall Study|Protocol Violation|1|||
19711000|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
19711001|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
19711002|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
19711003|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
19711004|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
19711005|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
19396030|NCT02443155|41640502|FG001|Overall Study|Protocol Violation|0|||
19396031|NCT02443155|41640503|FG002|Overall Study|Protocol Violation|1|||
19396032|NCT02443155|41640504|FG003|Overall Study|Protocol Violation|1|||
19396033|NCT02443155|41640501|FG000|Overall Study|Death|0|||
19711006|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
19711007|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
19396034|NCT02443155|41640502|FG001|Overall Study|Death|0|||
19396035|NCT02443155|41640503|FG002|Overall Study|Death|1|||
19396036|NCT02443155|41640504|FG003|Overall Study|Death|0|||
19396037|NCT02460159|41640517|FG000|Overall Study|Adverse Event|4|||
19396038|NCT02460159|41640518|FG001|Overall Study|Adverse Event|1|||
19396039|NCT02460159|41640517|FG000|Overall Study|Withdrawal by Subject|2|||
19396040|NCT02460159|41640518|FG001|Overall Study|Withdrawal by Subject|0|||
19396041|NCT02498067|41640524|FG000|Overall Study|Lost to Follow-up|22|||
19396042|NCT02498067|41640524|FG000|Overall Study|Did not meet inclusion criteria|11|||
19396043|NCT02497755|41640532|FG000|Overall Study|Protocol Violation|1|||
19396044|NCT02497755|41640533|FG001|Overall Study|Protocol Violation|0|||
19396045|NCT02619175|41640542|FG000|Overall Study|Withdrawal by Subject|1|||
19396046|NCT02619175|41640543|FG001|Overall Study|Withdrawal by Subject|0|||
19396047|NCT02619175|41640542|FG000|Overall Study|foot pain|1|||
19396048|NCT02619175|41640543|FG001|Overall Study|foot pain|0|||
19396049|NCT01360021|41640560|FG000|Overall Study|Eligibility criteria + other|2|||
19396050|NCT01360021|41640561|FG001|Overall Study|Eligibility criteria + other|1|||
19396051|NCT01360021|41640562|FG002|Overall Study|Eligibility criteria + other|1|||
19396052|NCT01360021|41640560|FG000|Overall Study|Protocol Violation|0|||
19396053|NCT01360021|41640561|FG001|Overall Study|Protocol Violation|0|||
19396054|NCT01360021|41640562|FG002|Overall Study|Protocol Violation|1|||
19396055|NCT01360021|41640560|FG000|Overall Study|Withdrawal by Subject|4|||
19396056|NCT01360021|41640561|FG001|Overall Study|Withdrawal by Subject|0|||
19396057|NCT01360021|41640562|FG002|Overall Study|Withdrawal by Subject|2|||
19396058|NCT01360021|41640560|FG000|Overall Study|Adverse Event|2|||
19396059|NCT01360021|41640561|FG001|Overall Study|Adverse Event|3|||
19396060|NCT01360021|41640562|FG002|Overall Study|Adverse Event|3|||
19396061|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
19396062|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
19396063|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
19396064|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
19396065|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Other|13|||
19396066|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
19396067|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
19396068|NCT02497287|41640579|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
19396069|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
19396070|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
19396071|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
19396072|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
19396073|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
19396074|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
19396075|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
19396076|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
19396077|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
19396078|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
19396079|NCT02497287|41640579|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
19396080|NCT02497287|41640579|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
19396081|NCT02497287|41640579|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
19396082|NCT02497287|41640579|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
19396083|NCT02497287|41640579|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
19396084|NCT02497287|41640579|FG000|Follow-up Phase (4 Week)|Other|1|||
19396085|NCT02458287|41640589|FG000|Overall Study|Adverse Event|0|||
19396086|NCT02458287|41640590|FG001|Overall Study|Adverse Event|0|||
19396087|NCT02458287|41640591|FG002|Overall Study|Adverse Event|0|||
19396088|NCT02458287|41640592|FG003|Overall Study|Adverse Event|1|||
19396089|NCT02458287|41640589|FG000|Overall Study|Lost to Follow-up|0|||
19396090|NCT02458287|41640590|FG001|Overall Study|Lost to Follow-up|1|||
19396091|NCT02458287|41640591|FG002|Overall Study|Lost to Follow-up|1|||
19396092|NCT02458287|41640592|FG003|Overall Study|Lost to Follow-up|0|||
19396093|NCT02458287|41640589|FG000|Overall Study|Protocol Violation|0|||
19396094|NCT02458287|41640590|FG001|Overall Study|Protocol Violation|1|||
19396095|NCT02458287|41640591|FG002|Overall Study|Protocol Violation|0|||
19396096|NCT02458287|41640592|FG003|Overall Study|Protocol Violation|0|||
19396097|NCT02458287|41640589|FG000|Overall Study|Withdrawal by Subject|0|||
19396098|NCT02458287|41640590|FG001|Overall Study|Withdrawal by Subject|2|||
19396099|NCT02458287|41640591|FG002|Overall Study|Withdrawal by Subject|2|||
19396100|NCT02458287|41640592|FG003|Overall Study|Withdrawal by Subject|1|||
19396101|NCT02458287|41640589|FG000|Overall Study|Relocated Out of State|0|||
19396102|NCT02458287|41640590|FG001|Overall Study|Relocated Out of State|0|||
19396103|NCT02458287|41640591|FG002|Overall Study|Relocated Out of State|0|||
19396104|NCT02458287|41640592|FG003|Overall Study|Relocated Out of State|1|||
19396105|NCT02441517|41640608|FG000|Overall Study|Lost to Follow-up|1|||
19396106|NCT02441517|41640608|FG000|Overall Study|Withdrawal by Subject|2|||
19396107|NCT02441517|41640608|FG000|Overall Study|Study Terminated by Sponsor|1|||
19396108|NCT02457819|41640612|FG000|Overall Study|reason not given|8|||
19396109|NCT02457819|41640612|FG000|Overall Study|Withdrawal by Subject|24|||
19396110|NCT02457819|41640612|FG000|Overall Study|Protocol Violation|1|||
19396111|NCT02457819|41640612|FG000|Overall Study|non compliance with study drug|4|||
19396112|NCT02457819|41640612|FG000|Overall Study|Lost to Follow-up|10|||
19396113|NCT02457819|41640612|FG000|Overall Study|Lack of Efficacy|19|||
19396114|NCT02457819|41640612|FG000|Overall Study|Adverse Event|33|||
19396115|NCT02496039|41640616|FG000|Overall Study|Adverse Event|3|||
19396116|NCT02496039|41640616|FG000|Overall Study|Protocol Violation|1|||
19396117|NCT02441283|41640620|FG000|Overall Study|Withdrew consent|15|||
19396118|NCT02441283|41640620|FG000|Overall Study|Lost to Follow-up|42|||
19396119|NCT02441283|41640620|FG000|Overall Study|Death|1|||
19396120|NCT02441283|41640620|FG000|Overall Study|Other, not specified|32|||
19396121|NCT02495883|41640626|FG000|Overall Study|Excessive head motion|1|||
19396122|NCT02495883|41640627|FG001|Overall Study|Excessive head motion|0|||
19396123|NCT02495025|41640634|FG000|Overall Study|Lost to Follow-up|21|||
19396124|NCT02495025|41640635|FG001|Overall Study|Lost to Follow-up|14|||
19396125|NCT02495025|41640634|FG000|Overall Study|Withdrawal by Subject|5|||
19396126|NCT02495025|41640635|FG001|Overall Study|Withdrawal by Subject|0|||
19396127|NCT02439957|41640643|FG000|Overall Study|Study Terminated|3|||
19396128|NCT02439957|41640644|FG001|Overall Study|Study Terminated|3|||
19396129|NCT02494401|41640652|FG000|Overall Study|Lost to Follow-up|22|||
19396130|NCT02494401|41640653|FG001|Overall Study|Lost to Follow-up|25|||
19396131|NCT02494401|41640652|FG000|Overall Study|Withdrawal by Subject|3|||
19396132|NCT02494401|41640653|FG001|Overall Study|Withdrawal by Subject|2|||
19396133|NCT02457195|41640659|FG000|Overall Study|Adverse Event|3|||
19396134|NCT02457195|41640659|FG000|Overall Study|Protocol Violation|2|||
19396135|NCT02457195|41640659|FG000|Overall Study|Withdrawal by Subject|4|||
19396136|NCT02456727|41640665|FG000|Overall Study|Lost to Follow-up|63|||
19396137|NCT02456727|41640666|FG001|Overall Study|Lost to Follow-up|65|||
19396138|NCT02456727|41640665|FG000|Overall Study|Death|2|||
19396139|NCT02456727|41640666|FG001|Overall Study|Death|1|||
19396140|NCT02456727|41640665|FG000|Overall Study|Withdrawal by Subject|1|||
19396141|NCT02456727|41640666|FG001|Overall Study|Withdrawal by Subject|10|||
19396142|NCT02456727|41640665|FG000|Overall Study|Never Initiated Treatment|43|||
19396143|NCT02456727|41640666|FG001|Overall Study|Never Initiated Treatment|30|||
19396144|NCT02456103|41640688|FG000|Overall Study|Study Closure|207|||
19396145|NCT02456103|41640688|FG000|Overall Study|Physician Decision|1|||
19396146|NCT02456103|41640688|FG000|Overall Study|Required prohibited medications|5|||
19396147|NCT02456103|41640688|FG000|Overall Study|Protocol Violation|1|||
19396148|NCT02456103|41640688|FG000|Overall Study|Adverse Event|5|||
19396149|NCT02456103|41640688|FG000|Overall Study|Abnormal Laboratory Value|2|||
19396150|NCT02456103|41640688|FG000|Overall Study|Lost to Follow-up|1|||
19396151|NCT02456103|41640688|FG000|Overall Study|Withdrawal by Subject|24|||
19396152|NCT01653327|41640692|FG000|Overall Study|Withdrawal by Subject|1|||
19396153|NCT02493855|41640701|FG000|Overall Study|Non-compliance|1|||
19396154|NCT02493855|41640702|FG001|Overall Study|Non-compliance|0|||
19396155|NCT02493855|41640703|FG002|Overall Study|Non-compliance|0|||
19396156|NCT02493855|41640701|FG000|Overall Study|Adverse Event|0|||
19396157|NCT02493855|41640702|FG001|Overall Study|Adverse Event|1|||
19396158|NCT02493855|41640703|FG002|Overall Study|Adverse Event|0|||
19396159|NCT02493855|41640701|FG000|Overall Study|Withdrawal by Subject|1|||
19396160|NCT02493855|41640702|FG001|Overall Study|Withdrawal by Subject|0|||
19396161|NCT02493855|41640703|FG002|Overall Study|Withdrawal by Subject|0|||
19396162|NCT02438787|41640714|FG000|Overall Study|Adverse Event|1|||
19396163|NCT02438787|41640715|FG001|Overall Study|Adverse Event|0|||
19396164|NCT02438787|41640716|FG002|Overall Study|Adverse Event|2|||
19396165|NCT02438787|41640714|FG000|Overall Study|Lack of Efficacy|1|||
19396166|NCT02438787|41640715|FG001|Overall Study|Lack of Efficacy|2|||
19396167|NCT02438787|41640716|FG002|Overall Study|Lack of Efficacy|0|||
19396168|NCT02438787|41640714|FG000|Overall Study|Lost to Follow-up|0|||
19396169|NCT02438787|41640715|FG001|Overall Study|Lost to Follow-up|1|||
19396170|NCT02438787|41640716|FG002|Overall Study|Lost to Follow-up|0|||
19396171|NCT02438787|41640714|FG000|Overall Study|Protocol Violation|0|||
19396172|NCT02438787|41640715|FG001|Overall Study|Protocol Violation|0|||
19396173|NCT02438787|41640716|FG002|Overall Study|Protocol Violation|1|||
19396174|NCT02438787|41640714|FG000|Overall Study|Withdrawal by Subject|15|||
19396175|NCT02438787|41640715|FG001|Overall Study|Withdrawal by Subject|7|||
19396176|NCT02438787|41640716|FG002|Overall Study|Withdrawal by Subject|10|||
19396177|NCT02438787|41640714|FG000|Overall Study|Study discontinued by sponsor|64|||
19396178|NCT02438787|41640715|FG001|Overall Study|Study discontinued by sponsor|72|||
19396179|NCT02438787|41640716|FG002|Overall Study|Study discontinued by sponsor|69|||
19396180|NCT02438787|41640714|FG000|Overall Study|Other|0|||
19396181|NCT02438787|41640715|FG001|Overall Study|Other|1|||
19396182|NCT02438787|41640716|FG002|Overall Study|Other|0|||
19396183|NCT02438787|41640714|FG000|Overall Study|Site terminated by sponsor|0|||
19396184|NCT02438787|41640715|FG001|Overall Study|Site terminated by sponsor|0|||
19396185|NCT02438787|41640716|FG002|Overall Study|Site terminated by sponsor|1|||
19396186|NCT02493777|41640731|FG000|Overall Study|Lost to Follow-up|0|||
19396187|NCT02493777|41640732|FG001|Overall Study|Lost to Follow-up|1|||
19396188|NCT02616601|41640741|FG000|Overall Study|Withdrawal by Subject|4|||
19396189|NCT02616601|41640742|FG001|Overall Study|Withdrawal by Subject|4|||
19396190|NCT02616601|41640743|FG002|Overall Study|Withdrawal by Subject|3|||
19396191|NCT02616601|41640741|FG000|Overall Study|Adverse Event|2|||
19396192|NCT02616601|41640742|FG001|Overall Study|Adverse Event|0|||
19396193|NCT02616601|41640743|FG002|Overall Study|Adverse Event|2|||
19396194|NCT02616601|41640741|FG000|Overall Study|Death|1|||
19396195|NCT02616601|41640742|FG001|Overall Study|Death|0|||
19396196|NCT02616601|41640743|FG002|Overall Study|Death|0|||
19396197|NCT02616601|41640741|FG000|Overall Study|Lost to Follow-up|1|||
19396198|NCT02616601|41640742|FG001|Overall Study|Lost to Follow-up|0|||
19396199|NCT02616601|41640743|FG002|Overall Study|Lost to Follow-up|1|||
19396200|NCT02616601|41640741|FG000|Overall Study|Non-Compliance with Test Article|1|||
19396201|NCT02616601|41640742|FG001|Overall Study|Non-Compliance with Test Article|0|||
19396202|NCT02616601|41640743|FG002|Overall Study|Non-Compliance with Test Article|1|||
19396203|NCT02492997|41640753|FG000|Overall Study|Withdrawal by Subject|1|||
19396204|NCT02492997|41640754|FG001|Overall Study|Withdrawal by Subject|0|||
19396205|NCT02492997|41640753|FG000|Overall Study|Gained Weight|1|||
19396206|NCT02492997|41640754|FG001|Overall Study|Gained Weight|0|||
19396207|NCT02492997|41640753|FG000|Overall Study|Lost to Follow-up|0|||
19396208|NCT02492997|41640754|FG001|Overall Study|Lost to Follow-up|1|||
19396209|NCT02437305|41640762|FG000|Overall Study|Lost to Follow-up|18|||
19396210|NCT02437305|41640763|FG001|Overall Study|Lost to Follow-up|12|||
19396211|NCT02492841|41640772|FG000|Overall Study|Lost to Follow-up|34|||
19396212|NCT02492841|41640773|FG001|Overall Study|Lost to Follow-up|31|||
19396213|NCT02492841|41640774|FG002|Overall Study|Lost to Follow-up|35|||
19396214|NCT02436915|41640787|FG000|Overall Study|Withdrawal by Subject|0|||
19396215|NCT02436915|41640788|FG001|Overall Study|Withdrawal by Subject|1|||
19396216|NCT02492763|41640800|FG000|Overall Study|Withdrawal by Subject|0|||
19396217|NCT02492763|41640801|FG001|Overall Study|Withdrawal by Subject|2|||
19396218|NCT02492763|41640802|FG002|Overall Study|Withdrawal by Subject|1|||
19396219|NCT02492763|41640803|FG003|Overall Study|Withdrawal by Subject|0|||
19396220|NCT02492763|41640800|FG000|Overall Study|Adverse Event|3|||
19396221|NCT02492763|41640801|FG001|Overall Study|Adverse Event|1|||
19396222|NCT02492763|41640802|FG002|Overall Study|Adverse Event|1|||
19396223|NCT02492763|41640803|FG003|Overall Study|Adverse Event|2|||
19396224|NCT02492763|41640800|FG000|Overall Study|Death|0|||
19396225|NCT02492763|41640801|FG001|Overall Study|Death|0|||
19396226|NCT02492763|41640802|FG002|Overall Study|Death|1|||
19396227|NCT02492763|41640803|FG003|Overall Study|Death|0|||
19396228|NCT02492763|41640800|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
19396229|NCT02492763|41640801|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
19396230|NCT02492763|41640802|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
19396231|NCT02492763|41640803|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
19396232|NCT02492763|41640800|FG000|Overall Study|Lost to Follow-up|0|||
19396233|NCT02492763|41640801|FG001|Overall Study|Lost to Follow-up|0|||
19396234|NCT02492763|41640802|FG002|Overall Study|Lost to Follow-up|1|||
19396235|NCT02492763|41640803|FG003|Overall Study|Lost to Follow-up|0|||
19396236|NCT02492763|41640800|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19396237|NCT02492763|41640801|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19396238|NCT02492763|41640802|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19396239|NCT02492763|41640803|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19396240|NCT02492763|41640800|FG000|Overall Study|Screen Failure|0|||
19396241|NCT02492763|41640801|FG001|Overall Study|Screen Failure|0|||
19396242|NCT02492763|41640802|FG002|Overall Study|Screen Failure|0|||
19396243|NCT02492763|41640803|FG003|Overall Study|Screen Failure|1|||
19396244|NCT02492763|41640800|FG000|Overall Study|Study Terminated by Sponsor|13|||
19396245|NCT02492763|41640801|FG001|Overall Study|Study Terminated by Sponsor|10|||
19396246|NCT02492763|41640802|FG002|Overall Study|Study Terminated by Sponsor|6|||
19396247|NCT02492763|41640803|FG003|Overall Study|Study Terminated by Sponsor|10|||
19396248|NCT02491671|41640815|FG000|Overall Study|Adverse Event|6|||
19396249|NCT02491671|41640816|FG001|Overall Study|Adverse Event|8|||
19396250|NCT02491671|41640815|FG000|Overall Study|Death|0|||
19396251|NCT02491671|41640816|FG001|Overall Study|Death|2|||
19396252|NCT02491671|41640815|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
19396253|NCT02491671|41640816|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
19396254|NCT02453841|41640822|FG000|Overall Study|Protocol Violation|1|||
19396255|NCT02453841|41640822|FG000|Overall Study|Unable to obtain blood samples|2|||
19396256|NCT02453685|41640828|FG000|Overall Study|Adverse Event|0|||
19396257|NCT02453685|41640829|FG001|Overall Study|Adverse Event|1|||
19396258|NCT02453685|41640828|FG000|Overall Study|Protocol Violation|7|||
19396259|NCT02453685|41640829|FG001|Overall Study|Protocol Violation|4|||
19396260|NCT02453685|41640828|FG000|Overall Study|Lost to Follow-up|0|||
19396261|NCT02453685|41640829|FG001|Overall Study|Lost to Follow-up|1|||
19396262|NCT02453685|41640828|FG000|Overall Study|Withdrawal by Subject|8|||
19396263|NCT02453685|41640829|FG001|Overall Study|Withdrawal by Subject|4|||
19396264|NCT02453685|41640828|FG000|Overall Study|Unclassified|4|||
19396265|NCT02453685|41640829|FG001|Overall Study|Unclassified|2|||
19396266|NCT02436759|41640837|FG000|Overall Study|Adverse Event|3|||
19396267|NCT02436759|41640838|FG001|Overall Study|Adverse Event|0|||
19396268|NCT02436759|41640837|FG000|Overall Study|Protocol Violation|1|||
19396269|NCT02436759|41640838|FG001|Overall Study|Protocol Violation|0|||
19396270|NCT02436759|41640837|FG000|Overall Study|Withdrawal by Subject|0|||
19396271|NCT02436759|41640838|FG001|Overall Study|Withdrawal by Subject|1|||
19396272|NCT02436681|41640844|FG000|Overall Study|Lost to Follow-up|10|||
19396273|NCT02436681|41640844|FG000|Overall Study|Withdrawal by Subject|2|||
19396274|NCT02436681|41640844|FG000|Overall Study|Death|2|||
19396275|NCT02436135|41640850|FG000|Overall Study|Progressive Disease|3|||
19396276|NCT02436135|41640851|FG001|Overall Study|Progressive Disease|1|||
19396277|NCT02436135|41640850|FG000|Overall Study|Investigator Discretion|1|||
19396278|NCT02436135|41640851|FG001|Overall Study|Investigator Discretion|2|||
19396279|NCT02436135|41640850|FG000|Overall Study|Adverse Event|1|||
19396280|NCT02436135|41640851|FG001|Overall Study|Adverse Event|0|||
19396281|NCT02436135|41640850|FG000|Overall Study|Withdrawal by Participant|1|||
19396282|NCT02436135|41640851|FG001|Overall Study|Withdrawal by Participant|0|||
19396283|NCT02436135|41640850|FG000|Overall Study|Study Terminated By Sponsor|0|||
19396284|NCT02436135|41640851|FG001|Overall Study|Study Terminated By Sponsor|1|||
19396285|NCT02489799|41640859|FG000|Overall Study|Lost to Follow-up|4|||
19396286|NCT02489799|41640860|FG001|Overall Study|Lost to Follow-up|1|||
19396287|NCT02489799|41640859|FG000|Overall Study|Failure to Maintain Eligibility|4|||
19396288|NCT02489799|41640860|FG001|Overall Study|Failure to Maintain Eligibility|6|||
19396289|NCT02489799|41640859|FG000|Overall Study|Withdrawal by Subject|1|||
19396290|NCT02489799|41640860|FG001|Overall Study|Withdrawal by Subject|1|||
19396291|NCT02489799|41640859|FG000|Overall Study|Death|0|||
19396292|NCT02489799|41640860|FG001|Overall Study|Death|1|||
19396293|NCT02435277|41640870|FG000|Overall Study|Adverse Event|1|||
19396294|NCT02435277|41640871|FG001|Overall Study|Adverse Event|1|||
19396295|NCT02435277|41640872|FG002|Overall Study|Adverse Event|0|||
19396296|NCT02435277|41640873|FG003|Overall Study|Adverse Event|0|||
19396297|NCT02435277|41640870|FG000|Overall Study|Withdrawal by Subject|1|||
19396298|NCT02435277|41640871|FG001|Overall Study|Withdrawal by Subject|0|||
19396299|NCT02435277|41640872|FG002|Overall Study|Withdrawal by Subject|0|||
19396300|NCT02435277|41640873|FG003|Overall Study|Withdrawal by Subject|0|||
19396301|NCT02420223|41640885|FG000|Overall Study|Adverse Event|1|||
19396302|NCT02420223|41640886|FG001|Overall Study|Adverse Event|0|||
19396303|NCT02420223|41640885|FG000|Overall Study|Physician Decision|0|||
19396304|NCT02420223|41640886|FG001|Overall Study|Physician Decision|2|||
19396305|NCT02433483|41640892|FG000|Overall Study|Unacceptable toxicity|1|||
19396306|NCT02433483|41640892|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
19396307|NCT02419755|41640898|FG000|Overall Study|Death|1|||
19396308|NCT02419755|41640899|FG001|Overall Study|Death|3|||
19396309|NCT02419755|41640898|FG000|Overall Study|Relapse|0|||
19396310|NCT02419755|41640899|FG001|Overall Study|Relapse|1|||
19396311|NCT02419755|41640898|FG000|Overall Study|Ineligible|1|||
19396312|NCT02419755|41640899|FG001|Overall Study|Ineligible|0|||
19396313|NCT02419755|41640898|FG000|Overall Study|Withdrawal by Subject|1|||
19396314|NCT02419755|41640899|FG001|Overall Study|Withdrawal by Subject|0|||
19396315|NCT02488551|41640909|FG000|Overall Study|Lost to Follow-up|4|||
19396316|NCT02488551|41640910|FG001|Overall Study|Lost to Follow-up|7|||
19396317|NCT02488551|41640911|FG002|Overall Study|Lost to Follow-up|0|||
19396318|NCT02488551|41640912|FG003|Overall Study|Lost to Follow-up|0|||
19396319|NCT02488551|41640909|FG000|Overall Study|Military Deployment|1|||
19396320|NCT02488551|41640910|FG001|Overall Study|Military Deployment|1|||
19627806|NCT00839072|42077238|FG000|First Intervention Period|Withdrawal by Subject|1|||
19627807|NCT00839072|42077239|FG001|First Intervention Period|Withdrawal by Subject|0|||
19627808|NCT00839072|42077238|FG000|First Intervention Period|Adverse Event|1|||
19396321|NCT02488551|41640911|FG002|Overall Study|Military Deployment|0|||
19396322|NCT02488551|41640912|FG003|Overall Study|Military Deployment|0|||
19396323|NCT02488239|41640922|FG000|Overall Study|Death|3|||
19396324|NCT02488239|41640922|FG000|Overall Study|Withdrawal by Subject|3|||
19396325|NCT02488239|41640922|FG000|Overall Study|Physician Decision|2|||
19396326|NCT02488239|41640922|FG000|Overall Study|Consent ineligible|1|||
19396327|NCT02488239|41640922|FG000|Overall Study|Did not undergo implant procedure|1|||
19396328|NCT02488005|41640927|FG000|Overall Study|Lost to Follow-up|2|||
19396329|NCT02487771|41640933|FG000|Overall Study|Lost to Follow-up|2|||
19396330|NCT02487771|41640934|FG001|Overall Study|Lost to Follow-up|3|||
19396331|NCT02487771|41640933|FG000|Overall Study|Moved out of area|5|||
19396332|NCT02487771|41640934|FG001|Overall Study|Moved out of area|6|||
19396333|NCT02487771|41640933|FG000|Overall Study|Withdrawal by Subject|3|||
19396334|NCT02487771|41640934|FG001|Overall Study|Withdrawal by Subject|5|||
19396335|NCT01359943|41640943|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
19396336|NCT01359943|41640944|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
19396337|NCT01359943|41640945|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
19396338|NCT01359943|41640943|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
19396339|NCT01359943|41640944|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
19396340|NCT01359943|41640945|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
19396341|NCT01359943|41640943|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
19396342|NCT01359943|41640944|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
19396343|NCT01359943|41640945|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
19396344|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
19396345|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
19396346|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
19396347|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
19396348|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
19396349|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
19396350|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
19396351|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
19396352|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
19396353|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
19396354|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
19396355|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
19396356|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
19396357|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
19396358|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
19396359|NCT01359943|41640943|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
19396360|NCT01359943|41640944|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
19396361|NCT01359943|41640945|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
19396362|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
19396363|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
19396364|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
19396365|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
19396366|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
19396367|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
19396368|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
19396369|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
19396370|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
19396371|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
19396372|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
19396373|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
19396374|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
19396375|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
19396376|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
19396377|NCT01359943|41640943|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
19396378|NCT01359943|41640944|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
19396379|NCT01359943|41640945|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
19396380|NCT02432703|41640957|FG000|Overall Study|Adverse Event|1|||
19396381|NCT02432703|41640958|FG001|Overall Study|Adverse Event|4|||
19396382|NCT02432703|41640957|FG000|Overall Study|Lack of Efficacy|1|||
19396383|NCT02432703|41640958|FG001|Overall Study|Lack of Efficacy|0|||
19396384|NCT02432703|41640957|FG000|Overall Study|Lost to Follow-up|5|||
19396385|NCT02432703|41640958|FG001|Overall Study|Lost to Follow-up|3|||
19396386|NCT02432703|41640957|FG000|Overall Study|Withdrawal by Subject|9|||
19396387|NCT02432703|41640958|FG001|Overall Study|Withdrawal by Subject|6|||
19396388|NCT02432703|41640957|FG000|Overall Study|Other|6|||
19396389|NCT02432703|41640958|FG001|Overall Study|Other|5|||
19396390|NCT02486757|41640964|FG000|Overall Study|Lost to Follow-up|1|||
19396391|NCT02418819|41640972|FG000|Overall Study|Adverse Event|0|||
19396392|NCT02418819|41640973|FG001|Overall Study|Adverse Event|0|||
19396393|NCT02418819|41640974|FG002|Overall Study|Adverse Event|1|||
19396394|NCT02418819|41640975|FG003|Overall Study|Adverse Event|0|||
19396395|NCT02418819|41640972|FG000|Overall Study|Lost to Follow-up|1|||
19396396|NCT02418819|41640973|FG001|Overall Study|Lost to Follow-up|0|||
19396397|NCT02418819|41640974|FG002|Overall Study|Lost to Follow-up|0|||
19396398|NCT02418819|41640975|FG003|Overall Study|Lost to Follow-up|0|||
19396399|NCT02418819|41640972|FG000|Overall Study|No longer meets eligibility criteria|0|||
19396400|NCT02418819|41640973|FG001|Overall Study|No longer meets eligibility criteria|0|||
19396401|NCT02418819|41640974|FG002|Overall Study|No longer meets eligibility criteria|1|||
19396402|NCT02418819|41640975|FG003|Overall Study|No longer meets eligibility criteria|0|||
19396403|NCT02418819|41640972|FG000|Overall Study|No longer willing to participate|0|||
19396404|NCT02418819|41640973|FG001|Overall Study|No longer willing to participate|0|||
19396405|NCT02418819|41640974|FG002|Overall Study|No longer willing to participate|2|||
19396406|NCT02418819|41640975|FG003|Overall Study|No longer willing to participate|1|||
19396407|NCT02576639|41640990|FG000|Overall Study|Withdrawal by Subject|1|||
19396408|NCT02576639|41640991|FG001|Overall Study|Withdrawal by Subject|2|||
19396409|NCT02576639|41640992|FG002|Overall Study|Withdrawal by Subject|1|||
19396410|NCT02576639|41640993|FG003|Overall Study|Withdrawal by Subject|0|||
19396411|NCT02576639|41640994|FG004|Overall Study|Withdrawal by Subject|1|||
19396412|NCT02576639|41640990|FG000|Overall Study|Adverse Event|1|||
19396413|NCT02576639|41640991|FG001|Overall Study|Adverse Event|0|||
19396414|NCT02576639|41640992|FG002|Overall Study|Adverse Event|1|||
19396415|NCT02576639|41640993|FG003|Overall Study|Adverse Event|1|||
19396416|NCT02576639|41640994|FG004|Overall Study|Adverse Event|2|||
19396417|NCT02576639|41640990|FG000|Overall Study|Physician Decision|0|||
19396418|NCT02576639|41640991|FG001|Overall Study|Physician Decision|0|||
19396419|NCT02576639|41640992|FG002|Overall Study|Physician Decision|0|||
19396420|NCT02576639|41640993|FG003|Overall Study|Physician Decision|0|||
19396421|NCT02576639|41640994|FG004|Overall Study|Physician Decision|1|||
19396422|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
19396423|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
19396424|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
19396425|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
19396426|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
19396427|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
19396428|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
19396429|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
19396430|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
19396431|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
19396432|NCT02418585|41641012|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
19396433|NCT02418585|41641013|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
19396434|NCT02418585|41641012|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
19396435|NCT02418585|41641013|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
19396436|NCT02418585|41641012|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
19396437|NCT02418585|41641013|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
19396438|NCT02418585|41641012|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
19396439|NCT02418585|41641013|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
19396440|NCT02418585|41641012|FG000|Follow-up Phase (24 Weeks)|Other|3|||
19396441|NCT02418585|41641013|FG001|Follow-up Phase (24 Weeks)|Other|2|||
19396442|NCT02417961|41641021|FG000|Overall Study|Adverse Event|1|||
19396443|NCT02417961|41641021|FG000|Overall Study|Lost to Follow-up|1|||
19396444|NCT02417961|41641021|FG000|Overall Study|Withdrawal by Subject|2|||
19396445|NCT01596127|41641025|FG000|Overall Study|Patient Ineligible|1|||
19396446|NCT01595581|41641040|FG000|Overall Study|Withdrawal by Subject|1|||
19396447|NCT01595581|41641041|FG001|Overall Study|Withdrawal by Subject|0|||
19396448|NCT01610687|41641049|FG000|Overall Study|Lack of Efficacy|26|||
19396449|NCT01610687|41641049|FG000|Overall Study|Adverse Event|18|||
19396450|NCT01610687|41641049|FG000|Overall Study|Moved out of area|6|||
19396451|NCT01610687|41641049|FG000|Overall Study|Withdrawal by Subject|7|||
19396452|NCT01610687|41641049|FG000|Overall Study|Lost to Follow-up|4|||
19396453|NCT01610687|41641049|FG000|Overall Study|Symptom control without study medication|2|||
19396454|NCT01610687|41641049|FG000|Overall Study|Unable to make journey|1|||
19396455|NCT01610687|41641049|FG000|Overall Study|Death|1|||
19396456|NCT01610687|41641049|FG000|Overall Study|Cannabis affecting job|1|||
19396457|NCT01610687|41641049|FG000|Overall Study|Felt more alter without study medication|1|||
19396458|NCT02615509|41641053|FG000|Overall Study|Lost to Follow-up|134|||
19396459|NCT02615509|41641053|FG000|Overall Study|Death|4|||
19396460|NCT02615509|41641053|FG000|Overall Study|Withdrawal by Subject|8|||
19396461|NCT03300817|41641057|FG000|Overall Study|Withdrawal by Subject|1|||
19396462|NCT03300817|41641057|FG000|Overall Study|Adverse Event|1|||
19396463|NCT03300817|41641057|FG000|Overall Study|Subject Found to be Ineligible|2|||
19396464|NCT02575079|41641067|FG000|Overall Study|Death|3|||
19396465|NCT02575079|41641068|FG001|Overall Study|Death|0|||
19396466|NCT02575079|41641067|FG000|Overall Study|Withdrawal by Subject|3|||
19396467|NCT02575079|41641068|FG001|Overall Study|Withdrawal by Subject|0|||
19396468|NCT02574845|41641079|FG000|Overall Study|Consent withdrawn further participation|0|||
19396469|NCT02574845|41641080|FG001|Overall Study|Consent withdrawn further participation|0|||
19396470|NCT02574845|41641081|FG002|Overall Study|Consent withdrawn further participation|0|||
19396471|NCT02574845|41641082|FG003|Overall Study|Consent withdrawn further participation|0|||
19396472|NCT02574845|41641083|FG004|Overall Study|Consent withdrawn further participation|1|||
19396473|NCT02574845|41641084|FG005|Overall Study|Consent withdrawn further participation|0|||
19396474|NCT02574845|41641079|FG000|Overall Study|Adverse Event|0|||
19396475|NCT02574845|41641080|FG001|Overall Study|Adverse Event|1|||
19396476|NCT02574845|41641081|FG002|Overall Study|Adverse Event|0|||
19396477|NCT02574845|41641082|FG003|Overall Study|Adverse Event|0|||
19396478|NCT02574845|41641083|FG004|Overall Study|Adverse Event|0|||
19396479|NCT02574845|41641084|FG005|Overall Study|Adverse Event|1|||
19396480|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Adverse Event|10|||
19396481|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Adverse Event|9|||
19396482|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Adverse Event|7|||
19517841|NCT01526928|41930799|FG002|Overall Study|Protocol Deviation|0|||
19396483|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
19396484|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
19396485|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
19396486|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
19396487|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
19396488|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
19396489|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Physician Decision|7|||
19396490|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Physician Decision|3|||
19396491|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Physician Decision|2|||
19396492|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Pregnancy|2|||
19396493|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Pregnancy|1|||
19396494|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Pregnancy|3|||
19396495|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
19396496|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
19396497|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
19396498|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
19396499|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
19396500|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
19396501|NCT02614183|41641101|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
19396502|NCT02614183|41641102|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
19396503|NCT02614183|41641103|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
19396504|NCT02614183|41641101|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
19396505|NCT02614183|41641102|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
19396506|NCT02614183|41641103|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
19396507|NCT02614183|41641101|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
19396508|NCT02614183|41641102|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
19396509|NCT02614183|41641103|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
19396510|NCT02614183|41641101|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
19396511|NCT02614183|41641102|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
19396512|NCT02614183|41641103|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
19396513|NCT02614183|41641101|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
19396514|NCT02614183|41641102|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
19396515|NCT02614183|41641103|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
19396516|NCT02612155|41641128|FG000|Overall Study|Death|1|||
19396517|NCT02612155|41641129|FG001|Overall Study|Death|1|||
19396518|NCT02612155|41641128|FG000|Overall Study|Lost to Follow-up|2|||
19396519|NCT02612155|41641129|FG001|Overall Study|Lost to Follow-up|2|||
19396520|NCT02614729|41641137|FG000|Overall Study|Withdrawal by Subject|1|||
19396521|NCT02614729|41641138|FG001|Overall Study|Withdrawal by Subject|0|||
19396522|NCT02613871|41641146|FG000|Overall Study|Death|2|||
19396523|NCT02613871|41641146|FG000|Overall Study|Withdrew Consent|1|||
19396524|NCT05021081|41641152|FG000|Phase 2|Subject enrolled in error|1|||
19396525|NCT05021081|41641153|FG001|Phase 2|Subject enrolled in error|1|||
19396526|NCT05021081|41641154|FG002|Phase 2|Subject enrolled in error|0|||
19396527|NCT02612077|41641170|FG000|Overall Study|Adverse Event|3|||
19396528|NCT02612077|41641170|FG000|Overall Study|Withdrawal by Subject|9|||
19396529|NCT02612077|41641170|FG000|Overall Study|Protocol Violation|28|||
19396530|NCT02612077|41641170|FG000|Overall Study|Lost to Follow-up|20|||
19396531|NCT02612077|41641170|FG000|Overall Study|Death|377|||
19396532|NCT02612077|41641170|FG000|Overall Study|Moved or Changed Medical Team|23|||
19396533|NCT02612077|41641170|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
19396534|NCT02612077|41641170|FG000|Overall Study|Disease Progression|3|||
19396535|NCT02612077|41641170|FG000|Overall Study|Unknown reason|2|||
19396536|NCT02613481|41641177|FG000|Overall Study|Lost to Follow-up|7|||
19396537|NCT02613481|41641177|FG000|Overall Study|Withdrawal by Subject|2|||
19396538|NCT02613403|41641185|FG000|Overall Study|Lost to Follow-up|0|||
19396539|NCT02613403|41641186|FG001|Overall Study|Lost to Follow-up|1|||
19396540|NCT02613403|41641187|FG002|Overall Study|Lost to Follow-up|0|||
19396541|NCT02613403|41641188|FG003|Overall Study|Lost to Follow-up|0|||
19396542|NCT02613403|41641189|FG004|Overall Study|Lost to Follow-up|0|||
19396543|NCT02613403|41641185|FG000|Overall Study|Withdrawal by Subject|2|||
19396544|NCT02613403|41641186|FG001|Overall Study|Withdrawal by Subject|0|||
19396545|NCT02613403|41641187|FG002|Overall Study|Withdrawal by Subject|0|||
19396546|NCT02613403|41641188|FG003|Overall Study|Withdrawal by Subject|0|||
19396547|NCT02613403|41641189|FG004|Overall Study|Withdrawal by Subject|0|||
19396548|NCT02572817|41641201|FG000|Overall Study|Death|6|||
19396549|NCT02572817|41641202|FG001|Overall Study|Death|3|||
19396550|NCT02572817|41641201|FG000|Overall Study|Lost to Follow-up|3|||
19396551|NCT02572817|41641202|FG001|Overall Study|Lost to Follow-up|3|||
19396552|NCT02566109|41641208|FG000|Overall Study|Withdrawal by Subject|1|||
19396553|NCT02566031|41641214|FG000|Overall Study|Patient/guardian decision|14|||
19396554|NCT02566031|41641215|FG001|Overall Study|Patient/guardian decision|7|||
19396555|NCT02566031|41641214|FG000|Overall Study|Protocol deviation|2|||
19396556|NCT02566031|41641215|FG001|Overall Study|Protocol deviation|3|||
19396557|NCT02566031|41641214|FG000|Overall Study|Adverse Event|3|||
19396558|NCT02566031|41641215|FG001|Overall Study|Adverse Event|1|||
19396559|NCT02566031|41641214|FG000|Overall Study|Lost to Follow-up|1|||
19396560|NCT02566031|41641215|FG001|Overall Study|Lost to Follow-up|1|||
19396561|NCT02569853|41641224|FG000|Overall Study|Adverse Event|2|||
19396562|NCT02569853|41641225|FG001|Overall Study|Adverse Event|0|||
19396563|NCT02569853|41641224|FG000|Overall Study|Withdrawal by Subject|3|||
19396564|NCT02569853|41641225|FG001|Overall Study|Withdrawal by Subject|2|||
19396565|NCT02569853|41641224|FG000|Overall Study|Lost to Follow-up|3|||
19396566|NCT02569853|41641225|FG001|Overall Study|Lost to Follow-up|3|||
19396567|NCT02569853|41641224|FG000|Overall Study|Protocol Violation|1|||
19396568|NCT02569853|41641225|FG001|Overall Study|Protocol Violation|1|||
19396569|NCT02569853|41641224|FG000|Overall Study|Did not experience migraine attack|10|||
19396570|NCT02569853|41641225|FG001|Overall Study|Did not experience migraine attack|7|||
19396571|NCT02569853|41641224|FG000|Overall Study|Physician Decision|1|||
19396572|NCT02569853|41641225|FG001|Overall Study|Physician Decision|1|||
19396573|NCT02570711|41641235|FG000|Overall Study|Death|1|||
19396574|NCT02570711|41641236|FG001|Overall Study|Death|0|||
19396575|NCT02570711|41641235|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
19396576|NCT02570711|41641236|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
19396577|NCT02570165|41641249|FG000|Overall Study|Adverse Event|1|||
19396578|NCT02570165|41641250|FG001|Overall Study|Adverse Event|0|||
19396579|NCT02570165|41641251|FG002|Overall Study|Adverse Event|2|||
19396580|NCT02570165|41641252|FG003|Overall Study|Adverse Event|0|||
19396581|NCT02570165|41641253|FG004|Overall Study|Adverse Event|0|||
19396582|NCT02570165|41641254|FG005|Overall Study|Adverse Event|0|||
19396583|NCT02570165|41641255|FG006|Overall Study|Adverse Event|0|||
19396584|NCT02570165|41641249|FG000|Overall Study|Lack of Efficacy|0|||
19396585|NCT02570165|41641250|FG001|Overall Study|Lack of Efficacy|1|||
19396586|NCT02570165|41641251|FG002|Overall Study|Lack of Efficacy|0|||
19396587|NCT02570165|41641252|FG003|Overall Study|Lack of Efficacy|0|||
19396588|NCT02570165|41641253|FG004|Overall Study|Lack of Efficacy|4|||
19396589|NCT02570165|41641254|FG005|Overall Study|Lack of Efficacy|0|||
19711008|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
19711009|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
19711010|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
19711011|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
19711012|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
19711013|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
19711014|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
19711015|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
19711016|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
19711017|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
19711018|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
19711019|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
19711020|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
19711021|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
19711022|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
19711023|NCT03605680|42154231|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
19711024|NCT03605680|42154232|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
19711025|NCT03605680|42154233|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
19711026|NCT03605680|42154234|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
19711027|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
19711028|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
19711029|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
19396590|NCT02570165|41641255|FG006|Overall Study|Lack of Efficacy|0|||
19396591|NCT02570165|41641249|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
19396592|NCT02570165|41641250|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
19396593|NCT02570165|41641251|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
19396594|NCT02570165|41641252|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
19396595|NCT02570165|41641253|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
19396596|NCT02570165|41641254|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
19396597|NCT02570165|41641255|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
19396598|NCT02570165|41641249|FG000|Overall Study|Lost to Follow-up|0|||
19396599|NCT02570165|41641250|FG001|Overall Study|Lost to Follow-up|0|||
19396600|NCT02570165|41641251|FG002|Overall Study|Lost to Follow-up|1|||
19396601|NCT02570165|41641252|FG003|Overall Study|Lost to Follow-up|1|||
19396602|NCT02570165|41641253|FG004|Overall Study|Lost to Follow-up|0|||
19396603|NCT02570165|41641254|FG005|Overall Study|Lost to Follow-up|0|||
19396604|NCT02570165|41641255|FG006|Overall Study|Lost to Follow-up|0|||
19396605|NCT02570165|41641249|FG000|Overall Study|Physician Decision|0|||
19396606|NCT02570165|41641250|FG001|Overall Study|Physician Decision|1|||
19396607|NCT02570165|41641251|FG002|Overall Study|Physician Decision|0|||
19396608|NCT02570165|41641252|FG003|Overall Study|Physician Decision|0|||
19396609|NCT02570165|41641253|FG004|Overall Study|Physician Decision|0|||
19396610|NCT02570165|41641254|FG005|Overall Study|Physician Decision|0|||
19396611|NCT02570165|41641255|FG006|Overall Study|Physician Decision|0|||
19396612|NCT02570165|41641249|FG000|Overall Study|Withdrawal by Subject|0|||
19396613|NCT02570165|41641250|FG001|Overall Study|Withdrawal by Subject|0|||
19396614|NCT02570165|41641251|FG002|Overall Study|Withdrawal by Subject|0|||
19396615|NCT02570165|41641252|FG003|Overall Study|Withdrawal by Subject|2|||
19396616|NCT02570165|41641253|FG004|Overall Study|Withdrawal by Subject|1|||
19396617|NCT02570165|41641254|FG005|Overall Study|Withdrawal by Subject|0|||
19396618|NCT02570165|41641255|FG006|Overall Study|Withdrawal by Subject|0|||
19396619|NCT02570165|41641249|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396620|NCT02570165|41641250|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396621|NCT02570165|41641251|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396622|NCT02570165|41641252|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396623|NCT02570165|41641253|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396624|NCT02570165|41641254|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
19396625|NCT02570165|41641255|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
19396626|NCT02570165|41641249|FG000|Overall Study|Withdrawal Request by GSK|0|||
19396627|NCT02570165|41641250|FG001|Overall Study|Withdrawal Request by GSK|0|||
19396628|NCT02570165|41641251|FG002|Overall Study|Withdrawal Request by GSK|2|||
19396629|NCT02570165|41641252|FG003|Overall Study|Withdrawal Request by GSK|0|||
19396630|NCT02570165|41641253|FG004|Overall Study|Withdrawal Request by GSK|0|||
19396631|NCT02570165|41641254|FG005|Overall Study|Withdrawal Request by GSK|0|||
19396632|NCT02570165|41641255|FG006|Overall Study|Withdrawal Request by GSK|0|||
19396633|NCT02564471|41641275|FG000|Overall Study|Adverse Event|1|||
19396634|NCT02564471|41641276|FG001|Overall Study|Adverse Event|0|||
19396635|NCT02564471|41641277|FG002|Overall Study|Adverse Event|0|||
19396636|NCT02564471|41641278|FG003|Overall Study|Adverse Event|0|||
19396637|NCT02564471|41641275|FG000|Overall Study|Withdrawal by Subject|2|||
19396638|NCT02564471|41641276|FG001|Overall Study|Withdrawal by Subject|1|||
19396639|NCT02564471|41641277|FG002|Overall Study|Withdrawal by Subject|3|||
19396640|NCT02564471|41641278|FG003|Overall Study|Withdrawal by Subject|0|||
19396641|NCT02564471|41641275|FG000|Overall Study|Lost to Follow-up|0|||
19396642|NCT02564471|41641276|FG001|Overall Study|Lost to Follow-up|2|||
19396643|NCT02564471|41641277|FG002|Overall Study|Lost to Follow-up|0|||
19396644|NCT02564471|41641278|FG003|Overall Study|Lost to Follow-up|0|||
19396645|NCT02563067|41641291|FG000|Overall Study|Subject/guardian decision|14|||
19396646|NCT02563067|41641292|FG001|Overall Study|Subject/guardian decision|20|||
19396647|NCT02563067|41641293|FG002|Overall Study|Subject/guardian decision|16|||
19396648|NCT02563067|41641291|FG000|Overall Study|Physician Decision|0|||
19396649|NCT02563067|41641292|FG001|Overall Study|Physician Decision|1|||
19396650|NCT02563067|41641293|FG002|Overall Study|Physician Decision|3|||
19396651|NCT02563067|41641291|FG000|Overall Study|Lost to Follow-up|1|||
19396652|NCT02563067|41641292|FG001|Overall Study|Lost to Follow-up|2|||
19396653|NCT02563067|41641293|FG002|Overall Study|Lost to Follow-up|0|||
19396654|NCT02563067|41641291|FG000|Overall Study|Technical problems|0|||
19396655|NCT02563067|41641292|FG001|Overall Study|Technical problems|1|||
19396656|NCT02563067|41641293|FG002|Overall Study|Technical problems|0|||
19396657|NCT02563067|41641291|FG000|Overall Study|Lack of Efficacy|1|||
19396658|NCT02563067|41641292|FG001|Overall Study|Lack of Efficacy|0|||
19396659|NCT02563067|41641293|FG002|Overall Study|Lack of Efficacy|0|||
19396660|NCT02563067|41641291|FG000|Overall Study|Death|0|||
19396661|NCT02563067|41641292|FG001|Overall Study|Death|1|||
19396662|NCT02563067|41641293|FG002|Overall Study|Death|1|||
19396663|NCT02563067|41641291|FG000|Overall Study|Adverse Event|2|||
19396664|NCT02563067|41641292|FG001|Overall Study|Adverse Event|1|||
19396665|NCT02563067|41641293|FG002|Overall Study|Adverse Event|0|||
19396666|NCT02563067|41641291|FG000|Overall Study|Death post Treatment/safety period|1|||
19396667|NCT02563067|41641292|FG001|Overall Study|Death post Treatment/safety period|0|||
19396668|NCT02563067|41641293|FG002|Overall Study|Death post Treatment/safety period|0|||
19396669|NCT02568683|41641303|FG000|Overall Study|Death|0|||
19396670|NCT02568683|41641304|FG001|Overall Study|Death|2|||
19396671|NCT02568683|41641303|FG000|Overall Study|Withdrew Consent|1|||
19396672|NCT02568683|41641304|FG001|Overall Study|Withdrew Consent|0|||
19396673|NCT02568683|41641303|FG000|Overall Study|Study Terminated By Sponsor|5|||
19396674|NCT02568683|41641304|FG001|Overall Study|Study Terminated By Sponsor|2|||
19396675|NCT02563925|41641310|FG000|Overall Study|Withdrawal by Subject|2|||
19396676|NCT01663727|41641317|FG000|Overall Study|Death|161|||
19396677|NCT01663727|41641318|FG001|Overall Study|Death|155|||
19396678|NCT01663727|41641317|FG000|Overall Study|Lost to Follow-up|10|||
19396679|NCT01663727|41641318|FG001|Overall Study|Lost to Follow-up|8|||
19396680|NCT01663727|41641317|FG000|Overall Study|Withdrawal by Subject|18|||
19396681|NCT01663727|41641318|FG001|Overall Study|Withdrawal by Subject|25|||
19396682|NCT01663727|41641317|FG000|Overall Study|Study Terminated|51|||
19396683|NCT01663727|41641318|FG001|Overall Study|Study Terminated|50|||
19396684|NCT01663727|41641317|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
19396685|NCT01663727|41641318|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
19396686|NCT01663727|41641317|FG000|Overall Study|Withdrawal prior to dosing.|1|||
19396687|NCT01663727|41641318|FG001|Overall Study|Withdrawal prior to dosing.|0|||
19396688|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
19396689|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
19396690|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
19396691|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
19396692|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
19396693|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19396694|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19396695|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
19396696|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
19396697|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
19396698|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
19396699|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19396700|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
19396701|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
19396702|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
19396703|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
19396704|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
19396705|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
19396706|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
19396707|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
19396708|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
19396709|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
19396710|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
19396711|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
19396712|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Screen failure|0|||
19396713|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Screen failure|1|||
19396714|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Screen failure|2|||
19396715|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Screen failure|0|||
19396716|NCT02614261|41641327|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
19396717|NCT02614261|41641328|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
19396718|NCT02614261|41641329|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
19396719|NCT02614261|41641330|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
19396720|NCT02614261|41641327|FG000|Open-Label Extension Phase|Adverse Event|23|||
19396721|NCT02614261|41641328|FG001|Open-Label Extension Phase|Adverse Event|12|||
19396722|NCT02614261|41641329|FG002|Open-Label Extension Phase|Adverse Event|11|||
19396723|NCT02614261|41641330|FG003|Open-Label Extension Phase|Adverse Event|0|||
19396724|NCT02614261|41641327|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
19396725|NCT02614261|41641328|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
19396726|NCT02614261|41641329|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
19396727|NCT02614261|41641330|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
19396728|NCT02614261|41641327|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
19396729|NCT02614261|41641328|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
19396730|NCT02614261|41641329|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
19396731|NCT02614261|41641330|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
19396732|NCT02614261|41641327|FG000|Open-Label Extension Phase|Physician Decision|2|||
19396733|NCT02614261|41641328|FG001|Open-Label Extension Phase|Physician Decision|0|||
19396734|NCT02614261|41641329|FG002|Open-Label Extension Phase|Physician Decision|0|||
19396735|NCT02614261|41641330|FG003|Open-Label Extension Phase|Physician Decision|0|||
19396736|NCT02614261|41641327|FG000|Open-Label Extension Phase|Pregnancy|1|||
19396737|NCT02614261|41641328|FG001|Open-Label Extension Phase|Pregnancy|2|||
19396738|NCT02614261|41641329|FG002|Open-Label Extension Phase|Pregnancy|1|||
19396739|NCT02614261|41641330|FG003|Open-Label Extension Phase|Pregnancy|0|||
19396740|NCT02614261|41641327|FG000|Open-Label Extension Phase|Protocol Violation|3|||
19396741|NCT02614261|41641328|FG001|Open-Label Extension Phase|Protocol Violation|4|||
19396742|NCT02614261|41641329|FG002|Open-Label Extension Phase|Protocol Violation|1|||
19396743|NCT02614261|41641330|FG003|Open-Label Extension Phase|Protocol Violation|0|||
19396744|NCT02614261|41641327|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
19396745|NCT02614261|41641328|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
19396746|NCT02614261|41641329|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
19396747|NCT02614261|41641330|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
19396748|NCT02614261|41641327|FG000|Follow-up Phase|Adverse Event|2|||
19396749|NCT02614261|41641328|FG001|Follow-up Phase|Adverse Event|0|||
19396750|NCT02614261|41641329|FG002|Follow-up Phase|Adverse Event|1|||
19396751|NCT02614261|41641330|FG003|Follow-up Phase|Adverse Event|0|||
19396752|NCT02614261|41641327|FG000|Follow-up Phase|Lost to Follow-up|12|||
19396753|NCT02614261|41641328|FG001|Follow-up Phase|Lost to Follow-up|5|||
19396754|NCT02614261|41641329|FG002|Follow-up Phase|Lost to Follow-up|2|||
19396755|NCT02614261|41641330|FG003|Follow-up Phase|Lost to Follow-up|0|||
19396756|NCT02614261|41641327|FG000|Follow-up Phase|Physician Decision|5|||
19396757|NCT02614261|41641328|FG001|Follow-up Phase|Physician Decision|1|||
19396758|NCT02614261|41641329|FG002|Follow-up Phase|Physician Decision|0|||
19396759|NCT02614261|41641330|FG003|Follow-up Phase|Physician Decision|0|||
19396760|NCT02614261|41641327|FG000|Follow-up Phase|Pregnancy|0|||
19396761|NCT02614261|41641328|FG001|Follow-up Phase|Pregnancy|1|||
19396762|NCT02614261|41641329|FG002|Follow-up Phase|Pregnancy|0|||
19396763|NCT02614261|41641330|FG003|Follow-up Phase|Pregnancy|0|||
19396764|NCT02614261|41641327|FG000|Follow-up Phase|Protocol Violation|1|||
19396765|NCT02614261|41641328|FG001|Follow-up Phase|Protocol Violation|0|||
19396766|NCT02614261|41641329|FG002|Follow-up Phase|Protocol Violation|0|||
19396767|NCT02614261|41641330|FG003|Follow-up Phase|Protocol Violation|0|||
19396768|NCT02614261|41641327|FG000|Follow-up Phase|Withdrawal by Subject|12|||
19396769|NCT02614261|41641328|FG001|Follow-up Phase|Withdrawal by Subject|4|||
19396770|NCT02614261|41641329|FG002|Follow-up Phase|Withdrawal by Subject|11|||
19396771|NCT02614261|41641330|FG003|Follow-up Phase|Withdrawal by Subject|0|||
19396772|NCT02614261|41641327|FG000|Israel Addendum|Withdrawal by Subject|0|||
19396773|NCT02614261|41641328|FG001|Israel Addendum|Withdrawal by Subject|0|||
19396774|NCT02614261|41641329|FG002|Israel Addendum|Withdrawal by Subject|0|||
19396775|NCT02614261|41641330|FG003|Israel Addendum|Withdrawal by Subject|4|||
19396776|NCT01594411|41641356|FG000|Overall Study|Lost to Follow-up|2|||
19396777|NCT01594333|41641365|FG000|Overall Study|Death|96|||
19396778|NCT01594333|41641366|FG001|Overall Study|Death|83|||
19396779|NCT01594333|41641365|FG000|Overall Study|Lost to Follow-up|5|||
19396780|NCT01594333|41641366|FG001|Overall Study|Lost to Follow-up|5|||
19396781|NCT01594333|41641365|FG000|Overall Study|Withdrawal by Subject|60|||
19396782|NCT01594333|41641366|FG001|Overall Study|Withdrawal by Subject|63|||
19396783|NCT02609659|41641372|FG000|Overall Study|Adverse Event|1|||
19396784|NCT02609659|41641372|FG000|Overall Study|Lost to Follow-up|6|||
19396785|NCT02609659|41641372|FG000|Overall Study|Other|1|||
19396794|NCT02612779|41641387|FG000|Overall Study|Administrative reason by sponsor|4|||
19396795|NCT02612779|41641388|FG001|Overall Study|Administrative reason by sponsor|1|||
19396796|NCT02612779|41641387|FG000|Overall Study|No longer meet study criteria|0|||
19396797|NCT02612779|41641388|FG001|Overall Study|No longer meet study criteria|1|||
19396798|NCT02612779|41641387|FG000|Overall Study|Disease progression|29|||
19396799|NCT02612779|41641388|FG001|Overall Study|Disease progression|2|||
19396800|NCT02612779|41641387|FG000|Overall Study|Study drug toxicity|10|||
19396801|NCT02612779|41641388|FG001|Overall Study|Study drug toxicity|1|||
19396802|NCT02612779|41641387|FG000|Overall Study|Death|1|||
19396803|NCT02612779|41641388|FG001|Overall Study|Death|0|||
19396804|NCT02612779|41641387|FG000|Overall Study|Adverse event unrelated to study drug|5|||
19396805|NCT02612779|41641388|FG001|Overall Study|Adverse event unrelated to study drug|0|||
19396806|NCT02612779|41641387|FG000|Overall Study|Participant withdrew consent|4|||
19396807|NCT02612779|41641388|FG001|Overall Study|Participant withdrew consent|0|||
19396808|NCT02612779|41641387|FG000|Overall Study|Lost to Follow-up|1|||
19396809|NCT02612779|41641388|FG001|Overall Study|Lost to Follow-up|0|||
19396810|NCT02612779|41641387|FG000|Overall Study|Maximum clinical benefit|10|||
19396811|NCT02612779|41641388|FG001|Overall Study|Maximum clinical benefit|1|||
19396812|NCT02612779|41641387|FG000|Overall Study|Other reasons|4|||
19396813|NCT02612779|41641388|FG001|Overall Study|Other reasons|0|||
19396814|NCT02612623|41641399|FG000|Overall Study|Withdrawal by Subject|0|||
19396815|NCT02612623|41641400|FG001|Overall Study|Withdrawal by Subject|1|||
19396816|NCT02612623|41641401|FG002|Overall Study|Withdrawal by Subject|0|||
19396817|NCT02612623|41641402|FG003|Overall Study|Withdrawal by Subject|0|||
19396818|NCT02612623|41641399|FG000|Overall Study|Adverse Event|1|||
19396819|NCT02612623|41641400|FG001|Overall Study|Adverse Event|0|||
19396820|NCT02612623|41641401|FG002|Overall Study|Adverse Event|1|||
19396821|NCT02612623|41641402|FG003|Overall Study|Adverse Event|0|||
19396822|NCT02607865|41641416|FG000|Overall Study|Lost to Follow-up|9|||
19396823|NCT02607865|41641417|FG001|Overall Study|Lost to Follow-up|7|||
19396824|NCT02607865|41641418|FG002|Overall Study|Lost to Follow-up|7|||
19396825|NCT02607865|41641419|FG003|Overall Study|Lost to Follow-up|5|||
19396826|NCT02607865|41641416|FG000|Overall Study|Withdrawal by Subject|18|||
19396827|NCT02607865|41641417|FG001|Overall Study|Withdrawal by Subject|18|||
19517842|NCT01526928|41930800|FG003|Overall Study|Protocol Deviation|2|||
19396828|NCT02607865|41641418|FG002|Overall Study|Withdrawal by Subject|17|||
19396829|NCT02607865|41641419|FG003|Overall Study|Withdrawal by Subject|8|||
19396830|NCT02607865|41641416|FG000|Overall Study|Death|5|||
19396831|NCT02607865|41641417|FG001|Overall Study|Death|4|||
19396832|NCT02607865|41641418|FG002|Overall Study|Death|1|||
19396833|NCT02607865|41641419|FG003|Overall Study|Death|3|||
19396834|NCT02607865|41641416|FG000|Overall Study|Unclassified|1|||
19396835|NCT02607865|41641417|FG001|Overall Study|Unclassified|1|||
19396836|NCT02607865|41641418|FG002|Overall Study|Unclassified|2|||
19396837|NCT02607865|41641419|FG003|Overall Study|Unclassified|0|||
19396838|NCT01668667|41641433|FG000|Overall Study|Adverse Event|3|||
19396839|NCT01668667|41641434|FG001|Overall Study|Adverse Event|6|||
19396840|NCT01668667|41641435|FG002|Overall Study|Adverse Event|4|||
19396841|NCT01668667|41641436|FG003|Overall Study|Adverse Event|4|||
19396842|NCT01668667|41641433|FG000|Overall Study|Lack of Efficacy|3|||
19396843|NCT01668667|41641434|FG001|Overall Study|Lack of Efficacy|2|||
19396844|NCT01668667|41641435|FG002|Overall Study|Lack of Efficacy|2|||
19396845|NCT01668667|41641436|FG003|Overall Study|Lack of Efficacy|3|||
19396846|NCT01668667|41641433|FG000|Overall Study|Protocol Violation|6|||
19396847|NCT01668667|41641434|FG001|Overall Study|Protocol Violation|10|||
19396848|NCT01668667|41641435|FG002|Overall Study|Protocol Violation|12|||
19396849|NCT01668667|41641436|FG003|Overall Study|Protocol Violation|5|||
19396850|NCT01668667|41641433|FG000|Overall Study|Lost to Follow-up|9|||
19396851|NCT01668667|41641434|FG001|Overall Study|Lost to Follow-up|4|||
19396852|NCT01668667|41641435|FG002|Overall Study|Lost to Follow-up|7|||
19396853|NCT01668667|41641436|FG003|Overall Study|Lost to Follow-up|6|||
19396854|NCT01668667|41641433|FG000|Overall Study|Physician Decision|3|||
19396855|NCT01668667|41641434|FG001|Overall Study|Physician Decision|0|||
19396856|NCT01668667|41641435|FG002|Overall Study|Physician Decision|1|||
19396857|NCT01668667|41641436|FG003|Overall Study|Physician Decision|0|||
19396858|NCT01668667|41641433|FG000|Overall Study|Withdrawal by Subject|7|||
19396859|NCT01668667|41641434|FG001|Overall Study|Withdrawal by Subject|4|||
19396860|NCT01668667|41641435|FG002|Overall Study|Withdrawal by Subject|5|||
19396861|NCT01668667|41641436|FG003|Overall Study|Withdrawal by Subject|5|||
19396862|NCT02608879|41641449|FG000|Overall Study|Lost to Follow-up|1|||
19396863|NCT02608879|41641450|FG001|Overall Study|Lost to Follow-up|0|||
19396864|NCT02608879|41641451|FG002|Overall Study|Lost to Follow-up|0|||
19396865|NCT02608879|41641449|FG000|Overall Study|Did not meet continuation criteria|0|||
19396866|NCT02608879|41641450|FG001|Overall Study|Did not meet continuation criteria|0|||
19396867|NCT02608879|41641451|FG002|Overall Study|Did not meet continuation criteria|3|||
19396868|NCT02608099|41641461|FG000|Overall Study|Ablation procedure not initiated|3|||
19396869|NCT02608099|41641462|FG001|Overall Study|Ablation procedure not initiated|2|||
19396870|NCT01668589|41641472|FG000|Overall Study|Lost to Follow-up|29|||
19396871|NCT01668589|41641473|FG001|Overall Study|Lost to Follow-up|37|||
19396872|NCT01668589|41641474|FG002|Overall Study|Lost to Follow-up|15|||
19396873|NCT01668589|41641475|FG003|Overall Study|Lost to Follow-up|5|||
19396874|NCT01668589|41641472|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
19396875|NCT01668589|41641473|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
19396876|NCT01668589|41641474|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
19396877|NCT01668589|41641475|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
19396878|NCT01668589|41641472|FG000|Overall Study|Death|12|||
19396879|NCT01668589|41641473|FG001|Overall Study|Death|3|||
19396880|NCT01668589|41641474|FG002|Overall Study|Death|2|||
19396881|NCT01668589|41641475|FG003|Overall Study|Death|11|||
19396882|NCT01668589|41641472|FG000|Overall Study|Other|44|||
19396883|NCT01668589|41641473|FG001|Overall Study|Other|10|||
19396884|NCT01668589|41641474|FG002|Overall Study|Other|7|||
19396885|NCT01668589|41641475|FG003|Overall Study|Other|15|||
19396886|NCT02432235|41641497|FG000|Overall Study|Death|1|||
19396887|NCT02432235|41641498|FG001|Overall Study|Death|1|||
19396888|NCT02432235|41641499|FG002|Overall Study|Death|2|||
19396889|NCT02432235|41641500|FG003|Overall Study|Death|2|||
19396890|NCT02432235|41641501|FG004|Overall Study|Death|1|||
19396891|NCT02432235|41641502|FG005|Overall Study|Death|3|||
19396892|NCT02432235|41641503|FG006|Overall Study|Death|11|||
19396893|NCT02432235|41641504|FG007|Overall Study|Death|15|||
19396894|NCT02432235|41641505|FG008|Overall Study|Death|15|||
19396895|NCT02432235|41641506|FG009|Overall Study|Death|3|||
19396896|NCT02432235|41641507|FG010|Overall Study|Death|1|||
19396897|NCT02432235|41641508|FG011|Overall Study|Death|0|||
19396898|NCT02432235|41641497|FG000|Overall Study|Withdrawal by Subject|0|||
19396899|NCT02432235|41641498|FG001|Overall Study|Withdrawal by Subject|1|||
19396900|NCT02432235|41641499|FG002|Overall Study|Withdrawal by Subject|0|||
19396901|NCT02432235|41641500|FG003|Overall Study|Withdrawal by Subject|0|||
19396902|NCT02432235|41641501|FG004|Overall Study|Withdrawal by Subject|0|||
19396903|NCT02432235|41641502|FG005|Overall Study|Withdrawal by Subject|2|||
19396904|NCT02432235|41641503|FG006|Overall Study|Withdrawal by Subject|5|||
19396905|NCT02432235|41641504|FG007|Overall Study|Withdrawal by Subject|3|||
19396906|NCT02432235|41641505|FG008|Overall Study|Withdrawal by Subject|1|||
19396907|NCT02432235|41641506|FG009|Overall Study|Withdrawal by Subject|0|||
19396908|NCT02432235|41641507|FG010|Overall Study|Withdrawal by Subject|0|||
19396909|NCT02432235|41641508|FG011|Overall Study|Withdrawal by Subject|0|||
19396910|NCT02432235|41641497|FG000|Overall Study|Lost to Follow-up|0|||
19396911|NCT02432235|41641498|FG001|Overall Study|Lost to Follow-up|0|||
19396912|NCT02432235|41641499|FG002|Overall Study|Lost to Follow-up|0|||
19396913|NCT02432235|41641500|FG003|Overall Study|Lost to Follow-up|0|||
19396914|NCT02432235|41641501|FG004|Overall Study|Lost to Follow-up|0|||
19396915|NCT02432235|41641502|FG005|Overall Study|Lost to Follow-up|1|||
19396916|NCT02432235|41641503|FG006|Overall Study|Lost to Follow-up|0|||
19396917|NCT02432235|41641504|FG007|Overall Study|Lost to Follow-up|0|||
19396918|NCT02432235|41641505|FG008|Overall Study|Lost to Follow-up|1|||
19396919|NCT02432235|41641506|FG009|Overall Study|Lost to Follow-up|0|||
19396920|NCT02432235|41641507|FG010|Overall Study|Lost to Follow-up|0|||
19396921|NCT02432235|41641508|FG011|Overall Study|Lost to Follow-up|0|||
19396922|NCT02432235|41641497|FG000|Overall Study|Miscellaneous|0|||
19396923|NCT02432235|41641498|FG001|Overall Study|Miscellaneous|0|||
19396924|NCT02432235|41641499|FG002|Overall Study|Miscellaneous|0|||
19396925|NCT02432235|41641500|FG003|Overall Study|Miscellaneous|0|||
19396926|NCT02432235|41641501|FG004|Overall Study|Miscellaneous|1|||
19396927|NCT02432235|41641502|FG005|Overall Study|Miscellaneous|6|||
19396928|NCT02432235|41641503|FG006|Overall Study|Miscellaneous|2|||
19396929|NCT02432235|41641504|FG007|Overall Study|Miscellaneous|2|||
19396930|NCT02432235|41641505|FG008|Overall Study|Miscellaneous|4|||
19396931|NCT02432235|41641506|FG009|Overall Study|Miscellaneous|0|||
19396932|NCT02432235|41641507|FG010|Overall Study|Miscellaneous|0|||
19396933|NCT02432235|41641508|FG011|Overall Study|Miscellaneous|1|||
19396934|NCT02431533|41641538|FG000|Overall Study|Withdrawal by Subject|1|||
19396935|NCT02431533|41641539|FG001|Overall Study|Withdrawal by Subject|3|||
19396936|NCT02431533|41641538|FG000|Overall Study|Developed Exclusionary criteria|1|||
19396937|NCT02431533|41641539|FG001|Overall Study|Developed Exclusionary criteria|0|||
19396938|NCT02416791|41641548|FG000|6 Months|Lost to Follow-up|0|||
19396939|NCT02416791|41641549|FG001|6 Months|Lost to Follow-up|0|||
19396940|NCT02416791|41641550|FG002|6 Months|Lost to Follow-up|1|||
19396941|NCT02414841|41641560|FG000|Overall Study|Withdrawal by Subject|7|||
19396942|NCT02414841|41641561|FG001|Overall Study|Withdrawal by Subject|5|||
19396943|NCT02414841|41641560|FG000|Overall Study|Lost to Follow-up|13|||
19396944|NCT02414841|41641561|FG001|Overall Study|Lost to Follow-up|6|||
19396945|NCT02414841|41641560|FG000|Overall Study|Death|17|||
19396946|NCT02414841|41641561|FG001|Overall Study|Death|14|||
19517843|NCT01526928|41930801|FG004|Overall Study|Protocol Deviation|0|||
19517844|NCT01526928|41930802|FG005|Overall Study|Protocol Deviation|0|||
19517845|NCT01526928|41930797|FG000|Overall Study|Missing|0|||
19517846|NCT01526928|41930798|FG001|Overall Study|Missing|0|||
19517847|NCT01526928|41930799|FG002|Overall Study|Missing|1|||
19517848|NCT01526928|41930800|FG003|Overall Study|Missing|0|||
19517849|NCT01526928|41930801|FG004|Overall Study|Missing|2|||
19517850|NCT01526928|41930802|FG005|Overall Study|Missing|0|||
19517851|NCT01549860|41930860|FG000|Overall Study|Withdrawal by Subject|1|||
19517852|NCT01549860|41930861|FG001|Overall Study|Withdrawal by Subject|0|||
19517853|NCT01549860|41930860|FG000|Overall Study|Physician Decision|1|||
19517854|NCT01549860|41930861|FG001|Overall Study|Physician Decision|1|||
19517855|NCT01549392|41930869|FG000|Overall Study|Withdrawal by Subject|1|||
19517856|NCT01549392|41930870|FG001|Overall Study|Withdrawal by Subject|0|||
19517857|NCT01574274|41930878|FG000|Overall Study|Ineligible|0|||
19517858|NCT01574274|41930879|FG001|Overall Study|Ineligible|1|||
19517859|NCT01574274|41930878|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
19517860|NCT01574274|41930879|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
19517861|NCT01574274|41930878|FG000|Overall Study|Ph+ B-ALL|3|||
19517862|NCT01574274|41930879|FG001|Overall Study|Ph+ B-ALL|4|||
19517863|NCT01574274|41930878|FG000|Overall Study|Induction Death|2|||
19517864|NCT01574274|41930879|FG001|Overall Study|Induction Death|0|||
19517865|NCT01574274|41930878|FG000|Overall Study|Induction Failure|4|||
19517866|NCT01574274|41930879|FG001|Overall Study|Induction Failure|1|||
19517867|NCT01574274|41930878|FG000|Overall Study|Adverse Event|16|||
19517868|NCT01574274|41930879|FG001|Overall Study|Adverse Event|13|||
19517869|NCT01574274|41930878|FG000|Overall Study|Remission Death|1|||
19517870|NCT01574274|41930879|FG001|Overall Study|Remission Death|0|||
19517871|NCT01574274|41930878|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
19517872|NCT01574274|41930879|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
19517873|NCT01574274|41930878|FG000|Overall Study|Other, unknown|3|||
19517874|NCT01574274|41930879|FG001|Overall Study|Other, unknown|2|||
19517875|NCT01526148|41930887|FG000|Overall Study|Adverse Event|6|||
19517876|NCT01526148|41930888|FG001|Overall Study|Adverse Event|5|||
19517877|NCT01526148|41930887|FG000|Overall Study|Lost to Follow-up|3|||
19396947|NCT02414841|41641560|FG000|Overall Study|Received a Kidney Transplant|13|||
19396948|NCT02414841|41641561|FG001|Overall Study|Received a Kidney Transplant|4|||
19396949|NCT02414841|41641560|FG000|Overall Study|Randomized But Not Treated|6|||
19396950|NCT02414841|41641561|FG001|Overall Study|Randomized But Not Treated|4|||
19517878|NCT01526148|41930888|FG001|Overall Study|Lost to Follow-up|6|||
19396951|NCT02413593|41641569|FG000|Overall Study|Lost to Follow-up|3|||
19396952|NCT02413593|41641569|FG000|Overall Study|Adverse Event|1|||
19396953|NCT01652703|41641579|FG000|Overall Study|Withdrawal by Subject|0|||
19396954|NCT01652703|41641580|FG001|Overall Study|Withdrawal by Subject|1|||
19396955|NCT01652703|41641581|FG002|Overall Study|Withdrawal by Subject|3|||
19396956|NCT01652703|41641582|FG003|Overall Study|Withdrawal by Subject|1|||
19396957|NCT01652703|41641583|FG004|Overall Study|Withdrawal by Subject|0|||
19396958|NCT01652703|41641584|FG005|Overall Study|Withdrawal by Subject|1|||
19396959|NCT01652703|41641579|FG000|Overall Study|Other|0|||
19396960|NCT01652703|41641580|FG001|Overall Study|Other|0|||
19396961|NCT01652703|41641581|FG002|Overall Study|Other|0|||
19396962|NCT01652703|41641582|FG003|Overall Study|Other|1|||
19396963|NCT01652703|41641583|FG004|Overall Study|Other|1|||
19396964|NCT01652703|41641584|FG005|Overall Study|Other|1|||
19396965|NCT01652469|41641600|FG000|Overall Study|Withdrawal by Subject|1|||
19396966|NCT01652469|41641601|FG001|Overall Study|Withdrawal by Subject|4|||
19396967|NCT01652469|41641600|FG000|Overall Study|Lost to Follow-up|0|||
19396968|NCT01652469|41641601|FG001|Overall Study|Lost to Follow-up|2|||
19396969|NCT02429427|41641609|FG000|Overall Study|Adverse Event|220|||
19396970|NCT02429427|41641610|FG001|Overall Study|Adverse Event|92|||
19396971|NCT02429427|41641609|FG000|Overall Study|Protocol Violation|10|||
19396972|NCT02429427|41641610|FG001|Overall Study|Protocol Violation|6|||
19396973|NCT02429427|41641609|FG000|Overall Study|Lost to Follow-up|15|||
19396974|NCT02429427|41641610|FG001|Overall Study|Lost to Follow-up|6|||
19396975|NCT02429427|41641609|FG000|Overall Study|Withdrawal by Subject|64|||
19396976|NCT02429427|41641610|FG001|Overall Study|Withdrawal by Subject|34|||
19396977|NCT02429427|41641609|FG000|Overall Study|Other|62|||
19396978|NCT02429427|41641610|FG001|Overall Study|Other|41|||
19396979|NCT02412735|41641619|FG000|Overall Study|Adverse Event|0|||
19396980|NCT02412735|41641620|FG001|Overall Study|Adverse Event|1|||
19396981|NCT02412735|41641621|FG002|Overall Study|Adverse Event|2|||
19396982|NCT02412735|41641619|FG000|Overall Study|Withdrawal by Subject|23|||
19396983|NCT02412735|41641620|FG001|Overall Study|Withdrawal by Subject|27|||
19396984|NCT02412735|41641621|FG002|Overall Study|Withdrawal by Subject|22|||
19396985|NCT02412735|41641619|FG000|Overall Study|Investigator Decision|3|||
19396986|NCT02412735|41641620|FG001|Overall Study|Investigator Decision|3|||
19396987|NCT02412735|41641621|FG002|Overall Study|Investigator Decision|2|||
19396988|NCT02412735|41641619|FG000|Overall Study|Lost to Follow-up|17|||
19396989|NCT02412735|41641620|FG001|Overall Study|Lost to Follow-up|11|||
19396990|NCT02412735|41641621|FG002|Overall Study|Lost to Follow-up|18|||
19396991|NCT02412735|41641619|FG000|Overall Study|Reason not Specified|3|||
19396992|NCT02412735|41641620|FG001|Overall Study|Reason not Specified|2|||
19396993|NCT02412735|41641621|FG002|Overall Study|Reason not Specified|2|||
19396994|NCT02412657|41641632|FG000|Overall Study|Lost to Follow-up|1|||
19396995|NCT02412657|41641633|FG001|Overall Study|Lost to Follow-up|0|||
19396996|NCT02412657|41641634|FG002|Overall Study|Lost to Follow-up|0|||
19396997|NCT02412657|41641632|FG000|Overall Study|Protocol Violation|0|||
19396998|NCT02412657|41641633|FG001|Overall Study|Protocol Violation|2|||
19396999|NCT02412657|41641634|FG002|Overall Study|Protocol Violation|3|||
19397000|NCT02428413|41641644|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
19397001|NCT02428413|41641645|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
19397002|NCT02428413|41641644|FG000|Overall Study|Protocol Violation|1|||
19397003|NCT02428413|41641645|FG001|Overall Study|Protocol Violation|2|||
19397004|NCT02428413|41641644|FG000|Overall Study|Case Cancelled|2|||
19397005|NCT02428413|41641645|FG001|Overall Study|Case Cancelled|0|||
19397006|NCT02428413|41641644|FG000|Overall Study|Missed Cases|1|||
19397007|NCT02428413|41641645|FG001|Overall Study|Missed Cases|2|||
19397008|NCT02428413|41641644|FG000|Overall Study|Nurse Refusal|1|||
19397009|NCT02428413|41641645|FG001|Overall Study|Nurse Refusal|0|||
19397010|NCT02412111|41641653|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
19397011|NCT02412111|41641654|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
19397012|NCT02412111|41641655|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
19397013|NCT02412111|41641653|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
19397014|NCT02412111|41641654|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
19397015|NCT02412111|41641655|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
19397016|NCT02412111|41641653|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
19397017|NCT02412111|41641654|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
19397018|NCT02412111|41641655|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
19397019|NCT02412111|41641653|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
19397020|NCT02412111|41641654|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
19397021|NCT02412111|41641655|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
19397022|NCT02412111|41641653|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
19397023|NCT02412111|41641654|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
19397024|NCT02412111|41641655|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
19397025|NCT02412111|41641653|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
19397026|NCT02412111|41641654|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
19397027|NCT02412111|41641655|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
19397028|NCT02412111|41641653|FG000|Active Comparator Period (8 Weeks)|Other|0|||
19397029|NCT02412111|41641654|FG001|Active Comparator Period (8 Weeks)|Other|0|||
19397030|NCT02412111|41641655|FG002|Active Comparator Period (8 Weeks)|Other|2|||
19397031|NCT02427477|41641667|FG000|Period 1|Adverse Event|1|||
19397032|NCT02427477|41641668|FG001|Period 1|Adverse Event|0|||
19397033|NCT02427399|41641679|FG000|Overall Study|Protocol Violation|14|||
19397034|NCT02427399|41641680|FG001|Overall Study|Protocol Violation|16|||
19397035|NCT02427399|41641681|FG002|Overall Study|Protocol Violation|12|||
19397036|NCT02427399|41641682|FG003|Overall Study|Protocol Violation|18|||
19397037|NCT02427399|41641683|FG004|Overall Study|Protocol Violation|15|||
19397038|NCT02426541|41641697|FG000|Overall Study|Protocol Violation|1|||
19397039|NCT02426541|41641698|FG001|Overall Study|Protocol Violation|0|||
19397040|NCT02484651|41641706|FG000|Overall Study|Patients' data files were corrupted.|1|||
19397041|NCT02484651|41641707|FG001|Overall Study|Patients' data files were corrupted.|1|||
19397042|NCT02484651|41641706|FG000|Overall Study|BIS monitoring failed.|1|||
19397043|NCT02484651|41641707|FG001|Overall Study|BIS monitoring failed.|1|||
19397044|NCT02484651|41641706|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
19397045|NCT02484651|41641707|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
19397046|NCT02410551|41641714|FG000|Overall Study|Adverse Event|1|||
19397047|NCT02410551|41641714|FG000|Overall Study|Withdrawal by Subject|1|||
19397048|NCT02410551|41641714|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
19397049|NCT02424591|41641721|FG000|Overall Study|Protocol Violation|2|||
19397050|NCT02424591|41641722|FG001|Overall Study|Protocol Violation|3|||
19397051|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
19397052|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
19397053|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
19397054|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
19397055|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
19397056|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
19397057|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
19397058|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
19397059|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
19397060|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
19397061|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
19397062|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
19397063|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
19397064|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
19397065|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
19397066|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
19397067|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
19397068|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
19397069|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
19397070|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
19397071|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
19397072|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
19397073|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
19397074|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
19397075|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
19397076|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
19397077|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
19397078|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
19397079|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
19397080|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
19397081|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
19397082|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
19397083|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
19397084|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
19397085|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
19397086|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
19397087|NCT02603419|41641734|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
19627809|NCT00839072|42077239|FG001|First Intervention Period|Adverse Event|1|||
19397088|NCT02603419|41641735|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
19397089|NCT02603419|41641736|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
19397090|NCT02603419|41641737|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
19397091|NCT02603419|41641738|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
19397092|NCT02603419|41641739|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
19397093|NCT02603419|41641734|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
19397094|NCT02603419|41641735|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
19397095|NCT02603419|41641736|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
19397096|NCT02603419|41641737|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
19397097|NCT02603419|41641738|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
19397098|NCT02603419|41641739|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
19397099|NCT02603419|41641734|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
19397100|NCT02603419|41641735|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
19397101|NCT02603419|41641736|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
19397102|NCT02603419|41641737|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
19397103|NCT02603419|41641738|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
19397104|NCT02603419|41641739|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
19397105|NCT02603419|41641734|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
19397106|NCT02603419|41641735|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
19397107|NCT02603419|41641736|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
19397108|NCT02603419|41641737|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
19397109|NCT02603419|41641738|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
19397110|NCT02603419|41641739|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
19397111|NCT02408523|41641756|FG000|Overall Study|Adverse Event|4|||
19397112|NCT02408523|41641757|FG001|Overall Study|Adverse Event|10|||
19397113|NCT02408523|41641756|FG000|Overall Study|Lack of Efficacy|0|||
19397114|NCT02408523|41641757|FG001|Overall Study|Lack of Efficacy|1|||
19397115|NCT02408523|41641756|FG000|Overall Study|Protocol Violation|1|||
19397116|NCT02408523|41641757|FG001|Overall Study|Protocol Violation|2|||
19397117|NCT02408523|41641756|FG000|Overall Study|Lost to Follow-up|2|||
19397118|NCT02408523|41641757|FG001|Overall Study|Lost to Follow-up|3|||
19397119|NCT02408523|41641756|FG000|Overall Study|Withdrawal by Subject|3|||
19397120|NCT02408523|41641757|FG001|Overall Study|Withdrawal by Subject|1|||
19397121|NCT02408523|41641756|FG000|Overall Study|Sponsor request|1|||
19397122|NCT02408523|41641757|FG001|Overall Study|Sponsor request|0|||
19397123|NCT02408523|41641756|FG000|Overall Study|Did not satisfy extension conditions|0|||
19397124|NCT02408523|41641757|FG001|Overall Study|Did not satisfy extension conditions|1|||
19397125|NCT01668355|41641773|FG000|Overall Study|Death|3|||
19397126|NCT01668355|41641774|FG001|Overall Study|Death|1|||
19397127|NCT01668355|41641773|FG000|Overall Study|Withdrawal by Subject|6|||
19397128|NCT01668355|41641774|FG001|Overall Study|Withdrawal by Subject|1|||
19397129|NCT01667731|41641786|FG000|Overall Study|Enrolled but not treated|0|||
19397130|NCT01667731|41641787|FG001|Overall Study|Enrolled but not treated|0|||
19397131|NCT01667731|41641788|FG002|Overall Study|Enrolled but not treated|0|||
19397132|NCT01667731|41641789|FG003|Overall Study|Enrolled but not treated|0|||
19397133|NCT01667731|41641790|FG004|Overall Study|Enrolled but not treated|1|||
19397134|NCT01667731|41641786|FG000|Overall Study|Efficacy Failure|1|||
19397135|NCT01667731|41641787|FG001|Overall Study|Efficacy Failure|12|||
19397136|NCT01667731|41641788|FG002|Overall Study|Efficacy Failure|0|||
19397137|NCT01667731|41641789|FG003|Overall Study|Efficacy Failure|1|||
19397138|NCT01667731|41641790|FG004|Overall Study|Efficacy Failure|24|||
19397139|NCT01667731|41641786|FG000|Overall Study|Lost to Follow-up|2|||
19397140|NCT01667731|41641787|FG001|Overall Study|Lost to Follow-up|3|||
19397141|NCT01667731|41641788|FG002|Overall Study|Lost to Follow-up|1|||
19397142|NCT01667731|41641789|FG003|Overall Study|Lost to Follow-up|1|||
19397143|NCT01667731|41641790|FG004|Overall Study|Lost to Follow-up|2|||
19397144|NCT01667731|41641786|FG000|Overall Study|Subject Withdrew Consent|2|||
19397145|NCT01667731|41641787|FG001|Overall Study|Subject Withdrew Consent|0|||
19397146|NCT01667731|41641788|FG002|Overall Study|Subject Withdrew Consent|1|||
19397147|NCT01667731|41641789|FG003|Overall Study|Subject Withdrew Consent|0|||
19397148|NCT01667731|41641790|FG004|Overall Study|Subject Withdrew Consent|1|||
19397149|NCT01667731|41641786|FG000|Overall Study|Death|0|||
19397150|NCT01667731|41641787|FG001|Overall Study|Death|1|||
19397151|NCT01667731|41641788|FG002|Overall Study|Death|0|||
19397152|NCT01667731|41641789|FG003|Overall Study|Death|0|||
19397153|NCT01667731|41641790|FG004|Overall Study|Death|0|||
19397154|NCT02605837|41641805|FG000|Overall Study|Adverse Event|3|||
19397155|NCT02605837|41641806|FG001|Overall Study|Adverse Event|1|||
19517879|NCT01526148|41930887|FG000|Overall Study|Withdrawal by Subject|2|||
19517880|NCT01526148|41930888|FG001|Overall Study|Withdrawal by Subject|0|||
19397156|NCT02605837|41641805|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19397157|NCT02605837|41641806|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19397158|NCT02605837|41641805|FG000|Overall Study|Withdrawal by Subject|8|||
19397159|NCT02605837|41641806|FG001|Overall Study|Withdrawal by Subject|8|||
19517881|NCT01526148|41930887|FG000|Overall Study|Unstable Medical Condition|1|||
19397160|NCT02605837|41641805|FG000|Overall Study|Physician Decision|0|||
19397161|NCT02605837|41641806|FG001|Overall Study|Physician Decision|1|||
19397162|NCT02423343|41641819|FG000|Overall Study|Withdrawal by Subject|0|||
19397163|NCT02423343|41641820|FG001|Overall Study|Withdrawal by Subject|1|||
19397164|NCT02423343|41641821|FG002|Overall Study|Withdrawal by Subject|0|||
19397165|NCT02423343|41641822|FG003|Overall Study|Withdrawal by Subject|0|||
19397166|NCT02423343|41641823|FG004|Overall Study|Withdrawal by Subject|0|||
19397167|NCT02423343|41641824|FG005|Overall Study|Withdrawal by Subject|0|||
19397168|NCT02423343|41641819|FG000|Overall Study|Progressive Disease|0|||
19397169|NCT02423343|41641820|FG001|Overall Study|Progressive Disease|0|||
19397170|NCT02423343|41641821|FG002|Overall Study|Progressive Disease|0|||
19397171|NCT02423343|41641822|FG003|Overall Study|Progressive Disease|0|||
19397172|NCT02423343|41641823|FG004|Overall Study|Progressive Disease|2|||
19397173|NCT02423343|41641824|FG005|Overall Study|Progressive Disease|0|||
19397174|NCT02423343|41641819|FG000|Overall Study|Adverse Event|0|||
19397175|NCT02423343|41641820|FG001|Overall Study|Adverse Event|0|||
19397176|NCT02423343|41641821|FG002|Overall Study|Adverse Event|0|||
19397177|NCT02423343|41641822|FG003|Overall Study|Adverse Event|0|||
19397178|NCT02423343|41641823|FG004|Overall Study|Adverse Event|2|||
19397179|NCT02423343|41641824|FG005|Overall Study|Adverse Event|0|||
19397180|NCT02423343|41641819|FG000|Overall Study|Death|0|||
19397181|NCT02423343|41641820|FG001|Overall Study|Death|0|||
19397182|NCT02423343|41641821|FG002|Overall Study|Death|0|||
19397183|NCT02423343|41641822|FG003|Overall Study|Death|0|||
19397184|NCT02423343|41641823|FG004|Overall Study|Death|1|||
19397185|NCT02423343|41641824|FG005|Overall Study|Death|0|||
19397186|NCT02605447|41641852|FG000|Overall Study|Death|66|||
19397187|NCT02605447|41641852|FG000|Overall Study|Physician Decision|1|||
19397188|NCT02605447|41641852|FG000|Overall Study|Lost to Follow-up|24|||
19397189|NCT02605447|41641852|FG000|Overall Study|Withdrawal by Subject|10|||
19397190|NCT02605447|41641852|FG000|Overall Study|Not disclosed|1|||
19397191|NCT02485899|41641859|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
19397192|NCT02485899|41641860|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
19397193|NCT02485899|41641859|FG000|Overall Study|Withdrawal by Subject|1|||
19397194|NCT02485899|41641860|FG001|Overall Study|Withdrawal by Subject|0|||
19397195|NCT02485899|41641859|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
19397196|NCT02485899|41641860|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
19397197|NCT02423109|41641866|FG000|Lens 1|Adverse Event|1|||
19397198|NCT02423109|41641867|FG001|Lens 1|Adverse Event|0|||
19397199|NCT02420691|41641875|FG000|Overall Study|Adverse Event|3|||
19397200|NCT02420691|41641875|FG000|Overall Study|Withdrawal by Subject|3|||
19397201|NCT02406651|41641879|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
19397202|NCT02406261|41641886|FG000|Period 1|Lost to Follow-up|2|||
19397203|NCT02406261|41641887|FG001|Period 1|Lost to Follow-up|0|||
19397204|NCT02406261|41641886|FG000|Period 1|Adverse Event|1|||
19397205|NCT02406261|41641887|FG001|Period 1|Adverse Event|0|||
19397206|NCT02406261|41641886|FG000|Period 2|Physician Decision|0|||
19397207|NCT02406261|41641887|FG001|Period 2|Physician Decision|1|||
19397208|NCT02406261|41641886|FG000|Period 2|Protocol Violation|0|||
19397209|NCT02406261|41641887|FG001|Period 2|Protocol Violation|1|||
19397210|NCT02406261|41641886|FG000|Period 2|Withdrawal by Subject|0|||
19397211|NCT02406261|41641887|FG001|Period 2|Withdrawal by Subject|1|||
19397212|NCT02405091|41641897|FG000|Overall Study|Adverse Event|16|||
19397213|NCT02405091|41641898|FG001|Overall Study|Adverse Event|10|||
19397214|NCT02405091|41641899|FG002|Overall Study|Adverse Event|0|||
19397215|NCT02405091|41641897|FG000|Overall Study|Protocol Violation|1|||
19397216|NCT02405091|41641898|FG001|Overall Study|Protocol Violation|0|||
19397217|NCT02405091|41641899|FG002|Overall Study|Protocol Violation|0|||
19397218|NCT02405091|41641897|FG000|Overall Study|Noncompliance|1|||
19397219|NCT02405091|41641898|FG001|Overall Study|Noncompliance|6|||
19397220|NCT02405091|41641899|FG002|Overall Study|Noncompliance|2|||
19397221|NCT02405091|41641897|FG000|Overall Study|Withdrawal by Subject|4|||
19397222|NCT02405091|41641898|FG001|Overall Study|Withdrawal by Subject|8|||
19397223|NCT02405091|41641899|FG002|Overall Study|Withdrawal by Subject|0|||
19397224|NCT02405091|41641897|FG000|Overall Study|Death|0|||
19397225|NCT02405091|41641898|FG001|Overall Study|Death|1|||
19397226|NCT02405091|41641899|FG002|Overall Study|Death|0|||
19397227|NCT02405091|41641897|FG000|Overall Study|Lost to Follow-up|5|||
19397228|NCT02405091|41641898|FG001|Overall Study|Lost to Follow-up|6|||
19397229|NCT02405091|41641899|FG002|Overall Study|Lost to Follow-up|0|||
19397230|NCT02405091|41641897|FG000|Overall Study|Physician Decision|2|||
19397231|NCT02405091|41641898|FG001|Overall Study|Physician Decision|2|||
19397232|NCT02405091|41641899|FG002|Overall Study|Physician Decision|0|||
19397233|NCT02485353|41641910|FG000|Overall Study|Death|1|||
19517882|NCT01526148|41930888|FG001|Overall Study|Unstable Medical Condition|0|||
19397234|NCT02485353|41641910|FG000|Overall Study|Disease Progression|1|||
19397235|NCT02603107|41641916|FG000|Randomized Phase|Withdrew consent|8|||
19397236|NCT02603107|41641917|FG001|Randomized Phase|Withdrew consent|15|||
19397237|NCT02603107|41641916|FG000|Randomized Phase|Lost to Follow-up|1|||
19397238|NCT02603107|41641917|FG001|Randomized Phase|Lost to Follow-up|3|||
19397239|NCT02603107|41641916|FG000|Randomized Phase|Adverse Event|2|||
19397240|NCT02603107|41641917|FG001|Randomized Phase|Adverse Event|0|||
19397241|NCT02603107|41641916|FG000|Randomized Phase|Death|1|||
19397242|NCT02603107|41641917|FG001|Randomized Phase|Death|1|||
19397243|NCT02603107|41641916|FG000|Randomized Phase|Non-compliance with study drug|1|||
19397244|NCT02603107|41641917|FG001|Randomized Phase|Non-compliance with study drug|1|||
19397245|NCT02603107|41641916|FG000|Randomized Phase|Investigator's discretion|0|||
19397246|NCT02603107|41641917|FG001|Randomized Phase|Investigator's discretion|1|||
19397247|NCT02603107|41641916|FG000|Randomized Phase|Lack of Efficacy|1|||
19397248|NCT02603107|41641917|FG001|Randomized Phase|Lack of Efficacy|0|||
19397249|NCT02603107|41641916|FG000|Randomized Phase|Protocol Violation|1|||
19397250|NCT02603107|41641917|FG001|Randomized Phase|Protocol Violation|0|||
19397251|NCT02603107|41641916|FG000|Optional Extension Phase|Lost to Follow-up|3|||
19397252|NCT02603107|41641917|FG001|Optional Extension Phase|Lost to Follow-up|3|||
19397253|NCT02603107|41641916|FG000|Optional Extension Phase|Withdrew consent|3|||
19397254|NCT02603107|41641917|FG001|Optional Extension Phase|Withdrew consent|2|||
19397255|NCT02603107|41641916|FG000|Optional Extension Phase|Investigator's discretion|2|||
19397256|NCT02603107|41641917|FG001|Optional Extension Phase|Investigator's discretion|2|||
19397257|NCT02603107|41641916|FG000|Optional Extension Phase|Pregnancy|0|||
19397258|NCT02603107|41641917|FG001|Optional Extension Phase|Pregnancy|3|||
19397259|NCT02603107|41641916|FG000|Optional Extension Phase|Adverse Event|0|||
19397260|NCT02603107|41641917|FG001|Optional Extension Phase|Adverse Event|2|||
19397261|NCT02603107|41641916|FG000|Optional Extension Phase|Not treated in extension phase|0|||
19397262|NCT02603107|41641917|FG001|Optional Extension Phase|Not treated in extension phase|1|||
19397263|NCT02603107|41641916|FG000|Optional Extension Phase|Protocol Violation|1|||
19397264|NCT02603107|41641917|FG001|Optional Extension Phase|Protocol Violation|0|||
19397265|NCT02484729|41641935|FG000|Overall Study|Failure of IntelliCap Error|0|||
19397266|NCT02484729|41641936|FG001|Overall Study|Failure of IntelliCap Error|0|||
19397267|NCT02484729|41641937|FG002|Overall Study|Failure of IntelliCap Error|0|||
19397268|NCT02484729|41641938|FG003|Overall Study|Failure of IntelliCap Error|0|||
19397269|NCT02484729|41641939|FG004|Overall Study|Failure of IntelliCap Error|0|||
19397270|NCT02484729|41641940|FG005|Overall Study|Failure of IntelliCap Error|0|||
19397271|NCT02484729|41641941|FG006|Overall Study|Failure of IntelliCap Error|0|||
19397272|NCT02484729|41641942|FG007|Overall Study|Failure of IntelliCap Error|0|||
19397273|NCT02484729|41641943|FG008|Overall Study|Failure of IntelliCap Error|0|||
19397274|NCT02484729|41641944|FG009|Overall Study|Failure of IntelliCap Error|1|||
19397275|NCT02601625|41641982|FG000|Overall Study|Lost to Follow-up|0|||
19397276|NCT02601625|41641983|FG001|Overall Study|Lost to Follow-up|0|||
19397277|NCT02601625|41641984|FG002|Overall Study|Lost to Follow-up|1|||
19397278|NCT02601625|41641985|FG003|Overall Study|Lost to Follow-up|1|||
19397279|NCT02601469|41642011|FG000|Overall Study|Enrolled in Error|1|||
19397280|NCT02601469|41642012|FG001|Overall Study|Enrolled in Error|0|||
19397281|NCT02604589|41642021|FG000|Overall Study|catheter dislodgement|0|||
19397282|NCT02604589|41642022|FG001|Overall Study|catheter dislodgement|0|||
19397283|NCT02604589|41642023|FG002|Overall Study|catheter dislodgement|1|||
19397284|NCT02601001|41642034|FG000|Dosing Period 2|Adverse Event|0|||
19397285|NCT02601001|41642035|FG001|Dosing Period 2|Adverse Event|0|||
19397286|NCT02601001|41642036|FG002|Dosing Period 2|Adverse Event|0|||
19397287|NCT02601001|41642037|FG003|Dosing Period 2|Adverse Event|0|||
19397288|NCT02601001|41642038|FG004|Dosing Period 2|Adverse Event|0|||
19397289|NCT02601001|41642039|FG005|Dosing Period 2|Adverse Event|0|||
19397290|NCT02601001|41642040|FG006|Dosing Period 2|Adverse Event|1|||
19397291|NCT02604199|41642065|FG000|Overall Study|Pregnancy|0|||
19397292|NCT02604199|41642066|FG001|Overall Study|Pregnancy|0|||
19397293|NCT02604199|41642067|FG002|Overall Study|Pregnancy|0|||
19397294|NCT02604199|41642068|FG003|Overall Study|Pregnancy|1|||
19397295|NCT02604199|41642065|FG000|Overall Study|Study terminated by sponsor|0|||
19397296|NCT02604199|41642066|FG001|Overall Study|Study terminated by sponsor|2|||
19397297|NCT02604199|41642067|FG002|Overall Study|Study terminated by sponsor|0|||
19397298|NCT02604199|41642068|FG003|Overall Study|Study terminated by sponsor|2|||
19397299|NCT02604199|41642065|FG000|Overall Study|Withdrawal by Subject|0|||
19397300|NCT02604199|41642066|FG001|Overall Study|Withdrawal by Subject|1|||
19397301|NCT02604199|41642067|FG002|Overall Study|Withdrawal by Subject|0|||
19397302|NCT02604199|41642068|FG003|Overall Study|Withdrawal by Subject|0|||
19397303|NCT02600845|41642081|FG000|Overall Study|Reason Not Specified|3|||
19397304|NCT02600845|41642081|FG000|Overall Study|Non-compliance with Study Procedures|10|||
19397305|NCT02600845|41642081|FG000|Overall Study|Consent Withdrawal|5|||
19397306|NCT02599129|41642087|FG000|Overall Study|Lack of Efficacy|2|||
19397307|NCT02599129|41642088|FG001|Overall Study|Lack of Efficacy|2|||
19397308|NCT02599129|41642087|FG000|Overall Study|Lost to Follow-up|1|||
19397309|NCT02599129|41642088|FG001|Overall Study|Lost to Follow-up|0|||
19397310|NCT02599129|41642087|FG000|Overall Study|Withdrawal by Subject|2|||
19397311|NCT02599129|41642088|FG001|Overall Study|Withdrawal by Subject|1|||
19397312|NCT02596711|41642097|FG000|Overall Study|Lost to Follow-up|1|||
19397313|NCT02596711|41642098|FG001|Overall Study|Lost to Follow-up|2|||
19397314|NCT02596711|41642099|FG002|Overall Study|Lost to Follow-up|3|||
19397315|NCT02596009|41642107|FG000|Overall Study|Administrative problems|0|||
19397316|NCT02596009|41642108|FG001|Overall Study|Administrative problems|1|||
19397317|NCT02596009|41642109|FG002|Overall Study|Administrative problems|0|||
19397318|NCT02596009|41642110|FG003|Overall Study|Administrative problems|0|||
19397319|NCT02596009|41642111|FG004|Overall Study|Administrative problems|0|||
19397320|NCT02596009|41642112|FG005|Overall Study|Administrative problems|0|||
19397321|NCT02590939|41642120|FG000|Overall Study|Withdrawal by Subject|3|||
19397322|NCT02590939|41642121|FG001|Overall Study|Withdrawal by Subject|1|||
19397323|NCT02590939|41642120|FG000|Overall Study|Failed the nociceptive test|2|||
19397324|NCT02590939|41642121|FG001|Overall Study|Failed the nociceptive test|1|||
19397325|NCT02598193|41642127|FG000|Overall Study|Adverse Event|13|||
19397326|NCT02598193|41642127|FG000|Overall Study|Withdrawal by Subject|1|||
19397327|NCT02598193|41642127|FG000|Overall Study|Listed in active lung transplant list|1|||
19397328|NCT02598193|41642127|FG000|Overall Study|Does not want to take Nintedanib|1|||
19397329|NCT02595073|41642133|FG000|Overall Study|Progressive Disease|0|||
19397330|NCT02595073|41642134|FG001|Overall Study|Progressive Disease|1|||
19397331|NCT02595073|41642133|FG000|Overall Study|Protocol Violation|2|||
19397332|NCT02595073|41642134|FG001|Overall Study|Protocol Violation|0|||
19397333|NCT02593825|41642142|FG000|Intervention|Lost to Follow-up|10|||
19397334|NCT02593825|41642143|FG001|Intervention|Lost to Follow-up|12|||
19397335|NCT02388165|41642153|FG000|Overall Study|Study terminated by sponsor|5|||
19397336|NCT02388165|41642154|FG001|Overall Study|Study terminated by sponsor|5|||
19397337|NCT02388165|41642153|FG000|Overall Study|Other|11|||
19397338|NCT02388165|41642154|FG001|Overall Study|Other|13|||
19397339|NCT02388165|41642153|FG000|Overall Study|No longer meet eligibility criteria|40|||
19397340|NCT02388165|41642154|FG001|Overall Study|No longer meet eligibility criteria|43|||
19397341|NCT02388165|41642153|FG000|Overall Study|Withdrawal of consent|31|||
19397342|NCT02388165|41642154|FG001|Overall Study|Withdrawal of consent|32|||
19397343|NCT02388165|41642153|FG000|Overall Study|Lost to Follow-up|19|||
19397344|NCT02388165|41642154|FG001|Overall Study|Lost to Follow-up|20|||
19397345|NCT02388165|41642153|FG000|Overall Study|Death|13|||
19397346|NCT02388165|41642154|FG001|Overall Study|Death|10|||
19397347|NCT02388165|41642153|FG000|Overall Study|Adverse Event|3|||
19397348|NCT02388165|41642154|FG001|Overall Study|Adverse Event|5|||
19397349|NCT02388165|41642153|FG000|Overall Study|Did not meet entrance criteria|5|||
19397350|NCT02388165|41642154|FG001|Overall Study|Did not meet entrance criteria|2|||
19397351|NCT02404545|41642162|FG000|Overall Study|Sponsor Termination|6|||
19397352|NCT02404545|41642163|FG001|Overall Study|Sponsor Termination|6|||
19397353|NCT02420379|41642172|FG000|Overall Study|Withdrawal by Subject|0|||
19397354|NCT02420379|41642173|FG001|Overall Study|Withdrawal by Subject|3|||
19397355|NCT02420379|41642172|FG000|Overall Study|Unable to complete due to schooling|0|||
19397356|NCT02420379|41642173|FG001|Overall Study|Unable to complete due to schooling|1|||
19397357|NCT02420379|41642172|FG000|Overall Study|Transitioned to commercial drug|1|||
19397358|NCT02420379|41642173|FG001|Overall Study|Transitioned to commercial drug|0|||
19397359|NCT02347761|41642182|FG000|All Collected|Death|1|||
19397360|NCT02347761|41642183|FG001|All Collected|Death|0|||
19397361|NCT02347761|41642184|FG002|All Collected|Death|0|||
19397362|NCT02347761|41642182|FG000|All Collected|Lost to Follow-up|3|||
19397363|NCT02347761|41642183|FG001|All Collected|Lost to Follow-up|2|||
19397364|NCT02347761|41642184|FG002|All Collected|Lost to Follow-up|3|||
19397365|NCT02347761|41642182|FG000|All Collected|Withdrawal by Subject|11|||
19397366|NCT02347761|41642183|FG001|All Collected|Withdrawal by Subject|11|||
19397367|NCT02347761|41642184|FG002|All Collected|Withdrawal by Subject|22|||
19397368|NCT02347761|41642182|FG000|All Collected|invetigator disretion|2|||
19397369|NCT02347761|41642183|FG001|All Collected|invetigator disretion|0|||
19397370|NCT02347761|41642184|FG002|All Collected|invetigator disretion|0|||
19397371|NCT02347761|41642182|FG000|All Collected|instillation site pain|0|||
19397372|NCT02347761|41642183|FG001|All Collected|instillation site pain|0|||
19397373|NCT02347761|41642184|FG002|All Collected|instillation site pain|1|||
19397374|NCT02347761|41642182|FG000|All Collected|exacerbation of COPD|0|||
19397375|NCT02347761|41642183|FG001|All Collected|exacerbation of COPD|0|||
19397376|NCT02347761|41642184|FG002|All Collected|exacerbation of COPD|1|||
19397377|NCT02347761|41642182|FG000|All Collected|moved/travel|0|||
19397378|NCT02347761|41642183|FG001|All Collected|moved/travel|1|||
19397379|NCT02347761|41642184|FG002|All Collected|moved/travel|0|||
19397380|NCT02347761|41642182|FG000|On Study Treatment|Lack of Efficacy|2|||
19397381|NCT02347761|41642183|FG001|On Study Treatment|Lack of Efficacy|3|||
19397382|NCT02347761|41642184|FG002|On Study Treatment|Lack of Efficacy|4|||
19397383|NCT02347761|41642182|FG000|On Study Treatment|non-compliance with study medication|0|||
19397384|NCT02347761|41642183|FG001|On Study Treatment|non-compliance with study medication|0|||
19397385|NCT02347761|41642184|FG002|On Study Treatment|non-compliance with study medication|2|||
19397386|NCT02347761|41642182|FG000|On Study Treatment|Withdrawal by Subject|7|||
19397387|NCT02347761|41642183|FG001|On Study Treatment|Withdrawal by Subject|3|||
19397388|NCT02347761|41642184|FG002|On Study Treatment|Withdrawal by Subject|5|||
19397389|NCT02347761|41642182|FG000|On Study Treatment|move/travel|2|||
19397390|NCT02347761|41642183|FG001|On Study Treatment|move/travel|6|||
19397391|NCT02347761|41642184|FG002|On Study Treatment|move/travel|5|||
19397392|NCT02347761|41642182|FG000|On Study Treatment|dissastisfaction with device|2|||
19397393|NCT02347761|41642183|FG001|On Study Treatment|dissastisfaction with device|1|||
19397394|NCT02347761|41642184|FG002|On Study Treatment|dissastisfaction with device|4|||
19397395|NCT02347761|41642182|FG000|On Study Treatment|Lost to Follow-up|2|||
19397396|NCT02347761|41642183|FG001|On Study Treatment|Lost to Follow-up|1|||
19397397|NCT02347761|41642184|FG002|On Study Treatment|Lost to Follow-up|1|||
19397398|NCT02347761|41642182|FG000|On Study Treatment|investigator discretion|2|||
19397399|NCT02347761|41642183|FG001|On Study Treatment|investigator discretion|0|||
19397400|NCT02347761|41642184|FG002|On Study Treatment|investigator discretion|0|||
19397401|NCT02347761|41642182|FG000|On Study Treatment|durg not working|0|||
19397402|NCT02347761|41642183|FG001|On Study Treatment|durg not working|1|||
19397403|NCT02347761|41642184|FG002|On Study Treatment|durg not working|1|||
19397404|NCT02347761|41642182|FG000|On Study Treatment|Adverse Event|10|||
19397405|NCT02347761|41642183|FG001|On Study Treatment|Adverse Event|8|||
19397406|NCT02347761|41642184|FG002|On Study Treatment|Adverse Event|20|||
19397407|NCT02596945|41642192|FG000|Overall Study|No documentation of study drug dosing|3|||
19397408|NCT02596945|41642192|FG000|Overall Study|Other|32|||
19397409|NCT02596945|41642192|FG000|Overall Study|Change to hemodialysis|15|||
19397410|NCT02596945|41642192|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
19397411|NCT02596945|41642192|FG000|Overall Study|Withdrawal by Subject|1|||
19397412|NCT02596945|41642192|FG000|Overall Study|Missing|1|||
19397413|NCT02404389|41642210|FG000|Overall Study|Adverse Event|1|||
19397414|NCT02404389|41642211|FG001|Overall Study|Adverse Event|0|||
19397415|NCT02404389|41642212|FG002|Overall Study|Adverse Event|1|||
19397416|NCT02404389|41642213|FG003|Overall Study|Adverse Event|0|||
19397417|NCT02404389|41642214|FG004|Overall Study|Adverse Event|2|||
19397418|NCT02404389|41642210|FG000|Overall Study|Subject/guardian decision|1|||
19397419|NCT02404389|41642211|FG001|Overall Study|Subject/guardian decision|0|||
19397420|NCT02404389|41642212|FG002|Overall Study|Subject/guardian decision|0|||
19397421|NCT02404389|41642213|FG003|Overall Study|Subject/guardian decision|1|||
19397422|NCT02404389|41642214|FG004|Overall Study|Subject/guardian decision|1|||
19397423|NCT01667419|41642232|FG000|Overall Study|Reason Not Specified|1|||
19397424|NCT01667419|41642233|FG001|Overall Study|Reason Not Specified|0|||
19397425|NCT01667419|41642234|FG002|Overall Study|Reason Not Specified|0|||
19397426|NCT01667419|41642235|FG003|Overall Study|Reason Not Specified|0|||
19397427|NCT01667419|41642232|FG000|Overall Study|Withdrawal by Subject|16|||
19397428|NCT01667419|41642233|FG001|Overall Study|Withdrawal by Subject|8|||
19397429|NCT01667419|41642234|FG002|Overall Study|Withdrawal by Subject|9|||
19397430|NCT01667419|41642235|FG003|Overall Study|Withdrawal by Subject|8|||
19397431|NCT01667419|41642232|FG000|Overall Study|Non-compliance|0|||
19397432|NCT01667419|41642233|FG001|Overall Study|Non-compliance|0|||
19397433|NCT01667419|41642234|FG002|Overall Study|Non-compliance|0|||
19397434|NCT01667419|41642235|FG003|Overall Study|Non-compliance|1|||
19397435|NCT01667419|41642232|FG000|Overall Study|Protocol Violation|1|||
19397436|NCT01667419|41642233|FG001|Overall Study|Protocol Violation|0|||
19397437|NCT01667419|41642234|FG002|Overall Study|Protocol Violation|0|||
19397438|NCT01667419|41642235|FG003|Overall Study|Protocol Violation|0|||
19397439|NCT01667419|41642232|FG000|Overall Study|Lost to Follow-up|7|||
19397440|NCT01667419|41642233|FG001|Overall Study|Lost to Follow-up|6|||
19397441|NCT01667419|41642234|FG002|Overall Study|Lost to Follow-up|2|||
19397442|NCT01667419|41642235|FG003|Overall Study|Lost to Follow-up|4|||
19397443|NCT01667419|41642232|FG000|Overall Study|Death|18|||
19397444|NCT01667419|41642233|FG001|Overall Study|Death|33|||
19397445|NCT01667419|41642234|FG002|Overall Study|Death|25|||
19397446|NCT01667419|41642235|FG003|Overall Study|Death|26|||
19397447|NCT02588833|41642252|FG000|Part 1|Withdrawal by Subject|1|||
19397448|NCT02588833|41642253|FG001|Part 1|Withdrawal by Subject|0|||
19397449|NCT02588833|41642252|FG000|Part 2A|Physician Decision|0|||
19397450|NCT02588833|41642253|FG001|Part 2A|Physician Decision|1|||
19397451|NCT02588833|41642252|FG000|Part 2A|Withdrawal by Subject|0|||
19397452|NCT02588833|41642253|FG001|Part 2A|Withdrawal by Subject|1|||
19397453|NCT02588833|41642252|FG000|Part 2B|Adverse Event|0|||
19397454|NCT02588833|41642253|FG001|Part 2B|Adverse Event|1|||
19397455|NCT02588833|41642252|FG000|Part 2C|Adverse Event|0|||
19397456|NCT02588833|41642253|FG001|Part 2C|Adverse Event|1|||
19397457|NCT02588833|41642252|FG000|Part 2C|Withdrawal by Subject|0|||
19397458|NCT02588833|41642253|FG001|Part 2C|Withdrawal by Subject|1|||
19397459|NCT02588833|41642252|FG000|Part 3 (Safety Follow-up)|Other|0|||
19397460|NCT02588833|41642253|FG001|Part 3 (Safety Follow-up)|Other|2|||
19397461|NCT01667107|41642262|FG000|Overall Study|Adverse Event|4|||
19397462|NCT01667107|41642263|FG001|Overall Study|Adverse Event|3|||
19397463|NCT01667107|41642262|FG000|Overall Study|Tolerability issues|0|||
19397464|NCT01667107|41642263|FG001|Overall Study|Tolerability issues|2|||
19397465|NCT01667107|41642262|FG000|Overall Study|Protocol Violation|0|||
19397466|NCT01667107|41642263|FG001|Overall Study|Protocol Violation|1|||
19397467|NCT01667107|41642262|FG000|Overall Study|Lack of Efficacy|0|||
19397468|NCT01667107|41642263|FG001|Overall Study|Lack of Efficacy|1|||
19397469|NCT02590003|41642287|FG000|Overall Study|Death|1|||
19397470|NCT02590003|41642288|FG001|Overall Study|Death|2|||
19397471|NCT02404311|41642317|FG000|Part A: Month 0-18|Death|2|||
19397472|NCT02404311|41642318|FG001|Part A: Month 0-18|Death|0|||
19397473|NCT02404311|41642319|FG002|Part A: Month 0-18|Death|0|||
19397474|NCT02404311|41642320|FG003|Part A: Month 0-18|Death|0|||
19397475|NCT02404311|41642321|FG004|Part A: Month 0-18|Death|0|||
19397476|NCT02404311|41642317|FG000|Part A: Month 0-18|Physician Decision|1|||
19397477|NCT02404311|41642318|FG001|Part A: Month 0-18|Physician Decision|0|||
19397478|NCT02404311|41642319|FG002|Part A: Month 0-18|Physician Decision|0|||
19397479|NCT02404311|41642320|FG003|Part A: Month 0-18|Physician Decision|0|||
19397480|NCT02404311|41642321|FG004|Part A: Month 0-18|Physician Decision|0|||
19397481|NCT02404311|41642317|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
19397482|NCT02404311|41642318|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
19397483|NCT02404311|41642319|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
19397484|NCT02404311|41642320|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
19397485|NCT02404311|41642321|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
19397486|NCT02404311|41642317|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
19397487|NCT02404311|41642318|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
19397488|NCT02404311|41642319|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
19397489|NCT02404311|41642320|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
19397490|NCT02404311|41642321|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
19397491|NCT02404311|41642317|FG000|Part A: Month 0-18|HIV Infection|6|||
19397492|NCT02404311|41642318|FG001|Part A: Month 0-18|HIV Infection|2|||
19397493|NCT02404311|41642319|FG002|Part A: Month 0-18|HIV Infection|0|||
19397494|NCT02404311|41642320|FG003|Part A: Month 0-18|HIV Infection|0|||
19397495|NCT02404311|41642321|FG004|Part A: Month 0-18|HIV Infection|0|||
19397496|NCT02404311|41642317|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
19397497|NCT02404311|41642318|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
19397498|NCT02404311|41642319|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
19397499|NCT02404311|41642320|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
19397500|NCT02404311|41642321|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
19397501|NCT01650519|41642335|FG000|Overall Study|Withdrawal by Subject|1|||
19397502|NCT01650519|41642336|FG001|Overall Study|Withdrawal by Subject|0|||
19397503|NCT01650285|41642342|FG000|Overall Study|Adverse Event|1|||
19397504|NCT02347527|41642350|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
19397505|NCT02347527|41642351|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
19397506|NCT02347527|41642352|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
19397507|NCT02347527|41642353|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
19397508|NCT02347527|41642350|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
19397509|NCT02347527|41642351|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
19397510|NCT02347527|41642352|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
19397511|NCT02347527|41642353|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
19397512|NCT02347527|41642350|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
19397513|NCT02347527|41642351|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
19397514|NCT02347527|41642352|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
19397515|NCT02347527|41642353|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
19397516|NCT02347527|41642350|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
19397517|NCT02347527|41642351|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
19397518|NCT02347527|41642352|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
19397519|NCT02347527|41642353|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
19397520|NCT02347527|41642350|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
19397521|NCT02347527|41642351|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
19397522|NCT02347527|41642352|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
19397523|NCT02347527|41642353|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
19397524|NCT02386839|41642367|FG000|Overall Study|Death|1|||
19397525|NCT02386839|41642368|FG001|Overall Study|Death|0|||
19397526|NCT02386839|41642367|FG000|Overall Study|Withdrawal by Subject|9|||
19397527|NCT02386839|41642368|FG001|Overall Study|Withdrawal by Subject|10|||
19397528|NCT02386839|41642367|FG000|Overall Study|Lost to Follow-up|4|||
19397529|NCT02386839|41642368|FG001|Overall Study|Lost to Follow-up|4|||
19397530|NCT02386839|41642367|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
19397531|NCT02386839|41642368|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
19397532|NCT02386839|41642367|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
19397533|NCT02386839|41642368|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
19397534|NCT02386839|41642367|FG000|Overall Study|Other (unspecified)|1|||
19397535|NCT02386839|41642368|FG001|Overall Study|Other (unspecified)|0|||
19397536|NCT01649271|41642380|FG000|Overall Study|Progressive disease|4|||
19397537|NCT01649271|41642381|FG001|Overall Study|Progressive disease|5|||
19397538|NCT01649271|41642380|FG000|Overall Study|Other Adverse Event|0|||
19397539|NCT01649271|41642381|FG001|Overall Study|Other Adverse Event|2|||
19397540|NCT01649271|41642380|FG000|Overall Study|Withdrawal by Subject|1|||
19397541|NCT01649271|41642381|FG001|Overall Study|Withdrawal by Subject|0|||
19397542|NCT01649271|41642380|FG000|Overall Study|Other than stated above|1|||
19397543|NCT01649271|41642381|FG001|Overall Study|Other than stated above|0|||
19397544|NCT02385669|41642388|FG000|Overall Study|Adverse Event|2|||
19397545|NCT02402907|41642394|FG000|Overall Study|Delivered vaginally|9|||
19397546|NCT02402907|41642395|FG001|Overall Study|Delivered vaginally|3|||
19397547|NCT02402907|41642394|FG000|Overall Study|Delivered outside of Sinai|1|||
19397548|NCT02402907|41642395|FG001|Overall Study|Delivered outside of Sinai|1|||
19397549|NCT02402907|41642394|FG000|Overall Study|Lost to follow up after C-Section|10|||
19397550|NCT02402907|41642395|FG001|Overall Study|Lost to follow up after C-Section|23|||
19397551|NCT02345889|41642405|FG000|Overall Study|Inadequate Bowel Prep|17|||
19397552|NCT02345889|41642406|FG001|Overall Study|Inadequate Bowel Prep|16|||
19397553|NCT02345889|41642407|FG002|Overall Study|Inadequate Bowel Prep|18|||
19397554|NCT02345889|41642408|FG003|Overall Study|Inadequate Bowel Prep|14|||
19397555|NCT02345889|41642405|FG000|Overall Study|Polyposis identified during procedure|1|||
19397556|NCT02345889|41642406|FG001|Overall Study|Polyposis identified during procedure|1|||
19397557|NCT02345889|41642407|FG002|Overall Study|Polyposis identified during procedure|0|||
19397558|NCT02345889|41642408|FG003|Overall Study|Polyposis identified during procedure|1|||
19397559|NCT02345889|41642405|FG000|Overall Study|Recognized ineligible post-randomization|1|||
19397560|NCT02345889|41642406|FG001|Overall Study|Recognized ineligible post-randomization|0|||
19397561|NCT02345889|41642407|FG002|Overall Study|Recognized ineligible post-randomization|2|||
19397562|NCT02345889|41642408|FG003|Overall Study|Recognized ineligible post-randomization|1|||
19397563|NCT02345889|41642405|FG000|Overall Study|Ulcerative Colitis identified|1|||
19397564|NCT02345889|41642406|FG001|Overall Study|Ulcerative Colitis identified|0|||
19397565|NCT02345889|41642407|FG002|Overall Study|Ulcerative Colitis identified|0|||
19397566|NCT02345889|41642408|FG003|Overall Study|Ulcerative Colitis identified|0|||
19397567|NCT02345889|41642405|FG000|Overall Study|Cecum not intubated|1|||
19397568|NCT02345889|41642406|FG001|Overall Study|Cecum not intubated|0|||
19397569|NCT02345889|41642407|FG002|Overall Study|Cecum not intubated|0|||
19397570|NCT02345889|41642408|FG003|Overall Study|Cecum not intubated|0|||
19397571|NCT02345811|41642418|FG000|First Intervention|Withdrawal by Subject|1|||
19397572|NCT02345811|41642419|FG001|First Intervention|Withdrawal by Subject|1|||
19397573|NCT02344173|41642427|FG000|Procedure|Ablation Procedure Not Performed|7|||
19397574|NCT02344173|41642427|FG000|12-month Visit|Death|8|||
19397575|NCT02344173|41642427|FG000|12-month Visit|Withdrawal by Subject|30|||
19397576|NCT02344173|41642427|FG000|12-month Visit|Lost to Follow-up|58|||
19397577|NCT02586493|41642433|FG000|Overall Study|Adverse Event|4|||
19397578|NCT02586493|41642433|FG000|Overall Study|Protocol Violation|6|||
19397579|NCT02586493|41642433|FG000|Overall Study|Lost to Follow-up|1|||
19397580|NCT02586493|41642433|FG000|Overall Study|Withdrawal by Subject|1|||
19397581|NCT02400333|41642441|FG000|Overall Study|Withdrawal by Subject|0|||
19397582|NCT02400333|41642442|FG001|Overall Study|Withdrawal by Subject|1|||
19397583|NCT02400333|41642443|FG002|Overall Study|Withdrawal by Subject|0|||
19397584|NCT02400333|41642444|FG003|Overall Study|Withdrawal by Subject|1|||
19397585|NCT02400333|41642441|FG000|Overall Study|Protocol Violation|1|||
19397586|NCT02400333|41642442|FG001|Overall Study|Protocol Violation|0|||
19397587|NCT02400333|41642443|FG002|Overall Study|Protocol Violation|2|||
19397588|NCT02400333|41642444|FG003|Overall Study|Protocol Violation|1|||
19397589|NCT02399475|41642457|FG000|Overall Study|Physician Decision|1|||
19397590|NCT02399475|41642458|FG001|Overall Study|Physician Decision|0|||
19397591|NCT02399163|41642464|FG000|Overall Study|Adverse Event|2|||
19397592|NCT02399163|41642464|FG000|Overall Study|Protocol Deviation|2|||
19397593|NCT02399163|41642464|FG000|Overall Study|Withdrawal by Participant|5|||
19397594|NCT02398227|41642478|FG000|Overall Study|Lost to Follow-up|21|||
19397595|NCT02398227|41642479|FG001|Overall Study|Lost to Follow-up|12|||
19397596|NCT02398227|41642478|FG000|Overall Study|Withdrawal by Subject|5|||
19397597|NCT02398227|41642479|FG001|Overall Study|Withdrawal by Subject|6|||
19397598|NCT02398227|41642478|FG000|Overall Study|Removed from treatment and dropped out|1|||
19397599|NCT02398227|41642479|FG001|Overall Study|Removed from treatment and dropped out|0|||
19397600|NCT02397915|41642485|FG000|Period 1|Protocol Violation|0|||
19397601|NCT02397915|41642486|FG001|Period 1|Protocol Violation|1|||
19397602|NCT02397915|41642487|FG002|Period 1|Protocol Violation|0|||
19397603|NCT02397915|41642488|FG003|Period 1|Protocol Violation|0|||
19397604|NCT02397915|41642485|FG000|Period 1|Physician Decision|1|||
19397605|NCT02397915|41642486|FG001|Period 1|Physician Decision|0|||
19397606|NCT02397915|41642487|FG002|Period 1|Physician Decision|0|||
19397607|NCT02397915|41642488|FG003|Period 1|Physician Decision|0|||
19397608|NCT02397837|41642498|FG000|Overall Study|Withdrawal by Subject|6|||
19397609|NCT02397837|41642499|FG001|Overall Study|Withdrawal by Subject|5|||
19397610|NCT02397837|41642498|FG000|Overall Study|Physician Decision|1|||
19397611|NCT02397837|41642499|FG001|Overall Study|Physician Decision|1|||
19397612|NCT02586415|41642507|FG000|Overall Study|Death|13|||
19397613|NCT02586415|41642508|FG001|Overall Study|Death|23|||
19397614|NCT02586415|41642507|FG000|Overall Study|Lost to Follow-up|1|||
19397615|NCT02586415|41642508|FG001|Overall Study|Lost to Follow-up|2|||
19397616|NCT02383173|41642517|FG000|Overall Study|Palliative Care Team withdrew|0|||
19397617|NCT02383173|41642518|FG001|Overall Study|Palliative Care Team withdrew|2|||
19397618|NCT02383017|41642526|FG000|Overall Study|Injury Sustained Outside Study|1|||
19397619|NCT02383017|41642527|FG001|Overall Study|Injury Sustained Outside Study|0|||
19397620|NCT02383017|41642526|FG000|Overall Study|Compliance|3|||
19397621|NCT02383017|41642527|FG001|Overall Study|Compliance|2|||
19397622|NCT02383017|41642526|FG000|Overall Study|Found to be Hypogonadal|1|||
19397623|NCT02383017|41642527|FG001|Overall Study|Found to be Hypogonadal|0|||
19397624|NCT02382939|41642535|FG000|Overall Study|Adverse Event|1|||
19397625|NCT02382939|41642536|FG001|Overall Study|Adverse Event|1|||
19397626|NCT02382939|41642535|FG000|Overall Study|Withdrawal by Subject|2|||
19397627|NCT02382939|41642536|FG001|Overall Study|Withdrawal by Subject|2|||
19397628|NCT02587819|41642543|FG000|Overall Study|Adverse Event|1|||
19397629|NCT02587819|41642543|FG000|Overall Study|Lost to Follow-up|1|||
19397630|NCT01666951|41642550|FG000|Overall Study|Not dosed|1|||
19397631|NCT01666951|41642551|FG001|Overall Study|Not dosed|1|||
19397632|NCT02586805|41642561|FG000|Overall Study|Withdrawal by Subject|3|||
19397633|NCT02586805|41642562|FG001|Overall Study|Withdrawal by Subject|1|||
19397634|NCT02586805|41642563|FG002|Overall Study|Withdrawal by Subject|1|||
19397635|NCT02586805|41642564|FG003|Overall Study|Withdrawal by Subject|2|||
19397636|NCT02586805|41642561|FG000|Overall Study|Adverse Event|2|||
19397637|NCT02586805|41642562|FG001|Overall Study|Adverse Event|0|||
19397638|NCT02586805|41642563|FG002|Overall Study|Adverse Event|1|||
19397639|NCT02586805|41642564|FG003|Overall Study|Adverse Event|0|||
19397640|NCT02586805|41642561|FG000|Overall Study|Lost to Follow-up|0|||
19397641|NCT02586805|41642562|FG001|Overall Study|Lost to Follow-up|0|||
19397642|NCT02586805|41642563|FG002|Overall Study|Lost to Follow-up|1|||
19397643|NCT02586805|41642564|FG003|Overall Study|Lost to Follow-up|0|||
19397644|NCT02586805|41642561|FG000|Overall Study|Physician Decision|1|||
19397645|NCT02586805|41642562|FG001|Overall Study|Physician Decision|0|||
19397646|NCT02586805|41642563|FG002|Overall Study|Physician Decision|0|||
19397647|NCT02586805|41642564|FG003|Overall Study|Physician Decision|0|||
19397648|NCT02586727|41642576|FG000|Overall Study|Lost to Follow-up|1|||
19397649|NCT02586727|41642577|FG001|Overall Study|Lost to Follow-up|0|||
19397650|NCT02580877|41642585|FG000|Overall Study|Withdrawal by Subject|1|||
19397651|NCT02580877|41642586|FG001|Overall Study|Withdrawal by Subject|3|||
19397652|NCT02580877|41642585|FG000|Overall Study|Adverse Event|0|||
19397653|NCT02580877|41642586|FG001|Overall Study|Adverse Event|1|||
19397654|NCT02582983|41642602|FG000|Overall Study|Death|3|||
19397655|NCT02582983|41642602|FG000|Overall Study|Withdrawal by Subject|2|||
19397656|NCT02582983|41642602|FG000|Overall Study|Adverse Event|1|||
19397657|NCT02582749|41642608|FG000|Overall Study|Study terminated by funder|5|||
19397658|NCT02582749|41642609|FG001|Overall Study|Study terminated by funder|10|||
19397659|NCT02582749|41642608|FG000|Overall Study|Withdrawal by Subject|0|||
19397660|NCT02582749|41642609|FG001|Overall Study|Withdrawal by Subject|1|||
19397661|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
19397662|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
19397663|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Death|1|||
19397664|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Death|0|||
19397665|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Adverse Event|1|||
19397666|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Adverse Event|0|||
19397667|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
19397668|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
19397669|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Physician Decision|2|||
19397670|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Physician Decision|1|||
19397671|NCT02586025|41642617|FG000|Neoadjuvant Treatment|Progressive Disease|2|||
19397672|NCT02586025|41642618|FG001|Neoadjuvant Treatment|Progressive Disease|3|||
19397673|NCT02586025|41642617|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133|||
19397674|NCT02586025|41642618|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61|||
19397675|NCT02586025|41642617|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
19397676|NCT02586025|41642618|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
19397677|NCT02586025|41642617|FG000|Adjuvant Treatment|Physician Decision|0|||
19397678|NCT02586025|41642618|FG001|Adjuvant Treatment|Physician Decision|1|||
19397679|NCT02586025|41642617|FG000|Adjuvant Treatment|Recurrent Disease|1|||
19397680|NCT02586025|41642618|FG001|Adjuvant Treatment|Recurrent Disease|4|||
19397681|NCT02586025|41642617|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56|||
19397682|NCT02586025|41642618|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35|||
19397683|NCT02582671|41642624|FG000|Overall Study|Failure to return|1|||
19397684|NCT02582671|41642624|FG000|Overall Study|Other, not specified|1|||
19397685|NCT02585713|41642631|FG000|Overall Study|Withdrew prior to treatment|2|||
19397686|NCT02585713|41642632|FG001|Overall Study|Withdrew prior to treatment|7|||
19397687|NCT02585713|41642631|FG000|Overall Study|Other|3|||
19397688|NCT02585713|41642632|FG001|Overall Study|Other|1|||
19397689|NCT02579863|41642640|FG000|Overall Study|Final Disposition Unknown|2|||
19397690|NCT02579863|41642641|FG001|Overall Study|Final Disposition Unknown|1|||
19397691|NCT02579863|41642640|FG000|Overall Study|Adverse Event|18|||
19397692|NCT02579863|41642641|FG001|Overall Study|Adverse Event|11|||
19397693|NCT02579863|41642640|FG000|Overall Study|Death|31|||
19397694|NCT02579863|41642641|FG001|Overall Study|Death|29|||
19397695|NCT02579863|41642640|FG000|Overall Study|Lost to Follow-up|2|||
19397696|NCT02579863|41642641|FG001|Overall Study|Lost to Follow-up|1|||
19397697|NCT02579863|41642640|FG000|Overall Study|Physician Decision|1|||
19397698|NCT02579863|41642641|FG001|Overall Study|Physician Decision|2|||
19397699|NCT02579863|41642640|FG000|Overall Study|Screen Failure|0|||
19397700|NCT02579863|41642641|FG001|Overall Study|Screen Failure|2|||
19397701|NCT02579863|41642640|FG000|Overall Study|Study Terminated at Selected Sites|82|||
19397702|NCT02579863|41642641|FG001|Overall Study|Study Terminated at Selected Sites|88|||
19397703|NCT02579863|41642640|FG000|Overall Study|Withdrawal by Subject|20|||
19397704|NCT02579863|41642641|FG001|Overall Study|Withdrawal by Subject|20|||
19397705|NCT02582515|41642649|FG000|Overall Study|Withdrawal by Subject|0|||
19397706|NCT02582515|41642650|FG001|Overall Study|Withdrawal by Subject|1|||
19397707|NCT02579629|41642659|FG000|Overall Study|Withdrawal by Subject|0|||
19397708|NCT02579629|41642660|FG001|Overall Study|Withdrawal by Subject|1|||
19397709|NCT02579629|41642661|FG002|Overall Study|Withdrawal by Subject|0|||
19397710|NCT02579629|41642659|FG000|Overall Study|Screen Failure|2|||
19397711|NCT02579629|41642660|FG001|Overall Study|Screen Failure|0|||
19397712|NCT02579629|41642661|FG002|Overall Study|Screen Failure|2|||
19397713|NCT02343939|41642678|FG000|Overall Study|Death|0|||
19397714|NCT02343939|41642679|FG001|Overall Study|Death|15|||
19397715|NCT02343939|41642680|FG002|Overall Study|Death|4|||
19397716|NCT02343939|41642681|FG003|Overall Study|Death|2|||
19397717|NCT02343939|41642682|FG004|Overall Study|Death|5|||
19397718|NCT02343939|41642683|FG005|Overall Study|Death|11|||
19397719|NCT02343939|41642684|FG006|Overall Study|Death|8|||
19397720|NCT02343939|41642685|FG007|Overall Study|Death|22|||
19397721|NCT02343939|41642686|FG008|Overall Study|Death|1|||
19397722|NCT02343939|41642678|FG000|Overall Study|Study terminated by sponsor|0|||
19397723|NCT02343939|41642679|FG001|Overall Study|Study terminated by sponsor|27|||
19397724|NCT02343939|41642680|FG002|Overall Study|Study terminated by sponsor|0|||
19397725|NCT02343939|41642681|FG003|Overall Study|Study terminated by sponsor|1|||
19397726|NCT02343939|41642682|FG004|Overall Study|Study terminated by sponsor|1|||
19397727|NCT02343939|41642683|FG005|Overall Study|Study terminated by sponsor|5|||
19397728|NCT02343939|41642684|FG006|Overall Study|Study terminated by sponsor|3|||
19397729|NCT02343939|41642685|FG007|Overall Study|Study terminated by sponsor|4|||
19397730|NCT02343939|41642686|FG008|Overall Study|Study terminated by sponsor|0|||
19397731|NCT02343939|41642678|FG000|Overall Study|Withdrew consent|3|||
19397732|NCT02343939|41642679|FG001|Overall Study|Withdrew consent|6|||
19397733|NCT02343939|41642680|FG002|Overall Study|Withdrew consent|1|||
19397734|NCT02343939|41642681|FG003|Overall Study|Withdrew consent|2|||
19397735|NCT02343939|41642682|FG004|Overall Study|Withdrew consent|2|||
19397736|NCT02343939|41642683|FG005|Overall Study|Withdrew consent|0|||
19397737|NCT02343939|41642684|FG006|Overall Study|Withdrew consent|0|||
19397738|NCT02343939|41642685|FG007|Overall Study|Withdrew consent|8|||
19397739|NCT02343939|41642686|FG008|Overall Study|Withdrew consent|6|||
19397740|NCT02343939|41642678|FG000|Overall Study|Treatment failure|0|||
19397741|NCT02343939|41642679|FG001|Overall Study|Treatment failure|0|||
19397742|NCT02343939|41642680|FG002|Overall Study|Treatment failure|0|||
19397743|NCT02343939|41642681|FG003|Overall Study|Treatment failure|0|||
19397744|NCT02343939|41642682|FG004|Overall Study|Treatment failure|0|||
19397745|NCT02343939|41642683|FG005|Overall Study|Treatment failure|0|||
19397746|NCT02343939|41642684|FG006|Overall Study|Treatment failure|2|||
19397747|NCT02343939|41642685|FG007|Overall Study|Treatment failure|1|||
19397748|NCT02343939|41642686|FG008|Overall Study|Treatment failure|0|||
19397749|NCT02343939|41642678|FG000|Overall Study|Investigator's discretion|0|||
19397750|NCT02343939|41642679|FG001|Overall Study|Investigator's discretion|0|||
19397751|NCT02343939|41642680|FG002|Overall Study|Investigator's discretion|0|||
19397752|NCT02343939|41642681|FG003|Overall Study|Investigator's discretion|1|||
19397753|NCT02343939|41642682|FG004|Overall Study|Investigator's discretion|0|||
19397754|NCT02343939|41642683|FG005|Overall Study|Investigator's discretion|0|||
19397755|NCT02343939|41642684|FG006|Overall Study|Investigator's discretion|1|||
19397756|NCT02343939|41642685|FG007|Overall Study|Investigator's discretion|0|||
19397757|NCT02343939|41642686|FG008|Overall Study|Investigator's discretion|0|||
19397758|NCT02343939|41642678|FG000|Overall Study|Adverse Event|0|||
19397759|NCT02343939|41642679|FG001|Overall Study|Adverse Event|0|||
19397760|NCT02343939|41642680|FG002|Overall Study|Adverse Event|0|||
19397761|NCT02343939|41642681|FG003|Overall Study|Adverse Event|0|||
19397762|NCT02343939|41642682|FG004|Overall Study|Adverse Event|0|||
19397763|NCT02343939|41642683|FG005|Overall Study|Adverse Event|1|||
19397764|NCT02343939|41642684|FG006|Overall Study|Adverse Event|0|||
19397765|NCT02343939|41642685|FG007|Overall Study|Adverse Event|0|||
19397766|NCT02343939|41642686|FG008|Overall Study|Adverse Event|0|||
19397767|NCT02343939|41642678|FG000|Overall Study|Never Treated With ENTO|0|||
19397768|NCT02343939|41642679|FG001|Overall Study|Never Treated With ENTO|0|||
19397769|NCT02343939|41642680|FG002|Overall Study|Never Treated With ENTO|0|||
19397770|NCT02343939|41642681|FG003|Overall Study|Never Treated With ENTO|0|||
19397771|NCT02343939|41642682|FG004|Overall Study|Never Treated With ENTO|0|||
19397772|NCT02343939|41642683|FG005|Overall Study|Never Treated With ENTO|0|||
19397773|NCT02343939|41642684|FG006|Overall Study|Never Treated With ENTO|1|||
19397774|NCT02343939|41642685|FG007|Overall Study|Never Treated With ENTO|2|||
19397775|NCT02343939|41642686|FG008|Overall Study|Never Treated With ENTO|0|||
19397776|NCT02397447|41642722|FG000|Overall Study|Lost to Follow-up|2|||
19397777|NCT02397447|41642723|FG001|Overall Study|Lost to Follow-up|2|||
19397778|NCT02397057|41642731|FG000|Overall Study|Withdrawal by Subject|6|||
19397779|NCT02397057|41642732|FG001|Overall Study|Withdrawal by Subject|7|||
19397780|NCT02397057|41642731|FG000|Overall Study|Lost to Follow-up|4|||
19397781|NCT02397057|41642732|FG001|Overall Study|Lost to Follow-up|3|||
19397782|NCT02397057|41642731|FG000|Overall Study|Death|1|||
19397783|NCT02397057|41642732|FG001|Overall Study|Death|0|||
19397784|NCT02397057|41642731|FG000|Overall Study|Adverse Event|0|||
19397785|NCT02397057|41642732|FG001|Overall Study|Adverse Event|1|||
19397786|NCT02397057|41642731|FG000|Overall Study|Physician Decision|0|||
19397787|NCT02397057|41642732|FG001|Overall Study|Physician Decision|1|||
19397788|NCT02397057|41642731|FG000|Overall Study|Subject did not receive study drug|0|||
19397789|NCT02397057|41642732|FG001|Overall Study|Subject did not receive study drug|1|||
19397790|NCT02343549|41642738|FG000|Overall Study|Death|11|||
19397791|NCT02343549|41642738|FG000|Overall Study|Withdrawal by Subject|2|||
19397792|NCT02343159|41642745|FG000|Overall Study|Early Study Termination|16|||
19397793|NCT02343159|41642746|FG001|Overall Study|Early Study Termination|19|||
19397794|NCT02343159|41642747|FG002|Overall Study|Early Study Termination|23|||
19397795|NCT02343159|41642745|FG000|Overall Study|Physician Decision|2|||
19397796|NCT02343159|41642746|FG001|Overall Study|Physician Decision|0|||
19397797|NCT02343159|41642747|FG002|Overall Study|Physician Decision|1|||
19397798|NCT02343159|41642745|FG000|Overall Study|Withdrawal by Subject|3|||
19397799|NCT02343159|41642746|FG001|Overall Study|Withdrawal by Subject|0|||
19397800|NCT02343159|41642747|FG002|Overall Study|Withdrawal by Subject|2|||
19397801|NCT02343159|41642745|FG000|Overall Study|Lost to Follow-up|0|||
19397802|NCT02343159|41642746|FG001|Overall Study|Lost to Follow-up|2|||
19397803|NCT02343159|41642747|FG002|Overall Study|Lost to Follow-up|2|||
19397804|NCT02343159|41642745|FG000|Overall Study|Adverse Event|4|||
19397805|NCT02343159|41642746|FG001|Overall Study|Adverse Event|4|||
19397806|NCT02343159|41642747|FG002|Overall Study|Adverse Event|2|||
19397807|NCT02343159|41642745|FG000|Overall Study|Sponsor Decision|0|||
19397808|NCT02343159|41642746|FG001|Overall Study|Sponsor Decision|1|||
19397809|NCT02343159|41642747|FG002|Overall Study|Sponsor Decision|0|||
19397810|NCT02343159|41642745|FG000|Overall Study|Enrollment Error|1|||
19397811|NCT02343159|41642746|FG001|Overall Study|Enrollment Error|0|||
19397812|NCT02343159|41642747|FG002|Overall Study|Enrollment Error|0|||
19397813|NCT02395653|41642756|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
19397814|NCT02395653|41642756|FG000|Overall Study|Consent Withdrawn at Screening|1|||
19397815|NCT02395653|41642756|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
19397816|NCT02395653|41642756|FG000|Overall Study|Investigator Decision at Screening|1|||
19517883|NCT01526148|41930887|FG000|Overall Study|Unable to discontinue concomitant med|1|||
19517884|NCT01526148|41930888|FG001|Overall Study|Unable to discontinue concomitant med|0|||
19517885|NCT01526148|41930887|FG000|Overall Study|Moved out of state|1|||
19517886|NCT01526148|41930888|FG001|Overall Study|Moved out of state|0|||
19517887|NCT01526148|41930887|FG000|Overall Study|Incarcerated|0|||
19517888|NCT01526148|41930888|FG001|Overall Study|Incarcerated|2|||
19517889|NCT01572948|41930896|FG000|Overall Study|Lost to Follow-up|1|||
19517890|NCT01572948|41930897|FG001|Overall Study|Lost to Follow-up|0|||
19517891|NCT01572948|41930896|FG000|Overall Study|unable to contact|0|||
19517892|NCT01572948|41930897|FG001|Overall Study|unable to contact|1|||
19517893|NCT01525602|41930915|FG000|Overall Study|Adverse Event|1|||
19517894|NCT01525602|41930916|FG001|Overall Study|Adverse Event|0|||
19517895|NCT01525602|41930917|FG002|Overall Study|Adverse Event|1|||
19517896|NCT01525602|41930918|FG003|Overall Study|Adverse Event|1|||
19517897|NCT01525602|41930919|FG004|Overall Study|Adverse Event|3|||
19517898|NCT01525602|41930920|FG005|Overall Study|Adverse Event|3|||
19517899|NCT01525602|41930921|FG006|Overall Study|Adverse Event|0|||
19517900|NCT01525602|41930922|FG007|Overall Study|Adverse Event|1|||
19517901|NCT01525602|41930915|FG000|Overall Study|Disease progression|6|||
19517902|NCT01525602|41930916|FG001|Overall Study|Disease progression|3|||
19517903|NCT01525602|41930917|FG002|Overall Study|Disease progression|2|||
19517904|NCT01525602|41930918|FG003|Overall Study|Disease progression|5|||
19517905|NCT01525602|41930919|FG004|Overall Study|Disease progression|22|||
19517906|NCT01525602|41930920|FG005|Overall Study|Disease progression|2|||
19517907|NCT01525602|41930921|FG006|Overall Study|Disease progression|3|||
19517908|NCT01525602|41930922|FG007|Overall Study|Disease progression|3|||
19397817|NCT02395653|41642756|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
19517909|NCT01525602|41930915|FG000|Overall Study|Clinical progression|2|||
19517910|NCT01525602|41930916|FG001|Overall Study|Clinical progression|0|||
19397818|NCT02395653|41642756|FG000|Overall Study|Withdrawal by Subject|1|||
19397819|NCT02395653|41642756|FG000|Overall Study|Lost to Follow-up|1|||
19397820|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
19397821|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
19397822|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
19397823|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
19397824|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
19397825|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
19397826|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
19397827|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
19397828|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
19397829|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
19397830|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
19397831|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
19397832|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
19397833|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
19397834|NCT01664923|41642762|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
19397835|NCT01664923|41642763|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
19397836|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
19397837|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
19397838|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
19397839|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
19397840|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
19397841|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
19397842|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
19397843|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
19397844|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
19397845|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
19397846|NCT01664923|41642762|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
19397847|NCT01664923|41642763|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
19397848|NCT01664533|41642773|FG000|Overall Study|Death|42|||
19397849|NCT01664533|41642773|FG000|Overall Study|Lost to Follow-up|3|||
19397850|NCT01664533|41642773|FG000|Overall Study|Study termination|9|||
19397851|NCT01664533|41642773|FG000|Overall Study|Protocol Violation|3|||
19397852|NCT02584855|41642778|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
19397853|NCT02584855|41642779|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
19397854|NCT02584855|41642780|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
19397855|NCT02584855|41642781|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
19397856|NCT02584855|41642782|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
19397857|NCT02584855|41642783|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
19397858|NCT02584855|41642778|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
19397859|NCT02584855|41642779|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
19397860|NCT02584855|41642780|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
19397861|NCT02584855|41642781|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
19397862|NCT02584855|41642782|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
19397863|NCT02584855|41642783|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
19397864|NCT02584855|41642778|FG000|Open-Label Treatment Period|Adverse Event|14|||
19397865|NCT02584855|41642779|FG001|Open-Label Treatment Period|Adverse Event|0|||
19397866|NCT02584855|41642780|FG002|Open-Label Treatment Period|Adverse Event|0|||
19397867|NCT02584855|41642781|FG003|Open-Label Treatment Period|Adverse Event|0|||
19397868|NCT02584855|41642782|FG004|Open-Label Treatment Period|Adverse Event|0|||
19397869|NCT02584855|41642783|FG005|Open-Label Treatment Period|Adverse Event|0|||
19397870|NCT02584855|41642778|FG000|Open-Label Treatment Period|Death|2|||
19397871|NCT02584855|41642779|FG001|Open-Label Treatment Period|Death|0|||
19397872|NCT02584855|41642780|FG002|Open-Label Treatment Period|Death|0|||
19397873|NCT02584855|41642781|FG003|Open-Label Treatment Period|Death|0|||
19397874|NCT02584855|41642782|FG004|Open-Label Treatment Period|Death|0|||
19397875|NCT02584855|41642783|FG005|Open-Label Treatment Period|Death|0|||
19397876|NCT02584855|41642778|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
19397877|NCT02584855|41642779|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
19397878|NCT02584855|41642780|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
19397879|NCT02584855|41642781|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
19397880|NCT02584855|41642782|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
19397881|NCT02584855|41642783|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
19397882|NCT02584855|41642778|FG000|Open-Label Treatment Period|Protocol Violation|1|||
19397883|NCT02584855|41642779|FG001|Open-Label Treatment Period|Protocol Violation|0|||
19397884|NCT02584855|41642780|FG002|Open-Label Treatment Period|Protocol Violation|0|||
19397885|NCT02584855|41642781|FG003|Open-Label Treatment Period|Protocol Violation|0|||
19397886|NCT02584855|41642782|FG004|Open-Label Treatment Period|Protocol Violation|0|||
19397887|NCT02584855|41642783|FG005|Open-Label Treatment Period|Protocol Violation|0|||
19397888|NCT02584855|41642778|FG000|Open-Label Treatment Period|No PI Available|2|||
19397889|NCT02584855|41642779|FG001|Open-Label Treatment Period|No PI Available|0|||
19397890|NCT02584855|41642780|FG002|Open-Label Treatment Period|No PI Available|0|||
19397891|NCT02584855|41642781|FG003|Open-Label Treatment Period|No PI Available|0|||
19397892|NCT02584855|41642782|FG004|Open-Label Treatment Period|No PI Available|0|||
19397893|NCT02584855|41642783|FG005|Open-Label Treatment Period|No PI Available|0|||
19397894|NCT02584855|41642778|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
19397895|NCT02584855|41642779|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
19397896|NCT02584855|41642780|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
19397897|NCT02584855|41642781|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
19397898|NCT02584855|41642782|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
19397899|NCT02584855|41642783|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
19397900|NCT02584855|41642778|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
19397901|NCT02584855|41642779|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
19397902|NCT02584855|41642780|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
19397903|NCT02584855|41642781|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
19397904|NCT02584855|41642782|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
19397905|NCT02584855|41642783|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
19397906|NCT02584855|41642778|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
19397907|NCT02584855|41642779|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
19397908|NCT02584855|41642780|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
19397909|NCT02584855|41642781|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
19397910|NCT02584855|41642782|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
19397911|NCT02584855|41642783|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
19397912|NCT02584855|41642778|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
19397913|NCT02584855|41642779|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
19397914|NCT02584855|41642780|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
19397915|NCT02584855|41642781|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
19397916|NCT02584855|41642782|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
19397917|NCT02584855|41642783|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
19397918|NCT02584855|41642778|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
19397919|NCT02584855|41642779|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
19397920|NCT02584855|41642780|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
19397921|NCT02584855|41642781|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
19397922|NCT02584855|41642782|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
19397923|NCT02584855|41642783|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
19397924|NCT02584855|41642778|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19397925|NCT02584855|41642779|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19397926|NCT02584855|41642780|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19397927|NCT02584855|41642781|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19397928|NCT02584855|41642782|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
19517911|NCT01525602|41930917|FG002|Overall Study|Clinical progression|0|||
19517912|NCT01525602|41930918|FG003|Overall Study|Clinical progression|0|||
19517913|NCT01525602|41930919|FG004|Overall Study|Clinical progression|0|||
19517914|NCT01525602|41930920|FG005|Overall Study|Clinical progression|0|||
19517915|NCT01525602|41930921|FG006|Overall Study|Clinical progression|1|||
19517916|NCT01525602|41930922|FG007|Overall Study|Clinical progression|1|||
19517917|NCT01525602|41930915|FG000|Overall Study|Non-compliance|0|||
19517918|NCT01525602|41930916|FG001|Overall Study|Non-compliance|0|||
19517919|NCT01525602|41930917|FG002|Overall Study|Non-compliance|0|||
19517920|NCT01525602|41930918|FG003|Overall Study|Non-compliance|0|||
19517921|NCT01525602|41930919|FG004|Overall Study|Non-compliance|1|||
19517922|NCT01525602|41930920|FG005|Overall Study|Non-compliance|0|||
19517923|NCT01525602|41930921|FG006|Overall Study|Non-compliance|0|||
19517924|NCT01525602|41930922|FG007|Overall Study|Non-compliance|0|||
19517925|NCT01525602|41930915|FG000|Overall Study|Withdrawal by Subject|0|||
19517926|NCT01525602|41930916|FG001|Overall Study|Withdrawal by Subject|0|||
19517927|NCT01525602|41930917|FG002|Overall Study|Withdrawal by Subject|0|||
19517928|NCT01525602|41930918|FG003|Overall Study|Withdrawal by Subject|0|||
19517929|NCT01525602|41930919|FG004|Overall Study|Withdrawal by Subject|3|||
19517930|NCT01525602|41930920|FG005|Overall Study|Withdrawal by Subject|1|||
19517931|NCT01525602|41930921|FG006|Overall Study|Withdrawal by Subject|0|||
19517932|NCT01525602|41930922|FG007|Overall Study|Withdrawal by Subject|1|||
19517933|NCT01525602|41930915|FG000|Overall Study|Physician Decision|0|||
19517934|NCT01525602|41930916|FG001|Overall Study|Physician Decision|0|||
19517935|NCT01525602|41930917|FG002|Overall Study|Physician Decision|0|||
19517936|NCT01525602|41930918|FG003|Overall Study|Physician Decision|0|||
19517937|NCT01525602|41930919|FG004|Overall Study|Physician Decision|3|||
19517938|NCT01525602|41930920|FG005|Overall Study|Physician Decision|0|||
19517939|NCT01525602|41930921|FG006|Overall Study|Physician Decision|1|||
19627810|NCT00839072|42077238|FG000|Second Intervention Period|Withdrawal by Subject|1|||
19517940|NCT01525602|41930922|FG007|Overall Study|Physician Decision|0|||
19517941|NCT01525602|41930915|FG000|Overall Study|Death|0|||
19397929|NCT02584855|41642783|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
19397930|NCT02584855|41642778|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
19397931|NCT02584855|41642779|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
19397932|NCT02584855|41642780|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
19397933|NCT02584855|41642781|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
19397934|NCT02584855|41642782|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
19397935|NCT02584855|41642783|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
19397936|NCT02581891|41642798|FG000|Overall Study|Adverse Event|4|||
19397937|NCT02581891|41642799|FG001|Overall Study|Adverse Event|6|||
19397938|NCT02581891|41642798|FG000|Overall Study|Death|3|||
19397939|NCT02581891|41642799|FG001|Overall Study|Death|4|||
19397940|NCT02581891|41642798|FG000|Overall Study|Lost to Follow-up|1|||
19397941|NCT02581891|41642799|FG001|Overall Study|Lost to Follow-up|2|||
19397942|NCT02581891|41642798|FG000|Overall Study|Physician Decision|0|||
19397943|NCT02581891|41642799|FG001|Overall Study|Physician Decision|1|||
19374366|NCT02234843|41616023|FG000|Overall Study|Efficacy outcome reached|2|||
19374367|NCT02234843|41616024|FG001|Overall Study|Efficacy outcome reached|0|||
19374368|NCT02234843|41616025|FG002|Overall Study|Efficacy outcome reached|0|||
19374369|NCT02234843|41616026|FG003|Overall Study|Efficacy outcome reached|0|||
19374370|NCT02234843|41616027|FG004|Overall Study|Efficacy outcome reached|0|||
19374371|NCT02234843|41616028|FG005|Overall Study|Efficacy outcome reached|2|||
19374372|NCT02234843|41616029|FG006|Overall Study|Efficacy outcome reached|0|||
19374373|NCT02234843|41616030|FG007|Overall Study|Efficacy outcome reached|0|||
19374374|NCT02234843|41616031|FG008|Overall Study|Efficacy outcome reached|0|||
19374375|NCT02234843|41616032|FG009|Overall Study|Efficacy outcome reached|0|||
19374376|NCT02234843|41616023|FG000|Overall Study|Patient convenience|2|||
19374377|NCT02234843|41616024|FG001|Overall Study|Patient convenience|0|||
19374378|NCT02234843|41616025|FG002|Overall Study|Patient convenience|0|||
19374379|NCT02234843|41616026|FG003|Overall Study|Patient convenience|0|||
19374380|NCT02234843|41616027|FG004|Overall Study|Patient convenience|0|||
19374381|NCT02234843|41616028|FG005|Overall Study|Patient convenience|1|||
19374382|NCT02234843|41616029|FG006|Overall Study|Patient convenience|0|||
19374383|NCT02234843|41616030|FG007|Overall Study|Patient convenience|0|||
19374384|NCT02234843|41616031|FG008|Overall Study|Patient convenience|0|||
19374385|NCT02234843|41616032|FG009|Overall Study|Patient convenience|0|||
19374386|NCT02234843|41616023|FG000|Overall Study|Withdrawal by Subject|5|||
19374387|NCT02234843|41616024|FG001|Overall Study|Withdrawal by Subject|1|||
19374388|NCT02234843|41616025|FG002|Overall Study|Withdrawal by Subject|1|||
19374389|NCT02234843|41616026|FG003|Overall Study|Withdrawal by Subject|0|||
19374390|NCT02234843|41616027|FG004|Overall Study|Withdrawal by Subject|0|||
19374391|NCT02234843|41616028|FG005|Overall Study|Withdrawal by Subject|7|||
19374392|NCT02234843|41616029|FG006|Overall Study|Withdrawal by Subject|0|||
19374393|NCT02234843|41616030|FG007|Overall Study|Withdrawal by Subject|0|||
19374394|NCT02234843|41616031|FG008|Overall Study|Withdrawal by Subject|0|||
19374395|NCT02234843|41616032|FG009|Overall Study|Withdrawal by Subject|0|||
19374396|NCT02234843|41616023|FG000|Overall Study|Recovery|1|||
19374397|NCT02234843|41616024|FG001|Overall Study|Recovery|0|||
19374398|NCT02234843|41616025|FG002|Overall Study|Recovery|0|||
19374399|NCT02234843|41616026|FG003|Overall Study|Recovery|0|||
19374400|NCT02234843|41616027|FG004|Overall Study|Recovery|0|||
19374401|NCT02234843|41616028|FG005|Overall Study|Recovery|0|||
19374402|NCT02234843|41616029|FG006|Overall Study|Recovery|0|||
19374403|NCT02234843|41616030|FG007|Overall Study|Recovery|0|||
19374404|NCT02234843|41616031|FG008|Overall Study|Recovery|0|||
19374405|NCT02234843|41616032|FG009|Overall Study|Recovery|0|||
19374406|NCT02234843|41616023|FG000|Overall Study|Other|0|||
19374407|NCT02234843|41616024|FG001|Overall Study|Other|2|||
19374408|NCT02234843|41616025|FG002|Overall Study|Other|0|||
19374409|NCT02234843|41616026|FG003|Overall Study|Other|1|||
19374410|NCT02234843|41616027|FG004|Overall Study|Other|0|||
19374411|NCT02234843|41616028|FG005|Overall Study|Other|1|||
19374412|NCT02234843|41616029|FG006|Overall Study|Other|0|||
19374413|NCT02234843|41616030|FG007|Overall Study|Other|1|||
19374414|NCT02234843|41616031|FG008|Overall Study|Other|0|||
19374415|NCT02234843|41616032|FG009|Overall Study|Other|0|||
19374416|NCT02234843|41616023|FG000|Overall Study|Physician Decision|4|||
19397944|NCT02581891|41642798|FG000|Overall Study|Withdrawal by Subject|4|||
19374417|NCT02234843|41616024|FG001|Overall Study|Physician Decision|1|||
19374418|NCT02234843|41616025|FG002|Overall Study|Physician Decision|0|||
19374419|NCT02234843|41616026|FG003|Overall Study|Physician Decision|1|||
19374420|NCT02234843|41616027|FG004|Overall Study|Physician Decision|0|||
19374421|NCT02234843|41616028|FG005|Overall Study|Physician Decision|0|||
19374422|NCT02234843|41616029|FG006|Overall Study|Physician Decision|0|||
19374423|NCT02234843|41616030|FG007|Overall Study|Physician Decision|1|||
19374424|NCT02234843|41616031|FG008|Overall Study|Physician Decision|0|||
19374425|NCT02234843|41616032|FG009|Overall Study|Physician Decision|0|||
19374426|NCT02234843|41616023|FG000|Overall Study|Adverse Event|5|||
19374427|NCT02234843|41616024|FG001|Overall Study|Adverse Event|1|||
19397945|NCT02581891|41642799|FG001|Overall Study|Withdrawal by Subject|5|||
19397946|NCT02581891|41642798|FG000|Overall Study|Other Reasons|3|||
19397947|NCT02581891|41642799|FG001|Overall Study|Other Reasons|1|||
19397948|NCT02581891|41642798|FG000|Overall Study|Discontinued during followup|1|||
19397949|NCT02581891|41642799|FG001|Overall Study|Discontinued during followup|0|||
19397950|NCT02581345|41642808|FG000|Part 1: up to Week 16|Adverse Event|3|||
19397951|NCT02581345|41642809|FG001|Part 1: up to Week 16|Adverse Event|8|||
19397952|NCT02581345|41642810|FG002|Part 1: up to Week 16|Adverse Event|0|||
19397953|NCT02581345|41642811|FG003|Part 1: up to Week 16|Adverse Event|0|||
19397954|NCT02581345|41642808|FG000|Part 1: up to Week 16|Physician Decision|2|||
19397955|NCT02581345|41642809|FG001|Part 1: up to Week 16|Physician Decision|4|||
19397956|NCT02581345|41642810|FG002|Part 1: up to Week 16|Physician Decision|0|||
19397957|NCT02581345|41642811|FG003|Part 1: up to Week 16|Physician Decision|0|||
19397958|NCT02581345|41642808|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
19397959|NCT02581345|41642809|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
19397960|NCT02581345|41642810|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
19397961|NCT02581345|41642811|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
19397962|NCT02581345|41642808|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
19397963|NCT02581345|41642809|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
19397964|NCT02581345|41642810|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
19397965|NCT02581345|41642811|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
19397966|NCT02581345|41642808|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
19397967|NCT02581345|41642809|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
19397968|NCT02581345|41642810|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
19397969|NCT02581345|41642811|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
19397970|NCT02581345|41642808|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
19397971|NCT02581345|41642809|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
19397972|NCT02581345|41642810|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
19397973|NCT02581345|41642811|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
19397974|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
19397975|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
19397976|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
19397977|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
19397978|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
19397979|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
19397980|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
19397981|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
19397982|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
19397983|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
19397984|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
19397985|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
19397986|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
19397987|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
19397988|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
19397989|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
19397990|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
19397991|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
19397992|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
19397993|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
19397994|NCT02581345|41642808|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
19397995|NCT02581345|41642809|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
19397996|NCT02581345|41642810|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
19397997|NCT02581345|41642811|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
19397998|NCT02581189|41642829|FG000|Overall Study|Failure to return|36|||
19397999|NCT02581189|41642829|FG000|Overall Study|Withdrew consent|5|||
19398000|NCT02581189|41642829|FG000|Overall Study|Death|3|||
19398001|NCT02581189|41642829|FG000|Overall Study|Insufficient virological response|2|||
19398002|NCT02581189|41642829|FG000|Overall Study|Other, not specified|7|||
19398003|NCT00352027|41642836|FG000|Overall Study|Progressive disease|3|||
19398004|NCT02577523|41642864|FG000|Overall Study|Adverse Event|1|||
19398005|NCT02577523|41642865|FG001|Overall Study|Adverse Event|1|||
19398006|NCT02577523|41642864|FG000|Overall Study|Lack of Efficacy|1|||
19398007|NCT02577523|41642865|FG001|Overall Study|Lack of Efficacy|1|||
19398008|NCT02577523|41642864|FG000|Overall Study|Withdrawal by Subject|1|||
19398009|NCT02577523|41642865|FG001|Overall Study|Withdrawal by Subject|0|||
19398010|NCT02576977|41642873|FG000|Overall Study|Adverse Event|13|||
19398011|NCT02576977|41642874|FG001|Overall Study|Adverse Event|2|||
19398012|NCT02576977|41642873|FG000|Overall Study|Death|73|||
19398013|NCT02576977|41642874|FG001|Overall Study|Death|60|||
19398014|NCT02576977|41642873|FG000|Overall Study|Screen failure|1|||
19398015|NCT02576977|41642874|FG001|Overall Study|Screen failure|0|||
19398016|NCT02576977|41642873|FG000|Overall Study|Study Terminated at Selected Sites|27|||
19398017|NCT02576977|41642874|FG001|Overall Study|Study Terminated at Selected Sites|50|||
19398018|NCT02576977|41642873|FG000|Overall Study|Withdrawal by Subject|11|||
19711030|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
19398019|NCT02576977|41642874|FG001|Overall Study|Withdrawal by Subject|11|||
19398020|NCT02576977|41642873|FG000|Overall Study|Final Disposition Unknown|0|||
19398021|NCT02576977|41642874|FG001|Overall Study|Final Disposition Unknown|1|||
19398022|NCT02576977|41642873|FG000|Overall Study|Lost to Follow-up|1|||
19398023|NCT02576977|41642874|FG001|Overall Study|Lost to Follow-up|0|||
19398024|NCT02576977|41642873|FG000|Overall Study|Progressive Disease|0|||
19398025|NCT02576977|41642874|FG001|Overall Study|Progressive Disease|1|||
19398026|NCT02576587|41642891|FG000|Baseline|Equipment failure|0|||
19398027|NCT02576587|41642892|FG001|Baseline|Equipment failure|1|||
19398028|NCT02576587|41642891|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
19398029|NCT02576587|41642892|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
19398030|NCT02576587|41642891|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
19398031|NCT02576587|41642892|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
19398032|NCT02576587|41642891|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
19398033|NCT02576587|41642892|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
19398034|NCT03016975|41642916|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
19398035|NCT03016975|41642917|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
19398036|NCT03016975|41642918|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
19398037|NCT03016975|41642916|FG000|At 6 Months Follow-up|Death|2|||
19398038|NCT03016975|41642917|FG001|At 6 Months Follow-up|Death|0|||
19398039|NCT03016975|41642918|FG002|At 6 Months Follow-up|Death|0|||
19398040|NCT03016975|41642916|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
19398041|NCT03016975|41642917|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
19398042|NCT03016975|41642918|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
19398043|NCT03016975|41642916|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
19398044|NCT03016975|41642917|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
19398045|NCT03016975|41642918|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
19398046|NCT03016975|41642916|FG000|At 6 Months Follow-up|Aborted implant|1|||
19398047|NCT03016975|41642917|FG001|At 6 Months Follow-up|Aborted implant|0|||
19398048|NCT03016975|41642918|FG002|At 6 Months Follow-up|Aborted implant|0|||
19398049|NCT03016975|41642916|FG000|At 2 Year Follow-up|Death|1|||
19398050|NCT03016975|41642917|FG001|At 2 Year Follow-up|Death|0|||
19398051|NCT03016975|41642918|FG002|At 2 Year Follow-up|Death|0|||
19398052|NCT03016975|41642916|FG000|At 3 Year Follow-up|Death|1|||
19398053|NCT03016975|41642917|FG001|At 3 Year Follow-up|Death|0|||
19398054|NCT03016975|41642918|FG002|At 3 Year Follow-up|Death|0|||
19398055|NCT03016975|41642916|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
19398056|NCT03016975|41642917|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
19398057|NCT03016975|41642918|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
19398058|NCT05340751|41642972|FG000|Overall Study|Physician Decision|3|||
19398059|NCT02575807|41642981|FG000|Overall Study|Death|8|||
19398060|NCT02575807|41642982|FG001|Overall Study|Death|3|||
19398061|NCT02575807|41642983|FG002|Overall Study|Death|7|||
19398062|NCT02575807|41642984|FG003|Overall Study|Death|0|||
19398063|NCT02575807|41642985|FG004|Overall Study|Death|1|||
19398064|NCT02575807|41642981|FG000|Overall Study|Study terminated by Sponsor|0|||
19398065|NCT02575807|41642982|FG001|Overall Study|Study terminated by Sponsor|1|||
19398066|NCT02575807|41642983|FG002|Overall Study|Study terminated by Sponsor|7|||
19398067|NCT02575807|41642984|FG003|Overall Study|Study terminated by Sponsor|0|||
19398068|NCT02575807|41642985|FG004|Overall Study|Study terminated by Sponsor|1|||
19398069|NCT02575807|41642981|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
19398070|NCT02575807|41642982|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
19398071|NCT02575807|41642983|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
19398072|NCT02575807|41642984|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
19398073|NCT02575807|41642985|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
19398074|NCT02575807|41642981|FG000|Overall Study|Terminated due to physician decision|0|||
19398075|NCT02575807|41642982|FG001|Overall Study|Terminated due to physician decision|0|||
19398076|NCT02575807|41642983|FG002|Overall Study|Terminated due to physician decision|1|||
19398077|NCT02575807|41642984|FG003|Overall Study|Terminated due to physician decision|0|||
19398078|NCT02575807|41642985|FG004|Overall Study|Terminated due to physician decision|0|||
19398079|NCT02575807|41642981|FG000|Overall Study|Subject ineligible - medical implant|0|||
19398080|NCT02575807|41642982|FG001|Overall Study|Subject ineligible - medical implant|0|||
19398081|NCT02575807|41642983|FG002|Overall Study|Subject ineligible - medical implant|0|||
19398082|NCT02575807|41642984|FG003|Overall Study|Subject ineligible - medical implant|1|||
19398083|NCT02575807|41642985|FG004|Overall Study|Subject ineligible - medical implant|0|||
19398084|NCT02575807|41642981|FG000|Overall Study|Withdrawal by Subject|0|||
19398085|NCT02575807|41642982|FG001|Overall Study|Withdrawal by Subject|0|||
19398086|NCT02575807|41642983|FG002|Overall Study|Withdrawal by Subject|1|||
19398087|NCT02575807|41642984|FG003|Overall Study|Withdrawal by Subject|1|||
19398088|NCT02575807|41642985|FG004|Overall Study|Withdrawal by Subject|2|||
19398089|NCT02575339|41643020|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
19398090|NCT02575339|41643021|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
19398091|NCT02575339|41643022|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
19398092|NCT02575339|41643020|FG000|Study Treatment|Disease Progression|5|||
19398093|NCT02575339|41643021|FG001|Study Treatment|Disease Progression|2|||
19398094|NCT02575339|41643022|FG002|Study Treatment|Disease Progression|0|||
19398095|NCT02575339|41643020|FG000|Study Treatment|Adverse Event|1|||
19398096|NCT02575339|41643021|FG001|Study Treatment|Adverse Event|2|||
19398097|NCT02575339|41643022|FG002|Study Treatment|Adverse Event|0|||
19398098|NCT02575339|41643020|FG000|Follow up|Death|6|||
19398099|NCT02575339|41643021|FG001|Follow up|Death|2|||
19398100|NCT02575339|41643022|FG002|Follow up|Death|0|||
19398101|NCT02575339|41643020|FG000|Follow up|Study Terminated|0|||
19398102|NCT02575339|41643021|FG001|Follow up|Study Terminated|2|||
19398103|NCT02575339|41643022|FG002|Follow up|Study Terminated|0|||
19398104|NCT02575339|41643020|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
19398105|NCT02575339|41643021|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
19398106|NCT02575339|41643022|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
19398107|NCT01712659|41643035|FG000|Dose Escalation|Physician Decision|0|||
19398108|NCT01712659|41643036|FG001|Dose Escalation|Physician Decision|1|||
19398109|NCT01712659|41643037|FG002|Dose Escalation|Physician Decision|0|||
19398110|NCT01712659|41643038|FG003|Dose Escalation|Physician Decision|0|||
19398111|NCT01712659|41643039|FG004|Dose Escalation|Physician Decision|0|||
19398112|NCT01712659|41643035|FG000|Dose Escalation|Unable to take study drug|0|||
19398113|NCT01712659|41643036|FG001|Dose Escalation|Unable to take study drug|1|||
19398114|NCT01712659|41643037|FG002|Dose Escalation|Unable to take study drug|0|||
19398115|NCT01712659|41643038|FG003|Dose Escalation|Unable to take study drug|0|||
19398116|NCT01712659|41643039|FG004|Dose Escalation|Unable to take study drug|0|||
19398117|NCT01712659|41643035|FG000|Dose Expansion|Early disease progression|1|||
19398118|NCT01712659|41643036|FG001|Dose Expansion|Early disease progression|0|||
19398119|NCT01712659|41643037|FG002|Dose Expansion|Early disease progression|0|||
19398120|NCT01712659|41643038|FG003|Dose Expansion|Early disease progression|0|||
19398121|NCT01712659|41643039|FG004|Dose Expansion|Early disease progression|0|||
19398122|NCT01712659|41643035|FG000|Dose Expansion|Physician Decision|1|||
19398123|NCT01712659|41643036|FG001|Dose Expansion|Physician Decision|0|||
19398124|NCT01712659|41643037|FG002|Dose Expansion|Physician Decision|0|||
19398125|NCT01712659|41643038|FG003|Dose Expansion|Physician Decision|0|||
19398126|NCT01712659|41643039|FG004|Dose Expansion|Physician Decision|0|||
19398127|NCT01610713|41643065|FG000|Overall Study|Adverse Event|3|||
19398128|NCT01610713|41643066|FG001|Overall Study|Adverse Event|0|||
19398129|NCT01610713|41643065|FG000|Overall Study|Lack of Efficacy|1|||
19398130|NCT01610713|41643066|FG001|Overall Study|Lack of Efficacy|0|||
19398131|NCT01610713|41643065|FG000|Overall Study|low mood and poor motivation|1|||
19398132|NCT01610713|41643066|FG001|Overall Study|low mood and poor motivation|0|||
19398133|NCT01610713|41643065|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
19398134|NCT01610713|41643066|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
19398135|NCT01610713|41643065|FG000|Overall Study|Lost to Follow-up|0|||
19398136|NCT01610713|41643066|FG001|Overall Study|Lost to Follow-up|1|||
19398137|NCT01606189|41643072|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
19398138|NCT01606189|41643073|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
19398139|NCT01606189|41643074|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
19398140|NCT01606189|41643075|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
19398141|NCT01606189|41643076|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
19398142|NCT01606189|41643077|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
19398143|NCT01606189|41643072|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
19398144|NCT01606189|41643073|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
19398145|NCT01606189|41643074|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
19398146|NCT01606189|41643075|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
19398147|NCT01606189|41643076|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
19398148|NCT01606189|41643077|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
19398149|NCT01663987|41643087|FG000|Overall Study|Adverse Event|7|||
19398150|NCT01663987|41643088|FG001|Overall Study|Adverse Event|2|||
19398151|NCT01663987|41643087|FG000|Overall Study|Lost to Follow-up|1|||
19398152|NCT01663987|41643088|FG001|Overall Study|Lost to Follow-up|1|||
19398153|NCT01663987|41643087|FG000|Overall Study|Withdrawal by Subject|2|||
19398154|NCT01663987|41643088|FG001|Overall Study|Withdrawal by Subject|3|||
19398155|NCT01663987|41643087|FG000|Overall Study|Other reason not defined above|3|||
19398156|NCT01663987|41643088|FG001|Overall Study|Other reason not defined above|0|||
19627811|NCT00839072|42077239|FG001|Second Intervention Period|Withdrawal by Subject|0|||
19398157|NCT02380677|41643106|FG000|Overall Study|Adverse Event|0|||
19398158|NCT02380677|41643107|FG001|Overall Study|Adverse Event|0|||
19398159|NCT02380677|41643108|FG002|Overall Study|Adverse Event|0|||
19398160|NCT02380677|41643109|FG003|Overall Study|Adverse Event|1|||
19398161|NCT02380677|41643110|FG004|Overall Study|Adverse Event|1|||
19398162|NCT02380677|41643111|FG005|Overall Study|Adverse Event|4|||
19398163|NCT02380677|41643112|FG006|Overall Study|Adverse Event|2|||
19398164|NCT02380677|41643113|FG007|Overall Study|Adverse Event|2|||
19398165|NCT02380677|41643114|FG008|Overall Study|Adverse Event|2|||
19398166|NCT02380677|41643115|FG009|Overall Study|Adverse Event|1|||
19398167|NCT02380677|41643116|FG010|Overall Study|Adverse Event|2|||
19398168|NCT02380677|41643117|FG011|Overall Study|Adverse Event|1|||
19398169|NCT02380677|41643106|FG000|Overall Study|Physician Decision|1|||
19398170|NCT02380677|41643107|FG001|Overall Study|Physician Decision|0|||
19398171|NCT02380677|41643108|FG002|Overall Study|Physician Decision|1|||
19398172|NCT02380677|41643109|FG003|Overall Study|Physician Decision|1|||
19398173|NCT02380677|41643110|FG004|Overall Study|Physician Decision|0|||
19398174|NCT02380677|41643111|FG005|Overall Study|Physician Decision|0|||
19398175|NCT02380677|41643112|FG006|Overall Study|Physician Decision|0|||
19398176|NCT02380677|41643113|FG007|Overall Study|Physician Decision|0|||
19398177|NCT02380677|41643114|FG008|Overall Study|Physician Decision|0|||
19398178|NCT02380677|41643115|FG009|Overall Study|Physician Decision|0|||
19398179|NCT02380677|41643116|FG010|Overall Study|Physician Decision|0|||
19398180|NCT02380677|41643117|FG011|Overall Study|Physician Decision|0|||
19398181|NCT02380677|41643106|FG000|Overall Study|Lack of Efficacy|0|||
19398182|NCT02380677|41643107|FG001|Overall Study|Lack of Efficacy|1|||
19398183|NCT02380677|41643108|FG002|Overall Study|Lack of Efficacy|2|||
19398184|NCT02380677|41643109|FG003|Overall Study|Lack of Efficacy|0|||
19398185|NCT02380677|41643110|FG004|Overall Study|Lack of Efficacy|4|||
19398186|NCT02380677|41643111|FG005|Overall Study|Lack of Efficacy|1|||
19398187|NCT02380677|41643112|FG006|Overall Study|Lack of Efficacy|1|||
19398188|NCT02380677|41643113|FG007|Overall Study|Lack of Efficacy|2|||
19398189|NCT02380677|41643114|FG008|Overall Study|Lack of Efficacy|2|||
19398190|NCT02380677|41643115|FG009|Overall Study|Lack of Efficacy|0|||
19398191|NCT02380677|41643116|FG010|Overall Study|Lack of Efficacy|2|||
19398192|NCT02380677|41643117|FG011|Overall Study|Lack of Efficacy|1|||
19398193|NCT02380677|41643106|FG000|Overall Study|Withdrawal by Subject|0|||
19398194|NCT02380677|41643107|FG001|Overall Study|Withdrawal by Subject|0|||
19398195|NCT02380677|41643108|FG002|Overall Study|Withdrawal by Subject|0|||
19398196|NCT02380677|41643109|FG003|Overall Study|Withdrawal by Subject|0|||
19398197|NCT02380677|41643110|FG004|Overall Study|Withdrawal by Subject|0|||
19398198|NCT02380677|41643111|FG005|Overall Study|Withdrawal by Subject|0|||
19398199|NCT02380677|41643112|FG006|Overall Study|Withdrawal by Subject|0|||
19398200|NCT02380677|41643113|FG007|Overall Study|Withdrawal by Subject|0|||
19627812|NCT00855803|42077245|FG000|Overall Study|Death|2|||
19627813|NCT00855803|42077245|FG000|Overall Study|Lost to Follow-up|2|||
19374428|NCT02234843|41616025|FG002|Overall Study|Adverse Event|1|||
19374429|NCT02234843|41616026|FG003|Overall Study|Adverse Event|3|||
19374430|NCT02234843|41616027|FG004|Overall Study|Adverse Event|2|||
19374431|NCT02234843|41616028|FG005|Overall Study|Adverse Event|1|||
19374432|NCT02234843|41616029|FG006|Overall Study|Adverse Event|0|||
19374433|NCT02234843|41616030|FG007|Overall Study|Adverse Event|0|||
19374434|NCT02234843|41616031|FG008|Overall Study|Adverse Event|1|||
19374435|NCT02234843|41616032|FG009|Overall Study|Adverse Event|0|||
19374436|NCT02234843|41616023|FG000|Overall Study|Non-compliance with study drug|1|||
19374437|NCT02234843|41616024|FG001|Overall Study|Non-compliance with study drug|0|||
19374438|NCT02234843|41616025|FG002|Overall Study|Non-compliance with study drug|0|||
19374439|NCT02234843|41616026|FG003|Overall Study|Non-compliance with study drug|0|||
19374440|NCT02234843|41616027|FG004|Overall Study|Non-compliance with study drug|0|||
19374441|NCT02234843|41616028|FG005|Overall Study|Non-compliance with study drug|1|||
19374442|NCT02234843|41616029|FG006|Overall Study|Non-compliance with study drug|1|||
19374443|NCT02234843|41616030|FG007|Overall Study|Non-compliance with study drug|0|||
19374444|NCT02234843|41616031|FG008|Overall Study|Non-compliance with study drug|0|||
19374445|NCT02234843|41616032|FG009|Overall Study|Non-compliance with study drug|0|||
19374446|NCT02234843|41616023|FG000|Overall Study|Lost to Follow-up|0|||
19374447|NCT02234843|41616024|FG001|Overall Study|Lost to Follow-up|1|||
19374448|NCT02234843|41616025|FG002|Overall Study|Lost to Follow-up|0|||
19374449|NCT02234843|41616026|FG003|Overall Study|Lost to Follow-up|0|||
19374450|NCT02234843|41616027|FG004|Overall Study|Lost to Follow-up|0|||
19374451|NCT02234843|41616028|FG005|Overall Study|Lost to Follow-up|0|||
19374452|NCT02234843|41616029|FG006|Overall Study|Lost to Follow-up|1|||
19374453|NCT02234843|41616030|FG007|Overall Study|Lost to Follow-up|0|||
19374454|NCT02234843|41616031|FG008|Overall Study|Lost to Follow-up|0|||
19374455|NCT02234843|41616032|FG009|Overall Study|Lost to Follow-up|0|||
19374456|NCT02740231|41616069|FG000|Overall Study|Withdrawal by Subject|1|||
19374457|NCT02740231|41616070|FG001|Overall Study|Withdrawal by Subject|1|||
19374458|NCT02740231|41616071|FG002|Overall Study|Withdrawal by Subject|1|||
19374459|NCT02740231|41616072|FG003|Overall Study|Withdrawal by Subject|0|||
19374460|NCT02740231|41616069|FG000|Overall Study|Lack of Efficacy|0|||
19374461|NCT02740231|41616070|FG001|Overall Study|Lack of Efficacy|1|||
19374462|NCT02740231|41616071|FG002|Overall Study|Lack of Efficacy|0|||
19374463|NCT02740231|41616072|FG003|Overall Study|Lack of Efficacy|4|||
19374464|NCT02740231|41616069|FG000|Overall Study|Lost to Follow-up|1|||
19374465|NCT02740231|41616070|FG001|Overall Study|Lost to Follow-up|3|||
19374466|NCT02740231|41616071|FG002|Overall Study|Lost to Follow-up|0|||
19374467|NCT02740231|41616072|FG003|Overall Study|Lost to Follow-up|3|||
19398201|NCT02380677|41643114|FG008|Overall Study|Withdrawal by Subject|0|||
19398202|NCT02380677|41643115|FG009|Overall Study|Withdrawal by Subject|1|||
19398203|NCT02380677|41643116|FG010|Overall Study|Withdrawal by Subject|0|||
19398204|NCT02380677|41643117|FG011|Overall Study|Withdrawal by Subject|3|||
19398205|NCT02380677|41643106|FG000|Overall Study|Other|0|||
19398206|NCT02380677|41643107|FG001|Overall Study|Other|0|||
19398207|NCT02380677|41643108|FG002|Overall Study|Other|0|||
19398208|NCT02380677|41643109|FG003|Overall Study|Other|1|||
19398209|NCT02380677|41643110|FG004|Overall Study|Other|1|||
19398210|NCT02380677|41643111|FG005|Overall Study|Other|1|||
19398211|NCT02380677|41643112|FG006|Overall Study|Other|0|||
19398212|NCT02380677|41643113|FG007|Overall Study|Other|0|||
19398213|NCT02380677|41643114|FG008|Overall Study|Other|0|||
19398214|NCT02380677|41643115|FG009|Overall Study|Other|0|||
19398215|NCT02380677|41643116|FG010|Overall Study|Other|0|||
19398216|NCT02380677|41643117|FG011|Overall Study|Other|0|||
19398217|NCT02380287|41643153|FG000|Overall Study|Adverse Event|0|||
19398218|NCT02380287|41643154|FG001|Overall Study|Adverse Event|0|||
19398219|NCT02380287|41643155|FG002|Overall Study|Adverse Event|1|||
19398220|NCT02380287|41643156|FG003|Overall Study|Adverse Event|0|||
19398221|NCT02380287|41643157|FG004|Overall Study|Adverse Event|0|||
19398222|NCT02380287|41643158|FG005|Overall Study|Adverse Event|0|||
19398223|NCT02380287|41643159|FG006|Overall Study|Adverse Event|0|||
19398224|NCT02380287|41643160|FG007|Overall Study|Adverse Event|0|||
19398225|NCT02343003|41643187|FG000|Overall Study|Withdrawal by Subject|9|||
19398226|NCT02343003|41643188|FG001|Overall Study|Withdrawal by Subject|4|||
19398227|NCT02343003|41643187|FG000|Overall Study|Lost to Follow-up|5|||
19398228|NCT02343003|41643188|FG001|Overall Study|Lost to Follow-up|1|||
19398229|NCT02343003|41643187|FG000|Overall Study|Protocol Violation|1|||
19398230|NCT02343003|41643188|FG001|Overall Study|Protocol Violation|0|||
19398231|NCT02343003|41643187|FG000|Overall Study|Death|0|||
19398232|NCT02343003|41643188|FG001|Overall Study|Death|1|||
19398233|NCT02343003|41643187|FG000|Overall Study|exclusion criteria met|1|||
19398234|NCT02343003|41643188|FG001|Overall Study|exclusion criteria met|1|||
19398235|NCT02343003|41643187|FG000|Overall Study|terminated by sponsor|2|||
19398236|NCT02343003|41643188|FG001|Overall Study|terminated by sponsor|0|||
19398237|NCT02394561|41643196|FG000|CORE Phase|Adverse Event|7|||
19398238|NCT02394561|41643197|FG001|CORE Phase|Adverse Event|9|||
19398239|NCT02394561|41643196|FG000|CORE Phase|Death|0|||
19398240|NCT02394561|41643197|FG001|CORE Phase|Death|1|||
19398241|NCT02394561|41643196|FG000|CORE Phase|Pregnancy|1|||
19398242|NCT02394561|41643197|FG001|CORE Phase|Pregnancy|0|||
19398243|NCT02394561|41643196|FG000|CORE Phase|Lost to Follow-up|1|||
19398244|NCT02394561|41643197|FG001|CORE Phase|Lost to Follow-up|0|||
19398245|NCT02394561|41643196|FG000|CORE Phase|Physician Decision|1|||
19398246|NCT02394561|41643197|FG001|CORE Phase|Physician Decision|1|||
19398247|NCT02394561|41643196|FG000|CORE Phase|Withdrawal by Subject|2|||
19398248|NCT02394561|41643197|FG001|CORE Phase|Withdrawal by Subject|2|||
19398249|NCT02394561|41643196|FG000|CORE Phase|Lack of Efficacy|1|||
19398250|NCT02394561|41643197|FG001|CORE Phase|Lack of Efficacy|6|||
19398251|NCT02394561|41643196|FG000|Extension Phase|Adverse Event|6|||
19398252|NCT02394561|41643197|FG001|Extension Phase|Adverse Event|1|||
19398253|NCT02394561|41643196|FG000|Extension Phase|Death|0|||
19398254|NCT02394561|41643197|FG001|Extension Phase|Death|1|||
19398255|NCT02394561|41643196|FG000|Extension Phase|Protocol Violation|1|||
19398256|NCT02394561|41643197|FG001|Extension Phase|Protocol Violation|0|||
19398257|NCT02394561|41643196|FG000|Extension Phase|Lost to Follow-up|1|||
19398258|NCT02394561|41643197|FG001|Extension Phase|Lost to Follow-up|0|||
19398259|NCT02394561|41643196|FG000|Extension Phase|Physician Decision|0|||
19398260|NCT02394561|41643197|FG001|Extension Phase|Physician Decision|2|||
19398261|NCT02394561|41643196|FG000|Extension Phase|Withdrawal by Subject|0|||
19398262|NCT02394561|41643197|FG001|Extension Phase|Withdrawal by Subject|5|||
19398263|NCT02394561|41643196|FG000|Extension Phase|Lack of Efficacy|3|||
19398264|NCT02394561|41643197|FG001|Extension Phase|Lack of Efficacy|3|||
19398265|NCT02342223|41643206|FG000|Overall Study|Lost to Follow-up|1|||
19398266|NCT02393547|41643210|FG000|Overall Study|Adverse Event|2|||
19398267|NCT02393547|41643210|FG000|Overall Study|Withdrawal by Subject|3|||
19398268|NCT02393547|41643210|FG000|Overall Study|Lost to Follow-up|1|||
19398269|NCT02574637|41643219|FG000|Double-blind Period|Adverse Event|1|||
19398270|NCT02574637|41643220|FG001|Double-blind Period|Adverse Event|0|||
19398271|NCT02574637|41643221|FG002|Double-blind Period|Adverse Event|0|||
19398272|NCT02574637|41643222|FG003|Double-blind Period|Adverse Event|0|||
19398273|NCT02574637|41643223|FG004|Double-blind Period|Adverse Event|0|||
19398274|NCT02574637|41643224|FG005|Double-blind Period|Adverse Event|0|||
19398275|NCT02574637|41643225|FG006|Double-blind Period|Adverse Event|0|||
19398276|NCT02574637|41643226|FG007|Double-blind Period|Adverse Event|0|||
19398277|NCT02574637|41643227|FG008|Double-blind Period|Adverse Event|0|||
19398278|NCT02574637|41643228|FG009|Double-blind Period|Adverse Event|0|||
19398279|NCT02574637|41643219|FG000|Double-blind Period|Lack of Efficacy|0|||
19398280|NCT02574637|41643220|FG001|Double-blind Period|Lack of Efficacy|0|||
19398281|NCT02574637|41643221|FG002|Double-blind Period|Lack of Efficacy|2|||
19517942|NCT01525602|41930916|FG001|Overall Study|Death|0|||
19398282|NCT02574637|41643222|FG003|Double-blind Period|Lack of Efficacy|0|||
19398283|NCT02574637|41643223|FG004|Double-blind Period|Lack of Efficacy|0|||
19398284|NCT02574637|41643224|FG005|Double-blind Period|Lack of Efficacy|0|||
19398285|NCT02574637|41643225|FG006|Double-blind Period|Lack of Efficacy|0|||
19398286|NCT02574637|41643226|FG007|Double-blind Period|Lack of Efficacy|0|||
19398287|NCT02574637|41643227|FG008|Double-blind Period|Lack of Efficacy|0|||
19398288|NCT02574637|41643228|FG009|Double-blind Period|Lack of Efficacy|0|||
19398289|NCT02574637|41643219|FG000|Double-blind Period|Protocol Deviation|1|||
19398290|NCT02574637|41643220|FG001|Double-blind Period|Protocol Deviation|0|||
19398291|NCT02574637|41643221|FG002|Double-blind Period|Protocol Deviation|0|||
19398292|NCT02574637|41643222|FG003|Double-blind Period|Protocol Deviation|0|||
19398293|NCT02574637|41643223|FG004|Double-blind Period|Protocol Deviation|0|||
19398294|NCT02574637|41643224|FG005|Double-blind Period|Protocol Deviation|0|||
19398295|NCT02574637|41643225|FG006|Double-blind Period|Protocol Deviation|0|||
19517943|NCT01525602|41930917|FG002|Overall Study|Death|0|||
19517944|NCT01525602|41930918|FG003|Overall Study|Death|0|||
19517945|NCT01525602|41930919|FG004|Overall Study|Death|1|||
19517946|NCT01525602|41930920|FG005|Overall Study|Death|1|||
19517947|NCT01525602|41930921|FG006|Overall Study|Death|0|||
19517948|NCT01525602|41930922|FG007|Overall Study|Death|0|||
19517949|NCT01525602|41930915|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517950|NCT01525602|41930916|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517951|NCT01525602|41930917|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517952|NCT01525602|41930918|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517953|NCT01525602|41930919|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517954|NCT01525602|41930920|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
19517955|NCT01525602|41930921|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
19517956|NCT01525602|41930922|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
19517957|NCT01549002|41930949|FG000|Overall Study|Excessive pain|0|||
19517958|NCT01549002|41930950|FG001|Overall Study|Excessive pain|2|||
19517959|NCT01549002|41930949|FG000|Overall Study|Moderate sedation required|0|||
19517960|NCT01549002|41930950|FG001|Overall Study|Moderate sedation required|2|||
19517961|NCT01548768|41930960|FG000|Overall Study|Withdrawal by Subject|0|||
19517962|NCT01548768|41930961|FG001|Overall Study|Withdrawal by Subject|2|||
19517963|NCT01548768|41930962|FG002|Overall Study|Withdrawal by Subject|1|||
19517964|NCT01548768|41930963|FG003|Overall Study|Withdrawal by Subject|0|||
19517965|NCT01548768|41930960|FG000|Overall Study|Physician Decision|1|||
19517966|NCT01548768|41930961|FG001|Overall Study|Physician Decision|0|||
19517967|NCT01548768|41930962|FG002|Overall Study|Physician Decision|0|||
19627814|NCT00855803|42077245|FG000|Overall Study|Technical inability to undergo procedure|2|||
19627815|NCT00855803|42077245|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
19627816|NCT00855803|42077245|FG000|Overall Study|Withdrawal by Subject|3|||
19627817|NCT00855803|42077245|FG000|Overall Study|Physician Decision|3|||
19627818|NCT03553836|42077251|FG000|Overall Study|Ongoing in Study|460|||
19627819|NCT03553836|42077252|FG001|Overall Study|Ongoing in Study|459|||
19627820|NCT03553836|42077251|FG000|Overall Study|Withdrawal by Subject|9|||
19627821|NCT03553836|42077252|FG001|Overall Study|Withdrawal by Subject|10|||
19627822|NCT03553836|42077251|FG000|Overall Study|Lost to Follow-up|1|||
19627823|NCT03553836|42077252|FG001|Overall Study|Lost to Follow-up|3|||
19627824|NCT03553836|42077251|FG000|Overall Study|Death|17|||
19627825|NCT03553836|42077252|FG001|Overall Study|Death|17|||
19627826|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
19627827|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
19627828|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
19627829|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
19627830|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
19627831|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
19627832|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
19627833|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
19627834|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
19627835|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
19627836|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
19627837|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
19627838|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
19627839|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
19627840|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
19627841|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
19627842|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Missing|3|||
19627843|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Missing|1|||
19627844|NCT00838916|42077261|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
19627845|NCT00838916|42077262|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
19398296|NCT02574637|41643226|FG007|Double-blind Period|Protocol Deviation|0|||
19517968|NCT01548768|41930963|FG003|Overall Study|Physician Decision|0|||
19517969|NCT01548768|41930960|FG000|Overall Study|Adverse Event|0|||
19398297|NCT02574637|41643227|FG008|Double-blind Period|Protocol Deviation|0|||
19398298|NCT02574637|41643228|FG009|Double-blind Period|Protocol Deviation|0|||
19398299|NCT02574637|41643219|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
19398300|NCT02574637|41643220|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
19398301|NCT02574637|41643221|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
19398302|NCT02574637|41643222|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
19398303|NCT02574637|41643223|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
19398304|NCT02574637|41643224|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
19398305|NCT02574637|41643225|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
19398306|NCT02574637|41643226|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
19398307|NCT02574637|41643227|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
19398308|NCT02574637|41643228|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
19398309|NCT02574637|41643219|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
19398310|NCT02574637|41643220|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
19398311|NCT02574637|41643221|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
19398312|NCT02574637|41643222|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
19398313|NCT02574637|41643223|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
19398314|NCT02574637|41643224|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
19398315|NCT02574637|41643225|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
19398316|NCT02574637|41643226|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
19398317|NCT02574637|41643227|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
19398318|NCT02574637|41643228|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
19398319|NCT02574637|41643219|FG000|Double-blind Period|Reason Not Specified|0|||
19398320|NCT02574637|41643220|FG001|Double-blind Period|Reason Not Specified|0|||
19398321|NCT02574637|41643221|FG002|Double-blind Period|Reason Not Specified|0|||
19398322|NCT02574637|41643222|FG003|Double-blind Period|Reason Not Specified|1|||
19398323|NCT02574637|41643223|FG004|Double-blind Period|Reason Not Specified|0|||
19398324|NCT02574637|41643224|FG005|Double-blind Period|Reason Not Specified|0|||
19398325|NCT02574637|41643225|FG006|Double-blind Period|Reason Not Specified|0|||
19398326|NCT02574637|41643226|FG007|Double-blind Period|Reason Not Specified|0|||
19398327|NCT02574637|41643227|FG008|Double-blind Period|Reason Not Specified|0|||
19398328|NCT02574637|41643228|FG009|Double-blind Period|Reason Not Specified|0|||
19398329|NCT02574637|41643219|FG000|Open-label (OL) Period|Adverse Event|0|||
19398330|NCT02574637|41643220|FG001|Open-label (OL) Period|Adverse Event|0|||
19398331|NCT02574637|41643221|FG002|Open-label (OL) Period|Adverse Event|0|||
19398332|NCT02574637|41643222|FG003|Open-label (OL) Period|Adverse Event|0|||
19398333|NCT02574637|41643223|FG004|Open-label (OL) Period|Adverse Event|0|||
19398334|NCT02574637|41643224|FG005|Open-label (OL) Period|Adverse Event|0|||
19398335|NCT02574637|41643225|FG006|Open-label (OL) Period|Adverse Event|0|||
19398336|NCT02574637|41643226|FG007|Open-label (OL) Period|Adverse Event|0|||
19398337|NCT02574637|41643227|FG008|Open-label (OL) Period|Adverse Event|1|||
19398338|NCT02574637|41643228|FG009|Open-label (OL) Period|Adverse Event|0|||
19398339|NCT02574637|41643219|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
19398340|NCT02574637|41643220|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
19398341|NCT02574637|41643221|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
19398342|NCT02574637|41643222|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
19398343|NCT02574637|41643223|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
19398344|NCT02574637|41643224|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
19398345|NCT02574637|41643225|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
19398346|NCT02574637|41643226|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
19398347|NCT02574637|41643227|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
19398348|NCT02574637|41643228|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
19398349|NCT02574637|41643219|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398350|NCT02574637|41643220|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398351|NCT02574637|41643221|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398352|NCT02574637|41643222|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398353|NCT02574637|41643223|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398354|NCT02574637|41643224|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
19398355|NCT02574637|41643225|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
19398356|NCT02574637|41643226|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
19398357|NCT02574637|41643227|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
19398358|NCT02574637|41643228|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
19398359|NCT02392611|41643258|FG000|Overall Study|Adverse Event|0|||
19398360|NCT02392611|41643259|FG001|Overall Study|Adverse Event|0|||
19398361|NCT02392611|41643260|FG002|Overall Study|Adverse Event|0|||
19398362|NCT02392611|41643261|FG003|Overall Study|Adverse Event|1|||
19398363|NCT02392611|41643262|FG004|Overall Study|Adverse Event|0|||
19398364|NCT02392611|41643263|FG005|Overall Study|Adverse Event|0|||
19398365|NCT02392611|41643264|FG006|Overall Study|Adverse Event|0|||
19398366|NCT02392611|41643265|FG007|Overall Study|Adverse Event|0|||
19398367|NCT02392611|41643266|FG008|Overall Study|Adverse Event|0|||
19398368|NCT02392611|41643258|FG000|Overall Study|Progressive disease|0|||
19398369|NCT02392611|41643259|FG001|Overall Study|Progressive disease|0|||
19398370|NCT02392611|41643260|FG002|Overall Study|Progressive disease|0|||
19398371|NCT02392611|41643261|FG003|Overall Study|Progressive disease|2|||
19398372|NCT02392611|41643262|FG004|Overall Study|Progressive disease|1|||
19398373|NCT02392611|41643263|FG005|Overall Study|Progressive disease|0|||
19398374|NCT02392611|41643264|FG006|Overall Study|Progressive disease|0|||
19398375|NCT02392611|41643265|FG007|Overall Study|Progressive disease|0|||
19398376|NCT02392611|41643266|FG008|Overall Study|Progressive disease|0|||
19398377|NCT02392611|41643258|FG000|Overall Study|Death|1|||
19398378|NCT02392611|41643259|FG001|Overall Study|Death|0|||
19398379|NCT02392611|41643260|FG002|Overall Study|Death|0|||
19398380|NCT02392611|41643261|FG003|Overall Study|Death|0|||
19627846|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
19627847|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
19627848|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
19627849|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
19627850|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
19627851|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
19398381|NCT02392611|41643262|FG004|Overall Study|Death|0|||
19398382|NCT02392611|41643263|FG005|Overall Study|Death|1|||
19398383|NCT02392611|41643264|FG006|Overall Study|Death|0|||
19398384|NCT02392611|41643265|FG007|Overall Study|Death|0|||
19398385|NCT02392611|41643266|FG008|Overall Study|Death|0|||
19398386|NCT02392611|41643258|FG000|Overall Study|Withdrawal by Subject|0|||
19398387|NCT02392611|41643259|FG001|Overall Study|Withdrawal by Subject|0|||
19398388|NCT02392611|41643260|FG002|Overall Study|Withdrawal by Subject|0|||
19398389|NCT02392611|41643261|FG003|Overall Study|Withdrawal by Subject|1|||
19398390|NCT02392611|41643262|FG004|Overall Study|Withdrawal by Subject|0|||
19398391|NCT02392611|41643263|FG005|Overall Study|Withdrawal by Subject|0|||
19398392|NCT02392611|41643264|FG006|Overall Study|Withdrawal by Subject|0|||
19398393|NCT02392611|41643265|FG007|Overall Study|Withdrawal by Subject|0|||
19398394|NCT02392611|41643266|FG008|Overall Study|Withdrawal by Subject|0|||
19398395|NCT02392611|41643258|FG000|Overall Study|Lost to Follow-up|0|||
19398396|NCT02392611|41643259|FG001|Overall Study|Lost to Follow-up|0|||
19398397|NCT02392611|41643260|FG002|Overall Study|Lost to Follow-up|0|||
19398398|NCT02392611|41643261|FG003|Overall Study|Lost to Follow-up|0|||
19398399|NCT02392611|41643262|FG004|Overall Study|Lost to Follow-up|0|||
19398400|NCT02392611|41643263|FG005|Overall Study|Lost to Follow-up|0|||
19398401|NCT02392611|41643264|FG006|Overall Study|Lost to Follow-up|1|||
19398402|NCT02392611|41643265|FG007|Overall Study|Lost to Follow-up|0|||
19398403|NCT02392611|41643266|FG008|Overall Study|Lost to Follow-up|0|||
19398404|NCT02392611|41643258|FG000|Overall Study|Enrolled, not treated|0|||
19398405|NCT02392611|41643259|FG001|Overall Study|Enrolled, not treated|0|||
19398406|NCT02392611|41643260|FG002|Overall Study|Enrolled, not treated|0|||
19398407|NCT02392611|41643261|FG003|Overall Study|Enrolled, not treated|2|||
19398408|NCT02392611|41643262|FG004|Overall Study|Enrolled, not treated|0|||
19398409|NCT02392611|41643263|FG005|Overall Study|Enrolled, not treated|0|||
19398410|NCT02392611|41643264|FG006|Overall Study|Enrolled, not treated|0|||
19398411|NCT02392611|41643265|FG007|Overall Study|Enrolled, not treated|0|||
19398412|NCT02392611|41643266|FG008|Overall Study|Enrolled, not treated|0|||
19398413|NCT02378961|41643290|FG000|Overall Study|Lack of Efficacy|4|||
19398414|NCT02378961|41643291|FG001|Overall Study|Lack of Efficacy|2|||
19398415|NCT02378961|41643292|FG002|Overall Study|Lack of Efficacy|0|||
19398416|NCT02378961|41643293|FG003|Overall Study|Lack of Efficacy|1|||
19398417|NCT02378961|41643290|FG000|Overall Study|Death|0|||
19398418|NCT02378961|41643291|FG001|Overall Study|Death|0|||
19398419|NCT02378961|41643292|FG002|Overall Study|Death|1|||
19398420|NCT02378961|41643293|FG003|Overall Study|Death|0|||
19398421|NCT02378883|41643303|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
19398422|NCT02378883|41643303|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
19398423|NCT02378883|41643303|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
19398424|NCT02378883|41643303|FG000|30 Day Follow-Up|Physician Decision|2|||
19398425|NCT02378883|41643303|FG000|30 Day Follow-Up|Missed Visit|2|||
19398426|NCT02378883|41643303|FG000|30 Day Follow-Up|Death|1|||
19398427|NCT02378883|41643303|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
19398428|NCT02378883|41643303|FG000|12 Months Follow-Up|Death|2|||
19398429|NCT02574481|41643312|FG000|Overall Study|Withdrawal by Subject|6|||
19398430|NCT02574481|41643313|FG001|Overall Study|Withdrawal by Subject|4|||
19398431|NCT02574481|41643314|FG002|Overall Study|Withdrawal by Subject|1|||
19398432|NCT02574481|41643315|FG003|Overall Study|Withdrawal by Subject|0|||
19398433|NCT02574481|41643312|FG000|Overall Study|Adverse Event|2|||
19398434|NCT02574481|41643313|FG001|Overall Study|Adverse Event|0|||
19398435|NCT02574481|41643314|FG002|Overall Study|Adverse Event|0|||
19398436|NCT02574481|41643315|FG003|Overall Study|Adverse Event|0|||
19711031|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
19398437|NCT02574481|41643312|FG000|Overall Study|Visit Missed|12|||
19398438|NCT02574481|41643313|FG001|Overall Study|Visit Missed|4|||
19398439|NCT02574481|41643314|FG002|Overall Study|Visit Missed|2|||
19398440|NCT02574481|41643315|FG003|Overall Study|Visit Missed|0|||
19398441|NCT02574481|41643312|FG000|Overall Study|Other|1|||
19398442|NCT02574481|41643313|FG001|Overall Study|Other|0|||
19398443|NCT02574481|41643314|FG002|Overall Study|Other|0|||
19398444|NCT02574481|41643315|FG003|Overall Study|Other|0|||
19398445|NCT02574481|41643312|FG000|Overall Study|Death|6|||
19398446|NCT02574481|41643313|FG001|Overall Study|Death|6|||
19398447|NCT02574481|41643314|FG002|Overall Study|Death|0|||
19398448|NCT02574481|41643315|FG003|Overall Study|Death|0|||
19398449|NCT02340975|41643334|FG000|Overall Study|Death|6|||
19398450|NCT02340975|41643335|FG001|Overall Study|Death|23|||
19398451|NCT02340975|41643336|FG002|Overall Study|Death|21|||
19398452|NCT02340975|41643337|FG003|Overall Study|Death|7|||
19398453|NCT02340975|41643338|FG004|Overall Study|Death|21|||
19398454|NCT02340975|41643339|FG005|Overall Study|Death|13|||
19398455|NCT02340975|41643334|FG000|Overall Study|Lost to Follow-up|0|||
19398456|NCT02340975|41643335|FG001|Overall Study|Lost to Follow-up|0|||
19398457|NCT02340975|41643336|FG002|Overall Study|Lost to Follow-up|0|||
19398458|NCT02340975|41643337|FG003|Overall Study|Lost to Follow-up|0|||
19398459|NCT02340975|41643338|FG004|Overall Study|Lost to Follow-up|2|||
19398460|NCT02340975|41643339|FG005|Overall Study|Lost to Follow-up|0|||
19398461|NCT02340975|41643334|FG000|Overall Study|Withdrawal by Subject|0|||
19398462|NCT02340975|41643335|FG001|Overall Study|Withdrawal by Subject|0|||
19398463|NCT02340975|41643336|FG002|Overall Study|Withdrawal by Subject|3|||
19398464|NCT02340975|41643337|FG003|Overall Study|Withdrawal by Subject|3|||
19398465|NCT02340975|41643338|FG004|Overall Study|Withdrawal by Subject|2|||
19398466|NCT02340975|41643339|FG005|Overall Study|Withdrawal by Subject|0|||
19398467|NCT02340975|41643334|FG000|Overall Study|Other|0|||
19398468|NCT02340975|41643335|FG001|Overall Study|Other|4|||
19398469|NCT02340975|41643336|FG002|Overall Study|Other|0|||
19398470|NCT02340975|41643337|FG003|Overall Study|Other|2|||
19398471|NCT02340975|41643338|FG004|Overall Study|Other|0|||
19398472|NCT02340975|41643339|FG005|Overall Study|Other|6|||
19398473|NCT02392377|41643356|FG000|Overall Study|Withdrawal by Subject|0|||
19398474|NCT02392377|41643357|FG001|Overall Study|Withdrawal by Subject|1|||
19398475|NCT02340819|41643365|FG000|Overall Study|Adverse Event|1|||
19398476|NCT02340819|41643365|FG000|Overall Study|Withdrawal by Subject|2|||
19398477|NCT02340819|41643365|FG000|Overall Study|Discontinued with other reason|1|||
19398478|NCT02340663|41643371|FG000|Overall Study|Lost to Follow-up|1|||
19398479|NCT02340663|41643372|FG001|Overall Study|Lost to Follow-up|0|||
19398480|NCT02340663|41643371|FG000|Overall Study|Protocol Violation|1|||
19398481|NCT02340663|41643372|FG001|Overall Study|Protocol Violation|0|||
19398482|NCT02340663|41643371|FG000|Overall Study|Withdrawal by Subject|3|||
19398483|NCT02340663|41643372|FG001|Overall Study|Withdrawal by Subject|1|||
19398484|NCT02573467|41643382|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
19398485|NCT02573467|41643383|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
19398486|NCT02573467|41643384|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
19398487|NCT02573467|41643385|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
19398488|NCT02573467|41643382|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
19398489|NCT02573467|41643383|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
19398490|NCT02573467|41643384|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
19398491|NCT02573467|41643385|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
19398492|NCT02573467|41643382|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
19398493|NCT02573467|41643383|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
19398494|NCT02573467|41643384|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
19398495|NCT02573467|41643385|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
19398496|NCT02573467|41643382|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
19398497|NCT02573467|41643383|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
19398498|NCT02573467|41643384|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
19398499|NCT02573467|41643385|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
19398500|NCT02573467|41643382|FG000|Post-treatment Follow up Epoch|Death|1|||
19398501|NCT02573467|41643383|FG001|Post-treatment Follow up Epoch|Death|1|||
19398502|NCT02573467|41643384|FG002|Post-treatment Follow up Epoch|Death|0|||
19398503|NCT02573467|41643385|FG003|Post-treatment Follow up Epoch|Death|1|||
19398504|NCT02573467|41643382|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
19398505|NCT02573467|41643383|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
19398506|NCT02573467|41643384|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
19398507|NCT02573467|41643385|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
19398508|NCT02573467|41643382|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
19398509|NCT02573467|41643383|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
19398510|NCT02573467|41643384|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
19398511|NCT02573467|41643385|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
19398512|NCT02337387|41643400|FG000|Overall Study|Adverse Event|0|||
19398513|NCT02337387|41643401|FG001|Overall Study|Adverse Event|1|||
19398514|NCT02337387|41643402|FG002|Overall Study|Adverse Event|0|||
19398515|NCT02337387|41643403|FG003|Overall Study|Adverse Event|0|||
19398516|NCT02337387|41643400|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
19398517|NCT02337387|41643401|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
19398518|NCT02337387|41643402|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
19398519|NCT02337387|41643403|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
19398520|NCT02574247|41643416|FG000|Overall Study|Withdrawal by Subject|1|||
19398521|NCT02574247|41643417|FG001|Overall Study|Withdrawal by Subject|0|||
19398522|NCT02574247|41643418|FG002|Overall Study|Withdrawal by Subject|0|||
19398523|NCT02574247|41643416|FG000|Overall Study|Did not meet inclusion criteria|4|||
19398524|NCT02574247|41643417|FG001|Overall Study|Did not meet inclusion criteria|3|||
19398525|NCT02574247|41643418|FG002|Overall Study|Did not meet inclusion criteria|5|||
19398526|NCT02391363|41643430|FG000|Overall Study|Lost to Follow-up|5|||
19398527|NCT02391363|41643431|FG001|Overall Study|Lost to Follow-up|5|||
19398528|NCT02391363|41643430|FG000|Overall Study|Withdrawal by Subject|6|||
19398529|NCT02391363|41643431|FG001|Overall Study|Withdrawal by Subject|3|||
19398530|NCT02569957|41643439|FG000|Overall Study|Withdrawal by Subject|0|||
19398531|NCT02569957|41643440|FG001|Overall Study|Withdrawal by Subject|1|||
19398532|NCT01649427|41643448|FG000|Overall Study|Adverse Event|1|||
19398533|NCT01649427|41643449|FG001|Overall Study|Adverse Event|1|||
19398534|NCT01649427|41643448|FG000|Overall Study|Withdrawal by Subject|8|||
19398535|NCT01649427|41643449|FG001|Overall Study|Withdrawal by Subject|7|||
19398536|NCT01649427|41643448|FG000|Overall Study|Lost to Follow-up|0|||
19398537|NCT01649427|41643449|FG001|Overall Study|Lost to Follow-up|1|||
19398538|NCT01649427|41643448|FG000|Overall Study|Graft loss|0|||
19398539|NCT01649427|41643449|FG001|Overall Study|Graft loss|1|||
19398540|NCT01649427|41643448|FG000|Overall Study|Surgical problems during nephrectomy|2|||
19398541|NCT01649427|41643449|FG001|Overall Study|Surgical problems during nephrectomy|2|||
19398542|NCT02375373|41643455|FG000|Overall Study|Withdrawal by Subject|11|||
19398543|NCT02336607|41643463|FG000|Overall Study|Physician Decision|1|||
19398544|NCT02336607|41643464|FG001|Overall Study|Physician Decision|4|||
19398545|NCT02336607|41643465|FG002|Overall Study|Physician Decision|3|||
19398546|NCT02336607|41643466|FG003|Overall Study|Physician Decision|15|||
19398547|NCT02336607|41643463|FG000|Overall Study|Lack of Efficacy|1|||
19398548|NCT02336607|41643464|FG001|Overall Study|Lack of Efficacy|0|||
19398549|NCT02336607|41643465|FG002|Overall Study|Lack of Efficacy|0|||
19398550|NCT02336607|41643466|FG003|Overall Study|Lack of Efficacy|2|||
19398551|NCT02336607|41643463|FG000|Overall Study|Lost to Follow-up|2|||
19398552|NCT02336607|41643464|FG001|Overall Study|Lost to Follow-up|1|||
19398553|NCT02336607|41643465|FG002|Overall Study|Lost to Follow-up|0|||
19398554|NCT02336607|41643466|FG003|Overall Study|Lost to Follow-up|21|||
19398555|NCT02336607|41643463|FG000|Overall Study|Protocol Violation|0|||
19398556|NCT02336607|41643464|FG001|Overall Study|Protocol Violation|1|||
19398557|NCT02336607|41643465|FG002|Overall Study|Protocol Violation|1|||
19398558|NCT02336607|41643466|FG003|Overall Study|Protocol Violation|3|||
19398559|NCT02336607|41643463|FG000|Overall Study|Adverse Event|0|||
19398560|NCT02336607|41643464|FG001|Overall Study|Adverse Event|2|||
19398561|NCT02336607|41643465|FG002|Overall Study|Adverse Event|2|||
19398562|NCT02336607|41643466|FG003|Overall Study|Adverse Event|26|||
19398563|NCT02336607|41643463|FG000|Overall Study|Withdrawal by Subject|0|||
19398564|NCT02336607|41643464|FG001|Overall Study|Withdrawal by Subject|2|||
19398565|NCT02336607|41643465|FG002|Overall Study|Withdrawal by Subject|0|||
19398566|NCT02336607|41643466|FG003|Overall Study|Withdrawal by Subject|20|||
19398567|NCT02374671|41643479|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
19398568|NCT02374671|41643480|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
19398569|NCT02374671|41643481|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
19398570|NCT02374671|41643479|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
19398571|NCT02374671|41643480|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
19398572|NCT02374671|41643481|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
19398573|NCT02374671|41643479|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
19398574|NCT02374671|41643480|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
19398575|NCT02374671|41643481|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
19398576|NCT02374671|41643479|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
19398577|NCT02374671|41643480|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
19398578|NCT02374671|41643481|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
19398579|NCT02374671|41643479|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
19398580|NCT02374671|41643480|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
19517970|NCT01548768|41930961|FG001|Overall Study|Adverse Event|0|||
19517971|NCT01548768|41930962|FG002|Overall Study|Adverse Event|0|||
19517972|NCT01548768|41930963|FG003|Overall Study|Adverse Event|1|||
19517973|NCT01548768|41930960|FG000|Overall Study|Non-Compliance|0|||
19517974|NCT01548768|41930961|FG001|Overall Study|Non-Compliance|0|||
19517975|NCT01548768|41930962|FG002|Overall Study|Non-Compliance|0|||
19517976|NCT01548768|41930963|FG003|Overall Study|Non-Compliance|3|||
19627852|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
19627853|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
19517977|NCT01572792|41930980|FG000|Lead-in Study|Lost to Follow-up|5|||
19398581|NCT02374671|41643481|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
19398582|NCT02569801|41643489|FG000|Overall Study|Withdrawal by Subject|9|||
19398583|NCT02569801|41643490|FG001|Overall Study|Withdrawal by Subject|9|||
19398584|NCT02569801|41643489|FG000|Overall Study|Sponsor Decision|13|||
19398585|NCT02569801|41643490|FG001|Overall Study|Sponsor Decision|14|||
19398586|NCT02569801|41643489|FG000|Overall Study|Progressive Disease|2|||
19398587|NCT02569801|41643490|FG001|Overall Study|Progressive Disease|7|||
19398588|NCT02569801|41643489|FG000|Overall Study|Lost to Follow-up|0|||
19398589|NCT02569801|41643490|FG001|Overall Study|Lost to Follow-up|1|||
19398590|NCT02569801|41643489|FG000|Overall Study|Death|12|||
19398591|NCT02569801|41643490|FG001|Overall Study|Death|4|||
19398592|NCT02573311|41643498|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
19398593|NCT02573311|41643499|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
19398594|NCT02573311|41643498|FG000|Disposition for Part 2|Physician Decision|25|||
19398595|NCT02573311|41643499|FG001|Disposition for Part 2|Physician Decision|7|||
19398596|NCT02573311|41643498|FG000|Disposition for Part 2|Adverse Event|36|||
19398597|NCT02573311|41643499|FG001|Disposition for Part 2|Adverse Event|5|||
19398598|NCT02573311|41643498|FG000|Disposition for Part 2|Lost to Follow-up|76|||
19398599|NCT02573311|41643499|FG001|Disposition for Part 2|Lost to Follow-up|7|||
19398600|NCT02573311|41643498|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
19398601|NCT02573311|41643499|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
19398602|NCT02573311|41643498|FG000|Disposition for Part 2|Investigator decision|0|||
19398603|NCT02573311|41643499|FG001|Disposition for Part 2|Investigator decision|1|||
19398604|NCT02573311|41643498|FG000|Disposition for Part 2|Other than specified above|13|||
19398605|NCT02573311|41643499|FG001|Disposition for Part 2|Other than specified above|3|||
19398606|NCT02571049|41643505|FG000|Screening|Did not meet entry criteria|2|||
19398607|NCT02571049|41643506|FG001|Screening|Did not meet entry criteria|2|||
19398608|NCT02571049|41643505|FG000|Randomization|No migraine attack|0|||
19398609|NCT02571049|41643506|FG001|Randomization|No migraine attack|1|||
19398610|NCT02571049|41643505|FG000|Randomization|Adverse Event|0|||
19398611|NCT02571049|41643506|FG001|Randomization|Adverse Event|1|||
19398612|NCT02573155|41643514|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
19398613|NCT02573155|41643515|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
19398614|NCT02573155|41643514|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
19398615|NCT02573155|41643515|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
19398616|NCT02573155|41643514|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
19398617|NCT02573155|41643515|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
19398618|NCT02573155|41643514|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
19398619|NCT02573155|41643515|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
19398620|NCT02573155|41643514|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
19398621|NCT02573155|41643515|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
19398622|NCT02573155|41643514|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
19398623|NCT02573155|41643515|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
19398624|NCT02573155|41643514|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
19398625|NCT02573155|41643515|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
19398626|NCT02573155|41643514|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
19398627|NCT02573155|41643515|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
19398628|NCT02568475|41643543|FG000|Overall Study|Lost to Follow-up|40|||
19398629|NCT02568475|41643544|FG001|Overall Study|Lost to Follow-up|39|||
19398630|NCT02568475|41643543|FG000|Overall Study|Withdrawal by Subject|2|||
19398631|NCT02568475|41643544|FG001|Overall Study|Withdrawal by Subject|0|||
19398632|NCT02568475|41643543|FG000|Overall Study|Discharged home|4|||
19398633|NCT02568475|41643544|FG001|Overall Study|Discharged home|4|||
19398634|NCT02568475|41643543|FG000|Overall Study|Short-term: Discharge location unknown|4|||
19398635|NCT02568475|41643544|FG001|Overall Study|Short-term: Discharge location unknown|0|||
19398636|NCT02568475|41643543|FG000|Overall Study|Transferred to another facility|1|||
19398637|NCT02568475|41643544|FG001|Overall Study|Transferred to another facility|0|||
19398638|NCT02568397|41643550|FG000|Period 2|Withdrawal by Subject|0|||
19398639|NCT02568397|41643551|FG001|Period 2|Withdrawal by Subject|1|||
19398640|NCT02568397|41643550|FG000|Period 2|Physician Decision|0|||
19517978|NCT01572792|41930981|FG001|Lead-in Study|Lost to Follow-up|9|||
19398641|NCT02568397|41643551|FG001|Period 2|Physician Decision|1|||
19398642|NCT02566525|41643568|FG000|Overall Study|Protocol Violation|3|||
19398643|NCT02566525|41643569|FG001|Overall Study|Protocol Violation|5|||
19398644|NCT02567227|41643579|FG000|9 Weeks|Adverse Event|5|||
19398645|NCT02567227|41643580|FG001|9 Weeks|Adverse Event|5|||
19398646|NCT02567227|41643579|FG000|9 Weeks|Withdrawal by Subject|18|||
19398647|NCT02567227|41643580|FG001|9 Weeks|Withdrawal by Subject|8|||
19398648|NCT02567227|41643579|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
19398649|NCT02567227|41643580|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
19398650|NCT02567227|41643579|FG000|6 Month|Death|2|||
19398651|NCT02567227|41643580|FG001|6 Month|Death|0|||
19398652|NCT02567227|41643579|FG000|6 Month|Lost to Follow-up|43|||
19398653|NCT02567227|41643580|FG001|6 Month|Lost to Follow-up|40|||
19398654|NCT02567227|41643579|FG000|12 Months|Lost to Follow-up|31|||
19398655|NCT02567227|41643580|FG001|12 Months|Lost to Follow-up|32|||
19398656|NCT02567227|41643579|FG000|12 Months|Death|0|||
19398657|NCT02567227|41643580|FG001|12 Months|Death|2|||
19398658|NCT02336451|41643591|FG000|Overall Study|Adverse Event|1|||
19398659|NCT02336451|41643592|FG001|Overall Study|Adverse Event|2|||
19398660|NCT02336451|41643593|FG002|Overall Study|Adverse Event|0|||
19398661|NCT02336451|41643594|FG003|Overall Study|Adverse Event|6|||
19398662|NCT02336451|41643595|FG004|Overall Study|Adverse Event|4|||
19398663|NCT02336451|41643591|FG000|Overall Study|Death|6|||
19398664|NCT02336451|41643592|FG001|Overall Study|Death|2|||
19398665|NCT02336451|41643593|FG002|Overall Study|Death|3|||
19398666|NCT02336451|41643594|FG003|Overall Study|Death|6|||
19398667|NCT02336451|41643595|FG004|Overall Study|Death|6|||
19398668|NCT02336451|41643591|FG000|Overall Study|Physician Decision|9|||
19398669|NCT02336451|41643592|FG001|Overall Study|Physician Decision|6|||
19398670|NCT02336451|41643593|FG002|Overall Study|Physician Decision|7|||
19398671|NCT02336451|41643594|FG003|Overall Study|Physician Decision|16|||
19398672|NCT02336451|41643595|FG004|Overall Study|Physician Decision|3|||
19398673|NCT02336451|41643591|FG000|Overall Study|Progressive disease|23|||
19398674|NCT02336451|41643592|FG001|Overall Study|Progressive disease|26|||
19398675|NCT02336451|41643593|FG002|Overall Study|Progressive disease|2|||
19398676|NCT02336451|41643594|FG003|Overall Study|Progressive disease|14|||
19398677|NCT02336451|41643595|FG004|Overall Study|Progressive disease|4|||
19398678|NCT02336451|41643591|FG000|Overall Study|Protocol Violation|1|||
19398679|NCT02336451|41643592|FG001|Overall Study|Protocol Violation|0|||
19398680|NCT02336451|41643593|FG002|Overall Study|Protocol Violation|0|||
19398681|NCT02336451|41643594|FG003|Overall Study|Protocol Violation|0|||
19398682|NCT02336451|41643595|FG004|Overall Study|Protocol Violation|0|||
19398683|NCT02336451|41643591|FG000|Overall Study|Patient/guardian decision|2|||
19398684|NCT02336451|41643592|FG001|Overall Study|Patient/guardian decision|4|||
19398685|NCT02336451|41643593|FG002|Overall Study|Patient/guardian decision|0|||
19398686|NCT02336451|41643594|FG003|Overall Study|Patient/guardian decision|2|||
19398687|NCT02336451|41643595|FG004|Overall Study|Patient/guardian decision|1|||
19398688|NCT02374593|41643611|FG000|Overall Study|non-compliant|2|||
19398689|NCT02374593|41643612|FG001|Overall Study|non-compliant|0|||
19398690|NCT01648101|41643625|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
19398691|NCT01648101|41643626|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
19398692|NCT01648101|41643627|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
19398693|NCT01648101|41643625|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
19398694|NCT01648101|41643626|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
19398695|NCT01648101|41643627|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
19398696|NCT01648101|41643625|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
19398697|NCT01648101|41643626|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
19398698|NCT01648101|41643627|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
19398699|NCT01648101|41643625|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
19398700|NCT01648101|41643626|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
19398701|NCT01648101|41643627|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
19398702|NCT01648101|41643625|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
19398703|NCT01648101|41643626|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
19398704|NCT01648101|41643627|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
19398705|NCT01648101|41643625|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
19398706|NCT01648101|41643626|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
19398707|NCT01648101|41643627|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
19398708|NCT01648101|41643625|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
19398709|NCT01648101|41643626|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
19398710|NCT01648101|41643627|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
19398711|NCT01648101|41643625|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
19398712|NCT01648101|41643626|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
19398713|NCT01648101|41643627|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
19627854|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
19627855|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
19398714|NCT01648101|41643625|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
19398715|NCT01648101|41643626|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
19398716|NCT01648101|41643627|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
19398717|NCT01648101|41643625|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
19627856|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
19398718|NCT01648101|41643626|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
19398719|NCT01648101|41643627|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
19398720|NCT01648101|41643625|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
19398721|NCT01648101|41643626|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
19398722|NCT01648101|41643627|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
19398723|NCT02336373|41643639|FG000|Overall Study|Protocol closed early|4|||
19398724|NCT02336373|41643639|FG000|Overall Study|Physician Decision|14|||
19398725|NCT02372799|41643648|FG000|Treatment Period|Adverse Event|3|||
19398726|NCT02372799|41643649|FG001|Treatment Period|Adverse Event|10|||
19398727|NCT02372799|41643650|FG002|Treatment Period|Adverse Event|6|||
19398728|NCT02372799|41643648|FG000|Treatment Period|Insufficient therapeutic response|2|||
19398729|NCT02372799|41643649|FG001|Treatment Period|Insufficient therapeutic response|2|||
19398730|NCT02372799|41643650|FG002|Treatment Period|Insufficient therapeutic response|0|||
19398731|NCT02372799|41643648|FG000|Treatment Period|Withdrawal by Subject|10|||
19398732|NCT02372799|41643649|FG001|Treatment Period|Withdrawal by Subject|10|||
19398733|NCT02372799|41643650|FG002|Treatment Period|Withdrawal by Subject|2|||
19398734|NCT02372799|41643648|FG000|Treatment Period|Lost to Follow-up|11|||
19398735|NCT02372799|41643649|FG001|Treatment Period|Lost to Follow-up|5|||
19398736|NCT02372799|41643650|FG002|Treatment Period|Lost to Follow-up|3|||
19398737|NCT02372799|41643648|FG000|Treatment Period|Protocol Violation|3|||
19398738|NCT02372799|41643649|FG001|Treatment Period|Protocol Violation|0|||
19398739|NCT02372799|41643650|FG002|Treatment Period|Protocol Violation|0|||
19398740|NCT02372799|41643648|FG000|Treatment Period|Non-compliance with study drug|4|||
19398741|NCT02372799|41643649|FG001|Treatment Period|Non-compliance with study drug|4|||
19398742|NCT02372799|41643650|FG002|Treatment Period|Non-compliance with study drug|4|||
19398743|NCT02372799|41643648|FG000|Treatment Period|Miscellaneous Reasons|1|||
19398744|NCT02372799|41643649|FG001|Treatment Period|Miscellaneous Reasons|1|||
19398745|NCT02372799|41643650|FG002|Treatment Period|Miscellaneous Reasons|0|||
19398746|NCT02372799|41643648|FG000|Down-taper Period|Lost to Follow-up|1|||
19398747|NCT02372799|41643649|FG001|Down-taper Period|Lost to Follow-up|2|||
19398748|NCT02372799|41643650|FG002|Down-taper Period|Lost to Follow-up|2|||
19398749|NCT02566993|41643660|FG000|Overall Study|Randomized but not treated|5|||
19398750|NCT02566993|41643661|FG001|Overall Study|Randomized but not treated|16|||
19398751|NCT02566993|41643660|FG000|Overall Study|Progressive disease|213|||
19398752|NCT02566993|41643661|FG001|Overall Study|Progressive disease|152|||
19398753|NCT02566993|41643660|FG000|Overall Study|Withdrawal by Subject|12|||
19398754|NCT02566993|41643661|FG001|Overall Study|Withdrawal by Subject|28|||
19398755|NCT02566993|41643660|FG000|Overall Study|Death|17|||
19398756|NCT02566993|41643661|FG001|Overall Study|Death|23|||
19398757|NCT02566993|41643660|FG000|Overall Study|Physician Decision|10|||
19398758|NCT02566993|41643661|FG001|Overall Study|Physician Decision|17|||
19398759|NCT02566993|41643660|FG000|Overall Study|Study drug-related adverse event|20|||
19398760|NCT02566993|41643661|FG001|Overall Study|Study drug-related adverse event|41|||
19398761|NCT02566993|41643660|FG000|Overall Study|Non study drug-related adverse event|9|||
19398762|NCT02566993|41643661|FG001|Overall Study|Non study drug-related adverse event|9|||
19398763|NCT02566993|41643660|FG000|Overall Study|Symptomatic deterioration|9|||
19398764|NCT02566993|41643661|FG001|Overall Study|Symptomatic deterioration|16|||
19398765|NCT02566993|41643660|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
19398766|NCT02566993|41643661|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
19398767|NCT02566993|41643660|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
19398768|NCT02566993|41643661|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
19398769|NCT02566993|41643660|FG000|Overall Study|Screening failure|2|||
19398770|NCT02566993|41643661|FG001|Overall Study|Screening failure|0|||
19398771|NCT02566993|41643660|FG000|Overall Study|Lost to Follow-up|0|||
19398772|NCT02566993|41643661|FG001|Overall Study|Lost to Follow-up|1|||
19398773|NCT02566993|41643660|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
19398774|NCT02566993|41643661|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
19398775|NCT02311881|41643672|FG000|Overall Study|Did not meet the study criteria|2|||
19398776|NCT02311881|41643673|FG001|Overall Study|Did not meet the study criteria|2|||
19398777|NCT02311881|41643674|FG002|Overall Study|Did not meet the study criteria|0|||
19398778|NCT02311881|41643672|FG000|Overall Study|Adverse Event|7|||
19398779|NCT02311881|41643673|FG001|Overall Study|Adverse Event|15|||
19398780|NCT02311881|41643674|FG002|Overall Study|Adverse Event|8|||
19398781|NCT02311881|41643672|FG000|Overall Study|Lost to Follow-up|3|||
19398782|NCT02311881|41643673|FG001|Overall Study|Lost to Follow-up|3|||
19398783|NCT02311881|41643674|FG002|Overall Study|Lost to Follow-up|2|||
19398784|NCT02311881|41643672|FG000|Overall Study|Protocol Violation|1|||
19398785|NCT02311881|41643673|FG001|Overall Study|Protocol Violation|2|||
19398786|NCT02311881|41643674|FG002|Overall Study|Protocol Violation|3|||
19398787|NCT02311881|41643672|FG000|Overall Study|Withdrawal of consent|14|||
19398788|NCT02311881|41643673|FG001|Overall Study|Withdrawal of consent|16|||
19398789|NCT02311881|41643674|FG002|Overall Study|Withdrawal of consent|17|||
19398790|NCT02311881|41643672|FG000|Overall Study|Other|0|||
19398791|NCT02311881|41643673|FG001|Overall Study|Other|0|||
19398792|NCT02311881|41643674|FG002|Overall Study|Other|1|||
19398793|NCT02311881|41643672|FG000|Overall Study|Lack of Efficacy|1|||
19398794|NCT02311881|41643673|FG001|Overall Study|Lack of Efficacy|2|||
19398795|NCT02311881|41643674|FG002|Overall Study|Lack of Efficacy|0|||
19398796|NCT02311881|41643672|FG000|Overall Study|Subject has border line pregnancy test|1|||
19398797|NCT02311881|41643673|FG001|Overall Study|Subject has border line pregnancy test|0|||
19398798|NCT02311881|41643674|FG002|Overall Study|Subject has border line pregnancy test|0|||
19398799|NCT02311881|41643672|FG000|Overall Study|Withdrawal by Subject|3|||
19398800|NCT02311881|41643673|FG001|Overall Study|Withdrawal by Subject|1|||
19398801|NCT02311881|41643674|FG002|Overall Study|Withdrawal by Subject|4|||
19398802|NCT02311881|41643672|FG000|Overall Study|Sponsor Decision|1|||
19398803|NCT02311881|41643673|FG001|Overall Study|Sponsor Decision|1|||
19398804|NCT02311881|41643674|FG002|Overall Study|Sponsor Decision|1|||
19398805|NCT02311881|41643672|FG000|Overall Study|Protocol Deviation|1|||
19398806|NCT02311881|41643673|FG001|Overall Study|Protocol Deviation|0|||
19398807|NCT02311881|41643674|FG002|Overall Study|Protocol Deviation|0|||
19398808|NCT02311881|41643672|FG000|Overall Study|Non-Compliance|1|||
19398809|NCT02311881|41643673|FG001|Overall Study|Non-Compliance|0|||
19398810|NCT02311881|41643674|FG002|Overall Study|Non-Compliance|2|||
19398811|NCT02311881|41643672|FG000|Overall Study|Physician Decision|0|||
19398812|NCT02311881|41643673|FG001|Overall Study|Physician Decision|0|||
19398813|NCT02311881|41643674|FG002|Overall Study|Physician Decision|1|||
19398814|NCT02311881|41643672|FG000|Overall Study|Medical Monitor Discretion|0|||
19398815|NCT02311881|41643673|FG001|Overall Study|Medical Monitor Discretion|0|||
19398816|NCT02311881|41643674|FG002|Overall Study|Medical Monitor Discretion|1|||
19398817|NCT02311881|41643672|FG000|Overall Study|Participant taking another medication|0|||
19398818|NCT02311881|41643673|FG001|Overall Study|Participant taking another medication|0|||
19398819|NCT02311881|41643674|FG002|Overall Study|Participant taking another medication|1|||
19398820|NCT02311881|41643672|FG000|Overall Study|Serious Adverse Event|0|||
19398821|NCT02311881|41643673|FG001|Overall Study|Serious Adverse Event|1|||
19398822|NCT02311881|41643674|FG002|Overall Study|Serious Adverse Event|0|||
19398823|NCT02565511|41643689|FG000|Overall Study|Study terminated by Sponsor|35|||
19398824|NCT02565511|41643690|FG001|Overall Study|Study terminated by Sponsor|22|||
19398825|NCT02565511|41643691|FG002|Overall Study|Study terminated by Sponsor|235|||
19398826|NCT02565511|41643692|FG003|Overall Study|Study terminated by Sponsor|156|||
19398827|NCT02565511|41643689|FG000|Overall Study|Withdrawal by Subject|3|||
19517979|NCT01572792|41930982|FG002|Lead-in Study|Lost to Follow-up|4|||
19517980|NCT01572792|41930983|FG003|Lead-in Study|Lost to Follow-up|2|||
19517981|NCT01572792|41930984|FG004|Lead-in Study|Lost to Follow-up|4|||
19374468|NCT02740231|41616069|FG000|Overall Study|Adverse Event|0|||
19374469|NCT02740231|41616070|FG001|Overall Study|Adverse Event|1|||
19374470|NCT02740231|41616071|FG002|Overall Study|Adverse Event|0|||
19374471|NCT02740231|41616072|FG003|Overall Study|Adverse Event|1|||
19374472|NCT02750345|41616082|FG000|Intervention 1|Adverse Event|0|||
19374473|NCT02750345|41616083|FG001|Intervention 1|Adverse Event|0|||
19374474|NCT02750345|41616084|FG002|Intervention 1|Adverse Event|0|||
19374475|NCT02750345|41616085|FG003|Intervention 1|Adverse Event|0|||
19374476|NCT02750345|41616086|FG004|Intervention 1|Adverse Event|1|||
19374477|NCT02750345|41616087|FG005|Intervention 1|Adverse Event|0|||
19374478|NCT02640625|41616097|FG000|Overall Study|Adverse Event|1|||
19374479|NCT01329263|41616104|FG000|Overall Study|Lost to Follow-up|4|||
19374480|NCT01329263|41616105|FG001|Overall Study|Lost to Follow-up|21|||
19374481|NCT01329263|41616104|FG000|Overall Study|Withdrawal by Subject|1|||
19374482|NCT01329263|41616105|FG001|Overall Study|Withdrawal by Subject|2|||
19374483|NCT02474329|41616113|FG000|Overall Study|Withdraw or did not contribute data.|13|||
19374484|NCT01388491|41616120|FG000|Overall Study|Adverse Event|10|||
19374485|NCT01388491|41616121|FG001|Overall Study|Adverse Event|9|||
19374486|NCT01388491|41616120|FG000|Overall Study|Sponsor Request|9|||
19374487|NCT01388491|41616121|FG001|Overall Study|Sponsor Request|7|||
19374488|NCT01388491|41616120|FG000|Overall Study|Withdrawal by Subject|6|||
19374489|NCT01388491|41616121|FG001|Overall Study|Withdrawal by Subject|10|||
19374490|NCT01388491|41616120|FG000|Overall Study|Lost to Follow-up|4|||
19374491|NCT01388491|41616121|FG001|Overall Study|Lost to Follow-up|3|||
19374492|NCT01388491|41616120|FG000|Overall Study|Protocol Violation|2|||
19374493|NCT01388491|41616121|FG001|Overall Study|Protocol Violation|0|||
19374494|NCT01388491|41616120|FG000|Overall Study|Noncompliance|2|||
19374495|NCT01388491|41616121|FG001|Overall Study|Noncompliance|0|||
19374496|NCT01388491|41616120|FG000|Overall Study|Pregnancy|1|||
19374497|NCT01388491|41616121|FG001|Overall Study|Pregnancy|0|||
19374498|NCT02749799|41616127|FG000|Overall Study|Adverse Event|2|||
19374499|NCT02749799|41616127|FG000|Overall Study|Lost to Follow-up|4|||
19374500|NCT02749799|41616127|FG000|Overall Study|Protocol Violation|1|||
19374501|NCT02749799|41616127|FG000|Overall Study|Withdrawal by Subject|1|||
19374502|NCT03253393|41616134|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
19398828|NCT02565511|41643690|FG001|Overall Study|Withdrawal by Subject|0|||
19398829|NCT02565511|41643691|FG002|Overall Study|Withdrawal by Subject|12|||
19711032|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
19374503|NCT03253393|41616135|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
19374504|NCT03253393|41616136|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
19398830|NCT02565511|41643692|FG003|Overall Study|Withdrawal by Subject|5|||
19398831|NCT02565511|41643689|FG000|Overall Study|Adverse Event|0|||
19398832|NCT02565511|41643690|FG001|Overall Study|Adverse Event|0|||
19398833|NCT02565511|41643691|FG002|Overall Study|Adverse Event|1|||
19398834|NCT02565511|41643692|FG003|Overall Study|Adverse Event|1|||
19398835|NCT02565511|41643689|FG000|Overall Study|Lost to Follow-up|4|||
19398836|NCT02565511|41643690|FG001|Overall Study|Lost to Follow-up|1|||
19398837|NCT02565511|41643691|FG002|Overall Study|Lost to Follow-up|0|||
19398838|NCT02565511|41643692|FG003|Overall Study|Lost to Follow-up|1|||
19398839|NCT02565511|41643689|FG000|Overall Study|Physician Decision|0|||
19398840|NCT02565511|41643690|FG001|Overall Study|Physician Decision|0|||
19398841|NCT02565511|41643691|FG002|Overall Study|Physician Decision|0|||
19398842|NCT02565511|41643692|FG003|Overall Study|Physician Decision|1|||
19398843|NCT02565511|41643689|FG000|Overall Study|Protocol deviation|0|||
19398844|NCT02565511|41643690|FG001|Overall Study|Protocol deviation|0|||
19398845|NCT02565511|41643691|FG002|Overall Study|Protocol deviation|3|||
19398846|NCT02565511|41643692|FG003|Overall Study|Protocol deviation|0|||
19398847|NCT02561455|41643706|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
19398848|NCT02561455|41643707|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
19398849|NCT02561455|41643708|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
19398850|NCT02561455|41643709|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
19398851|NCT02561455|41643706|FG000|Overall Study|Withdrawal by Subject|1|||
19398852|NCT02561455|41643707|FG001|Overall Study|Withdrawal by Subject|0|||
19398853|NCT02561455|41643708|FG002|Overall Study|Withdrawal by Subject|1|||
19398854|NCT02561455|41643709|FG003|Overall Study|Withdrawal by Subject|0|||
19398855|NCT02561455|41643706|FG000|Overall Study|Disease Progression|0|||
19398856|NCT02561455|41643707|FG001|Overall Study|Disease Progression|1|||
19398857|NCT02561455|41643708|FG002|Overall Study|Disease Progression|0|||
19398858|NCT02561455|41643709|FG003|Overall Study|Disease Progression|0|||
19398859|NCT02561299|41643721|FG000|Overall Study|Death|2|||
19398860|NCT02561299|41643722|FG001|Overall Study|Death|4|||
19398861|NCT02561299|41643721|FG000|Overall Study|Lost to Follow-up|1|||
19398862|NCT02561299|41643722|FG001|Overall Study|Lost to Follow-up|0|||
19398863|NCT02561299|41643721|FG000|Overall Study|Withdrawal by Subject|2|||
19398864|NCT02561299|41643722|FG001|Overall Study|Withdrawal by Subject|2|||
19398865|NCT02566759|41643745|FG000|All Parts|Withdrawal by Subject|0|||
19398866|NCT02566759|41643746|FG001|All Parts|Withdrawal by Subject|1|||
19398867|NCT02566759|41643747|FG002|All Parts|Withdrawal by Subject|0|||
19398868|NCT02566759|41643748|FG003|All Parts|Withdrawal by Subject|0|||
19398869|NCT02566759|41643749|FG004|All Parts|Withdrawal by Subject|0|||
19398870|NCT02566759|41643750|FG005|All Parts|Withdrawal by Subject|0|||
19398871|NCT02566759|41643751|FG006|All Parts|Withdrawal by Subject|0|||
19398872|NCT02566759|41643752|FG007|All Parts|Withdrawal by Subject|0|||
19398873|NCT02566759|41643753|FG008|All Parts|Withdrawal by Subject|0|||
19398874|NCT02566759|41643754|FG009|All Parts|Withdrawal by Subject|0|||
19398875|NCT02566759|41643755|FG010|All Parts|Withdrawal by Subject|0|||
19398876|NCT02566759|41643756|FG011|All Parts|Withdrawal by Subject|0|||
19398877|NCT02566759|41643757|FG012|All Parts|Withdrawal by Subject|0|||
19398878|NCT02566759|41643758|FG013|All Parts|Withdrawal by Subject|0|||
19398879|NCT02566759|41643759|FG014|All Parts|Withdrawal by Subject|0|||
19398880|NCT02566759|41643760|FG015|All Parts|Withdrawal by Subject|0|||
19398881|NCT02566759|41643761|FG016|All Parts|Withdrawal by Subject|0|||
19398882|NCT02566759|41643745|FG000|All Parts|Adverse Event|0|||
19398883|NCT02566759|41643746|FG001|All Parts|Adverse Event|0|||
19398884|NCT02566759|41643747|FG002|All Parts|Adverse Event|0|||
19398885|NCT02566759|41643748|FG003|All Parts|Adverse Event|0|||
19398886|NCT02566759|41643749|FG004|All Parts|Adverse Event|0|||
19398887|NCT02566759|41643750|FG005|All Parts|Adverse Event|0|||
19398888|NCT02566759|41643751|FG006|All Parts|Adverse Event|0|||
19398889|NCT02566759|41643752|FG007|All Parts|Adverse Event|0|||
19398890|NCT02566759|41643753|FG008|All Parts|Adverse Event|0|||
19398891|NCT02566759|41643754|FG009|All Parts|Adverse Event|0|||
19398892|NCT02566759|41643755|FG010|All Parts|Adverse Event|0|||
19517982|NCT01572792|41930980|FG000|Lead-in Study|Withdrawal by Subject|22|||
19627857|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
19627858|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
19627859|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
19627860|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
19627861|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
19627862|NCT00838916|42077261|FG000|Follow-up Period (8 Weeks)|Missing|3|||
19398893|NCT02566759|41643756|FG011|All Parts|Adverse Event|0|||
19398894|NCT02566759|41643757|FG012|All Parts|Adverse Event|1|||
19398895|NCT02566759|41643758|FG013|All Parts|Adverse Event|3|||
19398896|NCT02566759|41643759|FG014|All Parts|Adverse Event|0|||
19398897|NCT02566759|41643760|FG015|All Parts|Adverse Event|0|||
19398898|NCT02566759|41643761|FG016|All Parts|Adverse Event|0|||
19517983|NCT01572792|41930981|FG001|Lead-in Study|Withdrawal by Subject|11|||
19398899|NCT02566759|41643745|FG000|All Parts|Other|0|||
19398900|NCT02566759|41643746|FG001|All Parts|Other|0|||
19398901|NCT02566759|41643747|FG002|All Parts|Other|0|||
19398902|NCT02566759|41643748|FG003|All Parts|Other|0|||
19398903|NCT02566759|41643749|FG004|All Parts|Other|0|||
19398904|NCT02566759|41643750|FG005|All Parts|Other|0|||
19398905|NCT02566759|41643751|FG006|All Parts|Other|0|||
19627863|NCT00838916|42077262|FG001|Follow-up Period (8 Weeks)|Missing|0|||
19627864|NCT00838682|42077270|FG000|Overall Study|Lost to Follow-up|21|||
19627865|NCT00838682|42077271|FG001|Overall Study|Lost to Follow-up|14|||
19627866|NCT00838682|42077270|FG000|Overall Study|detection of exclusion criteria|4|||
19627867|NCT00838682|42077271|FG001|Overall Study|detection of exclusion criteria|3|||
19627868|NCT00838682|42077270|FG000|Overall Study|Protocol Violation|0|||
19627869|NCT00838682|42077271|FG001|Overall Study|Protocol Violation|1|||
19627870|NCT00838682|42077270|FG000|Overall Study|Withdrawal by Subject|0|||
19627871|NCT00838682|42077271|FG001|Overall Study|Withdrawal by Subject|1|||
19627872|NCT00820040|42077277|FG000|Overall Study|Death|1|||
19627873|NCT00820040|42077277|FG000|Overall Study|Sponsor terminated study|1|||
19398906|NCT02566759|41643752|FG007|All Parts|Other|0|||
19398907|NCT02566759|41643753|FG008|All Parts|Other|0|||
19517984|NCT01572792|41930982|FG002|Lead-in Study|Withdrawal by Subject|12|||
19517985|NCT01572792|41930983|FG003|Lead-in Study|Withdrawal by Subject|24|||
19517986|NCT01572792|41930984|FG004|Lead-in Study|Withdrawal by Subject|11|||
19517987|NCT01572792|41930980|FG000|Lead-in Study|Protocol Violation|19|||
19517988|NCT01572792|41930981|FG001|Lead-in Study|Protocol Violation|10|||
19517989|NCT01572792|41930982|FG002|Lead-in Study|Protocol Violation|12|||
19517990|NCT01572792|41930983|FG003|Lead-in Study|Protocol Violation|13|||
19517991|NCT01572792|41930984|FG004|Lead-in Study|Protocol Violation|21|||
19517992|NCT01572792|41930980|FG000|Lead-in Study|Lack of Efficacy|20|||
19517993|NCT01572792|41930981|FG001|Lead-in Study|Lack of Efficacy|5|||
19517994|NCT01572792|41930982|FG002|Lead-in Study|Lack of Efficacy|4|||
19398908|NCT02566759|41643754|FG009|All Parts|Other|0|||
19398909|NCT02566759|41643755|FG010|All Parts|Other|0|||
19398910|NCT02566759|41643756|FG011|All Parts|Other|0|||
19398911|NCT02566759|41643757|FG012|All Parts|Other|0|||
19398912|NCT02566759|41643758|FG013|All Parts|Other|2|||
19398913|NCT02566759|41643759|FG014|All Parts|Other|0|||
19398914|NCT02566759|41643760|FG015|All Parts|Other|0|||
19398915|NCT02566759|41643761|FG016|All Parts|Other|0|||
19398916|NCT02566759|41643745|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398917|NCT02566759|41643746|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398918|NCT02566759|41643747|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398919|NCT02566759|41643748|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398920|NCT02566759|41643749|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398921|NCT02566759|41643750|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398922|NCT02566759|41643751|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398923|NCT02566759|41643752|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398924|NCT02566759|41643753|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398925|NCT02566759|41643754|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398926|NCT02566759|41643755|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398927|NCT02566759|41643756|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398928|NCT02566759|41643757|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398929|NCT02566759|41643758|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398930|NCT02566759|41643759|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398931|NCT02566759|41643760|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
19398932|NCT02566759|41643761|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
19398933|NCT02335983|41643826|FG000|Overall Study|Sponsor Decision|0|||
19398934|NCT02335983|41643827|FG001|Overall Study|Sponsor Decision|0|||
19398935|NCT02335983|41643828|FG002|Overall Study|Sponsor Decision|1|||
19398936|NCT02335983|41643829|FG003|Overall Study|Sponsor Decision|1|||
19398937|NCT02335983|41643830|FG004|Overall Study|Sponsor Decision|0|||
19398938|NCT02335983|41643831|FG005|Overall Study|Sponsor Decision|1|||
19398939|NCT02335983|41643826|FG000|Overall Study|Withdrawal by Subject|3|||
19398940|NCT02335983|41643827|FG001|Overall Study|Withdrawal by Subject|2|||
19398941|NCT02335983|41643828|FG002|Overall Study|Withdrawal by Subject|2|||
19398942|NCT02335983|41643829|FG003|Overall Study|Withdrawal by Subject|1|||
19398943|NCT02335983|41643830|FG004|Overall Study|Withdrawal by Subject|3|||
19398944|NCT02335983|41643831|FG005|Overall Study|Withdrawal by Subject|9|||
19398945|NCT02335983|41643826|FG000|Overall Study|Death|0|||
19398946|NCT02335983|41643827|FG001|Overall Study|Death|0|||
19398947|NCT02335983|41643828|FG002|Overall Study|Death|2|||
19398948|NCT02335983|41643829|FG003|Overall Study|Death|0|||
19398949|NCT02335983|41643830|FG004|Overall Study|Death|0|||
19398950|NCT02335983|41643831|FG005|Overall Study|Death|0|||
19398951|NCT02335983|41643826|FG000|Overall Study|Lost to Follow-up|0|||
19398952|NCT02335983|41643827|FG001|Overall Study|Lost to Follow-up|0|||
19517995|NCT01572792|41930983|FG003|Lead-in Study|Lack of Efficacy|8|||
19627874|NCT00820040|42077277|FG000|Overall Study|Screen failure|1|||
19627875|NCT00803712|42077283|FG000|Overall Study|Noncompliance|3|||
19398953|NCT02335983|41643828|FG002|Overall Study|Lost to Follow-up|0|||
19398954|NCT02335983|41643829|FG003|Overall Study|Lost to Follow-up|0|||
19398955|NCT02335983|41643830|FG004|Overall Study|Lost to Follow-up|0|||
19398956|NCT02335983|41643831|FG005|Overall Study|Lost to Follow-up|1|||
19517996|NCT01572792|41930984|FG004|Lead-in Study|Lack of Efficacy|10|||
19517997|NCT01572792|41930980|FG000|Lead-in Study|Adverse Event|21|||
19398957|NCT02335983|41643826|FG000|Overall Study|Protocol Specified Criteria|5|||
19398958|NCT02335983|41643827|FG001|Overall Study|Protocol Specified Criteria|7|||
19398959|NCT02335983|41643828|FG002|Overall Study|Protocol Specified Criteria|27|||
19398960|NCT02335983|41643829|FG003|Overall Study|Protocol Specified Criteria|7|||
19398961|NCT02335983|41643830|FG004|Overall Study|Protocol Specified Criteria|5|||
19398962|NCT02335983|41643831|FG005|Overall Study|Protocol Specified Criteria|21|||
19398963|NCT04640311|41643867|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
19398964|NCT04640311|41643868|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398965|NCT04640311|41643869|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398966|NCT04640311|41643870|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398967|NCT04640311|41643871|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398968|NCT04640311|41643872|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398969|NCT04640311|41643873|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398970|NCT04640311|41643874|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398971|NCT04640311|41643875|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398972|NCT04640311|41643876|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398973|NCT04640311|41643877|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398974|NCT04640311|41643878|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398975|NCT04640311|41643879|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19398976|NCT04640311|41643867|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398977|NCT04640311|41643868|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
19398978|NCT04640311|41643869|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398979|NCT04640311|41643870|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398980|NCT04640311|41643871|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398981|NCT04640311|41643872|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398982|NCT04640311|41643873|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398983|NCT04640311|41643874|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398984|NCT04640311|41643875|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398985|NCT04640311|41643876|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398986|NCT04640311|41643877|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398987|NCT04640311|41643878|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398988|NCT04640311|41643879|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
19398989|NCT04640311|41643867|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398990|NCT04640311|41643868|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
19398991|NCT04640311|41643869|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398992|NCT04640311|41643870|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398993|NCT04640311|41643871|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398994|NCT04640311|41643872|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398995|NCT04640311|41643873|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398996|NCT04640311|41643874|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398997|NCT04640311|41643875|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398998|NCT04640311|41643876|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19398999|NCT04640311|41643877|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399000|NCT04640311|41643878|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399001|NCT04640311|41643879|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399002|NCT04640311|41643867|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
19399003|NCT04640311|41643868|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
19399004|NCT04640311|41643869|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
19399005|NCT04640311|41643870|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19627876|NCT00803712|42077284|FG001|Overall Study|Noncompliance|0|||
19399006|NCT04640311|41643871|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399007|NCT04640311|41643872|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399008|NCT04640311|41643873|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399009|NCT04640311|41643874|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399010|NCT04640311|41643875|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399011|NCT04640311|41643876|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399012|NCT04640311|41643877|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399013|NCT04640311|41643878|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399014|NCT04640311|41643879|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
19399015|NCT04640311|41643867|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399016|NCT04640311|41643868|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399017|NCT04640311|41643869|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
19399018|NCT04640311|41643870|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399019|NCT04640311|41643871|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399020|NCT04640311|41643872|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399021|NCT04640311|41643873|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399022|NCT04640311|41643874|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399023|NCT04640311|41643875|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399024|NCT04640311|41643876|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399025|NCT04640311|41643877|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399026|NCT04640311|41643878|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399027|NCT04640311|41643879|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
19399028|NCT04640311|41643867|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399029|NCT04640311|41643868|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399030|NCT04640311|41643869|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399031|NCT04640311|41643870|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
19399032|NCT04640311|41643871|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399033|NCT04640311|41643872|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399034|NCT04640311|41643873|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
19399035|NCT04640311|41643874|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399036|NCT04640311|41643875|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399037|NCT04640311|41643876|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399038|NCT04640311|41643877|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399039|NCT04640311|41643878|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399040|NCT04640311|41643879|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
19399041|NCT04640311|41643867|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399042|NCT04640311|41643868|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399043|NCT04640311|41643869|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399044|NCT04640311|41643870|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399045|NCT04640311|41643871|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399046|NCT04640311|41643872|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
19399047|NCT04640311|41643873|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399048|NCT04640311|41643874|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399049|NCT04640311|41643875|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
19399050|NCT04640311|41643876|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399051|NCT04640311|41643877|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399052|NCT04640311|41643878|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399053|NCT04640311|41643879|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
19399054|NCT04640311|41643867|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399055|NCT04640311|41643868|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399056|NCT04640311|41643869|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399057|NCT04640311|41643870|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399058|NCT04640311|41643871|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399059|NCT04640311|41643872|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399060|NCT04640311|41643873|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
19399061|NCT04640311|41643874|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399062|NCT04640311|41643875|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399063|NCT04640311|41643876|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399064|NCT04640311|41643877|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
19399065|NCT04640311|41643878|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399066|NCT04640311|41643879|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
19399067|NCT04640311|41643867|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399068|NCT04640311|41643868|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399069|NCT04640311|41643869|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399070|NCT04640311|41643870|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399071|NCT04640311|41643871|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399072|NCT04640311|41643872|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399073|NCT04640311|41643873|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399074|NCT04640311|41643874|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399075|NCT04640311|41643875|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399076|NCT04640311|41643876|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399077|NCT04640311|41643877|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399078|NCT04640311|41643878|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
19399079|NCT04640311|41643879|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
19399080|NCT02334423|41643910|FG000|Overall Study|Protocol Violation|10|||
19399081|NCT02334423|41643911|FG001|Overall Study|Protocol Violation|3|||
19399082|NCT02310789|41643917|FG000|Overall Study|Adverse Event|1|||
19399083|NCT02372253|41643923|FG000|Overall Study|Non Compliance|2|||
19399084|NCT02372253|41643924|FG001|Overall Study|Non Compliance|0|||
19399085|NCT02559895|41643936|FG000|Overall Study|Adverse Event|3|||
19399086|NCT02559895|41643937|FG001|Overall Study|Adverse Event|3|||
19399087|NCT02559895|41643938|FG002|Overall Study|Adverse Event|2|||
19399088|NCT02559895|41643939|FG003|Overall Study|Adverse Event|1|||
19399089|NCT02559895|41643936|FG000|Overall Study|Lack of Efficacy|2|||
19399090|NCT02559895|41643937|FG001|Overall Study|Lack of Efficacy|3|||
19399091|NCT02559895|41643938|FG002|Overall Study|Lack of Efficacy|2|||
19399092|NCT02559895|41643939|FG003|Overall Study|Lack of Efficacy|8|||
19399093|NCT02559895|41643936|FG000|Overall Study|Lost to Follow-up|22|||
19399094|NCT02559895|41643937|FG001|Overall Study|Lost to Follow-up|16|||
19399095|NCT02559895|41643938|FG002|Overall Study|Lost to Follow-up|12|||
19399096|NCT02559895|41643939|FG003|Overall Study|Lost to Follow-up|17|||
19399097|NCT02559895|41643936|FG000|Overall Study|Physician Decision|1|||
19399098|NCT02559895|41643937|FG001|Overall Study|Physician Decision|1|||
19399099|NCT02559895|41643938|FG002|Overall Study|Physician Decision|3|||
19399100|NCT02559895|41643939|FG003|Overall Study|Physician Decision|0|||
19399101|NCT02559895|41643936|FG000|Overall Study|Withdrawal by Subject|16|||
19399102|NCT02559895|41643937|FG001|Overall Study|Withdrawal by Subject|9|||
19399103|NCT02559895|41643938|FG002|Overall Study|Withdrawal by Subject|20|||
19399104|NCT02559895|41643939|FG003|Overall Study|Withdrawal by Subject|9|||
19399105|NCT02559895|41643936|FG000|Overall Study|Study Burden|10|||
19399106|NCT02559895|41643937|FG001|Overall Study|Study Burden|16|||
19399107|NCT02559895|41643938|FG002|Overall Study|Study Burden|12|||
19399108|NCT02559895|41643939|FG003|Overall Study|Study Burden|22|||
19399109|NCT02559895|41643936|FG000|Overall Study|Other|1|||
19399110|NCT02559895|41643937|FG001|Overall Study|Other|5|||
19399111|NCT02559895|41643938|FG002|Overall Study|Other|3|||
19399112|NCT02559895|41643939|FG003|Overall Study|Other|3|||
19399113|NCT02371629|41643951|FG000|Overall Study|Patient decision|14|||
19399114|NCT02371629|41643952|FG001|Overall Study|Patient decision|10|||
19399115|NCT02371629|41643951|FG000|Overall Study|Adverse Event|8|||
19399116|NCT02371629|41643952|FG001|Overall Study|Adverse Event|8|||
19399117|NCT02371629|41643951|FG000|Overall Study|Physician Decision|2|||
19399118|NCT02371629|41643952|FG001|Overall Study|Physician Decision|3|||
19399119|NCT02371629|41643951|FG000|Overall Study|Death|1|||
19399120|NCT02371629|41643952|FG001|Overall Study|Death|1|||
19399121|NCT02371629|41643951|FG000|Overall Study|Noncompliance with study treatment|1|||
19399122|NCT02371629|41643952|FG001|Overall Study|Noncompliance with study treatment|0|||
19399123|NCT02371629|41643951|FG000|Overall Study|Lack of Efficacy|0|||
19399124|NCT02371629|41643952|FG001|Overall Study|Lack of Efficacy|2|||
19399125|NCT02371629|41643951|FG000|Overall Study|Protocol deviation|0|||
19399126|NCT02371629|41643952|FG001|Overall Study|Protocol deviation|1|||
19399127|NCT02559817|41643963|FG000|Treatment Period|Adverse Event|1|||
19399128|NCT02559817|41643964|FG001|Treatment Period|Adverse Event|0|||
19399129|NCT02559817|41643965|FG002|Treatment Period|Adverse Event|1|||
19399130|NCT02559817|41643966|FG003|Treatment Period|Adverse Event|0|||
19399131|NCT02559817|41643967|FG004|Treatment Period|Adverse Event|0|||
19399132|NCT02559817|41643963|FG000|Treatment Period|Lack of Efficacy|0|||
19399133|NCT02559817|41643964|FG001|Treatment Period|Lack of Efficacy|1|||
19399134|NCT02559817|41643965|FG002|Treatment Period|Lack of Efficacy|0|||
19399135|NCT02559817|41643966|FG003|Treatment Period|Lack of Efficacy|0|||
19399136|NCT02559817|41643967|FG004|Treatment Period|Lack of Efficacy|0|||
19399137|NCT02559817|41643963|FG000|Treatment Period|Lost to Follow-up|0|||
19399138|NCT02559817|41643964|FG001|Treatment Period|Lost to Follow-up|1|||
19399139|NCT02559817|41643965|FG002|Treatment Period|Lost to Follow-up|0|||
19399140|NCT02559817|41643966|FG003|Treatment Period|Lost to Follow-up|1|||
19399141|NCT02559817|41643967|FG004|Treatment Period|Lost to Follow-up|0|||
19399142|NCT02559817|41643963|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
19399143|NCT02559817|41643964|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
19399144|NCT02559817|41643965|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
19399145|NCT02559817|41643966|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
19399146|NCT02559817|41643967|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
19399147|NCT02559817|41643963|FG000|Treatment Period|Protocol Violation|0|||
19399148|NCT02559817|41643964|FG001|Treatment Period|Protocol Violation|0|||
19399149|NCT02559817|41643965|FG002|Treatment Period|Protocol Violation|0|||
19399150|NCT02559817|41643966|FG003|Treatment Period|Protocol Violation|1|||
19399151|NCT02559817|41643967|FG004|Treatment Period|Protocol Violation|0|||
19399152|NCT02564887|41643981|FG000|Overall Study|Lost to Follow-up|6|||
19399153|NCT02564887|41643982|FG001|Overall Study|Lost to Follow-up|0|||
19399154|NCT02333487|41643993|FG000|Overall Study|Adverse Event|0|||
19399155|NCT02333487|41643994|FG001|Overall Study|Adverse Event|2|||
19399156|NCT02333487|41643995|FG002|Overall Study|Adverse Event|0|||
19399157|NCT02333331|41644008|FG000|Overall Study|Adverse Event|1|||
19399158|NCT02333331|41644009|FG001|Overall Study|Adverse Event|0|||
19399159|NCT02333331|41644010|FG002|Overall Study|Adverse Event|4|||
19517998|NCT01572792|41930981|FG001|Lead-in Study|Adverse Event|21|||
19517999|NCT01572792|41930982|FG002|Lead-in Study|Adverse Event|22|||
19518000|NCT01572792|41930983|FG003|Lead-in Study|Adverse Event|16|||
19518001|NCT01572792|41930984|FG004|Lead-in Study|Adverse Event|14|||
19518002|NCT01572792|41930980|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
19518003|NCT01572792|41930981|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
19627877|NCT00803712|42077283|FG000|Overall Study|Adverse Event|5|||
19627878|NCT00803712|42077284|FG001|Overall Study|Adverse Event|0|||
19627879|NCT00803712|42077283|FG000|Overall Study|Death|8|||
19627880|NCT00803712|42077284|FG001|Overall Study|Death|7|||
19627881|NCT00803712|42077283|FG000|Overall Study|Lost to Follow-up|3|||
19627882|NCT00803712|42077284|FG001|Overall Study|Lost to Follow-up|1|||
19627883|NCT00803712|42077283|FG000|Overall Study|Withdrawal by Subject|2|||
19627884|NCT00803712|42077284|FG001|Overall Study|Withdrawal by Subject|4|||
19627885|NCT00803712|42077283|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
19627886|NCT00803712|42077284|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
19627887|NCT00803712|42077283|FG000|Overall Study|Protocol criteria (other)|0|||
19627888|NCT00803712|42077284|FG001|Overall Study|Protocol criteria (other)|2|||
19627889|NCT00803712|42077283|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
19627890|NCT00803712|42077284|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
19627891|NCT00803712|42077283|FG000|Overall Study|Administrative decision|2|||
19627892|NCT00803712|42077284|FG001|Overall Study|Administrative decision|3|||
19627893|NCT00803712|42077283|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
19627894|NCT00803712|42077284|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
19627895|NCT00591344|42077292|FG000|Overall Study|Transportation issues|1|||
19627896|NCT00591344|42077293|FG001|Overall Study|Transportation issues|0|||
19399160|NCT02333331|41644011|FG003|Overall Study|Adverse Event|1|||
19399161|NCT02333331|41644008|FG000|Overall Study|Death|0|||
19399162|NCT02333331|41644009|FG001|Overall Study|Death|0|||
19399163|NCT02333331|41644010|FG002|Overall Study|Death|2|||
19518004|NCT01572792|41930982|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
19518005|NCT01572792|41930983|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
19399164|NCT02333331|41644011|FG003|Overall Study|Death|0|||
19399165|NCT02333331|41644008|FG000|Overall Study|Lost to Follow-up|0|||
19399166|NCT02333331|41644009|FG001|Overall Study|Lost to Follow-up|0|||
19399167|NCT02333331|41644010|FG002|Overall Study|Lost to Follow-up|1|||
19399168|NCT02333331|41644011|FG003|Overall Study|Lost to Follow-up|0|||
19399169|NCT02333331|41644008|FG000|Overall Study|Physician Decision|0|||
19399170|NCT02333331|41644009|FG001|Overall Study|Physician Decision|1|||
19399171|NCT02333331|41644010|FG002|Overall Study|Physician Decision|0|||
19399172|NCT02333331|41644011|FG003|Overall Study|Physician Decision|0|||
19518006|NCT01572792|41930984|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
19518007|NCT01572792|41930980|FG000|Extension Study|Lost to Follow-up|6|||
19518008|NCT01572792|41930981|FG001|Extension Study|Lost to Follow-up|2|||
19518009|NCT01572792|41930982|FG002|Extension Study|Lost to Follow-up|0|||
19518010|NCT01572792|41930983|FG003|Extension Study|Lost to Follow-up|3|||
19627897|NCT00591344|42077292|FG000|Overall Study|Moved out of state|1|||
19627898|NCT00591344|42077293|FG001|Overall Study|Moved out of state|0|||
19627899|NCT00591344|42077292|FG000|Overall Study|Medical complications|1|||
19627900|NCT00591344|42077293|FG001|Overall Study|Medical complications|3|||
19627901|NCT00591344|42077292|FG000|Overall Study|Underwent DBS|2|||
19399173|NCT02333331|41644008|FG000|Overall Study|Protocol Deviation|0|||
19399174|NCT02333331|41644009|FG001|Overall Study|Protocol Deviation|3|||
19399175|NCT02333331|41644010|FG002|Overall Study|Protocol Deviation|2|||
19399176|NCT02333331|41644011|FG003|Overall Study|Protocol Deviation|1|||
19399177|NCT02333331|41644008|FG000|Overall Study|Patient/Guardian Decision|1|||
19399178|NCT02333331|41644009|FG001|Overall Study|Patient/Guardian Decision|2|||
19399179|NCT02333331|41644010|FG002|Overall Study|Patient/Guardian Decision|9|||
19518011|NCT01572792|41930984|FG004|Extension Study|Lost to Follow-up|3|||
19399180|NCT02333331|41644011|FG003|Overall Study|Patient/Guardian Decision|1|||
19399181|NCT02563561|41644024|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
19399182|NCT02563561|41644025|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
19399183|NCT02563561|41644026|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
19399184|NCT02563561|41644024|FG000|Overall Study|Withdrew of Consent|1|||
19399185|NCT02563561|41644025|FG001|Overall Study|Withdrew of Consent|1|||
19399186|NCT02563561|41644026|FG002|Overall Study|Withdrew of Consent|2|||
19399187|NCT02563561|41644024|FG000|Overall Study|Lost to Follow-up|1|||
19399188|NCT02563561|41644025|FG001|Overall Study|Lost to Follow-up|1|||
19399189|NCT02563561|41644026|FG002|Overall Study|Lost to Follow-up|0|||
19399190|NCT02563561|41644024|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
19399191|NCT02563561|41644025|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
19399192|NCT02563561|41644026|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
19399193|NCT02563561|41644024|FG000|Overall Study|Investigator Decision|3|||
19399194|NCT02563561|41644025|FG001|Overall Study|Investigator Decision|4|||
19399195|NCT02563561|41644026|FG002|Overall Study|Investigator Decision|2|||
19399196|NCT02563561|41644024|FG000|Overall Study|Sponsor Decision|5|||
19399197|NCT02563561|41644025|FG001|Overall Study|Sponsor Decision|2|||
19399198|NCT02563561|41644026|FG002|Overall Study|Sponsor Decision|4|||
19399199|NCT02563561|41644024|FG000|Overall Study|Other|1|||
19399200|NCT02563561|41644025|FG001|Overall Study|Other|5|||
19399201|NCT02563561|41644026|FG002|Overall Study|Other|2|||
19399202|NCT02559505|41644042|FG000|Overall Study|Lost to Follow-up|23|||
19399203|NCT02559505|41644043|FG001|Overall Study|Lost to Follow-up|20|||
19399204|NCT02559505|41644042|FG000|Overall Study|Withdrawal by Subject|4|||
19399205|NCT02559505|41644043|FG001|Overall Study|Withdrawal by Subject|2|||
19399206|NCT04476043|41644065|FG000|Overall Study|Withdrawal by Subject|1|||
19399207|NCT04476043|41644066|FG001|Overall Study|Withdrawal by Subject|3|||
19399208|NCT04476043|41644067|FG002|Overall Study|Withdrawal by Subject|4|||
19399209|NCT04476043|41644068|FG003|Overall Study|Withdrawal by Subject|1|||
19399210|NCT04476043|41644065|FG000|Overall Study|Lost to Follow-up|1|||
19399211|NCT04476043|41644066|FG001|Overall Study|Lost to Follow-up|1|||
19399212|NCT04476043|41644067|FG002|Overall Study|Lost to Follow-up|2|||
19399213|NCT04476043|41644068|FG003|Overall Study|Lost to Follow-up|1|||
19399214|NCT04476043|41644065|FG000|Overall Study|Adverse Event|2|||
19399215|NCT04476043|41644066|FG001|Overall Study|Adverse Event|0|||
19399216|NCT04476043|41644067|FG002|Overall Study|Adverse Event|1|||
19399217|NCT04476043|41644068|FG003|Overall Study|Adverse Event|0|||
19399218|NCT04476043|41644065|FG000|Overall Study|Protocol Violation|0|||
19399219|NCT04476043|41644066|FG001|Overall Study|Protocol Violation|1|||
19399220|NCT04476043|41644067|FG002|Overall Study|Protocol Violation|0|||
19399221|NCT04476043|41644068|FG003|Overall Study|Protocol Violation|0|||
19399222|NCT04191967|41644082|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
19399223|NCT04191967|41644082|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
19399224|NCT02556307|41644088|FG000|Overall Study|Premature treatment interruption|11|||
19399225|NCT02556307|41644088|FG000|Overall Study|Lost to Follow-up|36|||
19399226|NCT02556307|41644088|FG000|Overall Study|Change to triple therapy|4|||
19399227|NCT02556307|41644088|FG000|Overall Study|Enrolled but not treated|2|||
19399228|NCT04364737|41644094|FG000|Overall Study|Withdrawal by Subject|4|||
19399229|NCT04364737|41644095|FG001|Overall Study|Withdrawal by Subject|9|||
19399230|NCT04364737|41644094|FG000|Overall Study|Lost to Follow-up|1|||
19399231|NCT04364737|41644095|FG001|Overall Study|Lost to Follow-up|1|||
19399232|NCT02559115|41644101|FG000|Overall Study|Withdrawal by Subject|3|||
19399233|NCT01662895|41644119|FG000|Overall Study|Lost to Follow-up|0|||
19399234|NCT01662895|41644120|FG001|Overall Study|Lost to Follow-up|1|||
19399235|NCT04147195|41644128|FG000|Overall Study|Adverse Event|0|||
19399236|NCT04147195|41644129|FG001|Overall Study|Adverse Event|3|||
19399237|NCT04147195|41644128|FG000|Overall Study|Study Terminated by Sponsor|4|||
19399238|NCT04147195|41644129|FG001|Overall Study|Study Terminated by Sponsor|2|||
19399239|NCT04147195|41644128|FG000|Overall Study|Withdrawal by Subject|0|||
19399240|NCT04147195|41644129|FG001|Overall Study|Withdrawal by Subject|1|||
19399241|NCT02557399|41644138|FG000|Overall Study|Adverse Event|6|||
19399242|NCT02557399|41644139|FG001|Overall Study|Adverse Event|5|||
19399243|NCT02557399|41644138|FG000|Overall Study|Protocol Violation|0|||
19399244|NCT02557399|41644139|FG001|Overall Study|Protocol Violation|1|||
19399245|NCT02557399|41644138|FG000|Overall Study|Protocol-defined stopping criteria|0|||
19399246|NCT02557399|41644139|FG001|Overall Study|Protocol-defined stopping criteria|1|||
19399247|NCT02557399|41644138|FG000|Overall Study|Withdrawal by Subject|1|||
19399248|NCT02557399|41644139|FG001|Overall Study|Withdrawal by Subject|1|||
19399249|NCT02555371|41644148|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
19399250|NCT02555371|41644149|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
19399251|NCT02555371|41644150|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
19399252|NCT02555371|41644151|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
19399253|NCT02555371|41644152|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
19399254|NCT02555371|41644148|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
19399255|NCT02555371|41644149|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
19399256|NCT02555371|41644150|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
19399257|NCT02555371|41644151|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
19399258|NCT02555371|41644152|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
19399259|NCT02555371|41644148|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
19399260|NCT02555371|41644149|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
19399261|NCT02555371|41644150|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
19399262|NCT02555371|41644151|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
19399263|NCT02555371|41644152|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
19399264|NCT02555371|41644148|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
19399265|NCT02555371|41644149|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
19399266|NCT02555371|41644150|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
19399267|NCT02555371|41644151|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
19399268|NCT02555371|41644152|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
19399269|NCT02555371|41644148|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
19399270|NCT02555371|41644149|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
19399271|NCT02555371|41644150|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
19399272|NCT02555371|41644151|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
19399273|NCT02555371|41644152|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
19399274|NCT02555371|41644148|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
19399275|NCT02555371|41644149|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
19399276|NCT02555371|41644150|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
19399277|NCT02555371|41644151|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
19399278|NCT02555371|41644152|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
19399279|NCT02555371|41644148|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
19399280|NCT02555371|41644149|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
19399281|NCT02555371|41644150|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
19399282|NCT02555371|41644151|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
19399283|NCT02555371|41644152|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
19399284|NCT02555371|41644148|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
19399285|NCT02555371|41644149|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
19399286|NCT02555371|41644150|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
19399287|NCT02555371|41644151|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
19399288|NCT02555371|41644152|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
19399289|NCT02555371|41644148|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
19399290|NCT02555371|41644149|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
19399291|NCT02555371|41644150|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
19399292|NCT02555371|41644151|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
19399293|NCT02555371|41644152|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
19399294|NCT02555371|41644148|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
19399295|NCT02555371|41644149|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
19399296|NCT02555371|41644150|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
19399297|NCT02555371|41644151|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
19399298|NCT02555371|41644152|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
19399299|NCT02555371|41644148|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
19399300|NCT02555371|41644149|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
19399301|NCT02555371|41644150|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
19399302|NCT02555371|41644151|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
19399303|NCT02555371|41644152|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
19399304|NCT02555371|41644148|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
19399305|NCT02555371|41644149|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
19399306|NCT02555371|41644150|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
19399307|NCT02555371|41644151|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
19399308|NCT02555371|41644152|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
19399309|NCT02555371|41644148|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
19399310|NCT02555371|41644149|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
19399311|NCT02555371|41644150|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
19399312|NCT02555371|41644151|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
19711033|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
19711034|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
19711035|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19711036|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19711037|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19711038|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
19711039|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
19399313|NCT02555371|41644152|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
19399314|NCT02555371|41644148|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
19399315|NCT02555371|41644149|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
19399316|NCT02555371|41644150|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
19399317|NCT02555371|41644151|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
19399318|NCT02555371|41644152|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
19399319|NCT02555215|41644161|FG000|Overall Study|Other|1|||
19399320|NCT02555215|41644161|FG000|Overall Study|Investigator Decision|2|||
19399321|NCT02555683|41644168|FG000|Overall Study|Physician Decision|1|||
19399322|NCT02555683|41644169|FG001|Overall Study|Physician Decision|0|||
19399323|NCT02555683|41644170|FG002|Overall Study|Physician Decision|2|||
19399324|NCT02555683|41644168|FG000|Overall Study|Lost to Follow-up|2|||
19399325|NCT02555683|41644169|FG001|Overall Study|Lost to Follow-up|1|||
19399326|NCT02555683|41644170|FG002|Overall Study|Lost to Follow-up|2|||
19399327|NCT02555683|41644168|FG000|Overall Study|Technical Problems|1|||
19399328|NCT02555683|41644169|FG001|Overall Study|Technical Problems|1|||
19399329|NCT02555683|41644170|FG002|Overall Study|Technical Problems|0|||
19399330|NCT02555683|41644168|FG000|Overall Study|Protocol deviation|0|||
19399331|NCT02555683|41644169|FG001|Overall Study|Protocol deviation|1|||
19399332|NCT02555683|41644170|FG002|Overall Study|Protocol deviation|0|||
19399333|NCT02555683|41644168|FG000|Overall Study|Lack of Efficacy|2|||
19399334|NCT02555683|41644169|FG001|Overall Study|Lack of Efficacy|0|||
19399335|NCT02555683|41644170|FG002|Overall Study|Lack of Efficacy|0|||
19399336|NCT02555683|41644168|FG000|Overall Study|Death|0|||
19399337|NCT02555683|41644169|FG001|Overall Study|Death|1|||
19399338|NCT02555683|41644170|FG002|Overall Study|Death|2|||
19399339|NCT02555683|41644168|FG000|Overall Study|Adverse Event|1|||
19399340|NCT02555683|41644169|FG001|Overall Study|Adverse Event|0|||
19399341|NCT02555683|41644170|FG002|Overall Study|Adverse Event|1|||
19399342|NCT02555683|41644168|FG000|Overall Study|Subject/guardian decision|12|||
19399343|NCT02555683|41644169|FG001|Overall Study|Subject/guardian decision|12|||
19399344|NCT02555683|41644170|FG002|Overall Study|Subject/guardian decision|22|||
19399345|NCT02555683|41644168|FG000|Overall Study|Death post Treatment/safety period|0|||
19399346|NCT02555683|41644169|FG001|Overall Study|Death post Treatment/safety period|1|||
19399347|NCT02555683|41644170|FG002|Overall Study|Death post Treatment/safety period|0|||
19399348|NCT02554981|41644178|FG000|Overall Study|Adverse Event|1|||
19399349|NCT02554981|41644178|FG000|Overall Study|Administrative Reasons|1|||
19399350|NCT02554981|41644178|FG000|Overall Study|Other Miscellaneous Reasons|3|||
19399351|NCT02556775|41644186|FG000|Overall Study|Withdrawal by Subject|1|||
19399352|NCT02556775|41644187|FG001|Overall Study|Withdrawal by Subject|0|||
19399353|NCT02556775|41644188|FG002|Overall Study|Withdrawal by Subject|1|||
19399354|NCT02556775|41644189|FG003|Overall Study|Withdrawal by Subject|0|||
19399355|NCT02556775|41644186|FG000|Overall Study|Lost to Follow-up|1|||
19399356|NCT02556775|41644187|FG001|Overall Study|Lost to Follow-up|0|||
19399357|NCT02556775|41644188|FG002|Overall Study|Lost to Follow-up|0|||
19399358|NCT02556775|41644189|FG003|Overall Study|Lost to Follow-up|0|||
19399359|NCT01662505|41644204|FG000|Overall Study|Progressive disease|6|||
19399360|NCT01662505|41644205|FG001|Overall Study|Progressive disease|1|||
19399361|NCT01662505|41644206|FG002|Overall Study|Progressive disease|5|||
19399362|NCT01662505|41644204|FG000|Overall Study|Refused cont. medication|0|||
19399363|NCT01662505|41644205|FG001|Overall Study|Refused cont. medication|0|||
19399364|NCT01662505|41644206|FG002|Overall Study|Refused cont. medication|1|||
19399365|NCT01662505|41644204|FG000|Overall Study|Not specified above|1|||
19399366|NCT01662505|41644205|FG001|Overall Study|Not specified above|3|||
19399367|NCT01662505|41644206|FG002|Overall Study|Not specified above|2|||
19399368|NCT03796195|41644215|FG000|Overall Study|Study closed early|1|||
19399369|NCT02554513|41644249|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
19399370|NCT02554513|41644250|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
19399371|NCT02554279|41644264|FG000|Overall Study|Adverse Event|2|||
19399372|NCT02554279|41644265|FG001|Overall Study|Adverse Event|5|||
19399373|NCT02554279|41644264|FG000|Overall Study|Lost to Follow-up|3|||
19399374|NCT02554279|41644265|FG001|Overall Study|Lost to Follow-up|2|||
19399375|NCT02554279|41644264|FG000|Overall Study|Withdrawal by Subject|6|||
19399376|NCT02554279|41644265|FG001|Overall Study|Withdrawal by Subject|4|||
19399377|NCT02554279|41644264|FG000|Overall Study|Protocol Violation|2|||
19627902|NCT00591344|42077293|FG001|Overall Study|Underwent DBS|2|||
19399378|NCT02554279|41644265|FG001|Overall Study|Protocol Violation|1|||
19399379|NCT02554279|41644264|FG000|Overall Study|Other reason|19|||
19399380|NCT02554279|41644265|FG001|Overall Study|Other reason|6|||
19399381|NCT02554903|41644280|FG000|Overall Study|Death|1|||
19399382|NCT02554903|41644281|FG001|Overall Study|Death|1|||
19399383|NCT02554903|41644280|FG000|Overall Study|Physician Decision|2|||
19399384|NCT02554903|41644281|FG001|Overall Study|Physician Decision|2|||
19399385|NCT02554903|41644280|FG000|Overall Study|Heart Transplant|1|||
19399386|NCT02554903|41644281|FG001|Overall Study|Heart Transplant|2|||
19399387|NCT02332707|41644306|FG000|Overall Study|Adverse Event|0|||
19399388|NCT02332707|41644307|FG001|Overall Study|Adverse Event|0|||
19399389|NCT02332707|41644308|FG002|Overall Study|Adverse Event|0|||
19399390|NCT02332707|41644309|FG003|Overall Study|Adverse Event|0|||
19399391|NCT02332707|41644310|FG004|Overall Study|Adverse Event|0|||
19399392|NCT02332707|41644311|FG005|Overall Study|Adverse Event|0|||
19399393|NCT02332707|41644312|FG006|Overall Study|Adverse Event|0|||
19399394|NCT02332707|41644313|FG007|Overall Study|Adverse Event|0|||
19399395|NCT02332707|41644314|FG008|Overall Study|Adverse Event|0|||
19399396|NCT02332707|41644315|FG009|Overall Study|Adverse Event|0|||
19627903|NCT00591344|42077292|FG000|Overall Study|Death|0|||
19627904|NCT00591344|42077293|FG001|Overall Study|Death|1|||
19627905|NCT00591344|42077292|FG000|Overall Study|Lost to Follow-up|0|||
19627906|NCT00591344|42077293|FG001|Overall Study|Lost to Follow-up|1|||
19627907|NCT00591344|42077292|FG000|Overall Study|Did not want to come off medication|0|||
19627908|NCT00591344|42077293|FG001|Overall Study|Did not want to come off medication|1|||
19627909|NCT00803634|42077305|FG000|Overall Study|Withdrew Consent|1|||
19627910|NCT00803634|42077306|FG001|Overall Study|Withdrew Consent|0|||
19627911|NCT00803634|42077305|FG000|Overall Study|Lost to Follow-up|2|||
19627912|NCT00803634|42077306|FG001|Overall Study|Lost to Follow-up|3|||
19627913|NCT00803634|42077305|FG000|Overall Study|Death|3|||
19627914|NCT00803634|42077306|FG001|Overall Study|Death|2|||
19627915|NCT00838526|42077315|FG000|Overall Study|Adverse Event|3|||
19627916|NCT00838526|42077316|FG001|Overall Study|Adverse Event|12|||
19399397|NCT02332707|41644316|FG010|Overall Study|Adverse Event|0|||
19399398|NCT02332707|41644317|FG011|Overall Study|Adverse Event|0|||
19399399|NCT02332707|41644318|FG012|Overall Study|Adverse Event|1|||
19399400|NCT02332707|41644319|FG013|Overall Study|Adverse Event|0|||
19399401|NCT02332707|41644320|FG014|Overall Study|Adverse Event|0|||
19399402|NCT02332707|41644321|FG015|Overall Study|Adverse Event|0|||
19399403|NCT02332707|41644322|FG016|Overall Study|Adverse Event|0|||
19399404|NCT02332707|41644323|FG017|Overall Study|Adverse Event|0|||
19399405|NCT02332707|41644306|FG000|Overall Study|Lost to Follow-up|0|||
19399406|NCT02332707|41644307|FG001|Overall Study|Lost to Follow-up|0|||
19399407|NCT02332707|41644308|FG002|Overall Study|Lost to Follow-up|0|||
19399408|NCT02332707|41644309|FG003|Overall Study|Lost to Follow-up|0|||
19399409|NCT02332707|41644310|FG004|Overall Study|Lost to Follow-up|0|||
19399410|NCT02332707|41644311|FG005|Overall Study|Lost to Follow-up|1|||
19399411|NCT02332707|41644312|FG006|Overall Study|Lost to Follow-up|0|||
19399412|NCT02332707|41644313|FG007|Overall Study|Lost to Follow-up|0|||
19399413|NCT02332707|41644314|FG008|Overall Study|Lost to Follow-up|0|||
19399414|NCT02332707|41644315|FG009|Overall Study|Lost to Follow-up|0|||
19399415|NCT02332707|41644316|FG010|Overall Study|Lost to Follow-up|2|||
19399416|NCT02332707|41644317|FG011|Overall Study|Lost to Follow-up|0|||
19399417|NCT02332707|41644318|FG012|Overall Study|Lost to Follow-up|3|||
19399418|NCT02332707|41644319|FG013|Overall Study|Lost to Follow-up|0|||
19399419|NCT02332707|41644320|FG014|Overall Study|Lost to Follow-up|0|||
19399420|NCT02332707|41644321|FG015|Overall Study|Lost to Follow-up|0|||
19399421|NCT02332707|41644322|FG016|Overall Study|Lost to Follow-up|0|||
19399422|NCT02332707|41644323|FG017|Overall Study|Lost to Follow-up|0|||
19399423|NCT02332707|41644306|FG000|Overall Study|Physician Decision|0|||
19399424|NCT02332707|41644307|FG001|Overall Study|Physician Decision|0|||
19399425|NCT02332707|41644308|FG002|Overall Study|Physician Decision|0|||
19399426|NCT02332707|41644309|FG003|Overall Study|Physician Decision|1|||
19399427|NCT02332707|41644310|FG004|Overall Study|Physician Decision|0|||
19399428|NCT02332707|41644311|FG005|Overall Study|Physician Decision|0|||
19399429|NCT02332707|41644312|FG006|Overall Study|Physician Decision|0|||
19711040|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
19711041|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
19399430|NCT02332707|41644313|FG007|Overall Study|Physician Decision|0|||
19399431|NCT02332707|41644314|FG008|Overall Study|Physician Decision|0|||
19399432|NCT02332707|41644315|FG009|Overall Study|Physician Decision|0|||
19399433|NCT02332707|41644316|FG010|Overall Study|Physician Decision|0|||
19399434|NCT02332707|41644317|FG011|Overall Study|Physician Decision|0|||
19399435|NCT02332707|41644318|FG012|Overall Study|Physician Decision|1|||
19399436|NCT02332707|41644319|FG013|Overall Study|Physician Decision|0|||
19399437|NCT02332707|41644320|FG014|Overall Study|Physician Decision|0|||
19399438|NCT02332707|41644321|FG015|Overall Study|Physician Decision|0|||
19399439|NCT02332707|41644322|FG016|Overall Study|Physician Decision|0|||
19399440|NCT02332707|41644323|FG017|Overall Study|Physician Decision|0|||
19399441|NCT02332707|41644306|FG000|Overall Study|Withdrawal by Subject|0|||
19399442|NCT02332707|41644307|FG001|Overall Study|Withdrawal by Subject|0|||
19399443|NCT02332707|41644308|FG002|Overall Study|Withdrawal by Subject|1|||
19627917|NCT00838526|42077315|FG000|Overall Study|Lost to Follow-up|4|||
19627918|NCT00838526|42077316|FG001|Overall Study|Lost to Follow-up|12|||
19399444|NCT02332707|41644309|FG003|Overall Study|Withdrawal by Subject|0|||
19399445|NCT02332707|41644310|FG004|Overall Study|Withdrawal by Subject|0|||
19399446|NCT02332707|41644311|FG005|Overall Study|Withdrawal by Subject|0|||
19627919|NCT00838526|42077315|FG000|Overall Study|Withdrawal by Subject|4|||
19627920|NCT00838526|42077316|FG001|Overall Study|Withdrawal by Subject|5|||
19399447|NCT02332707|41644312|FG006|Overall Study|Withdrawal by Subject|0|||
19399448|NCT02332707|41644313|FG007|Overall Study|Withdrawal by Subject|0|||
19627921|NCT00838526|42077315|FG000|Overall Study|Lack of Efficacy|2|||
19399449|NCT02332707|41644314|FG008|Overall Study|Withdrawal by Subject|0|||
19399450|NCT02332707|41644315|FG009|Overall Study|Withdrawal by Subject|3|||
19399451|NCT02332707|41644316|FG010|Overall Study|Withdrawal by Subject|0|||
19399452|NCT02332707|41644317|FG011|Overall Study|Withdrawal by Subject|0|||
19399453|NCT02332707|41644318|FG012|Overall Study|Withdrawal by Subject|0|||
19399454|NCT02332707|41644319|FG013|Overall Study|Withdrawal by Subject|0|||
19399455|NCT02332707|41644320|FG014|Overall Study|Withdrawal by Subject|0|||
19399456|NCT02332707|41644321|FG015|Overall Study|Withdrawal by Subject|0|||
19399457|NCT02332707|41644322|FG016|Overall Study|Withdrawal by Subject|0|||
19399458|NCT02332707|41644323|FG017|Overall Study|Withdrawal by Subject|0|||
19399459|NCT02370615|41644363|FG000|Overall Study|Adverse Event|1|||
19399460|NCT02370615|41644364|FG001|Overall Study|Adverse Event|0|||
19399461|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
19399462|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
19399463|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
19399464|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
19399465|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
19399466|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
19399467|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
19399468|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
19399469|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
19399470|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
19399471|NCT02307513|41644379|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
19399472|NCT02307513|41644380|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
19399473|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
19399474|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
19399475|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
19399476|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
19399477|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
19399478|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
19399479|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
19399480|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
19399481|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
19399482|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
19399483|NCT02307513|41644379|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
19399484|NCT02307513|41644380|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
19399485|NCT02307513|41644379|FG000|Long-term Extension|Physician Decision|1|||
19399486|NCT02307513|41644380|FG001|Long-term Extension|Physician Decision|0|||
19399487|NCT02332239|41644392|FG000|Overall Study|Lost to Follow-up|4|||
19399488|NCT02332239|41644393|FG001|Overall Study|Lost to Follow-up|6|||
19399489|NCT02370537|41644404|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
19399490|NCT02370537|41644405|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
19399491|NCT02370537|41644406|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
19399492|NCT02370537|41644404|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
19399493|NCT02370537|41644405|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
19399494|NCT02370537|41644406|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
19399495|NCT02370537|41644404|FG000|Part B|Not randomised to receive treatment|1|||
19399496|NCT02370537|41644405|FG001|Part B|Not randomised to receive treatment|2|||
19399497|NCT02370537|41644406|FG002|Part B|Not randomised to receive treatment|259|||
19399498|NCT02370537|41644404|FG000|Part B|Withdrawal by Subject|0|||
19399499|NCT02370537|41644405|FG001|Part B|Withdrawal by Subject|1|||
19399500|NCT02370537|41644406|FG002|Part B|Withdrawal by Subject|0|||
19399501|NCT02330055|41644425|FG000|Overall Study|technical issues|2|||
19627922|NCT00838526|42077316|FG001|Overall Study|Lack of Efficacy|3|||
19711042|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
19627923|NCT00838526|42077315|FG000|Overall Study|Other|11|||
19627924|NCT00838526|42077316|FG001|Overall Study|Other|7|||
19627925|NCT00818246|42077335|FG000|Overall Study|Impossible to match pictures|5|||
19627926|NCT00818168|42077339|FG000|Overall Study|Lack of Efficacy|18|||
19627927|NCT00818168|42077339|FG000|Overall Study|Pregnancy|2|||
19627928|NCT00818168|42077339|FG000|Overall Study|Withdrawal by Subject|16|||
19627929|NCT00818168|42077339|FG000|Overall Study|Lost to Follow-up|7|||
19399502|NCT02330055|41644426|FG001|Overall Study|technical issues|0|||
19399503|NCT02330055|41644425|FG000|Overall Study|participant forgot to wear device|5|||
19399504|NCT02330055|41644426|FG001|Overall Study|participant forgot to wear device|5|||
19399505|NCT02330055|41644425|FG000|Overall Study|data for less than 60 minutes|3|||
19399506|NCT02330055|41644426|FG001|Overall Study|data for less than 60 minutes|3|||
19399507|NCT02330055|41644425|FG000|Overall Study|participant did not sleep|0|||
19399508|NCT02330055|41644426|FG001|Overall Study|participant did not sleep|1|||
19399509|NCT02306265|41644432|FG000|Overall Study|Withdrawal by Subject|1|||
19399510|NCT02329743|41644440|FG000|Overall Study|Adverse Event|1|||
19399511|NCT02329743|41644441|FG001|Overall Study|Adverse Event|1|||
19399512|NCT02329743|41644442|FG002|Overall Study|Adverse Event|3|||
19399513|NCT02329743|41644440|FG000|Overall Study|Lost to Follow-up|1|||
19399514|NCT02329743|41644441|FG001|Overall Study|Lost to Follow-up|0|||
19399515|NCT02329743|41644442|FG002|Overall Study|Lost to Follow-up|1|||
19399516|NCT02329743|41644440|FG000|Overall Study|Withdrawal by Subject|4|||
19399517|NCT02329743|41644441|FG001|Overall Study|Withdrawal by Subject|4|||
19399518|NCT02329743|41644442|FG002|Overall Study|Withdrawal by Subject|1|||
19399519|NCT02329743|41644440|FG000|Overall Study|Other|0|||
19399520|NCT02329743|41644441|FG001|Overall Study|Other|2|||
19399521|NCT02329743|41644442|FG002|Overall Study|Other|3|||
19399522|NCT02329431|41644452|FG000|Overall Study|Lost to Follow-up|20|||
19399523|NCT02329431|41644453|FG001|Overall Study|Lost to Follow-up|13|||
19399524|NCT02328105|41644459|FG000|Overall Study|Death|6|||
19399525|NCT02328105|41644459|FG000|Overall Study|Withdrawal by Subject|1|||
19399526|NCT02328105|41644459|FG000|Overall Study|Still On Study in Follow-Up|4|||
19399527|NCT02305797|41644465|FG000|Overall Study|Adverse Event|11|||
19399528|NCT02305797|41644466|FG001|Overall Study|Adverse Event|2|||
19399529|NCT02305797|41644465|FG000|Overall Study|Withdrawal by Subject|9|||
19399530|NCT02305797|41644466|FG001|Overall Study|Withdrawal by Subject|10|||
19399531|NCT02305797|41644465|FG000|Overall Study|Lack of Efficacy|6|||
19399532|NCT02305797|41644466|FG001|Overall Study|Lack of Efficacy|0|||
19399533|NCT02305797|41644465|FG000|Overall Study|Lost to Follow-up|5|||
19399534|NCT02305797|41644466|FG001|Overall Study|Lost to Follow-up|11|||
19399535|NCT02305797|41644465|FG000|Overall Study|Pregnancy|0|||
19399536|NCT02305797|41644466|FG001|Overall Study|Pregnancy|2|||
19399537|NCT02305797|41644465|FG000|Overall Study|Noncompliance|14|||
19399538|NCT02305797|41644466|FG001|Overall Study|Noncompliance|12|||
19399539|NCT02305797|41644465|FG000|Overall Study|Reason not collected|0|||
19399540|NCT02305797|41644466|FG001|Overall Study|Reason not collected|1|||
19399541|NCT01646073|41644474|FG000|Period A (12 Weeks)|Adverse Event|0|||
19399542|NCT01646073|41644475|FG001|Period A (12 Weeks)|Adverse Event|2|||
19399543|NCT01646073|41644474|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
19399544|NCT01646073|41644475|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
19399545|NCT01646073|41644474|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
19399546|NCT01646073|41644475|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
19399547|NCT01646073|41644474|FG000|Period A (12 Weeks)|Protocol Violation|0|||
19399548|NCT01646073|41644475|FG001|Period A (12 Weeks)|Protocol Violation|1|||
19399549|NCT01646073|41644474|FG000|Period A (12 Weeks)|Other|0|||
19399550|NCT01646073|41644475|FG001|Period A (12 Weeks)|Other|1|||
19399551|NCT01646073|41644474|FG000|Period B (12 Weeks)|Adverse Event|0|||
19399552|NCT01646073|41644475|FG001|Period B (12 Weeks)|Adverse Event|7|||
19399553|NCT01646073|41644474|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
19399554|NCT01646073|41644475|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
19399555|NCT01646073|41644474|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
19399556|NCT01646073|41644475|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
19399557|NCT02328027|41644486|FG000|Overall Study|Withdrawal by Subject|0|||
19399558|NCT02328027|41644487|FG001|Overall Study|Withdrawal by Subject|1|||
19399559|NCT02551159|41644497|FG000|Overall Study|Death|352|||
19399560|NCT02551159|41644498|FG001|Overall Study|Death|174|||
19399561|NCT02551159|41644499|FG002|Overall Study|Death|161|||
19399562|NCT02551159|41644497|FG000|Overall Study|Withdrawal by Subject|8|||
19399563|NCT02551159|41644498|FG001|Overall Study|Withdrawal by Subject|5|||
19518012|NCT01572792|41930980|FG000|Extension Study|Withdrawal by Subject|7|||
19518013|NCT01572792|41930981|FG001|Extension Study|Withdrawal by Subject|6|||
19518014|NCT01572792|41930982|FG002|Extension Study|Withdrawal by Subject|11|||
19399564|NCT02551159|41644499|FG002|Overall Study|Withdrawal by Subject|16|||
19399565|NCT02551159|41644497|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
19399566|NCT02551159|41644498|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
19399567|NCT02551159|41644499|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
19399568|NCT02305563|41644512|FG000|Treatment Period|Disease progression|0|||
19518015|NCT01572792|41930983|FG003|Extension Study|Withdrawal by Subject|8|||
19399569|NCT02305563|41644513|FG001|Treatment Period|Disease progression|0|||
19399570|NCT02305563|41644514|FG002|Treatment Period|Disease progression|15|||
19399571|NCT02305563|41644515|FG003|Treatment Period|Disease progression|6|||
19399572|NCT02305563|41644516|FG004|Treatment Period|Disease progression|6|||
19399573|NCT02305563|41644512|FG000|Treatment Period|Study drug toxicity|0|||
19399574|NCT02305563|41644513|FG001|Treatment Period|Study drug toxicity|0|||
19399575|NCT02305563|41644514|FG002|Treatment Period|Study drug toxicity|0|||
19399576|NCT02305563|41644515|FG003|Treatment Period|Study drug toxicity|1|||
19399577|NCT02305563|41644516|FG004|Treatment Period|Study drug toxicity|2|||
19399578|NCT02305563|41644512|FG000|Treatment Period|Death|0|||
19399579|NCT02305563|41644513|FG001|Treatment Period|Death|0|||
19399580|NCT02305563|41644514|FG002|Treatment Period|Death|1|||
19399581|NCT02305563|41644515|FG003|Treatment Period|Death|2|||
19399582|NCT02305563|41644516|FG004|Treatment Period|Death|1|||
19399583|NCT02305563|41644512|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
19399584|NCT02305563|41644513|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
19399585|NCT02305563|41644514|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
19399586|NCT02305563|41644515|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
19399587|NCT02305563|41644516|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
19399588|NCT02305563|41644512|FG000|Treatment Period|Participant request to stop therapy|0|||
19399589|NCT02305563|41644513|FG001|Treatment Period|Participant request to stop therapy|2|||
19399590|NCT02305563|41644514|FG002|Treatment Period|Participant request to stop therapy|0|||
19399591|NCT02305563|41644515|FG003|Treatment Period|Participant request to stop therapy|1|||
19399592|NCT02305563|41644516|FG004|Treatment Period|Participant request to stop therapy|0|||
19399593|NCT02305563|41644512|FG000|Treatment Period|Participant withdrew consent|0|||
19399594|NCT02305563|41644513|FG001|Treatment Period|Participant withdrew consent|0|||
19399595|NCT02305563|41644514|FG002|Treatment Period|Participant withdrew consent|1|||
19399596|NCT02305563|41644515|FG003|Treatment Period|Participant withdrew consent|1|||
19399597|NCT02305563|41644516|FG004|Treatment Period|Participant withdrew consent|1|||
19399598|NCT02305563|41644512|FG000|Treatment Period|Maximum clinical benefit|0|||
19399599|NCT02305563|41644513|FG001|Treatment Period|Maximum clinical benefit|0|||
19399600|NCT02305563|41644514|FG002|Treatment Period|Maximum clinical benefit|0|||
19399601|NCT02305563|41644515|FG003|Treatment Period|Maximum clinical benefit|0|||
19399602|NCT02305563|41644516|FG004|Treatment Period|Maximum clinical benefit|1|||
19399603|NCT02305563|41644512|FG000|Treatment Period|Poor/non-compliance|0|||
19399604|NCT02305563|41644513|FG001|Treatment Period|Poor/non-compliance|0|||
19399605|NCT02305563|41644514|FG002|Treatment Period|Poor/non-compliance|0|||
19399606|NCT02305563|41644515|FG003|Treatment Period|Poor/non-compliance|0|||
19399607|NCT02305563|41644516|FG004|Treatment Period|Poor/non-compliance|1|||
19399608|NCT02305563|41644512|FG000|Treatment Period|Administrative reason by Sponsor|0|||
19399609|NCT02305563|41644513|FG001|Treatment Period|Administrative reason by Sponsor|0|||
19399610|NCT02305563|41644514|FG002|Treatment Period|Administrative reason by Sponsor|0|||
19399611|NCT02305563|41644515|FG003|Treatment Period|Administrative reason by Sponsor|0|||
19399612|NCT02305563|41644516|FG004|Treatment Period|Administrative reason by Sponsor|1|||
19399613|NCT02305563|41644512|FG000|Treatment Period|other reason|2|||
19399614|NCT02305563|41644513|FG001|Treatment Period|other reason|0|||
19399615|NCT02305563|41644514|FG002|Treatment Period|other reason|2|||
19399616|NCT02305563|41644515|FG003|Treatment Period|other reason|2|||
19399617|NCT02305563|41644516|FG004|Treatment Period|other reason|1|||
19399618|NCT02305563|41644512|FG000|Treatment Period|Randomized but not treated|0|||
19399619|NCT02305563|41644513|FG001|Treatment Period|Randomized but not treated|0|||
19399620|NCT02305563|41644514|FG002|Treatment Period|Randomized but not treated|0|||
19399621|NCT02305563|41644515|FG003|Treatment Period|Randomized but not treated|0|||
19399622|NCT02305563|41644516|FG004|Treatment Period|Randomized but not treated|2|||
19399623|NCT02305563|41644512|FG000|Treatment Period|added ULO, then disease progression|0|||
19399624|NCT02305563|41644513|FG001|Treatment Period|added ULO, then disease progression|0|||
19399625|NCT02305563|41644514|FG002|Treatment Period|added ULO, then disease progression|0|||
19399626|NCT02305563|41644515|FG003|Treatment Period|added ULO, then disease progression|0|||
19399627|NCT02305563|41644516|FG004|Treatment Period|added ULO, then disease progression|4|||
19399628|NCT02305563|41644512|FG000|Treatment Period|added ULO; then other reason|0|||
19399629|NCT02305563|41644513|FG001|Treatment Period|added ULO; then other reason|0|||
19399630|NCT02305563|41644514|FG002|Treatment Period|added ULO; then other reason|0|||
19399631|NCT02305563|41644515|FG003|Treatment Period|added ULO; then other reason|0|||
19399632|NCT02305563|41644516|FG004|Treatment Period|added ULO; then other reason|1|||
19399633|NCT02305563|41644512|FG000|Treatment Period|added ULO, then request to stop|0|||
19399634|NCT02305563|41644513|FG001|Treatment Period|added ULO, then request to stop|0|||
19399635|NCT02305563|41644514|FG002|Treatment Period|added ULO, then request to stop|0|||
19399636|NCT02305563|41644515|FG003|Treatment Period|added ULO, then request to stop|0|||
19399637|NCT02305563|41644516|FG004|Treatment Period|added ULO, then request to stop|1|||
19399638|NCT02305563|41644512|FG000|Follow-up Period|Death|0|||
19399639|NCT02305563|41644513|FG001|Follow-up Period|Death|0|||
19399640|NCT02305563|41644514|FG002|Follow-up Period|Death|5|||
19399641|NCT02305563|41644515|FG003|Follow-up Period|Death|4|||
19399642|NCT02305563|41644516|FG004|Follow-up Period|Death|7|||
19399643|NCT02305563|41644512|FG000|Follow-up Period|Participant withdrew consent|0|||
19399644|NCT02305563|41644513|FG001|Follow-up Period|Participant withdrew consent|0|||
19399645|NCT02305563|41644514|FG002|Follow-up Period|Participant withdrew consent|2|||
19399646|NCT02305563|41644515|FG003|Follow-up Period|Participant withdrew consent|1|||
19399647|NCT02305563|41644516|FG004|Follow-up Period|Participant withdrew consent|0|||
19399648|NCT02305563|41644512|FG000|Follow-up Period|other reason|0|||
19399649|NCT02305563|41644513|FG001|Follow-up Period|other reason|0|||
19399650|NCT02305563|41644514|FG002|Follow-up Period|other reason|0|||
19399651|NCT02305563|41644515|FG003|Follow-up Period|other reason|0|||
19399652|NCT02305563|41644516|FG004|Follow-up Period|other reason|1|||
19399653|NCT02305563|41644512|FG000|Follow-up Period|Followup no longer required per protocol|3|||
19399654|NCT02305563|41644513|FG001|Follow-up Period|Followup no longer required per protocol|3|||
19399655|NCT02305563|41644514|FG002|Follow-up Period|Followup no longer required per protocol|4|||
19399656|NCT02305563|41644515|FG003|Follow-up Period|Followup no longer required per protocol|1|||
19399657|NCT02305563|41644516|FG004|Follow-up Period|Followup no longer required per protocol|4|||
19399658|NCT02327325|41644535|FG000|Overall Study|Withdrawal by Subject|1|||
19399659|NCT02327325|41644536|FG001|Overall Study|Withdrawal by Subject|4|||
19399660|NCT02327325|41644537|FG002|Overall Study|Withdrawal by Subject|4|||
19399661|NCT02327325|41644535|FG000|Overall Study|Excluded by Study Team|0|||
19399662|NCT02327325|41644536|FG001|Overall Study|Excluded by Study Team|0|||
19399663|NCT02327325|41644537|FG002|Overall Study|Excluded by Study Team|1|||
19399664|NCT02304705|41644547|FG000|Overall Study|Withdrawal by Subject|2|||
19399665|NCT02304705|41644548|FG001|Overall Study|Withdrawal by Subject|0|||
19399666|NCT02304705|41644547|FG000|Overall Study|Physician Decision|2|||
19399667|NCT02304705|41644548|FG001|Overall Study|Physician Decision|4|||
19399668|NCT02304705|41644547|FG000|Overall Study|Death|0|||
19399669|NCT02304705|41644548|FG001|Overall Study|Death|1|||
19399670|NCT02304705|41644547|FG000|Overall Study|Lost to Follow-up|0|||
19399671|NCT02304705|41644548|FG001|Overall Study|Lost to Follow-up|2|||
19399672|NCT02553499|41644568|FG000|Overall Study|Adverse Event|0|||
19399673|NCT02553499|41644569|FG001|Overall Study|Adverse Event|0|||
19399674|NCT02553499|41644570|FG002|Overall Study|Adverse Event|0|||
19399675|NCT02553499|41644571|FG003|Overall Study|Adverse Event|0|||
19399676|NCT02553499|41644572|FG004|Overall Study|Adverse Event|0|||
19399677|NCT02553499|41644573|FG005|Overall Study|Adverse Event|0|||
19399678|NCT02553499|41644574|FG006|Overall Study|Adverse Event|1|||
19399679|NCT02553499|41644575|FG007|Overall Study|Adverse Event|1|||
19399680|NCT02553499|41644576|FG008|Overall Study|Adverse Event|0|||
19399681|NCT02553499|41644577|FG009|Overall Study|Adverse Event|0|||
19399682|NCT02553499|41644578|FG010|Overall Study|Adverse Event|0|||
19399683|NCT02553499|41644579|FG011|Overall Study|Adverse Event|0|||
19399684|NCT02553499|41644580|FG012|Overall Study|Adverse Event|0|||
19399685|NCT02553499|41644581|FG013|Overall Study|Adverse Event|1|||
19399686|NCT02553499|41644568|FG000|Overall Study|Death|0|||
19399687|NCT02553499|41644569|FG001|Overall Study|Death|1|||
19399688|NCT02553499|41644570|FG002|Overall Study|Death|1|||
19399689|NCT02553499|41644571|FG003|Overall Study|Death|0|||
19399690|NCT02553499|41644572|FG004|Overall Study|Death|1|||
19399691|NCT02553499|41644573|FG005|Overall Study|Death|2|||
19399692|NCT02553499|41644574|FG006|Overall Study|Death|0|||
19399693|NCT02553499|41644575|FG007|Overall Study|Death|0|||
19399694|NCT02553499|41644576|FG008|Overall Study|Death|0|||
19399695|NCT02553499|41644577|FG009|Overall Study|Death|0|||
19399696|NCT02553499|41644578|FG010|Overall Study|Death|1|||
19399697|NCT02553499|41644579|FG011|Overall Study|Death|0|||
19399698|NCT02553499|41644580|FG012|Overall Study|Death|0|||
19399699|NCT02553499|41644581|FG013|Overall Study|Death|0|||
19399700|NCT02553499|41644568|FG000|Overall Study|Lost to Follow-up|0|||
19399701|NCT02553499|41644569|FG001|Overall Study|Lost to Follow-up|0|||
19399702|NCT02553499|41644570|FG002|Overall Study|Lost to Follow-up|0|||
19399703|NCT02553499|41644571|FG003|Overall Study|Lost to Follow-up|0|||
19399704|NCT02553499|41644572|FG004|Overall Study|Lost to Follow-up|0|||
19399705|NCT02553499|41644573|FG005|Overall Study|Lost to Follow-up|0|||
19399706|NCT02553499|41644574|FG006|Overall Study|Lost to Follow-up|1|||
19399707|NCT02553499|41644575|FG007|Overall Study|Lost to Follow-up|0|||
19399708|NCT02553499|41644576|FG008|Overall Study|Lost to Follow-up|0|||
19399709|NCT02553499|41644577|FG009|Overall Study|Lost to Follow-up|0|||
19399710|NCT02553499|41644578|FG010|Overall Study|Lost to Follow-up|0|||
19399711|NCT02553499|41644579|FG011|Overall Study|Lost to Follow-up|0|||
19399712|NCT02553499|41644580|FG012|Overall Study|Lost to Follow-up|0|||
19399713|NCT02553499|41644581|FG013|Overall Study|Lost to Follow-up|0|||
19399714|NCT02553499|41644568|FG000|Overall Study|Physician Decision|0|||
19399715|NCT02553499|41644569|FG001|Overall Study|Physician Decision|1|||
19399716|NCT02553499|41644570|FG002|Overall Study|Physician Decision|1|||
19399717|NCT02553499|41644571|FG003|Overall Study|Physician Decision|0|||
19399718|NCT02553499|41644572|FG004|Overall Study|Physician Decision|1|||
19399719|NCT02553499|41644573|FG005|Overall Study|Physician Decision|0|||
19399720|NCT02553499|41644574|FG006|Overall Study|Physician Decision|0|||
19399721|NCT02553499|41644575|FG007|Overall Study|Physician Decision|1|||
19399722|NCT02553499|41644576|FG008|Overall Study|Physician Decision|1|||
19399723|NCT02553499|41644577|FG009|Overall Study|Physician Decision|2|||
19399724|NCT02553499|41644578|FG010|Overall Study|Physician Decision|1|||
19399725|NCT02553499|41644579|FG011|Overall Study|Physician Decision|3|||
19399726|NCT02553499|41644580|FG012|Overall Study|Physician Decision|1|||
19399727|NCT02553499|41644581|FG013|Overall Study|Physician Decision|0|||
19399728|NCT02553499|41644568|FG000|Overall Study|Progressive Disease|0|||
19399729|NCT02553499|41644569|FG001|Overall Study|Progressive Disease|0|||
19399730|NCT02553499|41644570|FG002|Overall Study|Progressive Disease|0|||
19399731|NCT02553499|41644571|FG003|Overall Study|Progressive Disease|2|||
19399732|NCT02553499|41644572|FG004|Overall Study|Progressive Disease|1|||
19399733|NCT02553499|41644573|FG005|Overall Study|Progressive Disease|1|||
19399734|NCT02553499|41644574|FG006|Overall Study|Progressive Disease|1|||
19399735|NCT02553499|41644575|FG007|Overall Study|Progressive Disease|0|||
19399736|NCT02553499|41644576|FG008|Overall Study|Progressive Disease|0|||
19399737|NCT02553499|41644577|FG009|Overall Study|Progressive Disease|1|||
19399738|NCT02553499|41644578|FG010|Overall Study|Progressive Disease|0|||
19399739|NCT02553499|41644579|FG011|Overall Study|Progressive Disease|0|||
19399740|NCT02553499|41644580|FG012|Overall Study|Progressive Disease|2|||
19399741|NCT02553499|41644581|FG013|Overall Study|Progressive Disease|1|||
19399742|NCT02553499|41644568|FG000|Overall Study|Study Terminated by Sponsor|0|||
19399743|NCT02553499|41644569|FG001|Overall Study|Study Terminated by Sponsor|0|||
19399744|NCT02553499|41644570|FG002|Overall Study|Study Terminated by Sponsor|0|||
19399745|NCT02553499|41644571|FG003|Overall Study|Study Terminated by Sponsor|0|||
19399746|NCT02553499|41644572|FG004|Overall Study|Study Terminated by Sponsor|0|||
19399747|NCT02553499|41644573|FG005|Overall Study|Study Terminated by Sponsor|0|||
19399748|NCT02553499|41644574|FG006|Overall Study|Study Terminated by Sponsor|0|||
19399749|NCT02553499|41644575|FG007|Overall Study|Study Terminated by Sponsor|0|||
19399750|NCT02553499|41644576|FG008|Overall Study|Study Terminated by Sponsor|1|||
19399751|NCT02553499|41644577|FG009|Overall Study|Study Terminated by Sponsor|0|||
19399752|NCT02553499|41644578|FG010|Overall Study|Study Terminated by Sponsor|0|||
19399753|NCT02553499|41644579|FG011|Overall Study|Study Terminated by Sponsor|0|||
19399754|NCT02553499|41644580|FG012|Overall Study|Study Terminated by Sponsor|0|||
19399755|NCT02553499|41644581|FG013|Overall Study|Study Terminated by Sponsor|0|||
19399756|NCT02553499|41644568|FG000|Overall Study|Withdrawal by Subject|2|||
19399757|NCT02553499|41644569|FG001|Overall Study|Withdrawal by Subject|0|||
19399758|NCT02553499|41644570|FG002|Overall Study|Withdrawal by Subject|0|||
19399759|NCT02553499|41644571|FG003|Overall Study|Withdrawal by Subject|0|||
19399760|NCT02553499|41644572|FG004|Overall Study|Withdrawal by Subject|0|||
19399761|NCT02553499|41644573|FG005|Overall Study|Withdrawal by Subject|0|||
19399762|NCT02553499|41644574|FG006|Overall Study|Withdrawal by Subject|0|||
19399763|NCT02553499|41644575|FG007|Overall Study|Withdrawal by Subject|1|||
19399764|NCT02553499|41644576|FG008|Overall Study|Withdrawal by Subject|1|||
19399765|NCT02553499|41644577|FG009|Overall Study|Withdrawal by Subject|0|||
19399766|NCT02553499|41644578|FG010|Overall Study|Withdrawal by Subject|1|||
19399767|NCT02553499|41644579|FG011|Overall Study|Withdrawal by Subject|0|||
19399768|NCT02553499|41644580|FG012|Overall Study|Withdrawal by Subject|0|||
19399769|NCT02553499|41644581|FG013|Overall Study|Withdrawal by Subject|0|||
19399770|NCT02553421|41644614|FG000|Overall Study|Lost to Follow-up|21|||
19399771|NCT02553421|41644615|FG001|Overall Study|Lost to Follow-up|1|||
19399772|NCT02553421|41644614|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
19399773|NCT02553421|41644615|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
19399774|NCT02553421|41644614|FG000|Overall Study|Improper Device Placement|3|||
19399775|NCT02553421|41644615|FG001|Overall Study|Improper Device Placement|0|||
19399776|NCT02549287|41644624|FG000|Overall Study|Lost to Follow-up|65|||
19399777|NCT02549287|41644625|FG001|Overall Study|Lost to Follow-up|26|||
19399778|NCT02549287|41644624|FG000|Overall Study|Withdrawal by Subject|15|||
19399779|NCT02549287|41644625|FG001|Overall Study|Withdrawal by Subject|6|||
19399780|NCT02553265|41644631|FG000|Enrollment|Death|0|||
19399781|NCT02553265|41644632|FG001|Enrollment|Death|0|||
19399782|NCT02553265|41644633|FG002|Enrollment|Death|1|||
19399783|NCT02553265|41644631|FG000|First Intervention (28 Days)|Adverse Event|1|||
19399784|NCT02553265|41644632|FG001|First Intervention (28 Days)|Adverse Event|0|||
19399785|NCT02553265|41644633|FG002|First Intervention (28 Days)|Adverse Event|0|||
19399786|NCT02553265|41644631|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
19399787|NCT02553265|41644632|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
19399788|NCT02553265|41644633|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
19399789|NCT02553265|41644631|FG000|Second Intervention (28 Days)|Adverse Event|1|||
19399790|NCT02553265|41644632|FG001|Second Intervention (28 Days)|Adverse Event|0|||
19399791|NCT02553265|41644633|FG002|Second Intervention (28 Days)|Adverse Event|0|||
19399792|NCT02553265|41644631|FG000|Third Intervention (28 Days)|Adverse Event|1|||
19399793|NCT02553265|41644632|FG001|Third Intervention (28 Days)|Adverse Event|0|||
19399794|NCT02553265|41644633|FG002|Third Intervention (28 Days)|Adverse Event|0|||
19399795|NCT02553265|41644631|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
19399796|NCT02553265|41644632|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
19399797|NCT02553265|41644633|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
19399798|NCT02561195|41644650|FG000|Vaccination 1 to 3|Adverse Event|4|||
19399799|NCT02561195|41644651|FG001|Vaccination 1 to 3|Adverse Event|5|||
19399800|NCT02561195|41644652|FG002|Vaccination 1 to 3|Adverse Event|0|||
19399801|NCT02561195|41644653|FG003|Vaccination 1 to 3|Adverse Event|3|||
19399802|NCT02561195|41644654|FG004|Vaccination 1 to 3|Adverse Event|4|||
19399803|NCT02561195|41644655|FG005|Vaccination 1 to 3|Adverse Event|0|||
19399804|NCT02561195|41644656|FG006|Vaccination 1 to 3|Adverse Event|0|||
19399805|NCT02561195|41644657|FG007|Vaccination 1 to 3|Adverse Event|0|||
19399806|NCT02561195|41644658|FG008|Vaccination 1 to 3|Adverse Event|0|||
19399807|NCT02561195|41644659|FG009|Vaccination 1 to 3|Adverse Event|0|||
19399808|NCT02561195|41644660|FG010|Vaccination 1 to 3|Adverse Event|0|||
19399809|NCT02561195|41644661|FG011|Vaccination 1 to 3|Adverse Event|0|||
19399810|NCT02561195|41644662|FG012|Vaccination 1 to 3|Adverse Event|0|||
19399811|NCT02561195|41644663|FG013|Vaccination 1 to 3|Adverse Event|0|||
19399812|NCT02561195|41644650|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
19399813|NCT02561195|41644651|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
19399814|NCT02561195|41644652|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
19399815|NCT02561195|41644653|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
19399816|NCT02561195|41644654|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
19399817|NCT02561195|41644655|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
19399818|NCT02561195|41644656|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
19399819|NCT02561195|41644657|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
19399820|NCT02561195|41644658|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
19399821|NCT02561195|41644659|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
19399822|NCT02561195|41644660|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
19399823|NCT02561195|41644661|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
19399824|NCT02561195|41644662|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
19399825|NCT02561195|41644663|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
19399826|NCT02561195|41644650|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399827|NCT02561195|41644651|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
19399828|NCT02561195|41644652|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399829|NCT02561195|41644653|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
19399830|NCT02561195|41644654|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
19399831|NCT02561195|41644655|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
19399832|NCT02561195|41644656|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399833|NCT02561195|41644657|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399834|NCT02561195|41644658|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399835|NCT02561195|41644659|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399836|NCT02561195|41644660|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399837|NCT02561195|41644661|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399838|NCT02561195|41644662|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399839|NCT02561195|41644663|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
19399840|NCT02561195|41644650|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
19399841|NCT02561195|41644651|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
19399842|NCT02561195|41644652|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
19399843|NCT02561195|41644653|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
19399844|NCT02561195|41644654|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
19399845|NCT02561195|41644655|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
19399846|NCT02561195|41644656|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
19399847|NCT02561195|41644657|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
19399848|NCT02561195|41644658|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
19399849|NCT02561195|41644659|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
19399850|NCT02561195|41644660|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
19399851|NCT02561195|41644661|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
19399852|NCT02561195|41644662|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
19399853|NCT02561195|41644663|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
19399854|NCT02561195|41644650|FG000|Vaccination 1 to 3|Other|7|||
19399855|NCT02561195|41644651|FG001|Vaccination 1 to 3|Other|3|||
19399856|NCT02561195|41644652|FG002|Vaccination 1 to 3|Other|1|||
19399857|NCT02561195|41644653|FG003|Vaccination 1 to 3|Other|7|||
19399858|NCT02561195|41644654|FG004|Vaccination 1 to 3|Other|5|||
19518016|NCT01572792|41930984|FG004|Extension Study|Withdrawal by Subject|14|||
19518017|NCT01572792|41930980|FG000|Extension Study|Protocol Violation|0|||
19518018|NCT01572792|41930981|FG001|Extension Study|Protocol Violation|4|||
19518019|NCT01572792|41930982|FG002|Extension Study|Protocol Violation|3|||
19518020|NCT01572792|41930983|FG003|Extension Study|Protocol Violation|4|||
19627930|NCT00818168|42077339|FG000|Overall Study|Adverse Event|19|||
19399859|NCT02561195|41644655|FG005|Vaccination 1 to 3|Other|1|||
19399860|NCT02561195|41644656|FG006|Vaccination 1 to 3|Other|0|||
19399861|NCT02561195|41644657|FG007|Vaccination 1 to 3|Other|0|||
19399862|NCT02561195|41644658|FG008|Vaccination 1 to 3|Other|0|||
19399863|NCT02561195|41644659|FG009|Vaccination 1 to 3|Other|0|||
19399864|NCT02561195|41644660|FG010|Vaccination 1 to 3|Other|0|||
19399865|NCT02561195|41644661|FG011|Vaccination 1 to 3|Other|0|||
19399866|NCT02561195|41644662|FG012|Vaccination 1 to 3|Other|0|||
19399867|NCT02561195|41644663|FG013|Vaccination 1 to 3|Other|0|||
19399868|NCT02561195|41644650|FG000|Vaccination 1 to 3|Protocol Violation|1|||
19399869|NCT02561195|41644651|FG001|Vaccination 1 to 3|Protocol Violation|0|||
19518021|NCT01572792|41930984|FG004|Extension Study|Protocol Violation|3|||
19518022|NCT01572792|41930980|FG000|Extension Study|Lack of Efficacy|2|||
19399870|NCT02561195|41644652|FG002|Vaccination 1 to 3|Protocol Violation|1|||
19399871|NCT02561195|41644653|FG003|Vaccination 1 to 3|Protocol Violation|2|||
19399872|NCT02561195|41644654|FG004|Vaccination 1 to 3|Protocol Violation|5|||
19399873|NCT02561195|41644655|FG005|Vaccination 1 to 3|Protocol Violation|2|||
19399874|NCT02561195|41644656|FG006|Vaccination 1 to 3|Protocol Violation|0|||
19399875|NCT02561195|41644657|FG007|Vaccination 1 to 3|Protocol Violation|0|||
19399876|NCT02561195|41644658|FG008|Vaccination 1 to 3|Protocol Violation|0|||
19399877|NCT02561195|41644659|FG009|Vaccination 1 to 3|Protocol Violation|0|||
19399878|NCT02561195|41644660|FG010|Vaccination 1 to 3|Protocol Violation|0|||
19399879|NCT02561195|41644661|FG011|Vaccination 1 to 3|Protocol Violation|0|||
19399880|NCT02561195|41644662|FG012|Vaccination 1 to 3|Protocol Violation|0|||
19399881|NCT02561195|41644663|FG013|Vaccination 1 to 3|Protocol Violation|0|||
19399882|NCT02561195|41644650|FG000|Vaccination 1 to 3|Death|2|||
19399883|NCT02561195|41644651|FG001|Vaccination 1 to 3|Death|1|||
19399884|NCT02561195|41644652|FG002|Vaccination 1 to 3|Death|0|||
19399885|NCT02561195|41644653|FG003|Vaccination 1 to 3|Death|2|||
19399886|NCT02561195|41644654|FG004|Vaccination 1 to 3|Death|0|||
19399887|NCT02561195|41644655|FG005|Vaccination 1 to 3|Death|0|||
19399888|NCT02561195|41644656|FG006|Vaccination 1 to 3|Death|0|||
19399889|NCT02561195|41644657|FG007|Vaccination 1 to 3|Death|0|||
19399890|NCT02561195|41644658|FG008|Vaccination 1 to 3|Death|0|||
19399891|NCT02561195|41644659|FG009|Vaccination 1 to 3|Death|0|||
19399892|NCT02561195|41644660|FG010|Vaccination 1 to 3|Death|0|||
19399893|NCT02561195|41644661|FG011|Vaccination 1 to 3|Death|0|||
19399894|NCT02561195|41644662|FG012|Vaccination 1 to 3|Death|0|||
19399895|NCT02561195|41644663|FG013|Vaccination 1 to 3|Death|0|||
19399896|NCT02561195|41644650|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
19399897|NCT02561195|41644651|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
19399898|NCT02561195|41644652|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
19399899|NCT02561195|41644653|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
19399900|NCT02561195|41644654|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
19399901|NCT02561195|41644655|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399902|NCT02561195|41644656|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399903|NCT02561195|41644657|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399904|NCT02561195|41644658|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399905|NCT02561195|41644659|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399906|NCT02561195|41644660|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399907|NCT02561195|41644661|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399908|NCT02561195|41644662|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399909|NCT02561195|41644663|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
19399910|NCT02561195|41644650|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
19399911|NCT02561195|41644651|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
19399912|NCT02561195|41644652|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
19399913|NCT02561195|41644653|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
19399914|NCT02561195|41644654|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
19399915|NCT02561195|41644655|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
19399916|NCT02561195|41644656|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
19399917|NCT02561195|41644657|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
19399918|NCT02561195|41644658|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
19399919|NCT02561195|41644659|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
19399920|NCT02561195|41644660|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
19399921|NCT02561195|41644661|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
19399922|NCT02561195|41644662|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
19399923|NCT02561195|41644663|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
19399924|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399925|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399926|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399927|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399928|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399929|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399930|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399931|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19399932|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
19399933|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
19399934|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
19627931|NCT00818168|42077339|FG000|Overall Study|Reason for Non-completion Not reported|6|||
19399935|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
19399936|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
19399937|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
19627932|NCT00818168|42077339|FG000|Overall Study|Participant Moved|2|||
19399938|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399939|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399940|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399941|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399942|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399943|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399944|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399945|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399946|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399947|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399948|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399949|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399950|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
19399951|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
19399952|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Death|0|||
19399953|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Death|0|||
19399954|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Death|0|||
19399955|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Death|0|||
19399956|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Death|0|||
19399957|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Death|0|||
19399958|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Death|0|||
19399959|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Death|0|||
19399960|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Death|0|||
19399961|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Death|1|||
19399962|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Death|0|||
19399963|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Death|0|||
19399964|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Death|0|||
19399965|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Death|0|||
19399966|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399967|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399968|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399969|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399970|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399971|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399972|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
19399973|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
19399974|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399975|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
19399976|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
19399977|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
19399978|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
19399979|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
19399980|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399981|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399982|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399983|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399984|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399985|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399986|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399987|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399988|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399989|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399990|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
19399991|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
19399992|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
19399993|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
19399994|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Other|0|||
19399995|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Other|0|||
19399996|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Other|0|||
19399997|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Other|0|||
19399998|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Other|0|||
19399999|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Other|0|||
19400000|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Other|0|||
19400001|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Other|0|||
19400002|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Other|0|||
19400003|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Other|0|||
19400004|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Other|2|||
19400005|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Other|2|||
19400006|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Other|1|||
19400007|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Other|0|||
19400008|NCT02561195|41644650|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400009|NCT02561195|41644651|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400010|NCT02561195|41644652|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400011|NCT02561195|41644653|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400012|NCT02561195|41644654|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400013|NCT02561195|41644655|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400014|NCT02561195|41644656|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
19400015|NCT02561195|41644657|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400016|NCT02561195|41644658|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400017|NCT02561195|41644659|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400018|NCT02561195|41644660|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
19400019|NCT02561195|41644661|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
19400020|NCT02561195|41644662|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
19400021|NCT02561195|41644663|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
19400022|NCT01663103|41644697|FG000|Overall Study|Withdrawal by Subject|1|||
19400023|NCT01663103|41644698|FG001|Overall Study|Withdrawal by Subject|2|||
19400024|NCT01663103|41644697|FG000|Overall Study|Adverse Event|1|||
19400025|NCT01663103|41644698|FG001|Overall Study|Adverse Event|0|||
19400026|NCT01663103|41644697|FG000|Overall Study|dog bite|1|||
19400027|NCT01663103|41644698|FG001|Overall Study|dog bite|0|||
19400028|NCT02560025|41644717|FG000|Overall Study|Ineligible after consent/ registration|3|||
19400029|NCT02566889|41644741|FG000|Overall Study|Withdrawal by Subject|3|||
19400030|NCT02566889|41644742|FG001|Overall Study|Withdrawal by Subject|1|||
19400031|NCT02566889|41644741|FG000|Overall Study|Adverse Event|4|||
19400032|NCT02566889|41644742|FG001|Overall Study|Adverse Event|2|||
19400033|NCT02566889|41644741|FG000|Overall Study|Other|6|||
19400034|NCT02566889|41644742|FG001|Overall Study|Other|2|||
19400035|NCT02566577|41644749|FG000|Overall Study|Withdrawal by Subject|1|||
19400036|NCT02566577|41644750|FG001|Overall Study|Withdrawal by Subject|1|||
19400037|NCT02566577|41644749|FG000|Overall Study|Equipment failure|1|||
19400038|NCT02566577|41644750|FG001|Overall Study|Equipment failure|1|||
19400039|NCT02566577|41644749|FG000|Overall Study|Physical limitation|1|||
19400040|NCT02566577|41644750|FG001|Overall Study|Physical limitation|0|||
19400041|NCT02559713|41644758|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
19400042|NCT01358981|41644769|FG000|Period 1|Withdrawal by Subject|0|||
19400043|NCT01358981|41644770|FG001|Period 1|Withdrawal by Subject|0|||
19400044|NCT01358981|41644771|FG002|Period 1|Withdrawal by Subject|0|||
19400045|NCT01358981|41644772|FG003|Period 1|Withdrawal by Subject|1|||
19400046|NCT01358981|41644773|FG004|Period 1|Withdrawal by Subject|0|||
19400047|NCT01358981|41644774|FG005|Period 1|Withdrawal by Subject|0|||
19400048|NCT01358981|41644775|FG006|Period 1|Withdrawal by Subject|0|||
19400049|NCT02548585|41644807|FG000|Overall Study|Withdrawal by Subject|0|||
19400050|NCT02548585|41644808|FG001|Overall Study|Withdrawal by Subject|0|||
19400051|NCT02548585|41644809|FG002|Overall Study|Withdrawal by Subject|0|||
19400052|NCT02548585|41644810|FG003|Overall Study|Withdrawal by Subject|0|||
19400053|NCT02548585|41644811|FG004|Overall Study|Withdrawal by Subject|0|||
19400054|NCT02548585|41644812|FG005|Overall Study|Withdrawal by Subject|1|||
19400055|NCT02548585|41644813|FG006|Overall Study|Withdrawal by Subject|0|||
19400056|NCT02548585|41644807|FG000|Overall Study|Lost to Follow-up|1|||
19400057|NCT02548585|41644808|FG001|Overall Study|Lost to Follow-up|0|||
19400058|NCT02548585|41644809|FG002|Overall Study|Lost to Follow-up|0|||
19400059|NCT02548585|41644810|FG003|Overall Study|Lost to Follow-up|0|||
19400060|NCT02548585|41644811|FG004|Overall Study|Lost to Follow-up|0|||
19400061|NCT02548585|41644812|FG005|Overall Study|Lost to Follow-up|0|||
19400062|NCT02548585|41644813|FG006|Overall Study|Lost to Follow-up|0|||
19400063|NCT02548585|41644807|FG000|Overall Study|Other|1|||
19400064|NCT02548585|41644808|FG001|Overall Study|Other|0|||
19400065|NCT02548585|41644809|FG002|Overall Study|Other|0|||
19400066|NCT02548585|41644810|FG003|Overall Study|Other|2|||
19400067|NCT02548585|41644811|FG004|Overall Study|Other|3|||
19400068|NCT02548585|41644812|FG005|Overall Study|Other|0|||
19400069|NCT02548585|41644813|FG006|Overall Study|Other|1|||
19400070|NCT02548585|41644807|FG000|Overall Study|Randomized but not treated|0|||
19400071|NCT02548585|41644808|FG001|Overall Study|Randomized but not treated|0|||
19400072|NCT02548585|41644809|FG002|Overall Study|Randomized but not treated|0|||
19400073|NCT02548585|41644810|FG003|Overall Study|Randomized but not treated|0|||
19518023|NCT01572792|41930981|FG001|Extension Study|Lack of Efficacy|3|||
19518024|NCT01572792|41930982|FG002|Extension Study|Lack of Efficacy|3|||
19518025|NCT01572792|41930983|FG003|Extension Study|Lack of Efficacy|2|||
19518026|NCT01572792|41930984|FG004|Extension Study|Lack of Efficacy|2|||
19518027|NCT01572792|41930980|FG000|Extension Study|Adverse Event|7|||
19518028|NCT01572792|41930981|FG001|Extension Study|Adverse Event|6|||
19518029|NCT01572792|41930982|FG002|Extension Study|Adverse Event|5|||
19518030|NCT01572792|41930983|FG003|Extension Study|Adverse Event|6|||
19518031|NCT01572792|41930984|FG004|Extension Study|Adverse Event|4|||
19518032|NCT01572792|41930980|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
19518033|NCT01572792|41930981|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
19518034|NCT01572792|41930982|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
19518035|NCT01572792|41930983|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
19400074|NCT02548585|41644811|FG004|Overall Study|Randomized but not treated|0|||
19518036|NCT01572792|41930984|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
19400075|NCT02548585|41644812|FG005|Overall Study|Randomized but not treated|1|||
19400076|NCT02548585|41644813|FG006|Overall Study|Randomized but not treated|0|||
19400077|NCT02547649|41644857|FG000|Overall Study|Lost to Follow-up|3|||
19400078|NCT02547649|41644858|FG001|Overall Study|Lost to Follow-up|1|||
19400079|NCT02547649|41644859|FG002|Overall Study|Lost to Follow-up|1|||
19400080|NCT02547649|41644857|FG000|Overall Study|Not vaccinated|0|||
19400081|NCT02547649|41644858|FG001|Overall Study|Not vaccinated|0|||
19400082|NCT02547649|41644859|FG002|Overall Study|Not vaccinated|1|||
19400083|NCT02547649|41644857|FG000|Overall Study|Withdrawal by Subject|0|||
19400084|NCT02547649|41644858|FG001|Overall Study|Withdrawal by Subject|4|||
19400085|NCT02547649|41644859|FG002|Overall Study|Withdrawal by Subject|2|||
19400086|NCT02535715|41644879|FG000|Overall Study|Withdrawal by Subject|0|||
19400087|NCT02535715|41644880|FG001|Overall Study|Withdrawal by Subject|0|||
19400088|NCT02535715|41644881|FG002|Overall Study|Withdrawal by Subject|1|||
19400089|NCT02336815|41644894|FG000|Overall Study|Disease Progression|45|||
19400090|NCT02336815|41644895|FG001|Overall Study|Disease Progression|70|||
19400091|NCT02336815|41644894|FG000|Overall Study|Adverse Event|18|||
19400092|NCT02336815|41644895|FG001|Overall Study|Adverse Event|39|||
19400093|NCT02336815|41644894|FG000|Overall Study|Physician Decision|11|||
19400094|NCT02336815|41644895|FG001|Overall Study|Physician Decision|4|||
19400095|NCT02336815|41644894|FG000|Overall Study|Withdrawal by Subject|3|||
19400096|NCT02336815|41644895|FG001|Overall Study|Withdrawal by Subject|2|||
19400097|NCT02336815|41644894|FG000|Overall Study|Lost to Follow-up|1|||
19400098|NCT02336815|41644895|FG001|Overall Study|Lost to Follow-up|3|||
19400099|NCT02336815|41644894|FG000|Overall Study|Other|1|||
19400100|NCT02336815|41644895|FG001|Overall Study|Other|5|||
19400101|NCT02543203|41644905|FG000|Overall Study|Unpalatable Fragrance|2|||
19400102|NCT02543203|41644906|FG001|Overall Study|Unpalatable Fragrance|2|||
19400103|NCT02543203|41644905|FG000|Overall Study|Lost to Follow-up|1|||
19400104|NCT02543203|41644906|FG001|Overall Study|Lost to Follow-up|0|||
19400105|NCT02543203|41644905|FG000|Overall Study|Increased Irritability|1|||
19400106|NCT02543203|41644906|FG001|Overall Study|Increased Irritability|0|||
19400107|NCT02543203|41644905|FG000|Overall Study|Family|1|||
19400108|NCT02543203|41644906|FG001|Overall Study|Family|2|||
19400109|NCT02543203|41644905|FG000|Overall Study|Negative Behavior|1|||
19400110|NCT02543203|41644906|FG001|Overall Study|Negative Behavior|0|||
19400111|NCT02543203|41644905|FG000|Overall Study|Withdrawal by Subject|0|||
19400112|NCT02543203|41644906|FG001|Overall Study|Withdrawal by Subject|1|||
19400113|NCT02546323|41644922|FG000|Overall Study|Withdrawal by Subject|36|||
19400114|NCT02546323|41644923|FG001|Overall Study|Withdrawal by Subject|33|||
19400115|NCT02546323|41644922|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
19400116|NCT02546323|41644923|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
19400117|NCT02546323|41644922|FG000|Overall Study|Adverse Event|17|||
19400118|NCT02546323|41644923|FG001|Overall Study|Adverse Event|11|||
19400119|NCT02546323|41644922|FG000|Overall Study|Patient Specific Reasons|1|||
19400120|NCT02546323|41644923|FG001|Overall Study|Patient Specific Reasons|2|||
19400121|NCT02546323|41644922|FG000|Overall Study|Lost to Follow-up|2|||
19400122|NCT02546323|41644923|FG001|Overall Study|Lost to Follow-up|3|||
19400123|NCT02546323|41644922|FG000|Overall Study|Non-compliance with Study Drug|2|||
19400124|NCT02546323|41644923|FG001|Overall Study|Non-compliance with Study Drug|2|||
19400125|NCT02546323|41644922|FG000|Overall Study|Met Withdrawal Criteria|2|||
19400126|NCT02546323|41644923|FG001|Overall Study|Met Withdrawal Criteria|14|||
19400127|NCT02545933|41644932|FG000|Overall Study|Adverse Event|3|||
19400128|NCT02545933|41644933|FG001|Overall Study|Adverse Event|0|||
19400129|NCT02545933|41644934|FG002|Overall Study|Adverse Event|0|||
19400130|NCT02545933|41644932|FG000|Overall Study|Withdrawal by Subject|2|||
19400131|NCT02545933|41644933|FG001|Overall Study|Withdrawal by Subject|3|||
19400132|NCT02545933|41644934|FG002|Overall Study|Withdrawal by Subject|3|||
19400133|NCT02545933|41644932|FG000|Overall Study|Protocol Violation|1|||
19400134|NCT02545933|41644933|FG001|Overall Study|Protocol Violation|0|||
19400135|NCT02545933|41644934|FG002|Overall Study|Protocol Violation|1|||
19400136|NCT01661179|41644942|FG000|Overall Study|Death|1|||
19400137|NCT01661179|41644942|FG000|Overall Study|Withdrawal by Subject|1|||
19400138|NCT01661179|41644942|FG000|Overall Study|Other Eligibility criteria|4|||
19400139|NCT02545543|41644948|FG000|Overall Study|Lost to Follow-up|67|||
19400140|NCT02545543|41644949|FG001|Overall Study|Lost to Follow-up|25|||
19400141|NCT02545543|41644948|FG000|Overall Study|Physician Decision|3|||
19400142|NCT02545543|41644949|FG001|Overall Study|Physician Decision|0|||
19400143|NCT02545543|41644948|FG000|Overall Study|Withdrawal by Subject|9|||
19400144|NCT02545543|41644949|FG001|Overall Study|Withdrawal by Subject|8|||
19400145|NCT02545543|41644948|FG000|Overall Study|Noncomplaince|1|||
19400146|NCT02545543|41644949|FG001|Overall Study|Noncomplaince|0|||
19400147|NCT02545543|41644948|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
19400148|NCT02545543|41644949|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
19400149|NCT02542267|41644957|FG000|Overall Study|Withdrawal by Subject|10|||
19400150|NCT02542267|41644957|FG000|Overall Study|Physician Decision|6|||
19518037|NCT01547598|41930999|FG000|Overall Study|Withdrew consent|1|||
19518038|NCT01547598|41931000|FG001|Overall Study|Withdrew consent|1|||
19400151|NCT02542267|41644957|FG000|Overall Study|Lost to Follow-up|4|||
19400152|NCT02542267|41644957|FG000|Overall Study|Death|13|||
19400153|NCT02542267|41644957|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
19400154|NCT02542267|41644957|FG000|Overall Study|Other|9|||
19400155|NCT02545075|41644963|FG000|Randomization|Lost to Follow-up|0|||
19400156|NCT02545075|41644964|FG001|Randomization|Lost to Follow-up|1|||
19400157|NCT02545075|41644963|FG000|Randomization|Withdrawal by Subject|0|||
19400158|NCT02545075|41644964|FG001|Randomization|Withdrawal by Subject|6|||
19400159|NCT02545075|41644963|FG000|Treatment|Disease progression|71|||
19400160|NCT02545075|41644964|FG001|Treatment|Disease progression|32|||
19400161|NCT02545075|41644963|FG000|Treatment|Participant dicontinued study treatment|7|||
19400162|NCT02545075|41644964|FG001|Treatment|Participant dicontinued study treatment|9|||
19400163|NCT02545075|41644963|FG000|Treatment|Withdrawal by Subject|1|||
19400164|NCT02545075|41644964|FG001|Treatment|Withdrawal by Subject|0|||
19400165|NCT02545075|41644963|FG000|Treatment|Adverse event not related to study drug|1|||
19400166|NCT02545075|41644964|FG001|Treatment|Adverse event not related to study drug|0|||
19400167|NCT02545075|41644963|FG000|Treatment|Death|1|||
19400168|NCT02545075|41644964|FG001|Treatment|Death|0|||
19400169|NCT02545075|41644963|FG000|Treatment|Participant drug toxicity|1|||
19400170|NCT02545075|41644964|FG001|Treatment|Participant drug toxicity|0|||
19400171|NCT02545075|41644963|FG000|Treatment|Completed treatment|40|||
19400172|NCT02545075|41644964|FG001|Treatment|Completed treatment|12|||
19400173|NCT03004183|41644979|FG000|Overall Study|Adverse Event|7|||
19400174|NCT03004183|41644979|FG000|Overall Study|Lost to Follow-up|1|||
19400175|NCT03004183|41644979|FG000|Overall Study|Physician Decision|40|||
19400176|NCT03004183|41644979|FG000|Overall Study|Withdrawal by Subject|1|||
19400177|NCT03004183|41644979|FG000|Overall Study|COVID-19|1|||
19400178|NCT02544763|41644986|FG000|Overall Study|Adverse Event|8|||
19400179|NCT02544763|41644987|FG001|Overall Study|Adverse Event|8|||
19400180|NCT02544763|41644988|FG002|Overall Study|Adverse Event|0|||
19400181|NCT02544763|41644986|FG000|Overall Study|Withdrawn by parent/guardian|1|||
19400182|NCT02544763|41644987|FG001|Overall Study|Withdrawn by parent/guardian|1|||
19400183|NCT02544763|41644988|FG002|Overall Study|Withdrawn by parent/guardian|1|||
19400184|NCT02544763|41644986|FG000|Overall Study|Met withdrawal criteria|0|||
19400185|NCT02544763|41644987|FG001|Overall Study|Met withdrawal criteria|2|||
19400186|NCT02544763|41644988|FG002|Overall Study|Met withdrawal criteria|0|||
19400187|NCT02544763|41644986|FG000|Overall Study|Physician Decision|0|||
19400188|NCT02544763|41644987|FG001|Overall Study|Physician Decision|1|||
19400189|NCT02544763|41644988|FG002|Overall Study|Physician Decision|0|||
19400190|NCT02544763|41644986|FG000|Overall Study|Difficulties taking IMP|1|||
19400191|NCT02544763|41644987|FG001|Overall Study|Difficulties taking IMP|0|||
19400192|NCT02544763|41644988|FG002|Overall Study|Difficulties taking IMP|0|||
19400193|NCT02556203|41644998|FG000|Overall Study|Withdrawal by Subject|21|||
19400194|NCT02556203|41644999|FG001|Overall Study|Withdrawal by Subject|21|||
19400195|NCT02556203|41644998|FG000|Overall Study|Lost to Follow-up|5|||
19400196|NCT02556203|41644999|FG001|Overall Study|Lost to Follow-up|5|||
19400197|NCT02556203|41644998|FG000|Overall Study|Adverse Event|1|||
19400198|NCT02556203|41644999|FG001|Overall Study|Adverse Event|0|||
19400199|NCT02558231|41645016|FG000|Overall Study|Death|4|||
19400200|NCT02558231|41645017|FG001|Overall Study|Death|12|||
19400201|NCT02558231|41645016|FG000|Overall Study|Lost to Follow-up|7|||
19400202|NCT02558231|41645017|FG001|Overall Study|Lost to Follow-up|4|||
19400203|NCT02558231|41645016|FG000|Overall Study|Withdrawal by Subject|7|||
19400204|NCT02558231|41645017|FG001|Overall Study|Withdrawal by Subject|4|||
19400205|NCT02558231|41645016|FG000|Overall Study|Physician Decision|7|||
19400206|NCT02558231|41645017|FG001|Overall Study|Physician Decision|5|||
19400207|NCT02558231|41645016|FG000|Overall Study|Sponsor Decision|0|||
19400208|NCT02558231|41645017|FG001|Overall Study|Sponsor Decision|1|||
19400209|NCT02554877|41645027|FG000|Overall Study|Adverse Event|2|||
19400210|NCT02554877|41645028|FG001|Overall Study|Adverse Event|0|||
19400211|NCT02554877|41645029|FG002|Overall Study|Adverse Event|0|||
19400212|NCT02554877|41645030|FG003|Overall Study|Adverse Event|1|||
19400213|NCT02554877|41645027|FG000|Overall Study|Lost to Follow-up|1|||
19400214|NCT02554877|41645028|FG001|Overall Study|Lost to Follow-up|1|||
19400215|NCT02554877|41645029|FG002|Overall Study|Lost to Follow-up|1|||
19400216|NCT02554877|41645030|FG003|Overall Study|Lost to Follow-up|2|||
19400217|NCT02554877|41645027|FG000|Overall Study|Did not meet entrance criteria|0|||
19400218|NCT02554877|41645028|FG001|Overall Study|Did not meet entrance criteria|0|||
19400219|NCT02554877|41645029|FG002|Overall Study|Did not meet entrance criteria|1|||
19400220|NCT02554877|41645030|FG003|Overall Study|Did not meet entrance criteria|0|||
19400221|NCT02554877|41645027|FG000|Overall Study|No longer met eligibility criteria|1|||
19400222|NCT02554877|41645028|FG001|Overall Study|No longer met eligibility criteria|0|||
19400223|NCT02554877|41645029|FG002|Overall Study|No longer met eligibility criteria|1|||
19400224|NCT02554877|41645030|FG003|Overall Study|No longer met eligibility criteria|1|||
19400225|NCT02554877|41645027|FG000|Overall Study|Protocol Violation|3|||
19400226|NCT02554877|41645028|FG001|Overall Study|Protocol Violation|1|||
19400227|NCT02554877|41645029|FG002|Overall Study|Protocol Violation|1|||
19400228|NCT02554877|41645030|FG003|Overall Study|Protocol Violation|0|||
19400229|NCT02554877|41645027|FG000|Overall Study|Other|1|||
19400230|NCT02554877|41645028|FG001|Overall Study|Other|3|||
19400231|NCT02554877|41645029|FG002|Overall Study|Other|0|||
19400232|NCT02554877|41645030|FG003|Overall Study|Other|3|||
19400233|NCT02554877|41645027|FG000|Overall Study|Insufficient clinical response|4|||
19400234|NCT02554877|41645028|FG001|Overall Study|Insufficient clinical response|0|||
19400235|NCT02554877|41645029|FG002|Overall Study|Insufficient clinical response|0|||
19400236|NCT02554877|41645030|FG003|Overall Study|Insufficient clinical response|0|||
19400237|NCT02554877|41645027|FG000|Overall Study|No longer willing to participate|0|||
19400238|NCT02554877|41645028|FG001|Overall Study|No longer willing to participate|2|||
19400239|NCT02554877|41645029|FG002|Overall Study|No longer willing to participate|2|||
19400240|NCT02554877|41645030|FG003|Overall Study|No longer willing to participate|0|||
19400241|NCT02554721|41645045|FG000|Overall Study|Adverse Event|1|||
19400242|NCT02554721|41645046|FG001|Overall Study|Adverse Event|0|||
19400243|NCT02554721|41645047|FG002|Overall Study|Adverse Event|0|||
19400244|NCT02554721|41645048|FG003|Overall Study|Adverse Event|0|||
19400245|NCT02554721|41645049|FG004|Overall Study|Adverse Event|1|||
19400246|NCT02554721|41645045|FG000|Overall Study|Noncompliance|0|||
19400247|NCT02554721|41645046|FG001|Overall Study|Noncompliance|0|||
19400248|NCT02554721|41645047|FG002|Overall Study|Noncompliance|0|||
19400249|NCT02554721|41645048|FG003|Overall Study|Noncompliance|0|||
19400250|NCT02554721|41645049|FG004|Overall Study|Noncompliance|1|||
19400251|NCT02552225|41645060|FG000|Overall Study|Withdrawal by Subject|1|||
19400252|NCT02552225|41645061|FG001|Overall Study|Withdrawal by Subject|0|||
19400253|NCT02552147|41645067|FG000|First Intervention (7 Days)|Protocol Violation|1|||
19400254|NCT02552147|41645068|FG001|First Intervention (7 Days)|Protocol Violation|0|||
19400255|NCT02552147|41645067|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
19400256|NCT02552147|41645068|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
19400257|NCT01662635|41645074|FG000|Overall Study|scarce samples for evaluation|30|||
19400258|NCT02534935|41645083|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
19400259|NCT02534935|41645084|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
19400260|NCT02534935|41645085|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
19400261|NCT02534935|41645083|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
19400262|NCT02534935|41645084|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
19400263|NCT02534935|41645085|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
19400264|NCT02534935|41645083|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
19400265|NCT02534935|41645084|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
19400266|NCT02534935|41645085|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
19400267|NCT02534935|41645083|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
19400268|NCT02534935|41645084|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
19400269|NCT02534935|41645085|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
19400270|NCT02534935|41645083|FG000|Stage 1: 24 Months|Adverse Event|0|||
19400271|NCT02534935|41645084|FG001|Stage 1: 24 Months|Adverse Event|2|||
19400272|NCT02534935|41645085|FG002|Stage 1: 24 Months|Adverse Event|0|||
19400273|NCT02534935|41645083|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
19400274|NCT02534935|41645084|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
19400275|NCT02534935|41645085|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
19400276|NCT02534935|41645083|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
19400277|NCT02534935|41645084|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
19400278|NCT02534935|41645085|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
19400279|NCT02544451|41645114|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
19400280|NCT02544451|41645115|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
19400281|NCT02544451|41645116|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
19400282|NCT02544451|41645117|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
19400283|NCT02544451|41645114|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
19400284|NCT02544451|41645115|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
19400285|NCT02544451|41645116|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
19518039|NCT01547598|41930999|FG000|Overall Study|Lost to Follow-up|1|||
19518040|NCT01547598|41931000|FG001|Overall Study|Lost to Follow-up|1|||
19518041|NCT01547598|41930999|FG000|Overall Study|Adverse Event|1|||
19400286|NCT02544451|41645117|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
19400287|NCT02544451|41645114|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
19400288|NCT02544451|41645115|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
19400289|NCT02544451|41645116|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
19400290|NCT02544451|41645117|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
19400291|NCT02544451|41645114|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
19400292|NCT02544451|41645115|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
19400293|NCT02544451|41645116|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
19400294|NCT02544451|41645117|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
19400295|NCT02544451|41645114|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
19400296|NCT02544451|41645115|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
19400297|NCT02544451|41645116|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
19400298|NCT02544451|41645117|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
19400299|NCT02544451|41645114|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
19400300|NCT02544451|41645115|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
19400301|NCT02544451|41645116|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
19400302|NCT02544451|41645117|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
19400303|NCT02544373|41645137|FG000|Overall Study|Lost to Follow-up|5|||
19400304|NCT02544373|41645138|FG001|Overall Study|Lost to Follow-up|3|||
19400305|NCT02544373|41645137|FG000|Overall Study|Withdrawal by Subject|8|||
19400306|NCT02544373|41645138|FG001|Overall Study|Withdrawal by Subject|2|||
19400307|NCT02551991|41645150|FG000|Overall Study|Death|5|||
19400308|NCT02551991|41645151|FG001|Overall Study|Death|7|||
19400309|NCT02551991|41645152|FG002|Overall Study|Death|8|||
19400310|NCT02551991|41645153|FG003|Overall Study|Death|7|||
19400311|NCT02551991|41645154|FG004|Overall Study|Death|17|||
19400312|NCT02551991|41645150|FG000|Overall Study|Withdrawal by Subject|1|||
19400313|NCT02551991|41645151|FG001|Overall Study|Withdrawal by Subject|0|||
19400314|NCT02551991|41645152|FG002|Overall Study|Withdrawal by Subject|0|||
19400315|NCT02551991|41645153|FG003|Overall Study|Withdrawal by Subject|0|||
19400316|NCT02551991|41645154|FG004|Overall Study|Withdrawal by Subject|2|||
19400317|NCT02551991|41645150|FG000|Overall Study|Lost to Follow-up|0|||
19400318|NCT02551991|41645151|FG001|Overall Study|Lost to Follow-up|0|||
19400319|NCT02551991|41645152|FG002|Overall Study|Lost to Follow-up|1|||
19400320|NCT02551991|41645153|FG003|Overall Study|Lost to Follow-up|0|||
19400321|NCT02551991|41645154|FG004|Overall Study|Lost to Follow-up|0|||
19400322|NCT02551991|41645150|FG000|Overall Study|Sponsor Decision|1|||
19400323|NCT02551991|41645151|FG001|Overall Study|Sponsor Decision|0|||
19400324|NCT02551991|41645152|FG002|Overall Study|Sponsor Decision|1|||
19400325|NCT02551991|41645153|FG003|Overall Study|Sponsor Decision|0|||
19400326|NCT02551991|41645154|FG004|Overall Study|Sponsor Decision|5|||
19400327|NCT02551991|41645150|FG000|Overall Study|Other|0|||
19400328|NCT02551991|41645151|FG001|Overall Study|Other|0|||
19400329|NCT02551991|41645152|FG002|Overall Study|Other|0|||
19400330|NCT02551991|41645153|FG003|Overall Study|Other|0|||
19400331|NCT02551991|41645154|FG004|Overall Study|Other|1|||
19400332|NCT01661933|41645167|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
19400333|NCT01661933|41645167|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
19400334|NCT02544217|41645179|FG000|Overall Study|Withdrawal by Subject|1|||
19400335|NCT02544217|41645180|FG001|Overall Study|Withdrawal by Subject|1|||
19400336|NCT02544217|41645181|FG002|Overall Study|Withdrawal by Subject|0|||
19400337|NCT02544217|41645182|FG003|Overall Study|Withdrawal by Subject|0|||
19400338|NCT02544217|41645183|FG004|Overall Study|Withdrawal by Subject|0|||
19400339|NCT02544217|41645184|FG005|Overall Study|Withdrawal by Subject|0|||
19400340|NCT02533999|41645253|FG000|Overall Study|Lost to Follow-up|3|||
19400341|NCT02533999|41645254|FG001|Overall Study|Lost to Follow-up|5|||
19400342|NCT02533999|41645253|FG000|Overall Study|Protocol Violation|3|||
19400343|NCT02533999|41645254|FG001|Overall Study|Protocol Violation|0|||
19400344|NCT02533999|41645253|FG000|Overall Study|Adverse Event|0|||
19400345|NCT02533999|41645254|FG001|Overall Study|Adverse Event|1|||
19400346|NCT02533999|41645253|FG000|Overall Study|Randomized but intervention not received|0|||
19400347|NCT02533999|41645254|FG001|Overall Study|Randomized but intervention not received|1|||
19400348|NCT02533531|41645260|FG000|Overall Study|Device did not turn on|1|||
19400349|NCT02533453|41645264|FG000|Overall Study|Adverse Event|6|||
19400350|NCT02533453|41645264|FG000|Overall Study|Protocol Violation|1|||
19400351|NCT02533453|41645264|FG000|Overall Study|Withdrawal by Subject|2|||
19400352|NCT02533375|41645268|FG000|Overall Study|Lack of Efficacy|3|||
19400353|NCT02533375|41645268|FG000|Overall Study|Adverse Event|2|||
19400354|NCT01553149|41645274|FG000|Overall Study|Adverse Event|0|||
19400355|NCT01553149|41645275|FG001|Overall Study|Adverse Event|9|||
19400356|NCT01553149|41645274|FG000|Overall Study|Physician Decision|5|||
19400357|NCT01553149|41645275|FG001|Overall Study|Physician Decision|10|||
19518042|NCT01547598|41931000|FG001|Overall Study|Adverse Event|1|||
19400358|NCT01553149|41645274|FG000|Overall Study|Ineligible|0|||
19400359|NCT01553149|41645275|FG001|Overall Study|Ineligible|1|||
19400360|NCT02551055|41645288|FG000|Overall Study|Death|2|||
19400361|NCT02551055|41645289|FG001|Overall Study|Death|4|||
19400362|NCT02551055|41645290|FG002|Overall Study|Death|2|||
19400363|NCT02551055|41645291|FG003|Overall Study|Death|2|||
19400364|NCT02551055|41645292|FG004|Overall Study|Death|2|||
19400365|NCT02551055|41645293|FG005|Overall Study|Death|1|||
19400366|NCT02551055|41645294|FG006|Overall Study|Death|2|||
19400367|NCT02551055|41645295|FG007|Overall Study|Death|0|||
19400368|NCT02551055|41645288|FG000|Overall Study|Study Terminated by Sponsor|1|||
19400369|NCT02551055|41645289|FG001|Overall Study|Study Terminated by Sponsor|1|||
19400370|NCT02551055|41645290|FG002|Overall Study|Study Terminated by Sponsor|0|||
19400371|NCT02551055|41645291|FG003|Overall Study|Study Terminated by Sponsor|2|||
19400372|NCT02551055|41645292|FG004|Overall Study|Study Terminated by Sponsor|2|||
19400373|NCT02551055|41645293|FG005|Overall Study|Study Terminated by Sponsor|0|||
19400374|NCT02551055|41645294|FG006|Overall Study|Study Terminated by Sponsor|0|||
19400375|NCT02551055|41645295|FG007|Overall Study|Study Terminated by Sponsor|0|||
19400376|NCT02551055|41645288|FG000|Overall Study|Withdrawal by Subject|1|||
19400377|NCT02551055|41645289|FG001|Overall Study|Withdrawal by Subject|1|||
19400378|NCT02551055|41645290|FG002|Overall Study|Withdrawal by Subject|0|||
19400379|NCT02551055|41645291|FG003|Overall Study|Withdrawal by Subject|1|||
19400380|NCT02551055|41645292|FG004|Overall Study|Withdrawal by Subject|2|||
19400381|NCT02551055|41645293|FG005|Overall Study|Withdrawal by Subject|0|||
19400382|NCT02551055|41645294|FG006|Overall Study|Withdrawal by Subject|0|||
19400383|NCT02551055|41645295|FG007|Overall Study|Withdrawal by Subject|0|||
19400384|NCT02551055|41645288|FG000|Overall Study|Reason not specified|0|||
19400385|NCT02551055|41645289|FG001|Overall Study|Reason not specified|0|||
19400386|NCT02551055|41645290|FG002|Overall Study|Reason not specified|0|||
19400387|NCT02551055|41645291|FG003|Overall Study|Reason not specified|0|||
19400388|NCT02551055|41645292|FG004|Overall Study|Reason not specified|1|||
19400389|NCT02551055|41645293|FG005|Overall Study|Reason not specified|0|||
19400390|NCT02551055|41645294|FG006|Overall Study|Reason not specified|1|||
19400391|NCT02551055|41645295|FG007|Overall Study|Reason not specified|0|||
19400392|NCT02542943|41645316|FG000|Overall Study|Lost to Follow-up|1|||
19400393|NCT02542943|41645317|FG001|Overall Study|Lost to Follow-up|0|||
19400394|NCT02542943|41645318|FG002|Overall Study|Lost to Follow-up|0|||
19400395|NCT02542943|41645316|FG000|Overall Study|Withdrawal by Subject|0|||
19400396|NCT02542943|41645317|FG001|Overall Study|Withdrawal by Subject|1|||
19400397|NCT02542943|41645318|FG002|Overall Study|Withdrawal by Subject|0|||
19400398|NCT02542865|41645329|FG000|Overall Study|Identified as screen failure|1|||
19400399|NCT02542865|41645330|FG001|Overall Study|Identified as screen failure|0|||
19400400|NCT02542865|41645329|FG000|Overall Study|Withdrawal by Subject|16|||
19400401|NCT02542865|41645330|FG001|Overall Study|Withdrawal by Subject|0|||
19400402|NCT03644927|41645336|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
19400403|NCT03644927|41645337|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
19400404|NCT02542631|41645344|FG000|Overall Study|Adverse Event|1|||
19400405|NCT02542631|41645345|FG001|Overall Study|Adverse Event|1|||
19400406|NCT02542631|41645344|FG000|Overall Study|Sponsor Termination|1|||
19400407|NCT02542631|41645345|FG001|Overall Study|Sponsor Termination|0|||
19400408|NCT02542631|41645344|FG000|Overall Study|Withdrawal by Subject|11|||
19400409|NCT02542631|41645345|FG001|Overall Study|Withdrawal by Subject|16|||
19400410|NCT02542631|41645344|FG000|Overall Study|Protocol Violation|1|||
19400411|NCT02542631|41645345|FG001|Overall Study|Protocol Violation|1|||
19400412|NCT02542631|41645344|FG000|Overall Study|Physician Decision|6|||
19400413|NCT02542631|41645345|FG001|Overall Study|Physician Decision|4|||
19400414|NCT02542631|41645344|FG000|Overall Study|Lost to Follow-up|6|||
19400415|NCT02542631|41645345|FG001|Overall Study|Lost to Follow-up|5|||
19400416|NCT02542631|41645344|FG000|Overall Study|Death|1|||
19400417|NCT02542631|41645345|FG001|Overall Study|Death|2|||
19400418|NCT02542631|41645344|FG000|Overall Study|Other|2|||
19400419|NCT02542631|41645345|FG001|Overall Study|Other|1|||
19400420|NCT02542631|41645344|FG000|Overall Study|Used Prohibited Medication|2|||
19400421|NCT02542631|41645345|FG001|Overall Study|Used Prohibited Medication|1|||
19400422|NCT02549573|41645353|FG000|Overall Study|Withdrawal by Subject|0|||
19400423|NCT02549573|41645354|FG001|Overall Study|Withdrawal by Subject|2|||
19400424|NCT02549573|41645353|FG000|Overall Study|Protocol Violation|0|||
19518043|NCT01547598|41930999|FG000|Overall Study|Protocol Violation|1|||
19518044|NCT01547598|41931000|FG001|Overall Study|Protocol Violation|1|||
19518045|NCT01547598|41930999|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19400425|NCT02549573|41645354|FG001|Overall Study|Protocol Violation|1|||
19400426|NCT02542397|41645360|FG000|Overall Study|Death|2|||
19400427|NCT02542397|41645360|FG000|Overall Study|Physician Decision|6|||
19518046|NCT01547598|41931000|FG001|Overall Study|Other Miscellaneous Reasons|1|||
19400428|NCT02542397|41645360|FG000|Overall Study|Withdrawal by Subject|6|||
19400429|NCT02542397|41645360|FG000|Overall Study|Lost to Follow-up|2|||
19400430|NCT02549339|41645367|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
19400431|NCT02549339|41645368|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
19400432|NCT02549339|41645367|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
19400433|NCT02549339|41645368|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
19400434|NCT02549339|41645367|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
19400435|NCT02549339|41645368|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
19400436|NCT02549339|41645367|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
19400437|NCT02549339|41645368|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
19400438|NCT02549339|41645367|FG000|12-month Follow-up|Lack of Efficacy|0|||
19400439|NCT02549339|41645368|FG001|12-month Follow-up|Lack of Efficacy|2|||
19400440|NCT02549339|41645367|FG000|12-month Follow-up|Withdrawal by Subject|8|||
19400441|NCT02549339|41645368|FG001|12-month Follow-up|Withdrawal by Subject|3|||
19400442|NCT02549339|41645367|FG000|12-month Follow-up|Lost to Follow-up|1|||
19400443|NCT02549339|41645368|FG001|12-month Follow-up|Lost to Follow-up|3|||
19400444|NCT02549339|41645367|FG000|12-month Follow-up|Other|0|||
19400445|NCT02549339|41645368|FG001|12-month Follow-up|Other|3|||
19400446|NCT02549027|41645376|FG000|Washout After Period 4|Withdrawal by Subject|0|||
19400447|NCT02549027|41645377|FG001|Washout After Period 4|Withdrawal by Subject|1|||
19400448|NCT02549027|41645378|FG002|Washout After Period 4|Withdrawal by Subject|1|||
19400449|NCT02549027|41645379|FG003|Washout After Period 4|Withdrawal by Subject|1|||
19400450|NCT02549027|41645380|FG004|Washout After Period 4|Withdrawal by Subject|0|||
19400451|NCT02549027|41645381|FG005|Washout After Period 4|Withdrawal by Subject|0|||
19400452|NCT02549027|41645376|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
19400453|NCT02549027|41645377|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
19400454|NCT02549027|41645378|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
19400455|NCT02549027|41645379|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
19400456|NCT02549027|41645380|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
19400457|NCT02549027|41645381|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
19400458|NCT02529553|41645409|FG000|Overall Study|Progressive Disease|1|||
19400459|NCT02529553|41645410|FG001|Overall Study|Progressive Disease|0|||
19400460|NCT02529553|41645411|FG002|Overall Study|Progressive Disease|1|||
19400461|NCT02529553|41645412|FG003|Overall Study|Progressive Disease|3|||
19400462|NCT02529553|41645413|FG004|Overall Study|Progressive Disease|2|||
19400463|NCT02529553|41645414|FG005|Overall Study|Progressive Disease|3|||
19400464|NCT02529553|41645415|FG006|Overall Study|Progressive Disease|3|||
19400465|NCT02529553|41645416|FG007|Overall Study|Progressive Disease|5|||
19400466|NCT02529553|41645417|FG008|Overall Study|Progressive Disease|3|||
19400467|NCT02529553|41645409|FG000|Overall Study|Physician Decision|0|||
19400468|NCT02529553|41645410|FG001|Overall Study|Physician Decision|1|||
19400469|NCT02529553|41645411|FG002|Overall Study|Physician Decision|0|||
19400470|NCT02529553|41645412|FG003|Overall Study|Physician Decision|0|||
19400471|NCT02529553|41645413|FG004|Overall Study|Physician Decision|1|||
19400472|NCT02529553|41645414|FG005|Overall Study|Physician Decision|0|||
19400473|NCT02529553|41645415|FG006|Overall Study|Physician Decision|0|||
19400474|NCT02529553|41645416|FG007|Overall Study|Physician Decision|0|||
19400475|NCT02529553|41645417|FG008|Overall Study|Physician Decision|0|||
19400476|NCT02529553|41645409|FG000|Overall Study|Withdrawal by Subject|0|||
19400477|NCT02529553|41645410|FG001|Overall Study|Withdrawal by Subject|0|||
19400478|NCT02529553|41645411|FG002|Overall Study|Withdrawal by Subject|0|||
19400479|NCT02529553|41645412|FG003|Overall Study|Withdrawal by Subject|0|||
19400480|NCT02529553|41645413|FG004|Overall Study|Withdrawal by Subject|0|||
19400481|NCT02529553|41645414|FG005|Overall Study|Withdrawal by Subject|1|||
19400482|NCT02529553|41645415|FG006|Overall Study|Withdrawal by Subject|0|||
19400483|NCT02529553|41645416|FG007|Overall Study|Withdrawal by Subject|1|||
19400484|NCT02529553|41645417|FG008|Overall Study|Withdrawal by Subject|0|||
19400485|NCT02547935|41645441|FG000|Overall Study|Other|0|||
19400486|NCT02547935|41645442|FG001|Overall Study|Other|1|||
19400487|NCT02547935|41645443|FG002|Overall Study|Other|0|||
19400488|NCT02547935|41645441|FG000|Overall Study|Withdrawal by Subject|2|||
19400489|NCT02547935|41645442|FG001|Overall Study|Withdrawal by Subject|3|||
19400490|NCT02547935|41645443|FG002|Overall Study|Withdrawal by Subject|4|||
19400491|NCT02547935|41645441|FG000|Overall Study|Screen Failure|2|||
19400492|NCT02547935|41645442|FG001|Overall Study|Screen Failure|0|||
19400493|NCT02547935|41645443|FG002|Overall Study|Screen Failure|0|||
19400494|NCT02547935|41645441|FG000|Overall Study|Physician Decision|0|||
19400495|NCT02547935|41645442|FG001|Overall Study|Physician Decision|1|||
19400496|NCT02547935|41645443|FG002|Overall Study|Physician Decision|0|||
19400497|NCT02547935|41645441|FG000|Overall Study|Lost to Follow-up|0|||
19400498|NCT02547935|41645442|FG001|Overall Study|Lost to Follow-up|2|||
19400499|NCT02547935|41645443|FG002|Overall Study|Lost to Follow-up|1|||
19400500|NCT02547935|41645441|FG000|Overall Study|Death|1|||
19400501|NCT02547935|41645442|FG001|Overall Study|Death|1|||
19400502|NCT02547935|41645443|FG002|Overall Study|Death|0|||
19400503|NCT02554019|41645456|FG000|Overall Study|Withdrawal by Subject|1|||
19400504|NCT02554019|41645457|FG001|Overall Study|Withdrawal by Subject|0|||
19400505|NCT02554019|41645458|FG002|Overall Study|Withdrawal by Subject|2|||
19400506|NCT02554019|41645456|FG000|Overall Study|Adverse Event|1|||
19400507|NCT02554019|41645457|FG001|Overall Study|Adverse Event|0|||
19400508|NCT02554019|41645458|FG002|Overall Study|Adverse Event|0|||
19400509|NCT02327169|41645481|FG000|Overall Study|Progressive Disease|1|||
19400510|NCT02327169|41645482|FG001|Overall Study|Progressive Disease|3|||
19400511|NCT02327169|41645483|FG002|Overall Study|Progressive Disease|4|||
19400512|NCT02327169|41645484|FG003|Overall Study|Progressive Disease|3|||
19400513|NCT02327169|41645485|FG004|Overall Study|Progressive Disease|4|||
19400514|NCT02327169|41645486|FG005|Overall Study|Progressive Disease|3|||
19400515|NCT02327169|41645487|FG006|Overall Study|Progressive Disease|3|||
19400516|NCT02327169|41645488|FG007|Overall Study|Progressive Disease|3|||
19400517|NCT02327169|41645489|FG008|Overall Study|Progressive Disease|4|||
19400518|NCT02327169|41645490|FG009|Overall Study|Progressive Disease|4|||
19400519|NCT02327169|41645491|FG010|Overall Study|Progressive Disease|4|||
19400520|NCT02327169|41645492|FG011|Overall Study|Progressive Disease|3|||
19400521|NCT02327169|41645493|FG012|Overall Study|Progressive Disease|1|||
19400522|NCT02327169|41645494|FG013|Overall Study|Progressive Disease|3|||
19400523|NCT02327169|41645495|FG014|Overall Study|Progressive Disease|3|||
19400524|NCT02327169|41645481|FG000|Overall Study|Adverse Event|2|||
19400525|NCT02327169|41645482|FG001|Overall Study|Adverse Event|0|||
19400526|NCT02327169|41645483|FG002|Overall Study|Adverse Event|1|||
19400527|NCT02327169|41645484|FG003|Overall Study|Adverse Event|0|||
19400528|NCT02327169|41645485|FG004|Overall Study|Adverse Event|1|||
19400529|NCT02327169|41645486|FG005|Overall Study|Adverse Event|0|||
19400530|NCT02327169|41645487|FG006|Overall Study|Adverse Event|0|||
19400531|NCT02327169|41645488|FG007|Overall Study|Adverse Event|0|||
19400532|NCT02327169|41645489|FG008|Overall Study|Adverse Event|0|||
19400533|NCT02327169|41645490|FG009|Overall Study|Adverse Event|2|||
19400534|NCT02327169|41645491|FG010|Overall Study|Adverse Event|0|||
19400535|NCT02327169|41645492|FG011|Overall Study|Adverse Event|3|||
19400536|NCT02327169|41645493|FG012|Overall Study|Adverse Event|0|||
19400537|NCT02327169|41645494|FG013|Overall Study|Adverse Event|2|||
19400538|NCT02327169|41645495|FG014|Overall Study|Adverse Event|1|||
19400539|NCT02327169|41645481|FG000|Overall Study|Symptomatic Deterioration|0|||
19400540|NCT02327169|41645482|FG001|Overall Study|Symptomatic Deterioration|0|||
19400541|NCT02327169|41645483|FG002|Overall Study|Symptomatic Deterioration|1|||
19400542|NCT02327169|41645484|FG003|Overall Study|Symptomatic Deterioration|0|||
19400543|NCT02327169|41645485|FG004|Overall Study|Symptomatic Deterioration|1|||
19400544|NCT02327169|41645486|FG005|Overall Study|Symptomatic Deterioration|1|||
19400545|NCT02327169|41645487|FG006|Overall Study|Symptomatic Deterioration|0|||
19400546|NCT02327169|41645488|FG007|Overall Study|Symptomatic Deterioration|0|||
19400547|NCT02327169|41645489|FG008|Overall Study|Symptomatic Deterioration|2|||
19400548|NCT02327169|41645490|FG009|Overall Study|Symptomatic Deterioration|1|||
19400549|NCT02327169|41645491|FG010|Overall Study|Symptomatic Deterioration|0|||
19400550|NCT02327169|41645492|FG011|Overall Study|Symptomatic Deterioration|0|||
19400551|NCT02327169|41645493|FG012|Overall Study|Symptomatic Deterioration|0|||
19400552|NCT02327169|41645494|FG013|Overall Study|Symptomatic Deterioration|2|||
19400553|NCT02327169|41645495|FG014|Overall Study|Symptomatic Deterioration|1|||
19400554|NCT02327169|41645481|FG000|Overall Study|Reason Not Specified|0|||
19400555|NCT02327169|41645482|FG001|Overall Study|Reason Not Specified|0|||
19400556|NCT02327169|41645483|FG002|Overall Study|Reason Not Specified|1|||
19400557|NCT02327169|41645484|FG003|Overall Study|Reason Not Specified|0|||
19400558|NCT02327169|41645485|FG004|Overall Study|Reason Not Specified|0|||
19400559|NCT02327169|41645486|FG005|Overall Study|Reason Not Specified|0|||
19400560|NCT02327169|41645487|FG006|Overall Study|Reason Not Specified|0|||
19400561|NCT02327169|41645488|FG007|Overall Study|Reason Not Specified|0|||
19400562|NCT02327169|41645489|FG008|Overall Study|Reason Not Specified|0|||
19400563|NCT02327169|41645490|FG009|Overall Study|Reason Not Specified|1|||
19400564|NCT02327169|41645491|FG010|Overall Study|Reason Not Specified|2|||
19400565|NCT02327169|41645492|FG011|Overall Study|Reason Not Specified|1|||
19400566|NCT02327169|41645493|FG012|Overall Study|Reason Not Specified|0|||
19400567|NCT02327169|41645494|FG013|Overall Study|Reason Not Specified|0|||
19400568|NCT02327169|41645495|FG014|Overall Study|Reason Not Specified|2|||
19400569|NCT02327169|41645481|FG000|Overall Study|Withdrawal by Subject|1|||
19400570|NCT02327169|41645482|FG001|Overall Study|Withdrawal by Subject|0|||
19400571|NCT02327169|41645483|FG002|Overall Study|Withdrawal by Subject|0|||
19400572|NCT02327169|41645484|FG003|Overall Study|Withdrawal by Subject|0|||
19400573|NCT02327169|41645485|FG004|Overall Study|Withdrawal by Subject|1|||
19400574|NCT02327169|41645486|FG005|Overall Study|Withdrawal by Subject|0|||
19400575|NCT02327169|41645487|FG006|Overall Study|Withdrawal by Subject|0|||
19400576|NCT02327169|41645488|FG007|Overall Study|Withdrawal by Subject|1|||
19400577|NCT02327169|41645489|FG008|Overall Study|Withdrawal by Subject|0|||
19400578|NCT02327169|41645490|FG009|Overall Study|Withdrawal by Subject|0|||
19400579|NCT02327169|41645491|FG010|Overall Study|Withdrawal by Subject|0|||
19400580|NCT02327169|41645492|FG011|Overall Study|Withdrawal by Subject|0|||
19400581|NCT02327169|41645493|FG012|Overall Study|Withdrawal by Subject|0|||
19400582|NCT02327169|41645494|FG013|Overall Study|Withdrawal by Subject|0|||
19400583|NCT02327169|41645495|FG014|Overall Study|Withdrawal by Subject|3|||
19400584|NCT02327169|41645481|FG000|Overall Study|Lost to Follow-up|0|||
19400585|NCT02327169|41645482|FG001|Overall Study|Lost to Follow-up|0|||
19400586|NCT02327169|41645483|FG002|Overall Study|Lost to Follow-up|0|||
19400587|NCT02327169|41645484|FG003|Overall Study|Lost to Follow-up|0|||
19400588|NCT02327169|41645485|FG004|Overall Study|Lost to Follow-up|1|||
19400589|NCT02327169|41645486|FG005|Overall Study|Lost to Follow-up|0|||
19400590|NCT02327169|41645487|FG006|Overall Study|Lost to Follow-up|0|||
19400591|NCT02327169|41645488|FG007|Overall Study|Lost to Follow-up|0|||
19400592|NCT02327169|41645489|FG008|Overall Study|Lost to Follow-up|0|||
19400593|NCT02327169|41645490|FG009|Overall Study|Lost to Follow-up|0|||
19400594|NCT02327169|41645491|FG010|Overall Study|Lost to Follow-up|0|||
19400595|NCT02327169|41645492|FG011|Overall Study|Lost to Follow-up|0|||
19400596|NCT02327169|41645493|FG012|Overall Study|Lost to Follow-up|0|||
19400597|NCT02327169|41645494|FG013|Overall Study|Lost to Follow-up|0|||
19400598|NCT02327169|41645495|FG014|Overall Study|Lost to Follow-up|0|||
19400599|NCT02327013|41645540|FG000|Overall Study|Adverse Event|4|||
19400600|NCT02327013|41645541|FG001|Overall Study|Adverse Event|4|||
19400601|NCT02327013|41645542|FG002|Overall Study|Adverse Event|3|||
19400602|NCT02327013|41645543|FG003|Overall Study|Adverse Event|0|||
19400603|NCT02327013|41645544|FG004|Overall Study|Adverse Event|1|||
19400604|NCT02327013|41645540|FG000|Overall Study|Lack of Efficacy|2|||
19400605|NCT02327013|41645541|FG001|Overall Study|Lack of Efficacy|0|||
19400606|NCT02327013|41645542|FG002|Overall Study|Lack of Efficacy|5|||
19400607|NCT02327013|41645543|FG003|Overall Study|Lack of Efficacy|0|||
19400608|NCT02327013|41645544|FG004|Overall Study|Lack of Efficacy|1|||
19400609|NCT02327013|41645540|FG000|Overall Study|Non-compliance with IMP|1|||
19400610|NCT02327013|41645541|FG001|Overall Study|Non-compliance with IMP|2|||
19400611|NCT02327013|41645542|FG002|Overall Study|Non-compliance with IMP|7|||
19400612|NCT02327013|41645543|FG003|Overall Study|Non-compliance with IMP|0|||
19400613|NCT02327013|41645544|FG004|Overall Study|Non-compliance with IMP|0|||
19518047|NCT01547286|41931007|FG000|Overall Study|Did not meet all eligibility criteria|1|||
19518048|NCT01547286|41931007|FG000|Overall Study|Physician Decision|1|||
19518049|NCT01547130|41931014|FG000|Overall Study|Lost to Follow-up|9|||
19518050|NCT01547130|41931015|FG001|Overall Study|Lost to Follow-up|5|||
19518051|NCT01524978|41931040|FG000|Overall Study|Other|16|||
19518052|NCT01524978|41931041|FG001|Overall Study|Other|2|||
19518053|NCT01524978|41931042|FG002|Overall Study|Other|1|||
19518054|NCT01524978|41931043|FG003|Overall Study|Other|2|||
19518055|NCT01524978|41931044|FG004|Overall Study|Other|1|||
19518056|NCT01524978|41931045|FG005|Overall Study|Other|3|||
19518057|NCT01524978|41931046|FG006|Overall Study|Other|17|||
19518058|NCT01524978|41931047|FG007|Overall Study|Other|1|||
19518059|NCT01524978|41931048|FG008|Overall Study|Other|2|||
19518060|NCT01524978|41931049|FG009|Overall Study|Other|2|||
19518061|NCT01524978|41931050|FG010|Overall Study|Other|5|||
19518062|NCT01524978|41931040|FG000|Overall Study|Withdrawal by Subject|12|||
19518063|NCT01524978|41931041|FG001|Overall Study|Withdrawal by Subject|0|||
19518064|NCT01524978|41931042|FG002|Overall Study|Withdrawal by Subject|1|||
19518065|NCT01524978|41931043|FG003|Overall Study|Withdrawal by Subject|1|||
19518066|NCT01524978|41931044|FG004|Overall Study|Withdrawal by Subject|3|||
19518067|NCT01524978|41931045|FG005|Overall Study|Withdrawal by Subject|1|||
19518068|NCT01524978|41931046|FG006|Overall Study|Withdrawal by Subject|6|||
19518069|NCT01524978|41931047|FG007|Overall Study|Withdrawal by Subject|2|||
19518070|NCT01524978|41931048|FG008|Overall Study|Withdrawal by Subject|4|||
19518071|NCT01524978|41931049|FG009|Overall Study|Withdrawal by Subject|0|||
19518072|NCT01524978|41931050|FG010|Overall Study|Withdrawal by Subject|5|||
19518073|NCT01524978|41931040|FG000|Overall Study|Lost to Follow-up|0|||
19518074|NCT01524978|41931041|FG001|Overall Study|Lost to Follow-up|0|||
19518075|NCT01524978|41931042|FG002|Overall Study|Lost to Follow-up|3|||
19518076|NCT01524978|41931043|FG003|Overall Study|Lost to Follow-up|0|||
19518077|NCT01524978|41931044|FG004|Overall Study|Lost to Follow-up|1|||
19627933|NCT00817778|42077345|FG000|Overall Study|Adverse Event|1|||
19627934|NCT00817778|42077346|FG001|Overall Study|Adverse Event|0|||
19400614|NCT02327013|41645540|FG000|Overall Study|Withdrawal of Consent|1|||
19400615|NCT02327013|41645541|FG001|Overall Study|Withdrawal of Consent|0|||
19400616|NCT02327013|41645542|FG002|Overall Study|Withdrawal of Consent|3|||
19400617|NCT02327013|41645543|FG003|Overall Study|Withdrawal of Consent|0|||
19400618|NCT02327013|41645544|FG004|Overall Study|Withdrawal of Consent|0|||
19400619|NCT02327013|41645540|FG000|Overall Study|Lost to Follow-up|2|||
19400620|NCT02327013|41645541|FG001|Overall Study|Lost to Follow-up|4|||
19400621|NCT02327013|41645542|FG002|Overall Study|Lost to Follow-up|5|||
19400622|NCT02327013|41645543|FG003|Overall Study|Lost to Follow-up|0|||
19518078|NCT01524978|41931045|FG005|Overall Study|Lost to Follow-up|1|||
19518079|NCT01524978|41931046|FG006|Overall Study|Lost to Follow-up|2|||
19518080|NCT01524978|41931047|FG007|Overall Study|Lost to Follow-up|0|||
19518081|NCT01524978|41931048|FG008|Overall Study|Lost to Follow-up|1|||
19518082|NCT01524978|41931049|FG009|Overall Study|Lost to Follow-up|1|||
19518083|NCT01524978|41931050|FG010|Overall Study|Lost to Follow-up|1|||
19400623|NCT02327013|41645544|FG004|Overall Study|Lost to Follow-up|0|||
19400624|NCT02327013|41645540|FG000|Overall Study|Administrative or other reason(s)|1|||
19400625|NCT02327013|41645541|FG001|Overall Study|Administrative or other reason(s)|5|||
19400626|NCT02327013|41645542|FG002|Overall Study|Administrative or other reason(s)|11|||
19400627|NCT02327013|41645543|FG003|Overall Study|Administrative or other reason(s)|1|||
19400628|NCT02327013|41645544|FG004|Overall Study|Administrative or other reason(s)|1|||
19400629|NCT02327013|41645540|FG000|Overall Study|Protocol Violation|0|||
19400630|NCT02327013|41645541|FG001|Overall Study|Protocol Violation|0|||
19400631|NCT02327013|41645542|FG002|Overall Study|Protocol Violation|3|||
19400632|NCT02327013|41645543|FG003|Overall Study|Protocol Violation|0|||
19400633|NCT02327013|41645544|FG004|Overall Study|Protocol Violation|1|||
19400634|NCT02327013|41645540|FG000|Overall Study|Withdrawal before treatment|2|||
19400635|NCT02327013|41645541|FG001|Overall Study|Withdrawal before treatment|1|||
19400636|NCT02327013|41645542|FG002|Overall Study|Withdrawal before treatment|5|||
19400637|NCT02327013|41645543|FG003|Overall Study|Withdrawal before treatment|0|||
19400638|NCT02327013|41645544|FG004|Overall Study|Withdrawal before treatment|0|||
19400639|NCT02301975|41645567|FG000|Overall Study|Adverse Event|8|||
19400640|NCT02301975|41645568|FG001|Overall Study|Adverse Event|3|||
19400641|NCT02301975|41645569|FG002|Overall Study|Adverse Event|2|||
19400642|NCT02301975|41645567|FG000|Overall Study|Lack of Efficacy|1|||
19400643|NCT02301975|41645568|FG001|Overall Study|Lack of Efficacy|1|||
19400644|NCT02301975|41645569|FG002|Overall Study|Lack of Efficacy|1|||
19400645|NCT02301975|41645567|FG000|Overall Study|Protocol Violation|3|||
19400646|NCT02301975|41645568|FG001|Overall Study|Protocol Violation|5|||
19400647|NCT02301975|41645569|FG002|Overall Study|Protocol Violation|3|||
19518084|NCT01524978|41931040|FG000|Overall Study|Death|34|||
19518085|NCT01524978|41931041|FG001|Overall Study|Death|2|||
19518086|NCT01524978|41931042|FG002|Overall Study|Death|5|||
19518087|NCT01524978|41931043|FG003|Overall Study|Death|24|||
19518088|NCT01524978|41931044|FG004|Overall Study|Death|4|||
19518089|NCT01524978|41931045|FG005|Overall Study|Death|4|||
19518090|NCT01524978|41931046|FG006|Overall Study|Death|1|||
19518091|NCT01524978|41931047|FG007|Overall Study|Death|9|||
19518092|NCT01524978|41931048|FG008|Overall Study|Death|5|||
19518093|NCT01524978|41931049|FG009|Overall Study|Death|6|||
19518094|NCT01524978|41931050|FG010|Overall Study|Death|17|||
19518095|NCT01524900|41931070|FG000|Overall Study|Lost to Follow-up|3|||
19518096|NCT01524900|41931071|FG001|Overall Study|Lost to Follow-up|12|||
19518097|NCT01524900|41931072|FG002|Overall Study|Lost to Follow-up|1|||
19518098|NCT01524900|41931073|FG003|Overall Study|Lost to Follow-up|0|||
19518099|NCT01524900|41931074|FG004|Overall Study|Lost to Follow-up|0|||
19518100|NCT01524900|41931070|FG000|Overall Study|Other reason than stated above|1|||
19518101|NCT01524900|41931071|FG001|Overall Study|Other reason than stated above|1|||
19518102|NCT01524900|41931072|FG002|Overall Study|Other reason than stated above|0|||
19518103|NCT01524900|41931073|FG003|Overall Study|Other reason than stated above|0|||
19518104|NCT01524900|41931074|FG004|Overall Study|Other reason than stated above|0|||
19518105|NCT01524900|41931070|FG000|Overall Study|No reason documented|2|||
19518106|NCT01524900|41931071|FG001|Overall Study|No reason documented|1|||
19518107|NCT01524900|41931072|FG002|Overall Study|No reason documented|0|||
19518108|NCT01524900|41931073|FG003|Overall Study|No reason documented|1|||
19518109|NCT01524900|41931074|FG004|Overall Study|No reason documented|0|||
19518110|NCT01524198|41931089|FG000|Overall Study|Protocol Violation|8|||
19518111|NCT01524198|41931090|FG001|Overall Study|Protocol Violation|6|||
19518112|NCT01524198|41931089|FG000|Overall Study|Withdrawal by Subject|15|||
19518113|NCT01524198|41931090|FG001|Overall Study|Withdrawal by Subject|10|||
19518114|NCT01523886|41931098|FG000|Overall Study|surgery cancelled|0|||
19518115|NCT01523886|41931099|FG001|Overall Study|surgery cancelled|1|||
19518116|NCT01546038|41931111|FG000|Overall Study|Death|15|||
19518117|NCT01546038|41931112|FG001|Overall Study|Death|6|||
19518118|NCT01546038|41931113|FG002|Overall Study|Death|4|||
19518119|NCT01546038|41931114|FG003|Overall Study|Death|2|||
19518120|NCT01546038|41931115|FG004|Overall Study|Death|9|||
19518121|NCT01546038|41931116|FG005|Overall Study|Death|3|||
19518122|NCT01546038|41931117|FG006|Overall Study|Death|46|||
19518123|NCT01546038|41931118|FG007|Overall Study|Death|76|||
19518124|NCT01546038|41931119|FG008|Overall Study|Death|39|||
19518125|NCT01546038|41931111|FG000|Overall Study|Lost to Follow-up|0|||
19518126|NCT01546038|41931112|FG001|Overall Study|Lost to Follow-up|0|||
19518127|NCT01546038|41931113|FG002|Overall Study|Lost to Follow-up|0|||
19518128|NCT01546038|41931114|FG003|Overall Study|Lost to Follow-up|0|||
19518129|NCT01546038|41931115|FG004|Overall Study|Lost to Follow-up|1|||
19518130|NCT01546038|41931116|FG005|Overall Study|Lost to Follow-up|0|||
19518131|NCT01546038|41931117|FG006|Overall Study|Lost to Follow-up|2|||
19400648|NCT02301975|41645567|FG000|Overall Study|Lost to Follow-up|0|||
19400649|NCT02301975|41645568|FG001|Overall Study|Lost to Follow-up|2|||
19518132|NCT01546038|41931118|FG007|Overall Study|Lost to Follow-up|1|||
19518133|NCT01546038|41931119|FG008|Overall Study|Lost to Follow-up|0|||
19518134|NCT01546038|41931111|FG000|Overall Study|Withdrawal by Subject|1|||
19518135|NCT01546038|41931112|FG001|Overall Study|Withdrawal by Subject|0|||
19518136|NCT01546038|41931113|FG002|Overall Study|Withdrawal by Subject|0|||
19400650|NCT02301975|41645569|FG002|Overall Study|Lost to Follow-up|2|||
19400651|NCT02301975|41645567|FG000|Overall Study|Physician Decision|4|||
19400652|NCT02301975|41645568|FG001|Overall Study|Physician Decision|2|||
19400653|NCT02301975|41645569|FG002|Overall Study|Physician Decision|3|||
19400654|NCT02301975|41645567|FG000|Overall Study|Withdrawal by Subject|15|||
19400655|NCT02301975|41645568|FG001|Overall Study|Withdrawal by Subject|12|||
19400656|NCT02301975|41645569|FG002|Overall Study|Withdrawal by Subject|11|||
19400657|NCT02301897|41645580|FG000|Treatment Course 1|Non-Compliance|0|||
19400658|NCT02301897|41645581|FG001|Treatment Course 1|Non-Compliance|0|||
19400659|NCT02301897|41645582|FG002|Treatment Course 1|Non-Compliance|1|||
19400660|NCT02301897|41645580|FG000|Treatment Course 1|Adverse Event|1|||
19400661|NCT02301897|41645581|FG001|Treatment Course 1|Adverse Event|1|||
19400662|NCT02301897|41645582|FG002|Treatment Course 1|Adverse Event|0|||
19400663|NCT02301897|41645580|FG000|Treatment Course 1|Lost to Follow-up|1|||
19400664|NCT02301897|41645581|FG001|Treatment Course 1|Lost to Follow-up|2|||
19400665|NCT02301897|41645582|FG002|Treatment Course 1|Lost to Follow-up|1|||
19400666|NCT02301897|41645580|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
19400667|NCT02301897|41645581|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
19400668|NCT02301897|41645582|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
19400669|NCT02301897|41645580|FG000|Treatment Course 1|Withdrawal by Subject|0|||
19400670|NCT02301897|41645581|FG001|Treatment Course 1|Withdrawal by Subject|0|||
19400671|NCT02301897|41645582|FG002|Treatment Course 1|Withdrawal by Subject|2|||
19400672|NCT02301897|41645580|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
19400673|NCT02301897|41645581|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
19400674|NCT02301897|41645582|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
19400675|NCT02301897|41645580|FG000|Treatment Course 2|Lost to Follow-up|0|||
19400676|NCT02301897|41645581|FG001|Treatment Course 2|Lost to Follow-up|2|||
19400677|NCT02301897|41645582|FG002|Treatment Course 2|Lost to Follow-up|0|||
19400678|NCT02301897|41645580|FG000|Treatment Course 2|Pregnancy|0|||
19400679|NCT02301897|41645581|FG001|Treatment Course 2|Pregnancy|1|||
19400680|NCT02301897|41645582|FG002|Treatment Course 2|Pregnancy|1|||
19400681|NCT02301897|41645580|FG000|Treatment Course 2|Withdrawal by Subject|0|||
19400682|NCT02301897|41645581|FG001|Treatment Course 2|Withdrawal by Subject|2|||
19400683|NCT02301897|41645582|FG002|Treatment Course 2|Withdrawal by Subject|0|||
19400684|NCT02301897|41645580|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
19400685|NCT02301897|41645581|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
19400686|NCT02301897|41645582|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
19400687|NCT02301429|41645590|FG000|Overall Study|not acceptable vascular anatomy|3|||
19400688|NCT02300259|41645597|FG000|Period 1|Adverse Event|0|||
19400689|NCT02300259|41645598|FG001|Period 1|Adverse Event|0|||
19400690|NCT02300259|41645599|FG002|Period 1|Adverse Event|1|||
19400691|NCT02300259|41645597|FG000|Period 1|Withdrawal by Subject|0|||
19400692|NCT02300259|41645598|FG001|Period 1|Withdrawal by Subject|0|||
19400693|NCT02300259|41645599|FG002|Period 1|Withdrawal by Subject|1|||
19400694|NCT02300259|41645597|FG000|Period 2|Adverse Event|1|||
19400695|NCT02300259|41645598|FG001|Period 2|Adverse Event|0|||
19400696|NCT02300259|41645599|FG002|Period 2|Adverse Event|0|||
19400697|NCT02300259|41645597|FG000|Period 2|Withdrawal by Subject|0|||
19400698|NCT02300259|41645598|FG001|Period 2|Withdrawal by Subject|0|||
19400699|NCT02300259|41645599|FG002|Period 2|Withdrawal by Subject|1|||
19400700|NCT02367885|41645621|FG000|Overall Study|Lost to Follow-up|1|||
19400701|NCT02367885|41645622|FG001|Overall Study|Lost to Follow-up|0|||
19400702|NCT02367885|41645623|FG002|Overall Study|Lost to Follow-up|0|||
19400703|NCT02367885|41645621|FG000|Overall Study|Withdrawal by Subject|1|||
19400704|NCT02367885|41645622|FG001|Overall Study|Withdrawal by Subject|0|||
19400705|NCT02367885|41645623|FG002|Overall Study|Withdrawal by Subject|0|||
19400706|NCT02367729|41645636|FG000|Overall Study|Organic disorder diagnosed|2|||
19400707|NCT02367729|41645637|FG001|Overall Study|Organic disorder diagnosed|1|||
19400708|NCT02367729|41645636|FG000|Overall Study|Adverse Event|1|||
19400709|NCT02367729|41645637|FG001|Overall Study|Adverse Event|2|||
19400710|NCT02367729|41645636|FG000|Overall Study|Withdrawal by Subject|0|||
19400711|NCT02367729|41645637|FG001|Overall Study|Withdrawal by Subject|5|||
19627935|NCT00817778|42077345|FG000|Overall Study|Withdrawal by Subject|1|||
19400712|NCT02366637|41645644|FG000|First Intervention Period|Adverse Event|0|||
19400713|NCT02366637|41645645|FG001|First Intervention Period|Adverse Event|1|||
19400714|NCT02366637|41645644|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
19400715|NCT02366637|41645645|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
19400716|NCT02366637|41645644|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
19400717|NCT02366637|41645645|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
19400718|NCT02300103|41645651|FG000|Overall Study|Lack of Efficacy|3|||
19400719|NCT02300103|41645651|FG000|Overall Study|Protocol Violation|1|||
19400720|NCT02300103|41645651|FG000|Overall Study|Withdrew Consent|2|||
19400721|NCT02326467|41645655|FG000|Overall Study|Withdrawal by Subject|1|||
19400722|NCT02299635|41645660|FG000|Overall Study|Adverse Event|2|||
19400723|NCT02299635|41645660|FG000|Overall Study|Death|1|||
19400724|NCT02299635|41645660|FG000|Overall Study|Global deterioration of health status|1|||
19400725|NCT02299635|41645660|FG000|Overall Study|Objective progression or relapse|10|||
19400726|NCT02299635|41645660|FG000|Overall Study|Withdrawal by Subject|2|||
19400727|NCT02299635|41645660|FG000|Overall Study|Other|3|||
19400728|NCT02366091|41645668|FG000|Overall Study|Withdrawal by Subject|3|||
19400729|NCT02366091|41645669|FG001|Overall Study|Withdrawal by Subject|7|||
19400730|NCT02366091|41645670|FG002|Overall Study|Withdrawal by Subject|3|||
19400731|NCT02366091|41645671|FG003|Overall Study|Withdrawal by Subject|1|||
19400732|NCT02326155|41645683|FG000|Overall Study|Adverse Event|21|||
19400733|NCT02326155|41645684|FG001|Overall Study|Adverse Event|5|||
19400734|NCT02326155|41645683|FG000|Overall Study|Death|3|||
19400735|NCT02326155|41645684|FG001|Overall Study|Death|0|||
19400736|NCT02326155|41645683|FG000|Overall Study|Lack of Efficacy|49|||
19400737|NCT02326155|41645684|FG001|Overall Study|Lack of Efficacy|5|||
19400738|NCT02326155|41645683|FG000|Overall Study|Lost to Follow-up|14|||
19400739|NCT02326155|41645684|FG001|Overall Study|Lost to Follow-up|3|||
19400740|NCT02326155|41645683|FG000|Overall Study|Protocol Violation|2|||
19400741|NCT02326155|41645684|FG001|Overall Study|Protocol Violation|0|||
19400742|NCT02326155|41645683|FG000|Overall Study|Withdrawal by Subject|34|||
19400743|NCT02326155|41645684|FG001|Overall Study|Withdrawal by Subject|11|||
19400744|NCT02326155|41645683|FG000|Overall Study|Disease progression|37|||
19400745|NCT02326155|41645684|FG001|Overall Study|Disease progression|4|||
19400746|NCT02326155|41645683|FG000|Overall Study|Study close|188|||
19400747|NCT02326155|41645684|FG001|Overall Study|Study close|21|||
19400748|NCT02326155|41645683|FG000|Overall Study|except for study close|46|||
19400749|NCT02326155|41645684|FG001|Overall Study|except for study close|13|||
19400750|NCT02299167|41645690|FG000|Overall Study|patients were excluded from the study|11|||
19400751|NCT01647711|41645699|FG000|Overall Study|Progressive disease|6|||
19400752|NCT01647711|41645700|FG001|Overall Study|Progressive disease|2|||
19400753|NCT01647711|41645701|FG002|Overall Study|Progressive disease|6|||
19400754|NCT01647711|41645702|FG003|Overall Study|Progressive disease|8|||
19400755|NCT01647711|41645703|FG004|Overall Study|Progressive disease|2|||
19400756|NCT01647711|41645699|FG000|Overall Study|Other adverse event|0|||
19400757|NCT01647711|41645700|FG001|Overall Study|Other adverse event|0|||
19400758|NCT01647711|41645701|FG002|Overall Study|Other adverse event|2|||
19400759|NCT01647711|41645702|FG003|Overall Study|Other adverse event|0|||
19400760|NCT01647711|41645703|FG004|Overall Study|Other adverse event|2|||
19400761|NCT01647711|41645699|FG000|Overall Study|Protocol Violation|0|||
19400762|NCT01647711|41645700|FG001|Overall Study|Protocol Violation|0|||
19400763|NCT01647711|41645701|FG002|Overall Study|Protocol Violation|0|||
19400764|NCT01647711|41645702|FG003|Overall Study|Protocol Violation|0|||
19400765|NCT01647711|41645703|FG004|Overall Study|Protocol Violation|1|||
19400766|NCT01647711|41645699|FG000|Overall Study|Refused to continue taking medication|0|||
19400767|NCT01647711|41645700|FG001|Overall Study|Refused to continue taking medication|0|||
19400768|NCT01647711|41645701|FG002|Overall Study|Refused to continue taking medication|0|||
19400769|NCT01647711|41645702|FG003|Overall Study|Refused to continue taking medication|2|||
19400770|NCT01647711|41645703|FG004|Overall Study|Refused to continue taking medication|1|||
19400771|NCT01647711|41645699|FG000|Overall Study|Other reason not defined|0|||
19400772|NCT01647711|41645700|FG001|Overall Study|Other reason not defined|1|||
19400773|NCT01647711|41645701|FG002|Overall Study|Other reason not defined|1|||
19400774|NCT01647711|41645702|FG003|Overall Study|Other reason not defined|1|||
19400775|NCT01647711|41645703|FG004|Overall Study|Other reason not defined|0|||
19400776|NCT02540993|41645719|FG000|Overall Study|Lost to Follow-up|5|||
19400777|NCT02540993|41645720|FG001|Overall Study|Lost to Follow-up|3|||
19400778|NCT02540993|41645719|FG000|Overall Study|Withdrawal by Subject|4|||
19400779|NCT02540993|41645720|FG001|Overall Study|Withdrawal by Subject|6|||
19400780|NCT02540993|41645719|FG000|Overall Study|GCP violations|33|||
19400781|NCT02540993|41645720|FG001|Overall Study|GCP violations|27|||
19400782|NCT02547233|41645728|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
19400783|NCT02547233|41645729|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
19400784|NCT02547233|41645728|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
19400785|NCT02547233|41645729|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
19400786|NCT02547233|41645728|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
19400787|NCT02547233|41645729|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
19400788|NCT02547233|41645728|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
19400789|NCT02547233|41645729|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
19400790|NCT02547233|41645728|FG000|12-month Follow-up|Withdrawal by Subject|10|||
19400791|NCT02547233|41645729|FG001|12-month Follow-up|Withdrawal by Subject|10|||
19400792|NCT02547233|41645728|FG000|12-month Follow-up|Lost to Follow-up|3|||
19400793|NCT02547233|41645729|FG001|12-month Follow-up|Lost to Follow-up|3|||
19400794|NCT02547233|41645728|FG000|12-month Follow-up|Lack of Efficacy|1|||
19400795|NCT02547233|41645729|FG001|12-month Follow-up|Lack of Efficacy|2|||
19400796|NCT02547233|41645728|FG000|12-month Follow-up|Protocol Violation|0|||
19400797|NCT02547233|41645729|FG001|12-month Follow-up|Protocol Violation|1|||
19400798|NCT02547233|41645728|FG000|12-month Follow-up|Other|0|||
19400799|NCT02547233|41645729|FG001|12-month Follow-up|Other|1|||
19400800|NCT02546765|41645741|FG000|Overall Study|Withdrawal by Subject|0|||
19400801|NCT02546765|41645742|FG001|Overall Study|Withdrawal by Subject|1|||
19400802|NCT02546765|41645743|FG002|Overall Study|Withdrawal by Subject|0|||
19400803|NCT02546765|41645744|FG003|Overall Study|Withdrawal by Subject|0|||
19400804|NCT02553629|41645767|FG000|Overall Study|Logistic reasons|3|||
19400805|NCT02553629|41645768|FG001|Overall Study|Logistic reasons|6|||
19400806|NCT02546609|41645777|FG000|Overall Study|Withdrawal by Subject|0|||
19400807|NCT02546609|41645778|FG001|Overall Study|Withdrawal by Subject|1|||
19400808|NCT02546609|41645779|FG002|Overall Study|Withdrawal by Subject|2|||
19400809|NCT02546609|41645777|FG000|Overall Study|Adverse Event|0|||
19400810|NCT02546609|41645778|FG001|Overall Study|Adverse Event|6|||
19400811|NCT02546609|41645779|FG002|Overall Study|Adverse Event|1|||
19400812|NCT02546609|41645777|FG000|Overall Study|Protocol Violation|0|||
19400813|NCT02546609|41645778|FG001|Overall Study|Protocol Violation|1|||
19400814|NCT02546609|41645779|FG002|Overall Study|Protocol Violation|1|||
19400815|NCT02546609|41645777|FG000|Overall Study|Lost to Follow-up|2|||
19400816|NCT02546609|41645778|FG001|Overall Study|Lost to Follow-up|3|||
19400817|NCT02546609|41645779|FG002|Overall Study|Lost to Follow-up|1|||
19400818|NCT02546609|41645777|FG000|Overall Study|travel or work schedule restriction|0|||
19400819|NCT02546609|41645778|FG001|Overall Study|travel or work schedule restriction|0|||
19400820|NCT02546609|41645779|FG002|Overall Study|travel or work schedule restriction|2|||
19400821|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
19400822|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
19400823|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
19400824|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
19400825|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
19400826|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
19400827|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Death|1|||
19400828|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Death|3|||
19400829|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
19400830|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
19400831|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
19400832|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
19400833|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
19400834|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
19518137|NCT01546038|41931114|FG003|Overall Study|Withdrawal by Subject|1|||
19518138|NCT01546038|41931115|FG004|Overall Study|Withdrawal by Subject|0|||
19518139|NCT01546038|41931116|FG005|Overall Study|Withdrawal by Subject|1|||
19518140|NCT01546038|41931117|FG006|Overall Study|Withdrawal by Subject|3|||
19518141|NCT01546038|41931118|FG007|Overall Study|Withdrawal by Subject|3|||
19518142|NCT01546038|41931119|FG008|Overall Study|Withdrawal by Subject|1|||
19518143|NCT01546038|41931111|FG000|Overall Study|: Randomized, not treated|0|||
19518144|NCT01546038|41931112|FG001|Overall Study|: Randomized, not treated|0|||
19518145|NCT01546038|41931113|FG002|Overall Study|: Randomized, not treated|0|||
19518146|NCT01546038|41931114|FG003|Overall Study|: Randomized, not treated|0|||
19518147|NCT01546038|41931115|FG004|Overall Study|: Randomized, not treated|0|||
19518148|NCT01546038|41931116|FG005|Overall Study|: Randomized, not treated|0|||
19518149|NCT01546038|41931117|FG006|Overall Study|: Randomized, not treated|2|||
19518150|NCT01546038|41931118|FG007|Overall Study|: Randomized, not treated|4|||
19518151|NCT01546038|41931119|FG008|Overall Study|: Randomized, not treated|3|||
19518152|NCT01571232|41931171|FG000|Overall Study|Lost to Follow-up|0|||
19518153|NCT01571232|41931172|FG001|Overall Study|Lost to Follow-up|1|||
19518154|NCT01571232|41931171|FG000|Overall Study|Withdrawal by Subject|1|||
19518155|NCT01571232|41931172|FG001|Overall Study|Withdrawal by Subject|0|||
19518156|NCT01544478|41931179|FG000|Overall Study|Adverse Event|1|||
19518157|NCT01544478|41931179|FG000|Overall Study|Death|1|||
19518158|NCT01544478|41931179|FG000|Overall Study|Lost to Follow-up|48|||
19518159|NCT01544478|41931179|FG000|Overall Study|Physician Decision|15|||
19518160|NCT01544478|41931179|FG000|Overall Study|Pregnancy|1|||
19518161|NCT01544478|41931179|FG000|Overall Study|Withdrawal by Subject|52|||
19518162|NCT01522950|41931186|FG000|Overall Study|Withdrawal by Subject|3|||
19518163|NCT01522950|41931187|FG001|Overall Study|Withdrawal by Subject|2|||
19518164|NCT01522950|41931188|FG002|Overall Study|Withdrawal by Subject|1|||
19518165|NCT01522950|41931186|FG000|Overall Study|Adverse Event|3|||
19518166|NCT01522950|41931187|FG001|Overall Study|Adverse Event|1|||
19518167|NCT01522950|41931188|FG002|Overall Study|Adverse Event|1|||
19518168|NCT01522950|41931186|FG000|Overall Study|Protocol Violation|0|||
19518169|NCT01522950|41931187|FG001|Overall Study|Protocol Violation|0|||
19518170|NCT01522950|41931188|FG002|Overall Study|Protocol Violation|2|||
19518171|NCT01522950|41931186|FG000|Overall Study|Death|0|||
19518172|NCT01522950|41931187|FG001|Overall Study|Death|1|||
19518173|NCT01522950|41931188|FG002|Overall Study|Death|1|||
19518174|NCT01522950|41931186|FG000|Overall Study|Study Medication Sensitivity|0|||
19518175|NCT01522950|41931187|FG001|Overall Study|Study Medication Sensitivity|1|||
19518176|NCT01522950|41931188|FG002|Overall Study|Study Medication Sensitivity|0|||
19400835|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
19400836|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
19400837|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
19400838|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
19400839|NCT02553317|41645789|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
19400840|NCT02553317|41645790|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
19400841|NCT02325219|41645800|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
19400842|NCT02325219|41645801|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
19400843|NCT02325219|41645802|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
19400844|NCT02325219|41645803|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
19400845|NCT02325219|41645804|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
19400846|NCT02325219|41645800|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
19400847|NCT02325219|41645801|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
19400848|NCT02325219|41645802|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19400849|NCT02325219|41645803|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19400850|NCT02325219|41645804|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
19400851|NCT02325219|41645800|FG000|Controlled Period (Week 0 - 16)|Other|0|||
19400852|NCT02325219|41645801|FG001|Controlled Period (Week 0 - 16)|Other|0|||
19400853|NCT02325219|41645802|FG002|Controlled Period (Week 0 - 16)|Other|1|||
19400854|NCT02325219|41645803|FG003|Controlled Period (Week 0 - 16)|Other|0|||
19400855|NCT02325219|41645804|FG004|Controlled Period (Week 0 - 16)|Other|0|||
19400856|NCT02325219|41645800|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
19400857|NCT02325219|41645801|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
19400858|NCT02325219|41645802|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
19400859|NCT02325219|41645803|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
19400860|NCT02325219|41645804|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
19400861|NCT02325219|41645800|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
19400862|NCT02325219|41645801|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
19518177|NCT01522404|41931198|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
19518178|NCT01522404|41931199|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
19518179|NCT01522404|41931198|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
19518180|NCT01522404|41931199|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
19518181|NCT01522404|41931198|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
19518182|NCT01522404|41931199|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
19518183|NCT01570686|41931215|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19518184|NCT01570686|41931216|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19518185|NCT01570686|41931215|FG000|Overall Study|Administrative problems|0|||
19518186|NCT01570686|41931216|FG001|Overall Study|Administrative problems|1|||
19518187|NCT01570686|41931215|FG000|Overall Study|Adverse Event|8|||
19518188|NCT01570686|41931216|FG001|Overall Study|Adverse Event|6|||
19518189|NCT01570686|41931215|FG000|Overall Study|Lost to Follow-up|4|||
19518190|NCT01570686|41931216|FG001|Overall Study|Lost to Follow-up|3|||
19518191|NCT01570686|41931215|FG000|Overall Study|Protocol Deviation|3|||
19518192|NCT01570686|41931216|FG001|Overall Study|Protocol Deviation|0|||
19518193|NCT01570686|41931215|FG000|Overall Study|Withdrawal by Subject|4|||
19518194|NCT01570686|41931216|FG001|Overall Study|Withdrawal by Subject|4|||
19518195|NCT01570686|41931215|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19518196|NCT01570686|41931216|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19518197|NCT01522248|41931224|FG000|Overall Study|Lost to Follow-up|1|||
19518198|NCT01522248|41931225|FG001|Overall Study|Lost to Follow-up|0|||
19518199|NCT01543776|41931238|FG000|Overall Study|Withdrawal by Subject|2|||
19518200|NCT01543776|41931239|FG001|Overall Study|Withdrawal by Subject|2|||
19518201|NCT01518192|41931248|FG000|Overall Study|Lost to Follow-up|29|||
19518202|NCT01518192|41931249|FG001|Overall Study|Lost to Follow-up|26|||
19518203|NCT01518192|41931250|FG002|Overall Study|Lost to Follow-up|35|||
19518204|NCT01569594|41931264|FG000|Overall Study|Physician Decision|4|||
19518205|NCT01569594|41931264|FG000|Overall Study|Death|13|||
19518206|NCT01569594|41931264|FG000|Overall Study|Lost to Follow-up|22|||
19518207|NCT01569594|41931264|FG000|Overall Study|Adverse Event|2|||
19518208|NCT01569594|41931264|FG000|Overall Study|Withdrawal by Subject|13|||
19518209|NCT01569594|41931264|FG000|Overall Study|Other|4|||
19518210|NCT01569594|41931264|FG000|Overall Study|No ECM used|9|||
19518211|NCT01517802|41931268|FG000|Overall Study|Death|1|||
19518212|NCT01520922|41931274|FG000|Treatment Phase|Physician Decision|2|||
19518213|NCT01520922|41931275|FG001|Treatment Phase|Physician Decision|1|||
19518214|NCT01520922|41931274|FG000|Treatment Phase|Progression|0|||
19518215|NCT01520922|41931275|FG001|Treatment Phase|Progression|2|||
19627936|NCT00817778|42077346|FG001|Overall Study|Withdrawal by Subject|1|||
19518216|NCT01520922|41931274|FG000|Treatment Phase|Adverse Event|3|||
19518217|NCT01520922|41931275|FG001|Treatment Phase|Adverse Event|5|||
19518218|NCT01520922|41931274|FG000|Follow up|Lost to Follow-up|0|||
19518219|NCT01520922|41931275|FG001|Follow up|Lost to Follow-up|1|||
19400863|NCT02325219|41645802|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
19400864|NCT02325219|41645803|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
19400865|NCT02325219|41645804|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
19400866|NCT02325219|41645800|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19400867|NCT02325219|41645801|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
19400868|NCT02325219|41645802|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19400869|NCT02325219|41645803|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19400870|NCT02325219|41645804|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
19400871|NCT02297841|41645820|FG000|Overall Study|Withdrawal by Subject|1|||
19400872|NCT02297841|41645820|FG000|Overall Study|Protocol Violation|7|||
19400873|NCT02365467|41645824|FG000|Overall Study|Death|3|||
19400874|NCT02324361|41645830|FG000|Overall Study|Lost to Follow-up|5|||
19400875|NCT02324361|41645831|FG001|Overall Study|Lost to Follow-up|2|||
19400876|NCT02365233|41645840|FG000|Overall Study|IRB withheld the data|1|||
19400877|NCT02365233|41645841|FG001|Overall Study|IRB withheld the data|2|||
19400878|NCT02365233|41645842|FG002|Overall Study|IRB withheld the data|2|||
19400879|NCT02324205|41645850|FG000|Overall Study|Withdrawal by Subject|37|||
19400880|NCT02324049|41645854|FG000|Part C|Study terminated|11|||
19400881|NCT02364999|41645860|FG000|Overall Study|Death|136|||
19400882|NCT02364999|41645861|FG001|Overall Study|Death|138|||
19400883|NCT02364999|41645860|FG000|Overall Study|Lost to Follow-up|10|||
19400884|NCT02364999|41645861|FG001|Overall Study|Lost to Follow-up|15|||
19400885|NCT02364999|41645860|FG000|Overall Study|Protocol Violation|3|||
19400886|NCT02364999|41645861|FG001|Overall Study|Protocol Violation|2|||
19400887|NCT02364999|41645860|FG000|Overall Study|Withdrawal by Subject|14|||
19400888|NCT02364999|41645861|FG001|Overall Study|Withdrawal by Subject|14|||
19400889|NCT02364999|41645860|FG000|Overall Study|Other|0|||
19400890|NCT02364999|41645861|FG001|Overall Study|Other|1|||
19400891|NCT02364999|41645860|FG000|Overall Study|Randomized but did not receive treatment|2|||
19400892|NCT02364999|41645861|FG001|Overall Study|Randomized but did not receive treatment|3|||
19400893|NCT02322879|41645870|FG000|First Intervention|Physician Decision|1|||
19400894|NCT02322879|41645871|FG001|First Intervention|Physician Decision|0|||
19400895|NCT02322411|41645879|FG000|Overall Study|Lost to Follow-up|4|||
19400896|NCT02322411|41645880|FG001|Overall Study|Lost to Follow-up|7|||
19400897|NCT02322411|41645879|FG000|Overall Study|Withdrawal by Subject|1|||
19400898|NCT02322411|41645880|FG001|Overall Study|Withdrawal by Subject|0|||
19400899|NCT02322021|41645890|FG000|Core Phase|Adverse Event|1|||
19400900|NCT02322021|41645891|FG001|Core Phase|Adverse Event|3|||
19400901|NCT02322021|41645892|FG002|Core Phase|Adverse Event|4|||
19400902|NCT02322021|41645893|FG003|Core Phase|Adverse Event|2|||
19400903|NCT02322021|41645894|FG004|Core Phase|Adverse Event|0|||
19400904|NCT02322021|41645890|FG000|Core Phase|Participant Choice|4|||
19400905|NCT02322021|41645891|FG001|Core Phase|Participant Choice|5|||
19400906|NCT02322021|41645892|FG002|Core Phase|Participant Choice|4|||
19400907|NCT02322021|41645893|FG003|Core Phase|Participant Choice|2|||
19400908|NCT02322021|41645894|FG004|Core Phase|Participant Choice|0|||
19400909|NCT02322021|41645890|FG000|Core Phase|Lost to Follow-up|0|||
19400910|NCT02322021|41645891|FG001|Core Phase|Lost to Follow-up|0|||
19400911|NCT02322021|41645892|FG002|Core Phase|Lost to Follow-up|0|||
19400912|NCT02322021|41645893|FG003|Core Phase|Lost to Follow-up|1|||
19400913|NCT02322021|41645894|FG004|Core Phase|Lost to Follow-up|0|||
19400914|NCT02322021|41645890|FG000|Core Phase|Other|0|||
19400915|NCT02322021|41645891|FG001|Core Phase|Other|0|||
19400916|NCT02322021|41645892|FG002|Core Phase|Other|1|||
19400917|NCT02322021|41645893|FG003|Core Phase|Other|0|||
19400918|NCT02322021|41645894|FG004|Core Phase|Other|0|||
19400919|NCT02322021|41645890|FG000|Extension Phase|Adverse Event|0|||
19400920|NCT02322021|41645891|FG001|Extension Phase|Adverse Event|0|||
19400921|NCT02322021|41645892|FG002|Extension Phase|Adverse Event|0|||
19400922|NCT02322021|41645893|FG003|Extension Phase|Adverse Event|0|||
19400923|NCT02322021|41645894|FG004|Extension Phase|Adverse Event|3|||
19400924|NCT02322021|41645890|FG000|Extension Phase|Participant Choice|0|||
19400925|NCT02322021|41645891|FG001|Extension Phase|Participant Choice|0|||
19400926|NCT02322021|41645892|FG002|Extension Phase|Participant Choice|0|||
19400927|NCT02322021|41645893|FG003|Extension Phase|Participant Choice|0|||
19400928|NCT02322021|41645894|FG004|Extension Phase|Participant Choice|6|||
19400929|NCT02322021|41645890|FG000|Extension Phase|Other|0|||
19400930|NCT02322021|41645891|FG001|Extension Phase|Other|0|||
19400931|NCT02322021|41645892|FG002|Extension Phase|Other|0|||
19400932|NCT02322021|41645893|FG003|Extension Phase|Other|0|||
19400933|NCT02322021|41645894|FG004|Extension Phase|Other|3|||
19400934|NCT02322021|41645890|FG000|Extension Phase|Lost to Follow-up|0|||
19400935|NCT02322021|41645891|FG001|Extension Phase|Lost to Follow-up|0|||
19400936|NCT02322021|41645892|FG002|Extension Phase|Lost to Follow-up|0|||
19400937|NCT02322021|41645893|FG003|Extension Phase|Lost to Follow-up|0|||
19400938|NCT02322021|41645894|FG004|Extension Phase|Lost to Follow-up|1|||
19400939|NCT02322021|41645890|FG000|Extension Phase|Study terminated by sponsor|0|||
19400940|NCT02322021|41645891|FG001|Extension Phase|Study terminated by sponsor|0|||
19400941|NCT02322021|41645892|FG002|Extension Phase|Study terminated by sponsor|0|||
19400942|NCT02322021|41645893|FG003|Extension Phase|Study terminated by sponsor|0|||
19518220|NCT01520922|41931274|FG000|Survival Follow-up|Withdrawal by Subject|1|||
19518221|NCT01520922|41931275|FG001|Survival Follow-up|Withdrawal by Subject|0|||
19518222|NCT01569438|41931283|FG000|Overall Study|Lack of Efficacy|1|||
19518223|NCT01569438|41931284|FG001|Overall Study|Lack of Efficacy|2|||
19518224|NCT01569438|41931283|FG000|Overall Study|Withdrawal by Subject|0|||
19518225|NCT01569438|41931284|FG001|Overall Study|Withdrawal by Subject|3|||
19518226|NCT01569438|41931283|FG000|Overall Study|Adverse Event|2|||
19518227|NCT01569438|41931284|FG001|Overall Study|Adverse Event|15|||
19518228|NCT01569438|41931283|FG000|Overall Study|Protocol Violation|2|||
19518229|NCT01569438|41931284|FG001|Overall Study|Protocol Violation|0|||
19518230|NCT01569438|41931283|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
19518231|NCT01569438|41931284|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
19400943|NCT02322021|41645894|FG004|Extension Phase|Study terminated by sponsor|28|||
19400944|NCT02363439|41645909|FG000|Overall Study|Lack of Efficacy|4|||
19400945|NCT02363283|41645913|FG000|Overall Study|Withdrawal by Subject|1|||
19400946|NCT02363283|41645913|FG000|Overall Study|Not eligible due to transaminitis|1|||
19400947|NCT02321319|41645917|FG000|Overall Study|Product discontinued|5|||
19400948|NCT02294175|41645923|FG000|Overall Study|Withdrawal by Subject|1|||
19400949|NCT02294175|41645924|FG001|Overall Study|Withdrawal by Subject|2|||
19400950|NCT02294175|41645923|FG000|Overall Study|pt taking excluded medication|3|||
19400951|NCT02294175|41645924|FG001|Overall Study|pt taking excluded medication|1|||
19400952|NCT02294175|41645923|FG000|Overall Study|Protocol Violation|1|||
19400953|NCT02294175|41645924|FG001|Overall Study|Protocol Violation|0|||
19400954|NCT02294175|41645923|FG000|Overall Study|Lost to Follow-up|0|||
19400955|NCT02294175|41645924|FG001|Overall Study|Lost to Follow-up|1|||
19400956|NCT02294175|41645923|FG000|Overall Study|wound healed|0|||
19400957|NCT02294175|41645924|FG001|Overall Study|wound healed|2|||
19400958|NCT02088541|41645935|FG000|Overall Study|Adverse Event|3|||
19400959|NCT02088541|41645936|FG001|Overall Study|Adverse Event|0|||
19400960|NCT02088541|41645937|FG002|Overall Study|Adverse Event|3|||
19400961|NCT02088541|41645938|FG003|Overall Study|Adverse Event|3|||
19400962|NCT02088541|41645939|FG004|Overall Study|Adverse Event|0|||
19400963|NCT02088541|41645935|FG000|Overall Study|Death|51|||
19400964|NCT02088541|41645936|FG001|Overall Study|Death|21|||
19400965|NCT02088541|41645937|FG002|Overall Study|Death|85|||
19400966|NCT02088541|41645938|FG003|Overall Study|Death|28|||
19400967|NCT02088541|41645939|FG004|Overall Study|Death|38|||
19400968|NCT02088541|41645935|FG000|Overall Study|Lost to Follow-up|2|||
19400969|NCT02088541|41645936|FG001|Overall Study|Lost to Follow-up|0|||
19400970|NCT02088541|41645937|FG002|Overall Study|Lost to Follow-up|1|||
19400971|NCT02088541|41645938|FG003|Overall Study|Lost to Follow-up|0|||
19400972|NCT02088541|41645939|FG004|Overall Study|Lost to Follow-up|0|||
19400973|NCT02088541|41645935|FG000|Overall Study|Physician Decision|2|||
19400974|NCT02088541|41645936|FG001|Overall Study|Physician Decision|1|||
19400975|NCT02088541|41645937|FG002|Overall Study|Physician Decision|2|||
19400976|NCT02088541|41645938|FG003|Overall Study|Physician Decision|0|||
19400977|NCT02088541|41645939|FG004|Overall Study|Physician Decision|2|||
19400978|NCT02088541|41645935|FG000|Overall Study|Disease progression|7|||
19400979|NCT02088541|41645936|FG001|Overall Study|Disease progression|1|||
19400980|NCT02088541|41645937|FG002|Overall Study|Disease progression|2|||
19400981|NCT02088541|41645938|FG003|Overall Study|Disease progression|3|||
19400982|NCT02088541|41645939|FG004|Overall Study|Disease progression|1|||
19400983|NCT02088541|41645935|FG000|Overall Study|Study terminated by sponsor|1|||
19400984|NCT02088541|41645936|FG001|Overall Study|Study terminated by sponsor|1|||
19400985|NCT02088541|41645937|FG002|Overall Study|Study terminated by sponsor|12|||
19400986|NCT02088541|41645938|FG003|Overall Study|Study terminated by sponsor|2|||
19400987|NCT02088541|41645939|FG004|Overall Study|Study terminated by sponsor|6|||
19400988|NCT02088541|41645935|FG000|Overall Study|Withdrawal by Subject|3|||
19400989|NCT02088541|41645936|FG001|Overall Study|Withdrawal by Subject|2|||
19400990|NCT02088541|41645937|FG002|Overall Study|Withdrawal by Subject|9|||
19400991|NCT02088541|41645938|FG003|Overall Study|Withdrawal by Subject|7|||
19400992|NCT02088541|41645939|FG004|Overall Study|Withdrawal by Subject|10|||
19400993|NCT02088541|41645935|FG000|Overall Study|Other|2|||
19400994|NCT02088541|41645936|FG001|Overall Study|Other|1|||
19400995|NCT02088541|41645937|FG002|Overall Study|Other|3|||
19400996|NCT02088541|41645938|FG003|Overall Study|Other|1|||
19400997|NCT02088541|41645939|FG004|Overall Study|Other|1|||
19400998|NCT02294019|41645949|FG000|Overall Study|Adverse Event|2|||
19400999|NCT02294019|41645949|FG000|Overall Study|Protocol Violation|68|||
19518232|NCT01569438|41931283|FG000|Overall Study|Sponsor/Physician decision|1|||
19401000|NCT02294019|41645949|FG000|Overall Study|Lost to Follow-up|31|||
19401001|NCT02294019|41645949|FG000|Overall Study|Other|1|||
19401002|NCT02294019|41645949|FG000|Overall Study|Withdrawal by Subject|1|||
19401003|NCT02320149|41645955|FG000|Overall Study|Adverse Event|3|||
19401004|NCT02320149|41645956|FG001|Overall Study|Adverse Event|7|||
19401005|NCT02320149|41645955|FG000|Overall Study|Withdrawal of Consent|28|||
19401006|NCT02320149|41645956|FG001|Overall Study|Withdrawal of Consent|32|||
19401007|NCT02320149|41645955|FG000|Overall Study|Lost to Follow-up|21|||
19401008|NCT02320149|41645956|FG001|Overall Study|Lost to Follow-up|34|||
19401009|NCT02320149|41645955|FG000|Overall Study|Protocol Violation|2|||
19401010|NCT02320149|41645956|FG001|Overall Study|Protocol Violation|1|||
19401011|NCT02320149|41645955|FG000|Overall Study|Noncompliance with Study Treatment|7|||
19401012|NCT02320149|41645956|FG001|Overall Study|Noncompliance with Study Treatment|2|||
19401013|NCT02320149|41645955|FG000|Overall Study|Lack of Efficacy|0|||
19401014|NCT02320149|41645956|FG001|Overall Study|Lack of Efficacy|1|||
19401015|NCT02320149|41645955|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19401016|NCT02320149|41645956|FG001|Overall Study|Other Miscellaneous Reasons|3|||
19401017|NCT02540083|41645962|FG000|Overall Study|Withdrawal by Subject|16|||
19401018|NCT02293863|41645969|FG000|Overall Study|Death|4|||
19401019|NCT02293863|41645970|FG001|Overall Study|Death|6|||
19401020|NCT02293863|41645971|FG002|Overall Study|Death|4|||
19401021|NCT02293863|41645969|FG000|Overall Study|Lost to Follow-up|2|||
19401022|NCT02293863|41645970|FG001|Overall Study|Lost to Follow-up|2|||
19401023|NCT02293863|41645971|FG002|Overall Study|Lost to Follow-up|2|||
19401024|NCT02293863|41645969|FG000|Overall Study|Withdrawal by Subject|3|||
19401025|NCT02293863|41645970|FG001|Overall Study|Withdrawal by Subject|3|||
19401026|NCT02293863|41645971|FG002|Overall Study|Withdrawal by Subject|1|||
19401027|NCT02293863|41645969|FG000|Overall Study|Reason Not Specified|0|||
19401028|NCT02293863|41645970|FG001|Overall Study|Reason Not Specified|2|||
19401029|NCT02293863|41645971|FG002|Overall Study|Reason Not Specified|2|||
19401030|NCT02293395|41645983|FG000|Overall Study|Lost to Follow-up|1|||
19401031|NCT02293395|41645984|FG001|Overall Study|Lost to Follow-up|0|||
19401032|NCT02293395|41645983|FG000|Overall Study|Withdrawal by Subject|8|||
19401033|NCT02293395|41645984|FG001|Overall Study|Withdrawal by Subject|7|||
19401034|NCT02025985|41645995|FG000|Overall Study|Consent withdrawn|0|||
19401035|NCT02025985|41645996|FG001|Overall Study|Consent withdrawn|0|||
19401036|NCT02025985|41645997|FG002|Overall Study|Consent withdrawn|1|||
19401037|NCT02025985|41645998|FG003|Overall Study|Consent withdrawn|0|||
19401038|NCT02025985|41645999|FG004|Overall Study|Consent withdrawn|0|||
19401039|NCT02025985|41645995|FG000|Overall Study|Termination of study by Sponsor|4|||
19401040|NCT02025985|41645996|FG001|Overall Study|Termination of study by Sponsor|3|||
19401041|NCT02025985|41645997|FG002|Overall Study|Termination of study by Sponsor|1|||
19401042|NCT02025985|41645998|FG003|Overall Study|Termination of study by Sponsor|1|||
19401043|NCT02025985|41645999|FG004|Overall Study|Termination of study by Sponsor|3|||
19401044|NCT02025985|41645995|FG000|Overall Study|Death|21|||
19401045|NCT02025985|41645996|FG001|Overall Study|Death|20|||
19401046|NCT02025985|41645997|FG002|Overall Study|Death|23|||
19401047|NCT02025985|41645998|FG003|Overall Study|Death|20|||
19401048|NCT02025985|41645999|FG004|Overall Study|Death|17|||
19401049|NCT02528305|41646013|FG000|Overall Study|Withdrawal by Subject|1|||
19401050|NCT02528305|41646013|FG000|Overall Study|Adverse Event|1|||
19401051|NCT02528305|41646013|FG000|Overall Study|Physician Decision|1|||
19401052|NCT02532517|41646019|FG000|Overall Study|Did not complete 24-Month visit|4|||
19401053|NCT02532517|41646019|FG000|Overall Study|Failed Angiographic eligibility|1|||
19401054|NCT02532517|41646019|FG000|Overall Study|Lost to Follow-up|4|||
19401055|NCT02532517|41646019|FG000|Overall Study|Withdrawal by Subject|4|||
19401056|NCT02532517|41646019|FG000|Overall Study|Death|4|||
19401057|NCT02545049|41646025|FG000|Overall Study|Withdrawal by Subject|1|||
19401058|NCT02545049|41646026|FG001|Overall Study|Withdrawal by Subject|7|||
19401059|NCT02545049|41646025|FG000|Overall Study|Lost to Follow-up|4|||
19401060|NCT02545049|41646026|FG001|Overall Study|Lost to Follow-up|6|||
19401061|NCT02545049|41646025|FG000|Overall Study|GCP violations|37|||
19401062|NCT02545049|41646026|FG001|Overall Study|GCP violations|48|||
19401063|NCT02532283|41646034|FG000|Overall Study|Adverse Event|0|||
19401064|NCT02532283|41646035|FG001|Overall Study|Adverse Event|1|||
19401065|NCT02532283|41646034|FG000|Overall Study|Death|1|||
19401066|NCT02532283|41646035|FG001|Overall Study|Death|0|||
19401067|NCT02532283|41646034|FG000|Overall Study|Lost to Follow-up|0|||
19401068|NCT02532283|41646035|FG001|Overall Study|Lost to Follow-up|1|||
19401069|NCT02532283|41646034|FG000|Overall Study|Withdrawal by Subject|8|||
19401070|NCT02532283|41646035|FG001|Overall Study|Withdrawal by Subject|3|||
19401071|NCT01349959|41646056|FG000|Overall Study|Adverse Event|7|||
19401072|NCT01295125|41646076|FG000|Overall Study|Study stopped prematurely|9|||
19401073|NCT02540291|41646084|FG000|Overall Study|Death|7|||
19401074|NCT02540291|41646085|FG001|Overall Study|Death|7|||
19401075|NCT02540291|41646086|FG002|Overall Study|Death|5|||
19401076|NCT02540291|41646087|FG003|Overall Study|Death|7|||
19401077|NCT02540291|41646084|FG000|Overall Study|Lost to Follow-up|0|||
19401078|NCT02540291|41646085|FG001|Overall Study|Lost to Follow-up|0|||
19401079|NCT02540291|41646086|FG002|Overall Study|Lost to Follow-up|1|||
19401080|NCT02540291|41646087|FG003|Overall Study|Lost to Follow-up|0|||
19401081|NCT02540291|41646084|FG000|Overall Study|Withdrawal Of Consent|0|||
19401082|NCT02540291|41646085|FG001|Overall Study|Withdrawal Of Consent|1|||
19401083|NCT02540291|41646086|FG002|Overall Study|Withdrawal Of Consent|0|||
19401084|NCT02540291|41646087|FG003|Overall Study|Withdrawal Of Consent|0|||
19401085|NCT02540291|41646084|FG000|Overall Study|Study Terminated By Sponsor|1|||
19401086|NCT02540291|41646085|FG001|Overall Study|Study Terminated By Sponsor|0|||
19401087|NCT02540291|41646086|FG002|Overall Study|Study Terminated By Sponsor|0|||
19401088|NCT02540291|41646087|FG003|Overall Study|Study Terminated By Sponsor|0|||
19401089|NCT02540291|41646084|FG000|Overall Study|Other|0|||
19401090|NCT02540291|41646085|FG001|Overall Study|Other|0|||
19401091|NCT02540291|41646086|FG002|Overall Study|Other|1|||
19401092|NCT02540291|41646087|FG003|Overall Study|Other|0|||
19401093|NCT02540213|41646099|FG000|Overall Study|Death/adverse event|18|||
19401094|NCT02540213|41646099|FG000|Overall Study|Administrative reasons|3|||
19401095|NCT02540213|41646099|FG000|Overall Study|Kidney transplant|3|||
19401096|NCT02540213|41646099|FG000|Overall Study|Lack of Efficacy|6|||
19401097|NCT02540213|41646099|FG000|Overall Study|Consent withdrawn|7|||
19401098|NCT02540213|41646099|FG000|Overall Study|Enrolled but not treated|2|||
19401099|NCT02544503|41646105|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
19401100|NCT02544503|41646106|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
19401101|NCT02544503|41646105|FG000|Overall Study|Lost to Follow-up|9|||
19401102|NCT02544503|41646106|FG001|Overall Study|Lost to Follow-up|0|||
19401103|NCT02544503|41646105|FG000|Overall Study|Withdrawal by Subject|1|||
19401104|NCT02544503|41646106|FG001|Overall Study|Withdrawal by Subject|0|||
19401105|NCT02552303|41646116|FG000|Allocation|Withdrawal by Subject|2|||
19401106|NCT02552303|41646117|FG001|Allocation|Withdrawal by Subject|1|||
19401107|NCT02552303|41646118|FG002|Allocation|Withdrawal by Subject|1|||
19401108|NCT02552303|41646119|FG003|Allocation|Withdrawal by Subject|1|||
19401109|NCT02552303|41646116|FG000|Allocation|ineligible|1|||
19401110|NCT02552303|41646117|FG001|Allocation|ineligible|1|||
19401111|NCT02552303|41646118|FG002|Allocation|ineligible|0|||
19401112|NCT02552303|41646119|FG003|Allocation|ineligible|0|||
19401113|NCT02552303|41646116|FG000|Follow-Up|Lost to Follow-up|0|||
19401114|NCT02552303|41646117|FG001|Follow-Up|Lost to Follow-up|0|||
19401115|NCT02552303|41646118|FG002|Follow-Up|Lost to Follow-up|1|||
19401116|NCT02552303|41646119|FG003|Follow-Up|Lost to Follow-up|0|||
19401117|NCT02552303|41646116|FG000|Follow-Up|ineligible|0|||
19401118|NCT02552303|41646117|FG001|Follow-Up|ineligible|2|||
19401119|NCT02552303|41646118|FG002|Follow-Up|ineligible|0|||
19401120|NCT02552303|41646119|FG003|Follow-Up|ineligible|0|||
19401121|NCT01660711|41646129|FG000|Overall Study|Adverse Event|7|||
19401122|NCT01660711|41646129|FG000|Overall Study|Withdrawal by Subject|1|||
19401123|NCT02544113|41646135|FG000|Overall Study|Death|3|||
19401124|NCT02544113|41646136|FG001|Overall Study|Death|4|||
19401125|NCT02538965|41646142|FG000|Treatment Period|Other = Death due to disease progression|1|||
19401126|NCT02538965|41646142|FG000|Treatment Period|Adverse Event|2|||
19518233|NCT01569438|41931284|FG001|Overall Study|Sponsor/Physician decision|1|||
19518234|NCT01569438|41931283|FG000|Overall Study|Unable to adhere to study schedule|0|||
19518235|NCT01569438|41931284|FG001|Overall Study|Unable to adhere to study schedule|1|||
19518236|NCT01517412|41931292|FG000|Overall Study|Adverse Event|10|||
19518237|NCT01517412|41931293|FG001|Overall Study|Adverse Event|11|||
19518238|NCT01517412|41931292|FG000|Overall Study|Lack of Efficacy|10|||
19518239|NCT01517412|41931293|FG001|Overall Study|Lack of Efficacy|5|||
19518240|NCT01517412|41931292|FG000|Overall Study|Poor compliance to protocol|8|||
19518241|NCT01517412|41931293|FG001|Overall Study|Poor compliance to protocol|3|||
19518242|NCT01517412|41931292|FG000|Overall Study|Other than specified above|8|||
19518243|NCT01517412|41931293|FG001|Overall Study|Other than specified above|5|||
19518244|NCT01517178|41931299|FG000|Period 1|Adverse Event|1|||
19518245|NCT01517178|41931300|FG001|Period 1|Adverse Event|2|||
19518246|NCT01517178|41931299|FG000|Period 1|Lack of Efficacy|0|||
19518247|NCT01517178|41931300|FG001|Period 1|Lack of Efficacy|1|||
19518248|NCT01517178|41931299|FG000|Period 1|E.g. study termination|3|||
19518249|NCT01517178|41931300|FG001|Period 1|E.g. study termination|1|||
19518250|NCT01517178|41931299|FG000|Period 1|Withdrawal by Subject|0|||
19518251|NCT01517178|41931300|FG001|Period 1|Withdrawal by Subject|1|||
19518252|NCT01517178|41931299|FG000|Period 2|Adverse Event|1|||
19518253|NCT01517178|41931300|FG001|Period 2|Adverse Event|0|||
19518254|NCT01517178|41931299|FG000|Period 2|Withdrawal by Subject|3|||
19518255|NCT01517178|41931300|FG001|Period 2|Withdrawal by Subject|0|||
19518256|NCT01517178|41931299|FG000|Period 2|E.g. study termination|2|||
19518257|NCT01517178|41931300|FG001|Period 2|E.g. study termination|2|||
19518258|NCT01489956|41931308|FG000|Overall Study|Lost to Follow-up|1|||
19518259|NCT01489956|41931309|FG001|Overall Study|Lost to Follow-up|0|||
19518260|NCT01489956|41931310|FG002|Overall Study|Lost to Follow-up|0|||
19518261|NCT01489956|41931308|FG000|Overall Study|Withdrawal by Subject|0|||
19518262|NCT01489956|41931309|FG001|Overall Study|Withdrawal by Subject|0|||
19518263|NCT01489956|41931310|FG002|Overall Study|Withdrawal by Subject|1|||
19518264|NCT01516008|41931321|FG000|Overall Study|Adverse Event|0|||
19518265|NCT01516008|41931322|FG001|Overall Study|Adverse Event|2|||
19401127|NCT02538965|41646142|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
19401128|NCT02538965|41646142|FG000|Treatment Period|Treatment Failure|9|||
19401129|NCT02538965|41646142|FG000|Treatment Period|Disease Progression|1|||
19518266|NCT01516008|41931323|FG002|Overall Study|Adverse Event|7|||
19518267|NCT01516008|41931321|FG000|Overall Study|Lack of Efficacy|44|||
19518268|NCT01516008|41931322|FG001|Overall Study|Lack of Efficacy|14|||
19401130|NCT02538965|41646142|FG000|Treatment Period|Physician Decision|2|||
19401131|NCT02538965|41646142|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
19401132|NCT02538965|41646142|FG000|Follow-Up Period|Withdrawal by Parent|4|||
19401133|NCT02543801|41646150|FG000|Overall Study|Protocol Violation|1|||
19401134|NCT02543801|41646151|FG001|Overall Study|Protocol Violation|2|||
19401135|NCT02543801|41646152|FG002|Overall Study|Protocol Violation|0|||
19401136|NCT02543801|41646153|FG003|Overall Study|Protocol Violation|0|||
19401137|NCT02470091|41646165|FG000|Overall Study|Withdrawal by Subject|1|||
19401138|NCT02470091|41646166|FG001|Overall Study|Withdrawal by Subject|0|||
19401139|NCT02470091|41646165|FG000|Overall Study|Ineligible|0|||
19401140|NCT02470091|41646166|FG001|Overall Study|Ineligible|2|||
19401141|NCT02362503|41646177|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
19401142|NCT02362503|41646178|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
19401143|NCT02362503|41646179|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
19401144|NCT02362503|41646177|FG000|Double-blind Period-Up to 8 Days|Death|1|||
19401145|NCT02362503|41646178|FG001|Double-blind Period-Up to 8 Days|Death|0|||
19401146|NCT02362503|41646179|FG002|Double-blind Period-Up to 8 Days|Death|0|||
19401147|NCT02362503|41646177|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
19401148|NCT02362503|41646178|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
19401149|NCT02362503|41646179|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
19401150|NCT02362503|41646177|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
19401151|NCT02362503|41646178|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
19401152|NCT02362503|41646179|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
19401153|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
19401154|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
19401155|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
19401156|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
19401157|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
19401158|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
19401159|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
19401160|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
19401161|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
19401162|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
19401163|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
19401164|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
19401165|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
19401166|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
19401167|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
19401168|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
19401169|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
19401170|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
19401171|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
19401172|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
19401173|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
19401174|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
19401175|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
19401176|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
19401177|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
19401178|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
19401179|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
19401180|NCT02362503|41646177|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
19401181|NCT02362503|41646178|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
19401182|NCT02362503|41646179|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
19401183|NCT02535065|41646190|FG000|Overall Study|Death|13|||
19401184|NCT02535065|41646190|FG000|Overall Study|Lost to Follow-up|1|||
19401185|NCT02535065|41646190|FG000|Overall Study|Withdrawal by Subject|6|||
19401186|NCT02530619|41646194|FG000|Registered for Study|Withdrawal by Subject|2|||
19401187|NCT02530619|41646194|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
19401188|NCT02530619|41646194|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
19627937|NCT00817778|42077345|FG000|Overall Study|Protocol Violation|0|||
19627938|NCT00817778|42077346|FG001|Overall Study|Protocol Violation|1|||
19627939|NCT00817778|42077345|FG000|Overall Study|Study-specific discontinuation criteria|0|||
19627940|NCT00817778|42077346|FG001|Overall Study|Study-specific discontinuation criteria|1|||
19627941|NCT00817778|42077345|FG000|Overall Study|Poor venous access|1|||
19627942|NCT00817778|42077346|FG001|Overall Study|Poor venous access|0|||
19627943|NCT00813098|42077355|FG000|Overall Study|Adverse Event|2|||
19627944|NCT00813098|42077356|FG001|Overall Study|Adverse Event|4|||
19627945|NCT00813098|42077357|FG002|Overall Study|Adverse Event|1|||
19627946|NCT00813098|42077355|FG000|Overall Study|Withdrawal by Subject|0|||
19627947|NCT00813098|42077356|FG001|Overall Study|Withdrawal by Subject|1|||
19627948|NCT00813098|42077357|FG002|Overall Study|Withdrawal by Subject|0|||
19627949|NCT00813098|42077355|FG000|Overall Study|Inability to complete study procedures|1|||
19627950|NCT00813098|42077356|FG001|Overall Study|Inability to complete study procedures|0|||
19627951|NCT00813098|42077357|FG002|Overall Study|Inability to complete study procedures|0|||
19627952|NCT00813098|42077355|FG000|Overall Study|Lost to Follow-up|0|||
19627953|NCT00813098|42077356|FG001|Overall Study|Lost to Follow-up|1|||
19627954|NCT00813098|42077357|FG002|Overall Study|Lost to Follow-up|0|||
19627955|NCT00813098|42077355|FG000|Overall Study|Protocol Violation|0|||
19401189|NCT02530619|41646194|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
19401190|NCT02530619|41646194|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
19401191|NCT02530619|41646194|FG000|Follow-up Period (6 Months)|Death|4|||
19401192|NCT02530619|41646194|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
19401193|NCT02530619|41646194|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
19401194|NCT02530385|41646200|FG000|Overall Study|Withdrawal by Subject|0|||
19401195|NCT02530385|41646201|FG001|Overall Study|Withdrawal by Subject|1|||
19401196|NCT02362425|41646211|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
19401197|NCT02362425|41646212|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
19401198|NCT02362425|41646213|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
19401199|NCT02362425|41646214|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
19401200|NCT02362425|41646211|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
19401201|NCT02362425|41646212|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
19401202|NCT02362425|41646213|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
19401203|NCT02362425|41646214|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
19401204|NCT02362425|41646211|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
19401205|NCT02362425|41646212|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
19401206|NCT02362425|41646213|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
19401207|NCT02362425|41646214|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
19401208|NCT02362425|41646211|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
19401209|NCT02362425|41646212|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
19401210|NCT02362425|41646213|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
19401211|NCT02362425|41646214|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
19401212|NCT02362425|41646211|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
19401213|NCT02362425|41646212|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
19401214|NCT02362425|41646213|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
19401215|NCT02362425|41646214|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
19401216|NCT02362425|41646211|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
19401217|NCT02362425|41646212|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
19401218|NCT02362425|41646213|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
19401219|NCT02362425|41646214|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
19401220|NCT02362425|41646211|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
19401221|NCT02362425|41646212|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
19401222|NCT02362425|41646213|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
19401223|NCT02362425|41646214|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
19401224|NCT02362425|41646211|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
19401225|NCT02362425|41646212|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
19401226|NCT02362425|41646213|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
19401227|NCT02362425|41646214|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
19401228|NCT02362269|41646227|FG000|Overall Study|Moved|1|||
19401229|NCT02362269|41646228|FG001|Overall Study|Moved|0|||
19401230|NCT02362269|41646227|FG000|Overall Study|Lost to Follow-up|0|||
19401231|NCT02362269|41646228|FG001|Overall Study|Lost to Follow-up|6|||
19401232|NCT02529995|41646236|FG000|Part A|Ongoing Study at Data Cut-off|14|||
19401233|NCT02529995|41646237|FG001|Part A|Ongoing Study at Data Cut-off|16|||
19401234|NCT02529995|41646236|FG000|Part A|Discontinued Study|1|||
19401235|NCT02529995|41646237|FG001|Part A|Discontinued Study|0|||
19401236|NCT02529995|41646236|FG000|Part B|Ongoing Study at Data Cut-off|0|||
19401237|NCT02529995|41646237|FG001|Part B|Ongoing Study at Data Cut-off|7|||
19401238|NCT02529995|41646236|FG000|Part B|Discontinued Study|6|||
19401239|NCT02529995|41646237|FG001|Part B|Discontinued Study|5|||
19401240|NCT02529137|41646243|FG000|Overall Study|Discontinuation for different reasons|8|||
19401241|NCT02319759|41646250|FG000|Week 0 - 16|Lack of Efficacy|1|||
19401242|NCT02319759|41646251|FG001|Week 0 - 16|Lack of Efficacy|0|||
19401243|NCT02319759|41646252|FG002|Week 0 - 16|Lack of Efficacy|0|||
19401244|NCT02319759|41646253|FG003|Week 0 - 16|Lack of Efficacy|0|||
19401245|NCT02319759|41646254|FG004|Week 0 - 16|Lack of Efficacy|0|||
19401246|NCT02319759|41646250|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
19401247|NCT02319759|41646251|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
19401248|NCT02319759|41646252|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
19401249|NCT02319759|41646253|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
19401250|NCT02319759|41646254|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
19401251|NCT02319759|41646250|FG000|Week 16 - 24|Lack of Efficacy|1|||
19401252|NCT02319759|41646251|FG001|Week 16 - 24|Lack of Efficacy|0|||
19401253|NCT02319759|41646252|FG002|Week 16 - 24|Lack of Efficacy|1|||
19401254|NCT02319759|41646253|FG003|Week 16 - 24|Lack of Efficacy|0|||
19401255|NCT02319759|41646254|FG004|Week 16 - 24|Lack of Efficacy|0|||
19401256|NCT02319759|41646250|FG000|Week 16 - 24|Lost to Follow-up|1|||
19401257|NCT02319759|41646251|FG001|Week 16 - 24|Lost to Follow-up|0|||
19401258|NCT02319759|41646252|FG002|Week 16 - 24|Lost to Follow-up|0|||
19401259|NCT02319759|41646253|FG003|Week 16 - 24|Lost to Follow-up|0|||
19401260|NCT02319759|41646254|FG004|Week 16 - 24|Lost to Follow-up|0|||
19401261|NCT02319759|41646250|FG000|Week 16 - 24|Withdrawal by Subject|0|||
19401262|NCT02319759|41646251|FG001|Week 16 - 24|Withdrawal by Subject|0|||
19401263|NCT02319759|41646252|FG002|Week 16 - 24|Withdrawal by Subject|2|||
19401264|NCT02319759|41646253|FG003|Week 16 - 24|Withdrawal by Subject|0|||
19401265|NCT02319759|41646254|FG004|Week 16 - 24|Withdrawal by Subject|0|||
19401266|NCT02319759|41646250|FG000|Week 24 - 56|Adverse Event|0|||
19401267|NCT02319759|41646251|FG001|Week 24 - 56|Adverse Event|0|||
19401268|NCT02319759|41646252|FG002|Week 24 - 56|Adverse Event|2|||
19401269|NCT02319759|41646253|FG003|Week 24 - 56|Adverse Event|0|||
19401270|NCT02319759|41646254|FG004|Week 24 - 56|Adverse Event|0|||
19401271|NCT02319759|41646250|FG000|Week 24 - 56|Lack of Efficacy|0|||
19401272|NCT02319759|41646251|FG001|Week 24 - 56|Lack of Efficacy|0|||
19401273|NCT02319759|41646252|FG002|Week 24 - 56|Lack of Efficacy|0|||
19401274|NCT02319759|41646253|FG003|Week 24 - 56|Lack of Efficacy|2|||
19401275|NCT02319759|41646254|FG004|Week 24 - 56|Lack of Efficacy|1|||
19401276|NCT02319759|41646250|FG000|Week 24 - 56|Withdrawal by Subject|0|||
19401277|NCT02319759|41646251|FG001|Week 24 - 56|Withdrawal by Subject|1|||
19401278|NCT02319759|41646252|FG002|Week 24 - 56|Withdrawal by Subject|0|||
19401279|NCT02319759|41646253|FG003|Week 24 - 56|Withdrawal by Subject|0|||
19401280|NCT02319759|41646254|FG004|Week 24 - 56|Withdrawal by Subject|0|||
19401281|NCT02319759|41646250|FG000|Week 24 - 56|Lost to Follow-up|0|||
19401282|NCT02319759|41646251|FG001|Week 24 - 56|Lost to Follow-up|0|||
19401283|NCT02319759|41646252|FG002|Week 24 - 56|Lost to Follow-up|0|||
19401284|NCT02319759|41646253|FG003|Week 24 - 56|Lost to Follow-up|0|||
19401285|NCT02319759|41646254|FG004|Week 24 - 56|Lost to Follow-up|1|||
19401286|NCT02293005|41646267|FG000|Overall Study|Adverse Event|2|||
19401287|NCT02293005|41646267|FG000|Overall Study|Death|4|||
19401288|NCT02293005|41646267|FG000|Overall Study|Lost to Follow-up|1|||
19401289|NCT02293005|41646267|FG000|Overall Study|Withdrawal by Subject|2|||
19401290|NCT02293005|41646267|FG000|Overall Study|Progression|17|||
19401291|NCT02319525|41646273|FG000|Overall Study|Withdrawal by Subject|2|||
19401292|NCT02319525|41646274|FG001|Overall Study|Withdrawal by Subject|1|||
19401293|NCT02292927|41646282|FG000|Overall Study|Protocol Violation|13|||
19401294|NCT02292927|41646283|FG001|Overall Study|Protocol Violation|7|||
19401295|NCT02292849|41646295|FG000|Overall Study|Lost to Follow-up|0|||
19401296|NCT02292849|41646296|FG001|Overall Study|Lost to Follow-up|2|||
19401297|NCT02292849|41646297|FG002|Overall Study|Lost to Follow-up|2|||
19401298|NCT02292849|41646295|FG000|Overall Study|Physician Decision|4|||
19401299|NCT02292849|41646296|FG001|Overall Study|Physician Decision|0|||
19401300|NCT02292849|41646297|FG002|Overall Study|Physician Decision|0|||
19401301|NCT02318667|41646305|FG000|Overall Study|Adverse Event|1|||
19401302|NCT02318667|41646305|FG000|Overall Study|Lack of Efficacy|6|||
19401303|NCT02318667|41646305|FG000|Overall Study|Protocol Violation|2|||
19401304|NCT02292771|41646315|FG000|Overall Study|Withdrawal by Subject|2|||
19401305|NCT02292771|41646316|FG001|Overall Study|Withdrawal by Subject|1|||
19401306|NCT02292771|41646315|FG000|Overall Study|Lost to Follow-up|2|||
19401307|NCT02292771|41646316|FG001|Overall Study|Lost to Follow-up|1|||
19401308|NCT02291913|41646326|FG000|Overall Study|Progressive Disease|32|||
19401309|NCT02291913|41646326|FG000|Overall Study|Adverse Event|11|||
19401310|NCT02291913|41646326|FG000|Overall Study|Death|2|||
19401311|NCT02291913|41646326|FG000|Overall Study|Physician Decision|1|||
19401312|NCT02291913|41646326|FG000|Overall Study|Withdrawal by Subject|1|||
19401313|NCT02291913|41646326|FG000|Overall Study|Protocol Violation|1|||
19401314|NCT02291679|41646333|FG000|Overall Study|Adverse Event|2|||
19401315|NCT02291679|41646334|FG001|Overall Study|Adverse Event|12|||
19518269|NCT01516008|41931323|FG002|Overall Study|Lack of Efficacy|10|||
19401316|NCT02291679|41646335|FG002|Overall Study|Adverse Event|19|||
19401317|NCT02291679|41646333|FG000|Overall Study|Protocol Violation|5|||
19401318|NCT02291679|41646334|FG001|Overall Study|Protocol Violation|1|||
19401319|NCT02291679|41646335|FG002|Overall Study|Protocol Violation|7|||
19401320|NCT02291679|41646333|FG000|Overall Study|Withdrew Consent|18|||
19401321|NCT02291679|41646334|FG001|Overall Study|Withdrew Consent|10|||
19401322|NCT02291679|41646335|FG002|Overall Study|Withdrew Consent|15|||
19401323|NCT02291679|41646333|FG000|Overall Study|Lost to Follow-up|12|||
19401324|NCT02291679|41646334|FG001|Overall Study|Lost to Follow-up|10|||
19401325|NCT02291679|41646335|FG002|Overall Study|Lost to Follow-up|9|||
19401326|NCT02291679|41646333|FG000|Overall Study|Insufficient Therapeutic Response|5|||
19401327|NCT02291679|41646334|FG001|Overall Study|Insufficient Therapeutic Response|5|||
19401328|NCT02291679|41646335|FG002|Overall Study|Insufficient Therapeutic Response|7|||
19401329|NCT02291679|41646333|FG000|Overall Study|Other|2|||
19401330|NCT02291679|41646334|FG001|Overall Study|Other|4|||
19401331|NCT02291679|41646335|FG002|Overall Study|Other|2|||
19401332|NCT02291601|41646342|FG000|Abdomen|Did not qualify|333|||
19401333|NCT02291601|41646343|FG001|Abdomen|Did not qualify|54|||
19401334|NCT02291601|41646344|FG002|Abdomen|Did not qualify|339|||
19401335|NCT02291601|41646342|FG000|Groin|Did not qualify|183|||
19401336|NCT02291601|41646343|FG001|Groin|Did not qualify|30|||
19401337|NCT02291601|41646344|FG002|Groin|Did not qualify|177|||
19401338|NCT02360475|41646359|FG000|Overall Study|Lost to Follow-up|4|||
19401339|NCT02360475|41646360|FG001|Overall Study|Lost to Follow-up|12|||
19401340|NCT02360475|41646361|FG002|Overall Study|Lost to Follow-up|6|||
19401341|NCT02360475|41646362|FG003|Overall Study|Lost to Follow-up|4|||
19401342|NCT02360475|41646359|FG000|Overall Study|Withdrawal by Subject|0|||
19401343|NCT02360475|41646360|FG001|Overall Study|Withdrawal by Subject|1|||
19401344|NCT02360475|41646361|FG002|Overall Study|Withdrawal by Subject|2|||
19401345|NCT02360475|41646362|FG003|Overall Study|Withdrawal by Subject|0|||
19401346|NCT02360475|41646359|FG000|Overall Study|Migrated/moved from study area|0|||
19401347|NCT02360475|41646360|FG001|Overall Study|Migrated/moved from study area|0|||
19401348|NCT02360475|41646361|FG002|Overall Study|Migrated/moved from study area|0|||
19401349|NCT02360475|41646362|FG003|Overall Study|Migrated/moved from study area|1|||
19401350|NCT02360397|41646372|FG000|Overall Study|Incomplete screening|3|||
19401351|NCT02360397|41646372|FG000|Overall Study|Adverse Event|1|||
19401352|NCT02317809|41646377|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
19401353|NCT02317809|41646378|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
19401354|NCT02317809|41646377|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
19401355|NCT02317809|41646378|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
19401356|NCT02359851|41646387|FG000|Overall Study|Death|1|||
19401357|NCT02359851|41646387|FG000|Overall Study|Disease progression|1|||
19401358|NCT01607905|41646398|FG000|Overall Study|Withdrawal by participant|7|||
19401359|NCT01607905|41646399|FG001|Overall Study|Withdrawal by participant|2|||
19401360|NCT01607905|41646400|FG002|Overall Study|Withdrawal by participant|4|||
19401361|NCT01607905|41646401|FG003|Overall Study|Withdrawal by participant|6|||
19401362|NCT01607905|41646402|FG004|Overall Study|Withdrawal by participant|0|||
19401363|NCT01607905|41646403|FG005|Overall Study|Withdrawal by participant|4|||
19401364|NCT01607905|41646404|FG006|Overall Study|Withdrawal by participant|12|||
19401365|NCT01607905|41646398|FG000|Overall Study|Incidence or severity of AEs|5|||
19401366|NCT01607905|41646399|FG001|Overall Study|Incidence or severity of AEs|1|||
19401367|NCT01607905|41646400|FG002|Overall Study|Incidence or severity of AEs|1|||
19401368|NCT01607905|41646401|FG003|Overall Study|Incidence or severity of AEs|3|||
19401369|NCT01607905|41646402|FG004|Overall Study|Incidence or severity of AEs|0|||
19401370|NCT01607905|41646403|FG005|Overall Study|Incidence or severity of AEs|2|||
19401371|NCT01607905|41646404|FG006|Overall Study|Incidence or severity of AEs|8|||
19401372|NCT01607905|41646398|FG000|Overall Study|Disease progression|44|||
19401373|NCT01607905|41646399|FG001|Overall Study|Disease progression|16|||
19401374|NCT01607905|41646400|FG002|Overall Study|Disease progression|15|||
19401375|NCT01607905|41646401|FG003|Overall Study|Disease progression|11|||
19401376|NCT01607905|41646402|FG004|Overall Study|Disease progression|6|||
19401377|NCT01607905|41646403|FG005|Overall Study|Disease progression|7|||
19401378|NCT01607905|41646404|FG006|Overall Study|Disease progression|21|||
19401379|NCT01607905|41646398|FG000|Overall Study|Non-compliance with study procedures|0|||
19401380|NCT01607905|41646399|FG001|Overall Study|Non-compliance with study procedures|0|||
19401381|NCT01607905|41646400|FG002|Overall Study|Non-compliance with study procedures|0|||
19401382|NCT01607905|41646401|FG003|Overall Study|Non-compliance with study procedures|0|||
19401383|NCT01607905|41646402|FG004|Overall Study|Non-compliance with study procedures|0|||
19401384|NCT01607905|41646403|FG005|Overall Study|Non-compliance with study procedures|0|||
19401385|NCT01607905|41646404|FG006|Overall Study|Non-compliance with study procedures|1|||
19518270|NCT01516008|41931321|FG000|Overall Study|Protocol Violation|1|||
19401386|NCT01607905|41646398|FG000|Overall Study|Death|1|||
19401387|NCT01607905|41646399|FG001|Overall Study|Death|1|||
19401388|NCT01607905|41646400|FG002|Overall Study|Death|1|||
19401389|NCT01607905|41646401|FG003|Overall Study|Death|1|||
19401390|NCT01607905|41646402|FG004|Overall Study|Death|0|||
19401391|NCT01607905|41646403|FG005|Overall Study|Death|0|||
19401392|NCT01607905|41646404|FG006|Overall Study|Death|3|||
19401393|NCT01607905|41646398|FG000|Overall Study|Other treatments become available|1|||
19401394|NCT01607905|41646399|FG001|Overall Study|Other treatments become available|0|||
19401395|NCT01607905|41646400|FG002|Overall Study|Other treatments become available|0|||
19401396|NCT01607905|41646401|FG003|Overall Study|Other treatments become available|0|||
19401397|NCT01607905|41646402|FG004|Overall Study|Other treatments become available|0|||
19401398|NCT01607905|41646403|FG005|Overall Study|Other treatments become available|0|||
19401399|NCT01607905|41646404|FG006|Overall Study|Other treatments become available|1|||
19401400|NCT01607905|41646398|FG000|Overall Study|Investigator discretion|0|||
19401401|NCT01607905|41646399|FG001|Overall Study|Investigator discretion|0|||
19401402|NCT01607905|41646400|FG002|Overall Study|Investigator discretion|0|||
19401403|NCT01607905|41646401|FG003|Overall Study|Investigator discretion|0|||
19401404|NCT01607905|41646402|FG004|Overall Study|Investigator discretion|0|||
19401405|NCT01607905|41646403|FG005|Overall Study|Investigator discretion|1|||
19401406|NCT01607905|41646404|FG006|Overall Study|Investigator discretion|0|||
19401407|NCT01607905|41646398|FG000|Overall Study|Other|1|||
19401408|NCT01607905|41646399|FG001|Overall Study|Other|0|||
19401409|NCT01607905|41646400|FG002|Overall Study|Other|0|||
19401410|NCT01607905|41646401|FG003|Overall Study|Other|0|||
19401411|NCT01607905|41646402|FG004|Overall Study|Other|0|||
19401412|NCT01607905|41646403|FG005|Overall Study|Other|0|||
19401413|NCT01607905|41646404|FG006|Overall Study|Other|1|||
19401414|NCT01607905|41646398|FG000|Overall Study|Randomized but not treated|1|||
19401415|NCT01607905|41646399|FG001|Overall Study|Randomized but not treated|0|||
19401416|NCT01607905|41646400|FG002|Overall Study|Randomized but not treated|0|||
19401417|NCT01607905|41646401|FG003|Overall Study|Randomized but not treated|0|||
19401418|NCT01607905|41646402|FG004|Overall Study|Randomized but not treated|1|||
19401419|NCT01607905|41646403|FG005|Overall Study|Randomized but not treated|1|||
19401420|NCT01607905|41646404|FG006|Overall Study|Randomized but not treated|0|||
19401421|NCT02536963|41646462|FG000|Overall Study|Withdrawal by Subject|18|||
19401422|NCT00602641|41646468|FG000|Overall Study|Never started protocol therapy|6|||
19401423|NCT00602641|41646469|FG001|Overall Study|Never started protocol therapy|2|||
19401424|NCT00602641|41646468|FG000|Overall Study|Still on treatment at time of analysis|8|||
19401425|NCT00602641|41646469|FG001|Overall Study|Still on treatment at time of analysis|15|||
19401426|NCT00602641|41646468|FG000|Overall Study|Adverse Event|62|||
19401427|NCT00602641|41646469|FG001|Overall Study|Adverse Event|53|||
19401428|NCT00602641|41646468|FG000|Overall Study|Disease progression|38|||
19401429|NCT00602641|41646469|FG001|Overall Study|Disease progression|55|||
19401430|NCT00602641|41646468|FG000|Overall Study|Death|6|||
19401431|NCT00602641|41646469|FG001|Overall Study|Death|5|||
19401432|NCT00602641|41646468|FG000|Overall Study|Withdrawal by Subject|15|||
19401433|NCT00602641|41646469|FG001|Overall Study|Withdrawal by Subject|12|||
19401434|NCT00602641|41646468|FG000|Overall Study|Alternative therapy|5|||
19401435|NCT00602641|41646469|FG001|Overall Study|Alternative therapy|2|||
19401436|NCT00602641|41646468|FG000|Overall Study|Other Complicating Disease|5|||
19401437|NCT00602641|41646469|FG001|Overall Study|Other Complicating Disease|2|||
19401438|NCT00602641|41646468|FG000|Overall Study|Physician Decision|5|||
19401439|NCT00602641|41646469|FG001|Overall Study|Physician Decision|4|||
19401440|NCT00602641|41646468|FG000|Overall Study|Administrative Closure|1|||
19401441|NCT00602641|41646469|FG001|Overall Study|Administrative Closure|1|||
19401442|NCT00602641|41646468|FG000|Overall Study|Other|3|||
19401443|NCT00602641|41646469|FG001|Overall Study|Other|1|||
19401444|NCT02531113|41646475|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
19401445|NCT02531113|41646475|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
19401446|NCT02531113|41646475|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
19401447|NCT02531113|41646475|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
19401448|NCT02531113|41646475|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
19401449|NCT02531113|41646475|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
19401450|NCT02531113|41646475|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
19401451|NCT02531113|41646475|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
19401452|NCT02531035|41646481|FG000|Overall Study|Death|0|||
19401453|NCT02531035|41646482|FG001|Overall Study|Death|1|||
19401454|NCT02531035|41646481|FG000|Overall Study|Protocol Violation|1|||
19401455|NCT02531035|41646482|FG001|Overall Study|Protocol Violation|1|||
19401456|NCT02531035|41646481|FG000|Overall Study|Noncompliance with study drug|8|||
19401457|NCT02531035|41646482|FG001|Overall Study|Noncompliance with study drug|3|||
19401458|NCT02531035|41646481|FG000|Overall Study|Physician Decision|1|||
19401459|NCT02531035|41646482|FG001|Overall Study|Physician Decision|0|||
19401460|NCT02531035|41646481|FG000|Overall Study|Adverse Event|16|||
19401461|NCT02531035|41646482|FG001|Overall Study|Adverse Event|45|||
19401462|NCT02531035|41646481|FG000|Overall Study|Other|3|||
19401463|NCT02531035|41646482|FG001|Overall Study|Other|2|||
19401464|NCT02531035|41646481|FG000|Overall Study|Withdrawal by Subject|42|||
19401465|NCT02531035|41646482|FG001|Overall Study|Withdrawal by Subject|32|||
19401466|NCT02531035|41646481|FG000|Overall Study|Lost to Follow-up|8|||
19401467|NCT02531035|41646482|FG001|Overall Study|Lost to Follow-up|10|||
19401468|NCT02531035|41646481|FG000|Overall Study|Randomized, not treated|2|||
19401469|NCT02531035|41646482|FG001|Overall Study|Randomized, not treated|1|||
19401470|NCT01659853|41646498|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
19518271|NCT01516008|41931322|FG001|Overall Study|Protocol Violation|0|||
19518272|NCT01516008|41931323|FG002|Overall Study|Protocol Violation|0|||
19401471|NCT01659853|41646499|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
19401472|NCT01659853|41646498|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
19401473|NCT01659853|41646499|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
19401474|NCT01660243|41646511|FG000|Overall Study|Adverse Event|1|||
19401475|NCT01660243|41646512|FG001|Overall Study|Adverse Event|0|||
19401476|NCT01660243|41646513|FG002|Overall Study|Adverse Event|1|||
19401477|NCT01660243|41646514|FG003|Overall Study|Adverse Event|0|||
19401478|NCT01660243|41646511|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
19401479|NCT01660243|41646512|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
19401480|NCT01660243|41646513|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
19401481|NCT01660243|41646514|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
19401482|NCT01660243|41646511|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
19401483|NCT01660243|41646512|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
19401484|NCT01660243|41646513|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
19401485|NCT01660243|41646514|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
19401486|NCT01660243|41646511|FG000|Overall Study|Randomization error|0|||
19401487|NCT01660243|41646512|FG001|Overall Study|Randomization error|0|||
19401488|NCT01660243|41646513|FG002|Overall Study|Randomization error|0|||
19401489|NCT01660243|41646514|FG003|Overall Study|Randomization error|1|||
19401490|NCT01659151|41646528|FG000|Overall Study|Inadequate TIL growth|1|||
19401491|NCT02522767|41646534|FG000|Double-blind|Withdrawal by Subject|8|||
19401492|NCT02522767|41646535|FG001|Double-blind|Withdrawal by Subject|11|||
19401493|NCT02522767|41646534|FG000|Double-blind|Lost to Follow-up|1|||
19401494|NCT02522767|41646535|FG001|Double-blind|Lost to Follow-up|0|||
19401495|NCT02522767|41646534|FG000|Double-blind|Adverse Event|1|||
19401496|NCT02522767|41646535|FG001|Double-blind|Adverse Event|10|||
19401497|NCT02522767|41646534|FG000|Double-blind|Protocol Violation|0|||
19401498|NCT02522767|41646535|FG001|Double-blind|Protocol Violation|1|||
19401499|NCT02522767|41646534|FG000|Double-blind|Lack of Efficacy|0|||
19401500|NCT02522767|41646535|FG001|Double-blind|Lack of Efficacy|2|||
19401501|NCT02522767|41646534|FG000|Double-blind|Protocol Deviation|1|||
19401502|NCT02522767|41646535|FG001|Double-blind|Protocol Deviation|0|||
19401503|NCT02522767|41646534|FG000|Open-label|Withdrawal by Subject|2|||
19401504|NCT02522767|41646535|FG001|Open-label|Withdrawal by Subject|3|||
19401505|NCT02522767|41646534|FG000|Open-label|Lost to Follow-up|0|||
19401506|NCT02522767|41646535|FG001|Open-label|Lost to Follow-up|1|||
19401507|NCT02522767|41646534|FG000|Open-label|Adverse Event|2|||
19401508|NCT02522767|41646535|FG001|Open-label|Adverse Event|1|||
19401509|NCT02522767|41646534|FG000|Open-label|Lack of Efficacy|1|||
19401510|NCT02522767|41646535|FG001|Open-label|Lack of Efficacy|1|||
19401511|NCT02522767|41646534|FG000|Open-label|Protocol Violation|0|||
19401512|NCT02522767|41646535|FG001|Open-label|Protocol Violation|1|||
19401513|NCT02522377|41646545|FG000|Overall Study|Withdrawal by Subject|1|||
19401514|NCT02522377|41646546|FG001|Overall Study|Withdrawal by Subject|0|||
19401515|NCT02522377|41646545|FG000|Overall Study|Remission Achieved|3|||
19401516|NCT02522377|41646546|FG001|Overall Study|Remission Achieved|0|||
19401517|NCT01657903|41646552|FG000|Overall Study|Lost to Follow-up|1|||
19401518|NCT01657903|41646552|FG000|Overall Study|Withdrawal by Subject|1|||
19401519|NCT01656733|41646565|FG000|Overall Study|No permission to collect birth outcomes|0|||
19401520|NCT01656733|41646566|FG001|Overall Study|No permission to collect birth outcomes|1|||
19401521|NCT01656733|41646565|FG000|Overall Study|Delivery at another hospital|0|||
19401522|NCT01656733|41646566|FG001|Overall Study|Delivery at another hospital|2|||
19401523|NCT01656733|41646565|FG000|Overall Study|Spontaneous abortion|0|||
19401524|NCT01656733|41646566|FG001|Overall Study|Spontaneous abortion|1|||
19401525|NCT01656967|41646574|FG000|Overall Study|faulty monitor|1|||
19401526|NCT01656967|41646575|FG001|Overall Study|faulty monitor|0|||
19401527|NCT01656967|41646574|FG000|Overall Study|unsuccessful ETT insertion|3|||
19401528|NCT01656967|41646575|FG001|Overall Study|unsuccessful ETT insertion|2|||
19401529|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
19401530|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
19401531|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Death|0|||
19401532|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Death|1|||
19401533|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
19401534|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
19401535|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
19401536|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
19401537|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
19401538|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
19401539|NCT01656889|41646587|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
19401540|NCT01656889|41646588|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
19401541|NCT01656889|41646587|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
19401542|NCT01656889|41646588|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
19401543|NCT01656889|41646587|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
19401544|NCT01656889|41646588|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
19401545|NCT01656889|41646587|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
19401546|NCT01656889|41646588|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
19401547|NCT01656889|41646587|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
19401548|NCT01656889|41646588|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
19401549|NCT02522299|41646596|FG000|Overall Study|Adverse Event|2|||
19401550|NCT02522299|41646597|FG001|Overall Study|Adverse Event|0|||
19401551|NCT02522299|41646596|FG000|Overall Study|Physician Decision|0|||
19401552|NCT02522299|41646597|FG001|Overall Study|Physician Decision|1|||
19401553|NCT02522299|41646596|FG000|Overall Study|Withdrawal by Subject|2|||
19401554|NCT02522299|41646597|FG001|Overall Study|Withdrawal by Subject|0|||
19401555|NCT01365091|41646621|FG000|Period 1|Adverse Event|1|||
19401556|NCT01365091|41646622|FG001|Period 1|Adverse Event|0|||
19401557|NCT01365091|41646623|FG002|Period 1|Adverse Event|2|||
19401558|NCT01365091|41646624|FG003|Period 1|Adverse Event|3|||
19401559|NCT01365091|41646621|FG000|Period 1|Positive test result for drugs of abuse|1|||
19401560|NCT01365091|41646622|FG001|Period 1|Positive test result for drugs of abuse|0|||
19401561|NCT01365091|41646623|FG002|Period 1|Positive test result for drugs of abuse|0|||
19401562|NCT01365091|41646624|FG003|Period 1|Positive test result for drugs of abuse|0|||
19401563|NCT01365091|41646621|FG000|Period 1|No longer met study criteria|0|||
19401564|NCT01365091|41646622|FG001|Period 1|No longer met study criteria|1|||
19401565|NCT01365091|41646623|FG002|Period 1|No longer met study criteria|0|||
19401566|NCT01365091|41646624|FG003|Period 1|No longer met study criteria|0|||
19401567|NCT01365091|41646621|FG000|Period 1|Withdrawal by Subject|0|||
19401568|NCT01365091|41646622|FG001|Period 1|Withdrawal by Subject|1|||
19401569|NCT01365091|41646623|FG002|Period 1|Withdrawal by Subject|0|||
19401570|NCT01365091|41646624|FG003|Period 1|Withdrawal by Subject|0|||
19401571|NCT01365091|41646621|FG000|Period 1|Personal reasons|0|||
19401572|NCT01365091|41646622|FG001|Period 1|Personal reasons|0|||
19401573|NCT01365091|41646623|FG002|Period 1|Personal reasons|1|||
19401574|NCT01365091|41646624|FG003|Period 1|Personal reasons|0|||
19401575|NCT01365091|41646621|FG000|Period 2|Withdrawal by Subject|1|||
19401576|NCT01365091|41646622|FG001|Period 2|Withdrawal by Subject|0|||
19401577|NCT01365091|41646623|FG002|Period 2|Withdrawal by Subject|0|||
19401578|NCT01365091|41646624|FG003|Period 2|Withdrawal by Subject|0|||
19401579|NCT01365091|41646621|FG000|Period 2|Adverse Event|0|||
19401580|NCT01365091|41646622|FG001|Period 2|Adverse Event|0|||
19401581|NCT01365091|41646623|FG002|Period 2|Adverse Event|1|||
19401582|NCT01365091|41646624|FG003|Period 2|Adverse Event|0|||
19401583|NCT01364467|41646650|FG000|Overall Study|Lost to Follow-up|1|||
19401584|NCT01364467|41646651|FG001|Overall Study|Lost to Follow-up|2|||
19401585|NCT02520661|41646659|FG000|Overall Study|Lost to Follow-up|7|||
19401586|NCT02520661|41646660|FG001|Overall Study|Lost to Follow-up|3|||
19401587|NCT02520661|41646659|FG000|Overall Study|Admitted from ED|49|||
19401588|NCT02520661|41646660|FG001|Overall Study|Admitted from ED|48|||
19401589|NCT02520661|41646659|FG000|Overall Study|ED greater than 24 hours|29|||
19401590|NCT02520661|41646660|FG001|Overall Study|ED greater than 24 hours|38|||
19401591|NCT02520661|41646659|FG000|Overall Study|other ineligibility|14|||
19518273|NCT01516008|41931321|FG000|Overall Study|Reason not specified|0|||
19518274|NCT01516008|41931322|FG001|Overall Study|Reason not specified|0|||
19518275|NCT01516008|41931323|FG002|Overall Study|Reason not specified|1|||
19518276|NCT01489254|41931334|FG000|Double-blind Part|Adverse Event|7|||
19518277|NCT01489254|41931335|FG001|Double-blind Part|Adverse Event|2|||
19518278|NCT01489254|41931336|FG002|Double-blind Part|Adverse Event|2|||
19518279|NCT01489254|41931337|FG003|Double-blind Part|Adverse Event|0|||
19518280|NCT01489254|41931334|FG000|Double-blind Part|Pregnancy|1|||
19518281|NCT01489254|41931335|FG001|Double-blind Part|Pregnancy|3|||
19518282|NCT01489254|41931336|FG002|Double-blind Part|Pregnancy|0|||
19518283|NCT01489254|41931337|FG003|Double-blind Part|Pregnancy|0|||
19518284|NCT01489254|41931334|FG000|Double-blind Part|Withdrawal by Subject|12|||
19518285|NCT01489254|41931335|FG001|Double-blind Part|Withdrawal by Subject|20|||
19518286|NCT01489254|41931336|FG002|Double-blind Part|Withdrawal by Subject|1|||
19518287|NCT01489254|41931337|FG003|Double-blind Part|Withdrawal by Subject|0|||
19518288|NCT01489254|41931334|FG000|Double-blind Part|Lost to Follow-up|1|||
19518289|NCT01489254|41931335|FG001|Double-blind Part|Lost to Follow-up|2|||
19518290|NCT01489254|41931336|FG002|Double-blind Part|Lost to Follow-up|0|||
19518291|NCT01489254|41931337|FG003|Double-blind Part|Lost to Follow-up|0|||
19518292|NCT01489254|41931334|FG000|Double-blind Part|Other reasons for not completing study|4|||
19518293|NCT01489254|41931335|FG001|Double-blind Part|Other reasons for not completing study|6|||
19518294|NCT01489254|41931336|FG002|Double-blind Part|Other reasons for not completing study|0|||
19401592|NCT02520661|41646660|FG001|Overall Study|other ineligibility|22|||
19401593|NCT02520661|41646659|FG000|Overall Study|Withdrawal by Subject|7|||
19401594|NCT02520661|41646660|FG001|Overall Study|Withdrawal by Subject|16|||
19401595|NCT01364389|41646673|FG000|Overall Study|Withdrawal by Subject|0|||
19401596|NCT01364389|41646674|FG001|Overall Study|Withdrawal by Subject|1|||
19401597|NCT01364389|41646675|FG002|Overall Study|Withdrawal by Subject|0|||
19401598|NCT01364389|41646673|FG000|Overall Study|Protocol deviation|0|||
19401599|NCT01364389|41646674|FG001|Overall Study|Protocol deviation|0|||
19401600|NCT01364389|41646675|FG002|Overall Study|Protocol deviation|1|||
19401601|NCT01364389|41646673|FG000|Overall Study|Administrative problems|1|||
19401602|NCT01364389|41646674|FG001|Overall Study|Administrative problems|0|||
19401603|NCT01364389|41646675|FG002|Overall Study|Administrative problems|0|||
19401604|NCT01364389|41646673|FG000|Overall Study|Adverse Event|1|||
19401605|NCT01364389|41646674|FG001|Overall Study|Adverse Event|0|||
19401606|NCT01364389|41646675|FG002|Overall Study|Adverse Event|0|||
19401607|NCT01364233|41646683|FG000|Overall Study|Lost to Follow-up|1|||
19401608|NCT02291289|41646691|FG000|Induction Treatment|Not Dosed|2|||
19401609|NCT02291289|41646692|FG001|Induction Treatment|Not Dosed|0|||
19401610|NCT02291289|41646693|FG002|Induction Treatment|Not Dosed|0|||
19401611|NCT02291289|41646694|FG003|Induction Treatment|Not Dosed|9|||
19401612|NCT02291289|41646695|FG004|Induction Treatment|Not Dosed|0|||
19401613|NCT02291289|41646696|FG005|Induction Treatment|Not Dosed|0|||
19401614|NCT02291289|41646697|FG006|Induction Treatment|Not Dosed|0|||
19401615|NCT02291289|41646698|FG007|Induction Treatment|Not Dosed|0|||
19401616|NCT02291289|41646699|FG008|Induction Treatment|Not Dosed|0|||
19401617|NCT02291289|41646700|FG009|Induction Treatment|Not Dosed|1|||
19401618|NCT02291289|41646701|FG010|Induction Treatment|Not Dosed|0|||
19518295|NCT01489254|41931337|FG003|Double-blind Part|Other reasons for not completing study|0|||
19518296|NCT01489254|41931334|FG000|Open-label Extension Part|Adverse Event|0|||
19518297|NCT01489254|41931335|FG001|Open-label Extension Part|Adverse Event|0|||
19518298|NCT01489254|41931336|FG002|Open-label Extension Part|Adverse Event|0|||
19518299|NCT01489254|41931337|FG003|Open-label Extension Part|Adverse Event|10|||
19518300|NCT01489254|41931334|FG000|Open-label Extension Part|Pregnancy|0|||
19518301|NCT01489254|41931335|FG001|Open-label Extension Part|Pregnancy|0|||
19518302|NCT01489254|41931336|FG002|Open-label Extension Part|Pregnancy|0|||
19518303|NCT01489254|41931337|FG003|Open-label Extension Part|Pregnancy|3|||
19518304|NCT01489254|41931334|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
19518305|NCT01489254|41931335|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
19518306|NCT01489254|41931336|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
19518307|NCT01489254|41931337|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
19518308|NCT01489254|41931334|FG000|Open-label Extension Part|Protocol Violation|0|||
19518309|NCT01489254|41931335|FG001|Open-label Extension Part|Protocol Violation|0|||
19518310|NCT01489254|41931336|FG002|Open-label Extension Part|Protocol Violation|0|||
19518311|NCT01489254|41931337|FG003|Open-label Extension Part|Protocol Violation|1|||
19518312|NCT01489254|41931334|FG000|Open-label Extension Part|Lost to Follow-up|0|||
19518313|NCT01489254|41931335|FG001|Open-label Extension Part|Lost to Follow-up|0|||
19518314|NCT01489254|41931336|FG002|Open-label Extension Part|Lost to Follow-up|0|||
19518315|NCT01489254|41931337|FG003|Open-label Extension Part|Lost to Follow-up|9|||
19518316|NCT01489254|41931334|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
19518317|NCT01489254|41931335|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
19518318|NCT01489254|41931336|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
19518319|NCT01489254|41931337|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
19518320|NCT01489020|41931352|FG000|Overall Study|Withdrawal by Subject|1|||
19518321|NCT01489020|41931353|FG001|Overall Study|Withdrawal by Subject|0|||
19518322|NCT01489020|41931354|FG002|Overall Study|Withdrawal by Subject|0|||
19518323|NCT01489020|41931355|FG003|Overall Study|Withdrawal by Subject|0|||
19518324|NCT01489020|41931356|FG004|Overall Study|Withdrawal by Subject|0|||
19518325|NCT01489020|41931357|FG005|Overall Study|Withdrawal by Subject|0|||
19518326|NCT01489020|41931352|FG000|Overall Study|Adverse Event|0|||
19518327|NCT01489020|41931353|FG001|Overall Study|Adverse Event|0|||
19518328|NCT01489020|41931354|FG002|Overall Study|Adverse Event|3|||
19518329|NCT01489020|41931355|FG003|Overall Study|Adverse Event|0|||
19518330|NCT01489020|41931356|FG004|Overall Study|Adverse Event|3|||
19518331|NCT01489020|41931357|FG005|Overall Study|Adverse Event|0|||
19518332|NCT01489020|41931352|FG000|Overall Study|Concomitant disease|0|||
19518333|NCT01489020|41931353|FG001|Overall Study|Concomitant disease|0|||
19518334|NCT01489020|41931354|FG002|Overall Study|Concomitant disease|0|||
19518335|NCT01489020|41931355|FG003|Overall Study|Concomitant disease|0|||
19518336|NCT01489020|41931356|FG004|Overall Study|Concomitant disease|3|||
19518337|NCT01489020|41931357|FG005|Overall Study|Concomitant disease|0|||
19518338|NCT01514760|41931377|FG000|Overall Study|Lost to Follow-up|2|||
19518339|NCT01514682|41931383|FG000|Overall Study|Withdrawal by Subject|2|||
19518340|NCT01514682|41931384|FG001|Overall Study|Withdrawal by Subject|3|||
19518341|NCT01514682|41931383|FG000|Overall Study|Physician Decision|4|||
19518342|NCT01514682|41931384|FG001|Overall Study|Physician Decision|3|||
19518343|NCT01514448|41931392|FG000|Overall Study|Death|7|||
19518344|NCT01514448|41931393|FG001|Overall Study|Death|8|||
19518345|NCT01514448|41931392|FG000|Overall Study|Withdrawal by Subject|2|||
19518346|NCT01514448|41931393|FG001|Overall Study|Withdrawal by Subject|0|||
19401619|NCT02291289|41646702|FG011|Induction Treatment|Not Dosed|0|||
19401620|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401621|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401622|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19518347|NCT01514448|41931392|FG000|Overall Study|Lost to Follow-up|2|||
19518348|NCT01514448|41931393|FG001|Overall Study|Lost to Follow-up|0|||
19518349|NCT01514448|41931392|FG000|Overall Study|New Cancer Therapy|1|||
19518350|NCT01514448|41931393|FG001|Overall Study|New Cancer Therapy|0|||
19518351|NCT01514370|41931402|FG000|Overall Study|Protocol Violation|2|||
19518352|NCT01514370|41931403|FG001|Overall Study|Protocol Violation|3|||
19518353|NCT01514370|41931402|FG000|Overall Study|Lost to Follow-up|0|||
19518354|NCT01514370|41931403|FG001|Overall Study|Lost to Follow-up|2|||
19518355|NCT01514370|41931402|FG000|Overall Study|Withdrawal by Subject|2|||
19518356|NCT01514370|41931403|FG001|Overall Study|Withdrawal by Subject|1|||
19518357|NCT01514370|41931402|FG000|Overall Study|Adverse Event|1|||
19518358|NCT01514370|41931403|FG001|Overall Study|Adverse Event|3|||
19518359|NCT01514370|41931402|FG000|Overall Study|Other|6|||
19518360|NCT01514370|41931403|FG001|Overall Study|Other|7|||
19518361|NCT01519674|41931413|FG000|Overall Study|Adverse Event|3|||
19518362|NCT01519674|41931414|FG001|Overall Study|Adverse Event|3|||
19518363|NCT01519674|41931415|FG002|Overall Study|Adverse Event|0|||
19518364|NCT01519674|41931413|FG000|Overall Study|Lack of Efficacy|1|||
19518365|NCT01519674|41931414|FG001|Overall Study|Lack of Efficacy|1|||
19518366|NCT01519674|41931415|FG002|Overall Study|Lack of Efficacy|1|||
19627956|NCT00813098|42077356|FG001|Overall Study|Protocol Violation|0|||
19627957|NCT00813098|42077357|FG002|Overall Study|Protocol Violation|1|||
19627958|NCT00813098|42077355|FG000|Overall Study|Principal Investigator decision|0|||
19627959|NCT00813098|42077356|FG001|Overall Study|Principal Investigator decision|1|||
19627960|NCT00813098|42077357|FG002|Overall Study|Principal Investigator decision|0|||
19627961|NCT00813098|42077355|FG000|Overall Study|Withdrew Consent|0|||
19711043|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
19711044|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
19627962|NCT00813098|42077356|FG001|Overall Study|Withdrew Consent|1|||
19627963|NCT00813098|42077357|FG002|Overall Study|Withdrew Consent|0|||
19627964|NCT00796653|42077369|FG000|Overall Study|Adverse Event|19|||
19627965|NCT00796653|42077370|FG001|Overall Study|Adverse Event|16|||
19627966|NCT00796653|42077371|FG002|Overall Study|Adverse Event|16|||
19711045|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
19518367|NCT01519674|41931413|FG000|Overall Study|Protocol Violation|0|||
19518368|NCT01519674|41931414|FG001|Overall Study|Protocol Violation|3|||
19518369|NCT01519674|41931415|FG002|Overall Study|Protocol Violation|1|||
19518370|NCT01519674|41931413|FG000|Overall Study|Withdrawal Criteria|7|||
19518371|NCT01519674|41931414|FG001|Overall Study|Withdrawal Criteria|2|||
19518372|NCT01519674|41931415|FG002|Overall Study|Withdrawal Criteria|7|||
19518373|NCT01519674|41931413|FG000|Overall Study|Unsclassified|10|||
19518374|NCT01519674|41931414|FG001|Overall Study|Unsclassified|4|||
19711046|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
19711047|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
19711048|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
19711049|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
19711050|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
19711051|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
19711052|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
19518375|NCT01519674|41931415|FG002|Overall Study|Unsclassified|3|||
19627967|NCT00796653|42077372|FG003|Overall Study|Adverse Event|16|||
19518376|NCT01519518|41931425|FG000|Overall Study|Consent not available|7|||
19518377|NCT01519518|41931426|FG001|Overall Study|Consent not available|10|||
19518378|NCT01519206|41931432|FG000|Overall Study|Lost to Follow-up|3|||
19518379|NCT01519206|41931432|FG000|Overall Study|Missed Visit|2|||
19518380|NCT01518972|41931445|FG000|Overall Study|Lost to Follow-up|2|||
19518381|NCT01518972|41931446|FG001|Overall Study|Lost to Follow-up|1|||
19518382|NCT01518972|41931445|FG000|Overall Study|Withdrawal by Subject|1|||
19518383|NCT01518972|41931446|FG001|Overall Study|Withdrawal by Subject|0|||
19518384|NCT01518972|41931445|FG000|Overall Study|Moved from area|1|||
19518385|NCT01518972|41931446|FG001|Overall Study|Moved from area|0|||
19518386|NCT01518972|41931445|FG000|Overall Study|Transportation problems|1|||
19518387|NCT01518972|41931446|FG001|Overall Study|Transportation problems|0|||
19518388|NCT01518972|41931445|FG000|Overall Study|Exclusionary medical condition|1|||
19518389|NCT01518972|41931446|FG001|Overall Study|Exclusionary medical condition|0|||
19518390|NCT01518972|41931445|FG000|Overall Study|Missed safety visits|0|||
19518391|NCT01518972|41931446|FG001|Overall Study|Missed safety visits|1|||
19518392|NCT01518972|41931445|FG000|Overall Study|Exclusionary medication|0|||
19518393|NCT01518972|41931446|FG001|Overall Study|Exclusionary medication|1|||
19518394|NCT01518972|41931445|FG000|Overall Study|Declined medication starting on day 12|0|||
19518395|NCT01518972|41931446|FG001|Overall Study|Declined medication starting on day 12|1|||
19518396|NCT01514136|41931454|FG000|Test Period 1; Test A|Protocol Violation|1|||
19518397|NCT01514136|41931455|FG001|Test Period 1; Test A|Protocol Violation|0|||
19518398|NCT01514136|41931456|FG002|Test Period 1; Test A|Protocol Violation|0|||
19518399|NCT01514136|41931457|FG003|Test Period 1; Test A|Protocol Violation|0|||
19518400|NCT01514136|41931458|FG004|Test Period 1; Test A|Protocol Violation|0|||
19518401|NCT01514136|41931459|FG005|Test Period 1; Test A|Protocol Violation|0|||
19518402|NCT01514136|41931460|FG006|Test Period 1; Test A|Protocol Violation|0|||
19518403|NCT01514136|41931461|FG007|Test Period 1; Test A|Protocol Violation|0|||
19518404|NCT01514136|41931454|FG000|Test Period 1; Test A|Break from study holiday|2|||
19518405|NCT01514136|41931455|FG001|Test Period 1; Test A|Break from study holiday|0|||
19518406|NCT01514136|41931456|FG002|Test Period 1; Test A|Break from study holiday|0|||
19518407|NCT01514136|41931457|FG003|Test Period 1; Test A|Break from study holiday|0|||
19518408|NCT01514136|41931458|FG004|Test Period 1; Test A|Break from study holiday|0|||
19518409|NCT01514136|41931459|FG005|Test Period 1; Test A|Break from study holiday|0|||
19518410|NCT01514136|41931460|FG006|Test Period 1; Test A|Break from study holiday|0|||
19518411|NCT01514136|41931461|FG007|Test Period 1; Test A|Break from study holiday|0|||
19518412|NCT01514136|41931454|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
19518413|NCT01514136|41931455|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
19518414|NCT01514136|41931456|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
19518415|NCT01514136|41931457|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
19518416|NCT01514136|41931458|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
19518417|NCT01514136|41931459|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
19518418|NCT01514136|41931460|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
19518419|NCT01514136|41931461|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
19518420|NCT01514136|41931454|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518421|NCT01514136|41931455|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518422|NCT01514136|41931456|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518423|NCT01514136|41931457|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
19518424|NCT01514136|41931458|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518425|NCT01514136|41931459|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518426|NCT01514136|41931460|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518427|NCT01514136|41931461|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
19518428|NCT01514136|41931454|FG000|Test Period 2; Test A*|Adverse Event|0|||
19518429|NCT01514136|41931455|FG001|Test Period 2; Test A*|Adverse Event|0|||
19518430|NCT01514136|41931456|FG002|Test Period 2; Test A*|Adverse Event|0|||
19518431|NCT01514136|41931457|FG003|Test Period 2; Test A*|Adverse Event|0|||
19518432|NCT01514136|41931458|FG004|Test Period 2; Test A*|Adverse Event|1|||
19518433|NCT01514136|41931459|FG005|Test Period 2; Test A*|Adverse Event|0|||
19401623|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401624|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
19401625|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
19401626|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401627|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401628|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401629|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19401630|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
19518434|NCT01514136|41931460|FG006|Test Period 2; Test A*|Adverse Event|0|||
19711053|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
19401631|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
19518435|NCT01514136|41931461|FG007|Test Period 2; Test A*|Adverse Event|0|||
19518436|NCT01514136|41931454|FG000|Test Period 2; Test A*|Holiday|0|||
19401632|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
19401633|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
19401634|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
19401635|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
19401636|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
19401637|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
19401638|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
19401639|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
19401640|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
19401641|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
19401642|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
19401643|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
19401644|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Death|0|||
19401645|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Death|23|||
19401646|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Death|13|||
19401647|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Death|0|||
19401648|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Death|185|||
19401649|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Death|100|||
19401650|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Death|0|||
19401651|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Death|1|||
19401652|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Death|1|||
19401653|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Death|0|||
19401654|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Death|26|||
19401655|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Death|11|||
19401656|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Adverse Event|0|||
19401657|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Adverse Event|0|||
19401658|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Adverse Event|0|||
19401659|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Adverse Event|0|||
19401660|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Adverse Event|1|||
19401661|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Adverse Event|0|||
19401662|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Adverse Event|0|||
19401663|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Adverse Event|0|||
19401664|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Adverse Event|0|||
19401665|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Adverse Event|0|||
19401666|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Adverse Event|0|||
19401667|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Adverse Event|0|||
19401668|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401669|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401670|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401671|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401672|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
19401673|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
19401674|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401675|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
19401676|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401677|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
19401678|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
19401679|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
19401680|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Other|0|||
19401681|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Other|0|||
19401682|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Other|1|||
19401683|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Other|0|||
19401684|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Other|29|||
19401685|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Other|8|||
19401686|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Other|0|||
19401687|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Other|0|||
19401688|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Other|1|||
19401689|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Other|0|||
19401690|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Other|0|||
19401691|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Other|0|||
19401692|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Physician Decision|0|||
19401693|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Physician Decision|0|||
19401694|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Physician Decision|0|||
19401695|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Physician Decision|0|||
19401696|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Physician Decision|2|||
19401697|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Physician Decision|0|||
19401698|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Physician Decision|0|||
19401699|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Physician Decision|0|||
19401700|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Physician Decision|0|||
19401701|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Physician Decision|0|||
19401702|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Physician Decision|0|||
19401703|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Physician Decision|1|||
19401704|NCT02291289|41646691|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
19401705|NCT02291289|41646692|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
19401706|NCT02291289|41646693|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
19401707|NCT02291289|41646694|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
19401708|NCT02291289|41646695|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
19401709|NCT02291289|41646696|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
19401710|NCT02291289|41646697|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
19401711|NCT02291289|41646698|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
19401712|NCT02291289|41646699|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
19401713|NCT02291289|41646700|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
19401714|NCT02291289|41646701|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
19401715|NCT02291289|41646702|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
19401716|NCT02291289|41646691|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
19401717|NCT02291289|41646692|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
19401718|NCT02291289|41646693|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
19401719|NCT02291289|41646694|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
19401720|NCT02291289|41646695|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
19401721|NCT02291289|41646696|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
19401722|NCT02291289|41646697|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
19401723|NCT02291289|41646698|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
19401724|NCT02291289|41646699|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
19401725|NCT02291289|41646700|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
19401726|NCT02291289|41646701|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
19401727|NCT02291289|41646702|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
19401728|NCT02317575|41646727|FG000|Period 1|Difficulty with venous cannulation|0|||
19401729|NCT02317575|41646728|FG001|Period 1|Difficulty with venous cannulation|1|||
19401730|NCT02317575|41646729|FG002|Period 1|Difficulty with venous cannulation|0|||
19401731|NCT02317575|41646730|FG003|Period 1|Difficulty with venous cannulation|0|||
19401732|NCT02317575|41646731|FG004|Period 1|Difficulty with venous cannulation|0|||
19401733|NCT02317575|41646727|FG000|Period 1|Withdrawal by Subject|1|||
19401734|NCT02317575|41646728|FG001|Period 1|Withdrawal by Subject|0|||
19401735|NCT02317575|41646729|FG002|Period 1|Withdrawal by Subject|0|||
19401736|NCT02317575|41646730|FG003|Period 1|Withdrawal by Subject|0|||
19401737|NCT02317575|41646731|FG004|Period 1|Withdrawal by Subject|0|||
19401738|NCT02316717|41646752|FG000|Overall Study|Adverse Event|2|||
19401739|NCT02316717|41646753|FG001|Overall Study|Adverse Event|2|||
19401740|NCT02316717|41646754|FG002|Overall Study|Adverse Event|0|||
19401741|NCT02316717|41646752|FG000|Overall Study|Lost to Follow-up|1|||
19401742|NCT02316717|41646753|FG001|Overall Study|Lost to Follow-up|2|||
19401743|NCT02316717|41646754|FG002|Overall Study|Lost to Follow-up|1|||
19401744|NCT02316717|41646752|FG000|Overall Study|Non compliance|3|||
19401745|NCT02316717|41646753|FG001|Overall Study|Non compliance|1|||
19401746|NCT02316717|41646754|FG002|Overall Study|Non compliance|0|||
19401747|NCT02316717|41646752|FG000|Overall Study|Protocol Violation|2|||
19401748|NCT02316717|41646753|FG001|Overall Study|Protocol Violation|0|||
19401749|NCT02316717|41646754|FG002|Overall Study|Protocol Violation|0|||
19401750|NCT02316717|41646752|FG000|Overall Study|Withdrawal by Subject|2|||
19401751|NCT02316717|41646753|FG001|Overall Study|Withdrawal by Subject|1|||
19401752|NCT02316717|41646754|FG002|Overall Study|Withdrawal by Subject|1|||
19401753|NCT02316717|41646752|FG000|Overall Study|Death|0|||
19401754|NCT02316717|41646753|FG001|Overall Study|Death|0|||
19401755|NCT02316717|41646754|FG002|Overall Study|Death|1|||
19401756|NCT02316717|41646752|FG000|Overall Study|Physician Decision|0|||
19401757|NCT02316717|41646753|FG001|Overall Study|Physician Decision|1|||
19401758|NCT02316717|41646754|FG002|Overall Study|Physician Decision|0|||
19401759|NCT02316717|41646752|FG000|Overall Study|TBC|1|||
19401760|NCT02316717|41646753|FG001|Overall Study|TBC|0|||
19401761|NCT02316717|41646754|FG002|Overall Study|TBC|0|||
19401762|NCT02290821|41646767|FG000|Overall Study|Withdrawal by Subject|1|||
19401763|NCT02290821|41646768|FG001|Overall Study|Withdrawal by Subject|1|||
19401764|NCT02290821|41646767|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
19401765|NCT02290821|41646768|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
19401766|NCT02290821|41646767|FG000|Overall Study|Lost to Follow-up|3|||
19401767|NCT02290821|41646768|FG001|Overall Study|Lost to Follow-up|2|||
19401768|NCT02289963|41646776|FG000|Overall Study|Adverse Event|1|||
19401769|NCT02289963|41646777|FG001|Overall Study|Adverse Event|2|||
19401770|NCT02289963|41646776|FG000|Overall Study|Poor compliance to protocol|1|||
19401771|NCT02289963|41646777|FG001|Overall Study|Poor compliance to protocol|0|||
19401772|NCT02289963|41646776|FG000|Overall Study|Withdrawal by Subject|1|||
19401773|NCT02289963|41646777|FG001|Overall Study|Withdrawal by Subject|0|||
19401774|NCT02289963|41646776|FG000|Overall Study|Last injection missed|2|||
19401775|NCT02289963|41646777|FG001|Overall Study|Last injection missed|2|||
19401776|NCT02289963|41646776|FG000|Overall Study|End treatment visit outside visit window|0|||
19401777|NCT02289963|41646777|FG001|Overall Study|End treatment visit outside visit window|4|||
19401778|NCT02289963|41646776|FG000|Overall Study|Other than specified above|0|||
19401779|NCT02289963|41646777|FG001|Overall Study|Other than specified above|2|||
19401780|NCT02358369|41646786|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
19401781|NCT02358369|41646787|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
19401782|NCT02358369|41646788|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
19401783|NCT02358369|41646789|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
19401784|NCT02358369|41646790|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
19401785|NCT02358369|41646786|FG000|Treatment Period A/B|Adverse Event|0|||
19401786|NCT02358369|41646787|FG001|Treatment Period A/B|Adverse Event|0|||
19401787|NCT02358369|41646788|FG002|Treatment Period A/B|Adverse Event|1|||
19401788|NCT02358369|41646789|FG003|Treatment Period A/B|Adverse Event|2|||
19401789|NCT02358369|41646790|FG004|Treatment Period A/B|Adverse Event|0|||
19401790|NCT02358369|41646786|FG000|Treatment Period A/B|Death|0|||
19401791|NCT02358369|41646787|FG001|Treatment Period A/B|Death|0|||
19401792|NCT02358369|41646788|FG002|Treatment Period A/B|Death|1|||
19401793|NCT02358369|41646789|FG003|Treatment Period A/B|Death|0|||
19401794|NCT02358369|41646790|FG004|Treatment Period A/B|Death|0|||
19401795|NCT02358369|41646786|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
19401796|NCT02358369|41646787|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
19401797|NCT02358369|41646788|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
19401798|NCT02358369|41646789|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
19401799|NCT02358369|41646790|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
19401800|NCT02358369|41646786|FG000|Treatment Period C|Adverse Event|0|||
19401801|NCT02358369|41646787|FG001|Treatment Period C|Adverse Event|0|||
19401802|NCT02358369|41646788|FG002|Treatment Period C|Adverse Event|0|||
19401803|NCT02358369|41646789|FG003|Treatment Period C|Adverse Event|0|||
19401804|NCT02358369|41646790|FG004|Treatment Period C|Adverse Event|7|||
19401805|NCT02316171|41646802|FG000|Overall Study|difficulties with urinary catheter|1|||
19401806|NCT02316171|41646803|FG001|Overall Study|difficulties with urinary catheter|0|||
19401807|NCT02316171|41646804|FG002|Overall Study|difficulties with urinary catheter|0|||
19401808|NCT02316171|41646805|FG003|Overall Study|difficulties with urinary catheter|0|||
19401809|NCT02289729|41646811|FG000|Overall Study|Lack of Efficacy|3|||
19401810|NCT02289729|41646811|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
19401811|NCT02289729|41646811|FG000|Overall Study|Withdrawal by Subject|1|||
19401812|NCT02289729|41646811|FG000|Overall Study|Death|1|||
19401813|NCT02315625|41646817|FG000|First Intervention|Disease Progression|1|||
19401814|NCT02315625|41646818|FG001|First Intervention|Disease Progression|0|||
19401815|NCT02315625|41646817|FG000|Second Intervention|Physician Decision|2|||
19401816|NCT02315625|41646818|FG001|Second Intervention|Physician Decision|1|||
19401817|NCT02315625|41646817|FG000|Second Intervention|Study closure|1|||
19401818|NCT02315625|41646818|FG001|Second Intervention|Study closure|0|||
19401819|NCT02315625|41646817|FG000|Second Intervention|Disease Progression|1|||
19401820|NCT02315625|41646818|FG001|Second Intervention|Disease Progression|0|||
19401821|NCT02357979|41646828|FG000|Overall Study|Lost to Follow-up|5|||
19401822|NCT02357979|41646829|FG001|Overall Study|Lost to Follow-up|5|||
19401823|NCT02357901|41646838|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
19401824|NCT02357901|41646839|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
19401825|NCT02357901|41646840|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
19401826|NCT02357901|41646841|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
19401827|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
19401828|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
19401829|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
19401830|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
19401831|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
19401832|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
19401833|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
19401834|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
19401835|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
19401836|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
19401837|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
19401838|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
19401839|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
19401840|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
19401841|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
19401842|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
19401843|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
19401844|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
19401845|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
19401846|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
19401847|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
19401848|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
19401849|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
19401850|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
19401851|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
19401852|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
19401853|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
19401854|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
19401855|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
19401856|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
19401857|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
19401858|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
19401859|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
19401860|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
19401861|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
19401862|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
19401863|NCT02357901|41646838|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
19401864|NCT02357901|41646839|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
19401865|NCT02357901|41646840|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
19401866|NCT02357901|41646841|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
19401867|NCT01601847|41646851|FG000|Overall Study|Death|1|||
19401868|NCT01601847|41646852|FG001|Overall Study|Death|0|||
19401869|NCT01601847|41646851|FG000|Overall Study|Withdrawal by Subject|11|||
19401870|NCT01601847|41646852|FG001|Overall Study|Withdrawal by Subject|7|||
19401871|NCT01601847|41646851|FG000|Overall Study|Lost to Follow-up|1|||
19401872|NCT01601847|41646852|FG001|Overall Study|Lost to Follow-up|3|||
19401873|NCT02515669|41646862|FG000|228 Week Open-Label Phase|Other|0|||
19401874|NCT02515669|41646863|FG001|228 Week Open-Label Phase|Other|0|||
19401875|NCT02515669|41646864|FG002|228 Week Open-Label Phase|Other|1|||
19401876|NCT02515669|41646865|FG003|228 Week Open-Label Phase|Other|4|||
19401877|NCT02515669|41646862|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
19401878|NCT02515669|41646863|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
19401879|NCT02515669|41646864|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
19401880|NCT02515669|41646865|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
19401881|NCT02515669|41646862|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
19401882|NCT02515669|41646863|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
19401883|NCT02515669|41646864|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
19401884|NCT02515669|41646865|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
19401885|NCT02515669|41646862|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
19401886|NCT02515669|41646863|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
19401887|NCT02515669|41646864|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
19401888|NCT02515669|41646865|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
19401889|NCT02515669|41646862|FG000|228 Week Open-Label Phase|Missing|0|||
19401890|NCT02515669|41646863|FG001|228 Week Open-Label Phase|Missing|2|||
19401891|NCT02515669|41646864|FG002|228 Week Open-Label Phase|Missing|2|||
19401892|NCT02515669|41646865|FG003|228 Week Open-Label Phase|Missing|2|||
19401893|NCT02515279|41646895|FG000|Overall Study|Adverse Event|7|||
19401894|NCT02515279|41646895|FG000|Overall Study|Lack of Efficacy|31|||
19401895|NCT02515279|41646895|FG000|Overall Study|Lost to Follow-up|9|||
19401896|NCT02515279|41646895|FG000|Overall Study|Withdrawal by Subject|18|||
19401897|NCT02515279|41646895|FG000|Overall Study|End-of-treatment visit not attended|17|||
19401898|NCT02515279|41646895|FG000|Overall Study|Other|22|||
19401899|NCT02515045|41646901|FG000|Overall Study|Adverse Event|0|||
19401900|NCT02515045|41646902|FG001|Overall Study|Adverse Event|3|||
19401901|NCT02515045|41646903|FG002|Overall Study|Adverse Event|3|||
19401902|NCT02515045|41646901|FG000|Overall Study|Lost to Follow-up|0|||
19401903|NCT02515045|41646902|FG001|Overall Study|Lost to Follow-up|1|||
19401904|NCT02515045|41646903|FG002|Overall Study|Lost to Follow-up|1|||
19401905|NCT02514577|41646913|FG000|Overall Study|Lost to Follow-up|6|||
19401906|NCT02514577|41646914|FG001|Overall Study|Lost to Follow-up|6|||
19401907|NCT02514577|41646913|FG000|Overall Study|Protocol Violation|1|||
19401908|NCT02514577|41646914|FG001|Overall Study|Protocol Violation|0|||
19401909|NCT02514577|41646913|FG000|Overall Study|Withdrawal by Subject|6|||
19401910|NCT02514577|41646914|FG001|Overall Study|Withdrawal by Subject|6|||
19401911|NCT02514577|41646913|FG000|Overall Study|Adverse Event|1|||
19401912|NCT02514577|41646914|FG001|Overall Study|Adverse Event|1|||
19401913|NCT02513485|41646922|FG000|Overall Study|Adverse Event|1|||
19401914|NCT02513485|41646923|FG001|Overall Study|Adverse Event|0|||
19401915|NCT02289417|41646932|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
19401916|NCT02289417|41646933|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401917|NCT02289417|41646934|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
19401918|NCT02289417|41646935|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401919|NCT02289417|41646936|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401920|NCT02289417|41646937|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401921|NCT02289417|41646938|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401922|NCT02289417|41646939|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401923|NCT02289417|41646940|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
19401924|NCT02289417|41646932|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
19401925|NCT02289417|41646933|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
19401926|NCT02289417|41646934|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
19401927|NCT02289417|41646935|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401928|NCT02289417|41646936|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401929|NCT02289417|41646937|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401930|NCT02289417|41646938|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401931|NCT02289417|41646939|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401932|NCT02289417|41646940|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
19401933|NCT02289417|41646932|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401934|NCT02289417|41646933|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
19401935|NCT02289417|41646934|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401936|NCT02289417|41646935|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401937|NCT02289417|41646936|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401938|NCT02289417|41646937|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401939|NCT02289417|41646938|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401940|NCT02289417|41646939|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401941|NCT02289417|41646940|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
19401942|NCT02289417|41646932|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
19401943|NCT02289417|41646933|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401944|NCT02289417|41646934|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401945|NCT02289417|41646935|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401946|NCT02289417|41646936|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401947|NCT02289417|41646937|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401948|NCT02289417|41646938|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401949|NCT02289417|41646939|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401950|NCT02289417|41646940|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
19401951|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
19401952|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
19401953|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
19401954|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
19401955|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
19401956|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
19401957|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
19401958|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
19401959|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
19401960|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401961|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401962|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
19401963|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401964|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401965|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401966|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401967|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401968|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
19401969|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
19401970|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
19401971|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
19401972|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
19401973|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
19401974|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
19401975|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
19401976|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
19401977|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
19401978|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19401979|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19401980|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
19401981|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19401982|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
19401983|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
19401984|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19401985|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19518437|NCT01514136|41931455|FG001|Test Period 2; Test A*|Holiday|0|||
19518438|NCT01514136|41931456|FG002|Test Period 2; Test A*|Holiday|0|||
19401986|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
19401987|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401988|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401989|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401990|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401991|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401992|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401993|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
19401994|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401995|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
19401996|NCT02289417|41646932|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19401997|NCT02289417|41646933|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19401998|NCT02289417|41646934|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19401999|NCT02289417|41646935|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
19402000|NCT02289417|41646936|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19402001|NCT02289417|41646937|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19402002|NCT02289417|41646938|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
19402003|NCT02289417|41646939|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19627968|NCT00796653|42077369|FG000|Overall Study|Lost to Follow-up|2|||
19627969|NCT00796653|42077370|FG001|Overall Study|Lost to Follow-up|1|||
19627970|NCT00796653|42077371|FG002|Overall Study|Lost to Follow-up|2|||
19627971|NCT00796653|42077372|FG003|Overall Study|Lost to Follow-up|3|||
19711054|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
19402004|NCT02289417|41646940|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
19402005|NCT02289417|41646932|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
19402006|NCT02289417|41646933|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
19402007|NCT02289417|41646934|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
19402008|NCT02289417|41646935|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
19402009|NCT02289417|41646936|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
19402010|NCT02289417|41646937|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
19402011|NCT02289417|41646938|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
19402012|NCT02289417|41646939|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
19402013|NCT02289417|41646940|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
19402014|NCT02289417|41646932|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402015|NCT02289417|41646933|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402016|NCT02289417|41646934|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402017|NCT02289417|41646935|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402018|NCT02289417|41646936|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402019|NCT02289417|41646937|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19711055|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
19711056|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
19711057|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
19711058|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
19402020|NCT02289417|41646938|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
19402021|NCT02289417|41646939|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
19402022|NCT02289417|41646940|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
19402023|NCT02289417|41646932|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402024|NCT02289417|41646933|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402025|NCT02289417|41646934|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402026|NCT02289417|41646935|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402027|NCT02289417|41646936|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19518439|NCT01514136|41931457|FG003|Test Period 2; Test A*|Holiday|0|||
19518440|NCT01514136|41931458|FG004|Test Period 2; Test A*|Holiday|1|||
19627972|NCT00796653|42077369|FG000|Overall Study|Withdrawal by Subject|16|||
19627973|NCT00796653|42077370|FG001|Overall Study|Withdrawal by Subject|8|||
19627974|NCT00796653|42077371|FG002|Overall Study|Withdrawal by Subject|8|||
19627975|NCT00796653|42077372|FG003|Overall Study|Withdrawal by Subject|13|||
19627976|NCT00796653|42077369|FG000|Overall Study|Lack of Efficacy|8|||
19627977|NCT00796653|42077370|FG001|Overall Study|Lack of Efficacy|1|||
19627978|NCT00796653|42077371|FG002|Overall Study|Lack of Efficacy|3|||
19627979|NCT00796653|42077372|FG003|Overall Study|Lack of Efficacy|2|||
19627980|NCT00796653|42077369|FG000|Overall Study|Non compliance with protocol|2|||
19627981|NCT00796653|42077370|FG001|Overall Study|Non compliance with protocol|2|||
19627982|NCT00796653|42077371|FG002|Overall Study|Non compliance with protocol|0|||
19627983|NCT00796653|42077372|FG003|Overall Study|Non compliance with protocol|2|||
19627984|NCT00796653|42077369|FG000|Overall Study|Other reason not described above|4|||
19627985|NCT00796653|42077370|FG001|Overall Study|Other reason not described above|9|||
19627986|NCT00796653|42077371|FG002|Overall Study|Other reason not described above|7|||
19711059|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
19711060|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
19402028|NCT02289417|41646937|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402029|NCT02289417|41646938|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
19402030|NCT02289417|41646939|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
19402031|NCT02289417|41646940|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
19402032|NCT02289417|41646932|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402033|NCT02289417|41646933|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402034|NCT02289417|41646934|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402035|NCT02289417|41646935|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402036|NCT02289417|41646936|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402037|NCT02289417|41646937|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402038|NCT02289417|41646938|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402039|NCT02289417|41646939|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
19402040|NCT02289417|41646940|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
19402041|NCT02512861|41646958|FG000|Overall Study|Protocol Violation|3|||
19402042|NCT02512861|41646959|FG001|Overall Study|Protocol Violation|7|||
19402043|NCT02512861|41646958|FG000|Overall Study|Physician Decision|3|||
19402044|NCT02512861|41646959|FG001|Overall Study|Physician Decision|1|||
19402045|NCT02512861|41646958|FG000|Overall Study|Withdrawal by Subject|0|||
19402046|NCT02512861|41646959|FG001|Overall Study|Withdrawal by Subject|1|||
19402047|NCT02288559|41646969|FG000|Overall Study|Adverse Event|1|||
19402048|NCT02288559|41646970|FG001|Overall Study|Adverse Event|1|||
19402049|NCT02288559|41646971|FG002|Overall Study|Adverse Event|5|||
19402050|NCT02288559|41646972|FG003|Overall Study|Adverse Event|0|||
19402051|NCT02288559|41646969|FG000|Overall Study|Death|0|||
19402052|NCT02288559|41646970|FG001|Overall Study|Death|0|||
19402053|NCT02288559|41646971|FG002|Overall Study|Death|1|||
19402054|NCT02288559|41646972|FG003|Overall Study|Death|0|||
19402055|NCT02288559|41646969|FG000|Overall Study|Lost to Follow-up|0|||
19402056|NCT02288559|41646970|FG001|Overall Study|Lost to Follow-up|0|||
19402057|NCT02288559|41646971|FG002|Overall Study|Lost to Follow-up|0|||
19402058|NCT02288559|41646972|FG003|Overall Study|Lost to Follow-up|1|||
19402059|NCT02288559|41646969|FG000|Overall Study|Withdrawal by Subject|0|||
19402060|NCT02288559|41646970|FG001|Overall Study|Withdrawal by Subject|0|||
19402061|NCT02288559|41646971|FG002|Overall Study|Withdrawal by Subject|2|||
19402062|NCT02288559|41646972|FG003|Overall Study|Withdrawal by Subject|1|||
19402063|NCT02288559|41646969|FG000|Overall Study|Reason Not Specified|0|||
19402064|NCT02288559|41646970|FG001|Overall Study|Reason Not Specified|0|||
19402065|NCT02288559|41646971|FG002|Overall Study|Reason Not Specified|3|||
19402066|NCT02288559|41646972|FG003|Overall Study|Reason Not Specified|0|||
19402067|NCT02288325|41646984|FG000|Run-in Period|Adverse Event|48|||
19402068|NCT02288325|41646985|FG001|Run-in Period|Adverse Event|0|||
19402069|NCT02288325|41646986|FG002|Run-in Period|Adverse Event|0|||
19402070|NCT02288325|41646984|FG000|Run-in Period|Lack of Efficacy|16|||
19402071|NCT02288325|41646985|FG001|Run-in Period|Lack of Efficacy|0|||
19402072|NCT02288325|41646986|FG002|Run-in Period|Lack of Efficacy|0|||
19402073|NCT02288325|41646984|FG000|Run-in Period|Withdrawal of Consent|28|||
19402074|NCT02288325|41646985|FG001|Run-in Period|Withdrawal of Consent|0|||
19402075|NCT02288325|41646986|FG002|Run-in Period|Withdrawal of Consent|0|||
19402076|NCT02288325|41646984|FG000|Run-in Period|Lost to Follow-up|25|||
19402077|NCT02288325|41646985|FG001|Run-in Period|Lost to Follow-up|0|||
19402078|NCT02288325|41646986|FG002|Run-in Period|Lost to Follow-up|0|||
19402079|NCT02288325|41646984|FG000|Run-in Period|Protocol Violation|17|||
19402080|NCT02288325|41646985|FG001|Run-in Period|Protocol Violation|0|||
19402081|NCT02288325|41646986|FG002|Run-in Period|Protocol Violation|0|||
19402082|NCT02288325|41646984|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
19402083|NCT02288325|41646985|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
19402084|NCT02288325|41646986|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
19402085|NCT02288325|41646984|FG000|Run-in Period|Reason not Specified|8|||
19402086|NCT02288325|41646985|FG001|Run-in Period|Reason not Specified|0|||
19402087|NCT02288325|41646986|FG002|Run-in Period|Reason not Specified|0|||
19402088|NCT02288325|41646984|FG000|Stabilization Period|Adverse Event|13|||
19402089|NCT02288325|41646985|FG001|Stabilization Period|Adverse Event|0|||
19402090|NCT02288325|41646986|FG002|Stabilization Period|Adverse Event|0|||
19402091|NCT02288325|41646984|FG000|Stabilization Period|Lack of Efficacy|22|||
19402092|NCT02288325|41646985|FG001|Stabilization Period|Lack of Efficacy|0|||
19402093|NCT02288325|41646986|FG002|Stabilization Period|Lack of Efficacy|0|||
19402094|NCT02288325|41646984|FG000|Stabilization Period|Withdrawal of Consent|23|||
19402095|NCT02288325|41646985|FG001|Stabilization Period|Withdrawal of Consent|0|||
19402096|NCT02288325|41646986|FG002|Stabilization Period|Withdrawal of Consent|0|||
19402097|NCT02288325|41646984|FG000|Stabilization Period|Lost to Follow-up|12|||
19402098|NCT02288325|41646985|FG001|Stabilization Period|Lost to Follow-up|0|||
19402099|NCT02288325|41646986|FG002|Stabilization Period|Lost to Follow-up|0|||
19402100|NCT02288325|41646984|FG000|Stabilization Period|Protocol Violation|8|||
19402101|NCT02288325|41646985|FG001|Stabilization Period|Protocol Violation|0|||
19402102|NCT02288325|41646986|FG002|Stabilization Period|Protocol Violation|0|||
19402103|NCT02288325|41646984|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
19402104|NCT02288325|41646985|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
19402105|NCT02288325|41646986|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
19402106|NCT02288325|41646984|FG000|Stabilization Period|Reason not Specified|15|||
19402107|NCT02288325|41646985|FG001|Stabilization Period|Reason not Specified|0|||
19402108|NCT02288325|41646986|FG002|Stabilization Period|Reason not Specified|0|||
19402109|NCT02288325|41646984|FG000|Double-blind Treatment Period|Adverse Event|0|||
19402110|NCT02288325|41646985|FG001|Double-blind Treatment Period|Adverse Event|2|||
19402111|NCT02288325|41646986|FG002|Double-blind Treatment Period|Adverse Event|5|||
19402112|NCT02288325|41646984|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
19402113|NCT02288325|41646985|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
19402114|NCT02288325|41646986|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
19402115|NCT02288325|41646984|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
19402116|NCT02288325|41646985|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
19402117|NCT02288325|41646986|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
19402118|NCT02288325|41646984|FG000|Double-blind Treatment Period|Protocol Violation|0|||
19402119|NCT02288325|41646985|FG001|Double-blind Treatment Period|Protocol Violation|1|||
19402120|NCT02288325|41646986|FG002|Double-blind Treatment Period|Protocol Violation|2|||
19402121|NCT02288325|41646984|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
19402122|NCT02288325|41646985|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
19402123|NCT02288325|41646986|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
19402124|NCT02288325|41646984|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
19402125|NCT02288325|41646985|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
19402126|NCT02288325|41646986|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
19402127|NCT02509117|41647003|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402128|NCT02509117|41647004|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
19402129|NCT02509117|41647005|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402130|NCT02509117|41647006|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402131|NCT02509117|41647007|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402132|NCT02509117|41647008|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402133|NCT02509117|41647009|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402134|NCT02509117|41647010|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402135|NCT02509117|41647011|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402136|NCT02509117|41647012|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
19402137|NCT02509117|41647003|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402138|NCT02509117|41647004|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402139|NCT02509117|41647005|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402140|NCT02509117|41647006|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402141|NCT02509117|41647007|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402142|NCT02509117|41647008|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402143|NCT02509117|41647009|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402144|NCT02509117|41647010|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402145|NCT02509117|41647011|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
19402146|NCT02509117|41647012|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
19402147|NCT02509117|41647003|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402148|NCT02509117|41647004|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402149|NCT02509117|41647005|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402150|NCT02509117|41647006|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402151|NCT02509117|41647007|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402152|NCT02509117|41647008|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402153|NCT02509117|41647009|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402154|NCT02509117|41647010|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402155|NCT02509117|41647011|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
19402156|NCT02509117|41647012|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
19402157|NCT01654549|41647052|FG000|Overall Study|H.pylori eradication not successful|0|||
19402158|NCT01654549|41647053|FG001|Overall Study|H.pylori eradication not successful|1|||
19402159|NCT02508649|41647067|FG000|Overall Study|Withdrawal by Subject|4|||
19402160|NCT02508649|41647068|FG001|Overall Study|Withdrawal by Subject|6|||
19402161|NCT02508649|41647069|FG002|Overall Study|Withdrawal by Subject|5|||
19402162|NCT02508649|41647070|FG003|Overall Study|Withdrawal by Subject|6|||
19402163|NCT02508649|41647067|FG000|Overall Study|Investigator withdrew the subject|1|||
19402164|NCT02508649|41647068|FG001|Overall Study|Investigator withdrew the subject|2|||
19402165|NCT02508649|41647069|FG002|Overall Study|Investigator withdrew the subject|1|||
19402166|NCT02508649|41647070|FG003|Overall Study|Investigator withdrew the subject|0|||
19402167|NCT02508649|41647067|FG000|Overall Study|Post randomization screening failure|12|||
19402168|NCT02508649|41647068|FG001|Overall Study|Post randomization screening failure|4|||
19402169|NCT02508649|41647069|FG002|Overall Study|Post randomization screening failure|9|||
19402170|NCT02508649|41647070|FG003|Overall Study|Post randomization screening failure|3|||
19402171|NCT02508649|41647067|FG000|Overall Study|Lost to Follow-up|1|||
19402172|NCT02508649|41647068|FG001|Overall Study|Lost to Follow-up|1|||
19402173|NCT02508649|41647069|FG002|Overall Study|Lost to Follow-up|0|||
19402174|NCT02508649|41647070|FG003|Overall Study|Lost to Follow-up|1|||
19402175|NCT02505217|41647085|FG000|Overall Study|Withdrawal by Subject|1|||
19402176|NCT02505217|41647086|FG001|Overall Study|Withdrawal by Subject|2|||
19402177|NCT02504827|41647092|FG000|Overall Study|Could not produce sputum|1|||
19402178|NCT02504671|41647102|FG000|Overall Study|Withdrawal by Subject|1|||
19402179|NCT02504671|41647103|FG001|Overall Study|Withdrawal by Subject|5|||
19402180|NCT02504671|41647104|FG002|Overall Study|Withdrawal by Subject|4|||
19402181|NCT02504671|41647105|FG003|Overall Study|Withdrawal by Subject|4|||
19402182|NCT02504671|41647106|FG004|Overall Study|Withdrawal by Subject|5|||
19402183|NCT02504671|41647107|FG005|Overall Study|Withdrawal by Subject|3|||
19402184|NCT02504671|41647102|FG000|Overall Study|Lack of Efficacy|1|||
19402185|NCT02504671|41647103|FG001|Overall Study|Lack of Efficacy|3|||
19402186|NCT02504671|41647104|FG002|Overall Study|Lack of Efficacy|1|||
19402187|NCT02504671|41647105|FG003|Overall Study|Lack of Efficacy|0|||
19402188|NCT02504671|41647106|FG004|Overall Study|Lack of Efficacy|4|||
19402189|NCT02504671|41647107|FG005|Overall Study|Lack of Efficacy|4|||
19402190|NCT02504671|41647102|FG000|Overall Study|Adverse Event|1|||
19402191|NCT02504671|41647103|FG001|Overall Study|Adverse Event|1|||
19402192|NCT02504671|41647104|FG002|Overall Study|Adverse Event|0|||
19402193|NCT02504671|41647105|FG003|Overall Study|Adverse Event|1|||
19402194|NCT02504671|41647106|FG004|Overall Study|Adverse Event|0|||
19402195|NCT02504671|41647107|FG005|Overall Study|Adverse Event|2|||
19402196|NCT02504671|41647102|FG000|Overall Study|Protocol Violation|2|||
19402197|NCT02504671|41647103|FG001|Overall Study|Protocol Violation|1|||
19402198|NCT02504671|41647104|FG002|Overall Study|Protocol Violation|0|||
19402199|NCT02504671|41647105|FG003|Overall Study|Protocol Violation|0|||
19402200|NCT02504671|41647106|FG004|Overall Study|Protocol Violation|0|||
19402201|NCT02504671|41647107|FG005|Overall Study|Protocol Violation|1|||
19402202|NCT02504671|41647102|FG000|Overall Study|Lost to Follow-up|0|||
19374505|NCT03128671|41616152|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
19402203|NCT02504671|41647103|FG001|Overall Study|Lost to Follow-up|0|||
19402204|NCT02504671|41647104|FG002|Overall Study|Lost to Follow-up|2|||
19402205|NCT02504671|41647105|FG003|Overall Study|Lost to Follow-up|0|||
19402206|NCT02504671|41647106|FG004|Overall Study|Lost to Follow-up|0|||
19402207|NCT02504671|41647107|FG005|Overall Study|Lost to Follow-up|1|||
19518441|NCT01514136|41931459|FG005|Test Period 2; Test A*|Holiday|0|||
19518442|NCT01514136|41931460|FG006|Test Period 2; Test A*|Holiday|0|||
19518443|NCT01514136|41931461|FG007|Test Period 2; Test A*|Holiday|0|||
19518444|NCT01514136|41931454|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518445|NCT01514136|41931455|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518446|NCT01514136|41931456|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518447|NCT01514136|41931457|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518448|NCT01514136|41931458|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518449|NCT01514136|41931459|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
19518450|NCT01514136|41931460|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518451|NCT01514136|41931461|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
19518452|NCT01514136|41931454|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
19518453|NCT01514136|41931455|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
19518454|NCT01514136|41931456|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
19518455|NCT01514136|41931457|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
19374506|NCT03128671|41616153|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
19374507|NCT03128671|41616152|FG000|Allocation|Death|1|||
19374508|NCT03128671|41616153|FG001|Allocation|Death|0|||
19374509|NCT03128671|41616152|FG000|Allocation|Withdrawal by Subject|4|||
19374510|NCT03128671|41616153|FG001|Allocation|Withdrawal by Subject|0|||
19374511|NCT03128671|41616152|FG000|Intervention|Withdrawal by Subject|11|||
19374512|NCT03128671|41616153|FG001|Intervention|Withdrawal by Subject|10|||
19374513|NCT03128671|41616152|FG000|Intervention|Palliative/hospice care initiated|9|||
19374514|NCT03128671|41616153|FG001|Intervention|Palliative/hospice care initiated|10|||
19374515|NCT03128671|41616152|FG000|Intervention|Death|13|||
19374516|NCT03128671|41616153|FG001|Intervention|Death|11|||
19374517|NCT03128671|41616152|FG000|Intervention|Interrupted by hurricane|1|||
19374518|NCT03128671|41616153|FG001|Intervention|Interrupted by hurricane|0|||
19374519|NCT03128671|41616152|FG000|Intervention|Physician Decision|2|||
19374520|NCT03128671|41616153|FG001|Intervention|Physician Decision|3|||
19374521|NCT02925338|41616164|FG000|Overall Study|Death|0|||
19374522|NCT02925338|41616165|FG001|Overall Study|Death|2|||
19374523|NCT02925338|41616166|FG002|Overall Study|Death|1|||
19374524|NCT02925338|41616167|FG003|Overall Study|Death|0|||
19402208|NCT02504671|41647102|FG000|Overall Study|Protocol defined stopping criteria|7|||
19402209|NCT02504671|41647103|FG001|Overall Study|Protocol defined stopping criteria|4|||
19402210|NCT02504671|41647104|FG002|Overall Study|Protocol defined stopping criteria|3|||
19402211|NCT02504671|41647105|FG003|Overall Study|Protocol defined stopping criteria|5|||
19402212|NCT02504671|41647106|FG004|Overall Study|Protocol defined stopping criteria|3|||
19402213|NCT02504671|41647107|FG005|Overall Study|Protocol defined stopping criteria|3|||
19402214|NCT02314143|41647124|FG000|Overall Study|Adverse Event|0|||
19402215|NCT02314143|41647125|FG001|Overall Study|Adverse Event|6|||
19402216|NCT02314143|41647126|FG002|Overall Study|Adverse Event|4|||
19402217|NCT02314143|41647124|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
19402218|NCT02314143|41647125|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
19402219|NCT02314143|41647126|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
19402220|NCT02314143|41647124|FG000|Overall Study|Physician Decision|2|||
19402221|NCT02314143|41647125|FG001|Overall Study|Physician Decision|1|||
19402222|NCT02314143|41647126|FG002|Overall Study|Physician Decision|0|||
19402223|NCT02314143|41647124|FG000|Overall Study|Withdrawal by Subject|1|||
19402224|NCT02314143|41647125|FG001|Overall Study|Withdrawal by Subject|0|||
19402225|NCT02314143|41647126|FG002|Overall Study|Withdrawal by Subject|1|||
19402226|NCT02288091|41647135|FG000|Overall Study|Lost to Follow-up|1|||
19402227|NCT02288091|41647135|FG000|Overall Study|Screen fail|7|||
19402228|NCT02503501|41647141|FG000|Overall Study|Physician Decision|1|||
19402229|NCT02503501|41647142|FG001|Overall Study|Physician Decision|0|||
19402230|NCT02503501|41647141|FG000|Overall Study|Protocol Violation|0|||
19402231|NCT02503501|41647142|FG001|Overall Study|Protocol Violation|1|||
19402232|NCT02503501|41647141|FG000|Overall Study|Withdrawal by Subject|0|||
19402233|NCT02503501|41647142|FG001|Overall Study|Withdrawal by Subject|2|||
19402234|NCT02502097|41647152|FG000|Period 1|Adverse Event|0|||
19402235|NCT02502097|41647153|FG001|Period 1|Adverse Event|0|||
19402236|NCT02502097|41647154|FG002|Period 1|Adverse Event|1|||
19402237|NCT02502097|41647155|FG003|Period 1|Adverse Event|0|||
19402238|NCT02502097|41647152|FG000|Wash Out Period|Adverse Event|0|||
19402239|NCT02502097|41647153|FG001|Wash Out Period|Adverse Event|1|||
19402240|NCT02502097|41647154|FG002|Wash Out Period|Adverse Event|1|||
19402241|NCT02502097|41647155|FG003|Wash Out Period|Adverse Event|1|||
19402242|NCT02502097|41647152|FG000|Period 2|Adverse Event|0|||
19402243|NCT02502097|41647153|FG001|Period 2|Adverse Event|0|||
19402244|NCT02502097|41647154|FG002|Period 2|Adverse Event|1|||
19402245|NCT02502097|41647155|FG003|Period 2|Adverse Event|0|||
19402246|NCT02501629|41647164|FG000|Overall Study|Death|0|||
19402247|NCT02501629|41647165|FG001|Overall Study|Death|1|||
19402248|NCT02501629|41647164|FG000|Overall Study|Withdrawn from study by sponsor|1|||
19402249|NCT02501629|41647165|FG001|Overall Study|Withdrawn from study by sponsor|0|||
19402250|NCT02501629|41647164|FG000|Overall Study|Early termination by sponsor|1|||
19402251|NCT02501629|41647165|FG001|Overall Study|Early termination by sponsor|0|||
19402252|NCT02501629|41647164|FG000|Overall Study|Withdrawal by Subject|3|||
19402253|NCT02501629|41647165|FG001|Overall Study|Withdrawal by Subject|5|||
19402254|NCT02501629|41647164|FG000|Overall Study|Subject did not return to site|0|||
19402255|NCT02501629|41647165|FG001|Overall Study|Subject did not return to site|1|||
19402256|NCT02501473|41647178|FG000|Overall Study|Study Terminated|2|||
19402257|NCT02501473|41647179|FG001|Overall Study|Study Terminated|3|||
19402258|NCT02501473|41647180|FG002|Overall Study|Study Terminated|7|||
19402259|NCT02501473|41647181|FG003|Overall Study|Study Terminated|9|||
19402260|NCT02501473|41647182|FG004|Overall Study|Study Terminated|2|||
19402261|NCT02501473|41647183|FG005|Overall Study|Study Terminated|10|||
19402262|NCT02501473|41647184|FG006|Overall Study|Study Terminated|1|||
19402263|NCT02501473|41647185|FG007|Overall Study|Study Terminated|0|||
19402264|NCT02501473|41647178|FG000|Overall Study|Withdrawal by Subject|0|||
19402265|NCT02501473|41647179|FG001|Overall Study|Withdrawal by Subject|0|||
19402266|NCT02501473|41647180|FG002|Overall Study|Withdrawal by Subject|3|||
19402267|NCT02501473|41647181|FG003|Overall Study|Withdrawal by Subject|3|||
19402268|NCT02501473|41647182|FG004|Overall Study|Withdrawal by Subject|2|||
19402269|NCT02501473|41647183|FG005|Overall Study|Withdrawal by Subject|2|||
19402270|NCT02501473|41647184|FG006|Overall Study|Withdrawal by Subject|0|||
19402271|NCT02501473|41647185|FG007|Overall Study|Withdrawal by Subject|0|||
19402272|NCT02501473|41647178|FG000|Overall Study|Death|0|||
19402273|NCT02501473|41647179|FG001|Overall Study|Death|0|||
19402274|NCT02501473|41647180|FG002|Overall Study|Death|1|||
19402275|NCT02501473|41647181|FG003|Overall Study|Death|1|||
19402276|NCT02501473|41647182|FG004|Overall Study|Death|0|||
19402277|NCT02501473|41647183|FG005|Overall Study|Death|1|||
19402278|NCT02501473|41647184|FG006|Overall Study|Death|0|||
19402279|NCT02501473|41647185|FG007|Overall Study|Death|0|||
19402280|NCT02501473|41647178|FG000|Overall Study|Lost to Follow-up|1|||
19402281|NCT02501473|41647179|FG001|Overall Study|Lost to Follow-up|0|||
19402282|NCT02501473|41647180|FG002|Overall Study|Lost to Follow-up|1|||
19402283|NCT02501473|41647181|FG003|Overall Study|Lost to Follow-up|0|||
19402284|NCT02501473|41647182|FG004|Overall Study|Lost to Follow-up|0|||
19402285|NCT02501473|41647183|FG005|Overall Study|Lost to Follow-up|1|||
19402286|NCT02501473|41647184|FG006|Overall Study|Lost to Follow-up|0|||
19402287|NCT02501473|41647185|FG007|Overall Study|Lost to Follow-up|0|||
19402288|NCT02501473|41647178|FG000|Overall Study|Reason not specified|0|||
19402289|NCT02501473|41647179|FG001|Overall Study|Reason not specified|0|||
19402290|NCT02501473|41647180|FG002|Overall Study|Reason not specified|1|||
19402291|NCT02501473|41647181|FG003|Overall Study|Reason not specified|1|||
19402292|NCT02501473|41647182|FG004|Overall Study|Reason not specified|0|||
19402293|NCT02501473|41647183|FG005|Overall Study|Reason not specified|0|||
19402294|NCT02501473|41647184|FG006|Overall Study|Reason not specified|0|||
19402295|NCT02501473|41647185|FG007|Overall Study|Reason not specified|0|||
19402296|NCT02501161|41647203|FG000|Overall Study|Adverse Event|2|||
19402297|NCT02501161|41647204|FG001|Overall Study|Adverse Event|6|||
19402298|NCT02501161|41647203|FG000|Overall Study|Lost to Follow-up|7|||
19402299|NCT02501161|41647204|FG001|Overall Study|Lost to Follow-up|4|||
19402300|NCT02501161|41647203|FG000|Overall Study|Withdrawal by Subject|10|||
19402301|NCT02501161|41647204|FG001|Overall Study|Withdrawal by Subject|15|||
19402302|NCT02501161|41647203|FG000|Overall Study|Other|3|||
19402303|NCT02501161|41647204|FG001|Overall Study|Other|0|||
19402304|NCT02500537|41647212|FG000|Overall Study|Death|2|||
19402305|NCT02500537|41647213|FG001|Overall Study|Death|0|||
19402306|NCT02500537|41647212|FG000|Overall Study|Lost to Follow-up|0|||
19402307|NCT02500537|41647213|FG001|Overall Study|Lost to Follow-up|1|||
19402308|NCT02500537|41647212|FG000|Overall Study|Withdrawal by Subject|1|||
19402309|NCT02500537|41647213|FG001|Overall Study|Withdrawal by Subject|0|||
19402310|NCT02498821|41647222|FG000|Overall Study|Screen failure|3|||
19402311|NCT02498821|41647223|FG001|Overall Study|Screen failure|5|||
19402312|NCT02313909|41647231|FG000|Overall Study|Consent withdrawn by participant|33|||
19402313|NCT02313909|41647232|FG001|Overall Study|Consent withdrawn by participant|33|||
19402314|NCT02313909|41647231|FG000|Overall Study|Lost to Follow-up|24|||
19402315|NCT02313909|41647232|FG001|Overall Study|Lost to Follow-up|17|||
19402316|NCT02287467|41647240|FG000|Overall Study|Protocol Violation|12|||
19402317|NCT02287467|41647241|FG001|Overall Study|Protocol Violation|9|||
19402318|NCT02287233|41647253|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
19402319|NCT02287233|41647254|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
19402320|NCT02287233|41647255|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
19402321|NCT02287233|41647253|FG000|Overall Study|Adverse Event Related to Progression|0|||
19402322|NCT02287233|41647254|FG001|Overall Study|Adverse Event Related to Progression|2|||
19402323|NCT02287233|41647255|FG002|Overall Study|Adverse Event Related to Progression|8|||
19402324|NCT02287233|41647253|FG000|Overall Study|Physician Decision|1|||
19402325|NCT02287233|41647254|FG001|Overall Study|Physician Decision|2|||
19402326|NCT02287233|41647255|FG002|Overall Study|Physician Decision|4|||
19402327|NCT02287233|41647253|FG000|Overall Study|Progressive Disease with Death|0|||
19402328|NCT02287233|41647254|FG001|Overall Study|Progressive Disease with Death|0|||
19402329|NCT02287233|41647255|FG002|Overall Study|Progressive Disease with Death|10|||
19402330|NCT02287233|41647253|FG000|Overall Study|Progressive Disease Without Death|2|||
19402331|NCT02287233|41647254|FG001|Overall Study|Progressive Disease Without Death|3|||
19402332|NCT02287233|41647255|FG002|Overall Study|Progressive Disease Without Death|20|||
19402333|NCT02287233|41647253|FG000|Overall Study|Withdrawal by Subject|1|||
19402334|NCT02287233|41647254|FG001|Overall Study|Withdrawal by Subject|1|||
19402335|NCT02287233|41647255|FG002|Overall Study|Withdrawal by Subject|7|||
19402336|NCT02287233|41647253|FG000|Overall Study|Other|3|||
19402337|NCT02287233|41647254|FG001|Overall Study|Other|0|||
19402338|NCT02287233|41647255|FG002|Overall Study|Other|15|||
19402339|NCT02287233|41647253|FG000|Overall Study|Did Not Receive Treatment|0|||
19402340|NCT02287233|41647254|FG001|Overall Study|Did Not Receive Treatment|0|||
19402341|NCT02287233|41647255|FG002|Overall Study|Did Not Receive Treatment|2|||
19402342|NCT01646385|41647268|FG000|Overall Study|Death|202|||
19402343|NCT01646385|41647269|FG001|Overall Study|Death|222|||
19402344|NCT01646385|41647268|FG000|Overall Study|Switched to alternate biologic|636|||
19402345|NCT01646385|41647269|FG001|Overall Study|Switched to alternate biologic|649|||
19402346|NCT02286843|41647275|FG000|Overall Study|Not Treated|4|||
19402347|NCT02286843|41647275|FG000|Overall Study|Protocol Violation|1|||
19402348|NCT02286843|41647275|FG000|Overall Study|Withdrawal by Subject|1|||
19402349|NCT02282163|41647279|FG000|Overall Study|Protocol Violation|1|||
19402350|NCT02281773|41647297|FG000|Overall Study|Adverse Event|6|||
19402351|NCT02281773|41647298|FG001|Overall Study|Adverse Event|1|||
19402352|NCT02281773|41647299|FG002|Overall Study|Adverse Event|4|||
19402353|NCT02281773|41647300|FG003|Overall Study|Adverse Event|8|||
19402354|NCT02281773|41647301|FG004|Overall Study|Adverse Event|9|||
19402355|NCT02281773|41647297|FG000|Overall Study|Protocol Violation|1|||
19402356|NCT02281773|41647298|FG001|Overall Study|Protocol Violation|0|||
19402357|NCT02281773|41647299|FG002|Overall Study|Protocol Violation|0|||
19402358|NCT02281773|41647300|FG003|Overall Study|Protocol Violation|2|||
19402359|NCT02281773|41647301|FG004|Overall Study|Protocol Violation|2|||
19402360|NCT02281773|41647297|FG000|Overall Study|Lost to Follow-up|2|||
19402361|NCT02281773|41647298|FG001|Overall Study|Lost to Follow-up|2|||
19402362|NCT02281773|41647299|FG002|Overall Study|Lost to Follow-up|6|||
19402363|NCT02281773|41647300|FG003|Overall Study|Lost to Follow-up|2|||
19402364|NCT02281773|41647301|FG004|Overall Study|Lost to Follow-up|10|||
19402365|NCT02281773|41647297|FG000|Overall Study|Withdrawal by Subject|2|||
19402366|NCT02281773|41647298|FG001|Overall Study|Withdrawal by Subject|8|||
19402367|NCT02281773|41647299|FG002|Overall Study|Withdrawal by Subject|6|||
19402368|NCT02281773|41647300|FG003|Overall Study|Withdrawal by Subject|6|||
19402369|NCT02281773|41647301|FG004|Overall Study|Withdrawal by Subject|8|||
19402370|NCT02281773|41647297|FG000|Overall Study|Other Reason|0|||
19402371|NCT02281773|41647298|FG001|Overall Study|Other Reason|4|||
19402372|NCT02281773|41647299|FG002|Overall Study|Other Reason|2|||
19402373|NCT02281773|41647300|FG003|Overall Study|Other Reason|3|||
19402374|NCT02281773|41647301|FG004|Overall Study|Other Reason|1|||
19402375|NCT02285361|41647313|FG000|Overall Study|Protocol Violation|43|||
19402376|NCT02285361|41647313|FG000|Overall Study|Lost to Follow-up|5|||
19402377|NCT02285361|41647313|FG000|Overall Study|Not taken GIOTRIF|2|||
19402378|NCT02285361|41647313|FG000|Overall Study|Consented prior to the contract date|1|||
19402379|NCT02354235|41647319|FG000|Overall Study|Adverse Event|2|||
19402380|NCT02354235|41647320|FG001|Overall Study|Adverse Event|2|||
19402381|NCT02354235|41647319|FG000|Overall Study|Physician Decision|0|||
19402382|NCT02354235|41647320|FG001|Overall Study|Physician Decision|1|||
19402383|NCT02354235|41647319|FG000|Overall Study|Withdrawal by Subject|1|||
19402384|NCT02354235|41647320|FG001|Overall Study|Withdrawal by Subject|3|||
19402385|NCT02354235|41647319|FG000|Overall Study|Conflict with the stopping criteria|0|||
19402386|NCT02354235|41647320|FG001|Overall Study|Conflict with the stopping criteria|1|||
19402387|NCT02280291|41647330|FG000|Overall Study|Lost to Follow-up|2|||
19402388|NCT02280291|41647331|FG001|Overall Study|Lost to Follow-up|1|||
19402389|NCT02280291|41647332|FG002|Overall Study|Lost to Follow-up|3|||
19402390|NCT02280291|41647333|FG003|Overall Study|Lost to Follow-up|8|||
19402391|NCT02280291|41647330|FG000|Overall Study|Protocol Violation|1|||
19402392|NCT02280291|41647331|FG001|Overall Study|Protocol Violation|0|||
19402393|NCT02280291|41647332|FG002|Overall Study|Protocol Violation|0|||
19402394|NCT02280291|41647333|FG003|Overall Study|Protocol Violation|0|||
19402395|NCT02280291|41647330|FG000|Overall Study|Other|1|||
19402396|NCT02280291|41647331|FG001|Overall Study|Other|1|||
19402397|NCT02280291|41647332|FG002|Overall Study|Other|0|||
19402398|NCT02280291|41647333|FG003|Overall Study|Other|0|||
19402399|NCT02284893|41647347|FG000|26 Week (Short Term)|Adverse Event|1|||
19402400|NCT02284893|41647348|FG001|26 Week (Short Term)|Adverse Event|9|||
19402401|NCT02284893|41647347|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
19402402|NCT02284893|41647348|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
19402403|NCT02284893|41647347|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
19402404|NCT02284893|41647348|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
19402405|NCT02284893|41647347|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
19402406|NCT02284893|41647348|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
19402407|NCT02284893|41647347|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
19402408|NCT02284893|41647348|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
19402409|NCT02284893|41647347|FG000|26 Week (Short Term)|Other|1|||
19402410|NCT02284893|41647348|FG001|26 Week (Short Term)|Other|1|||
19402411|NCT02284893|41647347|FG000|52 Week (Long Term)|Adverse Event|3|||
19402412|NCT02284893|41647348|FG001|52 Week (Long Term)|Adverse Event|1|||
19402413|NCT02284893|41647347|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
19402414|NCT02284893|41647348|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
19402415|NCT02284893|41647347|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
19402416|NCT02284893|41647348|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
19402417|NCT02284893|41647347|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
19402418|NCT02284893|41647348|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
19402419|NCT02284893|41647347|FG000|52 Week (Long Term)|Non-Compliance|2|||
19402420|NCT02284893|41647348|FG001|52 Week (Long Term)|Non-Compliance|3|||
19402421|NCT02284347|41647354|FG000|Overall Study|Lost to Follow-up|2|||
19402422|NCT02284347|41647354|FG000|Overall Study|Withdrawn prior to treatment|1|||
19402423|NCT02279043|41647361|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
19402424|NCT02279043|41647362|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
19402425|NCT02279043|41647363|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
19402426|NCT02279043|41647361|FG000|Overall Study|Lost to Follow-up|46|||
19518456|NCT01514136|41931458|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
19518457|NCT01514136|41931459|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
19518458|NCT01514136|41931460|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
19402427|NCT02279043|41647362|FG001|Overall Study|Lost to Follow-up|88|||
19402428|NCT02279043|41647363|FG002|Overall Study|Lost to Follow-up|0|||
19402429|NCT02283411|41647369|FG000|Overall Study|Withdrawal by Subject|3|||
19402430|NCT02283411|41647369|FG000|Overall Study|Screen Failed|28|||
19402431|NCT02351817|41647373|FG000|Period 1|Adverse Event|1|||
19402432|NCT02351817|41647374|FG001|Period 1|Adverse Event|2|||
19402433|NCT02351817|41647373|FG000|Period 1|Lack of Efficacy|0|||
19402434|NCT02351817|41647374|FG001|Period 1|Lack of Efficacy|1|||
19402435|NCT02351817|41647373|FG000|Period 2|Adverse Event|0|||
19402436|NCT02351817|41647374|FG001|Period 2|Adverse Event|2|||
19518459|NCT01514136|41931461|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
19402437|NCT02351817|41647373|FG000|Period 2|Protocol Violation|1|||
19402438|NCT02351817|41647374|FG001|Period 2|Protocol Violation|0|||
19402439|NCT02351349|41647383|FG000|Overall Study|Withdrawal by Subject|2|||
19402440|NCT02351349|41647384|FG001|Overall Study|Withdrawal by Subject|3|||
19402441|NCT02484547|41647398|FG000|Placebo-Controlled Period|Adverse Event|10|||
19402442|NCT02484547|41647399|FG001|Placebo-Controlled Period|Adverse Event|13|||
19402443|NCT02484547|41647400|FG002|Placebo-Controlled Period|Adverse Event|20|||
19402444|NCT02484547|41647401|FG003|Placebo-Controlled Period|Adverse Event|0|||
19402445|NCT02484547|41647402|FG004|Placebo-Controlled Period|Adverse Event|0|||
19402446|NCT02484547|41647403|FG005|Placebo-Controlled Period|Adverse Event|0|||
19402447|NCT02484547|41647404|FG006|Placebo-Controlled Period|Adverse Event|0|||
19402448|NCT02484547|41647398|FG000|Placebo-Controlled Period|Change of Treatment|0|||
19402449|NCT02484547|41647399|FG001|Placebo-Controlled Period|Change of Treatment|0|||
19402450|NCT02484547|41647400|FG002|Placebo-Controlled Period|Change of Treatment|1|||
19402451|NCT02484547|41647401|FG003|Placebo-Controlled Period|Change of Treatment|0|||
19402452|NCT02484547|41647402|FG004|Placebo-Controlled Period|Change of Treatment|0|||
19402453|NCT02484547|41647403|FG005|Placebo-Controlled Period|Change of Treatment|0|||
19402454|NCT02484547|41647404|FG006|Placebo-Controlled Period|Change of Treatment|0|||
19402455|NCT02484547|41647398|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
19402456|NCT02484547|41647399|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
19402457|NCT02484547|41647400|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
19402458|NCT02484547|41647401|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
19402459|NCT02484547|41647402|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
19402460|NCT02484547|41647403|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
19402461|NCT02484547|41647404|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
19402462|NCT02484547|41647398|FG000|Placebo-Controlled Period|Death|5|||
19402463|NCT02484547|41647399|FG001|Placebo-Controlled Period|Death|0|||
19402464|NCT02484547|41647400|FG002|Placebo-Controlled Period|Death|6|||
19402465|NCT02484547|41647401|FG003|Placebo-Controlled Period|Death|0|||
19402466|NCT02484547|41647402|FG004|Placebo-Controlled Period|Death|0|||
19402467|NCT02484547|41647403|FG005|Placebo-Controlled Period|Death|0|||
19402468|NCT02484547|41647404|FG006|Placebo-Controlled Period|Death|0|||
19402469|NCT02484547|41647398|FG000|Placebo-Controlled Period|Disease Progression|2|||
19402470|NCT02484547|41647399|FG001|Placebo-Controlled Period|Disease Progression|0|||
19402471|NCT02484547|41647400|FG002|Placebo-Controlled Period|Disease Progression|1|||
19402472|NCT02484547|41647401|FG003|Placebo-Controlled Period|Disease Progression|0|||
19402473|NCT02484547|41647402|FG004|Placebo-Controlled Period|Disease Progression|0|||
19402474|NCT02484547|41647403|FG005|Placebo-Controlled Period|Disease Progression|0|||
19402475|NCT02484547|41647404|FG006|Placebo-Controlled Period|Disease Progression|0|||
19402476|NCT02484547|41647398|FG000|Placebo-Controlled Period|Investigator Decision|2|||
19402477|NCT02484547|41647399|FG001|Placebo-Controlled Period|Investigator Decision|2|||
19402478|NCT02484547|41647400|FG002|Placebo-Controlled Period|Investigator Decision|5|||
19402479|NCT02484547|41647401|FG003|Placebo-Controlled Period|Investigator Decision|0|||
19402480|NCT02484547|41647402|FG004|Placebo-Controlled Period|Investigator Decision|0|||
19402481|NCT02484547|41647403|FG005|Placebo-Controlled Period|Investigator Decision|0|||
19402482|NCT02484547|41647404|FG006|Placebo-Controlled Period|Investigator Decision|0|||
19402483|NCT02484547|41647398|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
19402484|NCT02484547|41647399|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
19402485|NCT02484547|41647400|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
19402486|NCT02484547|41647401|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
19402487|NCT02484547|41647402|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
19402488|NCT02484547|41647403|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
19402489|NCT02484547|41647404|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
19402490|NCT02484547|41647398|FG000|Placebo-Controlled Period|Relocation|1|||
19402491|NCT02484547|41647399|FG001|Placebo-Controlled Period|Relocation|1|||
19402492|NCT02484547|41647400|FG002|Placebo-Controlled Period|Relocation|1|||
19402493|NCT02484547|41647401|FG003|Placebo-Controlled Period|Relocation|0|||
19402494|NCT02484547|41647402|FG004|Placebo-Controlled Period|Relocation|0|||
19402495|NCT02484547|41647403|FG005|Placebo-Controlled Period|Relocation|0|||
19402496|NCT02484547|41647404|FG006|Placebo-Controlled Period|Relocation|0|||
19402497|NCT02484547|41647398|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
19402498|NCT02484547|41647399|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
19402499|NCT02484547|41647400|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
19402500|NCT02484547|41647401|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
19402501|NCT02484547|41647402|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
19402502|NCT02484547|41647403|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
19402503|NCT02484547|41647404|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
19402504|NCT02484547|41647398|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
19402505|NCT02484547|41647399|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
19402506|NCT02484547|41647400|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
19711061|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
19711062|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
19402507|NCT02484547|41647401|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19402508|NCT02484547|41647402|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19402509|NCT02484547|41647403|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19402510|NCT02484547|41647404|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
19402511|NCT02484547|41647398|FG000|Placebo-Controlled Period|Reason not Specified|216|||
19402512|NCT02484547|41647399|FG001|Placebo-Controlled Period|Reason not Specified|194|||
19402513|NCT02484547|41647400|FG002|Placebo-Controlled Period|Reason not Specified|183|||
19402514|NCT02484547|41647401|FG003|Placebo-Controlled Period|Reason not Specified|0|||
19402515|NCT02484547|41647402|FG004|Placebo-Controlled Period|Reason not Specified|0|||
19402516|NCT02484547|41647403|FG005|Placebo-Controlled Period|Reason not Specified|0|||
19402517|NCT02484547|41647404|FG006|Placebo-Controlled Period|Reason not Specified|0|||
19402518|NCT02484547|41647398|FG000|Long-Term Extension Period|Adverse Event|0|||
19402519|NCT02484547|41647399|FG001|Long-Term Extension Period|Adverse Event|0|||
19402520|NCT02484547|41647400|FG002|Long-Term Extension Period|Adverse Event|0|||
19402521|NCT02484547|41647401|FG003|Long-Term Extension Period|Adverse Event|0|||
19402522|NCT02484547|41647402|FG004|Long-Term Extension Period|Adverse Event|1|||
19402523|NCT02484547|41647403|FG005|Long-Term Extension Period|Adverse Event|3|||
19402524|NCT02484547|41647404|FG006|Long-Term Extension Period|Adverse Event|2|||
19402525|NCT02484547|41647398|FG000|Long-Term Extension Period|Death|0|||
19402526|NCT02484547|41647399|FG001|Long-Term Extension Period|Death|0|||
19402527|NCT02484547|41647400|FG002|Long-Term Extension Period|Death|0|||
19402528|NCT02484547|41647401|FG003|Long-Term Extension Period|Death|0|||
19402529|NCT02484547|41647402|FG004|Long-Term Extension Period|Death|0|||
19402530|NCT02484547|41647403|FG005|Long-Term Extension Period|Death|3|||
19402531|NCT02484547|41647404|FG006|Long-Term Extension Period|Death|0|||
19402532|NCT02484547|41647398|FG000|Long-Term Extension Period|Disease Progression|0|||
19402533|NCT02484547|41647399|FG001|Long-Term Extension Period|Disease Progression|0|||
19402534|NCT02484547|41647400|FG002|Long-Term Extension Period|Disease Progression|0|||
19402535|NCT02484547|41647401|FG003|Long-Term Extension Period|Disease Progression|0|||
19402536|NCT02484547|41647402|FG004|Long-Term Extension Period|Disease Progression|2|||
19402537|NCT02484547|41647403|FG005|Long-Term Extension Period|Disease Progression|4|||
19402538|NCT02484547|41647404|FG006|Long-Term Extension Period|Disease Progression|0|||
19402539|NCT02484547|41647398|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
19402540|NCT02484547|41647399|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
19402541|NCT02484547|41647400|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
19402542|NCT02484547|41647401|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
19402543|NCT02484547|41647402|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
19402544|NCT02484547|41647403|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
19402545|NCT02484547|41647404|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
19402546|NCT02484547|41647398|FG000|Long-Term Extension Period|Loss of Capacity|0|||
19402547|NCT02484547|41647399|FG001|Long-Term Extension Period|Loss of Capacity|0|||
19402548|NCT02484547|41647400|FG002|Long-Term Extension Period|Loss of Capacity|0|||
19402549|NCT02484547|41647401|FG003|Long-Term Extension Period|Loss of Capacity|0|||
19402550|NCT02484547|41647402|FG004|Long-Term Extension Period|Loss of Capacity|1|||
19402551|NCT02484547|41647403|FG005|Long-Term Extension Period|Loss of Capacity|0|||
19402552|NCT02484547|41647404|FG006|Long-Term Extension Period|Loss of Capacity|0|||
19402553|NCT02484547|41647398|FG000|Long-Term Extension Period|Change of Treatment|0|||
19402554|NCT02484547|41647399|FG001|Long-Term Extension Period|Change of Treatment|0|||
19402555|NCT02484547|41647400|FG002|Long-Term Extension Period|Change of Treatment|0|||
19402556|NCT02484547|41647401|FG003|Long-Term Extension Period|Change of Treatment|0|||
19402557|NCT02484547|41647402|FG004|Long-Term Extension Period|Change of Treatment|0|||
19402558|NCT02484547|41647403|FG005|Long-Term Extension Period|Change of Treatment|0|||
19402559|NCT02484547|41647404|FG006|Long-Term Extension Period|Change of Treatment|1|||
19402560|NCT02484547|41647398|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
19402561|NCT02484547|41647399|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
19402562|NCT02484547|41647400|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
19402563|NCT02484547|41647401|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
19402564|NCT02484547|41647402|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
19402565|NCT02484547|41647403|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
19402566|NCT02484547|41647404|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
19402567|NCT02484547|41647398|FG000|Long-Term Extension Period|Investigator Decision|0|||
19402568|NCT02484547|41647399|FG001|Long-Term Extension Period|Investigator Decision|0|||
19402569|NCT02484547|41647400|FG002|Long-Term Extension Period|Investigator Decision|0|||
19402570|NCT02484547|41647401|FG003|Long-Term Extension Period|Investigator Decision|2|||
19402571|NCT02484547|41647402|FG004|Long-Term Extension Period|Investigator Decision|1|||
19402572|NCT02484547|41647403|FG005|Long-Term Extension Period|Investigator Decision|0|||
19402573|NCT02484547|41647404|FG006|Long-Term Extension Period|Investigator Decision|1|||
19402574|NCT02484547|41647398|FG000|Long-Term Extension Period|Relocation|0|||
19402575|NCT02484547|41647399|FG001|Long-Term Extension Period|Relocation|0|||
19402576|NCT02484547|41647400|FG002|Long-Term Extension Period|Relocation|0|||
19402577|NCT02484547|41647401|FG003|Long-Term Extension Period|Relocation|1|||
19518460|NCT01514136|41931454|FG000|Test Period 2; Test C*|holiday|0|||
19402578|NCT02484547|41647402|FG004|Long-Term Extension Period|Relocation|1|||
19402579|NCT02484547|41647403|FG005|Long-Term Extension Period|Relocation|0|||
19402580|NCT02484547|41647404|FG006|Long-Term Extension Period|Relocation|0|||
19402581|NCT02484547|41647398|FG000|Long-Term Extension Period|Study Visit Burden|0|||
19402582|NCT02484547|41647399|FG001|Long-Term Extension Period|Study Visit Burden|0|||
19402583|NCT02484547|41647400|FG002|Long-Term Extension Period|Study Visit Burden|0|||
19402584|NCT02484547|41647401|FG003|Long-Term Extension Period|Study Visit Burden|2|||
19402585|NCT02484547|41647402|FG004|Long-Term Extension Period|Study Visit Burden|0|||
19402586|NCT02484547|41647403|FG005|Long-Term Extension Period|Study Visit Burden|0|||
19402587|NCT02484547|41647404|FG006|Long-Term Extension Period|Study Visit Burden|3|||
19402588|NCT02484547|41647398|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
19402589|NCT02484547|41647399|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
19402590|NCT02484547|41647400|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
19402591|NCT02484547|41647401|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
19402592|NCT02484547|41647402|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
19402593|NCT02484547|41647403|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
19402594|NCT02484547|41647404|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
19402595|NCT02484547|41647398|FG000|Long-Term Extension Period|Reason not Specified|0|||
19402596|NCT02484547|41647399|FG001|Long-Term Extension Period|Reason not Specified|0|||
19402597|NCT02484547|41647400|FG002|Long-Term Extension Period|Reason not Specified|0|||
19402598|NCT02484547|41647401|FG003|Long-Term Extension Period|Reason not Specified|119|||
19402599|NCT02484547|41647402|FG004|Long-Term Extension Period|Reason not Specified|117|||
19402600|NCT02484547|41647403|FG005|Long-Term Extension Period|Reason not Specified|223|||
19402601|NCT02484547|41647404|FG006|Long-Term Extension Period|Reason not Specified|231|||
19402602|NCT02517541|41647416|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
19402603|NCT02517541|41647416|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
19402604|NCT02517541|41647416|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
19402605|NCT02517541|41647416|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
19402606|NCT02517541|41647416|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
19402607|NCT02517541|41647416|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
19402608|NCT02496091|41647422|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19402609|NCT02483611|41647430|FG000|Overall Study|Protocol Violation|0|||
19402610|NCT02483611|41647431|FG001|Overall Study|Protocol Violation|0|||
19402611|NCT02483611|41647432|FG002|Overall Study|Protocol Violation|1|||
19402612|NCT02483533|41647442|FG000|Overall Study|Lack of Efficacy|50|||
19402613|NCT02483533|41647443|FG001|Overall Study|Lack of Efficacy|50|||
19402614|NCT02482129|41647451|FG000|Overall Study|Adverse Event-prior to treatment|0|||
19402615|NCT02482129|41647452|FG001|Overall Study|Adverse Event-prior to treatment|1|||
19402616|NCT02482129|41647451|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
19402617|NCT02482129|41647452|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
19402618|NCT02482129|41647451|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
19402619|NCT02482129|41647452|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
19402620|NCT02482129|41647451|FG000|Overall Study|Criteria not met-prior to treatment|1|||
19402621|NCT02482129|41647452|FG001|Overall Study|Criteria not met-prior to treatment|0|||
19402622|NCT02482129|41647451|FG000|Overall Study|Adverse Event|1|||
19402623|NCT02482129|41647452|FG001|Overall Study|Adverse Event|0|||
19402624|NCT02482129|41647451|FG000|Overall Study|Withdrawal by Subject|2|||
19402625|NCT02482129|41647452|FG001|Overall Study|Withdrawal by Subject|0|||
19402626|NCT02482129|41647451|FG000|Overall Study|Criteria not met|1|||
19402627|NCT02482129|41647452|FG001|Overall Study|Criteria not met|0|||
19402628|NCT02495857|41647463|FG000|Overall Study|Adverse Event|5|||
19402629|NCT02495857|41647464|FG001|Overall Study|Adverse Event|0|||
19402630|NCT02495857|41647465|FG002|Overall Study|Adverse Event|1|||
19402631|NCT02495857|41647463|FG000|Overall Study|Withdrawal by Subject|9|||
19402632|NCT02495857|41647464|FG001|Overall Study|Withdrawal by Subject|6|||
19402633|NCT02495857|41647465|FG002|Overall Study|Withdrawal by Subject|10|||
19402634|NCT02495857|41647463|FG000|Overall Study|Physician Decision|0|||
19402635|NCT02495857|41647464|FG001|Overall Study|Physician Decision|1|||
19402636|NCT02495857|41647465|FG002|Overall Study|Physician Decision|0|||
19402637|NCT02495857|41647463|FG000|Overall Study|Protocol Violation|1|||
19402638|NCT02495857|41647464|FG001|Overall Study|Protocol Violation|1|||
19402639|NCT02495857|41647465|FG002|Overall Study|Protocol Violation|2|||
19402640|NCT02495857|41647463|FG000|Overall Study|Lost to Follow-up|4|||
19402641|NCT02495857|41647464|FG001|Overall Study|Lost to Follow-up|5|||
19402642|NCT02495857|41647465|FG002|Overall Study|Lost to Follow-up|3|||
19711063|NCT03605680|42154231|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
19711064|NCT03605680|42154232|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
19402643|NCT02495857|41647463|FG000|Overall Study|Other|3|||
19402644|NCT02495857|41647464|FG001|Overall Study|Other|3|||
19402645|NCT02495857|41647465|FG002|Overall Study|Other|2|||
19402646|NCT02495389|41647473|FG000|Overall Study|Withdrawal by Subject|40|||
19402647|NCT02495233|41647479|FG000|Overall Study|Miscellaneous|0|||
19402648|NCT02495233|41647480|FG001|Overall Study|Miscellaneous|1|||
19402649|NCT02495077|41647488|FG000|Overall Study|Adverse Event|0|||
19402650|NCT02495077|41647489|FG001|Overall Study|Adverse Event|1|||
19402651|NCT02495077|41647490|FG002|Overall Study|Adverse Event|1|||
19402652|NCT02495077|41647491|FG003|Overall Study|Adverse Event|0|||
19402653|NCT02495077|41647488|FG000|Overall Study|Death|3|||
19402654|NCT02495077|41647489|FG001|Overall Study|Death|5|||
19402655|NCT02495077|41647490|FG002|Overall Study|Death|0|||
19402656|NCT02495077|41647491|FG003|Overall Study|Death|0|||
19402657|NCT02495077|41647488|FG000|Overall Study|Lost to Follow-up|6|||
19402658|NCT02495077|41647489|FG001|Overall Study|Lost to Follow-up|4|||
19402659|NCT02495077|41647490|FG002|Overall Study|Lost to Follow-up|0|||
19402660|NCT02495077|41647491|FG003|Overall Study|Lost to Follow-up|0|||
19402661|NCT02495077|41647488|FG000|Overall Study|Physician Decision|2|||
19402662|NCT02495077|41647489|FG001|Overall Study|Physician Decision|1|||
19402663|NCT02495077|41647490|FG002|Overall Study|Physician Decision|4|||
19402664|NCT02495077|41647491|FG003|Overall Study|Physician Decision|0|||
19402665|NCT02495077|41647488|FG000|Overall Study|Protocol Violation|0|||
19402666|NCT02495077|41647489|FG001|Overall Study|Protocol Violation|1|||
19402667|NCT02495077|41647490|FG002|Overall Study|Protocol Violation|0|||
19402668|NCT02495077|41647491|FG003|Overall Study|Protocol Violation|0|||
19402669|NCT02495077|41647488|FG000|Overall Study|Screen Failure|0|||
19402670|NCT02495077|41647489|FG001|Overall Study|Screen Failure|0|||
19402671|NCT02495077|41647490|FG002|Overall Study|Screen Failure|0|||
19402672|NCT02495077|41647491|FG003|Overall Study|Screen Failure|48|||
19402673|NCT02495077|41647488|FG000|Overall Study|Withdrawal by Subject|7|||
19402674|NCT02495077|41647489|FG001|Overall Study|Withdrawal by Subject|7|||
19402675|NCT02495077|41647490|FG002|Overall Study|Withdrawal by Subject|7|||
19402676|NCT02495077|41647491|FG003|Overall Study|Withdrawal by Subject|0|||
19402677|NCT02495077|41647488|FG000|Overall Study|Covid-19 research restrictions|1|||
19402678|NCT02495077|41647489|FG001|Overall Study|Covid-19 research restrictions|0|||
19402679|NCT02495077|41647490|FG002|Overall Study|Covid-19 research restrictions|0|||
19402680|NCT02495077|41647491|FG003|Overall Study|Covid-19 research restrictions|0|||
19402681|NCT02495077|41647488|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
19402682|NCT02495077|41647489|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
19402683|NCT02495077|41647490|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
19402684|NCT02495077|41647491|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
19402685|NCT02495077|41647488|FG000|Overall Study|Incarcerated|0|||
19402686|NCT02495077|41647489|FG001|Overall Study|Incarcerated|1|||
19402687|NCT02495077|41647490|FG002|Overall Study|Incarcerated|0|||
19402688|NCT02495077|41647491|FG003|Overall Study|Incarcerated|0|||
19402689|NCT02495077|41647488|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
19402690|NCT02495077|41647489|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
19402691|NCT02495077|41647490|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
19402692|NCT02495077|41647491|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
19402693|NCT02495077|41647488|FG000|Overall Study|Timing of transplant and randomization|0|||
19402694|NCT02495077|41647489|FG001|Overall Study|Timing of transplant and randomization|0|||
19402695|NCT02495077|41647490|FG002|Overall Study|Timing of transplant and randomization|5|||
19402696|NCT02495077|41647491|FG003|Overall Study|Timing of transplant and randomization|0|||
19402697|NCT02278341|41647499|FG000|Overall Study|Randomized but never received study drug|1|||
19402698|NCT02278341|41647500|FG001|Overall Study|Randomized but never received study drug|1|||
19402699|NCT02278341|41647499|FG000|Overall Study|Adverse Event|3|||
19402700|NCT02278341|41647500|FG001|Overall Study|Adverse Event|0|||
19402701|NCT02278341|41647499|FG000|Overall Study|Death|68|||
19402702|NCT02278341|41647500|FG001|Overall Study|Death|56|||
19402703|NCT02278341|41647499|FG000|Overall Study|Withdrawal by Subject|30|||
19402704|NCT02278341|41647500|FG001|Overall Study|Withdrawal by Subject|19|||
19402705|NCT02278341|41647499|FG000|Overall Study|Lost to Follow-up|0|||
19402706|NCT02278341|41647500|FG001|Overall Study|Lost to Follow-up|1|||
19402707|NCT02278341|41647499|FG000|Overall Study|Physician Decision|1|||
19402708|NCT02278341|41647500|FG001|Overall Study|Physician Decision|1|||
19402709|NCT02278341|41647499|FG000|Overall Study|Miscellaneous|15|||
19402710|NCT02278341|41647500|FG001|Overall Study|Miscellaneous|14|||
19402711|NCT02282631|41647509|FG000|Overall Study|Lost to Follow-up|2|||
19402712|NCT02282631|41647510|FG001|Overall Study|Lost to Follow-up|0|||
19402713|NCT02278263|41647525|FG000|Overall Study|Protocol Violation|7|||
19402714|NCT02278263|41647526|FG001|Overall Study|Protocol Violation|0|||
19402715|NCT02278263|41647527|FG002|Overall Study|Protocol Violation|9|||
19402716|NCT02349789|41647538|FG000|Overall Study|Withdrawal by Subject|2|||
19402717|NCT02349711|41647544|FG000|Overall Study|Withdrawal by Subject|2|||
19402718|NCT02349711|41647545|FG001|Overall Study|Withdrawal by Subject|1|||
19402719|NCT02349711|41647544|FG000|Overall Study|Lost to Follow-up|1|||
19402720|NCT02349711|41647545|FG001|Overall Study|Lost to Follow-up|1|||
19402721|NCT02494921|41647556|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
19402722|NCT02494921|41647557|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
19402723|NCT02494921|41647558|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
19402724|NCT02494921|41647559|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
19402725|NCT02494921|41647560|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
19402726|NCT02494921|41647556|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
19402727|NCT02494921|41647557|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
19402728|NCT02494921|41647558|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
19402729|NCT02494921|41647559|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
19402730|NCT02494921|41647560|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
19402731|NCT02494921|41647556|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
19402732|NCT02494921|41647557|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
19402733|NCT02494921|41647558|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
19402734|NCT02494921|41647559|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
19402735|NCT02494921|41647560|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
19402736|NCT01653847|41647580|FG000|Overall Study|Withdrawal by Subject|1|||
19402737|NCT01653847|41647581|FG001|Overall Study|Withdrawal by Subject|0|||
19402738|NCT02493751|41647589|FG000|Overall Study|Withdrawal by Subject|2|||
19402739|NCT02493751|41647590|FG001|Overall Study|Withdrawal by Subject|8|||
19402740|NCT02493751|41647589|FG000|Overall Study|Death|6|||
19402741|NCT02493751|41647590|FG001|Overall Study|Death|13|||
19402742|NCT02493751|41647589|FG000|Overall Study|Lost to Follow-up|2|||
19402743|NCT02493751|41647590|FG001|Overall Study|Lost to Follow-up|3|||
19402744|NCT02493751|41647589|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
19402745|NCT02493751|41647590|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
19402746|NCT02493517|41647599|FG000|Overall Study|Protocol Violation|1|||
19402747|NCT02493517|41647600|FG001|Overall Study|Protocol Violation|2|||
19402748|NCT02493517|41647599|FG000|Overall Study|Withdrawal by Subject|1|||
19402749|NCT02493517|41647600|FG001|Overall Study|Withdrawal by Subject|2|||
19402750|NCT02493517|41647599|FG000|Overall Study|Adverse Event|0|||
19402751|NCT02493517|41647600|FG001|Overall Study|Adverse Event|2|||
19402752|NCT02493517|41647599|FG000|Overall Study|Missed study visit|0|||
19402753|NCT02493517|41647600|FG001|Overall Study|Missed study visit|1|||
19402754|NCT02493361|41647608|FG000|Overall Study|Withdrawal by Subject|3|||
19402755|NCT02493127|41647614|FG000|Overall Study|Lost to Follow-up|1|||
19402756|NCT02493127|41647615|FG001|Overall Study|Lost to Follow-up|1|||
19402757|NCT02478463|41647623|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
19402758|NCT02478463|41647623|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
19402759|NCT02478463|41647623|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
19402760|NCT02491411|41647629|FG000|Overall Study|Physician Decision|4|||
19402761|NCT02517463|41647635|FG000|Overall Study|Lost to Follow-up|5|||
19402762|NCT02517463|41647636|FG001|Overall Study|Lost to Follow-up|2|||
19402763|NCT02516605|41647647|FG000|Overall Study|Protocol Violation|0|||
19402764|NCT02516605|41647648|FG001|Overall Study|Protocol Violation|0|||
19402765|NCT02516605|41647649|FG002|Overall Study|Protocol Violation|0|||
19402766|NCT02516605|41647650|FG003|Overall Study|Protocol Violation|0|||
19402767|NCT02516605|41647651|FG004|Overall Study|Protocol Violation|1|||
19402768|NCT02516605|41647647|FG000|Overall Study|Withdrawal by Subject|0|||
19402769|NCT02516605|41647648|FG001|Overall Study|Withdrawal by Subject|0|||
19402770|NCT02516605|41647649|FG002|Overall Study|Withdrawal by Subject|0|||
19402771|NCT02516605|41647650|FG003|Overall Study|Withdrawal by Subject|1|||
19402772|NCT02516605|41647651|FG004|Overall Study|Withdrawal by Subject|0|||
19402773|NCT02490475|41647671|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
19402774|NCT02490475|41647672|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
19402775|NCT02490475|41647673|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
19402776|NCT02490475|41647674|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
19402777|NCT02490475|41647671|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
19402778|NCT02490475|41647672|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
19402779|NCT02490475|41647673|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
19402780|NCT02490475|41647674|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
19402781|NCT02490475|41647671|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
19402782|NCT02490475|41647672|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
19402783|NCT02490475|41647673|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
19402784|NCT02490475|41647674|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
19402785|NCT02490475|41647671|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
19402786|NCT02490475|41647672|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
19402787|NCT02490475|41647673|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
19402788|NCT02490475|41647674|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
19402789|NCT02490475|41647671|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
19402790|NCT02490475|41647672|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
19402791|NCT02490475|41647673|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
19402792|NCT02490475|41647674|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
19402793|NCT02490475|41647671|FG000|Period 2: Extension Phase|Refused Treatment|0|||
19402794|NCT02490475|41647672|FG001|Period 2: Extension Phase|Refused Treatment|0|||
19402795|NCT02490475|41647673|FG002|Period 2: Extension Phase|Refused Treatment|0|||
19402796|NCT02490475|41647674|FG003|Period 2: Extension Phase|Refused Treatment|1|||
19402797|NCT02490475|41647671|FG000|Period 2: Extension Phase|Adverse Event|0|||
19402798|NCT02490475|41647672|FG001|Period 2: Extension Phase|Adverse Event|0|||
19402799|NCT02490475|41647673|FG002|Period 2: Extension Phase|Adverse Event|1|||
19402800|NCT02490475|41647674|FG003|Period 2: Extension Phase|Adverse Event|0|||
19402801|NCT02477839|41647697|FG000|Overall Study|Adverse Event|0|||
19402802|NCT02477839|41647698|FG001|Overall Study|Adverse Event|1|||
19402803|NCT02477839|41647697|FG000|Overall Study|Protocol Violation|0|||
19402804|NCT02477839|41647698|FG001|Overall Study|Protocol Violation|2|||
19402805|NCT02477839|41647697|FG000|Overall Study|Withdrawal by Subject|3|||
19402806|NCT02477839|41647698|FG001|Overall Study|Withdrawal by Subject|3|||
19402807|NCT02477839|41647697|FG000|Overall Study|Participant had PGS during V6|0|||
19402808|NCT02477839|41647698|FG001|Overall Study|Participant had PGS during V6|1|||
19402809|NCT02477839|41647697|FG000|Overall Study|Parents decided to stop medication|0|||
19402810|NCT02477839|41647698|FG001|Overall Study|Parents decided to stop medication|1|||
19402811|NCT02477839|41647697|FG000|Overall Study|Lack of tolerability|0|||
19402812|NCT02477839|41647698|FG001|Overall Study|Lack of tolerability|1|||
19402813|NCT02477839|41647697|FG000|Overall Study|Exclusion criterion|0|||
19402814|NCT02477839|41647698|FG001|Overall Study|Exclusion criterion|1|||
19402815|NCT02489773|41647708|FG000|Overall Study|Lost to Follow-up|4|||
19402816|NCT02489773|41647709|FG001|Overall Study|Lost to Follow-up|1|||
19402817|NCT02489773|41647708|FG000|Overall Study|Physician Decision|1|||
19402818|NCT02489773|41647709|FG001|Overall Study|Physician Decision|0|||
19402819|NCT02489773|41647708|FG000|Overall Study|Withdrawal by Subject|1|||
19402820|NCT02489773|41647709|FG001|Overall Study|Withdrawal by Subject|0|||
19402821|NCT02489773|41647708|FG000|Overall Study|Leave the country or the state|1|||
19402822|NCT02489773|41647709|FG001|Overall Study|Leave the country or the state|1|||
19402823|NCT02488915|41647715|FG000|Overall Study|Death|21|||
19402824|NCT02488915|41647715|FG000|Overall Study|Lost to Follow-up|4|||
19402825|NCT02488915|41647715|FG000|Overall Study|Withdrawal by Subject|1|||
19402826|NCT02488681|41647719|FG000|Overall Study|Implant unsuccessful|7|||
19402827|NCT02477605|41647725|FG000|Overall Study|Discontinued prior to treatment|1|||
19402828|NCT02477605|41647726|FG001|Overall Study|Discontinued prior to treatment|0|||
19402829|NCT02477605|41647725|FG000|Overall Study|Lost to Follow-up|0|||
19402830|NCT02477605|41647726|FG001|Overall Study|Lost to Follow-up|2|||
19402831|NCT02477605|41647725|FG000|Overall Study|Withdrawal by Subject|0|||
19402832|NCT02477605|41647726|FG001|Overall Study|Withdrawal by Subject|1|||
19402833|NCT02477605|41647725|FG000|Overall Study|Administered gas during surgery|0|||
19402834|NCT02477605|41647726|FG001|Overall Study|Administered gas during surgery|1|||
19402835|NCT02477527|41647736|FG000|Overall Study|Lost to Follow-up|2|||
19402836|NCT02477527|41647736|FG000|Overall Study|Withdrawal by Subject|1|||
19402837|NCT02477527|41647736|FG000|Overall Study|Screen Failure|3|||
19402838|NCT02477215|41647744|FG000|Dose Escalation Phase|Physician Decision|1|||
19402839|NCT02477215|41647745|FG001|Dose Escalation Phase|Physician Decision|2|||
19402840|NCT02477215|41647746|FG002|Dose Escalation Phase|Physician Decision|0|||
19402841|NCT02477215|41647744|FG000|Fixed Dose Phase|Physician Decision|0|||
19402842|NCT02477215|41647745|FG001|Fixed Dose Phase|Physician Decision|7|||
19402843|NCT02477215|41647746|FG002|Fixed Dose Phase|Physician Decision|0|||
19402844|NCT02487199|41647759|FG000|Overall Study|Withdrew Consent|0|||
19402845|NCT02487199|41647760|FG001|Overall Study|Withdrew Consent|1|||
19402846|NCT02475733|41647768|FG000|Overall Study|Withdrawal by Subject|1|||
19402847|NCT02475733|41647769|FG001|Overall Study|Withdrawal by Subject|0|||
19402848|NCT02475733|41647768|FG000|Overall Study|Physician Decision|1|||
19402849|NCT02475733|41647769|FG001|Overall Study|Physician Decision|0|||
19402850|NCT02486653|41647777|FG000|Overall Study|Withdrawal by Subject|1|||
19402851|NCT02486653|41647778|FG001|Overall Study|Withdrawal by Subject|3|||
19402852|NCT02486653|41647777|FG000|Overall Study|Protocol Violation|1|||
19402853|NCT02486653|41647778|FG001|Overall Study|Protocol Violation|0|||
19402854|NCT02486653|41647777|FG000|Overall Study|surgery cancelled|4|||
19402855|NCT02486653|41647778|FG001|Overall Study|surgery cancelled|1|||
19402856|NCT02475655|41647786|FG000|Overall Study|Lost to Follow-up|0|||
19402857|NCT02475655|41647787|FG001|Overall Study|Lost to Follow-up|1|||
19402858|NCT02475265|41647793|FG000|Overall Study|Physician Decision|1|||
19402859|NCT02475265|41647793|FG000|Overall Study|Withdrawal by Subject|2|||
19402860|NCT02485717|41647800|FG000|Overall Study|Lost to Follow-up|6|||
19402861|NCT02485717|41647801|FG001|Overall Study|Lost to Follow-up|0|||
19402862|NCT02485717|41647802|FG002|Overall Study|Lost to Follow-up|0|||
19402863|NCT02485717|41647800|FG000|Overall Study|Withdrawal by Subject|0|||
19402864|NCT02485717|41647801|FG001|Overall Study|Withdrawal by Subject|0|||
19402865|NCT02485717|41647802|FG002|Overall Study|Withdrawal by Subject|1|||
19402866|NCT02485717|41647800|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
19402867|NCT02485717|41647801|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
19402868|NCT02485717|41647802|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
19402869|NCT02485717|41647800|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
19402870|NCT02485717|41647801|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
19402871|NCT02485717|41647802|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
19402872|NCT02451007|41647810|FG000|Overall Study|Withdrawal by Subject|4|||
19402873|NCT02451007|41647810|FG000|Overall Study|Adverse Event|1|||
19402874|NCT02451007|41647810|FG000|Overall Study|Disease Progression|2|||
19402875|NCT02485483|41647816|FG000|Overall Study|Depression at baseline|15|||
19402876|NCT02485483|41647817|FG001|Overall Study|Depression at baseline|0|||
19402877|NCT02485483|41647816|FG000|Overall Study|Discontinued after baseline|39|||
19402878|NCT02485483|41647817|FG001|Overall Study|Discontinued after baseline|0|||
19402879|NCT02473471|41647823|FG000|Overall Study|poor oral hygiene|2|||
19402880|NCT02473471|41647823|FG000|Overall Study|Lost to Follow-up|1|||
19402881|NCT02450539|41647835|FG000|Overall Study|Withdrawal by Subject|12|||
19402882|NCT02450539|41647836|FG001|Overall Study|Withdrawal by Subject|6|||
19402883|NCT02450539|41647835|FG000|Overall Study|Lost to Follow-up|4|||
19402884|NCT02450539|41647836|FG001|Overall Study|Lost to Follow-up|1|||
19402885|NCT02449915|41647847|FG000|Overall Study|Exclusion criteria - drug use|1|||
19402886|NCT02449915|41647848|FG001|Overall Study|Exclusion criteria - drug use|0|||
19402887|NCT02449915|41647847|FG000|Overall Study|Withdrawal by Subject|0|||
19402888|NCT02449915|41647848|FG001|Overall Study|Withdrawal by Subject|2|||
19402889|NCT02449915|41647847|FG000|Overall Study|Intraoperative surgical findings|1|||
19402890|NCT02449915|41647848|FG001|Overall Study|Intraoperative surgical findings|1|||
19402891|NCT02449915|41647847|FG000|Overall Study|Abnormal preop lab|0|||
19402892|NCT02449915|41647848|FG001|Overall Study|Abnormal preop lab|1|||
19402893|NCT02420119|41647854|FG000|Overall Study|insufficient laboratory data|5|||
19402894|NCT02473393|41647862|FG000|Overall Study|Adverse Event|0|||
19402895|NCT02473393|41647863|FG001|Overall Study|Adverse Event|0|||
19402896|NCT02473393|41647864|FG002|Overall Study|Adverse Event|1|||
19402897|NCT02473393|41647865|FG003|Overall Study|Adverse Event|0|||
19402898|NCT02473393|41647862|FG000|Overall Study|Withdrawal by Subject|0|||
19402899|NCT02473393|41647863|FG001|Overall Study|Withdrawal by Subject|0|||
19402900|NCT02473393|41647864|FG002|Overall Study|Withdrawal by Subject|1|||
19402901|NCT02473393|41647865|FG003|Overall Study|Withdrawal by Subject|1|||
19402902|NCT02419573|41647877|FG000|Overall Study|Lost to Follow-up|3|||
19402903|NCT02419573|41647878|FG001|Overall Study|Lost to Follow-up|0|||
19402904|NCT02419573|41647877|FG000|Overall Study|Withdrawal by Subject|1|||
19402905|NCT02419573|41647878|FG001|Overall Study|Withdrawal by Subject|0|||
19402906|NCT02472847|41647886|FG000|Overall Study|Withdrawal by Subject|1|||
19402907|NCT02472847|41647887|FG001|Overall Study|Withdrawal by Subject|5|||
19402908|NCT02472145|41647896|FG000|Overall Study|Death|10|||
19402909|NCT02472145|41647897|FG001|Overall Study|Death|101|||
19402910|NCT02472145|41647898|FG002|Overall Study|Death|99|||
19402911|NCT02472145|41647896|FG000|Overall Study|Lost to Follow-up|0|||
19402912|NCT02472145|41647897|FG001|Overall Study|Lost to Follow-up|1|||
19402913|NCT02472145|41647898|FG002|Overall Study|Lost to Follow-up|0|||
19402914|NCT02472145|41647896|FG000|Overall Study|Withdrawal by Subject|0|||
19402915|NCT02472145|41647897|FG001|Overall Study|Withdrawal by Subject|9|||
19402916|NCT02472145|41647898|FG002|Overall Study|Withdrawal by Subject|13|||
19402917|NCT02472145|41647896|FG000|Overall Study|Sponsor decision|0|||
19402918|NCT02472145|41647897|FG001|Overall Study|Sponsor decision|3|||
19402919|NCT02472145|41647898|FG002|Overall Study|Sponsor decision|2|||
19402920|NCT02472145|41647896|FG000|Overall Study|Other|0|||
19402921|NCT02472145|41647897|FG001|Overall Study|Other|45|||
19402922|NCT02472145|41647898|FG002|Overall Study|Other|43|||
19402923|NCT02418949|41647909|FG000|Overall Study|Withdrawal by Subject|1|||
19402924|NCT02418949|41647910|FG001|Overall Study|Withdrawal by Subject|0|||
19402925|NCT02418949|41647911|FG002|Overall Study|Withdrawal by Subject|1|||
19402926|NCT02418949|41647912|FG003|Overall Study|Withdrawal by Subject|1|||
19402927|NCT02418949|41647909|FG000|Overall Study|Lost to Follow-up|1|||
19402928|NCT02418949|41647910|FG001|Overall Study|Lost to Follow-up|0|||
19402929|NCT02418949|41647911|FG002|Overall Study|Lost to Follow-up|1|||
19402930|NCT02418949|41647912|FG003|Overall Study|Lost to Follow-up|0|||
19402931|NCT02418949|41647909|FG000|Overall Study|Physician Decision|1|||
19402932|NCT02418949|41647910|FG001|Overall Study|Physician Decision|1|||
19402933|NCT02418949|41647911|FG002|Overall Study|Physician Decision|1|||
19402934|NCT02418949|41647912|FG003|Overall Study|Physician Decision|0|||
19402935|NCT02448043|41647924|FG000|Overall Study|Withdrawal by Subject|2|||
19402936|NCT02448043|41647925|FG001|Overall Study|Withdrawal by Subject|2|||
19402937|NCT02448043|41647924|FG000|Overall Study|Protocol Violation|1|||
19402938|NCT02448043|41647925|FG001|Overall Study|Protocol Violation|2|||
19402939|NCT02447887|41647934|FG000|Overall Study|Study was terminated|3|||
19402940|NCT02471755|41647940|FG000|Overall Study|Withdrawal by Subject|1|||
19402941|NCT02471755|41647941|FG001|Overall Study|Withdrawal by Subject|0|||
19402942|NCT02471755|41647940|FG000|Overall Study|Lost to Follow-up|0|||
19402943|NCT02471755|41647941|FG001|Overall Study|Lost to Follow-up|1|||
19402944|NCT02470429|41647949|FG000|Overall Study|Adverse Event|1|||
19402945|NCT02470429|41647950|FG001|Overall Study|Adverse Event|0|||
19402946|NCT02470429|41647949|FG000|Overall Study|Withdrawal by Subject|1|||
19402947|NCT02470429|41647950|FG001|Overall Study|Withdrawal by Subject|0|||
19402948|NCT02447497|41647961|FG000|Overall Study|Did not meet treatment day baseline.|6|||
19402949|NCT02447497|41647962|FG001|Overall Study|Did not meet treatment day baseline.|5|||
19402950|NCT02447497|41647963|FG002|Overall Study|Did not meet treatment day baseline.|2|||
19402951|NCT02447497|41647964|FG003|Overall Study|Did not meet treatment day baseline.|2|||
19402952|NCT02447497|41647961|FG000|Overall Study|Dressing was compromised|0|||
19402953|NCT02447497|41647962|FG001|Overall Study|Dressing was compromised|1|||
19402954|NCT02447497|41647963|FG002|Overall Study|Dressing was compromised|0|||
19402955|NCT02447497|41647964|FG003|Overall Study|Dressing was compromised|0|||
19402956|NCT02417935|41647984|FG000|Treatment Period|Adverse Event|12|||
19402957|NCT02417935|41647985|FG001|Treatment Period|Adverse Event|10|||
19402958|NCT02417935|41647984|FG000|Treatment Period|Lost to Follow-up|1|||
19402959|NCT02417935|41647985|FG001|Treatment Period|Lost to Follow-up|0|||
19402960|NCT02417935|41647984|FG000|Treatment Period|Entry Criteria not met|0|||
19402961|NCT02417935|41647985|FG001|Treatment Period|Entry Criteria not met|1|||
19402962|NCT02417935|41647984|FG000|Treatment Period|Protocol Violation|2|||
19402963|NCT02417935|41647985|FG001|Treatment Period|Protocol Violation|1|||
19402964|NCT02417935|41647984|FG000|Treatment Period|Withdrawal by Subject|3|||
19402965|NCT02417935|41647985|FG001|Treatment Period|Withdrawal by Subject|3|||
19402966|NCT02417935|41647984|FG000|Treatment Period|Physician Decision|3|||
19402967|NCT02417935|41647985|FG001|Treatment Period|Physician Decision|1|||
19402968|NCT02417233|41647994|FG000|Overall Study|Death|4|||
19402969|NCT02417233|41647995|FG001|Overall Study|Death|10|||
19402970|NCT02417233|41647996|FG002|Overall Study|Death|14|||
19402971|NCT02417233|41647994|FG000|Overall Study|Lost to Follow-up|27|||
19402972|NCT02417233|41647995|FG001|Overall Study|Lost to Follow-up|39|||
19402973|NCT02417233|41647996|FG002|Overall Study|Lost to Follow-up|34|||
19402974|NCT02417233|41647994|FG000|Overall Study|Protocol Violation|2|||
19402975|NCT02417233|41647995|FG001|Overall Study|Protocol Violation|0|||
19402976|NCT02417233|41647996|FG002|Overall Study|Protocol Violation|2|||
19402977|NCT02417233|41647994|FG000|Overall Study|Withdrawal by Subject|2|||
19402978|NCT02417233|41647995|FG001|Overall Study|Withdrawal by Subject|1|||
19402979|NCT02417233|41647996|FG002|Overall Study|Withdrawal by Subject|8|||
19402980|NCT02417233|41647994|FG000|Overall Study|Relocation out of study area|1|||
19402981|NCT02417233|41647995|FG001|Overall Study|Relocation out of study area|0|||
19402982|NCT02417233|41647996|FG002|Overall Study|Relocation out of study area|1|||
19402983|NCT02417233|41647994|FG000|Overall Study|Mentally unstable|0|||
19402984|NCT02417233|41647995|FG001|Overall Study|Mentally unstable|1|||
19402985|NCT02417233|41647996|FG002|Overall Study|Mentally unstable|0|||
19402986|NCT02447029|41648007|FG000|Overall Study|Withdrawal by Subject|3|||
19402987|NCT02447029|41648008|FG001|Overall Study|Withdrawal by Subject|2|||
19402988|NCT02416453|41648025|FG000|Overall Study|Adverse Event|0|||
19402989|NCT02416453|41648026|FG001|Overall Study|Adverse Event|0|||
19402990|NCT02416453|41648027|FG002|Overall Study|Adverse Event|0|||
19402991|NCT02416453|41648028|FG003|Overall Study|Adverse Event|2|||
19402992|NCT02416453|41648029|FG004|Overall Study|Adverse Event|0|||
19402993|NCT02416453|41648030|FG005|Overall Study|Adverse Event|1|||
19402994|NCT02416453|41648031|FG006|Overall Study|Adverse Event|0|||
19402995|NCT02416453|41648032|FG007|Overall Study|Adverse Event|0|||
19402996|NCT02416453|41648033|FG008|Overall Study|Adverse Event|0|||
19402997|NCT02416453|41648034|FG009|Overall Study|Adverse Event|0|||
19402998|NCT02416453|41648035|FG010|Overall Study|Adverse Event|0|||
19402999|NCT02416453|41648025|FG000|Overall Study|Lost to Follow-up|1|||
19403000|NCT02416453|41648026|FG001|Overall Study|Lost to Follow-up|3|||
19403001|NCT02416453|41648027|FG002|Overall Study|Lost to Follow-up|0|||
19403002|NCT02416453|41648028|FG003|Overall Study|Lost to Follow-up|8|||
19403003|NCT02416453|41648029|FG004|Overall Study|Lost to Follow-up|0|||
19403004|NCT02416453|41648030|FG005|Overall Study|Lost to Follow-up|5|||
19403005|NCT02416453|41648031|FG006|Overall Study|Lost to Follow-up|1|||
19403006|NCT02416453|41648032|FG007|Overall Study|Lost to Follow-up|3|||
19403007|NCT02416453|41648033|FG008|Overall Study|Lost to Follow-up|1|||
19403008|NCT02416453|41648034|FG009|Overall Study|Lost to Follow-up|0|||
19403009|NCT02416453|41648035|FG010|Overall Study|Lost to Follow-up|0|||
19403010|NCT02416453|41648025|FG000|Overall Study|Physician Decision|0|||
19403011|NCT02416453|41648026|FG001|Overall Study|Physician Decision|0|||
19403012|NCT02416453|41648027|FG002|Overall Study|Physician Decision|0|||
19403013|NCT02416453|41648028|FG003|Overall Study|Physician Decision|0|||
19403014|NCT02416453|41648029|FG004|Overall Study|Physician Decision|0|||
19403015|NCT02416453|41648030|FG005|Overall Study|Physician Decision|1|||
19403016|NCT02416453|41648031|FG006|Overall Study|Physician Decision|1|||
19403017|NCT02416453|41648032|FG007|Overall Study|Physician Decision|1|||
19403018|NCT02416453|41648033|FG008|Overall Study|Physician Decision|0|||
19403019|NCT02416453|41648034|FG009|Overall Study|Physician Decision|0|||
19403020|NCT02416453|41648035|FG010|Overall Study|Physician Decision|0|||
19403021|NCT02416453|41648025|FG000|Overall Study|Withdrawal by Subject|2|||
19403022|NCT02416453|41648026|FG001|Overall Study|Withdrawal by Subject|0|||
19403023|NCT02416453|41648027|FG002|Overall Study|Withdrawal by Subject|0|||
19403024|NCT02416453|41648028|FG003|Overall Study|Withdrawal by Subject|5|||
19403025|NCT02416453|41648029|FG004|Overall Study|Withdrawal by Subject|1|||
19403026|NCT02416453|41648030|FG005|Overall Study|Withdrawal by Subject|8|||
19403027|NCT02416453|41648031|FG006|Overall Study|Withdrawal by Subject|0|||
19403028|NCT02416453|41648032|FG007|Overall Study|Withdrawal by Subject|8|||
19518461|NCT01514136|41931455|FG001|Test Period 2; Test C*|holiday|0|||
19403029|NCT02416453|41648033|FG008|Overall Study|Withdrawal by Subject|4|||
19403030|NCT02416453|41648034|FG009|Overall Study|Withdrawal by Subject|0|||
19403031|NCT02416453|41648035|FG010|Overall Study|Withdrawal by Subject|0|||
19403032|NCT02416453|41648025|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403033|NCT02416453|41648026|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403034|NCT02416453|41648027|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
19403035|NCT02416453|41648028|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403036|NCT02416453|41648029|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403037|NCT02416453|41648030|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403038|NCT02416453|41648031|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403039|NCT02416453|41648032|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403040|NCT02416453|41648033|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403041|NCT02416453|41648034|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403042|NCT02416453|41648035|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
19403043|NCT02416453|41648025|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403044|NCT02416453|41648026|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403045|NCT02416453|41648027|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403046|NCT02416453|41648028|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403047|NCT02416453|41648029|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403048|NCT02416453|41648030|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
19403049|NCT02416453|41648031|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403050|NCT02416453|41648032|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403051|NCT02416453|41648033|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403052|NCT02416453|41648034|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403053|NCT02416453|41648035|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
19403054|NCT02469961|41648067|FG000|Overall Study|Physician Decision|4|||
19403055|NCT02469961|41648068|FG001|Overall Study|Physician Decision|1|||
19403056|NCT02415595|41648083|FG000|Overall Study|Administrative reason by sponsor|39|||
19403057|NCT02415595|41648084|FG001|Overall Study|Administrative reason by sponsor|40|||
19403058|NCT02415595|41648085|FG002|Overall Study|Administrative reason by sponsor|41|||
19403059|NCT02415595|41648086|FG003|Overall Study|Administrative reason by sponsor|39|||
19403060|NCT02415595|41648083|FG000|Overall Study|Adverse Event|1|||
19403061|NCT02415595|41648084|FG001|Overall Study|Adverse Event|3|||
19403062|NCT02415595|41648085|FG002|Overall Study|Adverse Event|5|||
19403063|NCT02415595|41648086|FG003|Overall Study|Adverse Event|10|||
19403064|NCT02415595|41648083|FG000|Overall Study|Lack of Efficacy|4|||
19403065|NCT02415595|41648084|FG001|Overall Study|Lack of Efficacy|4|||
19403066|NCT02415595|41648085|FG002|Overall Study|Lack of Efficacy|0|||
19403067|NCT02415595|41648086|FG003|Overall Study|Lack of Efficacy|0|||
19403068|NCT02415595|41648083|FG000|Overall Study|Lost to Follow-up|1|||
19403069|NCT02415595|41648084|FG001|Overall Study|Lost to Follow-up|3|||
19403070|NCT02415595|41648085|FG002|Overall Study|Lost to Follow-up|1|||
19403071|NCT02415595|41648086|FG003|Overall Study|Lost to Follow-up|1|||
19403072|NCT02415595|41648083|FG000|Overall Study|Poor/Non-compliance|1|||
19403073|NCT02415595|41648084|FG001|Overall Study|Poor/Non-compliance|0|||
19403074|NCT02415595|41648085|FG002|Overall Study|Poor/Non-compliance|1|||
19403075|NCT02415595|41648086|FG003|Overall Study|Poor/Non-compliance|0|||
19403076|NCT02415595|41648083|FG000|Overall Study|Reached stopping criteria|0|||
19403077|NCT02415595|41648084|FG001|Overall Study|Reached stopping criteria|1|||
19403078|NCT02415595|41648085|FG002|Overall Study|Reached stopping criteria|1|||
19403079|NCT02415595|41648086|FG003|Overall Study|Reached stopping criteria|0|||
19403080|NCT02415595|41648083|FG000|Overall Study|Withdrawal by Subject|4|||
19403081|NCT02415595|41648084|FG001|Overall Study|Withdrawal by Subject|0|||
19403082|NCT02415595|41648085|FG002|Overall Study|Withdrawal by Subject|1|||
19403083|NCT02415595|41648086|FG003|Overall Study|Withdrawal by Subject|3|||
19403084|NCT02415595|41648083|FG000|Overall Study|Other|0|||
19403085|NCT02415595|41648084|FG001|Overall Study|Other|1|||
19403086|NCT02415595|41648085|FG002|Overall Study|Other|1|||
19403087|NCT02415595|41648086|FG003|Overall Study|Other|0|||
19403088|NCT02446717|41648102|FG000|Overall Study|Adverse Event|0|||
19403089|NCT02446717|41648103|FG001|Overall Study|Adverse Event|0|||
19403090|NCT02446717|41648104|FG002|Overall Study|Adverse Event|1|||
19403091|NCT02446717|41648105|FG003|Overall Study|Adverse Event|0|||
19403092|NCT02446717|41648106|FG004|Overall Study|Adverse Event|0|||
19403093|NCT02446717|41648102|FG000|Overall Study|Lost to Follow-up|0|||
19403094|NCT02446717|41648103|FG001|Overall Study|Lost to Follow-up|1|||
19403095|NCT02446717|41648104|FG002|Overall Study|Lost to Follow-up|1|||
19403096|NCT02446717|41648105|FG003|Overall Study|Lost to Follow-up|0|||
19403097|NCT02446717|41648106|FG004|Overall Study|Lost to Follow-up|1|||
19403098|NCT02446717|41648102|FG000|Overall Study|Withdrew consent|0|||
19711065|NCT03605680|42154233|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
19403099|NCT02446717|41648103|FG001|Overall Study|Withdrew consent|0|||
19403100|NCT02446717|41648104|FG002|Overall Study|Withdrew consent|0|||
19403101|NCT02446717|41648105|FG003|Overall Study|Withdrew consent|1|||
19403102|NCT02446717|41648106|FG004|Overall Study|Withdrew consent|0|||
19403103|NCT02469415|41648118|FG000|Overall Study|Withdrawal by Subject|1|||
19403104|NCT02469415|41648118|FG000|Overall Study|Investigational agent placed on hold|2|||
19403105|NCT02446171|41648126|FG000|Overall Study|Withdrawal by Subject|0|||
19403106|NCT02446171|41648127|FG001|Overall Study|Withdrawal by Subject|0|||
19403107|NCT02446171|41648128|FG002|Overall Study|Withdrawal by Subject|2|||
19403108|NCT02446171|41648129|FG003|Overall Study|Withdrawal by Subject|0|||
19403109|NCT02446015|41648143|FG000|Overall Study|Adverse Event|0|||
19403110|NCT02446015|41648144|FG001|Overall Study|Adverse Event|1|||
19403111|NCT02446015|41648143|FG000|Overall Study|Withdrawal by Subject|1|||
19403112|NCT02446015|41648144|FG001|Overall Study|Withdrawal by Subject|0|||
19403113|NCT02415127|41648153|FG000|Overall Study|Adverse Event|1|||
19403114|NCT02415127|41648154|FG001|Overall Study|Adverse Event|0|||
19403115|NCT02468557|41648160|FG000|Overall Study|Adverse Event|1|||
19403116|NCT02468557|41648160|FG000|Overall Study|Death|1|||
19403117|NCT02468557|41648160|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
19403118|NCT02468557|41648160|FG000|Overall Study|All Enrolled but Never Dosed|4|||
19403119|NCT02413489|41648171|FG000|Overall Study|Death|11|||
19403120|NCT02413489|41648172|FG001|Overall Study|Death|3|||
19403121|NCT02413489|41648173|FG002|Overall Study|Death|4|||
19403122|NCT02413489|41648171|FG000|Overall Study|Withdrawal by Subject|2|||
19403123|NCT02413489|41648172|FG001|Overall Study|Withdrawal by Subject|0|||
19403124|NCT02413489|41648173|FG002|Overall Study|Withdrawal by Subject|0|||
19403125|NCT02413489|41648171|FG000|Overall Study|Study Terminated By Sponsor|2|||
19403126|NCT02413489|41648172|FG001|Overall Study|Study Terminated By Sponsor|13|||
19403127|NCT02413489|41648173|FG002|Overall Study|Study Terminated By Sponsor|1|||
19403128|NCT02413333|41648185|FG000|Period 1|Adverse Event|1|||
19403129|NCT02413333|41648186|FG001|Period 1|Adverse Event|0|||
19403130|NCT02413333|41648185|FG000|Period 1|Reason Not Specified|0|||
19403131|NCT02413333|41648186|FG001|Period 1|Reason Not Specified|1|||
19403132|NCT02413333|41648185|FG000|Period 2|Protocol Deviation|1|||
19403133|NCT02413333|41648186|FG001|Period 2|Protocol Deviation|0|||
19403134|NCT02413255|41648209|FG000|Overall Study|Voluntary Withdrawal|0|||
19403135|NCT02413255|41648210|FG001|Overall Study|Voluntary Withdrawal|0|||
19403136|NCT02413255|41648211|FG002|Overall Study|Voluntary Withdrawal|0|||
19403137|NCT02413255|41648212|FG003|Overall Study|Voluntary Withdrawal|0|||
19403138|NCT02413255|41648213|FG004|Overall Study|Voluntary Withdrawal|0|||
19403139|NCT02413255|41648214|FG005|Overall Study|Voluntary Withdrawal|0|||
19403140|NCT02413255|41648215|FG006|Overall Study|Voluntary Withdrawal|0|||
19403141|NCT02413255|41648216|FG007|Overall Study|Voluntary Withdrawal|0|||
19403142|NCT02413255|41648217|FG008|Overall Study|Voluntary Withdrawal|0|||
19403143|NCT02413255|41648218|FG009|Overall Study|Voluntary Withdrawal|0|||
19403144|NCT02413255|41648219|FG010|Overall Study|Voluntary Withdrawal|0|||
19403145|NCT02413255|41648220|FG011|Overall Study|Voluntary Withdrawal|0|||
19403146|NCT02413255|41648221|FG012|Overall Study|Voluntary Withdrawal|0|||
19403147|NCT02413255|41648222|FG013|Overall Study|Voluntary Withdrawal|0|||
19403148|NCT02413255|41648223|FG014|Overall Study|Voluntary Withdrawal|1|||
19403149|NCT02413255|41648224|FG015|Overall Study|Voluntary Withdrawal|0|||
19403150|NCT02413255|41648225|FG016|Overall Study|Voluntary Withdrawal|0|||
19403151|NCT02444533|41648278|FG000|Overall Study|Not able to complete forms|0|||
19403152|NCT02444533|41648279|FG001|Overall Study|Not able to complete forms|2|||
19403153|NCT02444533|41648278|FG000|Overall Study|Only gave post-procedure complications|2|||
19403154|NCT02444533|41648279|FG001|Overall Study|Only gave post-procedure complications|2|||
19403155|NCT01651039|41648285|FG000|Overall Study|Non-evaluables|5|||
19403156|NCT01651039|41648285|FG000|Overall Study|Physician Decision|2|||
19403157|NCT01651039|41648285|FG000|Overall Study|Withdrawal by Subject|1|||
19403158|NCT01651039|41648285|FG000|Overall Study|Progressive Disease|22|||
19403159|NCT02349633|41648303|FG000|Overall Study|Death|0|||
19403160|NCT02349633|41648304|FG001|Overall Study|Death|1|||
19403161|NCT02349633|41648305|FG002|Overall Study|Death|0|||
19403162|NCT02349633|41648306|FG003|Overall Study|Death|0|||
19403163|NCT02349633|41648307|FG004|Overall Study|Death|0|||
19403164|NCT02349633|41648308|FG005|Overall Study|Death|1|||
19403165|NCT02349633|41648309|FG006|Overall Study|Death|1|||
19403166|NCT02349633|41648310|FG007|Overall Study|Death|1|||
19403167|NCT02349633|41648311|FG008|Overall Study|Death|0|||
19403168|NCT02349633|41648312|FG009|Overall Study|Death|1|||
19403169|NCT02349633|41648313|FG010|Overall Study|Death|0|||
19403170|NCT02349633|41648314|FG011|Overall Study|Death|0|||
19403171|NCT02349633|41648315|FG012|Overall Study|Death|0|||
19403172|NCT02349633|41648316|FG013|Overall Study|Death|0|||
19403173|NCT02349633|41648303|FG000|Overall Study|Withdrawal by Subject|0|||
19403174|NCT02349633|41648304|FG001|Overall Study|Withdrawal by Subject|0|||
19403175|NCT02349633|41648305|FG002|Overall Study|Withdrawal by Subject|0|||
19403176|NCT02349633|41648306|FG003|Overall Study|Withdrawal by Subject|1|||
19403177|NCT02349633|41648307|FG004|Overall Study|Withdrawal by Subject|0|||
19403178|NCT02349633|41648308|FG005|Overall Study|Withdrawal by Subject|0|||
19403179|NCT02349633|41648309|FG006|Overall Study|Withdrawal by Subject|0|||
19403180|NCT02349633|41648310|FG007|Overall Study|Withdrawal by Subject|2|||
19403181|NCT02349633|41648311|FG008|Overall Study|Withdrawal by Subject|2|||
19403182|NCT02349633|41648312|FG009|Overall Study|Withdrawal by Subject|1|||
19403183|NCT02349633|41648313|FG010|Overall Study|Withdrawal by Subject|0|||
19403184|NCT02349633|41648314|FG011|Overall Study|Withdrawal by Subject|0|||
19403185|NCT02349633|41648315|FG012|Overall Study|Withdrawal by Subject|0|||
19403186|NCT02349633|41648316|FG013|Overall Study|Withdrawal by Subject|0|||
19403187|NCT02349633|41648303|FG000|Overall Study|Withdrawal of informed consent|0|||
19403188|NCT02349633|41648304|FG001|Overall Study|Withdrawal of informed consent|0|||
19403189|NCT02349633|41648305|FG002|Overall Study|Withdrawal of informed consent|0|||
19403190|NCT02349633|41648306|FG003|Overall Study|Withdrawal of informed consent|1|||
19403191|NCT02349633|41648307|FG004|Overall Study|Withdrawal of informed consent|1|||
19403192|NCT02349633|41648308|FG005|Overall Study|Withdrawal of informed consent|0|||
19403193|NCT02349633|41648309|FG006|Overall Study|Withdrawal of informed consent|0|||
19403194|NCT02349633|41648310|FG007|Overall Study|Withdrawal of informed consent|3|||
19403195|NCT02349633|41648311|FG008|Overall Study|Withdrawal of informed consent|0|||
19403196|NCT02349633|41648312|FG009|Overall Study|Withdrawal of informed consent|0|||
19403197|NCT02349633|41648313|FG010|Overall Study|Withdrawal of informed consent|0|||
19403198|NCT02349633|41648314|FG011|Overall Study|Withdrawal of informed consent|0|||
19403199|NCT02349633|41648315|FG012|Overall Study|Withdrawal of informed consent|0|||
19403200|NCT02349633|41648316|FG013|Overall Study|Withdrawal of informed consent|0|||
19403201|NCT02349633|41648303|FG000|Overall Study|Transition to compassionate use|0|||
19403202|NCT02349633|41648304|FG001|Overall Study|Transition to compassionate use|0|||
19403203|NCT02349633|41648305|FG002|Overall Study|Transition to compassionate use|0|||
19403204|NCT02349633|41648306|FG003|Overall Study|Transition to compassionate use|0|||
19403205|NCT02349633|41648307|FG004|Overall Study|Transition to compassionate use|1|||
19403206|NCT02349633|41648308|FG005|Overall Study|Transition to compassionate use|0|||
19403207|NCT02349633|41648309|FG006|Overall Study|Transition to compassionate use|0|||
19403208|NCT02349633|41648310|FG007|Overall Study|Transition to compassionate use|3|||
19403209|NCT02349633|41648311|FG008|Overall Study|Transition to compassionate use|0|||
19403210|NCT02349633|41648312|FG009|Overall Study|Transition to compassionate use|1|||
19403211|NCT02349633|41648313|FG010|Overall Study|Transition to compassionate use|0|||
19403212|NCT02349633|41648314|FG011|Overall Study|Transition to compassionate use|0|||
19403213|NCT02349633|41648315|FG012|Overall Study|Transition to compassionate use|0|||
19403214|NCT02349633|41648316|FG013|Overall Study|Transition to compassionate use|0|||
19403215|NCT02349633|41648303|FG000|Overall Study|Early termination of survival follow-up|0|||
19403216|NCT02349633|41648304|FG001|Overall Study|Early termination of survival follow-up|0|||
19403217|NCT02349633|41648305|FG002|Overall Study|Early termination of survival follow-up|0|||
19403218|NCT02349633|41648306|FG003|Overall Study|Early termination of survival follow-up|0|||
19403219|NCT02349633|41648307|FG004|Overall Study|Early termination of survival follow-up|0|||
19403220|NCT02349633|41648308|FG005|Overall Study|Early termination of survival follow-up|0|||
19403221|NCT02349633|41648309|FG006|Overall Study|Early termination of survival follow-up|0|||
19403222|NCT02349633|41648310|FG007|Overall Study|Early termination of survival follow-up|4|||
19403223|NCT02349633|41648311|FG008|Overall Study|Early termination of survival follow-up|0|||
19403224|NCT02349633|41648312|FG009|Overall Study|Early termination of survival follow-up|0|||
19403225|NCT02349633|41648313|FG010|Overall Study|Early termination of survival follow-up|0|||
19403226|NCT02349633|41648314|FG011|Overall Study|Early termination of survival follow-up|0|||
19403227|NCT02349633|41648315|FG012|Overall Study|Early termination of survival follow-up|0|||
19403228|NCT02349633|41648316|FG013|Overall Study|Early termination of survival follow-up|0|||
19403229|NCT02349633|41648303|FG000|Overall Study|Termination by sponsor|0|||
19403230|NCT02349633|41648304|FG001|Overall Study|Termination by sponsor|0|||
19403231|NCT02349633|41648305|FG002|Overall Study|Termination by sponsor|0|||
19403232|NCT02349633|41648306|FG003|Overall Study|Termination by sponsor|0|||
19403233|NCT02349633|41648307|FG004|Overall Study|Termination by sponsor|0|||
19403234|NCT02349633|41648308|FG005|Overall Study|Termination by sponsor|0|||
19403235|NCT02349633|41648309|FG006|Overall Study|Termination by sponsor|0|||
19403236|NCT02349633|41648310|FG007|Overall Study|Termination by sponsor|1|||
19403237|NCT02349633|41648311|FG008|Overall Study|Termination by sponsor|0|||
19403238|NCT02349633|41648312|FG009|Overall Study|Termination by sponsor|2|||
19403239|NCT02349633|41648313|FG010|Overall Study|Termination by sponsor|0|||
19403240|NCT02349633|41648314|FG011|Overall Study|Termination by sponsor|0|||
19403241|NCT02349633|41648315|FG012|Overall Study|Termination by sponsor|0|||
19403242|NCT02349633|41648316|FG013|Overall Study|Termination by sponsor|0|||
19403243|NCT02349633|41648303|FG000|Overall Study|Other|0|||
19403244|NCT02349633|41648304|FG001|Overall Study|Other|0|||
19403245|NCT02349633|41648305|FG002|Overall Study|Other|0|||
19403246|NCT02349633|41648306|FG003|Overall Study|Other|0|||
19403247|NCT02349633|41648307|FG004|Overall Study|Other|0|||
19403248|NCT02349633|41648308|FG005|Overall Study|Other|0|||
19403249|NCT02349633|41648309|FG006|Overall Study|Other|0|||
19403250|NCT02349633|41648310|FG007|Overall Study|Other|2|||
19403251|NCT02349633|41648311|FG008|Overall Study|Other|0|||
19403252|NCT02349633|41648312|FG009|Overall Study|Other|0|||
19403253|NCT02349633|41648313|FG010|Overall Study|Other|0|||
19403254|NCT02349633|41648314|FG011|Overall Study|Other|0|||
19403255|NCT02349633|41648315|FG012|Overall Study|Other|0|||
19403256|NCT02349633|41648316|FG013|Overall Study|Other|0|||
19403257|NCT02275611|41648381|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
19403258|NCT02275611|41648382|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
19403259|NCT02275611|41648383|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
19403260|NCT02275611|41648384|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
19403261|NCT01642251|41648399|FG000|Overall Study|Progressive disease|0|||
19403262|NCT01642251|41648400|FG001|Overall Study|Progressive disease|0|||
19403263|NCT01642251|41648401|FG002|Overall Study|Progressive disease|3|||
19403264|NCT01642251|41648402|FG003|Overall Study|Progressive disease|3|||
19403265|NCT01642251|41648399|FG000|Overall Study|Adverse Event|0|||
19403266|NCT01642251|41648400|FG001|Overall Study|Adverse Event|0|||
19403267|NCT01642251|41648401|FG002|Overall Study|Adverse Event|5|||
19403268|NCT01642251|41648402|FG003|Overall Study|Adverse Event|4|||
19403269|NCT01642251|41648399|FG000|Overall Study|Death|0|||
19403270|NCT01642251|41648400|FG001|Overall Study|Death|0|||
19403271|NCT01642251|41648401|FG002|Overall Study|Death|1|||
19403272|NCT01642251|41648402|FG003|Overall Study|Death|3|||
19403273|NCT01642251|41648399|FG000|Overall Study|Withdrawal by Subject|0|||
19403274|NCT01642251|41648400|FG001|Overall Study|Withdrawal by Subject|0|||
19403275|NCT01642251|41648401|FG002|Overall Study|Withdrawal by Subject|1|||
19403276|NCT01642251|41648402|FG003|Overall Study|Withdrawal by Subject|3|||
19403277|NCT01642251|41648399|FG000|Overall Study|Alternative therapy|0|||
19403278|NCT01642251|41648400|FG001|Overall Study|Alternative therapy|0|||
19403279|NCT01642251|41648401|FG002|Overall Study|Alternative therapy|0|||
19403280|NCT01642251|41648402|FG003|Overall Study|Alternative therapy|2|||
19403281|NCT01642251|41648399|FG000|Overall Study|Other complicating disease|0|||
19403282|NCT01642251|41648400|FG001|Overall Study|Other complicating disease|0|||
19403283|NCT01642251|41648401|FG002|Overall Study|Other complicating disease|1|||
19403284|NCT01642251|41648402|FG003|Overall Study|Other complicating disease|0|||
19403285|NCT01642251|41648399|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
19403286|NCT01642251|41648400|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
19403287|NCT01642251|41648401|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
19403288|NCT01642251|41648402|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
19403289|NCT02275065|41648416|FG000|Overall Study|Randomized but not treated|1|||
19403290|NCT02275065|41648417|FG001|Overall Study|Randomized but not treated|0|||
19403291|NCT02275065|41648418|FG002|Overall Study|Randomized but not treated|1|||
19403292|NCT02275065|41648419|FG003|Overall Study|Randomized but not treated|1|||
19403293|NCT02275065|41648420|FG004|Overall Study|Randomized but not treated|0|||
19403294|NCT02273973|41648434|FG000|Overall Study|Adverse Event|4|||
19403295|NCT02273973|41648435|FG001|Overall Study|Adverse Event|0|||
19403296|NCT02273973|41648434|FG000|Overall Study|Withdrawal by Subject|2|||
19403297|NCT02273973|41648435|FG001|Overall Study|Withdrawal by Subject|3|||
19403298|NCT02273973|41648434|FG000|Overall Study|Death|1|||
19403299|NCT02273973|41648435|FG001|Overall Study|Death|0|||
19403300|NCT02273973|41648434|FG000|Overall Study|Non-compliance|1|||
19518462|NCT01514136|41931456|FG002|Test Period 2; Test C*|holiday|0|||
19518463|NCT01514136|41931457|FG003|Test Period 2; Test C*|holiday|0|||
19518464|NCT01514136|41931458|FG004|Test Period 2; Test C*|holiday|0|||
19518465|NCT01514136|41931459|FG005|Test Period 2; Test C*|holiday|0|||
19518466|NCT01514136|41931460|FG006|Test Period 2; Test C*|holiday|1|||
19518467|NCT01514136|41931461|FG007|Test Period 2; Test C*|holiday|0|||
19518468|NCT01514136|41931454|FG000|Test Period 2; Test C*|Protocol Violation|0|||
19518469|NCT01514136|41931455|FG001|Test Period 2; Test C*|Protocol Violation|0|||
19518470|NCT01514136|41931456|FG002|Test Period 2; Test C*|Protocol Violation|0|||
19518471|NCT01514136|41931457|FG003|Test Period 2; Test C*|Protocol Violation|0|||
19518472|NCT01514136|41931458|FG004|Test Period 2; Test C*|Protocol Violation|0|||
19518473|NCT01514136|41931459|FG005|Test Period 2; Test C*|Protocol Violation|0|||
19518474|NCT01514136|41931460|FG006|Test Period 2; Test C*|Protocol Violation|1|||
19518475|NCT01514136|41931461|FG007|Test Period 2; Test C*|Protocol Violation|0|||
19518476|NCT01513590|41931489|FG000|Overall Study|Adverse Event|2|||
19518477|NCT01513590|41931490|FG001|Overall Study|Adverse Event|3|||
19518478|NCT01513590|41931489|FG000|Overall Study|Withdrawal Criteria|3|||
19518479|NCT01513590|41931490|FG001|Overall Study|Withdrawal Criteria|0|||
19518480|NCT01513590|41931489|FG000|Overall Study|Unclassified|5|||
19518481|NCT01513590|41931490|FG001|Overall Study|Unclassified|10|||
19403301|NCT02273973|41648435|FG001|Overall Study|Non-compliance|0|||
19403302|NCT02273973|41648434|FG000|Overall Study|Protocol Violation|1|||
19403303|NCT02273973|41648435|FG001|Overall Study|Protocol Violation|0|||
19403304|NCT02273973|41648434|FG000|Overall Study|Progression of disease|0|||
19403305|NCT02273973|41648435|FG001|Overall Study|Progression of disease|2|||
19403306|NCT02273973|41648434|FG000|Overall Study|Lost to Follow-up|0|||
19403307|NCT02273973|41648435|FG001|Overall Study|Lost to Follow-up|1|||
19518482|NCT01512264|41931500|FG000|Overall Study|Lost to Follow-up|0|||
19518483|NCT01512264|41931501|FG001|Overall Study|Lost to Follow-up|0|||
19518484|NCT01512264|41931502|FG002|Overall Study|Lost to Follow-up|0|||
19518485|NCT01512264|41931503|FG003|Overall Study|Lost to Follow-up|1|||
19403308|NCT02273973|41648434|FG000|Overall Study|Physician Decision|0|||
19403309|NCT02273973|41648435|FG001|Overall Study|Physician Decision|1|||
19403310|NCT02273973|41648434|FG000|Overall Study|Reason not specified|0|||
19403311|NCT02273973|41648435|FG001|Overall Study|Reason not specified|1|||
19403312|NCT02273739|41648445|FG000|Overall Study|Progression of Disease|3|||
19403313|NCT02273739|41648446|FG001|Overall Study|Progression of Disease|4|||
19403314|NCT02273739|41648447|FG002|Overall Study|Progression of Disease|5|||
19403315|NCT02273739|41648448|FG003|Overall Study|Progression of Disease|2|||
19403316|NCT02273739|41648445|FG000|Overall Study|Death|0|||
19403317|NCT02273739|41648446|FG001|Overall Study|Death|0|||
19403318|NCT02273739|41648447|FG002|Overall Study|Death|0|||
19403319|NCT02273739|41648448|FG003|Overall Study|Death|2|||
19403320|NCT02273739|41648445|FG000|Overall Study|Adverse Event|0|||
19403321|NCT02273739|41648446|FG001|Overall Study|Adverse Event|0|||
19403322|NCT02273739|41648447|FG002|Overall Study|Adverse Event|0|||
19403323|NCT02273739|41648448|FG003|Overall Study|Adverse Event|1|||
19403324|NCT02273739|41648445|FG000|Overall Study|Withdrawal by Subject|0|||
19403325|NCT02273739|41648446|FG001|Overall Study|Withdrawal by Subject|0|||
19403326|NCT02273739|41648447|FG002|Overall Study|Withdrawal by Subject|2|||
19403327|NCT02273739|41648448|FG003|Overall Study|Withdrawal by Subject|1|||
19403328|NCT02273739|41648445|FG000|Overall Study|Physician Decision|0|||
19403329|NCT02273739|41648446|FG001|Overall Study|Physician Decision|0|||
19403330|NCT02273739|41648447|FG002|Overall Study|Physician Decision|0|||
19403331|NCT02273739|41648448|FG003|Overall Study|Physician Decision|1|||
19403332|NCT02273037|41648465|FG000|Overall Study|Lost to Follow-up|1|||
19403333|NCT02273037|41648466|FG001|Overall Study|Lost to Follow-up|0|||
19403334|NCT02273037|41648465|FG000|Overall Study|Delivered before monitoring initiated|1|||
19403335|NCT02273037|41648466|FG001|Overall Study|Delivered before monitoring initiated|3|||
19403336|NCT02273037|41648465|FG000|Overall Study|Breech delivery|2|||
19403337|NCT02273037|41648466|FG001|Overall Study|Breech delivery|3|||
19403338|NCT02273037|41648465|FG000|Overall Study|Multiple delivery|2|||
19403339|NCT02273037|41648466|FG001|Overall Study|Multiple delivery|2|||
19403340|NCT02273037|41648465|FG000|Overall Study|Other complication|2|||
19403341|NCT02273037|41648466|FG001|Overall Study|Other complication|0|||
19403342|NCT02465515|41648476|FG000|Overall Study|Investigator site closed|4|||
19403343|NCT02465515|41648477|FG001|Overall Study|Investigator site closed|5|||
19403344|NCT02465515|41648476|FG000|Overall Study|Withdrawal by Subject|74|||
19403345|NCT02465515|41648477|FG001|Overall Study|Withdrawal by Subject|43|||
19403346|NCT02465515|41648476|FG000|Overall Study|Physician Decision|8|||
19403347|NCT02465515|41648477|FG001|Overall Study|Physician Decision|12|||
19403348|NCT02465515|41648476|FG000|Overall Study|Lost to Follow-up|68|||
19403349|NCT02465515|41648477|FG001|Overall Study|Lost to Follow-up|51|||
19403350|NCT02412631|41648485|FG000|Overall Study|Adverse Event|1|||
19403351|NCT02412631|41648486|FG001|Overall Study|Adverse Event|2|||
19403352|NCT02412631|41648485|FG000|Overall Study|Lost to Follow-up|5|||
19403353|NCT02412631|41648486|FG001|Overall Study|Lost to Follow-up|9|||
19403354|NCT02412631|41648485|FG000|Overall Study|Withdrawal by Subject|9|||
19403355|NCT02412631|41648486|FG001|Overall Study|Withdrawal by Subject|3|||
19403356|NCT02412631|41648485|FG000|Overall Study|Early stop by FDA|5|||
19403357|NCT02412631|41648486|FG001|Overall Study|Early stop by FDA|2|||
19403358|NCT02412631|41648485|FG000|Overall Study|Unspecified reason|6|||
19403359|NCT02412631|41648486|FG001|Overall Study|Unspecified reason|8|||
19403360|NCT02272803|41648494|FG000|Overall Study|Disease progression|16|||
19403361|NCT02272803|41648495|FG001|Overall Study|Disease progression|8|||
19403362|NCT02272803|41648494|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
19403363|NCT02272803|41648495|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
19403364|NCT02272803|41648494|FG000|Overall Study|Study drug toxicity|4|||
19403365|NCT02272803|41648495|FG001|Overall Study|Study drug toxicity|9|||
19403366|NCT02272803|41648494|FG000|Overall Study|Participant request to discontinue study treatment|3|||
19403367|NCT02272803|41648495|FG001|Overall Study|Participant request to discontinue study treatment|7|||
19403368|NCT02272803|41648494|FG000|Overall Study|Maximum clinical benefit|4|||
19403369|NCT02272803|41648495|FG001|Overall Study|Maximum clinical benefit|2|||
19403370|NCT02272803|41648494|FG000|Overall Study|Poor/non-compliance|2|||
19403371|NCT02272803|41648495|FG001|Overall Study|Poor/non-compliance|2|||
19403372|NCT02272803|41648494|FG000|Overall Study|Withdrawal by Subject|2|||
19403373|NCT02272803|41648495|FG001|Overall Study|Withdrawal by Subject|1|||
19403374|NCT02272803|41648494|FG000|Overall Study|Death|0|||
19403375|NCT02272803|41648495|FG001|Overall Study|Death|1|||
19403376|NCT02272803|41648494|FG000|Overall Study|Other reasons|1|||
19403377|NCT02272803|41648495|FG001|Overall Study|Other reasons|3|||
19403378|NCT02272803|41648494|FG000|Overall Study|Administrative reason by sponsor|5|||
19403379|NCT02272803|41648495|FG001|Overall Study|Administrative reason by sponsor|4|||
19403380|NCT02272725|41648503|FG000|Overall Study|equipment malfunction|2|||
19403381|NCT02272725|41648504|FG001|Overall Study|equipment malfunction|0|||
19403382|NCT01650805|41648512|FG000|Overall Study|Withdrawal by Subject|1|||
19403383|NCT01650805|41648513|FG001|Overall Study|Withdrawal by Subject|0|||
19403384|NCT02442349|41648519|FG000|Overall Study|Death|14|||
19403385|NCT02442349|41648519|FG000|Overall Study|Withdrawal by Subject|8|||
19403386|NCT02442349|41648519|FG000|Overall Study|On-going Study at Data Cut-off|149|||
19403387|NCT02411539|41648525|FG000|Overall Study|Lost to Follow-up|2|||
19403388|NCT02411539|41648526|FG001|Overall Study|Lost to Follow-up|0|||
19403389|NCT02411539|41648525|FG000|Overall Study|Confounding medical condition|0|||
19403390|NCT02411539|41648526|FG001|Overall Study|Confounding medical condition|1|||
19403391|NCT02465437|41648539|FG000|Overall Study|Physician Decision|0|||
19403392|NCT02465437|41648540|FG001|Overall Study|Physician Decision|0|||
19403393|NCT02465437|41648541|FG002|Overall Study|Physician Decision|1|||
19403394|NCT02465437|41648542|FG003|Overall Study|Physician Decision|0|||
19403395|NCT02465437|41648539|FG000|Overall Study|Withdrawal by Subject|1|||
19403396|NCT02465437|41648540|FG001|Overall Study|Withdrawal by Subject|0|||
19403397|NCT02465437|41648541|FG002|Overall Study|Withdrawal by Subject|0|||
19403398|NCT02465437|41648542|FG003|Overall Study|Withdrawal by Subject|1|||
19403399|NCT02465437|41648539|FG000|Overall Study|Adverse Event|0|||
19403400|NCT02465437|41648540|FG001|Overall Study|Adverse Event|1|||
19403401|NCT02465437|41648541|FG002|Overall Study|Adverse Event|0|||
19403402|NCT02465437|41648542|FG003|Overall Study|Adverse Event|0|||
19403403|NCT02442271|41648550|FG000|Overall Study|Adverse Event|1|||
19403404|NCT02442271|41648550|FG000|Overall Study|Withdrew Consent|1|||
19403405|NCT02442271|41648550|FG000|Overall Study|Lost to Follow-up|1|||
19403406|NCT02442271|41648550|FG000|Overall Study|Other|1|||
19403407|NCT02465203|41648571|FG000|Overall Study|Protocol Violation|1|||
19403408|NCT02465203|41648572|FG001|Overall Study|Protocol Violation|1|||
19403409|NCT02465203|41648573|FG002|Overall Study|Protocol Violation|1|||
19403410|NCT02465203|41648571|FG000|Overall Study|Study terminated by sponsor|50|||
19403411|NCT02465203|41648572|FG001|Overall Study|Study terminated by sponsor|34|||
19403412|NCT02465203|41648573|FG002|Overall Study|Study terminated by sponsor|11|||
19403413|NCT02465203|41648571|FG000|Overall Study|New therapy for study indication|4|||
19403414|NCT02465203|41648572|FG001|Overall Study|New therapy for study indication|0|||
19403415|NCT02465203|41648573|FG002|Overall Study|New therapy for study indication|0|||
19403416|NCT02465203|41648571|FG000|Overall Study|Patient/guardian decision|1|||
19403417|NCT02465203|41648572|FG001|Overall Study|Patient/guardian decision|1|||
19403418|NCT02465203|41648573|FG002|Overall Study|Patient/guardian decision|1|||
19403419|NCT02463409|41648580|FG000|Overall Study|Withdrawal by Subject|1|||
19403420|NCT02463409|41648580|FG000|Overall Study|Screen failure|1|||
19403421|NCT02528357|41648603|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403422|NCT02528357|41648604|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
19403423|NCT02528357|41648605|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403424|NCT02528357|41648606|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403425|NCT02528357|41648607|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403426|NCT02528357|41648608|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403427|NCT02528357|41648609|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403428|NCT02528357|41648610|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403429|NCT02528357|41648611|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403430|NCT02528357|41648612|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403431|NCT02528357|41648613|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403432|NCT02528357|41648614|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403433|NCT02528357|41648615|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403434|NCT02528357|41648616|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403435|NCT02528357|41648617|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403436|NCT02528357|41648618|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403437|NCT02528357|41648619|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403438|NCT02528357|41648620|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403439|NCT02528357|41648621|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
19403440|NCT02528357|41648603|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403441|NCT02528357|41648604|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403442|NCT02528357|41648605|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403443|NCT02528357|41648606|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
19403444|NCT02528357|41648607|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403445|NCT02528357|41648608|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
19403446|NCT02528357|41648609|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403447|NCT02528357|41648610|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
19403448|NCT02528357|41648611|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403449|NCT02528357|41648612|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403450|NCT02528357|41648613|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403451|NCT02528357|41648614|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403452|NCT02528357|41648615|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403453|NCT02528357|41648616|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403454|NCT02528357|41648617|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403455|NCT02528357|41648618|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403456|NCT02528357|41648619|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403457|NCT02528357|41648620|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403458|NCT02528357|41648621|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
19403459|NCT02528357|41648603|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403460|NCT02528357|41648604|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403461|NCT02528357|41648605|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
19403462|NCT02528357|41648606|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403463|NCT02528357|41648607|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
19403464|NCT02528357|41648608|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403465|NCT02528357|41648609|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
19403466|NCT02528357|41648610|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
19403467|NCT02528357|41648611|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403468|NCT02528357|41648612|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403469|NCT02528357|41648613|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19627987|NCT00796653|42077372|FG003|Overall Study|Other reason not described above|4|||
19627988|NCT00806286|42077393|FG000|Overall Study|Adverse Event|5|||
19403470|NCT02528357|41648614|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403471|NCT02528357|41648615|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403472|NCT02528357|41648616|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403473|NCT02528357|41648617|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403474|NCT02528357|41648618|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403475|NCT02528357|41648619|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403476|NCT02528357|41648620|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403477|NCT02528357|41648621|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
19403478|NCT02528357|41648603|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403479|NCT02528357|41648604|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403480|NCT02528357|41648605|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403481|NCT02528357|41648606|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403482|NCT02528357|41648607|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403483|NCT02528357|41648608|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403484|NCT02528357|41648609|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403485|NCT02528357|41648610|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403486|NCT02528357|41648611|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403487|NCT02528357|41648612|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403488|NCT02528357|41648613|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403489|NCT02528357|41648614|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403490|NCT02528357|41648615|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403491|NCT02528357|41648616|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403492|NCT02528357|41648617|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403493|NCT02528357|41648618|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403494|NCT02528357|41648619|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403495|NCT02528357|41648620|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403496|NCT02528357|41648621|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403497|NCT02528357|41648603|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403498|NCT02528357|41648604|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403499|NCT02528357|41648605|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19518486|NCT01512108|41931515|FG000|Overall Study|Adverse Event|9|||
19627989|NCT00806286|42077394|FG001|Overall Study|Adverse Event|2|||
19627990|NCT00806286|42077395|FG002|Overall Study|Adverse Event|0|||
19627991|NCT00806286|42077393|FG000|Overall Study|Disease progression|31|||
19627992|NCT00806286|42077394|FG001|Overall Study|Disease progression|38|||
19627993|NCT00806286|42077395|FG002|Overall Study|Disease progression|1|||
19627994|NCT00806286|42077393|FG000|Overall Study|Death|1|||
19627995|NCT00806286|42077394|FG001|Overall Study|Death|6|||
19627996|NCT00806286|42077395|FG002|Overall Study|Death|0|||
19627997|NCT00806286|42077393|FG000|Overall Study|Lost to Follow-up|0|||
19627998|NCT00806286|42077394|FG001|Overall Study|Lost to Follow-up|1|||
19627999|NCT00806286|42077395|FG002|Overall Study|Lost to Follow-up|0|||
19403500|NCT02528357|41648606|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403501|NCT02528357|41648607|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403502|NCT02528357|41648608|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403503|NCT02528357|41648609|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403504|NCT02528357|41648610|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403505|NCT02528357|41648611|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403506|NCT02528357|41648612|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403507|NCT02528357|41648613|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403508|NCT02528357|41648614|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403509|NCT02528357|41648615|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403510|NCT02528357|41648616|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
19403511|NCT02528357|41648617|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
19403512|NCT02528357|41648618|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403513|NCT02528357|41648619|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403514|NCT02528357|41648620|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403515|NCT02528357|41648621|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
19403516|NCT02528357|41648603|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403517|NCT02528357|41648604|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403518|NCT02528357|41648605|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403519|NCT02528357|41648606|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403520|NCT02528357|41648607|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403521|NCT02528357|41648608|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403522|NCT02528357|41648609|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403523|NCT02528357|41648610|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403524|NCT02528357|41648611|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403525|NCT02528357|41648612|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403526|NCT02528357|41648613|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403527|NCT02528357|41648614|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403528|NCT02528357|41648615|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403529|NCT02528357|41648616|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
19403530|NCT02528357|41648617|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403531|NCT02528357|41648618|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403532|NCT02528357|41648619|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403533|NCT02528357|41648620|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403534|NCT02528357|41648621|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
19403535|NCT02528357|41648603|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403536|NCT02528357|41648604|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403537|NCT02528357|41648605|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403538|NCT02528357|41648606|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403539|NCT02528357|41648607|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403540|NCT02528357|41648608|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403541|NCT02528357|41648609|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403542|NCT02528357|41648610|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403543|NCT02528357|41648611|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403544|NCT02528357|41648612|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403545|NCT02528357|41648613|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
19403546|NCT02528357|41648614|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403547|NCT02528357|41648615|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
19403548|NCT02528357|41648616|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
19403549|NCT02528357|41648617|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
19403550|NCT02528357|41648618|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403551|NCT02528357|41648619|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403552|NCT02528357|41648620|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403553|NCT02528357|41648621|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
19403554|NCT02528357|41648603|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403555|NCT02528357|41648604|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403556|NCT02528357|41648605|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403557|NCT02528357|41648606|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403558|NCT02528357|41648607|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403559|NCT02528357|41648608|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403560|NCT02528357|41648609|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403561|NCT02528357|41648610|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403562|NCT02528357|41648611|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403563|NCT02528357|41648612|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403564|NCT02528357|41648613|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403565|NCT02528357|41648614|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
19403566|NCT02528357|41648615|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
19403567|NCT02528357|41648616|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403568|NCT02528357|41648617|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403569|NCT02528357|41648618|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403570|NCT02528357|41648619|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403571|NCT02528357|41648620|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403572|NCT02528357|41648621|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403573|NCT02528357|41648603|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403574|NCT02528357|41648604|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403575|NCT02528357|41648605|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403576|NCT02528357|41648606|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403577|NCT02528357|41648607|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403578|NCT02528357|41648608|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403579|NCT02528357|41648609|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403580|NCT02528357|41648610|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403581|NCT02528357|41648611|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403582|NCT02528357|41648612|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403583|NCT02528357|41648613|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403584|NCT02528357|41648614|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403585|NCT02528357|41648615|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403586|NCT02528357|41648616|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403587|NCT02528357|41648617|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403588|NCT02528357|41648618|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403589|NCT02528357|41648619|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
19403590|NCT02528357|41648620|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403591|NCT02528357|41648621|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
19403592|NCT02528357|41648603|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403593|NCT02528357|41648604|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403594|NCT02528357|41648605|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403595|NCT02528357|41648606|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403596|NCT02528357|41648607|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403597|NCT02528357|41648608|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403598|NCT02528357|41648609|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403599|NCT02528357|41648610|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403600|NCT02528357|41648611|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403601|NCT02528357|41648612|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403602|NCT02528357|41648613|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403603|NCT02528357|41648614|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403604|NCT02528357|41648615|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403605|NCT02528357|41648616|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403606|NCT02528357|41648617|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19403607|NCT02528357|41648618|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
19518487|NCT01512108|41931516|FG001|Overall Study|Adverse Event|4|||
19518488|NCT01512108|41931515|FG000|Overall Study|Protocol Violation|1|||
19518489|NCT01512108|41931516|FG001|Overall Study|Protocol Violation|2|||
19518490|NCT01512108|41931515|FG000|Overall Study|Withdrawal Criteria|1|||
19518491|NCT01512108|41931516|FG001|Overall Study|Withdrawal Criteria|0|||
19518492|NCT01512108|41931515|FG000|Overall Study|Unclassified|11|||
19518493|NCT01512108|41931516|FG001|Overall Study|Unclassified|3|||
19518494|NCT01486758|41931524|FG000|Overall Study|Lost to Follow-up|0|||
19518495|NCT01486758|41931525|FG001|Overall Study|Lost to Follow-up|1|||
19403608|NCT02528357|41648619|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
19403609|NCT02528357|41648620|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
19403610|NCT02528357|41648621|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
19403611|NCT02463331|41648663|FG000|Overall Study|Adverse Event|4|||
19403612|NCT02463331|41648664|FG001|Overall Study|Adverse Event|2|||
19403613|NCT02463331|41648663|FG000|Overall Study|Lost to Follow-up|1|||
19403614|NCT02463331|41648664|FG001|Overall Study|Lost to Follow-up|1|||
19403615|NCT02463331|41648663|FG000|Overall Study|Pregnancy|2|||
19403616|NCT02463331|41648664|FG001|Overall Study|Pregnancy|3|||
19403617|NCT02463331|41648663|FG000|Overall Study|Lack of Efficacy|6|||
19403618|NCT02463331|41648664|FG001|Overall Study|Lack of Efficacy|0|||
19403619|NCT02463331|41648663|FG000|Overall Study|Physician Decision|3|||
19403620|NCT02463331|41648664|FG001|Overall Study|Physician Decision|0|||
19403621|NCT02410837|41648670|FG000|Overall Study|Death|387|||
19403622|NCT02410837|41648670|FG000|Overall Study|Lost to Follow-up|50|||
19403623|NCT02410837|41648670|FG000|Overall Study|Withdrawal by Subject|44|||
19403624|NCT02410837|41648670|FG000|Overall Study|Physician Decision|6|||
19403625|NCT02410837|41648670|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
19403626|NCT02314247|41648676|FG000|Overall Study|Adverse Event|2|||
19403627|NCT02314247|41648677|FG001|Overall Study|Adverse Event|1|||
19403628|NCT02314247|41648678|FG002|Overall Study|Adverse Event|0|||
19403629|NCT02314247|41648676|FG000|Overall Study|Withdrawal by Subject|1|||
19403630|NCT02314247|41648677|FG001|Overall Study|Withdrawal by Subject|3|||
19403631|NCT02314247|41648678|FG002|Overall Study|Withdrawal by Subject|1|||
19403632|NCT02314247|41648676|FG000|Overall Study|Progression of Disease|6|||
19403633|NCT02314247|41648677|FG001|Overall Study|Progression of Disease|2|||
19403634|NCT02314247|41648678|FG002|Overall Study|Progression of Disease|0|||
19403635|NCT02463097|41648688|FG000|Overall Study|Withdrawal by Subject|1|||
19403636|NCT02441179|41648694|FG000|Overall Study|Withdrawal by Subject|1|||
19403637|NCT02441179|41648695|FG001|Overall Study|Withdrawal by Subject|1|||
19403638|NCT02462473|41648702|FG000|Overall Study|Death|1|||
19403639|NCT02462473|41648702|FG000|Overall Study|Other|3|||
19403640|NCT02440789|41648715|FG000|Overall Study|Withdrawal by Subject|3|||
19403641|NCT02440789|41648715|FG000|Overall Study|Not willing to adhere to reqs|1|||
19403642|NCT02462083|41648719|FG000|Overall Study|Sponsor request|39|||
19403643|NCT02462083|41648719|FG000|Overall Study|Withdrawal by Subject|87|||
19403644|NCT02462083|41648719|FG000|Overall Study|Lost to Follow-up|41|||
19403645|NCT02462083|41648719|FG000|Overall Study|Lack of Efficacy|151|||
19403646|NCT02462083|41648719|FG000|Overall Study|Pregnancy|1|||
19403647|NCT02462083|41648719|FG000|Overall Study|Protocol Violation|6|||
19403648|NCT02462083|41648719|FG000|Overall Study|Adverse Event|33|||
19403649|NCT02462083|41648719|FG000|Overall Study|Worsening condition|16|||
19403650|NCT02462083|41648719|FG000|Overall Study|Other than specified|45|||
19403651|NCT02538341|41648725|FG000|Overall Study|Lost to Follow-up|51|||
19403652|NCT02538341|41648726|FG001|Overall Study|Lost to Follow-up|46|||
19403653|NCT02538341|41648725|FG000|Overall Study|Withdrawal by Subject|3|||
19403654|NCT02538341|41648726|FG001|Overall Study|Withdrawal by Subject|1|||
19403655|NCT02538341|41648725|FG000|Overall Study|Death|2|||
19403656|NCT02538341|41648726|FG001|Overall Study|Death|0|||
19403657|NCT02538107|41648732|FG000|Overall Study|Did not receive any Mircera dose|11|||
19403658|NCT02538107|41648732|FG000|Overall Study|Missing|5|||
19403659|NCT02538107|41648732|FG000|Overall Study|Necessity of dialysis|20|||
19403660|NCT02538107|41648732|FG000|Overall Study|Administration of other ESA|11|||
19403661|NCT02538107|41648732|FG000|Overall Study|No further treatment necessary|18|||
19403662|NCT02538107|41648732|FG000|Overall Study|Withdrawal by Subject|17|||
19403663|NCT02538107|41648732|FG000|Overall Study|Death|4|||
19403664|NCT02538107|41648732|FG000|Overall Study|Administrative reason|5|||
19403665|NCT02538107|41648732|FG000|Overall Study|Adverse Event|4|||
19403666|NCT02538107|41648732|FG000|Overall Study|Surgery|1|||
19403667|NCT02538107|41648732|FG000|Overall Study|Other|7|||
19403668|NCT02538107|41648732|FG000|Overall Study|Not recorded|7|||
19403669|NCT02538029|41648749|FG000|Overall Study|unable to complete cognitive assessments|1|||
19403670|NCT02538029|41648750|FG001|Overall Study|unable to complete cognitive assessments|0|||
19403671|NCT02538029|41648751|FG002|Overall Study|unable to complete cognitive assessments|1|||
19403672|NCT02272413|41648763|FG000|Randomized Through Treatment Start|Not treated|3|||
19403673|NCT02272413|41648764|FG001|Randomized Through Treatment Start|Not treated|5|||
19403674|NCT02272413|41648763|FG000|Pre-switch Period|Adverse Event|38|||
19403675|NCT02272413|41648764|FG001|Pre-switch Period|Adverse Event|37|||
19403676|NCT02272413|41648763|FG000|Pre-switch Period|Death|26|||
19403677|NCT02272413|41648764|FG001|Pre-switch Period|Death|26|||
19403678|NCT02272413|41648763|FG000|Pre-switch Period|Withdrawal by Subject|27|||
19403679|NCT02272413|41648764|FG001|Pre-switch Period|Withdrawal by Subject|15|||
19403680|NCT02272413|41648763|FG000|Pre-switch Period|Physician Decision|6|||
19403681|NCT02272413|41648764|FG001|Pre-switch Period|Physician Decision|18|||
19403682|NCT02272413|41648763|FG000|Pre-switch Period|Progressive disease|185|||
19403683|NCT02272413|41648764|FG001|Pre-switch Period|Progressive disease|173|||
19403684|NCT02272413|41648763|FG000|Pre-switch Period|Lost to Follow-up|0|||
19403685|NCT02272413|41648764|FG001|Pre-switch Period|Lost to Follow-up|2|||
19403686|NCT02272413|41648763|FG000|Pre-switch Period|Protocol Violation|1|||
19403687|NCT02272413|41648764|FG001|Pre-switch Period|Protocol Violation|0|||
19403688|NCT02272413|41648763|FG000|Pre-switch Period|Other than listed|10|||
19403689|NCT02272413|41648764|FG001|Pre-switch Period|Other than listed|11|||
19403690|NCT02272413|41648763|FG000|Post-switch Period|Adverse Event|4|||
19403691|NCT02272413|41648764|FG001|Post-switch Period|Adverse Event|4|||
19403692|NCT02272413|41648763|FG000|Post-switch Period|Death|3|||
19403693|NCT02272413|41648764|FG001|Post-switch Period|Death|2|||
19403694|NCT02272413|41648763|FG000|Post-switch Period|Withdrawal by Subject|1|||
19403695|NCT02272413|41648764|FG001|Post-switch Period|Withdrawal by Subject|2|||
19403696|NCT02272413|41648763|FG000|Post-switch Period|Physician Decision|1|||
19403697|NCT02272413|41648764|FG001|Post-switch Period|Physician Decision|1|||
19403698|NCT02272413|41648763|FG000|Post-switch Period|Progressive disease|21|||
19403699|NCT02272413|41648764|FG001|Post-switch Period|Progressive disease|21|||
19403700|NCT02272413|41648763|FG000|Post-switch Period|Study terminated by sponsor|8|||
19403701|NCT02272413|41648764|FG001|Post-switch Period|Study terminated by sponsor|11|||
19403702|NCT02272413|41648763|FG000|Post-switch Period|Other than listed|4|||
19403703|NCT02272413|41648764|FG001|Post-switch Period|Other than listed|5|||
19403704|NCT02396381|41648776|FG000|Overall Study|Adverse Event|3|||
19403705|NCT02396381|41648777|FG001|Overall Study|Adverse Event|2|||
19403706|NCT02396381|41648776|FG000|Overall Study|Withdrawal by Subject|33|||
19403707|NCT02396381|41648777|FG001|Overall Study|Withdrawal by Subject|24|||
19403708|NCT02396381|41648776|FG000|Overall Study|Lost to Follow-up|49|||
19403709|NCT02396381|41648777|FG001|Overall Study|Lost to Follow-up|31|||
19403710|NCT02396381|41648776|FG000|Overall Study|Protocol Violation|1|||
19403711|NCT02396381|41648777|FG001|Overall Study|Protocol Violation|0|||
19403712|NCT02396381|41648776|FG000|Overall Study|Site terminated by sponsor|7|||
19403713|NCT02396381|41648777|FG001|Overall Study|Site terminated by sponsor|8|||
19403714|NCT02396381|41648776|FG000|Overall Study|Physician Decision|5|||
19403715|NCT02396381|41648777|FG001|Overall Study|Physician Decision|5|||
19403716|NCT02396381|41648776|FG000|Overall Study|Pregnancy|2|||
19403717|NCT02396381|41648777|FG001|Overall Study|Pregnancy|0|||
19403718|NCT02396381|41648776|FG000|Overall Study|Non-compliance with study procedures|1|||
19403719|NCT02396381|41648777|FG001|Overall Study|Non-compliance with study procedures|0|||
19403720|NCT02396381|41648776|FG000|Overall Study|Moved out of town/state|1|||
19403721|NCT02396381|41648777|FG001|Overall Study|Moved out of town/state|3|||
19403722|NCT02396381|41648776|FG000|Overall Study|Could not complete visit|1|||
19403723|NCT02396381|41648777|FG001|Overall Study|Could not complete visit|0|||
19403724|NCT02396381|41648776|FG000|Overall Study|Possible conflict of interest|1|||
19403725|NCT02396381|41648777|FG001|Overall Study|Possible conflict of interest|0|||
19403726|NCT02396381|41648776|FG000|Overall Study|Randomization/Screening Error|3|||
19403727|NCT02396381|41648777|FG001|Overall Study|Randomization/Screening Error|1|||
19403728|NCT02532647|41648789|FG000|Overall Study|Did not receive trial medication|1|||
19403729|NCT02532647|41648790|FG001|Overall Study|Did not receive trial medication|0|||
19403730|NCT02532647|41648791|FG002|Overall Study|Did not receive trial medication|1|||
19403731|NCT02537015|41648799|FG000|Overall Study|Adverse Event|3|||
19403732|NCT02537015|41648799|FG000|Overall Study|Withdrawal by Subject|2|||
19403733|NCT02537015|41648799|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19403734|NCT02271945|41648805|FG000|Overall Study|Death|3|||
19403735|NCT02271945|41648806|FG001|Overall Study|Death|3|||
19403736|NCT02271945|41648805|FG000|Overall Study|Withdrawal by Subject|1|||
19403737|NCT02271945|41648806|FG001|Overall Study|Withdrawal by Subject|1|||
19403738|NCT02271945|41648805|FG000|Overall Study|Other|1|||
19403739|NCT02271945|41648806|FG001|Overall Study|Other|1|||
19403740|NCT01660763|41648814|FG000|Overall Study|Lack of Efficacy|45|||
19403741|NCT01660763|41648815|FG001|Overall Study|Lack of Efficacy|50|||
19403742|NCT01660763|41648814|FG000|Overall Study|Adverse Event|22|||
19403743|NCT01660763|41648815|FG001|Overall Study|Adverse Event|7|||
19403744|NCT01660763|41648814|FG000|Overall Study|Protocol Violation|1|||
19403745|NCT01660763|41648815|FG001|Overall Study|Protocol Violation|0|||
19403746|NCT01660763|41648814|FG000|Overall Study|Withdrawal by Subject|4|||
19403747|NCT01660763|41648815|FG001|Overall Study|Withdrawal by Subject|0|||
19403748|NCT01660763|41648814|FG000|Overall Study|Patient ready for early discharge|28|||
19403749|NCT01660763|41648815|FG001|Overall Study|Patient ready for early discharge|4|||
19518496|NCT01463982|41931536|FG000|Overall Study|Withdrawal by Subject|0|||
19403750|NCT01937117|41648821|FG000|Overall Study|Disease Progression|7|||
19403751|NCT01937117|41648821|FG000|Overall Study|Physician Decision|4|||
19403752|NCT01937117|41648821|FG000|Overall Study|Adverse Event|2|||
19403753|NCT02268045|41648827|FG000|Overall Study|Death|4|||
19403754|NCT02268045|41648828|FG001|Overall Study|Death|4|||
19403755|NCT02268045|41648827|FG000|Overall Study|Disease Progression|2|||
19403756|NCT02268045|41648828|FG001|Overall Study|Disease Progression|1|||
19403757|NCT02268045|41648827|FG000|Overall Study|Adverse Event|7|||
19403758|NCT02268045|41648828|FG001|Overall Study|Adverse Event|7|||
19403759|NCT02268045|41648827|FG000|Overall Study|Withdrawal by Subject|2|||
19403760|NCT02268045|41648828|FG001|Overall Study|Withdrawal by Subject|6|||
19403761|NCT02268045|41648827|FG000|Overall Study|Physician Decision|0|||
19403762|NCT02268045|41648828|FG001|Overall Study|Physician Decision|1|||
19403763|NCT02268045|41648827|FG000|Overall Study|Protocol Violation|1|||
19403764|NCT02268045|41648828|FG001|Overall Study|Protocol Violation|1|||
19403765|NCT02536781|41648838|FG000|Overall Study|Lost to Follow-up|2|||
19403766|NCT02536781|41648839|FG001|Overall Study|Lost to Follow-up|0|||
19403767|NCT02267187|41648845|FG000|Overall Study|Physician Decision|2|||
19403768|NCT02267187|41648845|FG000|Overall Study|Screen fail|3|||
19518497|NCT01463982|41931537|FG001|Overall Study|Withdrawal by Subject|1|||
19518498|NCT01463982|41931538|FG002|Overall Study|Withdrawal by Subject|1|||
19518499|NCT01463982|41931539|FG003|Overall Study|Withdrawal by Subject|0|||
19518500|NCT01463982|41931536|FG000|Overall Study|Treatment delay over 5 week|0|||
19518501|NCT01463982|41931537|FG001|Overall Study|Treatment delay over 5 week|0|||
19518502|NCT01463982|41931538|FG002|Overall Study|Treatment delay over 5 week|1|||
19518503|NCT01463982|41931539|FG003|Overall Study|Treatment delay over 5 week|0|||
19518504|NCT01486446|41931551|FG000|Overall Study|Adverse Event|1|||
19518505|NCT01486446|41931552|FG001|Overall Study|Adverse Event|0|||
19518506|NCT01485354|41931558|FG000|Overall Study|Withdrawal by Subject|5|||
19518507|NCT01510158|41931565|FG000|Overall Study|Adverse Event|7|||
19518508|NCT01510158|41931566|FG001|Overall Study|Adverse Event|8|||
19518509|NCT01510158|41931567|FG002|Overall Study|Adverse Event|5|||
19518510|NCT01510158|41931565|FG000|Overall Study|Gout flare|1|||
19518511|NCT01510158|41931566|FG001|Overall Study|Gout flare|0|||
19518512|NCT01510158|41931567|FG002|Overall Study|Gout flare|0|||
19518513|NCT01510158|41931565|FG000|Overall Study|Protocol Violation|17|||
19518514|NCT01510158|41931566|FG001|Overall Study|Protocol Violation|16|||
19518515|NCT01510158|41931567|FG002|Overall Study|Protocol Violation|24|||
19518516|NCT01510158|41931565|FG000|Overall Study|Sponsor terminated study.|2|||
19518517|NCT01510158|41931566|FG001|Overall Study|Sponsor terminated study.|0|||
19518518|NCT01510158|41931567|FG002|Overall Study|Sponsor terminated study.|2|||
19518519|NCT01510158|41931565|FG000|Overall Study|Lost to Follow-up|13|||
19518520|NCT01510158|41931566|FG001|Overall Study|Lost to Follow-up|16|||
19518521|NCT01510158|41931567|FG002|Overall Study|Lost to Follow-up|9|||
19518522|NCT01510158|41931565|FG000|Overall Study|Withdrawal by Subject|10|||
19518523|NCT01510158|41931566|FG001|Overall Study|Withdrawal by Subject|13|||
19518524|NCT01510158|41931567|FG002|Overall Study|Withdrawal by Subject|10|||
19518525|NCT01510158|41931565|FG000|Overall Study|Death|1|||
19518526|NCT01510158|41931566|FG001|Overall Study|Death|0|||
19518527|NCT01510158|41931567|FG002|Overall Study|Death|0|||
19518528|NCT01485120|41931584|FG000|Overall Study|Withdrawal by Subject|2|||
19518529|NCT01484496|41931591|FG000|Period 1|Protocol Violation|3|||
19518530|NCT01484496|41931592|FG001|Period 1|Protocol Violation|4|||
19518531|NCT01484496|41931593|FG002|Period 1|Protocol Violation|0|||
19518532|NCT01484496|41931594|FG003|Period 1|Protocol Violation|0|||
19518533|NCT01484496|41931591|FG000|Period 1|Physician Decision|5|||
19518534|NCT01484496|41931592|FG001|Period 1|Physician Decision|1|||
19518535|NCT01484496|41931593|FG002|Period 1|Physician Decision|0|||
19518536|NCT01484496|41931594|FG003|Period 1|Physician Decision|0|||
19518537|NCT01484496|41931591|FG000|Period 1|Lack of Efficacy|10|||
19518538|NCT01484496|41931592|FG001|Period 1|Lack of Efficacy|15|||
19518539|NCT01484496|41931593|FG002|Period 1|Lack of Efficacy|0|||
19518540|NCT01484496|41931594|FG003|Period 1|Lack of Efficacy|0|||
19518541|NCT01484496|41931591|FG000|Period 1|Adverse Event|25|||
19518542|NCT01484496|41931592|FG001|Period 1|Adverse Event|40|||
19518543|NCT01484496|41931593|FG002|Period 1|Adverse Event|0|||
19518544|NCT01484496|41931594|FG003|Period 1|Adverse Event|0|||
19518545|NCT01484496|41931591|FG000|Period 1|Withdrawal by Subject|15|||
19518546|NCT01484496|41931592|FG001|Period 1|Withdrawal by Subject|12|||
19518547|NCT01484496|41931593|FG002|Period 1|Withdrawal by Subject|0|||
19518548|NCT01484496|41931594|FG003|Period 1|Withdrawal by Subject|0|||
19518549|NCT01484496|41931591|FG000|Period 1|Lost to Follow-up|2|||
19518550|NCT01484496|41931592|FG001|Period 1|Lost to Follow-up|6|||
19518551|NCT01484496|41931593|FG002|Period 1|Lost to Follow-up|0|||
19518552|NCT01484496|41931594|FG003|Period 1|Lost to Follow-up|0|||
19518553|NCT01484496|41931591|FG000|Period 1|Positive Pregnancy|1|||
19628000|NCT00806286|42077393|FG000|Overall Study|Withdrawal by Subject|8|||
19518554|NCT01484496|41931592|FG001|Period 1|Positive Pregnancy|6|||
19518555|NCT01484496|41931593|FG002|Period 1|Positive Pregnancy|0|||
19518556|NCT01484496|41931594|FG003|Period 1|Positive Pregnancy|0|||
19518557|NCT01484496|41931591|FG000|Period 1|Treatment Failure|3|||
19518558|NCT01484496|41931592|FG001|Period 1|Treatment Failure|6|||
19518559|NCT01484496|41931593|FG002|Period 1|Treatment Failure|0|||
19518560|NCT01484496|41931594|FG003|Period 1|Treatment Failure|0|||
19518561|NCT01484496|41931591|FG000|Period 1|Lack of Compliance|2|||
19518562|NCT01484496|41931592|FG001|Period 1|Lack of Compliance|1|||
19518563|NCT01484496|41931593|FG002|Period 1|Lack of Compliance|0|||
19518564|NCT01484496|41931594|FG003|Period 1|Lack of Compliance|0|||
19518565|NCT01484496|41931591|FG000|Period 1|Unable to Visit Site|0|||
19518566|NCT01484496|41931592|FG001|Period 1|Unable to Visit Site|2|||
19518567|NCT01484496|41931593|FG002|Period 1|Unable to Visit Site|0|||
19403769|NCT02532179|41648849|FG000|Overall Study|Lost to Follow-up|1|||
19403770|NCT02532179|41648849|FG000|Overall Study|Pregnancy|1|||
19403771|NCT02532179|41648849|FG000|Overall Study|Subject received depot steroid injection|1|||
19403772|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
19403773|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
19403774|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
19403775|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
19403776|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
19403777|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
19403778|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
19403779|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
19403780|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
19403781|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
19403782|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
19403783|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
19403784|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
19403785|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
19403786|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
19403787|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
19403788|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
19403789|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
19403790|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
19403791|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
19403792|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
19403793|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
19403794|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
19403795|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
19403796|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
19403797|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
19403798|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
19403799|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
19403800|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
19403801|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
19403802|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
19403803|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
19403804|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
19403805|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
19403806|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
19403807|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
19403808|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
19403809|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
19403810|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
19403811|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
19403812|NCT02409667|41648853|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
19403813|NCT02409667|41648854|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
19403814|NCT02409667|41648855|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
19403815|NCT02409667|41648856|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
19403816|NCT02409667|41648857|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
19403817|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
19403818|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
19403819|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
19403820|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
19403821|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
19403822|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
19403823|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
19403824|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
19403825|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
19403826|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
19403827|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
19403828|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
19403829|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
19518568|NCT01484496|41931594|FG003|Period 1|Unable to Visit Site|0|||
19628001|NCT00806286|42077394|FG001|Overall Study|Withdrawal by Subject|3|||
19628002|NCT00806286|42077395|FG002|Overall Study|Withdrawal by Subject|1|||
19403830|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
19403831|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
19403832|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
19403833|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
19403834|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
19403835|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
19403836|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
19403837|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
19403838|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
19403839|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
19403840|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
19403841|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
19403842|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
19403843|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
19403844|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
19403845|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
19403846|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
19403847|NCT02409667|41648853|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
19403848|NCT02409667|41648854|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
19403849|NCT02409667|41648855|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
19403850|NCT02409667|41648856|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
19403851|NCT02409667|41648857|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
19403852|NCT01641939|41648871|FG000|Overall Study|Death|90|||
19403853|NCT01641939|41648872|FG001|Overall Study|Death|187|||
19403854|NCT01641939|41648873|FG002|Overall Study|Death|61|||
19403855|NCT01641939|41648871|FG000|Overall Study|Lost to Follow-up|3|||
19403856|NCT01641939|41648872|FG001|Overall Study|Lost to Follow-up|2|||
19403857|NCT01641939|41648873|FG002|Overall Study|Lost to Follow-up|1|||
19403858|NCT01641939|41648871|FG000|Overall Study|Withdrawal by Subject|14|||
19403859|NCT01641939|41648872|FG001|Overall Study|Withdrawal by Subject|11|||
19403860|NCT01641939|41648873|FG002|Overall Study|Withdrawal by Subject|5|||
19403861|NCT01641939|41648871|FG000|Overall Study|Study Terminated by Sponsor|10|||
19403862|NCT01641939|41648872|FG001|Overall Study|Study Terminated by Sponsor|28|||
19403863|NCT01641939|41648873|FG002|Overall Study|Study Terminated by Sponsor|3|||
19403864|NCT01641861|41648885|FG000|Overall Study|Lost to Follow-up|21|||
19403865|NCT01641861|41648886|FG001|Overall Study|Lost to Follow-up|16|||
19403866|NCT01641861|41648885|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
19403867|NCT01641861|41648886|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
19403868|NCT01641861|41648885|FG000|Overall Study|Died due to drowning|0|||
19403869|NCT01641861|41648886|FG001|Overall Study|Died due to drowning|1|||
19403870|NCT02409355|41648894|FG000|Overall Study|Withdrawal by Subject|1|||
19403871|NCT02409355|41648895|FG001|Overall Study|Withdrawal by Subject|0|||
19403872|NCT02409355|41648894|FG000|Overall Study|Death|1|||
19403873|NCT02409355|41648895|FG001|Overall Study|Death|1|||
19403874|NCT02409355|41648894|FG000|Overall Study|Study terminated by Sponsor|2|||
19403875|NCT02409355|41648895|FG001|Overall Study|Study terminated by Sponsor|3|||
19403876|NCT02408887|41648903|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
19403877|NCT02408887|41648904|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
19403878|NCT02408887|41648903|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
19403879|NCT02408887|41648904|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
19403880|NCT02266875|41648912|FG000|Overall Study|Withdrawal by Subject|9|||
19403881|NCT02266875|41648913|FG001|Overall Study|Withdrawal by Subject|0|||
19403882|NCT02266875|41648912|FG000|Overall Study|Lost to Follow-up|2|||
19403883|NCT02266875|41648913|FG001|Overall Study|Lost to Follow-up|0|||
19403884|NCT02438371|41648921|FG000|Overall Study|Lost to Follow-up|3|||
19403885|NCT02438371|41648922|FG001|Overall Study|Lost to Follow-up|2|||
19403886|NCT02438371|41648921|FG000|Overall Study|Withdrawal by Subject|1|||
19403887|NCT02438371|41648922|FG001|Overall Study|Withdrawal by Subject|1|||
19403888|NCT02438137|41648930|FG000|Overall Study|Lost to Follow-up|3|||
19403889|NCT02438137|41648931|FG001|Overall Study|Lost to Follow-up|2|||
19403890|NCT02438137|41648930|FG000|Overall Study|Adverse Event|1|||
19403891|NCT02438137|41648931|FG001|Overall Study|Adverse Event|0|||
19403892|NCT02438137|41648930|FG000|Overall Study|Withdrawal by Subject|4|||
19403893|NCT02438137|41648931|FG001|Overall Study|Withdrawal by Subject|3|||
19403894|NCT02438137|41648930|FG000|Overall Study|Physician Decision|0|||
19403895|NCT02438137|41648931|FG001|Overall Study|Physician Decision|1|||
19403896|NCT02437903|41648939|FG000|Overall Study|Adverse Event|1|||
19403897|NCT02437903|41648939|FG000|Overall Study|Withdrawal by Subject|1|||
19403898|NCT02437903|41648939|FG000|Overall Study|Lost to Follow-up|3|||
19403899|NCT02437513|41648944|FG000|Overall Study|Withdrawal by Subject|2|||
19403900|NCT02460991|41648950|FG000|Overall Study|Withdrawal by Subject|0|||
19518569|NCT01484496|41931591|FG000|Period 2|Lack of Efficacy|0|||
19403901|NCT02460991|41648951|FG001|Overall Study|Withdrawal by Subject|2|||
19403902|NCT02407249|41648962|FG000|Overall Study|Did not complete 12-month follow-up|13|||
19403903|NCT02407249|41648962|FG000|Overall Study|Not treated|13|||
19403904|NCT02460679|41648966|FG000|Overall Study|Investigator Decision|1|||
19403905|NCT02460679|41648966|FG000|Overall Study|Withdrawal by Subject|4|||
19403906|NCT02459899|41648974|FG000|Overall Study|Adverse Event|1|||
19403907|NCT02459899|41648975|FG001|Overall Study|Adverse Event|1|||
19403908|NCT02459899|41648976|FG002|Overall Study|Adverse Event|0|||
19403909|NCT02459899|41648977|FG003|Overall Study|Adverse Event|0|||
19403910|NCT02459899|41648974|FG000|Overall Study|Lost to Follow-up|1|||
19403911|NCT02459899|41648975|FG001|Overall Study|Lost to Follow-up|2|||
19403912|NCT02459899|41648976|FG002|Overall Study|Lost to Follow-up|0|||
19403913|NCT02459899|41648977|FG003|Overall Study|Lost to Follow-up|1|||
19403914|NCT02459899|41648974|FG000|Overall Study|Non-compliance with the treatment|0|||
19403915|NCT02459899|41648975|FG001|Overall Study|Non-compliance with the treatment|0|||
19403916|NCT02459899|41648976|FG002|Overall Study|Non-compliance with the treatment|0|||
19403917|NCT02459899|41648977|FG003|Overall Study|Non-compliance with the treatment|1|||
19403918|NCT02459899|41648974|FG000|Overall Study|Withdrawal by Subject|1|||
19403919|NCT02459899|41648975|FG001|Overall Study|Withdrawal by Subject|3|||
19403920|NCT02459899|41648976|FG002|Overall Study|Withdrawal by Subject|0|||
19403921|NCT02459899|41648977|FG003|Overall Study|Withdrawal by Subject|0|||
19403922|NCT02436889|41648989|FG000|Overall Study|No improvement in symptoms|1|||
19403923|NCT02436889|41648990|FG001|Overall Study|No improvement in symptoms|0|||
19403924|NCT02436889|41648989|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
19403925|NCT02436889|41648990|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
19403926|NCT02436811|41648999|FG000|Overall Study|Lost to Follow-up|2|||
19403927|NCT02436811|41649000|FG001|Overall Study|Lost to Follow-up|9|||
19403928|NCT02436811|41649001|FG002|Overall Study|Lost to Follow-up|7|||
19403929|NCT02436577|41649015|FG000|Overall Study|Protocol Deviation|0|||
19403930|NCT02436577|41649016|FG001|Overall Study|Protocol Deviation|1|||
19403931|NCT02436577|41649017|FG002|Overall Study|Protocol Deviation|0|||
19403932|NCT02436577|41649018|FG003|Overall Study|Protocol Deviation|0|||
19403933|NCT02436577|41649019|FG004|Overall Study|Protocol Deviation|0|||
19403934|NCT02436577|41649020|FG005|Overall Study|Protocol Deviation|0|||
19403935|NCT02265705|41649030|FG000|Treatment Period Week 0-24|Adverse Event|3|||
19403936|NCT02265705|41649031|FG001|Treatment Period Week 0-24|Adverse Event|2|||
19403937|NCT02265705|41649032|FG002|Treatment Period Week 0-24|Adverse Event|0|||
19403938|NCT02265705|41649033|FG003|Treatment Period Week 0-24|Adverse Event|0|||
19403939|NCT02265705|41649034|FG004|Treatment Period Week 0-24|Adverse Event|0|||
19403940|NCT02265705|41649035|FG005|Treatment Period Week 0-24|Adverse Event|0|||
19403941|NCT02265705|41649036|FG006|Treatment Period Week 0-24|Adverse Event|0|||
19403942|NCT02265705|41649030|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
19403943|NCT02265705|41649031|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
19403944|NCT02265705|41649032|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
19403945|NCT02265705|41649033|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
19403946|NCT02265705|41649034|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
19403947|NCT02265705|41649035|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
19403948|NCT02265705|41649036|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
19403949|NCT02265705|41649030|FG000|Treatment Period Week 0-24|Physician Decision|1|||
19403950|NCT02265705|41649031|FG001|Treatment Period Week 0-24|Physician Decision|0|||
19403951|NCT02265705|41649032|FG002|Treatment Period Week 0-24|Physician Decision|0|||
19403952|NCT02265705|41649033|FG003|Treatment Period Week 0-24|Physician Decision|0|||
19403953|NCT02265705|41649034|FG004|Treatment Period Week 0-24|Physician Decision|0|||
19403954|NCT02265705|41649035|FG005|Treatment Period Week 0-24|Physician Decision|0|||
19403955|NCT02265705|41649036|FG006|Treatment Period Week 0-24|Physician Decision|0|||
19403956|NCT02265705|41649030|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
19403957|NCT02265705|41649031|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
19403958|NCT02265705|41649032|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
19403959|NCT02265705|41649033|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
19403960|NCT02265705|41649034|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
19403961|NCT02265705|41649035|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
19403962|NCT02265705|41649036|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
19403963|NCT02265705|41649030|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403964|NCT02265705|41649031|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
19403965|NCT02265705|41649032|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403966|NCT02265705|41649033|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403967|NCT02265705|41649034|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403968|NCT02265705|41649035|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403969|NCT02265705|41649036|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
19403970|NCT02265705|41649030|FG000|Rescue Period|Withdrawal by Subject|0|||
19403971|NCT02265705|41649031|FG001|Rescue Period|Withdrawal by Subject|0|||
19403972|NCT02265705|41649032|FG002|Rescue Period|Withdrawal by Subject|1|||
19403973|NCT02265705|41649033|FG003|Rescue Period|Withdrawal by Subject|0|||
19403974|NCT02265705|41649034|FG004|Rescue Period|Withdrawal by Subject|0|||
19403975|NCT02265705|41649035|FG005|Rescue Period|Withdrawal by Subject|0|||
19403976|NCT02265705|41649036|FG006|Rescue Period|Withdrawal by Subject|0|||
19518570|NCT01484496|41931592|FG001|Period 2|Lack of Efficacy|0|||
19518571|NCT01484496|41931593|FG002|Period 2|Lack of Efficacy|1|||
19518572|NCT01484496|41931594|FG003|Period 2|Lack of Efficacy|3|||
19518573|NCT01484496|41931591|FG000|Period 2|Adverse Event|0|||
19518574|NCT01484496|41931592|FG001|Period 2|Adverse Event|0|||
19518575|NCT01484496|41931593|FG002|Period 2|Adverse Event|5|||
19518576|NCT01484496|41931594|FG003|Period 2|Adverse Event|13|||
19518577|NCT01484496|41931591|FG000|Period 2|Other|0|||
19518578|NCT01484496|41931592|FG001|Period 2|Other|0|||
19518579|NCT01484496|41931593|FG002|Period 2|Other|9|||
19518580|NCT01484496|41931594|FG003|Period 2|Other|6|||
19518581|NCT01509846|41931607|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
19518582|NCT01509846|41931608|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
19518583|NCT01509846|41931609|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
19518584|NCT01509846|41931610|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
19518585|NCT01509846|41931611|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
19518586|NCT01509846|41931607|FG000|Received Vaccination 2|Illness|0|||
19518587|NCT01509846|41931608|FG001|Received Vaccination 2|Illness|0|||
19518588|NCT01509846|41931609|FG002|Received Vaccination 2|Illness|0|||
19518589|NCT01509846|41931610|FG003|Received Vaccination 2|Illness|0|||
19518590|NCT01509846|41931611|FG004|Received Vaccination 2|Illness|1|||
19518591|NCT01509846|41931607|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
19518592|NCT01509846|41931608|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
19518593|NCT01509846|41931609|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
19518594|NCT01509846|41931610|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
19518595|NCT01509846|41931611|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
19518596|NCT01509846|41931607|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
19518597|NCT01509846|41931608|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
19518598|NCT01509846|41931609|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
19518599|NCT01509846|41931610|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
19518600|NCT01509846|41931611|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
19518601|NCT01509846|41931607|FG000|Received Vaccination 3|Pregnancy|0|||
19518602|NCT01509846|41931608|FG001|Received Vaccination 3|Pregnancy|0|||
19518603|NCT01509846|41931609|FG002|Received Vaccination 3|Pregnancy|0|||
19518604|NCT01509846|41931610|FG003|Received Vaccination 3|Pregnancy|1|||
19518605|NCT01509846|41931611|FG004|Received Vaccination 3|Pregnancy|0|||
19403977|NCT02265705|41649030|FG000|Rescue Period|Death|0|||
19403978|NCT02265705|41649031|FG001|Rescue Period|Death|0|||
19403979|NCT02265705|41649032|FG002|Rescue Period|Death|1|||
19403980|NCT02265705|41649033|FG003|Rescue Period|Death|0|||
19403981|NCT02265705|41649034|FG004|Rescue Period|Death|0|||
19403982|NCT02265705|41649035|FG005|Rescue Period|Death|0|||
19403983|NCT02265705|41649036|FG006|Rescue Period|Death|0|||
19403984|NCT02265705|41649030|FG000|Rescue Period|Lack of Efficacy|0|||
19403985|NCT02265705|41649031|FG001|Rescue Period|Lack of Efficacy|0|||
19403986|NCT02265705|41649032|FG002|Rescue Period|Lack of Efficacy|1|||
19403987|NCT02265705|41649033|FG003|Rescue Period|Lack of Efficacy|0|||
19403988|NCT02265705|41649034|FG004|Rescue Period|Lack of Efficacy|0|||
19403989|NCT02265705|41649035|FG005|Rescue Period|Lack of Efficacy|0|||
19403990|NCT02265705|41649036|FG006|Rescue Period|Lack of Efficacy|0|||
19403991|NCT02265705|41649030|FG000|Open Label Period|Adverse Event|0|||
19403992|NCT02265705|41649031|FG001|Open Label Period|Adverse Event|0|||
19403993|NCT02265705|41649032|FG002|Open Label Period|Adverse Event|0|||
19403994|NCT02265705|41649033|FG003|Open Label Period|Adverse Event|2|||
19403995|NCT02265705|41649034|FG004|Open Label Period|Adverse Event|2|||
19403996|NCT02265705|41649035|FG005|Open Label Period|Adverse Event|0|||
19403997|NCT02265705|41649036|FG006|Open Label Period|Adverse Event|0|||
19403998|NCT02265705|41649030|FG000|Open Label Period|Physician Decision|0|||
19403999|NCT02265705|41649031|FG001|Open Label Period|Physician Decision|0|||
19404000|NCT02265705|41649032|FG002|Open Label Period|Physician Decision|0|||
19404001|NCT02265705|41649033|FG003|Open Label Period|Physician Decision|0|||
19404002|NCT02265705|41649034|FG004|Open Label Period|Physician Decision|1|||
19404003|NCT02265705|41649035|FG005|Open Label Period|Physician Decision|0|||
19404004|NCT02265705|41649036|FG006|Open Label Period|Physician Decision|0|||
19404005|NCT02265705|41649030|FG000|Open Label Period|Withdrawal by Subject|0|||
19404006|NCT02265705|41649031|FG001|Open Label Period|Withdrawal by Subject|0|||
19404007|NCT02265705|41649032|FG002|Open Label Period|Withdrawal by Subject|0|||
19404008|NCT02265705|41649033|FG003|Open Label Period|Withdrawal by Subject|0|||
19404009|NCT02265705|41649034|FG004|Open Label Period|Withdrawal by Subject|2|||
19404010|NCT02265705|41649035|FG005|Open Label Period|Withdrawal by Subject|0|||
19404011|NCT02265705|41649036|FG006|Open Label Period|Withdrawal by Subject|0|||
19518606|NCT01509846|41931607|FG000|Received Vaccination 3|Lost to Follow-up|0|||
19518607|NCT01509846|41931608|FG001|Received Vaccination 3|Lost to Follow-up|0|||
19518608|NCT01509846|41931609|FG002|Received Vaccination 3|Lost to Follow-up|1|||
19628003|NCT00806286|42077393|FG000|Overall Study|Physician Decision|2|||
19404012|NCT02265705|41649030|FG000|Follow-up Period|Sponsor Decision|0|||
19404013|NCT02265705|41649031|FG001|Follow-up Period|Sponsor Decision|0|||
19404014|NCT02265705|41649032|FG002|Follow-up Period|Sponsor Decision|0|||
19404015|NCT02265705|41649033|FG003|Follow-up Period|Sponsor Decision|0|||
19404016|NCT02265705|41649034|FG004|Follow-up Period|Sponsor Decision|0|||
19404017|NCT02265705|41649035|FG005|Follow-up Period|Sponsor Decision|1|||
19404018|NCT02265705|41649036|FG006|Follow-up Period|Sponsor Decision|6|||
19404019|NCT02265705|41649030|FG000|Follow-up Period|Adverse Event|0|||
19404020|NCT02265705|41649031|FG001|Follow-up Period|Adverse Event|0|||
19404021|NCT02265705|41649032|FG002|Follow-up Period|Adverse Event|0|||
19404022|NCT02265705|41649033|FG003|Follow-up Period|Adverse Event|0|||
19404023|NCT02265705|41649034|FG004|Follow-up Period|Adverse Event|0|||
19404024|NCT02265705|41649035|FG005|Follow-up Period|Adverse Event|0|||
19404025|NCT02265705|41649036|FG006|Follow-up Period|Adverse Event|3|||
19404026|NCT02265705|41649030|FG000|Follow-up Period|Physician Decision|0|||
19404027|NCT02265705|41649031|FG001|Follow-up Period|Physician Decision|0|||
19404028|NCT02265705|41649032|FG002|Follow-up Period|Physician Decision|0|||
19404029|NCT02265705|41649033|FG003|Follow-up Period|Physician Decision|0|||
19404030|NCT02265705|41649034|FG004|Follow-up Period|Physician Decision|0|||
19404031|NCT02265705|41649035|FG005|Follow-up Period|Physician Decision|0|||
19404032|NCT02265705|41649036|FG006|Follow-up Period|Physician Decision|1|||
19404033|NCT02265705|41649030|FG000|Follow-up Period|Withdrawal by Subject|0|||
19404034|NCT02265705|41649031|FG001|Follow-up Period|Withdrawal by Subject|0|||
19404035|NCT02265705|41649032|FG002|Follow-up Period|Withdrawal by Subject|0|||
19404036|NCT02265705|41649033|FG003|Follow-up Period|Withdrawal by Subject|0|||
19404037|NCT02265705|41649034|FG004|Follow-up Period|Withdrawal by Subject|0|||
19404038|NCT02265705|41649035|FG005|Follow-up Period|Withdrawal by Subject|0|||
19404039|NCT02265705|41649036|FG006|Follow-up Period|Withdrawal by Subject|1|||
19404040|NCT02459665|41649051|FG000|Overall Study|Withdrawal by Subject|0|||
19404041|NCT02459665|41649052|FG001|Overall Study|Withdrawal by Subject|1|||
19404042|NCT02459665|41649053|FG002|Overall Study|Withdrawal by Subject|1|||
19404043|NCT02459665|41649054|FG003|Overall Study|Withdrawal by Subject|2|||
19404044|NCT02459587|41649073|FG000|3-Month Follow-up Assessment|Death|0|||
19404045|NCT02459587|41649074|FG001|3-Month Follow-up Assessment|Death|2|||
19404046|NCT02459587|41649073|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
19404047|NCT02459587|41649074|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
19404048|NCT02459587|41649073|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
19404049|NCT02459587|41649074|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
19404050|NCT02459587|41649073|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
19404051|NCT02459587|41649074|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
19404052|NCT02459587|41649073|FG000|6-month Follow-up Assessment|Death|2|||
19404053|NCT02459587|41649074|FG001|6-month Follow-up Assessment|Death|1|||
19404054|NCT02459587|41649073|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
19404055|NCT02459587|41649074|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
19404056|NCT02459587|41649073|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
19404057|NCT02459587|41649074|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
19404058|NCT02459587|41649073|FG000|12-month Follow-up Assessment|Death|2|||
19404059|NCT02459587|41649074|FG001|12-month Follow-up Assessment|Death|0|||
19404060|NCT02459587|41649073|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
19404061|NCT02459587|41649074|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
19404062|NCT02459587|41649073|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
19404063|NCT02459587|41649074|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
19404064|NCT02459587|41649073|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
19404065|NCT02459587|41649074|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
19404066|NCT02265237|41649085|FG000|As Treated (Overall Study)|Adverse Event|1|||
19404067|NCT02265237|41649086|FG001|As Treated (Overall Study)|Adverse Event|1|||
19404068|NCT02265237|41649087|FG002|As Treated (Overall Study)|Adverse Event|0|||
19404069|NCT02265237|41649088|FG003|As Treated (Overall Study)|Adverse Event|0|||
19404070|NCT02265237|41649085|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
19404071|NCT02265237|41649086|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
19404072|NCT02265237|41649087|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
19404073|NCT02265237|41649088|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
19404074|NCT02265237|41649085|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
19404075|NCT02265237|41649086|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
19404076|NCT02265237|41649087|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
19404077|NCT02265237|41649088|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
19404078|NCT02265237|41649085|FG000|As Treated (Overall Study)|Other|2|||
19404079|NCT02265237|41649086|FG001|As Treated (Overall Study)|Other|0|||
19711066|NCT03605680|42154234|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
19404080|NCT02265237|41649087|FG002|As Treated (Overall Study)|Other|3|||
19404081|NCT02265237|41649088|FG003|As Treated (Overall Study)|Other|1|||
19404082|NCT02263365|41649101|FG000|Overall Study|Physician Decision|22|||
19404083|NCT02263365|41649102|FG001|Overall Study|Physician Decision|18|||
19404084|NCT02261493|41649112|FG000|Overall Study|Noncompliance|0|||
19711067|NCT03572218|42154245|FG000|Overall Study|Lost to Follow-up|3|||
19404085|NCT02261493|41649113|FG001|Overall Study|Noncompliance|0|||
19404086|NCT02261493|41649114|FG002|Overall Study|Noncompliance|2|||
19404087|NCT02261493|41649112|FG000|Overall Study|Physician Decision|0|||
19404088|NCT02261493|41649113|FG001|Overall Study|Physician Decision|1|||
19404089|NCT02261493|41649114|FG002|Overall Study|Physician Decision|0|||
19404090|NCT02261493|41649112|FG000|Overall Study|Undisclosed alcohol abuse|0|||
19404091|NCT02261493|41649113|FG001|Overall Study|Undisclosed alcohol abuse|1|||
19404092|NCT02261493|41649114|FG002|Overall Study|Undisclosed alcohol abuse|0|||
19404093|NCT02261493|41649112|FG000|Overall Study|Protocol Violation|1|||
19404094|NCT02261493|41649113|FG001|Overall Study|Protocol Violation|0|||
19404095|NCT02261493|41649114|FG002|Overall Study|Protocol Violation|0|||
19404096|NCT02261493|41649112|FG000|Overall Study|Personal Reasons|14|||
19404097|NCT02261493|41649113|FG001|Overall Study|Personal Reasons|14|||
19404098|NCT02261493|41649114|FG002|Overall Study|Personal Reasons|16|||
19404099|NCT02261493|41649112|FG000|Overall Study|Lost to Follow-up|14|||
19404100|NCT02261493|41649113|FG001|Overall Study|Lost to Follow-up|27|||
19404101|NCT02261493|41649114|FG002|Overall Study|Lost to Follow-up|8|||
19404102|NCT02261493|41649112|FG000|Overall Study|Pregnancy|1|||
19404103|NCT02261493|41649113|FG001|Overall Study|Pregnancy|2|||
19404104|NCT02261493|41649114|FG002|Overall Study|Pregnancy|0|||
19404105|NCT02261493|41649112|FG000|Overall Study|Lack of Efficacy|0|||
19404106|NCT02261493|41649113|FG001|Overall Study|Lack of Efficacy|1|||
19404107|NCT02261493|41649114|FG002|Overall Study|Lack of Efficacy|0|||
19404108|NCT02261493|41649112|FG000|Overall Study|Adverse Event|0|||
19404109|NCT02261493|41649113|FG001|Overall Study|Adverse Event|1|||
19404110|NCT02261493|41649114|FG002|Overall Study|Adverse Event|0|||
19404111|NCT02260791|41649124|FG000|Overall Study|Lost to Follow-up|4|||
19404112|NCT02260791|41649125|FG001|Overall Study|Lost to Follow-up|4|||
19404113|NCT02260791|41649124|FG000|Overall Study|Lack of Efficacy|2|||
19404114|NCT02260791|41649125|FG001|Overall Study|Lack of Efficacy|1|||
19404115|NCT02260791|41649124|FG000|Overall Study|Adverse Event|13|||
19404116|NCT02260791|41649125|FG001|Overall Study|Adverse Event|9|||
19404117|NCT02260791|41649124|FG000|Overall Study|Death|1|||
19404118|NCT02260791|41649125|FG001|Overall Study|Death|0|||
19404119|NCT02260791|41649124|FG000|Overall Study|Withdrawal by Subject|11|||
19404120|NCT02260791|41649125|FG001|Overall Study|Withdrawal by Subject|16|||
19404121|NCT02260791|41649124|FG000|Overall Study|Screen failure|0|||
19404122|NCT02260791|41649125|FG001|Overall Study|Screen failure|1|||
19404123|NCT02260791|41649124|FG000|Overall Study|Protocol deviation|2|||
19404124|NCT02260791|41649125|FG001|Overall Study|Protocol deviation|3|||
19404125|NCT02260635|41649133|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
19404126|NCT02260635|41649134|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
19404127|NCT02260635|41649133|FG000|Open-Label Extension|Study Termination|25|||
19404128|NCT02260635|41649134|FG001|Open-Label Extension|Study Termination|25|||
19404129|NCT02260635|41649133|FG000|Open-Label Extension|Withdrawal by Subject|1|||
19404130|NCT02260635|41649134|FG001|Open-Label Extension|Withdrawal by Subject|0|||
19404131|NCT02259231|41649149|FG000|Overall Study|Adverse Event|1|||
19404132|NCT02259231|41649150|FG001|Overall Study|Adverse Event|1|||
19404133|NCT02259231|41649151|FG002|Overall Study|Adverse Event|2|||
19404134|NCT02259231|41649152|FG003|Overall Study|Adverse Event|0|||
19404135|NCT02259231|41649153|FG004|Overall Study|Adverse Event|0|||
19404136|NCT02259231|41649154|FG005|Overall Study|Adverse Event|0|||
19404137|NCT02259231|41649155|FG006|Overall Study|Adverse Event|0|||
19404138|NCT02259231|41649149|FG000|Overall Study|Progressive Disease|4|||
19404139|NCT02259231|41649150|FG001|Overall Study|Progressive Disease|5|||
19404140|NCT02259231|41649151|FG002|Overall Study|Progressive Disease|4|||
19404141|NCT02259231|41649152|FG003|Overall Study|Progressive Disease|5|||
19404142|NCT02259231|41649153|FG004|Overall Study|Progressive Disease|4|||
19404143|NCT02259231|41649154|FG005|Overall Study|Progressive Disease|5|||
19404144|NCT02259231|41649155|FG006|Overall Study|Progressive Disease|4|||
19404145|NCT02259231|41649149|FG000|Overall Study|Sponsor termination of study|1|||
19404146|NCT02259231|41649150|FG001|Overall Study|Sponsor termination of study|0|||
19404147|NCT02259231|41649151|FG002|Overall Study|Sponsor termination of study|0|||
19404148|NCT02259231|41649152|FG003|Overall Study|Sponsor termination of study|1|||
19404149|NCT02259231|41649153|FG004|Overall Study|Sponsor termination of study|2|||
19404150|NCT02259231|41649154|FG005|Overall Study|Sponsor termination of study|1|||
19404151|NCT02259231|41649155|FG006|Overall Study|Sponsor termination of study|1|||
19404152|NCT02258529|41649171|FG000|Overall Study|Study Terminated by Sponsor|9|||
19518609|NCT01509846|41931610|FG003|Received Vaccination 3|Lost to Follow-up|0|||
19404153|NCT02258529|41649171|FG000|Overall Study|Adverse Event|1|||
19518610|NCT01509846|41931611|FG004|Received Vaccination 3|Lost to Follow-up|0|||
19404154|NCT02256969|41649178|FG000|Overall Study|Screenfailed or withdrew|2|||
19404155|NCT02256969|41649179|FG001|Overall Study|Screenfailed or withdrew|1|||
19404156|NCT02256969|41649180|FG002|Overall Study|Screenfailed or withdrew|1|||
19404157|NCT02256891|41649190|FG000|Overall Study|Death|0|||
19404158|NCT02256891|41649191|FG001|Overall Study|Death|2|||
19404159|NCT02256891|41649190|FG000|Overall Study|Lost to Follow-up|0|||
19404160|NCT02256891|41649191|FG001|Overall Study|Lost to Follow-up|3|||
19404161|NCT02256891|41649190|FG000|Overall Study|Physician Decision|7|||
19404162|NCT02256891|41649191|FG001|Overall Study|Physician Decision|3|||
19404163|NCT02256891|41649190|FG000|Overall Study|Screen Fail|5|||
19404164|NCT02256891|41649191|FG001|Overall Study|Screen Fail|4|||
19404165|NCT02256891|41649190|FG000|Overall Study|Equipment Malfunction|0|||
19404166|NCT02256891|41649191|FG001|Overall Study|Equipment Malfunction|1|||
19404167|NCT02256267|41649199|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
19404168|NCT02256267|41649199|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
19404169|NCT01641471|41649208|FG000|Overall Study|Withdrawal by Subject|19|||
19404170|NCT01641471|41649209|FG001|Overall Study|Withdrawal by Subject|19|||
19404171|NCT01641471|41649208|FG000|Overall Study|Lost to Follow-up|2|||
19404172|NCT01641471|41649209|FG001|Overall Study|Lost to Follow-up|4|||
19404173|NCT01641471|41649208|FG000|Overall Study|Protocol Violation|2|||
19404174|NCT01641471|41649209|FG001|Overall Study|Protocol Violation|4|||
19404175|NCT02255565|41649218|FG000|Overall Study|Withdrawal by Subject|0|||
19404176|NCT02255565|41649219|FG001|Overall Study|Withdrawal by Subject|1|||
19404177|NCT02255565|41649220|FG002|Overall Study|Withdrawal by Subject|0|||
19404178|NCT01640301|41649263|FG000|Overall Study|Death|0|||
19404179|NCT01640301|41649264|FG001|Overall Study|Death|8|||
19518611|NCT01462344|41931632|FG000|Overall Study|Withdrawal by Subject|245|||
19518612|NCT01462344|41931633|FG001|Overall Study|Withdrawal by Subject|226|||
19518613|NCT01462344|41931632|FG000|Overall Study|Adverse Event|24|||
19518614|NCT01462344|41931633|FG001|Overall Study|Adverse Event|23|||
19518615|NCT01462344|41931632|FG000|Overall Study|Asthma Exacerbation|34|||
19518616|NCT01462344|41931633|FG001|Overall Study|Asthma Exacerbation|35|||
19518617|NCT01462344|41931632|FG000|Overall Study|Lack of Efficacy|5|||
19518618|NCT01462344|41931633|FG001|Overall Study|Lack of Efficacy|6|||
19518619|NCT01462344|41931632|FG000|Overall Study|Protocol Violation|68|||
19518620|NCT01462344|41931633|FG001|Overall Study|Protocol Violation|53|||
19518621|NCT01462344|41931632|FG000|Overall Study|Lost to Follow-up|7|||
19518622|NCT01462344|41931633|FG001|Overall Study|Lost to Follow-up|7|||
19518623|NCT01484028|41931639|FG000|Period 1|Lost to Follow-up|0|||
19518624|NCT01484028|41931640|FG001|Period 1|Lost to Follow-up|1|||
19518625|NCT01484028|41931641|FG002|Period 1|Lost to Follow-up|0|||
19518626|NCT01484028|41931642|FG003|Period 1|Lost to Follow-up|0|||
19518627|NCT01484028|41931639|FG000|Period 1|Non-Compliance to Protocol|0|||
19518628|NCT01484028|41931640|FG001|Period 1|Non-Compliance to Protocol|1|||
19518629|NCT01484028|41931641|FG002|Period 1|Non-Compliance to Protocol|0|||
19518630|NCT01484028|41931642|FG003|Period 1|Non-Compliance to Protocol|1|||
19518631|NCT01484028|41931639|FG000|Period 1|Lens Discomfort|0|||
19518632|NCT01484028|41931640|FG001|Period 1|Lens Discomfort|1|||
19518633|NCT01484028|41931641|FG002|Period 1|Lens Discomfort|0|||
19518634|NCT01484028|41931642|FG003|Period 1|Lens Discomfort|0|||
19518635|NCT01462266|41931652|FG000|Overall Study|Adverse Event|7|||
19518636|NCT01462266|41931653|FG001|Overall Study|Adverse Event|6|||
19518637|NCT01462266|41931652|FG000|Overall Study|Death|2|||
19518638|NCT01462266|41931653|FG001|Overall Study|Death|1|||
19518639|NCT01462266|41931652|FG000|Overall Study|Lack of Efficacy|0|||
19518640|NCT01462266|41931653|FG001|Overall Study|Lack of Efficacy|2|||
19518641|NCT01462266|41931652|FG000|Overall Study|Lost to Follow-up|4|||
19518642|NCT01462266|41931653|FG001|Overall Study|Lost to Follow-up|3|||
19518643|NCT01462266|41931652|FG000|Overall Study|Non-compliance with study drug|3|||
19518644|NCT01462266|41931653|FG001|Overall Study|Non-compliance with study drug|0|||
19518645|NCT01462266|41931652|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
19518646|NCT01462266|41931653|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
19518647|NCT01462266|41931652|FG000|Overall Study|Physician Decision|2|||
19518648|NCT01462266|41931653|FG001|Overall Study|Physician Decision|5|||
19518649|NCT01462266|41931652|FG000|Overall Study|Protocol Violation|1|||
19518650|NCT01462266|41931653|FG001|Overall Study|Protocol Violation|3|||
19518651|NCT01462266|41931652|FG000|Overall Study|Withdrawal by Subject|7|||
19518652|NCT01462266|41931653|FG001|Overall Study|Withdrawal by Subject|2|||
19518653|NCT01462266|41931652|FG000|Overall Study|Screen failure|1|||
19518654|NCT01462266|41931653|FG001|Overall Study|Screen failure|1|||
19518655|NCT01508910|41931662|FG000|Treatment|Death|2|||
19518656|NCT01508910|41931663|FG001|Treatment|Death|3|||
19518657|NCT01508910|41931664|FG002|Treatment|Death|2|||
19518658|NCT01508910|41931665|FG003|Treatment|Death|0|||
19518659|NCT01508910|41931662|FG000|Treatment|Lost to Follow-up|0|||
19518660|NCT01508910|41931663|FG001|Treatment|Lost to Follow-up|0|||
19518661|NCT01508910|41931664|FG002|Treatment|Lost to Follow-up|2|||
19518662|NCT01508910|41931665|FG003|Treatment|Lost to Follow-up|1|||
19404180|NCT01642407|41649272|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
19404181|NCT01642407|41649272|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
19404182|NCT01642407|41649272|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
19518663|NCT01508910|41931662|FG000|Treatment|Withdrawal by Subject|0|||
19518664|NCT01508910|41931663|FG001|Treatment|Withdrawal by Subject|1|||
19518665|NCT01508910|41931664|FG002|Treatment|Withdrawal by Subject|6|||
19518666|NCT01508910|41931665|FG003|Treatment|Withdrawal by Subject|1|||
19518667|NCT01508910|41931662|FG000|Treatment|Sponsor Decision|0|||
19518668|NCT01508910|41931663|FG001|Treatment|Sponsor Decision|0|||
19518669|NCT01508910|41931664|FG002|Treatment|Sponsor Decision|0|||
19518670|NCT01508910|41931665|FG003|Treatment|Sponsor Decision|1|||
19518671|NCT01462110|41931679|FG000|Overall Study|Adverse Event|1|||
19518672|NCT01462110|41931680|FG001|Overall Study|Adverse Event|0|||
19518673|NCT01508676|41931688|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
19518674|NCT01508676|41931689|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
19518675|NCT01508676|41931688|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
19518676|NCT01508676|41931689|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
19518677|NCT01508676|41931688|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
19518678|NCT01508676|41931689|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
19518679|NCT01508676|41931688|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
19518680|NCT01508676|41931689|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
19518681|NCT01508676|41931688|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
19518682|NCT01508676|41931689|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
19518683|NCT01508130|41931698|FG000|Overall Study|Adverse Event|81|||
19518684|NCT01508130|41931699|FG001|Overall Study|Adverse Event|28|||
19518685|NCT01508130|41931698|FG000|Overall Study|Death|3|||
19518686|NCT01508130|41931699|FG001|Overall Study|Death|1|||
19518687|NCT01508130|41931698|FG000|Overall Study|Protocol Violation|2|||
19518688|NCT01508130|41931699|FG001|Overall Study|Protocol Violation|0|||
19518689|NCT01508130|41931698|FG000|Overall Study|Lost to Follow-up|25|||
19518690|NCT01508130|41931699|FG001|Overall Study|Lost to Follow-up|2|||
19518691|NCT01508130|41931698|FG000|Overall Study|Withdrawal by Subject|3|||
19518692|NCT01508130|41931699|FG001|Overall Study|Withdrawal by Subject|3|||
19518693|NCT01508130|41931698|FG000|Overall Study|Subject's substantial non-compliance|25|||
19518694|NCT01508130|41931699|FG001|Overall Study|Subject's substantial non-compliance|9|||
19518695|NCT01508130|41931698|FG000|Overall Study|Insufficient therapeutic response|74|||
19518696|NCT01508130|41931699|FG001|Overall Study|Insufficient therapeutic response|23|||
19518697|NCT01508130|41931698|FG000|Overall Study|Administrative|14|||
19518698|NCT01508130|41931699|FG001|Overall Study|Administrative|3|||
19518699|NCT01482312|41931707|FG000|Period 1, 90 Minutes of Wear|Other|1|||
19518700|NCT01482312|41931708|FG001|Period 1, 90 Minutes of Wear|Other|0|||
19518701|NCT01482312|41931709|FG002|Period 1, 90 Minutes of Wear|Other|0|||
19628004|NCT00806286|42077394|FG001|Overall Study|Physician Decision|2|||
19628005|NCT00806286|42077395|FG002|Overall Study|Physician Decision|0|||
19628006|NCT00806286|42077393|FG000|Overall Study|Due to a variety of reasons|7|||
19628007|NCT00806286|42077394|FG001|Overall Study|Due to a variety of reasons|2|||
19628008|NCT00806286|42077395|FG002|Overall Study|Due to a variety of reasons|1|||
19518702|NCT01482312|41931707|FG000|Period 2, 90 Minutes of Wear|Other|1|||
19518703|NCT01482312|41931708|FG001|Period 2, 90 Minutes of Wear|Other|0|||
19518704|NCT01482312|41931709|FG002|Period 2, 90 Minutes of Wear|Other|0|||
19518705|NCT01461096|41931719|FG000|Overall Study|Death|3|||
19518706|NCT01461096|41931720|FG001|Overall Study|Death|6|||
19518707|NCT01461096|41931719|FG000|Overall Study|Severe debilitation, unable to continue|1|||
19518708|NCT01461096|41931720|FG001|Overall Study|Severe debilitation, unable to continue|1|||
19518709|NCT01461096|41931719|FG000|Overall Study|Subj not able to get to clinic|15|||
19518710|NCT01461096|41931720|FG001|Overall Study|Subj not able to get to clinic|13|||
19518711|NCT01461096|41931719|FG000|Overall Study|Site is closing|27|||
19518712|NCT01461096|41931720|FG001|Overall Study|Site is closing|30|||
19518713|NCT01461096|41931719|FG000|Overall Study|Withdrawal by Subject|5|||
19518714|NCT01461096|41931720|FG001|Overall Study|Withdrawal by Subject|3|||
19518715|NCT01461096|41931719|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
19518716|NCT01461096|41931720|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
19518717|NCT01461096|41931719|FG000|Overall Study|Lost to Follow-up|8|||
19518718|NCT01461096|41931720|FG001|Overall Study|Lost to Follow-up|4|||
19518719|NCT01507896|41931727|FG000|Overall Study|Withdrawal by Subject|1|||
19518720|NCT01507896|41931727|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
19518721|NCT01507662|41931742|FG000|Overall Study|Death|26|||
19518722|NCT01507662|41931743|FG001|Overall Study|Death|18|||
19518723|NCT01507662|41931742|FG000|Overall Study|Withdrawal by Subject|290|||
19518724|NCT01507662|41931743|FG001|Overall Study|Withdrawal by Subject|287|||
19518725|NCT01507662|41931742|FG000|Overall Study|Lost to Follow-up|498|||
19518726|NCT01507662|41931743|FG001|Overall Study|Lost to Follow-up|523|||
19518727|NCT01507662|41931742|FG000|Overall Study|Proxy interview done|2|||
19518728|NCT01507662|41931743|FG001|Overall Study|Proxy interview done|3|||
19518729|NCT01506960|41931749|FG000|Overall Study|Did not meet angiographic criteria|47|||
19518730|NCT01480674|41931755|FG000|Overall Study|Death|23|||
19518731|NCT01480674|41931755|FG000|Overall Study|Lost to Follow-up|2|||
19628009|NCT00590538|42077403|FG000|Overall Study|Study terminated before completed|2|||
19518732|NCT01480674|41931755|FG000|Overall Study|visit not done|10|||
19518733|NCT01506882|41931761|FG000|Overall Study|Lack of Efficacy|4|||
19518734|NCT01506882|41931762|FG001|Overall Study|Lack of Efficacy|3|||
19518735|NCT01506882|41931761|FG000|Overall Study|Lost to Follow-up|1|||
19628010|NCT00796419|42077409|FG000|Overall Study|Death|0|||
19404183|NCT02255097|41649276|FG000|Overall Study|Death|151|||
19404184|NCT02255097|41649276|FG000|Overall Study|Lost to Follow-up|5|||
19404185|NCT02255097|41649276|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
19404186|NCT02255097|41649276|FG000|Overall Study|Withdrawal by Subject|7|||
19404187|NCT02255097|41649276|FG000|Overall Study|Allocated but not treated|1|||
19404188|NCT02254551|41649281|FG000|Dose Escalation|Physician Decision|1|||
19404189|NCT02254551|41649281|FG000|Dose Escalation|Dose-limiting toxicity|2|||
19404190|NCT01641237|41649288|FG000|Period II|Withdrawal by Subject|1|||
19404191|NCT01641237|41649289|FG001|Period II|Withdrawal by Subject|0|||
19404192|NCT01641237|41649290|FG002|Period II|Withdrawal by Subject|0|||
19404193|NCT01641237|41649291|FG003|Period II|Withdrawal by Subject|0|||
19404194|NCT01641237|41649288|FG000|Period III|Lost to Follow-up|1|||
19404195|NCT01641237|41649289|FG001|Period III|Lost to Follow-up|0|||
19404196|NCT01641237|41649290|FG002|Period III|Lost to Follow-up|0|||
19404197|NCT01641237|41649291|FG003|Period III|Lost to Follow-up|0|||
19404198|NCT01639833|41649303|FG000|Overall Study|Death|4|||
19404199|NCT01639833|41649304|FG001|Overall Study|Death|2|||
19404200|NCT01639833|41649303|FG000|Overall Study|Withdrawal by Subject|2|||
19404201|NCT01639833|41649304|FG001|Overall Study|Withdrawal by Subject|2|||
19404202|NCT01639131|41649310|FG000|Overall Study|Disease Progression|6|||
19404203|NCT01641159|41649316|FG000|Overall Study|Lost to Follow-up|2|||
19404204|NCT01641159|41649317|FG001|Overall Study|Lost to Follow-up|1|||
19404205|NCT01641159|41649316|FG000|Overall Study|Withdrawal by Subject|0|||
19404206|NCT01641159|41649317|FG001|Overall Study|Withdrawal by Subject|1|||
19404207|NCT01641081|41649323|FG000|Period 1|Sponsor request (potential unblinding)|0|||
19404208|NCT01641081|41649324|FG001|Period 1|Sponsor request (potential unblinding)|0|||
19404209|NCT01641081|41649325|FG002|Period 1|Sponsor request (potential unblinding)|0|||
19404210|NCT01641081|41649326|FG003|Period 1|Sponsor request (potential unblinding)|0|||
19404211|NCT01641081|41649327|FG004|Period 1|Sponsor request (potential unblinding)|0|||
19404212|NCT01641081|41649328|FG005|Period 1|Sponsor request (potential unblinding)|0|||
19404213|NCT01641081|41649329|FG006|Period 1|Sponsor request (potential unblinding)|1|||
19404214|NCT01641081|41649330|FG007|Period 1|Sponsor request (potential unblinding)|0|||
19404215|NCT01641081|41649331|FG008|Period 1|Sponsor request (potential unblinding)|0|||
19404216|NCT01641081|41649332|FG009|Period 1|Sponsor request (potential unblinding)|0|||
19404217|NCT01641081|41649323|FG000|Period 1|Protocol Violation|0|||
19404218|NCT01641081|41649324|FG001|Period 1|Protocol Violation|0|||
19404219|NCT01641081|41649325|FG002|Period 1|Protocol Violation|0|||
19404220|NCT01641081|41649326|FG003|Period 1|Protocol Violation|0|||
19404221|NCT01641081|41649327|FG004|Period 1|Protocol Violation|1|||
19404222|NCT01641081|41649328|FG005|Period 1|Protocol Violation|0|||
19404223|NCT01641081|41649329|FG006|Period 1|Protocol Violation|0|||
19404224|NCT01641081|41649330|FG007|Period 1|Protocol Violation|1|||
19404225|NCT01641081|41649331|FG008|Period 1|Protocol Violation|0|||
19404226|NCT01641081|41649332|FG009|Period 1|Protocol Violation|0|||
19404227|NCT01641081|41649323|FG000|Period 1|Adverse Event|1|||
19404228|NCT01641081|41649324|FG001|Period 1|Adverse Event|0|||
19404229|NCT01641081|41649325|FG002|Period 1|Adverse Event|0|||
19404230|NCT01641081|41649326|FG003|Period 1|Adverse Event|0|||
19404231|NCT01641081|41649327|FG004|Period 1|Adverse Event|0|||
19404232|NCT01641081|41649328|FG005|Period 1|Adverse Event|0|||
19404233|NCT01641081|41649329|FG006|Period 1|Adverse Event|0|||
19404234|NCT01641081|41649330|FG007|Period 1|Adverse Event|2|||
19404235|NCT01641081|41649331|FG008|Period 1|Adverse Event|0|||
19404236|NCT01641081|41649332|FG009|Period 1|Adverse Event|0|||
19404237|NCT01641081|41649323|FG000|Period 2|Adverse Event|0|||
19404238|NCT01641081|41649324|FG001|Period 2|Adverse Event|0|||
19404239|NCT01641081|41649325|FG002|Period 2|Adverse Event|0|||
19404240|NCT01641081|41649326|FG003|Period 2|Adverse Event|0|||
19404241|NCT01641081|41649327|FG004|Period 2|Adverse Event|0|||
19404242|NCT01641081|41649328|FG005|Period 2|Adverse Event|1|||
19404243|NCT01641081|41649329|FG006|Period 2|Adverse Event|0|||
19404244|NCT01641081|41649330|FG007|Period 2|Adverse Event|0|||
19404245|NCT01641081|41649331|FG008|Period 2|Adverse Event|0|||
19404246|NCT01641081|41649332|FG009|Period 2|Adverse Event|0|||
19404247|NCT01641081|41649323|FG000|Period 2|Withdrawal by Subject|0|||
19404248|NCT01641081|41649324|FG001|Period 2|Withdrawal by Subject|0|||
19404249|NCT01641081|41649325|FG002|Period 2|Withdrawal by Subject|0|||
19404250|NCT01641081|41649326|FG003|Period 2|Withdrawal by Subject|1|||
19404251|NCT01641081|41649327|FG004|Period 2|Withdrawal by Subject|0|||
19404252|NCT01641081|41649328|FG005|Period 2|Withdrawal by Subject|0|||
19404253|NCT01641081|41649329|FG006|Period 2|Withdrawal by Subject|2|||
19404254|NCT01641081|41649330|FG007|Period 2|Withdrawal by Subject|0|||
19404255|NCT01641081|41649331|FG008|Period 2|Withdrawal by Subject|0|||
19404256|NCT01641081|41649332|FG009|Period 2|Withdrawal by Subject|0|||
19404257|NCT01641081|41649323|FG000|Period 2|Protocol Violation|1|||
19404258|NCT01641081|41649324|FG001|Period 2|Protocol Violation|0|||
19404259|NCT01641081|41649325|FG002|Period 2|Protocol Violation|0|||
19404260|NCT01641081|41649326|FG003|Period 2|Protocol Violation|0|||
19404261|NCT01641081|41649327|FG004|Period 2|Protocol Violation|0|||
19404262|NCT01641081|41649328|FG005|Period 2|Protocol Violation|0|||
19404263|NCT01641081|41649329|FG006|Period 2|Protocol Violation|0|||
19404264|NCT01641081|41649330|FG007|Period 2|Protocol Violation|0|||
19404265|NCT01641081|41649331|FG008|Period 2|Protocol Violation|0|||
19404266|NCT01641081|41649332|FG009|Period 2|Protocol Violation|0|||
19404267|NCT01641081|41649323|FG000|Period 3|Adverse Event|0|||
19404268|NCT01641081|41649324|FG001|Period 3|Adverse Event|0|||
19404269|NCT01641081|41649325|FG002|Period 3|Adverse Event|1|||
19404270|NCT01641081|41649326|FG003|Period 3|Adverse Event|0|||
19404271|NCT01641081|41649327|FG004|Period 3|Adverse Event|0|||
19404272|NCT01641081|41649328|FG005|Period 3|Adverse Event|0|||
19404273|NCT01641081|41649329|FG006|Period 3|Adverse Event|0|||
19404274|NCT01641081|41649330|FG007|Period 3|Adverse Event|0|||
19404275|NCT01641081|41649331|FG008|Period 3|Adverse Event|0|||
19404276|NCT01641081|41649332|FG009|Period 3|Adverse Event|0|||
19404277|NCT01641081|41649323|FG000|Period 3|Withdrawal by Subject|0|||
19404278|NCT01641081|41649324|FG001|Period 3|Withdrawal by Subject|0|||
19404279|NCT01641081|41649325|FG002|Period 3|Withdrawal by Subject|0|||
19404280|NCT01641081|41649326|FG003|Period 3|Withdrawal by Subject|0|||
19404281|NCT01641081|41649327|FG004|Period 3|Withdrawal by Subject|0|||
19404282|NCT01641081|41649328|FG005|Period 3|Withdrawal by Subject|0|||
19404283|NCT01641081|41649329|FG006|Period 3|Withdrawal by Subject|0|||
19404284|NCT01641081|41649330|FG007|Period 3|Withdrawal by Subject|0|||
19404285|NCT01641081|41649331|FG008|Period 3|Withdrawal by Subject|1|||
19404286|NCT01641081|41649332|FG009|Period 3|Withdrawal by Subject|0|||
19404287|NCT01641081|41649323|FG000|Period 4|Adverse Event|0|||
19404288|NCT01641081|41649324|FG001|Period 4|Adverse Event|1|||
19404289|NCT01641081|41649325|FG002|Period 4|Adverse Event|0|||
19404290|NCT01641081|41649326|FG003|Period 4|Adverse Event|1|||
19404291|NCT01641081|41649327|FG004|Period 4|Adverse Event|0|||
19404292|NCT01641081|41649328|FG005|Period 4|Adverse Event|0|||
19404293|NCT01641081|41649329|FG006|Period 4|Adverse Event|0|||
19404294|NCT01641081|41649330|FG007|Period 4|Adverse Event|0|||
19404295|NCT01641081|41649331|FG008|Period 4|Adverse Event|0|||
19404296|NCT01641081|41649332|FG009|Period 4|Adverse Event|0|||
19404297|NCT01641081|41649323|FG000|Period 5|Adverse Event|0|||
19404298|NCT01641081|41649324|FG001|Period 5|Adverse Event|0|||
19404299|NCT01641081|41649325|FG002|Period 5|Adverse Event|2|||
19404300|NCT01641081|41649326|FG003|Period 5|Adverse Event|0|||
19404301|NCT01641081|41649327|FG004|Period 5|Adverse Event|0|||
19404302|NCT01641081|41649328|FG005|Period 5|Adverse Event|0|||
19404303|NCT01641081|41649329|FG006|Period 5|Adverse Event|0|||
19404304|NCT01641081|41649330|FG007|Period 5|Adverse Event|0|||
19404305|NCT01641081|41649331|FG008|Period 5|Adverse Event|0|||
19404306|NCT01641081|41649332|FG009|Period 5|Adverse Event|0|||
19404307|NCT01640925|41649346|FG000|Overall Study|Withdrawal by Subject|1|||
19404308|NCT01640925|41649347|FG001|Overall Study|Withdrawal by Subject|0|||
19404309|NCT01640925|41649346|FG000|Overall Study|Previously enrolled in this trial|13|||
19404310|NCT01640925|41649347|FG001|Overall Study|Previously enrolled in this trial|11|||
19404311|NCT01638429|41649353|FG000|Overall Study|Withdrawal by Subject|1|||
19404312|NCT01639755|41649361|FG000|Overall Study|Study Ongoing|15|||
19404313|NCT01639755|41649361|FG000|Overall Study|Patient had device explantation|4|||
19404314|NCT01601535|41649371|FG000|Phase 1|Adverse Event|1|||
19404315|NCT01601535|41649372|FG001|Phase 1|Adverse Event|0|||
19404316|NCT01601535|41649373|FG002|Phase 1|Adverse Event|2|||
19404317|NCT01601535|41649374|FG003|Phase 1|Adverse Event|1|||
19404318|NCT01601535|41649375|FG004|Phase 1|Adverse Event|0|||
19404319|NCT01601535|41649376|FG005|Phase 1|Adverse Event|0|||
19404320|NCT01601535|41649371|FG000|Phase 1|Withdrawal by Subject|2|||
19404321|NCT01601535|41649372|FG001|Phase 1|Withdrawal by Subject|1|||
19404322|NCT01601535|41649373|FG002|Phase 1|Withdrawal by Subject|1|||
19404323|NCT01601535|41649374|FG003|Phase 1|Withdrawal by Subject|2|||
19404324|NCT01601535|41649375|FG004|Phase 1|Withdrawal by Subject|0|||
19404325|NCT01601535|41649376|FG005|Phase 1|Withdrawal by Subject|0|||
19404326|NCT01601535|41649371|FG000|Phase 1|Progressive Disease|2|||
19404327|NCT01601535|41649372|FG001|Phase 1|Progressive Disease|3|||
19404328|NCT01601535|41649373|FG002|Phase 1|Progressive Disease|2|||
19404329|NCT01601535|41649374|FG003|Phase 1|Progressive Disease|1|||
19404330|NCT01601535|41649375|FG004|Phase 1|Progressive Disease|0|||
19404331|NCT01601535|41649376|FG005|Phase 1|Progressive Disease|0|||
19404332|NCT01601535|41649371|FG000|Phase 1|Started Another Treatment|1|||
19404333|NCT01601535|41649372|FG001|Phase 1|Started Another Treatment|2|||
19404334|NCT01601535|41649373|FG002|Phase 1|Started Another Treatment|0|||
19404335|NCT01601535|41649374|FG003|Phase 1|Started Another Treatment|0|||
19404336|NCT01601535|41649375|FG004|Phase 1|Started Another Treatment|0|||
19404337|NCT01601535|41649376|FG005|Phase 1|Started Another Treatment|0|||
19404338|NCT01601535|41649371|FG000|Phase 2|Adverse Event|0|||
19404339|NCT01601535|41649372|FG001|Phase 2|Adverse Event|0|||
19404340|NCT01601535|41649373|FG002|Phase 2|Adverse Event|0|||
19404341|NCT01601535|41649374|FG003|Phase 2|Adverse Event|0|||
19404342|NCT01601535|41649375|FG004|Phase 2|Adverse Event|5|||
19404343|NCT01601535|41649376|FG005|Phase 2|Adverse Event|1|||
19404344|NCT01601535|41649371|FG000|Phase 2|Withdrawal by Subject|0|||
19404345|NCT01601535|41649372|FG001|Phase 2|Withdrawal by Subject|0|||
19404346|NCT01601535|41649373|FG002|Phase 2|Withdrawal by Subject|0|||
19404347|NCT01601535|41649374|FG003|Phase 2|Withdrawal by Subject|0|||
19404348|NCT01601535|41649375|FG004|Phase 2|Withdrawal by Subject|8|||
19404349|NCT01601535|41649376|FG005|Phase 2|Withdrawal by Subject|2|||
19404350|NCT01601535|41649371|FG000|Phase 2|Progressive Disease|0|||
19404351|NCT01601535|41649372|FG001|Phase 2|Progressive Disease|0|||
19404352|NCT01601535|41649373|FG002|Phase 2|Progressive Disease|0|||
19404353|NCT01601535|41649374|FG003|Phase 2|Progressive Disease|0|||
19404354|NCT01601535|41649375|FG004|Phase 2|Progressive Disease|5|||
19404355|NCT01601535|41649376|FG005|Phase 2|Progressive Disease|7|||
19404356|NCT01601535|41649371|FG000|Phase 2|Started Another Treatment|0|||
19404357|NCT01601535|41649372|FG001|Phase 2|Started Another Treatment|0|||
19404358|NCT01601535|41649373|FG002|Phase 2|Started Another Treatment|0|||
19404359|NCT01601535|41649374|FG003|Phase 2|Started Another Treatment|0|||
19404360|NCT01601535|41649375|FG004|Phase 2|Started Another Treatment|1|||
19404361|NCT01601535|41649376|FG005|Phase 2|Started Another Treatment|2|||
19404362|NCT01638819|41649401|FG000|Overall Study|Lost to Follow-up|1|||
19404363|NCT01638819|41649402|FG001|Overall Study|Lost to Follow-up|0|||
19404364|NCT01363713|41649407|FG000|Overall Study|Adverse Event|1|||
19404365|NCT01363713|41649407|FG000|Overall Study|Protocol Violation|3|||
19404366|NCT01363713|41649407|FG000|Overall Study|Withdrawal by Subject|2|||
19404367|NCT01637961|41649411|FG000|Overall Study|Ineligible: wrong primary|1|||
19404368|NCT01637961|41649411|FG000|Overall Study|Ineligible: inadequate pathology|1|||
19404369|NCT04183335|41649423|FG000|Overall Study|Adverse Event|1|||
19404370|NCT04183335|41649424|FG001|Overall Study|Adverse Event|0|||
19628011|NCT00796419|42077410|FG001|Overall Study|Death|1|||
19628012|NCT00796107|42077416|FG000|Overall Study|Lack of Efficacy|1|||
19374525|NCT02925338|41616168|FG004|Overall Study|Death|0|||
19374526|NCT02925338|41616164|FG000|Overall Study|Lost to Follow-up|30|||
19374527|NCT02925338|41616165|FG001|Overall Study|Lost to Follow-up|10|||
19374528|NCT02925338|41616166|FG002|Overall Study|Lost to Follow-up|1|||
19374529|NCT02925338|41616167|FG003|Overall Study|Lost to Follow-up|16|||
19374530|NCT02925338|41616168|FG004|Overall Study|Lost to Follow-up|3|||
19374531|NCT02925338|41616164|FG000|Overall Study|Withdrawal by Subject|3|||
19374532|NCT02925338|41616165|FG001|Overall Study|Withdrawal by Subject|0|||
19374533|NCT02925338|41616166|FG002|Overall Study|Withdrawal by Subject|3|||
19374534|NCT02925338|41616167|FG003|Overall Study|Withdrawal by Subject|2|||
19374535|NCT02925338|41616168|FG004|Overall Study|Withdrawal by Subject|2|||
19374536|NCT02925338|41616164|FG000|Overall Study|Missing|38|||
19374537|NCT02925338|41616165|FG001|Overall Study|Missing|27|||
19374538|NCT02925338|41616166|FG002|Overall Study|Missing|0|||
19374539|NCT02925338|41616167|FG003|Overall Study|Missing|3|||
19374540|NCT02925338|41616168|FG004|Overall Study|Missing|2|||
19374541|NCT02925338|41616164|FG000|Overall Study|Participant's Decision|11|||
19374542|NCT02925338|41616165|FG001|Overall Study|Participant's Decision|7|||
19374543|NCT02925338|41616166|FG002|Overall Study|Participant's Decision|3|||
19374544|NCT02925338|41616167|FG003|Overall Study|Participant's Decision|8|||
19374545|NCT02925338|41616168|FG004|Overall Study|Participant's Decision|1|||
19374546|NCT02925338|41616164|FG000|Overall Study|Treatment Discontinuation|144|||
19374547|NCT02925338|41616165|FG001|Overall Study|Treatment Discontinuation|65|||
19374548|NCT02925338|41616166|FG002|Overall Study|Treatment Discontinuation|56|||
19374549|NCT02925338|41616167|FG003|Overall Study|Treatment Discontinuation|131|||
19374550|NCT02925338|41616168|FG004|Overall Study|Treatment Discontinuation|22|||
19374551|NCT02543528|41616186|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
19374552|NCT02543528|41616187|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
19374553|NCT02543528|41616188|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
19374554|NCT02543528|41616189|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
19374555|NCT02543528|41616190|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
19374556|NCT02543528|41616186|FG000|Adaptation Period|Lens Handling Difficultes|0|||
19374557|NCT02543528|41616187|FG001|Adaptation Period|Lens Handling Difficultes|0|||
19374558|NCT02543528|41616188|FG002|Adaptation Period|Lens Handling Difficultes|0|||
19374559|NCT02543528|41616189|FG003|Adaptation Period|Lens Handling Difficultes|0|||
19374560|NCT02543528|41616190|FG004|Adaptation Period|Lens Handling Difficultes|8|||
19374561|NCT02543528|41616186|FG000|Adaptation Period|Lost to Follow-up|0|||
19374562|NCT02543528|41616187|FG001|Adaptation Period|Lost to Follow-up|0|||
19374563|NCT02543528|41616188|FG002|Adaptation Period|Lost to Follow-up|0|||
19374564|NCT02543528|41616189|FG003|Adaptation Period|Lost to Follow-up|0|||
19374565|NCT02543528|41616190|FG004|Adaptation Period|Lost to Follow-up|14|||
19374566|NCT02543528|41616186|FG000|Adaptation Period|Adverse Event|0|||
19374567|NCT02543528|41616187|FG001|Adaptation Period|Adverse Event|0|||
19374568|NCT02543528|41616188|FG002|Adaptation Period|Adverse Event|0|||
19374569|NCT02543528|41616189|FG003|Adaptation Period|Adverse Event|0|||
19374570|NCT02543528|41616190|FG004|Adaptation Period|Adverse Event|2|||
19374571|NCT02543528|41616186|FG000|Extended Wear Period|Adverse Event|17|||
19374572|NCT02543528|41616187|FG001|Extended Wear Period|Adverse Event|11|||
19374573|NCT02543528|41616188|FG002|Extended Wear Period|Adverse Event|16|||
19404371|NCT04183335|41649423|FG000|Overall Study|Withdrawal by Subject|12|||
19404372|NCT04183335|41649424|FG001|Overall Study|Withdrawal by Subject|3|||
19404373|NCT04199793|41649432|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
19404374|NCT04199793|41649433|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
19404375|NCT04199793|41649432|FG000|Overall Study|Withdrawal by Subject|1|||
19404376|NCT04199793|41649433|FG001|Overall Study|Withdrawal by Subject|1|||
19404377|NCT01636947|41649441|FG000|Overall Study|Not Treated|2|||
19404378|NCT01636947|41649442|FG001|Overall Study|Not Treated|2|||
19404379|NCT01636947|41649441|FG000|Overall Study|Lost to Follow-up|4|||
19404380|NCT01636947|41649442|FG001|Overall Study|Lost to Follow-up|0|||
19404381|NCT01636947|41649441|FG000|Overall Study|Protocol Violation|1|||
19404382|NCT01636947|41649442|FG001|Overall Study|Protocol Violation|1|||
19404383|NCT01636947|41649441|FG000|Overall Study|Withdrawal by Subject|3|||
19404384|NCT01636947|41649442|FG001|Overall Study|Withdrawal by Subject|3|||
19404385|NCT01636947|41649441|FG000|Overall Study|Adverse Event|1|||
19404386|NCT01636947|41649442|FG001|Overall Study|Adverse Event|1|||
19404387|NCT01636947|41649441|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
19404388|NCT01636947|41649442|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
19404389|NCT01635933|41649450|FG000|Overall Study|Adverse Event|1|||
19404390|NCT01635933|41649451|FG001|Overall Study|Adverse Event|0|||
19404391|NCT01635933|41649450|FG000|Overall Study|Lost to Follow-up|0|||
19404392|NCT01635933|41649451|FG001|Overall Study|Lost to Follow-up|5|||
19404393|NCT01635933|41649450|FG000|Overall Study|Subject decision|1|||
19404394|NCT01635933|41649451|FG001|Overall Study|Subject decision|1|||
19404395|NCT01635933|41649450|FG000|Overall Study|Noncompliance|0|||
19404396|NCT01635933|41649451|FG001|Overall Study|Noncompliance|1|||
19404397|NCT01635933|41649450|FG000|Overall Study|No longer had transportation|0|||
19404398|NCT01635933|41649451|FG001|Overall Study|No longer had transportation|1|||
19404399|NCT01635855|41649457|FG000|Overall Study|Withdrawal by Subject|4|||
19404400|NCT03052725|41649463|FG000|Overall Study|Adverse Event|2|||
19404401|NCT03052725|41649464|FG001|Overall Study|Adverse Event|0|||
19404402|NCT03052725|41649463|FG000|Overall Study|Withdrawal by Subject|3|||
19404403|NCT03052725|41649464|FG001|Overall Study|Withdrawal by Subject|4|||
19404404|NCT03052725|41649463|FG000|Overall Study|Pregnancy|0|||
19404405|NCT03052725|41649464|FG001|Overall Study|Pregnancy|1|||
19404406|NCT03052725|41649463|FG000|Overall Study|Site closure|0|||
19404407|NCT03052725|41649464|FG001|Overall Study|Site closure|1|||
19404408|NCT03052725|41649463|FG000|Overall Study|Study terminated by sponsor|143|||
19404409|NCT03052725|41649464|FG001|Overall Study|Study terminated by sponsor|144|||
19404410|NCT02775435|41649471|FG000|Overall Study|Adverse Event|48|||
19404411|NCT02775435|41649472|FG001|Overall Study|Adverse Event|25|||
19404412|NCT02775435|41649471|FG000|Overall Study|Lost to Follow-up|0|||
19404413|NCT02775435|41649472|FG001|Overall Study|Lost to Follow-up|2|||
19404414|NCT02775435|41649471|FG000|Overall Study|Physician Decision|5|||
19404415|NCT02775435|41649472|FG001|Overall Study|Physician Decision|6|||
19404416|NCT02775435|41649471|FG000|Overall Study|Withdrawal by Subject|5|||
19404417|NCT02775435|41649472|FG001|Overall Study|Withdrawal by Subject|9|||
19404418|NCT02775435|41649471|FG000|Overall Study|Progressive Disease|86|||
19404419|NCT02775435|41649472|FG001|Overall Study|Progressive Disease|140|||
19404420|NCT02775435|41649471|FG000|Overall Study|Clinical Progression|13|||
19404421|NCT02775435|41649472|FG001|Overall Study|Clinical Progression|26|||
19404422|NCT02775435|41649471|FG000|Overall Study|Ongoing in Study|121|||
19404423|NCT02775435|41649472|FG001|Overall Study|Ongoing in Study|72|||
19404424|NCT02775435|41649471|FG000|Overall Study|Not Treated|0|||
19404425|NCT02775435|41649472|FG001|Overall Study|Not Treated|1|||
19404426|NCT01635153|41649497|FG000|Overall Study|Lost to Follow-up|40|||
19404427|NCT01635153|41649498|FG001|Overall Study|Lost to Follow-up|43|||
19404428|NCT01636713|41649507|FG000|Overall Study|Adverse Event|16|||
19404429|NCT01636713|41649508|FG001|Overall Study|Adverse Event|16|||
19404430|NCT01636713|41649509|FG002|Overall Study|Adverse Event|7|||
19404431|NCT01636713|41649507|FG000|Overall Study|Lack of Efficacy|6|||
19404432|NCT01636713|41649508|FG001|Overall Study|Lack of Efficacy|6|||
19404433|NCT01636713|41649509|FG002|Overall Study|Lack of Efficacy|2|||
19404434|NCT01636713|41649507|FG000|Overall Study|Protocol Violation|3|||
19404435|NCT01636713|41649508|FG001|Overall Study|Protocol Violation|0|||
19404436|NCT01636713|41649509|FG002|Overall Study|Protocol Violation|1|||
19404437|NCT01636713|41649507|FG000|Overall Study|Lost to Follow-up|0|||
19404438|NCT01636713|41649508|FG001|Overall Study|Lost to Follow-up|0|||
19404439|NCT01636713|41649509|FG002|Overall Study|Lost to Follow-up|1|||
19404440|NCT01636713|41649507|FG000|Overall Study|Withdrawal by Subject|5|||
19404441|NCT01636713|41649508|FG001|Overall Study|Withdrawal by Subject|4|||
19404442|NCT01636713|41649509|FG002|Overall Study|Withdrawal by Subject|8|||
19404443|NCT01636713|41649507|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
19404444|NCT01636713|41649508|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
19404445|NCT01636713|41649509|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
19404446|NCT01600053|41649517|FG000|Overall Study|Adverse Event|2|||
19404447|NCT01600053|41649517|FG000|Overall Study|trial will not meet the interim endpoint|9|||
19404448|NCT01068249|41649521|FG000|Overall Study|Death|1|||
19404449|NCT01068249|41649521|FG000|Overall Study|Withdrawal by Subject|3|||
19404450|NCT00098475|41649537|FG000|Step 1|Progressive disease|33|||
19404451|NCT00098475|41649538|FG001|Step 1|Progressive disease|35|||
19404452|NCT00098475|41649539|FG002|Step 1|Progressive disease|2|||
19404453|NCT00098475|41649540|FG003|Step 1|Progressive disease|1|||
19404454|NCT00098475|41649537|FG000|Step 1|Adverse Event|56|||
19404455|NCT00098475|41649538|FG001|Step 1|Adverse Event|37|||
19404456|NCT00098475|41649539|FG002|Step 1|Adverse Event|0|||
19404457|NCT00098475|41649540|FG003|Step 1|Adverse Event|1|||
19404458|NCT00098475|41649537|FG000|Step 1|Death|8|||
19404459|NCT00098475|41649538|FG001|Step 1|Death|5|||
19404460|NCT00098475|41649539|FG002|Step 1|Death|0|||
19404461|NCT00098475|41649540|FG003|Step 1|Death|1|||
19404462|NCT00098475|41649537|FG000|Step 1|Withdrawal by Subject|14|||
19404463|NCT00098475|41649538|FG001|Step 1|Withdrawal by Subject|11|||
19404464|NCT00098475|41649539|FG002|Step 1|Withdrawal by Subject|0|||
19404465|NCT00098475|41649540|FG003|Step 1|Withdrawal by Subject|0|||
19404466|NCT00098475|41649537|FG000|Step 1|Physician Decision|5|||
19404467|NCT00098475|41649538|FG001|Step 1|Physician Decision|2|||
19404468|NCT00098475|41649539|FG002|Step 1|Physician Decision|0|||
19404469|NCT00098475|41649540|FG003|Step 1|Physician Decision|0|||
19404470|NCT00098475|41649537|FG000|Step 1|Alternative therapy|31|||
19404471|NCT00098475|41649538|FG001|Step 1|Alternative therapy|43|||
19404472|NCT00098475|41649539|FG002|Step 1|Alternative therapy|1|||
19404473|NCT00098475|41649540|FG003|Step 1|Alternative therapy|0|||
19404474|NCT00098475|41649537|FG000|Step 1|Other disease|2|||
19404475|NCT00098475|41649538|FG001|Step 1|Other disease|1|||
19404476|NCT00098475|41649539|FG002|Step 1|Other disease|1|||
19404477|NCT00098475|41649540|FG003|Step 1|Other disease|0|||
19404478|NCT00098475|41649537|FG000|Step 1|Never started treatment|0|||
19404479|NCT00098475|41649538|FG001|Step 1|Never started treatment|2|||
19404480|NCT00098475|41649539|FG002|Step 1|Never started treatment|0|||
19404481|NCT00098475|41649540|FG003|Step 1|Never started treatment|0|||
19404482|NCT00098475|41649537|FG000|Step 1|Still on treatment as of this analysis|14|||
19404483|NCT00098475|41649538|FG001|Step 1|Still on treatment as of this analysis|27|||
19404484|NCT00098475|41649539|FG002|Step 1|Still on treatment as of this analysis|0|||
19404485|NCT00098475|41649540|FG003|Step 1|Still on treatment as of this analysis|0|||
19404486|NCT00098475|41649537|FG000|Step 1|Knee surgery|1|||
19404487|NCT00098475|41649538|FG001|Step 1|Knee surgery|0|||
19404488|NCT00098475|41649539|FG002|Step 1|Knee surgery|0|||
19404489|NCT00098475|41649540|FG003|Step 1|Knee surgery|0|||
19404490|NCT00098475|41649537|FG000|Step 1|Complications|1|||
19404491|NCT00098475|41649538|FG001|Step 1|Complications|0|||
19404492|NCT00098475|41649539|FG002|Step 1|Complications|0|||
19404493|NCT00098475|41649540|FG003|Step 1|Complications|0|||
19404494|NCT00098475|41649537|FG000|Step 1|Cannot comply due to other tx|0|||
19404495|NCT00098475|41649538|FG001|Step 1|Cannot comply due to other tx|1|||
19404496|NCT00098475|41649539|FG002|Step 1|Cannot comply due to other tx|0|||
19404497|NCT00098475|41649540|FG003|Step 1|Cannot comply due to other tx|0|||
19404498|NCT00098475|41649537|FG000|Step 1|Both patient and physician's decision|2|||
19404499|NCT00098475|41649538|FG001|Step 1|Both patient and physician's decision|1|||
19404500|NCT00098475|41649539|FG002|Step 1|Both patient and physician's decision|0|||
19404501|NCT00098475|41649540|FG003|Step 1|Both patient and physician's decision|0|||
19404502|NCT00098475|41649537|FG000|Step 1|Incorrect disease assessment|2|||
19404503|NCT00098475|41649538|FG001|Step 1|Incorrect disease assessment|0|||
19404504|NCT00098475|41649539|FG002|Step 1|Incorrect disease assessment|0|||
19404505|NCT00098475|41649540|FG003|Step 1|Incorrect disease assessment|0|||
19404506|NCT00098475|41649537|FG000|Step 1|Off treatment for > specified timeframe|1|||
19404507|NCT00098475|41649538|FG001|Step 1|Off treatment for > specified timeframe|1|||
19404508|NCT00098475|41649539|FG002|Step 1|Off treatment for > specified timeframe|0|||
19404509|NCT00098475|41649540|FG003|Step 1|Off treatment for > specified timeframe|0|||
19404510|NCT00098475|41649537|FG000|Step 1|Declining performance status|0|||
19404511|NCT00098475|41649538|FG001|Step 1|Declining performance status|1|||
19404512|NCT00098475|41649539|FG002|Step 1|Declining performance status|0|||
19404513|NCT00098475|41649540|FG003|Step 1|Declining performance status|0|||
19404514|NCT00098475|41649537|FG000|Step 1|Insurance issue|0|||
19404515|NCT00098475|41649538|FG001|Step 1|Insurance issue|1|||
19404516|NCT00098475|41649539|FG002|Step 1|Insurance issue|0|||
19404517|NCT00098475|41649540|FG003|Step 1|Insurance issue|0|||
19404518|NCT00098475|41649537|FG000|Step 1|Rising paraprotein|0|||
19404519|NCT00098475|41649538|FG001|Step 1|Rising paraprotein|1|||
19404520|NCT00098475|41649539|FG002|Step 1|Rising paraprotein|0|||
19404521|NCT00098475|41649540|FG003|Step 1|Rising paraprotein|0|||
19404522|NCT00098475|41649537|FG000|Step 1|Referred to other physicians|0|||
19404523|NCT00098475|41649538|FG001|Step 1|Referred to other physicians|1|||
19404524|NCT00098475|41649539|FG002|Step 1|Referred to other physicians|0|||
19404525|NCT00098475|41649540|FG003|Step 1|Referred to other physicians|0|||
19404526|NCT00098475|41649537|FG000|Step 1|Criteria to continue treatment not met|0|||
19404527|NCT00098475|41649538|FG001|Step 1|Criteria to continue treatment not met|1|||
19404528|NCT00098475|41649539|FG002|Step 1|Criteria to continue treatment not met|0|||
19404529|NCT00098475|41649540|FG003|Step 1|Criteria to continue treatment not met|0|||
19404530|NCT00098475|41649537|FG000|Step 1|Misinterpretation of lab data|0|||
19404531|NCT00098475|41649538|FG001|Step 1|Misinterpretation of lab data|1|||
19404532|NCT00098475|41649539|FG002|Step 1|Misinterpretation of lab data|0|||
19404533|NCT00098475|41649540|FG003|Step 1|Misinterpretation of lab data|0|||
19404534|NCT00098475|41649537|FG000|Step 1|Patient fell with fracture|1|||
19404535|NCT00098475|41649538|FG001|Step 1|Patient fell with fracture|0|||
19404536|NCT00098475|41649539|FG002|Step 1|Patient fell with fracture|0|||
19404537|NCT00098475|41649540|FG003|Step 1|Patient fell with fracture|0|||
19404538|NCT00098475|41649537|FG000|Step 1|Not documented|0|||
19404539|NCT00098475|41649538|FG001|Step 1|Not documented|1|||
19404540|NCT00098475|41649539|FG002|Step 1|Not documented|0|||
19404541|NCT00098475|41649540|FG003|Step 1|Not documented|0|||
19404542|NCT00098475|41649537|FG000|Step 2|Disease progression|1|||
19404543|NCT00098475|41649538|FG001|Step 2|Disease progression|4|||
19404544|NCT00098475|41649539|FG002|Step 2|Disease progression|0|||
19404545|NCT00098475|41649540|FG003|Step 2|Disease progression|0|||
19404546|NCT00098475|41649537|FG000|Step 2|Adverse Event|2|||
19404547|NCT00098475|41649538|FG001|Step 2|Adverse Event|0|||
19404548|NCT00098475|41649539|FG002|Step 2|Adverse Event|0|||
19404549|NCT00098475|41649540|FG003|Step 2|Adverse Event|0|||
19404550|NCT00098475|41649537|FG000|Step 2|Withdrawal by Subject|0|||
19404551|NCT00098475|41649538|FG001|Step 2|Withdrawal by Subject|2|||
19404552|NCT00098475|41649539|FG002|Step 2|Withdrawal by Subject|0|||
19404553|NCT00098475|41649540|FG003|Step 2|Withdrawal by Subject|0|||
19404554|NCT00098475|41649537|FG000|Step 2|Physician Decision|0|||
19404555|NCT00098475|41649538|FG001|Step 2|Physician Decision|1|||
19404556|NCT00098475|41649539|FG002|Step 2|Physician Decision|0|||
19404557|NCT00098475|41649540|FG003|Step 2|Physician Decision|0|||
19404558|NCT00098475|41649537|FG000|Step 2|Alternative therapy|1|||
19404559|NCT00098475|41649538|FG001|Step 2|Alternative therapy|2|||
19404560|NCT00098475|41649539|FG002|Step 2|Alternative therapy|0|||
19404561|NCT00098475|41649540|FG003|Step 2|Alternative therapy|0|||
19404562|NCT00098475|41649537|FG000|Step 2|Never started treatment|1|||
19404563|NCT00098475|41649538|FG001|Step 2|Never started treatment|1|||
19404564|NCT00098475|41649539|FG002|Step 2|Never started treatment|0|||
19404565|NCT00098475|41649540|FG003|Step 2|Never started treatment|0|||
19404566|NCT02246673|41649555|FG000|Overall Study|Sponsor Decision|1|||
19404567|NCT02246673|41649556|FG001|Overall Study|Sponsor Decision|0|||
19404568|NCT02246673|41649557|FG002|Overall Study|Sponsor Decision|0|||
19404569|NCT02246673|41649558|FG003|Overall Study|Sponsor Decision|0|||
19404570|NCT02246673|41649559|FG004|Overall Study|Sponsor Decision|0|||
19404571|NCT02246673|41649555|FG000|Overall Study|Withdrawal by Subject|0|||
19404572|NCT02246673|41649556|FG001|Overall Study|Withdrawal by Subject|0|||
19404573|NCT02246673|41649557|FG002|Overall Study|Withdrawal by Subject|0|||
19404574|NCT02246673|41649558|FG003|Overall Study|Withdrawal by Subject|0|||
19404575|NCT02246673|41649559|FG004|Overall Study|Withdrawal by Subject|1|||
19404576|NCT02246673|41649555|FG000|Overall Study|Lost to Follow-up|0|||
19404577|NCT02246673|41649556|FG001|Overall Study|Lost to Follow-up|0|||
19404578|NCT02246673|41649557|FG002|Overall Study|Lost to Follow-up|0|||
19404579|NCT02246673|41649558|FG003|Overall Study|Lost to Follow-up|1|||
19404580|NCT02246673|41649559|FG004|Overall Study|Lost to Follow-up|0|||
19404581|NCT02246673|41649555|FG000|Overall Study|Protocol Violation|0|||
19404582|NCT02246673|41649556|FG001|Overall Study|Protocol Violation|0|||
19404583|NCT02246673|41649557|FG002|Overall Study|Protocol Violation|0|||
19404584|NCT02246673|41649558|FG003|Overall Study|Protocol Violation|1|||
19404585|NCT02246673|41649559|FG004|Overall Study|Protocol Violation|0|||
19404586|NCT02246439|41649621|FG000|Overall Study|Adverse Event|3|||
19404587|NCT02246439|41649622|FG001|Overall Study|Adverse Event|0|||
19404588|NCT02246439|41649621|FG000|Overall Study|Lost to Follow-up|7|||
19404589|NCT02246439|41649622|FG001|Overall Study|Lost to Follow-up|5|||
19404590|NCT02246439|41649621|FG000|Overall Study|Protocol Violation|0|||
19404591|NCT02246439|41649622|FG001|Overall Study|Protocol Violation|2|||
19404592|NCT02246439|41649621|FG000|Overall Study|Physician Decision|0|||
19404593|NCT02246439|41649622|FG001|Overall Study|Physician Decision|1|||
19404594|NCT02246439|41649621|FG000|Overall Study|Unkonwn|1|||
19404595|NCT02246439|41649622|FG001|Overall Study|Unkonwn|3|||
19404596|NCT02246439|41649621|FG000|Overall Study|Withdrawal by Subject|1|||
19404597|NCT02246439|41649622|FG001|Overall Study|Withdrawal by Subject|0|||
19404598|NCT02245737|41649631|FG000|Overall Study|Adverse Event|23|||
19404599|NCT02245737|41649632|FG001|Overall Study|Adverse Event|26|||
19404600|NCT02245737|41649633|FG002|Overall Study|Adverse Event|33|||
19404601|NCT02245737|41649631|FG000|Overall Study|Condition Worsened|9|||
19404602|NCT02245737|41649632|FG001|Overall Study|Condition Worsened|10|||
19404603|NCT02245737|41649633|FG002|Overall Study|Condition Worsened|9|||
19404604|NCT02245737|41649631|FG000|Overall Study|Death|2|||
19404605|NCT02245737|41649632|FG001|Overall Study|Death|4|||
19404606|NCT02245737|41649633|FG002|Overall Study|Death|4|||
19404607|NCT02245737|41649631|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
19404608|NCT02245737|41649632|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
19404609|NCT02245737|41649633|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
19404610|NCT02245737|41649631|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
19404611|NCT02245737|41649632|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
19404612|NCT02245737|41649633|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
19404613|NCT02245737|41649631|FG000|Overall Study|Lost to Follow-up|2|||
19404614|NCT02245737|41649632|FG001|Overall Study|Lost to Follow-up|5|||
19404615|NCT02245737|41649633|FG002|Overall Study|Lost to Follow-up|4|||
19404616|NCT02245737|41649631|FG000|Overall Study|Other-determined by Investigator|9|||
19404617|NCT02245737|41649632|FG001|Overall Study|Other-determined by Investigator|10|||
19404618|NCT02245737|41649633|FG002|Overall Study|Other-determined by Investigator|10|||
19404619|NCT02245737|41649631|FG000|Overall Study|Physician Decision|6|||
19404620|NCT02245737|41649632|FG001|Overall Study|Physician Decision|3|||
19404621|NCT02245737|41649633|FG002|Overall Study|Physician Decision|6|||
19404622|NCT02245737|41649631|FG000|Overall Study|Protocol Violation|3|||
19404623|NCT02245737|41649632|FG001|Overall Study|Protocol Violation|2|||
19404624|NCT02245737|41649633|FG002|Overall Study|Protocol Violation|3|||
19404625|NCT02245737|41649631|FG000|Overall Study|Withdrawal by Subject|40|||
19404626|NCT02245737|41649632|FG001|Overall Study|Withdrawal by Subject|41|||
19404627|NCT02245737|41649633|FG002|Overall Study|Withdrawal by Subject|44|||
19404628|NCT02245737|41649631|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
19404629|NCT02245737|41649632|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
19404630|NCT02245737|41649633|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
19404631|NCT02245737|41649631|FG000|Overall Study|Sponsor Decision|445|||
19404632|NCT02245737|41649632|FG001|Overall Study|Sponsor Decision|430|||
19404633|NCT02245737|41649633|FG002|Overall Study|Sponsor Decision|432|||
19404634|NCT02244957|41649645|FG000|Overall Study|Lack of Efficacy|1|||
19404635|NCT02244957|41649646|FG001|Overall Study|Lack of Efficacy|0|||
19404636|NCT02243865|41649656|FG000|Overall Study|Protocol Violation|1|||
19404637|NCT02243865|41649657|FG001|Overall Study|Protocol Violation|3|||
19404638|NCT02243865|41649656|FG000|Overall Study|Lost to Follow-up|1|||
19404639|NCT02243865|41649657|FG001|Overall Study|Lost to Follow-up|1|||
19404640|NCT02243865|41649656|FG000|Overall Study|Withdrawal by Subject|1|||
19404641|NCT02243865|41649657|FG001|Overall Study|Withdrawal by Subject|0|||
19404642|NCT02243865|41649656|FG000|Overall Study|Adverse Event|1|||
19404643|NCT02243865|41649657|FG001|Overall Study|Adverse Event|1|||
19404644|NCT02243631|41649667|FG000|Overall Study|no synovial fluid on second aspirate|0|||
19404645|NCT02243631|41649668|FG001|Overall Study|no synovial fluid on second aspirate|1|||
19404646|NCT02242305|41649676|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
19404647|NCT02242305|41649677|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
19404648|NCT02242305|41649676|FG000|Overall Study|Adverse Event|1|||
19404649|NCT02242305|41649677|FG001|Overall Study|Adverse Event|0|||
19404650|NCT02242305|41649676|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
19404651|NCT02242305|41649677|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
19404652|NCT02242305|41649676|FG000|Overall Study|Subject withdraws inform consent|0|||
19404653|NCT02242305|41649677|FG001|Overall Study|Subject withdraws inform consent|4|||
19404654|NCT02242305|41649676|FG000|Overall Study|Lost to Follow-up|2|||
19404655|NCT02242305|41649677|FG001|Overall Study|Lost to Follow-up|0|||
19404656|NCT02240121|41649685|FG000|Overall Study|Protocol Violation|1|||
19404657|NCT02240121|41649686|FG001|Overall Study|Protocol Violation|2|||
19404658|NCT02240121|41649685|FG000|Overall Study|Physician Decision|0|||
19404659|NCT02240121|41649686|FG001|Overall Study|Physician Decision|1|||
19404660|NCT02240121|41649685|FG000|Overall Study|Change in protocol interpretation|1|||
19404661|NCT02240121|41649686|FG001|Overall Study|Change in protocol interpretation|0|||
19404662|NCT02240121|41649685|FG000|Overall Study|Lack of Efficacy|2|||
19404663|NCT02240121|41649686|FG001|Overall Study|Lack of Efficacy|3|||
19404664|NCT02240121|41649685|FG000|Overall Study|Site closed|1|||
19404665|NCT02240121|41649686|FG001|Overall Study|Site closed|1|||
19404666|NCT02240121|41649685|FG000|Overall Study|Pregnancy|1|||
19404667|NCT02240121|41649686|FG001|Overall Study|Pregnancy|0|||
19628013|NCT00796107|42077416|FG000|Overall Study|Progressive Disease|5|||
19374574|NCT02543528|41616189|FG003|Extended Wear Period|Adverse Event|3|||
19374575|NCT02543528|41616190|FG004|Extended Wear Period|Adverse Event|0|||
19374576|NCT02543528|41616186|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
19374577|NCT02543528|41616187|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
19374578|NCT02543528|41616188|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
19374579|NCT02543528|41616189|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
19374580|NCT02543528|41616190|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
19404668|NCT02240121|41649685|FG000|Overall Study|Adverse Event|2|||
19404669|NCT02240121|41649686|FG001|Overall Study|Adverse Event|4|||
19404670|NCT02240121|41649685|FG000|Overall Study|Withdrawal by Subject|6|||
19404671|NCT02240121|41649686|FG001|Overall Study|Withdrawal by Subject|2|||
19404672|NCT02240121|41649685|FG000|Overall Study|Lost to Follow-up|3|||
19404673|NCT02240121|41649686|FG001|Overall Study|Lost to Follow-up|4|||
19404674|NCT02240121|41649685|FG000|Overall Study|Other than specified|1|||
19404675|NCT02240121|41649686|FG001|Overall Study|Other than specified|3|||
19404676|NCT02239263|41649692|FG000|Overall Study|Protocol Violation|6|||
19404677|NCT02238483|41649700|FG000|Overall Study|Withdrawal by Subject|2|||
19404678|NCT02238483|41649701|FG001|Overall Study|Withdrawal by Subject|7|||
19404679|NCT02238483|41649700|FG000|Overall Study|Lost to Follow-up|1|||
19404680|NCT02238483|41649701|FG001|Overall Study|Lost to Follow-up|1|||
19404681|NCT02238483|41649700|FG000|Overall Study|Protocol Violation|1|||
19404682|NCT02238483|41649701|FG001|Overall Study|Protocol Violation|2|||
19404683|NCT02238483|41649700|FG000|Overall Study|Death|1|||
19404684|NCT02238483|41649701|FG001|Overall Study|Death|0|||
19404685|NCT02238483|41649700|FG000|Overall Study|Adverse Event|7|||
19404686|NCT02238483|41649701|FG001|Overall Study|Adverse Event|3|||
19404687|NCT02238483|41649700|FG000|Overall Study|Withdrawn due to physician decision|1|||
19404688|NCT02238483|41649701|FG001|Overall Study|Withdrawn due to physician decision|0|||
19404689|NCT02238483|41649700|FG000|Overall Study|Completion status not recorded|1|||
19404690|NCT02238483|41649701|FG001|Overall Study|Completion status not recorded|1|||
19404691|NCT02238483|41649700|FG000|Overall Study|Illness in family member|1|||
19404692|NCT02238483|41649701|FG001|Overall Study|Illness in family member|0|||
19404693|NCT01632891|41649709|FG000|Overall Study|Lost to Follow-up|0|||
19404694|NCT01632891|41649710|FG001|Overall Study|Lost to Follow-up|1|||
19404695|NCT01632891|41649709|FG000|Overall Study|Withdrawal by Subject|1|||
19404696|NCT01632891|41649710|FG001|Overall Study|Withdrawal by Subject|0|||
19404697|NCT02208999|41649722|FG000|Overall Study|Lost to Follow-up|1|||
19404698|NCT02208843|41649741|FG000|Overall Study|Clinical symptoms of progression|2|||
19404699|NCT02208843|41649741|FG000|Overall Study|Progression disease according to RECIST|24|||
19404700|NCT02208843|41649741|FG000|Overall Study|Adverse Event|12|||
19404701|NCT02208843|41649741|FG000|Overall Study|Protocol Violation|1|||
19404702|NCT02208843|41649741|FG000|Overall Study|Withdrawal by Subject|1|||
19404703|NCT02208843|41649741|FG000|Overall Study|Switched to commercial afatinib|20|||
19404704|NCT02208063|41649747|FG000|Overall Study|Death|3|||
19404705|NCT02208063|41649748|FG001|Overall Study|Death|5|||
19404706|NCT02208063|41649747|FG000|Overall Study|Not Specified in report|3|||
19404707|NCT02208063|41649748|FG001|Overall Study|Not Specified in report|4|||
19404708|NCT02208063|41649747|FG000|Overall Study|Withdrawal by Subject|5|||
19404709|NCT02208063|41649748|FG001|Overall Study|Withdrawal by Subject|2|||
19404710|NCT02208063|41649747|FG000|Overall Study|Lost to Follow-up|1|||
19404711|NCT02208063|41649748|FG001|Overall Study|Lost to Follow-up|0|||
19404712|NCT02207907|41649756|FG000|Overall Study|Lost to Follow-up|3|||
19404713|NCT02207907|41649757|FG001|Overall Study|Lost to Follow-up|1|||
19404714|NCT02207907|41649756|FG000|Overall Study|Withdrawal by Subject|5|||
19404715|NCT02207907|41649757|FG001|Overall Study|Withdrawal by Subject|6|||
19404716|NCT02207907|41649756|FG000|Overall Study|Did not meet study criteria|3|||
19404717|NCT02207907|41649757|FG001|Overall Study|Did not meet study criteria|0|||
19404718|NCT02207907|41649756|FG000|Overall Study|Pregnancy|0|||
19404719|NCT02207907|41649757|FG001|Overall Study|Pregnancy|1|||
19404720|NCT02207829|41649766|FG000|Overall Study|Adverse Event|10|||
19404721|NCT02207829|41649767|FG001|Overall Study|Adverse Event|9|||
19404722|NCT02207829|41649766|FG000|Overall Study|Lack of Efficacy|7|||
19404723|NCT02207829|41649767|FG001|Overall Study|Lack of Efficacy|5|||
19404724|NCT02207829|41649766|FG000|Overall Study|Lost to Follow-up|2|||
19404725|NCT02207829|41649767|FG001|Overall Study|Lost to Follow-up|2|||
19404726|NCT02207829|41649766|FG000|Overall Study|Protocol deviation|5|||
19404727|NCT02207829|41649767|FG001|Overall Study|Protocol deviation|4|||
19404728|NCT02207829|41649766|FG000|Overall Study|Withdrew consent|18|||
19404729|NCT02207829|41649767|FG001|Overall Study|Withdrew consent|14|||
19404730|NCT02237157|41649773|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
19404731|NCT02237157|41649774|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
19404732|NCT02237157|41649775|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
19404733|NCT02237157|41649776|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
19404734|NCT02237157|41649773|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
19404735|NCT02237157|41649774|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
19404736|NCT02237157|41649775|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
19404737|NCT02237157|41649776|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
19404738|NCT02237001|41649783|FG000|Overall Study|Lost to Follow-up|2|||
19404739|NCT02237001|41649783|FG000|Overall Study|Withdrawal by Subject|1|||
19404740|NCT02237001|41649783|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
19404741|NCT02237001|41649783|FG000|Overall Study|Re-operation|4|||
19404742|NCT02237001|41649783|FG000|Overall Study|Incarceration|1|||
19404743|NCT02236611|41649789|FG000|Overall Study|Adverse Event|10|||
19404744|NCT02236611|41649790|FG001|Overall Study|Adverse Event|16|||
19404745|NCT02236611|41649789|FG000|Overall Study|Lack of Efficacy|4|||
19404746|NCT02236611|41649790|FG001|Overall Study|Lack of Efficacy|7|||
19404747|NCT02236611|41649789|FG000|Overall Study|Lost to Follow-up|0|||
19404748|NCT02236611|41649790|FG001|Overall Study|Lost to Follow-up|2|||
19404749|NCT02236611|41649789|FG000|Overall Study|Protocol deviation|3|||
19404750|NCT02236611|41649790|FG001|Overall Study|Protocol deviation|5|||
19404751|NCT02236611|41649789|FG000|Overall Study|Withdrew consent|9|||
19404752|NCT02236611|41649790|FG001|Overall Study|Withdrew consent|4|||
19404753|NCT02234583|41649798|FG000|Overall Study|Adverse Event|172|||
19404754|NCT02234583|41649799|FG001|Overall Study|Adverse Event|156|||
19404755|NCT02234583|41649798|FG000|Overall Study|Withdrawal by Subject|109|||
19404756|NCT02234583|41649799|FG001|Overall Study|Withdrawal by Subject|157|||
19404757|NCT02234583|41649798|FG000|Overall Study|Lost to Follow-up|0|||
19404758|NCT02234583|41649799|FG001|Overall Study|Lost to Follow-up|1|||
19404759|NCT02234583|41649798|FG000|Overall Study|Lack of Efficacy|58|||
19404760|NCT02234583|41649799|FG001|Overall Study|Lack of Efficacy|103|||
19404761|NCT02234583|41649798|FG000|Overall Study|Protocol Violation|35|||
19404762|NCT02234583|41649799|FG001|Overall Study|Protocol Violation|42|||
19404763|NCT02234583|41649798|FG000|Overall Study|Other|39|||
19404764|NCT02234583|41649799|FG001|Overall Study|Other|97|||
19404765|NCT03686397|41649813|FG000|Overall Study|Lack of Efficacy|3|||
19404766|NCT03686397|41649814|FG001|Overall Study|Lack of Efficacy|5|||
19404767|NCT03686397|41649813|FG000|Overall Study|Adverse Event|0|||
19404768|NCT03686397|41649814|FG001|Overall Study|Adverse Event|1|||
19404769|NCT03686397|41649813|FG000|Overall Study|Protocol Violation|0|||
19404770|NCT03686397|41649814|FG001|Overall Study|Protocol Violation|1|||
19404771|NCT03686397|41649813|FG000|Overall Study|Withdrawal by Subject|0|||
19404772|NCT03686397|41649814|FG001|Overall Study|Withdrawal by Subject|1|||
19404773|NCT03686397|41649813|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
19404774|NCT03686397|41649814|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
19404775|NCT02233803|41649820|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
19404776|NCT02233803|41649821|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
19404777|NCT02233803|41649820|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
19404778|NCT02233803|41649821|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
19404779|NCT02233803|41649820|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
19404780|NCT02233803|41649821|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
19404781|NCT02233803|41649820|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
19404782|NCT02233803|41649821|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
19404783|NCT02233803|41649820|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
19404784|NCT02233803|41649821|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
19404785|NCT02233803|41649820|FG000|Washout Period (4-Wks)|Physician Decision|1|||
19404786|NCT02233803|41649821|FG001|Washout Period (4-Wks)|Physician Decision|0|||
19404787|NCT02233803|41649820|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
19404788|NCT02233803|41649821|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
19404789|NCT02233803|41649820|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
19404790|NCT02233803|41649821|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
19404791|NCT02233803|41649820|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
19404792|NCT02233803|41649821|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
19404793|NCT02233647|41649829|FG000|Overall Study|Adverse Event|1|||
19404794|NCT02233413|41649835|FG000|Overall Study|Lost to Follow-up|7|||
19404795|NCT02233413|41649836|FG001|Overall Study|Lost to Follow-up|9|||
19404796|NCT02233413|41649835|FG000|Overall Study|Withdrawal by Subject|4|||
19404797|NCT02233413|41649836|FG001|Overall Study|Withdrawal by Subject|5|||
19404798|NCT01632579|41649842|FG000|Washout Period|Adverse Event|1|||
19404799|NCT01632579|41649843|FG001|Washout Period|Adverse Event|0|||
19404800|NCT01632579|41649844|FG002|Washout Period|Adverse Event|0|||
19404801|NCT01632579|41649845|FG003|Washout Period|Adverse Event|0|||
19404802|NCT01632579|41649846|FG004|Washout Period|Adverse Event|0|||
19404803|NCT01632579|41649847|FG005|Washout Period|Adverse Event|0|||
19404804|NCT01632579|41649848|FG006|Washout Period|Adverse Event|0|||
19404805|NCT01632579|41649849|FG007|Washout Period|Adverse Event|0|||
19404806|NCT01632579|41649850|FG008|Washout Period|Adverse Event|0|||
19404807|NCT01632579|41649842|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
19404808|NCT01632579|41649843|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
19404809|NCT01632579|41649844|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
19404810|NCT01632579|41649845|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
19404811|NCT01632579|41649846|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
19404812|NCT01632579|41649847|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
19404813|NCT01632579|41649848|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
19404814|NCT01632579|41649849|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
19404815|NCT01632579|41649850|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
19404816|NCT01632345|41649879|FG000|Treatment: Part I|Adverse Event|1|||
19404817|NCT01632345|41649880|FG001|Treatment: Part I|Adverse Event|4|||
19404818|NCT01632345|41649881|FG002|Treatment: Part I|Adverse Event|2|||
19404819|NCT01632345|41649882|FG003|Treatment: Part I|Adverse Event|1|||
19404820|NCT01632345|41649883|FG004|Treatment: Part I|Adverse Event|3|||
19404821|NCT01632345|41649884|FG005|Treatment: Part I|Adverse Event|0|||
19404822|NCT01632345|41649885|FG006|Treatment: Part I|Adverse Event|0|||
19404823|NCT01632345|41649879|FG000|Treatment: Part I|Lack of Efficacy|0|||
19404824|NCT01632345|41649880|FG001|Treatment: Part I|Lack of Efficacy|1|||
19404825|NCT01632345|41649881|FG002|Treatment: Part I|Lack of Efficacy|0|||
19404826|NCT01632345|41649882|FG003|Treatment: Part I|Lack of Efficacy|1|||
19404827|NCT01632345|41649883|FG004|Treatment: Part I|Lack of Efficacy|1|||
19404828|NCT01632345|41649884|FG005|Treatment: Part I|Lack of Efficacy|0|||
19404829|NCT01632345|41649885|FG006|Treatment: Part I|Lack of Efficacy|0|||
19404830|NCT01632345|41649879|FG000|Treatment: Part I|Lost to Follow-up|3|||
19404831|NCT01632345|41649880|FG001|Treatment: Part I|Lost to Follow-up|2|||
19404832|NCT01632345|41649881|FG002|Treatment: Part I|Lost to Follow-up|1|||
19404833|NCT01632345|41649882|FG003|Treatment: Part I|Lost to Follow-up|3|||
19404834|NCT01632345|41649883|FG004|Treatment: Part I|Lost to Follow-up|4|||
19404835|NCT01632345|41649884|FG005|Treatment: Part I|Lost to Follow-up|0|||
19404836|NCT01632345|41649885|FG006|Treatment: Part I|Lost to Follow-up|0|||
19404837|NCT01632345|41649879|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
19404838|NCT01632345|41649880|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
19404839|NCT01632345|41649881|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
19404840|NCT01632345|41649882|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
19404841|NCT01632345|41649883|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
19404842|NCT01632345|41649884|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
19404843|NCT01632345|41649885|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
19404844|NCT01632345|41649879|FG000|Treatment: Part I|Physician Decision|2|||
19404845|NCT01632345|41649880|FG001|Treatment: Part I|Physician Decision|1|||
19404846|NCT01632345|41649881|FG002|Treatment: Part I|Physician Decision|0|||
19404847|NCT01632345|41649882|FG003|Treatment: Part I|Physician Decision|0|||
19404848|NCT01632345|41649883|FG004|Treatment: Part I|Physician Decision|1|||
19404849|NCT01632345|41649884|FG005|Treatment: Part I|Physician Decision|0|||
19404850|NCT01632345|41649885|FG006|Treatment: Part I|Physician Decision|0|||
19404851|NCT01632345|41649879|FG000|Treatment: Part I|Pregnancy|0|||
19404852|NCT01632345|41649880|FG001|Treatment: Part I|Pregnancy|1|||
19404853|NCT01632345|41649881|FG002|Treatment: Part I|Pregnancy|0|||
19404854|NCT01632345|41649882|FG003|Treatment: Part I|Pregnancy|0|||
19404855|NCT01632345|41649883|FG004|Treatment: Part I|Pregnancy|0|||
19404856|NCT01632345|41649884|FG005|Treatment: Part I|Pregnancy|0|||
19404857|NCT01632345|41649885|FG006|Treatment: Part I|Pregnancy|0|||
19404858|NCT01632345|41649879|FG000|Treatment: Part I|Protocol Deviation|0|||
19404859|NCT01632345|41649880|FG001|Treatment: Part I|Protocol Deviation|0|||
19404860|NCT01632345|41649881|FG002|Treatment: Part I|Protocol Deviation|1|||
19404861|NCT01632345|41649882|FG003|Treatment: Part I|Protocol Deviation|1|||
19404862|NCT01632345|41649883|FG004|Treatment: Part I|Protocol Deviation|0|||
19404863|NCT01632345|41649884|FG005|Treatment: Part I|Protocol Deviation|0|||
19404864|NCT01632345|41649885|FG006|Treatment: Part I|Protocol Deviation|0|||
19404865|NCT01632345|41649879|FG000|Treatment: Part I|Withdrawal by Subject|3|||
19404866|NCT01632345|41649880|FG001|Treatment: Part I|Withdrawal by Subject|4|||
19404867|NCT01632345|41649881|FG002|Treatment: Part I|Withdrawal by Subject|4|||
19404868|NCT01632345|41649882|FG003|Treatment: Part I|Withdrawal by Subject|1|||
19404869|NCT01632345|41649883|FG004|Treatment: Part I|Withdrawal by Subject|4|||
19404870|NCT01632345|41649884|FG005|Treatment: Part I|Withdrawal by Subject|0|||
19404871|NCT01632345|41649885|FG006|Treatment: Part I|Withdrawal by Subject|0|||
19404872|NCT01632345|41649879|FG000|Treatment: Part II|Adverse Event|0|||
19404873|NCT01632345|41649880|FG001|Treatment: Part II|Adverse Event|0|||
19404874|NCT01632345|41649881|FG002|Treatment: Part II|Adverse Event|0|||
19404875|NCT01632345|41649882|FG003|Treatment: Part II|Adverse Event|0|||
19404876|NCT01632345|41649883|FG004|Treatment: Part II|Adverse Event|0|||
19404877|NCT01632345|41649884|FG005|Treatment: Part II|Adverse Event|3|||
19404878|NCT01632345|41649885|FG006|Treatment: Part II|Adverse Event|8|||
19404879|NCT01632345|41649879|FG000|Treatment: Part II|Lost to Follow-up|0|||
19404880|NCT01632345|41649880|FG001|Treatment: Part II|Lost to Follow-up|0|||
19404881|NCT01632345|41649881|FG002|Treatment: Part II|Lost to Follow-up|0|||
19404882|NCT01632345|41649882|FG003|Treatment: Part II|Lost to Follow-up|0|||
19404883|NCT01632345|41649883|FG004|Treatment: Part II|Lost to Follow-up|0|||
19404884|NCT01632345|41649884|FG005|Treatment: Part II|Lost to Follow-up|3|||
19404885|NCT01632345|41649885|FG006|Treatment: Part II|Lost to Follow-up|1|||
19404886|NCT01632345|41649879|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404887|NCT01632345|41649880|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404888|NCT01632345|41649881|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404889|NCT01632345|41649882|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404890|NCT01632345|41649883|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404891|NCT01632345|41649884|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
19404892|NCT01632345|41649885|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
19404893|NCT01632345|41649879|FG000|Treatment: Part II|Withdrawal by Subject|0|||
19404894|NCT01632345|41649880|FG001|Treatment: Part II|Withdrawal by Subject|0|||
19404895|NCT01632345|41649881|FG002|Treatment: Part II|Withdrawal by Subject|0|||
19404896|NCT01632345|41649882|FG003|Treatment: Part II|Withdrawal by Subject|0|||
19404897|NCT01632345|41649883|FG004|Treatment: Part II|Withdrawal by Subject|0|||
19404898|NCT01632345|41649884|FG005|Treatment: Part II|Withdrawal by Subject|2|||
19404899|NCT01632345|41649885|FG006|Treatment: Part II|Withdrawal by Subject|2|||
19404900|NCT02232243|41649903|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
19404901|NCT02232243|41649904|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
19404902|NCT02232243|41649905|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
19404903|NCT02205333|41649923|FG000|Overall Study|Death|5|||
19404904|NCT02205333|41649924|FG001|Overall Study|Death|6|||
19404905|NCT02205333|41649925|FG002|Overall Study|Death|2|||
19404906|NCT02205333|41649926|FG003|Overall Study|Death|6|||
19404907|NCT02205333|41649927|FG004|Overall Study|Death|5|||
19404908|NCT02205333|41649928|FG005|Overall Study|Death|3|||
19404909|NCT02205333|41649929|FG006|Overall Study|Death|3|||
19404910|NCT02205333|41649930|FG007|Overall Study|Death|2|||
19404911|NCT02205333|41649931|FG008|Overall Study|Death|0|||
19404912|NCT02205333|41649923|FG000|Overall Study|Withdrawal by Subject|1|||
19404913|NCT02205333|41649924|FG001|Overall Study|Withdrawal by Subject|0|||
19404914|NCT02205333|41649925|FG002|Overall Study|Withdrawal by Subject|0|||
19404915|NCT02205333|41649926|FG003|Overall Study|Withdrawal by Subject|1|||
19404916|NCT02205333|41649927|FG004|Overall Study|Withdrawal by Subject|0|||
19404917|NCT02205333|41649928|FG005|Overall Study|Withdrawal by Subject|0|||
19404918|NCT02205333|41649929|FG006|Overall Study|Withdrawal by Subject|2|||
19404919|NCT02205333|41649930|FG007|Overall Study|Withdrawal by Subject|0|||
19404920|NCT02205333|41649931|FG008|Overall Study|Withdrawal by Subject|0|||
19404921|NCT02230683|41649951|FG000|Overall Study|Adverse Event|1|||
19404922|NCT02230527|41649963|FG000|Overall Study|Withdrawal by Subject|1|||
19404923|NCT02230527|41649964|FG001|Overall Study|Withdrawal by Subject|1|||
19404924|NCT02230527|41649963|FG000|Overall Study|Death|1|||
19404925|NCT02230527|41649964|FG001|Overall Study|Death|0|||
19404926|NCT02230527|41649963|FG000|Overall Study|Lost to Follow-up|2|||
19404927|NCT02230527|41649964|FG001|Overall Study|Lost to Follow-up|1|||
19404928|NCT02230527|41649963|FG000|Overall Study|Other|1|||
19404929|NCT02230527|41649964|FG001|Overall Study|Other|0|||
19404930|NCT02204319|41649970|FG000|Overall Study|Pregnancy|1|||
19404931|NCT02204319|41649970|FG000|Overall Study|Withdrawal by Subject|2|||
19404932|NCT02204007|41649977|FG000|Overall Study|Surgery Canceled|1|||
19404933|NCT02204007|41649978|FG001|Overall Study|Surgery Canceled|1|||
19518736|NCT01506882|41931762|FG001|Overall Study|Lost to Follow-up|0|||
19518737|NCT01506882|41931761|FG000|Overall Study|Withdrawal by Subject|9|||
19518738|NCT01506882|41931762|FG001|Overall Study|Withdrawal by Subject|3|||
19518739|NCT01506882|41931761|FG000|Overall Study|SAE, non-fatal|2|||
19518740|NCT01506882|41931762|FG001|Overall Study|SAE, non-fatal|0|||
19518741|NCT01506882|41931761|FG000|Overall Study|AE, non-serious non-fatal|3|||
19518742|NCT01506882|41931762|FG001|Overall Study|AE, non-serious non-fatal|1|||
19518743|NCT01506882|41931761|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
19518744|NCT01506882|41931762|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19518745|NCT01506882|41931761|FG000|Overall Study|Other Reason|2|||
19518746|NCT01506882|41931762|FG001|Overall Study|Other Reason|0|||
19518747|NCT01506726|41931772|FG000|Overall Study|Adverse Event|1|||
19518748|NCT01506726|41931773|FG001|Overall Study|Adverse Event|2|||
19518749|NCT01505868|41931784|FG000|Overall Study|Withdrawal by Subject|1|||
19518750|NCT01505868|41931785|FG001|Overall Study|Withdrawal by Subject|0|||
19518751|NCT01505868|41931786|FG002|Overall Study|Withdrawal by Subject|0|||
19518752|NCT01505868|41931787|FG003|Overall Study|Withdrawal by Subject|0|||
19518753|NCT01505868|41931788|FG004|Overall Study|Withdrawal by Subject|0|||
19518754|NCT01505634|41931803|FG000|Overall Study|Withdrawal by Subject|2|||
19518755|NCT01505634|41931804|FG001|Overall Study|Withdrawal by Subject|5|||
19518756|NCT01505634|41931805|FG002|Overall Study|Withdrawal by Subject|1|||
19518757|NCT01505634|41931803|FG000|Overall Study|Physician Decision|1|||
19518758|NCT01505634|41931804|FG001|Overall Study|Physician Decision|1|||
19518759|NCT01505634|41931805|FG002|Overall Study|Physician Decision|0|||
19518760|NCT01505634|41931803|FG000|Overall Study|Adverse Event|1|||
19518761|NCT01505634|41931804|FG001|Overall Study|Adverse Event|0|||
19518762|NCT01505634|41931805|FG002|Overall Study|Adverse Event|0|||
19518763|NCT01505634|41931803|FG000|Overall Study|Insufficient supply of drug at site|1|||
19518764|NCT01505634|41931804|FG001|Overall Study|Insufficient supply of drug at site|0|||
19518765|NCT01505634|41931805|FG002|Overall Study|Insufficient supply of drug at site|0|||
19518766|NCT01505634|41931803|FG000|Overall Study|Protocol Violation|2|||
19518767|NCT01505634|41931804|FG001|Overall Study|Protocol Violation|0|||
19518768|NCT01505634|41931805|FG002|Overall Study|Protocol Violation|0|||
19518769|NCT01505634|41931803|FG000|Overall Study|Lost to Follow-up|1|||
19518770|NCT01505634|41931804|FG001|Overall Study|Lost to Follow-up|4|||
19518771|NCT01505634|41931805|FG002|Overall Study|Lost to Follow-up|4|||
19518772|NCT01505634|41931803|FG000|Overall Study|Death|1|||
19518773|NCT01505634|41931804|FG001|Overall Study|Death|0|||
19518774|NCT01505634|41931805|FG002|Overall Study|Death|0|||
19628014|NCT00795951|42077420|FG000|Overall Study|Lost to Follow-up|1|||
19711068|NCT03572218|42154246|FG001|Overall Study|Lost to Follow-up|2|||
19518775|NCT01505634|41931803|FG000|Overall Study|In a conflict zone|0|||
19518776|NCT01505634|41931804|FG001|Overall Study|In a conflict zone|0|||
19518777|NCT01505634|41931805|FG002|Overall Study|In a conflict zone|1|||
19404934|NCT02203851|41649984|FG000|Overall Study|Lost to Follow-up|4|||
19404935|NCT02203851|41649984|FG000|Overall Study|Withdrawal by Subject|6|||
19404936|NCT02203851|41649984|FG000|Overall Study|Other|1|||
19404937|NCT02228967|41649997|FG000|Overall Study|Lost to Follow-up|146|||
19404938|NCT02228967|41649998|FG001|Overall Study|Lost to Follow-up|142|||
19518778|NCT01460628|41931813|FG000|Overall Study|Adverse Event|3|||
19404939|NCT02228967|41649997|FG000|Overall Study|Withdrawal by Subject|13|||
19404940|NCT02228967|41649998|FG001|Overall Study|Withdrawal by Subject|18|||
19404941|NCT02227875|41650006|FG000|Overall Study|Protocol Violation|10|||
19404942|NCT02227875|41650007|FG001|Overall Study|Protocol Violation|7|||
19404943|NCT02227875|41650006|FG000|Overall Study|Other|1|||
19404944|NCT02227875|41650007|FG001|Overall Study|Other|3|||
19404945|NCT02227875|41650006|FG000|Overall Study|Physician Decision|1|||
19404946|NCT02227875|41650007|FG001|Overall Study|Physician Decision|0|||
19404947|NCT02227875|41650006|FG000|Overall Study|Adverse Event|3|||
19404948|NCT02227875|41650007|FG001|Overall Study|Adverse Event|0|||
19404949|NCT02227875|41650006|FG000|Overall Study|Withdrawal by Subject|12|||
19404950|NCT02227875|41650007|FG001|Overall Study|Withdrawal by Subject|13|||
19404951|NCT02227875|41650006|FG000|Overall Study|Lost to Follow-up|10|||
19404952|NCT02227875|41650007|FG001|Overall Study|Lost to Follow-up|10|||
19404953|NCT02203149|41650018|FG000|Part 1|Adverse Event|0|||
19404954|NCT02203149|41650019|FG001|Part 1|Adverse Event|1|||
19404955|NCT02203149|41650020|FG002|Part 1|Adverse Event|0|||
19404956|NCT02203149|41650021|FG003|Part 1|Adverse Event|0|||
19404957|NCT02203149|41650022|FG004|Part 1|Adverse Event|0|||
19404958|NCT02203149|41650018|FG000|Part 2|Death|0|||
19404959|NCT02203149|41650019|FG001|Part 2|Death|0|||
19404960|NCT02203149|41650020|FG002|Part 2|Death|1|||
19404961|NCT02203149|41650021|FG003|Part 2|Death|1|||
19404962|NCT02203149|41650022|FG004|Part 2|Death|0|||
19404963|NCT02203149|41650018|FG000|Part 2|Withdrawal by Subject|0|||
19404964|NCT02203149|41650019|FG001|Part 2|Withdrawal by Subject|0|||
19404965|NCT02203149|41650020|FG002|Part 2|Withdrawal by Subject|0|||
19404966|NCT02203149|41650021|FG003|Part 2|Withdrawal by Subject|1|||
19404967|NCT02203149|41650022|FG004|Part 2|Withdrawal by Subject|0|||
19404968|NCT02203149|41650018|FG000|Part 2|Adverse Event|0|||
19404969|NCT02203149|41650019|FG001|Part 2|Adverse Event|0|||
19404970|NCT02203149|41650020|FG002|Part 2|Adverse Event|0|||
19404971|NCT02203149|41650021|FG003|Part 2|Adverse Event|1|||
19404972|NCT02203149|41650022|FG004|Part 2|Adverse Event|1|||
19404973|NCT02203071|41650046|FG000|Overall Study|Lost to Follow-up|3|||
19404974|NCT02203071|41650047|FG001|Overall Study|Lost to Follow-up|1|||
19404975|NCT02202837|41650055|FG000|Overall Study|Enbrel treatment discontinued|36|||
19404976|NCT02202837|41650056|FG001|Overall Study|Enbrel treatment discontinued|4|||
19404977|NCT02202837|41650055|FG000|Overall Study|Other|10|||
19404978|NCT02202837|41650056|FG001|Overall Study|Other|0|||
19404979|NCT02202837|41650055|FG000|Overall Study|Lost to Follow-up|7|||
19404980|NCT02202837|41650056|FG001|Overall Study|Lost to Follow-up|1|||
19404981|NCT02202759|41650065|FG000|Overall Study|Study Terminated by Sponsor|3|||
19404982|NCT02202759|41650066|FG001|Overall Study|Study Terminated by Sponsor|3|||
19404983|NCT02202759|41650067|FG002|Overall Study|Study Terminated by Sponsor|3|||
19404984|NCT02202759|41650065|FG000|Overall Study|Withdrawal by Subject|2|||
19404985|NCT02202759|41650066|FG001|Overall Study|Withdrawal by Subject|1|||
19404986|NCT02202759|41650067|FG002|Overall Study|Withdrawal by Subject|1|||
19404987|NCT02202759|41650065|FG000|Overall Study|Reason not Specified|4|||
19404988|NCT02202759|41650066|FG001|Overall Study|Reason not Specified|11|||
19404989|NCT02202759|41650067|FG002|Overall Study|Reason not Specified|10|||
19404990|NCT02226549|41650076|FG000|Overall Study|Randomized but Never Treated|1|||
19404991|NCT02226549|41650077|FG001|Overall Study|Randomized but Never Treated|0|||
19404992|NCT02226549|41650076|FG000|Overall Study|Lost to Follow-up|0|||
19404993|NCT02226549|41650077|FG001|Overall Study|Lost to Follow-up|1|||
19404994|NCT02226003|41650086|FG000|Overall Study|Lost to Follow-up|2|||
19711069|NCT03572218|42154245|FG000|Overall Study|No longer available for study visits|2|||
19711070|NCT03572218|42154246|FG001|Overall Study|No longer available for study visits|1|||
19711071|NCT03572218|42154245|FG000|Overall Study|No longer interested|1|||
19711072|NCT03572218|42154246|FG001|Overall Study|No longer interested|2|||
19711073|NCT00111813|42154252|FG000|Overall Study|Adverse Event|1|||
19711074|NCT00111813|42154253|FG001|Overall Study|Adverse Event|2|||
19711075|NCT00111813|42154254|FG002|Overall Study|Adverse Event|4|||
19711076|NCT00111813|42154255|FG003|Overall Study|Adverse Event|2|||
19711077|NCT00111813|42154256|FG004|Overall Study|Adverse Event|2|||
19404995|NCT02226003|41650087|FG001|Overall Study|Lost to Follow-up|1|||
19404996|NCT02226003|41650088|FG002|Overall Study|Lost to Follow-up|3|||
19404997|NCT02226003|41650086|FG000|Overall Study|Withdrawal by Subject|0|||
19628015|NCT00795951|42077420|FG000|Overall Study|Withdrawal by Subject|1|||
19404998|NCT02226003|41650087|FG001|Overall Study|Withdrawal by Subject|0|||
19404999|NCT02226003|41650088|FG002|Overall Study|Withdrawal by Subject|3|||
19628016|NCT00795717|42077427|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
19405000|NCT02225223|41650098|FG000|Overall Study|Death|10|||
19405001|NCT02225223|41650099|FG001|Overall Study|Death|1|||
19405002|NCT02225223|41650098|FG000|Overall Study|Lost to Follow-up|5|||
19405003|NCT02225223|41650099|FG001|Overall Study|Lost to Follow-up|0|||
19405004|NCT02225223|41650098|FG000|Overall Study|Other|1|||
19405005|NCT02225223|41650099|FG001|Overall Study|Other|2|||
19405006|NCT02225223|41650098|FG000|Overall Study|Physician Decision|1|||
19711078|NCT00111813|42154257|FG005|Overall Study|Adverse Event|2|||
19711079|NCT00111813|42154252|FG000|Overall Study|Progressive disease|2|||
19405007|NCT02225223|41650099|FG001|Overall Study|Physician Decision|0|||
19405008|NCT02225223|41650098|FG000|Overall Study|Withdrawal by Subject|2|||
19405009|NCT02225223|41650099|FG001|Overall Study|Withdrawal by Subject|2|||
19405010|NCT01634139|41650108|FG000|Overall Study|Non compliant with protocol|1|||
19405011|NCT01634139|41650109|FG001|Overall Study|Non compliant with protocol|0|||
19405012|NCT01634139|41650110|FG002|Overall Study|Non compliant with protocol|0|||
19405013|NCT01634139|41650108|FG000|Overall Study|Consent withdrawn not due to AE|4|||
19405014|NCT01634139|41650109|FG001|Overall Study|Consent withdrawn not due to AE|3|||
19405015|NCT01634139|41650110|FG002|Overall Study|Consent withdrawn not due to AE|2|||
19405016|NCT01634139|41650108|FG000|Overall Study|Other|4|||
19405017|NCT01634139|41650109|FG001|Overall Study|Other|0|||
19405018|NCT01634139|41650110|FG002|Overall Study|Other|3|||
19405019|NCT01634139|41650108|FG000|Overall Study|Lost to Follow-up|0|||
19405020|NCT01634139|41650109|FG001|Overall Study|Lost to Follow-up|2|||
19405021|NCT01634139|41650110|FG002|Overall Study|Lost to Follow-up|0|||
19405022|NCT01634139|41650108|FG000|Overall Study|Not treated|1|||
19405023|NCT01634139|41650109|FG001|Overall Study|Not treated|1|||
19405024|NCT01634139|41650110|FG002|Overall Study|Not treated|0|||
19405025|NCT02224755|41650120|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
19405026|NCT02224755|41650121|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
19405027|NCT02224755|41650120|FG000|Two Year Follow up Post-implant|Death|103|||
19405028|NCT02224755|41650121|FG001|Two Year Follow up Post-implant|Death|98|||
19405029|NCT02224755|41650120|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
19405030|NCT02224755|41650121|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
19405031|NCT02224755|41650120|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
19405032|NCT02224755|41650121|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
19405033|NCT02224755|41650120|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
19405034|NCT02224755|41650121|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
19405035|NCT02404441|41650141|FG000|Phase 1 Part|Adverse Event|1|||
19405036|NCT02404441|41650142|FG001|Phase 1 Part|Adverse Event|0|||
19405037|NCT02404441|41650143|FG002|Phase 1 Part|Adverse Event|0|||
19405038|NCT02404441|41650144|FG003|Phase 1 Part|Adverse Event|0|||
19405039|NCT02404441|41650145|FG004|Phase 1 Part|Adverse Event|0|||
19405040|NCT02404441|41650146|FG005|Phase 1 Part|Adverse Event|0|||
19405041|NCT02404441|41650147|FG006|Phase 1 Part|Adverse Event|0|||
19405042|NCT02404441|41650148|FG007|Phase 1 Part|Adverse Event|0|||
19405043|NCT02404441|41650149|FG008|Phase 1 Part|Adverse Event|0|||
19405044|NCT02404441|41650150|FG009|Phase 1 Part|Adverse Event|0|||
19405045|NCT02404441|41650141|FG000|Phase 1 Part|Physician Decision|0|||
19405046|NCT02404441|41650142|FG001|Phase 1 Part|Physician Decision|1|||
19405047|NCT02404441|41650143|FG002|Phase 1 Part|Physician Decision|0|||
19374581|NCT02543528|41616186|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
19374582|NCT02543528|41616187|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
19374583|NCT02543528|41616188|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
19374584|NCT02543528|41616189|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
19374585|NCT02543528|41616190|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
19374586|NCT02543528|41616186|FG000|Extended Wear Period|Lost to Follow-up|0|||
19374587|NCT02543528|41616187|FG001|Extended Wear Period|Lost to Follow-up|1|||
19374588|NCT02543528|41616188|FG002|Extended Wear Period|Lost to Follow-up|2|||
19374589|NCT02543528|41616189|FG003|Extended Wear Period|Lost to Follow-up|1|||
19374590|NCT02543528|41616190|FG004|Extended Wear Period|Lost to Follow-up|0|||
19374591|NCT02543528|41616186|FG000|Extended Wear Period|Withdrawal by Subject|10|||
19374592|NCT02543528|41616187|FG001|Extended Wear Period|Withdrawal by Subject|9|||
19374593|NCT02543528|41616188|FG002|Extended Wear Period|Withdrawal by Subject|4|||
19374594|NCT02543528|41616189|FG003|Extended Wear Period|Withdrawal by Subject|5|||
19374595|NCT02543528|41616190|FG004|Extended Wear Period|Withdrawal by Subject|0|||
19374596|NCT00156533|41616208|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
19374597|NCT00156533|41616209|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
19374598|NCT00156533|41616210|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
19374599|NCT00156533|41616211|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
19374600|NCT00156533|41616208|FG000|Overall Study|Withdrawal by Subject|1|||
19374601|NCT00156533|41616209|FG001|Overall Study|Withdrawal by Subject|0|||
19374602|NCT00156533|41616210|FG002|Overall Study|Withdrawal by Subject|0|||
19374603|NCT00156533|41616211|FG003|Overall Study|Withdrawal by Subject|1|||
19405048|NCT02404441|41650144|FG003|Phase 1 Part|Physician Decision|0|||
19405049|NCT02404441|41650145|FG004|Phase 1 Part|Physician Decision|0|||
19405050|NCT02404441|41650146|FG005|Phase 1 Part|Physician Decision|0|||
19405051|NCT02404441|41650147|FG006|Phase 1 Part|Physician Decision|0|||
19405052|NCT02404441|41650148|FG007|Phase 1 Part|Physician Decision|0|||
19405053|NCT02404441|41650149|FG008|Phase 1 Part|Physician Decision|0|||
19405054|NCT02404441|41650150|FG009|Phase 1 Part|Physician Decision|0|||
19405055|NCT02404441|41650141|FG000|Phase 1 Part|Progressive Disease|14|||
19405056|NCT02404441|41650142|FG001|Phase 1 Part|Progressive Disease|11|||
19405057|NCT02404441|41650143|FG002|Phase 1 Part|Progressive Disease|7|||
19405058|NCT02404441|41650144|FG003|Phase 1 Part|Progressive Disease|6|||
19405059|NCT02404441|41650145|FG004|Phase 1 Part|Progressive Disease|9|||
19405060|NCT02404441|41650146|FG005|Phase 1 Part|Progressive Disease|0|||
19405061|NCT02404441|41650147|FG006|Phase 1 Part|Progressive Disease|0|||
19405062|NCT02404441|41650148|FG007|Phase 1 Part|Progressive Disease|0|||
19405063|NCT02404441|41650149|FG008|Phase 1 Part|Progressive Disease|0|||
19405064|NCT02404441|41650150|FG009|Phase 1 Part|Progressive Disease|0|||
19405065|NCT02404441|41650141|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
19405066|NCT02404441|41650142|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
19405067|NCT02404441|41650143|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
19405068|NCT02404441|41650144|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
19405069|NCT02404441|41650145|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
19405070|NCT02404441|41650146|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
19405071|NCT02404441|41650147|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
19405072|NCT02404441|41650148|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
19405073|NCT02404441|41650149|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
19405074|NCT02404441|41650150|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
19405075|NCT02404441|41650141|FG000|Phase 1 Part|Death|1|||
19405076|NCT02404441|41650142|FG001|Phase 1 Part|Death|1|||
19405077|NCT02404441|41650143|FG002|Phase 1 Part|Death|1|||
19405078|NCT02404441|41650144|FG003|Phase 1 Part|Death|0|||
19405079|NCT02404441|41650145|FG004|Phase 1 Part|Death|1|||
19405080|NCT02404441|41650146|FG005|Phase 1 Part|Death|0|||
19405081|NCT02404441|41650147|FG006|Phase 1 Part|Death|0|||
19405082|NCT02404441|41650148|FG007|Phase 1 Part|Death|0|||
19405083|NCT02404441|41650149|FG008|Phase 1 Part|Death|0|||
19405084|NCT02404441|41650150|FG009|Phase 1 Part|Death|0|||
19405085|NCT02404441|41650141|FG000|Phase 2 Part|Adverse Event|0|||
19405086|NCT02404441|41650142|FG001|Phase 2 Part|Adverse Event|0|||
19405087|NCT02404441|41650143|FG002|Phase 2 Part|Adverse Event|0|||
19405088|NCT02404441|41650144|FG003|Phase 2 Part|Adverse Event|0|||
19405089|NCT02404441|41650145|FG004|Phase 2 Part|Adverse Event|0|||
19405090|NCT02404441|41650146|FG005|Phase 2 Part|Adverse Event|2|||
19405091|NCT02404441|41650147|FG006|Phase 2 Part|Adverse Event|3|||
19405092|NCT02404441|41650148|FG007|Phase 2 Part|Adverse Event|3|||
19405093|NCT02404441|41650149|FG008|Phase 2 Part|Adverse Event|6|||
19405094|NCT02404441|41650150|FG009|Phase 2 Part|Adverse Event|1|||
19405095|NCT02404441|41650141|FG000|Phase 2 Part|Physician Decision|0|||
19405096|NCT02404441|41650142|FG001|Phase 2 Part|Physician Decision|0|||
19405097|NCT02404441|41650143|FG002|Phase 2 Part|Physician Decision|0|||
19405098|NCT02404441|41650144|FG003|Phase 2 Part|Physician Decision|0|||
19405099|NCT02404441|41650145|FG004|Phase 2 Part|Physician Decision|0|||
19405100|NCT02404441|41650146|FG005|Phase 2 Part|Physician Decision|7|||
19405101|NCT02404441|41650147|FG006|Phase 2 Part|Physician Decision|9|||
19405102|NCT02404441|41650148|FG007|Phase 2 Part|Physician Decision|2|||
19405103|NCT02404441|41650149|FG008|Phase 2 Part|Physician Decision|1|||
19405104|NCT02404441|41650150|FG009|Phase 2 Part|Physician Decision|3|||
19405105|NCT02404441|41650141|FG000|Phase 2 Part|Progressive disease|0|||
19405106|NCT02404441|41650142|FG001|Phase 2 Part|Progressive disease|0|||
19405107|NCT02404441|41650143|FG002|Phase 2 Part|Progressive disease|0|||
19405108|NCT02404441|41650144|FG003|Phase 2 Part|Progressive disease|0|||
19405109|NCT02404441|41650145|FG004|Phase 2 Part|Progressive disease|0|||
19405110|NCT02404441|41650146|FG005|Phase 2 Part|Progressive disease|43|||
19405111|NCT02404441|41650147|FG006|Phase 2 Part|Progressive disease|32|||
19405112|NCT02404441|41650148|FG007|Phase 2 Part|Progressive disease|31|||
19405113|NCT02404441|41650149|FG008|Phase 2 Part|Progressive disease|39|||
19405114|NCT02404441|41650150|FG009|Phase 2 Part|Progressive disease|27|||
19405115|NCT02404441|41650141|FG000|Phase 2 Part|Subject/guardian decision|0|||
19405116|NCT02404441|41650142|FG001|Phase 2 Part|Subject/guardian decision|0|||
19405117|NCT02404441|41650143|FG002|Phase 2 Part|Subject/guardian decision|0|||
19405118|NCT02404441|41650144|FG003|Phase 2 Part|Subject/guardian decision|0|||
19405119|NCT02404441|41650145|FG004|Phase 2 Part|Subject/guardian decision|0|||
19405120|NCT02404441|41650146|FG005|Phase 2 Part|Subject/guardian decision|3|||
19405121|NCT02404441|41650147|FG006|Phase 2 Part|Subject/guardian decision|9|||
19405122|NCT02404441|41650148|FG007|Phase 2 Part|Subject/guardian decision|0|||
19405123|NCT02404441|41650149|FG008|Phase 2 Part|Subject/guardian decision|3|||
19405124|NCT02404441|41650150|FG009|Phase 2 Part|Subject/guardian decision|2|||
19405125|NCT02404441|41650141|FG000|Phase 2 Part|Death|0|||
19405126|NCT02404441|41650142|FG001|Phase 2 Part|Death|0|||
19405127|NCT02404441|41650143|FG002|Phase 2 Part|Death|0|||
19405128|NCT02404441|41650144|FG003|Phase 2 Part|Death|0|||
19405129|NCT02404441|41650145|FG004|Phase 2 Part|Death|0|||
19405130|NCT02404441|41650146|FG005|Phase 2 Part|Death|4|||
19405131|NCT02404441|41650147|FG006|Phase 2 Part|Death|8|||
19405132|NCT02404441|41650148|FG007|Phase 2 Part|Death|4|||
19405133|NCT02404441|41650149|FG008|Phase 2 Part|Death|10|||
19405134|NCT02404441|41650150|FG009|Phase 2 Part|Death|9|||
19405135|NCT02101281|41650196|FG000|Overall Study|Adverse Event|0|||
19405136|NCT02101281|41650197|FG001|Overall Study|Adverse Event|1|||
19405137|NCT02224599|41650209|FG000|Overall Study|Physician Decision|1|||
19405138|NCT02224599|41650209|FG000|Overall Study|Progression of Disease|1|||
19405139|NCT02201901|41650216|FG000|Overall Study|Randomized but never treated|0|||
19405140|NCT02201901|41650217|FG001|Overall Study|Randomized but never treated|1|||
19405141|NCT02201901|41650218|FG002|Overall Study|Randomized but never treated|0|||
19405142|NCT02201901|41650216|FG000|Overall Study|Lack of Efficacy|7|||
19405143|NCT02201901|41650217|FG001|Overall Study|Lack of Efficacy|1|||
19405144|NCT02201901|41650218|FG002|Overall Study|Lack of Efficacy|6|||
19405145|NCT02201901|41650216|FG000|Overall Study|Death|3|||
19405146|NCT02201901|41650217|FG001|Overall Study|Death|3|||
19405147|NCT02201901|41650218|FG002|Overall Study|Death|3|||
19405148|NCT02201901|41650216|FG000|Overall Study|Lost to Follow-up|2|||
19405149|NCT02201901|41650217|FG001|Overall Study|Lost to Follow-up|3|||
19405150|NCT02201901|41650218|FG002|Overall Study|Lost to Follow-up|2|||
19405151|NCT02201901|41650216|FG000|Overall Study|Withdrew Consent|2|||
19405152|NCT02201901|41650217|FG001|Overall Study|Withdrew Consent|0|||
19405153|NCT02201901|41650218|FG002|Overall Study|Withdrew Consent|2|||
19405154|NCT02201901|41650216|FG000|Overall Study|Adverse Event|1|||
19405155|NCT02201901|41650217|FG001|Overall Study|Adverse Event|1|||
19405156|NCT02201901|41650218|FG002|Overall Study|Adverse Event|0|||
19405157|NCT02201277|41650229|FG000|Overall Study|Death|3|||
19405158|NCT02201277|41650230|FG001|Overall Study|Death|4|||
19405159|NCT02201277|41650229|FG000|Overall Study|Lost to Follow-up|2|||
19405160|NCT02201277|41650230|FG001|Overall Study|Lost to Follow-up|1|||
19405161|NCT02201277|41650229|FG000|Overall Study|Failed retrieval|1|||
19405162|NCT02201277|41650230|FG001|Overall Study|Failed retrieval|0|||
19405163|NCT02201277|41650229|FG000|Overall Study|Physician Decision|1|||
19405164|NCT02201277|41650230|FG001|Overall Study|Physician Decision|0|||
19405165|NCT02224053|41650240|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
19405166|NCT02224053|41650240|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
19405167|NCT02224053|41650240|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
19405168|NCT02224053|41650240|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
19405169|NCT02224053|41650240|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
19405170|NCT02457793|41650252|FG000|Overall Study|Reason not specified|0|||
19405171|NCT02457793|41650253|FG001|Overall Study|Reason not specified|0|||
19405172|NCT02457793|41650254|FG002|Overall Study|Reason not specified|0|||
19405173|NCT02457793|41650255|FG003|Overall Study|Reason not specified|1|||
19405174|NCT02457793|41650256|FG004|Overall Study|Reason not specified|1|||
19405175|NCT02457793|41650257|FG005|Overall Study|Reason not specified|1|||
19405176|NCT02457793|41650252|FG000|Overall Study|Withdrawal by Subject|0|||
19405177|NCT02457793|41650253|FG001|Overall Study|Withdrawal by Subject|4|||
19405178|NCT02457793|41650254|FG002|Overall Study|Withdrawal by Subject|2|||
19405179|NCT02457793|41650255|FG003|Overall Study|Withdrawal by Subject|2|||
19405180|NCT02457793|41650256|FG004|Overall Study|Withdrawal by Subject|2|||
19405181|NCT02457793|41650257|FG005|Overall Study|Withdrawal by Subject|2|||
19405182|NCT02457793|41650252|FG000|Overall Study|Adverse Event|0|||
19405183|NCT02457793|41650253|FG001|Overall Study|Adverse Event|0|||
19405184|NCT02457793|41650254|FG002|Overall Study|Adverse Event|0|||
19405185|NCT02457793|41650255|FG003|Overall Study|Adverse Event|1|||
19405186|NCT02457793|41650256|FG004|Overall Study|Adverse Event|0|||
19405187|NCT02457793|41650257|FG005|Overall Study|Adverse Event|0|||
19405188|NCT02457793|41650252|FG000|Overall Study|Physician Decision|1|||
19405189|NCT02457793|41650253|FG001|Overall Study|Physician Decision|0|||
19405190|NCT02457793|41650254|FG002|Overall Study|Physician Decision|1|||
19405191|NCT02457793|41650255|FG003|Overall Study|Physician Decision|1|||
19405192|NCT02457793|41650256|FG004|Overall Study|Physician Decision|1|||
19405193|NCT02457793|41650257|FG005|Overall Study|Physician Decision|3|||
19405194|NCT01650259|41650274|FG000|Overall Study|Improvement|105|||
19405195|NCT01650259|41650275|FG001|Overall Study|Improvement|0|||
19405196|NCT01650259|41650274|FG000|Overall Study|Adverse Event|127|||
19405197|NCT01650259|41650275|FG001|Overall Study|Adverse Event|0|||
19405198|NCT01650259|41650274|FG000|Overall Study|Lack of Efficacy|143|||
19405199|NCT01650259|41650275|FG001|Overall Study|Lack of Efficacy|0|||
19405200|NCT01650259|41650274|FG000|Overall Study|Lost to Follow-up|435|||
19405201|NCT01650259|41650275|FG001|Overall Study|Lost to Follow-up|0|||
19405202|NCT01650259|41650274|FG000|Overall Study|Patients had no visit after entry|70|||
19405203|NCT01650259|41650275|FG001|Overall Study|Patients had no visit after entry|0|||
19405204|NCT01650259|41650274|FG000|Overall Study|CRF not collected|98|||
19405205|NCT01650259|41650275|FG001|Overall Study|CRF not collected|82|||
19405206|NCT01650259|41650274|FG000|Overall Study|Not treated|1|||
19405207|NCT01650259|41650275|FG001|Overall Study|Not treated|7|||
19405208|NCT01650259|41650274|FG000|Overall Study|Other than listed|64|||
19405209|NCT01650259|41650275|FG001|Overall Study|Other than listed|146|||
19405210|NCT02434939|41650281|FG000|Overall Study|Lack of Efficacy|34|||
19405211|NCT02434939|41650282|FG001|Overall Study|Lack of Efficacy|48|||
19405212|NCT02434939|41650281|FG000|Overall Study|Withdrawal by Subject|3|||
19405213|NCT02434939|41650282|FG001|Overall Study|Withdrawal by Subject|0|||
19405214|NCT02434939|41650281|FG000|Overall Study|Adverse Event|0|||
19405215|NCT02434939|41650282|FG001|Overall Study|Adverse Event|1|||
19405216|NCT02434471|41650289|FG000|Overall Study|Physician Decision|9|||
19405217|NCT02457637|41650294|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
19405218|NCT02457325|41650301|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
19405219|NCT02457325|41650302|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
19405220|NCT02434081|41650308|FG000|Overall Study|Death (never started treatment)|2|||
19405221|NCT02434081|41650308|FG000|Overall Study|Death|2|||
19405222|NCT02434081|41650308|FG000|Overall Study|Progression|20|||
19405223|NCT02434081|41650308|FG000|Overall Study|Adverse Event|20|||
19405224|NCT02434081|41650308|FG000|Overall Study|Physician Decision|2|||
19405225|NCT02434081|41650308|FG000|Overall Study|Withdrawal by Subject|1|||
19405226|NCT02434081|41650308|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
19405227|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
19405228|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
19405229|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
19405230|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
19405231|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
19405232|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
19405233|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
19405234|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
19405235|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
19405236|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
19405237|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
19405238|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
19405239|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
19405240|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
19405241|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
19405242|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
19405243|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
19405244|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
19405245|NCT02222493|41650314|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
19405246|NCT02222493|41650315|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
19405247|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
19405248|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
19405249|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
19405250|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
19405251|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
19405252|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
19405253|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
19405254|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
19405255|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
19405256|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
19405257|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
19405258|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
19405259|NCT02222493|41650314|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
19405260|NCT02222493|41650315|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
19405261|NCT02222493|41650314|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
19405262|NCT02222493|41650315|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
19405263|NCT02222493|41650314|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
19405264|NCT02222493|41650315|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
19405265|NCT02222493|41650314|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
19405266|NCT02222493|41650315|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
19405267|NCT02222493|41650314|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
19405268|NCT02222493|41650315|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
19405269|NCT02222493|41650314|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
19405270|NCT02222493|41650315|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
19405271|NCT02433379|41650334|FG000|Overall Study|Screen Failures|55|||
19405272|NCT02433379|41650334|FG000|Overall Study|Death|57|||
19405273|NCT02433379|41650334|FG000|Overall Study|Total Withdrawals|209|||
19405274|NCT02199795|41650342|FG000|Overall Study|no longer met inclusion criteria|1|||
19405275|NCT02199795|41650343|FG001|Overall Study|no longer met inclusion criteria|0|||
19405276|NCT02199795|41650342|FG000|Overall Study|withdrew due to shoulder pain|1|||
19405277|NCT02199795|41650343|FG001|Overall Study|withdrew due to shoulder pain|0|||
19405278|NCT02403817|41650351|FG000|Overall Study|Withdrawal by Subject|5|||
19405279|NCT02403817|41650352|FG001|Overall Study|Withdrawal by Subject|0|||
19405280|NCT02403271|41650358|FG000|Period 1|Other varied reasons|1|||
19405281|NCT02403271|41650359|FG001|Period 1|Other varied reasons|0|||
19405282|NCT02403271|41650358|FG000|Period 2|Withdrawal by Subject|0|||
19405283|NCT02403271|41650359|FG001|Period 2|Withdrawal by Subject|14|||
19405284|NCT02403271|41650358|FG000|Period 2|Death|0|||
19405285|NCT02403271|41650359|FG001|Period 2|Death|84|||
19405286|NCT02403271|41650358|FG000|Period 2|Lost to Follow-up|0|||
19405287|NCT02403271|41650359|FG001|Period 2|Lost to Follow-up|2|||
19405288|NCT02403271|41650358|FG000|Period 2|Study Terminated by Sponsor|0|||
19405289|NCT02403271|41650359|FG001|Period 2|Study Terminated by Sponsor|14|||
19405290|NCT02403271|41650358|FG000|Period 2|Other varied reasons|0|||
19405291|NCT02403271|41650359|FG001|Period 2|Other varied reasons|10|||
19405292|NCT02219685|41650367|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
19405293|NCT02219685|41650368|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
19405294|NCT02219685|41650367|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
19405295|NCT02219685|41650368|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
19405296|NCT02457247|41650380|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
19405297|NCT02457247|41650381|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
19405298|NCT02457247|41650382|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
19405299|NCT02457247|41650383|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
19405300|NCT02457247|41650380|FG000|Period 1|Significant Protocol Deviation|1|||
19405301|NCT02457247|41650381|FG001|Period 1|Significant Protocol Deviation|1|||
19405302|NCT02457247|41650382|FG002|Period 1|Significant Protocol Deviation|0|||
19405303|NCT02457247|41650383|FG003|Period 1|Significant Protocol Deviation|0|||
19405304|NCT02457247|41650380|FG000|Period 1|Voluntary Withdrawal|1|||
19405305|NCT02457247|41650381|FG001|Period 1|Voluntary Withdrawal|0|||
19405306|NCT02457247|41650382|FG002|Period 1|Voluntary Withdrawal|0|||
19405307|NCT02457247|41650383|FG003|Period 1|Voluntary Withdrawal|0|||
19405308|NCT02457247|41650380|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
19405309|NCT02457247|41650381|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
19405310|NCT02457247|41650382|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
19405311|NCT02457247|41650383|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
19405312|NCT02457247|41650380|FG000|Period 2|Significant Protocol Deviation|1|||
19405313|NCT02457247|41650381|FG001|Period 2|Significant Protocol Deviation|0|||
19405314|NCT02457247|41650382|FG002|Period 2|Significant Protocol Deviation|0|||
19405315|NCT02457247|41650383|FG003|Period 2|Significant Protocol Deviation|0|||
19405316|NCT02457247|41650380|FG000|Period 2|Lost to Follow-up|0|||
19405317|NCT02457247|41650381|FG001|Period 2|Lost to Follow-up|1|||
19405318|NCT02457247|41650382|FG002|Period 2|Lost to Follow-up|0|||
19405319|NCT02457247|41650383|FG003|Period 2|Lost to Follow-up|0|||
19405320|NCT02457247|41650380|FG000|Period 2|Voluntary Withdrawal|1|||
19405321|NCT02457247|41650381|FG001|Period 2|Voluntary Withdrawal|1|||
19405322|NCT02457247|41650382|FG002|Period 2|Voluntary Withdrawal|0|||
19405323|NCT02457247|41650383|FG003|Period 2|Voluntary Withdrawal|0|||
19405324|NCT02401867|41650399|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
19405325|NCT02401867|41650399|FG000|Analysis|Cervical assay could not be conducted|9|||
19405326|NCT02198235|41650407|FG000|Overall Study|Lost to Follow-up|3|||
19405327|NCT02198235|41650408|FG001|Overall Study|Lost to Follow-up|2|||
19405328|NCT02198235|41650409|FG002|Overall Study|Lost to Follow-up|2|||
19405329|NCT02253147|41650417|FG000|Overall Study|Protocol Violation|30|||
19405330|NCT02253147|41650417|FG000|Overall Study|Did not consent to study extension|9|||
19405331|NCT02253147|41650417|FG000|Overall Study|Conditional re-treatment at W52|5|||
19405332|NCT02253147|41650417|FG000|Overall Study|Lost to Follow-up|2|||
19405333|NCT02253147|41650417|FG000|Overall Study|Withdrawal by Subject|1|||
19405334|NCT02217501|41650425|FG000|Overall Study|Death|3|||
19405335|NCT02217501|41650426|FG001|Overall Study|Death|4|||
19405336|NCT01649869|41650434|FG000|Overall Study|Family member illness|1|||
19405337|NCT01649869|41650435|FG001|Overall Study|Family member illness|0|||
19405338|NCT01649869|41650434|FG000|Overall Study|Required treatment outside protocol|1|||
19405339|NCT01649869|41650435|FG001|Overall Study|Required treatment outside protocol|0|||
19405340|NCT01649869|41650434|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
19405341|NCT01649869|41650435|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
19405342|NCT02197377|41650445|FG000|Overall Study|Insertion Failure|0|||
19405343|NCT02197377|41650446|FG001|Overall Study|Insertion Failure|3|||
19405344|NCT02400307|41650454|FG000|Overall Study|Enrolled and Never Dosed|1|||
19405345|NCT02400307|41650455|FG001|Overall Study|Enrolled and Never Dosed|0|||
19405346|NCT02196675|41650464|FG000|Overall Study|Withdrawal by Subject|1|||
19405347|NCT02196675|41650465|FG001|Overall Study|Withdrawal by Subject|0|||
19405348|NCT02196675|41650466|FG002|Overall Study|Withdrawal by Subject|0|||
19405349|NCT02196675|41650464|FG000|Overall Study|Intra-operative surgical exclusion|1|||
19405350|NCT02196675|41650465|FG001|Overall Study|Intra-operative surgical exclusion|1|||
19405351|NCT02196675|41650466|FG002|Overall Study|Intra-operative surgical exclusion|0|||
19405352|NCT02196675|41650464|FG000|Overall Study|Protocol Violation|0|||
19405353|NCT02196675|41650465|FG001|Overall Study|Protocol Violation|1|||
19405354|NCT02196675|41650466|FG002|Overall Study|Protocol Violation|0|||
19405355|NCT02196675|41650464|FG000|Overall Study|Death|0|||
19405356|NCT02196675|41650465|FG001|Overall Study|Death|0|||
19405357|NCT02196675|41650466|FG002|Overall Study|Death|1|||
19405358|NCT02399449|41650476|FG000|Overall Study|Withdrawal by Subject|3|||
19405359|NCT02399449|41650477|FG001|Overall Study|Withdrawal by Subject|9|||
19405360|NCT02399449|41650476|FG000|Overall Study|Physician Decision|0|||
19405361|NCT02399449|41650477|FG001|Overall Study|Physician Decision|1|||
19405362|NCT02217345|41650485|FG000|Overall Study|Lost to Follow-up|2|||
19405363|NCT02217345|41650486|FG001|Overall Study|Lost to Follow-up|1|||
19405364|NCT02217345|41650485|FG000|Overall Study|Withdrawal by Subject|3|||
19405365|NCT02217345|41650486|FG001|Overall Study|Withdrawal by Subject|2|||
19405366|NCT02217345|41650485|FG000|Overall Study|Adverse Event|2|||
19405367|NCT02217345|41650486|FG001|Overall Study|Adverse Event|1|||
19405368|NCT02217345|41650485|FG000|Overall Study|Physician Decision|0|||
19405369|NCT02217345|41650486|FG001|Overall Study|Physician Decision|1|||
19405370|NCT01652287|41650494|FG000|Overall Study|Withdrawal by Subject|2|||
19405371|NCT01652287|41650495|FG001|Overall Study|Withdrawal by Subject|0|||
19405372|NCT02251743|41650503|FG000|Overall Study|Withdrawal by Subject|1|||
19405373|NCT02251743|41650504|FG001|Overall Study|Withdrawal by Subject|1|||
19405374|NCT02453191|41650510|FG000|Overall Study|Withdrawal by Subject|1|||
19405375|NCT02428855|41650514|FG000|Overall Study|Withdrawal by Subject|2|||
19405376|NCT02428699|41650518|FG000|Washout Period 1|Screen Failure|1|||
19405377|NCT02428699|41650519|FG001|Washout Period 1|Screen Failure|2|||
19405378|NCT02428231|41650532|FG000|Overall Study|Other|10|||
19405379|NCT02428231|41650533|FG001|Overall Study|Other|16|||
19405380|NCT02428231|41650532|FG000|Overall Study|Required Symptomatic Therapy|0|||
19405381|NCT02428231|41650533|FG001|Overall Study|Required Symptomatic Therapy|1|||
19405382|NCT02428231|41650532|FG000|Overall Study|Adverse Event|3|||
19405383|NCT02428231|41650533|FG001|Overall Study|Adverse Event|0|||
19405384|NCT02427841|41650539|FG000|Overall Study|Physician Decision|8|||
19405385|NCT02397889|41650545|FG000|Overall Study|Physician Decision|1|||
19405386|NCT02397889|41650546|FG001|Overall Study|Physician Decision|0|||
19405387|NCT02397655|41650552|FG000|Overall Study|data not completed|1301|||
19405388|NCT02396953|41650559|FG000|Overall Study|Withdrawal by Subject|0|||
19405389|NCT02396953|41650560|FG001|Overall Study|Withdrawal by Subject|0|||
19405390|NCT02396953|41650561|FG002|Overall Study|Withdrawal by Subject|1|||
19405391|NCT02396953|41650559|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
19405392|NCT02396953|41650560|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
19405393|NCT02396953|41650561|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
19405394|NCT02396953|41650559|FG000|Overall Study|Personal Reasons|1|||
19405395|NCT02396953|41650560|FG001|Overall Study|Personal Reasons|1|||
19405396|NCT02396953|41650561|FG002|Overall Study|Personal Reasons|0|||
19405397|NCT02387983|41650576|FG000|Overall Study|Adverse Event|4|||
19405398|NCT02387983|41650576|FG000|Overall Study|Protocol Violation|1|||
19405399|NCT02387983|41650576|FG000|Overall Study|Withdrawal by Subject|2|||
19405400|NCT02395627|41650583|FG000|Overall Study|Withdrawal by Subject|0|||
19405401|NCT02395627|41650584|FG001|Overall Study|Withdrawal by Subject|2|||
19405402|NCT02395627|41650585|FG002|Overall Study|Withdrawal by Subject|0|||
19405403|NCT02395627|41650583|FG000|Overall Study|Did not receive pembrolizumab|3|||
19405404|NCT02395627|41650584|FG001|Overall Study|Did not receive pembrolizumab|1|||
19405405|NCT02395627|41650585|FG002|Overall Study|Did not receive pembrolizumab|0|||
19405406|NCT02395471|41650597|FG000|Overall Study|Lost to Follow-up|2|||
19405407|NCT02395471|41650598|FG001|Overall Study|Lost to Follow-up|0|||
19405408|NCT02395471|41650597|FG000|Overall Study|Withdrawal by Subject|2|||
19405409|NCT02395471|41650598|FG001|Overall Study|Withdrawal by Subject|1|||
19405410|NCT02395471|41650597|FG000|Overall Study|Physician Decision|1|||
19405411|NCT02395471|41650598|FG001|Overall Study|Physician Decision|0|||
19405412|NCT02395471|41650597|FG000|Overall Study|Protocol Violation|0|||
19405413|NCT02395471|41650598|FG001|Overall Study|Protocol Violation|1|||
19405414|NCT02395471|41650597|FG000|Overall Study|Failure to swollow sponge twice|1|||
19405415|NCT02395471|41650598|FG001|Overall Study|Failure to swollow sponge twice|0|||
19405416|NCT02395471|41650597|FG000|Overall Study|Patient did not return for procedure|0|||
19405417|NCT02395471|41650598|FG001|Overall Study|Patient did not return for procedure|1|||
19405418|NCT02395471|41650597|FG000|Overall Study|Subject not eligible|1|||
19405419|NCT02395471|41650598|FG001|Overall Study|Subject not eligible|0|||
19405420|NCT02395081|41650616|FG000|Overall Study|Withdrawal by Subject|1|||
19405421|NCT02395081|41650617|FG001|Overall Study|Withdrawal by Subject|1|||
19405422|NCT02395081|41650618|FG002|Overall Study|Withdrawal by Subject|0|||
19405423|NCT02395081|41650616|FG000|Overall Study|Moved where blood couldn't be collected|4|||
19405424|NCT02395081|41650617|FG001|Overall Study|Moved where blood couldn't be collected|1|||
19405425|NCT02395081|41650618|FG002|Overall Study|Moved where blood couldn't be collected|3|||
19405426|NCT02395081|41650616|FG000|Overall Study|Fetal Loss|2|||
19405427|NCT02395081|41650617|FG001|Overall Study|Fetal Loss|3|||
19405428|NCT02395081|41650618|FG002|Overall Study|Fetal Loss|1|||
19405429|NCT02394925|41650629|FG000|Overall Study|Adverse Event|1|||
19405430|NCT02394925|41650629|FG000|Overall Study|Lens Discomfort|3|||
19405431|NCT02394925|41650629|FG000|Overall Study|Lens handling difficulities|5|||
19405432|NCT02394925|41650629|FG000|Overall Study|Lost to Follow-up|9|||
19405433|NCT02394925|41650629|FG000|Overall Study|Protocol Violation|5|||
19405434|NCT02394925|41650629|FG000|Overall Study|No longer meet eligibility criteria|1|||
19405435|NCT02394925|41650629|FG000|Overall Study|Unsatisfactory Visual Response|5|||
19405436|NCT02427607|41650633|FG000|Overall Study|Withdrawal by Subject|1|||
19405437|NCT02426125|41650639|FG000|Overall Study|Lost to Follow-up|12|||
19405438|NCT02426125|41650640|FG001|Overall Study|Lost to Follow-up|10|||
19405439|NCT02426125|41650639|FG000|Overall Study|Protocol Violation|1|||
19405440|NCT02426125|41650640|FG001|Overall Study|Protocol Violation|0|||
19405441|NCT02426125|41650639|FG000|Overall Study|Withdrawal by Subject|16|||
19405442|NCT02426125|41650640|FG001|Overall Study|Withdrawal by Subject|16|||
19405443|NCT02425111|41650648|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
19405444|NCT02425111|41650648|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
19405445|NCT02425111|41650648|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
19405446|NCT02425111|41650648|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
19405447|NCT02425111|41650648|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
19405448|NCT02425111|41650648|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
19405449|NCT02424565|41650653|FG000|Period 1 (D0)|Protocol Violation|0|||
19405450|NCT02424565|41650654|FG001|Period 1 (D0)|Protocol Violation|1|||
19405451|NCT02424253|41650662|FG000|Overall Study|Other, unspecified|1|||
19405452|NCT02424253|41650663|FG001|Overall Study|Other, unspecified|0|||
19405453|NCT02424253|41650662|FG000|Overall Study|Compliance problems|1|||
19405454|NCT02424253|41650663|FG001|Overall Study|Compliance problems|0|||
19405455|NCT02424253|41650662|FG000|Overall Study|Physician Decision|2|||
19405456|NCT02424253|41650663|FG001|Overall Study|Physician Decision|0|||
19405457|NCT02424253|41650662|FG000|Overall Study|Lack of Efficacy|0|||
19405458|NCT02424253|41650663|FG001|Overall Study|Lack of Efficacy|7|||
19405459|NCT02424253|41650662|FG000|Overall Study|Adverse Event|2|||
19405460|NCT02424253|41650663|FG001|Overall Study|Adverse Event|0|||
19405461|NCT02424253|41650662|FG000|Overall Study|Consent withdrawn by subject|4|||
19405462|NCT02424253|41650663|FG001|Overall Study|Consent withdrawn by subject|1|||
19405463|NCT02424253|41650662|FG000|Overall Study|Lost to Follow-up|1|||
19405464|NCT02424253|41650663|FG001|Overall Study|Lost to Follow-up|1|||
19405465|NCT02393755|41650671|FG000|Overall Study|Withdrawal by Subject|0|||
19405466|NCT02393755|41650672|FG001|Overall Study|Withdrawal by Subject|3|||
19405467|NCT02393755|41650671|FG000|Overall Study|Adverse Event|0|||
19405468|NCT02393755|41650672|FG001|Overall Study|Adverse Event|2|||
19405469|NCT02393755|41650671|FG000|Overall Study|Physician Decision|0|||
19405470|NCT02393755|41650672|FG001|Overall Study|Physician Decision|2|||
19405471|NCT02393209|41650679|FG000|Overall Study|Study Terminated by Sponsor|1|||
19405472|NCT02393209|41650680|FG001|Overall Study|Study Terminated by Sponsor|1|||
19405473|NCT02393209|41650681|FG002|Overall Study|Study Terminated by Sponsor|0|||
19405474|NCT02393209|41650682|FG003|Overall Study|Study Terminated by Sponsor|0|||
19405475|NCT02393209|41650679|FG000|Overall Study|Withdrawal by Patient|1|||
19405476|NCT02393209|41650680|FG001|Overall Study|Withdrawal by Patient|0|||
19405477|NCT02393209|41650681|FG002|Overall Study|Withdrawal by Patient|0|||
19405478|NCT02393209|41650682|FG003|Overall Study|Withdrawal by Patient|0|||
19405479|NCT02393209|41650679|FG000|Overall Study|Death|2|||
19405480|NCT02393209|41650680|FG001|Overall Study|Death|2|||
19405481|NCT02393209|41650681|FG002|Overall Study|Death|0|||
19405482|NCT02393209|41650682|FG003|Overall Study|Death|0|||
19405483|NCT02393209|41650679|FG000|Overall Study|Death due to Disease Progression|2|||
19405484|NCT02393209|41650680|FG001|Overall Study|Death due to Disease Progression|2|||
19405485|NCT02393209|41650681|FG002|Overall Study|Death due to Disease Progression|0|||
19405486|NCT02393209|41650682|FG003|Overall Study|Death due to Disease Progression|0|||
19405487|NCT02393209|41650679|FG000|Overall Study|Death from Legionella Infection|0|||
19405488|NCT02393209|41650680|FG001|Overall Study|Death from Legionella Infection|1|||
19405489|NCT02393209|41650681|FG002|Overall Study|Death from Legionella Infection|0|||
19405490|NCT02393209|41650682|FG003|Overall Study|Death from Legionella Infection|0|||
19405491|NCT02393209|41650679|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
19405492|NCT02393209|41650680|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
19405493|NCT02393209|41650681|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
19405494|NCT02393209|41650682|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
19405495|NCT02393209|41650679|FG000|Overall Study|Lost to Follow-up|0|||
19405496|NCT02393209|41650680|FG001|Overall Study|Lost to Follow-up|1|||
19405497|NCT02393209|41650681|FG002|Overall Study|Lost to Follow-up|0|||
19405498|NCT02393209|41650682|FG003|Overall Study|Lost to Follow-up|0|||
19405499|NCT02424097|41650693|FG000|Overall Study|Lost to Follow-up|1|||
19405500|NCT02424097|41650694|FG001|Overall Study|Lost to Follow-up|2|||
19405501|NCT02392507|41650700|FG000|Induction Regimen|Death|3|||
19405502|NCT02392507|41650700|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
19405503|NCT02392507|41650700|FG000|Induction Regimen|Physician Decision|1|||
19405504|NCT02392507|41650700|FG000|Induction Regimen|Withdrawal by Subject|2|||
19405505|NCT02392507|41650700|FG000|Maintenance Regimen|Death|1|||
19405506|NCT02392507|41650700|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
19405507|NCT02386345|41650709|FG000|Overall Study|Not treated|14|||
19405508|NCT02386345|41650709|FG000|Overall Study|Lost to Follow-up|1|||
19405509|NCT02386345|41650709|FG000|Overall Study|Adverse Event|5|||
19405510|NCT02386345|41650709|FG000|Overall Study|Repeat Procedure|10|||
19405511|NCT02386345|41650709|FG000|Overall Study|Did not complete 12-month follow-up|72|||
19405512|NCT01651117|41650717|FG000|Overall Study|Death|2|||
19405513|NCT01651117|41650718|FG001|Overall Study|Death|3|||
19405514|NCT01651117|41650719|FG002|Overall Study|Death|2|||
19405515|NCT01651117|41650720|FG003|Overall Study|Death|2|||
19405516|NCT02386189|41650735|FG000|Overall Study|Lost to Follow-up|2|||
19405517|NCT02386189|41650736|FG001|Overall Study|Lost to Follow-up|3|||
19405518|NCT02386189|41650735|FG000|Overall Study|Withdrawal by Subject|1|||
19405519|NCT02386189|41650736|FG001|Overall Study|Withdrawal by Subject|0|||
19405520|NCT02386189|41650735|FG000|Overall Study|Death|1|||
19405521|NCT02386189|41650736|FG001|Overall Study|Death|0|||
19405522|NCT02385799|41650744|FG000|Overall Study|Lost to Follow-up|1|||
19405523|NCT02385799|41650745|FG001|Overall Study|Lost to Follow-up|2|||
19405524|NCT02385799|41650744|FG000|Overall Study|Adverse Event|4|||
19405525|NCT02385799|41650745|FG001|Overall Study|Adverse Event|2|||
19405526|NCT02385799|41650744|FG000|Overall Study|Withdrawal by Subject|0|||
19405527|NCT02385799|41650745|FG001|Overall Study|Withdrawal by Subject|4|||
19405528|NCT02422303|41650753|FG000|Overall Study|Lost to Follow-up|1|||
19405529|NCT02422303|41650754|FG001|Overall Study|Lost to Follow-up|1|||
19405530|NCT02392195|41650760|FG000|Overall Study|Lost to Follow-up|4|||
19405531|NCT02392195|41650760|FG000|Overall Study|Withdrawal by Subject|4|||
19405532|NCT02391961|41650766|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
19405533|NCT02391961|41650767|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
19405534|NCT02391961|41650766|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
19405535|NCT02391961|41650767|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
19405536|NCT02391961|41650766|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19405537|NCT02391961|41650767|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19405538|NCT02384941|41650776|FG000|Overall Study|Adverse Event|11|||
19405539|NCT02384941|41650777|FG001|Overall Study|Adverse Event|13|||
19405540|NCT02384941|41650778|FG002|Overall Study|Adverse Event|17|||
19405541|NCT02384941|41650776|FG000|Overall Study|Lost to Follow-up|3|||
19405542|NCT02384941|41650777|FG001|Overall Study|Lost to Follow-up|2|||
19405543|NCT02384941|41650778|FG002|Overall Study|Lost to Follow-up|1|||
19405544|NCT02384941|41650776|FG000|Overall Study|Non-Compliance With Study Drug|2|||
19405545|NCT02384941|41650777|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19405546|NCT02384941|41650778|FG002|Overall Study|Non-Compliance With Study Drug|1|||
19405547|NCT02384941|41650776|FG000|Overall Study|Physician Decision|1|||
19405548|NCT02384941|41650777|FG001|Overall Study|Physician Decision|1|||
19405549|NCT02384941|41650778|FG002|Overall Study|Physician Decision|0|||
19405550|NCT02384941|41650776|FG000|Overall Study|Protocol Violation|3|||
19405551|NCT02384941|41650777|FG001|Overall Study|Protocol Violation|0|||
19405552|NCT02384941|41650778|FG002|Overall Study|Protocol Violation|0|||
19405553|NCT02384941|41650776|FG000|Overall Study|Withdrawal by Subject|26|||
19405554|NCT02384941|41650777|FG001|Overall Study|Withdrawal by Subject|19|||
19405555|NCT02384941|41650778|FG002|Overall Study|Withdrawal by Subject|20|||
19405556|NCT02384941|41650776|FG000|Overall Study|Pregnancy|0|||
19405557|NCT02384941|41650777|FG001|Overall Study|Pregnancy|0|||
19405558|NCT02384941|41650778|FG002|Overall Study|Pregnancy|1|||
19405559|NCT02384941|41650776|FG000|Overall Study|Other than specified above|4|||
19405560|NCT02384941|41650777|FG001|Overall Study|Other than specified above|0|||
19405561|NCT02384941|41650778|FG002|Overall Study|Other than specified above|1|||
19405562|NCT02384395|41650787|FG000|Overall Study|Physician Decision|4|||
19405563|NCT02384395|41650787|FG000|Overall Study|Withdrawal by Subject|3|||
19405564|NCT02384395|41650787|FG000|Overall Study|Lost to Follow-up|3|||
19405565|NCT02420353|41650793|FG000|Overall Study|Withdrawal by Subject|0|||
19405566|NCT02420353|41650794|FG001|Overall Study|Withdrawal by Subject|1|||
19405567|NCT02391337|41650802|FG000|6 Months Follow-up|Death|5|||
19405568|NCT02391337|41650803|FG001|6 Months Follow-up|Death|4|||
19405569|NCT02391337|41650802|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
19405570|NCT02391337|41650803|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
19405571|NCT02391337|41650802|FG000|12 Months Follow-up|Death|2|||
19405572|NCT02391337|41650803|FG001|12 Months Follow-up|Death|0|||
19405573|NCT02391337|41650802|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
19405574|NCT02391337|41650803|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
19405575|NCT02391337|41650802|FG000|12 Months Follow-up|Lost to Follow-up|0|||
19405576|NCT02391337|41650803|FG001|12 Months Follow-up|Lost to Follow-up|2|||
19405577|NCT02382991|41650811|FG000|Overall Study|Adverse Event|1|||
19405578|NCT02382991|41650812|FG001|Overall Study|Adverse Event|2|||
19405579|NCT02382991|41650811|FG000|Overall Study|Lost to Follow-up|1|||
19405580|NCT02382991|41650812|FG001|Overall Study|Lost to Follow-up|0|||
19405581|NCT02382991|41650811|FG000|Overall Study|Withdrawal by Subject|0|||
19405582|NCT02382991|41650812|FG001|Overall Study|Withdrawal by Subject|1|||
19405583|NCT02390557|41650820|FG000|Wave 2|Survey non-respondent|72|||
19405584|NCT02390557|41650821|FG001|Wave 2|Survey non-respondent|41|||
19405585|NCT02390557|41650822|FG002|Wave 2|Survey non-respondent|23|||
19405586|NCT01649791|41650830|FG000|Overall Study|Disease Progression|2|||
19405587|NCT01649791|41650830|FG000|Overall Study|Adverse Event|1|||
19405588|NCT01649557|41650837|FG000|Overall Study|Lost to Follow-up|5|||
19405589|NCT01649557|41650838|FG001|Overall Study|Lost to Follow-up|0|||
19405590|NCT01649557|41650839|FG002|Overall Study|Lost to Follow-up|3|||
19405591|NCT01649557|41650837|FG000|Overall Study|Adverse Event|7|||
19405592|NCT01649557|41650838|FG001|Overall Study|Adverse Event|5|||
19405593|NCT01649557|41650839|FG002|Overall Study|Adverse Event|1|||
19405594|NCT01649557|41650837|FG000|Overall Study|Met withdrawal criteria|4|||
19405595|NCT01649557|41650838|FG001|Overall Study|Met withdrawal criteria|0|||
19405596|NCT01649557|41650839|FG002|Overall Study|Met withdrawal criteria|0|||
19405597|NCT01649557|41650837|FG000|Overall Study|Physician Decision|8|||
19405598|NCT01649557|41650838|FG001|Overall Study|Physician Decision|2|||
19405599|NCT01649557|41650839|FG002|Overall Study|Physician Decision|1|||
19405600|NCT01649557|41650837|FG000|Overall Study|Withdrawal by Subject|15|||
19405601|NCT01649557|41650838|FG001|Overall Study|Withdrawal by Subject|5|||
19405602|NCT01649557|41650839|FG002|Overall Study|Withdrawal by Subject|4|||
19405603|NCT01649557|41650837|FG000|Overall Study|Protocol deviation|0|||
19405604|NCT01649557|41650838|FG001|Overall Study|Protocol deviation|2|||
19405605|NCT01649557|41650839|FG002|Overall Study|Protocol deviation|0|||
19405606|NCT01649557|41650837|FG000|Overall Study|Lack of Efficacy|5|||
19405607|NCT01649557|41650838|FG001|Overall Study|Lack of Efficacy|0|||
19405608|NCT01649557|41650839|FG002|Overall Study|Lack of Efficacy|0|||
19405609|NCT02390245|41650847|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
19405610|NCT02390245|41650848|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
19405611|NCT02390245|41650849|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
19405612|NCT02390245|41650847|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
19405613|NCT02390245|41650848|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
19405614|NCT02390245|41650849|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
19405615|NCT02390167|41650858|FG000|Overall Study|Lost to Follow-up|1|||
19405616|NCT02347657|41650868|FG000|Overall Study|Physician Decision|0|||
19405617|NCT02347657|41650869|FG001|Overall Study|Physician Decision|1|||
19405618|NCT02347657|41650868|FG000|Overall Study|Adverse Event|8|||
19405619|NCT02347657|41650869|FG001|Overall Study|Adverse Event|4|||
19405620|NCT02347657|41650868|FG000|Overall Study|Withdrawal by Subject|6|||
19405621|NCT02347657|41650869|FG001|Overall Study|Withdrawal by Subject|7|||
19405622|NCT02347657|41650868|FG000|Overall Study|Randomized but not treated|1|||
19405623|NCT02347657|41650869|FG001|Overall Study|Randomized but not treated|0|||
19405624|NCT02347657|41650868|FG000|Overall Study|Other|3|||
19405625|NCT02347657|41650869|FG001|Overall Study|Other|3|||
19405626|NCT02347189|41650876|FG000|Overall Study|No implant attempted of study device|9|||
19405627|NCT02347189|41650876|FG000|Overall Study|No primary outcome data available|2|||
19405628|NCT02382133|41650891|FG000|Overall Study|Death|22|||
19405629|NCT02382133|41650891|FG000|Overall Study|transfer out of ICU|4|||
19405630|NCT02382133|41650891|FG000|Overall Study|Physician Decision|2|||
19405631|NCT02382133|41650891|FG000|Overall Study|arterial catheter loss|4|||
19405632|NCT02382133|41650891|FG000|Overall Study|pressure injury both sites|1|||
19405633|NCT02346877|41650897|FG000|Overall Study|Adverse Event|1|||
19405634|NCT02346877|41650898|FG001|Overall Study|Adverse Event|0|||
19405635|NCT02346877|41650897|FG000|Overall Study|Administrative Decision|1|||
19405636|NCT02346877|41650898|FG001|Overall Study|Administrative Decision|0|||
19405637|NCT02346877|41650897|FG000|Overall Study|Sponsor Decision|12|||
19405638|NCT02346877|41650898|FG001|Overall Study|Sponsor Decision|0|||
19405639|NCT02346877|41650897|FG000|Overall Study|Missing|5|||
19405640|NCT02346877|41650898|FG001|Overall Study|Missing|0|||
19405641|NCT02346721|41650904|FG000|Overall Study|Withdrew Consent|3|||
19405642|NCT02346721|41650904|FG000|Overall Study|Lack of Efficacy|1|||
19405643|NCT02389621|41650912|FG000|Treatment Period|Withdrawal by Subject|1|||
19405644|NCT02389621|41650913|FG001|Treatment Period|Withdrawal by Subject|1|||
19405645|NCT02389621|41650912|FG000|Posttreatment Period|Adverse Event|3|||
19518779|NCT01460628|41931813|FG000|Overall Study|Withdrawal by Subject|2|||
19518780|NCT01480596|41931819|FG000|Overall Study|Adverse Event|3|||
19628017|NCT00795717|42077428|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
19628018|NCT00795717|42077427|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
19628019|NCT00795717|42077428|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
19405646|NCT02389621|41650913|FG001|Posttreatment Period|Adverse Event|1|||
19405647|NCT02389621|41650912|FG000|Posttreatment Period|Withdrawal by Subject|3|||
19405648|NCT02389621|41650913|FG001|Posttreatment Period|Withdrawal by Subject|2|||
19405649|NCT02389621|41650912|FG000|Posttreatment Period|Lost to Follow-up|1|||
19628020|NCT00795717|42077427|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
19405650|NCT02389621|41650913|FG001|Posttreatment Period|Lost to Follow-up|1|||
19405651|NCT02389621|41650912|FG000|Posttreatment Period|Other - Miscellaneous|2|||
19405652|NCT02389621|41650913|FG001|Posttreatment Period|Other - Miscellaneous|0|||
19405653|NCT02388997|41650925|FG000|Overall Study|Adverse Event|1|||
19405654|NCT02388997|41650926|FG001|Overall Study|Adverse Event|2|||
19405655|NCT02388997|41650925|FG000|Overall Study|Withdrawal by Subject|2|||
19405656|NCT02388997|41650926|FG001|Overall Study|Withdrawal by Subject|1|||
19405657|NCT02388997|41650925|FG000|Overall Study|Lung function exclusion criteria|0|||
19405658|NCT02388997|41650926|FG001|Overall Study|Lung function exclusion criteria|2|||
19405659|NCT02388997|41650925|FG000|Overall Study|Tested positive for virus during run-in|0|||
19518781|NCT01480596|41931820|FG001|Overall Study|Adverse Event|0|||
19405660|NCT02388997|41650926|FG001|Overall Study|Tested positive for virus during run-in|1|||
19405661|NCT02388763|41650932|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
19405662|NCT02388763|41650933|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
19405663|NCT02388763|41650932|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
19405664|NCT02388763|41650933|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
19405665|NCT02388295|41650945|FG000|Dose Escalation Week 1|Adverse Event|1|||
19405666|NCT02388295|41650946|FG001|Dose Escalation Week 1|Adverse Event|2|||
19405667|NCT02388295|41650947|FG002|Dose Escalation Week 1|Adverse Event|1|||
19405668|NCT02388295|41650945|FG000|Dose Escalation Week 1|Determined not eligible|1|||
19405669|NCT02388295|41650946|FG001|Dose Escalation Week 1|Determined not eligible|1|||
19405670|NCT02388295|41650947|FG002|Dose Escalation Week 1|Determined not eligible|1|||
19405671|NCT02388295|41650945|FG000|Dose Escalation Week 2|Protocol Violation|0|||
19405672|NCT02388295|41650946|FG001|Dose Escalation Week 2|Protocol Violation|1|||
19405673|NCT02388295|41650947|FG002|Dose Escalation Week 2|Protocol Violation|0|||
19405674|NCT02388295|41650945|FG000|Dose Escalation Week 2|Determined not eligible|1|||
19405675|NCT02388295|41650946|FG001|Dose Escalation Week 2|Determined not eligible|1|||
19405676|NCT02388295|41650947|FG002|Dose Escalation Week 2|Determined not eligible|1|||
19405677|NCT02388295|41650945|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
19405678|NCT02388295|41650946|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
19405679|NCT02388295|41650947|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
19405680|NCT02345161|41650957|FG000|Overall Study|Withdrawal by Subject|25|||
19405681|NCT02345161|41650958|FG001|Overall Study|Withdrawal by Subject|33|||
19405682|NCT02345161|41650957|FG000|Overall Study|Adverse Event|16|||
19405683|NCT02345161|41650958|FG001|Overall Study|Adverse Event|19|||
19405684|NCT02345161|41650957|FG000|Overall Study|Physician Decision|4|||
19405685|NCT02345161|41650958|FG001|Overall Study|Physician Decision|4|||
19405686|NCT02345161|41650957|FG000|Overall Study|Lost to Follow-up|0|||
19405687|NCT02345161|41650958|FG001|Overall Study|Lost to Follow-up|1|||
19405688|NCT02251275|41650974|FG000|Overall Study|Adverse Event|23|||
19405689|NCT02251275|41650975|FG001|Overall Study|Adverse Event|60|||
19405690|NCT02251275|41650976|FG002|Overall Study|Adverse Event|28|||
19405691|NCT02251275|41650977|FG003|Overall Study|Adverse Event|0|||
19405692|NCT02251275|41650978|FG004|Overall Study|Adverse Event|0|||
19405693|NCT02251275|41650974|FG000|Overall Study|Lost to Follow-up|5|||
19405694|NCT02251275|41650975|FG001|Overall Study|Lost to Follow-up|6|||
19405695|NCT02251275|41650976|FG002|Overall Study|Lost to Follow-up|4|||
19405696|NCT02251275|41650977|FG003|Overall Study|Lost to Follow-up|0|||
19405697|NCT02251275|41650978|FG004|Overall Study|Lost to Follow-up|0|||
19405698|NCT02251275|41650974|FG000|Overall Study|Physician Decision|19|||
19405699|NCT02251275|41650975|FG001|Overall Study|Physician Decision|30|||
19405700|NCT02251275|41650976|FG002|Overall Study|Physician Decision|26|||
19405701|NCT02251275|41650977|FG003|Overall Study|Physician Decision|0|||
19405702|NCT02251275|41650978|FG004|Overall Study|Physician Decision|1|||
19405703|NCT02251275|41650974|FG000|Overall Study|Protocol Deviation|0|||
19405704|NCT02251275|41650975|FG001|Overall Study|Protocol Deviation|0|||
19405705|NCT02251275|41650976|FG002|Overall Study|Protocol Deviation|1|||
19405706|NCT02251275|41650977|FG003|Overall Study|Protocol Deviation|0|||
19405707|NCT02251275|41650978|FG004|Overall Study|Protocol Deviation|0|||
19405708|NCT02251275|41650974|FG000|Overall Study|Withdrawal by Subject|25|||
19405709|NCT02251275|41650975|FG001|Overall Study|Withdrawal by Subject|51|||
19405710|NCT02251275|41650976|FG002|Overall Study|Withdrawal by Subject|35|||
19405711|NCT02251275|41650977|FG003|Overall Study|Withdrawal by Subject|1|||
19405712|NCT02251275|41650978|FG004|Overall Study|Withdrawal by Subject|0|||
19405713|NCT02379637|41650992|FG000|Overall Study|Protocol Violation|0|||
19405714|NCT02379637|41650993|FG001|Overall Study|Protocol Violation|1|||
19405715|NCT02379637|41650992|FG000|Overall Study|Adverse Event|1|||
19405716|NCT02379637|41650993|FG001|Overall Study|Adverse Event|0|||
19405717|NCT02379637|41650992|FG000|Overall Study|Withdrawal by Subject|1|||
19405718|NCT02379637|41650993|FG001|Overall Study|Withdrawal by Subject|0|||
19405719|NCT02195583|41650999|FG000|Overall Study|Lost to Follow-up|1|||
19405720|NCT02195583|41650999|FG000|Overall Study|Withdrawal by Subject|4|||
19405721|NCT02195583|41650999|FG000|Overall Study|Adverse Event|2|||
19405722|NCT02195583|41650999|FG000|Overall Study|Other Reason|2|||
19405723|NCT02379091|41651018|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19405724|NCT02379091|41651019|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
19405725|NCT02379091|41651020|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19405726|NCT02379091|41651021|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
19405727|NCT02379091|41651018|FG000|Overall Study|Principal Investigator Discretion|0|||
19405728|NCT02379091|41651019|FG001|Overall Study|Principal Investigator Discretion|1|||
19405729|NCT02379091|41651020|FG002|Overall Study|Principal Investigator Discretion|0|||
19405730|NCT02379091|41651021|FG003|Overall Study|Principal Investigator Discretion|0|||
19405731|NCT02379091|41651018|FG000|Overall Study|Lost to Follow-up|0|||
19405732|NCT02379091|41651019|FG001|Overall Study|Lost to Follow-up|0|||
19405733|NCT02379091|41651020|FG002|Overall Study|Lost to Follow-up|0|||
19405734|NCT02379091|41651021|FG003|Overall Study|Lost to Follow-up|1|||
19518782|NCT01480596|41931819|FG000|Overall Study|MG exacerbation or change in medication|2|||
19405735|NCT02379091|41651018|FG000|Overall Study|Voluntary Withdrawal|2|||
19405736|NCT02379091|41651019|FG001|Overall Study|Voluntary Withdrawal|5|||
19405737|NCT02379091|41651020|FG002|Overall Study|Voluntary Withdrawal|2|||
19405738|NCT02379091|41651021|FG003|Overall Study|Voluntary Withdrawal|4|||
19405739|NCT02379091|41651018|FG000|Overall Study|Study Termination|7|||
19405740|NCT02379091|41651019|FG001|Overall Study|Study Termination|2|||
19405741|NCT02379091|41651020|FG002|Overall Study|Study Termination|5|||
19405742|NCT02379091|41651021|FG003|Overall Study|Study Termination|8|||
19405743|NCT02379091|41651018|FG000|Overall Study|Lack of Efficacy|3|||
19405744|NCT02379091|41651019|FG001|Overall Study|Lack of Efficacy|0|||
19405745|NCT02379091|41651020|FG002|Overall Study|Lack of Efficacy|0|||
19405746|NCT02379091|41651021|FG003|Overall Study|Lack of Efficacy|0|||
19405747|NCT02378935|41651040|FG000|Overall Study|Lack of Efficacy|10|||
19405748|NCT02378935|41651041|FG001|Overall Study|Lack of Efficacy|0|||
19405749|NCT02378935|41651042|FG002|Overall Study|Lack of Efficacy|2|||
19405750|NCT02378935|41651043|FG003|Overall Study|Lack of Efficacy|6|||
19405751|NCT02378935|41651044|FG004|Overall Study|Lack of Efficacy|0|||
19405752|NCT02378935|41651045|FG005|Overall Study|Lack of Efficacy|0|||
19405753|NCT02378935|41651046|FG006|Overall Study|Lack of Efficacy|0|||
19405754|NCT02378935|41651040|FG000|Overall Study|Death|0|||
19405755|NCT02378935|41651041|FG001|Overall Study|Death|0|||
19405756|NCT02378935|41651042|FG002|Overall Study|Death|1|||
19405757|NCT02378935|41651043|FG003|Overall Study|Death|0|||
19405758|NCT02378935|41651044|FG004|Overall Study|Death|0|||
19405759|NCT02378935|41651045|FG005|Overall Study|Death|0|||
19405760|NCT02378935|41651046|FG006|Overall Study|Death|0|||
19405761|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
19405762|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
19405763|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
19405764|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
19405765|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
19405766|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
19405767|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
19405768|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
19405769|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
19405770|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
19405771|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
19405772|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
19405773|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
19405774|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
19405775|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
19405776|NCT02250651|41651065|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
19405777|NCT02250651|41651066|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
19405778|NCT02250651|41651067|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
19405779|NCT02250651|41651065|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
19405780|NCT02250651|41651066|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
19405781|NCT02250651|41651067|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
19405782|NCT02250651|41651065|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
19405783|NCT02250651|41651066|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
19405784|NCT02250651|41651067|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
19405785|NCT02250651|41651065|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
19405786|NCT02250651|41651066|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
19405787|NCT02250651|41651067|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
19405788|NCT02250651|41651065|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
19518783|NCT01480596|41931820|FG001|Overall Study|MG exacerbation or change in medication|2|||
19405789|NCT02250651|41651066|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
19405790|NCT02250651|41651067|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
19405791|NCT02250651|41651065|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
19405792|NCT02250651|41651066|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
19405793|NCT02250651|41651067|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
19405794|NCT02250651|41651065|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
19405795|NCT02250651|41651066|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
19405796|NCT02250651|41651067|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
19405797|NCT02250651|41651065|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
19405798|NCT02250651|41651066|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
19405799|NCT02250651|41651067|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
19405800|NCT02250651|41651065|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
19405801|NCT02250651|41651066|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
19405802|NCT02250651|41651067|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
19518784|NCT01480284|41931828|FG000|Overall Study|Withdrawal by Subject|2|||
19405803|NCT02250651|41651065|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
19405804|NCT02250651|41651066|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
19405805|NCT02250651|41651067|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
19405806|NCT02377921|41651077|FG000|Overall Study|Subject non-compliance|1|||
19405807|NCT02377921|41651078|FG001|Overall Study|Subject non-compliance|1|||
19405808|NCT02311153|41651086|FG000|Overall Study|Lost to Follow-up|5|||
19405809|NCT02311153|41651087|FG001|Overall Study|Lost to Follow-up|7|||
19405810|NCT02195427|41651095|FG000|Overall Study|Did not consent to study extension|13|||
19405811|NCT02195427|41651096|FG001|Overall Study|Did not consent to study extension|9|||
19405812|NCT02195427|41651095|FG000|Overall Study|Withdrawal by Subject|4|||
19405813|NCT02195427|41651096|FG001|Overall Study|Withdrawal by Subject|2|||
19405814|NCT02195427|41651095|FG000|Overall Study|Lost to Follow-up|0|||
19405815|NCT02195427|41651096|FG001|Overall Study|Lost to Follow-up|1|||
19405816|NCT02195427|41651095|FG000|Overall Study|Protocol Violation|7|||
19405817|NCT02195427|41651096|FG001|Overall Study|Protocol Violation|14|||
19405818|NCT02195427|41651095|FG000|Overall Study|Conditional re-treatment at W52|2|||
19405819|NCT02195427|41651096|FG001|Overall Study|Conditional re-treatment at W52|1|||
19405820|NCT02214225|41651109|FG000|Overall Study|Lost to Follow-up|46|||
19405821|NCT02214225|41651110|FG001|Overall Study|Lost to Follow-up|18|||
19405822|NCT02214225|41651111|FG002|Overall Study|Lost to Follow-up|18|||
19405823|NCT02214225|41651109|FG000|Overall Study|Withdrawal by Subject|2|||
19405824|NCT02214225|41651110|FG001|Overall Study|Withdrawal by Subject|0|||
19405825|NCT02214225|41651111|FG002|Overall Study|Withdrawal by Subject|2|||
19405826|NCT02214225|41651109|FG000|Overall Study|Death|5|||
19405827|NCT02214225|41651110|FG001|Overall Study|Death|0|||
19405828|NCT02214225|41651111|FG002|Overall Study|Death|1|||
19405829|NCT02214225|41651109|FG000|Overall Study|randomized in error, not vaccinated|2|||
19405830|NCT02214225|41651110|FG001|Overall Study|randomized in error, not vaccinated|1|||
19405831|NCT02214225|41651111|FG002|Overall Study|randomized in error, not vaccinated|1|||
19405832|NCT02250183|41651142|FG000|Overall Study|Withdrawal by Subject|2|||
19405833|NCT02250183|41651142|FG000|Overall Study|Adverse Event|5|||
19405834|NCT02250183|41651142|FG000|Overall Study|Lost to Follow-up|1|||
19405835|NCT02249949|41651149|FG000|Overall Study|Cancelled prior to treatment|2|||
19405836|NCT02249091|41651155|FG000|Overall Study|Lack of Efficacy|8|||
19405837|NCT02249091|41651156|FG001|Overall Study|Lack of Efficacy|3|||
19405838|NCT02249091|41651155|FG000|Overall Study|Physician Decision|4|||
19405839|NCT02249091|41651156|FG001|Overall Study|Physician Decision|1|||
19405840|NCT02249091|41651155|FG000|Overall Study|Withdrawal by Subject|2|||
19405841|NCT02249091|41651156|FG001|Overall Study|Withdrawal by Subject|2|||
19405842|NCT02249091|41651155|FG000|Overall Study|Death|3|||
19405843|NCT02249091|41651156|FG001|Overall Study|Death|4|||
19405844|NCT02249091|41651155|FG000|Overall Study|Adverse Event|1|||
19405845|NCT02249091|41651156|FG001|Overall Study|Adverse Event|0|||
19405846|NCT02249091|41651155|FG000|Overall Study|Stable disease with following SCT|0|||
19405847|NCT02249091|41651156|FG001|Overall Study|Stable disease with following SCT|1|||
19405848|NCT02249091|41651155|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
19405849|NCT02249091|41651156|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
19405850|NCT02249091|41651155|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
19405851|NCT02249091|41651156|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
19405852|NCT02249091|41651155|FG000|Overall Study|Refractory AML|1|||
19405853|NCT02249091|41651156|FG001|Overall Study|Refractory AML|1|||
19405854|NCT02248857|41651165|FG000|3 Month|Withdrawal by Subject|9|||
19405855|NCT02248857|41651166|FG001|3 Month|Withdrawal by Subject|3|||
19405856|NCT02248857|41651167|FG002|3 Month|Withdrawal by Subject|4|||
19405857|NCT02248857|41651165|FG000|3 Month|Unable to reach for 3 month|35|||
19405858|NCT02248857|41651166|FG001|3 Month|Unable to reach for 3 month|29|||
19405859|NCT02248857|41651167|FG002|3 Month|Unable to reach for 3 month|26|||
19405860|NCT02248857|41651165|FG000|3 Month|Partially completed, unable to finish|2|||
19405861|NCT02248857|41651166|FG001|3 Month|Partially completed, unable to finish|2|||
19405862|NCT02248857|41651167|FG002|3 Month|Partially completed, unable to finish|1|||
19405863|NCT02248857|41651165|FG000|6 Month|Lost to Follow-up|27|||
19405864|NCT02248857|41651166|FG001|6 Month|Lost to Follow-up|26|||
19405865|NCT02248857|41651167|FG002|6 Month|Lost to Follow-up|15|||
19405866|NCT02248857|41651165|FG000|6 Month|Partially completed, unable to finish|0|||
19405867|NCT02248857|41651166|FG001|6 Month|Partially completed, unable to finish|1|||
19405868|NCT02248857|41651167|FG002|6 Month|Partially completed, unable to finish|0|||
19405869|NCT02248857|41651165|FG000|6 Month|Withdrawal by Subject|0|||
19405870|NCT02248857|41651166|FG001|6 Month|Withdrawal by Subject|2|||
19405871|NCT02248857|41651167|FG002|6 Month|Withdrawal by Subject|2|||
19405872|NCT02248857|41651165|FG000|6 Month|Death|1|||
19405873|NCT02248857|41651166|FG001|6 Month|Death|0|||
19405874|NCT02248857|41651167|FG002|6 Month|Death|0|||
19405875|NCT02213055|41651177|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
19405876|NCT02213055|41651178|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
19405877|NCT02213055|41651177|FG000|Overall Study|Protocol was not Followed during Study|1|||
19405878|NCT02213055|41651178|FG001|Overall Study|Protocol was not Followed during Study|0|||
19405879|NCT02213055|41651177|FG000|Overall Study|Documentation Issue at Enrollment|1|||
19405880|NCT02213055|41651178|FG001|Overall Study|Documentation Issue at Enrollment|0|||
19405881|NCT02213055|41651177|FG000|Overall Study|Documentation Issue during Study|10|||
19405882|NCT02213055|41651178|FG001|Overall Study|Documentation Issue during Study|0|||
19405883|NCT02213055|41651177|FG000|Overall Study|Did not have Live Lice|8|||
19405884|NCT02213055|41651178|FG001|Overall Study|Did not have Live Lice|0|||
19405885|NCT02213055|41651177|FG000|Overall Study|Had another Treatment during the Study|3|||
19405886|NCT02213055|41651178|FG001|Overall Study|Had another Treatment during the Study|0|||
19405887|NCT02213055|41651177|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
19405888|NCT02213055|41651178|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
19405889|NCT02213055|41651177|FG000|Overall Study|Did not Return to School|5|||
19405890|NCT02213055|41651178|FG001|Overall Study|Did not Return to School|0|||
19405891|NCT02310763|41651187|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
19405892|NCT02310763|41651188|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
19405893|NCT02310763|41651189|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
19405894|NCT02310763|41651187|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
19405895|NCT02310763|41651188|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
19405896|NCT02310763|41651189|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
19405897|NCT02310763|41651187|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
19405898|NCT02310763|41651188|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
19405899|NCT02310763|41651189|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
19405900|NCT02310763|41651187|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
19405901|NCT02310763|41651188|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
19405902|NCT02310763|41651189|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
19405903|NCT02310763|41651187|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
19405904|NCT02310763|41651188|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
19405905|NCT02310763|41651189|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
19405906|NCT02342743|41651215|FG000|Baseline Period|Withdrawal by Subject|3|||
19405907|NCT02342743|41651215|FG000|Baseline Period|Lost to Follow-up|2|||
19405908|NCT02342743|41651215|FG000|Baseline Period|Change in prophylactic medication|3|||
19405909|NCT02342743|41651215|FG000|Baseline Period|Screening failure regarding baseline|7|||
19405910|NCT02342743|41651215|FG000|Treatment Period|Withdrawal by Subject|2|||
19405911|NCT02342743|41651215|FG000|Treatment Period|Lost to Follow-up|8|||
19405912|NCT02342743|41651215|FG000|Treatment Period|Change in prophylactic medication|1|||
19405913|NCT02377063|41651219|FG000|Overall Study|Non-compliance|5|||
19405914|NCT02309515|41651225|FG000|Overall Study|Withdrawal by Subject|0|||
19405915|NCT02309515|41651226|FG001|Overall Study|Withdrawal by Subject|1|||
19405916|NCT02309359|41651237|FG000|Overall Study|Adverse Event|4|||
19405917|NCT02309359|41651238|FG001|Overall Study|Adverse Event|5|||
19405918|NCT02309359|41651239|FG002|Overall Study|Adverse Event|5|||
19405919|NCT02309359|41651240|FG003|Overall Study|Adverse Event|4|||
19405920|NCT02309359|41651241|FG004|Overall Study|Adverse Event|4|||
19405921|NCT02309359|41651237|FG000|Overall Study|Death|1|||
19405922|NCT02309359|41651238|FG001|Overall Study|Death|0|||
19405923|NCT02309359|41651239|FG002|Overall Study|Death|0|||
19405924|NCT02309359|41651240|FG003|Overall Study|Death|0|||
19405925|NCT02309359|41651241|FG004|Overall Study|Death|0|||
19405926|NCT02309359|41651237|FG000|Overall Study|Withdrawal by Subject|2|||
19405927|NCT02309359|41651238|FG001|Overall Study|Withdrawal by Subject|2|||
19405928|NCT02309359|41651239|FG002|Overall Study|Withdrawal by Subject|4|||
19405929|NCT02309359|41651240|FG003|Overall Study|Withdrawal by Subject|4|||
19405930|NCT02309359|41651241|FG004|Overall Study|Withdrawal by Subject|0|||
19405931|NCT02309359|41651237|FG000|Overall Study|Lack of Efficacy|3|||
19405932|NCT02309359|41651238|FG001|Overall Study|Lack of Efficacy|1|||
19405933|NCT02309359|41651239|FG002|Overall Study|Lack of Efficacy|0|||
19405934|NCT02309359|41651240|FG003|Overall Study|Lack of Efficacy|0|||
19405935|NCT02309359|41651241|FG004|Overall Study|Lack of Efficacy|3|||
19405936|NCT02309359|41651237|FG000|Overall Study|Lost to Follow-up|0|||
19405937|NCT02309359|41651238|FG001|Overall Study|Lost to Follow-up|0|||
19405938|NCT02309359|41651239|FG002|Overall Study|Lost to Follow-up|0|||
19405939|NCT02309359|41651240|FG003|Overall Study|Lost to Follow-up|1|||
19405940|NCT02309359|41651241|FG004|Overall Study|Lost to Follow-up|0|||
19405941|NCT02309359|41651237|FG000|Overall Study|Other|2|||
19405942|NCT02309359|41651238|FG001|Overall Study|Other|0|||
19405943|NCT02309359|41651239|FG002|Overall Study|Other|2|||
19405944|NCT02309359|41651240|FG003|Overall Study|Other|3|||
19405945|NCT02309359|41651241|FG004|Overall Study|Other|2|||
19405946|NCT02247531|41651257|FG000|Overall Study|Adverse Event|3|||
19405947|NCT02247531|41651258|FG001|Overall Study|Adverse Event|4|||
19405948|NCT02247531|41651259|FG002|Overall Study|Adverse Event|9|||
19405949|NCT02247531|41651257|FG000|Overall Study|Death|8|||
19405950|NCT02247531|41651258|FG001|Overall Study|Death|9|||
19405951|NCT02247531|41651259|FG002|Overall Study|Death|5|||
19628021|NCT00795717|42077428|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
19628022|NCT00795717|42077427|FG000|Phase II|too busy|0|||
19405952|NCT02247531|41651257|FG000|Overall Study|Lost to Follow-up|1|||
19405953|NCT02247531|41651258|FG001|Overall Study|Lost to Follow-up|8|||
19405954|NCT02247531|41651259|FG002|Overall Study|Lost to Follow-up|3|||
19405955|NCT02247531|41651257|FG000|Overall Study|Non-compliance|2|||
19405956|NCT02247531|41651258|FG001|Overall Study|Non-compliance|2|||
19405957|NCT02247531|41651259|FG002|Overall Study|Non-compliance|0|||
19405958|NCT02247531|41651257|FG000|Overall Study|Withdrawal by Subject|26|||
19405959|NCT02247531|41651258|FG001|Overall Study|Withdrawal by Subject|31|||
19405960|NCT02247531|41651259|FG002|Overall Study|Withdrawal by Subject|25|||
19405961|NCT02247531|41651257|FG000|Overall Study|Study Terminated by Sponsor|64|||
19405962|NCT02247531|41651258|FG001|Overall Study|Study Terminated by Sponsor|66|||
19405963|NCT02247531|41651259|FG002|Overall Study|Study Terminated by Sponsor|62|||
19405964|NCT02247531|41651257|FG000|Overall Study|Physician Decision|0|||
19405965|NCT02247531|41651258|FG001|Overall Study|Physician Decision|2|||
19405966|NCT02247531|41651259|FG002|Overall Study|Physician Decision|2|||
19405967|NCT02247531|41651257|FG000|Overall Study|Unspecified Reason|2|||
19405968|NCT02247531|41651258|FG001|Overall Study|Unspecified Reason|3|||
19405969|NCT02247531|41651259|FG002|Overall Study|Unspecified Reason|4|||
19405970|NCT02375971|41651270|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
19405971|NCT02375971|41651271|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
19405972|NCT02375971|41651272|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
19405973|NCT02375971|41651270|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
19405974|NCT02375971|41651271|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
19405975|NCT02375971|41651272|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
19405976|NCT02375971|41651270|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
19405977|NCT02375971|41651271|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
19405978|NCT02375971|41651272|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
19405979|NCT02375971|41651270|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
19405980|NCT02375971|41651271|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
19405981|NCT02375971|41651272|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
19405982|NCT02375971|41651270|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
19405983|NCT02375971|41651271|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
19405984|NCT02375971|41651272|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
19405985|NCT02375971|41651270|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
19405986|NCT02375971|41651271|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
19405987|NCT02375971|41651272|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
19405988|NCT02375971|41651270|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
19405989|NCT02375971|41651271|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
19405990|NCT02375971|41651272|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
19405991|NCT02375971|41651270|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
19405992|NCT02375971|41651271|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
19405993|NCT02375971|41651272|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
19405994|NCT02308735|41651284|FG000|Overall Study|Physician Decision|2|||
19405995|NCT02308735|41651285|FG001|Overall Study|Physician Decision|0|||
19405996|NCT02308735|41651286|FG002|Overall Study|Physician Decision|0|||
19405997|NCT02308735|41651287|FG003|Overall Study|Physician Decision|2|||
19405998|NCT02212197|41651300|FG000|Overall Study|Need for radiotherapy|1|||
19405999|NCT02212197|41651301|FG001|Overall Study|Need for radiotherapy|0|||
19406000|NCT02212197|41651302|FG002|Overall Study|Need for radiotherapy|0|||
19406001|NCT02193165|41651313|FG000|4 Week Product Use|Lost to Follow-up|1|||
19406002|NCT02193165|41651314|FG001|4 Week Product Use|Lost to Follow-up|1|||
19406003|NCT02193165|41651315|FG002|4 Week Product Use|Lost to Follow-up|1|||
19406004|NCT02193165|41651313|FG000|6 Week Product Use|Lost to Follow-up|0|||
19406005|NCT02193165|41651314|FG001|6 Week Product Use|Lost to Follow-up|1|||
19406006|NCT02193165|41651315|FG002|6 Week Product Use|Lost to Follow-up|0|||
19406007|NCT01617460|41651323|FG000|Overall Study|Adverse Event|10|||
19406008|NCT01617460|41651323|FG000|Overall Study|Physician Decision|16|||
19406009|NCT01617460|41651323|FG000|Overall Study|Protocol Violation|5|||
19406010|NCT01617460|41651323|FG000|Overall Study|Withdrawal by Subject|9|||
19406011|NCT01890148|41651327|FG000|Overall Study|Adverse Event|1|||
19406012|NCT01889602|41651334|FG000|First Intervention|Adverse Event|1|||
19406013|NCT01889602|41651335|FG001|First Intervention|Adverse Event|1|||
19406014|NCT01889602|41651336|FG002|First Intervention|Adverse Event|1|||
19406015|NCT01889602|41651334|FG000|First Intervention|Protocol Violation|0|||
19406016|NCT01889602|41651335|FG001|First Intervention|Protocol Violation|1|||
19406017|NCT01889602|41651336|FG002|First Intervention|Protocol Violation|1|||
19406018|NCT01889602|41651334|FG000|First Intervention|Study ending|0|||
19406019|NCT01889602|41651335|FG001|First Intervention|Study ending|1|||
19406020|NCT01889602|41651336|FG002|First Intervention|Study ending|0|||
19406021|NCT01889602|41651334|FG000|Second Intervention|Adverse Event|0|||
19406022|NCT01889602|41651335|FG001|Second Intervention|Adverse Event|0|||
19406023|NCT01889602|41651336|FG002|Second Intervention|Adverse Event|1|||
19406024|NCT01889602|41651334|FG000|Second Intervention|Study ending|1|||
19628023|NCT00795717|42077428|FG001|Phase II|too busy|1|||
19406025|NCT01889602|41651335|FG001|Second Intervention|Study ending|0|||
19406026|NCT01889602|41651336|FG002|Second Intervention|Study ending|0|||
19628024|NCT00805740|42077437|FG000|Overall Study|Death|7|||
19406027|NCT01889602|41651334|FG000|Second Intervention|Withdrawal by Subject|0|||
19406028|NCT01889602|41651335|FG001|Second Intervention|Withdrawal by Subject|0|||
19406029|NCT01889602|41651336|FG002|Second Intervention|Withdrawal by Subject|1|||
19406030|NCT01889602|41651334|FG000|Third Intervention|Protocol Violation|1|||
19406031|NCT01889602|41651335|FG001|Third Intervention|Protocol Violation|0|||
19406032|NCT01889602|41651336|FG002|Third Intervention|Protocol Violation|0|||
19406033|NCT01889602|41651334|FG000|Third Intervention|Withdrawal by Subject|2|||
19406034|NCT01889602|41651335|FG001|Third Intervention|Withdrawal by Subject|2|||
19406035|NCT01889602|41651336|FG002|Third Intervention|Withdrawal by Subject|0|||
19628025|NCT00805740|42077438|FG001|Overall Study|Death|4|||
19406036|NCT01935700|41651354|FG000|Overall Study|Withdrawal by Subject|1|||
19406037|NCT01935700|41651355|FG001|Overall Study|Withdrawal by Subject|0|||
19406038|NCT01935700|41651354|FG000|Overall Study|Physician Decision|4|||
19406039|NCT01935700|41651355|FG001|Overall Study|Physician Decision|0|||
19406040|NCT01618162|41651365|FG000|Overall Study|Protocol Violation|13|||
19406041|NCT01618162|41651366|FG001|Overall Study|Protocol Violation|10|||
19406042|NCT01618162|41651365|FG000|Overall Study|Adverse Event|9|||
19406043|NCT01618162|41651366|FG001|Overall Study|Adverse Event|2|||
19406044|NCT01618162|41651365|FG000|Overall Study|Withdrawal Criteria|2|||
19406045|NCT01618162|41651366|FG001|Overall Study|Withdrawal Criteria|10|||
19406046|NCT01618162|41651365|FG000|Overall Study|Unclassified|14|||
19406047|NCT01618162|41651366|FG001|Overall Study|Unclassified|13|||
19406048|NCT02193087|41651376|FG000|Overall Study|Adverse Event|2|||
19406049|NCT02193087|41651377|FG001|Overall Study|Adverse Event|0|||
19406050|NCT02193087|41651378|FG002|Overall Study|Adverse Event|0|||
19406051|NCT02193087|41651379|FG003|Overall Study|Adverse Event|11|||
19406052|NCT02193087|41651376|FG000|Overall Study|Lost to Follow-up|14|||
19406053|NCT02193087|41651377|FG001|Overall Study|Lost to Follow-up|6|||
19406054|NCT02193087|41651378|FG002|Overall Study|Lost to Follow-up|4|||
19406055|NCT02193087|41651379|FG003|Overall Study|Lost to Follow-up|37|||
19406056|NCT02193087|41651376|FG000|Overall Study|Protocol Violation|2|||
19406057|NCT02193087|41651377|FG001|Overall Study|Protocol Violation|0|||
19406058|NCT02193087|41651378|FG002|Overall Study|Protocol Violation|1|||
19406059|NCT02193087|41651379|FG003|Overall Study|Protocol Violation|2|||
19406060|NCT02193087|41651376|FG000|Overall Study|Withdrawal by Subject|10|||
19406061|NCT02193087|41651377|FG001|Overall Study|Withdrawal by Subject|3|||
19406062|NCT02193087|41651378|FG002|Overall Study|Withdrawal by Subject|1|||
19406063|NCT02193087|41651379|FG003|Overall Study|Withdrawal by Subject|19|||
19406064|NCT02193087|41651376|FG000|Overall Study|Other Reason Not Specified|7|||
19406065|NCT02193087|41651377|FG001|Overall Study|Other Reason Not Specified|2|||
19406066|NCT02193087|41651378|FG002|Overall Study|Other Reason Not Specified|1|||
19406067|NCT02193087|41651379|FG003|Overall Study|Other Reason Not Specified|9|||
19406068|NCT02193087|41651376|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
19406069|NCT02193087|41651377|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
19406070|NCT02193087|41651378|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
19406071|NCT02193087|41651379|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
19406072|NCT01617070|41651396|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
19406073|NCT02341417|41651409|FG000|Overall Study|Withdrawal by Subject|0|||
19406074|NCT02341417|41651410|FG001|Overall Study|Withdrawal by Subject|2|||
19406075|NCT02341417|41651411|FG002|Overall Study|Withdrawal by Subject|0|||
19406076|NCT02341417|41651409|FG000|Overall Study|Decision by sponsor|2|||
19406077|NCT02341417|41651410|FG001|Overall Study|Decision by sponsor|0|||
19406078|NCT02341417|41651411|FG002|Overall Study|Decision by sponsor|0|||
19406079|NCT02341417|41651409|FG000|Overall Study|Death|0|||
19406080|NCT02341417|41651410|FG001|Overall Study|Death|0|||
19406081|NCT02341417|41651411|FG002|Overall Study|Death|1|||
19406082|NCT01888900|41651422|FG000|Overall Study|failed treatment|0|||
19406083|NCT01888900|41651423|FG001|Overall Study|failed treatment|2|||
19406084|NCT02340949|41651433|FG000|Overall Study|Adverse Event|4|||
19406085|NCT02340949|41651434|FG001|Overall Study|Adverse Event|2|||
19406086|NCT02340949|41651433|FG000|Overall Study|Withdrawal by Subject|2|||
19406087|NCT02340949|41651434|FG001|Overall Study|Withdrawal by Subject|0|||
19406088|NCT02340949|41651433|FG000|Overall Study|Progression disease|6|||
19406089|NCT02340949|41651434|FG001|Overall Study|Progression disease|2|||
19406090|NCT02340949|41651433|FG000|Overall Study|Death|3|||
19406091|NCT02340949|41651434|FG001|Overall Study|Death|0|||
19406092|NCT02340949|41651433|FG000|Overall Study|Physician Decision|1|||
19406093|NCT02340949|41651434|FG001|Overall Study|Physician Decision|0|||
19406094|NCT01646203|41651443|FG000|Overall Study|Adverse Event|2|||
19406095|NCT01646203|41651444|FG001|Overall Study|Adverse Event|0|||
19406096|NCT01646203|41651445|FG002|Overall Study|Adverse Event|1|||
19406097|NCT01646203|41651443|FG000|Overall Study|Withdrawal by Subject|0|||
19406098|NCT01646203|41651444|FG001|Overall Study|Withdrawal by Subject|1|||
19406099|NCT01646203|41651445|FG002|Overall Study|Withdrawal by Subject|0|||
19406100|NCT01646203|41651443|FG000|Overall Study|Physician's Decision|0|||
19628026|NCT00805740|42077437|FG000|Overall Study|Withdrawal by Subject|1|||
19406101|NCT01646203|41651444|FG001|Overall Study|Physician's Decision|1|||
19406102|NCT01646203|41651445|FG002|Overall Study|Physician's Decision|0|||
19406103|NCT02375347|41651458|FG000|Overall Study|Protocol Violation|1|||
19406104|NCT02374957|41651464|FG000|Overall Study|Patient did not complete forms correctly|1|||
19406105|NCT02374957|41651465|FG001|Overall Study|Patient did not complete forms correctly|0|||
19406106|NCT02374255|41651475|FG000|Overall Study|Withdrawal by Subject|2|||
19406107|NCT02374255|41651476|FG001|Overall Study|Withdrawal by Subject|0|||
19406108|NCT02374255|41651477|FG002|Overall Study|Withdrawal by Subject|0|||
19406109|NCT02374255|41651478|FG003|Overall Study|Withdrawal by Subject|0|||
19406110|NCT02308033|41651496|FG000|Overall Study|Normal Gram stain at Baseline|13|||
19406111|NCT02308033|41651497|FG001|Overall Study|Normal Gram stain at Baseline|10|||
19406112|NCT02308033|41651496|FG000|Overall Study|Positive for STD at Baseline|7|||
19406113|NCT02308033|41651497|FG001|Overall Study|Positive for STD at Baseline|4|||
19406114|NCT02308033|41651496|FG000|Overall Study|Lost to Follow-up|6|||
19406115|NCT02308033|41651497|FG001|Overall Study|Lost to Follow-up|5|||
19406116|NCT02339155|41651505|FG000|Overall Study|Adverse Event|0|||
19406117|NCT02339155|41651506|FG001|Overall Study|Adverse Event|6|||
19406118|NCT02339155|41651505|FG000|Overall Study|Death|1|||
19406119|NCT02339155|41651506|FG001|Overall Study|Death|1|||
19406120|NCT02339155|41651505|FG000|Overall Study|Lost to Follow-up|8|||
19406121|NCT02339155|41651506|FG001|Overall Study|Lost to Follow-up|9|||
19406122|NCT02339155|41651505|FG000|Overall Study|Physician Decision|2|||
19406123|NCT02339155|41651506|FG001|Overall Study|Physician Decision|1|||
19406124|NCT02339155|41651505|FG000|Overall Study|Withdrawal by Subject|4|||
19406125|NCT02339155|41651506|FG001|Overall Study|Withdrawal by Subject|4|||
19406126|NCT02211261|41651525|FG000|Overall Study|Withdrawal by Subject|0|||
19406127|NCT02211261|41651526|FG001|Overall Study|Withdrawal by Subject|0|||
19406128|NCT02211261|41651527|FG002|Overall Study|Withdrawal by Subject|1|||
19406129|NCT02211261|41651528|FG003|Overall Study|Withdrawal by Subject|0|||
19406130|NCT02211261|41651529|FG004|Overall Study|Withdrawal by Subject|2|||
19406131|NCT02211261|41651530|FG005|Overall Study|Withdrawal by Subject|0|||
19406132|NCT02211261|41651531|FG006|Overall Study|Withdrawal by Subject|0|||
19406133|NCT02211261|41651532|FG007|Overall Study|Withdrawal by Subject|0|||
19406134|NCT02211261|41651533|FG008|Overall Study|Withdrawal by Subject|0|||
19406135|NCT02211261|41651534|FG009|Overall Study|Withdrawal by Subject|0|||
19406136|NCT02211261|41651535|FG010|Overall Study|Withdrawal by Subject|0|||
19406137|NCT02211261|41651525|FG000|Overall Study|Other|0|||
19406138|NCT02211261|41651526|FG001|Overall Study|Other|0|||
19406139|NCT02211261|41651527|FG002|Overall Study|Other|0|||
19406140|NCT02211261|41651528|FG003|Overall Study|Other|0|||
19406141|NCT02211261|41651529|FG004|Overall Study|Other|0|||
19406142|NCT02211261|41651530|FG005|Overall Study|Other|1|||
19406143|NCT02211261|41651531|FG006|Overall Study|Other|0|||
19406144|NCT02211261|41651532|FG007|Overall Study|Other|0|||
19406145|NCT02211261|41651533|FG008|Overall Study|Other|0|||
19406146|NCT02211261|41651534|FG009|Overall Study|Other|2|||
19406147|NCT02211261|41651535|FG010|Overall Study|Other|0|||
19406148|NCT02211261|41651525|FG000|Overall Study|Lost to Follow-up|0|||
19406149|NCT02211261|41651526|FG001|Overall Study|Lost to Follow-up|0|||
19406150|NCT02211261|41651527|FG002|Overall Study|Lost to Follow-up|0|||
19406151|NCT02211261|41651528|FG003|Overall Study|Lost to Follow-up|0|||
19406152|NCT02211261|41651529|FG004|Overall Study|Lost to Follow-up|0|||
19406153|NCT02211261|41651530|FG005|Overall Study|Lost to Follow-up|0|||
19406154|NCT02211261|41651531|FG006|Overall Study|Lost to Follow-up|0|||
19406155|NCT02211261|41651532|FG007|Overall Study|Lost to Follow-up|1|||
19406156|NCT02211261|41651533|FG008|Overall Study|Lost to Follow-up|0|||
19406157|NCT02211261|41651534|FG009|Overall Study|Lost to Follow-up|0|||
19406158|NCT02211261|41651535|FG010|Overall Study|Lost to Follow-up|0|||
19406159|NCT02170077|41651571|FG000|Overall Study|Withdrawal by Subject|3|||
19406160|NCT02170077|41651572|FG001|Overall Study|Withdrawal by Subject|4|||
19406161|NCT02170077|41651573|FG002|Overall Study|Withdrawal by Subject|2|||
19406162|NCT02170077|41651571|FG000|Overall Study|Adverse Event|4|||
19406163|NCT02170077|41651572|FG001|Overall Study|Adverse Event|4|||
19406164|NCT02170077|41651573|FG002|Overall Study|Adverse Event|4|||
19406165|NCT02170077|41651571|FG000|Overall Study|Lost to Follow-up|0|||
19406166|NCT02170077|41651572|FG001|Overall Study|Lost to Follow-up|1|||
19406167|NCT02170077|41651573|FG002|Overall Study|Lost to Follow-up|0|||
19406168|NCT02170077|41651571|FG000|Overall Study|Exclusion criteria|2|||
19406169|NCT02170077|41651572|FG001|Overall Study|Exclusion criteria|2|||
19406170|NCT02170077|41651573|FG002|Overall Study|Exclusion criteria|5|||
19406171|NCT02170077|41651571|FG000|Overall Study|Exacerbation of seizures|0|||
19406172|NCT02170077|41651572|FG001|Overall Study|Exacerbation of seizures|2|||
19406173|NCT02170077|41651573|FG002|Overall Study|Exacerbation of seizures|1|||
19406174|NCT02210091|41651583|FG000|Overall Study|Physician Decision|0|||
19406175|NCT02210091|41651584|FG001|Overall Study|Physician Decision|1|||
19406176|NCT02210091|41651583|FG000|Overall Study|Withdrawal by Sponsor|0|||
19406177|NCT02210091|41651584|FG001|Overall Study|Withdrawal by Sponsor|1|||
19406178|NCT02338999|41651608|FG000|First Intervention|Withdrawal by Subject|3|||
19406179|NCT02338999|41651609|FG001|First Intervention|Withdrawal by Subject|1|||
19406180|NCT02338999|41651608|FG000|Washout Period|Withdrawal by Subject|0|||
19406181|NCT02338999|41651609|FG001|Washout Period|Withdrawal by Subject|2|||
19406182|NCT02338999|41651608|FG000|Second Intervention|Withdrawal by Subject|0|||
19406183|NCT02338999|41651609|FG001|Second Intervention|Withdrawal by Subject|2|||
19406184|NCT02169219|41651615|FG000|Overall Study|Lack of Efficacy|6|||
19406185|NCT02191605|41651629|FG000|Overall Study|Lost to Follow-up|9|||
19406186|NCT02191605|41651630|FG001|Overall Study|Lost to Follow-up|4|||
19406187|NCT02191605|41651631|FG002|Overall Study|Lost to Follow-up|7|||
19406188|NCT02191605|41651632|FG003|Overall Study|Lost to Follow-up|3|||
19406189|NCT02191605|41651633|FG004|Overall Study|Lost to Follow-up|4|||
19406190|NCT02191137|41651645|FG000|Treatment|Death|4|||
19406191|NCT02191137|41651645|FG000|Treatment|Withdrawal by Subject|3|||
19406192|NCT02191137|41651645|FG000|Treatment|Adverse Event|2|||
19406193|NCT02191137|41651645|FG000|Treatment|Other|1|||
19406194|NCT02191137|41651645|FG000|Follow-up|Lost to Follow-up|2|||
19406195|NCT02191137|41651645|FG000|Follow-up|Ongoing/unknown|2|||
19406196|NCT02191137|41651645|FG000|Follow-up|Adverse Event|1|||
19406197|NCT02168439|41651651|FG000|Overall Study|Protocol Violation|0|||
19406198|NCT02168439|41651652|FG001|Overall Study|Protocol Violation|2|||
19406199|NCT02190591|41651660|FG000|Overall Study|Withdrawal by Subject|1|||
19406200|NCT02190591|41651661|FG001|Overall Study|Withdrawal by Subject|8|||
19406201|NCT02190591|41651660|FG000|Overall Study|Protocol Violation|1|||
19406202|NCT02190591|41651661|FG001|Overall Study|Protocol Violation|0|||
19406203|NCT02190591|41651660|FG000|Overall Study|did not use peanut ball as instructed|0|||
19406204|NCT02190591|41651661|FG001|Overall Study|did not use peanut ball as instructed|2|||
19406205|NCT02190591|41651660|FG000|Overall Study|face presentation so she was ineligible|0|||
19406206|NCT02190591|41651661|FG001|Overall Study|face presentation so she was ineligible|1|||
19406207|NCT02190435|41651669|FG000|Overall Study|First 12 patients were lead-ins|12|||
19406208|NCT02190435|41651670|FG001|Overall Study|First 12 patients were lead-ins|0|||
19406209|NCT02190435|41651669|FG000|Overall Study|3 consented screen fails|3|||
19406210|NCT02190435|41651670|FG001|Overall Study|3 consented screen fails|0|||
19406211|NCT02338843|41651678|FG000|Overall Study|Adverse Event|2|||
19406212|NCT02338843|41651679|FG001|Overall Study|Adverse Event|1|||
19406213|NCT02338843|41651678|FG000|Overall Study|Death|40|||
19406214|NCT02338843|41651679|FG001|Overall Study|Death|53|||
19406215|NCT02338843|41651678|FG000|Overall Study|Physician Decision|1|||
19406216|NCT02338843|41651679|FG001|Overall Study|Physician Decision|0|||
19406217|NCT02338843|41651678|FG000|Overall Study|Withdrawal by Subject|0|||
19406218|NCT02338843|41651679|FG001|Overall Study|Withdrawal by Subject|2|||
19406219|NCT02338843|41651678|FG000|Overall Study|Subject Recovered|0|||
19406220|NCT02338843|41651679|FG001|Overall Study|Subject Recovered|2|||
19406221|NCT02338843|41651678|FG000|Overall Study|Discontinued prior to randomizat|1|||
19406222|NCT02338843|41651679|FG001|Overall Study|Discontinued prior to randomizat|0|||
19406223|NCT02190279|41651688|FG000|Overall Study|Withdrawal consent|1|||
19406224|NCT02190279|41651689|FG001|Overall Study|Withdrawal consent|0|||
19406225|NCT02190279|41651690|FG002|Overall Study|Withdrawal consent|1|||
19406226|NCT02190279|41651688|FG000|Overall Study|Lost to Follow-up|2|||
19406227|NCT02190279|41651689|FG001|Overall Study|Lost to Follow-up|0|||
19406228|NCT02190279|41651690|FG002|Overall Study|Lost to Follow-up|0|||
19406229|NCT02190279|41651688|FG000|Overall Study|Refused further treatment|0|||
19406230|NCT02190279|41651689|FG001|Overall Study|Refused further treatment|0|||
19406231|NCT02190279|41651690|FG002|Overall Study|Refused further treatment|1|||
19406232|NCT02190279|41651688|FG000|Overall Study|Screening failure|0|||
19406233|NCT02190279|41651689|FG001|Overall Study|Screening failure|0|||
19406234|NCT02190279|41651690|FG002|Overall Study|Screening failure|1|||
19406235|NCT02135445|41651702|FG000|Overall Study|Lost to Follow-up|1|||
19406236|NCT02135445|41651703|FG001|Overall Study|Lost to Follow-up|0|||
19406237|NCT02135445|41651702|FG000|Overall Study|Withdrawal by Subject|1|||
19406238|NCT02135445|41651703|FG001|Overall Study|Withdrawal by Subject|0|||
19406239|NCT02374099|41651711|FG000|Overall Study|Adverse Event|1|||
19406240|NCT02374099|41651712|FG001|Overall Study|Adverse Event|0|||
19406241|NCT02374099|41651711|FG000|Overall Study|Progressive Disease|35|||
19406242|NCT02374099|41651712|FG001|Overall Study|Progressive Disease|40|||
19406243|NCT02374099|41651711|FG000|Overall Study|Withdrawal by Subject|5|||
19406244|NCT02374099|41651712|FG001|Overall Study|Withdrawal by Subject|1|||
19406245|NCT02374099|41651711|FG000|Overall Study|Miscellaneous|2|||
19406246|NCT02374099|41651712|FG001|Overall Study|Miscellaneous|3|||
19406247|NCT02374099|41651711|FG000|Overall Study|Randomized, but not treated|2|||
19406248|NCT02374099|41651712|FG001|Overall Study|Randomized, but not treated|1|||
19406249|NCT02374099|41651711|FG000|Overall Study|Study Terminated by Sponsor|3|||
19406250|NCT02374099|41651712|FG001|Overall Study|Study Terminated by Sponsor|4|||
19406251|NCT02134977|41651718|FG000|Overall Study|Protocol Deviation|102|||
19406252|NCT02374021|41651724|FG000|Overall Study|Adverse Event|1|||
19406253|NCT02374021|41651725|FG001|Overall Study|Adverse Event|0|||
19711080|NCT00111813|42154253|FG001|Overall Study|Progressive disease|1|||
19406254|NCT02374021|41651724|FG000|Overall Study|Lost to Follow-up|3|||
19406255|NCT02374021|41651725|FG001|Overall Study|Lost to Follow-up|2|||
19406256|NCT02374021|41651724|FG000|Overall Study|Physician Decision|0|||
19406257|NCT02374021|41651725|FG001|Overall Study|Physician Decision|3|||
19406258|NCT02374021|41651724|FG000|Overall Study|Withdrawal by Subject|6|||
19406259|NCT02374021|41651725|FG001|Overall Study|Withdrawal by Subject|5|||
19406260|NCT02374021|41651724|FG000|Overall Study|Poor Adherence|0|||
19406261|NCT02374021|41651725|FG001|Overall Study|Poor Adherence|1|||
19406262|NCT02374021|41651724|FG000|Overall Study|Scan protocol not followed|0|||
19406263|NCT02374021|41651725|FG001|Overall Study|Scan protocol not followed|1|||
19406264|NCT02374021|41651724|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
19406265|NCT02374021|41651725|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
19406266|NCT02134587|41651731|FG000|Overall Study|Did not completed all meetings|30|||
19406267|NCT02372383|41651742|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
19406268|NCT02372383|41651743|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
19406269|NCT02372383|41651744|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
19406270|NCT01648699|41651754|FG000|Overall Study|Death|1|||
19406271|NCT01648699|41651754|FG000|Overall Study|Lost to Follow-up|2|||
19406272|NCT01648699|41651754|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
19406273|NCT02134353|41651769|FG000|Overall Study|Adverse Event|10|||
19406274|NCT02134353|41651770|FG001|Overall Study|Adverse Event|6|||
19406275|NCT02134353|41651769|FG000|Overall Study|Lost to Follow-up|1|||
19406276|NCT02134353|41651770|FG001|Overall Study|Lost to Follow-up|1|||
19406277|NCT02134353|41651769|FG000|Overall Study|Lack of Efficacy|2|||
19406278|NCT02134353|41651770|FG001|Overall Study|Lack of Efficacy|1|||
19406279|NCT02134353|41651769|FG000|Overall Study|Withdrawal by Subject|12|||
19406280|NCT02134353|41651770|FG001|Overall Study|Withdrawal by Subject|13|||
19406281|NCT02134353|41651769|FG000|Overall Study|Death|0|||
19406282|NCT02134353|41651770|FG001|Overall Study|Death|1|||
19406283|NCT02134353|41651769|FG000|Overall Study|Pregnancy|0|||
19406284|NCT02134353|41651770|FG001|Overall Study|Pregnancy|1|||
19406285|NCT02134353|41651769|FG000|Overall Study|Relocation|1|||
19406286|NCT02134353|41651770|FG001|Overall Study|Relocation|0|||
19406287|NCT02134353|41651769|FG000|Overall Study|Other - Patient's Choice|0|||
19406288|NCT02134353|41651770|FG001|Overall Study|Other - Patient's Choice|1|||
19406289|NCT01646125|41651778|FG000|Overall Study|Untreated|2|||
19406290|NCT01646125|41651779|FG001|Overall Study|Untreated|5|||
19406291|NCT01646125|41651778|FG000|Overall Study|Adverse Event|2|||
19406292|NCT01646125|41651779|FG001|Overall Study|Adverse Event|1|||
19406293|NCT01646125|41651778|FG000|Overall Study|Death|1|||
19406294|NCT01646125|41651779|FG001|Overall Study|Death|1|||
19406295|NCT01646125|41651778|FG000|Overall Study|Physician Decision|1|||
19406296|NCT01646125|41651779|FG001|Overall Study|Physician Decision|3|||
19406297|NCT01646125|41651778|FG000|Overall Study|Progressive disease|22|||
19406298|NCT01646125|41651779|FG001|Overall Study|Progressive disease|16|||
19406299|NCT01646125|41651778|FG000|Overall Study|Study terminated by sponsor|2|||
19406300|NCT01646125|41651779|FG001|Overall Study|Study terminated by sponsor|1|||
19406301|NCT01646125|41651778|FG000|Overall Study|Subject/Guardian decision|1|||
19406302|NCT01646125|41651779|FG001|Overall Study|Subject/Guardian decision|1|||
19406303|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
19406304|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406305|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406306|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406307|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406308|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406309|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
19406310|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
19406311|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
19406312|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
19406313|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
19406314|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
19406315|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
19406316|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
19406317|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
19406318|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
19406319|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
19406320|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
19406321|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
19406322|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
19406323|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
19406324|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
19406325|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
19406326|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
19406327|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
19406328|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
19406329|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
19406330|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
19406331|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
19406332|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
19406333|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
19711081|NCT00111813|42154254|FG002|Overall Study|Progressive disease|5|||
19406334|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
19406335|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
19406336|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
19406337|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
19406338|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
19406339|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
19406340|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
19406341|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
19406342|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
19406343|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
19406344|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
19406345|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
19406346|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406347|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406348|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406349|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406350|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406351|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
19406352|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406353|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
19406354|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406355|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406356|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406357|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406358|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
19406359|NCT01362790|41651792|FG000|Pilot Phase & Phase 2|Death on study|0|||
19406360|NCT01362790|41651793|FG001|Pilot Phase & Phase 2|Death on study|0|||
19406361|NCT01362790|41651794|FG002|Pilot Phase & Phase 2|Death on study|0|||
19406362|NCT01362790|41651795|FG003|Pilot Phase & Phase 2|Death on study|1|||
19406363|NCT01362790|41651796|FG004|Pilot Phase & Phase 2|Death on study|0|||
19406364|NCT01362790|41651797|FG005|Pilot Phase & Phase 2|Death on study|0|||
19406365|NCT01362790|41651798|FG006|Pilot Phase & Phase 2|Death on study|0|||
19406366|NCT01362790|41651792|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
19406367|NCT01362790|41651793|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
19406368|NCT01362790|41651794|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
19406369|NCT01362790|41651795|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
19406370|NCT01362790|41651796|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
19406371|NCT01362790|41651797|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
19406372|NCT01362790|41651798|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
19406373|NCT01362790|41651792|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406374|NCT01362790|41651793|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406375|NCT01362790|41651794|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406376|NCT01362790|41651795|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406377|NCT01362790|41651796|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
19406378|NCT01362790|41651797|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406379|NCT01362790|41651798|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
19406380|NCT01362790|41651792|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
19406381|NCT01362790|41651793|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
19406382|NCT01362790|41651794|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
19406383|NCT01362790|41651795|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
19406384|NCT01362790|41651796|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
19406385|NCT01362790|41651797|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
19406386|NCT01362790|41651798|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
19406387|NCT02167893|41651818|FG000|Overall Study|Investigator transferred|85|||
19406388|NCT02167893|41651818|FG000|Overall Study|Investigator health reasons|10|||
19406389|NCT02167893|41651818|FG000|Overall Study|Case report forms not collected|68|||
19406390|NCT02167035|41651824|FG000|Overall Study|Adverse Event|2|||
19406391|NCT02167035|41651825|FG001|Overall Study|Adverse Event|2|||
19406392|NCT02167035|41651824|FG000|Overall Study|Lost to Follow-up|3|||
19406393|NCT02167035|41651825|FG001|Overall Study|Lost to Follow-up|3|||
19406394|NCT02167035|41651824|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
19406395|NCT02167035|41651825|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
19406396|NCT01615198|41651835|FG000|Overall Study|Withdrawal by Subject|5|||
19406397|NCT01615198|41651836|FG001|Overall Study|Withdrawal by Subject|5|||
19406398|NCT01615198|41651835|FG000|Overall Study|Protocol deviation|1|||
19628027|NCT00805740|42077438|FG001|Overall Study|Withdrawal by Subject|0|||
19628028|NCT00805740|42077437|FG000|Overall Study|Lost to Follow-up|1|||
19406399|NCT01615198|41651836|FG001|Overall Study|Protocol deviation|1|||
19406400|NCT01615198|41651835|FG000|Overall Study|Physician Decision|5|||
19406401|NCT01615198|41651836|FG001|Overall Study|Physician Decision|1|||
19628029|NCT00805740|42077438|FG001|Overall Study|Lost to Follow-up|0|||
19406402|NCT01615198|41651835|FG000|Overall Study|Lost to Follow-up|1|||
19406403|NCT01615198|41651836|FG001|Overall Study|Lost to Follow-up|1|||
19406404|NCT01615198|41651835|FG000|Overall Study|Lack of Efficacy|1|||
19406405|NCT01615198|41651836|FG001|Overall Study|Lack of Efficacy|6|||
19406406|NCT01615198|41651835|FG000|Overall Study|Adverse Event|11|||
19406407|NCT01615198|41651836|FG001|Overall Study|Adverse Event|5|||
19406408|NCT02337907|41651848|FG000|Overall Study|Other than listed|1|||
19406409|NCT02337907|41651849|FG001|Overall Study|Other than listed|0|||
19406410|NCT02337907|41651850|FG002|Overall Study|Other than listed|0|||
19406411|NCT02337907|41651851|FG003|Overall Study|Other than listed|1|||
19406412|NCT02337907|41651852|FG004|Overall Study|Other than listed|1|||
19406413|NCT02337907|41651853|FG005|Overall Study|Other than listed|0|||
19406414|NCT02337907|41651848|FG000|Overall Study|Withdrawal by Subject|2|||
19406415|NCT02337907|41651849|FG001|Overall Study|Withdrawal by Subject|3|||
19406416|NCT02337907|41651850|FG002|Overall Study|Withdrawal by Subject|0|||
19406417|NCT02337907|41651851|FG003|Overall Study|Withdrawal by Subject|2|||
19406418|NCT02337907|41651852|FG004|Overall Study|Withdrawal by Subject|5|||
19406419|NCT02337907|41651853|FG005|Overall Study|Withdrawal by Subject|0|||
19406420|NCT02337907|41651848|FG000|Overall Study|Lost to Follow-up|0|||
19406421|NCT02337907|41651849|FG001|Overall Study|Lost to Follow-up|0|||
19406422|NCT02337907|41651850|FG002|Overall Study|Lost to Follow-up|0|||
19406423|NCT02337907|41651851|FG003|Overall Study|Lost to Follow-up|0|||
19406424|NCT02337907|41651852|FG004|Overall Study|Lost to Follow-up|0|||
19406425|NCT02337907|41651853|FG005|Overall Study|Lost to Follow-up|1|||
19406426|NCT02337907|41651848|FG000|Overall Study|Adverse Event|1|||
19406427|NCT02337907|41651849|FG001|Overall Study|Adverse Event|1|||
19406428|NCT02337907|41651850|FG002|Overall Study|Adverse Event|1|||
19406429|NCT02337907|41651851|FG003|Overall Study|Adverse Event|1|||
19406430|NCT02337907|41651852|FG004|Overall Study|Adverse Event|4|||
19406431|NCT02337907|41651853|FG005|Overall Study|Adverse Event|0|||
19406432|NCT01913470|41651870|FG000|Overall Study|Lost to Follow-up|0|||
19406433|NCT01913470|41651871|FG001|Overall Study|Lost to Follow-up|1|||
19406434|NCT01913470|41651870|FG000|Overall Study|Physician Decision|0|||
19406435|NCT01913470|41651871|FG001|Overall Study|Physician Decision|1|||
19406436|NCT01913470|41651870|FG000|Overall Study|Withdrawal by Subject|0|||
19406437|NCT01913470|41651871|FG001|Overall Study|Withdrawal by Subject|1|||
19406438|NCT02372071|41651878|FG000|Overall Study|Protocol Violation|18|||
19406439|NCT02337751|41651885|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
19406440|NCT02337751|41651886|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
19406441|NCT02337751|41651885|FG000|Overall Study|Voluntary Withdrawal|6|||
19406442|NCT02337751|41651886|FG001|Overall Study|Voluntary Withdrawal|8|||
19406443|NCT02337751|41651885|FG000|Overall Study|Lack of Efficacy|2|||
19406444|NCT02337751|41651886|FG001|Overall Study|Lack of Efficacy|5|||
19406445|NCT02337751|41651885|FG000|Overall Study|Investigator's Judgement|1|||
19406446|NCT02337751|41651886|FG001|Overall Study|Investigator's Judgement|0|||
19406447|NCT02166333|41651897|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
19406448|NCT02166333|41651898|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
19406449|NCT02166333|41651899|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
19406450|NCT02166333|41651900|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
19406451|NCT02166333|41651901|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
19406452|NCT02166333|41651902|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
19406453|NCT02166333|41651897|FG000|Stage 1|Death|4|||
19406454|NCT02166333|41651898|FG001|Stage 1|Death|0|||
19406455|NCT02166333|41651899|FG002|Stage 1|Death|2|||
19406456|NCT02166333|41651900|FG003|Stage 1|Death|0|||
19406457|NCT02166333|41651901|FG004|Stage 1|Death|3|||
19406458|NCT02166333|41651902|FG005|Stage 1|Death|2|||
19406459|NCT02166333|41651897|FG000|Stage 1|Lost to Follow-up|12|||
19406460|NCT02166333|41651898|FG001|Stage 1|Lost to Follow-up|0|||
19406461|NCT02166333|41651899|FG002|Stage 1|Lost to Follow-up|6|||
19406462|NCT02166333|41651900|FG003|Stage 1|Lost to Follow-up|0|||
19406463|NCT02166333|41651901|FG004|Stage 1|Lost to Follow-up|3|||
19406464|NCT02166333|41651902|FG005|Stage 1|Lost to Follow-up|3|||
19406465|NCT02166333|41651897|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
19406466|NCT02166333|41651898|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
19406467|NCT02166333|41651899|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
19406468|NCT02166333|41651900|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
19711082|NCT00111813|42154255|FG003|Overall Study|Progressive disease|3|||
19711083|NCT00111813|42154256|FG004|Overall Study|Progressive disease|4|||
19406469|NCT02166333|41651901|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
19406470|NCT02166333|41651902|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
19406471|NCT02166333|41651897|FG000|Stage 2|Death|4|||
19406472|NCT02166333|41651898|FG001|Stage 2|Death|2|||
19406473|NCT02166333|41651899|FG002|Stage 2|Death|1|||
19711084|NCT00111813|42154257|FG005|Overall Study|Progressive disease|3|||
19406474|NCT02166333|41651900|FG003|Stage 2|Death|0|||
19406475|NCT02166333|41651901|FG004|Stage 2|Death|0|||
19406476|NCT02166333|41651902|FG005|Stage 2|Death|1|||
19406477|NCT02166333|41651897|FG000|Stage 2|Lost to Follow-up|23|||
19406478|NCT02166333|41651898|FG001|Stage 2|Lost to Follow-up|4|||
19406479|NCT02166333|41651899|FG002|Stage 2|Lost to Follow-up|11|||
19406480|NCT02166333|41651900|FG003|Stage 2|Lost to Follow-up|9|||
19406481|NCT02166333|41651901|FG004|Stage 2|Lost to Follow-up|3|||
19406482|NCT02166333|41651902|FG005|Stage 2|Lost to Follow-up|6|||
19406483|NCT02132949|41651916|FG000|Overall Study|Death|7|||
19406484|NCT02132949|41651917|FG001|Overall Study|Death|13|||
19406485|NCT02132949|41651916|FG000|Overall Study|Lost to Follow-up|14|||
19518785|NCT01480284|41931829|FG001|Overall Study|Withdrawal by Subject|0|||
19518786|NCT01480284|41931828|FG000|Overall Study|Adverse Event|1|||
19518787|NCT01480284|41931829|FG001|Overall Study|Adverse Event|0|||
19518788|NCT01480284|41931828|FG000|Overall Study|Study closed/terminated|3|||
19518789|NCT01480284|41931829|FG001|Overall Study|Study closed/terminated|0|||
19518790|NCT01480284|41931828|FG000|Overall Study|Lost to Follow-up|1|||
19518791|NCT01480284|41931829|FG001|Overall Study|Lost to Follow-up|0|||
19518792|NCT01480284|41931828|FG000|Overall Study|Physician Decision|1|||
19518793|NCT01480284|41931829|FG001|Overall Study|Physician Decision|0|||
19518794|NCT01459614|41931837|FG000|Overall Study|Adverse Event|1|||
19518795|NCT01459614|41931838|FG001|Overall Study|Adverse Event|0|||
19518796|NCT01459068|41931846|FG000|Overall Study|Withdrawal by Subject|8|||
19518797|NCT01459068|41931847|FG001|Overall Study|Withdrawal by Subject|18|||
19518798|NCT01459068|41931846|FG000|Overall Study|Lost to Follow-up|31|||
19518799|NCT01459068|41931847|FG001|Overall Study|Lost to Follow-up|15|||
19518800|NCT01459068|41931846|FG000|Overall Study|Death|0|||
19518801|NCT01459068|41931847|FG001|Overall Study|Death|1|||
19518802|NCT01458522|41931855|FG000|Overall Study|Withdrawal by Subject|2|||
19518803|NCT01458522|41931856|FG001|Overall Study|Withdrawal by Subject|2|||
19518804|NCT01458522|41931855|FG000|Overall Study|Physician Decision|1|||
19518805|NCT01458522|41931856|FG001|Overall Study|Physician Decision|9|||
19518806|NCT01505010|41931870|FG000|Overall Study|Protocol Violation|0|||
19518807|NCT01505010|41931871|FG001|Overall Study|Protocol Violation|1|||
19518808|NCT01505010|41931870|FG000|Overall Study|Lost to Follow-up|0|||
19518809|NCT01505010|41931871|FG001|Overall Study|Lost to Follow-up|1|||
19518810|NCT01458366|41931882|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
19518811|NCT01458366|41931883|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
19518812|NCT01458366|41931884|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
19518813|NCT01458366|41931885|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
19518814|NCT01458366|41931886|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
19518815|NCT01458366|41931882|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
19518816|NCT01458366|41931883|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
19518817|NCT01458366|41931884|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
19518818|NCT01458366|41931885|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
19518819|NCT01458366|41931886|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
19518820|NCT01458210|41931894|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
19518821|NCT01458210|41931894|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
19518822|NCT01458210|41931894|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
19518823|NCT01458210|41931894|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
19518824|NCT01478958|41931904|FG000|Overall Study|Withdrawal by Subject|1|||
19518825|NCT01478958|41931905|FG001|Overall Study|Withdrawal by Subject|1|||
19518826|NCT01478958|41931906|FG002|Overall Study|Withdrawal by Subject|1|||
19518827|NCT01478958|41931904|FG000|Overall Study|Weight loss|1|||
19518828|NCT01478958|41931905|FG001|Overall Study|Weight loss|0|||
19518829|NCT01478958|41931906|FG002|Overall Study|Weight loss|0|||
19518830|NCT01478958|41931904|FG000|Overall Study|Re-located|0|||
19518831|NCT01478958|41931905|FG001|Overall Study|Re-located|1|||
19518832|NCT01478958|41931906|FG002|Overall Study|Re-located|0|||
19518833|NCT01478958|41931904|FG000|Overall Study|Unable to comply|0|||
19518834|NCT01478958|41931905|FG001|Overall Study|Unable to comply|0|||
19518835|NCT01478958|41931906|FG002|Overall Study|Unable to comply|2|||
19518836|NCT01458132|41931916|FG000|Overall Study|Other|15|||
19518837|NCT01458132|41931917|FG001|Overall Study|Other|3|||
19518838|NCT01457352|41931925|FG000|Period 1|Adverse Event|2|||
19518839|NCT01457352|41931926|FG001|Period 1|Adverse Event|0|||
19518840|NCT01457352|41931925|FG000|Period 1|Withdrawal by Subject|2|||
19518841|NCT01457352|41931926|FG001|Period 1|Withdrawal by Subject|0|||
19406486|NCT02132949|41651917|FG001|Overall Study|Lost to Follow-up|4|||
19518842|NCT01457352|41931925|FG000|Period 1|Physician Decision|2|||
19518843|NCT01457352|41931926|FG001|Period 1|Physician Decision|0|||
19518844|NCT01457352|41931925|FG000|Period 1|MS related disease progression|1|||
19518845|NCT01457352|41931926|FG001|Period 1|MS related disease progression|0|||
19518846|NCT01457352|41931925|FG000|Period 1|Withdrawn|1|||
19406487|NCT02132949|41651916|FG000|Overall Study|Withdrawal by Subject|6|||
19406488|NCT02132949|41651917|FG001|Overall Study|Withdrawal by Subject|5|||
19518847|NCT01457352|41931926|FG001|Period 1|Withdrawn|0|||
19518848|NCT01457352|41931925|FG000|Period 1|withdrew per sponsor|1|||
19406489|NCT02132949|41651916|FG000|Overall Study|Noncompliance|5|||
19406490|NCT02132949|41651917|FG001|Overall Study|Noncompliance|1|||
19406491|NCT02132949|41651916|FG000|Overall Study|Physician Decision|3|||
19406492|NCT02132949|41651917|FG001|Overall Study|Physician Decision|1|||
19406493|NCT02132949|41651916|FG000|Overall Study|Disease Progression|3|||
19406494|NCT02132949|41651917|FG001|Overall Study|Disease Progression|0|||
19406495|NCT02132949|41651916|FG000|Overall Study|Adverse Event|2|||
19406496|NCT02132949|41651917|FG001|Overall Study|Adverse Event|1|||
19406497|NCT02132949|41651916|FG000|Overall Study|Withdrew Prior to Treatment|1|||
19406498|NCT02132949|41651917|FG001|Overall Study|Withdrew Prior to Treatment|2|||
19406499|NCT02132949|41651916|FG000|Overall Study|Reason Unspecified|0|||
19406500|NCT02132949|41651917|FG001|Overall Study|Reason Unspecified|1|||
19406501|NCT02165397|41651926|FG000|Overall Study|Death|7|||
19406502|NCT02165397|41651927|FG001|Overall Study|Death|10|||
19406503|NCT02165397|41651928|FG002|Overall Study|Death|8|||
19406504|NCT02165397|41651926|FG000|Overall Study|Lost to Follow-up|1|||
19406505|NCT02165397|41651927|FG001|Overall Study|Lost to Follow-up|3|||
19406506|NCT02165397|41651928|FG002|Overall Study|Lost to Follow-up|0|||
19406507|NCT02165397|41651926|FG000|Overall Study|Withdrawal by Subject|6|||
19406508|NCT02165397|41651927|FG001|Overall Study|Withdrawal by Subject|6|||
19406509|NCT02165397|41651928|FG002|Overall Study|Withdrawal by Subject|1|||
19406510|NCT02165397|41651926|FG000|Overall Study|Other, Not Specified|0|||
19406511|NCT02165397|41651927|FG001|Overall Study|Other, Not Specified|0|||
19406512|NCT02165397|41651928|FG002|Overall Study|Other, Not Specified|1|||
19406513|NCT02132637|41651940|FG000|Study Period 1|Withdrawal by Subject|0|||
19406514|NCT02132637|41651941|FG001|Study Period 1|Withdrawal by Subject|4|||
19406515|NCT02132637|41651940|FG000|Study Period 1|Physician Decision|1|||
19406516|NCT02132637|41651941|FG001|Study Period 1|Physician Decision|0|||
19406517|NCT02132637|41651940|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
19406518|NCT02132637|41651941|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
19406519|NCT02132637|41651940|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
19406520|NCT02132637|41651941|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
19406521|NCT02164929|41651951|FG000|Overall Study|Converted to open procedure|1|||
19406522|NCT02164929|41651952|FG001|Overall Study|Converted to open procedure|0|||
19406523|NCT02164929|41651953|FG002|Overall Study|Converted to open procedure|0|||
19406524|NCT02164929|41651954|FG003|Overall Study|Converted to open procedure|2|||
19406525|NCT02164929|41651951|FG000|Overall Study|Failed regional block|0|||
19406526|NCT02164929|41651952|FG001|Overall Study|Failed regional block|0|||
19406527|NCT02164929|41651953|FG002|Overall Study|Failed regional block|1|||
19406528|NCT02164929|41651954|FG003|Overall Study|Failed regional block|0|||
19406529|NCT01888432|41651966|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
19406530|NCT01888432|41651967|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
19406531|NCT01888432|41651966|FG000|12-month Analysis (FAS)|Physician Decision|1|||
19406532|NCT01888432|41651967|FG001|12-month Analysis (FAS)|Physician Decision|1|||
19406533|NCT01888432|41651966|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
19406534|NCT01888432|41651967|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
19406535|NCT01888432|41651966|FG000|12-month Analysis (FAS)|Death|4|||
19406536|NCT01888432|41651967|FG001|12-month Analysis (FAS)|Death|3|||
19406537|NCT01888432|41651966|FG000|24-month Analysis (FAS)|Graft loss|0|||
19406538|NCT01888432|41651967|FG001|24-month Analysis (FAS)|Graft loss|1|||
19406539|NCT01888432|41651966|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
19406540|NCT01888432|41651967|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
19406541|NCT01888432|41651966|FG000|24-month Analysis (FAS)|Physician Decision|2|||
19406542|NCT01888432|41651967|FG001|24-month Analysis (FAS)|Physician Decision|4|||
19406543|NCT01888432|41651966|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
19406544|NCT01888432|41651967|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
19406545|NCT01888432|41651966|FG000|24-month Analysis (FAS)|Death|8|||
19406546|NCT01888432|41651967|FG001|24-month Analysis (FAS)|Death|4|||
19406547|NCT01888432|41651966|FG000|36-month Analysis (Extension)|Death|1|||
19406548|NCT01888432|41651967|FG001|36-month Analysis (Extension)|Death|0|||
19406549|NCT02188719|41651979|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
19406550|NCT02188719|41651980|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
19406551|NCT02188719|41651981|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
19406552|NCT02188719|41651982|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
19406553|NCT01934140|41651992|FG000|Persistence Phase (Year 6-10)|Other|24|||
19518849|NCT01457352|41931926|FG001|Period 1|withdrew per sponsor|0|||
19406554|NCT01934140|41651993|FG001|Persistence Phase (Year 6-10)|Other|6|||
19406555|NCT01934140|41651992|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
19628030|NCT00805740|42077437|FG000|Overall Study|Randomized, but not treated|2|||
19628031|NCT00805740|42077438|FG001|Overall Study|Randomized, but not treated|0|||
19406556|NCT01934140|41651993|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
19406557|NCT01934140|41651992|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
19406558|NCT01934140|41651993|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
19406559|NCT01934140|41651992|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
19518850|NCT01457352|41931925|FG000|Period 1|Protocol Violation|4|||
19406560|NCT01934140|41651993|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
19406561|NCT01934140|41651992|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
19406562|NCT01934140|41651993|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
19406563|NCT01934140|41651992|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
19406564|NCT01934140|41651993|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
19406565|NCT01934140|41651992|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
19406566|NCT01934140|41651993|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
19406567|NCT01934140|41651992|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
19406568|NCT01934140|41651993|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
19406569|NCT01933672|41652001|FG000|Metformin Run-in Period|Adverse Event|1|||
19406570|NCT01933672|41652002|FG001|Metformin Run-in Period|Adverse Event|0|||
19406571|NCT01933672|41652003|FG002|Metformin Run-in Period|Adverse Event|0|||
19406572|NCT01933672|41652004|FG003|Metformin Run-in Period|Adverse Event|0|||
19406573|NCT01933672|41652005|FG004|Metformin Run-in Period|Adverse Event|0|||
19406574|NCT01933672|41652006|FG005|Metformin Run-in Period|Adverse Event|0|||
19406575|NCT01933672|41652007|FG006|Metformin Run-in Period|Adverse Event|0|||
19406576|NCT01933672|41652001|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
19406577|NCT01933672|41652002|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406578|NCT01933672|41652003|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406579|NCT01933672|41652004|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406580|NCT01933672|41652005|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406581|NCT01933672|41652006|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406582|NCT01933672|41652007|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
19406583|NCT01933672|41652001|FG000|Metformin Run-in Period|Other|5|||
19406584|NCT01933672|41652002|FG001|Metformin Run-in Period|Other|0|||
19406585|NCT01933672|41652003|FG002|Metformin Run-in Period|Other|0|||
19406586|NCT01933672|41652004|FG003|Metformin Run-in Period|Other|0|||
19406587|NCT01933672|41652005|FG004|Metformin Run-in Period|Other|0|||
19406588|NCT01933672|41652006|FG005|Metformin Run-in Period|Other|0|||
19406589|NCT01933672|41652007|FG006|Metformin Run-in Period|Other|0|||
19406590|NCT01933672|41652001|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406591|NCT01933672|41652002|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406592|NCT01933672|41652003|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406593|NCT01933672|41652004|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406594|NCT01933672|41652005|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
19406595|NCT01933672|41652006|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406596|NCT01933672|41652007|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406597|NCT01933672|41652001|FG000|First Intervention Period (12-16 Days)|Other|0|||
19406598|NCT01933672|41652002|FG001|First Intervention Period (12-16 Days)|Other|0|||
19406599|NCT01933672|41652003|FG002|First Intervention Period (12-16 Days)|Other|1|||
19406600|NCT01933672|41652004|FG003|First Intervention Period (12-16 Days)|Other|0|||
19406601|NCT01933672|41652005|FG004|First Intervention Period (12-16 Days)|Other|0|||
19406602|NCT01933672|41652006|FG005|First Intervention Period (12-16 Days)|Other|1|||
19406603|NCT01933672|41652007|FG006|First Intervention Period (12-16 Days)|Other|0|||
19406604|NCT01933672|41652001|FG000|Second Intervention Period (12-16 Days)|Other|0|||
19406605|NCT01933672|41652002|FG001|Second Intervention Period (12-16 Days)|Other|1|||
19406606|NCT01933672|41652003|FG002|Second Intervention Period (12-16 Days)|Other|1|||
19406607|NCT01933672|41652004|FG003|Second Intervention Period (12-16 Days)|Other|0|||
19406608|NCT01933672|41652005|FG004|Second Intervention Period (12-16 Days)|Other|0|||
19406609|NCT01933672|41652006|FG005|Second Intervention Period (12-16 Days)|Other|0|||
19406610|NCT01933672|41652007|FG006|Second Intervention Period (12-16 Days)|Other|0|||
19406611|NCT01933672|41652001|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406612|NCT01933672|41652002|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406613|NCT01933672|41652003|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406614|NCT01933672|41652004|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
19406615|NCT01933672|41652005|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406616|NCT01933672|41652006|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406617|NCT01933672|41652007|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
19406618|NCT01933672|41652001|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406619|NCT01933672|41652002|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
19406620|NCT01933672|41652003|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406621|NCT01933672|41652004|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406622|NCT01933672|41652005|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406623|NCT01933672|41652006|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406624|NCT01933672|41652007|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
19406625|NCT02164539|41652026|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
19406626|NCT02164539|41652027|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
19406627|NCT02164539|41652028|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
19406628|NCT02164539|41652029|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
19406629|NCT02164539|41652030|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
19406630|NCT02164539|41652031|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
19406631|NCT02164539|41652032|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
19406632|NCT02164539|41652026|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
19406633|NCT02164539|41652027|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
19406634|NCT02164539|41652028|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
19406635|NCT02164539|41652029|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
19406636|NCT02164539|41652030|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
19406637|NCT02164539|41652031|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
19406638|NCT02164539|41652032|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
19406639|NCT02164539|41652026|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
19406640|NCT02164539|41652027|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
19406641|NCT02164539|41652028|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
19406642|NCT02164539|41652029|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
19406643|NCT02164539|41652030|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
19406644|NCT02164539|41652031|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
19406645|NCT02164539|41652032|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
19406646|NCT02164539|41652026|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
19406647|NCT02164539|41652027|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406648|NCT02164539|41652028|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406649|NCT02164539|41652029|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406650|NCT02164539|41652030|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406651|NCT02164539|41652031|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406652|NCT02164539|41652032|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
19406653|NCT02164539|41652026|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
19406654|NCT02164539|41652027|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
19406655|NCT02164539|41652028|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
19406656|NCT02164539|41652029|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
19406657|NCT02164539|41652030|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
19406658|NCT02164539|41652031|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
19406659|NCT02164539|41652032|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
19406660|NCT02164539|41652026|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
19406661|NCT02164539|41652027|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
19406662|NCT02164539|41652028|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
19406663|NCT02164539|41652029|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
19406664|NCT02164539|41652030|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
19406665|NCT02164539|41652031|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
19406666|NCT02164539|41652032|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
19406667|NCT02188485|41652049|FG000|Overall Study|Withdrawal by Subject|2|||
19406668|NCT02188485|41652050|FG001|Overall Study|Withdrawal by Subject|1|||
19406669|NCT02188485|41652049|FG000|Overall Study|PI withdrew, lack of capacity|0|||
19406670|NCT02188485|41652050|FG001|Overall Study|PI withdrew, lack of capacity|2|||
19406671|NCT02132247|41652058|FG000|Overall Study|Protocol Violation|1|||
19406672|NCT02132247|41652059|FG001|Overall Study|Protocol Violation|0|||
19406673|NCT01629381|41652067|FG000|Overall Study|Withdrawal by Subject|2|||
19406674|NCT01629381|41652068|FG001|Overall Study|Withdrawal by Subject|5|||
19406675|NCT02131311|41652078|FG000|Overall Study|Adverse Event|2|||
19406676|NCT02131311|41652078|FG000|Overall Study|Protocol Violation|1|||
19406677|NCT02131311|41652078|FG000|Overall Study|Lost to Follow-up|1|||
19406678|NCT01628913|41652085|FG000|Overall Study|Adverse Event|12|||
19406679|NCT01628913|41652086|FG001|Overall Study|Adverse Event|5|||
19406680|NCT01628913|41652085|FG000|Overall Study|Disease Progression|11|||
19406681|NCT01628913|41652086|FG001|Overall Study|Disease Progression|14|||
19406682|NCT01628913|41652085|FG000|Overall Study|Protocol Violation|1|||
19406683|NCT01628913|41652086|FG001|Overall Study|Protocol Violation|0|||
19406684|NCT01628913|41652085|FG000|Overall Study|Death|1|||
19406685|NCT01628913|41652086|FG001|Overall Study|Death|0|||
19406686|NCT01628913|41652085|FG000|Overall Study|study terminated by Sponsor|4|||
19406687|NCT01628913|41652086|FG001|Overall Study|study terminated by Sponsor|9|||
19406688|NCT01628913|41652085|FG000|Overall Study|Withdrawal by Subject|1|||
19406689|NCT01628913|41652086|FG001|Overall Study|Withdrawal by Subject|0|||
19406690|NCT01628913|41652085|FG000|Overall Study|Physician Decision|1|||
19406691|NCT01628913|41652086|FG001|Overall Study|Physician Decision|3|||
19406692|NCT02164383|41652094|FG000|Overall Study|Lost to Follow-up|1|||
19406693|NCT02164383|41652095|FG001|Overall Study|Lost to Follow-up|0|||
19406694|NCT02131233|41652103|FG000|Overall Study|Not Treated|2|||
19406695|NCT02131233|41652104|FG001|Overall Study|Not Treated|3|||
19406696|NCT02131233|41652103|FG000|Overall Study|Adverse Event|7|||
19406697|NCT02131233|41652104|FG001|Overall Study|Adverse Event|6|||
19406698|NCT02131233|41652103|FG000|Overall Study|Death|0|||
19406699|NCT02131233|41652104|FG001|Overall Study|Death|1|||
19406700|NCT02131233|41652103|FG000|Overall Study|Lack of Efficacy|6|||
19406701|NCT02131233|41652104|FG001|Overall Study|Lack of Efficacy|3|||
19406702|NCT02131233|41652103|FG000|Overall Study|Lost to Follow-up|14|||
19406703|NCT02131233|41652104|FG001|Overall Study|Lost to Follow-up|13|||
19406704|NCT02131233|41652103|FG000|Overall Study|Non-Compliance With Study Drug|8|||
19406705|NCT02131233|41652104|FG001|Overall Study|Non-Compliance With Study Drug|5|||
19406706|NCT02131233|41652103|FG000|Overall Study|Physician Decision|7|||
19406707|NCT02131233|41652104|FG001|Overall Study|Physician Decision|0|||
19406708|NCT02131233|41652103|FG000|Overall Study|Pregnancy|4|||
19406709|NCT02131233|41652104|FG001|Overall Study|Pregnancy|0|||
19406710|NCT02131233|41652103|FG000|Overall Study|Withdrawal by Subject|18|||
19406711|NCT02131233|41652104|FG001|Overall Study|Withdrawal by Subject|11|||
19406712|NCT02131155|41652112|FG000|Overall Study|Adverse Event|1|||
19406713|NCT02131155|41652113|FG001|Overall Study|Adverse Event|0|||
19406714|NCT02131155|41652112|FG000|Overall Study|Treatment completed|1|||
19406715|NCT02131155|41652113|FG001|Overall Study|Treatment completed|0|||
19406716|NCT02131155|41652112|FG000|Overall Study|Primary tumour recurrence|2|||
19406717|NCT02131155|41652113|FG001|Overall Study|Primary tumour recurrence|1|||
19406718|NCT02131155|41652112|FG000|Overall Study|Refused to continue study medication|1|||
19406719|NCT02131155|41652113|FG001|Overall Study|Refused to continue study medication|0|||
19406720|NCT02131155|41652112|FG000|Overall Study|Study early termination|20|||
19406721|NCT02131155|41652113|FG001|Overall Study|Study early termination|10|||
19406722|NCT01933594|41652125|FG000|Overall Study|Lost to Follow-up|1|||
19406723|NCT01933594|41652126|FG001|Overall Study|Lost to Follow-up|0|||
19406724|NCT01933594|41652127|FG002|Overall Study|Lost to Follow-up|0|||
19406725|NCT01933594|41652128|FG003|Overall Study|Lost to Follow-up|0|||
19406726|NCT01933594|41652129|FG004|Overall Study|Lost to Follow-up|1|||
19406727|NCT01933594|41652130|FG005|Overall Study|Lost to Follow-up|0|||
19406728|NCT01933594|41652125|FG000|Overall Study|Ineligible for subsequent study step|0|||
19406729|NCT01933594|41652126|FG001|Overall Study|Ineligible for subsequent study step|0|||
19406730|NCT01933594|41652127|FG002|Overall Study|Ineligible for subsequent study step|0|||
19406731|NCT01933594|41652128|FG003|Overall Study|Ineligible for subsequent study step|0|||
19406732|NCT01933594|41652129|FG004|Overall Study|Ineligible for subsequent study step|1|||
19406733|NCT01933594|41652130|FG005|Overall Study|Ineligible for subsequent study step|0|||
19406734|NCT01932970|41652148|FG000|Overall Study|Withdrawal by Subject|5|||
19406735|NCT01932970|41652148|FG000|Overall Study|Death|1|||
19406736|NCT01932970|41652148|FG000|Overall Study|Lost to Follow-up|2|||
19406737|NCT01932970|41652148|FG000|Overall Study|Protocol Specified Criteria|10|||
19406738|NCT01912768|41652154|FG000|Overall Study|Adverse Event|2|||
19406739|NCT01912768|41652155|FG001|Overall Study|Adverse Event|0|||
19406740|NCT01912768|41652154|FG000|Overall Study|Lost to Follow-up|2|||
19406741|NCT01912768|41652155|FG001|Overall Study|Lost to Follow-up|1|||
19406742|NCT01912768|41652154|FG000|Overall Study|Withdrawal by Subject|5|||
19406743|NCT01912768|41652155|FG001|Overall Study|Withdrawal by Subject|3|||
19406744|NCT01912768|41652154|FG000|Overall Study|Randomized in error|1|||
19406745|NCT01912768|41652155|FG001|Overall Study|Randomized in error|0|||
19406746|NCT02305849|41652165|FG000|Overall Study|Adverse Event|10|||
19406747|NCT02305849|41652166|FG001|Overall Study|Adverse Event|12|||
19406748|NCT02305849|41652167|FG002|Overall Study|Adverse Event|7|||
19406749|NCT02305849|41652168|FG003|Overall Study|Adverse Event|3|||
19406750|NCT02305849|41652165|FG000|Overall Study|Lack of Efficacy|10|||
19406751|NCT02305849|41652166|FG001|Overall Study|Lack of Efficacy|6|||
19406752|NCT02305849|41652167|FG002|Overall Study|Lack of Efficacy|3|||
19406753|NCT02305849|41652168|FG003|Overall Study|Lack of Efficacy|9|||
19406754|NCT02305849|41652165|FG000|Overall Study|Withdrawal by Subject|2|||
19406755|NCT02305849|41652166|FG001|Overall Study|Withdrawal by Subject|2|||
19406756|NCT02305849|41652167|FG002|Overall Study|Withdrawal by Subject|1|||
19406757|NCT02305849|41652168|FG003|Overall Study|Withdrawal by Subject|4|||
19406758|NCT02305849|41652165|FG000|Overall Study|Lost to Follow-up|0|||
19406759|NCT02305849|41652166|FG001|Overall Study|Lost to Follow-up|2|||
19406760|NCT02305849|41652167|FG002|Overall Study|Lost to Follow-up|0|||
19406761|NCT02305849|41652168|FG003|Overall Study|Lost to Follow-up|0|||
19406762|NCT02305849|41652165|FG000|Overall Study|Protocol Violation|3|||
19406763|NCT02305849|41652166|FG001|Overall Study|Protocol Violation|2|||
19406764|NCT02305849|41652167|FG002|Overall Study|Protocol Violation|1|||
19406765|NCT02305849|41652168|FG003|Overall Study|Protocol Violation|1|||
19406766|NCT02305849|41652165|FG000|Overall Study|Lab data met discontinuation criteria|0|||
19406767|NCT02305849|41652166|FG001|Overall Study|Lab data met discontinuation criteria|1|||
19406768|NCT02305849|41652167|FG002|Overall Study|Lab data met discontinuation criteria|2|||
19628032|NCT00795639|42077446|FG000|Overall Study|Death|1|||
19628033|NCT00795639|42077447|FG001|Overall Study|Death|6|||
19406769|NCT02305849|41652168|FG003|Overall Study|Lab data met discontinuation criteria|1|||
19406770|NCT02305849|41652165|FG000|Overall Study|Miscellaneous|1|||
19406771|NCT02305849|41652166|FG001|Overall Study|Miscellaneous|2|||
19406772|NCT02305849|41652167|FG002|Overall Study|Miscellaneous|4|||
19406773|NCT02305849|41652168|FG003|Overall Study|Miscellaneous|1|||
19406774|NCT02305849|41652165|FG000|Overall Study|Not fulfill eligibility criteria|1|||
19406775|NCT02305849|41652166|FG001|Overall Study|Not fulfill eligibility criteria|1|||
19406776|NCT02305849|41652167|FG002|Overall Study|Not fulfill eligibility criteria|0|||
19406777|NCT02305849|41652168|FG003|Overall Study|Not fulfill eligibility criteria|0|||
19628034|NCT00795639|42077446|FG000|Overall Study|Withdrawal by Subject|1|||
19406778|NCT02371759|41652207|FG000|Overall Study|Protocol Violation|3|||
19406779|NCT02371759|41652208|FG001|Overall Study|Protocol Violation|1|||
19406780|NCT02371759|41652209|FG002|Overall Study|Protocol Violation|1|||
19406781|NCT02371759|41652210|FG003|Overall Study|Protocol Violation|0|||
19406782|NCT02371759|41652211|FG004|Overall Study|Protocol Violation|3|||
19406783|NCT02371759|41652212|FG005|Overall Study|Protocol Violation|1|||
19406784|NCT02371759|41652213|FG006|Overall Study|Protocol Violation|0|||
19406785|NCT02371759|41652214|FG007|Overall Study|Protocol Violation|3|||
19406786|NCT02371759|41652207|FG000|Overall Study|Withdrawal by Subject|0|||
19406787|NCT02371759|41652208|FG001|Overall Study|Withdrawal by Subject|0|||
19406788|NCT02371759|41652209|FG002|Overall Study|Withdrawal by Subject|0|||
19406789|NCT02371759|41652210|FG003|Overall Study|Withdrawal by Subject|0|||
19406790|NCT02371759|41652211|FG004|Overall Study|Withdrawal by Subject|0|||
19406791|NCT02371759|41652212|FG005|Overall Study|Withdrawal by Subject|0|||
19406792|NCT02371759|41652213|FG006|Overall Study|Withdrawal by Subject|0|||
19406793|NCT02371759|41652214|FG007|Overall Study|Withdrawal by Subject|1|||
19406794|NCT02531633|41652237|FG000|Part A (52 Weeks)|Sponsor request|24|||
19406795|NCT02531633|41652238|FG001|Part A (52 Weeks)|Sponsor request|24|||
19406796|NCT02531633|41652239|FG002|Part A (52 Weeks)|Sponsor request|18|||
19406797|NCT02531633|41652240|FG003|Part A (52 Weeks)|Sponsor request|18|||
19406798|NCT02531633|41652241|FG004|Part A (52 Weeks)|Sponsor request|19|||
19406799|NCT02531633|41652242|FG005|Part A (52 Weeks)|Sponsor request|0|||
19406800|NCT02531633|41652243|FG006|Part A (52 Weeks)|Sponsor request|0|||
19406801|NCT02531633|41652244|FG007|Part A (52 Weeks)|Sponsor request|0|||
19406802|NCT02531633|41652245|FG008|Part A (52 Weeks)|Sponsor request|0|||
19406803|NCT02531633|41652246|FG009|Part A (52 Weeks)|Sponsor request|0|||
19406804|NCT02531633|41652237|FG000|Part A (52 Weeks)|Protocol Violation|1|||
19406805|NCT02531633|41652238|FG001|Part A (52 Weeks)|Protocol Violation|0|||
19406806|NCT02531633|41652239|FG002|Part A (52 Weeks)|Protocol Violation|0|||
19406807|NCT02531633|41652240|FG003|Part A (52 Weeks)|Protocol Violation|0|||
19406808|NCT02531633|41652241|FG004|Part A (52 Weeks)|Protocol Violation|0|||
19406809|NCT02531633|41652242|FG005|Part A (52 Weeks)|Protocol Violation|0|||
19406810|NCT02531633|41652243|FG006|Part A (52 Weeks)|Protocol Violation|0|||
19406811|NCT02531633|41652244|FG007|Part A (52 Weeks)|Protocol Violation|0|||
19406812|NCT02531633|41652245|FG008|Part A (52 Weeks)|Protocol Violation|0|||
19406813|NCT02531633|41652246|FG009|Part A (52 Weeks)|Protocol Violation|0|||
19406814|NCT02531633|41652237|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
19406815|NCT02531633|41652238|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
19406816|NCT02531633|41652239|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
19406817|NCT02531633|41652240|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
19406818|NCT02531633|41652241|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
19406819|NCT02531633|41652242|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
19406820|NCT02531633|41652243|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
19406821|NCT02531633|41652244|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
19406822|NCT02531633|41652245|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
19406823|NCT02531633|41652246|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
19406824|NCT02531633|41652237|FG000|Part A (52 Weeks)|Physician Decision|1|||
19406825|NCT02531633|41652238|FG001|Part A (52 Weeks)|Physician Decision|4|||
19406826|NCT02531633|41652239|FG002|Part A (52 Weeks)|Physician Decision|3|||
19406827|NCT02531633|41652240|FG003|Part A (52 Weeks)|Physician Decision|1|||
19518851|NCT01457352|41931926|FG001|Period 1|Protocol Violation|0|||
19406828|NCT02531633|41652241|FG004|Part A (52 Weeks)|Physician Decision|0|||
19406829|NCT02531633|41652242|FG005|Part A (52 Weeks)|Physician Decision|0|||
19406830|NCT02531633|41652243|FG006|Part A (52 Weeks)|Physician Decision|0|||
19406831|NCT02531633|41652244|FG007|Part A (52 Weeks)|Physician Decision|0|||
19406832|NCT02531633|41652245|FG008|Part A (52 Weeks)|Physician Decision|0|||
19406833|NCT02531633|41652246|FG009|Part A (52 Weeks)|Physician Decision|0|||
19406834|NCT02531633|41652237|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
19406835|NCT02531633|41652238|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
19406836|NCT02531633|41652239|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
19406837|NCT02531633|41652240|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
19406838|NCT02531633|41652241|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
19406839|NCT02531633|41652242|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
19406840|NCT02531633|41652243|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
19406841|NCT02531633|41652244|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
19406842|NCT02531633|41652245|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
19406843|NCT02531633|41652246|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
19406844|NCT02531633|41652237|FG000|Part A (52 Weeks)|Other|2|||
19406845|NCT02531633|41652238|FG001|Part A (52 Weeks)|Other|0|||
19406846|NCT02531633|41652239|FG002|Part A (52 Weeks)|Other|0|||
19406847|NCT02531633|41652240|FG003|Part A (52 Weeks)|Other|0|||
19406848|NCT02531633|41652241|FG004|Part A (52 Weeks)|Other|0|||
19406849|NCT02531633|41652242|FG005|Part A (52 Weeks)|Other|0|||
19406850|NCT02531633|41652243|FG006|Part A (52 Weeks)|Other|0|||
19406851|NCT02531633|41652244|FG007|Part A (52 Weeks)|Other|0|||
19406852|NCT02531633|41652245|FG008|Part A (52 Weeks)|Other|0|||
19406853|NCT02531633|41652246|FG009|Part A (52 Weeks)|Other|0|||
19406854|NCT02531633|41652237|FG000|Part B (104 Weeks)|Sponsor request|0|||
19406855|NCT02531633|41652238|FG001|Part B (104 Weeks)|Sponsor request|0|||
19406856|NCT02531633|41652239|FG002|Part B (104 Weeks)|Sponsor request|0|||
19406857|NCT02531633|41652240|FG003|Part B (104 Weeks)|Sponsor request|0|||
19406858|NCT02531633|41652241|FG004|Part B (104 Weeks)|Sponsor request|0|||
19406859|NCT02531633|41652242|FG005|Part B (104 Weeks)|Sponsor request|8|||
19406860|NCT02531633|41652243|FG006|Part B (104 Weeks)|Sponsor request|5|||
19406861|NCT02531633|41652244|FG007|Part B (104 Weeks)|Sponsor request|3|||
19406862|NCT02531633|41652245|FG008|Part B (104 Weeks)|Sponsor request|5|||
19406863|NCT02531633|41652246|FG009|Part B (104 Weeks)|Sponsor request|4|||
19406864|NCT02531633|41652237|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
19406865|NCT02531633|41652238|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
19406866|NCT02531633|41652239|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
19406867|NCT02531633|41652240|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
19406868|NCT02531633|41652241|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
19406869|NCT02531633|41652242|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
19406870|NCT02531633|41652243|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
19406871|NCT02531633|41652244|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
19406872|NCT02531633|41652245|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
19406873|NCT02531633|41652246|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
19406874|NCT02536313|41652288|FG000|Overall Study|Lack of Efficacy|0|||
19406875|NCT02536313|41652289|FG001|Overall Study|Lack of Efficacy|1|||
19406876|NCT02187861|41652301|FG000|Overall Study|Adverse Event|2|||
19406877|NCT02187861|41652302|FG001|Overall Study|Adverse Event|1|||
19406878|NCT02187861|41652303|FG002|Overall Study|Adverse Event|2|||
19406879|NCT02187861|41652304|FG003|Overall Study|Adverse Event|1|||
19406880|NCT02187861|41652301|FG000|Overall Study|Death|0|||
19406881|NCT02187861|41652302|FG001|Overall Study|Death|3|||
19406882|NCT02187861|41652303|FG002|Overall Study|Death|1|||
19406883|NCT02187861|41652304|FG003|Overall Study|Death|2|||
19406884|NCT02187861|41652301|FG000|Overall Study|Physician Decision|0|||
19406885|NCT02187861|41652302|FG001|Overall Study|Physician Decision|1|||
19406886|NCT02187861|41652303|FG002|Overall Study|Physician Decision|0|||
19406887|NCT02187861|41652304|FG003|Overall Study|Physician Decision|3|||
19406888|NCT02187861|41652301|FG000|Overall Study|Progressive Disease|4|||
19406889|NCT02187861|41652302|FG001|Overall Study|Progressive Disease|42|||
19406890|NCT02187861|41652303|FG002|Overall Study|Progressive Disease|19|||
19406891|NCT02187861|41652304|FG003|Overall Study|Progressive Disease|22|||
19406892|NCT02187861|41652301|FG000|Overall Study|Withdrawal by Subject|0|||
19406893|NCT02187861|41652302|FG001|Overall Study|Withdrawal by Subject|0|||
19406894|NCT02187861|41652303|FG002|Overall Study|Withdrawal by Subject|3|||
19406895|NCT02187861|41652304|FG003|Overall Study|Withdrawal by Subject|3|||
19406896|NCT02187861|41652301|FG000|Overall Study|Other|0|||
19406897|NCT02187861|41652302|FG001|Overall Study|Other|1|||
19406898|NCT02187861|41652303|FG002|Overall Study|Other|7|||
19406899|NCT02187861|41652304|FG003|Overall Study|Other|1|||
19406900|NCT02163993|41652319|FG000|Treatment Period|Adverse Event|0|||
19406901|NCT02163993|41652320|FG001|Treatment Period|Adverse Event|1|||
19406902|NCT02163993|41652321|FG002|Treatment Period|Adverse Event|0|||
19406903|NCT02163993|41652322|FG003|Treatment Period|Adverse Event|0|||
19406904|NCT02163993|41652323|FG004|Treatment Period|Adverse Event|1|||
19406905|NCT02163993|41652319|FG000|Treatment Period|Lost to Follow-up|2|||
19406906|NCT02163993|41652320|FG001|Treatment Period|Lost to Follow-up|3|||
19406907|NCT02163993|41652321|FG002|Treatment Period|Lost to Follow-up|1|||
19406908|NCT02163993|41652322|FG003|Treatment Period|Lost to Follow-up|3|||
19406909|NCT02163993|41652323|FG004|Treatment Period|Lost to Follow-up|1|||
19406910|NCT02163993|41652319|FG000|Treatment Period|Physician Decision|1|||
19406911|NCT02163993|41652320|FG001|Treatment Period|Physician Decision|0|||
19406912|NCT02163993|41652321|FG002|Treatment Period|Physician Decision|0|||
19406913|NCT02163993|41652322|FG003|Treatment Period|Physician Decision|0|||
19406914|NCT02163993|41652323|FG004|Treatment Period|Physician Decision|0|||
19406915|NCT02163993|41652319|FG000|Treatment Period|Protocol Violation|2|||
19406916|NCT02163993|41652320|FG001|Treatment Period|Protocol Violation|1|||
19406917|NCT02163993|41652321|FG002|Treatment Period|Protocol Violation|0|||
19406918|NCT02163993|41652322|FG003|Treatment Period|Protocol Violation|1|||
19406919|NCT02163993|41652323|FG004|Treatment Period|Protocol Violation|2|||
19406920|NCT02163993|41652319|FG000|Treatment Period|Withdrawal by Subject|6|||
19406921|NCT02163993|41652320|FG001|Treatment Period|Withdrawal by Subject|4|||
19406922|NCT02163993|41652321|FG002|Treatment Period|Withdrawal by Subject|1|||
19406923|NCT02163993|41652322|FG003|Treatment Period|Withdrawal by Subject|4|||
19406924|NCT02163993|41652323|FG004|Treatment Period|Withdrawal by Subject|1|||
19406925|NCT02163993|41652319|FG000|Treatment Period|Not treated|1|||
19406926|NCT02163993|41652320|FG001|Treatment Period|Not treated|0|||
19406927|NCT02163993|41652321|FG002|Treatment Period|Not treated|0|||
19406928|NCT02163993|41652322|FG003|Treatment Period|Not treated|1|||
19406929|NCT02163993|41652323|FG004|Treatment Period|Not treated|2|||
19406930|NCT02163993|41652319|FG000|Post-treatment Period|Adverse Event|0|||
19406931|NCT02163993|41652320|FG001|Post-treatment Period|Adverse Event|0|||
19406932|NCT02163993|41652321|FG002|Post-treatment Period|Adverse Event|1|||
19406933|NCT02163993|41652322|FG003|Post-treatment Period|Adverse Event|0|||
19406934|NCT02163993|41652323|FG004|Post-treatment Period|Adverse Event|0|||
19406935|NCT02163993|41652319|FG000|Post-treatment Period|Lost to Follow-up|2|||
19406936|NCT02163993|41652320|FG001|Post-treatment Period|Lost to Follow-up|2|||
19406937|NCT02163993|41652321|FG002|Post-treatment Period|Lost to Follow-up|3|||
19406938|NCT02163993|41652322|FG003|Post-treatment Period|Lost to Follow-up|1|||
19406939|NCT02163993|41652323|FG004|Post-treatment Period|Lost to Follow-up|0|||
19406940|NCT02163993|41652319|FG000|Post-treatment Period|Protocol Violation|0|||
19406941|NCT02163993|41652320|FG001|Post-treatment Period|Protocol Violation|0|||
19406942|NCT02163993|41652321|FG002|Post-treatment Period|Protocol Violation|0|||
19406943|NCT02163993|41652322|FG003|Post-treatment Period|Protocol Violation|0|||
19406944|NCT02163993|41652323|FG004|Post-treatment Period|Protocol Violation|1|||
19406945|NCT02163993|41652319|FG000|Post-treatment Period|Withdrawal by Subject|2|||
19406946|NCT02163993|41652320|FG001|Post-treatment Period|Withdrawal by Subject|4|||
19406947|NCT02163993|41652321|FG002|Post-treatment Period|Withdrawal by Subject|0|||
19406948|NCT02163993|41652322|FG003|Post-treatment Period|Withdrawal by Subject|1|||
19406949|NCT02163993|41652323|FG004|Post-treatment Period|Withdrawal by Subject|2|||
19406950|NCT02527421|41652346|FG000|Overall Study|Withdrawal by Subject|1|||
19406951|NCT02527421|41652347|FG001|Overall Study|Withdrawal by Subject|0|||
19406952|NCT02163915|41652358|FG000|Overall Study|Withdrawal by Subject|2|||
19406953|NCT02163915|41652359|FG001|Overall Study|Withdrawal by Subject|0|||
19406954|NCT02163915|41652360|FG002|Overall Study|Withdrawal by Subject|2|||
19406955|NCT02163915|41652361|FG003|Overall Study|Withdrawal by Subject|2|||
19406956|NCT02163915|41652362|FG004|Overall Study|Withdrawal by Subject|2|||
19406957|NCT02163915|41652358|FG000|Overall Study|Study termination|1|||
19406958|NCT02163915|41652359|FG001|Overall Study|Study termination|0|||
19406959|NCT02163915|41652360|FG002|Overall Study|Study termination|0|||
19406960|NCT02163915|41652361|FG003|Overall Study|Study termination|0|||
19406961|NCT02163915|41652362|FG004|Overall Study|Study termination|2|||
19406962|NCT02163915|41652358|FG000|Overall Study|Physician Decision|0|||
19406963|NCT02163915|41652359|FG001|Overall Study|Physician Decision|0|||
19406964|NCT02163915|41652360|FG002|Overall Study|Physician Decision|0|||
19406965|NCT02163915|41652361|FG003|Overall Study|Physician Decision|1|||
19406966|NCT02163915|41652362|FG004|Overall Study|Physician Decision|0|||
19406967|NCT02163759|41652381|FG000|Overall Study|Withdrawal by Subject|1|||
19406968|NCT02163759|41652382|FG001|Overall Study|Withdrawal by Subject|5|||
19406969|NCT02163759|41652383|FG002|Overall Study|Withdrawal by Subject|1|||
19406970|NCT02163759|41652381|FG000|Overall Study|Adverse Event|0|||
19628035|NCT00795639|42077447|FG001|Overall Study|Withdrawal by Subject|3|||
19628036|NCT00795639|42077446|FG000|Overall Study|Pregnancy|1|||
19406971|NCT02163759|41652382|FG001|Overall Study|Adverse Event|0|||
19406972|NCT02163759|41652383|FG002|Overall Study|Adverse Event|1|||
19406973|NCT02163759|41652381|FG000|Overall Study|Death|0|||
19406974|NCT02163759|41652382|FG001|Overall Study|Death|0|||
19406975|NCT02163759|41652383|FG002|Overall Study|Death|1|||
19406976|NCT02371369|41652396|FG000|Part 1|Physician Decision|0|||
19406977|NCT02371369|41652397|FG001|Part 1|Physician Decision|3|||
19406978|NCT02371369|41652396|FG000|Part 1|Adverse Event|8|||
19406979|NCT02371369|41652397|FG001|Part 1|Adverse Event|0|||
19406980|NCT02371369|41652396|FG000|Part 1|Withdrawal by Subject|1|||
19406981|NCT02371369|41652397|FG001|Part 1|Withdrawal by Subject|6|||
19406982|NCT02371369|41652396|FG000|Part 1|Disease progression|0|||
19406983|NCT02371369|41652397|FG001|Part 1|Disease progression|1|||
19406984|NCT02371369|41652396|FG000|Part 1|Protocol Violation|0|||
19406985|NCT02371369|41652397|FG001|Part 1|Protocol Violation|1|||
19406986|NCT02371369|41652396|FG000|Part 2|Adverse Event|6|||
19406987|NCT02371369|41652397|FG001|Part 2|Adverse Event|5|||
19406988|NCT02371369|41652396|FG000|Part 2|Withdrawal by Subject|16|||
19406989|NCT02371369|41652397|FG001|Part 2|Withdrawal by Subject|6|||
19406990|NCT02371369|41652396|FG000|Part 2|Investigator decision|1|||
19406991|NCT02371369|41652397|FG001|Part 2|Investigator decision|2|||
19406992|NCT02371369|41652396|FG000|Part 2|Death|0|||
19406993|NCT02371369|41652397|FG001|Part 2|Death|1|||
19406994|NCT02371369|41652396|FG000|Part 2|Disease progression|1|||
19406995|NCT02371369|41652397|FG001|Part 2|Disease progression|0|||
19406996|NCT02371369|41652396|FG000|Part 2|Subject Noncompliance|1|||
19406997|NCT02371369|41652397|FG001|Part 2|Subject Noncompliance|0|||
19406998|NCT02371369|41652396|FG000|Part 2|Lost to Follow-up|1|||
19406999|NCT02371369|41652397|FG001|Part 2|Lost to Follow-up|1|||
19407000|NCT02371369|41652396|FG000|Part 2|Subject transitioned to commercial supply|6|||
19407001|NCT02371369|41652397|FG001|Part 2|Subject transitioned to commercial supply|4|||
19407002|NCT02371369|41652396|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
19407003|NCT02371369|41652397|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
19407004|NCT02371369|41652396|FG000|Part 2|Surgical resection of tumor|1|||
19407005|NCT02371369|41652397|FG001|Part 2|Surgical resection of tumor|1|||
19407006|NCT02371369|41652396|FG000|Part 2|Other|0|||
19407007|NCT02371369|41652397|FG001|Part 2|Other|1|||
19407008|NCT02187783|41652419|FG000|Overall Study|Adverse Event|8|||
19407009|NCT02187783|41652419|FG000|Overall Study|Death|3|||
19407010|NCT02187783|41652419|FG000|Overall Study|Progressive disease|80|||
19407011|NCT02187783|41652419|FG000|Overall Study|Protocol Violation|3|||
19407012|NCT02187783|41652419|FG000|Overall Study|Physician Decision|2|||
19407013|NCT02187783|41652419|FG000|Overall Study|Withdrawal by Subject|9|||
19407014|NCT02187783|41652419|FG000|Overall Study|Study terminated by sponsor|1|||
19407015|NCT02337361|41652425|FG000|3-month Follow-up|Lost to Follow-up|19|||
19407016|NCT02337361|41652426|FG001|3-month Follow-up|Lost to Follow-up|14|||
19407017|NCT02337361|41652425|FG000|6-month Follow-up|Lost to Follow-up|2|||
19407018|NCT02337361|41652426|FG001|6-month Follow-up|Lost to Follow-up|4|||
19407019|NCT02336737|41652433|FG000|Overall Study|Withdrawal by Subject|5|||
19407020|NCT02336737|41652433|FG000|Overall Study|Physician Decision|8|||
19407021|NCT02130765|41652442|FG000|Overall Study|Did not receive treatment|4|||
19407022|NCT02130765|41652443|FG001|Overall Study|Did not receive treatment|0|||
19407023|NCT02130765|41652444|FG002|Overall Study|Did not receive treatment|0|||
19407024|NCT02130765|41652445|FG003|Overall Study|Did not receive treatment|0|||
19407025|NCT02305381|41652460|FG000|Overall Study|Unclassified|5|||
19407026|NCT02305381|41652461|FG001|Overall Study|Unclassified|5|||
19407027|NCT02305381|41652462|FG002|Overall Study|Unclassified|7|||
19407028|NCT02336425|41652474|FG000|Overall Study|Study terminated.|2|||
19407029|NCT02336425|41652475|FG001|Overall Study|Study terminated.|2|||
19407030|NCT02336425|41652476|FG002|Overall Study|Study terminated.|3|||
19407031|NCT02336425|41652477|FG003|Overall Study|Study terminated.|3|||
19407032|NCT02163447|41652490|FG000|Overall Study|Withdrawal by Subject|2|||
19407033|NCT02163447|41652491|FG001|Overall Study|Withdrawal by Subject|0|||
19407034|NCT02163447|41652492|FG002|Overall Study|Withdrawal by Subject|1|||
19407035|NCT02163447|41652490|FG000|Overall Study|Lost to Follow-up|1|||
19407036|NCT02163447|41652491|FG001|Overall Study|Lost to Follow-up|3|||
19407037|NCT02163447|41652492|FG002|Overall Study|Lost to Follow-up|0|||
19407038|NCT02163447|41652490|FG000|Overall Study|Moved out of study area|2|||
19407039|NCT02163447|41652491|FG001|Overall Study|Moved out of study area|3|||
19407040|NCT02163447|41652492|FG002|Overall Study|Moved out of study area|2|||
19407041|NCT02163447|41652490|FG000|Overall Study|Became HIV infected at time of delivery|1|||
19407042|NCT02163447|41652491|FG001|Overall Study|Became HIV infected at time of delivery|0|||
19407043|NCT02163447|41652492|FG002|Overall Study|Became HIV infected at time of delivery|0|||
19407044|NCT02370667|41652513|FG000|Overall Study|Lost to Follow-up|0|||
19407045|NCT02370667|41652514|FG001|Overall Study|Lost to Follow-up|1|||
19407046|NCT02370667|41652515|FG002|Overall Study|Lost to Follow-up|0|||
19407047|NCT02130297|41652523|FG000|Overall Study|Lost to Follow-up|4|||
19407048|NCT01931956|41652531|FG000|Overall Study|Death|42|||
19407049|NCT01931956|41652532|FG001|Overall Study|Death|7|||
19407050|NCT01931956|41652533|FG002|Overall Study|Death|379|||
19407051|NCT01931956|41652534|FG003|Overall Study|Death|96|||
19407052|NCT01931956|41652531|FG000|Overall Study|Withdrawal by Subject|5|||
19407053|NCT01931956|41652532|FG001|Overall Study|Withdrawal by Subject|0|||
19407054|NCT01931956|41652533|FG002|Overall Study|Withdrawal by Subject|70|||
19407055|NCT01931956|41652534|FG003|Overall Study|Withdrawal by Subject|30|||
19407056|NCT01931956|41652531|FG000|Overall Study|Lost to Follow-up|2|||
19407057|NCT01931956|41652532|FG001|Overall Study|Lost to Follow-up|0|||
19407058|NCT01931956|41652533|FG002|Overall Study|Lost to Follow-up|11|||
19407059|NCT01931956|41652534|FG003|Overall Study|Lost to Follow-up|7|||
19407060|NCT01931956|41652531|FG000|Overall Study|Expected|2|||
19407061|NCT01931956|41652532|FG001|Overall Study|Expected|0|||
19407062|NCT01931956|41652533|FG002|Overall Study|Expected|6|||
19407063|NCT01931956|41652534|FG003|Overall Study|Expected|0|||
19407064|NCT01931956|41652531|FG000|Overall Study|Not due|0|||
19407065|NCT01931956|41652532|FG001|Overall Study|Not due|0|||
19407066|NCT01931956|41652533|FG002|Overall Study|Not due|21|||
19407067|NCT01931956|41652534|FG003|Overall Study|Not due|0|||
19407068|NCT01887418|41652560|FG000|Overall Study|Travelling difficulties|0|||
19407069|NCT01887418|41652561|FG001|Overall Study|Travelling difficulties|0|||
19407070|NCT01887418|41652562|FG002|Overall Study|Travelling difficulties|1|||
19407071|NCT01886716|41652574|FG000|Week 1|Lost to Follow-up|0|||
19407072|NCT01886716|41652575|FG001|Week 1|Lost to Follow-up|0|||
19407073|NCT01886716|41652576|FG002|Week 1|Lost to Follow-up|2|||
19407074|NCT01886716|41652577|FG003|Week 1|Lost to Follow-up|2|||
19407075|NCT01886716|41652574|FG000|Week 2|Lost to Follow-up|3|||
19407076|NCT01886716|41652575|FG001|Week 2|Lost to Follow-up|2|||
19407077|NCT01886716|41652576|FG002|Week 2|Lost to Follow-up|1|||
19407078|NCT01886716|41652577|FG003|Week 2|Lost to Follow-up|3|||
19407079|NCT01886716|41652574|FG000|Week 3|Lost to Follow-up|1|||
19407080|NCT01886716|41652575|FG001|Week 3|Lost to Follow-up|1|||
19407081|NCT01886716|41652576|FG002|Week 3|Lost to Follow-up|0|||
19407082|NCT01886716|41652577|FG003|Week 3|Lost to Follow-up|1|||
19407083|NCT01912612|41652589|FG000|Overall Study|Adverse Event|4|||
19407084|NCT01912612|41652590|FG001|Overall Study|Adverse Event|0|||
19407085|NCT01912612|41652591|FG002|Overall Study|Adverse Event|0|||
19407086|NCT01912612|41652589|FG000|Overall Study|Withdrew consent|1|||
19407087|NCT01912612|41652590|FG001|Overall Study|Withdrew consent|0|||
19407088|NCT01912612|41652591|FG002|Overall Study|Withdrew consent|0|||
19407089|NCT01912612|41652589|FG000|Overall Study|Study design change|0|||
19407090|NCT01912612|41652590|FG001|Overall Study|Study design change|0|||
19407091|NCT01912612|41652591|FG002|Overall Study|Study design change|3|||
19407092|NCT02370511|41652600|FG000|Overall Study|Death|10|||
19407093|NCT02370511|41652601|FG001|Overall Study|Death|7|||
19407094|NCT02370511|41652602|FG002|Overall Study|Death|1|||
19407095|NCT02370511|41652600|FG000|Overall Study|Withdrawal by Subject|2|||
19407096|NCT02370511|41652601|FG001|Overall Study|Withdrawal by Subject|0|||
19407097|NCT02370511|41652602|FG002|Overall Study|Withdrawal by Subject|0|||
19407098|NCT02370511|41652600|FG000|Overall Study|Lost to Follow-up|0|||
19407099|NCT02370511|41652601|FG001|Overall Study|Lost to Follow-up|4|||
19407100|NCT02370511|41652602|FG002|Overall Study|Lost to Follow-up|0|||
19407101|NCT02303041|41652612|FG000|Overall Study|Adverse Event|1|||
19407102|NCT02303041|41652613|FG001|Overall Study|Adverse Event|2|||
19407103|NCT02302807|41652621|FG000|Overall Study|Withdrawal by Subject|28|||
19407104|NCT02302807|41652622|FG001|Overall Study|Withdrawal by Subject|11|||
19407105|NCT02302807|41652621|FG000|Overall Study|Lost to Follow-up|4|||
19407106|NCT02302807|41652622|FG001|Overall Study|Lost to Follow-up|6|||
19407107|NCT02302807|41652621|FG000|Overall Study|Death|397|||
19407108|NCT02302807|41652622|FG001|Overall Study|Death|385|||
19407109|NCT02302807|41652621|FG000|Overall Study|Study Terminated By Sponsor|35|||
19407110|NCT02302807|41652622|FG001|Overall Study|Study Terminated By Sponsor|64|||
19407111|NCT02302807|41652621|FG000|Overall Study|Physician Decision|0|||
19407112|NCT02302807|41652622|FG001|Overall Study|Physician Decision|1|||
19407113|NCT02335489|41652641|FG000|Overall Study|Sponsor terminated study|4|||
19711085|NCT00111813|42154252|FG000|Overall Study|Lack of Efficacy|0|||
19711086|NCT00111813|42154253|FG001|Overall Study|Lack of Efficacy|0|||
19711087|NCT00111813|42154254|FG002|Overall Study|Lack of Efficacy|0|||
19711088|NCT00111813|42154255|FG003|Overall Study|Lack of Efficacy|0|||
19711089|NCT00111813|42154256|FG004|Overall Study|Lack of Efficacy|0|||
19407114|NCT02335489|41652641|FG000|Overall Study|Lost to Follow-up|1|||
19407115|NCT02335489|41652641|FG000|Overall Study|Withdrawal by Subject|2|||
19407116|NCT02335489|41652641|FG000|Overall Study|Physician Decision|2|||
19407117|NCT02335489|41652641|FG000|Overall Study|Lack of Efficacy|1|||
19407118|NCT02527343|41652647|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
19407119|NCT02527343|41652648|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
19407120|NCT02527343|41652649|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
19407121|NCT02527343|41652650|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
19407122|NCT02527343|41652651|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
19407123|NCT02527343|41652652|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
19407124|NCT02527343|41652647|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
19407125|NCT02527343|41652648|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
19407126|NCT02527343|41652649|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
19407127|NCT02527343|41652650|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
19407128|NCT02527343|41652651|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
19407129|NCT02527343|41652652|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
19407130|NCT02527343|41652647|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
19407131|NCT02527343|41652648|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
19407132|NCT02527343|41652649|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
19407133|NCT02527343|41652650|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
19407134|NCT02527343|41652651|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
19407135|NCT02527343|41652652|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
19407136|NCT02527343|41652647|FG000|RT Period: Weeks 1 to 52|Other|4|||
19407137|NCT02527343|41652648|FG001|RT Period: Weeks 1 to 52|Other|3|||
19407138|NCT02527343|41652649|FG002|RT Period: Weeks 1 to 52|Other|0|||
19407139|NCT02527343|41652650|FG003|RT Period: Weeks 1 to 52|Other|0|||
19407140|NCT02527343|41652651|FG004|RT Period: Weeks 1 to 52|Other|0|||
19407141|NCT02527343|41652652|FG005|RT Period: Weeks 1 to 52|Other|0|||
19407142|NCT02527343|41652647|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
19407143|NCT02527343|41652648|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
19407144|NCT02527343|41652649|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
19407145|NCT02527343|41652650|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
19407146|NCT02527343|41652651|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
19407147|NCT02527343|41652652|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
19407148|NCT02527343|41652647|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
19407149|NCT02527343|41652648|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
19407150|NCT02527343|41652649|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
19407151|NCT02527343|41652650|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
19407152|NCT02527343|41652651|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
19407153|NCT02527343|41652652|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
19407154|NCT02527343|41652647|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
19628037|NCT00795639|42077447|FG001|Overall Study|Pregnancy|0|||
19711090|NCT00111813|42154257|FG005|Overall Study|Lack of Efficacy|1|||
19407155|NCT02527343|41652648|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
19407156|NCT02527343|41652649|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
19407157|NCT02527343|41652650|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
19407158|NCT02527343|41652651|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
19407159|NCT02527343|41652652|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
19407160|NCT02527343|41652647|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
19407161|NCT02527343|41652648|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
19407162|NCT02527343|41652649|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
19407163|NCT02527343|41652650|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
19407164|NCT02527343|41652651|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
19407165|NCT02527343|41652652|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
19407166|NCT02527343|41652647|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
19407167|NCT02527343|41652648|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
19407168|NCT02527343|41652649|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
19407169|NCT02527343|41652650|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
19407170|NCT02527343|41652651|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
19407171|NCT02527343|41652652|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
19407172|NCT02527343|41652647|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
19407173|NCT02527343|41652648|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
19407174|NCT02527343|41652649|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
19407175|NCT02527343|41652650|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
19407176|NCT02527343|41652651|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
19407177|NCT02527343|41652652|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
19407178|NCT02527343|41652647|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
19407179|NCT02527343|41652648|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
19407180|NCT02527343|41652649|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
19407181|NCT02527343|41652650|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
19407182|NCT02527343|41652651|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
19407183|NCT02527343|41652652|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
19407184|NCT02527343|41652647|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
19407185|NCT02527343|41652648|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
19407186|NCT02527343|41652649|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
19407187|NCT02527343|41652650|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
19407188|NCT02527343|41652651|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
19407189|NCT02527343|41652652|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
19407190|NCT02527343|41652647|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
19407191|NCT02527343|41652648|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
19407192|NCT02527343|41652649|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
19407193|NCT02527343|41652650|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
19407194|NCT02527343|41652651|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
19407195|NCT02527343|41652652|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
19407196|NCT01931566|41652670|FG000|Overall Study|Randomized But Not Treated|6|||
19407197|NCT01931566|41652671|FG001|Overall Study|Randomized But Not Treated|9|||
19407198|NCT01931566|41652672|FG002|Overall Study|Randomized But Not Treated|14|||
19407199|NCT01931566|41652670|FG000|Overall Study|Adverse Event|37|||
19407200|NCT01931566|41652671|FG001|Overall Study|Adverse Event|167|||
19407201|NCT01931566|41652672|FG002|Overall Study|Adverse Event|132|||
19407202|NCT01931566|41652670|FG000|Overall Study|Major Protocol Deviation|5|||
19407203|NCT01931566|41652671|FG001|Overall Study|Major Protocol Deviation|14|||
19407204|NCT01931566|41652672|FG002|Overall Study|Major Protocol Deviation|21|||
19407205|NCT01931566|41652670|FG000|Overall Study|Lost to Follow-up|3|||
19407206|NCT01931566|41652671|FG001|Overall Study|Lost to Follow-up|26|||
19407207|NCT01931566|41652672|FG002|Overall Study|Lost to Follow-up|23|||
19407208|NCT01931566|41652670|FG000|Overall Study|Voluntary Withdrawal|78|||
19407209|NCT01931566|41652671|FG001|Overall Study|Voluntary Withdrawal|245|||
19407210|NCT01931566|41652672|FG002|Overall Study|Voluntary Withdrawal|225|||
19407211|NCT01931566|41652670|FG000|Overall Study|Study Termination|289|||
19407212|NCT01931566|41652671|FG001|Overall Study|Study Termination|968|||
19407213|NCT01931566|41652672|FG002|Overall Study|Study Termination|1037|||
19407214|NCT01931566|41652670|FG000|Overall Study|Reason Not Specified|11|||
19407215|NCT01931566|41652671|FG001|Overall Study|Reason Not Specified|47|||
19407216|NCT01931566|41652672|FG002|Overall Study|Reason Not Specified|53|||
19407217|NCT01931566|41652670|FG000|Overall Study|Missing|0|||
19407218|NCT01931566|41652671|FG001|Overall Study|Missing|0|||
19407219|NCT01931566|41652672|FG002|Overall Study|Missing|1|||
19407220|NCT01912456|41652683|FG000|Period 1|Physician Decision|0|||
19628038|NCT00795639|42077446|FG000|Overall Study|Adverse Event|5|||
19407221|NCT01912456|41652684|FG001|Period 1|Physician Decision|0|||
19407222|NCT01912456|41652685|FG002|Period 1|Physician Decision|1|||
19407223|NCT01912456|41652686|FG003|Period 1|Physician Decision|0|||
19407224|NCT01912456|41652683|FG000|Period 1|non-compliance|1|||
19407225|NCT01912456|41652684|FG001|Period 1|non-compliance|0|||
19407226|NCT01912456|41652685|FG002|Period 1|non-compliance|0|||
19407227|NCT01912456|41652686|FG003|Period 1|non-compliance|1|||
19407228|NCT01912456|41652683|FG000|Period 1|Adverse Event|1|||
19407229|NCT01912456|41652684|FG001|Period 1|Adverse Event|0|||
19407230|NCT01912456|41652685|FG002|Period 1|Adverse Event|0|||
19407231|NCT01912456|41652686|FG003|Period 1|Adverse Event|1|||
19407232|NCT01912456|41652683|FG000|Period 1|Withdrawal by Subject|0|||
19407233|NCT01912456|41652684|FG001|Period 1|Withdrawal by Subject|1|||
19407234|NCT01912456|41652685|FG002|Period 1|Withdrawal by Subject|1|||
19407235|NCT01912456|41652686|FG003|Period 1|Withdrawal by Subject|1|||
19407236|NCT01912456|41652683|FG000|Period 2|Lack of Efficacy|0|||
19407237|NCT01912456|41652684|FG001|Period 2|Lack of Efficacy|2|||
19407238|NCT01912456|41652685|FG002|Period 2|Lack of Efficacy|0|||
19407239|NCT01912456|41652686|FG003|Period 2|Lack of Efficacy|0|||
19407240|NCT01912456|41652683|FG000|Period 2|Adverse Event|0|||
19407241|NCT01912456|41652684|FG001|Period 2|Adverse Event|0|||
19407242|NCT01912456|41652685|FG002|Period 2|Adverse Event|0|||
19407243|NCT01912456|41652686|FG003|Period 2|Adverse Event|1|||
19407244|NCT01885936|41652698|FG000|Overall Study|Withdrawal by Subject|1|||
19407245|NCT01885936|41652699|FG001|Overall Study|Withdrawal by Subject|0|||
19407246|NCT01912222|41652708|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
19407247|NCT01912222|41652709|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
19407248|NCT01912222|41652710|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
19407249|NCT01912222|41652708|FG000|Part B: Treatment Period|Progressive disease|10|||
19407250|NCT01912222|41652709|FG001|Part B: Treatment Period|Progressive disease|12|||
19407251|NCT01912222|41652710|FG002|Part B: Treatment Period|Progressive disease|15|||
19407252|NCT01912222|41652708|FG000|Part B: Treatment Period|Adverse Event|1|||
19407253|NCT01912222|41652709|FG001|Part B: Treatment Period|Adverse Event|2|||
19407254|NCT01912222|41652710|FG002|Part B: Treatment Period|Adverse Event|3|||
19407255|NCT01912222|41652708|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
19407256|NCT01912222|41652709|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
19407257|NCT01912222|41652710|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
19407258|NCT02525861|41652721|FG000|Overall Study|Adverse Event|1|||
19407259|NCT02525861|41652722|FG001|Overall Study|Adverse Event|0|||
19407260|NCT02525861|41652721|FG000|Overall Study|Withdrawal by Subject|0|||
19407261|NCT02525861|41652722|FG001|Overall Study|Withdrawal by Subject|1|||
19407262|NCT02525861|41652721|FG000|Overall Study|Physician Decision|0|||
19407263|NCT02525861|41652722|FG001|Overall Study|Physician Decision|1|||
19407264|NCT02524847|41652730|FG000|Overall Study|Adverse Event|4|||
19407265|NCT02524847|41652730|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
19407266|NCT02524847|41652730|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
19407267|NCT02524847|41652730|FG000|Overall Study|Death|1|||
19407268|NCT02524847|41652730|FG000|Overall Study|Reason not Specified|1|||
19407269|NCT02525627|41652737|FG000|Overall Study|Revision|1|||
19407270|NCT02525627|41652738|FG001|Overall Study|Revision|1|||
19407271|NCT02525627|41652737|FG000|Overall Study|Withdrawal by Subject|1|||
19407272|NCT02525627|41652738|FG001|Overall Study|Withdrawal by Subject|2|||
19407273|NCT02525627|41652737|FG000|Overall Study|Death|1|||
19407274|NCT02525627|41652738|FG001|Overall Study|Death|0|||
19407275|NCT02525627|41652737|FG000|Overall Study|Site terminated|11|||
19407276|NCT02525627|41652738|FG001|Overall Study|Site terminated|10|||
19407277|NCT02129205|41652754|FG000|Overall Study|Withdrawal by Subject|0|||
19407278|NCT02129205|41652755|FG001|Overall Study|Withdrawal by Subject|0|||
19407279|NCT02129205|41652756|FG002|Overall Study|Withdrawal by Subject|0|||
19407280|NCT02129205|41652757|FG003|Overall Study|Withdrawal by Subject|0|||
19407281|NCT02129205|41652758|FG004|Overall Study|Withdrawal by Subject|1|||
19407282|NCT02129205|41652759|FG005|Overall Study|Withdrawal by Subject|1|||
19407283|NCT02129205|41652760|FG006|Overall Study|Withdrawal by Subject|1|||
19407284|NCT02129205|41652761|FG007|Overall Study|Withdrawal by Subject|0|||
19407285|NCT02129205|41652762|FG008|Overall Study|Withdrawal by Subject|1|||
19407286|NCT02129205|41652763|FG009|Overall Study|Withdrawal by Subject|0|||
19407287|NCT02129205|41652754|FG000|Overall Study|Other|1|||
19407288|NCT02129205|41652755|FG001|Overall Study|Other|0|||
19407289|NCT02129205|41652756|FG002|Overall Study|Other|0|||
19407290|NCT02129205|41652757|FG003|Overall Study|Other|0|||
19407291|NCT02129205|41652758|FG004|Overall Study|Other|2|||
19407292|NCT02129205|41652759|FG005|Overall Study|Other|3|||
19407293|NCT02129205|41652760|FG006|Overall Study|Other|3|||
19407294|NCT02129205|41652761|FG007|Overall Study|Other|2|||
19407295|NCT02129205|41652762|FG008|Overall Study|Other|1|||
19407296|NCT02129205|41652763|FG009|Overall Study|Other|0|||
19407297|NCT02128269|41652787|FG000|Treatment Period|Adverse Event|1|||
19407298|NCT02128269|41652787|FG000|Treatment Period|Physician Decision|1|||
19407299|NCT01626885|41652791|FG000|Overall Study|Adverse Event|8|||
19407300|NCT01626885|41652791|FG000|Overall Study|Withdrawal by Subject|4|||
19407301|NCT02524379|41652795|FG000|Overall Study|Death|1|||
19407302|NCT02524145|41652802|FG000|Overall Study|Withdrawal by Subject|2|||
19407303|NCT02524145|41652803|FG001|Overall Study|Withdrawal by Subject|2|||
19628039|NCT00795639|42077447|FG001|Overall Study|Adverse Event|2|||
19407304|NCT02524145|41652804|FG002|Overall Study|Withdrawal by Subject|3|||
19407305|NCT01658813|41652812|FG000|Overall Study|Disease progression|3|||
19407306|NCT02187471|41652824|FG000|Overall Study|Protocol Violation|4|||
19407307|NCT02187471|41652825|FG001|Overall Study|Protocol Violation|5|||
19407308|NCT02187471|41652826|FG002|Overall Study|Protocol Violation|4|||
19407309|NCT02187471|41652827|FG003|Overall Study|Protocol Violation|4|||
19407310|NCT02187471|41652824|FG000|Overall Study|Missing|0|||
19407311|NCT02187471|41652825|FG001|Overall Study|Missing|0|||
19407312|NCT02187471|41652826|FG002|Overall Study|Missing|0|||
19407313|NCT02187471|41652827|FG003|Overall Study|Missing|1|||
19407314|NCT02187471|41652824|FG000|Overall Study|Lack of Efficacy|18|||
19407315|NCT02187471|41652825|FG001|Overall Study|Lack of Efficacy|9|||
19407316|NCT02187471|41652826|FG002|Overall Study|Lack of Efficacy|13|||
19407317|NCT02187471|41652827|FG003|Overall Study|Lack of Efficacy|11|||
19407318|NCT02187471|41652824|FG000|Overall Study|Adverse Event|24|||
19407319|NCT02187471|41652825|FG001|Overall Study|Adverse Event|34|||
19407320|NCT02187471|41652826|FG002|Overall Study|Adverse Event|44|||
19407321|NCT02187471|41652827|FG003|Overall Study|Adverse Event|36|||
19407322|NCT02187471|41652824|FG000|Overall Study|Withdrawal by Subject|23|||
19407323|NCT02187471|41652825|FG001|Overall Study|Withdrawal by Subject|29|||
19407324|NCT02187471|41652826|FG002|Overall Study|Withdrawal by Subject|22|||
19407325|NCT02187471|41652827|FG003|Overall Study|Withdrawal by Subject|24|||
19407326|NCT02187471|41652824|FG000|Overall Study|Other|7|||
19407327|NCT02187471|41652825|FG001|Overall Study|Other|5|||
19407328|NCT02187471|41652826|FG002|Overall Study|Other|3|||
19407329|NCT02187471|41652827|FG003|Overall Study|Other|4|||
19407330|NCT02525471|41652838|FG000|Overall Study|Screen Failure|6|||
19407331|NCT02525471|41652838|FG000|Overall Study|Withdrawal by Subject|4|||
19407332|NCT02525471|41652838|FG000|Overall Study|Death|1|||
19407333|NCT01658735|41652846|FG000|Overall Study|Lack of Efficacy|1|||
19407334|NCT01658735|41652847|FG001|Overall Study|Lack of Efficacy|0|||
19407335|NCT01658735|41652848|FG002|Overall Study|Lack of Efficacy|1|||
19407336|NCT01658735|41652846|FG000|Overall Study|Lost to Follow-up|1|||
19407337|NCT01658735|41652847|FG001|Overall Study|Lost to Follow-up|1|||
19407338|NCT01658735|41652848|FG002|Overall Study|Lost to Follow-up|0|||
19407339|NCT01658735|41652846|FG000|Overall Study|Protocol Violation|0|||
19407340|NCT01658735|41652847|FG001|Overall Study|Protocol Violation|1|||
19407341|NCT01658735|41652848|FG002|Overall Study|Protocol Violation|0|||
19407342|NCT01658735|41652846|FG000|Overall Study|Withdrawal by Subject|3|||
19407343|NCT01658735|41652847|FG001|Overall Study|Withdrawal by Subject|5|||
19407344|NCT01658735|41652848|FG002|Overall Study|Withdrawal by Subject|3|||
19407345|NCT02523599|41652858|FG000|Overall Study|Adverse Event|1|||
19407346|NCT02523599|41652859|FG001|Overall Study|Adverse Event|0|||
19407347|NCT02523599|41652858|FG000|Overall Study|Physician Decision|1|||
19407348|NCT02523599|41652859|FG001|Overall Study|Physician Decision|0|||
19407349|NCT02523599|41652858|FG000|Overall Study|Lost to Follow-up|4|||
19407350|NCT02523599|41652859|FG001|Overall Study|Lost to Follow-up|1|||
19407351|NCT02523599|41652858|FG000|Overall Study|Did not return for Day 30 visit|2|||
19407352|NCT02523599|41652859|FG001|Overall Study|Did not return for Day 30 visit|0|||
19407353|NCT02187159|41652869|FG000|Overall Study|Protocol Violation|4|||
19407354|NCT02187159|41652870|FG001|Overall Study|Protocol Violation|6|||
19407355|NCT02187159|41652871|FG002|Overall Study|Protocol Violation|3|||
19407356|NCT02187159|41652872|FG003|Overall Study|Protocol Violation|4|||
19407357|NCT02187159|41652869|FG000|Overall Study|Lack of Efficacy|10|||
19407358|NCT02187159|41652870|FG001|Overall Study|Lack of Efficacy|5|||
19407359|NCT02187159|41652871|FG002|Overall Study|Lack of Efficacy|4|||
19407360|NCT02187159|41652872|FG003|Overall Study|Lack of Efficacy|7|||
19407361|NCT02187159|41652869|FG000|Overall Study|Adverse Event|28|||
19407362|NCT02187159|41652870|FG001|Overall Study|Adverse Event|33|||
19407363|NCT02187159|41652871|FG002|Overall Study|Adverse Event|42|||
19407364|NCT02187159|41652872|FG003|Overall Study|Adverse Event|50|||
19407365|NCT02187159|41652869|FG000|Overall Study|Withdrawal by Subject|24|||
19407366|NCT02187159|41652870|FG001|Overall Study|Withdrawal by Subject|28|||
19407367|NCT02187159|41652871|FG002|Overall Study|Withdrawal by Subject|25|||
19407368|NCT02187159|41652872|FG003|Overall Study|Withdrawal by Subject|26|||
19407369|NCT02187159|41652869|FG000|Overall Study|Other|3|||
19407370|NCT02187159|41652870|FG001|Overall Study|Other|7|||
19407371|NCT02187159|41652871|FG002|Overall Study|Other|3|||
19407372|NCT02187159|41652872|FG003|Overall Study|Other|9|||
19407373|NCT02335411|41652885|FG000|Overall Study|Death|223|||
19407374|NCT02335411|41652886|FG001|Overall Study|Death|22|||
19407375|NCT02335411|41652887|FG002|Overall Study|Death|26|||
19407376|NCT02335411|41652885|FG000|Overall Study|Physician Decision|3|||
19407377|NCT02335411|41652886|FG001|Overall Study|Physician Decision|0|||
19407378|NCT02335411|41652887|FG002|Overall Study|Physician Decision|0|||
19407379|NCT02335411|41652885|FG000|Overall Study|Protocol Violation|1|||
19407380|NCT02335411|41652886|FG001|Overall Study|Protocol Violation|0|||
19407381|NCT02335411|41652887|FG002|Overall Study|Protocol Violation|0|||
19407382|NCT02335411|41652885|FG000|Overall Study|Withdrawal by Subject|11|||
19407383|NCT02335411|41652886|FG001|Overall Study|Withdrawal by Subject|0|||
19407384|NCT02335411|41652887|FG002|Overall Study|Withdrawal by Subject|3|||
19407385|NCT02335411|41652885|FG000|Overall Study|Sponsor Decision|12|||
19407386|NCT02335411|41652886|FG001|Overall Study|Sponsor Decision|3|||
19407387|NCT02335411|41652887|FG002|Overall Study|Sponsor Decision|2|||
19407388|NCT02335411|41652885|FG000|Overall Study|Adverse Event|9|||
19407389|NCT02335411|41652886|FG001|Overall Study|Adverse Event|0|||
19407390|NCT02335411|41652887|FG002|Overall Study|Adverse Event|0|||
19407391|NCT02186301|41652901|FG000|Overall Study|Progressive Disease|7|||
19407392|NCT02186301|41652902|FG001|Overall Study|Progressive Disease|22|||
19407393|NCT02186301|41652903|FG002|Overall Study|Progressive Disease|27|||
19407394|NCT02186301|41652901|FG000|Overall Study|Adverse Event|5|||
19407395|NCT02186301|41652902|FG001|Overall Study|Adverse Event|5|||
19407396|NCT02186301|41652903|FG002|Overall Study|Adverse Event|5|||
19407397|NCT02186301|41652901|FG000|Overall Study|Death|1|||
19407398|NCT02186301|41652902|FG001|Overall Study|Death|0|||
19407399|NCT02186301|41652903|FG002|Overall Study|Death|0|||
19407400|NCT02186301|41652901|FG000|Overall Study|Withdrawal by Subject|5|||
19407401|NCT02186301|41652902|FG001|Overall Study|Withdrawal by Subject|1|||
19407402|NCT02186301|41652903|FG002|Overall Study|Withdrawal by Subject|3|||
19407403|NCT02186301|41652901|FG000|Overall Study|Physician Decision|1|||
19407404|NCT02186301|41652902|FG001|Overall Study|Physician Decision|0|||
19407405|NCT02186301|41652903|FG002|Overall Study|Physician Decision|1|||
19407406|NCT02186301|41652901|FG000|Overall Study|Study Terminated by Sponsor|1|||
19407407|NCT02186301|41652902|FG001|Overall Study|Study Terminated by Sponsor|0|||
19407408|NCT02186301|41652903|FG002|Overall Study|Study Terminated by Sponsor|11|||
19407409|NCT02186301|41652901|FG000|Overall Study|Protocol Deviation|0|||
19407410|NCT02186301|41652902|FG001|Overall Study|Protocol Deviation|2|||
19407411|NCT02186301|41652903|FG002|Overall Study|Protocol Deviation|0|||
19407412|NCT02186301|41652901|FG000|Overall Study|Missing|0|||
19407413|NCT02186301|41652902|FG001|Overall Study|Missing|0|||
19407414|NCT02186301|41652903|FG002|Overall Study|Missing|2|||
19407415|NCT02186301|41652901|FG000|Overall Study|Other|0|||
19407416|NCT02186301|41652902|FG001|Overall Study|Other|0|||
19407417|NCT02186301|41652903|FG002|Overall Study|Other|1|||
19407418|NCT02186223|41652913|FG000|Overall Study|Not eligible for device placement|6|||
19407419|NCT02186223|41652913|FG000|Overall Study|Unable to obtain femoral access|3|||
19407420|NCT02186223|41652913|FG000|Overall Study|Death|3|||
19407421|NCT02186223|41652913|FG000|Overall Study|Device in place less than 48 hours|9|||
19407422|NCT02163057|41652920|FG000|Overall Study|Participant Refusal to Continue|2|||
19407423|NCT02163057|41652921|FG001|Overall Study|Participant Refusal to Continue|2|||
19407424|NCT02163057|41652920|FG000|Overall Study|Participant Significant Noncompliance|0|||
19407425|NCT02163057|41652921|FG001|Overall Study|Participant Significant Noncompliance|1|||
19407426|NCT02163057|41652920|FG000|Overall Study|Progression of Disease|1|||
19407427|NCT02163057|41652921|FG001|Overall Study|Progression of Disease|2|||
19407428|NCT02185521|41652929|FG000|Overall Study|Withdrawal by Subject|1|||
19407429|NCT02185521|41652929|FG000|Overall Study|Protocol Violation|1|||
19407430|NCT01599585|41652936|FG000|Overall Study|Withdrawal by Subject|16|||
19407431|NCT01599585|41652937|FG001|Overall Study|Withdrawal by Subject|9|||
19407432|NCT01599585|41652936|FG000|Overall Study|Lost to Follow-up|3|||
19407433|NCT01599585|41652937|FG001|Overall Study|Lost to Follow-up|5|||
19407434|NCT01599585|41652936|FG000|Overall Study|randomized did not start treatment|3|||
19407435|NCT01599585|41652937|FG001|Overall Study|randomized did not start treatment|3|||
19407436|NCT02185053|41652943|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
19407437|NCT02185053|41652944|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
19407438|NCT02185053|41652945|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
19407439|NCT02185053|41652943|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
19407440|NCT02185053|41652944|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
19407441|NCT02185053|41652945|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
19407442|NCT02185053|41652943|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
19407443|NCT02185053|41652944|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
19407444|NCT02185053|41652945|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
19407445|NCT02185053|41652943|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
19407446|NCT02185053|41652944|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
19407447|NCT02185053|41652945|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
19407448|NCT02185053|41652943|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
19407449|NCT02185053|41652944|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
19407450|NCT02185053|41652945|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
19407451|NCT02185053|41652943|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
19407452|NCT02185053|41652944|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
19407453|NCT02185053|41652945|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
19407454|NCT02185053|41652943|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
19407455|NCT02185053|41652944|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
19407456|NCT02185053|41652945|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
19407457|NCT02185053|41652943|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
19407458|NCT02185053|41652944|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
19407459|NCT02185053|41652945|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
19628040|NCT00795639|42077446|FG000|Overall Study|Other|0|||
19407460|NCT02161731|41652954|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
19407461|NCT02161731|41652955|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
19407462|NCT02161731|41652954|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
19407463|NCT02161731|41652955|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
19407464|NCT02124759|41652965|FG000|Overall Study|Withdrawal by Subject|3|||
19407465|NCT02124759|41652966|FG001|Overall Study|Withdrawal by Subject|1|||
19407466|NCT02124759|41652967|FG002|Overall Study|Withdrawal by Subject|1|||
19407467|NCT02124759|41652965|FG000|Overall Study|Screen Fail|2|||
19407468|NCT02124759|41652966|FG001|Overall Study|Screen Fail|2|||
19407469|NCT02124759|41652967|FG002|Overall Study|Screen Fail|3|||
19407470|NCT02302339|41652984|FG000|Overall Study|Lost to Follow-up|1|||
19407471|NCT02302339|41652985|FG001|Overall Study|Lost to Follow-up|0|||
19407472|NCT02302339|41652986|FG002|Overall Study|Lost to Follow-up|0|||
19407473|NCT02302339|41652987|FG003|Overall Study|Lost to Follow-up|0|||
19407474|NCT02302339|41652984|FG000|Overall Study|Withdrawal by Subject|0|||
19407475|NCT02302339|41652985|FG001|Overall Study|Withdrawal by Subject|2|||
19407476|NCT02302339|41652986|FG002|Overall Study|Withdrawal by Subject|1|||
19407477|NCT02302339|41652987|FG003|Overall Study|Withdrawal by Subject|0|||
19407478|NCT02161575|41652998|FG000|Overall Study|Protocol Violation|8|||
19407479|NCT02161575|41652998|FG000|Overall Study|Lack of Efficacy|1|||
19407480|NCT02161575|41652998|FG000|Overall Study|Adverse Event|2|||
19407481|NCT02370121|41653004|FG000|Overall Study|Lost to Follow-up|1|||
19407482|NCT02370121|41653005|FG001|Overall Study|Lost to Follow-up|1|||
19407483|NCT02161185|41653011|FG000|Treatment Phase|Administrative/Other|7|||
19407484|NCT02159469|41653015|FG000|Overall Study|Missing Completion status|1|||
19407485|NCT02159469|41653015|FG000|Overall Study|Adverse Event|5|||
19407486|NCT02159469|41653015|FG000|Overall Study|Non-compliance|2|||
19407487|NCT02159469|41653015|FG000|Overall Study|Withdrawal by Subject|9|||
19407488|NCT02159469|41653015|FG000|Overall Study|Lost to Follow-up|1|||
19407489|NCT02159469|41653015|FG000|Overall Study|Sponsor's request|2|||
19407490|NCT02159469|41653015|FG000|Overall Study|Met Stopping Criteria|3|||
19407491|NCT02159469|41653015|FG000|Overall Study|Other|1|||
19407492|NCT02159469|41653015|FG000|Overall Study|Multiple|29|||
19407493|NCT02123511|41653022|FG000|Overall Study|Cancelled treatment|1|||
19407494|NCT02123511|41653023|FG001|Overall Study|Cancelled treatment|0|||
19407495|NCT02123511|41653022|FG000|Overall Study|Incomplete data|1|||
19407496|NCT02123511|41653023|FG001|Overall Study|Incomplete data|3|||
19407497|NCT02123511|41653022|FG000|Overall Study|Ineligible|0|||
19407498|NCT02123511|41653023|FG001|Overall Study|Ineligible|1|||
19407499|NCT02122887|41653031|FG000|Overall Study|Withdrawal by Subject|20|||
19407500|NCT02122887|41653032|FG001|Overall Study|Withdrawal by Subject|2|||
19407501|NCT02182947|41653038|FG000|Overall Study|Withdrawal by Subject|7|||
19407502|NCT02182947|41653038|FG000|Overall Study|Lost to Follow-up|3|||
19407503|NCT02182947|41653038|FG000|Overall Study|Failed screening activities|8|||
19407504|NCT02370043|41653042|FG000|Overall Study|Withdrawal by Subject|0|||
19407505|NCT02370043|41653043|FG001|Overall Study|Withdrawal by Subject|0|||
19407506|NCT02370043|41653044|FG002|Overall Study|Withdrawal by Subject|0|||
19407507|NCT02370043|41653045|FG003|Overall Study|Withdrawal by Subject|0|||
19407508|NCT02370043|41653046|FG004|Overall Study|Withdrawal by Subject|1|||
19407509|NCT02370043|41653047|FG005|Overall Study|Withdrawal by Subject|1|||
19407510|NCT02301403|41653077|FG000|Overall Study|Withdrawal by Subject|28|||
19407511|NCT02301403|41653078|FG001|Overall Study|Withdrawal by Subject|41|||
19407512|NCT02301169|41653086|FG000|Overall Study|Adverse Event|1|||
19407513|NCT02301169|41653087|FG001|Overall Study|Adverse Event|0|||
19407514|NCT02333383|41653093|FG000|Overall Study|Adalimumab discontinuation|21|||
19407515|NCT02333383|41653093|FG000|Overall Study|Lost to Follow-up|15|||
19407516|NCT02333383|41653093|FG000|Overall Study|Withdrawal by Subject|3|||
19407517|NCT02333383|41653093|FG000|Overall Study|Transfer to another hospital|2|||
19407518|NCT02332915|41653099|FG000|Overall Study|Moved out of region|3|||
19407519|NCT02332915|41653100|FG001|Overall Study|Moved out of region|0|||
19407520|NCT02332915|41653099|FG000|Overall Study|Unrelated illness|1|||
19407521|NCT02332915|41653100|FG001|Overall Study|Unrelated illness|1|||
19407522|NCT02332915|41653099|FG000|Overall Study|Travel distance prohibitive|0|||
19407523|NCT02332915|41653100|FG001|Overall Study|Travel distance prohibitive|1|||
19407524|NCT02332915|41653099|FG000|Overall Study|did not meet inclusion criteria|2|||
19407525|NCT02332915|41653100|FG001|Overall Study|did not meet inclusion criteria|4|||
19407526|NCT02369341|41653113|FG000|Overall Study|Migrated/moved from study area|1|||
19407527|NCT02369341|41653114|FG001|Overall Study|Migrated/moved from study area|0|||
19407528|NCT02121795|41653126|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
19407529|NCT02121795|41653127|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
19407530|NCT02121795|41653126|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
19407531|NCT02121795|41653127|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
19407532|NCT02121795|41653126|FG000|Double-Blind Phase|Lost to Follow-up|7|||
19407533|NCT02121795|41653127|FG001|Double-Blind Phase|Lost to Follow-up|4|||
19407534|NCT02121795|41653126|FG000|Double-Blind Phase|Physician Decision|2|||
19407535|NCT02121795|41653127|FG001|Double-Blind Phase|Physician Decision|5|||
19407536|NCT02121795|41653126|FG000|Double-Blind Phase|Adverse Event|5|||
19407537|NCT02121795|41653127|FG001|Double-Blind Phase|Adverse Event|0|||
19407538|NCT02121795|41653126|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
19407539|NCT02121795|41653127|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19407540|NCT02121795|41653126|FG000|Double-Blind Phase|Protocol Violation|0|||
19407541|NCT02121795|41653127|FG001|Double-Blind Phase|Protocol Violation|3|||
19407542|NCT02121795|41653126|FG000|Double-Blind Phase|Death|1|||
19407543|NCT02121795|41653127|FG001|Double-Blind Phase|Death|1|||
19407544|NCT02121795|41653126|FG000|Open-Label Phase|Physician Decision|8|||
19407545|NCT02121795|41653127|FG001|Open-Label Phase|Physician Decision|8|||
19407546|NCT02121795|41653126|FG000|Open-Label Phase|Withdrawal by Subject|3|||
19407547|NCT02121795|41653127|FG001|Open-Label Phase|Withdrawal by Subject|2|||
19407548|NCT02121795|41653126|FG000|Open-Label Phase|Lost to Follow-up|1|||
19407549|NCT02121795|41653127|FG001|Open-Label Phase|Lost to Follow-up|0|||
19407550|NCT02158533|41653138|FG000|Stage 1|Adverse Event|6|||
19407551|NCT02158533|41653139|FG001|Stage 1|Adverse Event|4|||
19407552|NCT02158533|41653140|FG002|Stage 1|Adverse Event|7|||
19407553|NCT02158533|41653141|FG003|Stage 1|Adverse Event|0|||
19407554|NCT02158533|41653142|FG004|Stage 1|Adverse Event|0|||
19407555|NCT02158533|41653143|FG005|Stage 1|Adverse Event|0|||
19407556|NCT02158533|41653138|FG000|Stage 1|Withdrawal by Subject|3|||
19407557|NCT02158533|41653139|FG001|Stage 1|Withdrawal by Subject|2|||
19407558|NCT02158533|41653140|FG002|Stage 1|Withdrawal by Subject|1|||
19407559|NCT02158533|41653141|FG003|Stage 1|Withdrawal by Subject|0|||
19407560|NCT02158533|41653142|FG004|Stage 1|Withdrawal by Subject|0|||
19407561|NCT02158533|41653143|FG005|Stage 1|Withdrawal by Subject|0|||
19407562|NCT02158533|41653138|FG000|Stage 1|Lack of Efficacy|1|||
19407563|NCT02158533|41653139|FG001|Stage 1|Lack of Efficacy|0|||
19407564|NCT02158533|41653140|FG002|Stage 1|Lack of Efficacy|0|||
19407565|NCT02158533|41653141|FG003|Stage 1|Lack of Efficacy|0|||
19407566|NCT02158533|41653142|FG004|Stage 1|Lack of Efficacy|0|||
19407567|NCT02158533|41653143|FG005|Stage 1|Lack of Efficacy|0|||
19407568|NCT02158533|41653138|FG000|Stage 1|Lost to Follow-up|3|||
19407569|NCT02158533|41653139|FG001|Stage 1|Lost to Follow-up|1|||
19407570|NCT02158533|41653140|FG002|Stage 1|Lost to Follow-up|0|||
19407571|NCT02158533|41653141|FG003|Stage 1|Lost to Follow-up|0|||
19407572|NCT02158533|41653142|FG004|Stage 1|Lost to Follow-up|0|||
19407573|NCT02158533|41653143|FG005|Stage 1|Lost to Follow-up|0|||
19407574|NCT02158533|41653138|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
19407575|NCT02158533|41653139|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
19407576|NCT02158533|41653140|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
19407577|NCT02158533|41653141|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
19407578|NCT02158533|41653142|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
19407579|NCT02158533|41653143|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
19407580|NCT02158533|41653138|FG000|Stage 1|Non-compliance with study visits|1|||
19407581|NCT02158533|41653139|FG001|Stage 1|Non-compliance with study visits|0|||
19407582|NCT02158533|41653140|FG002|Stage 1|Non-compliance with study visits|0|||
19407583|NCT02158533|41653141|FG003|Stage 1|Non-compliance with study visits|0|||
19407584|NCT02158533|41653142|FG004|Stage 1|Non-compliance with study visits|0|||
19407585|NCT02158533|41653143|FG005|Stage 1|Non-compliance with study visits|0|||
19407586|NCT02158533|41653138|FG000|Stage 2|Adverse Event|0|||
19407587|NCT02158533|41653139|FG001|Stage 2|Adverse Event|0|||
19407588|NCT02158533|41653140|FG002|Stage 2|Adverse Event|0|||
19407589|NCT02158533|41653141|FG003|Stage 2|Adverse Event|0|||
19407590|NCT02158533|41653142|FG004|Stage 2|Adverse Event|0|||
19407591|NCT02158533|41653143|FG005|Stage 2|Adverse Event|1|||
19407592|NCT02158533|41653138|FG000|Stage 2|Lack of Efficacy|0|||
19407593|NCT02158533|41653139|FG001|Stage 2|Lack of Efficacy|0|||
19407594|NCT02158533|41653140|FG002|Stage 2|Lack of Efficacy|0|||
19407595|NCT02158533|41653141|FG003|Stage 2|Lack of Efficacy|0|||
19407596|NCT02158533|41653142|FG004|Stage 2|Lack of Efficacy|1|||
19407597|NCT02158533|41653143|FG005|Stage 2|Lack of Efficacy|0|||
19407598|NCT02158533|41653138|FG000|Stage 2|Lost to Follow-up|0|||
19407599|NCT02158533|41653139|FG001|Stage 2|Lost to Follow-up|0|||
19407600|NCT02158533|41653140|FG002|Stage 2|Lost to Follow-up|0|||
19407601|NCT02158533|41653141|FG003|Stage 2|Lost to Follow-up|1|||
19407602|NCT02158533|41653142|FG004|Stage 2|Lost to Follow-up|1|||
19407603|NCT02158533|41653143|FG005|Stage 2|Lost to Follow-up|2|||
19407604|NCT02158533|41653138|FG000|Stage 2|Withdrawal by Subject|0|||
19407605|NCT02158533|41653139|FG001|Stage 2|Withdrawal by Subject|0|||
19407606|NCT02158533|41653140|FG002|Stage 2|Withdrawal by Subject|0|||
19407607|NCT02158533|41653141|FG003|Stage 2|Withdrawal by Subject|0|||
19407608|NCT02158533|41653142|FG004|Stage 2|Withdrawal by Subject|1|||
19407609|NCT02158533|41653143|FG005|Stage 2|Withdrawal by Subject|2|||
19407610|NCT02158533|41653138|FG000|Stage 2|Physician Decision|0|||
19407611|NCT02158533|41653139|FG001|Stage 2|Physician Decision|0|||
19407612|NCT02158533|41653140|FG002|Stage 2|Physician Decision|0|||
19407613|NCT02158533|41653141|FG003|Stage 2|Physician Decision|0|||
19407614|NCT02158533|41653142|FG004|Stage 2|Physician Decision|1|||
19407615|NCT02158533|41653143|FG005|Stage 2|Physician Decision|0|||
19407616|NCT02158533|41653138|FG000|Stage 2|Pregnancy|0|||
19407617|NCT02158533|41653139|FG001|Stage 2|Pregnancy|0|||
19407618|NCT02158533|41653140|FG002|Stage 2|Pregnancy|0|||
19407619|NCT02158533|41653141|FG003|Stage 2|Pregnancy|1|||
19407620|NCT02158533|41653142|FG004|Stage 2|Pregnancy|0|||
19407621|NCT02158533|41653143|FG005|Stage 2|Pregnancy|0|||
19407622|NCT02158533|41653138|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
19407623|NCT02158533|41653139|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
19407624|NCT02158533|41653140|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
19407625|NCT02158533|41653141|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
19407626|NCT02158533|41653142|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
19407627|NCT02158533|41653143|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
19407628|NCT02158533|41653138|FG000|Stage 2|Non-adherence with study visits|0|||
19407629|NCT02158533|41653139|FG001|Stage 2|Non-adherence with study visits|0|||
19407630|NCT02158533|41653140|FG002|Stage 2|Non-adherence with study visits|0|||
19407631|NCT02158533|41653141|FG003|Stage 2|Non-adherence with study visits|0|||
19407632|NCT02158533|41653142|FG004|Stage 2|Non-adherence with study visits|0|||
19407633|NCT02158533|41653143|FG005|Stage 2|Non-adherence with study visits|1|||
19407634|NCT02120781|41653159|FG000|Overall Study|Physician Decision|2|||
19407635|NCT02120781|41653160|FG001|Overall Study|Physician Decision|0|||
19407636|NCT02120781|41653159|FG000|Overall Study|Completion not documented|2|||
19407637|NCT02120781|41653160|FG001|Overall Study|Completion not documented|1|||
19407638|NCT02120625|41653166|FG000|Overall Study|Physician Decision|2|||
19407639|NCT02120469|41653173|FG000|Overall Study|HER-2/neu-amplified|1|||
19407640|NCT02120469|41653174|FG001|Overall Study|HER-2/neu-amplified|0|||
19407641|NCT02120469|41653175|FG002|Overall Study|HER-2/neu-amplified|1|||
19407642|NCT02157519|41653188|FG000|Overall Study|Death|3|||
19407643|NCT02157519|41653189|FG001|Overall Study|Death|1|||
19407644|NCT02157519|41653188|FG000|Overall Study|Withdrawal by Subject|7|||
19407645|NCT02157519|41653189|FG001|Overall Study|Withdrawal by Subject|0|||
19407646|NCT02157519|41653188|FG000|Overall Study|Lost to Follow-up|1|||
19407647|NCT02157519|41653189|FG001|Overall Study|Lost to Follow-up|0|||
19407648|NCT02180061|41653197|FG000|Overall Study|Adverse Event|4|||
19407649|NCT02180061|41653198|FG001|Overall Study|Adverse Event|2|||
19407650|NCT02180061|41653197|FG000|Overall Study|Clinical Progression|5|||
19407651|NCT02180061|41653198|FG001|Overall Study|Clinical Progression|1|||
19407652|NCT02180061|41653197|FG000|Overall Study|Progressive Disease|15|||
19407653|NCT02180061|41653198|FG001|Overall Study|Progressive Disease|5|||
19407654|NCT02180061|41653197|FG000|Overall Study|Physician Decision|1|||
19407655|NCT02180061|41653198|FG001|Overall Study|Physician Decision|0|||
19407656|NCT02179515|41653207|FG000|Overall Study|switched to alternative treatment|0|||
19407657|NCT02179515|41653208|FG001|Overall Study|switched to alternative treatment|1|||
19407658|NCT02179515|41653209|FG002|Overall Study|switched to alternative treatment|1|||
19407659|NCT02179515|41653207|FG000|Overall Study|Death|0|||
19407660|NCT02179515|41653208|FG001|Overall Study|Death|1|||
19407661|NCT02179515|41653209|FG002|Overall Study|Death|1|||
19407662|NCT02179515|41653207|FG000|Overall Study|refused further treatment|0|||
19407663|NCT02179515|41653208|FG001|Overall Study|refused further treatment|3|||
19407664|NCT02179515|41653209|FG002|Overall Study|refused further treatment|4|||
19407665|NCT02179515|41653207|FG000|Overall Study|Disease progression on study|2|||
19407666|NCT02179515|41653208|FG001|Overall Study|Disease progression on study|11|||
19407667|NCT02179515|41653209|FG002|Overall Study|Disease progression on study|8|||
19407668|NCT02120157|41653221|FG000|Overall Study|Death|8|||
19407669|NCT02119299|41653227|FG000|Overall Study|Withdrawal by Subject|7|||
19407670|NCT02119299|41653227|FG000|Overall Study|Lack of Efficacy|1|||
19407671|NCT02119299|41653227|FG000|Overall Study|Pregnancy|1|||
19407672|NCT02156271|41653233|FG000|Overall Study|Physician Decision|4|||
19407673|NCT02156271|41653234|FG001|Overall Study|Physician Decision|3|||
19407674|NCT01365455|41653243|FG000|Induction Period|Adverse Event|5|||
19407675|NCT01365455|41653244|FG001|Induction Period|Adverse Event|3|||
19407676|NCT01365455|41653245|FG002|Induction Period|Adverse Event|4|||
19407677|NCT01365455|41653246|FG003|Induction Period|Adverse Event|0|||
19407678|NCT01365455|41653247|FG004|Induction Period|Adverse Event|0|||
19407679|NCT01365455|41653243|FG000|Induction Period|Lack of Efficacy|1|||
19407680|NCT01365455|41653244|FG001|Induction Period|Lack of Efficacy|1|||
19407681|NCT01365455|41653245|FG002|Induction Period|Lack of Efficacy|0|||
19407682|NCT01365455|41653246|FG003|Induction Period|Lack of Efficacy|0|||
19407683|NCT01365455|41653247|FG004|Induction Period|Lack of Efficacy|0|||
19407684|NCT01365455|41653243|FG000|Induction Period|Pregnancy|0|||
19407685|NCT01365455|41653244|FG001|Induction Period|Pregnancy|1|||
19407686|NCT01365455|41653245|FG002|Induction Period|Pregnancy|0|||
19711091|NCT00111813|42154252|FG000|Overall Study|Other|0|||
19407687|NCT01365455|41653246|FG003|Induction Period|Pregnancy|0|||
19407688|NCT01365455|41653247|FG004|Induction Period|Pregnancy|0|||
19407689|NCT01365455|41653243|FG000|Induction Period|Protocol deviation|0|||
19407690|NCT01365455|41653244|FG001|Induction Period|Protocol deviation|1|||
19407691|NCT01365455|41653245|FG002|Induction Period|Protocol deviation|1|||
19407692|NCT01365455|41653246|FG003|Induction Period|Protocol deviation|0|||
19407693|NCT01365455|41653247|FG004|Induction Period|Protocol deviation|0|||
19407694|NCT01365455|41653243|FG000|Induction Period|Subject/guardian decision|9|||
19711092|NCT00111813|42154253|FG001|Overall Study|Other|0|||
19407695|NCT01365455|41653244|FG001|Induction Period|Subject/guardian decision|1|||
19407696|NCT01365455|41653245|FG002|Induction Period|Subject/guardian decision|8|||
19407697|NCT01365455|41653246|FG003|Induction Period|Subject/guardian decision|0|||
19407698|NCT01365455|41653247|FG004|Induction Period|Subject/guardian decision|0|||
19407699|NCT01365455|41653243|FG000|Induction Period|Lost to Follow-up|0|||
19407700|NCT01365455|41653244|FG001|Induction Period|Lost to Follow-up|0|||
19407701|NCT01365455|41653245|FG002|Induction Period|Lost to Follow-up|3|||
19407702|NCT01365455|41653246|FG003|Induction Period|Lost to Follow-up|0|||
19407703|NCT01365455|41653247|FG004|Induction Period|Lost to Follow-up|0|||
19407704|NCT01365455|41653243|FG000|Maintenance Period|Adverse Event|12|||
19407705|NCT01365455|41653244|FG001|Maintenance Period|Adverse Event|5|||
19407706|NCT01365455|41653245|FG002|Maintenance Period|Adverse Event|1|||
19407707|NCT01365455|41653246|FG003|Maintenance Period|Adverse Event|2|||
19407708|NCT01365455|41653247|FG004|Maintenance Period|Adverse Event|4|||
19407709|NCT01365455|41653243|FG000|Maintenance Period|Lack of Efficacy|10|||
19407710|NCT01365455|41653244|FG001|Maintenance Period|Lack of Efficacy|2|||
19407711|NCT01365455|41653245|FG002|Maintenance Period|Lack of Efficacy|0|||
19407712|NCT01365455|41653246|FG003|Maintenance Period|Lack of Efficacy|2|||
19407713|NCT01365455|41653247|FG004|Maintenance Period|Lack of Efficacy|2|||
19407714|NCT01365455|41653243|FG000|Maintenance Period|Lost to Follow-up|2|||
19407715|NCT01365455|41653244|FG001|Maintenance Period|Lost to Follow-up|4|||
19407716|NCT01365455|41653245|FG002|Maintenance Period|Lost to Follow-up|0|||
19407717|NCT01365455|41653246|FG003|Maintenance Period|Lost to Follow-up|0|||
19407718|NCT01365455|41653247|FG004|Maintenance Period|Lost to Follow-up|3|||
19407719|NCT01365455|41653243|FG000|Maintenance Period|Non-compliance with study treatment|0|||
19407720|NCT01365455|41653244|FG001|Maintenance Period|Non-compliance with study treatment|0|||
19407721|NCT01365455|41653245|FG002|Maintenance Period|Non-compliance with study treatment|0|||
19407722|NCT01365455|41653246|FG003|Maintenance Period|Non-compliance with study treatment|1|||
19407723|NCT01365455|41653247|FG004|Maintenance Period|Non-compliance with study treatment|0|||
19407724|NCT01365455|41653243|FG000|Maintenance Period|Physician Decision|0|||
19407725|NCT01365455|41653244|FG001|Maintenance Period|Physician Decision|1|||
19407726|NCT01365455|41653245|FG002|Maintenance Period|Physician Decision|0|||
19407727|NCT01365455|41653246|FG003|Maintenance Period|Physician Decision|0|||
19407728|NCT01365455|41653247|FG004|Maintenance Period|Physician Decision|1|||
19407729|NCT01365455|41653243|FG000|Maintenance Period|Pregnancy|0|||
19407730|NCT01365455|41653244|FG001|Maintenance Period|Pregnancy|4|||
19407731|NCT01365455|41653245|FG002|Maintenance Period|Pregnancy|0|||
19407732|NCT01365455|41653246|FG003|Maintenance Period|Pregnancy|0|||
19407733|NCT01365455|41653247|FG004|Maintenance Period|Pregnancy|2|||
19407734|NCT01365455|41653243|FG000|Maintenance Period|Protocol deviation|1|||
19407735|NCT01365455|41653244|FG001|Maintenance Period|Protocol deviation|1|||
19407736|NCT01365455|41653245|FG002|Maintenance Period|Protocol deviation|0|||
19407737|NCT01365455|41653246|FG003|Maintenance Period|Protocol deviation|0|||
19407738|NCT01365455|41653247|FG004|Maintenance Period|Protocol deviation|0|||
19407739|NCT01365455|41653243|FG000|Maintenance Period|Subject/guardian decision|4|||
19407740|NCT01365455|41653244|FG001|Maintenance Period|Subject/guardian decision|6|||
19407741|NCT01365455|41653245|FG002|Maintenance Period|Subject/guardian decision|2|||
19407742|NCT01365455|41653246|FG003|Maintenance Period|Subject/guardian decision|4|||
19407743|NCT01365455|41653247|FG004|Maintenance Period|Subject/guardian decision|1|||
19407744|NCT02155881|41653267|FG000|Overall Study|Withdrawal by Subject|0|||
19407745|NCT02155881|41653268|FG001|Overall Study|Withdrawal by Subject|2|||
19407746|NCT02155881|41653267|FG000|Overall Study|Inappropriately randomized|2|||
19407747|NCT02155881|41653268|FG001|Overall Study|Inappropriately randomized|2|||
19407748|NCT01658579|41653278|FG000|Treatment Period A|Other|0|||
19407749|NCT01658579|41653279|FG001|Treatment Period A|Other|0|||
19407750|NCT01658579|41653280|FG002|Treatment Period A|Other|1|||
19407751|NCT01658579|41653281|FG003|Treatment Period A|Other|1|||
19407752|NCT01658579|41653278|FG000|Treatment Period A|Adverse Event|1|||
19407753|NCT01658579|41653279|FG001|Treatment Period A|Adverse Event|0|||
19407754|NCT01658579|41653280|FG002|Treatment Period A|Adverse Event|0|||
19407755|NCT01658579|41653281|FG003|Treatment Period A|Adverse Event|0|||
19407756|NCT01658579|41653278|FG000|Treatment Period B|Other|0|||
19407757|NCT01658579|41653279|FG001|Treatment Period B|Other|0|||
19407758|NCT01658579|41653280|FG002|Treatment Period B|Other|0|||
19407759|NCT01658579|41653281|FG003|Treatment Period B|Other|1|||
19407760|NCT02155647|41653289|FG000|Overall Study|Still on Treatment|26|||
19407761|NCT02155647|41653290|FG001|Overall Study|Still on Treatment|26|||
19407762|NCT02155647|41653289|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
19407763|NCT02155647|41653290|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
19407764|NCT02154087|41653296|FG000|Overall Study|Study Termination|1|||
19407765|NCT02118597|41653300|FG000|Overall Study|Sponsor terminated the study|14|||
19407766|NCT02118597|41653300|FG000|Overall Study|Serious Adverse Event|1|||
19407767|NCT02118597|41653300|FG000|Overall Study|Investigator's decision|1|||
19407768|NCT01659125|41653304|FG000|Overall Study|Withdrawal by Subject|2|||
19407769|NCT01659125|41653304|FG000|Overall Study|Lost to Follow-up|7|||
19407770|NCT01659125|41653304|FG000|Overall Study|Technical Problem|1|||
19407771|NCT01659125|41653304|FG000|Overall Study|Time Constraints|2|||
19407772|NCT01659125|41653304|FG000|Overall Study|Failed to Start Treatment|2|||
19407773|NCT01657253|41653310|FG000|Overall Study|Lost to Follow-up|6|||
19407774|NCT01657253|41653311|FG001|Overall Study|Lost to Follow-up|5|||
19407775|NCT01657253|41653310|FG000|Overall Study|Withdrawal by Subject|11|||
19407776|NCT01657253|41653311|FG001|Overall Study|Withdrawal by Subject|12|||
19407777|NCT01657253|41653310|FG000|Overall Study|Adverse Event|0|||
19407778|NCT01657253|41653311|FG001|Overall Study|Adverse Event|1|||
19407779|NCT02117427|41653320|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
19407780|NCT02117427|41653321|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
19407781|NCT02117427|41653322|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
19407782|NCT02117427|41653320|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
19407783|NCT02117427|41653321|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
19407784|NCT02117427|41653322|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
19407785|NCT02117427|41653320|FG000|Overall Study|Physician Decision|0|||
19407786|NCT02117427|41653321|FG001|Overall Study|Physician Decision|2|||
19407787|NCT02117427|41653322|FG002|Overall Study|Physician Decision|0|||
19407788|NCT02117427|41653320|FG000|Overall Study|No longer meets inclusion criteria|0|||
19407789|NCT02117427|41653321|FG001|Overall Study|No longer meets inclusion criteria|1|||
19407790|NCT02117427|41653322|FG002|Overall Study|No longer meets inclusion criteria|0|||
19407791|NCT02117427|41653320|FG000|Overall Study|Death|0|||
19407792|NCT02117427|41653321|FG001|Overall Study|Death|1|||
19407793|NCT02117427|41653322|FG002|Overall Study|Death|0|||
19407794|NCT02117349|41653330|FG000|Overall Study|Withdrawal by Subject|1|||
19407795|NCT02117349|41653331|FG001|Overall Study|Withdrawal by Subject|0|||
19518852|NCT01457352|41931925|FG000|Period 1|Did not meet eligibility criteria|3|||
19518853|NCT01457352|41931926|FG001|Period 1|Did not meet eligibility criteria|0|||
19518854|NCT01457352|41931925|FG000|Period 2|Withdrawal by Subject|23|||
19518855|NCT01457352|41931926|FG001|Period 2|Withdrawal by Subject|0|||
19518856|NCT01457352|41931925|FG000|Period 2|Adverse Event|22|||
19518857|NCT01457352|41931926|FG001|Period 2|Adverse Event|0|||
19518858|NCT01457352|41931925|FG000|Period 2|no analysis|10|||
19518859|NCT01457352|41931926|FG001|Period 2|no analysis|0|||
19518860|NCT01457352|41931925|FG000|Period 2|Lack of Efficacy|8|||
19518861|NCT01457352|41931926|FG001|Period 2|Lack of Efficacy|0|||
19518862|NCT01457352|41931925|FG000|Period 2|Protocol Violation|4|||
19518863|NCT01457352|41931926|FG001|Period 2|Protocol Violation|0|||
19518864|NCT01457352|41931925|FG000|Period 2|Sponsor's withdrawal|7|||
19518865|NCT01457352|41931926|FG001|Period 2|Sponsor's withdrawal|0|||
19518866|NCT01457352|41931925|FG000|Period 2|Lost to Follow-up|1|||
19518867|NCT01457352|41931926|FG001|Period 2|Lost to Follow-up|0|||
19518868|NCT01457352|41931925|FG000|Period 2|dose change|1|||
19518869|NCT01457352|41931926|FG001|Period 2|dose change|0|||
19407796|NCT02117349|41653330|FG000|Overall Study|Lost to Follow-up|1|||
19518870|NCT01457352|41931925|FG000|Period 2|Physician Decision|1|||
19518871|NCT01457352|41931926|FG001|Period 2|Physician Decision|0|||
19518872|NCT01457352|41931925|FG000|Period 2|Did not meet eligibility criteria|3|||
19518873|NCT01457352|41931926|FG001|Period 2|Did not meet eligibility criteria|0|||
19518874|NCT01457352|41931925|FG000|Period 3|Adverse Event|1|||
19518875|NCT01457352|41931926|FG001|Period 3|Adverse Event|1|||
19518876|NCT01457352|41931925|FG000|Period 3|Withdrawal by Subject|0|||
19518877|NCT01457352|41931926|FG001|Period 3|Withdrawal by Subject|2|||
19518878|NCT01457352|41931925|FG000|Period 3|incorrect treatment|0|||
19518879|NCT01457352|41931926|FG001|Period 3|incorrect treatment|1|||
19518880|NCT01457352|41931925|FG000|Period 3|Sponsor's withdrawal|0|||
19518881|NCT01457352|41931926|FG001|Period 3|Sponsor's withdrawal|1|||
19518882|NCT01457118|41931940|FG000|Overall Study|Adverse Event|1|||
19518883|NCT01457118|41931941|FG001|Overall Study|Adverse Event|0|||
19628041|NCT00795639|42077447|FG001|Overall Study|Other|2|||
19407797|NCT02117349|41653331|FG001|Overall Study|Lost to Follow-up|1|||
19407798|NCT02117349|41653330|FG000|Overall Study|Death|1|||
19407799|NCT02117349|41653331|FG001|Overall Study|Death|0|||
19518884|NCT01457118|41931942|FG002|Overall Study|Adverse Event|0|||
19518885|NCT01457118|41931943|FG003|Overall Study|Adverse Event|1|||
19518886|NCT01457118|41931940|FG000|Overall Study|Clinical Progression|0|||
19518887|NCT01457118|41931941|FG001|Overall Study|Clinical Progression|1|||
19518888|NCT01457118|41931942|FG002|Overall Study|Clinical Progression|0|||
19518889|NCT01457118|41931943|FG003|Overall Study|Clinical Progression|1|||
19518890|NCT01457118|41931940|FG000|Overall Study|Physician Decision|2|||
19518891|NCT01457118|41931941|FG001|Overall Study|Physician Decision|0|||
19628042|NCT00795639|42077446|FG000|Overall Study|Terminated by sponsor|13|||
19407800|NCT01626495|41653337|FG000|Overall Study|Adverse Event|3|||
19407801|NCT01626495|41653337|FG000|Overall Study|Disease progression|27|||
19407802|NCT01626495|41653337|FG000|Overall Study|Withdrawal by Subject|1|||
19407803|NCT01626495|41653337|FG000|Overall Study|Administrative problem|1|||
19407804|NCT01626495|41653337|FG000|Overall Study|Death|2|||
19407805|NCT01626495|41653337|FG000|Overall Study|Physician Decision|1|||
19407806|NCT01626495|41653337|FG000|Overall Study|New cancer therapy|16|||
19407807|NCT01626495|41653337|FG000|Overall Study|Manufacturing failure|1|||
19407808|NCT02177175|41653343|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
19407809|NCT02177175|41653344|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
19407810|NCT02153073|41653350|FG000|Overall Study|Case Report Forms Uncollected|230|||
19407811|NCT02153073|41653350|FG000|Overall Study|Protocol Deviation|68|||
19407812|NCT01657877|41653354|FG000|Overall Study|Withdrawal by Subject|4|||
19407813|NCT01657877|41653354|FG000|Overall Study|Protocol Violation|6|||
19407814|NCT01657877|41653354|FG000|Overall Study|Adverse Event|2|||
19407815|NCT01657877|41653354|FG000|Overall Study|Other Reason|2|||
19407816|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
19407817|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407818|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407819|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407820|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407821|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407822|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407823|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407824|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19407825|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
19407826|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407827|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407828|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407829|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407830|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407831|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407832|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407833|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19407834|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
19407835|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407836|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407837|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407838|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407839|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407840|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407841|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407842|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19407843|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
19407844|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407845|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407846|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407847|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407848|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407849|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407850|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407851|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
19407852|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
19407853|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407854|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407855|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407856|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407857|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407858|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407859|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407860|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19407861|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
19407862|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407863|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407864|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407865|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407866|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407867|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19374604|NCT00156533|41616208|FG000|Overall Study|Failed Screening|1|||
19374605|NCT00156533|41616209|FG001|Overall Study|Failed Screening|0|||
19374606|NCT00156533|41616210|FG002|Overall Study|Failed Screening|1|||
19374607|NCT00156533|41616211|FG003|Overall Study|Failed Screening|1|||
19374608|NCT01660022|41616229|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
19374609|NCT01660022|41616230|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
19374610|NCT01660022|41616231|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
19374611|NCT01660022|41616232|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
19374612|NCT01660022|41616233|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
19374613|NCT01660022|41616234|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
19374614|NCT01660022|41616229|FG000|First Sequence (7 Days)|Adverse Event|0|||
19374615|NCT01660022|41616230|FG001|First Sequence (7 Days)|Adverse Event|0|||
19374616|NCT01660022|41616231|FG002|First Sequence (7 Days)|Adverse Event|0|||
19374617|NCT01660022|41616232|FG003|First Sequence (7 Days)|Adverse Event|0|||
19374618|NCT01660022|41616233|FG004|First Sequence (7 Days)|Adverse Event|1|||
19374619|NCT01660022|41616234|FG005|First Sequence (7 Days)|Adverse Event|3|||
19374620|NCT01660022|41616229|FG000|First Sequence (7 Days)|Protocol Violation|0|||
19374621|NCT01660022|41616230|FG001|First Sequence (7 Days)|Protocol Violation|0|||
19374622|NCT01660022|41616231|FG002|First Sequence (7 Days)|Protocol Violation|0|||
19374623|NCT01660022|41616232|FG003|First Sequence (7 Days)|Protocol Violation|0|||
19374624|NCT01660022|41616233|FG004|First Sequence (7 Days)|Protocol Violation|0|||
19374625|NCT01660022|41616234|FG005|First Sequence (7 Days)|Protocol Violation|1|||
19374626|NCT00156065|41616263|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
19374627|NCT00156065|41616264|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
19374628|NCT00156065|41616265|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
19374629|NCT00156065|41616263|FG000|Overall Study|Adverse Event|8|||
19374630|NCT00156065|41616264|FG001|Overall Study|Adverse Event|11|||
19374631|NCT00156065|41616265|FG002|Overall Study|Adverse Event|4|||
19374632|NCT00156065|41616263|FG000|Overall Study|Lack of Efficacy|2|||
19374633|NCT00156065|41616264|FG001|Overall Study|Lack of Efficacy|9|||
19374634|NCT00156065|41616265|FG002|Overall Study|Lack of Efficacy|3|||
19374635|NCT00156065|41616263|FG000|Overall Study|Withdrawal by Subject|13|||
19374636|NCT00156065|41616264|FG001|Overall Study|Withdrawal by Subject|26|||
19374637|NCT00156065|41616265|FG002|Overall Study|Withdrawal by Subject|16|||
19374638|NCT00156065|41616263|FG000|Overall Study|Lost to Follow-up|5|||
19374639|NCT00156065|41616264|FG001|Overall Study|Lost to Follow-up|7|||
19374640|NCT00156065|41616265|FG002|Overall Study|Lost to Follow-up|1|||
19374641|NCT00156065|41616263|FG000|Overall Study|Other|2|||
19374642|NCT00156065|41616264|FG001|Overall Study|Other|9|||
19374643|NCT00156065|41616265|FG002|Overall Study|Other|3|||
19374644|NCT01554956|41616276|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
19374645|NCT01554956|41616277|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
19374646|NCT01554956|41616278|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
19374647|NCT01554956|41616276|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
19374648|NCT01554956|41616277|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
19374649|NCT01554956|41616278|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
19374650|NCT01554956|41616276|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
19374651|NCT01554956|41616277|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
19374652|NCT01554956|41616278|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
19374653|NCT02138786|41616299|FG000|Overall Study|Adverse Event|0|||
19374654|NCT02138786|41616300|FG001|Overall Study|Adverse Event|2|||
19374655|NCT02138786|41616301|FG002|Overall Study|Adverse Event|1|||
19374656|NCT02138786|41616299|FG000|Overall Study|Death|1|||
19374657|NCT02138786|41616300|FG001|Overall Study|Death|7|||
19374658|NCT02138786|41616301|FG002|Overall Study|Death|2|||
19374659|NCT02138786|41616299|FG000|Overall Study|Disease Progression|1|||
19374660|NCT02138786|41616300|FG001|Overall Study|Disease Progression|1|||
19374661|NCT02138786|41616301|FG002|Overall Study|Disease Progression|3|||
19374662|NCT02138786|41616299|FG000|Overall Study|Withdrawal by Subject|1|||
19374663|NCT02138786|41616300|FG001|Overall Study|Withdrawal by Subject|2|||
19374664|NCT02138786|41616301|FG002|Overall Study|Withdrawal by Subject|0|||
19374665|NCT02138786|41616299|FG000|Overall Study|Patient's Wish|0|||
19374666|NCT02138786|41616300|FG001|Overall Study|Patient's Wish|2|||
19374667|NCT02138786|41616301|FG002|Overall Study|Patient's Wish|0|||
19374668|NCT02138786|41616299|FG000|Overall Study|Sponsor Terminated Study|0|||
19374669|NCT02138786|41616300|FG001|Overall Study|Sponsor Terminated Study|1|||
19374670|NCT02138786|41616301|FG002|Overall Study|Sponsor Terminated Study|1|||
19374671|NCT02138786|41616299|FG000|Overall Study|Non-Compliance|0|||
19374672|NCT02138786|41616300|FG001|Overall Study|Non-Compliance|0|||
19374673|NCT02138786|41616301|FG002|Overall Study|Non-Compliance|1|||
19407868|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407869|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19407870|NCT02175771|41653379|FG000|Run-In Period (Pre-assignment)|Other|8|||
19407871|NCT02175771|41653380|FG001|Run-In Period (Pre-assignment)|Other|0|||
19407872|NCT02175771|41653381|FG002|Run-In Period (Pre-assignment)|Other|0|||
19407873|NCT02175771|41653382|FG003|Run-In Period (Pre-assignment)|Other|0|||
19407874|NCT02175771|41653383|FG004|Run-In Period (Pre-assignment)|Other|0|||
19407875|NCT02175771|41653384|FG005|Run-In Period (Pre-assignment)|Other|0|||
19407876|NCT02175771|41653385|FG006|Run-In Period (Pre-assignment)|Other|0|||
19407877|NCT02175771|41653386|FG007|Run-In Period (Pre-assignment)|Other|0|||
19407878|NCT02175771|41653387|FG008|Run-In Period (Pre-assignment)|Other|0|||
19407879|NCT02175771|41653379|FG000|Treatment Period|Adverse Event|0|||
19407880|NCT02175771|41653380|FG001|Treatment Period|Adverse Event|2|||
19407881|NCT02175771|41653381|FG002|Treatment Period|Adverse Event|1|||
19407882|NCT02175771|41653382|FG003|Treatment Period|Adverse Event|1|||
19407883|NCT02175771|41653383|FG004|Treatment Period|Adverse Event|1|||
19407884|NCT02175771|41653384|FG005|Treatment Period|Adverse Event|3|||
19407885|NCT02175771|41653385|FG006|Treatment Period|Adverse Event|2|||
19407886|NCT02175771|41653386|FG007|Treatment Period|Adverse Event|0|||
19407887|NCT02175771|41653387|FG008|Treatment Period|Adverse Event|1|||
19407888|NCT02175771|41653379|FG000|Treatment Period|Withdrawal by Subject|0|||
19407889|NCT02175771|41653380|FG001|Treatment Period|Withdrawal by Subject|9|||
19407890|NCT02175771|41653381|FG002|Treatment Period|Withdrawal by Subject|3|||
19407891|NCT02175771|41653382|FG003|Treatment Period|Withdrawal by Subject|6|||
19407892|NCT02175771|41653383|FG004|Treatment Period|Withdrawal by Subject|2|||
19407893|NCT02175771|41653384|FG005|Treatment Period|Withdrawal by Subject|4|||
19407894|NCT02175771|41653385|FG006|Treatment Period|Withdrawal by Subject|2|||
19407895|NCT02175771|41653386|FG007|Treatment Period|Withdrawal by Subject|9|||
19407896|NCT02175771|41653387|FG008|Treatment Period|Withdrawal by Subject|2|||
19407897|NCT02175771|41653379|FG000|Treatment Period|Noncompliance|0|||
19407898|NCT02175771|41653380|FG001|Treatment Period|Noncompliance|1|||
19407899|NCT02175771|41653381|FG002|Treatment Period|Noncompliance|2|||
19407900|NCT02175771|41653382|FG003|Treatment Period|Noncompliance|0|||
19407901|NCT02175771|41653383|FG004|Treatment Period|Noncompliance|0|||
19407902|NCT02175771|41653384|FG005|Treatment Period|Noncompliance|0|||
19407903|NCT02175771|41653385|FG006|Treatment Period|Noncompliance|0|||
19407904|NCT02175771|41653386|FG007|Treatment Period|Noncompliance|0|||
19407905|NCT02175771|41653387|FG008|Treatment Period|Noncompliance|1|||
19407906|NCT02175771|41653379|FG000|Treatment Period|Protocol Violation|0|||
19407907|NCT02175771|41653380|FG001|Treatment Period|Protocol Violation|0|||
19407908|NCT02175771|41653381|FG002|Treatment Period|Protocol Violation|0|||
19407909|NCT02175771|41653382|FG003|Treatment Period|Protocol Violation|0|||
19407910|NCT02175771|41653383|FG004|Treatment Period|Protocol Violation|0|||
19407911|NCT02175771|41653384|FG005|Treatment Period|Protocol Violation|0|||
19407912|NCT02175771|41653385|FG006|Treatment Period|Protocol Violation|0|||
19407913|NCT02175771|41653386|FG007|Treatment Period|Protocol Violation|1|||
19407914|NCT02175771|41653387|FG008|Treatment Period|Protocol Violation|0|||
19407915|NCT02175771|41653379|FG000|Treatment Period|Disease progression|0|||
19407916|NCT02175771|41653380|FG001|Treatment Period|Disease progression|0|||
19407917|NCT02175771|41653381|FG002|Treatment Period|Disease progression|0|||
19407918|NCT02175771|41653382|FG003|Treatment Period|Disease progression|0|||
19407919|NCT02175771|41653383|FG004|Treatment Period|Disease progression|0|||
19407920|NCT02175771|41653384|FG005|Treatment Period|Disease progression|0|||
19407921|NCT02175771|41653385|FG006|Treatment Period|Disease progression|0|||
19407922|NCT02175771|41653386|FG007|Treatment Period|Disease progression|2|||
19407923|NCT02175771|41653387|FG008|Treatment Period|Disease progression|0|||
19407924|NCT02175771|41653379|FG000|Treatment Period|Lost to Follow-up|0|||
19407925|NCT02175771|41653380|FG001|Treatment Period|Lost to Follow-up|3|||
19407926|NCT02175771|41653381|FG002|Treatment Period|Lost to Follow-up|1|||
19407927|NCT02175771|41653382|FG003|Treatment Period|Lost to Follow-up|3|||
19407928|NCT02175771|41653383|FG004|Treatment Period|Lost to Follow-up|1|||
19407929|NCT02175771|41653384|FG005|Treatment Period|Lost to Follow-up|2|||
19407930|NCT02175771|41653385|FG006|Treatment Period|Lost to Follow-up|1|||
19407931|NCT02175771|41653386|FG007|Treatment Period|Lost to Follow-up|2|||
19407932|NCT02175771|41653387|FG008|Treatment Period|Lost to Follow-up|2|||
19407933|NCT02175771|41653379|FG000|Treatment Period|Lack of Efficacy|0|||
19407934|NCT02175771|41653380|FG001|Treatment Period|Lack of Efficacy|0|||
19407935|NCT02175771|41653381|FG002|Treatment Period|Lack of Efficacy|0|||
19407936|NCT02175771|41653382|FG003|Treatment Period|Lack of Efficacy|0|||
19407937|NCT02175771|41653383|FG004|Treatment Period|Lack of Efficacy|0|||
19407938|NCT02175771|41653384|FG005|Treatment Period|Lack of Efficacy|1|||
19407939|NCT02175771|41653385|FG006|Treatment Period|Lack of Efficacy|0|||
19407940|NCT02175771|41653386|FG007|Treatment Period|Lack of Efficacy|1|||
19407941|NCT02175771|41653387|FG008|Treatment Period|Lack of Efficacy|0|||
19407942|NCT02175771|41653379|FG000|Treatment Period|Other|0|||
19407943|NCT02175771|41653380|FG001|Treatment Period|Other|1|||
19407944|NCT02175771|41653381|FG002|Treatment Period|Other|0|||
19407945|NCT02175771|41653382|FG003|Treatment Period|Other|3|||
19407946|NCT02175771|41653383|FG004|Treatment Period|Other|1|||
19407947|NCT02175771|41653384|FG005|Treatment Period|Other|0|||
19407948|NCT02175771|41653385|FG006|Treatment Period|Other|0|||
19407949|NCT02175771|41653386|FG007|Treatment Period|Other|2|||
19407950|NCT02175771|41653387|FG008|Treatment Period|Other|0|||
19407951|NCT01657799|41653408|FG000|Overall Study|Adverse Event Related to progression|6|||
19407952|NCT01657799|41653409|FG001|Overall Study|Adverse Event Related to progression|8|||
19407953|NCT01657799|41653410|FG002|Overall Study|Adverse Event Related to progression|12|||
19407954|NCT01657799|41653408|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
19407955|NCT01657799|41653409|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
19407956|NCT01657799|41653410|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
19407957|NCT01657799|41653408|FG000|Overall Study|Withdrawal by Subject|13|||
19407958|NCT01657799|41653409|FG001|Overall Study|Withdrawal by Subject|10|||
19407959|NCT01657799|41653410|FG002|Overall Study|Withdrawal by Subject|10|||
19407960|NCT01657799|41653408|FG000|Overall Study|Lost to Follow-up|1|||
19407961|NCT01657799|41653409|FG001|Overall Study|Lost to Follow-up|0|||
19407962|NCT01657799|41653410|FG002|Overall Study|Lost to Follow-up|1|||
19407963|NCT01657799|41653408|FG000|Overall Study|Disease Progression|2|||
19407964|NCT01657799|41653409|FG001|Overall Study|Disease Progression|4|||
19407965|NCT01657799|41653410|FG002|Overall Study|Disease Progression|4|||
19407966|NCT01657799|41653408|FG000|Overall Study|Progressive Disease Clinical|7|||
19407967|NCT01657799|41653409|FG001|Overall Study|Progressive Disease Clinical|4|||
19407968|NCT01657799|41653410|FG002|Overall Study|Progressive Disease Clinical|7|||
19407969|NCT01657799|41653408|FG000|Overall Study|Radiographic & Clinical Progression|16|||
19407970|NCT01657799|41653409|FG001|Overall Study|Radiographic & Clinical Progression|11|||
19407971|NCT01657799|41653410|FG002|Overall Study|Radiographic & Clinical Progression|15|||
19407972|NCT01657799|41653408|FG000|Overall Study|Other|52|||
19407973|NCT01657799|41653409|FG001|Overall Study|Other|62|||
19407974|NCT01657799|41653410|FG002|Overall Study|Other|49|||
19407975|NCT02116803|41653420|FG000|Overall Study|Adverse Event|2|||
19407976|NCT02116803|41653421|FG001|Overall Study|Adverse Event|1|||
19407977|NCT02116803|41653420|FG000|Overall Study|Physician Decision|1|||
19407978|NCT02116803|41653421|FG001|Overall Study|Physician Decision|0|||
19407979|NCT02116803|41653420|FG000|Overall Study|Progressive disease|4|||
19407980|NCT02116803|41653421|FG001|Overall Study|Progressive disease|0|||
19407981|NCT02116803|41653420|FG000|Overall Study|Study terminated by sponsor|2|||
19407982|NCT02116803|41653421|FG001|Overall Study|Study terminated by sponsor|1|||
19407983|NCT02116803|41653420|FG000|Overall Study|Death|1|||
19407984|NCT02116803|41653421|FG001|Overall Study|Death|0|||
19407985|NCT02115321|41653429|FG000|Overall Study|Death|1|||
19407986|NCT02115321|41653430|FG001|Overall Study|Death|0|||
19407987|NCT02367781|41653438|FG000|Overall Study|Withdrawal by Subject|20|||
19407988|NCT02367781|41653439|FG001|Overall Study|Withdrawal by Subject|13|||
19407989|NCT02367781|41653438|FG000|Overall Study|Protocol Violation|0|||
19407990|NCT02367781|41653439|FG001|Overall Study|Protocol Violation|1|||
19407991|NCT02367781|41653438|FG000|Overall Study|Physician Decision|7|||
19407992|NCT02367781|41653439|FG001|Overall Study|Physician Decision|0|||
19407993|NCT02367781|41653438|FG000|Overall Study|Randomized in Error|5|||
19407994|NCT02367781|41653439|FG001|Overall Study|Randomized in Error|4|||
19407995|NCT02367781|41653438|FG000|Overall Study|Non-Compliance|1|||
19407996|NCT02367781|41653439|FG001|Overall Study|Non-Compliance|0|||
19407997|NCT02367781|41653438|FG000|Overall Study|Lost to Follow-up|1|||
19407998|NCT02367781|41653439|FG001|Overall Study|Lost to Follow-up|2|||
19407999|NCT02367781|41653438|FG000|Overall Study|Death|330|||
19408000|NCT02367781|41653439|FG001|Overall Study|Death|176|||
19408001|NCT02367781|41653438|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
19408002|NCT02367781|41653439|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
19408003|NCT02367781|41653438|FG000|Overall Study|Prolonged Hospitalization|1|||
19408004|NCT02367781|41653439|FG001|Overall Study|Prolonged Hospitalization|0|||
19408005|NCT02367781|41653438|FG000|Overall Study|Death Prior First Dose|1|||
19408006|NCT02367781|41653439|FG001|Overall Study|Death Prior First Dose|0|||
19408007|NCT02367781|41653438|FG000|Overall Study|Administrative-Change Facility|1|||
19408008|NCT02367781|41653439|FG001|Overall Study|Administrative-Change Facility|0|||
19408009|NCT02367781|41653438|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
19408010|NCT02367781|41653439|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
19408011|NCT02367781|41653438|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
19408012|NCT02367781|41653439|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
19408013|NCT02367781|41653438|FG000|Overall Study|Study Terminated by Sponsor|3|||
19408014|NCT02367781|41653439|FG001|Overall Study|Study Terminated by Sponsor|1|||
19408015|NCT02367781|41653438|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
19408016|NCT02367781|41653439|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
19408017|NCT02367781|41653438|FG000|Overall Study|Sponsor Decision|2|||
19408018|NCT02367781|41653439|FG001|Overall Study|Sponsor Decision|0|||
19408019|NCT02367781|41653438|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
19518892|NCT01457118|41931942|FG002|Overall Study|Physician Decision|0|||
19408020|NCT02367781|41653439|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
19408021|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Technical problems|0|||
19408022|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Technical problems|0|||
19408023|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Technical problems|0|||
19408024|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Technical problems|1|||
19408025|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
19408026|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
19408027|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
19408028|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
19408029|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
19408030|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
19408031|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
19408032|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
19408033|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
19408034|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
19408035|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
19408036|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
19408037|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Death|0|||
19408038|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Death|3|||
19408039|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Death|1|||
19408040|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Death|0|||
19408041|NCT02152761|41653451|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
19408042|NCT02152761|41653452|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
19408043|NCT02152761|41653453|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
19408044|NCT02152761|41653454|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
19408045|NCT02152761|41653451|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
19408046|NCT02152761|41653452|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
19408047|NCT02152761|41653453|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
19408048|NCT02152761|41653454|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
19408049|NCT02152761|41653451|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
19408050|NCT02152761|41653452|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
19408051|NCT02152761|41653453|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
19408052|NCT02152761|41653454|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
19408053|NCT02152761|41653451|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
19408054|NCT02152761|41653452|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
19408055|NCT02152761|41653453|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
19408056|NCT02152761|41653454|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
19408057|NCT02152761|41653451|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
19408058|NCT02152761|41653452|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
19408059|NCT02152761|41653453|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
19408060|NCT02152761|41653454|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
19408061|NCT02152605|41653476|FG000|Overall Study|Adverse Event|6|||
19408062|NCT02152605|41653477|FG001|Overall Study|Adverse Event|8|||
19408063|NCT02152605|41653476|FG000|Overall Study|Lack of Efficacy|7|||
19408064|NCT02152605|41653477|FG001|Overall Study|Lack of Efficacy|4|||
19408065|NCT02152605|41653476|FG000|Overall Study|Protocol deviation|1|||
19408066|NCT02152605|41653477|FG001|Overall Study|Protocol deviation|4|||
19408067|NCT02152605|41653476|FG000|Overall Study|Lost to Follow-up|1|||
19408068|NCT02152605|41653477|FG001|Overall Study|Lost to Follow-up|0|||
19408069|NCT02152605|41653476|FG000|Overall Study|Withdrew consent|4|||
19408070|NCT02152605|41653477|FG001|Overall Study|Withdrew consent|2|||
19408071|NCT02152371|41653486|FG000|Overall Study|Adverse Event|6|||
19408072|NCT02152371|41653487|FG001|Overall Study|Adverse Event|2|||
19408073|NCT02152371|41653486|FG000|Overall Study|Withdrawal by Subject|3|||
19408074|NCT02152371|41653487|FG001|Overall Study|Withdrawal by Subject|7|||
19408075|NCT02152371|41653486|FG000|Overall Study|Protocol Violation|2|||
19408076|NCT02152371|41653487|FG001|Overall Study|Protocol Violation|3|||
19408077|NCT02152371|41653486|FG000|Overall Study|Lost to Follow-up|1|||
19408078|NCT02152371|41653487|FG001|Overall Study|Lost to Follow-up|0|||
19408079|NCT02152371|41653486|FG000|Overall Study|Lack of Efficacy|0|||
19408080|NCT02152371|41653487|FG001|Overall Study|Lack of Efficacy|1|||
19408081|NCT02152371|41653486|FG000|Overall Study|Physician Decision|0|||
19408082|NCT02152371|41653487|FG001|Overall Study|Physician Decision|2|||
19408083|NCT02152371|41653486|FG000|Overall Study|Reason Not Given|0|||
19408084|NCT02152371|41653487|FG001|Overall Study|Reason Not Given|1|||
19408085|NCT02332291|41653495|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
19408086|NCT02332291|41653496|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
19408087|NCT02332291|41653495|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
19408088|NCT02332291|41653496|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
19408089|NCT02332291|41653495|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
19628043|NCT00795639|42077447|FG001|Overall Study|Terminated by sponsor|12|||
19628044|NCT00795639|42077446|FG000|Overall Study|Randomized and not treated|0|||
19408090|NCT02332291|41653496|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
19408091|NCT02332291|41653495|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
19408092|NCT02332291|41653496|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
19408093|NCT02332291|41653495|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
19408094|NCT02332291|41653496|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
19408095|NCT02332291|41653495|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
19408096|NCT02332291|41653496|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
19408097|NCT01656395|41653512|FG000|Overall Study|Adverse Event|1|||
19408098|NCT01656395|41653513|FG001|Overall Study|Adverse Event|14|||
19408099|NCT01656395|41653514|FG002|Overall Study|Adverse Event|5|||
19408100|NCT01656395|41653515|FG003|Overall Study|Adverse Event|4|||
19408101|NCT01656395|41653516|FG004|Overall Study|Adverse Event|5|||
19408102|NCT01656395|41653517|FG005|Overall Study|Adverse Event|7|||
19408103|NCT01656395|41653518|FG006|Overall Study|Adverse Event|0|||
19408104|NCT01656395|41653519|FG007|Overall Study|Adverse Event|0|||
19408105|NCT01656395|41653512|FG000|Overall Study|Lack of Efficacy|1|||
19408106|NCT01656395|41653513|FG001|Overall Study|Lack of Efficacy|8|||
19408107|NCT01656395|41653514|FG002|Overall Study|Lack of Efficacy|6|||
19408108|NCT01656395|41653515|FG003|Overall Study|Lack of Efficacy|1|||
19408109|NCT01656395|41653516|FG004|Overall Study|Lack of Efficacy|1|||
19408110|NCT01656395|41653517|FG005|Overall Study|Lack of Efficacy|6|||
19408111|NCT01656395|41653518|FG006|Overall Study|Lack of Efficacy|0|||
19408112|NCT01656395|41653519|FG007|Overall Study|Lack of Efficacy|0|||
19408113|NCT01656395|41653512|FG000|Overall Study|Lost to Follow-up|1|||
19408114|NCT01656395|41653513|FG001|Overall Study|Lost to Follow-up|0|||
19408115|NCT01656395|41653514|FG002|Overall Study|Lost to Follow-up|0|||
19408116|NCT01656395|41653515|FG003|Overall Study|Lost to Follow-up|0|||
19408117|NCT01656395|41653516|FG004|Overall Study|Lost to Follow-up|0|||
19408118|NCT01656395|41653517|FG005|Overall Study|Lost to Follow-up|0|||
19408119|NCT01656395|41653518|FG006|Overall Study|Lost to Follow-up|0|||
19408120|NCT01656395|41653519|FG007|Overall Study|Lost to Follow-up|0|||
19408121|NCT01656395|41653512|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19408122|NCT01656395|41653513|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19408123|NCT01656395|41653514|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19408124|NCT01656395|41653515|FG003|Overall Study|Non-Compliance with Study Drug|0|||
19408125|NCT01656395|41653516|FG004|Overall Study|Non-Compliance with Study Drug|1|||
19408126|NCT01656395|41653517|FG005|Overall Study|Non-Compliance with Study Drug|1|||
19408127|NCT01656395|41653518|FG006|Overall Study|Non-Compliance with Study Drug|0|||
19408128|NCT01656395|41653519|FG007|Overall Study|Non-Compliance with Study Drug|0|||
19408129|NCT01656395|41653512|FG000|Overall Study|Other|0|||
19408130|NCT01656395|41653513|FG001|Overall Study|Other|0|||
19408131|NCT01656395|41653514|FG002|Overall Study|Other|1|||
19408132|NCT01656395|41653515|FG003|Overall Study|Other|0|||
19408133|NCT01656395|41653516|FG004|Overall Study|Other|0|||
19408134|NCT01656395|41653517|FG005|Overall Study|Other|1|||
19408135|NCT01656395|41653518|FG006|Overall Study|Other|0|||
19408136|NCT01656395|41653519|FG007|Overall Study|Other|0|||
19408137|NCT01656395|41653512|FG000|Overall Study|Physician Decision|2|||
19408138|NCT01656395|41653513|FG001|Overall Study|Physician Decision|3|||
19408139|NCT01656395|41653514|FG002|Overall Study|Physician Decision|3|||
19408140|NCT01656395|41653515|FG003|Overall Study|Physician Decision|2|||
19408141|NCT01656395|41653516|FG004|Overall Study|Physician Decision|3|||
19408142|NCT01656395|41653517|FG005|Overall Study|Physician Decision|3|||
19408143|NCT01656395|41653518|FG006|Overall Study|Physician Decision|0|||
19408144|NCT01656395|41653519|FG007|Overall Study|Physician Decision|0|||
19408145|NCT01656395|41653512|FG000|Overall Study|Pregnancy|0|||
19408146|NCT01656395|41653513|FG001|Overall Study|Pregnancy|0|||
19408147|NCT01656395|41653514|FG002|Overall Study|Pregnancy|1|||
19408148|NCT01656395|41653515|FG003|Overall Study|Pregnancy|0|||
19408149|NCT01656395|41653516|FG004|Overall Study|Pregnancy|0|||
19408150|NCT01656395|41653517|FG005|Overall Study|Pregnancy|0|||
19408151|NCT01656395|41653518|FG006|Overall Study|Pregnancy|0|||
19408152|NCT01656395|41653519|FG007|Overall Study|Pregnancy|0|||
19408153|NCT01656395|41653512|FG000|Overall Study|Progressive Disease|0|||
19408154|NCT01656395|41653513|FG001|Overall Study|Progressive Disease|0|||
19408155|NCT01656395|41653514|FG002|Overall Study|Progressive Disease|0|||
19408156|NCT01656395|41653515|FG003|Overall Study|Progressive Disease|0|||
19408157|NCT01656395|41653516|FG004|Overall Study|Progressive Disease|0|||
19408158|NCT01656395|41653517|FG005|Overall Study|Progressive Disease|1|||
19408159|NCT01656395|41653518|FG006|Overall Study|Progressive Disease|0|||
19408160|NCT01656395|41653519|FG007|Overall Study|Progressive Disease|0|||
19408161|NCT01656395|41653512|FG000|Overall Study|Protocol Violation|6|||
19408162|NCT01656395|41653513|FG001|Overall Study|Protocol Violation|6|||
19408163|NCT01656395|41653514|FG002|Overall Study|Protocol Violation|9|||
19408164|NCT01656395|41653515|FG003|Overall Study|Protocol Violation|2|||
19408165|NCT01656395|41653516|FG004|Overall Study|Protocol Violation|4|||
19408166|NCT01656395|41653517|FG005|Overall Study|Protocol Violation|10|||
19408167|NCT01656395|41653518|FG006|Overall Study|Protocol Violation|0|||
19408168|NCT01656395|41653519|FG007|Overall Study|Protocol Violation|0|||
19408169|NCT01656395|41653512|FG000|Overall Study|Screen Failure|2|||
19408170|NCT01656395|41653513|FG001|Overall Study|Screen Failure|1|||
19408171|NCT01656395|41653514|FG002|Overall Study|Screen Failure|7|||
19408172|NCT01656395|41653515|FG003|Overall Study|Screen Failure|1|||
19408173|NCT01656395|41653516|FG004|Overall Study|Screen Failure|0|||
19408174|NCT01656395|41653517|FG005|Overall Study|Screen Failure|8|||
19408175|NCT01656395|41653518|FG006|Overall Study|Screen Failure|0|||
19408176|NCT01656395|41653519|FG007|Overall Study|Screen Failure|0|||
19408177|NCT01656395|41653512|FG000|Overall Study|Withdrawal by Subject|3|||
19408178|NCT01656395|41653513|FG001|Overall Study|Withdrawal by Subject|1|||
19408179|NCT01656395|41653514|FG002|Overall Study|Withdrawal by Subject|4|||
19408180|NCT01656395|41653515|FG003|Overall Study|Withdrawal by Subject|2|||
19408181|NCT01656395|41653516|FG004|Overall Study|Withdrawal by Subject|0|||
19408182|NCT01656395|41653517|FG005|Overall Study|Withdrawal by Subject|3|||
19408183|NCT01656395|41653518|FG006|Overall Study|Withdrawal by Subject|0|||
19408184|NCT01656395|41653519|FG007|Overall Study|Withdrawal by Subject|0|||
19408185|NCT02114931|41653535|FG000|Overall Study|Withdrawal by Subject|15|||
19408186|NCT02114931|41653536|FG001|Overall Study|Withdrawal by Subject|18|||
19408187|NCT02114931|41653535|FG000|Overall Study|Adverse Event|4|||
19408188|NCT02114931|41653536|FG001|Overall Study|Adverse Event|6|||
19408189|NCT02114931|41653535|FG000|Overall Study|Lost to Follow-up|3|||
19408190|NCT02114931|41653536|FG001|Overall Study|Lost to Follow-up|3|||
19408191|NCT02114931|41653535|FG000|Overall Study|Physician Decision|1|||
19408192|NCT02114931|41653536|FG001|Overall Study|Physician Decision|2|||
19408193|NCT02114931|41653535|FG000|Overall Study|Other|2|||
19408194|NCT02114931|41653536|FG001|Overall Study|Other|1|||
19408195|NCT01657019|41653542|FG000|Overall Study|Withdrawal by Subject|65|||
19408196|NCT01657019|41653542|FG000|Overall Study|Adverse Event|55|||
19408197|NCT01657019|41653542|FG000|Overall Study|Lost to Follow-up|48|||
19408198|NCT01657019|41653542|FG000|Overall Study|Protocol Violation|6|||
19408199|NCT01657019|41653542|FG000|Overall Study|Lack of Efficacy|3|||
19408200|NCT01657019|41653542|FG000|Overall Study|Other|58|||
19408201|NCT02329327|41653548|FG000|Overall Study|Death|78|||
19408202|NCT02329327|41653549|FG001|Overall Study|Death|0|||
19408203|NCT02329327|41653548|FG000|Overall Study|Withdrawal by Subject|3|||
19408204|NCT02329327|41653549|FG001|Overall Study|Withdrawal by Subject|0|||
19408205|NCT02329327|41653548|FG000|Overall Study|Lost to Follow-up|4|||
19408206|NCT02329327|41653549|FG001|Overall Study|Lost to Follow-up|0|||
19408207|NCT02328937|41653568|FG000|Period 1|Lost to Follow-up|0|||
19408208|NCT02328937|41653569|FG001|Period 1|Lost to Follow-up|0|||
19408209|NCT02328937|41653570|FG002|Period 1|Lost to Follow-up|0|||
19408210|NCT02328937|41653571|FG003|Period 1|Lost to Follow-up|1|||
19408211|NCT02328937|41653572|FG004|Period 1|Lost to Follow-up|0|||
19408212|NCT02328937|41653573|FG005|Period 1|Lost to Follow-up|0|||
19408213|NCT02328937|41653568|FG000|Period 2|Adverse Event|0|||
19408214|NCT02328937|41653569|FG001|Period 2|Adverse Event|0|||
19408215|NCT02328937|41653570|FG002|Period 2|Adverse Event|1|||
19408216|NCT02328937|41653571|FG003|Period 2|Adverse Event|0|||
19408217|NCT02328937|41653572|FG004|Period 2|Adverse Event|0|||
19408218|NCT02328937|41653573|FG005|Period 2|Adverse Event|0|||
19408219|NCT02328547|41653583|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
19408220|NCT02328547|41653584|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
19408221|NCT02328547|41653583|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
19408222|NCT02328547|41653584|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
19408223|NCT02300311|41653598|FG000|Overall Study|Other than the reason specified|1|||
19408224|NCT02300311|41653599|FG001|Overall Study|Other than the reason specified|0|||
19408225|NCT02300311|41653598|FG000|Overall Study|Refused to continue taking medication|18|||
19408226|NCT02300311|41653599|FG001|Overall Study|Refused to continue taking medication|0|||
19408227|NCT02300233|41653608|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
19408228|NCT02300233|41653609|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
19408229|NCT02300233|41653610|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
19408230|NCT02300233|41653608|FG000|Overall Study|Withdrawal by Subject|1|||
19408231|NCT02300233|41653609|FG001|Overall Study|Withdrawal by Subject|0|||
19408232|NCT02300233|41653610|FG002|Overall Study|Withdrawal by Subject|3|||
19408233|NCT02300233|41653608|FG000|Overall Study|Investigator Judgement|0|||
19408234|NCT02300233|41653609|FG001|Overall Study|Investigator Judgement|0|||
19628045|NCT00795639|42077447|FG001|Overall Study|Randomized and not treated|1|||
19408235|NCT02300233|41653610|FG002|Overall Study|Investigator Judgement|1|||
19408236|NCT02300233|41653608|FG000|Overall Study|Reason Not Specified|0|||
19408237|NCT02300233|41653609|FG001|Overall Study|Reason Not Specified|0|||
19408238|NCT02300233|41653610|FG002|Overall Study|Reason Not Specified|5|||
19408239|NCT02175225|41653621|FG000|Overall Study|Withdrawal by Subject|1|||
19408240|NCT02175225|41653622|FG001|Overall Study|Withdrawal by Subject|2|||
19408241|NCT02175225|41653621|FG000|Overall Study|Lost to Follow-up|6|||
19408242|NCT02175225|41653622|FG001|Overall Study|Lost to Follow-up|7|||
19408243|NCT02175225|41653621|FG000|Overall Study|Study drug not administered|1|||
19408244|NCT02175225|41653622|FG001|Overall Study|Study drug not administered|2|||
19628046|NCT00589602|42077453|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
19408247|NCT02299375|41653634|FG000|Overall Study|Adverse Event, serious fatal|1|||
19408248|NCT02299375|41653635|FG001|Overall Study|Adverse Event, serious fatal|3|||
19408249|NCT02299375|41653634|FG000|Overall Study|Adverse Event, non-fatal|8|||
19408250|NCT02299375|41653635|FG001|Overall Study|Adverse Event, non-fatal|9|||
19408251|NCT02299375|41653634|FG000|Overall Study|Lack of Efficacy|1|||
19408252|NCT02299375|41653635|FG001|Overall Study|Lack of Efficacy|3|||
19408253|NCT02299375|41653634|FG000|Overall Study|Protocol Violation|1|||
19408254|NCT02299375|41653635|FG001|Overall Study|Protocol Violation|3|||
19408255|NCT02299375|41653634|FG000|Overall Study|Other: Met stopping criteria|1|||
19408256|NCT02299375|41653635|FG001|Overall Study|Other: Met stopping criteria|0|||
19408257|NCT02299375|41653634|FG000|Overall Study|Other: Study closed/terminated|66|||
19408258|NCT02299375|41653635|FG001|Overall Study|Other: Study closed/terminated|55|||
19408259|NCT02299375|41653634|FG000|Overall Study|Lost to Follow-up|0|||
19408260|NCT02299375|41653635|FG001|Overall Study|Lost to Follow-up|2|||
19408261|NCT02299375|41653634|FG000|Overall Study|Physician Decision|1|||
19408262|NCT02299375|41653635|FG001|Overall Study|Physician Decision|1|||
19408263|NCT02299375|41653634|FG000|Overall Study|Withdrawal by Subject|1|||
19408264|NCT02299375|41653635|FG001|Overall Study|Withdrawal by Subject|4|||
19408265|NCT02151903|41653644|FG000|Overall Study|Withdrawal by Subject|1|||
19408266|NCT02151903|41653645|FG001|Overall Study|Withdrawal by Subject|0|||
19408267|NCT02151903|41653644|FG000|Overall Study|Progressive disease|2|||
19408268|NCT02151903|41653645|FG001|Overall Study|Progressive disease|1|||
19408269|NCT02151591|41653653|FG000|Overall Study|Lost to Follow-up|6|||
19408270|NCT02151591|41653654|FG001|Overall Study|Lost to Follow-up|3|||
19408271|NCT02174523|41653662|FG000|Overall Study|Withdrawal by Subject|1|||
19408272|NCT02174523|41653663|FG001|Overall Study|Withdrawal by Subject|0|||
19408273|NCT02297815|41653670|FG000|Overall Study|Lost to Follow-up|236|||
19408274|NCT02297815|41653671|FG001|Overall Study|Lost to Follow-up|140|||
19408275|NCT02114385|41653681|FG000|Overall Study|Withdrawal by Subject|3|||
19408276|NCT02114385|41653682|FG001|Overall Study|Withdrawal by Subject|2|||
19408277|NCT02114385|41653681|FG000|Overall Study|Lost to Follow-up|0|||
19408278|NCT02114385|41653682|FG001|Overall Study|Lost to Follow-up|6|||
19408279|NCT02114151|41653688|FG000|Overall Study|Death|1|||
19408280|NCT02114151|41653688|FG000|Overall Study|Lost to Follow-up|1|||
19408281|NCT02114151|41653688|FG000|Overall Study|Withdrawal by Subject|5|||
19408282|NCT02297503|41653694|FG000|Overall Study|Withdrawal by Subject|1|||
19408283|NCT02297503|41653695|FG001|Overall Study|Withdrawal by Subject|1|||
19408284|NCT02297503|41653694|FG000|Overall Study|Protocol Violation|1|||
19408285|NCT02297503|41653695|FG001|Overall Study|Protocol Violation|0|||
19408286|NCT02297503|41653694|FG000|Overall Study|Pregnancy|0|||
19408287|NCT02297503|41653695|FG001|Overall Study|Pregnancy|1|||
19408288|NCT02297503|41653694|FG000|Overall Study|Lost to Follow-up|0|||
19408289|NCT02297503|41653695|FG001|Overall Study|Lost to Follow-up|1|||
19408290|NCT02297503|41653694|FG000|Overall Study|Medical reason|0|||
19408291|NCT02297503|41653695|FG001|Overall Study|Medical reason|1|||
19408292|NCT02113449|41653710|FG000|Overall Study|Adverse Event|4|||
19408293|NCT02366923|41653718|FG000|Overall Study|Withdrawal by Subject|1|||
19408294|NCT02366923|41653718|FG000|Overall Study|Positive Slit Lamp Findings|2|||
19408295|NCT02366923|41653718|FG000|Overall Study|High Astigmatism|3|||
19408296|NCT02326597|41653725|FG000|Overall Study|Lost to Follow-up|42|||
19408297|NCT02326597|41653726|FG001|Overall Study|Lost to Follow-up|32|||
19408298|NCT02366767|41653736|FG000|Overall Study|left for home after 1 day at camp|1|||
19408299|NCT02366767|41653737|FG001|Overall Study|left for home after 1 day at camp|0|||
19408300|NCT02150343|41653747|FG000|Overall Study|Adverse Event|2|||
19408301|NCT02150343|41653748|FG001|Overall Study|Adverse Event|0|||
19408302|NCT02150343|41653749|FG002|Overall Study|Adverse Event|1|||
19408303|NCT02150343|41653750|FG003|Overall Study|Adverse Event|1|||
19408304|NCT02150343|41653747|FG000|Overall Study|Withdrawal by Subject|13|||
19408305|NCT02150343|41653748|FG001|Overall Study|Withdrawal by Subject|10|||
19408306|NCT02150343|41653749|FG002|Overall Study|Withdrawal by Subject|9|||
19408307|NCT02150343|41653750|FG003|Overall Study|Withdrawal by Subject|4|||
19408308|NCT02150343|41653747|FG000|Overall Study|Lost to Follow-up|4|||
19628047|NCT00794157|42077462|FG000|Overall Study|Adverse Event|4|||
19628048|NCT00794157|42077463|FG001|Overall Study|Adverse Event|1|||
19408309|NCT02150343|41653748|FG001|Overall Study|Lost to Follow-up|4|||
19408310|NCT02150343|41653749|FG002|Overall Study|Lost to Follow-up|2|||
19408311|NCT02150343|41653750|FG003|Overall Study|Lost to Follow-up|3|||
19408312|NCT02150343|41653747|FG000|Overall Study|Other|2|||
19408313|NCT02150343|41653748|FG001|Overall Study|Other|6|||
19408314|NCT02150343|41653749|FG002|Overall Study|Other|0|||
19408315|NCT02150343|41653750|FG003|Overall Study|Other|2|||
19408316|NCT02149875|41653763|FG000|Overall Study|Lost to Follow-up|3|||
19408317|NCT02149875|41653764|FG001|Overall Study|Lost to Follow-up|4|||
19408318|NCT02149875|41653765|FG002|Overall Study|Lost to Follow-up|5|||
19408319|NCT02149875|41653763|FG000|Overall Study|Withdrawal by Subject|3|||
19408320|NCT02149875|41653764|FG001|Overall Study|Withdrawal by Subject|2|||
19408321|NCT02149875|41653765|FG002|Overall Study|Withdrawal by Subject|2|||
19628049|NCT00794157|42077464|FG002|Overall Study|Adverse Event|8|||
19628050|NCT00794157|42077462|FG000|Overall Study|Subject withdrew consent|2|||
19408322|NCT02149875|41653763|FG000|Overall Study|Physician Decision|1|||
19408323|NCT02149875|41653764|FG001|Overall Study|Physician Decision|2|||
19408324|NCT02149875|41653765|FG002|Overall Study|Physician Decision|2|||
19408325|NCT02112045|41653775|FG000|Overall Study|Withdrawal by Subject|1|||
19408326|NCT02112045|41653776|FG001|Overall Study|Withdrawal by Subject|0|||
19408327|NCT01629693|41653784|FG000|Overall Study|Lost to Follow-up|2|||
19408328|NCT01629693|41653785|FG001|Overall Study|Lost to Follow-up|4|||
19408329|NCT01629693|41653784|FG000|Overall Study|Withdrawal by Subject|2|||
19408330|NCT01629693|41653785|FG001|Overall Study|Withdrawal by Subject|2|||
19408331|NCT01629693|41653784|FG000|Overall Study|Adverse Event|1|||
19408332|NCT01629693|41653785|FG001|Overall Study|Adverse Event|0|||
19408333|NCT01629693|41653784|FG000|Overall Study|Investigator decision|0|||
19408334|NCT01629693|41653785|FG001|Overall Study|Investigator decision|1|||
19408335|NCT01629693|41653784|FG000|Overall Study|Poor comfort of study lenses|0|||
19408336|NCT01629693|41653785|FG001|Overall Study|Poor comfort of study lenses|2|||
19408337|NCT01629693|41653784|FG000|Overall Study|Subject decision unrelated to AE|0|||
19408338|NCT01629693|41653785|FG001|Overall Study|Subject decision unrelated to AE|1|||
19408339|NCT02147691|41653793|FG000|Overall Study|Withdrawal by Subject|2|||
19408340|NCT02147691|41653794|FG001|Overall Study|Withdrawal by Subject|0|||
19408341|NCT02147691|41653793|FG000|Overall Study|Adverse Event|2|||
19408342|NCT02147691|41653794|FG001|Overall Study|Adverse Event|0|||
19408343|NCT02147691|41653793|FG000|Overall Study|Lost to Follow-up|0|||
19408344|NCT02147691|41653794|FG001|Overall Study|Lost to Follow-up|1|||
19408345|NCT02111811|41653802|FG000|Treatment Phase|Lost to Follow-up|22|||
19408346|NCT02111811|41653803|FG001|Treatment Phase|Lost to Follow-up|18|||
19408347|NCT02111811|41653802|FG000|Treatment Phase|Death|2|||
19408348|NCT02111811|41653803|FG001|Treatment Phase|Death|0|||
19408349|NCT02111811|41653802|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
19408350|NCT02111811|41653803|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
19408351|NCT02111811|41653802|FG000|Follow up Period (Aim 2)|Death|2|||
19408352|NCT02111811|41653803|FG001|Follow up Period (Aim 2)|Death|0|||
19408353|NCT01655693|41653812|FG000|Overall Study|Progression of Disease|92|||
19408354|NCT01655693|41653813|FG001|Overall Study|Progression of Disease|76|||
19408355|NCT01655693|41653814|FG002|Overall Study|Progression of Disease|58|||
19408356|NCT01655693|41653812|FG000|Overall Study|Death|8|||
19408357|NCT01655693|41653813|FG001|Overall Study|Death|9|||
19408358|NCT01655693|41653814|FG002|Overall Study|Death|12|||
19408359|NCT01655693|41653812|FG000|Overall Study|Serious Adverse Event|3|||
19408360|NCT01655693|41653813|FG001|Overall Study|Serious Adverse Event|15|||
19408361|NCT01655693|41653814|FG002|Overall Study|Serious Adverse Event|11|||
19408362|NCT01655693|41653812|FG000|Overall Study|Withdrawal by Subject|3|||
19408363|NCT01655693|41653813|FG001|Overall Study|Withdrawal by Subject|2|||
19408364|NCT01655693|41653814|FG002|Overall Study|Withdrawal by Subject|20|||
19408365|NCT01655693|41653812|FG000|Overall Study|Adverse Event|3|||
19408366|NCT01655693|41653813|FG001|Overall Study|Adverse Event|11|||
19408367|NCT01655693|41653814|FG002|Overall Study|Adverse Event|3|||
19408368|NCT01655693|41653812|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
19408369|NCT01655693|41653813|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
19408370|NCT01655693|41653814|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
19408371|NCT01655693|41653812|FG000|Overall Study|Non-Compliance|0|||
19408372|NCT01655693|41653813|FG001|Overall Study|Non-Compliance|0|||
19408373|NCT01655693|41653814|FG002|Overall Study|Non-Compliance|7|||
19408374|NCT01655693|41653812|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
19408375|NCT01655693|41653813|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
19408376|NCT01655693|41653814|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
19408377|NCT01655693|41653812|FG000|Overall Study|Protocol Violation|1|||
19408378|NCT01655693|41653813|FG001|Overall Study|Protocol Violation|0|||
19408379|NCT01655693|41653814|FG002|Overall Study|Protocol Violation|3|||
19408380|NCT01655693|41653812|FG000|Overall Study|Lost to Follow-up|1|||
19408381|NCT01655693|41653813|FG001|Overall Study|Lost to Follow-up|0|||
19408382|NCT01655693|41653814|FG002|Overall Study|Lost to Follow-up|1|||
19408383|NCT01655693|41653812|FG000|Overall Study|Screening Failure|1|||
19408384|NCT01655693|41653813|FG001|Overall Study|Screening Failure|0|||
19408385|NCT01655693|41653814|FG002|Overall Study|Screening Failure|0|||
19408386|NCT01655693|41653812|FG000|Overall Study|Other|8|||
19408387|NCT01655693|41653813|FG001|Overall Study|Other|6|||
19408388|NCT01655693|41653814|FG002|Overall Study|Other|15|||
19408389|NCT01655381|41653832|FG000|Overall Study|Investigator Decision|1|||
19408390|NCT01655381|41653832|FG000|Overall Study|Moved to Another City|1|||
19408391|NCT01655381|41653832|FG000|Overall Study|Insufficient Treatment Response|1|||
19408392|NCT01656161|41653837|FG000|Overall Study|Death|3|||
19408393|NCT01656161|41653837|FG000|Overall Study|Adverse Event|2|||
19408394|NCT01656161|41653837|FG000|Overall Study|Protocol Violation|1|||
19408395|NCT01656161|41653837|FG000|Overall Study|Withdrawal by Subject|1|||
19408396|NCT02111577|41653846|FG000|Overall Study|Protocol Violation|2|||
19408397|NCT02111577|41653847|FG001|Overall Study|Protocol Violation|0|||
19408398|NCT02111577|41653846|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
19518893|NCT01457118|41931943|FG003|Overall Study|Physician Decision|0|||
19408399|NCT02111577|41653847|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
19408400|NCT02111577|41653846|FG000|Overall Study|Failure to produce study treatment|6|||
19408401|NCT02111577|41653847|FG001|Overall Study|Failure to produce study treatment|0|||
19408402|NCT02111577|41653846|FG000|Overall Study|Death|518|||
19408403|NCT02111577|41653847|FG001|Overall Study|Death|254|||
19408404|NCT02111577|41653846|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
19408405|NCT02111577|41653847|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
19408406|NCT02111577|41653846|FG000|Overall Study|Adverse Event|1|||
19408407|NCT02111577|41653847|FG001|Overall Study|Adverse Event|1|||
19408408|NCT02111577|41653846|FG000|Overall Study|Withdrawal by Subject|51|||
19408409|NCT02111577|41653847|FG001|Overall Study|Withdrawal by Subject|23|||
19408410|NCT02111577|41653846|FG000|Overall Study|Disease progression|0|||
19408411|NCT02111577|41653847|FG001|Overall Study|Disease progression|1|||
19408412|NCT02111577|41653846|FG000|Overall Study|Lost to Follow-up|19|||
19408413|NCT02111577|41653847|FG001|Overall Study|Lost to Follow-up|10|||
19408414|NCT02170779|41653857|FG000|Overall Study|Withdrawal by Subject|1|||
19408415|NCT02170779|41653858|FG001|Overall Study|Withdrawal by Subject|0|||
19408416|NCT02170779|41653857|FG000|Overall Study|Lost to Follow-up|0|||
19408417|NCT02170779|41653858|FG001|Overall Study|Lost to Follow-up|1|||
19408418|NCT02147067|41653866|FG000|Overall Study|Withdrawal by Subject|2|||
19408419|NCT02147067|41653867|FG001|Overall Study|Withdrawal by Subject|2|||
19408420|NCT02170389|41653873|FG000|Overall Study|Study terminated prior to start of treat|1|||
19408421|NCT02146599|41653877|FG000|Overall Study|Failed to meet inclusion criteria|5|||
19408422|NCT02146365|41653887|FG000|Overall Study|Lost to Follow-up|2|||
19408423|NCT02146365|41653888|FG001|Overall Study|Lost to Follow-up|1|||
19408424|NCT02146365|41653889|FG002|Overall Study|Lost to Follow-up|3|||
19408425|NCT02146365|41653890|FG003|Overall Study|Lost to Follow-up|3|||
19408426|NCT02146365|41653891|FG004|Overall Study|Lost to Follow-up|1|||
19408427|NCT02146365|41653892|FG005|Overall Study|Lost to Follow-up|1|||
19408428|NCT02146365|41653893|FG006|Overall Study|Lost to Follow-up|0|||
19408429|NCT02146365|41653894|FG007|Overall Study|Lost to Follow-up|1|||
19408430|NCT02146365|41653887|FG000|Overall Study|Withdrawal by Subject|1|||
19408431|NCT02146365|41653888|FG001|Overall Study|Withdrawal by Subject|2|||
19408432|NCT02146365|41653889|FG002|Overall Study|Withdrawal by Subject|1|||
19408433|NCT02146365|41653890|FG003|Overall Study|Withdrawal by Subject|5|||
19408434|NCT02146365|41653891|FG004|Overall Study|Withdrawal by Subject|1|||
19408435|NCT02146365|41653892|FG005|Overall Study|Withdrawal by Subject|0|||
19408436|NCT02146365|41653893|FG006|Overall Study|Withdrawal by Subject|0|||
19408437|NCT02146365|41653894|FG007|Overall Study|Withdrawal by Subject|0|||
19408438|NCT02146365|41653887|FG000|Overall Study|Unable to Comply with Protocol|0|||
19408439|NCT02146365|41653888|FG001|Overall Study|Unable to Comply with Protocol|1|||
19408440|NCT02146365|41653889|FG002|Overall Study|Unable to Comply with Protocol|1|||
19408441|NCT02146365|41653890|FG003|Overall Study|Unable to Comply with Protocol|0|||
19408442|NCT02146365|41653891|FG004|Overall Study|Unable to Comply with Protocol|0|||
19408443|NCT02146365|41653892|FG005|Overall Study|Unable to Comply with Protocol|0|||
19408444|NCT02146365|41653893|FG006|Overall Study|Unable to Comply with Protocol|0|||
19408445|NCT02146365|41653894|FG007|Overall Study|Unable to Comply with Protocol|0|||
19408446|NCT02146365|41653887|FG000|Overall Study|Other|1|||
19408447|NCT02146365|41653888|FG001|Overall Study|Other|0|||
19408448|NCT02146365|41653889|FG002|Overall Study|Other|2|||
19408449|NCT02146365|41653890|FG003|Overall Study|Other|1|||
19408450|NCT02146365|41653891|FG004|Overall Study|Other|0|||
19408451|NCT02146365|41653892|FG005|Overall Study|Other|0|||
19408452|NCT02146365|41653893|FG006|Overall Study|Other|0|||
19408453|NCT02146365|41653894|FG007|Overall Study|Other|0|||
19408454|NCT02146131|41653914|FG000|Overall Study|Physician Decision|61|||
19408455|NCT02146131|41653915|FG001|Overall Study|Physician Decision|56|||
19408456|NCT02107131|41653923|FG000|Overall Study|Lost to Follow-up|4|||
19408457|NCT02107131|41653924|FG001|Overall Study|Lost to Follow-up|4|||
19408458|NCT02107131|41653923|FG000|Overall Study|Physician Decision|1|||
19408459|NCT02107131|41653924|FG001|Overall Study|Physician Decision|0|||
19408460|NCT02107131|41653923|FG000|Overall Study|Withdrawal by Subject|2|||
19408461|NCT02107131|41653924|FG001|Overall Study|Withdrawal by Subject|0|||
19408462|NCT02107131|41653923|FG000|Overall Study|mental instability|1|||
19408463|NCT02107131|41653924|FG001|Overall Study|mental instability|0|||
19408464|NCT02107131|41653923|FG000|Overall Study|Death|0|||
19408465|NCT02107131|41653924|FG001|Overall Study|Death|1|||
19408466|NCT02107131|41653923|FG000|Overall Study|Protocol Violation|0|||
19408467|NCT02107131|41653924|FG001|Overall Study|Protocol Violation|4|||
19408468|NCT02106975|41653934|FG000|Overall Study|Death|25|||
19408469|NCT02106975|41653935|FG001|Overall Study|Death|39|||
19408470|NCT02145429|41653943|FG000|Overall Study|Death|4|||
19408471|NCT02145429|41653944|FG001|Overall Study|Death|5|||
19408472|NCT02145429|41653943|FG000|Overall Study|Lost to Follow-up|4|||
19408473|NCT02145429|41653944|FG001|Overall Study|Lost to Follow-up|3|||
19408474|NCT02145429|41653943|FG000|Overall Study|Withdrawal by Subject|8|||
19408475|NCT02145429|41653944|FG001|Overall Study|Withdrawal by Subject|3|||
19408476|NCT02144337|41653952|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
19408477|NCT02144337|41653953|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
19408478|NCT02144337|41653952|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
19408479|NCT02144337|41653953|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
19408480|NCT02144337|41653952|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
19408481|NCT02144337|41653953|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
19408482|NCT02144337|41653952|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
19408483|NCT02144337|41653953|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
19408484|NCT02144337|41653952|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
19408485|NCT02144337|41653953|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
19408486|NCT02520011|41653963|FG000|Overall Study|Adverse Event|0|||
19408487|NCT02520011|41653964|FG001|Overall Study|Adverse Event|1|||
19408488|NCT02520011|41653965|FG002|Overall Study|Adverse Event|2|||
19408489|NCT02520011|41653963|FG000|Overall Study|Death|0|||
19408490|NCT02520011|41653964|FG001|Overall Study|Death|8|||
19408491|NCT02520011|41653965|FG002|Overall Study|Death|1|||
19408492|NCT02520011|41653963|FG000|Overall Study|Lack of Efficacy|4|||
19408493|NCT02520011|41653964|FG001|Overall Study|Lack of Efficacy|26|||
19408494|NCT02520011|41653965|FG002|Overall Study|Lack of Efficacy|4|||
19408495|NCT02520011|41653963|FG000|Overall Study|Physician Decision|0|||
19408496|NCT02520011|41653964|FG001|Overall Study|Physician Decision|2|||
19408497|NCT02520011|41653965|FG002|Overall Study|Physician Decision|0|||
19408498|NCT02520011|41653963|FG000|Overall Study|Withdrawal by Subject|1|||
19408499|NCT02520011|41653964|FG001|Overall Study|Withdrawal by Subject|3|||
19408500|NCT02520011|41653965|FG002|Overall Study|Withdrawal by Subject|0|||
19408501|NCT02520011|41653963|FG000|Overall Study|Protocol Deviation|0|||
19408502|NCT02520011|41653964|FG001|Overall Study|Protocol Deviation|1|||
19408503|NCT02520011|41653965|FG002|Overall Study|Protocol Deviation|0|||
19408504|NCT02520011|41653963|FG000|Overall Study|Patient went to hospice|0|||
19408505|NCT02520011|41653964|FG001|Overall Study|Patient went to hospice|1|||
19408506|NCT02520011|41653965|FG002|Overall Study|Patient went to hospice|0|||
19408507|NCT02520011|41653963|FG000|Overall Study|Progressive disease following response|0|||
19408508|NCT02520011|41653964|FG001|Overall Study|Progressive disease following response|4|||
19408509|NCT02520011|41653965|FG002|Overall Study|Progressive disease following response|2|||
19408510|NCT02519231|41653980|FG000|Overall Study|Lost to Follow-up|2|||
19408511|NCT02519231|41653981|FG001|Overall Study|Lost to Follow-up|5|||
19408512|NCT02519231|41653980|FG000|Overall Study|Withdrawal by Subject|0|||
19408513|NCT02519231|41653981|FG001|Overall Study|Withdrawal by Subject|1|||
19408514|NCT02106351|41653992|FG000|Treatment Cycle 1|Adverse Event|2|||
19408515|NCT02106351|41653993|FG001|Treatment Cycle 1|Adverse Event|0|||
19408516|NCT02106351|41653994|FG002|Treatment Cycle 1|Adverse Event|0|||
19408517|NCT02106351|41653992|FG000|Treatment Cycle 1|Consent withdrawn|1|||
19408518|NCT02106351|41653993|FG001|Treatment Cycle 1|Consent withdrawn|0|||
19408519|NCT02106351|41653994|FG002|Treatment Cycle 1|Consent withdrawn|2|||
19408520|NCT02106351|41653992|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
19408521|NCT02106351|41653993|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
19408522|NCT02106351|41653994|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
19408523|NCT02106351|41653992|FG000|Treatment Cycle 1|Other|0|||
19408524|NCT02106351|41653993|FG001|Treatment Cycle 1|Other|3|||
19408525|NCT02106351|41653994|FG002|Treatment Cycle 1|Other|1|||
19408526|NCT02106351|41653992|FG000|Treatment Cycle 1|Randomised but not treated|1|||
19408527|NCT02106351|41653993|FG001|Treatment Cycle 1|Randomised but not treated|0|||
19408528|NCT02106351|41653994|FG002|Treatment Cycle 1|Randomised but not treated|1|||
19408529|NCT02106351|41653992|FG000|Treatment Cycle 2|Adverse Event|0|||
19408530|NCT02106351|41653993|FG001|Treatment Cycle 2|Adverse Event|2|||
19408531|NCT02106351|41653994|FG002|Treatment Cycle 2|Adverse Event|0|||
19408532|NCT02106351|41653992|FG000|Treatment Cycle 2|Consent withdrawn|0|||
19408533|NCT02106351|41653993|FG001|Treatment Cycle 2|Consent withdrawn|1|||
19408534|NCT02106351|41653994|FG002|Treatment Cycle 2|Consent withdrawn|1|||
19408535|NCT02106351|41653992|FG000|Treatment Cycle 2|Other|0|||
19408536|NCT02106351|41653993|FG001|Treatment Cycle 2|Other|2|||
19408537|NCT02106351|41653994|FG002|Treatment Cycle 2|Other|2|||
19408538|NCT02106351|41653992|FG000|Treatment Cycle 3|Adverse Event|0|||
19408539|NCT02106351|41653993|FG001|Treatment Cycle 3|Adverse Event|1|||
19408540|NCT02106351|41653994|FG002|Treatment Cycle 3|Adverse Event|0|||
19408541|NCT02106351|41653992|FG000|Treatment Cycle 3|Consent withdrawn|0|||
19408542|NCT02106351|41653993|FG001|Treatment Cycle 3|Consent withdrawn|0|||
19408543|NCT02106351|41653994|FG002|Treatment Cycle 3|Consent withdrawn|2|||
19408544|NCT02106351|41653992|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
19408545|NCT02106351|41653993|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
19408546|NCT02106351|41653994|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
19408547|NCT02106351|41653992|FG000|Treatment Cycle 3|Other|0|||
19408548|NCT02106351|41653993|FG001|Treatment Cycle 3|Other|2|||
19408549|NCT02106351|41653994|FG002|Treatment Cycle 3|Other|3|||
19408550|NCT02106351|41653992|FG000|Treatment Cycle 4|Consent withdrawn|0|||
19408551|NCT02106351|41653993|FG001|Treatment Cycle 4|Consent withdrawn|0|||
19408552|NCT02106351|41653994|FG002|Treatment Cycle 4|Consent withdrawn|2|||
19408553|NCT02106351|41653992|FG000|Treatment Cycle 4|Other|0|||
19408554|NCT02106351|41653993|FG001|Treatment Cycle 4|Other|1|||
19408555|NCT02106351|41653994|FG002|Treatment Cycle 4|Other|0|||
19408556|NCT02143947|41654010|FG000|Overall Study|Lost to Follow-up|4|||
19408557|NCT02143947|41654011|FG001|Overall Study|Lost to Follow-up|2|||
19408558|NCT02075073|41654022|FG000|Overall Study|Withdrawal by Subject|0|||
19408559|NCT02075073|41654023|FG001|Overall Study|Withdrawal by Subject|1|||
19408560|NCT02075073|41654024|FG002|Overall Study|Withdrawal by Subject|0|||
19408561|NCT02074059|41654038|FG000|Overall Study|Death|0|||
19408562|NCT02074059|41654039|FG001|Overall Study|Death|0|||
19408563|NCT02074059|41654040|FG002|Overall Study|Death|0|||
19408564|NCT02074059|41654041|FG003|Overall Study|Death|0|||
19408565|NCT02074059|41654042|FG004|Overall Study|Death|1|||
19408566|NCT02074059|41654043|FG005|Overall Study|Death|1|||
19408567|NCT01364597|41654062|FG000|Overall Study|Adverse Event|4|||
19408568|NCT01364597|41654063|FG001|Overall Study|Adverse Event|5|||
19408569|NCT01364597|41654064|FG002|Overall Study|Adverse Event|16|||
19408570|NCT01364597|41654065|FG003|Overall Study|Adverse Event|7|||
19408571|NCT01364597|41654062|FG000|Overall Study|Lack of Efficacy|4|||
19408572|NCT01364597|41654063|FG001|Overall Study|Lack of Efficacy|4|||
19408573|NCT01364597|41654064|FG002|Overall Study|Lack of Efficacy|23|||
19408574|NCT01364597|41654065|FG003|Overall Study|Lack of Efficacy|8|||
19408575|NCT01364597|41654062|FG000|Overall Study|Protocol Violation|0|||
19408576|NCT01364597|41654063|FG001|Overall Study|Protocol Violation|0|||
19408577|NCT01364597|41654064|FG002|Overall Study|Protocol Violation|2|||
19408578|NCT01364597|41654065|FG003|Overall Study|Protocol Violation|0|||
19408579|NCT01364597|41654062|FG000|Overall Study|Lost to Follow-up|0|||
19408580|NCT01364597|41654063|FG001|Overall Study|Lost to Follow-up|0|||
19408581|NCT01364597|41654064|FG002|Overall Study|Lost to Follow-up|5|||
19408582|NCT01364597|41654065|FG003|Overall Study|Lost to Follow-up|3|||
19408583|NCT01364597|41654062|FG000|Overall Study|Withdrawal by Subject|4|||
19408584|NCT01364597|41654063|FG001|Overall Study|Withdrawal by Subject|1|||
19408585|NCT01364597|41654064|FG002|Overall Study|Withdrawal by Subject|18|||
19408586|NCT01364597|41654065|FG003|Overall Study|Withdrawal by Subject|6|||
19408587|NCT01364597|41654062|FG000|Overall Study|Non compliance|1|||
19408588|NCT01364597|41654063|FG001|Overall Study|Non compliance|0|||
19408589|NCT01364597|41654064|FG002|Overall Study|Non compliance|1|||
19408590|NCT01364597|41654065|FG003|Overall Study|Non compliance|0|||
19408591|NCT01364597|41654062|FG000|Overall Study|Lack of compliance|1|||
19408592|NCT01364597|41654063|FG001|Overall Study|Lack of compliance|0|||
19408593|NCT01364597|41654064|FG002|Overall Study|Lack of compliance|0|||
19408594|NCT01364597|41654065|FG003|Overall Study|Lack of compliance|0|||
19408595|NCT01364597|41654062|FG000|Overall Study|End of treatment epilepsy|1|||
19408596|NCT01364597|41654063|FG001|Overall Study|End of treatment epilepsy|0|||
19408597|NCT01364597|41654064|FG002|Overall Study|End of treatment epilepsy|0|||
19408598|NCT01364597|41654065|FG003|Overall Study|End of treatment epilepsy|0|||
19408599|NCT01364597|41654062|FG000|Overall Study|No Seizures|1|||
19408600|NCT01364597|41654063|FG001|Overall Study|No Seizures|0|||
19408601|NCT01364597|41654064|FG002|Overall Study|No Seizures|0|||
19408602|NCT01364597|41654065|FG003|Overall Study|No Seizures|0|||
19408603|NCT01364597|41654062|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
19408604|NCT01364597|41654063|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
19408605|NCT01364597|41654064|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
19408606|NCT01364597|41654065|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
19408607|NCT01364597|41654062|FG000|Overall Study|Cure|1|||
19408608|NCT01364597|41654063|FG001|Overall Study|Cure|0|||
19408609|NCT01364597|41654064|FG002|Overall Study|Cure|0|||
19408610|NCT01364597|41654065|FG003|Overall Study|Cure|0|||
19408611|NCT01364597|41654062|FG000|Overall Study|Patient was moving|0|||
19408612|NCT01364597|41654063|FG001|Overall Study|Patient was moving|1|||
19408613|NCT01364597|41654064|FG002|Overall Study|Patient was moving|0|||
19408614|NCT01364597|41654065|FG003|Overall Study|Patient was moving|0|||
19408615|NCT01364597|41654062|FG000|Overall Study|Seizures resolved|0|||
19408616|NCT01364597|41654063|FG001|Overall Study|Seizures resolved|0|||
19408617|NCT01364597|41654064|FG002|Overall Study|Seizures resolved|1|||
19408618|NCT01364597|41654065|FG003|Overall Study|Seizures resolved|0|||
19408619|NCT01364597|41654062|FG000|Overall Study|Patient became seizure-free after surgery|0|||
19408620|NCT01364597|41654063|FG001|Overall Study|Patient became seizure-free after surgery|0|||
19408621|NCT01364597|41654064|FG002|Overall Study|Patient became seizure-free after surgery|1|||
19408622|NCT01364597|41654065|FG003|Overall Study|Patient became seizure-free after surgery|0|||
19408623|NCT01364597|41654062|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
19408624|NCT01364597|41654063|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
19408625|NCT01364597|41654064|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
19408626|NCT01364597|41654065|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
19408627|NCT01364597|41654062|FG000|Overall Study|Patient cured from Epilepsy|0|||
19408628|NCT01364597|41654063|FG001|Overall Study|Patient cured from Epilepsy|0|||
19408629|NCT01364597|41654064|FG002|Overall Study|Patient cured from Epilepsy|1|||
19408630|NCT01364597|41654065|FG003|Overall Study|Patient cured from Epilepsy|0|||
19408631|NCT01364597|41654062|FG000|Overall Study|Investigator decision|0|||
19408632|NCT01364597|41654063|FG001|Overall Study|Investigator decision|0|||
19408633|NCT01364597|41654064|FG002|Overall Study|Investigator decision|1|||
19408634|NCT01364597|41654065|FG003|Overall Study|Investigator decision|0|||
19408635|NCT01364597|41654062|FG000|Overall Study|Sponsor recommended discontinuation|0|||
19408636|NCT01364597|41654063|FG001|Overall Study|Sponsor recommended discontinuation|0|||
19408637|NCT01364597|41654064|FG002|Overall Study|Sponsor recommended discontinuation|0|||
19408638|NCT01364597|41654065|FG003|Overall Study|Sponsor recommended discontinuation|1|||
19408639|NCT01364597|41654062|FG000|Overall Study|Parents went abroad with the patient|0|||
19408640|NCT01364597|41654063|FG001|Overall Study|Parents went abroad with the patient|0|||
19408641|NCT01364597|41654064|FG002|Overall Study|Parents went abroad with the patient|1|||
19408642|NCT01364597|41654065|FG003|Overall Study|Parents went abroad with the patient|0|||
19408643|NCT01364597|41654062|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
19408644|NCT01364597|41654063|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
19408645|NCT01364597|41654064|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
19408646|NCT01364597|41654065|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
19408647|NCT01364597|41654062|FG000|Overall Study|BRV administration dropout|0|||
19408648|NCT01364597|41654063|FG001|Overall Study|BRV administration dropout|0|||
19408649|NCT01364597|41654064|FG002|Overall Study|BRV administration dropout|1|||
19408650|NCT01364597|41654065|FG003|Overall Study|BRV administration dropout|0|||
19408651|NCT01364597|41654062|FG000|Overall Study|Dropout|0|||
19408652|NCT01364597|41654063|FG001|Overall Study|Dropout|0|||
19408653|NCT01364597|41654064|FG002|Overall Study|Dropout|3|||
19408654|NCT01364597|41654065|FG003|Overall Study|Dropout|1|||
19408655|NCT01364597|41654062|FG000|Overall Study|Unreliable subject|0|||
19408656|NCT01364597|41654063|FG001|Overall Study|Unreliable subject|0|||
19408657|NCT01364597|41654064|FG002|Overall Study|Unreliable subject|0|||
19408658|NCT01364597|41654065|FG003|Overall Study|Unreliable subject|1|||
19408659|NCT01364597|41654062|FG000|Overall Study|Other|0|||
19408660|NCT01364597|41654063|FG001|Overall Study|Other|0|||
19408661|NCT01364597|41654064|FG002|Overall Study|Other|0|||
19408662|NCT01364597|41654065|FG003|Overall Study|Other|1|||
19408663|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
19408664|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
19408665|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
19408666|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
19408667|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Adverse Event|7|||
19408668|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Adverse Event|8|||
19408669|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Adverse Event|8|||
19408670|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Adverse Event|9|||
19408671|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
19408672|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
19408673|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
19408674|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
19408675|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
19408676|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
19408677|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
19408678|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
19408679|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Pregnancy|0|||
19408680|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Pregnancy|2|||
19408681|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Pregnancy|2|||
19408682|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Pregnancy|0|||
19408683|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Non-compliance|1|||
19408684|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Non-compliance|0|||
19408685|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Non-compliance|0|||
19408686|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Non-compliance|3|||
19408687|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Other|3|||
19408688|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Other|0|||
19408689|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Other|3|||
19408690|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Other|2|||
19408691|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
19408692|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
19408693|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
19408694|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
19408695|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
19408696|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
19408697|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
19408698|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
19408699|NCT02143713|41654082|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
19711093|NCT00111813|42154254|FG002|Overall Study|Other|1|||
19711094|NCT00111813|42154255|FG003|Overall Study|Other|0|||
19408700|NCT02143713|41654083|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
19408701|NCT02143713|41654084|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
19408702|NCT02143713|41654085|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
19408703|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
19408704|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
19408705|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
19408706|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
19408707|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
19408708|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
19408709|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
19408710|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
19408711|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
19408712|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
19408713|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
19408714|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
19408715|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
19408716|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
19408717|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
19408718|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
19408719|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
19408720|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
19408721|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
19408722|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
19408723|NCT02143713|41654082|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
19408724|NCT02143713|41654083|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
19408725|NCT02143713|41654084|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
19408726|NCT02143713|41654085|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
19408727|NCT02519855|41654098|FG000|Overall Study|Adverse Event|0|||
19408728|NCT02519855|41654099|FG001|Overall Study|Adverse Event|1|||
19408729|NCT02519855|41654098|FG000|Overall Study|Lost to Follow-up|3|||
19408730|NCT02519855|41654099|FG001|Overall Study|Lost to Follow-up|3|||
19408731|NCT02142387|41654107|FG000|Overall Study|<19 years old|49|||
19408732|NCT02142387|41654108|FG001|Overall Study|<19 years old|326|||
19408733|NCT02142387|41654107|FG000|Overall Study|non-cardiac etiology|504|||
19408734|NCT02142387|41654108|FG001|Overall Study|non-cardiac etiology|3431|||
19408735|NCT02142387|41654107|FG000|Overall Study|CPR not performed|74|||
19408736|NCT02142387|41654108|FG001|Overall Study|CPR not performed|473|||
19408737|NCT02142387|41654107|FG000|Overall Study|witnessed by paramedic|139|||
19408738|NCT02142387|41654108|FG001|Overall Study|witnessed by paramedic|917|||
19408739|NCT02142387|41654107|FG000|Overall Study|incomplete data|1|||
19408740|NCT02142387|41654108|FG001|Overall Study|incomplete data|9|||
19408741|NCT02142387|41654107|FG000|Overall Study|occurred not at home|298|||
19408742|NCT02142387|41654108|FG001|Overall Study|occurred not at home|2474|||
19408743|NCT02518919|41654117|FG000|Overall Study|Protocol Violation|1|||
19408744|NCT02518919|41654118|FG001|Overall Study|Protocol Violation|1|||
19408745|NCT02518919|41654119|FG002|Overall Study|Protocol Violation|2|||
19408746|NCT02518685|41654129|FG000|Overall Study|Adverse Event|29|||
19408747|NCT02518685|41654130|FG001|Overall Study|Adverse Event|1|||
19408748|NCT02518685|41654129|FG000|Overall Study|Withdrawal by Subject|10|||
19408749|NCT02518685|41654130|FG001|Overall Study|Withdrawal by Subject|3|||
19408750|NCT02518685|41654129|FG000|Overall Study|relocation, study fatigue|7|||
19408751|NCT02518685|41654130|FG001|Overall Study|relocation, study fatigue|2|||
19408752|NCT02518685|41654129|FG000|Overall Study|Pregnancy|1|||
19408753|NCT02518685|41654130|FG001|Overall Study|Pregnancy|0|||
19408754|NCT02518685|41654129|FG000|Overall Study|Physician Decision|1|||
19408755|NCT02518685|41654130|FG001|Overall Study|Physician Decision|0|||
19408756|NCT02518685|41654129|FG000|Overall Study|Lost to Follow-up|1|||
19408757|NCT02518685|41654130|FG001|Overall Study|Lost to Follow-up|4|||
19408758|NCT02520089|41654139|FG000|Overall Study|Lost to Follow-up|3|||
19408759|NCT02520089|41654140|FG001|Overall Study|Lost to Follow-up|4|||
19408760|NCT02105961|41654149|FG000|Overall Study|Adverse Event|18|||
19408761|NCT02105961|41654150|FG001|Overall Study|Adverse Event|7|||
19408762|NCT02105961|41654151|FG002|Overall Study|Adverse Event|13|||
19408763|NCT02105961|41654149|FG000|Overall Study|Lack of Efficacy|3|||
19408764|NCT02105961|41654150|FG001|Overall Study|Lack of Efficacy|0|||
19408765|NCT02105961|41654151|FG002|Overall Study|Lack of Efficacy|3|||
19408766|NCT02105961|41654149|FG000|Overall Study|Lost to Follow-up|2|||
19408767|NCT02105961|41654150|FG001|Overall Study|Lost to Follow-up|0|||
19408768|NCT02105961|41654151|FG002|Overall Study|Lost to Follow-up|1|||
19408769|NCT02105961|41654149|FG000|Overall Study|Physician Decision|3|||
19408770|NCT02105961|41654150|FG001|Overall Study|Physician Decision|3|||
19408771|NCT02105961|41654151|FG002|Overall Study|Physician Decision|2|||
19408772|NCT02105961|41654149|FG000|Overall Study|Withdrawal by Subject|15|||
19408773|NCT02105961|41654150|FG001|Overall Study|Withdrawal by Subject|7|||
19408774|NCT02105961|41654151|FG002|Overall Study|Withdrawal by Subject|11|||
19408775|NCT02141997|41654164|FG000|Overall Study|Adverse Event|0|||
19408776|NCT02141997|41654165|FG001|Overall Study|Adverse Event|2|||
19408777|NCT02141997|41654166|FG002|Overall Study|Adverse Event|0|||
19408778|NCT02141997|41654167|FG003|Overall Study|Adverse Event|1|||
19408779|NCT02141997|41654164|FG000|Overall Study|Participant noncompliance|1|||
19408780|NCT02141997|41654165|FG001|Overall Study|Participant noncompliance|0|||
19408781|NCT02141997|41654166|FG002|Overall Study|Participant noncompliance|0|||
19408782|NCT02141997|41654167|FG003|Overall Study|Participant noncompliance|0|||
19408783|NCT02141997|41654164|FG000|Overall Study|Withdrew consent|1|||
19408784|NCT02141997|41654165|FG001|Overall Study|Withdrew consent|0|||
19408785|NCT02141997|41654166|FG002|Overall Study|Withdrew consent|3|||
19408786|NCT02141997|41654167|FG003|Overall Study|Withdrew consent|0|||
19408787|NCT02141997|41654164|FG000|Overall Study|Other|1|||
19408788|NCT02141997|41654165|FG001|Overall Study|Other|4|||
19408789|NCT02141997|41654166|FG002|Overall Study|Other|0|||
19408790|NCT02141997|41654167|FG003|Overall Study|Other|0|||
19408791|NCT01628367|41654179|FG000|Overall Study|Adverse Event|1|||
19408792|NCT01628367|41654180|FG001|Overall Study|Adverse Event|0|||
19408793|NCT01627899|41654186|FG000|Overall Study|Study terminated early by sponsor.|5|||
19408794|NCT02519777|41654193|FG000|Overall Study|Death|1|||
19408795|NCT02519777|41654194|FG001|Overall Study|Death|0|||
19408796|NCT02519777|41654195|FG002|Overall Study|Death|0|||
19408797|NCT02519777|41654193|FG000|Overall Study|Lost to Follow-up|0|||
19408798|NCT02519777|41654194|FG001|Overall Study|Lost to Follow-up|4|||
19408799|NCT02519777|41654195|FG002|Overall Study|Lost to Follow-up|2|||
19408800|NCT02519777|41654193|FG000|Overall Study|Withdrawal by Subject|3|||
19408801|NCT02519777|41654194|FG001|Overall Study|Withdrawal by Subject|1|||
19408802|NCT02519777|41654195|FG002|Overall Study|Withdrawal by Subject|0|||
19408803|NCT02519777|41654193|FG000|Overall Study|Severe Debilitation|1|||
19408804|NCT02519777|41654194|FG001|Overall Study|Severe Debilitation|1|||
19408805|NCT02519777|41654195|FG002|Overall Study|Severe Debilitation|1|||
19408806|NCT02519777|41654193|FG000|Overall Study|Not able to get to clinic|1|||
19408807|NCT02519777|41654194|FG001|Overall Study|Not able to get to clinic|2|||
19408808|NCT02519777|41654195|FG002|Overall Study|Not able to get to clinic|1|||
19408809|NCT02515331|41654206|FG000|Overall Study|Withdrawal by Subject|0|||
19408810|NCT02515331|41654207|FG001|Overall Study|Withdrawal by Subject|0|||
19408811|NCT02515331|41654208|FG002|Overall Study|Withdrawal by Subject|1|||
19408812|NCT02515331|41654206|FG000|Overall Study|Protocol deviation|0|||
19408813|NCT02515331|41654207|FG001|Overall Study|Protocol deviation|0|||
19408814|NCT02515331|41654208|FG002|Overall Study|Protocol deviation|3|||
19408815|NCT02515331|41654206|FG000|Overall Study|Adverse Event|2|||
19408816|NCT02515331|41654207|FG001|Overall Study|Adverse Event|0|||
19408817|NCT02515331|41654208|FG002|Overall Study|Adverse Event|0|||
19408818|NCT02515097|41654218|FG000|Overall Study|Lost to Follow-up|4|||
19408819|NCT02515097|41654219|FG001|Overall Study|Lost to Follow-up|2|||
19408820|NCT02515097|41654218|FG000|Overall Study|Withdrawal by Subject|1|||
19408821|NCT02515097|41654219|FG001|Overall Study|Withdrawal by Subject|3|||
19408822|NCT02515097|41654218|FG000|Overall Study|Adverse Event|2|||
19408823|NCT02515097|41654219|FG001|Overall Study|Adverse Event|1|||
19408824|NCT02141295|41654228|FG000|Overall Study|Adverse Event|1|||
19408825|NCT02141295|41654229|FG001|Overall Study|Adverse Event|18|||
19408826|NCT02141295|41654230|FG002|Overall Study|Adverse Event|11|||
19408827|NCT02141295|41654228|FG000|Overall Study|Physician Decision|2|||
19408828|NCT02141295|41654229|FG001|Overall Study|Physician Decision|19|||
19408829|NCT02141295|41654230|FG002|Overall Study|Physician Decision|14|||
19408830|NCT02141295|41654228|FG000|Overall Study|Study terminated by sponsor|0|||
19408831|NCT02141295|41654229|FG001|Overall Study|Study terminated by sponsor|6|||
19408832|NCT02141295|41654230|FG002|Overall Study|Study terminated by sponsor|6|||
19408833|NCT02141295|41654228|FG000|Overall Study|Non-compliance|0|||
19518894|NCT01457118|41931940|FG000|Overall Study|Progressive Disease by RECIST|12|||
19518895|NCT01457118|41931941|FG001|Overall Study|Progressive Disease by RECIST|3|||
19518896|NCT01457118|41931942|FG002|Overall Study|Progressive Disease by RECIST|1|||
19711095|NCT00111813|42154256|FG004|Overall Study|Other|0|||
19711096|NCT00111813|42154257|FG005|Overall Study|Other|0|||
19408834|NCT02141295|41654229|FG001|Overall Study|Non-compliance|1|||
19408835|NCT02141295|41654230|FG002|Overall Study|Non-compliance|0|||
19408836|NCT02141295|41654228|FG000|Overall Study|Progressive disease|3|||
19408837|NCT02141295|41654229|FG001|Overall Study|Progressive disease|32|||
19408838|NCT02141295|41654230|FG002|Overall Study|Progressive disease|50|||
19408839|NCT02141295|41654228|FG000|Overall Study|Reason not specified|0|||
19408840|NCT02141295|41654229|FG001|Overall Study|Reason not specified|9|||
19408841|NCT02141295|41654230|FG002|Overall Study|Reason not specified|10|||
19408842|NCT02141295|41654228|FG000|Overall Study|Withdrawal by Subject|0|||
19711097|NCT00118287|42154272|FG000|Overall Study|Intracranial haemorrhage|1|||
19408843|NCT02141295|41654229|FG001|Overall Study|Withdrawal by Subject|9|||
19408844|NCT02141295|41654230|FG002|Overall Study|Withdrawal by Subject|4|||
19408845|NCT02514551|41654242|FG000|Overall Study|Lost to Follow-up|0|||
19408846|NCT02514551|41654243|FG001|Overall Study|Lost to Follow-up|1|||
19408847|NCT02514551|41654242|FG000|Overall Study|Participant Never Treated|0|||
19408848|NCT02514551|41654243|FG001|Overall Study|Participant Never Treated|2|||
19408849|NCT02141217|41654252|FG000|Overall Study|Adverse Event|1|||
19408850|NCT02141217|41654253|FG001|Overall Study|Adverse Event|2|||
19408851|NCT02141217|41654252|FG000|Overall Study|Protocol Violation|1|||
19408852|NCT02141217|41654253|FG001|Overall Study|Protocol Violation|4|||
19408853|NCT02141217|41654252|FG000|Overall Study|Withdrawal by Subject|6|||
19408854|NCT02141217|41654253|FG001|Overall Study|Withdrawal by Subject|0|||
19408855|NCT02141217|41654252|FG000|Overall Study|Lost to Follow-up|1|||
19408856|NCT02141217|41654253|FG001|Overall Study|Lost to Follow-up|1|||
19408857|NCT02141217|41654252|FG000|Overall Study|Physician Decision|1|||
19408858|NCT02141217|41654253|FG001|Overall Study|Physician Decision|0|||
19408859|NCT02141217|41654252|FG000|Overall Study|Surgical Intervention|1|||
19408860|NCT02141217|41654253|FG001|Overall Study|Surgical Intervention|1|||
19408861|NCT02138253|41654264|FG000|Overall Study|Adverse Event|3|||
19408862|NCT02138253|41654265|FG001|Overall Study|Adverse Event|3|||
19408863|NCT02138253|41654264|FG000|Overall Study|Lost to Follow-up|2|||
19408864|NCT02138253|41654265|FG001|Overall Study|Lost to Follow-up|1|||
19408865|NCT02138253|41654264|FG000|Overall Study|Physician Decision|2|||
19408866|NCT02138253|41654265|FG001|Overall Study|Physician Decision|0|||
19408867|NCT02138253|41654264|FG000|Overall Study|Non compliance|1|||
19408868|NCT02138253|41654265|FG001|Overall Study|Non compliance|0|||
19408869|NCT02138253|41654264|FG000|Overall Study|Withdrawal by Subject|1|||
19408870|NCT02138253|41654265|FG001|Overall Study|Withdrawal by Subject|0|||
19408871|NCT02514473|41654273|FG000|Overall Study|Adverse Event|0|||
19408872|NCT02514473|41654274|FG001|Overall Study|Adverse Event|2|||
19408873|NCT02514473|41654273|FG000|Overall Study|Withdrawal by Subject|2|||
19408874|NCT02514473|41654274|FG001|Overall Study|Withdrawal by Subject|1|||
19408875|NCT02514473|41654273|FG000|Overall Study|Lost to Follow-up|0|||
19408876|NCT02514473|41654274|FG001|Overall Study|Lost to Follow-up|1|||
19408877|NCT02514473|41654273|FG000|Overall Study|Other|1|||
19408878|NCT02514473|41654274|FG001|Overall Study|Other|1|||
19408879|NCT02513771|41654283|FG000|Overall Study|Lost to Follow-up|1|||
19408880|NCT02513771|41654284|FG001|Overall Study|Lost to Follow-up|1|||
19408881|NCT02513771|41654283|FG000|Overall Study|Not being able to get to clinic|1|||
19408882|NCT02513771|41654284|FG001|Overall Study|Not being able to get to clinic|0|||
19408883|NCT02104947|41654292|FG000|Overall Study|Withdrawal by Subject|10|||
19408884|NCT02104947|41654293|FG001|Overall Study|Withdrawal by Subject|3|||
19408885|NCT02104947|41654292|FG000|Overall Study|Lost to Follow-up|4|||
19408886|NCT02104947|41654293|FG001|Overall Study|Lost to Follow-up|4|||
19408887|NCT02104947|41654292|FG000|Overall Study|Protocol Violation|6|||
19408888|NCT02104947|41654293|FG001|Overall Study|Protocol Violation|8|||
19408889|NCT02104947|41654292|FG000|Overall Study|Adverse Event|57|||
19408890|NCT02104947|41654293|FG001|Overall Study|Adverse Event|38|||
19408891|NCT02104947|41654292|FG000|Overall Study|Other than stated above|2|||
19408892|NCT02104947|41654293|FG001|Overall Study|Other than stated above|3|||
19408893|NCT02513459|41654303|FG000|Overall Study|Adverse Event|7|||
19408894|NCT02513459|41654303|FG000|Overall Study|Withdrew consent|5|||
19408895|NCT02513459|41654303|FG000|Overall Study|Loss of efficacy|2|||
19408896|NCT02513459|41654303|FG000|Overall Study|Pregnancy|2|||
19408897|NCT02513459|41654303|FG000|Overall Study|Subject decision|2|||
19518897|NCT01457118|41931943|FG003|Overall Study|Progressive Disease by RECIST|0|||
19518898|NCT01457118|41931940|FG000|Overall Study|Withdrawal by Subject|5|||
19518899|NCT01457118|41931941|FG001|Overall Study|Withdrawal by Subject|0|||
19518900|NCT01457118|41931942|FG002|Overall Study|Withdrawal by Subject|0|||
19518901|NCT01457118|41931943|FG003|Overall Study|Withdrawal by Subject|0|||
19518902|NCT01456962|41931955|FG000|Overall Study|Lost to Follow-up|2|||
19518903|NCT01456962|41931956|FG001|Overall Study|Lost to Follow-up|1|||
19408898|NCT02513459|41654303|FG000|Overall Study|Lack of response|1|||
19408899|NCT02513459|41654303|FG000|Overall Study|Reproductive plans|1|||
19408900|NCT02513459|41654303|FG000|Overall Study|Surgery planned-- not done|1|||
19408901|NCT02104557|41654312|FG000|Overall Study|Adverse Event|24|||
19408902|NCT02104557|41654312|FG000|Overall Study|Lost to Follow-up|34|||
19408903|NCT02104557|41654312|FG000|Overall Study|Violated the usage and dosage|14|||
19408904|NCT02104557|41654312|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
19408905|NCT02104557|41654312|FG000|Overall Study|Administered Sayana prior to the contract|1|||
19518904|NCT01501110|41931964|FG000|Overall Study|Death|0|||
19518905|NCT01501110|41931965|FG001|Overall Study|Death|1|||
19518906|NCT01500720|41931973|FG000|Overall Study|Randomized But Not Treated|1|||
19408906|NCT02104557|41654312|FG000|Overall Study|Other|17|||
19408907|NCT02104557|41654312|FG000|Overall Study|Change to other contraception methods|5|||
19408908|NCT02104557|41654312|FG000|Overall Study|Discontinuation due to no pain|1|||
19408909|NCT02104557|41654312|FG000|Overall Study|Withdrawal consent|2|||
19408910|NCT02104557|41654312|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
19408911|NCT02104557|41654312|FG000|Overall Study|Discontinuation of contraception|9|||
19408912|NCT02069379|41654318|FG000|Baseline Measurements|Lost to Follow-up|1|||
19408913|NCT02069379|41654319|FG001|Baseline Measurements|Lost to Follow-up|0|||
19408914|NCT02069379|41654320|FG002|Baseline Measurements|Lost to Follow-up|0|||
19408915|NCT02069379|41654321|FG003|Baseline Measurements|Lost to Follow-up|0|||
19408916|NCT02069379|41654318|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
19408917|NCT02069379|41654319|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
19408918|NCT02069379|41654320|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
19408919|NCT02069379|41654321|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
19408920|NCT02069379|41654318|FG000|First Treatment Arm|Lost to Follow-up|0|||
19408921|NCT02069379|41654319|FG001|First Treatment Arm|Lost to Follow-up|1|||
19408922|NCT02069379|41654320|FG002|First Treatment Arm|Lost to Follow-up|1|||
19408923|NCT02069379|41654321|FG003|First Treatment Arm|Lost to Follow-up|0|||
19408924|NCT02069379|41654318|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
19408925|NCT02069379|41654319|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
19408926|NCT02069379|41654320|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
19408927|NCT02069379|41654321|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
19408928|NCT02069379|41654318|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
19408929|NCT02069379|41654319|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
19408930|NCT02069379|41654320|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
19408931|NCT02069379|41654321|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
19408932|NCT02069379|41654318|FG000|Second Treatment Arm|Lost to Follow-up|0|||
19408933|NCT02069379|41654319|FG001|Second Treatment Arm|Lost to Follow-up|0|||
19408934|NCT02069379|41654320|FG002|Second Treatment Arm|Lost to Follow-up|1|||
19408935|NCT02069379|41654321|FG003|Second Treatment Arm|Lost to Follow-up|0|||
19408936|NCT02511431|41654337|FG000|Treatment|Lost to Follow-up|0|||
19408937|NCT02511431|41654338|FG001|Treatment|Lost to Follow-up|0|||
19408938|NCT02511431|41654339|FG002|Treatment|Lost to Follow-up|1|||
19408939|NCT02511431|41654340|FG003|Treatment|Lost to Follow-up|0|||
19408940|NCT02511431|41654341|FG004|Treatment|Lost to Follow-up|0|||
19408941|NCT02511431|41654342|FG005|Treatment|Lost to Follow-up|1|||
19408942|NCT02137785|41654359|FG000|Overall Study|Lost to Follow-up|1|||
19408943|NCT02137785|41654360|FG001|Overall Study|Lost to Follow-up|0|||
19408944|NCT02137785|41654359|FG000|Overall Study|Withdrawal by Subject|1|||
19408945|NCT02137785|41654360|FG001|Overall Study|Withdrawal by Subject|4|||
19408946|NCT02137785|41654359|FG000|Overall Study|subject moved out of state|1|||
19408947|NCT02137785|41654360|FG001|Overall Study|subject moved out of state|0|||
19408948|NCT01655069|41654370|FG000|Overall Study|Physician Decision|0|||
19408949|NCT01655069|41654371|FG001|Overall Study|Physician Decision|0|||
19408950|NCT01655069|41654372|FG002|Overall Study|Physician Decision|0|||
19408951|NCT01655069|41654373|FG003|Overall Study|Physician Decision|1|||
19408952|NCT01655069|41654370|FG000|Overall Study|Adverse Event|6|||
19408953|NCT01655069|41654371|FG001|Overall Study|Adverse Event|7|||
19408954|NCT01655069|41654372|FG002|Overall Study|Adverse Event|2|||
19408955|NCT01655069|41654373|FG003|Overall Study|Adverse Event|3|||
19408956|NCT01655069|41654370|FG000|Overall Study|Lack of Efficacy|0|||
19408957|NCT01655069|41654371|FG001|Overall Study|Lack of Efficacy|1|||
19408958|NCT01655069|41654372|FG002|Overall Study|Lack of Efficacy|0|||
19408959|NCT01655069|41654373|FG003|Overall Study|Lack of Efficacy|0|||
19408960|NCT01655069|41654370|FG000|Overall Study|No Treatment Needed|0|||
19408961|NCT01655069|41654371|FG001|Overall Study|No Treatment Needed|1|||
19408962|NCT01655069|41654372|FG002|Overall Study|No Treatment Needed|0|||
19408963|NCT01655069|41654373|FG003|Overall Study|No Treatment Needed|0|||
19408964|NCT01655069|41654370|FG000|Overall Study|Withdrawal by Subject|2|||
19408965|NCT01655069|41654371|FG001|Overall Study|Withdrawal by Subject|3|||
19408966|NCT01655069|41654372|FG002|Overall Study|Withdrawal by Subject|0|||
19408967|NCT01655069|41654373|FG003|Overall Study|Withdrawal by Subject|0|||
19408968|NCT02068599|41654384|FG000|Overall Study|Adverse Event|4|||
19408969|NCT02068599|41654385|FG001|Overall Study|Adverse Event|1|||
19408970|NCT02068599|41654386|FG002|Overall Study|Adverse Event|1|||
19408971|NCT02068599|41654384|FG000|Overall Study|Withdrawal by Subject|2|||
19408972|NCT02068599|41654385|FG001|Overall Study|Withdrawal by Subject|7|||
19408973|NCT02068599|41654386|FG002|Overall Study|Withdrawal by Subject|5|||
19408974|NCT02068599|41654384|FG000|Overall Study|Protocol Violation|4|||
19408975|NCT02068599|41654385|FG001|Overall Study|Protocol Violation|2|||
19408976|NCT02068599|41654386|FG002|Overall Study|Protocol Violation|3|||
19408977|NCT02068599|41654384|FG000|Overall Study|Lost to Follow-up|1|||
19408978|NCT02068599|41654385|FG001|Overall Study|Lost to Follow-up|0|||
19408979|NCT02068599|41654386|FG002|Overall Study|Lost to Follow-up|0|||
19408980|NCT02068599|41654384|FG000|Overall Study|Lack of Efficacy|0|||
19408981|NCT02068599|41654385|FG001|Overall Study|Lack of Efficacy|0|||
19408982|NCT02068599|41654386|FG002|Overall Study|Lack of Efficacy|3|||
19408983|NCT02068599|41654384|FG000|Overall Study|Noncompliance|0|||
19408984|NCT02068599|41654385|FG001|Overall Study|Noncompliance|0|||
19408985|NCT02068599|41654386|FG002|Overall Study|Noncompliance|1|||
19408986|NCT01654601|41654396|FG000|1st Administration|Withdrawal by Subject|2|||
19408987|NCT01654601|41654397|FG001|1st Administration|Withdrawal by Subject|0|||
19408988|NCT01654601|41654396|FG000|1st Administration|Protocol Violation|0|||
19408989|NCT01654601|41654397|FG001|1st Administration|Protocol Violation|2|||
19408990|NCT01654601|41654396|FG000|2nd Administration|Adverse Event|1|||
19408991|NCT01654601|41654397|FG001|2nd Administration|Adverse Event|0|||
19408992|NCT01654601|41654396|FG000|2nd Administration|Protocol Violation|0|||
19408993|NCT01654601|41654397|FG001|2nd Administration|Protocol Violation|1|||
19408994|NCT01654523|41654403|FG000|Overall Study|Withdrawal by Subject|1|||
19408995|NCT02068443|41654410|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19408996|NCT02068443|41654411|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
19408997|NCT02068443|41654412|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
19408998|NCT02068443|41654410|FG000|Overall Study|Voluntary Withdrawal|4|||
19408999|NCT02068443|41654411|FG001|Overall Study|Voluntary Withdrawal|0|||
19409000|NCT02068443|41654412|FG002|Overall Study|Voluntary Withdrawal|1|||
19409001|NCT02068443|41654410|FG000|Overall Study|Lack of Efficacy|2|||
19409002|NCT02068443|41654411|FG001|Overall Study|Lack of Efficacy|1|||
19409003|NCT02068443|41654412|FG002|Overall Study|Lack of Efficacy|0|||
19409004|NCT02068443|41654410|FG000|Overall Study|Other Reason Not Specified|1|||
19409005|NCT02068443|41654411|FG001|Overall Study|Other Reason Not Specified|0|||
19409006|NCT02068443|41654412|FG002|Overall Study|Other Reason Not Specified|0|||
19409007|NCT02508935|41654420|FG000|Overall Study|Withdrawal by Subject|1|||
19409008|NCT02508935|41654420|FG000|Overall Study|Withdrawal by Caregiver|8|||
19409009|NCT02508935|41654420|FG000|Overall Study|Pain Score <4|1|||
19409010|NCT02508935|41654420|FG000|Overall Study|Emesis|3|||
19409011|NCT02508935|41654420|FG000|Overall Study|Adverse Event|3|||
19409012|NCT02508935|41654420|FG000|Overall Study|Protocol Violation|1|||
19409013|NCT02508935|41654420|FG000|Overall Study|Physician Decision|1|||
19409014|NCT02508935|41654420|FG000|Overall Study|Trial terminated by sponsor|5|||
19409015|NCT02508701|41654430|FG000|Overall Study|Lost to Follow-up|9|||
19409016|NCT02508701|41654431|FG001|Overall Study|Lost to Follow-up|5|||
19409017|NCT02508701|41654432|FG002|Overall Study|Lost to Follow-up|5|||
19409018|NCT02508701|41654433|FG003|Overall Study|Lost to Follow-up|3|||
19409019|NCT02507375|41654449|FG000|Overall Study|Progressive Disease|4|||
19409020|NCT02507375|41654450|FG001|Overall Study|Progressive Disease|5|||
19409021|NCT02507375|41654449|FG000|Overall Study|Death|0|||
19409022|NCT02507375|41654450|FG001|Overall Study|Death|1|||
19409023|NCT02507375|41654449|FG000|Overall Study|Refused treatment|0|||
19409024|NCT02507375|41654450|FG001|Overall Study|Refused treatment|1|||
19409025|NCT02507375|41654449|FG000|Overall Study|Adverse Event|0|||
19409026|NCT02507375|41654450|FG001|Overall Study|Adverse Event|1|||
19409027|NCT02507297|41654462|FG000|Overall Study|Withdrawal by Subject|1|||
19409028|NCT02507297|41654463|FG001|Overall Study|Withdrawal by Subject|0|||
19409029|NCT02507297|41654462|FG000|Overall Study|Lost to Follow-up|0|||
19409030|NCT02507297|41654463|FG001|Overall Study|Lost to Follow-up|1|||
19409031|NCT02507219|41654469|FG000|Overall Study|Physician Decision|1|||
19409032|NCT02507219|41654470|FG001|Overall Study|Physician Decision|0|||
19409033|NCT02507219|41654471|FG002|Overall Study|Physician Decision|0|||
19409034|NCT02507219|41654472|FG003|Overall Study|Physician Decision|0|||
19409035|NCT02507219|41654473|FG004|Overall Study|Physician Decision|0|||
19409036|NCT02507219|41654474|FG005|Overall Study|Physician Decision|0|||
19409037|NCT02507219|41654469|FG000|Overall Study|Withdrawal by Subject|0|||
19409038|NCT02507219|41654470|FG001|Overall Study|Withdrawal by Subject|0|||
19409039|NCT02507219|41654471|FG002|Overall Study|Withdrawal by Subject|0|||
19409040|NCT02507219|41654472|FG003|Overall Study|Withdrawal by Subject|0|||
19409041|NCT02507219|41654473|FG004|Overall Study|Withdrawal by Subject|1|||
19518907|NCT01500720|41931974|FG001|Overall Study|Randomized But Not Treated|1|||
19518908|NCT01500720|41931973|FG000|Overall Study|Other|4|||
19518909|NCT01500720|41931974|FG001|Overall Study|Other|8|||
19518910|NCT01500252|41931982|FG000|Overall Study|Death|4|||
19628051|NCT00794157|42077463|FG001|Overall Study|Subject withdrew consent|0|||
19409042|NCT02507219|41654474|FG005|Overall Study|Withdrawal by Subject|0|||
19409043|NCT02483975|41654484|FG000|Overall Study|Adverse Event|0|||
19409044|NCT02483975|41654485|FG001|Overall Study|Adverse Event|1|||
19409045|NCT02483975|41654484|FG000|Overall Study|Lost to Follow-up|0|||
19409046|NCT02483975|41654485|FG001|Overall Study|Lost to Follow-up|1|||
19409047|NCT02483975|41654484|FG000|Overall Study|Physician Decision|2|||
19409048|NCT02483975|41654485|FG001|Overall Study|Physician Decision|0|||
19518911|NCT01500252|41931983|FG001|Overall Study|Death|2|||
19409049|NCT02047227|41654496|FG000|Overall Study|Adverse Event|2|||
19409050|NCT02047227|41654497|FG001|Overall Study|Adverse Event|4|||
19409051|NCT02047227|41654496|FG000|Overall Study|Lost to Follow-up|0|||
19409052|NCT02047227|41654497|FG001|Overall Study|Lost to Follow-up|3|||
19409053|NCT02047227|41654496|FG000|Overall Study|Protocol Violation|1|||
19409054|NCT02047227|41654497|FG001|Overall Study|Protocol Violation|0|||
19409055|NCT02047227|41654496|FG000|Overall Study|Spontaneous pregnancy|1|||
19409056|NCT02047227|41654497|FG001|Overall Study|Spontaneous pregnancy|0|||
19409057|NCT02047227|41654496|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
19409058|NCT02047227|41654497|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
19409059|NCT02047227|41654496|FG000|Overall Study|No oocytes retrieved|21|||
19409060|NCT02047227|41654497|FG001|Overall Study|No oocytes retrieved|20|||
19409061|NCT02047227|41654496|FG000|Overall Study|No fertilization|61|||
19409062|NCT02047227|41654497|FG001|Overall Study|No fertilization|51|||
19409063|NCT02047227|41654496|FG000|Overall Study|Intention to freeze all embryos|1|||
19409064|NCT02047227|41654497|FG001|Overall Study|Intention to freeze all embryos|0|||
19409065|NCT02047227|41654496|FG000|Overall Study|All embryos discarded|12|||
19409066|NCT02047227|41654497|FG001|Overall Study|All embryos discarded|11|||
19409067|NCT02047227|41654496|FG000|Overall Study|Other|10|||
19409068|NCT02047227|41654497|FG001|Overall Study|Other|9|||
19409069|NCT02483585|41654505|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
19409070|NCT02483585|41654506|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
19409071|NCT02483585|41654505|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
19409072|NCT02483585|41654506|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
19409073|NCT02483585|41654505|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
19409074|NCT02483585|41654506|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
19409075|NCT02483585|41654505|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
19409076|NCT02483585|41654506|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
19409077|NCT02483585|41654505|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
19409078|NCT02483585|41654506|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
19409079|NCT02483585|41654505|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
19409080|NCT02483585|41654506|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
19409081|NCT02483585|41654505|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
19409082|NCT02483585|41654506|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
19409083|NCT02046993|41654518|FG000|Overall Study|Withdrawal by Subject|2|||
19409084|NCT02046993|41654519|FG001|Overall Study|Withdrawal by Subject|10|||
19409085|NCT02046993|41654518|FG000|Overall Study|Lost to Follow-up|1|||
19409086|NCT02046993|41654519|FG001|Overall Study|Lost to Follow-up|1|||
19409087|NCT02101983|41654529|FG000|Overall Study|Physician Decision|1|||
19409088|NCT02101983|41654530|FG001|Overall Study|Physician Decision|0|||
19409089|NCT02482805|41654539|FG000|Overall Study|Lost to Follow-up|4|||
19409090|NCT02482805|41654540|FG001|Overall Study|Lost to Follow-up|4|||
19409091|NCT02482805|41654541|FG002|Overall Study|Lost to Follow-up|0|||
19409092|NCT02503865|41654552|FG000|Overall Study|Moved out of area|1|||
19409093|NCT02503865|41654553|FG001|Overall Study|Moved out of area|8|||
19409094|NCT02503865|41654554|FG002|Overall Study|Moved out of area|0|||
19409095|NCT02503865|41654552|FG000|Overall Study|Refused treatment|4|||
19409096|NCT02503865|41654553|FG001|Overall Study|Refused treatment|39|||
19409097|NCT02503865|41654554|FG002|Overall Study|Refused treatment|2|||
19409098|NCT01623531|41654565|FG000|Overall Study|Death|1|||
19409099|NCT01623531|41654566|FG001|Overall Study|Death|0|||
19409100|NCT01623531|41654565|FG000|Overall Study|Protocol Violation|2|||
19409101|NCT01623531|41654566|FG001|Overall Study|Protocol Violation|1|||
19409102|NCT01623531|41654565|FG000|Overall Study|Missing data at primary outcome time poi|1|||
19409103|NCT01623531|41654566|FG001|Overall Study|Missing data at primary outcome time poi|1|||
19409104|NCT02503787|41654575|FG000|Enrollment|Withdrawal by Subject|6|||
19409105|NCT02503787|41654575|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
19409106|NCT02503787|41654575|FG000|Enrollment|Physician Decision|2|||
19409107|NCT02503787|41654575|FG000|Enrollment|Insurance issue|2|||
19409108|NCT02503787|41654575|FG000|Enrollment|Lost to Follow-up|1|||
19409109|NCT02503787|41654575|FG000|Enrollment|Study closure|1|||
19409110|NCT02503787|41654575|FG000|Enrollment|Adverse Event|1|||
19409111|NCT02503787|41654575|FG000|Enrollment|Protocol Violation|1|||
19409112|NCT02503787|41654575|FG000|Enrollment|Inability to implant system|1|||
19409113|NCT02503787|41654575|FG000|Enrollment|Unable to be programmed|1|||
19409114|NCT02503787|41654575|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
19409115|NCT02503787|41654575|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
19409116|NCT02503787|41654575|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
19409117|NCT02503787|41654575|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
19409118|NCT02503787|41654575|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
19409119|NCT02503787|41654575|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
19409120|NCT02482571|41654579|FG000|Overall Study|Adverse Event|1|||
19409121|NCT02482571|41654579|FG000|Overall Study|Scanner or Respiract failure|3|||
19409122|NCT02482571|41654579|FG000|Overall Study|Withdrawal by Subject|4|||
19409123|NCT02481947|41654586|FG000|Overall Study|Withdrawal by Subject|24|||
19409124|NCT02481947|41654587|FG001|Overall Study|Withdrawal by Subject|10|||
19518912|NCT01500252|41931982|FG000|Overall Study|Lost to Follow-up|5|||
19518913|NCT01500252|41931983|FG001|Overall Study|Lost to Follow-up|4|||
19518914|NCT01476696|41931990|FG000|Overall Study|Sponsor decision|2|||
19518915|NCT01476696|41931991|FG001|Overall Study|Sponsor decision|1|||
19409125|NCT02481947|41654586|FG000|Overall Study|Lost to Follow-up|11|||
19409126|NCT02481947|41654587|FG001|Overall Study|Lost to Follow-up|5|||
19409127|NCT02481947|41654586|FG000|Overall Study|Adverse Event|6|||
19409128|NCT02481947|41654587|FG001|Overall Study|Adverse Event|11|||
19409129|NCT02481947|41654586|FG000|Overall Study|Physician Decision|4|||
19409130|NCT02481947|41654587|FG001|Overall Study|Physician Decision|5|||
19409131|NCT02481947|41654586|FG000|Overall Study|Protocol Violation|1|||
19409132|NCT02481947|41654587|FG001|Overall Study|Protocol Violation|5|||
19409133|NCT02503085|41654593|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
19409134|NCT02503085|41654594|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
19409135|NCT02503085|41654595|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
19409136|NCT02503085|41654596|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
19409137|NCT02481869|41654605|FG000|Overall Study|Lost to Follow-up|3|||
19409138|NCT02481869|41654606|FG001|Overall Study|Lost to Follow-up|4|||
19409139|NCT02481869|41654605|FG000|Overall Study|Withdrawal by Subject|2|||
19409140|NCT02481869|41654606|FG001|Overall Study|Withdrawal by Subject|0|||
19409141|NCT02502149|41654613|FG000|Intermediate|Discontinued prematurely|1|||
19409142|NCT02502149|41654614|FG001|Intermediate|Discontinued prematurely|0|||
19409143|NCT02502149|41654615|FG002|Intermediate|Discontinued prematurely|0|||
19409144|NCT02502149|41654616|FG003|Intermediate|Discontinued prematurely|0|||
19409145|NCT02502149|41654617|FG004|Intermediate|Discontinued prematurely|0|||
19409146|NCT02480621|41654636|FG000|Randomization|Withdrawal by Subject|1|||
19409147|NCT02480621|41654637|FG001|Randomization|Withdrawal by Subject|0|||
19409148|NCT02480621|41654636|FG000|Randomization|Surgeon did not give intervention|0|||
19409149|NCT02480621|41654637|FG001|Randomization|Surgeon did not give intervention|1|||
19409150|NCT02480621|41654636|FG000|Follow Up|Lost to Follow-up|4|||
19409151|NCT02480621|41654637|FG001|Follow Up|Lost to Follow-up|2|||
19409152|NCT02046603|41654645|FG000|Overall Study|Other|11|||
19409153|NCT02046603|41654646|FG001|Overall Study|Other|66|||
19409154|NCT02046603|41654645|FG000|Overall Study|Protocol Violation|0|||
19409155|NCT02046603|41654646|FG001|Overall Study|Protocol Violation|1|||
19409156|NCT02046603|41654645|FG000|Overall Study|Participant/legal guardian decision|1|||
19409157|NCT02046603|41654646|FG001|Overall Study|Participant/legal guardian decision|3|||
19409158|NCT02046603|41654645|FG000|Overall Study|Physician Decision|2|||
19409159|NCT02046603|41654646|FG001|Overall Study|Physician Decision|1|||
19409160|NCT02046603|41654645|FG000|Overall Study|Lost to Follow-up|1|||
19409161|NCT02046603|41654646|FG001|Overall Study|Lost to Follow-up|2|||
19409162|NCT02046603|41654645|FG000|Overall Study|Death|0|||
19409163|NCT02046603|41654646|FG001|Overall Study|Death|1|||
19409164|NCT02046603|41654645|FG000|Overall Study|Adverse Event|0|||
19409165|NCT02046603|41654646|FG001|Overall Study|Adverse Event|1|||
19409166|NCT01885078|41654661|FG000|Treatment Period|Adverse Event|52|||
19409167|NCT01885078|41654662|FG001|Treatment Period|Adverse Event|136|||
19409168|NCT01885078|41654663|FG002|Treatment Period|Adverse Event|30|||
19409169|NCT01885078|41654664|FG003|Treatment Period|Adverse Event|73|||
19409170|NCT01885078|41654665|FG004|Treatment Period|Adverse Event|17|||
19409171|NCT01885078|41654666|FG005|Treatment Period|Adverse Event|72|||
19409172|NCT01885078|41654667|FG006|Treatment Period|Adverse Event|24|||
19409173|NCT01885078|41654668|FG007|Treatment Period|Adverse Event|5|||
19409174|NCT01885078|41654669|FG008|Treatment Period|Adverse Event|0|||
19409175|NCT01885078|41654670|FG009|Treatment Period|Adverse Event|0|||
19409176|NCT01885078|41654661|FG000|Treatment Period|Death|13|||
19409177|NCT01885078|41654662|FG001|Treatment Period|Death|33|||
19409178|NCT01885078|41654663|FG002|Treatment Period|Death|5|||
19409179|NCT01885078|41654664|FG003|Treatment Period|Death|9|||
19409180|NCT01885078|41654665|FG004|Treatment Period|Death|2|||
19409181|NCT01885078|41654666|FG005|Treatment Period|Death|10|||
19409182|NCT01885078|41654667|FG006|Treatment Period|Death|3|||
19409183|NCT01885078|41654668|FG007|Treatment Period|Death|2|||
19409184|NCT01885078|41654669|FG008|Treatment Period|Death|0|||
19409185|NCT01885078|41654670|FG009|Treatment Period|Death|0|||
19409186|NCT01885078|41654661|FG000|Treatment Period|Lack of Efficacy|12|||
19409187|NCT01885078|41654662|FG001|Treatment Period|Lack of Efficacy|33|||
19409188|NCT01885078|41654663|FG002|Treatment Period|Lack of Efficacy|10|||
19409189|NCT01885078|41654664|FG003|Treatment Period|Lack of Efficacy|23|||
19409190|NCT01885078|41654665|FG004|Treatment Period|Lack of Efficacy|24|||
19409191|NCT01885078|41654666|FG005|Treatment Period|Lack of Efficacy|58|||
19409192|NCT01885078|41654667|FG006|Treatment Period|Lack of Efficacy|9|||
19628052|NCT00794157|42077464|FG002|Overall Study|Subject withdrew consent|3|||
19628053|NCT00794157|42077462|FG000|Overall Study|Lost to Follow-up|2|||
19409193|NCT01885078|41654668|FG007|Treatment Period|Lack of Efficacy|5|||
19628054|NCT00794157|42077463|FG001|Overall Study|Lost to Follow-up|0|||
19409194|NCT01885078|41654669|FG008|Treatment Period|Lack of Efficacy|0|||
19409195|NCT01885078|41654670|FG009|Treatment Period|Lack of Efficacy|0|||
19409196|NCT01885078|41654661|FG000|Treatment Period|Lost to Follow-up|16|||
19409197|NCT01885078|41654662|FG001|Treatment Period|Lost to Follow-up|19|||
19409198|NCT01885078|41654663|FG002|Treatment Period|Lost to Follow-up|7|||
19409199|NCT01885078|41654664|FG003|Treatment Period|Lost to Follow-up|9|||
19409200|NCT01885078|41654665|FG004|Treatment Period|Lost to Follow-up|2|||
19628055|NCT00794157|42077464|FG002|Overall Study|Lost to Follow-up|1|||
19409201|NCT01885078|41654666|FG005|Treatment Period|Lost to Follow-up|8|||
19409202|NCT01885078|41654667|FG006|Treatment Period|Lost to Follow-up|2|||
19409203|NCT01885078|41654668|FG007|Treatment Period|Lost to Follow-up|0|||
19409204|NCT01885078|41654669|FG008|Treatment Period|Lost to Follow-up|0|||
19409205|NCT01885078|41654670|FG009|Treatment Period|Lost to Follow-up|0|||
19409206|NCT01885078|41654661|FG000|Treatment Period|Physician Decision|19|||
19409207|NCT01885078|41654662|FG001|Treatment Period|Physician Decision|21|||
19409208|NCT01885078|41654663|FG002|Treatment Period|Physician Decision|5|||
19409209|NCT01885078|41654664|FG003|Treatment Period|Physician Decision|12|||
19409210|NCT01885078|41654665|FG004|Treatment Period|Physician Decision|9|||
19409211|NCT01885078|41654666|FG005|Treatment Period|Physician Decision|24|||
19409212|NCT01885078|41654667|FG006|Treatment Period|Physician Decision|4|||
19409213|NCT01885078|41654668|FG007|Treatment Period|Physician Decision|3|||
19409214|NCT01885078|41654669|FG008|Treatment Period|Physician Decision|0|||
19409215|NCT01885078|41654670|FG009|Treatment Period|Physician Decision|0|||
19409216|NCT01885078|41654661|FG000|Treatment Period|Protocol Violation|3|||
19409217|NCT01885078|41654662|FG001|Treatment Period|Protocol Violation|5|||
19409218|NCT01885078|41654663|FG002|Treatment Period|Protocol Violation|0|||
19409219|NCT01885078|41654664|FG003|Treatment Period|Protocol Violation|3|||
19409220|NCT01885078|41654665|FG004|Treatment Period|Protocol Violation|1|||
19409221|NCT01885078|41654666|FG005|Treatment Period|Protocol Violation|6|||
19409222|NCT01885078|41654667|FG006|Treatment Period|Protocol Violation|0|||
19409223|NCT01885078|41654668|FG007|Treatment Period|Protocol Violation|0|||
19409224|NCT01885078|41654669|FG008|Treatment Period|Protocol Violation|0|||
19409225|NCT01885078|41654670|FG009|Treatment Period|Protocol Violation|0|||
19409226|NCT01885078|41654661|FG000|Treatment Period|Sponsor Decision|245|||
19409227|NCT01885078|41654662|FG001|Treatment Period|Sponsor Decision|648|||
19409228|NCT01885078|41654663|FG002|Treatment Period|Sponsor Decision|49|||
19409229|NCT01885078|41654664|FG003|Treatment Period|Sponsor Decision|90|||
19409230|NCT01885078|41654665|FG004|Treatment Period|Sponsor Decision|20|||
19409231|NCT01885078|41654666|FG005|Treatment Period|Sponsor Decision|38|||
19409232|NCT01885078|41654667|FG006|Treatment Period|Sponsor Decision|162|||
19409233|NCT01885078|41654668|FG007|Treatment Period|Sponsor Decision|3|||
19409234|NCT01885078|41654669|FG008|Treatment Period|Sponsor Decision|0|||
19409235|NCT01885078|41654670|FG009|Treatment Period|Sponsor Decision|0|||
19409236|NCT01885078|41654661|FG000|Treatment Period|Withdrawal by Subject|72|||
19409237|NCT01885078|41654662|FG001|Treatment Period|Withdrawal by Subject|132|||
19409238|NCT01885078|41654663|FG002|Treatment Period|Withdrawal by Subject|25|||
19409239|NCT01885078|41654664|FG003|Treatment Period|Withdrawal by Subject|63|||
19409240|NCT01885078|41654665|FG004|Treatment Period|Withdrawal by Subject|15|||
19409241|NCT01885078|41654666|FG005|Treatment Period|Withdrawal by Subject|34|||
19409242|NCT01885078|41654667|FG006|Treatment Period|Withdrawal by Subject|17|||
19409243|NCT01885078|41654668|FG007|Treatment Period|Withdrawal by Subject|10|||
19409244|NCT01885078|41654669|FG008|Treatment Period|Withdrawal by Subject|0|||
19409245|NCT01885078|41654670|FG009|Treatment Period|Withdrawal by Subject|0|||
19409246|NCT01885078|41654661|FG000|Treatment Period|Other|0|||
19409247|NCT01885078|41654662|FG001|Treatment Period|Other|0|||
19409248|NCT01885078|41654663|FG002|Treatment Period|Other|0|||
19409249|NCT01885078|41654664|FG003|Treatment Period|Other|1|||
19409250|NCT01885078|41654665|FG004|Treatment Period|Other|0|||
19409251|NCT01885078|41654666|FG005|Treatment Period|Other|0|||
19409252|NCT01885078|41654667|FG006|Treatment Period|Other|0|||
19409253|NCT01885078|41654668|FG007|Treatment Period|Other|0|||
19409254|NCT01885078|41654669|FG008|Treatment Period|Other|0|||
19409255|NCT01885078|41654670|FG009|Treatment Period|Other|0|||
19409256|NCT01885078|41654661|FG000|Step-down Period|Sponsor Decision|0|||
19409257|NCT01885078|41654662|FG001|Step-down Period|Sponsor Decision|0|||
19409258|NCT01885078|41654663|FG002|Step-down Period|Sponsor Decision|0|||
19409259|NCT01885078|41654664|FG003|Step-down Period|Sponsor Decision|0|||
19409260|NCT01885078|41654665|FG004|Step-down Period|Sponsor Decision|0|||
19409261|NCT01885078|41654666|FG005|Step-down Period|Sponsor Decision|0|||
19409262|NCT01885078|41654667|FG006|Step-down Period|Sponsor Decision|0|||
19409263|NCT01885078|41654668|FG007|Step-down Period|Sponsor Decision|0|||
19409264|NCT01885078|41654669|FG008|Step-down Period|Sponsor Decision|1|||
19409265|NCT01885078|41654670|FG009|Step-down Period|Sponsor Decision|1|||
19409266|NCT01885078|41654661|FG000|Step-down Period|Adverse Event|0|||
19409267|NCT01885078|41654662|FG001|Step-down Period|Adverse Event|0|||
19409268|NCT01885078|41654663|FG002|Step-down Period|Adverse Event|0|||
19409269|NCT01885078|41654664|FG003|Step-down Period|Adverse Event|0|||
19409270|NCT01885078|41654665|FG004|Step-down Period|Adverse Event|0|||
19409271|NCT01885078|41654666|FG005|Step-down Period|Adverse Event|0|||
19409272|NCT01885078|41654667|FG006|Step-down Period|Adverse Event|0|||
19409273|NCT01885078|41654668|FG007|Step-down Period|Adverse Event|0|||
19409274|NCT01885078|41654669|FG008|Step-down Period|Adverse Event|29|||
19409275|NCT01885078|41654670|FG009|Step-down Period|Adverse Event|38|||
19409276|NCT01885078|41654661|FG000|Step-down Period|Withdrawal by Subject|0|||
19409277|NCT01885078|41654662|FG001|Step-down Period|Withdrawal by Subject|0|||
19409278|NCT01885078|41654663|FG002|Step-down Period|Withdrawal by Subject|0|||
19409279|NCT01885078|41654664|FG003|Step-down Period|Withdrawal by Subject|0|||
19409280|NCT01885078|41654665|FG004|Step-down Period|Withdrawal by Subject|0|||
19409281|NCT01885078|41654666|FG005|Step-down Period|Withdrawal by Subject|0|||
19409282|NCT01885078|41654667|FG006|Step-down Period|Withdrawal by Subject|0|||
19409283|NCT01885078|41654668|FG007|Step-down Period|Withdrawal by Subject|0|||
19409284|NCT01885078|41654669|FG008|Step-down Period|Withdrawal by Subject|25|||
19409285|NCT01885078|41654670|FG009|Step-down Period|Withdrawal by Subject|15|||
19409286|NCT01885078|41654661|FG000|Step-down Period|Physician Decision|0|||
19409287|NCT01885078|41654662|FG001|Step-down Period|Physician Decision|0|||
19409288|NCT01885078|41654663|FG002|Step-down Period|Physician Decision|0|||
19409289|NCT01885078|41654664|FG003|Step-down Period|Physician Decision|0|||
19409290|NCT01885078|41654665|FG004|Step-down Period|Physician Decision|0|||
19409291|NCT01885078|41654666|FG005|Step-down Period|Physician Decision|0|||
19409292|NCT01885078|41654667|FG006|Step-down Period|Physician Decision|0|||
19409293|NCT01885078|41654668|FG007|Step-down Period|Physician Decision|0|||
19409294|NCT01885078|41654669|FG008|Step-down Period|Physician Decision|7|||
19409295|NCT01885078|41654670|FG009|Step-down Period|Physician Decision|2|||
19409296|NCT01885078|41654661|FG000|Step-down Period|Death|0|||
19409297|NCT01885078|41654662|FG001|Step-down Period|Death|0|||
19409298|NCT01885078|41654663|FG002|Step-down Period|Death|0|||
19409299|NCT01885078|41654664|FG003|Step-down Period|Death|0|||
19409300|NCT01885078|41654665|FG004|Step-down Period|Death|0|||
19409301|NCT01885078|41654666|FG005|Step-down Period|Death|0|||
19409302|NCT01885078|41654667|FG006|Step-down Period|Death|0|||
19409303|NCT01885078|41654668|FG007|Step-down Period|Death|0|||
19409304|NCT01885078|41654669|FG008|Step-down Period|Death|4|||
19409305|NCT01885078|41654670|FG009|Step-down Period|Death|3|||
19409306|NCT01885078|41654661|FG000|Step-down Period|Lost to Follow-up|0|||
19409307|NCT01885078|41654662|FG001|Step-down Period|Lost to Follow-up|0|||
19409308|NCT01885078|41654663|FG002|Step-down Period|Lost to Follow-up|0|||
19409309|NCT01885078|41654664|FG003|Step-down Period|Lost to Follow-up|0|||
19409310|NCT01885078|41654665|FG004|Step-down Period|Lost to Follow-up|0|||
19409311|NCT01885078|41654666|FG005|Step-down Period|Lost to Follow-up|0|||
19409312|NCT01885078|41654667|FG006|Step-down Period|Lost to Follow-up|0|||
19409313|NCT01885078|41654668|FG007|Step-down Period|Lost to Follow-up|0|||
19409314|NCT01885078|41654669|FG008|Step-down Period|Lost to Follow-up|1|||
19409315|NCT01885078|41654670|FG009|Step-down Period|Lost to Follow-up|1|||
19409316|NCT01885078|41654661|FG000|Step-down Period|Lack of Efficacy|0|||
19409317|NCT01885078|41654662|FG001|Step-down Period|Lack of Efficacy|0|||
19409318|NCT01885078|41654663|FG002|Step-down Period|Lack of Efficacy|0|||
19409319|NCT01885078|41654664|FG003|Step-down Period|Lack of Efficacy|0|||
19409320|NCT01885078|41654665|FG004|Step-down Period|Lack of Efficacy|0|||
19409321|NCT01885078|41654666|FG005|Step-down Period|Lack of Efficacy|0|||
19409322|NCT01885078|41654667|FG006|Step-down Period|Lack of Efficacy|0|||
19409323|NCT01885078|41654668|FG007|Step-down Period|Lack of Efficacy|0|||
19409324|NCT01885078|41654669|FG008|Step-down Period|Lack of Efficacy|1|||
19409325|NCT01885078|41654670|FG009|Step-down Period|Lack of Efficacy|0|||
19409326|NCT01885078|41654661|FG000|Step-down Period|Protocol Violation|0|||
19409327|NCT01885078|41654662|FG001|Step-down Period|Protocol Violation|0|||
19409328|NCT01885078|41654663|FG002|Step-down Period|Protocol Violation|0|||
19409329|NCT01885078|41654664|FG003|Step-down Period|Protocol Violation|0|||
19409330|NCT01885078|41654665|FG004|Step-down Period|Protocol Violation|0|||
19409331|NCT01885078|41654666|FG005|Step-down Period|Protocol Violation|0|||
19409332|NCT01885078|41654667|FG006|Step-down Period|Protocol Violation|0|||
19409333|NCT01885078|41654668|FG007|Step-down Period|Protocol Violation|0|||
19409334|NCT01885078|41654669|FG008|Step-down Period|Protocol Violation|1|||
19409335|NCT01885078|41654670|FG009|Step-down Period|Protocol Violation|1|||
19409336|NCT02046369|41654693|FG000|Overall Study|Adverse Event|3|||
19409337|NCT02046369|41654694|FG001|Overall Study|Adverse Event|3|||
19409338|NCT02046369|41654693|FG000|Overall Study|Lack of Efficacy|3|||
19409339|NCT02046369|41654694|FG001|Overall Study|Lack of Efficacy|3|||
19409340|NCT02046369|41654693|FG000|Overall Study|Lost to Follow-up|3|||
19409341|NCT02046369|41654694|FG001|Overall Study|Lost to Follow-up|3|||
19409342|NCT02046369|41654693|FG000|Overall Study|Protocol Violation|1|||
19409343|NCT02046369|41654694|FG001|Overall Study|Protocol Violation|2|||
19409344|NCT02046369|41654693|FG000|Overall Study|Withdrawal by Subject|3|||
19409345|NCT02046369|41654694|FG001|Overall Study|Withdrawal by Subject|6|||
19409346|NCT02046369|41654693|FG000|Overall Study|never received study drug|0|||
19409347|NCT02046369|41654694|FG001|Overall Study|never received study drug|1|||
19409348|NCT02046369|41654693|FG000|Overall Study|non compliance|1|||
19409349|NCT02046369|41654694|FG001|Overall Study|non compliance|0|||
19409350|NCT02101359|41654702|FG000|Overall Study|Not included|23|||
19409351|NCT02101359|41654703|FG001|Overall Study|Not included|13|||
19409352|NCT02101359|41654702|FG000|Overall Study|Withdrawal by Subject|5|||
19409353|NCT02101359|41654703|FG001|Overall Study|Withdrawal by Subject|4|||
19409354|NCT02101359|41654702|FG000|Overall Study|Lost to Follow-up|1|||
19409355|NCT02101359|41654703|FG001|Overall Study|Lost to Follow-up|0|||
19409356|NCT02101359|41654702|FG000|Overall Study|Protocol Violation|0|||
19409357|NCT02101359|41654703|FG001|Overall Study|Protocol Violation|2|||
19409358|NCT02100969|41654709|FG000|Overall Study|Did not pass screening phase|1|||
19409359|NCT01885000|41654716|FG000|Overall Study|Adverse Event|1|||
19409360|NCT01885000|41654717|FG001|Overall Study|Adverse Event|0|||
19409361|NCT01885000|41654716|FG000|Overall Study|Withdrawal by Subject|1|||
19409362|NCT01885000|41654717|FG001|Overall Study|Withdrawal by Subject|1|||
19409363|NCT01885000|41654716|FG000|Overall Study|Protocol Violation|0|||
19409364|NCT01885000|41654717|FG001|Overall Study|Protocol Violation|1|||
19409365|NCT01884688|41654723|FG000|Overall Study|Screen Failure|2|||
19409366|NCT01883362|41654729|FG000|Treatment|Adverse Event|1|||
19409367|NCT01883362|41654730|FG001|Treatment|Adverse Event|8|||
19409368|NCT01883362|41654729|FG000|Treatment|Withdrawal by Subject|6|||
19409369|NCT01883362|41654730|FG001|Treatment|Withdrawal by Subject|2|||
19409370|NCT01883362|41654729|FG000|Treatment|Administrative problems|4|||
19409371|NCT01883362|41654730|FG001|Treatment|Administrative problems|1|||
19409372|NCT01883362|41654729|FG000|Treatment|Relapse|4|||
19409373|NCT01883362|41654730|FG001|Treatment|Relapse|2|||
19409374|NCT01883362|41654729|FG000|Treatment|Randomized, not treated|1|||
19409375|NCT01883362|41654730|FG001|Treatment|Randomized, not treated|1|||
19409376|NCT01883362|41654729|FG000|Post Treatment Follow-up|Protocol Violation|0|||
19409377|NCT01883362|41654730|FG001|Post Treatment Follow-up|Protocol Violation|1|||
19409378|NCT01883362|41654729|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
19409379|NCT01883362|41654730|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
19409380|NCT01883362|41654729|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
19409381|NCT01883362|41654730|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
19409382|NCT01883362|41654729|FG000|Post Treatment Follow-up|Administrative problems|2|||
19409383|NCT01883362|41654730|FG001|Post Treatment Follow-up|Administrative problems|0|||
19409384|NCT01883362|41654729|FG000|Post Treatment Follow-up|Death|8|||
19409385|NCT01883362|41654730|FG001|Post Treatment Follow-up|Death|4|||
19409386|NCT01883362|41654729|FG000|Post Treatment Follow-up|Relapse|1|||
19409387|NCT01883362|41654730|FG001|Post Treatment Follow-up|Relapse|2|||
19409388|NCT02100813|41654748|FG000|Overall Study|Adverse Event|0|||
19409389|NCT02100813|41654749|FG001|Overall Study|Adverse Event|0|||
19409390|NCT02100813|41654750|FG002|Overall Study|Adverse Event|0|||
19409391|NCT02100813|41654751|FG003|Overall Study|Adverse Event|0|||
19409392|NCT02100813|41654752|FG004|Overall Study|Adverse Event|0|||
19409393|NCT02100813|41654753|FG005|Overall Study|Adverse Event|0|||
19409394|NCT02100813|41654754|FG006|Overall Study|Adverse Event|0|||
19409395|NCT02100813|41654755|FG007|Overall Study|Adverse Event|1|||
19409396|NCT01930162|41654777|FG000|Overall Study|Abnormal test procedure result(s)|4|||
19409397|NCT01930162|41654777|FG000|Overall Study|Death|1|||
19409398|NCT02045979|41654785|FG000|Overall Study|Informed Consent Withdrawn|2|||
19409399|NCT02045979|41654786|FG001|Overall Study|Informed Consent Withdrawn|0|||
19409400|NCT02045979|41654787|FG002|Overall Study|Informed Consent Withdrawn|1|||
19409401|NCT02045979|41654785|FG000|Overall Study|not specified above|0|||
19409402|NCT02045979|41654786|FG001|Overall Study|not specified above|1|||
19409403|NCT02045979|41654787|FG002|Overall Study|not specified above|0|||
19409404|NCT01929226|41654797|FG000|Overall Study|Lost to Follow-up|4|||
19409405|NCT01929226|41654798|FG001|Overall Study|Lost to Follow-up|0|||
19409406|NCT01929226|41654797|FG000|Overall Study|Withdrawal by Subject|1|||
19409407|NCT01929226|41654798|FG001|Overall Study|Withdrawal by Subject|1|||
19409408|NCT02045433|41654805|FG000|Overall Study|Withdrawal by Subject|1|||
19409409|NCT01911442|41654812|FG000|Overall Study|Adverse Event|2|||
19409410|NCT01911442|41654813|FG001|Overall Study|Adverse Event|2|||
19409411|NCT01911442|41654814|FG002|Overall Study|Adverse Event|4|||
19409412|NCT01911442|41654812|FG000|Overall Study|Lack of Efficacy|1|||
19409413|NCT01911442|41654813|FG001|Overall Study|Lack of Efficacy|1|||
19409414|NCT01911442|41654814|FG002|Overall Study|Lack of Efficacy|1|||
19409415|NCT01911442|41654812|FG000|Overall Study|Lost to Follow-up|2|||
19409416|NCT01911442|41654813|FG001|Overall Study|Lost to Follow-up|0|||
19409417|NCT01911442|41654814|FG002|Overall Study|Lost to Follow-up|1|||
19409418|NCT01911442|41654812|FG000|Overall Study|Withdrawal by Subject|1|||
19409419|NCT01911442|41654813|FG001|Overall Study|Withdrawal by Subject|0|||
19409420|NCT01911442|41654814|FG002|Overall Study|Withdrawal by Subject|6|||
19409421|NCT01911442|41654812|FG000|Overall Study|Mother's Work Schedule|0|||
19409422|NCT01911442|41654813|FG001|Overall Study|Mother's Work Schedule|1|||
19409423|NCT01911442|41654814|FG002|Overall Study|Mother's Work Schedule|0|||
19409424|NCT01928758|41654828|FG000|Overall Study|Lost to Follow-up|14|||
19409425|NCT01928758|41654829|FG001|Overall Study|Lost to Follow-up|9|||
19409426|NCT01928758|41654828|FG000|Overall Study|Withdrawal by Subject|5|||
19409427|NCT01928758|41654829|FG001|Overall Study|Withdrawal by Subject|2|||
19409428|NCT01928758|41654828|FG000|Overall Study|Adverse Event|3|||
19628056|NCT00794157|42077462|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19409429|NCT01928758|41654829|FG001|Overall Study|Adverse Event|5|||
19409430|NCT01928758|41654828|FG000|Overall Study|Protocol Violation|3|||
19409431|NCT01928758|41654829|FG001|Overall Study|Protocol Violation|4|||
19409432|NCT01910116|41654838|FG000|Overall Study|Adverse Event|0|||
19409433|NCT01910116|41654839|FG001|Overall Study|Adverse Event|3|||
19409434|NCT01910116|41654838|FG000|Overall Study|Lack of Efficacy|3|||
19409435|NCT01910116|41654839|FG001|Overall Study|Lack of Efficacy|4|||
19409436|NCT01910116|41654838|FG000|Overall Study|Lost to Follow-up|1|||
19409437|NCT01910116|41654839|FG001|Overall Study|Lost to Follow-up|0|||
19409438|NCT01910116|41654838|FG000|Overall Study|Protocol Violation|1|||
19409439|NCT01910116|41654839|FG001|Overall Study|Protocol Violation|2|||
19409440|NCT01910116|41654838|FG000|Overall Study|Withdrawal by Subject|8|||
19409441|NCT01910116|41654839|FG001|Overall Study|Withdrawal by Subject|3|||
19409442|NCT01910116|41654838|FG000|Overall Study|uncertain allocation|1|||
19409443|NCT01910116|41654839|FG001|Overall Study|uncertain allocation|3|||
19409444|NCT01910116|41654838|FG000|Overall Study|incomplete data|0|||
19409445|NCT01910116|41654839|FG001|Overall Study|incomplete data|1|||
19409446|NCT01614886|41654847|FG000|Overall Study|Adverse Event|15|||
19409447|NCT01614886|41654848|FG001|Overall Study|Adverse Event|20|||
19409448|NCT01614886|41654847|FG000|Overall Study|Withdrawal by Subject|4|||
19409449|NCT01614886|41654848|FG001|Overall Study|Withdrawal by Subject|4|||
19409450|NCT01614886|41654847|FG000|Overall Study|Death|1|||
19409451|NCT01614886|41654848|FG001|Overall Study|Death|0|||
19409452|NCT01614886|41654847|FG000|Overall Study|Protocol deviation|0|||
19409453|NCT01614886|41654848|FG001|Overall Study|Protocol deviation|2|||
19409454|NCT01880554|41654854|FG000|Overall Study|Protocol Violation|14|||
19409455|NCT01880554|41654854|FG000|Overall Study|Simon's design requirements|2|||
19409456|NCT02100657|41654862|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
19409457|NCT02100657|41654863|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
19409458|NCT02100657|41654864|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
19409459|NCT02100657|41654862|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
19409460|NCT02100657|41654863|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
19409461|NCT02100657|41654864|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
19409462|NCT02100657|41654862|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
19409463|NCT02100657|41654863|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
19409464|NCT02100657|41654864|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
19409465|NCT02100657|41654862|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
19409466|NCT02100657|41654863|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
19409467|NCT02100657|41654864|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
19409468|NCT02100657|41654862|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
19409469|NCT02100657|41654863|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
19409470|NCT02100657|41654864|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
19409471|NCT02100657|41654862|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
19409472|NCT02100657|41654863|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
19409473|NCT02100657|41654864|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
19409474|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
19409475|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
19409476|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
19409477|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Death|0|||
19409478|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Death|0|||
19409479|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Death|1|||
19409480|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
19409481|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
19409482|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
19409483|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
19409484|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
19409485|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
19409486|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
19409487|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
19409488|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
19409489|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
19409490|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
19409491|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
19409492|NCT02100657|41654862|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
19409493|NCT02100657|41654863|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
19409494|NCT02100657|41654864|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
19409495|NCT02067663|41654875|FG000|Overall Study|Lost to Follow-up|13|||
19409496|NCT02067663|41654876|FG001|Overall Study|Lost to Follow-up|14|||
19409497|NCT01909804|41654894|FG000|Overall Study|Randomized but Never Treated|0|||
19409498|NCT01909804|41654895|FG001|Overall Study|Randomized but Never Treated|0|||
19409499|NCT01909804|41654896|FG002|Overall Study|Randomized but Never Treated|0|||
19409500|NCT01909804|41654897|FG003|Overall Study|Randomized but Never Treated|0|||
19409501|NCT01909804|41654898|FG004|Overall Study|Randomized but Never Treated|0|||
19409502|NCT01909804|41654899|FG005|Overall Study|Randomized but Never Treated|0|||
19409503|NCT01909804|41654900|FG006|Overall Study|Randomized but Never Treated|1|||
19409504|NCT01909804|41654901|FG007|Overall Study|Randomized but Never Treated|0|||
19409505|NCT01909804|41654902|FG008|Overall Study|Randomized but Never Treated|0|||
19409506|NCT01909804|41654903|FG009|Overall Study|Randomized but Never Treated|0|||
19409507|NCT01909804|41654904|FG010|Overall Study|Randomized but Never Treated|0|||
19409508|NCT01909804|41654905|FG011|Overall Study|Randomized but Never Treated|1|||
19409509|NCT01909804|41654894|FG000|Overall Study|Death|0|||
19409510|NCT01909804|41654895|FG001|Overall Study|Death|0|||
19409511|NCT01909804|41654896|FG002|Overall Study|Death|0|||
19409512|NCT01909804|41654897|FG003|Overall Study|Death|0|||
19409513|NCT01909804|41654898|FG004|Overall Study|Death|0|||
19409514|NCT01909804|41654899|FG005|Overall Study|Death|0|||
19409515|NCT01909804|41654900|FG006|Overall Study|Death|0|||
19409516|NCT01909804|41654901|FG007|Overall Study|Death|0|||
19409517|NCT01909804|41654902|FG008|Overall Study|Death|0|||
19409518|NCT01909804|41654903|FG009|Overall Study|Death|0|||
19409519|NCT01909804|41654904|FG010|Overall Study|Death|1|||
19409520|NCT01909804|41654905|FG011|Overall Study|Death|0|||
19409521|NCT01909804|41654894|FG000|Overall Study|Lack of Efficacy|4|||
19409522|NCT01909804|41654895|FG001|Overall Study|Lack of Efficacy|1|||
19409523|NCT01909804|41654896|FG002|Overall Study|Lack of Efficacy|0|||
19409524|NCT01909804|41654897|FG003|Overall Study|Lack of Efficacy|0|||
19409525|NCT01909804|41654898|FG004|Overall Study|Lack of Efficacy|7|||
19409526|NCT01909804|41654899|FG005|Overall Study|Lack of Efficacy|3|||
19409527|NCT01909804|41654900|FG006|Overall Study|Lack of Efficacy|1|||
19409528|NCT01909804|41654901|FG007|Overall Study|Lack of Efficacy|1|||
19409529|NCT01909804|41654902|FG008|Overall Study|Lack of Efficacy|0|||
19409530|NCT01909804|41654903|FG009|Overall Study|Lack of Efficacy|1|||
19409531|NCT01909804|41654904|FG010|Overall Study|Lack of Efficacy|0|||
19409532|NCT01909804|41654905|FG011|Overall Study|Lack of Efficacy|1|||
19409533|NCT01909804|41654894|FG000|Overall Study|Withdrew Consent|0|||
19409534|NCT01909804|41654895|FG001|Overall Study|Withdrew Consent|0|||
19409535|NCT01909804|41654896|FG002|Overall Study|Withdrew Consent|0|||
19409536|NCT01909804|41654897|FG003|Overall Study|Withdrew Consent|0|||
19409537|NCT01909804|41654898|FG004|Overall Study|Withdrew Consent|1|||
19409538|NCT01909804|41654899|FG005|Overall Study|Withdrew Consent|1|||
19409539|NCT01909804|41654900|FG006|Overall Study|Withdrew Consent|0|||
19409540|NCT01909804|41654901|FG007|Overall Study|Withdrew Consent|0|||
19409541|NCT01909804|41654902|FG008|Overall Study|Withdrew Consent|0|||
19409542|NCT01909804|41654903|FG009|Overall Study|Withdrew Consent|0|||
19409543|NCT01909804|41654904|FG010|Overall Study|Withdrew Consent|0|||
19409544|NCT01909804|41654905|FG011|Overall Study|Withdrew Consent|0|||
19409545|NCT01909804|41654894|FG000|Overall Study|Protocol Violation|0|||
19409546|NCT01909804|41654895|FG001|Overall Study|Protocol Violation|0|||
19409547|NCT01909804|41654896|FG002|Overall Study|Protocol Violation|0|||
19409548|NCT01909804|41654897|FG003|Overall Study|Protocol Violation|0|||
19409549|NCT01909804|41654898|FG004|Overall Study|Protocol Violation|0|||
19409550|NCT01909804|41654899|FG005|Overall Study|Protocol Violation|0|||
19409551|NCT01909804|41654900|FG006|Overall Study|Protocol Violation|0|||
19409552|NCT01909804|41654901|FG007|Overall Study|Protocol Violation|0|||
19409553|NCT01909804|41654902|FG008|Overall Study|Protocol Violation|0|||
19409554|NCT01909804|41654903|FG009|Overall Study|Protocol Violation|0|||
19409555|NCT01909804|41654904|FG010|Overall Study|Protocol Violation|0|||
19409556|NCT01909804|41654905|FG011|Overall Study|Protocol Violation|1|||
19409557|NCT01880086|41654929|FG000|Overall Study|Lost to Follow-up|1|||
19409558|NCT01880086|41654930|FG001|Overall Study|Lost to Follow-up|1|||
19409559|NCT01879852|41654938|FG000|Overall Study|Withdrawal by Subject|2|||
19409560|NCT01879852|41654939|FG001|Overall Study|Withdrawal by Subject|0|||
19409561|NCT01879618|41654945|FG000|Overall Study|Does not meet entrance criteria|1|||
19409562|NCT01879618|41654945|FG000|Overall Study|Withdrawal by Subject|1|||
19409563|NCT01879618|41654945|FG000|Overall Study|Surgery;changed schedule; not available|8|||
19409564|NCT01879618|41654945|FG000|Overall Study|Protocol Violation|6|||
19628057|NCT00794157|42077463|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19628058|NCT00794157|42077464|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19409565|NCT01879618|41654945|FG000|Overall Study|Adverse Event|5|||
19409566|NCT01926886|41654949|FG000|Overall Study|Administrative/other|1|||
19409567|NCT01926886|41654950|FG001|Overall Study|Administrative/other|0|||
19409568|NCT01926886|41654949|FG000|Overall Study|Adverse event/intercurrent illness|4|||
19409569|NCT01926886|41654950|FG001|Overall Study|Adverse event/intercurrent illness|0|||
19409570|NCT01926886|41654949|FG000|Overall Study|Disease progression/recurrence|4|||
19409571|NCT01926886|41654950|FG001|Overall Study|Disease progression/recurrence|0|||
19409572|NCT01926886|41654949|FG000|Overall Study|Withdrawal by Subject|15|||
19409573|NCT01926886|41654950|FG001|Overall Study|Withdrawal by Subject|0|||
19409574|NCT01926886|41654949|FG000|Overall Study|Failure to return|3|||
19409575|NCT01926886|41654950|FG001|Overall Study|Failure to return|0|||
19409576|NCT01926886|41654949|FG000|Overall Study|Recurrence of disease|1|||
19409577|NCT01926886|41654950|FG001|Overall Study|Recurrence of disease|0|||
19518916|NCT01476696|41931992|FG002|Overall Study|Sponsor decision|0|||
19409578|NCT01926886|41654949|FG000|Overall Study|Progression of disease|2|||
19409579|NCT01926886|41654950|FG001|Overall Study|Progression of disease|0|||
19409580|NCT01926886|41654949|FG000|Overall Study|Death|1|||
19409581|NCT01926886|41654950|FG001|Overall Study|Death|0|||
19409582|NCT01926886|41654949|FG000|Overall Study|Did not cooperate|1|||
19409583|NCT01926886|41654950|FG001|Overall Study|Did not cooperate|0|||
19409584|NCT01909336|41654959|FG000|Overall Study|Lost to Follow-up|4|||
19409585|NCT01909336|41654960|FG001|Overall Study|Lost to Follow-up|2|||
19409586|NCT01909336|41654961|FG002|Overall Study|Lost to Follow-up|2|||
19409587|NCT01909336|41654959|FG000|Overall Study|Physician Decision|0|||
19409588|NCT01909336|41654960|FG001|Overall Study|Physician Decision|1|||
19409589|NCT01909336|41654961|FG002|Overall Study|Physician Decision|1|||
19409590|NCT01926028|41654972|FG000|Overall Study|Lost to Follow-up|7|||
19409591|NCT01926028|41654973|FG001|Overall Study|Lost to Follow-up|6|||
19409592|NCT01926028|41654974|FG002|Overall Study|Lost to Follow-up|0|||
19409593|NCT01926028|41654972|FG000|Overall Study|Physician Decision|1|||
19409594|NCT01926028|41654973|FG001|Overall Study|Physician Decision|5|||
19409595|NCT01926028|41654974|FG002|Overall Study|Physician Decision|0|||
19409596|NCT01926028|41654972|FG000|Overall Study|Withdrawal by Subject|9|||
19409597|NCT01926028|41654973|FG001|Overall Study|Withdrawal by Subject|9|||
19409598|NCT01926028|41654974|FG002|Overall Study|Withdrawal by Subject|2|||
19409599|NCT01926028|41654972|FG000|Overall Study|Non compliance or other reasons|4|||
19409600|NCT01926028|41654973|FG001|Overall Study|Non compliance or other reasons|2|||
19409601|NCT01926028|41654974|FG002|Overall Study|Non compliance or other reasons|0|||
19409602|NCT01925950|41654985|FG000|Part 2|Withdrawal by Subject|1|||
19409603|NCT01925950|41654986|FG001|Part 2|Withdrawal by Subject|0|||
19409604|NCT01878292|41654995|FG000|Randomized|Protocol Violation|1|||
19409605|NCT01878292|41654996|FG001|Randomized|Protocol Violation|0|||
19409606|NCT01878292|41654997|FG002|Randomized|Protocol Violation|0|||
19409607|NCT01878292|41654995|FG000|Randomized|Lost to Follow-up|1|||
19409608|NCT01878292|41654996|FG001|Randomized|Lost to Follow-up|0|||
19409609|NCT01878292|41654997|FG002|Randomized|Lost to Follow-up|0|||
19409610|NCT01878292|41654995|FG000|Randomized|Adverse Event|1|||
19409611|NCT01878292|41654996|FG001|Randomized|Adverse Event|0|||
19409612|NCT01878292|41654997|FG002|Randomized|Adverse Event|0|||
19409613|NCT01878292|41654995|FG000|Double-blind Treatment Period|Other Reasons|2|||
19409614|NCT01878292|41654996|FG001|Double-blind Treatment Period|Other Reasons|0|||
19409615|NCT01878292|41654997|FG002|Double-blind Treatment Period|Other Reasons|0|||
19409616|NCT01878292|41654995|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
19409617|NCT01878292|41654996|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
19409618|NCT01878292|41654997|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
19409619|NCT01878292|41654995|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
19409620|NCT01878292|41654996|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
19409621|NCT01878292|41654997|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
19409622|NCT01878292|41654995|FG000|Double-blind Treatment Period|Protocol Violation|3|||
19409623|NCT01878292|41654996|FG001|Double-blind Treatment Period|Protocol Violation|4|||
19409624|NCT01878292|41654997|FG002|Double-blind Treatment Period|Protocol Violation|2|||
19409625|NCT01878292|41654995|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
19409626|NCT01878292|41654996|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
19409627|NCT01878292|41654997|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
19409628|NCT01878292|41654995|FG000|Double-blind Treatment Period|Adverse Event|4|||
19409629|NCT01878292|41654996|FG001|Double-blind Treatment Period|Adverse Event|9|||
19409630|NCT01878292|41654997|FG002|Double-blind Treatment Period|Adverse Event|8|||
19409631|NCT01878292|41654995|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
19409632|NCT01878292|41654996|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
19409633|NCT01878292|41654997|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
19409634|NCT01908634|41655005|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
19409635|NCT01908634|41655005|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
19409636|NCT01878214|41655015|FG000|Overall Study|Withdrawal by Subject|18|||
19409637|NCT01878214|41655016|FG001|Overall Study|Withdrawal by Subject|7|||
19409638|NCT01878214|41655015|FG000|Overall Study|Death|0|||
19409639|NCT01878214|41655016|FG001|Overall Study|Death|1|||
19409640|NCT01878214|41655015|FG000|Overall Study|Lost to Follow-up|35|||
19409641|NCT01878214|41655016|FG001|Overall Study|Lost to Follow-up|36|||
19409642|NCT01907854|41655024|FG000|Overall Study|Protocol Violation|1|||
19409643|NCT01907854|41655025|FG001|Overall Study|Protocol Violation|1|||
19409644|NCT01907854|41655024|FG000|Overall Study|Withdrawal by Subject|9|||
19409645|NCT01907854|41655025|FG001|Overall Study|Withdrawal by Subject|7|||
19409646|NCT01907854|41655024|FG000|Overall Study|Lost to Follow-up|2|||
19409647|NCT01907854|41655025|FG001|Overall Study|Lost to Follow-up|2|||
19409648|NCT01907854|41655024|FG000|Overall Study|Unclassified|4|||
19409649|NCT01907854|41655025|FG001|Overall Study|Unclassified|3|||
19409650|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
19628059|NCT00794157|42077462|FG000|Overall Study|Administrative problems|1|||
19409651|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
19409652|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
19409653|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
19409654|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
19409655|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
19409656|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
19409657|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
19409658|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
19409659|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
19409660|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
19409661|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
19409662|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
19409663|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
19409664|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
19409665|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
19409666|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
19409667|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
19409668|NCT02480153|41655033|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
19409669|NCT02480153|41655034|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
19409670|NCT02480153|41655035|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
19409671|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
19409672|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
19409673|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
19409674|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
19409675|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
19409676|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
19409677|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
19409678|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
19409679|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
19409680|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
19409681|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
19409682|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
19409683|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
19409684|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
19409685|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
19409686|NCT02480153|41655033|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
19409687|NCT02480153|41655034|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
19409688|NCT02480153|41655035|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
19409689|NCT02480153|41655033|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
19409690|NCT02480153|41655034|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
19409691|NCT02480153|41655035|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
19409692|NCT02480153|41655033|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
19409693|NCT02480153|41655034|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
19409694|NCT02480153|41655035|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
19409695|NCT02480153|41655033|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
19409696|NCT02480153|41655034|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
19409697|NCT02480153|41655035|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
19409698|NCT02480153|41655033|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
19409699|NCT02480153|41655034|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
19409700|NCT02480153|41655035|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
19409701|NCT02480153|41655033|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
19409702|NCT02480153|41655034|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
19409703|NCT02480153|41655035|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
19409704|NCT02500979|41655060|FG000|Period 1|Hyperglycemia|1|||
19409705|NCT02500979|41655061|FG001|Period 1|Hyperglycemia|0|||
19409706|NCT02500979|41655060|FG000|Period 1|Severe non-compliance to protocol|0|||
19409707|NCT02500979|41655061|FG001|Period 1|Severe non-compliance to protocol|1|||
19409708|NCT02500979|41655060|FG000|Period 1|Adverse Event|1|||
19409709|NCT02500979|41655061|FG001|Period 1|Adverse Event|0|||
19409710|NCT02500979|41655060|FG000|Period 1|Subject decision|2|||
19409711|NCT02500979|41655061|FG001|Period 1|Subject decision|0|||
19409712|NCT02500979|41655060|FG000|Period 2|Change in risk|1|||
19409713|NCT02500979|41655061|FG001|Period 2|Change in risk|0|||
19409714|NCT02500901|41655067|FG000|Overall Study|Disease ProgressionDD|2|||
19409715|NCT02479139|41655077|FG000|Overall Study|Lost to Follow-up|2|||
19409716|NCT02479139|41655078|FG001|Overall Study|Lost to Follow-up|4|||
19409717|NCT02479139|41655079|FG002|Overall Study|Lost to Follow-up|4|||
19409718|NCT02479139|41655080|FG003|Overall Study|Lost to Follow-up|2|||
19409719|NCT02479139|41655081|FG004|Overall Study|Lost to Follow-up|3|||
19409720|NCT02479139|41655082|FG005|Overall Study|Lost to Follow-up|5|||
19409721|NCT02479139|41655077|FG000|Overall Study|Withdrew Consent|5|||
19409722|NCT02479139|41655078|FG001|Overall Study|Withdrew Consent|6|||
19409723|NCT02479139|41655079|FG002|Overall Study|Withdrew Consent|1|||
19409724|NCT02479139|41655080|FG003|Overall Study|Withdrew Consent|4|||
19518917|NCT01476696|41931990|FG000|Overall Study|Withdrawal by Subject|1|||
19409725|NCT02479139|41655081|FG004|Overall Study|Withdrew Consent|1|||
19409726|NCT02479139|41655082|FG005|Overall Study|Withdrew Consent|1|||
19409727|NCT02479139|41655077|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
19409728|NCT02479139|41655078|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
19409729|NCT02479139|41655079|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
19409730|NCT02479139|41655080|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
19409731|NCT02479139|41655081|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
19409732|NCT02479139|41655082|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
19409733|NCT02479139|41655077|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19409734|NCT02479139|41655078|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19409735|NCT02479139|41655079|FG002|Overall Study|Other Miscellaneous Reasons|1|||
19409736|NCT02479139|41655080|FG003|Overall Study|Other Miscellaneous Reasons|1|||
19409737|NCT02479139|41655081|FG004|Overall Study|Other Miscellaneous Reasons|1|||
19409738|NCT02479139|41655082|FG005|Overall Study|Other Miscellaneous Reasons|0|||
19409739|NCT02478359|41655098|FG000|Overall Study|Disenrolled from health plan|106|||
19409740|NCT02478359|41655099|FG001|Overall Study|Disenrolled from health plan|65|||
19409741|NCT01877668|41655112|FG000|Overall Study|Death|0|||
19409742|NCT01877668|41655113|FG001|Overall Study|Death|0|||
19409743|NCT01877668|41655114|FG002|Overall Study|Death|0|||
19409744|NCT01877668|41655115|FG003|Overall Study|Death|1|||
19409745|NCT01877668|41655116|FG004|Overall Study|Death|0|||
19409746|NCT01877668|41655112|FG000|Overall Study|No longer met study criteria|1|||
19409747|NCT01877668|41655113|FG001|Overall Study|No longer met study criteria|0|||
19409748|NCT01877668|41655114|FG002|Overall Study|No longer met study criteria|1|||
19409749|NCT01877668|41655115|FG003|Overall Study|No longer met study criteria|0|||
19409750|NCT01877668|41655116|FG004|Overall Study|No longer met study criteria|0|||
19409751|NCT01877668|41655112|FG000|Overall Study|Insufficient clinical response|0|||
19409752|NCT01877668|41655113|FG001|Overall Study|Insufficient clinical response|1|||
19409753|NCT01877668|41655114|FG002|Overall Study|Insufficient clinical response|2|||
19409754|NCT01877668|41655115|FG003|Overall Study|Insufficient clinical response|2|||
19409755|NCT01877668|41655116|FG004|Overall Study|Insufficient clinical response|0|||
19409756|NCT01877668|41655112|FG000|Overall Study|Lost to Follow-up|0|||
19409757|NCT01877668|41655113|FG001|Overall Study|Lost to Follow-up|2|||
19409758|NCT01877668|41655114|FG002|Overall Study|Lost to Follow-up|1|||
19409759|NCT01877668|41655115|FG003|Overall Study|Lost to Follow-up|0|||
19409760|NCT01877668|41655116|FG004|Overall Study|Lost to Follow-up|0|||
19409761|NCT01877668|41655112|FG000|Overall Study|Withdrawal by Subject|2|||
19409762|NCT01877668|41655113|FG001|Overall Study|Withdrawal by Subject|0|||
19409763|NCT01877668|41655114|FG002|Overall Study|Withdrawal by Subject|3|||
19409764|NCT01877668|41655115|FG003|Overall Study|Withdrawal by Subject|2|||
19409765|NCT01877668|41655116|FG004|Overall Study|Withdrawal by Subject|2|||
19409766|NCT01877668|41655112|FG000|Overall Study|Other|1|||
19409767|NCT01877668|41655113|FG001|Overall Study|Other|1|||
19409768|NCT01877668|41655114|FG002|Overall Study|Other|1|||
19409769|NCT01877668|41655115|FG003|Overall Study|Other|1|||
19409770|NCT01877668|41655116|FG004|Overall Study|Other|3|||
19409771|NCT01877668|41655112|FG000|Overall Study|Protocol Violation|1|||
19409772|NCT01877668|41655113|FG001|Overall Study|Protocol Violation|1|||
19409773|NCT01877668|41655114|FG002|Overall Study|Protocol Violation|0|||
19409774|NCT01877668|41655115|FG003|Overall Study|Protocol Violation|0|||
19409775|NCT01877668|41655116|FG004|Overall Study|Protocol Violation|3|||
19409776|NCT01877668|41655112|FG000|Overall Study|Adverse event related to study drug|2|||
19409777|NCT01877668|41655113|FG001|Overall Study|Adverse event related to study drug|2|||
19628060|NCT00794157|42077463|FG001|Overall Study|Administrative problems|7|||
19409778|NCT01877668|41655114|FG002|Overall Study|Adverse event related to study drug|2|||
19409779|NCT01877668|41655115|FG003|Overall Study|Adverse event related to study drug|2|||
19409780|NCT01877668|41655116|FG004|Overall Study|Adverse event related to study drug|1|||
19409781|NCT01877668|41655112|FG000|Overall Study|Adverse event unrelated to study drug|4|||
19409782|NCT01877668|41655113|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19409783|NCT01877668|41655114|FG002|Overall Study|Adverse event unrelated to study drug|2|||
19409784|NCT01877668|41655115|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19409785|NCT01877668|41655116|FG004|Overall Study|Adverse event unrelated to study drug|1|||
19409786|NCT01877278|41655134|FG000|Overall Study|Lost to Follow-up|3|||
19409787|NCT01877278|41655135|FG001|Overall Study|Lost to Follow-up|3|||
19409788|NCT01906372|41655141|FG000|Overall Study|Withdrawal by Subject|2|||
19409789|NCT01925170|41655146|FG000|Overall Study|Unverified cancer status|53|||
19409790|NCT01925014|41655154|FG000|Overall Study|Inappropriate enrollment|4|||
19409791|NCT01925014|41655155|FG001|Overall Study|Inappropriate enrollment|6|||
19409792|NCT01925014|41655154|FG000|Overall Study|Withdrawal by Subject|5|||
19409793|NCT01925014|41655155|FG001|Overall Study|Withdrawal by Subject|13|||
19409794|NCT01876810|41655161|FG000|Overall Study|Physician Decision|0|||
19628061|NCT00794157|42077464|FG002|Overall Study|Administrative problems|4|||
19628062|NCT00794157|42077462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19409795|NCT01876810|41655162|FG001|Overall Study|Physician Decision|1|||
19409796|NCT01876732|41655171|FG000|Overall Study|MMA was not over 800mg/dL|75|||
19409797|NCT01905592|41655178|FG000|Overall Study|Disease Progression|51|||
19409798|NCT01905592|41655179|FG001|Overall Study|Disease Progression|110|||
19409799|NCT01905592|41655178|FG000|Overall Study|Toxicity|1|||
19409800|NCT01905592|41655179|FG001|Overall Study|Toxicity|16|||
19409801|NCT01905592|41655178|FG000|Overall Study|Physician Decision|0|||
19409802|NCT01905592|41655179|FG001|Overall Study|Physician Decision|2|||
19409803|NCT01905592|41655178|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
19409804|NCT01905592|41655179|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
19409805|NCT01905592|41655178|FG000|Overall Study|Protocol Violation|0|||
19409806|NCT01905592|41655179|FG001|Overall Study|Protocol Violation|1|||
19409807|NCT01905592|41655178|FG000|Overall Study|Sponsor's decision|1|||
19409808|NCT01905592|41655179|FG001|Overall Study|Sponsor's decision|1|||
19409809|NCT01905592|41655178|FG000|Overall Study|Not treated|7|||
19409810|NCT01905592|41655179|FG001|Overall Study|Not treated|3|||
19409811|NCT01905592|41655178|FG000|Overall Study|Withdrawal by Subject|10|||
19409812|NCT01905592|41655179|FG001|Overall Study|Withdrawal by Subject|2|||
19409813|NCT01876420|41655185|FG000|Overall Study|Missed 30 day visit|1|||
19409814|NCT01875874|41655189|FG000|Overall Study|Death|3|||
19409815|NCT02500121|41655196|FG000|Overall Study|Lost to Follow-up|0|||
19409816|NCT02500121|41655197|FG001|Overall Study|Lost to Follow-up|1|||
19409817|NCT02500121|41655196|FG000|Overall Study|Withdrawal by Subject|1|||
19409818|NCT02500121|41655197|FG001|Overall Study|Withdrawal by Subject|1|||
19409819|NCT02500121|41655196|FG000|Overall Study|Death|26|||
19409820|NCT02500121|41655197|FG001|Overall Study|Death|24|||
19409821|NCT01875250|41655207|FG000|Overall Study|Adverse Event|2|||
19409822|NCT01875250|41655208|FG001|Overall Study|Adverse Event|0|||
19409823|NCT01904032|41655218|FG000|Overall Study|Adverse Event|3|||
19409824|NCT01904032|41655219|FG001|Overall Study|Adverse Event|1|||
19409825|NCT01904032|41655218|FG000|Overall Study|Lost to Follow-up|4|||
19409826|NCT01904032|41655219|FG001|Overall Study|Lost to Follow-up|2|||
19409827|NCT01903876|41655227|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
19409828|NCT01903876|41655228|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
19409829|NCT01903876|41655227|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
19628063|NCT00794157|42077463|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19409830|NCT01903876|41655228|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
19409831|NCT01921348|41655236|FG000|Overall Study|Withdrawal by Subject|1|||
19409832|NCT01921348|41655237|FG001|Overall Study|Withdrawal by Subject|0|||
19409833|NCT01921348|41655236|FG000|Overall Study|Lost to Follow-up|0|||
19409834|NCT01921348|41655237|FG001|Overall Study|Lost to Follow-up|2|||
19409835|NCT01921270|41655243|FG000|Overall Study|Withdrawal by Subject|1|||
19409836|NCT02325739|41655258|FG000|Phase I Part|Adverse Event|1|||
19409837|NCT02325739|41655259|FG001|Phase I Part|Adverse Event|0|||
19409838|NCT02325739|41655260|FG002|Phase I Part|Adverse Event|1|||
19409839|NCT02325739|41655261|FG003|Phase I Part|Adverse Event|2|||
19409840|NCT02325739|41655262|FG004|Phase I Part|Adverse Event|3|||
19409841|NCT02325739|41655263|FG005|Phase I Part|Adverse Event|1|||
19409842|NCT02325739|41655264|FG006|Phase I Part|Adverse Event|0|||
19409843|NCT02325739|41655265|FG007|Phase I Part|Adverse Event|2|||
19409844|NCT02325739|41655266|FG008|Phase I Part|Adverse Event|0|||
19409845|NCT02325739|41655267|FG009|Phase I Part|Adverse Event|0|||
19409846|NCT02325739|41655268|FG010|Phase I Part|Adverse Event|0|||
19409847|NCT02325739|41655258|FG000|Phase I Part|Progressive disease|9|||
19409848|NCT02325739|41655259|FG001|Phase I Part|Progressive disease|6|||
19409849|NCT02325739|41655260|FG002|Phase I Part|Progressive disease|3|||
19409850|NCT02325739|41655261|FG003|Phase I Part|Progressive disease|23|||
19409851|NCT02325739|41655262|FG004|Phase I Part|Progressive disease|14|||
19409852|NCT02325739|41655263|FG005|Phase I Part|Progressive disease|6|||
19409853|NCT02325739|41655264|FG006|Phase I Part|Progressive disease|6|||
19409854|NCT02325739|41655265|FG007|Phase I Part|Progressive disease|3|||
19409855|NCT02325739|41655266|FG008|Phase I Part|Progressive disease|0|||
19409856|NCT02325739|41655267|FG009|Phase I Part|Progressive disease|0|||
19409857|NCT02325739|41655268|FG010|Phase I Part|Progressive disease|0|||
19409858|NCT02325739|41655258|FG000|Phase I Part|Subject/guardian decision|1|||
19409859|NCT02325739|41655259|FG001|Phase I Part|Subject/guardian decision|0|||
19409860|NCT02325739|41655260|FG002|Phase I Part|Subject/guardian decision|1|||
19409861|NCT02325739|41655261|FG003|Phase I Part|Subject/guardian decision|1|||
19409862|NCT02325739|41655262|FG004|Phase I Part|Subject/guardian decision|0|||
19409863|NCT02325739|41655263|FG005|Phase I Part|Subject/guardian decision|0|||
19409864|NCT02325739|41655264|FG006|Phase I Part|Subject/guardian decision|0|||
19409865|NCT02325739|41655265|FG007|Phase I Part|Subject/guardian decision|1|||
19518918|NCT01476696|41931991|FG001|Overall Study|Withdrawal by Subject|0|||
19628064|NCT00794157|42077464|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19409866|NCT02325739|41655266|FG008|Phase I Part|Subject/guardian decision|0|||
19409867|NCT02325739|41655267|FG009|Phase I Part|Subject/guardian decision|0|||
19409868|NCT02325739|41655268|FG010|Phase I Part|Subject/guardian decision|0|||
19409869|NCT02325739|41655258|FG000|Phase I Part|Death|0|||
19409870|NCT02325739|41655259|FG001|Phase I Part|Death|0|||
19409871|NCT02325739|41655260|FG002|Phase I Part|Death|0|||
19409872|NCT02325739|41655261|FG003|Phase I Part|Death|0|||
19409873|NCT02325739|41655262|FG004|Phase I Part|Death|2|||
19409874|NCT02325739|41655263|FG005|Phase I Part|Death|0|||
19409875|NCT02325739|41655264|FG006|Phase I Part|Death|0|||
19409876|NCT02325739|41655265|FG007|Phase I Part|Death|0|||
19409877|NCT02325739|41655266|FG008|Phase I Part|Death|0|||
19409878|NCT02325739|41655267|FG009|Phase I Part|Death|0|||
19409879|NCT02325739|41655268|FG010|Phase I Part|Death|0|||
19409880|NCT02325739|41655258|FG000|Phase II Part|Adverse Event|0|||
19409881|NCT02325739|41655259|FG001|Phase II Part|Adverse Event|0|||
19409882|NCT02325739|41655260|FG002|Phase II Part|Adverse Event|0|||
19409883|NCT02325739|41655261|FG003|Phase II Part|Adverse Event|0|||
19409884|NCT02325739|41655262|FG004|Phase II Part|Adverse Event|0|||
19409885|NCT02325739|41655263|FG005|Phase II Part|Adverse Event|0|||
19409886|NCT02325739|41655264|FG006|Phase II Part|Adverse Event|0|||
19409887|NCT02325739|41655265|FG007|Phase II Part|Adverse Event|0|||
19409888|NCT02325739|41655266|FG008|Phase II Part|Adverse Event|4|||
19409889|NCT02325739|41655267|FG009|Phase II Part|Adverse Event|5|||
19409890|NCT02325739|41655268|FG010|Phase II Part|Adverse Event|1|||
19409891|NCT02325739|41655258|FG000|Phase II Part|Physician Decision|0|||
19409892|NCT02325739|41655259|FG001|Phase II Part|Physician Decision|0|||
19409893|NCT02325739|41655260|FG002|Phase II Part|Physician Decision|0|||
19409894|NCT02325739|41655261|FG003|Phase II Part|Physician Decision|0|||
19409895|NCT02325739|41655262|FG004|Phase II Part|Physician Decision|0|||
19409896|NCT02325739|41655263|FG005|Phase II Part|Physician Decision|0|||
19409897|NCT02325739|41655264|FG006|Phase II Part|Physician Decision|0|||
19409898|NCT02325739|41655265|FG007|Phase II Part|Physician Decision|0|||
19409899|NCT02325739|41655266|FG008|Phase II Part|Physician Decision|0|||
19409900|NCT02325739|41655267|FG009|Phase II Part|Physician Decision|1|||
19409901|NCT02325739|41655268|FG010|Phase II Part|Physician Decision|0|||
19409902|NCT02325739|41655258|FG000|Phase II Part|Progressive disease|0|||
19409903|NCT02325739|41655259|FG001|Phase II Part|Progressive disease|0|||
19409904|NCT02325739|41655260|FG002|Phase II Part|Progressive disease|0|||
19409905|NCT02325739|41655261|FG003|Phase II Part|Progressive disease|0|||
19409906|NCT02325739|41655262|FG004|Phase II Part|Progressive disease|0|||
19409907|NCT02325739|41655263|FG005|Phase II Part|Progressive disease|0|||
19409908|NCT02325739|41655264|FG006|Phase II Part|Progressive disease|0|||
19409909|NCT02325739|41655265|FG007|Phase II Part|Progressive disease|0|||
19409910|NCT02325739|41655266|FG008|Phase II Part|Progressive disease|22|||
19409911|NCT02325739|41655267|FG009|Phase II Part|Progressive disease|29|||
19409912|NCT02325739|41655268|FG010|Phase II Part|Progressive disease|18|||
19409913|NCT02325739|41655258|FG000|Phase II Part|Subject/guardian decision|0|||
19409914|NCT02325739|41655259|FG001|Phase II Part|Subject/guardian decision|0|||
19409915|NCT02325739|41655260|FG002|Phase II Part|Subject/guardian decision|0|||
19409916|NCT02325739|41655261|FG003|Phase II Part|Subject/guardian decision|0|||
19409917|NCT02325739|41655262|FG004|Phase II Part|Subject/guardian decision|0|||
19409918|NCT02325739|41655263|FG005|Phase II Part|Subject/guardian decision|0|||
19409919|NCT02325739|41655264|FG006|Phase II Part|Subject/guardian decision|0|||
19409920|NCT02325739|41655265|FG007|Phase II Part|Subject/guardian decision|0|||
19409921|NCT02325739|41655266|FG008|Phase II Part|Subject/guardian decision|4|||
19409922|NCT02325739|41655267|FG009|Phase II Part|Subject/guardian decision|1|||
19409923|NCT02325739|41655268|FG010|Phase II Part|Subject/guardian decision|1|||
19409924|NCT01903720|41655313|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
19409925|NCT01903720|41655313|FG000|Overall Study|Adverse Event|1|||
19409926|NCT01903720|41655313|FG000|Overall Study|Rescinding of informed consent|2|||
19409927|NCT01903720|41655313|FG000|Overall Study|Lost to Follow-up|2|||
19409928|NCT01903720|41655313|FG000|Overall Study|Treatment with alternative drug|1|||
19409929|NCT02366689|41655320|FG000|Overall Study|Withdrawal by Subject|1|||
19409930|NCT02366689|41655321|FG001|Overall Study|Withdrawal by Subject|0|||
19409931|NCT02366689|41655322|FG002|Overall Study|Withdrawal by Subject|1|||
19409932|NCT02366689|41655320|FG000|Overall Study|Lost to Follow-up|3|||
19409933|NCT02366689|41655321|FG001|Overall Study|Lost to Follow-up|2|||
19409934|NCT02366689|41655322|FG002|Overall Study|Lost to Follow-up|0|||
19409935|NCT02366689|41655320|FG000|Overall Study|Pregnancy|0|||
19409936|NCT02366689|41655321|FG001|Overall Study|Pregnancy|1|||
19409937|NCT02366689|41655322|FG002|Overall Study|Pregnancy|1|||
19409938|NCT01903252|41655332|FG000|Double-Blind Induction|Adverse Event|20|||
19409939|NCT01903252|41655333|FG001|Double-Blind Induction|Adverse Event|18|||
19409940|NCT01903252|41655334|FG002|Double-Blind Induction|Adverse Event|0|||
19409941|NCT01903252|41655335|FG003|Double-Blind Induction|Adverse Event|0|||
19409942|NCT01903252|41655336|FG004|Double-Blind Induction|Adverse Event|0|||
19409943|NCT01903252|41655337|FG005|Double-Blind Induction|Adverse Event|0|||
19409944|NCT01903252|41655332|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
19409945|NCT01903252|41655333|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
19409946|NCT01903252|41655334|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
19409947|NCT01903252|41655335|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
19409948|NCT01903252|41655336|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
19409949|NCT01903252|41655337|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
19409950|NCT01903252|41655332|FG000|Double-Blind Induction|Physician Decision|2|||
19409951|NCT01903252|41655333|FG001|Double-Blind Induction|Physician Decision|3|||
19409952|NCT01903252|41655334|FG002|Double-Blind Induction|Physician Decision|0|||
19409953|NCT01903252|41655335|FG003|Double-Blind Induction|Physician Decision|0|||
19409954|NCT01903252|41655336|FG004|Double-Blind Induction|Physician Decision|0|||
19409955|NCT01903252|41655337|FG005|Double-Blind Induction|Physician Decision|0|||
19409956|NCT01903252|41655332|FG000|Double-Blind Induction|non-compliance,|7|||
19409957|NCT01903252|41655333|FG001|Double-Blind Induction|non-compliance,|7|||
19409958|NCT01903252|41655334|FG002|Double-Blind Induction|non-compliance,|0|||
19409959|NCT01903252|41655335|FG003|Double-Blind Induction|non-compliance,|0|||
19409960|NCT01903252|41655336|FG004|Double-Blind Induction|non-compliance,|0|||
19409961|NCT01903252|41655337|FG005|Double-Blind Induction|non-compliance,|0|||
19409962|NCT01903252|41655332|FG000|Extended Induction, Open-Label|Adverse Event|0|||
19409963|NCT01903252|41655333|FG001|Extended Induction, Open-Label|Adverse Event|0|||
19409964|NCT01903252|41655334|FG002|Extended Induction, Open-Label|Adverse Event|17|||
19409965|NCT01903252|41655335|FG003|Extended Induction, Open-Label|Adverse Event|0|||
19409966|NCT01903252|41655336|FG004|Extended Induction, Open-Label|Adverse Event|0|||
19409967|NCT01903252|41655337|FG005|Extended Induction, Open-Label|Adverse Event|0|||
19409968|NCT01903252|41655332|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
19409969|NCT01903252|41655333|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
19409970|NCT01903252|41655334|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
19409971|NCT01903252|41655335|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
19409972|NCT01903252|41655336|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
19409973|NCT01903252|41655337|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
19518919|NCT01476696|41931992|FG002|Overall Study|Withdrawal by Subject|0|||
19518920|NCT01500096|41932009|FG000|Overall Study|Lost to Follow-up|1|||
19518921|NCT01500096|41932010|FG001|Overall Study|Lost to Follow-up|0|||
19518922|NCT01500096|41932011|FG002|Overall Study|Lost to Follow-up|0|||
19518923|NCT01500096|41932012|FG003|Overall Study|Lost to Follow-up|2|||
19518924|NCT01455012|41932024|FG000|Overall Study|Adverse Event|0|||
19518925|NCT01455012|41932025|FG001|Overall Study|Adverse Event|2|||
19518926|NCT01455012|41932024|FG000|Overall Study|Lack of Efficacy|6|||
19518927|NCT01455012|41932025|FG001|Overall Study|Lack of Efficacy|1|||
19518928|NCT01455012|41932024|FG000|Overall Study|Withdrawal by Subject|3|||
19518929|NCT01455012|41932025|FG001|Overall Study|Withdrawal by Subject|1|||
19518930|NCT01455012|41932024|FG000|Overall Study|Unknown reason|2|||
19518931|NCT01455012|41932025|FG001|Overall Study|Unknown reason|0|||
19518932|NCT01454934|41932033|FG000|Overall Study|Clinical progression|28|||
19518933|NCT01454934|41932034|FG001|Overall Study|Clinical progression|25|||
19518934|NCT01454934|41932033|FG000|Overall Study|Other|6|||
19518935|NCT01454934|41932034|FG001|Overall Study|Other|17|||
19518936|NCT01454934|41932033|FG000|Overall Study|Adverse Event|28|||
19518937|NCT01454934|41932034|FG001|Overall Study|Adverse Event|24|||
19518938|NCT01454934|41932033|FG000|Overall Study|Withdrawn consent|2|||
19518939|NCT01454934|41932034|FG001|Overall Study|Withdrawn consent|5|||
19518940|NCT01454934|41932033|FG000|Overall Study|Withdrawal by Subject|11|||
19518941|NCT01454934|41932034|FG001|Overall Study|Withdrawal by Subject|15|||
19518942|NCT01454934|41932033|FG000|Overall Study|Disease progression|194|||
19518943|NCT01454934|41932034|FG001|Overall Study|Disease progression|181|||
19518944|NCT01454934|41932033|FG000|Overall Study|Lost to Follow-up|0|||
19518945|NCT01454934|41932034|FG001|Overall Study|Lost to Follow-up|1|||
19518946|NCT01454934|41932033|FG000|Overall Study|Not treated|1|||
19518947|NCT01454934|41932034|FG001|Overall Study|Not treated|2|||
19518948|NCT01454778|41932040|FG000|Overall Study|Lost to Follow-up|2|||
19518949|NCT01454778|41932040|FG000|Overall Study|Death|1|||
19518950|NCT01454076|41932049|FG000|Overall Study|Other|2|||
19518951|NCT01454076|41932050|FG001|Overall Study|Other|0|||
19518952|NCT01454076|41932051|FG002|Overall Study|Other|0|||
19518953|NCT01454076|41932052|FG003|Overall Study|Other|1|||
19518954|NCT01454076|41932053|FG004|Overall Study|Other|2|||
19518955|NCT01454076|41932049|FG000|Overall Study|Withdrawal by Subject|3|||
19518956|NCT01454076|41932050|FG001|Overall Study|Withdrawal by Subject|4|||
19518957|NCT01454076|41932051|FG002|Overall Study|Withdrawal by Subject|2|||
19518958|NCT01454076|41932052|FG003|Overall Study|Withdrawal by Subject|1|||
19518959|NCT01454076|41932053|FG004|Overall Study|Withdrawal by Subject|2|||
19518960|NCT01454076|41932049|FG000|Overall Study|Adverse Event|8|||
19518961|NCT01454076|41932050|FG001|Overall Study|Adverse Event|2|||
19518962|NCT01454076|41932051|FG002|Overall Study|Adverse Event|7|||
19409974|NCT01903252|41655332|FG000|Extended Induction, Open-Label|Physician Decision|0|||
19518963|NCT01454076|41932052|FG003|Overall Study|Adverse Event|0|||
19518964|NCT01454076|41932053|FG004|Overall Study|Adverse Event|2|||
19518965|NCT01453998|41932077|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
19518966|NCT01453998|41932078|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
19518967|NCT01453998|41932079|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
19518968|NCT01453374|41932090|FG000|Overall Study|Adverse Event|7|||
19518969|NCT01453374|41932090|FG000|Overall Study|Lack of Efficacy|1|||
19518970|NCT01453374|41932090|FG000|Overall Study|Lost to Follow-up|3|||
19518971|NCT01453374|41932090|FG000|Overall Study|Withdrawal by Subject|5|||
19518972|NCT01453374|41932090|FG000|Overall Study|Incarcerated|2|||
19409975|NCT01903252|41655333|FG001|Extended Induction, Open-Label|Physician Decision|0|||
19409976|NCT01903252|41655334|FG002|Extended Induction, Open-Label|Physician Decision|1|||
19409977|NCT01903252|41655335|FG003|Extended Induction, Open-Label|Physician Decision|0|||
19409978|NCT01903252|41655336|FG004|Extended Induction, Open-Label|Physician Decision|0|||
19409979|NCT01903252|41655337|FG005|Extended Induction, Open-Label|Physician Decision|0|||
19409980|NCT01903252|41655332|FG000|Maintenance, Open-Label|Adverse Event|0|||
19409981|NCT01903252|41655333|FG001|Maintenance, Open-Label|Adverse Event|0|||
19409982|NCT01903252|41655334|FG002|Maintenance, Open-Label|Adverse Event|0|||
19409983|NCT01903252|41655335|FG003|Maintenance, Open-Label|Adverse Event|3|||
19409984|NCT01903252|41655336|FG004|Maintenance, Open-Label|Adverse Event|9|||
19409985|NCT01903252|41655337|FG005|Maintenance, Open-Label|Adverse Event|14|||
19409986|NCT01903252|41655332|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
19409987|NCT01903252|41655333|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
19409988|NCT01903252|41655334|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
19409989|NCT01903252|41655335|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
19409990|NCT01903252|41655336|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
19409991|NCT01903252|41655337|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
19409992|NCT01903252|41655332|FG000|Maintenance, Open-Label|Other|0|||
19409993|NCT01903252|41655333|FG001|Maintenance, Open-Label|Other|0|||
19409994|NCT01903252|41655334|FG002|Maintenance, Open-Label|Other|0|||
19409995|NCT01903252|41655335|FG003|Maintenance, Open-Label|Other|2|||
19409996|NCT01903252|41655336|FG004|Maintenance, Open-Label|Other|6|||
19409997|NCT01903252|41655337|FG005|Maintenance, Open-Label|Other|2|||
19409998|NCT01920958|41655355|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
19409999|NCT01613716|41655359|FG000|Overall Study|screen failures|3|||
19410000|NCT01613716|41655359|FG000|Overall Study|Lost to Follow-up|4|||
19410001|NCT01872910|41655369|FG000|Overall Study|Lost to Follow-up|2|||
19410002|NCT01872910|41655370|FG001|Overall Study|Lost to Follow-up|0|||
19410003|NCT01872910|41655371|FG002|Overall Study|Lost to Follow-up|2|||
19410004|NCT01872910|41655372|FG003|Overall Study|Lost to Follow-up|0|||
19410005|NCT01872910|41655373|FG004|Overall Study|Lost to Follow-up|0|||
19410006|NCT01872910|41655374|FG005|Overall Study|Lost to Follow-up|0|||
19410007|NCT01920568|41655389|FG000|Overall Study|Adverse Event|27|||
19410008|NCT01920568|41655390|FG001|Overall Study|Adverse Event|8|||
19410009|NCT01920568|41655389|FG000|Overall Study|Protocol Violation|5|||
19410010|NCT01920568|41655390|FG001|Overall Study|Protocol Violation|3|||
19410011|NCT01920568|41655389|FG000|Overall Study|Lost to Follow-up|2|||
19410012|NCT01920568|41655390|FG001|Overall Study|Lost to Follow-up|2|||
19410013|NCT01920568|41655389|FG000|Overall Study|Physician Decision|13|||
19410014|NCT01920568|41655390|FG001|Overall Study|Physician Decision|4|||
19410015|NCT01920568|41655389|FG000|Overall Study|Withdrawal by Subject|79|||
19410016|NCT01920568|41655390|FG001|Overall Study|Withdrawal by Subject|55|||
19410017|NCT01920568|41655389|FG000|Overall Study|Death due to disease progression|25|||
19410018|NCT01920568|41655390|FG001|Overall Study|Death due to disease progression|12|||
19410019|NCT01902628|41655397|FG000|Overall Study|Withdrawal of participant's consent|7|||
19410020|NCT01902628|41655397|FG000|Overall Study|Adverse Event|41|||
19410021|NCT01902628|41655397|FG000|Overall Study|Lost to Follow-up|35|||
19410022|NCT01920178|41655403|FG000|Overall Study|Lost to Follow-up|2|||
19410023|NCT01920178|41655404|FG001|Overall Study|Lost to Follow-up|1|||
19410024|NCT01901848|41655412|FG000|Randomized and Treated|Lost to Follow-up|3|||
19410025|NCT01901848|41655413|FG001|Randomized and Treated|Lost to Follow-up|6|||
19410026|NCT01901848|41655412|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
19410027|NCT01901848|41655413|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
19410028|NCT01901614|41655421|FG000|Overall Study|Adverse Event|0|||
19410029|NCT01901614|41655422|FG001|Overall Study|Adverse Event|1|||
19410030|NCT01901614|41655421|FG000|Overall Study|Lost to Follow-up|1|||
19410031|NCT01901614|41655422|FG001|Overall Study|Lost to Follow-up|0|||
19410032|NCT01901614|41655421|FG000|Overall Study|Screen Fail|1|||
19410033|NCT01901614|41655422|FG001|Overall Study|Screen Fail|0|||
19410034|NCT01901302|41655430|FG000|Overall Study|Adverse Event|2|||
19410035|NCT01901302|41655431|FG001|Overall Study|Adverse Event|1|||
19410036|NCT01901302|41655430|FG000|Overall Study|Lack of Efficacy|0|||
19410037|NCT01901302|41655431|FG001|Overall Study|Lack of Efficacy|2|||
19410038|NCT01901302|41655430|FG000|Overall Study|Study Terminated by Sponsor|23|||
19410039|NCT01901302|41655431|FG001|Overall Study|Study Terminated by Sponsor|20|||
19410040|NCT01901302|41655430|FG000|Overall Study|Withdrawal by Subject|2|||
19518973|NCT01453296|41932096|FG000|Treatment Period 1|Adverse Event|0|||
19410041|NCT01901302|41655431|FG001|Overall Study|Withdrawal by Subject|0|||
19410042|NCT01919398|41655440|FG000|Overall Study|Progressive Disease|0|||
19410043|NCT01919398|41655441|FG001|Overall Study|Progressive Disease|0|||
19410044|NCT01919398|41655442|FG002|Overall Study|Progressive Disease|4|||
19628065|NCT00794157|42077462|FG000|Overall Study|Protocol deviation|0|||
19628066|NCT00794157|42077463|FG001|Overall Study|Protocol deviation|1|||
19410045|NCT02500043|41655452|FG000|Overall Study|Randomized, but not Treated|2|||
19410046|NCT02500043|41655453|FG001|Overall Study|Randomized, but not Treated|2|||
19410047|NCT02500043|41655452|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
19628067|NCT00794157|42077464|FG002|Overall Study|Protocol deviation|1|||
19410048|NCT02500043|41655453|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
19410049|NCT02500043|41655452|FG000|Overall Study|Adverse Event|33|||
19410050|NCT02500043|41655453|FG001|Overall Study|Adverse Event|11|||
19410051|NCT02500043|41655452|FG000|Overall Study|Clinical Progression|54|||
19410052|NCT02500043|41655453|FG001|Overall Study|Clinical Progression|35|||
19410053|NCT02500043|41655452|FG000|Overall Study|Radiological Progression|192|||
19410054|NCT02500043|41655453|FG001|Overall Study|Radiological Progression|110|||
19410055|NCT02500043|41655452|FG000|Overall Study|Physician's Decision|11|||
19410056|NCT02500043|41655453|FG001|Overall Study|Physician's Decision|3|||
19410057|NCT02500043|41655452|FG000|Overall Study|Withdrawal by Subject|14|||
19410058|NCT02500043|41655453|FG001|Overall Study|Withdrawal by Subject|4|||
19410059|NCT02500043|41655452|FG000|Overall Study|Death|11|||
19410060|NCT02500043|41655453|FG001|Overall Study|Death|2|||
19410061|NCT02500043|41655452|FG000|Overall Study|Protocol Deviation|1|||
19410062|NCT02500043|41655453|FG001|Overall Study|Protocol Deviation|0|||
19410063|NCT02499575|41655461|FG000|Overall Study|Protocol Violation|0|||
19410064|NCT02499575|41655462|FG001|Overall Study|Protocol Violation|1|||
19410065|NCT02065791|41655470|FG000|Overall Study|Closed Site|1|||
19410066|NCT02065791|41655471|FG001|Overall Study|Closed Site|1|||
19410067|NCT02065791|41655470|FG000|Overall Study|Withdrawal by Subject|11|||
19410068|NCT02065791|41655471|FG001|Overall Study|Withdrawal by Subject|5|||
19410069|NCT02065791|41655470|FG000|Overall Study|Lost to Follow-up|13|||
19410070|NCT02065791|41655471|FG001|Overall Study|Lost to Follow-up|9|||
19410071|NCT02499263|41655477|FG000|Overall Study|Lost to Follow-up|9|||
19410072|NCT02499263|41655477|FG000|Overall Study|Participant's withdrawal of consent|4|||
19410073|NCT02499263|41655477|FG000|Overall Study|Lack of Efficacy|22|||
19410074|NCT02499263|41655477|FG000|Overall Study|investigator's judgment|12|||
19410075|NCT02499263|41655477|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
19410076|NCT02499263|41655477|FG000|Overall Study|Participant's decision|3|||
19410077|NCT02499263|41655477|FG000|Overall Study|Pregnancy|1|||
19410078|NCT01654289|41655484|FG000|Overall Study|Withdrawal by Subject|10|||
19410079|NCT01654289|41655485|FG001|Overall Study|Withdrawal by Subject|8|||
19410080|NCT01654289|41655486|FG002|Overall Study|Withdrawal by Subject|5|||
19410081|NCT01654289|41655484|FG000|Overall Study|Withdrew from intervention only|17|||
19410082|NCT01654289|41655485|FG001|Overall Study|Withdrew from intervention only|20|||
19410083|NCT01654289|41655486|FG002|Overall Study|Withdrew from intervention only|0|||
19410084|NCT02499029|41655496|FG000|Overall Study|Lost to Follow-up|2|||
19410085|NCT02499029|41655497|FG001|Overall Study|Lost to Follow-up|2|||
19410086|NCT02499029|41655496|FG000|Overall Study|Physician Decision|2|||
19410087|NCT02499029|41655497|FG001|Overall Study|Physician Decision|1|||
19410088|NCT02499029|41655496|FG000|Overall Study|Death|1|||
19410089|NCT02499029|41655497|FG001|Overall Study|Death|0|||
19410090|NCT02477111|41655503|FG000|Overall Study|Death|5|||
19410091|NCT02477111|41655503|FG000|Overall Study|Withdrawal by Subject|2|||
19410092|NCT02477111|41655503|FG000|Overall Study|missed visit|4|||
19410093|NCT02065713|41655511|FG000|Overall Study|Adverse Event|0|||
19410094|NCT02065713|41655512|FG001|Overall Study|Adverse Event|1|||
19410095|NCT02065713|41655511|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19410096|NCT02065713|41655512|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19410097|NCT02497781|41655520|FG000|Overall Study|Withdrawal by Subject|2|||
19410098|NCT02497781|41655521|FG001|Overall Study|Withdrawal by Subject|0|||
19410099|NCT02497781|41655520|FG000|Overall Study|Lack of Efficacy|0|||
19410100|NCT02497781|41655521|FG001|Overall Study|Lack of Efficacy|1|||
19410101|NCT02497781|41655520|FG000|Overall Study|Randomised but not treated|1|||
19410102|NCT02497781|41655521|FG001|Overall Study|Randomised but not treated|1|||
19410103|NCT02497781|41655520|FG000|Overall Study|Lost to Follow-up|1|||
19410104|NCT02497781|41655521|FG001|Overall Study|Lost to Follow-up|1|||
19410105|NCT02497469|41655529|FG000|Overall Study|Randomized but not Treated|0|||
19410106|NCT02497469|41655530|FG001|Overall Study|Randomized but not Treated|2|||
19410107|NCT02497469|41655529|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
19410108|NCT02497469|41655530|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
19410109|NCT02497469|41655529|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
19410110|NCT02497469|41655530|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
19410111|NCT02497469|41655529|FG000|Overall Study|Significant Protocol Deviation|4|||
19410112|NCT02497469|41655530|FG001|Overall Study|Significant Protocol Deviation|5|||
19410113|NCT02497469|41655529|FG000|Overall Study|Lost to Follow-up|14|||
19410114|NCT02497469|41655530|FG001|Overall Study|Lost to Follow-up|4|||
19410115|NCT02497469|41655529|FG000|Overall Study|Voluntary Withdrawal|39|||
19410116|NCT02497469|41655530|FG001|Overall Study|Voluntary Withdrawal|41|||
19410117|NCT02497469|41655529|FG000|Overall Study|Pregnancy|1|||
19410118|NCT02497469|41655530|FG001|Overall Study|Pregnancy|1|||
19410119|NCT02497469|41655529|FG000|Overall Study|Lack of Efficacy|86|||
19410120|NCT02497469|41655530|FG001|Overall Study|Lack of Efficacy|40|||
19410121|NCT02497469|41655529|FG000|Overall Study|Reason not Specified|6|||
19410122|NCT02497469|41655530|FG001|Overall Study|Reason not Specified|6|||
19410123|NCT02497391|41655536|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
19410124|NCT02497391|41655537|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
19410125|NCT02497391|41655538|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
19410126|NCT02497391|41655539|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
19410127|NCT02497391|41655540|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
19410128|NCT02497391|41655541|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
19410129|NCT02497391|41655536|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
19410130|NCT02497391|41655537|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
19410131|NCT02497391|41655538|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
19410132|NCT02497391|41655539|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
19410133|NCT02497391|41655540|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
19410134|NCT02497391|41655541|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
19410135|NCT02497391|41655536|FG000|Period 3 (14 Days)|Adverse Event|0|||
19410136|NCT02497391|41655537|FG001|Period 3 (14 Days)|Adverse Event|1|||
19374674|NCT02529488|41616307|FG000|Overall Study|Adverse Event|1|||
19410137|NCT02497391|41655538|FG002|Period 3 (14 Days)|Adverse Event|0|||
19410138|NCT02497391|41655539|FG003|Period 3 (14 Days)|Adverse Event|0|||
19410139|NCT02497391|41655540|FG004|Period 3 (14 Days)|Adverse Event|0|||
19410140|NCT02497391|41655541|FG005|Period 3 (14 Days)|Adverse Event|0|||
19410141|NCT02497391|41655536|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
19410142|NCT02497391|41655537|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
19410143|NCT02497391|41655538|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
19410144|NCT02497391|41655539|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
19410145|NCT02497391|41655540|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
19410146|NCT02497391|41655541|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
19410147|NCT02497391|41655536|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
19410148|NCT02497391|41655537|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
19410149|NCT02497391|41655538|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
19410150|NCT02497391|41655539|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
19374675|NCT02529488|41616307|FG000|Overall Study|Death|3|||
19374676|NCT01329419|41616315|FG000|Overall Study|Protocol Violation|235|||
19374677|NCT01329341|41616320|FG000|Overall Study|Withdrawal by Subject|44|||
19374678|NCT02532764|41616334|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374679|NCT02532764|41616335|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374680|NCT02532764|41616336|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374681|NCT02532764|41616337|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374682|NCT02532764|41616338|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374683|NCT02532764|41616339|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374684|NCT02532764|41616340|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
19374685|NCT02532764|41616341|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
19374686|NCT02532764|41616342|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
19374687|NCT02532764|41616343|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
19374688|NCT02528942|41616370|FG000|Overall Study|Did not meet imaging criteria|9|||
19374689|NCT02528942|41616370|FG000|Overall Study|Lost to Follow-up|25|||
19374690|NCT02527148|41616376|FG000|Overall Study|Did not receive study intervention|1|||
19374691|NCT02527148|41616377|FG001|Overall Study|Did not receive study intervention|0|||
19374692|NCT02291614|41616396|FG000|Overall Study|Lost to Follow-up|0|||
19374693|NCT02291614|41616397|FG001|Overall Study|Lost to Follow-up|0|||
19374694|NCT02291614|41616398|FG002|Overall Study|Lost to Follow-up|0|||
19374695|NCT02291614|41616399|FG003|Overall Study|Lost to Follow-up|0|||
19374696|NCT02291614|41616400|FG004|Overall Study|Lost to Follow-up|0|||
19374697|NCT02291614|41616401|FG005|Overall Study|Lost to Follow-up|0|||
19374698|NCT02291614|41616402|FG006|Overall Study|Lost to Follow-up|0|||
19374699|NCT02291614|41616403|FG007|Overall Study|Lost to Follow-up|1|||
19374700|NCT02291614|41616404|FG008|Overall Study|Lost to Follow-up|0|||
19374701|NCT02291614|41616405|FG009|Overall Study|Lost to Follow-up|0|||
19374702|NCT02291614|41616406|FG010|Overall Study|Lost to Follow-up|0|||
19374703|NCT02291614|41616396|FG000|Overall Study|Withdrawal by Subject|0|||
19374704|NCT02291614|41616397|FG001|Overall Study|Withdrawal by Subject|1|||
19374705|NCT02291614|41616398|FG002|Overall Study|Withdrawal by Subject|0|||
19374706|NCT02291614|41616399|FG003|Overall Study|Withdrawal by Subject|0|||
19374707|NCT02291614|41616400|FG004|Overall Study|Withdrawal by Subject|0|||
19374708|NCT02291614|41616401|FG005|Overall Study|Withdrawal by Subject|0|||
19374709|NCT02291614|41616402|FG006|Overall Study|Withdrawal by Subject|0|||
19374710|NCT02291614|41616403|FG007|Overall Study|Withdrawal by Subject|0|||
19374711|NCT02291614|41616404|FG008|Overall Study|Withdrawal by Subject|0|||
19374712|NCT02291614|41616405|FG009|Overall Study|Withdrawal by Subject|2|||
19374713|NCT02291614|41616406|FG010|Overall Study|Withdrawal by Subject|2|||
19374714|NCT02291614|41616396|FG000|Overall Study|Decision by sponsor|0|||
19374715|NCT02291614|41616397|FG001|Overall Study|Decision by sponsor|0|||
19374716|NCT02291614|41616398|FG002|Overall Study|Decision by sponsor|0|||
19374717|NCT02291614|41616399|FG003|Overall Study|Decision by sponsor|1|||
19374718|NCT02291614|41616400|FG004|Overall Study|Decision by sponsor|0|||
19374719|NCT02291614|41616401|FG005|Overall Study|Decision by sponsor|0|||
19374720|NCT02291614|41616402|FG006|Overall Study|Decision by sponsor|0|||
19374721|NCT02291614|41616403|FG007|Overall Study|Decision by sponsor|0|||
19410151|NCT02497391|41655540|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
19410152|NCT02497391|41655541|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
19410153|NCT02476175|41655549|FG000|Overall Study|Adverse Event|2|||
19410154|NCT02065557|41655556|FG000|Induction Period|Withdrawal by Subject|2|||
19410155|NCT02065557|41655557|FG001|Induction Period|Withdrawal by Subject|1|||
19410156|NCT02065557|41655558|FG002|Induction Period|Withdrawal by Subject|0|||
19410157|NCT02065557|41655559|FG003|Induction Period|Withdrawal by Subject|0|||
19410158|NCT02065557|41655560|FG004|Induction Period|Withdrawal by Subject|0|||
19410159|NCT02065557|41655561|FG005|Induction Period|Withdrawal by Subject|0|||
19410160|NCT02065557|41655556|FG000|Induction Period|Lack of Efficacy|2|||
19410161|NCT02065557|41655557|FG001|Induction Period|Lack of Efficacy|1|||
19410162|NCT02065557|41655558|FG002|Induction Period|Lack of Efficacy|1|||
19410163|NCT02065557|41655559|FG003|Induction Period|Lack of Efficacy|0|||
19410164|NCT02065557|41655560|FG004|Induction Period|Lack of Efficacy|0|||
19410165|NCT02065557|41655561|FG005|Induction Period|Lack of Efficacy|0|||
19410166|NCT02065557|41655556|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
19410167|NCT02065557|41655557|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
19410168|NCT02065557|41655558|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
19410169|NCT02065557|41655559|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
19410170|NCT02065557|41655560|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
19410171|NCT02065557|41655561|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
19410172|NCT02065557|41655556|FG000|Induction Period|Non-Responder at Week 8|4|||
19410173|NCT02065557|41655557|FG001|Induction Period|Non-Responder at Week 8|4|||
19410174|NCT02065557|41655558|FG002|Induction Period|Non-Responder at Week 8|0|||
19410175|NCT02065557|41655559|FG003|Induction Period|Non-Responder at Week 8|0|||
19410176|NCT02065557|41655560|FG004|Induction Period|Non-Responder at Week 8|0|||
19410177|NCT02065557|41655561|FG005|Induction Period|Non-Responder at Week 8|0|||
19410178|NCT02065557|41655556|FG000|Induction Period|Adverse Event|1|||
19410179|NCT02065557|41655557|FG001|Induction Period|Adverse Event|1|||
19410180|NCT02065557|41655558|FG002|Induction Period|Adverse Event|0|||
19410181|NCT02065557|41655559|FG003|Induction Period|Adverse Event|0|||
19410182|NCT02065557|41655560|FG004|Induction Period|Adverse Event|0|||
19410183|NCT02065557|41655561|FG005|Induction Period|Adverse Event|0|||
19410184|NCT02065557|41655556|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
19410185|NCT02065557|41655557|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
19410186|NCT02065557|41655558|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
19410187|NCT02065557|41655559|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
19410188|NCT02065557|41655560|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
19410189|NCT02065557|41655561|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
19410190|NCT02065557|41655556|FG000|Maintenance Period|Withdrawal by Subject|0|||
19410191|NCT02065557|41655557|FG001|Maintenance Period|Withdrawal by Subject|0|||
19410192|NCT02065557|41655558|FG002|Maintenance Period|Withdrawal by Subject|0|||
19410193|NCT02065557|41655559|FG003|Maintenance Period|Withdrawal by Subject|0|||
19410194|NCT02065557|41655560|FG004|Maintenance Period|Withdrawal by Subject|2|||
19410195|NCT02065557|41655561|FG005|Maintenance Period|Withdrawal by Subject|1|||
19410196|NCT02065557|41655556|FG000|Maintenance Period|Lack of Efficacy|0|||
19410197|NCT02065557|41655557|FG001|Maintenance Period|Lack of Efficacy|0|||
19410198|NCT02065557|41655558|FG002|Maintenance Period|Lack of Efficacy|0|||
19410199|NCT02065557|41655559|FG003|Maintenance Period|Lack of Efficacy|0|||
19410200|NCT02065557|41655560|FG004|Maintenance Period|Lack of Efficacy|5|||
19410201|NCT02065557|41655561|FG005|Maintenance Period|Lack of Efficacy|2|||
19410202|NCT02065557|41655556|FG000|Maintenance Period|Subject Non-Compliance|0|||
19410203|NCT02065557|41655557|FG001|Maintenance Period|Subject Non-Compliance|0|||
19410204|NCT02065557|41655558|FG002|Maintenance Period|Subject Non-Compliance|0|||
19410205|NCT02065557|41655559|FG003|Maintenance Period|Subject Non-Compliance|0|||
19410206|NCT02065557|41655560|FG004|Maintenance Period|Subject Non-Compliance|0|||
19410207|NCT02065557|41655561|FG005|Maintenance Period|Subject Non-Compliance|1|||
19410208|NCT02065245|41655593|FG000|Infusion 1|Lost to Follow-up|0|||
19410209|NCT02065245|41655594|FG001|Infusion 1|Lost to Follow-up|0|||
19410210|NCT02065245|41655595|FG002|Infusion 1|Lost to Follow-up|0|||
19410211|NCT02065245|41655596|FG003|Infusion 1|Lost to Follow-up|0|||
19410212|NCT02065245|41655597|FG004|Infusion 1|Lost to Follow-up|0|||
19410213|NCT02065245|41655598|FG005|Infusion 1|Lost to Follow-up|0|||
19410214|NCT02065245|41655599|FG006|Infusion 1|Lost to Follow-up|1|||
19410215|NCT02065245|41655593|FG000|Infusion 1|Death|0|||
19410216|NCT02065245|41655594|FG001|Infusion 1|Death|0|||
19410217|NCT02065245|41655595|FG002|Infusion 1|Death|1|||
19410218|NCT02065245|41655596|FG003|Infusion 1|Death|0|||
19410219|NCT02065245|41655597|FG004|Infusion 1|Death|1|||
19410220|NCT02065245|41655598|FG005|Infusion 1|Death|0|||
19410221|NCT02065245|41655599|FG006|Infusion 1|Death|0|||
19410222|NCT02065245|41655593|FG000|Infusion 2|Death|0|||
19410223|NCT02065245|41655594|FG001|Infusion 2|Death|0|||
19410224|NCT02065245|41655595|FG002|Infusion 2|Death|0|||
19410225|NCT02065245|41655596|FG003|Infusion 2|Death|0|||
19410226|NCT02065245|41655597|FG004|Infusion 2|Death|0|||
19410227|NCT02065245|41655598|FG005|Infusion 2|Death|0|||
19410228|NCT02065245|41655599|FG006|Infusion 2|Death|1|||
19410229|NCT02065245|41655593|FG000|Infusion 3|Lost to Follow-up|1|||
19410230|NCT02065245|41655594|FG001|Infusion 3|Lost to Follow-up|1|||
19410231|NCT02065245|41655595|FG002|Infusion 3|Lost to Follow-up|0|||
19410232|NCT02065245|41655596|FG003|Infusion 3|Lost to Follow-up|0|||
19410233|NCT02065245|41655597|FG004|Infusion 3|Lost to Follow-up|0|||
19410234|NCT02065245|41655598|FG005|Infusion 3|Lost to Follow-up|0|||
19410235|NCT02065245|41655599|FG006|Infusion 3|Lost to Follow-up|0|||
19410236|NCT02043015|41655615|FG000|Overall Study|Lost to Follow-up|4|||
19410237|NCT02043015|41655615|FG000|Overall Study|Withdrawal by Subject|4|||
19410238|NCT02043015|41655615|FG000|Overall Study|Removed once target enrollment reached|15|||
19410239|NCT02043015|41655615|FG000|Overall Study|Participant moved away from study city|4|||
19410240|NCT02043015|41655615|FG000|Overall Study|Incarceration|1|||
19410241|NCT02064231|41655621|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
19410242|NCT02064231|41655622|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
19410243|NCT02064231|41655623|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
19410244|NCT02064231|41655624|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
19410245|NCT02064231|41655621|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
19410246|NCT02064231|41655622|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
19410247|NCT02064231|41655623|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
19410248|NCT02064231|41655624|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
19410249|NCT02064231|41655621|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
19410250|NCT02064231|41655622|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
19410251|NCT02064231|41655623|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
19410252|NCT02064231|41655624|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
19410253|NCT02064231|41655621|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
19410254|NCT02064231|41655622|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
19410255|NCT02064231|41655623|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
19410256|NCT02064231|41655624|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
19410257|NCT02063217|41655639|FG000|Overall Study|Withdrawal by Subject|1|||
19410258|NCT02063217|41655640|FG001|Overall Study|Withdrawal by Subject|0|||
19410259|NCT02063217|41655641|FG002|Overall Study|Withdrawal by Subject|0|||
19410260|NCT02497001|41655653|FG000|Overall Study|Lost to Follow-up|10|||
19410261|NCT02497001|41655654|FG001|Overall Study|Lost to Follow-up|2|||
19410262|NCT02497001|41655655|FG002|Overall Study|Lost to Follow-up|0|||
19410263|NCT02497001|41655656|FG003|Overall Study|Lost to Follow-up|2|||
19410264|NCT02497001|41655653|FG000|Overall Study|Adverse Event|28|||
19410265|NCT02497001|41655654|FG001|Overall Study|Adverse Event|30|||
19410266|NCT02497001|41655655|FG002|Overall Study|Adverse Event|11|||
19410267|NCT02497001|41655656|FG003|Overall Study|Adverse Event|11|||
19410268|NCT02497001|41655653|FG000|Overall Study|Withdrawal by Subject|14|||
19410269|NCT02497001|41655654|FG001|Overall Study|Withdrawal by Subject|37|||
19410270|NCT02497001|41655655|FG002|Overall Study|Withdrawal by Subject|19|||
19410271|NCT02497001|41655656|FG003|Overall Study|Withdrawal by Subject|15|||
19410272|NCT02497001|41655653|FG000|Overall Study|Physician Decision|5|||
19410273|NCT02497001|41655654|FG001|Overall Study|Physician Decision|11|||
19410274|NCT02497001|41655655|FG002|Overall Study|Physician Decision|5|||
19410275|NCT02497001|41655656|FG003|Overall Study|Physician Decision|1|||
19410276|NCT02497001|41655653|FG000|Overall Study|subjects that were not treated|1|||
19410277|NCT02497001|41655654|FG001|Overall Study|subjects that were not treated|2|||
19410278|NCT02497001|41655655|FG002|Overall Study|subjects that were not treated|2|||
19410279|NCT02497001|41655656|FG003|Overall Study|subjects that were not treated|1|||
19410280|NCT02497001|41655653|FG000|Overall Study|Major Protocol Deviation|3|||
19410281|NCT02497001|41655654|FG001|Overall Study|Major Protocol Deviation|4|||
19410282|NCT02497001|41655655|FG002|Overall Study|Major Protocol Deviation|4|||
19410283|NCT02497001|41655656|FG003|Overall Study|Major Protocol Deviation|4|||
19410284|NCT02497001|41655653|FG000|Overall Study|Lack of Efficacy|10|||
19410285|NCT02497001|41655654|FG001|Overall Study|Lack of Efficacy|16|||
19410286|NCT02497001|41655655|FG002|Overall Study|Lack of Efficacy|6|||
19410287|NCT02497001|41655656|FG003|Overall Study|Lack of Efficacy|6|||
19410288|NCT02497001|41655653|FG000|Overall Study|Protocol Violation|3|||
19410289|NCT02497001|41655654|FG001|Overall Study|Protocol Violation|1|||
19410290|NCT02497001|41655655|FG002|Overall Study|Protocol Violation|3|||
19410291|NCT02497001|41655656|FG003|Overall Study|Protocol Violation|1|||
19410292|NCT02366143|41655672|FG000|Overall Study|Death|307|||
19410293|NCT02366143|41655673|FG001|Overall Study|Death|278|||
19410294|NCT02366143|41655674|FG002|Overall Study|Death|280|||
19410295|NCT02366143|41655672|FG000|Overall Study|Lost to Follow-up|2|||
19410296|NCT02366143|41655673|FG001|Overall Study|Lost to Follow-up|4|||
19410297|NCT02366143|41655674|FG002|Overall Study|Lost to Follow-up|2|||
19410298|NCT02366143|41655672|FG000|Overall Study|Physician Decision|1|||
19410299|NCT02366143|41655673|FG001|Overall Study|Physician Decision|2|||
19410300|NCT02366143|41655674|FG002|Overall Study|Physician Decision|1|||
19410301|NCT02366143|41655672|FG000|Overall Study|Protocol Violation|0|||
19410302|NCT02366143|41655673|FG001|Overall Study|Protocol Violation|0|||
19410303|NCT02366143|41655674|FG002|Overall Study|Protocol Violation|2|||
19410304|NCT02366143|41655672|FG000|Overall Study|Withdrawal by Subject|16|||
19410305|NCT02366143|41655673|FG001|Overall Study|Withdrawal by Subject|17|||
19410306|NCT02366143|41655674|FG002|Overall Study|Withdrawal by Subject|22|||
19410307|NCT02366143|41655672|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
19410308|NCT02366143|41655673|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
19410309|NCT02366143|41655674|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
19410310|NCT02366143|41655672|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
19410311|NCT02366143|41655673|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
19410312|NCT02366143|41655674|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
19410313|NCT02366143|41655672|FG000|Overall Study|Randomization Error|1|||
19410314|NCT02366143|41655673|FG001|Overall Study|Randomization Error|0|||
19410315|NCT02366143|41655674|FG002|Overall Study|Randomization Error|0|||
19410316|NCT02366143|41655672|FG000|Overall Study|PI Move and Site Closure|1|||
19410317|NCT02366143|41655673|FG001|Overall Study|PI Move and Site Closure|0|||
19410318|NCT02366143|41655674|FG002|Overall Study|PI Move and Site Closure|1|||
19410319|NCT02366143|41655672|FG000|Overall Study|Study Terminated By Sponsor|0|||
19410320|NCT02366143|41655673|FG001|Overall Study|Study Terminated By Sponsor|0|||
19410321|NCT02366143|41655674|FG002|Overall Study|Study Terminated By Sponsor|2|||
19410322|NCT02366143|41655672|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
19410323|NCT02366143|41655673|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
19410324|NCT02366143|41655674|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
19410325|NCT02366143|41655672|FG000|Overall Study|Patient moved to roll-over study|1|||
19410326|NCT02366143|41655673|FG001|Overall Study|Patient moved to roll-over study|19|||
19410327|NCT02366143|41655674|FG002|Overall Study|Patient moved to roll-over study|28|||
19410328|NCT02366143|41655672|FG000|Overall Study|Patient moved to commercial stock|0|||
19410329|NCT02366143|41655673|FG001|Overall Study|Patient moved to commercial stock|0|||
19410330|NCT02366143|41655674|FG002|Overall Study|Patient moved to commercial stock|1|||
19410331|NCT02366143|41655672|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
19410332|NCT02366143|41655673|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
19410333|NCT02366143|41655674|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
19410334|NCT02366143|41655672|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
19410335|NCT02366143|41655673|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
19410336|NCT02366143|41655674|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
19410337|NCT02366143|41655672|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
19410338|NCT02366143|41655673|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
19410339|NCT02366143|41655674|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
19410340|NCT02366143|41655672|FG000|Overall Study|Requester's instructions|1|||
19410341|NCT02366143|41655673|FG001|Overall Study|Requester's instructions|1|||
19410342|NCT02366143|41655674|FG002|Overall Study|Requester's instructions|1|||
19410343|NCT02366143|41655672|FG000|Overall Study|Uneligible|0|||
19410344|NCT02366143|41655673|FG001|Overall Study|Uneligible|1|||
19410345|NCT02366143|41655674|FG002|Overall Study|Uneligible|0|||
19410346|NCT02366143|41655672|FG000|Overall Study|Post Trial Migration|0|||
19410347|NCT02366143|41655673|FG001|Overall Study|Post Trial Migration|1|||
19410348|NCT02366143|41655674|FG002|Overall Study|Post Trial Migration|0|||
19410349|NCT02366143|41655672|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
19410350|NCT02366143|41655673|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
19410351|NCT02366143|41655674|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
19410352|NCT02366143|41655672|FG000|Overall Study|Patient switched to PTAP|0|||
19410353|NCT02366143|41655673|FG001|Overall Study|Patient switched to PTAP|1|||
19410354|NCT02366143|41655674|FG002|Overall Study|Patient switched to PTAP|0|||
19410355|NCT02366143|41655672|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
19410356|NCT02366143|41655673|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
19410357|NCT02366143|41655674|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
19410358|NCT02098395|41655690|FG000|Overall Study|Protocol Violation|2|||
19410359|NCT02098395|41655691|FG001|Overall Study|Protocol Violation|2|||
19410360|NCT02098395|41655692|FG002|Overall Study|Protocol Violation|0|||
19410361|NCT02098395|41655693|FG003|Overall Study|Protocol Violation|7|||
19410362|NCT02098395|41655690|FG000|Overall Study|Withdrawal by Subject|10|||
19410363|NCT02098395|41655691|FG001|Overall Study|Withdrawal by Subject|10|||
19410364|NCT02098395|41655692|FG002|Overall Study|Withdrawal by Subject|5|||
19410365|NCT02098395|41655693|FG003|Overall Study|Withdrawal by Subject|13|||
19410366|NCT02098395|41655690|FG000|Overall Study|Adverse Event|12|||
19410367|NCT02098395|41655691|FG001|Overall Study|Adverse Event|19|||
19410368|NCT02098395|41655692|FG002|Overall Study|Adverse Event|34|||
19410369|NCT02098395|41655693|FG003|Overall Study|Adverse Event|2|||
19410370|NCT02098395|41655690|FG000|Overall Study|Lost to Follow-up|2|||
19410371|NCT02098395|41655691|FG001|Overall Study|Lost to Follow-up|1|||
19410372|NCT02098395|41655692|FG002|Overall Study|Lost to Follow-up|0|||
19410373|NCT02098395|41655693|FG003|Overall Study|Lost to Follow-up|3|||
19410374|NCT02098395|41655690|FG000|Overall Study|Unclassified|0|||
19410375|NCT02098395|41655691|FG001|Overall Study|Unclassified|0|||
19410376|NCT02098395|41655692|FG002|Overall Study|Unclassified|3|||
19410377|NCT02098395|41655693|FG003|Overall Study|Unclassified|2|||
19410378|NCT02041923|41655705|FG000|Overall Study|Lost to Follow-up|26|||
19410379|NCT02041923|41655706|FG001|Overall Study|Lost to Follow-up|30|||
19410380|NCT02062437|41655714|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
19410381|NCT02062437|41655714|FG000|Overall Study|Patient not available for the 2y visit|18|||
19410382|NCT02062437|41655714|FG000|Overall Study|Death|2|||
19410383|NCT02062437|41655714|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
19410384|NCT02365519|41655720|FG000|Randomized and Treated|Adverse Event|0|||
19410385|NCT02365519|41655721|FG001|Randomized and Treated|Adverse Event|1|||
19410386|NCT02365519|41655722|FG002|Randomized and Treated|Adverse Event|0|||
19410387|NCT02365519|41655720|FG000|Randomized and Treated|Withdrawal by Subject|0|||
19410388|NCT02365519|41655721|FG001|Randomized and Treated|Withdrawal by Subject|1|||
19410389|NCT02365519|41655722|FG002|Randomized and Treated|Withdrawal by Subject|1|||
19410390|NCT02061813|41655731|FG000|Overall Study|Withdrawal by Subject|1|||
19410391|NCT02061813|41655731|FG000|Overall Study|Protocol Violation|2|||
19410392|NCT02096835|41655741|FG000|Overall Study|Withdrawal by Subject|1|||
19410393|NCT02096835|41655742|FG001|Overall Study|Withdrawal by Subject|0|||
19410394|NCT02096835|41655743|FG002|Overall Study|Withdrawal by Subject|0|||
19410395|NCT02096835|41655741|FG000|Overall Study|converted to open procedures|1|||
19410396|NCT02096835|41655742|FG001|Overall Study|converted to open procedures|0|||
19410397|NCT02096835|41655743|FG002|Overall Study|converted to open procedures|0|||
19410398|NCT02096835|41655741|FG000|Overall Study|Lost to Follow-up|1|||
19410399|NCT02096835|41655742|FG001|Overall Study|Lost to Follow-up|0|||
19410400|NCT02096835|41655743|FG002|Overall Study|Lost to Follow-up|1|||
19410401|NCT02324569|41655753|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
19410402|NCT02324569|41655754|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
19410403|NCT02324569|41655753|FG000|Overall Study|Voluntary Withdrawal|3|||
19410404|NCT02324569|41655754|FG001|Overall Study|Voluntary Withdrawal|6|||
19410405|NCT02324569|41655753|FG000|Overall Study|Lack of Efficacy|2|||
19410406|NCT02324569|41655754|FG001|Overall Study|Lack of Efficacy|3|||
19410407|NCT02324569|41655753|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
19410408|NCT02324569|41655754|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
19410409|NCT02324569|41655753|FG000|Overall Study|Inconvenient Schedule|2|||
19410410|NCT02324569|41655754|FG001|Overall Study|Inconvenient Schedule|0|||
19410411|NCT02294773|41655762|FG000|Overall Study|Withdrawal by Subject|0|||
19410412|NCT02294773|41655763|FG001|Overall Study|Withdrawal by Subject|2|||
19410413|NCT02365285|41655773|FG000|Overall Study|Physician Decision|0|||
19410414|NCT02365285|41655774|FG001|Overall Study|Physician Decision|1|||
19410415|NCT02365285|41655775|FG002|Overall Study|Physician Decision|1|||
19410416|NCT02365285|41655776|FG003|Overall Study|Physician Decision|0|||
19410417|NCT02365285|41655773|FG000|Overall Study|Adverse Event|0|||
19410418|NCT02365285|41655774|FG001|Overall Study|Adverse Event|0|||
19410419|NCT02365285|41655775|FG002|Overall Study|Adverse Event|0|||
19410420|NCT02365285|41655776|FG003|Overall Study|Adverse Event|2|||
19410421|NCT02041299|41655790|FG000|Overall Study|Adverse Event|9|||
19410422|NCT02041299|41655791|FG001|Overall Study|Adverse Event|3|||
19410423|NCT02041299|41655790|FG000|Overall Study|Lost to Follow-up|4|||
19410424|NCT02041299|41655791|FG001|Overall Study|Lost to Follow-up|1|||
19410425|NCT02041299|41655790|FG000|Overall Study|Physician Decision|1|||
19410426|NCT02041299|41655791|FG001|Overall Study|Physician Decision|1|||
19410427|NCT02041299|41655790|FG000|Overall Study|Withdrawal by Subject|13|||
19410428|NCT02041299|41655791|FG001|Overall Study|Withdrawal by Subject|7|||
19410429|NCT02041299|41655790|FG000|Overall Study|Protocol Violation|11|||
19410430|NCT02041299|41655791|FG001|Overall Study|Protocol Violation|4|||
19410431|NCT02041299|41655790|FG000|Overall Study|Termination of the study|7|||
19410432|NCT02041299|41655791|FG001|Overall Study|Termination of the study|3|||
19410433|NCT02041299|41655790|FG000|Overall Study|Required bone marrow transplant|0|||
19410434|NCT02041299|41655791|FG001|Overall Study|Required bone marrow transplant|1|||
19410435|NCT02041299|41655790|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
19410436|NCT02041299|41655791|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
19410437|NCT01645735|41655803|FG000|Overall Study|Physician Decision|2|||
19410438|NCT01645735|41655804|FG001|Overall Study|Physician Decision|0|||
19410439|NCT01645735|41655803|FG000|Overall Study|Withdrawal by Subject|1|||
19410440|NCT01645735|41655804|FG001|Overall Study|Withdrawal by Subject|0|||
19410441|NCT01645735|41655803|FG000|Overall Study|Protocol Violation|1|||
19410442|NCT01645735|41655804|FG001|Overall Study|Protocol Violation|0|||
19410443|NCT01645735|41655803|FG000|Overall Study|Adverse Event|0|||
19410444|NCT01645735|41655804|FG001|Overall Study|Adverse Event|1|||
19410445|NCT02365207|41655811|FG000|Overall Study|Withdrawal by Subject|1|||
19410446|NCT02365207|41655811|FG000|Overall Study|Physician Decision|1|||
19410447|NCT01645111|41655815|FG000|Overall Study|Did not require Clevidipine|15|||
19410448|NCT02364037|41655821|FG000|Overall Study|Withdrawal by Subject|7|||
19410449|NCT02364037|41655822|FG001|Overall Study|Withdrawal by Subject|4|||
19410450|NCT02364037|41655821|FG000|Overall Study|Lost to Follow-up|37|||
19410451|NCT02364037|41655822|FG001|Overall Study|Lost to Follow-up|49|||
19410452|NCT01919164|41655833|FG000|Overall Study|Adverse Event|6|||
19410453|NCT01919164|41655834|FG001|Overall Study|Adverse Event|4|||
19410454|NCT01919164|41655835|FG002|Overall Study|Adverse Event|9|||
19410455|NCT01919164|41655836|FG003|Overall Study|Adverse Event|3|||
19410456|NCT01919164|41655837|FG004|Overall Study|Adverse Event|2|||
19410457|NCT01919164|41655833|FG000|Overall Study|Lost to Follow-up|2|||
19410458|NCT01919164|41655834|FG001|Overall Study|Lost to Follow-up|2|||
19410459|NCT01919164|41655835|FG002|Overall Study|Lost to Follow-up|2|||
19410460|NCT01919164|41655836|FG003|Overall Study|Lost to Follow-up|0|||
19410461|NCT01919164|41655837|FG004|Overall Study|Lost to Follow-up|4|||
19410462|NCT01919164|41655833|FG000|Overall Study|Death|1|||
19410463|NCT01919164|41655834|FG001|Overall Study|Death|0|||
19410464|NCT01919164|41655835|FG002|Overall Study|Death|0|||
19410465|NCT01919164|41655836|FG003|Overall Study|Death|0|||
19410466|NCT01919164|41655837|FG004|Overall Study|Death|0|||
19410467|NCT01919164|41655833|FG000|Overall Study|Protocol Violation|6|||
19410468|NCT01919164|41655834|FG001|Overall Study|Protocol Violation|0|||
19410469|NCT01919164|41655835|FG002|Overall Study|Protocol Violation|3|||
19410470|NCT01919164|41655836|FG003|Overall Study|Protocol Violation|2|||
19410471|NCT01919164|41655837|FG004|Overall Study|Protocol Violation|2|||
19410472|NCT01919164|41655833|FG000|Overall Study|Disease progression|2|||
19410473|NCT01919164|41655834|FG001|Overall Study|Disease progression|2|||
19410474|NCT01919164|41655835|FG002|Overall Study|Disease progression|1|||
19410475|NCT01919164|41655836|FG003|Overall Study|Disease progression|2|||
19410476|NCT01919164|41655837|FG004|Overall Study|Disease progression|1|||
19410477|NCT01919164|41655833|FG000|Overall Study|Withdrew consent|13|||
19410478|NCT01919164|41655834|FG001|Overall Study|Withdrew consent|13|||
19410479|NCT01919164|41655835|FG002|Overall Study|Withdrew consent|14|||
19410480|NCT01919164|41655836|FG003|Overall Study|Withdrew consent|14|||
19410481|NCT01919164|41655837|FG004|Overall Study|Withdrew consent|9|||
19410482|NCT01919164|41655833|FG000|Overall Study|Other Un-specified|13|||
19410483|NCT01919164|41655834|FG001|Overall Study|Other Un-specified|9|||
19410484|NCT01919164|41655835|FG002|Overall Study|Other Un-specified|8|||
19410485|NCT01919164|41655836|FG003|Overall Study|Other Un-specified|7|||
19410486|NCT01919164|41655837|FG004|Overall Study|Other Un-specified|15|||
19410487|NCT01901224|41655849|FG000|Overall Study|study was not funded and terminated|2|||
19410488|NCT01901146|41655855|FG000|Neoadjuvant Phase|Death|1|||
19410489|NCT01901146|41655856|FG001|Neoadjuvant Phase|Death|2|||
19410490|NCT01901146|41655857|FG002|Neoadjuvant Phase|Death|0|||
19410491|NCT01901146|41655858|FG003|Neoadjuvant Phase|Death|0|||
19410492|NCT01901146|41655859|FG004|Neoadjuvant Phase|Death|0|||
19410493|NCT01901146|41655855|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
19410494|NCT01901146|41655856|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
19410495|NCT01901146|41655857|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
19410496|NCT01901146|41655858|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
19410497|NCT01901146|41655859|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
19410498|NCT01901146|41655855|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
19410499|NCT01901146|41655856|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
19410500|NCT01901146|41655857|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
19410501|NCT01901146|41655858|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
19410502|NCT01901146|41655859|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
19410503|NCT01901146|41655855|FG000|Neoadjuvant Phase|Physician Decision|1|||
19410504|NCT01901146|41655856|FG001|Neoadjuvant Phase|Physician Decision|2|||
19410505|NCT01901146|41655857|FG002|Neoadjuvant Phase|Physician Decision|0|||
19410506|NCT01901146|41655858|FG003|Neoadjuvant Phase|Physician Decision|0|||
19410507|NCT01901146|41655859|FG004|Neoadjuvant Phase|Physician Decision|0|||
19410508|NCT01901146|41655855|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
19410509|NCT01901146|41655856|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
19410510|NCT01901146|41655857|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
19410511|NCT01901146|41655858|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
19410512|NCT01901146|41655859|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
19410513|NCT01901146|41655855|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
19410514|NCT01901146|41655856|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
19410515|NCT01901146|41655857|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
19518974|NCT01453296|41932097|FG001|Treatment Period 1|Adverse Event|1|||
19410516|NCT01901146|41655858|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
19410517|NCT01901146|41655859|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
19410518|NCT01901146|41655855|FG000|Adjuvant Phase|Other|0|||
19410519|NCT01901146|41655856|FG001|Adjuvant Phase|Other|0|||
19410520|NCT01901146|41655857|FG002|Adjuvant Phase|Other|1|||
19410521|NCT01901146|41655858|FG003|Adjuvant Phase|Other|0|||
19410522|NCT01901146|41655859|FG004|Adjuvant Phase|Other|0|||
19410523|NCT01901146|41655855|FG000|Adjuvant Phase|Death|0|||
19410524|NCT01901146|41655856|FG001|Adjuvant Phase|Death|0|||
19410525|NCT01901146|41655857|FG002|Adjuvant Phase|Death|0|||
19410526|NCT01901146|41655858|FG003|Adjuvant Phase|Death|0|||
19410527|NCT01901146|41655859|FG004|Adjuvant Phase|Death|3|||
19410528|NCT01901146|41655855|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
19410529|NCT01901146|41655856|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
19410530|NCT01901146|41655857|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
19410531|NCT01901146|41655858|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
19410532|NCT01901146|41655859|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
19410533|NCT01901146|41655855|FG000|Adjuvant Phase|Physician Decision|0|||
19410534|NCT01901146|41655856|FG001|Adjuvant Phase|Physician Decision|0|||
19410535|NCT01901146|41655857|FG002|Adjuvant Phase|Physician Decision|9|||
19410536|NCT01901146|41655858|FG003|Adjuvant Phase|Physician Decision|2|||
19410537|NCT01901146|41655859|FG004|Adjuvant Phase|Physician Decision|4|||
19410538|NCT01901146|41655855|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
19410539|NCT01901146|41655856|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
19410540|NCT01901146|41655857|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
19410541|NCT01901146|41655858|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
19410542|NCT01901146|41655859|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
19410543|NCT01644643|41655872|FG000|Overall Study|Death|1|||
19410544|NCT01644643|41655873|FG001|Overall Study|Death|0|||
19410545|NCT01644643|41655874|FG002|Overall Study|Death|3|||
19410546|NCT01644643|41655875|FG003|Overall Study|Death|3|||
19410547|NCT01644643|41655872|FG000|Overall Study|Lost to Follow-up|0|||
19410548|NCT01644643|41655873|FG001|Overall Study|Lost to Follow-up|0|||
19410549|NCT01644643|41655874|FG002|Overall Study|Lost to Follow-up|0|||
19410550|NCT01644643|41655875|FG003|Overall Study|Lost to Follow-up|4|||
19410551|NCT01644643|41655872|FG000|Overall Study|Withdrawal by Subject|1|||
19410552|NCT01644643|41655873|FG001|Overall Study|Withdrawal by Subject|0|||
19410553|NCT01644643|41655874|FG002|Overall Study|Withdrawal by Subject|2|||
19410554|NCT01644643|41655875|FG003|Overall Study|Withdrawal by Subject|1|||
19410555|NCT01644643|41655872|FG000|Overall Study|Other Eligibility criteria|0|||
19410556|NCT01644643|41655873|FG001|Overall Study|Other Eligibility criteria|0|||
19410557|NCT01644643|41655874|FG002|Overall Study|Other Eligibility criteria|0|||
19410558|NCT01644643|41655875|FG003|Overall Study|Other Eligibility criteria|2|||
19410559|NCT01864564|41655893|FG000|Overall Study|Lost to Follow-up|17|||
19410560|NCT01864564|41655894|FG001|Overall Study|Lost to Follow-up|23|||
19410561|NCT01864564|41655893|FG000|Overall Study|Withdrawal by Subject|20|||
19410562|NCT01864564|41655894|FG001|Overall Study|Withdrawal by Subject|11|||
19410563|NCT01864564|41655893|FG000|Overall Study|Protocol Violation|0|||
19410564|NCT01864564|41655894|FG001|Overall Study|Protocol Violation|27|||
19410565|NCT01864564|41655893|FG000|Overall Study|not reported|0|||
19410566|NCT01864564|41655894|FG001|Overall Study|not reported|34|||
19374722|NCT02291614|41616404|FG008|Overall Study|Decision by sponsor|0|||
19374723|NCT02291614|41616405|FG009|Overall Study|Decision by sponsor|0|||
19374724|NCT02291614|41616406|FG010|Overall Study|Decision by sponsor|0|||
19374725|NCT02291614|41616396|FG000|Overall Study|Death|0|||
19374726|NCT02291614|41616397|FG001|Overall Study|Death|0|||
19374727|NCT02291614|41616398|FG002|Overall Study|Death|1|||
19374728|NCT02291614|41616399|FG003|Overall Study|Death|0|||
19374729|NCT02291614|41616400|FG004|Overall Study|Death|1|||
19374730|NCT02291614|41616401|FG005|Overall Study|Death|1|||
19374731|NCT02291614|41616402|FG006|Overall Study|Death|1|||
19374732|NCT02291614|41616403|FG007|Overall Study|Death|0|||
19374733|NCT02291614|41616404|FG008|Overall Study|Death|0|||
19374734|NCT02291614|41616405|FG009|Overall Study|Death|0|||
19374735|NCT02291614|41616406|FG010|Overall Study|Death|0|||
19374736|NCT02526524|41616442|FG000|Overall Study|Withdrawal by Subject|3|||
19374737|NCT02526524|41616443|FG001|Overall Study|Withdrawal by Subject|3|||
19374738|NCT02526524|41616444|FG002|Overall Study|Withdrawal by Subject|6|||
19374739|NCT02526524|41616445|FG003|Overall Study|Withdrawal by Subject|1|||
19374740|NCT02526524|41616446|FG004|Overall Study|Withdrawal by Subject|9|||
19374741|NCT02526524|41616447|FG005|Overall Study|Withdrawal by Subject|5|||
19374742|NCT02526524|41616442|FG000|Overall Study|Adverse Event|3|||
19374743|NCT02526524|41616443|FG001|Overall Study|Adverse Event|2|||
19374744|NCT02526524|41616444|FG002|Overall Study|Adverse Event|4|||
19374745|NCT02526524|41616445|FG003|Overall Study|Adverse Event|2|||
19374746|NCT02526524|41616446|FG004|Overall Study|Adverse Event|6|||
19374747|NCT02526524|41616447|FG005|Overall Study|Adverse Event|8|||
19374748|NCT02526524|41616442|FG000|Overall Study|Lost to Follow-up|2|||
19374749|NCT02526524|41616443|FG001|Overall Study|Lost to Follow-up|3|||
19374750|NCT02526524|41616444|FG002|Overall Study|Lost to Follow-up|8|||
19374751|NCT02526524|41616445|FG003|Overall Study|Lost to Follow-up|1|||
19374752|NCT02526524|41616446|FG004|Overall Study|Lost to Follow-up|2|||
19374753|NCT02526524|41616447|FG005|Overall Study|Lost to Follow-up|5|||
19374754|NCT02526524|41616442|FG000|Overall Study|Protocol Violation|3|||
19410567|NCT01864174|41655902|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
19410568|NCT01864174|41655903|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
19410569|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
19410570|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
19410571|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
19410572|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
19410573|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
19410574|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
19410575|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Death|1|||
19410576|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Death|0|||
19410577|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
19410578|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
19410579|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
19410580|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
19410581|NCT01864174|41655902|FG000|Double Blind - Compliant Randomized|Other|6|||
19410582|NCT01864174|41655903|FG001|Double Blind - Compliant Randomized|Other|10|||
19410583|NCT01864174|41655902|FG000|Off Treatment Follow-Up|Other|2|||
19410584|NCT01864174|41655903|FG001|Off Treatment Follow-Up|Other|0|||
19410585|NCT01864174|41655902|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
19410586|NCT01864174|41655903|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
19410587|NCT01864018|41655911|FG000|Overall Study|Ineligible|3|||
19410588|NCT01864018|41655912|FG001|Overall Study|Ineligible|1|||
19410589|NCT01900444|41655923|FG000|Overall Study|Protocol Violation|2|||
19410590|NCT01900444|41655923|FG000|Overall Study|Lost to Follow-up|1|||
19410591|NCT02294227|41655930|FG000|Overall Study|Death|0|||
19410592|NCT02294227|41655931|FG001|Overall Study|Death|0|||
19410593|NCT02294227|41655932|FG002|Overall Study|Death|1|||
19410594|NCT02294227|41655930|FG000|Overall Study|Subject/Guardian Decision|6|||
19410595|NCT02294227|41655931|FG001|Overall Study|Subject/Guardian Decision|3|||
19410596|NCT02294227|41655932|FG002|Overall Study|Subject/Guardian Decision|7|||
19410597|NCT02294227|41655930|FG000|Overall Study|Physician Decision|1|||
19410598|NCT02294227|41655931|FG001|Overall Study|Physician Decision|2|||
19410599|NCT02294227|41655932|FG002|Overall Study|Physician Decision|1|||
19410600|NCT02294227|41655930|FG000|Overall Study|Lost to Follow-up|1|||
19410601|NCT02294227|41655931|FG001|Overall Study|Lost to Follow-up|0|||
19410602|NCT02294227|41655932|FG002|Overall Study|Lost to Follow-up|0|||
19410603|NCT02294227|41655930|FG000|Overall Study|Lack of Efficacy|11|||
19410604|NCT02294227|41655931|FG001|Overall Study|Lack of Efficacy|12|||
19410605|NCT02294227|41655932|FG002|Overall Study|Lack of Efficacy|8|||
19410606|NCT02294227|41655930|FG000|Overall Study|Adverse Event|6|||
19410607|NCT02294227|41655931|FG001|Overall Study|Adverse Event|8|||
19410608|NCT02294227|41655932|FG002|Overall Study|Adverse Event|2|||
19410609|NCT02496767|41655946|FG000|Open-label Lead-in Phase|Adverse Event|176|||
19410610|NCT02496767|41655947|FG001|Open-label Lead-in Phase|Adverse Event|0|||
19410611|NCT02496767|41655948|FG002|Open-label Lead-in Phase|Adverse Event|0|||
19410612|NCT02496767|41655949|FG003|Open-label Lead-in Phase|Adverse Event|0|||
19410613|NCT02496767|41655950|FG004|Open-label Lead-in Phase|Adverse Event|0|||
19410614|NCT02496767|41655951|FG005|Open-label Lead-in Phase|Adverse Event|0|||
19410615|NCT02496767|41655952|FG006|Open-label Lead-in Phase|Adverse Event|0|||
19410616|NCT02496767|41655953|FG007|Open-label Lead-in Phase|Adverse Event|0|||
19410617|NCT02496767|41655946|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
19410618|NCT02496767|41655947|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
19410619|NCT02496767|41655948|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
19410620|NCT02496767|41655949|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
19410621|NCT02496767|41655950|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
19410622|NCT02496767|41655951|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
19410623|NCT02496767|41655952|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
19410624|NCT02496767|41655953|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
19410625|NCT02496767|41655946|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
19410626|NCT02496767|41655947|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410627|NCT02496767|41655948|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410628|NCT02496767|41655949|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410629|NCT02496767|41655950|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410630|NCT02496767|41655951|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410631|NCT02496767|41655952|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410632|NCT02496767|41655953|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
19410633|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
19410634|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
19410635|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
19410636|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
19410637|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
19410638|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
19410639|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
19410640|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
19410641|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
19410642|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
19410643|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
19410644|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
19410645|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
19410646|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
19410647|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
19410648|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
19410649|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
19410650|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
19410651|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
19410652|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
19410653|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
19410654|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
19410655|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
19410656|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
19410657|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
19410658|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
19410659|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
19410660|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
19410661|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
19410662|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
19410663|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
19410664|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
19410665|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19410666|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
19410667|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
19410668|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
19410669|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
19410670|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19410671|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19410672|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19410673|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410674|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
19410675|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
19410676|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410677|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410678|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410679|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410680|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
19410681|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19410682|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
19410683|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19410684|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
19410685|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
19410686|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19410687|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19410688|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19410689|NCT02496767|41655946|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410690|NCT02496767|41655947|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
19410691|NCT02496767|41655948|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410692|NCT02496767|41655949|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410693|NCT02496767|41655950|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410694|NCT02496767|41655951|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410695|NCT02496767|41655952|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410696|NCT02496767|41655953|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
19410697|NCT02496767|41655946|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410698|NCT02496767|41655947|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410699|NCT02496767|41655948|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410700|NCT02496767|41655949|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410701|NCT02496767|41655950|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410702|NCT02496767|41655951|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
19410703|NCT02496767|41655952|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
19410704|NCT02496767|41655953|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
19410705|NCT02496767|41655946|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
19410706|NCT02496767|41655947|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
19410707|NCT02496767|41655948|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
19410708|NCT02496767|41655949|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
19410709|NCT02496767|41655950|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
19410710|NCT02496767|41655951|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
19410711|NCT02496767|41655952|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
19410712|NCT02496767|41655953|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
19410713|NCT02496767|41655946|FG000|Double-blind, Withdrawal Phase|Death|0|||
19410714|NCT02496767|41655947|FG001|Double-blind, Withdrawal Phase|Death|0|||
19410715|NCT02496767|41655948|FG002|Double-blind, Withdrawal Phase|Death|0|||
19410716|NCT02496767|41655949|FG003|Double-blind, Withdrawal Phase|Death|0|||
19410717|NCT02496767|41655950|FG004|Double-blind, Withdrawal Phase|Death|0|||
19410718|NCT02496767|41655951|FG005|Double-blind, Withdrawal Phase|Death|0|||
19410719|NCT02496767|41655952|FG006|Double-blind, Withdrawal Phase|Death|1|||
19410720|NCT02496767|41655953|FG007|Double-blind, Withdrawal Phase|Death|2|||
19410721|NCT02496767|41655946|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
19410722|NCT02496767|41655947|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
19410723|NCT02496767|41655948|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
19410724|NCT02496767|41655949|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
19410725|NCT02496767|41655950|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
19410726|NCT02496767|41655951|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
19410727|NCT02496767|41655952|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
19410728|NCT02496767|41655953|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
19410729|NCT02496533|41655969|FG000|Overall Study|Lack of data on outcome|3|||
19410730|NCT02496533|41655970|FG001|Overall Study|Lack of data on outcome|0|||
19410731|NCT02496533|41655969|FG000|Overall Study|Patient did not complete all measures|0|||
19410732|NCT02496533|41655970|FG001|Overall Study|Patient did not complete all measures|4|||
19410733|NCT02496533|41655969|FG000|Overall Study|Late for radiologic testing|0|||
19410734|NCT02496533|41655970|FG001|Overall Study|Late for radiologic testing|2|||
19410735|NCT02496221|41655976|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
19410736|NCT02496221|41655977|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
19410737|NCT02496221|41655976|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
19410738|NCT02496221|41655977|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
19410739|NCT02496221|41655976|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
19410740|NCT02496221|41655977|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
19410741|NCT02475629|41655985|FG000|Overall Study|Adverse Event|1|||
19410742|NCT02475629|41655985|FG000|Overall Study|Death|4|||
19410743|NCT02475629|41655985|FG000|Overall Study|Physician Decision|1|||
19410744|NCT02475629|41655985|FG000|Overall Study|Withdrawal by Subject|1|||
19410745|NCT02475629|41655985|FG000|Overall Study|Lost to Follow-up|1|||
19410746|NCT02475629|41655985|FG000|Overall Study|Subject non-compliance|1|||
19410747|NCT02475395|41655991|FG000|Overall Study|Protocol Violation|30|||
19410748|NCT02475395|41655992|FG001|Overall Study|Protocol Violation|3|||
19410749|NCT01653743|41656000|FG000|Overall Study|Withdrawal by Subject|1|||
19410750|NCT01653743|41656001|FG001|Overall Study|Withdrawal by Subject|0|||
19410751|NCT01653743|41656000|FG000|Overall Study|Investigator discretion|3|||
19410752|NCT01653743|41656001|FG001|Overall Study|Investigator discretion|0|||
19410753|NCT02293993|41656011|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
19410754|NCT02293993|41656012|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
19410755|NCT02293993|41656013|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
19410756|NCT02293993|41656014|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
19410757|NCT02293993|41656011|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
19410758|NCT02293993|41656012|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
19410759|NCT02293993|41656013|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
19410760|NCT02293993|41656014|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
19410761|NCT02293993|41656011|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
19410762|NCT02293993|41656012|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
19410763|NCT02293993|41656013|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
19410764|NCT02293993|41656014|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
19410765|NCT02293993|41656011|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
19410766|NCT02293993|41656012|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
19410767|NCT02293993|41656013|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
19410768|NCT02293993|41656014|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
19410769|NCT02293993|41656011|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
19410770|NCT02293993|41656012|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
19410771|NCT02293993|41656013|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
19410772|NCT02293993|41656014|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
19410773|NCT02322775|41656034|FG000|Overall Study|Adverse Event|1|||
19410774|NCT02322775|41656035|FG001|Overall Study|Adverse Event|0|||
19410775|NCT02322775|41656034|FG000|Overall Study|Lost to Follow-up|0|||
19410776|NCT02322775|41656035|FG001|Overall Study|Lost to Follow-up|1|||
19410777|NCT02322775|41656034|FG000|Overall Study|Protocol Violation|1|||
19410778|NCT02322775|41656035|FG001|Overall Study|Protocol Violation|0|||
19410779|NCT02322775|41656034|FG000|Overall Study|Withdrawal by Subject|3|||
19410780|NCT02322775|41656035|FG001|Overall Study|Withdrawal by Subject|4|||
19410781|NCT02322775|41656034|FG000|Overall Study|Not willing to perform all FU visits|0|||
19410782|NCT02322775|41656035|FG001|Overall Study|Not willing to perform all FU visits|1|||
19410783|NCT02322229|41656041|FG000|Overall Study|Physician Decision|2|||
19410784|NCT02363959|41656048|FG000|Overall Study|Medical instability|1|||
19410785|NCT02363959|41656049|FG001|Overall Study|Medical instability|0|||
19410786|NCT02362789|41656057|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
19410787|NCT02362789|41656058|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
19410788|NCT02362789|41656059|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
19410789|NCT02362789|41656057|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
19410790|NCT02362789|41656058|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
19410791|NCT02362789|41656059|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
19410792|NCT02362789|41656057|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
19410793|NCT02362789|41656058|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
19410794|NCT02362789|41656059|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
19410795|NCT02362789|41656057|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
19410796|NCT02362789|41656058|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
19410797|NCT02362789|41656059|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
19410798|NCT02362789|41656057|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
19410799|NCT02362789|41656058|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
19410800|NCT02362789|41656059|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
19410801|NCT01646827|41656068|FG000|Overall Study|Lost to Follow-up|0|||
19410802|NCT01646827|41656069|FG001|Overall Study|Lost to Follow-up|3|||
19410803|NCT01646827|41656068|FG000|Overall Study|Physician Decision|1|||
19410804|NCT01646827|41656069|FG001|Overall Study|Physician Decision|2|||
19410805|NCT01646827|41656068|FG000|Overall Study|Withdrawal by Subject|1|||
19410806|NCT01646827|41656069|FG001|Overall Study|Withdrawal by Subject|0|||
19410807|NCT02293837|41656079|FG000|Overall Study|Lost to Follow-up|0|||
19410808|NCT02293837|41656080|FG001|Overall Study|Lost to Follow-up|2|||
19410809|NCT02293837|41656081|FG002|Overall Study|Lost to Follow-up|1|||
19410810|NCT02293837|41656082|FG003|Overall Study|Lost to Follow-up|0|||
19410811|NCT02293837|41656079|FG000|Overall Study|Withdrawal by Subject|2|||
19410812|NCT02293837|41656080|FG001|Overall Study|Withdrawal by Subject|1|||
19410813|NCT02293837|41656081|FG002|Overall Study|Withdrawal by Subject|2|||
19410814|NCT02293837|41656082|FG003|Overall Study|Withdrawal by Subject|1|||
19410815|NCT02293837|41656079|FG000|Overall Study|COVID-19 Related|1|||
19410816|NCT02293837|41656080|FG001|Overall Study|COVID-19 Related|1|||
19628068|NCT00588237|42077472|FG000|Overall Study|Evaluable for toxicity only|3|||
19628069|NCT00588237|42077472|FG000|Overall Study|Patien not treated|1|||
19410817|NCT02293837|41656081|FG002|Overall Study|COVID-19 Related|0|||
19410818|NCT02293837|41656082|FG003|Overall Study|COVID-19 Related|0|||
19410819|NCT02293837|41656079|FG000|Overall Study|Participant ill and could not be infused|0|||
19410820|NCT02293837|41656080|FG001|Overall Study|Participant ill and could not be infused|0|||
19410821|NCT02293837|41656081|FG002|Overall Study|Participant ill and could not be infused|1|||
19410822|NCT02293837|41656082|FG003|Overall Study|Participant ill and could not be infused|0|||
19410823|NCT02361307|41656098|FG000|Overall Study|Unstable medical condition.|0|||
19410824|NCT02361307|41656099|FG001|Overall Study|Unstable medical condition.|1|||
19410825|NCT02320903|41656108|FG000|Overall Study|Withdrawal by Subject|0|||
19410826|NCT02320903|41656109|FG001|Overall Study|Withdrawal by Subject|9|||
19410827|NCT02320903|41656110|FG002|Overall Study|Withdrawal by Subject|9|||
19410828|NCT02320903|41656108|FG000|Overall Study|Exited therapy; no longer eligible|8|||
19410829|NCT02320903|41656109|FG001|Overall Study|Exited therapy; no longer eligible|2|||
19410830|NCT02320903|41656110|FG002|Overall Study|Exited therapy; no longer eligible|2|||
19410831|NCT02320903|41656108|FG000|Overall Study|Lost to Follow-up|0|||
19410832|NCT02320903|41656109|FG001|Overall Study|Lost to Follow-up|5|||
19410833|NCT02320903|41656110|FG002|Overall Study|Lost to Follow-up|5|||
19410834|NCT02320123|41656121|FG000|Overall Study|Lost to Follow-up|4|||
19410835|NCT02320123|41656122|FG001|Overall Study|Lost to Follow-up|6|||
19410836|NCT02320123|41656121|FG000|Overall Study|Death|6|||
19410837|NCT02320123|41656122|FG001|Overall Study|Death|5|||
19410838|NCT02360995|41656135|FG000|Overall Study|Lost to Follow-up|2|||
19410839|NCT02360995|41656136|FG001|Overall Study|Lost to Follow-up|0|||
19410840|NCT02360995|41656137|FG002|Overall Study|Lost to Follow-up|2|||
19410841|NCT02360995|41656135|FG000|Overall Study|Withdrawal by Subject|0|||
19410842|NCT02360995|41656136|FG001|Overall Study|Withdrawal by Subject|1|||
19410843|NCT02360995|41656137|FG002|Overall Study|Withdrawal by Subject|0|||
19410844|NCT02360605|41656147|FG000|Overall Study|Withdrawal by Subject|4|||
19410845|NCT02360605|41656148|FG001|Overall Study|Withdrawal by Subject|9|||
19410846|NCT02360605|41656147|FG000|Overall Study|Lost to Follow-up|7|||
19410847|NCT02360605|41656148|FG001|Overall Study|Lost to Follow-up|8|||
19410848|NCT02360605|41656147|FG000|Overall Study|Death|0|||
19410849|NCT02360605|41656148|FG001|Overall Study|Death|1|||
19410850|NCT02360293|41656158|FG000|Overall Study|Lost to Follow-up|73|||
19410851|NCT02360293|41656159|FG001|Overall Study|Lost to Follow-up|95|||
19410852|NCT02360293|41656158|FG000|Overall Study|Withdrawal by Subject|2|||
19410853|NCT02360293|41656159|FG001|Overall Study|Withdrawal by Subject|1|||
19410854|NCT02360293|41656158|FG000|Overall Study|Excluded|1|||
19410855|NCT02360293|41656159|FG001|Overall Study|Excluded|0|||
19410856|NCT02359903|41656167|FG000|Overall Study|Adverse Event|0|||
19410857|NCT02359903|41656168|FG001|Overall Study|Adverse Event|2|||
19410858|NCT02291419|41656176|FG000|Overall Study|Early study termination|1|||
19410859|NCT02291419|41656177|FG001|Overall Study|Early study termination|5|||
19410860|NCT02319031|41656185|FG000|Treatment Period|Death|1|||
19410861|NCT02319031|41656186|FG001|Treatment Period|Death|0|||
19410862|NCT02318797|41656194|FG000|Overall Study|Death|3|||
19410863|NCT02318797|41656195|FG001|Overall Study|Death|6|||
19410864|NCT02318797|41656194|FG000|Overall Study|Lost to Follow-up|85|||
19410865|NCT02318797|41656195|FG001|Overall Study|Lost to Follow-up|96|||
19410866|NCT02359435|41656203|FG000|Overall Study|Lost to Follow-up|4|||
19410867|NCT02359435|41656204|FG001|Overall Study|Lost to Follow-up|4|||
19410868|NCT02318719|41656214|FG000|Double-blind Phase|Adverse Event|7|||
19410869|NCT02318719|41656215|FG001|Double-blind Phase|Adverse Event|6|||
19410870|NCT02318719|41656216|FG002|Double-blind Phase|Adverse Event|12|||
19410871|NCT02318719|41656217|FG003|Double-blind Phase|Adverse Event|4|||
19410872|NCT02318719|41656218|FG004|Double-blind Phase|Adverse Event|0|||
19410873|NCT02318719|41656214|FG000|Double-blind Phase|Lack of Efficacy|5|||
19410874|NCT02318719|41656215|FG001|Double-blind Phase|Lack of Efficacy|0|||
19410875|NCT02318719|41656216|FG002|Double-blind Phase|Lack of Efficacy|1|||
19410876|NCT02318719|41656217|FG003|Double-blind Phase|Lack of Efficacy|1|||
19410877|NCT02318719|41656218|FG004|Double-blind Phase|Lack of Efficacy|0|||
19410878|NCT02318719|41656214|FG000|Double-blind Phase|Protocol Violation|0|||
19410879|NCT02318719|41656215|FG001|Double-blind Phase|Protocol Violation|1|||
19410880|NCT02318719|41656216|FG002|Double-blind Phase|Protocol Violation|3|||
19410881|NCT02318719|41656217|FG003|Double-blind Phase|Protocol Violation|0|||
19410882|NCT02318719|41656218|FG004|Double-blind Phase|Protocol Violation|0|||
19410883|NCT02318719|41656214|FG000|Double-blind Phase|Withdrawal by Subject|25|||
19410884|NCT02318719|41656215|FG001|Double-blind Phase|Withdrawal by Subject|7|||
19410885|NCT02318719|41656216|FG002|Double-blind Phase|Withdrawal by Subject|9|||
19410886|NCT02318719|41656217|FG003|Double-blind Phase|Withdrawal by Subject|10|||
19410887|NCT02318719|41656218|FG004|Double-blind Phase|Withdrawal by Subject|0|||
19410888|NCT02318719|41656214|FG000|Double-blind Phase|Other|1|||
19410889|NCT02318719|41656215|FG001|Double-blind Phase|Other|2|||
19410890|NCT02318719|41656216|FG002|Double-blind Phase|Other|0|||
19410891|NCT02318719|41656217|FG003|Double-blind Phase|Other|0|||
19410892|NCT02318719|41656218|FG004|Double-blind Phase|Other|0|||
19410893|NCT02318719|41656214|FG000|Open-label Extension Phase|Adverse Event|0|||
19410894|NCT02318719|41656215|FG001|Open-label Extension Phase|Adverse Event|0|||
19410895|NCT02318719|41656216|FG002|Open-label Extension Phase|Adverse Event|0|||
19410896|NCT02318719|41656217|FG003|Open-label Extension Phase|Adverse Event|0|||
19410897|NCT02318719|41656218|FG004|Open-label Extension Phase|Adverse Event|15|||
19410898|NCT02318719|41656214|FG000|Open-label Extension Phase|Death|0|||
19410899|NCT02318719|41656215|FG001|Open-label Extension Phase|Death|0|||
19410900|NCT02318719|41656216|FG002|Open-label Extension Phase|Death|0|||
19410901|NCT02318719|41656217|FG003|Open-label Extension Phase|Death|0|||
19410902|NCT02318719|41656218|FG004|Open-label Extension Phase|Death|1|||
19410903|NCT02318719|41656214|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
19410904|NCT02318719|41656215|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
19410905|NCT02318719|41656216|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
19410906|NCT02318719|41656217|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
19410907|NCT02318719|41656218|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
19410908|NCT02318719|41656214|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
19410909|NCT02318719|41656215|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
19410910|NCT02318719|41656216|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
19410911|NCT02318719|41656217|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
19410912|NCT02318719|41656218|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
19410913|NCT02318719|41656214|FG000|Open-label Extension Phase|Other|0|||
19410914|NCT02318719|41656215|FG001|Open-label Extension Phase|Other|0|||
19410915|NCT02318719|41656216|FG002|Open-label Extension Phase|Other|0|||
19410916|NCT02318719|41656217|FG003|Open-label Extension Phase|Other|0|||
19410917|NCT02318719|41656218|FG004|Open-label Extension Phase|Other|7|||
19410918|NCT01870726|41656237|FG000|Overall Study|Withdrawal of informed consent|0|||
19410919|NCT01870726|41656238|FG001|Overall Study|Withdrawal of informed consent|0|||
19410920|NCT01870726|41656239|FG002|Overall Study|Withdrawal of informed consent|0|||
19410921|NCT01870726|41656240|FG003|Overall Study|Withdrawal of informed consent|1|||
19410922|NCT01870726|41656241|FG004|Overall Study|Withdrawal of informed consent|0|||
19410923|NCT01870726|41656242|FG005|Overall Study|Withdrawal of informed consent|0|||
19410924|NCT01870726|41656243|FG006|Overall Study|Withdrawal of informed consent|0|||
19410925|NCT01870726|41656237|FG000|Overall Study|Withdrawal by Subject|0|||
19410926|NCT01870726|41656238|FG001|Overall Study|Withdrawal by Subject|1|||
19410927|NCT01870726|41656239|FG002|Overall Study|Withdrawal by Subject|0|||
19410928|NCT01870726|41656240|FG003|Overall Study|Withdrawal by Subject|0|||
19410929|NCT01870726|41656241|FG004|Overall Study|Withdrawal by Subject|0|||
19410930|NCT01870726|41656242|FG005|Overall Study|Withdrawal by Subject|0|||
19410931|NCT01870726|41656243|FG006|Overall Study|Withdrawal by Subject|0|||
19410932|NCT01870726|41656237|FG000|Overall Study|Adverse Event|0|||
19410933|NCT01870726|41656238|FG001|Overall Study|Adverse Event|0|||
19410934|NCT01870726|41656239|FG002|Overall Study|Adverse Event|0|||
19410935|NCT01870726|41656240|FG003|Overall Study|Adverse Event|0|||
19410936|NCT01870726|41656241|FG004|Overall Study|Adverse Event|1|||
19410937|NCT01870726|41656242|FG005|Overall Study|Adverse Event|1|||
19410938|NCT01870726|41656243|FG006|Overall Study|Adverse Event|0|||
19410939|NCT01870726|41656237|FG000|Overall Study|Progressive disease|5|||
19410940|NCT01870726|41656238|FG001|Overall Study|Progressive disease|5|||
19410941|NCT01870726|41656239|FG002|Overall Study|Progressive disease|4|||
19410942|NCT01870726|41656240|FG003|Overall Study|Progressive disease|5|||
19410943|NCT01870726|41656241|FG004|Overall Study|Progressive disease|6|||
19410944|NCT01870726|41656242|FG005|Overall Study|Progressive disease|4|||
19410945|NCT01870726|41656243|FG006|Overall Study|Progressive disease|10|||
19410946|NCT01900054|41656268|FG000|Overall Study|Physician Decision|1|||
19410947|NCT01900054|41656268|FG000|Overall Study|Withdrawal by Subject|1|||
19410948|NCT01612156|41656274|FG000|Overall Study|Protocol Violation|2|||
19410949|NCT01612156|41656275|FG001|Overall Study|Protocol Violation|0|||
19410950|NCT01899742|41656283|FG000|Overall Study|Adverse Event|5|||
19410951|NCT01899742|41656284|FG001|Overall Study|Adverse Event|4|||
19410952|NCT01899742|41656283|FG000|Overall Study|Lack of Efficacy|1|||
19410953|NCT01899742|41656284|FG001|Overall Study|Lack of Efficacy|5|||
19410954|NCT01899742|41656283|FG000|Overall Study|Protocol Violation|2|||
19410955|NCT01899742|41656284|FG001|Overall Study|Protocol Violation|2|||
19410956|NCT01899742|41656283|FG000|Overall Study|Withdrawal by Subject|9|||
19410957|NCT01899742|41656284|FG001|Overall Study|Withdrawal by Subject|5|||
19410958|NCT01615822|41656293|FG000|Period 1|Withdrawal by Subject|0|||
19410959|NCT01615822|41656294|FG001|Period 1|Withdrawal by Subject|1|||
19410960|NCT01615822|41656295|FG002|Period 1|Withdrawal by Subject|0|||
19410961|NCT01615822|41656293|FG000|Period 1|Adverse Event|1|||
19410962|NCT01615822|41656294|FG001|Period 1|Adverse Event|1|||
19410963|NCT01615822|41656295|FG002|Period 1|Adverse Event|0|||
19410964|NCT01615822|41656293|FG000|Period 2|Lost to Follow-up|0|||
19410965|NCT01615822|41656294|FG001|Period 2|Lost to Follow-up|1|||
19410966|NCT01615822|41656295|FG002|Period 2|Lost to Follow-up|2|||
19410967|NCT01898884|41656311|FG000|Multiple Dose Period|Adverse Event|0|||
19410968|NCT01898884|41656312|FG001|Multiple Dose Period|Adverse Event|0|||
19410969|NCT01898884|41656313|FG002|Multiple Dose Period|Adverse Event|0|||
19410970|NCT01898884|41656314|FG003|Multiple Dose Period|Adverse Event|0|||
19410971|NCT01898884|41656315|FG004|Multiple Dose Period|Adverse Event|0|||
19410972|NCT01898884|41656316|FG005|Multiple Dose Period|Adverse Event|0|||
19410973|NCT01898884|41656317|FG006|Multiple Dose Period|Adverse Event|1|||
19410974|NCT01898884|41656318|FG007|Multiple Dose Period|Adverse Event|0|||
19410975|NCT01898884|41656319|FG008|Multiple Dose Period|Adverse Event|0|||
19410976|NCT01898884|41656311|FG000|Multiple Dose Period|Randomized Not Treated|0|||
19410977|NCT01898884|41656312|FG001|Multiple Dose Period|Randomized Not Treated|0|||
19410978|NCT01898884|41656313|FG002|Multiple Dose Period|Randomized Not Treated|0|||
19410979|NCT01898884|41656314|FG003|Multiple Dose Period|Randomized Not Treated|0|||
19410980|NCT01898884|41656315|FG004|Multiple Dose Period|Randomized Not Treated|0|||
19410981|NCT01898884|41656316|FG005|Multiple Dose Period|Randomized Not Treated|0|||
19410982|NCT01898884|41656317|FG006|Multiple Dose Period|Randomized Not Treated|0|||
19410983|NCT01898884|41656318|FG007|Multiple Dose Period|Randomized Not Treated|0|||
19410984|NCT01898884|41656319|FG008|Multiple Dose Period|Randomized Not Treated|1|||
19410985|NCT01613326|41656357|FG000|Overall Study|Adverse Event|7|||
19518975|NCT01453296|41932096|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
19518976|NCT01453296|41932097|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
19518977|NCT01453296|41932096|FG000|Treatment Period 2|Adverse Event|1|||
19410986|NCT01613326|41656358|FG001|Overall Study|Adverse Event|5|||
19410987|NCT01613326|41656357|FG000|Overall Study|Withdrawal by Subject|3|||
19410988|NCT01613326|41656358|FG001|Overall Study|Withdrawal by Subject|4|||
19410989|NCT01613326|41656357|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19518978|NCT01453296|41932097|FG001|Treatment Period 2|Adverse Event|0|||
19410990|NCT01613326|41656358|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19410991|NCT01613326|41656357|FG000|Overall Study|inability to use device|1|||
19410992|NCT01613326|41656358|FG001|Overall Study|inability to use device|0|||
19410993|NCT01613326|41656357|FG000|Overall Study|Lack of Efficacy|0|||
19410994|NCT01613326|41656358|FG001|Overall Study|Lack of Efficacy|1|||
19410995|NCT01613326|41656357|FG000|Overall Study|Lost to Follow-up|0|||
19410996|NCT01613326|41656358|FG001|Overall Study|Lost to Follow-up|1|||
19410997|NCT01613326|41656357|FG000|Overall Study|Administrative|0|||
19410998|NCT01613326|41656358|FG001|Overall Study|Administrative|2|||
19410999|NCT01613326|41656357|FG000|Overall Study|Protocol Violation|0|||
19411000|NCT01613326|41656358|FG001|Overall Study|Protocol Violation|1|||
19411001|NCT01613248|41656370|FG000|Overall Study|Adverse Event|0|||
19411002|NCT01613248|41656371|FG001|Overall Study|Adverse Event|0|||
19411003|NCT01613248|41656372|FG002|Overall Study|Adverse Event|0|||
19411004|NCT01613248|41656373|FG003|Overall Study|Adverse Event|1|||
19411005|NCT01613248|41656374|FG004|Overall Study|Adverse Event|0|||
19411006|NCT01613248|41656375|FG005|Overall Study|Adverse Event|0|||
19411007|NCT01613248|41656370|FG000|Overall Study|Withdrawal by Subject|3|||
19411008|NCT01613248|41656371|FG001|Overall Study|Withdrawal by Subject|2|||
19411009|NCT01613248|41656372|FG002|Overall Study|Withdrawal by Subject|2|||
19411010|NCT01613248|41656373|FG003|Overall Study|Withdrawal by Subject|5|||
19411011|NCT01613248|41656374|FG004|Overall Study|Withdrawal by Subject|0|||
19411012|NCT01613248|41656375|FG005|Overall Study|Withdrawal by Subject|1|||
19411013|NCT01613248|41656370|FG000|Overall Study|Lost to Follow-up|5|||
19411014|NCT01613248|41656371|FG001|Overall Study|Lost to Follow-up|7|||
19411015|NCT01613248|41656372|FG002|Overall Study|Lost to Follow-up|4|||
19411016|NCT01613248|41656373|FG003|Overall Study|Lost to Follow-up|8|||
19411017|NCT01613248|41656374|FG004|Overall Study|Lost to Follow-up|4|||
19411018|NCT01613248|41656375|FG005|Overall Study|Lost to Follow-up|2|||
19411019|NCT01613248|41656370|FG000|Overall Study|Study Terminated by Sponsor|4|||
19411020|NCT01613248|41656371|FG001|Overall Study|Study Terminated by Sponsor|6|||
19411021|NCT01613248|41656372|FG002|Overall Study|Study Terminated by Sponsor|8|||
19411022|NCT01613248|41656373|FG003|Overall Study|Study Terminated by Sponsor|8|||
19411023|NCT01613248|41656374|FG004|Overall Study|Study Terminated by Sponsor|9|||
19411024|NCT01613248|41656375|FG005|Overall Study|Study Terminated by Sponsor|11|||
19411025|NCT01613248|41656370|FG000|Overall Study|Physician Decision|8|||
19411026|NCT01613248|41656371|FG001|Overall Study|Physician Decision|8|||
19411027|NCT01613248|41656372|FG002|Overall Study|Physician Decision|9|||
19411028|NCT01613248|41656373|FG003|Overall Study|Physician Decision|4|||
19411029|NCT01613248|41656374|FG004|Overall Study|Physician Decision|7|||
19411030|NCT01613248|41656375|FG005|Overall Study|Physician Decision|6|||
19411031|NCT01613248|41656370|FG000|Overall Study|Lack of Qualifying Event|9|||
19411032|NCT01613248|41656371|FG001|Overall Study|Lack of Qualifying Event|11|||
19411033|NCT01613248|41656372|FG002|Overall Study|Lack of Qualifying Event|10|||
19411034|NCT01613248|41656373|FG003|Overall Study|Lack of Qualifying Event|11|||
19411035|NCT01613248|41656374|FG004|Overall Study|Lack of Qualifying Event|15|||
19411036|NCT01613248|41656375|FG005|Overall Study|Lack of Qualifying Event|18|||
19411037|NCT01613248|41656370|FG000|Overall Study|Pregnancy|0|||
19411038|NCT01613248|41656371|FG001|Overall Study|Pregnancy|0|||
19411039|NCT01613248|41656372|FG002|Overall Study|Pregnancy|0|||
19411040|NCT01613248|41656373|FG003|Overall Study|Pregnancy|1|||
19411041|NCT01613248|41656374|FG004|Overall Study|Pregnancy|0|||
19411042|NCT01613248|41656375|FG005|Overall Study|Pregnancy|0|||
19411043|NCT01898806|41656389|FG000|Overall Study|Withdrawal by Subject|2|||
19411044|NCT01898806|41656389|FG000|Overall Study|Physician Decision|1|||
19411045|NCT02291029|41656399|FG000|Overall Study|Withdrawal by Subject|0|||
19411046|NCT02291029|41656400|FG001|Overall Study|Withdrawal by Subject|0|||
19411047|NCT02291029|41656401|FG002|Overall Study|Withdrawal by Subject|1|||
19411048|NCT02291029|41656402|FG003|Overall Study|Withdrawal by Subject|0|||
19411049|NCT02291029|41656403|FG004|Overall Study|Withdrawal by Subject|0|||
19411050|NCT02291029|41656404|FG005|Overall Study|Withdrawal by Subject|0|||
19411051|NCT02291029|41656399|FG000|Overall Study|Adverse Event|0|||
19411052|NCT02291029|41656400|FG001|Overall Study|Adverse Event|1|||
19411053|NCT02291029|41656401|FG002|Overall Study|Adverse Event|0|||
19411054|NCT02291029|41656402|FG003|Overall Study|Adverse Event|0|||
19411055|NCT02291029|41656403|FG004|Overall Study|Adverse Event|0|||
19411056|NCT02291029|41656404|FG005|Overall Study|Adverse Event|0|||
19411057|NCT02290873|41656421|FG000|Overall Study|Withdrawal by Subject|0|||
19411058|NCT02290873|41656422|FG001|Overall Study|Withdrawal by Subject|1|||
19411059|NCT02290873|41656423|FG002|Overall Study|Withdrawal by Subject|1|||
19411060|NCT02290873|41656421|FG000|Overall Study|Nellcor device error|1|||
19411061|NCT02290873|41656422|FG001|Overall Study|Nellcor device error|0|||
19411062|NCT02290873|41656423|FG002|Overall Study|Nellcor device error|0|||
19411063|NCT02290873|41656421|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
19411064|NCT02290873|41656422|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
19411065|NCT02290873|41656423|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
19411066|NCT02290873|41656421|FG000|Overall Study|Protocol Violation|0|||
19411067|NCT02290873|41656422|FG001|Overall Study|Protocol Violation|0|||
19411068|NCT02290873|41656423|FG002|Overall Study|Protocol Violation|1|||
19411069|NCT02290405|41656434|FG000|Overall Study|Withdrawal by Subject|1|||
19411070|NCT02290405|41656435|FG001|Overall Study|Withdrawal by Subject|0|||
19411071|NCT02359045|41656443|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
19411072|NCT02359045|41656444|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19411073|NCT02359045|41656443|FG000|Overall Study|Lost to Follow-up|1|||
19411074|NCT02359045|41656444|FG001|Overall Study|Lost to Follow-up|1|||
19411075|NCT02359045|41656443|FG000|Overall Study|Adverse Event|0|||
19411076|NCT02359045|41656444|FG001|Overall Study|Adverse Event|1|||
19411077|NCT02358343|41656465|FG000|Screening Intervention|Death|0|||
19411078|NCT02358343|41656466|FG001|Screening Intervention|Death|2|||
19411079|NCT02358343|41656467|FG002|Screening Intervention|Death|0|||
19411080|NCT02358343|41656468|FG003|Screening Intervention|Death|0|||
19411081|NCT02358343|41656469|FG004|Screening Intervention|Death|0|||
19411082|NCT02358343|41656465|FG000|Screening Intervention|Withdrawal by Subject|1|||
19411083|NCT02358343|41656466|FG001|Screening Intervention|Withdrawal by Subject|0|||
19411084|NCT02358343|41656467|FG002|Screening Intervention|Withdrawal by Subject|0|||
19411085|NCT02358343|41656468|FG003|Screening Intervention|Withdrawal by Subject|0|||
19411086|NCT02358343|41656469|FG004|Screening Intervention|Withdrawal by Subject|0|||
19411087|NCT02358343|41656465|FG000|Screening Intervention|Determined Ineligible|5|||
19411088|NCT02358343|41656466|FG001|Screening Intervention|Determined Ineligible|6|||
19411089|NCT02358343|41656467|FG002|Screening Intervention|Determined Ineligible|0|||
19411090|NCT02358343|41656468|FG003|Screening Intervention|Determined Ineligible|0|||
19628070|NCT00790023|42077479|FG000|Overall Study|Adverse Event|2|||
19628071|NCT00790023|42077480|FG001|Overall Study|Adverse Event|1|||
19628072|NCT00790023|42077481|FG002|Overall Study|Adverse Event|4|||
19628073|NCT00790023|42077479|FG000|Overall Study|Protocol Violation|2|||
19628074|NCT00790023|42077480|FG001|Overall Study|Protocol Violation|4|||
19628075|NCT00790023|42077481|FG002|Overall Study|Protocol Violation|2|||
19628076|NCT00790023|42077479|FG000|Overall Study|Withdrawal by Subject|2|||
19628077|NCT00790023|42077480|FG001|Overall Study|Withdrawal by Subject|0|||
19628078|NCT00790023|42077481|FG002|Overall Study|Withdrawal by Subject|6|||
19628079|NCT00790023|42077479|FG000|Overall Study|Lost to Follow-up|0|||
19628080|NCT00790023|42077480|FG001|Overall Study|Lost to Follow-up|0|||
19628081|NCT00790023|42077481|FG002|Overall Study|Lost to Follow-up|1|||
19628082|NCT00790023|42077479|FG000|Overall Study|Other|5|||
19628083|NCT00790023|42077480|FG001|Overall Study|Other|5|||
19628084|NCT00790023|42077481|FG002|Overall Study|Other|8|||
19628085|NCT00588822|42077490|FG000|Overall Study|progression of disease|8|||
19628086|NCT00589914|42077496|FG000|Overall Study|Adverse Event|19|||
19628087|NCT00589914|42077497|FG001|Overall Study|Adverse Event|10|||
19411091|NCT02358343|41656469|FG004|Screening Intervention|Determined Ineligible|0|||
19411092|NCT02358343|41656465|FG000|Comparative Efficacy Trial / Observation|Death|0|||
19411093|NCT02358343|41656466|FG001|Comparative Efficacy Trial / Observation|Death|0|||
19411094|NCT02358343|41656467|FG002|Comparative Efficacy Trial / Observation|Death|2|||
19411095|NCT02358343|41656468|FG003|Comparative Efficacy Trial / Observation|Death|0|||
19411096|NCT02358343|41656469|FG004|Comparative Efficacy Trial / Observation|Death|0|||
19411097|NCT02358343|41656465|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
19411098|NCT02358343|41656466|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
19411099|NCT02358343|41656467|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
19411100|NCT02358343|41656468|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
19411101|NCT02358343|41656469|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
19411102|NCT02358343|41656465|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
19411103|NCT02358343|41656466|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
19411104|NCT02358343|41656467|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
19411105|NCT02358343|41656468|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
19411106|NCT02358343|41656469|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
19411107|NCT02356783|41656482|FG000|Overall Study|Lost to Follow-up|1|||
19411108|NCT02356783|41656483|FG001|Overall Study|Lost to Follow-up|3|||
19411109|NCT02289469|41656491|FG000|Overall Study|Unable to match a control|6|||
19411110|NCT02289469|41656492|FG001|Overall Study|Unable to match a control|0|||
19411111|NCT02289079|41656500|FG000|Overall Study|Physician Decision|2|||
19411112|NCT02289079|41656501|FG001|Overall Study|Physician Decision|0|||
19411113|NCT02289079|41656500|FG000|Overall Study|Lost to Follow-up|0|||
19411114|NCT02289079|41656501|FG001|Overall Study|Lost to Follow-up|1|||
19411115|NCT02318095|41656507|FG000|Overall Study|Adverse Event|1|||
19411116|NCT02317705|41656512|FG000|Overall Study|Withdrawal by Subject|3|||
19411117|NCT02317705|41656512|FG000|Overall Study|Physician Decision|1|||
19411118|NCT02317705|41656512|FG000|Overall Study|Drug not usable|1|||
19411119|NCT02474069|41656516|FG000|Selection Phase (SP)|Adverse Event|8|||
19411120|NCT02474069|41656517|FG001|Selection Phase (SP)|Adverse Event|0|||
19411121|NCT02474069|41656518|FG002|Selection Phase (SP)|Adverse Event|0|||
19411122|NCT02474069|41656516|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
19411123|NCT02474069|41656517|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
19411124|NCT02474069|41656518|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
19411125|NCT02474069|41656516|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
19411126|NCT02474069|41656517|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
19411127|NCT02474069|41656518|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
19411128|NCT02474069|41656516|FG000|Selection Phase (SP)|Physician Decision|1|||
19628088|NCT00589914|42077496|FG000|Overall Study|Death|2|||
19628089|NCT00589914|42077497|FG001|Overall Study|Death|0|||
19411129|NCT02474069|41656517|FG001|Selection Phase (SP)|Physician Decision|0|||
19411130|NCT02474069|41656518|FG002|Selection Phase (SP)|Physician Decision|0|||
19411131|NCT02474069|41656516|FG000|Selection Phase (SP)|Protocol Violation|1|||
19411132|NCT02474069|41656517|FG001|Selection Phase (SP)|Protocol Violation|0|||
19411133|NCT02474069|41656518|FG002|Selection Phase (SP)|Protocol Violation|0|||
19411134|NCT02474069|41656516|FG000|Selection Phase (SP)|No longer requires treatment|1|||
19411135|NCT02474069|41656517|FG001|Selection Phase (SP)|No longer requires treatment|0|||
19411136|NCT02474069|41656518|FG002|Selection Phase (SP)|No longer requires treatment|0|||
19411137|NCT02474069|41656516|FG000|Selection Phase (SP)|Technical Problem|1|||
19411138|NCT02474069|41656517|FG001|Selection Phase (SP)|Technical Problem|0|||
19411139|NCT02474069|41656518|FG002|Selection Phase (SP)|Technical Problem|0|||
19411140|NCT02474069|41656516|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
19411141|NCT02474069|41656517|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
19411142|NCT02474069|41656518|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
19411143|NCT02474069|41656516|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
19411144|NCT02474069|41656517|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
19411145|NCT02474069|41656518|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
19411146|NCT02474069|41656516|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
19411147|NCT02474069|41656517|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
19411148|NCT02474069|41656518|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
19411149|NCT02474069|41656516|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
19411150|NCT02474069|41656517|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
19411151|NCT02474069|41656518|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
19411152|NCT02474069|41656516|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
19411153|NCT02474069|41656517|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
19411154|NCT02474069|41656518|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
19411155|NCT02474069|41656516|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
19411156|NCT02474069|41656517|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
19411157|NCT02474069|41656518|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
19411158|NCT02317627|41656531|FG000|Overall Study|Withdrawal by Subject|0|||
19411159|NCT02317627|41656532|FG001|Overall Study|Withdrawal by Subject|1|||
19411160|NCT02317627|41656533|FG002|Overall Study|Withdrawal by Subject|1|||
19411161|NCT02317627|41656531|FG000|Overall Study|Lost to Follow-up|2|||
19411162|NCT02317627|41656532|FG001|Overall Study|Lost to Follow-up|0|||
19411163|NCT02317627|41656533|FG002|Overall Study|Lost to Follow-up|0|||
19411164|NCT02317627|41656531|FG000|Overall Study|Stopped by Investigator|0|||
19411165|NCT02317627|41656532|FG001|Overall Study|Stopped by Investigator|1|||
19411166|NCT02317627|41656533|FG002|Overall Study|Stopped by Investigator|0|||
19411167|NCT02317627|41656531|FG000|Overall Study|Adverse Event|0|||
19411168|NCT02317627|41656532|FG001|Overall Study|Adverse Event|2|||
19411169|NCT02317627|41656533|FG002|Overall Study|Adverse Event|3|||
19411170|NCT02317627|41656531|FG000|Overall Study|Non-compliance with study drug|0|||
19411171|NCT02317627|41656532|FG001|Overall Study|Non-compliance with study drug|1|||
19411172|NCT02317627|41656533|FG002|Overall Study|Non-compliance with study drug|0|||
19411173|NCT02517905|41656549|FG000|Overall Study|Lost to Follow-up|4|||
19411174|NCT02517905|41656550|FG001|Overall Study|Lost to Follow-up|0|||
19411175|NCT02517905|41656549|FG000|Overall Study|Withdrawal by Subject|4|||
19411176|NCT02517905|41656550|FG001|Overall Study|Withdrawal by Subject|0|||
19411177|NCT02517905|41656549|FG000|Overall Study|Screen failure|2|||
19411178|NCT02517905|41656550|FG001|Overall Study|Screen failure|2|||
19411179|NCT02473913|41656558|FG000|Overall Study|Lost to Follow-up|3|||
19411180|NCT02473913|41656559|FG001|Overall Study|Lost to Follow-up|3|||
19411181|NCT02316847|41656567|FG000|Overall Study|Adverse Event|0|||
19411182|NCT02316847|41656568|FG001|Overall Study|Adverse Event|3|||
19411183|NCT02316847|41656567|FG000|Overall Study|Lost to Follow-up|0|||
19411184|NCT02316847|41656568|FG001|Overall Study|Lost to Follow-up|2|||
19411185|NCT02316847|41656567|FG000|Overall Study|Physician Decision|0|||
19411186|NCT02316847|41656568|FG001|Overall Study|Physician Decision|1|||
19411187|NCT02316847|41656567|FG000|Overall Study|Pregnancy|0|||
19411188|NCT02316847|41656568|FG001|Overall Study|Pregnancy|1|||
19411189|NCT02316847|41656567|FG000|Overall Study|Withdrawal by Subject|2|||
19411190|NCT02316847|41656568|FG001|Overall Study|Withdrawal by Subject|9|||
19411191|NCT02316847|41656567|FG000|Overall Study|Noncompliance with study drug|0|||
19411192|NCT02316847|41656568|FG001|Overall Study|Noncompliance with study drug|3|||
19411193|NCT02316847|41656567|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
19411194|NCT02316847|41656568|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
19411195|NCT02473523|41656576|FG000|Overall Study|Death|1|||
19411196|NCT02473523|41656576|FG000|Overall Study|Lost to Follow-up|1|||
19411197|NCT02316769|41656582|FG000|Overall Study|Physician Decision|1|||
19628090|NCT00589914|42077496|FG000|Overall Study|Lack of Efficacy|40|||
19628091|NCT00589914|42077497|FG001|Overall Study|Lack of Efficacy|43|||
19411198|NCT02316769|41656583|FG001|Overall Study|Physician Decision|0|||
19411199|NCT02316769|41656582|FG000|Overall Study|Withdrawal by Subject|1|||
19411200|NCT02316769|41656583|FG001|Overall Study|Withdrawal by Subject|0|||
19411201|NCT02473445|41656589|FG000|Overall Study|Withdrawal by Subject|2|||
19411202|NCT02473445|41656589|FG000|Overall Study|Sponsor Decision|20|||
19411203|NCT02473367|41656593|FG000|Wait 1|Withdrawal by Subject|1|||
19411204|NCT02473367|41656593|FG000|Period 4|Lost to Follow-up|1|||
19411205|NCT02316613|41656603|FG000|Overall Study|Death|63|||
19411206|NCT02316613|41656603|FG000|Overall Study|Lost to Follow-up|9|||
19411207|NCT02316613|41656603|FG000|Overall Study|Lymphoma transformation|2|||
19411208|NCT02316613|41656603|FG000|Overall Study|Participant moved/changed medical team|11|||
19411209|NCT02316613|41656603|FG000|Overall Study|No data and duplicate cases|5|||
19411210|NCT02316613|41656603|FG000|Overall Study|Did not met selection criteria|14|||
19411211|NCT02492165|41656622|FG000|Overall Study|Withdrawal by Subject|0|||
19411212|NCT02492165|41656623|FG001|Overall Study|Withdrawal by Subject|1|||
19411213|NCT02492165|41656624|FG002|Overall Study|Withdrawal by Subject|0|||
19411214|NCT02492165|41656625|FG003|Overall Study|Withdrawal by Subject|0|||
19411215|NCT02355691|41656637|FG000|Overall Study|Loss of Research Personnel|7|||
19411216|NCT02355691|41656638|FG001|Overall Study|Loss of Research Personnel|9|||
19411217|NCT02473289|41656646|FG000|Overall Study|Adverse Event|2|||
19411218|NCT02473289|41656647|FG001|Overall Study|Adverse Event|3|||
19411219|NCT02473289|41656646|FG000|Overall Study|Lost to Follow-up|1|||
19411220|NCT02473289|41656647|FG001|Overall Study|Lost to Follow-up|1|||
19411221|NCT02473289|41656646|FG000|Overall Study|Protocol Violation|0|||
19411222|NCT02473289|41656647|FG001|Overall Study|Protocol Violation|1|||
19411223|NCT02473289|41656646|FG000|Overall Study|Withdrawal of consent|6|||
19411224|NCT02473289|41656647|FG001|Overall Study|Withdrawal of consent|7|||
19411225|NCT02473289|41656646|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
19411226|NCT02473289|41656647|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
19411227|NCT02473289|41656646|FG000|Overall Study|Other|2|||
19411228|NCT02473289|41656647|FG001|Overall Study|Other|0|||
19411229|NCT02354599|41656659|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19411230|NCT02354599|41656660|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
19411231|NCT02354599|41656661|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19411232|NCT02354599|41656662|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
19411233|NCT02354599|41656663|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
19411234|NCT02354599|41656664|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
19411235|NCT02354599|41656659|FG000|Overall Study|Withdrawal by Subject|1|||
19411236|NCT02354599|41656660|FG001|Overall Study|Withdrawal by Subject|1|||
19411237|NCT02354599|41656661|FG002|Overall Study|Withdrawal by Subject|0|||
19411238|NCT02354599|41656662|FG003|Overall Study|Withdrawal by Subject|0|||
19411239|NCT02354599|41656663|FG004|Overall Study|Withdrawal by Subject|0|||
19411240|NCT02354599|41656664|FG005|Overall Study|Withdrawal by Subject|0|||
19411241|NCT02316223|41656687|FG000|Overall Study|Lack of Efficacy|0|||
19411242|NCT02316223|41656688|FG001|Overall Study|Lack of Efficacy|1|||
19411243|NCT02316223|41656689|FG002|Overall Study|Lack of Efficacy|1|||
19411244|NCT02316223|41656687|FG000|Overall Study|Lost to Follow-up|27|||
19411245|NCT02316223|41656688|FG001|Overall Study|Lost to Follow-up|34|||
19411246|NCT02316223|41656689|FG002|Overall Study|Lost to Follow-up|36|||
19411247|NCT02316223|41656687|FG000|Overall Study|COPD Diagnosis|3|||
19411248|NCT02316223|41656688|FG001|Overall Study|COPD Diagnosis|2|||
19411249|NCT02316223|41656689|FG002|Overall Study|COPD Diagnosis|3|||
19411250|NCT02316223|41656687|FG000|Overall Study|Reside outside study area|1|||
19411251|NCT02316223|41656688|FG001|Overall Study|Reside outside study area|1|||
19411252|NCT02316223|41656689|FG002|Overall Study|Reside outside study area|1|||
19411253|NCT02316223|41656687|FG000|Overall Study|No asthma|2|||
19411254|NCT02316223|41656688|FG001|Overall Study|No asthma|0|||
19411255|NCT02316223|41656689|FG002|Overall Study|No asthma|0|||
19411256|NCT02316223|41656687|FG000|Overall Study|Discontinued by PI|11|||
19411257|NCT02316223|41656688|FG001|Overall Study|Discontinued by PI|19|||
19411258|NCT02316223|41656689|FG002|Overall Study|Discontinued by PI|3|||
19411259|NCT02286895|41656699|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
19411260|NCT02286895|41656700|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
19411261|NCT02286895|41656699|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
19411262|NCT02286895|41656700|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
19411263|NCT02286895|41656699|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
19411264|NCT02286895|41656700|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
19411265|NCT02472977|41656709|FG000|Overall Study|Disease progression|4|||
19411266|NCT02472977|41656710|FG001|Overall Study|Disease progression|25|||
19411267|NCT02472977|41656711|FG002|Overall Study|Disease progression|6|||
19411268|NCT02472977|41656709|FG000|Overall Study|Withdrawal by Subject|0|||
19411269|NCT02472977|41656710|FG001|Overall Study|Withdrawal by Subject|1|||
19411270|NCT02472977|41656711|FG002|Overall Study|Withdrawal by Subject|0|||
19411271|NCT02472977|41656709|FG000|Overall Study|Study drug toxicity|2|||
19411272|NCT02472977|41656710|FG001|Overall Study|Study drug toxicity|0|||
19411273|NCT02472977|41656711|FG002|Overall Study|Study drug toxicity|2|||
19411274|NCT02472977|41656709|FG000|Overall Study|Subject request to discontinue treatment|0|||
19411275|NCT02472977|41656710|FG001|Overall Study|Subject request to discontinue treatment|1|||
19411276|NCT02472977|41656711|FG002|Overall Study|Subject request to discontinue treatment|0|||
19411277|NCT02060487|41656722|FG000|Overall Study|Other|1|||
19411278|NCT02060487|41656723|FG001|Overall Study|Other|2|||
19411279|NCT02060487|41656724|FG002|Overall Study|Other|1|||
19411280|NCT02060487|41656722|FG000|Overall Study|Lack of Efficacy|0|||
19411281|NCT02060487|41656723|FG001|Overall Study|Lack of Efficacy|1|||
19411282|NCT02060487|41656724|FG002|Overall Study|Lack of Efficacy|0|||
19411283|NCT02060487|41656722|FG000|Overall Study|Withdrawal by Subject|3|||
19411284|NCT02060487|41656723|FG001|Overall Study|Withdrawal by Subject|10|||
19411285|NCT02060487|41656724|FG002|Overall Study|Withdrawal by Subject|4|||
19411286|NCT02060487|41656722|FG000|Overall Study|Study Terminated By Sponsor|87|||
19411287|NCT02060487|41656723|FG001|Overall Study|Study Terminated By Sponsor|89|||
19411288|NCT02060487|41656724|FG002|Overall Study|Study Terminated By Sponsor|100|||
19411289|NCT02060487|41656722|FG000|Overall Study|Randomized in error|1|||
19411290|NCT02060487|41656723|FG001|Overall Study|Randomized in error|0|||
19411291|NCT02060487|41656724|FG002|Overall Study|Randomized in error|0|||
19518979|NCT01453296|41932096|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19518980|NCT01453296|41932097|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19518981|NCT01453140|41932103|FG000|Overall Study|Adverse Event|3|||
19518982|NCT01499940|41932111|FG000|Overall Study|Study was withdrawn before completion.|9|||
19518983|NCT01499160|41932115|FG000|Overall Study|Adverse Event|1|||
19518984|NCT01499160|41932115|FG000|Overall Study|Withdrawal by Subject|1|||
19518985|NCT01498692|41932120|FG000|Overall Study|Death|4|||
19518986|NCT01498692|41932120|FG000|Overall Study|Withdrawal by Subject|1|||
19518987|NCT01498692|41932120|FG000|Overall Study|Missed 12-month visit|3|||
19518988|NCT01498068|41932126|FG000|Overall Study|Withdrawal by Subject|1|||
19518989|NCT01498068|41932127|FG001|Overall Study|Withdrawal by Subject|1|||
19518990|NCT01497366|41932135|FG000|Overall Study|Virologic failure|2|||
19518991|NCT01497366|41932136|FG001|Overall Study|Virologic failure|50|||
19518992|NCT01497366|41932135|FG000|Overall Study|Lost to Follow-up|11|||
19518993|NCT01497366|41932136|FG001|Overall Study|Lost to Follow-up|10|||
19518994|NCT01497366|41932135|FG000|Overall Study|Withdrawal by Subject|6|||
19411292|NCT02060487|41656722|FG000|Overall Study|Protocol Violation|0|||
19518995|NCT01497366|41932136|FG001|Overall Study|Withdrawal by Subject|6|||
19518996|NCT01497366|41932135|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
19518997|NCT01497366|41932136|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
19518998|NCT01497366|41932135|FG000|Overall Study|Other|5|||
19518999|NCT01497366|41932136|FG001|Overall Study|Other|0|||
19519000|NCT01497366|41932135|FG000|Overall Study|Death|1|||
19519001|NCT01497366|41932136|FG001|Overall Study|Death|1|||
19519002|NCT01497366|41932135|FG000|Overall Study|Randomized but not treated|7|||
19519003|NCT01497366|41932136|FG001|Overall Study|Randomized but not treated|21|||
19519004|NCT01496976|41932143|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
19519005|NCT01475838|41932149|FG000|Randomized Phase|Randomized but Not Treated|0|||
19519006|NCT01475838|41932150|FG001|Randomized Phase|Randomized but Not Treated|5|||
19519007|NCT01475838|41932149|FG000|Randomized Phase|Adverse Event|6|||
19519008|NCT01475838|41932150|FG001|Randomized Phase|Adverse Event|1|||
19519009|NCT01475838|41932149|FG000|Randomized Phase|Pregnancy|0|||
19519010|NCT01475838|41932150|FG001|Randomized Phase|Pregnancy|1|||
19411293|NCT02060487|41656723|FG001|Overall Study|Protocol Violation|1|||
19411294|NCT02060487|41656724|FG002|Overall Study|Protocol Violation|1|||
19411295|NCT02060487|41656722|FG000|Overall Study|Lost to Follow-up|3|||
19411296|NCT02060487|41656723|FG001|Overall Study|Lost to Follow-up|0|||
19411297|NCT02060487|41656724|FG002|Overall Study|Lost to Follow-up|2|||
19411298|NCT02060487|41656722|FG000|Overall Study|Death|34|||
19411299|NCT02060487|41656723|FG001|Overall Study|Death|25|||
19411300|NCT02060487|41656724|FG002|Overall Study|Death|19|||
19411301|NCT02060487|41656722|FG000|Overall Study|Adverse Event|0|||
19411302|NCT02060487|41656723|FG001|Overall Study|Adverse Event|0|||
19411303|NCT02060487|41656724|FG002|Overall Study|Adverse Event|1|||
19411304|NCT02059395|41656734|FG000|Overall Study|Lost to Follow-up|2|||
19411305|NCT02059395|41656735|FG001|Overall Study|Lost to Follow-up|4|||
19411306|NCT02059239|41656743|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
19411307|NCT02059239|41656744|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
19411308|NCT02059239|41656743|FG000|Overall Study|Physician Decision|1|||
19411309|NCT02059239|41656744|FG001|Overall Study|Physician Decision|0|||
19411310|NCT02059161|41656753|FG000|Overall Study|Pregnancy|0|||
19411311|NCT02059161|41656754|FG001|Overall Study|Pregnancy|2|||
19411312|NCT02059161|41656753|FG000|Overall Study|Adverse Event|2|||
19519011|NCT01475838|41932149|FG000|Randomized Phase|Investigators Discretion|1|||
19519012|NCT01475838|41932150|FG001|Randomized Phase|Investigators Discretion|2|||
19519013|NCT01475838|41932149|FG000|Randomized Phase|Withdrew Consent|10|||
19411313|NCT02059161|41656754|FG001|Overall Study|Adverse Event|6|||
19411314|NCT02059161|41656753|FG000|Overall Study|Lost to Follow-up|20|||
19411315|NCT02059161|41656754|FG001|Overall Study|Lost to Follow-up|12|||
19411316|NCT02059161|41656753|FG000|Overall Study|Physician Decision|4|||
19411317|NCT02059161|41656754|FG001|Overall Study|Physician Decision|4|||
19411318|NCT02059161|41656753|FG000|Overall Study|Protocol Violation|1|||
19519014|NCT01475838|41932150|FG001|Randomized Phase|Withdrew Consent|14|||
19519015|NCT01475838|41932149|FG000|Randomized Phase|Lost to Follow-up|3|||
19411319|NCT02059161|41656754|FG001|Overall Study|Protocol Violation|1|||
19411320|NCT02059161|41656753|FG000|Overall Study|Withdrawal by Subject|16|||
19411321|NCT02059161|41656754|FG001|Overall Study|Withdrawal by Subject|13|||
19411322|NCT02059161|41656753|FG000|Overall Study|Randomized in error, no study drug|0|||
19411323|NCT02059161|41656754|FG001|Overall Study|Randomized in error, no study drug|1|||
19411324|NCT02059161|41656753|FG000|Overall Study|Non-compliance with study drug|6|||
19411325|NCT02059161|41656754|FG001|Overall Study|Non-compliance with study drug|2|||
19411326|NCT01897714|41656766|FG000|Phase I (Dose Escalation)|Disease progression|3|||
19411327|NCT01897714|41656767|FG001|Phase I (Dose Escalation)|Disease progression|5|||
19411328|NCT01897714|41656768|FG002|Phase I (Dose Escalation)|Disease progression|1|||
19411329|NCT01897714|41656769|FG003|Phase I (Dose Escalation)|Disease progression|3|||
19411330|NCT01897714|41656770|FG004|Phase I (Dose Escalation)|Disease progression|0|||
19411331|NCT01897714|41656771|FG005|Phase I (Dose Escalation)|Disease progression|0|||
19411332|NCT01897714|41656766|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
19411333|NCT01897714|41656767|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
19411334|NCT01897714|41656768|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
19411335|NCT01897714|41656769|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
19411336|NCT01897714|41656770|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
19411337|NCT01897714|41656771|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
19411338|NCT01897714|41656766|FG000|Phase I (Dose Escalation)|Other|0|||
19411339|NCT01897714|41656767|FG001|Phase I (Dose Escalation)|Other|1|||
19411340|NCT01897714|41656768|FG002|Phase I (Dose Escalation)|Other|0|||
19411341|NCT01897714|41656769|FG003|Phase I (Dose Escalation)|Other|0|||
19411342|NCT01897714|41656770|FG004|Phase I (Dose Escalation)|Other|0|||
19411343|NCT01897714|41656771|FG005|Phase I (Dose Escalation)|Other|0|||
19411344|NCT01897714|41656766|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
19411345|NCT01897714|41656767|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
19411346|NCT01897714|41656768|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
19411347|NCT01897714|41656769|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
19411348|NCT01897714|41656770|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
19411349|NCT01897714|41656771|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
19411350|NCT01897714|41656766|FG000|Phase II (MTD)|Lost to Follow-up|0|||
19411351|NCT01897714|41656767|FG001|Phase II (MTD)|Lost to Follow-up|0|||
19411352|NCT01897714|41656768|FG002|Phase II (MTD)|Lost to Follow-up|0|||
19411353|NCT01897714|41656769|FG003|Phase II (MTD)|Lost to Follow-up|0|||
19411354|NCT01897714|41656770|FG004|Phase II (MTD)|Lost to Follow-up|1|||
19411355|NCT01897714|41656771|FG005|Phase II (MTD)|Lost to Follow-up|0|||
19411356|NCT01897714|41656766|FG000|Phase II (MTD)|Death|0|||
19411357|NCT01897714|41656767|FG001|Phase II (MTD)|Death|0|||
19411358|NCT01897714|41656768|FG002|Phase II (MTD)|Death|0|||
19411359|NCT01897714|41656769|FG003|Phase II (MTD)|Death|0|||
19411360|NCT01897714|41656770|FG004|Phase II (MTD)|Death|25|||
19411361|NCT01897714|41656771|FG005|Phase II (MTD)|Death|10|||
19411362|NCT01897714|41656766|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
19411363|NCT01897714|41656767|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
19411364|NCT01897714|41656768|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
19411365|NCT01897714|41656769|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
19411366|NCT01897714|41656770|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
19411367|NCT01897714|41656771|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
19411368|NCT01897714|41656766|FG000|Phase II (MTD)|Other|0|||
19411369|NCT01897714|41656767|FG001|Phase II (MTD)|Other|0|||
19411370|NCT01897714|41656768|FG002|Phase II (MTD)|Other|0|||
19411371|NCT01897714|41656769|FG003|Phase II (MTD)|Other|0|||
19411372|NCT01897714|41656770|FG004|Phase II (MTD)|Other|3|||
19411373|NCT01897714|41656771|FG005|Phase II (MTD)|Other|0|||
19411374|NCT01861522|41656789|FG000|Overall Study|Adverse Event|1|||
19411375|NCT01861522|41656790|FG001|Overall Study|Adverse Event|0|||
19411376|NCT01861522|41656789|FG000|Overall Study|Withdrawal by Subject|2|||
19411377|NCT01861522|41656790|FG001|Overall Study|Withdrawal by Subject|0|||
19411378|NCT01860976|41656798|FG000|Blinded Treatment|Adverse Event|1|||
19411379|NCT01860976|41656799|FG001|Blinded Treatment|Adverse Event|3|||
19411380|NCT01860976|41656798|FG000|Blinded Treatment|Lack of Efficacy|5|||
19411381|NCT01860976|41656799|FG001|Blinded Treatment|Lack of Efficacy|12|||
19411382|NCT01860976|41656798|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
19411383|NCT01860976|41656799|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
19411384|NCT01860976|41656798|FG000|Blinded Treatment|Withdrawal by Subject|3|||
19411385|NCT01860976|41656799|FG001|Blinded Treatment|Withdrawal by Subject|5|||
19411386|NCT01860976|41656798|FG000|Blinded Treatment|Subject no longer met criteria|1|||
19411387|NCT01860976|41656799|FG001|Blinded Treatment|Subject no longer met criteria|0|||
19411388|NCT01860976|41656798|FG000|Blinded Treatment|Entered Open-Label in error|0|||
19411389|NCT01860976|41656799|FG001|Blinded Treatment|Entered Open-Label in error|1|||
19411390|NCT01860976|41656798|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
19411391|NCT01860976|41656799|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
19411392|NCT01860976|41656798|FG000|Open-Label|Adverse Event|2|||
19411393|NCT01860976|41656799|FG001|Open-Label|Adverse Event|4|||
19411394|NCT01860976|41656798|FG000|Open-Label|Lack of Efficacy|16|||
19411395|NCT01860976|41656799|FG001|Open-Label|Lack of Efficacy|8|||
19411396|NCT01860976|41656798|FG000|Open-Label|Lost to Follow-up|1|||
19411397|NCT01860976|41656799|FG001|Open-Label|Lost to Follow-up|2|||
19411398|NCT01860976|41656798|FG000|Open-Label|Subject request discontinue treatment|4|||
19411399|NCT01860976|41656799|FG001|Open-Label|Subject request discontinue treatment|3|||
19411400|NCT01860976|41656798|FG000|Open-Label|Withdrawal by Subject|4|||
19411401|NCT01860976|41656799|FG001|Open-Label|Withdrawal by Subject|1|||
19411402|NCT01860976|41656798|FG000|Open-Label|Other Reasons|1|||
19411403|NCT01860976|41656799|FG001|Open-Label|Other Reasons|1|||
19411404|NCT01860976|41656798|FG000|Long Term Extension|Adverse Event|4|||
19411405|NCT01860976|41656799|FG001|Long Term Extension|Adverse Event|0|||
19411406|NCT01860976|41656798|FG000|Long Term Extension|Lack of Efficacy|2|||
19411407|NCT01860976|41656799|FG001|Long Term Extension|Lack of Efficacy|0|||
19411408|NCT01860976|41656798|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
19411409|NCT01860976|41656799|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
19411410|NCT01860976|41656798|FG000|Long Term Extension|Lost to Follow-up|2|||
19411411|NCT01860976|41656799|FG001|Long Term Extension|Lost to Follow-up|0|||
19411412|NCT01860976|41656798|FG000|Long Term Extension|subject withdrew consent|7|||
19411413|NCT01860976|41656799|FG001|Long Term Extension|subject withdrew consent|0|||
19411414|NCT01860040|41656810|FG000|Overall Study|Withdrawal by Subject|1|||
19411415|NCT01860040|41656811|FG001|Overall Study|Withdrawal by Subject|0|||
19411416|NCT01896934|41656816|FG000|Overall Study|Adverse Event|1|||
19411417|NCT01896934|41656816|FG000|Overall Study|Withdrawal by Subject|1|||
19411418|NCT02039505|41656823|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
19411419|NCT02039505|41656824|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
19411420|NCT02039505|41656825|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
19411421|NCT02039505|41656826|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
19411422|NCT02039505|41656827|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
19411423|NCT02039505|41656828|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
19411424|NCT02039505|41656829|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
19411425|NCT02039505|41656823|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
19411426|NCT02039505|41656824|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
19411427|NCT02039505|41656825|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
19411428|NCT02039505|41656826|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
19411429|NCT02039505|41656827|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
19411430|NCT02039505|41656828|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
19411431|NCT02039505|41656829|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
19411432|NCT02039505|41656823|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
19411433|NCT02039505|41656824|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411434|NCT02039505|41656825|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411435|NCT02039505|41656826|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411436|NCT02039505|41656827|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411437|NCT02039505|41656828|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411438|NCT02039505|41656829|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
19411439|NCT02039505|41656823|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
19411440|NCT02039505|41656824|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
19411441|NCT02039505|41656825|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
19411442|NCT02039505|41656826|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
19411443|NCT02039505|41656827|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
19411444|NCT02039505|41656828|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
19411445|NCT02039505|41656829|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
19411446|NCT02039505|41656823|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
19411447|NCT02039505|41656824|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
19411448|NCT02039505|41656825|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
19411449|NCT02039505|41656826|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
19411450|NCT02039505|41656827|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
19411451|NCT02039505|41656828|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
19411452|NCT02039505|41656829|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
19411453|NCT02039505|41656823|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
19411454|NCT02039505|41656824|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
19411455|NCT02039505|41656825|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
19411456|NCT02039505|41656826|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
19411457|NCT02039505|41656827|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
19411458|NCT02039505|41656828|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
19411459|NCT02039505|41656829|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
19411460|NCT02039505|41656823|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411461|NCT02039505|41656824|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411462|NCT02039505|41656825|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411463|NCT02039505|41656826|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
19411464|NCT02039505|41656827|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411465|NCT02039505|41656828|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411466|NCT02039505|41656829|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
19411467|NCT02039505|41656823|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411468|NCT02039505|41656824|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411469|NCT02039505|41656825|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411470|NCT02039505|41656826|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411471|NCT02039505|41656827|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411472|NCT02039505|41656828|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
19411473|NCT02039505|41656829|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
19411474|NCT02039505|41656823|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411475|NCT02039505|41656824|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411476|NCT02039505|41656825|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411477|NCT02039505|41656826|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411478|NCT02039505|41656827|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411479|NCT02039505|41656828|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
19411480|NCT02039505|41656829|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
19411481|NCT02039505|41656823|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411482|NCT02039505|41656824|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411483|NCT02039505|41656825|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411484|NCT02039505|41656826|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411485|NCT02039505|41656827|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411486|NCT02039505|41656828|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
19411487|NCT02039505|41656829|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
19411488|NCT02039505|41656823|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411489|NCT02039505|41656824|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411490|NCT02039505|41656825|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411491|NCT02039505|41656826|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411492|NCT02039505|41656827|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411493|NCT02039505|41656828|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
19411494|NCT02039505|41656829|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
19411495|NCT02095197|41656851|FG000|Overall Study|Lost to Follow-up|0|||
19411496|NCT02095197|41656852|FG001|Overall Study|Lost to Follow-up|3|||
19411497|NCT02039427|41656862|FG000|Overall Study|Duration of surgery > 3h|1|||
19411498|NCT02039427|41656863|FG001|Overall Study|Duration of surgery > 3h|1|||
19411499|NCT02039427|41656864|FG002|Overall Study|Duration of surgery > 3h|0|||
19411500|NCT02039427|41656865|FG003|Overall Study|Duration of surgery > 3h|0|||
19411501|NCT02039427|41656862|FG000|Overall Study|Withdrawal on concent|0|||
19411502|NCT02039427|41656863|FG001|Overall Study|Withdrawal on concent|0|||
19411503|NCT02039427|41656864|FG002|Overall Study|Withdrawal on concent|0|||
19411504|NCT02039427|41656865|FG003|Overall Study|Withdrawal on concent|1|||
19411505|NCT02039427|41656862|FG000|Overall Study|Cancellation of surgery|0|||
19411506|NCT02039427|41656863|FG001|Overall Study|Cancellation of surgery|0|||
19411507|NCT02039427|41656864|FG002|Overall Study|Cancellation of surgery|1|||
19411508|NCT02039427|41656865|FG003|Overall Study|Cancellation of surgery|0|||
19411509|NCT02039427|41656862|FG000|Overall Study|Loss of follow - up|1|||
19411510|NCT02039427|41656863|FG001|Overall Study|Loss of follow - up|0|||
19411511|NCT02039427|41656864|FG002|Overall Study|Loss of follow - up|2|||
19411512|NCT02039427|41656865|FG003|Overall Study|Loss of follow - up|4|||
19411513|NCT02039427|41656862|FG000|Overall Study|Steroid Use|1|||
19411514|NCT02039427|41656863|FG001|Overall Study|Steroid Use|0|||
19411515|NCT02039427|41656864|FG002|Overall Study|Steroid Use|0|||
19411516|NCT02039427|41656865|FG003|Overall Study|Steroid Use|0|||
19411517|NCT02094885|41656881|FG000|Overall Study|Death|1|||
19411518|NCT02094885|41656882|FG001|Overall Study|Death|5|||
19411519|NCT02094885|41656881|FG000|Overall Study|Withdrawn due to age|1|||
19411520|NCT02094885|41656882|FG001|Overall Study|Withdrawn due to age|0|||
19411521|NCT01896856|41656894|FG000|Overall Study|Transportation issues / Non-compliance|0|||
19411522|NCT01896856|41656895|FG001|Overall Study|Transportation issues / Non-compliance|0|||
19411523|NCT01896856|41656896|FG002|Overall Study|Transportation issues / Non-compliance|1|||
19411524|NCT01896856|41656897|FG003|Overall Study|Transportation issues / Non-compliance|0|||
19411525|NCT01896856|41656898|FG004|Overall Study|Transportation issues / Non-compliance|0|||
19411526|NCT01896856|41656899|FG005|Overall Study|Transportation issues / Non-compliance|0|||
19411527|NCT02038959|41656916|FG000|Overall Study|Withdrawal by Subject|6|||
19411528|NCT02038959|41656917|FG001|Overall Study|Withdrawal by Subject|8|||
19411529|NCT01896700|41656925|FG000|Overall Study|Adverse Event|4|||
19411530|NCT01896700|41656926|FG001|Overall Study|Adverse Event|5|||
19411531|NCT01896700|41656925|FG000|Overall Study|Withdrawal by Subject|0|||
19411532|NCT01896700|41656926|FG001|Overall Study|Withdrawal by Subject|1|||
19411533|NCT02352493|41656950|FG000|Overall Study|Pregnancy|0|||
19411534|NCT02352493|41656951|FG001|Overall Study|Pregnancy|0|||
19411535|NCT02352493|41656952|FG002|Overall Study|Pregnancy|0|||
19411536|NCT02352493|41656953|FG003|Overall Study|Pregnancy|0|||
19411537|NCT02352493|41656954|FG004|Overall Study|Pregnancy|0|||
19411538|NCT02352493|41656955|FG005|Overall Study|Pregnancy|0|||
19411539|NCT02352493|41656956|FG006|Overall Study|Pregnancy|1|||
19411540|NCT02352493|41656957|FG007|Overall Study|Pregnancy|0|||
19411541|NCT02352493|41656958|FG008|Overall Study|Pregnancy|1|||
19411542|NCT02352493|41656959|FG009|Overall Study|Pregnancy|0|||
19411543|NCT02352493|41656960|FG010|Overall Study|Pregnancy|0|||
19411544|NCT02352493|41656961|FG011|Overall Study|Pregnancy|0|||
19411545|NCT02352493|41656962|FG012|Overall Study|Pregnancy|0|||
19411546|NCT02352493|41656963|FG013|Overall Study|Pregnancy|0|||
19411547|NCT02352493|41656964|FG014|Overall Study|Pregnancy|0|||
19411548|NCT02352493|41656965|FG015|Overall Study|Pregnancy|0|||
19411549|NCT02352493|41656966|FG016|Overall Study|Pregnancy|0|||
19411550|NCT02352493|41656967|FG017|Overall Study|Pregnancy|0|||
19411551|NCT02352493|41656950|FG000|Overall Study|Withdrawal by Subject|0|||
19411552|NCT02352493|41656951|FG001|Overall Study|Withdrawal by Subject|0|||
19411553|NCT02352493|41656952|FG002|Overall Study|Withdrawal by Subject|0|||
19411554|NCT02352493|41656953|FG003|Overall Study|Withdrawal by Subject|0|||
19411555|NCT02352493|41656954|FG004|Overall Study|Withdrawal by Subject|0|||
19411556|NCT02352493|41656955|FG005|Overall Study|Withdrawal by Subject|0|||
19411557|NCT02352493|41656956|FG006|Overall Study|Withdrawal by Subject|0|||
19411558|NCT02352493|41656957|FG007|Overall Study|Withdrawal by Subject|0|||
19411559|NCT02352493|41656958|FG008|Overall Study|Withdrawal by Subject|1|||
19411560|NCT02352493|41656959|FG009|Overall Study|Withdrawal by Subject|0|||
19411561|NCT02352493|41656960|FG010|Overall Study|Withdrawal by Subject|0|||
19411562|NCT02352493|41656961|FG011|Overall Study|Withdrawal by Subject|0|||
19411563|NCT02352493|41656962|FG012|Overall Study|Withdrawal by Subject|0|||
19411564|NCT02352493|41656963|FG013|Overall Study|Withdrawal by Subject|0|||
19411565|NCT02352493|41656964|FG014|Overall Study|Withdrawal by Subject|1|||
19411566|NCT02352493|41656965|FG015|Overall Study|Withdrawal by Subject|0|||
19411567|NCT02352493|41656966|FG016|Overall Study|Withdrawal by Subject|0|||
19411568|NCT02352493|41656967|FG017|Overall Study|Withdrawal by Subject|0|||
19411569|NCT02352493|41656950|FG000|Overall Study|Lost to Follow-up|0|||
19411570|NCT02352493|41656951|FG001|Overall Study|Lost to Follow-up|0|||
19411571|NCT02352493|41656952|FG002|Overall Study|Lost to Follow-up|0|||
19411572|NCT02352493|41656953|FG003|Overall Study|Lost to Follow-up|0|||
19411573|NCT02352493|41656954|FG004|Overall Study|Lost to Follow-up|0|||
19411574|NCT02352493|41656955|FG005|Overall Study|Lost to Follow-up|0|||
19411575|NCT02352493|41656956|FG006|Overall Study|Lost to Follow-up|0|||
19411576|NCT02352493|41656957|FG007|Overall Study|Lost to Follow-up|0|||
19411577|NCT02352493|41656958|FG008|Overall Study|Lost to Follow-up|0|||
19411578|NCT02352493|41656959|FG009|Overall Study|Lost to Follow-up|1|||
19411579|NCT02352493|41656960|FG010|Overall Study|Lost to Follow-up|0|||
19411580|NCT02352493|41656961|FG011|Overall Study|Lost to Follow-up|0|||
19411581|NCT02352493|41656962|FG012|Overall Study|Lost to Follow-up|1|||
19411582|NCT02352493|41656963|FG013|Overall Study|Lost to Follow-up|2|||
19411583|NCT02352493|41656964|FG014|Overall Study|Lost to Follow-up|0|||
19411584|NCT02352493|41656965|FG015|Overall Study|Lost to Follow-up|0|||
19411585|NCT02352493|41656966|FG016|Overall Study|Lost to Follow-up|0|||
19411586|NCT02352493|41656967|FG017|Overall Study|Lost to Follow-up|0|||
19411587|NCT02286193|41657022|FG000|Overall Study|Referred: CRS unable to make contact|62|||
19411588|NCT02286193|41657022|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
19411589|NCT02286193|41657022|FG000|Overall Study|Referred: Declined service|38|||
19411590|NCT01896232|41657029|FG000|Overall Study|Death|6|||
19411591|NCT01896232|41657030|FG001|Overall Study|Death|10|||
19411592|NCT01896232|41657029|FG000|Overall Study|Withdrawal by Subject|32|||
19519016|NCT01475838|41932150|FG001|Randomized Phase|Lost to Follow-up|4|||
19411593|NCT01896232|41657030|FG001|Overall Study|Withdrawal by Subject|31|||
19411594|NCT01896232|41657029|FG000|Overall Study|Sponsor Decision|2|||
19411595|NCT01896232|41657030|FG001|Overall Study|Sponsor Decision|0|||
19411596|NCT01896232|41657029|FG000|Overall Study|Lost to Follow-up|9|||
19411597|NCT01896232|41657030|FG001|Overall Study|Lost to Follow-up|12|||
19411598|NCT02460224|41657065|FG000|Overall Study|Adverse Event|0|||
19411599|NCT02460224|41657066|FG001|Overall Study|Adverse Event|0|||
19411600|NCT02460224|41657067|FG002|Overall Study|Adverse Event|0|||
19411601|NCT02460224|41657068|FG003|Overall Study|Adverse Event|0|||
19411602|NCT02460224|41657069|FG004|Overall Study|Adverse Event|0|||
19411603|NCT02460224|41657070|FG005|Overall Study|Adverse Event|0|||
19411604|NCT02460224|41657071|FG006|Overall Study|Adverse Event|1|||
19411605|NCT02460224|41657072|FG007|Overall Study|Adverse Event|0|||
19411606|NCT02460224|41657073|FG008|Overall Study|Adverse Event|0|||
19411607|NCT02460224|41657074|FG009|Overall Study|Adverse Event|0|||
19411608|NCT02460224|41657075|FG010|Overall Study|Adverse Event|0|||
19411609|NCT02460224|41657076|FG011|Overall Study|Adverse Event|0|||
19411610|NCT02460224|41657077|FG012|Overall Study|Adverse Event|1|||
19411611|NCT02460224|41657078|FG013|Overall Study|Adverse Event|0|||
19411612|NCT02460224|41657079|FG014|Overall Study|Adverse Event|0|||
19411613|NCT02460224|41657080|FG015|Overall Study|Adverse Event|0|||
19411614|NCT02460224|41657081|FG016|Overall Study|Adverse Event|1|||
19411615|NCT02460224|41657082|FG017|Overall Study|Adverse Event|0|||
19411616|NCT02460224|41657083|FG018|Overall Study|Adverse Event|1|||
19411617|NCT02460224|41657084|FG019|Overall Study|Adverse Event|0|||
19411618|NCT02460224|41657085|FG020|Overall Study|Adverse Event|1|||
19411619|NCT02460224|41657086|FG021|Overall Study|Adverse Event|1|||
19411620|NCT02460224|41657087|FG022|Overall Study|Adverse Event|1|||
19411621|NCT02460224|41657088|FG023|Overall Study|Adverse Event|0|||
19411622|NCT02460224|41657089|FG024|Overall Study|Adverse Event|0|||
19411623|NCT02460224|41657090|FG025|Overall Study|Adverse Event|0|||
19411624|NCT02460224|41657091|FG026|Overall Study|Adverse Event|11|||
19411625|NCT02460224|41657092|FG027|Overall Study|Adverse Event|1|||
19411626|NCT02460224|41657093|FG028|Overall Study|Adverse Event|6|||
19411627|NCT02460224|41657065|FG000|Overall Study|Death|0|||
19411628|NCT02460224|41657066|FG001|Overall Study|Death|0|||
19411629|NCT02460224|41657067|FG002|Overall Study|Death|0|||
19411630|NCT02460224|41657068|FG003|Overall Study|Death|0|||
19411631|NCT02460224|41657069|FG004|Overall Study|Death|0|||
19411632|NCT02460224|41657070|FG005|Overall Study|Death|2|||
19411633|NCT02460224|41657071|FG006|Overall Study|Death|1|||
19411634|NCT02460224|41657072|FG007|Overall Study|Death|0|||
19411635|NCT02460224|41657073|FG008|Overall Study|Death|0|||
19411636|NCT02460224|41657074|FG009|Overall Study|Death|1|||
19411637|NCT02460224|41657075|FG010|Overall Study|Death|0|||
19411638|NCT02460224|41657076|FG011|Overall Study|Death|0|||
19411639|NCT02460224|41657077|FG012|Overall Study|Death|0|||
19411640|NCT02460224|41657078|FG013|Overall Study|Death|1|||
19411641|NCT02460224|41657079|FG014|Overall Study|Death|0|||
19411642|NCT02460224|41657080|FG015|Overall Study|Death|0|||
19411643|NCT02460224|41657081|FG016|Overall Study|Death|2|||
19411644|NCT02460224|41657082|FG017|Overall Study|Death|1|||
19411645|NCT02460224|41657083|FG018|Overall Study|Death|0|||
19411646|NCT02460224|41657084|FG019|Overall Study|Death|2|||
19411647|NCT02460224|41657085|FG020|Overall Study|Death|0|||
19411648|NCT02460224|41657086|FG021|Overall Study|Death|0|||
19411649|NCT02460224|41657087|FG022|Overall Study|Death|0|||
19411650|NCT02460224|41657088|FG023|Overall Study|Death|0|||
19411651|NCT02460224|41657089|FG024|Overall Study|Death|1|||
19411652|NCT02460224|41657090|FG025|Overall Study|Death|1|||
19411653|NCT02460224|41657091|FG026|Overall Study|Death|5|||
19411654|NCT02460224|41657092|FG027|Overall Study|Death|0|||
19411655|NCT02460224|41657093|FG028|Overall Study|Death|1|||
19411656|NCT02460224|41657065|FG000|Overall Study|Lost to Follow-up|0|||
19411657|NCT02460224|41657066|FG001|Overall Study|Lost to Follow-up|0|||
19411658|NCT02460224|41657067|FG002|Overall Study|Lost to Follow-up|0|||
19411659|NCT02460224|41657068|FG003|Overall Study|Lost to Follow-up|0|||
19411660|NCT02460224|41657069|FG004|Overall Study|Lost to Follow-up|0|||
19411661|NCT02460224|41657070|FG005|Overall Study|Lost to Follow-up|0|||
19411662|NCT02460224|41657071|FG006|Overall Study|Lost to Follow-up|0|||
19411663|NCT02460224|41657072|FG007|Overall Study|Lost to Follow-up|0|||
19411664|NCT02460224|41657073|FG008|Overall Study|Lost to Follow-up|0|||
19411665|NCT02460224|41657074|FG009|Overall Study|Lost to Follow-up|0|||
19411666|NCT02460224|41657075|FG010|Overall Study|Lost to Follow-up|0|||
19411667|NCT02460224|41657076|FG011|Overall Study|Lost to Follow-up|0|||
19411668|NCT02460224|41657077|FG012|Overall Study|Lost to Follow-up|0|||
19411669|NCT02460224|41657078|FG013|Overall Study|Lost to Follow-up|0|||
19411670|NCT02460224|41657079|FG014|Overall Study|Lost to Follow-up|0|||
19411671|NCT02460224|41657080|FG015|Overall Study|Lost to Follow-up|0|||
19411672|NCT02460224|41657081|FG016|Overall Study|Lost to Follow-up|0|||
19411673|NCT02460224|41657082|FG017|Overall Study|Lost to Follow-up|0|||
19628092|NCT00589914|42077496|FG000|Overall Study|Lost to Follow-up|11|||
19411674|NCT02460224|41657083|FG018|Overall Study|Lost to Follow-up|0|||
19411675|NCT02460224|41657084|FG019|Overall Study|Lost to Follow-up|0|||
19411676|NCT02460224|41657085|FG020|Overall Study|Lost to Follow-up|0|||
19411677|NCT02460224|41657086|FG021|Overall Study|Lost to Follow-up|0|||
19411678|NCT02460224|41657087|FG022|Overall Study|Lost to Follow-up|1|||
19411679|NCT02460224|41657088|FG023|Overall Study|Lost to Follow-up|0|||
19411680|NCT02460224|41657089|FG024|Overall Study|Lost to Follow-up|0|||
19411681|NCT02460224|41657090|FG025|Overall Study|Lost to Follow-up|0|||
19411682|NCT02460224|41657091|FG026|Overall Study|Lost to Follow-up|0|||
19411683|NCT02460224|41657092|FG027|Overall Study|Lost to Follow-up|0|||
19411684|NCT02460224|41657093|FG028|Overall Study|Lost to Follow-up|0|||
19411685|NCT02460224|41657065|FG000|Overall Study|Physician Decision|0|||
19411686|NCT02460224|41657066|FG001|Overall Study|Physician Decision|1|||
19411687|NCT02460224|41657067|FG002|Overall Study|Physician Decision|0|||
19411688|NCT02460224|41657068|FG003|Overall Study|Physician Decision|0|||
19411689|NCT02460224|41657069|FG004|Overall Study|Physician Decision|1|||
19411690|NCT02460224|41657070|FG005|Overall Study|Physician Decision|0|||
19628093|NCT00589914|42077497|FG001|Overall Study|Lost to Follow-up|18|||
19411691|NCT02460224|41657071|FG006|Overall Study|Physician Decision|0|||
19411692|NCT02460224|41657072|FG007|Overall Study|Physician Decision|1|||
19411693|NCT02460224|41657073|FG008|Overall Study|Physician Decision|0|||
19411694|NCT02460224|41657074|FG009|Overall Study|Physician Decision|0|||
19411695|NCT02460224|41657075|FG010|Overall Study|Physician Decision|0|||
19411696|NCT02460224|41657076|FG011|Overall Study|Physician Decision|1|||
19411697|NCT02460224|41657077|FG012|Overall Study|Physician Decision|0|||
19411698|NCT02460224|41657078|FG013|Overall Study|Physician Decision|1|||
19411699|NCT02460224|41657079|FG014|Overall Study|Physician Decision|0|||
19411700|NCT02460224|41657080|FG015|Overall Study|Physician Decision|0|||
19411701|NCT02460224|41657081|FG016|Overall Study|Physician Decision|2|||
19411702|NCT02460224|41657082|FG017|Overall Study|Physician Decision|1|||
19411703|NCT02460224|41657083|FG018|Overall Study|Physician Decision|1|||
19411704|NCT02460224|41657084|FG019|Overall Study|Physician Decision|2|||
19411705|NCT02460224|41657085|FG020|Overall Study|Physician Decision|1|||
19411706|NCT02460224|41657086|FG021|Overall Study|Physician Decision|1|||
19411707|NCT02460224|41657087|FG022|Overall Study|Physician Decision|0|||
19411708|NCT02460224|41657088|FG023|Overall Study|Physician Decision|0|||
19411709|NCT02460224|41657089|FG024|Overall Study|Physician Decision|1|||
19411710|NCT02460224|41657090|FG025|Overall Study|Physician Decision|0|||
19411711|NCT02460224|41657091|FG026|Overall Study|Physician Decision|14|||
19411712|NCT02460224|41657092|FG027|Overall Study|Physician Decision|1|||
19411713|NCT02460224|41657093|FG028|Overall Study|Physician Decision|6|||
19411714|NCT02460224|41657065|FG000|Overall Study|Progressive disease|15|||
19411715|NCT02460224|41657066|FG001|Overall Study|Progressive disease|11|||
19411716|NCT02460224|41657067|FG002|Overall Study|Progressive disease|5|||
19411717|NCT02460224|41657068|FG003|Overall Study|Progressive disease|6|||
19411718|NCT02460224|41657069|FG004|Overall Study|Progressive disease|3|||
19411719|NCT02460224|41657070|FG005|Overall Study|Progressive disease|26|||
19411720|NCT02460224|41657071|FG006|Overall Study|Progressive disease|28|||
19411721|NCT02460224|41657072|FG007|Overall Study|Progressive disease|4|||
19411722|NCT02460224|41657073|FG008|Overall Study|Progressive disease|5|||
19411723|NCT02460224|41657074|FG009|Overall Study|Progressive disease|9|||
19411724|NCT02460224|41657075|FG010|Overall Study|Progressive disease|5|||
19411725|NCT02460224|41657076|FG011|Overall Study|Progressive disease|4|||
19411726|NCT02460224|41657077|FG012|Overall Study|Progressive disease|5|||
19411727|NCT02460224|41657078|FG013|Overall Study|Progressive disease|4|||
19411728|NCT02460224|41657079|FG014|Overall Study|Progressive disease|5|||
19411729|NCT02460224|41657080|FG015|Overall Study|Progressive disease|5|||
19411730|NCT02460224|41657081|FG016|Overall Study|Progressive disease|15|||
19411731|NCT02460224|41657082|FG017|Overall Study|Progressive disease|3|||
19411732|NCT02460224|41657083|FG018|Overall Study|Progressive disease|8|||
19411733|NCT02460224|41657084|FG019|Overall Study|Progressive disease|3|||
19411734|NCT02460224|41657085|FG020|Overall Study|Progressive disease|4|||
19411735|NCT02460224|41657086|FG021|Overall Study|Progressive disease|9|||
19411736|NCT02460224|41657087|FG022|Overall Study|Progressive disease|4|||
19411737|NCT02460224|41657088|FG023|Overall Study|Progressive disease|11|||
19411738|NCT02460224|41657089|FG024|Overall Study|Progressive disease|4|||
19411739|NCT02460224|41657090|FG025|Overall Study|Progressive disease|5|||
19411740|NCT02460224|41657091|FG026|Overall Study|Progressive disease|85|||
19411741|NCT02460224|41657092|FG027|Overall Study|Progressive disease|17|||
19411742|NCT02460224|41657093|FG028|Overall Study|Progressive disease|77|||
19411743|NCT02460224|41657065|FG000|Overall Study|Subject/guardian decision|2|||
19411744|NCT02460224|41657066|FG001|Overall Study|Subject/guardian decision|0|||
19411745|NCT02460224|41657067|FG002|Overall Study|Subject/guardian decision|1|||
19411746|NCT02460224|41657068|FG003|Overall Study|Subject/guardian decision|0|||
19411747|NCT02460224|41657069|FG004|Overall Study|Subject/guardian decision|2|||
19411748|NCT02460224|41657070|FG005|Overall Study|Subject/guardian decision|2|||
19411749|NCT02460224|41657071|FG006|Overall Study|Subject/guardian decision|0|||
19411750|NCT02460224|41657072|FG007|Overall Study|Subject/guardian decision|0|||
19411751|NCT02460224|41657073|FG008|Overall Study|Subject/guardian decision|1|||
19411752|NCT02460224|41657074|FG009|Overall Study|Subject/guardian decision|1|||
19411753|NCT02460224|41657075|FG010|Overall Study|Subject/guardian decision|0|||
19411754|NCT02460224|41657076|FG011|Overall Study|Subject/guardian decision|1|||
19411755|NCT02460224|41657077|FG012|Overall Study|Subject/guardian decision|0|||
19411756|NCT02460224|41657078|FG013|Overall Study|Subject/guardian decision|0|||
19411757|NCT02460224|41657079|FG014|Overall Study|Subject/guardian decision|0|||
19411758|NCT02460224|41657080|FG015|Overall Study|Subject/guardian decision|1|||
19411759|NCT02460224|41657081|FG016|Overall Study|Subject/guardian decision|0|||
19411760|NCT02460224|41657082|FG017|Overall Study|Subject/guardian decision|1|||
19411761|NCT02460224|41657083|FG018|Overall Study|Subject/guardian decision|2|||
19411762|NCT02460224|41657084|FG019|Overall Study|Subject/guardian decision|0|||
19411763|NCT02460224|41657085|FG020|Overall Study|Subject/guardian decision|0|||
19411764|NCT02460224|41657086|FG021|Overall Study|Subject/guardian decision|1|||
19411765|NCT02460224|41657087|FG022|Overall Study|Subject/guardian decision|0|||
19411766|NCT02460224|41657088|FG023|Overall Study|Subject/guardian decision|0|||
19411767|NCT02460224|41657089|FG024|Overall Study|Subject/guardian decision|0|||
19411768|NCT02460224|41657090|FG025|Overall Study|Subject/guardian decision|0|||
19411769|NCT02460224|41657091|FG026|Overall Study|Subject/guardian decision|6|||
19411770|NCT02460224|41657092|FG027|Overall Study|Subject/guardian decision|2|||
19411771|NCT02460224|41657093|FG028|Overall Study|Subject/guardian decision|3|||
19411772|NCT02094573|41657167|FG000|Overall Study|Adverse Event|4|||
19411773|NCT02094573|41657168|FG001|Overall Study|Adverse Event|14|||
19411774|NCT02094573|41657167|FG000|Overall Study|Clinical Progressive Disease|9|||
19411775|NCT02094573|41657168|FG001|Overall Study|Clinical Progressive Disease|13|||
19411776|NCT02094573|41657167|FG000|Overall Study|Death|11|||
19411777|NCT02094573|41657168|FG001|Overall Study|Death|3|||
19411778|NCT02094573|41657167|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
19411779|NCT02094573|41657168|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
19411780|NCT02094573|41657167|FG000|Overall Study|Non-compliance with Study Drug|1|||
19411781|NCT02094573|41657168|FG001|Overall Study|Non-compliance with Study Drug|1|||
19411782|NCT02094573|41657167|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
19411783|NCT02094573|41657168|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
19411784|NCT02094573|41657167|FG000|Overall Study|Physician Decision|4|||
19411785|NCT02094573|41657168|FG001|Overall Study|Physician Decision|4|||
19411786|NCT02094573|41657167|FG000|Overall Study|Site Terminated by Sponsor|10|||
19411787|NCT02094573|41657168|FG001|Overall Study|Site Terminated by Sponsor|17|||
19411788|NCT02094573|41657167|FG000|Overall Study|Withdrawal by Subject|6|||
19411789|NCT02094573|41657168|FG001|Overall Study|Withdrawal by Subject|8|||
19411790|NCT02094573|41657167|FG000|Overall Study|Randomized but not Treated|3|||
19411791|NCT02094573|41657168|FG001|Overall Study|Randomized but not Treated|0|||
19411792|NCT01859494|41657174|FG000|Overall Study|Adverse Event|1|||
19411793|NCT01858636|41657178|FG000|Overall Study|No Device Deployment Attempted|24|||
19411794|NCT01858636|41657178|FG000|Overall Study|Physician Decision|1|||
19411795|NCT01858636|41657178|FG000|Overall Study|Death|1|||
19411796|NCT01858636|41657178|FG000|Overall Study|Lost to Follow-up|1|||
19411797|NCT01858636|41657178|FG000|Overall Study|Withdrawal by Subject|1|||
19411798|NCT02058849|41657185|FG000|Overall Study|Hospitalization|1|||
19411799|NCT02058849|41657186|FG001|Overall Study|Hospitalization|1|||
19411800|NCT02058849|41657185|FG000|Overall Study|Death|1|||
19411801|NCT02058849|41657186|FG001|Overall Study|Death|0|||
19411802|NCT02058849|41657185|FG000|Overall Study|Lost to Follow-up|1|||
19411803|NCT02058849|41657186|FG001|Overall Study|Lost to Follow-up|0|||
19411804|NCT02058849|41657185|FG000|Overall Study|Withdrawal by Subject|4|||
19411805|NCT02058849|41657186|FG001|Overall Study|Withdrawal by Subject|0|||
19411806|NCT01858558|41657194|FG000|Overall Study|Death|1|||
19411807|NCT01858558|41657195|FG001|Overall Study|Death|1|||
19411808|NCT01858558|41657194|FG000|Overall Study|Lost to Follow-up|1|||
19411809|NCT01858558|41657195|FG001|Overall Study|Lost to Follow-up|0|||
19411810|NCT01858558|41657194|FG000|Overall Study|Disease progression|3|||
19411811|NCT01858558|41657195|FG001|Overall Study|Disease progression|1|||
19411812|NCT01858558|41657194|FG000|Overall Study|Product contamination|2|||
19411813|NCT01858558|41657195|FG001|Overall Study|Product contamination|0|||
19411814|NCT01858558|41657194|FG000|Overall Study|Failed expansion of cell product|2|||
19411815|NCT01858558|41657195|FG001|Overall Study|Failed expansion of cell product|0|||
19411816|NCT02058537|41657201|FG000|Overall Study|Withdrawal by Subject|1|||
19411817|NCT01612000|41657209|FG000|Overall Study|Lost to Follow-up|6|||
19411818|NCT01612000|41657210|FG001|Overall Study|Lost to Follow-up|4|||
19411819|NCT01612000|41657211|FG002|Overall Study|Lost to Follow-up|4|||
19411820|NCT01612000|41657212|FG003|Overall Study|Lost to Follow-up|8|||
19411821|NCT01612000|41657209|FG000|Overall Study|Physician Decision|0|||
19411822|NCT01612000|41657210|FG001|Overall Study|Physician Decision|0|||
19411823|NCT01612000|41657211|FG002|Overall Study|Physician Decision|1|||
19411824|NCT01612000|41657212|FG003|Overall Study|Physician Decision|0|||
19411825|NCT01612000|41657209|FG000|Overall Study|Withdrawal by Subject|3|||
19411826|NCT01612000|41657210|FG001|Overall Study|Withdrawal by Subject|1|||
19411827|NCT01612000|41657211|FG002|Overall Study|Withdrawal by Subject|2|||
19411828|NCT01612000|41657212|FG003|Overall Study|Withdrawal by Subject|2|||
19411829|NCT01895608|41657226|FG000|Overall Study|change in health status|0|||
19411830|NCT01895608|41657227|FG001|Overall Study|change in health status|1|||
19411831|NCT01895608|41657228|FG002|Overall Study|change in health status|1|||
19411832|NCT01895608|41657229|FG003|Overall Study|change in health status|0|||
19411833|NCT01895608|41657226|FG000|Overall Study|Withdrawal by Subject|0|||
19411834|NCT01895608|41657227|FG001|Overall Study|Withdrawal by Subject|0|||
19411835|NCT01895608|41657228|FG002|Overall Study|Withdrawal by Subject|2|||
19411836|NCT01895608|41657229|FG003|Overall Study|Withdrawal by Subject|0|||
19411837|NCT02409680|41657241|FG000|Overall Study|Lost to Follow-up|15|||
19411838|NCT02409680|41657242|FG001|Overall Study|Lost to Follow-up|30|||
19411839|NCT01895452|41657250|FG000|Overall Study|Adverse Event|1|||
19411840|NCT01895452|41657251|FG001|Overall Study|Adverse Event|4|||
19411841|NCT01895452|41657250|FG000|Overall Study|Lost to Follow-up|1|||
19411842|NCT01895452|41657251|FG001|Overall Study|Lost to Follow-up|5|||
19411843|NCT01895452|41657250|FG000|Overall Study|Pregnancy|0|||
19411844|NCT01895452|41657251|FG001|Overall Study|Pregnancy|1|||
19411845|NCT01895452|41657250|FG000|Overall Study|Withdrawal by Subject|2|||
19411846|NCT01895452|41657251|FG001|Overall Study|Withdrawal by Subject|14|||
19411847|NCT01895452|41657250|FG000|Overall Study|Underlying disease|0|||
19411848|NCT01895452|41657251|FG001|Overall Study|Underlying disease|3|||
19411849|NCT01895452|41657250|FG000|Overall Study|Noncompliance with study drug|0|||
19411850|NCT01895452|41657251|FG001|Overall Study|Noncompliance with study drug|1|||
19411851|NCT02094417|41657261|FG000|Overall Study|Adverse Event|0|||
19411852|NCT02094417|41657262|FG001|Overall Study|Adverse Event|0|||
19411853|NCT02094417|41657263|FG002|Overall Study|Adverse Event|0|||
19411854|NCT02094417|41657264|FG003|Overall Study|Adverse Event|1|||
19411855|NCT02094417|41657261|FG000|Overall Study|Eligibility criteria|0|||
19411856|NCT02094417|41657262|FG001|Overall Study|Eligibility criteria|1|||
19411857|NCT02094417|41657263|FG002|Overall Study|Eligibility criteria|0|||
19411858|NCT02094417|41657264|FG003|Overall Study|Eligibility criteria|0|||
19411859|NCT02094417|41657261|FG000|Overall Study|No responder|4|||
19411860|NCT02094417|41657262|FG001|Overall Study|No responder|4|||
19411861|NCT02094417|41657263|FG002|Overall Study|No responder|4|||
19411862|NCT02094417|41657264|FG003|Overall Study|No responder|3|||
19411863|NCT02094417|41657261|FG000|Overall Study|Unable to conduct observations or assess|0|||
19411864|NCT02094417|41657262|FG001|Overall Study|Unable to conduct observations or assess|1|||
19411865|NCT02094417|41657263|FG002|Overall Study|Unable to conduct observations or assess|0|||
19411866|NCT02094417|41657264|FG003|Overall Study|Unable to conduct observations or assess|0|||
19411867|NCT02094417|41657261|FG000|Overall Study|Withdrawal by Subject|1|||
19411868|NCT02094417|41657262|FG001|Overall Study|Withdrawal by Subject|2|||
19411869|NCT02094417|41657263|FG002|Overall Study|Withdrawal by Subject|1|||
19411870|NCT02094417|41657264|FG003|Overall Study|Withdrawal by Subject|3|||
19411871|NCT01894984|41657276|FG000|Overall Study|Other|314|||
19411872|NCT01894984|41657277|FG001|Overall Study|Other|175|||
19411873|NCT02375672|41657283|FG000|Overall Study|remain on follow up|20|||
19411874|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
19411875|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
19411876|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
19411877|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
19411878|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
19411879|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19411880|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19411881|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19411882|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
19411883|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
19411884|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
19411885|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
19411886|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
19411887|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
19411888|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
19411889|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
19411890|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
19411891|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
19411892|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
19411893|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
19411894|NCT01894516|41657291|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
19411895|NCT01894516|41657292|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
19411896|NCT01894516|41657293|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
19411897|NCT01894516|41657294|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
19411898|NCT01894516|41657291|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
19411899|NCT01894516|41657292|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
19411900|NCT01894516|41657293|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
19411901|NCT01894516|41657294|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
19411902|NCT01894516|41657291|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19411903|NCT01894516|41657292|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19411904|NCT01894516|41657293|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
19411905|NCT01894516|41657294|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19411906|NCT02491463|41657312|FG000|Overall Study|Withdrawal by Subject|1|||
19411907|NCT02491463|41657313|FG001|Overall Study|Withdrawal by Subject|2|||
19411908|NCT02491463|41657314|FG002|Overall Study|Withdrawal by Subject|0|||
19411909|NCT02491463|41657315|FG003|Overall Study|Withdrawal by Subject|0|||
19411910|NCT02491463|41657312|FG000|Overall Study|Migrated/moved from study area|1|||
19411911|NCT02491463|41657313|FG001|Overall Study|Migrated/moved from study area|5|||
19411912|NCT02491463|41657314|FG002|Overall Study|Migrated/moved from study area|1|||
19411913|NCT02491463|41657315|FG003|Overall Study|Migrated/moved from study area|1|||
19411914|NCT02491463|41657312|FG000|Overall Study|Lost to Follow-up|0|||
19411915|NCT02491463|41657313|FG001|Overall Study|Lost to Follow-up|3|||
19628094|NCT00589914|42077496|FG000|Overall Study|Pregnancy|1|||
19628095|NCT00589914|42077497|FG001|Overall Study|Pregnancy|0|||
19411916|NCT02491463|41657314|FG002|Overall Study|Lost to Follow-up|3|||
19411917|NCT02491463|41657315|FG003|Overall Study|Lost to Follow-up|0|||
19411918|NCT02038881|41657328|FG000|Overall Study|Withdrawal by Subject|0|||
19411919|NCT02038881|41657329|FG001|Overall Study|Withdrawal by Subject|0|||
19411920|NCT02038881|41657330|FG002|Overall Study|Withdrawal by Subject|1|||
19411921|NCT02038881|41657328|FG000|Overall Study|Lost to Follow-up|2|||
19411922|NCT02038881|41657329|FG001|Overall Study|Lost to Follow-up|0|||
19411923|NCT02038881|41657330|FG002|Overall Study|Lost to Follow-up|0|||
19411924|NCT02038881|41657328|FG000|Overall Study|incarcerated|1|||
19411925|NCT02038881|41657329|FG001|Overall Study|incarcerated|0|||
19411926|NCT02038881|41657330|FG002|Overall Study|incarcerated|0|||
19411927|NCT01857622|41657343|FG000|Overall Study|Adverse Event|5|||
19411928|NCT01857622|41657344|FG001|Overall Study|Adverse Event|0|||
19411929|NCT01857622|41657345|FG002|Overall Study|Adverse Event|2|||
19411930|NCT01857622|41657343|FG000|Overall Study|Physician Decision|1|||
19411931|NCT01857622|41657344|FG001|Overall Study|Physician Decision|0|||
19411932|NCT01857622|41657345|FG002|Overall Study|Physician Decision|0|||
19411933|NCT01857622|41657343|FG000|Overall Study|Protocol Violation|4|||
19411934|NCT01857622|41657344|FG001|Overall Study|Protocol Violation|1|||
19411935|NCT01857622|41657345|FG002|Overall Study|Protocol Violation|0|||
19411936|NCT01857622|41657343|FG000|Overall Study|Withdrawal by Subject|1|||
19411937|NCT01857622|41657344|FG001|Overall Study|Withdrawal by Subject|0|||
19411938|NCT01857622|41657345|FG002|Overall Study|Withdrawal by Subject|0|||
19411939|NCT01857310|41657355|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
19411940|NCT01857310|41657356|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
19411941|NCT02472353|41657364|FG000|Overall Study|Lost to Follow-up|1|||
19411942|NCT02472353|41657365|FG001|Overall Study|Lost to Follow-up|1|||
19411943|NCT02472353|41657364|FG000|Overall Study|Withdrawal by Subject|2|||
19411944|NCT02472353|41657365|FG001|Overall Study|Withdrawal by Subject|1|||
19411945|NCT02472353|41657364|FG000|Overall Study|Study Termination|1|||
19411946|NCT02472353|41657365|FG001|Overall Study|Study Termination|4|||
19411947|NCT02491073|41657373|FG000|Overall Study|screen failure|1|||
19411948|NCT02491073|41657374|FG001|Overall Study|screen failure|0|||
19411949|NCT02314117|41657398|FG000|Overall Study|Lost to Follow-up|9|||
19411950|NCT02314117|41657399|FG001|Overall Study|Lost to Follow-up|14|||
19411951|NCT02314117|41657398|FG000|Overall Study|Withdrawal by Subject|3|||
19411952|NCT02314117|41657399|FG001|Overall Study|Withdrawal by Subject|2|||
19411953|NCT01893346|41657410|FG000|Overall Study|Lost to Follow-up|0|||
19411954|NCT01893346|41657411|FG001|Overall Study|Lost to Follow-up|1|||
19411955|NCT01893346|41657412|FG002|Overall Study|Lost to Follow-up|0|||
19411956|NCT01893346|41657413|FG003|Overall Study|Lost to Follow-up|0|||
19411957|NCT01893346|41657410|FG000|Overall Study|Protocol Violation|1|||
19411958|NCT01893346|41657411|FG001|Overall Study|Protocol Violation|0|||
19411959|NCT01893346|41657412|FG002|Overall Study|Protocol Violation|0|||
19411960|NCT01893346|41657413|FG003|Overall Study|Protocol Violation|0|||
19411961|NCT01893346|41657410|FG000|Overall Study|Withdrawal by Subject|2|||
19411962|NCT01893346|41657411|FG001|Overall Study|Withdrawal by Subject|0|||
19411963|NCT01893346|41657412|FG002|Overall Study|Withdrawal by Subject|0|||
19411964|NCT01893346|41657413|FG003|Overall Study|Withdrawal by Subject|0|||
19411965|NCT02490371|41657425|FG000|Overall Study|Lost to Follow-up|1|||
19411966|NCT02490371|41657426|FG001|Overall Study|Lost to Follow-up|1|||
19411967|NCT01856686|41657434|FG000|Overall Study|Lost to Follow-up|5|||
19411968|NCT01856686|41657435|FG001|Overall Study|Lost to Follow-up|11|||
19411969|NCT02058147|41657444|FG000|Overall Study|Randomized but not treated|0|||
19411970|NCT02058147|41657445|FG001|Overall Study|Randomized but not treated|0|||
19411971|NCT02058147|41657446|FG002|Overall Study|Randomized but not treated|1|||
19411972|NCT02058147|41657444|FG000|Overall Study|Adverse Event|12|||
19411973|NCT02058147|41657445|FG001|Overall Study|Adverse Event|9|||
19411974|NCT02058147|41657446|FG002|Overall Study|Adverse Event|21|||
19411975|NCT02058147|41657444|FG000|Overall Study|Lack of Efficacy|1|||
19411976|NCT02058147|41657445|FG001|Overall Study|Lack of Efficacy|0|||
19411977|NCT02058147|41657446|FG002|Overall Study|Lack of Efficacy|3|||
19411978|NCT02058147|41657444|FG000|Overall Study|Poor compliance to protocol|8|||
19411979|NCT02058147|41657445|FG001|Overall Study|Poor compliance to protocol|9|||
19411980|NCT02058147|41657446|FG002|Overall Study|Poor compliance to protocol|4|||
19411981|NCT02058147|41657444|FG000|Overall Study|Other than specified|8|||
19411982|NCT02058147|41657445|FG001|Overall Study|Other than specified|9|||
19411983|NCT02058147|41657446|FG002|Overall Study|Other than specified|0|||
19411984|NCT02489981|41657454|FG000|Overall Study|Adverse Event|21|||
19411985|NCT02489981|41657454|FG000|Overall Study|Insufficient effectiveness|16|||
19411986|NCT02489981|41657454|FG000|Overall Study|Improved|31|||
19411987|NCT02489981|41657454|FG000|Overall Study|Lost to Follow-up|31|||
19411988|NCT02489981|41657454|FG000|Overall Study|Other than listed|28|||
19411989|NCT02471183|41657458|FG000|Main Treatment Period|Adverse Event|1|||
19411990|NCT02471183|41657458|FG000|Main Treatment Period|Withdrawal by Subject|1|||
19411991|NCT02471183|41657458|FG000|Extended Treatment Period|Lack of Efficacy|1|||
19411992|NCT01855828|41657462|FG000|Overall Study|Adverse Event|1|||
19411993|NCT01855828|41657462|FG000|Overall Study|Withdrawal by Subject|1|||
19411994|NCT02489279|41657473|FG000|Overall Study|Lost to Follow-up|12|||
19411995|NCT02489279|41657474|FG001|Overall Study|Lost to Follow-up|10|||
19411996|NCT02489045|41657480|FG000|Overall Study|unable to collect usable data|53|||
19411997|NCT02489045|41657480|FG000|Follow-up|Lost to Follow-up|10|||
19411998|NCT02488109|41657486|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
19411999|NCT02488109|41657487|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
19412000|NCT02488109|41657486|FG000|12-month Follow-Up|Lost to Follow-up|4|||
19412001|NCT02488109|41657487|FG001|12-month Follow-Up|Lost to Follow-up|7|||
19412002|NCT02351167|41657498|FG000|Overall Study|Withdrawal by Subject|19|||
19412003|NCT02351167|41657499|FG001|Overall Study|Withdrawal by Subject|18|||
19412004|NCT02351167|41657500|FG002|Overall Study|Withdrawal by Subject|21|||
19412005|NCT02350309|41657515|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
19412006|NCT02350309|41657516|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
19412007|NCT02350309|41657517|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
19412008|NCT02350309|41657518|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
19412009|NCT02350309|41657519|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
19412010|NCT02350309|41657520|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
19412011|NCT02350309|41657515|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
19412012|NCT02350309|41657516|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
19412013|NCT02350309|41657517|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
19412014|NCT02350309|41657518|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
19412015|NCT02350309|41657519|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
19519017|NCT01475838|41932149|FG000|Randomized Phase|Participant Noncompliance|1|||
19519018|NCT01475838|41932150|FG001|Randomized Phase|Participant Noncompliance|5|||
19519019|NCT01475838|41932149|FG000|Randomized Phase|Protocol Violation|9|||
19519020|NCT01475838|41932150|FG001|Randomized Phase|Protocol Violation|4|||
19519021|NCT01475838|41932149|FG000|Extension Phase|Participant Noncompliance|1|||
19519022|NCT01475838|41932150|FG001|Extension Phase|Participant Noncompliance|0|||
19519023|NCT01451814|41932159|FG000|Overall Study|Withdrawal by Subject|1|||
19519024|NCT01451814|41932160|FG001|Overall Study|Withdrawal by Subject|1|||
19519025|NCT01451814|41932159|FG000|Overall Study|Lost to Follow-up|5|||
19519026|NCT01451814|41932160|FG001|Overall Study|Lost to Follow-up|4|||
19519027|NCT01475370|41932169|FG000|Overall Study|Exacerbation of primary disease|2|||
19519028|NCT01475370|41932170|FG001|Overall Study|Exacerbation of primary disease|2|||
19519029|NCT01475370|41932171|FG002|Overall Study|Exacerbation of primary disease|2|||
19519030|NCT01475370|41932169|FG000|Overall Study|Study drug administration difficult|0|||
19519031|NCT01475370|41932170|FG001|Overall Study|Study drug administration difficult|1|||
19519032|NCT01475370|41932171|FG002|Overall Study|Study drug administration difficult|1|||
19519033|NCT01475370|41932169|FG000|Overall Study|Other than specified|1|||
19519034|NCT01475370|41932170|FG001|Overall Study|Other than specified|0|||
19519035|NCT01475370|41932171|FG002|Overall Study|Other than specified|0|||
19519036|NCT01496430|41932182|FG000|Overall Study|Adverse Event|0|||
19519037|NCT01496430|41932183|FG001|Overall Study|Adverse Event|0|||
19519038|NCT01496430|41932184|FG002|Overall Study|Adverse Event|1|||
19519039|NCT01496430|41932182|FG000|Overall Study|Major Protocol Deviation|0|||
19519040|NCT01496430|41932183|FG001|Overall Study|Major Protocol Deviation|0|||
19519041|NCT01496430|41932184|FG002|Overall Study|Major Protocol Deviation|1|||
19519042|NCT01496430|41932182|FG000|Overall Study|Lost to Follow-up|2|||
19519043|NCT01496430|41932183|FG001|Overall Study|Lost to Follow-up|3|||
19519044|NCT01496430|41932184|FG002|Overall Study|Lost to Follow-up|1|||
19519045|NCT01496430|41932182|FG000|Overall Study|Voluntary Withdrawal|2|||
19519046|NCT01496430|41932183|FG001|Overall Study|Voluntary Withdrawal|1|||
19519047|NCT01496430|41932184|FG002|Overall Study|Voluntary Withdrawal|6|||
19519048|NCT01496430|41932182|FG000|Overall Study|Principal Investigator Discretion|0|||
19519049|NCT01496430|41932183|FG001|Overall Study|Principal Investigator Discretion|1|||
19519050|NCT01496430|41932184|FG002|Overall Study|Principal Investigator Discretion|1|||
19519051|NCT01496430|41932182|FG000|Overall Study|Other|2|||
19519052|NCT01496430|41932183|FG001|Overall Study|Other|0|||
19519053|NCT01496430|41932184|FG002|Overall Study|Other|0|||
19519054|NCT01451424|41932196|FG000|Overall Study|Withdrawal by Subject|1|||
19519055|NCT01451424|41932197|FG001|Overall Study|Withdrawal by Subject|1|||
19519056|NCT01451424|41932198|FG002|Overall Study|Withdrawal by Subject|0|||
19412016|NCT02350309|41657520|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
19412017|NCT02038647|41657537|FG000|Overall Study|Progressive Disease|50|||
19412018|NCT02038647|41657538|FG001|Overall Study|Progressive Disease|59|||
19412019|NCT02038647|41657537|FG000|Overall Study|Adverse Event|18|||
19412020|NCT02038647|41657538|FG001|Overall Study|Adverse Event|10|||
19519057|NCT01451424|41932199|FG003|Overall Study|Withdrawal by Subject|2|||
19519058|NCT01451424|41932196|FG000|Overall Study|Lost to Follow-up|0|||
19519059|NCT01451424|41932197|FG001|Overall Study|Lost to Follow-up|1|||
19519060|NCT01451424|41932198|FG002|Overall Study|Lost to Follow-up|0|||
19519061|NCT01451424|41932199|FG003|Overall Study|Lost to Follow-up|1|||
19519062|NCT01451424|41932196|FG000|Overall Study|Physician Decision|0|||
19519063|NCT01451424|41932197|FG001|Overall Study|Physician Decision|0|||
19519064|NCT01451424|41932198|FG002|Overall Study|Physician Decision|1|||
19519065|NCT01451424|41932199|FG003|Overall Study|Physician Decision|1|||
19519066|NCT01451424|41932196|FG000|Overall Study|Adverse Event|0|||
19519067|NCT01451424|41932197|FG001|Overall Study|Adverse Event|0|||
19519068|NCT01451424|41932198|FG002|Overall Study|Adverse Event|0|||
19519069|NCT01451424|41932199|FG003|Overall Study|Adverse Event|1|||
19519070|NCT01475214|41932217|FG000|Overall Study|Lost to Follow-up|1|||
19519071|NCT01475214|41932218|FG001|Overall Study|Lost to Follow-up|0|||
19519072|NCT01475214|41932219|FG002|Overall Study|Lost to Follow-up|1|||
19519073|NCT01475214|41932217|FG000|Overall Study|Physician Decision|2|||
19519074|NCT01475214|41932218|FG001|Overall Study|Physician Decision|0|||
19519075|NCT01475214|41932219|FG002|Overall Study|Physician Decision|0|||
19519076|NCT01475214|41932217|FG000|Overall Study|Withdrawal by Subject|2|||
19519077|NCT01475214|41932218|FG001|Overall Study|Withdrawal by Subject|4|||
19519078|NCT01475214|41932219|FG002|Overall Study|Withdrawal by Subject|1|||
19519079|NCT01496274|41932230|FG000|Overall Study|Protocol Violation|0|||
19519080|NCT01496274|41932231|FG001|Overall Study|Protocol Violation|1|||
19519081|NCT01496274|41932230|FG000|Overall Study|Adverse Event|1|||
19519082|NCT01496274|41932231|FG001|Overall Study|Adverse Event|1|||
19519083|NCT01496274|41932230|FG000|Overall Study|Withdrawal by Subject|2|||
19519084|NCT01496274|41932231|FG001|Overall Study|Withdrawal by Subject|0|||
19519085|NCT01496274|41932230|FG000|Overall Study|Lost to Follow-up|0|||
19519086|NCT01496274|41932231|FG001|Overall Study|Lost to Follow-up|3|||
19519087|NCT01475136|41932256|FG000|Overall Study|Sponsor Decision|0|||
19519088|NCT01475136|41932257|FG001|Overall Study|Sponsor Decision|1|||
19519089|NCT01475136|41932258|FG002|Overall Study|Sponsor Decision|0|||
19519090|NCT01475136|41932259|FG003|Overall Study|Sponsor Decision|0|||
19519091|NCT01475136|41932256|FG000|Overall Study|Entry Criteria Not Met|0|||
19519092|NCT01475136|41932257|FG001|Overall Study|Entry Criteria Not Met|2|||
19519093|NCT01475136|41932258|FG002|Overall Study|Entry Criteria Not Met|3|||
19519094|NCT01475136|41932259|FG003|Overall Study|Entry Criteria Not Met|1|||
19519095|NCT01475136|41932256|FG000|Overall Study|Withdrawal by Subject|0|||
19519096|NCT01475136|41932257|FG001|Overall Study|Withdrawal by Subject|0|||
19519097|NCT01475136|41932258|FG002|Overall Study|Withdrawal by Subject|0|||
19519098|NCT01475136|41932259|FG003|Overall Study|Withdrawal by Subject|2|||
19519099|NCT01475136|41932256|FG000|Overall Study|Adverse Event|1|||
19519100|NCT01475136|41932257|FG001|Overall Study|Adverse Event|0|||
19519101|NCT01475136|41932258|FG002|Overall Study|Adverse Event|0|||
19519102|NCT01475136|41932259|FG003|Overall Study|Adverse Event|1|||
19519103|NCT01475136|41932256|FG000|Overall Study|Death|0|||
19519104|NCT01475136|41932257|FG001|Overall Study|Death|0|||
19519105|NCT01475136|41932258|FG002|Overall Study|Death|0|||
19519106|NCT01475136|41932259|FG003|Overall Study|Death|1|||
19519107|NCT01474746|41932271|FG000|Overall Study|Lost to Follow-up|1|||
19519108|NCT01474746|41932272|FG001|Overall Study|Lost to Follow-up|1|||
19519109|NCT01474746|41932271|FG000|Overall Study|Withdrawal by Subject|2|||
19519110|NCT01474746|41932272|FG001|Overall Study|Withdrawal by Subject|1|||
19519111|NCT01450800|41932280|FG000|Overall Study|Protocol Violation|1|||
19519112|NCT01450800|41932281|FG001|Overall Study|Protocol Violation|3|||
19519113|NCT01474512|41932292|FG000|Induction Period|Adverse Event|6|||
19519114|NCT01474512|41932293|FG001|Induction Period|Adverse Event|10|||
19519115|NCT01474512|41932294|FG002|Induction Period|Adverse Event|10|||
19519116|NCT01474512|41932295|FG003|Induction Period|Adverse Event|0|||
19412021|NCT02038647|41657537|FG000|Overall Study|Symptomatic Deterioration|7|||
19412022|NCT02038647|41657538|FG001|Overall Study|Symptomatic Deterioration|7|||
19412023|NCT02038647|41657537|FG000|Overall Study|Withdrawal by Subject|5|||
19412024|NCT02038647|41657538|FG001|Overall Study|Withdrawal by Subject|2|||
19412025|NCT02038647|41657537|FG000|Overall Study|Not Reported|0|||
19412026|NCT02038647|41657538|FG001|Overall Study|Not Reported|1|||
19412027|NCT02038647|41657537|FG000|Overall Study|Ongoing at Datacut|9|||
19412028|NCT02038647|41657538|FG001|Overall Study|Ongoing at Datacut|10|||
19412029|NCT02058069|41657544|FG000|Overall Study|Exclusion due to implant size|5|||
19412030|NCT02058069|41657544|FG000|Overall Study|Withdrawal by Subject|6|||
19412031|NCT02057835|41657558|FG000|Overall Study|Withdrawal by Subject|0|||
19412032|NCT02057835|41657559|FG001|Overall Study|Withdrawal by Subject|2|||
19412033|NCT02057835|41657560|FG002|Overall Study|Withdrawal by Subject|0|||
19519117|NCT01474512|41932296|FG004|Induction Period|Adverse Event|0|||
19519118|NCT01474512|41932297|FG005|Induction Period|Adverse Event|0|||
19519119|NCT01474512|41932298|FG006|Induction Period|Adverse Event|0|||
19519120|NCT01474512|41932299|FG007|Induction Period|Adverse Event|0|||
19519121|NCT01474512|41932300|FG008|Induction Period|Adverse Event|0|||
19519122|NCT01474512|41932301|FG009|Induction Period|Adverse Event|0|||
19519123|NCT01474512|41932302|FG010|Induction Period|Adverse Event|0|||
19519124|NCT01474512|41932303|FG011|Induction Period|Adverse Event|0|||
19412034|NCT02057835|41657561|FG003|Overall Study|Withdrawal by Subject|0|||
19412035|NCT02057835|41657562|FG004|Overall Study|Withdrawal by Subject|0|||
19412036|NCT02057835|41657563|FG005|Overall Study|Withdrawal by Subject|0|||
19412037|NCT02057835|41657564|FG006|Overall Study|Withdrawal by Subject|0|||
19412038|NCT02057835|41657565|FG007|Overall Study|Withdrawal by Subject|0|||
19412039|NCT02057835|41657566|FG008|Overall Study|Withdrawal by Subject|0|||
19412040|NCT02057835|41657567|FG009|Overall Study|Withdrawal by Subject|0|||
19412041|NCT02057757|41657598|FG000|Overall Study|Withdrawal by Subject|3|||
19412042|NCT02057757|41657599|FG001|Overall Study|Withdrawal by Subject|5|||
19412043|NCT02057757|41657598|FG000|Overall Study|Death|2|||
19412044|NCT02057757|41657599|FG001|Overall Study|Death|0|||
19412045|NCT02057757|41657598|FG000|Overall Study|Lost to Follow-up|8|||
19412046|NCT02057757|41657599|FG001|Overall Study|Lost to Follow-up|3|||
19412047|NCT02057757|41657598|FG000|Overall Study|Non-compliance|1|||
19412048|NCT02057757|41657599|FG001|Overall Study|Non-compliance|0|||
19412049|NCT02037477|41657613|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
19412050|NCT02037477|41657614|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
19412051|NCT02037477|41657615|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
19412052|NCT02037477|41657616|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
19412053|NCT02057523|41657626|FG000|Overall Study|Withdrawal by Subject|1|||
19412054|NCT02057523|41657626|FG000|Overall Study|Lack of Efficacy|1|||
19412055|NCT02037165|41657635|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
19412056|NCT02037165|41657636|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
19412057|NCT02037165|41657637|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
19412058|NCT02037165|41657638|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
19412059|NCT02037165|41657639|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
19412060|NCT02470403|41657660|FG000|Overall Study|Adverse Event|1|||
19412061|NCT02470403|41657661|FG001|Overall Study|Adverse Event|0|||
19412062|NCT02470403|41657662|FG002|Overall Study|Adverse Event|0|||
19412063|NCT02470403|41657663|FG003|Overall Study|Adverse Event|0|||
19412064|NCT02470403|41657664|FG004|Overall Study|Adverse Event|0|||
19412065|NCT02470403|41657660|FG000|Overall Study|Lost to Follow-up|0|||
19412066|NCT02470403|41657661|FG001|Overall Study|Lost to Follow-up|1|||
19412067|NCT02470403|41657662|FG002|Overall Study|Lost to Follow-up|0|||
19412068|NCT02470403|41657663|FG003|Overall Study|Lost to Follow-up|0|||
19412069|NCT02470403|41657664|FG004|Overall Study|Lost to Follow-up|0|||
19412070|NCT02470403|41657660|FG000|Overall Study|Subject/guardian decision|1|||
19412071|NCT02470403|41657661|FG001|Overall Study|Subject/guardian decision|0|||
19412072|NCT02470403|41657662|FG002|Overall Study|Subject/guardian decision|0|||
19412073|NCT02470403|41657663|FG003|Overall Study|Subject/guardian decision|4|||
19412074|NCT02470403|41657664|FG004|Overall Study|Subject/guardian decision|0|||
19412075|NCT01855750|41657681|FG000|Overall Study|Death|78|||
19412076|NCT01855750|41657682|FG001|Overall Study|Death|78|||
19412077|NCT01855750|41657681|FG000|Overall Study|Lost to Follow-up|9|||
19412078|NCT01855750|41657682|FG001|Overall Study|Lost to Follow-up|23|||
19412079|NCT01855750|41657681|FG000|Overall Study|Withdrawal by Subject|35|||
19412080|NCT01855750|41657682|FG001|Overall Study|Withdrawal by Subject|28|||
19412081|NCT01855750|41657681|FG000|Overall Study|Sponsor ends the study|297|||
19412082|NCT01855750|41657682|FG001|Overall Study|Sponsor ends the study|290|||
19412083|NCT01855126|41657690|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
19412084|NCT01855126|41657691|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
19412085|NCT01855126|41657690|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
19412086|NCT01855126|41657691|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
19412087|NCT01622673|41657707|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19412088|NCT01622673|41657708|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19628096|NCT00589914|42077496|FG000|Overall Study|Withdrawal by Subject|55|||
19374755|NCT02526524|41616443|FG001|Overall Study|Protocol Violation|1|||
19374756|NCT02526524|41616444|FG002|Overall Study|Protocol Violation|5|||
19374757|NCT02526524|41616445|FG003|Overall Study|Protocol Violation|3|||
19374758|NCT02526524|41616446|FG004|Overall Study|Protocol Violation|4|||
19374759|NCT02526524|41616447|FG005|Overall Study|Protocol Violation|3|||
19374760|NCT02526524|41616442|FG000|Overall Study|Loss of Glucose Control|0|||
19374761|NCT02526524|41616443|FG001|Overall Study|Loss of Glucose Control|0|||
19374762|NCT02526524|41616444|FG002|Overall Study|Loss of Glucose Control|3|||
19374763|NCT02526524|41616445|FG003|Overall Study|Loss of Glucose Control|0|||
19374764|NCT02526524|41616446|FG004|Overall Study|Loss of Glucose Control|2|||
19374765|NCT02526524|41616447|FG005|Overall Study|Loss of Glucose Control|0|||
19374766|NCT02526524|41616442|FG000|Overall Study|Physician Decision|0|||
19374767|NCT02526524|41616443|FG001|Overall Study|Physician Decision|0|||
19374768|NCT02526524|41616444|FG002|Overall Study|Physician Decision|0|||
19374769|NCT02526524|41616445|FG003|Overall Study|Physician Decision|0|||
19374770|NCT02526524|41616446|FG004|Overall Study|Physician Decision|1|||
19374771|NCT02526524|41616447|FG005|Overall Study|Physician Decision|0|||
19374772|NCT02526524|41616442|FG000|Overall Study|Sponsor Decision|1|||
19374773|NCT02526524|41616443|FG001|Overall Study|Sponsor Decision|0|||
19374774|NCT02526524|41616444|FG002|Overall Study|Sponsor Decision|0|||
19412089|NCT01622673|41657709|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19412090|NCT01622673|41657710|FG003|Treatment Period 1|Withdrawal by Subject|1|||
19412091|NCT01622673|41657711|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19412092|NCT01622673|41657712|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19412093|NCT01622673|41657707|FG000|Treatment Period 1|Protocol Violation|0|||
19412094|NCT01622673|41657708|FG001|Treatment Period 1|Protocol Violation|1|||
19412095|NCT01622673|41657709|FG002|Treatment Period 1|Protocol Violation|0|||
19412096|NCT01622673|41657710|FG003|Treatment Period 1|Protocol Violation|0|||
19412097|NCT01622673|41657711|FG004|Treatment Period 1|Protocol Violation|0|||
19412098|NCT01622673|41657712|FG005|Treatment Period 1|Protocol Violation|0|||
19412099|NCT01622673|41657707|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19412100|NCT01622673|41657708|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19412101|NCT01622673|41657709|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19412102|NCT01622673|41657710|FG003|Treatment Period 2|Withdrawal by Subject|1|||
19412103|NCT01622673|41657711|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19412104|NCT01622673|41657712|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19412105|NCT01622673|41657707|FG000|Treatment Period 3|Protocol Violation|0|||
19412106|NCT01622673|41657708|FG001|Treatment Period 3|Protocol Violation|1|||
19412107|NCT01622673|41657709|FG002|Treatment Period 3|Protocol Violation|0|||
19412108|NCT01622673|41657710|FG003|Treatment Period 3|Protocol Violation|0|||
19412109|NCT01622673|41657711|FG004|Treatment Period 3|Protocol Violation|0|||
19412110|NCT01622673|41657712|FG005|Treatment Period 3|Protocol Violation|0|||
19412111|NCT01855048|41657737|FG000|Overall Study|Withdrawal by Subject|0|||
19412112|NCT01855048|41657738|FG001|Overall Study|Withdrawal by Subject|1|||
19412113|NCT01855048|41657739|FG002|Overall Study|Withdrawal by Subject|0|||
19412114|NCT01855048|41657740|FG003|Overall Study|Withdrawal by Subject|0|||
19412115|NCT01855048|41657741|FG004|Overall Study|Withdrawal by Subject|1|||
19412116|NCT01855048|41657742|FG005|Overall Study|Withdrawal by Subject|0|||
19412117|NCT02469857|41657768|FG000|Overall Study|Death|24|||
19412118|NCT02469857|41657769|FG001|Overall Study|Death|29|||
19412119|NCT02469857|41657768|FG000|Overall Study|Discontinuation|1|||
19412120|NCT02469857|41657769|FG001|Overall Study|Discontinuation|3|||
19412121|NCT02036853|41657779|FG000|Overall Study|Adverse Event|0|||
19412122|NCT02036853|41657780|FG001|Overall Study|Adverse Event|2|||
19412123|NCT02036853|41657779|FG000|Overall Study|Lack of Efficacy|0|||
19412124|NCT02036853|41657780|FG001|Overall Study|Lack of Efficacy|2|||
19412125|NCT02036853|41657779|FG000|Overall Study|Physician Decision|0|||
19412126|NCT02036853|41657780|FG001|Overall Study|Physician Decision|1|||
19412127|NCT02036853|41657779|FG000|Overall Study|Withdrawal by Subject|0|||
19412128|NCT02036853|41657780|FG001|Overall Study|Withdrawal by Subject|1|||
19412129|NCT02469623|41657786|FG000|Overall Study|Not consented for long-term follow-up|4|||
19412130|NCT02469623|41657786|FG000|Overall Study|Lost to Follow-up|4|||
19412131|NCT02469623|41657786|FG000|Overall Study|Withdrawal by Subject|2|||
19412132|NCT02469623|41657786|FG000|Overall Study|Death|3|||
19412133|NCT02469077|41657793|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
19412134|NCT02469077|41657794|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
19412135|NCT02469077|41657793|FG000|Post Randomization/Intervention Period|Relocated|1|||
19412136|NCT02469077|41657794|FG001|Post Randomization/Intervention Period|Relocated|1|||
19412137|NCT02469077|41657793|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
19412138|NCT02469077|41657794|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
19412139|NCT02469077|41657793|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
19412140|NCT02469077|41657794|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
19412141|NCT02486627|41657806|FG000|Overall Study|Death|1|||
19412142|NCT02486627|41657807|FG001|Overall Study|Death|0|||
19412143|NCT02486627|41657806|FG000|Overall Study|Other Unspecified|0|||
19412144|NCT02486627|41657807|FG001|Overall Study|Other Unspecified|2|||
19412145|NCT02486627|41657806|FG000|Overall Study|Consent Withdrawn by Participant|4|||
19412146|NCT02486627|41657807|FG001|Overall Study|Consent Withdrawn by Participant|3|||
19412147|NCT02486627|41657806|FG000|Overall Study|Significant Participant Noncompliance|1|||
19412148|NCT02486627|41657807|FG001|Overall Study|Significant Participant Noncompliance|1|||
19412149|NCT02486627|41657806|FG000|Overall Study|Lost to Follow-up|1|||
19412150|NCT02486627|41657807|FG001|Overall Study|Lost to Follow-up|3|||
19412151|NCT01644565|41657813|FG000|Overall Study|Undisclosed Medical History|1|||
19412152|NCT01644565|41657814|FG001|Overall Study|Undisclosed Medical History|0|||
19412153|NCT01644565|41657815|FG002|Overall Study|Undisclosed Medical History|0|||
19412154|NCT01644565|41657816|FG003|Overall Study|Undisclosed Medical History|0|||
19412155|NCT01644565|41657817|FG004|Overall Study|Undisclosed Medical History|0|||
19412156|NCT01644565|41657818|FG005|Overall Study|Undisclosed Medical History|0|||
19412157|NCT01644565|41657819|FG006|Overall Study|Undisclosed Medical History|0|||
19412158|NCT01644565|41657820|FG007|Overall Study|Undisclosed Medical History|0|||
19412159|NCT01644565|41657821|FG008|Overall Study|Undisclosed Medical History|0|||
19412160|NCT01644565|41657813|FG000|Overall Study|Lost to Follow-up|0|||
19412161|NCT01644565|41657814|FG001|Overall Study|Lost to Follow-up|0|||
19412162|NCT01644565|41657815|FG002|Overall Study|Lost to Follow-up|0|||
19412163|NCT01644565|41657816|FG003|Overall Study|Lost to Follow-up|1|||
19412164|NCT01644565|41657817|FG004|Overall Study|Lost to Follow-up|0|||
19412165|NCT01644565|41657818|FG005|Overall Study|Lost to Follow-up|0|||
19412166|NCT01644565|41657819|FG006|Overall Study|Lost to Follow-up|0|||
19412167|NCT01644565|41657820|FG007|Overall Study|Lost to Follow-up|2|||
19412168|NCT01644565|41657821|FG008|Overall Study|Lost to Follow-up|0|||
19412169|NCT01644565|41657813|FG000|Overall Study|Family emergency|0|||
19412170|NCT01644565|41657814|FG001|Overall Study|Family emergency|0|||
19412171|NCT01644565|41657815|FG002|Overall Study|Family emergency|0|||
19412172|NCT01644565|41657816|FG003|Overall Study|Family emergency|0|||
19412173|NCT01644565|41657817|FG004|Overall Study|Family emergency|1|||
19412174|NCT01644565|41657818|FG005|Overall Study|Family emergency|0|||
19412175|NCT01644565|41657819|FG006|Overall Study|Family emergency|0|||
19412176|NCT01644565|41657820|FG007|Overall Study|Family emergency|0|||
19412177|NCT01644565|41657821|FG008|Overall Study|Family emergency|0|||
19412178|NCT01644565|41657813|FG000|Overall Study|Relocation|0|||
19412179|NCT01644565|41657814|FG001|Overall Study|Relocation|0|||
19412180|NCT01644565|41657815|FG002|Overall Study|Relocation|0|||
19412181|NCT01644565|41657816|FG003|Overall Study|Relocation|0|||
19412182|NCT01644565|41657817|FG004|Overall Study|Relocation|0|||
19412183|NCT01644565|41657818|FG005|Overall Study|Relocation|0|||
19412184|NCT01644565|41657819|FG006|Overall Study|Relocation|0|||
19412185|NCT01644565|41657820|FG007|Overall Study|Relocation|0|||
19412186|NCT01644565|41657821|FG008|Overall Study|Relocation|1|||
19412187|NCT02485925|41657841|FG000|Overall Study|Withdrawal by Subject|3|||
19412188|NCT02485925|41657841|FG000|Overall Study|Death|1|||
19412189|NCT02485925|41657841|FG000|Overall Study|Lost to Follow-up|11|||
19412190|NCT02282293|41657847|FG000|Overall Study|Lost to Follow-up|2|||
19412191|NCT02282293|41657848|FG001|Overall Study|Lost to Follow-up|2|||
19412192|NCT02282293|41657847|FG000|Overall Study|Unable to comply with study procedures|1|||
19412193|NCT02282293|41657848|FG001|Overall Study|Unable to comply with study procedures|0|||
19412194|NCT02282293|41657847|FG000|Overall Study|Moved out of study area|0|||
19412195|NCT02282293|41657848|FG001|Overall Study|Moved out of study area|1|||
19412196|NCT01854658|41657858|FG000|Overall Study|Protocol Violation|6|||
19412197|NCT01854658|41657859|FG001|Overall Study|Protocol Violation|2|||
19412198|NCT01854658|41657860|FG002|Overall Study|Protocol Violation|2|||
19412199|NCT01854658|41657861|FG003|Overall Study|Protocol Violation|1|||
19412200|NCT01854658|41657858|FG000|Overall Study|Physician Decision|7|||
19412201|NCT01854658|41657859|FG001|Overall Study|Physician Decision|5|||
19412202|NCT01854658|41657860|FG002|Overall Study|Physician Decision|2|||
19412203|NCT01854658|41657861|FG003|Overall Study|Physician Decision|4|||
19412204|NCT01854658|41657858|FG000|Overall Study|Lost to Follow-up|8|||
19412205|NCT01854658|41657859|FG001|Overall Study|Lost to Follow-up|9|||
19412206|NCT01854658|41657860|FG002|Overall Study|Lost to Follow-up|8|||
19412207|NCT01854658|41657861|FG003|Overall Study|Lost to Follow-up|4|||
19412208|NCT01854658|41657858|FG000|Overall Study|Withdrawal by Subject|28|||
19412209|NCT01854658|41657859|FG001|Overall Study|Withdrawal by Subject|21|||
19412210|NCT01854658|41657860|FG002|Overall Study|Withdrawal by Subject|29|||
19412211|NCT01854658|41657861|FG003|Overall Study|Withdrawal by Subject|15|||
19412212|NCT01854658|41657858|FG000|Overall Study|Protocol-specified criteria|15|||
19412213|NCT01854658|41657859|FG001|Overall Study|Protocol-specified criteria|15|||
19412214|NCT01854658|41657860|FG002|Overall Study|Protocol-specified criteria|10|||
19412215|NCT01854658|41657861|FG003|Overall Study|Protocol-specified criteria|7|||
19412216|NCT01854658|41657858|FG000|Overall Study|Lack of Efficacy|3|||
19412217|NCT01854658|41657859|FG001|Overall Study|Lack of Efficacy|8|||
19412218|NCT01854658|41657860|FG002|Overall Study|Lack of Efficacy|4|||
19412219|NCT01854658|41657861|FG003|Overall Study|Lack of Efficacy|7|||
19412220|NCT01854658|41657858|FG000|Overall Study|Adverse Event|21|||
19412221|NCT01854658|41657859|FG001|Overall Study|Adverse Event|14|||
19412222|NCT01854658|41657860|FG002|Overall Study|Adverse Event|23|||
19412223|NCT01854658|41657861|FG003|Overall Study|Adverse Event|19|||
19519125|NCT01474512|41932304|FG012|Induction Period|Adverse Event|0|||
19519126|NCT01474512|41932305|FG013|Induction Period|Adverse Event|0|||
19519127|NCT01474512|41932306|FG014|Induction Period|Adverse Event|0|||
19519128|NCT01474512|41932307|FG015|Induction Period|Adverse Event|0|||
19519129|NCT01474512|41932308|FG016|Induction Period|Adverse Event|0|||
19519130|NCT01474512|41932309|FG017|Induction Period|Adverse Event|0|||
19519131|NCT01474512|41932292|FG000|Induction Period|Lack of Efficacy|7|||
19519132|NCT01474512|41932293|FG001|Induction Period|Lack of Efficacy|1|||
19519133|NCT01474512|41932294|FG002|Induction Period|Lack of Efficacy|0|||
19519134|NCT01474512|41932295|FG003|Induction Period|Lack of Efficacy|0|||
19519135|NCT01474512|41932296|FG004|Induction Period|Lack of Efficacy|0|||
19519136|NCT01474512|41932297|FG005|Induction Period|Lack of Efficacy|0|||
19412224|NCT01854658|41657858|FG000|Overall Study|Administrative reasons|5|||
19412225|NCT01854658|41657859|FG001|Overall Study|Administrative reasons|1|||
19412226|NCT01854658|41657860|FG002|Overall Study|Administrative reasons|2|||
19412227|NCT01854658|41657861|FG003|Overall Study|Administrative reasons|2|||
19412228|NCT01892020|41657871|FG000|Period 1|Adverse Event|1|||
19412229|NCT01892020|41657872|FG001|Period 1|Adverse Event|1|||
19412230|NCT01892020|41657871|FG000|Period 1|Protocol Violation|2|||
19412231|NCT01892020|41657872|FG001|Period 1|Protocol Violation|4|||
19412232|NCT01892020|41657871|FG000|Period 1|Unclassified|0|||
19519137|NCT01474512|41932298|FG006|Induction Period|Lack of Efficacy|0|||
19412233|NCT01892020|41657872|FG001|Period 1|Unclassified|1|||
19412234|NCT01892020|41657871|FG000|Period 2|Protocol Violation|1|||
19412235|NCT01892020|41657872|FG001|Period 2|Protocol Violation|0|||
19412236|NCT02485691|41657880|FG000|Overall Study|Adverse Event|25|||
19412237|NCT02485691|41657881|FG001|Overall Study|Adverse Event|11|||
19412238|NCT02485691|41657880|FG000|Overall Study|Poor compliance to protocol|0|||
19412239|NCT02485691|41657881|FG001|Overall Study|Poor compliance to protocol|1|||
19412240|NCT02485691|41657880|FG000|Overall Study|Disease progression|57|||
19412241|NCT02485691|41657881|FG001|Overall Study|Disease progression|92|||
19412242|NCT02485691|41657880|FG000|Overall Study|Investigator's decision|23|||
19412243|NCT02485691|41657881|FG001|Overall Study|Investigator's decision|5|||
19412244|NCT02485691|41657880|FG000|Overall Study|Participant's request|13|||
19412245|NCT02485691|41657881|FG001|Overall Study|Participant's request|6|||
19412246|NCT02485691|41657880|FG000|Overall Study|Other reason|8|||
19412247|NCT02485691|41657881|FG001|Overall Study|Other reason|9|||
19412248|NCT02485691|41657880|FG000|Overall Study|Randomized and not treated|3|||
19412249|NCT02485691|41657881|FG001|Overall Study|Randomized and not treated|2|||
19412250|NCT02517515|41657890|FG000|Overall Study|Adverse Event|0|||
19412251|NCT02517515|41657891|FG001|Overall Study|Adverse Event|1|||
19412252|NCT02517515|41657890|FG000|Overall Study|Withdrew Consent|0|||
19412253|NCT02517515|41657891|FG001|Overall Study|Withdrew Consent|1|||
19412254|NCT02517515|41657890|FG000|Overall Study|Lost to Follow-up|1|||
19412255|NCT02517515|41657891|FG001|Overall Study|Lost to Follow-up|0|||
19412256|NCT02517515|41657890|FG000|Overall Study|Other|1|||
19412257|NCT02517515|41657891|FG001|Overall Study|Other|0|||
19412258|NCT02466659|41657900|FG000|Overall Study|Lost to Follow-up|5|||
19412259|NCT02466659|41657901|FG001|Overall Study|Lost to Follow-up|2|||
19412260|NCT01891864|41657909|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
19412261|NCT01891864|41657910|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
19412262|NCT01891864|41657911|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
19412263|NCT01891864|41657912|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
19412264|NCT01891864|41657913|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
19412265|NCT01891864|41657914|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
19412266|NCT01891864|41657909|FG000|Treatment Period 1|Physician Decision|0|||
19412267|NCT01891864|41657910|FG001|Treatment Period 1|Physician Decision|1|||
19412268|NCT01891864|41657911|FG002|Treatment Period 1|Physician Decision|0|||
19412269|NCT01891864|41657912|FG003|Treatment Period 1|Physician Decision|0|||
19412270|NCT01891864|41657913|FG004|Treatment Period 1|Physician Decision|0|||
19412271|NCT01891864|41657914|FG005|Treatment Period 1|Physician Decision|0|||
19412272|NCT01891864|41657909|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
19412273|NCT01891864|41657910|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
19412274|NCT01891864|41657911|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
19412275|NCT01891864|41657912|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
19412276|NCT01891864|41657913|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
19412277|NCT01891864|41657914|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
19412278|NCT01891864|41657909|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
19412279|NCT01891864|41657910|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
19412280|NCT01891864|41657911|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
19412281|NCT01891864|41657912|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
19412282|NCT01891864|41657913|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
19412283|NCT01891864|41657914|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
19412284|NCT01891864|41657909|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19412285|NCT01891864|41657910|FG001|Treatment Period 1|Withdrawal by Subject|5|||
19412286|NCT01891864|41657911|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19412287|NCT01891864|41657912|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19412288|NCT01891864|41657913|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19412289|NCT01891864|41657914|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19412290|NCT01891864|41657909|FG000|Treatment Period 1|Lost to Follow-up|1|||
19412291|NCT01891864|41657910|FG001|Treatment Period 1|Lost to Follow-up|0|||
19412292|NCT01891864|41657911|FG002|Treatment Period 1|Lost to Follow-up|0|||
19412293|NCT01891864|41657912|FG003|Treatment Period 1|Lost to Follow-up|0|||
19412294|NCT01891864|41657913|FG004|Treatment Period 1|Lost to Follow-up|0|||
19412295|NCT01891864|41657914|FG005|Treatment Period 1|Lost to Follow-up|0|||
19412296|NCT01891864|41657909|FG000|Treatment Period 2|Protocol Violation|0|||
19412297|NCT01891864|41657910|FG001|Treatment Period 2|Protocol Violation|0|||
19412298|NCT01891864|41657911|FG002|Treatment Period 2|Protocol Violation|0|||
19412299|NCT01891864|41657912|FG003|Treatment Period 2|Protocol Violation|1|||
19412300|NCT01891864|41657913|FG004|Treatment Period 2|Protocol Violation|0|||
19412301|NCT01891864|41657914|FG005|Treatment Period 2|Protocol Violation|0|||
19412302|NCT01891864|41657909|FG000|Treatment Period 2|Physician Decision|0|||
19412303|NCT01891864|41657910|FG001|Treatment Period 2|Physician Decision|0|||
19412304|NCT01891864|41657911|FG002|Treatment Period 2|Physician Decision|1|||
19412305|NCT01891864|41657912|FG003|Treatment Period 2|Physician Decision|0|||
19412306|NCT01891864|41657913|FG004|Treatment Period 2|Physician Decision|0|||
19412307|NCT01891864|41657914|FG005|Treatment Period 2|Physician Decision|0|||
19412308|NCT01891864|41657909|FG000|Treatment Period 2|Site Termination|0|||
19412309|NCT01891864|41657910|FG001|Treatment Period 2|Site Termination|0|||
19412310|NCT01891864|41657911|FG002|Treatment Period 2|Site Termination|1|||
19412311|NCT01891864|41657912|FG003|Treatment Period 2|Site Termination|2|||
19412312|NCT01891864|41657913|FG004|Treatment Period 2|Site Termination|0|||
19412313|NCT01891864|41657914|FG005|Treatment Period 2|Site Termination|0|||
19412314|NCT01891864|41657909|FG000|Treatment Period 2|Lack of Efficacy|0|||
19412315|NCT01891864|41657910|FG001|Treatment Period 2|Lack of Efficacy|0|||
19412316|NCT01891864|41657911|FG002|Treatment Period 2|Lack of Efficacy|1|||
19412317|NCT01891864|41657912|FG003|Treatment Period 2|Lack of Efficacy|0|||
19412318|NCT01891864|41657913|FG004|Treatment Period 2|Lack of Efficacy|1|||
19412319|NCT01891864|41657914|FG005|Treatment Period 2|Lack of Efficacy|0|||
19412320|NCT01891864|41657909|FG000|Treatment Period 2|Adverse Event|0|||
19412321|NCT01891864|41657910|FG001|Treatment Period 2|Adverse Event|0|||
19412322|NCT01891864|41657911|FG002|Treatment Period 2|Adverse Event|1|||
19412323|NCT01891864|41657912|FG003|Treatment Period 2|Adverse Event|2|||
19412324|NCT01891864|41657913|FG004|Treatment Period 2|Adverse Event|0|||
19412325|NCT01891864|41657914|FG005|Treatment Period 2|Adverse Event|4|||
19412326|NCT01891864|41657909|FG000|Treatment Period 2|Termination of Site|0|||
19412327|NCT01891864|41657910|FG001|Treatment Period 2|Termination of Site|0|||
19412328|NCT01891864|41657911|FG002|Treatment Period 2|Termination of Site|0|||
19412329|NCT01891864|41657912|FG003|Treatment Period 2|Termination of Site|0|||
19412330|NCT01891864|41657913|FG004|Treatment Period 2|Termination of Site|2|||
19412331|NCT01891864|41657914|FG005|Treatment Period 2|Termination of Site|0|||
19412332|NCT01891864|41657909|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19412333|NCT01891864|41657910|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19412334|NCT01891864|41657911|FG002|Treatment Period 2|Withdrawal by Subject|3|||
19412335|NCT01891864|41657912|FG003|Treatment Period 2|Withdrawal by Subject|4|||
19412336|NCT01891864|41657913|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19412337|NCT01891864|41657914|FG005|Treatment Period 2|Withdrawal by Subject|1|||
19412338|NCT01891864|41657909|FG000|Extension Period|Lack of Efficacy|0|||
19412339|NCT01891864|41657910|FG001|Extension Period|Lack of Efficacy|0|||
19412340|NCT01891864|41657911|FG002|Extension Period|Lack of Efficacy|0|||
19412341|NCT01891864|41657912|FG003|Extension Period|Lack of Efficacy|1|||
19412342|NCT01891864|41657913|FG004|Extension Period|Lack of Efficacy|1|||
19412343|NCT01891864|41657914|FG005|Extension Period|Lack of Efficacy|0|||
19412344|NCT01891864|41657909|FG000|Extension Period|Pregnancy|0|||
19412345|NCT01891864|41657910|FG001|Extension Period|Pregnancy|0|||
19412346|NCT01891864|41657911|FG002|Extension Period|Pregnancy|1|||
19412347|NCT01891864|41657912|FG003|Extension Period|Pregnancy|0|||
19412348|NCT01891864|41657913|FG004|Extension Period|Pregnancy|0|||
19412349|NCT01891864|41657914|FG005|Extension Period|Pregnancy|0|||
19412350|NCT01891864|41657909|FG000|Extension Period|Adverse Event|0|||
19412351|NCT01891864|41657910|FG001|Extension Period|Adverse Event|0|||
19412352|NCT01891864|41657911|FG002|Extension Period|Adverse Event|4|||
19412353|NCT01891864|41657912|FG003|Extension Period|Adverse Event|2|||
19412354|NCT01891864|41657913|FG004|Extension Period|Adverse Event|2|||
19412355|NCT01891864|41657914|FG005|Extension Period|Adverse Event|0|||
19412356|NCT01891864|41657909|FG000|Extension Period|Withdrawal by Subject|0|||
19412357|NCT01891864|41657910|FG001|Extension Period|Withdrawal by Subject|0|||
19412358|NCT01891864|41657911|FG002|Extension Period|Withdrawal by Subject|1|||
19412359|NCT01891864|41657912|FG003|Extension Period|Withdrawal by Subject|2|||
19412360|NCT01891864|41657913|FG004|Extension Period|Withdrawal by Subject|4|||
19412361|NCT01891864|41657914|FG005|Extension Period|Withdrawal by Subject|0|||
19412362|NCT01891864|41657909|FG000|Extension Period|Lost to Follow-up|0|||
19412363|NCT01891864|41657910|FG001|Extension Period|Lost to Follow-up|0|||
19412364|NCT01891864|41657911|FG002|Extension Period|Lost to Follow-up|2|||
19412365|NCT01891864|41657912|FG003|Extension Period|Lost to Follow-up|0|||
19412366|NCT01891864|41657913|FG004|Extension Period|Lost to Follow-up|0|||
19412367|NCT01891864|41657914|FG005|Extension Period|Lost to Follow-up|0|||
19412368|NCT02485301|41657928|FG000|Overall Study|Serious Adverse Events|2|||
19412369|NCT02485301|41657929|FG001|Overall Study|Serious Adverse Events|1|||
19412370|NCT02485301|41657928|FG000|Overall Study|Protocol Violation|0|||
19412371|NCT02485301|41657929|FG001|Overall Study|Protocol Violation|1|||
19412372|NCT02485301|41657928|FG000|Overall Study|Withdrawal by Subject|6|||
19412373|NCT02485301|41657929|FG001|Overall Study|Withdrawal by Subject|7|||
19412374|NCT02485301|41657928|FG000|Overall Study|Migrated/moved from study area|10|||
19412375|NCT02485301|41657929|FG001|Overall Study|Migrated/moved from study area|19|||
19412376|NCT02485301|41657928|FG000|Overall Study|Lost to Follow-up|17|||
19412377|NCT02485301|41657929|FG001|Overall Study|Lost to Follow-up|17|||
19412378|NCT02485301|41657928|FG000|Overall Study|Other|3|||
19412379|NCT02485301|41657929|FG001|Overall Study|Other|4|||
19412380|NCT02484911|41657937|FG000|Overall Study|Withdrawal by Subject|2|||
19412381|NCT02484911|41657938|FG001|Overall Study|Withdrawal by Subject|1|||
19412382|NCT02484911|41657937|FG000|Overall Study|Protocol Violation|2|||
19412383|NCT02484911|41657938|FG001|Overall Study|Protocol Violation|1|||
19412384|NCT01891396|41657948|FG000|Overall Study|Withdrawal by Subject|4|||
19412385|NCT01891396|41657949|FG001|Overall Study|Withdrawal by Subject|4|||
19412386|NCT01891396|41657950|FG002|Overall Study|Withdrawal by Subject|3|||
19412387|NCT01891396|41657948|FG000|Overall Study|Lost to Follow-up|0|||
19412388|NCT01891396|41657949|FG001|Overall Study|Lost to Follow-up|1|||
19412389|NCT01891396|41657950|FG002|Overall Study|Lost to Follow-up|0|||
19412390|NCT02466425|41657964|FG000|Overall Study|Adverse Event|3|||
19412391|NCT02466425|41657965|FG001|Overall Study|Adverse Event|11|||
19412392|NCT02466425|41657964|FG000|Overall Study|Lack of Efficacy|4|||
19412393|NCT02466425|41657965|FG001|Overall Study|Lack of Efficacy|1|||
19412394|NCT02466425|41657964|FG000|Overall Study|Lost to Follow-up|3|||
19412395|NCT02466425|41657965|FG001|Overall Study|Lost to Follow-up|0|||
19412396|NCT02466425|41657964|FG000|Overall Study|Protocol Violation|1|||
19412397|NCT02466425|41657965|FG001|Overall Study|Protocol Violation|0|||
19412398|NCT02466425|41657964|FG000|Overall Study|Withdrawal by Subject|0|||
19412399|NCT02466425|41657965|FG001|Overall Study|Withdrawal by Subject|1|||
19412400|NCT02466425|41657964|FG000|Overall Study|Other|1|||
19412401|NCT02466425|41657965|FG001|Overall Study|Other|3|||
19412402|NCT02466425|41657964|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
19412403|NCT02466425|41657965|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19412404|NCT02451917|41657973|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
19412405|NCT02451917|41657974|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
19412406|NCT02451917|41657973|FG000|First Intervention (24 Weeks)|Death|0|||
19412407|NCT02451917|41657974|FG001|First Intervention (24 Weeks)|Death|1|||
19412408|NCT02451917|41657973|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
19412409|NCT02451917|41657974|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
19412410|NCT02349451|41657987|FG000|Overall Study|Withdrawal by Subject|0|||
19412411|NCT02349451|41657988|FG001|Overall Study|Withdrawal by Subject|1|||
19412412|NCT02349451|41657989|FG002|Overall Study|Withdrawal by Subject|2|||
19412413|NCT02349451|41657990|FG003|Overall Study|Withdrawal by Subject|1|||
19412414|NCT02409368|41658007|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
19412415|NCT02409368|41658008|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
19412416|NCT02409368|41658009|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
19412417|NCT02409368|41658010|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
19412418|NCT02409368|41658007|FG000|ECOG Reclassification|Death|1|||
19412419|NCT02409368|41658008|FG001|ECOG Reclassification|Death|5|||
19412420|NCT02409368|41658009|FG002|ECOG Reclassification|Death|0|||
19412421|NCT02409368|41658010|FG003|ECOG Reclassification|Death|0|||
19412422|NCT02409368|41658007|FG000|ECOG Reclassification|Disease Progression|113|||
19412423|NCT02409368|41658008|FG001|ECOG Reclassification|Disease Progression|382|||
19412424|NCT02409368|41658009|FG002|ECOG Reclassification|Disease Progression|70|||
19412425|NCT02409368|41658010|FG003|ECOG Reclassification|Disease Progression|1|||
19412426|NCT02409368|41658007|FG000|ECOG Reclassification|Lost to Follow-up|1|||
19412427|NCT02409368|41658008|FG001|ECOG Reclassification|Lost to Follow-up|5|||
19412428|NCT02409368|41658009|FG002|ECOG Reclassification|Lost to Follow-up|0|||
19412429|NCT02409368|41658010|FG003|ECOG Reclassification|Lost to Follow-up|0|||
19412430|NCT02409368|41658007|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
19412431|NCT02409368|41658008|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
19412432|NCT02409368|41658009|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
19412433|NCT02409368|41658010|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
19412434|NCT02409368|41658007|FG000|ECOG Reclassification|Poor/non-compliance|0|||
19412435|NCT02409368|41658008|FG001|ECOG Reclassification|Poor/non-compliance|3|||
19412436|NCT02409368|41658009|FG002|ECOG Reclassification|Poor/non-compliance|2|||
19412437|NCT02409368|41658010|FG003|ECOG Reclassification|Poor/non-compliance|0|||
19412438|NCT02409368|41658007|FG000|ECOG Reclassification|Study drug toxicity|17|||
19412439|NCT02409368|41658008|FG001|ECOG Reclassification|Study drug toxicity|42|||
19412440|NCT02409368|41658009|FG002|ECOG Reclassification|Study drug toxicity|7|||
19412441|NCT02409368|41658010|FG003|ECOG Reclassification|Study drug toxicity|0|||
19412442|NCT02409368|41658007|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
19412443|NCT02409368|41658008|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
19412444|NCT02409368|41658009|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
19412445|NCT02409368|41658010|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
19412446|NCT02409368|41658007|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
19412447|NCT02409368|41658008|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
19412448|NCT02409368|41658009|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
19412449|NCT02409368|41658010|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
19412450|NCT02409368|41658007|FG000|ECOG Reclassification|Participant withdrew consent|2|||
19412451|NCT02409368|41658008|FG001|ECOG Reclassification|Participant withdrew consent|3|||
19412452|NCT02409368|41658009|FG002|ECOG Reclassification|Participant withdrew consent|4|||
19412453|NCT02409368|41658010|FG003|ECOG Reclassification|Participant withdrew consent|0|||
19412454|NCT02409368|41658007|FG000|ECOG Reclassification|Other Reasons|5|||
19412455|NCT02409368|41658008|FG001|ECOG Reclassification|Other Reasons|26|||
19412456|NCT02409368|41658009|FG002|ECOG Reclassification|Other Reasons|2|||
19412457|NCT02409368|41658010|FG003|ECOG Reclassification|Other Reasons|0|||
19412458|NCT02409368|41658007|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
19412459|NCT02409368|41658008|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
19412460|NCT02409368|41658009|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
19412461|NCT02409368|41658010|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
19412462|NCT01853878|41658023|FG000|Overall Study|Recurrence|2|||
19412463|NCT01853878|41658024|FG001|Overall Study|Recurrence|0|||
19412464|NCT01853878|41658023|FG000|Overall Study|Adverse Event|2|||
19412465|NCT01853878|41658024|FG001|Overall Study|Adverse Event|0|||
19412466|NCT01853878|41658023|FG000|Overall Study|Withdrawal by Subject|3|||
19412467|NCT01853878|41658024|FG001|Overall Study|Withdrawal by Subject|1|||
19412468|NCT01853878|41658023|FG000|Overall Study|Migrated/moved from the study area|1|||
19412469|NCT01853878|41658024|FG001|Overall Study|Migrated/moved from the study area|0|||
19412470|NCT01853878|41658023|FG000|Overall Study|Other|55|||
19412471|NCT01853878|41658024|FG001|Overall Study|Other|43|||
19412472|NCT02342678|41658032|FG000|Overall Study|Lost to Follow-up|0|||
19412473|NCT02342678|41658033|FG001|Overall Study|Lost to Follow-up|1|||
19412474|NCT02342678|41658032|FG000|Overall Study|Too busy to complete study|0|||
19412475|NCT02342678|41658033|FG001|Overall Study|Too busy to complete study|2|||
19412476|NCT02342678|41658032|FG000|Overall Study|Family illness/emergency|0|||
19412477|NCT02342678|41658033|FG001|Overall Study|Family illness/emergency|1|||
19412478|NCT02342678|41658032|FG000|Overall Study|Illness/medical reason|1|||
19412479|NCT02342678|41658033|FG001|Overall Study|Illness/medical reason|1|||
19412480|NCT02408120|41658041|FG000|Overall Study|Withdrawal by Subject|0|||
19412481|NCT02408120|41658042|FG001|Overall Study|Withdrawal by Subject|1|||
19412482|NCT02408120|41658041|FG000|Overall Study|Treatment Refusal|1|||
19412483|NCT02408120|41658042|FG001|Overall Study|Treatment Refusal|0|||
19412484|NCT02408120|41658041|FG000|Overall Study|Received Steroids|1|||
19412485|NCT02408120|41658042|FG001|Overall Study|Received Steroids|1|||
19412486|NCT02408120|41658041|FG000|Overall Study|Discharged same day|1|||
19412487|NCT02408120|41658042|FG001|Overall Study|Discharged same day|1|||
19412488|NCT02408120|41658041|FG000|Overall Study|Did not receive insulin|1|||
19412489|NCT02408120|41658042|FG001|Overall Study|Did not receive insulin|2|||
19412490|NCT02342288|41658050|FG000|Overall Study|no protocol anesthesiologist available|3|||
19412491|NCT02342288|41658051|FG001|Overall Study|no protocol anesthesiologist available|2|||
19412492|NCT02342288|41658050|FG000|Overall Study|anesthesia leak in system|1|||
19412493|NCT02342288|41658051|FG001|Overall Study|anesthesia leak in system|0|||
19412494|NCT02342288|41658050|FG000|Overall Study|Withdrawal by Subject|1|||
19412495|NCT02342288|41658051|FG001|Overall Study|Withdrawal by Subject|0|||
19412496|NCT02342288|41658050|FG000|Overall Study|coordinator contaminated with blood|0|||
19412497|NCT02342288|41658051|FG001|Overall Study|coordinator contaminated with blood|1|||
19412498|NCT02342288|41658050|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
19412499|NCT02342288|41658051|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
19412500|NCT02342288|41658050|FG000|Overall Study|coordinator not available|0|||
19412501|NCT02342288|41658051|FG001|Overall Study|coordinator not available|2|||
19412502|NCT01853644|41658057|FG000|Registration and Treatment Start|Did not start treatment|1|||
19412503|NCT01853644|41658057|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
19412504|NCT01853644|41658057|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
19412505|NCT01853644|41658057|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
19412506|NCT01853644|41658057|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
19412507|NCT01853644|41658057|FG000|Continued Treatment After First Response|Adverse Event|2|||
19412508|NCT01853644|41658057|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
19412509|NCT02374346|41658061|FG000|Overall Study|operated or discharged during weekend|48|||
19412510|NCT01853254|41658067|FG000|Overall Study|Abnormal Laboratory Test|1|||
19412511|NCT01853254|41658067|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
19412512|NCT01853254|41658067|FG000|Overall Study|Death|1|||
19412513|NCT01853254|41658067|FG000|Overall Study|Failure to Return|43|||
19412514|NCT01853254|41658067|FG000|Overall Study|Insufficient Therapeutic Response|22|||
19412515|NCT01853254|41658067|FG000|Overall Study|Refusal of Treatment|1|||
19412516|NCT01853254|41658067|FG000|Overall Study|Other Protocol Violation|1|||
19412517|NCT01853254|41658067|FG000|Overall Study|Withdrawal of Consent|16|||
19412518|NCT01853254|41658067|FG000|Overall Study|Administrative/Other|16|||
19412519|NCT02373098|41658073|FG000|Overall Study|Lost to Follow-up|1|||
19412520|NCT02373098|41658074|FG001|Overall Study|Lost to Follow-up|0|||
19412521|NCT02373098|41658073|FG000|Overall Study|Protocol Violation|3|||
19412522|NCT02373098|41658074|FG001|Overall Study|Protocol Violation|0|||
19412523|NCT02373098|41658073|FG000|Overall Study|Withdrawal by Subject|5|||
19412524|NCT02373098|41658074|FG001|Overall Study|Withdrawal by Subject|0|||
19412525|NCT02373098|41658073|FG000|Overall Study|Adverse Event|3|||
19412526|NCT02373098|41658074|FG001|Overall Study|Adverse Event|0|||
19412527|NCT01853176|41658088|FG000|Overall Study|Study terminated|4|||
19412528|NCT01853176|41658089|FG001|Overall Study|Study terminated|0|||
19412529|NCT02372396|41658097|FG000|Overall Study|Lost to Follow-up|7|||
19412530|NCT02372396|41658098|FG001|Overall Study|Lost to Follow-up|9|||
19412531|NCT01835548|41658106|FG000|Dose Optimization Period|Adverse Event|0|||
19412532|NCT01835548|41658107|FG001|Dose Optimization Period|Adverse Event|0|||
19412533|NCT01835548|41658108|FG002|Dose Optimization Period|Adverse Event|1|||
19412534|NCT01835548|41658106|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
19412535|NCT01835548|41658107|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
19412536|NCT01835548|41658108|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
19412537|NCT01835548|41658106|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19412538|NCT01835548|41658107|FG001|Double-Blind Treatment Period|Adverse Event|1|||
19412539|NCT01835548|41658108|FG002|Double-Blind Treatment Period|Adverse Event|0|||
19412540|NCT01835548|41658106|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19412541|NCT01835548|41658107|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
19412542|NCT01835548|41658108|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19412543|NCT02340962|41658122|FG000|Overall Study|Lost to Follow-up|1|||
19412544|NCT02340962|41658123|FG001|Overall Study|Lost to Follow-up|0|||
19412545|NCT01852942|41658131|FG000|Overall Study|Physician Decision|1|||
19412546|NCT01852942|41658132|FG001|Overall Study|Physician Decision|0|||
19412547|NCT01852942|41658131|FG000|Overall Study|Death|1|||
19412548|NCT01852942|41658132|FG001|Overall Study|Death|1|||
19412549|NCT01852942|41658131|FG000|Overall Study|Withdrawal by Subject|2|||
19412550|NCT01852942|41658132|FG001|Overall Study|Withdrawal by Subject|3|||
19412551|NCT01852942|41658131|FG000|Overall Study|Lost to Follow-up|1|||
19412552|NCT01852942|41658132|FG001|Overall Study|Lost to Follow-up|2|||
19412553|NCT01852162|41658141|FG000|Overall Study|Adverse Event|1|||
19412554|NCT01852162|41658142|FG001|Overall Study|Adverse Event|0|||
19412555|NCT01852162|41658141|FG000|Overall Study|Withdrawal by Subject|3|||
19412556|NCT01852162|41658142|FG001|Overall Study|Withdrawal by Subject|1|||
19412557|NCT01835470|41658148|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
19412558|NCT01835470|41658148|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
19412559|NCT02451137|41658155|FG000|Overall Study|Randomized but not treated|19|||
19412560|NCT02451137|41658156|FG001|Overall Study|Randomized but not treated|27|||
19412561|NCT02451137|41658155|FG000|Overall Study|Adverse Event|43|||
19412562|NCT02451137|41658156|FG001|Overall Study|Adverse Event|42|||
19412563|NCT02451137|41658155|FG000|Overall Study|Lack of Efficacy|4|||
19412564|NCT02451137|41658156|FG001|Overall Study|Lack of Efficacy|9|||
19412565|NCT02451137|41658155|FG000|Overall Study|Participant decision:discontinue insulin|41|||
19412566|NCT02451137|41658156|FG001|Overall Study|Participant decision:discontinue insulin|43|||
19412567|NCT02451137|41658155|FG000|Overall Study|Hypoglycemia|2|||
19412568|NCT02451137|41658156|FG001|Overall Study|Hypoglycemia|1|||
19412569|NCT02451137|41658155|FG000|Overall Study|Investigator's decision|23|||
19412570|NCT02451137|41658156|FG001|Overall Study|Investigator's decision|19|||
19412571|NCT02451137|41658155|FG000|Overall Study|Lost to Follow-up|53|||
19412572|NCT02451137|41658156|FG001|Overall Study|Lost to Follow-up|61|||
19412573|NCT02451137|41658155|FG000|Overall Study|Physician Decision|6|||
19412574|NCT02451137|41658156|FG001|Overall Study|Physician Decision|5|||
19412575|NCT02451137|41658155|FG000|Overall Study|Sponsor decision|13|||
19412576|NCT02451137|41658156|FG001|Overall Study|Sponsor decision|25|||
19412577|NCT02451137|41658155|FG000|Overall Study|Withdrawal by Subject|40|||
19412578|NCT02451137|41658156|FG001|Overall Study|Withdrawal by Subject|63|||
19412579|NCT02451137|41658155|FG000|Overall Study|Other than specified above|2|||
19412580|NCT02451137|41658156|FG001|Overall Study|Other than specified above|3|||
19519138|NCT01474512|41932299|FG007|Induction Period|Lack of Efficacy|0|||
19412581|NCT02372006|41658165|FG000|Overall Study|Progressive disease|8|||
19412582|NCT02372006|41658166|FG001|Overall Study|Progressive disease|7|||
19412583|NCT02372006|41658167|FG002|Overall Study|Progressive disease|34|||
19412584|NCT02372006|41658165|FG000|Overall Study|Dose limiting toxicity|0|||
19412585|NCT02372006|41658166|FG001|Overall Study|Dose limiting toxicity|1|||
19412586|NCT02372006|41658167|FG002|Overall Study|Dose limiting toxicity|0|||
19412587|NCT02372006|41658165|FG000|Overall Study|Adverse Event|0|||
19412588|NCT02372006|41658166|FG001|Overall Study|Adverse Event|0|||
19412589|NCT02372006|41658167|FG002|Overall Study|Adverse Event|3|||
19412590|NCT02372006|41658165|FG000|Overall Study|Withdrawal by Subject|0|||
19412591|NCT02372006|41658166|FG001|Overall Study|Withdrawal by Subject|1|||
19412592|NCT02372006|41658167|FG002|Overall Study|Withdrawal by Subject|1|||
19412593|NCT02372006|41658165|FG000|Overall Study|Other reason for not completing|0|||
19412594|NCT02372006|41658166|FG001|Overall Study|Other reason for not completing|0|||
19412595|NCT02372006|41658167|FG002|Overall Study|Other reason for not completing|1|||
19412596|NCT02406248|41658176|FG000|Overall Study|Death|7|||
19412597|NCT02406248|41658176|FG000|Overall Study|Withdrawal by Subject|2|||
19412598|NCT02450903|41658180|FG000|Overall Study|Adverse Event|3|||
19412599|NCT02450903|41658180|FG000|Overall Study|Progressive disease|15|||
19412600|NCT02450903|41658180|FG000|Overall Study|Switched to commercial drug|1|||
19412601|NCT02450903|41658180|FG000|Overall Study|Subject/guardian decision|1|||
19412602|NCT02371616|41658186|FG000|Overall Study|Protocol Violation|2|||
19412603|NCT02371616|41658187|FG001|Overall Study|Protocol Violation|1|||
19412604|NCT02371616|41658186|FG000|Overall Study|Adverse Event|0|||
19412605|NCT02371616|41658187|FG001|Overall Study|Adverse Event|1|||
19412606|NCT02371616|41658186|FG000|Overall Study|Withdrawal of Consent|1|||
19412607|NCT02371616|41658187|FG001|Overall Study|Withdrawal of Consent|0|||
19412608|NCT02371616|41658186|FG000|Overall Study|Other (Not specified)|1|||
19412609|NCT02371616|41658187|FG001|Overall Study|Other (Not specified)|5|||
19412610|NCT02370914|41658193|FG000|Overall Study|Protocol Violation|2|||
19412611|NCT02370602|41658203|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19412612|NCT02370602|41658204|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
19412613|NCT02370602|41658205|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19412614|NCT02370602|41658206|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
19412615|NCT02370602|41658207|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
19412616|NCT02370602|41658208|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
19412617|NCT02370368|41658227|FG000|Overall Study|Adverse Event|1|||
19412618|NCT02370368|41658228|FG001|Overall Study|Adverse Event|2|||
19412619|NCT02370368|41658227|FG000|Overall Study|Withdrawal by Subject|5|||
19412620|NCT02370368|41658228|FG001|Overall Study|Withdrawal by Subject|4|||
19412621|NCT02340806|41658236|FG000|Overall Study|Protocol Violation|2|||
19412622|NCT02340806|41658237|FG001|Overall Study|Protocol Violation|0|||
19412623|NCT02340806|41658236|FG000|Overall Study|epidural catheter replaced|2|||
19412624|NCT02340806|41658237|FG001|Overall Study|epidural catheter replaced|1|||
19412625|NCT02340806|41658236|FG000|Overall Study|history of chronic pain medication|1|||
19412626|NCT02340806|41658237|FG001|Overall Study|history of chronic pain medication|0|||
19412627|NCT02340806|41658236|FG000|Overall Study|re-dose < 90 min of CSE|1|||
19412628|NCT02340806|41658237|FG001|Overall Study|re-dose < 90 min of CSE|3|||
19412629|NCT02338154|41658243|FG000|Overall Study|Death|46|||
19412630|NCT02338154|41658243|FG000|Overall Study|Valve Implant Failure|17|||
19412631|NCT02338154|41658243|FG000|Overall Study|Valve Explant|11|||
19412632|NCT02338154|41658243|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
19412633|NCT02338154|41658243|FG000|Overall Study|Lost to Follow-up|8|||
19412634|NCT02338154|41658243|FG000|Overall Study|Other Reason|3|||
19412635|NCT02338154|41658243|FG000|Overall Study|Patients Without Exit Form|47|||
19412636|NCT02338154|41658243|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
19412637|NCT01835158|41658257|FG000|Overall Study|Withdrawal by Subject|1|||
19412638|NCT01835158|41658258|FG001|Overall Study|Withdrawal by Subject|6|||
19412639|NCT02337764|41658264|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
19412640|NCT02337764|41658264|FG000|Overall Study|Voluntary Withdrawal|12|||
19412641|NCT02337764|41658264|FG000|Overall Study|Lack of Efficacy|2|||
19412642|NCT01834222|41658268|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
19412643|NCT01833832|41658272|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
19412644|NCT01833520|41658278|FG000|Overall Study|Lack of Efficacy|3|||
19412645|NCT01833520|41658279|FG001|Overall Study|Lack of Efficacy|3|||
19412646|NCT01833520|41658280|FG002|Overall Study|Lack of Efficacy|8|||
19412647|NCT01833520|41658281|FG003|Overall Study|Lack of Efficacy|3|||
19412648|NCT01850602|41658295|FG000|Overall Study|Adverse Event|7|||
19412649|NCT01850602|41658296|FG001|Overall Study|Adverse Event|10|||
19412650|NCT01850602|41658295|FG000|Overall Study|Physician Decision|2|||
19412651|NCT01850602|41658296|FG001|Overall Study|Physician Decision|1|||
19412652|NCT01850602|41658295|FG000|Overall Study|Withdrawal by Subject|2|||
19412653|NCT01850602|41658296|FG001|Overall Study|Withdrawal by Subject|4|||
19412654|NCT01850602|41658295|FG000|Overall Study|Decrease in serum calcium|2|||
19412655|NCT01850602|41658296|FG001|Overall Study|Decrease in serum calcium|3|||
19412656|NCT01850602|41658295|FG000|Overall Study|Increase in serum ferritin|1|||
19412657|NCT01850602|41658296|FG001|Overall Study|Increase in serum ferritin|0|||
19412658|NCT01832818|41658302|FG000|Overall Study|Lost to Follow-up|6|||
19412659|NCT02405780|41658310|FG000|Period I|Adverse Event|8|||
19412660|NCT02405780|41658311|FG001|Period I|Adverse Event|0|||
19412661|NCT02405780|41658312|FG002|Period I|Adverse Event|3|||
19412662|NCT02405780|41658313|FG003|Period I|Adverse Event|7|||
19412663|NCT02405780|41658310|FG000|Period I|Medical reasons|1|||
19412664|NCT02405780|41658311|FG001|Period I|Medical reasons|1|||
19412665|NCT02405780|41658312|FG002|Period I|Medical reasons|0|||
19412666|NCT02405780|41658313|FG003|Period I|Medical reasons|1|||
19412667|NCT02405780|41658310|FG000|Period I|Screening Failure|1|||
19412668|NCT02405780|41658311|FG001|Period I|Screening Failure|0|||
19412669|NCT02405780|41658312|FG002|Period I|Screening Failure|1|||
19412670|NCT02405780|41658313|FG003|Period I|Screening Failure|0|||
19412671|NCT02405780|41658310|FG000|Period I|Withdrawal by Subject|9|||
19412672|NCT02405780|41658311|FG001|Period I|Withdrawal by Subject|1|||
19412673|NCT02405780|41658312|FG002|Period I|Withdrawal by Subject|3|||
19412674|NCT02405780|41658313|FG003|Period I|Withdrawal by Subject|4|||
19412675|NCT02405780|41658310|FG000|Period I|Non-compliance with study procedures|8|||
19412676|NCT02405780|41658311|FG001|Period I|Non-compliance with study procedures|6|||
19412677|NCT02405780|41658312|FG002|Period I|Non-compliance with study procedures|8|||
19412678|NCT02405780|41658313|FG003|Period I|Non-compliance with study procedures|11|||
19412679|NCT02405780|41658310|FG000|Period II|Adverse Event|3|||
19412680|NCT02405780|41658311|FG001|Period II|Adverse Event|5|||
19412681|NCT02405780|41658312|FG002|Period II|Adverse Event|4|||
19412682|NCT02405780|41658313|FG003|Period II|Adverse Event|11|||
19412683|NCT02405780|41658310|FG000|Period II|Medical reason|0|||
19412684|NCT02405780|41658311|FG001|Period II|Medical reason|1|||
19412685|NCT02405780|41658312|FG002|Period II|Medical reason|0|||
19412686|NCT02405780|41658313|FG003|Period II|Medical reason|0|||
19412687|NCT02405780|41658310|FG000|Period II|Pregnancy|0|||
19412688|NCT02405780|41658311|FG001|Period II|Pregnancy|0|||
19412689|NCT02405780|41658312|FG002|Period II|Pregnancy|1|||
19412690|NCT02405780|41658313|FG003|Period II|Pregnancy|0|||
19412691|NCT02405780|41658310|FG000|Period II|Withdrawal by Subject|7|||
19412692|NCT02405780|41658311|FG001|Period II|Withdrawal by Subject|4|||
19412693|NCT02405780|41658312|FG002|Period II|Withdrawal by Subject|0|||
19412694|NCT02405780|41658313|FG003|Period II|Withdrawal by Subject|3|||
19412695|NCT02405780|41658310|FG000|Period II|Non-compliance with study procedures|5|||
19412696|NCT02405780|41658311|FG001|Period II|Non-compliance with study procedures|2|||
19412697|NCT02405780|41658312|FG002|Period II|Non-compliance with study procedures|7|||
19412698|NCT02405780|41658313|FG003|Period II|Non-compliance with study procedures|4|||
19412699|NCT02369510|41658341|FG000|Overall Study|Spilled Medication|1|||
19412700|NCT02369510|41658342|FG001|Overall Study|Spilled Medication|2|||
19412701|NCT02369510|41658343|FG002|Overall Study|Spilled Medication|1|||
19412702|NCT02369510|41658341|FG000|Overall Study|Epidural Activation|1|||
19412703|NCT02369510|41658342|FG001|Overall Study|Epidural Activation|1|||
19412704|NCT02369510|41658343|FG002|Overall Study|Epidural Activation|5|||
19412705|NCT01650194|41658351|FG000|Overall Study|Progressive Disease (PD)|35|||
19412706|NCT01650194|41658351|FG000|Overall Study|Withdrawal by Subject|2|||
19412707|NCT01650194|41658351|FG000|Overall Study|Miscellaneous|10|||
19412708|NCT02367716|41658356|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
19412709|NCT02366936|41658361|FG000|Overall Study|Withdrawal by Subject|2|||
19412710|NCT02366936|41658361|FG000|Overall Study|Lost to Follow-up|4|||
19412711|NCT02366936|41658361|FG000|Overall Study|Physician Decision|2|||
19412712|NCT01648166|41658367|FG000|Overall Study|inadequate toenail samples|53|||
19412713|NCT01648166|41658368|FG001|Overall Study|inadequate toenail samples|100|||
19412714|NCT02336282|41658374|FG000|Overall Study|Unrelated illness|1|||
19412715|NCT02336282|41658374|FG000|Overall Study|Uncomfortable with technology|1|||
19412716|NCT02336282|41658374|FG000|Overall Study|Lost to Follow-up|1|||
19412717|NCT02336282|41658374|FG000|Overall Study|Not enough time to complete sessions|2|||
19412718|NCT02404220|41658390|FG000|Overall Study|Adverse Event|0|||
19412719|NCT02404220|41658391|FG001|Overall Study|Adverse Event|0|||
19412720|NCT02404220|41658392|FG002|Overall Study|Adverse Event|1|||
19412721|NCT02404220|41658393|FG003|Overall Study|Adverse Event|0|||
19412722|NCT02404220|41658390|FG000|Overall Study|Death|5|||
19412723|NCT02404220|41658391|FG001|Overall Study|Death|5|||
19412724|NCT02404220|41658392|FG002|Overall Study|Death|3|||
19412725|NCT02404220|41658393|FG003|Overall Study|Death|8|||
19412726|NCT02404220|41658390|FG000|Overall Study|Progressive Disease|0|||
19412727|NCT02404220|41658391|FG001|Overall Study|Progressive Disease|0|||
19412728|NCT02404220|41658392|FG002|Overall Study|Progressive Disease|1|||
19412729|NCT02404220|41658393|FG003|Overall Study|Progressive Disease|1|||
19412730|NCT02404220|41658390|FG000|Overall Study|Study Terminated by Sponsor|0|||
19412731|NCT02404220|41658391|FG001|Overall Study|Study Terminated by Sponsor|0|||
19412732|NCT02404220|41658392|FG002|Overall Study|Study Terminated by Sponsor|2|||
19412733|NCT02404220|41658393|FG003|Overall Study|Study Terminated by Sponsor|1|||
19412734|NCT02404220|41658390|FG000|Overall Study|Withdrawal by Subject|0|||
19412735|NCT02404220|41658391|FG001|Overall Study|Withdrawal by Subject|1|||
19412736|NCT02404220|41658392|FG002|Overall Study|Withdrawal by Subject|0|||
19412737|NCT02404220|41658393|FG003|Overall Study|Withdrawal by Subject|0|||
19412738|NCT02404220|41658390|FG000|Overall Study|Enrolled but Never Treated|0|||
19412739|NCT02404220|41658391|FG001|Overall Study|Enrolled but Never Treated|2|||
19412740|NCT02404220|41658392|FG002|Overall Study|Enrolled but Never Treated|0|||
19412741|NCT02404220|41658393|FG003|Overall Study|Enrolled but Never Treated|0|||
19412742|NCT02335658|41658405|FG000|Overall Study|Adverse Event|18|||
19412743|NCT02335658|41658406|FG001|Overall Study|Adverse Event|12|||
19412744|NCT02335658|41658405|FG000|Overall Study|Lack of Efficacy|4|||
19412745|NCT02335658|41658406|FG001|Overall Study|Lack of Efficacy|5|||
19412746|NCT02335658|41658405|FG000|Overall Study|Pregnancy|1|||
19412747|NCT02335658|41658406|FG001|Overall Study|Pregnancy|0|||
19412748|NCT02335658|41658405|FG000|Overall Study|Withdrawal by Subject|13|||
19412749|NCT02335658|41658406|FG001|Overall Study|Withdrawal by Subject|21|||
19412750|NCT02335658|41658405|FG000|Overall Study|non-compliance|2|||
19412751|NCT02335658|41658406|FG001|Overall Study|non-compliance|3|||
19412752|NCT02335658|41658405|FG000|Overall Study|other reason|2|||
19412753|NCT02335658|41658406|FG001|Overall Study|other reason|3|||
19412754|NCT02366468|41658416|FG000|Overall Study|Adverse Event|2|||
19412755|NCT02366468|41658417|FG001|Overall Study|Adverse Event|0|||
19412756|NCT02366468|41658416|FG000|Overall Study|Withdrawal by Subject|1|||
19412757|NCT02366468|41658417|FG001|Overall Study|Withdrawal by Subject|5|||
19412758|NCT02366468|41658416|FG000|Overall Study|Lost to Follow-up|2|||
19412759|NCT02366468|41658417|FG001|Overall Study|Lost to Follow-up|0|||
19412760|NCT02366468|41658416|FG000|Overall Study|Death|1|||
19412761|NCT02366468|41658417|FG001|Overall Study|Death|2|||
19412762|NCT02366468|41658416|FG000|Overall Study|Other|0|||
19412763|NCT02366468|41658417|FG001|Overall Study|Other|2|||
19412764|NCT02366312|41658425|FG000|Overall Study|Lost to Follow-up|0|||
19412765|NCT02366312|41658426|FG001|Overall Study|Lost to Follow-up|1|||
19412766|NCT02335346|41658432|FG000|Overall Study|Adverse Event|11|||
19412767|NCT02335346|41658432|FG000|Overall Study|Withdrawal by Subject|1|||
19412768|NCT02403674|41658438|FG000|Overall Study|Adverse Event|10|||
19412769|NCT02403674|41658439|FG001|Overall Study|Adverse Event|23|||
19412770|NCT02403674|41658438|FG000|Overall Study|Death|1|||
19412771|NCT02403674|41658439|FG001|Overall Study|Death|3|||
19412772|NCT02403674|41658438|FG000|Overall Study|Lack of Efficacy|18|||
19412773|NCT02403674|41658439|FG001|Overall Study|Lack of Efficacy|10|||
19412774|NCT02403674|41658438|FG000|Overall Study|Lost to Follow-up|6|||
19412775|NCT02403674|41658439|FG001|Overall Study|Lost to Follow-up|7|||
19412776|NCT02403674|41658438|FG000|Overall Study|Noncompliance with study drug|1|||
19412777|NCT02403674|41658439|FG001|Overall Study|Noncompliance with study drug|2|||
19412778|NCT02403674|41658438|FG000|Overall Study|Withdrawal by Subject|8|||
19412779|NCT02403674|41658439|FG001|Overall Study|Withdrawal by Subject|11|||
19412780|NCT02403674|41658438|FG000|Overall Study|Physician Decision|2|||
19412781|NCT02403674|41658439|FG001|Overall Study|Physician Decision|2|||
19412782|NCT02403674|41658438|FG000|Overall Study|Not treated with study drug|4|||
19412783|NCT02403674|41658439|FG001|Overall Study|Not treated with study drug|2|||
19412784|NCT02403674|41658438|FG000|Overall Study|Pregnancy|1|||
19412785|NCT02403674|41658439|FG001|Overall Study|Pregnancy|1|||
19412786|NCT02403674|41658438|FG000|Overall Study|Protocol Violation|4|||
19412787|NCT02403674|41658439|FG001|Overall Study|Protocol Violation|2|||
19412788|NCT02403206|41658447|FG000|Overall Study|Lost to Follow-up|4|||
19412789|NCT02403206|41658448|FG001|Overall Study|Lost to Follow-up|3|||
19412790|NCT02403206|41658447|FG000|Overall Study|Physician Decision|2|||
19412791|NCT02403206|41658448|FG001|Overall Study|Physician Decision|0|||
19412792|NCT02403206|41658447|FG000|Overall Study|Withdrawal by Subject|3|||
19412793|NCT02403206|41658448|FG001|Overall Study|Withdrawal by Subject|3|||
19412794|NCT02403206|41658447|FG000|Overall Study|Reason not given|2|||
19412795|NCT02403206|41658448|FG001|Overall Study|Reason not given|4|||
19412796|NCT02333630|41658457|FG000|Overall Study|Lost to Follow-up|5|||
19412797|NCT02333630|41658458|FG001|Overall Study|Lost to Follow-up|2|||
19412798|NCT02401412|41658470|FG000|Overall Study|Lost to Follow-up|1|||
19412799|NCT02401412|41658471|FG001|Overall Study|Lost to Follow-up|0|||
19412800|NCT02401412|41658470|FG000|Overall Study|Discontinued Intervention|15|||
19412801|NCT02401412|41658471|FG001|Overall Study|Discontinued Intervention|21|||
19412802|NCT02401412|41658470|FG000|Overall Study|Withdrawal by Subject|4|||
19412803|NCT02401412|41658471|FG001|Overall Study|Withdrawal by Subject|4|||
19412804|NCT02401412|41658470|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
19412805|NCT02401412|41658471|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
19412806|NCT02401412|41658470|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
19412807|NCT02401412|41658471|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
19412808|NCT02365298|41658477|FG000|Period 2|incorrect Rx dispensed|1|||
19412809|NCT02365298|41658478|FG001|Period 2|incorrect Rx dispensed|0|||
19412810|NCT02365298|41658477|FG000|Period 2|Discontinued at request of Sponsor|1|||
19412811|NCT02365298|41658478|FG001|Period 2|Discontinued at request of Sponsor|0|||
19412812|NCT02365298|41658477|FG000|Period 2|Test Article longer available|0|||
19412813|NCT02365298|41658478|FG001|Period 2|Test Article longer available|1|||
19412814|NCT02365298|41658477|FG000|Period 2|Protocol Violation|0|||
19412815|NCT02365298|41658478|FG001|Period 2|Protocol Violation|1|||
19412816|NCT02365064|41658486|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
19412817|NCT02365064|41658487|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
19412818|NCT02365064|41658486|FG000|Overall Study|Withdrawal by Subject|6|||
19412819|NCT02365064|41658487|FG001|Overall Study|Withdrawal by Subject|9|||
19412820|NCT02365064|41658486|FG000|Overall Study|Treatment intolerance|2|||
19412821|NCT02365064|41658487|FG001|Overall Study|Treatment intolerance|4|||
19412822|NCT02401256|41658493|FG000|Overall Study|Adverse Event|5|||
19412823|NCT02401256|41658493|FG000|Overall Study|Withdrawal by Subject|12|||
19412824|NCT02349295|41658502|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
19412825|NCT02349295|41658503|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
19412826|NCT02349295|41658504|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
19412827|NCT02349295|41658505|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412828|NCT02349295|41658506|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412829|NCT02349295|41658507|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412830|NCT02349295|41658508|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412831|NCT02349295|41658509|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412832|NCT02349295|41658510|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412833|NCT02349295|41658511|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412834|NCT02349295|41658512|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412835|NCT02349295|41658513|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412836|NCT02349295|41658514|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412837|NCT02349295|41658515|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
19412838|NCT02349295|41658502|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
19412839|NCT02349295|41658503|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
19412840|NCT02349295|41658504|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
19412841|NCT02349295|41658505|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412842|NCT02349295|41658506|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412843|NCT02349295|41658507|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412844|NCT02349295|41658508|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412845|NCT02349295|41658509|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412846|NCT02349295|41658510|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412847|NCT02349295|41658511|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412848|NCT02349295|41658512|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412849|NCT02349295|41658513|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412850|NCT02349295|41658514|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412851|NCT02349295|41658515|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
19412852|NCT02349295|41658502|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
19412853|NCT02349295|41658503|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
19412854|NCT02349295|41658504|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
19412855|NCT02349295|41658505|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412856|NCT02349295|41658506|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412857|NCT02349295|41658507|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412858|NCT02349295|41658508|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412859|NCT02349295|41658509|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412860|NCT02349295|41658510|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412861|NCT02349295|41658511|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412862|NCT02349295|41658512|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412863|NCT02349295|41658513|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412864|NCT02349295|41658514|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412865|NCT02349295|41658515|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
19412866|NCT02349295|41658502|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
19412867|NCT02349295|41658503|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
19412868|NCT02349295|41658504|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
19412869|NCT02349295|41658505|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412870|NCT02349295|41658506|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412871|NCT02349295|41658507|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412872|NCT02349295|41658508|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412873|NCT02349295|41658509|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412874|NCT02349295|41658510|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412875|NCT02349295|41658511|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412876|NCT02349295|41658512|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412877|NCT02349295|41658513|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412878|NCT02349295|41658514|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412879|NCT02349295|41658515|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
19412880|NCT02349295|41658502|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19519139|NCT01474512|41932300|FG008|Induction Period|Lack of Efficacy|0|||
19519140|NCT01474512|41932301|FG009|Induction Period|Lack of Efficacy|0|||
19412881|NCT02349295|41658503|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
19412882|NCT02349295|41658504|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
19412883|NCT02349295|41658505|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412884|NCT02349295|41658506|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412885|NCT02349295|41658507|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412886|NCT02349295|41658508|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412887|NCT02349295|41658509|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412888|NCT02349295|41658510|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412889|NCT02349295|41658511|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412890|NCT02349295|41658512|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412891|NCT02349295|41658513|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412892|NCT02349295|41658514|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412893|NCT02349295|41658515|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
19412894|NCT02349295|41658502|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
19412895|NCT02349295|41658503|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
19412896|NCT02349295|41658504|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
19412897|NCT02349295|41658505|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
19412898|NCT02349295|41658506|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
19412899|NCT02349295|41658507|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
19412900|NCT02349295|41658508|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
19412901|NCT02349295|41658509|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
19412902|NCT02349295|41658510|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
19412903|NCT02349295|41658511|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
19412904|NCT02349295|41658512|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
19412905|NCT02349295|41658513|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
19412906|NCT02349295|41658514|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
19412907|NCT02349295|41658515|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
19412908|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412909|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412910|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412911|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412912|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412913|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412914|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412915|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
19412916|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
19412917|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
19412918|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
19412919|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412920|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412921|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
19412922|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412923|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412924|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412925|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412926|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412927|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412928|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412929|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
19412930|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
19412931|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
19412932|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
19412933|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412934|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412935|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
19412936|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412937|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412938|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412939|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412940|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412941|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412942|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412943|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
19412944|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412945|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
19412946|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19519141|NCT01474512|41932302|FG010|Induction Period|Lack of Efficacy|0|||
19412947|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412948|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412949|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
19412950|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
19412951|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
19412952|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
19412953|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
19412954|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
19412955|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
19412956|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
19412957|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
19412958|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
19412959|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
19412960|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
19412961|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
19412962|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
19412963|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
19412964|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412965|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412966|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412967|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412968|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412969|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412970|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412971|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
19412972|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
19412973|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
19412974|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
19412975|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412976|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412977|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
19412978|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412979|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412980|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412981|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412982|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412983|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412984|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412985|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
19412986|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
19412987|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412988|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412989|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412990|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412991|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
19412992|NCT02349295|41658502|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412993|NCT02349295|41658503|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412994|NCT02349295|41658504|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412995|NCT02349295|41658505|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412996|NCT02349295|41658506|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412997|NCT02349295|41658507|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412998|NCT02349295|41658508|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19412999|NCT02349295|41658509|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
19413000|NCT02349295|41658510|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
19413001|NCT02349295|41658511|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19413002|NCT02349295|41658512|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19413003|NCT02349295|41658513|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19413004|NCT02349295|41658514|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19413005|NCT02349295|41658515|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
19413006|NCT02349295|41658502|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413007|NCT02349295|41658503|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413008|NCT02349295|41658504|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413009|NCT02349295|41658505|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19519142|NCT01474512|41932303|FG011|Induction Period|Lack of Efficacy|0|||
19413010|NCT02349295|41658506|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413011|NCT02349295|41658507|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413012|NCT02349295|41658508|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413013|NCT02349295|41658509|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413014|NCT02349295|41658510|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413015|NCT02349295|41658511|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413016|NCT02349295|41658512|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
19413017|NCT02349295|41658513|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
19413018|NCT02349295|41658514|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
19413019|NCT02349295|41658515|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
19413020|NCT02349295|41658502|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413021|NCT02349295|41658503|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413022|NCT02349295|41658504|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413023|NCT02349295|41658505|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413024|NCT02349295|41658506|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413025|NCT02349295|41658507|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413026|NCT02349295|41658508|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413027|NCT02349295|41658509|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413028|NCT02349295|41658510|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413029|NCT02349295|41658511|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413030|NCT02349295|41658512|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413031|NCT02349295|41658513|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
19413032|NCT02349295|41658514|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
19413033|NCT02349295|41658515|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
19413034|NCT02349295|41658502|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413035|NCT02349295|41658503|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413036|NCT02349295|41658504|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413037|NCT02349295|41658505|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413038|NCT02349295|41658506|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413039|NCT02349295|41658507|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413040|NCT02349295|41658508|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413041|NCT02349295|41658509|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413042|NCT02349295|41658510|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413043|NCT02349295|41658511|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413044|NCT02349295|41658512|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413045|NCT02349295|41658513|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
19413046|NCT02349295|41658514|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
19413047|NCT02349295|41658515|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
19413048|NCT02349295|41658502|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413049|NCT02349295|41658503|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413050|NCT02349295|41658504|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413051|NCT02349295|41658505|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413052|NCT02349295|41658506|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413053|NCT02349295|41658507|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413054|NCT02349295|41658508|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413055|NCT02349295|41658509|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413056|NCT02349295|41658510|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413057|NCT02349295|41658511|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413058|NCT02349295|41658512|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413059|NCT02349295|41658513|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
19413060|NCT02349295|41658514|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413061|NCT02349295|41658515|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
19413062|NCT02349295|41658502|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413063|NCT02349295|41658503|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413064|NCT02349295|41658504|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413065|NCT02349295|41658505|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413066|NCT02349295|41658506|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413067|NCT02349295|41658507|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413068|NCT02349295|41658508|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413069|NCT02349295|41658509|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413070|NCT02349295|41658510|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413071|NCT02349295|41658511|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413072|NCT02349295|41658512|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413073|NCT02349295|41658513|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
19519143|NCT01474512|41932304|FG012|Induction Period|Lack of Efficacy|0|||
19413074|NCT02349295|41658514|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413075|NCT02349295|41658515|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
19413076|NCT02281357|41658542|FG000|Overall Study|Adverse Event|2|||
19413077|NCT02281357|41658543|FG001|Overall Study|Adverse Event|1|||
19413078|NCT02281357|41658542|FG000|Overall Study|Lost to Follow-up|1|||
19413079|NCT02281357|41658543|FG001|Overall Study|Lost to Follow-up|0|||
19413080|NCT02281357|41658542|FG000|Overall Study|Withdrawal by Subject|4|||
19413081|NCT02281357|41658543|FG001|Overall Study|Withdrawal by Subject|3|||
19413082|NCT02284243|41658551|FG000|Overall Study|Lack of Efficacy|3|||
19413083|NCT02284243|41658552|FG001|Overall Study|Lack of Efficacy|3|||
19413084|NCT02284243|41658551|FG000|Overall Study|Adverse Event|1|||
19413085|NCT02284243|41658552|FG001|Overall Study|Adverse Event|0|||
19413086|NCT02284009|41658560|FG000|Overall Study|Adverse Event|3|||
19413087|NCT02284009|41658561|FG001|Overall Study|Adverse Event|0|||
19413088|NCT02284009|41658560|FG000|Overall Study|Lost to Follow-up|1|||
19413089|NCT02284009|41658561|FG001|Overall Study|Lost to Follow-up|3|||
19413090|NCT02284009|41658560|FG000|Overall Study|Physician Decision|0|||
19413091|NCT02284009|41658561|FG001|Overall Study|Physician Decision|2|||
19413092|NCT02284009|41658560|FG000|Overall Study|Withdrawal by Subject|2|||
19413093|NCT02284009|41658561|FG001|Overall Study|Withdrawal by Subject|5|||
19413094|NCT02280499|41658569|FG000|Overall Study|Death|14|||
19413095|NCT02280499|41658569|FG000|Overall Study|Lost to Follow-up|42|||
19413096|NCT02280499|41658569|FG000|Overall Study|Adverse Event|5|||
19413097|NCT02400476|41658579|FG000|Overall Study|Adverse Event|57|||
19413098|NCT02400476|41658580|FG001|Overall Study|Adverse Event|10|||
19413099|NCT02400476|41658581|FG002|Overall Study|Adverse Event|22|||
19413100|NCT02400476|41658582|FG003|Overall Study|Adverse Event|19|||
19413101|NCT02400476|41658583|FG004|Overall Study|Adverse Event|5|||
19413102|NCT02400476|41658584|FG005|Overall Study|Adverse Event|8|||
19413103|NCT02400476|41658579|FG000|Overall Study|Withdrawal by Subject|4|||
19413104|NCT02400476|41658580|FG001|Overall Study|Withdrawal by Subject|1|||
19413105|NCT02400476|41658581|FG002|Overall Study|Withdrawal by Subject|12|||
19413106|NCT02400476|41658582|FG003|Overall Study|Withdrawal by Subject|7|||
19413107|NCT02400476|41658583|FG004|Overall Study|Withdrawal by Subject|5|||
19413108|NCT02400476|41658584|FG005|Overall Study|Withdrawal by Subject|5|||
19413109|NCT02400476|41658579|FG000|Overall Study|Lost to Follow-up|0|||
19413110|NCT02400476|41658580|FG001|Overall Study|Lost to Follow-up|0|||
19413111|NCT02400476|41658581|FG002|Overall Study|Lost to Follow-up|0|||
19413112|NCT02400476|41658582|FG003|Overall Study|Lost to Follow-up|1|||
19413113|NCT02400476|41658583|FG004|Overall Study|Lost to Follow-up|3|||
19413114|NCT02400476|41658584|FG005|Overall Study|Lost to Follow-up|1|||
19413115|NCT02400476|41658579|FG000|Overall Study|Physician Decision|0|||
19413116|NCT02400476|41658580|FG001|Overall Study|Physician Decision|0|||
19413117|NCT02400476|41658581|FG002|Overall Study|Physician Decision|1|||
19413118|NCT02400476|41658582|FG003|Overall Study|Physician Decision|1|||
19413119|NCT02400476|41658583|FG004|Overall Study|Physician Decision|0|||
19413120|NCT02400476|41658584|FG005|Overall Study|Physician Decision|1|||
19413121|NCT02400476|41658579|FG000|Overall Study|Other, Disease Progression|0|||
19413122|NCT02400476|41658580|FG001|Overall Study|Other, Disease Progression|1|||
19413123|NCT02400476|41658581|FG002|Overall Study|Other, Disease Progression|2|||
19413124|NCT02400476|41658582|FG003|Overall Study|Other, Disease Progression|1|||
19413125|NCT02400476|41658583|FG004|Overall Study|Other, Disease Progression|2|||
19413126|NCT02400476|41658584|FG005|Overall Study|Other, Disease Progression|1|||
19413127|NCT02400476|41658579|FG000|Overall Study|Other, Decreased Quality of Life|0|||
19413128|NCT02400476|41658580|FG001|Overall Study|Other, Decreased Quality of Life|0|||
19413129|NCT02400476|41658581|FG002|Overall Study|Other, Decreased Quality of Life|2|||
19413130|NCT02400476|41658582|FG003|Overall Study|Other, Decreased Quality of Life|0|||
19413131|NCT02400476|41658583|FG004|Overall Study|Other, Decreased Quality of Life|0|||
19413132|NCT02400476|41658584|FG005|Overall Study|Other, Decreased Quality of Life|0|||
19413133|NCT02400476|41658579|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
19413134|NCT02400476|41658580|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
19413135|NCT02400476|41658581|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
19413136|NCT02400476|41658582|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
19413137|NCT02400476|41658583|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
19413138|NCT02400476|41658584|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
19413139|NCT02363738|41658600|FG000|Overall Study|Adverse Event|5|||
19413140|NCT02363738|41658601|FG001|Overall Study|Adverse Event|2|||
19413141|NCT02363738|41658600|FG000|Overall Study|Lack of Efficacy|1|||
19413142|NCT02363738|41658601|FG001|Overall Study|Lack of Efficacy|2|||
19413143|NCT02363738|41658600|FG000|Overall Study|Lost to Follow-up|2|||
19413144|NCT02363738|41658601|FG001|Overall Study|Lost to Follow-up|1|||
19413145|NCT02331680|41658610|FG000|Overall Study|Adverse Event|3|||
19413146|NCT02331680|41658611|FG001|Overall Study|Adverse Event|0|||
19413147|NCT02331680|41658612|FG002|Overall Study|Adverse Event|2|||
19413148|NCT02331680|41658610|FG000|Overall Study|Physician Decision|1|||
19413149|NCT02331680|41658611|FG001|Overall Study|Physician Decision|1|||
19413150|NCT02331680|41658612|FG002|Overall Study|Physician Decision|2|||
19413151|NCT02331680|41658610|FG000|Overall Study|Withdrawal by Subject|0|||
19413152|NCT02331680|41658611|FG001|Overall Study|Withdrawal by Subject|1|||
19413153|NCT02331680|41658612|FG002|Overall Study|Withdrawal by Subject|2|||
19413154|NCT02331680|41658610|FG000|Overall Study|Met withdrawal criteria|2|||
19413155|NCT02331680|41658611|FG001|Overall Study|Met withdrawal criteria|2|||
19413156|NCT02331680|41658612|FG002|Overall Study|Met withdrawal criteria|5|||
19413157|NCT02331680|41658610|FG000|Overall Study|Non-compliance with study drug|0|||
19413158|NCT02331680|41658611|FG001|Overall Study|Non-compliance with study drug|0|||
19519144|NCT01474512|41932305|FG013|Induction Period|Lack of Efficacy|0|||
19519145|NCT01474512|41932306|FG014|Induction Period|Lack of Efficacy|0|||
19519146|NCT01474512|41932307|FG015|Induction Period|Lack of Efficacy|0|||
19519147|NCT01474512|41932308|FG016|Induction Period|Lack of Efficacy|0|||
19519148|NCT01474512|41932309|FG017|Induction Period|Lack of Efficacy|0|||
19519149|NCT01474512|41932292|FG000|Induction Period|Withdrawal by Subject|6|||
19519150|NCT01474512|41932293|FG001|Induction Period|Withdrawal by Subject|6|||
19519151|NCT01474512|41932294|FG002|Induction Period|Withdrawal by Subject|5|||
19519152|NCT01474512|41932295|FG003|Induction Period|Withdrawal by Subject|0|||
19519153|NCT01474512|41932296|FG004|Induction Period|Withdrawal by Subject|0|||
19519154|NCT01474512|41932297|FG005|Induction Period|Withdrawal by Subject|0|||
19519155|NCT01474512|41932298|FG006|Induction Period|Withdrawal by Subject|0|||
19519156|NCT01474512|41932299|FG007|Induction Period|Withdrawal by Subject|0|||
19519157|NCT01474512|41932300|FG008|Induction Period|Withdrawal by Subject|0|||
19519158|NCT01474512|41932301|FG009|Induction Period|Withdrawal by Subject|0|||
19519159|NCT01474512|41932302|FG010|Induction Period|Withdrawal by Subject|0|||
19519160|NCT01474512|41932303|FG011|Induction Period|Withdrawal by Subject|0|||
19519161|NCT01474512|41932304|FG012|Induction Period|Withdrawal by Subject|0|||
19519162|NCT01474512|41932305|FG013|Induction Period|Withdrawal by Subject|0|||
19519163|NCT01474512|41932306|FG014|Induction Period|Withdrawal by Subject|0|||
19519164|NCT01474512|41932307|FG015|Induction Period|Withdrawal by Subject|0|||
19519165|NCT01474512|41932308|FG016|Induction Period|Withdrawal by Subject|0|||
19413159|NCT02331680|41658612|FG002|Overall Study|Non-compliance with study drug|1|||
19413160|NCT02331680|41658610|FG000|Overall Study|Protocol Violation|0|||
19519166|NCT01474512|41932309|FG017|Induction Period|Withdrawal by Subject|0|||
19519167|NCT01474512|41932292|FG000|Induction Period|Protocol Violation|3|||
19413161|NCT02331680|41658611|FG001|Overall Study|Protocol Violation|0|||
19519168|NCT01474512|41932293|FG001|Induction Period|Protocol Violation|6|||
19519169|NCT01474512|41932294|FG002|Induction Period|Protocol Violation|0|||
19519170|NCT01474512|41932295|FG003|Induction Period|Protocol Violation|0|||
19519171|NCT01474512|41932296|FG004|Induction Period|Protocol Violation|0|||
19519172|NCT01474512|41932297|FG005|Induction Period|Protocol Violation|0|||
19519173|NCT01474512|41932298|FG006|Induction Period|Protocol Violation|0|||
19519174|NCT01474512|41932299|FG007|Induction Period|Protocol Violation|0|||
19519175|NCT01474512|41932300|FG008|Induction Period|Protocol Violation|0|||
19519176|NCT01474512|41932301|FG009|Induction Period|Protocol Violation|0|||
19519177|NCT01474512|41932302|FG010|Induction Period|Protocol Violation|0|||
19519178|NCT01474512|41932303|FG011|Induction Period|Protocol Violation|0|||
19519179|NCT01474512|41932304|FG012|Induction Period|Protocol Violation|0|||
19519180|NCT01474512|41932305|FG013|Induction Period|Protocol Violation|0|||
19519181|NCT01474512|41932306|FG014|Induction Period|Protocol Violation|0|||
19519182|NCT01474512|41932307|FG015|Induction Period|Protocol Violation|0|||
19519183|NCT01474512|41932308|FG016|Induction Period|Protocol Violation|0|||
19519184|NCT01474512|41932309|FG017|Induction Period|Protocol Violation|0|||
19519185|NCT01474512|41932292|FG000|Induction Period|Sponsor Decision|1|||
19519186|NCT01474512|41932293|FG001|Induction Period|Sponsor Decision|1|||
19519187|NCT01474512|41932294|FG002|Induction Period|Sponsor Decision|1|||
19519188|NCT01474512|41932295|FG003|Induction Period|Sponsor Decision|0|||
19519189|NCT01474512|41932296|FG004|Induction Period|Sponsor Decision|0|||
19519190|NCT01474512|41932297|FG005|Induction Period|Sponsor Decision|0|||
19519191|NCT01474512|41932298|FG006|Induction Period|Sponsor Decision|0|||
19519192|NCT01474512|41932299|FG007|Induction Period|Sponsor Decision|0|||
19519193|NCT01474512|41932300|FG008|Induction Period|Sponsor Decision|0|||
19519194|NCT01474512|41932301|FG009|Induction Period|Sponsor Decision|0|||
19519195|NCT01474512|41932302|FG010|Induction Period|Sponsor Decision|0|||
19519196|NCT01474512|41932303|FG011|Induction Period|Sponsor Decision|0|||
19519197|NCT01474512|41932304|FG012|Induction Period|Sponsor Decision|0|||
19519198|NCT01474512|41932305|FG013|Induction Period|Sponsor Decision|0|||
19519199|NCT01474512|41932306|FG014|Induction Period|Sponsor Decision|0|||
19519200|NCT01474512|41932307|FG015|Induction Period|Sponsor Decision|0|||
19519201|NCT01474512|41932308|FG016|Induction Period|Sponsor Decision|0|||
19413162|NCT02331680|41658612|FG002|Overall Study|Protocol Violation|3|||
19413163|NCT02331446|41658624|FG000|Overall Study|Lost to Follow-up|2|||
19413164|NCT02331446|41658625|FG001|Overall Study|Lost to Follow-up|1|||
19519202|NCT01474512|41932309|FG017|Induction Period|Sponsor Decision|0|||
19519203|NCT01474512|41932292|FG000|Induction Period|Lost to Follow-up|1|||
19519204|NCT01474512|41932293|FG001|Induction Period|Lost to Follow-up|0|||
19519205|NCT01474512|41932294|FG002|Induction Period|Lost to Follow-up|2|||
19413165|NCT02331446|41658626|FG002|Overall Study|Lost to Follow-up|0|||
19413166|NCT02331446|41658627|FG003|Overall Study|Lost to Follow-up|1|||
19413167|NCT02331446|41658624|FG000|Overall Study|Personal Problem|2|||
19413168|NCT02331446|41658625|FG001|Overall Study|Personal Problem|0|||
19413169|NCT02331446|41658626|FG002|Overall Study|Personal Problem|0|||
19413170|NCT02331446|41658627|FG003|Overall Study|Personal Problem|0|||
19413171|NCT02331446|41658624|FG000|Overall Study|Disease|0|||
19413172|NCT02331446|41658625|FG001|Overall Study|Disease|2|||
19413173|NCT02331446|41658626|FG002|Overall Study|Disease|2|||
19413174|NCT02331446|41658627|FG003|Overall Study|Disease|1|||
19413175|NCT02331446|41658624|FG000|Overall Study|Physician Decision|0|||
19413176|NCT02331446|41658625|FG001|Overall Study|Physician Decision|1|||
19413177|NCT02331446|41658626|FG002|Overall Study|Physician Decision|0|||
19413178|NCT02331446|41658627|FG003|Overall Study|Physician Decision|1|||
19413179|NCT02331446|41658624|FG000|Overall Study|Lost before baseline analysis|0|||
19413180|NCT02331446|41658625|FG001|Overall Study|Lost before baseline analysis|1|||
19413181|NCT02331446|41658626|FG002|Overall Study|Lost before baseline analysis|1|||
19413182|NCT02331446|41658627|FG003|Overall Study|Lost before baseline analysis|0|||
19413183|NCT02349061|41658639|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
19413184|NCT02349061|41658640|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
19413185|NCT02349061|41658641|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
19413186|NCT02349061|41658639|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
19413187|NCT02349061|41658640|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
19413188|NCT02349061|41658641|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
19413189|NCT02349061|41658639|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
19413190|NCT02349061|41658640|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
19413191|NCT02349061|41658641|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
19413192|NCT02349061|41658639|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
19413193|NCT02349061|41658640|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
19413194|NCT02349061|41658641|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
19413195|NCT02349061|41658639|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
19413196|NCT02349061|41658640|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
19413197|NCT02349061|41658641|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
19413198|NCT02349061|41658639|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
19413199|NCT02349061|41658640|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
19413200|NCT02349061|41658641|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
19413201|NCT02349061|41658639|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
19413202|NCT02349061|41658640|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
19413203|NCT02349061|41658641|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
19413204|NCT02349061|41658639|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
19413205|NCT02349061|41658640|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
19413206|NCT02349061|41658641|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
19413207|NCT02349061|41658639|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
19413208|NCT02349061|41658640|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
19413209|NCT02349061|41658641|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
19413210|NCT02349061|41658639|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
19413211|NCT02349061|41658640|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
19413212|NCT02349061|41658641|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
19413213|NCT02349061|41658639|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
19413214|NCT02349061|41658640|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
19413215|NCT02349061|41658641|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
19413216|NCT02349061|41658639|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
19413217|NCT02349061|41658640|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
19413218|NCT02349061|41658641|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
19413219|NCT02349061|41658639|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
19413220|NCT02349061|41658640|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
19413221|NCT02349061|41658641|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
19413222|NCT02331368|41658651|FG000|Overall Study|Withdrawal by Subject|3|||
19413223|NCT02362724|41658657|FG000|Overall Study|Withdrawal by Subject|3|||
19413224|NCT02362724|41658658|FG001|Overall Study|Withdrawal by Subject|1|||
19413225|NCT02362724|41658657|FG000|Overall Study|Adverse Event|3|||
19413226|NCT02362724|41658658|FG001|Overall Study|Adverse Event|0|||
19711098|NCT00118287|42154272|FG000|Overall Study|Muscle pain|1|||
19413227|NCT02362646|41658666|FG000|Overall Study|Death|15|||
19413228|NCT02362646|41658667|FG001|Overall Study|Death|8|||
19413229|NCT02362646|41658666|FG000|Overall Study|Withdrawal by Subject|2|||
19413230|NCT02362646|41658667|FG001|Overall Study|Withdrawal by Subject|2|||
19413231|NCT02362646|41658666|FG000|Overall Study|received transplant|21|||
19413232|NCT02362646|41658667|FG001|Overall Study|received transplant|14|||
19413233|NCT02280421|41658677|FG000|Washout (2 Weeks)|Adverse Event|0|||
19413234|NCT02280421|41658678|FG001|Washout (2 Weeks)|Adverse Event|1|||
19413235|NCT02280421|41658677|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
19413236|NCT02280421|41658678|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
19413237|NCT02362412|41658696|FG000|Treatment Period III|Lost to Follow-up|0|||
19413238|NCT02362412|41658697|FG001|Treatment Period III|Lost to Follow-up|1|||
19413239|NCT02280187|41658709|FG000|Overall Study|Lost to Follow-up|218|||
19413240|NCT02347813|41658715|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
19413241|NCT02347813|41658716|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
19413242|NCT02347813|41658715|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
19413243|NCT02347813|41658716|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
19413244|NCT02329730|41658726|FG000|Overall Study|Protocol Violation|0|||
19413245|NCT02329730|41658727|FG001|Overall Study|Protocol Violation|0|||
19413246|NCT02329730|41658728|FG002|Overall Study|Protocol Violation|0|||
19413247|NCT02329730|41658729|FG003|Overall Study|Protocol Violation|0|||
19413248|NCT02329730|41658730|FG004|Overall Study|Protocol Violation|2|||
19413249|NCT02329730|41658731|FG005|Overall Study|Protocol Violation|2|||
19413250|NCT02329730|41658732|FG006|Overall Study|Protocol Violation|0|||
19413251|NCT02329730|41658733|FG007|Overall Study|Protocol Violation|0|||
19413252|NCT02329730|41658734|FG008|Overall Study|Protocol Violation|0|||
19413253|NCT02329730|41658735|FG009|Overall Study|Protocol Violation|0|||
19413254|NCT02329730|41658736|FG010|Overall Study|Protocol Violation|0|||
19413255|NCT02329730|41658737|FG011|Overall Study|Protocol Violation|0|||
19413256|NCT02329730|41658726|FG000|Overall Study|Withdrawal by Subject|0|||
19413257|NCT02329730|41658727|FG001|Overall Study|Withdrawal by Subject|0|||
19413258|NCT02329730|41658728|FG002|Overall Study|Withdrawal by Subject|0|||
19413259|NCT02329730|41658729|FG003|Overall Study|Withdrawal by Subject|0|||
19413260|NCT02329730|41658730|FG004|Overall Study|Withdrawal by Subject|1|||
19413261|NCT02329730|41658731|FG005|Overall Study|Withdrawal by Subject|0|||
19413262|NCT02329730|41658732|FG006|Overall Study|Withdrawal by Subject|1|||
19413263|NCT02329730|41658733|FG007|Overall Study|Withdrawal by Subject|1|||
19413264|NCT02329730|41658734|FG008|Overall Study|Withdrawal by Subject|1|||
19413265|NCT02329730|41658735|FG009|Overall Study|Withdrawal by Subject|1|||
19413266|NCT02329730|41658736|FG010|Overall Study|Withdrawal by Subject|0|||
19413267|NCT02329730|41658737|FG011|Overall Study|Withdrawal by Subject|0|||
19413268|NCT02328326|41658757|FG000|Overall Study|Withdrawal by Subject|10|||
19413269|NCT02328326|41658758|FG001|Overall Study|Withdrawal by Subject|3|||
19413270|NCT02328326|41658757|FG000|Overall Study|Death|2|||
19413271|NCT02328326|41658758|FG001|Overall Study|Death|1|||
19413272|NCT02328326|41658757|FG000|Overall Study|Lost to Follow-up|10|||
19413273|NCT02328326|41658758|FG001|Overall Study|Lost to Follow-up|4|||
19413274|NCT01649804|41658766|FG000|Overall Study|Administrative/Other|8|||
19413275|NCT02397278|41658772|FG000|Overall Study|Withdrawal by Subject|0|||
19413276|NCT02397278|41658773|FG001|Overall Study|Withdrawal by Subject|2|||
19413277|NCT02397278|41658772|FG000|Overall Study|Deemed ineligible following surgery|1|||
19413278|NCT02397278|41658773|FG001|Overall Study|Deemed ineligible following surgery|1|||
19413279|NCT02360228|41658782|FG000|Overall Study|Withdrawal by Subject|1|||
19413280|NCT02360228|41658783|FG001|Overall Study|Withdrawal by Subject|0|||
19413281|NCT02360228|41658784|FG002|Overall Study|Withdrawal by Subject|0|||
19413282|NCT02360228|41658782|FG000|Overall Study|Self-discontinued medication|0|||
19413283|NCT02360228|41658783|FG001|Overall Study|Self-discontinued medication|1|||
19413284|NCT02360228|41658784|FG002|Overall Study|Self-discontinued medication|0|||
19413285|NCT02360228|41658782|FG000|Overall Study|Unstable symptoms during screening|0|||
19413286|NCT02360228|41658783|FG001|Overall Study|Unstable symptoms during screening|0|||
19413287|NCT02360228|41658784|FG002|Overall Study|Unstable symptoms during screening|1|||
19413288|NCT02359994|41658794|FG000|Overall Population Study|Adverse Event|1|||
19413289|NCT02359994|41658795|FG001|Overall Population Study|Adverse Event|1|||
19413290|NCT02359994|41658794|FG000|Overall Population Study|Death|1|||
19413291|NCT02359994|41658795|FG001|Overall Population Study|Death|5|||
19413292|NCT02359994|41658794|FG000|Overall Population Study|Lost to Follow-up|1|||
19413293|NCT02359994|41658795|FG001|Overall Population Study|Lost to Follow-up|1|||
19413294|NCT02359994|41658794|FG000|Overall Population Study|Withdrawal by Subject|1|||
19413295|NCT02359994|41658795|FG001|Overall Population Study|Withdrawal by Subject|0|||
19413296|NCT02359994|41658794|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
19413297|NCT02359994|41658795|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
19413298|NCT02359994|41658794|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
19413299|NCT02359994|41658795|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
19413300|NCT02359994|41658794|FG000|Extended Oncology 24-Month Survival|Death|19|||
19413301|NCT02359994|41658795|FG001|Extended Oncology 24-Month Survival|Death|21|||
19413302|NCT02359994|41658794|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
19413303|NCT02359994|41658795|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
19413304|NCT02326298|41658804|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19519206|NCT01474512|41932295|FG003|Induction Period|Lost to Follow-up|0|||
19519207|NCT01474512|41932296|FG004|Induction Period|Lost to Follow-up|0|||
19413305|NCT02326298|41658805|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413306|NCT02326298|41658806|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
19711099|NCT00130689|42154276|FG000|Overall Study|Progressive Disease|29|||
19413307|NCT02326298|41658807|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413308|NCT02326298|41658808|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413309|NCT02326298|41658809|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413310|NCT02326298|41658810|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413311|NCT02326298|41658811|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413312|NCT02326298|41658812|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413313|NCT02326298|41658813|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413314|NCT02326298|41658814|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413315|NCT02326298|41658815|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413316|NCT02326298|41658816|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413317|NCT02326298|41658817|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
19413318|NCT02326298|41658804|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
19413319|NCT02326298|41658805|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413320|NCT02326298|41658806|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413321|NCT02326298|41658807|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413322|NCT02326298|41658808|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413323|NCT02326298|41658809|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413324|NCT02326298|41658810|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413325|NCT02326298|41658811|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413326|NCT02326298|41658812|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413327|NCT02326298|41658813|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413328|NCT02326298|41658814|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413329|NCT02326298|41658815|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413330|NCT02326298|41658816|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413331|NCT02326298|41658817|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
19413332|NCT02326298|41658804|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
19413333|NCT02326298|41658805|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
19413334|NCT02326298|41658806|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413335|NCT02326298|41658807|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413336|NCT02326298|41658808|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413337|NCT02326298|41658809|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413338|NCT02326298|41658810|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413339|NCT02326298|41658811|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413340|NCT02326298|41658812|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413341|NCT02326298|41658813|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413342|NCT02326298|41658814|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413343|NCT02326298|41658815|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413344|NCT02326298|41658816|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413345|NCT02326298|41658817|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
19413346|NCT02326298|41658804|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
19413347|NCT02326298|41658805|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
19413348|NCT02326298|41658806|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413349|NCT02326298|41658807|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413350|NCT02326298|41658808|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413351|NCT02326298|41658809|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413352|NCT02326298|41658810|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413353|NCT02326298|41658811|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413354|NCT02326298|41658812|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413355|NCT02326298|41658813|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413356|NCT02326298|41658814|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413357|NCT02326298|41658815|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413358|NCT02326298|41658816|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413359|NCT02326298|41658817|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
19413360|NCT02326298|41658804|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413361|NCT02326298|41658805|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413362|NCT02326298|41658806|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
19413363|NCT02326298|41658807|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413364|NCT02326298|41658808|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413365|NCT02326298|41658809|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413366|NCT02326298|41658810|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413367|NCT02326298|41658811|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413368|NCT02326298|41658812|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413369|NCT02326298|41658813|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413370|NCT02326298|41658814|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19519208|NCT01474512|41932297|FG005|Induction Period|Lost to Follow-up|0|||
19413371|NCT02326298|41658815|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413372|NCT02326298|41658816|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413373|NCT02326298|41658817|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
19413374|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413375|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413376|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413377|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413378|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413379|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19413380|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
19413381|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19413382|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19413383|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
19413384|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413385|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413386|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413387|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
19413388|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413389|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413390|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413391|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413392|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413393|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
19413394|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
19413395|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413396|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
19413397|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413398|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413399|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413400|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413401|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
19413402|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413403|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413404|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413405|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413406|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413407|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
19413408|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413409|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413410|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413411|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413412|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413413|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413414|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413415|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
19413416|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413417|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413418|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413419|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413420|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413421|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413422|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
19413423|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413424|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413425|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413426|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413427|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413428|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413429|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
19413430|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19711100|NCT00130689|42154276|FG000|Overall Study|Death|1|||
19413431|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413432|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413433|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413434|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413435|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413436|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413437|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
19413438|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413439|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413440|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413441|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413442|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413443|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
19413444|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413445|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413446|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413447|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413448|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413449|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413450|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
19413451|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
19413452|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413453|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413454|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413455|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413456|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413457|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
19413458|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413459|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413460|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413461|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413462|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413463|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413464|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413465|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
19413466|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413467|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413468|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413469|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413470|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413471|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
19413472|NCT02326298|41658804|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413473|NCT02326298|41658805|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413474|NCT02326298|41658806|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413475|NCT02326298|41658807|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413476|NCT02326298|41658808|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413477|NCT02326298|41658809|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
19413478|NCT02326298|41658810|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413479|NCT02326298|41658811|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413480|NCT02326298|41658812|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413481|NCT02326298|41658813|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413482|NCT02326298|41658814|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413483|NCT02326298|41658815|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413484|NCT02326298|41658816|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413485|NCT02326298|41658817|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
19413486|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
19413487|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
19413488|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
19413489|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
19413490|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
19413491|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
19374775|NCT02526524|41616445|FG003|Overall Study|Sponsor Decision|0|||
19374776|NCT02526524|41616446|FG004|Overall Study|Sponsor Decision|0|||
19374777|NCT02526524|41616447|FG005|Overall Study|Sponsor Decision|0|||
19374778|NCT02526290|41616461|FG000|Overall Study|Adverse Event|3|||
19374779|NCT02526290|41616461|FG000|Overall Study|Withdrawal by Subject|4|||
19374780|NCT02526290|41616461|FG000|Overall Study|Physician Decision|1|||
19374781|NCT02319148|41616468|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
19413492|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
19413493|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
19413494|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
19413495|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
19413496|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
19413497|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
19413498|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
19413499|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
19413500|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413501|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413502|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413503|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413504|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413505|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413506|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413507|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413508|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413509|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19374782|NCT02319148|41616469|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
19374783|NCT02319148|41616470|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
19374784|NCT02319148|41616471|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
19374785|NCT02319148|41616468|FG000|Second Intervention Period|No longer willing to participate|0|||
19374786|NCT02319148|41616469|FG001|Second Intervention Period|No longer willing to participate|1|||
19374787|NCT02319148|41616470|FG002|Second Intervention Period|No longer willing to participate|0|||
19374788|NCT02319148|41616471|FG003|Second Intervention Period|No longer willing to participate|0|||
19374789|NCT02319148|41616468|FG000|Second Intervention Period|Other|0|||
19374790|NCT02319148|41616469|FG001|Second Intervention Period|Other|0|||
19374791|NCT02319148|41616470|FG002|Second Intervention Period|Other|0|||
19374792|NCT02319148|41616471|FG003|Second Intervention Period|Other|1|||
19374793|NCT02526212|41616492|FG000|Overall Study|Incarceration|1|||
19374794|NCT02526212|41616493|FG001|Overall Study|Incarceration|0|||
19374795|NCT02526212|41616492|FG000|Overall Study|Lost to Follow-up|1|||
19374796|NCT02526212|41616493|FG001|Overall Study|Lost to Follow-up|0|||
19374797|NCT02526212|41616492|FG000|Overall Study|Death|0|||
19374798|NCT02526212|41616493|FG001|Overall Study|Death|1|||
19374799|NCT02532374|41616499|FG000|Overall Study|Withdrawal by Subject|1|||
19374800|NCT02532374|41616499|FG000|Overall Study|Physician Decision|1|||
19374801|NCT02525744|41616511|FG000|Period 1|Physician Decision|0|||
19374802|NCT02525744|41616512|FG001|Period 1|Physician Decision|0|||
19374803|NCT02525744|41616513|FG002|Period 1|Physician Decision|1|||
19374804|NCT02525744|41616514|FG003|Period 1|Physician Decision|0|||
19374805|NCT02525744|41616511|FG000|Period 3|Adverse Event|0|||
19374806|NCT02525744|41616512|FG001|Period 3|Adverse Event|1|||
19374807|NCT02525744|41616513|FG002|Period 3|Adverse Event|0|||
19374808|NCT02525744|41616514|FG003|Period 3|Adverse Event|0|||
19374809|NCT02525744|41616511|FG000|Period 4|Withdrawal by Subject|1|||
19374810|NCT02525744|41616512|FG001|Period 4|Withdrawal by Subject|0|||
19374811|NCT02525744|41616513|FG002|Period 4|Withdrawal by Subject|0|||
19374812|NCT02525744|41616514|FG003|Period 4|Withdrawal by Subject|0|||
19374813|NCT02525744|41616511|FG000|Period 5|Physician Decision|1|||
19374814|NCT02525744|41616512|FG001|Period 5|Physician Decision|0|||
19374815|NCT02525744|41616513|FG002|Period 5|Physician Decision|0|||
19374816|NCT02525744|41616514|FG003|Period 5|Physician Decision|0|||
19374817|NCT00152477|41616527|FG000|Chemotherapy Period|Adverse Event|9|||
19374818|NCT00152477|41616528|FG001|Chemotherapy Period|Adverse Event|4|||
19374819|NCT00152477|41616529|FG002|Chemotherapy Period|Adverse Event|5|||
19374820|NCT00152477|41616527|FG000|Chemotherapy Period|Death|1|||
19374821|NCT00152477|41616528|FG001|Chemotherapy Period|Death|3|||
19374822|NCT00152477|41616529|FG002|Chemotherapy Period|Death|3|||
19374823|NCT00152477|41616527|FG000|Chemotherapy Period|Lack of Efficacy|4|||
19374824|NCT00152477|41616528|FG001|Chemotherapy Period|Lack of Efficacy|5|||
19374825|NCT00152477|41616529|FG002|Chemotherapy Period|Lack of Efficacy|6|||
19374826|NCT00152477|41616527|FG000|Chemotherapy Period|Lost to Follow-up|1|||
19374827|NCT00152477|41616528|FG001|Chemotherapy Period|Lost to Follow-up|0|||
19374828|NCT00152477|41616529|FG002|Chemotherapy Period|Lost to Follow-up|1|||
19374829|NCT00152477|41616527|FG000|Chemotherapy Period|Protocol Violation|1|||
19374830|NCT00152477|41616528|FG001|Chemotherapy Period|Protocol Violation|1|||
19413510|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413511|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
19413512|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
19413513|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
19413514|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413515|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413516|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413517|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413518|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413519|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413520|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413521|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413522|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413523|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413524|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413525|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19413526|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
19413527|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
19413528|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413529|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413530|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413531|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413532|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413533|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413534|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413535|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413536|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413537|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413538|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413539|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413540|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
19413541|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
19413542|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413543|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413544|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413545|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413546|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413547|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413548|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413549|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413550|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413551|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413552|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
19413553|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
19413554|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
19413555|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
19413556|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413557|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413558|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413559|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413560|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413561|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413562|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413563|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413564|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413565|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413566|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
19413567|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
19413568|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
19413569|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
19413570|NCT02326298|41658804|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413571|NCT02326298|41658805|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413572|NCT02326298|41658806|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413573|NCT02326298|41658807|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413574|NCT02326298|41658808|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413575|NCT02326298|41658809|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413576|NCT02326298|41658810|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413577|NCT02326298|41658811|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413578|NCT02326298|41658812|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413579|NCT02326298|41658813|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413580|NCT02326298|41658814|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
19413581|NCT02326298|41658815|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
19413582|NCT02326298|41658816|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
19413583|NCT02326298|41658817|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
19413584|NCT02396420|41658826|FG000|Overall Study|Death|1|||
19413585|NCT02279719|41658838|FG000|Overall Study|Patients randomized but never treated|0|||
19413586|NCT02279719|41658839|FG001|Overall Study|Patients randomized but never treated|0|||
19413587|NCT02279719|41658840|FG002|Overall Study|Patients randomized but never treated|0|||
19413588|NCT02279719|41658841|FG003|Overall Study|Patients randomized but never treated|0|||
19413589|NCT02279719|41658842|FG004|Overall Study|Patients randomized but never treated|3|||
19413590|NCT02279719|41658843|FG005|Overall Study|Patients randomized but never treated|0|||
19413591|NCT02279719|41658844|FG006|Overall Study|Patients randomized but never treated|3|||
19413592|NCT02279407|41658881|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
19413593|NCT02279407|41658882|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
19413594|NCT02279407|41658883|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
19413595|NCT02279407|41658884|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
19413596|NCT02279407|41658881|FG000|Overall Study|Withdrawal by Subject|1|||
19413597|NCT02279407|41658882|FG001|Overall Study|Withdrawal by Subject|0|||
19413598|NCT02279407|41658883|FG002|Overall Study|Withdrawal by Subject|1|||
19413599|NCT02279407|41658884|FG003|Overall Study|Withdrawal by Subject|1|||
19413600|NCT02279407|41658881|FG000|Overall Study|Adverse Event|1|||
19413601|NCT02279407|41658882|FG001|Overall Study|Adverse Event|1|||
19413602|NCT02279407|41658883|FG002|Overall Study|Adverse Event|2|||
19413603|NCT02279407|41658884|FG003|Overall Study|Adverse Event|0|||
19413604|NCT02326220|41658896|FG000|Double-blind Treatment Period|Adverse Event|1|||
19413605|NCT02326220|41658897|FG001|Double-blind Treatment Period|Adverse Event|2|||
19413606|NCT02326220|41658898|FG002|Double-blind Treatment Period|Adverse Event|0|||
19413607|NCT02326220|41658896|FG000|Double-blind Treatment Period|Protocol Violation|0|||
19413608|NCT02326220|41658897|FG001|Double-blind Treatment Period|Protocol Violation|1|||
19413609|NCT02326220|41658898|FG002|Double-blind Treatment Period|Protocol Violation|0|||
19413610|NCT02326220|41658896|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
19413611|NCT02326220|41658897|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
19413612|NCT02326220|41658898|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19413613|NCT02326220|41658896|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
19413614|NCT02326220|41658897|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
19413615|NCT02326220|41658898|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
19413616|NCT02326220|41658896|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
19413617|NCT02326220|41658897|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
19413618|NCT02326220|41658898|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
19413619|NCT02279173|41658908|FG000|Overall Study|Protocol-specified Criteria|67|||
19413620|NCT02279173|41658908|FG000|Overall Study|Withdrawal by Subject|20|||
19413621|NCT02279173|41658908|FG000|Overall Study|Decision by Sponsor|4|||
19413622|NCT02279173|41658908|FG000|Overall Study|Lost to Follow-up|3|||
19413623|NCT02282917|41658914|FG000|Overall Study|Withdrawal by Subject|1|||
19413624|NCT02282917|41658914|FG000|Overall Study|Screen Failure/Not Eligible|1|||
19413625|NCT02358668|41658921|FG000|Overall Study|Adverse Event|2|||
19413626|NCT02358668|41658922|FG001|Overall Study|Adverse Event|0|||
19413627|NCT02358668|41658923|FG002|Overall Study|Adverse Event|0|||
19413628|NCT02358668|41658921|FG000|Overall Study|Withdrawal by Subject|0|||
19413629|NCT02358668|41658922|FG001|Overall Study|Withdrawal by Subject|1|||
19413630|NCT02358668|41658923|FG002|Overall Study|Withdrawal by Subject|0|||
19413631|NCT02282605|41658934|FG000|Overall Study|negative SA result on Day -1|3|||
19413632|NCT02282605|41658935|FG001|Overall Study|negative SA result on Day -1|0|||
19413633|NCT02282605|41658936|FG002|Overall Study|negative SA result on Day -1|0|||
19413634|NCT02282527|41658946|FG000|Overall Study|Lost to Follow-up|0|||
19413635|NCT02282527|41658947|FG001|Overall Study|Lost to Follow-up|1|||
19413636|NCT02282527|41658946|FG000|Overall Study|Lack of home health aid|1|||
19413637|NCT02282527|41658947|FG001|Overall Study|Lack of home health aid|0|||
19413638|NCT02278939|41658958|FG000|Overall Study|lack of time|1|||
19413639|NCT02278939|41658959|FG001|Overall Study|lack of time|0|||
19413640|NCT02278939|41658958|FG000|Overall Study|Lost to Follow-up|1|||
19413641|NCT02278939|41658959|FG001|Overall Study|Lost to Follow-up|1|||
19413642|NCT02278939|41658958|FG000|Overall Study|death in family|1|||
19413643|NCT02278939|41658959|FG001|Overall Study|death in family|0|||
19413644|NCT02278939|41658958|FG000|Overall Study|family emergency unable to commit|2|||
19413645|NCT02278939|41658959|FG001|Overall Study|family emergency unable to commit|0|||
19413646|NCT02278471|41658967|FG000|Overall Study|Lost to Follow-up|6|||
19413647|NCT02278471|41658968|FG001|Overall Study|Lost to Follow-up|15|||
19413648|NCT02278471|41658967|FG000|Overall Study|Death|2|||
19413649|NCT02278471|41658968|FG001|Overall Study|Death|2|||
19413650|NCT02278471|41658967|FG000|Overall Study|Withdrawal by Subject|0|||
19413651|NCT02278471|41658968|FG001|Overall Study|Withdrawal by Subject|3|||
19413652|NCT02278003|41658977|FG000|Overall Study|Withdrawal by Subject|11|||
19413653|NCT02278003|41658978|FG001|Overall Study|Withdrawal by Subject|0|||
19413654|NCT02278003|41658977|FG000|Overall Study|Not Treated|1|||
19413655|NCT02278003|41658978|FG001|Overall Study|Not Treated|0|||
19413656|NCT02278003|41658977|FG000|Overall Study|Recognition task improperly completed|7|||
19413657|NCT02278003|41658978|FG001|Overall Study|Recognition task improperly completed|0|||
19413658|NCT02277769|41658987|FG000|Overall Study|Protocol Violation|3|||
19413659|NCT02277769|41658988|FG001|Overall Study|Protocol Violation|3|||
19413660|NCT02277769|41658989|FG002|Overall Study|Protocol Violation|5|||
19413661|NCT02277769|41658987|FG000|Overall Study|Lack of Efficacy|17|||
19413662|NCT02277769|41658988|FG001|Overall Study|Lack of Efficacy|0|||
19413663|NCT02277769|41658989|FG002|Overall Study|Lack of Efficacy|4|||
19413664|NCT02277769|41658987|FG000|Overall Study|Adverse Event|14|||
19413665|NCT02277769|41658988|FG001|Overall Study|Adverse Event|2|||
19413666|NCT02277769|41658989|FG002|Overall Study|Adverse Event|4|||
19413667|NCT02277769|41658987|FG000|Overall Study|Other than specified above|12|||
19413668|NCT02277769|41658988|FG001|Overall Study|Other than specified above|8|||
19413669|NCT02277769|41658989|FG002|Overall Study|Other than specified above|5|||
19413670|NCT01641991|41659001|FG000|Overall Study|Physician Decision|0|||
19413671|NCT01641991|41659002|FG001|Overall Study|Physician Decision|1|||
19413672|NCT01641991|41659003|FG002|Overall Study|Physician Decision|7|||
19413673|NCT01641991|41659004|FG003|Overall Study|Physician Decision|5|||
19413674|NCT01641991|41659001|FG000|Overall Study|Withdrawal by Subject|4|||
19413675|NCT01641991|41659002|FG001|Overall Study|Withdrawal by Subject|2|||
19413676|NCT01641991|41659003|FG002|Overall Study|Withdrawal by Subject|1|||
19413677|NCT01641991|41659004|FG003|Overall Study|Withdrawal by Subject|5|||
19413678|NCT01641991|41659001|FG000|Overall Study|Adverse Event|2|||
19413679|NCT01641991|41659002|FG001|Overall Study|Adverse Event|1|||
19413680|NCT01641991|41659003|FG002|Overall Study|Adverse Event|2|||
19413681|NCT01641991|41659004|FG003|Overall Study|Adverse Event|1|||
19413682|NCT01641991|41659001|FG000|Overall Study|Lost to Follow-up|0|||
19413683|NCT01641991|41659002|FG001|Overall Study|Lost to Follow-up|2|||
19413684|NCT01641991|41659003|FG002|Overall Study|Lost to Follow-up|3|||
19413685|NCT01641991|41659004|FG003|Overall Study|Lost to Follow-up|1|||
19413686|NCT01641991|41659001|FG000|Overall Study|Protocol Violation|1|||
19413687|NCT01641991|41659002|FG001|Overall Study|Protocol Violation|1|||
19413688|NCT01641991|41659003|FG002|Overall Study|Protocol Violation|3|||
19413689|NCT01641991|41659004|FG003|Overall Study|Protocol Violation|0|||
19413690|NCT01641991|41659001|FG000|Overall Study|Pregnancy|0|||
19413691|NCT01641991|41659002|FG001|Overall Study|Pregnancy|0|||
19413692|NCT01641991|41659003|FG002|Overall Study|Pregnancy|1|||
19413693|NCT01641991|41659004|FG003|Overall Study|Pregnancy|0|||
19413694|NCT01641991|41659001|FG000|Overall Study|no longer eligible|2|||
19413695|NCT01641991|41659002|FG001|Overall Study|no longer eligible|1|||
19413696|NCT01641991|41659003|FG002|Overall Study|no longer eligible|0|||
19413697|NCT01641991|41659004|FG003|Overall Study|no longer eligible|4|||
19413698|NCT02277691|41659017|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
19413699|NCT02277691|41659017|FG000|Overall Study|Voluntary Withdrawal|7|||
19413700|NCT02277691|41659017|FG000|Overall Study|Lack of Efficacy|5|||
19413701|NCT02277691|41659017|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
19413702|NCT02395172|41659023|FG000|Overall Study|Participants randomized but not treated|3|||
19413703|NCT02395172|41659024|FG001|Overall Study|Participants randomized but not treated|31|||
19413704|NCT02276053|41659030|FG000|Overall Study|Death|2|||
19413705|NCT02276053|41659030|FG000|Overall Study|Adverse Event|5|||
19413706|NCT02276053|41659030|FG000|Overall Study|Lack of Efficacy|2|||
19413707|NCT02276053|41659030|FG000|Overall Study|Withdrawal by Subject|1|||
19413708|NCT02276053|41659030|FG000|Overall Study|Patient does not meet selection criteria|3|||
19413709|NCT02276053|41659030|FG000|Overall Study|Patient needs to increase baseline AED|1|||
19413710|NCT02275819|41659037|FG000|Overall Study|Adverse Event|0|||
19413711|NCT02275819|41659038|FG001|Overall Study|Adverse Event|1|||
19413712|NCT02358044|41659046|FG000|Overall Study|Adverse Event|0|||
19413713|NCT02358044|41659047|FG001|Overall Study|Adverse Event|1|||
19413714|NCT02358044|41659046|FG000|Overall Study|Lost to Follow-up|2|||
19413715|NCT02358044|41659047|FG001|Overall Study|Lost to Follow-up|1|||
19413716|NCT02358044|41659046|FG000|Overall Study|Physician Decision|0|||
19413717|NCT02358044|41659047|FG001|Overall Study|Physician Decision|1|||
19413718|NCT02358044|41659046|FG000|Overall Study|Withdrawal by Subject|0|||
19413719|NCT02358044|41659047|FG001|Overall Study|Withdrawal by Subject|4|||
19413720|NCT02275117|41659058|FG000|Overall Study|Adverse Event|0|||
19413721|NCT02275117|41659059|FG001|Overall Study|Adverse Event|0|||
19413722|NCT02275117|41659060|FG002|Overall Study|Adverse Event|0|||
19413723|NCT02275117|41659061|FG003|Overall Study|Adverse Event|0|||
19413724|NCT02275117|41659062|FG004|Overall Study|Adverse Event|1|||
19413725|NCT02275117|41659058|FG000|Overall Study|Lack of Efficacy|6|||
19413726|NCT02275117|41659059|FG001|Overall Study|Lack of Efficacy|7|||
19413727|NCT02275117|41659060|FG002|Overall Study|Lack of Efficacy|5|||
19413728|NCT02275117|41659061|FG003|Overall Study|Lack of Efficacy|2|||
19413729|NCT02275117|41659062|FG004|Overall Study|Lack of Efficacy|10|||
19413730|NCT02275117|41659058|FG000|Overall Study|Lost to Follow-up|11|||
19413731|NCT02275117|41659059|FG001|Overall Study|Lost to Follow-up|16|||
19413732|NCT02275117|41659060|FG002|Overall Study|Lost to Follow-up|15|||
19413733|NCT02275117|41659061|FG003|Overall Study|Lost to Follow-up|16|||
19413734|NCT02275117|41659062|FG004|Overall Study|Lost to Follow-up|8|||
19413735|NCT02275117|41659058|FG000|Overall Study|Physician Decision|0|||
19413736|NCT02275117|41659059|FG001|Overall Study|Physician Decision|1|||
19413737|NCT02275117|41659060|FG002|Overall Study|Physician Decision|1|||
19413738|NCT02275117|41659061|FG003|Overall Study|Physician Decision|0|||
19413739|NCT02275117|41659062|FG004|Overall Study|Physician Decision|1|||
19413740|NCT02275117|41659058|FG000|Overall Study|Protocol Violation|1|||
19413741|NCT02275117|41659059|FG001|Overall Study|Protocol Violation|0|||
19413742|NCT02275117|41659060|FG002|Overall Study|Protocol Violation|1|||
19413743|NCT02275117|41659061|FG003|Overall Study|Protocol Violation|1|||
19413744|NCT02275117|41659062|FG004|Overall Study|Protocol Violation|0|||
19413745|NCT02275117|41659058|FG000|Overall Study|Withdrawal by Subject|6|||
19413746|NCT02275117|41659059|FG001|Overall Study|Withdrawal by Subject|4|||
19413747|NCT02275117|41659060|FG002|Overall Study|Withdrawal by Subject|7|||
19413748|NCT02275117|41659061|FG003|Overall Study|Withdrawal by Subject|3|||
19413749|NCT02275117|41659062|FG004|Overall Study|Withdrawal by Subject|3|||
19413750|NCT02275117|41659058|FG000|Overall Study|Terminated by Sponsor|4|||
19413751|NCT02275117|41659059|FG001|Overall Study|Terminated by Sponsor|4|||
19413752|NCT02275117|41659060|FG002|Overall Study|Terminated by Sponsor|4|||
19413753|NCT02275117|41659061|FG003|Overall Study|Terminated by Sponsor|6|||
19413754|NCT02275117|41659062|FG004|Overall Study|Terminated by Sponsor|4|||
19413755|NCT02275117|41659058|FG000|Overall Study|Worsening of Study Indication|0|||
19413756|NCT02275117|41659059|FG001|Overall Study|Worsening of Study Indication|1|||
19413757|NCT02275117|41659060|FG002|Overall Study|Worsening of Study Indication|2|||
19413758|NCT02275117|41659061|FG003|Overall Study|Worsening of Study Indication|0|||
19413759|NCT02275117|41659062|FG004|Overall Study|Worsening of Study Indication|0|||
19413760|NCT02275117|41659058|FG000|Overall Study|Study Burden|5|||
19413761|NCT02275117|41659059|FG001|Overall Study|Study Burden|4|||
19413762|NCT02275117|41659060|FG002|Overall Study|Study Burden|7|||
19413763|NCT02275117|41659061|FG003|Overall Study|Study Burden|5|||
19413764|NCT02275117|41659062|FG004|Overall Study|Study Burden|7|||
19413765|NCT02275117|41659058|FG000|Overall Study|Other|1|||
19413766|NCT02275117|41659059|FG001|Overall Study|Other|0|||
19413767|NCT02275117|41659060|FG002|Overall Study|Other|0|||
19413768|NCT02275117|41659061|FG003|Overall Study|Other|0|||
19413769|NCT02275117|41659062|FG004|Overall Study|Other|2|||
19413770|NCT02274493|41659074|FG000|Overall Study|Withdrawal by Subject|1|||
19413771|NCT02273167|41659081|FG000|Overall Study|Adverse Event|1|||
19413772|NCT02273167|41659082|FG001|Overall Study|Adverse Event|0|||
19413773|NCT02273167|41659083|FG002|Overall Study|Adverse Event|0|||
19413774|NCT02273167|41659081|FG000|Overall Study|Protocol Violation|3|||
19413775|NCT02273167|41659082|FG001|Overall Study|Protocol Violation|1|||
19413776|NCT02273167|41659083|FG002|Overall Study|Protocol Violation|1|||
19413777|NCT02273167|41659081|FG000|Overall Study|Lost to Follow-up|0|||
19413778|NCT02273167|41659082|FG001|Overall Study|Lost to Follow-up|1|||
19413779|NCT02273167|41659083|FG002|Overall Study|Lost to Follow-up|1|||
19413780|NCT02273167|41659081|FG000|Overall Study|Withdrawal by Subject|10|||
19413781|NCT02273167|41659082|FG001|Overall Study|Withdrawal by Subject|12|||
19413782|NCT02273167|41659083|FG002|Overall Study|Withdrawal by Subject|11|||
19413783|NCT02273167|41659081|FG000|Overall Study|Various|10|||
19413784|NCT02273167|41659082|FG001|Overall Study|Various|9|||
19413785|NCT02273167|41659083|FG002|Overall Study|Various|8|||
19413786|NCT01850524|41659094|FG000|Overall Study|Ongoing on Treatment|57|||
19413787|NCT01850524|41659095|FG001|Overall Study|Ongoing on Treatment|54|||
19413788|NCT01850524|41659094|FG000|Overall Study|Adverse Event|96|||
19413789|NCT01850524|41659095|FG001|Overall Study|Adverse Event|122|||
19413790|NCT01850524|41659094|FG000|Overall Study|Lost to Follow-up|2|||
19413791|NCT01850524|41659095|FG001|Overall Study|Lost to Follow-up|0|||
19413792|NCT01850524|41659094|FG000|Overall Study|Progressive Disease|166|||
19413793|NCT01850524|41659095|FG001|Overall Study|Progressive Disease|123|||
19413794|NCT01850524|41659094|FG000|Overall Study|Protocol Violation|1|||
19413795|NCT01850524|41659095|FG001|Overall Study|Protocol Violation|2|||
19413796|NCT01850524|41659094|FG000|Overall Study|Withdrawal by Subject|8|||
19413797|NCT01850524|41659095|FG001|Overall Study|Withdrawal by Subject|19|||
19413798|NCT01850524|41659094|FG000|Overall Study|Participant Wished to Discontinue Treatment|15|||
19413799|NCT01850524|41659095|FG001|Overall Study|Participant Wished to Discontinue Treatment|22|||
19413800|NCT01850524|41659094|FG000|Overall Study|Investigator Decision|4|||
19413801|NCT01850524|41659095|FG001|Overall Study|Investigator Decision|4|||
19413802|NCT01850524|41659094|FG000|Overall Study|Participants Removed From Study|0|||
19413803|NCT01850524|41659095|FG001|Overall Study|Participants Removed From Study|1|||
19413804|NCT01850524|41659094|FG000|Overall Study|Medical Monitor Decision|0|||
19374831|NCT00152477|41616529|FG002|Chemotherapy Period|Protocol Violation|0|||
19374832|NCT00152477|41616527|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
19374833|NCT00152477|41616528|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
19374834|NCT00152477|41616529|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
19374835|NCT00152477|41616527|FG000|Chemotherapy Period|Progression of Disease|6|||
19374836|NCT00152477|41616528|FG001|Chemotherapy Period|Progression of Disease|8|||
19374837|NCT00152477|41616529|FG002|Chemotherapy Period|Progression of Disease|4|||
19374838|NCT00152477|41616527|FG000|Chemotherapy Period|Investigator decision|0|||
19374839|NCT00152477|41616528|FG001|Chemotherapy Period|Investigator decision|0|||
19374840|NCT00152477|41616529|FG002|Chemotherapy Period|Investigator decision|1|||
19374841|NCT00152477|41616527|FG000|Chemotherapy Period|Patient condition worsened|1|||
19374842|NCT00152477|41616528|FG001|Chemotherapy Period|Patient condition worsened|0|||
19374843|NCT00152477|41616529|FG002|Chemotherapy Period|Patient condition worsened|0|||
19374844|NCT00152477|41616527|FG000|Monotherapy Period|Adverse Event|1|||
19374845|NCT00152477|41616528|FG001|Monotherapy Period|Adverse Event|0|||
19374846|NCT00152477|41616529|FG002|Monotherapy Period|Adverse Event|5|||
19374847|NCT00152477|41616527|FG000|Monotherapy Period|Death|2|||
19374848|NCT00152477|41616528|FG001|Monotherapy Period|Death|0|||
19374849|NCT00152477|41616529|FG002|Monotherapy Period|Death|1|||
19374850|NCT00152477|41616527|FG000|Monotherapy Period|Lack of Efficacy|7|||
19374851|NCT00152477|41616528|FG001|Monotherapy Period|Lack of Efficacy|16|||
19374852|NCT00152477|41616529|FG002|Monotherapy Period|Lack of Efficacy|10|||
19374853|NCT00152477|41616527|FG000|Monotherapy Period|Protocol Violation|0|||
19374854|NCT00152477|41616528|FG001|Monotherapy Period|Protocol Violation|1|||
19374855|NCT00152477|41616529|FG002|Monotherapy Period|Protocol Violation|0|||
19374856|NCT00152477|41616527|FG000|Monotherapy Period|Withdrawal by Subject|0|||
19374857|NCT00152477|41616528|FG001|Monotherapy Period|Withdrawal by Subject|0|||
19374858|NCT00152477|41616529|FG002|Monotherapy Period|Withdrawal by Subject|4|||
19374859|NCT00152477|41616527|FG000|Monotherapy Period|Progression of Disease|5|||
19374860|NCT00152477|41616528|FG001|Monotherapy Period|Progression of Disease|11|||
19374861|NCT00152477|41616529|FG002|Monotherapy Period|Progression of Disease|12|||
19374862|NCT00152477|41616527|FG000|Monotherapy Period|Patient decision|0|||
19374863|NCT00152477|41616528|FG001|Monotherapy Period|Patient decision|1|||
19374864|NCT00152477|41616529|FG002|Monotherapy Period|Patient decision|1|||
19374865|NCT00152477|41616527|FG000|Monotherapy Period|Study personel decision|0|||
19374866|NCT00152477|41616528|FG001|Monotherapy Period|Study personel decision|0|||
19374867|NCT00152477|41616529|FG002|Monotherapy Period|Study personel decision|1|||
19374868|NCT02525588|41616542|FG000|Overall Study|Death|3|||
19374869|NCT02525588|41616543|FG001|Overall Study|Death|1|||
19374870|NCT02525588|41616542|FG000|Overall Study|Lost to Follow-up|2|||
19374871|NCT02525588|41616543|FG001|Overall Study|Lost to Follow-up|0|||
19374872|NCT02525588|41616542|FG000|Overall Study|Withdrawal by Subject|1|||
19374873|NCT02525588|41616543|FG001|Overall Study|Withdrawal by Subject|1|||
19374874|NCT02525588|41616542|FG000|Overall Study|Adverse Event|0|||
19374875|NCT02525588|41616543|FG001|Overall Study|Adverse Event|1|||
19374876|NCT00153179|41616551|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
19374877|NCT00153179|41616552|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
19374878|NCT00153179|41616553|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
19374879|NCT00153179|41616554|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
19374880|NCT02531594|41616564|FG000|Overall Study|Withdrawal by Subject|7|||
19374881|NCT02531594|41616565|FG001|Overall Study|Withdrawal by Subject|8|||
19374882|NCT02743949|41616574|FG000|Overall Study|Adverse Event|0|||
19374883|NCT02743949|41616575|FG001|Overall Study|Adverse Event|0|||
19374884|NCT02743949|41616576|FG002|Overall Study|Adverse Event|2|||
19374885|NCT02743949|41616574|FG000|Overall Study|Significant Protocol Deviation|2|||
19374886|NCT02743949|41616575|FG001|Overall Study|Significant Protocol Deviation|0|||
19374887|NCT02743949|41616576|FG002|Overall Study|Significant Protocol Deviation|1|||
19374888|NCT02743949|41616574|FG000|Overall Study|Voluntary Withdrawal|2|||
19374889|NCT02743949|41616575|FG001|Overall Study|Voluntary Withdrawal|1|||
19374890|NCT02743949|41616576|FG002|Overall Study|Voluntary Withdrawal|0|||
19374891|NCT02531438|41616586|FG000|Overall Study|Adverse Event|7|||
19374892|NCT02531438|41616587|FG001|Overall Study|Adverse Event|9|||
19374893|NCT02531438|41616586|FG000|Overall Study|Lost to Follow-up|0|||
19374894|NCT02531438|41616587|FG001|Overall Study|Lost to Follow-up|3|||
19374895|NCT02531438|41616586|FG000|Overall Study|Withdrawal by Subject|7|||
19374896|NCT02531438|41616587|FG001|Overall Study|Withdrawal by Subject|8|||
19374897|NCT02531438|41616586|FG000|Overall Study|Physician Decision|0|||
19374898|NCT02531438|41616587|FG001|Overall Study|Physician Decision|1|||
19374899|NCT02531438|41616586|FG000|Overall Study|Death|6|||
19374900|NCT02531438|41616587|FG001|Overall Study|Death|3|||
19374901|NCT02531438|41616586|FG000|Overall Study|Randomized, but Not Treated|4|||
19374902|NCT02531438|41616587|FG001|Overall Study|Randomized, but Not Treated|0|||
19374903|NCT02531438|41616586|FG000|Overall Study|Missed EOT/PTE Visit|5|||
19628097|NCT00589914|42077497|FG001|Overall Study|Withdrawal by Subject|49|||
19628098|NCT00589914|42077496|FG000|Overall Study|Other|22|||
19413805|NCT01850524|41659095|FG001|Overall Study|Medical Monitor Decision|1|||
19413806|NCT01850524|41659094|FG000|Overall Study|Participants Decision|2|||
19413807|NCT01850524|41659095|FG001|Overall Study|Participants Decision|2|||
19413808|NCT01850524|41659094|FG000|Overall Study|Progressive Disease Per Local Lab|1|||
19413809|NCT01850524|41659095|FG001|Overall Study|Progressive Disease Per Local Lab|0|||
19413810|NCT01850524|41659094|FG000|Overall Study|Lack of Improvement|0|||
19413811|NCT01850524|41659095|FG001|Overall Study|Lack of Improvement|1|||
19413812|NCT01850524|41659094|FG000|Overall Study|Minimal Response|1|||
19413813|NCT01850524|41659095|FG001|Overall Study|Minimal Response|0|||
19413814|NCT01850524|41659094|FG000|Overall Study|Comorbidities|1|||
19413815|NCT01850524|41659095|FG001|Overall Study|Comorbidities|0|||
19413816|NCT02272777|41659105|FG000|Overall Study|Adverse Event|0|||
19413817|NCT02272777|41659106|FG001|Overall Study|Adverse Event|1|||
19413818|NCT02272777|41659105|FG000|Overall Study|Withdrawal by Subject|0|||
19413819|NCT02272777|41659106|FG001|Overall Study|Withdrawal by Subject|3|||
19413820|NCT02272777|41659105|FG000|Overall Study|Lost to Follow-up|2|||
19413821|NCT02272777|41659106|FG001|Overall Study|Lost to Follow-up|0|||
19413822|NCT02272777|41659105|FG000|Overall Study|Other|2|||
19413823|NCT02272777|41659106|FG001|Overall Study|Other|0|||
19413824|NCT02357810|41659112|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
19413825|NCT02357810|41659112|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
19413826|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Adverse Event|5|||
19413827|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
19413828|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
19413829|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
19413830|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Death|1|||
19413831|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Physician Decision|1|||
19413832|NCT02357810|41659112|FG000|Reached 12 Weeks Response|Other|1|||
19413833|NCT02357810|41659112|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
19413834|NCT02357810|41659112|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
19413835|NCT02357810|41659112|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
19413836|NCT02357810|41659112|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
19413837|NCT02357810|41659112|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
19413838|NCT02357810|41659112|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
19413839|NCT02357576|41659118|FG000|Treatment Period|Withdrawal by Subject|0|||
19413840|NCT02357576|41659119|FG001|Treatment Period|Withdrawal by Subject|1|||
19413841|NCT02357576|41659118|FG000|Treatment Period|Physician Decision|0|||
19413842|NCT02357576|41659119|FG001|Treatment Period|Physician Decision|1|||
19413843|NCT02357576|41659118|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
19413844|NCT02357576|41659119|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
19413845|NCT02357576|41659118|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
19413846|NCT02357576|41659119|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
19413847|NCT02357576|41659118|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
19413848|NCT02357576|41659119|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
19413849|NCT02357576|41659118|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
19413850|NCT02357576|41659119|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
19413851|NCT01850446|41659127|FG000|Overall Study|Lack of Efficacy|1|||
19413852|NCT01850446|41659128|FG001|Overall Study|Lack of Efficacy|0|||
19413853|NCT01850446|41659127|FG000|Overall Study|Withdrawal by Subject|4|||
19413854|NCT01850446|41659128|FG001|Overall Study|Withdrawal by Subject|0|||
19413855|NCT01850446|41659127|FG000|Overall Study|Protocol Violation|0|||
19413856|NCT01850446|41659128|FG001|Overall Study|Protocol Violation|2|||
19413857|NCT02465567|41659138|FG000|Overall Study|Adverse Event|118|||
19413858|NCT02465567|41659139|FG001|Overall Study|Adverse Event|113|||
19413859|NCT02465567|41659140|FG002|Overall Study|Adverse Event|147|||
19413860|NCT02465567|41659141|FG003|Overall Study|Adverse Event|138|||
19413861|NCT02465567|41659138|FG000|Overall Study|Lack of Efficacy|103|||
19413862|NCT02465567|41659139|FG001|Overall Study|Lack of Efficacy|102|||
19413863|NCT02465567|41659140|FG002|Overall Study|Lack of Efficacy|171|||
19413864|NCT02465567|41659141|FG003|Overall Study|Lack of Efficacy|135|||
19413865|NCT02465567|41659138|FG000|Overall Study|Withdrawal by Subject|104|||
19413866|NCT02465567|41659139|FG001|Overall Study|Withdrawal by Subject|94|||
19413867|NCT02465567|41659140|FG002|Overall Study|Withdrawal by Subject|123|||
19413868|NCT02465567|41659141|FG003|Overall Study|Withdrawal by Subject|130|||
19413869|NCT02465567|41659138|FG000|Overall Study|Physician Decision|23|||
19413870|NCT02465567|41659139|FG001|Overall Study|Physician Decision|33|||
19413871|NCT02465567|41659140|FG002|Overall Study|Physician Decision|38|||
19413872|NCT02465567|41659141|FG003|Overall Study|Physician Decision|28|||
19413873|NCT02465567|41659138|FG000|Overall Study|Major Protocol Deviation|24|||
19413874|NCT02465567|41659139|FG001|Overall Study|Major Protocol Deviation|26|||
19413875|NCT02465567|41659140|FG002|Overall Study|Major Protocol Deviation|22|||
19413876|NCT02465567|41659141|FG003|Overall Study|Major Protocol Deviation|25|||
19413877|NCT02465567|41659138|FG000|Overall Study|Lost to Follow-up|25|||
19413878|NCT02465567|41659139|FG001|Overall Study|Lost to Follow-up|21|||
19413879|NCT02465567|41659140|FG002|Overall Study|Lost to Follow-up|19|||
19413880|NCT02465567|41659141|FG003|Overall Study|Lost to Follow-up|15|||
19413881|NCT02465567|41659138|FG000|Overall Study|Protocol Specified Criteria|20|||
19413882|NCT02465567|41659139|FG001|Overall Study|Protocol Specified Criteria|10|||
19413883|NCT02465567|41659140|FG002|Overall Study|Protocol Specified Criteria|9|||
19413884|NCT02465567|41659141|FG003|Overall Study|Protocol Specified Criteria|12|||
19413885|NCT02465567|41659138|FG000|Overall Study|Administrative Reasons|12|||
19519209|NCT01474512|41932298|FG006|Induction Period|Lost to Follow-up|0|||
19519210|NCT01474512|41932299|FG007|Induction Period|Lost to Follow-up|0|||
19519211|NCT01474512|41932300|FG008|Induction Period|Lost to Follow-up|0|||
19519212|NCT01474512|41932301|FG009|Induction Period|Lost to Follow-up|0|||
19519213|NCT01474512|41932302|FG010|Induction Period|Lost to Follow-up|0|||
19519214|NCT01474512|41932303|FG011|Induction Period|Lost to Follow-up|0|||
19413886|NCT02465567|41659139|FG001|Overall Study|Administrative Reasons|9|||
19413887|NCT02465567|41659140|FG002|Overall Study|Administrative Reasons|11|||
19519215|NCT01474512|41932304|FG012|Induction Period|Lost to Follow-up|0|||
19519216|NCT01474512|41932305|FG013|Induction Period|Lost to Follow-up|0|||
19519217|NCT01474512|41932306|FG014|Induction Period|Lost to Follow-up|0|||
19519218|NCT01474512|41932307|FG015|Induction Period|Lost to Follow-up|0|||
19519219|NCT01474512|41932308|FG016|Induction Period|Lost to Follow-up|0|||
19519220|NCT01474512|41932309|FG017|Induction Period|Lost to Follow-up|0|||
19519221|NCT01474512|41932292|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519222|NCT01474512|41932293|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519223|NCT01474512|41932294|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519224|NCT01474512|41932295|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
19519225|NCT01474512|41932296|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
19519226|NCT01474512|41932297|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
19519227|NCT01474512|41932298|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
19519228|NCT01474512|41932299|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519229|NCT01474512|41932300|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519230|NCT01474512|41932301|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519231|NCT01474512|41932302|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519232|NCT01474512|41932303|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519233|NCT01474512|41932304|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519234|NCT01474512|41932305|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519235|NCT01474512|41932306|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519236|NCT01474512|41932307|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519237|NCT01474512|41932308|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519238|NCT01474512|41932309|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
19519239|NCT01474512|41932292|FG000|Maintenance Period|Adverse Event|0|||
19519240|NCT01474512|41932293|FG001|Maintenance Period|Adverse Event|0|||
19519241|NCT01474512|41932294|FG002|Maintenance Period|Adverse Event|0|||
19519242|NCT01474512|41932295|FG003|Maintenance Period|Adverse Event|4|||
19519243|NCT01474512|41932296|FG004|Maintenance Period|Adverse Event|2|||
19519244|NCT01474512|41932297|FG005|Maintenance Period|Adverse Event|7|||
19519245|NCT01474512|41932298|FG006|Maintenance Period|Adverse Event|0|||
19519246|NCT01474512|41932299|FG007|Maintenance Period|Adverse Event|19|||
19519247|NCT01474512|41932300|FG008|Maintenance Period|Adverse Event|1|||
19519248|NCT01474512|41932301|FG009|Maintenance Period|Adverse Event|3|||
19519249|NCT01474512|41932302|FG010|Maintenance Period|Adverse Event|0|||
19519250|NCT01474512|41932303|FG011|Maintenance Period|Adverse Event|0|||
19519251|NCT01474512|41932304|FG012|Maintenance Period|Adverse Event|0|||
19519252|NCT01474512|41932305|FG013|Maintenance Period|Adverse Event|0|||
19519253|NCT01474512|41932306|FG014|Maintenance Period|Adverse Event|0|||
19519254|NCT01474512|41932307|FG015|Maintenance Period|Adverse Event|0|||
19519255|NCT01474512|41932308|FG016|Maintenance Period|Adverse Event|0|||
19519256|NCT01474512|41932309|FG017|Maintenance Period|Adverse Event|0|||
19519257|NCT01474512|41932292|FG000|Maintenance Period|Withdrawal by Subject|0|||
19519258|NCT01474512|41932293|FG001|Maintenance Period|Withdrawal by Subject|0|||
19519259|NCT01474512|41932294|FG002|Maintenance Period|Withdrawal by Subject|0|||
19519260|NCT01474512|41932295|FG003|Maintenance Period|Withdrawal by Subject|6|||
19519261|NCT01474512|41932296|FG004|Maintenance Period|Withdrawal by Subject|2|||
19519262|NCT01474512|41932297|FG005|Maintenance Period|Withdrawal by Subject|3|||
19519263|NCT01474512|41932298|FG006|Maintenance Period|Withdrawal by Subject|1|||
19519264|NCT01474512|41932299|FG007|Maintenance Period|Withdrawal by Subject|6|||
19519265|NCT01474512|41932300|FG008|Maintenance Period|Withdrawal by Subject|3|||
19519266|NCT01474512|41932301|FG009|Maintenance Period|Withdrawal by Subject|1|||
19519267|NCT01474512|41932302|FG010|Maintenance Period|Withdrawal by Subject|0|||
19519268|NCT01474512|41932303|FG011|Maintenance Period|Withdrawal by Subject|0|||
19519269|NCT01474512|41932304|FG012|Maintenance Period|Withdrawal by Subject|0|||
19519270|NCT01474512|41932305|FG013|Maintenance Period|Withdrawal by Subject|0|||
19711101|NCT00130689|42154276|FG000|Overall Study|Clinical Deterioration|4|||
19413888|NCT02465567|41659141|FG003|Overall Study|Administrative Reasons|5|||
19413889|NCT02465567|41659138|FG000|Overall Study|Randomized but not treated|1|||
19519271|NCT01474512|41932306|FG014|Maintenance Period|Withdrawal by Subject|0|||
19519272|NCT01474512|41932307|FG015|Maintenance Period|Withdrawal by Subject|0|||
19711102|NCT00130689|42154276|FG000|Overall Study|Withdrawal by Subject|3|||
19413890|NCT02465567|41659139|FG001|Overall Study|Randomized but not treated|5|||
19413891|NCT02465567|41659140|FG002|Overall Study|Randomized but not treated|4|||
19413892|NCT02465567|41659141|FG003|Overall Study|Randomized but not treated|5|||
19413893|NCT02465567|41659138|FG000|Overall Study|enrolled in >1 studies|18|||
19413894|NCT02465567|41659139|FG001|Overall Study|enrolled in >1 studies|11|||
19413895|NCT02465567|41659140|FG002|Overall Study|enrolled in >1 studies|19|||
19413896|NCT02465567|41659141|FG003|Overall Study|enrolled in >1 studies|15|||
19413897|NCT02465567|41659138|FG000|Overall Study|missing PI Signature|1|||
19413898|NCT02465567|41659139|FG001|Overall Study|missing PI Signature|0|||
19413899|NCT02465567|41659140|FG002|Overall Study|missing PI Signature|0|||
19413900|NCT02465567|41659141|FG003|Overall Study|missing PI Signature|0|||
19413901|NCT01644175|41659153|FG000|Overall Study|Randomized But Not Treated|0|||
19413902|NCT01644175|41659154|FG001|Overall Study|Randomized But Not Treated|2|||
19413903|NCT01644175|41659153|FG000|Overall Study|Adverse Event|8|||
19413904|NCT01644175|41659154|FG001|Overall Study|Adverse Event|13|||
19413905|NCT01644175|41659153|FG000|Overall Study|Death|1|||
19413906|NCT01644175|41659154|FG001|Overall Study|Death|2|||
19413907|NCT01644175|41659153|FG000|Overall Study|Poor compliance to protocol|9|||
19413908|NCT01644175|41659154|FG001|Overall Study|Poor compliance to protocol|10|||
19413909|NCT01644175|41659153|FG000|Overall Study|Physician Decision|1|||
19413910|NCT01644175|41659154|FG001|Overall Study|Physician Decision|2|||
19413911|NCT01644175|41659153|FG000|Overall Study|Participant Moved|1|||
19413912|NCT01644175|41659154|FG001|Overall Study|Participant Moved|2|||
19413913|NCT01644175|41659153|FG000|Overall Study|Consent withdrawn by participant|3|||
19413914|NCT01644175|41659154|FG001|Overall Study|Consent withdrawn by participant|4|||
19413915|NCT01644175|41659153|FG000|Overall Study|Related to Autoinjector Administration|2|||
19413916|NCT01644175|41659154|FG001|Overall Study|Related to Autoinjector Administration|1|||
19413917|NCT01644175|41659153|FG000|Overall Study|Last visit outside protocol visit window|4|||
19413918|NCT01644175|41659154|FG001|Overall Study|Last visit outside protocol visit window|11|||
19413919|NCT01644175|41659153|FG000|Overall Study|Selection criteria finally not met|0|||
19413920|NCT01644175|41659154|FG001|Overall Study|Selection criteria finally not met|1|||
19413921|NCT01644175|41659153|FG000|Overall Study|Site closure|2|||
19413922|NCT01644175|41659154|FG001|Overall Study|Site closure|2|||
19413923|NCT01644175|41659153|FG000|Overall Study|Lost to Follow-up|1|||
19413924|NCT01644175|41659154|FG001|Overall Study|Lost to Follow-up|0|||
19413925|NCT01644175|41659153|FG000|Overall Study|Other than specified above|0|||
19413926|NCT01644175|41659154|FG001|Overall Study|Other than specified above|3|||
19413927|NCT02357420|41659164|FG000|Overall Study|Adverse Event|3|||
19413928|NCT02357420|41659165|FG001|Overall Study|Adverse Event|3|||
19413929|NCT02357420|41659166|FG002|Overall Study|Adverse Event|8|||
19413930|NCT02357420|41659167|FG003|Overall Study|Adverse Event|9|||
19413931|NCT02357420|41659164|FG000|Overall Study|Investigator Decision|1|||
19413932|NCT02357420|41659165|FG001|Overall Study|Investigator Decision|0|||
19413933|NCT02357420|41659166|FG002|Overall Study|Investigator Decision|0|||
19413934|NCT02357420|41659167|FG003|Overall Study|Investigator Decision|0|||
19413935|NCT02357420|41659164|FG000|Overall Study|Prohibited Medication|1|||
19413936|NCT02357420|41659165|FG001|Overall Study|Prohibited Medication|1|||
19413937|NCT02357420|41659166|FG002|Overall Study|Prohibited Medication|0|||
19413938|NCT02357420|41659167|FG003|Overall Study|Prohibited Medication|0|||
19413939|NCT02357420|41659164|FG000|Overall Study|Protocol Non-compliance|0|||
19413940|NCT02357420|41659165|FG001|Overall Study|Protocol Non-compliance|0|||
19413941|NCT02357420|41659166|FG002|Overall Study|Protocol Non-compliance|0|||
19413942|NCT02357420|41659167|FG003|Overall Study|Protocol Non-compliance|1|||
19413943|NCT02357420|41659164|FG000|Overall Study|Withdrawn Consent|4|||
19413944|NCT02357420|41659165|FG001|Overall Study|Withdrawn Consent|8|||
19413945|NCT02357420|41659166|FG002|Overall Study|Withdrawn Consent|6|||
19413946|NCT02357420|41659167|FG003|Overall Study|Withdrawn Consent|6|||
19413947|NCT02357420|41659164|FG000|Overall Study|Lost to Follow-up|3|||
19413948|NCT02357420|41659165|FG001|Overall Study|Lost to Follow-up|0|||
19413949|NCT02357420|41659166|FG002|Overall Study|Lost to Follow-up|2|||
19413950|NCT02357420|41659167|FG003|Overall Study|Lost to Follow-up|3|||
19413951|NCT01832038|41659177|FG000|Overall Study|Death|5|||
19413952|NCT01832038|41659177|FG000|Overall Study|Adverse Event|50|||
19413953|NCT01832038|41659177|FG000|Overall Study|Lack of Efficacy|81|||
19413954|NCT01832038|41659177|FG000|Overall Study|Protocol Violation|7|||
19413955|NCT01832038|41659177|FG000|Overall Study|Lost to Follow-up|10|||
19413956|NCT01832038|41659177|FG000|Overall Study|Withdrawal by Subject|49|||
19413957|NCT01832038|41659177|FG000|Overall Study|Visit non-compliance|2|||
19413958|NCT01832038|41659177|FG000|Overall Study|Subject refused to return visit|2|||
19413959|NCT01832038|41659177|FG000|Overall Study|Not convenient to come back to site|2|||
19413960|NCT01832038|41659177|FG000|Overall Study|Participant was asked to quit|5|||
19413961|NCT01832038|41659177|FG000|Overall Study|Back home|1|||
19413962|NCT01832038|41659177|FG000|Overall Study|Pregnancy|1|||
19413963|NCT01832038|41659177|FG000|Overall Study|Low compliance|3|||
19413964|NCT01832038|41659177|FG000|Overall Study|Prohibit procedure|2|||
19413965|NCT01832038|41659177|FG000|Overall Study|Not possible to visit the hospital|1|||
19413966|NCT01832038|41659177|FG000|Overall Study|Changes of implementation system|3|||
19413967|NCT01832038|41659177|FG000|Overall Study|Plan to pregnancy|7|||
19413968|NCT01832038|41659177|FG000|Overall Study|Bad mood and has suicidal thought|1|||
19413969|NCT01832038|41659177|FG000|Overall Study|Prohibited concomitant medication|1|||
19413970|NCT01832038|41659177|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
19413971|NCT01832038|41659177|FG000|Overall Study|Subject considered the efficacy was poor|1|||
19413972|NCT01849588|41659182|FG000|Overall Study|Lack of Efficacy|3|||
19413973|NCT02357342|41659188|FG000|First 6 Months|Death|2|||
19413974|NCT02357342|41659189|FG001|First 6 Months|Death|0|||
19413975|NCT02271529|41659195|FG000|Overall Study|Withdrawal by Subject|1|||
19413976|NCT02325518|41659201|FG000|Overall Study|Adverse Event|4|||
19413977|NCT02325518|41659202|FG001|Overall Study|Adverse Event|1|||
19413978|NCT02325518|41659201|FG000|Overall Study|Physician Decision|0|||
19413979|NCT02325518|41659202|FG001|Overall Study|Physician Decision|1|||
19413980|NCT02325518|41659201|FG000|Overall Study|Withdrawal by Subject|0|||
19413981|NCT02325518|41659202|FG001|Overall Study|Withdrawal by Subject|1|||
19413982|NCT02270983|41659212|FG000|Overall Study|Adverse Event|3|||
19413983|NCT02270983|41659213|FG001|Overall Study|Adverse Event|2|||
19413984|NCT02270983|41659214|FG002|Overall Study|Adverse Event|6|||
19413985|NCT02270983|41659212|FG000|Overall Study|Lack of Efficacy|2|||
19413986|NCT02270983|41659213|FG001|Overall Study|Lack of Efficacy|1|||
19413987|NCT02270983|41659214|FG002|Overall Study|Lack of Efficacy|1|||
19413988|NCT02270983|41659212|FG000|Overall Study|Withdrawal by Subject|1|||
19413989|NCT02270983|41659213|FG001|Overall Study|Withdrawal by Subject|0|||
19413990|NCT02270983|41659214|FG002|Overall Study|Withdrawal by Subject|2|||
19413991|NCT02270983|41659212|FG000|Overall Study|Lost to Follow-up|1|||
19413992|NCT02270983|41659213|FG001|Overall Study|Lost to Follow-up|1|||
19413993|NCT02270983|41659214|FG002|Overall Study|Lost to Follow-up|2|||
19413994|NCT02270983|41659212|FG000|Overall Study|Protocol Violation|1|||
19413995|NCT02270983|41659213|FG001|Overall Study|Protocol Violation|1|||
19413996|NCT02270983|41659214|FG002|Overall Study|Protocol Violation|1|||
19413997|NCT02270983|41659212|FG000|Overall Study|family emergency|0|||
19413998|NCT02270983|41659213|FG001|Overall Study|family emergency|1|||
19413999|NCT02270983|41659214|FG002|Overall Study|family emergency|0|||
19414000|NCT02270983|41659212|FG000|Overall Study|study procedure non-compliance|1|||
19414001|NCT02270983|41659213|FG001|Overall Study|study procedure non-compliance|0|||
19414002|NCT02270983|41659214|FG002|Overall Study|study procedure non-compliance|0|||
19414003|NCT02270983|41659212|FG000|Overall Study|moved away from study site|0|||
19414004|NCT02270983|41659213|FG001|Overall Study|moved away from study site|1|||
19414005|NCT02270983|41659214|FG002|Overall Study|moved away from study site|0|||
19414006|NCT02449889|41659225|FG000|Overall Study|Adverse Event|1|||
19414007|NCT02449889|41659226|FG001|Overall Study|Adverse Event|2|||
19414008|NCT02449889|41659227|FG002|Overall Study|Adverse Event|0|||
19414009|NCT02449889|41659225|FG000|Overall Study|Protocol Violation|0|||
19414010|NCT02449889|41659226|FG001|Overall Study|Protocol Violation|4|||
19414011|NCT02449889|41659227|FG002|Overall Study|Protocol Violation|1|||
19414012|NCT01831804|41659244|FG000|Overall Study|Adverse Event|0|||
19414013|NCT01831804|41659245|FG001|Overall Study|Adverse Event|0|||
19414014|NCT01831804|41659246|FG002|Overall Study|Adverse Event|0|||
19414015|NCT01831804|41659247|FG003|Overall Study|Adverse Event|0|||
19414016|NCT01831804|41659248|FG004|Overall Study|Adverse Event|0|||
19414017|NCT01831804|41659249|FG005|Overall Study|Adverse Event|0|||
19414018|NCT01831804|41659250|FG006|Overall Study|Adverse Event|1|||
19414019|NCT01831804|41659251|FG007|Overall Study|Adverse Event|0|||
19414020|NCT01831804|41659252|FG008|Overall Study|Adverse Event|1|||
19414021|NCT01831804|41659244|FG000|Overall Study|Protocol Violation|0|||
19414022|NCT01831804|41659245|FG001|Overall Study|Protocol Violation|0|||
19414023|NCT01831804|41659246|FG002|Overall Study|Protocol Violation|2|||
19414024|NCT01831804|41659247|FG003|Overall Study|Protocol Violation|0|||
19414025|NCT01831804|41659248|FG004|Overall Study|Protocol Violation|0|||
19414026|NCT01831804|41659249|FG005|Overall Study|Protocol Violation|0|||
19414027|NCT01831804|41659250|FG006|Overall Study|Protocol Violation|0|||
19414028|NCT01831804|41659251|FG007|Overall Study|Protocol Violation|0|||
19414029|NCT01831804|41659252|FG008|Overall Study|Protocol Violation|0|||
19414030|NCT01831804|41659244|FG000|Overall Study|Protocol defined stopping criteria|1|||
19414031|NCT01831804|41659245|FG001|Overall Study|Protocol defined stopping criteria|1|||
19414032|NCT01831804|41659246|FG002|Overall Study|Protocol defined stopping criteria|3|||
19414033|NCT01831804|41659247|FG003|Overall Study|Protocol defined stopping criteria|0|||
19414034|NCT01831804|41659248|FG004|Overall Study|Protocol defined stopping criteria|1|||
19414035|NCT01831804|41659249|FG005|Overall Study|Protocol defined stopping criteria|0|||
19414036|NCT01831804|41659250|FG006|Overall Study|Protocol defined stopping criteria|0|||
19414037|NCT01831804|41659251|FG007|Overall Study|Protocol defined stopping criteria|0|||
19414038|NCT01831804|41659252|FG008|Overall Study|Protocol defined stopping criteria|0|||
19414039|NCT01831804|41659244|FG000|Overall Study|Lost to Follow-up|0|||
19414040|NCT01831804|41659245|FG001|Overall Study|Lost to Follow-up|0|||
19414041|NCT01831804|41659246|FG002|Overall Study|Lost to Follow-up|1|||
19414042|NCT01831804|41659247|FG003|Overall Study|Lost to Follow-up|0|||
19414043|NCT01831804|41659248|FG004|Overall Study|Lost to Follow-up|0|||
19414044|NCT01831804|41659249|FG005|Overall Study|Lost to Follow-up|0|||
19414045|NCT01831804|41659250|FG006|Overall Study|Lost to Follow-up|0|||
19414046|NCT01831804|41659251|FG007|Overall Study|Lost to Follow-up|0|||
19414047|NCT01831804|41659252|FG008|Overall Study|Lost to Follow-up|1|||
19414048|NCT01831804|41659244|FG000|Overall Study|Investigator discretion|0|||
19414049|NCT01831804|41659245|FG001|Overall Study|Investigator discretion|0|||
19414050|NCT01831804|41659246|FG002|Overall Study|Investigator discretion|0|||
19414051|NCT01831804|41659247|FG003|Overall Study|Investigator discretion|0|||
19414052|NCT01831804|41659248|FG004|Overall Study|Investigator discretion|1|||
19414053|NCT01831804|41659249|FG005|Overall Study|Investigator discretion|0|||
19414054|NCT01831804|41659250|FG006|Overall Study|Investigator discretion|0|||
19414055|NCT01831804|41659251|FG007|Overall Study|Investigator discretion|1|||
19414056|NCT01831804|41659252|FG008|Overall Study|Investigator discretion|0|||
19414057|NCT01831804|41659244|FG000|Overall Study|Withdrew Consent|0|||
19414058|NCT01831804|41659245|FG001|Overall Study|Withdrew Consent|1|||
19414059|NCT01831804|41659246|FG002|Overall Study|Withdrew Consent|0|||
19414060|NCT01831804|41659247|FG003|Overall Study|Withdrew Consent|0|||
19414061|NCT01831804|41659248|FG004|Overall Study|Withdrew Consent|0|||
19414062|NCT01831804|41659249|FG005|Overall Study|Withdrew Consent|0|||
19414063|NCT01831804|41659250|FG006|Overall Study|Withdrew Consent|0|||
19414064|NCT01831804|41659251|FG007|Overall Study|Withdrew Consent|2|||
19414065|NCT01831804|41659252|FG008|Overall Study|Withdrew Consent|0|||
19414066|NCT02270671|41659283|FG000|Overall Study|Withdrawal by Subject|1|||
19414067|NCT02270671|41659284|FG001|Overall Study|Withdrawal by Subject|1|||
19414068|NCT02270671|41659283|FG000|Overall Study|Protocol Violation|0|||
19414069|NCT02270671|41659284|FG001|Overall Study|Protocol Violation|1|||
19414070|NCT02270671|41659283|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
19414071|NCT02270671|41659284|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
19414072|NCT02270671|41659283|FG000|Overall Study|Lost to Follow-up|2|||
19414073|NCT02270671|41659284|FG001|Overall Study|Lost to Follow-up|1|||
19414074|NCT02324270|41659293|FG000|Overall Study|Withdrawal by Subject|0|||
19414075|NCT02324270|41659294|FG001|Overall Study|Withdrawal by Subject|1|||
19414076|NCT02324270|41659295|FG002|Overall Study|Withdrawal by Subject|0|||
19414077|NCT02324270|41659293|FG000|Overall Study|Lost to Follow-up|4|||
19414078|NCT02324270|41659294|FG001|Overall Study|Lost to Follow-up|3|||
19414079|NCT02324270|41659295|FG002|Overall Study|Lost to Follow-up|4|||
19414080|NCT02324270|41659293|FG000|Overall Study|Protocol Violation|0|||
19414081|NCT02324270|41659294|FG001|Overall Study|Protocol Violation|1|||
19414082|NCT02324270|41659295|FG002|Overall Study|Protocol Violation|1|||
19414083|NCT02324270|41659293|FG000|Overall Study|Non Compliance with Study Drug|1|||
19414084|NCT02324270|41659294|FG001|Overall Study|Non Compliance with Study Drug|2|||
19414085|NCT02324270|41659295|FG002|Overall Study|Non Compliance with Study Drug|0|||
19414086|NCT02270515|41659303|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
19414087|NCT02270515|41659303|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
19414088|NCT02270515|41659303|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
19414089|NCT02270515|41659303|FG000|Intervention Period 1: 0-6 Months|Death|7|||
19414090|NCT02270515|41659303|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
19414091|NCT02270515|41659303|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
19414092|NCT02270515|41659303|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
19414093|NCT02270515|41659303|FG000|Intervention Period 2: 6-12 Months|Death|5|||
19414094|NCT02270515|41659303|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
19414095|NCT02270515|41659303|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
19414096|NCT02270515|41659303|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
19414097|NCT02270515|41659303|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
19414098|NCT02270515|41659303|FG000|Intervention Period 3: 12-18 Months|Death|3|||
19414099|NCT02270515|41659303|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
19414100|NCT02448875|41659317|FG000|Overall Study|Adverse Event|2|||
19414101|NCT02448875|41659318|FG001|Overall Study|Adverse Event|1|||
19414102|NCT02448875|41659319|FG002|Overall Study|Adverse Event|0|||
19414103|NCT02448875|41659317|FG000|Overall Study|Lost to Follow-up|1|||
19414104|NCT02448875|41659318|FG001|Overall Study|Lost to Follow-up|0|||
19414105|NCT02448875|41659319|FG002|Overall Study|Lost to Follow-up|0|||
19414106|NCT02448875|41659317|FG000|Overall Study|Investigator Decision|3|||
19414107|NCT02448875|41659318|FG001|Overall Study|Investigator Decision|0|||
19414108|NCT02448875|41659319|FG002|Overall Study|Investigator Decision|1|||
19414109|NCT02448875|41659317|FG000|Overall Study|Withdrawal by Subject|1|||
19414110|NCT02448875|41659318|FG001|Overall Study|Withdrawal by Subject|0|||
19414111|NCT02448875|41659319|FG002|Overall Study|Withdrawal by Subject|0|||
19414112|NCT01831726|41659330|FG000|Overall Study|Adverse Event|16|||
19414113|NCT01831726|41659330|FG000|Overall Study|Death|7|||
19414114|NCT01831726|41659330|FG000|Overall Study|Disease Progression|49|||
19414115|NCT01831726|41659330|FG000|Overall Study|Physician Decision|1|||
19414116|NCT01831726|41659330|FG000|Overall Study|Subject/guardian decision|7|||
19414117|NCT01831258|41659334|FG000|Overall Study|Withdrawal by Subject|2|||
19414118|NCT01831258|41659335|FG001|Overall Study|Withdrawal by Subject|1|||
19414119|NCT01831258|41659334|FG000|Overall Study|Lost to Follow-up|3|||
19414120|NCT01831258|41659335|FG001|Overall Study|Lost to Follow-up|2|||
19414121|NCT01849276|41659343|FG000|Followed for Survival for 5 Years|Death|1|||
19414122|NCT01849276|41659343|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
19414123|NCT02465489|41659347|FG000|Overall Study|Adverse Event|5|||
19414124|NCT01829464|41659362|FG000|Overall Study|Adverse Event|1|||
19414125|NCT01829464|41659363|FG001|Overall Study|Adverse Event|0|||
19414126|NCT01829464|41659364|FG002|Overall Study|Adverse Event|0|||
19414127|NCT01829464|41659362|FG000|Overall Study|Lost to Follow-up|0|||
19414128|NCT01829464|41659363|FG001|Overall Study|Lost to Follow-up|0|||
19414129|NCT01829464|41659364|FG002|Overall Study|Lost to Follow-up|1|||
19414130|NCT01829464|41659362|FG000|Overall Study|Withdrawal by Subject|2|||
19414131|NCT01829464|41659363|FG001|Overall Study|Withdrawal by Subject|0|||
19414132|NCT01829464|41659364|FG002|Overall Study|Withdrawal by Subject|0|||
19414133|NCT01829464|41659362|FG000|Overall Study|Study terminated by sponsor|25|||
19414134|NCT01829464|41659363|FG001|Overall Study|Study terminated by sponsor|28|||
19414135|NCT01829464|41659364|FG002|Overall Study|Study terminated by sponsor|25|||
19414136|NCT01829464|41659362|FG000|Overall Study|Lack of Efficacy|0|||
19414137|NCT01829464|41659363|FG001|Overall Study|Lack of Efficacy|1|||
19414138|NCT01829464|41659364|FG002|Overall Study|Lack of Efficacy|0|||
19414139|NCT01847092|41659374|FG000|Overall Study|Adverse Event|12|||
19414140|NCT01847092|41659375|FG001|Overall Study|Adverse Event|3|||
19414141|NCT01847092|41659374|FG000|Overall Study|Withdrawal by Subject|5|||
19414142|NCT01847092|41659375|FG001|Overall Study|Withdrawal by Subject|5|||
19414143|NCT01847092|41659374|FG000|Overall Study|Protocol Specified|8|||
19414144|NCT01847092|41659375|FG001|Overall Study|Protocol Specified|0|||
19414145|NCT01847092|41659374|FG000|Overall Study|Physician Decision|1|||
19414146|NCT01847092|41659375|FG001|Overall Study|Physician Decision|1|||
19414147|NCT01847092|41659374|FG000|Overall Study|Protocol Violation|0|||
19414148|NCT01847092|41659375|FG001|Overall Study|Protocol Violation|2|||
19414149|NCT01601821|41659383|FG000|Overall Study|Death|2|||
19414150|NCT01601821|41659384|FG001|Overall Study|Death|5|||
19414151|NCT01601821|41659383|FG000|Overall Study|Protocol Violation|2|||
19414152|NCT01601821|41659384|FG001|Overall Study|Protocol Violation|2|||
19414153|NCT01601821|41659383|FG000|Overall Study|Lost to Follow-up|6|||
19414154|NCT01601821|41659384|FG001|Overall Study|Lost to Follow-up|14|||
19414155|NCT01601821|41659383|FG000|Overall Study|Withdrawal by Subject|1|||
19414156|NCT01601821|41659384|FG001|Overall Study|Withdrawal by Subject|0|||
19414157|NCT01601821|41659383|FG000|Overall Study|Graft Loss|6|||
19414158|NCT01601821|41659384|FG001|Overall Study|Graft Loss|6|||
19414159|NCT01601821|41659383|FG000|Overall Study|Study Events|7|||
19414160|NCT01601821|41659384|FG001|Overall Study|Study Events|1|||
19414161|NCT01601821|41659383|FG000|Overall Study|Other|5|||
19414162|NCT01601821|41659384|FG001|Overall Study|Other|1|||
19414163|NCT02323646|41659393|FG000|Treatment Course 1|Adverse Event|1|||
19414164|NCT02323646|41659394|FG001|Treatment Course 1|Adverse Event|0|||
19414165|NCT02323646|41659395|FG002|Treatment Course 1|Adverse Event|1|||
19414166|NCT02323646|41659393|FG000|Treatment Course 1|Heavy Bleeding|1|||
19414167|NCT02323646|41659394|FG001|Treatment Course 1|Heavy Bleeding|1|||
19414168|NCT02323646|41659395|FG002|Treatment Course 1|Heavy Bleeding|0|||
19414169|NCT02323646|41659393|FG000|Treatment Course 1|Lost to Follow-up|1|||
19414170|NCT02323646|41659394|FG001|Treatment Course 1|Lost to Follow-up|0|||
19414171|NCT02323646|41659395|FG002|Treatment Course 1|Lost to Follow-up|2|||
19414172|NCT02323646|41659393|FG000|Treatment Course 1|Withdrawal by Subject|0|||
19414173|NCT02323646|41659394|FG001|Treatment Course 1|Withdrawal by Subject|2|||
19414174|NCT02323646|41659395|FG002|Treatment Course 1|Withdrawal by Subject|0|||
19414175|NCT02323646|41659393|FG000|Treatment Course 2|Adverse Event|1|||
19414176|NCT02323646|41659394|FG001|Treatment Course 2|Adverse Event|0|||
19414177|NCT02323646|41659395|FG002|Treatment Course 2|Adverse Event|1|||
19414178|NCT02323646|41659393|FG000|Treatment Course 2|Lost to Follow-up|0|||
19414179|NCT02323646|41659394|FG001|Treatment Course 2|Lost to Follow-up|0|||
19414180|NCT02323646|41659395|FG002|Treatment Course 2|Lost to Follow-up|1|||
19414181|NCT02323646|41659393|FG000|Treatment Course 2|Non-compliance|0|||
19519273|NCT01474512|41932308|FG016|Maintenance Period|Withdrawal by Subject|0|||
19519274|NCT01474512|41932309|FG017|Maintenance Period|Withdrawal by Subject|0|||
19519275|NCT01474512|41932292|FG000|Maintenance Period|Lost to Follow-up|0|||
19519276|NCT01474512|41932293|FG001|Maintenance Period|Lost to Follow-up|0|||
19414182|NCT02323646|41659394|FG001|Treatment Course 2|Non-compliance|1|||
19414183|NCT02323646|41659395|FG002|Treatment Course 2|Non-compliance|1|||
19414184|NCT01846624|41659403|FG000|Overall Study|Died during induction, no midostaurin|1|||
19414185|NCT01829230|41659409|FG000|Overall Study|Protocol Violation|0|||
19414186|NCT01829230|41659410|FG001|Overall Study|Protocol Violation|2|||
19519277|NCT01474512|41932294|FG002|Maintenance Period|Lost to Follow-up|0|||
19519278|NCT01474512|41932295|FG003|Maintenance Period|Lost to Follow-up|3|||
19414187|NCT01829230|41659409|FG000|Overall Study|Withdrawal by Subject|0|||
19414188|NCT01829230|41659410|FG001|Overall Study|Withdrawal by Subject|1|||
19414189|NCT01829230|41659409|FG000|Overall Study|Lost to Follow-up|1|||
19414190|NCT01829230|41659410|FG001|Overall Study|Lost to Follow-up|1|||
19414191|NCT02269657|41659416|FG000|Overall Study|Protocol Violation|3|||
19414192|NCT02269423|41659426|FG000|Overall Study|Discontinued due to change in residence|0|||
19414193|NCT02269423|41659427|FG001|Overall Study|Discontinued due to change in residence|1|||
19414194|NCT02269423|41659428|FG002|Overall Study|Discontinued due to change in residence|0|||
19414195|NCT02269423|41659429|FG003|Overall Study|Discontinued due to change in residence|1|||
19414196|NCT01844986|41659441|FG000|Overall Study|Severe non-compliance to protocol|1|||
19414197|NCT01844986|41659442|FG001|Overall Study|Severe non-compliance to protocol|0|||
19414198|NCT01844986|41659441|FG000|Overall Study|Withdrawal by Subject|21|||
19414199|NCT01844986|41659442|FG001|Overall Study|Withdrawal by Subject|14|||
19414200|NCT01844986|41659441|FG000|Overall Study|Death|55|||
19414201|NCT01844986|41659442|FG001|Overall Study|Death|26|||
19414202|NCT01827670|41659450|FG000|Overall Study|Withdrawal of Consent|3|||
19414203|NCT01827670|41659451|FG001|Overall Study|Withdrawal of Consent|2|||
19414204|NCT01827670|41659450|FG000|Overall Study|Lost to Follow-up|0|||
19414205|NCT01827670|41659451|FG001|Overall Study|Lost to Follow-up|1|||
19414206|NCT02267317|41659465|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
19414207|NCT02267317|41659466|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
19414208|NCT02267317|41659467|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
19414209|NCT02267317|41659468|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
19414210|NCT02267317|41659469|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
19414211|NCT02267317|41659470|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
19519279|NCT01474512|41932296|FG004|Maintenance Period|Lost to Follow-up|3|||
19519280|NCT01474512|41932297|FG005|Maintenance Period|Lost to Follow-up|0|||
19519281|NCT01474512|41932298|FG006|Maintenance Period|Lost to Follow-up|0|||
19519282|NCT01474512|41932299|FG007|Maintenance Period|Lost to Follow-up|2|||
19519283|NCT01474512|41932300|FG008|Maintenance Period|Lost to Follow-up|1|||
19519284|NCT01474512|41932301|FG009|Maintenance Period|Lost to Follow-up|1|||
19519285|NCT01474512|41932302|FG010|Maintenance Period|Lost to Follow-up|0|||
19519286|NCT01474512|41932303|FG011|Maintenance Period|Lost to Follow-up|0|||
19519287|NCT01474512|41932304|FG012|Maintenance Period|Lost to Follow-up|0|||
19519288|NCT01474512|41932305|FG013|Maintenance Period|Lost to Follow-up|0|||
19414212|NCT02267317|41659465|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
19414213|NCT02267317|41659466|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
19414214|NCT02267317|41659467|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
19414215|NCT02267317|41659468|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
19414216|NCT02267317|41659469|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
19414217|NCT02267317|41659470|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
19414218|NCT01844830|41659486|FG000|Overall Study|Withdrawal by Subject|1|||
19414219|NCT01844830|41659487|FG001|Overall Study|Withdrawal by Subject|0|||
19414220|NCT01827592|41659496|FG000|Overall Study|Adverse Event|11|||
19414221|NCT01827592|41659497|FG001|Overall Study|Adverse Event|9|||
19414222|NCT01827592|41659498|FG002|Overall Study|Adverse Event|2|||
19414223|NCT01827592|41659496|FG000|Overall Study|Physician Decision|0|||
19414224|NCT01827592|41659497|FG001|Overall Study|Physician Decision|2|||
19414225|NCT01827592|41659498|FG002|Overall Study|Physician Decision|1|||
19414226|NCT01827592|41659496|FG000|Overall Study|Protocol Violation|2|||
19414227|NCT01827592|41659497|FG001|Overall Study|Protocol Violation|1|||
19414228|NCT01827592|41659498|FG002|Overall Study|Protocol Violation|0|||
19414229|NCT01827592|41659496|FG000|Overall Study|Lost to Follow-up|1|||
19414230|NCT01827592|41659497|FG001|Overall Study|Lost to Follow-up|2|||
19414231|NCT01827592|41659498|FG002|Overall Study|Lost to Follow-up|2|||
19414232|NCT01827592|41659496|FG000|Overall Study|Withdrawal by Subject|12|||
19414233|NCT01827592|41659497|FG001|Overall Study|Withdrawal by Subject|11|||
19414234|NCT01827592|41659498|FG002|Overall Study|Withdrawal by Subject|11|||
19414235|NCT01827592|41659496|FG000|Overall Study|Patient's substantial non-compliance|1|||
19414236|NCT01827592|41659497|FG001|Overall Study|Patient's substantial non-compliance|1|||
19414237|NCT01827592|41659498|FG002|Overall Study|Patient's substantial non-compliance|6|||
19414238|NCT01827592|41659496|FG000|Overall Study|Trial terminated by Sponsor|47|||
19414239|NCT01827592|41659497|FG001|Overall Study|Trial terminated by Sponsor|53|||
19414240|NCT01827592|41659498|FG002|Overall Study|Trial terminated by Sponsor|51|||
19414241|NCT01827592|41659496|FG000|Overall Study|Others|0|||
19414242|NCT01827592|41659497|FG001|Overall Study|Others|1|||
19414243|NCT01827592|41659498|FG002|Overall Study|Others|3|||
19414244|NCT02323334|41659516|FG000|Period 3|Lost to Follow-up|0|||
19519289|NCT01474512|41932306|FG014|Maintenance Period|Lost to Follow-up|0|||
19519290|NCT01474512|41932307|FG015|Maintenance Period|Lost to Follow-up|0|||
19519291|NCT01474512|41932308|FG016|Maintenance Period|Lost to Follow-up|0|||
19414245|NCT02323334|41659517|FG001|Period 3|Lost to Follow-up|0|||
19519292|NCT01474512|41932309|FG017|Maintenance Period|Lost to Follow-up|0|||
19519293|NCT01474512|41932292|FG000|Maintenance Period|Death|0|||
19414246|NCT02323334|41659518|FG002|Period 3|Lost to Follow-up|1|||
19414247|NCT02323334|41659519|FG003|Period 3|Lost to Follow-up|0|||
19414248|NCT02323334|41659520|FG004|Period 3|Lost to Follow-up|0|||
19414249|NCT02323334|41659521|FG005|Period 3|Lost to Follow-up|0|||
19414250|NCT02323334|41659522|FG006|Period 3|Lost to Follow-up|0|||
19414251|NCT02323334|41659523|FG007|Period 3|Lost to Follow-up|0|||
19414252|NCT02323334|41659524|FG008|Period 3|Lost to Follow-up|0|||
19414253|NCT02323334|41659525|FG009|Period 3|Lost to Follow-up|0|||
19414254|NCT02323334|41659526|FG010|Period 3|Lost to Follow-up|0|||
19414255|NCT02323334|41659527|FG011|Period 3|Lost to Follow-up|0|||
19414256|NCT02323334|41659528|FG012|Period 3|Lost to Follow-up|0|||
19414257|NCT02323334|41659529|FG013|Period 3|Lost to Follow-up|0|||
19414258|NCT02323334|41659530|FG014|Period 3|Lost to Follow-up|0|||
19414259|NCT02323334|41659531|FG015|Period 3|Lost to Follow-up|0|||
19414260|NCT02323334|41659532|FG016|Period 3|Lost to Follow-up|0|||
19414261|NCT02323334|41659516|FG000|Period 3|Withdrawal by Subject|1|||
19414262|NCT02323334|41659517|FG001|Period 3|Withdrawal by Subject|0|||
19414263|NCT02323334|41659518|FG002|Period 3|Withdrawal by Subject|0|||
19414264|NCT02323334|41659519|FG003|Period 3|Withdrawal by Subject|0|||
19414265|NCT02323334|41659520|FG004|Period 3|Withdrawal by Subject|0|||
19414266|NCT02323334|41659521|FG005|Period 3|Withdrawal by Subject|0|||
19414267|NCT02323334|41659522|FG006|Period 3|Withdrawal by Subject|0|||
19414268|NCT02323334|41659523|FG007|Period 3|Withdrawal by Subject|0|||
19414269|NCT02323334|41659524|FG008|Period 3|Withdrawal by Subject|0|||
19414270|NCT02323334|41659525|FG009|Period 3|Withdrawal by Subject|0|||
19414271|NCT02323334|41659526|FG010|Period 3|Withdrawal by Subject|0|||
19414272|NCT02323334|41659527|FG011|Period 3|Withdrawal by Subject|0|||
19414273|NCT02323334|41659528|FG012|Period 3|Withdrawal by Subject|0|||
19414274|NCT02323334|41659529|FG013|Period 3|Withdrawal by Subject|0|||
19414275|NCT02323334|41659530|FG014|Period 3|Withdrawal by Subject|0|||
19414276|NCT02323334|41659531|FG015|Period 3|Withdrawal by Subject|0|||
19414277|NCT02323334|41659532|FG016|Period 3|Withdrawal by Subject|0|||
19414278|NCT02448719|41659605|FG000|Overall Study|Withdrawal by Subject|0|||
19414279|NCT02448719|41659606|FG001|Overall Study|Withdrawal by Subject|0|||
19414280|NCT02448719|41659607|FG002|Overall Study|Withdrawal by Subject|0|||
19414281|NCT02448719|41659608|FG003|Overall Study|Withdrawal by Subject|0|||
19414282|NCT02448719|41659609|FG004|Overall Study|Withdrawal by Subject|1|||
19414283|NCT02448719|41659610|FG005|Overall Study|Withdrawal by Subject|0|||
19414284|NCT02448719|41659611|FG006|Overall Study|Withdrawal by Subject|0|||
19414285|NCT02448719|41659612|FG007|Overall Study|Withdrawal by Subject|0|||
19414286|NCT02448719|41659613|FG008|Overall Study|Withdrawal by Subject|0|||
19414287|NCT02448719|41659614|FG009|Overall Study|Withdrawal by Subject|0|||
19414288|NCT02448719|41659615|FG010|Overall Study|Withdrawal by Subject|0|||
19414289|NCT02322866|41659678|FG000|Overall Study|Adverse Event|6|||
19414290|NCT02322866|41659679|FG001|Overall Study|Adverse Event|11|||
19414291|NCT02322866|41659678|FG000|Overall Study|Withdrawal of Consent|16|||
19414292|NCT02322866|41659679|FG001|Overall Study|Withdrawal of Consent|25|||
19414293|NCT02322866|41659678|FG000|Overall Study|Lost to Follow-up|36|||
19414294|NCT02322866|41659679|FG001|Overall Study|Lost to Follow-up|39|||
19414295|NCT02322866|41659678|FG000|Overall Study|Protocol Violation|1|||
19414296|NCT02322866|41659679|FG001|Overall Study|Protocol Violation|0|||
19414297|NCT02322866|41659678|FG000|Overall Study|Noncompliance with Treatment|3|||
19414298|NCT02322866|41659679|FG001|Overall Study|Noncompliance with Treatment|4|||
19414299|NCT02322866|41659678|FG000|Overall Study|Lack of Efficacy|3|||
19414300|NCT02322866|41659679|FG001|Overall Study|Lack of Efficacy|1|||
19414301|NCT02322866|41659678|FG000|Overall Study|Other Miscellaneous Reasons|6|||
19414302|NCT02322866|41659679|FG001|Overall Study|Other Miscellaneous Reasons|6|||
19414303|NCT01844518|41659687|FG000|Overall Study|Adverse Event|7|||
19414304|NCT01844518|41659688|FG001|Overall Study|Adverse Event|1|||
19414305|NCT01844518|41659687|FG000|Overall Study|Lack of Efficacy|17|||
19414306|NCT01844518|41659688|FG001|Overall Study|Lack of Efficacy|5|||
19414307|NCT01844518|41659687|FG000|Overall Study|Participant's request to discontinue|4|||
19414308|NCT01844518|41659688|FG001|Overall Study|Participant's request to discontinue|1|||
19414309|NCT01844518|41659687|FG000|Overall Study|Poor/Non-compliance|1|||
19414310|NCT01844518|41659688|FG001|Overall Study|Poor/Non-compliance|0|||
19414311|NCT01844518|41659687|FG000|Overall Study|No Longer Met Study Criteria|2|||
19414312|NCT01844518|41659688|FG001|Overall Study|No Longer Met Study Criteria|0|||
19414313|NCT01844518|41659687|FG000|Overall Study|Withdrawal by Subject|9|||
19414314|NCT01844518|41659688|FG001|Overall Study|Withdrawal by Subject|0|||
19414315|NCT01844518|41659687|FG000|Overall Study|Pregnancy|1|||
19414316|NCT01844518|41659688|FG001|Overall Study|Pregnancy|0|||
19414317|NCT01640353|41659697|FG000|Overall Study|Withdrew prior to treatment|10|||
19414318|NCT01640353|41659697|FG000|Overall Study|Withdrawn from analysis at term site|12|||
19414319|NCT01640353|41659697|FG000|Overall Study|Withdrawal by Subject|5|||
19414320|NCT01640353|41659697|FG000|Overall Study|Death|2|||
19414321|NCT01640353|41659697|FG000|Overall Study|Early site termination|3|||
19414322|NCT01640353|41659697|FG000|Overall Study|Lost to Follow-up|12|||
19414323|NCT01640353|41659697|FG000|Overall Study|Physician Decision|1|||
19414324|NCT02463071|41659704|FG000|Overall Study|Adverse Event|3|||
19628099|NCT00589914|42077497|FG001|Overall Study|Other|17|||
19414325|NCT02463071|41659705|FG001|Overall Study|Adverse Event|5|||
19414326|NCT02463071|41659706|FG002|Overall Study|Adverse Event|1|||
19414327|NCT02463071|41659704|FG000|Overall Study|Death|1|||
19414328|NCT02463071|41659705|FG001|Overall Study|Death|0|||
19414329|NCT02463071|41659706|FG002|Overall Study|Death|0|||
19414330|NCT02463071|41659704|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
19414331|NCT02463071|41659705|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19414332|NCT02463071|41659706|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
19414333|NCT02463071|41659704|FG000|Overall Study|Reason not specified|7|||
19414334|NCT02463071|41659705|FG001|Overall Study|Reason not specified|9|||
19414335|NCT02463071|41659706|FG002|Overall Study|Reason not specified|4|||
19414336|NCT02463071|41659704|FG000|Overall Study|Protocol Violation|0|||
19414337|NCT02463071|41659705|FG001|Overall Study|Protocol Violation|2|||
19414338|NCT02463071|41659706|FG002|Overall Study|Protocol Violation|0|||
19414339|NCT02463071|41659704|FG000|Overall Study|Lost to Follow-up|0|||
19414340|NCT02463071|41659705|FG001|Overall Study|Lost to Follow-up|0|||
19414341|NCT02463071|41659706|FG002|Overall Study|Lost to Follow-up|1|||
19414342|NCT02266381|41659717|FG000|Overall Study|Physician Decision|3|||
19414343|NCT02266381|41659718|FG001|Overall Study|Physician Decision|5|||
19414344|NCT02266381|41659719|FG002|Overall Study|Physician Decision|4|||
19414345|NCT01827046|41659731|FG000|Overall Study|Lost to Follow-up|1|||
19414346|NCT01827046|41659732|FG001|Overall Study|Lost to Follow-up|5|||
19414347|NCT01827046|41659731|FG000|Overall Study|Withdrawal by Subject|0|||
19414348|NCT01827046|41659732|FG001|Overall Study|Withdrawal by Subject|4|||
19414349|NCT02356562|41659740|FG000|Overall Study|Withdrawal by Subject|0|||
19414350|NCT02356562|41659741|FG001|Overall Study|Withdrawal by Subject|1|||
19414351|NCT02356562|41659740|FG000|Overall Study|Re-entered treatment in a previous study|1|||
19414352|NCT02356562|41659741|FG001|Overall Study|Re-entered treatment in a previous study|0|||
19414353|NCT02356562|41659740|FG000|Overall Study|site closure|1|||
19414354|NCT02356562|41659741|FG001|Overall Study|site closure|0|||
19414355|NCT02448563|41659752|FG000|Overall Study|Lost to Follow-up|16|||
19414356|NCT02448563|41659753|FG001|Overall Study|Lost to Follow-up|10|||
19414357|NCT02448563|41659752|FG000|Overall Study|Withdrawal by Subject|0|||
19414358|NCT02448563|41659753|FG001|Overall Study|Withdrawal by Subject|1|||
19414359|NCT02266225|41659763|FG000|Overall Study|Lost to Follow-up|2|||
19414360|NCT02266225|41659763|FG000|Overall Study|Death|1|||
19414361|NCT02266225|41659763|FG000|Overall Study|Withdrawal by Subject|13|||
19414362|NCT02354690|41659768|FG000|Overall Study|Physician Decision|1|||
19414363|NCT02354222|41659774|FG000|Overall Study|Adverse Event|0|||
19414364|NCT02354222|41659775|FG001|Overall Study|Adverse Event|3|||
19414365|NCT02354222|41659774|FG000|Overall Study|Physician Decision|1|||
19414366|NCT02354222|41659775|FG001|Overall Study|Physician Decision|1|||
19414367|NCT02354222|41659774|FG000|Overall Study|Pregnancy|1|||
19414368|NCT02354222|41659775|FG001|Overall Study|Pregnancy|0|||
19414369|NCT02354222|41659774|FG000|Overall Study|Withdrawal by Subject|2|||
19414370|NCT02354222|41659775|FG001|Overall Study|Withdrawal by Subject|3|||
19414371|NCT02354222|41659774|FG000|Overall Study|Conflict with the stopping criteria|0|||
19414372|NCT02354222|41659775|FG001|Overall Study|Conflict with the stopping criteria|4|||
19414373|NCT02353442|41659783|FG000|Overall Study|Withdrawal by Subject|3|||
19414374|NCT02353442|41659784|FG001|Overall Study|Withdrawal by Subject|4|||
19414375|NCT02351960|41659792|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
19414376|NCT02351960|41659793|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
19414377|NCT02351960|41659792|FG000|Overall Study|Voluntary Withdrawal|5|||
19414378|NCT02351960|41659793|FG001|Overall Study|Voluntary Withdrawal|4|||
19414379|NCT02351960|41659792|FG000|Overall Study|Significant Protocol Deviation|0|||
19414380|NCT02351960|41659793|FG001|Overall Study|Significant Protocol Deviation|5|||
19414381|NCT02351180|41659802|FG000|Overall Study|Withdrawal by Subject|1|||
19414382|NCT02351180|41659803|FG001|Overall Study|Withdrawal by Subject|0|||
19414383|NCT02350478|41659811|FG000|Overall Study|Lost to Follow-up|5|||
19414384|NCT02350478|41659812|FG001|Overall Study|Lost to Follow-up|1|||
19414385|NCT02349542|41659818|FG000|Overall Study|Withdrawal by Subject|5|||
19414386|NCT02321930|41659822|FG000|Overall Study|Lost to Follow-up|1|||
19414387|NCT01647542|41659829|FG000|Overall Study|Major Protocol Deviation|1|||
19414388|NCT01647542|41659830|FG001|Overall Study|Major Protocol Deviation|0|||
19414389|NCT01647542|41659831|FG002|Overall Study|Major Protocol Deviation|0|||
19414390|NCT01647542|41659829|FG000|Overall Study|Adverse Event|4|||
19414391|NCT01647542|41659830|FG001|Overall Study|Adverse Event|5|||
19414392|NCT01647542|41659831|FG002|Overall Study|Adverse Event|4|||
19414393|NCT01647542|41659829|FG000|Overall Study|Lost to Follow-up|0|||
19414394|NCT01647542|41659830|FG001|Overall Study|Lost to Follow-up|2|||
19414395|NCT01647542|41659831|FG002|Overall Study|Lost to Follow-up|2|||
19414396|NCT01647542|41659829|FG000|Overall Study|Withdrawal by Subject|6|||
19414397|NCT01647542|41659830|FG001|Overall Study|Withdrawal by Subject|4|||
19414398|NCT01647542|41659831|FG002|Overall Study|Withdrawal by Subject|0|||
19414399|NCT01647542|41659829|FG000|Overall Study|Study Termination|64|||
19414400|NCT01647542|41659830|FG001|Overall Study|Study Termination|61|||
19414401|NCT01647542|41659831|FG002|Overall Study|Study Termination|65|||
19414402|NCT01647542|41659829|FG000|Overall Study|Lack of Efficacy|1|||
19414403|NCT01647542|41659830|FG001|Overall Study|Lack of Efficacy|1|||
19414404|NCT01647542|41659831|FG002|Overall Study|Lack of Efficacy|0|||
19414405|NCT01647542|41659829|FG000|Overall Study|Death|0|||
19414406|NCT01647542|41659830|FG001|Overall Study|Death|0|||
19414407|NCT01647542|41659831|FG002|Overall Study|Death|1|||
19414408|NCT02321462|41659841|FG000|Overall Study|Withdrawal by Subject|5|||
19414409|NCT02321462|41659842|FG001|Overall Study|Withdrawal by Subject|2|||
19414410|NCT02321462|41659841|FG000|Overall Study|Subject withdrawn before any treatment|1|||
19414411|NCT02321462|41659842|FG001|Overall Study|Subject withdrawn before any treatment|1|||
19414412|NCT02391584|41659851|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
19414413|NCT02391584|41659852|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
19414414|NCT02391584|41659851|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
19414415|NCT02391584|41659852|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
19414416|NCT02391584|41659851|FG000|3 Month|Lost to Follow-up|1|||
19414417|NCT02391584|41659852|FG001|3 Month|Lost to Follow-up|0|||
19414418|NCT02391584|41659851|FG000|6 Month|Withdrawal by Subject|1|||
19414419|NCT02391584|41659852|FG001|6 Month|Withdrawal by Subject|0|||
19414420|NCT02391584|41659851|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
19414421|NCT02391584|41659852|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
19414422|NCT02266147|41659865|FG000|PART 1: Dose Escalation|Physician Decision|0|||
19414423|NCT02266147|41659866|FG001|PART 1: Dose Escalation|Physician Decision|0|||
19414424|NCT02266147|41659867|FG002|PART 1: Dose Escalation|Physician Decision|1|||
19414425|NCT02266147|41659868|FG003|PART 1: Dose Escalation|Physician Decision|0|||
19414426|NCT02266147|41659865|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
19414427|NCT02266147|41659866|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
19414428|NCT02266147|41659867|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
19414429|NCT02266147|41659868|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
19414430|NCT02266147|41659865|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
19414431|NCT02266147|41659866|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
19414432|NCT02266147|41659867|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
19414433|NCT02266147|41659868|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
19519294|NCT01474512|41932293|FG001|Maintenance Period|Death|0|||
19519295|NCT01474512|41932294|FG002|Maintenance Period|Death|0|||
19519296|NCT01474512|41932295|FG003|Maintenance Period|Death|0|||
19519297|NCT01474512|41932296|FG004|Maintenance Period|Death|0|||
19519298|NCT01474512|41932297|FG005|Maintenance Period|Death|2|||
19519299|NCT01474512|41932298|FG006|Maintenance Period|Death|0|||
19519300|NCT01474512|41932299|FG007|Maintenance Period|Death|0|||
19519301|NCT01474512|41932300|FG008|Maintenance Period|Death|0|||
19519302|NCT01474512|41932301|FG009|Maintenance Period|Death|0|||
19519303|NCT01474512|41932302|FG010|Maintenance Period|Death|0|||
19519304|NCT01474512|41932303|FG011|Maintenance Period|Death|0|||
19519305|NCT01474512|41932304|FG012|Maintenance Period|Death|0|||
19711103|NCT00130689|42154276|FG000|Overall Study|Ineligible|6|||
19414434|NCT02266147|41659865|FG000|PART 1: Dose Escalation|Other|1|||
19414435|NCT02266147|41659866|FG001|PART 1: Dose Escalation|Other|1|||
19414436|NCT02266147|41659867|FG002|PART 1: Dose Escalation|Other|0|||
19414437|NCT02266147|41659868|FG003|PART 1: Dose Escalation|Other|0|||
19414438|NCT02266147|41659865|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
19414439|NCT02266147|41659866|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
19414440|NCT02266147|41659867|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
19414441|NCT02266147|41659868|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
19414442|NCT02266147|41659865|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
19414443|NCT02266147|41659866|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
19414444|NCT02266147|41659867|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
19414445|NCT02266147|41659868|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
19414446|NCT02264977|41659880|FG000|Overall Study|Death|3|||
19414447|NCT02264977|41659880|FG000|Overall Study|Physician Decision|1|||
19414448|NCT02264977|41659880|FG000|Overall Study|Refuse to return|1|||
19414449|NCT02264821|41659887|FG000|Overall Study|Protocol Violation|1|||
19414450|NCT02264821|41659888|FG001|Overall Study|Protocol Violation|3|||
19414451|NCT02264821|41659889|FG002|Overall Study|Protocol Violation|6|||
19414452|NCT02261467|41659899|FG000|Overall Study|Enrolled in Error|1|||
19414453|NCT02261467|41659900|FG001|Overall Study|Enrolled in Error|0|||
19519306|NCT01474512|41932305|FG013|Maintenance Period|Death|0|||
19374904|NCT02531438|41616587|FG001|Overall Study|Missed EOT/PTE Visit|2|||
19374905|NCT02531438|41616586|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
19374906|NCT02531438|41616587|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
19374907|NCT02289898|41616596|FG000|Overall Study|Death|5|||
19374908|NCT02289898|41616597|FG001|Overall Study|Death|4|||
19374909|NCT02289898|41616598|FG002|Overall Study|Death|3|||
19374910|NCT02289898|41616596|FG000|Overall Study|Physician Decision|2|||
19374911|NCT02289898|41616597|FG001|Overall Study|Physician Decision|5|||
19374912|NCT02289898|41616598|FG002|Overall Study|Physician Decision|2|||
19414454|NCT02261467|41659899|FG000|Overall Study|Protocol Violation|0|||
19414455|NCT02261467|41659900|FG001|Overall Study|Protocol Violation|1|||
19414456|NCT02261467|41659899|FG000|Overall Study|Personal Reasons|17|||
19414457|NCT02261467|41659900|FG001|Overall Study|Personal Reasons|22|||
19414458|NCT02261467|41659899|FG000|Overall Study|Lost to Follow-up|2|||
19519307|NCT01474512|41932306|FG014|Maintenance Period|Death|0|||
19519308|NCT01474512|41932307|FG015|Maintenance Period|Death|0|||
19374913|NCT02289898|41616596|FG000|Overall Study|Withdrawal by Subject|0|||
19711104|NCT03605212|42154285|FG000|Treatment Period|Adverse Event|1|||
19414459|NCT02261467|41659900|FG001|Overall Study|Lost to Follow-up|13|||
19414460|NCT02261467|41659899|FG000|Overall Study|Adverse Event|1|||
19414461|NCT02261467|41659900|FG001|Overall Study|Adverse Event|1|||
19414462|NCT02260921|41659908|FG000|Overall Study|Adverse Event|1|||
19414463|NCT02260921|41659909|FG001|Overall Study|Adverse Event|0|||
19414464|NCT02260921|41659908|FG000|Overall Study|Lost to Follow-up|4|||
19414465|NCT02260921|41659909|FG001|Overall Study|Lost to Follow-up|3|||
19414466|NCT02260921|41659908|FG000|Overall Study|Withdraw Consent|4|||
19414467|NCT02260921|41659909|FG001|Overall Study|Withdraw Consent|1|||
19414468|NCT02260921|41659908|FG000|Overall Study|Death|1|||
19414469|NCT02260921|41659909|FG001|Overall Study|Death|0|||
19414470|NCT02260921|41659908|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
19414471|NCT02260921|41659909|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
19414472|NCT01643473|41659917|FG000|Overall Study|Lost to Follow-up|1|||
19414473|NCT01643473|41659918|FG001|Overall Study|Lost to Follow-up|0|||
19414474|NCT02258659|41659924|FG000|Overall Study|Withdrawal by Subject|1|||
19414475|NCT02320058|41659930|FG000|Overall Study|Death|25|||
19414476|NCT02320058|41659931|FG001|Overall Study|Death|10|||
19414477|NCT02320058|41659930|FG000|Overall Study|Lost to Follow-up|4|||
19414478|NCT02320058|41659931|FG001|Overall Study|Lost to Follow-up|0|||
19414479|NCT02320058|41659930|FG000|Overall Study|Other reasons|4|||
19414480|NCT02320058|41659931|FG001|Overall Study|Other reasons|1|||
19414481|NCT02320058|41659930|FG000|Overall Study|Withdrawal by Subject|8|||
19414482|NCT02320058|41659931|FG001|Overall Study|Withdrawal by Subject|2|||
19414483|NCT02320058|41659930|FG000|Overall Study|Not reported|1|||
19414484|NCT02320058|41659931|FG001|Overall Study|Not reported|0|||
19414485|NCT02319668|41659939|FG000|Overall Study|Other (Not specified)|0|||
19414486|NCT02319668|41659940|FG001|Overall Study|Other (Not specified)|2|||
19414487|NCT02092467|41659952|FG000|Overall Study|Death|49|||
19414488|NCT02092467|41659953|FG001|Overall Study|Death|66|||
19414489|NCT02092467|41659954|FG002|Overall Study|Death|38|||
19414490|NCT02092467|41659952|FG000|Overall Study|Lost to Follow-up|38|||
19414491|NCT02092467|41659953|FG001|Overall Study|Lost to Follow-up|35|||
19414492|NCT02092467|41659954|FG002|Overall Study|Lost to Follow-up|40|||
19414493|NCT02092467|41659952|FG000|Overall Study|Global Deterioration of Health Status|1|||
19414494|NCT02092467|41659953|FG001|Overall Study|Global Deterioration of Health Status|0|||
19414495|NCT02092467|41659954|FG002|Overall Study|Global Deterioration of Health Status|0|||
19414496|NCT02092467|41659952|FG000|Overall Study|Other|32|||
19414497|NCT02092467|41659953|FG001|Overall Study|Other|30|||
19414498|NCT02092467|41659954|FG002|Overall Study|Other|24|||
19414499|NCT02092467|41659952|FG000|Overall Study|Withdrawal by Subject|282|||
19414500|NCT02092467|41659953|FG001|Overall Study|Withdrawal by Subject|327|||
19414501|NCT02092467|41659954|FG002|Overall Study|Withdrawal by Subject|289|||
19414502|NCT02092467|41659952|FG000|Overall Study|Randomized but not treated|2|||
19414503|NCT02092467|41659953|FG001|Overall Study|Randomized but not treated|1|||
19414504|NCT02092467|41659954|FG002|Overall Study|Randomized but not treated|7|||
19414505|NCT02462759|41659966|FG000|Part 1: Double Blind|Death|1|||
19414506|NCT02462759|41659967|FG001|Part 1: Double Blind|Death|0|||
19414507|NCT02462759|41659968|FG002|Part 1: Double Blind|Death|0|||
19414508|NCT02349386|41659983|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
19414509|NCT02349386|41659984|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
19414510|NCT02349386|41659985|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
19414511|NCT02349386|41659986|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
19414512|NCT02349386|41659983|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
19414513|NCT02349386|41659984|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
19414514|NCT02349386|41659985|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
19414515|NCT02349386|41659986|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
19414516|NCT02349386|41659983|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
19414517|NCT02349386|41659984|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
19414518|NCT02349386|41659985|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
19414519|NCT02349386|41659986|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
19414520|NCT02349386|41659983|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
19414521|NCT02349386|41659984|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
19414522|NCT02349386|41659985|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
19414523|NCT02349386|41659986|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
19414524|NCT02349386|41659983|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
19414525|NCT02349386|41659984|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
19414526|NCT02349386|41659985|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
19414527|NCT02349386|41659986|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
19414528|NCT02349386|41659983|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
19414529|NCT02349386|41659984|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
19414530|NCT02349386|41659985|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
19519309|NCT01474512|41932308|FG016|Maintenance Period|Death|0|||
19414531|NCT02349386|41659986|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
19414532|NCT02036775|41659996|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
19414533|NCT02036775|41659997|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
19414534|NCT02036775|41659998|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
19414535|NCT02036775|41659999|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
19414536|NCT02036775|41660000|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
19414537|NCT02036775|41660001|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
19414538|NCT02092389|41660009|FG000|Overall Study|Adverse Event|1|||
19414539|NCT02092389|41660009|FG000|Overall Study|Other|5|||
19414540|NCT02034591|41660013|FG000|Overall Study|Withdrawal by Subject|0|||
19414541|NCT02034591|41660014|FG001|Overall Study|Withdrawal by Subject|0|||
19414542|NCT02034591|41660015|FG002|Overall Study|Withdrawal by Subject|0|||
19414543|NCT02034591|41660016|FG003|Overall Study|Withdrawal by Subject|0|||
19414544|NCT02034591|41660017|FG004|Overall Study|Withdrawal by Subject|1|||
19414545|NCT02034591|41660018|FG005|Overall Study|Withdrawal by Subject|0|||
19414546|NCT02391116|41660027|FG000|Treatment|Withdrawal by Subject|1|||
19414547|NCT02391116|41660027|FG000|Treatment|Protocol Violation|1|||
19414548|NCT02391116|41660027|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
19414549|NCT02391116|41660027|FG000|Treatment|AE with Clinical PD|3|||
19414550|NCT02391116|41660027|FG000|Safety Follow-up|Adverse Event|1|||
19414551|NCT02391116|41660027|FG000|Safety Follow-up|Withdrawal by Subject|4|||
19414552|NCT02391116|41660027|FG000|Safety Follow-up|Switching to Other Therapy|4|||
19414553|NCT02391116|41660027|FG000|Safety Follow-up|No Follow Up|1|||
19414554|NCT02391116|41660027|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
19414555|NCT02391116|41660027|FG000|Active Follow-up|Withdrawal by Subject|1|||
19414556|NCT02391116|41660027|FG000|Active Follow-up|Switching to Other Therapy|2|||
19414557|NCT02391116|41660027|FG000|Survival Follow-up|Withdrawal by Subject|3|||
19414558|NCT02391116|41660027|FG000|Survival Follow-up|Switching to Other Therapy|1|||
19414559|NCT02091921|41660038|FG000|Overall Study|Adverse Event|3|||
19414560|NCT02447081|41660045|FG000|Overall Study|Death|161|||
19414561|NCT02447081|41660045|FG000|Overall Study|Lost to Follow-up|36|||
19414562|NCT02447081|41660045|FG000|Overall Study|Visit not completed|17|||
19414563|NCT02447081|41660045|FG000|Overall Study|unsuccessful implant procedure|10|||
19414564|NCT02391038|41660049|FG000|Overall Study|Progressive disease|3|||
19414565|NCT02391038|41660050|FG001|Overall Study|Progressive disease|3|||
19414566|NCT02391038|41660051|FG002|Overall Study|Progressive disease|6|||
19414567|NCT02462603|41660060|FG000|Overall Study|Investigator Decision|1|||
19414568|NCT02462603|41660060|FG000|Overall Study|Non-Compliance|1|||
19414569|NCT02462603|41660060|FG000|Overall Study|Withdrawal by Subject|2|||
19414570|NCT02034513|41660066|FG000|Overall Study|Adverse Event|11|||
19414571|NCT02034513|41660067|FG001|Overall Study|Adverse Event|10|||
19414572|NCT02034513|41660066|FG000|Overall Study|Lack of Efficacy|0|||
19414573|NCT02034513|41660067|FG001|Overall Study|Lack of Efficacy|1|||
19414574|NCT02034513|41660066|FG000|Overall Study|Lost to Follow-up|6|||
19414575|NCT02034513|41660067|FG001|Overall Study|Lost to Follow-up|7|||
19414576|NCT02034513|41660066|FG000|Overall Study|Pregnancy|0|||
19414577|NCT02034513|41660067|FG001|Overall Study|Pregnancy|3|||
19414578|NCT02034513|41660066|FG000|Overall Study|Protocol Violation|7|||
19414579|NCT02034513|41660067|FG001|Overall Study|Protocol Violation|10|||
19414580|NCT02034513|41660066|FG000|Overall Study|Withdrawal by Subject|25|||
19414581|NCT02034513|41660067|FG001|Overall Study|Withdrawal by Subject|25|||
19414582|NCT02034513|41660066|FG000|Overall Study|Unclassified|0|||
19414583|NCT02034513|41660067|FG001|Overall Study|Unclassified|1|||
19414584|NCT02348840|41660079|FG000|Overall Study|Withdrawal by Subject|2|||
19414585|NCT02348840|41660080|FG001|Overall Study|Withdrawal by Subject|1|||
19414586|NCT02348840|41660081|FG002|Overall Study|Withdrawal by Subject|0|||
19414587|NCT02348840|41660082|FG003|Overall Study|Withdrawal by Subject|0|||
19414588|NCT02462057|41660097|FG000|Overall Study|Left Vitality|32|||
19414589|NCT02462057|41660098|FG001|Overall Study|Left Vitality|27|||
19414590|NCT02462057|41660099|FG002|Overall Study|Left Vitality|23|||
19414591|NCT02462057|41660100|FG003|Overall Study|Left Vitality|35|||
19414592|NCT02462057|41660101|FG004|Overall Study|Left Vitality|33|||
19414593|NCT02462057|41660097|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
19414594|NCT02462057|41660098|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
19414595|NCT02462057|41660099|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
19414596|NCT02462057|41660100|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
19414597|NCT02462057|41660101|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
19414598|NCT02461745|41660115|FG000|Overall Study|Lack of Efficacy|9|||
19414599|NCT02461745|41660116|FG001|Overall Study|Lack of Efficacy|1|||
19414600|NCT02461745|41660115|FG000|Overall Study|Lost to Follow-up|2|||
19414601|NCT02461745|41660116|FG001|Overall Study|Lost to Follow-up|2|||
19414602|NCT02461745|41660115|FG000|Overall Study|Withdrawal by Subject|3|||
19414603|NCT02461745|41660116|FG001|Overall Study|Withdrawal by Subject|1|||
19414604|NCT02034435|41660126|FG000|Overall Study|Withdrawal by Subject|1|||
19519310|NCT01474512|41932309|FG017|Maintenance Period|Death|0|||
19519311|NCT01474512|41932292|FG000|Maintenance Period|Physician Decision|0|||
19414605|NCT02034435|41660127|FG001|Overall Study|Withdrawal by Subject|0|||
19414606|NCT02034435|41660128|FG002|Overall Study|Withdrawal by Subject|0|||
19414607|NCT02034435|41660129|FG003|Overall Study|Withdrawal by Subject|0|||
19414608|NCT02034435|41660126|FG000|Overall Study|Illness|0|||
19414609|NCT02034435|41660127|FG001|Overall Study|Illness|2|||
19414610|NCT02034435|41660128|FG002|Overall Study|Illness|0|||
19414611|NCT02034435|41660129|FG003|Overall Study|Illness|0|||
19414612|NCT02034435|41660126|FG000|Overall Study|Inadequate IV access|1|||
19414613|NCT02034435|41660127|FG001|Overall Study|Inadequate IV access|0|||
19414614|NCT02034435|41660128|FG002|Overall Study|Inadequate IV access|0|||
19414615|NCT02034435|41660129|FG003|Overall Study|Inadequate IV access|1|||
19414616|NCT02033889|41660142|FG000|Overall Study|Adverse Event|3|||
19414617|NCT02033889|41660143|FG001|Overall Study|Adverse Event|1|||
19414618|NCT02033889|41660144|FG002|Overall Study|Adverse Event|3|||
19414619|NCT02033889|41660142|FG000|Overall Study|Death|3|||
19414620|NCT02033889|41660143|FG001|Overall Study|Death|1|||
19414621|NCT02033889|41660144|FG002|Overall Study|Death|2|||
19414622|NCT02033889|41660142|FG000|Overall Study|Excluded Medication|1|||
19414623|NCT02033889|41660143|FG001|Overall Study|Excluded Medication|1|||
19414624|NCT02033889|41660144|FG002|Overall Study|Excluded Medication|0|||
19519312|NCT01474512|41932293|FG001|Maintenance Period|Physician Decision|0|||
19519313|NCT01474512|41932294|FG002|Maintenance Period|Physician Decision|0|||
19628100|NCT00789555|42077506|FG000|Overall Study|Protocol Amendment|78|||
19711105|NCT03605212|42154286|FG001|Treatment Period|Adverse Event|0|||
19414625|NCT02033889|41660142|FG000|Overall Study|Lost to Follow-up|8|||
19414626|NCT02033889|41660143|FG001|Overall Study|Lost to Follow-up|5|||
19414627|NCT02033889|41660144|FG002|Overall Study|Lost to Follow-up|6|||
19414628|NCT02033889|41660142|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19414629|NCT02033889|41660143|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19414630|NCT02033889|41660144|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19414631|NCT02033889|41660142|FG000|Overall Study|Physician Decision|0|||
19414632|NCT02033889|41660143|FG001|Overall Study|Physician Decision|1|||
19414633|NCT02033889|41660144|FG002|Overall Study|Physician Decision|1|||
19414634|NCT02033889|41660142|FG000|Overall Study|Participant moved|0|||
19414635|NCT02033889|41660143|FG001|Overall Study|Participant moved|1|||
19414636|NCT02033889|41660144|FG002|Overall Study|Participant moved|0|||
19414637|NCT02033889|41660142|FG000|Overall Study|Withdrawal by Subject|18|||
19414638|NCT02033889|41660143|FG001|Overall Study|Withdrawal by Subject|10|||
19414639|NCT02033889|41660144|FG002|Overall Study|Withdrawal by Subject|13|||
19414640|NCT02447003|41660154|FG000|Overall Study|Other|0|||
19414641|NCT02447003|41660155|FG001|Overall Study|Other|4|||
19414642|NCT02447003|41660154|FG000|Overall Study|Site discontinued|0|||
19414643|NCT02447003|41660155|FG001|Overall Study|Site discontinued|2|||
19414644|NCT02447003|41660154|FG000|Overall Study|Physician Decision|0|||
19414645|NCT02447003|41660155|FG001|Overall Study|Physician Decision|1|||
19414646|NCT02447003|41660154|FG000|Overall Study|Withdrawal by Subject|4|||
19414647|NCT02447003|41660155|FG001|Overall Study|Withdrawal by Subject|3|||
19414648|NCT02447003|41660154|FG000|Overall Study|Sponsor Decision|6|||
19414649|NCT02447003|41660155|FG001|Overall Study|Sponsor Decision|11|||
19414650|NCT02447003|41660154|FG000|Overall Study|Progressive Disease|1|||
19414651|NCT02447003|41660155|FG001|Overall Study|Progressive Disease|0|||
19414652|NCT02447003|41660154|FG000|Overall Study|Lost to Follow-up|5|||
19414653|NCT02447003|41660155|FG001|Overall Study|Lost to Follow-up|0|||
19414654|NCT02447003|41660154|FG000|Overall Study|Death|154|||
19414655|NCT02447003|41660155|FG001|Overall Study|Death|63|||
19414656|NCT01844284|41660165|FG000|Overall Study|Lost to Follow-up|12|||
19414657|NCT01844284|41660166|FG001|Overall Study|Lost to Follow-up|7|||
19414658|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Refused|1|||
19414659|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Refused|3|||
19414660|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Medical|0|||
19414661|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Medical|1|||
19414662|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
19414663|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
19414664|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
19414665|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
19414666|NCT02054715|41660174|FG000|Baseline/Follow-up 1|No Reason|0|||
19414667|NCT02054715|41660175|FG001|Baseline/Follow-up 1|No Reason|1|||
19414668|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
19414669|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
19414670|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Ineligible|3|||
19414671|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Ineligible|0|||
19414672|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Hospitalization|1|||
19414673|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Hospitalization|0|||
19414674|NCT02054715|41660174|FG000|Baseline/Follow-up 1|Changed Mind|1|||
19414675|NCT02054715|41660175|FG001|Baseline/Follow-up 1|Changed Mind|0|||
19519314|NCT01474512|41932295|FG003|Maintenance Period|Physician Decision|0|||
19628101|NCT00789555|42077507|FG001|Overall Study|Protocol Amendment|76|||
19711106|NCT03605212|42154287|FG002|Treatment Period|Adverse Event|0|||
19414676|NCT02054715|41660174|FG000|Follow-up 2|Lost to Followup|3|||
19414677|NCT02054715|41660175|FG001|Follow-up 2|Lost to Followup|1|||
19414678|NCT02054715|41660174|FG000|Follow-up 2|Refused|3|||
19414679|NCT02054715|41660175|FG001|Follow-up 2|Refused|2|||
19414680|NCT02054715|41660174|FG000|Follow-up 2|Followup Not Completed|3|||
19414681|NCT02054715|41660175|FG001|Follow-up 2|Followup Not Completed|4|||
19414682|NCT02054715|41660174|FG000|Follow-up 2|Ineligible|4|||
19414683|NCT02054715|41660175|FG001|Follow-up 2|Ineligible|5|||
19414684|NCT02054715|41660174|FG000|Follow-up 2|Death|3|||
19414685|NCT02054715|41660175|FG001|Follow-up 2|Death|3|||
19414686|NCT02054715|41660174|FG000|Follow-up 2|Hospitalization|0|||
19414687|NCT02054715|41660175|FG001|Follow-up 2|Hospitalization|2|||
19414688|NCT02054715|41660174|FG000|Follow-up 2|Changed MD/Facility|0|||
19414689|NCT02054715|41660175|FG001|Follow-up 2|Changed MD/Facility|1|||
19414690|NCT02054715|41660174|FG000|Follow-up 2|Changed Mind|0|||
19414691|NCT02054715|41660175|FG001|Follow-up 2|Changed Mind|1|||
19414692|NCT02054715|41660174|FG000|Follow-up 2|No Reason|2|||
19414693|NCT02054715|41660175|FG001|Follow-up 2|No Reason|0|||
19414694|NCT02054715|41660174|FG000|Follow-up 2|Treatment Change or Delay|1|||
19414695|NCT02054715|41660175|FG001|Follow-up 2|Treatment Change or Delay|0|||
19414696|NCT02446769|41660181|FG000|Screening Period|Screen Failure|11|||
19414697|NCT02446769|41660182|FG001|Screening Period|Screen Failure|0|||
19414698|NCT02446769|41660183|FG002|Screening Period|Screen Failure|0|||
19414699|NCT02446769|41660181|FG000|Study Period|Randomized in Error|0|||
19414700|NCT02446769|41660182|FG001|Study Period|Randomized in Error|2|||
19414701|NCT02446769|41660183|FG002|Study Period|Randomized in Error|0|||
19414702|NCT02420093|41660192|FG000|Overall Study|Withdrawal by Subject|1|||
19414703|NCT02420093|41660193|FG001|Overall Study|Withdrawal by Subject|1|||
19414704|NCT02419937|41660201|FG000|Overall Study|Lost to Follow-up|1|||
19414705|NCT02419937|41660202|FG001|Overall Study|Lost to Follow-up|0|||
19414706|NCT02054481|41660212|FG000|Overall Study|Adverse Event|1|||
19414707|NCT02054481|41660213|FG001|Overall Study|Adverse Event|1|||
19414708|NCT02054481|41660214|FG002|Overall Study|Adverse Event|0|||
19414709|NCT02054481|41660215|FG003|Overall Study|Adverse Event|1|||
19414710|NCT02054481|41660212|FG000|Overall Study|Lost to Follow-up|1|||
19414711|NCT02054481|41660213|FG001|Overall Study|Lost to Follow-up|0|||
19414712|NCT02054481|41660214|FG002|Overall Study|Lost to Follow-up|0|||
19414713|NCT02054481|41660215|FG003|Overall Study|Lost to Follow-up|0|||
19414714|NCT02054481|41660212|FG000|Overall Study|Other reason|2|||
19414715|NCT02054481|41660213|FG001|Overall Study|Other reason|1|||
19414716|NCT02054481|41660214|FG002|Overall Study|Other reason|2|||
19414717|NCT02054481|41660215|FG003|Overall Study|Other reason|0|||
19414718|NCT01610752|41660229|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
19414719|NCT01610752|41660230|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
19414720|NCT01610752|41660231|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
19414721|NCT02054325|41660241|FG000|Overall Study|Lost to Follow-up|8|||
19414722|NCT02054325|41660242|FG001|Overall Study|Lost to Follow-up|5|||
19414723|NCT02446691|41660248|FG000|Overall Study|Withdrawal by Subject|2|||
19414724|NCT02446691|41660248|FG000|Overall Study|Lost to Follow-up|8|||
19414725|NCT02446691|41660248|FG000|Overall Study|Protocol Violation|1|||
19414726|NCT02091375|41660254|FG000|Overall Study|Adverse Event|8|||
19414727|NCT02091375|41660255|FG001|Overall Study|Adverse Event|1|||
19414728|NCT02091375|41660254|FG000|Overall Study|Lost to Follow-up|0|||
19414729|NCT02091375|41660255|FG001|Overall Study|Lost to Follow-up|1|||
19414730|NCT02091375|41660254|FG000|Overall Study|Withdrawal by Subject|0|||
19414731|NCT02091375|41660255|FG001|Overall Study|Withdrawal by Subject|1|||
19414732|NCT02091375|41660254|FG000|Overall Study|Withdrawn by the investigator|1|||
19414733|NCT02091375|41660255|FG001|Overall Study|Withdrawn by the investigator|0|||
19414734|NCT02032875|41660263|FG000|Treatment Period|Adverse Event|1|||
19414735|NCT02032875|41660264|FG001|Treatment Period|Adverse Event|0|||
19414736|NCT02032875|41660263|FG000|Treatment Period|Liver transplant, No extension needed|0|||
19414737|NCT02032875|41660264|FG001|Treatment Period|Liver transplant, No extension needed|1|||
19414738|NCT02032875|41660263|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
19414739|NCT02032875|41660264|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
19414740|NCT02032875|41660263|FG000|Follow-up Period|Death|0|||
19414741|NCT02032875|41660264|FG001|Follow-up Period|Death|1|||
19414742|NCT02032875|41660263|FG000|Follow-up Period|Virologic Relapse|3|||
19414743|NCT02032875|41660264|FG001|Follow-up Period|Virologic Relapse|10|||
19414744|NCT02032407|41660271|FG000|Overall Study|Lost to Follow-up|2|||
19414745|NCT02032407|41660271|FG000|Overall Study|Pregnancy|1|||
19414746|NCT02032407|41660271|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19414747|NCT01843972|41660289|FG000|Overall Study|Withdrawal by Subject|0|||
19414748|NCT01843972|41660290|FG001|Overall Study|Withdrawal by Subject|0|||
19414749|NCT01843972|41660291|FG002|Overall Study|Withdrawal by Subject|0|||
19414750|NCT01843972|41660292|FG003|Overall Study|Withdrawal by Subject|0|||
19414751|NCT01843972|41660293|FG004|Overall Study|Withdrawal by Subject|1|||
19414752|NCT01843972|41660294|FG005|Overall Study|Withdrawal by Subject|0|||
19414753|NCT01843972|41660295|FG006|Overall Study|Withdrawal by Subject|0|||
19414754|NCT01843972|41660296|FG007|Overall Study|Withdrawal by Subject|0|||
19414755|NCT01843972|41660297|FG008|Overall Study|Withdrawal by Subject|0|||
19414756|NCT01843972|41660298|FG009|Overall Study|Withdrawal by Subject|0|||
19414757|NCT01826422|41660336|FG000|Overall Study|Withdrawal by Subject|1|||
19414758|NCT01826422|41660337|FG001|Overall Study|Withdrawal by Subject|3|||
19414759|NCT01843660|41660343|FG000|Overall Study|Other|30|||
19414760|NCT02090283|41660350|FG000|Overall Study|Withdrawal by Subject|6|||
19414761|NCT02090283|41660351|FG001|Overall Study|Withdrawal by Subject|6|||
19414762|NCT02090283|41660352|FG002|Overall Study|Withdrawal by Subject|6|||
19414763|NCT02090283|41660350|FG000|Overall Study|Sponsor Terminated Study|6|||
19414764|NCT02090283|41660351|FG001|Overall Study|Sponsor Terminated Study|6|||
19414765|NCT02090283|41660352|FG002|Overall Study|Sponsor Terminated Study|1|||
19414766|NCT02090283|41660350|FG000|Overall Study|Lost to Follow-up|2|||
19414767|NCT02090283|41660351|FG001|Overall Study|Lost to Follow-up|2|||
19414768|NCT02090283|41660352|FG002|Overall Study|Lost to Follow-up|3|||
19414769|NCT02090283|41660350|FG000|Overall Study|Adverse Event|1|||
19414770|NCT02090283|41660351|FG001|Overall Study|Adverse Event|1|||
19414771|NCT02090283|41660352|FG002|Overall Study|Adverse Event|0|||
19414772|NCT02090283|41660350|FG000|Overall Study|Protocol Violation|2|||
19414773|NCT02090283|41660351|FG001|Overall Study|Protocol Violation|0|||
19414774|NCT02090283|41660352|FG002|Overall Study|Protocol Violation|0|||
19414775|NCT02032173|41660360|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
19414776|NCT02031471|41660364|FG000|24 Week Treatment Period|Adverse Event|6|||
19414777|NCT02031471|41660364|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
19414778|NCT02031471|41660364|FG000|24 Week Treatment Period|Protocol Violation|1|||
19414779|NCT02031471|41660364|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
19414780|NCT02031471|41660364|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
19414781|NCT02031471|41660364|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
19414782|NCT02031471|41660364|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
19414783|NCT02461589|41660378|FG000|Overall Study|Withdrawal by Subject|5|||
19414784|NCT02461589|41660379|FG001|Overall Study|Withdrawal by Subject|1|||
19414785|NCT02461589|41660380|FG002|Overall Study|Withdrawal by Subject|3|||
19414786|NCT02461589|41660381|FG003|Overall Study|Withdrawal by Subject|2|||
19414787|NCT02461589|41660382|FG004|Overall Study|Withdrawal by Subject|1|||
19414788|NCT02461589|41660383|FG005|Overall Study|Withdrawal by Subject|2|||
19414789|NCT02461589|41660384|FG006|Overall Study|Withdrawal by Subject|1|||
19414790|NCT02461589|41660385|FG007|Overall Study|Withdrawal by Subject|3|||
19414791|NCT02461589|41660386|FG008|Overall Study|Withdrawal by Subject|3|||
19414792|NCT02461589|41660387|FG009|Overall Study|Withdrawal by Subject|1|||
19414793|NCT02461589|41660378|FG000|Overall Study|Lost to Follow-up|0|||
19414794|NCT02461589|41660379|FG001|Overall Study|Lost to Follow-up|0|||
19414795|NCT02461589|41660380|FG002|Overall Study|Lost to Follow-up|2|||
19414796|NCT02461589|41660381|FG003|Overall Study|Lost to Follow-up|3|||
19414797|NCT02461589|41660382|FG004|Overall Study|Lost to Follow-up|1|||
19414798|NCT02461589|41660383|FG005|Overall Study|Lost to Follow-up|1|||
19414799|NCT02461589|41660384|FG006|Overall Study|Lost to Follow-up|3|||
19414800|NCT02461589|41660385|FG007|Overall Study|Lost to Follow-up|1|||
19414801|NCT02461589|41660386|FG008|Overall Study|Lost to Follow-up|3|||
19414802|NCT02461589|41660387|FG009|Overall Study|Lost to Follow-up|1|||
19414803|NCT02461589|41660378|FG000|Overall Study|Death|0|||
19414804|NCT02461589|41660379|FG001|Overall Study|Death|0|||
19414805|NCT02461589|41660380|FG002|Overall Study|Death|0|||
19414806|NCT02461589|41660381|FG003|Overall Study|Death|0|||
19414807|NCT02461589|41660382|FG004|Overall Study|Death|0|||
19414808|NCT02461589|41660383|FG005|Overall Study|Death|0|||
19414809|NCT02461589|41660384|FG006|Overall Study|Death|0|||
19414810|NCT02461589|41660385|FG007|Overall Study|Death|1|||
19414811|NCT02461589|41660386|FG008|Overall Study|Death|0|||
19414812|NCT02461589|41660387|FG009|Overall Study|Death|0|||
19414813|NCT02461589|41660378|FG000|Overall Study|Unclassified|0|||
19414814|NCT02461589|41660379|FG001|Overall Study|Unclassified|0|||
19414815|NCT02461589|41660380|FG002|Overall Study|Unclassified|0|||
19414816|NCT02461589|41660381|FG003|Overall Study|Unclassified|0|||
19414817|NCT02461589|41660382|FG004|Overall Study|Unclassified|0|||
19414818|NCT02461589|41660383|FG005|Overall Study|Unclassified|0|||
19414819|NCT02461589|41660384|FG006|Overall Study|Unclassified|1|||
19414820|NCT02461589|41660385|FG007|Overall Study|Unclassified|0|||
19414821|NCT02461589|41660386|FG008|Overall Study|Unclassified|0|||
19414822|NCT02461589|41660387|FG009|Overall Study|Unclassified|2|||
19414823|NCT02461589|41660378|FG000|Overall Study|Missing follow-up information|1|||
19414824|NCT02461589|41660379|FG001|Overall Study|Missing follow-up information|1|||
19414825|NCT02461589|41660380|FG002|Overall Study|Missing follow-up information|0|||
19414826|NCT02461589|41660381|FG003|Overall Study|Missing follow-up information|0|||
19414827|NCT02461589|41660382|FG004|Overall Study|Missing follow-up information|0|||
19414828|NCT02461589|41660383|FG005|Overall Study|Missing follow-up information|0|||
19414829|NCT02461589|41660384|FG006|Overall Study|Missing follow-up information|1|||
19414830|NCT02461589|41660385|FG007|Overall Study|Missing follow-up information|0|||
19414831|NCT02461589|41660386|FG008|Overall Study|Missing follow-up information|0|||
19414832|NCT02461589|41660387|FG009|Overall Study|Missing follow-up information|0|||
19414833|NCT02461589|41660378|FG000|Overall Study|Withdrawal from trial before exposure|0|||
19414834|NCT02461589|41660379|FG001|Overall Study|Withdrawal from trial before exposure|0|||
19414835|NCT02461589|41660380|FG002|Overall Study|Withdrawal from trial before exposure|0|||
19414836|NCT02461589|41660381|FG003|Overall Study|Withdrawal from trial before exposure|0|||
19414837|NCT02461589|41660382|FG004|Overall Study|Withdrawal from trial before exposure|0|||
19414838|NCT02461589|41660383|FG005|Overall Study|Withdrawal from trial before exposure|0|||
19414839|NCT02461589|41660384|FG006|Overall Study|Withdrawal from trial before exposure|0|||
19414840|NCT02461589|41660385|FG007|Overall Study|Withdrawal from trial before exposure|0|||
19414841|NCT02461589|41660386|FG008|Overall Study|Withdrawal from trial before exposure|0|||
19414842|NCT02461589|41660387|FG009|Overall Study|Withdrawal from trial before exposure|1|||
19414843|NCT02089737|41660409|FG000|Overall Study|Survey form not completed|5|||
19414844|NCT02089737|41660409|FG000|Overall Study|Not treated|1|||
19414845|NCT02460575|41660416|FG000|Overall Study|Lost to Follow-up|1|||
19414846|NCT02460575|41660417|FG001|Overall Study|Lost to Follow-up|0|||
19414847|NCT02089347|41660425|FG000|Overall Study|Protocol Violation|1|||
19414848|NCT02089347|41660426|FG001|Overall Study|Protocol Violation|0|||
19414849|NCT02445755|41660432|FG000|Overall Study|Withdrawal by Subject|2|||
19414850|NCT02445755|41660432|FG000|Overall Study|Protocol Violation|6|||
19414851|NCT02445755|41660432|FG000|Overall Study|Screen Failure|5|||
19414852|NCT02419469|41660439|FG000|Overall Study|Withdrawal by Subject|1|||
19414853|NCT02419313|41660443|FG000|First Intervention|Lost to Follow-up|2|||
19414854|NCT02419313|41660444|FG001|First Intervention|Lost to Follow-up|0|||
19414855|NCT02419313|41660443|FG000|Second Intervention|Lost to Follow-up|1|||
19414856|NCT02419313|41660444|FG001|Second Intervention|Lost to Follow-up|0|||
19414857|NCT02419001|41660452|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
19414858|NCT02419001|41660453|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
19414859|NCT02031237|41660461|FG000|Overall Study|Death|1|||
19414860|NCT02031237|41660462|FG001|Overall Study|Death|5|||
19414861|NCT02031237|41660463|FG002|Overall Study|Death|0|||
19414862|NCT02031237|41660461|FG000|Overall Study|Physician Decision|0|||
19414863|NCT02031237|41660462|FG001|Overall Study|Physician Decision|1|||
19414864|NCT02031237|41660463|FG002|Overall Study|Physician Decision|0|||
19414865|NCT02031237|41660461|FG000|Overall Study|Withdrawal by Subject|2|||
19414866|NCT02031237|41660462|FG001|Overall Study|Withdrawal by Subject|2|||
19414867|NCT02031237|41660463|FG002|Overall Study|Withdrawal by Subject|0|||
19414868|NCT02031237|41660461|FG000|Overall Study|Protocol Violation|2|||
19414869|NCT02031237|41660462|FG001|Overall Study|Protocol Violation|6|||
19414870|NCT02031237|41660463|FG002|Overall Study|Protocol Violation|0|||
19414871|NCT02031237|41660461|FG000|Overall Study|Alternate Treatment Given|0|||
19414872|NCT02031237|41660462|FG001|Overall Study|Alternate Treatment Given|0|||
19414873|NCT02031237|41660463|FG002|Overall Study|Alternate Treatment Given|3|||
19414874|NCT02088957|41660470|FG000|Overall Study|Lack of Efficacy|1|||
19414875|NCT02088957|41660471|FG001|Overall Study|Lack of Efficacy|0|||
19414876|NCT02418845|41660479|FG000|Overall Study|Lost to Follow-up|7|||
19414877|NCT02418845|41660480|FG001|Overall Study|Lost to Follow-up|2|||
19414878|NCT02418845|41660479|FG000|Overall Study|Lack of Efficacy|0|||
19414879|NCT02418845|41660480|FG001|Overall Study|Lack of Efficacy|3|||
19414880|NCT02418845|41660479|FG000|Overall Study|Physician Decision|5|||
19414881|NCT02418845|41660480|FG001|Overall Study|Physician Decision|5|||
19414882|NCT02418845|41660479|FG000|Overall Study|Protocol Violation|1|||
19414883|NCT02418845|41660480|FG001|Overall Study|Protocol Violation|0|||
19414884|NCT02418845|41660479|FG000|Overall Study|Withdrawal by Subject|3|||
19414885|NCT02418845|41660480|FG001|Overall Study|Withdrawal by Subject|2|||
19414886|NCT02030847|41660486|FG000|Overall Study|Death|10|||
19414887|NCT02030847|41660486|FG000|Overall Study|Disease Progression|15|||
19414888|NCT02030847|41660486|FG000|Overall Study|New Cancer Therapy|8|||
19414889|NCT02030847|41660486|FG000|Overall Study|Physician Decision|3|||
19414890|NCT02030847|41660486|FG000|Overall Study|Withdrawal by Subject|1|||
19414891|NCT02088177|41660491|FG000|Overall Study|Lost to Follow-up|3|||
19414892|NCT02030535|41660495|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
19414893|NCT02029989|41660511|FG000|Overall Study|Withdrawal by Subject|1|||
19414894|NCT02029989|41660512|FG001|Overall Study|Withdrawal by Subject|0|||
19414895|NCT02029989|41660511|FG000|Overall Study|Withdrawal: Fear of needles|1|||
19414896|NCT02029989|41660512|FG001|Overall Study|Withdrawal: Fear of needles|0|||
19711107|NCT03605212|42154288|FG003|Treatment Period|Adverse Event|0|||
19414897|NCT02029989|41660511|FG000|Overall Study|Change of location|2|||
19414898|NCT02029989|41660512|FG001|Overall Study|Change of location|3|||
19414899|NCT02029989|41660511|FG000|Overall Study|Physician Decision|2|||
19414900|NCT02029989|41660512|FG001|Overall Study|Physician Decision|0|||
19414901|NCT02029989|41660511|FG000|Overall Study|Lost to Follow-up|9|||
19414902|NCT02029989|41660512|FG001|Overall Study|Lost to Follow-up|7|||
19414903|NCT02029989|41660511|FG000|Overall Study|Death|0|||
19414904|NCT02029989|41660512|FG001|Overall Study|Death|1|||
19414905|NCT02029989|41660511|FG000|Overall Study|Protocol Violation|1|||
19414906|NCT02029989|41660512|FG001|Overall Study|Protocol Violation|0|||
19414907|NCT02048241|41660520|FG000|Overall Study|Withdrawal by Subject|0|||
19414908|NCT02048241|41660521|FG001|Overall Study|Withdrawal by Subject|1|||
19628102|NCT00789555|42077508|FG002|Overall Study|Protocol Amendment|80|||
19414909|NCT02087943|41660530|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
19414910|NCT02087943|41660531|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
19414911|NCT02087943|41660532|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
19414912|NCT02087943|41660533|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
19414913|NCT02087943|41660534|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
19414914|NCT02087943|41660530|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
19414915|NCT02087943|41660531|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
19414916|NCT02087943|41660532|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
19414917|NCT02087943|41660533|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
19414918|NCT02087943|41660534|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
19414919|NCT02087943|41660530|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
19414920|NCT02087943|41660531|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
19414921|NCT02087943|41660532|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
19414922|NCT02087943|41660533|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
19414923|NCT02087943|41660534|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
19414924|NCT02087943|41660530|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
19414925|NCT02087943|41660531|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
19414926|NCT02087943|41660532|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
19414927|NCT02087943|41660533|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
19414928|NCT02087943|41660534|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
19414929|NCT02087943|41660530|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
19414930|NCT02087943|41660531|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
19414931|NCT02087943|41660532|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
19414932|NCT02087943|41660533|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
19414933|NCT02087943|41660534|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
19414934|NCT02087943|41660530|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
19414935|NCT02087943|41660531|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
19414936|NCT02087943|41660532|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
19414937|NCT02087943|41660533|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
19414938|NCT02087943|41660534|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
19414939|NCT02087943|41660530|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
19414940|NCT02087943|41660531|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
19414941|NCT02087943|41660532|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
19414942|NCT02087943|41660533|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
19414943|NCT02087943|41660534|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
19414944|NCT02087943|41660530|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
19414945|NCT02087943|41660531|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
19414946|NCT02087943|41660532|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
19414947|NCT02087943|41660533|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
19414948|NCT02087943|41660534|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
19414949|NCT02087943|41660530|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
19414950|NCT02087943|41660531|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
19414951|NCT02087943|41660532|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
19414952|NCT02087943|41660533|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
19414953|NCT02087943|41660534|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
19414954|NCT02087943|41660530|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
19414955|NCT02087943|41660531|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
19414956|NCT02087943|41660532|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
19414957|NCT02087943|41660533|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
19414958|NCT02087943|41660534|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
19414959|NCT02029521|41660548|FG000|Overall Study|Protocol Violation|1|||
19414960|NCT02029521|41660549|FG001|Overall Study|Protocol Violation|0|||
19414961|NCT02029521|41660548|FG000|Overall Study|Withdrawal by Subject|1|||
19414962|NCT02029521|41660549|FG001|Overall Study|Withdrawal by Subject|1|||
19414963|NCT02443883|41660570|FG000|Overall Study|Adverse Event|0|||
19414964|NCT02443883|41660571|FG001|Overall Study|Adverse Event|1|||
19414965|NCT02443883|41660572|FG002|Overall Study|Adverse Event|0|||
19414966|NCT02443883|41660573|FG003|Overall Study|Adverse Event|0|||
19414967|NCT02443883|41660570|FG000|Overall Study|Lost to Follow-up|3|||
19414968|NCT02443883|41660571|FG001|Overall Study|Lost to Follow-up|2|||
19414969|NCT02443883|41660572|FG002|Overall Study|Lost to Follow-up|1|||
19414970|NCT02443883|41660573|FG003|Overall Study|Lost to Follow-up|0|||
19414971|NCT02443883|41660570|FG000|Overall Study|Physician Decision|1|||
19414972|NCT02443883|41660571|FG001|Overall Study|Physician Decision|1|||
19414973|NCT02443883|41660572|FG002|Overall Study|Physician Decision|0|||
19414974|NCT02443883|41660573|FG003|Overall Study|Physician Decision|3|||
19414975|NCT02443883|41660570|FG000|Overall Study|Withdrawal by Subject|1|||
19414976|NCT02443883|41660571|FG001|Overall Study|Withdrawal by Subject|0|||
19414977|NCT02443883|41660572|FG002|Overall Study|Withdrawal by Subject|0|||
19414978|NCT02443883|41660573|FG003|Overall Study|Withdrawal by Subject|2|||
19414979|NCT02443883|41660570|FG000|Overall Study|Randomized, but never treated|1|||
19414980|NCT02443883|41660571|FG001|Overall Study|Randomized, but never treated|0|||
19414981|NCT02443883|41660572|FG002|Overall Study|Randomized, but never treated|0|||
19414982|NCT02443883|41660573|FG003|Overall Study|Randomized, but never treated|0|||
19414983|NCT02460263|41660583|FG000|Transition Period|Withdrawal by Subject|1|||
19414984|NCT02460263|41660583|FG000|Transition Period|Death|1|||
19414985|NCT02443805|41660593|FG000|Overall Study|Adverse Event|100|||
19711108|NCT03605212|42154289|FG004|Treatment Period|Adverse Event|0|||
19711109|NCT03605212|42154285|FG000|Treatment Period|Physician Decision|0|||
19711110|NCT03605212|42154286|FG001|Treatment Period|Physician Decision|0|||
19628103|NCT00789555|42077506|FG000|Overall Study|Adverse Event|17|||
19628104|NCT00789555|42077507|FG001|Overall Study|Adverse Event|7|||
19628105|NCT00789555|42077508|FG002|Overall Study|Adverse Event|10|||
19414986|NCT02443805|41660594|FG001|Overall Study|Adverse Event|18|||
19414987|NCT02443805|41660593|FG000|Overall Study|Withdrawal by Subject|73|||
19414988|NCT02443805|41660594|FG001|Overall Study|Withdrawal by Subject|74|||
19414989|NCT02443805|41660593|FG000|Overall Study|Lost to Follow-up|19|||
19414990|NCT02443805|41660594|FG001|Overall Study|Lost to Follow-up|14|||
19414991|NCT02443805|41660593|FG000|Overall Study|Pregnancy|6|||
19414992|NCT02443805|41660594|FG001|Overall Study|Pregnancy|5|||
19414993|NCT02443805|41660593|FG000|Overall Study|Protocol Violation|2|||
19414994|NCT02443805|41660594|FG001|Overall Study|Protocol Violation|4|||
19414995|NCT02443805|41660593|FG000|Overall Study|Lack of Efficacy|1|||
19414996|NCT02443805|41660594|FG001|Overall Study|Lack of Efficacy|1|||
19414997|NCT02443805|41660593|FG000|Overall Study|Non-compliance with study drug|6|||
19414998|NCT02443805|41660594|FG001|Overall Study|Non-compliance with study drug|4|||
19414999|NCT02443805|41660593|FG000|Overall Study|Withdrawal by parent/guardian|3|||
19415000|NCT02443805|41660594|FG001|Overall Study|Withdrawal by parent/guardian|5|||
19415001|NCT02443805|41660593|FG000|Overall Study|Any other reason not above-mentioned|3|||
19415002|NCT02443805|41660594|FG001|Overall Study|Any other reason not above-mentioned|2|||
19415003|NCT01652885|41660600|FG000|Overall Study|Adverse Event|1|||
19415004|NCT02459951|41660604|FG000|Overall Study|Unable to meet holding requirement|1|||
19415005|NCT02087241|41660613|FG000|Overall Study|Death|2|||
19415006|NCT02087241|41660614|FG001|Overall Study|Death|1|||
19415007|NCT02087241|41660615|FG002|Overall Study|Death|1|||
19415008|NCT02087241|41660616|FG003|Overall Study|Death|1|||
19415009|NCT02087241|41660613|FG000|Overall Study|Withdrawal by Subject|1|||
19415010|NCT02087241|41660614|FG001|Overall Study|Withdrawal by Subject|0|||
19415011|NCT02087241|41660615|FG002|Overall Study|Withdrawal by Subject|0|||
19415012|NCT02087241|41660616|FG003|Overall Study|Withdrawal by Subject|1|||
19415013|NCT02087241|41660613|FG000|Overall Study|Progressive Disease|0|||
19415014|NCT02087241|41660614|FG001|Overall Study|Progressive Disease|0|||
19415015|NCT02087241|41660615|FG002|Overall Study|Progressive Disease|0|||
19415016|NCT02087241|41660616|FG003|Overall Study|Progressive Disease|1|||
19415017|NCT02087241|41660613|FG000|Overall Study|Study Terminated by Sponsor|0|||
19415018|NCT02087241|41660614|FG001|Overall Study|Study Terminated by Sponsor|2|||
19415019|NCT02087241|41660615|FG002|Overall Study|Study Terminated by Sponsor|0|||
19415020|NCT02087241|41660616|FG003|Overall Study|Study Terminated by Sponsor|4|||
19415021|NCT02087085|41660632|FG000|Overall Study|Adverse Event|10|||
19415022|NCT02087085|41660633|FG001|Overall Study|Adverse Event|14|||
19415023|NCT02087085|41660632|FG000|Overall Study|Lack of Efficacy|4|||
19415024|NCT02087085|41660633|FG001|Overall Study|Lack of Efficacy|3|||
19415025|NCT02087085|41660632|FG000|Overall Study|Lost to Follow-up|6|||
19415026|NCT02087085|41660633|FG001|Overall Study|Lost to Follow-up|4|||
19415027|NCT02087085|41660632|FG000|Overall Study|Withdrawal by Subject|9|||
19415028|NCT02087085|41660633|FG001|Overall Study|Withdrawal by Subject|11|||
19415029|NCT02087085|41660632|FG000|Overall Study|Protocol Violation|1|||
19415030|NCT02087085|41660633|FG001|Overall Study|Protocol Violation|0|||
19415031|NCT02087085|41660632|FG000|Overall Study|Study Terminated by Sponsor|87|||
19415032|NCT02087085|41660633|FG001|Overall Study|Study Terminated by Sponsor|80|||
19415033|NCT02087085|41660632|FG000|Overall Study|Other Miscellaneous Reasons|3|||
19415034|NCT02087085|41660633|FG001|Overall Study|Other Miscellaneous Reasons|4|||
19415035|NCT02443337|41660641|FG000|Overall Study|Adverse Event|0|||
19415036|NCT02443337|41660642|FG001|Overall Study|Adverse Event|1|||
19415037|NCT02443337|41660641|FG000|Overall Study|Clinical Progressive Disease|3|||
19415038|NCT02443337|41660642|FG001|Overall Study|Clinical Progressive Disease|0|||
19415039|NCT02443337|41660641|FG000|Overall Study|Withdrawal by Subject|2|||
19415040|NCT02443337|41660642|FG001|Overall Study|Withdrawal by Subject|1|||
19415041|NCT02443103|41660653|FG000|Overall Study|Adverse Event|2|||
19415042|NCT02443103|41660653|FG000|Overall Study|Noncompliance|1|||
19519315|NCT01474512|41932296|FG004|Maintenance Period|Physician Decision|0|||
19415043|NCT02022657|41660657|FG000|Overall Study|Withdrawal by Subject|2|||
19415044|NCT02022657|41660658|FG001|Overall Study|Withdrawal by Subject|0|||
19415045|NCT02022657|41660659|FG002|Overall Study|Withdrawal by Subject|1|||
19415046|NCT02022657|41660660|FG003|Overall Study|Withdrawal by Subject|0|||
19415047|NCT02022657|41660661|FG004|Overall Study|Withdrawal by Subject|0|||
19415048|NCT02022657|41660662|FG005|Overall Study|Withdrawal by Subject|0|||
19415049|NCT02022657|41660657|FG000|Overall Study|Physician Decision|0|||
19415050|NCT02022657|41660658|FG001|Overall Study|Physician Decision|0|||
19415051|NCT02022657|41660659|FG002|Overall Study|Physician Decision|0|||
19415052|NCT02022657|41660660|FG003|Overall Study|Physician Decision|0|||
19415053|NCT02022657|41660661|FG004|Overall Study|Physician Decision|0|||
19415054|NCT02022657|41660662|FG005|Overall Study|Physician Decision|1|||
19415055|NCT02418455|41660668|FG000|48-Week Treatment Period|Other- Not Specified|1|||
19415056|NCT02418455|41660668|FG000|Continuation Period|Sponsor Decision|7|||
19415057|NCT02417753|41660674|FG000|Overall Study|Death|1|||
19415058|NCT02417441|41660680|FG000|Overall Study|Inconclusive due to missing data|52|||
19415059|NCT02417441|41660681|FG001|Overall Study|Inconclusive due to missing data|19|||
19415060|NCT02021643|41660694|FG000|Overall Study|Enrolled but Never Treated|1|||
19415061|NCT02021643|41660695|FG001|Overall Study|Enrolled but Never Treated|0|||
19415062|NCT02021643|41660696|FG002|Overall Study|Enrolled but Never Treated|0|||
19415063|NCT02021643|41660697|FG003|Overall Study|Enrolled but Never Treated|0|||
19415064|NCT02021643|41660694|FG000|Overall Study|Adverse Event|0|||
19415065|NCT02021643|41660695|FG001|Overall Study|Adverse Event|1|||
19415066|NCT02021643|41660696|FG002|Overall Study|Adverse Event|0|||
19415067|NCT02021643|41660697|FG003|Overall Study|Adverse Event|0|||
19415068|NCT02021643|41660694|FG000|Overall Study|Death|0|||
19415069|NCT02021643|41660695|FG001|Overall Study|Death|1|||
19415070|NCT02021643|41660696|FG002|Overall Study|Death|0|||
19415071|NCT02021643|41660697|FG003|Overall Study|Death|0|||
19415072|NCT02021643|41660694|FG000|Overall Study|Investigator's Discretion|1|||
19415073|NCT02021643|41660695|FG001|Overall Study|Investigator's Discretion|0|||
19415074|NCT02021643|41660696|FG002|Overall Study|Investigator's Discretion|0|||
19415075|NCT02021643|41660697|FG003|Overall Study|Investigator's Discretion|0|||
19415076|NCT02021643|41660694|FG000|Overall Study|Lack of Efficacy|7|||
19415077|NCT02021643|41660695|FG001|Overall Study|Lack of Efficacy|6|||
19415078|NCT02021643|41660696|FG002|Overall Study|Lack of Efficacy|0|||
19415079|NCT02021643|41660697|FG003|Overall Study|Lack of Efficacy|12|||
19415080|NCT02021643|41660694|FG000|Overall Study|Lost to Follow-up|0|||
19415081|NCT02021643|41660695|FG001|Overall Study|Lost to Follow-up|1|||
19415082|NCT02021643|41660696|FG002|Overall Study|Lost to Follow-up|0|||
19415083|NCT02021643|41660697|FG003|Overall Study|Lost to Follow-up|0|||
19415084|NCT02021643|41660694|FG000|Overall Study|Withdrew Consent|0|||
19415085|NCT02021643|41660695|FG001|Overall Study|Withdrew Consent|1|||
19415086|NCT02021643|41660696|FG002|Overall Study|Withdrew Consent|0|||
19415087|NCT02021643|41660697|FG003|Overall Study|Withdrew Consent|0|||
19415088|NCT02415959|41660718|FG000|Overall Study|Adverse Event|0|||
19415089|NCT02415959|41660719|FG001|Overall Study|Adverse Event|1|||
19415090|NCT02415959|41660720|FG002|Overall Study|Adverse Event|0|||
19415091|NCT02415959|41660721|FG003|Overall Study|Adverse Event|0|||
19415092|NCT02415959|41660722|FG004|Overall Study|Adverse Event|0|||
19415093|NCT02415959|41660718|FG000|Overall Study|Protocol Violation|0|||
19415094|NCT02415959|41660719|FG001|Overall Study|Protocol Violation|0|||
19415095|NCT02415959|41660720|FG002|Overall Study|Protocol Violation|0|||
19415096|NCT02415959|41660721|FG003|Overall Study|Protocol Violation|1|||
19415097|NCT02415959|41660722|FG004|Overall Study|Protocol Violation|0|||
19415098|NCT02021565|41660736|FG000|Baseline Through Intervention|Death|0|||
19415099|NCT02021565|41660737|FG001|Baseline Through Intervention|Death|1|||
19415100|NCT02021565|41660736|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
19415101|NCT02021565|41660737|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
19415102|NCT02021565|41660736|FG000|Baseline Through Intervention|Protocol Violation|0|||
19415103|NCT02021565|41660737|FG001|Baseline Through Intervention|Protocol Violation|7|||
19415104|NCT02021565|41660736|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
19415105|NCT02021565|41660737|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
19415106|NCT02021565|41660736|FG000|3-month Follow-up|Death|3|||
19415107|NCT02021565|41660737|FG001|3-month Follow-up|Death|0|||
19415108|NCT02021565|41660736|FG000|3-month Follow-up|Withdrawal by Subject|4|||
19415109|NCT02021565|41660737|FG001|3-month Follow-up|Withdrawal by Subject|0|||
19415110|NCT02021565|41660736|FG000|3-month Follow-up|Protocol Violation|3|||
19415111|NCT02021565|41660737|FG001|3-month Follow-up|Protocol Violation|2|||
19415112|NCT02021331|41660747|FG000|Overall Study|Adverse Event|0|||
19415113|NCT02021331|41660748|FG001|Overall Study|Adverse Event|2|||
19415114|NCT02085135|41660756|FG000|Overall Study|Adverse Event|4|||
19628106|NCT00789555|42077506|FG000|Overall Study|Lost to Follow-up|9|||
19415115|NCT02085135|41660757|FG001|Overall Study|Adverse Event|7|||
19415116|NCT02085135|41660756|FG000|Overall Study|Lost to Follow-up|2|||
19415117|NCT02085135|41660757|FG001|Overall Study|Lost to Follow-up|2|||
19415118|NCT02085135|41660756|FG000|Overall Study|Withdrawal by Subject|3|||
19415119|NCT02085135|41660757|FG001|Overall Study|Withdrawal by Subject|0|||
19415120|NCT02085135|41660756|FG000|Overall Study|Lack of Efficacy|2|||
19415121|NCT02085135|41660757|FG001|Overall Study|Lack of Efficacy|0|||
19415122|NCT02441309|41660766|FG000|Overall Study|Disease progression|2|||
19415123|NCT02441309|41660767|FG001|Overall Study|Disease progression|1|||
19415124|NCT02441309|41660768|FG002|Overall Study|Disease progression|2|||
19415125|NCT02441309|41660766|FG000|Overall Study|Adverse Event|0|||
19415126|NCT02441309|41660767|FG001|Overall Study|Adverse Event|1|||
19415127|NCT02441309|41660768|FG002|Overall Study|Adverse Event|0|||
19415128|NCT02441309|41660766|FG000|Overall Study|Withdrawal by Subject|1|||
19415129|NCT02441309|41660767|FG001|Overall Study|Withdrawal by Subject|0|||
19415130|NCT02441309|41660768|FG002|Overall Study|Withdrawal by Subject|1|||
19415131|NCT02027025|41660782|FG000|Overall Study|Adverse Event|0|||
19415132|NCT02027025|41660783|FG001|Overall Study|Adverse Event|1|||
19415133|NCT02027025|41660784|FG002|Overall Study|Adverse Event|1|||
19415134|NCT02027025|41660782|FG000|Overall Study|Protocol Violation|1|||
19415135|NCT02027025|41660783|FG001|Overall Study|Protocol Violation|0|||
19415136|NCT02027025|41660784|FG002|Overall Study|Protocol Violation|0|||
19415137|NCT02027025|41660782|FG000|Overall Study|Lost to Follow-up|0|||
19415138|NCT02027025|41660783|FG001|Overall Study|Lost to Follow-up|2|||
19415139|NCT02027025|41660784|FG002|Overall Study|Lost to Follow-up|0|||
19415140|NCT02027025|41660782|FG000|Overall Study|Withdrawal by Subject|0|||
19415141|NCT02027025|41660783|FG001|Overall Study|Withdrawal by Subject|1|||
19415142|NCT02027025|41660784|FG002|Overall Study|Withdrawal by Subject|0|||
19415143|NCT02027025|41660782|FG000|Overall Study|Sponsor's decision|0|||
19415144|NCT02027025|41660783|FG001|Overall Study|Sponsor's decision|1|||
19415145|NCT02027025|41660784|FG002|Overall Study|Sponsor's decision|0|||
19415146|NCT01652729|41660806|FG000|Overall Study|Withdrawal by Subject|14|||
19415147|NCT01652729|41660807|FG001|Overall Study|Withdrawal by Subject|7|||
19415148|NCT01652729|41660808|FG002|Overall Study|Withdrawal by Subject|7|||
19415149|NCT01652729|41660806|FG000|Overall Study|Adverse Event|4|||
19415150|NCT01652729|41660807|FG001|Overall Study|Adverse Event|0|||
19415151|NCT01652729|41660808|FG002|Overall Study|Adverse Event|3|||
19415152|NCT01652729|41660806|FG000|Overall Study|Physician Decision|1|||
19415153|NCT01652729|41660807|FG001|Overall Study|Physician Decision|0|||
19415154|NCT01652729|41660808|FG002|Overall Study|Physician Decision|1|||
19415155|NCT01652729|41660806|FG000|Overall Study|Protocol Violation|1|||
19415156|NCT01652729|41660807|FG001|Overall Study|Protocol Violation|0|||
19415157|NCT01652729|41660808|FG002|Overall Study|Protocol Violation|0|||
19415158|NCT01652729|41660806|FG000|Overall Study|Lost to Follow-up|6|||
19415159|NCT01652729|41660807|FG001|Overall Study|Lost to Follow-up|6|||
19415160|NCT01652729|41660808|FG002|Overall Study|Lost to Follow-up|3|||
19415161|NCT01652729|41660806|FG000|Overall Study|Administrative|1|||
19415162|NCT01652729|41660807|FG001|Overall Study|Administrative|0|||
19415163|NCT01652729|41660808|FG002|Overall Study|Administrative|0|||
19415164|NCT02083965|41660818|FG000|Treatment Period|Other|1|||
19415165|NCT02083965|41660819|FG001|Treatment Period|Other|0|||
19415166|NCT02438813|41660827|FG000|Overall Study|Patient Decision|59|||
19519316|NCT01474512|41932297|FG005|Maintenance Period|Physician Decision|1|||
19519317|NCT01474512|41932298|FG006|Maintenance Period|Physician Decision|0|||
19519318|NCT01474512|41932299|FG007|Maintenance Period|Physician Decision|2|||
19519319|NCT01474512|41932300|FG008|Maintenance Period|Physician Decision|0|||
19519320|NCT01474512|41932301|FG009|Maintenance Period|Physician Decision|0|||
19519321|NCT01474512|41932302|FG010|Maintenance Period|Physician Decision|0|||
19519322|NCT01474512|41932303|FG011|Maintenance Period|Physician Decision|0|||
19519323|NCT01474512|41932304|FG012|Maintenance Period|Physician Decision|0|||
19519324|NCT01474512|41932305|FG013|Maintenance Period|Physician Decision|0|||
19519325|NCT01474512|41932306|FG014|Maintenance Period|Physician Decision|0|||
19519326|NCT01474512|41932307|FG015|Maintenance Period|Physician Decision|0|||
19519327|NCT01474512|41932308|FG016|Maintenance Period|Physician Decision|0|||
19519328|NCT01474512|41932309|FG017|Maintenance Period|Physician Decision|0|||
19519329|NCT01474512|41932292|FG000|Maintenance Period|Clinical Relapse|0|||
19519330|NCT01474512|41932293|FG001|Maintenance Period|Clinical Relapse|0|||
19519331|NCT01474512|41932294|FG002|Maintenance Period|Clinical Relapse|0|||
19519332|NCT01474512|41932295|FG003|Maintenance Period|Clinical Relapse|1|||
19519333|NCT01474512|41932296|FG004|Maintenance Period|Clinical Relapse|0|||
19519334|NCT01474512|41932297|FG005|Maintenance Period|Clinical Relapse|0|||
19519335|NCT01474512|41932298|FG006|Maintenance Period|Clinical Relapse|0|||
19519336|NCT01474512|41932299|FG007|Maintenance Period|Clinical Relapse|0|||
19519337|NCT01474512|41932300|FG008|Maintenance Period|Clinical Relapse|0|||
19519338|NCT01474512|41932301|FG009|Maintenance Period|Clinical Relapse|0|||
19519339|NCT01474512|41932302|FG010|Maintenance Period|Clinical Relapse|0|||
19415167|NCT02438813|41660827|FG000|Overall Study|Patient Lost to Follow-Up|137|||
19415168|NCT02438813|41660827|FG000|Overall Study|Study Ended by Sponsor|80|||
19415169|NCT02438813|41660827|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
19415170|NCT02437409|41660841|FG000|Overall Study|Withdrawal by Subject|3|||
19415171|NCT02437409|41660841|FG000|Overall Study|Screening failure|12|||
19415172|NCT02459093|41660848|FG000|Overall Study|Protocol Violation|6|||
19415173|NCT02459093|41660849|FG001|Overall Study|Protocol Violation|11|||
19415174|NCT02459093|41660848|FG000|Overall Study|Lost to Follow-up|6|||
19415175|NCT02459093|41660849|FG001|Overall Study|Lost to Follow-up|7|||
19415176|NCT02458469|41660855|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19415177|NCT02458469|41660856|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19415178|NCT02458469|41660857|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
19415179|NCT02458469|41660858|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19415180|NCT02458469|41660859|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19415181|NCT02458469|41660860|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
19415182|NCT02458469|41660855|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
19415183|NCT02458469|41660856|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
19415184|NCT02458469|41660857|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
19415185|NCT02458469|41660858|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
19415186|NCT02458469|41660859|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
19415187|NCT02458469|41660860|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
19415188|NCT02458469|41660855|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415189|NCT02458469|41660856|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415190|NCT02458469|41660857|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415191|NCT02458469|41660858|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415192|NCT02458469|41660859|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415193|NCT02458469|41660860|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
19415194|NCT01843348|41660871|FG000|Overall Study|Withdrawal by Subject|4|||
19415195|NCT01843348|41660872|FG001|Overall Study|Withdrawal by Subject|16|||
19415196|NCT01843348|41660873|FG002|Overall Study|Withdrawal by Subject|18|||
19415197|NCT01843348|41660871|FG000|Overall Study|Lost to Follow-up|5|||
19415198|NCT01843348|41660872|FG001|Overall Study|Lost to Follow-up|4|||
19415199|NCT01843348|41660873|FG002|Overall Study|Lost to Follow-up|2|||
19415200|NCT01843348|41660871|FG000|Overall Study|Death|5|||
19415201|NCT01843348|41660872|FG001|Overall Study|Death|3|||
19415202|NCT01843348|41660873|FG002|Overall Study|Death|4|||
19415203|NCT01843348|41660871|FG000|Overall Study|Graft loss/retransplantation|5|||
19415204|NCT01843348|41660872|FG001|Overall Study|Graft loss/retransplantation|8|||
19415205|NCT01843348|41660873|FG002|Overall Study|Graft loss/retransplantation|11|||
19415206|NCT01843348|41660871|FG000|Overall Study|Various reasons|4|||
19415207|NCT01843348|41660872|FG001|Overall Study|Various reasons|9|||
19415208|NCT01843348|41660873|FG002|Overall Study|Various reasons|6|||
19415209|NCT01843192|41660886|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
19415210|NCT01843192|41660887|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
19415211|NCT01843192|41660888|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
19415212|NCT01825876|41660896|FG000|Period 2|Withdrawal by Subject|0|||
19415213|NCT01825876|41660897|FG001|Period 2|Withdrawal by Subject|1|||
19415214|NCT01842958|41660908|FG000|Overall Study|Lost to Follow-up|1|||
19415215|NCT01842958|41660909|FG001|Overall Study|Lost to Follow-up|1|||
19415216|NCT02413229|41660923|FG000|Overall Study|Adverse Event|0|||
19415217|NCT02413229|41660924|FG001|Overall Study|Adverse Event|0|||
19415218|NCT02413229|41660925|FG002|Overall Study|Adverse Event|0|||
19415219|NCT02413229|41660926|FG003|Overall Study|Adverse Event|1|||
19415220|NCT02413229|41660927|FG004|Overall Study|Adverse Event|0|||
19415221|NCT02413229|41660928|FG005|Overall Study|Adverse Event|0|||
19415222|NCT02413229|41660929|FG006|Overall Study|Adverse Event|0|||
19415223|NCT02413229|41660930|FG007|Overall Study|Adverse Event|1|||
19415224|NCT02413229|41660923|FG000|Overall Study|Lost to Follow-up|0|||
19415225|NCT02413229|41660924|FG001|Overall Study|Lost to Follow-up|0|||
19415226|NCT02413229|41660925|FG002|Overall Study|Lost to Follow-up|1|||
19415227|NCT02413229|41660926|FG003|Overall Study|Lost to Follow-up|0|||
19415228|NCT02413229|41660927|FG004|Overall Study|Lost to Follow-up|2|||
19415229|NCT02413229|41660928|FG005|Overall Study|Lost to Follow-up|0|||
19415230|NCT02413229|41660929|FG006|Overall Study|Lost to Follow-up|0|||
19415231|NCT02413229|41660930|FG007|Overall Study|Lost to Follow-up|0|||
19415232|NCT02413229|41660923|FG000|Overall Study|Withdrawal by Subject|1|||
19415233|NCT02413229|41660924|FG001|Overall Study|Withdrawal by Subject|1|||
19415234|NCT02413229|41660925|FG002|Overall Study|Withdrawal by Subject|0|||
19415235|NCT02413229|41660926|FG003|Overall Study|Withdrawal by Subject|0|||
19415236|NCT02413229|41660927|FG004|Overall Study|Withdrawal by Subject|1|||
19415237|NCT02413229|41660928|FG005|Overall Study|Withdrawal by Subject|0|||
19415238|NCT02413229|41660929|FG006|Overall Study|Withdrawal by Subject|0|||
19415239|NCT02413229|41660930|FG007|Overall Study|Withdrawal by Subject|2|||
19415240|NCT02413229|41660923|FG000|Overall Study|Progressive Disease|0|||
19415241|NCT02413229|41660924|FG001|Overall Study|Progressive Disease|0|||
19415242|NCT02413229|41660925|FG002|Overall Study|Progressive Disease|0|||
19415243|NCT02413229|41660926|FG003|Overall Study|Progressive Disease|0|||
19415244|NCT02413229|41660927|FG004|Overall Study|Progressive Disease|0|||
19415245|NCT02413229|41660928|FG005|Overall Study|Progressive Disease|0|||
19415246|NCT02413229|41660929|FG006|Overall Study|Progressive Disease|0|||
19415247|NCT02413229|41660930|FG007|Overall Study|Progressive Disease|1|||
19519340|NCT01474512|41932303|FG011|Maintenance Period|Clinical Relapse|0|||
19415248|NCT01825798|41660950|FG000|Overall Study|Adverse Event|1|||
19415249|NCT01825798|41660951|FG001|Overall Study|Adverse Event|5|||
19415250|NCT01825798|41660950|FG000|Overall Study|Lost to Follow-up|1|||
19415251|NCT01825798|41660951|FG001|Overall Study|Lost to Follow-up|0|||
19415252|NCT01824472|41660960|FG000|Overall Study|Lost to Follow-up|0|||
19415253|NCT01824472|41660961|FG001|Overall Study|Lost to Follow-up|0|||
19415254|NCT01824472|41660962|FG002|Overall Study|Lost to Follow-up|1|||
19415255|NCT01824472|41660960|FG000|Overall Study|Withdrawal by Subject|1|||
19415256|NCT01824472|41660961|FG001|Overall Study|Withdrawal by Subject|5|||
19415257|NCT01824472|41660962|FG002|Overall Study|Withdrawal by Subject|3|||
19415258|NCT01824472|41660960|FG000|Overall Study|Ineligible post randomization&screening|0|||
19415259|NCT01824472|41660961|FG001|Overall Study|Ineligible post randomization&screening|2|||
19415260|NCT01824472|41660962|FG002|Overall Study|Ineligible post randomization&screening|0|||
19415261|NCT02412761|41660970|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415262|NCT02412761|41660971|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
19415263|NCT02412761|41660972|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
19415264|NCT02412761|41660973|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415265|NCT02412761|41660974|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
19415266|NCT02412761|41660975|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
19415267|NCT01842334|41660985|FG000|Overall Study|Withdrawal by Subject|3|||
19415268|NCT01842334|41660986|FG001|Overall Study|Withdrawal by Subject|3|||
19415269|NCT01842334|41660985|FG000|Overall Study|Moved away mid-study|0|||
19415270|NCT01842334|41660986|FG001|Overall Study|Moved away mid-study|1|||
19415271|NCT02457611|41660992|FG000|Overall Study|Lost to Follow-up|3|||
19415272|NCT02457065|41660998|FG000|Overall Study|Lost to Follow-up|9|||
19415273|NCT02457065|41660999|FG001|Overall Study|Lost to Follow-up|11|||
19415274|NCT02083653|41661008|FG000|Overall Study|Randomized but not Treated|0|||
19415275|NCT02083653|41661009|FG001|Overall Study|Randomized but not Treated|2|||
19415276|NCT02083653|41661010|FG002|Overall Study|Randomized but not Treated|7|||
19415277|NCT02083653|41661008|FG000|Overall Study|Adverse Event|12|||
19415278|NCT02083653|41661009|FG001|Overall Study|Adverse Event|5|||
19415279|NCT02083653|41661010|FG002|Overall Study|Adverse Event|4|||
19415280|NCT02083653|41661008|FG000|Overall Study|Lost to Follow-up|1|||
19415281|NCT02083653|41661009|FG001|Overall Study|Lost to Follow-up|0|||
19415282|NCT02083653|41661010|FG002|Overall Study|Lost to Follow-up|0|||
19415283|NCT02083653|41661008|FG000|Overall Study|Death|2|||
19415284|NCT02083653|41661009|FG001|Overall Study|Death|2|||
19415285|NCT02083653|41661010|FG002|Overall Study|Death|2|||
19415286|NCT02083653|41661008|FG000|Overall Study|Progressive Disease|65|||
19415287|NCT02083653|41661009|FG001|Overall Study|Progressive Disease|73|||
19415288|NCT02083653|41661010|FG002|Overall Study|Progressive Disease|63|||
19415289|NCT02083653|41661008|FG000|Overall Study|Withdrawal by Subject|2|||
19415290|NCT02083653|41661009|FG001|Overall Study|Withdrawal by Subject|1|||
19415291|NCT02083653|41661010|FG002|Overall Study|Withdrawal by Subject|2|||
19415292|NCT02083653|41661008|FG000|Overall Study|Other Events|0|||
19415293|NCT02083653|41661009|FG001|Overall Study|Other Events|2|||
19415294|NCT02083653|41661010|FG002|Overall Study|Other Events|2|||
19415295|NCT02083653|41661008|FG000|Overall Study|Reason Missing|0|||
19415296|NCT02083653|41661009|FG001|Overall Study|Reason Missing|0|||
19415297|NCT02083653|41661010|FG002|Overall Study|Reason Missing|4|||
19415298|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Adverse Event|12|||
19415299|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Adverse Event|3|||
19415300|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Adverse Event|4|||
19415301|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Adverse Event|2|||
19415302|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
19415303|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
19415304|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
19415305|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
19415306|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
19415307|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
19415308|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
19415309|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
19415310|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
19415311|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
19415312|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
19415313|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
19415314|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
19415315|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
19415316|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
19415317|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
19415318|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
19415319|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
19415320|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
19415321|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
19415322|NCT02436239|41661022|FG000|Open-Lable Treatment Period|Other Reason|1|||
19415323|NCT02436239|41661023|FG001|Open-Lable Treatment Period|Other Reason|1|||
19415324|NCT02436239|41661024|FG002|Open-Lable Treatment Period|Other Reason|0|||
19415325|NCT02436239|41661025|FG003|Open-Lable Treatment Period|Other Reason|0|||
19415326|NCT02436239|41661022|FG000|Down-Taper Period|Withdrawal by Subject|4|||
19415327|NCT02436239|41661023|FG001|Down-Taper Period|Withdrawal by Subject|4|||
19415328|NCT02436239|41661024|FG002|Down-Taper Period|Withdrawal by Subject|1|||
19415329|NCT02436239|41661025|FG003|Down-Taper Period|Withdrawal by Subject|2|||
19415330|NCT02026011|41661037|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
19415331|NCT02026011|41661038|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
19415332|NCT02026011|41661037|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
19415333|NCT02026011|41661038|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
19415334|NCT02026011|41661037|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
19415335|NCT02026011|41661038|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
19415336|NCT02026011|41661037|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
19415337|NCT02026011|41661038|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
19415338|NCT02436005|41661047|FG000|Second Intervention|Adverse Event|0|||
19415339|NCT02436005|41661048|FG001|Second Intervention|Adverse Event|1|||
19415340|NCT02456909|41661056|FG000|Overall Study|Did not receive allocated intervention|24|||
19415341|NCT02456909|41661057|FG001|Overall Study|Did not receive allocated intervention|26|||
19415342|NCT02456909|41661056|FG000|Overall Study|Did not complete the primary outcome|0|||
19415343|NCT02456909|41661057|FG001|Overall Study|Did not complete the primary outcome|1|||
19415344|NCT02025621|41661065|FG000|Overall Study|Withdrawal by Subject|1|||
19415345|NCT02025621|41661066|FG001|Overall Study|Withdrawal by Subject|0|||
19415346|NCT02025621|41661065|FG000|Overall Study|Death|0|||
19415347|NCT02025621|41661066|FG001|Overall Study|Death|1|||
19415348|NCT02025621|41661065|FG000|Overall Study|No longer eligible|10|||
19415349|NCT02025621|41661066|FG001|Overall Study|No longer eligible|15|||
19415350|NCT02025621|41661065|FG000|Overall Study|Surgery initiated before infusion|3|||
19415351|NCT02025621|41661066|FG001|Overall Study|Surgery initiated before infusion|3|||
19415352|NCT02020941|41661072|FG000|Overall Study|Adverse Event|1|||
19415353|NCT02020941|41661072|FG000|Overall Study|Physician Decision|2|||
19415354|NCT02020941|41661072|FG000|Overall Study|Withdrawal by Subject|1|||
19415355|NCT02020941|41661072|FG000|Overall Study|Disease Progression|4|||
19415356|NCT02024529|41661078|FG000|Overall Study|Withdrawal by Subject|11|||
19415357|NCT02024529|41661079|FG001|Overall Study|Withdrawal by Subject|21|||
19415358|NCT02024529|41661078|FG000|Overall Study|Lost to Follow-up|2|||
19415359|NCT02024529|41661079|FG001|Overall Study|Lost to Follow-up|4|||
19415360|NCT02020863|41661087|FG000|Overall Study|Discovery of Metastatic disease|4|||
19415361|NCT02020863|41661087|FG000|Overall Study|Team chose not to place an a line|1|||
19415362|NCT01824394|41661094|FG000|Overall Study|Early Termination|1|||
19415363|NCT01824394|41661095|FG001|Overall Study|Early Termination|1|||
19415364|NCT01824394|41661096|FG002|Overall Study|Early Termination|3|||
19415365|NCT01824394|41661094|FG000|Overall Study|Withdrawn due to Study Termination|91|||
19415366|NCT01824394|41661095|FG001|Overall Study|Withdrawn due to Study Termination|83|||
19415367|NCT01824394|41661096|FG002|Overall Study|Withdrawn due to Study Termination|41|||
19415368|NCT01824394|41661094|FG000|Overall Study|Lost to Follow-up|0|||
19415369|NCT01824394|41661095|FG001|Overall Study|Lost to Follow-up|9|||
19415370|NCT01824394|41661096|FG002|Overall Study|Lost to Follow-up|3|||
19415371|NCT01824394|41661094|FG000|Overall Study|Death|3|||
19415372|NCT01824394|41661095|FG001|Overall Study|Death|2|||
19415373|NCT01824394|41661096|FG002|Overall Study|Death|4|||
19415374|NCT01824394|41661094|FG000|Overall Study|Discontinued Subjects|1|||
19415375|NCT01824394|41661095|FG001|Overall Study|Discontinued Subjects|1|||
19415376|NCT01824394|41661096|FG002|Overall Study|Discontinued Subjects|2|||
19415377|NCT01824394|41661094|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
19415378|NCT01824394|41661095|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
19415379|NCT01824394|41661096|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
19415380|NCT01823536|41661110|FG000|Overall Study|Lost to Follow-up|1|||
19415381|NCT01823536|41661111|FG001|Overall Study|Lost to Follow-up|0|||
19415382|NCT01823536|41661112|FG002|Overall Study|Lost to Follow-up|0|||
19415383|NCT01823536|41661113|FG003|Overall Study|Lost to Follow-up|1|||
19415384|NCT01823536|41661114|FG004|Overall Study|Lost to Follow-up|1|||
19415385|NCT01823536|41661115|FG005|Overall Study|Lost to Follow-up|0|||
19415386|NCT01823536|41661110|FG000|Overall Study|Protocol Violation|0|||
19415387|NCT01823536|41661111|FG001|Overall Study|Protocol Violation|1|||
19415388|NCT01823536|41661112|FG002|Overall Study|Protocol Violation|0|||
19415389|NCT01823536|41661113|FG003|Overall Study|Protocol Violation|0|||
19415390|NCT01823536|41661114|FG004|Overall Study|Protocol Violation|0|||
19415391|NCT01823536|41661115|FG005|Overall Study|Protocol Violation|0|||
19415392|NCT01823536|41661110|FG000|Overall Study|Withdrawal by Subject|1|||
19415393|NCT01823536|41661111|FG001|Overall Study|Withdrawal by Subject|1|||
19415394|NCT01823536|41661112|FG002|Overall Study|Withdrawal by Subject|0|||
19415395|NCT01823536|41661113|FG003|Overall Study|Withdrawal by Subject|0|||
19415396|NCT01823536|41661114|FG004|Overall Study|Withdrawal by Subject|0|||
19415397|NCT01823536|41661115|FG005|Overall Study|Withdrawal by Subject|0|||
19415398|NCT01823536|41661110|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
19415399|NCT01823536|41661111|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
19415400|NCT01823536|41661112|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
19415401|NCT01823536|41661113|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
19415402|NCT01823536|41661114|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
19415403|NCT01823536|41661115|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
19415404|NCT01823536|41661110|FG000|Overall Study|Met exclusion criterion No 6|0|||
19415405|NCT01823536|41661111|FG001|Overall Study|Met exclusion criterion No 6|0|||
19415406|NCT01823536|41661112|FG002|Overall Study|Met exclusion criterion No 6|0|||
19415407|NCT01823536|41661113|FG003|Overall Study|Met exclusion criterion No 6|1|||
19415408|NCT01823536|41661114|FG004|Overall Study|Met exclusion criterion No 6|0|||
19415409|NCT01823536|41661115|FG005|Overall Study|Met exclusion criterion No 6|0|||
19415410|NCT01823536|41661110|FG000|Overall Study|Subject moved out of the state|0|||
19415411|NCT01823536|41661111|FG001|Overall Study|Subject moved out of the state|0|||
19415412|NCT01823536|41661112|FG002|Overall Study|Subject moved out of the state|0|||
19415413|NCT01823536|41661113|FG003|Overall Study|Subject moved out of the state|0|||
19415414|NCT01823536|41661114|FG004|Overall Study|Subject moved out of the state|1|||
19415415|NCT01823536|41661115|FG005|Overall Study|Subject moved out of the state|0|||
19415416|NCT01841554|41661128|FG000|Overall Study|Death|7|||
19415417|NCT01841554|41661128|FG000|Overall Study|No Implantation|1|||
19415418|NCT01841554|41661128|FG000|Overall Study|Discontinued Follow Up|5|||
19415419|NCT01841554|41661128|FG000|Overall Study|Study exit due to secondary intervention|6|||
19415420|NCT01823224|41661134|FG000|Overall Study|Lost to Follow-up|5|||
19415421|NCT01823224|41661135|FG001|Overall Study|Lost to Follow-up|6|||
19415422|NCT01823224|41661134|FG000|Overall Study|didn't qualify|1|||
19415423|NCT01823224|41661135|FG001|Overall Study|didn't qualify|2|||
19415424|NCT01823224|41661134|FG000|Overall Study|pharmacy error|0|||
19415425|NCT01823224|41661135|FG001|Overall Study|pharmacy error|1|||
19415426|NCT01823224|41661134|FG000|Overall Study|missed med dose|0|||
19415427|NCT01823224|41661135|FG001|Overall Study|missed med dose|1|||
19415428|NCT01823224|41661134|FG000|Overall Study|Withdrawal by Subject|0|||
19415429|NCT01823224|41661135|FG001|Overall Study|Withdrawal by Subject|1|||
19415430|NCT01840228|41661145|FG000|Overall Study|Lost to Follow-up|1|||
19415431|NCT01840228|41661146|FG001|Overall Study|Lost to Follow-up|1|||
19415432|NCT01839916|41661156|FG000|Overall Study|Death|9|||
19415433|NCT01839916|41661156|FG000|Overall Study|Physician Decision|17|||
19415434|NCT01839916|41661156|FG000|Overall Study|Relapse|12|||
19415435|NCT01839916|41661156|FG000|Overall Study|GVHD|2|||
19415436|NCT01839916|41661156|FG000|Overall Study|Graft Failure|1|||
19415437|NCT01823146|41661162|FG000|Overall Study|Withdrawal by Subject|0|||
19415438|NCT01823146|41661163|FG001|Overall Study|Withdrawal by Subject|1|||
19415439|NCT01823146|41661162|FG000|Overall Study|Lost to Follow-up|2|||
19415440|NCT01823146|41661163|FG001|Overall Study|Lost to Follow-up|1|||
19415441|NCT02083185|41661172|FG000|Overall Study|Lost to Follow-up|0|||
19415442|NCT02083185|41661173|FG001|Overall Study|Lost to Follow-up|3|||
19415443|NCT02083185|41661174|FG002|Overall Study|Lost to Follow-up|0|||
19415444|NCT02083185|41661172|FG000|Overall Study|Withdrawal by Subject|9|||
19415445|NCT02083185|41661173|FG001|Overall Study|Withdrawal by Subject|15|||
19415446|NCT02083185|41661174|FG002|Overall Study|Withdrawal by Subject|1|||
19415447|NCT02083185|41661172|FG000|Overall Study|Death|2|||
19415448|NCT02083185|41661173|FG001|Overall Study|Death|2|||
19415449|NCT02083185|41661174|FG002|Overall Study|Death|1|||
19415450|NCT02083185|41661172|FG000|Overall Study|Reason not Specified|9|||
19415451|NCT02083185|41661173|FG001|Overall Study|Reason not Specified|6|||
19415452|NCT02083185|41661174|FG002|Overall Study|Reason not Specified|5|||
19415453|NCT02083185|41661172|FG000|Overall Study|Study Terminated by Sponsor|0|||
19415454|NCT02083185|41661173|FG001|Overall Study|Study Terminated by Sponsor|1|||
19415455|NCT02083185|41661174|FG002|Overall Study|Study Terminated by Sponsor|0|||
19415456|NCT02083185|41661172|FG000|Overall Study|Did not Receive Study Drug|0|||
19415457|NCT02083185|41661173|FG001|Overall Study|Did not Receive Study Drug|2|||
19415458|NCT02083185|41661174|FG002|Overall Study|Did not Receive Study Drug|0|||
19415459|NCT02019927|41661188|FG000|Overall Study|Lost to Follow-up|2|||
19415460|NCT02019927|41661189|FG001|Overall Study|Lost to Follow-up|4|||
19415461|NCT02019927|41661190|FG002|Overall Study|Lost to Follow-up|1|||
19415462|NCT02019927|41661191|FG003|Overall Study|Lost to Follow-up|2|||
19415463|NCT02019927|41661192|FG004|Overall Study|Lost to Follow-up|3|||
19415464|NCT02019927|41661193|FG005|Overall Study|Lost to Follow-up|1|||
19415465|NCT02412371|41661217|FG000|Overall Study|Withdrawal by Subject|0|||
19415466|NCT02412371|41661218|FG001|Overall Study|Withdrawal by Subject|2|||
19415467|NCT02412371|41661219|FG002|Overall Study|Withdrawal by Subject|0|||
19415468|NCT02412371|41661220|FG003|Overall Study|Withdrawal by Subject|1|||
19415469|NCT02412371|41661221|FG004|Overall Study|Withdrawal by Subject|1|||
19415470|NCT02412371|41661222|FG005|Overall Study|Withdrawal by Subject|0|||
19415471|NCT02412371|41661217|FG000|Overall Study|Sponsor Discontinued Study|1|||
19415472|NCT02412371|41661218|FG001|Overall Study|Sponsor Discontinued Study|4|||
19415473|NCT02412371|41661219|FG002|Overall Study|Sponsor Discontinued Study|6|||
19415474|NCT02412371|41661220|FG003|Overall Study|Sponsor Discontinued Study|4|||
19415475|NCT02412371|41661221|FG004|Overall Study|Sponsor Discontinued Study|5|||
19415476|NCT02412371|41661222|FG005|Overall Study|Sponsor Discontinued Study|0|||
19415477|NCT02412371|41661217|FG000|Overall Study|Death|4|||
19415478|NCT02412371|41661218|FG001|Overall Study|Death|2|||
19415479|NCT02412371|41661219|FG002|Overall Study|Death|1|||
19415480|NCT02412371|41661220|FG003|Overall Study|Death|3|||
19415481|NCT02412371|41661221|FG004|Overall Study|Death|5|||
19415482|NCT02412371|41661222|FG005|Overall Study|Death|2|||
19415483|NCT02412371|41661217|FG000|Overall Study|Other|2|||
19415484|NCT02412371|41661218|FG001|Overall Study|Other|1|||
19415485|NCT02412371|41661219|FG002|Overall Study|Other|0|||
19415486|NCT02412371|41661220|FG003|Overall Study|Other|0|||
19415487|NCT02412371|41661221|FG004|Overall Study|Other|1|||
19415488|NCT02412371|41661222|FG005|Overall Study|Other|3|||
19415489|NCT02411747|41661239|FG000|Overall Study|Withdrawal by Subject|1|||
19415490|NCT02411747|41661240|FG001|Overall Study|Withdrawal by Subject|0|||
19415491|NCT02411747|41661239|FG000|Overall Study|Protocol Violation|2|||
19415492|NCT02411747|41661240|FG001|Overall Study|Protocol Violation|4|||
19415493|NCT01822756|41661251|FG000|Overall Study|Adverse Event|0|||
19415494|NCT01822756|41661252|FG001|Overall Study|Adverse Event|0|||
19415495|NCT01822756|41661253|FG002|Overall Study|Adverse Event|0|||
19415496|NCT01822756|41661254|FG003|Overall Study|Adverse Event|2|||
19415497|NCT01822756|41661255|FG004|Overall Study|Adverse Event|0|||
19415498|NCT01822756|41661251|FG000|Overall Study|Disease progression|11|||
19415499|NCT01822756|41661252|FG001|Overall Study|Disease progression|1|||
19415500|NCT01822756|41661253|FG002|Overall Study|Disease progression|7|||
19415501|NCT01822756|41661254|FG003|Overall Study|Disease progression|2|||
19415502|NCT01822756|41661255|FG004|Overall Study|Disease progression|6|||
19415503|NCT01822756|41661251|FG000|Overall Study|Death|2|||
19415504|NCT01822756|41661252|FG001|Overall Study|Death|2|||
19415505|NCT01822756|41661253|FG002|Overall Study|Death|1|||
19415506|NCT01822756|41661254|FG003|Overall Study|Death|0|||
19415507|NCT01822756|41661255|FG004|Overall Study|Death|0|||
19415508|NCT01822756|41661251|FG000|Overall Study|Lost to Follow-up|1|||
19415509|NCT01822756|41661252|FG001|Overall Study|Lost to Follow-up|0|||
19415510|NCT01822756|41661253|FG002|Overall Study|Lost to Follow-up|1|||
19415511|NCT01822756|41661254|FG003|Overall Study|Lost to Follow-up|0|||
19415512|NCT01822756|41661255|FG004|Overall Study|Lost to Follow-up|1|||
19415513|NCT01822756|41661251|FG000|Overall Study|Physician Decision|0|||
19415514|NCT01822756|41661252|FG001|Overall Study|Physician Decision|1|||
19415515|NCT01822756|41661253|FG002|Overall Study|Physician Decision|0|||
19415516|NCT01822756|41661254|FG003|Overall Study|Physician Decision|0|||
19415517|NCT01822756|41661255|FG004|Overall Study|Physician Decision|0|||
19415518|NCT01822756|41661251|FG000|Overall Study|disease progression & patient preference|2|||
19415519|NCT01822756|41661252|FG001|Overall Study|disease progression & patient preference|0|||
19415520|NCT01822756|41661253|FG002|Overall Study|disease progression & patient preference|1|||
19415521|NCT01822756|41661254|FG003|Overall Study|disease progression & patient preference|0|||
19415522|NCT01822756|41661255|FG004|Overall Study|disease progression & patient preference|0|||
19415523|NCT01822678|41661270|FG000|Overall Study|Withdrawal by Subject|5|||
19415524|NCT01822678|41661271|FG001|Overall Study|Withdrawal by Subject|4|||
19415525|NCT01822678|41661272|FG002|Overall Study|Withdrawal by Subject|4|||
19415526|NCT01822678|41661270|FG000|Overall Study|Adverse Event|4|||
19415527|NCT01822678|41661271|FG001|Overall Study|Adverse Event|3|||
19415528|NCT01822678|41661272|FG002|Overall Study|Adverse Event|1|||
19415529|NCT01822678|41661270|FG000|Overall Study|Lack of Efficacy|3|||
19415530|NCT01822678|41661271|FG001|Overall Study|Lack of Efficacy|6|||
19415531|NCT01822678|41661272|FG002|Overall Study|Lack of Efficacy|5|||
19415532|NCT01822678|41661270|FG000|Overall Study|Lost to Follow-up|0|||
19415533|NCT01822678|41661271|FG001|Overall Study|Lost to Follow-up|2|||
19415534|NCT01822678|41661272|FG002|Overall Study|Lost to Follow-up|1|||
19415535|NCT01822366|41661284|FG000|Overall Study|Lost to Follow-up|5|||
19415536|NCT01822366|41661285|FG001|Overall Study|Lost to Follow-up|1|||
19415537|NCT01822366|41661286|FG002|Overall Study|Lost to Follow-up|5|||
19415538|NCT01822366|41661287|FG003|Overall Study|Lost to Follow-up|1|||
19415539|NCT01822366|41661284|FG000|Overall Study|Withdrawal by Subject|0|||
19415540|NCT01822366|41661285|FG001|Overall Study|Withdrawal by Subject|6|||
19415541|NCT01822366|41661286|FG002|Overall Study|Withdrawal by Subject|0|||
19415542|NCT01822366|41661287|FG003|Overall Study|Withdrawal by Subject|6|||
19415543|NCT01822366|41661284|FG000|Overall Study|Partial Intervention Completion|0|||
19415544|NCT01822366|41661285|FG001|Overall Study|Partial Intervention Completion|15|||
19415545|NCT01822366|41661286|FG002|Overall Study|Partial Intervention Completion|0|||
19415546|NCT01822366|41661287|FG003|Overall Study|Partial Intervention Completion|15|||
19415547|NCT01838590|41661319|FG000|Overall Study|Lack of Efficacy|12|||
19628107|NCT00789555|42077507|FG001|Overall Study|Lost to Follow-up|10|||
19415548|NCT01838590|41661320|FG001|Overall Study|Lack of Efficacy|4|||
19415549|NCT01838590|41661319|FG000|Overall Study|Lost to Follow-up|0|||
19628108|NCT00789555|42077508|FG002|Overall Study|Lost to Follow-up|18|||
19415550|NCT01838590|41661320|FG001|Overall Study|Lost to Follow-up|1|||
19415551|NCT01611454|41661332|FG000|Overall Study|Lack of Efficacy|18|||
19415552|NCT01611454|41661333|FG001|Overall Study|Lack of Efficacy|10|||
19415553|NCT01611298|41661343|FG000|Overall Study|Relapsed|2|||
19415554|NCT01822132|41661349|FG000|Overall Study|Lost to Follow-up|4|||
19415555|NCT01822132|41661350|FG001|Overall Study|Lost to Follow-up|2|||
19415556|NCT01821898|41661364|FG000|Overall Study|Withdrawal by Subject|2|||
19415557|NCT01821898|41661365|FG001|Overall Study|Withdrawal by Subject|1|||
19415558|NCT02411591|41661375|FG000|Overall Study|Adverse Event|0|||
19415559|NCT02411591|41661376|FG001|Overall Study|Adverse Event|4|||
19415560|NCT02411591|41661377|FG002|Overall Study|Adverse Event|2|||
19415561|NCT02411591|41661375|FG000|Overall Study|Withdrawal by Subject|0|||
19415562|NCT02411591|41661376|FG001|Overall Study|Withdrawal by Subject|3|||
19415563|NCT02411591|41661377|FG002|Overall Study|Withdrawal by Subject|0|||
19415564|NCT02411591|41661375|FG000|Overall Study|Physician Decision|0|||
19415565|NCT02411591|41661376|FG001|Overall Study|Physician Decision|3|||
19415566|NCT02411591|41661377|FG002|Overall Study|Physician Decision|1|||
19415567|NCT02454959|41661393|FG000|Overall Study|Protocol-Specified Criteria|3|||
19415568|NCT02454959|41661393|FG000|Overall Study|Physician Decision|1|||
19415569|NCT02454959|41661393|FG000|Overall Study|Withdrawal by Subject|3|||
19415570|NCT02454959|41661393|FG000|Overall Study|Adverse Event|2|||
19415571|NCT01821118|41661401|FG000|Overall Study|Death|0|||
19415572|NCT01821118|41661402|FG001|Overall Study|Death|1|||
19415573|NCT01650779|41661408|FG000|Overall Study|Withdrawal by Subject|1|||
19415574|NCT02411201|41661412|FG000|Overall Study|Adverse Event|2|||
19415575|NCT02411201|41661412|FG000|Overall Study|Withdrawal by Subject|2|||
19415576|NCT02411201|41661412|FG000|Overall Study|Age group completed|2|||
19415577|NCT01838044|41661420|FG000|Overall Study|Adverse Event|4|||
19415578|NCT01838044|41661421|FG001|Overall Study|Adverse Event|6|||
19415579|NCT01838044|41661420|FG000|Overall Study|Protocol Violation|3|||
19415580|NCT01838044|41661421|FG001|Overall Study|Protocol Violation|3|||
19415581|NCT01838044|41661420|FG000|Overall Study|Withdrawal by Subject|0|||
19415582|NCT01838044|41661421|FG001|Overall Study|Withdrawal by Subject|2|||
19415583|NCT01838044|41661420|FG000|Overall Study|Insufficient clinical response|1|||
19415584|NCT01838044|41661421|FG001|Overall Study|Insufficient clinical response|2|||
19415585|NCT01838044|41661420|FG000|Overall Study|Medication error without associated AE|0|||
19415586|NCT01838044|41661421|FG001|Overall Study|Medication error without associated AE|1|||
19415587|NCT01838044|41661420|FG000|Overall Study|Lost to Follow-up|0|||
19415588|NCT01838044|41661421|FG001|Overall Study|Lost to Follow-up|2|||
19415589|NCT02410811|41661432|FG000|Overall Study|Withdrawal by Subject|0|||
19415590|NCT02410811|41661433|FG001|Overall Study|Withdrawal by Subject|0|||
19415591|NCT02410811|41661434|FG002|Overall Study|Withdrawal by Subject|1|||
19415592|NCT02410811|41661435|FG003|Overall Study|Withdrawal by Subject|0|||
19415593|NCT02435381|41661445|FG000|Overall Study|Lost to Follow-up|2|||
19415594|NCT02435381|41661446|FG001|Overall Study|Lost to Follow-up|1|||
19415595|NCT01837966|41661462|FG000|Overall Study|Withdrawal by Subject|2|||
19415596|NCT01837966|41661463|FG001|Overall Study|Withdrawal by Subject|1|||
19415597|NCT02435147|41661469|FG000|Overall Study|non-evaluable DXA scan|11|||
19415598|NCT02435069|41661473|FG000|Dose Response - First Intervention|Adverse Event|0|||
19415599|NCT02435069|41661474|FG001|Dose Response - First Intervention|Adverse Event|1|||
19415600|NCT02435069|41661475|FG002|Dose Response - First Intervention|Adverse Event|1|||
19415601|NCT02435069|41661476|FG003|Dose Response - First Intervention|Adverse Event|0|||
19415602|NCT02435069|41661477|FG004|Dose Response - First Intervention|Adverse Event|0|||
19415603|NCT02435069|41661473|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
19415604|NCT02435069|41661474|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
19415605|NCT02435069|41661475|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
19415606|NCT02435069|41661476|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
19415607|NCT02435069|41661477|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
19415608|NCT02454101|41661499|FG000|Overall Study|Adverse Event|2|||
19415609|NCT02454101|41661500|FG001|Overall Study|Adverse Event|3|||
19415610|NCT02454101|41661499|FG000|Overall Study|Lost to Follow-up|3|||
19415611|NCT02454101|41661500|FG001|Overall Study|Lost to Follow-up|4|||
19415612|NCT02409719|41661508|FG000|Overall Study|Lost to Follow-up|3|||
19415613|NCT02409719|41661509|FG001|Overall Study|Lost to Follow-up|3|||
19415614|NCT01820572|41661517|FG000|Randomization|Not Treated|2|||
19415615|NCT01820572|41661518|FG001|Randomization|Not Treated|1|||
19415616|NCT01820572|41661517|FG000|Treatment Period|Adverse Event|12|||
19519341|NCT01474512|41932304|FG012|Maintenance Period|Clinical Relapse|0|||
19519342|NCT01474512|41932305|FG013|Maintenance Period|Clinical Relapse|0|||
19415617|NCT01820572|41661518|FG001|Treatment Period|Adverse Event|7|||
19415618|NCT01820572|41661517|FG000|Treatment Period|Death|3|||
19415619|NCT01820572|41661518|FG001|Treatment Period|Death|3|||
19415620|NCT01820572|41661517|FG000|Treatment Period|Lack of Efficacy|1|||
19415621|NCT01820572|41661518|FG001|Treatment Period|Lack of Efficacy|0|||
19415622|NCT01820572|41661517|FG000|Treatment Period|poor/non compliance|0|||
19415623|NCT01820572|41661518|FG001|Treatment Period|poor/non compliance|3|||
19415624|NCT01820572|41661517|FG000|Treatment Period|request to discontinue|6|||
19415625|NCT01820572|41661518|FG001|Treatment Period|request to discontinue|11|||
19415626|NCT01820572|41661517|FG000|Treatment Period|No longer meets study criteria|3|||
19519343|NCT01474512|41932306|FG014|Maintenance Period|Clinical Relapse|0|||
19415627|NCT01820572|41661518|FG001|Treatment Period|No longer meets study criteria|10|||
19415628|NCT01820572|41661517|FG000|Treatment Period|withdrew consent|1|||
19415629|NCT01820572|41661518|FG001|Treatment Period|withdrew consent|2|||
19415630|NCT01820260|41661538|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415631|NCT01820260|41661539|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415632|NCT01820260|41661540|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415633|NCT01820260|41661541|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415634|NCT01820260|41661542|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415635|NCT01820260|41661543|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415636|NCT01820260|41661544|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
19415637|NCT01820260|41661545|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415638|NCT01820260|41661546|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415639|NCT01820260|41661547|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415640|NCT01820260|41661548|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415641|NCT01820260|41661549|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415642|NCT01820260|41661550|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415643|NCT01820260|41661551|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
19415644|NCT01820260|41661538|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415645|NCT01820260|41661539|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415646|NCT01820260|41661540|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415647|NCT01820260|41661541|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415648|NCT01820260|41661542|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415649|NCT01820260|41661543|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415650|NCT01820260|41661544|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415651|NCT01820260|41661545|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415652|NCT01820260|41661546|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415653|NCT01820260|41661547|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
19415654|NCT01820260|41661548|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415655|NCT01820260|41661549|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415656|NCT01820260|41661550|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415657|NCT01820260|41661551|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
19415658|NCT01610596|41661589|FG000|Overall Study|Lost to Follow-up|0|||
19415659|NCT01610596|41661590|FG001|Overall Study|Lost to Follow-up|1|||
19415660|NCT01818700|41661596|FG000|Overall Study|Adverse Event|67|||
19415661|NCT01818700|41661596|FG000|Overall Study|Lack of Efficacy|2|||
19415662|NCT01818700|41661596|FG000|Overall Study|Lost to Follow-up|5|||
19415663|NCT01818700|41661596|FG000|Overall Study|Withdrawal by Subject|27|||
19415664|NCT01818700|41661596|FG000|Overall Study|Protocol Violation|2|||
19415665|NCT01818700|41661596|FG000|Overall Study|Other|1|||
19415666|NCT01817764|41661604|FG000|Overall Study|Adverse Event|7|||
19415667|NCT01817764|41661605|FG001|Overall Study|Adverse Event|10|||
19415668|NCT01817764|41661604|FG000|Overall Study|Lack of Efficacy|9|||
19415669|NCT01817764|41661605|FG001|Overall Study|Lack of Efficacy|7|||
19415670|NCT01817764|41661604|FG000|Overall Study|Protocol Violation|7|||
19415671|NCT01817764|41661605|FG001|Overall Study|Protocol Violation|5|||
19415672|NCT01817764|41661604|FG000|Overall Study|Lost to Follow-up|1|||
19415673|NCT01817764|41661605|FG001|Overall Study|Lost to Follow-up|4|||
19415674|NCT01817764|41661604|FG000|Overall Study|Withdrawal by Subject|10|||
19415675|NCT01817764|41661605|FG001|Overall Study|Withdrawal by Subject|12|||
19415676|NCT01803880|41661614|FG000|Overall Study|Adverse Event|1|||
19415677|NCT01803880|41661615|FG001|Overall Study|Adverse Event|0|||
19415678|NCT01803880|41661616|FG002|Overall Study|Adverse Event|0|||
19415679|NCT01803880|41661614|FG000|Overall Study|Withdrawal by Subject|1|||
19415680|NCT01803880|41661615|FG001|Overall Study|Withdrawal by Subject|1|||
19415681|NCT01803880|41661616|FG002|Overall Study|Withdrawal by Subject|4|||
19415682|NCT01803880|41661614|FG000|Overall Study|Physician Decision|0|||
19415683|NCT01803880|41661615|FG001|Overall Study|Physician Decision|0|||
19628109|NCT00789555|42077506|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
19628110|NCT00789555|42077507|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
19374914|NCT02289898|41616597|FG001|Overall Study|Withdrawal by Subject|4|||
19374915|NCT02289898|41616598|FG002|Overall Study|Withdrawal by Subject|1|||
19374916|NCT02289898|41616596|FG000|Overall Study|Adverse Event|3|||
19374917|NCT02289898|41616597|FG001|Overall Study|Adverse Event|5|||
19374918|NCT02289898|41616598|FG002|Overall Study|Adverse Event|5|||
19374919|NCT02289898|41616596|FG000|Overall Study|Disease progression|34|||
19374920|NCT02289898|41616597|FG001|Overall Study|Disease progression|28|||
19374921|NCT02289898|41616598|FG002|Overall Study|Disease progression|34|||
19374922|NCT02289898|41616596|FG000|Overall Study|Use of another anticancer therapy|0|||
19374923|NCT02289898|41616597|FG001|Overall Study|Use of another anticancer therapy|0|||
19374924|NCT02289898|41616598|FG002|Overall Study|Use of another anticancer therapy|1|||
19374925|NCT02289898|41616596|FG000|Overall Study|Other|8|||
19374926|NCT02289898|41616597|FG001|Overall Study|Other|7|||
19374927|NCT02289898|41616598|FG002|Overall Study|Other|10|||
19374928|NCT01660412|41616605|FG000|Overall Study|Protocol Violation|0|||
19374929|NCT01660412|41616606|FG001|Overall Study|Protocol Violation|3|||
19374930|NCT01659554|41616612|FG000|Overall Study|Study Termination|4|||
19374931|NCT01659320|41616616|FG000|Overall Study|Withdrawal by Subject|2|||
19374932|NCT01659320|41616616|FG000|Overall Study|Physician Decision|1|||
19415684|NCT01803880|41661616|FG002|Overall Study|Physician Decision|1|||
19415685|NCT01803880|41661614|FG000|Overall Study|Unable to return for follow-up visits|0|||
19415686|NCT01803880|41661615|FG001|Overall Study|Unable to return for follow-up visits|1|||
19415687|NCT01803880|41661616|FG002|Overall Study|Unable to return for follow-up visits|2|||
19415688|NCT01803880|41661614|FG000|Overall Study|Lost to Follow-up|1|||
19415689|NCT01803880|41661615|FG001|Overall Study|Lost to Follow-up|2|||
19415690|NCT01803880|41661616|FG002|Overall Study|Lost to Follow-up|3|||
19415691|NCT01803880|41661614|FG000|Overall Study|Protocol Violation|1|||
19415692|NCT01803880|41661615|FG001|Overall Study|Protocol Violation|0|||
19415693|NCT01803880|41661616|FG002|Overall Study|Protocol Violation|0|||
19415694|NCT01803880|41661614|FG000|Overall Study|Early study termination|0|||
19415695|NCT01803880|41661615|FG001|Overall Study|Early study termination|6|||
19415696|NCT01803880|41661616|FG002|Overall Study|Early study termination|5|||
19415697|NCT01803880|41661614|FG000|Overall Study|Incomplete data entry by sites|2|||
19415698|NCT01803880|41661615|FG001|Overall Study|Incomplete data entry by sites|0|||
19415699|NCT01803880|41661616|FG002|Overall Study|Incomplete data entry by sites|0|||
19415700|NCT01803646|41661628|FG000|Overall Study|Protocol Violation|1|||
19415701|NCT01803646|41661629|FG001|Overall Study|Protocol Violation|0|||
19415702|NCT01803646|41661628|FG000|Overall Study|Adverse Event|1|||
19415703|NCT01803646|41661629|FG001|Overall Study|Adverse Event|1|||
19415704|NCT01803646|41661628|FG000|Overall Study|Withdrawal by Subject|9|||
19415705|NCT01803646|41661629|FG001|Overall Study|Withdrawal by Subject|6|||
19415706|NCT01803646|41661628|FG000|Overall Study|Randomization error|1|||
19415707|NCT01803646|41661629|FG001|Overall Study|Randomization error|2|||
19415708|NCT01803646|41661628|FG000|Overall Study|Lost to Follow-up|5|||
19415709|NCT01803646|41661629|FG001|Overall Study|Lost to Follow-up|1|||
19415710|NCT01817530|41661643|FG000|Overall Study|Exclusionary Medication Received|0|||
19415711|NCT01817530|41661644|FG001|Overall Study|Exclusionary Medication Received|0|||
19415712|NCT01817530|41661645|FG002|Overall Study|Exclusionary Medication Received|0|||
19415713|NCT01817530|41661646|FG003|Overall Study|Exclusionary Medication Received|0|||
19415714|NCT01817530|41661647|FG004|Overall Study|Exclusionary Medication Received|1|||
19415715|NCT01817530|41661648|FG005|Overall Study|Exclusionary Medication Received|0|||
19415716|NCT01817530|41661649|FG006|Overall Study|Exclusionary Medication Received|0|||
19415717|NCT01817530|41661650|FG007|Overall Study|Exclusionary Medication Received|0|||
19415718|NCT01817530|41661643|FG000|Overall Study|Adverse Event|6|||
19415719|NCT01817530|41661644|FG001|Overall Study|Adverse Event|3|||
19415720|NCT01817530|41661645|FG002|Overall Study|Adverse Event|2|||
19415721|NCT01817530|41661646|FG003|Overall Study|Adverse Event|5|||
19415722|NCT01817530|41661647|FG004|Overall Study|Adverse Event|0|||
19415723|NCT01817530|41661648|FG005|Overall Study|Adverse Event|10|||
19415724|NCT01817530|41661649|FG006|Overall Study|Adverse Event|5|||
19415725|NCT01817530|41661650|FG007|Overall Study|Adverse Event|8|||
19415726|NCT01817530|41661643|FG000|Overall Study|Subject Noncompliant|3|||
19415727|NCT01817530|41661644|FG001|Overall Study|Subject Noncompliant|1|||
19415728|NCT01817530|41661645|FG002|Overall Study|Subject Noncompliant|0|||
19415729|NCT01817530|41661646|FG003|Overall Study|Subject Noncompliant|4|||
19415730|NCT01817530|41661647|FG004|Overall Study|Subject Noncompliant|0|||
19415731|NCT01817530|41661648|FG005|Overall Study|Subject Noncompliant|1|||
19415732|NCT01817530|41661649|FG006|Overall Study|Subject Noncompliant|1|||
19415733|NCT01817530|41661650|FG007|Overall Study|Subject Noncompliant|1|||
19415734|NCT01817530|41661643|FG000|Overall Study|Lack of Efficacy|1|||
19415735|NCT01817530|41661644|FG001|Overall Study|Lack of Efficacy|0|||
19415736|NCT01817530|41661645|FG002|Overall Study|Lack of Efficacy|0|||
19415737|NCT01817530|41661646|FG003|Overall Study|Lack of Efficacy|0|||
19415738|NCT01817530|41661647|FG004|Overall Study|Lack of Efficacy|0|||
19415739|NCT01817530|41661648|FG005|Overall Study|Lack of Efficacy|1|||
19415740|NCT01817530|41661649|FG006|Overall Study|Lack of Efficacy|0|||
19415741|NCT01817530|41661650|FG007|Overall Study|Lack of Efficacy|1|||
19374933|NCT01660334|41616620|FG000|Overall Study|Lost to Follow-up|1|||
19374934|NCT01660256|41616627|FG000|Overall Study|Adverse Event|4|||
19374935|NCT01660256|41616628|FG001|Overall Study|Adverse Event|0|||
19415742|NCT01817530|41661643|FG000|Overall Study|Pregnancy|0|||
19415743|NCT01817530|41661644|FG001|Overall Study|Pregnancy|0|||
19415744|NCT01817530|41661645|FG002|Overall Study|Pregnancy|0|||
19415745|NCT01817530|41661646|FG003|Overall Study|Pregnancy|0|||
19415746|NCT01817530|41661647|FG004|Overall Study|Pregnancy|0|||
19415747|NCT01817530|41661648|FG005|Overall Study|Pregnancy|1|||
19415748|NCT01817530|41661649|FG006|Overall Study|Pregnancy|0|||
19415749|NCT01817530|41661650|FG007|Overall Study|Pregnancy|0|||
19415750|NCT01817530|41661643|FG000|Overall Study|Other|0|||
19415751|NCT01817530|41661644|FG001|Overall Study|Other|1|||
19415752|NCT01817530|41661645|FG002|Overall Study|Other|0|||
19415753|NCT01817530|41661646|FG003|Overall Study|Other|0|||
19415754|NCT01817530|41661647|FG004|Overall Study|Other|1|||
19415755|NCT01817530|41661648|FG005|Overall Study|Other|0|||
19415756|NCT01817530|41661649|FG006|Overall Study|Other|5|||
19415757|NCT01817530|41661650|FG007|Overall Study|Other|0|||
19415758|NCT01817530|41661643|FG000|Overall Study|Surgery or Invasive Intervention|1|||
19415759|NCT01817530|41661644|FG001|Overall Study|Surgery or Invasive Intervention|0|||
19415760|NCT01817530|41661645|FG002|Overall Study|Surgery or Invasive Intervention|0|||
19415761|NCT01817530|41661646|FG003|Overall Study|Surgery or Invasive Intervention|0|||
19415762|NCT01817530|41661647|FG004|Overall Study|Surgery or Invasive Intervention|1|||
19415763|NCT01817530|41661648|FG005|Overall Study|Surgery or Invasive Intervention|1|||
19415764|NCT01817530|41661649|FG006|Overall Study|Surgery or Invasive Intervention|1|||
19415765|NCT01817530|41661650|FG007|Overall Study|Surgery or Invasive Intervention|0|||
19415766|NCT01817530|41661643|FG000|Overall Study|Consent Withdrawn by Subject|3|||
19415767|NCT01817530|41661644|FG001|Overall Study|Consent Withdrawn by Subject|4|||
19415768|NCT01817530|41661645|FG002|Overall Study|Consent Withdrawn by Subject|7|||
19415769|NCT01817530|41661646|FG003|Overall Study|Consent Withdrawn by Subject|3|||
19415770|NCT01817530|41661647|FG004|Overall Study|Consent Withdrawn by Subject|5|||
19415771|NCT01817530|41661648|FG005|Overall Study|Consent Withdrawn by Subject|3|||
19415772|NCT01817530|41661649|FG006|Overall Study|Consent Withdrawn by Subject|3|||
19415773|NCT01817530|41661650|FG007|Overall Study|Consent Withdrawn by Subject|10|||
19415774|NCT01817530|41661643|FG000|Overall Study|Lost to Follow-up|1|||
19415775|NCT01817530|41661644|FG001|Overall Study|Lost to Follow-up|4|||
19415776|NCT01817530|41661645|FG002|Overall Study|Lost to Follow-up|2|||
19415777|NCT01817530|41661646|FG003|Overall Study|Lost to Follow-up|1|||
19415778|NCT01817530|41661647|FG004|Overall Study|Lost to Follow-up|3|||
19415779|NCT01817530|41661648|FG005|Overall Study|Lost to Follow-up|2|||
19415780|NCT01817530|41661649|FG006|Overall Study|Lost to Follow-up|8|||
19415781|NCT01817530|41661650|FG007|Overall Study|Lost to Follow-up|4|||
19415782|NCT01816984|41661668|FG000|Overall Study|declining health status|1|||
19415783|NCT01816906|41661674|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
19415784|NCT01816906|41661675|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
19415785|NCT01816906|41661674|FG000|Six Months|Lost to Follow-up|14|||
19415786|NCT01816906|41661675|FG001|Six Months|Lost to Follow-up|16|||
19415787|NCT01816906|41661674|FG000|12 Months|Adverse Event|2|||
19415788|NCT01816906|41661675|FG001|12 Months|Adverse Event|2|||
19415789|NCT01816906|41661674|FG000|12 Months|Death|0|||
19415790|NCT01816906|41661675|FG001|12 Months|Death|2|||
19415791|NCT01816906|41661674|FG000|12 Months|Lost to Follow-up|2|||
19415792|NCT01816906|41661675|FG001|12 Months|Lost to Follow-up|1|||
19415793|NCT01816594|41661684|FG000|Overall Study|Local Progress|0|||
19415794|NCT01816594|41661685|FG001|Overall Study|Local Progress|2|||
19415795|NCT01816594|41661684|FG000|Overall Study|Adverse Event|9|||
19415796|NCT01816594|41661685|FG001|Overall Study|Adverse Event|0|||
19415797|NCT01816594|41661684|FG000|Overall Study|Withdrawal by Subject|1|||
19415798|NCT01816594|41661685|FG001|Overall Study|Withdrawal by Subject|0|||
19415799|NCT01816594|41661684|FG000|Overall Study|Physician Decision|1|||
19415800|NCT01816594|41661685|FG001|Overall Study|Physician Decision|0|||
19415801|NCT01802320|41661697|FG000|Overall Study|Death|1|||
19415802|NCT01802320|41661697|FG000|Overall Study|Withdrawal by Subject|1|||
19415803|NCT02453711|41661710|FG000|Overall Study|Withdrawal by Subject|5|||
19415804|NCT02453711|41661711|FG001|Overall Study|Withdrawal by Subject|4|||
19415805|NCT02453711|41661712|FG002|Overall Study|Withdrawal by Subject|6|||
19415806|NCT02453711|41661713|FG003|Overall Study|Withdrawal by Subject|4|||
19415807|NCT02453711|41661714|FG004|Overall Study|Withdrawal by Subject|1|||
19415808|NCT02453711|41661715|FG005|Overall Study|Withdrawal by Subject|1|||
19415809|NCT02453711|41661716|FG006|Overall Study|Withdrawal by Subject|0|||
19415810|NCT02453711|41661717|FG007|Overall Study|Withdrawal by Subject|1|||
19415811|NCT02453711|41661718|FG008|Overall Study|Withdrawal by Subject|7|||
19415812|NCT02453711|41661710|FG000|Overall Study|Lost to Follow-up|5|||
19415813|NCT02453711|41661711|FG001|Overall Study|Lost to Follow-up|3|||
19415814|NCT02453711|41661712|FG002|Overall Study|Lost to Follow-up|2|||
19415815|NCT02453711|41661713|FG003|Overall Study|Lost to Follow-up|3|||
19415816|NCT02453711|41661714|FG004|Overall Study|Lost to Follow-up|1|||
19415817|NCT02453711|41661715|FG005|Overall Study|Lost to Follow-up|5|||
19415818|NCT02453711|41661716|FG006|Overall Study|Lost to Follow-up|2|||
19415819|NCT02453711|41661717|FG007|Overall Study|Lost to Follow-up|6|||
19415820|NCT02453711|41661718|FG008|Overall Study|Lost to Follow-up|6|||
19415821|NCT02453711|41661710|FG000|Overall Study|Death|0|||
19415822|NCT02453711|41661711|FG001|Overall Study|Death|0|||
19415823|NCT02453711|41661712|FG002|Overall Study|Death|0|||
19415824|NCT02453711|41661713|FG003|Overall Study|Death|0|||
19415825|NCT02453711|41661714|FG004|Overall Study|Death|0|||
19415826|NCT02453711|41661715|FG005|Overall Study|Death|0|||
19415827|NCT02453711|41661716|FG006|Overall Study|Death|1|||
19415828|NCT02453711|41661717|FG007|Overall Study|Death|0|||
19415829|NCT02453711|41661718|FG008|Overall Study|Death|0|||
19415830|NCT02453711|41661710|FG000|Overall Study|Unclassified|1|||
19415831|NCT02453711|41661711|FG001|Overall Study|Unclassified|0|||
19415832|NCT02453711|41661712|FG002|Overall Study|Unclassified|1|||
19415833|NCT02453711|41661713|FG003|Overall Study|Unclassified|0|||
19415834|NCT02453711|41661714|FG004|Overall Study|Unclassified|0|||
19415835|NCT02453711|41661715|FG005|Overall Study|Unclassified|0|||
19415836|NCT02453711|41661716|FG006|Overall Study|Unclassified|0|||
19415837|NCT02453711|41661717|FG007|Overall Study|Unclassified|0|||
19415838|NCT02453711|41661718|FG008|Overall Study|Unclassified|0|||
19415839|NCT02453555|41661740|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
19415840|NCT02453555|41661741|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
19415841|NCT02453555|41661742|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
19415842|NCT02453555|41661743|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
19415843|NCT02453555|41661744|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
19415844|NCT02453555|41661745|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
19415845|NCT02453555|41661740|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
19415846|NCT02453555|41661741|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
19415847|NCT02453555|41661742|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
19415848|NCT02453555|41661743|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
19415849|NCT02453555|41661744|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
19415850|NCT02453555|41661745|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
19415851|NCT02453555|41661740|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
19415852|NCT02453555|41661741|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
19415853|NCT02453555|41661742|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19415854|NCT02453555|41661743|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19415855|NCT02453555|41661744|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19415856|NCT02453555|41661745|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
19415857|NCT02453555|41661740|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
19415858|NCT02453555|41661741|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
19415859|NCT02453555|41661742|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
19415860|NCT02453555|41661743|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
19415861|NCT02453555|41661744|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
19415862|NCT02453555|41661745|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
19415863|NCT02453555|41661740|FG000|Extension Period|Adverse Event|0|||
19415864|NCT02453555|41661741|FG001|Extension Period|Adverse Event|0|||
19415865|NCT02453555|41661742|FG002|Extension Period|Adverse Event|1|||
19415866|NCT02453555|41661743|FG003|Extension Period|Adverse Event|2|||
19415867|NCT02453555|41661744|FG004|Extension Period|Adverse Event|1|||
19415868|NCT02453555|41661745|FG005|Extension Period|Adverse Event|1|||
19415869|NCT02453555|41661740|FG000|Extension Period|Protocol Violation|0|||
19415870|NCT02453555|41661741|FG001|Extension Period|Protocol Violation|0|||
19415871|NCT02453555|41661742|FG002|Extension Period|Protocol Violation|1|||
19415872|NCT02453555|41661743|FG003|Extension Period|Protocol Violation|0|||
19415873|NCT02453555|41661744|FG004|Extension Period|Protocol Violation|0|||
19415874|NCT02453555|41661745|FG005|Extension Period|Protocol Violation|0|||
19415875|NCT02453555|41661740|FG000|Extension Period|Withdrawal by Subject|0|||
19415876|NCT02453555|41661741|FG001|Extension Period|Withdrawal by Subject|0|||
19415877|NCT02453555|41661742|FG002|Extension Period|Withdrawal by Subject|1|||
19415878|NCT02453555|41661743|FG003|Extension Period|Withdrawal by Subject|0|||
19415879|NCT02453555|41661744|FG004|Extension Period|Withdrawal by Subject|0|||
19415880|NCT02453555|41661745|FG005|Extension Period|Withdrawal by Subject|0|||
19415881|NCT02453321|41661758|FG000|Overall Study|Weakness|1|||
19415882|NCT02453321|41661759|FG001|Overall Study|Weakness|1|||
19415883|NCT02453321|41661760|FG002|Overall Study|Weakness|2|||
19415884|NCT02453321|41661758|FG000|Overall Study|Deep Venous Thrombosis|0|||
19415885|NCT02453321|41661759|FG001|Overall Study|Deep Venous Thrombosis|1|||
19415886|NCT02453321|41661760|FG002|Overall Study|Deep Venous Thrombosis|0|||
19415887|NCT01610284|41661773|FG000|Randomization Phase|Adverse Event|1|||
19415888|NCT01610284|41661774|FG001|Randomization Phase|Adverse Event|0|||
19415889|NCT01610284|41661773|FG000|Randomization Phase|Physician Decision|1|||
19415890|NCT01610284|41661774|FG001|Randomization Phase|Physician Decision|1|||
19415891|NCT01610284|41661773|FG000|Randomization Phase|Death|0|||
19415892|NCT01610284|41661774|FG001|Randomization Phase|Death|1|||
19415893|NCT01610284|41661773|FG000|Treatment Phase|Adverse Event|80|||
19415894|NCT01610284|41661774|FG001|Treatment Phase|Adverse Event|12|||
19415895|NCT01610284|41661773|FG000|Treatment Phase|Lost to Follow-up|1|||
19415896|NCT01610284|41661774|FG001|Treatment Phase|Lost to Follow-up|0|||
19415897|NCT01610284|41661773|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
19415898|NCT01610284|41661774|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
19415899|NCT01610284|41661773|FG000|Treatment Phase|Physician Decision|27|||
19415900|NCT01610284|41661774|FG001|Treatment Phase|Physician Decision|24|||
19415901|NCT01610284|41661773|FG000|Treatment Phase|Progressive Disease|377|||
19415902|NCT01610284|41661774|FG001|Treatment Phase|Progressive Disease|486|||
19415903|NCT01610284|41661773|FG000|Treatment Phase|Protocol Deviation|2|||
19415904|NCT01610284|41661774|FG001|Treatment Phase|Protocol Deviation|3|||
19519344|NCT01474512|41932307|FG015|Maintenance Period|Clinical Relapse|0|||
19519345|NCT01474512|41932308|FG016|Maintenance Period|Clinical Relapse|0|||
19519346|NCT01474512|41932309|FG017|Maintenance Period|Clinical Relapse|0|||
19519347|NCT01474512|41932292|FG000|Maintenance Period|Lack of Efficacy|0|||
19519348|NCT01474512|41932293|FG001|Maintenance Period|Lack of Efficacy|0|||
19415905|NCT01610284|41661773|FG000|Treatment Phase|Study terminated by Sponsor|18|||
19415906|NCT01610284|41661774|FG001|Treatment Phase|Study terminated by Sponsor|15|||
19415907|NCT01610284|41661773|FG000|Treatment Phase|Subject/Guardian Decision|55|||
19415908|NCT01610284|41661774|FG001|Treatment Phase|Subject/Guardian Decision|23|||
19415909|NCT01610284|41661773|FG000|Treatment Phase|Death|6|||
19415910|NCT01610284|41661774|FG001|Treatment Phase|Death|5|||
19415911|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
19415912|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
19415913|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
19415914|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
19415915|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
19415916|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
19415917|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
19415918|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
19415919|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
19415920|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
19415921|NCT01610284|41661773|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
19415922|NCT01610284|41661774|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
19415923|NCT02452463|41661783|FG000|Overall Study|Death|1|||
19415924|NCT02452463|41661784|FG001|Overall Study|Death|0|||
19415925|NCT02452463|41661785|FG002|Overall Study|Death|0|||
19415926|NCT02452463|41661783|FG000|Overall Study|Study Suspended|1|||
19415927|NCT02452463|41661784|FG001|Overall Study|Study Suspended|0|||
19415928|NCT02452463|41661785|FG002|Overall Study|Study Suspended|0|||
19415929|NCT02452463|41661783|FG000|Overall Study|Recommended by DSMB|0|||
19415930|NCT02452463|41661784|FG001|Overall Study|Recommended by DSMB|1|||
19415931|NCT02452463|41661785|FG002|Overall Study|Recommended by DSMB|0|||
19415932|NCT02452463|41661783|FG000|Overall Study|Withdrawal by Subject|0|||
19415933|NCT02452463|41661784|FG001|Overall Study|Withdrawal by Subject|1|||
19415934|NCT02452463|41661785|FG002|Overall Study|Withdrawal by Subject|0|||
19415935|NCT02432105|41661796|FG000|Overall Study|Lost to Follow-up|1|||
19415936|NCT02432105|41661797|FG001|Overall Study|Lost to Follow-up|1|||
19415937|NCT02432105|41661798|FG002|Overall Study|Lost to Follow-up|0|||
19415938|NCT02432105|41661796|FG000|Overall Study|Withdrawal by Subject|1|||
19415939|NCT02432105|41661797|FG001|Overall Study|Withdrawal by Subject|0|||
19415940|NCT02432105|41661798|FG002|Overall Study|Withdrawal by Subject|1|||
19415941|NCT02432105|41661796|FG000|Overall Study|Culture positive for yeast|0|||
19415942|NCT02432105|41661797|FG001|Overall Study|Culture positive for yeast|1|||
19415943|NCT02432105|41661798|FG002|Overall Study|Culture positive for yeast|0|||
19415944|NCT02432105|41661796|FG000|Overall Study|Randomized in error|0|||
19415945|NCT02432105|41661797|FG001|Overall Study|Randomized in error|0|||
19415946|NCT02432105|41661798|FG002|Overall Study|Randomized in error|2|||
19415947|NCT02431793|41661810|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
19415948|NCT02431793|41661811|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
19415949|NCT02431793|41661812|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
19415950|NCT02431793|41661810|FG000|Overall Study|Withdrawal by Subject|7|||
19415951|NCT02431793|41661811|FG001|Overall Study|Withdrawal by Subject|5|||
19415952|NCT02431793|41661812|FG002|Overall Study|Withdrawal by Subject|5|||
19415953|NCT02431793|41661810|FG000|Overall Study|Lost to Follow-up|101|||
19415954|NCT02431793|41661811|FG001|Overall Study|Lost to Follow-up|122|||
19415955|NCT02431793|41661812|FG002|Overall Study|Lost to Follow-up|104|||
19415956|NCT01801930|41661824|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
19415957|NCT01801930|41661825|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
19415958|NCT01801930|41661826|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
19415959|NCT01801930|41661827|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
19415960|NCT01801930|41661824|FG000|Overall Study|DLT occurs|0|||
19415961|NCT01801930|41661825|FG001|Overall Study|DLT occurs|1|||
19415962|NCT01801930|41661826|FG002|Overall Study|DLT occurs|0|||
19415963|NCT01801930|41661827|FG003|Overall Study|DLT occurs|0|||
19415964|NCT01610206|41661839|FG000|Overall Study|Adverse Event|10|||
19415965|NCT01610206|41661840|FG001|Overall Study|Adverse Event|30|||
19415966|NCT01816048|41661846|FG000|Overall Study|Adverse Event|1|||
19519349|NCT01474512|41932294|FG002|Maintenance Period|Lack of Efficacy|0|||
19415967|NCT01816048|41661846|FG000|Overall Study|Death|1|||
19415968|NCT01816048|41661846|FG000|Overall Study|Withdrawal by Subject|1|||
19415969|NCT01816048|41661846|FG000|Overall Study|Disease Progression|3|||
19415970|NCT01612858|41661853|FG000|Overall Study|Withdrawal by Subject|5|||
19415971|NCT01612858|41661854|FG001|Overall Study|Withdrawal by Subject|1|||
19415972|NCT01612780|41661860|FG000|Overall Study|Treatment not completed|1|||
19415973|NCT01612780|41661860|FG000|Overall Study|Withdrawal by Subject|5|||
19415974|NCT01612702|41661866|FG000|Overall Study|Protocol Violation|11|||
19415975|NCT01612702|41661867|FG001|Overall Study|Protocol Violation|11|||
19415976|NCT02431559|41661877|FG000|Overall Study|Adverse Event|0|||
19415977|NCT02431559|41661878|FG001|Overall Study|Adverse Event|1|||
19415978|NCT02431559|41661879|FG002|Overall Study|Adverse Event|0|||
19415979|NCT02431559|41661880|FG003|Overall Study|Adverse Event|4|||
19415980|NCT02431559|41661877|FG000|Overall Study|Progressive disease|2|||
19415981|NCT02431559|41661878|FG001|Overall Study|Progressive disease|1|||
19415982|NCT02431559|41661879|FG002|Overall Study|Progressive disease|4|||
19415983|NCT02431559|41661880|FG003|Overall Study|Progressive disease|22|||
19415984|NCT02431559|41661877|FG000|Overall Study|Withdrawal by Subject|0|||
19415985|NCT02431559|41661878|FG001|Overall Study|Withdrawal by Subject|1|||
19415986|NCT02431559|41661879|FG002|Overall Study|Withdrawal by Subject|0|||
19415987|NCT02431559|41661880|FG003|Overall Study|Withdrawal by Subject|4|||
19415988|NCT02431559|41661877|FG000|Overall Study|Physician Decision|0|||
19415989|NCT02431559|41661878|FG001|Overall Study|Physician Decision|0|||
19415990|NCT02431559|41661879|FG002|Overall Study|Physician Decision|0|||
19415991|NCT02431559|41661880|FG003|Overall Study|Physician Decision|1|||
19415992|NCT02388269|41661894|FG000|Overall Study|Adverse Event|2|||
19415993|NCT02388269|41661895|FG001|Overall Study|Adverse Event|0|||
19415994|NCT02388269|41661896|FG002|Overall Study|Adverse Event|0|||
19415995|NCT02388269|41661894|FG000|Overall Study|Withdrawal by Subject|1|||
19415996|NCT02388269|41661895|FG001|Overall Study|Withdrawal by Subject|2|||
19415997|NCT02388269|41661896|FG002|Overall Study|Withdrawal by Subject|0|||
19415998|NCT02388269|41661894|FG000|Overall Study|less than 50% stimulations|1|||
19415999|NCT02388269|41661895|FG001|Overall Study|less than 50% stimulations|0|||
19416000|NCT02388269|41661896|FG002|Overall Study|less than 50% stimulations|0|||
19416001|NCT02388269|41661894|FG000|Overall Study|no diary data|3|||
19416002|NCT02388269|41661895|FG001|Overall Study|no diary data|0|||
19416003|NCT02388269|41661896|FG002|Overall Study|no diary data|0|||
19416004|NCT02388269|41661894|FG000|Overall Study|Protocol Violation|2|||
19416005|NCT02388269|41661895|FG001|Overall Study|Protocol Violation|0|||
19711111|NCT03605212|42154287|FG002|Treatment Period|Physician Decision|0|||
19711112|NCT03605212|42154288|FG003|Treatment Period|Physician Decision|0|||
19711113|NCT03605212|42154289|FG004|Treatment Period|Physician Decision|1|||
19711114|NCT03603652|42154302|FG000|Overall Study|Death|2|||
19416006|NCT02388269|41661896|FG002|Overall Study|Protocol Violation|0|||
19416007|NCT02388269|41661894|FG000|Overall Study|Screen Failure|0|||
19416008|NCT02388269|41661895|FG001|Overall Study|Screen Failure|0|||
19416009|NCT02388269|41661896|FG002|Overall Study|Screen Failure|10|||
19416010|NCT01652573|41661922|FG000|Overall Study|Adverse Event|0|||
19416011|NCT01652573|41661923|FG001|Overall Study|Adverse Event|1|||
19416012|NCT02388191|41661931|FG000|Overall Study|Patient did not receive IUD|1|||
19416013|NCT02388191|41661932|FG001|Overall Study|Patient did not receive IUD|0|||
19416014|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
19416015|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
19416016|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
19416017|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
19416018|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
19416019|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
19416020|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
19416021|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
19416022|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
19416023|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
19416024|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
19416025|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
19416026|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
19416027|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
19416028|NCT01815736|41661940|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
19711115|NCT00117507|42154306|FG000|Overall Study|Adverse Event|4|||
19711116|NCT00117507|42154306|FG000|Overall Study|Abnormal laboratory values|3|||
19416029|NCT01815736|41661941|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
19416030|NCT01815736|41661940|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
19416031|NCT01815736|41661941|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
19416032|NCT01815736|41661940|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
19416033|NCT01815736|41661941|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
19416034|NCT01815736|41661940|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
19416035|NCT01815736|41661941|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
19416036|NCT01815736|41661940|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
19416037|NCT01815736|41661941|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
19416038|NCT01815736|41661940|FG000|Extension Treatment Phase- After Week 96|Death|1|||
19416039|NCT01815736|41661941|FG001|Extension Treatment Phase- After Week 96|Death|0|||
19416040|NCT01651949|41661952|FG000|Overall Study|Unknown status|4|||
19416041|NCT01651949|41661953|FG001|Overall Study|Unknown status|4|||
19416042|NCT01651949|41661954|FG002|Overall Study|Unknown status|0|||
19416043|NCT01651949|41661952|FG000|Overall Study|Lost to Follow-up|30|||
19416044|NCT01651949|41661953|FG001|Overall Study|Lost to Follow-up|56|||
19416045|NCT01651949|41661954|FG002|Overall Study|Lost to Follow-up|20|||
19416046|NCT01651949|41661952|FG000|Overall Study|Protocol Violation|0|||
19416047|NCT01651949|41661953|FG001|Overall Study|Protocol Violation|2|||
19416048|NCT01651949|41661954|FG002|Overall Study|Protocol Violation|1|||
19416049|NCT01651949|41661952|FG000|Overall Study|Physician Decision|0|||
19416050|NCT01651949|41661953|FG001|Overall Study|Physician Decision|2|||
19416051|NCT01651949|41661954|FG002|Overall Study|Physician Decision|0|||
19416052|NCT01651949|41661952|FG000|Overall Study|Adverse Event|0|||
19416053|NCT01651949|41661953|FG001|Overall Study|Adverse Event|2|||
19416054|NCT01651949|41661954|FG002|Overall Study|Adverse Event|1|||
19416055|NCT01651949|41661952|FG000|Overall Study|Screen failure|2|||
19416056|NCT01651949|41661953|FG001|Overall Study|Screen failure|2|||
19416057|NCT01651949|41661954|FG002|Overall Study|Screen failure|0|||
19416058|NCT01651949|41661952|FG000|Overall Study|Withdrawal by Subject|17|||
19416059|NCT01651949|41661953|FG001|Overall Study|Withdrawal by Subject|18|||
19416060|NCT01651949|41661954|FG002|Overall Study|Withdrawal by Subject|9|||
19416061|NCT02387957|41661965|FG000|Overall Study|The study was discontinued|21|||
19416062|NCT02387957|41661966|FG001|Overall Study|The study was discontinued|21|||
19416063|NCT02387957|41661967|FG002|Overall Study|The study was discontinued|20|||
19416064|NCT01800916|41661975|FG000|Test Period 1 (1 Week)|Convex product user|0|||
19416065|NCT01800916|41661976|FG001|Test Period 1 (1 Week)|Convex product user|0|||
19416066|NCT01800916|41661977|FG002|Test Period 1 (1 Week)|Convex product user|0|||
19416067|NCT01800916|41661978|FG003|Test Period 1 (1 Week)|Convex product user|1|||
19416068|NCT01800916|41661979|FG004|Test Period 1 (1 Week)|Convex product user|0|||
19416069|NCT01800916|41661980|FG005|Test Period 1 (1 Week)|Convex product user|0|||
19416070|NCT01800916|41661981|FG006|Test Period 1 (1 Week)|Convex product user|0|||
19416071|NCT01800916|41661982|FG007|Test Period 1 (1 Week)|Convex product user|0|||
19416072|NCT01800916|41661983|FG008|Test Period 1 (1 Week)|Convex product user|0|||
19416073|NCT01800916|41661975|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
19416074|NCT01800916|41661976|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
19416075|NCT01800916|41661977|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
19416076|NCT01800916|41661978|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
19416077|NCT01800916|41661979|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
19416078|NCT01800916|41661980|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
19416079|NCT01800916|41661981|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
19416080|NCT01800916|41661982|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
19416081|NCT01800916|41661983|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
19416082|NCT01800058|41661993|FG000|Overall Study|Lost to Follow-up|1|||
19416083|NCT01815580|41662000|FG000|Overall Study|Lost to Follow-up|4|||
19416084|NCT01815580|41662001|FG001|Overall Study|Lost to Follow-up|7|||
19416085|NCT01815580|41662000|FG000|Overall Study|Withdrawal by Subject|3|||
19416086|NCT01815580|41662001|FG001|Overall Study|Withdrawal by Subject|4|||
19416087|NCT01815580|41662000|FG000|Overall Study|Excluded from analysis|5|||
19416088|NCT01815580|41662001|FG001|Overall Study|Excluded from analysis|4|||
19416089|NCT01651403|41662014|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
19416090|NCT01651403|41662015|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
19416091|NCT01651403|41662014|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
19416092|NCT01651403|41662015|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
19416093|NCT01651403|41662014|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
19416094|NCT01651403|41662015|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
19416095|NCT01651403|41662014|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
19416096|NCT01651403|41662015|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
19416097|NCT01651403|41662014|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
19416098|NCT01651403|41662015|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
19416099|NCT01651403|41662014|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
19416100|NCT01651403|41662015|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
19416101|NCT01799590|41662029|FG000|Overall Study|Adverse Event|13|||
19416102|NCT01799590|41662030|FG001|Overall Study|Adverse Event|7|||
19416103|NCT01799590|41662031|FG002|Overall Study|Adverse Event|5|||
19416104|NCT01799590|41662029|FG000|Overall Study|Pregnancy|2|||
19416105|NCT01799590|41662030|FG001|Overall Study|Pregnancy|0|||
19416106|NCT01799590|41662031|FG002|Overall Study|Pregnancy|0|||
19416107|NCT01799590|41662029|FG000|Overall Study|Lack of Efficacy|3|||
19416108|NCT01799590|41662030|FG001|Overall Study|Lack of Efficacy|1|||
19416109|NCT01799590|41662031|FG002|Overall Study|Lack of Efficacy|3|||
19416110|NCT01799590|41662029|FG000|Overall Study|Participants convenience|4|||
19416111|NCT01799590|41662030|FG001|Overall Study|Participants convenience|4|||
19416112|NCT01799590|41662031|FG002|Overall Study|Participants convenience|2|||
19416113|NCT01799590|41662029|FG000|Overall Study|Aggravation of complications|0|||
19416114|NCT01799590|41662030|FG001|Overall Study|Aggravation of complications|1|||
19416115|NCT01799590|41662031|FG002|Overall Study|Aggravation of complications|1|||
19416116|NCT01799590|41662029|FG000|Overall Study|Using drugs with restricted days of use|0|||
19416117|NCT01799590|41662030|FG001|Overall Study|Using drugs with restricted days of use|3|||
19416118|NCT01799590|41662031|FG002|Overall Study|Using drugs with restricted days of use|2|||
19416119|NCT01799590|41662029|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
19416120|NCT01799590|41662030|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
19416121|NCT01799590|41662031|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
19416122|NCT01799590|41662029|FG000|Overall Study|Other|3|||
19416123|NCT01799590|41662030|FG001|Overall Study|Other|0|||
19416124|NCT01799590|41662031|FG002|Overall Study|Other|1|||
19416125|NCT01815424|41662042|FG000|Week 0 to 16|Adverse Event|1|||
19416126|NCT01815424|41662043|FG001|Week 0 to 16|Adverse Event|3|||
19416127|NCT01815424|41662044|FG002|Week 0 to 16|Adverse Event|3|||
19416128|NCT01815424|41662045|FG003|Week 0 to 16|Adverse Event|0|||
19416129|NCT01815424|41662046|FG004|Week 0 to 16|Adverse Event|0|||
19416130|NCT01815424|41662042|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
19416131|NCT01815424|41662043|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
19416132|NCT01815424|41662044|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
19416133|NCT01815424|41662045|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
19416134|NCT01815424|41662046|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
19416135|NCT01815424|41662042|FG000|Week 0 to 16|Lost to Follow-up|0|||
19416136|NCT01815424|41662043|FG001|Week 0 to 16|Lost to Follow-up|1|||
19416137|NCT01815424|41662044|FG002|Week 0 to 16|Lost to Follow-up|0|||
19416138|NCT01815424|41662045|FG003|Week 0 to 16|Lost to Follow-up|0|||
19416139|NCT01815424|41662046|FG004|Week 0 to 16|Lost to Follow-up|0|||
19416140|NCT01815424|41662042|FG000|Week 0 to 16|Withdrawal by Subject|0|||
19416141|NCT01815424|41662043|FG001|Week 0 to 16|Withdrawal by Subject|0|||
19416142|NCT01815424|41662044|FG002|Week 0 to 16|Withdrawal by Subject|1|||
19416143|NCT01815424|41662045|FG003|Week 0 to 16|Withdrawal by Subject|0|||
19416144|NCT01815424|41662046|FG004|Week 0 to 16|Withdrawal by Subject|0|||
19416145|NCT01815424|41662042|FG000|Week 0 to 16|Other|1|||
19416146|NCT01815424|41662043|FG001|Week 0 to 16|Other|0|||
19416147|NCT01815424|41662044|FG002|Week 0 to 16|Other|3|||
19416148|NCT01815424|41662045|FG003|Week 0 to 16|Other|0|||
19416149|NCT01815424|41662046|FG004|Week 0 to 16|Other|0|||
19416150|NCT01815424|41662042|FG000|Week 0 to 16|Protocol Violation|1|||
19416151|NCT01815424|41662043|FG001|Week 0 to 16|Protocol Violation|0|||
19416152|NCT01815424|41662044|FG002|Week 0 to 16|Protocol Violation|0|||
19416153|NCT01815424|41662045|FG003|Week 0 to 16|Protocol Violation|0|||
19416154|NCT01815424|41662046|FG004|Week 0 to 16|Protocol Violation|0|||
19416155|NCT01815424|41662042|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
19416156|NCT01815424|41662043|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
19416157|NCT01815424|41662044|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
19416158|NCT01815424|41662045|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
19416159|NCT01815424|41662046|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
19416160|NCT01815424|41662042|FG000|Week 16 to 52|Other|0|||
19416161|NCT01815424|41662043|FG001|Week 16 to 52|Other|1|||
19416162|NCT01815424|41662044|FG002|Week 16 to 52|Other|0|||
19416163|NCT01815424|41662045|FG003|Week 16 to 52|Other|0|||
19416164|NCT01815424|41662046|FG004|Week 16 to 52|Other|0|||
19416165|NCT01815424|41662042|FG000|Week 16 to 52|Adverse Event|0|||
19416166|NCT01815424|41662043|FG001|Week 16 to 52|Adverse Event|0|||
19416167|NCT01815424|41662044|FG002|Week 16 to 52|Adverse Event|0|||
19416168|NCT01815424|41662045|FG003|Week 16 to 52|Adverse Event|0|||
19416169|NCT01815424|41662046|FG004|Week 16 to 52|Adverse Event|1|||
19416170|NCT01815424|41662042|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
19416171|NCT01815424|41662043|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
19416172|NCT01815424|41662044|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
19416173|NCT01815424|41662045|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
19416174|NCT01815424|41662046|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
19416175|NCT01815424|41662042|FG000|Week 16 to 52|Lost to Follow-up|0|||
19416176|NCT01815424|41662043|FG001|Week 16 to 52|Lost to Follow-up|2|||
19416177|NCT01815424|41662044|FG002|Week 16 to 52|Lost to Follow-up|0|||
19416178|NCT01815424|41662045|FG003|Week 16 to 52|Lost to Follow-up|2|||
19416179|NCT01815424|41662046|FG004|Week 16 to 52|Lost to Follow-up|1|||
19416180|NCT01815424|41662042|FG000|Week 16 to 52|Withdrawal by Subject|1|||
19628111|NCT00789555|42077508|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
19628112|NCT00789555|42077506|FG000|Overall Study|Treatment failure|11|||
19416181|NCT01815424|41662043|FG001|Week 16 to 52|Withdrawal by Subject|2|||
19416182|NCT01815424|41662044|FG002|Week 16 to 52|Withdrawal by Subject|0|||
19416183|NCT01815424|41662045|FG003|Week 16 to 52|Withdrawal by Subject|0|||
19416184|NCT01815424|41662046|FG004|Week 16 to 52|Withdrawal by Subject|0|||
19416185|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
19416186|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
19416187|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
19416188|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
19416189|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
19416190|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
19416191|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
19416192|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
19416193|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
19416194|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
19416195|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
19416196|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
19416197|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
19416198|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
19416199|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
19416200|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
19416201|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
19416202|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
19416203|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
19416204|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
19416205|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
19416206|NCT02431247|41662061|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
19416207|NCT02431247|41662062|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
19416208|NCT02431247|41662063|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
19416209|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
19416210|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
19416211|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
19416212|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
19416213|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
19416214|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
19416215|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
19416216|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
19416217|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
19416218|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
19416219|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
19416220|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
19416221|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
19416222|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
19416223|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
19416224|NCT02431247|41662061|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
19416225|NCT02431247|41662062|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
19416226|NCT02431247|41662063|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
19416227|NCT01814878|41662077|FG000|Overall Study|Adverse Event|16|||
19416228|NCT01814878|41662078|FG001|Overall Study|Adverse Event|5|||
19416229|NCT01814878|41662077|FG000|Overall Study|Withdrawal by Subject|20|||
19416230|NCT01814878|41662078|FG001|Overall Study|Withdrawal by Subject|16|||
19416231|NCT01814878|41662077|FG000|Overall Study|Protocol Violation|5|||
19416232|NCT01814878|41662078|FG001|Overall Study|Protocol Violation|5|||
19416233|NCT01814878|41662077|FG000|Overall Study|Physician Decision|3|||
19416234|NCT01814878|41662078|FG001|Overall Study|Physician Decision|1|||
19416235|NCT01814878|41662077|FG000|Overall Study|Screening failure (drop-out)|0|||
19416236|NCT01814878|41662078|FG001|Overall Study|Screening failure (drop-out)|3|||
19416237|NCT01814878|41662077|FG000|Overall Study|Other|2|||
19416238|NCT01814878|41662078|FG001|Overall Study|Other|0|||
19416239|NCT02407457|41662086|FG000|1 Month|Death|3|||
19416240|NCT02407457|41662087|FG001|1 Month|Death|0|||
19416241|NCT02407457|41662086|FG000|1 Month|Lost to Follow-up|1|||
19416242|NCT02407457|41662087|FG001|1 Month|Lost to Follow-up|1|||
19416243|NCT02407457|41662086|FG000|1 Month|missed visit|2|||
19416244|NCT02407457|41662087|FG001|1 Month|missed visit|6|||
19416245|NCT02407457|41662086|FG000|6-Month|Death|2|||
19416246|NCT02407457|41662087|FG001|6-Month|Death|8|||
19416247|NCT02407457|41662086|FG000|6-Month|Lost to Follow-up|2|||
19416248|NCT02407457|41662087|FG001|6-Month|Lost to Follow-up|2|||
19416249|NCT02407457|41662086|FG000|6-Month|missed visit|15|||
19416250|NCT02407457|41662087|FG001|6-Month|missed visit|12|||
19416251|NCT02407457|41662086|FG000|6-Month|Over Due|1|||
19416252|NCT02407457|41662087|FG001|6-Month|Over Due|2|||
19416253|NCT02407457|41662086|FG000|6-Month|Open Repair|0|||
19416254|NCT02407457|41662087|FG001|6-Month|Open Repair|1|||
19416255|NCT02407457|41662086|FG000|1 Year|Death|6|||
19416256|NCT02407457|41662087|FG001|1 Year|Death|11|||
19416257|NCT02407457|41662086|FG000|1 Year|Lost to Follow-up|3|||
19416258|NCT02407457|41662087|FG001|1 Year|Lost to Follow-up|2|||
19416259|NCT02407457|41662086|FG000|1 Year|Missed Visit|18|||
19416260|NCT02407457|41662087|FG001|1 Year|Missed Visit|10|||
19416261|NCT02407457|41662086|FG000|1 Year|Over Due|6|||
19416262|NCT02407457|41662087|FG001|1 Year|Over Due|4|||
19416263|NCT02407457|41662086|FG000|1 Year|Open Repair|0|||
19416264|NCT02407457|41662087|FG001|1 Year|Open Repair|1|||
19416265|NCT02407457|41662086|FG000|2-year|Death|14|||
19416266|NCT02407457|41662087|FG001|2-year|Death|8|||
19416267|NCT02407457|41662086|FG000|2-year|Lost to Follow-up|6|||
19416268|NCT02407457|41662087|FG001|2-year|Lost to Follow-up|9|||
19416269|NCT02407457|41662086|FG000|2-year|Missed Visit|13|||
19416270|NCT02407457|41662087|FG001|2-year|Missed Visit|11|||
19416271|NCT02407457|41662086|FG000|2-year|Over Due|1|||
19416272|NCT02407457|41662087|FG001|2-year|Over Due|5|||
19416273|NCT02407457|41662086|FG000|2-year|Open Repair|0|||
19416274|NCT02407457|41662087|FG001|2-year|Open Repair|2|||
19416275|NCT02407457|41662086|FG000|3-year|Death|11|||
19416276|NCT02407457|41662087|FG001|3-year|Death|10|||
19416277|NCT02407457|41662086|FG000|3-year|Lost to Follow-up|6|||
19416278|NCT02407457|41662087|FG001|3-year|Lost to Follow-up|9|||
19416279|NCT02407457|41662086|FG000|3-year|Missed Visit|21|||
19416280|NCT02407457|41662087|FG001|3-year|Missed Visit|16|||
19416281|NCT02407457|41662086|FG000|3-year|Over Due|4|||
19416282|NCT02407457|41662087|FG001|3-year|Over Due|3|||
19416283|NCT02407457|41662086|FG000|4-year|Death|14|||
19416284|NCT02407457|41662087|FG001|4-year|Death|7|||
19416285|NCT02407457|41662086|FG000|4-year|Lost to Follow-up|9|||
19416286|NCT02407457|41662087|FG001|4-year|Lost to Follow-up|12|||
19416287|NCT02407457|41662086|FG000|4-year|Over Due|10|||
19416288|NCT02407457|41662087|FG001|4-year|Over Due|5|||
19416289|NCT02407457|41662086|FG000|4-year|Missed Visit|13|||
19416290|NCT02407457|41662087|FG001|4-year|Missed Visit|13|||
19416291|NCT02407457|41662086|FG000|4-year|Pending visit|19|||
19416292|NCT02407457|41662087|FG001|4-year|Pending visit|14|||
19416293|NCT02407457|41662086|FG000|4-year|Not Due|16|||
19416294|NCT02407457|41662087|FG001|4-year|Not Due|10|||
19416295|NCT02407457|41662086|FG000|5-year|Death|6|||
19416296|NCT02407457|41662087|FG001|5-year|Death|1|||
19416297|NCT02407457|41662086|FG000|5-year|Lost to Follow-up|4|||
19416298|NCT02407457|41662087|FG001|5-year|Lost to Follow-up|4|||
19416299|NCT02407457|41662086|FG000|5-year|Missed Visit|10|||
19416300|NCT02407457|41662087|FG001|5-year|Missed Visit|9|||
19416301|NCT02407457|41662086|FG000|5-year|Pending Visit|18|||
19416302|NCT02407457|41662087|FG001|5-year|Pending Visit|17|||
19416303|NCT02407457|41662086|FG000|5-year|Not Due|54|||
19416304|NCT02407457|41662087|FG001|5-year|Not Due|46|||
19416305|NCT01814800|41662093|FG000|Overall Study|Adverse Event|2|||
19416306|NCT01814800|41662093|FG000|Overall Study|Pregnancy|1|||
19416307|NCT01814800|41662093|FG000|Overall Study|Sponsor decision|1|||
19416308|NCT01814800|41662093|FG000|Overall Study|Subject relocation|1|||
19416309|NCT01814332|41662099|FG000|Overall Study|Adverse Event|8|||
19416310|NCT01814332|41662100|FG001|Overall Study|Adverse Event|3|||
19416311|NCT01814332|41662099|FG000|Overall Study|Withdrawal by Subject|3|||
19519350|NCT01474512|41932295|FG003|Maintenance Period|Lack of Efficacy|1|||
19519351|NCT01474512|41932296|FG004|Maintenance Period|Lack of Efficacy|0|||
19519352|NCT01474512|41932297|FG005|Maintenance Period|Lack of Efficacy|0|||
19519353|NCT01474512|41932298|FG006|Maintenance Period|Lack of Efficacy|0|||
19519354|NCT01474512|41932299|FG007|Maintenance Period|Lack of Efficacy|11|||
19519355|NCT01474512|41932300|FG008|Maintenance Period|Lack of Efficacy|11|||
19519356|NCT01474512|41932301|FG009|Maintenance Period|Lack of Efficacy|12|||
19519357|NCT01474512|41932302|FG010|Maintenance Period|Lack of Efficacy|0|||
19519358|NCT01474512|41932303|FG011|Maintenance Period|Lack of Efficacy|0|||
19519359|NCT01474512|41932304|FG012|Maintenance Period|Lack of Efficacy|0|||
19519360|NCT01474512|41932305|FG013|Maintenance Period|Lack of Efficacy|0|||
19519361|NCT01474512|41932306|FG014|Maintenance Period|Lack of Efficacy|0|||
19519362|NCT01474512|41932307|FG015|Maintenance Period|Lack of Efficacy|0|||
19519363|NCT01474512|41932308|FG016|Maintenance Period|Lack of Efficacy|0|||
19519364|NCT01474512|41932309|FG017|Maintenance Period|Lack of Efficacy|0|||
19519365|NCT01474512|41932292|FG000|Maintenance Period|Protocol Violation|0|||
19519366|NCT01474512|41932293|FG001|Maintenance Period|Protocol Violation|0|||
19519367|NCT01474512|41932294|FG002|Maintenance Period|Protocol Violation|0|||
19519368|NCT01474512|41932295|FG003|Maintenance Period|Protocol Violation|1|||
19519369|NCT01474512|41932296|FG004|Maintenance Period|Protocol Violation|0|||
19519370|NCT01474512|41932297|FG005|Maintenance Period|Protocol Violation|0|||
19519371|NCT01474512|41932298|FG006|Maintenance Period|Protocol Violation|0|||
19519372|NCT01474512|41932299|FG007|Maintenance Period|Protocol Violation|1|||
19519373|NCT01474512|41932300|FG008|Maintenance Period|Protocol Violation|0|||
19416312|NCT01814332|41662100|FG001|Overall Study|Withdrawal by Subject|8|||
19416313|NCT01814332|41662099|FG000|Overall Study|Protocol Violation|0|||
19416314|NCT01814332|41662100|FG001|Overall Study|Protocol Violation|4|||
19416315|NCT01814332|41662099|FG000|Overall Study|Lost to Follow-up|5|||
19416316|NCT01814332|41662100|FG001|Overall Study|Lost to Follow-up|1|||
19416317|NCT02407223|41662109|FG000|Overall Study|Adverse Event|1|||
19416318|NCT02407223|41662110|FG001|Overall Study|Adverse Event|0|||
19416319|NCT02407223|41662111|FG002|Overall Study|Adverse Event|1|||
19416320|NCT02407223|41662109|FG000|Overall Study|Lack of Efficacy|6|||
19416321|NCT02407223|41662110|FG001|Overall Study|Lack of Efficacy|6|||
19416322|NCT02407223|41662111|FG002|Overall Study|Lack of Efficacy|4|||
19416323|NCT02407223|41662109|FG000|Overall Study|Lost to Follow-up|1|||
19416324|NCT02407223|41662110|FG001|Overall Study|Lost to Follow-up|0|||
19416325|NCT02407223|41662111|FG002|Overall Study|Lost to Follow-up|2|||
19416326|NCT02407223|41662109|FG000|Overall Study|Withdrawal by Subject|2|||
19416327|NCT02407223|41662110|FG001|Overall Study|Withdrawal by Subject|4|||
19416328|NCT02407223|41662111|FG002|Overall Study|Withdrawal by Subject|4|||
19416329|NCT02407223|41662109|FG000|Overall Study|Study Terminated by Sponsor|77|||
19416330|NCT02407223|41662110|FG001|Overall Study|Study Terminated by Sponsor|80|||
19416331|NCT02407223|41662111|FG002|Overall Study|Study Terminated by Sponsor|86|||
19416332|NCT02407223|41662109|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
19416333|NCT02407223|41662110|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
19416334|NCT02407223|41662111|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
19416335|NCT02407223|41662109|FG000|Overall Study|Other|29|||
19416336|NCT02407223|41662110|FG001|Overall Study|Other|27|||
19416337|NCT02407223|41662111|FG002|Overall Study|Other|25|||
19416338|NCT01797562|41662121|FG000|Overall Study|Protocol Violation|5|||
19416339|NCT01813474|41662129|FG000|Overall Study|Withdrawal by Subject|0|||
19416340|NCT01813474|41662130|FG001|Overall Study|Withdrawal by Subject|0|||
19416341|NCT01813474|41662131|FG002|Overall Study|Withdrawal by Subject|1|||
19416342|NCT01813474|41662129|FG000|Overall Study|Adverse Event|1|||
19416343|NCT01813474|41662130|FG001|Overall Study|Adverse Event|1|||
19416344|NCT01813474|41662131|FG002|Overall Study|Adverse Event|0|||
19416345|NCT01813474|41662129|FG000|Overall Study|Lack of Efficacy|2|||
19416346|NCT01813474|41662130|FG001|Overall Study|Lack of Efficacy|6|||
19416347|NCT01813474|41662131|FG002|Overall Study|Lack of Efficacy|9|||
19416348|NCT01813474|41662129|FG000|Overall Study|Death|0|||
19416349|NCT01813474|41662130|FG001|Overall Study|Death|0|||
19416350|NCT01813474|41662131|FG002|Overall Study|Death|1|||
19416351|NCT01868542|41662142|FG000|Overall Study|Protocol Violation|0|||
19416352|NCT01868542|41662143|FG001|Overall Study|Protocol Violation|1|||
19416353|NCT01868542|41662142|FG000|Overall Study|Unclassified|0|||
19416354|NCT01868542|41662143|FG001|Overall Study|Unclassified|1|||
19416355|NCT01797094|41662151|FG000|Overall Study|Adverse Event|1|||
19416356|NCT01797094|41662152|FG001|Overall Study|Adverse Event|1|||
19416357|NCT01797094|41662151|FG000|Overall Study|Personal Reasons|4|||
19416358|NCT01797094|41662152|FG001|Overall Study|Personal Reasons|0|||
19416359|NCT01797094|41662151|FG000|Overall Study|Protocol Violation|0|||
19416360|NCT01797094|41662152|FG001|Overall Study|Protocol Violation|1|||
19416361|NCT01797094|41662151|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19416362|NCT01797094|41662152|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19416363|NCT02383589|41662160|FG000|Treatment Period|Adverse Event|1|||
19416364|NCT02383589|41662161|FG001|Treatment Period|Adverse Event|3|||
19416365|NCT02383589|41662160|FG000|Treatment Period|Lost to Follow-up|0|||
19416366|NCT02383589|41662161|FG001|Treatment Period|Lost to Follow-up|1|||
19416367|NCT02383589|41662160|FG000|Treatment Period|Withdrawal by Subject|0|||
19416368|NCT02383589|41662161|FG001|Treatment Period|Withdrawal by Subject|5|||
19416369|NCT02383589|41662160|FG000|Treatment Period|Non-compliance with study drug|0|||
19416370|NCT02383589|41662161|FG001|Treatment Period|Non-compliance with study drug|1|||
19416371|NCT02383589|41662160|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
19416372|NCT02383589|41662161|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
19416373|NCT02383589|41662160|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
19416374|NCT02383589|41662161|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
19416375|NCT02383589|41662160|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
19416376|NCT02383589|41662161|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
19416377|NCT01810432|41662169|FG000|Washout|Protocol Violation|0|||
19416378|NCT01810432|41662170|FG001|Washout|Protocol Violation|1|||
19416379|NCT01810432|41662169|FG000|Washout|Adverse Event|1|||
19416380|NCT01810432|41662170|FG001|Washout|Adverse Event|0|||
19416381|NCT01810432|41662169|FG000|Period 2|Withdrawal by Subject|2|||
19416382|NCT01810432|41662170|FG001|Period 2|Withdrawal by Subject|1|||
19416383|NCT01810432|41662169|FG000|Period 2|Physician Decision|1|||
19416384|NCT01810432|41662170|FG001|Period 2|Physician Decision|0|||
19416385|NCT01810432|41662169|FG000|Period 2|Lost to Follow-up|1|||
19416386|NCT01810432|41662170|FG001|Period 2|Lost to Follow-up|1|||
19416387|NCT01796860|41662176|FG000|Overall Study|Withdrawal by Subject|3|||
19416388|NCT01796548|41662180|FG000|Overall Study|Lost to Follow-up|1|||
19416389|NCT01796548|41662180|FG000|Overall Study|Other|2|||
19416390|NCT02406677|41662186|FG000|Overall Study|Death|16|||
19416391|NCT02406677|41662187|FG001|Overall Study|Death|8|||
19416392|NCT02406677|41662186|FG000|Overall Study|Discharged without P2Y12|1|||
19416393|NCT02406677|41662187|FG001|Overall Study|Discharged without P2Y12|3|||
19416394|NCT02406677|41662186|FG000|Overall Study|Discharged on prasugrel|283|||
19416395|NCT02406677|41662187|FG001|Overall Study|Discharged on prasugrel|587|||
19416396|NCT02406677|41662186|FG000|Overall Study|Withdrawal by Subject|1|||
19416397|NCT02406677|41662187|FG001|Overall Study|Withdrawal by Subject|0|||
19416398|NCT02404805|41662203|FG000|Overall Study|Withdrawal by Subject|1|||
19416399|NCT02404805|41662204|FG001|Overall Study|Withdrawal by Subject|0|||
19416400|NCT02404805|41662205|FG002|Overall Study|Withdrawal by Subject|0|||
19416401|NCT02404805|41662206|FG003|Overall Study|Withdrawal by Subject|0|||
19416402|NCT02404805|41662207|FG004|Overall Study|Withdrawal by Subject|0|||
19416403|NCT02404805|41662208|FG005|Overall Study|Withdrawal by Subject|0|||
19416404|NCT02430311|41662219|FG000|Part A|Adverse Event|0|||
19416405|NCT02430311|41662220|FG001|Part A|Adverse Event|1|||
19416406|NCT02430311|41662219|FG000|Part A|Withdrawal by Subject|1|||
19416407|NCT02430311|41662220|FG001|Part A|Withdrawal by Subject|0|||
19416408|NCT02430311|41662219|FG000|Part B|Meet study-specific withdrawal criteria|6|||
19416409|NCT02430311|41662220|FG001|Part B|Meet study-specific withdrawal criteria|6|||
19416410|NCT02430311|41662219|FG000|Part B|Withdrawal by Subject|2|||
19416411|NCT02430311|41662220|FG001|Part B|Withdrawal by Subject|2|||
19416412|NCT02430311|41662219|FG000|Part B|Adverse Event|1|||
19416413|NCT02430311|41662220|FG001|Part B|Adverse Event|0|||
19416414|NCT02430311|41662219|FG000|Part B|Death|1|||
19416415|NCT02430311|41662220|FG001|Part B|Death|0|||
19416416|NCT02383433|41662235|FG000|Overall Study|Disease progression|2|||
19416417|NCT02404649|41662241|FG000|Overall Study|Adverse Event|1|||
19416418|NCT02404649|41662242|FG001|Overall Study|Adverse Event|2|||
19416419|NCT02383355|41662250|FG000|Overall Study|Adverse Event|2|||
19416420|NCT02383355|41662251|FG001|Overall Study|Adverse Event|0|||
19416421|NCT02381795|41662257|FG000|Overall Study|Withdrawal by Subject|1|||
19416422|NCT02381795|41662257|FG000|Overall Study|Study Terminated|2|||
19416423|NCT02404493|41662263|FG000|Overall Study|Adverse Event|1|||
19416424|NCT02404493|41662264|FG001|Overall Study|Adverse Event|1|||
19416425|NCT02380859|41662272|FG000|Overall Study|Withdrawal by Subject|2|||
19416426|NCT02380859|41662273|FG001|Overall Study|Withdrawal by Subject|0|||
19416427|NCT02380703|41662281|FG000|Overall Study|Withdrawal by Subject|12|||
19416428|NCT02380703|41662282|FG001|Overall Study|Withdrawal by Subject|9|||
19416429|NCT02380703|41662281|FG000|Overall Study|Lost to Follow-up|12|||
19416430|NCT02380703|41662282|FG001|Overall Study|Lost to Follow-up|12|||
19416431|NCT02380703|41662281|FG000|Overall Study|Caregiver death|1|||
19416432|NCT02380703|41662282|FG001|Overall Study|Caregiver death|0|||
19416433|NCT02380703|41662281|FG000|Overall Study|Person with dementia (PWD) death|7|||
19416434|NCT02380703|41662282|FG001|Overall Study|Person with dementia (PWD) death|8|||
19416435|NCT02380703|41662281|FG000|Overall Study|Entered Long-term Care|4|||
19416436|NCT02380703|41662282|FG001|Overall Study|Entered Long-term Care|7|||
19416437|NCT02379923|41662288|FG000|Overall Study|Death|5|||
19416438|NCT02379221|41662295|FG000|Overall Study|Lost to Follow-up|1|||
19416439|NCT02404103|41662306|FG000|Overall Study|Adverse Event|1|||
19416440|NCT02404103|41662307|FG001|Overall Study|Adverse Event|0|||
19416441|NCT02404103|41662306|FG000|Overall Study|Lost to Follow-up|3|||
19416442|NCT02404103|41662307|FG001|Overall Study|Lost to Follow-up|3|||
19416443|NCT02404025|41662323|FG000|Overall Study|Adverse Event|1|||
19416444|NCT02404025|41662323|FG000|Overall Study|Lack of Efficacy|3|||
19416445|NCT02377817|41662329|FG000|Overall Study|Transportation/childcare barriers.|2|||
19416446|NCT02377817|41662330|FG001|Overall Study|Transportation/childcare barriers.|0|||
19416447|NCT02377817|41662329|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
19416448|NCT02377817|41662330|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
19416449|NCT02403635|41662338|FG000|Overall Study|Not eligible|9|||
19416450|NCT02402933|41662358|FG000|Overall Study|Withdrawal by Subject|4|||
19416451|NCT02402933|41662358|FG000|Overall Study|Discontinued; Site Termination|10|||
19416452|NCT01796470|41662367|FG000|Overall Study|Adverse Event|4|||
19416453|NCT01796470|41662368|FG001|Overall Study|Adverse Event|2|||
19416454|NCT01796470|41662369|FG002|Overall Study|Adverse Event|2|||
19416455|NCT01796470|41662370|FG003|Overall Study|Adverse Event|1|||
19416456|NCT01796470|41662371|FG004|Overall Study|Adverse Event|3|||
19416457|NCT01796470|41662367|FG000|Overall Study|Death|2|||
19416458|NCT01796470|41662368|FG001|Overall Study|Death|0|||
19416459|NCT01796470|41662369|FG002|Overall Study|Death|0|||
19416460|NCT01796470|41662370|FG003|Overall Study|Death|0|||
19416461|NCT01796470|41662371|FG004|Overall Study|Death|1|||
19416462|NCT01796470|41662367|FG000|Overall Study|Initiated New Therapy|9|||
19416463|NCT01796470|41662368|FG001|Overall Study|Initiated New Therapy|0|||
19416464|NCT01796470|41662369|FG002|Overall Study|Initiated New Therapy|0|||
19416465|NCT01796470|41662370|FG003|Overall Study|Initiated New Therapy|0|||
19416466|NCT01796470|41662371|FG004|Overall Study|Initiated New Therapy|2|||
19416467|NCT01796470|41662367|FG000|Overall Study|Lost to Follow-up|0|||
19416468|NCT01796470|41662368|FG001|Overall Study|Lost to Follow-up|1|||
19416469|NCT01796470|41662369|FG002|Overall Study|Lost to Follow-up|0|||
19416470|NCT01796470|41662370|FG003|Overall Study|Lost to Follow-up|0|||
19416471|NCT01796470|41662371|FG004|Overall Study|Lost to Follow-up|0|||
19416472|NCT01796470|41662367|FG000|Overall Study|Physician Decision|5|||
19416473|NCT01796470|41662368|FG001|Overall Study|Physician Decision|4|||
19416474|NCT01796470|41662369|FG002|Overall Study|Physician Decision|1|||
19416475|NCT01796470|41662370|FG003|Overall Study|Physician Decision|0|||
19416476|NCT01796470|41662371|FG004|Overall Study|Physician Decision|1|||
19416477|NCT01796470|41662367|FG000|Overall Study|Progressive Disease|7|||
19416478|NCT01796470|41662368|FG001|Overall Study|Progressive Disease|7|||
19416479|NCT01796470|41662369|FG002|Overall Study|Progressive Disease|3|||
19416480|NCT01796470|41662370|FG003|Overall Study|Progressive Disease|2|||
19416481|NCT01796470|41662371|FG004|Overall Study|Progressive Disease|0|||
19416482|NCT01796470|41662367|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
19416483|NCT01796470|41662368|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
19416484|NCT01796470|41662369|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
19416485|NCT01796470|41662370|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
19416486|NCT01796470|41662371|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
19416487|NCT01796470|41662367|FG000|Overall Study|Withdrawal by Subject|7|||
19416488|NCT01796470|41662368|FG001|Overall Study|Withdrawal by Subject|0|||
19416489|NCT01796470|41662369|FG002|Overall Study|Withdrawal by Subject|0|||
19416490|NCT01796470|41662370|FG003|Overall Study|Withdrawal by Subject|0|||
19416491|NCT01796470|41662371|FG004|Overall Study|Withdrawal by Subject|1|||
19416492|NCT01796392|41662389|FG000|Overall Study|Withdrawal by Subject|2|||
19416493|NCT01796392|41662390|FG001|Overall Study|Withdrawal by Subject|0|||
19416494|NCT01796392|41662389|FG000|Overall Study|Death|5|||
19416495|NCT01796392|41662390|FG001|Overall Study|Death|1|||
19416496|NCT01796392|41662389|FG000|Overall Study|Excluded for medical reasons|1|||
19416497|NCT01796392|41662390|FG001|Overall Study|Excluded for medical reasons|2|||
19416498|NCT01796392|41662389|FG000|Overall Study|Lost to Follow-up|1|||
19416499|NCT01796392|41662390|FG001|Overall Study|Lost to Follow-up|0|||
19416500|NCT01868074|41662398|FG000|Overall Study|Lost to Follow-up|3|||
19416501|NCT01868074|41662399|FG001|Overall Study|Lost to Follow-up|2|||
19416502|NCT01868074|41662398|FG000|Overall Study|Withdrawal by Subject|4|||
19416503|NCT01868074|41662399|FG001|Overall Study|Withdrawal by Subject|2|||
19416504|NCT01810042|41662405|FG000|Overall Study|Lost to Follow-up|10|||
19416505|NCT02424539|41662412|FG000|Overall Study|Adverse Event|0|||
19416506|NCT02424539|41662413|FG001|Overall Study|Adverse Event|0|||
19416507|NCT02424539|41662414|FG002|Overall Study|Adverse Event|1|||
19416508|NCT02424539|41662412|FG000|Overall Study|Physician Decision|0|||
19416509|NCT02424539|41662413|FG001|Overall Study|Physician Decision|0|||
19416510|NCT02424539|41662414|FG002|Overall Study|Physician Decision|1|||
19416511|NCT02424539|41662412|FG000|Overall Study|Withdrawal by Subject|3|||
19416512|NCT02424539|41662413|FG001|Overall Study|Withdrawal by Subject|1|||
19416513|NCT02424539|41662414|FG002|Overall Study|Withdrawal by Subject|0|||
19416514|NCT02424539|41662412|FG000|Overall Study|Other: Reached stopping criteria|11|||
19416515|NCT02424539|41662413|FG001|Overall Study|Other: Reached stopping criteria|7|||
19416516|NCT02424539|41662414|FG002|Overall Study|Other: Reached stopping criteria|6|||
19416517|NCT01809262|41662422|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416518|NCT01809262|41662423|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416519|NCT01809262|41662424|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416520|NCT01809262|41662425|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416521|NCT01809262|41662426|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
19416522|NCT01809262|41662427|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416523|NCT01809262|41662428|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416524|NCT01809262|41662429|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416525|NCT01809262|41662430|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416526|NCT01809262|41662431|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
19416527|NCT01809262|41662422|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416528|NCT01809262|41662423|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
19416529|NCT01809262|41662424|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416530|NCT01809262|41662425|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416531|NCT01809262|41662426|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416532|NCT01809262|41662427|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416533|NCT01809262|41662428|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416534|NCT01809262|41662429|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416535|NCT01809262|41662430|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416536|NCT01809262|41662431|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
19416537|NCT01808248|41662445|FG000|Overall Study|Lack of Efficacy|3|||
19416538|NCT01808248|41662445|FG000|Overall Study|Withdrawal by Subject|1|||
19416539|NCT01808248|41662445|FG000|Overall Study|Lost to Follow-up|1|||
19416540|NCT02424383|41662451|FG000|Overall Study|Withdrawal by Subject|32|||
19416541|NCT02424383|41662451|FG000|Overall Study|Death|170|||
19628113|NCT00789555|42077507|FG001|Overall Study|Treatment failure|8|||
19628114|NCT00789555|42077508|FG002|Overall Study|Treatment failure|12|||
19416542|NCT02424383|41662451|FG000|Overall Study|Sponsor's decision|3|||
19416543|NCT02424383|41662451|FG000|Overall Study|Investigator's decision|44|||
19416544|NCT02424383|41662451|FG000|Overall Study|Lost to Follow-up|81|||
19416545|NCT02424383|41662451|FG000|Overall Study|Other|7|||
19416546|NCT02424383|41662451|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
19416547|NCT01867294|41662459|FG000|Overall Study|Withdrawal by Subject|1|||
19416548|NCT01867294|41662460|FG001|Overall Study|Withdrawal by Subject|1|||
19416549|NCT01867294|41662461|FG002|Overall Study|Withdrawal by Subject|0|||
19416550|NCT01867294|41662462|FG003|Overall Study|Withdrawal by Subject|0|||
19416551|NCT02424149|41662472|FG000|Overall Study|surgery cancelled|2|||
19416552|NCT02424149|41662473|FG001|Overall Study|surgery cancelled|0|||
19416553|NCT02424149|41662472|FG000|Overall Study|Withdrawal by Subject|0|||
19416554|NCT02424149|41662473|FG001|Overall Study|Withdrawal by Subject|1|||
19416555|NCT02423291|41662479|FG000|Overall Study|Lack of Efficacy|14|||
19416556|NCT02423291|41662479|FG000|Overall Study|Adverse Event|1|||
19416557|NCT02401529|41662485|FG000|Overall Study|Lost to Follow-up|2|||
19416558|NCT02401529|41662486|FG001|Overall Study|Lost to Follow-up|1|||
19416559|NCT02401529|41662485|FG000|Overall Study|Physician Decision|2|||
19416560|NCT02401529|41662486|FG001|Overall Study|Physician Decision|6|||
19416561|NCT02401529|41662485|FG000|Overall Study|Protocol Violation|5|||
19416562|NCT02401529|41662486|FG001|Overall Study|Protocol Violation|0|||
19416563|NCT01867216|41662500|FG000|Overall Study|Withdrawal by Subject|2|||
19416564|NCT01867216|41662501|FG001|Overall Study|Withdrawal by Subject|0|||
19416565|NCT01867216|41662502|FG002|Overall Study|Withdrawal by Subject|0|||
19416566|NCT01867216|41662503|FG003|Overall Study|Withdrawal by Subject|0|||
19416567|NCT01867216|41662504|FG004|Overall Study|Withdrawal by Subject|1|||
19416568|NCT01867216|41662505|FG005|Overall Study|Withdrawal by Subject|0|||
19416569|NCT01867216|41662506|FG006|Overall Study|Withdrawal by Subject|1|||
19416570|NCT01867216|41662500|FG000|Overall Study|Physician Decision|1|||
19416571|NCT01867216|41662501|FG001|Overall Study|Physician Decision|0|||
19416572|NCT01867216|41662502|FG002|Overall Study|Physician Decision|0|||
19416573|NCT01867216|41662503|FG003|Overall Study|Physician Decision|0|||
19416574|NCT01867216|41662504|FG004|Overall Study|Physician Decision|0|||
19416575|NCT01867216|41662505|FG005|Overall Study|Physician Decision|0|||
19416576|NCT01867216|41662506|FG006|Overall Study|Physician Decision|0|||
19416577|NCT01867216|41662500|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
19416578|NCT01867216|41662501|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416579|NCT01867216|41662502|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416580|NCT01867216|41662503|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416581|NCT01867216|41662504|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416582|NCT01867216|41662505|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416583|NCT01867216|41662506|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
19416584|NCT01866826|41662528|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
19416585|NCT01866826|41662529|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
19416586|NCT01866826|41662528|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
19416587|NCT01866826|41662529|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
19416588|NCT01866826|41662528|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
19416589|NCT01866826|41662529|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
19416590|NCT01791244|41662546|FG000|Overall Study|Adverse Event|5|||
19416591|NCT01791244|41662547|FG001|Overall Study|Adverse Event|7|||
19416592|NCT01791244|41662546|FG000|Overall Study|Insufficient clinical response|10|||
19416593|NCT01791244|41662547|FG001|Overall Study|Insufficient clinical response|10|||
19416594|NCT01791244|41662546|FG000|Overall Study|Laboratory Abnormality|0|||
19416595|NCT01791244|41662547|FG001|Overall Study|Laboratory Abnormality|1|||
19416596|NCT01865812|41662555|FG000|Primary Treatment Phase|Adverse Event|2|||
19416597|NCT01865812|41662556|FG001|Primary Treatment Phase|Adverse Event|0|||
19416598|NCT01865812|41662555|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
19416599|NCT01865812|41662556|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
19416600|NCT01865812|41662555|FG000|Long-term Safety Extension Phase|Pruritus|0|||
19416601|NCT01865812|41662556|FG001|Long-term Safety Extension Phase|Pruritus|3|||
19416602|NCT01865812|41662555|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
19416603|NCT01865812|41662556|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
19416604|NCT01865812|41662555|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
19416605|NCT01865812|41662556|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
19416606|NCT01808092|41662565|FG000|Overall Study|Death|39|||
19416607|NCT01808092|41662566|FG001|Overall Study|Death|29|||
19416608|NCT01808092|41662565|FG000|Overall Study|Lost to Follow-up|3|||
19416609|NCT01808092|41662566|FG001|Overall Study|Lost to Follow-up|7|||
19416610|NCT01808092|41662565|FG000|Overall Study|Withdrawal by Subject|9|||
19416611|NCT01808092|41662566|FG001|Overall Study|Withdrawal by Subject|4|||
19416612|NCT01808092|41662565|FG000|Overall Study|Other Eligibility criteria|3|||
19416613|NCT01808092|41662566|FG001|Overall Study|Other Eligibility criteria|5|||
19416614|NCT01774084|41662574|FG000|Overall Study|Personal reasons|1|||
19416615|NCT01774084|41662575|FG001|Overall Study|Personal reasons|0|||
19416616|NCT01807234|41662587|FG000|Overall Study|Lost to Follow-up|2|||
19416617|NCT01807234|41662588|FG001|Overall Study|Lost to Follow-up|5|||
19628115|NCT00789555|42077506|FG000|Overall Study|Protocol Violation|6|||
19416618|NCT01807234|41662589|FG002|Overall Study|Lost to Follow-up|1|||
19416619|NCT01807234|41662590|FG003|Overall Study|Lost to Follow-up|1|||
19416620|NCT01807234|41662591|FG004|Overall Study|Lost to Follow-up|1|||
19416621|NCT01807234|41662592|FG005|Overall Study|Lost to Follow-up|2|||
19416622|NCT01807234|41662587|FG000|Overall Study|Withdrawal by Subject|3|||
19416623|NCT01807234|41662588|FG001|Overall Study|Withdrawal by Subject|1|||
19416624|NCT01807234|41662589|FG002|Overall Study|Withdrawal by Subject|1|||
19416625|NCT01807234|41662590|FG003|Overall Study|Withdrawal by Subject|1|||
19416626|NCT01807234|41662591|FG004|Overall Study|Withdrawal by Subject|2|||
19416627|NCT01807234|41662592|FG005|Overall Study|Withdrawal by Subject|1|||
19416628|NCT01807234|41662587|FG000|Overall Study|Lack of Efficacy|0|||
19416629|NCT01807234|41662588|FG001|Overall Study|Lack of Efficacy|0|||
19416630|NCT01807234|41662589|FG002|Overall Study|Lack of Efficacy|0|||
19416631|NCT01807234|41662590|FG003|Overall Study|Lack of Efficacy|0|||
19416632|NCT01807234|41662591|FG004|Overall Study|Lack of Efficacy|1|||
19416633|NCT01807234|41662592|FG005|Overall Study|Lack of Efficacy|1|||
19416634|NCT01790932|41662602|FG000|Overall Study|Disease Progression|41|||
19416635|NCT01790932|41662602|FG000|Overall Study|Adverse Event|7|||
19416636|NCT01790932|41662602|FG000|Overall Study|Physician Decision|1|||
19416637|NCT01790932|41662602|FG000|Overall Study|Withdrawal by Subject|1|||
19416638|NCT02377427|41662608|FG000|Part A (Up to Week 20)|Physician Decision|1|||
19416639|NCT02377427|41662609|FG001|Part A (Up to Week 20)|Physician Decision|0|||
19416640|NCT02377427|41662610|FG002|Part A (Up to Week 20)|Physician Decision|0|||
19416641|NCT02377427|41662611|FG003|Part A (Up to Week 20)|Physician Decision|0|||
19416642|NCT02377427|41662612|FG004|Part A (Up to Week 20)|Physician Decision|0|||
19416643|NCT02377427|41662608|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
19416644|NCT02377427|41662609|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
19416645|NCT02377427|41662610|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
19416646|NCT02377427|41662611|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
19416647|NCT02377427|41662612|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
19416648|NCT02377427|41662608|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
19416649|NCT02377427|41662609|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
19416650|NCT02377427|41662610|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
19416651|NCT02377427|41662611|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
19416652|NCT02377427|41662612|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
19416653|NCT02377427|41662608|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
19416654|NCT02377427|41662609|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
19416655|NCT02377427|41662610|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
19416656|NCT02377427|41662611|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
19416657|NCT02377427|41662612|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
19416658|NCT01807156|41662625|FG000|Overall Study|Physician Decision|1|||
19416659|NCT02421887|41662631|FG000|Overall Study|Lost to Follow-up|5|||
19416660|NCT02421887|41662632|FG001|Overall Study|Lost to Follow-up|0|||
19416661|NCT02421887|41662631|FG000|Overall Study|Withdrawal by Subject|8|||
19416662|NCT02421887|41662632|FG001|Overall Study|Withdrawal by Subject|5|||
19416663|NCT02421887|41662631|FG000|Overall Study|Physician Decision|2|||
19416664|NCT02421887|41662632|FG001|Overall Study|Physician Decision|4|||
19416665|NCT02421887|41662631|FG000|Overall Study|Adverse Event|2|||
19416666|NCT02421887|41662632|FG001|Overall Study|Adverse Event|0|||
19416667|NCT01609582|41662640|FG000|Overall Study|Adverse Event|20|||
19416668|NCT01609582|41662641|FG001|Overall Study|Adverse Event|18|||
19416669|NCT01609582|41662640|FG000|Overall Study|Lost to Follow-up|10|||
19416670|NCT01609582|41662641|FG001|Overall Study|Lost to Follow-up|10|||
19416671|NCT01609582|41662640|FG000|Overall Study|Withdrawal by Subject|21|||
19416672|NCT01609582|41662641|FG001|Overall Study|Withdrawal by Subject|15|||
19416673|NCT01609582|41662640|FG000|Overall Study|Study Terminated by Sponsor|1543|||
19416674|NCT01609582|41662641|FG001|Overall Study|Study Terminated by Sponsor|1548|||
19416675|NCT01609582|41662640|FG000|Overall Study|Other|9|||
19416676|NCT01609582|41662641|FG001|Overall Study|Other|10|||
19416677|NCT01609582|41662640|FG000|Overall Study|Randomized, but not treated|0|||
19416678|NCT01609582|41662641|FG001|Overall Study|Randomized, but not treated|3|||
19416679|NCT01789606|41662649|FG000|Overall Study|Participant not Purchased the Product|0|||
19416680|NCT01789606|41662650|FG001|Overall Study|Participant not Purchased the Product|20|||
19416681|NCT01789606|41662649|FG000|Overall Study|Withdrawal by Subject|0|||
19416682|NCT01789606|41662650|FG001|Overall Study|Withdrawal by Subject|1|||
19416683|NCT01789606|41662649|FG000|Overall Study|Ineligible|6|||
19416684|NCT01789606|41662650|FG001|Overall Study|Ineligible|2|||
19416685|NCT01789606|41662649|FG000|Overall Study|Administrative Reasons|17|||
19416686|NCT01789606|41662650|FG001|Overall Study|Administrative Reasons|6|||
19416687|NCT01789606|41662649|FG000|Overall Study|No Study Medication Taken|0|||
19416688|NCT01789606|41662650|FG001|Overall Study|No Study Medication Taken|1|||
19416689|NCT01789606|41662649|FG000|Overall Study|Protocol Violation|0|||
19416690|NCT01789606|41662650|FG001|Overall Study|Protocol Violation|55|||
19416691|NCT01789606|41662649|FG000|Overall Study|Adverse Event|0|||
19416692|NCT01789606|41662650|FG001|Overall Study|Adverse Event|3|||
19416693|NCT01789606|41662649|FG000|Overall Study|Lost to Follow-up|0|||
19416694|NCT01789606|41662650|FG001|Overall Study|Lost to Follow-up|14|||
19416695|NCT01789606|41662649|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
19416696|NCT01789606|41662650|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
19416697|NCT01788358|41662655|FG000|Overall Study|Other|11|||
19416698|NCT01788358|41662655|FG000|Overall Study|Logistical difficulties|1|||
19416699|NCT01788358|41662655|FG000|Overall Study|Lost to Follow-up|5|||
19416700|NCT01788358|41662655|FG000|Overall Study|Protocol Violation|3|||
19416701|NCT01788358|41662655|FG000|Overall Study|Withdrawal by Subject|26|||
19416702|NCT01788358|41662655|FG000|Overall Study|Lack of Efficacy|1|||
19416703|NCT01788358|41662655|FG000|Overall Study|Adverse Event|51|||
19416704|NCT01773226|41662659|FG000|Overall Study|Withdrawal by Subject|1|||
19416705|NCT01773070|41662663|FG000|Overall Study|Withdrawal by Subject|24|||
19416706|NCT01773070|41662663|FG000|Overall Study|Lost to Follow-up|39|||
19416707|NCT01773070|41662663|FG000|Overall Study|Other|15|||
19416708|NCT01773070|41662663|FG000|Overall Study|Death (unrelated to study procedures)|3|||
19416709|NCT01772368|41662667|FG000|Overall Study|Adverse Event|1|||
19416710|NCT01772368|41662667|FG000|Overall Study|Withdrawal by Subject|3|||
19416711|NCT01772368|41662667|FG000|Overall Study|Protocol Violation|2|||
19416712|NCT01772368|41662667|FG000|Overall Study|Other|1|||
19416713|NCT01788046|41662685|FG000|Overall Study|Withdrawal by Subject|12|||
19416714|NCT01788046|41662686|FG001|Overall Study|Withdrawal by Subject|12|||
19416715|NCT01788046|41662685|FG000|Overall Study|Lost to Follow-up|12|||
19416716|NCT01788046|41662686|FG001|Overall Study|Lost to Follow-up|19|||
19416717|NCT01788046|41662685|FG000|Overall Study|Death|7|||
19416718|NCT01788046|41662686|FG001|Overall Study|Death|5|||
19416719|NCT01788046|41662685|FG000|Overall Study|Protocol Specified Criteria|25|||
19416720|NCT01788046|41662686|FG001|Overall Study|Protocol Specified Criteria|1|||
19416721|NCT01806298|41662692|FG000|Overall Study|Adverse Event|3|||
19416722|NCT01806298|41662692|FG000|Overall Study|Protocol Non-compliance|1|||
19416723|NCT01806298|41662692|FG000|Overall Study|Withdrawal by Subject|1|||
19416724|NCT01806298|41662692|FG000|Overall Study|Other|5|||
19416725|NCT01772134|41662699|FG000|Overall Study|Adverse Event|6|||
19416726|NCT01772134|41662700|FG001|Overall Study|Adverse Event|5|||
19416727|NCT01772134|41662701|FG002|Overall Study|Adverse Event|10|||
19416728|NCT01772134|41662699|FG000|Overall Study|Withdrew Consent|3|||
19416729|NCT01772134|41662700|FG001|Overall Study|Withdrew Consent|1|||
19416730|NCT01772134|41662701|FG002|Overall Study|Withdrew Consent|5|||
19416731|NCT01772134|41662699|FG000|Overall Study|Lost to Follow-up|2|||
19416732|NCT01772134|41662700|FG001|Overall Study|Lost to Follow-up|0|||
19416733|NCT01772134|41662701|FG002|Overall Study|Lost to Follow-up|0|||
19416734|NCT01772134|41662699|FG000|Overall Study|Protocol Deviation|4|||
19416735|NCT01772134|41662700|FG001|Overall Study|Protocol Deviation|3|||
19416736|NCT01772134|41662701|FG002|Overall Study|Protocol Deviation|3|||
19416737|NCT01772134|41662699|FG000|Overall Study|Lack of Efficacy|11|||
19416738|NCT01772134|41662700|FG001|Overall Study|Lack of Efficacy|5|||
19416739|NCT01772134|41662701|FG002|Overall Study|Lack of Efficacy|3|||
19416740|NCT01772134|41662699|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
19416741|NCT01772134|41662700|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
19416742|NCT01772134|41662701|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
19416743|NCT01772134|41662699|FG000|Overall Study|Randomized Study Medication Not Received|2|||
19416744|NCT01772134|41662700|FG001|Overall Study|Randomized Study Medication Not Received|0|||
19416745|NCT01772134|41662701|FG002|Overall Study|Randomized Study Medication Not Received|1|||
19416746|NCT01994889|41662712|FG000|Overall Study|Adverse Event|5|||
19416747|NCT01994889|41662713|FG001|Overall Study|Adverse Event|12|||
19416748|NCT01994889|41662714|FG002|Overall Study|Adverse Event|11|||
19416749|NCT01994889|41662712|FG000|Overall Study|Cardiac Device Implantation|0|||
19416750|NCT01994889|41662713|FG001|Overall Study|Cardiac Device Implantation|2|||
19416751|NCT01994889|41662714|FG002|Overall Study|Cardiac Device Implantation|0|||
19416752|NCT01994889|41662712|FG000|Overall Study|Organ Transplantation|1|||
19416753|NCT01994889|41662713|FG001|Overall Study|Organ Transplantation|5|||
19416754|NCT01994889|41662714|FG002|Overall Study|Organ Transplantation|5|||
19416755|NCT01994889|41662712|FG000|Overall Study|No longer willing to participate|8|||
19416756|NCT01994889|41662713|FG001|Overall Study|No longer willing to participate|17|||
19416757|NCT01994889|41662714|FG002|Overall Study|No longer willing to participate|37|||
19416758|NCT01994889|41662712|FG000|Overall Study|Lost to Follow-up|0|||
19416759|NCT01994889|41662713|FG001|Overall Study|Lost to Follow-up|1|||
19416760|NCT01994889|41662714|FG002|Overall Study|Lost to Follow-up|0|||
19416761|NCT01994889|41662712|FG000|Overall Study|Protocol Violation|0|||
19416762|NCT01994889|41662713|FG001|Overall Study|Protocol Violation|1|||
19416763|NCT01994889|41662714|FG002|Overall Study|Protocol Violation|1|||
19416764|NCT01994889|41662712|FG000|Overall Study|Death|14|||
19416765|NCT01994889|41662713|FG001|Overall Study|Death|25|||
19628116|NCT00789555|42077507|FG001|Overall Study|Protocol Violation|9|||
19416766|NCT01994889|41662714|FG002|Overall Study|Death|38|||
19416767|NCT02082483|41662723|FG000|Overall Study|Lost to Follow-up|1|||
19416768|NCT02082483|41662724|FG001|Overall Study|Lost to Follow-up|1|||
19416769|NCT02082483|41662723|FG000|Overall Study|Withdrawal by Subject|2|||
19416770|NCT02082483|41662724|FG001|Overall Study|Withdrawal by Subject|1|||
19416771|NCT02082483|41662723|FG000|Overall Study|Physician Decision|1|||
19416772|NCT02082483|41662724|FG001|Overall Study|Physician Decision|1|||
19416773|NCT02082483|41662723|FG000|Overall Study|Death|2|||
19416774|NCT02082483|41662724|FG001|Overall Study|Death|3|||
19416775|NCT02017899|41662737|FG000|Overall Study|Withdrawal by Subject|0|||
19416776|NCT02017899|41662738|FG001|Overall Study|Withdrawal by Subject|0|||
19416777|NCT02017899|41662739|FG002|Overall Study|Withdrawal by Subject|0|||
19416778|NCT02017899|41662740|FG003|Overall Study|Withdrawal by Subject|1|||
19416779|NCT02017899|41662741|FG004|Overall Study|Withdrawal by Subject|1|||
19416780|NCT02017899|41662742|FG005|Overall Study|Withdrawal by Subject|0|||
19416781|NCT01993329|41662762|FG000|Period 2|Adverse Event|0|||
19416782|NCT01993329|41662763|FG001|Period 2|Adverse Event|0|||
19416783|NCT01993329|41662764|FG002|Period 2|Adverse Event|0|||
19416784|NCT01993329|41662765|FG003|Period 2|Adverse Event|0|||
19416785|NCT01993329|41662766|FG004|Period 2|Adverse Event|0|||
19416786|NCT01993329|41662767|FG005|Period 2|Adverse Event|1|||
19416787|NCT01993329|41662762|FG000|Wash-out|Personal reasons|0|||
19416788|NCT01993329|41662763|FG001|Wash-out|Personal reasons|1|||
19416789|NCT01993329|41662764|FG002|Wash-out|Personal reasons|0|||
19416790|NCT01993329|41662765|FG003|Wash-out|Personal reasons|0|||
19416791|NCT01993329|41662766|FG004|Wash-out|Personal reasons|0|||
19416792|NCT01993329|41662767|FG005|Wash-out|Personal reasons|0|||
19416793|NCT02016183|41662779|FG000|Overall Study|Case Report Forms Uncollected|13|||
19416794|NCT02016183|41662779|FG000|Overall Study|Protocol Violation|52|||
19416795|NCT02377349|41662785|FG000|Overall Study|Serious Adverse Event|1|||
19416796|NCT02377349|41662786|FG001|Overall Study|Serious Adverse Event|0|||
19416797|NCT02377349|41662785|FG000|Overall Study|Protocol Violation|3|||
19416798|NCT02377349|41662786|FG001|Overall Study|Protocol Violation|2|||
19416799|NCT02377349|41662785|FG000|Overall Study|Withdrawal by Subject|5|||
19416800|NCT02377349|41662786|FG001|Overall Study|Withdrawal by Subject|3|||
19416801|NCT02377349|41662785|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
19416802|NCT02377349|41662786|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
19416803|NCT02377349|41662785|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
19416804|NCT02377349|41662786|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
19416805|NCT02377349|41662785|FG000|Overall Study|Other|0|||
19416806|NCT02377349|41662786|FG001|Overall Study|Other|1|||
19416807|NCT02421419|41662804|FG000|Overall Study|Physician Decision|0|||
19416808|NCT02421419|41662805|FG001|Overall Study|Physician Decision|0|||
19416809|NCT02421419|41662806|FG002|Overall Study|Physician Decision|1|||
19416810|NCT02420717|41662817|FG000|Overall Study|Did not receive all study medication|2|||
19416811|NCT02420717|41662818|FG001|Overall Study|Did not receive all study medication|0|||
19416812|NCT02420717|41662819|FG002|Overall Study|Did not receive all study medication|0|||
19416813|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
19416814|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
19416815|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
19416816|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
19416817|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
19416818|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
19416819|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
19416820|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
19519374|NCT01474512|41932301|FG009|Maintenance Period|Protocol Violation|1|||
19519375|NCT01474512|41932302|FG010|Maintenance Period|Protocol Violation|0|||
19519376|NCT01474512|41932303|FG011|Maintenance Period|Protocol Violation|0|||
19519377|NCT01474512|41932304|FG012|Maintenance Period|Protocol Violation|0|||
19519378|NCT01474512|41932305|FG013|Maintenance Period|Protocol Violation|0|||
19519379|NCT01474512|41932306|FG014|Maintenance Period|Protocol Violation|0|||
19519380|NCT01474512|41932307|FG015|Maintenance Period|Protocol Violation|0|||
19519381|NCT01474512|41932308|FG016|Maintenance Period|Protocol Violation|0|||
19519382|NCT01474512|41932309|FG017|Maintenance Period|Protocol Violation|0|||
19519383|NCT01474512|41932292|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
19519384|NCT01474512|41932293|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
19416821|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
19416822|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
19416823|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
19416824|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
19416825|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
19416826|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
19416827|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
19416828|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
19416829|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
19416830|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
19416831|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
19416832|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
19519385|NCT01474512|41932294|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
19519386|NCT01474512|41932295|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
19416833|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
19416834|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
19416835|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
19416836|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
19416837|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
19416838|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
19416839|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
19628117|NCT00789555|42077508|FG002|Overall Study|Protocol Violation|13|||
19416840|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
19416841|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
19416842|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
19416843|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
19416844|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
19416845|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
19416846|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
19416847|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
19416848|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
19416849|NCT02016105|41662829|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
19416850|NCT02016105|41662830|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
19416851|NCT02016105|41662831|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
19416852|NCT02016105|41662832|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
19416853|NCT02016105|41662833|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
19416854|NCT02016105|41662834|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
19416855|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
19416856|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
19416857|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
19416858|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
19416859|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
19416860|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
19416861|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
19416862|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
19416863|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
19416864|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
19416865|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
19416866|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
19416867|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
19416868|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
19416869|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
19416870|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
19416871|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
19416872|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
19416873|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Death|0|||
19416874|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Death|0|||
19416875|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Death|0|||
19416876|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Death|0|||
19416877|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Death|0|||
19416878|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Death|1|||
19416879|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
19416880|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
19416881|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
19416882|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
19416883|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
19416884|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
19416885|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
19416886|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
19416887|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
19416888|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
19416889|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
19416890|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
19416891|NCT02016105|41662829|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
19416892|NCT02016105|41662830|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
19416893|NCT02016105|41662831|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
19416894|NCT02016105|41662832|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
19416895|NCT02016105|41662833|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
19416896|NCT02016105|41662834|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
19416897|NCT02016105|41662829|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
19416898|NCT02016105|41662830|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
19416899|NCT02016105|41662831|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
19416900|NCT02016105|41662832|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
19416901|NCT02016105|41662833|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
19416902|NCT02016105|41662834|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
19416903|NCT02016105|41662829|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
19416904|NCT02016105|41662830|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
19416905|NCT02016105|41662831|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
19416906|NCT02016105|41662832|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
19416907|NCT02016105|41662833|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
19416908|NCT02016105|41662834|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
19416909|NCT02016105|41662829|FG000|EXTENSION PERIOD|Adverse Event|0|||
19416910|NCT02016105|41662830|FG001|EXTENSION PERIOD|Adverse Event|0|||
19416911|NCT02016105|41662831|FG002|EXTENSION PERIOD|Adverse Event|2|||
19416912|NCT02016105|41662832|FG003|EXTENSION PERIOD|Adverse Event|0|||
19416913|NCT02016105|41662833|FG004|EXTENSION PERIOD|Adverse Event|1|||
19416914|NCT02016105|41662834|FG005|EXTENSION PERIOD|Adverse Event|0|||
19416915|NCT02016105|41662829|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
19416916|NCT02016105|41662830|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
19416917|NCT02016105|41662831|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
19416918|NCT02016105|41662832|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
19416919|NCT02016105|41662833|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
19416920|NCT02016105|41662834|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
19416921|NCT02016105|41662829|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
19416922|NCT02016105|41662830|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
19416923|NCT02016105|41662831|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
19416924|NCT02016105|41662832|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
19416925|NCT02016105|41662833|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
19416926|NCT02016105|41662834|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
19416927|NCT02016105|41662829|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
19416928|NCT02016105|41662830|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
19416929|NCT02016105|41662831|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
19416930|NCT02016105|41662832|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
19416931|NCT02016105|41662833|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
19416932|NCT02016105|41662834|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
19416933|NCT02400905|41662848|FG000|Overall Study|Death|24|||
19416934|NCT02400905|41662848|FG000|Overall Study|Lost to Follow-up|18|||
19416935|NCT02400905|41662848|FG000|Overall Study|Withdrawal by Subject|16|||
19416936|NCT02400905|41662848|FG000|Overall Study|Physician Decision|4|||
19416937|NCT02400905|41662848|FG000|Overall Study|Other|1|||
19416938|NCT02400749|41662855|FG000|Week 0 -16|Withdrawal by Subject|5|||
19416939|NCT02400749|41662856|FG001|Week 0 -16|Withdrawal by Subject|5|||
19416940|NCT02400749|41662855|FG000|Week 0 -16|Adverse Event|3|||
19416941|NCT02400749|41662856|FG001|Week 0 -16|Adverse Event|1|||
19416942|NCT02400749|41662855|FG000|Week 0 -16|Lost to Follow-up|2|||
19416943|NCT02400749|41662856|FG001|Week 0 -16|Lost to Follow-up|0|||
19416944|NCT02400749|41662855|FG000|Week 0 -16|Protocol Violation|1|||
19416945|NCT02400749|41662856|FG001|Week 0 -16|Protocol Violation|0|||
19416946|NCT02400749|41662855|FG000|Week 17 - 32|Withdrawal by Subject|3|||
19416947|NCT02400749|41662856|FG001|Week 17 - 32|Withdrawal by Subject|2|||
19416948|NCT02400749|41662855|FG000|Week 17 - 32|Adverse Event|2|||
19416949|NCT02400749|41662856|FG001|Week 17 - 32|Adverse Event|1|||
19416950|NCT02420327|41662862|FG000|Overall Study|Adverse Event|7|||
19416951|NCT02420327|41662862|FG000|Overall Study|Pregnancy|1|||
19416952|NCT02420327|41662862|FG000|Overall Study|Withdrawal by Subject|6|||
19416953|NCT02420327|41662862|FG000|Overall Study|Lost to Follow-up|1|||
19416954|NCT02420327|41662862|FG000|Overall Study|Protocol Violation|1|||
19416955|NCT02374853|41662874|FG000|Overall Study|Surgery Cancelled|5|||
19416956|NCT02374853|41662875|FG001|Overall Study|Surgery Cancelled|11|||
19416957|NCT02015793|41662883|FG000|Overall Study|Adverse Event|3|||
19416958|NCT02015793|41662884|FG001|Overall Study|Adverse Event|3|||
19416959|NCT02015793|41662883|FG000|Overall Study|Withdrawal by Subject|1|||
19416960|NCT02015793|41662884|FG001|Overall Study|Withdrawal by Subject|1|||
19416961|NCT02347631|41662898|FG000|First Intervention (2 Months)|Adverse Event|1|||
19416962|NCT02347631|41662899|FG001|First Intervention (2 Months)|Adverse Event|1|||
19416963|NCT02347631|41662898|FG000|First Intervention (2 Months)|Pregnancy|1|||
19416964|NCT02347631|41662899|FG001|First Intervention (2 Months)|Pregnancy|0|||
19416965|NCT02347631|41662898|FG000|First Intervention (2 Months)|Moved out of area|0|||
19416966|NCT02347631|41662899|FG001|First Intervention (2 Months)|Moved out of area|2|||
19416967|NCT02347631|41662898|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
19416968|NCT02347631|41662899|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
19416969|NCT02347631|41662898|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
19416970|NCT02347631|41662899|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
19416971|NCT02347631|41662898|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
19416972|NCT02347631|41662899|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
19416973|NCT02347631|41662898|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
19416974|NCT02347631|41662899|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
19416975|NCT02347631|41662898|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
19416976|NCT02347631|41662899|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
19416977|NCT02015637|41662909|FG000|Overall Study|Lost to Follow-up|3|||
19416978|NCT02015637|41662910|FG001|Overall Study|Lost to Follow-up|5|||
19416979|NCT02015637|41662909|FG000|Overall Study|Adverse Event|3|||
19519387|NCT01474512|41932296|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
19628118|NCT00451321|42077524|FG000|Overall Study|Lost to Follow-up|3|||
19628119|NCT00451321|42077525|FG001|Overall Study|Lost to Follow-up|3|||
19416980|NCT02015637|41662910|FG001|Overall Study|Adverse Event|0|||
19416981|NCT02015637|41662909|FG000|Overall Study|Did not take study drug|2|||
19416982|NCT02015637|41662910|FG001|Overall Study|Did not take study drug|0|||
19416983|NCT02347085|41662916|FG000|Overall Study|Adverse Event|2|||
19416984|NCT02347085|41662916|FG000|Overall Study|Lack of Efficacy|1|||
19416985|NCT02347085|41662916|FG000|Overall Study|Withdrawal by Subject|4|||
19416986|NCT02347085|41662916|FG000|Overall Study|Lost to Follow-up|1|||
19416987|NCT02347085|41662916|FG000|Overall Study|Protocol Criteria|2|||
19416988|NCT02374463|41662924|FG000|Overall Study|Withdrawal by Subject|3|||
19416989|NCT02374463|41662925|FG001|Overall Study|Withdrawal by Subject|3|||
19416990|NCT02015481|41662932|FG000|Overall Study|Death|1|||
19416991|NCT02374307|41662939|FG000|3-months Follow-up|Lost to Follow-up|1|||
19416992|NCT02374307|41662940|FG001|3-months Follow-up|Lost to Follow-up|2|||
19416993|NCT02374307|41662939|FG000|3-months Follow-up|Withdrawal by Subject|1|||
19416994|NCT02374307|41662940|FG001|3-months Follow-up|Withdrawal by Subject|4|||
19416995|NCT02374307|41662939|FG000|3-months Follow-up|Death|1|||
19416996|NCT02374307|41662940|FG001|3-months Follow-up|Death|2|||
19416997|NCT02374307|41662939|FG000|3-months Follow-up|Missed first follow-up|5|||
19416998|NCT02374307|41662940|FG001|3-months Follow-up|Missed first follow-up|1|||
19416999|NCT02374307|41662939|FG000|6-months Follow-up|Lost to Follow-up|1|||
19417000|NCT02374307|41662940|FG001|6-months Follow-up|Lost to Follow-up|2|||
19417001|NCT02374307|41662939|FG000|6-months Follow-up|Death|2|||
19417002|NCT02374307|41662940|FG001|6-months Follow-up|Death|1|||
19417003|NCT02374307|41662939|FG000|6-months Follow-up|Withdrawal by Subject|0|||
19417004|NCT02374307|41662940|FG001|6-months Follow-up|Withdrawal by Subject|3|||
19417005|NCT02397473|41662948|FG000|Treatment Phase|Adverse Event|1|||
19417006|NCT02397473|41662949|FG001|Treatment Phase|Adverse Event|2|||
19417007|NCT02397473|41662948|FG000|Treatment Phase|Lack of Efficacy|8|||
19417008|NCT02397473|41662949|FG001|Treatment Phase|Lack of Efficacy|1|||
19417009|NCT02397473|41662948|FG000|Treatment Phase|Lost to Follow-up|1|||
19417010|NCT02397473|41662949|FG001|Treatment Phase|Lost to Follow-up|0|||
19417011|NCT02397473|41662948|FG000|Treatment Phase|Withdrawal by Subject|2|||
19417012|NCT02397473|41662949|FG001|Treatment Phase|Withdrawal by Subject|1|||
19417013|NCT02397473|41662948|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
19417014|NCT02397473|41662949|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
19519388|NCT01474512|41932297|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
19519389|NCT01474512|41932298|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
19519390|NCT01474512|41932299|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
19628120|NCT00451321|42077526|FG002|Overall Study|Lost to Follow-up|1|||
19628121|NCT00451321|42077527|FG003|Overall Study|Lost to Follow-up|3|||
19628122|NCT00451321|42077528|FG004|Overall Study|Lost to Follow-up|0|||
19628123|NCT00451321|42077529|FG005|Overall Study|Lost to Follow-up|1|||
19628124|NCT00451321|42077530|FG006|Overall Study|Lost to Follow-up|0|||
19628125|NCT00451321|42077531|FG007|Overall Study|Lost to Follow-up|0|||
19628126|NCT00451321|42077524|FG000|Overall Study|Withdrawal by Subject|3|||
19628127|NCT00451321|42077525|FG001|Overall Study|Withdrawal by Subject|1|||
19628128|NCT00451321|42077526|FG002|Overall Study|Withdrawal by Subject|0|||
19628129|NCT00451321|42077527|FG003|Overall Study|Withdrawal by Subject|4|||
19628130|NCT00451321|42077528|FG004|Overall Study|Withdrawal by Subject|0|||
19628131|NCT00451321|42077529|FG005|Overall Study|Withdrawal by Subject|0|||
19417015|NCT02397473|41662948|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
19417016|NCT02397473|41662949|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
19417017|NCT02397473|41662948|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
19519391|NCT01474512|41932300|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
19519392|NCT01474512|41932301|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
19519393|NCT01474512|41932302|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
19519394|NCT01474512|41932303|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
19519395|NCT01474512|41932304|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
19519396|NCT01474512|41932305|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
19519397|NCT01474512|41932306|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
19519398|NCT01474512|41932307|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
19519399|NCT01474512|41932308|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
19519400|NCT01474512|41932309|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
19519401|NCT01474512|41932292|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
19519402|NCT01474512|41932293|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
19519403|NCT01474512|41932294|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
19519404|NCT01474512|41932295|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
19519405|NCT01474512|41932296|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
19519406|NCT01474512|41932297|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
19519407|NCT01474512|41932298|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
19519408|NCT01474512|41932299|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
19519409|NCT01474512|41932300|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
19519410|NCT01474512|41932301|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
19519411|NCT01474512|41932302|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
19519412|NCT01474512|41932303|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
19519413|NCT01474512|41932304|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
19519414|NCT01474512|41932305|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
19519415|NCT01474512|41932306|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
19519416|NCT01474512|41932307|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
19628132|NCT00451321|42077530|FG006|Overall Study|Withdrawal by Subject|0|||
19628133|NCT00451321|42077531|FG007|Overall Study|Withdrawal by Subject|0|||
19417018|NCT02397473|41662949|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
19628134|NCT00451321|42077524|FG000|Overall Study|Study closed/terminated|1|||
19519417|NCT01474512|41932308|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
19519418|NCT01474512|41932309|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
19519419|NCT01474512|41932292|FG000|Long-Term Extension Period|Adverse Event|0|||
19519420|NCT01474512|41932293|FG001|Long-Term Extension Period|Adverse Event|0|||
19519421|NCT01474512|41932294|FG002|Long-Term Extension Period|Adverse Event|0|||
19519422|NCT01474512|41932295|FG003|Long-Term Extension Period|Adverse Event|0|||
19519423|NCT01474512|41932296|FG004|Long-Term Extension Period|Adverse Event|0|||
19519424|NCT01474512|41932297|FG005|Long-Term Extension Period|Adverse Event|0|||
19519425|NCT01474512|41932298|FG006|Long-Term Extension Period|Adverse Event|0|||
19519426|NCT01474512|41932299|FG007|Long-Term Extension Period|Adverse Event|0|||
19519427|NCT01474512|41932300|FG008|Long-Term Extension Period|Adverse Event|0|||
19519428|NCT01474512|41932301|FG009|Long-Term Extension Period|Adverse Event|0|||
19519429|NCT01474512|41932302|FG010|Long-Term Extension Period|Adverse Event|0|||
19519430|NCT01474512|41932303|FG011|Long-Term Extension Period|Adverse Event|1|||
19519431|NCT01474512|41932304|FG012|Long-Term Extension Period|Adverse Event|57|||
19519432|NCT01474512|41932305|FG013|Long-Term Extension Period|Adverse Event|58|||
19519433|NCT01474512|41932306|FG014|Long-Term Extension Period|Adverse Event|0|||
19519434|NCT01474512|41932307|FG015|Long-Term Extension Period|Adverse Event|0|||
19519435|NCT01474512|41932308|FG016|Long-Term Extension Period|Adverse Event|0|||
19519436|NCT01474512|41932309|FG017|Long-Term Extension Period|Adverse Event|0|||
19519437|NCT01474512|41932292|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
19519438|NCT01474512|41932293|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
19519439|NCT01474512|41932294|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
19519440|NCT01474512|41932295|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
19417019|NCT02397473|41662948|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
19417020|NCT02397473|41662949|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
19417021|NCT02397473|41662948|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
19417022|NCT02397473|41662949|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
19417023|NCT02344745|41662960|FG000|Overall Study|Data collection sheets were lost|2|||
19417024|NCT02344745|41662961|FG001|Overall Study|Data collection sheets were lost|0|||
19417025|NCT02370641|41662969|FG000|Overall Study|dropped study|4|||
19417026|NCT02370641|41662970|FG001|Overall Study|dropped study|2|||
19417027|NCT01621191|41662976|FG000|Overall Study|Adverse Event|9|||
19417028|NCT01621191|41662976|FG000|Overall Study|Withdrawal by Subject|8|||
19417029|NCT01621191|41662976|FG000|Overall Study|Lack of Efficacy|6|||
19417030|NCT01621191|41662976|FG000|Overall Study|Lost to Follow-up|1|||
19417031|NCT01621191|41662976|FG000|Overall Study|Site Removed From Study|1|||
19417032|NCT02343263|41662984|FG000|Overall Study|Physician Decision|5|||
19417033|NCT02343263|41662985|FG001|Overall Study|Physician Decision|3|||
19417034|NCT02343263|41662986|FG002|Overall Study|Physician Decision|1|||
19417035|NCT02081859|41663000|FG000|Overall Study|No fertilization|2|||
19417036|NCT02081859|41663001|FG001|Overall Study|No fertilization|2|||
19417037|NCT02081859|41663000|FG000|Overall Study|No sperm|1|||
19417038|NCT02081859|41663001|FG001|Overall Study|No sperm|0|||
19417039|NCT02081859|41663000|FG000|Overall Study|Unanticipated freeze all cycle|2|||
19417040|NCT02081859|41663001|FG001|Overall Study|Unanticipated freeze all cycle|6|||
19417041|NCT02081859|41663000|FG000|Overall Study|< 4 embryos|27|||
19417042|NCT02081859|41663001|FG001|Overall Study|< 4 embryos|23|||
19417043|NCT02081859|41663000|FG000|Overall Study|Other reasons|2|||
19417044|NCT02081859|41663001|FG001|Overall Study|Other reasons|0|||
19417045|NCT02342639|41663009|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
19417046|NCT02342639|41663010|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
19417047|NCT02342639|41663009|FG000|Overall Study|Protocol Violation|0|||
19417048|NCT02342639|41663010|FG001|Overall Study|Protocol Violation|2|||
19417049|NCT01625091|41663020|FG000|Intervention|Death|1|||
19417050|NCT01625091|41663021|FG001|Intervention|Death|1|||
19417051|NCT01625091|41663020|FG000|Intervention|Withdrawal by Subject|4|||
19417052|NCT01625091|41663021|FG001|Intervention|Withdrawal by Subject|1|||
19417053|NCT01625091|41663020|FG000|Intervention|Adverse Event|0|||
19417054|NCT01625091|41663021|FG001|Intervention|Adverse Event|2|||
19417055|NCT01625091|41663020|FG000|Intervention|Lost to Follow-up|4|||
19417056|NCT01625091|41663021|FG001|Intervention|Lost to Follow-up|4|||
19417057|NCT01625091|41663020|FG000|Intervention|Study termination|2|||
19417058|NCT01625091|41663021|FG001|Intervention|Study termination|3|||
19519441|NCT01474512|41932296|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
19519442|NCT01474512|41932297|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
19519443|NCT01474512|41932298|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
19628135|NCT00451321|42077525|FG001|Overall Study|Study closed/terminated|1|||
19417059|NCT01625091|41663020|FG000|Post-intervention|Death|0|||
19417060|NCT01625091|41663021|FG001|Post-intervention|Death|1|||
19417061|NCT01625091|41663020|FG000|Post-intervention|Lost to Follow-up|2|||
19417062|NCT01625091|41663021|FG001|Post-intervention|Lost to Follow-up|0|||
19417063|NCT01625091|41663020|FG000|Post-intervention|Study termination|2|||
19417064|NCT01625091|41663021|FG001|Post-intervention|Study termination|1|||
19417065|NCT02396849|41663029|FG000|Overall Study|Lost to Follow-up|1|||
19417066|NCT02396849|41663030|FG001|Overall Study|Lost to Follow-up|1|||
19417067|NCT02396849|41663029|FG000|Overall Study|Did not tolerate intervention|1|||
19417068|NCT02396849|41663030|FG001|Overall Study|Did not tolerate intervention|1|||
19417069|NCT02370251|41663038|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
19417070|NCT02370251|41663038|FG000|Overall Study|Death|4|||
19417071|NCT02396537|41663044|FG000|Overall Study|Protocol Violation|0|||
19417072|NCT02396537|41663045|FG001|Overall Study|Protocol Violation|1|||
19417073|NCT02342171|41663053|FG000|Overall Study|Death|4|||
19417074|NCT02342171|41663054|FG001|Overall Study|Death|87|||
19417075|NCT02342171|41663053|FG000|Overall Study|Received favipiravir|10|||
19417076|NCT02342171|41663054|FG001|Overall Study|Received favipiravir|0|||
19417077|NCT02342171|41663053|FG000|Overall Study|Missing cycle treshold value|1|||
19417078|NCT02342171|41663054|FG001|Overall Study|Missing cycle treshold value|0|||
19417079|NCT02342171|41663053|FG000|Overall Study|Unknown outcome|0|||
19417080|NCT02342171|41663054|FG001|Overall Study|Unknown outcome|1|||
19417081|NCT02342171|41663053|FG000|Overall Study|Missing age data|0|||
19417082|NCT02342171|41663054|FG001|Overall Study|Missing age data|1|||
19417083|NCT01624467|41663059|FG000|Overall Study|Withdrawal by Subject|2|||
19417084|NCT01624467|41663059|FG000|Overall Study|Lost to Follow-up|1|||
19417085|NCT01624467|41663059|FG000|Overall Study|Adverse Event|7|||
19417086|NCT01624467|41663059|FG000|Overall Study|Progressive Disease|19|||
19417087|NCT01624467|41663059|FG000|Overall Study|Per Sponsor Requirement|1|||
19417088|NCT01624467|41663059|FG000|Overall Study|Subject Withdrew from Treatment|1|||
19417089|NCT01624233|41663065|FG000|Period 2 - Induction|Adverse Event|1|||
19417090|NCT01624233|41663065|FG000|Period 3 - Maintenance|Adverse Event|2|||
19417091|NCT01624233|41663065|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
19417092|NCT01624233|41663065|FG000|Period 3 - Maintenance|Physician Decision|2|||
19417093|NCT01624233|41663065|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
19417094|NCT01624233|41663065|FG000|Period 4 - Drug Free Period|Relapsed|61|||
19417095|NCT01624233|41663065|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
19417096|NCT01624233|41663065|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
19417097|NCT01624233|41663065|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
19417098|NCT01624233|41663065|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
19417099|NCT01624233|41663065|FG000|Period 6: Follow-up|Adverse Event|3|||
19417100|NCT01624233|41663065|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
19417101|NCT01624233|41663065|FG000|Period 6: Follow-up|Physician Decision|1|||
19417102|NCT01624233|41663065|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
19417103|NCT01993017|41663076|FG000|Overall Study|Death|23|||
19417104|NCT01993017|41663077|FG001|Overall Study|Death|26|||
19417105|NCT01993017|41663078|FG002|Overall Study|Death|18|||
19417106|NCT01993017|41663076|FG000|Overall Study|Could not be contacted|43|||
19417107|NCT01993017|41663077|FG001|Overall Study|Could not be contacted|42|||
19417108|NCT01993017|41663078|FG002|Overall Study|Could not be contacted|38|||
19417109|NCT01993017|41663076|FG000|Overall Study|Dropped out|19|||
19417110|NCT01993017|41663077|FG001|Overall Study|Dropped out|6|||
19417111|NCT01993017|41663078|FG002|Overall Study|Dropped out|11|||
19417112|NCT01993017|41663076|FG000|Overall Study|Other reasons|17|||
19417113|NCT01993017|41663077|FG001|Overall Study|Other reasons|11|||
19417114|NCT01993017|41663078|FG002|Overall Study|Other reasons|7|||
19417115|NCT01993017|41663076|FG000|Overall Study|Ineligible after randomization|4|||
19417116|NCT01993017|41663077|FG001|Overall Study|Ineligible after randomization|5|||
19417117|NCT01993017|41663078|FG002|Overall Study|Ineligible after randomization|5|||
19417118|NCT01992549|41663087|FG000|Overall Study|Lost to Follow-up|2|||
19417119|NCT01992549|41663087|FG000|Overall Study|Serious Adverse Event|1|||
19417120|NCT01992549|41663087|FG000|Overall Study|Product Switch to Extend Half Life|1|||
19417121|NCT01992159|41663101|FG000|Overall Study|Withdrawal by Subject|4|||
19417122|NCT01992159|41663102|FG001|Overall Study|Withdrawal by Subject|7|||
19417123|NCT01992159|41663103|FG002|Overall Study|Withdrawal by Subject|0|||
19417124|NCT01992159|41663104|FG003|Overall Study|Withdrawal by Subject|3|||
19417125|NCT01992159|41663101|FG000|Overall Study|Adverse Event|0|||
19417126|NCT01992159|41663102|FG001|Overall Study|Adverse Event|1|||
19417127|NCT01992159|41663103|FG002|Overall Study|Adverse Event|0|||
19417128|NCT01992159|41663104|FG003|Overall Study|Adverse Event|1|||
19417129|NCT01992159|41663101|FG000|Overall Study|Death|0|||
19417130|NCT01992159|41663102|FG001|Overall Study|Death|0|||
19417131|NCT01992159|41663103|FG002|Overall Study|Death|1|||
19417132|NCT01992159|41663104|FG003|Overall Study|Death|0|||
19417133|NCT01988493|41663119|FG000|Overall Study|Randomized but not treated|0|||
19417134|NCT01988493|41663120|FG001|Overall Study|Randomized but not treated|0|||
19417135|NCT01988493|41663121|FG002|Overall Study|Randomized but not treated|0|||
19417136|NCT01988493|41663122|FG003|Overall Study|Randomized but not treated|0|||
19417137|NCT01988493|41663123|FG004|Overall Study|Randomized but not treated|1|||
19417138|NCT02081079|41663139|FG000|Overall Study|Lack of Efficacy|3|||
19417139|NCT02081079|41663140|FG001|Overall Study|Lack of Efficacy|2|||
19417140|NCT02081079|41663139|FG000|Overall Study|Lost to Follow-up|1|||
19417141|NCT02081079|41663140|FG001|Overall Study|Lost to Follow-up|0|||
19417142|NCT02081001|41663152|FG000|Overall Study|Adverse Event|0|||
19417143|NCT02081001|41663153|FG001|Overall Study|Adverse Event|0|||
19417144|NCT02081001|41663154|FG002|Overall Study|Adverse Event|0|||
19417145|NCT02081001|41663155|FG003|Overall Study|Adverse Event|0|||
19417146|NCT02081001|41663156|FG004|Overall Study|Adverse Event|1|||
19417147|NCT02081001|41663157|FG005|Overall Study|Adverse Event|0|||
19417148|NCT02081001|41663158|FG006|Overall Study|Adverse Event|0|||
19417149|NCT02081001|41663159|FG007|Overall Study|Adverse Event|0|||
19417150|NCT02081001|41663160|FG008|Overall Study|Adverse Event|0|||
19417151|NCT02081001|41663161|FG009|Overall Study|Adverse Event|0|||
19417152|NCT02081001|41663162|FG010|Overall Study|Adverse Event|0|||
19417153|NCT02081001|41663163|FG011|Overall Study|Adverse Event|0|||
19417154|NCT02080221|41663174|FG000|Overall Study|Withdrawal by Subject|1|||
19417155|NCT02080221|41663174|FG000|Overall Study|Clinical Progression of Disease|1|||
19417156|NCT02079909|41663181|FG000|Overall Study|Adverse Event|23|||
19417157|NCT02079909|41663182|FG001|Overall Study|Adverse Event|23|||
19417158|NCT02079909|41663183|FG002|Overall Study|Adverse Event|7|||
19417159|NCT02079909|41663181|FG000|Overall Study|Withdrawal by Subject|9|||
19417160|NCT02079909|41663182|FG001|Overall Study|Withdrawal by Subject|17|||
19417161|NCT02079909|41663183|FG002|Overall Study|Withdrawal by Subject|4|||
19417162|NCT02079909|41663181|FG000|Overall Study|Lost to Follow-up|2|||
19417163|NCT02079909|41663182|FG001|Overall Study|Lost to Follow-up|3|||
19417164|NCT02079909|41663183|FG002|Overall Study|Lost to Follow-up|1|||
19417165|NCT02079909|41663181|FG000|Overall Study|Death|2|||
19417166|NCT02079909|41663182|FG001|Overall Study|Death|2|||
19417167|NCT02079909|41663183|FG002|Overall Study|Death|0|||
19417168|NCT02079909|41663181|FG000|Overall Study|Lack of Efficacy|0|||
19417169|NCT02079909|41663182|FG001|Overall Study|Lack of Efficacy|0|||
19417170|NCT02079909|41663183|FG002|Overall Study|Lack of Efficacy|1|||
19417171|NCT02079909|41663181|FG000|Overall Study|Protocol Violation|0|||
19417172|NCT02079909|41663182|FG001|Overall Study|Protocol Violation|1|||
19417173|NCT02079909|41663183|FG002|Overall Study|Protocol Violation|1|||
19417174|NCT02079909|41663181|FG000|Overall Study|Physician Decision|0|||
19417175|NCT02079909|41663182|FG001|Overall Study|Physician Decision|1|||
19417176|NCT02079909|41663183|FG002|Overall Study|Physician Decision|1|||
19417177|NCT02079909|41663181|FG000|Overall Study|Relocation etc.|2|||
19417178|NCT02079909|41663182|FG001|Overall Study|Relocation etc.|2|||
19417179|NCT02079909|41663183|FG002|Overall Study|Relocation etc.|3|||
19417180|NCT02014467|41663193|FG000|Overall Study|Adverse Event|4|||
19417181|NCT02014467|41663194|FG001|Overall Study|Adverse Event|0|||
19417182|NCT02014467|41663193|FG000|Overall Study|Protocol Violation|3|||
19417183|NCT02014467|41663194|FG001|Overall Study|Protocol Violation|0|||
19417184|NCT02014467|41663193|FG000|Overall Study|Physician Decision|2|||
19417185|NCT02014467|41663194|FG001|Overall Study|Physician Decision|3|||
19417186|NCT02014467|41663193|FG000|Overall Study|Withdrawal by Subject|16|||
19417187|NCT02014467|41663194|FG001|Overall Study|Withdrawal by Subject|4|||
19417188|NCT02013765|41663200|FG000|Overall Study|Trial was terminated by sponsor|1|||
19417189|NCT02013687|41663208|FG000|Overall Study|Lost to Follow-up|0|||
19417190|NCT02013687|41663209|FG001|Overall Study|Lost to Follow-up|0|||
19417191|NCT02013687|41663210|FG002|Overall Study|Lost to Follow-up|1|||
19417192|NCT02013687|41663211|FG003|Overall Study|Lost to Follow-up|0|||
19417193|NCT02013687|41663208|FG000|Overall Study|Protocol Violation|0|||
19417194|NCT02013687|41663209|FG001|Overall Study|Protocol Violation|0|||
19417195|NCT02013687|41663210|FG002|Overall Study|Protocol Violation|0|||
19417196|NCT02013687|41663211|FG003|Overall Study|Protocol Violation|1|||
19417197|NCT02013687|41663208|FG000|Overall Study|Withdrawal by Subject|0|||
19417198|NCT02013687|41663209|FG001|Overall Study|Withdrawal by Subject|0|||
19417199|NCT02013687|41663210|FG002|Overall Study|Withdrawal by Subject|0|||
19417200|NCT02013687|41663211|FG003|Overall Study|Withdrawal by Subject|1|||
19417201|NCT02013687|41663208|FG000|Overall Study|Missed visits due to patient travel|0|||
19417202|NCT02013687|41663209|FG001|Overall Study|Missed visits due to patient travel|0|||
19417203|NCT02013687|41663210|FG002|Overall Study|Missed visits due to patient travel|1|||
19417204|NCT02013687|41663211|FG003|Overall Study|Missed visits due to patient travel|0|||
19417205|NCT02013609|41663225|FG000|Overall Study|Withdrawal by Subject|9|||
19417206|NCT02013609|41663225|FG000|Overall Study|Lost to Follow-up|3|||
19417207|NCT02013609|41663225|FG000|Overall Study|Adverse Event|3|||
19417208|NCT02013609|41663225|FG000|Overall Study|Met Withdrawal Criteria|3|||
19417209|NCT01988337|41663229|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
19417210|NCT02013531|41663235|FG000|Overall Study|Lost to Follow-up|3|||
19417211|NCT02013531|41663235|FG000|Overall Study|Met Withdrawal Criteria|1|||
19417212|NCT02013531|41663235|FG000|Overall Study|Withdrawal by Subject|1|||
19417213|NCT01988103|41663242|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
19417214|NCT01988103|41663243|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
19417215|NCT01988103|41663244|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
19417216|NCT01988103|41663245|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
19417217|NCT01988103|41663246|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
19417218|NCT01988103|41663242|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
19417219|NCT01988103|41663243|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
19417220|NCT01988103|41663244|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
19417221|NCT01988103|41663245|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
19417222|NCT01988103|41663246|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
19417223|NCT01988103|41663242|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
19417224|NCT01988103|41663243|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
19417225|NCT01988103|41663244|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
19417226|NCT01988103|41663245|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
19417227|NCT01988103|41663246|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
19417228|NCT01988103|41663242|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
19417229|NCT01988103|41663243|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
19417230|NCT01988103|41663244|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
19417231|NCT01988103|41663245|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
19417232|NCT01988103|41663246|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
19417233|NCT01988103|41663242|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
19417234|NCT01988103|41663243|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
19417235|NCT01988103|41663244|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
19417236|NCT01988103|41663245|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
19417237|NCT01988103|41663246|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
19417238|NCT01988103|41663242|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
19417239|NCT01988103|41663243|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
19417240|NCT01988103|41663244|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
19417241|NCT01988103|41663245|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
19417242|NCT01988103|41663246|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
19417243|NCT01988103|41663242|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
19417244|NCT01988103|41663243|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
19417245|NCT01988103|41663244|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
19417246|NCT01988103|41663245|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
19417247|NCT01988103|41663246|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
19417248|NCT02013375|41663261|FG000|Overall Study|Did not engraft|1|||
19417249|NCT02013375|41663261|FG000|Overall Study|Did not engraft|1|||
19417250|NCT02079519|41663266|FG000|Overall Study|Disease Progression|9|||
19417251|NCT02079519|41663266|FG000|Overall Study|Adverse Event|1|||
19417252|NCT01987557|41663273|FG000|Overall Study|Protocol Violation|1|||
19417253|NCT01987557|41663274|FG001|Overall Study|Protocol Violation|0|||
19417254|NCT01987557|41663275|FG002|Overall Study|Protocol Violation|1|||
19417255|NCT01987557|41663273|FG000|Overall Study|Withdrawal by Subject|2|||
19417256|NCT01987557|41663274|FG001|Overall Study|Withdrawal by Subject|1|||
19417257|NCT01987557|41663275|FG002|Overall Study|Withdrawal by Subject|2|||
19417258|NCT01987557|41663273|FG000|Overall Study|Adverse Event|0|||
19417259|NCT01987557|41663274|FG001|Overall Study|Adverse Event|2|||
19417260|NCT01987557|41663275|FG002|Overall Study|Adverse Event|0|||
19417261|NCT02078817|41663283|FG000|Overall Study|Withdrawal by Subject|1|||
19417262|NCT02011893|41663287|FG000|Enrollment to Randomization|Adverse Event|2|||
19417263|NCT02011893|41663288|FG001|Enrollment to Randomization|Adverse Event|0|||
19417264|NCT02011893|41663289|FG002|Enrollment to Randomization|Adverse Event|0|||
19417265|NCT02011893|41663287|FG000|Enrollment to Randomization|Physician Decision|10|||
19417266|NCT02011893|41663288|FG001|Enrollment to Randomization|Physician Decision|0|||
19417267|NCT02011893|41663289|FG002|Enrollment to Randomization|Physician Decision|0|||
19417268|NCT02011893|41663287|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
19417269|NCT02011893|41663288|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
19417270|NCT02011893|41663289|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
19417271|NCT02011893|41663287|FG000|Enrollment to Randomization|Screening Failure|29|||
19417272|NCT02011893|41663288|FG001|Enrollment to Randomization|Screening Failure|0|||
19417273|NCT02011893|41663289|FG002|Enrollment to Randomization|Screening Failure|0|||
19417274|NCT02011893|41663287|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
19417275|NCT02011893|41663288|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
19417276|NCT02011893|41663289|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
19417277|NCT02011893|41663287|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
19417278|NCT02011893|41663288|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
19417279|NCT02011893|41663289|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
19417280|NCT02011893|41663287|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
19417281|NCT02011893|41663288|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
19417282|NCT02011893|41663289|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
19417283|NCT02011893|41663287|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
19417284|NCT02011893|41663288|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
19417285|NCT02011893|41663289|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
19417286|NCT02011893|41663287|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
19417287|NCT02011893|41663288|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
19417288|NCT02011893|41663289|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
19417289|NCT02011113|41663294|FG000|Overall Study|Adverse Event|4|||
19417290|NCT02011113|41663294|FG000|Overall Study|Disease Progression (DP)|16|||
19417291|NCT02011113|41663294|FG000|Overall Study|Death|1|||
19417292|NCT02011113|41663294|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
19417293|NCT02011113|41663294|FG000|Overall Study|Investigator's judgement- DP|3|||
19417294|NCT02011113|41663294|FG000|Overall Study|Study terminated by sponsor|11|||
19417295|NCT01987479|41663299|FG000|Overall Study|Protocol Violation|1|||
19417296|NCT01987479|41663299|FG000|Overall Study|Physician Decision|2|||
19417297|NCT01987479|41663299|FG000|Overall Study|Participant/legal guardian decision|1|||
19417298|NCT01987479|41663299|FG000|Overall Study|Other|5|||
19417299|NCT01987479|41663299|FG000|Overall Study|Lost to Follow-up|1|||
19417300|NCT01987479|41663299|FG000|Overall Study|Adverse Event|7|||
19417301|NCT01620489|41663305|FG000|Overall Study|Adverse Event|17|||
19417302|NCT01620489|41663306|FG001|Overall Study|Adverse Event|4|||
19417303|NCT01620489|41663305|FG000|Overall Study|Protocol Violation|0|||
19417304|NCT01620489|41663306|FG001|Overall Study|Protocol Violation|3|||
19417305|NCT01620489|41663305|FG000|Overall Study|Withdrawal Criteria|17|||
19417306|NCT01620489|41663306|FG001|Overall Study|Withdrawal Criteria|25|||
19417307|NCT01620489|41663305|FG000|Overall Study|Unclassified|1|||
19417308|NCT01620489|41663306|FG001|Overall Study|Unclassified|2|||
19417309|NCT02076165|41663314|FG000|Overall Study|Lost to Follow-up|7|||
19417310|NCT02076165|41663315|FG001|Overall Study|Lost to Follow-up|5|||
19417311|NCT02076165|41663314|FG000|Overall Study|Refused follow-up assessment|1|||
19417312|NCT02076165|41663315|FG001|Overall Study|Refused follow-up assessment|1|||
19417313|NCT01620255|41663326|FG000|Overall Study|Withdrawal by Subject|4|||
19417314|NCT01620255|41663327|FG001|Overall Study|Withdrawal by Subject|1|||
19417315|NCT01620255|41663328|FG002|Overall Study|Withdrawal by Subject|1|||
19417316|NCT01620255|41663329|FG003|Overall Study|Withdrawal by Subject|2|||
19417317|NCT01620255|41663330|FG004|Overall Study|Withdrawal by Subject|4|||
19417318|NCT01620255|41663326|FG000|Overall Study|Participant underwent fecal transplant|0|||
19417319|NCT01620255|41663327|FG001|Overall Study|Participant underwent fecal transplant|0|||
19417320|NCT01620255|41663328|FG002|Overall Study|Participant underwent fecal transplant|1|||
19417321|NCT01620255|41663329|FG003|Overall Study|Participant underwent fecal transplant|0|||
19417322|NCT01620255|41663330|FG004|Overall Study|Participant underwent fecal transplant|0|||
19417323|NCT01620255|41663326|FG000|Overall Study|Non-compliance|0|||
19417324|NCT01620255|41663327|FG001|Overall Study|Non-compliance|1|||
19417325|NCT01620255|41663328|FG002|Overall Study|Non-compliance|0|||
19417326|NCT01620255|41663329|FG003|Overall Study|Non-compliance|0|||
19417327|NCT01620255|41663330|FG004|Overall Study|Non-compliance|0|||
19417328|NCT01620255|41663326|FG000|Overall Study|Adverse Event|0|||
19417329|NCT01620255|41663327|FG001|Overall Study|Adverse Event|4|||
19417330|NCT01620255|41663328|FG002|Overall Study|Adverse Event|0|||
19417331|NCT01620255|41663329|FG003|Overall Study|Adverse Event|1|||
19417332|NCT01620255|41663330|FG004|Overall Study|Adverse Event|1|||
19417333|NCT01620255|41663326|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
19417334|NCT01620255|41663327|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
19417335|NCT01620255|41663328|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
19417336|NCT01620255|41663329|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
19417337|NCT01620255|41663330|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
19417338|NCT02010567|41663347|FG000|Overall Study|Adverse Event|0|||
19417339|NCT02010567|41663348|FG001|Overall Study|Adverse Event|0|||
19417340|NCT02010567|41663349|FG002|Overall Study|Adverse Event|1|||
19417341|NCT02010567|41663350|FG003|Overall Study|Adverse Event|0|||
19417342|NCT02010567|41663351|FG004|Overall Study|Adverse Event|1|||
19417343|NCT01806064|41663366|FG000|Overall Study|Randomized Not Enrolled|0|||
19417344|NCT01806064|41663367|FG001|Overall Study|Randomized Not Enrolled|0|||
19417345|NCT01806064|41663368|FG002|Overall Study|Randomized Not Enrolled|0|||
19417346|NCT01806064|41663369|FG003|Overall Study|Randomized Not Enrolled|1|||
19417347|NCT01806064|41663370|FG004|Overall Study|Randomized Not Enrolled|2|||
19417348|NCT01804582|41663388|FG000|Overall Study|Lost to Follow-up|47|||
19417349|NCT01804582|41663389|FG001|Overall Study|Lost to Follow-up|56|||
19417350|NCT01804582|41663388|FG000|Overall Study|Physician Decision|2|||
19417351|NCT01804582|41663389|FG001|Overall Study|Physician Decision|0|||
19417352|NCT01787188|41663399|FG000|Overall Study|Adverse Event|2|||
19417353|NCT01787188|41663400|FG001|Overall Study|Adverse Event|4|||
19417354|NCT01787188|41663401|FG002|Overall Study|Adverse Event|6|||
19417355|NCT01787188|41663399|FG000|Overall Study|Lack of Efficacy|7|||
19417356|NCT01787188|41663400|FG001|Overall Study|Lack of Efficacy|3|||
19417357|NCT01787188|41663401|FG002|Overall Study|Lack of Efficacy|5|||
19417358|NCT01787188|41663399|FG000|Overall Study|Non-compliance with Study Drug|0|||
19417359|NCT01787188|41663400|FG001|Overall Study|Non-compliance with Study Drug|1|||
19417360|NCT01787188|41663401|FG002|Overall Study|Non-compliance with Study Drug|0|||
19417361|NCT01787188|41663399|FG000|Overall Study|Withdrawal by Subject|4|||
19417362|NCT01787188|41663400|FG001|Overall Study|Withdrawal by Subject|3|||
19417363|NCT01787188|41663401|FG002|Overall Study|Withdrawal by Subject|2|||
19417364|NCT01787188|41663399|FG000|Overall Study|Protocol Violation|3|||
19417365|NCT01787188|41663400|FG001|Overall Study|Protocol Violation|2|||
19417366|NCT01787188|41663401|FG002|Overall Study|Protocol Violation|3|||
19417367|NCT01787188|41663399|FG000|Overall Study|Lost to Follow-up|1|||
19417368|NCT01787188|41663400|FG001|Overall Study|Lost to Follow-up|2|||
19417369|NCT01787188|41663401|FG002|Overall Study|Lost to Follow-up|2|||
19417370|NCT01787188|41663399|FG000|Overall Study|Other, including patient moved|0|||
19417371|NCT01787188|41663400|FG001|Overall Study|Other, including patient moved|3|||
19417372|NCT01787188|41663401|FG002|Overall Study|Other, including patient moved|0|||
19417373|NCT01787032|41663415|FG000|Overall Study|Protocol Violation|0|||
19417374|NCT01787032|41663416|FG001|Overall Study|Protocol Violation|0|||
19417375|NCT01787032|41663417|FG002|Overall Study|Protocol Violation|0|||
19417376|NCT01787032|41663418|FG003|Overall Study|Protocol Violation|0|||
19417377|NCT01787032|41663419|FG004|Overall Study|Protocol Violation|1|||
19417378|NCT01787032|41663420|FG005|Overall Study|Protocol Violation|1|||
19417379|NCT01737268|41663430|FG000|Overall Study|Adverse Event|6|||
19417380|NCT01737268|41663430|FG000|Overall Study|Worsening of Target Disease|2|||
19417381|NCT01737268|41663430|FG000|Overall Study|In consideration of the patient's safety|1|||
19417382|NCT01769404|41663435|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
19417383|NCT01769404|41663436|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
19417384|NCT01769404|41663435|FG000|Treatment Period 1|Withdrawal by Subject|3|||
19417385|NCT01769404|41663436|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19417386|NCT01769404|41663435|FG000|Treatment Period 1|Sponsor decision|1|||
19417387|NCT01769404|41663436|FG001|Treatment Period 1|Sponsor decision|0|||
19417388|NCT01769404|41663435|FG000|Treatment Period 2|Sponsor decision|7|||
19417389|NCT01769404|41663436|FG001|Treatment Period 2|Sponsor decision|0|||
19417390|NCT01769326|41663448|FG000|Overall Study|Lost to Follow-up|1|||
19417391|NCT01769326|41663449|FG001|Overall Study|Lost to Follow-up|2|||
19417392|NCT01769326|41663450|FG002|Overall Study|Lost to Follow-up|0|||
19417393|NCT01769326|41663451|FG003|Overall Study|Lost to Follow-up|0|||
19417394|NCT01769326|41663448|FG000|Overall Study|unrelated injry|1|||
19417395|NCT01769326|41663449|FG001|Overall Study|unrelated injry|1|||
19417396|NCT01769326|41663450|FG002|Overall Study|unrelated injry|0|||
19417397|NCT01769326|41663451|FG003|Overall Study|unrelated injry|0|||
19417398|NCT01769326|41663448|FG000|Overall Study|got a job|0|||
19417399|NCT01769326|41663449|FG001|Overall Study|got a job|1|||
19417400|NCT01769326|41663450|FG002|Overall Study|got a job|0|||
19417401|NCT01769326|41663451|FG003|Overall Study|got a job|0|||
19417402|NCT01769326|41663448|FG000|Overall Study|Got sick and could not complete study|0|||
19417403|NCT01769326|41663449|FG001|Overall Study|Got sick and could not complete study|0|||
19417404|NCT01769326|41663450|FG002|Overall Study|Got sick and could not complete study|1|||
19417405|NCT01769326|41663451|FG003|Overall Study|Got sick and could not complete study|0|||
19417406|NCT01786564|41663461|FG000|Overall Study|Lost to Follow-up|47|||
19417407|NCT01786564|41663461|FG000|Overall Study|Ineligible|17|||
19417408|NCT01786330|41663467|FG000|Overall Study|Withdrawal by Subject|0|||
19417409|NCT01786330|41663468|FG001|Overall Study|Withdrawal by Subject|1|||
19417410|NCT01786330|41663467|FG000|Overall Study|Lost to Follow-up|0|||
19417411|NCT01786330|41663468|FG001|Overall Study|Lost to Follow-up|1|||
19417412|NCT01786330|41663467|FG000|Overall Study|Excluded intraoperatively|0|||
19417413|NCT01786330|41663468|FG001|Overall Study|Excluded intraoperatively|1|||
19417414|NCT01786330|41663467|FG000|Overall Study|Protocol Violation|1|||
19417415|NCT01786330|41663468|FG001|Overall Study|Protocol Violation|0|||
19417416|NCT01786174|41663476|FG000|Overall Study|Discontinued Study Drug|2|||
19417417|NCT01786174|41663477|FG001|Overall Study|Discontinued Study Drug|0|||
19417418|NCT01736566|41663488|FG000|Long Term Follow-up|Still collecting data|42|||
19417419|NCT01736566|41663489|FG001|Long Term Follow-up|Still collecting data|0|||
19417420|NCT01736566|41663490|FG002|Long Term Follow-up|Still collecting data|49|||
19417421|NCT01736566|41663491|FG003|Long Term Follow-up|Still collecting data|0|||
19417422|NCT01736566|41663492|FG004|Long Term Follow-up|Still collecting data|1|||
19417423|NCT01768858|41663517|FG000|Overall Study|Lost to Follow-up|9|||
19417424|NCT01768858|41663517|FG000|Overall Study|Lack of Efficacy|8|||
19417425|NCT01768858|41663517|FG000|Overall Study|Serious Adverse Event|1|||
19417426|NCT01768858|41663517|FG000|Overall Study|Participant moved to Germany|1|||
19417427|NCT01768858|41663517|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
19417428|NCT01768858|41663517|FG000|Overall Study|Exanthema|1|||
19417429|NCT01768858|41663517|FG000|Overall Study|Withdrawal by Subject|1|||
19417430|NCT01736254|41663521|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
19417431|NCT01736254|41663521|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
19417432|NCT01767376|41663532|FG000|Overall Study|Lost to Follow-up|3|||
19417433|NCT01767376|41663533|FG001|Overall Study|Lost to Follow-up|2|||
19417434|NCT01767376|41663534|FG002|Overall Study|Lost to Follow-up|0|||
19417435|NCT01767376|41663532|FG000|Overall Study|Withdrawal by Subject|1|||
19417436|NCT01767376|41663533|FG001|Overall Study|Withdrawal by Subject|1|||
19417437|NCT01767376|41663534|FG002|Overall Study|Withdrawal by Subject|0|||
19417438|NCT01767142|41663544|FG000|Overall Study|Lost to Follow-up|3|||
19417439|NCT01785628|41663550|FG000|Overall Study|Lost to Follow-up|2|||
19417440|NCT01785628|41663551|FG001|Overall Study|Lost to Follow-up|3|||
19417441|NCT01785472|41663560|FG000|Overall Study|Adverse Event|5|||
19417442|NCT01785472|41663561|FG001|Overall Study|Adverse Event|4|||
19417443|NCT01785472|41663562|FG002|Overall Study|Adverse Event|6|||
19417444|NCT01785472|41663560|FG000|Overall Study|Lack of Efficacy|2|||
19417445|NCT01785472|41663561|FG001|Overall Study|Lack of Efficacy|0|||
19417446|NCT01785472|41663562|FG002|Overall Study|Lack of Efficacy|1|||
19417447|NCT01785472|41663560|FG000|Overall Study|Lost to Follow-up|1|||
19417448|NCT01785472|41663561|FG001|Overall Study|Lost to Follow-up|2|||
19417449|NCT01785472|41663562|FG002|Overall Study|Lost to Follow-up|0|||
19417450|NCT01785472|41663560|FG000|Overall Study|Physician Decision|1|||
19417451|NCT01785472|41663561|FG001|Overall Study|Physician Decision|1|||
19417452|NCT01785472|41663562|FG002|Overall Study|Physician Decision|1|||
19417453|NCT01785472|41663560|FG000|Overall Study|Protocol deviation|0|||
19417454|NCT01785472|41663561|FG001|Overall Study|Protocol deviation|2|||
19417455|NCT01785472|41663562|FG002|Overall Study|Protocol deviation|2|||
19417456|NCT01785472|41663560|FG000|Overall Study|Subject/guardian decision|15|||
19417457|NCT01785472|41663561|FG001|Overall Study|Subject/guardian decision|10|||
19417458|NCT01785472|41663562|FG002|Overall Study|Subject/guardian decision|11|||
19417459|NCT01785472|41663560|FG000|Overall Study|Technical problems|0|||
19417460|NCT01785472|41663561|FG001|Overall Study|Technical problems|0|||
19417461|NCT01785472|41663562|FG002|Overall Study|Technical problems|1|||
19417462|NCT01785160|41663572|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
19417463|NCT01785160|41663572|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
19417464|NCT01736176|41663578|FG000|Overall Study|Adverse Event|3|||
19417465|NCT01736176|41663578|FG000|Overall Study|Withdrawal by Subject|4|||
19417466|NCT01736176|41663578|FG000|Overall Study|Lack of Efficacy|3|||
19417467|NCT01736176|41663578|FG000|Overall Study|Unable to Complete PEG Placement|1|||
19417468|NCT01735630|41663588|FG000|Overall Study|Adverse Event|8|||
19417469|NCT01735630|41663589|FG001|Overall Study|Adverse Event|7|||
19417470|NCT01735630|41663588|FG000|Overall Study|Lost to Follow-up|1|||
19417471|NCT01735630|41663589|FG001|Overall Study|Lost to Follow-up|0|||
19417472|NCT01735630|41663588|FG000|Overall Study|Physician Decision|0|||
19417473|NCT01735630|41663589|FG001|Overall Study|Physician Decision|1|||
19417474|NCT01735630|41663588|FG000|Overall Study|Sponsor Decision|2|||
19417475|NCT01735630|41663589|FG001|Overall Study|Sponsor Decision|1|||
19417476|NCT01735630|41663588|FG000|Overall Study|Withdrawal by Subject|7|||
19417477|NCT01735630|41663589|FG001|Overall Study|Withdrawal by Subject|9|||
19417478|NCT01735396|41663595|FG000|Overall Study|not evaluable|1|||
19417479|NCT01766206|41663599|FG000|Overall Study|Withdrawal by Subject|22|||
19417480|NCT01766206|41663599|FG000|Overall Study|Lost to Follow-up|10|||
19417481|NCT01766206|41663599|FG000|Overall Study|Inappropriate enrollment|18|||
19417482|NCT01766206|41663599|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
19417483|NCT01734850|41663606|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
19417484|NCT01734850|41663607|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
19417485|NCT01734850|41663608|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
19417486|NCT01734850|41663606|FG000|Overall Study|Not infused due to manufacturing failure|0|||
19417487|NCT01734850|41663607|FG001|Overall Study|Not infused due to manufacturing failure|0|||
19417488|NCT01734850|41663608|FG002|Overall Study|Not infused due to manufacturing failure|1|||
19417489|NCT01766050|41663619|FG000|Overall Study|Adverse Event|1|||
19417490|NCT01766050|41663619|FG000|Overall Study|Lost to Follow-up|1|||
19417491|NCT01766050|41663619|FG000|Overall Study|Withdrawal by Subject|2|||
19417492|NCT02341625|41663647|FG000|Overall Study|Disease Progression|2|||
19417493|NCT02341625|41663648|FG001|Overall Study|Disease Progression|2|||
19417494|NCT02341625|41663649|FG002|Overall Study|Disease Progression|3|||
19417495|NCT02341625|41663650|FG003|Overall Study|Disease Progression|6|||
19417496|NCT02341625|41663651|FG004|Overall Study|Disease Progression|7|||
19417497|NCT02341625|41663652|FG005|Overall Study|Disease Progression|7|||
19417498|NCT02341625|41663653|FG006|Overall Study|Disease Progression|28|||
19417499|NCT02341625|41663654|FG007|Overall Study|Disease Progression|5|||
19417500|NCT02341625|41663655|FG008|Overall Study|Disease Progression|4|||
19417501|NCT02341625|41663656|FG009|Overall Study|Disease Progression|19|||
19417502|NCT02341625|41663647|FG000|Overall Study|Study Drug Toxicity|0|||
19417503|NCT02341625|41663648|FG001|Overall Study|Study Drug Toxicity|0|||
19417504|NCT02341625|41663649|FG002|Overall Study|Study Drug Toxicity|0|||
19417505|NCT02341625|41663650|FG003|Overall Study|Study Drug Toxicity|1|||
19417506|NCT02341625|41663651|FG004|Overall Study|Study Drug Toxicity|0|||
19417507|NCT02341625|41663652|FG005|Overall Study|Study Drug Toxicity|3|||
19417508|NCT02341625|41663653|FG006|Overall Study|Study Drug Toxicity|10|||
19417509|NCT02341625|41663654|FG007|Overall Study|Study Drug Toxicity|0|||
19417510|NCT02341625|41663655|FG008|Overall Study|Study Drug Toxicity|0|||
19417511|NCT02341625|41663656|FG009|Overall Study|Study Drug Toxicity|3|||
19417512|NCT02341625|41663647|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417513|NCT02341625|41663648|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417514|NCT02341625|41663649|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417515|NCT02341625|41663650|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417516|NCT02341625|41663651|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417517|NCT02341625|41663652|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417518|NCT02341625|41663653|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
19417519|NCT02341625|41663654|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
19417520|NCT02341625|41663655|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
19417521|NCT02341625|41663656|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
19417522|NCT02341625|41663647|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417523|NCT02341625|41663648|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417524|NCT02341625|41663649|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417525|NCT02341625|41663650|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417526|NCT02341625|41663651|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417527|NCT02341625|41663652|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417528|NCT02341625|41663653|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
19417529|NCT02341625|41663654|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
19417530|NCT02341625|41663655|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417531|NCT02341625|41663656|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
19417532|NCT02341625|41663647|FG000|Overall Study|Participant Withdrew Consent|0|||
19417533|NCT02341625|41663648|FG001|Overall Study|Participant Withdrew Consent|0|||
19417534|NCT02341625|41663649|FG002|Overall Study|Participant Withdrew Consent|0|||
19417535|NCT02341625|41663650|FG003|Overall Study|Participant Withdrew Consent|1|||
19417536|NCT02341625|41663651|FG004|Overall Study|Participant Withdrew Consent|0|||
19417537|NCT02341625|41663652|FG005|Overall Study|Participant Withdrew Consent|0|||
19417538|NCT02341625|41663653|FG006|Overall Study|Participant Withdrew Consent|0|||
19417539|NCT02341625|41663654|FG007|Overall Study|Participant Withdrew Consent|0|||
19417540|NCT02341625|41663655|FG008|Overall Study|Participant Withdrew Consent|0|||
19417541|NCT02341625|41663656|FG009|Overall Study|Participant Withdrew Consent|0|||
19417542|NCT02341625|41663647|FG000|Overall Study|Completed Treatment as per Protocol|0|||
19417543|NCT02341625|41663648|FG001|Overall Study|Completed Treatment as per Protocol|0|||
19417544|NCT02341625|41663649|FG002|Overall Study|Completed Treatment as per Protocol|0|||
19417545|NCT02341625|41663650|FG003|Overall Study|Completed Treatment as per Protocol|0|||
19417546|NCT02341625|41663651|FG004|Overall Study|Completed Treatment as per Protocol|0|||
19417547|NCT02341625|41663652|FG005|Overall Study|Completed Treatment as per Protocol|0|||
19417548|NCT02341625|41663653|FG006|Overall Study|Completed Treatment as per Protocol|0|||
19417549|NCT02341625|41663654|FG007|Overall Study|Completed Treatment as per Protocol|0|||
19417550|NCT02341625|41663655|FG008|Overall Study|Completed Treatment as per Protocol|0|||
19417551|NCT02341625|41663656|FG009|Overall Study|Completed Treatment as per Protocol|1|||
19417552|NCT02341625|41663647|FG000|Overall Study|Other Reasons|0|||
19417553|NCT02341625|41663648|FG001|Overall Study|Other Reasons|0|||
19417554|NCT02341625|41663649|FG002|Overall Study|Other Reasons|0|||
19417555|NCT02341625|41663650|FG003|Overall Study|Other Reasons|0|||
19417556|NCT02341625|41663651|FG004|Overall Study|Other Reasons|1|||
19417557|NCT02341625|41663652|FG005|Overall Study|Other Reasons|0|||
19417558|NCT02341625|41663653|FG006|Overall Study|Other Reasons|5|||
19417559|NCT02341625|41663654|FG007|Overall Study|Other Reasons|0|||
19417560|NCT02341625|41663655|FG008|Overall Study|Other Reasons|0|||
19417561|NCT02341625|41663656|FG009|Overall Study|Other Reasons|2|||
19417562|NCT02341625|41663647|FG000|Overall Study|Not Reported|0|||
19417563|NCT02341625|41663648|FG001|Overall Study|Not Reported|0|||
19417564|NCT02341625|41663649|FG002|Overall Study|Not Reported|0|||
19417565|NCT02341625|41663650|FG003|Overall Study|Not Reported|0|||
19417566|NCT02341625|41663651|FG004|Overall Study|Not Reported|0|||
19417567|NCT02341625|41663652|FG005|Overall Study|Not Reported|0|||
19519444|NCT01474512|41932299|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
19519445|NCT01474512|41932300|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
19519446|NCT01474512|41932301|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
19519447|NCT01474512|41932302|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
19519448|NCT01474512|41932303|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
19519449|NCT01474512|41932304|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
19519450|NCT01474512|41932305|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
19519451|NCT01474512|41932306|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
19417568|NCT02341625|41663653|FG006|Overall Study|Not Reported|0|||
19417569|NCT02341625|41663654|FG007|Overall Study|Not Reported|0|||
19417570|NCT02341625|41663655|FG008|Overall Study|Not Reported|0|||
19417571|NCT02341625|41663656|FG009|Overall Study|Not Reported|3|||
19417572|NCT02370095|41663703|FG000|Overall Study|Withdrawal by Subject|0|||
19417573|NCT02370095|41663704|FG001|Overall Study|Withdrawal by Subject|1|||
19417574|NCT01784068|41663710|FG000|NTCS Phase|Adverse Event|5|||
19417575|NCT01784068|41663711|FG001|NTCS Phase|Adverse Event|0|||
19417576|NCT01784068|41663710|FG000|NTCS Phase|Physician Decision|2|||
19417577|NCT01784068|41663711|FG001|NTCS Phase|Physician Decision|0|||
19417578|NCT01784068|41663710|FG000|NTCS Phase|Patient/guardian decision|3|||
19417579|NCT01784068|41663711|FG001|NTCS Phase|Patient/guardian decision|0|||
19417580|NCT01784068|41663710|FG000|NTCS Phase|Death|2|||
19417581|NCT01784068|41663711|FG001|NTCS Phase|Death|0|||
19417582|NCT01784068|41663710|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
19417583|NCT01784068|41663711|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
19417584|NCT01784068|41663710|FG000|TFR Phase|Physician Decision|0|||
19417585|NCT01784068|41663711|FG001|TFR Phase|Physician Decision|1|||
19417586|NCT01784068|41663710|FG000|TFR Phase|Patient/guardian decision|0|||
19417587|NCT01784068|41663711|FG001|TFR Phase|Patient/guardian decision|3|||
19417588|NCT01784068|41663710|FG000|TFR Phase|Death|0|||
19417589|NCT01784068|41663711|FG001|TFR Phase|Death|1|||
19417590|NCT01784068|41663710|FG000|TFR Phase|Lack of Efficacy|0|||
19417591|NCT01784068|41663711|FG001|TFR Phase|Lack of Efficacy|88|||
19417592|NCT01783678|41663728|FG000|Overall Study|Randomized but Not Treated|0|||
19417593|NCT01783678|41663729|FG001|Overall Study|Randomized but Not Treated|0|||
19417594|NCT01783678|41663730|FG002|Overall Study|Randomized but Not Treated|0|||
19417595|NCT01783678|41663731|FG003|Overall Study|Randomized but Not Treated|1|||
19417596|NCT01783678|41663732|FG004|Overall Study|Randomized but Not Treated|0|||
19417597|NCT01783678|41663733|FG005|Overall Study|Randomized but Not Treated|0|||
19417598|NCT01783678|41663728|FG000|Overall Study|Lack of Efficacy|1|||
19417599|NCT01783678|41663729|FG001|Overall Study|Lack of Efficacy|13|||
19417600|NCT01783678|41663730|FG002|Overall Study|Lack of Efficacy|1|||
19417601|NCT01783678|41663731|FG003|Overall Study|Lack of Efficacy|3|||
19417602|NCT01783678|41663732|FG004|Overall Study|Lack of Efficacy|6|||
19417603|NCT01783678|41663733|FG005|Overall Study|Lack of Efficacy|5|||
19417604|NCT01783678|41663728|FG000|Overall Study|Lost to Follow-up|0|||
19417605|NCT01783678|41663729|FG001|Overall Study|Lost to Follow-up|4|||
19417606|NCT01783678|41663730|FG002|Overall Study|Lost to Follow-up|0|||
19417607|NCT01783678|41663731|FG003|Overall Study|Lost to Follow-up|2|||
19417608|NCT01783678|41663732|FG004|Overall Study|Lost to Follow-up|1|||
19417609|NCT01783678|41663733|FG005|Overall Study|Lost to Follow-up|0|||
19417610|NCT01783678|41663728|FG000|Overall Study|Withdrew Consent|1|||
19417611|NCT01783678|41663729|FG001|Overall Study|Withdrew Consent|1|||
19417612|NCT01783678|41663730|FG002|Overall Study|Withdrew Consent|0|||
19417613|NCT01783678|41663731|FG003|Overall Study|Withdrew Consent|2|||
19417614|NCT01783678|41663732|FG004|Overall Study|Withdrew Consent|0|||
19417615|NCT01783678|41663733|FG005|Overall Study|Withdrew Consent|0|||
19417616|NCT01734772|41663750|FG000|Overall Study|Adverse Event|1|||
19417617|NCT01734772|41663751|FG001|Overall Study|Adverse Event|2|||
19417618|NCT01734772|41663750|FG000|Overall Study|Withdrawal by Subject|0|||
19417619|NCT01734772|41663751|FG001|Overall Study|Withdrawal by Subject|1|||
19417620|NCT02340221|41663765|FG000|Overall Study|Death|100|||
19417621|NCT02340221|41663766|FG001|Overall Study|Death|197|||
19417622|NCT02340221|41663765|FG000|Overall Study|Withdrawal by Participant|24|||
19417623|NCT02340221|41663766|FG001|Overall Study|Withdrawal by Participant|37|||
19417624|NCT02340221|41663765|FG000|Overall Study|Lost to Follow-up|4|||
19417625|NCT02340221|41663766|FG001|Overall Study|Lost to Follow-up|15|||
19417626|NCT02340221|41663765|FG000|Overall Study|Reason Not Specified|85|||
19417627|NCT02340221|41663766|FG001|Overall Study|Reason Not Specified|165|||
19417628|NCT02340221|41663765|FG000|Overall Study|Study Terminated by Sponsor|1|||
19417629|NCT02340221|41663766|FG001|Overall Study|Study Terminated by Sponsor|3|||
19417630|NCT02339909|41663776|FG000|Overall Study|Became ineligible after randomisation|89|||
19417631|NCT02339909|41663777|FG001|Overall Study|Became ineligible after randomisation|63|||
19417632|NCT02339909|41663778|FG002|Overall Study|Became ineligible after randomisation|71|||
19417633|NCT02395133|41663790|FG000|Overall Study|Adverse Event|4|||
19417634|NCT02395133|41663791|FG001|Overall Study|Adverse Event|1|||
19417635|NCT02395133|41663792|FG002|Overall Study|Adverse Event|3|||
19417636|NCT02395133|41663793|FG003|Overall Study|Adverse Event|0|||
19417637|NCT02395133|41663790|FG000|Overall Study|Lack of Efficacy|1|||
19417638|NCT02395133|41663791|FG001|Overall Study|Lack of Efficacy|0|||
19417639|NCT02395133|41663792|FG002|Overall Study|Lack of Efficacy|1|||
19417640|NCT02395133|41663793|FG003|Overall Study|Lack of Efficacy|1|||
19417641|NCT02395133|41663790|FG000|Overall Study|Protocol Violation|1|||
19417642|NCT02395133|41663791|FG001|Overall Study|Protocol Violation|1|||
19417643|NCT02395133|41663792|FG002|Overall Study|Protocol Violation|0|||
19417644|NCT02395133|41663793|FG003|Overall Study|Protocol Violation|3|||
19417645|NCT02395133|41663790|FG000|Overall Study|Lost to Follow-up|0|||
19417646|NCT02395133|41663791|FG001|Overall Study|Lost to Follow-up|1|||
19417647|NCT02395133|41663792|FG002|Overall Study|Lost to Follow-up|1|||
19417648|NCT02395133|41663793|FG003|Overall Study|Lost to Follow-up|0|||
19417649|NCT02395133|41663790|FG000|Overall Study|Pregnancy|0|||
19417650|NCT02395133|41663791|FG001|Overall Study|Pregnancy|0|||
19417651|NCT02395133|41663792|FG002|Overall Study|Pregnancy|3|||
19417652|NCT02395133|41663793|FG003|Overall Study|Pregnancy|0|||
19417653|NCT02395133|41663790|FG000|Overall Study|Consent withdrawn with no reason given|1|||
19417654|NCT02395133|41663791|FG001|Overall Study|Consent withdrawn with no reason given|3|||
19417655|NCT02395133|41663792|FG002|Overall Study|Consent withdrawn with no reason given|0|||
19417656|NCT02395133|41663793|FG003|Overall Study|Consent withdrawn with no reason given|2|||
19417657|NCT02395133|41663790|FG000|Overall Study|Consent withdrawn with personal reason|0|||
19417658|NCT02395133|41663791|FG001|Overall Study|Consent withdrawn with personal reason|1|||
19417659|NCT02395133|41663792|FG002|Overall Study|Consent withdrawn with personal reason|0|||
19417660|NCT02395133|41663793|FG003|Overall Study|Consent withdrawn with personal reason|3|||
19417661|NCT02395133|41663790|FG000|Overall Study|Sponsor decision|2|||
19417662|NCT02395133|41663791|FG001|Overall Study|Sponsor decision|0|||
19417663|NCT02395133|41663792|FG002|Overall Study|Sponsor decision|0|||
19417664|NCT02395133|41663793|FG003|Overall Study|Sponsor decision|1|||
19417665|NCT02395133|41663790|FG000|Overall Study|Other than specified above|5|||
19417666|NCT02395133|41663791|FG001|Overall Study|Other than specified above|2|||
19417667|NCT02395133|41663792|FG002|Overall Study|Other than specified above|2|||
19417668|NCT02395133|41663793|FG003|Overall Study|Other than specified above|4|||
19417669|NCT02395055|41663805|FG000|Overall Study|Withdrawal by Subject|7|||
19417670|NCT02395055|41663806|FG001|Overall Study|Withdrawal by Subject|3|||
19417671|NCT02369159|41663814|FG000|Overall Study|Adverse Event|0|||
19417672|NCT02369159|41663815|FG001|Overall Study|Adverse Event|1|||
19417673|NCT02369159|41663814|FG000|Overall Study|Lost to Follow-up|1|||
19417674|NCT02369159|41663815|FG001|Overall Study|Lost to Follow-up|1|||
19417675|NCT02369159|41663814|FG000|Overall Study|Withdrawal by Subject|7|||
19417676|NCT02369159|41663815|FG001|Overall Study|Withdrawal by Subject|0|||
19417677|NCT02368691|41663832|FG000|Overall Study|Death|13|||
19417678|NCT02368691|41663832|FG000|Overall Study|Lack of Efficacy|15|||
19417679|NCT02368691|41663832|FG000|Overall Study|Physician Decision|4|||
19417680|NCT02394665|41663839|FG000|Overall Study|Physician Decision|1|||
19417681|NCT02394665|41663840|FG001|Overall Study|Physician Decision|0|||
19417682|NCT02394665|41663841|FG002|Overall Study|Physician Decision|0|||
19417683|NCT02367911|41663851|FG000|Overall Study|Withdrawal by Subject|3|||
19417684|NCT02367911|41663852|FG001|Overall Study|Withdrawal by Subject|2|||
19417685|NCT02367911|41663851|FG000|Overall Study|Lost to Follow-up|2|||
19417686|NCT02367911|41663852|FG001|Overall Study|Lost to Follow-up|2|||
19417687|NCT02339285|41663861|FG000|Overall Study|Withdrawal by Subject|0|||
19417688|NCT02339285|41663862|FG001|Overall Study|Withdrawal by Subject|1|||
19417689|NCT02339285|41663863|FG002|Overall Study|Withdrawal by Subject|1|||
19417690|NCT02339285|41663861|FG000|Overall Study|Lost to Follow-up|1|||
19417691|NCT02339285|41663862|FG001|Overall Study|Lost to Follow-up|1|||
19417692|NCT02339285|41663863|FG002|Overall Study|Lost to Follow-up|1|||
19417693|NCT02339285|41663861|FG000|Overall Study|Protocol Deviation|0|||
19417694|NCT02339285|41663862|FG001|Overall Study|Protocol Deviation|1|||
19417695|NCT02339285|41663863|FG002|Overall Study|Protocol Deviation|0|||
19417696|NCT02367833|41663874|FG000|Overall Study|Withdrawal by Subject|1|||
19417697|NCT02367833|41663875|FG001|Overall Study|Withdrawal by Subject|1|||
19417698|NCT02367833|41663876|FG002|Overall Study|Withdrawal by Subject|0|||
19417699|NCT02367521|41663886|FG000|Overall Study|severe headache after intervention|2|||
19417700|NCT02367521|41663887|FG001|Overall Study|severe headache after intervention|0|||
19417701|NCT02367521|41663886|FG000|Overall Study|unable to find transportation|2|||
19417702|NCT02367521|41663887|FG001|Overall Study|unable to find transportation|0|||
19417703|NCT02338193|41663896|FG000|Overall Study|Withdrawal by Subject|0|||
19417704|NCT02338193|41663897|FG001|Overall Study|Withdrawal by Subject|0|||
19417705|NCT02338193|41663898|FG002|Overall Study|Withdrawal by Subject|2|||
19417706|NCT02338193|41663896|FG000|Overall Study|Pregnancy|0|||
19417707|NCT02338193|41663897|FG001|Overall Study|Pregnancy|1|||
19417708|NCT02338193|41663898|FG002|Overall Study|Pregnancy|1|||
19417709|NCT02338193|41663896|FG000|Overall Study|Noncompliant with visits|2|||
19417710|NCT02338193|41663897|FG001|Overall Study|Noncompliant with visits|2|||
19417711|NCT02338193|41663898|FG002|Overall Study|Noncompliant with visits|7|||
19417712|NCT02338193|41663896|FG000|Overall Study|moved out of state|0|||
19417713|NCT02338193|41663897|FG001|Overall Study|moved out of state|1|||
19417714|NCT02338193|41663898|FG002|Overall Study|moved out of state|0|||
19417715|NCT02338193|41663896|FG000|Overall Study|intolerant of side effects|1|||
19417716|NCT02338193|41663897|FG001|Overall Study|intolerant of side effects|0|||
19417717|NCT02338193|41663898|FG002|Overall Study|intolerant of side effects|0|||
19417718|NCT01783444|41663909|FG000|Treatment Phase|Adverse Event|9|||
19417719|NCT01783444|41663910|FG001|Treatment Phase|Adverse Event|20|||
19417720|NCT01783444|41663911|FG002|Treatment Phase|Adverse Event|19|||
19417721|NCT01783444|41663909|FG000|Treatment Phase|Disease Progression|76|||
19417722|NCT01783444|41663910|FG001|Treatment Phase|Disease Progression|66|||
19417723|NCT01783444|41663911|FG002|Treatment Phase|Disease Progression|64|||
19417724|NCT01783444|41663909|FG000|Treatment Phase|Death|2|||
19417725|NCT01783444|41663910|FG001|Treatment Phase|Death|2|||
19417726|NCT01783444|41663911|FG002|Treatment Phase|Death|2|||
19417727|NCT01783444|41663909|FG000|Treatment Phase|Protocol Violation|1|||
19417728|NCT01783444|41663910|FG001|Treatment Phase|Protocol Violation|1|||
19417729|NCT01783444|41663911|FG002|Treatment Phase|Protocol Violation|2|||
19417730|NCT01783444|41663909|FG000|Treatment Phase|Withdrawal by Subject|6|||
19417731|NCT01783444|41663910|FG001|Treatment Phase|Withdrawal by Subject|8|||
19417732|NCT01783444|41663911|FG002|Treatment Phase|Withdrawal by Subject|9|||
19417733|NCT01783444|41663909|FG000|Treatment Phase|Administrative problems|2|||
19417734|NCT01783444|41663910|FG001|Treatment Phase|Administrative problems|0|||
19417735|NCT01783444|41663911|FG002|Treatment Phase|Administrative problems|1|||
19417736|NCT01783444|41663909|FG000|Treatment Phase|Physician Decision|8|||
19417737|NCT01783444|41663910|FG001|Treatment Phase|Physician Decision|6|||
19417738|NCT01783444|41663911|FG002|Treatment Phase|Physician Decision|5|||
19417739|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
19417740|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
19417741|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
19417742|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
19417743|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
19417744|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
19417745|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
19417746|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
19417747|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
19417748|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
19417749|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
19417750|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
19417751|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
19417752|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
19417753|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
19417754|NCT01783444|41663909|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
19417755|NCT01783444|41663910|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
19417756|NCT01783444|41663911|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
19417757|NCT02367131|41663920|FG000|Overall Study|Adverse Event|64|||
19417758|NCT02367131|41663920|FG000|Overall Study|No visit since the first visit|4|||
19417759|NCT02367131|41663920|FG000|Overall Study|Request by patient|54|||
19417760|NCT02367131|41663920|FG000|Overall Study|Improvement/remission|2|||
19417761|NCT02367131|41663920|FG000|Overall Study|No change/progressive disease|78|||
19417762|NCT02367131|41663920|FG000|Overall Study|Other than stated above|20|||
19417763|NCT02394275|41663924|FG000|Overall Study|Adverse Event|22|||
19417764|NCT02394275|41663924|FG000|Overall Study|Lost to Follow-up|7|||
19417765|NCT01608724|41663929|FG000|Overall Study|Withdrawal by Subject|131|||
19417766|NCT01608724|41663929|FG000|Overall Study|Lost to Follow-up|41|||
19417767|NCT01608724|41663929|FG000|Overall Study|Study-specific discontinuation criteria|32|||
19417768|NCT01608724|41663929|FG000|Overall Study|Adverse Event|29|||
19417769|NCT01608724|41663929|FG000|Overall Study|Protocol Violation|6|||
19417770|NCT01608724|41663929|FG000|Overall Study|bood sugar too high, etc.|3|||
19417771|NCT01608724|41663929|FG000|Overall Study|Safety reasons|1|||
19417772|NCT02366195|41663933|FG000|Overall Study|Protocol-specified criteria|3|||
19417773|NCT02366195|41663933|FG000|Overall Study|Withdrawal by Subject|9|||
19417774|NCT02366195|41663933|FG000|Overall Study|Lost to Follow-up|1|||
19417775|NCT02366195|41663933|FG000|Overall Study|Death|41|||
19417776|NCT02364947|41663940|FG000|Overall Study|Withdrawal by Subject|10|||
19417777|NCT02364947|41663941|FG001|Overall Study|Withdrawal by Subject|8|||
19417778|NCT02364947|41663942|FG002|Overall Study|Withdrawal by Subject|9|||
19417779|NCT02364947|41663940|FG000|Overall Study|Adverse Event|45|||
19417780|NCT02364947|41663941|FG001|Overall Study|Adverse Event|33|||
19417781|NCT02364947|41663942|FG002|Overall Study|Adverse Event|11|||
19417782|NCT02364947|41663940|FG000|Overall Study|Protocol Violation|1|||
19417783|NCT02364947|41663941|FG001|Overall Study|Protocol Violation|1|||
19417784|NCT02364947|41663942|FG002|Overall Study|Protocol Violation|1|||
19417785|NCT02364947|41663940|FG000|Overall Study|Physician Decision|3|||
19417786|NCT02364947|41663941|FG001|Overall Study|Physician Decision|2|||
19417787|NCT02364947|41663942|FG002|Overall Study|Physician Decision|5|||
19417788|NCT02364947|41663940|FG000|Overall Study|Death|0|||
19417789|NCT02364947|41663941|FG001|Overall Study|Death|1|||
19417790|NCT02364947|41663942|FG002|Overall Study|Death|0|||
19417791|NCT02392481|41663954|FG000|Overall Study|Adverse Event|0|||
19417792|NCT02392481|41663955|FG001|Overall Study|Adverse Event|0|||
19417793|NCT02392481|41663956|FG002|Overall Study|Adverse Event|1|||
19417794|NCT02392481|41663957|FG003|Overall Study|Adverse Event|2|||
19417795|NCT02392481|41663954|FG000|Overall Study|Withdrawal by Subject|0|||
19417796|NCT02392481|41663955|FG001|Overall Study|Withdrawal by Subject|0|||
19417797|NCT02392481|41663956|FG002|Overall Study|Withdrawal by Subject|1|||
19417798|NCT02392481|41663957|FG003|Overall Study|Withdrawal by Subject|0|||
19417799|NCT02392403|41663967|FG000|Overall Study|Adverse Event|1|||
19417800|NCT02392403|41663967|FG000|Overall Study|Death|1|||
19417801|NCT02392403|41663967|FG000|Overall Study|Withdrawal by Subject|1|||
19417802|NCT02392247|41663971|FG000|Overall Study|Withdrawal by Subject|1|||
19417803|NCT02392247|41663971|FG000|Overall Study|Surgery cancelled; no data|1|||
19417804|NCT02337725|41663977|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
19417805|NCT02337725|41663978|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
19417806|NCT02337725|41663977|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
19417807|NCT02337725|41663978|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
19417808|NCT02337725|41663977|FG000|Overall Study|Major Protocol Deviation|0|||
19417809|NCT02337725|41663978|FG001|Overall Study|Major Protocol Deviation|1|||
19417810|NCT02337725|41663977|FG000|Overall Study|Voluntary Withdrawal|14|||
19417811|NCT02337725|41663978|FG001|Overall Study|Voluntary Withdrawal|3|||
19417812|NCT02337725|41663977|FG000|Overall Study|Lack of Efficacy|4|||
19417813|NCT02337725|41663978|FG001|Overall Study|Lack of Efficacy|0|||
19417814|NCT02337491|41663986|FG000|Overall Study|Death|1|||
19417815|NCT02337491|41663987|FG001|Overall Study|Death|1|||
19417816|NCT02337491|41663986|FG000|Overall Study|Adverse Event|0|||
19417817|NCT02337491|41663987|FG001|Overall Study|Adverse Event|1|||
19417818|NCT02337491|41663986|FG000|Overall Study|Withdrawal by Subject|3|||
19417819|NCT02337491|41663987|FG001|Overall Study|Withdrawal by Subject|0|||
19417820|NCT02337491|41663986|FG000|Overall Study|Progressive Disease|44|||
19417821|NCT02337491|41663987|FG001|Overall Study|Progressive Disease|28|||
19417822|NCT02337491|41663986|FG000|Overall Study|On Treatment|2|||
19417823|NCT02337491|41663987|FG001|Overall Study|On Treatment|0|||
19417824|NCT01765582|41663997|FG000|Overall Study|Other|3|||
19417825|NCT01765582|41663998|FG001|Overall Study|Other|6|||
19417826|NCT01765582|41663999|FG002|Overall Study|Other|9|||
19417827|NCT01765582|41663997|FG000|Overall Study|Lost to Follow-up|2|||
19417828|NCT01765582|41663998|FG001|Overall Study|Lost to Follow-up|2|||
19417829|NCT01765582|41663999|FG002|Overall Study|Lost to Follow-up|1|||
19417830|NCT01765582|41663997|FG000|Overall Study|Death|31|||
19417831|NCT01765582|41663998|FG001|Overall Study|Death|36|||
19417832|NCT01765582|41663999|FG002|Overall Study|Death|33|||
19417833|NCT01765582|41663997|FG000|Overall Study|Sponsor Decision|46|||
19417834|NCT01765582|41663998|FG001|Overall Study|Sponsor Decision|42|||
19417835|NCT01765582|41663999|FG002|Overall Study|Sponsor Decision|42|||
19417836|NCT01765582|41663997|FG000|Overall Study|Withdrawal of Consent|11|||
19417837|NCT01765582|41663998|FG001|Overall Study|Withdrawal of Consent|6|||
19417838|NCT01765582|41663999|FG002|Overall Study|Withdrawal of Consent|10|||
19417839|NCT01649375|41664011|FG000|Up to Week 16|Adverse Event|2|||
19417840|NCT01649375|41664012|FG001|Up to Week 16|Adverse Event|5|||
19417841|NCT01649375|41664013|FG002|Up to Week 16|Adverse Event|4|||
19417842|NCT01649375|41664014|FG003|Up to Week 16|Adverse Event|0|||
19417843|NCT01649375|41664015|FG004|Up to Week 16|Adverse Event|0|||
19417844|NCT01649375|41664011|FG000|Up to Week 16|Lack of Efficacy|0|||
19417845|NCT01649375|41664012|FG001|Up to Week 16|Lack of Efficacy|0|||
19417846|NCT01649375|41664013|FG002|Up to Week 16|Lack of Efficacy|1|||
19417847|NCT01649375|41664014|FG003|Up to Week 16|Lack of Efficacy|0|||
19417848|NCT01649375|41664015|FG004|Up to Week 16|Lack of Efficacy|0|||
19417849|NCT01649375|41664011|FG000|Up to Week 16|Physician Decision|0|||
19417850|NCT01649375|41664012|FG001|Up to Week 16|Physician Decision|0|||
19417851|NCT01649375|41664013|FG002|Up to Week 16|Physician Decision|1|||
19417852|NCT01649375|41664014|FG003|Up to Week 16|Physician Decision|0|||
19417853|NCT01649375|41664015|FG004|Up to Week 16|Physician Decision|0|||
19417854|NCT01649375|41664011|FG000|Up to Week 16|Withdrawal by Subject|2|||
19417855|NCT01649375|41664012|FG001|Up to Week 16|Withdrawal by Subject|1|||
19417856|NCT01649375|41664013|FG002|Up to Week 16|Withdrawal by Subject|2|||
19417857|NCT01649375|41664014|FG003|Up to Week 16|Withdrawal by Subject|0|||
19417858|NCT01649375|41664015|FG004|Up to Week 16|Withdrawal by Subject|0|||
19417859|NCT01649375|41664011|FG000|Up to Week 16|Death|1|||
19417860|NCT01649375|41664012|FG001|Up to Week 16|Death|0|||
19417861|NCT01649375|41664013|FG002|Up to Week 16|Death|0|||
19417862|NCT01649375|41664014|FG003|Up to Week 16|Death|0|||
19417863|NCT01649375|41664015|FG004|Up to Week 16|Death|0|||
19417864|NCT01649375|41664011|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
19417865|NCT01649375|41664012|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
19417866|NCT01649375|41664013|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
19417867|NCT01649375|41664014|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
19417868|NCT01649375|41664015|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
19417869|NCT01649375|41664011|FG000|Week 16 up to Week 260|Non-compliance|0|||
19417870|NCT01649375|41664012|FG001|Week 16 up to Week 260|Non-compliance|1|||
19417871|NCT01649375|41664013|FG002|Week 16 up to Week 260|Non-compliance|0|||
19417872|NCT01649375|41664014|FG003|Week 16 up to Week 260|Non-compliance|1|||
19417873|NCT01649375|41664015|FG004|Week 16 up to Week 260|Non-compliance|0|||
19417874|NCT01649375|41664011|FG000|Week 16 up to Week 260|Physician Decision|0|||
19417875|NCT01649375|41664012|FG001|Week 16 up to Week 260|Physician Decision|2|||
19417876|NCT01649375|41664013|FG002|Week 16 up to Week 260|Physician Decision|0|||
19417877|NCT01649375|41664014|FG003|Week 16 up to Week 260|Physician Decision|0|||
19417878|NCT01649375|41664015|FG004|Week 16 up to Week 260|Physician Decision|0|||
19417879|NCT01649375|41664011|FG000|Week 16 up to Week 260|Technical issues|0|||
19417880|NCT01649375|41664012|FG001|Week 16 up to Week 260|Technical issues|1|||
19417881|NCT01649375|41664013|FG002|Week 16 up to Week 260|Technical issues|0|||
19417882|NCT01649375|41664014|FG003|Week 16 up to Week 260|Technical issues|1|||
19417883|NCT01649375|41664015|FG004|Week 16 up to Week 260|Technical issues|0|||
19417884|NCT01649375|41664011|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
19417885|NCT01649375|41664012|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
19417886|NCT01649375|41664013|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
19417887|NCT01649375|41664014|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
19417888|NCT01649375|41664015|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
19519452|NCT01474512|41932307|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
19519453|NCT01474512|41932308|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
19519454|NCT01474512|41932309|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
19519455|NCT01474512|41932292|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
19519456|NCT01474512|41932293|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
19519457|NCT01474512|41932294|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
19519458|NCT01474512|41932295|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
19519459|NCT01474512|41932296|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
19519460|NCT01474512|41932297|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
19519461|NCT01474512|41932298|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
19519462|NCT01474512|41932299|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
19519463|NCT01474512|41932300|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
19519464|NCT01474512|41932301|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
19519465|NCT01474512|41932302|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
19519466|NCT01474512|41932303|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
19519467|NCT01474512|41932304|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
19519468|NCT01474512|41932305|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
19519469|NCT01474512|41932306|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
19519470|NCT01474512|41932307|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
19519471|NCT01474512|41932308|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
19519472|NCT01474512|41932309|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
19519473|NCT01474512|41932292|FG000|Long-Term Extension Period|Physician Decision|0|||
19519474|NCT01474512|41932293|FG001|Long-Term Extension Period|Physician Decision|0|||
19519475|NCT01474512|41932294|FG002|Long-Term Extension Period|Physician Decision|0|||
19519476|NCT01474512|41932295|FG003|Long-Term Extension Period|Physician Decision|0|||
19519477|NCT01474512|41932296|FG004|Long-Term Extension Period|Physician Decision|0|||
19519478|NCT01474512|41932297|FG005|Long-Term Extension Period|Physician Decision|0|||
19519479|NCT01474512|41932298|FG006|Long-Term Extension Period|Physician Decision|0|||
19519480|NCT01474512|41932299|FG007|Long-Term Extension Period|Physician Decision|0|||
19519481|NCT01474512|41932300|FG008|Long-Term Extension Period|Physician Decision|0|||
19519482|NCT01474512|41932301|FG009|Long-Term Extension Period|Physician Decision|0|||
19519483|NCT01474512|41932302|FG010|Long-Term Extension Period|Physician Decision|0|||
19519484|NCT01474512|41932303|FG011|Long-Term Extension Period|Physician Decision|0|||
19519485|NCT01474512|41932304|FG012|Long-Term Extension Period|Physician Decision|21|||
19519486|NCT01474512|41932305|FG013|Long-Term Extension Period|Physician Decision|21|||
19519487|NCT01474512|41932306|FG014|Long-Term Extension Period|Physician Decision|0|||
19519488|NCT01474512|41932307|FG015|Long-Term Extension Period|Physician Decision|0|||
19519489|NCT01474512|41932308|FG016|Long-Term Extension Period|Physician Decision|0|||
19519490|NCT01474512|41932309|FG017|Long-Term Extension Period|Physician Decision|0|||
19519491|NCT01474512|41932292|FG000|Long-Term Extension Period|Clinical Relapse|0|||
19519492|NCT01474512|41932293|FG001|Long-Term Extension Period|Clinical Relapse|0|||
19519493|NCT01474512|41932294|FG002|Long-Term Extension Period|Clinical Relapse|0|||
19519494|NCT01474512|41932295|FG003|Long-Term Extension Period|Clinical Relapse|0|||
19519495|NCT01474512|41932296|FG004|Long-Term Extension Period|Clinical Relapse|0|||
19519496|NCT01474512|41932297|FG005|Long-Term Extension Period|Clinical Relapse|0|||
19519497|NCT01474512|41932298|FG006|Long-Term Extension Period|Clinical Relapse|0|||
19519498|NCT01474512|41932299|FG007|Long-Term Extension Period|Clinical Relapse|0|||
19519499|NCT01474512|41932300|FG008|Long-Term Extension Period|Clinical Relapse|0|||
19519500|NCT01474512|41932301|FG009|Long-Term Extension Period|Clinical Relapse|0|||
19519501|NCT01474512|41932302|FG010|Long-Term Extension Period|Clinical Relapse|0|||
19519502|NCT01474512|41932303|FG011|Long-Term Extension Period|Clinical Relapse|0|||
19519503|NCT01474512|41932304|FG012|Long-Term Extension Period|Clinical Relapse|9|||
19519504|NCT01474512|41932305|FG013|Long-Term Extension Period|Clinical Relapse|9|||
19519505|NCT01474512|41932306|FG014|Long-Term Extension Period|Clinical Relapse|0|||
19519506|NCT01474512|41932307|FG015|Long-Term Extension Period|Clinical Relapse|0|||
19519507|NCT01474512|41932308|FG016|Long-Term Extension Period|Clinical Relapse|0|||
19519508|NCT01474512|41932309|FG017|Long-Term Extension Period|Clinical Relapse|0|||
19417889|NCT01649375|41664011|FG000|Week 16 up to Week 260|Death|1|||
19417890|NCT01649375|41664012|FG001|Week 16 up to Week 260|Death|1|||
19417891|NCT01649375|41664013|FG002|Week 16 up to Week 260|Death|0|||
19417892|NCT01649375|41664014|FG003|Week 16 up to Week 260|Death|0|||
19417893|NCT01649375|41664015|FG004|Week 16 up to Week 260|Death|0|||
19417894|NCT01649375|41664011|FG000|Week 16 up to Week 260|Adverse Event|5|||
19417895|NCT01649375|41664012|FG001|Week 16 up to Week 260|Adverse Event|2|||
19417896|NCT01649375|41664013|FG002|Week 16 up to Week 260|Adverse Event|0|||
19417897|NCT01649375|41664014|FG003|Week 16 up to Week 260|Adverse Event|3|||
19417898|NCT01649375|41664015|FG004|Week 16 up to Week 260|Adverse Event|2|||
19417899|NCT02336555|41664025|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
19417900|NCT02336555|41664026|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
19417901|NCT02336555|41664025|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
19374936|NCT01660256|41616629|FG002|Overall Study|Adverse Event|2|||
19374937|NCT01660256|41616627|FG000|Overall Study|Withdrawal by Subject|1|||
19374938|NCT01660256|41616628|FG001|Overall Study|Withdrawal by Subject|0|||
19374939|NCT01660256|41616629|FG002|Overall Study|Withdrawal by Subject|2|||
19374940|NCT02034123|41616655|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374941|NCT02034123|41616656|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374942|NCT02034123|41616657|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374943|NCT02034123|41616658|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374944|NCT02034123|41616659|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
19374945|NCT02034123|41616660|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374946|NCT02034123|41616661|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374947|NCT02034123|41616662|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
19374948|NCT02034123|41616663|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
19374949|NCT02034123|41616664|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374950|NCT02034123|41616665|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374951|NCT02034123|41616666|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374952|NCT02034123|41616667|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374953|NCT02034123|41616668|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374954|NCT02034123|41616669|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374955|NCT02034123|41616670|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374956|NCT02034123|41616671|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374957|NCT02034123|41616672|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
19374958|NCT02034123|41616655|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374959|NCT02034123|41616656|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374960|NCT02034123|41616657|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374961|NCT02034123|41616658|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
19374962|NCT02034123|41616659|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374963|NCT02034123|41616660|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374964|NCT02034123|41616661|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374965|NCT02034123|41616662|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374966|NCT02034123|41616663|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374967|NCT02034123|41616664|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374968|NCT02034123|41616665|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374969|NCT02034123|41616666|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374970|NCT02034123|41616667|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374971|NCT02034123|41616668|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374972|NCT02034123|41616669|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374973|NCT02034123|41616670|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374974|NCT02034123|41616671|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374975|NCT02034123|41616672|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
19374976|NCT02034123|41616655|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374977|NCT02034123|41616656|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374978|NCT02034123|41616657|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374979|NCT02034123|41616658|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374980|NCT02034123|41616659|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374981|NCT02034123|41616660|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374982|NCT02034123|41616661|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374983|NCT02034123|41616662|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374984|NCT02034123|41616663|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
19374985|NCT02034123|41616664|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374986|NCT02034123|41616665|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19417902|NCT02336555|41664026|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
19519509|NCT01474512|41932292|FG000|Long-Term Extension Period|Death|0|||
19417903|NCT02336555|41664025|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
19417904|NCT02336555|41664026|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
19417905|NCT01648283|41664032|FG000|Overall Study|Withdrawal by Subject|14|||
19417906|NCT01649297|41664043|FG000|Overall Study|Adverse Event|5|||
19417907|NCT01649297|41664044|FG001|Overall Study|Adverse Event|5|||
19417908|NCT01649297|41664045|FG002|Overall Study|Adverse Event|4|||
19417909|NCT01649297|41664046|FG003|Overall Study|Adverse Event|13|||
19417910|NCT01649297|41664047|FG004|Overall Study|Adverse Event|1|||
19417911|NCT01649297|41664043|FG000|Overall Study|Lack of Efficacy|0|||
19417912|NCT01649297|41664044|FG001|Overall Study|Lack of Efficacy|0|||
19417913|NCT01649297|41664045|FG002|Overall Study|Lack of Efficacy|0|||
19417914|NCT01649297|41664046|FG003|Overall Study|Lack of Efficacy|0|||
19417915|NCT01649297|41664047|FG004|Overall Study|Lack of Efficacy|1|||
19417916|NCT01649297|41664043|FG000|Overall Study|Non compliant with Protocol|1|||
19417917|NCT01649297|41664044|FG001|Overall Study|Non compliant with Protocol|0|||
19417918|NCT01649297|41664045|FG002|Overall Study|Non compliant with Protocol|3|||
19417919|NCT01649297|41664046|FG003|Overall Study|Non compliant with Protocol|2|||
19417920|NCT01649297|41664047|FG004|Overall Study|Non compliant with Protocol|1|||
19417921|NCT01649297|41664043|FG000|Overall Study|Lost to Follow-up|1|||
19417922|NCT01649297|41664044|FG001|Overall Study|Lost to Follow-up|1|||
19417923|NCT01649297|41664045|FG002|Overall Study|Lost to Follow-up|4|||
19417924|NCT01649297|41664046|FG003|Overall Study|Lost to Follow-up|3|||
19417925|NCT01649297|41664047|FG004|Overall Study|Lost to Follow-up|0|||
19417926|NCT01649297|41664043|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
19417927|NCT01649297|41664044|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
19417928|NCT01649297|41664045|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
19417929|NCT01649297|41664046|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
19417930|NCT01649297|41664047|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
19417931|NCT01649297|41664043|FG000|Overall Study|For other reason|4|||
19417932|NCT01649297|41664044|FG001|Overall Study|For other reason|1|||
19417933|NCT01649297|41664045|FG002|Overall Study|For other reason|2|||
19417934|NCT01649297|41664046|FG003|Overall Study|For other reason|0|||
19417935|NCT01649297|41664047|FG004|Overall Study|For other reason|0|||
19417936|NCT01648205|41664059|FG000|Placebo|Pregnancy|1|||
19417937|NCT01648205|41664059|FG000|Placebo|Withdrawal by Subject|1|||
19417938|NCT01648205|41664059|FG000|Placebo|Protocol Violation|2|||
19417939|NCT01648205|41664059|FG000|Ranolazine|Death|1|||
19417940|NCT01648205|41664059|FG000|Ranolazine|Withdrawal by Subject|1|||
19417941|NCT01648205|41664059|FG000|Ranolazine|Protocol Violation|3|||
19417942|NCT02391545|41664069|FG000|Overall Study|Death|0|||
19417943|NCT02391545|41664070|FG001|Overall Study|Death|2|||
19417944|NCT02391545|41664069|FG000|Overall Study|Lost to Follow-up|0|||
19417945|NCT02391545|41664070|FG001|Overall Study|Lost to Follow-up|1|||
19417946|NCT02391545|41664069|FG000|Overall Study|Termination of study by sponsor|20|||
19417947|NCT02391545|41664070|FG001|Overall Study|Termination of study by sponsor|20|||
19417948|NCT02391545|41664069|FG000|Overall Study|Withdrawal by Subject|0|||
19417949|NCT02391545|41664070|FG001|Overall Study|Withdrawal by Subject|1|||
19417950|NCT02391545|41664069|FG000|Overall Study|Other Reasons|6|||
19417951|NCT02391545|41664070|FG001|Overall Study|Other Reasons|4|||
19417952|NCT02362451|41664079|FG000|Overall Study|Withdrawal by Subject|0|||
19417953|NCT02362451|41664080|FG001|Overall Study|Withdrawal by Subject|1|||
19417954|NCT02362451|41664079|FG000|Overall Study|Lack of Efficacy|2|||
19417955|NCT02362451|41664080|FG001|Overall Study|Lack of Efficacy|0|||
19417956|NCT02362451|41664079|FG000|Overall Study|Progression|1|||
19417957|NCT02362451|41664080|FG001|Overall Study|Progression|0|||
19417958|NCT02362451|41664079|FG000|Overall Study|Participant chose other therapy.|1|||
19417959|NCT02362451|41664080|FG001|Overall Study|Participant chose other therapy.|0|||
19417960|NCT01734382|41664089|FG000|Part 1|Adverse Event|2|||
19417961|NCT01734382|41664090|FG001|Part 1|Adverse Event|0|||
19417962|NCT01734382|41664091|FG002|Part 1|Adverse Event|0|||
19417963|NCT01734382|41664089|FG000|Part 2|Adverse Event|0|||
19417964|NCT01734382|41664090|FG001|Part 2|Adverse Event|0|||
19417965|NCT01734382|41664091|FG002|Part 2|Adverse Event|1|||
19417966|NCT01734382|41664089|FG000|Part 2|Lack of Efficacy|0|||
19417967|NCT01734382|41664090|FG001|Part 2|Lack of Efficacy|1|||
19417968|NCT01734382|41664091|FG002|Part 2|Lack of Efficacy|1|||
19417969|NCT01734382|41664089|FG000|Part 2|Other|0|||
19417970|NCT01734382|41664090|FG001|Part 2|Other|0|||
19417971|NCT01734382|41664091|FG002|Part 2|Other|1|||
19417972|NCT01734382|41664089|FG000|Part 2|Physician Decision|0|||
19417973|NCT01734382|41664090|FG001|Part 2|Physician Decision|0|||
19417974|NCT01734382|41664091|FG002|Part 2|Physician Decision|3|||
19417975|NCT01734382|41664089|FG000|Part 2|Protocol Violation|0|||
19417976|NCT01734382|41664090|FG001|Part 2|Protocol Violation|1|||
19417977|NCT01734382|41664091|FG002|Part 2|Protocol Violation|0|||
19519510|NCT01474512|41932293|FG001|Long-Term Extension Period|Death|0|||
19417978|NCT01734382|41664089|FG000|Part 2|Withdrawal by Subject|0|||
19417979|NCT01734382|41664090|FG001|Part 2|Withdrawal by Subject|0|||
19417980|NCT01734382|41664091|FG002|Part 2|Withdrawal by Subject|1|||
19417981|NCT02391311|41664105|FG000|Overall Study|Lost to Follow-up|2|||
19417982|NCT02391311|41664106|FG001|Overall Study|Lost to Follow-up|1|||
19417983|NCT02391311|41664105|FG000|Overall Study|deemed ineligible after baseline|1|||
19519511|NCT01474512|41932294|FG002|Long-Term Extension Period|Death|0|||
19519512|NCT01474512|41932295|FG003|Long-Term Extension Period|Death|0|||
19519513|NCT01474512|41932296|FG004|Long-Term Extension Period|Death|0|||
19519514|NCT01474512|41932297|FG005|Long-Term Extension Period|Death|0|||
19519515|NCT01474512|41932298|FG006|Long-Term Extension Period|Death|0|||
19519516|NCT01474512|41932299|FG007|Long-Term Extension Period|Death|0|||
19519517|NCT01474512|41932300|FG008|Long-Term Extension Period|Death|0|||
19519518|NCT01474512|41932301|FG009|Long-Term Extension Period|Death|0|||
19519519|NCT01474512|41932302|FG010|Long-Term Extension Period|Death|0|||
19519520|NCT01474512|41932303|FG011|Long-Term Extension Period|Death|0|||
19519521|NCT01474512|41932304|FG012|Long-Term Extension Period|Death|9|||
19519522|NCT01474512|41932305|FG013|Long-Term Extension Period|Death|9|||
19519523|NCT01474512|41932306|FG014|Long-Term Extension Period|Death|0|||
19519524|NCT01474512|41932307|FG015|Long-Term Extension Period|Death|0|||
19519525|NCT01474512|41932308|FG016|Long-Term Extension Period|Death|0|||
19519526|NCT01474512|41932309|FG017|Long-Term Extension Period|Death|0|||
19519527|NCT01474512|41932292|FG000|Long-Term Extension Period|Sponsor Decision|0|||
19519528|NCT01474512|41932293|FG001|Long-Term Extension Period|Sponsor Decision|0|||
19519529|NCT01474512|41932294|FG002|Long-Term Extension Period|Sponsor Decision|0|||
19519530|NCT01474512|41932295|FG003|Long-Term Extension Period|Sponsor Decision|0|||
19519531|NCT01474512|41932296|FG004|Long-Term Extension Period|Sponsor Decision|0|||
19519532|NCT01474512|41932297|FG005|Long-Term Extension Period|Sponsor Decision|0|||
19519533|NCT01474512|41932298|FG006|Long-Term Extension Period|Sponsor Decision|0|||
19519534|NCT01474512|41932299|FG007|Long-Term Extension Period|Sponsor Decision|0|||
19519535|NCT01474512|41932300|FG008|Long-Term Extension Period|Sponsor Decision|0|||
19519536|NCT01474512|41932301|FG009|Long-Term Extension Period|Sponsor Decision|0|||
19519537|NCT01474512|41932302|FG010|Long-Term Extension Period|Sponsor Decision|0|||
19519538|NCT01474512|41932303|FG011|Long-Term Extension Period|Sponsor Decision|0|||
19519539|NCT01474512|41932304|FG012|Long-Term Extension Period|Sponsor Decision|6|||
19519540|NCT01474512|41932305|FG013|Long-Term Extension Period|Sponsor Decision|6|||
19519541|NCT01474512|41932306|FG014|Long-Term Extension Period|Sponsor Decision|0|||
19519542|NCT01474512|41932307|FG015|Long-Term Extension Period|Sponsor Decision|0|||
19519543|NCT01474512|41932308|FG016|Long-Term Extension Period|Sponsor Decision|0|||
19519544|NCT01474512|41932309|FG017|Long-Term Extension Period|Sponsor Decision|0|||
19519545|NCT01474512|41932292|FG000|Long-Term Extension Period|Protocol Violation|0|||
19519546|NCT01474512|41932293|FG001|Long-Term Extension Period|Protocol Violation|0|||
19519547|NCT01474512|41932294|FG002|Long-Term Extension Period|Protocol Violation|0|||
19519548|NCT01474512|41932295|FG003|Long-Term Extension Period|Protocol Violation|0|||
19519549|NCT01474512|41932296|FG004|Long-Term Extension Period|Protocol Violation|0|||
19519550|NCT01474512|41932297|FG005|Long-Term Extension Period|Protocol Violation|0|||
19519551|NCT01474512|41932298|FG006|Long-Term Extension Period|Protocol Violation|0|||
19519552|NCT01474512|41932299|FG007|Long-Term Extension Period|Protocol Violation|0|||
19519553|NCT01474512|41932300|FG008|Long-Term Extension Period|Protocol Violation|0|||
19519554|NCT01474512|41932301|FG009|Long-Term Extension Period|Protocol Violation|0|||
19519555|NCT01474512|41932302|FG010|Long-Term Extension Period|Protocol Violation|0|||
19519556|NCT01474512|41932303|FG011|Long-Term Extension Period|Protocol Violation|0|||
19417984|NCT02391311|41664106|FG001|Overall Study|deemed ineligible after baseline|1|||
19417985|NCT01765426|41664116|FG000|Overall Study|Lost to Follow-up|0|||
19417986|NCT01765426|41664117|FG001|Overall Study|Lost to Follow-up|1|||
19417987|NCT01765426|41664118|FG002|Overall Study|Lost to Follow-up|0|||
19417988|NCT01765426|41664119|FG003|Overall Study|Lost to Follow-up|0|||
19417989|NCT01765270|41664131|FG000|Overall Study|Physician Decision|1|||
19417990|NCT01765270|41664132|FG001|Overall Study|Physician Decision|0|||
19417991|NCT01765270|41664131|FG000|Overall Study|Withdrawal by Subject|0|||
19417992|NCT01765270|41664132|FG001|Overall Study|Withdrawal by Subject|1|||
19519557|NCT01474512|41932304|FG012|Long-Term Extension Period|Protocol Violation|5|||
19519558|NCT01474512|41932305|FG013|Long-Term Extension Period|Protocol Violation|5|||
19519559|NCT01474512|41932306|FG014|Long-Term Extension Period|Protocol Violation|0|||
19519560|NCT01474512|41932307|FG015|Long-Term Extension Period|Protocol Violation|0|||
19519561|NCT01474512|41932308|FG016|Long-Term Extension Period|Protocol Violation|0|||
19417993|NCT01733758|41664143|FG000|Overall Study|Adverse Event|5|||
19417994|NCT01733758|41664144|FG001|Overall Study|Adverse Event|7|||
19417995|NCT01733758|41664145|FG002|Overall Study|Adverse Event|8|||
19519562|NCT01474512|41932309|FG017|Long-Term Extension Period|Protocol Violation|0|||
19519563|NCT01474512|41932292|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519564|NCT01474512|41932293|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519565|NCT01474512|41932294|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519566|NCT01474512|41932295|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519567|NCT01474512|41932296|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519568|NCT01474512|41932297|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19417996|NCT01733758|41664146|FG003|Overall Study|Adverse Event|1|||
19417997|NCT01733758|41664143|FG000|Overall Study|Withdrawal by Subject|1|||
19417998|NCT01733758|41664144|FG001|Overall Study|Withdrawal by Subject|1|||
19417999|NCT01733758|41664145|FG002|Overall Study|Withdrawal by Subject|5|||
19418000|NCT01733758|41664146|FG003|Overall Study|Withdrawal by Subject|3|||
19418001|NCT01733758|41664143|FG000|Overall Study|Persistent Hyperglycemia|3|||
19418002|NCT01733758|41664144|FG001|Overall Study|Persistent Hyperglycemia|2|||
19418003|NCT01733758|41664145|FG002|Overall Study|Persistent Hyperglycemia|0|||
19418004|NCT01733758|41664146|FG003|Overall Study|Persistent Hyperglycemia|0|||
19418005|NCT01733758|41664143|FG000|Overall Study|Protocol Violation|0|||
19418006|NCT01733758|41664144|FG001|Overall Study|Protocol Violation|1|||
19418007|NCT01733758|41664145|FG002|Overall Study|Protocol Violation|2|||
19418008|NCT01733758|41664146|FG003|Overall Study|Protocol Violation|2|||
19418009|NCT01733758|41664143|FG000|Overall Study|Non-compliance|1|||
19418010|NCT01733758|41664144|FG001|Overall Study|Non-compliance|0|||
19418011|NCT01733758|41664145|FG002|Overall Study|Non-compliance|0|||
19418012|NCT01733758|41664146|FG003|Overall Study|Non-compliance|0|||
19418013|NCT01733758|41664143|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
19418014|NCT01733758|41664144|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
19418015|NCT01733758|41664145|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
19418016|NCT01733758|41664146|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
19418017|NCT01733758|41664143|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
19418018|NCT01733758|41664144|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
19418019|NCT01733758|41664145|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
19418020|NCT01733758|41664146|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
19418021|NCT01607554|41664158|FG000|Overall Study|Disease progression|2|||
19418022|NCT01607476|41664165|FG000|Overall Study|Withdrawal by Subject|1|||
19418023|NCT01607476|41664166|FG001|Overall Study|Withdrawal by Subject|0|||
19418024|NCT01607476|41664167|FG002|Overall Study|Withdrawal by Subject|1|||
19418025|NCT01607476|41664165|FG000|Overall Study|Lost to Follow-up|0|||
19418026|NCT01607476|41664166|FG001|Overall Study|Lost to Follow-up|0|||
19418027|NCT01607476|41664167|FG002|Overall Study|Lost to Follow-up|2|||
19418028|NCT01765192|41664177|FG000|Treatment Period 1|Adverse Event|0|||
19418029|NCT01765192|41664178|FG001|Treatment Period 1|Adverse Event|1|||
19418030|NCT01765192|41664177|FG000|Washout Period|Voluntary Withdrawal|1|||
19418031|NCT01765192|41664178|FG001|Washout Period|Voluntary Withdrawal|1|||
19418032|NCT01765192|41664177|FG000|Washout Period|Reason not specified|1|||
19418033|NCT01765192|41664178|FG001|Washout Period|Reason not specified|0|||
19418034|NCT01765192|41664177|FG000|Treatment Period 2|Reason not specified|0|||
19418035|NCT01765192|41664178|FG001|Treatment Period 2|Reason not specified|2|||
19418036|NCT01765192|41664177|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
19418037|NCT01765192|41664178|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
19418038|NCT01733680|41664186|FG000|Overall Study|Withdrawal by Subject|0|||
19418039|NCT01733680|41664187|FG001|Overall Study|Withdrawal by Subject|1|||
19418040|NCT02348216|41664204|FG000|Overall Study|Death|4|||
19418041|NCT02348216|41664205|FG001|Overall Study|Death|27|||
19418042|NCT02348216|41664206|FG002|Overall Study|Death|3|||
19418043|NCT02348216|41664207|FG003|Overall Study|Death|18|||
19418044|NCT02348216|41664208|FG004|Overall Study|Death|9|||
19418045|NCT02348216|41664209|FG005|Overall Study|Death|23|||
19418046|NCT02348216|41664210|FG006|Overall Study|Death|6|||
19418047|NCT02348216|41664204|FG000|Overall Study|Full consent withdrawal|0|||
19418048|NCT02348216|41664205|FG001|Overall Study|Full consent withdrawal|0|||
19418049|NCT02348216|41664206|FG002|Overall Study|Full consent withdrawal|0|||
19418050|NCT02348216|41664207|FG003|Overall Study|Full consent withdrawal|1|||
19418051|NCT02348216|41664208|FG004|Overall Study|Full consent withdrawal|0|||
19418052|NCT02348216|41664209|FG005|Overall Study|Full consent withdrawal|0|||
19418053|NCT02348216|41664210|FG006|Overall Study|Full consent withdrawal|1|||
19418054|NCT02348216|41664204|FG000|Overall Study|Lost to Follow-up|0|||
19418055|NCT02348216|41664205|FG001|Overall Study|Lost to Follow-up|0|||
19418056|NCT02348216|41664206|FG002|Overall Study|Lost to Follow-up|0|||
19418057|NCT02348216|41664207|FG003|Overall Study|Lost to Follow-up|0|||
19418058|NCT02348216|41664208|FG004|Overall Study|Lost to Follow-up|0|||
19418059|NCT02348216|41664209|FG005|Overall Study|Lost to Follow-up|0|||
19418060|NCT02348216|41664210|FG006|Overall Study|Lost to Follow-up|1|||
19418061|NCT02348216|41664204|FG000|Overall Study|Still on study|3|||
19418062|NCT02348216|41664205|FG001|Overall Study|Still on study|50|||
19418063|NCT02348216|41664206|FG002|Overall Study|Still on study|21|||
19418064|NCT02348216|41664207|FG003|Overall Study|Still on study|19|||
19418065|NCT02348216|41664208|FG004|Overall Study|Still on study|32|||
19418066|NCT02348216|41664209|FG005|Overall Study|Still on study|27|||
19418067|NCT02348216|41664210|FG006|Overall Study|Still on study|32|||
19418068|NCT02348216|41664204|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
19418069|NCT02348216|41664205|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
19418070|NCT02348216|41664206|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
19418071|NCT02348216|41664207|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
19418072|NCT02348216|41664208|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
19418073|NCT02348216|41664209|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
19418074|NCT02348216|41664210|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
19418075|NCT02336165|41664253|FG000|Overall Study|Death|3|||
19418076|NCT02336165|41664254|FG001|Overall Study|Death|0|||
19418077|NCT02336165|41664255|FG002|Overall Study|Death|0|||
19418078|NCT02336165|41664256|FG003|Overall Study|Death|0|||
19418079|NCT02336165|41664257|FG004|Overall Study|Death|1|||
19418080|NCT02336165|41664253|FG000|Overall Study|Physician Decision|2|||
19418081|NCT02336165|41664254|FG001|Overall Study|Physician Decision|2|||
19418082|NCT02336165|41664255|FG002|Overall Study|Physician Decision|1|||
19418083|NCT02336165|41664256|FG003|Overall Study|Physician Decision|1|||
19418084|NCT02336165|41664257|FG004|Overall Study|Physician Decision|0|||
19418085|NCT02336165|41664253|FG000|Overall Study|Withdrawal by Subject|0|||
19418086|NCT02336165|41664254|FG001|Overall Study|Withdrawal by Subject|0|||
19418087|NCT02336165|41664255|FG002|Overall Study|Withdrawal by Subject|1|||
19418088|NCT02336165|41664256|FG003|Overall Study|Withdrawal by Subject|0|||
19418089|NCT02336165|41664257|FG004|Overall Study|Withdrawal by Subject|1|||
19418090|NCT02336165|41664253|FG000|Overall Study|Adverse Event|4|||
19418091|NCT02336165|41664254|FG001|Overall Study|Adverse Event|1|||
19418092|NCT02336165|41664255|FG002|Overall Study|Adverse Event|2|||
19418093|NCT02336165|41664256|FG003|Overall Study|Adverse Event|4|||
19418094|NCT02336165|41664257|FG004|Overall Study|Adverse Event|1|||
19418095|NCT02336165|41664253|FG000|Overall Study|Progressive disease|23|||
19418096|NCT02336165|41664254|FG001|Overall Study|Progressive disease|22|||
19418097|NCT02336165|41664255|FG002|Overall Study|Progressive disease|27|||
19418098|NCT02336165|41664256|FG003|Overall Study|Progressive disease|24|||
19418099|NCT02336165|41664257|FG004|Overall Study|Progressive disease|19|||
19418100|NCT02336165|41664253|FG000|Overall Study|Non-compliance|1|||
19418101|NCT02336165|41664254|FG001|Overall Study|Non-compliance|0|||
19418102|NCT02336165|41664255|FG002|Overall Study|Non-compliance|0|||
19418103|NCT02336165|41664256|FG003|Overall Study|Non-compliance|1|||
19418104|NCT02336165|41664257|FG004|Overall Study|Non-compliance|0|||
19418105|NCT02336165|41664253|FG000|Overall Study|Other|1|||
19418106|NCT02336165|41664254|FG001|Overall Study|Other|0|||
19418107|NCT02336165|41664255|FG002|Overall Study|Other|0|||
19418108|NCT02336165|41664256|FG003|Overall Study|Other|1|||
19418109|NCT02336165|41664257|FG004|Overall Study|Other|0|||
19418110|NCT02360111|41664273|FG000|Overall Study|Death|2|||
19418111|NCT02334683|41664279|FG000|First 12 Week Period|Lost to Follow-up|1|||
19418112|NCT02334683|41664280|FG001|First 12 Week Period|Lost to Follow-up|0|||
19418113|NCT02334683|41664279|FG000|Second 12 Week Period|Adverse Event|0|||
19418114|NCT02334683|41664280|FG001|Second 12 Week Period|Adverse Event|1|||
19418115|NCT02319044|41664289|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
19418116|NCT02319044|41664290|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
19418117|NCT02319044|41664291|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
19418118|NCT02319044|41664289|FG000|Overall Study|Withdrawal by Subject|3|||
19418119|NCT02319044|41664290|FG001|Overall Study|Withdrawal by Subject|3|||
19418120|NCT02319044|41664291|FG002|Overall Study|Withdrawal by Subject|6|||
19418121|NCT02319044|41664289|FG000|Overall Study|Condition under investigation worsened|100|||
19418122|NCT02319044|41664290|FG001|Overall Study|Condition under investigation worsened|50|||
19418123|NCT02319044|41664291|FG002|Overall Study|Condition under investigation worsened|46|||
19418124|NCT02319044|41664289|FG000|Overall Study|Adverse Event|17|||
19418125|NCT02319044|41664290|FG001|Overall Study|Adverse Event|2|||
19418126|NCT02319044|41664291|FG002|Overall Study|Adverse Event|8|||
19418127|NCT02319044|41664289|FG000|Overall Study|Study specific discontinuation criteria|2|||
19418128|NCT02319044|41664290|FG001|Overall Study|Study specific discontinuation criteria|2|||
19418129|NCT02319044|41664291|FG002|Overall Study|Study specific discontinuation criteria|1|||
19418130|NCT02319044|41664289|FG000|Overall Study|Not treated|0|||
19418131|NCT02319044|41664290|FG001|Overall Study|Not treated|2|||
19418132|NCT02319044|41664291|FG002|Overall Study|Not treated|2|||
19418133|NCT01649765|41664302|FG000|Overall Study|Adverse Event|5|||
19418134|NCT01649765|41664303|FG001|Overall Study|Adverse Event|3|||
19418135|NCT01649765|41664302|FG000|Overall Study|Lack of Efficacy|1|||
19628136|NCT00451321|42077526|FG002|Overall Study|Study closed/terminated|17|||
19418136|NCT01649765|41664303|FG001|Overall Study|Lack of Efficacy|1|||
19418137|NCT01649765|41664302|FG000|Overall Study|Physician Decision|0|||
19418138|NCT01649765|41664303|FG001|Overall Study|Physician Decision|3|||
19418139|NCT01649765|41664302|FG000|Overall Study|Protocol Violation|1|||
19418140|NCT01649765|41664303|FG001|Overall Study|Protocol Violation|0|||
19418141|NCT01649765|41664302|FG000|Overall Study|Withdrawal by Subject|2|||
19418142|NCT01649765|41664303|FG001|Overall Study|Withdrawal by Subject|1|||
19418143|NCT02317562|41664310|FG000|Overall Study|Physician Decision|1|||
19418144|NCT02317562|41664310|FG000|Overall Study|early termination of the study|8|||
19418145|NCT02317562|41664310|FG000|Overall Study|Lack of Efficacy|4|||
19418146|NCT02317562|41664310|FG000|Overall Study|Withdrawal by Subject|1|||
19418147|NCT02317016|41664314|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
19418148|NCT02317016|41664314|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
19418149|NCT02317016|41664314|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
19418150|NCT02317016|41664314|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
19418151|NCT02317016|41664314|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
19418152|NCT02317016|41664314|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
19418153|NCT02317016|41664314|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
19418154|NCT02311478|41664322|FG000|Overall Study|Withdrawal by Subject|1|||
19418155|NCT02311478|41664322|FG000|Overall Study|Lost to Follow-up|5|||
19418156|NCT02311478|41664322|FG000|Overall Study|Failed IUD Insertion|1|||
19418157|NCT02388932|41664327|FG000|Overall Study|Death|1|||
19418158|NCT02388776|41664332|FG000|Overall Study|Death|1|||
19418159|NCT02388776|41664332|FG000|Overall Study|Lost to Follow-up|1|||
19418160|NCT02316548|41664339|FG000|Overall Study|Protocol Violation|0|||
19418161|NCT02316548|41664340|FG001|Overall Study|Protocol Violation|1|||
19418162|NCT02281760|41664346|FG000|Overall Study|Withdrawal by Subject|1|||
19418163|NCT02390531|41664358|FG000|Overall Study|Death|0|||
19418164|NCT02390531|41664359|FG001|Overall Study|Death|2|||
19418165|NCT02390531|41664360|FG002|Overall Study|Death|0|||
19418166|NCT02390531|41664361|FG003|Overall Study|Death|1|||
19418167|NCT02390531|41664362|FG004|Overall Study|Death|0|||
19418168|NCT02390531|41664363|FG005|Overall Study|Death|0|||
19418169|NCT02390531|41664364|FG006|Overall Study|Death|0|||
19418170|NCT02390531|41664365|FG007|Overall Study|Death|1|||
19418171|NCT02390531|41664358|FG000|Overall Study|Protocol Violation|0|||
19418172|NCT02390531|41664359|FG001|Overall Study|Protocol Violation|0|||
19418173|NCT02390531|41664360|FG002|Overall Study|Protocol Violation|0|||
19418174|NCT02390531|41664361|FG003|Overall Study|Protocol Violation|0|||
19418175|NCT02390531|41664362|FG004|Overall Study|Protocol Violation|1|||
19418176|NCT02390531|41664363|FG005|Overall Study|Protocol Violation|0|||
19418177|NCT02390531|41664364|FG006|Overall Study|Protocol Violation|2|||
19418178|NCT02390531|41664365|FG007|Overall Study|Protocol Violation|0|||
19418179|NCT02390219|41664401|FG000|Overall Study|Death|1|||
19418180|NCT02390219|41664401|FG000|Overall Study|Physician Decision|1|||
19418181|NCT02390219|41664401|FG000|Overall Study|Adverse Event|6|||
19418182|NCT02390219|41664401|FG000|Overall Study|Withdrawal by Subject|1|||
19418183|NCT02390219|41664401|FG000|Overall Study|Lost to Follow-up|2|||
19418184|NCT02390219|41664401|FG000|Overall Study|Other|2|||
19418185|NCT02334215|41664408|FG000|Overall Study|Death|1|||
19418186|NCT02334215|41664409|FG001|Overall Study|Death|1|||
19418187|NCT02334215|41664410|FG002|Overall Study|Death|0|||
19418188|NCT02334215|41664408|FG000|Overall Study|Lost to Follow-up|1|||
19418189|NCT02334215|41664409|FG001|Overall Study|Lost to Follow-up|0|||
19418190|NCT02334215|41664410|FG002|Overall Study|Lost to Follow-up|4|||
19418191|NCT02334215|41664408|FG000|Overall Study|Withdrawal by Subject|2|||
19418192|NCT02334215|41664409|FG001|Overall Study|Withdrawal by Subject|2|||
19418193|NCT02334215|41664410|FG002|Overall Study|Withdrawal by Subject|1|||
19418194|NCT02334215|41664408|FG000|Overall Study|Not released from incarceration on time|3|||
19418195|NCT02334215|41664409|FG001|Overall Study|Not released from incarceration on time|3|||
19418196|NCT02334215|41664410|FG002|Overall Study|Not released from incarceration on time|3|||
19418197|NCT02334215|41664408|FG000|Overall Study|Incarcerated|0|||
19418198|NCT02334215|41664409|FG001|Overall Study|Incarcerated|0|||
19418199|NCT02334215|41664410|FG002|Overall Study|Incarcerated|7|||
19418200|NCT02359877|41664422|FG000|Overall Study|Withdrawal by Subject|1|||
19418201|NCT02359877|41664423|FG001|Overall Study|Withdrawal by Subject|0|||
19418202|NCT02359877|41664424|FG002|Overall Study|Withdrawal by Subject|0|||
19418203|NCT02359877|41664425|FG003|Overall Study|Withdrawal by Subject|2|||
19418204|NCT02359877|41664422|FG000|Overall Study|Adverse Event|0|||
19418205|NCT02359877|41664423|FG001|Overall Study|Adverse Event|0|||
19418206|NCT02359877|41664424|FG002|Overall Study|Adverse Event|0|||
19418207|NCT02359877|41664425|FG003|Overall Study|Adverse Event|1|||
19418208|NCT02389829|41664455|FG000|Overall Study|Lost to Follow-up|0|||
19418209|NCT02389829|41664456|FG001|Overall Study|Lost to Follow-up|1|||
19418210|NCT02358863|41664462|FG000|Overall Study|Physician Decision|3|||
19418211|NCT02358473|41664466|FG000|Overall Study|Disease Progession|6|||
19418212|NCT02358473|41664466|FG000|Overall Study|Adverse Event|3|||
19418213|NCT02358473|41664466|FG000|Overall Study|Withdrawal by Subject|2|||
19418214|NCT02358473|41664466|FG000|Overall Study|Physician Decision|2|||
19418215|NCT02357459|41664473|FG000|Overall Study|Adverse Event|0|||
19418216|NCT02357459|41664474|FG001|Overall Study|Adverse Event|1|||
19418217|NCT02357459|41664475|FG002|Overall Study|Adverse Event|1|||
19418218|NCT02357459|41664473|FG000|Overall Study|Withdrawal by Subject|5|||
19418219|NCT02357459|41664474|FG001|Overall Study|Withdrawal by Subject|3|||
19418220|NCT02357459|41664475|FG002|Overall Study|Withdrawal by Subject|3|||
19418221|NCT02357459|41664473|FG000|Overall Study|Physician Decision|0|||
19418222|NCT02357459|41664474|FG001|Overall Study|Physician Decision|2|||
19418223|NCT02357459|41664475|FG002|Overall Study|Physician Decision|0|||
19418224|NCT02357459|41664473|FG000|Overall Study|Protocol Violation|1|||
19418225|NCT02357459|41664474|FG001|Overall Study|Protocol Violation|1|||
19418226|NCT02357459|41664475|FG002|Overall Study|Protocol Violation|0|||
19418227|NCT02357459|41664473|FG000|Overall Study|Lost to Follow-up|1|||
19418228|NCT02357459|41664474|FG001|Overall Study|Lost to Follow-up|3|||
19418229|NCT02357459|41664475|FG002|Overall Study|Lost to Follow-up|0|||
19418230|NCT02357459|41664473|FG000|Overall Study|Lack of Efficacy|7|||
19418231|NCT02357459|41664474|FG001|Overall Study|Lack of Efficacy|4|||
19418232|NCT02357459|41664475|FG002|Overall Study|Lack of Efficacy|4|||
19418233|NCT02357459|41664473|FG000|Overall Study|Patient Relocated|2|||
19418234|NCT02357459|41664474|FG001|Overall Study|Patient Relocated|0|||
19418235|NCT02357459|41664475|FG002|Overall Study|Patient Relocated|0|||
19418236|NCT02357459|41664473|FG000|Overall Study|Instruction from PCP|1|||
19418237|NCT02357459|41664474|FG001|Overall Study|Instruction from PCP|0|||
19418238|NCT02357459|41664475|FG002|Overall Study|Instruction from PCP|0|||
19418239|NCT02357459|41664473|FG000|Overall Study|Incarceration|0|||
19418240|NCT02357459|41664474|FG001|Overall Study|Incarceration|0|||
19418241|NCT02357459|41664475|FG002|Overall Study|Incarceration|1|||
19418242|NCT02357459|41664473|FG000|Overall Study|Pre-planned Knee surgery|0|||
19418243|NCT02357459|41664474|FG001|Overall Study|Pre-planned Knee surgery|0|||
19418244|NCT02357459|41664475|FG002|Overall Study|Pre-planned Knee surgery|2|||
19418245|NCT02357459|41664473|FG000|Overall Study|Job Commitments|0|||
19418246|NCT02357459|41664474|FG001|Overall Study|Job Commitments|0|||
19418247|NCT02357459|41664475|FG002|Overall Study|Job Commitments|1|||
19418248|NCT02332889|41664486|FG000|Overall Study|Physician Decision|1|||
19418249|NCT02357147|41664492|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
19418250|NCT02357147|41664493|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
19418251|NCT02357147|41664492|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
19418252|NCT02357147|41664493|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
19418253|NCT02357147|41664492|FG000|Combination Treatment Phase|Investigator Discretion|1|||
19418254|NCT02357147|41664493|FG001|Combination Treatment Phase|Investigator Discretion|1|||
19418255|NCT02357147|41664492|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
19418256|NCT02357147|41664493|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
19418257|NCT02357147|41664492|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
19418258|NCT02357147|41664493|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
19418259|NCT02357147|41664492|FG000|Combination Treatment Phase|Adverse Event|12|||
19418260|NCT02357147|41664493|FG001|Combination Treatment Phase|Adverse Event|4|||
19418261|NCT02357147|41664492|FG000|Combination Treatment Phase|Death|1|||
19418262|NCT02357147|41664493|FG001|Combination Treatment Phase|Death|1|||
19418263|NCT02357147|41664492|FG000|Combination Treatment Phase|Sponsor Decision|0|||
19418264|NCT02357147|41664493|FG001|Combination Treatment Phase|Sponsor Decision|12|||
19418265|NCT02357147|41664492|FG000|Combination Treatment Phase|Other|1|||
19418266|NCT02357147|41664493|FG001|Combination Treatment Phase|Other|0|||
19418267|NCT02357147|41664492|FG000|Combination Treatment Phase|Not treated|0|||
19418268|NCT02357147|41664493|FG001|Combination Treatment Phase|Not treated|2|||
19418269|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
19418270|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
19418271|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
19418272|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
19418273|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
19418274|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
19418275|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Adverse Event|0|||
19418276|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Adverse Event|3|||
19418277|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
19418278|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
19418279|NCT02357147|41664492|FG000|Maintenance Treatment Phase|Not Treated|1|||
19418280|NCT02357147|41664493|FG001|Maintenance Treatment Phase|Not Treated|0|||
19418281|NCT02356211|41664505|FG000|Overall Study|Withdrawal by Subject|2|||
19418282|NCT02356211|41664506|FG001|Overall Study|Withdrawal by Subject|2|||
19418283|NCT02356211|41664505|FG000|Overall Study|ineligible|1|||
19418284|NCT02356211|41664506|FG001|Overall Study|ineligible|8|||
19418285|NCT02332655|41664512|FG000|Overall Study|Lack of Efficacy|1|||
19418286|NCT02388737|41664519|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
19418287|NCT02388737|41664520|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
19418288|NCT02388737|41664521|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
19418289|NCT02388737|41664519|FG000|Overall Study|Major Protocol Deviation|18|||
19418290|NCT02388737|41664520|FG001|Overall Study|Major Protocol Deviation|25|||
19418291|NCT02388737|41664521|FG002|Overall Study|Major Protocol Deviation|22|||
19418292|NCT02388737|41664519|FG000|Overall Study|Lost to Follow-up|5|||
19418293|NCT02388737|41664520|FG001|Overall Study|Lost to Follow-up|1|||
19418294|NCT02388737|41664521|FG002|Overall Study|Lost to Follow-up|4|||
19418295|NCT02388737|41664519|FG000|Overall Study|Voluntary Withdrawal|10|||
19418296|NCT02388737|41664520|FG001|Overall Study|Voluntary Withdrawal|18|||
19418297|NCT02388737|41664521|FG002|Overall Study|Voluntary Withdrawal|17|||
19418298|NCT02388737|41664519|FG000|Overall Study|Lack of Efficacy|3|||
19418299|NCT02388737|41664520|FG001|Overall Study|Lack of Efficacy|0|||
19418300|NCT02388737|41664521|FG002|Overall Study|Lack of Efficacy|3|||
19418301|NCT02388737|41664519|FG000|Overall Study|Reason Not Specified|5|||
19418302|NCT02388737|41664520|FG001|Overall Study|Reason Not Specified|5|||
19418303|NCT02388737|41664521|FG002|Overall Study|Reason Not Specified|4|||
19418304|NCT02355743|41664529|FG000|Overall Study|Withdrawal by Subject|1|||
19418305|NCT02355743|41664529|FG000|Overall Study|Lost to Follow-up|1|||
19418306|NCT02388347|41664538|FG000|Overall Study|Withdrawal by Subject|0|||
19418307|NCT02388347|41664539|FG001|Overall Study|Withdrawal by Subject|0|||
19418308|NCT02388347|41664540|FG002|Overall Study|Withdrawal by Subject|1|||
19418309|NCT02388347|41664541|FG003|Overall Study|Withdrawal by Subject|0|||
19418310|NCT02388347|41664542|FG004|Overall Study|Withdrawal by Subject|0|||
19418311|NCT02355665|41664560|FG000|Overall Study|Adverse Event|16|||
19418312|NCT02355665|41664561|FG001|Overall Study|Adverse Event|24|||
19418313|NCT02355665|41664560|FG000|Overall Study|Protocol Violation|2|||
19628137|NCT00451321|42077527|FG003|Overall Study|Study closed/terminated|5|||
19374987|NCT02034123|41616666|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374988|NCT02034123|41616667|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374989|NCT02034123|41616668|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374990|NCT02034123|41616669|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374991|NCT02034123|41616670|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374992|NCT02034123|41616671|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374993|NCT02034123|41616672|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
19374994|NCT02034123|41616655|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19374995|NCT02034123|41616656|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19374996|NCT02034123|41616657|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19374997|NCT02034123|41616658|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
19374998|NCT02034123|41616659|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
19374999|NCT02034123|41616660|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375000|NCT02034123|41616661|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375001|NCT02034123|41616662|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375002|NCT02034123|41616663|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375003|NCT02034123|41616664|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375004|NCT02034123|41616665|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375005|NCT02034123|41616666|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375006|NCT02034123|41616667|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375007|NCT02034123|41616668|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375008|NCT02034123|41616669|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375009|NCT02034123|41616670|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375010|NCT02034123|41616671|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375011|NCT02034123|41616672|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
19375012|NCT02530970|41616715|FG000|Overall Study|Adverse Event|8|||
19375013|NCT02530970|41616715|FG000|Overall Study|Lost to Follow-up|88|||
19375014|NCT02530970|41616715|FG000|Overall Study|Physician Decision|5|||
19375015|NCT02530970|41616715|FG000|Overall Study|Withdrawal by Subject|14|||
19375016|NCT02530970|41616715|FG000|Overall Study|Death|6|||
19375017|NCT02530970|41616715|FG000|Overall Study|Hospitalization|1|||
19375018|NCT02530970|41616715|FG000|Overall Study|Insurance|2|||
19375019|NCT02530970|41616715|FG000|Overall Study|Explant|2|||
19375020|NCT02530970|41616715|FG000|Overall Study|Change in Provider|5|||
19375021|NCT02530970|41616715|FG000|Overall Study|Relocation|3|||
19375022|NCT02318602|41616722|FG000|Overall Study|Adverse Event|0|||
19375023|NCT02318602|41616723|FG001|Overall Study|Adverse Event|1|||
19375024|NCT02318602|41616724|FG002|Overall Study|Adverse Event|1|||
19375025|NCT02318602|41616722|FG000|Overall Study|Withdrawal by Subject|0|||
19375026|NCT02318602|41616723|FG001|Overall Study|Withdrawal by Subject|3|||
19375027|NCT02318602|41616724|FG002|Overall Study|Withdrawal by Subject|0|||
19375028|NCT02318602|41616722|FG000|Overall Study|Death|1|||
19375029|NCT02318602|41616723|FG001|Overall Study|Death|0|||
19375030|NCT02318602|41616724|FG002|Overall Study|Death|0|||
19375031|NCT02318602|41616722|FG000|Overall Study|Guardian decision to withdraw|0|||
19375032|NCT02318602|41616723|FG001|Overall Study|Guardian decision to withdraw|0|||
19375033|NCT02318602|41616724|FG002|Overall Study|Guardian decision to withdraw|1|||
19375034|NCT02318368|41616740|FG000|Overall Study|Withdrawal by Subject|2|||
19375035|NCT02318368|41616741|FG001|Overall Study|Withdrawal by Subject|0|||
19375036|NCT02318368|41616740|FG000|Overall Study|Study terminated by the sponsor|5|||
19375037|NCT02318368|41616741|FG001|Overall Study|Study terminated by the sponsor|2|||
19375038|NCT02318368|41616740|FG000|Overall Study|Death|0|||
19375039|NCT02318368|41616741|FG001|Overall Study|Death|1|||
19375040|NCT02318134|41616749|FG000|Overall Study|Withdrawal by Subject|2|||
19418314|NCT02355665|41664561|FG001|Overall Study|Protocol Violation|0|||
19418315|NCT02355665|41664560|FG000|Overall Study|Withdrawal by Subject|90|||
19418316|NCT02355665|41664561|FG001|Overall Study|Withdrawal by Subject|100|||
19418317|NCT02355665|41664560|FG000|Overall Study|Lost to Follow-up|131|||
19418318|NCT02355665|41664561|FG001|Overall Study|Lost to Follow-up|103|||
19418319|NCT02355665|41664560|FG000|Overall Study|Death|4|||
19375041|NCT02318134|41616750|FG001|Overall Study|Withdrawal by Subject|1|||
19375042|NCT02317510|41616760|FG000|Overall Study|Adverse Event|0|||
19375043|NCT02317510|41616761|FG001|Overall Study|Adverse Event|1|||
19375044|NCT02317432|41616772|FG000|Overall Study|Death|4|||
19375045|NCT02317432|41616773|FG001|Overall Study|Death|1|||
19375046|NCT02317432|41616772|FG000|Overall Study|Lost to Follow-up|0|||
19375047|NCT02317432|41616773|FG001|Overall Study|Lost to Follow-up|5|||
19375048|NCT02317432|41616772|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
19375049|NCT02317432|41616773|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
19375050|NCT00494234|41616781|FG000|Overall Study|Lack of Efficacy|12|||
19375051|NCT00494234|41616782|FG001|Overall Study|Lack of Efficacy|9|||
19375052|NCT00494234|41616781|FG000|Overall Study|Withdrawal by Subject|1|||
19375053|NCT00494234|41616782|FG001|Overall Study|Withdrawal by Subject|0|||
19375054|NCT00494234|41616781|FG000|Overall Study|Death|2|||
19375055|NCT00494234|41616782|FG001|Overall Study|Death|1|||
19375056|NCT02289820|41616799|FG000|Overall Study|Withdrawal by Subject|2|||
19375057|NCT02289820|41616800|FG001|Overall Study|Withdrawal by Subject|1|||
19375058|NCT02289820|41616801|FG002|Overall Study|Withdrawal by Subject|2|||
19375059|NCT02289820|41616802|FG003|Overall Study|Withdrawal by Subject|1|||
19375060|NCT02289820|41616803|FG004|Overall Study|Withdrawal by Subject|0|||
19375061|NCT02289820|41616804|FG005|Overall Study|Withdrawal by Subject|0|||
19375062|NCT02289820|41616805|FG006|Overall Study|Withdrawal by Subject|1|||
19375063|NCT02289820|41616799|FG000|Overall Study|Death|0|||
19375064|NCT02289820|41616800|FG001|Overall Study|Death|0|||
19375065|NCT02289820|41616801|FG002|Overall Study|Death|1|||
19375066|NCT02289820|41616802|FG003|Overall Study|Death|0|||
19375067|NCT02289820|41616803|FG004|Overall Study|Death|0|||
19375068|NCT02289820|41616804|FG005|Overall Study|Death|0|||
19375069|NCT02289820|41616805|FG006|Overall Study|Death|0|||
19375070|NCT02289820|41616799|FG000|Overall Study|Lost to Follow-up|0|||
19375071|NCT02289820|41616800|FG001|Overall Study|Lost to Follow-up|0|||
19375072|NCT02289820|41616801|FG002|Overall Study|Lost to Follow-up|3|||
19375073|NCT02289820|41616802|FG003|Overall Study|Lost to Follow-up|1|||
19375074|NCT02289820|41616803|FG004|Overall Study|Lost to Follow-up|0|||
19375075|NCT02289820|41616804|FG005|Overall Study|Lost to Follow-up|1|||
19375076|NCT02289820|41616805|FG006|Overall Study|Lost to Follow-up|1|||
19375077|NCT02289820|41616799|FG000|Overall Study|withdrawal of consent|0|||
19375078|NCT02289820|41616800|FG001|Overall Study|withdrawal of consent|1|||
19375079|NCT02289820|41616801|FG002|Overall Study|withdrawal of consent|0|||
19375080|NCT02289820|41616802|FG003|Overall Study|withdrawal of consent|0|||
19375081|NCT02289820|41616803|FG004|Overall Study|withdrawal of consent|0|||
19375082|NCT02289820|41616804|FG005|Overall Study|withdrawal of consent|0|||
19375083|NCT02289820|41616805|FG006|Overall Study|withdrawal of consent|0|||
19375084|NCT02289742|41616827|FG000|First Wear Period|Adverse event prior to treatment|0|||
19375085|NCT02289742|41616828|FG001|First Wear Period|Adverse event prior to treatment|1|||
19375086|NCT02289742|41616829|FG002|First Wear Period|Adverse event prior to treatment|0|||
19375087|NCT02289742|41616830|FG003|First Wear Period|Adverse event prior to treatment|0|||
19375088|NCT02289742|41616827|FG000|First Wear Period|Adverse Event|0|||
19375089|NCT02289742|41616828|FG001|First Wear Period|Adverse Event|0|||
19375090|NCT02289742|41616829|FG002|First Wear Period|Adverse Event|1|||
19375091|NCT02289742|41616830|FG003|First Wear Period|Adverse Event|0|||
19375092|NCT02289742|41616827|FG000|First Wear Period|Other prior to treatment|0|||
19375093|NCT02289742|41616828|FG001|First Wear Period|Other prior to treatment|0|||
19375094|NCT02289742|41616829|FG002|First Wear Period|Other prior to treatment|0|||
19375095|NCT02289742|41616830|FG003|First Wear Period|Other prior to treatment|1|||
19375096|NCT02289742|41616827|FG000|Third Wear Period|Adverse Event|0|||
19375097|NCT02289742|41616828|FG001|Third Wear Period|Adverse Event|1|||
19375098|NCT02289742|41616829|FG002|Third Wear Period|Adverse Event|0|||
19375099|NCT02289742|41616830|FG003|Third Wear Period|Adverse Event|0|||
19375100|NCT02289742|41616827|FG000|Third Wear Period|Reason not given|0|||
19375101|NCT02289742|41616828|FG001|Third Wear Period|Reason not given|0|||
19375102|NCT02289742|41616829|FG002|Third Wear Period|Reason not given|0|||
19375103|NCT02289742|41616830|FG003|Third Wear Period|Reason not given|1|||
19375104|NCT02289352|41616847|FG000|Overall Study|Withdrawal by Subject|1|||
19375105|NCT02289352|41616848|FG001|Overall Study|Withdrawal by Subject|1|||
19375106|NCT02289352|41616849|FG002|Overall Study|Withdrawal by Subject|0|||
19375107|NCT02315560|41616858|FG000|Overall Study|noncompliance by subjects|3|||
19375108|NCT02288182|41616864|FG000|Overall Study|Adverse Event|0|||
19375109|NCT02288182|41616865|FG001|Overall Study|Adverse Event|1|||
19375110|NCT02288182|41616864|FG000|Overall Study|Lost to Follow-up|0|||
19418320|NCT02355665|41664561|FG001|Overall Study|Death|2|||
19375111|NCT02288182|41616865|FG001|Overall Study|Lost to Follow-up|1|||
19418321|NCT02355665|41664560|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
19418322|NCT02355665|41664561|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
19418323|NCT02010255|41664581|FG000|Overall Study|Death|0|||
19418324|NCT02010255|41664582|FG001|Overall Study|Death|1|||
19418325|NCT02010255|41664583|FG002|Overall Study|Death|4|||
19418326|NCT02010255|41664584|FG003|Overall Study|Death|4|||
19418327|NCT02010255|41664585|FG004|Overall Study|Death|2|||
19418328|NCT02010255|41664586|FG005|Overall Study|Death|0|||
19418329|NCT02010255|41664587|FG006|Overall Study|Death|1|||
19418330|NCT02010255|41664588|FG007|Overall Study|Death|1|||
19418331|NCT02010255|41664589|FG008|Overall Study|Death|1|||
19418332|NCT02010255|41664590|FG009|Overall Study|Death|0|||
19418333|NCT02010255|41664591|FG010|Overall Study|Death|1|||
19418334|NCT02010255|41664592|FG011|Overall Study|Death|1|||
19418335|NCT02010255|41664593|FG012|Overall Study|Death|0|||
19418336|NCT02010255|41664594|FG013|Overall Study|Death|0|||
19418337|NCT02010255|41664581|FG000|Overall Study|Lack of Efficacy|4|||
19418338|NCT02010255|41664582|FG001|Overall Study|Lack of Efficacy|1|||
19418339|NCT02010255|41664583|FG002|Overall Study|Lack of Efficacy|2|||
19418340|NCT02010255|41664584|FG003|Overall Study|Lack of Efficacy|1|||
19418341|NCT02010255|41664585|FG004|Overall Study|Lack of Efficacy|1|||
19418342|NCT02010255|41664586|FG005|Overall Study|Lack of Efficacy|0|||
19418343|NCT02010255|41664587|FG006|Overall Study|Lack of Efficacy|0|||
19418344|NCT02010255|41664588|FG007|Overall Study|Lack of Efficacy|0|||
19418345|NCT02010255|41664589|FG008|Overall Study|Lack of Efficacy|0|||
19418346|NCT02010255|41664590|FG009|Overall Study|Lack of Efficacy|0|||
19418347|NCT02010255|41664591|FG010|Overall Study|Lack of Efficacy|1|||
19418348|NCT02010255|41664592|FG011|Overall Study|Lack of Efficacy|0|||
19418349|NCT02010255|41664593|FG012|Overall Study|Lack of Efficacy|0|||
19418350|NCT02010255|41664594|FG013|Overall Study|Lack of Efficacy|0|||
19418351|NCT02010255|41664581|FG000|Overall Study|Withdrew Consent|1|||
19418352|NCT02010255|41664582|FG001|Overall Study|Withdrew Consent|0|||
19418353|NCT02010255|41664583|FG002|Overall Study|Withdrew Consent|0|||
19418354|NCT02010255|41664584|FG003|Overall Study|Withdrew Consent|1|||
19418355|NCT02010255|41664585|FG004|Overall Study|Withdrew Consent|0|||
19418356|NCT02010255|41664586|FG005|Overall Study|Withdrew Consent|0|||
19418357|NCT02010255|41664587|FG006|Overall Study|Withdrew Consent|0|||
19418358|NCT02010255|41664588|FG007|Overall Study|Withdrew Consent|0|||
19418359|NCT02010255|41664589|FG008|Overall Study|Withdrew Consent|0|||
19418360|NCT02010255|41664590|FG009|Overall Study|Withdrew Consent|0|||
19418361|NCT02010255|41664591|FG010|Overall Study|Withdrew Consent|0|||
19418362|NCT02010255|41664592|FG011|Overall Study|Withdrew Consent|0|||
19418363|NCT02010255|41664593|FG012|Overall Study|Withdrew Consent|0|||
19418364|NCT02010255|41664594|FG013|Overall Study|Withdrew Consent|0|||
19418365|NCT02010255|41664581|FG000|Overall Study|Adverse Event|1|||
19418366|NCT02010255|41664582|FG001|Overall Study|Adverse Event|0|||
19418367|NCT02010255|41664583|FG002|Overall Study|Adverse Event|0|||
19418368|NCT02010255|41664584|FG003|Overall Study|Adverse Event|0|||
19418369|NCT02010255|41664585|FG004|Overall Study|Adverse Event|0|||
19418370|NCT02010255|41664586|FG005|Overall Study|Adverse Event|0|||
19418371|NCT02010255|41664587|FG006|Overall Study|Adverse Event|0|||
19418372|NCT02010255|41664588|FG007|Overall Study|Adverse Event|0|||
19418373|NCT02010255|41664589|FG008|Overall Study|Adverse Event|0|||
19418374|NCT02010255|41664590|FG009|Overall Study|Adverse Event|0|||
19418375|NCT02010255|41664591|FG010|Overall Study|Adverse Event|0|||
19418376|NCT02010255|41664592|FG011|Overall Study|Adverse Event|0|||
19418377|NCT02010255|41664593|FG012|Overall Study|Adverse Event|0|||
19418378|NCT02010255|41664594|FG013|Overall Study|Adverse Event|0|||
19418379|NCT02010255|41664581|FG000|Overall Study|Lost to Follow-up|0|||
19418380|NCT02010255|41664582|FG001|Overall Study|Lost to Follow-up|0|||
19418381|NCT02010255|41664583|FG002|Overall Study|Lost to Follow-up|1|||
19418382|NCT02010255|41664584|FG003|Overall Study|Lost to Follow-up|0|||
19418383|NCT02010255|41664585|FG004|Overall Study|Lost to Follow-up|1|||
19418384|NCT02010255|41664586|FG005|Overall Study|Lost to Follow-up|0|||
19418385|NCT02010255|41664587|FG006|Overall Study|Lost to Follow-up|0|||
19418386|NCT02010255|41664588|FG007|Overall Study|Lost to Follow-up|0|||
19418387|NCT02010255|41664589|FG008|Overall Study|Lost to Follow-up|0|||
19418388|NCT02010255|41664590|FG009|Overall Study|Lost to Follow-up|0|||
19418389|NCT02010255|41664591|FG010|Overall Study|Lost to Follow-up|0|||
19418390|NCT02010255|41664592|FG011|Overall Study|Lost to Follow-up|0|||
19418391|NCT02010255|41664593|FG012|Overall Study|Lost to Follow-up|0|||
19418392|NCT02010255|41664594|FG013|Overall Study|Lost to Follow-up|0|||
19418393|NCT02010255|41664581|FG000|Overall Study|Randomized but Not Treated|0|||
19418394|NCT02010255|41664582|FG001|Overall Study|Randomized but Not Treated|0|||
19418395|NCT02010255|41664583|FG002|Overall Study|Randomized but Not Treated|0|||
19418396|NCT02010255|41664584|FG003|Overall Study|Randomized but Not Treated|0|||
19418397|NCT02010255|41664585|FG004|Overall Study|Randomized but Not Treated|0|||
19418398|NCT02010255|41664586|FG005|Overall Study|Randomized but Not Treated|0|||
19418399|NCT02010255|41664587|FG006|Overall Study|Randomized but Not Treated|0|||
19418400|NCT02010255|41664588|FG007|Overall Study|Randomized but Not Treated|0|||
19418401|NCT02010255|41664589|FG008|Overall Study|Randomized but Not Treated|0|||
19418402|NCT02010255|41664590|FG009|Overall Study|Randomized but Not Treated|0|||
19418403|NCT02010255|41664591|FG010|Overall Study|Randomized but Not Treated|0|||
19418404|NCT02010255|41664592|FG011|Overall Study|Randomized but Not Treated|0|||
19418405|NCT02010255|41664593|FG012|Overall Study|Randomized but Not Treated|0|||
19418406|NCT02010255|41664594|FG013|Overall Study|Randomized but Not Treated|1|||
19418407|NCT02354417|41664649|FG000|Overall Study|Physician Decision|1|||
19418408|NCT02332187|41664655|FG000|Overall Study|Withdrawal by Subject|2|||
19418409|NCT02332187|41664656|FG001|Overall Study|Withdrawal by Subject|2|||
19418410|NCT02332187|41664655|FG000|Overall Study|Adverse Event|0|||
19418411|NCT02332187|41664656|FG001|Overall Study|Adverse Event|1|||
19418412|NCT02330549|41664664|FG000|Overall Study|Adverse Event|1|||
19418413|NCT02330549|41664665|FG001|Overall Study|Adverse Event|0|||
19418414|NCT02330549|41664664|FG000|Overall Study|Subject withdrew consent|2|||
19418415|NCT02330549|41664665|FG001|Overall Study|Subject withdrew consent|1|||
19418416|NCT02330549|41664664|FG000|Overall Study|Failure to meet randomization criteria|1|||
19418417|NCT02330549|41664665|FG001|Overall Study|Failure to meet randomization criteria|0|||
19418418|NCT02009865|41664673|FG000|Overall Study|Adverse Event|0|||
19418419|NCT02009865|41664674|FG001|Overall Study|Adverse Event|2|||
19418420|NCT02009865|41664673|FG000|Overall Study|Protocol Violation|0|||
19418421|NCT02009865|41664674|FG001|Overall Study|Protocol Violation|2|||
19418422|NCT02009865|41664673|FG000|Overall Study|Withdrawal by Subject|1|||
19418423|NCT02009865|41664674|FG001|Overall Study|Withdrawal by Subject|1|||
19418424|NCT01620177|41664680|FG000|Overall Study|Failure at Screening Visit|43|||
19418425|NCT01620177|41664680|FG000|Overall Study|Withdrawal by Subject|26|||
19418426|NCT01620177|41664680|FG000|Overall Study|Lost to Follow-up|7|||
19418427|NCT01620177|41664680|FG000|Overall Study|Physician Decision|2|||
19418428|NCT01620177|41664680|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
19418429|NCT02075541|41664699|FG000|Overall Study|Serious Adverse Event|1|||
19418430|NCT02075541|41664700|FG001|Overall Study|Serious Adverse Event|4|||
19418431|NCT02075541|41664699|FG000|Overall Study|Protocol Violation|1|||
19418432|NCT02075541|41664700|FG001|Overall Study|Protocol Violation|0|||
19418433|NCT02075541|41664699|FG000|Overall Study|Withdrawal by Subject|1|||
19418434|NCT02075541|41664700|FG001|Overall Study|Withdrawal by Subject|3|||
19418435|NCT02075541|41664699|FG000|Overall Study|Sponsor study termination|0|||
19418436|NCT02075541|41664700|FG001|Overall Study|Sponsor study termination|1|||
19418437|NCT02075541|41664699|FG000|Overall Study|Other- unable to perform study procedure|1|||
19418438|NCT02075541|41664700|FG001|Overall Study|Other- unable to perform study procedure|0|||
19418439|NCT02330081|41664706|FG000|Overall Study|Adverse Event|1|||
19418440|NCT02330081|41664706|FG000|Overall Study|Donation did not meet criteria|1|||
19418441|NCT02330081|41664706|FG000|Overall Study|Protocol Violation|6|||
19418442|NCT01986855|41664716|FG000|Overall Study|Adverse Event|1|||
19418443|NCT01986855|41664717|FG001|Overall Study|Adverse Event|0|||
19418444|NCT01986855|41664718|FG002|Overall Study|Adverse Event|0|||
19418445|NCT01986855|41664716|FG000|Overall Study|Death|3|||
19418446|NCT01986855|41664717|FG001|Overall Study|Death|4|||
19418447|NCT01986855|41664718|FG002|Overall Study|Death|4|||
19418448|NCT01986855|41664716|FG000|Overall Study|Lost to Follow-up|2|||
19418449|NCT01986855|41664717|FG001|Overall Study|Lost to Follow-up|1|||
19418450|NCT01986855|41664718|FG002|Overall Study|Lost to Follow-up|0|||
19418451|NCT01986855|41664716|FG000|Overall Study|Screen Failure|0|||
19418452|NCT01986855|41664717|FG001|Overall Study|Screen Failure|1|||
19418453|NCT01986855|41664718|FG002|Overall Study|Screen Failure|0|||
19418454|NCT01986855|41664716|FG000|Overall Study|Participant Moved|0|||
19418455|NCT01986855|41664717|FG001|Overall Study|Participant Moved|0|||
19418456|NCT01986855|41664718|FG002|Overall Study|Participant Moved|2|||
19418457|NCT01986855|41664716|FG000|Overall Study|Withdrawal by Subject|7|||
19418458|NCT01986855|41664717|FG001|Overall Study|Withdrawal by Subject|8|||
19418459|NCT01986855|41664718|FG002|Overall Study|Withdrawal by Subject|5|||
19418460|NCT02075463|41664726|FG000|Overall Study|Adverse Event|3|||
19418461|NCT02075463|41664726|FG000|Overall Study|Par. reached stopping criteria|4|||
19418462|NCT02075463|41664726|FG000|Overall Study|Withdrawal by Subject|1|||
19418463|NCT02353871|41664733|FG000|Overall Study|Protocol deviation|0|||
19418464|NCT02353871|41664734|FG001|Overall Study|Protocol deviation|1|||
19418465|NCT02353871|41664733|FG000|Overall Study|Consent withdrawn|1|||
19418466|NCT02353871|41664734|FG001|Overall Study|Consent withdrawn|8|||
19418467|NCT02353871|41664733|FG000|Overall Study|Lost to Follow-up|2|||
19418468|NCT02353871|41664734|FG001|Overall Study|Lost to Follow-up|0|||
19418469|NCT02009397|41664740|FG000|Overall Study|Protocol Violation|6|||
19418470|NCT02009397|41664740|FG000|Overall Study|Death|8|||
19418471|NCT02009397|41664740|FG000|Overall Study|Lost to Follow-up|6|||
19418472|NCT02312219|41664746|FG000|Overall Study|Withdrawal by Subject|1|||
19418473|NCT02312219|41664747|FG001|Overall Study|Withdrawal by Subject|2|||
19418474|NCT02312219|41664746|FG000|Overall Study|could not schedule imaging in time|0|||
19418475|NCT02312219|41664747|FG001|Overall Study|could not schedule imaging in time|2|||
19418476|NCT02312219|41664746|FG000|Overall Study|Other|0|||
19418477|NCT02312219|41664747|FG001|Overall Study|Other|1|||
19418478|NCT02312219|41664746|FG000|Overall Study|Not randomized. Ineligible|0|||
19418479|NCT02312219|41664747|FG001|Overall Study|Not randomized. Ineligible|1|||
19418480|NCT01986231|41664753|FG000|Overall Study|Adverse Event|1|||
19418481|NCT02312063|41664759|FG000|Overall Study|Withdrawal by Subject|0|||
19418482|NCT02312063|41664760|FG001|Overall Study|Withdrawal by Subject|1|||
19418483|NCT02353169|41664771|FG000|Overall Study|QTc > 450 msec|1|||
19418484|NCT02353169|41664772|FG001|Overall Study|QTc > 450 msec|1|||
19418485|NCT02353169|41664773|FG002|Overall Study|QTc > 450 msec|1|||
19418486|NCT02353169|41664774|FG003|Overall Study|QTc > 450 msec|1|||
19418487|NCT02353169|41664771|FG000|Overall Study|OR team declined|2|||
19418488|NCT02353169|41664772|FG001|Overall Study|OR team declined|0|||
19418489|NCT02353169|41664773|FG002|Overall Study|OR team declined|0|||
19418490|NCT02353169|41664774|FG003|Overall Study|OR team declined|0|||
19418491|NCT02353169|41664771|FG000|Overall Study|Inhalational induction|0|||
19418492|NCT02353169|41664772|FG001|Overall Study|Inhalational induction|2|||
19418493|NCT02353169|41664773|FG002|Overall Study|Inhalational induction|0|||
19418494|NCT02353169|41664774|FG003|Overall Study|Inhalational induction|0|||
19418495|NCT02353169|41664771|FG000|Overall Study|ECG data error|0|||
19418496|NCT02353169|41664772|FG001|Overall Study|ECG data error|3|||
19418497|NCT02353169|41664773|FG002|Overall Study|ECG data error|2|||
19418498|NCT02353169|41664774|FG003|Overall Study|ECG data error|2|||
19418499|NCT02353169|41664771|FG000|Overall Study|Pre-op medication|0|||
19418500|NCT02353169|41664772|FG001|Overall Study|Pre-op medication|0|||
19418501|NCT02353169|41664773|FG002|Overall Study|Pre-op medication|1|||
19418502|NCT02353169|41664774|FG003|Overall Study|Pre-op medication|0|||
19418503|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
19418504|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
19418505|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
19418506|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
19418507|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
19418508|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
19418509|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
19418510|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
19418511|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
19418512|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
19418513|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
19418514|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
19418515|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
19519569|NCT01474512|41932298|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519570|NCT01474512|41932299|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519571|NCT01474512|41932300|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519572|NCT01474512|41932301|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519573|NCT01474512|41932302|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519574|NCT01474512|41932303|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519575|NCT01474512|41932304|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
19519576|NCT01474512|41932305|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
19519577|NCT01474512|41932306|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519578|NCT01474512|41932307|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519579|NCT01474512|41932308|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519580|NCT01474512|41932309|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
19519581|NCT01474512|41932292|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519582|NCT01474512|41932293|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519583|NCT01474512|41932294|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519584|NCT01474512|41932295|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519585|NCT01474512|41932296|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519586|NCT01474512|41932297|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519587|NCT01474512|41932298|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519588|NCT01474512|41932299|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519589|NCT01474512|41932300|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519590|NCT01474512|41932301|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519591|NCT01474512|41932302|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519592|NCT01474512|41932303|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
19519593|NCT01474512|41932304|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519594|NCT01474512|41932305|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519595|NCT01474512|41932306|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519596|NCT01474512|41932307|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519597|NCT01474512|41932308|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19418516|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
19418517|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
19519598|NCT01474512|41932309|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
19519599|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
19418518|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
19418519|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
19418520|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
19418521|NCT02009163|41664784|FG000|Open-label Period (Non-randomized)|Other|13|||
19418522|NCT02009163|41664785|FG001|Open-label Period (Non-randomized)|Other|0|||
19418523|NCT02009163|41664786|FG002|Open-label Period (Non-randomized)|Other|0|||
19418524|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
19418525|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
19418526|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
19418527|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
19418528|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
19418529|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
19418530|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Adverse Event|0|||
19418531|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Adverse Event|0|||
19418532|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Adverse Event|6|||
19418533|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
19418534|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
19418535|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
19418536|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
19418537|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
19418538|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
19418539|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Pregnancy|0|||
19418540|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Pregnancy|0|||
19418541|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Pregnancy|2|||
19418542|NCT02009163|41664784|FG000|Randomized-withdrawal Period|Other|0|||
19418543|NCT02009163|41664785|FG001|Randomized-withdrawal Period|Other|9|||
19418544|NCT02009163|41664786|FG002|Randomized-withdrawal Period|Other|5|||
19418545|NCT01983969|41664799|FG000|Overall Study|Disease Progression|0|||
19418546|NCT01983969|41664800|FG001|Overall Study|Disease Progression|1|||
19418547|NCT01983969|41664801|FG002|Overall Study|Disease Progression|0|||
19418548|NCT02008773|41664817|FG000|Overall Study|Adverse Event|3|||
19418549|NCT02008773|41664818|FG001|Overall Study|Adverse Event|3|||
19418550|NCT02008773|41664819|FG002|Overall Study|Adverse Event|1|||
19418551|NCT02008773|41664820|FG003|Overall Study|Adverse Event|2|||
19418552|NCT02008773|41664817|FG000|Overall Study|Medication Non-compliance|2|||
19418553|NCT02008773|41664818|FG001|Overall Study|Medication Non-compliance|1|||
19418554|NCT02008773|41664819|FG002|Overall Study|Medication Non-compliance|3|||
19418555|NCT02008773|41664820|FG003|Overall Study|Medication Non-compliance|2|||
19418556|NCT02008773|41664817|FG000|Overall Study|Withdrawal by Subject|8|||
19418557|NCT02008773|41664818|FG001|Overall Study|Withdrawal by Subject|4|||
19418558|NCT02008773|41664819|FG002|Overall Study|Withdrawal by Subject|7|||
19418559|NCT02008773|41664820|FG003|Overall Study|Withdrawal by Subject|6|||
19418560|NCT02008773|41664817|FG000|Overall Study|Lost to Follow-up|0|||
19418561|NCT02008773|41664818|FG001|Overall Study|Lost to Follow-up|1|||
19418562|NCT02008773|41664819|FG002|Overall Study|Lost to Follow-up|3|||
19418563|NCT02008773|41664820|FG003|Overall Study|Lost to Follow-up|2|||
19418564|NCT02257567|41664839|FG000|Overall Study|Adverse Event|0|||
19418565|NCT02257567|41664840|FG001|Overall Study|Adverse Event|0|||
19418566|NCT02257567|41664841|FG002|Overall Study|Adverse Event|0|||
19418567|NCT02257567|41664842|FG003|Overall Study|Adverse Event|1|||
19418568|NCT02257567|41664843|FG004|Overall Study|Adverse Event|1|||
19418569|NCT02257567|41664844|FG005|Overall Study|Adverse Event|0|||
19418570|NCT02257567|41664845|FG006|Overall Study|Adverse Event|0|||
19418571|NCT02257567|41664846|FG007|Overall Study|Adverse Event|0|||
19418572|NCT02257567|41664847|FG008|Overall Study|Adverse Event|1|||
19418573|NCT02257567|41664848|FG009|Overall Study|Adverse Event|0|||
19418574|NCT02257567|41664849|FG010|Overall Study|Adverse Event|0|||
19418575|NCT02257567|41664839|FG000|Overall Study|Death|2|||
19418576|NCT02257567|41664840|FG001|Overall Study|Death|2|||
19418577|NCT02257567|41664841|FG002|Overall Study|Death|2|||
19418578|NCT02257567|41664842|FG003|Overall Study|Death|4|||
19418579|NCT02257567|41664843|FG004|Overall Study|Death|15|||
19418580|NCT02257567|41664844|FG005|Overall Study|Death|11|||
19418581|NCT02257567|41664845|FG006|Overall Study|Death|26|||
19418582|NCT02257567|41664846|FG007|Overall Study|Death|30|||
19418583|NCT02257567|41664847|FG008|Overall Study|Death|2|||
19418584|NCT02257567|41664848|FG009|Overall Study|Death|18|||
19418585|NCT02257567|41664849|FG010|Overall Study|Death|65|||
19418586|NCT02257567|41664839|FG000|Overall Study|Lost to Follow-up|0|||
19418587|NCT02257567|41664840|FG001|Overall Study|Lost to Follow-up|0|||
19418588|NCT02257567|41664841|FG002|Overall Study|Lost to Follow-up|0|||
19418589|NCT02257567|41664842|FG003|Overall Study|Lost to Follow-up|0|||
19418590|NCT02257567|41664843|FG004|Overall Study|Lost to Follow-up|2|||
19418591|NCT02257567|41664844|FG005|Overall Study|Lost to Follow-up|2|||
19418592|NCT02257567|41664845|FG006|Overall Study|Lost to Follow-up|0|||
19418593|NCT02257567|41664846|FG007|Overall Study|Lost to Follow-up|0|||
19418594|NCT02257567|41664847|FG008|Overall Study|Lost to Follow-up|0|||
19418595|NCT02257567|41664848|FG009|Overall Study|Lost to Follow-up|1|||
19418596|NCT02257567|41664849|FG010|Overall Study|Lost to Follow-up|1|||
19418597|NCT02257567|41664839|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418598|NCT02257567|41664840|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418599|NCT02257567|41664841|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418600|NCT02257567|41664842|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418601|NCT02257567|41664843|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
19418602|NCT02257567|41664844|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418603|NCT02257567|41664845|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
19418604|NCT02257567|41664846|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418605|NCT02257567|41664847|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418606|NCT02257567|41664848|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418607|NCT02257567|41664849|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
19418608|NCT02257567|41664839|FG000|Overall Study|Physician Decision|0|||
19418609|NCT02257567|41664840|FG001|Overall Study|Physician Decision|0|||
19418610|NCT02257567|41664841|FG002|Overall Study|Physician Decision|0|||
19418611|NCT02257567|41664842|FG003|Overall Study|Physician Decision|0|||
19418612|NCT02257567|41664843|FG004|Overall Study|Physician Decision|0|||
19418613|NCT02257567|41664844|FG005|Overall Study|Physician Decision|0|||
19418614|NCT02257567|41664845|FG006|Overall Study|Physician Decision|0|||
19418615|NCT02257567|41664846|FG007|Overall Study|Physician Decision|2|||
19418616|NCT02257567|41664847|FG008|Overall Study|Physician Decision|0|||
19418617|NCT02257567|41664848|FG009|Overall Study|Physician Decision|1|||
19418618|NCT02257567|41664849|FG010|Overall Study|Physician Decision|0|||
19418619|NCT02257567|41664839|FG000|Overall Study|Withdrawal by Subject|0|||
19418620|NCT02257567|41664840|FG001|Overall Study|Withdrawal by Subject|0|||
19418621|NCT02257567|41664841|FG002|Overall Study|Withdrawal by Subject|2|||
19418622|NCT02257567|41664842|FG003|Overall Study|Withdrawal by Subject|0|||
19418623|NCT02257567|41664843|FG004|Overall Study|Withdrawal by Subject|0|||
19418624|NCT02257567|41664844|FG005|Overall Study|Withdrawal by Subject|6|||
19418625|NCT02257567|41664845|FG006|Overall Study|Withdrawal by Subject|6|||
19418626|NCT02257567|41664846|FG007|Overall Study|Withdrawal by Subject|6|||
19418627|NCT02257567|41664847|FG008|Overall Study|Withdrawal by Subject|1|||
19418628|NCT02257567|41664848|FG009|Overall Study|Withdrawal by Subject|1|||
19418629|NCT02257567|41664849|FG010|Overall Study|Withdrawal by Subject|10|||
19418630|NCT01642615|41664906|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
19418631|NCT01642615|41664907|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
19418632|NCT01642615|41664908|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
19418633|NCT01642615|41664906|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
19418634|NCT01642615|41664907|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
19418635|NCT01642615|41664908|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
19418636|NCT01642615|41664906|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
19418637|NCT01642615|41664907|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
19418638|NCT01642615|41664908|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
19418639|NCT01642615|41664906|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
19418640|NCT01642615|41664907|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
19418641|NCT01642615|41664908|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
19418642|NCT01642615|41664906|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
19418643|NCT01642615|41664907|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
19418644|NCT01642615|41664908|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
19418645|NCT01642615|41664906|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
19418646|NCT01642615|41664907|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
19418647|NCT01642615|41664908|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
19418648|NCT01642615|41664906|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
19418649|NCT01642615|41664907|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
19418650|NCT01642615|41664908|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
19418651|NCT01642615|41664906|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
19418652|NCT01642615|41664907|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
19519600|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
19519601|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
19519602|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
19519603|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
19519604|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
19519605|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
19519606|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
19519607|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
19418653|NCT01642615|41664908|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
19418654|NCT01642615|41664906|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
19418655|NCT01642615|41664907|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
19418656|NCT01642615|41664908|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
19418657|NCT02311361|41664920|FG000|Overall Study|Did not receive treatment|0|||
19418658|NCT02311361|41664921|FG001|Overall Study|Did not receive treatment|1|||
19418659|NCT02311361|41664922|FG002|Overall Study|Did not receive treatment|0|||
19418660|NCT02311361|41664923|FG003|Overall Study|Did not receive treatment|1|||
19418661|NCT02352779|41664940|FG000|Overall Study|Personal Issues|1|||
19418662|NCT02352779|41664941|FG001|Overall Study|Personal Issues|1|||
19418663|NCT02352779|41664942|FG002|Overall Study|Personal Issues|0|||
19418664|NCT02352779|41664940|FG000|Overall Study|Too Many Forms|2|||
19418665|NCT02352779|41664941|FG001|Overall Study|Too Many Forms|0|||
19418666|NCT02352779|41664942|FG002|Overall Study|Too Many Forms|0|||
19418667|NCT02352779|41664940|FG000|Overall Study|Feeling Overwhelmed|1|||
19418668|NCT02352779|41664941|FG001|Overall Study|Feeling Overwhelmed|0|||
19418669|NCT02352779|41664942|FG002|Overall Study|Feeling Overwhelmed|0|||
19418670|NCT02352779|41664940|FG000|Overall Study|Disliked Intervention|1|||
19418671|NCT02352779|41664941|FG001|Overall Study|Disliked Intervention|0|||
19418672|NCT02352779|41664942|FG002|Overall Study|Disliked Intervention|0|||
19418673|NCT02352779|41664940|FG000|Overall Study|Changed Mind|1|||
19418674|NCT02352779|41664941|FG001|Overall Study|Changed Mind|0|||
19418675|NCT02352779|41664942|FG002|Overall Study|Changed Mind|0|||
19418676|NCT02352779|41664940|FG000|Overall Study|Study Related Symptoms|1|||
19418677|NCT02352779|41664941|FG001|Overall Study|Study Related Symptoms|0|||
19418678|NCT02352779|41664942|FG002|Overall Study|Study Related Symptoms|0|||
19418679|NCT02352779|41664940|FG000|Overall Study|Absence of Symptoms|1|||
19418680|NCT02352779|41664941|FG001|Overall Study|Absence of Symptoms|0|||
19418681|NCT02352779|41664942|FG002|Overall Study|Absence of Symptoms|0|||
19418682|NCT02352779|41664940|FG000|Overall Study|Other Medical Reason|0|||
19418683|NCT02352779|41664941|FG001|Overall Study|Other Medical Reason|0|||
19418684|NCT02352779|41664942|FG002|Overall Study|Other Medical Reason|1|||
19418685|NCT02352779|41664940|FG000|Overall Study|No Reason|0|||
19418686|NCT02352779|41664941|FG001|Overall Study|No Reason|0|||
19418687|NCT02352779|41664942|FG002|Overall Study|No Reason|1|||
19418688|NCT02257489|41664959|FG000|Overall Study|Withdrawal by Subject|0|||
19418689|NCT02257489|41664960|FG001|Overall Study|Withdrawal by Subject|0|||
19418690|NCT02257489|41664961|FG002|Overall Study|Withdrawal by Subject|0|||
19418691|NCT02257489|41664962|FG003|Overall Study|Withdrawal by Subject|1|||
19418692|NCT02257489|41664963|FG004|Overall Study|Withdrawal by Subject|0|||
19418693|NCT02257489|41664964|FG005|Overall Study|Withdrawal by Subject|0|||
19418694|NCT02257489|41664965|FG006|Overall Study|Withdrawal by Subject|0|||
19519608|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
19519609|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
19519610|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
19519611|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
19519612|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
19519613|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
19519614|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
19519615|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
19519616|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
19519617|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519618|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519619|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519620|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519621|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519622|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519623|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519624|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519625|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519626|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519627|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519628|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19628138|NCT00451321|42077528|FG004|Overall Study|Study closed/terminated|7|||
19418695|NCT02257489|41664966|FG007|Overall Study|Withdrawal by Subject|0|||
19418696|NCT02257489|41664967|FG008|Overall Study|Withdrawal by Subject|0|||
19418697|NCT02329223|41664990|FG000|Overall Study|Withdrawal by Subject|1|||
19418698|NCT02329223|41664991|FG001|Overall Study|Withdrawal by Subject|2|||
19418699|NCT02329223|41664992|FG002|Overall Study|Withdrawal by Subject|5|||
19418700|NCT02329223|41664990|FG000|Overall Study|Physician Decision|0|||
19519629|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19418701|NCT02329223|41664991|FG001|Overall Study|Physician Decision|0|||
19418702|NCT02329223|41664992|FG002|Overall Study|Physician Decision|1|||
19418703|NCT02329223|41664990|FG000|Overall Study|Adverse Event|0|||
19418704|NCT02329223|41664991|FG001|Overall Study|Adverse Event|1|||
19418705|NCT02329223|41664992|FG002|Overall Study|Adverse Event|0|||
19418706|NCT01641601|41665002|FG000|Overall Study|Study discontinued.|3|||
19418707|NCT01641601|41665003|FG001|Overall Study|Study discontinued.|5|||
19418708|NCT02350127|41665011|FG000|4-Month Assessment|Withdrawal by Subject|10|||
19418709|NCT02350127|41665012|FG001|4-Month Assessment|Withdrawal by Subject|9|||
19418710|NCT02350127|41665011|FG000|4-Month Assessment|Death|1|||
19418711|NCT02350127|41665012|FG001|4-Month Assessment|Death|0|||
19418712|NCT02350127|41665011|FG000|8-Month Assessment|Death|1|||
19418713|NCT02350127|41665012|FG001|8-Month Assessment|Death|1|||
19418714|NCT02350127|41665011|FG000|8-Month Assessment|Withdrawal by Subject|5|||
19418715|NCT02350127|41665012|FG001|8-Month Assessment|Withdrawal by Subject|8|||
19418716|NCT02256553|41665019|FG000|Period I|Adverse Event|5|||
19418717|NCT02256553|41665019|FG000|Period I|Protocol Violation|1|||
19418718|NCT02256553|41665019|FG000|Period II|Adverse Event|1|||
19418719|NCT02256553|41665019|FG000|Period II|Subject Moved|1|||
19418720|NCT02256553|41665019|FG000|Period III|Adverse Event|3|||
19418721|NCT02349425|41665029|FG000|Period 1|Adverse Event|1|||
19418722|NCT02349425|41665030|FG001|Period 1|Adverse Event|1|||
19418723|NCT02349425|41665031|FG002|Period 1|Adverse Event|0|||
19418724|NCT02349425|41665032|FG003|Period 1|Adverse Event|0|||
19418725|NCT02349425|41665029|FG000|Period 2|Adverse Event|0|||
19418726|NCT02349425|41665030|FG001|Period 2|Adverse Event|1|||
19418727|NCT02349425|41665031|FG002|Period 2|Adverse Event|1|||
19418728|NCT02349425|41665032|FG003|Period 2|Adverse Event|0|||
19418729|NCT02310581|41665074|FG000|Overall Study|Adverse Event|1|||
19418730|NCT02310581|41665075|FG001|Overall Study|Adverse Event|1|||
19418731|NCT02310581|41665076|FG002|Overall Study|Adverse Event|1|||
19418732|NCT02310581|41665077|FG003|Overall Study|Adverse Event|0|||
19418733|NCT02310581|41665074|FG000|Overall Study|Withdrawal by Subject|2|||
19418734|NCT02310581|41665075|FG001|Overall Study|Withdrawal by Subject|1|||
19418735|NCT02310581|41665076|FG002|Overall Study|Withdrawal by Subject|0|||
19418736|NCT02310581|41665077|FG003|Overall Study|Withdrawal by Subject|1|||
19418737|NCT02309723|41665090|FG000|Overall Study|Withdrawal by Subject|24|||
19418738|NCT02309723|41665091|FG001|Overall Study|Withdrawal by Subject|23|||
19418739|NCT02309723|41665092|FG002|Overall Study|Withdrawal by Subject|24|||
19418740|NCT02309411|41665103|FG000|Overall Study|Physician Decision|1|||
19418741|NCT02309411|41665104|FG001|Overall Study|Physician Decision|0|||
19418742|NCT02309411|41665105|FG002|Overall Study|Physician Decision|0|||
19418743|NCT02309411|41665103|FG000|Overall Study|Withdrawal by Subject|1|||
19418744|NCT02309411|41665104|FG001|Overall Study|Withdrawal by Subject|1|||
19418745|NCT02309411|41665105|FG002|Overall Study|Withdrawal by Subject|0|||
19418746|NCT02008227|41665114|FG000|Overall Study|Lost to Follow-up|7|||
19418747|NCT02008227|41665115|FG001|Overall Study|Lost to Follow-up|9|||
19418748|NCT02008227|41665114|FG000|Overall Study|Death|494|||
19418749|NCT02008227|41665115|FG001|Overall Study|Death|485|||
19418750|NCT02008227|41665114|FG000|Overall Study|Withdrawal by Subject|67|||
19418751|NCT02008227|41665115|FG001|Overall Study|Withdrawal by Subject|36|||
19418752|NCT02008227|41665114|FG000|Overall Study|Study Terminated By Sponsor|44|||
19418753|NCT02008227|41665115|FG001|Overall Study|Study Terminated By Sponsor|83|||
19418754|NCT02006979|41665124|FG000|Overall Study|Withdrawal by Subject|1|||
19418755|NCT02006979|41665125|FG001|Overall Study|Withdrawal by Subject|1|||
19418756|NCT02006979|41665124|FG000|Overall Study|Protocol Violation|0|||
19418757|NCT02006979|41665125|FG001|Overall Study|Protocol Violation|1|||
19418758|NCT02348723|41665133|FG000|Overall Study|No ablation|21|||
19418759|NCT02348723|41665134|FG001|Overall Study|No ablation|20|||
19418760|NCT02348723|41665133|FG000|Overall Study|Non-compliant with Protocol|1|||
19418761|NCT02348723|41665134|FG001|Overall Study|Non-compliant with Protocol|0|||
19519630|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
19519631|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
19519632|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
19519633|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
19519634|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
19418762|NCT02348723|41665133|FG000|Overall Study|Lost to Follow-up|1|||
19418763|NCT02348723|41665134|FG001|Overall Study|Lost to Follow-up|1|||
19418764|NCT02348723|41665133|FG000|Overall Study|Consent withdrawn|1|||
19418765|NCT02348723|41665134|FG001|Overall Study|Consent withdrawn|3|||
19418766|NCT02348723|41665133|FG000|Overall Study|Reason other than specified|1|||
19418767|NCT02348723|41665134|FG001|Overall Study|Reason other than specified|1|||
19418768|NCT02348723|41665133|FG000|Overall Study|Adverse Event|3|||
19418769|NCT02348723|41665134|FG001|Overall Study|Adverse Event|1|||
19418770|NCT01967277|41665142|FG000|Overall Study|Lost to Follow-up|1|||
19418771|NCT01967277|41665143|FG001|Overall Study|Lost to Follow-up|2|||
19418772|NCT01967277|41665142|FG000|Overall Study|Unrelated illness|0|||
19418773|NCT01967277|41665143|FG001|Overall Study|Unrelated illness|1|||
19519635|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519636|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19418774|NCT02326883|41665152|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
19418775|NCT02326883|41665153|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
19418776|NCT02326883|41665154|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
19418777|NCT02006667|41665162|FG000|Overall Study|Adverse Event|3|||
19418778|NCT02006667|41665162|FG000|Overall Study|Death|2|||
19418779|NCT02006667|41665162|FG000|Overall Study|Withdrawal by Subject|1|||
19418780|NCT01983111|41665168|FG000|Overall Study|Withdrawal by Subject|8|||
19418781|NCT01983111|41665169|FG001|Overall Study|Withdrawal by Subject|6|||
19418782|NCT01983111|41665168|FG000|Overall Study|Adverse Event|4|||
19418783|NCT01983111|41665169|FG001|Overall Study|Adverse Event|0|||
19418784|NCT01983111|41665168|FG000|Overall Study|Protocol Violation|0|||
19418785|NCT01983111|41665169|FG001|Overall Study|Protocol Violation|1|||
19418786|NCT02348489|41665177|FG000|Overall Study|Death|336|||
19418787|NCT02348489|41665178|FG001|Overall Study|Death|335|||
19418788|NCT02348489|41665177|FG000|Overall Study|Withdrawal by Subject|14|||
19418789|NCT02348489|41665178|FG001|Overall Study|Withdrawal by Subject|27|||
19418790|NCT02348489|41665177|FG000|Overall Study|Lost to Follow-up|3|||
19418791|NCT02348489|41665178|FG001|Overall Study|Lost to Follow-up|5|||
19418792|NCT02309099|41665188|FG000|Overall Study|Adverse Event|2|||
19418793|NCT02309099|41665189|FG001|Overall Study|Adverse Event|0|||
19418794|NCT01966107|41665197|FG000|Overall Study|excluded from FAS|21|||
19418795|NCT01966107|41665198|FG001|Overall Study|excluded from FAS|20|||
19418796|NCT01966107|41665197|FG000|Overall Study|discontinued treatment|345|||
19418797|NCT01966107|41665198|FG001|Overall Study|discontinued treatment|372|||
19418798|NCT01966107|41665197|FG000|Overall Study|due to study closure|164|||
19418799|NCT01966107|41665198|FG001|Overall Study|due to study closure|186|||
19418800|NCT01966107|41665197|FG000|Overall Study|withdrew from the study|272|||
19418801|NCT01966107|41665198|FG001|Overall Study|withdrew from the study|303|||
19418802|NCT02347943|41665207|FG000|Overall Study|Study was cancelled|140|||
19418803|NCT02347943|41665208|FG001|Overall Study|Study was cancelled|67|||
19418804|NCT02347943|41665209|FG002|Overall Study|Study was cancelled|45|||
19418805|NCT01982331|41665219|FG000|Received Vaccination 2|Adverse Event|1|||
19418806|NCT01982331|41665220|FG001|Received Vaccination 2|Adverse Event|2|||
19418807|NCT01982331|41665219|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
19418808|NCT01982331|41665220|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
19418809|NCT01982331|41665219|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
19418810|NCT01982331|41665220|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
19418811|NCT02326025|41665228|FG000|Overall Study|Adverse Event|3|||
19418812|NCT02326025|41665229|FG001|Overall Study|Adverse Event|0|||
19418813|NCT02326025|41665228|FG000|Overall Study|Physician Decision|1|||
19418814|NCT02326025|41665229|FG001|Overall Study|Physician Decision|2|||
19418815|NCT02326025|41665228|FG000|Overall Study|Physician and Participant Decision|1|||
19418816|NCT02326025|41665229|FG001|Overall Study|Physician and Participant Decision|0|||
19418817|NCT02326025|41665228|FG000|Overall Study|Withdrawal by Subject|0|||
19418818|NCT02326025|41665229|FG001|Overall Study|Withdrawal by Subject|2|||
19418819|NCT02326025|41665228|FG000|Overall Study|Protocol Violation|0|||
19418820|NCT02326025|41665229|FG001|Overall Study|Protocol Violation|1|||
19418821|NCT01619865|41665248|FG000|Overall Study|Adverse Event|1|||
19418822|NCT01619865|41665248|FG000|Overall Study|Death|2|||
19418823|NCT01619865|41665248|FG000|Overall Study|subject not able to comply|1|||
19418824|NCT02006121|41665255|FG000|Double Blind Phase|Adverse Event|6|||
19418825|NCT02006121|41665256|FG001|Double Blind Phase|Adverse Event|0|||
19418826|NCT02006121|41665255|FG000|Double Blind Phase|Lack of Efficacy|1|||
19418827|NCT02006121|41665256|FG001|Double Blind Phase|Lack of Efficacy|16|||
19418828|NCT02006121|41665255|FG000|Double Blind Phase|Withdrawal by Subject|3|||
19418829|NCT02006121|41665256|FG001|Double Blind Phase|Withdrawal by Subject|4|||
19418830|NCT02006121|41665255|FG000|Double Blind Phase|Non-compliance with study drug|1|||
19418831|NCT02006121|41665256|FG001|Double Blind Phase|Non-compliance with study drug|3|||
19418832|NCT02006121|41665255|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
19418833|NCT02006121|41665256|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
19418834|NCT02006121|41665255|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
19418835|NCT02006121|41665256|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
19418836|NCT02006121|41665255|FG000|Open Label Phase|Adverse Event|15|||
19418837|NCT02006121|41665256|FG001|Open Label Phase|Adverse Event|0|||
19519637|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519638|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519639|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519640|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519641|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519642|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519643|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519644|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519645|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19418838|NCT02006121|41665255|FG000|Open Label Phase|Lack of Efficacy|2|||
19418839|NCT02006121|41665256|FG001|Open Label Phase|Lack of Efficacy|0|||
19519646|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19418840|NCT02006121|41665255|FG000|Open Label Phase|Protocol Violation|2|||
19418841|NCT02006121|41665256|FG001|Open Label Phase|Protocol Violation|0|||
19418842|NCT02006121|41665255|FG000|Open Label Phase|Withdrawal by Subject|3|||
19418843|NCT02006121|41665256|FG001|Open Label Phase|Withdrawal by Subject|0|||
19418844|NCT02006121|41665255|FG000|Open Label Phase|Non-compliance with study drug|3|||
19418845|NCT02006121|41665256|FG001|Open Label Phase|Non-compliance with study drug|0|||
19418846|NCT02005887|41665268|FG000|Overall Study|Protocol Violation|0|||
19418847|NCT02005887|41665269|FG001|Overall Study|Protocol Violation|2|||
19418848|NCT01982253|41665278|FG000|Overall Study|Withdrawal by Subject|1|||
19418849|NCT01982253|41665279|FG001|Overall Study|Withdrawal by Subject|0|||
19418850|NCT01982253|41665280|FG002|Overall Study|Withdrawal by Subject|0|||
19418851|NCT01982253|41665278|FG000|Overall Study|Study terminated by sponsor|1|||
19418852|NCT01982253|41665279|FG001|Overall Study|Study terminated by sponsor|4|||
19418853|NCT01982253|41665280|FG002|Overall Study|Study terminated by sponsor|4|||
19418854|NCT01619787|41665290|FG000|Overall Study|Lost to Follow-up|5|||
19418855|NCT01981473|41665299|FG000|Overall Study|Incorrect diagnosis of RA|0|||
19418856|NCT01981473|41665300|FG001|Overall Study|Incorrect diagnosis of RA|0|||
19418857|NCT01981473|41665301|FG002|Overall Study|Incorrect diagnosis of RA|1|||
19418858|NCT01981473|41665299|FG000|Overall Study|Received treatment for < 6 months|0|||
19418859|NCT01981473|41665300|FG001|Overall Study|Received treatment for < 6 months|0|||
19418860|NCT01981473|41665301|FG002|Overall Study|Received treatment for < 6 months|1|||
19418861|NCT01981473|41665299|FG000|Overall Study|Received treatment for >24 months|2|||
19418862|NCT01981473|41665300|FG001|Overall Study|Received treatment for >24 months|0|||
19418863|NCT01981473|41665301|FG002|Overall Study|Received treatment for >24 months|6|||
19418864|NCT02005029|41665314|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
19418865|NCT02005029|41665315|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
19418866|NCT02325791|41665343|FG000|Overall Study|Adverse Event|0|||
19418867|NCT02325791|41665344|FG001|Overall Study|Adverse Event|1|||
19418868|NCT02325791|41665345|FG002|Overall Study|Adverse Event|1|||
19418869|NCT02325791|41665346|FG003|Overall Study|Adverse Event|0|||
19418870|NCT02325791|41665343|FG000|Overall Study|Death|0|||
19418871|NCT02325791|41665344|FG001|Overall Study|Death|3|||
19418872|NCT02325791|41665345|FG002|Overall Study|Death|0|||
19418873|NCT02325791|41665346|FG003|Overall Study|Death|1|||
19418874|NCT02325791|41665343|FG000|Overall Study|Lost to Follow-up|0|||
19418875|NCT02325791|41665344|FG001|Overall Study|Lost to Follow-up|15|||
19418876|NCT02325791|41665345|FG002|Overall Study|Lost to Follow-up|14|||
19418877|NCT02325791|41665346|FG003|Overall Study|Lost to Follow-up|9|||
19418878|NCT02325791|41665343|FG000|Overall Study|Physician Decision|0|||
19418879|NCT02325791|41665344|FG001|Overall Study|Physician Decision|1|||
19418880|NCT02325791|41665345|FG002|Overall Study|Physician Decision|1|||
19418881|NCT02325791|41665346|FG003|Overall Study|Physician Decision|0|||
19418882|NCT02325791|41665343|FG000|Overall Study|Protocol Violation|0|||
19418883|NCT02325791|41665344|FG001|Overall Study|Protocol Violation|0|||
19418884|NCT02325791|41665345|FG002|Overall Study|Protocol Violation|1|||
19418885|NCT02325791|41665346|FG003|Overall Study|Protocol Violation|0|||
19418886|NCT02325791|41665343|FG000|Overall Study|Withdrawal by Subject|0|||
19418887|NCT02325791|41665344|FG001|Overall Study|Withdrawal by Subject|5|||
19418888|NCT02325791|41665345|FG002|Overall Study|Withdrawal by Subject|8|||
19418889|NCT02325791|41665346|FG003|Overall Study|Withdrawal by Subject|16|||
19418890|NCT02004873|41665359|FG000|Overall Study|Implant unsuccessful|6|||
19418891|NCT02004873|41665359|FG000|Overall Study|Awaiting 6-month visit|390|||
19418892|NCT02004873|41665359|FG000|Overall Study|Missed 6-month visit|4|||
19418893|NCT02004873|41665359|FG000|Overall Study|Death|23|||
19418894|NCT02004873|41665359|FG000|Overall Study|Withdrawal by Subject|1|||
19418895|NCT02347787|41665368|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
19418896|NCT02347787|41665369|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
19418897|NCT02347787|41665368|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
19418898|NCT02347787|41665369|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
19418899|NCT02347787|41665368|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
19418900|NCT02347787|41665369|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
19418901|NCT02347787|41665368|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
19418902|NCT02347787|41665369|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
19418903|NCT01979835|41665380|FG000|Primary Outcome SA Measurment|failed insertion|18|||
19418904|NCT01979835|41665380|FG000|Follow-up|Lost to Follow-up|32|||
19418905|NCT02282345|41665386|FG000|Overall Study|Progression|0|||
19418906|NCT02282345|41665387|FG001|Overall Study|Progression|1|||
19418907|NCT01732822|41665398|FG000|Overall Study|Withdrawal by Subject|123|||
19418908|NCT01732822|41665399|FG001|Overall Study|Withdrawal by Subject|113|||
19418909|NCT02004093|41665429|FG000|Overall Study|Death|2|||
19418910|NCT02004093|41665430|FG001|Overall Study|Death|1|||
19418911|NCT02004093|41665429|FG000|Overall Study|Lack of Efficacy|66|||
19628139|NCT00451321|42077529|FG005|Overall Study|Study closed/terminated|7|||
19418912|NCT02004093|41665430|FG001|Overall Study|Lack of Efficacy|62|||
19418913|NCT02004093|41665429|FG000|Overall Study|Protocol Violation|0|||
19418914|NCT02004093|41665430|FG001|Overall Study|Protocol Violation|1|||
19418915|NCT02004093|41665429|FG000|Overall Study|Lost to Follow-up|0|||
19418916|NCT02004093|41665430|FG001|Overall Study|Lost to Follow-up|1|||
19418917|NCT02004093|41665429|FG000|Overall Study|Withdrawal by Subject|3|||
19418918|NCT02004093|41665430|FG001|Overall Study|Withdrawal by Subject|7|||
19418919|NCT02004093|41665429|FG000|Overall Study|Other|3|||
19418920|NCT02004093|41665430|FG001|Overall Study|Other|1|||
19418921|NCT01641367|41665445|FG000|Cohorts|Death|18|||
19418922|NCT01641367|41665446|FG001|Cohorts|Death|1|||
19418923|NCT01641367|41665447|FG002|Cohorts|Death|2|||
19418924|NCT01641367|41665448|FG003|Cohorts|Death|0|||
19418925|NCT01641367|41665449|FG004|Cohorts|Death|1|||
19418926|NCT01641367|41665450|FG005|Cohorts|Death|1|||
19418927|NCT01641367|41665451|FG006|Cohorts|Death|0|||
19418928|NCT01641367|41665452|FG007|Cohorts|Death|0|||
19418929|NCT01641367|41665445|FG000|Cohorts|Lost to Follow-up|16|||
19418930|NCT01641367|41665446|FG001|Cohorts|Lost to Follow-up|0|||
19418931|NCT01641367|41665447|FG002|Cohorts|Lost to Follow-up|2|||
19418932|NCT01641367|41665448|FG003|Cohorts|Lost to Follow-up|0|||
19418933|NCT01641367|41665449|FG004|Cohorts|Lost to Follow-up|2|||
19418934|NCT01641367|41665450|FG005|Cohorts|Lost to Follow-up|0|||
19418935|NCT01641367|41665451|FG006|Cohorts|Lost to Follow-up|0|||
19418936|NCT01641367|41665452|FG007|Cohorts|Lost to Follow-up|0|||
19418937|NCT01641367|41665445|FG000|Randomized Adherence Intervention|Death|0|||
19418938|NCT01641367|41665446|FG001|Randomized Adherence Intervention|Death|0|||
19418939|NCT01641367|41665447|FG002|Randomized Adherence Intervention|Death|0|||
19418940|NCT01641367|41665448|FG003|Randomized Adherence Intervention|Death|0|||
19418941|NCT01641367|41665449|FG004|Randomized Adherence Intervention|Death|0|||
19418942|NCT01641367|41665450|FG005|Randomized Adherence Intervention|Death|0|||
19418943|NCT01641367|41665451|FG006|Randomized Adherence Intervention|Death|11|||
19418944|NCT01641367|41665452|FG007|Randomized Adherence Intervention|Death|12|||
19418945|NCT01641367|41665445|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418946|NCT01641367|41665446|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418947|NCT01641367|41665447|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418948|NCT01641367|41665448|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418949|NCT01641367|41665449|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418950|NCT01641367|41665450|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
19418951|NCT01641367|41665451|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
19418952|NCT01641367|41665452|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
19418953|NCT02325713|41665491|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418954|NCT02325713|41665492|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418955|NCT02325713|41665493|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418956|NCT02325713|41665494|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418957|NCT02325713|41665495|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418958|NCT02325713|41665496|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418959|NCT02325713|41665497|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418960|NCT02325713|41665498|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418961|NCT02325713|41665499|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418962|NCT02325713|41665500|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418963|NCT02325713|41665501|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
19418964|NCT02325713|41665502|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418965|NCT02325713|41665503|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418966|NCT02325713|41665504|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418967|NCT02325713|41665505|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418968|NCT02325713|41665506|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
19418969|NCT02325713|41665491|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
19418970|NCT02325713|41665492|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418971|NCT02325713|41665493|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418972|NCT02325713|41665494|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418973|NCT02325713|41665495|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418974|NCT02325713|41665496|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418975|NCT02325713|41665497|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418976|NCT02325713|41665498|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418977|NCT02325713|41665499|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418978|NCT02325713|41665500|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418979|NCT02325713|41665501|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418980|NCT02325713|41665502|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418981|NCT02325713|41665503|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418982|NCT02325713|41665504|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418983|NCT02325713|41665505|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418984|NCT02325713|41665506|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
19418985|NCT02325713|41665491|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19519647|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19418986|NCT02325713|41665492|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19628140|NCT00451321|42077530|FG006|Overall Study|Study closed/terminated|5|||
19628141|NCT00451321|42077531|FG007|Overall Study|Study closed/terminated|3|||
19628142|NCT00451321|42077524|FG000|Overall Study|Sponsor decision to amend protocol|0|||
19628143|NCT00451321|42077525|FG001|Overall Study|Sponsor decision to amend protocol|0|||
19628144|NCT00451321|42077526|FG002|Overall Study|Sponsor decision to amend protocol|0|||
19628145|NCT00451321|42077527|FG003|Overall Study|Sponsor decision to amend protocol|0|||
19628146|NCT00451321|42077528|FG004|Overall Study|Sponsor decision to amend protocol|0|||
19628147|NCT00451321|42077529|FG005|Overall Study|Sponsor decision to amend protocol|1|||
19418987|NCT02325713|41665493|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418988|NCT02325713|41665494|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418989|NCT02325713|41665495|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418990|NCT02325713|41665496|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418991|NCT02325713|41665497|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418992|NCT02325713|41665498|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418993|NCT02325713|41665499|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418994|NCT02325713|41665500|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
19418995|NCT02325713|41665501|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418996|NCT02325713|41665502|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418997|NCT02325713|41665503|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418998|NCT02325713|41665504|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19418999|NCT02325713|41665505|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19419000|NCT02325713|41665506|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
19419001|NCT02325401|41665521|FG000|Overall Study|Withdrawal by Subject|0|||
19419002|NCT02325401|41665522|FG001|Overall Study|Withdrawal by Subject|1|||
19419003|NCT02325401|41665523|FG002|Overall Study|Withdrawal by Subject|1|||
19419004|NCT02324699|41665537|FG000|Overall Study|study terminated|1|||
19419005|NCT01764256|41665545|FG000|Received All Vaccinations|Adverse Event|1|||
19419006|NCT01764256|41665546|FG001|Received All Vaccinations|Adverse Event|1|||
19419007|NCT01764256|41665547|FG002|Received All Vaccinations|Adverse Event|0|||
19419008|NCT01764256|41665548|FG003|Received All Vaccinations|Adverse Event|0|||
19419009|NCT01764256|41665545|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
19419010|NCT01764256|41665546|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
19419011|NCT01764256|41665547|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
19419012|NCT01764256|41665548|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
19419013|NCT01764256|41665545|FG000|Received All Vaccinations|Lost to Follow-up|1|||
19419014|NCT01764256|41665546|FG001|Received All Vaccinations|Lost to Follow-up|0|||
19419015|NCT01764256|41665547|FG002|Received All Vaccinations|Lost to Follow-up|0|||
19419016|NCT01764256|41665548|FG003|Received All Vaccinations|Lost to Follow-up|0|||
19419017|NCT01764256|41665545|FG000|Completed Study|Lost to Follow-up|0|||
19419018|NCT01764256|41665546|FG001|Completed Study|Lost to Follow-up|0|||
19419019|NCT01764256|41665547|FG002|Completed Study|Lost to Follow-up|0|||
19419020|NCT01764256|41665548|FG003|Completed Study|Lost to Follow-up|1|||
19419021|NCT01979523|41665564|FG000|Overall Study|Withdrawal by Subject|1|||
19419022|NCT01979523|41665565|FG001|Overall Study|Withdrawal by Subject|0|||
19419023|NCT02255461|41665577|FG000|Overall Study|Adverse Event|0|||
19419024|NCT02255461|41665578|FG001|Overall Study|Adverse Event|1|||
19419025|NCT02255461|41665579|FG002|Overall Study|Adverse Event|0|||
19419026|NCT02255461|41665580|FG003|Overall Study|Adverse Event|0|||
19419027|NCT02255461|41665581|FG004|Overall Study|Adverse Event|1|||
19419028|NCT02255461|41665577|FG000|Overall Study|Withdrawal by Subject|0|||
19419029|NCT02255461|41665578|FG001|Overall Study|Withdrawal by Subject|0|||
19419030|NCT02255461|41665579|FG002|Overall Study|Withdrawal by Subject|1|||
19419031|NCT02255461|41665580|FG003|Overall Study|Withdrawal by Subject|0|||
19419032|NCT02255461|41665581|FG004|Overall Study|Withdrawal by Subject|1|||
19419033|NCT02255461|41665577|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
19419034|NCT02255461|41665578|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
19419035|NCT02255461|41665579|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
19419036|NCT02255461|41665580|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
19419037|NCT02255461|41665581|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
19419038|NCT02255149|41665598|FG000|Overall Study|Lost to Follow-up|2|||
19419039|NCT02255149|41665598|FG000|Overall Study|Withdrawal by Subject|1|||
19419040|NCT02255149|41665598|FG000|Overall Study|Withdrawal by PI|1|||
19419041|NCT02255149|41665598|FG000|Overall Study|Implant Failure|1|||
19419042|NCT01764022|41665604|FG000|Overall Study|Death|3|||
19419043|NCT01764022|41665605|FG001|Overall Study|Death|5|||
19419044|NCT01764022|41665604|FG000|Overall Study|Withdrawal by Subject|2|||
19419045|NCT01764022|41665605|FG001|Overall Study|Withdrawal by Subject|6|||
19419046|NCT01764022|41665604|FG000|Overall Study|Lack of Efficacy|0|||
19419047|NCT01764022|41665605|FG001|Overall Study|Lack of Efficacy|1|||
19419048|NCT01764022|41665604|FG000|Overall Study|Physician Decision|0|||
19711117|NCT00117507|42154306|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19419049|NCT01764022|41665605|FG001|Overall Study|Physician Decision|2|||
19419050|NCT01764022|41665604|FG000|Overall Study|Lost to Follow-up|2|||
19419051|NCT01764022|41665605|FG001|Overall Study|Lost to Follow-up|0|||
19419052|NCT01764022|41665604|FG000|Overall Study|Protocol Violation|1|||
19419053|NCT01764022|41665605|FG001|Overall Study|Protocol Violation|0|||
19419054|NCT02003391|41665615|FG000|Overall Study|Withdrawal by Subject|2|||
19419055|NCT02003391|41665616|FG001|Overall Study|Withdrawal by Subject|1|||
19419056|NCT02003391|41665615|FG000|Overall Study|Protocol Violation|0|||
19419057|NCT02003391|41665616|FG001|Overall Study|Protocol Violation|1|||
19419058|NCT02003391|41665615|FG000|Overall Study|Adverse Event|1|||
19419059|NCT02003391|41665616|FG001|Overall Study|Adverse Event|0|||
19419060|NCT02254681|41665622|FG000|Overall Study|Lack of Efficacy|6|||
19419061|NCT01965327|41665627|FG000|Overall Study|Physician Decision|2|||
19419062|NCT02002689|41665631|FG000|Overall Study|Disease Progression|7|||
19419063|NCT02002689|41665631|FG000|Overall Study|Adverse Event|3|||
19419064|NCT01639729|41665635|FG000|Overall Study|Withdrawal by Subject|1|||
19419065|NCT01639729|41665636|FG001|Overall Study|Withdrawal by Subject|0|||
19419066|NCT01639729|41665637|FG002|Overall Study|Withdrawal by Subject|1|||
19419067|NCT01639729|41665638|FG003|Overall Study|Withdrawal by Subject|1|||
19419068|NCT01639729|41665639|FG004|Overall Study|Withdrawal by Subject|0|||
19419069|NCT01639729|41665640|FG005|Overall Study|Withdrawal by Subject|0|||
19419070|NCT02002533|41665652|FG000|Overall Study|Withdrawal by Subject|6|||
19419071|NCT02002533|41665653|FG001|Overall Study|Withdrawal by Subject|13|||
19419072|NCT02002533|41665652|FG000|Overall Study|Protocol Violation|0|||
19419073|NCT02002533|41665653|FG001|Overall Study|Protocol Violation|1|||
19419074|NCT02002533|41665652|FG000|Overall Study|Adverse Event|0|||
19419075|NCT02002533|41665653|FG001|Overall Study|Adverse Event|3|||
19419076|NCT02002533|41665652|FG000|Overall Study|Lost to Follow-up|0|||
19419077|NCT02002533|41665653|FG001|Overall Study|Lost to Follow-up|1|||
19419078|NCT02002221|41665662|FG000|Overall Study|Adverse Event|2|||
19419079|NCT02002221|41665663|FG001|Overall Study|Adverse Event|1|||
19419080|NCT02002221|41665662|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19419081|NCT02002221|41665663|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19419082|NCT02002221|41665662|FG000|Overall Study|Patient withdrew consent|0|||
19419083|NCT02002221|41665663|FG001|Overall Study|Patient withdrew consent|1|||
19419084|NCT01639495|41665669|FG000|Overall Study|Lost to Follow-up|6|||
19419085|NCT01639495|41665669|FG000|Overall Study|Consented but didn't have study catheter|4|||
19419086|NCT01639495|41665669|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
19419087|NCT01639495|41665669|FG000|Overall Study|No radiofrequency energy applied|2|||
19419088|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
19419089|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Death|1|||
19419090|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
19419091|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
19419092|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
19419093|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
19419094|NCT02001987|41665673|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
19419095|NCT02001987|41665673|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
19419096|NCT02001987|41665673|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
19419097|NCT02001987|41665673|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
19419098|NCT02001987|41665673|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
19419099|NCT02001987|41665673|FG000|LTE Period (52 Weeks)|Other|3|||
19419100|NCT01363765|41665684|FG000|Overall Study|non-diagnostic|2621|||
19419101|NCT01363765|41665685|FG001|Overall Study|non-diagnostic|1124|||
19419102|NCT01363765|41665684|FG000|Overall Study|duplicate records|736|||
19419103|NCT01363765|41665685|FG001|Overall Study|duplicate records|3177|||
19419104|NCT01363765|41665684|FG000|Overall Study|non-resident|156|||
19419105|NCT01363765|41665685|FG001|Overall Study|non-resident|76|||
19419106|NCT01363765|41665684|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
19419107|NCT01363765|41665685|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
19419108|NCT01363765|41665684|FG000|Overall Study|smear during intervention|2170|||
19419109|NCT01363765|41665685|FG001|Overall Study|smear during intervention|0|||
19419110|NCT02001051|41665695|FG000|Overall Study|Deemed not eligible following enrollment|0|||
19419111|NCT02001051|41665696|FG001|Overall Study|Deemed not eligible following enrollment|1|||
19419112|NCT01763164|41665704|FG000|Treatment Phase|Participant/Guardian decision|26|||
19419113|NCT01763164|41665705|FG001|Treatment Phase|Participant/Guardian decision|14|||
19419114|NCT01763164|41665704|FG000|Treatment Phase|Protocol Violation|1|||
19419115|NCT01763164|41665705|FG001|Treatment Phase|Protocol Violation|1|||
19419116|NCT01763164|41665704|FG000|Treatment Phase|Progressive Disease|142|||
19419117|NCT01763164|41665705|FG001|Treatment Phase|Progressive Disease|76|||
19419118|NCT01763164|41665704|FG000|Treatment Phase|Physician Decision|24|||
19419119|NCT01763164|41665705|FG001|Treatment Phase|Physician Decision|13|||
19419120|NCT01763164|41665704|FG000|Treatment Phase|Death|10|||
19419121|NCT01763164|41665705|FG001|Treatment Phase|Death|1|||
19419122|NCT01763164|41665704|FG000|Treatment Phase|Adverse Event|66|||
19419123|NCT01763164|41665705|FG001|Treatment Phase|Adverse Event|8|||
19419124|NCT01763164|41665704|FG000|Treatment Phase|Randomized but not Treated|0|||
19419125|NCT01763164|41665705|FG001|Treatment Phase|Randomized but not Treated|19|||
19419126|NCT01763164|41665704|FG000|Treatment Phase|Other|0|||
19419127|NCT01763164|41665705|FG001|Treatment Phase|Other|1|||
19419128|NCT01763164|41665704|FG000|Follow up Phase|New therapy for study indication|12|||
19419129|NCT01763164|41665705|FG001|Follow up Phase|New therapy for study indication|3|||
19419130|NCT01763164|41665704|FG000|Follow up Phase|Death|21|||
19419131|NCT01763164|41665705|FG001|Follow up Phase|Death|4|||
19419132|NCT01763164|41665704|FG000|Follow up Phase|Subject/guardian decision|9|||
19419133|NCT01763164|41665705|FG001|Follow up Phase|Subject/guardian decision|2|||
19419134|NCT01763164|41665704|FG000|Follow up Phase|Progressive disease|127|||
19419135|NCT01763164|41665705|FG001|Follow up Phase|Progressive disease|62|||
19419136|NCT01763164|41665704|FG000|Follow up Phase|Physician Decision|10|||
19419137|NCT01763164|41665705|FG001|Follow up Phase|Physician Decision|3|||
19419138|NCT01763164|41665704|FG000|Follow up Phase|Lost to Follow-up|1|||
19419139|NCT01763164|41665705|FG001|Follow up Phase|Lost to Follow-up|0|||
19419140|NCT01763164|41665704|FG000|Follow up Phase|Adverse Event|17|||
19419141|NCT01763164|41665705|FG001|Follow up Phase|Adverse Event|1|||
19419142|NCT01782742|41665713|FG000|Double-blind Treatment Phase|Adverse Event|1|||
19419143|NCT01782742|41665714|FG001|Double-blind Treatment Phase|Adverse Event|0|||
19419144|NCT01782664|41665728|FG000|Overall Study|Adverse Event|2|||
19419145|NCT01782664|41665729|FG001|Overall Study|Adverse Event|2|||
19419146|NCT01782664|41665730|FG002|Overall Study|Adverse Event|2|||
19419147|NCT01782664|41665731|FG003|Overall Study|Adverse Event|2|||
19419148|NCT01782664|41665732|FG004|Overall Study|Adverse Event|0|||
19419149|NCT01782664|41665733|FG005|Overall Study|Adverse Event|0|||
19419150|NCT01782664|41665728|FG000|Overall Study|Lack of Efficacy|2|||
19419151|NCT01782664|41665729|FG001|Overall Study|Lack of Efficacy|0|||
19419152|NCT01782664|41665730|FG002|Overall Study|Lack of Efficacy|2|||
19419153|NCT01782664|41665731|FG003|Overall Study|Lack of Efficacy|2|||
19419154|NCT01782664|41665732|FG004|Overall Study|Lack of Efficacy|0|||
19419155|NCT01782664|41665733|FG005|Overall Study|Lack of Efficacy|0|||
19419156|NCT01782664|41665728|FG000|Overall Study|Protocol Violation|0|||
19419157|NCT01782664|41665729|FG001|Overall Study|Protocol Violation|1|||
19419158|NCT01782664|41665730|FG002|Overall Study|Protocol Violation|0|||
19419159|NCT01782664|41665731|FG003|Overall Study|Protocol Violation|1|||
19419160|NCT01782664|41665732|FG004|Overall Study|Protocol Violation|0|||
19419161|NCT01782664|41665733|FG005|Overall Study|Protocol Violation|0|||
19419162|NCT01782664|41665728|FG000|Overall Study|Withdrawal by Subject|2|||
19419163|NCT01782664|41665729|FG001|Overall Study|Withdrawal by Subject|2|||
19419164|NCT01782664|41665730|FG002|Overall Study|Withdrawal by Subject|0|||
19419165|NCT01782664|41665731|FG003|Overall Study|Withdrawal by Subject|0|||
19419166|NCT01782664|41665732|FG004|Overall Study|Withdrawal by Subject|0|||
19419167|NCT01782664|41665733|FG005|Overall Study|Withdrawal by Subject|0|||
19419168|NCT01732588|41665750|FG000|First Intervention (7 Days)|Adverse Event|0|||
19419169|NCT01732588|41665751|FG001|First Intervention (7 Days)|Adverse Event|1|||
19419170|NCT01732588|41665752|FG002|First Intervention (7 Days)|Adverse Event|0|||
19419171|NCT01781962|41665760|FG000|Overall Study|Other Miscellaneous Reasons|5|||
19419172|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
19419173|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
19419174|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
19419175|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
19419176|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
19419177|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
19419178|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
19419179|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
19419180|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
19419181|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
19419182|NCT01639339|41665766|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
19419183|NCT01639339|41665767|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
19419184|NCT01639339|41665766|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
19419185|NCT01639339|41665767|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
19419186|NCT01639339|41665766|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
19419187|NCT01639339|41665767|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
19419188|NCT01639339|41665766|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
19419189|NCT01639339|41665767|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
19419190|NCT01639339|41665766|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
19419191|NCT01639339|41665767|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
19519648|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
19519649|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
19419192|NCT02000817|41665781|FG000|Overall Study|Withdrawal by Subject|2|||
19419193|NCT02000817|41665782|FG001|Overall Study|Withdrawal by Subject|0|||
19419194|NCT02000817|41665783|FG002|Overall Study|Withdrawal by Subject|0|||
19419195|NCT02000817|41665784|FG003|Overall Study|Withdrawal by Subject|0|||
19419196|NCT02000817|41665781|FG000|Overall Study|Adverse Event|0|||
19419197|NCT02000817|41665782|FG001|Overall Study|Adverse Event|1|||
19419198|NCT02000817|41665783|FG002|Overall Study|Adverse Event|0|||
19419199|NCT02000817|41665784|FG003|Overall Study|Adverse Event|0|||
19419200|NCT02000817|41665781|FG000|Overall Study|Lost to Follow-up|0|||
19419201|NCT02000817|41665782|FG001|Overall Study|Lost to Follow-up|0|||
19419202|NCT02000817|41665783|FG002|Overall Study|Lost to Follow-up|1|||
19419203|NCT02000817|41665784|FG003|Overall Study|Lost to Follow-up|0|||
19419204|NCT01641133|41665800|FG000|Overall Study|Protocol Violation|0|||
19419205|NCT01641133|41665801|FG001|Overall Study|Protocol Violation|1|||
19419206|NCT01641133|41665802|FG002|Overall Study|Protocol Violation|1|||
19419207|NCT01641133|41665800|FG000|Overall Study|Migrated/moved from study area|5|||
19419208|NCT01641133|41665801|FG001|Overall Study|Migrated/moved from study area|3|||
19419209|NCT01641133|41665802|FG002|Overall Study|Migrated/moved from study area|1|||
19419210|NCT01641133|41665800|FG000|Overall Study|Adverse Event|0|||
19419211|NCT01641133|41665801|FG001|Overall Study|Adverse Event|0|||
19419212|NCT01641133|41665802|FG002|Overall Study|Adverse Event|1|||
19419213|NCT01641133|41665800|FG000|Overall Study|Withdrawal by Subject|5|||
19419214|NCT01641133|41665801|FG001|Overall Study|Withdrawal by Subject|3|||
19419215|NCT01641133|41665802|FG002|Overall Study|Withdrawal by Subject|3|||
19419216|NCT01641133|41665800|FG000|Overall Study|Lost to Follow-up|0|||
19419217|NCT01641133|41665801|FG001|Overall Study|Lost to Follow-up|2|||
19419218|NCT01641133|41665802|FG002|Overall Study|Lost to Follow-up|2|||
19419219|NCT02000427|41665810|FG000|Overall Study|Death|22|||
19519650|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
19375112|NCT02522624|41616875|FG000|Overall Study|Technical failure|1|||
19375113|NCT02522624|41616876|FG001|Overall Study|Technical failure|0|||
19375114|NCT02287402|41616882|FG000|Treatment Period|Adverse Event|17|||
19375115|NCT02287402|41616882|FG000|Treatment Period|Voluntary Withdrawal|10|||
19375116|NCT02287402|41616882|FG000|Follow-up|Lost to Follow-up|1|||
19375117|NCT02287402|41616882|FG000|Follow-up|Voluntary Withdrawal|2|||
19375118|NCT02314780|41616889|FG000|Overall Study|organizational reasons|0|||
19375119|NCT02314780|41616890|FG001|Overall Study|organizational reasons|2|||
19375120|NCT02314780|41616891|FG002|Overall Study|organizational reasons|0|||
19375121|NCT02314780|41616889|FG000|Overall Study|Adverse Event|0|||
19375122|NCT02314780|41616890|FG001|Overall Study|Adverse Event|1|||
19375123|NCT02314780|41616891|FG002|Overall Study|Adverse Event|0|||
19375124|NCT02286466|41616901|FG000|Overall Study|Death|1|||
19375125|NCT02286466|41616902|FG001|Overall Study|Death|3|||
19375126|NCT02286466|41616901|FG000|Overall Study|Withdrawal by Subject|5|||
19375127|NCT02286466|41616902|FG001|Overall Study|Withdrawal by Subject|2|||
19375128|NCT02286466|41616901|FG000|Overall Study|Lost to Follow-up|1|||
19375129|NCT02286466|41616902|FG001|Overall Study|Lost to Follow-up|4|||
19375130|NCT02286466|41616901|FG000|Overall Study|Declined Clinician Assessment|0|||
19375131|NCT02286466|41616902|FG001|Overall Study|Declined Clinician Assessment|1|||
19375132|NCT02313766|41616911|FG000|Overall Study|surgery cancelled|1|||
19375133|NCT02313766|41616912|FG001|Overall Study|surgery cancelled|0|||
19375134|NCT02313766|41616913|FG002|Overall Study|surgery cancelled|0|||
19375135|NCT02313766|41616911|FG000|Overall Study|Lost to Follow-up|0|||
19375136|NCT02313766|41616912|FG001|Overall Study|Lost to Follow-up|2|||
19375137|NCT02313766|41616913|FG002|Overall Study|Lost to Follow-up|0|||
19375138|NCT02313766|41616911|FG000|Overall Study|Adverse Event|0|||
19375139|NCT02313766|41616912|FG001|Overall Study|Adverse Event|1|||
19375140|NCT02313766|41616913|FG002|Overall Study|Adverse Event|0|||
19375141|NCT01646398|41616923|FG000|Overall Study|Withdrawal by Subject|1|||
19375142|NCT01646398|41616924|FG001|Overall Study|Withdrawal by Subject|0|||
19375143|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
19375144|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
19375145|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
19375146|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
19375147|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
19375148|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
19375149|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
19375150|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
19375151|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
19375152|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
19375153|NCT01646320|41616932|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
19375154|NCT01646320|41616933|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
19375155|NCT01646320|41616932|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
19375156|NCT01646320|41616933|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
19375157|NCT01646320|41616932|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
19375158|NCT01646320|41616933|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
19375159|NCT01646320|41616932|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
19375160|NCT01646320|41616933|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
19419220|NCT04662073|41665816|FG000|Overall Study|Withdrawal by Subject|1|||
19419221|NCT04662073|41665817|FG001|Overall Study|Withdrawal by Subject|0|||
19419222|NCT01600885|41665823|FG000|First Period|Adverse Event|1|||
19419223|NCT01600885|41665824|FG001|First Period|Adverse Event|1|||
19419224|NCT01600885|41665823|FG000|First Period|moved out of area|1|||
19419225|NCT01600885|41665824|FG001|First Period|moved out of area|0|||
19419226|NCT01732510|41665837|FG000|Overall Study|Adverse Event|0|||
19419227|NCT01732510|41665838|FG001|Overall Study|Adverse Event|1|||
19419228|NCT01732510|41665839|FG002|Overall Study|Adverse Event|1|||
19419229|NCT01732510|41665840|FG003|Overall Study|Adverse Event|0|||
19419230|NCT01732510|41665841|FG004|Overall Study|Adverse Event|0|||
19419231|NCT01732510|41665842|FG005|Overall Study|Adverse Event|0|||
19419232|NCT01732510|41665843|FG006|Overall Study|Adverse Event|1|||
19419233|NCT01732510|41665837|FG000|Overall Study|Protocol Violation|0|||
19419234|NCT01732510|41665838|FG001|Overall Study|Protocol Violation|0|||
19419235|NCT01732510|41665839|FG002|Overall Study|Protocol Violation|0|||
19419236|NCT01732510|41665840|FG003|Overall Study|Protocol Violation|1|||
19419237|NCT01732510|41665841|FG004|Overall Study|Protocol Violation|0|||
19419238|NCT01732510|41665842|FG005|Overall Study|Protocol Violation|0|||
19419239|NCT01732510|41665843|FG006|Overall Study|Protocol Violation|0|||
19419240|NCT01732510|41665837|FG000|Overall Study|Withdrawal by Subject|1|||
19419241|NCT01732510|41665838|FG001|Overall Study|Withdrawal by Subject|3|||
19419242|NCT01732510|41665839|FG002|Overall Study|Withdrawal by Subject|2|||
19419243|NCT01732510|41665840|FG003|Overall Study|Withdrawal by Subject|1|||
19419244|NCT01732510|41665841|FG004|Overall Study|Withdrawal by Subject|5|||
19419245|NCT01732510|41665842|FG005|Overall Study|Withdrawal by Subject|0|||
19419246|NCT01732510|41665843|FG006|Overall Study|Withdrawal by Subject|1|||
19419247|NCT01732510|41665837|FG000|Overall Study|Lost to Follow-up|0|||
19419248|NCT01732510|41665838|FG001|Overall Study|Lost to Follow-up|0|||
19419249|NCT01732510|41665839|FG002|Overall Study|Lost to Follow-up|1|||
19419250|NCT01732510|41665840|FG003|Overall Study|Lost to Follow-up|1|||
19419251|NCT01732510|41665841|FG004|Overall Study|Lost to Follow-up|0|||
19419252|NCT01732510|41665842|FG005|Overall Study|Lost to Follow-up|1|||
19419253|NCT01732510|41665843|FG006|Overall Study|Lost to Follow-up|0|||
19419254|NCT01732510|41665837|FG000|Overall Study|Physician Decision|0|||
19419255|NCT01732510|41665838|FG001|Overall Study|Physician Decision|1|||
19419256|NCT01732510|41665839|FG002|Overall Study|Physician Decision|0|||
19419257|NCT01732510|41665840|FG003|Overall Study|Physician Decision|0|||
19419258|NCT01732510|41665841|FG004|Overall Study|Physician Decision|0|||
19419259|NCT01732510|41665842|FG005|Overall Study|Physician Decision|0|||
19419260|NCT01732510|41665843|FG006|Overall Study|Physician Decision|0|||
19419261|NCT01732510|41665837|FG000|Overall Study|Pregnancy|0|||
19419262|NCT01732510|41665838|FG001|Overall Study|Pregnancy|0|||
19419263|NCT01732510|41665839|FG002|Overall Study|Pregnancy|0|||
19419264|NCT01732510|41665840|FG003|Overall Study|Pregnancy|1|||
19419265|NCT01732510|41665841|FG004|Overall Study|Pregnancy|0|||
19419266|NCT01732510|41665842|FG005|Overall Study|Pregnancy|0|||
19419267|NCT01732510|41665843|FG006|Overall Study|Pregnancy|0|||
19419268|NCT01732510|41665837|FG000|Overall Study|Study Terminated By Sponsor|0|||
19419269|NCT01732510|41665838|FG001|Overall Study|Study Terminated By Sponsor|0|||
19419270|NCT01732510|41665839|FG002|Overall Study|Study Terminated By Sponsor|0|||
19419271|NCT01732510|41665840|FG003|Overall Study|Study Terminated By Sponsor|1|||
19419272|NCT01732510|41665841|FG004|Overall Study|Study Terminated By Sponsor|0|||
19419273|NCT01732510|41665842|FG005|Overall Study|Study Terminated By Sponsor|12|||
19419274|NCT01732510|41665843|FG006|Overall Study|Study Terminated By Sponsor|6|||
19419275|NCT01637077|41665864|FG000|Overall Study|Cancel|1|||
19419276|NCT01637077|41665865|FG001|Overall Study|Cancel|1|||
19419277|NCT01637077|41665864|FG000|Overall Study|Withdrawal by Subject|1|||
19419278|NCT01637077|41665865|FG001|Overall Study|Withdrawal by Subject|0|||
19419279|NCT01637077|41665864|FG000|Overall Study|No cycle 1 questionnaire data|2|||
19419280|NCT01637077|41665865|FG001|Overall Study|No cycle 1 questionnaire data|0|||
19419281|NCT02308163|41665875|FG000|Overall Study|Not fulfill eligible criteria|1|||
19419282|NCT02308163|41665876|FG001|Overall Study|Not fulfill eligible criteria|2|||
19419283|NCT02308163|41665877|FG002|Overall Study|Not fulfill eligible criteria|0|||
19419284|NCT02308163|41665878|FG003|Overall Study|Not fulfill eligible criteria|1|||
19419285|NCT02308163|41665879|FG004|Overall Study|Not fulfill eligible criteria|1|||
19419286|NCT02308163|41665875|FG000|Overall Study|Adverse Event|9|||
19419287|NCT02308163|41665876|FG001|Overall Study|Adverse Event|5|||
19419288|NCT02308163|41665877|FG002|Overall Study|Adverse Event|2|||
19419289|NCT02308163|41665878|FG003|Overall Study|Adverse Event|2|||
19419290|NCT02308163|41665879|FG004|Overall Study|Adverse Event|11|||
19419291|NCT02308163|41665875|FG000|Overall Study|Lack of Efficacy|11|||
19419292|NCT02308163|41665876|FG001|Overall Study|Lack of Efficacy|3|||
19419293|NCT02308163|41665877|FG002|Overall Study|Lack of Efficacy|8|||
19419294|NCT02308163|41665878|FG003|Overall Study|Lack of Efficacy|4|||
19419295|NCT02308163|41665879|FG004|Overall Study|Lack of Efficacy|6|||
19419296|NCT02308163|41665875|FG000|Overall Study|Withdrawal of consent|2|||
19419297|NCT02308163|41665876|FG001|Overall Study|Withdrawal of consent|3|||
19419298|NCT02308163|41665877|FG002|Overall Study|Withdrawal of consent|0|||
19419299|NCT02308163|41665878|FG003|Overall Study|Withdrawal of consent|2|||
19419300|NCT02308163|41665879|FG004|Overall Study|Withdrawal of consent|6|||
19419301|NCT02308163|41665875|FG000|Overall Study|Protocol Violation|3|||
19419302|NCT02308163|41665876|FG001|Overall Study|Protocol Violation|3|||
19419303|NCT02308163|41665877|FG002|Overall Study|Protocol Violation|3|||
19419304|NCT02308163|41665878|FG003|Overall Study|Protocol Violation|2|||
19419305|NCT02308163|41665879|FG004|Overall Study|Protocol Violation|5|||
19419306|NCT02308163|41665875|FG000|Overall Study|Lab data met discontinuation criteria|3|||
19419307|NCT02308163|41665876|FG001|Overall Study|Lab data met discontinuation criteria|0|||
19419308|NCT02308163|41665877|FG002|Overall Study|Lab data met discontinuation criteria|0|||
19419309|NCT02308163|41665878|FG003|Overall Study|Lab data met discontinuation criteria|2|||
19419310|NCT02308163|41665879|FG004|Overall Study|Lab data met discontinuation criteria|0|||
19419311|NCT02308163|41665875|FG000|Overall Study|Miscellaneous|2|||
19419312|NCT02308163|41665876|FG001|Overall Study|Miscellaneous|2|||
19419313|NCT02308163|41665877|FG002|Overall Study|Miscellaneous|1|||
19419314|NCT02308163|41665878|FG003|Overall Study|Miscellaneous|0|||
19419315|NCT02308163|41665879|FG004|Overall Study|Miscellaneous|5|||
19419316|NCT02000115|41665909|FG000|Overall Study|Death|56|||
19419317|NCT02000115|41665910|FG001|Overall Study|Death|45|||
19419318|NCT02000115|41665911|FG002|Overall Study|Death|0|||
19419319|NCT02000115|41665912|FG003|Overall Study|Death|0|||
19419320|NCT02000115|41665909|FG000|Overall Study|Missed Visit|6|||
19419321|NCT02000115|41665910|FG001|Overall Study|Missed Visit|8|||
19419322|NCT02000115|41665911|FG002|Overall Study|Missed Visit|1|||
19419323|NCT02000115|41665912|FG003|Overall Study|Missed Visit|0|||
19419324|NCT02000115|41665909|FG000|Overall Study|Protocol Violation|2|||
19419325|NCT02000115|41665910|FG001|Overall Study|Protocol Violation|1|||
19419326|NCT02000115|41665911|FG002|Overall Study|Protocol Violation|0|||
19419327|NCT02000115|41665912|FG003|Overall Study|Protocol Violation|0|||
19419328|NCT02000115|41665909|FG000|Overall Study|Physician Decision|2|||
19419329|NCT02000115|41665910|FG001|Overall Study|Physician Decision|0|||
19419330|NCT02000115|41665911|FG002|Overall Study|Physician Decision|0|||
19419331|NCT02000115|41665912|FG003|Overall Study|Physician Decision|0|||
19419332|NCT02000115|41665909|FG000|Overall Study|Withdrawal by Subject|11|||
19419333|NCT02000115|41665910|FG001|Overall Study|Withdrawal by Subject|11|||
19419334|NCT02000115|41665911|FG002|Overall Study|Withdrawal by Subject|0|||
19419335|NCT02000115|41665912|FG003|Overall Study|Withdrawal by Subject|0|||
19419336|NCT02000115|41665909|FG000|Overall Study|Lost to Follow-up|0|||
19419337|NCT02000115|41665910|FG001|Overall Study|Lost to Follow-up|1|||
19419338|NCT02000115|41665911|FG002|Overall Study|Lost to Follow-up|0|||
19419339|NCT02000115|41665912|FG003|Overall Study|Lost to Follow-up|0|||
19419340|NCT02000115|41665909|FG000|Overall Study|Non-compliance|2|||
19419341|NCT02000115|41665910|FG001|Overall Study|Non-compliance|1|||
19419342|NCT02000115|41665911|FG002|Overall Study|Non-compliance|0|||
19419343|NCT02000115|41665912|FG003|Overall Study|Non-compliance|0|||
19419344|NCT02000115|41665909|FG000|Overall Study|Withdrawn on day of randomization|0|||
19419345|NCT02000115|41665910|FG001|Overall Study|Withdrawn on day of randomization|1|||
19419346|NCT02000115|41665911|FG002|Overall Study|Withdrawn on day of randomization|0|||
19419347|NCT02000115|41665912|FG003|Overall Study|Withdrawn on day of randomization|0|||
19419348|NCT02000115|41665909|FG000|Overall Study|Still on Study|0|||
19419349|NCT02000115|41665910|FG001|Overall Study|Still on Study|0|||
19419350|NCT02000115|41665911|FG002|Overall Study|Still on Study|0|||
19419351|NCT02000115|41665912|FG003|Overall Study|Still on Study|53|||
19419352|NCT01999335|41665926|FG000|Overall Study|Discontinued before receiving treatment|0|||
19419353|NCT01999335|41665927|FG001|Overall Study|Discontinued before receiving treatment|0|||
19419354|NCT01999335|41665928|FG002|Overall Study|Discontinued before receiving treatment|0|||
19419355|NCT01999335|41665929|FG003|Overall Study|Discontinued before receiving treatment|0|||
19419356|NCT01999335|41665930|FG004|Overall Study|Discontinued before receiving treatment|2|||
19419357|NCT01978119|41665945|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
19419358|NCT01978119|41665946|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
19419359|NCT01978119|41665945|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
19419360|NCT01978119|41665946|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19419361|NCT01978119|41665945|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19419362|NCT01978119|41665946|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
19419363|NCT01999179|41665952|FG000|Overall Study|Adverse Event|1|||
19419364|NCT01999179|41665952|FG000|Overall Study|Lost to Follow-up|1|||
19419365|NCT01999179|41665952|FG000|Overall Study|Change in Therapy|3|||
19419366|NCT01999179|41665952|FG000|Overall Study|New catheter|2|||
19419367|NCT01977729|41665956|FG000|Overall Study|Study terminated|1|||
19419368|NCT01998477|41665964|FG000|Overall Study|Lost to Follow-up|4|||
19419369|NCT01998477|41665965|FG001|Overall Study|Lost to Follow-up|5|||
19419370|NCT01998477|41665964|FG000|Overall Study|Withdrawal by Subject|6|||
19419371|NCT01998477|41665965|FG001|Overall Study|Withdrawal by Subject|0|||
19419372|NCT01998399|41665998|FG000|Overall Study|Lost to Follow-up|1|||
19419373|NCT01998399|41665999|FG001|Overall Study|Lost to Follow-up|3|||
19419374|NCT01998399|41665998|FG000|Overall Study|Death|4|||
19519651|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
19519652|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
19519653|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519654|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519655|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519656|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519657|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519658|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519659|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519660|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519661|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519662|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519663|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519664|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519665|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519666|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519667|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519668|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
19519669|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
19519670|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
19519671|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
19519672|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
19519673|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
19519674|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
19519675|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
19519676|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
19519677|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
19519678|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
19519679|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
19519680|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
19519681|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
19519682|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
19519683|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
19519684|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
19519685|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
19519686|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
19519687|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
19519688|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
19519689|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519690|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519691|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519692|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519693|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519694|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519695|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519696|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519697|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519698|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519699|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519700|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519701|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519702|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519703|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519704|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
19519705|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
19519706|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
19519707|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
19519708|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
19519709|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
19419375|NCT01998399|41665999|FG001|Overall Study|Death|2|||
19419376|NCT01998399|41665998|FG000|Overall Study|Study stopped before dosing completed|3|||
19419377|NCT01998399|41665999|FG001|Overall Study|Study stopped before dosing completed|3|||
19419378|NCT01998399|41665998|FG000|Overall Study|Withdrawal by Subject|0|||
19419379|NCT01998399|41665999|FG001|Overall Study|Withdrawal by Subject|1|||
19419380|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
19419381|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
19419382|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
19519710|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
19519711|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
19419383|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
19419384|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
19419385|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
19419386|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
19419387|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
19419388|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
19419389|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
19419390|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
19419391|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
19419392|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
19419393|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
19419394|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
19419395|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
19419396|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
19419397|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
19419398|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
19419399|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
19419400|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
19419401|NCT01781572|41666016|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
19419402|NCT01781572|41666017|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
19419403|NCT01781572|41666018|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
19419404|NCT01781572|41666016|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
19419405|NCT01781572|41666017|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
19419406|NCT01781572|41666018|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
19419407|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
19419408|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
19419409|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
19419410|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
19419411|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
19419412|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
19419413|NCT01781572|41666016|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
19419414|NCT01781572|41666017|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
19419415|NCT01781572|41666018|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
19419416|NCT01781572|41666016|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
19419417|NCT01781572|41666017|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
19419418|NCT01781572|41666018|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
19419419|NCT01781572|41666016|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
19419420|NCT01781572|41666017|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
19419421|NCT01781572|41666018|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
19419422|NCT01781572|41666016|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
19419423|NCT01781572|41666017|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
19419424|NCT01781572|41666018|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
19419425|NCT01781572|41666016|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
19419426|NCT01781572|41666017|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
19419427|NCT01781572|41666018|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
19419428|NCT01781572|41666016|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
19419429|NCT01781572|41666017|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
19419430|NCT01781572|41666018|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
19419431|NCT01781572|41666016|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
19419432|NCT01781572|41666017|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
19419433|NCT01781572|41666018|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
19419434|NCT01977651|41666047|FG000|4 Month Treatment Period|Adverse Event|34|||
19419435|NCT01977651|41666047|FG000|4 Month Treatment Period|Death|3|||
19419436|NCT01977651|41666047|FG000|4 Month Treatment Period|Progressive Disease|43|||
19419437|NCT01977651|41666047|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
19419438|NCT01977651|41666047|FG000|4 Month Treatment Period|Physician Decision|4|||
19419439|NCT01977651|41666047|FG000|1 Year Extension Period|Adverse Event|14|||
19419440|NCT01977651|41666047|FG000|1 Year Extension Period|Death|10|||
19419441|NCT01977651|41666047|FG000|1 Year Extension Period|Lost to Follow-up|2|||
19419442|NCT01977651|41666047|FG000|1 Year Extension Period|Progressive Disease|86|||
19419443|NCT01977651|41666047|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
19419444|NCT01977651|41666047|FG000|1 Year Extension Period|Physician Decision|6|||
19419445|NCT01977651|41666047|FG000|1 Year Extension Period|Miscellaneous|1|||
19419446|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Adverse Event|5|||
19419447|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Death|13|||
19419448|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
19419449|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
19419450|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Physician Decision|4|||
19419451|NCT01977651|41666047|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
19419452|NCT01998243|41666053|FG000|Overall Study|Pregnancy|0|||
19419453|NCT01998243|41666054|FG001|Overall Study|Pregnancy|1|||
19419454|NCT01998243|41666053|FG000|Overall Study|Protocol Violation|5|||
19419455|NCT01998243|41666054|FG001|Overall Study|Protocol Violation|2|||
19419456|NCT01998243|41666053|FG000|Overall Study|Withdrawal by Subject|3|||
19419457|NCT01998243|41666054|FG001|Overall Study|Withdrawal by Subject|4|||
19419458|NCT01977573|41666066|FG000|Overall Study|Adverse Event|7|||
19419459|NCT01977573|41666067|FG001|Overall Study|Adverse Event|0|||
19419460|NCT01977573|41666068|FG002|Overall Study|Adverse Event|2|||
19419461|NCT01977573|41666069|FG003|Overall Study|Adverse Event|1|||
19419462|NCT01977573|41666066|FG000|Overall Study|Lost to Follow-up|1|||
19419463|NCT01977573|41666067|FG001|Overall Study|Lost to Follow-up|0|||
19419464|NCT01977573|41666068|FG002|Overall Study|Lost to Follow-up|0|||
19419465|NCT01977573|41666069|FG003|Overall Study|Lost to Follow-up|1|||
19419466|NCT01977573|41666066|FG000|Overall Study|Physician Decision|1|||
19419467|NCT01977573|41666067|FG001|Overall Study|Physician Decision|0|||
19419468|NCT01977573|41666068|FG002|Overall Study|Physician Decision|0|||
19419469|NCT01977573|41666069|FG003|Overall Study|Physician Decision|0|||
19419470|NCT01977573|41666066|FG000|Overall Study|Protocol Violation|3|||
19419471|NCT01977573|41666067|FG001|Overall Study|Protocol Violation|1|||
19419472|NCT01977573|41666068|FG002|Overall Study|Protocol Violation|0|||
19419473|NCT01977573|41666069|FG003|Overall Study|Protocol Violation|0|||
19419474|NCT01977573|41666066|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
19419475|NCT01977573|41666067|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
19419476|NCT01977573|41666068|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
19419477|NCT01977573|41666069|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
19419478|NCT01977573|41666066|FG000|Overall Study|Withdrawal by Subject|6|||
19419479|NCT01977573|41666067|FG001|Overall Study|Withdrawal by Subject|1|||
19419480|NCT01977573|41666068|FG002|Overall Study|Withdrawal by Subject|1|||
19419481|NCT01977573|41666069|FG003|Overall Study|Withdrawal by Subject|1|||
19419482|NCT01963767|41666082|FG000|Overall Study|Withdrawal by Subject|4|||
19419483|NCT01963767|41666083|FG001|Overall Study|Withdrawal by Subject|2|||
19419484|NCT01963767|41666082|FG000|Overall Study|Adverse Event|2|||
19419485|NCT01963767|41666083|FG001|Overall Study|Adverse Event|0|||
19419486|NCT01761292|41666092|FG000|Part 1|Adverse Event|1|||
19419487|NCT01761292|41666092|FG000|Part 1|not receiving treatment in Part 1|1|||
19419488|NCT01761292|41666092|FG000|Extension 1|Withdrawal by Subject|1|||
19419489|NCT01731886|41666105|FG000|Overall Study|Death|1|||
19419490|NCT01731886|41666106|FG001|Overall Study|Death|0|||
19419491|NCT01731886|41666105|FG000|Overall Study|Never started treatment|0|||
19419492|NCT01731886|41666106|FG001|Overall Study|Never started treatment|1|||
19419493|NCT01731886|41666105|FG000|Overall Study|Non-compliant|1|||
19419494|NCT01731886|41666106|FG001|Overall Study|Non-compliant|0|||
19419495|NCT01759420|41666113|FG000|Overall Study|Screen failure|5|||
19419496|NCT01759420|41666113|FG000|Overall Study|Inaccurate EKG machine readings|1|||
19419497|NCT01781026|41666117|FG000|Overall Study|Lack of Efficacy|2|||
19419498|NCT01607398|41666123|FG000|Overall Study|Adverse Event|0|||
19419499|NCT01607398|41666124|FG001|Overall Study|Adverse Event|2|||
19419500|NCT01607398|41666123|FG000|Overall Study|Severe COPD|2|||
19419501|NCT01607398|41666124|FG001|Overall Study|Severe COPD|0|||
19419502|NCT01779856|41666130|FG000|Overall Study|Withdrawal by Subject|15|||
19419503|NCT01779856|41666130|FG000|Overall Study|Death|3|||
19419504|NCT01779856|41666130|FG000|Overall Study|Physician Decision|1|||
19419505|NCT01779856|41666130|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
19419506|NCT01779856|41666130|FG000|Overall Study|Delays in scheduling implant|1|||
19419507|NCT01779856|41666130|FG000|Overall Study|Subject ineligible for Implant|2|||
19419508|NCT01729156|41666144|FG000|Overall Study|Withdrawal by Subject|1|||
19419509|NCT01729156|41666145|FG001|Overall Study|Withdrawal by Subject|0|||
19419510|NCT01729156|41666146|FG002|Overall Study|Withdrawal by Subject|0|||
19419511|NCT01779700|41666157|FG000|Overall Study|Adverse Event|4|||
19419512|NCT01779700|41666158|FG001|Overall Study|Adverse Event|3|||
19419513|NCT01779700|41666157|FG000|Overall Study|Withdrawal by Subject|0|||
19419514|NCT01779700|41666158|FG001|Overall Study|Withdrawal by Subject|2|||
19419515|NCT01778530|41666164|FG000|Overall Study|Progression on study|1|||
19419516|NCT01778530|41666164|FG000|Overall Study|Adverse event/side effect|1|||
19419517|NCT01778062|41666170|FG000|Overall Study|Adverse Event|1|||
19419518|NCT01778062|41666171|FG001|Overall Study|Adverse Event|3|||
19419519|NCT01778062|41666170|FG000|Overall Study|Consent Withdrawal|1|||
19419520|NCT01778062|41666171|FG001|Overall Study|Consent Withdrawal|5|||
19419521|NCT01778062|41666170|FG000|Overall Study|major protocol deviation|4|||
19419522|NCT01778062|41666171|FG001|Overall Study|major protocol deviation|3|||
19419523|NCT01759264|41666177|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
19419524|NCT01759264|41666177|FG000|Overall Study|Adverse Event|1|||
19419525|NCT01759264|41666177|FG000|Overall Study|Other|2|||
19419526|NCT01759264|41666177|FG000|Overall Study|Lost to Follow-up|2|||
19419527|NCT01759264|41666177|FG000|Overall Study|Withdrawal by Subject|3|||
19419528|NCT01759264|41666177|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
19419529|NCT01757704|41666184|FG000|Overall Study|Protocol Violation|1|||
19419530|NCT01757704|41666185|FG001|Overall Study|Protocol Violation|3|||
19419531|NCT01757392|41666191|FG000|Overall Study|Withdrawal by Subject|1|||
19419532|NCT01757392|41666191|FG000|Overall Study|Screen Fail|3|||
19419533|NCT01756846|41666197|FG000|Overall Study|Lost to Follow-up|5|||
19419534|NCT01756846|41666198|FG001|Overall Study|Lost to Follow-up|10|||
19419535|NCT01756846|41666197|FG000|Overall Study|Withdrawal by Subject|1|||
19419536|NCT01756846|41666198|FG001|Overall Study|Withdrawal by Subject|2|||
19419537|NCT01963611|41666209|FG000|Overall Study|Adverse Event|1|||
19419538|NCT01963611|41666210|FG001|Overall Study|Adverse Event|1|||
19519712|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
19519713|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
19519714|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
19519715|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
19519716|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
19519717|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
19519718|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
19519719|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
19519720|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
19519721|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
19519722|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
19519723|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
19519724|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
19519725|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519726|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519727|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519728|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519729|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519730|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519731|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519732|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519733|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519734|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519735|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519736|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519737|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519738|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519739|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
19519740|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519741|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
19519742|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
19519743|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519744|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519745|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519746|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519747|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519748|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519749|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519750|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519751|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519752|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519753|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519754|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519755|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519756|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519757|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
19519758|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519759|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
19519760|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
19375161|NCT01646320|41616932|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
19375162|NCT01646320|41616933|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
19375163|NCT01646320|41616932|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
19375164|NCT01646320|41616933|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
19375165|NCT02524730|41616939|FG000|Overall Study|Lost to Follow-up|5|||
19375166|NCT02524730|41616939|FG000|Overall Study|Withdrawal by Subject|18|||
19375167|NCT02524730|41616939|FG000|Overall Study|Death|10|||
19375168|NCT02524730|41616939|FG000|Overall Study|Adverse Event|8|||
19375169|NCT02524730|41616939|FG000|Overall Study|Protocol Violation|1|||
19419539|NCT01963611|41666211|FG002|Overall Study|Adverse Event|3|||
19419540|NCT01963611|41666212|FG003|Overall Study|Adverse Event|4|||
19419541|NCT01963611|41666213|FG004|Overall Study|Adverse Event|3|||
19419542|NCT01963611|41666209|FG000|Overall Study|Protocol Violation|0|||
19419543|NCT01963611|41666210|FG001|Overall Study|Protocol Violation|0|||
19419544|NCT01963611|41666211|FG002|Overall Study|Protocol Violation|0|||
19419545|NCT01963611|41666212|FG003|Overall Study|Protocol Violation|1|||
19419546|NCT01963611|41666213|FG004|Overall Study|Protocol Violation|0|||
19419547|NCT01963611|41666209|FG000|Overall Study|Lack of Efficacy|0|||
19419548|NCT01963611|41666210|FG001|Overall Study|Lack of Efficacy|0|||
19419549|NCT01963611|41666211|FG002|Overall Study|Lack of Efficacy|0|||
19419550|NCT01963611|41666212|FG003|Overall Study|Lack of Efficacy|1|||
19419551|NCT01963611|41666213|FG004|Overall Study|Lack of Efficacy|0|||
19419552|NCT01963611|41666209|FG000|Overall Study|Withdrawal by Subject|3|||
19419553|NCT01963611|41666210|FG001|Overall Study|Withdrawal by Subject|2|||
19419554|NCT01963611|41666211|FG002|Overall Study|Withdrawal by Subject|1|||
19419555|NCT01963611|41666212|FG003|Overall Study|Withdrawal by Subject|1|||
19419556|NCT01963611|41666213|FG004|Overall Study|Withdrawal by Subject|3|||
19419557|NCT01963611|41666209|FG000|Overall Study|Other|47|||
19419558|NCT01963611|41666210|FG001|Overall Study|Other|46|||
19419559|NCT01963611|41666211|FG002|Overall Study|Other|48|||
19419560|NCT01963611|41666212|FG003|Overall Study|Other|45|||
19419561|NCT01963611|41666213|FG004|Overall Study|Other|45|||
19419562|NCT01975701|41666226|FG000|Overall Study|Lost to Follow-up|1|||
19419563|NCT01975701|41666226|FG000|Overall Study|Death|23|||
19419564|NCT01975701|41666226|FG000|Overall Study|Physician Decision|1|||
19419565|NCT01962987|41666233|FG000|Overall Study|Adverse Event|4|||
19419566|NCT01962987|41666234|FG001|Overall Study|Adverse Event|4|||
19419567|NCT01962987|41666235|FG002|Overall Study|Adverse Event|0|||
19419568|NCT01962987|41666233|FG000|Overall Study|Lost to Follow-up|0|||
19419569|NCT01962987|41666234|FG001|Overall Study|Lost to Follow-up|0|||
19419570|NCT01962987|41666235|FG002|Overall Study|Lost to Follow-up|1|||
19419571|NCT01962987|41666233|FG000|Overall Study|Non compliance with dosing requirements|4|||
19419572|NCT01962987|41666234|FG001|Overall Study|Non compliance with dosing requirements|2|||
19419573|NCT01962987|41666235|FG002|Overall Study|Non compliance with dosing requirements|0|||
19419574|NCT01962987|41666233|FG000|Overall Study|Miscellaneous|1|||
19419575|NCT01962987|41666234|FG001|Overall Study|Miscellaneous|9|||
19419576|NCT01962987|41666235|FG002|Overall Study|Miscellaneous|2|||
19419577|NCT01962987|41666233|FG000|Overall Study|Restricted medication|5|||
19419578|NCT01962987|41666234|FG001|Overall Study|Restricted medication|1|||
19419579|NCT01962987|41666235|FG002|Overall Study|Restricted medication|1|||
19419580|NCT01962987|41666233|FG000|Overall Study|Serious Adverse Event|1|||
19419581|NCT01962987|41666234|FG001|Overall Study|Serious Adverse Event|0|||
19419582|NCT01962987|41666235|FG002|Overall Study|Serious Adverse Event|0|||
19419583|NCT01962987|41666233|FG000|Overall Study|Withdrawal by Subject|11|||
19419584|NCT01962987|41666234|FG001|Overall Study|Withdrawal by Subject|10|||
19419585|NCT01962987|41666235|FG002|Overall Study|Withdrawal by Subject|6|||
19419586|NCT01962987|41666233|FG000|Overall Study|Randomized in Error|4|||
19419587|NCT01962987|41666234|FG001|Overall Study|Randomized in Error|2|||
19419588|NCT01962987|41666235|FG002|Overall Study|Randomized in Error|2|||
19419589|NCT01962441|41666246|FG000|Randomized Period|Randomized but Never Treated|4|||
19419590|NCT01962441|41666247|FG001|Randomized Period|Randomized but Never Treated|2|||
19419591|NCT01962441|41666248|FG002|Randomized Period|Randomized but Never Treated|3|||
19419592|NCT01962441|41666246|FG000|Randomized Period|Lost to Follow-up|2|||
19419593|NCT01962441|41666247|FG001|Randomized Period|Lost to Follow-up|4|||
19419594|NCT01962441|41666248|FG002|Randomized Period|Lost to Follow-up|4|||
19419595|NCT01962441|41666246|FG000|Randomized Period|Withdrew Consent|3|||
19419596|NCT01962441|41666247|FG001|Randomized Period|Withdrew Consent|3|||
19419597|NCT01962441|41666248|FG002|Randomized Period|Withdrew Consent|2|||
19419598|NCT01962441|41666246|FG000|Randomized Period|Adverse Event|1|||
19419599|NCT01962441|41666247|FG001|Randomized Period|Adverse Event|1|||
19419600|NCT01962441|41666248|FG002|Randomized Period|Adverse Event|0|||
19419601|NCT01962441|41666246|FG000|Randomized Period|Death|0|||
19419602|NCT01962441|41666247|FG001|Randomized Period|Death|0|||
19419603|NCT01962441|41666248|FG002|Randomized Period|Death|2|||
19419604|NCT01962441|41666246|FG000|Randomized Period|Protocol Violation|0|||
19419605|NCT01962441|41666247|FG001|Randomized Period|Protocol Violation|1|||
19419606|NCT01962441|41666248|FG002|Randomized Period|Protocol Violation|0|||
19419607|NCT01962441|41666246|FG000|Retreatment Substudy|Lack of Efficacy|1|||
19419608|NCT01962441|41666247|FG001|Retreatment Substudy|Lack of Efficacy|0|||
19419609|NCT01962441|41666248|FG002|Retreatment Substudy|Lack of Efficacy|0|||
19419610|NCT01962441|41666246|FG000|Retreatment Substudy|Lost to Follow-up|1|||
19419611|NCT01962441|41666247|FG001|Retreatment Substudy|Lost to Follow-up|0|||
19519761|NCT01474512|41932292|FG000|Post-Treatment Follow-Up|Death|0|||
19419612|NCT01962441|41666248|FG002|Retreatment Substudy|Lost to Follow-up|0|||
19419613|NCT01638013|41666260|FG000|Overall Study|Adverse Event|36|||
19419614|NCT01638013|41666261|FG001|Overall Study|Adverse Event|29|||
19419615|NCT01638013|41666262|FG002|Overall Study|Adverse Event|48|||
19419616|NCT01638013|41666260|FG000|Overall Study|Lack of Efficacy|39|||
19419617|NCT01638013|41666261|FG001|Overall Study|Lack of Efficacy|11|||
19419618|NCT01638013|41666262|FG002|Overall Study|Lack of Efficacy|14|||
19419619|NCT01638013|41666260|FG000|Overall Study|Protocol Violation|10|||
19419620|NCT01638013|41666261|FG001|Overall Study|Protocol Violation|7|||
19419621|NCT01638013|41666262|FG002|Overall Study|Protocol Violation|11|||
19419622|NCT01638013|41666260|FG000|Overall Study|Met discontinuation criteria|4|||
19419623|NCT01638013|41666261|FG001|Overall Study|Met discontinuation criteria|0|||
19419624|NCT01638013|41666262|FG002|Overall Study|Met discontinuation criteria|7|||
19419625|NCT01638013|41666260|FG000|Overall Study|Subject Lost to Follow up|1|||
19419626|NCT01638013|41666261|FG001|Overall Study|Subject Lost to Follow up|0|||
19419627|NCT01638013|41666262|FG002|Overall Study|Subject Lost to Follow up|1|||
19419628|NCT01638013|41666260|FG000|Overall Study|Miscellaneous|25|||
19419629|NCT01638013|41666261|FG001|Overall Study|Miscellaneous|19|||
19419630|NCT01638013|41666262|FG002|Overall Study|Miscellaneous|23|||
19419631|NCT01638013|41666260|FG000|Overall Study|Withdrawal of Consent|16|||
19419632|NCT01638013|41666261|FG001|Overall Study|Withdrawal of Consent|12|||
19419633|NCT01638013|41666262|FG002|Overall Study|Withdrawal of Consent|16|||
19419634|NCT01638013|41666260|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
19419635|NCT01638013|41666261|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
19419636|NCT01638013|41666262|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
19419637|NCT01637623|41666277|FG000|Overall Study|Lost to Follow-up|0|||
19419638|NCT01637623|41666278|FG001|Overall Study|Lost to Follow-up|0|||
19419639|NCT01637623|41666279|FG002|Overall Study|Lost to Follow-up|2|||
19419640|NCT01637623|41666277|FG000|Overall Study|Physician Decision|1|||
19419641|NCT01637623|41666278|FG001|Overall Study|Physician Decision|0|||
19419642|NCT01637623|41666279|FG002|Overall Study|Physician Decision|1|||
19419643|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
19419644|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
19419645|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
19419646|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
19419647|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
19419648|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
19419649|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
19419650|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
19419651|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
19419652|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
19419653|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
19419654|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
19419655|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
19419656|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
19419657|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
19419658|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
19419659|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
19419660|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
19419661|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
19419662|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
19419663|NCT01962207|41666291|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
19419664|NCT01962207|41666292|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
19419665|NCT01962207|41666293|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
19419666|NCT01962207|41666294|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
19419667|NCT01995825|41666310|FG000|Overall Study|Withdrawal by Subject|1|||
19419668|NCT01995825|41666311|FG001|Overall Study|Withdrawal by Subject|0|||
19419669|NCT01995357|41666317|FG000|Period 5|Lack of Efficacy|1|||
19419670|NCT01995357|41666318|FG001|Period 5|Lack of Efficacy|0|||
19419671|NCT01995357|41666319|FG002|Period 5|Lack of Efficacy|0|||
19419672|NCT01995357|41666320|FG003|Period 5|Lack of Efficacy|0|||
19419673|NCT01995357|41666321|FG004|Period 5|Lack of Efficacy|0|||
19419674|NCT01995357|41666322|FG005|Period 5|Lack of Efficacy|0|||
19419675|NCT01995357|41666317|FG000|Period 5|Adverse Event|1|||
19419676|NCT01995357|41666318|FG001|Period 5|Adverse Event|0|||
19419677|NCT01995357|41666319|FG002|Period 5|Adverse Event|1|||
19419678|NCT01995357|41666320|FG003|Period 5|Adverse Event|0|||
19419679|NCT01995357|41666321|FG004|Period 5|Adverse Event|0|||
19419680|NCT01995357|41666322|FG005|Period 5|Adverse Event|0|||
19419681|NCT01638559|41666338|FG000|Overall Study|Lost to Follow-up|1|||
19419682|NCT01638559|41666338|FG000|Overall Study|Withdrawal by Subject|1|||
19419683|NCT01638559|41666338|FG000|Overall Study|Subject declined to travel for biopsy|1|||
19419684|NCT01756456|41666359|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
19419685|NCT01756456|41666360|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
19419686|NCT01756456|41666361|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
19419687|NCT01756456|41666362|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
19419688|NCT01756456|41666363|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
19419689|NCT01756456|41666364|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
19419690|NCT01756456|41666359|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
19419691|NCT01756456|41666360|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
19419692|NCT01756456|41666361|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
19419693|NCT01756456|41666362|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
19419694|NCT01756456|41666363|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
19419695|NCT01756456|41666364|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
19419696|NCT01756456|41666359|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
19419697|NCT01756456|41666360|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
19419698|NCT01756456|41666361|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
19419699|NCT01756456|41666362|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
19419700|NCT01756456|41666363|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
19419701|NCT01756456|41666364|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
19419702|NCT01756456|41666359|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
19419703|NCT01756456|41666360|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
19419704|NCT01756456|41666361|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
19419705|NCT01756456|41666362|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
19419706|NCT01756456|41666363|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
19419707|NCT01756456|41666364|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
19419708|NCT01756456|41666359|FG000|Treatment Period: Phase I/II|Other causes|0|||
19419709|NCT01756456|41666360|FG001|Treatment Period: Phase I/II|Other causes|0|||
19419710|NCT01756456|41666361|FG002|Treatment Period: Phase I/II|Other causes|0|||
19419711|NCT01756456|41666362|FG003|Treatment Period: Phase I/II|Other causes|1|||
19419712|NCT01756456|41666363|FG004|Treatment Period: Phase I/II|Other causes|2|||
19419713|NCT01756456|41666364|FG005|Treatment Period: Phase I/II|Other causes|2|||
19419714|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
19419715|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
19419716|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
19419717|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
19419718|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
19419719|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
19419720|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
19419721|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
19419722|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
19419723|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
19419724|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
19419725|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
19419726|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
19419727|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
19419728|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
19419729|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
19419730|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
19419731|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
19419732|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
19419733|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
19419734|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
19419735|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
19419736|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
19419737|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
19419738|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
19419739|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
19419740|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
19419741|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
19419742|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
19419743|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
19419744|NCT01756456|41666359|FG000|Follow Up Period Phase I/II|Other causes|0|||
19419745|NCT01756456|41666360|FG001|Follow Up Period Phase I/II|Other causes|0|||
19419746|NCT01756456|41666361|FG002|Follow Up Period Phase I/II|Other causes|0|||
19419747|NCT01756456|41666362|FG003|Follow Up Period Phase I/II|Other causes|1|||
19419748|NCT01756456|41666363|FG004|Follow Up Period Phase I/II|Other causes|3|||
19419749|NCT01756456|41666364|FG005|Follow Up Period Phase I/II|Other causes|5|||
19419750|NCT01756300|41666387|FG000|Overall Study|Death|1|||
19419751|NCT01756300|41666387|FG000|Overall Study|Withdrawal by Subject|1|||
19419752|NCT01995201|41666410|FG000|From Baseline Until Week 24|Adverse Event|4|||
19419753|NCT01995201|41666411|FG001|From Baseline Until Week 24|Adverse Event|15|||
19419754|NCT01995201|41666412|FG002|From Baseline Until Week 24|Adverse Event|0|||
19419755|NCT01995201|41666413|FG003|From Baseline Until Week 24|Adverse Event|0|||
19419756|NCT01995201|41666414|FG004|From Baseline Until Week 24|Adverse Event|0|||
19419757|NCT01995201|41666415|FG005|From Baseline Until Week 24|Adverse Event|0|||
19419758|NCT01995201|41666416|FG006|From Baseline Until Week 24|Adverse Event|0|||
19419759|NCT01995201|41666410|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419760|NCT01995201|41666411|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
19419761|NCT01995201|41666412|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419762|NCT01995201|41666413|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419763|NCT01995201|41666414|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419764|NCT01995201|41666415|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419765|NCT01995201|41666416|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
19419766|NCT01995201|41666410|FG000|From Baseline Until Week 24|Death|0|||
19419767|NCT01995201|41666411|FG001|From Baseline Until Week 24|Death|1|||
19419768|NCT01995201|41666412|FG002|From Baseline Until Week 24|Death|0|||
19419769|NCT01995201|41666413|FG003|From Baseline Until Week 24|Death|0|||
19419770|NCT01995201|41666414|FG004|From Baseline Until Week 24|Death|0|||
19419771|NCT01995201|41666415|FG005|From Baseline Until Week 24|Death|0|||
19419772|NCT01995201|41666416|FG006|From Baseline Until Week 24|Death|0|||
19419773|NCT01995201|41666410|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
19419774|NCT01995201|41666411|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
19419775|NCT01995201|41666412|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
19419776|NCT01995201|41666413|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
19419777|NCT01995201|41666414|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
19419778|NCT01995201|41666415|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
19419779|NCT01995201|41666416|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
19419780|NCT01995201|41666410|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
19419781|NCT01995201|41666411|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
19419782|NCT01995201|41666412|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
19419783|NCT01995201|41666413|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
19419784|NCT01995201|41666414|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
19419785|NCT01995201|41666415|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
19419786|NCT01995201|41666416|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
19419787|NCT01995201|41666410|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
19419788|NCT01995201|41666411|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
19419789|NCT01995201|41666412|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
19419790|NCT01995201|41666413|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
19419791|NCT01995201|41666414|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
19419792|NCT01995201|41666415|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
19419793|NCT01995201|41666416|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
19419794|NCT01995201|41666410|FG000|From Baseline Until Week 24|Physician Decision|0|||
19419795|NCT01995201|41666411|FG001|From Baseline Until Week 24|Physician Decision|2|||
19419796|NCT01995201|41666412|FG002|From Baseline Until Week 24|Physician Decision|0|||
19419797|NCT01995201|41666413|FG003|From Baseline Until Week 24|Physician Decision|0|||
19419798|NCT01995201|41666414|FG004|From Baseline Until Week 24|Physician Decision|0|||
19419799|NCT01995201|41666415|FG005|From Baseline Until Week 24|Physician Decision|0|||
19419800|NCT01995201|41666416|FG006|From Baseline Until Week 24|Physician Decision|0|||
19419801|NCT01995201|41666410|FG000|From Baseline Until Week 24|Protocol Violation|0|||
19419802|NCT01995201|41666411|FG001|From Baseline Until Week 24|Protocol Violation|9|||
19419803|NCT01995201|41666412|FG002|From Baseline Until Week 24|Protocol Violation|0|||
19419804|NCT01995201|41666413|FG003|From Baseline Until Week 24|Protocol Violation|0|||
19419805|NCT01995201|41666414|FG004|From Baseline Until Week 24|Protocol Violation|0|||
19419806|NCT01995201|41666415|FG005|From Baseline Until Week 24|Protocol Violation|0|||
19419807|NCT01995201|41666416|FG006|From Baseline Until Week 24|Protocol Violation|0|||
19419808|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Adverse Event|0|||
19419809|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Adverse Event|0|||
19419810|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Adverse Event|2|||
19419811|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Adverse Event|1|||
19419812|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Adverse Event|1|||
19419813|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Adverse Event|3|||
19419814|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Adverse Event|1|||
19419815|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Death|0|||
19419816|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Death|0|||
19419817|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Death|0|||
19419818|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Death|0|||
19419819|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Death|0|||
19419820|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Death|2|||
19419821|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Death|0|||
19419822|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
19419823|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
19419824|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
19419825|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
19419826|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
19419827|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
19419828|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
19419829|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
19419830|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
19419831|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
19419832|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
19419833|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
19419834|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
19419835|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
19419836|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
19419837|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
19419838|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
19419839|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
19419840|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
19419841|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
19419842|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
19419843|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Physician Decision|0|||
19419844|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Physician Decision|0|||
19419845|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Physician Decision|0|||
19419846|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Physician Decision|0|||
19419847|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Physician Decision|1|||
19419848|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Physician Decision|0|||
19419849|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Physician Decision|0|||
19419850|NCT01995201|41666410|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
19419851|NCT01995201|41666411|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
19419852|NCT01995201|41666412|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
19419853|NCT01995201|41666413|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
19419854|NCT01995201|41666414|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
19419855|NCT01995201|41666415|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
19419856|NCT01995201|41666416|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
19419857|NCT01728454|41666440|FG000|Stage 1 and 2|Pregnancy|1|||
19419858|NCT01728454|41666441|FG001|Stage 1 and 2|Pregnancy|0|||
19419859|NCT01728454|41666442|FG002|Stage 1 and 2|Pregnancy|0|||
19419860|NCT01728454|41666440|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
19419861|NCT01728454|41666441|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
19419862|NCT01728454|41666442|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
19419863|NCT01728454|41666440|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
19419864|NCT01728454|41666441|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
19419865|NCT01728454|41666442|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
19419866|NCT01728454|41666440|FG000|Stage 1 and 2|Lost to Follow-up|1|||
19419867|NCT01728454|41666441|FG001|Stage 1 and 2|Lost to Follow-up|1|||
19419868|NCT01728454|41666442|FG002|Stage 1 and 2|Lost to Follow-up|0|||
19419869|NCT01728454|41666440|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
19419870|NCT01728454|41666441|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
19419871|NCT01728454|41666442|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
19419872|NCT01728454|41666440|FG000|Stage 3|Reason Missing|0|||
19419873|NCT01728454|41666441|FG001|Stage 3|Reason Missing|0|||
19419874|NCT01728454|41666442|FG002|Stage 3|Reason Missing|1|||
19419875|NCT01728454|41666440|FG000|Stage 3|Subject Required Other Treatment|0|||
19419876|NCT01728454|41666441|FG001|Stage 3|Subject Required Other Treatment|1|||
19419877|NCT01728454|41666442|FG002|Stage 3|Subject Required Other Treatment|0|||
19419878|NCT01728454|41666440|FG000|Stage 3|Pregnancy|1|||
19419879|NCT01728454|41666441|FG001|Stage 3|Pregnancy|0|||
19419880|NCT01728454|41666442|FG002|Stage 3|Pregnancy|0|||
19419881|NCT01728454|41666440|FG000|Stage 3|Withdrew Consent|1|||
19419882|NCT01728454|41666441|FG001|Stage 3|Withdrew Consent|0|||
19419883|NCT01728454|41666442|FG002|Stage 3|Withdrew Consent|1|||
19419884|NCT01728454|41666440|FG000|Stage 3|Non-compliance with Protocol|0|||
19419885|NCT01728454|41666441|FG001|Stage 3|Non-compliance with Protocol|0|||
19419886|NCT01728454|41666442|FG002|Stage 3|Non-compliance with Protocol|1|||
19419887|NCT01728454|41666440|FG000|Stage 3|Lost to Follow-up|0|||
19419888|NCT01728454|41666441|FG001|Stage 3|Lost to Follow-up|3|||
19419889|NCT01728454|41666442|FG002|Stage 3|Lost to Follow-up|1|||
19419890|NCT01728454|41666440|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
19419891|NCT01728454|41666441|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
19419892|NCT01728454|41666442|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
19419893|NCT01636687|41666456|FG000|Induction Period|Withdrawal by Subject|1|||
19419894|NCT01636687|41666457|FG001|Induction Period|Withdrawal by Subject|0|||
19419895|NCT01636687|41666458|FG002|Induction Period|Withdrawal by Subject|0|||
19419896|NCT01636687|41666459|FG003|Induction Period|Withdrawal by Subject|0|||
19419897|NCT01636687|41666460|FG004|Induction Period|Withdrawal by Subject|0|||
19419898|NCT01636687|41666456|FG000|Induction Period|Adverse Event|1|||
19419899|NCT01636687|41666457|FG001|Induction Period|Adverse Event|0|||
19419900|NCT01636687|41666458|FG002|Induction Period|Adverse Event|0|||
19519762|NCT01474512|41932293|FG001|Post-Treatment Follow-Up|Death|0|||
19419901|NCT01636687|41666459|FG003|Induction Period|Adverse Event|0|||
19419902|NCT01636687|41666460|FG004|Induction Period|Adverse Event|1|||
19519763|NCT01474512|41932294|FG002|Post-Treatment Follow-Up|Death|0|||
19419903|NCT01636687|41666456|FG000|Induction Period|Lack of Efficacy|0|||
19419904|NCT01636687|41666457|FG001|Induction Period|Lack of Efficacy|0|||
19419905|NCT01636687|41666458|FG002|Induction Period|Lack of Efficacy|0|||
19419906|NCT01636687|41666459|FG003|Induction Period|Lack of Efficacy|0|||
19419907|NCT01636687|41666460|FG004|Induction Period|Lack of Efficacy|1|||
19419908|NCT01636687|41666456|FG000|Induction Period|Physician Decision|1|||
19419909|NCT01636687|41666457|FG001|Induction Period|Physician Decision|0|||
19419910|NCT01636687|41666458|FG002|Induction Period|Physician Decision|0|||
19419911|NCT01636687|41666459|FG003|Induction Period|Physician Decision|0|||
19419912|NCT01636687|41666460|FG004|Induction Period|Physician Decision|0|||
19419913|NCT01636687|41666456|FG000|Maintenance Period|Withdrawal by Subject|2|||
19419914|NCT01636687|41666457|FG001|Maintenance Period|Withdrawal by Subject|0|||
19419915|NCT01636687|41666458|FG002|Maintenance Period|Withdrawal by Subject|2|||
19419916|NCT01636687|41666459|FG003|Maintenance Period|Withdrawal by Subject|0|||
19419917|NCT01636687|41666460|FG004|Maintenance Period|Withdrawal by Subject|0|||
19419918|NCT01636687|41666456|FG000|Maintenance Period|Adverse Event|1|||
19419919|NCT01636687|41666457|FG001|Maintenance Period|Adverse Event|0|||
19419920|NCT01636687|41666458|FG002|Maintenance Period|Adverse Event|0|||
19419921|NCT01636687|41666459|FG003|Maintenance Period|Adverse Event|0|||
19419922|NCT01636687|41666460|FG004|Maintenance Period|Adverse Event|0|||
19419923|NCT01636687|41666456|FG000|Maintenance Period|Lack of Efficacy|4|||
19419924|NCT01636687|41666457|FG001|Maintenance Period|Lack of Efficacy|1|||
19419925|NCT01636687|41666458|FG002|Maintenance Period|Lack of Efficacy|0|||
19419926|NCT01636687|41666459|FG003|Maintenance Period|Lack of Efficacy|0|||
19419927|NCT01636687|41666460|FG004|Maintenance Period|Lack of Efficacy|0|||
19419928|NCT01636687|41666456|FG000|Maintenance Period|Lost to Follow-up|1|||
19419929|NCT01636687|41666457|FG001|Maintenance Period|Lost to Follow-up|1|||
19419930|NCT01636687|41666458|FG002|Maintenance Period|Lost to Follow-up|0|||
19419931|NCT01636687|41666459|FG003|Maintenance Period|Lost to Follow-up|0|||
19419932|NCT01636687|41666460|FG004|Maintenance Period|Lost to Follow-up|1|||
19419933|NCT01636687|41666456|FG000|Maintenance Period|Physician Decision|0|||
19419934|NCT01636687|41666457|FG001|Maintenance Period|Physician Decision|0|||
19419935|NCT01636687|41666458|FG002|Maintenance Period|Physician Decision|0|||
19419936|NCT01636687|41666459|FG003|Maintenance Period|Physician Decision|0|||
19419937|NCT01636687|41666460|FG004|Maintenance Period|Physician Decision|1|||
19419938|NCT01636687|41666456|FG000|Extension Period|technical problems|0|||
19419939|NCT01636687|41666457|FG001|Extension Period|technical problems|1|||
19419940|NCT01636687|41666458|FG002|Extension Period|technical problems|2|||
19419941|NCT01636687|41666459|FG003|Extension Period|technical problems|1|||
19419942|NCT01636687|41666460|FG004|Extension Period|technical problems|0|||
19419943|NCT01636687|41666456|FG000|Extension Period|Adverse Event|4|||
19419944|NCT01636687|41666457|FG001|Extension Period|Adverse Event|3|||
19419945|NCT01636687|41666458|FG002|Extension Period|Adverse Event|2|||
19419946|NCT01636687|41666459|FG003|Extension Period|Adverse Event|1|||
19419947|NCT01636687|41666460|FG004|Extension Period|Adverse Event|0|||
19419948|NCT01636687|41666456|FG000|Extension Period|Lack of Efficacy|7|||
19419949|NCT01636687|41666457|FG001|Extension Period|Lack of Efficacy|0|||
19419950|NCT01636687|41666458|FG002|Extension Period|Lack of Efficacy|2|||
19419951|NCT01636687|41666459|FG003|Extension Period|Lack of Efficacy|1|||
19419952|NCT01636687|41666460|FG004|Extension Period|Lack of Efficacy|0|||
19419953|NCT01636687|41666456|FG000|Extension Period|Lost to Follow-up|1|||
19419954|NCT01636687|41666457|FG001|Extension Period|Lost to Follow-up|0|||
19419955|NCT01636687|41666458|FG002|Extension Period|Lost to Follow-up|1|||
19419956|NCT01636687|41666459|FG003|Extension Period|Lost to Follow-up|0|||
19419957|NCT01636687|41666460|FG004|Extension Period|Lost to Follow-up|0|||
19419958|NCT01636687|41666456|FG000|Extension Period|Physician Decision|1|||
19419959|NCT01636687|41666457|FG001|Extension Period|Physician Decision|0|||
19419960|NCT01636687|41666458|FG002|Extension Period|Physician Decision|0|||
19419961|NCT01636687|41666459|FG003|Extension Period|Physician Decision|1|||
19419962|NCT01636687|41666460|FG004|Extension Period|Physician Decision|0|||
19419963|NCT01636687|41666456|FG000|Extension Period|study terminated by sponsor|33|||
19419964|NCT01636687|41666457|FG001|Extension Period|study terminated by sponsor|50|||
19419965|NCT01636687|41666458|FG002|Extension Period|study terminated by sponsor|17|||
19419966|NCT01636687|41666459|FG003|Extension Period|study terminated by sponsor|23|||
19419967|NCT01636687|41666460|FG004|Extension Period|study terminated by sponsor|0|||
19419968|NCT01636687|41666456|FG000|Extension Period|Withdrawal by Subject|1|||
19419969|NCT01636687|41666457|FG001|Extension Period|Withdrawal by Subject|0|||
19419970|NCT01636687|41666458|FG002|Extension Period|Withdrawal by Subject|1|||
19419971|NCT01636687|41666459|FG003|Extension Period|Withdrawal by Subject|1|||
19419972|NCT01636687|41666460|FG004|Extension Period|Withdrawal by Subject|0|||
19419973|NCT01636687|41666456|FG000|Follow-up Period|Withdrawal by Subject|1|||
19419974|NCT01636687|41666457|FG001|Follow-up Period|Withdrawal by Subject|0|||
19419975|NCT01636687|41666458|FG002|Follow-up Period|Withdrawal by Subject|0|||
19419976|NCT01636687|41666459|FG003|Follow-up Period|Withdrawal by Subject|0|||
19419977|NCT01636687|41666460|FG004|Follow-up Period|Withdrawal by Subject|1|||
19419978|NCT01634659|41666480|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
19419979|NCT01634659|41666481|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
19419980|NCT01634659|41666480|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
19419981|NCT01634659|41666481|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
19419982|NCT04863248|41666493|FG000|Overall Study|Sponsor Terminated|4|||
19419983|NCT04863248|41666494|FG001|Overall Study|Sponsor Terminated|1|||
19419984|NCT04863248|41666493|FG000|Overall Study|Death|0|||
19419985|NCT04863248|41666494|FG001|Overall Study|Death|1|||
19419986|NCT04863248|41666493|FG000|Overall Study|Withdrawal by Subject|0|||
19419987|NCT04863248|41666494|FG001|Overall Study|Withdrawal by Subject|1|||
19419988|NCT04498832|41666502|FG000|Overall Study|Adverse Event|1|||
19419989|NCT04498832|41666503|FG001|Overall Study|Adverse Event|3|||
19419990|NCT04498832|41666502|FG000|Overall Study|Withdrawal by Subject|0|||
19419991|NCT04498832|41666503|FG001|Overall Study|Withdrawal by Subject|1|||
19419992|NCT04285229|41666511|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
19419993|NCT04285229|41666512|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19419994|NCT04285229|41666513|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19419995|NCT04285229|41666514|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19419996|NCT04285229|41666515|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19419997|NCT04285229|41666516|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19419998|NCT04285229|41666511|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
19419999|NCT04285229|41666512|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
19420000|NCT04285229|41666513|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
19420001|NCT04285229|41666514|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
19420002|NCT04285229|41666515|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
19420003|NCT04285229|41666516|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
19420004|NCT04285229|41666511|FG000|Extended Treatment Period|Adverse Event|0|||
19420005|NCT04285229|41666512|FG001|Extended Treatment Period|Adverse Event|0|||
19420006|NCT04285229|41666513|FG002|Extended Treatment Period|Adverse Event|0|||
19420007|NCT04285229|41666514|FG003|Extended Treatment Period|Adverse Event|1|||
19420008|NCT04285229|41666515|FG004|Extended Treatment Period|Adverse Event|0|||
19420009|NCT04285229|41666516|FG005|Extended Treatment Period|Adverse Event|0|||
19420010|NCT04285229|41666511|FG000|Extended Treatment Period|Physician Decision|0|||
19420011|NCT04285229|41666512|FG001|Extended Treatment Period|Physician Decision|0|||
19420012|NCT04285229|41666513|FG002|Extended Treatment Period|Physician Decision|1|||
19420013|NCT04285229|41666514|FG003|Extended Treatment Period|Physician Decision|0|||
19420014|NCT04285229|41666515|FG004|Extended Treatment Period|Physician Decision|0|||
19420015|NCT04285229|41666516|FG005|Extended Treatment Period|Physician Decision|0|||
19420016|NCT04285229|41666511|FG000|Follow-up Period|Adverse Event|0|||
19420017|NCT04285229|41666512|FG001|Follow-up Period|Adverse Event|0|||
19420018|NCT04285229|41666513|FG002|Follow-up Period|Adverse Event|0|||
19420019|NCT04285229|41666514|FG003|Follow-up Period|Adverse Event|0|||
19420020|NCT04285229|41666515|FG004|Follow-up Period|Adverse Event|1|||
19420021|NCT04285229|41666516|FG005|Follow-up Period|Adverse Event|4|||
19420022|NCT04285229|41666511|FG000|Follow-up Period|Withdrawal by Subject|0|||
19420023|NCT04285229|41666512|FG001|Follow-up Period|Withdrawal by Subject|0|||
19420024|NCT04285229|41666513|FG002|Follow-up Period|Withdrawal by Subject|0|||
19420025|NCT04285229|41666514|FG003|Follow-up Period|Withdrawal by Subject|0|||
19420026|NCT04285229|41666515|FG004|Follow-up Period|Withdrawal by Subject|0|||
19420027|NCT04285229|41666516|FG005|Follow-up Period|Withdrawal by Subject|5|||
19420028|NCT04285229|41666511|FG000|Follow-up Period|Covid-19|0|||
19420029|NCT04285229|41666512|FG001|Follow-up Period|Covid-19|0|||
19420030|NCT04285229|41666513|FG002|Follow-up Period|Covid-19|0|||
19420031|NCT04285229|41666514|FG003|Follow-up Period|Covid-19|0|||
19420032|NCT04285229|41666515|FG004|Follow-up Period|Covid-19|0|||
19420033|NCT04285229|41666516|FG005|Follow-up Period|Covid-19|2|||
19420034|NCT04285229|41666511|FG000|Follow-up Period|Physician Decision|0|||
19420035|NCT04285229|41666512|FG001|Follow-up Period|Physician Decision|0|||
19420036|NCT04285229|41666513|FG002|Follow-up Period|Physician Decision|0|||
19420037|NCT04285229|41666514|FG003|Follow-up Period|Physician Decision|0|||
19420038|NCT04285229|41666515|FG004|Follow-up Period|Physician Decision|0|||
19420039|NCT04285229|41666516|FG005|Follow-up Period|Physician Decision|1|||
19420040|NCT04263454|41666533|FG000|Overall Study|Adverse Event|0|||
19420041|NCT04263454|41666534|FG001|Overall Study|Adverse Event|2|||
19420042|NCT04263454|41666533|FG000|Overall Study|Physician Decision|3|||
19420043|NCT04263454|41666534|FG001|Overall Study|Physician Decision|5|||
19420044|NCT04263454|41666533|FG000|Overall Study|Poor Data Quality|0|||
19420045|NCT04263454|41666534|FG001|Overall Study|Poor Data Quality|1|||
19420046|NCT04155463|41666544|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
19420047|NCT04155463|41666545|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
19420048|NCT04056611|41666551|FG000|Overall Study|Physician Decision|1|||
19420049|NCT04024462|41666557|FG000|Overall Study|Withdrawal by Subject|6|||
19420050|NCT04024462|41666558|FG001|Overall Study|Withdrawal by Subject|7|||
19420051|NCT04024462|41666557|FG000|Overall Study|Progressive Disease|0|||
19420052|NCT04024462|41666558|FG001|Overall Study|Progressive Disease|1|||
19420053|NCT04024462|41666557|FG000|Overall Study|Adverse Event|0|||
19420054|NCT04024462|41666558|FG001|Overall Study|Adverse Event|1|||
19420055|NCT04024462|41666557|FG000|Overall Study|Death|0|||
19420056|NCT04024462|41666558|FG001|Overall Study|Death|1|||
19420057|NCT04024462|41666557|FG000|Overall Study|Lost to Follow-up|1|||
19420058|NCT04024462|41666558|FG001|Overall Study|Lost to Follow-up|0|||
19420059|NCT04024462|41666557|FG000|Overall Study|Ongoing in the Study|94|||
19420060|NCT04024462|41666558|FG001|Overall Study|Ongoing in the Study|89|||
19420061|NCT04001803|41666564|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
19420062|NCT04001803|41666564|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
19420063|NCT04001803|41666564|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
19420064|NCT04001803|41666564|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
19420065|NCT04001803|41666564|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
19420066|NCT04001803|41666564|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
19420067|NCT04001803|41666564|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
19420068|NCT04001803|41666564|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
19420069|NCT04001803|41666564|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
19420070|NCT04001803|41666564|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
19420071|NCT03768427|41666573|FG000|Overall Study|Death|0|||
19420072|NCT03768427|41666574|FG001|Overall Study|Death|0|||
19420073|NCT03768427|41666575|FG002|Overall Study|Death|1|||
19420074|NCT03768427|41666576|FG003|Overall Study|Death|0|||
19420075|NCT03768427|41666573|FG000|Overall Study|Lost to Follow-up|2|||
19420076|NCT03768427|41666574|FG001|Overall Study|Lost to Follow-up|0|||
19420077|NCT03768427|41666575|FG002|Overall Study|Lost to Follow-up|0|||
19420078|NCT03768427|41666576|FG003|Overall Study|Lost to Follow-up|0|||
19420079|NCT03768427|41666573|FG000|Overall Study|Physician Decision|3|||
19420080|NCT03768427|41666574|FG001|Overall Study|Physician Decision|2|||
19420081|NCT03768427|41666575|FG002|Overall Study|Physician Decision|4|||
19420082|NCT03768427|41666576|FG003|Overall Study|Physician Decision|4|||
19420083|NCT03768427|41666573|FG000|Overall Study|Withdrawal by Subject|7|||
19420084|NCT03768427|41666574|FG001|Overall Study|Withdrawal by Subject|2|||
19420085|NCT03768427|41666575|FG002|Overall Study|Withdrawal by Subject|6|||
19420086|NCT03768427|41666576|FG003|Overall Study|Withdrawal by Subject|7|||
19420087|NCT03657160|41666592|FG000|Overall Study|Adverse Event|5|||
19420088|NCT03657160|41666593|FG001|Overall Study|Adverse Event|6|||
19420089|NCT03657160|41666592|FG000|Overall Study|Protocol Deviation|3|||
19420090|NCT03657160|41666593|FG001|Overall Study|Protocol Deviation|0|||
19420091|NCT03657160|41666592|FG000|Overall Study|Withdrawal by Subject|18|||
19420092|NCT03657160|41666593|FG001|Overall Study|Withdrawal by Subject|16|||
19420093|NCT03657160|41666592|FG000|Overall Study|Site Termination|1|||
19420094|NCT03657160|41666593|FG001|Overall Study|Site Termination|0|||
19420095|NCT03657160|41666592|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
19420096|NCT03657160|41666593|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
19420097|NCT03657160|41666592|FG000|Overall Study|Death|33|||
19420098|NCT03657160|41666593|FG001|Overall Study|Death|26|||
19420099|NCT03657160|41666592|FG000|Overall Study|Death (COVID-19-Related)|1|||
19420100|NCT03657160|41666593|FG001|Overall Study|Death (COVID-19-Related)|0|||
19420101|NCT03657160|41666592|FG000|Overall Study|Reason Not Specified|5|||
19420102|NCT03657160|41666593|FG001|Overall Study|Reason Not Specified|5|||
19420103|NCT03657160|41666592|FG000|Overall Study|Other (COVID-19-Related)|0|||
19420104|NCT03657160|41666593|FG001|Overall Study|Other (COVID-19-Related)|1|||
19420105|NCT03595228|41666599|FG000|Overall Study|Death|2|||
19420106|NCT03595228|41666599|FG000|Overall Study|Lack of Efficacy|13|||
19420107|NCT03595228|41666599|FG000|Overall Study|Withdrawal by Subject|3|||
19420108|NCT03595228|41666599|FG000|Overall Study|Withdrawal by Sponsor|1|||
19420109|NCT03572933|41666605|FG000|Overall Study|Adverse Event|4|||
19420110|NCT03572933|41666606|FG001|Overall Study|Adverse Event|1|||
19420111|NCT03572933|41666605|FG000|Overall Study|Withdrawal by Subject|0|||
19420112|NCT03572933|41666606|FG001|Overall Study|Withdrawal by Subject|1|||
19420113|NCT03558152|41666617|FG000|Overall Study|Adverse Event|0|||
19420114|NCT03558152|41666618|FG001|Overall Study|Adverse Event|0|||
19420115|NCT03558152|41666619|FG002|Overall Study|Adverse Event|1|||
19420116|NCT03558152|41666620|FG003|Overall Study|Adverse Event|1|||
19420117|NCT03558152|41666621|FG004|Overall Study|Adverse Event|2|||
19420118|NCT03558152|41666622|FG005|Overall Study|Adverse Event|1|||
19420119|NCT03558152|41666623|FG006|Overall Study|Adverse Event|1|||
19420120|NCT03558152|41666624|FG007|Overall Study|Adverse Event|0|||
19420121|NCT03558152|41666617|FG000|Overall Study|Death|0|||
19420122|NCT03558152|41666618|FG001|Overall Study|Death|0|||
19420123|NCT03558152|41666619|FG002|Overall Study|Death|0|||
19420124|NCT03558152|41666620|FG003|Overall Study|Death|0|||
19420125|NCT03558152|41666621|FG004|Overall Study|Death|1|||
19420126|NCT03558152|41666622|FG005|Overall Study|Death|0|||
19420127|NCT03558152|41666623|FG006|Overall Study|Death|0|||
19420128|NCT03558152|41666624|FG007|Overall Study|Death|0|||
19420129|NCT03558152|41666617|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
19420130|NCT03558152|41666618|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420131|NCT03558152|41666619|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420132|NCT03558152|41666620|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420133|NCT03558152|41666621|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420134|NCT03558152|41666622|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420135|NCT03558152|41666623|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420136|NCT03558152|41666624|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
19420137|NCT03558152|41666617|FG000|Overall Study|Miscalculation in mmcs|0|||
19420138|NCT03558152|41666618|FG001|Overall Study|Miscalculation in mmcs|0|||
19420139|NCT03558152|41666619|FG002|Overall Study|Miscalculation in mmcs|0|||
19420140|NCT03558152|41666620|FG003|Overall Study|Miscalculation in mmcs|0|||
19420141|NCT03558152|41666621|FG004|Overall Study|Miscalculation in mmcs|0|||
19420142|NCT03558152|41666622|FG005|Overall Study|Miscalculation in mmcs|0|||
19420143|NCT03558152|41666623|FG006|Overall Study|Miscalculation in mmcs|1|||
19420144|NCT03558152|41666624|FG007|Overall Study|Miscalculation in mmcs|0|||
19420145|NCT03558152|41666617|FG000|Overall Study|Mistake in calculation|0|||
19420146|NCT03558152|41666618|FG001|Overall Study|Mistake in calculation|0|||
19420147|NCT03558152|41666619|FG002|Overall Study|Mistake in calculation|0|||
19420148|NCT03558152|41666620|FG003|Overall Study|Mistake in calculation|1|||
19420149|NCT03558152|41666621|FG004|Overall Study|Mistake in calculation|0|||
19420150|NCT03558152|41666622|FG005|Overall Study|Mistake in calculation|0|||
19420151|NCT03558152|41666623|FG006|Overall Study|Mistake in calculation|0|||
19420152|NCT03558152|41666624|FG007|Overall Study|Mistake in calculation|0|||
19420153|NCT03558152|41666617|FG000|Overall Study|Mistake in evaluation of disease status|0|||
19420154|NCT03558152|41666618|FG001|Overall Study|Mistake in evaluation of disease status|0|||
19420155|NCT03558152|41666619|FG002|Overall Study|Mistake in evaluation of disease status|0|||
19420156|NCT03558152|41666620|FG003|Overall Study|Mistake in evaluation of disease status|0|||
19420157|NCT03558152|41666621|FG004|Overall Study|Mistake in evaluation of disease status|0|||
19420158|NCT03558152|41666622|FG005|Overall Study|Mistake in evaluation of disease status|0|||
19420159|NCT03558152|41666623|FG006|Overall Study|Mistake in evaluation of disease status|0|||
19420160|NCT03558152|41666624|FG007|Overall Study|Mistake in evaluation of disease status|1|||
19420161|NCT03558152|41666617|FG000|Overall Study|Physician Decision|0|||
19420162|NCT03558152|41666618|FG001|Overall Study|Physician Decision|0|||
19420163|NCT03558152|41666619|FG002|Overall Study|Physician Decision|0|||
19420164|NCT03558152|41666620|FG003|Overall Study|Physician Decision|0|||
19420165|NCT03558152|41666621|FG004|Overall Study|Physician Decision|0|||
19420166|NCT03558152|41666622|FG005|Overall Study|Physician Decision|0|||
19420167|NCT03558152|41666623|FG006|Overall Study|Physician Decision|1|||
19420168|NCT03558152|41666624|FG007|Overall Study|Physician Decision|0|||
19420169|NCT03558152|41666617|FG000|Overall Study|Withdrawal by Subject|2|||
19420170|NCT03558152|41666618|FG001|Overall Study|Withdrawal by Subject|3|||
19420171|NCT03558152|41666619|FG002|Overall Study|Withdrawal by Subject|2|||
19420172|NCT03558152|41666620|FG003|Overall Study|Withdrawal by Subject|1|||
19420173|NCT03558152|41666621|FG004|Overall Study|Withdrawal by Subject|1|||
19420174|NCT03558152|41666622|FG005|Overall Study|Withdrawal by Subject|1|||
19420175|NCT03558152|41666623|FG006|Overall Study|Withdrawal by Subject|3|||
19420176|NCT03558152|41666624|FG007|Overall Study|Withdrawal by Subject|2|||
19420177|NCT03558152|41666617|FG000|Overall Study|Lack of Efficacy|11|||
19420178|NCT03558152|41666618|FG001|Overall Study|Lack of Efficacy|11|||
19420179|NCT03558152|41666619|FG002|Overall Study|Lack of Efficacy|10|||
19420180|NCT03558152|41666620|FG003|Overall Study|Lack of Efficacy|11|||
19420181|NCT03558152|41666621|FG004|Overall Study|Lack of Efficacy|14|||
19420182|NCT03558152|41666622|FG005|Overall Study|Lack of Efficacy|12|||
19420183|NCT03558152|41666623|FG006|Overall Study|Lack of Efficacy|14|||
19420184|NCT03558152|41666624|FG007|Overall Study|Lack of Efficacy|13|||
19420185|NCT03558152|41666617|FG000|Overall Study|Protocol Violation|1|||
19420186|NCT03558152|41666618|FG001|Overall Study|Protocol Violation|1|||
19420187|NCT03558152|41666619|FG002|Overall Study|Protocol Violation|0|||
19420188|NCT03558152|41666620|FG003|Overall Study|Protocol Violation|1|||
19420189|NCT03558152|41666621|FG004|Overall Study|Protocol Violation|1|||
19420190|NCT03558152|41666622|FG005|Overall Study|Protocol Violation|0|||
19420191|NCT03558152|41666623|FG006|Overall Study|Protocol Violation|2|||
19420192|NCT03558152|41666624|FG007|Overall Study|Protocol Violation|0|||
19420193|NCT03461406|41666664|FG000|Overall Study|Death|1|||
19420194|NCT03461406|41666665|FG001|Overall Study|Death|2|||
19420195|NCT03461406|41666664|FG000|Overall Study|Consent Withdrawn by Participant|0|||
19420196|NCT03461406|41666665|FG001|Overall Study|Consent Withdrawn by Participant|1|||
19420197|NCT03461406|41666664|FG000|Overall Study|Screen Failure|3|||
19420198|NCT03461406|41666665|FG001|Overall Study|Screen Failure|1|||
19420199|NCT03461406|41666664|FG000|Overall Study|Reason not Specified|1|||
19420200|NCT03461406|41666665|FG001|Overall Study|Reason not Specified|3|||
19420201|NCT03461406|41666664|FG000|Overall Study|Lost to Follow-up|3|||
19420202|NCT03461406|41666665|FG001|Overall Study|Lost to Follow-up|0|||
19420203|NCT03408899|41666680|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
19420204|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2|||
19420205|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
19420206|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
19420207|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0|||
19420208|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
19420209|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1|||
19420210|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
19420211|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
19420212|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
19420213|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
19420214|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Death|0|||
19420215|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Death|0|||
19420216|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Death|1|||
19420217|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Death|0|||
19420218|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Death|0|||
19420219|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
19420220|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
19420221|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
19420222|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
19420223|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
19420224|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
19420225|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
19420226|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
19420227|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
19420228|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
19519764|NCT01474512|41932295|FG003|Post-Treatment Follow-Up|Death|0|||
19519765|NCT01474512|41932296|FG004|Post-Treatment Follow-Up|Death|0|||
19711118|NCT00117507|42154306|FG000|Overall Study|Patient withdrew consent|4|||
19711119|NCT00117507|42154306|FG000|Overall Study|Death|3|||
19711120|NCT03603496|42154313|FG000|Overall Study|Death|19|||
19420229|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Other|0|||
19420230|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Other|1|||
19420231|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Other|0|||
19420232|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Other|0|||
19420233|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Other|0|||
19420234|NCT03317496|41666693|FG000|Phase 1b Lead-in: Treatment|Ongoing|2|||
19420235|NCT03317496|41666694|FG001|Phase 1b Lead-in: Treatment|Ongoing|1|||
19420236|NCT03317496|41666695|FG002|Phase 1b Lead-in: Treatment|Ongoing|0|||
19420237|NCT03317496|41666696|FG003|Phase 1b Lead-in: Treatment|Ongoing|2|||
19420238|NCT03317496|41666697|FG004|Phase 1b Lead-in: Treatment|Ongoing|0|||
19420239|NCT03317496|41666693|FG000|Phase 1b Lead-in: Follow-up|Death|2|||
19420240|NCT03317496|41666694|FG001|Phase 1b Lead-in: Follow-up|Death|7|||
19420241|NCT03317496|41666695|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
19420242|NCT03317496|41666696|FG003|Phase 1b Lead-in: Follow-up|Death|3|||
19420243|NCT03317496|41666697|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
19420244|NCT03317496|41666693|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
19420245|NCT03317496|41666694|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
19420246|NCT03317496|41666695|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
19420247|NCT03317496|41666696|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
19420248|NCT03317496|41666697|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
19420249|NCT03317496|41666693|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
19420250|NCT03317496|41666694|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
19420251|NCT03317496|41666695|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
19420252|NCT03317496|41666696|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
19420253|NCT03317496|41666697|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
19420254|NCT03317496|41666693|FG000|Phase 1b Lead-in: Follow-up|Other|1|||
19420255|NCT03317496|41666694|FG001|Phase 1b Lead-in: Follow-up|Other|3|||
19420256|NCT03317496|41666695|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
19420257|NCT03317496|41666696|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
19420258|NCT03317496|41666697|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
19420259|NCT03317496|41666693|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0|||
19420260|NCT03317496|41666694|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1|||
19420261|NCT03317496|41666695|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0|||
19420262|NCT03317496|41666696|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0|||
19420263|NCT03317496|41666697|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0|||
19420264|NCT03317496|41666693|FG000|Phase 2: Treatment|Adverse Event|0|||
19420265|NCT03317496|41666694|FG001|Phase 2: Treatment|Adverse Event|0|||
19420266|NCT03317496|41666695|FG002|Phase 2: Treatment|Adverse Event|0|||
19420267|NCT03317496|41666696|FG003|Phase 2: Treatment|Adverse Event|0|||
19420268|NCT03317496|41666697|FG004|Phase 2: Treatment|Adverse Event|4|||
19420269|NCT03317496|41666693|FG000|Phase 2: Treatment|Death|0|||
19420270|NCT03317496|41666694|FG001|Phase 2: Treatment|Death|0|||
19420271|NCT03317496|41666695|FG002|Phase 2: Treatment|Death|0|||
19420272|NCT03317496|41666696|FG003|Phase 2: Treatment|Death|0|||
19420273|NCT03317496|41666697|FG004|Phase 2: Treatment|Death|1|||
19519766|NCT01474512|41932297|FG005|Post-Treatment Follow-Up|Death|0|||
19711121|NCT03603496|42154314|FG001|Overall Study|Death|24|||
19420274|NCT03317496|41666693|FG000|Phase 2: Treatment|Physician Decision|0|||
19420275|NCT03317496|41666694|FG001|Phase 2: Treatment|Physician Decision|0|||
19420276|NCT03317496|41666695|FG002|Phase 2: Treatment|Physician Decision|0|||
19420277|NCT03317496|41666696|FG003|Phase 2: Treatment|Physician Decision|0|||
19420278|NCT03317496|41666697|FG004|Phase 2: Treatment|Physician Decision|1|||
19420279|NCT03317496|41666693|FG000|Phase 2: Treatment|Progressive Disease|0|||
19420280|NCT03317496|41666694|FG001|Phase 2: Treatment|Progressive Disease|0|||
19420281|NCT03317496|41666695|FG002|Phase 2: Treatment|Progressive Disease|0|||
19420282|NCT03317496|41666696|FG003|Phase 2: Treatment|Progressive Disease|0|||
19420283|NCT03317496|41666697|FG004|Phase 2: Treatment|Progressive Disease|18|||
19420284|NCT03317496|41666693|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
19420285|NCT03317496|41666694|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
19420286|NCT03317496|41666695|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
19420287|NCT03317496|41666696|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
19420288|NCT03317496|41666697|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
19420289|NCT03317496|41666693|FG000|Phase 2: Treatment|Other|0|||
19420290|NCT03317496|41666694|FG001|Phase 2: Treatment|Other|0|||
19420291|NCT03317496|41666695|FG002|Phase 2: Treatment|Other|0|||
19420292|NCT03317496|41666696|FG003|Phase 2: Treatment|Other|0|||
19420293|NCT03317496|41666697|FG004|Phase 2: Treatment|Other|2|||
19420294|NCT03317496|41666693|FG000|Phase 2: Treatment|Ongoing|0|||
19420295|NCT03317496|41666694|FG001|Phase 2: Treatment|Ongoing|0|||
19420296|NCT03317496|41666695|FG002|Phase 2: Treatment|Ongoing|0|||
19420297|NCT03317496|41666696|FG003|Phase 2: Treatment|Ongoing|0|||
19420298|NCT03317496|41666697|FG004|Phase 2: Treatment|Ongoing|8|||
19420299|NCT03317496|41666693|FG000|Phase 2: Follow-up|Death|0|||
19420300|NCT03317496|41666694|FG001|Phase 2: Follow-up|Death|0|||
19420301|NCT03317496|41666695|FG002|Phase 2: Follow-up|Death|0|||
19420302|NCT03317496|41666696|FG003|Phase 2: Follow-up|Death|0|||
19420303|NCT03317496|41666697|FG004|Phase 2: Follow-up|Death|16|||
19420304|NCT03317496|41666693|FG000|Phase 2: Follow-up|Withdrawal by Subject|0|||
19420305|NCT03317496|41666694|FG001|Phase 2: Follow-up|Withdrawal by Subject|0|||
19420306|NCT03317496|41666695|FG002|Phase 2: Follow-up|Withdrawal by Subject|0|||
19420307|NCT03317496|41666696|FG003|Phase 2: Follow-up|Withdrawal by Subject|0|||
19420308|NCT03317496|41666697|FG004|Phase 2: Follow-up|Withdrawal by Subject|1|||
19420309|NCT03317496|41666693|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
19420310|NCT03317496|41666694|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
19420311|NCT03317496|41666695|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
19420312|NCT03317496|41666696|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
19420313|NCT03317496|41666697|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
19420314|NCT03317496|41666693|FG000|Phase 2: Follow-up|Other|0|||
19420315|NCT03317496|41666694|FG001|Phase 2: Follow-up|Other|0|||
19420316|NCT03317496|41666695|FG002|Phase 2: Follow-up|Other|0|||
19420317|NCT03317496|41666696|FG003|Phase 2: Follow-up|Other|0|||
19420318|NCT03317496|41666697|FG004|Phase 2: Follow-up|Other|6|||
19420319|NCT03317496|41666693|FG000|Phase 2: Follow-up|Ongoing|0|||
19420320|NCT03317496|41666694|FG001|Phase 2: Follow-up|Ongoing|0|||
19420321|NCT03317496|41666695|FG002|Phase 2: Follow-up|Ongoing|0|||
19420322|NCT03317496|41666696|FG003|Phase 2: Follow-up|Ongoing|0|||
19420323|NCT03317496|41666697|FG004|Phase 2: Follow-up|Ongoing|1|||
19420324|NCT03215810|41666708|FG000|Overall Study|Still responding to nivolumab|1|||
19420325|NCT03215810|41666708|FG000|Overall Study|Insufficient TIL growth|1|||
19420326|NCT03215810|41666708|FG000|Overall Study|Decline in performance status|1|||
19420327|NCT03215810|41666708|FG000|Overall Study|Withdrawal by Subject|1|||
19420328|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
19420329|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
19420330|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
19420331|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
19420332|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
19420333|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
19420334|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
19420335|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
19420336|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
19420337|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
19420338|NCT02528643|41666728|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
19420339|NCT02528643|41666729|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
19420340|NCT02528643|41666728|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
19420341|NCT02528643|41666729|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
19420342|NCT02421939|41666757|FG000|Overall Study|Progressive disease|70|||
19420343|NCT02421939|41666758|FG001|Overall Study|Progressive disease|16|||
19420344|NCT02421939|41666757|FG000|Overall Study|Lack of Efficacy|21|||
19420345|NCT02421939|41666758|FG001|Overall Study|Lack of Efficacy|31|||
19519767|NCT01474512|41932298|FG006|Post-Treatment Follow-Up|Death|0|||
19420346|NCT02421939|41666757|FG000|Overall Study|Death|36|||
19420347|NCT02421939|41666758|FG001|Overall Study|Death|10|||
19420348|NCT02421939|41666757|FG000|Overall Study|Disease relapse|33|||
19420349|NCT02421939|41666758|FG001|Overall Study|Disease relapse|2|||
19420350|NCT02421939|41666757|FG000|Overall Study|Adverse Event|28|||
19420351|NCT02421939|41666758|FG001|Overall Study|Adverse Event|5|||
19420352|NCT02421939|41666757|FG000|Overall Study|Withdrawal by Subject|5|||
19420353|NCT02421939|41666758|FG001|Overall Study|Withdrawal by Subject|24|||
19420354|NCT02421939|41666757|FG000|Overall Study|Physician Decision|11|||
19420355|NCT02421939|41666758|FG001|Overall Study|Physician Decision|11|||
19420356|NCT02421939|41666757|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
19420357|NCT02421939|41666758|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
19420358|NCT02421939|41666757|FG000|Overall Study|Miscellaneous|4|||
19420359|NCT02421939|41666758|FG001|Overall Study|Miscellaneous|5|||
19420360|NCT02421939|41666757|FG000|Overall Study|Protocol deviation|1|||
19420361|NCT02421939|41666758|FG001|Overall Study|Protocol deviation|1|||
19420362|NCT02175680|41666781|FG000|Overall Study|non-compliance|1|||
19420363|NCT02175680|41666781|FG000|Overall Study|other non-medical reason|1|||
19420364|NCT01983462|41666795|FG000|Overall Study|Adverse Event|1|||
19420365|NCT01983462|41666796|FG001|Overall Study|Adverse Event|0|||
19420366|NCT01983462|41666797|FG002|Overall Study|Adverse Event|0|||
19420367|NCT01974440|41666807|FG000|Overall Study|Lost to Follow-up|8|||
19420368|NCT01974440|41666808|FG001|Overall Study|Lost to Follow-up|7|||
19420369|NCT01974440|41666807|FG000|Overall Study|Withdrawal by Subject|20|||
19420370|NCT01974440|41666808|FG001|Overall Study|Withdrawal by Subject|19|||
19420371|NCT01974440|41666807|FG000|Overall Study|Ongoing|112|||
19420372|NCT01974440|41666808|FG001|Overall Study|Ongoing|116|||
19420373|NCT01559935|41666837|FG000|Car Phase|Toxicity|4|||
19420374|NCT01559935|41666837|FG000|Car Phase|Death|1|||
19420375|NCT01559935|41666837|FG000|Car Phase|Lack of Efficacy|2|||
19420376|NCT01559935|41666837|FG000|Car Phase|Lost to Follow-up|1|||
19420377|NCT01559935|41666837|FG000|Car Phase|Physician Decision|1|||
19420378|NCT01559935|41666837|FG000|Car Phase|Withdrawal by Subject|2|||
19420379|NCT01559935|41666837|FG000|Car Phase|Per protocol|1|||
19420380|NCT01559935|41666837|FG000|Car Phase|Insurance|1|||
19420381|NCT01559935|41666837|FG000|Car Phase|non-compliance|1|||
19420382|NCT01559935|41666837|FG000|BiRD Phase|Toxicity|1|||
19420383|NCT01559935|41666837|FG000|BiRD Phase|Lack of Efficacy|1|||
19420384|NCT01559935|41666837|FG000|BiRD Phase|Withdrawal by Subject|2|||
19420385|NCT01559935|41666837|FG000|Maintenance Phase|Remains on study|28|||
19420386|NCT01559935|41666837|FG000|Maintenance Phase|Toxicity|1|||
19420387|NCT01559935|41666837|FG000|Maintenance Phase|Lack of Efficacy|18|||
19420388|NCT01559935|41666837|FG000|Maintenance Phase|Withdrawal by Subject|5|||
19420389|NCT01559935|41666837|FG000|Maintenance Phase|Non-compliance|2|||
19420390|NCT01358877|41666843|FG000|Overall Study|Death|80|||
19420391|NCT01358877|41666844|FG001|Overall Study|Death|89|||
19420392|NCT01358877|41666843|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
19420393|NCT01358877|41666844|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
19420394|NCT01358877|41666843|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
19420395|NCT01358877|41666844|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
19420396|NCT01358877|41666843|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
19420397|NCT01358877|41666844|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
19420398|NCT01358877|41666843|FG000|Overall Study|Other|142|||
19420399|NCT01358877|41666844|FG001|Overall Study|Other|129|||
19420400|NCT00981058|41666852|FG000|Overall Study|Adverse Event|1|||
19420401|NCT00981058|41666853|FG001|Overall Study|Adverse Event|1|||
19420402|NCT00981058|41666852|FG000|Overall Study|Progressive Disease|61|||
19420403|NCT00981058|41666853|FG001|Overall Study|Progressive Disease|49|||
19420404|NCT00981058|41666852|FG000|Overall Study|Lost to Follow-up|16|||
19420405|NCT00981058|41666853|FG001|Overall Study|Lost to Follow-up|15|||
19420406|NCT00981058|41666852|FG000|Overall Study|New Anticancer Therapy|6|||
19420407|NCT00981058|41666853|FG001|Overall Study|New Anticancer Therapy|6|||
19420408|NCT00981058|41666852|FG000|Overall Study|Noncompliance|1|||
19420409|NCT00981058|41666853|FG001|Overall Study|Noncompliance|0|||
19420410|NCT00981058|41666852|FG000|Overall Study|Radiologist Error|0|||
19420411|NCT00981058|41666853|FG001|Overall Study|Radiologist Error|1|||
19420412|NCT00981058|41666852|FG000|Overall Study|Randomization Error|1|||
19420413|NCT00981058|41666853|FG001|Overall Study|Randomization Error|2|||
19420414|NCT00981058|41666852|FG000|Overall Study|Withdrawal by Subject|25|||
19420415|NCT00981058|41666853|FG001|Overall Study|Withdrawal by Subject|23|||
19420416|NCT00981058|41666852|FG000|Overall Study|On study treatment at conclusion|9|||
19420417|NCT00981058|41666853|FG001|Overall Study|On study treatment at conclusion|0|||
19420418|NCT00565851|41666867|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
19420419|NCT00565851|41666868|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
19420420|NCT00565851|41666869|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
19420421|NCT00565851|41666870|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
19420422|NCT00565851|41666871|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
19420423|NCT00565851|41666872|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
19420424|NCT00565851|41666873|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
19519768|NCT01474512|41932299|FG007|Post-Treatment Follow-Up|Death|0|||
19420425|NCT00565851|41666874|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
19420426|NCT00565851|41666867|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
19420427|NCT00565851|41666868|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
19420428|NCT00565851|41666869|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
19420429|NCT00565851|41666870|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
19420430|NCT00565851|41666871|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
19420431|NCT00565851|41666872|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
19420432|NCT00565851|41666873|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
19420433|NCT00565851|41666874|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
19420434|NCT00305227|41666898|FG000|Overall Study|Lost to Follow-up|7|||
19420435|NCT00305227|41666899|FG001|Overall Study|Lost to Follow-up|6|||
19420436|NCT01599793|41666907|FG000|Overall Study|Adverse Event|2|||
19420437|NCT01755598|41666922|FG000|Overall Study|Other|109|||
19420438|NCT01755598|41666923|FG001|Overall Study|Other|109|||
19420439|NCT01755598|41666922|FG000|Overall Study|Lost to Follow-up|32|||
19420440|NCT01755598|41666923|FG001|Overall Study|Lost to Follow-up|43|||
19420441|NCT01755598|41666922|FG000|Overall Study|Migrated/moved from study area|76|||
19420442|NCT01755598|41666923|FG001|Overall Study|Migrated/moved from study area|65|||
19420443|NCT01755598|41666922|FG000|Overall Study|Withdrawal by Subject|22|||
19420444|NCT01755598|41666923|FG001|Overall Study|Withdrawal by Subject|31|||
19420445|NCT01755598|41666922|FG000|Overall Study|Protocol Violation|7|||
19420446|NCT01755598|41666923|FG001|Overall Study|Protocol Violation|7|||
19420447|NCT01755598|41666922|FG000|Overall Study|Adverse Event|19|||
19420448|NCT01755598|41666923|FG001|Overall Study|Adverse Event|28|||
19420449|NCT01606306|41666935|FG000|Overall Study|Lack of Efficacy|2|||
19420450|NCT01606306|41666936|FG001|Overall Study|Lack of Efficacy|1|||
19420451|NCT01606306|41666937|FG002|Overall Study|Lack of Efficacy|4|||
19420452|NCT01606306|41666938|FG003|Overall Study|Lack of Efficacy|4|||
19420453|NCT01606306|41666939|FG004|Overall Study|Lack of Efficacy|1|||
19420454|NCT01606306|41666940|FG005|Overall Study|Lack of Efficacy|2|||
19420455|NCT01606306|41666935|FG000|Overall Study|Adverse Event|1|||
19420456|NCT01606306|41666936|FG001|Overall Study|Adverse Event|0|||
19420457|NCT01606306|41666937|FG002|Overall Study|Adverse Event|1|||
19420458|NCT01606306|41666938|FG003|Overall Study|Adverse Event|1|||
19420459|NCT01606306|41666939|FG004|Overall Study|Adverse Event|2|||
19420460|NCT01606306|41666940|FG005|Overall Study|Adverse Event|0|||
19420461|NCT01606306|41666935|FG000|Overall Study|Lost to Follow-up|7|||
19420462|NCT01606306|41666936|FG001|Overall Study|Lost to Follow-up|4|||
19420463|NCT01606306|41666937|FG002|Overall Study|Lost to Follow-up|5|||
19420464|NCT01606306|41666938|FG003|Overall Study|Lost to Follow-up|4|||
19519769|NCT01474512|41932300|FG008|Post-Treatment Follow-Up|Death|0|||
19519770|NCT01474512|41932301|FG009|Post-Treatment Follow-Up|Death|0|||
19519771|NCT01474512|41932302|FG010|Post-Treatment Follow-Up|Death|0|||
19519772|NCT01474512|41932303|FG011|Post-Treatment Follow-Up|Death|0|||
19519773|NCT01474512|41932304|FG012|Post-Treatment Follow-Up|Death|0|||
19519774|NCT01474512|41932305|FG013|Post-Treatment Follow-Up|Death|0|||
19519775|NCT01474512|41932306|FG014|Post-Treatment Follow-Up|Death|0|||
19519776|NCT01474512|41932307|FG015|Post-Treatment Follow-Up|Death|0|||
19519777|NCT01474512|41932308|FG016|Post-Treatment Follow-Up|Death|1|||
19519778|NCT01474512|41932309|FG017|Post-Treatment Follow-Up|Death|0|||
19519779|NCT01474434|41932343|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
19519780|NCT01474434|41932344|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
19519781|NCT01474434|41932345|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
19519782|NCT01474434|41932346|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
19519783|NCT01474434|41932343|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
19519784|NCT01474434|41932344|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
19519785|NCT01474434|41932345|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
19519786|NCT01474434|41932346|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
19519787|NCT01474434|41932343|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
19519788|NCT01474434|41932344|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
19519789|NCT01474434|41932345|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
19519790|NCT01474434|41932346|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
19519791|NCT01473732|41932362|FG000|Overall Study|Adverse Event|1|||
19519792|NCT01473732|41932363|FG001|Overall Study|Adverse Event|0|||
19519793|NCT01473732|41932362|FG000|Overall Study|Death|1|||
19519794|NCT01473732|41932363|FG001|Overall Study|Death|0|||
19519795|NCT01450098|41932371|FG000|Period 3|Protocol Violation|0|||
19519796|NCT01450098|41932372|FG001|Period 3|Protocol Violation|1|||
19420465|NCT01606306|41666939|FG004|Overall Study|Lost to Follow-up|3|||
19420466|NCT01606306|41666940|FG005|Overall Study|Lost to Follow-up|5|||
19420467|NCT01606306|41666935|FG000|Overall Study|Withdrawal by Subject|4|||
19420468|NCT01606306|41666936|FG001|Overall Study|Withdrawal by Subject|3|||
19420469|NCT01606306|41666937|FG002|Overall Study|Withdrawal by Subject|4|||
19420470|NCT01606306|41666938|FG003|Overall Study|Withdrawal by Subject|4|||
19420471|NCT01606306|41666939|FG004|Overall Study|Withdrawal by Subject|5|||
19420472|NCT01606306|41666940|FG005|Overall Study|Withdrawal by Subject|4|||
19420473|NCT01606306|41666935|FG000|Overall Study|Physician Decision|1|||
19420474|NCT01606306|41666936|FG001|Overall Study|Physician Decision|2|||
19420475|NCT01606306|41666937|FG002|Overall Study|Physician Decision|0|||
19420476|NCT01606306|41666938|FG003|Overall Study|Physician Decision|0|||
19420477|NCT01606306|41666939|FG004|Overall Study|Physician Decision|0|||
19420478|NCT01606306|41666940|FG005|Overall Study|Physician Decision|0|||
19420479|NCT01754194|41666948|FG000|Overall Study|Lost to Follow-up|39|||
19420480|NCT01754194|41666949|FG001|Overall Study|Lost to Follow-up|14|||
19420481|NCT01754194|41666948|FG000|Overall Study|Withdrawal by Subject|4|||
19420482|NCT01754194|41666949|FG001|Overall Study|Withdrawal by Subject|5|||
19420483|NCT01754194|41666948|FG000|Overall Study|Other|9|||
19420484|NCT01754194|41666949|FG001|Overall Study|Other|8|||
19420485|NCT01753570|41666960|FG000|Overall Study|Adverse Event|1|||
19420486|NCT01753570|41666961|FG001|Overall Study|Adverse Event|0|||
19420487|NCT01753570|41666962|FG002|Overall Study|Adverse Event|1|||
19420488|NCT01753570|41666960|FG000|Overall Study|Physician Decision|0|||
19420489|NCT01753570|41666961|FG001|Overall Study|Physician Decision|1|||
19420490|NCT01753570|41666962|FG002|Overall Study|Physician Decision|0|||
19420491|NCT01753570|41666960|FG000|Overall Study|Withdrawal by Subject|1|||
19420492|NCT01753570|41666961|FG001|Overall Study|Withdrawal by Subject|4|||
19420493|NCT01753570|41666962|FG002|Overall Study|Withdrawal by Subject|0|||
19420494|NCT01753336|41666971|FG000|Overall Study|Patient decision|12|||
19420495|NCT01753336|41666971|FG000|Overall Study|Lost to Follow-up|3|||
19420496|NCT01753336|41666971|FG000|Overall Study|Physician Decision|2|||
19420497|NCT01753336|41666971|FG000|Overall Study|Sponsor's decision|2|||
19420498|NCT01753336|41666971|FG000|Overall Study|Withdrawal by Subject|1|||
19420499|NCT01777282|41666980|FG000|Overall Study|Persistent Hyperglycemia|0|||
19420500|NCT01777282|41666981|FG001|Overall Study|Persistent Hyperglycemia|0|||
19420501|NCT01777282|41666982|FG002|Overall Study|Persistent Hyperglycemia|1|||
19420502|NCT01777282|41666983|FG003|Overall Study|Persistent Hyperglycemia|0|||
19420503|NCT01777282|41666984|FG004|Overall Study|Persistent Hyperglycemia|0|||
19420504|NCT01777282|41666980|FG000|Overall Study|New Antidiabetic Medication|0|||
19420505|NCT01777282|41666981|FG001|Overall Study|New Antidiabetic Medication|0|||
19420506|NCT01777282|41666982|FG002|Overall Study|New Antidiabetic Medication|1|||
19420507|NCT01777282|41666983|FG003|Overall Study|New Antidiabetic Medication|0|||
19420508|NCT01777282|41666984|FG004|Overall Study|New Antidiabetic Medication|0|||
19420509|NCT01777282|41666980|FG000|Overall Study|Adverse Event|4|||
19420510|NCT01777282|41666981|FG001|Overall Study|Adverse Event|4|||
19420511|NCT01777282|41666982|FG002|Overall Study|Adverse Event|2|||
19420512|NCT01777282|41666983|FG003|Overall Study|Adverse Event|1|||
19420513|NCT01777282|41666984|FG004|Overall Study|Adverse Event|3|||
19420514|NCT01777282|41666980|FG000|Overall Study|Withdrawal by Subject|4|||
19420515|NCT01777282|41666981|FG001|Overall Study|Withdrawal by Subject|0|||
19420516|NCT01777282|41666982|FG002|Overall Study|Withdrawal by Subject|0|||
19420517|NCT01777282|41666983|FG003|Overall Study|Withdrawal by Subject|1|||
19420518|NCT01777282|41666984|FG004|Overall Study|Withdrawal by Subject|2|||
19420519|NCT01777282|41666980|FG000|Overall Study|Protocol Violation|2|||
19420520|NCT01777282|41666981|FG001|Overall Study|Protocol Violation|0|||
19420521|NCT01777282|41666982|FG002|Overall Study|Protocol Violation|1|||
19420522|NCT01777282|41666983|FG003|Overall Study|Protocol Violation|0|||
19420523|NCT01777282|41666984|FG004|Overall Study|Protocol Violation|2|||
19420524|NCT01777282|41666980|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
19420525|NCT01777282|41666981|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
19420526|NCT01777282|41666982|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
19420527|NCT01777282|41666983|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
19420528|NCT01777282|41666984|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
19420529|NCT01975389|41666998|FG000|Overall Study|Adverse Event|10|||
19420530|NCT01975389|41666999|FG001|Overall Study|Adverse Event|6|||
19420531|NCT01975389|41666998|FG000|Overall Study|Death|61|||
19420532|NCT01975389|41666999|FG001|Overall Study|Death|54|||
19420533|NCT01975389|41666998|FG000|Overall Study|Lost to Follow-up|81|||
19420534|NCT01975389|41666999|FG001|Overall Study|Lost to Follow-up|86|||
19420535|NCT01975389|41666998|FG000|Overall Study|Withdrawal by Subject|90|||
19420536|NCT01975389|41666999|FG001|Overall Study|Withdrawal by Subject|76|||
19420537|NCT01975389|41666998|FG000|Overall Study|Other|6|||
19420538|NCT01975389|41666999|FG001|Overall Study|Other|9|||
19420539|NCT01975389|41666998|FG000|Overall Study|Randomized, not treated|4|||
19420540|NCT01975389|41666999|FG001|Overall Study|Randomized, not treated|5|||
19420541|NCT01946139|41667005|FG000|Overall Study|Withdrawal by Subject|8|||
19420542|NCT01946139|41667005|FG000|Overall Study|ineligible|8|||
19420543|NCT01946139|41667005|FG000|Overall Study|Specimens not available|4|||
19420544|NCT01974141|41667011|FG000|Overall Study|Other Reasons|28|||
19420545|NCT01974141|41667012|FG001|Overall Study|Other Reasons|18|||
19420546|NCT01974141|41667011|FG000|Overall Study|Protocol Violation|2|||
19420547|NCT01974141|41667012|FG001|Overall Study|Protocol Violation|6|||
19420548|NCT01974141|41667011|FG000|Overall Study|Personal Reasons|21|||
19420549|NCT01974141|41667012|FG001|Overall Study|Personal Reasons|20|||
19420550|NCT01974141|41667011|FG000|Overall Study|Lost to Follow-up|38|||
19420551|NCT01974141|41667012|FG001|Overall Study|Lost to Follow-up|29|||
19420552|NCT01974141|41667011|FG000|Overall Study|Pregnancy|3|||
19420553|NCT01974141|41667012|FG001|Overall Study|Pregnancy|3|||
19420554|NCT01974141|41667011|FG000|Overall Study|Lack of Efficacy|0|||
19420555|NCT01974141|41667012|FG001|Overall Study|Lack of Efficacy|1|||
19420556|NCT01974141|41667011|FG000|Overall Study|Adverse Event|4|||
19420557|NCT01974141|41667012|FG001|Overall Study|Adverse Event|5|||
19420558|NCT01945593|41667022|FG000|Overall Study|Adverse Event|0|||
19420559|NCT01945593|41667023|FG001|Overall Study|Adverse Event|0|||
19420560|NCT01945593|41667024|FG002|Overall Study|Adverse Event|0|||
19420561|NCT01945593|41667025|FG003|Overall Study|Adverse Event|5|||
19420562|NCT01945593|41667022|FG000|Overall Study|Physician Decision|0|||
19420563|NCT01945593|41667023|FG001|Overall Study|Physician Decision|0|||
19420564|NCT01945593|41667024|FG002|Overall Study|Physician Decision|1|||
19420565|NCT01945593|41667025|FG003|Overall Study|Physician Decision|1|||
19420566|NCT01945593|41667022|FG000|Overall Study|Withdrawal by Subject|0|||
19420567|NCT01945593|41667023|FG001|Overall Study|Withdrawal by Subject|2|||
19420568|NCT01945593|41667024|FG002|Overall Study|Withdrawal by Subject|0|||
19420569|NCT01945593|41667025|FG003|Overall Study|Withdrawal by Subject|4|||
19420570|NCT01945593|41667022|FG000|Overall Study|Protocol Violation|0|||
19420571|NCT01945593|41667023|FG001|Overall Study|Protocol Violation|2|||
19420572|NCT01945593|41667024|FG002|Overall Study|Protocol Violation|1|||
19420573|NCT01945593|41667025|FG003|Overall Study|Protocol Violation|3|||
19420574|NCT01945593|41667022|FG000|Overall Study|Death|0|||
19420575|NCT01945593|41667023|FG001|Overall Study|Death|0|||
19420576|NCT01945593|41667024|FG002|Overall Study|Death|1|||
19420577|NCT01945593|41667025|FG003|Overall Study|Death|0|||
19420578|NCT01945593|41667022|FG000|Overall Study|Other: Terminated|0|||
19420579|NCT01945593|41667023|FG001|Overall Study|Other: Terminated|0|||
19420580|NCT01945593|41667024|FG002|Overall Study|Other: Terminated|0|||
19420581|NCT01945593|41667025|FG003|Overall Study|Other: Terminated|1|||
19420582|NCT01945593|41667022|FG000|Overall Study|Other: Surgical Procedure|0|||
19420583|NCT01945593|41667023|FG001|Overall Study|Other: Surgical Procedure|2|||
19420584|NCT01945593|41667024|FG002|Overall Study|Other: Surgical Procedure|0|||
19420585|NCT01945593|41667025|FG003|Overall Study|Other: Surgical Procedure|6|||
19420586|NCT01945593|41667022|FG000|Overall Study|Other: Screen Failure|0|||
19420587|NCT01945593|41667023|FG001|Overall Study|Other: Screen Failure|2|||
19420588|NCT01945593|41667024|FG002|Overall Study|Other: Screen Failure|0|||
19420589|NCT01945593|41667025|FG003|Overall Study|Other: Screen Failure|0|||
19420590|NCT01945281|41667042|FG000|Overall Study|Adverse Event|1|||
19420591|NCT01945281|41667043|FG001|Overall Study|Adverse Event|0|||
19420592|NCT01945281|41667042|FG000|Overall Study|Death|3|||
19420593|NCT01945281|41667043|FG001|Overall Study|Death|3|||
19420594|NCT01945281|41667042|FG000|Overall Study|Physician Decision|1|||
19420595|NCT01945281|41667043|FG001|Overall Study|Physician Decision|1|||
19420596|NCT01945281|41667042|FG000|Overall Study|Technical Problems|1|||
19420597|NCT01945281|41667043|FG001|Overall Study|Technical Problems|0|||
19420598|NCT01961349|41667052|FG000|Overall Study|Withdrawal by Subject|1|||
19420599|NCT01961349|41667053|FG001|Overall Study|Withdrawal by Subject|4|||
19420600|NCT01961349|41667054|FG002|Overall Study|Withdrawal by Subject|0|||
19420601|NCT01961349|41667052|FG000|Overall Study|Adverse Event|0|||
19420602|NCT01961349|41667053|FG001|Overall Study|Adverse Event|0|||
19420603|NCT01961349|41667054|FG002|Overall Study|Adverse Event|1|||
19420604|NCT01961349|41667052|FG000|Overall Study|registration error, personal reason etc|2|||
19420605|NCT01961349|41667053|FG001|Overall Study|registration error, personal reason etc|2|||
19420606|NCT01961349|41667054|FG002|Overall Study|registration error, personal reason etc|1|||
19420607|NCT01973595|41667066|FG000|Washout|Withdrawal by Subject|1|||
19420608|NCT01973595|41667067|FG001|Washout|Withdrawal by Subject|0|||
19420609|NCT01973595|41667068|FG002|Washout|Withdrawal by Subject|1|||
19420610|NCT01973595|41667069|FG003|Washout|Withdrawal by Subject|0|||
19420611|NCT01944969|41667080|FG000|Overall Study|Adverse Event|1|||
19420612|NCT01944969|41667080|FG000|Overall Study|Lack of Efficacy|1|||
19420613|NCT01944969|41667080|FG000|Overall Study|Non-compliance with IMP|1|||
19420614|NCT01944969|41667080|FG000|Overall Study|Administrative or other reasons|23|||
19420615|NCT01961115|41667089|FG000|Overall Study|Disease Progression|1|||
19420616|NCT01961115|41667090|FG001|Overall Study|Disease Progression|0|||
19420617|NCT01961115|41667091|FG002|Overall Study|Disease Progression|3|||
19420618|NCT01961115|41667089|FG000|Overall Study|Adverse Event|1|||
19420619|NCT01961115|41667090|FG001|Overall Study|Adverse Event|0|||
19420620|NCT01961115|41667091|FG002|Overall Study|Adverse Event|1|||
19519797|NCT01450098|41932371|FG000|Period 3|Withdrawal by Subject|0|||
19420621|NCT01973439|41667099|FG000|Overall Study|Lost samples from one PK Day|2|||
19420622|NCT01973439|41667099|FG000|Overall Study|Vomiting after commencing once daily|1|||
19420623|NCT01973439|41667099|FG000|Overall Study|PK curve incomplete|2|||
19420624|NCT01973283|41667103|FG000|Overall Study|Lost to Follow-up|4|||
19420625|NCT01943799|41667113|FG000|Overall Study|Lost to Follow-up|0|||
19420626|NCT01943799|41667114|FG001|Overall Study|Lost to Follow-up|1|||
19420627|NCT01943799|41667115|FG002|Overall Study|Lost to Follow-up|1|||
19420628|NCT01943799|41667116|FG003|Overall Study|Lost to Follow-up|0|||
19420629|NCT01943799|41667113|FG000|Overall Study|Protocol Violation|1|||
19420630|NCT01943799|41667114|FG001|Overall Study|Protocol Violation|0|||
19420631|NCT01943799|41667115|FG002|Overall Study|Protocol Violation|0|||
19420632|NCT01943799|41667116|FG003|Overall Study|Protocol Violation|0|||
19420633|NCT01943799|41667113|FG000|Overall Study|Withdrawal by Subject|4|||
19420634|NCT01943799|41667114|FG001|Overall Study|Withdrawal by Subject|2|||
19420635|NCT01943799|41667115|FG002|Overall Study|Withdrawal by Subject|1|||
19420636|NCT01943799|41667116|FG003|Overall Study|Withdrawal by Subject|0|||
19420637|NCT01972659|41667128|FG000|Overall Study|Protocol Violation|2|||
19420638|NCT01972659|41667129|FG001|Overall Study|Protocol Violation|2|||
19420639|NCT01972659|41667128|FG000|Overall Study|problems realted to acceleromyograph|2|||
19420640|NCT01972659|41667129|FG001|Overall Study|problems realted to acceleromyograph|1|||
19420641|NCT01971723|41667137|FG000|Overall Study|Withdrawal by Subject|1|||
19420642|NCT01971723|41667138|FG001|Overall Study|Withdrawal by Subject|1|||
19420643|NCT01971723|41667137|FG000|Overall Study|Protocol Violation|1|||
19420644|NCT01971723|41667138|FG001|Overall Study|Protocol Violation|2|||
19420645|NCT01942785|41667144|FG000|Overall Study|Adverse Event|2|||
19420646|NCT01942785|41667144|FG000|Overall Study|Withdrawal by Subject|1|||
19420647|NCT01942785|41667144|FG000|Overall Study|Protocol Violation|1|||
19420648|NCT01774786|41667152|FG000|Overall Study|Death|300|||
19420649|NCT01774786|41667153|FG001|Overall Study|Death|319|||
19420650|NCT01774786|41667152|FG000|Overall Study|Lost to Follow-up|6|||
19420651|NCT01774786|41667153|FG001|Overall Study|Lost to Follow-up|7|||
19420652|NCT01774786|41667152|FG000|Overall Study|Withdrawal by Subject|18|||
19420653|NCT01774786|41667153|FG001|Overall Study|Withdrawal by Subject|14|||
19420654|NCT01774786|41667152|FG000|Overall Study|Physician Decision|2|||
19420655|NCT01774786|41667153|FG001|Overall Study|Physician Decision|0|||
19420656|NCT01774786|41667152|FG000|Overall Study|Non-compliance|0|||
19420657|NCT01774786|41667153|FG001|Overall Study|Non-compliance|1|||
19420658|NCT01774786|41667152|FG000|Overall Study|Reason Not Specified|2|||
19420659|NCT01774786|41667153|FG001|Overall Study|Reason Not Specified|5|||
19420660|NCT01960725|41667161|FG000|Overall Study|Lost to Follow-up|4|||
19420661|NCT01960725|41667162|FG001|Overall Study|Lost to Follow-up|3|||
19420662|NCT01960725|41667161|FG000|Overall Study|Withdrawal by Subject|1|||
19420663|NCT01960725|41667162|FG001|Overall Study|Withdrawal by Subject|0|||
19420664|NCT01960725|41667161|FG000|Overall Study|unable to obtain blood sample|1|||
19420665|NCT01960725|41667162|FG001|Overall Study|unable to obtain blood sample|2|||
19420666|NCT01942161|41667171|FG000|Overall Study|Adverse Event|1|||
19420667|NCT01942161|41667172|FG001|Overall Study|Adverse Event|2|||
19420668|NCT01942161|41667173|FG002|Overall Study|Adverse Event|5|||
19420669|NCT01942161|41667171|FG000|Overall Study|Physician Decision|3|||
19420670|NCT01942161|41667172|FG001|Overall Study|Physician Decision|1|||
19420671|NCT01942161|41667173|FG002|Overall Study|Physician Decision|0|||
19420672|NCT01942161|41667171|FG000|Overall Study|Protocol Violation|1|||
19420673|NCT01942161|41667172|FG001|Overall Study|Protocol Violation|0|||
19420674|NCT01942161|41667173|FG002|Overall Study|Protocol Violation|0|||
19420675|NCT01942161|41667171|FG000|Overall Study|Withdrawal by Subject|3|||
19420676|NCT01942161|41667172|FG001|Overall Study|Withdrawal by Subject|3|||
19420677|NCT01942161|41667173|FG002|Overall Study|Withdrawal by Subject|1|||
19420678|NCT01971645|41667184|FG000|Overall Study|Adverse Event|1|||
19420679|NCT01971645|41667185|FG001|Overall Study|Adverse Event|0|||
19420680|NCT01971645|41667186|FG002|Overall Study|Adverse Event|0|||
19420681|NCT01971645|41667184|FG000|Overall Study|Lost to Follow-up|1|||
19420682|NCT01971645|41667185|FG001|Overall Study|Lost to Follow-up|0|||
19420683|NCT01971645|41667186|FG002|Overall Study|Lost to Follow-up|1|||
19420684|NCT01971645|41667184|FG000|Overall Study|Protocol Violation|0|||
19420685|NCT01971645|41667185|FG001|Overall Study|Protocol Violation|0|||
19420686|NCT01971645|41667186|FG002|Overall Study|Protocol Violation|1|||
19420687|NCT01941537|41667196|FG000|Overall Study|Lack of Efficacy|1|||
19420688|NCT01941537|41667197|FG001|Overall Study|Lack of Efficacy|2|||
19420689|NCT01941537|41667196|FG000|Overall Study|Lost to Follow-up|1|||
19420690|NCT01941537|41667197|FG001|Overall Study|Lost to Follow-up|0|||
19420691|NCT01941537|41667196|FG000|Overall Study|Pregnancy|1|||
19420692|NCT01941537|41667197|FG001|Overall Study|Pregnancy|0|||
19420693|NCT01941537|41667196|FG000|Overall Study|Adverse Event|1|||
19420694|NCT01941537|41667197|FG001|Overall Study|Adverse Event|0|||
19420695|NCT01941537|41667196|FG000|Overall Study|Withdrawal by Subject|0|||
19420696|NCT01941537|41667197|FG001|Overall Study|Withdrawal by Subject|1|||
19420697|NCT01971567|41667206|FG000|Overall Study|Withdrawal by Subject|3|||
19420698|NCT01971567|41667207|FG001|Overall Study|Withdrawal by Subject|2|||
19420699|NCT01971567|41667206|FG000|Overall Study|Lost to Follow-up|1|||
19420700|NCT01971567|41667207|FG001|Overall Study|Lost to Follow-up|0|||
19420701|NCT01960413|41667215|FG000|Overall Study|Withdrawal by Subject|1|||
19420702|NCT01960413|41667216|FG001|Overall Study|Withdrawal by Subject|1|||
19420703|NCT01960413|41667215|FG000|Overall Study|Physician Decision|1|||
19420704|NCT01960413|41667216|FG001|Overall Study|Physician Decision|0|||
19420705|NCT01960413|41667215|FG000|Overall Study|Lost to Follow-up|2|||
19420706|NCT01960413|41667216|FG001|Overall Study|Lost to Follow-up|0|||
19420707|NCT01970475|41667224|FG000|Overall Study|Withdrawal by Subject|11|||
19420708|NCT01970475|41667225|FG001|Overall Study|Withdrawal by Subject|6|||
19420709|NCT01970475|41667224|FG000|Overall Study|Adverse Event|7|||
19420710|NCT01970475|41667225|FG001|Overall Study|Adverse Event|3|||
19420711|NCT01970475|41667224|FG000|Overall Study|Lost to Follow-up|2|||
19420712|NCT01970475|41667225|FG001|Overall Study|Lost to Follow-up|2|||
19420713|NCT01970475|41667224|FG000|Overall Study|Protocol Violation|1|||
19420714|NCT01970475|41667225|FG001|Overall Study|Protocol Violation|0|||
19420715|NCT01939977|41667233|FG000|Overall Study|Adverse Event|4|||
19420716|NCT01939977|41667234|FG001|Overall Study|Adverse Event|3|||
19420717|NCT01939977|41667233|FG000|Overall Study|Lack of Efficacy|3|||
19420718|NCT01939977|41667234|FG001|Overall Study|Lack of Efficacy|0|||
19420719|NCT01939977|41667233|FG000|Overall Study|Physician Decision|1|||
19420720|NCT01939977|41667234|FG001|Overall Study|Physician Decision|1|||
19420721|NCT01939977|41667233|FG000|Overall Study|Withdrawal by Subject|0|||
19420722|NCT01939977|41667234|FG001|Overall Study|Withdrawal by Subject|2|||
19420723|NCT01939977|41667233|FG000|Overall Study|Did not meet inclusion criteria|1|||
19420724|NCT01939977|41667234|FG001|Overall Study|Did not meet inclusion criteria|0|||
19420725|NCT01939977|41667233|FG000|Overall Study|Did not receive study medication|0|||
19420726|NCT01939977|41667234|FG001|Overall Study|Did not receive study medication|1|||
19420727|NCT01708954|41667243|FG000|Step 1|Disease progression|26|||
19420728|NCT01708954|41667244|FG001|Step 1|Disease progression|17|||
19420729|NCT01708954|41667245|FG002|Step 1|Disease progression|14|||
19420730|NCT01708954|41667243|FG000|Step 1|Adverse Event|3|||
19420731|NCT01708954|41667244|FG001|Step 1|Adverse Event|11|||
19420732|NCT01708954|41667245|FG002|Step 1|Adverse Event|13|||
19420733|NCT01708954|41667243|FG000|Step 1|Death|3|||
19420734|NCT01708954|41667244|FG001|Step 1|Death|2|||
19420735|NCT01708954|41667245|FG002|Step 1|Death|3|||
19420736|NCT01708954|41667243|FG000|Step 1|Withdrawal by Subject|2|||
19420737|NCT01708954|41667244|FG001|Step 1|Withdrawal by Subject|5|||
19420738|NCT01708954|41667245|FG002|Step 1|Withdrawal by Subject|3|||
19420739|NCT01708954|41667243|FG000|Step 1|Other complicating disease|0|||
19420740|NCT01708954|41667244|FG001|Step 1|Other complicating disease|2|||
19420741|NCT01708954|41667245|FG002|Step 1|Other complicating disease|0|||
19420742|NCT01708954|41667243|FG000|Step 1|Crossed over to Step 2|2|||
19420743|NCT01708954|41667244|FG001|Step 1|Crossed over to Step 2|0|||
19420744|NCT01708954|41667245|FG002|Step 1|Crossed over to Step 2|0|||
19420745|NCT01708954|41667243|FG000|Step 1|Symptomatic deterioration|1|||
19420746|NCT01708954|41667244|FG001|Step 1|Symptomatic deterioration|0|||
19420747|NCT01708954|41667245|FG002|Step 1|Symptomatic deterioration|1|||
19420748|NCT01708954|41667243|FG000|Step 1|Off-treatment reason not submitted|1|||
19420749|NCT01708954|41667244|FG001|Step 1|Off-treatment reason not submitted|1|||
19420750|NCT01708954|41667245|FG002|Step 1|Off-treatment reason not submitted|1|||
19420751|NCT01708954|41667243|FG000|Step 1|Ineligible or never received treatment|4|||
19420752|NCT01708954|41667244|FG001|Step 1|Ineligible or never received treatment|2|||
19420753|NCT01708954|41667245|FG002|Step 1|Ineligible or never received treatment|8|||
19420754|NCT01708954|41667243|FG000|Step 2|Disease progression|9|||
19420755|NCT01708954|41667244|FG001|Step 2|Disease progression|4|||
19420756|NCT01708954|41667245|FG002|Step 2|Disease progression|0|||
19420757|NCT01708954|41667243|FG000|Step 2|Adverse Event|3|||
19420758|NCT01708954|41667244|FG001|Step 2|Adverse Event|2|||
19420759|NCT01708954|41667245|FG002|Step 2|Adverse Event|0|||
19420760|NCT01708954|41667243|FG000|Step 2|Withdrawal by Subject|1|||
19420761|NCT01708954|41667244|FG001|Step 2|Withdrawal by Subject|1|||
19420762|NCT01708954|41667245|FG002|Step 2|Withdrawal by Subject|0|||
19420763|NCT01939899|41667259|FG000|Lead-in Dose Finding Phase|Death|0|||
19420764|NCT01939899|41667260|FG001|Lead-in Dose Finding Phase|Death|3|||
19420765|NCT01939899|41667261|FG002|Lead-in Dose Finding Phase|Death|1|||
19420766|NCT01939899|41667262|FG003|Lead-in Dose Finding Phase|Death|0|||
19420767|NCT01939899|41667263|FG004|Lead-in Dose Finding Phase|Death|0|||
19420768|NCT01939899|41667259|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
19420769|NCT01939899|41667260|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
19420770|NCT01939899|41667261|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
19420771|NCT01939899|41667262|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
19420772|NCT01939899|41667263|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
19420773|NCT01939899|41667259|FG000|Lead-in Dose Finding Phase|Other|0|||
19420774|NCT01939899|41667260|FG001|Lead-in Dose Finding Phase|Other|0|||
19420775|NCT01939899|41667261|FG002|Lead-in Dose Finding Phase|Other|1|||
19420776|NCT01939899|41667262|FG003|Lead-in Dose Finding Phase|Other|0|||
19420777|NCT01939899|41667263|FG004|Lead-in Dose Finding Phase|Other|0|||
19420778|NCT01939899|41667259|FG000|Phase 2|Withdrawal by Subject|0|||
19420779|NCT01939899|41667260|FG001|Phase 2|Withdrawal by Subject|0|||
19420780|NCT01939899|41667261|FG002|Phase 2|Withdrawal by Subject|0|||
19420781|NCT01939899|41667262|FG003|Phase 2|Withdrawal by Subject|2|||
19420782|NCT01939899|41667263|FG004|Phase 2|Withdrawal by Subject|0|||
19420783|NCT01939899|41667259|FG000|Phase 2|Disease Progression|0|||
19420784|NCT01939899|41667260|FG001|Phase 2|Disease Progression|0|||
19420785|NCT01939899|41667261|FG002|Phase 2|Disease Progression|0|||
19420786|NCT01939899|41667262|FG003|Phase 2|Disease Progression|9|||
19420787|NCT01939899|41667263|FG004|Phase 2|Disease Progression|1|||
19420788|NCT01970397|41667283|FG000|Overall Study|Adverse Event|0|||
19420789|NCT01970397|41667284|FG001|Overall Study|Adverse Event|1|||
19420790|NCT01970397|41667283|FG000|Overall Study|Lost to Follow-up|0|||
19420791|NCT01970397|41667284|FG001|Overall Study|Lost to Follow-up|1|||
19420792|NCT01970397|41667283|FG000|Overall Study|Personal Reasons|1|||
19420793|NCT01970397|41667284|FG001|Overall Study|Personal Reasons|2|||
19420794|NCT01970397|41667283|FG000|Overall Study|Protocol Violation|1|||
19420795|NCT01970397|41667284|FG001|Overall Study|Protocol Violation|1|||
19420796|NCT01970241|41667292|FG000|Overall Study|Withdrawal by Subject|2|||
19420797|NCT01970241|41667293|FG001|Overall Study|Withdrawal by Subject|0|||
19420798|NCT01970241|41667292|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
19420799|NCT01970241|41667293|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
19420800|NCT01939353|41667301|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
19420801|NCT01939353|41667301|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
19420802|NCT01939353|41667301|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
19420803|NCT01939353|41667301|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
19420804|NCT01939353|41667301|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
19420805|NCT01970007|41667305|FG000|Overall Study|Death|5|||
19420806|NCT01970007|41667305|FG000|Overall Study|Withdrawal by Subject|23|||
19420807|NCT01970007|41667305|FG000|Overall Study|Lost to Follow-up|24|||
19420808|NCT01970007|41667305|FG000|Overall Study|"Other endpoint"|3|||
19420809|NCT01728376|41667315|FG000|Overall Study|Adverse Event|1|||
19420810|NCT01728376|41667316|FG001|Overall Study|Adverse Event|1|||
19420811|NCT01728376|41667317|FG002|Overall Study|Adverse Event|1|||
19420812|NCT01728376|41667318|FG003|Overall Study|Adverse Event|1|||
19420813|NCT01728376|41667319|FG004|Overall Study|Adverse Event|1|||
19420814|NCT01728376|41667320|FG005|Overall Study|Adverse Event|0|||
19420815|NCT01728376|41667315|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
19420816|NCT01728376|41667316|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
19420817|NCT01728376|41667317|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
19420818|NCT01728376|41667318|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
19420819|NCT01728376|41667319|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
19420820|NCT01728376|41667320|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
19420821|NCT01728376|41667315|FG000|Overall Study|No relevant bacteria|2|||
19420822|NCT01728376|41667316|FG001|Overall Study|No relevant bacteria|0|||
19420823|NCT01728376|41667317|FG002|Overall Study|No relevant bacteria|0|||
19420824|NCT01728376|41667318|FG003|Overall Study|No relevant bacteria|0|||
19420825|NCT01728376|41667319|FG004|Overall Study|No relevant bacteria|1|||
19420826|NCT01728376|41667320|FG005|Overall Study|No relevant bacteria|1|||
19420827|NCT01728376|41667315|FG000|Overall Study|Did not receive treatment|0|||
19420828|NCT01728376|41667316|FG001|Overall Study|Did not receive treatment|1|||
19420829|NCT01728376|41667317|FG002|Overall Study|Did not receive treatment|0|||
19420830|NCT01728376|41667318|FG003|Overall Study|Did not receive treatment|0|||
19420831|NCT01728376|41667319|FG004|Overall Study|Did not receive treatment|0|||
19375170|NCT02524730|41616939|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
19375171|NCT01658150|41616943|FG000|Overall Study|Withdrawal by Subject|1|||
19375172|NCT02285998|41616950|FG000|Overall Study|Adverse Event|9|||
19375173|NCT02285998|41616951|FG001|Overall Study|Adverse Event|8|||
19375174|NCT02285998|41616950|FG000|Overall Study|Physician Decision|1|||
19375175|NCT02285998|41616951|FG001|Overall Study|Physician Decision|2|||
19375176|NCT02285998|41616950|FG000|Overall Study|Lost to Follow-up|176|||
19375177|NCT02285998|41616951|FG001|Overall Study|Lost to Follow-up|172|||
19375178|NCT02285998|41616950|FG000|Overall Study|Withdrawal by Subject|53|||
19375179|NCT02285998|41616951|FG001|Overall Study|Withdrawal by Subject|61|||
19375180|NCT02285998|41616950|FG000|Overall Study|Other Reasons|7|||
19375181|NCT02285998|41616951|FG001|Overall Study|Other Reasons|10|||
19375182|NCT01658072|41616959|FG000|Overall Study|Protocol Violation|4|||
19375183|NCT01658072|41616960|FG001|Overall Study|Protocol Violation|2|||
19375184|NCT02285920|41616970|FG000|Overall Study|Kidney transplantation|2|||
19375185|NCT02285920|41616971|FG001|Overall Study|Kidney transplantation|2|||
19375186|NCT02285920|41616972|FG002|Overall Study|Kidney transplantation|2|||
19375187|NCT02285920|41616973|FG003|Overall Study|Kidney transplantation|0|||
19375188|NCT02285920|41616970|FG000|Overall Study|Change to peritoneal dialysis|0|||
19375189|NCT02285920|41616971|FG001|Overall Study|Change to peritoneal dialysis|0|||
19375190|NCT02285920|41616972|FG002|Overall Study|Change to peritoneal dialysis|1|||
19375191|NCT02285920|41616973|FG003|Overall Study|Change to peritoneal dialysis|0|||
19375192|NCT02285920|41616970|FG000|Overall Study|Transfer to non-participating unit|0|||
19375193|NCT02285920|41616971|FG001|Overall Study|Transfer to non-participating unit|1|||
19375194|NCT02285920|41616972|FG002|Overall Study|Transfer to non-participating unit|0|||
19375195|NCT02285920|41616973|FG003|Overall Study|Transfer to non-participating unit|0|||
19375196|NCT02285920|41616970|FG000|Overall Study|Dialysis discontinuation|0|||
19420832|NCT01728376|41667320|FG005|Overall Study|Did not receive treatment|0|||
19420833|NCT01728376|41667315|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
19420834|NCT01728376|41667316|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
19420835|NCT01728376|41667317|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
19420836|NCT01728376|41667318|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
19420837|NCT01728376|41667319|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
19420838|NCT01728376|41667320|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
19420839|NCT01708174|41667337|FG000|Treatment Period|Withdrawal by Subject|1|||
19420840|NCT01708174|41667338|FG001|Treatment Period|Withdrawal by Subject|0|||
19420841|NCT01708174|41667339|FG002|Treatment Period|Withdrawal by Subject|0|||
19420842|NCT01708174|41667337|FG000|Treatment Period|Progressive disease|0|||
19420843|NCT01708174|41667338|FG001|Treatment Period|Progressive disease|1|||
19420844|NCT01708174|41667339|FG002|Treatment Period|Progressive disease|0|||
19420845|NCT01708174|41667337|FG000|Treatment Period|Death|0|||
19420846|NCT01708174|41667338|FG001|Treatment Period|Death|0|||
19420847|NCT01708174|41667339|FG002|Treatment Period|Death|1|||
19420848|NCT01708174|41667337|FG000|Treatment Period|Adverse Event|0|||
19420849|NCT01708174|41667338|FG001|Treatment Period|Adverse Event|1|||
19420850|NCT01708174|41667339|FG002|Treatment Period|Adverse Event|0|||
19420851|NCT02488759|41667354|FG000|Overall Study|Disease progression|74|||
19420852|NCT02488759|41667355|FG001|Overall Study|Disease progression|110|||
19420853|NCT02488759|41667356|FG002|Overall Study|Disease progression|62|||
19420854|NCT02488759|41667357|FG003|Overall Study|Disease progression|7|||
19420855|NCT02488759|41667358|FG004|Overall Study|Disease progression|4|||
19420856|NCT02488759|41667359|FG005|Overall Study|Disease progression|2|||
19420857|NCT02488759|41667354|FG000|Overall Study|Study drug toxicity|11|||
19420858|NCT02488759|41667355|FG001|Overall Study|Study drug toxicity|33|||
19420859|NCT02488759|41667356|FG002|Overall Study|Study drug toxicity|31|||
19420860|NCT02488759|41667357|FG003|Overall Study|Study drug toxicity|0|||
19420861|NCT02488759|41667358|FG004|Overall Study|Study drug toxicity|0|||
19420862|NCT02488759|41667359|FG005|Overall Study|Study drug toxicity|2|||
19420863|NCT02488759|41667354|FG000|Overall Study|Adverse event unrelated to study drug|9|||
19420864|NCT02488759|41667355|FG001|Overall Study|Adverse event unrelated to study drug|11|||
19420865|NCT02488759|41667356|FG002|Overall Study|Adverse event unrelated to study drug|7|||
19420866|NCT02488759|41667357|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19420867|NCT02488759|41667358|FG004|Overall Study|Adverse event unrelated to study drug|1|||
19420868|NCT02488759|41667359|FG005|Overall Study|Adverse event unrelated to study drug|0|||
19420869|NCT02488759|41667354|FG000|Overall Study|Participant request to discontinue study treatment|7|||
19420870|NCT02488759|41667355|FG001|Overall Study|Participant request to discontinue study treatment|8|||
19420871|NCT02488759|41667356|FG002|Overall Study|Participant request to discontinue study treatment|4|||
19420872|NCT02488759|41667357|FG003|Overall Study|Participant request to discontinue study treatment|0|||
19420873|NCT02488759|41667358|FG004|Overall Study|Participant request to discontinue study treatment|0|||
19420874|NCT02488759|41667359|FG005|Overall Study|Participant request to discontinue study treatment|0|||
19420875|NCT02488759|41667354|FG000|Overall Study|Withdrawal by Subject|2|||
19420876|NCT02488759|41667355|FG001|Overall Study|Withdrawal by Subject|0|||
19420877|NCT02488759|41667356|FG002|Overall Study|Withdrawal by Subject|3|||
19420878|NCT02488759|41667357|FG003|Overall Study|Withdrawal by Subject|0|||
19420879|NCT02488759|41667358|FG004|Overall Study|Withdrawal by Subject|0|||
19420880|NCT02488759|41667359|FG005|Overall Study|Withdrawal by Subject|2|||
19420881|NCT02488759|41667354|FG000|Overall Study|Lost to Follow-up|0|||
19420882|NCT02488759|41667355|FG001|Overall Study|Lost to Follow-up|1|||
19420883|NCT02488759|41667356|FG002|Overall Study|Lost to Follow-up|2|||
19420884|NCT02488759|41667357|FG003|Overall Study|Lost to Follow-up|0|||
19420885|NCT02488759|41667358|FG004|Overall Study|Lost to Follow-up|0|||
19420886|NCT02488759|41667359|FG005|Overall Study|Lost to Follow-up|0|||
19420887|NCT02488759|41667354|FG000|Overall Study|Maximum clinical benefit|3|||
19420888|NCT02488759|41667355|FG001|Overall Study|Maximum clinical benefit|0|||
19420889|NCT02488759|41667356|FG002|Overall Study|Maximum clinical benefit|1|||
19420890|NCT02488759|41667357|FG003|Overall Study|Maximum clinical benefit|0|||
19420891|NCT02488759|41667358|FG004|Overall Study|Maximum clinical benefit|0|||
19420892|NCT02488759|41667359|FG005|Overall Study|Maximum clinical benefit|0|||
19420893|NCT02488759|41667354|FG000|Overall Study|Completed treatment|0|||
19420894|NCT02488759|41667355|FG001|Overall Study|Completed treatment|0|||
19420895|NCT02488759|41667356|FG002|Overall Study|Completed treatment|0|||
19420896|NCT02488759|41667357|FG003|Overall Study|Completed treatment|0|||
19420897|NCT02488759|41667358|FG004|Overall Study|Completed treatment|0|||
19420898|NCT02488759|41667359|FG005|Overall Study|Completed treatment|116|||
19420899|NCT02488759|41667354|FG000|Overall Study|Other reasons|5|||
19420900|NCT02488759|41667355|FG001|Overall Study|Other reasons|32|||
19420901|NCT02488759|41667356|FG002|Overall Study|Other reasons|21|||
19420902|NCT02488759|41667357|FG003|Overall Study|Other reasons|1|||
19420903|NCT02488759|41667358|FG004|Overall Study|Other reasons|1|||
19420904|NCT02488759|41667359|FG005|Overall Study|Other reasons|1|||
19420905|NCT01605916|41667378|FG000|Overall Study|Adverse Event|1|||
19420906|NCT01605916|41667379|FG001|Overall Study|Adverse Event|0|||
19420907|NCT01605916|41667380|FG002|Overall Study|Adverse Event|0|||
19420908|NCT01605916|41667381|FG003|Overall Study|Adverse Event|1|||
19420909|NCT01605916|41667382|FG004|Overall Study|Adverse Event|0|||
19420910|NCT01605916|41667378|FG000|Overall Study|Lack of Efficacy|2|||
19420911|NCT01605916|41667379|FG001|Overall Study|Lack of Efficacy|3|||
19420912|NCT01605916|41667380|FG002|Overall Study|Lack of Efficacy|3|||
19420913|NCT01605916|41667381|FG003|Overall Study|Lack of Efficacy|5|||
19420914|NCT01605916|41667382|FG004|Overall Study|Lack of Efficacy|4|||
19420915|NCT01605916|41667378|FG000|Overall Study|Withdrawal by Subject|1|||
19420916|NCT01605916|41667379|FG001|Overall Study|Withdrawal by Subject|1|||
19420917|NCT01605916|41667380|FG002|Overall Study|Withdrawal by Subject|0|||
19420918|NCT01605916|41667381|FG003|Overall Study|Withdrawal by Subject|0|||
19420919|NCT01605916|41667382|FG004|Overall Study|Withdrawal by Subject|2|||
19420920|NCT01635283|41667395|FG000|Overall Study|Tumor Progression|3|||
19420921|NCT01635283|41667395|FG000|Overall Study|Lost to Follow-up|1|||
19420922|NCT01707004|41667402|FG000|Overall Study|Physician Decision|3|||
19628148|NCT00451321|42077530|FG006|Overall Study|Sponsor decision to amend protocol|1|||
19628149|NCT00451321|42077531|FG007|Overall Study|Sponsor decision to amend protocol|3|||
19628150|NCT00802464|42077557|FG000|Month 0 - Month 8|Adverse Event|0|||
19628151|NCT00802464|42077558|FG001|Month 0 - Month 8|Adverse Event|1|||
19519798|NCT01450098|41932372|FG001|Period 3|Withdrawal by Subject|2|||
19519799|NCT01449708|41932387|FG000|Overall Study|Protocol Violation|0|||
19519800|NCT01449708|41932388|FG001|Overall Study|Protocol Violation|1|||
19519801|NCT01449708|41932387|FG000|Overall Study|surgical complication|1|||
19519802|NCT01449708|41932388|FG001|Overall Study|surgical complication|2|||
19519803|NCT01449708|41932387|FG000|Overall Study|respiratory failure|1|||
19519804|NCT01449708|41932388|FG001|Overall Study|respiratory failure|0|||
19519805|NCT01449630|41932406|FG000|Period 1|Physician Decision|1|||
19519806|NCT01449630|41932407|FG001|Period 1|Physician Decision|0|||
19519807|NCT01449630|41932408|FG002|Period 1|Physician Decision|0|||
19519808|NCT01449630|41932409|FG003|Period 1|Physician Decision|1|||
19519809|NCT01449630|41932410|FG004|Period 1|Physician Decision|0|||
19519810|NCT01449630|41932411|FG005|Period 1|Physician Decision|0|||
19519811|NCT01449630|41932412|FG006|Period 1|Physician Decision|0|||
19519812|NCT01449630|41932413|FG007|Period 1|Physician Decision|0|||
19519813|NCT01449630|41932414|FG008|Period 1|Physician Decision|0|||
19519814|NCT01449630|41932406|FG000|Period 1|Sponsor Decision|0|||
19519815|NCT01449630|41932407|FG001|Period 1|Sponsor Decision|0|||
19519816|NCT01449630|41932408|FG002|Period 1|Sponsor Decision|0|||
19519817|NCT01449630|41932409|FG003|Period 1|Sponsor Decision|0|||
19519818|NCT01449630|41932410|FG004|Period 1|Sponsor Decision|0|||
19519819|NCT01449630|41932411|FG005|Period 1|Sponsor Decision|1|||
19519820|NCT01449630|41932412|FG006|Period 1|Sponsor Decision|0|||
19519821|NCT01449630|41932413|FG007|Period 1|Sponsor Decision|0|||
19519822|NCT01449630|41932414|FG008|Period 1|Sponsor Decision|0|||
19519823|NCT01449630|41932406|FG000|Period 2|Sponsor Decision|0|||
19519824|NCT01449630|41932407|FG001|Period 2|Sponsor Decision|0|||
19519825|NCT01449630|41932408|FG002|Period 2|Sponsor Decision|0|||
19519826|NCT01449630|41932409|FG003|Period 2|Sponsor Decision|0|||
19519827|NCT01449630|41932410|FG004|Period 2|Sponsor Decision|0|||
19519828|NCT01449630|41932411|FG005|Period 2|Sponsor Decision|0|||
19519829|NCT01449630|41932412|FG006|Period 2|Sponsor Decision|1|||
19519830|NCT01449630|41932413|FG007|Period 2|Sponsor Decision|0|||
19519831|NCT01449630|41932414|FG008|Period 2|Sponsor Decision|0|||
19519832|NCT01493778|41932436|FG000|Overall Study|Withdrawal by Subject|8|||
19519833|NCT01473420|41932451|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
19519834|NCT01473420|41932452|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
19519835|NCT01473420|41932451|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
19519836|NCT01473420|41932452|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
19519837|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
19519838|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
19519839|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
19519840|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
19519841|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
19519842|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
19519843|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
19519844|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
19628152|NCT00802464|42077559|FG002|Month 0 - Month 8|Adverse Event|1|||
19628153|NCT00802464|42077560|FG003|Month 0 - Month 8|Adverse Event|2|||
19519845|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
19519846|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
19519847|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
19519848|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
19519849|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
19519850|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
19519851|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
19519852|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
19519853|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
19628154|NCT00802464|42077557|FG000|Month 0 - Month 8|Protocol Violation|0|||
19519854|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
19519855|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
19628155|NCT00802464|42077558|FG001|Month 0 - Month 8|Protocol Violation|0|||
19628156|NCT00802464|42077559|FG002|Month 0 - Month 8|Protocol Violation|1|||
19628157|NCT00802464|42077560|FG003|Month 0 - Month 8|Protocol Violation|0|||
19420931|NCT01939197|41667424|FG000|Overall Study|Withdrawal by Subject|1|||
19628158|NCT00802464|42077557|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
19628159|NCT00802464|42077558|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
19628160|NCT00802464|42077559|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
19628161|NCT00802464|42077560|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
19628162|NCT00802464|42077557|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
19628163|NCT00802464|42077558|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
19420932|NCT01939197|41667425|FG001|Overall Study|Withdrawal by Subject|0|||
19420933|NCT01939197|41667426|FG002|Overall Study|Withdrawal by Subject|0|||
19420934|NCT01939197|41667427|FG003|Overall Study|Withdrawal by Subject|0|||
19420935|NCT01939197|41667428|FG004|Overall Study|Withdrawal by Subject|1|||
19420936|NCT01939197|41667429|FG005|Overall Study|Withdrawal by Subject|0|||
19420937|NCT01939197|41667430|FG006|Overall Study|Withdrawal by Subject|0|||
19420938|NCT01939197|41667424|FG000|Overall Study|Lost to Follow-up|0|||
19420939|NCT01939197|41667425|FG001|Overall Study|Lost to Follow-up|1|||
19420940|NCT01939197|41667426|FG002|Overall Study|Lost to Follow-up|0|||
19420941|NCT01939197|41667427|FG003|Overall Study|Lost to Follow-up|1|||
19420942|NCT01939197|41667428|FG004|Overall Study|Lost to Follow-up|3|||
19420943|NCT01939197|41667429|FG005|Overall Study|Lost to Follow-up|1|||
19420944|NCT01939197|41667430|FG006|Overall Study|Lost to Follow-up|2|||
19420945|NCT01969851|41667463|FG000|Overall Study|Adverse Event|0|||
19420946|NCT01969851|41667464|FG001|Overall Study|Adverse Event|0|||
19519856|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
19519857|NCT01473420|41932451|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
19519858|NCT01473420|41932452|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
19519859|NCT01492686|41932466|FG000|Double-blind Phase|Adverse Event|0|||
19519860|NCT01492686|41932467|FG001|Double-blind Phase|Adverse Event|2|||
19519861|NCT01492686|41932466|FG000|Double-blind Phase|Physician Decision|0|||
19519862|NCT01492686|41932467|FG001|Double-blind Phase|Physician Decision|1|||
19519863|NCT01492686|41932466|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19519864|NCT01492686|41932467|FG001|Double-blind Phase|Withdrawal by Subject|2|||
19519865|NCT01492686|41932466|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
19519866|NCT01492686|41932467|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
19519867|NCT01492686|41932466|FG000|Open-label Phase|Adverse Event|1|||
19519868|NCT01492686|41932467|FG001|Open-label Phase|Adverse Event|2|||
19519869|NCT01492686|41932466|FG000|Open-label Phase|Physician Decision|1|||
19519870|NCT01492686|41932467|FG001|Open-label Phase|Physician Decision|0|||
19519871|NCT01492686|41932466|FG000|Open-label Phase|Withdrawal by Subject|6|||
19519872|NCT01492686|41932467|FG001|Open-label Phase|Withdrawal by Subject|7|||
19519873|NCT01492686|41932466|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
19519874|NCT01492686|41932467|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
19519875|NCT01449006|41932477|FG000|Overall Study|Lost to Follow-up|1|||
19519876|NCT01449006|41932478|FG001|Overall Study|Lost to Follow-up|0|||
19519877|NCT01449006|41932477|FG000|Overall Study|Withdrawal by Subject|1|||
19519878|NCT01449006|41932478|FG001|Overall Study|Withdrawal by Subject|0|||
19519879|NCT01449006|41932477|FG000|Overall Study|Protocol Violation|1|||
19519880|NCT01449006|41932478|FG001|Overall Study|Protocol Violation|0|||
19519881|NCT01448850|41932486|FG000|Overall Study|Death|3|||
19519882|NCT01448850|41932487|FG001|Overall Study|Death|6|||
19519883|NCT01448850|41932486|FG000|Overall Study|Withdrawal by Subject|13|||
19519884|NCT01448850|41932487|FG001|Overall Study|Withdrawal by Subject|21|||
19519885|NCT01448850|41932486|FG000|Overall Study|Lost to Follow-up|3|||
19519886|NCT01448850|41932487|FG001|Overall Study|Lost to Follow-up|1|||
19519887|NCT01448850|41932486|FG000|Overall Study|Other|15|||
19519888|NCT01448850|41932487|FG001|Overall Study|Other|12|||
19519889|NCT01491672|41932497|FG000|Overall Study|Lost to Follow-up|0|||
19519890|NCT01491672|41932498|FG001|Overall Study|Lost to Follow-up|4|||
19519891|NCT01491672|41932499|FG002|Overall Study|Lost to Follow-up|1|||
19519892|NCT01491672|41932497|FG000|Overall Study|Withdrawal by Subject|6|||
19519893|NCT01491672|41932498|FG001|Overall Study|Withdrawal by Subject|7|||
19519894|NCT01491672|41932499|FG002|Overall Study|Withdrawal by Subject|0|||
19519895|NCT01491672|41932497|FG000|Overall Study|Adverse Event|8|||
19519896|NCT01491672|41932498|FG001|Overall Study|Adverse Event|10|||
19519897|NCT01491672|41932499|FG002|Overall Study|Adverse Event|4|||
19519898|NCT01491672|41932497|FG000|Overall Study|Disease progression|42|||
19420947|NCT01969851|41667465|FG002|Overall Study|Adverse Event|3|||
19519899|NCT01491672|41932498|FG001|Overall Study|Disease progression|34|||
19519900|NCT01491672|41932499|FG002|Overall Study|Disease progression|6|||
19519901|NCT01491672|41932497|FG000|Overall Study|Protocol deviation|0|||
19519902|NCT01491672|41932498|FG001|Overall Study|Protocol deviation|1|||
19519903|NCT01491672|41932499|FG002|Overall Study|Protocol deviation|0|||
19519904|NCT01491672|41932497|FG000|Overall Study|Death|0|||
19519905|NCT01491672|41932498|FG001|Overall Study|Death|4|||
19519906|NCT01491672|41932499|FG002|Overall Study|Death|0|||
19628164|NCT00802464|42077559|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
19420948|NCT01969851|41667463|FG000|Overall Study|Lack of Efficacy|0|||
19420949|NCT01969851|41667464|FG001|Overall Study|Lack of Efficacy|3|||
19420950|NCT01969851|41667465|FG002|Overall Study|Lack of Efficacy|1|||
19420951|NCT01969851|41667463|FG000|Overall Study|Withdrawal by Subject|1|||
19420952|NCT01969851|41667464|FG001|Overall Study|Withdrawal by Subject|0|||
19420953|NCT01969851|41667465|FG002|Overall Study|Withdrawal by Subject|1|||
19420954|NCT01969851|41667463|FG000|Overall Study|No effective dose in Titration period|0|||
19420955|NCT01969851|41667464|FG001|Overall Study|No effective dose in Titration period|0|||
19420956|NCT01969851|41667465|FG002|Overall Study|No effective dose in Titration period|1|||
19420957|NCT01969851|41667463|FG000|Overall Study|Sponsor decision|0|||
19519907|NCT01447446|41932515|FG000|Overall Study|Death|6|||
19519908|NCT01447446|41932516|FG001|Overall Study|Death|3|||
19519909|NCT01447446|41932517|FG002|Overall Study|Death|2|||
19519910|NCT01447446|41932518|FG003|Overall Study|Death|1|||
19519911|NCT01447446|41932519|FG004|Overall Study|Death|7|||
19519912|NCT01447446|41932520|FG005|Overall Study|Death|0|||
19519913|NCT01447446|41932515|FG000|Overall Study|Adverse Event|3|||
19519914|NCT01447446|41932516|FG001|Overall Study|Adverse Event|0|||
19519915|NCT01447446|41932517|FG002|Overall Study|Adverse Event|1|||
19519916|NCT01447446|41932518|FG003|Overall Study|Adverse Event|0|||
19519917|NCT01447446|41932519|FG004|Overall Study|Adverse Event|2|||
19519918|NCT01447446|41932520|FG005|Overall Study|Adverse Event|0|||
19519919|NCT01447446|41932515|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
19519920|NCT01447446|41932516|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
19519921|NCT01447446|41932517|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
19519922|NCT01447446|41932518|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
19519923|NCT01447446|41932519|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
19519924|NCT01447446|41932520|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
19519925|NCT01447446|41932515|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
19519926|NCT01447446|41932516|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
19519927|NCT01447446|41932517|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
19519928|NCT01447446|41932518|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
19519929|NCT01447446|41932519|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
19519930|NCT01447446|41932520|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
19519931|NCT01447446|41932515|FG000|Overall Study|Administrative/Other|34|||
19519932|NCT01447446|41932516|FG001|Overall Study|Administrative/Other|9|||
19519933|NCT01447446|41932517|FG002|Overall Study|Administrative/Other|10|||
19519934|NCT01447446|41932518|FG003|Overall Study|Administrative/Other|2|||
19519935|NCT01447446|41932519|FG004|Overall Study|Administrative/Other|33|||
19519936|NCT01447446|41932520|FG005|Overall Study|Administrative/Other|4|||
19519937|NCT01447446|41932515|FG000|Overall Study|SVR12 Assessment|13|||
19519938|NCT01447446|41932516|FG001|Overall Study|SVR12 Assessment|1|||
19519939|NCT01447446|41932517|FG002|Overall Study|SVR12 Assessment|2|||
19519940|NCT01447446|41932518|FG003|Overall Study|SVR12 Assessment|1|||
19519941|NCT01447446|41932519|FG004|Overall Study|SVR12 Assessment|5|||
19519942|NCT01447446|41932520|FG005|Overall Study|SVR12 Assessment|5|||
19519943|NCT01447446|41932515|FG000|Overall Study|New Treatment Started|8|||
19519944|NCT01447446|41932516|FG001|Overall Study|New Treatment Started|2|||
19519945|NCT01447446|41932517|FG002|Overall Study|New Treatment Started|1|||
19519946|NCT01447446|41932518|FG003|Overall Study|New Treatment Started|0|||
19519947|NCT01447446|41932519|FG004|Overall Study|New Treatment Started|2|||
19519948|NCT01447446|41932520|FG005|Overall Study|New Treatment Started|0|||
19519949|NCT01447446|41932515|FG000|Overall Study|Reason not Specified|1|||
19519950|NCT01447446|41932516|FG001|Overall Study|Reason not Specified|1|||
19519951|NCT01447446|41932517|FG002|Overall Study|Reason not Specified|1|||
19519952|NCT01447446|41932518|FG003|Overall Study|Reason not Specified|1|||
19519953|NCT01447446|41932519|FG004|Overall Study|Reason not Specified|1|||
19519954|NCT01447446|41932520|FG005|Overall Study|Reason not Specified|0|||
19519955|NCT01490814|41932542|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
19519956|NCT01490814|41932543|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
19519957|NCT01490814|41932542|FG000|Overall Study|Physician Decision|1|||
19519958|NCT01490814|41932543|FG001|Overall Study|Physician Decision|0|||
19519959|NCT01490814|41932542|FG000|Overall Study|Withdrawal by Subject|0|||
19519960|NCT01490814|41932543|FG001|Overall Study|Withdrawal by Subject|5|||
19519961|NCT01471782|41932555|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
19628165|NCT00802464|42077560|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
19628166|NCT00802464|42077557|FG000|Month 0 - Month 8|Other|0|||
19519962|NCT01471782|41932556|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
19519963|NCT01471782|41932557|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
19519964|NCT01471782|41932558|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
19519965|NCT01471782|41932559|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
19519966|NCT01471782|41932560|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
19519967|NCT01471782|41932555|FG000|Overall Study|Lack of Efficacy|1|||
19628167|NCT00802464|42077558|FG001|Month 0 - Month 8|Other|0|||
19519968|NCT01471782|41932556|FG001|Overall Study|Lack of Efficacy|2|||
19420958|NCT01969851|41667464|FG001|Overall Study|Sponsor decision|0|||
19420959|NCT01969851|41667465|FG002|Overall Study|Sponsor decision|1|||
19420960|NCT01938573|41667473|FG000|Overall Study|Lack of Efficacy|1|||
19420961|NCT01938573|41667474|FG001|Overall Study|Lack of Efficacy|0|||
19420962|NCT01938573|41667473|FG000|Overall Study|Operation at other hospital|1|||
19420963|NCT01938573|41667474|FG001|Overall Study|Operation at other hospital|0|||
19420964|NCT01937871|41667482|FG000|Overall Study|Adverse Event|6|||
19420965|NCT01937871|41667483|FG001|Overall Study|Adverse Event|6|||
19420966|NCT01937871|41667484|FG002|Overall Study|Adverse Event|2|||
19420967|NCT01937871|41667482|FG000|Overall Study|Lost to Follow-up|8|||
19420968|NCT01937871|41667483|FG001|Overall Study|Lost to Follow-up|2|||
19420969|NCT01937871|41667484|FG002|Overall Study|Lost to Follow-up|4|||
19420970|NCT01937871|41667482|FG000|Overall Study|Withdrawal by Subject|9|||
19628168|NCT00802464|42077559|FG002|Month 0 - Month 8|Other|1|||
19628169|NCT00802464|42077560|FG003|Month 0 - Month 8|Other|0|||
19628170|NCT00802464|42077557|FG000|Month 8 - Month 14|Adverse Event|0|||
19628171|NCT00802464|42077558|FG001|Month 8 - Month 14|Adverse Event|1|||
19628172|NCT00802464|42077559|FG002|Month 8 - Month 14|Adverse Event|0|||
19628173|NCT00802464|42077560|FG003|Month 8 - Month 14|Adverse Event|0|||
19628174|NCT00802464|42077557|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
19628175|NCT00802464|42077558|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
19628176|NCT00802464|42077559|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
19628177|NCT00802464|42077560|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
19420971|NCT01937871|41667483|FG001|Overall Study|Withdrawal by Subject|6|||
19420972|NCT01937871|41667484|FG002|Overall Study|Withdrawal by Subject|4|||
19420973|NCT01937871|41667482|FG000|Overall Study|Physician Decision|0|||
19420974|NCT01937871|41667483|FG001|Overall Study|Physician Decision|1|||
19420975|NCT01937871|41667484|FG002|Overall Study|Physician Decision|0|||
19420976|NCT01937871|41667482|FG000|Overall Study|Entry Criteria Not Met|1|||
19420977|NCT01937871|41667483|FG001|Overall Study|Entry Criteria Not Met|2|||
19420978|NCT01937871|41667484|FG002|Overall Study|Entry Criteria Not Met|1|||
19711122|NCT03603496|42154313|FG000|Overall Study|Lost to Follow-up|141|||
19711123|NCT03603496|42154314|FG001|Overall Study|Lost to Follow-up|141|||
19711124|NCT03603496|42154313|FG000|Overall Study|Withdrawal by Subject|26|||
19711125|NCT03603496|42154314|FG001|Overall Study|Withdrawal by Subject|20|||
19711126|NCT03603028|42154320|FG000|Overall Study|Withdrawal by Subject|1|||
19711127|NCT03602482|42154326|FG000|Overall Study|Withdrawal by Subject|6|||
19711128|NCT03602482|42154327|FG001|Overall Study|Withdrawal by Subject|7|||
19519969|NCT01471782|41932557|FG002|Overall Study|Lack of Efficacy|1|||
19519970|NCT01471782|41932558|FG003|Overall Study|Lack of Efficacy|1|||
19519971|NCT01471782|41932559|FG004|Overall Study|Lack of Efficacy|5|||
19519972|NCT01471782|41932560|FG005|Overall Study|Lack of Efficacy|18|||
19519973|NCT01471782|41932555|FG000|Overall Study|Adverse Event|1|||
19519974|NCT01471782|41932556|FG001|Overall Study|Adverse Event|1|||
19519975|NCT01471782|41932557|FG002|Overall Study|Adverse Event|2|||
19519976|NCT01471782|41932558|FG003|Overall Study|Adverse Event|2|||
19519977|NCT01471782|41932559|FG004|Overall Study|Adverse Event|3|||
19519978|NCT01471782|41932560|FG005|Overall Study|Adverse Event|1|||
19519979|NCT01471782|41932555|FG000|Overall Study|Other|0|||
19519980|NCT01471782|41932556|FG001|Overall Study|Other|0|||
19519981|NCT01471782|41932557|FG002|Overall Study|Other|1|||
19519982|NCT01471782|41932558|FG003|Overall Study|Other|1|||
19519983|NCT01471782|41932559|FG004|Overall Study|Other|6|||
19519984|NCT01471782|41932560|FG005|Overall Study|Other|5|||
19519985|NCT01471782|41932555|FG000|Overall Study|Change of Chemotherapy|1|||
19519986|NCT01471782|41932556|FG001|Overall Study|Change of Chemotherapy|1|||
19519987|NCT01471782|41932557|FG002|Overall Study|Change of Chemotherapy|0|||
19519988|NCT01471782|41932558|FG003|Overall Study|Change of Chemotherapy|0|||
19519989|NCT01471782|41932559|FG004|Overall Study|Change of Chemotherapy|1|||
19519990|NCT01471782|41932560|FG005|Overall Study|Change of Chemotherapy|4|||
19519991|NCT01471782|41932555|FG000|Overall Study|Disease Relapse|0|||
19519992|NCT01471782|41932556|FG001|Overall Study|Disease Relapse|0|||
19519993|NCT01471782|41932557|FG002|Overall Study|Disease Relapse|0|||
19519994|NCT01471782|41932558|FG003|Overall Study|Disease Relapse|1|||
19519995|NCT01471782|41932559|FG004|Overall Study|Disease Relapse|2|||
19628178|NCT00802464|42077557|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
19711129|NCT03602482|42154328|FG002|Overall Study|Withdrawal by Subject|0|||
19711130|NCT03602482|42154329|FG003|Overall Study|Withdrawal by Subject|0|||
19711131|NCT00096135|42154344|FG000|Overall Study|Physician Decision|20|||
19711132|NCT00096135|42154345|FG001|Overall Study|Physician Decision|4|||
19711133|NCT00096135|42154344|FG000|Overall Study|Refusal of further protocol therapy|4|||
19519996|NCT01471782|41932560|FG005|Overall Study|Disease Relapse|1|||
19519997|NCT01471782|41932555|FG000|Overall Study|Physician Decision|0|||
19519998|NCT01471782|41932556|FG001|Overall Study|Physician Decision|0|||
19519999|NCT01471782|41932557|FG002|Overall Study|Physician Decision|0|||
19520000|NCT01471782|41932558|FG003|Overall Study|Physician Decision|0|||
19520001|NCT01471782|41932559|FG004|Overall Study|Physician Decision|3|||
19520002|NCT01471782|41932560|FG005|Overall Study|Physician Decision|8|||
19628179|NCT00802464|42077558|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
19420995|NCT01269463|41667525|FG000|First Intervention|Withdrawal by Subject|1|||
19420996|NCT01269463|41667526|FG001|First Intervention|Withdrawal by Subject|0|||
19420997|NCT01269463|41667525|FG000|First Intervention|Adverse Event|1|||
19420998|NCT01269463|41667526|FG001|First Intervention|Adverse Event|0|||
19420999|NCT01269463|41667525|FG000|First Intervention|Lack of Efficacy|0|||
19421000|NCT01269463|41667526|FG001|First Intervention|Lack of Efficacy|1|||
19421001|NCT01269463|41667525|FG000|First Intervention|Physician Decision|0|||
19421002|NCT01269463|41667526|FG001|First Intervention|Physician Decision|1|||
19421003|NCT01706926|41667541|FG000|Overall Study|Lost to Follow-up|0|||
19421004|NCT01706926|41667542|FG001|Overall Study|Lost to Follow-up|0|||
19421005|NCT01706926|41667543|FG002|Overall Study|Lost to Follow-up|1|||
19421006|NCT01706926|41667544|FG003|Overall Study|Lost to Follow-up|0|||
19421007|NCT01706926|41667541|FG000|Overall Study|Withdrawal by Subject|2|||
19421008|NCT01706926|41667542|FG001|Overall Study|Withdrawal by Subject|0|||
19421009|NCT01706926|41667543|FG002|Overall Study|Withdrawal by Subject|1|||
19421010|NCT01706926|41667544|FG003|Overall Study|Withdrawal by Subject|2|||
19421011|NCT01706926|41667541|FG000|Overall Study|Other|4|||
19421012|NCT01706926|41667542|FG001|Overall Study|Other|4|||
19421013|NCT01706926|41667543|FG002|Overall Study|Other|4|||
19421014|NCT01706926|41667544|FG003|Overall Study|Other|3|||
19421015|NCT01634113|41667560|FG000|Overall Study|Not treated|0|||
19421016|NCT01634113|41667561|FG001|Overall Study|Not treated|0|||
19421017|NCT01634113|41667562|FG002|Overall Study|Not treated|1|||
19421018|NCT01706770|41667572|FG000|Overall Study|Lost to Follow-up|1|||
19421019|NCT01706770|41667573|FG001|Overall Study|Lost to Follow-up|0|||
19421020|NCT01706770|41667572|FG000|Overall Study|Physician Decision|1|||
19421021|NCT01706770|41667573|FG001|Overall Study|Physician Decision|0|||
19421022|NCT01937715|41667584|FG000|Overall Study|Death|0|||
19421023|NCT01937715|41667585|FG001|Overall Study|Death|0|||
19421024|NCT01937715|41667586|FG002|Overall Study|Death|0|||
19421025|NCT01937715|41667587|FG003|Overall Study|Death|1|||
19421026|NCT01937715|41667588|FG004|Overall Study|Death|0|||
19421027|NCT01937715|41667584|FG000|Overall Study|Withdrawal by Subject|0|||
19421028|NCT01937715|41667585|FG001|Overall Study|Withdrawal by Subject|1|||
19421029|NCT01937715|41667586|FG002|Overall Study|Withdrawal by Subject|0|||
19421030|NCT01937715|41667587|FG003|Overall Study|Withdrawal by Subject|0|||
19421031|NCT01937715|41667588|FG004|Overall Study|Withdrawal by Subject|2|||
19421032|NCT01937715|41667584|FG000|Overall Study|Other|0|||
19421033|NCT01937715|41667585|FG001|Overall Study|Other|0|||
19421034|NCT01937715|41667586|FG002|Overall Study|Other|0|||
19421035|NCT01937715|41667587|FG003|Overall Study|Other|3|||
19421036|NCT01937715|41667588|FG004|Overall Study|Other|0|||
19421037|NCT01937559|41667603|FG000|Overall Study|Physician Decision|3|||
19421038|NCT01937559|41667604|FG001|Overall Study|Physician Decision|3|||
19421039|NCT01937559|41667605|FG002|Overall Study|Physician Decision|0|||
19421040|NCT01937559|41667603|FG000|Overall Study|Withdrawal by Subject|6|||
19421041|NCT01937559|41667604|FG001|Overall Study|Withdrawal by Subject|4|||
19421042|NCT01937559|41667605|FG002|Overall Study|Withdrawal by Subject|0|||
19421043|NCT01937559|41667603|FG000|Overall Study|screen fail|2|||
19421044|NCT01937559|41667604|FG001|Overall Study|screen fail|4|||
19421045|NCT01937559|41667605|FG002|Overall Study|screen fail|0|||
19421046|NCT01960257|41667617|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
19421047|NCT01960257|41667618|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
19421048|NCT01960257|41667619|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
19421049|NCT01960257|41667617|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
19421050|NCT01960257|41667618|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
19421051|NCT01960257|41667619|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
19421052|NCT01960257|41667617|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
19421053|NCT01960257|41667618|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
19421054|NCT01960257|41667619|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
19421055|NCT01918371|41667631|FG000|Overall Study|Missing Data|1|||
19421056|NCT01918371|41667632|FG001|Overall Study|Missing Data|1|||
19421057|NCT01917747|41667640|FG000|Overall Study|Withdrawal by Subject|1|||
19421058|NCT01917747|41667641|FG001|Overall Study|Withdrawal by Subject|2|||
19421059|NCT01917747|41667640|FG000|Overall Study|Lost to Follow-up|18|||
19628180|NCT00802464|42077559|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
19628181|NCT00802464|42077560|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
19421060|NCT01917747|41667641|FG001|Overall Study|Lost to Follow-up|9|||
19421061|NCT01597791|41667653|FG000|Overall Study|Physician Decision|2|||
19421062|NCT01597791|41667654|FG001|Overall Study|Physician Decision|1|||
19421063|NCT01597791|41667653|FG000|Overall Study|Cesarean Section|6|||
19421064|NCT01597791|41667654|FG001|Overall Study|Cesarean Section|7|||
19421065|NCT01597791|41667653|FG000|Overall Study|Subject withdrawal|0|||
19421066|NCT01597791|41667654|FG001|Overall Study|Subject withdrawal|1|||
19421067|NCT01597791|41667653|FG000|Overall Study|Protocol Violation|0|||
19628182|NCT00450619|42077574|FG000|Overall Study|refused treatment after randomization|2|||
19628183|NCT00450619|42077575|FG001|Overall Study|refused treatment after randomization|0|||
19628184|NCT00450619|42077574|FG000|Overall Study|did not progress; refused further trmt|1|||
19628185|NCT00450619|42077575|FG001|Overall Study|did not progress; refused further trmt|1|||
19421068|NCT01597791|41667654|FG001|Overall Study|Protocol Violation|1|||
19421069|NCT01916967|41667663|FG000|Overall Study|Adverse Event|0|||
19421070|NCT01916967|41667664|FG001|Overall Study|Adverse Event|0|||
19421071|NCT01916967|41667665|FG002|Overall Study|Adverse Event|2|||
19421072|NCT01916967|41667663|FG000|Overall Study|Lack of Efficacy|0|||
19421073|NCT01916967|41667664|FG001|Overall Study|Lack of Efficacy|0|||
19421074|NCT01916967|41667665|FG002|Overall Study|Lack of Efficacy|6|||
19421075|NCT01916967|41667663|FG000|Overall Study|Physician Decision|0|||
19421076|NCT01916967|41667664|FG001|Overall Study|Physician Decision|0|||
19421077|NCT01916967|41667665|FG002|Overall Study|Physician Decision|1|||
19421078|NCT01916967|41667663|FG000|Overall Study|Protocol Violation|0|||
19421079|NCT01916967|41667664|FG001|Overall Study|Protocol Violation|1|||
19421080|NCT01916967|41667665|FG002|Overall Study|Protocol Violation|0|||
19421081|NCT01936623|41667677|FG000|Overall Study|Lost to Follow-up|0|||
19421082|NCT01936623|41667678|FG001|Overall Study|Lost to Follow-up|5|||
19421083|NCT01959243|41667686|FG000|Overall Study|Investigator Decision|3|||
19421084|NCT01959243|41667687|FG001|Overall Study|Investigator Decision|0|||
19421085|NCT01959243|41667686|FG000|Overall Study|Adverse Event|5|||
19421086|NCT01959243|41667687|FG001|Overall Study|Adverse Event|2|||
19421087|NCT01959243|41667686|FG000|Overall Study|Administrative reasons|2|||
19421088|NCT01959243|41667687|FG001|Overall Study|Administrative reasons|1|||
19421089|NCT01959243|41667686|FG000|Overall Study|Lost to Follow-up|3|||
19421090|NCT01959243|41667687|FG001|Overall Study|Lost to Follow-up|1|||
19421091|NCT01959165|41667697|FG000|Overall Study|Adverse Event|0|||
19421092|NCT01959165|41667698|FG001|Overall Study|Adverse Event|0|||
19421093|NCT01959165|41667699|FG002|Overall Study|Adverse Event|0|||
19421094|NCT01959165|41667700|FG003|Overall Study|Adverse Event|1|||
19421095|NCT01959165|41667697|FG000|Overall Study|Lack of Efficacy|1|||
19421096|NCT01959165|41667698|FG001|Overall Study|Lack of Efficacy|0|||
19421097|NCT01959165|41667699|FG002|Overall Study|Lack of Efficacy|0|||
19421098|NCT01959165|41667700|FG003|Overall Study|Lack of Efficacy|0|||
19421099|NCT01959165|41667697|FG000|Overall Study|overdose|0|||
19421100|NCT01959165|41667698|FG001|Overall Study|overdose|0|||
19421101|NCT01959165|41667699|FG002|Overall Study|overdose|0|||
19421102|NCT01959165|41667700|FG003|Overall Study|overdose|1|||
19421103|NCT01959165|41667697|FG000|Overall Study|Welfare recipient|0|||
19421104|NCT01959165|41667698|FG001|Overall Study|Welfare recipient|1|||
19421105|NCT01959165|41667699|FG002|Overall Study|Welfare recipient|0|||
19421106|NCT01959165|41667700|FG003|Overall Study|Welfare recipient|0|||
19421107|NCT01916109|41667710|FG000|Overall Study|Withdrawal by Subject|1|||
19421108|NCT01915095|41667721|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
19421109|NCT01915095|41667722|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
19421110|NCT01915095|41667723|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
19421111|NCT01915095|41667724|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
19421112|NCT01915095|41667725|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
19421113|NCT01958619|41667750|FG000|Overall Study|Protocol Violation|2|||
19421114|NCT01958619|41667751|FG001|Overall Study|Protocol Violation|0|||
19421115|NCT01958619|41667752|FG002|Overall Study|Protocol Violation|1|||
19421116|NCT01958619|41667753|FG003|Overall Study|Protocol Violation|0|||
19421117|NCT01752634|41667769|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
19421118|NCT01752634|41667770|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
19421119|NCT01752634|41667771|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
19421120|NCT01752634|41667772|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
19421121|NCT01752634|41667773|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
19421122|NCT01752634|41667774|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
19421123|NCT01752634|41667769|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
19421124|NCT01752634|41667770|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
19421125|NCT01752634|41667771|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
19421126|NCT01752634|41667772|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
19421127|NCT01752634|41667773|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
19421128|NCT01752634|41667774|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
19421129|NCT01752634|41667769|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
19421130|NCT01752634|41667770|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
19421131|NCT01752634|41667771|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
19421132|NCT01752634|41667772|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
19421133|NCT01752634|41667773|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
19421134|NCT01752634|41667774|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
19421135|NCT01752634|41667769|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
19421136|NCT01752634|41667770|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
19421137|NCT01752634|41667771|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
19421138|NCT01752634|41667772|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
19421139|NCT01752634|41667773|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
19421140|NCT01752634|41667774|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
19421141|NCT01752634|41667769|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
19421142|NCT01752634|41667770|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
19421143|NCT01752634|41667771|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
19421144|NCT01752634|41667772|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
19421145|NCT01752634|41667773|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
19421146|NCT01752634|41667774|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
19421147|NCT01752634|41667769|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
19421148|NCT01752634|41667770|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
19421149|NCT01752634|41667771|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
19421150|NCT01752634|41667772|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
19421151|NCT01752634|41667773|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
19421152|NCT01752634|41667774|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
19520003|NCT01471782|41932555|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19520004|NCT01471782|41932556|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19520005|NCT01471782|41932557|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
19520006|NCT01471782|41932558|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
19520007|NCT01471782|41932559|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
19520008|NCT01471782|41932560|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
19520009|NCT01471782|41932555|FG000|Overall Study|Death|0|||
19520010|NCT01471782|41932556|FG001|Overall Study|Death|0|||
19520011|NCT01471782|41932557|FG002|Overall Study|Death|0|||
19520012|NCT01471782|41932558|FG003|Overall Study|Death|0|||
19520013|NCT01471782|41932559|FG004|Overall Study|Death|0|||
19520014|NCT01471782|41932560|FG005|Overall Study|Death|1|||
19520015|NCT01490580|41932587|FG000|Overall Study|Parents withdrew consent|0|||
19520016|NCT01490580|41932588|FG001|Overall Study|Parents withdrew consent|2|||
19421153|NCT01752634|41667769|FG000|Week 24 to Week 260|Physician Decision|1|||
19421154|NCT01752634|41667770|FG001|Week 24 to Week 260|Physician Decision|2|||
19421155|NCT01752634|41667771|FG002|Week 24 to Week 260|Physician Decision|4|||
19421156|NCT01752634|41667772|FG003|Week 24 to Week 260|Physician Decision|2|||
19421157|NCT01752634|41667773|FG004|Week 24 to Week 260|Physician Decision|1|||
19421158|NCT01752634|41667774|FG005|Week 24 to Week 260|Physician Decision|0|||
19421159|NCT01752634|41667769|FG000|Week 24 to Week 260|Death|0|||
19421160|NCT01752634|41667770|FG001|Week 24 to Week 260|Death|1|||
19421161|NCT01752634|41667771|FG002|Week 24 to Week 260|Death|0|||
19421162|NCT01752634|41667772|FG003|Week 24 to Week 260|Death|0|||
19421163|NCT01752634|41667773|FG004|Week 24 to Week 260|Death|0|||
19421164|NCT01752634|41667774|FG005|Week 24 to Week 260|Death|0|||
19421165|NCT01752634|41667769|FG000|Week 24 to Week 260|Pregnancy|0|||
19421166|NCT01752634|41667770|FG001|Week 24 to Week 260|Pregnancy|0|||
19421167|NCT01752634|41667771|FG002|Week 24 to Week 260|Pregnancy|1|||
19421168|NCT01752634|41667772|FG003|Week 24 to Week 260|Pregnancy|0|||
19421169|NCT01752634|41667773|FG004|Week 24 to Week 260|Pregnancy|0|||
19421170|NCT01752634|41667774|FG005|Week 24 to Week 260|Pregnancy|0|||
19421171|NCT01752634|41667769|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
19421172|NCT01752634|41667770|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
19421173|NCT01752634|41667771|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
19421174|NCT01752634|41667772|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
19421175|NCT01752634|41667773|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
19421176|NCT01752634|41667774|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
19421177|NCT01752634|41667769|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
19421178|NCT01752634|41667770|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
19421179|NCT01752634|41667771|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
19421180|NCT01752634|41667772|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
19421181|NCT01752634|41667773|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
19421182|NCT01752634|41667774|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
19421183|NCT01752634|41667769|FG000|Week 24 to Week 260|Adverse Event|4|||
19421184|NCT01752634|41667770|FG001|Week 24 to Week 260|Adverse Event|8|||
19421185|NCT01752634|41667771|FG002|Week 24 to Week 260|Adverse Event|8|||
19421186|NCT01752634|41667772|FG003|Week 24 to Week 260|Adverse Event|4|||
19421187|NCT01752634|41667773|FG004|Week 24 to Week 260|Adverse Event|2|||
19421188|NCT01752634|41667774|FG005|Week 24 to Week 260|Adverse Event|0|||
19421189|NCT01933113|41667784|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
19421190|NCT01726270|41667788|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
19421191|NCT01726270|41667788|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
19421192|NCT01726270|41667788|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
19421193|NCT01726270|41667788|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
19421194|NCT01726270|41667788|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
19520017|NCT01490190|41932598|FG000|Overall Study|Withdrawal by Subject|9|||
19520018|NCT01490190|41932598|FG000|Overall Study|Adverse Event|17|||
19520019|NCT01490190|41932598|FG000|Overall Study|Protocol Violation|5|||
19421195|NCT01726270|41667788|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
19421196|NCT00942331|41667796|FG000|Overall Study|Did not start treatment|15|||
19421197|NCT00942331|41667797|FG001|Overall Study|Did not start treatment|22|||
19421198|NCT01914393|41667806|FG000|Overall Study|Protocol Violation|11|||
19520020|NCT01490190|41932598|FG000|Overall Study|Lost to Follow-up|13|||
19520021|NCT01490190|41932598|FG000|Overall Study|Relocation|1|||
19421199|NCT01914393|41667807|FG001|Overall Study|Protocol Violation|3|||
19421200|NCT01914393|41667808|FG002|Overall Study|Protocol Violation|19|||
19421201|NCT01914393|41667806|FG000|Overall Study|Lack of Efficacy|11|||
19421202|NCT01914393|41667807|FG001|Overall Study|Lack of Efficacy|16|||
19421203|NCT01914393|41667808|FG002|Overall Study|Lack of Efficacy|5|||
19421204|NCT01914393|41667806|FG000|Overall Study|no reason given|14|||
19421205|NCT01914393|41667807|FG001|Overall Study|no reason given|8|||
19421206|NCT01914393|41667808|FG002|Overall Study|no reason given|16|||
19421207|NCT01914393|41667806|FG000|Overall Study|Adverse Event|29|||
19421208|NCT01914393|41667807|FG001|Overall Study|Adverse Event|18|||
19421209|NCT01914393|41667808|FG002|Overall Study|Adverse Event|31|||
19421210|NCT01914393|41667806|FG000|Overall Study|Withdrawal by Subject|38|||
19421211|NCT01914393|41667807|FG001|Overall Study|Withdrawal by Subject|20|||
19421212|NCT01914393|41667808|FG002|Overall Study|Withdrawal by Subject|47|||
19421213|NCT01914393|41667806|FG000|Overall Study|Lost to Follow-up|12|||
19421214|NCT01914393|41667807|FG001|Overall Study|Lost to Follow-up|6|||
19421215|NCT01914393|41667808|FG002|Overall Study|Lost to Follow-up|19|||
19421216|NCT01914393|41667806|FG000|Overall Study|subject never dosed|0|||
19421217|NCT01914393|41667807|FG001|Overall Study|subject never dosed|0|||
19421218|NCT01914393|41667808|FG002|Overall Study|subject never dosed|1|||
19421219|NCT01931865|41667820|FG000|Overall Study|Lost to Follow-up|2|||
19421220|NCT01931865|41667820|FG000|Overall Study|Withdrawal by Subject|2|||
19421221|NCT01617447|41667827|FG000|Overall Study|Adverse Event|0|||
19421222|NCT01617447|41667828|FG001|Overall Study|Adverse Event|1|||
19421223|NCT01617447|41667827|FG000|Overall Study|Physician Decision|0|||
19421224|NCT01617447|41667828|FG001|Overall Study|Physician Decision|2|||
19421225|NCT00432679|41667836|FG000|Overall Study|Adverse Event|2|||
19421226|NCT00432679|41667837|FG001|Overall Study|Adverse Event|1|||
19421227|NCT00432679|41667836|FG000|Overall Study|Withdrawal by Subject|3|||
19421228|NCT00432679|41667837|FG001|Overall Study|Withdrawal by Subject|2|||
19421229|NCT01600105|41667845|FG000|Total Participants|Withdrawal by Subject|1|||
19421230|NCT01600105|41667846|FG001|Total Participants|Withdrawal by Subject|0|||
19421231|NCT01600105|41667845|FG000|Total Participants|No images in PACS|10|||
19421232|NCT01600105|41667846|FG001|Total Participants|No images in PACS|0|||
19421233|NCT01600105|41667845|FG000|Total Participants|Insufficient image quality|30|||
19421234|NCT01600105|41667846|FG001|Total Participants|Insufficient image quality|10|||
19421235|NCT01600105|41667845|FG000|Sub Study I|Insufficient image quality|0|||
19421236|NCT01600105|41667846|FG001|Sub Study I|Insufficient image quality|10|||
19421237|NCT01600105|41667845|FG000|Sub Study II|Withdrawal by Subject|1|||
19421238|NCT01600105|41667846|FG001|Sub Study II|Withdrawal by Subject|0|||
19421239|NCT01600105|41667845|FG000|Sub Study II|No images in PACS|1|||
19421240|NCT01600105|41667846|FG001|Sub Study II|No images in PACS|0|||
19421241|NCT01600105|41667845|FG000|Sub Study II|Insufficient image quality|3|||
19421242|NCT01600105|41667846|FG001|Sub Study II|Insufficient image quality|0|||
19421243|NCT01600105|41667845|FG000|Sub Study III|Insufficient image quality|5|||
19421244|NCT01600105|41667846|FG001|Sub Study III|Insufficient image quality|0|||
19421245|NCT01600105|41667845|FG000|Sub Study V|Poor Image Quality|2|||
19421246|NCT01600105|41667846|FG001|Sub Study V|Poor Image Quality|0|||
19421247|NCT02246647|41667858|FG000|Overall Study|Withdrawal by Subject|1|||
19421248|NCT02246647|41667859|FG001|Overall Study|Withdrawal by Subject|1|||
19421249|NCT02244619|41667881|FG000|Overall Study|Did not receive study intervention|8|||
19421250|NCT02244619|41667882|FG001|Overall Study|Did not receive study intervention|21|||
19421251|NCT02243371|41667890|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
19421252|NCT02243371|41667891|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
19421253|NCT02243371|41667890|FG000|Overall Study|Death (unrelated)|2|||
19421254|NCT02243371|41667891|FG001|Overall Study|Death (unrelated)|4|||
19421255|NCT02243371|41667890|FG000|Overall Study|Adverse Event (unrelated)|0|||
19421256|NCT02243371|41667891|FG001|Overall Study|Adverse Event (unrelated)|1|||
19421257|NCT02243371|41667890|FG000|Overall Study|Lack of Clinical Benefit|0|||
19421258|NCT02243371|41667891|FG001|Overall Study|Lack of Clinical Benefit|1|||
19421259|NCT02243371|41667890|FG000|Overall Study|Withdrawal by Subject|0|||
19421260|NCT02243371|41667891|FG001|Overall Study|Withdrawal by Subject|2|||
19421261|NCT01931475|41667899|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
19421262|NCT01931475|41667900|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
19421263|NCT01931475|41667899|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
19421264|NCT01931475|41667900|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
19421265|NCT01931475|41667899|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
19421266|NCT01931475|41667900|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
19421267|NCT01931475|41667899|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
19421268|NCT01931475|41667900|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
19421269|NCT01931475|41667899|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
19421270|NCT01931475|41667900|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
19421271|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
19421272|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
19421273|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
19421274|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
19421275|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
19421276|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
19421277|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
19421278|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
19421279|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
19421280|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
19421281|NCT01931475|41667899|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
19421282|NCT01931475|41667900|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
19421283|NCT01931397|41667911|FG000|Overall Study|Physician Decision|2|||
19421284|NCT01931397|41667911|FG000|Overall Study|Withdrawal by Subject|8|||
19421285|NCT01931397|41667911|FG000|Overall Study|moved out of state|1|||
19421286|NCT01929993|41667921|FG000|Overall Study|Protocol Violation|4|||
19421287|NCT01929993|41667922|FG001|Overall Study|Protocol Violation|6|||
19421288|NCT01929993|41667921|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
19421289|NCT01929993|41667922|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
19421290|NCT01912599|41667930|FG000|Overall Study|Withdrawal by Subject|0|||
19421291|NCT01912599|41667931|FG001|Overall Study|Withdrawal by Subject|1|||
19520022|NCT01490190|41932598|FG000|Overall Study|Inconvenience|1|||
19520023|NCT01490190|41932598|FG000|Overall Study|Ring expulsion|2|||
19520024|NCT01446042|41932605|FG000|Overall Study|Withdrawal by Subject|12|||
19520025|NCT01446042|41932606|FG001|Overall Study|Withdrawal by Subject|2|||
19520026|NCT01446042|41932607|FG002|Overall Study|Withdrawal by Subject|4|||
19520027|NCT01446042|41932605|FG000|Overall Study|Adverse Event|1|||
19520028|NCT01446042|41932606|FG001|Overall Study|Adverse Event|0|||
19520029|NCT01446042|41932607|FG002|Overall Study|Adverse Event|4|||
19520030|NCT01446042|41932605|FG000|Overall Study|Lost to Follow-up|5|||
19520031|NCT01446042|41932606|FG001|Overall Study|Lost to Follow-up|0|||
19520032|NCT01446042|41932607|FG002|Overall Study|Lost to Follow-up|0|||
19520033|NCT01446042|41932605|FG000|Overall Study|Other reasons|2|||
19520034|NCT01446042|41932606|FG001|Overall Study|Other reasons|1|||
19520035|NCT01446042|41932607|FG002|Overall Study|Other reasons|1|||
19520036|NCT01445886|41932615|FG000|Overall Study|Lost to Follow-up|2|||
19520037|NCT01445886|41932615|FG000|Overall Study|Protocol Violation|3|||
19520038|NCT01470612|41932623|FG000|Overall Study|Adverse Event|20|||
19520039|NCT01470612|41932624|FG001|Overall Study|Adverse Event|80|||
19520040|NCT01470612|41932623|FG000|Overall Study|Death|0|||
19520041|NCT01470612|41932624|FG001|Overall Study|Death|1|||
19520042|NCT01470612|41932623|FG000|Overall Study|Lack of Efficacy|20|||
19520043|NCT01470612|41932624|FG001|Overall Study|Lack of Efficacy|326|||
19520044|NCT01470612|41932623|FG000|Overall Study|Lost to Follow-up|2|||
19520045|NCT01470612|41932624|FG001|Overall Study|Lost to Follow-up|5|||
19520046|NCT01470612|41932623|FG000|Overall Study|Did not meet entrance criteria|0|||
19520047|NCT01470612|41932624|FG001|Overall Study|Did not meet entrance criteria|1|||
19520048|NCT01470612|41932623|FG000|Overall Study|Pregnancy|2|||
19520049|NCT01470612|41932624|FG001|Overall Study|Pregnancy|10|||
19520050|NCT01470612|41932623|FG000|Overall Study|Protocol Violation|2|||
19520051|NCT01470612|41932624|FG001|Overall Study|Protocol Violation|7|||
19520052|NCT01470612|41932623|FG000|Overall Study|Withdrawal by Subject|24|||
19520053|NCT01470612|41932624|FG001|Overall Study|Withdrawal by Subject|79|||
19520054|NCT01470612|41932623|FG000|Overall Study|Other|14|||
19520055|NCT01470612|41932624|FG001|Overall Study|Other|156|||
19520056|NCT01445730|41932630|FG000|Overall Study|Adverse Event|1|||
19520057|NCT01445730|41932630|FG000|Overall Study|For the advice of a dentist|1|||
19520058|NCT01445730|41932630|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
19520059|NCT01445652|41932636|FG000|Overall Study|Not comfortable in lenses|5|||
19520060|NCT01445652|41932637|FG001|Overall Study|Not comfortable in lenses|0|||
19520061|NCT01445652|41932636|FG000|Overall Study|Failed to attend scheduled visit|2|||
19520062|NCT01445652|41932637|FG001|Overall Study|Failed to attend scheduled visit|3|||
19520063|NCT01445652|41932636|FG000|Overall Study|Failed teach session|2|||
19520064|NCT01445652|41932637|FG001|Overall Study|Failed teach session|0|||
19520065|NCT01445652|41932636|FG000|Overall Study|Adverse Event|1|||
19520066|NCT01445652|41932637|FG001|Overall Study|Adverse Event|0|||
19520067|NCT01440816|41932645|FG000|Overall Study|Disease Progression|0|||
19520068|NCT01440816|41932646|FG001|Overall Study|Disease Progression|9|||
19628186|NCT00450619|42077574|FG000|Overall Study|Adverse Event|1|||
19421292|NCT01929681|41667939|FG000|Overall Study|Withdrawal by Subject|1|||
19421293|NCT01929681|41667940|FG001|Overall Study|Withdrawal by Subject|0|||
19421294|NCT01929681|41667939|FG000|Overall Study|Physician Decision|1|||
19520069|NCT01440816|41932645|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
19520070|NCT01440816|41932646|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
19520071|NCT01470144|41932654|FG000|Overall Study|Adverse Event|2|||
19520072|NCT01470144|41932654|FG000|Overall Study|Death|1|||
19520073|NCT01470144|41932654|FG000|Overall Study|Lung transplant|6|||
19421295|NCT01929681|41667940|FG001|Overall Study|Physician Decision|1|||
19421296|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
19421297|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
19421298|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
19421299|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
19421300|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421301|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421302|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421303|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421304|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421305|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421306|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421307|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
19421308|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
19421309|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
19421310|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
19421311|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
19421312|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421313|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421314|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421315|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421316|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421317|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421318|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421319|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
19421320|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
19421321|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
19421322|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
19421323|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
19421324|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421325|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421326|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421327|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421328|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421329|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421330|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421331|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
19421332|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
19421333|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
19421334|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
19421335|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
19421336|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421337|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421338|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421339|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421340|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421341|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421342|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421343|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
19421344|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421345|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421346|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
19421347|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
19421348|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421349|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421350|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421351|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421352|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421353|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421354|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421355|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
19421356|NCT01646177|41667950|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
19421357|NCT01646177|41667951|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
19520074|NCT01470144|41932654|FG000|Overall Study|Patient's and investigator's decision|1|||
19520075|NCT01443858|41932661|FG000|Overall Study|Withdrawal by Subject|9|||
19421358|NCT01646177|41667952|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
19421359|NCT01646177|41667953|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421360|NCT01646177|41667954|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421361|NCT01646177|41667955|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421362|NCT01646177|41667956|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421363|NCT01646177|41667957|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421364|NCT01646177|41667958|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421365|NCT01646177|41667959|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421366|NCT01646177|41667960|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421367|NCT01646177|41667961|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
19421368|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421369|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421370|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421371|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421372|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
19421373|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
19421374|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
19421375|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
19421376|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421377|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421378|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421379|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
19421380|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421381|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421382|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421383|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421384|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
19421385|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
19421386|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
19421387|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
19421388|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421389|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421390|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421391|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
19421392|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421393|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421394|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421395|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421396|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
19421397|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
19421398|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
19421399|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
19421400|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421401|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421402|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421403|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
19421404|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421405|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421406|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421407|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421408|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
19421409|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
19421410|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
19421411|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
19421412|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421413|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421414|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421415|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
19421416|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421417|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421418|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421419|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19520076|NCT01443858|41932662|FG001|Overall Study|Withdrawal by Subject|8|||
19520077|NCT01443858|41932663|FG002|Overall Study|Withdrawal by Subject|5|||
19421420|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
19421421|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
19421422|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
19421423|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
19421424|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421425|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421426|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421427|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
19421428|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421429|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421430|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421431|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421432|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
19421433|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
19421434|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421435|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
19421436|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421437|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421438|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421439|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
19421440|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421441|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421442|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421443|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421444|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
19421445|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
19421446|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
19421447|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
19421448|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421449|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421450|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421451|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
19421452|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
19421453|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
19421454|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
19421455|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
19421456|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
19421457|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
19421458|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
19421459|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
19421460|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
19421461|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
19421462|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
19421463|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
19421464|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421465|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421466|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421467|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421468|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
19421469|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
19421470|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
19421471|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
19421472|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421473|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421474|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421475|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
19421476|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421477|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421478|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421479|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421480|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421481|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421482|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421483|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
19421484|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421485|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421486|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421487|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
19421488|NCT01646177|41667950|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421489|NCT01646177|41667951|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421490|NCT01646177|41667952|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421491|NCT01646177|41667953|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421492|NCT01646177|41667954|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421493|NCT01646177|41667955|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
19421494|NCT01646177|41667956|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
19421495|NCT01646177|41667957|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
19421496|NCT01646177|41667958|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421497|NCT01646177|41667959|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421498|NCT01646177|41667960|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421499|NCT01646177|41667961|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
19421500|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421501|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421502|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421503|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421504|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421505|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421506|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421507|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
19421508|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
19421509|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
19421510|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
19421511|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
19421512|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421513|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421514|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421515|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421516|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421517|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421518|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421519|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
19421520|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
19421521|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
19421522|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
19421523|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
19421524|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421525|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421526|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421527|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421528|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421529|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421530|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421531|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
19421532|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
19421533|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
19421534|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
19421535|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
19421536|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421537|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421538|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421539|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421540|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421541|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421542|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421543|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
19421544|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
19421545|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
19421546|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
19520078|NCT01443858|41932661|FG000|Overall Study|Lack of Efficacy|1|||
19421547|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
19421548|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421549|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421550|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421551|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421552|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421553|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421554|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421555|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
19421556|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
19421557|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
19421558|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
19421559|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
19421560|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421561|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421562|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421563|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421564|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421565|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421566|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421567|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
19421568|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
19421569|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
19421570|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
19421571|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
19421572|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421573|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421574|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421575|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421576|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421577|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421578|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421579|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421580|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
19421581|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
19421582|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
19421583|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
19421584|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421585|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421586|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421587|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421588|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421589|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421590|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421591|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421592|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
19421593|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
19421594|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
19421595|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
19421596|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421597|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421598|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421599|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421600|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421601|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421602|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421603|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421604|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
19421605|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
19421606|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
19421607|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
19421608|NCT01646177|41667950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421609|NCT01646177|41667951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421610|NCT01646177|41667952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421611|NCT01646177|41667953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421612|NCT01646177|41667954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421613|NCT01646177|41667955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421614|NCT01646177|41667956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421615|NCT01646177|41667957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421616|NCT01646177|41667958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421617|NCT01646177|41667959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
19421618|NCT01646177|41667960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
19421619|NCT01646177|41667961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
19421620|NCT01912287|41667984|FG000|Overall Study|Ineligible|1|||
19421621|NCT01912287|41667985|FG001|Overall Study|Ineligible|0|||
19421622|NCT01912287|41667986|FG002|Overall Study|Ineligible|1|||
19421623|NCT01912287|41667984|FG000|Overall Study|No-show|0|||
19421624|NCT01912287|41667985|FG001|Overall Study|No-show|0|||
19421625|NCT01912287|41667986|FG002|Overall Study|No-show|1|||
19421626|NCT01912287|41667984|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
19421627|NCT01912287|41667985|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
19421628|NCT01912287|41667986|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
19421629|NCT01912287|41667984|FG000|Overall Study|Felt treatment no longer needed|0|||
19421630|NCT01912287|41667985|FG001|Overall Study|Felt treatment no longer needed|1|||
19421631|NCT01912287|41667986|FG002|Overall Study|Felt treatment no longer needed|0|||
19421632|NCT01912287|41667984|FG000|Overall Study|Life circumstances|4|||
19421633|NCT01912287|41667985|FG001|Overall Study|Life circumstances|2|||
19421634|NCT01912287|41667986|FG002|Overall Study|Life circumstances|0|||
19421635|NCT01912287|41667984|FG000|Overall Study|Lost Interest|1|||
19421636|NCT01912287|41667985|FG001|Overall Study|Lost Interest|0|||
19421637|NCT01912287|41667986|FG002|Overall Study|Lost Interest|0|||
19421638|NCT01912287|41667984|FG000|Overall Study|Uknown reason - subject drop out|5|||
19421639|NCT01912287|41667985|FG001|Overall Study|Uknown reason - subject drop out|7|||
19421640|NCT01912287|41667986|FG002|Overall Study|Uknown reason - subject drop out|3|||
19421641|NCT01912287|41667984|FG000|Overall Study|Missed Assesment|1|||
19421642|NCT01912287|41667985|FG001|Overall Study|Missed Assesment|1|||
19421643|NCT01912287|41667986|FG002|Overall Study|Missed Assesment|1|||
19421644|NCT01912287|41667984|FG000|Overall Study|Scheduling/change in availability|17|||
19421645|NCT01912287|41667985|FG001|Overall Study|Scheduling/change in availability|10|||
19421646|NCT01912287|41667986|FG002|Overall Study|Scheduling/change in availability|8|||
19421647|NCT01929135|41667996|FG000|Overall Study|Lost to Follow-up|1|||
19421648|NCT01929135|41667997|FG001|Overall Study|Lost to Follow-up|1|||
19421649|NCT01911819|41668008|FG000|Overall Study|Adverse Event|0|||
19421650|NCT01911819|41668009|FG001|Overall Study|Adverse Event|1|||
19421651|NCT01911819|41668010|FG002|Overall Study|Adverse Event|0|||
19421652|NCT01911819|41668008|FG000|Overall Study|Withdrawal by Subject|1|||
19421653|NCT01911819|41668009|FG001|Overall Study|Withdrawal by Subject|1|||
19421654|NCT01911819|41668010|FG002|Overall Study|Withdrawal by Subject|0|||
19421655|NCT02280863|41668020|FG000|Integrated Platform|Met stopping criteria|0|||
19421656|NCT02280863|41668021|FG001|Integrated Platform|Met stopping criteria|1|||
19421657|NCT01911429|41668034|FG000|Overall Study|Adverse Event|5|||
19421658|NCT01911429|41668035|FG001|Overall Study|Adverse Event|3|||
19421659|NCT01911429|41668036|FG002|Overall Study|Adverse Event|9|||
19421660|NCT01911429|41668034|FG000|Overall Study|Lack of Efficacy|1|||
19421661|NCT01911429|41668035|FG001|Overall Study|Lack of Efficacy|2|||
19421662|NCT01911429|41668036|FG002|Overall Study|Lack of Efficacy|4|||
19421663|NCT01911429|41668034|FG000|Overall Study|Lost to Follow-up|0|||
19421664|NCT01911429|41668035|FG001|Overall Study|Lost to Follow-up|0|||
19421665|NCT01911429|41668036|FG002|Overall Study|Lost to Follow-up|1|||
19421666|NCT01911429|41668034|FG000|Overall Study|Protocol Violation|0|||
19421667|NCT01911429|41668035|FG001|Overall Study|Protocol Violation|0|||
19421668|NCT01911429|41668036|FG002|Overall Study|Protocol Violation|1|||
19421669|NCT01911429|41668034|FG000|Overall Study|Withdrawal by Subject|5|||
19421670|NCT01911429|41668035|FG001|Overall Study|Withdrawal by Subject|5|||
19421671|NCT01911429|41668036|FG002|Overall Study|Withdrawal by Subject|4|||
19421672|NCT01911429|41668034|FG000|Overall Study|Accidental randomization|0|||
19421673|NCT01911429|41668035|FG001|Overall Study|Accidental randomization|0|||
19421674|NCT01911429|41668036|FG002|Overall Study|Accidental randomization|1|||
19421675|NCT01911429|41668034|FG000|Overall Study|subject left study|1|||
19421676|NCT01911429|41668035|FG001|Overall Study|subject left study|0|||
19421677|NCT01911429|41668036|FG002|Overall Study|subject left study|0|||
19421678|NCT02324465|41668046|FG000|Overall Study|device failure|0|||
19421679|NCT02324465|41668047|FG001|Overall Study|device failure|1|||
19421680|NCT02324153|41668055|FG000|Overall Study|Withdrawal by Subject|4|||
19421681|NCT02324153|41668056|FG001|Overall Study|Withdrawal by Subject|1|||
19421682|NCT02324153|41668055|FG000|Overall Study|Surgery postponed after randomization|3|||
19421683|NCT02324153|41668056|FG001|Overall Study|Surgery postponed after randomization|0|||
19421684|NCT02324153|41668055|FG000|Overall Study|Developed delirium preoperatively|1|||
19421685|NCT02324153|41668056|FG001|Overall Study|Developed delirium preoperatively|0|||
19421686|NCT02280473|41668064|FG000|Overall Study|Adverse Event|1|||
19421687|NCT02280473|41668065|FG001|Overall Study|Adverse Event|1|||
19421688|NCT02280473|41668064|FG000|Overall Study|Lack of Efficacy|0|||
19421689|NCT02280473|41668065|FG001|Overall Study|Lack of Efficacy|1|||
19421690|NCT02280473|41668064|FG000|Overall Study|Lost to Follow-up|0|||
19421691|NCT02280473|41668065|FG001|Overall Study|Lost to Follow-up|1|||
19421692|NCT01911273|41668073|FG000|Overall Study|Progression of Disease|1|||
19421693|NCT01911273|41668074|FG001|Overall Study|Progression of Disease|0|||
19421694|NCT01911273|41668073|FG000|Overall Study|Withdrawal by Subject|0|||
19421695|NCT01911273|41668074|FG001|Overall Study|Withdrawal by Subject|2|||
19421696|NCT02308007|41668083|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
19421697|NCT02308007|41668084|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
19421698|NCT02308007|41668085|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
19421699|NCT02308007|41668083|FG000|Overall Study|Positive for STD at Baseline|7|||
19421700|NCT02308007|41668084|FG001|Overall Study|Positive for STD at Baseline|11|||
19421701|NCT02308007|41668085|FG002|Overall Study|Positive for STD at Baseline|7|||
19421702|NCT02308007|41668083|FG000|Overall Study|Lost to Follow-up|3|||
19421703|NCT02308007|41668084|FG001|Overall Study|Lost to Follow-up|0|||
19421704|NCT02308007|41668085|FG002|Overall Study|Lost to Follow-up|1|||
19421705|NCT02278367|41668095|FG000|Overall Study|Physician Decision|5|||
19421706|NCT02278367|41668096|FG001|Overall Study|Physician Decision|0|||
19421707|NCT02278367|41668095|FG000|Overall Study|Withdrawal by Subject|5|||
19421708|NCT02278367|41668096|FG001|Overall Study|Withdrawal by Subject|0|||
19421709|NCT01910181|41668102|FG000|Overall Study|Death|37|||
19421710|NCT01910181|41668102|FG000|Overall Study|Lost to Follow-up|3|||
19421711|NCT01910181|41668102|FG000|Overall Study|Study Terminated by Sponsor|6|||
19421712|NCT01957215|41668109|FG000|Overall Study|Adverse Event|2|||
19421713|NCT01957215|41668110|FG001|Overall Study|Adverse Event|2|||
19421714|NCT01957215|41668109|FG000|Overall Study|Lost to Follow-up|3|||
19421715|NCT01957215|41668110|FG001|Overall Study|Lost to Follow-up|3|||
19421716|NCT01957215|41668109|FG000|Overall Study|Protocol Violation|1|||
19421717|NCT01957215|41668110|FG001|Overall Study|Protocol Violation|2|||
19421718|NCT01957215|41668109|FG000|Overall Study|Withdrawal by Subject|7|||
19421719|NCT01957215|41668110|FG001|Overall Study|Withdrawal by Subject|5|||
19421720|NCT02322749|41668120|FG000|Period 2|Adverse Event|0|||
19421721|NCT02322749|41668121|FG001|Period 2|Adverse Event|0|||
19421722|NCT02322749|41668122|FG002|Period 2|Adverse Event|0|||
19421723|NCT02322749|41668123|FG003|Period 2|Adverse Event|1|||
19421724|NCT02322749|41668124|FG004|Period 2|Adverse Event|0|||
19421725|NCT02322749|41668125|FG005|Period 2|Adverse Event|0|||
19421726|NCT02322749|41668120|FG000|Period 2|Withdrawal by Subject|0|||
19421727|NCT02322749|41668121|FG001|Period 2|Withdrawal by Subject|0|||
19421728|NCT02322749|41668122|FG002|Period 2|Withdrawal by Subject|0|||
19421729|NCT02322749|41668123|FG003|Period 2|Withdrawal by Subject|1|||
19421730|NCT02322749|41668124|FG004|Period 2|Withdrawal by Subject|0|||
19421731|NCT02322749|41668125|FG005|Period 2|Withdrawal by Subject|0|||
19421732|NCT02322749|41668120|FG000|Period 3|Withdrawal by Subject|0|||
19421733|NCT02322749|41668121|FG001|Period 3|Withdrawal by Subject|0|||
19421734|NCT02322749|41668122|FG002|Period 3|Withdrawal by Subject|1|||
19421735|NCT02322749|41668123|FG003|Period 3|Withdrawal by Subject|0|||
19421736|NCT02322749|41668124|FG004|Period 3|Withdrawal by Subject|0|||
19421737|NCT02322749|41668125|FG005|Period 3|Withdrawal by Subject|0|||
19421738|NCT01957137|41668134|FG000|Randomized Portion|Adverse Event|1|||
19421739|NCT01957137|41668134|FG000|Randomized Portion|Withdrawal by Subject|1|||
19421740|NCT01928433|41668149|FG000|Overall Study|Adverse Event|5|||
19421741|NCT01928433|41668150|FG001|Overall Study|Adverse Event|2|||
19421742|NCT01928433|41668151|FG002|Overall Study|Adverse Event|5|||
19421743|NCT01928433|41668149|FG000|Overall Study|Protocol Violation|0|||
19421744|NCT01928433|41668150|FG001|Overall Study|Protocol Violation|0|||
19421745|NCT01928433|41668151|FG002|Overall Study|Protocol Violation|2|||
19421746|NCT01928433|41668149|FG000|Overall Study|Lack of Efficacy|5|||
19421747|NCT01928433|41668150|FG001|Overall Study|Lack of Efficacy|4|||
19421748|NCT01928433|41668151|FG002|Overall Study|Lack of Efficacy|4|||
19421749|NCT01928433|41668149|FG000|Overall Study|Withdrawal by Subject|0|||
19421750|NCT01928433|41668150|FG001|Overall Study|Withdrawal by Subject|4|||
19421751|NCT01928433|41668151|FG002|Overall Study|Withdrawal by Subject|0|||
19421752|NCT01928433|41668149|FG000|Overall Study|Negative screening urine culture|7|||
19421753|NCT01928433|41668150|FG001|Overall Study|Negative screening urine culture|6|||
19421754|NCT01928433|41668151|FG002|Overall Study|Negative screening urine culture|10|||
19421755|NCT01928433|41668149|FG000|Overall Study|Lost to Follow-up|0|||
19421756|NCT01928433|41668150|FG001|Overall Study|Lost to Follow-up|2|||
19421757|NCT01928433|41668151|FG002|Overall Study|Lost to Follow-up|3|||
19421758|NCT01928433|41668149|FG000|Overall Study|Other reasons|3|||
19628187|NCT00450619|42077575|FG001|Overall Study|Adverse Event|0|||
19421759|NCT01928433|41668150|FG001|Overall Study|Other reasons|3|||
19421760|NCT01928433|41668151|FG002|Overall Study|Other reasons|4|||
19421761|NCT02322281|41668165|FG000|Overall Study|Progressive Disease|42|||
19421762|NCT02322281|41668166|FG001|Overall Study|Progressive Disease|14|||
19421763|NCT02322281|41668167|FG002|Overall Study|Progressive Disease|49|||
19421764|NCT02322281|41668165|FG000|Overall Study|Adverse Event|3|||
19628188|NCT00802074|42077588|FG000|Overall Study|Adverse Event|1|||
19421765|NCT02322281|41668166|FG001|Overall Study|Adverse Event|4|||
19421766|NCT02322281|41668167|FG002|Overall Study|Adverse Event|6|||
19421767|NCT02322281|41668165|FG000|Overall Study|Death|3|||
19421768|NCT02322281|41668166|FG001|Overall Study|Death|3|||
19421769|NCT02322281|41668167|FG002|Overall Study|Death|3|||
19421770|NCT02322281|41668165|FG000|Overall Study|Withdrawal by Subject|1|||
19421771|NCT02322281|41668166|FG001|Overall Study|Withdrawal by Subject|1|||
19421772|NCT02322281|41668167|FG002|Overall Study|Withdrawal by Subject|6|||
19421773|NCT02322281|41668165|FG000|Overall Study|Physician Decision|2|||
19421774|NCT02322281|41668166|FG001|Overall Study|Physician Decision|0|||
19421775|NCT02322281|41668167|FG002|Overall Study|Physician Decision|5|||
19421776|NCT02322281|41668165|FG000|Overall Study|Study Terminated by Sponsor|2|||
19421777|NCT02322281|41668166|FG001|Overall Study|Study Terminated by Sponsor|0|||
19421778|NCT02322281|41668167|FG002|Overall Study|Study Terminated by Sponsor|0|||
19421779|NCT02322281|41668165|FG000|Overall Study|Missing|0|||
19421780|NCT02322281|41668166|FG001|Overall Study|Missing|0|||
19421781|NCT02322281|41668167|FG002|Overall Study|Missing|1|||
19421782|NCT02322281|41668165|FG000|Overall Study|Miscellaneous|0|||
19421783|NCT02322281|41668166|FG001|Overall Study|Miscellaneous|0|||
19421784|NCT02322281|41668167|FG002|Overall Study|Miscellaneous|4|||
19421785|NCT02322125|41668177|FG000|Overall Study|Withdrawal by Subject|2|||
19421786|NCT02243293|41668198|FG000|Overall Study|Adverse Event|1|||
19421787|NCT02243293|41668199|FG001|Overall Study|Adverse Event|0|||
19421788|NCT02243293|41668200|FG002|Overall Study|Adverse Event|0|||
19421789|NCT02243293|41668201|FG003|Overall Study|Adverse Event|0|||
19421790|NCT02243293|41668202|FG004|Overall Study|Adverse Event|0|||
19421791|NCT02243293|41668203|FG005|Overall Study|Adverse Event|0|||
19421792|NCT02243293|41668204|FG006|Overall Study|Adverse Event|0|||
19421793|NCT02243293|41668205|FG007|Overall Study|Adverse Event|0|||
19421794|NCT02243293|41668206|FG008|Overall Study|Adverse Event|0|||
19421795|NCT02243293|41668207|FG009|Overall Study|Adverse Event|0|||
19421796|NCT02243293|41668208|FG010|Overall Study|Adverse Event|0|||
19421797|NCT02243293|41668209|FG011|Overall Study|Adverse Event|0|||
19421798|NCT02243293|41668210|FG012|Overall Study|Adverse Event|0|||
19421799|NCT02243293|41668211|FG013|Overall Study|Adverse Event|0|||
19421800|NCT02243293|41668212|FG014|Overall Study|Adverse Event|0|||
19421801|NCT02243293|41668213|FG015|Overall Study|Adverse Event|1|||
19421802|NCT02243293|41668214|FG016|Overall Study|Adverse Event|0|||
19421803|NCT02243293|41668215|FG017|Overall Study|Adverse Event|0|||
19421804|NCT02243293|41668216|FG018|Overall Study|Adverse Event|0|||
19421805|NCT02243293|41668217|FG019|Overall Study|Adverse Event|0|||
19421806|NCT02243293|41668218|FG020|Overall Study|Adverse Event|1|||
19421807|NCT02243293|41668219|FG021|Overall Study|Adverse Event|0|||
19421808|NCT02243293|41668198|FG000|Overall Study|Withdrawal by Subject|1|||
19421809|NCT02243293|41668199|FG001|Overall Study|Withdrawal by Subject|0|||
19421810|NCT02243293|41668200|FG002|Overall Study|Withdrawal by Subject|0|||
19421811|NCT02243293|41668201|FG003|Overall Study|Withdrawal by Subject|0|||
19421812|NCT02243293|41668202|FG004|Overall Study|Withdrawal by Subject|0|||
19421813|NCT02243293|41668203|FG005|Overall Study|Withdrawal by Subject|0|||
19421814|NCT02243293|41668204|FG006|Overall Study|Withdrawal by Subject|0|||
19421815|NCT02243293|41668205|FG007|Overall Study|Withdrawal by Subject|0|||
19421816|NCT02243293|41668206|FG008|Overall Study|Withdrawal by Subject|0|||
19421817|NCT02243293|41668207|FG009|Overall Study|Withdrawal by Subject|1|||
19421818|NCT02243293|41668208|FG010|Overall Study|Withdrawal by Subject|0|||
19421819|NCT02243293|41668209|FG011|Overall Study|Withdrawal by Subject|1|||
19421820|NCT02243293|41668210|FG012|Overall Study|Withdrawal by Subject|0|||
19421821|NCT02243293|41668211|FG013|Overall Study|Withdrawal by Subject|0|||
19421822|NCT02243293|41668212|FG014|Overall Study|Withdrawal by Subject|0|||
19421823|NCT02243293|41668213|FG015|Overall Study|Withdrawal by Subject|0|||
19421824|NCT02243293|41668214|FG016|Overall Study|Withdrawal by Subject|0|||
19421825|NCT02243293|41668215|FG017|Overall Study|Withdrawal by Subject|0|||
19421826|NCT02243293|41668216|FG018|Overall Study|Withdrawal by Subject|0|||
19421827|NCT02243293|41668217|FG019|Overall Study|Withdrawal by Subject|0|||
19421828|NCT02243293|41668218|FG020|Overall Study|Withdrawal by Subject|0|||
19421829|NCT02243293|41668219|FG021|Overall Study|Withdrawal by Subject|1|||
19421830|NCT02243293|41668198|FG000|Overall Study|Lost to Follow-up|0|||
19421831|NCT02243293|41668199|FG001|Overall Study|Lost to Follow-up|1|||
19421832|NCT02243293|41668200|FG002|Overall Study|Lost to Follow-up|1|||
19421833|NCT02243293|41668201|FG003|Overall Study|Lost to Follow-up|1|||
19421834|NCT02243293|41668202|FG004|Overall Study|Lost to Follow-up|0|||
19421835|NCT02243293|41668203|FG005|Overall Study|Lost to Follow-up|0|||
19421836|NCT02243293|41668204|FG006|Overall Study|Lost to Follow-up|3|||
19421837|NCT02243293|41668205|FG007|Overall Study|Lost to Follow-up|0|||
19421838|NCT02243293|41668206|FG008|Overall Study|Lost to Follow-up|0|||
19421839|NCT02243293|41668207|FG009|Overall Study|Lost to Follow-up|0|||
19421840|NCT02243293|41668208|FG010|Overall Study|Lost to Follow-up|0|||
19421841|NCT02243293|41668209|FG011|Overall Study|Lost to Follow-up|2|||
19421842|NCT02243293|41668210|FG012|Overall Study|Lost to Follow-up|0|||
19421843|NCT02243293|41668211|FG013|Overall Study|Lost to Follow-up|0|||
19421844|NCT02243293|41668212|FG014|Overall Study|Lost to Follow-up|0|||
19421845|NCT02243293|41668213|FG015|Overall Study|Lost to Follow-up|0|||
19421846|NCT02243293|41668214|FG016|Overall Study|Lost to Follow-up|3|||
19421847|NCT02243293|41668215|FG017|Overall Study|Lost to Follow-up|1|||
19421848|NCT02243293|41668216|FG018|Overall Study|Lost to Follow-up|0|||
19421849|NCT02243293|41668217|FG019|Overall Study|Lost to Follow-up|0|||
19421850|NCT02243293|41668218|FG020|Overall Study|Lost to Follow-up|1|||
19421851|NCT02243293|41668219|FG021|Overall Study|Lost to Follow-up|2|||
19421852|NCT02243293|41668198|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
19421853|NCT02243293|41668199|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
19421854|NCT02243293|41668200|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
19421855|NCT02243293|41668201|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
19421856|NCT02243293|41668202|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
19421857|NCT02243293|41668203|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
19421858|NCT02243293|41668204|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
19421859|NCT02243293|41668205|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
19421860|NCT02243293|41668206|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
19421861|NCT02243293|41668207|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
19421862|NCT02243293|41668208|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
19421863|NCT02243293|41668209|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
19421864|NCT02243293|41668210|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
19421865|NCT02243293|41668211|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
19421866|NCT02243293|41668212|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
19421867|NCT02243293|41668213|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
19421868|NCT02243293|41668214|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
19421869|NCT02243293|41668215|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
19421870|NCT02243293|41668216|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
19421871|NCT02243293|41668217|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
19421872|NCT02243293|41668218|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
19421873|NCT02243293|41668219|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
19421874|NCT02243293|41668198|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
19421875|NCT02243293|41668199|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
19421876|NCT02243293|41668200|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
19421877|NCT02243293|41668201|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
19421878|NCT02243293|41668202|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
19421879|NCT02243293|41668203|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
19421880|NCT02243293|41668204|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
19421881|NCT02243293|41668205|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
19421882|NCT02243293|41668206|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
19421883|NCT02243293|41668207|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
19421884|NCT02243293|41668208|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
19421885|NCT02243293|41668209|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
19421886|NCT02243293|41668210|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
19421887|NCT02243293|41668211|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
19421888|NCT02243293|41668212|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
19421889|NCT02243293|41668213|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
19421890|NCT02243293|41668214|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
19421891|NCT02243293|41668215|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
19421892|NCT02243293|41668216|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
19421893|NCT02243293|41668217|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
19421894|NCT02243293|41668218|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
19421895|NCT02243293|41668219|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
19421896|NCT02322047|41668260|FG000|Overall Study|Physician Decision|1|||
19421897|NCT02322047|41668261|FG001|Overall Study|Physician Decision|0|||
19421898|NCT02322047|41668262|FG002|Overall Study|Physician Decision|0|||
19421899|NCT02322047|41668263|FG003|Overall Study|Physician Decision|0|||
19421900|NCT02322047|41668260|FG000|Overall Study|Withdrawal by Subject|1|||
19421901|NCT02322047|41668261|FG001|Overall Study|Withdrawal by Subject|0|||
19421902|NCT02322047|41668262|FG002|Overall Study|Withdrawal by Subject|0|||
19421903|NCT02322047|41668263|FG003|Overall Study|Withdrawal by Subject|1|||
19421904|NCT02322047|41668260|FG000|Overall Study|Adverse Event|0|||
19421905|NCT02322047|41668261|FG001|Overall Study|Adverse Event|1|||
19421906|NCT02322047|41668262|FG002|Overall Study|Adverse Event|0|||
19421907|NCT02322047|41668263|FG003|Overall Study|Adverse Event|0|||
19421908|NCT02322047|41668260|FG000|Overall Study|Lost to Follow-up|0|||
19421909|NCT02322047|41668261|FG001|Overall Study|Lost to Follow-up|0|||
19421910|NCT02322047|41668262|FG002|Overall Study|Lost to Follow-up|1|||
19421911|NCT02322047|41668263|FG003|Overall Study|Lost to Follow-up|1|||
19421912|NCT02254291|41668276|FG000|Overall Study|Withdrawal by Subject|0|||
19421913|NCT02254291|41668277|FG001|Overall Study|Withdrawal by Subject|3|||
19421914|NCT02254291|41668278|FG002|Overall Study|Withdrawal by Subject|1|||
19520079|NCT01443858|41932662|FG001|Overall Study|Lack of Efficacy|0|||
19421915|NCT02254291|41668276|FG000|Overall Study|Missing follow-up information|0|||
19421916|NCT02254291|41668277|FG001|Overall Study|Missing follow-up information|0|||
19421917|NCT02254291|41668278|FG002|Overall Study|Missing follow-up information|1|||
19421918|NCT02253433|41668288|FG000|Overall Study|Unable to Contact|9|||
19421919|NCT02253433|41668289|FG001|Overall Study|Unable to Contact|16|||
19421920|NCT02253433|41668288|FG000|Overall Study|Death|1|||
19421921|NCT02253433|41668289|FG001|Overall Study|Death|1|||
19421922|NCT02253433|41668288|FG000|Overall Study|No Longer Interested|3|||
19421923|NCT02253433|41668289|FG001|Overall Study|No Longer Interested|15|||
19421924|NCT02253433|41668288|FG000|Overall Study|Out of Study Area|2|||
19421925|NCT02253433|41668289|FG001|Overall Study|Out of Study Area|7|||
19421926|NCT02253433|41668288|FG000|Overall Study|Uncomfortable with home visitors|0|||
19421927|NCT02253433|41668289|FG001|Overall Study|Uncomfortable with home visitors|3|||
19421928|NCT02253433|41668288|FG000|Overall Study|Unstable Housing/Homeless|0|||
19421929|NCT02253433|41668289|FG001|Overall Study|Unstable Housing/Homeless|7|||
19421930|NCT02253433|41668288|FG000|Overall Study|Too Busy|0|||
19421931|NCT02253433|41668289|FG001|Overall Study|Too Busy|4|||
19421932|NCT02253433|41668288|FG000|Overall Study|Medical or Other Concerns|1|||
19421933|NCT02253433|41668289|FG001|Overall Study|Medical or Other Concerns|2|||
19421934|NCT02242981|41668296|FG000|Overall Study|Withdrawal by Subject|1|||
19421935|NCT02277743|41668303|FG000|Overall Study|Protocol Violation|1|||
19421936|NCT02277743|41668304|FG001|Overall Study|Protocol Violation|1|||
19421937|NCT02277743|41668305|FG002|Overall Study|Protocol Violation|1|||
19421938|NCT02277743|41668303|FG000|Overall Study|Adverse Event|10|||
19421939|NCT02277743|41668304|FG001|Overall Study|Adverse Event|6|||
19421940|NCT02277743|41668305|FG002|Overall Study|Adverse Event|6|||
19421941|NCT02277743|41668303|FG000|Overall Study|Lack of Efficacy|11|||
19421942|NCT02277743|41668304|FG001|Overall Study|Lack of Efficacy|4|||
19421943|NCT02277743|41668305|FG002|Overall Study|Lack of Efficacy|3|||
19421944|NCT02277743|41668303|FG000|Overall Study|Other than specified above|18|||
19421945|NCT02277743|41668304|FG001|Overall Study|Other than specified above|5|||
19421946|NCT02277743|41668305|FG002|Overall Study|Other than specified above|16|||
19421947|NCT02242903|41668320|FG000|Overall Study|Withdrawal by Subject|1|||
19421948|NCT02242903|41668321|FG001|Overall Study|Withdrawal by Subject|0|||
19421949|NCT02242903|41668322|FG002|Overall Study|Withdrawal by Subject|0|||
19421950|NCT02242903|41668323|FG003|Overall Study|Withdrawal by Subject|0|||
19421951|NCT02242903|41668324|FG004|Overall Study|Withdrawal by Subject|0|||
19421952|NCT02242903|41668325|FG005|Overall Study|Withdrawal by Subject|0|||
19421953|NCT02242903|41668326|FG006|Overall Study|Withdrawal by Subject|0|||
19421954|NCT02320721|41668350|FG000|Overall Study|Adverse Event|6|||
19421955|NCT02320721|41668351|FG001|Overall Study|Adverse Event|6|||
19421956|NCT02320721|41668350|FG000|Overall Study|Lack of Efficacy|2|||
19421957|NCT02320721|41668351|FG001|Overall Study|Lack of Efficacy|0|||
19421958|NCT02320721|41668350|FG000|Overall Study|Poor compliance to protocol|3|||
19421959|NCT02320721|41668351|FG001|Overall Study|Poor compliance to protocol|7|||
19421960|NCT02320721|41668350|FG000|Overall Study|Randomized but not treated|0|||
19421961|NCT02320721|41668351|FG001|Overall Study|Randomized but not treated|1|||
19421962|NCT02320721|41668350|FG000|Overall Study|Hypoglycemia|1|||
19421963|NCT02320721|41668351|FG001|Overall Study|Hypoglycemia|0|||
19421964|NCT02320721|41668350|FG000|Overall Study|Other than specified above|15|||
19421965|NCT02320721|41668351|FG001|Overall Study|Other than specified above|20|||
19421966|NCT02320487|41668357|FG000|Overall Study|Reason not Specified|1|||
19421967|NCT02320487|41668357|FG000|Overall Study|Physician Decision|5|||
19421968|NCT02320487|41668357|FG000|Overall Study|Withdrawal by Subject|1|||
19421969|NCT02320487|41668357|FG000|Overall Study|Death|3|||
19421970|NCT02320487|41668357|FG000|Overall Study|Adverse Event|11|||
19421971|NCT02277119|41668364|FG000|Overall Study|Lack of Efficacy|1|||
19421972|NCT02277119|41668365|FG001|Overall Study|Lack of Efficacy|1|||
19421973|NCT02277119|41668366|FG002|Overall Study|Lack of Efficacy|1|||
19421974|NCT02277119|41668364|FG000|Overall Study|Protocol Violation|2|||
19421975|NCT02277119|41668365|FG001|Overall Study|Protocol Violation|3|||
19421976|NCT02277119|41668366|FG002|Overall Study|Protocol Violation|7|||
19421977|NCT02320253|41668377|FG000|Overall Study|Withdrawal by Subject|3|||
19421978|NCT02320253|41668378|FG001|Overall Study|Withdrawal by Subject|0|||
19421979|NCT02320253|41668379|FG002|Overall Study|Withdrawal by Subject|0|||
19421980|NCT02320253|41668377|FG000|Overall Study|Lost to Follow-up|2|||
19421981|NCT02320253|41668378|FG001|Overall Study|Lost to Follow-up|2|||
19421982|NCT02320253|41668379|FG002|Overall Study|Lost to Follow-up|1|||
19421983|NCT02320253|41668377|FG000|Overall Study|Death|1|||
19421984|NCT02320253|41668378|FG001|Overall Study|Death|0|||
19421985|NCT02320253|41668379|FG002|Overall Study|Death|1|||
19421986|NCT02276807|41668389|FG000|Overall Study|Withdrawal by Subject|8|||
19421987|NCT02276807|41668390|FG001|Overall Study|Withdrawal by Subject|7|||
19421988|NCT02276807|41668389|FG000|Overall Study|Lost to Follow-up|10|||
19421989|NCT02276807|41668390|FG001|Overall Study|Lost to Follow-up|10|||
19421990|NCT02252965|41668398|FG000|Overall Study|Adverse Event|9|||
19421991|NCT02252965|41668399|FG001|Overall Study|Adverse Event|14|||
19421992|NCT02252965|41668398|FG000|Overall Study|Lost to Follow-up|16|||
19421993|NCT02252965|41668399|FG001|Overall Study|Lost to Follow-up|8|||
19421994|NCT02252965|41668398|FG000|Overall Study|Protocol Violation|4|||
19421995|NCT02252965|41668399|FG001|Overall Study|Protocol Violation|5|||
19421996|NCT02252965|41668398|FG000|Overall Study|Lack of Efficacy|0|||
19421997|NCT02252965|41668399|FG001|Overall Study|Lack of Efficacy|2|||
19421998|NCT02252965|41668398|FG000|Overall Study|Withdrawal by Subject|7|||
19421999|NCT02252965|41668399|FG001|Overall Study|Withdrawal by Subject|9|||
19422000|NCT02252965|41668398|FG000|Overall Study|Other|4|||
19422001|NCT02252965|41668399|FG001|Overall Study|Other|5|||
19422002|NCT02242435|41668409|FG000|Overall Study|Lost to Follow-up|3|||
19422003|NCT02242435|41668410|FG001|Overall Study|Lost to Follow-up|4|||
19422004|NCT02242435|41668409|FG000|Overall Study|Adverse Event|3|||
19422005|NCT02242435|41668410|FG001|Overall Study|Adverse Event|2|||
19422006|NCT02242435|41668409|FG000|Overall Study|Withdrawal by Subject|13|||
19422007|NCT02242435|41668410|FG001|Overall Study|Withdrawal by Subject|8|||
19422008|NCT02242435|41668409|FG000|Overall Study|Death|0|||
19422009|NCT02242435|41668410|FG001|Overall Study|Death|1|||
19422010|NCT02242435|41668409|FG000|Overall Study|Protocol Violation|1|||
19422011|NCT02242435|41668410|FG001|Overall Study|Protocol Violation|0|||
19422012|NCT02242435|41668409|FG000|Overall Study|Physician Decision|0|||
19422013|NCT02242435|41668410|FG001|Overall Study|Physician Decision|1|||
19422014|NCT02251717|41668418|FG000|Overall Study|Adverse Event|0|||
19422015|NCT02251717|41668419|FG001|Overall Study|Adverse Event|1|||
19422016|NCT02251717|41668418|FG000|Overall Study|Withdrew Consent|1|||
19422017|NCT02251717|41668419|FG001|Overall Study|Withdrew Consent|0|||
19422018|NCT02242201|41668428|FG000|Overall Study|preoperative identified neuropathy|2|||
19422019|NCT02242201|41668429|FG001|Overall Study|preoperative identified neuropathy|0|||
19422020|NCT02242201|41668430|FG002|Overall Study|preoperative identified neuropathy|0|||
19422021|NCT02242201|41668428|FG000|Overall Study|planned post-op anticoagulation|1|||
19422022|NCT02242201|41668429|FG001|Overall Study|planned post-op anticoagulation|0|||
19422023|NCT02242201|41668430|FG002|Overall Study|planned post-op anticoagulation|0|||
19520080|NCT01443858|41932663|FG002|Overall Study|Lack of Efficacy|0|||
19520081|NCT01443858|41932661|FG000|Overall Study|Lost to Follow-up|5|||
19520082|NCT01443858|41932662|FG001|Overall Study|Lost to Follow-up|5|||
19520083|NCT01443858|41932663|FG002|Overall Study|Lost to Follow-up|2|||
19520084|NCT01443078|41932671|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
19520085|NCT01443078|41932671|FG000|Overall Study|Withdrawal by Subject|1|||
19520086|NCT01443078|41932671|FG000|Overall Study|Patient had brain mets|1|||
19520087|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
19520088|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
19520089|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Death|2|||
19520090|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Death|1|||
19520091|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
19520092|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
19520093|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
19520094|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
19520095|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Other|8|||
19520096|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Other|13|||
19520097|NCT01439880|41932677|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
19520098|NCT01439880|41932678|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
19520099|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
19520100|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
19520101|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
19520102|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
19520103|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Death|3|||
19520104|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Death|13|||
19520105|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
19520106|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
19520107|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Other|14|||
19520108|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Other|31|||
19520109|NCT01439880|41932677|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
19520110|NCT01439880|41932678|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
19520111|NCT01469364|41932695|FG000|Overall Study|Adverse Event|1|||
19520112|NCT01469364|41932695|FG000|Overall Study|Withdrawal by Subject|1|||
19520113|NCT01439724|41932701|FG000|Overall Study|missing consultation|9|||
19520114|NCT01439724|41932702|FG001|Overall Study|missing consultation|8|||
19520115|NCT01439568|41932710|FG000|Overall Study|Lost to Follow-up|1|||
19520116|NCT01439568|41932711|FG001|Overall Study|Lost to Follow-up|0|||
19520117|NCT01439568|41932710|FG000|Overall Study|Withdrawal by Subject|2|||
19520118|NCT01439568|41932711|FG001|Overall Study|Withdrawal by Subject|2|||
19520119|NCT01469052|41932723|FG000|Overall Study|Adverse Event|2|||
19520120|NCT01469052|41932724|FG001|Overall Study|Adverse Event|3|||
19628189|NCT00802074|42077589|FG001|Overall Study|Adverse Event|1|||
19422024|NCT02242201|41668428|FG000|Overall Study|changed surgical procedure|1|||
19422025|NCT02242201|41668429|FG001|Overall Study|changed surgical procedure|0|||
19520121|NCT01469052|41932725|FG002|Overall Study|Adverse Event|0|||
19520122|NCT01469052|41932726|FG003|Overall Study|Adverse Event|2|||
19422026|NCT02242201|41668430|FG002|Overall Study|changed surgical procedure|0|||
19422027|NCT02242201|41668428|FG000|Overall Study|postponed surgery|0|||
19422028|NCT02242201|41668429|FG001|Overall Study|postponed surgery|0|||
19422029|NCT02242201|41668430|FG002|Overall Study|postponed surgery|1|||
19422030|NCT02242201|41668428|FG000|Overall Study|preoperative opioid consumption|0|||
19422031|NCT02242201|41668429|FG001|Overall Study|preoperative opioid consumption|1|||
19422032|NCT02242201|41668430|FG002|Overall Study|preoperative opioid consumption|0|||
19422033|NCT02242045|41668438|FG000|Overall Study|Investigator's Discretion|1|||
19422034|NCT02242045|41668438|FG000|Overall Study|Progressive Disease|2|||
19422035|NCT02242045|41668438|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
19422036|NCT02242045|41668438|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
19422037|NCT02241889|41668442|FG000|Overall Study|device issues|0|||
19422038|NCT02241889|41668443|FG001|Overall Study|device issues|0|||
19422039|NCT02241889|41668444|FG002|Overall Study|device issues|1|||
19422040|NCT02241889|41668445|FG003|Overall Study|device issues|0|||
19422041|NCT02241889|41668446|FG004|Overall Study|device issues|0|||
19422042|NCT02241889|41668447|FG005|Overall Study|device issues|0|||
19422043|NCT02241889|41668442|FG000|Overall Study|Withdrawal by Subject|0|||
19422044|NCT02241889|41668443|FG001|Overall Study|Withdrawal by Subject|0|||
19422045|NCT02241889|41668444|FG002|Overall Study|Withdrawal by Subject|0|||
19422046|NCT02241889|41668445|FG003|Overall Study|Withdrawal by Subject|0|||
19422047|NCT02241889|41668446|FG004|Overall Study|Withdrawal by Subject|0|||
19422048|NCT02241889|41668447|FG005|Overall Study|Withdrawal by Subject|1|||
19422049|NCT02241733|41668457|FG000|Overall Study|Lost to Follow-up|9|||
19422050|NCT02241733|41668458|FG001|Overall Study|Lost to Follow-up|4|||
19422051|NCT02241733|41668457|FG000|Overall Study|Physician Decision|6|||
19422052|NCT02241733|41668458|FG001|Overall Study|Physician Decision|2|||
19422053|NCT02241733|41668457|FG000|Overall Study|Withdrawal by Subject|0|||
19422054|NCT02241733|41668458|FG001|Overall Study|Withdrawal by Subject|2|||
19422055|NCT02241733|41668457|FG000|Overall Study|Death|0|||
19422056|NCT02241733|41668458|FG001|Overall Study|Death|2|||
19422057|NCT02241343|41668464|FG000|Overall Study|Adverse Event|1|||
19422058|NCT02241187|41668469|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
19422059|NCT02249767|41668476|FG000|Overall Study|Did not use medication|8|||
19422060|NCT02249767|41668477|FG001|Overall Study|Did not use medication|9|||
19422061|NCT02249767|41668478|FG002|Overall Study|Did not use medication|8|||
19422062|NCT02239939|41668488|FG000|Overall Study|Adverse Event|1|||
19422063|NCT02239939|41668489|FG001|Overall Study|Adverse Event|0|||
19422064|NCT02239939|41668488|FG000|Overall Study|Withdrawal by Subject|1|||
19422065|NCT02239939|41668489|FG001|Overall Study|Withdrawal by Subject|1|||
19422066|NCT02239939|41668488|FG000|Overall Study|Lost to Follow-up|0|||
19422067|NCT02239939|41668489|FG001|Overall Study|Lost to Follow-up|1|||
19422068|NCT02248675|41668499|FG000|Overall Study|Lost to Follow-up|3|||
19422069|NCT02248675|41668500|FG001|Overall Study|Lost to Follow-up|1|||
19422070|NCT02207725|41668510|FG000|Overall Study|Did Not Receive Treatment|0|||
19422071|NCT02207725|41668511|FG001|Overall Study|Did Not Receive Treatment|1|||
19422072|NCT02207725|41668512|FG002|Overall Study|Did Not Receive Treatment|1|||
19422073|NCT02207725|41668513|FG003|Overall Study|Did Not Receive Treatment|1|||
19422074|NCT02238379|41668527|FG000|Overall Study|Lost to Follow-up|1|||
19422075|NCT02238379|41668528|FG001|Overall Study|Lost to Follow-up|0|||
19422076|NCT02238067|41668534|FG000|Overall Study|Not completed survey at Month 6|45|||
19422077|NCT02237911|41668541|FG000|Overall Study|Withdrawal by Subject|4|||
19422078|NCT02237911|41668542|FG001|Overall Study|Withdrawal by Subject|7|||
19422079|NCT02237911|41668543|FG002|Overall Study|Withdrawal by Subject|2|||
19422080|NCT02237911|41668541|FG000|Overall Study|Lost to Follow-up|3|||
19422081|NCT02237911|41668542|FG001|Overall Study|Lost to Follow-up|1|||
19422082|NCT02237911|41668543|FG002|Overall Study|Lost to Follow-up|1|||
19422083|NCT02234479|41668553|FG000|Overall Study|Withdrawal by Subject|1|||
19422084|NCT02234479|41668554|FG001|Overall Study|Withdrawal by Subject|3|||
19422085|NCT02207491|41668562|FG000|Overall Study|Adverse Event|20|||
19422086|NCT02207491|41668563|FG001|Overall Study|Adverse Event|4|||
19422087|NCT02207491|41668562|FG000|Overall Study|Withdrawal by Subject|3|||
19422088|NCT02207491|41668563|FG001|Overall Study|Withdrawal by Subject|2|||
19422089|NCT02207491|41668562|FG000|Overall Study|Non-compliant|0|||
19422090|NCT02207491|41668563|FG001|Overall Study|Non-compliant|1|||
19422091|NCT02207491|41668562|FG000|Overall Study|Lost to Follow-up|0|||
19422092|NCT02207491|41668563|FG001|Overall Study|Lost to Follow-up|1|||
19422093|NCT02207491|41668562|FG000|Overall Study|Lack of Efficacy|3|||
19422094|NCT02207491|41668563|FG001|Overall Study|Lack of Efficacy|0|||
19422095|NCT02207491|41668562|FG000|Overall Study|Physician Decision|2|||
19422096|NCT02207491|41668563|FG001|Overall Study|Physician Decision|0|||
19422097|NCT02207491|41668562|FG000|Overall Study|Protocol Violation|3|||
19422098|NCT02207491|41668563|FG001|Overall Study|Protocol Violation|5|||
19422099|NCT02315066|41668583|FG000|Overall Study|Lost to Follow-up|0|||
19422100|NCT02315066|41668584|FG001|Overall Study|Lost to Follow-up|1|||
19422101|NCT02315066|41668585|FG002|Overall Study|Lost to Follow-up|1|||
19422102|NCT02315066|41668586|FG003|Overall Study|Lost to Follow-up|0|||
19422103|NCT02315066|41668587|FG004|Overall Study|Lost to Follow-up|1|||
19422104|NCT02315066|41668588|FG005|Overall Study|Lost to Follow-up|0|||
19422105|NCT02315066|41668589|FG006|Overall Study|Lost to Follow-up|2|||
19422106|NCT02315066|41668590|FG007|Overall Study|Lost to Follow-up|1|||
19422107|NCT02315066|41668591|FG008|Overall Study|Lost to Follow-up|0|||
19422108|NCT02315066|41668592|FG009|Overall Study|Lost to Follow-up|0|||
19422109|NCT02315066|41668593|FG010|Overall Study|Lost to Follow-up|1|||
19422110|NCT02315066|41668594|FG011|Overall Study|Lost to Follow-up|2|||
19422111|NCT02315066|41668595|FG012|Overall Study|Lost to Follow-up|0|||
19422112|NCT02315066|41668596|FG013|Overall Study|Lost to Follow-up|4|||
19422113|NCT02315066|41668583|FG000|Overall Study|Death|2|||
19422114|NCT02315066|41668584|FG001|Overall Study|Death|7|||
19422115|NCT02315066|41668585|FG002|Overall Study|Death|6|||
19422116|NCT02315066|41668586|FG003|Overall Study|Death|11|||
19422117|NCT02315066|41668587|FG004|Overall Study|Death|10|||
19422118|NCT02315066|41668588|FG005|Overall Study|Death|3|||
19422119|NCT02315066|41668589|FG006|Overall Study|Death|9|||
19422120|NCT02315066|41668590|FG007|Overall Study|Death|9|||
19422121|NCT02315066|41668591|FG008|Overall Study|Death|10|||
19422122|NCT02315066|41668592|FG009|Overall Study|Death|8|||
19422123|NCT02315066|41668593|FG010|Overall Study|Death|10|||
19422124|NCT02315066|41668594|FG011|Overall Study|Death|7|||
19422125|NCT02315066|41668595|FG012|Overall Study|Death|8|||
19422126|NCT02315066|41668596|FG013|Overall Study|Death|21|||
19422127|NCT02315066|41668583|FG000|Overall Study|Other|0|||
19422128|NCT02315066|41668584|FG001|Overall Study|Other|0|||
19422129|NCT02315066|41668585|FG002|Overall Study|Other|0|||
19422130|NCT02315066|41668586|FG003|Overall Study|Other|0|||
19422131|NCT02315066|41668587|FG004|Overall Study|Other|0|||
19422132|NCT02315066|41668588|FG005|Overall Study|Other|0|||
19422133|NCT02315066|41668589|FG006|Overall Study|Other|0|||
19422134|NCT02315066|41668590|FG007|Overall Study|Other|1|||
19422135|NCT02315066|41668591|FG008|Overall Study|Other|1|||
19422136|NCT02315066|41668592|FG009|Overall Study|Other|2|||
19422137|NCT02315066|41668593|FG010|Overall Study|Other|0|||
19422138|NCT02315066|41668594|FG011|Overall Study|Other|0|||
19422139|NCT02315066|41668595|FG012|Overall Study|Other|0|||
19422140|NCT02315066|41668596|FG013|Overall Study|Other|0|||
19422141|NCT02315066|41668583|FG000|Overall Study|Subject refused further follow-up|0|||
19422142|NCT02315066|41668584|FG001|Overall Study|Subject refused further follow-up|2|||
19422143|NCT02315066|41668585|FG002|Overall Study|Subject refused further follow-up|2|||
19422144|NCT02315066|41668586|FG003|Overall Study|Subject refused further follow-up|0|||
19422145|NCT02315066|41668587|FG004|Overall Study|Subject refused further follow-up|0|||
19422146|NCT02315066|41668588|FG005|Overall Study|Subject refused further follow-up|0|||
19422147|NCT02315066|41668589|FG006|Overall Study|Subject refused further follow-up|2|||
19422148|NCT02315066|41668590|FG007|Overall Study|Subject refused further follow-up|3|||
19422149|NCT02315066|41668591|FG008|Overall Study|Subject refused further follow-up|0|||
19422150|NCT02315066|41668592|FG009|Overall Study|Subject refused further follow-up|1|||
19422151|NCT02315066|41668593|FG010|Overall Study|Subject refused further follow-up|1|||
19422152|NCT02315066|41668594|FG011|Overall Study|Subject refused further follow-up|2|||
19422153|NCT02315066|41668595|FG012|Overall Study|Subject refused further follow-up|2|||
19422154|NCT02315066|41668596|FG013|Overall Study|Subject refused further follow-up|4|||
19422155|NCT02315066|41668583|FG000|Overall Study|Study ongoing at date of cut-off|0|||
19422156|NCT02315066|41668584|FG001|Overall Study|Study ongoing at date of cut-off|0|||
19422157|NCT02315066|41668585|FG002|Overall Study|Study ongoing at date of cut-off|0|||
19422158|NCT02315066|41668586|FG003|Overall Study|Study ongoing at date of cut-off|0|||
19422159|NCT02315066|41668587|FG004|Overall Study|Study ongoing at date of cut-off|0|||
19422160|NCT02315066|41668588|FG005|Overall Study|Study ongoing at date of cut-off|0|||
19422161|NCT02315066|41668589|FG006|Overall Study|Study ongoing at date of cut-off|0|||
19422162|NCT02315066|41668590|FG007|Overall Study|Study ongoing at date of cut-off|0|||
19422163|NCT02315066|41668591|FG008|Overall Study|Study ongoing at date of cut-off|0|||
19422164|NCT02315066|41668592|FG009|Overall Study|Study ongoing at date of cut-off|0|||
19422165|NCT02315066|41668593|FG010|Overall Study|Study ongoing at date of cut-off|0|||
19422166|NCT02315066|41668594|FG011|Overall Study|Study ongoing at date of cut-off|0|||
19422167|NCT02315066|41668595|FG012|Overall Study|Study ongoing at date of cut-off|0|||
19422168|NCT02315066|41668596|FG013|Overall Study|Study ongoing at date of cut-off|1|||
19422169|NCT02207413|41668632|FG000|Overall Study|Withdrawal by Subject|1|||
19422170|NCT02207413|41668633|FG001|Overall Study|Withdrawal by Subject|0|||
19422171|NCT02207413|41668634|FG002|Overall Study|Withdrawal by Subject|0|||
19422172|NCT02207413|41668635|FG003|Overall Study|Withdrawal by Subject|0|||
19422173|NCT02207413|41668636|FG004|Overall Study|Withdrawal by Subject|3|||
19422174|NCT02207413|41668637|FG005|Overall Study|Withdrawal by Subject|7|||
19422175|NCT02207413|41668632|FG000|Overall Study|Lost to Follow-up|0|||
19422176|NCT02207413|41668633|FG001|Overall Study|Lost to Follow-up|0|||
19422177|NCT02207413|41668634|FG002|Overall Study|Lost to Follow-up|0|||
19422178|NCT02207413|41668635|FG003|Overall Study|Lost to Follow-up|1|||
19422179|NCT02207413|41668636|FG004|Overall Study|Lost to Follow-up|1|||
19422180|NCT02207413|41668637|FG005|Overall Study|Lost to Follow-up|5|||
19422181|NCT02207413|41668632|FG000|Overall Study|Adverse Event|0|||
19422182|NCT02207413|41668633|FG001|Overall Study|Adverse Event|0|||
19422183|NCT02207413|41668634|FG002|Overall Study|Adverse Event|0|||
19422184|NCT02207413|41668635|FG003|Overall Study|Adverse Event|0|||
19422185|NCT02207413|41668636|FG004|Overall Study|Adverse Event|2|||
19422186|NCT02207413|41668637|FG005|Overall Study|Adverse Event|1|||
19422187|NCT02207413|41668632|FG000|Overall Study|Migrated/moved from study area|0|||
19422188|NCT02207413|41668633|FG001|Overall Study|Migrated/moved from study area|0|||
19422189|NCT02207413|41668634|FG002|Overall Study|Migrated/moved from study area|0|||
19422190|NCT02207413|41668635|FG003|Overall Study|Migrated/moved from study area|0|||
19422191|NCT02207413|41668636|FG004|Overall Study|Migrated/moved from study area|1|||
19422192|NCT02207413|41668637|FG005|Overall Study|Migrated/moved from study area|0|||
19422193|NCT02309372|41668659|FG000|Overall Study|Lost to Follow-up|3|||
19422194|NCT02309372|41668660|FG001|Overall Study|Lost to Follow-up|2|||
19422195|NCT02276027|41668670|FG000|Overall Study|Death|1|||
19422196|NCT02276027|41668671|FG001|Overall Study|Death|0|||
19422197|NCT02276027|41668672|FG002|Overall Study|Death|0|||
19422198|NCT02276027|41668673|FG003|Overall Study|Death|2|||
19422199|NCT02276027|41668670|FG000|Overall Study|Physician Decision|0|||
19422200|NCT02276027|41668671|FG001|Overall Study|Physician Decision|0|||
19422201|NCT02276027|41668672|FG002|Overall Study|Physician Decision|0|||
19422202|NCT02276027|41668673|FG003|Overall Study|Physician Decision|1|||
19422203|NCT02276027|41668670|FG000|Overall Study|Progressive disease|1|||
19422204|NCT02276027|41668671|FG001|Overall Study|Progressive disease|13|||
19422205|NCT02276027|41668672|FG002|Overall Study|Progressive disease|12|||
19422206|NCT02276027|41668673|FG003|Overall Study|Progressive disease|14|||
19422207|NCT02276027|41668670|FG000|Overall Study|Subject/guardian decision|0|||
19422208|NCT02276027|41668671|FG001|Overall Study|Subject/guardian decision|1|||
19422209|NCT02276027|41668672|FG002|Overall Study|Subject/guardian decision|0|||
19422210|NCT02276027|41668673|FG003|Overall Study|Subject/guardian decision|3|||
19422211|NCT02276027|41668670|FG000|Overall Study|Adverse Event|0|||
19422212|NCT02276027|41668671|FG001|Overall Study|Adverse Event|2|||
19422213|NCT02276027|41668672|FG002|Overall Study|Adverse Event|8|||
19422214|NCT02276027|41668673|FG003|Overall Study|Adverse Event|2|||
19422215|NCT02309294|41668683|FG000|Overall Study|Withdrawal by Subject|2|||
19422216|NCT02233543|41668687|FG000|Period 1|Withdrawal by Subject|1|||
19422217|NCT02233543|41668688|FG001|Period 1|Withdrawal by Subject|0|||
19422218|NCT02233543|41668687|FG000|Period 1|Participants required other treatment.|2|||
19422219|NCT02233543|41668688|FG001|Period 1|Participants required other treatment.|3|||
19422220|NCT02233543|41668687|FG000|Period 2|Adverse Event|1|||
19422221|NCT02233543|41668688|FG001|Period 2|Adverse Event|0|||
19422222|NCT02233543|41668687|FG000|Period 2|Participant required other treatment.|0|||
19422223|NCT02233543|41668688|FG001|Period 2|Participant required other treatment.|1|||
19422224|NCT02233543|41668687|FG000|Period 2|COPD exacerbation|1|||
19422225|NCT02233543|41668688|FG001|Period 2|COPD exacerbation|0|||
19422226|NCT02309138|41668696|FG000|Overall Study|Withdrawal by Subject|44|||
19422227|NCT02309138|41668697|FG001|Overall Study|Withdrawal by Subject|15|||
19422228|NCT02309138|41668696|FG000|Overall Study|Protocol Violation|4|||
19422229|NCT02309138|41668697|FG001|Overall Study|Protocol Violation|2|||
19422230|NCT02309138|41668696|FG000|Overall Study|delivered before visit 2|0|||
19422231|NCT02309138|41668697|FG001|Overall Study|delivered before visit 2|1|||
19422232|NCT02233309|41668713|FG000|Overall Study|Physician Decision|5|||
19422233|NCT02204917|41668717|FG000|Overall Study|Protocol Violation|1|||
19422234|NCT02280044|41668726|FG000|Overall Study|Planned alternate|0|||
19422235|NCT02280044|41668727|FG001|Overall Study|Planned alternate|2|||
19422236|NCT02308748|41668733|FG000|Period 1|Withdrawal by Subject|0|||
19422237|NCT02308748|41668734|FG001|Period 1|Withdrawal by Subject|0|||
19422238|NCT02308748|41668735|FG002|Period 1|Withdrawal by Subject|1|||
19422239|NCT02308748|41668736|FG003|Period 1|Withdrawal by Subject|0|||
19422240|NCT02308748|41668737|FG004|Period 1|Withdrawal by Subject|0|||
19422241|NCT02308748|41668738|FG005|Period 1|Withdrawal by Subject|0|||
19422242|NCT02308748|41668739|FG006|Period 1|Withdrawal by Subject|0|||
19422243|NCT02308748|41668740|FG007|Period 1|Withdrawal by Subject|0|||
19422244|NCT02308748|41668741|FG008|Period 1|Withdrawal by Subject|0|||
19422245|NCT02308748|41668742|FG009|Period 1|Withdrawal by Subject|0|||
19422246|NCT02308748|41668733|FG000|Period 2|Adverse Event|0|||
19422247|NCT02308748|41668734|FG001|Period 2|Adverse Event|0|||
19422248|NCT02308748|41668735|FG002|Period 2|Adverse Event|0|||
19422249|NCT02308748|41668736|FG003|Period 2|Adverse Event|0|||
19422250|NCT02308748|41668737|FG004|Period 2|Adverse Event|0|||
19422251|NCT02308748|41668738|FG005|Period 2|Adverse Event|0|||
19422252|NCT02308748|41668739|FG006|Period 2|Adverse Event|0|||
19422253|NCT02308748|41668740|FG007|Period 2|Adverse Event|1|||
19422254|NCT02308748|41668741|FG008|Period 2|Adverse Event|0|||
19422255|NCT02308748|41668742|FG009|Period 2|Adverse Event|0|||
19422256|NCT02308748|41668733|FG000|Period 3|Protocol Violation|0|||
19422257|NCT02308748|41668734|FG001|Period 3|Protocol Violation|0|||
19422258|NCT02308748|41668735|FG002|Period 3|Protocol Violation|0|||
19422259|NCT02308748|41668736|FG003|Period 3|Protocol Violation|0|||
19422260|NCT02308748|41668737|FG004|Period 3|Protocol Violation|0|||
19422261|NCT02308748|41668738|FG005|Period 3|Protocol Violation|0|||
19422262|NCT02308748|41668739|FG006|Period 3|Protocol Violation|0|||
19422263|NCT02308748|41668740|FG007|Period 3|Protocol Violation|0|||
19422264|NCT02308748|41668741|FG008|Period 3|Protocol Violation|0|||
19422265|NCT02308748|41668742|FG009|Period 3|Protocol Violation|1|||
19422266|NCT02308748|41668733|FG000|Period 5|Adverse Event|1|||
19422267|NCT02308748|41668734|FG001|Period 5|Adverse Event|0|||
19422268|NCT02308748|41668735|FG002|Period 5|Adverse Event|0|||
19422269|NCT02308748|41668736|FG003|Period 5|Adverse Event|0|||
19422270|NCT02308748|41668737|FG004|Period 5|Adverse Event|0|||
19422271|NCT02308748|41668738|FG005|Period 5|Adverse Event|0|||
19422272|NCT02308748|41668739|FG006|Period 5|Adverse Event|0|||
19422273|NCT02308748|41668740|FG007|Period 5|Adverse Event|0|||
19422274|NCT02308748|41668741|FG008|Period 5|Adverse Event|1|||
19422275|NCT02308748|41668742|FG009|Period 5|Adverse Event|0|||
19422276|NCT01646216|41668756|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
19422277|NCT01646216|41668757|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
19422278|NCT01646216|41668756|FG000|Overall Study|Did not complete training|0|||
19422279|NCT01646216|41668757|FG001|Overall Study|Did not complete training|2|||
19422280|NCT01646216|41668756|FG000|Overall Study|Investigator decision|1|||
19422281|NCT01646216|41668757|FG001|Overall Study|Investigator decision|1|||
19422282|NCT02308124|41668770|FG000|Overall Study|Lost to Follow-up|6|||
19422283|NCT02308124|41668771|FG001|Overall Study|Lost to Follow-up|6|||
19422284|NCT02308124|41668772|FG002|Overall Study|Lost to Follow-up|6|||
19422285|NCT02308124|41668770|FG000|Overall Study|Adverse Event|0|||
19422286|NCT02308124|41668771|FG001|Overall Study|Adverse Event|2|||
19422287|NCT02308124|41668772|FG002|Overall Study|Adverse Event|2|||
19422288|NCT02232061|41668780|FG000|Overall Study|Administrative problems|1|||
19422289|NCT02232061|41668780|FG000|Overall Study|Withdrawal by Subject|1|||
19422290|NCT02275481|41668786|FG000|Overall Study|Death|2|||
19422291|NCT02275481|41668787|FG001|Overall Study|Death|1|||
19422292|NCT02275481|41668786|FG000|Overall Study|Lost to Follow-up|2|||
19422293|NCT02275481|41668787|FG001|Overall Study|Lost to Follow-up|0|||
19422294|NCT02275481|41668786|FG000|Overall Study|Withdrawal by Subject|3|||
19422295|NCT02275481|41668787|FG001|Overall Study|Withdrawal by Subject|0|||
19422296|NCT02275481|41668786|FG000|Overall Study|all other reasons combined|2|||
19422297|NCT02275481|41668787|FG001|Overall Study|all other reasons combined|1|||
19422298|NCT02275481|41668786|FG000|Overall Study|Physician Decision|0|||
19422299|NCT02275481|41668787|FG001|Overall Study|Physician Decision|1|||
19422300|NCT02204449|41668795|FG000|Overall Study|Lost to Follow-up|7|||
19422301|NCT02204449|41668796|FG001|Overall Study|Lost to Follow-up|9|||
19422302|NCT02204449|41668795|FG000|Overall Study|Death|0|||
19422303|NCT02204449|41668796|FG001|Overall Study|Death|1|||
19422304|NCT02204449|41668795|FG000|Overall Study|Withdrawal by Subject|0|||
19422305|NCT02204449|41668796|FG001|Overall Study|Withdrawal by Subject|1|||
19422306|NCT02308046|41668804|FG000|Overall Study|Negative yeast culture at Baseline|32|||
19422307|NCT02308046|41668805|FG001|Overall Study|Negative yeast culture at Baseline|33|||
19422308|NCT02308046|41668804|FG000|Overall Study|Positive for STD at Baseline|1|||
19422309|NCT02308046|41668805|FG001|Overall Study|Positive for STD at Baseline|2|||
19422310|NCT02308046|41668804|FG000|Overall Study|Lost to Follow-up|1|||
19422311|NCT02308046|41668805|FG001|Overall Study|Lost to Follow-up|3|||
19422312|NCT02318693|41668813|FG000|Overall Study|Protocol Violation|0|||
19422313|NCT02318693|41668814|FG001|Overall Study|Protocol Violation|1|||
19422314|NCT02230891|41668823|FG000|Baseline|Did not meet inclusion|0|||
19422315|NCT02230891|41668824|FG001|Baseline|Did not meet inclusion|1|||
19422316|NCT02230891|41668825|FG002|Baseline|Did not meet inclusion|1|||
19422317|NCT02230891|41668823|FG000|2 Week|Withdrawal by Subject|2|||
19422318|NCT02230891|41668824|FG001|2 Week|Withdrawal by Subject|2|||
19422319|NCT02230891|41668825|FG002|2 Week|Withdrawal by Subject|0|||
19422320|NCT02230891|41668823|FG000|2 Week|Consent withdrawn|1|||
19422321|NCT02230891|41668824|FG001|2 Week|Consent withdrawn|0|||
19422322|NCT02230891|41668825|FG002|2 Week|Consent withdrawn|0|||
19422323|NCT02230891|41668823|FG000|6 Month|Withdrawal by Subject|1|||
19422324|NCT02230891|41668824|FG001|6 Month|Withdrawal by Subject|1|||
19422325|NCT02230891|41668825|FG002|6 Month|Withdrawal by Subject|1|||
19422326|NCT02230891|41668823|FG000|6 Month|Physician Decision|0|||
19422327|NCT02230891|41668824|FG001|6 Month|Physician Decision|2|||
19422328|NCT02230891|41668825|FG002|6 Month|Physician Decision|0|||
19422329|NCT02230891|41668823|FG000|12 Month|Death|1|||
19422330|NCT02230891|41668824|FG001|12 Month|Death|0|||
19422331|NCT02230891|41668825|FG002|12 Month|Death|0|||
19422332|NCT02230891|41668823|FG000|12 Month|Lost to Follow-up|0|||
19422333|NCT02230891|41668824|FG001|12 Month|Lost to Follow-up|1|||
19422334|NCT02230891|41668825|FG002|12 Month|Lost to Follow-up|0|||
19628190|NCT00802074|42077590|FG002|Overall Study|Adverse Event|1|||
19422335|NCT02230891|41668823|FG000|12 Month|Withdrawal by Subject|0|||
19422336|NCT02230891|41668824|FG001|12 Month|Withdrawal by Subject|2|||
19422337|NCT02230891|41668825|FG002|12 Month|Withdrawal by Subject|0|||
19422338|NCT02230891|41668823|FG000|18 Month End of Study|Death|0|||
19422339|NCT02230891|41668824|FG001|18 Month End of Study|Death|0|||
19422340|NCT02230891|41668825|FG002|18 Month End of Study|Death|1|||
19422341|NCT02230891|41668823|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
19422342|NCT02230891|41668824|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
19422343|NCT02230891|41668825|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
19422344|NCT01646138|41668840|FG000|Overall Study|Lost to Follow-up|0|||
19422345|NCT01646138|41668841|FG001|Overall Study|Lost to Follow-up|0|||
19422346|NCT01646138|41668842|FG002|Overall Study|Lost to Follow-up|0|||
19422347|NCT01646138|41668843|FG003|Overall Study|Lost to Follow-up|0|||
19422348|NCT01646138|41668844|FG004|Overall Study|Lost to Follow-up|2|||
19422349|NCT02204371|41668856|FG000|Overall Study|Adverse Event|1|||
19422350|NCT02274857|41668862|FG000|Overall Study|Adverse Event|1|||
19422351|NCT02274857|41668863|FG001|Overall Study|Adverse Event|0|||
19422352|NCT02274857|41668862|FG000|Overall Study|Death|1|||
19422353|NCT02274857|41668863|FG001|Overall Study|Death|2|||
19422354|NCT02274857|41668862|FG000|Overall Study|Lost to Follow-up|3|||
19422355|NCT02274857|41668863|FG001|Overall Study|Lost to Follow-up|0|||
19422356|NCT02274857|41668862|FG000|Overall Study|Physician Decision|2|||
19422357|NCT02274857|41668863|FG001|Overall Study|Physician Decision|0|||
19422358|NCT02274857|41668862|FG000|Overall Study|Trial screen failure|0|||
19422359|NCT02274857|41668863|FG001|Overall Study|Trial screen failure|2|||
19422360|NCT02274857|41668862|FG000|Overall Study|Withdrawal by Subject|11|||
19422361|NCT02274857|41668863|FG001|Overall Study|Withdrawal by Subject|2|||
19520123|NCT01469052|41932727|FG004|Overall Study|Adverse Event|0|||
19520124|NCT01469052|41932728|FG005|Overall Study|Adverse Event|1|||
19520125|NCT01469052|41932723|FG000|Overall Study|Progressive disease|3|||
19520126|NCT01469052|41932724|FG001|Overall Study|Progressive disease|0|||
19520127|NCT01469052|41932725|FG002|Overall Study|Progressive disease|5|||
19520128|NCT01469052|41932726|FG003|Overall Study|Progressive disease|3|||
19520129|NCT01469052|41932727|FG004|Overall Study|Progressive disease|7|||
19520130|NCT01469052|41932728|FG005|Overall Study|Progressive disease|2|||
19520131|NCT01469052|41932723|FG000|Overall Study|Lack of Efficacy|0|||
19520132|NCT01469052|41932724|FG001|Overall Study|Lack of Efficacy|0|||
19520133|NCT01469052|41932725|FG002|Overall Study|Lack of Efficacy|0|||
19520134|NCT01469052|41932726|FG003|Overall Study|Lack of Efficacy|0|||
19520135|NCT01469052|41932727|FG004|Overall Study|Lack of Efficacy|0|||
19520136|NCT01469052|41932728|FG005|Overall Study|Lack of Efficacy|2|||
19520137|NCT01469052|41932723|FG000|Overall Study|Moved to rollover protocol|1|||
19520138|NCT01469052|41932724|FG001|Overall Study|Moved to rollover protocol|0|||
19520139|NCT01469052|41932725|FG002|Overall Study|Moved to rollover protocol|1|||
19520140|NCT01469052|41932726|FG003|Overall Study|Moved to rollover protocol|0|||
19520141|NCT01469052|41932727|FG004|Overall Study|Moved to rollover protocol|0|||
19520142|NCT01469052|41932728|FG005|Overall Study|Moved to rollover protocol|1|||
19520143|NCT01469052|41932723|FG000|Overall Study|Other|0|||
19520144|NCT01469052|41932724|FG001|Overall Study|Other|1|||
19520145|NCT01469052|41932725|FG002|Overall Study|Other|0|||
19520146|NCT01469052|41932726|FG003|Overall Study|Other|0|||
19520147|NCT01469052|41932727|FG004|Overall Study|Other|1|||
19520148|NCT01469052|41932728|FG005|Overall Study|Other|0|||
19520149|NCT01442688|41932742|FG000|First Intervention|Withdrawal by Subject|1|||
19520150|NCT01442688|41932743|FG001|First Intervention|Withdrawal by Subject|0|||
19520151|NCT01442688|41932742|FG000|First Intervention|subject incarcerated|1|||
19520152|NCT01442688|41932743|FG001|First Intervention|subject incarcerated|0|||
19520153|NCT01442688|41932742|FG000|Second Intervention|Adverse Event|1|||
19520154|NCT01442688|41932743|FG001|Second Intervention|Adverse Event|0|||
19520155|NCT01468818|41932749|FG000|Overall Study|Death during treatment|2|||
19520156|NCT01442376|41932756|FG000|Overall Study|Adverse Event|0|||
19520157|NCT01442376|41932757|FG001|Overall Study|Adverse Event|3|||
19520158|NCT01442376|41932758|FG002|Overall Study|Adverse Event|2|||
19520159|NCT01442376|41932756|FG000|Overall Study|Death|0|||
19520160|NCT01442376|41932757|FG001|Overall Study|Death|1|||
19520161|NCT01442376|41932758|FG002|Overall Study|Death|1|||
19520162|NCT01442376|41932756|FG000|Overall Study|Withdrawal of consent|0|||
19520163|NCT01442376|41932757|FG001|Overall Study|Withdrawal of consent|0|||
19520164|NCT01442376|41932758|FG002|Overall Study|Withdrawal of consent|1|||
19520165|NCT01442376|41932756|FG000|Overall Study|Patients not treated|2|||
19520166|NCT01442376|41932757|FG001|Overall Study|Patients not treated|3|||
19520167|NCT01442376|41932758|FG002|Overall Study|Patients not treated|1|||
19520168|NCT01442376|41932756|FG000|Overall Study|Not eligible for subsequent cycles|1|||
19520169|NCT01442376|41932757|FG001|Overall Study|Not eligible for subsequent cycles|2|||
19520170|NCT01442376|41932758|FG002|Overall Study|Not eligible for subsequent cycles|0|||
19422362|NCT02274857|41668862|FG000|Overall Study|Other|2|||
19520171|NCT01442064|41932772|FG000|Overall Study|Adverse Event|2|||
19520172|NCT01442064|41932773|FG001|Overall Study|Adverse Event|2|||
19520173|NCT01442064|41932774|FG002|Overall Study|Adverse Event|2|||
19520174|NCT01442064|41932775|FG003|Overall Study|Adverse Event|1|||
19520175|NCT01442064|41932776|FG004|Overall Study|Adverse Event|2|||
19520176|NCT01442064|41932777|FG005|Overall Study|Adverse Event|0|||
19520177|NCT01442064|41932772|FG000|Overall Study|Death|0|||
19520178|NCT01442064|41932773|FG001|Overall Study|Death|1|||
19520179|NCT01442064|41932774|FG002|Overall Study|Death|3|||
19520180|NCT01442064|41932775|FG003|Overall Study|Death|3|||
19520181|NCT01442064|41932776|FG004|Overall Study|Death|1|||
19422363|NCT02274857|41668863|FG001|Overall Study|Other|0|||
19422364|NCT02302859|41668872|FG000|Overall Study|Lost Phone|1|||
19422365|NCT02302859|41668873|FG001|Overall Study|Lost Phone|1|||
19422366|NCT02302859|41668872|FG000|Overall Study|Withdrawal by Subject|0|||
19422367|NCT02302859|41668873|FG001|Overall Study|Withdrawal by Subject|1|||
19422368|NCT02274311|41668879|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
19422369|NCT02316353|41668887|FG000|Overall Study|Pregnancy|1|||
19422370|NCT02316353|41668888|FG001|Overall Study|Pregnancy|3|||
19422371|NCT02316353|41668887|FG000|Overall Study|Adverse Event|1|||
19422372|NCT02316353|41668888|FG001|Overall Study|Adverse Event|3|||
19422373|NCT02316353|41668887|FG000|Overall Study|Withdrawal by Subject|6|||
19422374|NCT02316353|41668888|FG001|Overall Study|Withdrawal by Subject|2|||
19422375|NCT02273141|41668899|FG000|Overall Study|Adverse Event|0|||
19422376|NCT02273141|41668900|FG001|Overall Study|Adverse Event|1|||
19422377|NCT02273141|41668899|FG000|Overall Study|Lost to Follow-up|1|||
19422378|NCT02273141|41668900|FG001|Overall Study|Lost to Follow-up|3|||
19422379|NCT02273141|41668899|FG000|Overall Study|Withdrawal by Subject|10|||
19422380|NCT02273141|41668900|FG001|Overall Study|Withdrawal by Subject|15|||
19422381|NCT02273141|41668899|FG000|Overall Study|Various|6|||
19422382|NCT02273141|41668900|FG001|Overall Study|Various|6|||
19422383|NCT02314052|41668906|FG000|Cycle One|Adverse Event|0|||
19422384|NCT02314052|41668907|FG001|Cycle One|Adverse Event|0|||
19422385|NCT02314052|41668908|FG002|Cycle One|Adverse Event|0|||
19422386|NCT02314052|41668909|FG003|Cycle One|Adverse Event|1|||
19422387|NCT02314052|41668910|FG004|Cycle One|Adverse Event|0|||
19422388|NCT02314052|41668911|FG005|Cycle One|Adverse Event|0|||
19422389|NCT02279732|41668927|FG000|Overall Study|Death|23|||
19422390|NCT02279732|41668928|FG001|Overall Study|Death|20|||
19422391|NCT02279732|41668927|FG000|Overall Study|Disease Progression|13|||
19422392|NCT02279732|41668928|FG001|Overall Study|Disease Progression|3|||
19422393|NCT02279732|41668927|FG000|Overall Study|Withdrawal by Subject|2|||
19422394|NCT02279732|41668928|FG001|Overall Study|Withdrawal by Subject|7|||
19422395|NCT02279732|41668927|FG000|Overall Study|Adverse Event|1|||
19422396|NCT02279732|41668928|FG001|Overall Study|Adverse Event|2|||
19422397|NCT02279732|41668927|FG000|Overall Study|Administrative Reason By Sponsor|0|||
19422398|NCT02279732|41668928|FG001|Overall Study|Administrative Reason By Sponsor|2|||
19422399|NCT02279732|41668927|FG000|Overall Study|Study Drug Toxicity|2|||
19422400|NCT02279732|41668928|FG001|Overall Study|Study Drug Toxicity|0|||
19422401|NCT02279732|41668927|FG000|Overall Study|Lost to Follow-up|0|||
19422402|NCT02279732|41668928|FG001|Overall Study|Lost to Follow-up|1|||
19422403|NCT02279732|41668927|FG000|Overall Study|Maximum Clinical Benefit|1|||
19422404|NCT02279732|41668928|FG001|Overall Study|Maximum Clinical Benefit|0|||
19422405|NCT02279732|41668927|FG000|Overall Study|Subject Requested to Discontinue|0|||
19422406|NCT02279732|41668928|FG001|Overall Study|Subject Requested to Discontinue|1|||
19422407|NCT02279732|41668927|FG000|Overall Study|Other|53|||
19422408|NCT02279732|41668928|FG001|Overall Study|Other|67|||
19422409|NCT02279732|41668927|FG000|Overall Study|Other|3|||
19422410|NCT02279732|41668928|FG001|Overall Study|Other|3|||
19422411|NCT02279498|41668936|FG000|Overall Study|Adverse Event|3|||
19422412|NCT02279498|41668937|FG001|Overall Study|Adverse Event|0|||
19422413|NCT02279498|41668936|FG000|Overall Study|Lack of Efficacy|4|||
19422414|NCT02279498|41668937|FG001|Overall Study|Lack of Efficacy|0|||
19422415|NCT02279498|41668936|FG000|Overall Study|Lost to Follow-up|0|||
19422416|NCT02279498|41668937|FG001|Overall Study|Lost to Follow-up|1|||
19422417|NCT02279498|41668936|FG000|Overall Study|Withdrawal by Subject|9|||
19422418|NCT02279498|41668937|FG001|Overall Study|Withdrawal by Subject|2|||
19422419|NCT02279498|41668936|FG000|Overall Study|Undefined|2|||
19422420|NCT02279498|41668937|FG001|Overall Study|Undefined|1|||
19422421|NCT02307266|41668947|FG000|Overall Study|Adverse Event|3|||
19422422|NCT02307266|41668948|FG001|Overall Study|Adverse Event|1|||
19422423|NCT02307266|41668949|FG002|Overall Study|Adverse Event|5|||
19422424|NCT02307266|41668947|FG000|Overall Study|Withdrawal by Subject|2|||
19422425|NCT02307266|41668948|FG001|Overall Study|Withdrawal by Subject|0|||
19422426|NCT02307266|41668949|FG002|Overall Study|Withdrawal by Subject|1|||
19422427|NCT02307266|41668947|FG000|Overall Study|Lost to Follow-up|3|||
19422428|NCT02307266|41668948|FG001|Overall Study|Lost to Follow-up|0|||
19422429|NCT02307266|41668949|FG002|Overall Study|Lost to Follow-up|0|||
19422430|NCT02279420|41668957|FG000|Overall Study|Lost to Follow-up|23|||
19422431|NCT02278952|41668961|FG000|Overall Study|Insufficient Sample|6|||
19422432|NCT02278328|41668971|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
19422433|NCT02278328|41668972|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
19422434|NCT02278328|41668973|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
19422435|NCT02278328|41668971|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
19422436|NCT02278328|41668972|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
19422437|NCT02278328|41668973|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
19422438|NCT02278328|41668971|FG000|Neuropsych Screening|incomplete consent|0|||
19422439|NCT02278328|41668972|FG001|Neuropsych Screening|incomplete consent|0|||
19422440|NCT02278328|41668973|FG002|Neuropsych Screening|incomplete consent|2|||
19422441|NCT02314637|41668981|FG000|Overall Study|Adverse Event|4|||
19422442|NCT02314637|41668982|FG001|Overall Study|Adverse Event|8|||
19422443|NCT02314637|41668981|FG000|Overall Study|Lack of Efficacy|1|||
19422444|NCT02314637|41668982|FG001|Overall Study|Lack of Efficacy|0|||
19422445|NCT02314637|41668981|FG000|Overall Study|Physician Decision|5|||
19422446|NCT02314637|41668982|FG001|Overall Study|Physician Decision|2|||
19422447|NCT02314637|41668981|FG000|Overall Study|Withdrawal by Subject|5|||
19520182|NCT01442064|41932777|FG005|Overall Study|Death|3|||
19520183|NCT01442064|41932772|FG000|Overall Study|Lost to Follow-up|5|||
19520184|NCT01442064|41932773|FG001|Overall Study|Lost to Follow-up|5|||
19520185|NCT01442064|41932774|FG002|Overall Study|Lost to Follow-up|1|||
19520186|NCT01442064|41932775|FG003|Overall Study|Lost to Follow-up|1|||
19520187|NCT01442064|41932776|FG004|Overall Study|Lost to Follow-up|3|||
19520188|NCT01442064|41932777|FG005|Overall Study|Lost to Follow-up|3|||
19520189|NCT01442064|41932772|FG000|Overall Study|Physician Decision|1|||
19520190|NCT01442064|41932773|FG001|Overall Study|Physician Decision|1|||
19520191|NCT01442064|41932774|FG002|Overall Study|Physician Decision|2|||
19520192|NCT01442064|41932775|FG003|Overall Study|Physician Decision|3|||
19520193|NCT01442064|41932776|FG004|Overall Study|Physician Decision|3|||
19520194|NCT01442064|41932777|FG005|Overall Study|Physician Decision|1|||
19520195|NCT01442064|41932772|FG000|Overall Study|Withdrawal by Subject|6|||
19520196|NCT01442064|41932773|FG001|Overall Study|Withdrawal by Subject|3|||
19520197|NCT01442064|41932774|FG002|Overall Study|Withdrawal by Subject|2|||
19520198|NCT01442064|41932775|FG003|Overall Study|Withdrawal by Subject|2|||
19520199|NCT01442064|41932776|FG004|Overall Study|Withdrawal by Subject|2|||
19520200|NCT01442064|41932777|FG005|Overall Study|Withdrawal by Subject|1|||
19520201|NCT01442064|41932772|FG000|Overall Study|Sponsor decision|82|||
19520202|NCT01442064|41932773|FG001|Overall Study|Sponsor decision|88|||
19520203|NCT01442064|41932774|FG002|Overall Study|Sponsor decision|92|||
19520204|NCT01442064|41932775|FG003|Overall Study|Sponsor decision|88|||
19520205|NCT01442064|41932776|FG004|Overall Study|Sponsor decision|95|||
19520206|NCT01442064|41932777|FG005|Overall Study|Sponsor decision|87|||
19520207|NCT01442064|41932772|FG000|Overall Study|Subject non-compliance|0|||
19520208|NCT01442064|41932773|FG001|Overall Study|Subject non-compliance|0|||
19520209|NCT01442064|41932774|FG002|Overall Study|Subject non-compliance|0|||
19520210|NCT01442064|41932775|FG003|Overall Study|Subject non-compliance|0|||
19520211|NCT01442064|41932776|FG004|Overall Study|Subject non-compliance|0|||
19520212|NCT01442064|41932777|FG005|Overall Study|Subject non-compliance|2|||
19520213|NCT01442064|41932772|FG000|Overall Study|Condition mandated other intervention|1|||
19520214|NCT01442064|41932773|FG001|Overall Study|Condition mandated other intervention|1|||
19520215|NCT01442064|41932774|FG002|Overall Study|Condition mandated other intervention|2|||
19520216|NCT01442064|41932775|FG003|Overall Study|Condition mandated other intervention|0|||
19520217|NCT01442064|41932776|FG004|Overall Study|Condition mandated other intervention|0|||
19520218|NCT01442064|41932777|FG005|Overall Study|Condition mandated other intervention|2|||
19520219|NCT01467960|41932800|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
19520220|NCT01467960|41932801|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
19520221|NCT01467960|41932802|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
19520222|NCT01467960|41932803|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
19520223|NCT01467960|41932804|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
19520224|NCT01467960|41932805|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
19520225|NCT01441596|41932822|FG000|Overall Study|Other reason not defined below|0|||
19520226|NCT01441596|41932823|FG001|Overall Study|Other reason not defined below|2|||
19520227|NCT01441596|41932824|FG002|Overall Study|Other reason not defined below|1|||
19520228|NCT01441596|41932822|FG000|Overall Study|Withdrawal by Subject|4|||
19520229|NCT01441596|41932823|FG001|Overall Study|Withdrawal by Subject|0|||
19520230|NCT01441596|41932824|FG002|Overall Study|Withdrawal by Subject|2|||
19520231|NCT01441596|41932822|FG000|Overall Study|Not treated|0|||
19520232|NCT01441596|41932823|FG001|Overall Study|Not treated|1|||
19520233|NCT01441596|41932824|FG002|Overall Study|Not treated|1|||
19520234|NCT01441440|41932835|FG000|Overall Study|Death|1|||
19520235|NCT01441440|41932836|FG001|Overall Study|Death|0|||
19520236|NCT01441440|41932837|FG002|Overall Study|Death|1|||
19520237|NCT01441440|41932835|FG000|Overall Study|Adverse Event|2|||
19520238|NCT01441440|41932836|FG001|Overall Study|Adverse Event|9|||
19628191|NCT00802074|42077591|FG003|Overall Study|Adverse Event|0|||
19520239|NCT01441440|41932837|FG002|Overall Study|Adverse Event|9|||
19520240|NCT01441440|41932835|FG000|Overall Study|Lost to Follow-up|0|||
19520241|NCT01441440|41932836|FG001|Overall Study|Lost to Follow-up|2|||
19520242|NCT01441440|41932837|FG002|Overall Study|Lost to Follow-up|1|||
19520243|NCT01441440|41932835|FG000|Overall Study|Withdrawal by Subject|11|||
19520244|NCT01441440|41932836|FG001|Overall Study|Withdrawal by Subject|9|||
19422448|NCT02314637|41668982|FG001|Overall Study|Withdrawal by Subject|4|||
19422449|NCT02314637|41668981|FG000|Overall Study|Other Reason|1|||
19520245|NCT01441440|41932837|FG002|Overall Study|Withdrawal by Subject|9|||
19520246|NCT01441440|41932835|FG000|Overall Study|Pregnancy|1|||
19520247|NCT01441440|41932836|FG001|Overall Study|Pregnancy|0|||
19520248|NCT01441440|41932837|FG002|Overall Study|Pregnancy|0|||
19422450|NCT02314637|41668982|FG001|Overall Study|Other Reason|0|||
19422451|NCT01646645|41668988|FG000|Overall Study|No Treated|1|||
19422452|NCT01646645|41668988|FG000|Overall Study|Inevaluable Donor|29|||
19422453|NCT02272985|41668992|FG000|Overall Study|Withdrawal by Subject|1|||
19422454|NCT02272985|41668992|FG000|Overall Study|hip fracture|1|||
19422455|NCT02272985|41668992|FG000|Overall Study|kidney transplantation|1|||
19422456|NCT01644149|41668999|FG000|Overall Study|Withdrawal by Subject|1|||
19422457|NCT01644149|41669000|FG001|Overall Study|Withdrawal by Subject|0|||
19422458|NCT01644149|41668999|FG000|Overall Study|Lost to Follow-up|3|||
19422459|NCT01644149|41669000|FG001|Overall Study|Lost to Follow-up|1|||
19422460|NCT02313233|41669009|FG000|Overall Study|Withdrawal by Subject|1|||
19422461|NCT02313233|41669010|FG001|Overall Study|Withdrawal by Subject|2|||
19422462|NCT02313233|41669009|FG000|Overall Study|Administrative reason|1|||
19422463|NCT02313233|41669010|FG001|Overall Study|Administrative reason|1|||
19422464|NCT02305238|41669021|FG000|Overall Study|Death|2|||
19422465|NCT02305238|41669022|FG001|Overall Study|Death|1|||
19422466|NCT02305238|41669023|FG002|Overall Study|Death|0|||
19422467|NCT02305238|41669021|FG000|Overall Study|Progressive disease|4|||
19422468|NCT02305238|41669022|FG001|Overall Study|Progressive disease|4|||
19422469|NCT02305238|41669023|FG002|Overall Study|Progressive disease|0|||
19422470|NCT02305238|41669021|FG000|Overall Study|Logistical difficulties|1|||
19422471|NCT02305238|41669022|FG001|Overall Study|Logistical difficulties|3|||
19422472|NCT02305238|41669023|FG002|Overall Study|Logistical difficulties|0|||
19422473|NCT02305238|41669021|FG000|Overall Study|Protocol Violation|0|||
19422474|NCT02305238|41669022|FG001|Overall Study|Protocol Violation|3|||
19422475|NCT02305238|41669023|FG002|Overall Study|Protocol Violation|0|||
19422476|NCT02305238|41669021|FG000|Overall Study|Physician Decision|2|||
19422477|NCT02305238|41669022|FG001|Overall Study|Physician Decision|1|||
19422478|NCT02305238|41669023|FG002|Overall Study|Physician Decision|0|||
19422479|NCT02305238|41669021|FG000|Overall Study|Adverse Event|4|||
19422480|NCT02305238|41669022|FG001|Overall Study|Adverse Event|2|||
19422481|NCT02305238|41669023|FG002|Overall Study|Adverse Event|0|||
19422482|NCT02305238|41669021|FG000|Overall Study|Withdrawal by Subject|3|||
19422483|NCT02305238|41669022|FG001|Overall Study|Withdrawal by Subject|4|||
19422484|NCT02305238|41669023|FG002|Overall Study|Withdrawal by Subject|0|||
19422485|NCT02305238|41669021|FG000|Overall Study|Randomized failure|0|||
19422486|NCT02305238|41669022|FG001|Overall Study|Randomized failure|0|||
19422487|NCT02305238|41669023|FG002|Overall Study|Randomized failure|8|||
19422488|NCT02305238|41669021|FG000|Overall Study|Required procedure failed|0|||
19422489|NCT02305238|41669022|FG001|Overall Study|Required procedure failed|1|||
19422490|NCT02305238|41669023|FG002|Overall Study|Required procedure failed|0|||
19422491|NCT02313155|41669032|FG000|Overall Study|Lost to Follow-up|0|||
19422492|NCT02313155|41669033|FG001|Overall Study|Lost to Follow-up|1|||
19422493|NCT02204293|41669041|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
19422494|NCT02204293|41669042|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
19422495|NCT02204293|41669043|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
19422496|NCT02204293|41669044|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
19422497|NCT02204293|41669045|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
19422498|NCT02204293|41669046|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
19422499|NCT02204293|41669041|FG000|Core Study Part I|Adverse Event|1|||
19422500|NCT02204293|41669042|FG001|Core Study Part I|Adverse Event|0|||
19422501|NCT02204293|41669043|FG002|Core Study Part I|Adverse Event|0|||
19422502|NCT02204293|41669044|FG003|Core Study Part I|Adverse Event|0|||
19422503|NCT02204293|41669045|FG004|Core Study Part I|Adverse Event|0|||
19422504|NCT02204293|41669046|FG005|Core Study Part I|Adverse Event|0|||
19422505|NCT02204293|41669041|FG000|Core Study Part I|Physician Decision|0|||
19422506|NCT02204293|41669042|FG001|Core Study Part I|Physician Decision|3|||
19422507|NCT02204293|41669043|FG002|Core Study Part I|Physician Decision|0|||
19422508|NCT02204293|41669044|FG003|Core Study Part I|Physician Decision|0|||
19422509|NCT02204293|41669045|FG004|Core Study Part I|Physician Decision|0|||
19422510|NCT02204293|41669046|FG005|Core Study Part I|Physician Decision|0|||
19422511|NCT02204293|41669041|FG000|LTE Phase|Study Suspended|0|||
19422512|NCT02204293|41669042|FG001|LTE Phase|Study Suspended|0|||
19520249|NCT01441440|41932835|FG000|Overall Study|Lack of Efficacy|1|||
19422513|NCT02204293|41669043|FG002|LTE Phase|Study Suspended|0|||
19422514|NCT02204293|41669044|FG003|LTE Phase|Study Suspended|0|||
19422515|NCT02204293|41669045|FG004|LTE Phase|Study Suspended|0|||
19422516|NCT02204293|41669046|FG005|LTE Phase|Study Suspended|7|||
19422517|NCT02304926|41669062|FG000|Overall Study|Lost to Follow-up|2|||
19422518|NCT02304926|41669063|FG001|Overall Study|Lost to Follow-up|1|||
19422519|NCT01646255|41669073|FG000|Overall Study|Adverse Event|7|||
19422520|NCT01646255|41669074|FG001|Overall Study|Adverse Event|8|||
19422521|NCT01646255|41669073|FG000|Overall Study|Lack of Efficacy|2|||
19422522|NCT01646255|41669074|FG001|Overall Study|Lack of Efficacy|0|||
19422523|NCT01646255|41669073|FG000|Overall Study|Withdrawal by Subject|10|||
19422524|NCT01646255|41669074|FG001|Overall Study|Withdrawal by Subject|6|||
19422525|NCT01646255|41669073|FG000|Overall Study|Compliance is not well|1|||
19422526|NCT01646255|41669074|FG001|Overall Study|Compliance is not well|0|||
19422527|NCT01646255|41669073|FG000|Overall Study|Inclusion Criteria Deviation|1|||
19422528|NCT01646255|41669074|FG001|Overall Study|Inclusion Criteria Deviation|0|||
19422529|NCT02304380|41669087|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
19422530|NCT02304380|41669088|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
19422531|NCT02304380|41669089|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
19422532|NCT02304380|41669090|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
19422533|NCT02304380|41669091|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
19422534|NCT02304380|41669092|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
19422535|NCT02203591|41669114|FG000|Overall Study|Did not meet treatment day baseline|147|||
19422536|NCT02203591|41669115|FG001|Overall Study|Did not meet treatment day baseline|141|||
19422537|NCT02203591|41669116|FG002|Overall Study|Did not meet treatment day baseline|150|||
19422538|NCT02203591|41669117|FG003|Overall Study|Did not meet treatment day baseline|45|||
19422539|NCT02203591|41669118|FG004|Overall Study|Did not meet treatment day baseline|33|||
19422540|NCT02203591|41669119|FG005|Overall Study|Did not meet treatment day baseline|35|||
19422541|NCT02203591|41669120|FG006|Overall Study|Did not meet treatment day baseline|29|||
19422542|NCT02203591|41669121|FG007|Overall Study|Did not meet treatment day baseline|12|||
19422543|NCT02203591|41669114|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
19422544|NCT02203591|41669115|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
19422545|NCT02203591|41669116|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
19422546|NCT02203591|41669117|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
19422547|NCT02203591|41669118|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
19422548|NCT02203591|41669119|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
19422549|NCT02203591|41669120|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
19422550|NCT02203591|41669121|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
19422551|NCT01642277|41669145|FG000|Overall Study|Adverse Event|10|||
19422552|NCT01642277|41669146|FG001|Overall Study|Adverse Event|0|||
19422553|NCT01642277|41669145|FG000|Overall Study|Physician Decision|2|||
19422554|NCT01642277|41669146|FG001|Overall Study|Physician Decision|0|||
19422555|NCT01642277|41669145|FG000|Overall Study|Protocol Violation|1|||
19422556|NCT01642277|41669146|FG001|Overall Study|Protocol Violation|0|||
19422557|NCT01642277|41669145|FG000|Overall Study|Withdrawal by Subject|11|||
19422558|NCT01642277|41669146|FG001|Overall Study|Withdrawal by Subject|0|||
19422559|NCT02230189|41669156|FG000|Overall Study|Withdrawal by Subject|3|||
19422560|NCT02230189|41669157|FG001|Overall Study|Withdrawal by Subject|0|||
19422561|NCT02230189|41669158|FG002|Overall Study|Withdrawal by Subject|1|||
19422562|NCT02230189|41669156|FG000|Overall Study|Lost to Follow-up|1|||
19422563|NCT02230189|41669157|FG001|Overall Study|Lost to Follow-up|0|||
19422564|NCT02230189|41669158|FG002|Overall Study|Lost to Follow-up|0|||
19422565|NCT02230189|41669156|FG000|Overall Study|Physician Decision|1|||
19520250|NCT01441440|41932836|FG001|Overall Study|Lack of Efficacy|0|||
19520251|NCT01441440|41932837|FG002|Overall Study|Lack of Efficacy|1|||
19520252|NCT01441440|41932835|FG000|Overall Study|Moving|0|||
19520253|NCT01441440|41932836|FG001|Overall Study|Moving|1|||
19520254|NCT01441440|41932837|FG002|Overall Study|Moving|1|||
19520255|NCT01441440|41932835|FG000|Overall Study|Work-related matter|0|||
19520256|NCT01441440|41932836|FG001|Overall Study|Work-related matter|1|||
19520257|NCT01441440|41932837|FG002|Overall Study|Work-related matter|0|||
19520258|NCT01441440|41932835|FG000|Overall Study|Difficllty in keeping the schedule|1|||
19520259|NCT01441440|41932836|FG001|Overall Study|Difficllty in keeping the schedule|1|||
19520260|NCT01441440|41932837|FG002|Overall Study|Difficllty in keeping the schedule|0|||
19520261|NCT01438476|41932847|FG000|Overall Study|Protocol Violation|1|||
19520262|NCT01438476|41932848|FG001|Overall Study|Protocol Violation|0|||
19520263|NCT01438476|41932847|FG000|Overall Study|Withdrawal by Subject|1|||
19520264|NCT01438476|41932848|FG001|Overall Study|Withdrawal by Subject|0|||
19520265|NCT01438476|41932847|FG000|Overall Study|No Surgery- Disease|8|||
19520266|NCT01438476|41932848|FG001|Overall Study|No Surgery- Disease|10|||
19520267|NCT01438476|41932847|FG000|Overall Study|Communication barrier|0|||
19520268|NCT01438476|41932848|FG001|Overall Study|Communication barrier|1|||
19520269|NCT01467570|41932856|FG000|Overall Study|Lost to Follow-up|8|||
19520270|NCT01467570|41932857|FG001|Overall Study|Lost to Follow-up|9|||
19520271|NCT01437540|41932867|FG000|Overall Study|Not listed below|7|||
19520272|NCT01437540|41932868|FG001|Overall Study|Not listed below|6|||
19520273|NCT01437540|41932867|FG000|Overall Study|COPD exacerbation|13|||
19520274|NCT01437540|41932868|FG001|Overall Study|COPD exacerbation|3|||
19520275|NCT01437540|41932867|FG000|Overall Study|Lost to Follow-up|3|||
19520276|NCT01437540|41932868|FG001|Overall Study|Lost to Follow-up|5|||
19520277|NCT01437540|41932867|FG000|Overall Study|Lack of Efficacy|23|||
19520278|NCT01437540|41932868|FG001|Overall Study|Lack of Efficacy|11|||
19520279|NCT01437540|41932867|FG000|Overall Study|Protocol Violation|24|||
19520280|NCT01437540|41932868|FG001|Overall Study|Protocol Violation|12|||
19520281|NCT01437540|41932867|FG000|Overall Study|Adverse Event|26|||
19520282|NCT01437540|41932868|FG001|Overall Study|Adverse Event|13|||
19520283|NCT01437540|41932867|FG000|Overall Study|Withdrawal by Subject|31|||
19520284|NCT01437540|41932868|FG001|Overall Study|Withdrawal by Subject|15|||
19422566|NCT02230189|41669157|FG001|Overall Study|Physician Decision|0|||
19422567|NCT02230189|41669158|FG002|Overall Study|Physician Decision|0|||
19422568|NCT02304302|41669169|FG000|Overall Study|Adverse Event|2|||
19422569|NCT02304302|41669170|FG001|Overall Study|Adverse Event|3|||
19422570|NCT02304302|41669169|FG000|Overall Study|Lost to Follow-up|1|||
19422571|NCT02304302|41669170|FG001|Overall Study|Lost to Follow-up|4|||
19422572|NCT02304302|41669169|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
19422573|NCT02304302|41669170|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
19422574|NCT02276612|41669182|FG000|Overall Study|Death|1|||
19422575|NCT02276612|41669183|FG001|Overall Study|Death|0|||
19422576|NCT02276612|41669182|FG000|Overall Study|Pregnancy|1|||
19422577|NCT02276612|41669183|FG001|Overall Study|Pregnancy|0|||
19422578|NCT02276612|41669182|FG000|Overall Study|Withdrew Consent|1|||
19422579|NCT02276612|41669183|FG001|Overall Study|Withdrew Consent|0|||
19422580|NCT02276612|41669182|FG000|Overall Study|Lost to Follow-up|1|||
19422581|NCT02276612|41669183|FG001|Overall Study|Lost to Follow-up|0|||
19422582|NCT02301143|41669189|FG000|Induction Period|Enrolled But Not Treated|1|||
19422583|NCT02301143|41669190|FG001|Induction Period|Enrolled But Not Treated|0|||
19422584|NCT02301143|41669189|FG000|Induction Period|Death|1|||
19422585|NCT02301143|41669190|FG001|Induction Period|Death|0|||
19422586|NCT02301143|41669189|FG000|Induction Period|Adverse Event|22|||
19422587|NCT02301143|41669190|FG001|Induction Period|Adverse Event|0|||
19422588|NCT02301143|41669189|FG000|Induction Period|Progressive Disease|8|||
19422589|NCT02301143|41669190|FG001|Induction Period|Progressive Disease|0|||
19422590|NCT02301143|41669189|FG000|Induction Period|Withdrawal by Subject|3|||
19422591|NCT02301143|41669190|FG001|Induction Period|Withdrawal by Subject|0|||
19422592|NCT02301143|41669189|FG000|Induction Period|Noncompliance with Study Drug|1|||
19422593|NCT02301143|41669190|FG001|Induction Period|Noncompliance with Study Drug|0|||
19422594|NCT02301143|41669189|FG000|Induction Period|Physician Decision|4|||
19422595|NCT02301143|41669190|FG001|Induction Period|Physician Decision|0|||
19422596|NCT02301143|41669189|FG000|Induction Period|Symptomatic Deterioration|2|||
19422597|NCT02301143|41669190|FG001|Induction Period|Symptomatic Deterioration|0|||
19422598|NCT02301143|41669189|FG000|Induction Period|Protocol Violation|2|||
19422599|NCT02301143|41669190|FG001|Induction Period|Protocol Violation|0|||
19422600|NCT02301143|41669189|FG000|Induction Period|Other|1|||
19422601|NCT02301143|41669190|FG001|Induction Period|Other|0|||
19422602|NCT02301143|41669189|FG000|Investigator's Choice|Adverse Event|0|||
19422603|NCT02301143|41669190|FG001|Investigator's Choice|Adverse Event|3|||
19422604|NCT02301143|41669189|FG000|Investigator's Choice|Progressive Disease|0|||
19422605|NCT02301143|41669190|FG001|Investigator's Choice|Progressive Disease|3|||
19422606|NCT02301143|41669189|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
19422607|NCT02301143|41669190|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
19422608|NCT02301143|41669189|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
19422609|NCT02301143|41669190|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
19422610|NCT02301143|41669189|FG000|Investigator's Choice|Other|0|||
19422611|NCT02301143|41669190|FG001|Investigator's Choice|Other|1|||
19422612|NCT02301143|41669189|FG000|Investigator's Choice|Unresectable Surgery|0|||
19422613|NCT02301143|41669190|FG001|Investigator's Choice|Unresectable Surgery|1|||
19422614|NCT02276222|41669203|FG000|Overall Study|Adverse Event|62|||
19422615|NCT02276222|41669204|FG001|Overall Study|Adverse Event|11|||
19422616|NCT02276222|41669203|FG000|Overall Study|Death|3|||
19422617|NCT02276222|41669204|FG001|Overall Study|Death|4|||
19422618|NCT02276222|41669203|FG000|Overall Study|Lack of Efficacy|13|||
19422619|NCT02276222|41669204|FG001|Overall Study|Lack of Efficacy|3|||
19422620|NCT02276222|41669203|FG000|Overall Study|Protocol Violation|3|||
19422621|NCT02276222|41669204|FG001|Overall Study|Protocol Violation|2|||
19422622|NCT02276222|41669203|FG000|Overall Study|Withdrawal by Subject|79|||
19422623|NCT02276222|41669204|FG001|Overall Study|Withdrawal by Subject|33|||
19422624|NCT02276222|41669203|FG000|Overall Study|non compliance with study medication|6|||
19422625|NCT02276222|41669204|FG001|Overall Study|non compliance with study medication|2|||
19422626|NCT02276222|41669203|FG000|Overall Study|sponsor decision|0|||
19422627|NCT02276222|41669204|FG001|Overall Study|sponsor decision|3|||
19422628|NCT02276222|41669203|FG000|Overall Study|Lost to Follow-up|15|||
19422629|NCT02276222|41669204|FG001|Overall Study|Lost to Follow-up|5|||
19422630|NCT02276222|41669203|FG000|Overall Study|Physician Decision|2|||
19422631|NCT02276222|41669204|FG001|Overall Study|Physician Decision|1|||
19422632|NCT02276222|41669203|FG000|Overall Study|sheduling conflict|1|||
19422633|NCT02276222|41669204|FG001|Overall Study|sheduling conflict|0|||
19422634|NCT02276222|41669203|FG000|Overall Study|subject withdrew after randomization|1|||
19422635|NCT02276222|41669204|FG001|Overall Study|subject withdrew after randomization|0|||
19422636|NCT02275364|41669210|FG000|Period 1|Withdrawal by Subject|1|||
19520285|NCT01440972|41932876|FG000|Overall Study|Withdrawal by Subject|3|||
19422637|NCT02275364|41669211|FG001|Period 1|Withdrawal by Subject|0|||
19422638|NCT02275364|41669210|FG000|Period 1|Other reason|1|||
19422639|NCT02275364|41669211|FG001|Period 1|Other reason|0|||
19422640|NCT02275052|41669228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19422641|NCT02275052|41669229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
19422642|NCT02275052|41669230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19422643|NCT02275052|41669231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
19422644|NCT02275052|41669228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
19422645|NCT02275052|41669229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
19422646|NCT02275052|41669230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
19422647|NCT02275052|41669231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
19422648|NCT02275052|41669228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
19422649|NCT02275052|41669229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
19422650|NCT02275052|41669230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19422651|NCT02275052|41669231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
19422652|NCT02275052|41669228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
19422653|NCT02275052|41669229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
19422654|NCT02275052|41669230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
19422655|NCT02275052|41669231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
19422656|NCT02275052|41669228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
19422657|NCT02275052|41669229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
19422658|NCT02275052|41669230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
19422659|NCT02275052|41669231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
19422660|NCT02275052|41669228|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
19422661|NCT02275052|41669229|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
19422662|NCT02275052|41669230|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
19422663|NCT02275052|41669231|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
19422664|NCT02275052|41669228|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
19422665|NCT02275052|41669229|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
19422666|NCT02275052|41669230|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
19422667|NCT02275052|41669231|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
19422668|NCT02275052|41669228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19422669|NCT02275052|41669229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
19422670|NCT02275052|41669230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
19422671|NCT02275052|41669231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
19422672|NCT02275052|41669228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19422673|NCT02275052|41669229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
19422674|NCT02275052|41669230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
19422675|NCT02275052|41669231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
19422676|NCT02275052|41669228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
19422677|NCT02275052|41669229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
19422678|NCT02275052|41669230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
19422679|NCT02275052|41669231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
19422680|NCT02275052|41669228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19422681|NCT02275052|41669229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19422682|NCT02275052|41669230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
19422683|NCT02275052|41669231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
19422684|NCT02274038|41669237|FG000|Overall Study|Death|1|||
19422685|NCT02300558|41669243|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
19422686|NCT02300558|41669243|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
19422687|NCT02300558|41669243|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
19422688|NCT02300558|41669243|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
19422689|NCT02273960|41669255|FG000|Short Term Period|Lost to Follow-up|1|||
19422690|NCT02273960|41669256|FG001|Short Term Period|Lost to Follow-up|0|||
19422691|NCT02273960|41669257|FG002|Short Term Period|Lost to Follow-up|0|||
19422692|NCT02273960|41669258|FG003|Short Term Period|Lost to Follow-up|0|||
19422693|NCT02273960|41669255|FG000|Short Term Period|Lack of Efficacy|0|||
19422694|NCT02273960|41669256|FG001|Short Term Period|Lack of Efficacy|0|||
19422695|NCT02273960|41669257|FG002|Short Term Period|Lack of Efficacy|0|||
19422696|NCT02273960|41669258|FG003|Short Term Period|Lack of Efficacy|1|||
19422697|NCT02273960|41669255|FG000|Short Term Period|ST complete, not entering LTE|4|||
19422698|NCT02273960|41669256|FG001|Short Term Period|ST complete, not entering LTE|6|||
19422699|NCT02273960|41669257|FG002|Short Term Period|ST complete, not entering LTE|4|||
19422700|NCT02273960|41669258|FG003|Short Term Period|ST complete, not entering LTE|5|||
19422701|NCT02273960|41669255|FG000|Long Term Extension|Death|0|||
19422702|NCT02273960|41669256|FG001|Long Term Extension|Death|0|||
19422703|NCT02273960|41669257|FG002|Long Term Extension|Death|0|||
19422704|NCT02273960|41669258|FG003|Long Term Extension|Death|1|||
19422705|NCT01646021|41669270|FG000|Overall Study|Death|77|||
19422706|NCT01646021|41669271|FG001|Overall Study|Death|83|||
19422707|NCT01646021|41669270|FG000|Overall Study|Study Terminated by Sponsor|50|||
19422708|NCT01646021|41669271|FG001|Overall Study|Study Terminated by Sponsor|41|||
19422709|NCT01646021|41669270|FG000|Overall Study|Lost to Follow-up|2|||
19422710|NCT01646021|41669271|FG001|Overall Study|Lost to Follow-up|2|||
19422711|NCT01646021|41669270|FG000|Overall Study|Withdrawal by Subject|10|||
19422712|NCT01646021|41669271|FG001|Overall Study|Withdrawal by Subject|15|||
19422713|NCT01750918|41669288|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
19422714|NCT01750918|41669289|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
19422715|NCT01750918|41669290|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
19422716|NCT01750918|41669291|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
19422717|NCT01750918|41669292|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
19422718|NCT01750918|41669293|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
19422719|NCT01750918|41669294|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
19422720|NCT01750918|41669295|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
19422721|NCT01750918|41669288|FG000|Overall Study|Lost to Follow-up|0|||
19422722|NCT01750918|41669289|FG001|Overall Study|Lost to Follow-up|0|||
19422723|NCT01750918|41669290|FG002|Overall Study|Lost to Follow-up|2|||
19422724|NCT01750918|41669291|FG003|Overall Study|Lost to Follow-up|2|||
19422725|NCT01750918|41669292|FG004|Overall Study|Lost to Follow-up|0|||
19422726|NCT01750918|41669293|FG005|Overall Study|Lost to Follow-up|0|||
19422727|NCT01750918|41669294|FG006|Overall Study|Lost to Follow-up|0|||
19422728|NCT01750918|41669295|FG007|Overall Study|Lost to Follow-up|1|||
19422729|NCT01750918|41669288|FG000|Overall Study|Withdrawal by Subject|0|||
19422730|NCT01750918|41669289|FG001|Overall Study|Withdrawal by Subject|0|||
19422731|NCT01750918|41669290|FG002|Overall Study|Withdrawal by Subject|1|||
19422732|NCT01750918|41669291|FG003|Overall Study|Withdrawal by Subject|2|||
19422733|NCT01750918|41669292|FG004|Overall Study|Withdrawal by Subject|1|||
19422734|NCT01750918|41669293|FG005|Overall Study|Withdrawal by Subject|1|||
19422735|NCT01750918|41669294|FG006|Overall Study|Withdrawal by Subject|2|||
19422736|NCT01750918|41669295|FG007|Overall Study|Withdrawal by Subject|2|||
19422737|NCT02300987|41669327|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
19422738|NCT02300987|41669328|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
19422739|NCT02300987|41669327|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
19422740|NCT02300987|41669328|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
19422741|NCT02300987|41669327|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
19422742|NCT02300987|41669328|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
19422743|NCT02300987|41669327|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
19422744|NCT02300987|41669328|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
19422745|NCT02300987|41669327|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
19422746|NCT02300987|41669328|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
19422747|NCT01750840|41669335|FG000|Overall Study|Lost to Follow-up|4|||
19422748|NCT01606228|41669340|FG000|Overall Study|Lost to Follow-up|20|||
19422749|NCT01606228|41669340|FG000|Overall Study|Withdrawal by Subject|3|||
19422750|NCT01606228|41669340|FG000|Overall Study|Non-compliant|3|||
19422751|NCT01606228|41669340|FG000|Overall Study|Lack of Efficacy|2|||
19422752|NCT01606228|41669340|FG000|Overall Study|Adverse Event|1|||
19422753|NCT01706536|41669349|FG000|Overall Study|Withdrawal by Subject|1|||
19422754|NCT01706536|41669350|FG001|Overall Study|Withdrawal by Subject|0|||
19422755|NCT01706536|41669351|FG002|Overall Study|Withdrawal by Subject|1|||
19422756|NCT01706536|41669352|FG003|Overall Study|Withdrawal by Subject|0|||
19422757|NCT01706536|41669353|FG004|Overall Study|Withdrawal by Subject|0|||
19422758|NCT01706536|41669349|FG000|Overall Study|Adverse Event|2|||
19422759|NCT01706536|41669350|FG001|Overall Study|Adverse Event|3|||
19422760|NCT01706536|41669351|FG002|Overall Study|Adverse Event|4|||
19422761|NCT01706536|41669352|FG003|Overall Study|Adverse Event|3|||
19422762|NCT01706536|41669353|FG004|Overall Study|Adverse Event|2|||
19422763|NCT01706536|41669349|FG000|Overall Study|Lack of Efficacy|1|||
19422764|NCT01706536|41669350|FG001|Overall Study|Lack of Efficacy|0|||
19422765|NCT01706536|41669351|FG002|Overall Study|Lack of Efficacy|0|||
19422766|NCT01706536|41669352|FG003|Overall Study|Lack of Efficacy|1|||
19422767|NCT01706536|41669353|FG004|Overall Study|Lack of Efficacy|0|||
19422768|NCT01706536|41669349|FG000|Overall Study|non compliance|0|||
19422769|NCT01706536|41669350|FG001|Overall Study|non compliance|1|||
19422770|NCT01706536|41669351|FG002|Overall Study|non compliance|0|||
19422771|NCT01706536|41669352|FG003|Overall Study|non compliance|0|||
19422772|NCT01706536|41669353|FG004|Overall Study|non compliance|0|||
19422773|NCT02269943|41669368|FG000|Treatment Period|Death|0|||
19422774|NCT02269943|41669369|FG001|Treatment Period|Death|1|||
19422775|NCT02269943|41669368|FG000|Treatment Period|Adverse Event|1|||
19422776|NCT02269943|41669369|FG001|Treatment Period|Adverse Event|10|||
19422777|NCT02269943|41669368|FG000|Treatment Period|Progressive Disease|5|||
19422778|NCT02269943|41669369|FG001|Treatment Period|Progressive Disease|17|||
19422779|NCT02269943|41669368|FG000|Treatment Period|Symptomatic Deterioration|0|||
19422780|NCT02269943|41669369|FG001|Treatment Period|Symptomatic Deterioration|2|||
19422781|NCT02269943|41669368|FG000|Follow-Up Survival Period|Death|3|||
19422782|NCT02269943|41669369|FG001|Follow-Up Survival Period|Death|16|||
19628192|NCT00802074|42077592|FG004|Overall Study|Adverse Event|0|||
19422783|NCT02269943|41669368|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
19422784|NCT02269943|41669369|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
19422785|NCT02269943|41669368|FG000|Follow-Up Survival Period|Alive|2|||
19422786|NCT02269943|41669369|FG001|Follow-Up Survival Period|Alive|8|||
19422787|NCT01706458|41669377|FG000|Overall Study|Physician Decision|3|||
19422788|NCT01706458|41669378|FG001|Overall Study|Physician Decision|4|||
19422789|NCT02269787|41669386|FG000|Overall Study|Lost to Follow-up|20|||
19422790|NCT02269787|41669387|FG001|Overall Study|Lost to Follow-up|6|||
19422791|NCT02269787|41669386|FG000|Overall Study|Death|2|||
19422792|NCT02269787|41669387|FG001|Overall Study|Death|3|||
19422793|NCT02269787|41669386|FG000|Overall Study|Incapacitated|0|||
19422794|NCT02269787|41669387|FG001|Overall Study|Incapacitated|1|||
19422795|NCT01605370|41669395|FG000|Overall Study|Adverse Event|1|||
19422796|NCT01605370|41669396|FG001|Overall Study|Adverse Event|0|||
19422797|NCT02269709|41669402|FG000|Time of Enrollment|Withdrawal by Subject|3|||
19422798|NCT02269709|41669402|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
19422799|NCT02269709|41669402|FG000|Six Month Follow-up|Lost to Follow-up|12|||
19422800|NCT02269475|41669409|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
19422801|NCT02269475|41669410|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
19422802|NCT02269475|41669409|FG000|Overall Study|Withdrawal by Subject|0|||
19422803|NCT02269475|41669410|FG001|Overall Study|Withdrawal by Subject|1|||
19422804|NCT01605136|41669419|FG000|Study Period|Withdrawal by Subject|2|||
19422805|NCT01605136|41669420|FG001|Study Period|Withdrawal by Subject|0|||
19422806|NCT01605136|41669419|FG000|Study Period|Physician Decision|1|||
19422807|NCT01605136|41669420|FG001|Study Period|Physician Decision|1|||
19422808|NCT01605136|41669419|FG000|Study Period|Lost to Follow-up|0|||
19422809|NCT01605136|41669420|FG001|Study Period|Lost to Follow-up|2|||
19422810|NCT01605136|41669419|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
19422811|NCT01605136|41669420|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
19422812|NCT01706146|41669426|FG000|Overall Study|Withdrawal by Subject|1|||
19422813|NCT01706146|41669426|FG000|Overall Study|Adverse Event|3|||
19422814|NCT01706146|41669426|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
19422815|NCT02269241|41669430|FG000|Overall Study|Lost to Follow-up|269|||
19422816|NCT02269241|41669430|FG000|Overall Study|Withdrawal by Subject|155|||
19422817|NCT02269241|41669430|FG000|Overall Study|Protocol Violation|1|||
19422818|NCT02269241|41669430|FG000|Overall Study|Physician Decision|7|||
19422819|NCT02269241|41669430|FG000|Overall Study|Pregnancy|15|||
19422820|NCT02269241|41669430|FG000|Overall Study|Wish for pregnancy|5|||
19422821|NCT02269241|41669430|FG000|Overall Study|Development of an exclusion criteria|16|||
19422822|NCT02269241|41669430|FG000|Overall Study|Adverse Event|113|||
19422823|NCT02269241|41669430|FG000|Overall Study|At the specific request of the sponsor|20|||
19422824|NCT02269241|41669430|FG000|Overall Study|Several reasons not classified|53|||
19422825|NCT02269241|41669430|FG000|Overall Study|Screening failures|546|||
19422826|NCT01750684|41669437|FG000|Overall Study|Death|1|||
19422827|NCT01750684|41669438|FG001|Overall Study|Death|0|||
19422828|NCT01750684|41669437|FG000|Overall Study|Non-compliance with Study Drug|0|||
19422829|NCT01750684|41669438|FG001|Overall Study|Non-compliance with Study Drug|1|||
19422830|NCT01750684|41669437|FG000|Overall Study|Withdrawn by Sponsor|0|||
19422831|NCT01750684|41669438|FG001|Overall Study|Withdrawn by Sponsor|1|||
19422832|NCT01750684|41669437|FG000|Overall Study|Protocol Violation|1|||
19422833|NCT01750684|41669438|FG001|Overall Study|Protocol Violation|0|||
19422834|NCT01750294|41669445|FG000|Overall Study|Withdrawal by Subject|1|||
19422835|NCT01750294|41669445|FG000|Overall Study|Safety Endpoint|1|||
19422836|NCT01749982|41669453|FG000|Overall Study|Physician Decision|0|||
19422837|NCT01749982|41669454|FG001|Overall Study|Physician Decision|0|||
19422838|NCT01749982|41669455|FG002|Overall Study|Physician Decision|0|||
19422839|NCT01749982|41669456|FG003|Overall Study|Physician Decision|1|||
19422840|NCT01749982|41669453|FG000|Overall Study|Lost to Follow-up|0|||
19422841|NCT01749982|41669454|FG001|Overall Study|Lost to Follow-up|0|||
19422842|NCT01749982|41669455|FG002|Overall Study|Lost to Follow-up|0|||
19422843|NCT01749982|41669456|FG003|Overall Study|Lost to Follow-up|1|||
19422844|NCT01749982|41669453|FG000|Overall Study|Withdrawal by Subject|0|||
19422845|NCT01749982|41669454|FG001|Overall Study|Withdrawal by Subject|0|||
19422846|NCT01749982|41669455|FG002|Overall Study|Withdrawal by Subject|0|||
19422847|NCT01749982|41669456|FG003|Overall Study|Withdrawal by Subject|1|||
19422848|NCT02269163|41669468|FG000|Overall Study|Lost to Follow-up|1|||
19422849|NCT02269163|41669469|FG001|Overall Study|Lost to Follow-up|0|||
19422850|NCT02269163|41669468|FG000|Overall Study|Major protocol violation|0|||
19422851|NCT02269163|41669469|FG001|Overall Study|Major protocol violation|1|||
19422852|NCT02269163|41669468|FG000|Overall Study|Other|2|||
19422853|NCT02269163|41669469|FG001|Overall Study|Other|2|||
19422854|NCT02269163|41669468|FG000|Overall Study|Withdrawal by Subject|0|||
19422855|NCT02269163|41669469|FG001|Overall Study|Withdrawal by Subject|3|||
19422856|NCT02269163|41669468|FG000|Overall Study|Physician Decision|0|||
19422857|NCT02269163|41669469|FG001|Overall Study|Physician Decision|1|||
19422858|NCT01749826|41669479|FG000|Overall Study|Study Terminated|20|||
19422859|NCT01749826|41669480|FG001|Overall Study|Study Terminated|0|||
19422860|NCT02300129|41669486|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
19422861|NCT02300129|41669487|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
19422862|NCT02300129|41669488|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
19422863|NCT02300129|41669489|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
19422864|NCT02300129|41669486|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
19422865|NCT02300129|41669487|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
19422866|NCT02300129|41669488|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
19422867|NCT02300129|41669489|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
19422868|NCT02300129|41669486|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
19422869|NCT02300129|41669487|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
19422870|NCT02300129|41669488|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
19422871|NCT02300129|41669489|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
19422872|NCT02267135|41669501|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
19422873|NCT02267135|41669502|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
19422874|NCT02267135|41669501|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
19422875|NCT02267135|41669502|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
19422876|NCT02267135|41669501|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
19422877|NCT02267135|41669502|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
19422878|NCT02267135|41669501|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
19422879|NCT02267135|41669502|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
19422880|NCT02267135|41669501|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
19422881|NCT02267135|41669502|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
19422882|NCT02299427|41669513|FG000|Overall Study|Withdrawal by Subject|1|||
19422883|NCT02299427|41669514|FG001|Overall Study|Withdrawal by Subject|0|||
19422884|NCT02299427|41669513|FG000|Overall Study|Lost to Follow-up|1|||
19422885|NCT02299427|41669514|FG001|Overall Study|Lost to Follow-up|3|||
19422886|NCT02299427|41669513|FG000|Overall Study|not adherent to dog website use|21|||
19422887|NCT02299427|41669514|FG001|Overall Study|not adherent to dog website use|0|||
19422888|NCT01724866|41669524|FG000|Overall Study|Adverse Event|0|||
19422889|NCT01724866|41669525|FG001|Overall Study|Adverse Event|0|||
19422890|NCT01724866|41669526|FG002|Overall Study|Adverse Event|1|||
19422891|NCT01724866|41669527|FG003|Overall Study|Adverse Event|1|||
19422892|NCT01724866|41669524|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
19422893|NCT01724866|41669525|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
19422894|NCT01724866|41669526|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
19422895|NCT01724866|41669527|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
19422896|NCT01724866|41669524|FG000|Overall Study|Investigator's Discretion|0|||
19422897|NCT01724866|41669525|FG001|Overall Study|Investigator's Discretion|1|||
19422898|NCT01724866|41669526|FG002|Overall Study|Investigator's Discretion|1|||
19422899|NCT01724866|41669527|FG003|Overall Study|Investigator's Discretion|0|||
19422900|NCT01724866|41669524|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
19422901|NCT01724866|41669525|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
19422902|NCT01724866|41669526|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
19422903|NCT01724866|41669527|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
19422904|NCT01724866|41669524|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
19422905|NCT01724866|41669525|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
19422906|NCT01724866|41669526|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
19422907|NCT01724866|41669527|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
19422908|NCT02266433|41669539|FG000|Overall Study|Lost to Follow-up|54|||
19422909|NCT02266433|41669540|FG001|Overall Study|Lost to Follow-up|46|||
19422910|NCT02266433|41669539|FG000|Overall Study|Withdrawal by Subject|5|||
19422911|NCT02266433|41669540|FG001|Overall Study|Withdrawal by Subject|7|||
19422912|NCT01748890|41669547|FG000|Overall Study|Insufficient recruitment for analysis|4|||
19422913|NCT01747876|41669554|FG000|Overall Study|Adverse Event|1|||
19422914|NCT01747876|41669555|FG001|Overall Study|Adverse Event|0|||
19422915|NCT01747876|41669556|FG002|Overall Study|Adverse Event|2|||
19422916|NCT01747876|41669554|FG000|Overall Study|Withdrawal by Subject|0|||
19422917|NCT01747876|41669555|FG001|Overall Study|Withdrawal by Subject|1|||
19422918|NCT01747876|41669556|FG002|Overall Study|Withdrawal by Subject|1|||
19422919|NCT01747876|41669554|FG000|Overall Study|Disease progression|4|||
19422920|NCT01747876|41669555|FG001|Overall Study|Disease progression|13|||
19422921|NCT01747876|41669556|FG002|Overall Study|Disease progression|8|||
19422922|NCT01747876|41669554|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
19422923|NCT01747876|41669555|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
19422924|NCT01747876|41669556|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
19422925|NCT02273726|41669569|FG000|Overall Study|Death|70|||
19422926|NCT02273726|41669570|FG001|Overall Study|Death|62|||
19422927|NCT02273726|41669569|FG000|Overall Study|Withdrawal by Subject|41|||
19422928|NCT02273726|41669570|FG001|Overall Study|Withdrawal by Subject|29|||
19422929|NCT02273726|41669569|FG000|Overall Study|Kidney transplant|31|||
19422930|NCT02273726|41669570|FG001|Overall Study|Kidney transplant|39|||
19422931|NCT02273726|41669569|FG000|Overall Study|Physician Decision|30|||
19422932|NCT02273726|41669570|FG001|Overall Study|Physician Decision|15|||
19422933|NCT02273726|41669569|FG000|Overall Study|Adverse Event|27|||
19422934|NCT02273726|41669570|FG001|Overall Study|Adverse Event|9|||
19422935|NCT02273726|41669569|FG000|Overall Study|Lost to Follow-up|6|||
19422936|NCT02273726|41669570|FG001|Overall Study|Lost to Follow-up|3|||
19422937|NCT02273726|41669569|FG000|Overall Study|Lack of Efficacy|6|||
19422938|NCT02273726|41669570|FG001|Overall Study|Lack of Efficacy|1|||
19422939|NCT02273726|41669569|FG000|Overall Study|Protocol Violation|4|||
19422940|NCT02273726|41669570|FG001|Overall Study|Protocol Violation|0|||
19422941|NCT02273726|41669569|FG000|Overall Study|Other than specified|28|||
19422942|NCT02273726|41669570|FG001|Overall Study|Other than specified|30|||
19422943|NCT01723228|41669578|FG000|Overall Study|Adverse Event|2|||
19422944|NCT01723228|41669579|FG001|Overall Study|Adverse Event|6|||
19422945|NCT01723228|41669578|FG000|Overall Study|Withdrawal by Subject|2|||
19422946|NCT01723228|41669579|FG001|Overall Study|Withdrawal by Subject|1|||
19422947|NCT01723228|41669578|FG000|Overall Study|Protocol Violation|0|||
19422948|NCT01723228|41669579|FG001|Overall Study|Protocol Violation|2|||
19422949|NCT01723228|41669578|FG000|Overall Study|Lost to Follow-up|2|||
19422950|NCT01723228|41669579|FG001|Overall Study|Lost to Follow-up|1|||
19422951|NCT01723228|41669578|FG000|Overall Study|Other|2|||
19422952|NCT01723228|41669579|FG001|Overall Study|Other|1|||
19422953|NCT01747486|41669587|FG000|Stage 1|Physician Decision|3|||
19422954|NCT01747486|41669588|FG001|Stage 1|Physician Decision|0|||
19422955|NCT01747486|41669587|FG000|Stage 1|Withdrawal by Subject|4|||
19422956|NCT01747486|41669588|FG001|Stage 1|Withdrawal by Subject|3|||
19422957|NCT01747486|41669587|FG000|Stage 1|Disease progression|4|||
19422958|NCT01747486|41669588|FG001|Stage 1|Disease progression|9|||
19422959|NCT01747486|41669587|FG000|Stage 1|Death|1|||
19422960|NCT01747486|41669588|FG001|Stage 1|Death|1|||
19422961|NCT01747486|41669587|FG000|Stage 2|Physician Decision|2|||
19422962|NCT01747486|41669588|FG001|Stage 2|Physician Decision|0|||
19422963|NCT01747486|41669587|FG000|Stage 2|Withdrawal by Subject|1|||
19422964|NCT01747486|41669588|FG001|Stage 2|Withdrawal by Subject|0|||
19422965|NCT01747486|41669587|FG000|Stage 2|New Cancer Therapy|3|||
19422966|NCT01747486|41669588|FG001|Stage 2|New Cancer Therapy|0|||
19422967|NCT01747486|41669587|FG000|Stage 2|Disease Progression|3|||
19422968|NCT01747486|41669588|FG001|Stage 2|Disease Progression|0|||
19422969|NCT02273180|41669596|FG000|Overall Study|Adverse Event|2|||
19422970|NCT02273180|41669597|FG001|Overall Study|Adverse Event|2|||
19422971|NCT02273180|41669596|FG000|Overall Study|Lack of Efficacy|1|||
19422972|NCT02273180|41669597|FG001|Overall Study|Lack of Efficacy|0|||
19422973|NCT02273180|41669596|FG000|Overall Study|Protocol Violation|1|||
19422974|NCT02273180|41669597|FG001|Overall Study|Protocol Violation|7|||
19422975|NCT02273180|41669596|FG000|Overall Study|Randomized but not treated|1|||
19422976|NCT02273180|41669597|FG001|Overall Study|Randomized but not treated|0|||
19422977|NCT02273180|41669596|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
19422978|NCT02273180|41669597|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
19422979|NCT02273180|41669596|FG000|Overall Study|Other than specified above|21|||
19422980|NCT02273180|41669597|FG001|Overall Study|Other than specified above|10|||
19422981|NCT01746862|41669605|FG000|Overall Study|Withdrawal by Subject|1|||
19422982|NCT01746862|41669606|FG001|Overall Study|Withdrawal by Subject|1|||
19422983|NCT01746862|41669605|FG000|Overall Study|Protocol Violation|1|||
19422984|NCT01746862|41669606|FG001|Overall Study|Protocol Violation|0|||
19422985|NCT01746862|41669605|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
19422986|NCT01746862|41669606|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
19422987|NCT01746862|41669605|FG000|Overall Study|Entered puberty during the study|1|||
19422988|NCT01746862|41669606|FG001|Overall Study|Entered puberty during the study|0|||
19422989|NCT01745848|41669613|FG000|Overall Study|Adverse Event|6|||
19422990|NCT01745380|41669619|FG000|Overall Study|Lost to Follow-up|1|||
19422991|NCT01745380|41669620|FG001|Overall Study|Lost to Follow-up|0|||
19422992|NCT01745380|41669619|FG000|Overall Study|Lack of Efficacy|0|||
19422993|NCT01745380|41669620|FG001|Overall Study|Lack of Efficacy|1|||
19422994|NCT01745146|41669628|FG000|Overall Study|Withdrawal by Subject|1|||
19422995|NCT01745146|41669629|FG001|Overall Study|Withdrawal by Subject|3|||
19422996|NCT01745146|41669628|FG000|Overall Study|Lost to Follow-up|2|||
19422997|NCT01745146|41669629|FG001|Overall Study|Lost to Follow-up|0|||
19422998|NCT02272634|41669639|FG000|Overall Study|Adverse Event|1|||
19422999|NCT02272634|41669640|FG001|Overall Study|Adverse Event|0|||
19423000|NCT02272634|41669641|FG002|Overall Study|Adverse Event|0|||
19423001|NCT02272634|41669639|FG000|Overall Study|Protocol Violation|0|||
19423002|NCT02272634|41669640|FG001|Overall Study|Protocol Violation|0|||
19423003|NCT02272634|41669641|FG002|Overall Study|Protocol Violation|1|||
19423004|NCT02272634|41669639|FG000|Overall Study|Withdrawal by Subject|0|||
19423005|NCT02272634|41669640|FG001|Overall Study|Withdrawal by Subject|1|||
19423006|NCT02272634|41669641|FG002|Overall Study|Withdrawal by Subject|0|||
19423007|NCT02203513|41669657|FG000|Overall Study|Refused further treatment|2|||
19423008|NCT02203513|41669658|FG001|Overall Study|Refused further treatment|0|||
19423009|NCT02203513|41669659|FG002|Overall Study|Refused further treatment|1|||
19423010|NCT02203513|41669660|FG003|Overall Study|Refused further treatment|0|||
19423011|NCT02203513|41669661|FG004|Overall Study|Refused further treatment|0|||
19423012|NCT02203513|41669657|FG000|Overall Study|Switched to alternative treatment|3|||
19423013|NCT02203513|41669658|FG001|Overall Study|Switched to alternative treatment|4|||
19423014|NCT02203513|41669659|FG002|Overall Study|Switched to alternative treatment|0|||
19423015|NCT02203513|41669660|FG003|Overall Study|Switched to alternative treatment|0|||
19423016|NCT02203513|41669661|FG004|Overall Study|Switched to alternative treatment|4|||
19423017|NCT02203513|41669657|FG000|Overall Study|Did not receive investigational product (IP)|0|||
19423018|NCT02203513|41669658|FG001|Overall Study|Did not receive investigational product (IP)|1|||
19423019|NCT02203513|41669659|FG002|Overall Study|Did not receive investigational product (IP)|0|||
19520286|NCT01440972|41932877|FG001|Overall Study|Withdrawal by Subject|2|||
19520287|NCT01420536|41932885|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
19520288|NCT01420536|41932886|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
19520289|NCT01420068|41932896|FG000|Overall Study|Administrative problems|1|||
19520290|NCT01420068|41932897|FG001|Overall Study|Administrative problems|3|||
19520291|NCT01420068|41932896|FG000|Overall Study|Withdrawal by Subject|1|||
19520292|NCT01420068|41932897|FG001|Overall Study|Withdrawal by Subject|2|||
19520293|NCT01467492|41932905|FG000|Overall Study|Withdrawal by Subject|6|||
19423020|NCT02203513|41669660|FG003|Overall Study|Did not receive investigational product (IP)|0|||
19423021|NCT02203513|41669661|FG004|Overall Study|Did not receive investigational product (IP)|0|||
19423022|NCT02203513|41669657|FG000|Overall Study|Death (unrelated to study therapy)|1|||
19423023|NCT02203513|41669658|FG001|Overall Study|Death (unrelated to study therapy)|3|||
19423024|NCT02203513|41669659|FG002|Overall Study|Death (unrelated to study therapy)|1|||
19423025|NCT02203513|41669660|FG003|Overall Study|Death (unrelated to study therapy)|0|||
19423026|NCT02203513|41669661|FG004|Overall Study|Death (unrelated to study therapy)|2|||
19423027|NCT02203513|41669657|FG000|Overall Study|Lost to Follow-up|0|||
19423028|NCT02203513|41669658|FG001|Overall Study|Lost to Follow-up|0|||
19423029|NCT02203513|41669659|FG002|Overall Study|Lost to Follow-up|1|||
19423030|NCT02203513|41669660|FG003|Overall Study|Lost to Follow-up|1|||
19423031|NCT02203513|41669661|FG004|Overall Study|Lost to Follow-up|0|||
19423032|NCT02299934|41669675|FG000|Overall Study|Termination of study|13|||
19423033|NCT01703260|41669682|FG000|Overall Study|Adverse Event|1|||
19423034|NCT01703260|41669683|FG001|Overall Study|Adverse Event|2|||
19423035|NCT01703260|41669684|FG002|Overall Study|Adverse Event|2|||
19423036|NCT01703260|41669682|FG000|Overall Study|Lost to Follow-up|1|||
19423037|NCT01703260|41669683|FG001|Overall Study|Lost to Follow-up|0|||
19423038|NCT01703260|41669684|FG002|Overall Study|Lost to Follow-up|0|||
19423039|NCT01703260|41669682|FG000|Overall Study|Withdrawal by Subject|0|||
19423040|NCT01703260|41669683|FG001|Overall Study|Withdrawal by Subject|0|||
19423041|NCT01703260|41669684|FG002|Overall Study|Withdrawal by Subject|1|||
19423042|NCT01703260|41669682|FG000|Overall Study|Study Termination|1|||
19423043|NCT01703260|41669683|FG001|Overall Study|Study Termination|2|||
19423044|NCT01703260|41669684|FG002|Overall Study|Study Termination|0|||
19423045|NCT02203357|41669695|FG000|Overall Study|Lost to Follow-up|58|||
19423046|NCT02203357|41669696|FG001|Overall Study|Lost to Follow-up|66|||
19423047|NCT02203357|41669697|FG002|Overall Study|Lost to Follow-up|70|||
19423048|NCT02299388|41669710|FG000|Overall Study|Withdrawal by Subject|0|||
19423049|NCT02299388|41669711|FG001|Overall Study|Withdrawal by Subject|1|||
19423050|NCT02202577|41669719|FG000|Overall Study|Lost to Follow-up|6|||
19423051|NCT02202577|41669720|FG001|Overall Study|Lost to Follow-up|16|||
19423052|NCT02202577|41669719|FG000|Overall Study|Protocol Violation|7|||
19423053|NCT02202577|41669720|FG001|Overall Study|Protocol Violation|3|||
19423054|NCT02299076|41669728|FG000|Overall Study|Fraudulent Entries|20|||
19423055|NCT02299076|41669729|FG001|Overall Study|Fraudulent Entries|14|||
19423056|NCT01723072|41669737|FG000|Overall Study|Withdrawal by Subject|7|||
19423057|NCT01723072|41669738|FG001|Overall Study|Withdrawal by Subject|13|||
19423058|NCT01723072|41669737|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
19423059|NCT01723072|41669738|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
19423060|NCT01723072|41669737|FG000|Overall Study|Other|4|||
19423061|NCT01723072|41669738|FG001|Overall Study|Other|3|||
19423062|NCT01722994|41669746|FG000|Overall Study|Missing data|25|||
19423063|NCT01722994|41669747|FG001|Overall Study|Missing data|17|||
19423064|NCT02228395|41669755|FG000|First Intervention Period|No longer willing to participate|1|||
19423065|NCT02228395|41669756|FG001|First Intervention Period|No longer willing to participate|0|||
19423066|NCT02228395|41669757|FG002|First Intervention Period|No longer willing to participate|0|||
19423067|NCT02228395|41669755|FG000|First Intervention Period|Unable to comply with study dates|0|||
19520294|NCT01467492|41932906|FG001|Overall Study|Withdrawal by Subject|4|||
19520295|NCT01467492|41932905|FG000|Overall Study|Study Terminated by Sponsor|6|||
19423068|NCT02228395|41669756|FG001|First Intervention Period|Unable to comply with study dates|1|||
19423069|NCT02228395|41669757|FG002|First Intervention Period|Unable to comply with study dates|1|||
19423070|NCT02170051|41669769|FG000|Overall Study|Withdrawal by Subject|10|||
19423071|NCT02170051|41669770|FG001|Overall Study|Withdrawal by Subject|10|||
19423072|NCT02170051|41669769|FG000|Overall Study|Lost to Follow-up|1|||
19423073|NCT02170051|41669770|FG001|Overall Study|Lost to Follow-up|3|||
19423074|NCT02169739|41669778|FG000|Overall Study|Lost to Follow-up|0|||
19423075|NCT02169739|41669779|FG001|Overall Study|Lost to Follow-up|4|||
19423076|NCT02169505|41669786|FG000|Overall Study|Withdrawal by Subject|1|||
19423077|NCT01909791|41669793|FG000|Overall Study|Death|9|||
19423078|NCT01909791|41669794|FG001|Overall Study|Death|8|||
19423079|NCT01909791|41669795|FG002|Overall Study|Death|4|||
19423080|NCT01909791|41669793|FG000|Overall Study|Withdrawal by Subject|5|||
19423081|NCT01909791|41669794|FG001|Overall Study|Withdrawal by Subject|9|||
19423082|NCT01909791|41669795|FG002|Overall Study|Withdrawal by Subject|13|||
19423083|NCT01909791|41669793|FG000|Overall Study|Lost to Follow-up|5|||
19423084|NCT01909791|41669794|FG001|Overall Study|Lost to Follow-up|11|||
19423085|NCT01909791|41669795|FG002|Overall Study|Lost to Follow-up|10|||
19423086|NCT01909791|41669793|FG000|Overall Study|Missed Visit|2|||
19423087|NCT01909791|41669794|FG001|Overall Study|Missed Visit|0|||
19423088|NCT01909791|41669795|FG002|Overall Study|Missed Visit|1|||
19423089|NCT02202499|41669811|FG000|Overall Study|Cancer diagnosis|0|||
19423090|NCT02202499|41669812|FG001|Overall Study|Cancer diagnosis|0|||
19423091|NCT02202499|41669813|FG002|Overall Study|Cancer diagnosis|1|||
19423092|NCT02202499|41669811|FG000|Overall Study|Moved from area|0|||
19423093|NCT02202499|41669812|FG001|Overall Study|Moved from area|0|||
19423094|NCT02202499|41669813|FG002|Overall Study|Moved from area|1|||
19423095|NCT02202499|41669811|FG000|Overall Study|Declined before randomization|1|||
19423096|NCT02202499|41669812|FG001|Overall Study|Declined before randomization|0|||
19423097|NCT02202499|41669813|FG002|Overall Study|Declined before randomization|0|||
19423098|NCT02202499|41669811|FG000|Overall Study|Auto accident|1|||
19423099|NCT02202499|41669812|FG001|Overall Study|Auto accident|0|||
19423100|NCT02202499|41669813|FG002|Overall Study|Auto accident|0|||
19423101|NCT02202109|41669828|FG000|Overall Study|Lost to Follow-up|88|||
19423102|NCT02202109|41669829|FG001|Overall Study|Lost to Follow-up|87|||
19423103|NCT02202109|41669828|FG000|Overall Study|Withdrawal by Subject|2|||
19423104|NCT02202109|41669829|FG001|Overall Study|Withdrawal by Subject|0|||
19423105|NCT02227849|41669835|FG000|Overall Study|Adverse Event|4|||
19423106|NCT02227849|41669835|FG000|Overall Study|Physician Decision|1|||
19423107|NCT02227849|41669835|FG000|Overall Study|Withdrawal by Subject|3|||
19423108|NCT01927497|41669841|FG000|Overall Study|Death|0|||
19423109|NCT01927497|41669842|FG001|Overall Study|Death|1|||
19423110|NCT01927497|41669841|FG000|Overall Study|Protocol Violation|2|||
19423111|NCT01927497|41669842|FG001|Overall Study|Protocol Violation|0|||
19423112|NCT02169271|41669850|FG000|Overall Study|Protocol Violation|1|||
19423113|NCT02169271|41669851|FG001|Overall Study|Protocol Violation|2|||
19423114|NCT02202031|41669859|FG000|Overall Study|Lost to Follow-up|1|||
19423115|NCT02202031|41669860|FG001|Overall Study|Lost to Follow-up|0|||
19423116|NCT02202031|41669859|FG000|Overall Study|Too Busy|1|||
19423117|NCT02202031|41669860|FG001|Overall Study|Too Busy|3|||
19423118|NCT02202031|41669859|FG000|Overall Study|Illness/Medical Reason|0|||
19423119|NCT02202031|41669860|FG001|Overall Study|Illness/Medical Reason|2|||
19423120|NCT02202031|41669859|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
19423121|NCT02202031|41669860|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
19423122|NCT01644188|41669868|FG000|Overall Study|Adverse Event|44|||
19423123|NCT01644188|41669869|FG001|Overall Study|Adverse Event|20|||
19423124|NCT01644188|41669868|FG000|Overall Study|Poor compliance to protocol|26|||
19423125|NCT01644188|41669869|FG001|Overall Study|Poor compliance to protocol|14|||
19423126|NCT01644188|41669868|FG000|Overall Study|Physician Decision|1|||
19423127|NCT01644188|41669869|FG001|Overall Study|Physician Decision|3|||
19423128|NCT01644188|41669868|FG000|Overall Study|Participant moved|7|||
19423129|NCT01644188|41669869|FG001|Overall Study|Participant moved|2|||
19423130|NCT01644188|41669868|FG000|Overall Study|Related to auto-injector administration|2|||
19423131|NCT01644188|41669869|FG001|Overall Study|Related to auto-injector administration|2|||
19423132|NCT01644188|41669868|FG000|Overall Study|Consent withdrawn by participant|14|||
19423133|NCT01644188|41669869|FG001|Overall Study|Consent withdrawn by participant|7|||
19423134|NCT01644188|41669868|FG000|Overall Study|Selection criteria finally not met|2|||
19423135|NCT01644188|41669869|FG001|Overall Study|Selection criteria finally not met|0|||
19423136|NCT01644188|41669868|FG000|Overall Study|Lost to Follow-up|1|||
19423137|NCT01644188|41669869|FG001|Overall Study|Lost to Follow-up|0|||
19423138|NCT01644188|41669868|FG000|Overall Study|Death|4|||
19423139|NCT01644188|41669869|FG001|Overall Study|Death|3|||
19423140|NCT01644188|41669868|FG000|Overall Study|Last visit outside protocol visit window|14|||
19423141|NCT01644188|41669869|FG001|Overall Study|Last visit outside protocol visit window|16|||
19423142|NCT01644188|41669868|FG000|Overall Study|Site closure|1|||
19423143|NCT01644188|41669869|FG001|Overall Study|Site closure|1|||
19423144|NCT01644188|41669868|FG000|Overall Study|Other than specified above|6|||
19423145|NCT01644188|41669869|FG001|Overall Study|Other than specified above|7|||
19423146|NCT02201953|41669877|FG000|Overall Study|Randomized but Never Treated|1|||
19423147|NCT02201953|41669878|FG001|Overall Study|Randomized but Never Treated|5|||
19423148|NCT02201953|41669877|FG000|Overall Study|Lack of Efficacy|9|||
19423149|NCT02201953|41669878|FG001|Overall Study|Lack of Efficacy|30|||
19423150|NCT02201953|41669877|FG000|Overall Study|Lost to Follow-up|8|||
19423151|NCT02201953|41669878|FG001|Overall Study|Lost to Follow-up|8|||
19423152|NCT02201953|41669877|FG000|Overall Study|Withdrew Consent|2|||
19423153|NCT02201953|41669878|FG001|Overall Study|Withdrew Consent|5|||
19423154|NCT02201953|41669877|FG000|Overall Study|Adverse Event|0|||
19423155|NCT02201953|41669878|FG001|Overall Study|Adverse Event|5|||
19423156|NCT02201953|41669877|FG000|Overall Study|Death|0|||
19423157|NCT02201953|41669878|FG001|Overall Study|Death|3|||
19423158|NCT02271854|41669884|FG000|Overall Study|Withdrawal by Subject|2|||
19423159|NCT02271854|41669884|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
19423160|NCT02271854|41669884|FG000|Overall Study|Lost to Follow-up|1|||
19423161|NCT02296892|41669892|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
19423162|NCT02296892|41669893|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
19423163|NCT02296892|41669894|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
19423164|NCT02296892|41669892|FG000|Overall Study|Lost to Follow-up|5|||
19423165|NCT02296892|41669893|FG001|Overall Study|Lost to Follow-up|0|||
19423166|NCT02296892|41669894|FG002|Overall Study|Lost to Follow-up|1|||
19423167|NCT02270684|41669904|FG000|Overall Study|Lost to Follow-up|0|||
19423168|NCT02270684|41669905|FG001|Overall Study|Lost to Follow-up|3|||
19423169|NCT02270684|41669904|FG000|Overall Study|Study terminated|1|||
19423170|NCT02270684|41669905|FG001|Overall Study|Study terminated|0|||
19423171|NCT02168803|41669914|FG000|Overall Study|Lost to Follow-up|1|||
19423172|NCT02168803|41669915|FG001|Overall Study|Lost to Follow-up|0|||
19423173|NCT02168803|41669916|FG002|Overall Study|Lost to Follow-up|1|||
19423174|NCT02168803|41669914|FG000|Overall Study|Withdrawal by Subject|1|||
19423175|NCT02168803|41669915|FG001|Overall Study|Withdrawal by Subject|1|||
19423176|NCT02168803|41669916|FG002|Overall Study|Withdrawal by Subject|2|||
19423177|NCT02168803|41669914|FG000|Overall Study|Physician Decision|0|||
19423178|NCT02168803|41669915|FG001|Overall Study|Physician Decision|1|||
19423179|NCT02168803|41669916|FG002|Overall Study|Physician Decision|0|||
19423180|NCT02168803|41669914|FG000|Overall Study|Adverse Event|0|||
19423181|NCT02168803|41669915|FG001|Overall Study|Adverse Event|1|||
19423182|NCT02168803|41669916|FG002|Overall Study|Adverse Event|1|||
19423183|NCT02168803|41669914|FG000|Overall Study|Death|0|||
19423184|NCT02168803|41669915|FG001|Overall Study|Death|0|||
19423185|NCT02168803|41669916|FG002|Overall Study|Death|1|||
19423186|NCT02168803|41669914|FG000|Overall Study|Sponsor Decision|0|||
19423187|NCT02168803|41669915|FG001|Overall Study|Sponsor Decision|0|||
19423188|NCT02168803|41669916|FG002|Overall Study|Sponsor Decision|1|||
19423189|NCT02201329|41669931|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
19423190|NCT02201329|41669931|FG000|Overall Study|Withdrawal by Subject|2|||
19423191|NCT01927419|41669937|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
19423192|NCT01927419|41669938|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
19423193|NCT01927419|41669937|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
19423194|NCT01927419|41669938|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
19423195|NCT01927419|41669937|FG000|Treatment Period|Disease progression|17|||
19423196|NCT01927419|41669938|FG001|Treatment Period|Disease progression|20|||
19423197|NCT01927419|41669937|FG000|Treatment Period|Study drug toxicity|48|||
19423198|NCT01927419|41669938|FG001|Treatment Period|Study drug toxicity|10|||
19423199|NCT01927419|41669937|FG000|Treatment Period|Death|0|||
19423200|NCT01927419|41669938|FG001|Treatment Period|Death|1|||
19423201|NCT01927419|41669937|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
19423202|NCT01927419|41669938|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
19423203|NCT01927419|41669937|FG000|Treatment Period|Participant request to discontinue|12|||
19423204|NCT01927419|41669938|FG001|Treatment Period|Participant request to discontinue|4|||
19423205|NCT01927419|41669937|FG000|Treatment Period|Withdrawal by Subject|1|||
19423206|NCT01927419|41669938|FG001|Treatment Period|Withdrawal by Subject|1|||
19423207|NCT01927419|41669937|FG000|Treatment Period|Maximum Clinical Benefit|6|||
19520296|NCT01467492|41932906|FG001|Overall Study|Study Terminated by Sponsor|4|||
19520297|NCT01467492|41932905|FG000|Overall Study|Adverse Event|4|||
19423208|NCT01927419|41669938|FG001|Treatment Period|Maximum Clinical Benefit|2|||
19423209|NCT01927419|41669937|FG000|Treatment Period|Other reasons|3|||
19423210|NCT01927419|41669938|FG001|Treatment Period|Other reasons|4|||
19423211|NCT01927419|41669937|FG000|Treatment Period|Not Reported|1|||
19423212|NCT01927419|41669938|FG001|Treatment Period|Not Reported|1|||
19423213|NCT02168491|41669944|FG000|Overall Study|Withdrawal by Subject|1|||
19423214|NCT02225743|41669948|FG000|Overall Study|Withdrawal by Subject|18|||
19423215|NCT01721746|41669954|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
19423216|NCT01721746|41669955|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
19423217|NCT01721746|41669954|FG000|Pre-Treatment|Withdrawal by Subject|1|||
19423218|NCT01721746|41669955|FG001|Pre-Treatment|Withdrawal by Subject|16|||
19423219|NCT01721746|41669954|FG000|Pre-Treatment|Poor/Non-compliance|1|||
19423220|NCT01721746|41669955|FG001|Pre-Treatment|Poor/Non-compliance|0|||
19423221|NCT01721746|41669954|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
19423222|NCT01721746|41669955|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
19423223|NCT01721746|41669954|FG000|Treatment|Disease Progression|192|||
19423224|NCT01721746|41669955|FG001|Treatment|Disease Progression|74|||
19423225|NCT01721746|41669954|FG000|Treatment|Study Drug Toxicity|19|||
19423226|NCT01721746|41669955|FG001|Treatment|Study Drug Toxicity|11|||
19423227|NCT01721746|41669954|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
19423228|NCT01721746|41669955|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
19423229|NCT01721746|41669954|FG000|Treatment|Participant request to discontinue Study treatment|26|||
19423230|NCT01721746|41669955|FG001|Treatment|Participant request to discontinue Study treatment|7|||
19423231|NCT01721746|41669954|FG000|Treatment|Participant withdrew consent|4|||
19423232|NCT01721746|41669955|FG001|Treatment|Participant withdrew consent|2|||
19423233|NCT01721746|41669954|FG000|Treatment|Maximum Clinical Benefit|9|||
19423234|NCT01721746|41669955|FG001|Treatment|Maximum Clinical Benefit|3|||
19423235|NCT01721746|41669954|FG000|Treatment|Poor/Non-compliance|2|||
19423236|NCT01721746|41669955|FG001|Treatment|Poor/Non-compliance|0|||
19423237|NCT01721746|41669954|FG000|Treatment|Participant no longer met Study criteria|4|||
19423238|NCT01721746|41669955|FG001|Treatment|Participant no longer met Study criteria|0|||
19423239|NCT01721746|41669954|FG000|Treatment|Other reasons|6|||
19423240|NCT01721746|41669955|FG001|Treatment|Other reasons|2|||
19423241|NCT02225665|41669964|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
19423242|NCT02225665|41669965|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
19423243|NCT02225665|41669964|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
19423244|NCT02225665|41669965|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
19423245|NCT01721200|41669973|FG000|Overall Study|Lost to Follow-up|3|||
19423246|NCT01721200|41669974|FG001|Overall Study|Lost to Follow-up|5|||
19423247|NCT02225587|41669987|FG000|Overall Study|Adverse Event|5|||
19423248|NCT02225587|41669988|FG001|Overall Study|Adverse Event|5|||
19423249|NCT02225587|41669987|FG000|Overall Study|Lost to Follow-up|5|||
19423250|NCT02225587|41669988|FG001|Overall Study|Lost to Follow-up|5|||
19423251|NCT02225587|41669987|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19423252|NCT02225587|41669988|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19423253|NCT02225587|41669987|FG000|Overall Study|Physician Decision|2|||
19423254|NCT02225587|41669988|FG001|Overall Study|Physician Decision|0|||
19423255|NCT02225587|41669987|FG000|Overall Study|Protocol Violation|1|||
19423256|NCT02225587|41669988|FG001|Overall Study|Protocol Violation|0|||
19423257|NCT02225587|41669987|FG000|Overall Study|Participant Moved|1|||
19423258|NCT02225587|41669988|FG001|Overall Study|Participant Moved|0|||
19423259|NCT02225587|41669987|FG000|Overall Study|Withdrawal by Subject|13|||
19423260|NCT02225587|41669988|FG001|Overall Study|Withdrawal by Subject|28|||
19423261|NCT02296424|41669996|FG000|Part 1|New therapy for study indication|0|||
19423262|NCT02296424|41669997|FG001|Part 1|New therapy for study indication|1|||
19423263|NCT02296424|41669998|FG002|Part 1|New therapy for study indication|0|||
19423264|NCT02296424|41669999|FG003|Part 1|New therapy for study indication|0|||
19423265|NCT02296424|41669996|FG000|Part 1|Protocol Violation|0|||
19423266|NCT02296424|41669997|FG001|Part 1|Protocol Violation|1|||
19423267|NCT02296424|41669998|FG002|Part 1|Protocol Violation|0|||
19423268|NCT02296424|41669999|FG003|Part 1|Protocol Violation|0|||
19423269|NCT02296424|41669996|FG000|Part 1|Withdrawal by Subject|0|||
19423270|NCT02296424|41669997|FG001|Part 1|Withdrawal by Subject|2|||
19423271|NCT02296424|41669998|FG002|Part 1|Withdrawal by Subject|0|||
19423272|NCT02296424|41669999|FG003|Part 1|Withdrawal by Subject|0|||
19423273|NCT02296424|41669996|FG000|Part 1|Study terminated by sponsor|0|||
19423274|NCT02296424|41669997|FG001|Part 1|Study terminated by sponsor|1|||
19423275|NCT02296424|41669998|FG002|Part 1|Study terminated by sponsor|0|||
19423276|NCT02296424|41669999|FG003|Part 1|Study terminated by sponsor|0|||
19423277|NCT02296424|41669996|FG000|Part 1|Adverse Event|2|||
19423278|NCT02296424|41669997|FG001|Part 1|Adverse Event|11|||
19423279|NCT02296424|41669998|FG002|Part 1|Adverse Event|0|||
19423280|NCT02296424|41669999|FG003|Part 1|Adverse Event|0|||
19423281|NCT02296424|41669996|FG000|Part 1|Lack of Efficacy|5|||
19423282|NCT02296424|41669997|FG001|Part 1|Lack of Efficacy|17|||
19423283|NCT02296424|41669998|FG002|Part 1|Lack of Efficacy|0|||
19423284|NCT02296424|41669999|FG003|Part 1|Lack of Efficacy|0|||
19423285|NCT02296424|41669996|FG000|Part 1|16 directly started part II|16|||
19423286|NCT02296424|41669997|FG001|Part 1|16 directly started part II|0|||
19423287|NCT02296424|41669998|FG002|Part 1|16 directly started part II|0|||
19423288|NCT02296424|41669999|FG003|Part 1|16 directly started part II|0|||
19423289|NCT02296424|41669996|FG000|Part 2|Lack of Efficacy|0|||
19423290|NCT02296424|41669997|FG001|Part 2|Lack of Efficacy|0|||
19520298|NCT01467492|41932906|FG001|Overall Study|Adverse Event|3|||
19423291|NCT02296424|41669998|FG002|Part 2|Lack of Efficacy|1|||
19423292|NCT02296424|41669999|FG003|Part 2|Lack of Efficacy|0|||
19423293|NCT02296424|41669996|FG000|Part 2|Adverse Event|0|||
19423294|NCT02296424|41669997|FG001|Part 2|Adverse Event|0|||
19423295|NCT02296424|41669998|FG002|Part 2|Adverse Event|1|||
19423296|NCT02296424|41669999|FG003|Part 2|Adverse Event|0|||
19423297|NCT02296424|41669996|FG000|Part 2|Lost to Follow-up|0|||
19423298|NCT02296424|41669997|FG001|Part 2|Lost to Follow-up|0|||
19423299|NCT02296424|41669998|FG002|Part 2|Lost to Follow-up|1|||
19423300|NCT02296424|41669999|FG003|Part 2|Lost to Follow-up|0|||
19423301|NCT02201251|41670009|FG000|Overall Study|Adverse Event|1|||
19423302|NCT02201251|41670010|FG001|Overall Study|Adverse Event|1|||
19423303|NCT02201251|41670009|FG000|Overall Study|Protocol Violation|1|||
19423304|NCT02201251|41670010|FG001|Overall Study|Protocol Violation|0|||
19423305|NCT02201251|41670009|FG000|Overall Study|Noncompliance with Study Drug|0|||
19423306|NCT02201251|41670010|FG001|Overall Study|Noncompliance with Study Drug|1|||
19423307|NCT02201251|41670009|FG000|Overall Study|Withdrawal by Subject|2|||
19423308|NCT02201251|41670010|FG001|Overall Study|Withdrawal by Subject|1|||
19423309|NCT02296190|41670022|FG000|Overall Study|Lost to Follow-up|0|||
19423310|NCT02296190|41670023|FG001|Overall Study|Lost to Follow-up|0|||
19423311|NCT02296190|41670024|FG002|Overall Study|Lost to Follow-up|0|||
19423312|NCT02296190|41670025|FG003|Overall Study|Lost to Follow-up|0|||
19423313|NCT02296190|41670026|FG004|Overall Study|Lost to Follow-up|1|||
19423314|NCT02296190|41670027|FG005|Overall Study|Lost to Follow-up|0|||
19423315|NCT02296190|41670022|FG000|Overall Study|Failure to induce PSVT|6|||
19423316|NCT02296190|41670023|FG001|Overall Study|Failure to induce PSVT|10|||
19423317|NCT02296190|41670024|FG002|Overall Study|Failure to induce PSVT|5|||
19423318|NCT02296190|41670025|FG003|Overall Study|Failure to induce PSVT|13|||
19423319|NCT02296190|41670026|FG004|Overall Study|Failure to induce PSVT|8|||
19423320|NCT02296190|41670027|FG005|Overall Study|Failure to induce PSVT|0|||
19423321|NCT02296190|41670022|FG000|Overall Study|Physician Decision|1|||
19423322|NCT02296190|41670023|FG001|Overall Study|Physician Decision|1|||
19423323|NCT02296190|41670024|FG002|Overall Study|Physician Decision|0|||
19423324|NCT02296190|41670025|FG003|Overall Study|Physician Decision|1|||
19423325|NCT02296190|41670026|FG004|Overall Study|Physician Decision|2|||
19423326|NCT02296190|41670027|FG005|Overall Study|Physician Decision|0|||
19423327|NCT02296190|41670022|FG000|Overall Study|Withdrawal by Subject|0|||
19423328|NCT02296190|41670023|FG001|Overall Study|Withdrawal by Subject|1|||
19423329|NCT02296190|41670024|FG002|Overall Study|Withdrawal by Subject|0|||
19423330|NCT02296190|41670025|FG003|Overall Study|Withdrawal by Subject|0|||
19423331|NCT02296190|41670026|FG004|Overall Study|Withdrawal by Subject|0|||
19423332|NCT02296190|41670027|FG005|Overall Study|Withdrawal by Subject|0|||
19423333|NCT02296190|41670022|FG000|Overall Study|PSVT < 5 minutes|5|||
19423334|NCT02296190|41670023|FG001|Overall Study|PSVT < 5 minutes|6|||
19423335|NCT02296190|41670024|FG002|Overall Study|PSVT < 5 minutes|6|||
19423336|NCT02296190|41670025|FG003|Overall Study|PSVT < 5 minutes|6|||
19423337|NCT02296190|41670026|FG004|Overall Study|PSVT < 5 minutes|5|||
19423338|NCT02296190|41670027|FG005|Overall Study|PSVT < 5 minutes|0|||
19423339|NCT02296190|41670022|FG000|Overall Study|Patient was given Propofol|0|||
19423340|NCT02296190|41670023|FG001|Overall Study|Patient was given Propofol|1|||
19423341|NCT02296190|41670024|FG002|Overall Study|Patient was given Propofol|0|||
19423342|NCT02296190|41670025|FG003|Overall Study|Patient was given Propofol|1|||
19423343|NCT02296190|41670026|FG004|Overall Study|Patient was given Propofol|0|||
19423344|NCT02296190|41670027|FG005|Overall Study|Patient was given Propofol|0|||
19423345|NCT02296190|41670022|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
19423346|NCT02296190|41670023|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
19423347|NCT02296190|41670024|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
19423348|NCT02296190|41670025|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
19423349|NCT02296190|41670026|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
19423350|NCT02296190|41670027|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
19423351|NCT02296190|41670022|FG000|Overall Study|Blood pressure <100 after sedation|0|||
19423352|NCT02296190|41670023|FG001|Overall Study|Blood pressure <100 after sedation|0|||
19423353|NCT02296190|41670024|FG002|Overall Study|Blood pressure <100 after sedation|0|||
19423354|NCT02296190|41670025|FG003|Overall Study|Blood pressure <100 after sedation|1|||
19423355|NCT02296190|41670026|FG004|Overall Study|Blood pressure <100 after sedation|0|||
19423356|NCT02296190|41670027|FG005|Overall Study|Blood pressure <100 after sedation|0|||
19423357|NCT02296190|41670022|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
19423358|NCT02296190|41670023|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
19423359|NCT02296190|41670024|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
19423360|NCT02296190|41670025|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
19423361|NCT02296190|41670026|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
19423362|NCT02296190|41670027|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
19423363|NCT02296190|41670022|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
19423364|NCT02296190|41670023|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
19423365|NCT02296190|41670024|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
19423366|NCT02296190|41670025|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
19423367|NCT02296190|41670026|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
19423368|NCT02296190|41670027|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
19423369|NCT02296190|41670022|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
19423370|NCT02296190|41670023|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
19423371|NCT02296190|41670024|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
19423372|NCT02296190|41670025|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
19423373|NCT02296190|41670026|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
19423374|NCT02296190|41670027|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
19423375|NCT02296190|41670022|FG000|Overall Study|Lab result not available in time|1|||
19423376|NCT02296190|41670023|FG001|Overall Study|Lab result not available in time|0|||
19423377|NCT02296190|41670024|FG002|Overall Study|Lab result not available in time|0|||
19423378|NCT02296190|41670025|FG003|Overall Study|Lab result not available in time|0|||
19423379|NCT02296190|41670026|FG004|Overall Study|Lab result not available in time|0|||
19423380|NCT02296190|41670027|FG005|Overall Study|Lab result not available in time|0|||
19423381|NCT02296112|41670040|FG000|Overall Study|Disease progression|7|||
19423382|NCT02296112|41670040|FG000|Overall Study|Toxicity|1|||
19423383|NCT02296112|41670040|FG000|Overall Study|Began an alternate therapy|1|||
19423384|NCT02295644|41670053|FG000|Overall Study|Did not meet inclusion criterion|0|||
19423385|NCT02295644|41670054|FG001|Overall Study|Did not meet inclusion criterion|0|||
19423386|NCT02295644|41670055|FG002|Overall Study|Did not meet inclusion criterion|1|||
19423387|NCT02295644|41670056|FG003|Overall Study|Did not meet inclusion criterion|2|||
19423388|NCT02269670|41670066|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
19423389|NCT02225353|41670073|FG000|Overall Study|Lost to Follow-up|0|||
19423390|NCT02225353|41670074|FG001|Overall Study|Lost to Follow-up|1|||
19423391|NCT02225353|41670075|FG002|Overall Study|Lost to Follow-up|3|||
19423392|NCT02225353|41670073|FG000|Overall Study|Protocol Violation|4|||
19423393|NCT02225353|41670074|FG001|Overall Study|Protocol Violation|5|||
19423394|NCT02225353|41670075|FG002|Overall Study|Protocol Violation|12|||
19423395|NCT01641926|41670090|FG000|Overall Study|Adverse Event|5|||
19423396|NCT01641926|41670091|FG001|Overall Study|Adverse Event|2|||
19423397|NCT01641926|41670092|FG002|Overall Study|Adverse Event|3|||
19423398|NCT01641926|41670093|FG003|Overall Study|Adverse Event|1|||
19423399|NCT01641926|41670090|FG000|Overall Study|Lost to Follow-up|2|||
19423400|NCT01641926|41670091|FG001|Overall Study|Lost to Follow-up|2|||
19423401|NCT01641926|41670092|FG002|Overall Study|Lost to Follow-up|1|||
19423402|NCT01641926|41670093|FG003|Overall Study|Lost to Follow-up|0|||
19423403|NCT01641926|41670090|FG000|Overall Study|Physician Decision|6|||
19423404|NCT01641926|41670091|FG001|Overall Study|Physician Decision|5|||
19423405|NCT01641926|41670092|FG002|Overall Study|Physician Decision|0|||
19423406|NCT01641926|41670093|FG003|Overall Study|Physician Decision|1|||
19423407|NCT01641926|41670090|FG000|Overall Study|Protocol Violation|1|||
19423408|NCT01641926|41670091|FG001|Overall Study|Protocol Violation|0|||
19423409|NCT01641926|41670092|FG002|Overall Study|Protocol Violation|0|||
19423410|NCT01641926|41670093|FG003|Overall Study|Protocol Violation|1|||
19423411|NCT01641926|41670090|FG000|Overall Study|Withdrawal by Subject|13|||
19423412|NCT01641926|41670091|FG001|Overall Study|Withdrawal by Subject|5|||
19423413|NCT01641926|41670092|FG002|Overall Study|Withdrawal by Subject|6|||
19423414|NCT01641926|41670093|FG003|Overall Study|Withdrawal by Subject|1|||
19423415|NCT01641926|41670090|FG000|Overall Study|Not Treated|1|||
19423416|NCT01641926|41670091|FG001|Overall Study|Not Treated|1|||
19423417|NCT01641926|41670092|FG002|Overall Study|Not Treated|1|||
19423418|NCT01641926|41670093|FG003|Overall Study|Not Treated|0|||
19423419|NCT02295020|41670105|FG000|Overall Study|Adverse Event|0|||
19423420|NCT02295020|41670106|FG001|Overall Study|Adverse Event|1|||
19423421|NCT02295020|41670105|FG000|Overall Study|Withdrawal by Subject|3|||
19423422|NCT02295020|41670106|FG001|Overall Study|Withdrawal by Subject|2|||
19423423|NCT02200939|41670120|FG000|Overall Study|Participant withdrew consent|0|||
19423424|NCT02200939|41670121|FG001|Overall Study|Participant withdrew consent|1|||
19423425|NCT02200939|41670120|FG000|Overall Study|Lost to Follow-up|2|||
19423426|NCT02200939|41670121|FG001|Overall Study|Lost to Follow-up|9|||
19423427|NCT02200939|41670120|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
19520299|NCT01467492|41932905|FG000|Overall Study|Lost to Follow-up|3|||
19520300|NCT01467492|41932906|FG001|Overall Study|Lost to Follow-up|2|||
19520301|NCT01467492|41932905|FG000|Overall Study|Undefined|2|||
19520302|NCT01467492|41932906|FG001|Overall Study|Undefined|0|||
19520303|NCT01467492|41932905|FG000|Overall Study|Enrolled But Not Treated|1|||
19520304|NCT01467492|41932906|FG001|Overall Study|Enrolled But Not Treated|0|||
19520305|NCT01466790|41932921|FG000|Overall Study|Adverse Event|1|||
19520306|NCT01466790|41932922|FG001|Overall Study|Adverse Event|0|||
19520307|NCT01466790|41932923|FG002|Overall Study|Adverse Event|0|||
19520308|NCT01466790|41932924|FG003|Overall Study|Adverse Event|0|||
19520309|NCT01466790|41932925|FG004|Overall Study|Adverse Event|2|||
19520310|NCT01466790|41932926|FG005|Overall Study|Adverse Event|0|||
19711134|NCT00096135|42154345|FG001|Overall Study|Refusal of further protocol therapy|1|||
19423428|NCT02200939|41670121|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
19423429|NCT02294786|41670133|FG000|Overall Study|Withdrawal by Subject|0|||
19423430|NCT02294786|41670134|FG001|Overall Study|Withdrawal by Subject|1|||
19423431|NCT02294786|41670133|FG000|Overall Study|Physician Decision|6|||
19423432|NCT02294786|41670134|FG001|Overall Study|Physician Decision|7|||
19423433|NCT02294786|41670133|FG000|Overall Study|Lost to Follow-up|1|||
19423434|NCT02294786|41670134|FG001|Overall Study|Lost to Follow-up|2|||
19520311|NCT01466790|41932927|FG006|Overall Study|Adverse Event|0|||
19520312|NCT01466790|41932928|FG007|Overall Study|Adverse Event|0|||
19520313|NCT01466790|41932921|FG000|Overall Study|Lost to Follow-up|2|||
19423435|NCT02294786|41670133|FG000|Overall Study|Protocol Violation|1|||
19423436|NCT02294786|41670134|FG001|Overall Study|Protocol Violation|0|||
19423437|NCT02294786|41670133|FG000|Overall Study|Adverse Event|1|||
19423438|NCT02294786|41670134|FG001|Overall Study|Adverse Event|1|||
19423439|NCT02294786|41670133|FG000|Overall Study|Death|2|||
19423440|NCT02294786|41670134|FG001|Overall Study|Death|3|||
19423441|NCT02269124|41670143|FG000|Overall Study|Lost to Follow-up|1|||
19423442|NCT02269124|41670144|FG001|Overall Study|Lost to Follow-up|0|||
19423443|NCT02269124|41670143|FG000|Overall Study|Withdrawal by Subject|0|||
19423444|NCT02269124|41670144|FG001|Overall Study|Withdrawal by Subject|2|||
19423445|NCT01927341|41670156|FG000|Phase 1b|Lost to Follow-up|1|||
19423446|NCT01927341|41670157|FG001|Phase 1b|Lost to Follow-up|0|||
19423447|NCT01927341|41670158|FG002|Phase 1b|Lost to Follow-up|0|||
19423448|NCT01927341|41670159|FG003|Phase 1b|Lost to Follow-up|0|||
19423449|NCT01927341|41670160|FG004|Phase 1b|Lost to Follow-up|0|||
19423450|NCT01927341|41670156|FG000|Phase 1b|Death|2|||
19423451|NCT01927341|41670157|FG001|Phase 1b|Death|0|||
19423452|NCT01927341|41670158|FG002|Phase 1b|Death|0|||
19423453|NCT01927341|41670159|FG003|Phase 1b|Death|0|||
19423454|NCT01927341|41670160|FG004|Phase 1b|Death|0|||
19423455|NCT01927341|41670156|FG000|Phase 1b|Follow-up completed|7|||
19423456|NCT01927341|41670157|FG001|Phase 1b|Follow-up completed|0|||
19423457|NCT01927341|41670158|FG002|Phase 1b|Follow-up completed|0|||
19423458|NCT01927341|41670159|FG003|Phase 1b|Follow-up completed|0|||
19423459|NCT01927341|41670160|FG004|Phase 1b|Follow-up completed|0|||
19423460|NCT01927341|41670156|FG000|Phase 2|Lost to Follow-up|0|||
19423461|NCT01927341|41670157|FG001|Phase 2|Lost to Follow-up|1|||
19423462|NCT01927341|41670158|FG002|Phase 2|Lost to Follow-up|0|||
19423463|NCT01927341|41670159|FG003|Phase 2|Lost to Follow-up|0|||
19423464|NCT01927341|41670160|FG004|Phase 2|Lost to Follow-up|0|||
19423465|NCT01927341|41670156|FG000|Phase 2|Participant withdrew consent|0|||
19423466|NCT01927341|41670157|FG001|Phase 2|Participant withdrew consent|2|||
19423467|NCT01927341|41670158|FG002|Phase 2|Participant withdrew consent|1|||
19423468|NCT01927341|41670159|FG003|Phase 2|Participant withdrew consent|2|||
19423469|NCT01927341|41670160|FG004|Phase 2|Participant withdrew consent|3|||
19423470|NCT01927341|41670156|FG000|Phase 2|Death|0|||
19423471|NCT01927341|41670157|FG001|Phase 2|Death|4|||
19423472|NCT01927341|41670158|FG002|Phase 2|Death|0|||
19423473|NCT01927341|41670159|FG003|Phase 2|Death|3|||
19423474|NCT01927341|41670160|FG004|Phase 2|Death|2|||
19423475|NCT01927341|41670156|FG000|Phase 2|New cancer therapy|0|||
19423476|NCT01927341|41670157|FG001|Phase 2|New cancer therapy|1|||
19423477|NCT01927341|41670158|FG002|Phase 2|New cancer therapy|0|||
19423478|NCT01927341|41670159|FG003|Phase 2|New cancer therapy|4|||
19423479|NCT01927341|41670160|FG004|Phase 2|New cancer therapy|1|||
19423480|NCT01927341|41670156|FG000|Phase 2|Disease progression|0|||
19423481|NCT01927341|41670157|FG001|Phase 2|Disease progression|1|||
19423482|NCT01927341|41670158|FG002|Phase 2|Disease progression|1|||
19423483|NCT01927341|41670159|FG003|Phase 2|Disease progression|1|||
19423484|NCT01927341|41670160|FG004|Phase 2|Disease progression|0|||
19423485|NCT01927341|41670156|FG000|Phase 2|Follow-up completed|0|||
19423486|NCT01927341|41670157|FG001|Phase 2|Follow-up completed|6|||
19423487|NCT01927341|41670158|FG002|Phase 2|Follow-up completed|3|||
19423488|NCT01927341|41670159|FG003|Phase 2|Follow-up completed|5|||
19423489|NCT01927341|41670160|FG004|Phase 2|Follow-up completed|2|||
19423490|NCT02294474|41670178|FG000|Overall Study|Adverse Event|7|||
19423491|NCT02294474|41670179|FG001|Overall Study|Adverse Event|7|||
19423492|NCT02294474|41670178|FG000|Overall Study|Lack of Efficacy|2|||
19423493|NCT02294474|41670179|FG001|Overall Study|Lack of Efficacy|1|||
19423494|NCT02294474|41670178|FG000|Overall Study|Protocol Violation|4|||
19423495|NCT02294474|41670179|FG001|Overall Study|Protocol Violation|2|||
19423496|NCT02294474|41670178|FG000|Overall Study|Other than specified above|12|||
19423497|NCT02294474|41670179|FG001|Overall Study|Other than specified above|12|||
19423498|NCT02168101|41670189|FG000|Overall Study|Death|2|||
19423499|NCT02168101|41670190|FG001|Overall Study|Death|2|||
19423500|NCT02168101|41670191|FG002|Overall Study|Death|1|||
19423501|NCT01956123|41670202|FG000|COS Cycle 2|Protocol Violation|8|||
19423502|NCT01956123|41670203|FG001|COS Cycle 2|Protocol Violation|3|||
19423503|NCT01956123|41670204|FG002|COS Cycle 2|Protocol Violation|0|||
19423504|NCT01956123|41670205|FG003|COS Cycle 2|Protocol Violation|0|||
19423505|NCT01956123|41670202|FG000|COS Cycle 2|Adverse Event|3|||
19423506|NCT01956123|41670203|FG001|COS Cycle 2|Adverse Event|4|||
19423507|NCT01956123|41670204|FG002|COS Cycle 2|Adverse Event|0|||
19423508|NCT01956123|41670205|FG003|COS Cycle 2|Adverse Event|0|||
19423509|NCT01956123|41670202|FG000|COS Cycle 2|Personal Reasons|2|||
19423510|NCT01956123|41670203|FG001|COS Cycle 2|Personal Reasons|0|||
19423511|NCT01956123|41670204|FG002|COS Cycle 2|Personal Reasons|0|||
19423512|NCT01956123|41670205|FG003|COS Cycle 2|Personal Reasons|0|||
19423513|NCT01956123|41670202|FG000|COS Cycle 2|Withdrawal by Subject|1|||
19423514|NCT01956123|41670203|FG001|COS Cycle 2|Withdrawal by Subject|0|||
19423515|NCT01956123|41670204|FG002|COS Cycle 2|Withdrawal by Subject|0|||
19423516|NCT01956123|41670205|FG003|COS Cycle 2|Withdrawal by Subject|0|||
19423517|NCT01956123|41670202|FG000|COS Cycle 3|Protocol Violation|0|||
19423518|NCT01956123|41670203|FG001|COS Cycle 3|Protocol Violation|0|||
19423519|NCT01956123|41670204|FG002|COS Cycle 3|Protocol Violation|2|||
19423520|NCT01956123|41670205|FG003|COS Cycle 3|Protocol Violation|1|||
19423521|NCT01956123|41670202|FG000|COS Cycle 3|Adverse Event|0|||
19423522|NCT01956123|41670203|FG001|COS Cycle 3|Adverse Event|0|||
19423523|NCT01956123|41670204|FG002|COS Cycle 3|Adverse Event|3|||
19423524|NCT01956123|41670205|FG003|COS Cycle 3|Adverse Event|0|||
19423525|NCT01956123|41670202|FG000|COS Cycle 3|Personal Reasons|0|||
19423526|NCT01956123|41670203|FG001|COS Cycle 3|Personal Reasons|0|||
19423527|NCT01956123|41670204|FG002|COS Cycle 3|Personal Reasons|1|||
19423528|NCT01956123|41670205|FG003|COS Cycle 3|Personal Reasons|0|||
19423529|NCT01956123|41670202|FG000|COS Cycle 3|Withdrawal by Subject|0|||
19423530|NCT01956123|41670203|FG001|COS Cycle 3|Withdrawal by Subject|0|||
19423531|NCT01956123|41670204|FG002|COS Cycle 3|Withdrawal by Subject|0|||
19423532|NCT01956123|41670205|FG003|COS Cycle 3|Withdrawal by Subject|1|||
19423533|NCT02298179|41670228|FG000|Overall Study|Lost to Follow-up|0|||
19423534|NCT02298179|41670229|FG001|Overall Study|Lost to Follow-up|0|||
19423535|NCT02298179|41670230|FG002|Overall Study|Lost to Follow-up|1|||
19423536|NCT02298179|41670231|FG003|Overall Study|Lost to Follow-up|0|||
19423537|NCT02298179|41670232|FG004|Overall Study|Lost to Follow-up|0|||
19423538|NCT02298179|41670233|FG005|Overall Study|Lost to Follow-up|0|||
19423539|NCT02298179|41670234|FG006|Overall Study|Lost to Follow-up|0|||
19423540|NCT02298179|41670235|FG007|Overall Study|Lost to Follow-up|1|||
19423541|NCT02298179|41670236|FG008|Overall Study|Lost to Follow-up|0|||
19423542|NCT02298179|41670237|FG009|Overall Study|Lost to Follow-up|0|||
19423543|NCT02298179|41670238|FG010|Overall Study|Lost to Follow-up|0|||
19423544|NCT02298179|41670239|FG011|Overall Study|Lost to Follow-up|0|||
19423545|NCT02298023|41670268|FG000|Overall Study|Withdrawal by Subject|1|||
19423546|NCT02298023|41670269|FG001|Overall Study|Withdrawal by Subject|0|||
19423547|NCT02298023|41670270|FG002|Overall Study|Withdrawal by Subject|0|||
19423548|NCT02296931|41670283|FG000|Overall Study|Protocol Violation|0|||
19423549|NCT02296931|41670284|FG001|Overall Study|Protocol Violation|2|||
19423550|NCT02166697|41670290|FG000|Overall Study|Protocol Violation|347|||
19423551|NCT01909479|41670296|FG000|From Baseline to Week 26|Adverse Event|3|||
19423552|NCT01909479|41670297|FG001|From Baseline to Week 26|Adverse Event|2|||
19423553|NCT01909479|41670296|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
19423554|NCT01909479|41670297|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
19423555|NCT01909479|41670296|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
19423556|NCT01909479|41670297|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
19423557|NCT01909479|41670296|FG000|26 - 52 Weeks|Adverse Event|0|||
19423558|NCT01909479|41670297|FG001|26 - 52 Weeks|Adverse Event|1|||
19423559|NCT01909479|41670296|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
19423560|NCT01909479|41670297|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
19423561|NCT01909479|41670296|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
19423562|NCT01909479|41670297|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
19423563|NCT01909479|41670296|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
19423564|NCT01909479|41670297|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
19423565|NCT01909479|41670296|FG000|52 Weeks to End of Study|Adverse Event|2|||
19423566|NCT01909479|41670297|FG001|52 Weeks to End of Study|Adverse Event|1|||
19423567|NCT01909479|41670296|FG000|52 Weeks to End of Study|Death|0|||
19423568|NCT01909479|41670297|FG001|52 Weeks to End of Study|Death|1|||
19423569|NCT01909479|41670296|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
19423570|NCT01909479|41670297|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
19423571|NCT01909479|41670296|FG000|52 Weeks to End of Study|Protocol Violation|1|||
19423572|NCT01909479|41670297|FG001|52 Weeks to End of Study|Protocol Violation|0|||
19423573|NCT01909479|41670296|FG000|52 Weeks to End of Study|Progressive disease|1|||
19423574|NCT01909479|41670297|FG001|52 Weeks to End of Study|Progressive disease|1|||
19423575|NCT01909479|41670296|FG000|52 Weeks to End of Study|Personal reasons|2|||
19423576|NCT01909479|41670297|FG001|52 Weeks to End of Study|Personal reasons|1|||
19423577|NCT01909479|41670296|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
19423578|NCT01909479|41670297|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
19423579|NCT01909479|41670296|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
19423580|NCT01909479|41670297|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
19520314|NCT01466790|41932922|FG001|Overall Study|Lost to Follow-up|0|||
19520315|NCT01466790|41932923|FG002|Overall Study|Lost to Follow-up|0|||
19628193|NCT00802074|42077593|FG005|Overall Study|Adverse Event|0|||
19423581|NCT01909479|41670296|FG000|52 Weeks to End of Study|Lack of contact|1|||
19423582|NCT01909479|41670297|FG001|52 Weeks to End of Study|Lack of contact|0|||
19423583|NCT01909479|41670296|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
19423584|NCT01909479|41670297|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
19423585|NCT01909479|41670296|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
19423586|NCT01909479|41670297|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
19423587|NCT01955733|41670310|FG000|Period 1|Lost to Follow-up|1|||
19423588|NCT01955733|41670311|FG001|Period 1|Lost to Follow-up|0|||
19423589|NCT01955733|41670312|FG002|Period 1|Lost to Follow-up|0|||
19423590|NCT01955733|41670310|FG000|Period 2|Adverse Event|1|||
19423591|NCT01955733|41670311|FG001|Period 2|Adverse Event|0|||
19423592|NCT01955733|41670312|FG002|Period 2|Adverse Event|0|||
19423593|NCT01955733|41670310|FG000|Period 2|Physician Decision|0|||
19423594|NCT01955733|41670311|FG001|Period 2|Physician Decision|0|||
19423595|NCT01955733|41670312|FG002|Period 2|Physician Decision|1|||
19423596|NCT01955733|41670310|FG000|Period 2|Withdrawal by Subject|1|||
19423597|NCT01955733|41670311|FG001|Period 2|Withdrawal by Subject|3|||
19423598|NCT01955733|41670312|FG002|Period 2|Withdrawal by Subject|2|||
19423599|NCT01955733|41670310|FG000|Period 2|Study terminated by sponsor|8|||
19423600|NCT01955733|41670311|FG001|Period 2|Study terminated by sponsor|14|||
19423601|NCT01955733|41670312|FG002|Period 2|Study terminated by sponsor|16|||
19423602|NCT01955733|41670310|FG000|Period 2|Lost to Follow-up|2|||
19423603|NCT01955733|41670311|FG001|Period 2|Lost to Follow-up|0|||
19423604|NCT01955733|41670312|FG002|Period 2|Lost to Follow-up|0|||
19423605|NCT01955733|41670310|FG000|Period 2|Other not defined above|0|||
19423606|NCT01955733|41670311|FG001|Period 2|Other not defined above|2|||
19423607|NCT01955733|41670312|FG002|Period 2|Other not defined above|2|||
19423608|NCT02197897|41670320|FG000|Overall Study|not eligible|1|||
19423609|NCT02223793|41670327|FG000|Overall Study|Lost to Follow-up|10|||
19423610|NCT02223793|41670328|FG001|Overall Study|Lost to Follow-up|1|||
19423611|NCT02223793|41670329|FG002|Overall Study|Lost to Follow-up|2|||
19423612|NCT02223793|41670327|FG000|Overall Study|Withdrawal by Subject|3|||
19423613|NCT02223793|41670328|FG001|Overall Study|Withdrawal by Subject|2|||
19423614|NCT02223793|41670329|FG002|Overall Study|Withdrawal by Subject|3|||
19423615|NCT02223793|41670327|FG000|Overall Study|Moved/studycenter unable to participate|4|||
19423616|NCT02223793|41670328|FG001|Overall Study|Moved/studycenter unable to participate|6|||
19423617|NCT02223793|41670329|FG002|Overall Study|Moved/studycenter unable to participate|8|||
19423618|NCT01926015|41670339|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19423619|NCT01926015|41670340|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19423620|NCT01926015|41670339|FG000|Overall Study|Randomized not treated|2|||
19423621|NCT01926015|41670340|FG001|Overall Study|Randomized not treated|0|||
19423622|NCT02223715|41670346|FG000|Overall Study|Death|31|||
19423623|NCT02223715|41670346|FG000|Overall Study|Lost to Follow-up|73|||
19423624|NCT02196259|41670356|FG000|Overall Study|Researcher choice|0|||
19423625|NCT02196259|41670357|FG001|Overall Study|Researcher choice|0|||
19423626|NCT02196259|41670358|FG002|Overall Study|Researcher choice|1|||
19423627|NCT02196259|41670356|FG000|Overall Study|Partial data analysis|0|||
19423628|NCT02196259|41670357|FG001|Overall Study|Partial data analysis|3|||
19423629|NCT02196259|41670358|FG002|Overall Study|Partial data analysis|0|||
19423630|NCT02294396|41670369|FG000|Overall Study|Adverse Event|26|||
19423631|NCT02294396|41670370|FG001|Overall Study|Adverse Event|25|||
19423632|NCT02294396|41670371|FG002|Overall Study|Adverse Event|21|||
19423633|NCT02294396|41670372|FG003|Overall Study|Adverse Event|24|||
19423634|NCT02294396|41670369|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
19423635|NCT02294396|41670370|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
19423636|NCT02294396|41670371|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
19423637|NCT02294396|41670372|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
19423638|NCT02294396|41670369|FG000|Overall Study|Withdrawal by Subject|8|||
19423639|NCT02294396|41670370|FG001|Overall Study|Withdrawal by Subject|6|||
19423640|NCT02294396|41670371|FG002|Overall Study|Withdrawal by Subject|6|||
19423641|NCT02294396|41670372|FG003|Overall Study|Withdrawal by Subject|8|||
19423642|NCT02294396|41670369|FG000|Overall Study|Lost to Follow-up|0|||
19423643|NCT02294396|41670370|FG001|Overall Study|Lost to Follow-up|0|||
19423644|NCT02294396|41670371|FG002|Overall Study|Lost to Follow-up|1|||
19423645|NCT02294396|41670372|FG003|Overall Study|Lost to Follow-up|1|||
19423646|NCT02294396|41670369|FG000|Overall Study|Protocol Deviation|3|||
19423647|NCT02294396|41670370|FG001|Overall Study|Protocol Deviation|2|||
19423648|NCT02294396|41670371|FG002|Overall Study|Protocol Deviation|2|||
19423649|NCT02294396|41670372|FG003|Overall Study|Protocol Deviation|1|||
19423650|NCT02294396|41670369|FG000|Overall Study|Miscellaneous|2|||
19423651|NCT02294396|41670370|FG001|Overall Study|Miscellaneous|0|||
19423652|NCT02294396|41670371|FG002|Overall Study|Miscellaneous|5|||
19423653|NCT02294396|41670372|FG003|Overall Study|Miscellaneous|2|||
19423654|NCT01721044|41670385|FG000|Treatment Period|Adverse Event|7|||
19423655|NCT01721044|41670386|FG001|Treatment Period|Adverse Event|7|||
19423656|NCT01721044|41670387|FG002|Treatment Period|Adverse Event|10|||
19423657|NCT01721044|41670385|FG000|Treatment Period|Death|0|||
19423658|NCT01721044|41670386|FG001|Treatment Period|Death|0|||
19423659|NCT01721044|41670387|FG002|Treatment Period|Death|1|||
19423660|NCT01721044|41670385|FG000|Treatment Period|Lack of Efficacy|16|||
19423661|NCT01721044|41670386|FG001|Treatment Period|Lack of Efficacy|4|||
19423662|NCT01721044|41670387|FG002|Treatment Period|Lack of Efficacy|4|||
19423663|NCT01721044|41670385|FG000|Treatment Period|Lost to Follow-up|0|||
19423664|NCT01721044|41670386|FG001|Treatment Period|Lost to Follow-up|0|||
19423665|NCT01721044|41670387|FG002|Treatment Period|Lost to Follow-up|1|||
19423666|NCT01721044|41670385|FG000|Treatment Period|Physician Decision|1|||
19423667|NCT01721044|41670386|FG001|Treatment Period|Physician Decision|0|||
19423668|NCT01721044|41670387|FG002|Treatment Period|Physician Decision|2|||
19423669|NCT01721044|41670385|FG000|Treatment Period|Protocol Violation|1|||
19423670|NCT01721044|41670386|FG001|Treatment Period|Protocol Violation|0|||
19423671|NCT01721044|41670387|FG002|Treatment Period|Protocol Violation|0|||
19423672|NCT01721044|41670385|FG000|Treatment Period|Withdrawal by Subject|7|||
19423673|NCT01721044|41670386|FG001|Treatment Period|Withdrawal by Subject|6|||
19423674|NCT01721044|41670387|FG002|Treatment Period|Withdrawal by Subject|1|||
19423675|NCT02164981|41670409|FG000|Started|Withdrawal by Subject|2|||
19423676|NCT02164981|41670410|FG001|Started|Withdrawal by Subject|1|||
19423677|NCT02164981|41670411|FG002|Started|Withdrawal by Subject|0|||
19423678|NCT02164981|41670409|FG000|Started|Protocol Violation|2|||
19423679|NCT02164981|41670410|FG001|Started|Protocol Violation|0|||
19423680|NCT02164981|41670411|FG002|Started|Protocol Violation|0|||
19423681|NCT02164981|41670409|FG000|Started|Adverse Event|1|||
19423682|NCT02164981|41670410|FG001|Started|Adverse Event|2|||
19423683|NCT02164981|41670411|FG002|Started|Adverse Event|0|||
19423684|NCT02164981|41670409|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
19423685|NCT02164981|41670410|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
19423686|NCT02164981|41670411|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
19423687|NCT02164981|41670409|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
19423688|NCT02164981|41670410|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
19423689|NCT02164981|41670411|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
19423690|NCT02164981|41670409|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
19423691|NCT02164981|41670410|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
19423692|NCT02164981|41670411|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
19423693|NCT02195869|41670432|FG000|Overall Study|cGVHD Progression|5|||
19423694|NCT02195869|41670432|FG000|Overall Study|Malignancy Progression/relapse|2|||
19423695|NCT02195869|41670432|FG000|Overall Study|Adverse Event|15|||
19423696|NCT02195869|41670432|FG000|Overall Study|Withdrawal by Subject|7|||
19423697|NCT02195869|41670432|FG000|Overall Study|Physician Decision|4|||
19423698|NCT02195869|41670432|FG000|Overall Study|Study Terminated by Sponsor|7|||
19423699|NCT02195869|41670432|FG000|Overall Study|Noncompliance with study drug|2|||
19423700|NCT01908699|41670441|FG000|Overall Study|Adverse Event|8|||
19423701|NCT01908699|41670442|FG001|Overall Study|Adverse Event|12|||
19423702|NCT01908699|41670441|FG000|Overall Study|Lack of Efficacy|2|||
19423703|NCT01908699|41670442|FG001|Overall Study|Lack of Efficacy|2|||
19423704|NCT01908699|41670441|FG000|Overall Study|Lost to Follow-up|2|||
19423705|NCT01908699|41670442|FG001|Overall Study|Lost to Follow-up|4|||
19423706|NCT01908699|41670441|FG000|Overall Study|Physician Decision|8|||
19423707|NCT01908699|41670442|FG001|Overall Study|Physician Decision|8|||
19423708|NCT01908699|41670441|FG000|Overall Study|Withdrawal by Subject|15|||
19423709|NCT01908699|41670442|FG001|Overall Study|Withdrawal by Subject|10|||
19423710|NCT01908699|41670441|FG000|Overall Study|Pregnancy|0|||
19423711|NCT01908699|41670442|FG001|Overall Study|Pregnancy|1|||
19423712|NCT01908699|41670441|FG000|Overall Study|Randomized in Error|1|||
19423713|NCT01908699|41670442|FG001|Overall Study|Randomized in Error|0|||
19423714|NCT01908699|41670441|FG000|Overall Study|Death|9|||
19423715|NCT01908699|41670442|FG001|Overall Study|Death|12|||
19423716|NCT01908699|41670441|FG000|Overall Study|Progressive Disease|30|||
19423717|NCT01908699|41670442|FG001|Overall Study|Progressive Disease|29|||
19423718|NCT01599637|41670451|FG000|Overall Study|administrative problems|0|||
19423719|NCT01599637|41670452|FG001|Overall Study|administrative problems|2|||
19423720|NCT01599637|41670453|FG002|Overall Study|administrative problems|0|||
19423721|NCT01599637|41670451|FG000|Overall Study|Adverse Event|1|||
19423722|NCT01599637|41670452|FG001|Overall Study|Adverse Event|0|||
19423723|NCT01599637|41670453|FG002|Overall Study|Adverse Event|0|||
19423724|NCT02264639|41670468|FG000|Overall Study|Death (after completing single-dose phase)|1|||
19423725|NCT02264639|41670469|FG001|Overall Study|Death (after completing single-dose phase)|0|||
19423726|NCT02264639|41670470|FG002|Overall Study|Death (after completing single-dose phase)|0|||
19423727|NCT02264639|41670471|FG003|Overall Study|Death (after completing single-dose phase)|0|||
19423728|NCT02264639|41670472|FG004|Overall Study|Death (after completing single-dose phase)|0|||
19423729|NCT02264639|41670468|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
19423730|NCT02264639|41670469|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
19423731|NCT02264639|41670470|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
19423732|NCT02264639|41670471|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
19423733|NCT02264639|41670472|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
19423734|NCT02264639|41670468|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
19423735|NCT02264639|41670469|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
19423736|NCT02264639|41670470|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
19423737|NCT02264639|41670471|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
19423738|NCT02264639|41670472|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
19423739|NCT02264639|41670468|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
19423740|NCT02264639|41670469|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
19423741|NCT02264639|41670470|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
19423742|NCT02264639|41670471|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
19423743|NCT02264639|41670472|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
19423744|NCT01363011|41670489|FG000|Main Study|Adverse Event|2|||
19423745|NCT01363011|41670490|FG001|Main Study|Adverse Event|3|||
19423746|NCT01363011|41670489|FG000|Main Study|Investigator's Discretion|1|||
19423747|NCT01363011|41670490|FG001|Main Study|Investigator's Discretion|1|||
19423748|NCT01363011|41670489|FG000|Main Study|Withdrew Consent|1|||
19423749|NCT01363011|41670490|FG001|Main Study|Withdrew Consent|4|||
19423750|NCT01363011|41670489|FG000|Main Study|Protocol Violation|0|||
19423751|NCT01363011|41670490|FG001|Main Study|Protocol Violation|1|||
19423752|NCT01363011|41670489|FG000|Extension Phase|Adverse Event|1|||
19423753|NCT01363011|41670490|FG001|Extension Phase|Adverse Event|1|||
19423754|NCT01363011|41670489|FG000|Extension Phase|Lack of Efficacy|0|||
19423755|NCT01363011|41670490|FG001|Extension Phase|Lack of Efficacy|1|||
19423756|NCT01363011|41670489|FG000|Extension Phase|Investigator's Discretion|2|||
19423757|NCT01363011|41670490|FG001|Extension Phase|Investigator's Discretion|2|||
19423758|NCT01363011|41670489|FG000|Extension Phase|Withdrew Consent|0|||
19423759|NCT01363011|41670490|FG001|Extension Phase|Withdrew Consent|1|||
19423760|NCT01363011|41670489|FG000|Extension Phase|Lost to Follow-up|0|||
19423761|NCT01363011|41670490|FG001|Extension Phase|Lost to Follow-up|2|||
19423762|NCT01363011|41670489|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
19423763|NCT01363011|41670490|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
19423764|NCT02263547|41670496|FG000|Overall Study|Adverse Event|1|||
19423765|NCT02263547|41670496|FG000|Overall Study|Lost to Follow-up|2|||
19423766|NCT01925703|41670500|FG000|Overall Study|Physician Decision|1|||
19423767|NCT01925703|41670500|FG000|Overall Study|Lost to Follow-up|2|||
19423768|NCT01925703|41670500|FG000|Overall Study|Discharge prior to full iron repletion|1|||
19423769|NCT02195011|41670506|FG000|Overall Study|Adverse Event|4|||
19423770|NCT02195011|41670507|FG001|Overall Study|Adverse Event|0|||
19423771|NCT02195011|41670506|FG000|Overall Study|Progressive Disease|18|||
19423772|NCT02195011|41670507|FG001|Overall Study|Progressive Disease|1|||
19423773|NCT02195011|41670506|FG000|Overall Study|Withdrawal by Subject|3|||
19423774|NCT02195011|41670507|FG001|Overall Study|Withdrawal by Subject|0|||
19423775|NCT01617681|41670517|FG000|Period 1 Double Blind|Adverse Event|2|||
19423776|NCT01617681|41670518|FG001|Period 1 Double Blind|Adverse Event|0|||
19423777|NCT01617681|41670519|FG002|Period 1 Double Blind|Adverse Event|0|||
19423778|NCT01617681|41670520|FG003|Period 1 Double Blind|Adverse Event|2|||
19423779|NCT01617681|41670521|FG004|Period 1 Double Blind|Adverse Event|0|||
19423780|NCT01617681|41670517|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
19423781|NCT01617681|41670518|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
19423782|NCT01617681|41670519|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
19423783|NCT01617681|41670520|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
19423784|NCT01617681|41670521|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
19423785|NCT01617681|41670517|FG000|Period 2 Open Label|Adverse Event|0|||
19423786|NCT01617681|41670518|FG001|Period 2 Open Label|Adverse Event|0|||
19423787|NCT01617681|41670519|FG002|Period 2 Open Label|Adverse Event|0|||
19423788|NCT01617681|41670520|FG003|Period 2 Open Label|Adverse Event|0|||
19423789|NCT01617681|41670521|FG004|Period 2 Open Label|Adverse Event|3|||
19423790|NCT01617681|41670517|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
19423791|NCT01617681|41670518|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
19423792|NCT01617681|41670519|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
19423793|NCT01617681|41670520|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
19423794|NCT01617681|41670521|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
19423795|NCT02263079|41670533|FG000|Overall Study|Physician Decision|1|||
19423796|NCT02263079|41670534|FG001|Overall Study|Physician Decision|0|||
19423797|NCT02263079|41670535|FG002|Overall Study|Physician Decision|0|||
19423798|NCT02263079|41670533|FG000|Overall Study|Withdrawal by Subject|2|||
19423799|NCT02263079|41670534|FG001|Overall Study|Withdrawal by Subject|8|||
19423800|NCT02263079|41670535|FG002|Overall Study|Withdrawal by Subject|0|||
19423801|NCT02295995|41670545|FG000|Overall Study|Lost to Follow-up|5|||
19423802|NCT02295995|41670546|FG001|Overall Study|Lost to Follow-up|1|||
19423803|NCT02294981|41670553|FG000|Overall Study|Lost to Follow-up|1|||
19423804|NCT02262377|41670559|FG000|Overall Study|Lost to Follow-up|5|||
19423805|NCT02262377|41670560|FG001|Overall Study|Lost to Follow-up|6|||
19423806|NCT02262377|41670559|FG000|Overall Study|Found ineligible after enrollment|3|||
19423807|NCT02262377|41670560|FG001|Overall Study|Found ineligible after enrollment|0|||
19423808|NCT02262377|41670559|FG000|Overall Study|Withdrawal by Subject|4|||
19423809|NCT02262377|41670560|FG001|Overall Study|Withdrawal by Subject|0|||
19423810|NCT02260817|41670569|FG000|Overall Study|Lost to Follow-up|0|||
19423811|NCT02260817|41670570|FG001|Overall Study|Lost to Follow-up|14|||
19423812|NCT02260817|41670569|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
19423813|NCT02260817|41670570|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
19423814|NCT02260817|41670569|FG000|Overall Study|Observation, no biopsy|0|||
19423815|NCT02260817|41670570|FG001|Overall Study|Observation, no biopsy|1|||
19423816|NCT02260817|41670569|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
19423817|NCT02260817|41670570|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
19423818|NCT02260817|41670569|FG000|Overall Study|Protocol Violation|0|||
19423819|NCT02260817|41670570|FG001|Overall Study|Protocol Violation|14|||
19423820|NCT01642589|41670578|FG000|Overall Study|Withdrawal by Subject|1|||
19423821|NCT01642589|41670579|FG001|Overall Study|Withdrawal by Subject|1|||
19423822|NCT02268812|41670589|FG000|Overall Study|Adverse Event|8|||
19423823|NCT02268812|41670590|FG001|Overall Study|Adverse Event|26|||
19423824|NCT02268812|41670591|FG002|Overall Study|Adverse Event|7|||
19423825|NCT02268812|41670592|FG003|Overall Study|Adverse Event|10|||
19423826|NCT02268812|41670589|FG000|Overall Study|Protocol deviation|0|||
19423827|NCT02268812|41670590|FG001|Overall Study|Protocol deviation|0|||
19423828|NCT02268812|41670591|FG002|Overall Study|Protocol deviation|1|||
19423829|NCT02268812|41670592|FG003|Overall Study|Protocol deviation|0|||
19423830|NCT02268812|41670589|FG000|Overall Study|Withdrawal by Subject|0|||
19423831|NCT02268812|41670590|FG001|Overall Study|Withdrawal by Subject|1|||
19423832|NCT02268812|41670591|FG002|Overall Study|Withdrawal by Subject|0|||
19423833|NCT02268812|41670592|FG003|Overall Study|Withdrawal by Subject|0|||
19423834|NCT02268812|41670589|FG000|Overall Study|Physician Decision|3|||
19423835|NCT02268812|41670590|FG001|Overall Study|Physician Decision|1|||
19423836|NCT02268812|41670591|FG002|Overall Study|Physician Decision|0|||
19423837|NCT02268812|41670592|FG003|Overall Study|Physician Decision|1|||
19423838|NCT02268812|41670589|FG000|Overall Study|Other|5|||
19423839|NCT02268812|41670590|FG001|Overall Study|Other|4|||
19423840|NCT02268812|41670591|FG002|Overall Study|Other|1|||
19423841|NCT02268812|41670592|FG003|Overall Study|Other|3|||
19423842|NCT01954251|41670604|FG000|Overall Study|Adverse Event|5|||
19423843|NCT01954251|41670605|FG001|Overall Study|Adverse Event|7|||
19423844|NCT01954251|41670604|FG000|Overall Study|Lost to Follow-up|6|||
19423845|NCT01954251|41670605|FG001|Overall Study|Lost to Follow-up|6|||
19423846|NCT01954251|41670604|FG000|Overall Study|Withdrawal by Subject|2|||
19423847|NCT01954251|41670605|FG001|Overall Study|Withdrawal by Subject|6|||
19423848|NCT01644617|41670615|FG000|Overall Study|Withdrawal by Subject|3|||
19423849|NCT01644617|41670616|FG001|Overall Study|Withdrawal by Subject|4|||
19423850|NCT01644617|41670617|FG002|Overall Study|Withdrawal by Subject|1|||
19423851|NCT01644617|41670615|FG000|Overall Study|Lost to Follow-up|0|||
19423852|NCT01644617|41670616|FG001|Overall Study|Lost to Follow-up|1|||
19423853|NCT01644617|41670617|FG002|Overall Study|Lost to Follow-up|0|||
19423854|NCT01644617|41670615|FG000|Overall Study|Adverse Event|3|||
19423855|NCT01644617|41670616|FG001|Overall Study|Adverse Event|0|||
19423856|NCT01644617|41670617|FG002|Overall Study|Adverse Event|6|||
19423857|NCT02294318|41670627|FG000|Overall Study|Worsening of drinking|3|||
19423858|NCT02294318|41670628|FG001|Overall Study|Worsening of drinking|0|||
19423859|NCT02294318|41670627|FG000|Overall Study|Not exposed to intervention|0|||
19423860|NCT02294318|41670628|FG001|Overall Study|Not exposed to intervention|2|||
19423861|NCT02293499|41670637|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
19423862|NCT02293499|41670638|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
19423863|NCT02293499|41670639|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
19423864|NCT02293499|41670637|FG000|Intervention - Camp|Withdrawal by Subject|3|||
19423865|NCT02293499|41670638|FG001|Intervention - Camp|Withdrawal by Subject|6|||
19423866|NCT02293499|41670639|FG002|Intervention - Camp|Withdrawal by Subject|2|||
19423867|NCT02293499|41670637|FG000|Intervention - Camp|these are those not showing up at camp|24|||
19423868|NCT02293499|41670638|FG001|Intervention - Camp|these are those not showing up at camp|28|||
19423869|NCT02293499|41670639|FG002|Intervention - Camp|these are those not showing up at camp|4|||
19423870|NCT02293499|41670637|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
19423871|NCT02293499|41670638|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
19423872|NCT02293499|41670639|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
19423873|NCT02293499|41670637|FG000|3 Month Follow Up|Lost to Follow-up|14|||
19423874|NCT02293499|41670638|FG001|3 Month Follow Up|Lost to Follow-up|15|||
19423875|NCT02293499|41670639|FG002|3 Month Follow Up|Lost to Follow-up|6|||
19423876|NCT02293499|41670637|FG000|6 Month Follow Up|Lost to Follow-up|17|||
19423877|NCT02293499|41670638|FG001|6 Month Follow Up|Lost to Follow-up|27|||
19423878|NCT02293499|41670639|FG002|6 Month Follow Up|Lost to Follow-up|6|||
19423879|NCT02293499|41670637|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
19423880|NCT02293499|41670638|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
19423881|NCT02293499|41670639|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
19423882|NCT02293499|41670637|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
19423883|NCT02293499|41670638|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
19423884|NCT02293499|41670639|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
19423885|NCT02293499|41670637|FG000|9 Month Follow Up|Lost to Follow-up|24|||
19423886|NCT02293499|41670638|FG001|9 Month Follow Up|Lost to Follow-up|28|||
19423887|NCT02293499|41670639|FG002|9 Month Follow Up|Lost to Follow-up|4|||
19423888|NCT02293499|41670637|FG000|12 Month Follow Up|Lost to Follow-up|26|||
19423889|NCT02293499|41670638|FG001|12 Month Follow Up|Lost to Follow-up|25|||
19423890|NCT02293499|41670639|FG002|12 Month Follow Up|Lost to Follow-up|6|||
19423891|NCT02293499|41670637|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
19423892|NCT02293499|41670638|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
19423893|NCT02293499|41670639|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
19423894|NCT02293499|41670637|FG000|15 Month Follow Up|Lost to Follow-up|22|||
19520316|NCT01466790|41932924|FG003|Overall Study|Lost to Follow-up|0|||
19423895|NCT02293499|41670638|FG001|15 Month Follow Up|Lost to Follow-up|22|||
19423896|NCT02293499|41670639|FG002|15 Month Follow Up|Lost to Follow-up|7|||
19423897|NCT02257385|41670650|FG000|Overall Study|Adverse Event|12|||
19423898|NCT02257385|41670651|FG001|Overall Study|Adverse Event|8|||
19423899|NCT02257385|41670650|FG000|Overall Study|Lack of Efficacy|1|||
19423900|NCT02257385|41670651|FG001|Overall Study|Lack of Efficacy|2|||
19423901|NCT02257385|41670650|FG000|Overall Study|Protocol Violation|5|||
19423902|NCT02257385|41670651|FG001|Overall Study|Protocol Violation|7|||
19423903|NCT02257385|41670650|FG000|Overall Study|Lost to Follow-up|0|||
19423904|NCT02257385|41670651|FG001|Overall Study|Lost to Follow-up|1|||
19423905|NCT02257385|41670650|FG000|Overall Study|Withdrawal by Subject|4|||
19423906|NCT02257385|41670651|FG001|Overall Study|Withdrawal by Subject|4|||
19423907|NCT01629667|41670660|FG000|Overall Study|Lost to Follow-up|0|||
19423908|NCT01629667|41670661|FG001|Overall Study|Lost to Follow-up|1|||
19423909|NCT01629667|41670662|FG002|Overall Study|Lost to Follow-up|1|||
19423910|NCT01629667|41670660|FG000|Overall Study|Withdrawal by Subject|31|||
19423911|NCT01629667|41670661|FG001|Overall Study|Withdrawal by Subject|20|||
19423912|NCT01629667|41670662|FG002|Overall Study|Withdrawal by Subject|28|||
19423913|NCT01629667|41670660|FG000|Overall Study|Death|1|||
19423914|NCT01629667|41670661|FG001|Overall Study|Death|5|||
19423915|NCT01629667|41670662|FG002|Overall Study|Death|3|||
19423916|NCT01629667|41670660|FG000|Overall Study|Randomized, not treated|2|||
19423917|NCT01629667|41670661|FG001|Overall Study|Randomized, not treated|1|||
19423918|NCT01629667|41670662|FG002|Overall Study|Randomized, not treated|0|||
19423919|NCT01629667|41670660|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
19423920|NCT01629667|41670661|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
19423921|NCT01629667|41670662|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
19423922|NCT01629667|41670660|FG000|Overall Study|Requiring lung transplant|2|||
19423923|NCT01629667|41670661|FG001|Overall Study|Requiring lung transplant|1|||
19423924|NCT01629667|41670662|FG002|Overall Study|Requiring lung transplant|3|||
19423925|NCT01629667|41670660|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
19423926|NCT01629667|41670661|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
19423927|NCT01629667|41670662|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
19423928|NCT01629667|41670660|FG000|Overall Study|Started other medicine|1|||
19423929|NCT01629667|41670661|FG001|Overall Study|Started other medicine|0|||
19423930|NCT01629667|41670662|FG002|Overall Study|Started other medicine|1|||
19423931|NCT01629667|41670660|FG000|Overall Study|Site error in safety follow-up|0|||
19423932|NCT01629667|41670661|FG001|Overall Study|Site error in safety follow-up|0|||
19423933|NCT01629667|41670662|FG002|Overall Study|Site error in safety follow-up|1|||
19423934|NCT01629667|41670660|FG000|Overall Study|Enrolled in another clinical study|0|||
19423935|NCT01629667|41670661|FG001|Overall Study|Enrolled in another clinical study|1|||
19423936|NCT01629667|41670662|FG002|Overall Study|Enrolled in another clinical study|0|||
19423937|NCT01629667|41670660|FG000|Overall Study|Code break|1|||
19423938|NCT01629667|41670661|FG001|Overall Study|Code break|0|||
19423939|NCT01629667|41670662|FG002|Overall Study|Code break|0|||
19423940|NCT01645280|41670677|FG000|Overall Study|Death|0|||
19423941|NCT01645280|41670678|FG001|Overall Study|Death|1|||
19423942|NCT01645280|41670679|FG002|Overall Study|Death|0|||
19423943|NCT01645280|41670680|FG003|Overall Study|Death|0|||
19423944|NCT01645280|41670681|FG004|Overall Study|Death|0|||
19423945|NCT01645280|41670677|FG000|Overall Study|Withdrawal by Subject|4|||
19423946|NCT01645280|41670678|FG001|Overall Study|Withdrawal by Subject|0|||
19423947|NCT01645280|41670679|FG002|Overall Study|Withdrawal by Subject|2|||
19423948|NCT01645280|41670680|FG003|Overall Study|Withdrawal by Subject|4|||
19423949|NCT01645280|41670681|FG004|Overall Study|Withdrawal by Subject|5|||
19423950|NCT01645280|41670677|FG000|Overall Study|Lost to Follow-up|0|||
19423951|NCT01645280|41670678|FG001|Overall Study|Lost to Follow-up|0|||
19423952|NCT01645280|41670679|FG002|Overall Study|Lost to Follow-up|0|||
19423953|NCT01645280|41670680|FG003|Overall Study|Lost to Follow-up|2|||
19423954|NCT01645280|41670681|FG004|Overall Study|Lost to Follow-up|1|||
19423955|NCT01645280|41670677|FG000|Overall Study|Other|1|||
19423956|NCT01645280|41670678|FG001|Overall Study|Other|1|||
19423957|NCT01645280|41670679|FG002|Overall Study|Other|2|||
19423958|NCT01645280|41670680|FG003|Overall Study|Other|0|||
19423959|NCT01645280|41670681|FG004|Overall Study|Other|0|||
19423960|NCT01645280|41670677|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
19423961|NCT01645280|41670678|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
19423962|NCT01645280|41670679|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
19423963|NCT01645280|41670680|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
19423964|NCT01645280|41670681|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
19423965|NCT02256917|41670694|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
19423966|NCT02256917|41670694|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
19423967|NCT02256917|41670694|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
19711135|NCT00096135|42154344|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
19423968|NCT02256917|41670694|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
19423969|NCT02256917|41670694|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
19423970|NCT01629589|41670707|FG000|Overall Study|Protocol Violation|4|||
19423971|NCT01629589|41670708|FG001|Overall Study|Protocol Violation|2|||
19423972|NCT01629589|41670707|FG000|Overall Study|Lost to Follow-up|2|||
19423973|NCT01629589|41670708|FG001|Overall Study|Lost to Follow-up|1|||
19423974|NCT01629589|41670707|FG000|Overall Study|Withdrawal by Subject|2|||
19423975|NCT01629589|41670708|FG001|Overall Study|Withdrawal by Subject|3|||
19423976|NCT01629589|41670707|FG000|Overall Study|Did not receive study vaccine|0|||
19423977|NCT01629589|41670708|FG001|Overall Study|Did not receive study vaccine|1|||
19423978|NCT02256839|41670716|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
19423979|NCT02256839|41670717|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
19423980|NCT02220907|41670723|FG000|Overall Study|Adverse Event|7|||
19423981|NCT02220907|41670723|FG000|Overall Study|Physician Decision|1|||
19423982|NCT02220907|41670723|FG000|Overall Study|Withdrawal by Subject|2|||
19423983|NCT02220907|41670723|FG000|Overall Study|Conflict with the stopping criteria|1|||
19423984|NCT02255981|41670727|FG000|Overall Study|Lost to Follow-up|3|||
19423985|NCT02255981|41670727|FG000|Overall Study|Withdrawal by Subject|1|||
19423986|NCT01601873|41670739|FG000|Overall Study|Lost to Follow-up|2|||
19423987|NCT01601873|41670740|FG001|Overall Study|Lost to Follow-up|3|||
19423988|NCT02194933|41670748|FG000|Overall Study|Lost to Follow-up|1|||
19423989|NCT02194933|41670749|FG001|Overall Study|Lost to Follow-up|2|||
19423990|NCT02194933|41670748|FG000|Overall Study|Participant met withdrawal criteria|1|||
19423991|NCT02194933|41670749|FG001|Overall Study|Participant met withdrawal criteria|3|||
19423992|NCT02194933|41670748|FG000|Overall Study|Withdrawal by Subject|0|||
19423993|NCT02194933|41670749|FG001|Overall Study|Withdrawal by Subject|2|||
19423994|NCT02194933|41670748|FG000|Overall Study|Lack of Efficacy|1|||
19423995|NCT02194933|41670749|FG001|Overall Study|Lack of Efficacy|2|||
19423996|NCT01644890|41670759|FG000|Overall Study|Adverse Event|7|||
19423997|NCT01644890|41670760|FG001|Overall Study|Adverse Event|20|||
19423998|NCT01644890|41670759|FG000|Overall Study|Death|1|||
19423999|NCT01644890|41670760|FG001|Overall Study|Death|3|||
19424000|NCT01644890|41670759|FG000|Overall Study|Physician Decision|3|||
19424001|NCT01644890|41670760|FG001|Overall Study|Physician Decision|9|||
19424002|NCT01644890|41670759|FG000|Overall Study|Protocol Violation|6|||
19424003|NCT01644890|41670760|FG001|Overall Study|Protocol Violation|7|||
19424004|NCT01644890|41670759|FG000|Overall Study|Withdrawal by Subject|19|||
19424005|NCT01644890|41670760|FG001|Overall Study|Withdrawal by Subject|27|||
19424006|NCT01644890|41670759|FG000|Overall Study|Progression Disease|160|||
19424007|NCT01644890|41670760|FG001|Overall Study|Progression Disease|131|||
19424008|NCT01644890|41670759|FG000|Overall Study|Clinical Progression|6|||
19424009|NCT01644890|41670760|FG001|Overall Study|Clinical Progression|6|||
19424010|NCT01644890|41670759|FG000|Overall Study|> 28 days since last dose of study drug|6|||
19424011|NCT01644890|41670760|FG001|Overall Study|> 28 days since last dose of study drug|3|||
19424012|NCT01644890|41670759|FG000|Overall Study|Other|8|||
19424013|NCT01644890|41670760|FG001|Overall Study|Other|9|||
19424014|NCT01628965|41670766|FG000|Overall Study|Adverse Event|30|||
19424015|NCT01628965|41670766|FG000|Overall Study|Lack of Efficacy|7|||
19424016|NCT01628965|41670766|FG000|Overall Study|Withdrawal by Subject|3|||
19424017|NCT01628965|41670766|FG000|Overall Study|Lost to Follow-up|1|||
19424018|NCT01628965|41670766|FG000|Overall Study|Discontinuation criteria|8|||
19424019|NCT01644734|41670770|FG000|Overall Study|Adverse Event|4|||
19424020|NCT01644734|41670770|FG000|Overall Study|Lost to Follow-up|17|||
19424021|NCT01644734|41670770|FG000|Overall Study|Reasons other than stated above|7|||
19424022|NCT01644734|41670770|FG000|Overall Study|Missing documentation|238|||
19424023|NCT02255279|41670776|FG000|Overall Study|Lost to Follow-up|2|||
19424024|NCT02255279|41670777|FG001|Overall Study|Lost to Follow-up|2|||
19424025|NCT02255279|41670776|FG000|Overall Study|Protocol Violation|0|||
19424026|NCT02255279|41670777|FG001|Overall Study|Protocol Violation|1|||
19424027|NCT02255279|41670776|FG000|Overall Study|Withdrawal by Subject|3|||
19424028|NCT02255279|41670777|FG001|Overall Study|Withdrawal by Subject|6|||
19424029|NCT01643798|41670797|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
19424030|NCT01643798|41670798|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
19424031|NCT02194699|41670811|FG000|Randomised|Did not receive treatment|1|||
19424032|NCT02194699|41670812|FG001|Randomised|Did not receive treatment|5|||
19424033|NCT02194699|41670811|FG000|Randomised|Without potential for 52 weeks of IP|5|||
19424034|NCT02194699|41670812|FG001|Randomised|Without potential for 52 weeks of IP|5|||
19424035|NCT02194699|41670811|FG000|Randomised|Duplicate patient|2|||
19424036|NCT02194699|41670812|FG001|Randomised|Duplicate patient|1|||
19424037|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
19424038|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
19424039|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
19424040|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
19424041|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
19424042|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
19424043|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
19520317|NCT01466790|41932925|FG004|Overall Study|Lost to Follow-up|0|||
19711136|NCT00096135|42154345|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
19424044|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
19424045|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
19424046|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
19424047|NCT02194699|41670811|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
19424048|NCT02194699|41670812|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
19424049|NCT02293538|41670828|FG000|Overall Study|Adverse Event|0|||
19424050|NCT02293538|41670829|FG001|Overall Study|Adverse Event|1|||
19424051|NCT02293538|41670828|FG000|Overall Study|Lost to Follow-up|1|||
19424052|NCT02293538|41670829|FG001|Overall Study|Lost to Follow-up|0|||
19424053|NCT02293538|41670828|FG000|Overall Study|Withdrawal by Subject|0|||
19424054|NCT02293538|41670829|FG001|Overall Study|Withdrawal by Subject|1|||
19424055|NCT02194621|41670839|FG000|Overall Study|6 withdrew prior to randomization|2|||
19424056|NCT02194621|41670840|FG001|Overall Study|6 withdrew prior to randomization|2|||
19424057|NCT02194621|41670841|FG002|Overall Study|6 withdrew prior to randomization|2|||
19424058|NCT02194621|41670839|FG000|Overall Study|Withdrawal by Subject|4|||
19424059|NCT02194621|41670840|FG001|Overall Study|Withdrawal by Subject|4|||
19424060|NCT02194621|41670841|FG002|Overall Study|Withdrawal by Subject|7|||
19424061|NCT02220205|41670851|FG000|Overall Study|Withdrawal by Subject|1|||
19424062|NCT02220205|41670852|FG001|Overall Study|Withdrawal by Subject|0|||
19424063|NCT02266706|41670867|FG000|Overall Study|Withdrawal by Subject|0|||
19424064|NCT02266706|41670868|FG001|Overall Study|Withdrawal by Subject|1|||
19424065|NCT02266706|41670869|FG002|Overall Study|Withdrawal by Subject|1|||
19424066|NCT02266706|41670870|FG003|Overall Study|Withdrawal by Subject|0|||
19424067|NCT02266706|41670871|FG004|Overall Study|Withdrawal by Subject|0|||
19424068|NCT02266706|41670872|FG005|Overall Study|Withdrawal by Subject|1|||
19424069|NCT02266706|41670873|FG006|Overall Study|Withdrawal by Subject|0|||
19424070|NCT02266706|41670874|FG007|Overall Study|Withdrawal by Subject|0|||
19520318|NCT01466790|41932926|FG005|Overall Study|Lost to Follow-up|0|||
19520319|NCT01466790|41932927|FG006|Overall Study|Lost to Follow-up|0|||
19520320|NCT01466790|41932928|FG007|Overall Study|Lost to Follow-up|0|||
19520321|NCT01466790|41932921|FG000|Overall Study|Withdrawal by Subject|1|||
19520322|NCT01466790|41932922|FG001|Overall Study|Withdrawal by Subject|1|||
19520323|NCT01466790|41932923|FG002|Overall Study|Withdrawal by Subject|0|||
19520324|NCT01466790|41932924|FG003|Overall Study|Withdrawal by Subject|0|||
19520325|NCT01466790|41932925|FG004|Overall Study|Withdrawal by Subject|1|||
19520326|NCT01466790|41932926|FG005|Overall Study|Withdrawal by Subject|0|||
19520327|NCT01466790|41932927|FG006|Overall Study|Withdrawal by Subject|1|||
19520328|NCT01466790|41932928|FG007|Overall Study|Withdrawal by Subject|1|||
19520329|NCT01466166|41932942|FG000|Overall Study|Death|1|||
19520330|NCT01466166|41932942|FG000|Overall Study|Lost to Follow-up|7|||
19520331|NCT01466166|41932942|FG000|Overall Study|Infusion Reaction (IR)|27|||
19520332|NCT01466166|41932942|FG000|Overall Study|Adverse Event (Other than IR)|11|||
19520333|NCT01466166|41932942|FG000|Overall Study|Elevated Serum Uric Acid|78|||
19520334|NCT01466166|41932942|FG000|Overall Study|Withdrawal by Subject|13|||
19520335|NCT01466166|41932942|FG000|Overall Study|Sponsor Decision|4|||
19520336|NCT01466166|41932942|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
19520337|NCT01466166|41932942|FG000|Overall Study|Other|20|||
19520338|NCT01418352|41932950|FG000|Overall Study|Lost to Follow-up|2|||
19520339|NCT01418352|41932951|FG001|Overall Study|Lost to Follow-up|0|||
19520340|NCT01418352|41932952|FG002|Overall Study|Lost to Follow-up|0|||
19520341|NCT01418352|41932953|FG003|Overall Study|Lost to Follow-up|0|||
19520342|NCT01418352|41932950|FG000|Overall Study|Adverse Event|0|||
19520343|NCT01418352|41932951|FG001|Overall Study|Adverse Event|1|||
19520344|NCT01418352|41932952|FG002|Overall Study|Adverse Event|0|||
19520345|NCT01418352|41932953|FG003|Overall Study|Adverse Event|0|||
19520346|NCT01418352|41932950|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
19520347|NCT01418352|41932951|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
19520348|NCT01418352|41932952|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
19520349|NCT01418352|41932953|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
19520350|NCT01418352|41932950|FG000|Overall Study|Subject Withdrew Consent|0|||
19520351|NCT01418352|41932951|FG001|Overall Study|Subject Withdrew Consent|1|||
19520352|NCT01418352|41932952|FG002|Overall Study|Subject Withdrew Consent|2|||
19520353|NCT01418352|41932953|FG003|Overall Study|Subject Withdrew Consent|1|||
19520354|NCT01418352|41932950|FG000|Overall Study|Protocol Deviation|0|||
19520355|NCT01418352|41932951|FG001|Overall Study|Protocol Deviation|0|||
19520356|NCT01418352|41932952|FG002|Overall Study|Protocol Deviation|1|||
19628194|NCT00802074|42077588|FG000|Overall Study|Withdrawal by Subject|1|||
19424071|NCT02266706|41670875|FG008|Overall Study|Withdrawal by Subject|0|||
19424072|NCT02266706|41670867|FG000|Overall Study|Screen failure|0|||
19424073|NCT02266706|41670868|FG001|Overall Study|Screen failure|0|||
19424074|NCT02266706|41670869|FG002|Overall Study|Screen failure|0|||
19424075|NCT02266706|41670870|FG003|Overall Study|Screen failure|0|||
19520357|NCT01418352|41932953|FG003|Overall Study|Protocol Deviation|0|||
19520358|NCT01418352|41932950|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
19520359|NCT01418352|41932951|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
19520360|NCT01418352|41932952|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
19520361|NCT01418352|41932953|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
19520362|NCT01436370|41932971|FG000|Overall Study|Lost to Follow-up|0|||
19520363|NCT01436370|41932972|FG001|Overall Study|Lost to Follow-up|0|||
19520364|NCT01436370|41932973|FG002|Overall Study|Lost to Follow-up|0|||
19520365|NCT01436370|41932974|FG003|Overall Study|Lost to Follow-up|0|||
19520366|NCT01436370|41932975|FG004|Overall Study|Lost to Follow-up|1|||
19520367|NCT01436370|41932976|FG005|Overall Study|Lost to Follow-up|0|||
19520368|NCT01436370|41932977|FG006|Overall Study|Lost to Follow-up|0|||
19520369|NCT01436370|41932978|FG007|Overall Study|Lost to Follow-up|0|||
19520370|NCT01465464|41933006|FG000|Overall Study|Adverse Event|96|||
19520371|NCT01465464|41933007|FG001|Overall Study|Adverse Event|49|||
19520372|NCT01465464|41933006|FG000|Overall Study|Lack of Efficacy|139|||
19520373|NCT01465464|41933007|FG001|Overall Study|Lack of Efficacy|190|||
19520374|NCT01465464|41933006|FG000|Overall Study|Physician Decision|13|||
19520375|NCT01465464|41933007|FG001|Overall Study|Physician Decision|5|||
19520376|NCT01465464|41933006|FG000|Overall Study|Protocol Violation|1|||
19520377|NCT01465464|41933007|FG001|Overall Study|Protocol Violation|1|||
19628195|NCT00802074|42077589|FG001|Overall Study|Withdrawal by Subject|0|||
19628196|NCT00802074|42077590|FG002|Overall Study|Withdrawal by Subject|0|||
19628197|NCT00802074|42077591|FG003|Overall Study|Withdrawal by Subject|0|||
19628198|NCT00802074|42077592|FG004|Overall Study|Withdrawal by Subject|0|||
19628199|NCT00802074|42077593|FG005|Overall Study|Withdrawal by Subject|0|||
19628200|NCT00450385|42077610|FG000|Overall Study|Death|3|||
19520378|NCT01465464|41933006|FG000|Overall Study|Withdrawal by Subject|46|||
19520379|NCT01465464|41933007|FG001|Overall Study|Withdrawal by Subject|30|||
19520380|NCT01465464|41933006|FG000|Overall Study|Other|9|||
19520381|NCT01465464|41933007|FG001|Overall Study|Other|3|||
19520382|NCT01465464|41933006|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
19520383|NCT01465464|41933007|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
19520384|NCT01417104|41933015|FG000|Overall Study|Withdrawal by Subject|5|||
19520385|NCT01417104|41933016|FG001|Overall Study|Withdrawal by Subject|1|||
19520386|NCT01417104|41933015|FG000|Overall Study|Failure to make contact|0|||
19520387|NCT01417104|41933016|FG001|Overall Study|Failure to make contact|1|||
19520388|NCT01417104|41933015|FG000|Overall Study|Adverse Event|1|||
19520389|NCT01417104|41933016|FG001|Overall Study|Adverse Event|0|||
19520390|NCT01465386|41933022|FG000|Overall Study|Lack of Efficacy|3|||
19520391|NCT01465386|41933022|FG000|Overall Study|Adverse Event|1|||
19520392|NCT01465230|41933026|FG000|Overall Study|Withdrawal by Subject|2|||
19520393|NCT01435356|41933032|FG000|Overall Study|Adverse Event|2|||
19520394|NCT01435356|41933033|FG001|Overall Study|Adverse Event|0|||
19520395|NCT01435356|41933032|FG000|Overall Study|Disease progression/recurrence|17|||
19520396|NCT01435356|41933033|FG001|Overall Study|Disease progression/recurrence|10|||
19520397|NCT01435356|41933032|FG000|Overall Study|Protocol Violation|0|||
19520398|NCT01435356|41933033|FG001|Overall Study|Protocol Violation|1|||
19520399|NCT01435356|41933032|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
19520400|NCT01435356|41933033|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
19520401|NCT01435356|41933032|FG000|Overall Study|Withdrawal by Subject|1|||
19520402|NCT01435356|41933033|FG001|Overall Study|Withdrawal by Subject|1|||
19520403|NCT01435356|41933032|FG000|Overall Study|Facial palsy|1|||
19520404|NCT01435356|41933033|FG001|Overall Study|Facial palsy|0|||
19520405|NCT01435356|41933032|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
19520406|NCT01435356|41933033|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
19520407|NCT01435356|41933032|FG000|Overall Study|Physician Decision|1|||
19520408|NCT01435356|41933033|FG001|Overall Study|Physician Decision|0|||
19520409|NCT01435356|41933032|FG000|Overall Study|Patient decision|3|||
19520410|NCT01435356|41933033|FG001|Overall Study|Patient decision|0|||
19520411|NCT01435356|41933032|FG000|Overall Study|Patient moved to another city|1|||
19520412|NCT01435356|41933033|FG001|Overall Study|Patient moved to another city|1|||
19520413|NCT01435122|41933039|FG000|Overall Study|Early withdrawal due to toxicity|8|||
19628201|NCT00450385|42077610|FG000|Overall Study|Protocol Violation|1|||
19628202|NCT00450385|42077610|FG000|Overall Study|Withdrawal by Subject|2|||
19628203|NCT00450385|42077610|FG000|Overall Study|Lack of Efficacy|2|||
19628204|NCT00450385|42077610|FG000|Overall Study|Adverse Event|1|||
19628205|NCT00450385|42077610|FG000|Overall Study|Physician Decision|1|||
19628206|NCT00450385|42077610|FG000|Overall Study|Other|3|||
19520414|NCT01434810|41933045|FG000|Overall Study|Did not receive treatment|11|||
19520415|NCT01434810|41933046|FG001|Overall Study|Did not receive treatment|3|||
19520416|NCT01434810|41933045|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
19628207|NCT00588354|42077617|FG000|Baseline to 2 Weeks|Adverse Event|1|||
19628208|NCT00588354|42077618|FG001|Baseline to 2 Weeks|Adverse Event|0|||
19628209|NCT00588354|42077617|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
19628210|NCT00588354|42077618|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
19628211|NCT00588354|42077617|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
19520417|NCT01434810|41933046|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
19520418|NCT01393626|41933056|FG000|Overall Study|Adverse Event|2|||
19520419|NCT01393626|41933057|FG001|Overall Study|Adverse Event|1|||
19628212|NCT00588354|42077618|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
19628213|NCT00449761|42077625|FG000|Overall Study|Disease progression|12|||
19520420|NCT01393626|41933058|FG002|Overall Study|Adverse Event|5|||
19520421|NCT01393626|41933059|FG003|Overall Study|Adverse Event|0|||
19520422|NCT01393626|41933056|FG000|Overall Study|Did not meet entrance criteria|1|||
19520423|NCT01393626|41933057|FG001|Overall Study|Did not meet entrance criteria|0|||
19520424|NCT01393626|41933058|FG002|Overall Study|Did not meet entrance criteria|0|||
19520425|NCT01393626|41933059|FG003|Overall Study|Did not meet entrance criteria|0|||
19520426|NCT01393626|41933056|FG000|Overall Study|Lack of Efficacy|6|||
19520427|NCT01393626|41933057|FG001|Overall Study|Lack of Efficacy|6|||
19520428|NCT01393626|41933058|FG002|Overall Study|Lack of Efficacy|4|||
19520429|NCT01393626|41933059|FG003|Overall Study|Lack of Efficacy|1|||
19520430|NCT01393626|41933056|FG000|Overall Study|Lost to Follow-up|1|||
19520431|NCT01393626|41933057|FG001|Overall Study|Lost to Follow-up|1|||
19520432|NCT01393626|41933058|FG002|Overall Study|Lost to Follow-up|1|||
19520433|NCT01393626|41933059|FG003|Overall Study|Lost to Follow-up|0|||
19520434|NCT01393626|41933056|FG000|Overall Study|Withdrawal by Subject|6|||
19520435|NCT01393626|41933057|FG001|Overall Study|Withdrawal by Subject|4|||
19520436|NCT01393626|41933058|FG002|Overall Study|Withdrawal by Subject|0|||
19520437|NCT01393626|41933059|FG003|Overall Study|Withdrawal by Subject|0|||
19628214|NCT00449761|42077625|FG000|Overall Study|Death|5|||
19628215|NCT00449761|42077625|FG000|Overall Study|New cancer therapy|1|||
19628216|NCT00800982|42077632|FG000|Overall Study|Lost to Follow-up|1|||
19628217|NCT00800982|42077633|FG001|Overall Study|Lost to Follow-up|2|||
19628218|NCT00800982|42077632|FG000|Overall Study|Withdrawal by Subject|0|||
19628219|NCT00800982|42077633|FG001|Overall Study|Withdrawal by Subject|1|||
19628220|NCT00800982|42077632|FG000|Overall Study|Patient moved out of state|1|||
19628221|NCT00800982|42077633|FG001|Overall Study|Patient moved out of state|0|||
19628222|NCT00830960|42077645|FG000|Overall Study|Death|5|||
19628223|NCT00830960|42077646|FG001|Overall Study|Death|4|||
19628224|NCT00830960|42077647|FG002|Overall Study|Death|3|||
19628225|NCT00830960|42077648|FG003|Overall Study|Death|2|||
19628226|NCT00830960|42077649|FG004|Overall Study|Death|6|||
19628227|NCT00830960|42077650|FG005|Overall Study|Death|1|||
19711137|NCT00096135|42154344|FG000|Overall Study|Other, specify|15|||
19711138|NCT00096135|42154345|FG001|Overall Study|Other, specify|3|||
19711139|NCT00096135|42154344|FG000|Overall Study|Ineligible|2|||
19711140|NCT00096135|42154345|FG001|Overall Study|Ineligible|0|||
19711141|NCT00116805|42154353|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
19711142|NCT00116805|42154354|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
19711143|NCT00116805|42154353|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
19711144|NCT00116805|42154354|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
19711145|NCT00116805|42154353|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
19711146|NCT00116805|42154354|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
19711147|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
19711148|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
19711149|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
19711150|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
19424076|NCT02266706|41670871|FG004|Overall Study|Screen failure|0|||
19424077|NCT02266706|41670872|FG005|Overall Study|Screen failure|1|||
19424078|NCT02266706|41670873|FG006|Overall Study|Screen failure|1|||
19424079|NCT02266706|41670874|FG007|Overall Study|Screen failure|0|||
19424080|NCT02266706|41670875|FG008|Overall Study|Screen failure|0|||
19424081|NCT02266706|41670867|FG000|Overall Study|Enrollment in another study|0|||
19424082|NCT02266706|41670868|FG001|Overall Study|Enrollment in another study|0|||
19424083|NCT02266706|41670869|FG002|Overall Study|Enrollment in another study|0|||
19424084|NCT02266706|41670870|FG003|Overall Study|Enrollment in another study|1|||
19424085|NCT02266706|41670871|FG004|Overall Study|Enrollment in another study|0|||
19424086|NCT02266706|41670872|FG005|Overall Study|Enrollment in another study|0|||
19424087|NCT02266706|41670873|FG006|Overall Study|Enrollment in another study|0|||
19424088|NCT02266706|41670874|FG007|Overall Study|Enrollment in another study|0|||
19424089|NCT02266706|41670875|FG008|Overall Study|Enrollment in another study|0|||
19424090|NCT02293460|41670895|FG000|Overall Study|Protocol Violation|1|||
19424091|NCT02293460|41670895|FG000|Overall Study|Lack of Efficacy|2|||
19424092|NCT02293460|41670895|FG000|Overall Study|Adverse Event|2|||
19424093|NCT02293460|41670895|FG000|Overall Study|Withdrawal by Subject|1|||
19424094|NCT02266004|41670899|FG000|Overall Study|unrelated adverse event|1|||
19424095|NCT02266004|41670899|FG000|Overall Study|Physician Decision|1|||
19424096|NCT02292719|41670909|FG000|Overall Study|Withdrawal by Subject|0|||
19424097|NCT02292719|41670910|FG001|Overall Study|Withdrawal by Subject|0|||
19424098|NCT02292719|41670911|FG002|Overall Study|Withdrawal by Subject|0|||
19520438|NCT01393626|41933056|FG000|Overall Study|Other|1|||
19628228|NCT00830960|42077645|FG000|Overall Study|Lost to Follow-up|1|||
19628229|NCT00830960|42077646|FG001|Overall Study|Lost to Follow-up|1|||
19628230|NCT00830960|42077647|FG002|Overall Study|Lost to Follow-up|1|||
19711151|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
19628231|NCT00830960|42077648|FG003|Overall Study|Lost to Follow-up|0|||
19520439|NCT01393626|41933057|FG001|Overall Study|Other|0|||
19520440|NCT01393626|41933058|FG002|Overall Study|Other|0|||
19520441|NCT01393626|41933059|FG003|Overall Study|Other|0|||
19520442|NCT01393626|41933056|FG000|Overall Study|Protocol Violation|1|||
19520443|NCT01393626|41933057|FG001|Overall Study|Protocol Violation|0|||
19520444|NCT01393626|41933058|FG002|Overall Study|Protocol Violation|2|||
19520445|NCT01393626|41933059|FG003|Overall Study|Protocol Violation|0|||
19520446|NCT01434654|41933078|FG000|Overall Study|Withdrawal by Subject|1|||
19520447|NCT01434654|41933079|FG001|Overall Study|Withdrawal by Subject|0|||
19520448|NCT01434654|41933078|FG000|Overall Study|Lost to Follow-up|1|||
19520449|NCT01434654|41933079|FG001|Overall Study|Lost to Follow-up|0|||
19520450|NCT01393158|41933089|FG000|Overall Study|Adverse Event|1|||
19520451|NCT01393158|41933090|FG001|Overall Study|Adverse Event|0|||
19520452|NCT01413360|41933102|FG000|Overall Study|Lost to Follow-up|2|||
19520453|NCT01413360|41933102|FG000|Overall Study|Adverse Event|1|||
19520454|NCT01413204|41933109|FG000|Overall Study|Adverse Event|1|||
19520455|NCT01413204|41933110|FG001|Overall Study|Adverse Event|2|||
19520456|NCT01413204|41933111|FG002|Overall Study|Adverse Event|2|||
19520457|NCT01413204|41933109|FG000|Overall Study|Physician Decision|3|||
19520458|NCT01413204|41933110|FG001|Overall Study|Physician Decision|0|||
19520459|NCT01413204|41933111|FG002|Overall Study|Physician Decision|2|||
19520460|NCT01413204|41933109|FG000|Overall Study|Withdrawal by Subject|1|||
19520461|NCT01413204|41933110|FG001|Overall Study|Withdrawal by Subject|4|||
19520462|NCT01413204|41933111|FG002|Overall Study|Withdrawal by Subject|4|||
19520463|NCT01413204|41933109|FG000|Overall Study|Clearly not eligible for the study|0|||
19520464|NCT01413204|41933110|FG001|Overall Study|Clearly not eligible for the study|0|||
19520465|NCT01413204|41933111|FG002|Overall Study|Clearly not eligible for the study|1|||
19520466|NCT01413204|41933109|FG000|Overall Study|Fasting plasma glucose level increased|1|||
19520467|NCT01413204|41933110|FG001|Overall Study|Fasting plasma glucose level increased|0|||
19520468|NCT01413204|41933111|FG002|Overall Study|Fasting plasma glucose level increased|10|||
19520469|NCT01392378|41933124|FG000|Infant Series|Adverse Event|0|||
19520470|NCT01392378|41933125|FG001|Infant Series|Adverse Event|0|||
19520471|NCT01392378|41933126|FG002|Infant Series|Adverse Event|0|||
19520472|NCT01392378|41933127|FG003|Infant Series|Adverse Event|1|||
19520473|NCT01392378|41933128|FG004|Infant Series|Adverse Event|0|||
19520474|NCT01392378|41933124|FG000|Infant Series|Lost to Follow-up|0|||
19520475|NCT01392378|41933125|FG001|Infant Series|Lost to Follow-up|0|||
19520476|NCT01392378|41933126|FG002|Infant Series|Lost to Follow-up|0|||
19520477|NCT01392378|41933127|FG003|Infant Series|Lost to Follow-up|1|||
19520478|NCT01392378|41933128|FG004|Infant Series|Lost to Follow-up|0|||
19520479|NCT01392378|41933124|FG000|Infant Series|Protocol Violation|0|||
19520480|NCT01392378|41933125|FG001|Infant Series|Protocol Violation|1|||
19520481|NCT01392378|41933126|FG002|Infant Series|Protocol Violation|0|||
19520482|NCT01392378|41933127|FG003|Infant Series|Protocol Violation|0|||
19520483|NCT01392378|41933128|FG004|Infant Series|Protocol Violation|0|||
19520484|NCT01392378|41933124|FG000|Infant Series|Withdrawal by Parent|4|||
19520485|NCT01392378|41933125|FG001|Infant Series|Withdrawal by Parent|1|||
19520486|NCT01392378|41933126|FG002|Infant Series|Withdrawal by Parent|0|||
19520487|NCT01392378|41933127|FG003|Infant Series|Withdrawal by Parent|0|||
19520488|NCT01392378|41933128|FG004|Infant Series|Withdrawal by Parent|0|||
19520489|NCT01392378|41933124|FG000|After Infant Series|Lost to Follow-up|0|||
19520490|NCT01392378|41933125|FG001|After Infant Series|Lost to Follow-up|0|||
19520491|NCT01392378|41933126|FG002|After Infant Series|Lost to Follow-up|1|||
19520492|NCT01392378|41933127|FG003|After Infant Series|Lost to Follow-up|0|||
19520493|NCT01392378|41933128|FG004|After Infant Series|Lost to Follow-up|0|||
19520494|NCT01392378|41933124|FG000|After Infant Series|Withdrawal by Parent|0|||
19520495|NCT01392378|41933125|FG001|After Infant Series|Withdrawal by Parent|1|||
19520496|NCT01392378|41933126|FG002|After Infant Series|Withdrawal by Parent|1|||
19520497|NCT01392378|41933127|FG003|After Infant Series|Withdrawal by Parent|0|||
19520498|NCT01392378|41933128|FG004|After Infant Series|Withdrawal by Parent|1|||
19520499|NCT01392378|41933124|FG000|Toddler Dose|Lost to Follow-up|0|||
19520500|NCT01392378|41933125|FG001|Toddler Dose|Lost to Follow-up|0|||
19520501|NCT01392378|41933126|FG002|Toddler Dose|Lost to Follow-up|0|||
19520502|NCT01392378|41933127|FG003|Toddler Dose|Lost to Follow-up|1|||
19520503|NCT01392378|41933128|FG004|Toddler Dose|Lost to Follow-up|0|||
19520504|NCT01392378|41933124|FG000|Toddler Dose|Withdrawal by Parent|0|||
19520505|NCT01392378|41933125|FG001|Toddler Dose|Withdrawal by Parent|1|||
19520506|NCT01392378|41933126|FG002|Toddler Dose|Withdrawal by Parent|0|||
19520507|NCT01392378|41933127|FG003|Toddler Dose|Withdrawal by Parent|1|||
19628232|NCT00830960|42077649|FG004|Overall Study|Lost to Follow-up|0|||
19520508|NCT01392378|41933128|FG004|Toddler Dose|Withdrawal by Parent|1|||
19520509|NCT01412424|41933150|FG000|Core Treatment Period|Treatment Failure|24|||
19520510|NCT01412424|41933150|FG000|Core Treatment Period|Adverse Event|21|||
19520511|NCT01412424|41933150|FG000|Core Treatment Period|Patient Request|5|||
19520512|NCT01412424|41933150|FG000|Core Treatment Period|Lost to Follow-up|2|||
19520513|NCT01412424|41933150|FG000|Core Treatment Period|Sponsor Request|1|||
19520514|NCT01412424|41933150|FG000|Extension Treatment Period|Adverse Event|2|||
19628233|NCT00830960|42077650|FG005|Overall Study|Lost to Follow-up|1|||
19520515|NCT01412424|41933150|FG000|Extension Treatment Period|Treatment Failure|2|||
19520516|NCT01412424|41933150|FG000|Extension Treatment Period|Patient Request|2|||
19520517|NCT01433250|41933162|FG000|Overall Study|Protocol Violation|0|||
19520518|NCT01433250|41933163|FG001|Overall Study|Protocol Violation|1|||
19628234|NCT00830960|42077645|FG000|Overall Study|Withdrawal by Subject|19|||
19628235|NCT00830960|42077646|FG001|Overall Study|Withdrawal by Subject|19|||
19628236|NCT00830960|42077647|FG002|Overall Study|Withdrawal by Subject|18|||
19628237|NCT00830960|42077648|FG003|Overall Study|Withdrawal by Subject|23|||
19628238|NCT00830960|42077649|FG004|Overall Study|Withdrawal by Subject|16|||
19628239|NCT00830960|42077650|FG005|Overall Study|Withdrawal by Subject|21|||
19628240|NCT00830960|42077645|FG000|Overall Study|Sponsor Decision|1|||
19375197|NCT02285920|41616971|FG001|Overall Study|Dialysis discontinuation|1|||
19375198|NCT02285920|41616972|FG002|Overall Study|Dialysis discontinuation|0|||
19375199|NCT02285920|41616973|FG003|Overall Study|Dialysis discontinuation|0|||
19375200|NCT02285920|41616970|FG000|Overall Study|Death|2|||
19375201|NCT02285920|41616971|FG001|Overall Study|Death|0|||
19375202|NCT02285920|41616972|FG002|Overall Study|Death|2|||
19375203|NCT02285920|41616973|FG003|Overall Study|Death|1|||
19375204|NCT02035137|41616986|FG000|Overall Study|Physician Decision|0|||
19375205|NCT02035137|41616987|FG001|Overall Study|Physician Decision|0|||
19375206|NCT02035137|41616988|FG002|Overall Study|Physician Decision|1|||
19375207|NCT02035137|41616986|FG000|Overall Study|Withdrawal by Subject|0|||
19375208|NCT02035137|41616987|FG001|Overall Study|Withdrawal by Subject|1|||
19375209|NCT02035137|41616988|FG002|Overall Study|Withdrawal by Subject|2|||
19375210|NCT02035137|41616986|FG000|Overall Study|Ineligible|0|||
19375211|NCT02035137|41616987|FG001|Overall Study|Ineligible|1|||
19628241|NCT00830960|42077646|FG001|Overall Study|Sponsor Decision|2|||
19628242|NCT00830960|42077647|FG002|Overall Study|Sponsor Decision|3|||
19375212|NCT02035137|41616988|FG002|Overall Study|Ineligible|2|||
19375213|NCT02035137|41616986|FG000|Overall Study|Disease progression prior to treatment start|2|||
19628243|NCT00830960|42077648|FG003|Overall Study|Sponsor Decision|4|||
19628244|NCT00830960|42077649|FG004|Overall Study|Sponsor Decision|5|||
19628245|NCT00830960|42077650|FG005|Overall Study|Sponsor Decision|7|||
19628246|NCT00830960|42077645|FG000|Overall Study|No study drug received|7|||
19628247|NCT00830960|42077646|FG001|Overall Study|No study drug received|2|||
19520519|NCT01433250|41933162|FG000|Overall Study|Withdrawal by Subject|3|||
19520520|NCT01433250|41933163|FG001|Overall Study|Withdrawal by Subject|2|||
19520521|NCT01433172|41933172|FG000|Overall Study|Withdrawal by Subject|0|||
19520522|NCT01433172|41933173|FG001|Overall Study|Withdrawal by Subject|1|||
19520523|NCT01433172|41933174|FG002|Overall Study|Withdrawal by Subject|0|||
19520524|NCT01433172|41933172|FG000|Overall Study|Disease Progression|0|||
19520525|NCT01433172|41933173|FG001|Overall Study|Disease Progression|0|||
19520526|NCT01433172|41933174|FG002|Overall Study|Disease Progression|1|||
19520527|NCT01433172|41933172|FG000|Overall Study|Death|0|||
19520528|NCT01433172|41933173|FG001|Overall Study|Death|2|||
19520529|NCT01433172|41933174|FG002|Overall Study|Death|0|||
19520530|NCT01432938|41933182|FG000|First Intervention|Protocol Violation|1|||
19520531|NCT01432938|41933183|FG001|First Intervention|Protocol Violation|0|||
19520532|NCT01432938|41933182|FG000|First Intervention|Physician Decision|1|||
19520533|NCT01432938|41933183|FG001|First Intervention|Physician Decision|0|||
19520534|NCT01432938|41933182|FG000|Second Intervention|Adverse Event|1|||
19520535|NCT01432938|41933183|FG001|Second Intervention|Adverse Event|0|||
19520536|NCT01392300|41933192|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
19520537|NCT01392300|41933193|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
19520538|NCT01392300|41933194|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
19520539|NCT01392300|41933192|FG000|Main Period (MP)|Withdrawal by Subject|5|||
19520540|NCT01392300|41933193|FG001|Main Period (MP)|Withdrawal by Subject|1|||
19520541|NCT01392300|41933194|FG002|Main Period (MP)|Withdrawal by Subject|0|||
19520542|NCT01392300|41933192|FG000|Main Period (MP)|Lost to Follow-up|3|||
19520543|NCT01392300|41933193|FG001|Main Period (MP)|Lost to Follow-up|3|||
19520544|NCT01392300|41933194|FG002|Main Period (MP)|Lost to Follow-up|0|||
19520545|NCT01392300|41933192|FG000|Main Period (MP)|Non-compliance|1|||
19520546|NCT01392300|41933193|FG001|Main Period (MP)|Non-compliance|0|||
19520547|NCT01392300|41933194|FG002|Main Period (MP)|Non-compliance|0|||
19520548|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
19520549|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
19520550|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
19520551|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
19520552|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
19520553|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
19520554|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
19628248|NCT00830960|42077647|FG002|Overall Study|No study drug received|4|||
19628249|NCT00830960|42077648|FG003|Overall Study|No study drug received|3|||
19628250|NCT00830960|42077649|FG004|Overall Study|No study drug received|5|||
19628251|NCT00830960|42077650|FG005|Overall Study|No study drug received|7|||
19520555|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
19520556|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
19520557|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Death|0|||
19520558|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Death|0|||
19711152|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
19520559|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Death|4|||
19520560|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
19520561|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
19520562|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
19520563|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
19520564|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
19520565|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
19520566|NCT01392300|41933192|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
19520567|NCT01392300|41933193|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
19520568|NCT01392300|41933194|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
19520569|NCT01432626|41933201|FG000|Overall Study|LV function recovered|2|||
19520570|NCT01432626|41933201|FG000|Overall Study|Withdrawal by Subject|2|||
19520571|NCT01432626|41933201|FG000|Overall Study|Only 1 image competed|2|||
19520572|NCT01432626|41933201|FG000|Overall Study|Imaging agent not available|1|||
19520573|NCT01391832|41933207|FG000|Overall Study|Withdrawal by Subject|21|||
19520574|NCT01391832|41933208|FG001|Overall Study|Withdrawal by Subject|22|||
19520575|NCT01391832|41933207|FG000|Overall Study|Lost to Follow-up|0|||
19520576|NCT01391832|41933208|FG001|Overall Study|Lost to Follow-up|1|||
19520577|NCT01410474|41933216|FG000|Overall Study|Withdrawal by Subject|0|||
19520578|NCT01410474|41933217|FG001|Overall Study|Withdrawal by Subject|1|||
19520579|NCT01391130|41933232|FG000|Overall Study|Withdrawal by Subject|3|||
19520580|NCT01391130|41933233|FG001|Overall Study|Withdrawal by Subject|2|||
19520581|NCT01391130|41933232|FG000|Overall Study|Physician Decision|2|||
19628252|NCT00830804|42077687|FG000|Overall Study|Lost to Follow-up|4|||
19520582|NCT01391130|41933233|FG001|Overall Study|Physician Decision|3|||
19520583|NCT01391130|41933232|FG000|Overall Study|Did not Receive Drug|1|||
19520584|NCT01391130|41933233|FG001|Overall Study|Did not Receive Drug|1|||
19520585|NCT01410240|41933242|FG000|Overall Study|Physician Decision|0|||
19520586|NCT01410240|41933243|FG001|Overall Study|Physician Decision|0|||
19520587|NCT01410240|41933244|FG002|Overall Study|Physician Decision|1|||
19520588|NCT01410240|41933242|FG000|Overall Study|Missed week 6 assessments|1|||
19520589|NCT01410240|41933243|FG001|Overall Study|Missed week 6 assessments|1|||
19520590|NCT01410240|41933244|FG002|Overall Study|Missed week 6 assessments|1|||
19520591|NCT01409928|41933253|FG000|Overall Study|Physician Decision|12|||
19520592|NCT01390584|41933259|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
19520593|NCT01390584|41933260|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
19520594|NCT01390584|41933261|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
19520595|NCT01431534|41933273|FG000|Treatment Phase|Adverse Event|0|||
19520596|NCT01431534|41933274|FG001|Treatment Phase|Adverse Event|0|||
19520597|NCT01431534|41933275|FG002|Treatment Phase|Adverse Event|1|||
19520598|NCT01431534|41933273|FG000|Treatment Phase|Progressive Disease|4|||
19520599|NCT01431534|41933274|FG001|Treatment Phase|Progressive Disease|3|||
19520600|NCT01431534|41933275|FG002|Treatment Phase|Progressive Disease|10|||
19520601|NCT01409382|41933285|FG000|Overall Study|Lost to Follow-up|1|||
19520602|NCT01409382|41933286|FG001|Overall Study|Lost to Follow-up|1|||
19520603|NCT01409382|41933285|FG000|Overall Study|Protocol Violation|0|||
19520604|NCT01409382|41933286|FG001|Overall Study|Protocol Violation|3|||
19520605|NCT01409382|41933285|FG000|Overall Study|Multiple pregnancy|2|||
19520606|NCT01409382|41933286|FG001|Overall Study|Multiple pregnancy|4|||
19520607|NCT01409382|41933285|FG000|Overall Study|Still pregnant when study ended|13|||
19520608|NCT01409382|41933286|FG001|Overall Study|Still pregnant when study ended|2|||
19520609|NCT01409382|41933285|FG000|Overall Study|Did not manage to get pregnant|64|||
19520610|NCT01409382|41933286|FG001|Overall Study|Did not manage to get pregnant|70|||
19520611|NCT01409382|41933285|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
19520612|NCT01409382|41933286|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
19520613|NCT01408914|41933299|FG000|Overall Study|Could not complete tx in protocol period|5|||
19520614|NCT01408914|41933300|FG001|Overall Study|Could not complete tx in protocol period|5|||
19520615|NCT01408914|41933301|FG002|Overall Study|Could not complete tx in protocol period|6|||
19520616|NCT01408914|41933299|FG000|Overall Study|Lost to Follow-up|4|||
19520617|NCT01408914|41933300|FG001|Overall Study|Lost to Follow-up|1|||
19520618|NCT01408914|41933301|FG002|Overall Study|Lost to Follow-up|2|||
19520619|NCT01408914|41933299|FG000|Overall Study|Physician Decision|1|||
19520620|NCT01408914|41933300|FG001|Overall Study|Physician Decision|1|||
19520621|NCT01408914|41933301|FG002|Overall Study|Physician Decision|0|||
19520622|NCT01408914|41933299|FG000|Overall Study|Withdrawal by Subject|1|||
19520623|NCT01408914|41933300|FG001|Overall Study|Withdrawal by Subject|0|||
19520624|NCT01408914|41933301|FG002|Overall Study|Withdrawal by Subject|1|||
19520625|NCT01408914|41933299|FG000|Overall Study|Moved out of study jurisdiction|1|||
19520626|NCT01408914|41933300|FG001|Overall Study|Moved out of study jurisdiction|1|||
19520627|NCT01408914|41933301|FG002|Overall Study|Moved out of study jurisdiction|0|||
19520628|NCT01408914|41933299|FG000|Overall Study|Late exclusion|0|||
19520629|NCT01408914|41933300|FG001|Overall Study|Late exclusion|3|||
19520630|NCT01408914|41933301|FG002|Overall Study|Late exclusion|3|||
19520631|NCT01408914|41933299|FG000|Overall Study|Change in local TB/HIV norms|0|||
19520632|NCT01408914|41933300|FG001|Overall Study|Change in local TB/HIV norms|1|||
19520633|NCT01408914|41933301|FG002|Overall Study|Change in local TB/HIV norms|1|||
19520634|NCT01431144|41933311|FG000|Overall Study|Implant mobility and removal|2|||
19520635|NCT01431144|41933312|FG001|Overall Study|Implant mobility and removal|0|||
19520636|NCT01430754|41933321|FG000|Run-In Phase|Circadian Period Ineligible|24|||
19520637|NCT01430754|41933322|FG001|Run-In Phase|Circadian Period Ineligible|0|||
19520638|NCT01430754|41933321|FG000|Run-In Phase|Protocol Violation|6|||
19520639|NCT01430754|41933322|FG001|Run-In Phase|Protocol Violation|0|||
19520640|NCT01430754|41933321|FG000|Run-In Phase|Adverse Event|2|||
19520641|NCT01430754|41933322|FG001|Run-In Phase|Adverse Event|0|||
19520642|NCT01430754|41933321|FG000|Run-In Phase|Other|2|||
19520643|NCT01430754|41933322|FG001|Run-In Phase|Other|0|||
19520644|NCT01430754|41933321|FG000|Run-In Phase|Withdrawal by Subject|2|||
19520645|NCT01430754|41933322|FG001|Run-In Phase|Withdrawal by Subject|0|||
19520646|NCT01430754|41933321|FG000|Run-In Phase|Lost to Follow-up|1|||
19520647|NCT01430754|41933322|FG001|Run-In Phase|Lost to Follow-up|0|||
19520648|NCT01390428|41933336|FG000|Overall Study|Elective Surgery|0|||
19520649|NCT01390428|41933337|FG001|Overall Study|Elective Surgery|0|||
19520650|NCT01390428|41933338|FG002|Overall Study|Elective Surgery|0|||
19520651|NCT01390428|41933339|FG003|Overall Study|Elective Surgery|0|||
19520652|NCT01390428|41933340|FG004|Overall Study|Elective Surgery|1|||
19520653|NCT01390428|41933341|FG005|Overall Study|Elective Surgery|0|||
19520654|NCT01390428|41933336|FG000|Overall Study|Withdrawal by Subject|0|||
19520655|NCT01390428|41933337|FG001|Overall Study|Withdrawal by Subject|0|||
19520656|NCT01390428|41933338|FG002|Overall Study|Withdrawal by Subject|1|||
19520657|NCT01390428|41933339|FG003|Overall Study|Withdrawal by Subject|0|||
19520658|NCT01390428|41933340|FG004|Overall Study|Withdrawal by Subject|0|||
19520659|NCT01390428|41933341|FG005|Overall Study|Withdrawal by Subject|0|||
19520660|NCT01430130|41933355|FG000|Overall Study|Lost to Follow-up|1|||
19520661|NCT01430130|41933355|FG000|Overall Study|Infection on Control Side of Incision|1|||
19520662|NCT01407354|41933361|FG000|First Intervention|Withdrawal by Subject|0|||
19520663|NCT01407354|41933362|FG001|First Intervention|Withdrawal by Subject|2|||
19520664|NCT01407354|41933361|FG000|First Intervention|Adverse Event|1|||
19520665|NCT01407354|41933362|FG001|First Intervention|Adverse Event|0|||
19520666|NCT01407354|41933361|FG000|First Intervention|Physician Decision|1|||
19520667|NCT01407354|41933362|FG001|First Intervention|Physician Decision|0|||
19520668|NCT01407276|41933377|FG000|Overall Study|Withdrawal by Subject|0|||
19520669|NCT01407276|41933378|FG001|Overall Study|Withdrawal by Subject|0|||
19520670|NCT01407276|41933379|FG002|Overall Study|Withdrawal by Subject|0|||
19520671|NCT01407276|41933380|FG003|Overall Study|Withdrawal by Subject|0|||
19520672|NCT01407276|41933381|FG004|Overall Study|Withdrawal by Subject|0|||
19520673|NCT01407276|41933382|FG005|Overall Study|Withdrawal by Subject|0|||
19520674|NCT01407276|41933383|FG006|Overall Study|Withdrawal by Subject|0|||
19520675|NCT01407276|41933384|FG007|Overall Study|Withdrawal by Subject|1|||
19520676|NCT01390272|41933411|FG000|Overall Study|Death|3|||
19520677|NCT01390272|41933412|FG001|Overall Study|Death|2|||
19520678|NCT01390272|41933411|FG000|Overall Study|Withdrawal by Subject|9|||
19520679|NCT01390272|41933412|FG001|Overall Study|Withdrawal by Subject|5|||
19520680|NCT01390272|41933411|FG000|Overall Study|Patient moved, no longer eligible|5|||
19520681|NCT01390272|41933412|FG001|Overall Study|Patient moved, no longer eligible|8|||
19520682|NCT01429584|41933420|FG000|Overall Study|Withdrawal by Subject|1|||
19520683|NCT01429584|41933421|FG001|Overall Study|Withdrawal by Subject|0|||
19520684|NCT01429584|41933420|FG000|Overall Study|Protocol Violation|0|||
19520685|NCT01429584|41933421|FG001|Overall Study|Protocol Violation|1|||
19520686|NCT01406652|41933429|FG000|Overall Study|Lost-to-follow-up|3|||
19520687|NCT01406652|41933430|FG001|Overall Study|Lost-to-follow-up|4|||
19520688|NCT01406652|41933429|FG000|Overall Study|Withdrawal by Subject|2|||
19520689|NCT01406652|41933430|FG001|Overall Study|Withdrawal by Subject|2|||
19520690|NCT01406652|41933429|FG000|Overall Study|Insufficient follow-up|5|||
19520691|NCT01406652|41933430|FG001|Overall Study|Insufficient follow-up|4|||
19520692|NCT01406652|41933429|FG000|Overall Study|Infection not sure|10|||
19520693|NCT01406652|41933430|FG001|Overall Study|Infection not sure|10|||
19520694|NCT01406574|41933438|FG000|Overall Study|Adverse Event|0|||
19520695|NCT01406574|41933439|FG001|Overall Study|Adverse Event|0|||
19520696|NCT01406574|41933440|FG002|Overall Study|Adverse Event|1|||
19520697|NCT01406574|41933441|FG003|Overall Study|Adverse Event|3|||
19520698|NCT01406574|41933438|FG000|Overall Study|Physician Decision|0|||
19520699|NCT01406574|41933439|FG001|Overall Study|Physician Decision|0|||
19520700|NCT01406574|41933440|FG002|Overall Study|Physician Decision|0|||
19520701|NCT01406574|41933441|FG003|Overall Study|Physician Decision|1|||
19520702|NCT01406574|41933438|FG000|Overall Study|Withdrawal by Subject|0|||
19520703|NCT01406574|41933439|FG001|Overall Study|Withdrawal by Subject|1|||
19520704|NCT01406574|41933440|FG002|Overall Study|Withdrawal by Subject|0|||
19520705|NCT01406574|41933441|FG003|Overall Study|Withdrawal by Subject|0|||
19520706|NCT01406574|41933438|FG000|Overall Study|Definite progression of primary disease|1|||
19520707|NCT01406574|41933439|FG001|Overall Study|Definite progression of primary disease|0|||
19520708|NCT01406574|41933440|FG002|Overall Study|Definite progression of primary disease|0|||
19520709|NCT01406574|41933441|FG003|Overall Study|Definite progression of primary disease|0|||
19520710|NCT01405950|41933454|FG000|Overall Study|Withdrawal by Subject|1|||
19520711|NCT01405950|41933455|FG001|Overall Study|Withdrawal by Subject|0|||
19520712|NCT01405950|41933456|FG002|Overall Study|Withdrawal by Subject|0|||
19520713|NCT01405950|41933457|FG003|Overall Study|Withdrawal by Subject|0|||
19520714|NCT01405560|41933465|FG000|Overall Study|Physician Decision|1|||
19520715|NCT01428882|41933471|FG000|Overall Study|Lack of Efficacy|2|||
19520716|NCT01428882|41933472|FG001|Overall Study|Lack of Efficacy|7|||
19520717|NCT01428882|41933471|FG000|Overall Study|Protocol Violation|4|||
19520718|NCT01428882|41933472|FG001|Overall Study|Protocol Violation|3|||
19520719|NCT01428258|41933480|FG000|Intervention 1|Withdrawal by Subject|2|||
19520720|NCT01428258|41933481|FG001|Intervention 1|Withdrawal by Subject|0|||
19520721|NCT01389882|41933497|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
19520722|NCT01389882|41933498|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
19520723|NCT01389882|41933497|FG000|Overall Study|Withdrawal by Subject|0|||
19520724|NCT01389882|41933498|FG001|Overall Study|Withdrawal by Subject|1|||
19520725|NCT01426854|41933506|FG000|Overall Study|Adverse Event|1|||
19520726|NCT01426854|41933507|FG001|Overall Study|Adverse Event|5|||
19520727|NCT01426854|41933506|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
19520728|NCT01426854|41933507|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
19520729|NCT01426854|41933506|FG000|Overall Study|Lost to Follow-up|3|||
19520730|NCT01426854|41933507|FG001|Overall Study|Lost to Follow-up|0|||
19520731|NCT01426854|41933506|FG000|Overall Study|Noncompliance|0|||
19520732|NCT01426854|41933507|FG001|Overall Study|Noncompliance|1|||
19520733|NCT01426854|41933506|FG000|Overall Study|Treatment Failure|0|||
19520734|NCT01426854|41933507|FG001|Overall Study|Treatment Failure|16|||
19520735|NCT01426854|41933506|FG000|Overall Study|Protocol Deviation|0|||
19520736|NCT01426854|41933507|FG001|Overall Study|Protocol Deviation|1|||
19520737|NCT01426854|41933506|FG000|Overall Study|Other|3|||
19520738|NCT01426854|41933507|FG001|Overall Study|Other|2|||
19520739|NCT01426386|41933519|FG000|Overall Study|Adverse Event|0|||
19520740|NCT01426386|41933520|FG001|Overall Study|Adverse Event|1|||
19520741|NCT01426386|41933521|FG002|Overall Study|Adverse Event|0|||
19520742|NCT01426386|41933522|FG003|Overall Study|Adverse Event|0|||
19520743|NCT01426386|41933523|FG004|Overall Study|Adverse Event|0|||
19520744|NCT01426386|41933524|FG005|Overall Study|Adverse Event|0|||
19520745|NCT01426386|41933519|FG000|Overall Study|Did not attend scheduled visit|1|||
19520746|NCT01426386|41933520|FG001|Overall Study|Did not attend scheduled visit|4|||
19520747|NCT01426386|41933521|FG002|Overall Study|Did not attend scheduled visit|0|||
19520748|NCT01426386|41933522|FG003|Overall Study|Did not attend scheduled visit|0|||
19520749|NCT01426386|41933523|FG004|Overall Study|Did not attend scheduled visit|2|||
19520750|NCT01426386|41933524|FG005|Overall Study|Did not attend scheduled visit|1|||
19520751|NCT01426386|41933519|FG000|Overall Study|Poor response|2|||
19520752|NCT01426386|41933520|FG001|Overall Study|Poor response|1|||
19520753|NCT01426386|41933521|FG002|Overall Study|Poor response|2|||
19520754|NCT01426386|41933522|FG003|Overall Study|Poor response|0|||
19520755|NCT01426386|41933523|FG004|Overall Study|Poor response|1|||
19520756|NCT01426386|41933524|FG005|Overall Study|Poor response|0|||
19520757|NCT01426386|41933519|FG000|Overall Study|Personal reasons|0|||
19520758|NCT01426386|41933520|FG001|Overall Study|Personal reasons|0|||
19520759|NCT01426386|41933521|FG002|Overall Study|Personal reasons|0|||
19520760|NCT01426386|41933522|FG003|Overall Study|Personal reasons|0|||
19520761|NCT01426386|41933523|FG004|Overall Study|Personal reasons|1|||
19520762|NCT01426386|41933524|FG005|Overall Study|Personal reasons|0|||
19520763|NCT01404234|41933538|FG000|Overall Study|Withdrawal by Subject|2|||
19520764|NCT01403610|41933546|FG000|Overall Study|Withdrawal by Subject|2|||
19520765|NCT01403610|41933547|FG001|Overall Study|Withdrawal by Subject|0|||
19520766|NCT01403610|41933548|FG002|Overall Study|Withdrawal by Subject|0|||
19520767|NCT01403610|41933549|FG003|Overall Study|Withdrawal by Subject|0|||
19520768|NCT01403610|41933546|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
19520769|NCT01403610|41933547|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
19520770|NCT01403610|41933548|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
19520771|NCT01403610|41933549|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
19520772|NCT01403064|41933563|FG000|Overall Study|Death|0|||
19520773|NCT01403064|41933564|FG001|Overall Study|Death|0|||
19520774|NCT01403064|41933565|FG002|Overall Study|Death|1|||
19520775|NCT01403064|41933566|FG003|Overall Study|Death|1|||
19520776|NCT01403064|41933563|FG000|Overall Study|Withdrawal by Subject|0|||
19520777|NCT01403064|41933564|FG001|Overall Study|Withdrawal by Subject|0|||
19520778|NCT01403064|41933565|FG002|Overall Study|Withdrawal by Subject|1|||
19520779|NCT01403064|41933566|FG003|Overall Study|Withdrawal by Subject|1|||
19520780|NCT01403064|41933563|FG000|Overall Study|Other|1|||
19520781|NCT01403064|41933564|FG001|Overall Study|Other|0|||
19520782|NCT01403064|41933565|FG002|Overall Study|Other|2|||
19520783|NCT01403064|41933566|FG003|Overall Study|Other|1|||
19520784|NCT01402986|41933585|FG000|Overall Study|Withdrawal by Subject|7|||
19520785|NCT01402986|41933586|FG001|Overall Study|Withdrawal by Subject|10|||
19520786|NCT01402986|41933587|FG002|Overall Study|Withdrawal by Subject|7|||
19520787|NCT01402986|41933588|FG003|Overall Study|Withdrawal by Subject|13|||
19424099|NCT02292719|41670912|FG003|Overall Study|Withdrawal by Subject|1|||
19424100|NCT02292719|41670913|FG004|Overall Study|Withdrawal by Subject|1|||
19520788|NCT01402986|41933585|FG000|Overall Study|Death|0|||
19520789|NCT01402986|41933586|FG001|Overall Study|Death|0|||
19520790|NCT01402986|41933587|FG002|Overall Study|Death|0|||
19520791|NCT01402986|41933588|FG003|Overall Study|Death|2|||
19520792|NCT01402986|41933585|FG000|Overall Study|Lost to Follow-up|0|||
19520793|NCT01402986|41933586|FG001|Overall Study|Lost to Follow-up|0|||
19520794|NCT01402986|41933587|FG002|Overall Study|Lost to Follow-up|0|||
19375214|NCT02035137|41616987|FG001|Overall Study|Disease progression prior to treatment start|0|||
19375215|NCT02035137|41616988|FG002|Overall Study|Disease progression prior to treatment start|0|||
19375216|NCT02522780|41616998|FG000|Overall Study|Consent withdrawn by subject|5|||
19375217|NCT02522780|41616999|FG001|Overall Study|Consent withdrawn by subject|7|||
19375218|NCT02522780|41616998|FG000|Overall Study|Protocol deviation|1|||
19375219|NCT02522780|41616999|FG001|Overall Study|Protocol deviation|3|||
19375220|NCT02522780|41616998|FG000|Overall Study|Subject refused endoscopic procedure|0|||
19375221|NCT02522780|41616999|FG001|Overall Study|Subject refused endoscopic procedure|1|||
19375222|NCT02522780|41616998|FG000|Overall Study|Adverse event, non-fatal|11|||
19520795|NCT01402986|41933588|FG003|Overall Study|Lost to Follow-up|1|||
19520796|NCT01402986|41933585|FG000|Overall Study|Other|2|||
19520797|NCT01402986|41933586|FG001|Overall Study|Other|5|||
19520798|NCT01402986|41933587|FG002|Overall Study|Other|1|||
19520799|NCT01402986|41933588|FG003|Overall Study|Other|6|||
19424101|NCT02292719|41670914|FG005|Overall Study|Withdrawal by Subject|0|||
19424102|NCT02292719|41670909|FG000|Overall Study|Subject enrolled in new study.|0|||
19424103|NCT02292719|41670910|FG001|Overall Study|Subject enrolled in new study.|0|||
19424104|NCT02292719|41670911|FG002|Overall Study|Subject enrolled in new study.|1|||
19424105|NCT02292719|41670912|FG003|Overall Study|Subject enrolled in new study.|0|||
19424106|NCT02292719|41670913|FG004|Overall Study|Subject enrolled in new study.|0|||
19424107|NCT02292719|41670914|FG005|Overall Study|Subject enrolled in new study.|0|||
19424108|NCT02291861|41670932|FG000|Overall Study|Adverse Event|2|||
19424109|NCT02291861|41670933|FG001|Overall Study|Adverse Event|4|||
19424110|NCT02291861|41670934|FG002|Overall Study|Adverse Event|1|||
19424111|NCT02291861|41670935|FG003|Overall Study|Adverse Event|2|||
19424112|NCT02291861|41670932|FG000|Overall Study|Death|0|||
19424113|NCT02291861|41670933|FG001|Overall Study|Death|0|||
19424114|NCT02291861|41670934|FG002|Overall Study|Death|1|||
19424115|NCT02291861|41670935|FG003|Overall Study|Death|1|||
19424116|NCT02291861|41670932|FG000|Overall Study|Protocol Violation|1|||
19424117|NCT02291861|41670933|FG001|Overall Study|Protocol Violation|0|||
19424118|NCT02291861|41670934|FG002|Overall Study|Protocol Violation|0|||
19424119|NCT02291861|41670935|FG003|Overall Study|Protocol Violation|1|||
19424120|NCT02291861|41670932|FG000|Overall Study|Withdrawal by Subject|1|||
19424121|NCT02291861|41670933|FG001|Overall Study|Withdrawal by Subject|2|||
19424122|NCT02291861|41670934|FG002|Overall Study|Withdrawal by Subject|1|||
19424123|NCT02291861|41670935|FG003|Overall Study|Withdrawal by Subject|4|||
19424124|NCT02291861|41670932|FG000|Overall Study|Noncompliance|1|||
19424125|NCT02291861|41670933|FG001|Overall Study|Noncompliance|1|||
19424126|NCT02291861|41670934|FG002|Overall Study|Noncompliance|2|||
19424127|NCT02291861|41670935|FG003|Overall Study|Noncompliance|1|||
19424128|NCT02291861|41670932|FG000|Overall Study|Lost to Follow-up|2|||
19424129|NCT02291861|41670933|FG001|Overall Study|Lost to Follow-up|1|||
19424130|NCT02291861|41670934|FG002|Overall Study|Lost to Follow-up|4|||
19424131|NCT02291861|41670935|FG003|Overall Study|Lost to Follow-up|0|||
19424132|NCT02291861|41670932|FG000|Overall Study|Other|0|||
19424133|NCT02291861|41670933|FG001|Overall Study|Other|0|||
19424134|NCT02291861|41670934|FG002|Overall Study|Other|0|||
19424135|NCT02291861|41670935|FG003|Overall Study|Other|1|||
19424136|NCT02291549|41670947|FG000|Overall Study|Lost to Follow-up|1|||
19424137|NCT02291549|41670948|FG001|Overall Study|Lost to Follow-up|0|||
19424138|NCT02291549|41670947|FG000|Overall Study|Withdrawal by Subject|0|||
19424139|NCT02291549|41670948|FG001|Overall Study|Withdrawal by Subject|1|||
19424140|NCT02264990|41670958|FG000|Overall Study|Death|255|||
19424141|NCT02264990|41670959|FG001|Overall Study|Death|250|||
19424142|NCT02264990|41670958|FG000|Overall Study|Withdrawal by Subject|4|||
19424143|NCT02264990|41670959|FG001|Overall Study|Withdrawal by Subject|5|||
19424144|NCT02264990|41670958|FG000|Overall Study|Lost to Follow-up|1|||
19424145|NCT02264990|41670959|FG001|Overall Study|Lost to Follow-up|3|||
19424146|NCT02264990|41670958|FG000|Overall Study|Other|0|||
19424147|NCT02264990|41670959|FG001|Overall Study|Other|1|||
19424148|NCT02291237|41670968|FG000|Overall Study|Study Terminated by Sponsor|72|||
19424149|NCT02291237|41670969|FG001|Overall Study|Study Terminated by Sponsor|67|||
19424150|NCT02291237|41670968|FG000|Overall Study|Adverse Event|1|||
19424151|NCT02291237|41670969|FG001|Overall Study|Adverse Event|3|||
19424152|NCT02291237|41670968|FG000|Overall Study|Investigator's Discretion|0|||
19424153|NCT02291237|41670969|FG001|Overall Study|Investigator's Discretion|3|||
19424154|NCT02291237|41670968|FG000|Overall Study|Withdrew Consent|11|||
19424155|NCT02291237|41670969|FG001|Overall Study|Withdrew Consent|11|||
19424156|NCT02291237|41670968|FG000|Overall Study|Lost to Follow-up|0|||
19424157|NCT02291237|41670969|FG001|Overall Study|Lost to Follow-up|2|||
19424158|NCT02291237|41670968|FG000|Overall Study|Subject Required Prohibited Medication|2|||
19424159|NCT02291237|41670969|FG001|Overall Study|Subject Required Prohibited Medication|0|||
19424160|NCT02292446|41670975|FG000|Overall Study|Adverse Event|12|||
19424161|NCT02292446|41670975|FG000|Overall Study|Death|1|||
19424162|NCT02292446|41670975|FG000|Overall Study|Disease progression|2|||
19424163|NCT02292446|41670975|FG000|Overall Study|Subject/guardian decision|2|||
19424164|NCT02292446|41670975|FG000|Overall Study|Withdrawal by Subject|3|||
19424165|NCT02290925|41670984|FG000|First Period of Three Months|Lost to Follow-up|2|||
19424166|NCT02290925|41670985|FG001|First Period of Three Months|Lost to Follow-up|1|||
19424167|NCT02290925|41670984|FG000|First Period of Three Months|Death|1|||
19424168|NCT02290925|41670985|FG001|First Period of Three Months|Death|0|||
19424169|NCT02290925|41670984|FG000|First Period of Three Months|Insulin Started|1|||
19424170|NCT02290925|41670985|FG001|First Period of Three Months|Insulin Started|1|||
19424171|NCT02290925|41670984|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
19424172|NCT02290925|41670985|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
19424173|NCT02290925|41670984|FG000|Second Period of 3 Months|insulin started|0|||
19424174|NCT02290925|41670985|FG001|Second Period of 3 Months|insulin started|1|||
19424175|NCT02290691|41670995|FG000|Overall Study|Noncompliance|0|||
19424176|NCT02290691|41670996|FG001|Overall Study|Noncompliance|1|||
19424177|NCT02290691|41670995|FG000|Overall Study|Withdrawal by Subject|1|||
19424178|NCT02290691|41670996|FG001|Overall Study|Withdrawal by Subject|1|||
19424179|NCT02290691|41670995|FG000|Overall Study|Lost to Follow-up|7|||
19424180|NCT02290691|41670996|FG001|Overall Study|Lost to Follow-up|7|||
19424181|NCT02292212|41671002|FG000|ViE Phase|Withdrawal by Subject|1|||
19424182|NCT02292212|41671002|FG000|ViE Phase|Protocol Violation|2|||
19424183|NCT02291510|41671017|FG000|Overall Study|Adverse Event|0|||
19424184|NCT02291510|41671018|FG001|Overall Study|Adverse Event|0|||
19424185|NCT02291510|41671019|FG002|Overall Study|Adverse Event|0|||
19424186|NCT02291510|41671020|FG003|Overall Study|Adverse Event|1|||
19424187|NCT02290223|41671032|FG000|6 Months|Lost to Follow-up|9|||
19424188|NCT02290223|41671033|FG001|6 Months|Lost to Follow-up|6|||
19424189|NCT02290223|41671032|FG000|6 Months|Withdrawal by Subject|5|||
19424190|NCT02290223|41671033|FG001|6 Months|Withdrawal by Subject|0|||
19424191|NCT02290223|41671032|FG000|6 Months|deceased (not related to study)|2|||
19424192|NCT02290223|41671033|FG001|6 Months|deceased (not related to study)|0|||
19424193|NCT02290223|41671032|FG000|12 Months|Lost to Follow-up|16|||
19424194|NCT02290223|41671033|FG001|12 Months|Lost to Follow-up|10|||
19424195|NCT02290223|41671032|FG000|12 Months|Refusal|0|||
19424196|NCT02290223|41671033|FG001|12 Months|Refusal|1|||
19424197|NCT02289833|41671041|FG000|Overall Study|Study discontinuation|0|||
19424198|NCT02289833|41671042|FG001|Overall Study|Study discontinuation|1|||
19424199|NCT02289833|41671041|FG000|Overall Study|Lost to Follow-up|4|||
19424200|NCT02289833|41671042|FG001|Overall Study|Lost to Follow-up|0|||
19424201|NCT02289833|41671041|FG000|Overall Study|Death|23|||
19424202|NCT02289833|41671042|FG001|Overall Study|Death|16|||
19424203|NCT01702558|41671055|FG000|Overall Study|Withdrawal by Subject|0|||
19424204|NCT01702558|41671056|FG001|Overall Study|Withdrawal by Subject|0|||
19424205|NCT01702558|41671057|FG002|Overall Study|Withdrawal by Subject|0|||
19424206|NCT01702558|41671058|FG003|Overall Study|Withdrawal by Subject|12|||
19424207|NCT01702558|41671059|FG004|Overall Study|Withdrawal by Subject|4|||
19424208|NCT01702558|41671055|FG000|Overall Study|Lost to Follow-up|0|||
19424209|NCT01702558|41671056|FG001|Overall Study|Lost to Follow-up|0|||
19424210|NCT01702558|41671057|FG002|Overall Study|Lost to Follow-up|0|||
19424211|NCT01702558|41671058|FG003|Overall Study|Lost to Follow-up|3|||
19424212|NCT01702558|41671059|FG004|Overall Study|Lost to Follow-up|0|||
19424213|NCT01702558|41671055|FG000|Overall Study|Death|4|||
19424214|NCT01702558|41671056|FG001|Overall Study|Death|3|||
19424215|NCT01702558|41671057|FG002|Overall Study|Death|3|||
19424216|NCT01702558|41671058|FG003|Overall Study|Death|16|||
19424217|NCT01702558|41671059|FG004|Overall Study|Death|20|||
19424218|NCT01702558|41671055|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
19424219|NCT01702558|41671056|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
19424220|NCT01702558|41671057|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
19424221|NCT01702558|41671058|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
19424222|NCT01702558|41671059|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
19424223|NCT01702558|41671055|FG000|Overall Study|Study Terminated by Sponsor|0|||
19424224|NCT01702558|41671056|FG001|Overall Study|Study Terminated by Sponsor|1|||
19424225|NCT01702558|41671057|FG002|Overall Study|Study Terminated by Sponsor|0|||
19424226|NCT01702558|41671058|FG003|Overall Study|Study Terminated by Sponsor|0|||
19424227|NCT01702558|41671059|FG004|Overall Study|Study Terminated by Sponsor|1|||
19424228|NCT01702558|41671055|FG000|Overall Study|Other|0|||
19424229|NCT01702558|41671056|FG001|Overall Study|Other|0|||
19424230|NCT01702558|41671057|FG002|Overall Study|Other|0|||
19424231|NCT01702558|41671058|FG003|Overall Study|Other|16|||
19424232|NCT01702558|41671059|FG004|Overall Study|Other|17|||
19424233|NCT02287883|41671074|FG000|Overall Study|Death|8|||
19424234|NCT02287883|41671075|FG001|Overall Study|Death|7|||
19424235|NCT02287883|41671074|FG000|Overall Study|No longer eligible|222|||
19424236|NCT02287883|41671075|FG001|Overall Study|No longer eligible|182|||
19424237|NCT02287883|41671074|FG000|Overall Study|Non-response to survey|229|||
19424238|NCT02287883|41671075|FG001|Overall Study|Non-response to survey|237|||
19424239|NCT01743040|41671081|FG000|Overall Study|Death|1|||
19424240|NCT01743040|41671081|FG000|Overall Study|Lost to Follow-up|66|||
19424241|NCT01743040|41671081|FG000|Overall Study|Physician Decision|40|||
19424242|NCT01743040|41671081|FG000|Overall Study|Protocol Violation|1|||
19424243|NCT01743040|41671081|FG000|Overall Study|Withdrawal by Subject|121|||
19711153|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
19424244|NCT02194465|41671092|FG000|Overall Study|Adverse Event|6|||
19424245|NCT02194465|41671093|FG001|Overall Study|Adverse Event|1|||
19424246|NCT02194465|41671094|FG002|Overall Study|Adverse Event|4|||
19711154|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
19424247|NCT02194465|41671095|FG003|Overall Study|Adverse Event|4|||
19424248|NCT02194465|41671096|FG004|Overall Study|Adverse Event|4|||
19424249|NCT02194465|41671097|FG005|Overall Study|Adverse Event|2|||
19424250|NCT02194465|41671098|FG006|Overall Study|Adverse Event|0|||
19424251|NCT02194465|41671092|FG000|Overall Study|Lost to Follow-up|0|||
19424252|NCT02194465|41671093|FG001|Overall Study|Lost to Follow-up|0|||
19424253|NCT02194465|41671094|FG002|Overall Study|Lost to Follow-up|0|||
19424254|NCT02194465|41671095|FG003|Overall Study|Lost to Follow-up|1|||
19424255|NCT02194465|41671096|FG004|Overall Study|Lost to Follow-up|0|||
19424256|NCT02194465|41671097|FG005|Overall Study|Lost to Follow-up|1|||
19424257|NCT02194465|41671098|FG006|Overall Study|Lost to Follow-up|0|||
19424258|NCT02194465|41671092|FG000|Overall Study|Physician Decision|1|||
19424259|NCT02194465|41671093|FG001|Overall Study|Physician Decision|0|||
19424260|NCT02194465|41671094|FG002|Overall Study|Physician Decision|0|||
19424261|NCT02194465|41671095|FG003|Overall Study|Physician Decision|0|||
19424262|NCT02194465|41671096|FG004|Overall Study|Physician Decision|0|||
19424263|NCT02194465|41671097|FG005|Overall Study|Physician Decision|0|||
19424264|NCT02194465|41671098|FG006|Overall Study|Physician Decision|0|||
19424265|NCT02194465|41671092|FG000|Overall Study|Protocol Violation|1|||
19424266|NCT02194465|41671093|FG001|Overall Study|Protocol Violation|1|||
19424267|NCT02194465|41671094|FG002|Overall Study|Protocol Violation|2|||
19424268|NCT02194465|41671095|FG003|Overall Study|Protocol Violation|1|||
19424269|NCT02194465|41671096|FG004|Overall Study|Protocol Violation|1|||
19424270|NCT02194465|41671097|FG005|Overall Study|Protocol Violation|0|||
19424271|NCT02194465|41671098|FG006|Overall Study|Protocol Violation|0|||
19424272|NCT02194465|41671092|FG000|Overall Study|Withdrawal by Subject|1|||
19424273|NCT02194465|41671093|FG001|Overall Study|Withdrawal by Subject|3|||
19424274|NCT02194465|41671094|FG002|Overall Study|Withdrawal by Subject|1|||
19424275|NCT02194465|41671095|FG003|Overall Study|Withdrawal by Subject|2|||
19424276|NCT02194465|41671096|FG004|Overall Study|Withdrawal by Subject|2|||
19424277|NCT02194465|41671097|FG005|Overall Study|Withdrawal by Subject|1|||
19424278|NCT02194465|41671098|FG006|Overall Study|Withdrawal by Subject|2|||
19424279|NCT02194465|41671092|FG000|Overall Study|Discontinued follow-up period|0|||
19424280|NCT02194465|41671093|FG001|Overall Study|Discontinued follow-up period|2|||
19424281|NCT02194465|41671094|FG002|Overall Study|Discontinued follow-up period|1|||
19424282|NCT02194465|41671095|FG003|Overall Study|Discontinued follow-up period|0|||
19424283|NCT02194465|41671096|FG004|Overall Study|Discontinued follow-up period|2|||
19424284|NCT02194465|41671097|FG005|Overall Study|Discontinued follow-up period|0|||
19424285|NCT02194465|41671098|FG006|Overall Study|Discontinued follow-up period|0|||
19424286|NCT02287025|41671120|FG000|Overall Study|Not treated|2|||
19424287|NCT02287025|41671121|FG001|Overall Study|Not treated|0|||
19424288|NCT02287025|41671120|FG000|Overall Study|Progression of disease|3|||
19424289|NCT02287025|41671121|FG001|Overall Study|Progression of disease|2|||
19424290|NCT02287025|41671120|FG000|Overall Study|Adverse Event|2|||
19424291|NCT02287025|41671121|FG001|Overall Study|Adverse Event|4|||
19424292|NCT02287025|41671120|FG000|Overall Study|Withdrawal by Subject|2|||
19424293|NCT02287025|41671121|FG001|Overall Study|Withdrawal by Subject|2|||
19424294|NCT02287025|41671120|FG000|Overall Study|Screening failed|1|||
19424295|NCT02287025|41671121|FG001|Overall Study|Screening failed|1|||
19424296|NCT01720264|41671125|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
19424297|NCT01720264|41671125|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
19424298|NCT01720264|41671125|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
19424299|NCT01702246|41671129|FG000|Overall Study|Lost to Follow-up|2|||
19424300|NCT01702246|41671129|FG000|Overall Study|Withdrawal by Subject|2|||
19424301|NCT01702246|41671129|FG000|Overall Study|Physician Decision|1|||
19424302|NCT01631227|41671138|FG000|Overall Study|withdrawn consent|27|||
19424303|NCT01631227|41671139|FG001|Overall Study|withdrawn consent|21|||
19424304|NCT01631227|41671138|FG000|Overall Study|Adverse Event|1|||
19424305|NCT01631227|41671139|FG001|Overall Study|Adverse Event|0|||
19424306|NCT01631227|41671138|FG000|Overall Study|administrative|2|||
19424307|NCT01631227|41671139|FG001|Overall Study|administrative|1|||
19424308|NCT01719172|41671145|FG000|Overall Study|Lost to Follow-up|1|||
19424309|NCT01719172|41671145|FG000|Overall Study|Death|1|||
19424310|NCT02286947|41671149|FG000|Overall Study|Withdrawal by Subject|2|||
19424311|NCT02286713|41671157|FG000|One Week Follow-Up|Death|1|||
19424312|NCT02286713|41671158|FG001|One Week Follow-Up|Death|0|||
19424313|NCT02286713|41671157|FG000|One Week Follow-Up|Lost to Follow-up|17|||
19424314|NCT02286713|41671158|FG001|One Week Follow-Up|Lost to Follow-up|21|||
19424315|NCT02286713|41671157|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
19424316|NCT02286713|41671158|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
19424317|NCT02286713|41671157|FG000|Three Month Follow-Up|Death|1|||
19424318|NCT02286713|41671158|FG001|Three Month Follow-Up|Death|1|||
19424319|NCT02286713|41671157|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
19424320|NCT02286713|41671158|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
19424321|NCT02286713|41671157|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
19424322|NCT02286713|41671158|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
19424323|NCT02286713|41671157|FG000|Six Month Follow-Up|Death|2|||
19424324|NCT02286713|41671158|FG001|Six Month Follow-Up|Death|0|||
19424325|NCT02286713|41671157|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
19424326|NCT02286713|41671158|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
19424327|NCT02285855|41671166|FG000|Overall Study|Withdrawal by Subject|2|||
19424328|NCT02285855|41671167|FG001|Overall Study|Withdrawal by Subject|1|||
19424329|NCT02285777|41671175|FG000|Overall Study|Withdrawal by Subject|1|||
19424330|NCT02285777|41671176|FG001|Overall Study|Withdrawal by Subject|1|||
19424331|NCT02285777|41671175|FG000|Overall Study|Lost to Follow-up|4|||
19424332|NCT02285777|41671176|FG001|Overall Study|Lost to Follow-up|2|||
19424333|NCT02285153|41671184|FG000|Overall Study|Adverse Event|1|||
19424334|NCT02285153|41671185|FG001|Overall Study|Adverse Event|0|||
19424335|NCT02284373|41671194|FG000|Overall Study|Withdrawal by Subject|0|||
19424336|NCT02284373|41671195|FG001|Overall Study|Withdrawal by Subject|1|||
19424337|NCT02284373|41671196|FG002|Overall Study|Withdrawal by Subject|0|||
19424338|NCT02284373|41671194|FG000|Overall Study|Other|0|||
19424339|NCT02284373|41671195|FG001|Overall Study|Other|1|||
19424340|NCT02284373|41671196|FG002|Overall Study|Other|0|||
19424341|NCT02284373|41671194|FG000|Overall Study|Lost to Follow-up|0|||
19424342|NCT02284373|41671195|FG001|Overall Study|Lost to Follow-up|1|||
19424343|NCT02284373|41671196|FG002|Overall Study|Lost to Follow-up|0|||
19424344|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
19424345|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
19424346|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
19424347|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
19424348|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
19424349|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
19424350|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
19424351|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
19424352|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
19424353|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
19424354|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
19424355|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
19424356|NCT01632241|41671206|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
19424357|NCT01632241|41671207|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
19424358|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
19424359|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
19424360|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
19424361|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
19424362|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
19424363|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
19424364|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
19424365|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
19424366|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
19424367|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
19424368|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
19424369|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
19424370|NCT01632241|41671206|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
19424371|NCT01632241|41671207|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
19424372|NCT02263508|41671222|FG000|Overall Study|Withdrawal by Subject|1|||
19424373|NCT02263508|41671223|FG001|Overall Study|Withdrawal by Subject|23|||
19424374|NCT02263508|41671224|FG002|Overall Study|Withdrawal by Subject|17|||
19424375|NCT02263508|41671222|FG000|Overall Study|Sponsor Decision|12|||
19424376|NCT02263508|41671223|FG001|Overall Study|Sponsor Decision|165|||
19424377|NCT02263508|41671224|FG002|Overall Study|Sponsor Decision|182|||
19424378|NCT02263508|41671222|FG000|Overall Study|Lost to Follow-up|2|||
19424379|NCT02263508|41671223|FG001|Overall Study|Lost to Follow-up|7|||
19424380|NCT02263508|41671224|FG002|Overall Study|Lost to Follow-up|7|||
19424381|NCT02263508|41671222|FG000|Overall Study|Death|6|||
19424382|NCT02263508|41671223|FG001|Overall Study|Death|151|||
19424383|NCT02263508|41671224|FG002|Overall Study|Death|140|||
19424384|NCT02291432|41671235|FG000|Overall Study|Withdrawal by Subject|2|||
19424385|NCT02290340|41671243|FG000|Overall Study|Lost to Follow-up|0|||
19424386|NCT02290340|41671244|FG001|Overall Study|Lost to Follow-up|0|||
19424387|NCT02290340|41671245|FG002|Overall Study|Lost to Follow-up|0|||
19424388|NCT02290340|41671246|FG003|Overall Study|Lost to Follow-up|1|||
19424389|NCT02290340|41671243|FG000|Overall Study|Withdrawal by Subject|1|||
19424390|NCT02290340|41671244|FG001|Overall Study|Withdrawal by Subject|0|||
19424391|NCT02290340|41671245|FG002|Overall Study|Withdrawal by Subject|0|||
19424392|NCT02290340|41671246|FG003|Overall Study|Withdrawal by Subject|0|||
19424393|NCT02290340|41671243|FG000|Overall Study|Other|1|||
19424394|NCT02290340|41671244|FG001|Overall Study|Other|0|||
19424395|NCT02290340|41671245|FG002|Overall Study|Other|0|||
19424396|NCT02290340|41671246|FG003|Overall Study|Other|1|||
19424397|NCT02290028|41671259|FG000|Overall Study|Death|217|||
19424398|NCT02290028|41671259|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
19424399|NCT02290028|41671259|FG000|Overall Study|No longer under care of study physician|76|||
19424400|NCT02290028|41671259|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
19424401|NCT02290028|41671259|FG000|Overall Study|Withdrawal by Subject|52|||
19424402|NCT02290028|41671259|FG000|Overall Study|Study site closure|44|||
19424403|NCT02290028|41671259|FG000|Overall Study|Lost to Follow-up|34|||
19424404|NCT02290028|41671259|FG000|Overall Study|Miscellaneous|10|||
19424405|NCT02290028|41671259|FG000|Overall Study|Transition to EP PASSION|1295|||
19424406|NCT02290028|41671259|FG000|Overall Study|Planned study completion at 12 months|257|||
19424407|NCT01741792|41671269|FG000|Overall Study|Death|6|||
19424408|NCT01741792|41671270|FG001|Overall Study|Death|1|||
19424409|NCT01741792|41671271|FG002|Overall Study|Death|12|||
19424410|NCT02289950|41671287|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
19424411|NCT02289950|41671288|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
19424412|NCT02289950|41671287|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
19424413|NCT02289950|41671288|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
19424414|NCT02289950|41671287|FG000|Overall Study|Lost to Follow-up|1|||
19424415|NCT02289950|41671288|FG001|Overall Study|Lost to Follow-up|0|||
19424416|NCT02289950|41671287|FG000|Overall Study|Physician Decision|9|||
19424417|NCT02289950|41671288|FG001|Overall Study|Physician Decision|3|||
19424418|NCT02289950|41671287|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
19424419|NCT02289950|41671288|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
19424420|NCT02289950|41671287|FG000|Overall Study|Withdrawal by Subject|1|||
19424421|NCT02289950|41671288|FG001|Overall Study|Withdrawal by Subject|3|||
19424422|NCT02289950|41671287|FG000|Overall Study|Test article held for greater than 28 days|0|||
19424423|NCT02289950|41671288|FG001|Overall Study|Test article held for greater than 28 days|1|||
19424424|NCT02289950|41671287|FG000|Overall Study|Adverse Event|11|||
19424425|NCT02289950|41671288|FG001|Overall Study|Adverse Event|3|||
19424426|NCT02289950|41671287|FG000|Overall Study|Death|1|||
19424427|NCT02289950|41671288|FG001|Overall Study|Death|1|||
19424428|NCT02289950|41671287|FG000|Overall Study|Other|5|||
19424429|NCT02289950|41671288|FG001|Overall Study|Other|2|||
19424430|NCT02289950|41671287|FG000|Overall Study|Not Treated|2|||
19424431|NCT02289950|41671288|FG001|Overall Study|Not Treated|1|||
19424432|NCT01741012|41671294|FG000|Overall Study|Lost to Follow-up|1|||
19424433|NCT01741012|41671294|FG000|Overall Study|Withdrawal by Subject|2|||
19424434|NCT02288312|41671302|FG000|Overall Study|Pregnancy|1|||
19424435|NCT02288312|41671303|FG001|Overall Study|Pregnancy|0|||
19424436|NCT02288312|41671304|FG002|Overall Study|Pregnancy|0|||
19424437|NCT01740388|41671314|FG000|Overall Study|Withdrawal by Subject|1|||
19424438|NCT01740388|41671315|FG001|Overall Study|Withdrawal by Subject|2|||
19424439|NCT01740388|41671314|FG000|Overall Study|Lost to Follow-up|2|||
19424440|NCT01740388|41671315|FG001|Overall Study|Lost to Follow-up|0|||
19424441|NCT01740388|41671314|FG000|Overall Study|Physician Decision|2|||
19424442|NCT01740388|41671315|FG001|Overall Study|Physician Decision|6|||
19424443|NCT01740388|41671314|FG000|Overall Study|Subjects missing data, completed|41|||
19424444|NCT01740388|41671315|FG001|Overall Study|Subjects missing data, completed|36|||
19424445|NCT01740154|41671321|FG000|Overall Study|Adverse Event|1|||
19424446|NCT02287922|41671329|FG000|Overall Study|Adverse Event|1|||
19424447|NCT02287922|41671330|FG001|Overall Study|Adverse Event|1|||
19424448|NCT02287922|41671331|FG002|Overall Study|Adverse Event|3|||
19424449|NCT02287922|41671332|FG003|Overall Study|Adverse Event|4|||
19424450|NCT02287922|41671329|FG000|Overall Study|Withdrawal by Subject|1|||
19424451|NCT02287922|41671330|FG001|Overall Study|Withdrawal by Subject|1|||
19424452|NCT02287922|41671331|FG002|Overall Study|Withdrawal by Subject|1|||
19424453|NCT02287922|41671332|FG003|Overall Study|Withdrawal by Subject|2|||
19424454|NCT02287922|41671329|FG000|Overall Study|Lost to Follow-up|0|||
19424455|NCT02287922|41671330|FG001|Overall Study|Lost to Follow-up|0|||
19424456|NCT02287922|41671331|FG002|Overall Study|Lost to Follow-up|1|||
19424457|NCT02287922|41671332|FG003|Overall Study|Lost to Follow-up|0|||
19424458|NCT02287922|41671329|FG000|Overall Study|Sponsor's decision|0|||
19424459|NCT02287922|41671330|FG001|Overall Study|Sponsor's decision|0|||
19424460|NCT02287922|41671331|FG002|Overall Study|Sponsor's decision|0|||
19424461|NCT02287922|41671332|FG003|Overall Study|Sponsor's decision|1|||
19424462|NCT02287922|41671329|FG000|Overall Study|Other|1|||
19424463|NCT02287922|41671330|FG001|Overall Study|Other|0|||
19424464|NCT02287922|41671331|FG002|Overall Study|Other|2|||
19424465|NCT02287922|41671332|FG003|Overall Study|Other|0|||
19424466|NCT02287610|41671343|FG000|Overall Study|Lost to Follow-up|3|||
19424467|NCT02287610|41671343|FG000|Overall Study|Withdrawal by Subject|8|||
19424468|NCT02287610|41671343|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
19424469|NCT02262728|41671349|FG000|Follow-up Phase (3 Years)|Death|0|||
19424470|NCT02262728|41671350|FG001|Follow-up Phase (3 Years)|Death|1|||
19424471|NCT02262728|41671349|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
19424472|NCT02262728|41671350|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
19424473|NCT02262728|41671349|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
19424474|NCT02262728|41671350|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
19424475|NCT02262260|41671358|FG000|Overall Study|Adverse Event|4|||
19424476|NCT02262260|41671359|FG001|Overall Study|Adverse Event|1|||
19424477|NCT02262260|41671358|FG000|Overall Study|Withdrawal of consent|4|||
19424478|NCT02262260|41671359|FG001|Overall Study|Withdrawal of consent|2|||
19424479|NCT02262260|41671358|FG000|Overall Study|Lost to Follow-up|1|||
19424480|NCT02262260|41671359|FG001|Overall Study|Lost to Follow-up|2|||
19424481|NCT02262260|41671358|FG000|Overall Study|Protocol deviation|2|||
19424482|NCT02262260|41671359|FG001|Overall Study|Protocol deviation|5|||
19424483|NCT02285270|41671365|FG000|Overall Study|Lost to Follow-up|1|||
19424484|NCT02285270|41671365|FG000|Overall Study|Physician Decision|3|||
19424485|NCT02285270|41671365|FG000|Overall Study|Determined to be ineligible|1|||
19628253|NCT00830804|42077687|FG000|Overall Study|Death|1|||
19424486|NCT01717768|41671379|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424487|NCT01717768|41671380|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
19424488|NCT01717768|41671381|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424489|NCT01717768|41671382|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424490|NCT01717768|41671383|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424491|NCT01717768|41671384|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424492|NCT01717768|41671385|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424493|NCT01717768|41671386|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424494|NCT01717768|41671387|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424495|NCT01717768|41671388|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424496|NCT01717768|41671389|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424497|NCT01717768|41671390|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
19424498|NCT01717768|41671379|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424499|NCT01717768|41671380|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424500|NCT01717768|41671381|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424501|NCT01717768|41671382|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424502|NCT01717768|41671383|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424503|NCT01717768|41671384|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424504|NCT01717768|41671385|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424505|NCT01717768|41671386|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424506|NCT01717768|41671387|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424507|NCT01717768|41671388|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424508|NCT01717768|41671389|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
19424509|NCT01717768|41671390|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
19424510|NCT01717768|41671379|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424511|NCT01717768|41671380|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424512|NCT01717768|41671381|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424513|NCT01717768|41671382|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424514|NCT01717768|41671383|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424515|NCT01717768|41671384|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424516|NCT01717768|41671385|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424517|NCT01717768|41671386|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
19424518|NCT01717768|41671387|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424519|NCT01717768|41671388|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424520|NCT01717768|41671389|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424521|NCT01717768|41671390|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
19424522|NCT01717768|41671379|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424523|NCT01717768|41671380|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424524|NCT01717768|41671381|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424525|NCT01717768|41671382|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424526|NCT01717768|41671383|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424527|NCT01717768|41671384|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424528|NCT01717768|41671385|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424529|NCT01717768|41671386|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424530|NCT01717768|41671387|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424531|NCT01717768|41671388|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
19424532|NCT01717768|41671389|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424533|NCT01717768|41671390|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
19424534|NCT02260934|41671418|FG000|Overall Study|Lost to Follow-up|2|||
19424535|NCT02260934|41671419|FG001|Overall Study|Lost to Follow-up|1|||
19424536|NCT02260934|41671418|FG000|Overall Study|Withdrawal by Subject|0|||
19424537|NCT02260934|41671419|FG001|Overall Study|Withdrawal by Subject|2|||
19424538|NCT02260934|41671418|FG000|Overall Study|Participant Relocated|1|||
19424539|NCT02260934|41671419|FG001|Overall Study|Participant Relocated|0|||
19424540|NCT02260934|41671418|FG000|Overall Study|Site error|0|||
19424541|NCT02260934|41671419|FG001|Overall Study|Site error|1|||
19424542|NCT02285114|41671435|FG000|Overall Study|Investigator's Discretion|0|||
19424543|NCT02285114|41671436|FG001|Overall Study|Investigator's Discretion|2|||
19424544|NCT02285114|41671437|FG002|Overall Study|Investigator's Discretion|0|||
19424545|NCT02285114|41671435|FG000|Overall Study|Withdrew Consent|0|||
19424546|NCT02285114|41671436|FG001|Overall Study|Withdrew Consent|0|||
19424547|NCT02285114|41671437|FG002|Overall Study|Withdrew Consent|1|||
19424548|NCT02285114|41671435|FG000|Overall Study|Enrolled but not treated|1|||
19424549|NCT02285114|41671436|FG001|Overall Study|Enrolled but not treated|0|||
19424550|NCT02285114|41671437|FG002|Overall Study|Enrolled but not treated|0|||
19424551|NCT02285114|41671435|FG000|Overall Study|Still on study|21|||
19424552|NCT02285114|41671436|FG001|Overall Study|Still on study|5|||
19424553|NCT02285114|41671437|FG002|Overall Study|Still on study|2|||
19424554|NCT02260388|41671455|FG000|Overall Study|Lost to Follow-up|2|||
19424555|NCT02260388|41671456|FG001|Overall Study|Lost to Follow-up|8|||
19424556|NCT02260388|41671457|FG002|Overall Study|Lost to Follow-up|3|||
19424557|NCT02260388|41671458|FG003|Overall Study|Lost to Follow-up|4|||
19424558|NCT02260154|41671468|FG000|Overall Study|Screening failure|2|||
19424559|NCT02284178|41671475|FG000|Overall Study|Met exclusion criteria|49|||
19424560|NCT02284178|41671476|FG001|Overall Study|Met exclusion criteria|54|||
19424561|NCT01643408|41671482|FG000|Overall Study|Adverse Event|12|||
19424562|NCT01643408|41671482|FG000|Overall Study|Other|2|||
19424563|NCT02283788|41671490|FG000|Overall Study|Adverse Event|1|||
19424564|NCT02283788|41671491|FG001|Overall Study|Adverse Event|3|||
19424565|NCT02283788|41671492|FG002|Overall Study|Adverse Event|5|||
19424566|NCT02283788|41671493|FG003|Overall Study|Adverse Event|1|||
19424567|NCT02283788|41671490|FG000|Overall Study|Withdrawal by Subject|0|||
19424568|NCT02283788|41671491|FG001|Overall Study|Withdrawal by Subject|1|||
19424569|NCT02283788|41671492|FG002|Overall Study|Withdrawal by Subject|0|||
19424570|NCT02283788|41671493|FG003|Overall Study|Withdrawal by Subject|1|||
19424571|NCT01739764|41671506|FG000|Overall Study|Adverse Event|0|||
19424572|NCT01739764|41671507|FG001|Overall Study|Adverse Event|3|||
19424573|NCT01739764|41671508|FG002|Overall Study|Adverse Event|4|||
19424574|NCT01739764|41671506|FG000|Overall Study|Death|4|||
19424575|NCT01739764|41671507|FG001|Overall Study|Death|6|||
19424576|NCT01739764|41671508|FG002|Overall Study|Death|38|||
19424577|NCT01739764|41671506|FG000|Overall Study|Lost to Follow-up|0|||
19424578|NCT01739764|41671507|FG001|Overall Study|Lost to Follow-up|0|||
19424579|NCT01739764|41671508|FG002|Overall Study|Lost to Follow-up|5|||
19424580|NCT01739764|41671506|FG000|Overall Study|Non-Compliance|0|||
19424581|NCT01739764|41671507|FG001|Overall Study|Non-Compliance|0|||
19424582|NCT01739764|41671508|FG002|Overall Study|Non-Compliance|1|||
19424583|NCT01739764|41671506|FG000|Overall Study|Multiple Reasons|3|||
19424584|NCT01739764|41671507|FG001|Overall Study|Multiple Reasons|2|||
19424585|NCT01739764|41671508|FG002|Overall Study|Multiple Reasons|3|||
19424586|NCT01739764|41671506|FG000|Overall Study|Physician Decision|2|||
19424587|NCT01739764|41671507|FG001|Overall Study|Physician Decision|2|||
19424588|NCT01739764|41671508|FG002|Overall Study|Physician Decision|4|||
19424589|NCT01739764|41671506|FG000|Overall Study|Progressive Disease|3|||
19424590|NCT01739764|41671507|FG001|Overall Study|Progressive Disease|5|||
19424591|NCT01739764|41671508|FG002|Overall Study|Progressive Disease|16|||
19520800|NCT01402908|41933600|FG000|Overall Study|Withdrawal by Subject|30|||
19520801|NCT01402908|41933601|FG001|Overall Study|Withdrawal by Subject|17|||
19520802|NCT01402908|41933600|FG000|Overall Study|Lost to Follow-up|3|||
19520803|NCT01402908|41933601|FG001|Overall Study|Lost to Follow-up|1|||
19520804|NCT01402908|41933600|FG000|Overall Study|Physician Decision|1|||
19520805|NCT01402908|41933601|FG001|Overall Study|Physician Decision|0|||
19520806|NCT01389258|41933607|FG000|Overall Study|Lost to Follow-up|5|||
19520807|NCT01389102|41933617|FG000|Overall Study|Adverse Event|1|||
19520808|NCT01389102|41933618|FG001|Overall Study|Adverse Event|3|||
19520809|NCT01389102|41933619|FG002|Overall Study|Adverse Event|2|||
19520810|NCT01389102|41933620|FG003|Overall Study|Adverse Event|2|||
19520811|NCT01389102|41933621|FG004|Overall Study|Adverse Event|2|||
19520812|NCT01389102|41933622|FG005|Overall Study|Adverse Event|2|||
19520813|NCT01389102|41933617|FG000|Overall Study|Hurricane Katrina|4|||
19520814|NCT01389102|41933618|FG001|Overall Study|Hurricane Katrina|2|||
19520815|NCT01389102|41933619|FG002|Overall Study|Hurricane Katrina|3|||
19520816|NCT01389102|41933620|FG003|Overall Study|Hurricane Katrina|0|||
19520817|NCT01389102|41933621|FG004|Overall Study|Hurricane Katrina|3|||
19520818|NCT01389102|41933622|FG005|Overall Study|Hurricane Katrina|1|||
19520819|NCT01389102|41933617|FG000|Overall Study|Lost to Follow-up|4|||
19520820|NCT01389102|41933618|FG001|Overall Study|Lost to Follow-up|1|||
19520821|NCT01389102|41933619|FG002|Overall Study|Lost to Follow-up|1|||
19424592|NCT01739764|41671506|FG000|Overall Study|Protocol Violation|0|||
19424593|NCT01739764|41671507|FG001|Overall Study|Protocol Violation|0|||
19424594|NCT01739764|41671508|FG002|Overall Study|Protocol Violation|2|||
19520822|NCT01389102|41933620|FG003|Overall Study|Lost to Follow-up|2|||
19520823|NCT01389102|41933621|FG004|Overall Study|Lost to Follow-up|4|||
19520824|NCT01389102|41933622|FG005|Overall Study|Lost to Follow-up|1|||
19424595|NCT01739764|41671506|FG000|Overall Study|Study Terminated by Sponsor|8|||
19424596|NCT01739764|41671507|FG001|Overall Study|Study Terminated by Sponsor|13|||
19424597|NCT01739764|41671508|FG002|Overall Study|Study Terminated by Sponsor|26|||
19520825|NCT01389102|41933617|FG000|Overall Study|Protocol Violation|0|||
19520826|NCT01389102|41933618|FG001|Overall Study|Protocol Violation|0|||
19520827|NCT01389102|41933619|FG002|Overall Study|Protocol Violation|3|||
19520828|NCT01389102|41933620|FG003|Overall Study|Protocol Violation|0|||
19520829|NCT01389102|41933621|FG004|Overall Study|Protocol Violation|1|||
19424598|NCT01739764|41671506|FG000|Overall Study|Withdrawal by Subject|6|||
19424599|NCT01739764|41671507|FG001|Overall Study|Withdrawal by Subject|5|||
19424600|NCT01739764|41671508|FG002|Overall Study|Withdrawal by Subject|27|||
19424601|NCT01700530|41671519|FG000|Overall Study|Withdrawal by Subject|0|||
19424602|NCT01700530|41671520|FG001|Overall Study|Withdrawal by Subject|3|||
19424603|NCT01700530|41671521|FG002|Overall Study|Withdrawal by Subject|1|||
19424604|NCT01700140|41671532|FG000|Overall Study|Use of rescue drugs|3|||
19424605|NCT01700140|41671533|FG001|Overall Study|Use of rescue drugs|3|||
19424606|NCT01700140|41671534|FG002|Overall Study|Use of rescue drugs|1|||
19424607|NCT01700140|41671532|FG000|Overall Study|Discontinuation of radiotherapy|1|||
19424608|NCT01700140|41671533|FG001|Overall Study|Discontinuation of radiotherapy|0|||
19424609|NCT01700140|41671534|FG002|Overall Study|Discontinuation of radiotherapy|0|||
19424610|NCT01700140|41671532|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
19424611|NCT01700140|41671533|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
19424612|NCT01700140|41671534|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
19424613|NCT01700140|41671532|FG000|Overall Study|Aggravation of symptoms|1|||
19424614|NCT01700140|41671533|FG001|Overall Study|Aggravation of symptoms|0|||
19424615|NCT01700140|41671534|FG002|Overall Study|Aggravation of symptoms|0|||
19424616|NCT01700140|41671532|FG000|Overall Study|Adverse Event|0|||
19424617|NCT01700140|41671533|FG001|Overall Study|Adverse Event|1|||
19424618|NCT01700140|41671534|FG002|Overall Study|Adverse Event|0|||
19424619|NCT01700140|41671532|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
19424620|NCT01700140|41671533|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
19424621|NCT01700140|41671534|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
19424622|NCT01717456|41671547|FG000|End of Treatment|Physician Decision|0|||
19424623|NCT01717456|41671548|FG001|End of Treatment|Physician Decision|1|||
19424624|NCT01717456|41671547|FG000|End of Treatment|Lost to Follow-up|0|||
19424625|NCT01717456|41671548|FG001|End of Treatment|Lost to Follow-up|1|||
19424626|NCT01717456|41671547|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
19424627|NCT01717456|41671548|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
19424628|NCT01699750|41671557|FG000|Overall Study|Withdrew Consent|0|||
19424629|NCT01699750|41671558|FG001|Overall Study|Withdrew Consent|1|||
19424630|NCT01699750|41671557|FG000|Overall Study|Other|0|||
19424631|NCT01699750|41671558|FG001|Overall Study|Other|2|||
19424632|NCT01716754|41671572|FG000|Overall Study|Death|0|||
19424633|NCT01716754|41671573|FG001|Overall Study|Death|0|||
19424634|NCT01716754|41671574|FG002|Overall Study|Death|0|||
19424635|NCT01716754|41671575|FG003|Overall Study|Death|1|||
19424636|NCT01716754|41671572|FG000|Overall Study|Protocol deviation|0|||
19424637|NCT01716754|41671573|FG001|Overall Study|Protocol deviation|2|||
19424638|NCT01716754|41671574|FG002|Overall Study|Protocol deviation|7|||
19424639|NCT01716754|41671575|FG003|Overall Study|Protocol deviation|2|||
19424640|NCT01716754|41671572|FG000|Overall Study|Non-compliance with study treatment|0|||
19424641|NCT01716754|41671573|FG001|Overall Study|Non-compliance with study treatment|0|||
19424642|NCT01716754|41671574|FG002|Overall Study|Non-compliance with study treatment|1|||
19424643|NCT01716754|41671575|FG003|Overall Study|Non-compliance with study treatment|0|||
19424644|NCT01716754|41671572|FG000|Overall Study|Physician Decision|1|||
19424645|NCT01716754|41671573|FG001|Overall Study|Physician Decision|0|||
19424646|NCT01716754|41671574|FG002|Overall Study|Physician Decision|0|||
19424647|NCT01716754|41671575|FG003|Overall Study|Physician Decision|0|||
19424648|NCT01716754|41671572|FG000|Overall Study|Lost to Follow-up|1|||
19424649|NCT01716754|41671573|FG001|Overall Study|Lost to Follow-up|0|||
19424650|NCT01716754|41671574|FG002|Overall Study|Lost to Follow-up|0|||
19424651|NCT01716754|41671575|FG003|Overall Study|Lost to Follow-up|1|||
19424652|NCT01716754|41671572|FG000|Overall Study|Adverse Event|4|||
19424653|NCT01716754|41671573|FG001|Overall Study|Adverse Event|2|||
19424654|NCT01716754|41671574|FG002|Overall Study|Adverse Event|2|||
19424655|NCT01716754|41671575|FG003|Overall Study|Adverse Event|1|||
19424656|NCT01716754|41671572|FG000|Overall Study|Withdrawal by Subject|5|||
19424657|NCT01716754|41671573|FG001|Overall Study|Withdrawal by Subject|0|||
19424658|NCT01716754|41671574|FG002|Overall Study|Withdrawal by Subject|4|||
19424659|NCT01716754|41671575|FG003|Overall Study|Withdrawal by Subject|3|||
19424660|NCT01698814|41671586|FG000|Overall Study|Adverse Event|0|||
19424661|NCT01698814|41671587|FG001|Overall Study|Adverse Event|2|||
19424662|NCT01698814|41671586|FG000|Overall Study|Lost to Follow-up|0|||
19424663|NCT01698814|41671587|FG001|Overall Study|Lost to Follow-up|1|||
19424664|NCT01698814|41671586|FG000|Overall Study|Pregnancy|1|||
19424665|NCT01698814|41671587|FG001|Overall Study|Pregnancy|0|||
19424666|NCT01698814|41671586|FG000|Overall Study|Randomized in error|1|||
19424667|NCT01698814|41671587|FG001|Overall Study|Randomized in error|0|||
19424668|NCT01738984|41671595|FG000|Overall Study|Pregnancy|4|||
19424669|NCT01738984|41671596|FG001|Overall Study|Pregnancy|0|||
19424670|NCT01738984|41671595|FG000|Overall Study|Withdrawal by Subject|1|||
19424671|NCT01738984|41671596|FG001|Overall Study|Withdrawal by Subject|0|||
19424672|NCT01738984|41671595|FG000|Overall Study|Lost to Follow-up|59|||
19424673|NCT01738984|41671596|FG001|Overall Study|Lost to Follow-up|39|||
19424674|NCT01738594|41671605|FG000|Registration and Treatment Start|Adverse Event|0|||
19424675|NCT01738594|41671606|FG001|Registration and Treatment Start|Adverse Event|1|||
19424676|NCT01738594|41671607|FG002|Registration and Treatment Start|Adverse Event|0|||
19424677|NCT01738594|41671608|FG003|Registration and Treatment Start|Adverse Event|0|||
19424678|NCT01738594|41671609|FG004|Registration and Treatment Start|Adverse Event|0|||
19424679|NCT01738594|41671610|FG005|Registration and Treatment Start|Adverse Event|0|||
19424680|NCT01738594|41671611|FG006|Registration and Treatment Start|Adverse Event|0|||
19424681|NCT01738594|41671612|FG007|Registration and Treatment Start|Adverse Event|0|||
19424682|NCT01738594|41671605|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424683|NCT01738594|41671606|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424684|NCT01738594|41671607|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424685|NCT01738594|41671608|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424686|NCT01738594|41671609|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424687|NCT01738594|41671610|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
19424688|NCT01738594|41671611|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424689|NCT01738594|41671612|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
19424690|NCT01738594|41671605|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424691|NCT01738594|41671606|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
19424692|NCT01738594|41671607|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424693|NCT01738594|41671608|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424694|NCT01738594|41671609|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424695|NCT01738594|41671610|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424696|NCT01738594|41671611|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424697|NCT01738594|41671612|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
19424698|NCT01738594|41671605|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424699|NCT01738594|41671606|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424700|NCT01738594|41671607|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424701|NCT01738594|41671608|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424702|NCT01738594|41671609|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424703|NCT01738594|41671610|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
19424704|NCT01738594|41671611|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424705|NCT01738594|41671612|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
19424706|NCT01738594|41671605|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424707|NCT01738594|41671606|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424708|NCT01738594|41671607|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424709|NCT01738594|41671608|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424710|NCT01738594|41671609|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424711|NCT01738594|41671610|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
19424712|NCT01738594|41671611|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424713|NCT01738594|41671612|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
19424714|NCT01738594|41671605|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424715|NCT01738594|41671606|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424716|NCT01738594|41671607|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424717|NCT01738594|41671608|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424718|NCT01738594|41671609|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
19424719|NCT01738594|41671610|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424720|NCT01738594|41671611|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424721|NCT01738594|41671612|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
19424722|NCT01738594|41671605|FG000|Follow up for 1 Year|Death|0|||
19424723|NCT01738594|41671606|FG001|Follow up for 1 Year|Death|0|||
19424724|NCT01738594|41671607|FG002|Follow up for 1 Year|Death|0|||
19424725|NCT01738594|41671608|FG003|Follow up for 1 Year|Death|0|||
19424726|NCT01738594|41671609|FG004|Follow up for 1 Year|Death|0|||
19424727|NCT01738594|41671610|FG005|Follow up for 1 Year|Death|1|||
19424728|NCT01738594|41671611|FG006|Follow up for 1 Year|Death|0|||
19424729|NCT01738594|41671612|FG007|Follow up for 1 Year|Death|0|||
19424730|NCT01738594|41671605|FG000|Follow up for 1 Year|Other|0|||
19424731|NCT01738594|41671606|FG001|Follow up for 1 Year|Other|0|||
19424732|NCT01738594|41671607|FG002|Follow up for 1 Year|Other|0|||
19424733|NCT01738594|41671608|FG003|Follow up for 1 Year|Other|0|||
19424734|NCT01738594|41671609|FG004|Follow up for 1 Year|Other|0|||
19424735|NCT01738594|41671610|FG005|Follow up for 1 Year|Other|2|||
19424736|NCT01738594|41671611|FG006|Follow up for 1 Year|Other|0|||
19424737|NCT01738594|41671612|FG007|Follow up for 1 Year|Other|0|||
19424738|NCT01738438|41671622|FG000|Overall Study|Disease Progression|32|||
19424739|NCT01738438|41671622|FG000|Overall Study|Adverse Event|3|||
19424740|NCT01716520|41671626|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
19424741|NCT01716520|41671627|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
19424742|NCT01716520|41671628|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
19424743|NCT01716520|41671629|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
19424744|NCT01716520|41671630|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
19424745|NCT01716520|41671631|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
19424746|NCT01716520|41671626|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
19424747|NCT01716520|41671627|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424748|NCT01716520|41671628|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
19424749|NCT01716520|41671629|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
19424750|NCT01716520|41671630|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424751|NCT01716520|41671631|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
19424752|NCT01716520|41671626|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19424753|NCT01716520|41671627|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19424754|NCT01716520|41671628|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19424755|NCT01716520|41671629|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19424756|NCT01716520|41671630|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19424757|NCT01716520|41671631|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19424758|NCT01716520|41671626|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
19424759|NCT01716520|41671627|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
19424760|NCT01716520|41671628|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
19424761|NCT01716520|41671629|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
19424762|NCT01716520|41671630|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
19424763|NCT01716520|41671631|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
19424764|NCT01716520|41671626|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19424765|NCT01716520|41671627|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19424766|NCT01716520|41671628|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19424767|NCT01716520|41671629|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19424768|NCT01716520|41671630|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
19424769|NCT01716520|41671631|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
19424770|NCT01716520|41671626|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
19424771|NCT01716520|41671627|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
19424772|NCT01716520|41671628|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
19424773|NCT01716520|41671629|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
19424774|NCT01716520|41671630|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
19424775|NCT01716520|41671631|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
19424776|NCT01716520|41671626|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
19424777|NCT01716520|41671627|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
19424778|NCT01716520|41671628|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
19424779|NCT01716520|41671629|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
19424780|NCT01716520|41671630|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
19424781|NCT01716520|41671631|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
19424782|NCT01716520|41671626|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19424783|NCT01716520|41671627|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19424784|NCT01716520|41671628|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19424785|NCT01716520|41671629|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19424786|NCT01716520|41671630|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
19424787|NCT01716520|41671631|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
19424788|NCT01716520|41671626|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424789|NCT01716520|41671627|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424790|NCT01716520|41671628|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424791|NCT01716520|41671629|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
19424792|NCT01716520|41671630|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424793|NCT01716520|41671631|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
19424794|NCT01716520|41671626|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
19424795|NCT01716520|41671627|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
19424796|NCT01716520|41671628|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
19424797|NCT01716520|41671629|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
19424798|NCT01716520|41671630|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
19424799|NCT01716520|41671631|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
19424800|NCT01716520|41671626|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
19424801|NCT01716520|41671627|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
19424802|NCT01716520|41671628|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
19424803|NCT01716520|41671629|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
19424804|NCT01716520|41671630|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
19424805|NCT01716520|41671631|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
19424806|NCT01716520|41671626|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
19424807|NCT01716520|41671627|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
19424808|NCT01716520|41671628|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
19424809|NCT01716520|41671629|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
19424810|NCT01716520|41671630|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
19520830|NCT01389102|41933622|FG005|Overall Study|Protocol Violation|1|||
19520831|NCT01389102|41933617|FG000|Overall Study|Withdrawal by Subject|7|||
19424811|NCT01716520|41671631|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
19520832|NCT01389102|41933618|FG001|Overall Study|Withdrawal by Subject|4|||
19424812|NCT01716520|41671626|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
19424813|NCT01716520|41671627|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
19424814|NCT01716520|41671628|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
19424815|NCT01716520|41671629|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
19424816|NCT01716520|41671630|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
19424817|NCT01716520|41671631|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
19424818|NCT01716520|41671626|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19424819|NCT01716520|41671627|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19424820|NCT01716520|41671628|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19424821|NCT01716520|41671629|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19424822|NCT01716520|41671630|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19424823|NCT01716520|41671631|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
19424824|NCT01716520|41671626|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19424825|NCT01716520|41671627|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19424826|NCT01716520|41671628|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
19424827|NCT01716520|41671629|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19424828|NCT01716520|41671630|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19424829|NCT01716520|41671631|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
19424830|NCT01698268|41671641|FG000|Overall Study|Physician Decision|2|||
19424831|NCT01698268|41671642|FG001|Overall Study|Physician Decision|1|||
19424832|NCT01697956|41671650|FG000|Overall Study|Protocol Violation|1|||
19424833|NCT01697956|41671651|FG001|Overall Study|Protocol Violation|1|||
19424834|NCT01697800|41671665|FG000|Overall Study|Death|0|||
19424835|NCT01697800|41671666|FG001|Overall Study|Death|1|||
19424836|NCT01644500|41671675|FG000|Overall Study|Adverse Event|6|||
19424837|NCT01644500|41671676|FG001|Overall Study|Adverse Event|1|||
19424838|NCT01644500|41671677|FG002|Overall Study|Adverse Event|2|||
19424839|NCT01644500|41671675|FG000|Overall Study|Death|0|||
19424840|NCT01644500|41671676|FG001|Overall Study|Death|1|||
19424841|NCT01644500|41671677|FG002|Overall Study|Death|0|||
19424842|NCT01644500|41671675|FG000|Overall Study|Lost to Follow-up|3|||
19424843|NCT01644500|41671676|FG001|Overall Study|Lost to Follow-up|8|||
19424844|NCT01644500|41671677|FG002|Overall Study|Lost to Follow-up|0|||
19424845|NCT01644500|41671675|FG000|Overall Study|Protocol Violation|1|||
19424846|NCT01644500|41671676|FG001|Overall Study|Protocol Violation|1|||
19424847|NCT01644500|41671677|FG002|Overall Study|Protocol Violation|0|||
19424848|NCT01644500|41671675|FG000|Overall Study|Withdrawal by Subject|11|||
19424849|NCT01644500|41671676|FG001|Overall Study|Withdrawal by Subject|12|||
19424850|NCT01644500|41671677|FG002|Overall Study|Withdrawal by Subject|12|||
19424851|NCT01644500|41671675|FG000|Overall Study|Physician Decision|1|||
19424852|NCT01644500|41671676|FG001|Overall Study|Physician Decision|1|||
19424853|NCT01644500|41671677|FG002|Overall Study|Physician Decision|1|||
19424854|NCT01604824|41671689|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
19424855|NCT01604824|41671690|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
19424856|NCT01604824|41671691|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
19424857|NCT01604824|41671692|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
19424858|NCT01604824|41671693|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
19424859|NCT01604824|41671694|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
19424860|NCT01604824|41671689|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
19424861|NCT01604824|41671690|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
19424862|NCT01604824|41671691|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
19424863|NCT01604824|41671692|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
19424864|NCT01604824|41671693|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
19424865|NCT01604824|41671694|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
19424866|NCT01716052|41671708|FG000|Overall Study|Withdrawal of funding|1|||
19424867|NCT01716052|41671709|FG001|Overall Study|Withdrawal of funding|1|||
19424868|NCT01641692|41671715|FG000|Treatment Period 1|Adverse Event|1|||
19424869|NCT01641692|41671716|FG001|Treatment Period 1|Adverse Event|0|||
19424870|NCT01641692|41671717|FG002|Treatment Period 1|Adverse Event|0|||
19424871|NCT01641692|41671718|FG003|Treatment Period 1|Adverse Event|0|||
19424872|NCT01641692|41671719|FG004|Treatment Period 1|Adverse Event|0|||
19424873|NCT01641692|41671720|FG005|Treatment Period 1|Adverse Event|0|||
19424874|NCT01641692|41671721|FG006|Treatment Period 1|Adverse Event|0|||
19424875|NCT01641692|41671722|FG007|Treatment Period 1|Adverse Event|0|||
19424876|NCT01641692|41671715|FG000|Treatment Period 1|Lack of Efficacy|0|||
19424877|NCT01641692|41671716|FG001|Treatment Period 1|Lack of Efficacy|0|||
19424878|NCT01641692|41671717|FG002|Treatment Period 1|Lack of Efficacy|0|||
19424879|NCT01641692|41671718|FG003|Treatment Period 1|Lack of Efficacy|0|||
19424880|NCT01641692|41671719|FG004|Treatment Period 1|Lack of Efficacy|0|||
19424881|NCT01641692|41671720|FG005|Treatment Period 1|Lack of Efficacy|0|||
19424882|NCT01641692|41671721|FG006|Treatment Period 1|Lack of Efficacy|0|||
19424883|NCT01641692|41671722|FG007|Treatment Period 1|Lack of Efficacy|1|||
19424884|NCT01641692|41671715|FG000|Treatment Period 1|Protocol Violation|1|||
19424885|NCT01641692|41671716|FG001|Treatment Period 1|Protocol Violation|0|||
19424886|NCT01641692|41671717|FG002|Treatment Period 1|Protocol Violation|0|||
19424887|NCT01641692|41671718|FG003|Treatment Period 1|Protocol Violation|0|||
19424888|NCT01641692|41671719|FG004|Treatment Period 1|Protocol Violation|2|||
19424889|NCT01641692|41671720|FG005|Treatment Period 1|Protocol Violation|0|||
19424890|NCT01641692|41671721|FG006|Treatment Period 1|Protocol Violation|0|||
19424891|NCT01641692|41671722|FG007|Treatment Period 1|Protocol Violation|0|||
19424892|NCT01641692|41671715|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424893|NCT01641692|41671716|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424894|NCT01641692|41671717|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424895|NCT01641692|41671718|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424896|NCT01641692|41671719|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
19424897|NCT01641692|41671720|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424898|NCT01641692|41671721|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
19424899|NCT01641692|41671722|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
19424900|NCT01641692|41671715|FG000|Treatment Period 1|Lost to Follow-up|0|||
19424901|NCT01641692|41671716|FG001|Treatment Period 1|Lost to Follow-up|0|||
19424902|NCT01641692|41671717|FG002|Treatment Period 1|Lost to Follow-up|1|||
19424903|NCT01641692|41671718|FG003|Treatment Period 1|Lost to Follow-up|0|||
19424904|NCT01641692|41671719|FG004|Treatment Period 1|Lost to Follow-up|0|||
19424905|NCT01641692|41671720|FG005|Treatment Period 1|Lost to Follow-up|0|||
19424906|NCT01641692|41671721|FG006|Treatment Period 1|Lost to Follow-up|0|||
19424907|NCT01641692|41671722|FG007|Treatment Period 1|Lost to Follow-up|0|||
19424908|NCT01641692|41671715|FG000|Treatment Period 1|Physician Decision|0|||
19424909|NCT01641692|41671716|FG001|Treatment Period 1|Physician Decision|0|||
19424910|NCT01641692|41671717|FG002|Treatment Period 1|Physician Decision|0|||
19424911|NCT01641692|41671718|FG003|Treatment Period 1|Physician Decision|0|||
19424912|NCT01641692|41671719|FG004|Treatment Period 1|Physician Decision|1|||
19424913|NCT01641692|41671720|FG005|Treatment Period 1|Physician Decision|0|||
19424914|NCT01641692|41671721|FG006|Treatment Period 1|Physician Decision|0|||
19424915|NCT01641692|41671722|FG007|Treatment Period 1|Physician Decision|0|||
19424916|NCT01641692|41671715|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19424917|NCT01641692|41671716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19424918|NCT01641692|41671717|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19424919|NCT01641692|41671718|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19424920|NCT01641692|41671719|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19424921|NCT01641692|41671720|FG005|Treatment Period 1|Withdrawal by Subject|2|||
19424922|NCT01641692|41671721|FG006|Treatment Period 1|Withdrawal by Subject|0|||
19424923|NCT01641692|41671722|FG007|Treatment Period 1|Withdrawal by Subject|1|||
19424924|NCT01641692|41671715|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
19424925|NCT01641692|41671716|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424926|NCT01641692|41671717|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424927|NCT01641692|41671718|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424928|NCT01641692|41671719|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424929|NCT01641692|41671720|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424930|NCT01641692|41671721|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424931|NCT01641692|41671722|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
19424932|NCT01641692|41671715|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424933|NCT01641692|41671716|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424934|NCT01641692|41671717|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424935|NCT01641692|41671718|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424936|NCT01641692|41671719|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424937|NCT01641692|41671720|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424938|NCT01641692|41671721|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
19424939|NCT01641692|41671722|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19424940|NCT01641692|41671715|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
19424941|NCT01641692|41671716|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424942|NCT01641692|41671717|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
19424943|NCT01641692|41671718|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
19424944|NCT01641692|41671719|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
19424945|NCT01641692|41671720|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424946|NCT01641692|41671721|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424947|NCT01641692|41671722|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
19424948|NCT01641692|41671715|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19424949|NCT01641692|41671716|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19424950|NCT01641692|41671717|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19424951|NCT01641692|41671718|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19424952|NCT01641692|41671719|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19424953|NCT01641692|41671720|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19424954|NCT01641692|41671721|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19424955|NCT01641692|41671722|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19424956|NCT01641692|41671715|FG000|Treatment Period 2|Lack of Efficacy|1|||
19424957|NCT01641692|41671716|FG001|Treatment Period 2|Lack of Efficacy|0|||
19424958|NCT01641692|41671717|FG002|Treatment Period 2|Lack of Efficacy|0|||
19424959|NCT01641692|41671718|FG003|Treatment Period 2|Lack of Efficacy|0|||
19424960|NCT01641692|41671719|FG004|Treatment Period 2|Lack of Efficacy|0|||
19424961|NCT01641692|41671720|FG005|Treatment Period 2|Lack of Efficacy|0|||
19424962|NCT01641692|41671721|FG006|Treatment Period 2|Lack of Efficacy|0|||
19424963|NCT01641692|41671722|FG007|Treatment Period 2|Lack of Efficacy|0|||
19424964|NCT01641692|41671715|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
19424965|NCT01641692|41671716|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424966|NCT01641692|41671717|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424967|NCT01641692|41671718|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424968|NCT01641692|41671719|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424969|NCT01641692|41671720|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424970|NCT01641692|41671721|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424971|NCT01641692|41671722|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
19424972|NCT01641692|41671715|FG000|Treatment Period 2|Lost to Follow-up|0|||
19424973|NCT01641692|41671716|FG001|Treatment Period 2|Lost to Follow-up|0|||
19424974|NCT01641692|41671717|FG002|Treatment Period 2|Lost to Follow-up|0|||
19424975|NCT01641692|41671718|FG003|Treatment Period 2|Lost to Follow-up|0|||
19424976|NCT01641692|41671719|FG004|Treatment Period 2|Lost to Follow-up|0|||
19424977|NCT01641692|41671720|FG005|Treatment Period 2|Lost to Follow-up|1|||
19424978|NCT01641692|41671721|FG006|Treatment Period 2|Lost to Follow-up|0|||
19424979|NCT01641692|41671722|FG007|Treatment Period 2|Lost to Follow-up|0|||
19424980|NCT01641692|41671715|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19424981|NCT01641692|41671716|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19424982|NCT01641692|41671717|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19424983|NCT01641692|41671718|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19424984|NCT01641692|41671719|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19424985|NCT01641692|41671720|FG005|Treatment Period 2|Withdrawal by Subject|1|||
19424986|NCT01641692|41671721|FG006|Treatment Period 2|Withdrawal by Subject|0|||
19424987|NCT01641692|41671722|FG007|Treatment Period 2|Withdrawal by Subject|1|||
19424988|NCT01641692|41671715|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424989|NCT01641692|41671716|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424990|NCT01641692|41671717|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424991|NCT01641692|41671718|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424992|NCT01641692|41671719|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
19424993|NCT01641692|41671720|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424994|NCT01641692|41671721|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
19424995|NCT01641692|41671722|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
19424996|NCT01641692|41671715|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19424997|NCT01641692|41671716|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19424998|NCT01641692|41671717|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
19424999|NCT01641692|41671718|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19425000|NCT01641692|41671719|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19425001|NCT01641692|41671720|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
19520833|NCT01389102|41933619|FG002|Overall Study|Withdrawal by Subject|9|||
19520834|NCT01389102|41933620|FG003|Overall Study|Withdrawal by Subject|2|||
19520835|NCT01389102|41933621|FG004|Overall Study|Withdrawal by Subject|3|||
19520836|NCT01389102|41933622|FG005|Overall Study|Withdrawal by Subject|3|||
19520837|NCT01389102|41933617|FG000|Overall Study|Subject Traveling Out of Country|0|||
19520838|NCT01389102|41933618|FG001|Overall Study|Subject Traveling Out of Country|0|||
19520839|NCT01389102|41933619|FG002|Overall Study|Subject Traveling Out of Country|0|||
19520840|NCT01389102|41933620|FG003|Overall Study|Subject Traveling Out of Country|1|||
19520841|NCT01389102|41933621|FG004|Overall Study|Subject Traveling Out of Country|0|||
19520842|NCT01389102|41933622|FG005|Overall Study|Subject Traveling Out of Country|0|||
19520843|NCT01389102|41933617|FG000|Overall Study|Subject Moved|2|||
19520844|NCT01389102|41933618|FG001|Overall Study|Subject Moved|0|||
19520845|NCT01389102|41933619|FG002|Overall Study|Subject Moved|1|||
19520846|NCT01389102|41933620|FG003|Overall Study|Subject Moved|0|||
19520847|NCT01389102|41933621|FG004|Overall Study|Subject Moved|0|||
19520848|NCT01389102|41933622|FG005|Overall Study|Subject Moved|0|||
19520849|NCT01389102|41933617|FG000|Overall Study|Unavailable due to husband's illness|0|||
19520850|NCT01389102|41933618|FG001|Overall Study|Unavailable due to husband's illness|1|||
19520851|NCT01389102|41933619|FG002|Overall Study|Unavailable due to husband's illness|0|||
19520852|NCT01389102|41933620|FG003|Overall Study|Unavailable due to husband's illness|0|||
19520853|NCT01389102|41933621|FG004|Overall Study|Unavailable due to husband's illness|0|||
19520854|NCT01389102|41933622|FG005|Overall Study|Unavailable due to husband's illness|0|||
19520855|NCT01389102|41933617|FG000|Overall Study|Investigator Judgement|0|||
19425002|NCT01641692|41671721|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19425003|NCT01641692|41671722|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
19425004|NCT01641692|41671715|FG000|Treatment Period 3|Adverse Event|0|||
19425005|NCT01641692|41671716|FG001|Treatment Period 3|Adverse Event|0|||
19425006|NCT01641692|41671717|FG002|Treatment Period 3|Adverse Event|0|||
19425007|NCT01641692|41671718|FG003|Treatment Period 3|Adverse Event|0|||
19425008|NCT01641692|41671719|FG004|Treatment Period 3|Adverse Event|0|||
19425009|NCT01641692|41671720|FG005|Treatment Period 3|Adverse Event|0|||
19425010|NCT01641692|41671721|FG006|Treatment Period 3|Adverse Event|1|||
19425011|NCT01641692|41671722|FG007|Treatment Period 3|Adverse Event|0|||
19425012|NCT01641692|41671715|FG000|Treatment Period 3|Protocol Violation|0|||
19425013|NCT01641692|41671716|FG001|Treatment Period 3|Protocol Violation|0|||
19425014|NCT01641692|41671717|FG002|Treatment Period 3|Protocol Violation|1|||
19425015|NCT01641692|41671718|FG003|Treatment Period 3|Protocol Violation|0|||
19425016|NCT01641692|41671719|FG004|Treatment Period 3|Protocol Violation|0|||
19425017|NCT01641692|41671720|FG005|Treatment Period 3|Protocol Violation|0|||
19425018|NCT01641692|41671721|FG006|Treatment Period 3|Protocol Violation|0|||
19425019|NCT01641692|41671722|FG007|Treatment Period 3|Protocol Violation|0|||
19425020|NCT01641692|41671715|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425021|NCT01641692|41671716|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425022|NCT01641692|41671717|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425023|NCT01641692|41671718|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425024|NCT01641692|41671719|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425025|NCT01641692|41671720|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425026|NCT01641692|41671721|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
19425027|NCT01641692|41671722|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
19425028|NCT01641692|41671715|FG000|Treatment Period 3|Lost to Follow-up|0|||
19425029|NCT01641692|41671716|FG001|Treatment Period 3|Lost to Follow-up|1|||
19425030|NCT01641692|41671717|FG002|Treatment Period 3|Lost to Follow-up|0|||
19425031|NCT01641692|41671718|FG003|Treatment Period 3|Lost to Follow-up|0|||
19425032|NCT01641692|41671719|FG004|Treatment Period 3|Lost to Follow-up|0|||
19425033|NCT01641692|41671720|FG005|Treatment Period 3|Lost to Follow-up|0|||
19425034|NCT01641692|41671721|FG006|Treatment Period 3|Lost to Follow-up|0|||
19425035|NCT01641692|41671722|FG007|Treatment Period 3|Lost to Follow-up|0|||
19425036|NCT01641692|41671715|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425037|NCT01641692|41671716|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425038|NCT01641692|41671717|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425039|NCT01641692|41671718|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425040|NCT01641692|41671719|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425041|NCT01641692|41671720|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
19425042|NCT01641692|41671721|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425043|NCT01641692|41671722|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
19425044|NCT01641692|41671715|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
19425045|NCT01641692|41671716|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
19425046|NCT01641692|41671717|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
19425047|NCT01641692|41671718|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
19425048|NCT01641692|41671719|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
19425049|NCT01641692|41671720|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
19425050|NCT01641692|41671721|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
19425051|NCT01641692|41671722|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
19425052|NCT01682512|41671744|FG000|Overall Study|Adverse Event|6|||
19425053|NCT01682512|41671745|FG001|Overall Study|Adverse Event|5|||
19425054|NCT01682512|41671746|FG002|Overall Study|Adverse Event|2|||
19425055|NCT01682512|41671744|FG000|Overall Study|Withdrawal by Subject|2|||
19425056|NCT01682512|41671745|FG001|Overall Study|Withdrawal by Subject|6|||
19425057|NCT01682512|41671746|FG002|Overall Study|Withdrawal by Subject|3|||
19425058|NCT01682512|41671744|FG000|Overall Study|Physician Decision|0|||
19425059|NCT01682512|41671745|FG001|Overall Study|Physician Decision|2|||
19425060|NCT01682512|41671746|FG002|Overall Study|Physician Decision|0|||
19425061|NCT01682512|41671744|FG000|Overall Study|Study terminated by sponsor|46|||
19425062|NCT01682512|41671745|FG001|Overall Study|Study terminated by sponsor|43|||
19425063|NCT01682512|41671746|FG002|Overall Study|Study terminated by sponsor|0|||
19425064|NCT01682512|41671744|FG000|Overall Study|Lost to Follow-up|3|||
19425065|NCT01682512|41671745|FG001|Overall Study|Lost to Follow-up|0|||
19425066|NCT01682512|41671746|FG002|Overall Study|Lost to Follow-up|2|||
19425067|NCT01682512|41671744|FG000|Overall Study|Protocol Violation|2|||
19425068|NCT01682512|41671745|FG001|Overall Study|Protocol Violation|3|||
19425069|NCT01682512|41671746|FG002|Overall Study|Protocol Violation|2|||
19425070|NCT01682512|41671744|FG000|Overall Study|Primary lack of efficacy|10|||
19425071|NCT01682512|41671745|FG001|Overall Study|Primary lack of efficacy|7|||
19425072|NCT01682512|41671746|FG002|Overall Study|Primary lack of efficacy|7|||
19425073|NCT01682512|41671744|FG000|Overall Study|Secondary lack of efficacy|1|||
19425074|NCT01682512|41671745|FG001|Overall Study|Secondary lack of efficacy|1|||
19425075|NCT01682512|41671746|FG002|Overall Study|Secondary lack of efficacy|0|||
19425076|NCT01682512|41671744|FG000|Overall Study|Other than stated above|2|||
19425077|NCT01682512|41671745|FG001|Overall Study|Other than stated above|4|||
19425078|NCT01682512|41671746|FG002|Overall Study|Other than stated above|2|||
19425079|NCT02256488|41671758|FG000|Overall Study|Lost to Follow-up|6|||
19425080|NCT02256488|41671759|FG001|Overall Study|Lost to Follow-up|6|||
19425081|NCT02256488|41671760|FG002|Overall Study|Lost to Follow-up|9|||
19425082|NCT02256488|41671761|FG003|Overall Study|Lost to Follow-up|3|||
19425083|NCT02256488|41671758|FG000|Overall Study|OTHER|1|||
19425084|NCT02256488|41671759|FG001|Overall Study|OTHER|0|||
19425085|NCT02256488|41671760|FG002|Overall Study|OTHER|1|||
19425086|NCT02256488|41671761|FG003|Overall Study|OTHER|1|||
19425087|NCT02256488|41671758|FG000|Overall Study|Withdrawal by Subject|1|||
19425088|NCT02256488|41671759|FG001|Overall Study|Withdrawal by Subject|0|||
19425089|NCT02256488|41671760|FG002|Overall Study|Withdrawal by Subject|0|||
19425090|NCT02256488|41671761|FG003|Overall Study|Withdrawal by Subject|2|||
19425091|NCT01715896|41671774|FG000|Overall Study|Lost to Follow-up|0|||
19425092|NCT01715896|41671775|FG001|Overall Study|Lost to Follow-up|2|||
19425093|NCT01715896|41671774|FG000|Overall Study|Withdrawal by Subject|1|||
19425094|NCT01715896|41671775|FG001|Overall Study|Withdrawal by Subject|4|||
19425095|NCT01715896|41671774|FG000|Overall Study|Other|2|||
19425096|NCT01715896|41671775|FG001|Overall Study|Other|5|||
19425097|NCT02255552|41671784|FG000|Overall Study|Participants enrolled into another study|0|||
19425098|NCT02255552|41671785|FG001|Overall Study|Participants enrolled into another study|11|||
19425099|NCT02255552|41671784|FG000|Overall Study|Withdrawal by Subject|1|||
19425100|NCT02255552|41671785|FG001|Overall Study|Withdrawal by Subject|4|||
19425101|NCT01714726|41671793|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
19425102|NCT01714726|41671794|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
19425103|NCT01714726|41671795|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
19425104|NCT01714726|41671796|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
19425105|NCT01714726|41671793|FG000|Double-Blinded Induction Period|Adverse Event|0|||
19425106|NCT01714726|41671794|FG001|Double-Blinded Induction Period|Adverse Event|1|||
19425107|NCT01714726|41671795|FG002|Double-Blinded Induction Period|Adverse Event|0|||
19425108|NCT01714726|41671796|FG003|Double-Blinded Induction Period|Adverse Event|0|||
19425109|NCT01714726|41671793|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
19425110|NCT01714726|41671794|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
19425111|NCT01714726|41671795|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
19425112|NCT01714726|41671796|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
19425113|NCT01714726|41671793|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
19425114|NCT01714726|41671794|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
19425115|NCT01714726|41671795|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
19425116|NCT01714726|41671796|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
19425117|NCT01714726|41671793|FG000|Open-Label Period|Other|0|||
19425118|NCT01714726|41671794|FG001|Open-Label Period|Other|0|||
19425119|NCT01714726|41671795|FG002|Open-Label Period|Other|1|||
19425120|NCT01714726|41671796|FG003|Open-Label Period|Other|3|||
19425121|NCT01714726|41671793|FG000|Open-Label Period|Adverse Event|0|||
19425122|NCT01714726|41671794|FG001|Open-Label Period|Adverse Event|0|||
19425123|NCT01714726|41671795|FG002|Open-Label Period|Adverse Event|1|||
19425124|NCT01714726|41671796|FG003|Open-Label Period|Adverse Event|0|||
19425125|NCT01714726|41671793|FG000|Open-Label Period|Withdrawal by Subject|0|||
19425126|NCT01714726|41671794|FG001|Open-Label Period|Withdrawal by Subject|0|||
19425127|NCT01714726|41671795|FG002|Open-Label Period|Withdrawal by Subject|9|||
19425128|NCT01714726|41671796|FG003|Open-Label Period|Withdrawal by Subject|19|||
19425129|NCT01714726|41671793|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
19425130|NCT01714726|41671794|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
19425131|NCT01714726|41671795|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
19425132|NCT01714726|41671796|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
19425133|NCT01714726|41671793|FG000|Open-Label Period|Lost to Follow-up|0|||
19425134|NCT01714726|41671794|FG001|Open-Label Period|Lost to Follow-up|0|||
19425135|NCT01714726|41671795|FG002|Open-Label Period|Lost to Follow-up|3|||
19425136|NCT01714726|41671796|FG003|Open-Label Period|Lost to Follow-up|4|||
19425137|NCT02255474|41671809|FG000|Overall Study|Lost to Follow-up|1|||
19425138|NCT02255474|41671810|FG001|Overall Study|Lost to Follow-up|1|||
19425139|NCT02255474|41671811|FG002|Overall Study|Lost to Follow-up|3|||
19425140|NCT02255474|41671809|FG000|Overall Study|Withdrawal by Subject|1|||
19425141|NCT02255474|41671810|FG001|Overall Study|Withdrawal by Subject|1|||
19425142|NCT02255474|41671811|FG002|Overall Study|Withdrawal by Subject|0|||
19425143|NCT02254772|41671820|FG000|Overall Study|Ineligible|1|||
19425144|NCT02254772|41671820|FG000|Overall Study|Withdrawal by Subject|1|||
19425145|NCT02254460|41671824|FG000|Overall Study|Adverse Event|1|||
19425146|NCT02254460|41671825|FG001|Overall Study|Adverse Event|0|||
19425147|NCT01682044|41671831|FG000|Overall Study|Death|1|||
19425148|NCT01682044|41671831|FG000|Overall Study|Progression|3|||
19425149|NCT01696942|41671837|FG000|Overall Study|Withdrawal by Subject|1|||
19425150|NCT01696942|41671838|FG001|Overall Study|Withdrawal by Subject|0|||
19425151|NCT01696942|41671837|FG000|Overall Study|Protocol Violation|1|||
19425152|NCT01696942|41671838|FG001|Overall Study|Protocol Violation|2|||
19425153|NCT01696942|41671837|FG000|Overall Study|screen failure|0|||
19425154|NCT01696942|41671838|FG001|Overall Study|screen failure|1|||
19425155|NCT01640366|41671844|FG000|Overall Study|Withdrawal by Subject|1|||
19425156|NCT01640366|41671844|FG000|Overall Study|Protocol Violation|16|||
19425157|NCT01640366|41671844|FG000|Overall Study|Lost to Follow-up|5|||
19425158|NCT01640288|41671852|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
19425159|NCT01640288|41671853|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
19425160|NCT01640288|41671852|FG000|Overall Study|Screen Failure|20|||
19425161|NCT01640288|41671853|FG001|Overall Study|Screen Failure|18|||
19425162|NCT01640288|41671852|FG000|Overall Study|Withdrawn by PI|5|||
19425163|NCT01640288|41671853|FG001|Overall Study|Withdrawn by PI|0|||
19425164|NCT01640288|41671852|FG000|Overall Study|Withdrawal by Subject|1|||
19425165|NCT01640288|41671853|FG001|Overall Study|Withdrawal by Subject|0|||
19425166|NCT01639040|41671862|FG000|Overall Study|Adverse Event|1|||
19425167|NCT01639040|41671863|FG001|Overall Study|Adverse Event|0|||
19425168|NCT01640054|41671872|FG000|Overall Study|Study-specific disc criteria|1|||
19425169|NCT01640054|41671872|FG000|Overall Study|Lack of Efficacy|3|||
19425170|NCT01640054|41671872|FG000|Overall Study|Adverse Event|2|||
19425171|NCT01600586|41671878|FG000|Overall Study|Physician Decision|3|||
19425172|NCT01600586|41671879|FG001|Overall Study|Physician Decision|3|||
19425173|NCT01639742|41671892|FG000|Overall Study|Study Ongoing|17|||
19425174|NCT01639742|41671892|FG000|Overall Study|Lost to Follow-up|1|||
19425175|NCT02164513|41671899|FG000|Overall Study|Adverse Event|162|||
19425176|NCT02164513|41671900|FG001|Overall Study|Adverse Event|180|||
19425177|NCT02164513|41671901|FG002|Overall Study|Adverse Event|111|||
19425178|NCT02164513|41671899|FG000|Overall Study|Other: Study Closed or terminated|5|||
19425179|NCT02164513|41671900|FG001|Overall Study|Other: Study Closed or terminated|2|||
19425180|NCT02164513|41671901|FG002|Overall Study|Other: Study Closed or terminated|4|||
19425181|NCT02164513|41671899|FG000|Overall Study|Lost to Follow-up|30|||
19425182|NCT02164513|41671900|FG001|Overall Study|Lost to Follow-up|36|||
19425183|NCT02164513|41671901|FG002|Overall Study|Lost to Follow-up|22|||
19425184|NCT02164513|41671899|FG000|Overall Study|Physician Decision|47|||
19425185|NCT02164513|41671900|FG001|Overall Study|Physician Decision|57|||
19425186|NCT02164513|41671901|FG002|Overall Study|Physician Decision|28|||
19425187|NCT02164513|41671899|FG000|Overall Study|Withdrawal by Subject|192|||
19425188|NCT02164513|41671900|FG001|Overall Study|Withdrawal by Subject|261|||
19425189|NCT02164513|41671901|FG002|Overall Study|Withdrawal by Subject|130|||
19425190|NCT02164513|41671899|FG000|Overall Study|Other: Reason not provided by site|1|||
19425191|NCT02164513|41671900|FG001|Overall Study|Other: Reason not provided by site|0|||
19425192|NCT02164513|41671901|FG002|Overall Study|Other: Reason not provided by site|0|||
19425193|NCT02218489|41671912|FG000|Overall Study|Withdrawal by Subject|4|||
19425194|NCT02218489|41671913|FG001|Overall Study|Withdrawal by Subject|3|||
19425195|NCT02218489|41671912|FG000|Overall Study|Lost to Follow-up|1|||
19425196|NCT02218489|41671913|FG001|Overall Study|Lost to Follow-up|0|||
19425197|NCT02192905|41671920|FG000|Overall Study|Lost to Follow-up|1|||
19425198|NCT01713946|41671928|FG000|Overall Study|Death|0|||
19425199|NCT01713946|41671929|FG001|Overall Study|Death|2|||
19425200|NCT01713946|41671930|FG002|Overall Study|Death|2|||
19425201|NCT01713946|41671928|FG000|Overall Study|Adverse Event|19|||
19425202|NCT01713946|41671929|FG001|Overall Study|Adverse Event|14|||
19425203|NCT01713946|41671930|FG002|Overall Study|Adverse Event|13|||
19425204|NCT01713946|41671928|FG000|Overall Study|Withdrawal by Subject|12|||
19425205|NCT01713946|41671929|FG001|Overall Study|Withdrawal by Subject|12|||
19425206|NCT01713946|41671930|FG002|Overall Study|Withdrawal by Subject|8|||
19425207|NCT01713946|41671928|FG000|Overall Study|Lack of Efficacy|8|||
19425208|NCT01713946|41671929|FG001|Overall Study|Lack of Efficacy|8|||
19425209|NCT01713946|41671930|FG002|Overall Study|Lack of Efficacy|14|||
19425210|NCT01713946|41671928|FG000|Overall Study|Protocol Violation|2|||
19425211|NCT01713946|41671929|FG001|Overall Study|Protocol Violation|4|||
19425212|NCT01713946|41671930|FG002|Overall Study|Protocol Violation|1|||
19425213|NCT01713946|41671928|FG000|Overall Study|Lost to Follow-up|0|||
19425214|NCT01713946|41671929|FG001|Overall Study|Lost to Follow-up|0|||
19425215|NCT01713946|41671930|FG002|Overall Study|Lost to Follow-up|1|||
19425216|NCT01713946|41671928|FG000|Overall Study|Administrative problems|1|||
19425217|NCT01713946|41671929|FG001|Overall Study|Administrative problems|0|||
19425218|NCT01713946|41671930|FG002|Overall Study|Administrative problems|0|||
19425219|NCT01713946|41671928|FG000|Overall Study|Did not continue in Ext|0|||
19425220|NCT01713946|41671929|FG001|Overall Study|Did not continue in Ext|3|||
19425221|NCT01713946|41671930|FG002|Overall Study|Did not continue in Ext|0|||
19425222|NCT01713946|41671928|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
19425223|NCT01713946|41671929|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
19425224|NCT01713946|41671930|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
19425225|NCT01713946|41671928|FG000|Overall Study|Patients never switched to everolimus|0|||
19425226|NCT01713946|41671929|FG001|Overall Study|Patients never switched to everolimus|0|||
19425227|NCT01713946|41671930|FG002|Overall Study|Patients never switched to everolimus|5|||
19425228|NCT02163499|41671956|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
19425229|NCT02163499|41671956|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
19425230|NCT02163499|41671956|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
19425231|NCT02163499|41671956|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
19425232|NCT02163499|41671956|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
19425233|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
19425234|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
19425235|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
19425236|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
19425237|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
19425238|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
19425239|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
19425240|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
19425241|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
19425242|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Death|8|||
19425243|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
19425244|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
19425245|NCT02163499|41671956|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
19425246|NCT02163187|41671966|FG000|Overall Study|Device removed|1|||
19425247|NCT02163187|41671967|FG001|Overall Study|Device removed|0|||
19425248|NCT02163187|41671966|FG000|Overall Study|Progressive disease|1|||
19425249|NCT02163187|41671967|FG001|Overall Study|Progressive disease|0|||
19425250|NCT02191579|41671975|FG000|Treatment 1|Multiple Reasons Specified|27|||
19425251|NCT02191579|41671976|FG001|Treatment 1|Multiple Reasons Specified|58|||
19425252|NCT02191579|41671975|FG000|Treatment 2|Multiple Reasons Specified|0|||
19425253|NCT02191579|41671976|FG001|Treatment 2|Multiple Reasons Specified|25|||
19425254|NCT01363700|41671985|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
19425255|NCT01363700|41671986|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
19425256|NCT01363700|41671987|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
19425257|NCT01363700|41671988|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
19425258|NCT01363700|41671989|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
19425259|NCT01637402|41672000|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
19425260|NCT01637402|41672001|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
19425261|NCT01637402|41672000|FG000|Standard Dose Regimen|Adverse Event|1|||
19425262|NCT01637402|41672001|FG001|Standard Dose Regimen|Adverse Event|0|||
19425263|NCT01637402|41672000|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
19425264|NCT01637402|41672001|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
19425265|NCT01637402|41672000|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
19425266|NCT01637402|41672001|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
19425267|NCT01637402|41672000|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
19425268|NCT01637402|41672001|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
19425269|NCT01637402|41672000|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
19425270|NCT01637402|41672001|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
19425271|NCT02217475|41672029|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
19425272|NCT02217475|41672030|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
19425273|NCT02217475|41672031|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
19425274|NCT02217475|41672029|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
19425275|NCT02217475|41672030|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
19425276|NCT02217475|41672031|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
19425277|NCT02217475|41672029|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
19425278|NCT02217475|41672030|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
19425279|NCT02217475|41672031|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
19425280|NCT02217475|41672029|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
19425281|NCT02217475|41672030|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
19425282|NCT02217475|41672031|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
19425283|NCT02217475|41672029|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
19425284|NCT02217475|41672030|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
19425285|NCT02217475|41672031|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
19425286|NCT02217475|41672029|FG000|Discontinued After Period 1|Adverse Event|1|||
19425287|NCT02217475|41672030|FG001|Discontinued After Period 1|Adverse Event|2|||
19425288|NCT02217475|41672031|FG002|Discontinued After Period 1|Adverse Event|0|||
19425289|NCT02217475|41672029|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
19425290|NCT02217475|41672030|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
19425291|NCT02217475|41672031|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
19425292|NCT02217475|41672029|FG000|Discontinued After Period 1|Physician Decision|0|||
19425293|NCT02217475|41672030|FG001|Discontinued After Period 1|Physician Decision|0|||
19425294|NCT02217475|41672031|FG002|Discontinued After Period 1|Physician Decision|1|||
19425295|NCT02217475|41672029|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
19425296|NCT02217475|41672030|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
19425297|NCT02217475|41672031|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
19425298|NCT02217475|41672029|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
19425299|NCT02217475|41672030|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
19425300|NCT02217475|41672031|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
19425301|NCT02217475|41672029|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
19425302|NCT02217475|41672030|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
19425303|NCT02217475|41672031|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
19425304|NCT02217475|41672029|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
19425305|NCT02217475|41672030|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
19425306|NCT02217475|41672031|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
19425307|NCT02217475|41672029|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
19425308|NCT02217475|41672030|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
19425309|NCT02217475|41672031|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
19425310|NCT02191267|41672051|FG000|Overall Study|Withdrawal by Subject|1|||
19425311|NCT02191267|41672052|FG001|Overall Study|Withdrawal by Subject|0|||
19425312|NCT02191267|41672053|FG002|Overall Study|Withdrawal by Subject|0|||
19425313|NCT02189941|41672061|FG000|Overall Study|Non-compliance|0|||
19425314|NCT02189941|41672062|FG001|Overall Study|Non-compliance|0|||
19425315|NCT02189941|41672063|FG002|Overall Study|Non-compliance|1|||
19425316|NCT02216773|41672073|FG000|Overall Study|Disease progression|4|||
19425317|NCT02216773|41672074|FG001|Overall Study|Disease progression|2|||
19425318|NCT02216773|41672073|FG000|Overall Study|Insufficient FLRV|4|||
19425319|NCT02216773|41672074|FG001|Overall Study|Insufficient FLRV|0|||
19425320|NCT02216773|41672073|FG000|Overall Study|Abandoned|4|||
19425321|NCT02216773|41672074|FG001|Overall Study|Abandoned|3|||
19425322|NCT01601132|41672080|FG000|Overall Study|Patient withdrew consent|1|||
19425323|NCT01601132|41672080|FG000|Overall Study|Protocol deviation|1|||
19425324|NCT02162719|41672089|FG000|Overall Study|Death|41|||
19425325|NCT02162719|41672090|FG001|Overall Study|Death|46|||
19425326|NCT02162719|41672089|FG000|Overall Study|Lost to Follow-up|1|||
19425327|NCT02162719|41672090|FG001|Overall Study|Lost to Follow-up|3|||
19425328|NCT02162719|41672089|FG000|Overall Study|Disease Progression|2|||
19425329|NCT02162719|41672090|FG001|Overall Study|Disease Progression|1|||
19425330|NCT02162719|41672089|FG000|Overall Study|Withdrawal by Subject|8|||
19425331|NCT02162719|41672090|FG001|Overall Study|Withdrawal by Subject|2|||
19425332|NCT02162719|41672089|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
19425333|NCT02162719|41672090|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
19425334|NCT02161549|41672098|FG000|Overall Study|Physician Decision|6|||
19425335|NCT02161549|41672099|FG001|Overall Study|Physician Decision|2|||
19425336|NCT02189863|41672105|FG000|First 2 Weeks|Motion Sickness|4|||
19425337|NCT02189863|41672106|FG001|First 2 Weeks|Motion Sickness|2|||
19425338|NCT02189473|41672117|FG000|Overall Study|Death|22|||
19425339|NCT02189473|41672118|FG001|Overall Study|Death|23|||
19425340|NCT02189473|41672117|FG000|Overall Study|Lost to Follow-up|1|||
19425341|NCT02189473|41672118|FG001|Overall Study|Lost to Follow-up|2|||
19425342|NCT02188849|41672126|FG000|Overall Study|Lost to Follow-up|3|||
19425343|NCT02188849|41672127|FG001|Overall Study|Lost to Follow-up|8|||
19425344|NCT01636076|41672135|FG000|Overall Study|Terminated by sponsor|1|||
19425345|NCT01636076|41672136|FG001|Overall Study|Terminated by sponsor|1|||
19425346|NCT01636076|41672135|FG000|Overall Study|Lack of Efficacy|0|||
19425347|NCT01636076|41672136|FG001|Overall Study|Lack of Efficacy|1|||
19425348|NCT01636076|41672135|FG000|Overall Study|Lost to Follow-up|1|||
19425349|NCT01636076|41672136|FG001|Overall Study|Lost to Follow-up|0|||
19425350|NCT01636076|41672135|FG000|Overall Study|Physician Decision|1|||
19425351|NCT01636076|41672136|FG001|Overall Study|Physician Decision|1|||
19425352|NCT01636076|41672135|FG000|Overall Study|Non-compliance with study treatment|1|||
19425353|NCT01636076|41672136|FG001|Overall Study|Non-compliance with study treatment|1|||
19425354|NCT01636076|41672135|FG000|Overall Study|Adverse Event|6|||
19425355|NCT01636076|41672136|FG001|Overall Study|Adverse Event|11|||
19425356|NCT01636076|41672135|FG000|Overall Study|Withdrawal by Subject|7|||
19425357|NCT01636076|41672136|FG001|Overall Study|Withdrawal by Subject|10|||
19425358|NCT01635998|41672151|FG000|Overall Study|Death|1|||
19425359|NCT01635998|41672152|FG001|Overall Study|Death|1|||
19425360|NCT01635998|41672151|FG000|Overall Study|Lost to Follow-up|2|||
19425361|NCT01635998|41672152|FG001|Overall Study|Lost to Follow-up|1|||
19425362|NCT01635998|41672151|FG000|Overall Study|Withdrawal by Subject|1|||
19425363|NCT01635998|41672152|FG001|Overall Study|Withdrawal by Subject|5|||
19425364|NCT01635920|41672160|FG000|Overall Study|Adverse Event|1|||
19425365|NCT01635920|41672161|FG001|Overall Study|Adverse Event|0|||
19425366|NCT01635920|41672160|FG000|Overall Study|Lost to Follow-up|0|||
19425367|NCT01635920|41672161|FG001|Overall Study|Lost to Follow-up|1|||
19425368|NCT01635920|41672160|FG000|Overall Study|Subject decision|2|||
19425369|NCT01635920|41672161|FG001|Overall Study|Subject decision|0|||
19425370|NCT02160145|41672178|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
19425371|NCT02160145|41672179|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
19425372|NCT02160145|41672180|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
19425373|NCT02160145|41672178|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
19425374|NCT02160145|41672179|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
19425375|NCT02160145|41672180|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
19425376|NCT02160145|41672178|FG000|Randomized Double-blind Period|Subject decision|0|||
19425377|NCT02160145|41672179|FG001|Randomized Double-blind Period|Subject decision|21|||
19425378|NCT02160145|41672180|FG002|Randomized Double-blind Period|Subject decision|20|||
19425379|NCT02160145|41672178|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
19425380|NCT02160145|41672179|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
19425381|NCT02160145|41672180|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
19425382|NCT02160145|41672178|FG000|Randomized Double-blind Period|Physician Decision|0|||
19425383|NCT02160145|41672179|FG001|Randomized Double-blind Period|Physician Decision|7|||
19425384|NCT02160145|41672180|FG002|Randomized Double-blind Period|Physician Decision|5|||
19425385|NCT01696396|41672191|FG000|Overall Study|Withdrawal by Subject|19|||
19425386|NCT01696396|41672192|FG001|Overall Study|Withdrawal by Subject|5|||
19425387|NCT01696396|41672193|FG002|Overall Study|Withdrawal by Subject|19|||
19425388|NCT01696396|41672194|FG003|Overall Study|Withdrawal by Subject|11|||
19425389|NCT01696396|41672191|FG000|Overall Study|Decision by Sponsor|3|||
19425390|NCT01696396|41672192|FG001|Overall Study|Decision by Sponsor|1|||
19425391|NCT01696396|41672193|FG002|Overall Study|Decision by Sponsor|2|||
19425392|NCT01696396|41672194|FG003|Overall Study|Decision by Sponsor|2|||
19425393|NCT01696396|41672191|FG000|Overall Study|Lost to Follow-up|9|||
19425394|NCT01696396|41672192|FG001|Overall Study|Lost to Follow-up|1|||
19425395|NCT01696396|41672193|FG002|Overall Study|Lost to Follow-up|4|||
19425396|NCT01696396|41672194|FG003|Overall Study|Lost to Follow-up|1|||
19425397|NCT01696396|41672191|FG000|Overall Study|Death|0|||
19425398|NCT01696396|41672192|FG001|Overall Study|Death|0|||
19425399|NCT01696396|41672193|FG002|Overall Study|Death|1|||
19425400|NCT01696396|41672194|FG003|Overall Study|Death|0|||
19425401|NCT02216071|41672210|FG000|Overall Study|Withdrawal by Subject|7|||
19425402|NCT02216071|41672211|FG001|Overall Study|Withdrawal by Subject|2|||
19425403|NCT02216071|41672210|FG000|Overall Study|Lost to Follow-up|3|||
19425404|NCT02216071|41672211|FG001|Overall Study|Lost to Follow-up|3|||
19425405|NCT02216071|41672210|FG000|Overall Study|Protocol Violation|3|||
19425406|NCT02216071|41672211|FG001|Overall Study|Protocol Violation|5|||
19425407|NCT02216071|41672210|FG000|Overall Study|Other|2|||
19425408|NCT02216071|41672211|FG001|Overall Study|Other|2|||
19425409|NCT01681576|41672219|FG000|Period 1|Adverse Event|1|||
19425410|NCT01681576|41672220|FG001|Period 1|Adverse Event|0|||
19425411|NCT01681576|41672219|FG000|Period 1|Protocol Deviation|1|||
19425412|NCT01681576|41672220|FG001|Period 1|Protocol Deviation|0|||
19425413|NCT01681576|41672219|FG000|Period 2|subject/guardian decision|3|||
19425414|NCT01681576|41672220|FG001|Period 2|subject/guardian decision|1|||
19425415|NCT01681576|41672219|FG000|Period 2|Non-compliance with study treatment|1|||
19425416|NCT01681576|41672220|FG001|Period 2|Non-compliance with study treatment|0|||
19425417|NCT02188459|41672230|FG000|Overall Study|Lost to Follow-up|3|||
19425418|NCT02188459|41672231|FG001|Overall Study|Lost to Follow-up|4|||
19425419|NCT02188459|41672230|FG000|Overall Study|Early Termination|0|||
19425420|NCT02188459|41672231|FG001|Overall Study|Early Termination|3|||
19425421|NCT02214121|41672253|FG000|Part A|Patient decision|2|||
19425422|NCT02214121|41672254|FG001|Part A|Patient decision|0|||
19425423|NCT02214121|41672255|FG002|Part A|Patient decision|0|||
19425424|NCT02214121|41672253|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
19425425|NCT02214121|41672254|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
19425426|NCT02214121|41672255|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
19425427|NCT02214121|41672253|FG000|Part A|Other|1|||
19425428|NCT02214121|41672254|FG001|Part A|Other|0|||
19425429|NCT02214121|41672255|FG002|Part A|Other|0|||
19425430|NCT02214121|41672253|FG000|Part B|Patient decision|0|||
19425431|NCT02214121|41672254|FG001|Part B|Patient decision|1|||
19425432|NCT02214121|41672255|FG002|Part B|Patient decision|0|||
19425433|NCT02214121|41672253|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
19425434|NCT02214121|41672254|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
19425435|NCT02214121|41672255|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
19425436|NCT02214121|41672253|FG000|Part B|Lost to Follow-up|0|||
19425437|NCT02214121|41672254|FG001|Part B|Lost to Follow-up|0|||
19425438|NCT02214121|41672255|FG002|Part B|Lost to Follow-up|1|||
19425439|NCT01681186|41672283|FG000|Washout Period From Second Intervention|Adverse Event|0|||
19425440|NCT01681186|41672284|FG001|Washout Period From Second Intervention|Adverse Event|0|||
19425441|NCT01681186|41672285|FG002|Washout Period From Second Intervention|Adverse Event|0|||
19425442|NCT01681186|41672286|FG003|Washout Period From Second Intervention|Adverse Event|0|||
19425443|NCT01681186|41672287|FG004|Washout Period From Second Intervention|Adverse Event|0|||
19425444|NCT01681186|41672288|FG005|Washout Period From Second Intervention|Adverse Event|0|||
19711155|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
19425445|NCT01681186|41672289|FG006|Washout Period From Second Intervention|Adverse Event|1|||
19711156|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
19425446|NCT01681186|41672290|FG007|Washout Period From Second Intervention|Adverse Event|0|||
19425447|NCT01681186|41672283|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
19425448|NCT01681186|41672284|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
19425449|NCT01681186|41672285|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
19425450|NCT01681186|41672286|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
19425451|NCT01681186|41672287|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
19425452|NCT01681186|41672288|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
19425453|NCT01681186|41672289|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
19425454|NCT01681186|41672290|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
19425455|NCT01681186|41672283|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425456|NCT01681186|41672284|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425457|NCT01681186|41672285|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425458|NCT01681186|41672286|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425459|NCT01681186|41672287|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425460|NCT01681186|41672288|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425461|NCT01681186|41672289|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
19425462|NCT01681186|41672290|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
19425463|NCT01681186|41672283|FG000|Fourth Intervention|Protocol Violation|0|||
19425464|NCT01681186|41672284|FG001|Fourth Intervention|Protocol Violation|0|||
19425465|NCT01681186|41672285|FG002|Fourth Intervention|Protocol Violation|0|||
19425466|NCT01681186|41672286|FG003|Fourth Intervention|Protocol Violation|0|||
19425467|NCT01681186|41672287|FG004|Fourth Intervention|Protocol Violation|0|||
19425468|NCT01681186|41672288|FG005|Fourth Intervention|Protocol Violation|0|||
19425469|NCT01681186|41672289|FG006|Fourth Intervention|Protocol Violation|0|||
19425470|NCT01681186|41672290|FG007|Fourth Intervention|Protocol Violation|1|||
19425471|NCT03597464|41672322|FG000|Overall Study|Withdrawal by Subject|4|||
19425472|NCT03597464|41672323|FG001|Overall Study|Withdrawal by Subject|5|||
19425473|NCT03597464|41672322|FG000|Overall Study|Lost to Follow-up|3|||
19425474|NCT03597464|41672323|FG001|Overall Study|Lost to Follow-up|1|||
19425475|NCT03597464|41672322|FG000|Overall Study|Pregnancy|3|||
19425476|NCT03597464|41672323|FG001|Overall Study|Pregnancy|1|||
19425477|NCT03597464|41672322|FG000|Overall Study|Lack of Efficacy|2|||
19425478|NCT03597464|41672323|FG001|Overall Study|Lack of Efficacy|0|||
19425479|NCT03597464|41672322|FG000|Overall Study|Physician Decision|2|||
19425480|NCT03597464|41672323|FG001|Overall Study|Physician Decision|2|||
19425481|NCT03597464|41672322|FG000|Overall Study|Protocol Violation|1|||
19425482|NCT03597464|41672323|FG001|Overall Study|Protocol Violation|1|||
19425483|NCT03597464|41672322|FG000|Overall Study|Adverse Event|0|||
19425484|NCT03597464|41672323|FG001|Overall Study|Adverse Event|2|||
19425485|NCT03597464|41672322|FG000|Overall Study|Death|0|||
19425486|NCT03597464|41672323|FG001|Overall Study|Death|3|||
19425487|NCT01695772|41672331|FG000|Overall Study|Withdrawal by Subject|18|||
19425488|NCT01695772|41672331|FG000|Overall Study|Progressive Disease|8|||
19425489|NCT01695772|41672331|FG000|Overall Study|Investigator Decision|5|||
19425490|NCT01695772|41672331|FG000|Overall Study|Lost to Follow-up|4|||
19425491|NCT01695772|41672331|FG000|Overall Study|Protocol Violation|2|||
19425492|NCT01695772|41672331|FG000|Overall Study|Unspecified Reason|1|||
19425493|NCT02159521|41672335|FG000|Overall Study|Enrolled but not treated|3|||
19425494|NCT02159521|41672335|FG000|Overall Study|Withdrawal by Subject|7|||
19425495|NCT02159521|41672335|FG000|Overall Study|Lost to Follow-up|6|||
19425496|NCT02159521|41672335|FG000|Overall Study|Death|1|||
19425497|NCT02159521|41672335|FG000|Overall Study|Other than specified|1|||
19425498|NCT01636934|41672341|FG000|Overall Study|Withdrawal by Subject|3|||
19425499|NCT01636934|41672342|FG001|Overall Study|Withdrawal by Subject|2|||
19425500|NCT01636934|41672341|FG000|Overall Study|Chemo cancel|1|||
19425501|NCT01636934|41672342|FG001|Overall Study|Chemo cancel|0|||
19425502|NCT01636934|41672341|FG000|Overall Study|Too ill to continue|1|||
19425503|NCT01636934|41672342|FG001|Overall Study|Too ill to continue|0|||
19425504|NCT01636934|41672341|FG000|Overall Study|Never started study medication|1|||
19425505|NCT01636934|41672342|FG001|Overall Study|Never started study medication|1|||
19425506|NCT01712854|41672348|FG000|Overall Study|Physician Decision|1|||
19425507|NCT01693120|41672352|FG000|Enrollment|Lost to Follow-up|1|||
19425508|NCT01693120|41672352|FG000|Enrollment|Withdrawal by Subject|10|||
19425509|NCT01693120|41672352|FG000|Enrollment|Protocol Violation|46|||
19425510|NCT01693120|41672352|FG000|Enrollment|Physician Decision|3|||
19425511|NCT01693120|41672352|FG000|Enrollment|Adverse Event|1|||
19425512|NCT01693120|41672352|FG000|Enrollment|Study closed|8|||
19425513|NCT01693120|41672352|FG000|Enrollment|Other|1|||
19425514|NCT01693120|41672352|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
19425515|NCT01693120|41672352|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
19711157|NCT00116805|42154353|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
19425516|NCT01693120|41672352|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
19425517|NCT01693120|41672352|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
19425518|NCT01693120|41672352|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
19628254|NCT00830804|42077687|FG000|Overall Study|Unable to get to clinic|7|||
19628255|NCT00830804|42077687|FG000|Overall Study|Consent withdrawn|2|||
19425519|NCT02159365|41672356|FG000|Overall Study|Disease Progression|23|||
19425520|NCT02159365|41672356|FG000|Overall Study|Other reasons|11|||
19711158|NCT00116805|42154354|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
19711159|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
19711160|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
19711161|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
19711162|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
19425521|NCT02159365|41672356|FG000|Overall Study|Administrative reason by Sponsor|9|||
19425522|NCT02159365|41672356|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
19425523|NCT02159365|41672356|FG000|Overall Study|Study drug toxicity|7|||
19425524|NCT02159365|41672356|FG000|Overall Study|Maximum clinical benefit|3|||
19425525|NCT02159365|41672356|FG000|Overall Study|Subject request to discontinue treatment|3|||
19425526|NCT02159365|41672356|FG000|Overall Study|Subject withdrew consent|3|||
19425527|NCT02159365|41672356|FG000|Overall Study|Death|1|||
19425528|NCT02159365|41672356|FG000|Overall Study|Lost to Follow-up|1|||
19425529|NCT01712074|41672363|FG000|Placebo Run-in Period|Adverse Event|2|||
19425530|NCT01712074|41672364|FG001|Placebo Run-in Period|Adverse Event|0|||
19425531|NCT01712074|41672365|FG002|Placebo Run-in Period|Adverse Event|0|||
19425532|NCT01712074|41672363|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
19425533|NCT01712074|41672364|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
19425534|NCT01712074|41672365|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
19425535|NCT01712074|41672363|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
19425536|NCT01712074|41672364|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
19425537|NCT01712074|41672365|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
19425538|NCT01712074|41672363|FG000|Placebo Run-in Period|Other|1|||
19425539|NCT01712074|41672364|FG001|Placebo Run-in Period|Other|0|||
19425540|NCT01712074|41672365|FG002|Placebo Run-in Period|Other|0|||
19425541|NCT01712074|41672363|FG000|Placebo Run-in Period|No longer willing to participate|1|||
19425542|NCT01712074|41672364|FG001|Placebo Run-in Period|No longer willing to participate|0|||
19425543|NCT01712074|41672365|FG002|Placebo Run-in Period|No longer willing to participate|0|||
19425544|NCT01712074|41672363|FG000|Double Blind Period|Adverse Event|0|||
19425545|NCT01712074|41672364|FG001|Double Blind Period|Adverse Event|2|||
19425546|NCT01712074|41672365|FG002|Double Blind Period|Adverse Event|1|||
19425547|NCT01712074|41672363|FG000|Double Blind Period|No longer willing to participate|0|||
19425548|NCT01712074|41672364|FG001|Double Blind Period|No longer willing to participate|2|||
19425549|NCT01712074|41672365|FG002|Double Blind Period|No longer willing to participate|4|||
19425550|NCT01712074|41672363|FG000|Double Blind Period|Death|0|||
19425551|NCT01712074|41672364|FG001|Double Blind Period|Death|1|||
19425552|NCT01712074|41672365|FG002|Double Blind Period|Death|0|||
19425553|NCT01712074|41672363|FG000|Double Blind Period|Lost to Follow-up|0|||
19425554|NCT01712074|41672364|FG001|Double Blind Period|Lost to Follow-up|2|||
19425555|NCT01712074|41672365|FG002|Double Blind Period|Lost to Follow-up|1|||
19425556|NCT01712074|41672363|FG000|Double Blind Period|Other|0|||
19425557|NCT01712074|41672364|FG001|Double Blind Period|Other|4|||
19425558|NCT01712074|41672365|FG002|Double Blind Period|Other|1|||
19425559|NCT01712074|41672363|FG000|Double Blind Period|Protocol Violation|0|||
19425560|NCT01712074|41672364|FG001|Double Blind Period|Protocol Violation|0|||
19425561|NCT01712074|41672365|FG002|Double Blind Period|Protocol Violation|1|||
19425562|NCT01712074|41672363|FG000|Double Blind Period|No longer met eligibility criteria|0|||
19425563|NCT01712074|41672364|FG001|Double Blind Period|No longer met eligibility criteria|3|||
19425564|NCT01712074|41672365|FG002|Double Blind Period|No longer met eligibility criteria|0|||
19425565|NCT01711216|41672380|FG000|Overall Study|Adverse Event|4|||
19425566|NCT01711216|41672380|FG000|Overall Study|Pregnancy|56|||
19425567|NCT01711216|41672380|FG000|Overall Study|Withdrawal by Subject|6|||
19425568|NCT01711216|41672380|FG000|Overall Study|Lost to Follow-up|46|||
19425569|NCT01711216|41672380|FG000|Overall Study|variety of other minor reasons|83|||
19425570|NCT01711216|41672380|FG000|Overall Study|no reason specified|22|||
19520856|NCT01389102|41933618|FG001|Overall Study|Investigator Judgement|1|||
19520857|NCT01389102|41933619|FG002|Overall Study|Investigator Judgement|0|||
19520858|NCT01389102|41933620|FG003|Overall Study|Investigator Judgement|0|||
19520859|NCT01389102|41933621|FG004|Overall Study|Investigator Judgement|0|||
19520860|NCT01389102|41933622|FG005|Overall Study|Investigator Judgement|0|||
19520861|NCT01402284|41933642|FG000|Overall Study|Withdrawal consent|2|||
19520862|NCT01402284|41933642|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
19628256|NCT00830804|42077687|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
19628257|NCT00789477|42077697|FG000|Overall Study|Withdrawal by Subject|2|||
19711163|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
19628258|NCT00789477|42077698|FG001|Overall Study|Withdrawal by Subject|1|||
19628259|NCT00789477|42077699|FG002|Overall Study|Withdrawal by Subject|3|||
19520863|NCT01402284|41933642|FG000|Overall Study|Physician Decision|1|||
19520864|NCT01402284|41933642|FG000|Overall Study|Disease progression on study|10|||
19520865|NCT01425528|41933648|FG000|Overall Study|Withdrawal by Subject|1|||
19425571|NCT01692730|41672390|FG000|Overall Study|Lost to Follow-up|225|||
19425572|NCT01692730|41672391|FG001|Overall Study|Lost to Follow-up|227|||
19425573|NCT01691794|41672400|FG000|Overall Study|Poor/Non-Compliance|1|||
19425574|NCT01691794|41672401|FG001|Overall Study|Poor/Non-Compliance|4|||
19425575|NCT01691794|41672402|FG002|Overall Study|Poor/Non-Compliance|1|||
19425576|NCT01691794|41672400|FG000|Overall Study|Death|0|||
19425577|NCT01691794|41672401|FG001|Overall Study|Death|0|||
19425578|NCT01691794|41672402|FG002|Overall Study|Death|1|||
19425579|NCT01691794|41672400|FG000|Overall Study|Lack of Efficacy|0|||
19425580|NCT01691794|41672401|FG001|Overall Study|Lack of Efficacy|7|||
19425581|NCT01691794|41672402|FG002|Overall Study|Lack of Efficacy|1|||
19425582|NCT01691794|41672400|FG000|Overall Study|Participant request to discontinue|0|||
19425583|NCT01691794|41672401|FG001|Overall Study|Participant request to discontinue|1|||
19425584|NCT01691794|41672402|FG002|Overall Study|Participant request to discontinue|0|||
19425585|NCT01691794|41672400|FG000|Overall Study|Adverse Event|0|||
19425586|NCT01691794|41672401|FG001|Overall Study|Adverse Event|1|||
19425587|NCT01691794|41672402|FG002|Overall Study|Adverse Event|1|||
19425588|NCT01691794|41672400|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
19425589|NCT01691794|41672401|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
19425590|NCT01691794|41672402|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
19425591|NCT01691794|41672400|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
19425592|NCT01691794|41672401|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
19425593|NCT01691794|41672402|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
19425594|NCT01710514|41672412|FG000|Overall Study|Adverse Event|6|||
19425595|NCT01710514|41672413|FG001|Overall Study|Adverse Event|7|||
19425596|NCT01710514|41672412|FG000|Overall Study|Withdrawal by Subject|1|||
19425597|NCT01710514|41672413|FG001|Overall Study|Withdrawal by Subject|0|||
19425598|NCT01592344|41672424|FG000|Overall Study|Adverse Event|1|||
19425599|NCT01592344|41672425|FG001|Overall Study|Adverse Event|1|||
19425600|NCT01592344|41672424|FG000|Overall Study|Lack of Efficacy|1|||
19425601|NCT01592344|41672425|FG001|Overall Study|Lack of Efficacy|0|||
19425602|NCT01592344|41672424|FG000|Overall Study|not available at primary outcome visit|2|||
19425603|NCT01592344|41672425|FG001|Overall Study|not available at primary outcome visit|4|||
19425604|NCT01636778|41672431|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
19425605|NCT01636778|41672432|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
19425606|NCT01636778|41672433|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
19425607|NCT01636778|41672431|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
19425608|NCT01636778|41672432|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
19425609|NCT01636778|41672433|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
19425610|NCT01636778|41672431|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
19425611|NCT01636778|41672432|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
19425612|NCT01636778|41672433|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
19425613|NCT01636778|41672431|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
19425614|NCT01636778|41672432|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
19425615|NCT01636778|41672433|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
19425616|NCT01636778|41672431|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
19425617|NCT01636778|41672432|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
19425618|NCT01636778|41672433|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
19425619|NCT01636778|41672431|FG000|Follow-up Period After Part 2|Other|0|||
19425620|NCT01636778|41672432|FG001|Follow-up Period After Part 2|Other|0|||
19425621|NCT01636778|41672433|FG002|Follow-up Period After Part 2|Other|1|||
19425622|NCT01636778|41672431|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
19425623|NCT01636778|41672432|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
19425624|NCT01636778|41672433|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
19425625|NCT01636778|41672431|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
19425626|NCT01636778|41672432|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
19425627|NCT01636778|41672433|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
19425628|NCT02159053|41672444|FG000|Overall Study|Death|2|||
19425629|NCT02159053|41672445|FG001|Overall Study|Death|0|||
19425630|NCT02159053|41672446|FG002|Overall Study|Death|1|||
19425631|NCT02159053|41672444|FG000|Overall Study|Physician Decision|0|||
19425632|NCT02159053|41672445|FG001|Overall Study|Physician Decision|1|||
19375223|NCT02522780|41616999|FG001|Overall Study|Adverse event, non-fatal|16|||
19375224|NCT02285062|41617019|FG000|Overall Study|Withdrawal by Subject|12|||
19375225|NCT02285062|41617020|FG001|Overall Study|Withdrawal by Subject|17|||
19375226|NCT02285062|41617019|FG000|Overall Study|Death|58|||
19375227|NCT02285062|41617020|FG001|Overall Study|Death|62|||
19375228|NCT02285062|41617019|FG000|Overall Study|Lost to Follow-up|8|||
19375229|NCT02285062|41617020|FG001|Overall Study|Lost to Follow-up|5|||
19375230|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
19375231|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
19375232|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
19425633|NCT02159053|41672446|FG002|Overall Study|Physician Decision|1|||
19425634|NCT02159053|41672444|FG000|Overall Study|Lack of Efficacy|3|||
19425635|NCT02159053|41672445|FG001|Overall Study|Lack of Efficacy|4|||
19425636|NCT02159053|41672446|FG002|Overall Study|Lack of Efficacy|7|||
19425637|NCT02159053|41672444|FG000|Overall Study|Adverse Event|7|||
19425638|NCT02159053|41672445|FG001|Overall Study|Adverse Event|6|||
19425639|NCT02159053|41672446|FG002|Overall Study|Adverse Event|5|||
19425640|NCT02159053|41672444|FG000|Overall Study|Participants/guardian decision|8|||
19425641|NCT02159053|41672445|FG001|Overall Study|Participants/guardian decision|10|||
19425642|NCT02159053|41672446|FG002|Overall Study|Participants/guardian decision|6|||
19425643|NCT02158975|41672456|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
19425644|NCT02158663|41672463|FG000|Overall Study|Withdrawal by Subject|5|||
19425645|NCT02158663|41672464|FG001|Overall Study|Withdrawal by Subject|4|||
19425646|NCT02158039|41672472|FG000|Overall Study|Withdrawal by Subject|1|||
19520866|NCT01425528|41933649|FG001|Overall Study|Withdrawal by Subject|1|||
19520867|NCT01388790|41933655|FG000|Overall Study|Ongoing at data cut-off date|8|||
19520868|NCT01388478|41933659|FG000|Overall Study|Adverse Event|4|||
19520869|NCT01388478|41933659|FG000|Overall Study|Withdrawal by Subject|1|||
19520870|NCT01424670|41933665|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
19520871|NCT01424670|41933666|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
19520872|NCT01424670|41933665|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
19520873|NCT01424670|41933666|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
19520874|NCT01424670|41933665|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
19520875|NCT01424670|41933666|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
19520876|NCT01424670|41933665|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
19520877|NCT01424670|41933666|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
19520878|NCT01424670|41933665|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
19425647|NCT02158039|41672472|FG000|Overall Study|Screen Failure|9|||
19425648|NCT01635764|41672490|FG000|Overall Study|Adverse Event|46|||
19520879|NCT01424670|41933666|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
19520880|NCT01424670|41933665|FG000|Continuation Period|Adverse Event|13|||
19520881|NCT01424670|41933666|FG001|Continuation Period|Adverse Event|5|||
19520882|NCT01424670|41933665|FG000|Continuation Period|Lost to Follow-up|2|||
19520883|NCT01424670|41933666|FG001|Continuation Period|Lost to Follow-up|0|||
19520884|NCT01424670|41933665|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
19520885|NCT01424670|41933666|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
19425649|NCT01635764|41672490|FG000|Overall Study|Lack of Efficacy|76|||
19425650|NCT01635764|41672490|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
19425651|NCT01635764|41672490|FG000|Overall Study|Protocol Deviation|1|||
19520886|NCT01424670|41933665|FG000|Continuation Period|Physician Decision|5|||
19520887|NCT01424670|41933666|FG001|Continuation Period|Physician Decision|4|||
19520888|NCT01424670|41933665|FG000|Continuation Period|Withdrawal by Subject|13|||
19520889|NCT01424670|41933666|FG001|Continuation Period|Withdrawal by Subject|4|||
19520890|NCT01424514|41933674|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
19520891|NCT01424514|41933675|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
19520892|NCT01424514|41933674|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
19520893|NCT01424514|41933675|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
19520894|NCT01423812|41933688|FG000|Overall Study|Lost to Follow-up|2|||
19520895|NCT01423812|41933689|FG001|Overall Study|Lost to Follow-up|2|||
19520896|NCT01423812|41933688|FG000|Overall Study|Withdrawal by Subject|1|||
19520897|NCT01423812|41933689|FG001|Overall Study|Withdrawal by Subject|2|||
19520898|NCT01400958|41933699|FG000|Overall Study|Physician Decision|0|||
19520899|NCT01400958|41933700|FG001|Overall Study|Physician Decision|1|||
19520900|NCT01400958|41933699|FG000|Overall Study|Withdrawal by Subject|0|||
19520901|NCT01400958|41933700|FG001|Overall Study|Withdrawal by Subject|1|||
19520902|NCT01400958|41933699|FG000|Overall Study|Adverse Event|1|||
19520903|NCT01400958|41933700|FG001|Overall Study|Adverse Event|0|||
19520904|NCT01388166|41933706|FG000|Overall Study|Adverse Event|16|||
19520905|NCT01388166|41933706|FG000|Overall Study|Lost to Follow-up|30|||
19520906|NCT01388166|41933706|FG000|Overall Study|Others than specified above|13|||
19520907|NCT01400412|41933712|FG000|Overall Study|Lost to Follow-up|4|||
19520908|NCT01400412|41933713|FG001|Overall Study|Lost to Follow-up|7|||
19520909|NCT01400412|41933712|FG000|Overall Study|Withdrawal by Subject|3|||
19520910|NCT01400412|41933713|FG001|Overall Study|Withdrawal by Subject|4|||
19520911|NCT01400412|41933712|FG000|Overall Study|Unable to complete|3|||
19520912|NCT01400412|41933713|FG001|Overall Study|Unable to complete|3|||
19425652|NCT01635764|41672490|FG000|Overall Study|Withdrew Consent|67|||
19425653|NCT01635764|41672490|FG000|Overall Study|Lost to Follow-up|53|||
19520913|NCT01400412|41933712|FG000|Overall Study|Never started study treatment|0|||
19520914|NCT01400412|41933713|FG001|Overall Study|Never started study treatment|3|||
19520915|NCT01422876|41933731|FG000|Week 24|Lost to Follow-up|1|||
19520916|NCT01422876|41933732|FG001|Week 24|Lost to Follow-up|1|||
19520917|NCT01422876|41933733|FG002|Week 24|Lost to Follow-up|2|||
19520918|NCT01422876|41933734|FG003|Week 24|Lost to Follow-up|4|||
19425654|NCT01635764|41672490|FG000|Overall Study|Other|28|||
19425655|NCT03432260|41672506|FG000|Overall Study|Lost to Follow-up|1|||
19425656|NCT03432260|41672507|FG001|Overall Study|Lost to Follow-up|1|||
19425657|NCT03432260|41672508|FG002|Overall Study|Lost to Follow-up|0|||
19425658|NCT03432260|41672509|FG003|Overall Study|Lost to Follow-up|0|||
19425659|NCT03432260|41672510|FG004|Overall Study|Lost to Follow-up|1|||
19425660|NCT01634360|41672524|FG000|Overall Study|Adverse Event|10|||
19425661|NCT01634360|41672525|FG001|Overall Study|Adverse Event|34|||
19425662|NCT01634360|41672524|FG000|Overall Study|subject withdrew consent|13|||
19425663|NCT01634360|41672525|FG001|Overall Study|subject withdrew consent|23|||
19425664|NCT01634360|41672524|FG000|Overall Study|Protocol Violation|1|||
19425665|NCT01634360|41672525|FG001|Overall Study|Protocol Violation|1|||
19425666|NCT01634360|41672524|FG000|Overall Study|Lack of Efficacy|4|||
19425667|NCT01634360|41672525|FG001|Overall Study|Lack of Efficacy|14|||
19425668|NCT01634360|41672524|FG000|Overall Study|Other|3|||
19425669|NCT01634360|41672525|FG001|Overall Study|Other|20|||
19425670|NCT01634360|41672524|FG000|Overall Study|Study termination by sponsor|18|||
19425671|NCT01634360|41672525|FG001|Overall Study|Study termination by sponsor|44|||
19425672|NCT01635218|41672542|FG000|Overall Study|Lost to Follow-up|3|||
19425673|NCT01635218|41672543|FG001|Overall Study|Lost to Follow-up|7|||
19425674|NCT01635218|41672544|FG002|Overall Study|Lost to Follow-up|6|||
19425675|NCT02049866|41672552|FG000|Overall Study|Withdrawal by Subject|1|||
19425676|NCT04274894|41672556|FG000|Overall Study|Adverse Event|7|||
19425677|NCT04274894|41672556|FG000|Overall Study|Withdrew consent|5|||
19425678|NCT04274894|41672556|FG000|Overall Study|Lost to Follow-up|9|||
19425679|NCT04274894|41672556|FG000|Overall Study|COVID-19 infection|1|||
19425680|NCT04274894|41672556|FG000|Overall Study|Other, not specified|20|||
19425681|NCT02213263|41672562|FG000|Overall Study|Insufficient clinical response|4|||
19425682|NCT02213263|41672563|FG001|Overall Study|Insufficient clinical response|3|||
19425683|NCT02213263|41672562|FG000|Overall Study|Lost to Follow-up|0|||
19425684|NCT02213263|41672563|FG001|Overall Study|Lost to Follow-up|1|||
19425685|NCT02213263|41672562|FG000|Overall Study|No longer willing to participate|3|||
19425686|NCT02213263|41672563|FG001|Overall Study|No longer willing to participate|4|||
19425687|NCT02213263|41672562|FG000|Overall Study|Progressive disease|20|||
19425688|NCT02213263|41672563|FG001|Overall Study|Progressive disease|14|||
19425689|NCT02213263|41672562|FG000|Overall Study|Protocol Violation|0|||
19425690|NCT02213263|41672563|FG001|Overall Study|Protocol Violation|1|||
19425691|NCT02213263|41672562|FG000|Overall Study|Adverse Event|1|||
19425692|NCT02213263|41672563|FG001|Overall Study|Adverse Event|3|||
19425693|NCT02211313|41672571|FG000|Overall Study|Treatment Failure|5|||
19425694|NCT02211313|41672572|FG001|Overall Study|Treatment Failure|2|||
19425695|NCT02211313|41672571|FG000|Overall Study|No Follow up Questionnaires|1|||
19425696|NCT02211313|41672572|FG001|Overall Study|No Follow up Questionnaires|1|||
19425697|NCT02210689|41672581|FG000|Overall Study|Withdrawal by Subject|7|||
19425698|NCT02210689|41672582|FG001|Overall Study|Withdrawal by Subject|4|||
19425699|NCT02210689|41672583|FG002|Overall Study|Withdrawal by Subject|2|||
19425700|NCT02210689|41672581|FG000|Overall Study|Adverse Event|0|||
19425701|NCT02210689|41672582|FG001|Overall Study|Adverse Event|1|||
19425702|NCT02210689|41672583|FG002|Overall Study|Adverse Event|0|||
19425703|NCT02210689|41672581|FG000|Overall Study|Protocol Violation|1|||
19425704|NCT02210689|41672582|FG001|Overall Study|Protocol Violation|0|||
19425705|NCT02210689|41672583|FG002|Overall Study|Protocol Violation|0|||
19425706|NCT02210689|41672581|FG000|Overall Study|Lost to Follow-up|11|||
19425707|NCT02210689|41672582|FG001|Overall Study|Lost to Follow-up|9|||
19425708|NCT02210689|41672583|FG002|Overall Study|Lost to Follow-up|5|||
19425709|NCT02210689|41672581|FG000|Overall Study|Pregnancy|0|||
19425710|NCT02210689|41672582|FG001|Overall Study|Pregnancy|1|||
19425711|NCT02210689|41672583|FG002|Overall Study|Pregnancy|0|||
19425712|NCT02210689|41672581|FG000|Overall Study|Lack of Efficacy|0|||
19425713|NCT02210689|41672582|FG001|Overall Study|Lack of Efficacy|1|||
19425714|NCT02210689|41672583|FG002|Overall Study|Lack of Efficacy|5|||
19425715|NCT02210689|41672581|FG000|Overall Study|Prohibited medication|2|||
19425716|NCT02210689|41672582|FG001|Overall Study|Prohibited medication|8|||
19425717|NCT02210689|41672583|FG002|Overall Study|Prohibited medication|1|||
19425718|NCT02210689|41672581|FG000|Overall Study|Negative Nugent score at baseline|6|||
19425719|NCT02210689|41672582|FG001|Overall Study|Negative Nugent score at baseline|2|||
19425720|NCT02210689|41672583|FG002|Overall Study|Negative Nugent score at baseline|2|||
19425721|NCT02210689|41672581|FG000|Overall Study|Other|25|||
19425722|NCT02210689|41672582|FG001|Overall Study|Other|21|||
19425723|NCT02210689|41672583|FG002|Overall Study|Other|8|||
19425724|NCT02209597|41672591|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
19425725|NCT02209597|41672591|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
19425726|NCT02209597|41672591|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
19425727|NCT02209597|41672591|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
19425728|NCT02188303|41672620|FG000|Overall Study|Adverse Event|0|||
19425729|NCT02188303|41672621|FG001|Overall Study|Adverse Event|0|||
19425730|NCT02188303|41672622|FG002|Overall Study|Adverse Event|0|||
19425731|NCT02188303|41672623|FG003|Overall Study|Adverse Event|0|||
19425732|NCT02188303|41672624|FG004|Overall Study|Adverse Event|0|||
19425733|NCT02188303|41672625|FG005|Overall Study|Adverse Event|2|||
19425734|NCT02188303|41672626|FG006|Overall Study|Adverse Event|0|||
19425735|NCT02188303|41672627|FG007|Overall Study|Adverse Event|2|||
19425736|NCT02188303|41672620|FG000|Overall Study|Dose Termination Criteria Met|0|||
19425737|NCT02188303|41672621|FG001|Overall Study|Dose Termination Criteria Met|0|||
19425738|NCT02188303|41672622|FG002|Overall Study|Dose Termination Criteria Met|0|||
19425739|NCT02188303|41672623|FG003|Overall Study|Dose Termination Criteria Met|0|||
19425740|NCT02188303|41672624|FG004|Overall Study|Dose Termination Criteria Met|0|||
19425741|NCT02188303|41672625|FG005|Overall Study|Dose Termination Criteria Met|0|||
19425742|NCT02188303|41672626|FG006|Overall Study|Dose Termination Criteria Met|2|||
19425743|NCT02188303|41672627|FG007|Overall Study|Dose Termination Criteria Met|4|||
19425744|NCT04867382|41672663|FG000|Overall Study|Did not complete the survey|2|||
19425745|NCT04867382|41672664|FG001|Overall Study|Did not complete the survey|1|||
19425746|NCT02187055|41672673|FG000|Overall Study|Lack of Efficacy|10|||
19425747|NCT02187055|41672674|FG001|Overall Study|Lack of Efficacy|3|||
19425748|NCT02187055|41672675|FG002|Overall Study|Lack of Efficacy|7|||
19425749|NCT02187055|41672673|FG000|Overall Study|Lost to Follow-up|2|||
19425750|NCT02187055|41672674|FG001|Overall Study|Lost to Follow-up|7|||
19425751|NCT02187055|41672675|FG002|Overall Study|Lost to Follow-up|3|||
19425752|NCT02187055|41672673|FG000|Overall Study|No longer meets eligibility criteria|0|||
19425753|NCT02187055|41672674|FG001|Overall Study|No longer meets eligibility criteria|2|||
19425754|NCT02187055|41672675|FG002|Overall Study|No longer meets eligibility criteria|0|||
19425755|NCT02187055|41672673|FG000|Overall Study|No longer willing to participate|6|||
19425756|NCT02187055|41672674|FG001|Overall Study|No longer willing to participate|8|||
19425757|NCT02187055|41672675|FG002|Overall Study|No longer willing to participate|10|||
19425758|NCT02187055|41672673|FG000|Overall Study|Other|5|||
19425759|NCT02187055|41672674|FG001|Overall Study|Other|6|||
19425760|NCT02187055|41672675|FG002|Overall Study|Other|3|||
19425761|NCT02187055|41672673|FG000|Overall Study|Protocol Violation|9|||
19425762|NCT02187055|41672674|FG001|Overall Study|Protocol Violation|9|||
19425763|NCT02187055|41672675|FG002|Overall Study|Protocol Violation|4|||
19425764|NCT02187055|41672673|FG000|Overall Study|Pregnancy|3|||
19425765|NCT02187055|41672674|FG001|Overall Study|Pregnancy|1|||
19425766|NCT02187055|41672675|FG002|Overall Study|Pregnancy|0|||
19425767|NCT02187055|41672673|FG000|Overall Study|Withdrawal by Subject|11|||
19425768|NCT02187055|41672674|FG001|Overall Study|Withdrawal by Subject|11|||
19425769|NCT02187055|41672675|FG002|Overall Study|Withdrawal by Subject|11|||
19425770|NCT02187055|41672673|FG000|Overall Study|Adverse Event|21|||
19425771|NCT02187055|41672674|FG001|Overall Study|Adverse Event|26|||
19425772|NCT02187055|41672675|FG002|Overall Study|Adverse Event|36|||
19425773|NCT02187055|41672673|FG000|Overall Study|Death|2|||
19425774|NCT02187055|41672674|FG001|Overall Study|Death|0|||
19425775|NCT02187055|41672675|FG002|Overall Study|Death|0|||
19425776|NCT02246660|41672715|FG000|Overall Study|Withdrawal by Subject|0|||
19425777|NCT02246660|41672716|FG001|Overall Study|Withdrawal by Subject|1|||
19425778|NCT02246660|41672717|FG002|Overall Study|Withdrawal by Subject|0|||
19425779|NCT02246660|41672715|FG000|Overall Study|Death|0|||
19425780|NCT02246660|41672716|FG001|Overall Study|Death|0|||
19425781|NCT02246660|41672717|FG002|Overall Study|Death|1|||
19425782|NCT02246582|41672725|FG000|Overall Study|Withdrawal by Subject|3|||
19425783|NCT02246582|41672726|FG001|Overall Study|Withdrawal by Subject|4|||
19425784|NCT02137369|41672732|FG000|Overall Study|Withdrawal by Subject|3|||
19425785|NCT02137369|41672733|FG001|Overall Study|Withdrawal by Subject|2|||
19425786|NCT02137369|41672732|FG000|Overall Study|Adverse Event|2|||
19425787|NCT02137369|41672733|FG001|Overall Study|Adverse Event|0|||
19425788|NCT02137369|41672732|FG000|Overall Study|Lost to Follow-up|1|||
19425789|NCT02137369|41672733|FG001|Overall Study|Lost to Follow-up|0|||
19425790|NCT02137369|41672732|FG000|Overall Study|Moved away|2|||
19425791|NCT02137369|41672733|FG001|Overall Study|Moved away|0|||
19425792|NCT02135107|41672742|FG000|Treatment Period|Withdrawal by Subject|11|||
19425793|NCT02135107|41672743|FG001|Treatment Period|Withdrawal by Subject|0|||
19520919|NCT01422876|41933735|FG004|Week 24|Lost to Follow-up|2|||
19520920|NCT01422876|41933736|FG005|Week 24|Lost to Follow-up|0|||
19520921|NCT01422876|41933737|FG006|Week 24|Lost to Follow-up|1|||
19520922|NCT01422876|41933738|FG007|Week 24|Lost to Follow-up|3|||
19520923|NCT01422876|41933739|FG008|Week 24|Lost to Follow-up|3|||
19520924|NCT01422876|41933740|FG009|Week 24|Lost to Follow-up|4|||
19520925|NCT01422876|41933731|FG000|Week 24|Consent withdrawn|5|||
19520926|NCT01422876|41933732|FG001|Week 24|Consent withdrawn|1|||
19425794|NCT02135107|41672744|FG002|Treatment Period|Withdrawal by Subject|0|||
19425795|NCT02135107|41672745|FG003|Treatment Period|Withdrawal by Subject|0|||
19425796|NCT02135107|41672742|FG000|Treatment Period|Adverse Event|5|||
19425797|NCT02135107|41672743|FG001|Treatment Period|Adverse Event|2|||
19425798|NCT02135107|41672744|FG002|Treatment Period|Adverse Event|0|||
19425799|NCT02135107|41672745|FG003|Treatment Period|Adverse Event|0|||
19425800|NCT02135107|41672742|FG000|Treatment Period|Pregnancy|1|||
19425801|NCT02135107|41672743|FG001|Treatment Period|Pregnancy|0|||
19425802|NCT02135107|41672744|FG002|Treatment Period|Pregnancy|0|||
19520927|NCT01422876|41933733|FG002|Week 24|Consent withdrawn|3|||
19425803|NCT02135107|41672745|FG003|Treatment Period|Pregnancy|0|||
19425804|NCT02135107|41672742|FG000|Treatment Period|Other|115|||
19425805|NCT02135107|41672743|FG001|Treatment Period|Other|24|||
19425806|NCT02135107|41672744|FG002|Treatment Period|Other|0|||
19425807|NCT02135107|41672745|FG003|Treatment Period|Other|0|||
19425808|NCT02135107|41672742|FG000|Maintenance Therapy Period|Adverse Event|0|||
19425809|NCT02135107|41672743|FG001|Maintenance Therapy Period|Adverse Event|0|||
19425810|NCT02135107|41672744|FG002|Maintenance Therapy Period|Adverse Event|3|||
19425811|NCT02135107|41672745|FG003|Maintenance Therapy Period|Adverse Event|7|||
19425812|NCT02135107|41672742|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
19425813|NCT02135107|41672743|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
19425814|NCT02135107|41672744|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
19425815|NCT02135107|41672745|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
19520928|NCT01422876|41933734|FG003|Week 24|Consent withdrawn|4|||
19520929|NCT01422876|41933735|FG004|Week 24|Consent withdrawn|5|||
19520930|NCT01422876|41933736|FG005|Week 24|Consent withdrawn|6|||
19520931|NCT01422876|41933737|FG006|Week 24|Consent withdrawn|5|||
19520932|NCT01422876|41933738|FG007|Week 24|Consent withdrawn|4|||
19520933|NCT01422876|41933739|FG008|Week 24|Consent withdrawn|3|||
19520934|NCT01422876|41933740|FG009|Week 24|Consent withdrawn|6|||
19520935|NCT01422876|41933731|FG000|Week 24|Death|0|||
19520936|NCT01422876|41933732|FG001|Week 24|Death|1|||
19425816|NCT02135107|41672742|FG000|Maintenance Therapy Period|Pregnancy|0|||
19425817|NCT02135107|41672743|FG001|Maintenance Therapy Period|Pregnancy|0|||
19425818|NCT02135107|41672744|FG002|Maintenance Therapy Period|Pregnancy|0|||
19425819|NCT02135107|41672745|FG003|Maintenance Therapy Period|Pregnancy|1|||
19425820|NCT02135107|41672742|FG000|Maintenance Therapy Period|Other|0|||
19425821|NCT02135107|41672743|FG001|Maintenance Therapy Period|Other|0|||
19425822|NCT02135107|41672744|FG002|Maintenance Therapy Period|Other|7|||
19425823|NCT02135107|41672745|FG003|Maintenance Therapy Period|Other|8|||
19425824|NCT02155309|41672759|FG000|Overall Study|Protocol Violation|0|||
19425825|NCT02155309|41672760|FG001|Overall Study|Protocol Violation|0|||
19425826|NCT02155309|41672761|FG002|Overall Study|Protocol Violation|1|||
19425827|NCT02186821|41672768|FG000|Overall Study|Adverse Event|9|||
19425828|NCT02186821|41672768|FG000|Overall Study|Death|2|||
19425829|NCT02186821|41672768|FG000|Overall Study|Disease progression|32|||
19425830|NCT02186821|41672768|FG000|Overall Study|Protocol Violation|1|||
19425831|NCT02186821|41672768|FG000|Overall Study|Physician Decision|1|||
19425832|NCT02186821|41672768|FG000|Overall Study|Study terminated by sponsor|2|||
19425833|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
19425834|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
19425835|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
19425836|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
19425837|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
19425838|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
19425839|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
19425840|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
19425841|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
19425842|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
19425843|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
19425844|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
19425845|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
19425846|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
19425847|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
19425848|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
19425849|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
19425850|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
19425851|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
19425852|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
19425853|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
19425854|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
19425855|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
19425856|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
19425857|NCT01710358|41672775|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
19425858|NCT01710358|41672776|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
19425859|NCT01710358|41672777|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
19425860|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
19425861|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
19520937|NCT01422876|41933733|FG002|Week 24|Death|0|||
19425862|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
19520938|NCT01422876|41933734|FG003|Week 24|Death|0|||
19520939|NCT01422876|41933735|FG004|Week 24|Death|0|||
19520940|NCT01422876|41933736|FG005|Week 24|Death|0|||
19425863|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
19425864|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
19425865|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
19425866|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
19425867|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
19425868|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
19425869|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
19425870|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
19425871|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
19425872|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
19425873|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
19425874|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
19425875|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
19425876|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
19425877|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
19425878|NCT01710358|41672775|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
19425879|NCT01710358|41672776|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
19425880|NCT01710358|41672777|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
19425881|NCT01710358|41672775|FG000|Rescue Period|Adverse Event|0|||
19425882|NCT01710358|41672776|FG001|Rescue Period|Adverse Event|15|||
19425883|NCT01710358|41672777|FG002|Rescue Period|Adverse Event|0|||
19425884|NCT01710358|41672775|FG000|Rescue Period|Death|0|||
19425885|NCT01710358|41672776|FG001|Rescue Period|Death|1|||
19425886|NCT01710358|41672777|FG002|Rescue Period|Death|0|||
19425887|NCT01710358|41672775|FG000|Rescue Period|Lack of Efficacy|0|||
19425888|NCT01710358|41672776|FG001|Rescue Period|Lack of Efficacy|7|||
19425889|NCT01710358|41672777|FG002|Rescue Period|Lack of Efficacy|0|||
19425890|NCT01710358|41672775|FG000|Rescue Period|Withdrawal by Subject|0|||
19425891|NCT01710358|41672776|FG001|Rescue Period|Withdrawal by Subject|8|||
19425892|NCT01710358|41672777|FG002|Rescue Period|Withdrawal by Subject|0|||
19425893|NCT01633112|41672801|FG000|Overall Study|Lack of Efficacy|1|||
19425894|NCT01633112|41672802|FG001|Overall Study|Lack of Efficacy|6|||
19425895|NCT01633112|41672803|FG002|Overall Study|Lack of Efficacy|13|||
19425896|NCT01633112|41672801|FG000|Overall Study|Abnormal laboratory value(s)|3|||
19425897|NCT01633112|41672802|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19425898|NCT01633112|41672803|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19425899|NCT01633112|41672801|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19425900|NCT01633112|41672802|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19425901|NCT01633112|41672803|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19425902|NCT01633112|41672801|FG000|Overall Study|Administrative problems|1|||
19425903|NCT01633112|41672802|FG001|Overall Study|Administrative problems|2|||
19425904|NCT01633112|41672803|FG002|Overall Study|Administrative problems|5|||
19425905|NCT01633112|41672801|FG000|Overall Study|Adverse Event|16|||
19425906|NCT01633112|41672802|FG001|Overall Study|Adverse Event|18|||
19425907|NCT01633112|41672803|FG002|Overall Study|Adverse Event|20|||
19425908|NCT01633112|41672801|FG000|Overall Study|Lost to Follow-up|7|||
19425909|NCT01633112|41672802|FG001|Overall Study|Lost to Follow-up|19|||
19425910|NCT01633112|41672803|FG002|Overall Study|Lost to Follow-up|6|||
19425911|NCT01633112|41672801|FG000|Overall Study|Protocol Violation|4|||
19425912|NCT01633112|41672802|FG001|Overall Study|Protocol Violation|0|||
19425913|NCT01633112|41672803|FG002|Overall Study|Protocol Violation|2|||
19425914|NCT01633112|41672801|FG000|Overall Study|Subject no longer requires study drug|0|||
19425915|NCT01633112|41672802|FG001|Overall Study|Subject no longer requires study drug|0|||
19425916|NCT01633112|41672803|FG002|Overall Study|Subject no longer requires study drug|1|||
19425917|NCT01633112|41672801|FG000|Overall Study|Withdrawal by Subject|20|||
19425918|NCT01633112|41672802|FG001|Overall Study|Withdrawal by Subject|12|||
19425919|NCT01633112|41672803|FG002|Overall Study|Withdrawal by Subject|41|||
19425920|NCT01633112|41672801|FG000|Overall Study|missing Study Completion CRF|1|||
19425921|NCT01633112|41672802|FG001|Overall Study|missing Study Completion CRF|1|||
19425922|NCT01633112|41672803|FG002|Overall Study|missing Study Completion CRF|4|||
19425923|NCT01691482|41672812|FG000|Treatment Period 2|Adverse Event|0|||
19425924|NCT01691482|41672813|FG001|Treatment Period 2|Adverse Event|1|||
19425925|NCT01691482|41672812|FG000|Treatment Period 2|Protocol Violation|1|||
19425926|NCT01691482|41672813|FG001|Treatment Period 2|Protocol Violation|1|||
19425927|NCT02246114|41672822|FG000|Overall Study|miscarriage|1|||
19425928|NCT02246114|41672823|FG001|Overall Study|miscarriage|0|||
19425929|NCT01710046|41672831|FG000|Overall Study|Lost to Follow-up|1|||
19425930|NCT01710046|41672832|FG001|Overall Study|Lost to Follow-up|0|||
19425931|NCT02154529|41672842|FG000|Overall Study|Death|1|||
19425932|NCT02154529|41672843|FG001|Overall Study|Death|1|||
19425933|NCT02154529|41672844|FG002|Overall Study|Death|5|||
19425934|NCT02154529|41672845|FG003|Overall Study|Death|1|||
19425935|NCT02154529|41672842|FG000|Overall Study|Termination of study by sponsor|2|||
19425936|NCT02154529|41672843|FG001|Overall Study|Termination of study by sponsor|2|||
19425937|NCT02154529|41672844|FG002|Overall Study|Termination of study by sponsor|3|||
19425938|NCT02154529|41672845|FG003|Overall Study|Termination of study by sponsor|1|||
19425939|NCT02154529|41672842|FG000|Overall Study|Lost to Follow-up|1|||
19425940|NCT02154529|41672843|FG001|Overall Study|Lost to Follow-up|0|||
19425941|NCT02154529|41672844|FG002|Overall Study|Lost to Follow-up|0|||
19425942|NCT02154529|41672845|FG003|Overall Study|Lost to Follow-up|0|||
19425943|NCT01954017|41672860|FG000|Overall Study|Adverse Event|0|||
19425944|NCT01954017|41672861|FG001|Overall Study|Adverse Event|0|||
19425945|NCT01954017|41672862|FG002|Overall Study|Adverse Event|1|||
19425946|NCT01954017|41672860|FG000|Overall Study|Death|2|||
19425947|NCT01954017|41672861|FG001|Overall Study|Death|1|||
19425948|NCT01954017|41672862|FG002|Overall Study|Death|1|||
19425949|NCT01954017|41672860|FG000|Overall Study|Withdrawal by Subject|0|||
19425950|NCT01954017|41672861|FG001|Overall Study|Withdrawal by Subject|1|||
19425951|NCT01954017|41672862|FG002|Overall Study|Withdrawal by Subject|0|||
19425952|NCT01954017|41672860|FG000|Overall Study|Protocol Violation|0|||
19425953|NCT01954017|41672861|FG001|Overall Study|Protocol Violation|3|||
19425954|NCT01954017|41672862|FG002|Overall Study|Protocol Violation|2|||
19425955|NCT01954017|41672860|FG000|Overall Study|Necrotizing enterocolitis|1|||
19425956|NCT01954017|41672861|FG001|Overall Study|Necrotizing enterocolitis|0|||
19425957|NCT01954017|41672862|FG002|Overall Study|Necrotizing enterocolitis|1|||
19425958|NCT01954017|41672860|FG000|Overall Study|Enteral intake stopped >7 days|0|||
19425959|NCT01954017|41672861|FG001|Overall Study|Enteral intake stopped >7 days|1|||
19425960|NCT01954017|41672862|FG002|Overall Study|Enteral intake stopped >7 days|1|||
19425961|NCT01954017|41672860|FG000|Overall Study|All other reasons|2|||
19425962|NCT01954017|41672861|FG001|Overall Study|All other reasons|2|||
19425963|NCT01954017|41672862|FG002|Overall Study|All other reasons|7|||
19425964|NCT02154139|41672896|FG000|Overall Study|Injection not administered|2|||
19425965|NCT02154139|41672896|FG000|Overall Study|Other|2|||
19425966|NCT02154139|41672896|FG000|Overall Study|Investigator transferred|3|||
19425967|NCT02245568|41672900|FG000|Overall Study|Study terminated by Sponsor|346|||
19425968|NCT02245568|41672900|FG000|Overall Study|Adverse Event|144|||
19425969|NCT02245568|41672900|FG000|Overall Study|Lack of Efficacy|98|||
19425970|NCT02245568|41672900|FG000|Overall Study|Withdrawal by Caregiver|85|||
19425971|NCT02245568|41672900|FG000|Overall Study|Withdrawal by Subject|77|||
19425972|NCT02245568|41672900|FG000|Overall Study|Withdrawal by Legal Representative|31|||
19425973|NCT02245568|41672900|FG000|Overall Study|Missing (Site closure)|16|||
19425974|NCT02245568|41672900|FG000|Overall Study|Physician Decision|14|||
19425975|NCT02245568|41672900|FG000|Overall Study|Non-compliance with study drug|11|||
19425976|NCT02245568|41672900|FG000|Overall Study|Death|9|||
19425977|NCT02245568|41672900|FG000|Overall Study|Blue staining|6|||
19425978|NCT02245568|41672900|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
19425979|NCT02245568|41672900|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
19425980|NCT02245568|41672900|FG000|Overall Study|Lost to Follow-up|5|||
19425981|NCT02154061|41672906|FG000|Overall Study|Pregnancy|1|||
19425982|NCT02154061|41672907|FG001|Overall Study|Pregnancy|0|||
19425983|NCT02154061|41672906|FG000|Overall Study|enrolled but not vaccinated|1|||
19425984|NCT02154061|41672907|FG001|Overall Study|enrolled but not vaccinated|0|||
19425985|NCT01907217|41672915|FG000|Overall Study|Withdrawal by Subject|0|||
19425986|NCT01907217|41672916|FG001|Overall Study|Withdrawal by Subject|2|||
19425987|NCT01953783|41672924|FG000|Overall Study|Progressive disease|2|||
19425988|NCT02134015|41672930|FG000|Overall Study|Protocol Violation|0|||
19425989|NCT02134015|41672931|FG001|Overall Study|Protocol Violation|1|||
19425990|NCT02134015|41672930|FG000|Overall Study|Death|2|||
19425991|NCT02134015|41672931|FG001|Overall Study|Death|1|||
19425992|NCT02134015|41672930|FG000|Overall Study|Reason not provided|1|||
19425993|NCT02134015|41672931|FG001|Overall Study|Reason not provided|2|||
19425994|NCT02134015|41672930|FG000|Overall Study|Clinical progression|14|||
19425995|NCT02134015|41672931|FG001|Overall Study|Clinical progression|7|||
19425996|NCT02134015|41672930|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
19425997|NCT02134015|41672931|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
19425998|NCT02134015|41672930|FG000|Overall Study|Study terminated by sponsor|2|||
19425999|NCT02134015|41672931|FG001|Overall Study|Study terminated by sponsor|3|||
19426000|NCT02134015|41672930|FG000|Overall Study|Adverse Event|9|||
19426001|NCT02134015|41672931|FG001|Overall Study|Adverse Event|10|||
19426002|NCT02134015|41672930|FG000|Overall Study|Withdrawal by Subject|3|||
19426003|NCT02134015|41672931|FG001|Overall Study|Withdrawal by Subject|7|||
19426004|NCT01924845|41672937|FG000|Overall Study|Adverse Event|3|||
19426005|NCT01924845|41672937|FG000|Overall Study|Withdrawal by Subject|2|||
19426006|NCT01924845|41672937|FG000|Overall Study|Protocol Violation|1|||
19426007|NCT01630135|41672943|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
19426008|NCT01630135|41672944|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
19426009|NCT01691248|41672952|FG000|Overall Study|Protocol Violation|43|||
19426010|NCT01691248|41672953|FG001|Overall Study|Protocol Violation|27|||
19426011|NCT01691248|41672952|FG000|Overall Study|Adverse Event|24|||
19426012|NCT01691248|41672953|FG001|Overall Study|Adverse Event|22|||
19426013|NCT01691248|41672952|FG000|Overall Study|Withdrawal by Subject|20|||
19426014|NCT01691248|41672953|FG001|Overall Study|Withdrawal by Subject|18|||
19426015|NCT01691248|41672952|FG000|Overall Study|Confirmed CDAD|14|||
19426016|NCT01691248|41672953|FG001|Overall Study|Confirmed CDAD|31|||
19426017|NCT01691248|41672952|FG000|Overall Study|Lost to Follow-up|2|||
19426018|NCT01691248|41672953|FG001|Overall Study|Lost to Follow-up|5|||
19426019|NCT01691248|41672952|FG000|Overall Study|Reason not provided|4|||
19426020|NCT01691248|41672953|FG001|Overall Study|Reason not provided|4|||
19426021|NCT01691248|41672952|FG000|Overall Study|Not Treated|4|||
19426022|NCT01691248|41672953|FG001|Overall Study|Not Treated|7|||
19426023|NCT01924767|41672964|FG000|Overall Study|Adverse Event|1|||
19426024|NCT01924767|41672965|FG001|Overall Study|Adverse Event|0|||
19426025|NCT01924767|41672966|FG002|Overall Study|Adverse Event|1|||
19426026|NCT01924767|41672967|FG003|Overall Study|Adverse Event|0|||
19426027|NCT01924767|41672968|FG004|Overall Study|Adverse Event|0|||
19426028|NCT01691092|41672985|FG000|Overall Study|Lost to Follow-up|10|||
19426029|NCT01691092|41672985|FG000|Overall Study|Physician Decision|4|||
19426030|NCT01691092|41672985|FG000|Overall Study|Withdrawal by Subject|3|||
19426031|NCT01691092|41672985|FG000|Overall Study|non-compliance|3|||
19426032|NCT01691092|41672985|FG000|Overall Study|used for different study|2|||
19426033|NCT01691092|41672985|FG000|Overall Study|screen fail|19|||
19426034|NCT02133001|41672991|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
19426035|NCT02133001|41672992|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
19426036|NCT02133001|41672991|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
19426037|NCT02133001|41672992|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
19426038|NCT02133001|41672991|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
19426039|NCT02133001|41672992|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
19426040|NCT02133001|41672991|FG000|Double Blind (Day 1-25)|Other|2|||
19426041|NCT02133001|41672992|FG001|Double Blind (Day 1-25)|Other|2|||
19426042|NCT02133001|41672991|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
19426043|NCT02133001|41672992|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
19426044|NCT02133001|41672991|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
19426045|NCT02133001|41672992|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
19426046|NCT02133001|41672991|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
19426047|NCT02133001|41672992|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
19426048|NCT02133001|41672991|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
19426049|NCT02133001|41672992|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
19426050|NCT01709578|41673003|FG000|Overall Study|Rescued and entered in long term safety|63|||
19426051|NCT01709578|41673004|FG001|Overall Study|Rescued and entered in long term safety|25|||
19426052|NCT01709578|41673005|FG002|Overall Study|Rescued and entered in long term safety|26|||
19426053|NCT01709578|41673003|FG000|Overall Study|Adverse Event|9|||
19426054|NCT01709578|41673004|FG001|Overall Study|Adverse Event|18|||
19426055|NCT01709578|41673005|FG002|Overall Study|Adverse Event|17|||
19426056|NCT01709578|41673003|FG000|Overall Study|Lack of Efficacy|5|||
19426057|NCT01709578|41673004|FG001|Overall Study|Lack of Efficacy|4|||
19426058|NCT01709578|41673005|FG002|Overall Study|Lack of Efficacy|2|||
19426059|NCT01709578|41673003|FG000|Overall Study|Poor compliance to protocol|1|||
19426060|NCT01709578|41673004|FG001|Overall Study|Poor compliance to protocol|2|||
19426061|NCT01709578|41673005|FG002|Overall Study|Poor compliance to protocol|1|||
19426062|NCT01709578|41673003|FG000|Overall Study|Other, not related to safety or efficacy|2|||
19426063|NCT01709578|41673004|FG001|Overall Study|Other, not related to safety or efficacy|7|||
19426064|NCT01709578|41673005|FG002|Overall Study|Other, not related to safety or efficacy|5|||
19426065|NCT02132767|41673015|FG000|Overall Study|Death|3|||
19426066|NCT02132767|41673016|FG001|Overall Study|Death|2|||
19426067|NCT02132767|41673015|FG000|Overall Study|Withdrawal by Subject|10|||
19426068|NCT02132767|41673016|FG001|Overall Study|Withdrawal by Subject|9|||
19426069|NCT02132767|41673015|FG000|Overall Study|Lost to Follow-up|4|||
19426070|NCT02132767|41673016|FG001|Overall Study|Lost to Follow-up|4|||
19426071|NCT02153905|41673024|FG000|Overall Study|Death|1|||
19426072|NCT02153905|41673025|FG001|Overall Study|Death|0|||
19426073|NCT02153827|41673033|FG000|Overall Study|Lost to Follow-up|3|||
19426074|NCT02153827|41673034|FG001|Overall Study|Lost to Follow-up|9|||
19426075|NCT02153359|41673040|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
19426076|NCT02153359|41673041|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
19426077|NCT01691014|41673054|FG000|Overall Study|Premature Termination|1|||
19426078|NCT01691014|41673055|FG001|Overall Study|Premature Termination|6|||
19426079|NCT01691014|41673056|FG002|Overall Study|Premature Termination|0|||
19426080|NCT01691014|41673057|FG003|Overall Study|Premature Termination|3|||
19426081|NCT01691014|41673054|FG000|Overall Study|Other|0|||
19426082|NCT01691014|41673055|FG001|Overall Study|Other|0|||
19426083|NCT01691014|41673056|FG002|Overall Study|Other|2|||
19426084|NCT01691014|41673057|FG003|Overall Study|Other|0|||
19426085|NCT01691014|41673054|FG000|Overall Study|Withdrawal by Subject|0|||
19426086|NCT01691014|41673055|FG001|Overall Study|Withdrawal by Subject|1|||
19426087|NCT01691014|41673056|FG002|Overall Study|Withdrawal by Subject|1|||
19426088|NCT01691014|41673057|FG003|Overall Study|Withdrawal by Subject|1|||
19426089|NCT01691014|41673054|FG000|Overall Study|Adverse Event|0|||
19426090|NCT01691014|41673055|FG001|Overall Study|Adverse Event|5|||
19426091|NCT01691014|41673056|FG002|Overall Study|Adverse Event|1|||
19426092|NCT01691014|41673057|FG003|Overall Study|Adverse Event|1|||
19426093|NCT01691014|41673054|FG000|Overall Study|Lack of Efficacy|2|||
19426094|NCT01691014|41673055|FG001|Overall Study|Lack of Efficacy|3|||
19426095|NCT01691014|41673056|FG002|Overall Study|Lack of Efficacy|7|||
19426096|NCT01691014|41673057|FG003|Overall Study|Lack of Efficacy|0|||
19426097|NCT02245412|41673070|FG000|Treatment Period|Death|1|||
19426098|NCT02245412|41673071|FG001|Treatment Period|Death|1|||
19426099|NCT02245412|41673072|FG002|Treatment Period|Death|0|||
19426100|NCT02245412|41673070|FG000|Treatment Period|Physician Decision|1|||
19426101|NCT02245412|41673071|FG001|Treatment Period|Physician Decision|1|||
19426102|NCT02245412|41673072|FG002|Treatment Period|Physician Decision|0|||
19426103|NCT02245412|41673070|FG000|Treatment Period|Withdrawal by Subject|2|||
19426104|NCT02245412|41673071|FG001|Treatment Period|Withdrawal by Subject|1|||
19426105|NCT02245412|41673072|FG002|Treatment Period|Withdrawal by Subject|0|||
19426106|NCT02245412|41673070|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
19426107|NCT02245412|41673071|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
19426108|NCT02245412|41673072|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
19426109|NCT02245412|41673070|FG000|Follow-Up Period|Death|4|||
19426110|NCT02245412|41673071|FG001|Follow-Up Period|Death|2|||
19426111|NCT02245412|41673072|FG002|Follow-Up Period|Death|1|||
19426112|NCT02245412|41673070|FG000|Follow-Up Period|Physician Decision|1|||
19426113|NCT02245412|41673071|FG001|Follow-Up Period|Physician Decision|0|||
19426114|NCT02245412|41673072|FG002|Follow-Up Period|Physician Decision|0|||
19426115|NCT02245412|41673070|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
19426116|NCT02245412|41673071|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
19426117|NCT02245412|41673072|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
19426118|NCT02244944|41673080|FG000|Overall Study|Withdrawal by Subject|1|||
19426119|NCT02244944|41673080|FG000|Overall Study|Study Terminated|1|||
19426120|NCT01689532|41673086|FG000|Overall Study|Adverse Event|9|||
19426121|NCT01689532|41673087|FG001|Overall Study|Adverse Event|5|||
19426122|NCT01689532|41673086|FG000|Overall Study|Lack of Efficacy|2|||
19426123|NCT01689532|41673087|FG001|Overall Study|Lack of Efficacy|2|||
19426124|NCT01689532|41673086|FG000|Overall Study|Withdrawal by Subject|1|||
19426125|NCT01689532|41673087|FG001|Overall Study|Withdrawal by Subject|2|||
19426126|NCT01689532|41673086|FG000|Overall Study|Physician Decision|2|||
19426127|NCT01689532|41673087|FG001|Overall Study|Physician Decision|0|||
19426128|NCT01924689|41673099|FG000|Overall Study|Death|0|||
19426129|NCT01924689|41673100|FG001|Overall Study|Death|1|||
19426130|NCT01924689|41673101|FG002|Overall Study|Death|0|||
19426131|NCT01924689|41673102|FG003|Overall Study|Death|1|||
19426132|NCT01924689|41673103|FG004|Overall Study|Death|0|||
19426133|NCT01924689|41673104|FG005|Overall Study|Death|0|||
19426134|NCT01924689|41673099|FG000|Overall Study|Disease progression|0|||
19426135|NCT01924689|41673100|FG001|Overall Study|Disease progression|0|||
19426136|NCT01924689|41673101|FG002|Overall Study|Disease progression|2|||
19426137|NCT01924689|41673102|FG003|Overall Study|Disease progression|0|||
19426138|NCT01924689|41673103|FG004|Overall Study|Disease progression|3|||
19426139|NCT01924689|41673104|FG005|Overall Study|Disease progression|2|||
19426140|NCT01924689|41673099|FG000|Overall Study|New therapy or study|3|||
19426141|NCT01924689|41673100|FG001|Overall Study|New therapy or study|2|||
19426142|NCT01924689|41673101|FG002|Overall Study|New therapy or study|1|||
19426143|NCT01924689|41673102|FG003|Overall Study|New therapy or study|4|||
19426144|NCT01924689|41673103|FG004|Overall Study|New therapy or study|2|||
19426145|NCT01924689|41673104|FG005|Overall Study|New therapy or study|0|||
19426146|NCT01924689|41673099|FG000|Overall Study|Withdrawal of consent|0|||
19426147|NCT01924689|41673100|FG001|Overall Study|Withdrawal of consent|0|||
19426148|NCT01924689|41673101|FG002|Overall Study|Withdrawal of consent|1|||
19426149|NCT01924689|41673102|FG003|Overall Study|Withdrawal of consent|1|||
19426150|NCT01924689|41673103|FG004|Overall Study|Withdrawal of consent|0|||
19426151|NCT01924689|41673104|FG005|Overall Study|Withdrawal of consent|0|||
19426152|NCT01924689|41673099|FG000|Overall Study|Other|0|||
19426153|NCT01924689|41673100|FG001|Overall Study|Other|0|||
19426154|NCT01924689|41673101|FG002|Overall Study|Other|0|||
19426155|NCT01924689|41673102|FG003|Overall Study|Other|0|||
19426156|NCT01924689|41673103|FG004|Overall Study|Other|1|||
19426157|NCT01924689|41673104|FG005|Overall Study|Other|0|||
19426158|NCT01591330|41673122|FG000|Period 1|Adverse Event|1|||
19426159|NCT01591330|41673123|FG001|Period 1|Adverse Event|0|||
19426160|NCT01591330|41673124|FG002|Period 1|Adverse Event|0|||
19426161|NCT01591330|41673125|FG003|Period 1|Adverse Event|0|||
19426162|NCT01591330|41673122|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
19426163|NCT01591330|41673123|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
19426164|NCT01591330|41673124|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
19426165|NCT01591330|41673125|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
19426166|NCT01591330|41673122|FG000|Period 2|Adverse Event|1|||
19426167|NCT01591330|41673123|FG001|Period 2|Adverse Event|0|||
19426168|NCT01591330|41673124|FG002|Period 2|Adverse Event|0|||
19426169|NCT01591330|41673125|FG003|Period 2|Adverse Event|0|||
19426170|NCT01591096|41673135|FG000|Overall Study|Adverse Event|1|||
19426171|NCT01953003|41673141|FG000|Overall Study|Not treated|0|||
19426172|NCT01953003|41673142|FG001|Overall Study|Not treated|1|||
19426173|NCT01953003|41673141|FG000|Overall Study|Progressive disease|35|||
19426174|NCT01953003|41673142|FG001|Overall Study|Progressive disease|45|||
19426175|NCT01953003|41673141|FG000|Overall Study|Related Adverse events|7|||
19426176|NCT01953003|41673142|FG001|Overall Study|Related Adverse events|2|||
19426177|NCT01953003|41673141|FG000|Overall Study|Non-related adverse events|0|||
19426178|NCT01953003|41673142|FG001|Overall Study|Non-related adverse events|2|||
19426179|NCT01953003|41673141|FG000|Overall Study|Protocol Violation|0|||
19426180|NCT01953003|41673142|FG001|Overall Study|Protocol Violation|1|||
19426181|NCT01953003|41673141|FG000|Overall Study|Withdrawal by Subject|14|||
19426182|NCT01953003|41673142|FG001|Overall Study|Withdrawal by Subject|4|||
19426183|NCT01952691|41673148|FG000|Overall Study|Lost to Follow-up|2|||
19426184|NCT01709500|41673154|FG000|Overall Study|Randomized but not treated|0|||
19426185|NCT01709500|41673155|FG001|Overall Study|Randomized but not treated|1|||
19426186|NCT01709500|41673154|FG000|Overall Study|Adverse Event|5|||
19426187|NCT01709500|41673155|FG001|Overall Study|Adverse Event|1|||
19426188|NCT01709500|41673154|FG000|Overall Study|Poor compliance to protocol|2|||
19426189|NCT01709500|41673155|FG001|Overall Study|Poor compliance to protocol|1|||
19426190|NCT01709500|41673154|FG000|Overall Study|Other|3|||
19426191|NCT01709500|41673155|FG001|Overall Study|Other|1|||
19426192|NCT01709500|41673154|FG000|Overall Study|Related to IMP administration|1|||
19426193|NCT01709500|41673155|FG001|Overall Study|Related to IMP administration|0|||
19426194|NCT01709500|41673154|FG000|Overall Study|Treatment ongoing|156|||
19426195|NCT01709500|41673155|FG001|Overall Study|Treatment ongoing|78|||
19426196|NCT01599806|41673163|FG000|Overall Study|Lost to Follow-up|20|||
19426197|NCT01599806|41673164|FG001|Overall Study|Lost to Follow-up|20|||
19426198|NCT01599806|41673163|FG000|Overall Study|Withdrawal by Subject|12|||
19426199|NCT01599806|41673164|FG001|Overall Study|Withdrawal by Subject|12|||
19426200|NCT01599806|41673163|FG000|Overall Study|Other Eligibility criteria|11|||
19426201|NCT01599806|41673164|FG001|Overall Study|Other Eligibility criteria|9|||
19426202|NCT01599325|41673170|FG000|Primary Parent Phase|Adverse Event|5|||
19426203|NCT01599325|41673170|FG000|Primary Parent Phase|Disease Progression|7|||
19426204|NCT01599325|41673170|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
19426205|NCT01599325|41673170|FG000|Primary Parent Phase|Death|13|||
19426206|NCT01599325|41673170|FG000|Primary Parent Phase|Protocol Violation|1|||
19426207|NCT01599325|41673170|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
19426208|NCT01599325|41673170|FG000|Primary Parent Phase|Other|2|||
19426209|NCT01599325|41673170|FG000|Extension Phase|Study Closure|1|||
19426210|NCT01599325|41673170|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
19426211|NCT01599325|41673170|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
19426212|NCT01599325|41673170|FG000|Extension Phase|Disease Progression|1|||
19426213|NCT01599325|41673170|FG000|Extension Phase|Withdrawal by Subject|8|||
19426214|NCT01924299|41673177|FG000|Period 2|Withdrawal by Subject|1|||
19426215|NCT01924299|41673178|FG001|Period 2|Withdrawal by Subject|0|||
19426216|NCT01924299|41673177|FG000|Period 2|Adverse Event|0|||
19426217|NCT01924299|41673178|FG001|Period 2|Adverse Event|1|||
19426218|NCT02182999|41673192|FG000|Overall Study|Adverse Event|4|||
19426219|NCT02182999|41673193|FG001|Overall Study|Adverse Event|3|||
19426220|NCT02182999|41673192|FG000|Overall Study|Physician Decision|1|||
19426221|NCT02182999|41673193|FG001|Overall Study|Physician Decision|0|||
19426222|NCT02243696|41673199|FG000|Overall Study|Death|282|||
19426223|NCT02243696|41673199|FG000|Overall Study|Withdrawal by Subject|79|||
19426224|NCT02243696|41673199|FG000|Overall Study|Lost to Follow-up|57|||
19426225|NCT02243696|41673199|FG000|Overall Study|Subject No Longer has Study System|42|||
19426226|NCT02243696|41673199|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
19426227|NCT02243696|41673199|FG000|Overall Study|Study Terminated for EP PASSION|961|||
19426228|NCT01598311|41673205|FG000|Overall Study|Physician Decision|4|||
19426229|NCT01598311|41673206|FG001|Overall Study|Physician Decision|5|||
19426230|NCT01598311|41673205|FG000|Overall Study|Adverse Event|9|||
19426231|NCT01598311|41673206|FG001|Overall Study|Adverse Event|13|||
19426232|NCT01598311|41673205|FG000|Overall Study|Lost to Follow-up|7|||
19426233|NCT01598311|41673206|FG001|Overall Study|Lost to Follow-up|12|||
19426234|NCT01598311|41673205|FG000|Overall Study|Withdrawal by Subject|9|||
19426235|NCT01598311|41673206|FG001|Overall Study|Withdrawal by Subject|13|||
19426236|NCT01598311|41673205|FG000|Overall Study|No reason provided.|0|||
19426237|NCT01598311|41673206|FG001|Overall Study|No reason provided.|5|||
19426238|NCT01598311|41673205|FG000|Overall Study|Randomized but never treated|8|||
19426239|NCT01598311|41673206|FG001|Overall Study|Randomized but never treated|5|||
19426240|NCT01598311|41673205|FG000|Overall Study|Treated but no confirmed CDAD|9|||
19426241|NCT01598311|41673206|FG001|Overall Study|Treated but no confirmed CDAD|8|||
19426242|NCT01598311|41673205|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
19426243|NCT01598311|41673206|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
19426244|NCT02182843|41673212|FG000|Overall Study|Withdrawal by Subject|7|||
19426245|NCT02182843|41673212|FG000|Overall Study|Lost to Follow-up|2|||
19426246|NCT02182843|41673212|FG000|Overall Study|Adverse Event|1|||
19426247|NCT02208050|41673218|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
19426248|NCT02208050|41673219|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
19426249|NCT02978222|41673241|FG000|Overall Study|Withdrawal by Subject|2|||
19426250|NCT02978222|41673242|FG001|Overall Study|Withdrawal by Subject|2|||
19426251|NCT02978222|41673241|FG000|Overall Study|Physician Decision|2|||
19426252|NCT02978222|41673242|FG001|Overall Study|Physician Decision|0|||
19426253|NCT02978222|41673241|FG000|Overall Study|Adverse Event|0|||
19426254|NCT02978222|41673242|FG001|Overall Study|Adverse Event|1|||
19426255|NCT02978222|41673241|FG000|Overall Study|Death|1|||
19426256|NCT02978222|41673242|FG001|Overall Study|Death|0|||
19426257|NCT02978222|41673241|FG000|Overall Study|Disease Progression|32|||
19426258|NCT02978222|41673242|FG001|Overall Study|Disease Progression|32|||
19426259|NCT02978222|41673241|FG000|Overall Study|Early Study Termination|24|||
19426260|NCT02978222|41673242|FG001|Overall Study|Early Study Termination|21|||
19426261|NCT02181673|41673250|FG000|Up to Week 24|Adverse Event|2|||
19426262|NCT02181673|41673251|FG001|Up to Week 24|Adverse Event|0|||
19426263|NCT02181673|41673252|FG002|Up to Week 24|Adverse Event|3|||
19426264|NCT02181673|41673250|FG000|Up to Week 24|Death|1|||
19426265|NCT02181673|41673251|FG001|Up to Week 24|Death|0|||
19426266|NCT02181673|41673252|FG002|Up to Week 24|Death|0|||
19426267|NCT02181673|41673250|FG000|Up to Week 24|Lack of Efficacy|1|||
19426268|NCT02181673|41673251|FG001|Up to Week 24|Lack of Efficacy|0|||
19426269|NCT02181673|41673252|FG002|Up to Week 24|Lack of Efficacy|0|||
19426270|NCT02181673|41673250|FG000|Up to Week 24|Lost to Follow-up|1|||
19426271|NCT02181673|41673251|FG001|Up to Week 24|Lost to Follow-up|0|||
19426272|NCT02181673|41673252|FG002|Up to Week 24|Lost to Follow-up|0|||
19426273|NCT02181673|41673250|FG000|Up to Week 24|Physician Decision|0|||
19426274|NCT02181673|41673251|FG001|Up to Week 24|Physician Decision|0|||
19426275|NCT02181673|41673252|FG002|Up to Week 24|Physician Decision|3|||
19426276|NCT02181673|41673250|FG000|Up to Week 24|Withdrawal by Subject|10|||
19426277|NCT02181673|41673251|FG001|Up to Week 24|Withdrawal by Subject|0|||
19426278|NCT02181673|41673252|FG002|Up to Week 24|Withdrawal by Subject|1|||
19426279|NCT02181673|41673250|FG000|Up to Week 24|Other|2|||
19426280|NCT02181673|41673251|FG001|Up to Week 24|Other|0|||
19426281|NCT02181673|41673252|FG002|Up to Week 24|Other|3|||
19426282|NCT02181673|41673250|FG000|Up to Week 24|Randomized not Treated|0|||
19426283|NCT02181673|41673251|FG001|Up to Week 24|Randomized not Treated|0|||
19426284|NCT02181673|41673252|FG002|Up to Week 24|Randomized not Treated|1|||
19426285|NCT02181673|41673250|FG000|Week 24-Week 60|Adverse Event|0|||
19426286|NCT02181673|41673251|FG001|Week 24-Week 60|Adverse Event|4|||
19426287|NCT02181673|41673252|FG002|Week 24-Week 60|Adverse Event|10|||
19426288|NCT02181673|41673250|FG000|Week 24-Week 60|Other|0|||
19426289|NCT02181673|41673251|FG001|Week 24-Week 60|Other|2|||
19426290|NCT02181673|41673252|FG002|Week 24-Week 60|Other|1|||
19426291|NCT02181673|41673250|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
19426292|NCT02181673|41673251|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
19426293|NCT02181673|41673252|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
19426294|NCT02181673|41673250|FG000|Week 24-Week 60|Pregnancy|0|||
19426295|NCT02181673|41673251|FG001|Week 24-Week 60|Pregnancy|0|||
19426296|NCT02181673|41673252|FG002|Week 24-Week 60|Pregnancy|1|||
19426297|NCT02181673|41673250|FG000|Week 24-Week 60|Lack of Efficacy|0|||
19426298|NCT02181673|41673251|FG001|Week 24-Week 60|Lack of Efficacy|0|||
19426299|NCT02181673|41673252|FG002|Week 24-Week 60|Lack of Efficacy|1|||
19426300|NCT02181673|41673250|FG000|Week 24-Week 60|Lost to Follow-up|0|||
19426301|NCT02181673|41673251|FG001|Week 24-Week 60|Lost to Follow-up|0|||
19426302|NCT02181673|41673252|FG002|Week 24-Week 60|Lost to Follow-up|1|||
19426303|NCT02181673|41673250|FG000|Week 24-Week 60|Physician Decision|0|||
19426304|NCT02181673|41673251|FG001|Week 24-Week 60|Physician Decision|0|||
19426305|NCT02181673|41673252|FG002|Week 24-Week 60|Physician Decision|1|||
19426306|NCT02131129|41673261|FG000|Overall Study|Withdrawal by Subject|1|||
19426307|NCT02131129|41673262|FG001|Overall Study|Withdrawal by Subject|0|||
19426308|NCT02152345|41673270|FG000|Overall Study|Case Cancellations|2|||
19426309|NCT02152345|41673271|FG001|Overall Study|Case Cancellations|4|||
19426310|NCT02152345|41673270|FG000|Overall Study|Withdrawal by Subject|2|||
19426311|NCT02152345|41673271|FG001|Overall Study|Withdrawal by Subject|1|||
19426312|NCT02180659|41673279|FG000|Overall Study|Adverse Event|1|||
19426313|NCT02180659|41673280|FG001|Overall Study|Adverse Event|0|||
19426314|NCT02180659|41673279|FG000|Overall Study|Lost to Follow-up|4|||
19426315|NCT02180659|41673280|FG001|Overall Study|Lost to Follow-up|2|||
19426316|NCT02180659|41673279|FG000|Overall Study|Subject incarcerated during conduct|1|||
19426317|NCT02180659|41673280|FG001|Overall Study|Subject incarcerated during conduct|0|||
19426318|NCT02180659|41673279|FG000|Overall Study|Withdrawal by Subject|0|||
19426319|NCT02180659|41673280|FG001|Overall Study|Withdrawal by Subject|2|||
19426320|NCT02180659|41673279|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
19426321|NCT02180659|41673280|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
19426322|NCT02130427|41673286|FG000|Overall Study|Imaging results not interpretable|30|||
19426323|NCT02207816|41673293|FG000|Overall Study|Serious Adverse Event|0|||
19426324|NCT02207816|41673294|FG001|Overall Study|Serious Adverse Event|5|||
19426325|NCT02207816|41673295|FG002|Overall Study|Serious Adverse Event|2|||
19426326|NCT02207816|41673293|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
19426327|NCT02207816|41673294|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
19426328|NCT02207816|41673295|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
19426329|NCT02207816|41673293|FG000|Overall Study|Withdrawal by Subject|4|||
19426330|NCT02207816|41673294|FG001|Overall Study|Withdrawal by Subject|9|||
19426331|NCT02207816|41673295|FG002|Overall Study|Withdrawal by Subject|7|||
19426332|NCT02207816|41673293|FG000|Overall Study|Migrated/Moved From Study Area|41|||
19426333|NCT02207816|41673294|FG001|Overall Study|Migrated/Moved From Study Area|60|||
19426334|NCT02207816|41673295|FG002|Overall Study|Migrated/Moved From Study Area|51|||
19426335|NCT02207816|41673293|FG000|Overall Study|Lost to Follow-up|3|||
19426336|NCT02207816|41673294|FG001|Overall Study|Lost to Follow-up|9|||
19426337|NCT02207816|41673295|FG002|Overall Study|Lost to Follow-up|1|||
19426338|NCT02207816|41673293|FG000|Overall Study|Other|1|||
19426339|NCT02207816|41673294|FG001|Overall Study|Other|2|||
19426340|NCT02207816|41673295|FG002|Overall Study|Other|4|||
19426341|NCT02241512|41673308|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
19426342|NCT02241512|41673309|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
19426343|NCT02205476|41673317|FG000|Overall Study|Study termination by Sponsor|7|||
19426344|NCT02205476|41673318|FG001|Overall Study|Study termination by Sponsor|3|||
19426345|NCT01709110|41673332|FG000|Overall Study|Adverse Event|56|||
19426346|NCT01709110|41673333|FG001|Overall Study|Adverse Event|48|||
19426347|NCT01709110|41673332|FG000|Overall Study|Death|14|||
19426348|NCT01709110|41673333|FG001|Overall Study|Death|6|||
19426349|NCT01709110|41673332|FG000|Overall Study|Lost to Follow-up|7|||
19426350|NCT01709110|41673333|FG001|Overall Study|Lost to Follow-up|5|||
19426351|NCT01709110|41673332|FG000|Overall Study|Protocol Violation|4|||
19426352|NCT01709110|41673333|FG001|Overall Study|Protocol Violation|6|||
19426353|NCT01709110|41673332|FG000|Overall Study|Withdrawal by Subject|96|||
19426354|NCT01709110|41673333|FG001|Overall Study|Withdrawal by Subject|89|||
19426355|NCT01709110|41673332|FG000|Overall Study|Physician Decision|4|||
19426356|NCT01709110|41673333|FG001|Overall Study|Physician Decision|10|||
19426357|NCT01709110|41673332|FG000|Overall Study|Sponsor Decision|2|||
19426358|NCT01709110|41673333|FG001|Overall Study|Sponsor Decision|2|||
19426359|NCT01709110|41673332|FG000|Overall Study|Lack of Efficacy|1|||
19426360|NCT01709110|41673333|FG001|Overall Study|Lack of Efficacy|1|||
19426361|NCT01709110|41673332|FG000|Overall Study|Caregiver Decision|1|||
19426362|NCT01709110|41673333|FG001|Overall Study|Caregiver Decision|1|||
19426363|NCT02240108|41673341|FG000|Overall Study|Other than specified|8|||
19426364|NCT02240108|41673342|FG001|Overall Study|Other than specified|6|||
19426365|NCT02240108|41673341|FG000|Overall Study|Adverse Event|1|||
19426366|NCT02240108|41673342|FG001|Overall Study|Adverse Event|9|||
19426367|NCT02240108|41673341|FG000|Overall Study|Pregnancy|1|||
19426368|NCT02240108|41673342|FG001|Overall Study|Pregnancy|0|||
19426369|NCT02240108|41673341|FG000|Overall Study|Withdrawal by Subject|4|||
19426370|NCT02240108|41673342|FG001|Overall Study|Withdrawal by Subject|9|||
19426371|NCT02240108|41673341|FG000|Overall Study|StudyTerminated by Sponsor|0|||
19426372|NCT02240108|41673342|FG001|Overall Study|StudyTerminated by Sponsor|1|||
19426373|NCT02239640|41673348|FG000|Overall Study|Withdrawal by Subject|3|||
19426374|NCT02239640|41673348|FG000|Overall Study|Lost to Follow-up|72|||
19426375|NCT02239640|41673348|FG000|Overall Study|Death|142|||
19426376|NCT01590628|41673360|FG000|Overall Study|Death|2|||
19426377|NCT01590628|41673361|FG001|Overall Study|Death|0|||
19426378|NCT02130193|41673373|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
19426379|NCT02130193|41673374|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
19426380|NCT02130193|41673375|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
19426381|NCT02130193|41673373|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
19375233|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
19375234|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
19375235|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
19375236|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
19375237|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
19375238|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
19375239|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
19426382|NCT02130193|41673374|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
19426383|NCT02130193|41673375|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
19426384|NCT02130193|41673373|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
19426385|NCT02130193|41673374|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
19426386|NCT02130193|41673375|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
19426387|NCT02130193|41673373|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
19426388|NCT02130193|41673374|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
19426389|NCT02130193|41673375|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
19426390|NCT01590082|41673386|FG000|Overall Study|Withdrawal by Subject|1|||
19426391|NCT01590082|41673387|FG001|Overall Study|Withdrawal by Subject|0|||
19426392|NCT01590082|41673386|FG000|Overall Study|Ineligible|1|||
19426393|NCT01590082|41673387|FG001|Overall Study|Ineligible|0|||
19426394|NCT01631474|41673398|FG000|Overall Study|Lost to Follow-up|8|||
19426395|NCT01631474|41673399|FG001|Overall Study|Lost to Follow-up|5|||
19375240|NCT01352741|41617026|FG000|Open-label Tapentadol Titration Period|Other|4|||
19375241|NCT01352741|41617027|FG001|Open-label Tapentadol Titration Period|Other|0|||
19426396|NCT01631474|41673400|FG002|Overall Study|Lost to Follow-up|7|||
19426397|NCT01631474|41673401|FG003|Overall Study|Lost to Follow-up|5|||
19426398|NCT01631474|41673402|FG004|Overall Study|Lost to Follow-up|5|||
19426399|NCT01631474|41673398|FG000|Overall Study|Withdrawal by Subject|4|||
19426400|NCT01631474|41673399|FG001|Overall Study|Withdrawal by Subject|4|||
19426401|NCT01631474|41673400|FG002|Overall Study|Withdrawal by Subject|2|||
19426402|NCT01631474|41673401|FG003|Overall Study|Withdrawal by Subject|6|||
19426403|NCT01631474|41673402|FG004|Overall Study|Withdrawal by Subject|5|||
19426404|NCT01631474|41673398|FG000|Overall Study|Lack of Efficacy|2|||
19426405|NCT01631474|41673399|FG001|Overall Study|Lack of Efficacy|2|||
19426406|NCT01631474|41673400|FG002|Overall Study|Lack of Efficacy|0|||
19426407|NCT01631474|41673401|FG003|Overall Study|Lack of Efficacy|0|||
19426408|NCT01631474|41673402|FG004|Overall Study|Lack of Efficacy|2|||
19426409|NCT01631474|41673398|FG000|Overall Study|Noncompliance with Study Drug|0|||
19426410|NCT01631474|41673399|FG001|Overall Study|Noncompliance with Study Drug|0|||
19426411|NCT01631474|41673400|FG002|Overall Study|Noncompliance with Study Drug|0|||
19426412|NCT01631474|41673401|FG003|Overall Study|Noncompliance with Study Drug|0|||
19426413|NCT01631474|41673402|FG004|Overall Study|Noncompliance with Study Drug|1|||
19426414|NCT01631474|41673398|FG000|Overall Study|Adverse Event|0|||
19426415|NCT01631474|41673399|FG001|Overall Study|Adverse Event|1|||
19426416|NCT01631474|41673400|FG002|Overall Study|Adverse Event|0|||
19426417|NCT01631474|41673401|FG003|Overall Study|Adverse Event|0|||
19426418|NCT01631474|41673402|FG004|Overall Study|Adverse Event|0|||
19426419|NCT02203916|41673417|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19426420|NCT02203916|41673418|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
19426421|NCT02203916|41673419|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
19426422|NCT02203916|41673417|FG000|Overall Study|Major Protocol Deviation|1|||
19426423|NCT02203916|41673418|FG001|Overall Study|Major Protocol Deviation|1|||
19426424|NCT02203916|41673419|FG002|Overall Study|Major Protocol Deviation|0|||
19426425|NCT02203916|41673417|FG000|Overall Study|Lost to Follow-up|0|||
19426426|NCT02203916|41673418|FG001|Overall Study|Lost to Follow-up|1|||
19426427|NCT02203916|41673419|FG002|Overall Study|Lost to Follow-up|0|||
19426428|NCT02203916|41673417|FG000|Overall Study|Voluntary Withdrawal|3|||
19426429|NCT02203916|41673418|FG001|Overall Study|Voluntary Withdrawal|3|||
19426430|NCT02203916|41673419|FG002|Overall Study|Voluntary Withdrawal|8|||
19426431|NCT02203916|41673417|FG000|Overall Study|Lack of Efficacy|3|||
19426432|NCT02203916|41673418|FG001|Overall Study|Lack of Efficacy|0|||
19426433|NCT02203916|41673419|FG002|Overall Study|Lack of Efficacy|0|||
19375242|NCT01352741|41617026|FG000|Double-blind Comparative Period|Protocol Violation|2|||
19375243|NCT01352741|41617027|FG001|Double-blind Comparative Period|Protocol Violation|0|||
19375244|NCT01352741|41617026|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
19375245|NCT01352741|41617027|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
19375246|NCT01352741|41617026|FG000|Double-blind Comparative Period|Adverse Event|16|||
19375247|NCT01352741|41617027|FG001|Double-blind Comparative Period|Adverse Event|17|||
19375248|NCT01352741|41617026|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
19375249|NCT01352741|41617027|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
19375250|NCT01352741|41617026|FG000|Double-blind Comparative Period|Death|0|||
19375251|NCT01352741|41617027|FG001|Double-blind Comparative Period|Death|1|||
19375252|NCT01352741|41617026|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
19375253|NCT01352741|41617027|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
19375254|NCT01352741|41617026|FG000|Double-blind Comparative Period|Other|1|||
19375255|NCT01352741|41617027|FG001|Double-blind Comparative Period|Other|2|||
19375256|NCT01352741|41617026|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
19375257|NCT01352741|41617027|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
19375258|NCT01352741|41617026|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
19375259|NCT01352741|41617027|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
19375260|NCT01352741|41617026|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
19375261|NCT01352741|41617027|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
19375262|NCT01352741|41617026|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
19375263|NCT01352741|41617027|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
19375264|NCT01657292|41617047|FG000|Overall Study|Adverse Event|6|||
19426434|NCT02203916|41673417|FG000|Overall Study|Reason Not Specified|0|||
19426435|NCT02203916|41673418|FG001|Overall Study|Reason Not Specified|2|||
19426436|NCT02203916|41673419|FG002|Overall Study|Reason Not Specified|1|||
19426437|NCT02179177|41673443|FG000|Overall Study|Lost to Follow-up|1|||
19426438|NCT02179177|41673444|FG001|Overall Study|Lost to Follow-up|1|||
19426439|NCT02179177|41673443|FG000|Overall Study|Withdrawal by Subject|1|||
19426440|NCT02179177|41673444|FG001|Overall Study|Withdrawal by Subject|1|||
19426441|NCT02239328|41673450|FG000|Overall Study|Benign disease noted at time of surgery|6|||
19426442|NCT02239328|41673450|FG000|Overall Study|Equipment or website malfunction|2|||
19426443|NCT02129803|41673456|FG000|Overall Study|Protocol Violation|4|||
19426444|NCT02129803|41673457|FG001|Overall Study|Protocol Violation|0|||
19426445|NCT02129803|41673456|FG000|Overall Study|Physician Decision|0|||
19426446|NCT02129803|41673457|FG001|Overall Study|Physician Decision|1|||
19426447|NCT02129803|41673456|FG000|Overall Study|Difficulty sleeping|1|||
19426448|NCT02129803|41673457|FG001|Overall Study|Difficulty sleeping|0|||
19426449|NCT02129803|41673456|FG000|Overall Study|Morning headache|0|||
19426450|NCT02129803|41673457|FG001|Overall Study|Morning headache|1|||
19426451|NCT02129803|41673456|FG000|Overall Study|Withdrawal by Subject|1|||
19426452|NCT02129803|41673457|FG001|Overall Study|Withdrawal by Subject|1|||
19426453|NCT02239094|41673463|FG000|Overall Study|Withdrawal by Subject|1|||
19426454|NCT02239094|41673463|FG000|Overall Study|Remitted before started|1|||
19426455|NCT02129647|41673467|FG000|Overall Study|Adverse Event|2|||
19426456|NCT02129647|41673467|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
19426457|NCT02238626|41673475|FG000|Overall Study|Adverse Event|3|||
19426458|NCT02238626|41673476|FG001|Overall Study|Adverse Event|5|||
19426459|NCT02238626|41673477|FG002|Overall Study|Adverse Event|0|||
19426460|NCT02238626|41673478|FG003|Overall Study|Adverse Event|3|||
19426461|NCT02238626|41673475|FG000|Overall Study|Lost to Follow-up|2|||
19426462|NCT02238626|41673476|FG001|Overall Study|Lost to Follow-up|4|||
19426463|NCT02238626|41673477|FG002|Overall Study|Lost to Follow-up|2|||
19426464|NCT02238626|41673478|FG003|Overall Study|Lost to Follow-up|2|||
19426465|NCT02238626|41673475|FG000|Overall Study|Withdrawal by Subject|0|||
19426466|NCT02238626|41673476|FG001|Overall Study|Withdrawal by Subject|3|||
19426467|NCT02238626|41673477|FG002|Overall Study|Withdrawal by Subject|0|||
19426468|NCT02238626|41673478|FG003|Overall Study|Withdrawal by Subject|1|||
19426469|NCT02238626|41673475|FG000|Overall Study|Death|0|||
19426470|NCT02238626|41673476|FG001|Overall Study|Death|0|||
19426471|NCT02238626|41673477|FG002|Overall Study|Death|1|||
19426472|NCT02238626|41673478|FG003|Overall Study|Death|1|||
19426473|NCT02238626|41673475|FG000|Overall Study|Other|0|||
19426474|NCT02238626|41673476|FG001|Overall Study|Other|2|||
19426475|NCT02238626|41673477|FG002|Overall Study|Other|0|||
19426476|NCT02238626|41673478|FG003|Overall Study|Other|0|||
19426477|NCT02151643|41673504|FG000|Overall Study|Adverse Event|2|||
19426478|NCT02151643|41673505|FG001|Overall Study|Adverse Event|0|||
19426479|NCT02151643|41673506|FG002|Overall Study|Adverse Event|1|||
19426480|NCT02151643|41673507|FG003|Overall Study|Adverse Event|4|||
19426481|NCT02151643|41673508|FG004|Overall Study|Adverse Event|0|||
19426482|NCT02151643|41673504|FG000|Overall Study|Withdrawal by Subject|0|||
19426483|NCT02151643|41673505|FG001|Overall Study|Withdrawal by Subject|1|||
19426484|NCT02151643|41673506|FG002|Overall Study|Withdrawal by Subject|1|||
19426485|NCT02151643|41673507|FG003|Overall Study|Withdrawal by Subject|1|||
19426486|NCT02151643|41673508|FG004|Overall Study|Withdrawal by Subject|1|||
19426487|NCT02151643|41673504|FG000|Overall Study|Hyperphosphataemia|1|||
19426488|NCT02151643|41673505|FG001|Overall Study|Hyperphosphataemia|0|||
19426489|NCT02151643|41673506|FG002|Overall Study|Hyperphosphataemia|0|||
19426490|NCT02151643|41673507|FG003|Overall Study|Hyperphosphataemia|0|||
19426491|NCT02151643|41673508|FG004|Overall Study|Hyperphosphataemia|1|||
19426492|NCT02151643|41673504|FG000|Overall Study|High Ferritin levels|3|||
19426493|NCT02151643|41673505|FG001|Overall Study|High Ferritin levels|3|||
19426494|NCT02151643|41673506|FG002|Overall Study|High Ferritin levels|2|||
19426495|NCT02151643|41673507|FG003|Overall Study|High Ferritin levels|2|||
19426496|NCT02151643|41673508|FG004|Overall Study|High Ferritin levels|1|||
19426497|NCT02203838|41673524|FG000|Overall Study|Lack of Efficacy|7|||
19426498|NCT02203838|41673525|FG001|Overall Study|Lack of Efficacy|0|||
19426499|NCT02203838|41673526|FG002|Overall Study|Lack of Efficacy|1|||
19426500|NCT02203838|41673527|FG003|Overall Study|Lack of Efficacy|1|||
19426501|NCT02203838|41673524|FG000|Overall Study|Adverse Event|46|||
19426502|NCT02203838|41673525|FG001|Overall Study|Adverse Event|6|||
19426503|NCT02203838|41673526|FG002|Overall Study|Adverse Event|3|||
19426504|NCT02203838|41673527|FG003|Overall Study|Adverse Event|2|||
19426505|NCT02203838|41673524|FG000|Overall Study|Lost to Follow-up|39|||
19426506|NCT02203838|41673525|FG001|Overall Study|Lost to Follow-up|3|||
19426507|NCT02203838|41673526|FG002|Overall Study|Lost to Follow-up|2|||
19426508|NCT02203838|41673527|FG003|Overall Study|Lost to Follow-up|1|||
19426509|NCT02203838|41673524|FG000|Overall Study|Protocol Violation|7|||
19426510|NCT02203838|41673525|FG001|Overall Study|Protocol Violation|3|||
19426511|NCT02203838|41673526|FG002|Overall Study|Protocol Violation|0|||
19426512|NCT02203838|41673527|FG003|Overall Study|Protocol Violation|0|||
19426513|NCT02203838|41673524|FG000|Overall Study|Withdrawal by Subject|83|||
19426514|NCT02203838|41673525|FG001|Overall Study|Withdrawal by Subject|10|||
19426515|NCT02203838|41673526|FG002|Overall Study|Withdrawal by Subject|8|||
19426516|NCT02203838|41673527|FG003|Overall Study|Withdrawal by Subject|11|||
19426517|NCT02203838|41673524|FG000|Overall Study|Physician Decision|27|||
19426518|NCT02203838|41673525|FG001|Overall Study|Physician Decision|0|||
19426519|NCT02203838|41673526|FG002|Overall Study|Physician Decision|2|||
19426520|NCT02203838|41673527|FG003|Overall Study|Physician Decision|3|||
19426521|NCT02203838|41673524|FG000|Overall Study|Other|1|||
19426522|NCT02203838|41673525|FG001|Overall Study|Other|0|||
19426523|NCT02203838|41673526|FG002|Overall Study|Other|0|||
19426524|NCT02203838|41673527|FG003|Overall Study|Other|0|||
19426525|NCT02178787|41673539|FG000|Overall Study|Lost to Follow-up|1|||
19426526|NCT02178787|41673540|FG001|Overall Study|Lost to Follow-up|0|||
19426527|NCT02178787|41673539|FG000|Overall Study|Withdrawal by Subject|0|||
19426528|NCT02178787|41673540|FG001|Overall Study|Withdrawal by Subject|2|||
19426529|NCT02178787|41673539|FG000|Overall Study|No TCD window|3|||
19426530|NCT02178787|41673540|FG001|Overall Study|No TCD window|7|||
19426531|NCT02178787|41673539|FG000|Overall Study|Physician Decision|1|||
19426532|NCT02178787|41673540|FG001|Overall Study|Physician Decision|0|||
19426533|NCT02178709|41673548|FG000|Overall Study|Adverse Event|5|||
19426534|NCT02178709|41673548|FG000|Overall Study|Death|2|||
19426535|NCT02178709|41673548|FG000|Overall Study|Withdrawal by Subject|2|||
19426536|NCT02178709|41673548|FG000|Overall Study|Physician Decision|2|||
19426537|NCT02178709|41673548|FG000|Overall Study|Disease Progression|5|||
19426538|NCT02238080|41673552|FG000|Overall Study|Death|13|||
19628260|NCT00789477|42077700|FG003|Overall Study|Withdrawal by Subject|2|||
19426539|NCT02238080|41673552|FG000|Overall Study|Treatment interrupted|6|||
19426540|NCT02238080|41673552|FG000|Overall Study|Withdrawal by Subject|2|||
19426541|NCT02238080|41673552|FG000|Overall Study|Other|4|||
19426542|NCT02150863|41673559|FG000|Overall Study|Lost to Follow-up|0|||
19426543|NCT02150863|41673560|FG001|Overall Study|Lost to Follow-up|1|||
19426544|NCT02150863|41673561|FG002|Overall Study|Lost to Follow-up|0|||
19426545|NCT02178553|41673571|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
19426546|NCT02178553|41673572|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
19426547|NCT02178553|41673571|FG000|Overall Study|Physician Decision|0|||
19426548|NCT02178553|41673572|FG001|Overall Study|Physician Decision|4|||
19426549|NCT02178553|41673571|FG000|Overall Study|Technical problem with injection|1|||
19426550|NCT02178553|41673572|FG001|Overall Study|Technical problem with injection|3|||
19426551|NCT01627327|41673580|FG000|Overall Study|Adverse Event|6|||
19426552|NCT01627327|41673581|FG001|Overall Study|Adverse Event|12|||
19426553|NCT01627327|41673580|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
19426554|NCT01627327|41673581|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
19426555|NCT01627327|41673580|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
19426556|NCT01627327|41673581|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
19426557|NCT01627327|41673580|FG000|Overall Study|Protocol Violation|4|||
19426558|NCT01627327|41673581|FG001|Overall Study|Protocol Violation|10|||
19426559|NCT01627327|41673580|FG000|Overall Study|Lost to Follow-up|1|||
19426560|NCT01627327|41673581|FG001|Overall Study|Lost to Follow-up|3|||
19426561|NCT01627327|41673580|FG000|Overall Study|Physician Decision|1|||
19426562|NCT01627327|41673581|FG001|Overall Study|Physician Decision|0|||
19426563|NCT01627327|41673580|FG000|Overall Study|Withdrawal by Subject|3|||
19426564|NCT01627327|41673581|FG001|Overall Study|Withdrawal by Subject|3|||
19426565|NCT01627249|41673590|FG000|Overall Study|Death|3|||
19426566|NCT01627249|41673591|FG001|Overall Study|Death|5|||
19426567|NCT01627249|41673592|FG002|Overall Study|Death|3|||
19426568|NCT01627249|41673590|FG000|Overall Study|Withdrawal by Subject|12|||
19426569|NCT01627249|41673591|FG001|Overall Study|Withdrawal by Subject|6|||
19426570|NCT01627249|41673592|FG002|Overall Study|Withdrawal by Subject|9|||
19426571|NCT01627249|41673590|FG000|Overall Study|Missed Visit|1|||
19426572|NCT01627249|41673591|FG001|Overall Study|Missed Visit|1|||
19426573|NCT01627249|41673592|FG002|Overall Study|Missed Visit|0|||
19426574|NCT01688830|41673621|FG000|Overall Study|Lost to Follow-up|0|||
19426575|NCT01688830|41673622|FG001|Overall Study|Lost to Follow-up|0|||
19426576|NCT01688830|41673623|FG002|Overall Study|Lost to Follow-up|0|||
19426577|NCT01688830|41673624|FG003|Overall Study|Lost to Follow-up|0|||
19426578|NCT01688830|41673625|FG004|Overall Study|Lost to Follow-up|0|||
19426579|NCT01688830|41673626|FG005|Overall Study|Lost to Follow-up|0|||
19426580|NCT01688830|41673627|FG006|Overall Study|Lost to Follow-up|0|||
19426581|NCT01688830|41673628|FG007|Overall Study|Lost to Follow-up|0|||
19426582|NCT01688830|41673629|FG008|Overall Study|Lost to Follow-up|0|||
19426583|NCT01688830|41673630|FG009|Overall Study|Lost to Follow-up|0|||
19426584|NCT01688830|41673631|FG010|Overall Study|Lost to Follow-up|1|||
19426585|NCT01688830|41673632|FG011|Overall Study|Lost to Follow-up|0|||
19426586|NCT01688830|41673633|FG012|Overall Study|Lost to Follow-up|0|||
19426587|NCT01688830|41673634|FG013|Overall Study|Lost to Follow-up|0|||
19426588|NCT01688830|41673635|FG014|Overall Study|Lost to Follow-up|0|||
19426589|NCT01688830|41673636|FG015|Overall Study|Lost to Follow-up|0|||
19426590|NCT01688830|41673637|FG016|Overall Study|Lost to Follow-up|0|||
19426591|NCT01688830|41673638|FG017|Overall Study|Lost to Follow-up|0|||
19426592|NCT01688830|41673639|FG018|Overall Study|Lost to Follow-up|0|||
19426593|NCT01688830|41673640|FG019|Overall Study|Lost to Follow-up|0|||
19426594|NCT01688830|41673641|FG020|Overall Study|Lost to Follow-up|0|||
19426595|NCT02178475|41673725|FG000|Overall Study|Withdrawal by Subject|7|||
19426596|NCT02178475|41673725|FG000|Overall Study|Lost to Follow-up|10|||
19426597|NCT02178475|41673725|FG000|Overall Study|Death|13|||
19426598|NCT02178475|41673725|FG000|Overall Study|Protocol-specified Criteria|99|||
19426599|NCT01569022|41673729|FG000|First Intervention|Lost to Follow-up|2|||
19426600|NCT01569022|41673730|FG001|First Intervention|Lost to Follow-up|1|||
19426601|NCT01569022|41673729|FG000|Second Intervention|Lost to Follow-up|2|||
19426602|NCT01569022|41673730|FG001|Second Intervention|Lost to Follow-up|2|||
19426603|NCT01629823|41673741|FG000|Trial Period|Missed visit|11|||
19426604|NCT01629823|41673742|FG001|Trial Period|Missed visit|9|||
19426605|NCT01629823|41673743|FG002|Trial Period|Missed visit|8|||
19426606|NCT01629823|41673741|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
19426607|NCT01629823|41673742|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
19426608|NCT01629823|41673743|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
19426609|NCT01629823|41673741|FG000|Trial Period|Pregnancy|1|||
19426610|NCT01629823|41673742|FG001|Trial Period|Pregnancy|0|||
19426611|NCT01629823|41673743|FG002|Trial Period|Pregnancy|0|||
19426612|NCT01629823|41673741|FG000|Trial Period|Adverse Event|0|||
19426613|NCT01629823|41673742|FG001|Trial Period|Adverse Event|1|||
19426614|NCT01629823|41673743|FG002|Trial Period|Adverse Event|0|||
19426615|NCT01629823|41673741|FG000|Trial Period|Out-of-window visit|0|||
19426616|NCT01629823|41673742|FG001|Trial Period|Out-of-window visit|2|||
19426617|NCT01629823|41673743|FG002|Trial Period|Out-of-window visit|0|||
19426618|NCT01629823|41673741|FG000|Trial Period|Failed to hold medication|0|||
19426619|NCT01629823|41673742|FG001|Trial Period|Failed to hold medication|0|||
19426620|NCT01629823|41673743|FG002|Trial Period|Failed to hold medication|1|||
19426621|NCT01629823|41673741|FG000|Washout Period|Safety|2|||
19426622|NCT01629823|41673742|FG001|Washout Period|Safety|5|||
19426623|NCT01629823|41673743|FG002|Washout Period|Safety|0|||
19426624|NCT01629823|41673741|FG000|Washout Period|Pregnancy|1|||
19426625|NCT01629823|41673742|FG001|Washout Period|Pregnancy|0|||
19426626|NCT01629823|41673743|FG002|Washout Period|Pregnancy|0|||
19426627|NCT01629823|41673741|FG000|Washout Period|Protocol Violation|0|||
19426628|NCT01629823|41673742|FG001|Washout Period|Protocol Violation|1|||
19426629|NCT01629823|41673743|FG002|Washout Period|Protocol Violation|0|||
19426630|NCT01688050|41673751|FG000|Overall Study|Death|7|||
19426631|NCT01688050|41673751|FG000|Overall Study|Conversion to open repair|1|||
19426632|NCT01688050|41673751|FG000|Overall Study|Lost to Follow-up|13|||
19426633|NCT01688050|41673751|FG000|Overall Study|Withdrawal by Subject|10|||
19426634|NCT01604278|41673757|FG000|Overall Study|Lack of Efficacy|0|||
19426635|NCT01604278|41673758|FG001|Overall Study|Lack of Efficacy|1|||
19426636|NCT01604278|41673757|FG000|Overall Study|Lost to Follow-up|1|||
19426637|NCT01604278|41673758|FG001|Overall Study|Lost to Follow-up|0|||
19426638|NCT01604278|41673757|FG000|Overall Study|Administrative problems|2|||
19426639|NCT01604278|41673758|FG001|Overall Study|Administrative problems|1|||
19426640|NCT01604278|41673757|FG000|Overall Study|Withdrawal by Subject|3|||
19426641|NCT01604278|41673758|FG001|Overall Study|Withdrawal by Subject|3|||
19426642|NCT01604278|41673757|FG000|Overall Study|Adverse Event|3|||
19426643|NCT01604278|41673758|FG001|Overall Study|Adverse Event|5|||
19426644|NCT01604278|41673757|FG000|Overall Study|Protocol Deviation|5|||
19426645|NCT01604278|41673758|FG001|Overall Study|Protocol Deviation|3|||
19426646|NCT01687270|41673764|FG000|Overall Study|Lack of Efficacy|11|||
19426647|NCT01687270|41673764|FG000|Overall Study|Lost to Follow-up|1|||
19426648|NCT01589770|41673770|FG000|Overall Study|EGFR <60ml/min|6|||
19426649|NCT01589770|41673771|FG001|Overall Study|EGFR <60ml/min|4|||
19426650|NCT01589770|41673770|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
19426651|NCT01589770|41673771|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
19426652|NCT01588990|41673777|FG000|Phase A|Withdrawal by Subject|5|||
19426653|NCT01588990|41673777|FG000|Phase A|Physician Decision|11|||
19426654|NCT01588990|41673777|FG000|Phase A|Other|14|||
19426655|NCT01588990|41673777|FG000|Phase A|Lost to Follow-up|1|||
19426656|NCT01588990|41673777|FG000|Phase A|Death|5|||
19426657|NCT01588990|41673777|FG000|Phase A|Adverse Event|28|||
19426658|NCT01588990|41673777|FG000|Phase A|Still on therapy at end of study|6|||
19426659|NCT01588990|41673777|FG000|Phase B|Adverse Event|2|||
19426660|NCT01588990|41673777|FG000|Phase B|Still on therapy at end of study|5|||
19426661|NCT01588990|41673777|FG000|Phase B|Withdrawal by Subject|3|||
19426662|NCT01588990|41673777|FG000|Phase B|Physician Decision|4|||
19426663|NCT01588990|41673777|FG000|Phase B|Other|2|||
19426664|NCT02176525|41673793|FG000|Overall Study|Adverse Event|0|||
19426665|NCT02176525|41673794|FG001|Overall Study|Adverse Event|0|||
19426666|NCT02176525|41673795|FG002|Overall Study|Adverse Event|0|||
19426667|NCT02176525|41673796|FG003|Overall Study|Adverse Event|1|||
19426668|NCT02176525|41673797|FG004|Overall Study|Adverse Event|1|||
19426669|NCT02176525|41673798|FG005|Overall Study|Adverse Event|0|||
19426670|NCT02176525|41673799|FG006|Overall Study|Adverse Event|1|||
19426671|NCT02176525|41673800|FG007|Overall Study|Adverse Event|0|||
19426672|NCT02176525|41673793|FG000|Overall Study|not treated|1|||
19426673|NCT02176525|41673794|FG001|Overall Study|not treated|0|||
19426674|NCT02176525|41673795|FG002|Overall Study|not treated|0|||
19426675|NCT02176525|41673796|FG003|Overall Study|not treated|0|||
19426676|NCT02176525|41673797|FG004|Overall Study|not treated|0|||
19426677|NCT02176525|41673798|FG005|Overall Study|not treated|1|||
19426678|NCT02176525|41673799|FG006|Overall Study|not treated|0|||
19426679|NCT02176525|41673800|FG007|Overall Study|not treated|0|||
19426680|NCT02127931|41673826|FG000|Overall Study|Glitch in Game|1|||
19426681|NCT02127307|41673831|FG000|Overall Study|Protocol Violation|36|||
19426682|NCT02127307|41673831|FG000|Overall Study|Lost to Follow-up|2|||
19426683|NCT02127307|41673831|FG000|Overall Study|Death|101|||
19426684|NCT02127307|41673831|FG000|Overall Study|Other than specified above|169|||
19426685|NCT02126839|41673837|FG000|Overall Study|Adverse Event|0|||
19426686|NCT02126839|41673838|FG001|Overall Study|Adverse Event|1|||
19426687|NCT02126839|41673837|FG000|Overall Study|Withdrawal by Subject|1|||
19426688|NCT02126839|41673838|FG001|Overall Study|Withdrawal by Subject|0|||
19426689|NCT02126839|41673837|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19426690|NCT02126839|41673838|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19426691|NCT02126839|41673837|FG000|Overall Study|Protocol Violation|2|||
19426692|NCT02126839|41673838|FG001|Overall Study|Protocol Violation|3|||
19426693|NCT02126839|41673837|FG000|Overall Study|Sponsor request|0|||
19426694|NCT02126839|41673838|FG001|Overall Study|Sponsor request|1|||
19426695|NCT02126839|41673837|FG000|Overall Study|Lost to Follow-up|1|||
19426696|NCT02126839|41673838|FG001|Overall Study|Lost to Follow-up|4|||
19426697|NCT02126839|41673837|FG000|Overall Study|Other|5|||
19426698|NCT02126839|41673838|FG001|Overall Study|Other|5|||
19426699|NCT02125279|41673844|FG000|Overall Study|Lack of Efficacy|2|||
19426700|NCT02125279|41673844|FG000|Overall Study|Withdrawal by Subject|6|||
19426701|NCT02125279|41673844|FG000|Overall Study|Protocol Violation|1|||
19426702|NCT02125279|41673844|FG000|Overall Study|Lost to Follow-up|4|||
19426703|NCT02124811|41673852|FG000|Overall Study|Early termination|2|||
19426704|NCT02124811|41673853|FG001|Overall Study|Early termination|2|||
19426705|NCT02124811|41673852|FG000|Overall Study|Withdrawal by Subject|1|||
19426706|NCT02124811|41673853|FG001|Overall Study|Withdrawal by Subject|0|||
19426707|NCT02148445|41673861|FG000|Overall Study|Death|1|||
19426708|NCT02148445|41673862|FG001|Overall Study|Death|3|||
19426709|NCT02148211|41673870|FG000|Overall Study|Lost to Follow-up|352|||
19426710|NCT02147587|41673876|FG000|Overall Study|Adverse Event|9|||
19426711|NCT02147587|41673877|FG001|Overall Study|Adverse Event|4|||
19426712|NCT02147587|41673876|FG000|Overall Study|Lack of Efficacy|2|||
19426713|NCT02147587|41673877|FG001|Overall Study|Lack of Efficacy|1|||
19426714|NCT02147353|41673885|FG000|Overall Study|Lost to Follow-up|2|||
19426715|NCT02147353|41673886|FG001|Overall Study|Lost to Follow-up|0|||
19426716|NCT02147353|41673885|FG000|Overall Study|unable to make visits|4|||
19426717|NCT02147353|41673886|FG001|Overall Study|unable to make visits|0|||
19426718|NCT02147353|41673885|FG000|Overall Study|medication noncompliance|3|||
19426719|NCT02147353|41673886|FG001|Overall Study|medication noncompliance|0|||
19426720|NCT02147197|41673895|FG000|Overall Study|Adverse Event|1|||
19426721|NCT02147197|41673896|FG001|Overall Study|Adverse Event|0|||
19426722|NCT02147197|41673897|FG002|Overall Study|Adverse Event|0|||
19426723|NCT02147197|41673895|FG000|Overall Study|Withdrawal of Consent|4|||
19426724|NCT02147197|41673896|FG001|Overall Study|Withdrawal of Consent|3|||
19426725|NCT02147197|41673897|FG002|Overall Study|Withdrawal of Consent|2|||
19426726|NCT02147197|41673895|FG000|Overall Study|Lost to Follow-up|2|||
19426727|NCT02147197|41673896|FG001|Overall Study|Lost to Follow-up|3|||
19426728|NCT02147197|41673897|FG002|Overall Study|Lost to Follow-up|1|||
19426729|NCT02147197|41673895|FG000|Overall Study|Protocol Violation|1|||
19426730|NCT02147197|41673896|FG001|Overall Study|Protocol Violation|0|||
19426731|NCT02147197|41673897|FG002|Overall Study|Protocol Violation|3|||
19426732|NCT02147197|41673895|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19426733|NCT02147197|41673896|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19426734|NCT02147197|41673897|FG002|Overall Study|Other Miscellaneous Reasons|3|||
19426735|NCT02176291|41673907|FG000|Overall Study|Death|1|||
19426736|NCT02176291|41673908|FG001|Overall Study|Death|0|||
19426737|NCT02176291|41673907|FG000|Overall Study|non compliance with protocol|2|||
19426738|NCT02176291|41673908|FG001|Overall Study|non compliance with protocol|0|||
19426739|NCT02176291|41673907|FG000|Overall Study|Withdrawal by Subject|2|||
19426740|NCT02176291|41673908|FG001|Overall Study|Withdrawal by Subject|0|||
19426741|NCT02175745|41673914|FG000|Overall Study|Not Eligible|1|||
19426742|NCT02175277|41673918|FG000|Overall Study|Protocol-specified Criteria|1|||
19426743|NCT02124265|41673922|FG000|Overall Study|Adverse Event|1|||
19426744|NCT02146105|41673926|FG000|Overall Study|Adverse Event|1|||
19426745|NCT02146105|41673926|FG000|Overall Study|Withdrawal by Subject|5|||
19426746|NCT02175199|41673932|FG000|Overall Study|Withdrawal by Subject|1|||
19426747|NCT02175199|41673933|FG001|Overall Study|Withdrawal by Subject|5|||
19426748|NCT02175199|41673932|FG000|Overall Study|Randomized in Error|1|||
19426749|NCT02175199|41673933|FG001|Overall Study|Randomized in Error|0|||
19426750|NCT02175199|41673932|FG000|Overall Study|Sponsor Decision|1|||
19426751|NCT02175199|41673933|FG001|Overall Study|Sponsor Decision|0|||
19426752|NCT02123797|41673942|FG000|Baseline Intervention|Death|9|||
19426753|NCT02123797|41673943|FG001|Baseline Intervention|Death|16|||
19426754|NCT02123797|41673944|FG002|Baseline Intervention|Death|0|||
19426755|NCT02123797|41673945|FG003|Baseline Intervention|Death|0|||
19520941|NCT01422876|41933737|FG006|Week 24|Death|0|||
19426756|NCT02123797|41673946|FG004|Baseline Intervention|Death|0|||
19426757|NCT02123797|41673942|FG000|Baseline Intervention|Withdrawal by Subject|2|||
19426758|NCT02123797|41673943|FG001|Baseline Intervention|Withdrawal by Subject|8|||
19426759|NCT02123797|41673944|FG002|Baseline Intervention|Withdrawal by Subject|0|||
19520942|NCT01422876|41933738|FG007|Week 24|Death|0|||
19426760|NCT02123797|41673945|FG003|Baseline Intervention|Withdrawal by Subject|0|||
19426761|NCT02123797|41673946|FG004|Baseline Intervention|Withdrawal by Subject|0|||
19426762|NCT02123797|41673942|FG000|Baseline Intervention|Relocation|2|||
19426763|NCT02123797|41673943|FG001|Baseline Intervention|Relocation|0|||
19426764|NCT02123797|41673944|FG002|Baseline Intervention|Relocation|0|||
19426765|NCT02123797|41673945|FG003|Baseline Intervention|Relocation|0|||
19426766|NCT02123797|41673946|FG004|Baseline Intervention|Relocation|0|||
19426767|NCT02123797|41673942|FG000|Baseline Intervention|Out of window for initial survey|6|||
19426768|NCT02123797|41673943|FG001|Baseline Intervention|Out of window for initial survey|13|||
19426769|NCT02123797|41673944|FG002|Baseline Intervention|Out of window for initial survey|0|||
19426770|NCT02123797|41673945|FG003|Baseline Intervention|Out of window for initial survey|0|||
19426771|NCT02123797|41673946|FG004|Baseline Intervention|Out of window for initial survey|0|||
19426772|NCT02123797|41673942|FG000|Baseline Intervention|Lost to Follow-up|0|||
19426773|NCT02123797|41673943|FG001|Baseline Intervention|Lost to Follow-up|5|||
19426774|NCT02123797|41673944|FG002|Baseline Intervention|Lost to Follow-up|0|||
19426775|NCT02123797|41673945|FG003|Baseline Intervention|Lost to Follow-up|0|||
19426776|NCT02123797|41673946|FG004|Baseline Intervention|Lost to Follow-up|0|||
19426777|NCT02123797|41673942|FG000|Baseline Intervention|Other Disease|3|||
19426778|NCT02123797|41673943|FG001|Baseline Intervention|Other Disease|0|||
19426779|NCT02123797|41673944|FG002|Baseline Intervention|Other Disease|0|||
19426780|NCT02123797|41673945|FG003|Baseline Intervention|Other Disease|0|||
19426781|NCT02123797|41673946|FG004|Baseline Intervention|Other Disease|0|||
19426782|NCT02123797|41673942|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
19426783|NCT02123797|41673943|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
19426784|NCT02123797|41673944|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
19426785|NCT02123797|41673945|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
19426786|NCT02123797|41673946|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
19426787|NCT02123797|41673942|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
19426788|NCT02123797|41673943|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
19426789|NCT02123797|41673944|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
19426790|NCT02123797|41673945|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
19426791|NCT02123797|41673946|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
19426792|NCT02123797|41673942|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
19426793|NCT02123797|41673943|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
19426794|NCT02123797|41673944|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426795|NCT02123797|41673945|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426796|NCT02123797|41673946|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426797|NCT02123797|41673942|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
19426798|NCT02123797|41673943|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
19426799|NCT02123797|41673944|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
19426800|NCT02123797|41673945|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
19426801|NCT02123797|41673946|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
19426802|NCT02123797|41673942|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
19426803|NCT02123797|41673943|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
19426804|NCT02123797|41673944|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
19426805|NCT02123797|41673945|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
19426806|NCT02123797|41673946|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
19426807|NCT02123797|41673942|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
19426808|NCT02123797|41673943|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
19426809|NCT02123797|41673944|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
19426810|NCT02123797|41673945|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
19375265|NCT01657292|41617047|FG000|Overall Study|Withdrawal by Subject|2|||
19375266|NCT01657292|41617047|FG000|Overall Study|Violation of eligibility criteria|1|||
19375267|NCT01657292|41617047|FG000|Overall Study|Change of therapy|1|||
19375268|NCT00905567|41617063|FG000|Washout|Withdrawal by Subject|0|||
19375269|NCT00905567|41617064|FG001|Washout|Withdrawal by Subject|1|||
19375270|NCT02282020|41617070|FG000|Overall Study|Objective Disease Progression|128|||
19375271|NCT02282020|41617071|FG001|Overall Study|Objective Disease Progression|30|||
19375272|NCT02282020|41617070|FG000|Overall Study|Adverse Event|18|||
19375273|NCT02282020|41617071|FG001|Overall Study|Adverse Event|15|||
19375274|NCT02282020|41617070|FG000|Overall Study|Withdrawal by Subject|7|||
19375275|NCT02282020|41617071|FG001|Overall Study|Withdrawal by Subject|10|||
19375276|NCT02282020|41617070|FG000|Overall Study|Miscellaneous|5|||
19375277|NCT02282020|41617071|FG001|Overall Study|Miscellaneous|19|||
19375278|NCT02282020|41617070|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
19375279|NCT02282020|41617071|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
19375280|NCT02282020|41617070|FG000|Overall Study|Developed Discontinuation Criteria|0|||
19375281|NCT02282020|41617071|FG001|Overall Study|Developed Discontinuation Criteria|2|||
19375282|NCT02282020|41617070|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
19375283|NCT02282020|41617071|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
19426811|NCT02123797|41673946|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
19426812|NCT02123797|41673942|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
19426813|NCT02123797|41673943|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
19426814|NCT02123797|41673944|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
19426815|NCT02123797|41673945|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
19426816|NCT02123797|41673946|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
19426817|NCT02123797|41673942|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
19426818|NCT02123797|41673943|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
19426819|NCT02123797|41673944|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426820|NCT02123797|41673945|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426821|NCT02123797|41673946|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
19426822|NCT02123797|41673942|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
19426823|NCT02123797|41673943|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
19426824|NCT02123797|41673944|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
19426825|NCT02123797|41673945|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
19426826|NCT02123797|41673946|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
19426827|NCT02175121|41673971|FG000|Overall Study|Lack of Efficacy|1|||
19426828|NCT02175121|41673972|FG001|Overall Study|Lack of Efficacy|0|||
19426829|NCT02175121|41673973|FG002|Overall Study|Lack of Efficacy|0|||
19426830|NCT02175121|41673974|FG003|Overall Study|Lack of Efficacy|0|||
19426831|NCT02175121|41673975|FG004|Overall Study|Lack of Efficacy|0|||
19426832|NCT02175121|41673971|FG000|Overall Study|Lost to Follow-up|0|||
19426833|NCT02175121|41673972|FG001|Overall Study|Lost to Follow-up|1|||
19426834|NCT02175121|41673973|FG002|Overall Study|Lost to Follow-up|0|||
19426835|NCT02175121|41673974|FG003|Overall Study|Lost to Follow-up|1|||
19426836|NCT02175121|41673975|FG004|Overall Study|Lost to Follow-up|0|||
19426837|NCT02175121|41673971|FG000|Overall Study|Personal emergency|0|||
19426838|NCT02175121|41673972|FG001|Overall Study|Personal emergency|0|||
19426839|NCT02175121|41673973|FG002|Overall Study|Personal emergency|0|||
19426840|NCT02175121|41673974|FG003|Overall Study|Personal emergency|0|||
19426841|NCT02175121|41673975|FG004|Overall Study|Personal emergency|1|||
19426842|NCT02175121|41673971|FG000|Overall Study|Schedule conflict|0|||
19426843|NCT02175121|41673972|FG001|Overall Study|Schedule conflict|0|||
19426844|NCT02175121|41673973|FG002|Overall Study|Schedule conflict|1|||
19426845|NCT02175121|41673974|FG003|Overall Study|Schedule conflict|0|||
19426846|NCT02175121|41673975|FG004|Overall Study|Schedule conflict|0|||
19426847|NCT02175121|41673971|FG000|Overall Study|Time issues|0|||
19426848|NCT02175121|41673972|FG001|Overall Study|Time issues|0|||
19426849|NCT02175121|41673973|FG002|Overall Study|Time issues|1|||
19426850|NCT02175121|41673974|FG003|Overall Study|Time issues|0|||
19426851|NCT02175121|41673975|FG004|Overall Study|Time issues|0|||
19426852|NCT01568866|41673993|FG000|Overall Study|Disease Progression|208|||
19426853|NCT01568866|41673994|FG001|Overall Study|Disease Progression|183|||
19426854|NCT01568866|41673993|FG000|Overall Study|Adverse Event|94|||
19426855|NCT01568866|41673994|FG001|Overall Study|Adverse Event|96|||
19426856|NCT01568866|41673993|FG000|Overall Study|Patient Request|55|||
19426857|NCT01568866|41673994|FG001|Overall Study|Patient Request|71|||
19426858|NCT01568866|41673993|FG000|Overall Study|Physician Decision|40|||
19426859|NCT01568866|41673994|FG001|Overall Study|Physician Decision|32|||
19426860|NCT01568866|41673993|FG000|Overall Study|Withdrawal by Subject|19|||
19426861|NCT01568866|41673994|FG001|Overall Study|Withdrawal by Subject|11|||
19426862|NCT01568866|41673993|FG000|Overall Study|Death|10|||
19426863|NCT01568866|41673994|FG001|Overall Study|Death|18|||
19426864|NCT01568866|41673993|FG000|Overall Study|Protocol Non-compliance|2|||
19426865|NCT01568866|41673994|FG001|Overall Study|Protocol Non-compliance|4|||
19426866|NCT01568866|41673993|FG000|Overall Study|Lost to Follow-up|1|||
19426867|NCT01568866|41673994|FG001|Overall Study|Lost to Follow-up|0|||
19426868|NCT01568866|41673993|FG000|Overall Study|Randomized but Not Dosed|9|||
19426869|NCT01568866|41673994|FG001|Overall Study|Randomized but Not Dosed|1|||
19426870|NCT01568320|41674000|FG000|Overall Study|Death|20|||
19426871|NCT01568320|41674000|FG000|Overall Study|Lost to Follow-up|9|||
19426872|NCT01568320|41674000|FG000|Overall Study|Withdrawal by Subject|10|||
19426873|NCT01568320|41674000|FG000|Overall Study|Conversion to open repair|1|||
19426874|NCT01568320|41674000|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
19426875|NCT01567852|41674006|FG000|Overall Study|Withdrawal by Subject|3|||
19426876|NCT01567852|41674007|FG001|Overall Study|Withdrawal by Subject|6|||
19426877|NCT01567852|41674006|FG000|Overall Study|ECT discontinued|1|||
19426878|NCT01567852|41674007|FG001|Overall Study|ECT discontinued|1|||
19426879|NCT01588366|41674018|FG000|Overall Study|Adverse Event|0|||
19426880|NCT01588366|41674019|FG001|Overall Study|Adverse Event|1|||
19426881|NCT01588366|41674020|FG002|Overall Study|Adverse Event|0|||
19426882|NCT01588366|41674021|FG003|Overall Study|Adverse Event|1|||
19426883|NCT01588366|41674022|FG004|Overall Study|Adverse Event|0|||
19426884|NCT01588366|41674023|FG005|Overall Study|Adverse Event|2|||
19426885|NCT01686958|41674039|FG000|Overall Study|Withdrawal by Subject|1|||
19426886|NCT01686568|41674046|FG000|Main Study|Withdrawal by Subject|1|||
19426887|NCT01686568|41674047|FG001|Main Study|Withdrawal by Subject|3|||
19426888|NCT01686568|41674046|FG000|Main Study|Noncompliance with protocol|0|||
19426889|NCT01686568|41674047|FG001|Main Study|Noncompliance with protocol|1|||
19426890|NCT01686568|41674046|FG000|Main Study|Liver enzymes above range of exclusion|1|||
19426891|NCT01686568|41674047|FG001|Main Study|Liver enzymes above range of exclusion|0|||
19426892|NCT01686568|41674046|FG000|Sub-Study|Not consented for sub-study|2|||
19426893|NCT01686568|41674047|FG001|Sub-Study|Not consented for sub-study|2|||
19426894|NCT01567462|41674055|FG000|Overall Study|Withdrawal by Subject|4|||
19426895|NCT01567462|41674056|FG001|Overall Study|Withdrawal by Subject|7|||
19426896|NCT01587898|41674066|FG000|Overall Study|Adverse Event|1|||
19426897|NCT01587898|41674067|FG001|Overall Study|Adverse Event|1|||
19426898|NCT01587898|41674068|FG002|Overall Study|Adverse Event|0|||
19426899|NCT01587898|41674069|FG003|Overall Study|Adverse Event|0|||
19426900|NCT01587898|41674066|FG000|Overall Study|Protocol Violation|0|||
19426901|NCT01587898|41674067|FG001|Overall Study|Protocol Violation|2|||
19426902|NCT01587898|41674068|FG002|Overall Study|Protocol Violation|1|||
19426903|NCT01587898|41674069|FG003|Overall Study|Protocol Violation|1|||
19426904|NCT01587898|41674066|FG000|Overall Study|Lost to Follow-up|0|||
19426905|NCT01587898|41674067|FG001|Overall Study|Lost to Follow-up|0|||
19426906|NCT01587898|41674068|FG002|Overall Study|Lost to Follow-up|0|||
19426907|NCT01587898|41674069|FG003|Overall Study|Lost to Follow-up|1|||
19426908|NCT01587898|41674066|FG000|Overall Study|Withdrawal by Subject|2|||
19426909|NCT01587898|41674067|FG001|Overall Study|Withdrawal by Subject|1|||
19426910|NCT01587898|41674068|FG002|Overall Study|Withdrawal by Subject|0|||
19426911|NCT01587898|41674069|FG003|Overall Study|Withdrawal by Subject|0|||
19426912|NCT01587898|41674066|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
19426913|NCT01587898|41674067|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
19426914|NCT01587898|41674068|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
19426915|NCT01587898|41674069|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
19426916|NCT01567306|41674088|FG000|Overall Study|Protocol Violation|2|||
19426917|NCT01567306|41674089|FG001|Overall Study|Protocol Violation|2|||
19426918|NCT01567306|41674090|FG002|Overall Study|Protocol Violation|0|||
19426919|NCT01567306|41674091|FG003|Overall Study|Protocol Violation|3|||
19426920|NCT01567306|41674092|FG004|Overall Study|Protocol Violation|1|||
19426921|NCT01567306|41674093|FG005|Overall Study|Protocol Violation|1|||
19426922|NCT01567306|41674088|FG000|Overall Study|Change site living|1|||
19426923|NCT01567306|41674089|FG001|Overall Study|Change site living|0|||
19426924|NCT01567306|41674090|FG002|Overall Study|Change site living|0|||
19426925|NCT01567306|41674091|FG003|Overall Study|Change site living|0|||
19426926|NCT01567306|41674092|FG004|Overall Study|Change site living|0|||
19426927|NCT01567306|41674093|FG005|Overall Study|Change site living|0|||
19426928|NCT01567306|41674088|FG000|Overall Study|Adverse Event|0|||
19426929|NCT01567306|41674089|FG001|Overall Study|Adverse Event|0|||
19426930|NCT01567306|41674090|FG002|Overall Study|Adverse Event|0|||
19426931|NCT01567306|41674091|FG003|Overall Study|Adverse Event|2|||
19426932|NCT01567306|41674092|FG004|Overall Study|Adverse Event|4|||
19426933|NCT01567306|41674093|FG005|Overall Study|Adverse Event|1|||
19426934|NCT01567306|41674088|FG000|Overall Study|Lost to Follow-up|0|||
19426935|NCT01567306|41674089|FG001|Overall Study|Lost to Follow-up|0|||
19426936|NCT01567306|41674090|FG002|Overall Study|Lost to Follow-up|0|||
19426937|NCT01567306|41674091|FG003|Overall Study|Lost to Follow-up|0|||
19426938|NCT01567306|41674092|FG004|Overall Study|Lost to Follow-up|2|||
19426939|NCT01567306|41674093|FG005|Overall Study|Lost to Follow-up|0|||
19426940|NCT01567306|41674088|FG000|Overall Study|Withdrawal by Subject|0|||
19426941|NCT01567306|41674089|FG001|Overall Study|Withdrawal by Subject|0|||
19426942|NCT01567306|41674090|FG002|Overall Study|Withdrawal by Subject|0|||
19426943|NCT01567306|41674091|FG003|Overall Study|Withdrawal by Subject|0|||
19426944|NCT01567306|41674092|FG004|Overall Study|Withdrawal by Subject|0|||
19426945|NCT01567306|41674093|FG005|Overall Study|Withdrawal by Subject|1|||
19426946|NCT01587274|41674110|FG000|Overall Study|Lost to Follow-up|4|||
19426947|NCT01587274|41674111|FG001|Overall Study|Lost to Follow-up|5|||
19426948|NCT01587274|41674112|FG002|Overall Study|Lost to Follow-up|3|||
19520943|NCT01422876|41933739|FG008|Week 24|Death|0|||
19520944|NCT01422876|41933740|FG009|Week 24|Death|0|||
19426949|NCT01587118|41674120|FG000|Overall Study|Adverse Event|3|||
19426950|NCT01587118|41674120|FG000|Overall Study|Lost to Follow-up|2|||
19426951|NCT01587118|41674120|FG000|Overall Study|Relocation|1|||
19426952|NCT01587118|41674120|FG000|Overall Study|nonresponse|1|||
19426953|NCT01905657|41674127|FG000|Overall Study|Adverse Event|23|||
19426954|NCT01905657|41674128|FG001|Overall Study|Adverse Event|17|||
19426955|NCT01905657|41674129|FG002|Overall Study|Adverse Event|18|||
19426956|NCT01905657|41674127|FG000|Overall Study|Clinical Progression|103|||
19426957|NCT01905657|41674128|FG001|Overall Study|Clinical Progression|78|||
19426958|NCT01905657|41674129|FG002|Overall Study|Clinical Progression|59|||
19426959|NCT01905657|41674127|FG000|Overall Study|Death|40|||
19426960|NCT01905657|41674128|FG001|Overall Study|Death|43|||
19426961|NCT01905657|41674129|FG002|Overall Study|Death|47|||
19426962|NCT01905657|41674127|FG000|Overall Study|Excluded Medication|13|||
19520945|NCT01422876|41933731|FG000|Week 52|Lost to Follow-up|3|||
19520946|NCT01422876|41933732|FG001|Week 52|Lost to Follow-up|5|||
19426963|NCT01905657|41674128|FG001|Overall Study|Excluded Medication|16|||
19426964|NCT01905657|41674129|FG002|Overall Study|Excluded Medication|9|||
19426965|NCT01905657|41674127|FG000|Overall Study|Lost to Follow-up|1|||
19426966|NCT01905657|41674128|FG001|Overall Study|Lost to Follow-up|2|||
19426967|NCT01905657|41674129|FG002|Overall Study|Lost to Follow-up|1|||
19426968|NCT01905657|41674127|FG000|Overall Study|Physician Decision|5|||
19426969|NCT01905657|41674128|FG001|Overall Study|Physician Decision|8|||
19426970|NCT01905657|41674129|FG002|Overall Study|Physician Decision|12|||
19426971|NCT01905657|41674127|FG000|Overall Study|Protocol Violation|2|||
19426972|NCT01905657|41674128|FG001|Overall Study|Protocol Violation|1|||
19426973|NCT01905657|41674129|FG002|Overall Study|Protocol Violation|1|||
19426974|NCT01905657|41674127|FG000|Overall Study|Screen Failure|0|||
19426975|NCT01905657|41674128|FG001|Overall Study|Screen Failure|1|||
19426976|NCT01905657|41674129|FG002|Overall Study|Screen Failure|0|||
19426977|NCT01905657|41674127|FG000|Overall Study|Withdrawal by Subject|15|||
19426978|NCT01905657|41674128|FG001|Overall Study|Withdrawal by Subject|21|||
19426979|NCT01905657|41674129|FG002|Overall Study|Withdrawal by Subject|53|||
19426980|NCT01905657|41674127|FG000|Overall Study|Sponsor Decision|1|||
19426981|NCT01905657|41674128|FG001|Overall Study|Sponsor Decision|0|||
19426982|NCT01905657|41674129|FG002|Overall Study|Sponsor Decision|0|||
19426983|NCT02202980|41674154|FG000|Overall Study|Lack of Efficacy|1|||
19426984|NCT02202980|41674155|FG001|Overall Study|Lack of Efficacy|0|||
19426985|NCT02202980|41674156|FG002|Overall Study|Lack of Efficacy|7|||
19426986|NCT02202980|41674157|FG003|Overall Study|Lack of Efficacy|0|||
19426987|NCT02202980|41674158|FG004|Overall Study|Lack of Efficacy|3|||
19426988|NCT02202980|41674159|FG005|Overall Study|Lack of Efficacy|1|||
19426989|NCT02202980|41674160|FG006|Overall Study|Lack of Efficacy|11|||
19426990|NCT02202980|41674161|FG007|Overall Study|Lack of Efficacy|2|||
19426991|NCT02202980|41674162|FG008|Overall Study|Lack of Efficacy|2|||
19426992|NCT02202980|41674163|FG009|Overall Study|Lack of Efficacy|0|||
19520947|NCT01422876|41933733|FG002|Week 52|Lost to Follow-up|7|||
19520948|NCT01422876|41933734|FG003|Week 52|Lost to Follow-up|5|||
19520949|NCT01422876|41933735|FG004|Week 52|Lost to Follow-up|8|||
19520950|NCT01422876|41933736|FG005|Week 52|Lost to Follow-up|5|||
19520951|NCT01422876|41933737|FG006|Week 52|Lost to Follow-up|5|||
19520952|NCT01422876|41933738|FG007|Week 52|Lost to Follow-up|8|||
19520953|NCT01422876|41933739|FG008|Week 52|Lost to Follow-up|7|||
19520954|NCT01422876|41933740|FG009|Week 52|Lost to Follow-up|8|||
19520955|NCT01422876|41933731|FG000|Week 52|Consent withdrawn|9|||
19520956|NCT01422876|41933732|FG001|Week 52|Consent withdrawn|4|||
19520957|NCT01422876|41933733|FG002|Week 52|Consent withdrawn|6|||
19520958|NCT01422876|41933734|FG003|Week 52|Consent withdrawn|12|||
19520959|NCT01422876|41933735|FG004|Week 52|Consent withdrawn|7|||
19520960|NCT01422876|41933736|FG005|Week 52|Consent withdrawn|12|||
19520961|NCT01422876|41933737|FG006|Week 52|Consent withdrawn|10|||
19520962|NCT01422876|41933738|FG007|Week 52|Consent withdrawn|12|||
19520963|NCT01422876|41933739|FG008|Week 52|Consent withdrawn|13|||
19520964|NCT01422876|41933740|FG009|Week 52|Consent withdrawn|9|||
19520965|NCT01422876|41933731|FG000|Week 52|Death|0|||
19520966|NCT01422876|41933732|FG001|Week 52|Death|1|||
19520967|NCT01422876|41933733|FG002|Week 52|Death|0|||
19520968|NCT01422876|41933734|FG003|Week 52|Death|1|||
19520969|NCT01422876|41933735|FG004|Week 52|Death|0|||
19520970|NCT01422876|41933736|FG005|Week 52|Death|0|||
19520971|NCT01422876|41933737|FG006|Week 52|Death|1|||
19520972|NCT01422876|41933738|FG007|Week 52|Death|3|||
19520973|NCT01422876|41933739|FG008|Week 52|Death|1|||
19520974|NCT01422876|41933740|FG009|Week 52|Death|0|||
19520975|NCT01422720|41933758|FG000|Overall Study|Adverse Event|16|||
19520976|NCT01422720|41933758|FG000|Overall Study|Lack of Efficacy|1|||
19520977|NCT01422720|41933758|FG000|Overall Study|Withdrawal by Subject|4|||
19520978|NCT01422720|41933758|FG000|Overall Study|Ineligibility|1|||
19520979|NCT01387932|41933768|FG000|Randomized and Treated|Physician Decision|3|||
19520980|NCT01387932|41933769|FG001|Randomized and Treated|Physician Decision|2|||
19520981|NCT01387932|41933768|FG000|Randomized and Treated|Withdrawal by Subject|4|||
19520982|NCT01387932|41933769|FG001|Randomized and Treated|Withdrawal by Subject|2|||
19711164|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
19520983|NCT01387932|41933768|FG000|Survival Follow-up|Liver Transplant|24|||
19520984|NCT01387932|41933769|FG001|Survival Follow-up|Liver Transplant|28|||
19426993|NCT02202980|41674164|FG010|Overall Study|Lack of Efficacy|0|||
19426994|NCT02202980|41674165|FG011|Overall Study|Lack of Efficacy|3|||
19426995|NCT02202980|41674166|FG012|Overall Study|Lack of Efficacy|10|||
19426996|NCT02202980|41674167|FG013|Overall Study|Lack of Efficacy|0|||
19426997|NCT02202980|41674154|FG000|Overall Study|Protocol Violation|0|||
19520985|NCT01387932|41933768|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
19520986|NCT01387932|41933769|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
19520987|NCT01387932|41933768|FG000|Survival Follow-up|Withdrawal by Subject|2|||
19520988|NCT01387932|41933769|FG001|Survival Follow-up|Withdrawal by Subject|4|||
19520989|NCT01387932|41933768|FG000|Survival Follow-up|Lost to Follow-up|6|||
19520990|NCT01387932|41933769|FG001|Survival Follow-up|Lost to Follow-up|5|||
19520991|NCT01422408|41933777|FG000|Overall Study|Adverse Event|1|||
19520992|NCT01422408|41933777|FG000|Overall Study|Withdrawal by Subject|3|||
19426998|NCT02202980|41674155|FG001|Overall Study|Protocol Violation|0|||
19426999|NCT02202980|41674156|FG002|Overall Study|Protocol Violation|0|||
19427000|NCT02202980|41674157|FG003|Overall Study|Protocol Violation|3|||
19427001|NCT02202980|41674158|FG004|Overall Study|Protocol Violation|3|||
19427002|NCT02202980|41674159|FG005|Overall Study|Protocol Violation|0|||
19427003|NCT02202980|41674160|FG006|Overall Study|Protocol Violation|0|||
19427004|NCT02202980|41674161|FG007|Overall Study|Protocol Violation|0|||
19427005|NCT02202980|41674162|FG008|Overall Study|Protocol Violation|0|||
19427006|NCT02202980|41674163|FG009|Overall Study|Protocol Violation|0|||
19427007|NCT02202980|41674164|FG010|Overall Study|Protocol Violation|0|||
19427008|NCT02202980|41674165|FG011|Overall Study|Protocol Violation|0|||
19427009|NCT02202980|41674166|FG012|Overall Study|Protocol Violation|0|||
19427010|NCT02202980|41674167|FG013|Overall Study|Protocol Violation|0|||
19427011|NCT02202980|41674154|FG000|Overall Study|Lost to Follow-up|0|||
19427012|NCT02202980|41674155|FG001|Overall Study|Lost to Follow-up|1|||
19427013|NCT02202980|41674156|FG002|Overall Study|Lost to Follow-up|1|||
19427014|NCT02202980|41674157|FG003|Overall Study|Lost to Follow-up|1|||
19427015|NCT02202980|41674158|FG004|Overall Study|Lost to Follow-up|0|||
19427016|NCT02202980|41674159|FG005|Overall Study|Lost to Follow-up|0|||
19427017|NCT02202980|41674160|FG006|Overall Study|Lost to Follow-up|0|||
19427018|NCT02202980|41674161|FG007|Overall Study|Lost to Follow-up|1|||
19520993|NCT01399788|41933781|FG000|First Intervention Period|Adverse Event|1|||
19520994|NCT01399788|41933782|FG001|First Intervention Period|Adverse Event|0|||
19520995|NCT01387542|41933788|FG000|Overall Study|Adverse Event|3|||
19520996|NCT01387542|41933788|FG000|Overall Study|Withdrawal by Subject|1|||
19520997|NCT01387542|41933788|FG000|Overall Study|Changed diagnosis|1|||
19520998|NCT01387542|41933788|FG000|Overall Study|Insufficient response|1|||
19520999|NCT01387542|41933788|FG000|Overall Study|Non-compliant|1|||
19521000|NCT01387542|41933788|FG000|Overall Study|Lost to Follow-up|1|||
19521001|NCT01387230|41933795|FG000|Overall Study|Adverse Event|0|||
19521002|NCT01387230|41933796|FG001|Overall Study|Adverse Event|1|||
19521003|NCT01387230|41933797|FG002|Overall Study|Adverse Event|3|||
19521004|NCT01387230|41933795|FG000|Overall Study|Lack of Efficacy|8|||
19521005|NCT01387230|41933796|FG001|Overall Study|Lack of Efficacy|5|||
19521006|NCT01387230|41933797|FG002|Overall Study|Lack of Efficacy|4|||
19427019|NCT02202980|41674162|FG008|Overall Study|Lost to Follow-up|1|||
19427020|NCT02202980|41674163|FG009|Overall Study|Lost to Follow-up|0|||
19427021|NCT02202980|41674164|FG010|Overall Study|Lost to Follow-up|0|||
19427022|NCT02202980|41674165|FG011|Overall Study|Lost to Follow-up|0|||
19427023|NCT02202980|41674166|FG012|Overall Study|Lost to Follow-up|1|||
19427024|NCT02202980|41674167|FG013|Overall Study|Lost to Follow-up|0|||
19427025|NCT02202980|41674154|FG000|Overall Study|Withdrew Consent|0|||
19427026|NCT02202980|41674155|FG001|Overall Study|Withdrew Consent|1|||
19427027|NCT02202980|41674156|FG002|Overall Study|Withdrew Consent|2|||
19427028|NCT02202980|41674157|FG003|Overall Study|Withdrew Consent|0|||
19427029|NCT02202980|41674158|FG004|Overall Study|Withdrew Consent|0|||
19427030|NCT02202980|41674159|FG005|Overall Study|Withdrew Consent|0|||
19427031|NCT02202980|41674160|FG006|Overall Study|Withdrew Consent|0|||
19427032|NCT02202980|41674161|FG007|Overall Study|Withdrew Consent|0|||
19427033|NCT02202980|41674162|FG008|Overall Study|Withdrew Consent|1|||
19427034|NCT02202980|41674163|FG009|Overall Study|Withdrew Consent|0|||
19427035|NCT02202980|41674164|FG010|Overall Study|Withdrew Consent|0|||
19427036|NCT02202980|41674165|FG011|Overall Study|Withdrew Consent|0|||
19711165|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
19711166|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
19711167|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
19711168|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
19711169|NCT00116805|42154353|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
19711170|NCT00116805|42154354|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
19711171|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
19711172|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
19711173|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
19521007|NCT01387230|41933795|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
19521008|NCT01387230|41933796|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
19521009|NCT01387230|41933797|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
19521010|NCT01387230|41933795|FG000|Overall Study|Lost to Follow-up|0|||
19521011|NCT01387230|41933796|FG001|Overall Study|Lost to Follow-up|0|||
19711174|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
19711175|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
19711176|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
19711177|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
19711178|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
19711179|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
19711180|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
19521012|NCT01387230|41933797|FG002|Overall Study|Lost to Follow-up|1|||
19521013|NCT01387230|41933795|FG000|Overall Study|Withdrawal by Subject|4|||
19711181|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
19711182|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
19711183|NCT00116805|42154353|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
19711184|NCT00116805|42154354|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
19711185|NCT00116805|42154353|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
19711186|NCT00116805|42154354|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
19427037|NCT02202980|41674166|FG012|Overall Study|Withdrew Consent|0|||
19427038|NCT02202980|41674167|FG013|Overall Study|Withdrew Consent|0|||
19427039|NCT01952145|41674199|FG000|Overall Study|Protocol Violation|2|||
19427040|NCT01952145|41674200|FG001|Overall Study|Protocol Violation|1|||
19427041|NCT01952145|41674199|FG000|Overall Study|Death|0|||
19427042|NCT01952145|41674200|FG001|Overall Study|Death|1|||
19427043|NCT01952145|41674199|FG000|Overall Study|Adverse Event|9|||
19427044|NCT01952145|41674200|FG001|Overall Study|Adverse Event|0|||
19427045|NCT01952145|41674199|FG000|Overall Study|Withdrawal Criteria|16|||
19427046|NCT01952145|41674200|FG001|Overall Study|Withdrawal Criteria|11|||
19427047|NCT01952145|41674199|FG000|Overall Study|Unclassified|1|||
19427048|NCT01952145|41674200|FG001|Overall Study|Unclassified|1|||
19427049|NCT01923363|41674206|FG000|Overall Study|Protocol Violation|1|||
19427050|NCT01905267|41674212|FG000|Overall Study|Physician Decision|2|||
19427051|NCT01905267|41674213|FG001|Overall Study|Physician Decision|2|||
19427052|NCT01923285|41674221|FG000|Overall Study|Withdrawal by Subject|7|||
19427053|NCT01923285|41674222|FG001|Overall Study|Withdrawal by Subject|6|||
19427054|NCT01904721|41674235|FG000|Overall Study|Other Reasons|0|||
19427055|NCT01904721|41674236|FG001|Overall Study|Other Reasons|0|||
19427056|NCT01904721|41674237|FG002|Overall Study|Other Reasons|1|||
19427057|NCT01904721|41674238|FG003|Overall Study|Other Reasons|1|||
19427058|NCT01904721|41674239|FG004|Overall Study|Other Reasons|2|||
19427059|NCT01904721|41674240|FG005|Overall Study|Other Reasons|2|||
19427060|NCT01904721|41674241|FG006|Overall Study|Other Reasons|2|||
19427061|NCT01904721|41674235|FG000|Overall Study|Personal Reasons|0|||
19427062|NCT01904721|41674236|FG001|Overall Study|Personal Reasons|0|||
19427063|NCT01904721|41674237|FG002|Overall Study|Personal Reasons|0|||
19427064|NCT01904721|41674238|FG003|Overall Study|Personal Reasons|0|||
19427065|NCT01904721|41674239|FG004|Overall Study|Personal Reasons|2|||
19427066|NCT01904721|41674240|FG005|Overall Study|Personal Reasons|3|||
19427067|NCT01904721|41674241|FG006|Overall Study|Personal Reasons|3|||
19427068|NCT01904721|41674235|FG000|Overall Study|Lost to Follow-up|0|||
19427069|NCT01904721|41674236|FG001|Overall Study|Lost to Follow-up|0|||
19427070|NCT01904721|41674237|FG002|Overall Study|Lost to Follow-up|0|||
19427071|NCT01904721|41674238|FG003|Overall Study|Lost to Follow-up|0|||
19427072|NCT01904721|41674239|FG004|Overall Study|Lost to Follow-up|1|||
19427073|NCT01904721|41674240|FG005|Overall Study|Lost to Follow-up|3|||
19427074|NCT01904721|41674241|FG006|Overall Study|Lost to Follow-up|1|||
19427075|NCT01904721|41674235|FG000|Overall Study|Lack of Efficacy|0|||
19427076|NCT01904721|41674236|FG001|Overall Study|Lack of Efficacy|0|||
19427077|NCT01904721|41674237|FG002|Overall Study|Lack of Efficacy|0|||
19427078|NCT01904721|41674238|FG003|Overall Study|Lack of Efficacy|0|||
19427079|NCT01904721|41674239|FG004|Overall Study|Lack of Efficacy|0|||
19427080|NCT01904721|41674240|FG005|Overall Study|Lack of Efficacy|0|||
19427081|NCT01904721|41674241|FG006|Overall Study|Lack of Efficacy|1|||
19427082|NCT01904721|41674235|FG000|Overall Study|Adverse Event|0|||
19427083|NCT01904721|41674236|FG001|Overall Study|Adverse Event|0|||
19427084|NCT01904721|41674237|FG002|Overall Study|Adverse Event|0|||
19427085|NCT01904721|41674238|FG003|Overall Study|Adverse Event|0|||
19427086|NCT01904721|41674239|FG004|Overall Study|Adverse Event|3|||
19427087|NCT01904721|41674240|FG005|Overall Study|Adverse Event|1|||
19427088|NCT01904721|41674241|FG006|Overall Study|Adverse Event|0|||
19427089|NCT01904019|41674253|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
19427090|NCT01904019|41674253|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
19427091|NCT01904019|41674253|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
19427092|NCT01904019|41674253|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
19427093|NCT01904019|41674253|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
19427094|NCT01904019|41674253|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
19427095|NCT01922895|41674259|FG000|Overall Study|Death|0|||
19427096|NCT01922895|41674260|FG001|Overall Study|Death|1|||
19427097|NCT01922895|41674259|FG000|Overall Study|Withdrawal by Subject|1|||
19427098|NCT01922895|41674260|FG001|Overall Study|Withdrawal by Subject|2|||
19427099|NCT01922895|41674259|FG000|Overall Study|Lost to Follow-up|5|||
19427100|NCT01922895|41674260|FG001|Overall Study|Lost to Follow-up|11|||
19427101|NCT01922739|41674268|FG000|Titration/Adjustment Period|Adverse Event|3|||
19427102|NCT01922739|41674268|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
19427103|NCT01922739|41674268|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
19427104|NCT01922739|41674268|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
19427105|NCT01922739|41674268|FG000|Open-label Treatment Period|Adverse Event|6|||
19521014|NCT01387230|41933796|FG001|Overall Study|Withdrawal by Subject|1|||
19427106|NCT01922739|41674268|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
19427107|NCT01922739|41674268|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
19427108|NCT01922739|41674268|FG000|Open-label Treatment Period|Protocol Violation|5|||
19427109|NCT01922739|41674268|FG000|Open-label Treatment Period|Pregnancy|1|||
19427110|NCT01922739|41674268|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
19427111|NCT01922739|41674268|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
19427112|NCT01922739|41674268|FG000|Open-label Treatment Period|Physician Decision|1|||
19427113|NCT01922739|41674268|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
19427114|NCT02236988|41674288|FG000|Overall Study|Lost to Follow-up|0|||
19427115|NCT02236988|41674289|FG001|Overall Study|Lost to Follow-up|0|||
19427116|NCT02236988|41674290|FG002|Overall Study|Lost to Follow-up|0|||
19427117|NCT02236988|41674291|FG003|Overall Study|Lost to Follow-up|1|||
19427118|NCT02236988|41674288|FG000|Overall Study|Unable to Comply with Study Visits|0|||
19427119|NCT02236988|41674289|FG001|Overall Study|Unable to Comply with Study Visits|0|||
19427120|NCT02236988|41674290|FG002|Overall Study|Unable to Comply with Study Visits|0|||
19427121|NCT02236988|41674291|FG003|Overall Study|Unable to Comply with Study Visits|2|||
19427122|NCT02236598|41674344|FG000|Overall Study|Adverse Event|0|||
19427123|NCT02236598|41674345|FG001|Overall Study|Adverse Event|1|||
19427124|NCT02236598|41674344|FG000|Overall Study|Withdrawal by Subject|0|||
19427125|NCT02236598|41674345|FG001|Overall Study|Withdrawal by Subject|1|||
19427126|NCT01922349|41674355|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
19427127|NCT01922349|41674356|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
19427128|NCT01922349|41674357|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
19427129|NCT01922349|41674358|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
19427130|NCT02236520|41674396|FG000|Overall Study|Physician Decision|0|||
19427131|NCT02236520|41674397|FG001|Overall Study|Physician Decision|5|||
19427132|NCT02236520|41674398|FG002|Overall Study|Physician Decision|0|||
19427133|NCT02236520|41674399|FG003|Overall Study|Physician Decision|0|||
19427134|NCT02236520|41674396|FG000|Overall Study|Withdrawal by Subject|1|||
19427135|NCT02236520|41674397|FG001|Overall Study|Withdrawal by Subject|0|||
19427136|NCT02236520|41674398|FG002|Overall Study|Withdrawal by Subject|0|||
19427137|NCT02236520|41674399|FG003|Overall Study|Withdrawal by Subject|1|||
19427138|NCT02236520|41674396|FG000|Overall Study|Pregnancy|1|||
19427139|NCT02236520|41674397|FG001|Overall Study|Pregnancy|0|||
19427140|NCT02236520|41674398|FG002|Overall Study|Pregnancy|0|||
19427141|NCT02236520|41674399|FG003|Overall Study|Pregnancy|0|||
19427142|NCT01922271|41674411|FG000|WASHOUT Period|Withdrawal by Subject|1|||
19427143|NCT01922271|41674412|FG001|WASHOUT Period|Withdrawal by Subject|0|||
19427144|NCT02236130|41674420|FG000|Overall Study|Lost to Follow-up|7|||
19427145|NCT02236130|41674421|FG001|Overall Study|Lost to Follow-up|12|||
19427146|NCT02233946|41674429|FG000|Baseline|Withdrawal by Subject|2|||
19427147|NCT02233946|41674430|FG001|Baseline|Withdrawal by Subject|0|||
19427148|NCT02233946|41674429|FG000|3-months Follow-up|Lost to Follow-up|53|||
19427149|NCT02233946|41674430|FG001|3-months Follow-up|Lost to Follow-up|29|||
19427150|NCT02233946|41674429|FG000|6-months Follow-up|Lost to Follow-up|21|||
19427151|NCT02233946|41674430|FG001|6-months Follow-up|Lost to Follow-up|2|||
19427152|NCT02233946|41674429|FG000|9-month Follow-up|Lost to Follow-up|20|||
19427153|NCT02233946|41674430|FG001|9-month Follow-up|Lost to Follow-up|11|||
19427154|NCT02233946|41674429|FG000|12-month Follow-up|Lost to Follow-up|28|||
19427155|NCT02233946|41674430|FG001|12-month Follow-up|Lost to Follow-up|11|||
19427156|NCT02232698|41674438|FG000|Overall Study|Pregnancy|1|||
19427157|NCT02232698|41674439|FG001|Overall Study|Pregnancy|1|||
19427158|NCT02232698|41674438|FG000|Overall Study|Met exclusion criteria|1|||
19427159|NCT02232698|41674439|FG001|Overall Study|Met exclusion criteria|1|||
19427160|NCT02232698|41674438|FG000|Overall Study|Had device-associated symptoms|7|||
19427161|NCT02232698|41674439|FG001|Overall Study|Had device-associated symptoms|0|||
19427162|NCT02232698|41674438|FG000|Overall Study|Non-compliance with study device|1|||
19427163|NCT02232698|41674439|FG001|Overall Study|Non-compliance with study device|4|||
19427164|NCT02232698|41674438|FG000|Overall Study|Allocated to control group|0|||
19427165|NCT02232698|41674439|FG001|Overall Study|Allocated to control group|3|||
19427166|NCT02232698|41674438|FG000|Overall Study|Withdrawal by Subject|0|||
19427167|NCT02232698|41674439|FG001|Overall Study|Withdrawal by Subject|11|||
19427168|NCT01632878|41674447|FG000|Screening|Physician Decision|268|||
19427169|NCT01632878|41674447|FG000|Treatment|Lost to Follow-up|41|||
19427170|NCT01632878|41674447|FG000|Treatment|Withdrawal by Subject|36|||
19427171|NCT01632878|41674447|FG000|Treatment|Physician Decision|34|||
19427172|NCT01632878|41674447|FG000|Treatment|missing information|4|||
19427173|NCT01632878|41674447|FG000|Treatment|no information on study completion|43|||
19427174|NCT01632800|41674451|FG000|Overall Study|Subject did not fit in apparatus|1|||
19427175|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
19427176|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
19427177|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
19427178|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
19427179|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
19427180|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
19427181|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
19427182|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
19427183|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
19427184|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
19427185|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
19427186|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
19427187|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
19427188|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
19427189|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
19427190|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
19427191|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
19427192|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
19427193|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
19427194|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
19427195|NCT01641809|41674459|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
19427196|NCT01641809|41674460|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
19427197|NCT01641809|41674461|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
19427198|NCT01641809|41674462|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
19427199|NCT01641809|41674459|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
19427200|NCT01641809|41674460|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
19427201|NCT01641809|41674461|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
19427202|NCT01641809|41674462|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
19427203|NCT01641809|41674459|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
19427204|NCT01641809|41674460|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
19427205|NCT01641809|41674461|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
19427206|NCT01641809|41674462|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
19427207|NCT01641809|41674459|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
19427208|NCT01641809|41674460|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
19427209|NCT01641809|41674461|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
19427210|NCT01641809|41674462|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
19427211|NCT01641809|41674459|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
19427212|NCT01641809|41674460|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
19427213|NCT01641809|41674461|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
19427214|NCT01641809|41674462|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
19427215|NCT01641809|41674459|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
19427216|NCT01641809|41674460|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
19427217|NCT01641809|41674461|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
19427218|NCT01641809|41674462|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
19427219|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
19427220|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
19427221|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
19427222|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
19427223|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
19427224|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
19427225|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
19427226|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
19427227|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
19427228|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
19427229|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
19427230|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
19427231|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
19427232|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
19427233|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
19427234|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
19427235|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
19427236|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
19427237|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
19427238|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
19427239|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
19427240|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
19427241|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
19427242|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
19427243|NCT01641809|41674459|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
19427244|NCT01641809|41674460|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
19427245|NCT01641809|41674461|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
19427246|NCT01641809|41674462|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
19427247|NCT01632566|41674485|FG000|Overall Study|Withdrawal by Subject|0|||
19427248|NCT01632566|41674486|FG001|Overall Study|Withdrawal by Subject|1|||
19427249|NCT01632566|41674487|FG002|Overall Study|Withdrawal by Subject|0|||
19427250|NCT01632566|41674488|FG003|Overall Study|Withdrawal by Subject|0|||
19427251|NCT01632566|41674489|FG004|Overall Study|Withdrawal by Subject|0|||
19427252|NCT01632566|41674485|FG000|Overall Study|Sponsor Decision|0|||
19427253|NCT01632566|41674486|FG001|Overall Study|Sponsor Decision|2|||
19427254|NCT01632566|41674487|FG002|Overall Study|Sponsor Decision|9|||
19427255|NCT01632566|41674488|FG003|Overall Study|Sponsor Decision|2|||
19427256|NCT01632566|41674489|FG004|Overall Study|Sponsor Decision|2|||
19427257|NCT02254304|41674507|FG000|Overall Study|Adverse Event|2|||
19427258|NCT02254304|41674508|FG001|Overall Study|Adverse Event|1|||
19427259|NCT02254304|41674507|FG000|Overall Study|Lost to Follow-up|2|||
19427260|NCT02254304|41674508|FG001|Overall Study|Lost to Follow-up|2|||
19427261|NCT02254304|41674507|FG000|Overall Study|Protocol Violation|1|||
19427262|NCT02254304|41674508|FG001|Overall Study|Protocol Violation|0|||
19427263|NCT02254304|41674507|FG000|Overall Study|Withdrawal by Subject|3|||
19427264|NCT02254304|41674508|FG001|Overall Study|Withdrawal by Subject|0|||
19427265|NCT02254304|41674507|FG000|Overall Study|Injection site pain and Injection fear|1|||
19427266|NCT02254304|41674508|FG001|Overall Study|Injection site pain and Injection fear|0|||
19427267|NCT02254304|41674507|FG000|Overall Study|Personal causes|4|||
19427268|NCT02254304|41674508|FG001|Overall Study|Personal causes|1|||
19427269|NCT02254304|41674507|FG000|Overall Study|Personal decision|1|||
19427270|NCT02254304|41674508|FG001|Overall Study|Personal decision|0|||
19427271|NCT02174731|41674518|FG000|Overall Study|Participant decision|67|||
19427272|NCT02174731|41674519|FG001|Overall Study|Participant decision|64|||
19427273|NCT02174731|41674518|FG000|Overall Study|Incorrect enrolment before randomization|0|||
19427274|NCT02174731|41674519|FG001|Overall Study|Incorrect enrolment before randomization|1|||
19427275|NCT02174731|41674518|FG000|Overall Study|Missing|2|||
19427276|NCT02174731|41674519|FG001|Overall Study|Missing|0|||
19427277|NCT01922037|41674527|FG000|Overall Study|Withdrawal by Subject|2|||
19427278|NCT01922037|41674528|FG001|Overall Study|Withdrawal by Subject|44|||
19427279|NCT01922037|41674527|FG000|Overall Study|Adverse Event|1|||
19427280|NCT01922037|41674528|FG001|Overall Study|Adverse Event|7|||
19427281|NCT01922037|41674527|FG000|Overall Study|Death|0|||
19427282|NCT01922037|41674528|FG001|Overall Study|Death|5|||
19427283|NCT01922037|41674527|FG000|Overall Study|Pregnancy|0|||
19427284|NCT01922037|41674528|FG001|Overall Study|Pregnancy|2|||
19427285|NCT01922037|41674527|FG000|Overall Study|Participant non-compliance|4|||
19427286|NCT01922037|41674528|FG001|Overall Study|Participant non-compliance|46|||
19427287|NCT01922037|41674527|FG000|Overall Study|Investigator/Sponsor decision|1|||
19427288|NCT01922037|41674528|FG001|Overall Study|Investigator/Sponsor decision|4|||
19427289|NCT01922037|41674527|FG000|Overall Study|Other unspecified|2|||
19427290|NCT01922037|41674528|FG001|Overall Study|Other unspecified|66|||
19427291|NCT02282813|41674539|FG000|Overall Study|Withdrawal by Subject|4|||
19427292|NCT02282813|41674540|FG001|Overall Study|Withdrawal by Subject|5|||
19427293|NCT02282813|41674541|FG002|Overall Study|Withdrawal by Subject|0|||
19427294|NCT02282813|41674539|FG000|Overall Study|Adverse Event|3|||
19427295|NCT02282813|41674540|FG001|Overall Study|Adverse Event|10|||
19427296|NCT02282813|41674541|FG002|Overall Study|Adverse Event|1|||
19427297|NCT02282813|41674539|FG000|Overall Study|Subject non-compliance|1|||
19427298|NCT02282813|41674540|FG001|Overall Study|Subject non-compliance|4|||
19427299|NCT02282813|41674541|FG002|Overall Study|Subject non-compliance|0|||
19427300|NCT02282813|41674539|FG000|Overall Study|Physician Decision|0|||
19427301|NCT02282813|41674540|FG001|Overall Study|Physician Decision|3|||
19427302|NCT02282813|41674541|FG002|Overall Study|Physician Decision|1|||
19427303|NCT02282813|41674539|FG000|Overall Study|Lost to Follow-up|2|||
19427304|NCT02282813|41674540|FG001|Overall Study|Lost to Follow-up|0|||
19427305|NCT02282813|41674541|FG002|Overall Study|Lost to Follow-up|1|||
19427306|NCT02282813|41674539|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
19427307|NCT02282813|41674540|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
19427308|NCT02282813|41674541|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
19427309|NCT02282813|41674539|FG000|Overall Study|Lack of Efficacy|1|||
19427310|NCT02282813|41674540|FG001|Overall Study|Lack of Efficacy|0|||
19427311|NCT02282813|41674541|FG002|Overall Study|Lack of Efficacy|0|||
19427312|NCT02282813|41674539|FG000|Overall Study|Administrative reasons|0|||
19427313|NCT02282813|41674540|FG001|Overall Study|Administrative reasons|1|||
19427314|NCT02282813|41674541|FG002|Overall Study|Administrative reasons|0|||
19427315|NCT01903863|41674553|FG000|Overall Study|Physician Decision|2|||
19427316|NCT01903863|41674554|FG001|Overall Study|Physician Decision|0|||
19427317|NCT02123251|41674562|FG000|Overall Study|Death|1|||
19427318|NCT02123251|41674563|FG001|Overall Study|Death|1|||
19427319|NCT02123251|41674562|FG000|Overall Study|Withdrawal by Subject|0|||
19427320|NCT02123251|41674563|FG001|Overall Study|Withdrawal by Subject|3|||
19427321|NCT02123251|41674562|FG000|Overall Study|Lost Medicaid eligibility|29|||
19427322|NCT02123251|41674563|FG001|Overall Study|Lost Medicaid eligibility|22|||
19427323|NCT02123251|41674562|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
19427324|NCT02123251|41674563|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
19427325|NCT01902303|41674572|FG000|Overall Study|Adverse Event|0|||
19427326|NCT01902303|41674573|FG001|Overall Study|Adverse Event|1|||
19427327|NCT01902303|41674572|FG000|Overall Study|Lost to Follow-up|0|||
19427328|NCT01902303|41674573|FG001|Overall Study|Lost to Follow-up|1|||
19427329|NCT01902303|41674572|FG000|Overall Study|Protocol Violation|2|||
19427330|NCT01902303|41674573|FG001|Overall Study|Protocol Violation|2|||
19427331|NCT01902303|41674572|FG000|Overall Study|subject lost investigational product|0|||
19427332|NCT01902303|41674573|FG001|Overall Study|subject lost investigational product|1|||
19427333|NCT01902303|41674572|FG000|Overall Study|Did not develop a cold sore|21|||
19427334|NCT01902303|41674573|FG001|Overall Study|Did not develop a cold sore|19|||
19427335|NCT02122783|41674583|FG000|Overall Study|Adverse Event|0|||
19427336|NCT02122783|41674584|FG001|Overall Study|Adverse Event|1|||
19427337|NCT01921257|41674593|FG000|Overall Study|Adverse Event|1|||
19427338|NCT01921257|41674593|FG000|Overall Study|Protocol Violation|1|||
19427339|NCT01921257|41674593|FG000|Overall Study|Withdrawal by Subject|1|||
19427340|NCT02121847|41674598|FG000|Overall Study|Administrative Reasons|1|||
19427341|NCT02121847|41674598|FG000|Overall Study|Adverse Event|2|||
19427342|NCT01921179|41674604|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
19427343|NCT01921179|41674605|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
19427344|NCT01921179|41674604|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
19427345|NCT01921179|41674605|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
19427346|NCT01587040|41674616|FG000|Overall Study|Protocol Violation|0|||
19427347|NCT01587040|41674617|FG001|Overall Study|Protocol Violation|0|||
19427348|NCT01587040|41674618|FG002|Overall Study|Protocol Violation|1|||
19427349|NCT01587040|41674619|FG003|Overall Study|Protocol Violation|0|||
19427350|NCT01587040|41674616|FG000|Overall Study|Adverse Event|0|||
19427351|NCT01587040|41674617|FG001|Overall Study|Adverse Event|1|||
19427352|NCT01587040|41674618|FG002|Overall Study|Adverse Event|10|||
19427353|NCT01587040|41674619|FG003|Overall Study|Adverse Event|0|||
19427354|NCT01587040|41674616|FG000|Overall Study|Disease progression|12|||
19427355|NCT01587040|41674617|FG001|Overall Study|Disease progression|1|||
19427356|NCT01587040|41674618|FG002|Overall Study|Disease progression|15|||
19427357|NCT01587040|41674619|FG003|Overall Study|Disease progression|3|||
19427358|NCT01587040|41674616|FG000|Overall Study|Other than specified|5|||
19427359|NCT01587040|41674617|FG001|Overall Study|Other than specified|1|||
19427360|NCT01587040|41674618|FG002|Overall Study|Other than specified|11|||
19427361|NCT01587040|41674619|FG003|Overall Study|Other than specified|1|||
19427362|NCT02144701|41674631|FG000|Overall Study|development of relapse, GVHD or death|9|||
19427363|NCT02144701|41674632|FG001|Overall Study|development of relapse, GVHD or death|3|||
19427364|NCT01921101|41674640|FG000|Overall Study|Death|16|||
19427365|NCT01921101|41674641|FG001|Overall Study|Death|6|||
19427366|NCT01586806|41674650|FG000|Overall Study|Protocol Violation|0|||
19427367|NCT01586806|41674651|FG001|Overall Study|Protocol Violation|1|||
19427368|NCT01586806|41674652|FG002|Overall Study|Protocol Violation|0|||
19427369|NCT01586806|41674650|FG000|Overall Study|Withdrawal by Subject|1|||
19427370|NCT01586806|41674651|FG001|Overall Study|Withdrawal by Subject|0|||
19427371|NCT01586806|41674652|FG002|Overall Study|Withdrawal by Subject|0|||
19427372|NCT01586806|41674650|FG000|Overall Study|Lost to Follow-up|2|||
19427373|NCT01586806|41674651|FG001|Overall Study|Lost to Follow-up|3|||
19427374|NCT01586806|41674652|FG002|Overall Study|Lost to Follow-up|2|||
19427375|NCT02144077|41674662|FG000|Overall Study|Withdrawal by Subject|3|||
19427376|NCT02144077|41674663|FG001|Overall Study|Withdrawal by Subject|3|||
19427377|NCT02144077|41674662|FG000|Overall Study|Adverse Event|2|||
19427378|NCT02144077|41674663|FG001|Overall Study|Adverse Event|3|||
19427379|NCT02144077|41674662|FG000|Overall Study|Lost to Follow-up|2|||
19427380|NCT02144077|41674663|FG001|Overall Study|Lost to Follow-up|2|||
19427381|NCT02144077|41674662|FG000|Overall Study|Protocol Violation|1|||
19427382|NCT02144077|41674663|FG001|Overall Study|Protocol Violation|2|||
19427383|NCT02144077|41674662|FG000|Overall Study|Death|0|||
19427384|NCT02144077|41674663|FG001|Overall Study|Death|1|||
19427385|NCT02144077|41674662|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
19427386|NCT02144077|41674663|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
19427387|NCT02172625|41674671|FG000|Overall Study|Adverse Event|0|||
19427388|NCT02172625|41674672|FG001|Overall Study|Adverse Event|1|||
19427389|NCT02172625|41674671|FG000|Overall Study|Pregnancy|0|||
19427390|NCT02172625|41674672|FG001|Overall Study|Pregnancy|1|||
19427391|NCT02172625|41674671|FG000|Overall Study|car accident|0|||
19427392|NCT02172625|41674672|FG001|Overall Study|car accident|1|||
19427393|NCT02143843|41674682|FG000|Overall Study|Adverse Event|8|||
19427394|NCT02143843|41674682|FG000|Overall Study|Lack of Efficacy|2|||
19427395|NCT02143843|41674682|FG000|Overall Study|Withdrawal by Subject|2|||
19427396|NCT02121535|41674688|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
19427397|NCT02121535|41674689|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
19427398|NCT02121535|41674688|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
19427399|NCT02121535|41674689|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
19427400|NCT01586338|41674696|FG000|Overall Study|Adverse Event|3|||
19427401|NCT01586338|41674696|FG000|Overall Study|Lost to Follow-up|1|||
19427402|NCT01586338|41674696|FG000|Overall Study|Withdrawal by participant|3|||
19427403|NCT01586338|41674696|FG000|Overall Study|Other|1|||
19427404|NCT02143141|41674702|FG000|Overall Study|pain scores at 24 hours not collected|1|||
19427405|NCT02143141|41674703|FG001|Overall Study|pain scores at 24 hours not collected|0|||
19427406|NCT02171065|41674712|FG000|Overall Study|Withdrawal by Subject|1|||
19427407|NCT02171065|41674713|FG001|Overall Study|Withdrawal by Subject|0|||
19427408|NCT02171065|41674714|FG002|Overall Study|Withdrawal by Subject|0|||
19427409|NCT02171065|41674712|FG000|Overall Study|Lost to Follow-up|0|||
19427410|NCT02171065|41674713|FG001|Overall Study|Lost to Follow-up|0|||
19427411|NCT02171065|41674714|FG002|Overall Study|Lost to Follow-up|1|||
19427412|NCT01566604|41674726|FG000|Overall Study|Patient's inability to use the device|1|||
19427413|NCT01566604|41674727|FG001|Overall Study|Patient's inability to use the device|0|||
19427414|NCT01566604|41674726|FG000|Overall Study|Administrative problems|1|||
19427415|NCT01566604|41674727|FG001|Overall Study|Administrative problems|0|||
19427416|NCT01566604|41674726|FG000|Overall Study|Lack of Efficacy|1|||
19427417|NCT01566604|41674727|FG001|Overall Study|Lack of Efficacy|2|||
19427418|NCT01566604|41674726|FG000|Overall Study|Protocol deviation|2|||
19427419|NCT01566604|41674727|FG001|Overall Study|Protocol deviation|0|||
19427420|NCT01566604|41674726|FG000|Overall Study|Abnormal laboratory value|2|||
19427421|NCT01566604|41674727|FG001|Overall Study|Abnormal laboratory value|0|||
19427422|NCT01566604|41674726|FG000|Overall Study|Death|4|||
19427423|NCT01566604|41674727|FG001|Overall Study|Death|1|||
19427424|NCT01566604|41674726|FG000|Overall Study|Adverse Event|4|||
19427425|NCT01566604|41674727|FG001|Overall Study|Adverse Event|2|||
19427426|NCT01566604|41674726|FG000|Overall Study|Withdrawal by Subject|9|||
19427427|NCT01566604|41674727|FG001|Overall Study|Withdrawal by Subject|6|||
19427428|NCT01684930|41674735|FG000|Overall Study|Withdrawal by Subject|3|||
19427429|NCT01684930|41674736|FG001|Overall Study|Withdrawal by Subject|1|||
19427430|NCT01566214|41674744|FG000|Overall Study|Lost to Follow-up|3|||
19427431|NCT01566214|41674745|FG001|Overall Study|Lost to Follow-up|0|||
19427432|NCT02253992|41674754|FG000|Overall Study|Study drug toxicity|1|||
19427433|NCT02253992|41674755|FG001|Overall Study|Study drug toxicity|0|||
19427434|NCT02253992|41674756|FG002|Overall Study|Study drug toxicity|10|||
19427435|NCT02253992|41674754|FG000|Overall Study|Disease progression|4|||
19427436|NCT02253992|41674755|FG001|Overall Study|Disease progression|3|||
19427437|NCT02253992|41674756|FG002|Overall Study|Disease progression|98|||
19427438|NCT02253992|41674754|FG000|Overall Study|Withdrawal by Subject|0|||
19427439|NCT02253992|41674755|FG001|Overall Study|Withdrawal by Subject|0|||
19427440|NCT02253992|41674756|FG002|Overall Study|Withdrawal by Subject|3|||
19427441|NCT02253992|41674754|FG000|Overall Study|Adverse Event|0|||
19427442|NCT02253992|41674755|FG001|Overall Study|Adverse Event|0|||
19427443|NCT02253992|41674756|FG002|Overall Study|Adverse Event|8|||
19427444|NCT02253992|41674754|FG000|Overall Study|Death|0|||
19427445|NCT02253992|41674755|FG001|Overall Study|Death|0|||
19427446|NCT02253992|41674756|FG002|Overall Study|Death|1|||
19427447|NCT02253992|41674754|FG000|Overall Study|Subject discontinued study drug|1|||
19427448|NCT02253992|41674755|FG001|Overall Study|Subject discontinued study drug|0|||
19427449|NCT02253992|41674756|FG002|Overall Study|Subject discontinued study drug|1|||
19427450|NCT02253992|41674754|FG000|Overall Study|Completed treatment as per protocol|0|||
19427451|NCT02253992|41674755|FG001|Overall Study|Completed treatment as per protocol|1|||
19427452|NCT02253992|41674756|FG002|Overall Study|Completed treatment as per protocol|22|||
19427453|NCT02253992|41674754|FG000|Overall Study|Other|0|||
19427454|NCT02253992|41674755|FG001|Overall Study|Other|0|||
19427455|NCT02253992|41674756|FG002|Overall Study|Other|1|||
19427456|NCT02252588|41674780|FG000|Overall Study|Withdrawal by Subject|4|||
19427457|NCT02252588|41674781|FG001|Overall Study|Withdrawal by Subject|0|||
19427458|NCT01585558|41674790|FG000|Overall Study|Withdrawal by Subject|4|||
19427459|NCT01585558|41674791|FG001|Overall Study|Withdrawal by Subject|5|||
19427460|NCT01585558|41674792|FG002|Overall Study|Withdrawal by Subject|8|||
19427461|NCT01585558|41674790|FG000|Overall Study|Lost to Follow-up|2|||
19427462|NCT01585558|41674791|FG001|Overall Study|Lost to Follow-up|0|||
19427463|NCT01585558|41674792|FG002|Overall Study|Lost to Follow-up|3|||
19427464|NCT01585558|41674790|FG000|Overall Study|Adverse Event|3|||
19427465|NCT01585558|41674791|FG001|Overall Study|Adverse Event|4|||
19427466|NCT01585558|41674792|FG002|Overall Study|Adverse Event|1|||
19427467|NCT01585558|41674790|FG000|Overall Study|Protocol Violation|4|||
19427468|NCT01585558|41674791|FG001|Overall Study|Protocol Violation|3|||
19427469|NCT01585558|41674792|FG002|Overall Study|Protocol Violation|2|||
19427470|NCT01585558|41674790|FG000|Overall Study|Lack of Efficacy|0|||
19427471|NCT01585558|41674791|FG001|Overall Study|Lack of Efficacy|0|||
19427472|NCT01585558|41674792|FG002|Overall Study|Lack of Efficacy|1|||
19427473|NCT01565980|41674802|FG000|Overall Study|Death|1|||
19427474|NCT01565980|41674803|FG001|Overall Study|Death|0|||
19427475|NCT01565980|41674802|FG000|Overall Study|Lost to Follow-up|1|||
19427476|NCT01565980|41674803|FG001|Overall Study|Lost to Follow-up|0|||
19427477|NCT01565980|41674802|FG000|Overall Study|health complications|1|||
19427478|NCT01565980|41674803|FG001|Overall Study|health complications|1|||
19427479|NCT01565980|41674802|FG000|Overall Study|stopped medical treatment|1|||
19427480|NCT01565980|41674803|FG001|Overall Study|stopped medical treatment|0|||
19521015|NCT01387230|41933797|FG002|Overall Study|Withdrawal by Subject|0|||
19521016|NCT01387074|41933805|FG000|Overall Study|Lost to Follow-up|7|||
19521017|NCT01387074|41933805|FG000|Overall Study|Lack of Efficacy|1|||
19521018|NCT01386606|41933813|FG000|Overall Study|Adverse Event|0|||
19521019|NCT01386606|41933814|FG001|Overall Study|Adverse Event|1|||
19521020|NCT01386606|41933815|FG002|Overall Study|Adverse Event|0|||
19427481|NCT01565980|41674802|FG000|Overall Study|Withdrawal by Subject|0|||
19427482|NCT01565980|41674803|FG001|Overall Study|Withdrawal by Subject|3|||
19427483|NCT01585246|41674818|FG000|Overall Study|Lost to Follow-up|0|||
19427484|NCT01585246|41674819|FG001|Overall Study|Lost to Follow-up|0|||
19427485|NCT01585246|41674820|FG002|Overall Study|Lost to Follow-up|2|||
19427486|NCT01585246|41674821|FG003|Overall Study|Lost to Follow-up|1|||
19427487|NCT01585246|41674822|FG004|Overall Study|Lost to Follow-up|0|||
19427488|NCT01585246|41674818|FG000|Overall Study|Protocol Violation|0|||
19427489|NCT01585246|41674819|FG001|Overall Study|Protocol Violation|0|||
19427490|NCT01585246|41674820|FG002|Overall Study|Protocol Violation|0|||
19427491|NCT01585246|41674821|FG003|Overall Study|Protocol Violation|0|||
19427492|NCT01585246|41674822|FG004|Overall Study|Protocol Violation|1|||
19427493|NCT01585246|41674818|FG000|Overall Study|Withdrawal by Subject|0|||
19427494|NCT01585246|41674819|FG001|Overall Study|Withdrawal by Subject|0|||
19427495|NCT01585246|41674820|FG002|Overall Study|Withdrawal by Subject|1|||
19427496|NCT01585246|41674821|FG003|Overall Study|Withdrawal by Subject|2|||
19427497|NCT01585246|41674822|FG004|Overall Study|Withdrawal by Subject|1|||
19427498|NCT01585246|41674818|FG000|Overall Study|Other|0|||
19427499|NCT01585246|41674819|FG001|Overall Study|Other|1|||
19427500|NCT01585246|41674820|FG002|Overall Study|Other|1|||
19427501|NCT01585246|41674821|FG003|Overall Study|Other|1|||
19427502|NCT01585246|41674822|FG004|Overall Study|Other|0|||
19427503|NCT01585168|41674839|FG000|Overall Study|Lost to Follow-up|3|||
19427504|NCT01585168|41674840|FG001|Overall Study|Lost to Follow-up|1|||
19427505|NCT01585168|41674841|FG002|Overall Study|Lost to Follow-up|1|||
19427506|NCT01585168|41674842|FG003|Overall Study|Lost to Follow-up|1|||
19427507|NCT02252042|41674852|FG000|Overall Study|Death|170|||
19427508|NCT02252042|41674853|FG001|Overall Study|Death|192|||
19427509|NCT02252042|41674852|FG000|Overall Study|Physician Decision|0|||
19427510|NCT02252042|41674853|FG001|Overall Study|Physician Decision|1|||
19427511|NCT02252042|41674852|FG000|Overall Study|Withdrawal by Subject|13|||
19427512|NCT02252042|41674853|FG001|Overall Study|Withdrawal by Subject|20|||
19427513|NCT02252042|41674852|FG000|Overall Study|Ongoing in study|64|||
19427514|NCT02252042|41674853|FG001|Overall Study|Ongoing in study|35|||
19427515|NCT02232074|41674861|FG000|Overall Study|Withdrawal by Subject|5|||
19427516|NCT02232074|41674862|FG001|Overall Study|Withdrawal by Subject|3|||
19427517|NCT02232074|41674861|FG000|Overall Study|No legal concerns at baseline|36|||
19427518|NCT02232074|41674862|FG001|Overall Study|No legal concerns at baseline|41|||
19427519|NCT02232074|41674861|FG000|Overall Study|deemed ineligible|0|||
19427520|NCT02232074|41674862|FG001|Overall Study|deemed ineligible|1|||
19427521|NCT02142283|41674876|FG000|Overall Study|Death|20|||
19427522|NCT02142283|41674877|FG001|Overall Study|Death|18|||
19427523|NCT02142283|41674876|FG000|Overall Study|Withdrawal by Subject|1|||
19427524|NCT02142283|41674877|FG001|Overall Study|Withdrawal by Subject|3|||
19521021|NCT01386606|41933816|FG003|Overall Study|Adverse Event|0|||
19521022|NCT01386606|41933813|FG000|Overall Study|Withdrawal by Subject|0|||
19375284|NCT02281552|41617087|FG000|Overall Study|Medication error|1|||
19375285|NCT02281552|41617088|FG001|Overall Study|Medication error|0|||
19375286|NCT02281552|41617087|FG000|Overall Study|Insufficient clinical response|0|||
19375287|NCT02281552|41617088|FG001|Overall Study|Insufficient clinical response|1|||
19375288|NCT02281552|41617087|FG000|Overall Study|Adverse Event|3|||
19375289|NCT02281552|41617088|FG001|Overall Study|Adverse Event|9|||
19375290|NCT00890591|41617094|FG000|Overall Study|Lack of Efficacy|20|||
19375291|NCT02284906|41617103|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19375292|NCT02284906|41617104|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
19375293|NCT02284906|41617105|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19375294|NCT02284906|41617103|FG000|Overall Study|Major Protocol Deviation|0|||
19375295|NCT02284906|41617104|FG001|Overall Study|Major Protocol Deviation|1|||
19375296|NCT02284906|41617105|FG002|Overall Study|Major Protocol Deviation|0|||
19375297|NCT02284906|41617103|FG000|Overall Study|Voluntary Withdrawal|2|||
19375298|NCT02284906|41617104|FG001|Overall Study|Voluntary Withdrawal|4|||
19375299|NCT02284906|41617105|FG002|Overall Study|Voluntary Withdrawal|5|||
19375300|NCT02284906|41617103|FG000|Overall Study|Study Termination|0|||
19375301|NCT02284906|41617104|FG001|Overall Study|Study Termination|11|||
19375302|NCT02284906|41617105|FG002|Overall Study|Study Termination|14|||
19375303|NCT02284906|41617103|FG000|Overall Study|Reason not Specified|1|||
19375304|NCT02284906|41617104|FG001|Overall Study|Reason not Specified|1|||
19375305|NCT02284906|41617105|FG002|Overall Study|Reason not Specified|0|||
19375306|NCT02879305|41617115|FG000|Overall Study|Investigator Site Closed|55|||
19375307|NCT02879305|41617116|FG001|Overall Study|Investigator Site Closed|57|||
19375308|NCT02879305|41617115|FG000|Overall Study|Withdrawal by Subject|44|||
19375309|NCT02879305|41617116|FG001|Overall Study|Withdrawal by Subject|42|||
19427525|NCT02231918|41674886|FG000|Overall Study|Withdrawal by Subject|0|||
19427526|NCT02231918|41674887|FG001|Overall Study|Withdrawal by Subject|1|||
19427527|NCT02231918|41674888|FG002|Overall Study|Withdrawal by Subject|0|||
19427528|NCT02231918|41674886|FG000|Overall Study|Adverse Event|0|||
19427529|NCT02231918|41674887|FG001|Overall Study|Adverse Event|0|||
19427530|NCT02231918|41674888|FG002|Overall Study|Adverse Event|1|||
19427531|NCT02199314|41674896|FG000|Overall Study|Withdrawal by Subject|6|||
19427532|NCT02199314|41674896|FG000|Overall Study|Physician Decision|10|||
19427533|NCT02199080|41674900|FG000|Overall Study|Protocol Violation|12|||
19427534|NCT02251652|41674906|FG000|Overall Study|Withdrawal by Subject|1|||
19427535|NCT02197520|41674912|FG000|Period 1|Withdrawal by Subject|1|||
19427536|NCT02197520|41674913|FG001|Period 1|Withdrawal by Subject|0|||
19427537|NCT02197520|41674912|FG000|Period 2|Adverse Event|0|||
19427538|NCT02197520|41674913|FG001|Period 2|Adverse Event|2|||
19427539|NCT02197520|41674912|FG000|Period 2|Withdrawal by Subject|1|||
19427540|NCT02197520|41674913|FG001|Period 2|Withdrawal by Subject|0|||
19427541|NCT02230904|41674923|FG000|Overall Study|Safety follow up could not take place|0|||
19427542|NCT02230904|41674924|FG001|Overall Study|Safety follow up could not take place|1|||
19427543|NCT02230670|41674934|FG000|Overall Study|Adverse Event|1|||
19427544|NCT02230670|41674935|FG001|Overall Study|Adverse Event|2|||
19427545|NCT02230670|41674934|FG000|Overall Study|Withdrawal by Subject|2|||
19427546|NCT02230670|41674935|FG001|Overall Study|Withdrawal by Subject|2|||
19427547|NCT02230670|41674934|FG000|Overall Study|Physician Decision|0|||
19427548|NCT02230670|41674935|FG001|Overall Study|Physician Decision|1|||
19427549|NCT02230670|41674934|FG000|Overall Study|Protocol Violation|0|||
19427550|NCT02230670|41674935|FG001|Overall Study|Protocol Violation|1|||
19427551|NCT02230670|41674934|FG000|Overall Study|Progression to Child-Pugh C|1|||
19427552|NCT02230670|41674935|FG001|Overall Study|Progression to Child-Pugh C|2|||
19427553|NCT02197130|41674944|FG000|Overall Study|Adverse Event|13|||
19427554|NCT02197130|41674945|FG001|Overall Study|Adverse Event|4|||
19427555|NCT02197130|41674946|FG002|Overall Study|Adverse Event|23|||
19427556|NCT02197130|41674944|FG000|Overall Study|Death|0|||
19427557|NCT02197130|41674945|FG001|Overall Study|Death|1|||
19427558|NCT02197130|41674946|FG002|Overall Study|Death|0|||
19427559|NCT02197130|41674944|FG000|Overall Study|Lost to Follow-up|2|||
19427560|NCT02197130|41674945|FG001|Overall Study|Lost to Follow-up|0|||
19427561|NCT02197130|41674946|FG002|Overall Study|Lost to Follow-up|1|||
19427562|NCT02197130|41674944|FG000|Overall Study|Does not meet entrance criteria|0|||
19427563|NCT02197130|41674945|FG001|Overall Study|Does not meet entrance criteria|0|||
19427564|NCT02197130|41674946|FG002|Overall Study|Does not meet entrance criteria|1|||
19427565|NCT02197130|41674944|FG000|Overall Study|Withdrawal by Subject|0|||
19427566|NCT02197130|41674945|FG001|Overall Study|Withdrawal by Subject|3|||
19427567|NCT02197130|41674946|FG002|Overall Study|Withdrawal by Subject|4|||
19427568|NCT02197130|41674944|FG000|Overall Study|Other|1|||
19427569|NCT02197130|41674945|FG001|Overall Study|Other|0|||
19427570|NCT02197130|41674946|FG002|Overall Study|Other|3|||
19427571|NCT02196506|41674956|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
19427572|NCT02196506|41674957|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
19427573|NCT02196506|41674958|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
19427574|NCT02196506|41674959|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
19427575|NCT02196506|41674956|FG000|Phase A|Withdrawal by Subject|34|||
19427576|NCT02196506|41674957|FG001|Phase A|Withdrawal by Subject|0|||
19427577|NCT02196506|41674958|FG002|Phase A|Withdrawal by Subject|0|||
19427578|NCT02196506|41674959|FG003|Phase A|Withdrawal by Subject|0|||
19427579|NCT02196506|41674956|FG000|Phase A|Adverse Event|22|||
19427580|NCT02196506|41674957|FG001|Phase A|Adverse Event|0|||
19427581|NCT02196506|41674958|FG002|Phase A|Adverse Event|0|||
19427582|NCT02196506|41674959|FG003|Phase A|Adverse Event|0|||
19427583|NCT02196506|41674956|FG000|Phase A|Lost to Follow-up|9|||
19427584|NCT02196506|41674957|FG001|Phase A|Lost to Follow-up|0|||
19427585|NCT02196506|41674958|FG002|Phase A|Lost to Follow-up|0|||
19427586|NCT02196506|41674959|FG003|Phase A|Lost to Follow-up|0|||
19427587|NCT02196506|41674956|FG000|Phase A|Protocol deviation|12|||
19427588|NCT02196506|41674957|FG001|Phase A|Protocol deviation|0|||
19427589|NCT02196506|41674958|FG002|Phase A|Protocol deviation|0|||
19427590|NCT02196506|41674959|FG003|Phase A|Protocol deviation|0|||
19427591|NCT02196506|41674956|FG000|Phase A|Participant withdrawn by investigator|10|||
19427592|NCT02196506|41674957|FG001|Phase A|Participant withdrawn by investigator|0|||
19427593|NCT02196506|41674958|FG002|Phase A|Participant withdrawn by investigator|0|||
19427594|NCT02196506|41674959|FG003|Phase A|Participant withdrawn by investigator|0|||
19427595|NCT02196506|41674956|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
19427596|NCT02196506|41674957|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
19427597|NCT02196506|41674958|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
19427598|NCT02196506|41674959|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
19427599|NCT02196506|41674956|FG000|Phase B|Lack of Efficacy|0|||
19427600|NCT02196506|41674957|FG001|Phase B|Lack of Efficacy|1|||
19427601|NCT02196506|41674958|FG002|Phase B|Lack of Efficacy|2|||
19427602|NCT02196506|41674959|FG003|Phase B|Lack of Efficacy|0|||
19427603|NCT02196506|41674956|FG000|Phase B|Withdrawal by Participant|0|||
19427604|NCT02196506|41674957|FG001|Phase B|Withdrawal by Participant|8|||
19427605|NCT02196506|41674958|FG002|Phase B|Withdrawal by Participant|1|||
19427606|NCT02196506|41674959|FG003|Phase B|Withdrawal by Participant|0|||
19427607|NCT02196506|41674956|FG000|Phase B|Adverse Event|0|||
19427608|NCT02196506|41674957|FG001|Phase B|Adverse Event|4|||
19427609|NCT02196506|41674958|FG002|Phase B|Adverse Event|1|||
19427610|NCT02196506|41674959|FG003|Phase B|Adverse Event|0|||
19427611|NCT02196506|41674956|FG000|Phase B|Lost to Follow-up|0|||
19427612|NCT02196506|41674957|FG001|Phase B|Lost to Follow-up|2|||
19427613|NCT02196506|41674958|FG002|Phase B|Lost to Follow-up|1|||
19427614|NCT02196506|41674959|FG003|Phase B|Lost to Follow-up|0|||
19427615|NCT02196506|41674956|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
19427616|NCT02196506|41674957|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
19427617|NCT02196506|41674958|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
19427618|NCT02196506|41674959|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
19427619|NCT02196506|41674956|FG000|Phase A+|Withdrawal by Participant|0|||
19427620|NCT02196506|41674957|FG001|Phase A+|Withdrawal by Participant|0|||
19427621|NCT02196506|41674958|FG002|Phase A+|Withdrawal by Participant|0|||
19427622|NCT02196506|41674959|FG003|Phase A+|Withdrawal by Participant|5|||
19427623|NCT02196506|41674956|FG000|Phase A+|Adverse Event|0|||
19427624|NCT02196506|41674957|FG001|Phase A+|Adverse Event|0|||
19427625|NCT02196506|41674958|FG002|Phase A+|Adverse Event|0|||
19427626|NCT02196506|41674959|FG003|Phase A+|Adverse Event|1|||
19427627|NCT02196506|41674956|FG000|Phase A+|Lost to Follow-up|0|||
19427628|NCT02196506|41674957|FG001|Phase A+|Lost to Follow-up|0|||
19427629|NCT02196506|41674958|FG002|Phase A+|Lost to Follow-up|0|||
19427630|NCT02196506|41674959|FG003|Phase A+|Lost to Follow-up|6|||
19427631|NCT02196506|41674956|FG000|Phase A+|Participant withdrawn by investigator|0|||
19427632|NCT02196506|41674957|FG001|Phase A+|Participant withdrawn by investigator|0|||
19427633|NCT02196506|41674958|FG002|Phase A+|Participant withdrawn by investigator|0|||
19427634|NCT02196506|41674959|FG003|Phase A+|Participant withdrawn by investigator|1|||
19427635|NCT02228720|41674965|FG000|Open Label - Day 30|Lost to Follow-up|1|||
19427636|NCT02228564|41674969|FG000|Overall Study|Withdrawal by Subject|10|||
19427637|NCT02228564|41674969|FG000|Overall Study|Death|11|||
19427638|NCT02228564|41674969|FG000|Overall Study|Physician Decision|5|||
19427639|NCT02228564|41674969|FG000|Overall Study|Lost to Follow-up|17|||
19427640|NCT02228564|41674969|FG000|Overall Study|Other|6|||
19427641|NCT01640951|41674981|FG000|Overall Study|Adverse Event|8|||
19427642|NCT01640951|41674982|FG001|Overall Study|Adverse Event|3|||
19427643|NCT01640951|41674983|FG002|Overall Study|Adverse Event|10|||
19427644|NCT01640951|41674984|FG003|Overall Study|Adverse Event|6|||
19427645|NCT01640951|41674985|FG004|Overall Study|Adverse Event|1|||
19427646|NCT01640951|41674986|FG005|Overall Study|Adverse Event|11|||
19427647|NCT01640951|41674987|FG006|Overall Study|Adverse Event|1|||
19427648|NCT01640951|41674988|FG007|Overall Study|Adverse Event|3|||
19427649|NCT01640951|41674981|FG000|Overall Study|Lack of Efficacy|20|||
19427650|NCT01640951|41674982|FG001|Overall Study|Lack of Efficacy|1|||
19427651|NCT01640951|41674983|FG002|Overall Study|Lack of Efficacy|7|||
19427652|NCT01640951|41674984|FG003|Overall Study|Lack of Efficacy|14|||
19427653|NCT01640951|41674985|FG004|Overall Study|Lack of Efficacy|0|||
19427654|NCT01640951|41674986|FG005|Overall Study|Lack of Efficacy|6|||
19427655|NCT01640951|41674987|FG006|Overall Study|Lack of Efficacy|5|||
19427656|NCT01640951|41674988|FG007|Overall Study|Lack of Efficacy|6|||
19427657|NCT01640951|41674981|FG000|Overall Study|Lost to Follow-up|1|||
19427658|NCT01640951|41674982|FG001|Overall Study|Lost to Follow-up|0|||
19427659|NCT01640951|41674983|FG002|Overall Study|Lost to Follow-up|6|||
19427660|NCT01640951|41674984|FG003|Overall Study|Lost to Follow-up|2|||
19427661|NCT01640951|41674985|FG004|Overall Study|Lost to Follow-up|2|||
19427662|NCT01640951|41674986|FG005|Overall Study|Lost to Follow-up|3|||
19427663|NCT01640951|41674987|FG006|Overall Study|Lost to Follow-up|1|||
19427664|NCT01640951|41674988|FG007|Overall Study|Lost to Follow-up|1|||
19427665|NCT01640951|41674981|FG000|Overall Study|Non-compliance with study treatment|0|||
19427666|NCT01640951|41674982|FG001|Overall Study|Non-compliance with study treatment|0|||
19427667|NCT01640951|41674983|FG002|Overall Study|Non-compliance with study treatment|1|||
19427668|NCT01640951|41674984|FG003|Overall Study|Non-compliance with study treatment|1|||
19427669|NCT01640951|41674985|FG004|Overall Study|Non-compliance with study treatment|1|||
19427670|NCT01640951|41674986|FG005|Overall Study|Non-compliance with study treatment|4|||
19427671|NCT01640951|41674987|FG006|Overall Study|Non-compliance with study treatment|1|||
19427672|NCT01640951|41674988|FG007|Overall Study|Non-compliance with study treatment|0|||
19427673|NCT01640951|41674981|FG000|Overall Study|Physician Decision|2|||
19427674|NCT01640951|41674982|FG001|Overall Study|Physician Decision|5|||
19427675|NCT01640951|41674983|FG002|Overall Study|Physician Decision|2|||
19427676|NCT01640951|41674984|FG003|Overall Study|Physician Decision|2|||
19427677|NCT01640951|41674985|FG004|Overall Study|Physician Decision|2|||
19427678|NCT01640951|41674986|FG005|Overall Study|Physician Decision|3|||
19427679|NCT01640951|41674987|FG006|Overall Study|Physician Decision|3|||
19427680|NCT01640951|41674988|FG007|Overall Study|Physician Decision|0|||
19427681|NCT01640951|41674981|FG000|Overall Study|Pregnancy|3|||
19427682|NCT01640951|41674982|FG001|Overall Study|Pregnancy|0|||
19427683|NCT01640951|41674983|FG002|Overall Study|Pregnancy|0|||
19427684|NCT01640951|41674984|FG003|Overall Study|Pregnancy|4|||
19427685|NCT01640951|41674985|FG004|Overall Study|Pregnancy|0|||
19427686|NCT01640951|41674986|FG005|Overall Study|Pregnancy|0|||
19427687|NCT01640951|41674987|FG006|Overall Study|Pregnancy|2|||
19427688|NCT01640951|41674988|FG007|Overall Study|Pregnancy|0|||
19427689|NCT01640951|41674981|FG000|Overall Study|Protocol Deviation|0|||
19427690|NCT01640951|41674982|FG001|Overall Study|Protocol Deviation|1|||
19427691|NCT01640951|41674983|FG002|Overall Study|Protocol Deviation|2|||
19427692|NCT01640951|41674984|FG003|Overall Study|Protocol Deviation|1|||
19427693|NCT01640951|41674985|FG004|Overall Study|Protocol Deviation|0|||
19427694|NCT01640951|41674986|FG005|Overall Study|Protocol Deviation|1|||
19427695|NCT01640951|41674987|FG006|Overall Study|Protocol Deviation|0|||
19427696|NCT01640951|41674988|FG007|Overall Study|Protocol Deviation|0|||
19427697|NCT01640951|41674981|FG000|Overall Study|Subject/Guardian decision|12|||
19427698|NCT01640951|41674982|FG001|Overall Study|Subject/Guardian decision|4|||
19427699|NCT01640951|41674983|FG002|Overall Study|Subject/Guardian decision|13|||
19427700|NCT01640951|41674984|FG003|Overall Study|Subject/Guardian decision|15|||
19427701|NCT01640951|41674985|FG004|Overall Study|Subject/Guardian decision|7|||
19427702|NCT01640951|41674986|FG005|Overall Study|Subject/Guardian decision|19|||
19427703|NCT01640951|41674987|FG006|Overall Study|Subject/Guardian decision|5|||
19427704|NCT01640951|41674988|FG007|Overall Study|Subject/Guardian decision|4|||
19427705|NCT01640951|41674981|FG000|Overall Study|Death|0|||
19427706|NCT01640951|41674982|FG001|Overall Study|Death|1|||
19427707|NCT01640951|41674983|FG002|Overall Study|Death|1|||
19427708|NCT01640951|41674984|FG003|Overall Study|Death|0|||
19427709|NCT01640951|41674985|FG004|Overall Study|Death|0|||
19427710|NCT01640951|41674986|FG005|Overall Study|Death|0|||
19427711|NCT01640951|41674987|FG006|Overall Study|Death|0|||
19427712|NCT01640951|41674988|FG007|Overall Study|Death|2|||
19427713|NCT02228096|41675010|FG000|Overall Study|Study terminated by Sponsor|24|||
19427714|NCT02228096|41675010|FG000|Overall Study|Lack of Efficacy|18|||
19427715|NCT02228096|41675010|FG000|Overall Study|Death|12|||
19427716|NCT02228096|41675010|FG000|Overall Study|Physician Decision|3|||
19427717|NCT02228096|41675010|FG000|Overall Study|Subject/guardian decision|2|||
19427718|NCT02228096|41675010|FG000|Overall Study|New therapy for study indication|1|||
19427719|NCT02228096|41675010|FG000|Overall Study|Enrolled, not infused|11|||
19427720|NCT01640873|41675030|FG000|Overall Study|Protocol Violation|2|||
19427721|NCT01640873|41675031|FG001|Overall Study|Protocol Violation|1|||
19427722|NCT01683994|41675042|FG000|Overall Study|Withdrawal by Subject|1|||
19427723|NCT01683994|41675043|FG001|Overall Study|Withdrawal by Subject|0|||
19427724|NCT01683994|41675044|FG002|Overall Study|Withdrawal by Subject|0|||
19427725|NCT01683994|41675045|FG003|Overall Study|Withdrawal by Subject|1|||
19427726|NCT01683994|41675046|FG004|Overall Study|Withdrawal by Subject|0|||
19427727|NCT01683994|41675042|FG000|Overall Study|Intercurrent illness|0|||
19427728|NCT01683994|41675043|FG001|Overall Study|Intercurrent illness|0|||
19427729|NCT01683994|41675044|FG002|Overall Study|Intercurrent illness|0|||
19427730|NCT01683994|41675045|FG003|Overall Study|Intercurrent illness|2|||
19427731|NCT01683994|41675046|FG004|Overall Study|Intercurrent illness|1|||
19427732|NCT02247440|41675064|FG000|Overall Study|Withdrawal by Subject|1|||
19427733|NCT02247440|41675064|FG000|Overall Study|Lack of Efficacy|3|||
19427734|NCT01683838|41675070|FG000|Overall Study|Adverse Event|12|||
19427735|NCT01683838|41675071|FG001|Overall Study|Adverse Event|2|||
19427736|NCT01683838|41675070|FG000|Overall Study|Protocol Violation|3|||
19427737|NCT01683838|41675071|FG001|Overall Study|Protocol Violation|1|||
19427738|NCT01683838|41675070|FG000|Overall Study|Withdrawal by Subject|6|||
19427739|NCT01683838|41675071|FG001|Overall Study|Withdrawal by Subject|5|||
19427740|NCT01683838|41675070|FG000|Overall Study|Lost to Follow-up|1|||
19427741|NCT01683838|41675071|FG001|Overall Study|Lost to Follow-up|1|||
19427742|NCT01683838|41675070|FG000|Overall Study|Other|4|||
19427743|NCT01683838|41675071|FG001|Overall Study|Other|3|||
19427744|NCT01683604|41675077|FG000|Overall Study|Adverse Event|2|||
19427745|NCT01683604|41675077|FG000|Overall Study|Lack of Efficacy|1|||
19427746|NCT01683604|41675077|FG000|Overall Study|Other|2|||
19427747|NCT02196038|41675088|FG000|Overall Study|Death|16|||
19427748|NCT02196038|41675089|FG001|Overall Study|Death|21|||
19427749|NCT02196038|41675088|FG000|Overall Study|Withdrawal by Subject|0|||
19427750|NCT02196038|41675089|FG001|Overall Study|Withdrawal by Subject|1|||
19427751|NCT02196038|41675088|FG000|Overall Study|Lost to Follow-up|1|||
19427752|NCT02196038|41675089|FG001|Overall Study|Lost to Follow-up|0|||
19427753|NCT02141659|41675101|FG000|Overall Study|Major Protocol Deviation|0|||
19427754|NCT02141659|41675102|FG001|Overall Study|Major Protocol Deviation|1|||
19427755|NCT02141659|41675103|FG002|Overall Study|Major Protocol Deviation|0|||
19427756|NCT02141659|41675104|FG003|Overall Study|Major Protocol Deviation|0|||
19427757|NCT02141659|41675105|FG004|Overall Study|Major Protocol Deviation|0|||
19427758|NCT02141659|41675106|FG005|Overall Study|Major Protocol Deviation|0|||
19427759|NCT02141659|41675101|FG000|Overall Study|Lack of Efficacy|0|||
19427760|NCT02141659|41675102|FG001|Overall Study|Lack of Efficacy|0|||
19427761|NCT02141659|41675103|FG002|Overall Study|Lack of Efficacy|0|||
19427762|NCT02141659|41675104|FG003|Overall Study|Lack of Efficacy|0|||
19427763|NCT02141659|41675105|FG004|Overall Study|Lack of Efficacy|0|||
19427764|NCT02141659|41675106|FG005|Overall Study|Lack of Efficacy|1|||
19427765|NCT02141659|41675101|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
19427766|NCT02141659|41675102|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
19427767|NCT02141659|41675103|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
19427768|NCT02141659|41675104|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
19427769|NCT02141659|41675105|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
19427770|NCT02141659|41675106|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
19427771|NCT01640249|41675127|FG000|Period 1|Withdrawal by Subject|1|||
19427772|NCT01640249|41675128|FG001|Period 1|Withdrawal by Subject|0|||
19427773|NCT01640249|41675129|FG002|Period 1|Withdrawal by Subject|0|||
19427774|NCT01640249|41675130|FG003|Period 1|Withdrawal by Subject|0|||
19427775|NCT01640249|41675131|FG004|Period 1|Withdrawal by Subject|0|||
19427776|NCT01640249|41675132|FG005|Period 1|Withdrawal by Subject|1|||
19427777|NCT01640249|41675133|FG006|Period 1|Withdrawal by Subject|0|||
19427778|NCT02121301|41675155|FG000|Overall Study|Protocol Violation|1|||
19427779|NCT02121301|41675156|FG001|Overall Study|Protocol Violation|4|||
19427780|NCT02121301|41675157|FG002|Overall Study|Protocol Violation|1|||
19427781|NCT02227862|41675167|FG000|Overall Study|Protocol Violation|7|||
19427782|NCT02227862|41675168|FG001|Overall Study|Protocol Violation|9|||
19427783|NCT02227862|41675167|FG000|Overall Study|Other|0|||
19427784|NCT02227862|41675168|FG001|Overall Study|Other|2|||
19427785|NCT02227862|41675167|FG000|Overall Study|Adverse Event|4|||
19427786|NCT02227862|41675168|FG001|Overall Study|Adverse Event|3|||
19427787|NCT02227862|41675167|FG000|Overall Study|Withdrawal by Subject|7|||
19427788|NCT02227862|41675168|FG001|Overall Study|Withdrawal by Subject|6|||
19427789|NCT02227862|41675167|FG000|Overall Study|Lost to Follow-up|1|||
19427790|NCT02227862|41675168|FG001|Overall Study|Lost to Follow-up|2|||
19427791|NCT02120833|41675176|FG000|Overall Study|Adverse Event|1|||
19427792|NCT02120833|41675177|FG001|Overall Study|Adverse Event|0|||
19427793|NCT02120833|41675176|FG000|Overall Study|Withdrawal by Subject|2|||
19427794|NCT02120833|41675177|FG001|Overall Study|Withdrawal by Subject|0|||
19427795|NCT02120833|41675176|FG000|Overall Study|Lost to Follow-up|1|||
19427796|NCT02120833|41675177|FG001|Overall Study|Lost to Follow-up|1|||
19427797|NCT02170207|41675183|FG000|Overall Study|Case report forms unavailable|5|||
19427798|NCT02227784|41675191|FG000|Double-Blind Phase|Adverse Event|3|||
19427799|NCT02227784|41675192|FG001|Double-Blind Phase|Adverse Event|2|||
19427800|NCT02227784|41675193|FG002|Double-Blind Phase|Adverse Event|1|||
19427801|NCT02227784|41675194|FG003|Double-Blind Phase|Adverse Event|3|||
19427802|NCT02227784|41675195|FG004|Double-Blind Phase|Adverse Event|0|||
19427803|NCT02227784|41675191|FG000|Double-Blind Phase|Physician Decision|1|||
19427804|NCT02227784|41675192|FG001|Double-Blind Phase|Physician Decision|0|||
19427805|NCT02227784|41675193|FG002|Double-Blind Phase|Physician Decision|0|||
19427806|NCT02227784|41675194|FG003|Double-Blind Phase|Physician Decision|1|||
19427807|NCT02227784|41675195|FG004|Double-Blind Phase|Physician Decision|0|||
19427808|NCT02227784|41675191|FG000|Double-Blind Phase|Protocol Violation|0|||
19427809|NCT02227784|41675192|FG001|Double-Blind Phase|Protocol Violation|0|||
19427810|NCT02227784|41675193|FG002|Double-Blind Phase|Protocol Violation|1|||
19427811|NCT02227784|41675194|FG003|Double-Blind Phase|Protocol Violation|1|||
19427812|NCT02227784|41675195|FG004|Double-Blind Phase|Protocol Violation|0|||
19427813|NCT02227784|41675191|FG000|Double-Blind Phase|Sponsor Decision|34|||
19427814|NCT02227784|41675192|FG001|Double-Blind Phase|Sponsor Decision|15|||
19427815|NCT02227784|41675193|FG002|Double-Blind Phase|Sponsor Decision|14|||
19427816|NCT02227784|41675194|FG003|Double-Blind Phase|Sponsor Decision|32|||
19427817|NCT02227784|41675195|FG004|Double-Blind Phase|Sponsor Decision|0|||
19427818|NCT02227784|41675191|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
19427819|NCT02227784|41675192|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
19427820|NCT02227784|41675193|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
19427821|NCT02227784|41675194|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
19427822|NCT02227784|41675195|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
19427823|NCT02227784|41675191|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
19427824|NCT02227784|41675192|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
19427825|NCT02227784|41675193|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
19427826|NCT02227784|41675194|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
19427827|NCT02227784|41675195|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
19427828|NCT02227784|41675191|FG000|Open-Label Extension Phase (OLE)|Death|0|||
19427829|NCT02227784|41675192|FG001|Open-Label Extension Phase (OLE)|Death|0|||
19427830|NCT02227784|41675193|FG002|Open-Label Extension Phase (OLE)|Death|0|||
19427831|NCT02227784|41675194|FG003|Open-Label Extension Phase (OLE)|Death|0|||
19427832|NCT02227784|41675195|FG004|Open-Label Extension Phase (OLE)|Death|1|||
19427833|NCT02227784|41675191|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
19427834|NCT02227784|41675192|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
19427835|NCT02227784|41675193|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
19427836|NCT02227784|41675194|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
19427837|NCT02227784|41675195|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
19427838|NCT02227784|41675191|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
19427839|NCT02227784|41675192|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
19427840|NCT02227784|41675193|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
19427841|NCT02227784|41675194|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
19427842|NCT02227784|41675195|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
19427843|NCT01565668|41675210|FG000|Overall Study|Death|2|||
19427844|NCT01565668|41675211|FG001|Overall Study|Death|1|||
19427845|NCT01565668|41675210|FG000|Overall Study|Lack of Efficacy|4|||
19427846|NCT01565668|41675211|FG001|Overall Study|Lack of Efficacy|2|||
19427847|NCT01565668|41675210|FG000|Overall Study|Participant went on Hospice Care|1|||
19427848|NCT01565668|41675211|FG001|Overall Study|Participant went on Hospice Care|0|||
19427849|NCT01565668|41675210|FG000|Overall Study|Adverse Event|6|||
19427850|NCT01565668|41675211|FG001|Overall Study|Adverse Event|1|||
19427851|NCT01565668|41675210|FG000|Overall Study|Randomized, but never received drug|0|||
19427852|NCT01565668|41675211|FG001|Overall Study|Randomized, but never received drug|2|||
19427853|NCT01565668|41675210|FG000|Overall Study|Progressive disease|13|||
19427854|NCT01565668|41675211|FG001|Overall Study|Progressive disease|14|||
19427855|NCT01565668|41675210|FG000|Overall Study|Withdrawal by Subject|1|||
19427856|NCT01565668|41675211|FG001|Overall Study|Withdrawal by Subject|3|||
19427857|NCT01565668|41675210|FG000|Overall Study|HSCT Transplant|11|||
19427858|NCT01565668|41675211|FG001|Overall Study|HSCT Transplant|15|||
19427859|NCT01683058|41675217|FG000|Overall Study|Lost to Follow-up|9|||
19427860|NCT01683058|41675217|FG000|Overall Study|Adverse Event|6|||
19427861|NCT01683058|41675217|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
19427862|NCT01683058|41675217|FG000|Overall Study|Withdrawal by Subject|7|||
19427863|NCT01683058|41675217|FG000|Overall Study|Lack of Efficacy|2|||
19427864|NCT01626859|41675225|FG000|Overall Study|Adverse Event|1|||
19427865|NCT01626859|41675226|FG001|Overall Study|Adverse Event|3|||
19427866|NCT01626859|41675227|FG002|Overall Study|Adverse Event|2|||
19427867|NCT01626859|41675225|FG000|Overall Study|Physician Decision|0|||
19427868|NCT01626859|41675226|FG001|Overall Study|Physician Decision|1|||
19427869|NCT01626859|41675227|FG002|Overall Study|Physician Decision|0|||
19427870|NCT01626859|41675225|FG000|Overall Study|Withdrawal by Subject|1|||
19427871|NCT01626859|41675226|FG001|Overall Study|Withdrawal by Subject|4|||
19427872|NCT01626859|41675227|FG002|Overall Study|Withdrawal by Subject|2|||
19427873|NCT02193776|41675239|FG000|Overall Study|Consent withdrawn|1|||
19427874|NCT02193776|41675240|FG001|Overall Study|Consent withdrawn|0|||
19427875|NCT02193776|41675241|FG002|Overall Study|Consent withdrawn|0|||
19427876|NCT02193776|41675242|FG003|Overall Study|Consent withdrawn|0|||
19427877|NCT02193776|41675239|FG000|Overall Study|Failure to comply with protocol|0|||
19427878|NCT02193776|41675240|FG001|Overall Study|Failure to comply with protocol|1|||
19427879|NCT02193776|41675241|FG002|Overall Study|Failure to comply with protocol|0|||
19427880|NCT02193776|41675242|FG003|Overall Study|Failure to comply with protocol|0|||
19427881|NCT02193776|41675239|FG000|Overall Study|Investigator/Sponsor decision|1|||
19427882|NCT02193776|41675240|FG001|Overall Study|Investigator/Sponsor decision|1|||
19427883|NCT02193776|41675241|FG002|Overall Study|Investigator/Sponsor decision|0|||
19427884|NCT02193776|41675242|FG003|Overall Study|Investigator/Sponsor decision|0|||
19427885|NCT02193776|41675239|FG000|Overall Study|Death|1|||
19427886|NCT02193776|41675240|FG001|Overall Study|Death|0|||
19427887|NCT02193776|41675241|FG002|Overall Study|Death|0|||
19427888|NCT02193776|41675242|FG003|Overall Study|Death|0|||
19427889|NCT02193776|41675239|FG000|Overall Study|Adverse event/Specific toxicity|5|||
19427890|NCT02193776|41675240|FG001|Overall Study|Adverse event/Specific toxicity|5|||
19427891|NCT02193776|41675241|FG002|Overall Study|Adverse event/Specific toxicity|2|||
19427892|NCT02193776|41675242|FG003|Overall Study|Adverse event/Specific toxicity|2|||
19427893|NCT02170064|41675255|FG000|Overall Study|Withdrawal by Subject|5|||
19427894|NCT02170064|41675256|FG001|Overall Study|Withdrawal by Subject|1|||
19427895|NCT02170064|41675257|FG002|Overall Study|Withdrawal by Subject|1|||
19427896|NCT02170064|41675255|FG000|Overall Study|Physician Decision|1|||
19427897|NCT02170064|41675256|FG001|Overall Study|Physician Decision|1|||
19427898|NCT02170064|41675257|FG002|Overall Study|Physician Decision|0|||
19427899|NCT02169830|41675268|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
19427900|NCT02169830|41675269|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
19427901|NCT02169830|41675270|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
19427902|NCT02169830|41675268|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
19427903|NCT02169830|41675269|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
19427904|NCT02169830|41675270|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
19427905|NCT02169830|41675268|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
19427906|NCT02169830|41675269|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
19427907|NCT02169830|41675270|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
19427908|NCT02169830|41675268|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
19427909|NCT02169830|41675269|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
19427910|NCT02169830|41675270|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
19427911|NCT02169830|41675268|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
19427912|NCT02169830|41675269|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
19427913|NCT02169830|41675270|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
19427914|NCT02169674|41675280|FG000|Overall Study|Withdrawal by Subject|2|||
19427915|NCT02169674|41675281|FG001|Overall Study|Withdrawal by Subject|1|||
19427916|NCT02169674|41675280|FG000|Overall Study|Seroprotected|30|||
19427917|NCT02169674|41675281|FG001|Overall Study|Seroprotected|76|||
19427918|NCT02169674|41675280|FG000|Overall Study|Lost to Follow-up|0|||
19427919|NCT02169674|41675281|FG001|Overall Study|Lost to Follow-up|1|||
19427920|NCT02169284|41675289|FG000|Overall Study|Physician Decision|0|||
19427921|NCT02169284|41675290|FG001|Overall Study|Physician Decision|1|||
19427922|NCT02119819|41675304|FG000|Overall Study|Adverse Event|3|||
19427923|NCT02119819|41675305|FG001|Overall Study|Adverse Event|1|||
19427924|NCT02119819|41675306|FG002|Overall Study|Adverse Event|2|||
19427925|NCT02119819|41675307|FG003|Overall Study|Adverse Event|3|||
19427926|NCT02119819|41675308|FG004|Overall Study|Adverse Event|0|||
19427927|NCT02119819|41675309|FG005|Overall Study|Adverse Event|1|||
19427928|NCT02119819|41675304|FG000|Overall Study|Lack of Efficacy|0|||
19427929|NCT02119819|41675305|FG001|Overall Study|Lack of Efficacy|0|||
19427930|NCT02119819|41675306|FG002|Overall Study|Lack of Efficacy|0|||
19427931|NCT02119819|41675307|FG003|Overall Study|Lack of Efficacy|0|||
19427932|NCT02119819|41675308|FG004|Overall Study|Lack of Efficacy|0|||
19427933|NCT02119819|41675309|FG005|Overall Study|Lack of Efficacy|1|||
19427934|NCT02119819|41675304|FG000|Overall Study|Lost to Follow-up|0|||
19427935|NCT02119819|41675305|FG001|Overall Study|Lost to Follow-up|0|||
19427936|NCT02119819|41675306|FG002|Overall Study|Lost to Follow-up|1|||
19427937|NCT02119819|41675307|FG003|Overall Study|Lost to Follow-up|2|||
19427938|NCT02119819|41675308|FG004|Overall Study|Lost to Follow-up|1|||
19427939|NCT02119819|41675309|FG005|Overall Study|Lost to Follow-up|2|||
19427940|NCT02119819|41675304|FG000|Overall Study|Physician Decision|1|||
19427941|NCT02119819|41675305|FG001|Overall Study|Physician Decision|1|||
19427942|NCT02119819|41675306|FG002|Overall Study|Physician Decision|0|||
19427943|NCT02119819|41675307|FG003|Overall Study|Physician Decision|0|||
19427944|NCT02119819|41675308|FG004|Overall Study|Physician Decision|0|||
19427945|NCT02119819|41675309|FG005|Overall Study|Physician Decision|1|||
19427946|NCT02119819|41675304|FG000|Overall Study|Withdrawal by Subject|5|||
19427947|NCT02119819|41675305|FG001|Overall Study|Withdrawal by Subject|3|||
19427948|NCT02119819|41675306|FG002|Overall Study|Withdrawal by Subject|0|||
19427949|NCT02119819|41675307|FG003|Overall Study|Withdrawal by Subject|0|||
19427950|NCT02119819|41675308|FG004|Overall Study|Withdrawal by Subject|6|||
19427951|NCT02119819|41675309|FG005|Overall Study|Withdrawal by Subject|10|||
19427952|NCT02119819|41675304|FG000|Overall Study|Jury Duty|0|||
19427953|NCT02119819|41675305|FG001|Overall Study|Jury Duty|0|||
19427954|NCT02119819|41675306|FG002|Overall Study|Jury Duty|1|||
19427955|NCT02119819|41675307|FG003|Overall Study|Jury Duty|0|||
19427956|NCT02119819|41675308|FG004|Overall Study|Jury Duty|0|||
19427957|NCT02119819|41675309|FG005|Overall Study|Jury Duty|0|||
19427958|NCT02119819|41675304|FG000|Overall Study|Protocol Violation|0|||
19427959|NCT02119819|41675305|FG001|Overall Study|Protocol Violation|0|||
19427960|NCT02119819|41675306|FG002|Overall Study|Protocol Violation|0|||
19427961|NCT02119819|41675307|FG003|Overall Study|Protocol Violation|1|||
19427962|NCT02119819|41675308|FG004|Overall Study|Protocol Violation|0|||
19427963|NCT02119819|41675309|FG005|Overall Study|Protocol Violation|0|||
19427964|NCT02119819|41675304|FG000|Overall Study|Left the city to get a job|0|||
19427965|NCT02119819|41675305|FG001|Overall Study|Left the city to get a job|0|||
19427966|NCT02119819|41675306|FG002|Overall Study|Left the city to get a job|0|||
19427967|NCT02119819|41675307|FG003|Overall Study|Left the city to get a job|1|||
19427968|NCT02119819|41675308|FG004|Overall Study|Left the city to get a job|0|||
19427969|NCT02119819|41675309|FG005|Overall Study|Left the city to get a job|0|||
19427970|NCT02168816|41675325|FG000|Overall Study|Lost to Follow-up|2|||
19427971|NCT02168816|41675326|FG001|Overall Study|Lost to Follow-up|2|||
19427972|NCT01584232|41675334|FG000|Overall Study|Adverse Event|3|||
19427973|NCT01584232|41675335|FG001|Overall Study|Adverse Event|1|||
19427974|NCT01584232|41675334|FG000|Overall Study|Withdrawal by Subject|2|||
19427975|NCT01584232|41675335|FG001|Overall Study|Withdrawal by Subject|1|||
19427976|NCT01584232|41675334|FG000|Overall Study|Physician Decision|2|||
19427977|NCT01584232|41675335|FG001|Overall Study|Physician Decision|1|||
19427978|NCT01584232|41675334|FG000|Overall Study|Lost to Follow-up|1|||
19427979|NCT01584232|41675335|FG001|Overall Study|Lost to Follow-up|0|||
19427980|NCT01639703|41675341|FG000|Overall Study|Withdrawal by Subject|5|||
19427981|NCT01639703|41675341|FG000|Overall Study|Other reason|7|||
19427982|NCT02119663|41675359|FG000|Overall Study|Disease progression|26|||
19427983|NCT02119663|41675360|FG001|Overall Study|Disease progression|27|||
19427984|NCT02119663|41675359|FG000|Overall Study|Adverse Event|5|||
19521023|NCT01386606|41933814|FG001|Overall Study|Withdrawal by Subject|1|||
19427985|NCT02119663|41675360|FG001|Overall Study|Adverse Event|5|||
19427986|NCT02119663|41675359|FG000|Overall Study|Death|3|||
19427987|NCT02119663|41675360|FG001|Overall Study|Death|2|||
19427988|NCT02119663|41675359|FG000|Overall Study|Physician Decision|1|||
19427989|NCT02119663|41675360|FG001|Overall Study|Physician Decision|2|||
19427990|NCT02119663|41675359|FG000|Overall Study|Other unspecified|2|||
19427991|NCT02119663|41675360|FG001|Overall Study|Other unspecified|0|||
19427992|NCT02119663|41675359|FG000|Overall Study|Subject decision|0|||
19427993|NCT02119663|41675360|FG001|Overall Study|Subject decision|1|||
19427994|NCT02119663|41675359|FG000|Overall Study|Study Terminated by the Sponsor|3|||
19427995|NCT02119663|41675360|FG001|Overall Study|Study Terminated by the Sponsor|4|||
19427996|NCT01639469|41675368|FG000|Overall Study|Death|4|||
19427997|NCT01639469|41675369|FG001|Overall Study|Death|2|||
19427998|NCT01639469|41675368|FG000|Overall Study|Lost to Follow-up|1|||
19427999|NCT01639469|41675369|FG001|Overall Study|Lost to Follow-up|1|||
19428000|NCT02193074|41675377|FG000|Overall Study|Withdrawal by Subject|1|||
19428001|NCT02193074|41675378|FG001|Overall Study|Withdrawal by Subject|2|||
19428002|NCT02193074|41675377|FG000|Overall Study|Adverse Event|16|||
19428003|NCT02193074|41675378|FG001|Overall Study|Adverse Event|13|||
19428004|NCT02192606|41675386|FG000|Overall Study|surgery type was changed|1|||
19428005|NCT02192606|41675387|FG001|Overall Study|surgery type was changed|1|||
19428006|NCT02192606|41675386|FG000|Overall Study|Physician Decision|1|||
19428007|NCT02192606|41675387|FG001|Overall Study|Physician Decision|2|||
19428008|NCT02192606|41675386|FG000|Overall Study|3D equipment rep unable to join|0|||
19428009|NCT02192606|41675387|FG001|Overall Study|3D equipment rep unable to join|1|||
19428010|NCT01628107|41675393|FG000|Overall Study|Withdrawal by Subject|17|||
19428011|NCT01628107|41675393|FG000|Overall Study|Lost to Follow-up|4|||
19428012|NCT01628107|41675393|FG000|Overall Study|Adverse Event|33|||
19428013|NCT01628107|41675393|FG000|Overall Study|Physician Decision|2|||
19428014|NCT01628107|41675393|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
19428015|NCT01628107|41675393|FG000|Overall Study|Non-compliant with Study Procedures|10|||
19428016|NCT01628107|41675393|FG000|Overall Study|Not Treated|8|||
19428017|NCT01628107|41675393|FG000|Overall Study|Sponsor Decision|11|||
19428018|NCT01628107|41675393|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
19428019|NCT01628107|41675393|FG000|Overall Study|Relocated|8|||
19428020|NCT01628107|41675393|FG000|Overall Study|Kidney Transplant|9|||
19428021|NCT01628107|41675393|FG000|Overall Study|Use of Standard of Care|9|||
19428022|NCT01583530|41675403|FG000|Overall Study|Adverse Event|0|||
19428023|NCT01583530|41675404|FG001|Overall Study|Adverse Event|0|||
19428024|NCT01583530|41675405|FG002|Overall Study|Adverse Event|0|||
19428025|NCT01583530|41675406|FG003|Overall Study|Adverse Event|0|||
19428026|NCT01583530|41675407|FG004|Overall Study|Adverse Event|0|||
19428027|NCT01583530|41675408|FG005|Overall Study|Adverse Event|1|||
19428028|NCT01583530|41675403|FG000|Overall Study|Withdrawal by Subject|0|||
19428029|NCT01583530|41675404|FG001|Overall Study|Withdrawal by Subject|3|||
19428030|NCT01583530|41675405|FG002|Overall Study|Withdrawal by Subject|0|||
19428031|NCT01583530|41675406|FG003|Overall Study|Withdrawal by Subject|1|||
19428032|NCT01583530|41675407|FG004|Overall Study|Withdrawal by Subject|1|||
19428033|NCT01583530|41675408|FG005|Overall Study|Withdrawal by Subject|2|||
19428034|NCT01583530|41675403|FG000|Overall Study|Lost to Follow-up|0|||
19428035|NCT01583530|41675404|FG001|Overall Study|Lost to Follow-up|0|||
19428036|NCT01583530|41675405|FG002|Overall Study|Lost to Follow-up|0|||
19428037|NCT01583530|41675406|FG003|Overall Study|Lost to Follow-up|0|||
19428038|NCT01583530|41675407|FG004|Overall Study|Lost to Follow-up|3|||
19428039|NCT01583530|41675408|FG005|Overall Study|Lost to Follow-up|0|||
19428040|NCT01583530|41675403|FG000|Overall Study|Lack of compliance|0|||
19428041|NCT01583530|41675404|FG001|Overall Study|Lack of compliance|0|||
19428042|NCT01583530|41675405|FG002|Overall Study|Lack of compliance|0|||
19428043|NCT01583530|41675406|FG003|Overall Study|Lack of compliance|0|||
19428044|NCT01583530|41675407|FG004|Overall Study|Lack of compliance|1|||
19428045|NCT01583530|41675408|FG005|Overall Study|Lack of compliance|0|||
19428046|NCT01639001|41675427|FG000|Overall Study|Refused further follow-up|9|||
19428047|NCT01639001|41675428|FG001|Overall Study|Refused further follow-up|12|||
19428048|NCT01639001|41675427|FG000|Overall Study|Lost to Follow-up|3|||
19428049|NCT01639001|41675428|FG001|Overall Study|Lost to Follow-up|0|||
19428050|NCT01639001|41675427|FG000|Overall Study|Death|62|||
19428051|NCT01639001|41675428|FG001|Overall Study|Death|61|||
19428052|NCT01639001|41675427|FG000|Overall Study|Randomized but not treated|0|||
19428053|NCT01639001|41675428|FG001|Overall Study|Randomized but not treated|2|||
19428054|NCT01639001|41675427|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
19428055|NCT01639001|41675428|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
19428056|NCT02224664|41675436|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
19428057|NCT02224664|41675437|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
19428058|NCT02224664|41675438|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
19521024|NCT01386606|41933815|FG002|Overall Study|Withdrawal by Subject|1|||
19428059|NCT02224664|41675439|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
19428060|NCT02224664|41675440|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
19428061|NCT02224664|41675436|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
19428062|NCT02224664|41675437|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
19428063|NCT02224664|41675438|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
19428064|NCT02224664|41675439|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
19521025|NCT01386606|41933816|FG003|Overall Study|Withdrawal by Subject|0|||
19428065|NCT02224664|41675440|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
19428066|NCT02224664|41675436|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
19428067|NCT02224664|41675437|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
19428068|NCT02224664|41675438|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
19428069|NCT02224664|41675439|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
19428070|NCT02224664|41675440|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
19428071|NCT02168270|41675456|FG000|Overall Study|Lack of Efficacy|4|||
19428072|NCT02167256|41675462|FG000|Overall Study|Adverse Event|13|||
19428073|NCT02167256|41675463|FG001|Overall Study|Adverse Event|6|||
19428074|NCT02167256|41675462|FG000|Overall Study|Withdrawal by Subject|4|||
19428075|NCT02167256|41675463|FG001|Overall Study|Withdrawal by Subject|4|||
19428076|NCT02167256|41675462|FG000|Overall Study|non-compliance|3|||
19428077|NCT02167256|41675463|FG001|Overall Study|non-compliance|0|||
19428078|NCT02167256|41675462|FG000|Overall Study|Study partner unable to participate|1|||
19428079|NCT02167256|41675463|FG001|Overall Study|Study partner unable to participate|0|||
19428080|NCT02191046|41675471|FG000|Overall Study|low compliance|5|||
19428081|NCT02191046|41675472|FG001|Overall Study|low compliance|1|||
19428082|NCT02166476|41675480|FG000|Overall Study|Withdrawal by Subject|5|||
19428083|NCT02166476|41675481|FG001|Overall Study|Withdrawal by Subject|7|||
19428084|NCT02166476|41675480|FG000|Overall Study|Adverse Event|3|||
19428085|NCT02166476|41675481|FG001|Overall Study|Adverse Event|3|||
19428086|NCT02166476|41675480|FG000|Overall Study|Lost to Follow-up|5|||
19428087|NCT02166476|41675481|FG001|Overall Study|Lost to Follow-up|10|||
19428088|NCT02166476|41675480|FG000|Overall Study|Physician Decision|1|||
19428089|NCT02166476|41675481|FG001|Overall Study|Physician Decision|0|||
19428090|NCT02166476|41675480|FG000|Overall Study|Unable to Come for Visit|0|||
19428091|NCT02166476|41675481|FG001|Overall Study|Unable to Come for Visit|3|||
19428092|NCT02224274|41675492|FG000|Overall Study|Death|1|||
19428093|NCT02224274|41675493|FG001|Overall Study|Death|0|||
19428094|NCT02189252|41675503|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
19428095|NCT02189252|41675504|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
19428096|NCT02189252|41675505|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
19428097|NCT02189252|41675506|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
19428098|NCT02189252|41675503|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
19428099|NCT02189252|41675504|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
19428100|NCT02189252|41675505|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
19428101|NCT02189252|41675506|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
19428102|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
19428103|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
19428104|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
19428105|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428106|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428107|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428108|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428109|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428110|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19428111|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
19428112|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
19428113|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
19428114|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428115|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428116|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428117|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428118|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428119|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19428120|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
19428121|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
19428122|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428123|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428124|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428125|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428126|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19375310|NCT02879305|41617115|FG000|Overall Study|Lost to Follow-up|17|||
19375311|NCT02879305|41617116|FG001|Overall Study|Lost to Follow-up|12|||
19375312|NCT02879305|41617115|FG000|Overall Study|Other|1|||
19375313|NCT02879305|41617116|FG001|Overall Study|Other|0|||
19375314|NCT02281318|41617124|FG000|Overall Study|Adverse Event|2|||
19375315|NCT02281318|41617125|FG001|Overall Study|Adverse Event|2|||
19375316|NCT02281318|41617124|FG000|Overall Study|Lack of Efficacy|2|||
19375317|NCT02281318|41617125|FG001|Overall Study|Lack of Efficacy|0|||
19375318|NCT02281318|41617124|FG000|Overall Study|Lost to Follow-up|2|||
19375319|NCT02281318|41617125|FG001|Overall Study|Lost to Follow-up|1|||
19375320|NCT02281318|41617124|FG000|Overall Study|Physician Decision|2|||
19428127|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428128|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19428129|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
19428130|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
19428131|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
19428132|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428133|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428134|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428135|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428136|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428137|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19428138|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
19428139|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
19428140|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428141|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428142|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428143|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428144|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428145|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428146|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
19428147|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428148|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428149|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
19428150|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428151|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428152|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428153|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428154|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428155|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19428156|NCT01583374|41675520|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428157|NCT01583374|41675521|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
19428158|NCT01583374|41675522|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428159|NCT01583374|41675523|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428160|NCT01583374|41675524|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428161|NCT01583374|41675525|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428162|NCT01583374|41675526|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428163|NCT01583374|41675527|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428164|NCT01583374|41675528|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
19428165|NCT01583374|41675520|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428166|NCT01583374|41675521|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428167|NCT01583374|41675522|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428168|NCT01583374|41675523|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428169|NCT01583374|41675524|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428170|NCT01583374|41675525|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428171|NCT01583374|41675526|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428172|NCT01583374|41675527|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
19428173|NCT01583374|41675528|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
19428174|NCT01583374|41675520|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
19428175|NCT01583374|41675521|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
19428176|NCT01583374|41675522|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
19428177|NCT01583374|41675523|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
19428178|NCT01583374|41675524|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
19428179|NCT01583374|41675525|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
19428180|NCT01583374|41675526|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
19428181|NCT01583374|41675527|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
19428182|NCT01583374|41675528|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
19428183|NCT01583374|41675520|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
19428184|NCT01583374|41675521|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
19428185|NCT01583374|41675522|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
19428186|NCT01583374|41675523|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
19428187|NCT01583374|41675524|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
19428188|NCT01583374|41675525|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
19428189|NCT01583374|41675526|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
19428190|NCT01583374|41675527|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
19428191|NCT01583374|41675528|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
19521026|NCT01386606|41933813|FG000|Overall Study|Protocol Violation|1|||
19521027|NCT01386606|41933814|FG001|Overall Study|Protocol Violation|0|||
19428192|NCT01583374|41675520|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19428193|NCT01583374|41675521|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
19428194|NCT01583374|41675522|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
19428195|NCT01583374|41675523|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19428196|NCT01583374|41675524|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
19428197|NCT01583374|41675525|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19428198|NCT01583374|41675526|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19428199|NCT01583374|41675527|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19521028|NCT01386606|41933815|FG002|Overall Study|Protocol Violation|1|||
19521029|NCT01386606|41933816|FG003|Overall Study|Protocol Violation|1|||
19521030|NCT01386606|41933813|FG000|Overall Study|Lost to Follow-up|2|||
19521031|NCT01386606|41933814|FG001|Overall Study|Lost to Follow-up|0|||
19521032|NCT01386606|41933815|FG002|Overall Study|Lost to Follow-up|0|||
19521033|NCT01386606|41933816|FG003|Overall Study|Lost to Follow-up|0|||
19521034|NCT01386606|41933813|FG000|Overall Study|Subject incarcerated|0|||
19521035|NCT01386606|41933814|FG001|Overall Study|Subject incarcerated|1|||
19521036|NCT01386606|41933815|FG002|Overall Study|Subject incarcerated|0|||
19521037|NCT01386606|41933816|FG003|Overall Study|Subject incarcerated|0|||
19521038|NCT01386606|41933813|FG000|Overall Study|Unable to draw PK|1|||
19521039|NCT01386606|41933814|FG001|Overall Study|Unable to draw PK|0|||
19521040|NCT01386606|41933815|FG002|Overall Study|Unable to draw PK|0|||
19521041|NCT01386606|41933816|FG003|Overall Study|Unable to draw PK|0|||
19521042|NCT01386606|41933813|FG000|Overall Study|T levels too high|0|||
19521043|NCT01386606|41933814|FG001|Overall Study|T levels too high|1|||
19521044|NCT01386606|41933815|FG002|Overall Study|T levels too high|1|||
19521045|NCT01386606|41933816|FG003|Overall Study|T levels too high|0|||
19521046|NCT01385748|41933833|FG000|Overall Study|Withdrawal by Subject|7|||
19521047|NCT01385748|41933834|FG001|Overall Study|Withdrawal by Subject|4|||
19521048|NCT01385748|41933835|FG002|Overall Study|Withdrawal by Subject|5|||
19521049|NCT01385748|41933833|FG000|Overall Study|Noncompliance|3|||
19521050|NCT01385748|41933834|FG001|Overall Study|Noncompliance|1|||
19521051|NCT01385748|41933835|FG002|Overall Study|Noncompliance|6|||
19521052|NCT01385748|41933833|FG000|Overall Study|Other|1|||
19521053|NCT01385748|41933834|FG001|Overall Study|Other|7|||
19521054|NCT01385748|41933835|FG002|Overall Study|Other|1|||
19521055|NCT01385748|41933833|FG000|Overall Study|Adverse Event|4|||
19521056|NCT01385748|41933834|FG001|Overall Study|Adverse Event|2|||
19521057|NCT01385748|41933835|FG002|Overall Study|Adverse Event|1|||
19521058|NCT01397448|41933850|FG000|Overall Study|Adverse Event|4|||
19521059|NCT01397448|41933851|FG001|Overall Study|Adverse Event|4|||
19521060|NCT01397448|41933852|FG002|Overall Study|Adverse Event|6|||
19521061|NCT01397448|41933850|FG000|Overall Study|Withdrawal by Subject|4|||
19521062|NCT01397448|41933851|FG001|Overall Study|Withdrawal by Subject|4|||
19521063|NCT01397448|41933852|FG002|Overall Study|Withdrawal by Subject|3|||
19521064|NCT01397448|41933850|FG000|Overall Study|Lack of Efficacy|2|||
19521065|NCT01397448|41933851|FG001|Overall Study|Lack of Efficacy|0|||
19521066|NCT01397448|41933852|FG002|Overall Study|Lack of Efficacy|5|||
19521067|NCT01397448|41933850|FG000|Overall Study|Other|8|||
19521068|NCT01397448|41933851|FG001|Overall Study|Other|7|||
19521069|NCT01397448|41933852|FG002|Overall Study|Other|4|||
19521070|NCT01385202|41933860|FG000|Overall Study|Lost to Follow-up|6|||
19521071|NCT01385202|41933860|FG000|Overall Study|Not Eligible|11|||
19428200|NCT01583374|41675528|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
19428201|NCT01583374|41675520|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19428202|NCT01583374|41675521|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19428203|NCT01583374|41675522|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
19428204|NCT01583374|41675523|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19428205|NCT01583374|41675524|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
19428206|NCT01583374|41675525|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
19428207|NCT01583374|41675526|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19428208|NCT01583374|41675527|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19521072|NCT01385202|41933860|FG000|Overall Study|Withdrawn|1|||
19521073|NCT01384734|41933871|FG000|Overall Study|Adverse Event|0|||
19521074|NCT01384734|41933872|FG001|Overall Study|Adverse Event|3|||
19521075|NCT01384734|41933873|FG002|Overall Study|Adverse Event|0|||
19521076|NCT01384734|41933874|FG003|Overall Study|Adverse Event|2|||
19521077|NCT01384734|41933875|FG004|Overall Study|Adverse Event|7|||
19521078|NCT01384734|41933871|FG000|Overall Study|Death|1|||
19521079|NCT01384734|41933872|FG001|Overall Study|Death|0|||
19521080|NCT01384734|41933873|FG002|Overall Study|Death|1|||
19521081|NCT01384734|41933874|FG003|Overall Study|Death|0|||
19521082|NCT01384734|41933875|FG004|Overall Study|Death|0|||
19521083|NCT01384734|41933871|FG000|Overall Study|Continuation criteria not met|0|||
19521084|NCT01384734|41933872|FG001|Overall Study|Continuation criteria not met|0|||
19521085|NCT01384734|41933873|FG002|Overall Study|Continuation criteria not met|1|||
19521086|NCT01384734|41933874|FG003|Overall Study|Continuation criteria not met|1|||
19521087|NCT01384734|41933875|FG004|Overall Study|Continuation criteria not met|0|||
19521088|NCT01384734|41933871|FG000|Overall Study|Lack of Efficacy|3|||
19521089|NCT01384734|41933872|FG001|Overall Study|Lack of Efficacy|7|||
19521090|NCT01384734|41933873|FG002|Overall Study|Lack of Efficacy|4|||
19428209|NCT01583374|41675528|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
19428210|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
19428211|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
19428212|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
19428213|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
19428214|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
19428215|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
19428216|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
19428217|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
19428218|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
19428219|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
19428220|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
19428221|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
19521091|NCT01384734|41933874|FG003|Overall Study|Lack of Efficacy|4|||
19521092|NCT01384734|41933875|FG004|Overall Study|Lack of Efficacy|2|||
19521093|NCT01384734|41933871|FG000|Overall Study|Lost to Follow-up|5|||
19521094|NCT01384734|41933872|FG001|Overall Study|Lost to Follow-up|3|||
19521095|NCT01384734|41933873|FG002|Overall Study|Lost to Follow-up|3|||
19521096|NCT01384734|41933874|FG003|Overall Study|Lost to Follow-up|8|||
19521097|NCT01384734|41933875|FG004|Overall Study|Lost to Follow-up|5|||
19521098|NCT01384734|41933871|FG000|Overall Study|Non-compliance with study drug|1|||
19521099|NCT01384734|41933872|FG001|Overall Study|Non-compliance with study drug|2|||
19521100|NCT01384734|41933873|FG002|Overall Study|Non-compliance with study drug|6|||
19521101|NCT01384734|41933874|FG003|Overall Study|Non-compliance with study drug|0|||
19521102|NCT01384734|41933875|FG004|Overall Study|Non-compliance with study drug|2|||
19521103|NCT01384734|41933871|FG000|Overall Study|Pregnancy|0|||
19521104|NCT01384734|41933872|FG001|Overall Study|Pregnancy|1|||
19428222|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
19428223|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
19428224|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
19428225|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
19428226|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
19428227|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
19521105|NCT01384734|41933873|FG002|Overall Study|Pregnancy|0|||
19521106|NCT01384734|41933874|FG003|Overall Study|Pregnancy|0|||
19521107|NCT01384734|41933875|FG004|Overall Study|Pregnancy|1|||
19521108|NCT01384734|41933871|FG000|Overall Study|Sponsor terminated|0|||
19521109|NCT01384734|41933872|FG001|Overall Study|Sponsor terminated|0|||
19521110|NCT01384734|41933873|FG002|Overall Study|Sponsor terminated|0|||
19521111|NCT01384734|41933874|FG003|Overall Study|Sponsor terminated|0|||
19521112|NCT01384734|41933875|FG004|Overall Study|Sponsor terminated|1|||
19521113|NCT01384734|41933871|FG000|Overall Study|Withdrawal by Subject|5|||
19521114|NCT01384734|41933872|FG001|Overall Study|Withdrawal by Subject|5|||
19521115|NCT01384734|41933873|FG002|Overall Study|Withdrawal by Subject|6|||
19521116|NCT01384734|41933874|FG003|Overall Study|Withdrawal by Subject|7|||
19521117|NCT01384734|41933875|FG004|Overall Study|Withdrawal by Subject|9|||
19428228|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428229|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428230|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428231|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428232|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
19428233|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428234|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
19428235|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
19428236|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
19428237|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
19428238|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
19428239|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
19428240|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
19428241|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
19521118|NCT01384734|41933871|FG000|Overall Study|Investigator relocating|0|||
19521119|NCT01384734|41933872|FG001|Overall Study|Investigator relocating|2|||
19521120|NCT01384734|41933873|FG002|Overall Study|Investigator relocating|0|||
19521121|NCT01384734|41933874|FG003|Overall Study|Investigator relocating|3|||
19521122|NCT01384734|41933875|FG004|Overall Study|Investigator relocating|1|||
19521123|NCT01384734|41933871|FG000|Overall Study|Unable to come back for visit|1|||
19428242|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
19428243|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
19428244|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
19428245|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
19428246|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428247|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428248|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428249|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428250|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
19428251|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428252|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
19428253|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428254|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
19428255|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
19428256|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
19428257|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
19428258|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
19428259|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
19428260|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
19428261|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
19428262|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
19428263|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
19428264|NCT01583374|41675520|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
19521124|NCT01384734|41933872|FG001|Overall Study|Unable to come back for visit|0|||
19521125|NCT01384734|41933873|FG002|Overall Study|Unable to come back for visit|1|||
19521126|NCT01384734|41933874|FG003|Overall Study|Unable to come back for visit|1|||
19521127|NCT01384734|41933875|FG004|Overall Study|Unable to come back for visit|0|||
19428265|NCT01583374|41675521|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
19428266|NCT01583374|41675522|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
19428267|NCT01583374|41675523|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
19428268|NCT01583374|41675524|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
19428269|NCT01583374|41675525|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
19428270|NCT01583374|41675526|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
19521128|NCT01384734|41933871|FG000|Overall Study|Prison|0|||
19521129|NCT01384734|41933872|FG001|Overall Study|Prison|0|||
19521130|NCT01384734|41933873|FG002|Overall Study|Prison|1|||
19521131|NCT01384734|41933874|FG003|Overall Study|Prison|0|||
19521132|NCT01384734|41933875|FG004|Overall Study|Prison|0|||
19521133|NCT01384734|41933871|FG000|Overall Study|As per Exclusion criteria|0|||
19521134|NCT01384734|41933872|FG001|Overall Study|As per Exclusion criteria|1|||
19521135|NCT01384734|41933873|FG002|Overall Study|As per Exclusion criteria|0|||
19711187|NCT00116805|42154353|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
19711188|NCT00116805|42154354|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
19428271|NCT01583374|41675527|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
19428272|NCT01583374|41675528|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
19428273|NCT01583296|41675549|FG000|Overall Study|Withdrawal by Subject|11|||
19428274|NCT01583296|41675550|FG001|Overall Study|Withdrawal by Subject|10|||
19428275|NCT02222714|41675561|FG000|Overall Study|Death|0|||
19428276|NCT02222714|41675562|FG001|Overall Study|Death|2|||
19428277|NCT02222714|41675563|FG002|Overall Study|Death|3|||
19428278|NCT02222714|41675564|FG003|Overall Study|Death|4|||
19428279|NCT02222714|41675565|FG004|Overall Study|Death|6|||
19428280|NCT02222714|41675561|FG000|Overall Study|Withdrawal by Subject|0|||
19428281|NCT02222714|41675562|FG001|Overall Study|Withdrawal by Subject|0|||
19428282|NCT02222714|41675563|FG002|Overall Study|Withdrawal by Subject|1|||
19428283|NCT02222714|41675564|FG003|Overall Study|Withdrawal by Subject|0|||
19428284|NCT02222714|41675565|FG004|Overall Study|Withdrawal by Subject|1|||
19428285|NCT02164916|41675582|FG000|Overall Study|Adverse Event|3|||
19428286|NCT02164916|41675583|FG001|Overall Study|Adverse Event|8|||
19428287|NCT02164916|41675582|FG000|Overall Study|Death|1|||
19428288|NCT02164916|41675583|FG001|Overall Study|Death|1|||
19428289|NCT02164916|41675582|FG000|Overall Study|Refusal unrelated to adverse event|3|||
19428290|NCT02164916|41675583|FG001|Overall Study|Refusal unrelated to adverse event|7|||
19428291|NCT02164916|41675582|FG000|Overall Study|Progression|37|||
19428292|NCT02164916|41675583|FG001|Overall Study|Progression|26|||
19428293|NCT02164916|41675582|FG000|Overall Study|Not protocol specified|5|||
19428294|NCT02164916|41675583|FG001|Overall Study|Not protocol specified|1|||
19428295|NCT02164916|41675582|FG000|Overall Study|Reason under review|1|||
19428296|NCT02164916|41675583|FG001|Overall Study|Reason under review|6|||
19428297|NCT02164916|41675582|FG000|Overall Study|Not eligible|2|||
19521136|NCT01384734|41933874|FG003|Overall Study|As per Exclusion criteria|0|||
19521137|NCT01384734|41933875|FG004|Overall Study|As per Exclusion criteria|0|||
19428298|NCT02164916|41675583|FG001|Overall Study|Not eligible|5|||
19711189|NCT00116805|42154353|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
19428299|NCT02222558|41675594|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
19428300|NCT02222558|41675595|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
19428301|NCT02222558|41675596|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
19428302|NCT02222558|41675597|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
19428303|NCT02222558|41675598|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
19428304|NCT02222558|41675599|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
19428305|NCT02222558|41675594|FG000|Period 3|Withdrawal by Subject|0|||
19428306|NCT02222558|41675595|FG001|Period 3|Withdrawal by Subject|0|||
19428307|NCT02222558|41675596|FG002|Period 3|Withdrawal by Subject|0|||
19428308|NCT02222558|41675597|FG003|Period 3|Withdrawal by Subject|0|||
19428309|NCT02222558|41675598|FG004|Period 3|Withdrawal by Subject|0|||
19428310|NCT02222558|41675599|FG005|Period 3|Withdrawal by Subject|1|||
19428311|NCT02188784|41675615|FG000|Overall Study|Death|3|||
19428312|NCT02188784|41675616|FG001|Overall Study|Death|1|||
19428313|NCT02188784|41675615|FG000|Overall Study|Lost to Follow-up|1|||
19428314|NCT02188784|41675616|FG001|Overall Study|Lost to Follow-up|0|||
19428315|NCT02188784|41675615|FG000|Overall Study|Withdrawal by Subject|3|||
19428316|NCT02188784|41675616|FG001|Overall Study|Withdrawal by Subject|9|||
19428317|NCT02188784|41675615|FG000|Overall Study|Physician Decision|2|||
19428318|NCT02188784|41675616|FG001|Overall Study|Physician Decision|3|||
19428319|NCT02222246|41675639|FG000|Overall Study|No Emergency Department Visits|27|||
19428320|NCT02222246|41675640|FG001|Overall Study|No Emergency Department Visits|26|||
19428321|NCT02222246|41675639|FG000|Overall Study|Physician Decision|0|||
19428322|NCT02222246|41675640|FG001|Overall Study|Physician Decision|1|||
19428323|NCT02188160|41675650|FG000|Overall Study|Adverse Event|1|||
19428324|NCT02188160|41675651|FG001|Overall Study|Adverse Event|0|||
19428325|NCT02188160|41675650|FG000|Overall Study|Use of an excluded medication|0|||
19428326|NCT02188160|41675651|FG001|Overall Study|Use of an excluded medication|1|||
19428327|NCT02220998|41675659|FG000|Overall Study|Randomized but Never Treated|1|||
19428328|NCT02220998|41675660|FG001|Overall Study|Randomized but Never Treated|2|||
19428329|NCT02220998|41675659|FG000|Overall Study|Death|2|||
19428330|NCT02220998|41675660|FG001|Overall Study|Death|0|||
19428331|NCT02220998|41675659|FG000|Overall Study|Lack of Efficacy|0|||
19428332|NCT02220998|41675660|FG001|Overall Study|Lack of Efficacy|5|||
19428333|NCT02220998|41675659|FG000|Overall Study|Lost to Follow-up|4|||
19428334|NCT02220998|41675660|FG001|Overall Study|Lost to Follow-up|4|||
19428335|NCT02220920|41675668|FG000|Overall Study|Adverse Event|1|||
19428336|NCT02220920|41675669|FG001|Overall Study|Adverse Event|0|||
19428337|NCT02220920|41675668|FG000|Overall Study|Lack of Efficacy|0|||
19428338|NCT02220920|41675669|FG001|Overall Study|Lack of Efficacy|1|||
19428339|NCT02220920|41675668|FG000|Overall Study|Withdrawal by Subject|1|||
19428340|NCT02220920|41675669|FG001|Overall Study|Withdrawal by Subject|0|||
19428341|NCT02220920|41675668|FG000|Overall Study|Conflict with the stopping criteria|1|||
19428342|NCT02220920|41675669|FG001|Overall Study|Conflict with the stopping criteria|2|||
19428343|NCT03966053|41675675|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
19428344|NCT01583218|41675690|FG000|Overall Study|Withdrawal by Subject|43|||
19428345|NCT01583218|41675691|FG001|Overall Study|Withdrawal by Subject|29|||
19428346|NCT01583218|41675690|FG000|Overall Study|Death|206|||
19428347|NCT01583218|41675691|FG001|Overall Study|Death|211|||
19428348|NCT01583218|41675690|FG000|Overall Study|Lost to Follow-up|11|||
19428349|NCT01583218|41675691|FG001|Overall Study|Lost to Follow-up|17|||
19428350|NCT01583218|41675690|FG000|Overall Study|Adverse event or serious adverse event|3|||
19428351|NCT01583218|41675691|FG001|Overall Study|Adverse event or serious adverse event|3|||
19428352|NCT01583218|41675690|FG000|Overall Study|Patient /Family decision|3|||
19428353|NCT01583218|41675691|FG001|Overall Study|Patient /Family decision|0|||
19428354|NCT01583218|41675690|FG000|Overall Study|Cannot contact patient directly|1|||
19428355|NCT01583218|41675691|FG001|Overall Study|Cannot contact patient directly|2|||
19428356|NCT01583218|41675690|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
19428357|NCT01583218|41675691|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
19428358|NCT01583218|41675690|FG000|Overall Study|Patient did not wish to attend visits|0|||
19428359|NCT01583218|41675691|FG001|Overall Study|Patient did not wish to attend visits|1|||
19428360|NCT01583218|41675690|FG000|Overall Study|Patient randomized but not dosed|17|||
19428361|NCT01583218|41675691|FG001|Overall Study|Patient randomized but not dosed|16|||
19428362|NCT01583218|41675690|FG000|Overall Study|Patient was assessed via phone in person|1|||
19428363|NCT01583218|41675691|FG001|Overall Study|Patient was assessed via phone in person|0|||
19428364|NCT01583218|41675690|FG000|Overall Study|Patient deemed ineligible after random|2|||
19428365|NCT01583218|41675691|FG001|Overall Study|Patient deemed ineligible after random|0|||
19428366|NCT01583218|41675690|FG000|Overall Study|Patient was early terminated from study|0|||
19428367|NCT01583218|41675691|FG001|Overall Study|Patient was early terminated from study|1|||
19428368|NCT01583218|41675690|FG000|Overall Study|Patient was randomized due to mistake|1|||
19428369|NCT01583218|41675691|FG001|Overall Study|Patient was randomized due to mistake|0|||
19711190|NCT00116805|42154354|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
19428370|NCT01583218|41675690|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
19428371|NCT01583218|41675691|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
19428372|NCT01583218|41675690|FG000|Overall Study|Withdraw of consent on day of random|1|||
19428373|NCT01583218|41675691|FG001|Overall Study|Withdraw of consent on day of random|0|||
19428374|NCT01634555|41675697|FG000|Overall Study|Adverse Event|3|||
19428375|NCT01634555|41675697|FG000|Overall Study|Physician Decision|1|||
19428376|NCT01634243|41675704|FG000|Overall Study|Adverse Event|5|||
19428377|NCT01634243|41675705|FG001|Overall Study|Adverse Event|5|||
19428378|NCT01634243|41675704|FG000|Overall Study|Lack of Efficacy|1|||
19428379|NCT01634243|41675705|FG001|Overall Study|Lack of Efficacy|0|||
19428380|NCT01542034|41675722|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
19428381|NCT01542034|41675723|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
19428382|NCT01542034|41675722|FG000|Overall Study|Administrative decision|0|||
19428383|NCT01542034|41675723|FG001|Overall Study|Administrative decision|3|||
19428384|NCT01542034|41675722|FG000|Overall Study|Subject Noncompliance|1|||
19428385|NCT01542034|41675723|FG001|Overall Study|Subject Noncompliance|0|||
19428386|NCT01542034|41675722|FG000|Overall Study|Adverse Event|2|||
19428387|NCT01542034|41675723|FG001|Overall Study|Adverse Event|2|||
19428388|NCT01542034|41675722|FG000|Overall Study|Lost to Follow-up|7|||
19428389|NCT01542034|41675723|FG001|Overall Study|Lost to Follow-up|6|||
19428390|NCT01564732|41675731|FG000|Overall Study|Early termination by the study sponsor|6|||
19428391|NCT01564732|41675732|FG001|Overall Study|Early termination by the study sponsor|5|||
19428392|NCT01541644|41675738|FG000|Overall Study|Withdrawal by Subject|3|||
19428393|NCT01582282|41675745|FG000|Overall Study|Adverse Event|1|||
19428394|NCT01582282|41675746|FG001|Overall Study|Adverse Event|1|||
19428395|NCT01582282|41675747|FG002|Overall Study|Adverse Event|0|||
19428396|NCT01582282|41675745|FG000|Overall Study|Lost to Follow-up|1|||
19428397|NCT01582282|41675746|FG001|Overall Study|Lost to Follow-up|0|||
19428398|NCT01582282|41675747|FG002|Overall Study|Lost to Follow-up|0|||
19428399|NCT01582282|41675745|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
19428400|NCT01582282|41675746|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
19428401|NCT01582282|41675747|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
19428402|NCT01599650|41675758|FG000|Overall Study|Administrative issue|1|||
19428403|NCT01599650|41675759|FG001|Overall Study|Administrative issue|0|||
19428404|NCT01599650|41675760|FG002|Overall Study|Administrative issue|1|||
19428405|NCT01599650|41675758|FG000|Overall Study|Physician Decision|2|||
19428406|NCT01599650|41675759|FG001|Overall Study|Physician Decision|0|||
19428407|NCT01599650|41675760|FG002|Overall Study|Physician Decision|7|||
19428408|NCT01599650|41675758|FG000|Overall Study|Protocol Violation|0|||
19428409|NCT01599650|41675759|FG001|Overall Study|Protocol Violation|3|||
19711191|NCT00116805|42154353|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
19521138|NCT01384734|41933871|FG000|Overall Study|Missed End of treatment visit|0|||
19521139|NCT01384734|41933872|FG001|Overall Study|Missed End of treatment visit|0|||
19521140|NCT01384734|41933873|FG002|Overall Study|Missed End of treatment visit|0|||
19521141|NCT01384734|41933874|FG003|Overall Study|Missed End of treatment visit|1|||
19521142|NCT01384734|41933875|FG004|Overall Study|Missed End of treatment visit|0|||
19521143|NCT01384734|41933871|FG000|Overall Study|Adhesion problem|0|||
19521144|NCT01384734|41933872|FG001|Overall Study|Adhesion problem|0|||
19521145|NCT01384734|41933873|FG002|Overall Study|Adhesion problem|0|||
19521146|NCT01384734|41933874|FG003|Overall Study|Adhesion problem|1|||
19521147|NCT01384734|41933875|FG004|Overall Study|Adhesion problem|0|||
19521148|NCT01384734|41933871|FG000|Overall Study|Early termination|0|||
19521149|NCT01384734|41933872|FG001|Overall Study|Early termination|0|||
19521150|NCT01384734|41933873|FG002|Overall Study|Early termination|0|||
19521151|NCT01384734|41933874|FG003|Overall Study|Early termination|0|||
19711192|NCT00116805|42154354|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
19711193|NCT00116805|42154353|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
19428410|NCT01599650|41675760|FG002|Overall Study|Protocol Violation|0|||
19428411|NCT01599650|41675758|FG000|Overall Study|Death|2|||
19428412|NCT01599650|41675759|FG001|Overall Study|Death|1|||
19428413|NCT01599650|41675760|FG002|Overall Study|Death|2|||
19428414|NCT01599650|41675758|FG000|Overall Study|Lost to Follow-up|3|||
19428415|NCT01599650|41675759|FG001|Overall Study|Lost to Follow-up|3|||
19521152|NCT01384734|41933875|FG004|Overall Study|Early termination|1|||
19428416|NCT01599650|41675760|FG002|Overall Study|Lost to Follow-up|3|||
19428417|NCT01599650|41675758|FG000|Overall Study|Withdrawal by Subject|11|||
19428418|NCT01599650|41675759|FG001|Overall Study|Withdrawal by Subject|11|||
19428419|NCT01599650|41675760|FG002|Overall Study|Withdrawal by Subject|10|||
19428420|NCT01599650|41675758|FG000|Overall Study|Adverse Event|3|||
19428421|NCT01599650|41675759|FG001|Overall Study|Adverse Event|8|||
19428422|NCT01599650|41675760|FG002|Overall Study|Adverse Event|4|||
19428423|NCT01541254|41675770|FG000|Overall Study|Withdrawal by Subject|1|||
19428424|NCT01541254|41675770|FG000|Overall Study|excluded - metal allergy|1|||
19428425|NCT01541254|41675770|FG000|Overall Study|enrolled after study closed|1|||
19521153|NCT01384734|41933871|FG000|Overall Study|Physician Decision|1|||
19521154|NCT01384734|41933872|FG001|Overall Study|Physician Decision|0|||
19521155|NCT01384734|41933873|FG002|Overall Study|Physician Decision|0|||
19521156|NCT01384734|41933874|FG003|Overall Study|Physician Decision|0|||
19521157|NCT01384734|41933875|FG004|Overall Study|Physician Decision|0|||
19521158|NCT01396512|41933886|FG000|Overall Study|Withdrawal by Subject|0|||
19521159|NCT01396512|41933887|FG001|Overall Study|Withdrawal by Subject|1|||
19521160|NCT01396434|41933896|FG000|Overall Study|Lost to Follow-up|1|||
19521161|NCT01396434|41933897|FG001|Overall Study|Lost to Follow-up|0|||
19521162|NCT01396434|41933898|FG002|Overall Study|Lost to Follow-up|0|||
19521163|NCT01396434|41933896|FG000|Overall Study|Other|10|||
19521164|NCT01396434|41933897|FG001|Overall Study|Other|0|||
19521165|NCT01396434|41933898|FG002|Overall Study|Other|0|||
19521166|NCT01383954|41933906|FG000|Overall Study|Lack of Efficacy|2|||
19521167|NCT01383954|41933906|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
19521168|NCT01383954|41933906|FG000|Overall Study|Adverse Event|1|||
19521169|NCT01383954|41933906|FG000|Overall Study|Reason Not Specified|9|||
19521170|NCT01383486|41933910|FG000|Overall Study|Lost to Follow-up|10|||
19521171|NCT01383486|41933910|FG000|Overall Study|Incomplete information for analysis|2|||
19521172|NCT01383486|41933910|FG000|Overall Study|Did not take any product|6|||
19521173|NCT01383174|41933917|FG000|3 Month Assessment|Death|0|||
19521174|NCT01383174|41933918|FG001|3 Month Assessment|Death|1|||
19521175|NCT01383174|41933917|FG000|3 Month Assessment|Lost to Follow-up|2|||
19521176|NCT01383174|41933918|FG001|3 Month Assessment|Lost to Follow-up|0|||
19521177|NCT01383174|41933917|FG000|3 Month Assessment|Refused to complete|4|||
19521178|NCT01383174|41933918|FG001|3 Month Assessment|Refused to complete|0|||
19521179|NCT01383174|41933917|FG000|6 Month Assessment|Lost to Follow-up|1|||
19521180|NCT01383174|41933918|FG001|6 Month Assessment|Lost to Follow-up|1|||
19521181|NCT01383174|41933917|FG000|6 Month Assessment|Refused to complete|4|||
19521182|NCT01383174|41933918|FG001|6 Month Assessment|Refused to complete|0|||
19521183|NCT01396278|41933929|FG000|Overall Study|Adverse Event|0|||
19521184|NCT01396278|41933930|FG001|Overall Study|Adverse Event|0|||
19521185|NCT01396278|41933931|FG002|Overall Study|Adverse Event|0|||
19521186|NCT01396278|41933932|FG003|Overall Study|Adverse Event|2|||
19521187|NCT01396278|41933933|FG004|Overall Study|Adverse Event|0|||
19521188|NCT01396278|41933929|FG000|Overall Study|Withdraw due to trial termination|2|||
19521189|NCT01396278|41933930|FG001|Overall Study|Withdraw due to trial termination|1|||
19521190|NCT01396278|41933931|FG002|Overall Study|Withdraw due to trial termination|1|||
19521191|NCT01396278|41933932|FG003|Overall Study|Withdraw due to trial termination|0|||
19521192|NCT01396278|41933933|FG004|Overall Study|Withdraw due to trial termination|2|||
19521193|NCT01383096|41933948|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
19521194|NCT01383096|41933949|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
19521195|NCT01383096|41933950|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
19521196|NCT01383096|41933948|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
19521197|NCT01383096|41933949|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
19521198|NCT01383096|41933950|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
19521199|NCT01383096|41933948|FG000|Third Intervention (8 Days)|Elevated AST|0|||
19521200|NCT01383096|41933949|FG001|Third Intervention (8 Days)|Elevated AST|1|||
19521201|NCT01383096|41933950|FG002|Third Intervention (8 Days)|Elevated AST|0|||
19521202|NCT01383096|41933948|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
19521203|NCT01383096|41933949|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
19521204|NCT01383096|41933950|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
19521205|NCT01383096|41933948|FG000|Third Intervention (8 Days)|Adverse Event|1|||
19521206|NCT01383096|41933949|FG001|Third Intervention (8 Days)|Adverse Event|0|||
19521207|NCT01383096|41933950|FG002|Third Intervention (8 Days)|Adverse Event|0|||
19521208|NCT01383096|41933948|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
19521209|NCT01383096|41933949|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
19521210|NCT01383096|41933950|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
19521211|NCT01383096|41933948|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
19521212|NCT01383096|41933949|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
19521213|NCT01383096|41933950|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
19521214|NCT01383096|41933948|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
19521215|NCT01383096|41933949|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
19628261|NCT00789477|42077701|FG004|Overall Study|Withdrawal by Subject|3|||
19628262|NCT00789477|42077697|FG000|Overall Study|Protocol Violation|1|||
19628263|NCT00789477|42077698|FG001|Overall Study|Protocol Violation|0|||
19628264|NCT00789477|42077699|FG002|Overall Study|Protocol Violation|0|||
19628265|NCT00789477|42077700|FG003|Overall Study|Protocol Violation|1|||
19521216|NCT01383096|41933950|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
19521217|NCT01383096|41933948|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
19628266|NCT00789477|42077701|FG004|Overall Study|Protocol Violation|0|||
19521218|NCT01383096|41933949|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
19521219|NCT01383096|41933950|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
19628267|NCT00789477|42077697|FG000|Overall Study|Adverse Event|3|||
19628268|NCT00789477|42077698|FG001|Overall Study|Adverse Event|3|||
19521220|NCT01383096|41933948|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
19521221|NCT01383096|41933949|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
19521222|NCT01383096|41933950|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
19521223|NCT01383096|41933948|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
19521224|NCT01383096|41933949|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
19521225|NCT01383096|41933950|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
19521226|NCT01383018|41933987|FG000|Overall Study|Adverse Event|14|||
19521227|NCT01383018|41933987|FG000|Overall Study|Death|10|||
19521228|NCT01383018|41933987|FG000|Overall Study|Lost to Follow-up|5|||
19521229|NCT01383018|41933987|FG000|Overall Study|Physician Decision|5|||
19521230|NCT01383018|41933987|FG000|Overall Study|Withdrawal by Subject|9|||
19521231|NCT01383018|41933987|FG000|Overall Study|Subject not implanted|76|||
19521232|NCT01383018|41933987|FG000|Overall Study|Missed Visit|247|||
19521233|NCT01383018|41933987|FG000|Overall Study|Site closed early-not compliance related|7|||
19521234|NCT01383018|41933987|FG000|Overall Study|Patient moved away from site|1|||
19521235|NCT01383018|41933987|FG000|Overall Study|Subject Incarcerated|1|||
19521236|NCT01382940|41934001|FG000|Overall Study|Adverse Event|19|||
19521237|NCT01382940|41934001|FG000|Overall Study|Lost to Follow-up|4|||
19521238|NCT01382940|41934001|FG000|Overall Study|Physician Decision|7|||
19521239|NCT01382940|41934001|FG000|Overall Study|Withdrawal by Subject|23|||
19521240|NCT01382940|41934001|FG000|Overall Study|Protocol Violation|20|||
19521241|NCT01381926|41934007|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
19521242|NCT01381926|41934008|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
19521243|NCT01381926|41934007|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
19711194|NCT00116805|42154354|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
19711195|NCT00116805|42154353|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
19428426|NCT01541254|41675770|FG000|Overall Study|GI bleed prior to procedure|1|||
19428427|NCT01541254|41675770|FG000|Overall Study|stent not required|1|||
19428428|NCT01541254|41675770|FG000|Overall Study|alternate stent used|1|||
19428429|NCT02163902|41675776|FG000|Overall Study|Subject's Request|3|||
19428430|NCT02163902|41675777|FG001|Overall Study|Subject's Request|4|||
19428431|NCT02163902|41675776|FG000|Overall Study|Lost to Follow-up|6|||
19428432|NCT02163902|41675777|FG001|Overall Study|Lost to Follow-up|7|||
19428433|NCT02163902|41675776|FG000|Overall Study|Administrative Decision|2|||
19428434|NCT02163902|41675777|FG001|Overall Study|Administrative Decision|2|||
19428435|NCT01630616|41675789|FG000|Overall Study|Adverse Event|0|||
19428436|NCT01630616|41675790|FG001|Overall Study|Adverse Event|0|||
19428437|NCT01630616|41675791|FG002|Overall Study|Adverse Event|0|||
19428438|NCT01630616|41675792|FG003|Overall Study|Adverse Event|1|||
19428439|NCT01630616|41675793|FG004|Overall Study|Adverse Event|0|||
19428440|NCT01630616|41675794|FG005|Overall Study|Adverse Event|0|||
19428441|NCT01630616|41675789|FG000|Overall Study|Withdrawal by Subject|0|||
19428442|NCT01630616|41675790|FG001|Overall Study|Withdrawal by Subject|0|||
19428443|NCT01630616|41675791|FG002|Overall Study|Withdrawal by Subject|0|||
19428444|NCT01630616|41675792|FG003|Overall Study|Withdrawal by Subject|2|||
19428445|NCT01630616|41675793|FG004|Overall Study|Withdrawal by Subject|0|||
19428446|NCT01630616|41675794|FG005|Overall Study|Withdrawal by Subject|0|||
19428447|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
19428448|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
19428449|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
19428450|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
19428451|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
19428452|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
19428453|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
19428454|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
19428455|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
19428456|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
19428457|NCT03774875|41675813|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
19428458|NCT03774875|41675814|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
19428459|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
19428460|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
19428461|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
19428462|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
19428463|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
19428464|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
19428465|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
19521244|NCT01381926|41934008|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
19521245|NCT01395888|41934018|FG000|2-week Run-in Period|Adverse Event|2|||
19521246|NCT01395888|41934019|FG001|2-week Run-in Period|Adverse Event|0|||
19521247|NCT01395888|41934020|FG002|2-week Run-in Period|Adverse Event|0|||
19521248|NCT01395888|41934018|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
19521249|NCT01395888|41934019|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
19521250|NCT01395888|41934020|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
19521251|NCT01395888|41934018|FG000|2-week Run-in Period|Lost to Follow-up|1|||
19521252|NCT01395888|41934019|FG001|2-week Run-in Period|Lost to Follow-up|0|||
19521253|NCT01395888|41934020|FG002|2-week Run-in Period|Lost to Follow-up|0|||
19521254|NCT01395888|41934018|FG000|2-week Run-in Period|Protocol Violation|2|||
19521255|NCT01395888|41934019|FG001|2-week Run-in Period|Protocol Violation|0|||
19521256|NCT01395888|41934020|FG002|2-week Run-in Period|Protocol Violation|0|||
19521257|NCT01395888|41934018|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
19521258|NCT01395888|41934019|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19521259|NCT01395888|41934020|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19521260|NCT01395888|41934018|FG000|Treatment Period (TP)|Adverse Event|0|||
19521261|NCT01395888|41934019|FG001|Treatment Period (TP)|Adverse Event|7|||
19521262|NCT01395888|41934020|FG002|Treatment Period (TP)|Adverse Event|6|||
19521263|NCT01395888|41934018|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
19521264|NCT01395888|41934019|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
19521265|NCT01395888|41934020|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
19521266|NCT01395888|41934018|FG000|Treatment Period (TP)|Protocol Violation|0|||
19521267|NCT01395888|41934019|FG001|Treatment Period (TP)|Protocol Violation|1|||
19521268|NCT01395888|41934020|FG002|Treatment Period (TP)|Protocol Violation|5|||
19521269|NCT01395888|41934018|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
19521270|NCT01395888|41934019|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
19521271|NCT01395888|41934020|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
19521272|NCT01395888|41934018|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
19521273|NCT01395888|41934019|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
19521274|NCT01395888|41934020|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
19521275|NCT01395810|41934030|FG000|Overall Study|Adverse Event|0|||
19521276|NCT01395810|41934031|FG001|Overall Study|Adverse Event|1|||
19521277|NCT01395810|41934032|FG002|Overall Study|Adverse Event|0|||
19521278|NCT01395810|41934033|FG003|Overall Study|Adverse Event|0|||
19521279|NCT01395810|41934030|FG000|Overall Study|Lack of Efficacy|0|||
19521280|NCT01395810|41934031|FG001|Overall Study|Lack of Efficacy|1|||
19521281|NCT01395810|41934032|FG002|Overall Study|Lack of Efficacy|0|||
19521282|NCT01395810|41934033|FG003|Overall Study|Lack of Efficacy|0|||
19521283|NCT01395810|41934030|FG000|Overall Study|Withdrawal criteria|0|||
19428466|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
19428467|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
19428468|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
19428469|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
19428470|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
19428471|NCT03774875|41675813|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
19428472|NCT03774875|41675814|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
19428473|NCT02220764|41675827|FG000|Overall Study|Lost to Follow-up|3|||
19428474|NCT02220764|41675828|FG001|Overall Study|Lost to Follow-up|1|||
19428475|NCT02220764|41675827|FG000|Overall Study|Death|1|||
19428476|NCT02220764|41675828|FG001|Overall Study|Death|0|||
19428477|NCT01563172|41675834|FG000|Overall Study|Adverse Event|5|||
19428478|NCT01563172|41675834|FG000|Overall Study|Lost to Follow-up|2|||
19428479|NCT01563172|41675834|FG000|Overall Study|Other (Protocol deviation)|5|||
19428480|NCT01563172|41675834|FG000|Overall Study|Other (Not specified)|1|||
19428481|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
19428482|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
19428483|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
19428484|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
19428485|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
19428486|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
19521284|NCT01395810|41934031|FG001|Overall Study|Withdrawal criteria|2|||
19521285|NCT01395810|41934032|FG002|Overall Study|Withdrawal criteria|0|||
19521286|NCT01395810|41934033|FG003|Overall Study|Withdrawal criteria|0|||
19521287|NCT01395810|41934030|FG000|Overall Study|Unclassified|2|||
19521288|NCT01395810|41934031|FG001|Overall Study|Unclassified|0|||
19428487|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
19428488|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
19428489|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
19428490|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
19428491|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
19428492|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
19428493|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
19521289|NCT01395810|41934032|FG002|Overall Study|Unclassified|0|||
19521290|NCT01395810|41934033|FG003|Overall Study|Unclassified|0|||
19521291|NCT01381692|41934046|FG000|Overall Study|Adverse Event|1|||
19521292|NCT01381692|41934047|FG001|Overall Study|Adverse Event|0|||
19521293|NCT01381692|41934048|FG002|Overall Study|Adverse Event|0|||
19428494|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
19428495|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
19428496|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
19428497|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
19428498|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
19428499|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
19428500|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
19428501|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
19428502|NCT02161718|41675851|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
19428503|NCT02161718|41675852|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
19428504|NCT02161718|41675853|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
19428505|NCT02161718|41675851|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
19428506|NCT02161718|41675852|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
19428507|NCT02161718|41675853|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
19428508|NCT02161718|41675851|FG000|Post- Randomization Period|Lost to Follow-up|0|||
19428509|NCT02161718|41675852|FG001|Post- Randomization Period|Lost to Follow-up|9|||
19428510|NCT02161718|41675853|FG002|Post- Randomization Period|Lost to Follow-up|15|||
19428511|NCT02161718|41675851|FG000|Post- Randomization Period|Adverse Event|0|||
19428512|NCT02161718|41675852|FG001|Post- Randomization Period|Adverse Event|9|||
19428513|NCT02161718|41675853|FG002|Post- Randomization Period|Adverse Event|10|||
19428514|NCT02161718|41675851|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
19428515|NCT02161718|41675852|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
19428516|NCT02161718|41675853|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
19428517|NCT02161718|41675851|FG000|Post- Randomization Period|Physician Decision|0|||
19428518|NCT02161718|41675852|FG001|Post- Randomization Period|Physician Decision|2|||
19428519|NCT02161718|41675853|FG002|Post- Randomization Period|Physician Decision|4|||
19428520|NCT02161718|41675851|FG000|Post- Randomization Period|Protocol Violation|0|||
19428521|NCT02161718|41675852|FG001|Post- Randomization Period|Protocol Violation|2|||
19428522|NCT02161718|41675853|FG002|Post- Randomization Period|Protocol Violation|3|||
19428523|NCT02161718|41675851|FG000|Post- Randomization Period|Lack of Efficacy|0|||
19428524|NCT02161718|41675852|FG001|Post- Randomization Period|Lack of Efficacy|0|||
19428525|NCT02161718|41675853|FG002|Post- Randomization Period|Lack of Efficacy|1|||
19428526|NCT02161718|41675851|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
19428527|NCT02161718|41675852|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
19428528|NCT02161718|41675853|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
19428529|NCT02161718|41675851|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
19428530|NCT02161718|41675852|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
19428531|NCT02161718|41675853|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
19428532|NCT02161718|41675851|FG000|Post- Randomization Period|Relocation|0|||
19428533|NCT02161718|41675852|FG001|Post- Randomization Period|Relocation|3|||
19428534|NCT02161718|41675853|FG002|Post- Randomization Period|Relocation|0|||
19428535|NCT02219048|41675862|FG000|Overall Study|Adverse Event|2|||
19428536|NCT02219048|41675863|FG001|Overall Study|Adverse Event|5|||
19428537|NCT02219048|41675862|FG000|Overall Study|No longer meets eligibility criteria|1|||
19428538|NCT02219048|41675863|FG001|Overall Study|No longer meets eligibility criteria|0|||
19428539|NCT02219048|41675862|FG000|Overall Study|Study terminated by sponsor|16|||
19428540|NCT02219048|41675863|FG001|Overall Study|Study terminated by sponsor|15|||
19428541|NCT02219048|41675862|FG000|Overall Study|Withdrawal by Subject|2|||
19428542|NCT02219048|41675863|FG001|Overall Study|Withdrawal by Subject|0|||
19428543|NCT02219048|41675862|FG000|Overall Study|Other|0|||
19428544|NCT02219048|41675863|FG001|Overall Study|Other|1|||
19428545|NCT02218736|41675871|FG000|Overall Study|Withdrawal by Subject|10|||
19428546|NCT02218736|41675872|FG001|Overall Study|Withdrawal by Subject|9|||
19428547|NCT02218736|41675871|FG000|Overall Study|Protocol Violation|2|||
19428548|NCT02218736|41675872|FG001|Overall Study|Protocol Violation|0|||
19428549|NCT01540474|41675882|FG000|Vaccination Period|Lost to Follow-up|0|||
19428550|NCT01540474|41675883|FG001|Vaccination Period|Lost to Follow-up|1|||
19428551|NCT01540474|41675884|FG002|Vaccination Period|Lost to Follow-up|0|||
19428552|NCT01540474|41675885|FG003|Vaccination Period|Lost to Follow-up|0|||
19428553|NCT01580488|41675896|FG000|Overall Study|Withdrawal by Subject|1|||
19428554|NCT01580020|41675912|FG000|Overall Study|Lack of Efficacy|0|||
19428555|NCT01580020|41675913|FG001|Overall Study|Lack of Efficacy|5|||
19428556|NCT01580020|41675914|FG002|Overall Study|Lack of Efficacy|0|||
19428557|NCT01580020|41675915|FG003|Overall Study|Lack of Efficacy|1|||
19428558|NCT01580020|41675912|FG000|Overall Study|Withdrawal by Subject|0|||
19428559|NCT01580020|41675913|FG001|Overall Study|Withdrawal by Subject|1|||
19428560|NCT01580020|41675914|FG002|Overall Study|Withdrawal by Subject|1|||
19428561|NCT01580020|41675915|FG003|Overall Study|Withdrawal by Subject|0|||
19428562|NCT01580020|41675912|FG000|Overall Study|Adverse Event|1|||
19428563|NCT01580020|41675913|FG001|Overall Study|Adverse Event|1|||
19428564|NCT01580020|41675914|FG002|Overall Study|Adverse Event|1|||
19428565|NCT01580020|41675915|FG003|Overall Study|Adverse Event|1|||
19428566|NCT01580020|41675912|FG000|Overall Study|Administrative Problems|0|||
19428567|NCT01580020|41675913|FG001|Overall Study|Administrative Problems|0|||
19428568|NCT01580020|41675914|FG002|Overall Study|Administrative Problems|1|||
19521294|NCT01381692|41934049|FG003|Overall Study|Adverse Event|0|||
19521295|NCT01381692|41934050|FG004|Overall Study|Adverse Event|0|||
19521296|NCT01381692|41934051|FG005|Overall Study|Adverse Event|0|||
19521297|NCT01395030|41934059|FG000|Overall Study|Did not complete FCH PET/CT|7|||
19521298|NCT01381068|41934067|FG000|Overall Study|Death|1|||
19521299|NCT01381068|41934068|FG001|Overall Study|Death|0|||
19428569|NCT01580020|41675915|FG003|Overall Study|Administrative Problems|0|||
19428570|NCT01580020|41675912|FG000|Overall Study|Lost to Follow-up|0|||
19428571|NCT01580020|41675913|FG001|Overall Study|Lost to Follow-up|0|||
19428572|NCT01580020|41675914|FG002|Overall Study|Lost to Follow-up|1|||
19428573|NCT01580020|41675915|FG003|Overall Study|Lost to Follow-up|0|||
19428574|NCT01579474|41675931|FG000|Overall Study|Adverse Event|1|||
19428575|NCT01579474|41675932|FG001|Overall Study|Adverse Event|13|||
19428576|NCT01579474|41675933|FG002|Overall Study|Adverse Event|2|||
19428577|NCT01579474|41675934|FG003|Overall Study|Adverse Event|0|||
19428578|NCT01579474|41675935|FG004|Overall Study|Adverse Event|0|||
19428579|NCT01579474|41675936|FG005|Overall Study|Adverse Event|1|||
19428580|NCT01579474|41675931|FG000|Overall Study|Lack of Efficacy|1|||
19521300|NCT01394952|41934076|FG000|Overall Study|Lost to Follow-up|0|||
19521301|NCT01394952|41934077|FG001|Overall Study|Lost to Follow-up|5|||
19521302|NCT01394952|41934076|FG000|Overall Study|Withdrawal by Subject|10|||
19521303|NCT01394952|41934077|FG001|Overall Study|Withdrawal by Subject|5|||
19521304|NCT01394952|41934076|FG000|Overall Study|Physician Decision|2|||
19521305|NCT01394952|41934077|FG001|Overall Study|Physician Decision|0|||
19428581|NCT01579474|41675932|FG001|Overall Study|Lack of Efficacy|0|||
19428582|NCT01579474|41675933|FG002|Overall Study|Lack of Efficacy|0|||
19428583|NCT01579474|41675934|FG003|Overall Study|Lack of Efficacy|0|||
19428584|NCT01579474|41675935|FG004|Overall Study|Lack of Efficacy|1|||
19428585|NCT01579474|41675936|FG005|Overall Study|Lack of Efficacy|0|||
19428586|NCT01579474|41675931|FG000|Overall Study|Withdrawal by Subject|1|||
19428587|NCT01579474|41675932|FG001|Overall Study|Withdrawal by Subject|0|||
19428588|NCT01579474|41675933|FG002|Overall Study|Withdrawal by Subject|0|||
19428589|NCT01579474|41675934|FG003|Overall Study|Withdrawal by Subject|0|||
19428590|NCT01579474|41675935|FG004|Overall Study|Withdrawal by Subject|0|||
19428591|NCT01579474|41675936|FG005|Overall Study|Withdrawal by Subject|0|||
19428592|NCT01579318|41675949|FG000|Overall Study|Disease Progression|1|||
19428593|NCT01562782|41675955|FG000|Overall Study|Withdrawal by Subject|3|||
19428594|NCT01562782|41675956|FG001|Overall Study|Withdrawal by Subject|3|||
19428595|NCT01562782|41675955|FG000|Overall Study|screen failure|1|||
19428596|NCT01562782|41675956|FG001|Overall Study|screen failure|2|||
19428597|NCT01579006|41675962|FG000|Overall Study|Lack of Efficacy|10|||
19428598|NCT01579006|41675962|FG000|Overall Study|Adverse Event|13|||
19428599|NCT01579006|41675962|FG000|Overall Study|Withdrawal by Subject|5|||
19428600|NCT01579006|41675962|FG000|Overall Study|Non-compliance|3|||
19428601|NCT01579006|41675962|FG000|Overall Study|Due to participant's health fund|1|||
19428602|NCT01579006|41675962|FG000|Overall Study|Scheduled surgery|1|||
19428603|NCT01578850|41675968|FG000|Period 1|Insufficient Clinical Response|1|||
19428604|NCT01578850|41675969|FG001|Period 1|Insufficient Clinical Response|0|||
19428605|NCT01578850|41675970|FG002|Period 1|Insufficient Clinical Response|0|||
19428606|NCT01578850|41675968|FG000|Period 1|Adverse Event|11|||
19428607|NCT01578850|41675969|FG001|Period 1|Adverse Event|0|||
19428608|NCT01578850|41675970|FG002|Period 1|Adverse Event|0|||
19428609|NCT01578850|41675968|FG000|Period 1|Death|1|||
19428610|NCT01578850|41675969|FG001|Period 1|Death|0|||
19428611|NCT01578850|41675970|FG002|Period 1|Death|0|||
19428612|NCT01578850|41675968|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
19428613|NCT01578850|41675969|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
19428614|NCT01578850|41675970|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
19428615|NCT01578850|41675968|FG000|Period 1|Withdrawal by Subject|9|||
19428616|NCT01578850|41675969|FG001|Period 1|Withdrawal by Subject|0|||
19428617|NCT01578850|41675970|FG002|Period 1|Withdrawal by Subject|0|||
19428618|NCT01578850|41675968|FG000|Period 1|Study Terminated by Sponsor|3|||
19428619|NCT01578850|41675969|FG001|Period 1|Study Terminated by Sponsor|0|||
19428620|NCT01578850|41675970|FG002|Period 1|Study Terminated by Sponsor|0|||
19428621|NCT01578850|41675968|FG000|Period 2|Insufficient Clinical Response|0|||
19428622|NCT01578850|41675969|FG001|Period 2|Insufficient Clinical Response|1|||
19428623|NCT01578850|41675970|FG002|Period 2|Insufficient Clinical Response|0|||
19428624|NCT01578850|41675968|FG000|Period 2|Adverse Event|0|||
19428625|NCT01578850|41675969|FG001|Period 2|Adverse Event|3|||
19428626|NCT01578850|41675970|FG002|Period 2|Adverse Event|6|||
19428627|NCT01578850|41675968|FG000|Period 2|Lost to Follow-up|0|||
19428628|NCT01578850|41675969|FG001|Period 2|Lost to Follow-up|1|||
19521306|NCT01394952|41934076|FG000|Overall Study|Sponsor Decision|5|||
19521307|NCT01394952|41934077|FG001|Overall Study|Sponsor Decision|7|||
19521308|NCT01394718|41934085|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
19428629|NCT01578850|41675970|FG002|Period 2|Lost to Follow-up|2|||
19428630|NCT01578850|41675968|FG000|Period 2|Withdrawal by Subject|0|||
19428631|NCT01578850|41675969|FG001|Period 2|Withdrawal by Subject|2|||
19428632|NCT01578850|41675970|FG002|Period 2|Withdrawal by Subject|2|||
19428633|NCT01578850|41675968|FG000|Period 2|Study Terminated by Sponsor|0|||
19428634|NCT01578850|41675969|FG001|Period 2|Study Terminated by Sponsor|5|||
19428635|NCT01578850|41675970|FG002|Period 2|Study Terminated by Sponsor|4|||
19428636|NCT01578850|41675968|FG000|Period 2|Unspecified Reasons|0|||
19428637|NCT01578850|41675969|FG001|Period 2|Unspecified Reasons|1|||
19428638|NCT01578850|41675970|FG002|Period 2|Unspecified Reasons|0|||
19428639|NCT01539538|41675980|FG000|Overall Study|Adverse Event|13|||
19428640|NCT01539538|41675981|FG001|Overall Study|Adverse Event|18|||
19428641|NCT01539538|41675980|FG000|Overall Study|Lack of Efficacy|13|||
19428642|NCT01539538|41675981|FG001|Overall Study|Lack of Efficacy|16|||
19428643|NCT01539538|41675980|FG000|Overall Study|Withdrawal by Subject|2|||
19428644|NCT01539538|41675981|FG001|Overall Study|Withdrawal by Subject|3|||
19428645|NCT01539538|41675980|FG000|Overall Study|PCA no longer required or PCA problem|3|||
19428646|NCT01539538|41675981|FG001|Overall Study|PCA no longer required or PCA problem|7|||
19428647|NCT01562548|41675991|FG000|Overall Study|Lost to Follow-up|0|||
19428648|NCT01562548|41675992|FG001|Overall Study|Lost to Follow-up|0|||
19428649|NCT01562548|41675993|FG002|Overall Study|Lost to Follow-up|1|||
19428650|NCT01562548|41675994|FG003|Overall Study|Lost to Follow-up|0|||
19521309|NCT01394718|41934086|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
19521310|NCT01394250|41934094|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
19521311|NCT01394250|41934095|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
19521312|NCT01394250|41934094|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
19521313|NCT01394250|41934095|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
19521314|NCT01380990|41934103|FG000|Overall Study|Treatment Failure|1|||
19521315|NCT01380990|41934104|FG001|Overall Study|Treatment Failure|0|||
19521316|NCT01380990|41934103|FG000|Overall Study|Death|0|||
19521317|NCT01380990|41934104|FG001|Overall Study|Death|1|||
19521318|NCT01380834|41934116|FG000|Overall Study|Physician Decision|1|||
19521319|NCT01380834|41934117|FG001|Overall Study|Physician Decision|0|||
19521320|NCT00214422|41934126|FG000|Overall Study|Physician Decision|2|||
19521321|NCT00214422|41934127|FG001|Overall Study|Physician Decision|0|||
19521322|NCT00214422|41934128|FG002|Overall Study|Physician Decision|0|||
19521323|NCT00214422|41934126|FG000|Overall Study|Developed esophageal ca|1|||
19521324|NCT00214422|41934127|FG001|Overall Study|Developed esophageal ca|0|||
19521325|NCT00214422|41934128|FG002|Overall Study|Developed esophageal ca|0|||
19521326|NCT00214422|41934126|FG000|Overall Study|Pt taken off study|1|||
19521327|NCT00214422|41934127|FG001|Overall Study|Pt taken off study|1|||
19521328|NCT00214422|41934128|FG002|Overall Study|Pt taken off study|0|||
19521329|NCT00214422|41934126|FG000|Overall Study|Disease progression on study|1|||
19521330|NCT00214422|41934127|FG001|Overall Study|Disease progression on study|0|||
19521331|NCT00214422|41934128|FG002|Overall Study|Disease progression on study|0|||
19521332|NCT00214422|41934126|FG000|Overall Study|Unable to make a radiation treatment|0|||
19521333|NCT00214422|41934127|FG001|Overall Study|Unable to make a radiation treatment|0|||
19521334|NCT00214422|41934128|FG002|Overall Study|Unable to make a radiation treatment|1|||
19521335|NCT00218634|41934142|FG000|Overall Study|Lost to Follow-up|8|||
19521336|NCT00218634|41934143|FG001|Overall Study|Lost to Follow-up|15|||
19521337|NCT00217620|41934152|FG000|Overall Study|Adverse Event|2|||
19521338|NCT00217620|41934152|FG000|Overall Study|Progression|31|||
19521339|NCT00217620|41934152|FG000|Overall Study|Not Protocol Specified|4|||
19521340|NCT00217620|41934152|FG000|Overall Study|Ineligible|13|||
19521341|NCT00217620|41934152|FG000|Overall Study|Never received treatment|1|||
19521342|NCT00217464|41934160|FG000|Overall Study|Progression|15|||
19521343|NCT00217464|41934160|FG000|Overall Study|Other|2|||
19521344|NCT00214500|41934164|FG000|Treatment Period|Adverse Event|1|||
19521345|NCT00214500|41934164|FG000|Extension Period|Withdrawal by Subject|2|||
19521346|NCT00211536|41934173|FG000|Overall Study|Withdrawal by Subject|2|||
19521347|NCT00211536|41934174|FG001|Overall Study|Withdrawal by Subject|2|||
19521348|NCT00211536|41934173|FG000|Overall Study|Physician Decision|0|||
19521349|NCT00211536|41934174|FG001|Overall Study|Physician Decision|5|||
19521350|NCT00211536|41934173|FG000|Overall Study|Adverse Event|2|||
19521351|NCT00211536|41934174|FG001|Overall Study|Adverse Event|0|||
19521352|NCT04194528|41934180|FG000|Overall Study|Adverse Event|1|||
19521353|NCT04193202|41934186|FG000|Overall Study|Adverse Event|2|||
19521354|NCT04193202|41934187|FG001|Overall Study|Adverse Event|1|||
19521355|NCT04193202|41934186|FG000|Overall Study|Death|0|||
19521356|NCT04193202|41934187|FG001|Overall Study|Death|1|||
19428651|NCT01562314|41676008|FG000|Overall Study|Adverse Event|10|||
19428652|NCT01562314|41676009|FG001|Overall Study|Adverse Event|5|||
19428653|NCT01562314|41676008|FG000|Overall Study|Met Withdrawal Criteria|3|||
19428654|NCT01562314|41676009|FG001|Overall Study|Met Withdrawal Criteria|2|||
19521357|NCT04193202|41934186|FG000|Overall Study|Physician Decision|1|||
19521358|NCT04193202|41934187|FG001|Overall Study|Physician Decision|1|||
19521359|NCT04193202|41934186|FG000|Overall Study|Protocol Violation|2|||
19521360|NCT04193202|41934187|FG001|Overall Study|Protocol Violation|2|||
19521361|NCT04193202|41934186|FG000|Overall Study|Withdrawal by Subject|11|||
19521362|NCT04193202|41934187|FG001|Overall Study|Withdrawal by Subject|5|||
19521363|NCT03028740|41934271|FG000|Overall Study|Did not Receive Study Drug|4|||
19521364|NCT03028740|41934272|FG001|Overall Study|Did not Receive Study Drug|5|||
19521365|NCT03028740|41934271|FG000|Overall Study|Adverse Event|8|||
19521366|NCT03028740|41934272|FG001|Overall Study|Adverse Event|26|||
19521367|NCT03028740|41934271|FG000|Overall Study|Lack of Efficacy|0|||
19521368|NCT03028740|41934272|FG001|Overall Study|Lack of Efficacy|1|||
19521369|NCT03028740|41934271|FG000|Overall Study|Withdrawal by Subject|48|||
19521370|NCT03028740|41934272|FG001|Overall Study|Withdrawal by Subject|101|||
19521371|NCT03028740|41934271|FG000|Overall Study|Lost to Follow-up|30|||
19521372|NCT03028740|41934272|FG001|Overall Study|Lost to Follow-up|54|||
19521373|NCT03028740|41934271|FG000|Overall Study|Physician Decision|4|||
19521374|NCT03028740|41934272|FG001|Overall Study|Physician Decision|11|||
19521375|NCT03028740|41934271|FG000|Overall Study|Protocol Violation|4|||
19521376|NCT03028740|41934272|FG001|Overall Study|Protocol Violation|8|||
19521377|NCT03028740|41934271|FG000|Overall Study|Non-compliance with Study Drug|0|||
19521378|NCT03028740|41934272|FG001|Overall Study|Non-compliance with Study Drug|2|||
19521379|NCT03028740|41934271|FG000|Overall Study|Study Terminated by Sponsor|467|||
19521380|NCT03028740|41934272|FG001|Overall Study|Study Terminated by Sponsor|917|||
19521381|NCT03028740|41934271|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
19521382|NCT03028740|41934272|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
19521383|NCT03028740|41934271|FG000|Overall Study|Reason not Specified|1|||
19521384|NCT03028740|41934272|FG001|Overall Study|Reason not Specified|5|||
19521385|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
19521386|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
19521387|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
19521388|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
19521389|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
19521390|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
19428655|NCT01562314|41676008|FG000|Overall Study|Withdrawal by Subject|0|||
19428656|NCT01562314|41676009|FG001|Overall Study|Withdrawal by Subject|1|||
19428657|NCT01539226|41676017|FG000|Overall Study|Withdrawal by Subject|24|||
19428658|NCT01539226|41676018|FG001|Overall Study|Withdrawal by Subject|54|||
19428659|NCT01539226|41676017|FG000|Overall Study|Lost to Follow-up|20|||
19428660|NCT01539226|41676018|FG001|Overall Study|Lost to Follow-up|54|||
19428661|NCT01539226|41676017|FG000|Overall Study|Death|1|||
19428662|NCT01539226|41676018|FG001|Overall Study|Death|2|||
19428663|NCT01539226|41676017|FG000|Overall Study|Adverse Event|2|||
19428664|NCT01539226|41676018|FG001|Overall Study|Adverse Event|0|||
19428665|NCT01539226|41676017|FG000|Overall Study|Pregnancy|13|||
19428666|NCT01539226|41676018|FG001|Overall Study|Pregnancy|29|||
19428667|NCT01539226|41676017|FG000|Overall Study|inappropriate enrollment|0|||
19428668|NCT01539226|41676018|FG001|Overall Study|inappropriate enrollment|1|||
19428669|NCT01539226|41676017|FG000|Overall Study|Multiple Reasons|3|||
19428670|NCT01539226|41676018|FG001|Overall Study|Multiple Reasons|1|||
19428671|NCT01539226|41676017|FG000|Overall Study|not HIV seroconversion-related|93|||
19428672|NCT01539226|41676018|FG001|Overall Study|not HIV seroconversion-related|176|||
19428673|NCT01539226|41676017|FG000|Overall Study|HIV seroconversion-related|55|||
19428674|NCT01539226|41676018|FG001|Overall Study|HIV seroconversion-related|80|||
19428675|NCT01539226|41676017|FG000|Overall Study|Non-compliance|6|||
19428676|NCT01539226|41676018|FG001|Overall Study|Non-compliance|8|||
19428677|NCT01577758|41676024|FG000|Dose Escalation Phase|Adverse Event|0|||
19428678|NCT01577758|41676025|FG001|Dose Escalation Phase|Adverse Event|0|||
19428679|NCT01577758|41676026|FG002|Dose Escalation Phase|Adverse Event|0|||
19428680|NCT01577758|41676027|FG003|Dose Escalation Phase|Adverse Event|0|||
19428681|NCT01577758|41676028|FG004|Dose Escalation Phase|Adverse Event|0|||
19428682|NCT01577758|41676029|FG005|Dose Escalation Phase|Adverse Event|2|||
19428683|NCT01577758|41676030|FG006|Dose Escalation Phase|Adverse Event|1|||
19428684|NCT01577758|41676031|FG007|Dose Escalation Phase|Adverse Event|0|||
19428685|NCT01577758|41676024|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
19428686|NCT01577758|41676025|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
19428687|NCT01577758|41676026|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
19428688|NCT01577758|41676027|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
19428689|NCT01577758|41676028|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
19428690|NCT01577758|41676029|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
19428691|NCT01577758|41676030|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
19428692|NCT01577758|41676031|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
19428693|NCT01577758|41676024|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
19428694|NCT01577758|41676025|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
19428695|NCT01577758|41676026|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
19428696|NCT01577758|41676027|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19428697|NCT01577758|41676028|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
19428698|NCT01577758|41676029|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
19428699|NCT01577758|41676030|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
19428700|NCT01577758|41676031|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
19428701|NCT01577758|41676024|FG000|Dose Escalation Phase|Progression Disease|2|||
19428702|NCT01577758|41676025|FG001|Dose Escalation Phase|Progression Disease|2|||
19428703|NCT01577758|41676026|FG002|Dose Escalation Phase|Progression Disease|1|||
19428704|NCT01577758|41676027|FG003|Dose Escalation Phase|Progression Disease|2|||
19428705|NCT01577758|41676028|FG004|Dose Escalation Phase|Progression Disease|5|||
19428706|NCT01577758|41676029|FG005|Dose Escalation Phase|Progression Disease|0|||
19428707|NCT01577758|41676030|FG006|Dose Escalation Phase|Progression Disease|0|||
19428708|NCT01577758|41676031|FG007|Dose Escalation Phase|Progression Disease|0|||
19428709|NCT01577758|41676024|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428710|NCT01577758|41676025|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428711|NCT01577758|41676026|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428712|NCT01577758|41676027|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428713|NCT01577758|41676028|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428714|NCT01577758|41676029|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428715|NCT01577758|41676030|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
19428716|NCT01577758|41676031|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
19521391|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
19521392|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
19521393|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
19521394|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
19521395|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
19521396|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
19521397|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
19521398|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
19521399|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
19521400|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
19521401|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
19521402|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
19521403|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
19521404|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
19521405|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
19521406|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
19521407|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
19521408|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
19521409|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
19521410|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Other|1|||
19521411|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Other|0|||
19521412|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Other|0|||
19521413|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Other|0|||
19521414|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Other|1|||
19521415|NCT02980692|41934299|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
19521416|NCT02980692|41934300|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
19521417|NCT02980692|41934301|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
19521418|NCT02980692|41934302|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
19521419|NCT02980692|41934303|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
19521420|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Adverse Event|0|||
19428717|NCT01577758|41676024|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428718|NCT01577758|41676025|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428719|NCT01577758|41676026|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428720|NCT01577758|41676027|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428721|NCT01577758|41676028|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428722|NCT01577758|41676029|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
19428723|NCT01577758|41676030|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
19521421|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Adverse Event|0|||
19521422|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Adverse Event|0|||
19521423|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Adverse Event|1|||
19521424|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Adverse Event|1|||
19521425|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
19521426|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
19521427|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
19521428|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
19628269|NCT00789477|42077699|FG002|Overall Study|Adverse Event|1|||
19428724|NCT01577758|41676031|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
19428725|NCT01577758|41676024|FG000|mCRC Expansion Phase|Progression Disease|0|||
19521429|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
19521430|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
19521431|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
19521432|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
19521433|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
19521434|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
19521435|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Pregnancy|0|||
19521436|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Pregnancy|0|||
19521437|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Pregnancy|1|||
19428726|NCT01577758|41676025|FG001|mCRC Expansion Phase|Progression Disease|0|||
19428727|NCT01577758|41676026|FG002|mCRC Expansion Phase|Progression Disease|0|||
19428728|NCT01577758|41676027|FG003|mCRC Expansion Phase|Progression Disease|0|||
19428729|NCT01577758|41676028|FG004|mCRC Expansion Phase|Progression Disease|0|||
19428730|NCT01577758|41676029|FG005|mCRC Expansion Phase|Progression Disease|0|||
19428731|NCT01577758|41676030|FG006|mCRC Expansion Phase|Progression Disease|0|||
19428732|NCT01577758|41676031|FG007|mCRC Expansion Phase|Progression Disease|19|||
19428733|NCT01537432|41676053|FG000|Overall Study|Lost to Follow-up|3|||
19428734|NCT01537432|41676054|FG001|Overall Study|Lost to Follow-up|1|||
19428735|NCT01537432|41676053|FG000|Overall Study|Withdrawal by Subject|0|||
19428736|NCT01537432|41676054|FG001|Overall Study|Withdrawal by Subject|1|||
19428737|NCT01537432|41676053|FG000|Overall Study|Administrative problems|1|||
19428738|NCT01537432|41676054|FG001|Overall Study|Administrative problems|0|||
19428739|NCT01537432|41676053|FG000|Overall Study|Adverse Event|1|||
19428740|NCT01537432|41676054|FG001|Overall Study|Adverse Event|0|||
19428741|NCT01537432|41676053|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19428742|NCT01537432|41676054|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19428743|NCT01537198|41676060|FG000|Overall Study|RSV infection|2|||
19428744|NCT01537198|41676060|FG000|Overall Study|Adverse Event|4|||
19428745|NCT01537198|41676060|FG000|Overall Study|No Further Visits to the Clinic|37|||
19428746|NCT01537198|41676060|FG000|Overall Study|Other|111|||
19428747|NCT01537120|41676064|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
19428748|NCT01537120|41676064|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
19428749|NCT01537042|41676072|FG000|Overall Study|Adverse Event|0|||
19428750|NCT01537042|41676073|FG001|Overall Study|Adverse Event|2|||
19428751|NCT01537042|41676072|FG000|Overall Study|Lack of Efficacy|0|||
19428752|NCT01537042|41676073|FG001|Overall Study|Lack of Efficacy|1|||
19428753|NCT01537042|41676072|FG000|Overall Study|Protocol Violation|0|||
19428754|NCT01537042|41676073|FG001|Overall Study|Protocol Violation|1|||
19428755|NCT01537042|41676072|FG000|Overall Study|Other|0|||
19428756|NCT01537042|41676073|FG001|Overall Study|Other|1|||
19428757|NCT01536574|41676094|FG000|Overall Study|Adverse Event|4|||
19428758|NCT01536574|41676095|FG001|Overall Study|Adverse Event|5|||
19428759|NCT01536574|41676094|FG000|Overall Study|Withdrawal by Subject|1|||
19428760|NCT01536574|41676095|FG001|Overall Study|Withdrawal by Subject|2|||
19428761|NCT01536574|41676094|FG000|Overall Study|Lack of Efficacy|1|||
19428762|NCT01536574|41676095|FG001|Overall Study|Lack of Efficacy|0|||
19428763|NCT01536418|41676103|FG000|Overall Study|Protocol Violation|2|||
19428764|NCT01536418|41676104|FG001|Overall Study|Protocol Violation|3|||
19428765|NCT01536418|41676103|FG000|Overall Study|Physician Decision|1|||
19428766|NCT01536418|41676104|FG001|Overall Study|Physician Decision|3|||
19428767|NCT01536418|41676103|FG000|Overall Study|Study closed/terminated|41|||
19428768|NCT01536418|41676104|FG001|Overall Study|Study closed/terminated|37|||
19428769|NCT01536418|41676103|FG000|Overall Study|Lack of Efficacy|10|||
19428770|NCT01536418|41676104|FG001|Overall Study|Lack of Efficacy|16|||
19428771|NCT01536418|41676103|FG000|Overall Study|Adverse Event|9|||
19428772|NCT01536418|41676104|FG001|Overall Study|Adverse Event|4|||
19428773|NCT01536418|41676103|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
19428774|NCT01536418|41676104|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
19428775|NCT01536418|41676103|FG000|Overall Study|Withdrawal by Subject|5|||
19428776|NCT01536418|41676104|FG001|Overall Study|Withdrawal by Subject|3|||
19428777|NCT01576042|41676113|FG000|Overall Study|Physician Decision|2|||
19428778|NCT01576042|41676114|FG001|Overall Study|Physician Decision|0|||
19428779|NCT01561300|41676120|FG000|Run in on Placebo|Adverse Event|1|||
19428780|NCT01561300|41676121|FG001|Run in on Placebo|Adverse Event|0|||
19428781|NCT01536262|41676131|FG000|Overall Study|Adverse Event|6|||
19428782|NCT01536262|41676132|FG001|Overall Study|Adverse Event|1|||
19428783|NCT01536262|41676133|FG002|Overall Study|Adverse Event|2|||
19428784|NCT01536262|41676131|FG000|Overall Study|Withdrawal by Subject|1|||
19428785|NCT01536262|41676132|FG001|Overall Study|Withdrawal by Subject|1|||
19428786|NCT01536262|41676133|FG002|Overall Study|Withdrawal by Subject|0|||
19428787|NCT01536262|41676131|FG000|Overall Study|Other than stated above|1|||
19428788|NCT01536262|41676132|FG001|Overall Study|Other than stated above|0|||
19428789|NCT01536262|41676133|FG002|Overall Study|Other than stated above|0|||
19428790|NCT01560988|41676142|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
19428791|NCT01560988|41676143|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
19428792|NCT01560988|41676142|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
19428793|NCT01560988|41676143|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
19428794|NCT01560988|41676142|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
19428795|NCT01560988|41676143|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
19428796|NCT01535638|41676154|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
19428797|NCT01535638|41676155|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
19428798|NCT01535638|41676156|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
19428799|NCT01535638|41676157|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
19428800|NCT01535638|41676158|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
19428801|NCT01535638|41676159|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
19428802|NCT01535638|41676154|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
19428803|NCT01535638|41676155|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
19428804|NCT01535638|41676156|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
19428805|NCT01535638|41676157|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
19428806|NCT01535638|41676158|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
19428807|NCT01535638|41676159|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
19428808|NCT01535560|41676170|FG000|Overall Study|Adverse Event|12|||
19428809|NCT01535560|41676171|FG001|Overall Study|Adverse Event|7|||
19428810|NCT01535560|41676170|FG000|Overall Study|Lost to Follow-up|1|||
19428811|NCT01535560|41676171|FG001|Overall Study|Lost to Follow-up|3|||
19428812|NCT01535560|41676170|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
19428813|NCT01535560|41676171|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
19428814|NCT01535560|41676170|FG000|Overall Study|Treatment Failure|21|||
19428815|NCT01535560|41676171|FG001|Overall Study|Treatment Failure|83|||
19428816|NCT01535560|41676170|FG000|Overall Study|Other|0|||
19428817|NCT01535560|41676171|FG001|Overall Study|Other|1|||
19428818|NCT01535560|41676170|FG000|Overall Study|Randomized in Error|0|||
19428819|NCT01535560|41676171|FG001|Overall Study|Randomized in Error|1|||
19428820|NCT01575028|41676179|FG000|Overall Study|Physician Decision|0|||
19428821|NCT01575028|41676180|FG001|Overall Study|Physician Decision|1|||
19428822|NCT03576131|41676194|FG000|Overall Study|Investigator decision|0|||
19428823|NCT03576131|41676195|FG001|Overall Study|Investigator decision|0|||
19428824|NCT03576131|41676196|FG002|Overall Study|Investigator decision|0|||
19428825|NCT03576131|41676197|FG003|Overall Study|Investigator decision|1|||
19428826|NCT03576131|41676198|FG004|Overall Study|Investigator decision|0|||
19428827|NCT03576131|41676199|FG005|Overall Study|Investigator decision|1|||
19428828|NCT03576131|41676200|FG006|Overall Study|Investigator decision|0|||
19428829|NCT03576131|41676201|FG007|Overall Study|Investigator decision|0|||
19428830|NCT03576131|41676194|FG000|Overall Study|Withdrawal by Subject|1|||
19428831|NCT03576131|41676195|FG001|Overall Study|Withdrawal by Subject|1|||
19428832|NCT03576131|41676196|FG002|Overall Study|Withdrawal by Subject|0|||
19428833|NCT03576131|41676197|FG003|Overall Study|Withdrawal by Subject|1|||
19428834|NCT03576131|41676198|FG004|Overall Study|Withdrawal by Subject|2|||
19428835|NCT03576131|41676199|FG005|Overall Study|Withdrawal by Subject|3|||
19428836|NCT03576131|41676200|FG006|Overall Study|Withdrawal by Subject|1|||
19428837|NCT03576131|41676201|FG007|Overall Study|Withdrawal by Subject|0|||
19428838|NCT03576131|41676194|FG000|Overall Study|Death|3|||
19428839|NCT03576131|41676195|FG001|Overall Study|Death|3|||
19428840|NCT03576131|41676196|FG002|Overall Study|Death|1|||
19428841|NCT03576131|41676197|FG003|Overall Study|Death|5|||
19428842|NCT03576131|41676198|FG004|Overall Study|Death|4|||
19428843|NCT03576131|41676199|FG005|Overall Study|Death|1|||
19428844|NCT03576131|41676200|FG006|Overall Study|Death|0|||
19428845|NCT03576131|41676201|FG007|Overall Study|Death|1|||
19428846|NCT03576131|41676194|FG000|Overall Study|New anti-cancer treatment|5|||
19428847|NCT03576131|41676195|FG001|Overall Study|New anti-cancer treatment|1|||
19428848|NCT03576131|41676196|FG002|Overall Study|New anti-cancer treatment|2|||
19428849|NCT03576131|41676197|FG003|Overall Study|New anti-cancer treatment|3|||
19428850|NCT03576131|41676198|FG004|Overall Study|New anti-cancer treatment|0|||
19428851|NCT03576131|41676199|FG005|Overall Study|New anti-cancer treatment|0|||
19428852|NCT03576131|41676200|FG006|Overall Study|New anti-cancer treatment|0|||
19428853|NCT03576131|41676201|FG007|Overall Study|New anti-cancer treatment|0|||
19428854|NCT03576131|41676194|FG000|Overall Study|Unspecified reason|0|||
19428855|NCT03576131|41676195|FG001|Overall Study|Unspecified reason|0|||
19428856|NCT03576131|41676196|FG002|Overall Study|Unspecified reason|1|||
19428857|NCT03576131|41676197|FG003|Overall Study|Unspecified reason|1|||
19428858|NCT03576131|41676198|FG004|Overall Study|Unspecified reason|1|||
19428859|NCT03576131|41676199|FG005|Overall Study|Unspecified reason|1|||
19428860|NCT03576131|41676200|FG006|Overall Study|Unspecified reason|0|||
19428861|NCT03576131|41676201|FG007|Overall Study|Unspecified reason|0|||
19375321|NCT02281318|41617125|FG001|Overall Study|Physician Decision|0|||
19375322|NCT02281318|41617124|FG000|Overall Study|Withdrawal by Subject|6|||
19375323|NCT02281318|41617125|FG001|Overall Study|Withdrawal by Subject|2|||
19375324|NCT01657760|41617133|FG000|Overall Study|Withdrawal by Subject|0|||
19375325|NCT01657760|41617134|FG001|Overall Study|Withdrawal by Subject|0|||
19375326|NCT01657760|41617135|FG002|Overall Study|Withdrawal by Subject|0|||
19375327|NCT01657760|41617136|FG003|Overall Study|Withdrawal by Subject|1|||
19375328|NCT01657760|41617133|FG000|Overall Study|Physician Decision|1|||
19428862|NCT03576131|41676194|FG000|Overall Study|Subject non-compliance|0|||
19428863|NCT03576131|41676195|FG001|Overall Study|Subject non-compliance|0|||
19428864|NCT03576131|41676196|FG002|Overall Study|Subject non-compliance|0|||
19428865|NCT03576131|41676197|FG003|Overall Study|Subject non-compliance|0|||
19428866|NCT03576131|41676198|FG004|Overall Study|Subject non-compliance|0|||
19428867|NCT03576131|41676199|FG005|Overall Study|Subject non-compliance|1|||
19428868|NCT03576131|41676200|FG006|Overall Study|Subject non-compliance|0|||
19428869|NCT03576131|41676201|FG007|Overall Study|Subject non-compliance|0|||
19428870|NCT01574716|41676233|FG000|Part 1|Death|3|||
19428871|NCT01574716|41676234|FG001|Part 1|Death|1|||
19428872|NCT01574716|41676235|FG002|Part 1|Death|8|||
19428873|NCT01574716|41676236|FG003|Part 1|Death|0|||
19428874|NCT01574716|41676237|FG004|Part 1|Death|0|||
19428875|NCT01574716|41676233|FG000|Part 1|Discontinuation of study by sponsor|0|||
19428876|NCT01574716|41676234|FG001|Part 1|Discontinuation of study by sponsor|0|||
19428877|NCT01574716|41676235|FG002|Part 1|Discontinuation of study by sponsor|1|||
19428878|NCT01574716|41676236|FG003|Part 1|Discontinuation of study by sponsor|0|||
19428879|NCT01574716|41676237|FG004|Part 1|Discontinuation of study by sponsor|0|||
19428880|NCT01574716|41676233|FG000|Part 1|Withdrawal by Subject|0|||
19428881|NCT01574716|41676234|FG001|Part 1|Withdrawal by Subject|2|||
19428882|NCT01574716|41676235|FG002|Part 1|Withdrawal by Subject|0|||
19428883|NCT01574716|41676236|FG003|Part 1|Withdrawal by Subject|0|||
19428884|NCT01574716|41676237|FG004|Part 1|Withdrawal by Subject|0|||
19428885|NCT01574716|41676233|FG000|Part 1|Lost to Follow-up|0|||
19428886|NCT01574716|41676234|FG001|Part 1|Lost to Follow-up|1|||
19428887|NCT01574716|41676235|FG002|Part 1|Lost to Follow-up|0|||
19428888|NCT01574716|41676236|FG003|Part 1|Lost to Follow-up|0|||
19428889|NCT01574716|41676237|FG004|Part 1|Lost to Follow-up|0|||
19428890|NCT01574716|41676233|FG000|Part 2|Progressive disease|0|||
19428891|NCT01574716|41676234|FG001|Part 2|Progressive disease|0|||
19428892|NCT01574716|41676235|FG002|Part 2|Progressive disease|0|||
19428893|NCT01574716|41676236|FG003|Part 2|Progressive disease|1|||
19428894|NCT01574716|41676237|FG004|Part 2|Progressive disease|0|||
19428895|NCT01574716|41676233|FG000|Part 2|Death|0|||
19428896|NCT01574716|41676234|FG001|Part 2|Death|0|||
19428897|NCT01574716|41676235|FG002|Part 2|Death|0|||
19428898|NCT01574716|41676236|FG003|Part 2|Death|76|||
19428899|NCT01574716|41676237|FG004|Part 2|Death|35|||
19428900|NCT01574716|41676233|FG000|Part 2|Discontinuation of study by sponsor|0|||
19428901|NCT01574716|41676234|FG001|Part 2|Discontinuation of study by sponsor|0|||
19428902|NCT01574716|41676235|FG002|Part 2|Discontinuation of study by sponsor|0|||
19428903|NCT01574716|41676236|FG003|Part 2|Discontinuation of study by sponsor|51|||
19428904|NCT01574716|41676237|FG004|Part 2|Discontinuation of study by sponsor|31|||
19428905|NCT01574716|41676233|FG000|Part 2|Withdrawal by Subject|0|||
19428906|NCT01574716|41676234|FG001|Part 2|Withdrawal by Subject|0|||
19428907|NCT01574716|41676235|FG002|Part 2|Withdrawal by Subject|0|||
19428908|NCT01574716|41676236|FG003|Part 2|Withdrawal by Subject|5|||
19428909|NCT01574716|41676237|FG004|Part 2|Withdrawal by Subject|4|||
19428910|NCT01574716|41676233|FG000|Part 2|Brain metastases|0|||
19428911|NCT01574716|41676234|FG001|Part 2|Brain metastases|0|||
19428912|NCT01574716|41676235|FG002|Part 2|Brain metastases|0|||
19428913|NCT01574716|41676236|FG003|Part 2|Brain metastases|1|||
19428914|NCT01574716|41676237|FG004|Part 2|Brain metastases|0|||
19428915|NCT01574716|41676233|FG000|Part 2|Lost to Follow-up|0|||
19428916|NCT01574716|41676234|FG001|Part 2|Lost to Follow-up|0|||
19428917|NCT01574716|41676235|FG002|Part 2|Lost to Follow-up|0|||
19428918|NCT01574716|41676236|FG003|Part 2|Lost to Follow-up|3|||
19428919|NCT01574716|41676237|FG004|Part 2|Lost to Follow-up|0|||
19428920|NCT02161562|41676248|FG000|Overall Study|Withdrawal by Subject|5|||
19521438|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Pregnancy|1|||
19521439|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Pregnancy|0|||
19521440|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
19428921|NCT02161562|41676249|FG001|Overall Study|Withdrawal by Subject|8|||
19428922|NCT02161562|41676248|FG000|Overall Study|Protocol Violation|9|||
19428923|NCT02161562|41676249|FG001|Overall Study|Protocol Violation|4|||
19428924|NCT02161562|41676248|FG000|Overall Study|Pregnancy|1|||
19428925|NCT02161562|41676249|FG001|Overall Study|Pregnancy|2|||
19428926|NCT02161562|41676248|FG000|Overall Study|Lost to Follow-up|3|||
19428927|NCT02161562|41676249|FG001|Overall Study|Lost to Follow-up|1|||
19521441|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
19521442|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
19428928|NCT02161562|41676248|FG000|Overall Study|Lack of Efficacy|4|||
19428929|NCT02161562|41676249|FG001|Overall Study|Lack of Efficacy|1|||
19428930|NCT02161562|41676248|FG000|Overall Study|Adverse Event|1|||
19428931|NCT02161562|41676249|FG001|Overall Study|Adverse Event|1|||
19428932|NCT02161562|41676248|FG000|Overall Study|Participant moved back to home country|1|||
19428933|NCT02161562|41676249|FG001|Overall Study|Participant moved back to home country|0|||
19428934|NCT02161562|41676248|FG000|Overall Study|Withdrew due to being out of the country|1|||
19428935|NCT02161562|41676249|FG001|Overall Study|Withdrew due to being out of the country|0|||
19428936|NCT02161562|41676248|FG000|Overall Study|Participant moved out of province|1|||
19521443|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
19521444|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
19521445|NCT02980692|41934299|FG000|Double-blind Follow-up Period|Other|0|||
19521446|NCT02980692|41934300|FG001|Double-blind Follow-up Period|Other|0|||
19521447|NCT02980692|41934301|FG002|Double-blind Follow-up Period|Other|1|||
19521448|NCT02980692|41934302|FG003|Double-blind Follow-up Period|Other|1|||
19521449|NCT02980692|41934303|FG004|Double-blind Follow-up Period|Other|3|||
19428937|NCT02161562|41676249|FG001|Overall Study|Participant moved out of province|0|||
19428938|NCT01559116|41676268|FG000|Overall Study|Adverse Event|10|||
19521450|NCT00089778|41934609|FG000|Overall Study|Protocol Violation|0|||
19521451|NCT00089778|41934610|FG001|Overall Study|Protocol Violation|0|||
19521452|NCT00089778|41934611|FG002|Overall Study|Protocol Violation|1|||
19521453|NCT00089544|41934623|FG000|Overall Study|Ineligible|1|||
19428939|NCT01559116|41676268|FG000|Overall Study|Lack of Efficacy|1|||
19428940|NCT01559116|41676268|FG000|Overall Study|Lost to Follow-up|1|||
19428941|NCT01559116|41676268|FG000|Overall Study|Protocol Violation|1|||
19428942|NCT01559116|41676268|FG000|Overall Study|Withdrawal by Subject|4|||
19428943|NCT01559116|41676268|FG000|Overall Study|other than stated above|9|||
19428944|NCT01574326|41676287|FG000|Overall Study|Randomized but not treated|0|||
19428945|NCT01574326|41676288|FG001|Overall Study|Randomized but not treated|1|||
19428946|NCT01574326|41676287|FG000|Overall Study|Withdrawal by Participant|2|||
19428947|NCT01574326|41676288|FG001|Overall Study|Withdrawal by Participant|4|||
19428948|NCT01574326|41676287|FG000|Overall Study|Physician Decision|5|||
19428949|NCT01574326|41676288|FG001|Overall Study|Physician Decision|3|||
19521454|NCT00089544|41934624|FG001|Overall Study|Ineligible|0|||
19521455|NCT00089076|41934630|FG000|Overall Study|Alternate Therapy|1|||
19521456|NCT00089076|41934630|FG000|Overall Study|Withdrawal by Subject|2|||
19521457|NCT00089076|41934630|FG000|Overall Study|Progression|7|||
19521458|NCT00088374|41934634|FG000|Overall Study|patient did not receive any 17AAG|1|||
19521459|NCT00088374|41934634|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
19521460|NCT00087594|41934640|FG000|Overall Study|Adverse Event|2|||
19521461|NCT00087594|41934641|FG001|Overall Study|Adverse Event|3|||
19521462|NCT00087594|41934640|FG000|Overall Study|Lost to Follow-up|0|||
19521463|NCT00087594|41934641|FG001|Overall Study|Lost to Follow-up|2|||
19521464|NCT00087594|41934640|FG000|Overall Study|Withdrawal by Subject|4|||
19521465|NCT00087594|41934641|FG001|Overall Study|Withdrawal by Subject|2|||
19521466|NCT00087594|41934640|FG000|Overall Study|Lack of Efficacy|2|||
19521467|NCT00087594|41934641|FG001|Overall Study|Lack of Efficacy|5|||
19521468|NCT00087516|41934650|FG000|Overall Study|Adverse Event|10|||
19521469|NCT00087516|41934651|FG001|Overall Study|Adverse Event|10|||
19521470|NCT00087516|41934652|FG002|Overall Study|Adverse Event|3|||
19521471|NCT00087516|41934653|FG003|Overall Study|Adverse Event|6|||
19521472|NCT00087516|41934650|FG000|Overall Study|Lack of Efficacy|82|||
19521473|NCT00087516|41934651|FG001|Overall Study|Lack of Efficacy|80|||
19521474|NCT00087516|41934652|FG002|Overall Study|Lack of Efficacy|39|||
19521475|NCT00087516|41934653|FG003|Overall Study|Lack of Efficacy|29|||
19521476|NCT00087516|41934650|FG000|Overall Study|Lost to Follow-up|8|||
19521477|NCT00087516|41934651|FG001|Overall Study|Lost to Follow-up|6|||
19521478|NCT00087516|41934652|FG002|Overall Study|Lost to Follow-up|5|||
19521479|NCT00087516|41934653|FG003|Overall Study|Lost to Follow-up|5|||
19521480|NCT00087516|41934650|FG000|Overall Study|Protocol Violation|4|||
19521481|NCT00087516|41934651|FG001|Overall Study|Protocol Violation|8|||
19521482|NCT00087516|41934652|FG002|Overall Study|Protocol Violation|3|||
19521483|NCT00087516|41934653|FG003|Overall Study|Protocol Violation|6|||
19521484|NCT00087516|41934650|FG000|Overall Study|Withdrawal by Subject|16|||
19628270|NCT00789477|42077700|FG003|Overall Study|Adverse Event|0|||
19628271|NCT00789477|42077701|FG004|Overall Study|Adverse Event|0|||
19628272|NCT00789477|42077697|FG000|Overall Study|Death|1|||
19628273|NCT00789477|42077698|FG001|Overall Study|Death|1|||
19628274|NCT00789477|42077699|FG002|Overall Study|Death|2|||
19628275|NCT00789477|42077700|FG003|Overall Study|Death|2|||
19628276|NCT00789477|42077701|FG004|Overall Study|Death|0|||
19628277|NCT00789477|42077697|FG000|Overall Study|Lost to Follow-up|0|||
19628278|NCT00789477|42077698|FG001|Overall Study|Lost to Follow-up|1|||
19628279|NCT00789477|42077699|FG002|Overall Study|Lost to Follow-up|4|||
19628280|NCT00789477|42077700|FG003|Overall Study|Lost to Follow-up|2|||
19428950|NCT01574326|41676287|FG000|Overall Study|Adverse Event|1|||
19428951|NCT01574326|41676288|FG001|Overall Study|Adverse Event|3|||
19521485|NCT00087516|41934651|FG001|Overall Study|Withdrawal by Subject|27|||
19521486|NCT00087516|41934652|FG002|Overall Study|Withdrawal by Subject|11|||
19521487|NCT00087516|41934653|FG003|Overall Study|Withdrawal by Subject|12|||
19521488|NCT00087516|41934650|FG000|Overall Study|Site terminated|0|||
19521489|NCT00087516|41934651|FG001|Overall Study|Site terminated|2|||
19521490|NCT00087516|41934652|FG002|Overall Study|Site terminated|1|||
19521491|NCT00087516|41934653|FG003|Overall Study|Site terminated|0|||
19521492|NCT00087516|41934650|FG000|Overall Study|Protocol specified discontinuation|35|||
19628281|NCT00789477|42077701|FG004|Overall Study|Lost to Follow-up|4|||
19628282|NCT00789477|42077697|FG000|Overall Study|Lack of Efficacy|2|||
19521493|NCT00087516|41934651|FG001|Overall Study|Protocol specified discontinuation|33|||
19521494|NCT00087516|41934652|FG002|Overall Study|Protocol specified discontinuation|33|||
19521495|NCT00087516|41934653|FG003|Overall Study|Protocol specified discontinuation|26|||
19521496|NCT00087516|41934650|FG000|Overall Study|Patient moved|3|||
19521497|NCT00087516|41934651|FG001|Overall Study|Patient moved|2|||
19521498|NCT00087516|41934652|FG002|Overall Study|Patient moved|1|||
19521499|NCT00087516|41934653|FG003|Overall Study|Patient moved|0|||
19521500|NCT00087516|41934650|FG000|Overall Study|Patient was non-compliant|3|||
19521501|NCT00087516|41934651|FG001|Overall Study|Patient was non-compliant|1|||
19521502|NCT00087516|41934652|FG002|Overall Study|Patient was non-compliant|0|||
19521503|NCT00087516|41934653|FG003|Overall Study|Patient was non-compliant|0|||
19521504|NCT00087516|41934650|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
19521505|NCT00087516|41934651|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
19521506|NCT00087516|41934652|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
19521507|NCT00087516|41934653|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
19521508|NCT00087516|41934650|FG000|Overall Study|Other|0|||
19521509|NCT00087516|41934651|FG001|Overall Study|Other|0|||
19521510|NCT00087516|41934652|FG002|Overall Study|Other|1|||
19521511|NCT00087516|41934653|FG003|Overall Study|Other|0|||
19521512|NCT00087126|41934667|FG000|Overall Study|Ineligible - second primary|1|||
19521513|NCT00087126|41934667|FG000|Overall Study|Never treated|1|||
19521514|NCT03490734|41934680|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
19521515|NCT03490734|41934681|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
19521516|NCT03490734|41934682|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
19521517|NCT03490734|41934683|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
19521518|NCT03490734|41934680|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
19521519|NCT03490734|41934681|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
19521520|NCT03490734|41934682|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
19521521|NCT03490734|41934683|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
19521522|NCT03490734|41934680|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
19521523|NCT03490734|41934681|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
19521524|NCT03490734|41934682|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
19521525|NCT03490734|41934683|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
19428952|NCT01574326|41676287|FG000|Overall Study|Other: Mainly kidney transplant|8|||
19428953|NCT01574326|41676288|FG001|Overall Study|Other: Mainly kidney transplant|8|||
19428954|NCT01574248|41676301|FG000|Overall Study|Withdrawal by Subject|2|||
19428955|NCT01574248|41676302|FG001|Overall Study|Withdrawal by Subject|0|||
19428956|NCT01574248|41676301|FG000|Overall Study|Missing primary endpoint data|1|||
19428957|NCT01574248|41676302|FG001|Overall Study|Missing primary endpoint data|0|||
19521526|NCT03490734|41934680|FG000|Post-intervention Scan Visit|Adverse Event|2|||
19521527|NCT03490734|41934681|FG001|Post-intervention Scan Visit|Adverse Event|0|||
19521528|NCT03490734|41934682|FG002|Post-intervention Scan Visit|Adverse Event|0|||
19521529|NCT03490734|41934683|FG003|Post-intervention Scan Visit|Adverse Event|0|||
19628283|NCT00789477|42077698|FG001|Overall Study|Lack of Efficacy|0|||
19428958|NCT01573624|41676308|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
19428959|NCT01573624|41676309|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
19428960|NCT01573624|41676310|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
19428961|NCT01573624|41676311|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
19428962|NCT01573624|41676312|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
19428963|NCT01573624|41676313|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
19428964|NCT01573624|41676314|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
19428965|NCT01573624|41676308|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
19428966|NCT01573624|41676309|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
19428967|NCT01573624|41676310|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
19428968|NCT01573624|41676311|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
19428969|NCT01573624|41676312|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
19428970|NCT01573624|41676313|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
19428971|NCT01573624|41676314|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
19428972|NCT01573624|41676308|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
19428973|NCT01573624|41676309|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19428974|NCT01573624|41676310|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19428975|NCT01573624|41676311|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19428976|NCT01573624|41676312|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19521530|NCT03490734|41934680|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
19521531|NCT03490734|41934681|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
19521532|NCT03490734|41934682|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
19521533|NCT03490734|41934683|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
19521534|NCT03490734|41934680|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
19521535|NCT03490734|41934681|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
19521536|NCT03490734|41934682|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
19521537|NCT03490734|41934683|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
19521538|NCT00086346|41934694|FG000|Randomization|Did not receive test article|4|||
19521539|NCT00086346|41934695|FG001|Randomization|Did not receive test article|4|||
19521540|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Adverse Event|94|||
19521541|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Adverse Event|11|||
19521542|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
19521543|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
19521544|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
19521545|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
19521546|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
19521547|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
19521548|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
19521549|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
19521550|NCT00086346|41934694|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
19521551|NCT00086346|41934695|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
19521552|NCT00085566|41934704|FG000|Overall Study|Adverse Event|0|||
19521553|NCT00085566|41934705|FG001|Overall Study|Adverse Event|0|||
19521554|NCT00085566|41934706|FG002|Overall Study|Adverse Event|10|||
19521555|NCT00085566|41934704|FG000|Overall Study|Patient Not treated|0|||
19521556|NCT00085566|41934705|FG001|Overall Study|Patient Not treated|0|||
19521557|NCT00085566|41934706|FG002|Overall Study|Patient Not treated|3|||
19521558|NCT00085566|41934704|FG000|Overall Study|Clinical progression|0|||
19521559|NCT00085566|41934705|FG001|Overall Study|Clinical progression|0|||
19521560|NCT00085566|41934706|FG002|Overall Study|Clinical progression|1|||
19521561|NCT00085098|41934716|FG000|Overall Study|Withdrawal by Subject|0|||
19521562|NCT00085098|41934717|FG001|Overall Study|Withdrawal by Subject|1|||
19521563|NCT00085098|41934716|FG000|Overall Study|Ineligible|1|||
19521564|NCT00085098|41934717|FG001|Overall Study|Ineligible|1|||
19521565|NCT00084864|41934730|FG000|Overall Study|Adverse Event|1|||
19521566|NCT00084864|41934731|FG001|Overall Study|Adverse Event|0|||
19521567|NCT00084864|41934732|FG002|Overall Study|Adverse Event|0|||
19521568|NCT00084864|41934733|FG003|Overall Study|Adverse Event|0|||
19521569|NCT00084318|41934745|FG000|Overall Study|Withdrawal by Subject|5|||
19521570|NCT00084318|41934746|FG001|Overall Study|Withdrawal by Subject|2|||
19521571|NCT00084318|41934745|FG000|Overall Study|Protocol Violation|15|||
19521572|NCT00084318|41934746|FG001|Overall Study|Protocol Violation|11|||
19521573|NCT00084318|41934745|FG000|Overall Study|No protocol treatment|2|||
19521574|NCT00084318|41934746|FG001|Overall Study|No protocol treatment|0|||
19521575|NCT00084084|41934754|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
19521576|NCT00084084|41934754|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
19521577|NCT00083616|41934759|FG000|Overall Study|Disease Progression|16|||
19521578|NCT00083616|41934759|FG000|Overall Study|Lost to Follow-up|1|||
19521579|NCT00083616|41934759|FG000|Overall Study|Physician Decision|2|||
19521580|NCT00083616|41934759|FG000|Overall Study|Withdrawal by Subject|3|||
19521581|NCT00083616|41934759|FG000|Overall Study|Ineligibility determined|2|||
19521582|NCT00083616|41934759|FG000|Overall Study|Non-compliance|1|||
19521583|NCT00083616|41934759|FG000|Overall Study|Other|6|||
19521584|NCT00083226|41934763|FG000|Overall Study|Lack of Efficacy|19|||
19521585|NCT00083226|41934763|FG000|Overall Study|Adverse Event|9|||
19521586|NCT00083226|41934763|FG000|Overall Study|Death|4|||
19521587|NCT00083226|41934763|FG000|Overall Study|Withdrawal by Subject|4|||
19521588|NCT00083226|41934763|FG000|Overall Study|Other|2|||
19521589|NCT00083226|41934763|FG000|Overall Study|ineligible or not receiving treatment|4|||
19521590|NCT00082758|41934770|FG000|Overall Study|Adverse Event|0|||
19521591|NCT00082758|41934771|FG001|Overall Study|Adverse Event|2|||
19521592|NCT00082758|41934772|FG002|Overall Study|Adverse Event|0|||
19521593|NCT00082758|41934770|FG000|Overall Study|Lack of Efficacy|12|||
19521594|NCT00082758|41934771|FG001|Overall Study|Lack of Efficacy|13|||
19521595|NCT00082758|41934772|FG002|Overall Study|Lack of Efficacy|0|||
19521596|NCT00082758|41934770|FG000|Overall Study|Physician Decision|0|||
19521597|NCT00082758|41934771|FG001|Overall Study|Physician Decision|1|||
19521598|NCT00082758|41934772|FG002|Overall Study|Physician Decision|0|||
19521599|NCT00082758|41934770|FG000|Overall Study|Withdrawal by Subject|3|||
19521600|NCT00082758|41934771|FG001|Overall Study|Withdrawal by Subject|0|||
19521601|NCT00082758|41934772|FG002|Overall Study|Withdrawal by Subject|0|||
19521602|NCT00082758|41934770|FG000|Overall Study|Protocol Violation|0|||
19521603|NCT00082758|41934771|FG001|Overall Study|Protocol Violation|1|||
19521604|NCT00082758|41934772|FG002|Overall Study|Protocol Violation|0|||
19521605|NCT00088452|41934783|FG000|Overall Study|Did not receive intervention|1|||
19521606|NCT00088452|41934784|FG001|Overall Study|Did not receive intervention|0|||
19521607|NCT00088452|41934785|FG002|Overall Study|Did not receive intervention|1|||
19521608|NCT04686084|41934884|FG000|Overall Study|Lost to Follow-up|1|||
19521609|NCT04685538|41934891|FG000|Overall Study|Adverse Event|0|||
19521610|NCT04685538|41934892|FG001|Overall Study|Adverse Event|1|||
19521611|NCT04685538|41934891|FG000|Overall Study|Lost to Follow-up|0|||
19521612|NCT04685538|41934892|FG001|Overall Study|Lost to Follow-up|2|||
19521613|NCT04213326|41934904|FG000|Overall Study|Consent withdrawn|51|||
19521614|NCT04213326|41934905|FG001|Overall Study|Consent withdrawn|241|||
19521615|NCT04213326|41934904|FG000|Overall Study|Lost to Follow-up|50|||
19521616|NCT04213326|41934905|FG001|Overall Study|Lost to Follow-up|902|||
19521617|NCT04213326|41934904|FG000|Overall Study|Protocol Violation|3|||
19521618|NCT04213326|41934905|FG001|Overall Study|Protocol Violation|25|||
19521619|NCT04213326|41934904|FG000|Overall Study|Participant eligibility changed|106|||
19521620|NCT04213326|41934905|FG001|Overall Study|Participant eligibility changed|19|||
19521621|NCT04213326|41934904|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
19521622|NCT04213326|41934905|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
19521623|NCT04213326|41934904|FG000|Overall Study|Incomplete study visit|0|||
19521624|NCT04213326|41934905|FG001|Overall Study|Incomplete study visit|367|||
19521625|NCT01625286|41934918|FG000|Overall Study|Adverse Event|0|||
19521626|NCT01625286|41934919|FG001|Overall Study|Adverse Event|0|||
19521627|NCT01625286|41934920|FG002|Overall Study|Adverse Event|0|||
19521628|NCT01625286|41934921|FG003|Overall Study|Adverse Event|0|||
19521629|NCT01625286|41934922|FG004|Overall Study|Adverse Event|1|||
19521630|NCT01625286|41934923|FG005|Overall Study|Adverse Event|2|||
19521631|NCT01625286|41934924|FG006|Overall Study|Adverse Event|1|||
19521632|NCT01625286|41934918|FG000|Overall Study|Death|0|||
19521633|NCT01625286|41934919|FG001|Overall Study|Death|0|||
19521634|NCT01625286|41934920|FG002|Overall Study|Death|1|||
19521635|NCT01625286|41934921|FG003|Overall Study|Death|1|||
19521636|NCT01625286|41934922|FG004|Overall Study|Death|0|||
19521637|NCT01625286|41934923|FG005|Overall Study|Death|11|||
19521638|NCT01625286|41934924|FG006|Overall Study|Death|16|||
19521639|NCT01625286|41934918|FG000|Overall Study|Withdrawal by Subject|0|||
19521640|NCT01625286|41934919|FG001|Overall Study|Withdrawal by Subject|1|||
19521641|NCT01625286|41934920|FG002|Overall Study|Withdrawal by Subject|0|||
19521642|NCT01625286|41934921|FG003|Overall Study|Withdrawal by Subject|1|||
19521643|NCT01625286|41934922|FG004|Overall Study|Withdrawal by Subject|0|||
19521644|NCT01625286|41934923|FG005|Overall Study|Withdrawal by Subject|0|||
19521645|NCT01625286|41934924|FG006|Overall Study|Withdrawal by Subject|1|||
19521646|NCT01625286|41934918|FG000|Overall Study|Any reason not specifically recorded|0|||
19521647|NCT01625286|41934919|FG001|Overall Study|Any reason not specifically recorded|0|||
19628284|NCT00789477|42077699|FG002|Overall Study|Lack of Efficacy|0|||
19628285|NCT00789477|42077700|FG003|Overall Study|Lack of Efficacy|0|||
19628286|NCT00789477|42077701|FG004|Overall Study|Lack of Efficacy|0|||
19628287|NCT00789477|42077697|FG000|Overall Study|Other|2|||
19628288|NCT00789477|42077698|FG001|Overall Study|Other|0|||
19628289|NCT00789477|42077699|FG002|Overall Study|Other|1|||
19628290|NCT00789477|42077700|FG003|Overall Study|Other|3|||
19628291|NCT00789477|42077701|FG004|Overall Study|Other|0|||
19628292|NCT00796614|42077719|FG000|Overall Study|Adverse Event|1|||
19521648|NCT01625286|41934920|FG002|Overall Study|Any reason not specifically recorded|0|||
19521649|NCT01625286|41934921|FG003|Overall Study|Any reason not specifically recorded|0|||
19521650|NCT01625286|41934922|FG004|Overall Study|Any reason not specifically recorded|0|||
19521651|NCT01625286|41934923|FG005|Overall Study|Any reason not specifically recorded|1|||
19521652|NCT01625286|41934924|FG006|Overall Study|Any reason not specifically recorded|0|||
19521653|NCT01625286|41934918|FG000|Overall Study|Progressive disease|6|||
19521654|NCT01625286|41934919|FG001|Overall Study|Progressive disease|3|||
19521655|NCT01625286|41934920|FG002|Overall Study|Progressive disease|4|||
19521656|NCT01625286|41934921|FG003|Overall Study|Progressive disease|5|||
19521657|NCT01625286|41934922|FG004|Overall Study|Progressive disease|5|||
19521658|NCT01625286|41934923|FG005|Overall Study|Progressive disease|0|||
19521659|NCT01625286|41934924|FG006|Overall Study|Progressive disease|0|||
19521660|NCT01625286|41934918|FG000|Overall Study|Lost to Follow-up|0|||
19521661|NCT01625286|41934919|FG001|Overall Study|Lost to Follow-up|0|||
19521662|NCT01625286|41934920|FG002|Overall Study|Lost to Follow-up|0|||
19521663|NCT01625286|41934921|FG003|Overall Study|Lost to Follow-up|0|||
19521664|NCT01625286|41934922|FG004|Overall Study|Lost to Follow-up|0|||
19521665|NCT01625286|41934923|FG005|Overall Study|Lost to Follow-up|0|||
19521666|NCT01625286|41934924|FG006|Overall Study|Lost to Follow-up|1|||
19521667|NCT04083222|41934969|FG000|Overall Study|Voluntary Withdrawal|0|||
19521668|NCT04083222|41934970|FG001|Overall Study|Voluntary Withdrawal|1|||
19521669|NCT04083222|41934969|FG000|Overall Study|Reason not Specified|0|||
19521670|NCT04083222|41934970|FG001|Overall Study|Reason not Specified|1|||
19628293|NCT00796614|42077720|FG001|Overall Study|Adverse Event|2|||
19628294|NCT00796614|42077721|FG002|Overall Study|Adverse Event|0|||
19628295|NCT00796614|42077722|FG003|Overall Study|Adverse Event|0|||
19628296|NCT00796614|42077719|FG000|Overall Study|Protocol Violation|0|||
19375329|NCT01657760|41617134|FG001|Overall Study|Physician Decision|1|||
19628297|NCT00796614|42077720|FG001|Overall Study|Protocol Violation|0|||
19375330|NCT01657760|41617135|FG002|Overall Study|Physician Decision|1|||
19375331|NCT01657760|41617136|FG003|Overall Study|Physician Decision|2|||
19375332|NCT02280304|41617163|FG000|Overall Study|Lost to Follow-up|7|||
19375333|NCT02280304|41617164|FG001|Overall Study|Lost to Follow-up|8|||
19375334|NCT02283658|41617184|FG000|Overall Study|Withdrawal by Subject|1|||
19375335|NCT02279524|41617211|FG000|Overall Study|Withdrawal by Subject|3|||
19428977|NCT01573624|41676313|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19428978|NCT01573624|41676314|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
19428979|NCT01573624|41676308|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19428980|NCT01573624|41676309|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19428981|NCT01573624|41676310|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
19428982|NCT01573624|41676311|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19428983|NCT01573624|41676312|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19428984|NCT01573624|41676313|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
19428985|NCT01573624|41676314|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
19428986|NCT01573624|41676308|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
19428987|NCT01573624|41676309|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
19428988|NCT01573624|41676310|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
19428989|NCT01573624|41676311|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
19428990|NCT01573624|41676312|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
19428991|NCT01573624|41676313|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
19428992|NCT01573624|41676314|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
19428993|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19428994|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19428995|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19428996|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19428997|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19428998|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
19428999|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
19429000|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
19429001|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
19429002|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
19429003|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
19429004|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
19429005|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
19429006|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
19429007|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
19429008|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19429009|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
19429010|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
19429011|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19429012|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19429013|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
19429014|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429015|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429016|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429017|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429018|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429019|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
19429020|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
19429021|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19429022|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19429023|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19429024|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
19429025|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19429026|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
19429027|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
19429028|NCT01573624|41676308|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429029|NCT01573624|41676309|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429030|NCT01573624|41676310|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429031|NCT01573624|41676311|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429032|NCT01573624|41676312|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429033|NCT01573624|41676313|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429034|NCT01573624|41676314|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429035|NCT01573624|41676308|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
19429036|NCT01573624|41676309|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
19429037|NCT01573624|41676310|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
19429038|NCT01573624|41676311|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
19429039|NCT01573624|41676312|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
19429040|NCT01573624|41676313|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
19429041|NCT01573624|41676314|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
19429042|NCT01573624|41676308|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
19429043|NCT01573624|41676309|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
19429044|NCT01573624|41676310|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
19429045|NCT01573624|41676311|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
19429046|NCT01573624|41676312|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
19429047|NCT01573624|41676313|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
19429048|NCT01573624|41676314|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
19429049|NCT01573624|41676308|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
19429050|NCT01573624|41676309|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429051|NCT01573624|41676310|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429052|NCT01573624|41676311|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429053|NCT01573624|41676312|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429054|NCT01573624|41676313|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429055|NCT01573624|41676314|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
19429056|NCT01573624|41676308|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19429057|NCT01573624|41676309|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
19429058|NCT01573624|41676310|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
19429059|NCT01573624|41676311|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19429060|NCT01573624|41676312|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19429061|NCT01573624|41676313|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
19429062|NCT01573624|41676314|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
19429063|NCT01573624|41676308|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
19429064|NCT01573624|41676309|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429065|NCT01573624|41676310|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429066|NCT01573624|41676311|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429067|NCT01573624|41676312|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429068|NCT01573624|41676313|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429069|NCT01573624|41676314|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
19429070|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
19429071|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
19429072|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
19429073|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
19429074|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
19429075|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
19429076|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
19429077|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
19429078|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
19429079|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
19429080|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
19429081|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
19429082|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
19429083|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
19429084|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429085|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
19429086|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429087|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429088|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429089|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429090|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
19429091|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429092|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
19429093|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429094|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429095|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429096|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429097|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
19429098|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19429099|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19429100|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19429101|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19429102|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
19429103|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
19429104|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
19429105|NCT01573624|41676308|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429106|NCT01573624|41676309|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429107|NCT01573624|41676310|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429108|NCT01573624|41676311|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429109|NCT01573624|41676312|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429110|NCT01573624|41676313|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
19429111|NCT01573624|41676314|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
19429112|NCT01573624|41676308|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
19429113|NCT01573624|41676309|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19429114|NCT01573624|41676310|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19429115|NCT01573624|41676311|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
19429116|NCT01573624|41676312|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
19429117|NCT01573624|41676313|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
19429118|NCT01573624|41676314|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
19429119|NCT01573624|41676308|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
19429120|NCT01573624|41676309|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
19429121|NCT01573624|41676310|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
19429122|NCT01573624|41676311|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
19429123|NCT01573624|41676312|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
19429124|NCT01573624|41676313|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
19429125|NCT01573624|41676314|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
19429126|NCT01573624|41676308|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
19429127|NCT01573624|41676309|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429128|NCT01573624|41676310|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429129|NCT01573624|41676311|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429130|NCT01573624|41676312|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429131|NCT01573624|41676313|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429132|NCT01573624|41676314|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
19429133|NCT01573624|41676308|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
19429134|NCT01573624|41676309|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
19429135|NCT01573624|41676310|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
19429136|NCT01573624|41676311|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
19429137|NCT01573624|41676312|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
19429138|NCT01573624|41676313|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
19429139|NCT01573624|41676314|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
19429140|NCT01573624|41676308|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
19429141|NCT01573624|41676309|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429142|NCT01573624|41676310|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429143|NCT01573624|41676311|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429144|NCT01573624|41676312|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429145|NCT01573624|41676313|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429146|NCT01573624|41676314|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
19429147|NCT01557946|41676338|FG000|Overall Study|Adverse Event|3|||
19429148|NCT01557946|41676339|FG001|Overall Study|Adverse Event|0|||
19429149|NCT01534078|41676344|FG000|Overall Study|Death|1|||
19429150|NCT01534078|41676344|FG000|Overall Study|Withdrawal by Subject|1|||
19429151|NCT02185040|41676353|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
19429152|NCT02185040|41676354|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
19429153|NCT02185040|41676355|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
19429154|NCT02185040|41676356|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
19429155|NCT02185040|41676357|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
19429156|NCT02185040|41676358|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
19429157|NCT02185040|41676359|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
19429158|NCT02185040|41676353|FG000|Part 1 Treatment Phase|Adverse Event|1|||
19429159|NCT02185040|41676354|FG001|Part 1 Treatment Phase|Adverse Event|0|||
19429160|NCT02185040|41676355|FG002|Part 1 Treatment Phase|Adverse Event|0|||
19429161|NCT02185040|41676356|FG003|Part 1 Treatment Phase|Adverse Event|2|||
19429162|NCT02185040|41676357|FG004|Part 1 Treatment Phase|Adverse Event|3|||
19429163|NCT02185040|41676358|FG005|Part 1 Treatment Phase|Adverse Event|0|||
19429164|NCT02185040|41676359|FG006|Part 1 Treatment Phase|Adverse Event|0|||
19429165|NCT02185040|41676353|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429166|NCT02185040|41676354|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
19429167|NCT02185040|41676355|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429168|NCT02185040|41676356|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429169|NCT02185040|41676357|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429170|NCT02185040|41676358|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429171|NCT02185040|41676359|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
19429172|NCT02185040|41676353|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429173|NCT02185040|41676354|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
19429174|NCT02185040|41676355|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429175|NCT02185040|41676356|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429176|NCT02185040|41676357|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429177|NCT02185040|41676358|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429178|NCT02185040|41676359|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
19429179|NCT02185040|41676353|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
19429180|NCT02185040|41676354|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
19429181|NCT02185040|41676355|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
19429182|NCT02185040|41676356|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
19429183|NCT02185040|41676357|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
19429184|NCT02185040|41676358|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
19429185|NCT02185040|41676359|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
19429186|NCT02185040|41676353|FG000|Active Treatment Extension Phase|Adverse Event|0|||
19429187|NCT02185040|41676354|FG001|Active Treatment Extension Phase|Adverse Event|0|||
19429188|NCT02185040|41676355|FG002|Active Treatment Extension Phase|Adverse Event|0|||
19429189|NCT02185040|41676356|FG003|Active Treatment Extension Phase|Adverse Event|0|||
19429190|NCT02185040|41676357|FG004|Active Treatment Extension Phase|Adverse Event|0|||
19429191|NCT02185040|41676358|FG005|Active Treatment Extension Phase|Adverse Event|1|||
19429192|NCT02185040|41676359|FG006|Active Treatment Extension Phase|Adverse Event|4|||
19429193|NCT02185040|41676353|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
19429194|NCT02185040|41676354|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
19429195|NCT02185040|41676355|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
19429196|NCT02185040|41676356|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
19429197|NCT02185040|41676357|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
19429198|NCT02185040|41676358|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
19429199|NCT02185040|41676359|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
19429200|NCT02185040|41676353|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429201|NCT02185040|41676354|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429202|NCT02185040|41676355|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429203|NCT02185040|41676356|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429204|NCT02185040|41676357|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429205|NCT02185040|41676358|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
19429206|NCT02185040|41676359|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
19429207|NCT02161406|41676381|FG000|Overall Study|Death|2|||
19429208|NCT02161406|41676382|FG001|Overall Study|Death|1|||
19429209|NCT02161406|41676381|FG000|Overall Study|Lost to Follow-up|2|||
19429210|NCT02161406|41676382|FG001|Overall Study|Lost to Follow-up|1|||
19429211|NCT02161406|41676381|FG000|Overall Study|Withdrawal by Subject|2|||
19429212|NCT02161406|41676382|FG001|Overall Study|Withdrawal by Subject|4|||
19429213|NCT02161406|41676381|FG000|Overall Study|investigator withdrew subject|3|||
19429214|NCT02161406|41676382|FG001|Overall Study|investigator withdrew subject|1|||
19429215|NCT02161406|41676381|FG000|Overall Study|Lack of Efficacy|1|||
19429216|NCT02161406|41676382|FG001|Overall Study|Lack of Efficacy|1|||
19429217|NCT02161406|41676381|FG000|Overall Study|relocation|0|||
19429218|NCT02161406|41676382|FG001|Overall Study|relocation|1|||
19429219|NCT02161016|41676388|FG000|Overall Study|withdrawn by IRB|1|||
19429220|NCT01573000|41676394|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
19429221|NCT01573000|41676395|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
19429222|NCT01573000|41676394|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
19429223|NCT01573000|41676395|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
19429224|NCT01573000|41676394|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
19429225|NCT01573000|41676395|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
19429226|NCT01573000|41676394|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
19429227|NCT01573000|41676395|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
19429228|NCT01573000|41676394|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
19429229|NCT01573000|41676395|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
19429230|NCT01573000|41676394|FG000|Crossover Phase|Lack of Efficacy|0|||
19429231|NCT01573000|41676395|FG001|Crossover Phase|Lack of Efficacy|13|||
19429232|NCT01573000|41676394|FG000|Crossover Phase|Lost to Follow-up|0|||
19429233|NCT01573000|41676395|FG001|Crossover Phase|Lost to Follow-up|2|||
19429234|NCT01573000|41676394|FG000|Crossover Phase|Death|0|||
19429235|NCT01573000|41676395|FG001|Crossover Phase|Death|3|||
19429236|NCT01573000|41676394|FG000|Long-Term Follow-Up|Death|3|||
19429237|NCT01573000|41676395|FG001|Long-Term Follow-Up|Death|0|||
19429238|NCT01573000|41676394|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
19429239|NCT01573000|41676395|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
19429240|NCT01572922|41676405|FG000|Overall Study|Adverse Event|1|||
19429241|NCT01572922|41676405|FG000|Overall Study|Protocol Violation|1|||
19429242|NCT01572922|41676405|FG000|Overall Study|Death|1|||
19429243|NCT01572844|41676414|FG000|Overall Study|Physician Decision|1|||
19429244|NCT01572844|41676415|FG001|Overall Study|Physician Decision|1|||
19429245|NCT01557400|41676424|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
19429246|NCT01557400|41676424|FG000|Overall Study|Adverse Event|3|||
19429247|NCT01557400|41676424|FG000|Overall Study|Lost to Follow-up|5|||
19429248|NCT01557400|41676424|FG000|Overall Study|Withdrawal by Subject|9|||
19429249|NCT01533922|41676428|FG000|Overall Study|Adverse Event|5|||
19429250|NCT01533922|41676429|FG001|Overall Study|Adverse Event|8|||
19429251|NCT01533922|41676430|FG002|Overall Study|Adverse Event|6|||
19429252|NCT01533922|41676431|FG003|Overall Study|Adverse Event|3|||
19429253|NCT01533922|41676432|FG004|Overall Study|Adverse Event|4|||
19429254|NCT01533922|41676428|FG000|Overall Study|Lack of Efficacy|0|||
19429255|NCT01533922|41676429|FG001|Overall Study|Lack of Efficacy|0|||
19429256|NCT01533922|41676430|FG002|Overall Study|Lack of Efficacy|1|||
19429257|NCT01533922|41676431|FG003|Overall Study|Lack of Efficacy|0|||
19429258|NCT01533922|41676432|FG004|Overall Study|Lack of Efficacy|0|||
19429259|NCT01533922|41676428|FG000|Overall Study|Protocol Violation|0|||
19429260|NCT01533922|41676429|FG001|Overall Study|Protocol Violation|3|||
19429261|NCT01533922|41676430|FG002|Overall Study|Protocol Violation|0|||
19429262|NCT01533922|41676431|FG003|Overall Study|Protocol Violation|0|||
19429263|NCT01533922|41676432|FG004|Overall Study|Protocol Violation|1|||
19429264|NCT01533922|41676428|FG000|Overall Study|Withdrawal by Subject|3|||
19429265|NCT01533922|41676429|FG001|Overall Study|Withdrawal by Subject|1|||
19429266|NCT01533922|41676430|FG002|Overall Study|Withdrawal by Subject|2|||
19429267|NCT01533922|41676431|FG003|Overall Study|Withdrawal by Subject|2|||
19429268|NCT01533922|41676432|FG004|Overall Study|Withdrawal by Subject|1|||
19429269|NCT01533922|41676428|FG000|Overall Study|Other reason not defined above|2|||
19429270|NCT01533922|41676429|FG001|Overall Study|Other reason not defined above|0|||
19429271|NCT01533922|41676430|FG002|Overall Study|Other reason not defined above|1|||
19429272|NCT01533922|41676431|FG003|Overall Study|Other reason not defined above|0|||
19429273|NCT01533922|41676432|FG004|Overall Study|Other reason not defined above|0|||
19429274|NCT01533688|41676447|FG000|Overall Study|Withdrawal by Subject|5|||
19429275|NCT01533688|41676448|FG001|Overall Study|Withdrawal by Subject|4|||
19429276|NCT01533688|41676449|FG002|Overall Study|Withdrawal by Subject|3|||
19429277|NCT01533688|41676447|FG000|Overall Study|Medically unstable|1|||
19429278|NCT01533688|41676448|FG001|Overall Study|Medically unstable|3|||
19429279|NCT01533688|41676449|FG002|Overall Study|Medically unstable|3|||
19429280|NCT01533688|41676447|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
19429281|NCT01533688|41676448|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
19429282|NCT01533688|41676449|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
19429283|NCT01532986|41676461|FG000|Overall Study|Death|9|||
19429284|NCT01532986|41676462|FG001|Overall Study|Death|9|||
19429285|NCT01532986|41676461|FG000|Overall Study|Withdrawal by Subject|7|||
19429286|NCT01532986|41676462|FG001|Overall Study|Withdrawal by Subject|10|||
19429287|NCT01532986|41676461|FG000|Overall Study|Physician Decision|7|||
19429288|NCT01532986|41676462|FG001|Overall Study|Physician Decision|5|||
19429289|NCT01532908|41676471|FG000|Overall Study|Not Transplanted|1|||
19429290|NCT01532908|41676472|FG001|Overall Study|Not Transplanted|0|||
19429291|NCT02160782|41676478|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
19429292|NCT02160782|41676479|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
19429293|NCT02160782|41676480|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
19429294|NCT02160782|41676481|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
19429295|NCT02160782|41676482|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
19429296|NCT02160782|41676478|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
19429297|NCT02160782|41676479|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
19429298|NCT02160782|41676480|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
19429299|NCT02160782|41676481|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
19429300|NCT02160782|41676482|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
19429301|NCT02160782|41676478|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
19429302|NCT02160782|41676479|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
19429303|NCT02160782|41676480|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
19429304|NCT02160782|41676481|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
19429305|NCT02160782|41676482|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
19429306|NCT02160782|41676478|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
19521671|NCT03286842|41934976|FG000|Overall Study|Patients rolled over to another study|80|||
19628298|NCT00796614|42077721|FG002|Overall Study|Protocol Violation|2|||
19429307|NCT02160782|41676479|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
19429308|NCT02160782|41676480|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
19429309|NCT02160782|41676481|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
19429310|NCT02160782|41676482|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
19429311|NCT02160782|41676478|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
19429312|NCT02160782|41676479|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
19429313|NCT02160782|41676480|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
19429314|NCT02160782|41676481|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
19429315|NCT02160782|41676482|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
19429316|NCT02160782|41676478|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
19429317|NCT02160782|41676479|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
19429318|NCT02160782|41676480|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
19429319|NCT02160782|41676481|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
19429320|NCT02160782|41676482|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
19429321|NCT02160782|41676478|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
19429322|NCT02160782|41676479|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
19429323|NCT02160782|41676480|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
19429324|NCT02160782|41676481|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
19429325|NCT02160782|41676482|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
19429326|NCT02160626|41676509|FG000|Overall Study|Adverse Event|1|||
19429327|NCT02160626|41676510|FG001|Overall Study|Adverse Event|0|||
19429328|NCT02160626|41676511|FG002|Overall Study|Adverse Event|0|||
19429329|NCT02160626|41676509|FG000|Overall Study|Schedule not conducive to study visits|0|||
19429330|NCT02160626|41676510|FG001|Overall Study|Schedule not conducive to study visits|0|||
19429331|NCT02160626|41676511|FG002|Overall Study|Schedule not conducive to study visits|1|||
19429332|NCT02160626|41676509|FG000|Overall Study|Withdrawal by Subject|0|||
19429333|NCT02160626|41676510|FG001|Overall Study|Withdrawal by Subject|1|||
19429334|NCT02160626|41676511|FG002|Overall Study|Withdrawal by Subject|0|||
19429335|NCT02160314|41676523|FG000|Overall Study|Adverse Event|0|||
19429336|NCT02160314|41676524|FG001|Overall Study|Adverse Event|6|||
19429337|NCT02160314|41676523|FG000|Overall Study|Protocol Violation|0|||
19429338|NCT02160314|41676524|FG001|Overall Study|Protocol Violation|4|||
19429339|NCT02160314|41676523|FG000|Overall Study|Withdrawal by Subject|1|||
19429340|NCT02160314|41676524|FG001|Overall Study|Withdrawal by Subject|2|||
19429341|NCT02160314|41676523|FG000|Overall Study|Lost to Follow-up|0|||
19429342|NCT02160314|41676524|FG001|Overall Study|Lost to Follow-up|1|||
19429343|NCT02160002|41676532|FG000|Overall Study|Withdrawal by Subject|2|||
19429344|NCT02160002|41676533|FG001|Overall Study|Withdrawal by Subject|1|||
19429345|NCT02218268|41676539|FG000|24 Hour Washout|Physician Decision|11|||
19429346|NCT02218268|41676540|FG001|24 Hour Washout|Physician Decision|9|||
19429347|NCT02217878|41676548|FG000|Overall Study|required morphine due to chest pain|1|||
19429348|NCT02217878|41676549|FG001|Overall Study|required morphine due to chest pain|2|||
19429349|NCT02217878|41676548|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
19429350|NCT02217878|41676549|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
19429351|NCT02217566|41676555|FG000|Overall Study|Lost to Follow-up|2|||
19429352|NCT02217566|41676555|FG000|Overall Study|Death|3|||
19429353|NCT02217566|41676555|FG000|Overall Study|Early study termination|6|||
19429354|NCT02217410|41676562|FG000|Overall Study|Graft Loss|0|||
19429355|NCT02217410|41676563|FG001|Overall Study|Graft Loss|0|||
19429356|NCT02217410|41676564|FG002|Overall Study|Graft Loss|2|||
19429357|NCT02217410|41676562|FG000|Overall Study|Withdrawal by Subject|0|||
19429358|NCT02217410|41676563|FG001|Overall Study|Withdrawal by Subject|0|||
19429359|NCT02217410|41676564|FG002|Overall Study|Withdrawal by Subject|2|||
19429360|NCT02217410|41676562|FG000|Overall Study|Lost to Follow-up|0|||
19429361|NCT02217410|41676563|FG001|Overall Study|Lost to Follow-up|0|||
19429362|NCT02217410|41676564|FG002|Overall Study|Lost to Follow-up|1|||
19429363|NCT02217410|41676562|FG000|Overall Study|Lack of Efficacy|0|||
19429364|NCT02217410|41676563|FG001|Overall Study|Lack of Efficacy|1|||
19429365|NCT02217410|41676564|FG002|Overall Study|Lack of Efficacy|0|||
19429366|NCT02217410|41676562|FG000|Overall Study|Physician Decision|1|||
19429367|NCT02217410|41676563|FG001|Overall Study|Physician Decision|3|||
19429368|NCT02217410|41676564|FG002|Overall Study|Physician Decision|0|||
19429369|NCT02217332|41676577|FG000|Overall Study|Adverse Event|3|||
19429370|NCT02217332|41676577|FG000|Overall Study|Dose interruption >1 month|1|||
19628299|NCT00796614|42077722|FG003|Overall Study|Protocol Violation|0|||
19429371|NCT02217332|41676577|FG000|Overall Study|Protocol Violation (eligibility)|1|||
19429372|NCT02217332|41676577|FG000|Overall Study|Withdrawal by Subject|1|||
19429373|NCT02217332|41676577|FG000|Overall Study|Lost to Follow-up|1|||
19429374|NCT02184572|41676583|FG000|Overall Study|Lost to Follow-up|29|||
19429375|NCT02184572|41676584|FG001|Overall Study|Lost to Follow-up|21|||
19429376|NCT02184572|41676583|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
19429377|NCT02184572|41676584|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
19429378|NCT02184572|41676583|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
19429379|NCT02184572|41676584|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
19429380|NCT02184572|41676583|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
19429381|NCT02184572|41676584|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
19429382|NCT02184572|41676583|FG000|Overall Study|Traveling Outside The Country|1|||
19429383|NCT02184572|41676584|FG001|Overall Study|Traveling Outside The Country|0|||
19429384|NCT02184572|41676583|FG000|Overall Study|Withdrawal by Subject|14|||
19429385|NCT02184572|41676584|FG001|Overall Study|Withdrawal by Subject|9|||
19429386|NCT02181842|41676592|FG000|Overall Study|Case Report Forms Uncollected|2|||
19429387|NCT01632020|41676598|FG000|Overall Study|Withdrawal by Subject|1|||
19429388|NCT01632020|41676599|FG001|Overall Study|Withdrawal by Subject|0|||
19429389|NCT01632020|41676598|FG000|Overall Study|Adverse Event|1|||
19429390|NCT01632020|41676599|FG001|Overall Study|Adverse Event|0|||
19429391|NCT02181296|41676607|FG000|Overall Study|Lost to Follow-up|7|||
19429392|NCT02181296|41676608|FG001|Overall Study|Lost to Follow-up|6|||
19429393|NCT02215616|41676618|FG000|Overall Study|Sponsor requested to stop study drug|0|||
19429394|NCT02215616|41676619|FG001|Overall Study|Sponsor requested to stop study drug|0|||
19429395|NCT02215616|41676620|FG002|Overall Study|Sponsor requested to stop study drug|1|||
19429396|NCT02215616|41676621|FG003|Overall Study|Sponsor requested to stop study drug|4|||
19429397|NCT02215616|41676618|FG000|Overall Study|Death|1|||
19429398|NCT02215616|41676619|FG001|Overall Study|Death|0|||
19429399|NCT02215616|41676620|FG002|Overall Study|Death|0|||
19429400|NCT02215616|41676621|FG003|Overall Study|Death|0|||
19429401|NCT02215616|41676618|FG000|Overall Study|Adverse Event|7|||
19429402|NCT02215616|41676619|FG001|Overall Study|Adverse Event|4|||
19429403|NCT02215616|41676620|FG002|Overall Study|Adverse Event|9|||
19429404|NCT02215616|41676621|FG003|Overall Study|Adverse Event|2|||
19429405|NCT02215616|41676618|FG000|Overall Study|Withdrawal by Subject|1|||
19429406|NCT02215616|41676619|FG001|Overall Study|Withdrawal by Subject|8|||
19429407|NCT02215616|41676620|FG002|Overall Study|Withdrawal by Subject|2|||
19429408|NCT02215616|41676621|FG003|Overall Study|Withdrawal by Subject|5|||
19429409|NCT02215616|41676618|FG000|Overall Study|Non-compliance|0|||
19429410|NCT02215616|41676619|FG001|Overall Study|Non-compliance|2|||
19429411|NCT02215616|41676620|FG002|Overall Study|Non-compliance|1|||
19429412|NCT02215616|41676621|FG003|Overall Study|Non-compliance|0|||
19429413|NCT02215616|41676618|FG000|Overall Study|Protocol Violation|0|||
19429414|NCT02215616|41676619|FG001|Overall Study|Protocol Violation|2|||
19429415|NCT02215616|41676620|FG002|Overall Study|Protocol Violation|0|||
19429416|NCT02215616|41676621|FG003|Overall Study|Protocol Violation|0|||
19429417|NCT02215616|41676618|FG000|Overall Study|Lost to Follow-up|1|||
19429418|NCT02215616|41676619|FG001|Overall Study|Lost to Follow-up|1|||
19429419|NCT02215616|41676620|FG002|Overall Study|Lost to Follow-up|0|||
19429420|NCT02215616|41676621|FG003|Overall Study|Lost to Follow-up|1|||
19429421|NCT02215616|41676618|FG000|Overall Study|Other than specified|1|||
19429422|NCT02215616|41676619|FG001|Overall Study|Other than specified|0|||
19429423|NCT02215616|41676620|FG002|Overall Study|Other than specified|1|||
19429424|NCT02215616|41676621|FG003|Overall Study|Other than specified|1|||
19429425|NCT02213666|41676631|FG000|Overall Study|Withdrawal by Subject|1|||
19429426|NCT02213510|41676637|FG000|Overall Study|Death|0|||
19429427|NCT02213510|41676638|FG001|Overall Study|Death|1|||
19429428|NCT02213510|41676637|FG000|Overall Study|Lost to Follow-up|1|||
19429429|NCT02213510|41676638|FG001|Overall Study|Lost to Follow-up|0|||
19429430|NCT02158442|41676646|FG000|Overall Study|Withdrawal by Subject|1|||
19429431|NCT02158442|41676647|FG001|Overall Study|Withdrawal by Subject|0|||
19429432|NCT02158442|41676646|FG000|Overall Study|Perfusion staff not available|1|||
19429433|NCT02158442|41676647|FG001|Overall Study|Perfusion staff not available|0|||
19429434|NCT02158364|41676653|FG000|Overall Study|Case report forms uncollected|10|||
19429435|NCT02158364|41676653|FG000|Overall Study|Protocol Deviation|50|||
19429436|NCT02180672|41676659|FG000|Overall Study|Lost to Follow-up|5|||
19521672|NCT00639678|41934991|FG000|Overall Study|Withdrawal by Subject|3|||
19521673|NCT00639678|41934992|FG001|Overall Study|Withdrawal by Subject|0|||
19521674|NCT00639678|41934993|FG002|Overall Study|Withdrawal by Subject|4|||
19521675|NCT00639678|41934994|FG003|Overall Study|Withdrawal by Subject|0|||
19521676|NCT00639678|41934991|FG000|Overall Study|Lost to Follow-up|1|||
19521677|NCT00639678|41934992|FG001|Overall Study|Lost to Follow-up|0|||
19521678|NCT00639678|41934993|FG002|Overall Study|Lost to Follow-up|6|||
19521679|NCT00639678|41934994|FG003|Overall Study|Lost to Follow-up|0|||
19429437|NCT02180672|41676660|FG001|Overall Study|Lost to Follow-up|7|||
19429438|NCT02213198|41676668|FG000|Baseline|No show for intake|7|||
19429439|NCT02213198|41676669|FG001|Baseline|No show for intake|9|||
19429440|NCT02213198|41676668|FG000|Baseline|Withdrawal by Subject|34|||
19429441|NCT02213198|41676669|FG001|Baseline|Withdrawal by Subject|11|||
19429442|NCT02213198|41676668|FG000|Baseline|transferred out of clinic|7|||
19429443|NCT02213198|41676669|FG001|Baseline|transferred out of clinic|9|||
19429444|NCT02213198|41676668|FG000|Baseline|Lost to Follow-up|40|||
19429445|NCT02213198|41676669|FG001|Baseline|Lost to Follow-up|21|||
19429446|NCT02213198|41676668|FG000|Baseline|incarcerated,violent|0|||
19429447|NCT02213198|41676669|FG001|Baseline|incarcerated,violent|1|||
19429448|NCT02213198|41676668|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
19429449|NCT02213198|41676669|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
19429450|NCT02213198|41676668|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
19429451|NCT02213198|41676669|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
19429452|NCT02213198|41676668|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
19429453|NCT02213198|41676669|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
19429454|NCT02213198|41676668|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
19429455|NCT02213198|41676669|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
19429456|NCT02213198|41676668|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
19429457|NCT02213198|41676669|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
19429458|NCT02213198|41676668|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
19429459|NCT02213198|41676669|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
19429460|NCT02157506|41676680|FG000|Overall Study|Adverse Event|0|||
19429461|NCT02157506|41676681|FG001|Overall Study|Adverse Event|1|||
19429462|NCT02157506|41676682|FG002|Overall Study|Adverse Event|0|||
19429463|NCT02157506|41676683|FG003|Overall Study|Adverse Event|0|||
19429464|NCT02157506|41676684|FG004|Overall Study|Adverse Event|0|||
19429465|NCT02157506|41676680|FG000|Overall Study|Lost to Follow-up|0|||
19429466|NCT02157506|41676681|FG001|Overall Study|Lost to Follow-up|0|||
19429467|NCT02157506|41676682|FG002|Overall Study|Lost to Follow-up|1|||
19429468|NCT02157506|41676683|FG003|Overall Study|Lost to Follow-up|0|||
19429469|NCT02157506|41676684|FG004|Overall Study|Lost to Follow-up|0|||
19429470|NCT01920711|41676698|FG000|Overall Study|Death|347|||
19429471|NCT01920711|41676699|FG001|Overall Study|Death|356|||
19429472|NCT01920711|41676698|FG000|Overall Study|Lost to Follow-up|13|||
19429473|NCT01920711|41676699|FG001|Overall Study|Lost to Follow-up|14|||
19429474|NCT01920711|41676698|FG000|Overall Study|Withdrawal by Subject|4|||
19429475|NCT01920711|41676699|FG001|Overall Study|Withdrawal by Subject|3|||
19429476|NCT02180438|41676706|FG000|Overall Study|Lost to Follow-up|1|||
19429477|NCT02179190|41676710|FG000|Enrollment|Exit Prior to Device Attempt|11|||
19429478|NCT02179190|41676710|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
19429479|NCT02179190|41676710|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
19429480|NCT02179190|41676710|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
19429481|NCT02179190|41676710|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
19429482|NCT02179190|41676710|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
19429483|NCT02157116|41676714|FG000|Overall Study|Withdrawal by Subject|4|||
19429484|NCT02157116|41676714|FG000|Overall Study|Physician Decision|3|||
19429485|NCT02157116|41676714|FG000|Overall Study|Failed Screening|2|||
19429486|NCT01920555|41676723|FG000|Overall Study|Physician Decision|1|||
19429487|NCT01920555|41676724|FG001|Overall Study|Physician Decision|2|||
19429488|NCT01920555|41676725|FG002|Overall Study|Physician Decision|1|||
19429489|NCT01920555|41676726|FG003|Overall Study|Physician Decision|2|||
19429490|NCT01920555|41676727|FG004|Overall Study|Physician Decision|0|||
19429491|NCT01920555|41676723|FG000|Overall Study|Lack of Efficacy|2|||
19429492|NCT01920555|41676724|FG001|Overall Study|Lack of Efficacy|0|||
19429493|NCT01920555|41676725|FG002|Overall Study|Lack of Efficacy|0|||
19429494|NCT01920555|41676726|FG003|Overall Study|Lack of Efficacy|0|||
19429495|NCT01920555|41676727|FG004|Overall Study|Lack of Efficacy|0|||
19429496|NCT01920555|41676723|FG000|Overall Study|Travel Difficulties|1|||
19429497|NCT01920555|41676724|FG001|Overall Study|Travel Difficulties|1|||
19429498|NCT01920555|41676725|FG002|Overall Study|Travel Difficulties|0|||
19429499|NCT01920555|41676726|FG003|Overall Study|Travel Difficulties|0|||
19429500|NCT01920555|41676727|FG004|Overall Study|Travel Difficulties|1|||
19429501|NCT01920555|41676723|FG000|Overall Study|Lost to Follow-up|0|||
19429502|NCT01920555|41676724|FG001|Overall Study|Lost to Follow-up|1|||
19429503|NCT01920555|41676725|FG002|Overall Study|Lost to Follow-up|0|||
19429504|NCT01920555|41676726|FG003|Overall Study|Lost to Follow-up|1|||
19429505|NCT01920555|41676727|FG004|Overall Study|Lost to Follow-up|0|||
19429506|NCT02156804|41676739|FG000|Overall Study|Withdrawal by Subject|1|||
19429507|NCT02156492|41676746|FG000|Period 1|No Reason Given|0|||
19429508|NCT02156492|41676747|FG001|Period 1|No Reason Given|1|||
19429509|NCT02156492|41676748|FG002|Period 1|No Reason Given|0|||
19429510|NCT02156492|41676746|FG000|Period 3|Adverse Event|0|||
19429511|NCT02156492|41676747|FG001|Period 3|Adverse Event|1|||
19429512|NCT02156492|41676748|FG002|Period 3|Adverse Event|0|||
19429513|NCT01920477|41676768|FG000|Overall Study|Adverse Event|0|||
19429514|NCT01920477|41676769|FG001|Overall Study|Adverse Event|1|||
19429515|NCT01920477|41676768|FG000|Overall Study|Lack of Efficacy|1|||
19429516|NCT01920477|41676769|FG001|Overall Study|Lack of Efficacy|0|||
19429517|NCT01920477|41676768|FG000|Overall Study|Study closed/terminated|14|||
19429518|NCT01920477|41676769|FG001|Overall Study|Study closed/terminated|15|||
19429519|NCT01920477|41676768|FG000|Overall Study|Withdrawal by Subject|0|||
19429520|NCT01920477|41676769|FG001|Overall Study|Withdrawal by Subject|1|||
19429521|NCT02213042|41676778|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
19521680|NCT00639678|41934991|FG000|Overall Study|Adverse Event|0|||
19429522|NCT02213042|41676779|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
19429523|NCT02213042|41676780|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
19429524|NCT02213042|41676778|FG000|Overall Study|Adverse Event|2|||
19429525|NCT02213042|41676779|FG001|Overall Study|Adverse Event|1|||
19429526|NCT02213042|41676780|FG002|Overall Study|Adverse Event|0|||
19429527|NCT02213042|41676778|FG000|Overall Study|Withdrawal by Subject|0|||
19429528|NCT02213042|41676779|FG001|Overall Study|Withdrawal by Subject|1|||
19429529|NCT02213042|41676780|FG002|Overall Study|Withdrawal by Subject|1|||
19429530|NCT02213042|41676778|FG000|Overall Study|Protocol Violation|1|||
19429531|NCT02213042|41676779|FG001|Overall Study|Protocol Violation|0|||
19429532|NCT02213042|41676780|FG002|Overall Study|Protocol Violation|0|||
19429533|NCT02213042|41676778|FG000|Overall Study|Investigator discretion|0|||
19429534|NCT02213042|41676779|FG001|Overall Study|Investigator discretion|0|||
19429535|NCT02213042|41676780|FG002|Overall Study|Investigator discretion|1|||
19429536|NCT02212730|41676792|FG000|Overall Study|Tumor not of the required cell histology|1|||
19429537|NCT02212730|41676793|FG001|Overall Study|Tumor not of the required cell histology|0|||
19429538|NCT02212730|41676792|FG000|Overall Study|Withdrawal by Subject|1|||
19429539|NCT02212730|41676793|FG001|Overall Study|Withdrawal by Subject|0|||
19429540|NCT02212730|41676792|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
19429541|NCT02212730|41676793|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
19429542|NCT02178956|41676803|FG000|Overall Study|Lost to Follow-up|4|||
19429543|NCT02178956|41676804|FG001|Overall Study|Lost to Follow-up|4|||
19429544|NCT02178956|41676803|FG000|Overall Study|Sponsor terminated study|49|||
19429545|NCT02178956|41676804|FG001|Overall Study|Sponsor terminated study|58|||
19429546|NCT02178956|41676803|FG000|Overall Study|Withdrawal by Subject|15|||
19429547|NCT02178956|41676804|FG001|Overall Study|Withdrawal by Subject|11|||
19429548|NCT02178956|41676803|FG000|Overall Study|Various Reasons|3|||
19429549|NCT02178956|41676804|FG001|Overall Study|Various Reasons|5|||
19429550|NCT02211638|41676814|FG000|Overall Study|Case Report Forms Uncollected|291|||
19429551|NCT02211638|41676814|FG000|Overall Study|Protocol Violation|692|||
19429552|NCT02178566|41676820|FG000|Overall Study|patient did not complete due to noncompliance|0|||
19429553|NCT02178566|41676821|FG001|Overall Study|patient did not complete due to noncompliance|1|||
19429554|NCT02211014|41676829|FG000|Overall Study|Adverse Event|0|||
19429555|NCT02211014|41676830|FG001|Overall Study|Adverse Event|2|||
19429556|NCT02211014|41676829|FG000|Overall Study|Physician Decision|1|||
19429557|NCT02211014|41676830|FG001|Overall Study|Physician Decision|2|||
19429558|NCT02211014|41676829|FG000|Overall Study|Started another cancer therapy|1|||
19429559|NCT02211014|41676830|FG001|Overall Study|Started another cancer therapy|0|||
19429560|NCT02211014|41676829|FG000|Overall Study|Withdrawal by Subject|0|||
19429561|NCT02211014|41676830|FG001|Overall Study|Withdrawal by Subject|1|||
19429562|NCT02211014|41676829|FG000|Overall Study|In agreement with patient, no benefit|0|||
19429563|NCT02211014|41676830|FG001|Overall Study|In agreement with patient, no benefit|1|||
19429564|NCT01631864|41676854|FG000|Overall Study|Withdrawal by Subject|0|||
19429565|NCT01631864|41676855|FG001|Overall Study|Withdrawal by Subject|1|||
19429566|NCT01631864|41676854|FG000|Overall Study|Adverse Event|2|||
19429567|NCT01631864|41676855|FG001|Overall Study|Adverse Event|3|||
19429568|NCT02210780|41676863|FG000|Overall Study|Adverse Event|0|||
19429569|NCT02210780|41676864|FG001|Overall Study|Adverse Event|5|||
19429570|NCT02210780|41676863|FG000|Overall Study|Lost to Follow-up|2|||
19429571|NCT02210780|41676864|FG001|Overall Study|Lost to Follow-up|1|||
19429572|NCT02210780|41676863|FG000|Overall Study|Withdrawal by Subject|1|||
19429573|NCT02210780|41676864|FG001|Overall Study|Withdrawal by Subject|1|||
19429574|NCT02210780|41676863|FG000|Overall Study|Physician Decision|1|||
19429575|NCT02210780|41676864|FG001|Overall Study|Physician Decision|0|||
19429576|NCT02210780|41676863|FG000|Overall Study|Protocol Violation|1|||
19429577|NCT02210780|41676864|FG001|Overall Study|Protocol Violation|0|||
19429578|NCT02210780|41676863|FG000|Overall Study|Other than specified above|0|||
19429579|NCT02210780|41676864|FG001|Overall Study|Other than specified above|1|||
19429580|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
19429581|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
19429582|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
19429583|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
19429584|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
19429585|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
19429586|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
19429587|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
19429588|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
19429589|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
19429590|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
19429591|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
19429592|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
19429593|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
19429594|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
19429595|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429596|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429597|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429598|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429599|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429600|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
19429601|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
19429602|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
19429603|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
19429604|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
19429605|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
19429606|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
19429607|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
19429608|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429609|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
19429610|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429611|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429612|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429613|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429614|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
19429615|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
19429616|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
19429617|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
19429618|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
19429619|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
19429620|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
19429621|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
19429622|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
19429623|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
19429624|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
19429625|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
19429626|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
19429627|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
19429628|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
19429629|NCT01557244|41676875|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
19429630|NCT01557244|41676876|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
19429631|NCT01557244|41676877|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
19429632|NCT01557244|41676878|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
19429633|NCT01557244|41676879|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
19429634|NCT01557244|41676880|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
19429635|NCT01557244|41676881|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
19429636|NCT01557244|41676875|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
19429637|NCT01557244|41676876|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
19429638|NCT01557244|41676877|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
19429639|NCT01557244|41676878|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
19429640|NCT01557244|41676879|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
19429641|NCT01557244|41676880|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
19429642|NCT01557244|41676881|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
19429643|NCT01557244|41676875|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
19429644|NCT01557244|41676876|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
19429645|NCT01557244|41676877|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
19429646|NCT01557244|41676878|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
19429647|NCT01557244|41676879|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
19429648|NCT01557244|41676880|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
19429649|NCT01557244|41676881|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
19429650|NCT01557244|41676875|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19429651|NCT01557244|41676876|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19429652|NCT01557244|41676877|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19628300|NCT00796614|42077719|FG000|Overall Study|Lost to Follow-up|2|||
19429653|NCT01557244|41676878|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
19429654|NCT01557244|41676879|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19429655|NCT01557244|41676880|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19429656|NCT01557244|41676881|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
19429657|NCT01557244|41676875|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
19429658|NCT01557244|41676876|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
19429659|NCT01557244|41676877|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
19429660|NCT01557244|41676878|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
19429661|NCT01557244|41676879|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
19429662|NCT01557244|41676880|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
19429663|NCT01557244|41676881|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
19429664|NCT02155712|41676911|FG000|Primary Objective|Death|3|||
19429665|NCT02155712|41676912|FG001|Primary Objective|Death|0|||
19429666|NCT02155712|41676911|FG000|Primary Objective|Lost to Follow-up|22|||
19429667|NCT02155712|41676912|FG001|Primary Objective|Lost to Follow-up|0|||
19429668|NCT02155712|41676911|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
19429669|NCT02155712|41676912|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
19429670|NCT02155712|41676911|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
19429671|NCT02155712|41676912|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
19429672|NCT02155712|41676911|FG000|Primary Objective|Withdrawal by Subject|21|||
19429673|NCT02155712|41676912|FG001|Primary Objective|Withdrawal by Subject|0|||
19429674|NCT02177942|41676920|FG000|Overall Study|Adverse Event|1|||
19429675|NCT02177942|41676921|FG001|Overall Study|Adverse Event|0|||
19429676|NCT02177942|41676920|FG000|Overall Study|Lost to Follow-up|1|||
19429677|NCT02177942|41676921|FG001|Overall Study|Lost to Follow-up|1|||
19429678|NCT02177942|41676920|FG000|Overall Study|Protocol Violation|4|||
19429679|NCT02177942|41676921|FG001|Overall Study|Protocol Violation|6|||
19429680|NCT02177942|41676920|FG000|Overall Study|Withdrawal by Subject|71|||
19429681|NCT02177942|41676921|FG001|Overall Study|Withdrawal by Subject|81|||
19429682|NCT02155322|41676931|FG000|Overall Study|Adverse Event|1|||
19429683|NCT02155322|41676931|FG000|Overall Study|Physician Decision|1|||
19429684|NCT02155322|41676931|FG000|Overall Study|Relapse/Recurrence|8|||
19429685|NCT02155322|41676931|FG000|Overall Study|Withdrawal by Subject|4|||
19429686|NCT02210000|41676937|FG000|Overall Study|Study Terminated|11|||
19429687|NCT02210000|41676938|FG001|Overall Study|Study Terminated|12|||
19429688|NCT02210000|41676937|FG000|Overall Study|Withdrawal by Subject|7|||
19429689|NCT02210000|41676938|FG001|Overall Study|Withdrawal by Subject|1|||
19429690|NCT02210000|41676937|FG000|Overall Study|Adverse Event|1|||
19429691|NCT02210000|41676938|FG001|Overall Study|Adverse Event|5|||
19429692|NCT02210000|41676937|FG000|Overall Study|Lost to Follow-up|0|||
19429693|NCT02210000|41676938|FG001|Overall Study|Lost to Follow-up|2|||
19429694|NCT02210000|41676937|FG000|Overall Study|Physician Decision|0|||
19429695|NCT02210000|41676938|FG001|Overall Study|Physician Decision|1|||
19429696|NCT01531894|41676944|FG000|Overall Study|Physician Decision|8|||
19429697|NCT01531894|41676944|FG000|Overall Study|Death|1|||
19429698|NCT02209766|41676952|FG000|Overall Study|Withdrawal by Subject|0|||
19429699|NCT02209766|41676953|FG001|Overall Study|Withdrawal by Subject|0|||
19429700|NCT02209766|41676954|FG002|Overall Study|Withdrawal by Subject|0|||
19429701|NCT02209766|41676955|FG003|Overall Study|Withdrawal by Subject|1|||
19429702|NCT02209766|41676956|FG004|Overall Study|Withdrawal by Subject|0|||
19429703|NCT02209454|41676966|FG000|Second Period|Adverse Event|1|||
19429704|NCT02209454|41676967|FG001|Second Period|Adverse Event|0|||
19429705|NCT01571596|41676976|FG000|Overall Study|Adverse Event|2|||
19429706|NCT01571596|41676977|FG001|Overall Study|Adverse Event|0|||
19429707|NCT01571596|41676978|FG002|Overall Study|Adverse Event|0|||
19429708|NCT01571596|41676976|FG000|Overall Study|Study Terminated by the Sponsor|0|||
19429709|NCT01571596|41676977|FG001|Overall Study|Study Terminated by the Sponsor|1|||
19429710|NCT01571596|41676978|FG002|Overall Study|Study Terminated by the Sponsor|1|||
19429711|NCT01557166|41676990|FG000|Overall Study|Adverse Event|20|||
19429712|NCT01557166|41676991|FG001|Overall Study|Adverse Event|6|||
19429713|NCT01557166|41676990|FG000|Overall Study|Lack of Efficacy|2|||
19429714|NCT01557166|41676991|FG001|Overall Study|Lack of Efficacy|1|||
19429715|NCT01557166|41676990|FG000|Overall Study|Protocol Violation|8|||
19429716|NCT01557166|41676991|FG001|Overall Study|Protocol Violation|5|||
19429717|NCT01557166|41676990|FG000|Overall Study|Withdrawn consent|12|||
19429718|NCT01557166|41676991|FG001|Overall Study|Withdrawn consent|20|||
19429719|NCT01557166|41676990|FG000|Overall Study|Target dose not tolerated|1|||
19429720|NCT01557166|41676991|FG001|Overall Study|Target dose not tolerated|0|||
19429721|NCT01557166|41676990|FG000|Overall Study|Psychiatric disorder|1|||
19429722|NCT01557166|41676991|FG001|Overall Study|Psychiatric disorder|0|||
19429723|NCT01557166|41676990|FG000|Overall Study|Unclassified|2|||
19429724|NCT01557166|41676991|FG001|Overall Study|Unclassified|5|||
19429725|NCT01556932|41676997|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
19429726|NCT01556932|41676998|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
19429727|NCT02177786|41677007|FG000|Overall Study|Withdrew Consent|2|||
19429728|NCT02177786|41677008|FG001|Overall Study|Withdrew Consent|6|||
19429729|NCT02177786|41677009|FG002|Overall Study|Withdrew Consent|9|||
19429730|NCT02177786|41677010|FG003|Overall Study|Withdrew Consent|5|||
19429731|NCT02177786|41677007|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
19429732|NCT02177786|41677008|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
19429733|NCT02177786|41677009|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
19429734|NCT02177786|41677010|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
19429735|NCT02177786|41677007|FG000|Overall Study|Adverse Event|1|||
19429736|NCT02177786|41677008|FG001|Overall Study|Adverse Event|1|||
19429737|NCT02177786|41677009|FG002|Overall Study|Adverse Event|2|||
19429738|NCT02177786|41677010|FG003|Overall Study|Adverse Event|3|||
19429739|NCT02177786|41677007|FG000|Overall Study|Death|1|||
19429740|NCT02177786|41677008|FG001|Overall Study|Death|1|||
19429741|NCT02177786|41677009|FG002|Overall Study|Death|1|||
19429742|NCT02177786|41677010|FG003|Overall Study|Death|1|||
19429743|NCT02177786|41677007|FG000|Overall Study|Lost to Follow-up|0|||
19429744|NCT02177786|41677008|FG001|Overall Study|Lost to Follow-up|0|||
19429745|NCT02177786|41677009|FG002|Overall Study|Lost to Follow-up|2|||
19429746|NCT02177786|41677010|FG003|Overall Study|Lost to Follow-up|2|||
19429747|NCT02177786|41677007|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19429748|NCT02177786|41677008|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19429749|NCT02177786|41677009|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19429750|NCT02177786|41677010|FG003|Overall Study|Non-Compliance with Study Drug|1|||
19429751|NCT02177786|41677007|FG000|Overall Study|Protocol Violation|0|||
19429752|NCT02177786|41677008|FG001|Overall Study|Protocol Violation|0|||
19429753|NCT02177786|41677009|FG002|Overall Study|Protocol Violation|2|||
19429754|NCT02177786|41677010|FG003|Overall Study|Protocol Violation|0|||
19429755|NCT02177786|41677007|FG000|Overall Study|Progressive Disease|0|||
19429756|NCT02177786|41677008|FG001|Overall Study|Progressive Disease|1|||
19429757|NCT02177786|41677009|FG002|Overall Study|Progressive Disease|0|||
19429758|NCT02177786|41677010|FG003|Overall Study|Progressive Disease|0|||
19429759|NCT02177786|41677007|FG000|Overall Study|Missing study completion status|0|||
19429760|NCT02177786|41677008|FG001|Overall Study|Missing study completion status|1|||
19429761|NCT02177786|41677009|FG002|Overall Study|Missing study completion status|0|||
19429762|NCT02177786|41677010|FG003|Overall Study|Missing study completion status|0|||
19429763|NCT01555762|41677020|FG000|Overall Study|No information on Bevacizumab intake|11|||
19429764|NCT01555762|41677020|FG000|Overall Study|Missing start date of infusion|8|||
19429765|NCT01555762|41677020|FG000|Overall Study|75 years old or more ticked No|1|||
19429766|NCT01555762|41677020|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
19429767|NCT01555762|41677020|FG000|Overall Study|Death linked to progression of disease|165|||
19429768|NCT01555762|41677020|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
19429769|NCT01555762|41677020|FG000|Overall Study|Investigator's decision|10|||
19429770|NCT01555762|41677020|FG000|Overall Study|Participant not wishing to continue|5|||
19429771|NCT01555762|41677020|FG000|Overall Study|Missing data|1|||
19429772|NCT01555762|41677020|FG000|Overall Study|Death linked to an adverse event|14|||
19429773|NCT02153918|41677024|FG000|Overall Study|Refused further treatment|1|||
19429774|NCT02176928|41677030|FG000|Overall Study|Lost to Follow-up|2|||
19429775|NCT02176928|41677031|FG001|Overall Study|Lost to Follow-up|4|||
19628301|NCT00796614|42077720|FG001|Overall Study|Lost to Follow-up|2|||
19628302|NCT00796614|42077721|FG002|Overall Study|Lost to Follow-up|1|||
19429778|NCT01628510|41677043|FG000|Overall Study|Withdrawal by Subject|0|||
19429779|NCT01628510|41677044|FG001|Overall Study|Withdrawal by Subject|4|||
19429780|NCT01628510|41677043|FG000|Overall Study|Death|3|||
19429781|NCT01628510|41677044|FG001|Overall Study|Death|1|||
19429782|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
19429783|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
19429784|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
19429785|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
19429786|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
19429787|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
19429788|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
19429789|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
19429790|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
19429791|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
19429792|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
19429793|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
19429794|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
19429795|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
19429796|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
19429797|NCT01571362|41677052|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
19429798|NCT01571362|41677053|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
19628303|NCT00796614|42077722|FG003|Overall Study|Lost to Follow-up|0|||
19628304|NCT00796614|42077719|FG000|Overall Study|Withdrawal by Subject|1|||
19429799|NCT01571362|41677054|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
19429800|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19429801|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
19429802|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
19429803|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
19429804|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
19429805|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
19429806|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Adverse Event|0|||
19429807|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Adverse Event|9|||
19429808|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Adverse Event|14|||
19429809|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19429810|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
19429811|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
19429812|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
19429813|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
19429814|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
19429815|NCT01571362|41677052|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
19429816|NCT01571362|41677053|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
19429817|NCT01571362|41677054|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
19429818|NCT01571284|41677062|FG000|Overall Study|Participant's decision|84|||
19429819|NCT01571284|41677062|FG000|Overall Study|Lost to Follow-up|3|||
19429820|NCT01571284|41677062|FG000|Overall Study|Enrolled but not treated|2|||
19429821|NCT01571284|41677062|FG000|Overall Study|Other than specified above|80|||
19429822|NCT02137772|41677068|FG000|Overall Study|Adverse Event|6|||
19429823|NCT02137772|41677069|FG001|Overall Study|Adverse Event|3|||
19429824|NCT02137772|41677068|FG000|Overall Study|Death|71|||
19429825|NCT02137772|41677069|FG001|Overall Study|Death|44|||
19429826|NCT02137772|41677068|FG000|Overall Study|Lost to Follow-up|8|||
19429827|NCT02137772|41677069|FG001|Overall Study|Lost to Follow-up|4|||
19429828|NCT02137772|41677068|FG000|Overall Study|Physician Decision|15|||
19429829|NCT02137772|41677069|FG001|Overall Study|Physician Decision|5|||
19429830|NCT02137772|41677068|FG000|Overall Study|Withdrawal by Subject|28|||
19429831|NCT02137772|41677069|FG001|Overall Study|Withdrawal by Subject|17|||
19429832|NCT02137772|41677068|FG000|Overall Study|Non-compliance with study drug|1|||
19429833|NCT02137772|41677069|FG001|Overall Study|Non-compliance with study drug|0|||
19429834|NCT02137772|41677068|FG000|Overall Study|Not treated|3|||
19429835|NCT02137772|41677069|FG001|Overall Study|Not treated|2|||
19429836|NCT01555138|41677077|FG000|Overall Study|Death|0|||
19429837|NCT01555138|41677078|FG001|Overall Study|Death|1|||
19429838|NCT01555138|41677077|FG000|Overall Study|Lost to Follow-up|1|||
19429839|NCT01555138|41677078|FG001|Overall Study|Lost to Follow-up|0|||
19429840|NCT01555138|41677077|FG000|Overall Study|Abnormal Lab reults|1|||
19429841|NCT01555138|41677078|FG001|Overall Study|Abnormal Lab reults|3|||
19429842|NCT01555138|41677077|FG000|Overall Study|Lack of Efficacy|2|||
19429843|NCT01555138|41677078|FG001|Overall Study|Lack of Efficacy|2|||
19429844|NCT01555138|41677077|FG000|Overall Study|Protocol Violation|5|||
19429845|NCT01555138|41677078|FG001|Overall Study|Protocol Violation|3|||
19429846|NCT01555138|41677077|FG000|Overall Study|Administrative problems|8|||
19429847|NCT01555138|41677078|FG001|Overall Study|Administrative problems|0|||
19429848|NCT01555138|41677077|FG000|Overall Study|Withdrawal by Subject|16|||
19429849|NCT01555138|41677078|FG001|Overall Study|Withdrawal by Subject|15|||
19429850|NCT01555138|41677077|FG000|Overall Study|Adverse Event|14|||
19429851|NCT01555138|41677078|FG001|Overall Study|Adverse Event|14|||
19429852|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
19429853|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
19429854|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
19429855|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
19429856|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
19429857|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
19711196|NCT00116805|42154354|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
19429858|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
19429859|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
19429860|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
19429861|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
19429862|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
19429863|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
19429864|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
19429865|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
19429866|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
19429867|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
19429868|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
19521681|NCT00639678|41934992|FG001|Overall Study|Adverse Event|1|||
19429869|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
19429870|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
19429871|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
19429872|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
19429873|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
19429874|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
19429875|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
19429876|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
19429877|NCT02137226|41677086|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
19429878|NCT02137226|41677087|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
19429879|NCT02137226|41677088|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
19429880|NCT02137226|41677089|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
19429881|NCT02137226|41677090|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
19429882|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
19429883|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
19429884|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
19429885|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
19429886|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
19429887|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
19429888|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
19429889|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
19429890|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
19429891|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
19429892|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
19429893|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
19429894|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
19429895|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
19429896|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
19429897|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
19429898|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
19429899|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
19429900|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
19429901|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
19429902|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
19429903|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
19429904|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
19429905|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
19429906|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
19429907|NCT02137226|41677086|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
19429908|NCT02137226|41677087|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
19429909|NCT02137226|41677088|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
19429910|NCT02137226|41677089|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
19429911|NCT02137226|41677090|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
19429912|NCT01530334|41677098|FG000|Overall Study|Adverse Event|3|||
19429913|NCT01530334|41677098|FG000|Overall Study|unknown reason|1|||
19429914|NCT01530334|41677098|FG000|Overall Study|Progressive disease|47|||
19429915|NCT01570192|41677104|FG000|Overall Study|no qualifying organism|6|||
19429916|NCT01570192|41677105|FG001|Overall Study|no qualifying organism|12|||
19429917|NCT01570192|41677104|FG000|Overall Study|changed to palliative care|1|||
19429918|NCT01570192|41677105|FG001|Overall Study|changed to palliative care|0|||
19429919|NCT01570192|41677104|FG000|Overall Study|Physician Decision|0|||
19429920|NCT01570192|41677105|FG001|Overall Study|Physician Decision|1|||
19429921|NCT02136914|41677118|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
19429922|NCT02136914|41677119|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
19429923|NCT02136914|41677118|FG000|Overall Study|Withdrawal by Subject|3|||
19429924|NCT02136914|41677119|FG001|Overall Study|Withdrawal by Subject|10|||
19429925|NCT02136914|41677118|FG000|Overall Study|Subject Unwilling to Proceed|7|||
19429926|NCT02136914|41677119|FG001|Overall Study|Subject Unwilling to Proceed|2|||
19429927|NCT02136914|41677118|FG000|Overall Study|Lost to Follow-up|1|||
19429928|NCT02136914|41677119|FG001|Overall Study|Lost to Follow-up|1|||
19429929|NCT02136914|41677118|FG000|Overall Study|Did Not Receive Study Drug|2|||
19429930|NCT02136914|41677119|FG001|Overall Study|Did Not Receive Study Drug|0|||
19429931|NCT02136914|41677118|FG000|Overall Study|Lack of Efficacy|1|||
19429932|NCT02136914|41677119|FG001|Overall Study|Lack of Efficacy|0|||
19429933|NCT02136914|41677118|FG000|Overall Study|Death|0|||
19429934|NCT02136914|41677119|FG001|Overall Study|Death|1|||
19429935|NCT01530256|41677125|FG000|Overall Study|Death|2|||
19429936|NCT01554904|41677129|FG000|Overall Study|Withdrawal by Subject|3|||
19429937|NCT01554904|41677129|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
19429938|NCT01529632|41677135|FG000|Overall Study|Administrative problem|2|||
19429939|NCT01529632|41677136|FG001|Overall Study|Administrative problem|1|||
19429940|NCT01529632|41677135|FG000|Overall Study|Protocol Violation|0|||
19429941|NCT01529632|41677136|FG001|Overall Study|Protocol Violation|1|||
19429942|NCT01529632|41677135|FG000|Overall Study|Adverse Event|1|||
19429943|NCT01529632|41677136|FG001|Overall Study|Adverse Event|1|||
19429944|NCT01554514|41677142|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
19429945|NCT01554514|41677142|FG000|Overall Study|Physician Decision|1|||
19429946|NCT01553188|41677150|FG000|Overall Study|Patient choice|1|||
19429947|NCT01553188|41677151|FG001|Overall Study|Patient choice|0|||
19429948|NCT01553188|41677152|FG002|Overall Study|Patient choice|0|||
19429949|NCT01553188|41677153|FG003|Overall Study|Patient choice|0|||
19429950|NCT01553188|41677150|FG000|Overall Study|Intercurrent illness and adverse event|0|||
19429951|NCT01553188|41677151|FG001|Overall Study|Intercurrent illness and adverse event|1|||
19429952|NCT01553188|41677152|FG002|Overall Study|Intercurrent illness and adverse event|2|||
19429953|NCT01553188|41677153|FG003|Overall Study|Intercurrent illness and adverse event|0|||
19429954|NCT02175758|41677172|FG000|Treatment Phase|Lost to Follow-up|0|||
19429955|NCT02175758|41677173|FG001|Treatment Phase|Lost to Follow-up|1|||
19429956|NCT02175758|41677174|FG002|Treatment Phase|Lost to Follow-up|0|||
19429957|NCT02175758|41677175|FG003|Treatment Phase|Lost to Follow-up|0|||
19429958|NCT02175758|41677176|FG004|Treatment Phase|Lost to Follow-up|0|||
19429959|NCT02175758|41677177|FG005|Treatment Phase|Lost to Follow-up|0|||
19429960|NCT02175758|41677172|FG000|Treatment Phase|Adverse Event|0|||
19429961|NCT02175758|41677173|FG001|Treatment Phase|Adverse Event|0|||
19429962|NCT02175758|41677174|FG002|Treatment Phase|Adverse Event|0|||
19429963|NCT02175758|41677175|FG003|Treatment Phase|Adverse Event|0|||
19429964|NCT02175758|41677176|FG004|Treatment Phase|Adverse Event|1|||
19429965|NCT02175758|41677177|FG005|Treatment Phase|Adverse Event|0|||
19429966|NCT01529008|41677219|FG000|Bone Marrow Harvesting|Physician Decision|1|||
19429967|NCT01529008|41677220|FG001|Bone Marrow Harvesting|Physician Decision|1|||
19429968|NCT01529008|41677219|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
19429969|NCT01529008|41677220|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
19429970|NCT01529008|41677219|FG000|Treatment|Adverse Event|6|||
19429971|NCT01529008|41677220|FG001|Treatment|Adverse Event|0|||
19429972|NCT01529008|41677219|FG000|Treatment|Other|3|||
19429973|NCT01529008|41677220|FG001|Treatment|Other|1|||
19429974|NCT01529008|41677219|FG000|Efficacy Analysis|Protocol Violation|2|||
19429975|NCT01529008|41677220|FG001|Efficacy Analysis|Protocol Violation|0|||
19429976|NCT01529008|41677219|FG000|Efficacy Analysis|Physician Decision|0|||
19429977|NCT01529008|41677220|FG001|Efficacy Analysis|Physician Decision|1|||
19429978|NCT01529008|41677219|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
19429979|NCT01529008|41677220|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
19429980|NCT01599104|41677229|FG000|Overall Study|Withdrawal by Subject|1|||
19429981|NCT01599104|41677230|FG001|Overall Study|Withdrawal by Subject|1|||
19429982|NCT01599104|41677231|FG002|Overall Study|Withdrawal by Subject|2|||
19429983|NCT01599104|41677229|FG000|Overall Study|Technical Problems|1|||
19429984|NCT01599104|41677230|FG001|Overall Study|Technical Problems|0|||
19429985|NCT01599104|41677231|FG002|Overall Study|Technical Problems|0|||
19429986|NCT01599104|41677229|FG000|Overall Study|Physician Decision|3|||
19429987|NCT01599104|41677230|FG001|Overall Study|Physician Decision|2|||
19429988|NCT01599104|41677231|FG002|Overall Study|Physician Decision|2|||
19429989|NCT01599104|41677229|FG000|Overall Study|Non-compliance with study treatment|0|||
19429990|NCT01599104|41677230|FG001|Overall Study|Non-compliance with study treatment|1|||
19429991|NCT01599104|41677231|FG002|Overall Study|Non-compliance with study treatment|0|||
19429992|NCT01599104|41677229|FG000|Overall Study|Lack of Efficacy|4|||
19429993|NCT01599104|41677230|FG001|Overall Study|Lack of Efficacy|4|||
19429994|NCT01599104|41677231|FG002|Overall Study|Lack of Efficacy|10|||
19429995|NCT01599104|41677229|FG000|Overall Study|Adverse Event|7|||
19429996|NCT01599104|41677230|FG001|Overall Study|Adverse Event|6|||
19429997|NCT01599104|41677231|FG002|Overall Study|Adverse Event|12|||
19429998|NCT01569568|41677241|FG000|Overall Study|Physician Decision|0|||
19429999|NCT01569568|41677242|FG001|Overall Study|Physician Decision|2|||
19430000|NCT02136680|41677250|FG000|Overall Study|No Longer Interested|1|||
19430001|NCT02136680|41677251|FG001|Overall Study|No Longer Interested|1|||
19430002|NCT02136680|41677250|FG000|Overall Study|No longer receiving care at clinic|3|||
19430003|NCT02136680|41677251|FG001|Overall Study|No longer receiving care at clinic|5|||
19430004|NCT02136680|41677250|FG000|Overall Study|Moved away|5|||
19430005|NCT02136680|41677251|FG001|Overall Study|Moved away|4|||
19430006|NCT02136680|41677250|FG000|Overall Study|Unable to schedule|17|||
19430007|NCT02136680|41677251|FG001|Overall Study|Unable to schedule|16|||
19430008|NCT02136680|41677250|FG000|Overall Study|Study ended before interview due|6|||
19430009|NCT02136680|41677251|FG001|Overall Study|Study ended before interview due|3|||
19430010|NCT01552954|41677259|FG000|Overall Study|Adverse Event|1|||
19430011|NCT01552954|41677260|FG001|Overall Study|Adverse Event|2|||
19430012|NCT01552954|41677259|FG000|Overall Study|Lost to Follow-up|1|||
19430013|NCT01552954|41677260|FG001|Overall Study|Lost to Follow-up|1|||
19430014|NCT01552954|41677259|FG000|Overall Study|Withdrawal by Subject|1|||
19430015|NCT01552954|41677260|FG001|Overall Study|Withdrawal by Subject|1|||
19430016|NCT01552954|41677259|FG000|Overall Study|Protocol Violation|1|||
19430017|NCT01552954|41677260|FG001|Overall Study|Protocol Violation|2|||
19430018|NCT01552954|41677259|FG000|Overall Study|diagnosed DM|1|||
19430019|NCT01552954|41677260|FG001|Overall Study|diagnosed DM|0|||
19430020|NCT02175368|41677266|FG000|Overall Study|Lost to Follow-up|1|||
19430021|NCT01518244|41677270|FG000|Overall Study|Adverse Event|3|||
19430022|NCT01552408|41677276|FG000|Overall Study|Lost to Follow-up|2|||
19430023|NCT01552408|41677277|FG001|Overall Study|Lost to Follow-up|0|||
19430024|NCT01552408|41677276|FG000|Overall Study|Relocation|0|||
19430025|NCT01552408|41677277|FG001|Overall Study|Relocation|1|||
19430026|NCT01552408|41677276|FG000|Overall Study|Withdrawal by Subject|2|||
19430027|NCT01552408|41677277|FG001|Overall Study|Withdrawal by Subject|1|||
19430028|NCT01528696|41677286|FG000|Overall Study|See detailed description|18|||
19430029|NCT01528696|41677287|FG001|Overall Study|See detailed description|19|||
19430030|NCT02174276|41677297|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
19430031|NCT02174276|41677298|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
19430032|NCT02174276|41677299|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
19430033|NCT02174276|41677300|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
19430034|NCT02174276|41677297|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
19430035|NCT02174276|41677298|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
19430036|NCT02174276|41677299|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
19430037|NCT02174276|41677300|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
19430038|NCT02174276|41677297|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
19430039|NCT02174276|41677298|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
19430040|NCT02174276|41677299|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
19430041|NCT02174276|41677300|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
19430042|NCT02174276|41677297|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
19430043|NCT02174276|41677298|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
19430044|NCT02174276|41677299|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
19430045|NCT02174276|41677300|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
19430046|NCT02174276|41677297|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
19430047|NCT02174276|41677298|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
19430048|NCT02174276|41677299|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
19430049|NCT02174276|41677300|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
19430050|NCT02174276|41677297|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
19430051|NCT02174276|41677298|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
19430052|NCT02174276|41677299|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
19430053|NCT02174276|41677300|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
19430054|NCT01528072|41677310|FG000|Overall Study|Withdrawal by Subject|5|||
19430055|NCT01528072|41677310|FG000|Overall Study|Physician Decision|1|||
19430056|NCT01528072|41677310|FG000|Overall Study|Determined not eligible by AEAC|1|||
19430057|NCT01528072|41677310|FG000|Overall Study|Missed Visit|2|||
19430058|NCT01528072|41677310|FG000|Overall Study|Lost to Follow-up|5|||
19430059|NCT01528072|41677310|FG000|Overall Study|Explanted|2|||
19430060|NCT01528072|41677310|FG000|Overall Study|Site Closure|4|||
19430061|NCT01528072|41677310|FG000|Overall Study|Death|2|||
19430062|NCT01528072|41677310|FG000|Overall Study|Early Termination of Study|52|||
19430063|NCT01527682|41677314|FG000|Overall Study|Protocol Violation|8|||
19430064|NCT01527370|41677318|FG000|Overall Study|Withdrawal by Subject|4|||
19430065|NCT01527370|41677318|FG000|Overall Study|Physician Decision|1|||
19430066|NCT01527370|41677318|FG000|Overall Study|Death|1|||
19430067|NCT01527292|41677324|FG000|Overall Study|Physician Decision|0|||
19430068|NCT01527292|41677325|FG001|Overall Study|Physician Decision|3|||
19430069|NCT01516216|41677333|FG000|Overall Study|Adverse Event|2|||
19430070|NCT01516216|41677334|FG001|Overall Study|Adverse Event|4|||
19430071|NCT01516216|41677333|FG000|Overall Study|Disease Progression|38|||
19430072|NCT01516216|41677334|FG001|Overall Study|Disease Progression|34|||
19430073|NCT01516216|41677333|FG000|Overall Study|Withdrawal by Subject|9|||
19430074|NCT01516216|41677334|FG001|Overall Study|Withdrawal by Subject|11|||
19430075|NCT01516216|41677333|FG000|Overall Study|Potentially Curative Resection|6|||
19430076|NCT01516216|41677334|FG001|Overall Study|Potentially Curative Resection|12|||
19430077|NCT01516216|41677333|FG000|Overall Study|Nonadherence|2|||
19430078|NCT01516216|41677334|FG001|Overall Study|Nonadherence|3|||
19430079|NCT01516216|41677333|FG000|Overall Study|Physician Decision|6|||
19430080|NCT01516216|41677334|FG001|Overall Study|Physician Decision|3|||
19430081|NCT01516216|41677333|FG000|Overall Study|Prolonged Treatment Delay|5|||
19430082|NCT01516216|41677334|FG001|Overall Study|Prolonged Treatment Delay|1|||
19430083|NCT01516216|41677333|FG000|Overall Study|Intercurrent Illness|1|||
19430084|NCT01516216|41677334|FG001|Overall Study|Intercurrent Illness|0|||
19430085|NCT01516216|41677333|FG000|Overall Study|Death|1|||
19430086|NCT01516216|41677334|FG001|Overall Study|Death|1|||
19430087|NCT01950819|41677344|FG000|Overall Study|Graft Loss|35|||
19430088|NCT01950819|41677345|FG001|Overall Study|Graft Loss|30|||
19430089|NCT01950819|41677344|FG000|Overall Study|Death|29|||
19430090|NCT01950819|41677345|FG001|Overall Study|Death|34|||
19430091|NCT01950819|41677344|FG000|Overall Study|Subject / Gardian decision|54|||
19430092|NCT01950819|41677345|FG001|Overall Study|Subject / Gardian decision|51|||
19430093|NCT01950819|41677344|FG000|Overall Study|technical problems|2|||
19430094|NCT01950819|41677345|FG001|Overall Study|technical problems|0|||
19430095|NCT01950819|41677344|FG000|Overall Study|Pregnancy|0|||
19430096|NCT01950819|41677345|FG001|Overall Study|Pregnancy|2|||
19430097|NCT01950819|41677344|FG000|Overall Study|Lost to Follow-up|9|||
19430098|NCT01950819|41677345|FG001|Overall Study|Lost to Follow-up|17|||
19430099|NCT01514422|41677351|FG000|Overall Study|Lost to Follow-up|1|||
19430100|NCT01513330|41677355|FG000|SenSura Mio First,|Adverse Event|2|||
19430101|NCT01513330|41677356|FG001|SenSura Mio First,|Adverse Event|0|||
19430102|NCT01513330|41677355|FG000|SenSura Mio First,|Lack of Efficacy|0|||
19430103|NCT01513330|41677356|FG001|SenSura Mio First,|Lack of Efficacy|1|||
19430104|NCT01513330|41677355|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
19430105|NCT01513330|41677356|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
19430106|NCT01513330|41677355|FG000|SenSura Mio First,|Other|1|||
19430107|NCT01513330|41677356|FG001|SenSura Mio First,|Other|0|||
19430108|NCT01513330|41677355|FG000|Standard Care First,|Lack of Efficacy|2|||
19430109|NCT01513330|41677356|FG001|Standard Care First,|Lack of Efficacy|2|||
19430110|NCT01513330|41677355|FG000|Standard Care First,|Withdrawal by Subject|1|||
19430111|NCT01513330|41677356|FG001|Standard Care First,|Withdrawal by Subject|2|||
19430112|NCT01513330|41677355|FG000|Standard Care First,|Other|1|||
19430113|NCT01513330|41677356|FG001|Standard Care First,|Other|0|||
19430114|NCT01524796|41677362|FG000|Overall Study|Adverse Event|13|||
19430115|NCT01524796|41677362|FG000|Overall Study|Lack of Efficacy|3|||
19430116|NCT01524796|41677362|FG000|Overall Study|Lost to Follow-up|1|||
19430117|NCT01524796|41677362|FG000|Overall Study|The price|1|||
19430118|NCT01524796|41677362|FG000|Overall Study|Withdrawal by Subject|4|||
19430119|NCT01524796|41677362|FG000|Overall Study|Move|1|||
19430120|NCT01524796|41677362|FG000|Overall Study|Deterioration of pains|1|||
19430121|NCT01524796|41677362|FG000|Overall Study|Gall stone surgery|1|||
19430122|NCT01524796|41677362|FG000|Overall Study|Nervous about confidentiality|1|||
19430123|NCT01524796|41677362|FG000|Overall Study|Switch to carbamazapine|1|||
19430124|NCT01524796|41677362|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
19430125|NCT01547728|41677366|FG000|Overall Study|Change in procedure and equipment|1|||
19430126|NCT01547728|41677366|FG000|Overall Study|Drug not ready for subject|1|||
19430127|NCT01547728|41677366|FG000|Overall Study|Screen failure|39|||
19430128|NCT01523392|41677372|FG000|Treatment Period 1|Withdrawal by Subject|2|||
19430129|NCT01523392|41677373|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19430130|NCT01523392|41677372|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
19430131|NCT01523392|41677373|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
19430132|NCT01523392|41677372|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
19430133|NCT01523392|41677373|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
19430134|NCT01512160|41677385|FG000|Overall Study|Lost to Follow-up|1|||
19430135|NCT01512160|41677386|FG001|Overall Study|Lost to Follow-up|0|||
19430136|NCT01512160|41677387|FG002|Overall Study|Lost to Follow-up|0|||
19430137|NCT01512160|41677388|FG003|Overall Study|Lost to Follow-up|0|||
19430138|NCT01512160|41677385|FG000|Overall Study|Withdrawal by Subject|1|||
19430139|NCT01512160|41677386|FG001|Overall Study|Withdrawal by Subject|0|||
19430140|NCT01512160|41677387|FG002|Overall Study|Withdrawal by Subject|0|||
19430141|NCT01512160|41677388|FG003|Overall Study|Withdrawal by Subject|1|||
19430142|NCT01546168|41677401|FG000|Overall Study|Lost to Follow-up|1|||
19430143|NCT01546168|41677402|FG001|Overall Study|Lost to Follow-up|0|||
19430144|NCT01546168|41677401|FG000|Overall Study|Withdrawal by Subject|1|||
19430145|NCT01546168|41677402|FG001|Overall Study|Withdrawal by Subject|0|||
19430146|NCT01546168|41677401|FG000|Overall Study|ineligible after signing consent|2|||
19430147|NCT01546168|41677402|FG001|Overall Study|ineligible after signing consent|0|||
19430148|NCT01901289|41677408|FG000|Overall Study|Death|32|||
19430149|NCT01901289|41677408|FG000|Overall Study|Lost to Follow-up|16|||
19430150|NCT01901289|41677408|FG000|Overall Study|Withdrawal by Subject|35|||
19430151|NCT01901289|41677408|FG000|Overall Study|Other type of endpoint met|2|||
19430152|NCT01950741|41677412|FG000|Overall Study|Lost to Follow-up|1|||
19430153|NCT01950741|41677412|FG000|Overall Study|Death|1|||
19430154|NCT01950741|41677412|FG000|Overall Study|Withdrawal by Subject|1|||
19430155|NCT01950273|41677418|FG000|Overall Study|Protocol Violation|1|||
19430156|NCT01950273|41677419|FG001|Overall Study|Protocol Violation|0|||
19430157|NCT01950273|41677418|FG000|Overall Study|Withdrawal by Subject|2|||
19430158|NCT01950273|41677419|FG001|Overall Study|Withdrawal by Subject|0|||
19430159|NCT01950273|41677418|FG000|Overall Study|Other not defined above|1|||
19430160|NCT01950273|41677419|FG001|Overall Study|Other not defined above|0|||
19430161|NCT01919307|41677425|FG000|Overall Study|Withdrawal by Subject|9|||
19430162|NCT01919229|41677432|FG000|Overall Study|Subject/guardian decision|0|||
19430163|NCT01919229|41677433|FG001|Overall Study|Subject/guardian decision|0|||
19430164|NCT01919229|41677434|FG002|Overall Study|Subject/guardian decision|1|||
19430165|NCT01901055|41677444|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
19430166|NCT01901055|41677445|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
19430167|NCT01901055|41677444|FG000|Randomization But Not Titrated|Physician Decision|0|||
19430168|NCT01901055|41677445|FG001|Randomization But Not Titrated|Physician Decision|1|||
19430169|NCT01901055|41677444|FG000|Started Protocol to Week 6|Physician Decision|2|||
19430170|NCT01901055|41677445|FG001|Started Protocol to Week 6|Physician Decision|1|||
19430171|NCT01901055|41677444|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
19430172|NCT01901055|41677445|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
19430173|NCT01901055|41677444|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
19430174|NCT01901055|41677445|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
19430175|NCT01901055|41677444|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
19430176|NCT01901055|41677445|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
19430177|NCT01901055|41677444|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
19430178|NCT01901055|41677445|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
19430179|NCT01901055|41677444|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
19430180|NCT01901055|41677445|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
19430181|NCT01901055|41677444|FG000|Week 24|Withdrawal by Subject|13|||
19430182|NCT01901055|41677445|FG001|Week 24|Withdrawal by Subject|19|||
19430183|NCT01901055|41677444|FG000|Week 24|Physician Decision|1|||
19430184|NCT01901055|41677445|FG001|Week 24|Physician Decision|0|||
19430185|NCT01901055|41677444|FG000|Week 36|Withdrawal by Subject|0|||
19430186|NCT01901055|41677445|FG001|Week 36|Withdrawal by Subject|5|||
19430187|NCT01511536|41677457|FG000|Phase 1|Other|0|||
19430188|NCT01511536|41677458|FG001|Phase 1|Other|1|||
19430189|NCT01511536|41677459|FG002|Phase 1|Other|0|||
19430190|NCT01511536|41677457|FG000|Phase 2|Other|0|||
19430191|NCT01511536|41677458|FG001|Phase 2|Other|0|||
19430192|NCT01511536|41677459|FG002|Phase 2|Other|9|||
19430193|NCT01890759|41677469|FG000|Overall Study|Protocol Violation|0|||
19430194|NCT01890759|41677470|FG001|Overall Study|Protocol Violation|2|||
19430195|NCT01890759|41677469|FG000|Overall Study|Lost to Follow-up|0|||
19430196|NCT01890759|41677470|FG001|Overall Study|Lost to Follow-up|2|||
19430197|NCT01890759|41677469|FG000|Overall Study|Withdrawal by Subject|2|||
19430198|NCT01890759|41677470|FG001|Overall Study|Withdrawal by Subject|8|||
19430199|NCT01900899|41677478|FG000|Overall Study|Withdrawal by Subject|7|||
19430200|NCT01900899|41677479|FG001|Overall Study|Withdrawal by Subject|1|||
19430201|NCT01900899|41677478|FG000|Overall Study|Migrated from study area|2|||
19430202|NCT01900899|41677479|FG001|Overall Study|Migrated from study area|0|||
19430203|NCT01510912|41677485|FG000|Overall Study|Adverse Event|99|||
19430204|NCT01510912|41677485|FG000|Overall Study|Lack of Efficacy|12|||
19430205|NCT01510912|41677485|FG000|Overall Study|Non-compliance with trial drug|23|||
19430206|NCT01510912|41677485|FG000|Overall Study|Withdrawal by Subject|49|||
19430207|NCT01510912|41677485|FG000|Overall Study|Physician Decision|1|||
19430208|NCT01510912|41677485|FG000|Overall Study|Protocol Violation|27|||
19430209|NCT01510912|41677485|FG000|Overall Study|Lost to Follow-up|26|||
19430210|NCT01510912|41677485|FG000|Overall Study|Other, including joint replacement|5|||
19430211|NCT01510756|41677489|FG000|Overall Study|Death|1|||
19430212|NCT01510756|41677489|FG000|Overall Study|Lack of Efficacy|2|||
19430213|NCT01510756|41677489|FG000|Overall Study|Physician Decision|1|||
19430214|NCT01522456|41677493|FG000|Overall Study|Adverse Event|2|||
19430215|NCT01522456|41677493|FG000|Overall Study|Lost to Follow-up|2|||
19430216|NCT01522456|41677493|FG000|Overall Study|Withdrawal by Subject|2|||
19430217|NCT01522456|41677493|FG000|Overall Study|Pregnancy|1|||
19430218|NCT01522456|41677493|FG000|Overall Study|Tolerability Assessment|1|||
19430219|NCT01545934|41677506|FG000|Overall Study|Withdrawal by Subject|4|||
19430220|NCT01545934|41677507|FG001|Overall Study|Withdrawal by Subject|3|||
19430221|NCT01545934|41677506|FG000|Overall Study|Lost to Follow-up|1|||
19430222|NCT01545934|41677507|FG001|Overall Study|Lost to Follow-up|0|||
19430223|NCT01521364|41677514|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
19430224|NCT01521364|41677514|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
19430225|NCT01545388|41677528|FG000|Overall Study|Adverse Event|2|||
19430226|NCT01545388|41677529|FG001|Overall Study|Adverse Event|4|||
19430227|NCT01545388|41677530|FG002|Overall Study|Adverse Event|1|||
19430228|NCT01545388|41677528|FG000|Overall Study|Lack of Efficacy|3|||
19430229|NCT01545388|41677529|FG001|Overall Study|Lack of Efficacy|2|||
19430230|NCT01545388|41677530|FG002|Overall Study|Lack of Efficacy|5|||
19430231|NCT01545388|41677528|FG000|Overall Study|Participant moved or relocated|1|||
19430232|NCT01545388|41677529|FG001|Overall Study|Participant moved or relocated|0|||
19430233|NCT01545388|41677530|FG002|Overall Study|Participant moved or relocated|0|||
19430234|NCT01545388|41677528|FG000|Overall Study|Withdrawal by Subject|1|||
19430235|NCT01545388|41677529|FG001|Overall Study|Withdrawal by Subject|4|||
19430236|NCT01545388|41677530|FG002|Overall Study|Withdrawal by Subject|2|||
19430237|NCT01545388|41677528|FG000|Overall Study|Other|1|||
19430238|NCT01545388|41677529|FG001|Overall Study|Other|1|||
19430239|NCT01545388|41677530|FG002|Overall Study|Other|0|||
19430240|NCT01545076|41677538|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
19430241|NCT01545076|41677539|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
19430242|NCT01545076|41677540|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
19430243|NCT01545076|41677541|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
19430244|NCT01545076|41677542|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
19430245|NCT01545076|41677538|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
19430246|NCT01545076|41677539|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
19430247|NCT01545076|41677540|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
19430248|NCT01545076|41677541|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
19430249|NCT01545076|41677542|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
19430250|NCT01545076|41677538|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
19430251|NCT01545076|41677539|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
19430252|NCT01545076|41677540|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
19430253|NCT01545076|41677541|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
19430254|NCT01545076|41677542|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
19430255|NCT01545076|41677538|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
19430256|NCT01545076|41677539|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
19430257|NCT01545076|41677540|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
19430258|NCT01545076|41677541|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
19430259|NCT01545076|41677542|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
19430260|NCT01545076|41677538|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
19430261|NCT01545076|41677539|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
19430262|NCT01545076|41677540|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
19430263|NCT01545076|41677541|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
19430264|NCT01545076|41677542|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
19430265|NCT01545076|41677538|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
19430266|NCT01545076|41677539|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
19430267|NCT01545076|41677540|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
19430268|NCT01545076|41677541|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
19430269|NCT01545076|41677542|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
19430270|NCT01545076|41677538|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
19430271|NCT01545076|41677539|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
19430272|NCT01545076|41677540|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
19430273|NCT01545076|41677541|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
19430274|NCT01545076|41677542|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
19430275|NCT01545076|41677538|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
19430276|NCT01545076|41677539|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
19430277|NCT01545076|41677540|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
19430278|NCT01545076|41677541|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
19430279|NCT01545076|41677542|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
19430280|NCT01545076|41677538|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
19430281|NCT01545076|41677539|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
19430282|NCT01545076|41677540|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
19430283|NCT01545076|41677541|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
19430284|NCT01545076|41677542|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
19430285|NCT01544920|41677557|FG000|Overall Study|Adverse Event|0|||
19430286|NCT01544920|41677558|FG001|Overall Study|Adverse Event|3|||
19430287|NCT01544920|41677557|FG000|Overall Study|Death|0|||
19430288|NCT01544920|41677558|FG001|Overall Study|Death|1|||
19430289|NCT01544920|41677557|FG000|Overall Study|Lost to Follow-up|11|||
19430290|NCT01544920|41677558|FG001|Overall Study|Lost to Follow-up|12|||
19430291|NCT01544920|41677557|FG000|Overall Study|Protocol Violation|0|||
19430292|NCT01544920|41677558|FG001|Overall Study|Protocol Violation|2|||
19430293|NCT01544920|41677557|FG000|Overall Study|Physician Decision|4|||
19430294|NCT01544920|41677558|FG001|Overall Study|Physician Decision|1|||
19430295|NCT01544920|41677557|FG000|Overall Study|Withdrawal by Subject|4|||
19430296|NCT01544920|41677558|FG001|Overall Study|Withdrawal by Subject|4|||
19430297|NCT01509664|41677568|FG000|Overall Study|Lost to Follow-up|15|||
19430298|NCT01509664|41677569|FG001|Overall Study|Lost to Follow-up|21|||
19430299|NCT01543828|41677577|FG000|Treatment 2|Lost to Follow-up|1|||
19430300|NCT01543828|41677578|FG001|Treatment 2|Lost to Follow-up|0|||
19430301|NCT01520506|41677586|FG000|Overall Study|Missed Visit|4|||
19430302|NCT01520506|41677586|FG000|Overall Study|Lost to Follow-up|1|||
19430303|NCT01520506|41677586|FG000|Overall Study|Withdrawal by Subject|1|||
19430304|NCT01519960|41677593|FG000|Overall Study|Withdrawal from the study|26|||
19430305|NCT01519960|41677594|FG001|Overall Study|Withdrawal from the study|22|||
19430306|NCT01519960|41677595|FG002|Overall Study|Withdrawal from the study|5|||
19430307|NCT01543204|41677611|FG000|Overall Study|Non-compliance|1|||
19430308|NCT01543204|41677611|FG000|Overall Study|Adverse Event|1|||
19430309|NCT01543204|41677611|FG000|Overall Study|Withdrawal by Subject|4|||
19430310|NCT01543204|41677611|FG000|Overall Study|Requirement for Alternative Therapy|1|||
19430311|NCT01543204|41677611|FG000|Overall Study|Lost to Follow-up|1|||
19430312|NCT01488994|41677621|FG000|Overall Study|Withdrawal by Subject|0|||
19430313|NCT01488994|41677622|FG001|Overall Study|Withdrawal by Subject|1|||
19430314|NCT01508650|41677635|FG000|Overall Study|Lost to Follow-up|0|||
19430315|NCT01508650|41677636|FG001|Overall Study|Lost to Follow-up|3|||
19430316|NCT01488448|41677644|FG000|Overall Study|Withdrawal by Subject|3|||
19430317|NCT01488448|41677645|FG001|Overall Study|Withdrawal by Subject|1|||
19430318|NCT01488448|41677644|FG000|Overall Study|Adverse Event|9|||
19430319|NCT01488448|41677645|FG001|Overall Study|Adverse Event|4|||
19430320|NCT01488448|41677644|FG000|Overall Study|Physician Decision|4|||
19430321|NCT01488448|41677645|FG001|Overall Study|Physician Decision|9|||
19430322|NCT01488448|41677644|FG000|Overall Study|Protocol Violation|4|||
19430323|NCT01488448|41677645|FG001|Overall Study|Protocol Violation|3|||
19430324|NCT01518946|41677655|FG000|Open-label Phase|Other|4|||
19430325|NCT01518946|41677656|FG001|Open-label Phase|Other|0|||
19430326|NCT01518946|41677657|FG002|Open-label Phase|Other|0|||
19430327|NCT01518946|41677655|FG000|Randomized Phase (First Intervention)|Other|0|||
19430328|NCT01518946|41677656|FG001|Randomized Phase (First Intervention)|Other|1|||
19430329|NCT01518946|41677657|FG002|Randomized Phase (First Intervention)|Other|0|||
19430330|NCT01488370|41677667|FG000|Overall Study|Protocol Violation|0|||
19430331|NCT01488370|41677668|FG001|Overall Study|Protocol Violation|1|||
19430332|NCT01488370|41677669|FG002|Overall Study|Protocol Violation|1|||
19430333|NCT01518322|41677677|FG000|Overall Study|FeNO measurement was missing|13|||
19430334|NCT01507246|41677688|FG000|Overall Study|Required different surgical procedures|2|||
19430335|NCT01507246|41677689|FG001|Overall Study|Required different surgical procedures|1|||
19430336|NCT01507090|41677698|FG000|Overall Study|incomplete dataset|18|||
19430337|NCT01464346|41677712|FG000|Overall Study|Withdrawal by Subject|0|||
19430338|NCT01464346|41677713|FG001|Overall Study|Withdrawal by Subject|0|||
19430339|NCT01464346|41677714|FG002|Overall Study|Withdrawal by Subject|1|||
19430340|NCT01487200|41677741|FG000|Overall Study|Withdrawal by Subject|0|||
19430341|NCT01487200|41677742|FG001|Overall Study|Withdrawal by Subject|1|||
19430342|NCT01487200|41677743|FG002|Overall Study|Withdrawal by Subject|0|||
19430343|NCT01487200|41677744|FG003|Overall Study|Withdrawal by Subject|0|||
19430344|NCT01463878|41677757|FG000|Overall Study|no longer met criteria for tube feed|2|||
19430345|NCT01463878|41677758|FG001|Overall Study|no longer met criteria for tube feed|2|||
19430346|NCT01505608|41677766|FG000|Phase I|Lack of Efficacy|0|||
19430347|NCT01505608|41677767|FG001|Phase I|Lack of Efficacy|4|||
19430348|NCT01505608|41677766|FG000|Phase I|Adverse Event|0|||
19430349|NCT01505608|41677767|FG001|Phase I|Adverse Event|1|||
19430350|NCT01505608|41677766|FG000|Phase I|Withdrawal by Subject|0|||
19430351|NCT01505608|41677767|FG001|Phase I|Withdrawal by Subject|1|||
19430352|NCT01505608|41677766|FG000|Phase II|Lack of Efficacy|2|||
19430353|NCT01505608|41677767|FG001|Phase II|Lack of Efficacy|1|||
19430354|NCT01505608|41677766|FG000|Phase II|Protocol Violation|0|||
19430355|NCT01505608|41677767|FG001|Phase II|Protocol Violation|1|||
19430356|NCT01486966|41677778|FG000|Overall Study|Adverse Event|0|||
19430357|NCT01486966|41677779|FG001|Overall Study|Adverse Event|1|||
19430358|NCT01486966|41677778|FG000|Overall Study|Withdrawal by Subject|0|||
19430359|NCT01486966|41677779|FG001|Overall Study|Withdrawal by Subject|1|||
19430360|NCT01900665|41677787|FG000|Placebo Controlled Period|Death|9|||
19430361|NCT01900665|41677788|FG001|Placebo Controlled Period|Death|16|||
19430362|NCT01900665|41677787|FG000|Placebo Controlled Period|Adverse Event|48|||
19430363|NCT01900665|41677788|FG001|Placebo Controlled Period|Adverse Event|39|||
19430364|NCT01900665|41677787|FG000|Placebo Controlled Period|Protocol Violation|1|||
19430365|NCT01900665|41677788|FG001|Placebo Controlled Period|Protocol Violation|7|||
19430366|NCT01900665|41677787|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
19430367|NCT01900665|41677788|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
19430368|NCT01900665|41677787|FG000|Placebo Controlled Period|Physician Decision|11|||
19430369|NCT01900665|41677788|FG001|Placebo Controlled Period|Physician Decision|7|||
19430370|NCT01900665|41677787|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
19430371|NCT01900665|41677788|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
19430372|NCT01900665|41677787|FG000|Placebo Controlled Period|Caregiver Decision|33|||
19430373|NCT01900665|41677788|FG001|Placebo Controlled Period|Caregiver Decision|41|||
19430374|NCT01900665|41677787|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
19430375|NCT01900665|41677788|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
19430376|NCT01900665|41677787|FG000|Open Label Period|Adverse Event|16|||
19430377|NCT01900665|41677788|FG001|Open Label Period|Adverse Event|20|||
19430378|NCT01900665|41677787|FG000|Open Label Period|Death|5|||
19430379|NCT01900665|41677788|FG001|Open Label Period|Death|6|||
19430380|NCT01900665|41677787|FG000|Open Label Period|Lost to Follow-up|1|||
19430381|NCT01900665|41677788|FG001|Open Label Period|Lost to Follow-up|1|||
19430382|NCT01900665|41677787|FG000|Open Label Period|Parent/Caregiver Decision|33|||
19430383|NCT01900665|41677788|FG001|Open Label Period|Parent/Caregiver Decision|34|||
19430384|NCT01900665|41677787|FG000|Open Label Period|Physician Decision|4|||
19430385|NCT01900665|41677788|FG001|Open Label Period|Physician Decision|4|||
19430386|NCT01900665|41677787|FG000|Open Label Period|Protocol Violation|0|||
19430387|NCT01900665|41677788|FG001|Open Label Period|Protocol Violation|1|||
19430388|NCT01900665|41677787|FG000|Open Label Period|Sponsor Decision|802|||
19430389|NCT01900665|41677788|FG001|Open Label Period|Sponsor Decision|765|||
19430390|NCT01900665|41677787|FG000|Open Label Period|Withdrawal by Subject|20|||
19430391|NCT01900665|41677788|FG001|Open Label Period|Withdrawal by Subject|28|||
19430392|NCT01900431|41677799|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
19430393|NCT01900431|41677800|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
19430394|NCT01900431|41677801|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
19430395|NCT01900431|41677799|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
19430396|NCT01900431|41677800|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
19430397|NCT01900431|41677801|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
19430398|NCT01900431|41677799|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
19430399|NCT01900431|41677800|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
19430400|NCT01900431|41677801|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
19430401|NCT01900431|41677799|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
19430402|NCT01900431|41677800|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
19430403|NCT01900431|41677801|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
19430404|NCT01900431|41677799|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
19430405|NCT01900431|41677800|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
19430406|NCT01900431|41677801|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
19430407|NCT01900431|41677799|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
19430408|NCT01900431|41677800|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
19430409|NCT01900431|41677801|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
19430410|NCT01900431|41677799|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
19430411|NCT01900431|41677800|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
19430412|NCT01900431|41677801|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
19430413|NCT01900431|41677799|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
19430414|NCT01900431|41677800|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
19430415|NCT01900431|41677801|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
19430416|NCT01900431|41677799|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
19430417|NCT01900431|41677800|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
19430418|NCT01900431|41677801|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
19430419|NCT01948791|41677809|FG000|Overall Study|Adverse Event|12|||
19430420|NCT01948791|41677809|FG000|Overall Study|Lack of Efficacy|3|||
19430421|NCT01948791|41677809|FG000|Overall Study|Protocol Violation|2|||
19430422|NCT01948791|41677809|FG000|Overall Study|Withdrawal by Subject|5|||
19430423|NCT01948791|41677809|FG000|Overall Study|Lost to Follow-up|6|||
19430424|NCT01948791|41677809|FG000|Overall Study|Management issues|1|||
19430425|NCT01948791|41677809|FG000|Overall Study|Others|7|||
19430426|NCT01948791|41677809|FG000|Overall Study|Screening failure|35|||
19430427|NCT01899729|41677818|FG000|Overall Study|Adverse Event|1|||
19430428|NCT01899729|41677819|FG001|Overall Study|Adverse Event|0|||
19430429|NCT01899729|41677820|FG002|Overall Study|Adverse Event|0|||
19430430|NCT01899729|41677821|FG003|Overall Study|Adverse Event|0|||
19430431|NCT01899729|41677822|FG004|Overall Study|Adverse Event|1|||
19430432|NCT01899729|41677818|FG000|Overall Study|Withdrawal by Subject|1|||
19430433|NCT01899729|41677819|FG001|Overall Study|Withdrawal by Subject|2|||
19430434|NCT01899729|41677820|FG002|Overall Study|Withdrawal by Subject|0|||
19430435|NCT01899729|41677821|FG003|Overall Study|Withdrawal by Subject|0|||
19430436|NCT01899729|41677822|FG004|Overall Study|Withdrawal by Subject|0|||
19430437|NCT01899729|41677818|FG000|Overall Study|Lack of Efficacy|0|||
19430438|NCT01899729|41677819|FG001|Overall Study|Lack of Efficacy|0|||
19430439|NCT01899729|41677820|FG002|Overall Study|Lack of Efficacy|2|||
19430440|NCT01899729|41677821|FG003|Overall Study|Lack of Efficacy|0|||
19430441|NCT01899729|41677822|FG004|Overall Study|Lack of Efficacy|1|||
19430442|NCT01898091|41677836|FG000|Overall Study|Lost to Follow-up|1|||
19430443|NCT01898091|41677837|FG001|Overall Study|Lost to Follow-up|1|||
19430444|NCT01898091|41677836|FG000|Overall Study|Withdrawal by Subject|1|||
19430445|NCT01898091|41677837|FG001|Overall Study|Withdrawal by Subject|5|||
19628305|NCT00796614|42077720|FG001|Overall Study|Withdrawal by Subject|0|||
19628306|NCT00796614|42077721|FG002|Overall Study|Withdrawal by Subject|0|||
19430446|NCT01947855|41677846|FG000|Overall Study|Withdrawal by Subject|1|||
19430447|NCT01947855|41677847|FG001|Overall Study|Withdrawal by Subject|0|||
19430448|NCT01947855|41677848|FG002|Overall Study|Withdrawal by Subject|0|||
19430449|NCT01888965|41677856|FG000|Overall Study|Adverse Event|5|||
19430450|NCT01888965|41677856|FG000|Overall Study|Lack of Efficacy|4|||
19430451|NCT01888497|41677860|FG000|Washout Period 1|Withdrawal by Subject|0|||
19430452|NCT01888497|41677861|FG001|Washout Period 1|Withdrawal by Subject|0|||
19430453|NCT01888497|41677862|FG002|Washout Period 1|Withdrawal by Subject|1|||
19430454|NCT01888497|41677863|FG003|Washout Period 1|Withdrawal by Subject|1|||
19430455|NCT01888497|41677860|FG000|Washout Period 2|Adverse Event|0|||
19430456|NCT01888497|41677861|FG001|Washout Period 2|Adverse Event|0|||
19430457|NCT01888497|41677862|FG002|Washout Period 2|Adverse Event|0|||
19430458|NCT01888497|41677863|FG003|Washout Period 2|Adverse Event|1|||
19430459|NCT01888497|41677860|FG000|Washout Period 2|Withdrawal by Subject|0|||
19430460|NCT01888497|41677861|FG001|Washout Period 2|Withdrawal by Subject|0|||
19430461|NCT01888497|41677862|FG002|Washout Period 2|Withdrawal by Subject|0|||
19430462|NCT01888497|41677863|FG003|Washout Period 2|Withdrawal by Subject|1|||
19430463|NCT01505530|41677876|FG000|Overall Study|Progressive Disease|19|||
19430464|NCT01505530|41677877|FG001|Overall Study|Progressive Disease|17|||
19430465|NCT01505530|41677878|FG002|Overall Study|Progressive Disease|18|||
19430466|NCT01505530|41677876|FG000|Overall Study|Adverse Event|1|||
19430467|NCT01505530|41677877|FG001|Overall Study|Adverse Event|1|||
19430468|NCT01505530|41677878|FG002|Overall Study|Adverse Event|0|||
19430469|NCT01505530|41677876|FG000|Overall Study|Withdrawal by Subject|7|||
19430470|NCT01505530|41677877|FG001|Overall Study|Withdrawal by Subject|8|||
19430471|NCT01505530|41677878|FG002|Overall Study|Withdrawal by Subject|6|||
19430472|NCT01505530|41677876|FG000|Overall Study|Physician Decision|6|||
19430473|NCT01505530|41677877|FG001|Overall Study|Physician Decision|2|||
19430474|NCT01505530|41677878|FG002|Overall Study|Physician Decision|5|||
19430475|NCT01505530|41677876|FG000|Overall Study|Sponsor Decision|1|||
19430476|NCT01505530|41677877|FG001|Overall Study|Sponsor Decision|8|||
19430477|NCT01505530|41677878|FG002|Overall Study|Sponsor Decision|7|||
19430478|NCT01505530|41677876|FG000|Overall Study|Death|7|||
19430479|NCT01505530|41677877|FG001|Overall Study|Death|6|||
19430480|NCT01505530|41677878|FG002|Overall Study|Death|5|||
19430481|NCT01505530|41677876|FG000|Overall Study|entry criteria not met|0|||
19430482|NCT01505530|41677877|FG001|Overall Study|entry criteria not met|1|||
19430483|NCT01505530|41677878|FG002|Overall Study|entry criteria not met|0|||
19430484|NCT01485796|41677886|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
19430485|NCT01485796|41677886|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
19430486|NCT01485796|41677886|FG000|Period 2: Epoch 2|Adverse Event|3|||
19430487|NCT01485796|41677886|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
19430488|NCT01485796|41677886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
19430489|NCT01485796|41677886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
19430490|NCT01485796|41677886|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
19430491|NCT01485796|41677886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
19430492|NCT01505374|41677894|FG000|Overall Study|Lost to Follow-up|1|||
19430493|NCT01505374|41677895|FG001|Overall Study|Lost to Follow-up|0|||
19430494|NCT01897233|41677902|FG000|Part B (24 Weeks)|Adverse Event|1|||
19430495|NCT01897233|41677902|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
19430496|NCT01897233|41677902|FG000|Part B (24 Weeks)|Physician Decision|1|||
19430497|NCT01887717|41677912|FG000|Overall Study|Withdrawal by Subject|1|||
19430498|NCT01887717|41677913|FG001|Overall Study|Withdrawal by Subject|7|||
19430499|NCT01887717|41677912|FG000|Overall Study|Physician Decision|0|||
19430500|NCT01887717|41677913|FG001|Overall Study|Physician Decision|2|||
19430501|NCT01887717|41677912|FG000|Overall Study|Administrative reasons|5|||
19430502|NCT01887717|41677913|FG001|Overall Study|Administrative reasons|2|||
19430503|NCT01886781|41677921|FG000|Overall Study|Protocol Violation|5|||
19430504|NCT01886781|41677922|FG001|Overall Study|Protocol Violation|0|||
19430505|NCT01886781|41677921|FG000|Overall Study|Adverse Event|1|||
19430506|NCT01886781|41677922|FG001|Overall Study|Adverse Event|0|||
19430507|NCT01886781|41677921|FG000|Overall Study|Lost to Follow-up|5|||
19430508|NCT01886781|41677922|FG001|Overall Study|Lost to Follow-up|0|||
19430509|NCT01886781|41677921|FG000|Overall Study|Withdrawal by Subject|2|||
19430510|NCT01886781|41677922|FG001|Overall Study|Withdrawal by Subject|1|||
19430511|NCT01886781|41677921|FG000|Overall Study|Worsening of symptoms|1|||
19430512|NCT01886781|41677922|FG001|Overall Study|Worsening of symptoms|1|||
19430513|NCT01946529|41677931|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
19430514|NCT01946529|41677932|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
19430515|NCT01946529|41677933|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
19430516|NCT01946529|41677931|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
19430517|NCT01946529|41677932|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
19430518|NCT01946529|41677933|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
19430519|NCT01463098|41677954|FG000|Part A (11 Days)|Participant Choice|2|||
19430520|NCT01463098|41677955|FG001|Part A (11 Days)|Participant Choice|0|||
19430521|NCT01463098|41677956|FG002|Part A (11 Days)|Participant Choice|0|||
19430522|NCT01463098|41677957|FG003|Part A (11 Days)|Participant Choice|0|||
19430523|NCT01463098|41677958|FG004|Part A (11 Days)|Participant Choice|0|||
19430524|NCT01463098|41677959|FG005|Part A (11 Days)|Participant Choice|0|||
19430525|NCT01463098|41677960|FG006|Part A (11 Days)|Participant Choice|0|||
19430526|NCT01463098|41677961|FG007|Part A (11 Days)|Participant Choice|0|||
19430527|NCT01463098|41677962|FG008|Part A (11 Days)|Participant Choice|1|||
19430528|NCT01463098|41677963|FG009|Part A (11 Days)|Participant Choice|0|||
19430529|NCT01463098|41677964|FG010|Part A (11 Days)|Participant Choice|0|||
19430530|NCT01463098|41677965|FG011|Part A (11 Days)|Participant Choice|0|||
19430531|NCT01463098|41677966|FG012|Part A (11 Days)|Participant Choice|0|||
19430532|NCT01463098|41677967|FG013|Part A (11 Days)|Participant Choice|0|||
19430533|NCT01463098|41677954|FG000|Part A (11 Days)|Lost to Follow-up|0|||
19430534|NCT01463098|41677955|FG001|Part A (11 Days)|Lost to Follow-up|0|||
19430535|NCT01463098|41677956|FG002|Part A (11 Days)|Lost to Follow-up|0|||
19430536|NCT01463098|41677957|FG003|Part A (11 Days)|Lost to Follow-up|0|||
19430537|NCT01463098|41677958|FG004|Part A (11 Days)|Lost to Follow-up|1|||
19430538|NCT01463098|41677959|FG005|Part A (11 Days)|Lost to Follow-up|0|||
19430539|NCT01463098|41677960|FG006|Part A (11 Days)|Lost to Follow-up|0|||
19430540|NCT01463098|41677961|FG007|Part A (11 Days)|Lost to Follow-up|0|||
19430541|NCT01463098|41677962|FG008|Part A (11 Days)|Lost to Follow-up|0|||
19430542|NCT01463098|41677963|FG009|Part A (11 Days)|Lost to Follow-up|0|||
19430543|NCT01463098|41677964|FG010|Part A (11 Days)|Lost to Follow-up|0|||
19430544|NCT01463098|41677965|FG011|Part A (11 Days)|Lost to Follow-up|0|||
19430545|NCT01463098|41677966|FG012|Part A (11 Days)|Lost to Follow-up|0|||
19430546|NCT01463098|41677967|FG013|Part A (11 Days)|Lost to Follow-up|0|||
19430547|NCT01463098|41677954|FG000|Part B (11 Days)|Participant Choice|0|||
19430548|NCT01463098|41677955|FG001|Part B (11 Days)|Participant Choice|0|||
19430549|NCT01463098|41677956|FG002|Part B (11 Days)|Participant Choice|0|||
19430550|NCT01463098|41677957|FG003|Part B (11 Days)|Participant Choice|0|||
19430551|NCT01463098|41677958|FG004|Part B (11 Days)|Participant Choice|0|||
19430552|NCT01463098|41677959|FG005|Part B (11 Days)|Participant Choice|0|||
19430553|NCT01463098|41677960|FG006|Part B (11 Days)|Participant Choice|0|||
19430554|NCT01463098|41677961|FG007|Part B (11 Days)|Participant Choice|0|||
19430555|NCT01463098|41677962|FG008|Part B (11 Days)|Participant Choice|0|||
19430556|NCT01463098|41677963|FG009|Part B (11 Days)|Participant Choice|0|||
19430557|NCT01463098|41677964|FG010|Part B (11 Days)|Participant Choice|0|||
19430558|NCT01463098|41677965|FG011|Part B (11 Days)|Participant Choice|1|||
19430559|NCT01463098|41677966|FG012|Part B (11 Days)|Participant Choice|0|||
19430560|NCT01463098|41677967|FG013|Part B (11 Days)|Participant Choice|0|||
19430561|NCT01626079|41678019|FG000|Overall Study|Death|117|||
19430562|NCT01626079|41678020|FG001|Overall Study|Death|153|||
19430563|NCT01626079|41678021|FG002|Overall Study|Death|39|||
19430564|NCT01626079|41678019|FG000|Overall Study|Withdrawal by Subject|15|||
19430565|NCT01626079|41678020|FG001|Overall Study|Withdrawal by Subject|39|||
19430566|NCT01626079|41678021|FG002|Overall Study|Withdrawal by Subject|5|||
19430567|NCT01626079|41678019|FG000|Overall Study|Lost to Follow-up|5|||
19430568|NCT01626079|41678020|FG001|Overall Study|Lost to Follow-up|4|||
19430569|NCT01626079|41678021|FG002|Overall Study|Lost to Follow-up|2|||
19430570|NCT01626079|41678019|FG000|Overall Study|Missed Visits|13|||
19430571|NCT01626079|41678020|FG001|Overall Study|Missed Visits|5|||
19430572|NCT01626079|41678021|FG002|Overall Study|Missed Visits|6|||
19430573|NCT01462942|41678037|FG000|Overall Study|Adverse Event|7|||
19430574|NCT01462942|41678038|FG001|Overall Study|Adverse Event|12|||
19430575|NCT01462942|41678039|FG002|Overall Study|Adverse Event|10|||
19430576|NCT01462942|41678040|FG003|Overall Study|Adverse Event|11|||
19430577|NCT01462942|41678041|FG004|Overall Study|Adverse Event|11|||
19430578|NCT01462942|41678037|FG000|Overall Study|Other, including COPD exacerbation|3|||
19430579|NCT01462942|41678038|FG001|Overall Study|Other, including COPD exacerbation|5|||
19430580|NCT01462942|41678039|FG002|Overall Study|Other, including COPD exacerbation|2|||
19430581|NCT01462942|41678040|FG003|Overall Study|Other, including COPD exacerbation|8|||
19430582|NCT01462942|41678041|FG004|Overall Study|Other, including COPD exacerbation|5|||
19430583|NCT01462942|41678037|FG000|Overall Study|Withdrawal by Subject|14|||
19430584|NCT01462942|41678038|FG001|Overall Study|Withdrawal by Subject|10|||
19430585|NCT01462942|41678039|FG002|Overall Study|Withdrawal by Subject|14|||
19430586|NCT01462942|41678040|FG003|Overall Study|Withdrawal by Subject|16|||
19430587|NCT01462942|41678041|FG004|Overall Study|Withdrawal by Subject|19|||
19430588|NCT01462942|41678037|FG000|Overall Study|Lack of Efficacy|6|||
19430589|NCT01462942|41678038|FG001|Overall Study|Lack of Efficacy|0|||
19430590|NCT01462942|41678039|FG002|Overall Study|Lack of Efficacy|4|||
19430591|NCT01462942|41678040|FG003|Overall Study|Lack of Efficacy|5|||
19430592|NCT01462942|41678041|FG004|Overall Study|Lack of Efficacy|3|||
19430593|NCT01462942|41678037|FG000|Overall Study|Lost to Follow-up|0|||
19430594|NCT01462942|41678038|FG001|Overall Study|Lost to Follow-up|1|||
19430595|NCT01462942|41678039|FG002|Overall Study|Lost to Follow-up|1|||
19430596|NCT01462942|41678040|FG003|Overall Study|Lost to Follow-up|1|||
19430597|NCT01462942|41678041|FG004|Overall Study|Lost to Follow-up|1|||
19430598|NCT01462942|41678037|FG000|Overall Study|Protocol Violation|4|||
19430599|NCT01462942|41678038|FG001|Overall Study|Protocol Violation|6|||
19430600|NCT01462942|41678039|FG002|Overall Study|Protocol Violation|9|||
19430601|NCT01462942|41678040|FG003|Overall Study|Protocol Violation|9|||
19430602|NCT01462942|41678041|FG004|Overall Study|Protocol Violation|6|||
19430603|NCT01462630|41678053|FG000|Overall Study|Did not initiate therapy|3|||
19430604|NCT01462630|41678053|FG000|Overall Study|Death|1|||
19430605|NCT01462630|41678053|FG000|Overall Study|Protocol Violation|2|||
19430606|NCT01462630|41678053|FG000|Overall Study|Adverse Event|1|||
19430607|NCT01504204|41678059|FG000|Overall Study|Lost to Follow-up|1|||
19430608|NCT01504204|41678060|FG001|Overall Study|Lost to Follow-up|1|||
19430609|NCT01485640|41678066|FG000|Overall Study|Adverse Event|10|||
19430610|NCT01485640|41678066|FG000|Overall Study|Lack of Efficacy|2|||
19430611|NCT01485640|41678066|FG000|Overall Study|Protocol Violation|1|||
19430612|NCT01485640|41678066|FG000|Overall Study|Withdrawal by Subject|14|||
19430613|NCT01485640|41678066|FG000|Overall Study|Terminated by Sponsor|95|||
19430614|NCT02118961|41678072|FG000|Overall Study|Withdrawal by Subject|1|||
19430615|NCT02118961|41678073|FG001|Overall Study|Withdrawal by Subject|0|||
19430616|NCT02140645|41678085|FG000|Overall Study|Not linked|5489|||
19430617|NCT02140645|41678086|FG001|Overall Study|Not linked|61654|||
19430618|NCT02140645|41678087|FG002|Overall Study|Not linked|4236|||
19430619|NCT02140645|41678088|FG003|Overall Study|Not linked|13833|||
19430620|NCT02140645|41678089|FG004|Overall Study|Not linked|3286|||
19430621|NCT02140645|41678090|FG005|Overall Study|Not linked|70896|||
19430622|NCT02140567|41678099|FG000|Overall Study|Problems with recording equipment|6|||
19430623|NCT02140411|41678104|FG000|Overall Study|Adverse Event|1|||
19430624|NCT02139943|41678111|FG000|Overall Study|Adverse Event|0|||
19430625|NCT02139943|41678112|FG001|Overall Study|Adverse Event|1|||
19430626|NCT02139943|41678113|FG002|Overall Study|Adverse Event|2|||
19430627|NCT02139943|41678111|FG000|Overall Study|Lost to Follow-up|3|||
19430628|NCT02139943|41678112|FG001|Overall Study|Lost to Follow-up|2|||
19430629|NCT02139943|41678113|FG002|Overall Study|Lost to Follow-up|2|||
19430630|NCT02139943|41678111|FG000|Overall Study|Withdrawal by Subject|4|||
19430631|NCT02139943|41678112|FG001|Overall Study|Withdrawal by Subject|3|||
19430632|NCT02139943|41678113|FG002|Overall Study|Withdrawal by Subject|0|||
19430633|NCT02139943|41678111|FG000|Overall Study|Other|0|||
19430634|NCT02139943|41678112|FG001|Overall Study|Other|0|||
19430635|NCT02139943|41678113|FG002|Overall Study|Other|1|||
19430636|NCT02139943|41678111|FG000|Overall Study|Participant wishes to discontinue|2|||
19430637|NCT02139943|41678112|FG001|Overall Study|Participant wishes to discontinue|0|||
19430638|NCT02139943|41678113|FG002|Overall Study|Participant wishes to discontinue|0|||
19430639|NCT02139943|41678111|FG000|Overall Study|Participant in Poor Compliance|1|||
19430640|NCT02139943|41678112|FG001|Overall Study|Participant in Poor Compliance|0|||
19430641|NCT02139943|41678113|FG002|Overall Study|Participant in Poor Compliance|1|||
19430642|NCT02139943|41678111|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
19430643|NCT02139943|41678112|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
19430644|NCT02139943|41678113|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
19430645|NCT01485172|41678127|FG000|Overall Study|Adverse Event|2|||
19430646|NCT01485172|41678128|FG001|Overall Study|Adverse Event|1|||
19430647|NCT01485172|41678129|FG002|Overall Study|Adverse Event|2|||
19430648|NCT01485172|41678130|FG003|Overall Study|Adverse Event|2|||
19430649|NCT01485172|41678131|FG004|Overall Study|Adverse Event|1|||
19430650|NCT01485172|41678132|FG005|Overall Study|Adverse Event|2|||
19430651|NCT01485172|41678127|FG000|Overall Study|Lack of Efficacy|2|||
19430652|NCT01485172|41678128|FG001|Overall Study|Lack of Efficacy|0|||
19521682|NCT00639678|41934993|FG002|Overall Study|Adverse Event|0|||
19521683|NCT00639678|41934994|FG003|Overall Study|Adverse Event|0|||
19521684|NCT00639678|41934991|FG000|Overall Study|Lack of Compliance|0|||
19521685|NCT00639678|41934992|FG001|Overall Study|Lack of Compliance|0|||
19521686|NCT00639678|41934993|FG002|Overall Study|Lack of Compliance|1|||
19521687|NCT00639678|41934994|FG003|Overall Study|Lack of Compliance|0|||
19521688|NCT00638508|41935019|FG000|Overall Study|Physician Decision|5|||
19521689|NCT00638508|41935020|FG001|Overall Study|Physician Decision|2|||
19521690|NCT00637806|41935033|FG000|Double-blind Phase|Study Discontinued|2|||
19521691|NCT00637806|41935034|FG001|Double-blind Phase|Study Discontinued|0|||
19628307|NCT00796614|42077722|FG003|Overall Study|Withdrawal by Subject|1|||
19628308|NCT00796614|42077719|FG000|Overall Study|Other than stated|1|||
19628309|NCT00796614|42077720|FG001|Overall Study|Other than stated|0|||
19628310|NCT00796614|42077721|FG002|Overall Study|Other than stated|0|||
19628311|NCT00796614|42077722|FG003|Overall Study|Other than stated|0|||
19628312|NCT00448747|42077734|FG000|Overall Study|collapsed veins|1|||
19628313|NCT00448747|42077735|FG001|Overall Study|collapsed veins|0|||
19628314|NCT00830180|42077751|FG000|Overall Study|Adverse Event|6|||
19628315|NCT00830180|42077751|FG000|Overall Study|Death|11|||
19628316|NCT00830180|42077751|FG000|Overall Study|Insufficient clinical response|1|||
19628317|NCT00830180|42077751|FG000|Overall Study|Withdrawal by Subject|5|||
19628318|NCT00830180|42077751|FG000|Overall Study|Progressive disease|2|||
19430653|NCT01485172|41678129|FG002|Overall Study|Lack of Efficacy|0|||
19430654|NCT01485172|41678130|FG003|Overall Study|Lack of Efficacy|0|||
19430655|NCT01485172|41678131|FG004|Overall Study|Lack of Efficacy|0|||
19521692|NCT00637806|41935035|FG002|Double-blind Phase|Study Discontinued|1|||
19521693|NCT00637806|41935036|FG003|Double-blind Phase|Study Discontinued|0|||
19628319|NCT00830180|42077751|FG000|Overall Study|Other - Unspecified|1|||
19628320|NCT00863681|42077760|FG000|Overall Study|Other|2|||
19430656|NCT01485172|41678132|FG005|Overall Study|Lack of Efficacy|0|||
19430657|NCT01485172|41678127|FG000|Overall Study|Protocol Violation|0|||
19430658|NCT01485172|41678128|FG001|Overall Study|Protocol Violation|0|||
19430659|NCT01485172|41678129|FG002|Overall Study|Protocol Violation|4|||
19430660|NCT01485172|41678130|FG003|Overall Study|Protocol Violation|5|||
19430661|NCT01485172|41678131|FG004|Overall Study|Protocol Violation|1|||
19628321|NCT00863681|42077761|FG001|Overall Study|Other|0|||
19628322|NCT00863681|42077762|FG002|Overall Study|Other|0|||
19430662|NCT01485172|41678132|FG005|Overall Study|Protocol Violation|0|||
19430663|NCT01485172|41678127|FG000|Overall Study|Protocol defined stopping criteria|1|||
19430664|NCT01485172|41678128|FG001|Overall Study|Protocol defined stopping criteria|0|||
19430665|NCT01485172|41678129|FG002|Overall Study|Protocol defined stopping criteria|0|||
19430666|NCT01485172|41678130|FG003|Overall Study|Protocol defined stopping criteria|0|||
19430667|NCT01485172|41678131|FG004|Overall Study|Protocol defined stopping criteria|1|||
19430668|NCT01485172|41678132|FG005|Overall Study|Protocol defined stopping criteria|0|||
19430669|NCT01485172|41678127|FG000|Overall Study|Lost to Follow-up|0|||
19430670|NCT01485172|41678128|FG001|Overall Study|Lost to Follow-up|0|||
19430671|NCT01485172|41678129|FG002|Overall Study|Lost to Follow-up|1|||
19430672|NCT01485172|41678130|FG003|Overall Study|Lost to Follow-up|0|||
19430673|NCT01485172|41678131|FG004|Overall Study|Lost to Follow-up|0|||
19430674|NCT01485172|41678132|FG005|Overall Study|Lost to Follow-up|1|||
19430675|NCT01485172|41678127|FG000|Overall Study|Physician Decision|0|||
19430676|NCT01485172|41678128|FG001|Overall Study|Physician Decision|0|||
19430677|NCT01485172|41678129|FG002|Overall Study|Physician Decision|0|||
19430678|NCT01485172|41678130|FG003|Overall Study|Physician Decision|0|||
19430679|NCT01485172|41678131|FG004|Overall Study|Physician Decision|1|||
19430680|NCT01485172|41678132|FG005|Overall Study|Physician Decision|0|||
19430681|NCT01485172|41678127|FG000|Overall Study|Withdrawal by Subject|2|||
19430682|NCT01485172|41678128|FG001|Overall Study|Withdrawal by Subject|0|||
19430683|NCT01485172|41678129|FG002|Overall Study|Withdrawal by Subject|0|||
19430684|NCT01485172|41678130|FG003|Overall Study|Withdrawal by Subject|1|||
19430685|NCT01485172|41678131|FG004|Overall Study|Withdrawal by Subject|1|||
19430686|NCT01485172|41678132|FG005|Overall Study|Withdrawal by Subject|1|||
19430687|NCT02105701|41678150|FG000|Overall Study|Lost to Follow-up|1|||
19430688|NCT02105701|41678151|FG001|Overall Study|Lost to Follow-up|0|||
19430689|NCT02105701|41678152|FG002|Overall Study|Lost to Follow-up|2|||
19430690|NCT02105701|41678153|FG003|Overall Study|Lost to Follow-up|1|||
19430691|NCT02105701|41678150|FG000|Overall Study|Protocol Violation|0|||
19430692|NCT02105701|41678151|FG001|Overall Study|Protocol Violation|0|||
19430693|NCT02105701|41678152|FG002|Overall Study|Protocol Violation|1|||
19430694|NCT02105701|41678153|FG003|Overall Study|Protocol Violation|0|||
19430695|NCT02105701|41678150|FG000|Overall Study|Withdrawal by Subject|2|||
19430696|NCT02105701|41678151|FG001|Overall Study|Withdrawal by Subject|1|||
19430697|NCT02105701|41678152|FG002|Overall Study|Withdrawal by Subject|0|||
19430698|NCT02105701|41678153|FG003|Overall Study|Withdrawal by Subject|1|||
19430699|NCT02105701|41678150|FG000|Overall Study|Death|1|||
19430700|NCT02105701|41678151|FG001|Overall Study|Death|0|||
19430701|NCT02105701|41678152|FG002|Overall Study|Death|0|||
19430702|NCT02105701|41678153|FG003|Overall Study|Death|0|||
19430703|NCT01502956|41678165|FG000|Overall Study|Death|0|||
19430704|NCT01502956|41678166|FG001|Overall Study|Death|2|||
19430705|NCT01502956|41678165|FG000|Overall Study|Lost to Follow-up|14|||
19430706|NCT01502956|41678166|FG001|Overall Study|Lost to Follow-up|11|||
19430707|NCT01502956|41678165|FG000|Overall Study|Physician Decision|2|||
19430708|NCT01502956|41678166|FG001|Overall Study|Physician Decision|3|||
19430709|NCT01502956|41678165|FG000|Overall Study|Withdrawal by Subject|8|||
19430710|NCT01502956|41678166|FG001|Overall Study|Withdrawal by Subject|10|||
19430711|NCT01502644|41678175|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
19430712|NCT01502644|41678176|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
19430713|NCT01502644|41678177|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
19430714|NCT01502644|41678178|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
19430715|NCT01502644|41678175|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
19430716|NCT01502644|41678176|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
19430717|NCT01502644|41678177|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
19430718|NCT01502644|41678178|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
19430719|NCT01502644|41678175|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
19430720|NCT01502644|41678176|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
19430721|NCT01502644|41678177|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
19430722|NCT01502644|41678178|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
19430723|NCT01502644|41678175|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
19430724|NCT01502644|41678176|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
19430725|NCT01502644|41678177|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
19430726|NCT01502644|41678178|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
19430727|NCT01502644|41678175|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
19430728|NCT01502644|41678176|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
19430729|NCT01502644|41678177|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
19521694|NCT00637806|41935033|FG000|Extension Phase|Study Discontinued|0|||
19430730|NCT01502644|41678178|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
19430731|NCT01462318|41678188|FG000|Main Study / TP-DI Study|Other|2|||
19521695|NCT00637806|41935034|FG001|Extension Phase|Study Discontinued|0|||
19430732|NCT01462318|41678189|FG001|Main Study / TP-DI Study|Other|0|||
19430733|NCT01462318|41678190|FG002|Main Study / TP-DI Study|Other|0|||
19430734|NCT01462318|41678188|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
19430735|NCT01462318|41678189|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
19430736|NCT01462318|41678190|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
19430737|NCT01462318|41678188|FG000|Main Study / TP-DI Study|Adverse Event|4|||
19430738|NCT01462318|41678189|FG001|Main Study / TP-DI Study|Adverse Event|0|||
19430739|NCT01462318|41678190|FG002|Main Study / TP-DI Study|Adverse Event|0|||
19430740|NCT01462318|41678188|FG000|Extension Phase|Lost to Follow-up|0|||
19430741|NCT01462318|41678189|FG001|Extension Phase|Lost to Follow-up|0|||
19430742|NCT01462318|41678190|FG002|Extension Phase|Lost to Follow-up|1|||
19430743|NCT01462318|41678188|FG000|Extension Phase|Other|0|||
19430744|NCT01462318|41678189|FG001|Extension Phase|Other|0|||
19430745|NCT01462318|41678190|FG002|Extension Phase|Other|1|||
19430746|NCT01462318|41678188|FG000|Extension Phase|Disease Progression|0|||
19430747|NCT01462318|41678189|FG001|Extension Phase|Disease Progression|0|||
19430748|NCT01462318|41678190|FG002|Extension Phase|Disease Progression|1|||
19430749|NCT01462318|41678188|FG000|Extension Phase|Withdrawal by Subject|0|||
19430750|NCT01462318|41678189|FG001|Extension Phase|Withdrawal by Subject|0|||
19430751|NCT01462318|41678190|FG002|Extension Phase|Withdrawal by Subject|15|||
19430752|NCT01462318|41678188|FG000|Extension Phase|Investigator Decision|0|||
19430753|NCT01462318|41678189|FG001|Extension Phase|Investigator Decision|0|||
19430754|NCT01462318|41678190|FG002|Extension Phase|Investigator Decision|5|||
19430755|NCT01462318|41678188|FG000|Extension Phase|Adverse Event|0|||
19430756|NCT01462318|41678189|FG001|Extension Phase|Adverse Event|0|||
19430757|NCT01462318|41678190|FG002|Extension Phase|Adverse Event|22|||
19430758|NCT01485094|41678198|FG000|Overall Study|Adverse Event|1|||
19430759|NCT01485094|41678199|FG001|Overall Study|Adverse Event|1|||
19430760|NCT01485094|41678200|FG002|Overall Study|Adverse Event|1|||
19430761|NCT01485094|41678198|FG000|Overall Study|Lost to Follow-up|1|||
19430762|NCT01485094|41678199|FG001|Overall Study|Lost to Follow-up|0|||
19430763|NCT01485094|41678200|FG002|Overall Study|Lost to Follow-up|0|||
19430764|NCT01485094|41678198|FG000|Overall Study|Withdrawal by Subject|1|||
19430765|NCT01485094|41678199|FG001|Overall Study|Withdrawal by Subject|1|||
19430766|NCT01485094|41678200|FG002|Overall Study|Withdrawal by Subject|0|||
19430767|NCT01484938|41678208|FG000|Overall Study|Adverse Event|2|||
19430768|NCT01484938|41678208|FG000|Overall Study|Lost to Follow-up|1|||
19430769|NCT01484938|41678208|FG000|Overall Study|Noncompliance|1|||
19430770|NCT01502410|41678216|FG000|Overall Study|Adverse Event|1|||
19430771|NCT01502410|41678217|FG001|Overall Study|Adverse Event|2|||
19430772|NCT01502410|41678218|FG002|Overall Study|Adverse Event|0|||
19430773|NCT01502410|41678219|FG003|Overall Study|Adverse Event|0|||
19430774|NCT01502410|41678216|FG000|Overall Study|Lack of Efficacy|7|||
19430775|NCT01502410|41678217|FG001|Overall Study|Lack of Efficacy|7|||
19430776|NCT01502410|41678218|FG002|Overall Study|Lack of Efficacy|0|||
19430777|NCT01502410|41678219|FG003|Overall Study|Lack of Efficacy|0|||
19430778|NCT01502410|41678216|FG000|Overall Study|Physician Decision|0|||
19430779|NCT01502410|41678217|FG001|Overall Study|Physician Decision|1|||
19430780|NCT01502410|41678218|FG002|Overall Study|Physician Decision|0|||
19430781|NCT01502410|41678219|FG003|Overall Study|Physician Decision|0|||
19430782|NCT01502410|41678216|FG000|Overall Study|Withdrawal by Subject|2|||
19430783|NCT01502410|41678217|FG001|Overall Study|Withdrawal by Subject|0|||
19430784|NCT01502410|41678218|FG002|Overall Study|Withdrawal by Subject|0|||
19430785|NCT01502410|41678219|FG003|Overall Study|Withdrawal by Subject|0|||
19430786|NCT01462162|41678228|FG000|Overall Study|Adverse Event|5|||
19430787|NCT01462162|41678228|FG000|Overall Study|Lack of Efficacy|4|||
19430788|NCT01462162|41678228|FG000|Overall Study|Abnormal laboratory parameters|1|||
19430789|NCT01462162|41678228|FG000|Overall Study|Other|2|||
19430790|NCT01483924|41678238|FG000|Overall Study|Withdrawal by Subject|2|||
19430791|NCT01483924|41678239|FG001|Overall Study|Withdrawal by Subject|0|||
19430792|NCT01483924|41678240|FG002|Overall Study|Withdrawal by Subject|0|||
19430793|NCT01483924|41678241|FG003|Overall Study|Withdrawal by Subject|1|||
19430794|NCT01483924|41678242|FG004|Overall Study|Withdrawal by Subject|1|||
19430795|NCT01483924|41678238|FG000|Overall Study|Adverse Event|0|||
19430796|NCT01483924|41678239|FG001|Overall Study|Adverse Event|0|||
19430797|NCT01483924|41678240|FG002|Overall Study|Adverse Event|1|||
19430798|NCT01483924|41678241|FG003|Overall Study|Adverse Event|1|||
19430799|NCT01483924|41678242|FG004|Overall Study|Adverse Event|0|||
19430800|NCT01483924|41678238|FG000|Overall Study|Non-compliance|0|||
19430801|NCT01483924|41678239|FG001|Overall Study|Non-compliance|0|||
19430802|NCT01483924|41678240|FG002|Overall Study|Non-compliance|0|||
19430803|NCT01483924|41678241|FG003|Overall Study|Non-compliance|1|||
19430804|NCT01483924|41678242|FG004|Overall Study|Non-compliance|1|||
19430805|NCT01483924|41678238|FG000|Overall Study|Sponsor concern over ECG result|0|||
19430806|NCT01483924|41678239|FG001|Overall Study|Sponsor concern over ECG result|0|||
19430807|NCT01483924|41678240|FG002|Overall Study|Sponsor concern over ECG result|0|||
19430808|NCT01483924|41678241|FG003|Overall Study|Sponsor concern over ECG result|1|||
19430809|NCT01483924|41678242|FG004|Overall Study|Sponsor concern over ECG result|0|||
19430810|NCT01462084|41678263|FG000|Overall Study|Withdrawal by Subject|1|||
19430811|NCT01462084|41678264|FG001|Overall Study|Withdrawal by Subject|0|||
19430812|NCT01462084|41678263|FG000|Overall Study|Protocol Violation|1|||
19430813|NCT01462084|41678264|FG001|Overall Study|Protocol Violation|1|||
19430814|NCT02134028|41678279|FG000|Overall Study|Lack of Efficacy|1|||
19430815|NCT02134028|41678280|FG001|Overall Study|Lack of Efficacy|0|||
19430816|NCT02134028|41678281|FG002|Overall Study|Lack of Efficacy|3|||
19430817|NCT02134028|41678282|FG003|Overall Study|Lack of Efficacy|2|||
19430818|NCT02134028|41678283|FG004|Overall Study|Lack of Efficacy|1|||
19430819|NCT02134028|41678284|FG005|Overall Study|Lack of Efficacy|2|||
19430820|NCT02134028|41678285|FG006|Overall Study|Lack of Efficacy|1|||
19430821|NCT02134028|41678286|FG007|Overall Study|Lack of Efficacy|0|||
19430822|NCT02134028|41678279|FG000|Overall Study|Poor compliance to protocol|1|||
19430823|NCT02134028|41678280|FG001|Overall Study|Poor compliance to protocol|1|||
19430824|NCT02134028|41678281|FG002|Overall Study|Poor compliance to protocol|3|||
19430825|NCT02134028|41678282|FG003|Overall Study|Poor compliance to protocol|7|||
19430826|NCT02134028|41678283|FG004|Overall Study|Poor compliance to protocol|1|||
19430827|NCT02134028|41678284|FG005|Overall Study|Poor compliance to protocol|1|||
19430828|NCT02134028|41678285|FG006|Overall Study|Poor compliance to protocol|0|||
19430829|NCT02134028|41678286|FG007|Overall Study|Poor compliance to protocol|0|||
19430830|NCT02134028|41678279|FG000|Overall Study|Other unspecified|4|||
19430831|NCT02134028|41678280|FG001|Overall Study|Other unspecified|22|||
19430832|NCT02134028|41678281|FG002|Overall Study|Other unspecified|33|||
19430833|NCT02134028|41678282|FG003|Overall Study|Other unspecified|64|||
19430834|NCT02134028|41678283|FG004|Overall Study|Other unspecified|8|||
19430835|NCT02134028|41678284|FG005|Overall Study|Other unspecified|6|||
19430836|NCT02134028|41678285|FG006|Overall Study|Other unspecified|2|||
19430837|NCT02134028|41678286|FG007|Overall Study|Other unspecified|1|||
19430838|NCT02134028|41678279|FG000|Overall Study|Adverse Event|3|||
19430839|NCT02134028|41678280|FG001|Overall Study|Adverse Event|19|||
19430840|NCT02134028|41678281|FG002|Overall Study|Adverse Event|13|||
19430841|NCT02134028|41678282|FG003|Overall Study|Adverse Event|32|||
19430842|NCT02134028|41678283|FG004|Overall Study|Adverse Event|4|||
19430843|NCT02134028|41678284|FG005|Overall Study|Adverse Event|5|||
19430844|NCT02134028|41678285|FG006|Overall Study|Adverse Event|1|||
19430845|NCT02134028|41678286|FG007|Overall Study|Adverse Event|2|||
19430846|NCT02172950|41678308|FG000|Overall Study|Physician Decision|3|||
19430847|NCT02172950|41678309|FG001|Overall Study|Physician Decision|3|||
19430848|NCT02172950|41678308|FG000|Overall Study|Lack of Efficacy|1|||
19430849|NCT02172950|41678309|FG001|Overall Study|Lack of Efficacy|0|||
19430850|NCT02172950|41678308|FG000|Overall Study|Adverse Event|4|||
19430851|NCT02172950|41678309|FG001|Overall Study|Adverse Event|1|||
19430852|NCT02172950|41678308|FG000|Overall Study|Withdrawal by Subject|10|||
19430853|NCT02172950|41678309|FG001|Overall Study|Withdrawal by Subject|0|||
19430854|NCT02172950|41678308|FG000|Overall Study|Protocol Violation|1|||
19430855|NCT02172950|41678309|FG001|Overall Study|Protocol Violation|0|||
19430856|NCT02172950|41678308|FG000|Overall Study|Lost to Follow-up|1|||
19430857|NCT02172950|41678309|FG001|Overall Study|Lost to Follow-up|0|||
19430858|NCT02172950|41678308|FG000|Overall Study|Death|1|||
19430859|NCT02172950|41678309|FG001|Overall Study|Death|0|||
19430860|NCT02172950|41678308|FG000|Overall Study|Patient traveling|1|||
19430861|NCT02172950|41678309|FG001|Overall Study|Patient traveling|0|||
19430862|NCT02172950|41678308|FG000|Overall Study|Patient went to other country|1|||
19430863|NCT02172950|41678309|FG001|Overall Study|Patient went to other country|0|||
19430864|NCT02172950|41678308|FG000|Overall Study|Patient relocated overseas|1|||
19430865|NCT02172950|41678309|FG001|Overall Study|Patient relocated overseas|1|||
19430866|NCT02172950|41678308|FG000|Overall Study|Patient moving|1|||
19430867|NCT02172950|41678309|FG001|Overall Study|Patient moving|0|||
19430868|NCT02151266|41678319|FG000|Overall Study|Lost to Follow-up|1|||
19430869|NCT02151266|41678320|FG001|Overall Study|Lost to Follow-up|4|||
19430870|NCT02151266|41678321|FG002|Overall Study|Lost to Follow-up|1|||
19430871|NCT02151266|41678319|FG000|Overall Study|Did NOT receive intervention|3|||
19430872|NCT02151266|41678320|FG001|Overall Study|Did NOT receive intervention|6|||
19430873|NCT02151266|41678321|FG002|Overall Study|Did NOT receive intervention|2|||
19430874|NCT02151266|41678319|FG000|Overall Study|Not able to exercise|4|||
19430875|NCT02151266|41678320|FG001|Overall Study|Not able to exercise|5|||
19430876|NCT02151266|41678321|FG002|Overall Study|Not able to exercise|4|||
19430877|NCT02151110|41678337|FG000|Overall Study|Withdrawal by Subject|0|||
19430878|NCT02151110|41678338|FG001|Overall Study|Withdrawal by Subject|0|||
19430879|NCT02151110|41678339|FG002|Overall Study|Withdrawal by Subject|0|||
19430880|NCT02151110|41678340|FG003|Overall Study|Withdrawal by Subject|0|||
19430881|NCT02151110|41678341|FG004|Overall Study|Withdrawal by Subject|0|||
19430882|NCT02151110|41678342|FG005|Overall Study|Withdrawal by Subject|0|||
19430883|NCT02151110|41678343|FG006|Overall Study|Withdrawal by Subject|0|||
19430884|NCT02151110|41678344|FG007|Overall Study|Withdrawal by Subject|1|||
19430885|NCT02151110|41678337|FG000|Overall Study|Lost to Follow-up|0|||
19430886|NCT02151110|41678338|FG001|Overall Study|Lost to Follow-up|0|||
19430887|NCT02151110|41678339|FG002|Overall Study|Lost to Follow-up|0|||
19430888|NCT02151110|41678340|FG003|Overall Study|Lost to Follow-up|0|||
19430889|NCT02151110|41678341|FG004|Overall Study|Lost to Follow-up|0|||
19430890|NCT02151110|41678342|FG005|Overall Study|Lost to Follow-up|0|||
19430891|NCT02151110|41678343|FG006|Overall Study|Lost to Follow-up|0|||
19430892|NCT02151110|41678344|FG007|Overall Study|Lost to Follow-up|2|||
19430893|NCT02132312|41678371|FG000|Overall Study|Adverse Event|2|||
19430894|NCT02132312|41678372|FG001|Overall Study|Adverse Event|0|||
19430895|NCT02132312|41678371|FG000|Overall Study|Physician Decision|1|||
19430896|NCT02132312|41678372|FG001|Overall Study|Physician Decision|1|||
19430897|NCT02132312|41678371|FG000|Overall Study|Protocol Violation|0|||
19430898|NCT02132312|41678372|FG001|Overall Study|Protocol Violation|1|||
19430899|NCT02132312|41678371|FG000|Overall Study|Withdrawal by Subject|1|||
19430900|NCT02132312|41678372|FG001|Overall Study|Withdrawal by Subject|0|||
19430901|NCT02132312|41678371|FG000|Overall Study|Lost to Follow-up|2|||
19430902|NCT02132312|41678372|FG001|Overall Study|Lost to Follow-up|1|||
19430903|NCT02131766|41678378|FG000|Overall Study|Withdrawal by Subject|4|||
19430904|NCT02150954|41678387|FG000|Overall Study|Protocol Violation|1|||
19430905|NCT02150954|41678388|FG001|Overall Study|Protocol Violation|0|||
19430906|NCT02131532|41678394|FG000|Overall Study|Withdrawal by Subject|1|||
19430907|NCT02131532|41678394|FG000|Overall Study|Physician Decision|1|||
19430908|NCT02131532|41678394|FG000|Overall Study|Other health conditions|2|||
19430909|NCT02170688|41678408|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
19430910|NCT02170688|41678409|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
19430911|NCT02170688|41678410|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
19430912|NCT02170688|41678411|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
19430913|NCT02170688|41678412|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
19430914|NCT02170688|41678408|FG000|Overall Study|Full dose not received|0|||
19430915|NCT02170688|41678409|FG001|Overall Study|Full dose not received|1|||
19430916|NCT02170688|41678410|FG002|Overall Study|Full dose not received|0|||
19430917|NCT02170688|41678411|FG003|Overall Study|Full dose not received|0|||
19430918|NCT02170688|41678412|FG004|Overall Study|Full dose not received|0|||
19430919|NCT02170688|41678408|FG000|Overall Study|Physician Decision|0|||
19430920|NCT02170688|41678409|FG001|Overall Study|Physician Decision|0|||
19430921|NCT02170688|41678410|FG002|Overall Study|Physician Decision|1|||
19430922|NCT02170688|41678411|FG003|Overall Study|Physician Decision|0|||
19430923|NCT02170688|41678412|FG004|Overall Study|Physician Decision|0|||
19430924|NCT02170298|41678426|FG000|Overall Study|Withdrawal by Subject|0|||
19430925|NCT02170298|41678427|FG001|Overall Study|Withdrawal by Subject|1|||
19430926|NCT02170298|41678426|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
19430927|NCT02170298|41678427|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
19430928|NCT02131064|41678435|FG000|Overall Study|Death|5|||
19430929|NCT02131064|41678436|FG001|Overall Study|Death|6|||
19430930|NCT02131064|41678435|FG000|Overall Study|Lost to Follow-up|4|||
19430931|NCT02131064|41678436|FG001|Overall Study|Lost to Follow-up|8|||
19430932|NCT02131064|41678435|FG000|Overall Study|Withdrawal by Subject|14|||
19430933|NCT02131064|41678436|FG001|Overall Study|Withdrawal by Subject|18|||
19430934|NCT02131064|41678435|FG000|Overall Study|Other|2|||
19430935|NCT02131064|41678436|FG001|Overall Study|Other|2|||
19430936|NCT02130986|41678445|FG000|Overall Study|Withdrawal by Subject|4|||
19430937|NCT02130986|41678446|FG001|Overall Study|Withdrawal by Subject|4|||
19430938|NCT02130986|41678445|FG000|Overall Study|Lost to Follow-up|151|||
19430939|NCT02130986|41678446|FG001|Overall Study|Lost to Follow-up|160|||
19430940|NCT02130284|41678454|FG000|Overall Study|Withdrawal by Subject|3|||
19430941|NCT02130284|41678454|FG000|Overall Study|Subject Withdrew Consent|1|||
19430942|NCT02130284|41678454|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
19430943|NCT02130284|41678454|FG000|Overall Study|Subject was screened as backup for study|3|||
19430944|NCT02130284|41678454|FG000|Overall Study|Screen Failure|1|||
19430945|NCT02147288|41678460|FG000|Overall Study|post-operative hematoma|1|||
19430946|NCT02147288|41678461|FG001|Overall Study|post-operative hematoma|1|||
19430947|NCT02147288|41678462|FG002|Overall Study|post-operative hematoma|0|||
19430948|NCT02147288|41678463|FG003|Overall Study|post-operative hematoma|0|||
19430949|NCT02147288|41678464|FG004|Overall Study|post-operative hematoma|0|||
19430950|NCT02147288|41678465|FG005|Overall Study|post-operative hematoma|0|||
19430951|NCT02147288|41678466|FG006|Overall Study|post-operative hematoma|0|||
19430952|NCT02147288|41678467|FG007|Overall Study|post-operative hematoma|0|||
19430953|NCT02147288|41678468|FG008|Overall Study|post-operative hematoma|0|||
19430954|NCT02147288|41678469|FG009|Overall Study|post-operative hematoma|0|||
19430955|NCT02147288|41678460|FG000|Overall Study|complications from concurrent hernia rep|0|||
19430956|NCT02147288|41678461|FG001|Overall Study|complications from concurrent hernia rep|1|||
19430957|NCT02147288|41678462|FG002|Overall Study|complications from concurrent hernia rep|0|||
19430958|NCT02147288|41678463|FG003|Overall Study|complications from concurrent hernia rep|0|||
19430959|NCT02147288|41678464|FG004|Overall Study|complications from concurrent hernia rep|0|||
19430960|NCT02147288|41678465|FG005|Overall Study|complications from concurrent hernia rep|0|||
19430961|NCT02147288|41678466|FG006|Overall Study|complications from concurrent hernia rep|0|||
19430962|NCT02147288|41678467|FG007|Overall Study|complications from concurrent hernia rep|0|||
19628323|NCT00863681|42077760|FG000|Overall Study|Missing|1|||
19430963|NCT02147288|41678468|FG008|Overall Study|complications from concurrent hernia rep|0|||
19430964|NCT02147288|41678469|FG009|Overall Study|complications from concurrent hernia rep|0|||
19430965|NCT02147132|41678475|FG000|Overall Study|Lost to Follow-up|1|||
19430966|NCT02147132|41678476|FG001|Overall Study|Lost to Follow-up|0|||
19430967|NCT02147132|41678477|FG002|Overall Study|Lost to Follow-up|0|||
19430968|NCT02147132|41678478|FG003|Overall Study|Lost to Follow-up|0|||
19430969|NCT02146430|41678492|FG000|Overall Study|Protocol Violation|5|||
19430970|NCT02146430|41678493|FG001|Overall Study|Protocol Violation|4|||
19430971|NCT02146430|41678494|FG002|Overall Study|Protocol Violation|8|||
19430972|NCT02146430|41678495|FG003|Overall Study|Protocol Violation|6|||
19430973|NCT02146430|41678492|FG000|Overall Study|Lack of Efficacy|13|||
19430974|NCT02146430|41678493|FG001|Overall Study|Lack of Efficacy|11|||
19430975|NCT02146430|41678494|FG002|Overall Study|Lack of Efficacy|8|||
19430976|NCT02146430|41678495|FG003|Overall Study|Lack of Efficacy|5|||
19430977|NCT02146430|41678492|FG000|Overall Study|Adverse Event|20|||
19430978|NCT02146430|41678493|FG001|Overall Study|Adverse Event|40|||
19430979|NCT02146430|41678494|FG002|Overall Study|Adverse Event|32|||
19430980|NCT02146430|41678495|FG003|Overall Study|Adverse Event|49|||
19430981|NCT02146430|41678492|FG000|Overall Study|Reason missing or not reported|2|||
19430982|NCT02146430|41678493|FG001|Overall Study|Reason missing or not reported|3|||
19430983|NCT02146430|41678494|FG002|Overall Study|Reason missing or not reported|4|||
19430984|NCT02146430|41678495|FG003|Overall Study|Reason missing or not reported|5|||
19430985|NCT02146430|41678492|FG000|Overall Study|Withdrawal by Subject|27|||
19430986|NCT02146430|41678493|FG001|Overall Study|Withdrawal by Subject|29|||
19430987|NCT02146430|41678494|FG002|Overall Study|Withdrawal by Subject|30|||
19430988|NCT02146430|41678495|FG003|Overall Study|Withdrawal by Subject|34|||
19430989|NCT02129192|41678511|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
19430990|NCT02129192|41678512|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
19430991|NCT02105948|41678525|FG000|Overall Study|Adverse Event|10|||
19430992|NCT02105948|41678526|FG001|Overall Study|Adverse Event|7|||
19430993|NCT02105948|41678527|FG002|Overall Study|Adverse Event|11|||
19430994|NCT02105948|41678528|FG003|Overall Study|Adverse Event|11|||
19430995|NCT02105948|41678525|FG000|Overall Study|Lack of Efficacy|0|||
19430996|NCT02105948|41678526|FG001|Overall Study|Lack of Efficacy|1|||
19430997|NCT02105948|41678527|FG002|Overall Study|Lack of Efficacy|3|||
19430998|NCT02105948|41678528|FG003|Overall Study|Lack of Efficacy|2|||
19430999|NCT02105948|41678525|FG000|Overall Study|Lost to Follow-up|0|||
19431000|NCT02105948|41678526|FG001|Overall Study|Lost to Follow-up|0|||
19431001|NCT02105948|41678527|FG002|Overall Study|Lost to Follow-up|2|||
19431002|NCT02105948|41678528|FG003|Overall Study|Lost to Follow-up|1|||
19431003|NCT02105948|41678525|FG000|Overall Study|Physician Decision|2|||
19431004|NCT02105948|41678526|FG001|Overall Study|Physician Decision|2|||
19431005|NCT02105948|41678527|FG002|Overall Study|Physician Decision|2|||
19431006|NCT02105948|41678528|FG003|Overall Study|Physician Decision|2|||
19431007|NCT02105948|41678525|FG000|Overall Study|Withdrawal by Subject|15|||
19431008|NCT02105948|41678526|FG001|Overall Study|Withdrawal by Subject|10|||
19431009|NCT02105948|41678527|FG002|Overall Study|Withdrawal by Subject|10|||
19431010|NCT02105948|41678528|FG003|Overall Study|Withdrawal by Subject|11|||
19431011|NCT02128724|41678543|FG000|Overall Study|Death|1|||
19431012|NCT02128724|41678544|FG001|Overall Study|Death|0|||
19431013|NCT02128724|41678545|FG002|Overall Study|Death|0|||
19431014|NCT02128724|41678546|FG003|Overall Study|Death|0|||
19431015|NCT02128724|41678543|FG000|Overall Study|Adverse Event|0|||
19431016|NCT02128724|41678544|FG001|Overall Study|Adverse Event|1|||
19431017|NCT02128724|41678545|FG002|Overall Study|Adverse Event|0|||
19431018|NCT02128724|41678546|FG003|Overall Study|Adverse Event|0|||
19431019|NCT02128724|41678543|FG000|Overall Study|Physician Decision|0|||
19431020|NCT02128724|41678544|FG001|Overall Study|Physician Decision|0|||
19431021|NCT02128724|41678545|FG002|Overall Study|Physician Decision|0|||
19431022|NCT02128724|41678546|FG003|Overall Study|Physician Decision|2|||
19431023|NCT02128724|41678543|FG000|Overall Study|Withdrawal by Subject|0|||
19431024|NCT02128724|41678544|FG001|Overall Study|Withdrawal by Subject|0|||
19431025|NCT02128724|41678545|FG002|Overall Study|Withdrawal by Subject|0|||
19431026|NCT02128724|41678546|FG003|Overall Study|Withdrawal by Subject|1|||
19431027|NCT02128490|41678560|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
19431028|NCT02128490|41678561|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
19431029|NCT02128490|41678562|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
19431030|NCT02128490|41678563|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
19431031|NCT02128490|41678564|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
19431032|NCT02128490|41678560|FG000|Overall Study|Major Protocol Deviation|1|||
19431033|NCT02128490|41678561|FG001|Overall Study|Major Protocol Deviation|2|||
19431034|NCT02128490|41678562|FG002|Overall Study|Major Protocol Deviation|0|||
19431035|NCT02128490|41678563|FG003|Overall Study|Major Protocol Deviation|2|||
19431036|NCT02128490|41678564|FG004|Overall Study|Major Protocol Deviation|2|||
19431037|NCT02128490|41678560|FG000|Overall Study|Lost to Follow-up|0|||
19431038|NCT02128490|41678561|FG001|Overall Study|Lost to Follow-up|0|||
19431039|NCT02128490|41678562|FG002|Overall Study|Lost to Follow-up|1|||
19431040|NCT02128490|41678563|FG003|Overall Study|Lost to Follow-up|1|||
19431041|NCT02128490|41678564|FG004|Overall Study|Lost to Follow-up|1|||
19431042|NCT02128490|41678560|FG000|Overall Study|Voluntary Withdrawal|3|||
19431043|NCT02128490|41678561|FG001|Overall Study|Voluntary Withdrawal|3|||
19431044|NCT02128490|41678562|FG002|Overall Study|Voluntary Withdrawal|1|||
19431045|NCT02128490|41678563|FG003|Overall Study|Voluntary Withdrawal|1|||
19431046|NCT02128490|41678564|FG004|Overall Study|Voluntary Withdrawal|2|||
19431047|NCT02128490|41678560|FG000|Overall Study|Lack of Efficacy|0|||
19431048|NCT02128490|41678561|FG001|Overall Study|Lack of Efficacy|1|||
19431049|NCT02128490|41678562|FG002|Overall Study|Lack of Efficacy|0|||
19431050|NCT02128490|41678563|FG003|Overall Study|Lack of Efficacy|0|||
19431051|NCT02128490|41678564|FG004|Overall Study|Lack of Efficacy|0|||
19431052|NCT02128490|41678560|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
19431053|NCT02128490|41678561|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
19431054|NCT02128490|41678562|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
19431055|NCT02128490|41678563|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
19431056|NCT02128490|41678564|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
19431057|NCT02128490|41678560|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19431058|NCT02128490|41678561|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19431059|NCT02128490|41678562|FG002|Overall Study|Other Miscellaneous Reasons|2|||
19431060|NCT02128490|41678563|FG003|Overall Study|Other Miscellaneous Reasons|1|||
19431061|NCT02128490|41678564|FG004|Overall Study|Other Miscellaneous Reasons|1|||
19431062|NCT02146352|41678576|FG000|Overall Study|Death|1|||
19431063|NCT02146352|41678576|FG000|Overall Study|Patient entered hospice care|1|||
19431064|NCT02146274|41678580|FG000|Overall Study|Protocol Violation|73|||
19431065|NCT02105636|41678589|FG000|Pre-Treatment|Disease Progression|1|||
19431066|NCT02105636|41678590|FG001|Pre-Treatment|Disease Progression|0|||
19431067|NCT02105636|41678589|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
19431068|NCT02105636|41678590|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
19431069|NCT02105636|41678589|FG000|Pre-Treatment|Participant withdrew consent|0|||
19431070|NCT02105636|41678590|FG001|Pre-Treatment|Participant withdrew consent|6|||
19431071|NCT02105636|41678589|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
19431072|NCT02105636|41678590|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
19431073|NCT02105636|41678589|FG000|Treatment|Study Drug Toxicity|14|||
19431074|NCT02105636|41678590|FG001|Treatment|Study Drug Toxicity|10|||
19431075|NCT02105636|41678589|FG000|Treatment|Adverse event unrelated to study drug|19|||
19431076|NCT02105636|41678590|FG001|Treatment|Adverse event unrelated to study drug|3|||
19431077|NCT02105636|41678589|FG000|Treatment|Participant request to discontinue study treatment|8|||
19431078|NCT02105636|41678590|FG001|Treatment|Participant request to discontinue study treatment|6|||
19431079|NCT02105636|41678589|FG000|Treatment|Participant withdrew consent|5|||
19431080|NCT02105636|41678590|FG001|Treatment|Participant withdrew consent|1|||
19431081|NCT02105636|41678589|FG000|Treatment|Lost to Follow-up|1|||
19431082|NCT02105636|41678590|FG001|Treatment|Lost to Follow-up|0|||
19431083|NCT02105636|41678589|FG000|Treatment|Maximum Clinical Benefit|1|||
19431084|NCT02105636|41678590|FG001|Treatment|Maximum Clinical Benefit|3|||
19431085|NCT02105636|41678589|FG000|Treatment|Poor/Non-compliance|0|||
19431086|NCT02105636|41678590|FG001|Treatment|Poor/Non-compliance|1|||
19431087|NCT02105636|41678589|FG000|Treatment|Participant no longer meets study criteria|1|||
19431088|NCT02105636|41678590|FG001|Treatment|Participant no longer meets study criteria|0|||
19431089|NCT02105636|41678589|FG000|Treatment|Other reasons|1|||
19431090|NCT02105636|41678590|FG001|Treatment|Other reasons|0|||
19431091|NCT02105636|41678589|FG000|Treatment|Disease Progression|185|||
19431092|NCT02105636|41678590|FG001|Treatment|Disease Progression|87|||
19431093|NCT01626872|41678599|FG000|Overall Study|Physician Decision|13|||
19431094|NCT01626872|41678600|FG001|Overall Study|Physician Decision|9|||
19431095|NCT01626872|41678601|FG002|Overall Study|Physician Decision|6|||
19431096|NCT01626872|41678599|FG000|Overall Study|Withdrawal by Subject|19|||
19431097|NCT01626872|41678600|FG001|Overall Study|Withdrawal by Subject|27|||
19431098|NCT01626872|41678601|FG002|Overall Study|Withdrawal by Subject|8|||
19431099|NCT01626872|41678599|FG000|Overall Study|Adverse Event (including Death)|20|||
19431100|NCT01626872|41678600|FG001|Overall Study|Adverse Event (including Death)|28|||
19431101|NCT01626872|41678601|FG002|Overall Study|Adverse Event (including Death)|8|||
19431102|NCT01626872|41678599|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
19431103|NCT01626872|41678600|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
19431104|NCT01626872|41678601|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
19431105|NCT01598090|41678612|FG000|Treatment Period|Poor/non-compliance|0|||
19521696|NCT00637806|41935035|FG002|Extension Phase|Study Discontinued|0|||
19431106|NCT01598090|41678613|FG001|Treatment Period|Poor/non-compliance|2|||
19431107|NCT01598090|41678614|FG002|Treatment Period|Poor/non-compliance|0|||
19431108|NCT01598090|41678612|FG000|Treatment Period|No longer meet study criteria|0|||
19431109|NCT01598090|41678613|FG001|Treatment Period|No longer meet study criteria|1|||
19431110|NCT01598090|41678614|FG002|Treatment Period|No longer meet study criteria|0|||
19431111|NCT01598090|41678612|FG000|Treatment Period|Lack of Efficacy|5|||
19431112|NCT01598090|41678613|FG001|Treatment Period|Lack of Efficacy|14|||
19431113|NCT01598090|41678614|FG002|Treatment Period|Lack of Efficacy|6|||
19431114|NCT01598090|41678612|FG000|Treatment Period|Adverse Event|2|||
19431115|NCT01598090|41678613|FG001|Treatment Period|Adverse Event|33|||
19431116|NCT01598090|41678614|FG002|Treatment Period|Adverse Event|17|||
19431117|NCT01598090|41678612|FG000|Treatment Period|Other reasons|0|||
19431118|NCT01598090|41678613|FG001|Treatment Period|Other reasons|4|||
19431119|NCT01598090|41678614|FG002|Treatment Period|Other reasons|1|||
19431120|NCT01598090|41678612|FG000|Treatment Period|Withdrawal by Subject|3|||
19431121|NCT01598090|41678613|FG001|Treatment Period|Withdrawal by Subject|13|||
19431122|NCT01598090|41678614|FG002|Treatment Period|Withdrawal by Subject|10|||
19431123|NCT01598090|41678612|FG000|Treatment Period|Lost to Follow-up|1|||
19431124|NCT01598090|41678613|FG001|Treatment Period|Lost to Follow-up|5|||
19431125|NCT01598090|41678614|FG002|Treatment Period|Lost to Follow-up|1|||
19431126|NCT01598090|41678612|FG000|Follow-up Period|Death|0|||
19431127|NCT01598090|41678613|FG001|Follow-up Period|Death|1|||
19431128|NCT01598090|41678614|FG002|Follow-up Period|Death|0|||
19431129|NCT01598090|41678612|FG000|Follow-up Period|No longer required per protocol|1|||
19431130|NCT01598090|41678613|FG001|Follow-up Period|No longer required per protocol|3|||
19431131|NCT01598090|41678614|FG002|Follow-up Period|No longer required per protocol|2|||
19431132|NCT01598090|41678612|FG000|Follow-up Period|Not reported|0|||
19431133|NCT01598090|41678613|FG001|Follow-up Period|Not reported|10|||
19431134|NCT01598090|41678614|FG002|Follow-up Period|Not reported|4|||
19431135|NCT01598090|41678612|FG000|Follow-up Period|Withdrawal by Subject|0|||
19431136|NCT01598090|41678613|FG001|Follow-up Period|Withdrawal by Subject|3|||
19431137|NCT01598090|41678614|FG002|Follow-up Period|Withdrawal by Subject|2|||
19431138|NCT01598090|41678612|FG000|Follow-up Period|Other reasons|2|||
19431139|NCT01598090|41678613|FG001|Follow-up Period|Other reasons|8|||
19431140|NCT01598090|41678614|FG002|Follow-up Period|Other reasons|8|||
19431141|NCT01598090|41678612|FG000|Follow-up Period|Lost to Follow-up|2|||
19431142|NCT01598090|41678613|FG001|Follow-up Period|Lost to Follow-up|10|||
19431143|NCT01598090|41678614|FG002|Follow-up Period|Lost to Follow-up|12|||
19431144|NCT02105012|41678625|FG000|Overall Study|Withdrawal by Subject|11|||
19431145|NCT02105012|41678625|FG000|Overall Study|Protocol Specified Criteria|9|||
19431146|NCT02105012|41678625|FG000|Overall Study|Lost to Follow-up|4|||
19431147|NCT02105012|41678625|FG000|Overall Study|Protocol Violation|4|||
19431148|NCT02105012|41678625|FG000|Overall Study|Physician Decision|3|||
19431149|NCT02105012|41678625|FG000|Overall Study|Adverse Event|1|||
19431150|NCT02105012|41678625|FG000|Overall Study|Lack of Efficacy|1|||
19431151|NCT02145182|41678639|FG000|Overall Study|Adverse Event|4|||
19431152|NCT02145182|41678640|FG001|Overall Study|Adverse Event|1|||
19431153|NCT02145182|41678639|FG000|Overall Study|Death|7|||
19431154|NCT02145182|41678640|FG001|Overall Study|Death|7|||
19431155|NCT02145182|41678639|FG000|Overall Study|Lost to Follow-up|2|||
19431156|NCT02145182|41678640|FG001|Overall Study|Lost to Follow-up|2|||
19431157|NCT02145182|41678639|FG000|Overall Study|Pre-transplant Withdrawal|0|||
19431158|NCT02145182|41678640|FG001|Overall Study|Pre-transplant Withdrawal|2|||
19431159|NCT02145182|41678639|FG000|Overall Study|Withdrawal by Subject|5|||
19431160|NCT02145182|41678640|FG001|Overall Study|Withdrawal by Subject|4|||
19431161|NCT02145026|41678646|FG000|Overall Study|Adverse Event|2|||
19431162|NCT02145026|41678646|FG000|Overall Study|Death|4|||
19431163|NCT02145026|41678646|FG000|Overall Study|Withdrawal by Subject|2|||
19431164|NCT02145026|41678646|FG000|Overall Study|Physician Decision|4|||
19431165|NCT02144012|41678652|FG000|Overall Study|Adverse Event|1|||
19431166|NCT02144012|41678653|FG001|Overall Study|Adverse Event|0|||
19431167|NCT02144012|41678652|FG000|Overall Study|Death|1|||
19431168|NCT02144012|41678653|FG001|Overall Study|Death|0|||
19431169|NCT02144012|41678652|FG000|Overall Study|Withdrawal by Subject|11|||
19431170|NCT02144012|41678653|FG001|Overall Study|Withdrawal by Subject|3|||
19431171|NCT02144012|41678652|FG000|Overall Study|Study Terminated by Sponsor|18|||
19431172|NCT02144012|41678653|FG001|Overall Study|Study Terminated by Sponsor|12|||
19431173|NCT02144012|41678652|FG000|Overall Study|Other|3|||
19431174|NCT02144012|41678653|FG001|Overall Study|Other|0|||
19431175|NCT02103062|41678661|FG000|Overall Study|Adverse Event|1|||
19431176|NCT02103062|41678662|FG001|Overall Study|Adverse Event|2|||
19431177|NCT02103062|41678661|FG000|Overall Study|Progressive Disease|17|||
19431178|NCT02103062|41678662|FG001|Overall Study|Progressive Disease|20|||
19431179|NCT02103062|41678661|FG000|Overall Study|Death|0|||
19431180|NCT02103062|41678662|FG001|Overall Study|Death|1|||
19431181|NCT02141984|41678670|FG000|Overall Study|Lack of Efficacy|2|||
19431182|NCT02141672|41678677|FG000|Overall Study|Adverse Event|0|||
19431183|NCT02141672|41678678|FG001|Overall Study|Adverse Event|1|||
19431184|NCT02141672|41678679|FG002|Overall Study|Adverse Event|0|||
19431185|NCT02141672|41678677|FG000|Overall Study|Death|10|||
19431186|NCT02141672|41678678|FG001|Overall Study|Death|2|||
19431187|NCT02141672|41678679|FG002|Overall Study|Death|1|||
19431188|NCT02141672|41678677|FG000|Overall Study|Lack of Efficacy|0|||
19431189|NCT02141672|41678678|FG001|Overall Study|Lack of Efficacy|0|||
19431190|NCT02141672|41678679|FG002|Overall Study|Lack of Efficacy|2|||
19431191|NCT02141672|41678677|FG000|Overall Study|Lost to Follow-up|1|||
19431192|NCT02141672|41678678|FG001|Overall Study|Lost to Follow-up|1|||
19431193|NCT02141672|41678679|FG002|Overall Study|Lost to Follow-up|3|||
19431194|NCT02141672|41678677|FG000|Overall Study|Physician Decision|1|||
19431195|NCT02141672|41678678|FG001|Overall Study|Physician Decision|2|||
19431196|NCT02141672|41678679|FG002|Overall Study|Physician Decision|5|||
19431197|NCT02141672|41678677|FG000|Overall Study|Protocol Violation|0|||
19431198|NCT02141672|41678678|FG001|Overall Study|Protocol Violation|0|||
19431199|NCT02141672|41678679|FG002|Overall Study|Protocol Violation|1|||
19431200|NCT02141672|41678677|FG000|Overall Study|Withdrawal by Subject|3|||
19431201|NCT02141672|41678678|FG001|Overall Study|Withdrawal by Subject|2|||
19431202|NCT02141672|41678679|FG002|Overall Study|Withdrawal by Subject|5|||
19431203|NCT02141672|41678677|FG000|Overall Study|refused to follow-up|1|||
19431204|NCT02141672|41678678|FG001|Overall Study|refused to follow-up|0|||
19431205|NCT02141672|41678679|FG002|Overall Study|refused to follow-up|1|||
19431206|NCT02141516|41678690|FG000|Overall Study|Adverse Event|0|||
19431207|NCT02141516|41678691|FG001|Overall Study|Adverse Event|1|||
19431208|NCT02141516|41678692|FG002|Overall Study|Adverse Event|0|||
19431209|NCT02141516|41678690|FG000|Overall Study|Lost to Follow-up|0|||
19431210|NCT02141516|41678691|FG001|Overall Study|Lost to Follow-up|1|||
19431211|NCT02141516|41678692|FG002|Overall Study|Lost to Follow-up|0|||
19431212|NCT02141516|41678690|FG000|Overall Study|Other|0|||
19431213|NCT02141516|41678691|FG001|Overall Study|Other|3|||
19431214|NCT02141516|41678692|FG002|Overall Study|Other|0|||
19431215|NCT02141360|41678706|FG000|Overall Study|Withdrawal by Subject|6|||
19431216|NCT02141360|41678707|FG001|Overall Study|Withdrawal by Subject|0|||
19431217|NCT02141360|41678708|FG002|Overall Study|Withdrawal by Subject|0|||
19431218|NCT02141360|41678706|FG000|Overall Study|Study Terminated before Visit|1|||
19431219|NCT02141360|41678707|FG001|Overall Study|Study Terminated before Visit|0|||
19431220|NCT02141360|41678708|FG002|Overall Study|Study Terminated before Visit|0|||
19431221|NCT01628198|41678716|FG000|Overall Study|Lost to Follow-up|7|||
19431222|NCT01628198|41678716|FG000|Overall Study|Withdrawal by Subject|10|||
19431223|NCT01628198|41678716|FG000|Overall Study|Screen failure|1|||
19431224|NCT01628120|41678720|FG000|Overall Study|Withdrawal by Subject|7|||
19431225|NCT01628120|41678720|FG000|Overall Study|Adverse Event|12|||
19431226|NCT01628120|41678720|FG000|Overall Study|Lost to Follow-up|1|||
19431227|NCT01628120|41678720|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
19431228|NCT01628120|41678720|FG000|Overall Study|Non-compliant with Study Procedures|1|||
19431229|NCT01628120|41678720|FG000|Overall Study|Not Treated|3|||
19431230|NCT01628120|41678720|FG000|Overall Study|Sponsor Decision|5|||
19431231|NCT01628120|41678720|FG000|Overall Study|Switched Dialysis Method|2|||
19431232|NCT01628120|41678720|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
19431233|NCT01628120|41678720|FG000|Overall Study|Moved or Relocated|5|||
19431234|NCT01628120|41678720|FG000|Overall Study|Kidney Transplant|2|||
19431235|NCT01628120|41678720|FG000|Overall Study|Use of Standard of Care|1|||
19431236|NCT01627340|41678726|FG000|Overall Study|Adverse Event|1|||
19431237|NCT01627340|41678727|FG001|Overall Study|Adverse Event|0|||
19431238|NCT01627340|41678726|FG000|Overall Study|Lost to Follow-up|8|||
19431239|NCT01627340|41678727|FG001|Overall Study|Lost to Follow-up|4|||
19431240|NCT01627340|41678726|FG000|Overall Study|Pregnancy|1|||
19431241|NCT01627340|41678727|FG001|Overall Study|Pregnancy|0|||
19431242|NCT01627340|41678726|FG000|Overall Study|Withdrawal by Subject|2|||
19431243|NCT01627340|41678727|FG001|Overall Study|Withdrawal by Subject|0|||
19431244|NCT02125838|41678737|FG000|Overall Study|Lost to Follow-up|4|||
19431245|NCT02125838|41678738|FG001|Overall Study|Lost to Follow-up|4|||
19431246|NCT02125604|41678744|FG000|Overall Study|Other|4|||
19431247|NCT02125604|41678744|FG000|Overall Study|Investigator Decision|1|||
19431248|NCT02125604|41678744|FG000|Overall Study|Lost to Follow-up|2|||
19431249|NCT02125604|41678744|FG000|Overall Study|Consent Withdrawn|4|||
19431250|NCT02125604|41678744|FG000|Overall Study|Adverse Event|20|||
19431251|NCT02124746|41678751|FG000|Overall Study|Adverse Event|2|||
19431252|NCT02124746|41678752|FG001|Overall Study|Adverse Event|1|||
19431253|NCT02124746|41678753|FG002|Overall Study|Adverse Event|2|||
19431254|NCT02124746|41678751|FG000|Overall Study|Death|2|||
19431255|NCT02124746|41678752|FG001|Overall Study|Death|1|||
19431256|NCT02124746|41678753|FG002|Overall Study|Death|3|||
19431257|NCT02124746|41678751|FG000|Overall Study|Lack of Efficacy|3|||
19431258|NCT02124746|41678752|FG001|Overall Study|Lack of Efficacy|2|||
19431259|NCT02124746|41678753|FG002|Overall Study|Lack of Efficacy|2|||
19431260|NCT02124746|41678751|FG000|Overall Study|Physician Decision|6|||
19431261|NCT02124746|41678752|FG001|Overall Study|Physician Decision|4|||
19431262|NCT02124746|41678753|FG002|Overall Study|Physician Decision|5|||
19431263|NCT02124746|41678751|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19431264|NCT02124746|41678752|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19431265|NCT02124746|41678753|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19431266|NCT02124746|41678751|FG000|Overall Study|Withdrawal by Subject|3|||
19431267|NCT02124746|41678752|FG001|Overall Study|Withdrawal by Subject|3|||
19431268|NCT02124746|41678753|FG002|Overall Study|Withdrawal by Subject|0|||
19431269|NCT02124746|41678751|FG000|Overall Study|Study Terminated by Sponsor|0|||
19431270|NCT02124746|41678752|FG001|Overall Study|Study Terminated by Sponsor|0|||
19431271|NCT02124746|41678753|FG002|Overall Study|Study Terminated by Sponsor|6|||
19431272|NCT02124746|41678751|FG000|Overall Study|Disease Progression|3|||
19431273|NCT02124746|41678752|FG001|Overall Study|Disease Progression|6|||
19431274|NCT02124746|41678753|FG002|Overall Study|Disease Progression|4|||
19431275|NCT02123966|41678761|FG000|Overall Study|Intercurrent Illness|1|||
19431276|NCT02123576|41678767|FG000|Overall Study|Adverse Event|1|||
19431277|NCT02123576|41678768|FG001|Overall Study|Adverse Event|0|||
19431278|NCT01177397|41678786|FG000|Overall Study|Protocol Violation|0|||
19431279|NCT01177397|41678787|FG001|Overall Study|Protocol Violation|0|||
19431280|NCT01177397|41678788|FG002|Overall Study|Protocol Violation|0|||
19431281|NCT01177397|41678789|FG003|Overall Study|Protocol Violation|0|||
19431282|NCT01177397|41678790|FG004|Overall Study|Protocol Violation|0|||
19431283|NCT01177397|41678791|FG005|Overall Study|Protocol Violation|1|||
19431284|NCT01177397|41678792|FG006|Overall Study|Protocol Violation|0|||
19431285|NCT01177397|41678793|FG007|Overall Study|Protocol Violation|0|||
19431286|NCT01177397|41678794|FG008|Overall Study|Protocol Violation|0|||
19431287|NCT01177397|41678795|FG009|Overall Study|Protocol Violation|0|||
19431288|NCT01177397|41678796|FG010|Overall Study|Protocol Violation|0|||
19431289|NCT01177397|41678797|FG011|Overall Study|Protocol Violation|0|||
19431290|NCT01177397|41678786|FG000|Overall Study|Lost to Follow-up|0|||
19431291|NCT01177397|41678787|FG001|Overall Study|Lost to Follow-up|0|||
19431292|NCT01177397|41678788|FG002|Overall Study|Lost to Follow-up|0|||
19431293|NCT01177397|41678789|FG003|Overall Study|Lost to Follow-up|0|||
19431294|NCT01177397|41678790|FG004|Overall Study|Lost to Follow-up|1|||
19431295|NCT01177397|41678791|FG005|Overall Study|Lost to Follow-up|0|||
19431296|NCT01177397|41678792|FG006|Overall Study|Lost to Follow-up|0|||
19431297|NCT01177397|41678793|FG007|Overall Study|Lost to Follow-up|2|||
19431298|NCT01177397|41678794|FG008|Overall Study|Lost to Follow-up|0|||
19431299|NCT01177397|41678795|FG009|Overall Study|Lost to Follow-up|0|||
19431300|NCT01177397|41678796|FG010|Overall Study|Lost to Follow-up|0|||
19431301|NCT01177397|41678797|FG011|Overall Study|Lost to Follow-up|0|||
19431302|NCT01177397|41678786|FG000|Overall Study|Death|0|||
19431303|NCT01177397|41678787|FG001|Overall Study|Death|0|||
19431304|NCT01177397|41678788|FG002|Overall Study|Death|1|||
19431305|NCT01177397|41678789|FG003|Overall Study|Death|1|||
19431306|NCT01177397|41678790|FG004|Overall Study|Death|0|||
19431307|NCT01177397|41678791|FG005|Overall Study|Death|0|||
19431308|NCT01177397|41678792|FG006|Overall Study|Death|0|||
19431309|NCT01177397|41678793|FG007|Overall Study|Death|5|||
19431310|NCT01177397|41678794|FG008|Overall Study|Death|2|||
19431311|NCT01177397|41678795|FG009|Overall Study|Death|1|||
19431312|NCT01177397|41678796|FG010|Overall Study|Death|0|||
19431313|NCT01177397|41678797|FG011|Overall Study|Death|0|||
19431314|NCT01177397|41678786|FG000|Overall Study|Withdrawal by Subject|0|||
19431315|NCT01177397|41678787|FG001|Overall Study|Withdrawal by Subject|0|||
19431316|NCT01177397|41678788|FG002|Overall Study|Withdrawal by Subject|1|||
19431317|NCT01177397|41678789|FG003|Overall Study|Withdrawal by Subject|1|||
19431318|NCT01177397|41678790|FG004|Overall Study|Withdrawal by Subject|1|||
19431319|NCT01177397|41678791|FG005|Overall Study|Withdrawal by Subject|2|||
19431320|NCT01177397|41678792|FG006|Overall Study|Withdrawal by Subject|0|||
19431321|NCT01177397|41678793|FG007|Overall Study|Withdrawal by Subject|5|||
19431322|NCT01177397|41678794|FG008|Overall Study|Withdrawal by Subject|9|||
19431323|NCT01177397|41678795|FG009|Overall Study|Withdrawal by Subject|1|||
19431324|NCT01177397|41678796|FG010|Overall Study|Withdrawal by Subject|1|||
19431325|NCT01177397|41678797|FG011|Overall Study|Withdrawal by Subject|0|||
19431326|NCT01177397|41678786|FG000|Overall Study|Adverse Event|0|||
19431327|NCT01177397|41678787|FG001|Overall Study|Adverse Event|0|||
19431328|NCT01177397|41678788|FG002|Overall Study|Adverse Event|1|||
19431329|NCT01177397|41678789|FG003|Overall Study|Adverse Event|2|||
19431330|NCT01177397|41678790|FG004|Overall Study|Adverse Event|0|||
19431331|NCT01177397|41678791|FG005|Overall Study|Adverse Event|12|||
19431332|NCT01177397|41678792|FG006|Overall Study|Adverse Event|1|||
19431333|NCT01177397|41678793|FG007|Overall Study|Adverse Event|14|||
19431334|NCT01177397|41678794|FG008|Overall Study|Adverse Event|8|||
19431335|NCT01177397|41678795|FG009|Overall Study|Adverse Event|6|||
19431336|NCT01177397|41678796|FG010|Overall Study|Adverse Event|3|||
19431337|NCT01177397|41678797|FG011|Overall Study|Adverse Event|7|||
19431338|NCT01177397|41678786|FG000|Overall Study|Disease progression|1|||
19431339|NCT01177397|41678787|FG001|Overall Study|Disease progression|2|||
19431340|NCT01177397|41678788|FG002|Overall Study|Disease progression|5|||
19431341|NCT01177397|41678789|FG003|Overall Study|Disease progression|5|||
19431342|NCT01177397|41678790|FG004|Overall Study|Disease progression|4|||
19431343|NCT01177397|41678791|FG005|Overall Study|Disease progression|10|||
19431344|NCT01177397|41678792|FG006|Overall Study|Disease progression|10|||
19521697|NCT00637806|41935036|FG003|Extension Phase|Study Discontinued|1|||
19431345|NCT01177397|41678793|FG007|Overall Study|Disease progression|21|||
19431346|NCT01177397|41678794|FG008|Overall Study|Disease progression|18|||
19431347|NCT01177397|41678795|FG009|Overall Study|Disease progression|12|||
19431348|NCT01177397|41678796|FG010|Overall Study|Disease progression|10|||
19431349|NCT01177397|41678797|FG011|Overall Study|Disease progression|8|||
19431350|NCT01177397|41678786|FG000|Overall Study|Other reasons|0|||
19431351|NCT01177397|41678787|FG001|Overall Study|Other reasons|0|||
19431352|NCT01177397|41678788|FG002|Overall Study|Other reasons|1|||
19431353|NCT01177397|41678789|FG003|Overall Study|Other reasons|0|||
19431354|NCT01177397|41678790|FG004|Overall Study|Other reasons|1|||
19431355|NCT01177397|41678791|FG005|Overall Study|Other reasons|1|||
19431356|NCT01177397|41678792|FG006|Overall Study|Other reasons|2|||
19431357|NCT01177397|41678793|FG007|Overall Study|Other reasons|6|||
19431358|NCT01177397|41678794|FG008|Overall Study|Other reasons|10|||
19431359|NCT01177397|41678795|FG009|Overall Study|Other reasons|8|||
19431360|NCT01177397|41678796|FG010|Overall Study|Other reasons|0|||
19431361|NCT01177397|41678797|FG011|Overall Study|Other reasons|2|||
19431362|NCT00864227|41678838|FG000|Overall Study|Withdrawal by Subject|1|||
19431363|NCT00864227|41678838|FG000|Overall Study|Disease Relapse/Progression|3|||
19431364|NCT02102204|41678842|FG000|Overall Study|Withdrawal by Subject|137|||
19431365|NCT02102204|41678842|FG000|Overall Study|Death|92|||
19431366|NCT02102204|41678842|FG000|Overall Study|Lost to Follow-up|65|||
19431367|NCT02102204|41678842|FG000|Overall Study|Sponsor Decision|5|||
19431368|NCT02102204|41678842|FG000|Overall Study|Ongoing|5|||
19431369|NCT02141204|41678848|FG000|Overall Study|Lost to Follow-up|2|||
19431370|NCT02141204|41678849|FG001|Overall Study|Lost to Follow-up|1|||
19431371|NCT02141204|41678848|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
19431372|NCT02141204|41678849|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
19431373|NCT02141204|41678848|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
19431374|NCT02141204|41678849|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
19431375|NCT02141204|41678848|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
19431376|NCT02141204|41678849|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
19431377|NCT02140970|41678857|FG000|Overall Study|Lost to Follow-up|1|||
19431378|NCT02140970|41678858|FG001|Overall Study|Lost to Follow-up|2|||
19431379|NCT02140970|41678857|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
19431380|NCT02140970|41678858|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
19431381|NCT02140970|41678857|FG000|Overall Study|Did not meet inclusion criteria|0|||
19431382|NCT02140970|41678858|FG001|Overall Study|Did not meet inclusion criteria|1|||
19431383|NCT02101112|41678864|FG000|Overall Study|Adverse Event|0|||
19431384|NCT02101112|41678865|FG001|Overall Study|Adverse Event|0|||
19431385|NCT02101112|41678866|FG002|Overall Study|Adverse Event|1|||
19431386|NCT02101112|41678867|FG003|Overall Study|Adverse Event|0|||
19431387|NCT02101112|41678868|FG004|Overall Study|Adverse Event|0|||
19431388|NCT02101112|41678869|FG005|Overall Study|Adverse Event|0|||
19431389|NCT02101112|41678864|FG000|Overall Study|Withdrawal by Subject|0|||
19431390|NCT02101112|41678865|FG001|Overall Study|Withdrawal by Subject|0|||
19431391|NCT02101112|41678866|FG002|Overall Study|Withdrawal by Subject|0|||
19431392|NCT02101112|41678867|FG003|Overall Study|Withdrawal by Subject|0|||
19431393|NCT02101112|41678868|FG004|Overall Study|Withdrawal by Subject|1|||
19431394|NCT02101112|41678869|FG005|Overall Study|Withdrawal by Subject|0|||
19431395|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
19431396|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19431397|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19431398|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19431399|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19431400|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
19431401|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
19431402|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19431403|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19431404|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19431405|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19431406|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
19431407|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
19431408|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19431409|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19431410|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19431411|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19431412|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
19431413|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
19431414|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19431415|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19431416|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19431417|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19431418|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
19431419|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
19431420|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19431421|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19431422|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19431423|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19431424|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
19431425|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
19431426|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
19431427|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
19431428|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
19431429|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
19431430|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
19431431|NCT02139644|41678884|FG000|Run-In Period (Pre-assignment)|Other|6|||
19431432|NCT02139644|41678885|FG001|Run-In Period (Pre-assignment)|Other|0|||
19431433|NCT02139644|41678886|FG002|Run-In Period (Pre-assignment)|Other|0|||
19431434|NCT02139644|41678887|FG003|Run-In Period (Pre-assignment)|Other|0|||
19431435|NCT02139644|41678888|FG004|Run-In Period (Pre-assignment)|Other|0|||
19431436|NCT02139644|41678889|FG005|Run-In Period (Pre-assignment)|Other|0|||
19431437|NCT02139644|41678884|FG000|Treatment Period|Adverse Event|0|||
19431438|NCT02139644|41678885|FG001|Treatment Period|Adverse Event|0|||
19431439|NCT02139644|41678886|FG002|Treatment Period|Adverse Event|3|||
19431440|NCT02139644|41678887|FG003|Treatment Period|Adverse Event|2|||
19431441|NCT02139644|41678888|FG004|Treatment Period|Adverse Event|1|||
19431442|NCT02139644|41678889|FG005|Treatment Period|Adverse Event|6|||
19431443|NCT02139644|41678884|FG000|Treatment Period|Withdrawal by Subject|0|||
19431444|NCT02139644|41678885|FG001|Treatment Period|Withdrawal by Subject|0|||
19431445|NCT02139644|41678886|FG002|Treatment Period|Withdrawal by Subject|2|||
19431446|NCT02139644|41678887|FG003|Treatment Period|Withdrawal by Subject|2|||
19431447|NCT02139644|41678888|FG004|Treatment Period|Withdrawal by Subject|3|||
19431448|NCT02139644|41678889|FG005|Treatment Period|Withdrawal by Subject|2|||
19431449|NCT02139644|41678884|FG000|Treatment Period|Non-compliance|0|||
19431450|NCT02139644|41678885|FG001|Treatment Period|Non-compliance|0|||
19431451|NCT02139644|41678886|FG002|Treatment Period|Non-compliance|0|||
19431452|NCT02139644|41678887|FG003|Treatment Period|Non-compliance|1|||
19431453|NCT02139644|41678888|FG004|Treatment Period|Non-compliance|0|||
19431454|NCT02139644|41678889|FG005|Treatment Period|Non-compliance|0|||
19431455|NCT02139644|41678884|FG000|Treatment Period|Protocol Violation|0|||
19431456|NCT02139644|41678885|FG001|Treatment Period|Protocol Violation|0|||
19431457|NCT02139644|41678886|FG002|Treatment Period|Protocol Violation|0|||
19431458|NCT02139644|41678887|FG003|Treatment Period|Protocol Violation|1|||
19431459|NCT02139644|41678888|FG004|Treatment Period|Protocol Violation|1|||
19431460|NCT02139644|41678889|FG005|Treatment Period|Protocol Violation|1|||
19431461|NCT02139644|41678884|FG000|Treatment Period|Disease progression|0|||
19431462|NCT02139644|41678885|FG001|Treatment Period|Disease progression|0|||
19431463|NCT02139644|41678886|FG002|Treatment Period|Disease progression|0|||
19431464|NCT02139644|41678887|FG003|Treatment Period|Disease progression|1|||
19431465|NCT02139644|41678888|FG004|Treatment Period|Disease progression|1|||
19431466|NCT02139644|41678889|FG005|Treatment Period|Disease progression|2|||
19431467|NCT02139644|41678884|FG000|Treatment Period|Lost to Follow-up|0|||
19431468|NCT02139644|41678885|FG001|Treatment Period|Lost to Follow-up|0|||
19431469|NCT02139644|41678886|FG002|Treatment Period|Lost to Follow-up|1|||
19431470|NCT02139644|41678887|FG003|Treatment Period|Lost to Follow-up|1|||
19431471|NCT02139644|41678888|FG004|Treatment Period|Lost to Follow-up|1|||
19431472|NCT02139644|41678889|FG005|Treatment Period|Lost to Follow-up|1|||
19431473|NCT02139644|41678884|FG000|Treatment Period|Lack of Efficacy|0|||
19431474|NCT02139644|41678885|FG001|Treatment Period|Lack of Efficacy|0|||
19431475|NCT02139644|41678886|FG002|Treatment Period|Lack of Efficacy|1|||
19431476|NCT02139644|41678887|FG003|Treatment Period|Lack of Efficacy|0|||
19431477|NCT02139644|41678888|FG004|Treatment Period|Lack of Efficacy|1|||
19431478|NCT02139644|41678889|FG005|Treatment Period|Lack of Efficacy|4|||
19431479|NCT02139644|41678884|FG000|Treatment Period|Other|0|||
19431480|NCT02139644|41678885|FG001|Treatment Period|Other|3|||
19431481|NCT02139644|41678886|FG002|Treatment Period|Other|1|||
19431482|NCT02139644|41678887|FG003|Treatment Period|Other|1|||
19431483|NCT02139644|41678888|FG004|Treatment Period|Other|0|||
19431484|NCT02139644|41678889|FG005|Treatment Period|Other|1|||
19431485|NCT02100644|41678901|FG000|LTG Escalation Phase|Adverse Event|9|||
19431486|NCT02100644|41678902|FG001|LTG Escalation Phase|Adverse Event|0|||
19431487|NCT02100644|41678903|FG002|LTG Escalation Phase|Adverse Event|0|||
19431488|NCT02100644|41678901|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
19431489|NCT02100644|41678902|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
19431490|NCT02100644|41678903|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
19431491|NCT02100644|41678901|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
19431492|NCT02100644|41678902|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
19431493|NCT02100644|41678903|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
19431494|NCT02074982|41678909|FG000|Overall Study|Adverse Event|15|||
19431495|NCT02074982|41678910|FG001|Overall Study|Adverse Event|7|||
19431496|NCT02074982|41678909|FG000|Overall Study|Lack of Efficacy|6|||
19431497|NCT02074982|41678910|FG001|Overall Study|Lack of Efficacy|1|||
19431498|NCT02074982|41678909|FG000|Overall Study|Lost to Follow-up|9|||
19431499|NCT02074982|41678910|FG001|Overall Study|Lost to Follow-up|10|||
19431500|NCT02074982|41678909|FG000|Overall Study|Non-compliance with study treatment|0|||
19431501|NCT02074982|41678910|FG001|Overall Study|Non-compliance with study treatment|2|||
19431502|NCT02074982|41678909|FG000|Overall Study|Physician Decision|1|||
19431503|NCT02074982|41678910|FG001|Overall Study|Physician Decision|1|||
19431504|NCT02074982|41678909|FG000|Overall Study|Pregnancy|1|||
19431505|NCT02074982|41678910|FG001|Overall Study|Pregnancy|2|||
19431506|NCT02074982|41678909|FG000|Overall Study|Protocol deviation|4|||
19431507|NCT02074982|41678910|FG001|Overall Study|Protocol deviation|3|||
19431508|NCT02074982|41678909|FG000|Overall Study|Technical problems|0|||
19431509|NCT02074982|41678910|FG001|Overall Study|Technical problems|2|||
19431510|NCT02074982|41678909|FG000|Overall Study|Subject/guardian decision|15|||
19431511|NCT02074982|41678910|FG001|Overall Study|Subject/guardian decision|24|||
19431512|NCT02074982|41678909|FG000|Overall Study|Death|0|||
19431513|NCT02074982|41678910|FG001|Overall Study|Death|2|||
19431514|NCT02074514|41678920|FG000|Overall Study|Lack of Efficacy|3|||
19431515|NCT02074514|41678921|FG001|Overall Study|Lack of Efficacy|2|||
19431516|NCT02074514|41678920|FG000|Overall Study|Lost to Follow-up|0|||
19431517|NCT02074514|41678921|FG001|Overall Study|Lost to Follow-up|1|||
19431518|NCT02074514|41678920|FG000|Overall Study|Withdrew Consent|0|||
19431519|NCT02074514|41678921|FG001|Overall Study|Withdrew Consent|1|||
19431520|NCT02099708|41678931|FG000|Overall Study|Data Not Available|30|||
19431521|NCT02099708|41678931|FG000|Overall Study|Lost to Follow-up|141|||
19431522|NCT02099708|41678931|FG000|Overall Study|Other|29|||
19431523|NCT02073656|41678935|FG000|Primary Study|Lost to Follow-up|6|||
19431524|NCT02073656|41678935|FG000|Primary Study|Death|1|||
19431525|NCT02073656|41678935|FG000|Primary Study|Withdrew Consent|1|||
19431526|NCT02242643|41678943|FG000|Overall Study|Protocol Violation|1|||
19431527|NCT02242643|41678944|FG001|Overall Study|Protocol Violation|2|||
19431528|NCT02242643|41678943|FG000|Overall Study|Withdrawal by Subject|15|||
19431529|NCT02242643|41678944|FG001|Overall Study|Withdrawal by Subject|10|||
19431530|NCT02242643|41678943|FG000|Overall Study|Migrated/moved from study area|1|||
19431531|NCT02242643|41678944|FG001|Overall Study|Migrated/moved from study area|3|||
19431532|NCT02242643|41678943|FG000|Overall Study|Lost to Follow-up|54|||
19431533|NCT02242643|41678944|FG001|Overall Study|Lost to Follow-up|61|||
19431534|NCT02242643|41678943|FG000|Overall Study|Child placed in foster care by family|0|||
19431535|NCT02242643|41678944|FG001|Overall Study|Child placed in foster care by family|1|||
19431536|NCT02242643|41678943|FG000|Overall Study|Non-compliance|1|||
19431537|NCT02242643|41678944|FG001|Overall Study|Non-compliance|0|||
19431538|NCT02242643|41678943|FG000|Overall Study|Consent withdrawal by parent|1|||
19431539|NCT02242643|41678944|FG001|Overall Study|Consent withdrawal by parent|0|||
19431540|NCT02242643|41678943|FG000|Overall Study|Protocol requirements not followed|1|||
19431541|NCT02242643|41678944|FG001|Overall Study|Protocol requirements not followed|0|||
19431542|NCT02242643|41678943|FG000|Overall Study|Language barrier|1|||
19431543|NCT02242643|41678944|FG001|Overall Study|Language barrier|0|||
19431544|NCT02242643|41678943|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
19431545|NCT02242643|41678944|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
19431546|NCT02097290|41678952|FG000|Overall Study|Death|6|||
19431547|NCT02097290|41678952|FG000|Overall Study|Total Withdrawals|3|||
19431548|NCT02097290|41678952|FG000|Overall Study|Attempt|8|||
19431549|NCT02072174|41678958|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
19431550|NCT02072174|41678959|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
19431551|NCT02072174|41678958|FG000|Overall Study|Protocol Violation|16|||
19431552|NCT02072174|41678959|FG001|Overall Study|Protocol Violation|23|||
19431553|NCT02072174|41678958|FG000|Overall Study|Physician Decision|0|||
19431554|NCT02072174|41678959|FG001|Overall Study|Physician Decision|1|||
19431555|NCT02072174|41678958|FG000|Overall Study|Non-compliance with protocol requirement|2|||
19431556|NCT02072174|41678959|FG001|Overall Study|Non-compliance with protocol requirement|0|||
19431557|NCT02209181|41678971|FG000|Overall Study|Adverse Event|1|||
19431558|NCT02209181|41678972|FG001|Overall Study|Adverse Event|0|||
19431559|NCT02209181|41678973|FG002|Overall Study|Adverse Event|1|||
19431560|NCT02209181|41678974|FG003|Overall Study|Adverse Event|0|||
19431561|NCT02209181|41678971|FG000|Overall Study|Withdrawal by Subject|0|||
19431562|NCT02209181|41678972|FG001|Overall Study|Withdrawal by Subject|1|||
19431563|NCT02209181|41678973|FG002|Overall Study|Withdrawal by Subject|0|||
19431564|NCT02209181|41678974|FG003|Overall Study|Withdrawal by Subject|0|||
19431565|NCT02208089|41678986|FG000|Overall Study|Withdrawal by Subject|1|||
19431566|NCT02208089|41678987|FG001|Overall Study|Withdrawal by Subject|0|||
19431567|NCT02208089|41678986|FG000|Overall Study|Lost to Follow-up|6|||
19431568|NCT02208089|41678987|FG001|Overall Study|Lost to Follow-up|0|||
19431569|NCT02242487|41678996|FG000|Overall Study|Adverse Event|13|||
19431570|NCT02242487|41678997|FG001|Overall Study|Adverse Event|15|||
19431571|NCT02242487|41678996|FG000|Overall Study|Lack of Efficacy|4|||
19431572|NCT02242487|41678997|FG001|Overall Study|Lack of Efficacy|6|||
19431573|NCT02242487|41678996|FG000|Overall Study|Protocol Violation|2|||
19431574|NCT02242487|41678997|FG001|Overall Study|Protocol Violation|0|||
19431575|NCT02242487|41678996|FG000|Overall Study|Lost to Follow-up|2|||
19431576|NCT02242487|41678997|FG001|Overall Study|Lost to Follow-up|1|||
19431577|NCT02242487|41678996|FG000|Overall Study|Other - Miscellaneous|4|||
19431578|NCT02242487|41678997|FG001|Overall Study|Other - Miscellaneous|6|||
19431579|NCT02242487|41678996|FG000|Overall Study|Withdrawal by Subject|37|||
19431580|NCT02242487|41678997|FG001|Overall Study|Withdrawal by Subject|19|||
19431581|NCT02241785|41679005|FG000|Overall Study|Sponsor Termination|43|||
19431582|NCT02241785|41679005|FG000|Overall Study|Withdrawal by Subject|1|||
19431583|NCT02241785|41679005|FG000|Overall Study|Lost to Follow-up|2|||
19431584|NCT02241785|41679005|FG000|Overall Study|Adverse Event|1|||
19431585|NCT02241551|41679011|FG000|Overall Study|Adverse Event|1|||
19431586|NCT02241551|41679012|FG001|Overall Study|Adverse Event|0|||
19431587|NCT02207621|41679023|FG000|Overall Study|Adverse Event|71|||
19431588|NCT02207621|41679024|FG001|Overall Study|Adverse Event|15|||
19431589|NCT02207621|41679025|FG002|Overall Study|Adverse Event|132|||
19431590|NCT02207621|41679023|FG000|Overall Study|Withdrawal by Subject|9|||
19431591|NCT02207621|41679024|FG001|Overall Study|Withdrawal by Subject|9|||
19431592|NCT02207621|41679025|FG002|Overall Study|Withdrawal by Subject|13|||
19431593|NCT02207621|41679023|FG000|Overall Study|Non-Compliant|3|||
19431594|NCT02207621|41679024|FG001|Overall Study|Non-Compliant|3|||
19431595|NCT02207621|41679025|FG002|Overall Study|Non-Compliant|1|||
19431596|NCT02207621|41679023|FG000|Overall Study|Lost to Follow-up|1|||
19431597|NCT02207621|41679024|FG001|Overall Study|Lost to Follow-up|0|||
19431598|NCT02207621|41679025|FG002|Overall Study|Lost to Follow-up|3|||
19431599|NCT02207621|41679023|FG000|Overall Study|Lack of Efficacy|10|||
19431600|NCT02207621|41679024|FG001|Overall Study|Lack of Efficacy|2|||
19431601|NCT02207621|41679025|FG002|Overall Study|Lack of Efficacy|4|||
19431602|NCT02207621|41679023|FG000|Overall Study|Disallowed Concurrent Medication|2|||
19431603|NCT02207621|41679024|FG001|Overall Study|Disallowed Concurrent Medication|5|||
19431604|NCT02207621|41679025|FG002|Overall Study|Disallowed Concurrent Medication|2|||
19431605|NCT02207621|41679023|FG000|Overall Study|Physician Decision|1|||
19431606|NCT02207621|41679024|FG001|Overall Study|Physician Decision|2|||
19431607|NCT02207621|41679025|FG002|Overall Study|Physician Decision|2|||
19431608|NCT02207621|41679023|FG000|Overall Study|Protocol Violation|4|||
19431609|NCT02207621|41679024|FG001|Overall Study|Protocol Violation|10|||
19431610|NCT02207621|41679025|FG002|Overall Study|Protocol Violation|6|||
19431611|NCT02207621|41679023|FG000|Overall Study|Death|2|||
19431612|NCT02207621|41679024|FG001|Overall Study|Death|0|||
19431613|NCT02207621|41679025|FG002|Overall Study|Death|0|||
19431614|NCT02207621|41679023|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
19431615|NCT02207621|41679024|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
19431616|NCT02207621|41679025|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
19431617|NCT02240693|41679039|FG000|Overall Study|Adverse Event|0|||
19431618|NCT02240693|41679040|FG001|Overall Study|Adverse Event|0|||
19431619|NCT02240693|41679041|FG002|Overall Study|Adverse Event|0|||
19431620|NCT02240693|41679042|FG003|Overall Study|Adverse Event|0|||
19431621|NCT02240693|41679043|FG004|Overall Study|Adverse Event|1|||
19431622|NCT02240693|41679039|FG000|Overall Study|Withdrawal by Subject|0|||
19431623|NCT02240693|41679040|FG001|Overall Study|Withdrawal by Subject|0|||
19431624|NCT02240693|41679041|FG002|Overall Study|Withdrawal by Subject|2|||
19431625|NCT02240693|41679042|FG003|Overall Study|Withdrawal by Subject|1|||
19431626|NCT02240693|41679043|FG004|Overall Study|Withdrawal by Subject|0|||
19431627|NCT02240693|41679039|FG000|Overall Study|Other than specified|0|||
19431628|NCT02240693|41679040|FG001|Overall Study|Other than specified|0|||
19431629|NCT02240693|41679041|FG002|Overall Study|Other than specified|2|||
19431630|NCT02240693|41679042|FG003|Overall Study|Other than specified|0|||
19431631|NCT02240693|41679043|FG004|Overall Study|Other than specified|0|||
19431632|NCT02239679|41679060|FG000|Overall Study|Lost to Follow-up|1|||
19431633|NCT02239679|41679061|FG001|Overall Study|Lost to Follow-up|0|||
19431634|NCT02239679|41679062|FG002|Overall Study|Lost to Follow-up|0|||
19431635|NCT02239679|41679060|FG000|Overall Study|Withdrawal by Subject|2|||
19431636|NCT02239679|41679061|FG001|Overall Study|Withdrawal by Subject|3|||
19431637|NCT02239679|41679062|FG002|Overall Study|Withdrawal by Subject|1|||
19431638|NCT02072096|41679072|FG000|Overall Study|Lack of Efficacy|18|||
19431639|NCT02072096|41679073|FG001|Overall Study|Lack of Efficacy|29|||
19431640|NCT02072096|41679072|FG000|Overall Study|Protocol Violation|7|||
19431641|NCT02072096|41679073|FG001|Overall Study|Protocol Violation|7|||
19431642|NCT02072096|41679072|FG000|Overall Study|Withdrawal by Subject|5|||
19431643|NCT02072096|41679073|FG001|Overall Study|Withdrawal by Subject|7|||
19431644|NCT02072096|41679072|FG000|Overall Study|Adverse Event|5|||
19431645|NCT02072096|41679073|FG001|Overall Study|Adverse Event|2|||
19431646|NCT02072096|41679072|FG000|Overall Study|No Reason Provided|4|||
19431647|NCT02072096|41679073|FG001|Overall Study|No Reason Provided|2|||
19431648|NCT02072096|41679072|FG000|Overall Study|Death|2|||
19431649|NCT02072096|41679073|FG001|Overall Study|Death|0|||
19431650|NCT02072096|41679072|FG000|Overall Study|Physician Decision|0|||
19431651|NCT02072096|41679073|FG001|Overall Study|Physician Decision|1|||
19431652|NCT02072096|41679072|FG000|Overall Study|Study Terminated by Sponsor|43|||
19431653|NCT02072096|41679073|FG001|Overall Study|Study Terminated by Sponsor|30|||
19431654|NCT02072096|41679072|FG000|Overall Study|Lost to Follow-up|1|||
19431655|NCT02072096|41679073|FG001|Overall Study|Lost to Follow-up|0|||
19431656|NCT02071706|41679080|FG000|Overall Study|Adverse Event|1|||
19521698|NCT00637728|41935047|FG000|Double-blind Phase|Adverse Event|1|||
19431657|NCT02071706|41679080|FG000|Overall Study|Withdrawal by Subject|2|||
19431658|NCT01631825|41679084|FG000|Overall Study|Adverse Event|42|||
19431659|NCT01631825|41679084|FG000|Overall Study|Lack of Efficacy|7|||
19431660|NCT01631825|41679084|FG000|Overall Study|Withdrawal by Subject|9|||
19431661|NCT01631825|41679084|FG000|Overall Study|Protocol Violation|4|||
19431662|NCT01631825|41679084|FG000|Overall Study|Discontinuation criteria|1|||
19431663|NCT01631825|41679084|FG000|Overall Study|Physician Decision|2|||
19431664|NCT02071082|41679090|FG000|Overall Study|Enrolled and Never Treated|1|||
19431665|NCT02071082|41679091|FG001|Overall Study|Enrolled and Never Treated|1|||
19431666|NCT02071082|41679090|FG000|Overall Study|Adverse Event|0|||
19431667|NCT02071082|41679091|FG001|Overall Study|Adverse Event|1|||
19431668|NCT02071082|41679090|FG000|Overall Study|Withdrew Consent|0|||
19431669|NCT02071082|41679091|FG001|Overall Study|Withdrew Consent|4|||
19431670|NCT02071082|41679090|FG000|Overall Study|Lost to Follow-up|1|||
19431671|NCT02071082|41679091|FG001|Overall Study|Lost to Follow-up|1|||
19431672|NCT02123108|41679099|FG000|Overall Study|Death|2|||
19431673|NCT02123108|41679100|FG001|Overall Study|Death|3|||
19431674|NCT02097134|41679106|FG000|Overall Study|Physician Decision|4|||
19431675|NCT02097134|41679106|FG000|Overall Study|Non-Protocol Therapy|1|||
19431676|NCT02097134|41679106|FG000|Overall Study|Progressive Disease|3|||
19431677|NCT02097134|41679106|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
19431678|NCT02121392|41679113|FG000|Prior to Intervention|Protocol Violation|40|||
19431679|NCT02121392|41679114|FG001|Prior to Intervention|Protocol Violation|35|||
19431680|NCT02121392|41679113|FG000|Prior to Intervention|Withdrawal by Subject|8|||
19431681|NCT02121392|41679114|FG001|Prior to Intervention|Withdrawal by Subject|6|||
19431682|NCT02121392|41679113|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
19431683|NCT02121392|41679114|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
19431684|NCT02121392|41679113|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
19431685|NCT02121392|41679114|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
19431686|NCT02097056|41679120|FG000|Overall Study|Protocol Violation|2|||
19431687|NCT02097056|41679120|FG000|Overall Study|Withdrawal by Subject|15|||
19431688|NCT02097056|41679120|FG000|Overall Study|Lost to Follow-up|2|||
19431689|NCT02097056|41679120|FG000|Overall Study|Adverse Event|37|||
19431690|NCT02097056|41679120|FG000|Overall Study|Other|2|||
19431691|NCT02121002|41679127|FG000|Overall Study|Physician Decision|2|||
19431692|NCT02121002|41679128|FG001|Overall Study|Physician Decision|0|||
19431693|NCT02121002|41679129|FG002|Overall Study|Physician Decision|0|||
19431694|NCT02121002|41679127|FG000|Overall Study|Withdrawal by Subject|3|||
19431695|NCT02121002|41679128|FG001|Overall Study|Withdrawal by Subject|1|||
19431696|NCT02121002|41679129|FG002|Overall Study|Withdrawal by Subject|4|||
19431697|NCT02121002|41679127|FG000|Overall Study|Protocol Violation|1|||
19431698|NCT02121002|41679128|FG001|Overall Study|Protocol Violation|2|||
19431699|NCT02121002|41679129|FG002|Overall Study|Protocol Violation|4|||
19431700|NCT02121002|41679127|FG000|Overall Study|Concomitant therapy|0|||
19431701|NCT02121002|41679128|FG001|Overall Study|Concomitant therapy|1|||
19431702|NCT02121002|41679129|FG002|Overall Study|Concomitant therapy|1|||
19431703|NCT02121002|41679127|FG000|Overall Study|Others|1|||
19431704|NCT02121002|41679128|FG001|Overall Study|Others|0|||
19431705|NCT02121002|41679129|FG002|Overall Study|Others|1|||
19431706|NCT02096900|41679139|FG000|Overall Study|Did not receive medication|3|||
19431707|NCT02096900|41679140|FG001|Overall Study|Did not receive medication|1|||
19431708|NCT02096900|41679139|FG000|Overall Study|Surgery cancelled- medication received|1|||
19431709|NCT02096900|41679140|FG001|Overall Study|Surgery cancelled- medication received|1|||
19431710|NCT02120924|41679149|FG000|Overall Study|Lack of Efficacy|1|||
19431711|NCT02120924|41679150|FG001|Overall Study|Lack of Efficacy|2|||
19431712|NCT02120924|41679151|FG002|Overall Study|Lack of Efficacy|3|||
19431713|NCT02120924|41679149|FG000|Overall Study|Adverse Event|0|||
19431714|NCT02120924|41679150|FG001|Overall Study|Adverse Event|1|||
19431715|NCT02120924|41679151|FG002|Overall Study|Adverse Event|3|||
19431716|NCT02120924|41679149|FG000|Overall Study|Withdrawal by Subject|16|||
19431717|NCT02120924|41679150|FG001|Overall Study|Withdrawal by Subject|20|||
19431718|NCT02120924|41679151|FG002|Overall Study|Withdrawal by Subject|8|||
19431719|NCT02120924|41679149|FG000|Overall Study|Lost to Follow-up|14|||
19431720|NCT02120924|41679150|FG001|Overall Study|Lost to Follow-up|14|||
19431721|NCT02120924|41679151|FG002|Overall Study|Lost to Follow-up|11|||
19431722|NCT02120924|41679149|FG000|Overall Study|Pregnancy|2|||
19431723|NCT02120924|41679150|FG001|Overall Study|Pregnancy|0|||
19431724|NCT02120924|41679151|FG002|Overall Study|Pregnancy|0|||
19431725|NCT02120924|41679149|FG000|Overall Study|Protocol Violation|3|||
19431726|NCT02120924|41679150|FG001|Overall Study|Protocol Violation|7|||
19431727|NCT02120924|41679151|FG002|Overall Study|Protocol Violation|2|||
19431728|NCT02120924|41679149|FG000|Overall Study|Physician Decision|0|||
19431729|NCT02120924|41679150|FG001|Overall Study|Physician Decision|1|||
19431730|NCT02120924|41679151|FG002|Overall Study|Physician Decision|1|||
19431731|NCT02120924|41679149|FG000|Overall Study|Death|1|||
19431732|NCT02120924|41679150|FG001|Overall Study|Death|0|||
19431733|NCT02120924|41679151|FG002|Overall Study|Death|0|||
19431734|NCT02120924|41679149|FG000|Overall Study|Compliance with IP|5|||
19431735|NCT02120924|41679150|FG001|Overall Study|Compliance with IP|1|||
19431736|NCT02120924|41679151|FG002|Overall Study|Compliance with IP|1|||
19431737|NCT02096744|41679160|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
19431738|NCT02096744|41679161|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
19431739|NCT02096744|41679160|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
19431740|NCT02096744|41679161|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
19431741|NCT02096744|41679160|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
19431742|NCT02096744|41679161|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
19431743|NCT02096042|41679169|FG000|Overall Study|Disease Progression|1|||
19431744|NCT02096042|41679170|FG001|Overall Study|Disease Progression|0|||
19431745|NCT02096042|41679171|FG002|Overall Study|Disease Progression|0|||
19431746|NCT02120456|41679187|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431747|NCT02120456|41679188|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431748|NCT02120456|41679189|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431749|NCT02120456|41679190|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431750|NCT02120456|41679191|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431751|NCT02120456|41679192|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431752|NCT02120456|41679193|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
19431753|NCT02120456|41679194|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431754|NCT02120456|41679195|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
19431755|NCT02120456|41679187|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431756|NCT02120456|41679188|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431757|NCT02120456|41679189|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431758|NCT02120456|41679190|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431759|NCT02120456|41679191|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431760|NCT02120456|41679192|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431761|NCT02120456|41679193|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
19431762|NCT02120456|41679194|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431763|NCT02120456|41679195|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
19431764|NCT02120456|41679187|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431765|NCT02120456|41679188|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431766|NCT02120456|41679189|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431767|NCT02120456|41679190|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431768|NCT02120456|41679191|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431769|NCT02120456|41679192|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431770|NCT02120456|41679193|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431771|NCT02120456|41679194|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
19431772|NCT02120456|41679195|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
19431773|NCT02120300|41679219|FG000|Overall Study|Enrolled but Never Treated|2|||
19431774|NCT02120300|41679220|FG001|Overall Study|Enrolled but Never Treated|0|||
19431775|NCT02120300|41679221|FG002|Overall Study|Enrolled but Never Treated|0|||
19431776|NCT02120300|41679222|FG003|Overall Study|Enrolled but Never Treated|0|||
19431777|NCT02120300|41679219|FG000|Overall Study|Lack of Efficacy|0|||
19431778|NCT02120300|41679220|FG001|Overall Study|Lack of Efficacy|0|||
19431779|NCT02120300|41679221|FG002|Overall Study|Lack of Efficacy|0|||
19431780|NCT02120300|41679222|FG003|Overall Study|Lack of Efficacy|1|||
19431781|NCT02120300|41679219|FG000|Overall Study|Lost to Follow-up|1|||
19431782|NCT02120300|41679220|FG001|Overall Study|Lost to Follow-up|0|||
19431783|NCT02120300|41679221|FG002|Overall Study|Lost to Follow-up|0|||
19431784|NCT02120300|41679222|FG003|Overall Study|Lost to Follow-up|0|||
19431785|NCT02070380|41679238|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
19431786|NCT02070380|41679239|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
19431787|NCT02070380|41679240|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
19431788|NCT02070380|41679241|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
19431789|NCT02070380|41679238|FG000|Second Injection|Image sets missing or technically inadeq|0|||
19431790|NCT02070380|41679239|FG001|Second Injection|Image sets missing or technically inadeq|1|||
19431791|NCT02070380|41679240|FG002|Second Injection|Image sets missing or technically inadeq|0|||
19431792|NCT02070380|41679241|FG003|Second Injection|Image sets missing or technically inadeq|0|||
19431793|NCT02070380|41679238|FG000|Second Injection|Protocol Violation|0|||
19431794|NCT02070380|41679239|FG001|Second Injection|Protocol Violation|1|||
19431795|NCT02070380|41679240|FG002|Second Injection|Protocol Violation|1|||
19431796|NCT02070380|41679241|FG003|Second Injection|Protocol Violation|5|||
19431797|NCT02069366|41679259|FG000|Overall Study|Lost to Follow-up|0|||
19431798|NCT02069366|41679260|FG001|Overall Study|Lost to Follow-up|0|||
19431799|NCT02069366|41679261|FG002|Overall Study|Lost to Follow-up|1|||
19431800|NCT02069366|41679262|FG003|Overall Study|Lost to Follow-up|0|||
19431801|NCT02069366|41679263|FG004|Overall Study|Lost to Follow-up|0|||
19431802|NCT02069366|41679264|FG005|Overall Study|Lost to Follow-up|2|||
19431803|NCT02069366|41679259|FG000|Overall Study|Protocol Violation|0|||
19431804|NCT02069366|41679260|FG001|Overall Study|Protocol Violation|0|||
19431805|NCT02069366|41679261|FG002|Overall Study|Protocol Violation|1|||
19431806|NCT02069366|41679262|FG003|Overall Study|Protocol Violation|0|||
19431807|NCT02069366|41679263|FG004|Overall Study|Protocol Violation|0|||
19431808|NCT02069366|41679264|FG005|Overall Study|Protocol Violation|0|||
19431809|NCT02069366|41679259|FG000|Overall Study|Withdrawal by Subject|1|||
19431810|NCT02069366|41679260|FG001|Overall Study|Withdrawal by Subject|0|||
19431811|NCT02069366|41679261|FG002|Overall Study|Withdrawal by Subject|1|||
19431812|NCT02069366|41679262|FG003|Overall Study|Withdrawal by Subject|2|||
19431813|NCT02069366|41679263|FG004|Overall Study|Withdrawal by Subject|0|||
19431814|NCT02069366|41679264|FG005|Overall Study|Withdrawal by Subject|0|||
19431815|NCT02068508|41679279|FG000|Overall Study|Case report forms uncollected|27|||
19431816|NCT02068508|41679279|FG000|Overall Study|Patient did not visit the study site|1|||
19431817|NCT02068508|41679279|FG000|Overall Study|Protocol Violation|4|||
19711197|NCT00116805|42154353|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
19711198|NCT00116805|42154354|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
19711199|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
19711200|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
19711201|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
19711202|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
19711203|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
19711204|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
19711205|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
19431818|NCT02068352|41679286|FG000|Overall Study|Lost to Follow-up|0|||
19431819|NCT02068352|41679287|FG001|Overall Study|Lost to Follow-up|2|||
19431820|NCT02068352|41679288|FG002|Overall Study|Lost to Follow-up|0|||
19431821|NCT02068352|41679286|FG000|Overall Study|Adverse Event|4|||
19431822|NCT02068352|41679287|FG001|Overall Study|Adverse Event|2|||
19431823|NCT02068352|41679288|FG002|Overall Study|Adverse Event|7|||
19431824|NCT02068352|41679286|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
19431825|NCT02068352|41679287|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
19431826|NCT02068352|41679288|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
19431827|NCT02068352|41679286|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
19431828|NCT02068352|41679287|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
19431829|NCT02068352|41679288|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
19431830|NCT02068352|41679286|FG000|Overall Study|Protocol Deviation|0|||
19431831|NCT02068352|41679287|FG001|Overall Study|Protocol Deviation|0|||
19431832|NCT02068352|41679288|FG002|Overall Study|Protocol Deviation|1|||
19431833|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
19431834|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
19431835|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
19431836|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
19431837|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
19431838|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
19431839|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
19431840|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
19431841|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
19431842|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
19431843|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
19431844|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
19431845|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
19431846|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
19431847|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
19431848|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
19431849|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
19431850|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
19431851|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
19431852|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
19431853|NCT02207231|41679299|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
19431854|NCT02207231|41679300|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
19431855|NCT02207231|41679301|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
19431856|NCT02207231|41679302|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
19431857|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
19431858|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
19431859|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
19431860|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
19431861|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
19431862|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
19431863|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
19711206|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
19711207|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
19431864|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
19431865|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
19431866|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
19431867|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
19431868|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
19431869|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
19431870|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
19431871|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
19431872|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
19431873|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
19431874|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
19431875|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
19431876|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
19431877|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
19431878|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
19431879|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
19431880|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
19431881|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
19431882|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
19431883|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
19431884|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
19431885|NCT02207231|41679299|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
19431886|NCT02207231|41679300|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
19431887|NCT02207231|41679301|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
19431888|NCT02207231|41679302|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
19431889|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
19431890|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
19431891|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
19431892|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
19431893|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
19431894|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
19431895|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
19431896|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
19431897|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
19431898|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
19431899|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
19431900|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
19431901|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
19431902|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
19431903|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
19431904|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
19431905|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
19431906|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
19431907|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
19431908|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
19431909|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
19431910|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
19431911|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
19431912|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
19431913|NCT02207231|41679299|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
19431914|NCT02207231|41679300|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
19431915|NCT02207231|41679301|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
19431916|NCT02207231|41679302|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
19431917|NCT02239601|41679322|FG000|Overall Study|Withdrawal by Subject|3|||
19431918|NCT02239601|41679323|FG001|Overall Study|Withdrawal by Subject|4|||
19431919|NCT02239601|41679322|FG000|Overall Study|Protocol Violation|4|||
19431920|NCT02239601|41679323|FG001|Overall Study|Protocol Violation|2|||
19431921|NCT02236559|41679336|FG000|Overall Study|Met Exclusion|3|||
19431922|NCT02236559|41679337|FG001|Overall Study|Met Exclusion|6|||
19431923|NCT02236559|41679336|FG000|Overall Study|Did not Meet Inclusion|3|||
19431924|NCT02236559|41679337|FG001|Overall Study|Did not Meet Inclusion|3|||
19431925|NCT02236559|41679336|FG000|Overall Study|Subject Did Not Consent|4|||
19431926|NCT02236559|41679337|FG001|Overall Study|Subject Did Not Consent|2|||
19431927|NCT02236559|41679336|FG000|Overall Study|Physician Decision|1|||
19431928|NCT02236559|41679337|FG001|Overall Study|Physician Decision|1|||
19431929|NCT02236559|41679336|FG000|Overall Study|Withdrawal by Subject|1|||
19431930|NCT02236559|41679337|FG001|Overall Study|Withdrawal by Subject|0|||
19431931|NCT02206685|41679345|FG000|Overall Study|Surgery cancelled/changed|2|||
19431932|NCT02206685|41679346|FG001|Overall Study|Surgery cancelled/changed|3|||
19431933|NCT02206685|41679345|FG000|Overall Study|Withdrawal by Subject|1|||
19431934|NCT02206685|41679346|FG001|Overall Study|Withdrawal by Subject|2|||
19431935|NCT02206685|41679345|FG000|Overall Study|Protocol Violation|2|||
19431936|NCT02206685|41679346|FG001|Overall Study|Protocol Violation|2|||
19431937|NCT02206607|41679352|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
19431938|NCT02206607|41679353|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
19431939|NCT02206607|41679354|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
19431940|NCT02206607|41679355|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
19431941|NCT02206607|41679356|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
19431942|NCT02206607|41679352|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
19431943|NCT02206607|41679353|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
19431944|NCT02206607|41679354|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
19431945|NCT02206607|41679355|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
19431946|NCT02206607|41679356|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
19431947|NCT02119676|41679376|FG000|Overall Study|Adverse Event|9|||
19431948|NCT02119676|41679377|FG001|Overall Study|Adverse Event|17|||
19431949|NCT02119676|41679378|FG002|Overall Study|Adverse Event|10|||
19431950|NCT02119676|41679379|FG003|Overall Study|Adverse Event|10|||
19431951|NCT02119676|41679376|FG000|Overall Study|Disease progression|53|||
19431952|NCT02119676|41679377|FG001|Overall Study|Disease progression|55|||
19431953|NCT02119676|41679378|FG002|Overall Study|Disease progression|68|||
19431954|NCT02119676|41679379|FG003|Overall Study|Disease progression|73|||
19431955|NCT02119676|41679376|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
19431956|NCT02119676|41679377|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
19431957|NCT02119676|41679378|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
19431958|NCT02119676|41679379|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
19431959|NCT02119676|41679376|FG000|Overall Study|Physician Decision|4|||
19431960|NCT02119676|41679377|FG001|Overall Study|Physician Decision|2|||
19431961|NCT02119676|41679378|FG002|Overall Study|Physician Decision|3|||
19431962|NCT02119676|41679379|FG003|Overall Study|Physician Decision|2|||
19431963|NCT02119676|41679376|FG000|Overall Study|Death|9|||
19431964|NCT02119676|41679377|FG001|Overall Study|Death|3|||
19431965|NCT02119676|41679378|FG002|Overall Study|Death|2|||
19431966|NCT02119676|41679379|FG003|Overall Study|Death|1|||
19431967|NCT02119676|41679376|FG000|Overall Study|Noncompliance|0|||
19431968|NCT02119676|41679377|FG001|Overall Study|Noncompliance|1|||
19431969|NCT02119676|41679378|FG002|Overall Study|Noncompliance|0|||
19431970|NCT02119676|41679379|FG003|Overall Study|Noncompliance|0|||
19431971|NCT02119676|41679376|FG000|Overall Study|Lost to Follow-up|0|||
19431972|NCT02119676|41679377|FG001|Overall Study|Lost to Follow-up|0|||
19431973|NCT02119676|41679378|FG002|Overall Study|Lost to Follow-up|1|||
19431974|NCT02119676|41679379|FG003|Overall Study|Lost to Follow-up|0|||
19431975|NCT02119676|41679376|FG000|Overall Study|Protocol deviation|0|||
19431976|NCT02119676|41679377|FG001|Overall Study|Protocol deviation|0|||
19431977|NCT02119676|41679378|FG002|Overall Study|Protocol deviation|1|||
19431978|NCT02119676|41679379|FG003|Overall Study|Protocol deviation|0|||
19431979|NCT02119676|41679376|FG000|Overall Study|Other, unspecified|2|||
19431980|NCT02119676|41679377|FG001|Overall Study|Other, unspecified|1|||
19431981|NCT02119676|41679378|FG002|Overall Study|Other, unspecified|3|||
19431982|NCT02119676|41679379|FG003|Overall Study|Other, unspecified|4|||
19431983|NCT02119676|41679376|FG000|Overall Study|Did not receive study med|2|||
19431984|NCT02119676|41679377|FG001|Overall Study|Did not receive study med|2|||
19431985|NCT02119676|41679378|FG002|Overall Study|Did not receive study med|4|||
19431986|NCT02119676|41679379|FG003|Overall Study|Did not receive study med|5|||
19431987|NCT02206061|41679392|FG000|Overall Study|Withdrawal by Subject|4|||
19431988|NCT02206061|41679393|FG001|Overall Study|Withdrawal by Subject|7|||
19431989|NCT02206061|41679394|FG002|Overall Study|Withdrawal by Subject|1|||
19431990|NCT02206061|41679392|FG000|Overall Study|Lost to Follow-up|14|||
19431991|NCT02206061|41679393|FG001|Overall Study|Lost to Follow-up|7|||
19431992|NCT02206061|41679394|FG002|Overall Study|Lost to Follow-up|20|||
19431993|NCT02095106|41679404|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
19431994|NCT02095106|41679405|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
19431995|NCT01631747|41679417|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
19431996|NCT01631747|41679418|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
19431997|NCT01631747|41679417|FG000|Live Birth|Pregnancy Termination|1|||
19431998|NCT01631747|41679418|FG001|Live Birth|Pregnancy Termination|0|||
19431999|NCT01631747|41679417|FG000|Live Birth|MIscarriage|2|||
19432000|NCT01631747|41679418|FG001|Live Birth|MIscarriage|0|||
19432001|NCT01631747|41679417|FG000|Live Birth|Stillbirth|1|||
19432002|NCT01631747|41679418|FG001|Live Birth|Stillbirth|1|||
19432003|NCT01631747|41679417|FG000|One Year Infant Outcomes|Patient Refused|13|||
19432004|NCT01631747|41679418|FG001|One Year Infant Outcomes|Patient Refused|9|||
19432005|NCT02068118|41679427|FG000|18-month Comparative Study Period|Death|90|||
19432006|NCT02068118|41679428|FG001|18-month Comparative Study Period|Death|97|||
19432007|NCT02068118|41679427|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
19432008|NCT02068118|41679428|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
19432009|NCT02068118|41679427|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
19432010|NCT02068118|41679428|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
19432011|NCT02068118|41679427|FG000|18-month Comparative Study Period|Heart transplant|9|||
19432012|NCT02068118|41679428|FG001|18-month Comparative Study Period|Heart transplant|15|||
19432013|NCT02068118|41679427|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
19432014|NCT02068118|41679428|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
19432015|NCT02068118|41679427|FG000|18-month Comparative Study Period|Hemiplegia|0|||
19432016|NCT02068118|41679428|FG001|18-month Comparative Study Period|Hemiplegia|1|||
19432017|NCT02068118|41679427|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
19432018|NCT02068118|41679428|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
19432019|NCT02068118|41679427|FG000|18-month Comparative Study Period|Move|0|||
19432020|NCT02068118|41679428|FG001|18-month Comparative Study Period|Move|1|||
19432021|NCT02068118|41679427|FG000|18-month Comparative Study Period|Hearing loss|0|||
19432022|NCT02068118|41679428|FG001|18-month Comparative Study Period|Hearing loss|1|||
19432023|NCT02068118|41679427|FG000|Extension Period|Death|0|||
19432024|NCT02068118|41679428|FG001|Extension Period|Death|2|||
19432025|NCT02068118|41679427|FG000|Extension Period|Withdrawal by Subject|1|||
19432026|NCT02068118|41679428|FG001|Extension Period|Withdrawal by Subject|0|||
19432027|NCT02068118|41679427|FG000|Extension Period|Heart transplant|1|||
19432028|NCT02068118|41679428|FG001|Extension Period|Heart transplant|0|||
19432029|NCT02068118|41679427|FG000|Extension Period|Wrong device use|0|||
19432030|NCT02068118|41679428|FG001|Extension Period|Wrong device use|1|||
19432031|NCT01623830|41679438|FG000|Overall Study|Withdrawal by Subject|6|||
19432032|NCT01623830|41679439|FG001|Overall Study|Withdrawal by Subject|7|||
19432033|NCT01623830|41679438|FG000|Overall Study|Exclusion from Study|1|||
19432034|NCT01623830|41679439|FG001|Overall Study|Exclusion from Study|2|||
19432035|NCT01634165|41679445|FG000|Period 2|Adverse Event|0|||
19432036|NCT01634165|41679446|FG001|Period 2|Adverse Event|1|||
19432037|NCT01634165|41679447|FG002|Period 2|Adverse Event|0|||
19432038|NCT01634165|41679448|FG003|Period 2|Adverse Event|0|||
19432039|NCT03575897|41679460|FG000|Overall Study|Lost to Follow-up|12|||
19432040|NCT03575897|41679461|FG001|Overall Study|Lost to Follow-up|13|||
19432041|NCT02235311|41679469|FG000|Overall Study|Lost to Follow-up|0|||
19432042|NCT02235311|41679470|FG001|Overall Study|Lost to Follow-up|1|||
19432043|NCT02235311|41679469|FG000|Overall Study|Protocol Violation|0|||
19432044|NCT02235311|41679470|FG001|Overall Study|Protocol Violation|1|||
19432045|NCT02204579|41679476|FG000|Overall Study|Screen failures|2|||
19432046|NCT02235077|41679487|FG000|Overall Study|Death|5|||
19432047|NCT02235077|41679488|FG001|Overall Study|Death|7|||
19432048|NCT02235077|41679487|FG000|Overall Study|Lost to Follow-up|5|||
19432049|NCT02235077|41679488|FG001|Overall Study|Lost to Follow-up|6|||
19432050|NCT02235077|41679487|FG000|Overall Study|Withdrawal by Subject|8|||
19432051|NCT02235077|41679488|FG001|Overall Study|Withdrawal by Subject|5|||
19432052|NCT02235077|41679487|FG000|Overall Study|Physician Decision|0|||
19432053|NCT02235077|41679488|FG001|Overall Study|Physician Decision|1|||
19432054|NCT02234141|41679498|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432055|NCT02234141|41679499|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432056|NCT02234141|41679500|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432057|NCT02234141|41679501|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
19432058|NCT02234141|41679502|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432059|NCT02234141|41679503|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432060|NCT02234141|41679504|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
19432061|NCT02234141|41679498|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432062|NCT02234141|41679499|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
19432063|NCT02234141|41679500|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432064|NCT02234141|41679501|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432065|NCT02234141|41679502|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432066|NCT02234141|41679503|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432067|NCT02234141|41679504|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
19432068|NCT02234141|41679498|FG000|Treatment Period (24 Weeks)|Death|1|||
19432069|NCT02234141|41679499|FG001|Treatment Period (24 Weeks)|Death|2|||
19432070|NCT02234141|41679500|FG002|Treatment Period (24 Weeks)|Death|0|||
19432071|NCT02234141|41679501|FG003|Treatment Period (24 Weeks)|Death|1|||
19432072|NCT02234141|41679502|FG004|Treatment Period (24 Weeks)|Death|0|||
19432073|NCT02234141|41679503|FG005|Treatment Period (24 Weeks)|Death|0|||
19432074|NCT02234141|41679504|FG006|Treatment Period (24 Weeks)|Death|0|||
19432075|NCT02234141|41679498|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
19432076|NCT02234141|41679499|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
19432077|NCT02234141|41679500|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
19432078|NCT02234141|41679501|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
19432079|NCT02234141|41679502|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
19432080|NCT02234141|41679503|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
19432081|NCT02234141|41679504|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
19432082|NCT02234141|41679498|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19521699|NCT00637728|41935048|FG001|Double-blind Phase|Adverse Event|0|||
19432083|NCT02234141|41679499|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
19432084|NCT02234141|41679500|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19432085|NCT02234141|41679501|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19432086|NCT02234141|41679502|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19432087|NCT02234141|41679503|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19432088|NCT02234141|41679504|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
19432089|NCT02234141|41679498|FG000|Long-Term Treatment Period|Death|0|||
19432090|NCT02234141|41679499|FG001|Long-Term Treatment Period|Death|0|||
19432091|NCT02234141|41679500|FG002|Long-Term Treatment Period|Death|0|||
19432092|NCT02234141|41679501|FG003|Long-Term Treatment Period|Death|0|||
19432093|NCT02234141|41679502|FG004|Long-Term Treatment Period|Death|0|||
19432094|NCT02234141|41679503|FG005|Long-Term Treatment Period|Death|1|||
19432095|NCT02234141|41679504|FG006|Long-Term Treatment Period|Death|0|||
19432096|NCT02234141|41679498|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
19432097|NCT02234141|41679499|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
19432098|NCT02234141|41679500|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
19432099|NCT02234141|41679501|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
19432100|NCT02234141|41679502|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
19432101|NCT02234141|41679503|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
19432102|NCT02234141|41679504|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
19432103|NCT02234141|41679498|FG000|Long-Term Treatment Period|Adverse Event|4|||
19432104|NCT02234141|41679499|FG001|Long-Term Treatment Period|Adverse Event|0|||
19432105|NCT02234141|41679500|FG002|Long-Term Treatment Period|Adverse Event|5|||
19432106|NCT02234141|41679501|FG003|Long-Term Treatment Period|Adverse Event|0|||
19432107|NCT02234141|41679502|FG004|Long-Term Treatment Period|Adverse Event|1|||
19432108|NCT02234141|41679503|FG005|Long-Term Treatment Period|Adverse Event|1|||
19432109|NCT02234141|41679504|FG006|Long-Term Treatment Period|Adverse Event|1|||
19432110|NCT02234141|41679498|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
19432111|NCT02234141|41679499|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
19432112|NCT02234141|41679500|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
19432113|NCT02234141|41679501|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
19432114|NCT02234141|41679502|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
19432115|NCT02234141|41679503|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
19432116|NCT02234141|41679504|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
19432117|NCT02234141|41679498|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
19432118|NCT02234141|41679499|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
19432119|NCT02234141|41679500|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
19432120|NCT02234141|41679501|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
19432121|NCT02234141|41679502|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
19432122|NCT02234141|41679503|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
19432123|NCT02234141|41679504|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
19432124|NCT02234063|41679517|FG000|Overall Study|Lost to Follow-up|235|||
19432125|NCT02234063|41679518|FG001|Overall Study|Lost to Follow-up|42|||
19432126|NCT02234063|41679517|FG000|Overall Study|Withdrawal by Subject|20|||
19432127|NCT02234063|41679518|FG001|Overall Study|Withdrawal by Subject|1|||
19432128|NCT02232893|41679531|FG000|Overall Study|Withdrawal by Subject|4|||
19432129|NCT02232893|41679532|FG001|Overall Study|Withdrawal by Subject|1|||
19432130|NCT02232893|41679531|FG000|Overall Study|Adverse Event|0|||
19432131|NCT02232893|41679532|FG001|Overall Study|Adverse Event|1|||
19432132|NCT02232893|41679531|FG000|Overall Study|Sponsor request early termination|0|||
19432133|NCT02232893|41679532|FG001|Overall Study|Sponsor request early termination|1|||
19432134|NCT02232893|41679531|FG000|Overall Study|Developed exclusion criteria|0|||
19432135|NCT02232893|41679532|FG001|Overall Study|Developed exclusion criteria|1|||
19432136|NCT02232893|41679531|FG000|Overall Study|Other|0|||
19432137|NCT02232893|41679532|FG001|Overall Study|Other|3|||
19432138|NCT02203721|41679540|FG000|Overall Study|Lost to Follow-up|1|||
19432139|NCT02203721|41679541|FG001|Overall Study|Lost to Follow-up|0|||
19432140|NCT02203721|41679540|FG000|Overall Study|Death|0|||
19432141|NCT02203721|41679541|FG001|Overall Study|Death|2|||
19432142|NCT02203721|41679540|FG000|Overall Study|Illness|0|||
19432143|NCT02203721|41679541|FG001|Overall Study|Illness|1|||
19521700|NCT00637728|41935049|FG002|Double-blind Phase|Adverse Event|0|||
19521701|NCT00637728|41935047|FG000|Double-blind Phase|Non-compliance|2|||
19521702|NCT00637728|41935048|FG001|Double-blind Phase|Non-compliance|0|||
19521703|NCT00637728|41935049|FG002|Double-blind Phase|Non-compliance|0|||
19521704|NCT00637728|41935047|FG000|Double-blind Phase|Study Discontinued|1|||
19521705|NCT00637728|41935048|FG001|Double-blind Phase|Study Discontinued|1|||
19521706|NCT00637728|41935049|FG002|Double-blind Phase|Study Discontinued|0|||
19521707|NCT00637572|41935058|FG000|Overall Study|Adverse Event|1|||
19521708|NCT00637572|41935059|FG001|Overall Study|Adverse Event|2|||
19521709|NCT00637572|41935058|FG000|Overall Study|Death|0|||
19521710|NCT00637572|41935059|FG001|Overall Study|Death|1|||
19628324|NCT00863681|42077761|FG001|Overall Study|Missing|0|||
19432144|NCT01618695|41679551|FG000|Core Phase|Adverse Event|4|||
19432145|NCT01618695|41679552|FG001|Core Phase|Adverse Event|5|||
19432146|NCT01618695|41679553|FG002|Core Phase|Adverse Event|15|||
19432147|NCT01618695|41679554|FG003|Core Phase|Adverse Event|20|||
19432148|NCT01618695|41679551|FG000|Core Phase|Lost to Follow-up|0|||
19432149|NCT01618695|41679552|FG001|Core Phase|Lost to Follow-up|0|||
19432150|NCT01618695|41679553|FG002|Core Phase|Lost to Follow-up|1|||
19432151|NCT01618695|41679554|FG003|Core Phase|Lost to Follow-up|0|||
19432152|NCT01618695|41679551|FG000|Core Phase|Withdrawal by Subject|16|||
19432153|NCT01618695|41679552|FG001|Core Phase|Withdrawal by Subject|11|||
19432154|NCT01618695|41679553|FG002|Core Phase|Withdrawal by Subject|9|||
19432155|NCT01618695|41679554|FG003|Core Phase|Withdrawal by Subject|13|||
19432156|NCT01618695|41679551|FG000|Core Phase|Pregnancy|2|||
19432157|NCT01618695|41679552|FG001|Core Phase|Pregnancy|0|||
19432158|NCT01618695|41679553|FG002|Core Phase|Pregnancy|0|||
19432159|NCT01618695|41679554|FG003|Core Phase|Pregnancy|0|||
19432160|NCT01618695|41679551|FG000|Core Phase|Lack of Efficacy|1|||
19432161|NCT01618695|41679552|FG001|Core Phase|Lack of Efficacy|2|||
19432162|NCT01618695|41679553|FG002|Core Phase|Lack of Efficacy|1|||
19432163|NCT01618695|41679554|FG003|Core Phase|Lack of Efficacy|1|||
19432164|NCT01618695|41679551|FG000|Core Phase|Other than specified|1|||
19432165|NCT01618695|41679552|FG001|Core Phase|Other than specified|2|||
19432166|NCT01618695|41679553|FG002|Core Phase|Other than specified|2|||
19432167|NCT01618695|41679554|FG003|Core Phase|Other than specified|2|||
19432168|NCT01618695|41679551|FG000|Core Phase|Not treated|1|||
19432169|NCT01618695|41679552|FG001|Core Phase|Not treated|0|||
19432170|NCT01618695|41679553|FG002|Core Phase|Not treated|2|||
19432171|NCT01618695|41679554|FG003|Core Phase|Not treated|0|||
19432172|NCT01618695|41679551|FG000|Extension Phase|Lack of Efficacy|17|||
19432173|NCT01618695|41679552|FG001|Extension Phase|Lack of Efficacy|33|||
19432174|NCT01618695|41679553|FG002|Extension Phase|Lack of Efficacy|26|||
19432175|NCT01618695|41679554|FG003|Extension Phase|Lack of Efficacy|24|||
19432176|NCT01618695|41679551|FG000|Extension Phase|Pregnancy|2|||
19432177|NCT01618695|41679552|FG001|Extension Phase|Pregnancy|0|||
19432178|NCT01618695|41679553|FG002|Extension Phase|Pregnancy|1|||
19432179|NCT01618695|41679554|FG003|Extension Phase|Pregnancy|1|||
19432180|NCT01618695|41679551|FG000|Extension Phase|Withdrawal by Subject|43|||
19432181|NCT01618695|41679552|FG001|Extension Phase|Withdrawal by Subject|48|||
19432182|NCT01618695|41679553|FG002|Extension Phase|Withdrawal by Subject|42|||
19432183|NCT01618695|41679554|FG003|Extension Phase|Withdrawal by Subject|33|||
19432184|NCT01618695|41679551|FG000|Extension Phase|Adverse Event|18|||
19432185|NCT01618695|41679552|FG001|Extension Phase|Adverse Event|16|||
19432186|NCT01618695|41679553|FG002|Extension Phase|Adverse Event|9|||
19432187|NCT01618695|41679554|FG003|Extension Phase|Adverse Event|20|||
19432188|NCT01618695|41679551|FG000|Extension Phase|Lost to Follow-up|2|||
19432189|NCT01618695|41679552|FG001|Extension Phase|Lost to Follow-up|1|||
19432190|NCT01618695|41679553|FG002|Extension Phase|Lost to Follow-up|1|||
19432191|NCT01618695|41679554|FG003|Extension Phase|Lost to Follow-up|1|||
19432192|NCT01618695|41679551|FG000|Extension Phase|Other than specified|13|||
19432193|NCT01618695|41679552|FG001|Extension Phase|Other than specified|18|||
19432194|NCT01618695|41679553|FG002|Extension Phase|Other than specified|13|||
19432195|NCT01618695|41679554|FG003|Extension Phase|Other than specified|18|||
19432196|NCT01896531|41679567|FG000|Overall Study|Death|57|||
19432197|NCT01896531|41679568|FG001|Overall Study|Death|59|||
19432198|NCT01896531|41679567|FG000|Overall Study|Lost to Follow-up|3|||
19432199|NCT01896531|41679568|FG001|Overall Study|Lost to Follow-up|0|||
19432200|NCT01896531|41679567|FG000|Overall Study|Non-compliance|0|||
19432201|NCT01896531|41679568|FG001|Overall Study|Non-compliance|1|||
19432202|NCT01896531|41679567|FG000|Overall Study|Study Ended by Sponsor|7|||
19432203|NCT01896531|41679568|FG001|Overall Study|Study Ended by Sponsor|20|||
19432204|NCT01896531|41679567|FG000|Overall Study|Withdrawal by Subject|3|||
19432205|NCT01896531|41679568|FG001|Overall Study|Withdrawal by Subject|2|||
19432206|NCT01896531|41679567|FG000|Overall Study|Death Prior to Treatment|1|||
19432207|NCT01896531|41679568|FG001|Overall Study|Death Prior to Treatment|0|||
19432208|NCT01618305|41679576|FG000|Overall Study|Death|0|||
19432209|NCT01618305|41679577|FG001|Overall Study|Death|1|||
19432210|NCT01618305|41679576|FG000|Overall Study|Lost to Follow-up|11|||
19432211|NCT01618305|41679577|FG001|Overall Study|Lost to Follow-up|7|||
19432212|NCT01618305|41679576|FG000|Overall Study|Protocol Violation|1|||
19432213|NCT01618305|41679577|FG001|Overall Study|Protocol Violation|0|||
19432214|NCT01618305|41679576|FG000|Overall Study|Withdrawal by Subject|3|||
19432215|NCT01618305|41679577|FG001|Overall Study|Withdrawal by Subject|2|||
19432216|NCT01886313|41679589|FG000|Overall Study|Adverse Event|1|||
19432217|NCT01886313|41679590|FG001|Overall Study|Adverse Event|1|||
19432218|NCT01896297|41679596|FG000|Overall Study|Died in post treatment phase|1|||
19432219|NCT01884675|41679602|FG000|Overall Study|Study closed/terminated|3|||
19432220|NCT01884675|41679603|FG001|Overall Study|Study closed/terminated|2|||
19432221|NCT01884597|41679614|FG000|Overall Study|Adverse Event|0|||
19432222|NCT01884597|41679615|FG001|Overall Study|Adverse Event|0|||
19432223|NCT01884597|41679616|FG002|Overall Study|Adverse Event|1|||
19432224|NCT01884597|41679614|FG000|Overall Study|Lack of Efficacy|1|||
19432225|NCT01884597|41679615|FG001|Overall Study|Lack of Efficacy|0|||
19432226|NCT01884597|41679616|FG002|Overall Study|Lack of Efficacy|0|||
19432227|NCT01884597|41679614|FG000|Overall Study|Death|0|||
19432228|NCT01884597|41679615|FG001|Overall Study|Death|1|||
19432229|NCT01884597|41679616|FG002|Overall Study|Death|0|||
19432230|NCT01895361|41679633|FG000|Overall Study|Adverse Event|1|||
19432231|NCT01895361|41679634|FG001|Overall Study|Adverse Event|1|||
19432232|NCT01895361|41679635|FG002|Overall Study|Adverse Event|3|||
19432233|NCT01895361|41679633|FG000|Overall Study|Death|2|||
19432234|NCT01895361|41679634|FG001|Overall Study|Death|1|||
19432235|NCT01895361|41679635|FG002|Overall Study|Death|2|||
19432236|NCT01895361|41679633|FG000|Overall Study|Lost to Follow-up|4|||
19432237|NCT01895361|41679634|FG001|Overall Study|Lost to Follow-up|4|||
19432238|NCT01895361|41679635|FG002|Overall Study|Lost to Follow-up|6|||
19432239|NCT01895361|41679633|FG000|Overall Study|Non-compliance with study|1|||
19432240|NCT01895361|41679634|FG001|Overall Study|Non-compliance with study|3|||
19432241|NCT01895361|41679635|FG002|Overall Study|Non-compliance with study|1|||
19432242|NCT01895361|41679633|FG000|Overall Study|Physician Decision|2|||
19432243|NCT01895361|41679634|FG001|Overall Study|Physician Decision|2|||
19432244|NCT01895361|41679635|FG002|Overall Study|Physician Decision|2|||
19432245|NCT01895361|41679633|FG000|Overall Study|Withdrawal by Subject|7|||
19432246|NCT01895361|41679634|FG001|Overall Study|Withdrawal by Subject|6|||
19432247|NCT01895361|41679635|FG002|Overall Study|Withdrawal by Subject|6|||
19432248|NCT01895361|41679633|FG000|Overall Study|Lack of Efficacy|0|||
19432249|NCT01895361|41679634|FG001|Overall Study|Lack of Efficacy|1|||
19432250|NCT01895361|41679635|FG002|Overall Study|Lack of Efficacy|0|||
19432251|NCT01895361|41679633|FG000|Overall Study|Reasons different from categories above|7|||
19432252|NCT01895361|41679634|FG001|Overall Study|Reasons different from categories above|3|||
19432253|NCT01895361|41679635|FG002|Overall Study|Reasons different from categories above|4|||
19432254|NCT01883895|41679643|FG000|Overall Study|Lost to Follow-up|2|||
19432255|NCT01864005|41679649|FG000|Overall Study|Protocol Violation|0|||
19432256|NCT01864005|41679650|FG001|Overall Study|Protocol Violation|1|||
19432257|NCT01864005|41679649|FG000|Overall Study|Withdrawal by Subject|0|||
19432258|NCT01864005|41679650|FG001|Overall Study|Withdrawal by Subject|1|||
19432259|NCT01864005|41679649|FG000|Overall Study|Incorrect enrolment|1|||
19432260|NCT01864005|41679650|FG001|Overall Study|Incorrect enrolment|0|||
19432261|NCT01864005|41679649|FG000|Overall Study|Disease need|1|||
19432262|NCT01864005|41679650|FG001|Overall Study|Disease need|1|||
19432263|NCT01864005|41679649|FG000|Overall Study|Need GP IIb/IIIa|1|||
19432264|NCT01864005|41679650|FG001|Overall Study|Need GP IIb/IIIa|3|||
19432265|NCT01863849|41679658|FG000|Overall Study|Lost to Follow-up|1|||
19432266|NCT01863849|41679659|FG001|Overall Study|Lost to Follow-up|0|||
19432267|NCT01863771|41679666|FG000|Induction Phase|Adverse Event|9|||
19432268|NCT01863771|41679667|FG001|Induction Phase|Adverse Event|0|||
19432269|NCT01863771|41679668|FG002|Induction Phase|Adverse Event|0|||
19432270|NCT01863771|41679669|FG003|Induction Phase|Adverse Event|0|||
19432271|NCT01863771|41679666|FG000|Induction Phase|Lack of Efficacy|10|||
19432272|NCT01863771|41679667|FG001|Induction Phase|Lack of Efficacy|0|||
19432273|NCT01863771|41679668|FG002|Induction Phase|Lack of Efficacy|0|||
19432274|NCT01863771|41679669|FG003|Induction Phase|Lack of Efficacy|0|||
19432275|NCT01863771|41679666|FG000|Induction Phase|Withdrawal by Subject|2|||
19432276|NCT01863771|41679667|FG001|Induction Phase|Withdrawal by Subject|0|||
19432277|NCT01863771|41679668|FG002|Induction Phase|Withdrawal by Subject|0|||
19432278|NCT01863771|41679669|FG003|Induction Phase|Withdrawal by Subject|0|||
19432279|NCT01863771|41679666|FG000|Maintenance Phase|Adverse Event|0|||
19432280|NCT01863771|41679667|FG001|Maintenance Phase|Adverse Event|0|||
19432281|NCT01863771|41679668|FG002|Maintenance Phase|Adverse Event|1|||
19432282|NCT01863771|41679669|FG003|Maintenance Phase|Adverse Event|1|||
19432283|NCT01863771|41679666|FG000|Maintenance Phase|Lack of Efficacy|0|||
19432284|NCT01863771|41679667|FG001|Maintenance Phase|Lack of Efficacy|3|||
19432285|NCT01863771|41679668|FG002|Maintenance Phase|Lack of Efficacy|7|||
19432286|NCT01863771|41679669|FG003|Maintenance Phase|Lack of Efficacy|38|||
19432287|NCT01863771|41679666|FG000|Maintenance Phase|Physician Decision|0|||
19432288|NCT01863771|41679667|FG001|Maintenance Phase|Physician Decision|0|||
19432289|NCT01863771|41679668|FG002|Maintenance Phase|Physician Decision|2|||
19432290|NCT01863771|41679669|FG003|Maintenance Phase|Physician Decision|1|||
19432291|NCT01863771|41679666|FG000|Maintenance Phase|Pregnancy|0|||
19432292|NCT01863771|41679667|FG001|Maintenance Phase|Pregnancy|1|||
19432293|NCT01863771|41679668|FG002|Maintenance Phase|Pregnancy|0|||
19432294|NCT01863771|41679669|FG003|Maintenance Phase|Pregnancy|0|||
19628325|NCT00863681|42077762|FG002|Overall Study|Missing|0|||
19432295|NCT01863771|41679666|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19432296|NCT01863771|41679667|FG001|Maintenance Phase|Withdrawal by Subject|1|||
19432297|NCT01863771|41679668|FG002|Maintenance Phase|Withdrawal by Subject|2|||
19432298|NCT01863771|41679669|FG003|Maintenance Phase|Withdrawal by Subject|3|||
19432299|NCT01894581|41679679|FG000|Overall Study|Withdrawal by Subject|2|||
19432300|NCT01894581|41679680|FG001|Overall Study|Withdrawal by Subject|3|||
19432301|NCT01894581|41679679|FG000|Overall Study|Screen Failure|3|||
19432302|NCT01894581|41679680|FG001|Overall Study|Screen Failure|4|||
19432303|NCT02203331|41679692|FG000|Overall Study|Pregnancy|1|||
19432304|NCT02203331|41679693|FG001|Overall Study|Pregnancy|0|||
19432305|NCT02203331|41679694|FG002|Overall Study|Pregnancy|0|||
19432306|NCT02203331|41679695|FG003|Overall Study|Pregnancy|0|||
19432307|NCT02203331|41679696|FG004|Overall Study|Pregnancy|2|||
19432308|NCT02203331|41679697|FG005|Overall Study|Pregnancy|0|||
19432309|NCT02203331|41679692|FG000|Overall Study|Withdrawal by Subject|1|||
19432310|NCT02203331|41679693|FG001|Overall Study|Withdrawal by Subject|0|||
19432311|NCT02203331|41679694|FG002|Overall Study|Withdrawal by Subject|1|||
19432312|NCT02203331|41679695|FG003|Overall Study|Withdrawal by Subject|0|||
19432313|NCT02203331|41679696|FG004|Overall Study|Withdrawal by Subject|0|||
19432314|NCT02203331|41679697|FG005|Overall Study|Withdrawal by Subject|3|||
19432315|NCT02203331|41679692|FG000|Overall Study|Adverse Event|4|||
19432316|NCT02203331|41679693|FG001|Overall Study|Adverse Event|8|||
19432317|NCT02203331|41679694|FG002|Overall Study|Adverse Event|3|||
19432318|NCT02203331|41679695|FG003|Overall Study|Adverse Event|4|||
19432319|NCT02203331|41679696|FG004|Overall Study|Adverse Event|3|||
19432320|NCT02203331|41679697|FG005|Overall Study|Adverse Event|3|||
19432321|NCT02203331|41679692|FG000|Overall Study|Other Reasons|1|||
19432322|NCT02203331|41679693|FG001|Overall Study|Other Reasons|2|||
19432323|NCT02203331|41679694|FG002|Overall Study|Other Reasons|0|||
19432324|NCT02203331|41679695|FG003|Overall Study|Other Reasons|2|||
19432325|NCT02203331|41679696|FG004|Overall Study|Other Reasons|0|||
19432326|NCT02203331|41679697|FG005|Overall Study|Other Reasons|0|||
19432327|NCT02203331|41679692|FG000|Overall Study|Lack of Efficacy|0|||
19432328|NCT02203331|41679693|FG001|Overall Study|Lack of Efficacy|2|||
19432329|NCT02203331|41679694|FG002|Overall Study|Lack of Efficacy|1|||
19432330|NCT02203331|41679695|FG003|Overall Study|Lack of Efficacy|0|||
19432331|NCT02203331|41679696|FG004|Overall Study|Lack of Efficacy|0|||
19432332|NCT02203331|41679697|FG005|Overall Study|Lack of Efficacy|1|||
19432333|NCT02203331|41679692|FG000|Overall Study|Protocol Violation|0|||
19432334|NCT02203331|41679693|FG001|Overall Study|Protocol Violation|2|||
19432335|NCT02203331|41679694|FG002|Overall Study|Protocol Violation|0|||
19432336|NCT02203331|41679695|FG003|Overall Study|Protocol Violation|1|||
19432337|NCT02203331|41679696|FG004|Overall Study|Protocol Violation|1|||
19432338|NCT02203331|41679697|FG005|Overall Study|Protocol Violation|0|||
19432339|NCT02203331|41679692|FG000|Overall Study|Lost to Follow-up|0|||
19432340|NCT02203331|41679693|FG001|Overall Study|Lost to Follow-up|0|||
19432341|NCT02203331|41679694|FG002|Overall Study|Lost to Follow-up|0|||
19432342|NCT02203331|41679695|FG003|Overall Study|Lost to Follow-up|0|||
19432343|NCT02203331|41679696|FG004|Overall Study|Lost to Follow-up|1|||
19432344|NCT02203331|41679697|FG005|Overall Study|Lost to Follow-up|0|||
19432345|NCT01893411|41679714|FG000|Overall Study|Protocol Violation|1|||
19432346|NCT01893411|41679715|FG001|Overall Study|Protocol Violation|0|||
19432347|NCT01893411|41679716|FG002|Overall Study|Protocol Violation|0|||
19432348|NCT01893411|41679714|FG000|Overall Study|Physician Decision|1|||
19432349|NCT01893411|41679715|FG001|Overall Study|Physician Decision|1|||
19432350|NCT01893411|41679716|FG002|Overall Study|Physician Decision|2|||
19432351|NCT01893411|41679714|FG000|Overall Study|Lack of Efficacy|2|||
19432352|NCT01893411|41679715|FG001|Overall Study|Lack of Efficacy|1|||
19432353|NCT01893411|41679716|FG002|Overall Study|Lack of Efficacy|0|||
19432354|NCT01893411|41679714|FG000|Overall Study|Other|3|||
19432355|NCT01893411|41679715|FG001|Overall Study|Other|1|||
19432356|NCT01893411|41679716|FG002|Overall Study|Other|3|||
19432357|NCT01893411|41679714|FG000|Overall Study|Adverse Event|1|||
19432358|NCT01893411|41679715|FG001|Overall Study|Adverse Event|0|||
19432359|NCT01893411|41679716|FG002|Overall Study|Adverse Event|0|||
19432360|NCT01893411|41679714|FG000|Overall Study|Withdrawal by Subject|7|||
19432361|NCT01893411|41679715|FG001|Overall Study|Withdrawal by Subject|4|||
19432362|NCT01893411|41679716|FG002|Overall Study|Withdrawal by Subject|3|||
19432363|NCT01893411|41679714|FG000|Overall Study|Lost to Follow-up|2|||
19432364|NCT01893411|41679715|FG001|Overall Study|Lost to Follow-up|0|||
19432365|NCT01893411|41679716|FG002|Overall Study|Lost to Follow-up|1|||
19432366|NCT02232425|41679726|FG000|Overall Study|Lost to Follow-up|6|||
19432367|NCT02232425|41679727|FG001|Overall Study|Lost to Follow-up|2|||
19432368|NCT02232425|41679726|FG000|Overall Study|Adverse Event|2|||
19432369|NCT02232425|41679727|FG001|Overall Study|Adverse Event|0|||
19432370|NCT02232425|41679726|FG000|Overall Study|Withdrawal by Subject|5|||
19432371|NCT02232425|41679727|FG001|Overall Study|Withdrawal by Subject|6|||
19432372|NCT02232425|41679726|FG000|Overall Study|Lack of Efficacy|1|||
19432373|NCT02232425|41679727|FG001|Overall Study|Lack of Efficacy|0|||
19432374|NCT01631435|41679733|FG000|Overall Study|Adverse Event|2|||
19432375|NCT01631435|41679733|FG000|Overall Study|Withdrawal by Subject|2|||
19432376|NCT01631435|41679733|FG000|Overall Study|incomplete study procedure|5|||
19432377|NCT02230085|41679738|FG000|Overall Study|Physician Decision|1|||
19432378|NCT02230085|41679738|FG000|Overall Study|Withdrawal by Subject|3|||
19432379|NCT01882803|41679742|FG000|Overall Study|Disease Progression|53|||
19432380|NCT01882803|41679742|FG000|Overall Study|Adverse Event|22|||
19432381|NCT01882803|41679742|FG000|Overall Study|Death|7|||
19432382|NCT01882803|41679742|FG000|Overall Study|Physician Decision|7|||
19432383|NCT01882803|41679742|FG000|Overall Study|Protocol Violation|1|||
19432384|NCT01882803|41679742|FG000|Overall Study|Withdrawal by Subject|4|||
19432385|NCT02202785|41679750|FG000|Overall Study|Study Terminated by Sponsor|1|||
19432386|NCT02202785|41679751|FG001|Overall Study|Study Terminated by Sponsor|6|||
19432387|NCT02202785|41679752|FG002|Overall Study|Study Terminated by Sponsor|4|||
19432388|NCT02202785|41679750|FG000|Overall Study|Withdrawal by Subject|0|||
19432389|NCT02202785|41679751|FG001|Overall Study|Withdrawal by Subject|1|||
19432390|NCT02202785|41679752|FG002|Overall Study|Withdrawal by Subject|0|||
19432391|NCT02202785|41679750|FG000|Overall Study|Lost to Follow-up|0|||
19432392|NCT02202785|41679751|FG001|Overall Study|Lost to Follow-up|1|||
19432393|NCT02202785|41679752|FG002|Overall Study|Lost to Follow-up|0|||
19432394|NCT02202785|41679750|FG000|Overall Study|Reason not Specified|10|||
19432395|NCT02202785|41679751|FG001|Overall Study|Reason not Specified|7|||
19432396|NCT02202785|41679752|FG002|Overall Study|Reason not Specified|13|||
19432397|NCT01882647|41679762|FG000|Overall Study|Lost to Follow-up|2|||
19432398|NCT01882647|41679763|FG001|Overall Study|Lost to Follow-up|2|||
19432399|NCT01882647|41679762|FG000|Overall Study|Withdrawal by Subject|0|||
19432400|NCT01882647|41679763|FG001|Overall Study|Withdrawal by Subject|4|||
19432401|NCT01882257|41679772|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
19432402|NCT01882257|41679773|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
19432403|NCT01882257|41679774|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
19432404|NCT01882257|41679772|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
19432405|NCT01882257|41679773|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
19432406|NCT01882257|41679774|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
19432407|NCT01862991|41679784|FG000|Overall Study|Lost to Follow-up|2|||
19432408|NCT01862991|41679785|FG001|Overall Study|Lost to Follow-up|1|||
19432409|NCT01862991|41679786|FG002|Overall Study|Lost to Follow-up|1|||
19432410|NCT01862991|41679784|FG000|Overall Study|Protocol Violation|1|||
19432411|NCT01862991|41679785|FG001|Overall Study|Protocol Violation|0|||
19432412|NCT01862991|41679786|FG002|Overall Study|Protocol Violation|0|||
19432413|NCT02202551|41679798|FG000|Overall Study|Adverse Event|8|||
19432414|NCT02202551|41679799|FG001|Overall Study|Adverse Event|19|||
19432415|NCT02202551|41679800|FG002|Overall Study|Adverse Event|5|||
19432416|NCT02202551|41679801|FG003|Overall Study|Adverse Event|9|||
19432417|NCT02202551|41679798|FG000|Overall Study|Death|3|||
19432418|NCT02202551|41679799|FG001|Overall Study|Death|2|||
19432419|NCT02202551|41679800|FG002|Overall Study|Death|1|||
19432420|NCT02202551|41679801|FG003|Overall Study|Death|1|||
19432421|NCT02202551|41679798|FG000|Overall Study|Lost to Follow-up|0|||
19432422|NCT02202551|41679799|FG001|Overall Study|Lost to Follow-up|1|||
19432423|NCT02202551|41679800|FG002|Overall Study|Lost to Follow-up|0|||
19432424|NCT02202551|41679801|FG003|Overall Study|Lost to Follow-up|1|||
19432425|NCT02202551|41679798|FG000|Overall Study|Needed to take excluded medication|0|||
19432426|NCT02202551|41679799|FG001|Overall Study|Needed to take excluded medication|2|||
19432427|NCT02202551|41679800|FG002|Overall Study|Needed to take excluded medication|0|||
19432428|NCT02202551|41679801|FG003|Overall Study|Needed to take excluded medication|1|||
19432429|NCT02202551|41679798|FG000|Overall Study|Subject moved away|0|||
19432430|NCT02202551|41679799|FG001|Overall Study|Subject moved away|1|||
19432431|NCT02202551|41679800|FG002|Overall Study|Subject moved away|0|||
19432432|NCT02202551|41679801|FG003|Overall Study|Subject moved away|0|||
19432433|NCT02202551|41679798|FG000|Overall Study|DBS surgery|3|||
19432434|NCT02202551|41679799|FG001|Overall Study|DBS surgery|0|||
19432435|NCT02202551|41679800|FG002|Overall Study|DBS surgery|0|||
19432436|NCT02202551|41679801|FG003|Overall Study|DBS surgery|0|||
19432437|NCT02202551|41679798|FG000|Overall Study|Dyskinesia upon taper|1|||
19432438|NCT02202551|41679799|FG001|Overall Study|Dyskinesia upon taper|0|||
19432439|NCT02202551|41679800|FG002|Overall Study|Dyskinesia upon taper|0|||
19432440|NCT02202551|41679801|FG003|Overall Study|Dyskinesia upon taper|0|||
19432441|NCT02202551|41679798|FG000|Overall Study|Lack of Efficacy|0|||
19432442|NCT02202551|41679799|FG001|Overall Study|Lack of Efficacy|1|||
19432443|NCT02202551|41679800|FG002|Overall Study|Lack of Efficacy|0|||
19432444|NCT02202551|41679801|FG003|Overall Study|Lack of Efficacy|0|||
19432445|NCT02202551|41679798|FG000|Overall Study|Physician Decision|1|||
19432446|NCT02202551|41679799|FG001|Overall Study|Physician Decision|0|||
19432447|NCT02202551|41679800|FG002|Overall Study|Physician Decision|0|||
19432448|NCT02202551|41679801|FG003|Overall Study|Physician Decision|0|||
19432449|NCT02202551|41679798|FG000|Overall Study|Site closure|3|||
19432450|NCT02202551|41679799|FG001|Overall Study|Site closure|0|||
19432451|NCT02202551|41679800|FG002|Overall Study|Site closure|0|||
19432452|NCT02202551|41679801|FG003|Overall Study|Site closure|1|||
19432453|NCT02202551|41679798|FG000|Overall Study|Unable to complete visits per protocol|1|||
19432454|NCT02202551|41679799|FG001|Overall Study|Unable to complete visits per protocol|0|||
19432455|NCT02202551|41679800|FG002|Overall Study|Unable to complete visits per protocol|0|||
19432456|NCT02202551|41679801|FG003|Overall Study|Unable to complete visits per protocol|0|||
19432457|NCT02202551|41679798|FG000|Overall Study|Worsening Dyskinesia|0|||
19432458|NCT02202551|41679799|FG001|Overall Study|Worsening Dyskinesia|0|||
19432459|NCT02202551|41679800|FG002|Overall Study|Worsening Dyskinesia|0|||
19432460|NCT02202551|41679801|FG003|Overall Study|Worsening Dyskinesia|1|||
19432461|NCT02202551|41679798|FG000|Overall Study|Protocol Violation|0|||
19432462|NCT02202551|41679799|FG001|Overall Study|Protocol Violation|1|||
19432463|NCT02202551|41679800|FG002|Overall Study|Protocol Violation|0|||
19432464|NCT02202551|41679801|FG003|Overall Study|Protocol Violation|0|||
19432465|NCT02202551|41679798|FG000|Overall Study|Sponsor's decision|2|||
19432466|NCT02202551|41679799|FG001|Overall Study|Sponsor's decision|0|||
19432467|NCT02202551|41679800|FG002|Overall Study|Sponsor's decision|0|||
19432468|NCT02202551|41679801|FG003|Overall Study|Sponsor's decision|0|||
19432469|NCT02202551|41679798|FG000|Overall Study|Subject unwilling to proceed|1|||
19432470|NCT02202551|41679799|FG001|Overall Study|Subject unwilling to proceed|5|||
19432471|NCT02202551|41679800|FG002|Overall Study|Subject unwilling to proceed|3|||
19432472|NCT02202551|41679801|FG003|Overall Study|Subject unwilling to proceed|5|||
19432473|NCT02202551|41679798|FG000|Overall Study|Subject consent withdrawn|0|||
19432474|NCT02202551|41679799|FG001|Overall Study|Subject consent withdrawn|3|||
19432475|NCT02202551|41679800|FG002|Overall Study|Subject consent withdrawn|1|||
19432476|NCT02202551|41679801|FG003|Overall Study|Subject consent withdrawn|2|||
19432477|NCT02202551|41679798|FG000|Overall Study|eGFR<50mL/min/m2|2|||
19432478|NCT02202551|41679799|FG001|Overall Study|eGFR<50mL/min/m2|2|||
19432479|NCT02202551|41679800|FG002|Overall Study|eGFR<50mL/min/m2|0|||
19432480|NCT02202551|41679801|FG003|Overall Study|eGFR<50mL/min/m2|1|||
19432481|NCT02202317|41679815|FG000|Overall Study|Lost to Follow-up|1|||
19432482|NCT02118337|41679828|FG000|Overall Study|Other|1|||
19432483|NCT02118337|41679829|FG001|Overall Study|Other|0|||
19432484|NCT02118337|41679830|FG002|Overall Study|Other|0|||
19432485|NCT02118337|41679831|FG003|Overall Study|Other|0|||
19432486|NCT02118337|41679832|FG004|Overall Study|Other|2|||
19432487|NCT02118337|41679833|FG005|Overall Study|Other|3|||
19432488|NCT02118337|41679834|FG006|Overall Study|Other|1|||
19432489|NCT02118337|41679835|FG007|Overall Study|Other|28|||
19432490|NCT02118337|41679836|FG008|Overall Study|Other|15|||
19432491|NCT02118337|41679828|FG000|Overall Study|Lost to Follow-up|0|||
19432492|NCT02118337|41679829|FG001|Overall Study|Lost to Follow-up|0|||
19432493|NCT02118337|41679830|FG002|Overall Study|Lost to Follow-up|0|||
19432494|NCT02118337|41679831|FG003|Overall Study|Lost to Follow-up|0|||
19432495|NCT02118337|41679832|FG004|Overall Study|Lost to Follow-up|0|||
19432496|NCT02118337|41679833|FG005|Overall Study|Lost to Follow-up|0|||
19432497|NCT02118337|41679834|FG006|Overall Study|Lost to Follow-up|0|||
19432498|NCT02118337|41679835|FG007|Overall Study|Lost to Follow-up|1|||
19432499|NCT02118337|41679836|FG008|Overall Study|Lost to Follow-up|0|||
19432500|NCT02118337|41679828|FG000|Overall Study|Withdrawal by Subject|1|||
19432501|NCT02118337|41679829|FG001|Overall Study|Withdrawal by Subject|3|||
19432502|NCT02118337|41679830|FG002|Overall Study|Withdrawal by Subject|2|||
19432503|NCT02118337|41679831|FG003|Overall Study|Withdrawal by Subject|1|||
19432504|NCT02118337|41679832|FG004|Overall Study|Withdrawal by Subject|2|||
19432505|NCT02118337|41679833|FG005|Overall Study|Withdrawal by Subject|2|||
19432506|NCT02118337|41679834|FG006|Overall Study|Withdrawal by Subject|1|||
19432507|NCT02118337|41679835|FG007|Overall Study|Withdrawal by Subject|4|||
19432508|NCT02118337|41679836|FG008|Overall Study|Withdrawal by Subject|2|||
19432509|NCT02118337|41679828|FG000|Overall Study|Death|2|||
19432510|NCT02118337|41679829|FG001|Overall Study|Death|2|||
19432511|NCT02118337|41679830|FG002|Overall Study|Death|1|||
19432512|NCT02118337|41679831|FG003|Overall Study|Death|2|||
19432513|NCT02118337|41679832|FG004|Overall Study|Death|5|||
19432514|NCT02118337|41679833|FG005|Overall Study|Death|1|||
19432515|NCT02118337|41679834|FG006|Overall Study|Death|2|||
19432516|NCT02118337|41679835|FG007|Overall Study|Death|9|||
19432517|NCT02118337|41679836|FG008|Overall Study|Death|4|||
19432518|NCT02117713|41679860|FG000|Week 48|Adverse Event|4|||
19432519|NCT02117713|41679860|FG000|Week 48|Withdrawal by caregiver|2|||
19432520|NCT02117713|41679860|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
19432521|NCT02117713|41679860|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
19432522|NCT02117713|41679860|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
19432523|NCT02117713|41679860|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
19432524|NCT02105467|41679874|FG000|Period 1|Lost to Follow-up|1|||
19432525|NCT02105467|41679875|FG001|Period 1|Lost to Follow-up|0|||
19432526|NCT02105467|41679874|FG000|Period 1|Death|1|||
19432527|NCT02105467|41679875|FG001|Period 1|Death|0|||
19432528|NCT02105467|41679874|FG000|Period 2|Lost to Follow-up|1|||
19432529|NCT02105467|41679875|FG001|Period 2|Lost to Follow-up|0|||
19432530|NCT02105467|41679874|FG000|Period 2|Death|1|||
19432531|NCT02105467|41679875|FG001|Period 2|Death|0|||
19432532|NCT02105467|41679874|FG000|Period 2|Withdrawal by Subject|0|||
19432533|NCT02105467|41679875|FG001|Period 2|Withdrawal by Subject|2|||
19432534|NCT02105467|41679874|FG000|Period 3|Lost to Follow-up|0|||
19432535|NCT02105467|41679875|FG001|Period 3|Lost to Follow-up|1|||
19432536|NCT02202161|41679890|FG000|Overall Study|Adverse Event|1|||
19432537|NCT02202161|41679891|FG001|Overall Study|Adverse Event|1|||
19432538|NCT02202161|41679892|FG002|Overall Study|Adverse Event|0|||
19432539|NCT02202161|41679893|FG003|Overall Study|Adverse Event|0|||
19432540|NCT02202161|41679894|FG004|Overall Study|Adverse Event|0|||
19432541|NCT02202161|41679895|FG005|Overall Study|Adverse Event|1|||
19432542|NCT02202161|41679896|FG006|Overall Study|Adverse Event|0|||
19432543|NCT02202161|41679897|FG007|Overall Study|Adverse Event|0|||
19432544|NCT02202161|41679890|FG000|Overall Study|Did not meet continuation criteria|0|||
19432545|NCT02202161|41679891|FG001|Overall Study|Did not meet continuation criteria|0|||
19432546|NCT02202161|41679892|FG002|Overall Study|Did not meet continuation criteria|0|||
19432547|NCT02202161|41679893|FG003|Overall Study|Did not meet continuation criteria|0|||
19432548|NCT02202161|41679894|FG004|Overall Study|Did not meet continuation criteria|0|||
19432549|NCT02202161|41679895|FG005|Overall Study|Did not meet continuation criteria|0|||
19432550|NCT02202161|41679896|FG006|Overall Study|Did not meet continuation criteria|0|||
19432551|NCT02202161|41679897|FG007|Overall Study|Did not meet continuation criteria|3|||
19432552|NCT02202161|41679890|FG000|Overall Study|Physician Decision|0|||
19432553|NCT02202161|41679891|FG001|Overall Study|Physician Decision|0|||
19432554|NCT02202161|41679892|FG002|Overall Study|Physician Decision|0|||
19432555|NCT02202161|41679893|FG003|Overall Study|Physician Decision|0|||
19432556|NCT02202161|41679894|FG004|Overall Study|Physician Decision|0|||
19432557|NCT02202161|41679895|FG005|Overall Study|Physician Decision|0|||
19432558|NCT02202161|41679896|FG006|Overall Study|Physician Decision|0|||
19432559|NCT02202161|41679897|FG007|Overall Study|Physician Decision|3|||
19432560|NCT02202161|41679890|FG000|Overall Study|Withdrawal by Subject|0|||
19432561|NCT02202161|41679891|FG001|Overall Study|Withdrawal by Subject|0|||
19432562|NCT02202161|41679892|FG002|Overall Study|Withdrawal by Subject|0|||
19432563|NCT02202161|41679893|FG003|Overall Study|Withdrawal by Subject|0|||
19432564|NCT02202161|41679894|FG004|Overall Study|Withdrawal by Subject|1|||
19432565|NCT02202161|41679895|FG005|Overall Study|Withdrawal by Subject|0|||
19432566|NCT02202161|41679896|FG006|Overall Study|Withdrawal by Subject|0|||
19432567|NCT02202161|41679897|FG007|Overall Study|Withdrawal by Subject|0|||
19432568|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Adverse Event|76|||
19432569|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Adverse Event|0|||
19432570|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Adverse Event|0|||
19432571|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Death|3|||
19432572|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Death|0|||
19432573|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Death|0|||
19432574|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
19432575|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
19432576|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
19432577|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Physician Decision|9|||
19432578|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Physician Decision|0|||
19432579|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Physician Decision|0|||
19432580|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
19432581|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
19432582|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
19432583|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Disease progression|45|||
19432584|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Disease progression|0|||
19432585|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Disease progression|0|||
19432586|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
19432587|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
19432588|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
19432589|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
19432590|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
19432591|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
19432592|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
19432593|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
19432594|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
19711208|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
19711209|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
19711210|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
19711211|NCT00116805|42154353|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
19711212|NCT00116805|42154354|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
19711213|NCT00116805|42154353|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
19711214|NCT00116805|42154354|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
19711215|NCT00116805|42154353|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
19711216|NCT00116805|42154354|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
19711217|NCT00116805|42154353|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
19711218|NCT00116805|42154354|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
19711219|NCT00116805|42154353|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
19711220|NCT00116805|42154354|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
19711221|NCT00116805|42154353|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
19711222|NCT00116805|42154354|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
19521711|NCT00637572|41935058|FG000|Overall Study|Lost to Follow-up|0|||
19521712|NCT00637572|41935059|FG001|Overall Study|Lost to Follow-up|1|||
19432595|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
19432596|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
19432597|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
19432598|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
19432599|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
19432600|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
19432601|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
19432602|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
19432603|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
19432604|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
19432605|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
19432606|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
19432607|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
19432608|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
19432609|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
19432610|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
19432611|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
19432612|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
19432613|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Promotor request|1|||
19432614|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Promotor request|0|||
19432615|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Promotor request|0|||
19432616|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
19432617|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
19432618|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
19432619|NCT01461928|41679916|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
19432620|NCT01461928|41679917|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
19432621|NCT01461928|41679918|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
19432622|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Death|3|||
19432623|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Death|0|||
19432624|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Death|0|||
19432625|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
19432626|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
19432627|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
19432628|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
19432629|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
19432630|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
19432631|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Diseases progression|91|||
19432632|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Diseases progression|0|||
19432633|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Diseases progression|0|||
19432634|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Adverse Event|70|||
19432635|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Adverse Event|0|||
19432636|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Adverse Event|0|||
19432637|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Physician Decision|9|||
19432638|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Physician Decision|0|||
19432639|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Physician Decision|0|||
19432640|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
19432641|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
19432642|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
19432643|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
19432644|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
19432645|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
19432646|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
19432647|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
19432648|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
19432649|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Not compliant|1|||
19432650|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Not compliant|0|||
19432651|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Not compliant|0|||
19432652|NCT01461928|41679916|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
19432653|NCT01461928|41679917|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
19432654|NCT01461928|41679918|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
19432655|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Adverse Event|0|||
19432656|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Adverse Event|2|||
19432657|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Adverse Event|0|||
19432658|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Death|0|||
19432659|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Death|10|||
19432660|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Death|8|||
19432661|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Physician Decision|0|||
19432662|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Physician Decision|0|||
19432663|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Physician Decision|4|||
19432664|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
19432665|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
19432666|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
19432667|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Moved to another town|0|||
19432668|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Moved to another town|1|||
19432669|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Moved to another town|0|||
19432670|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Disease progression|0|||
19432671|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Disease progression|0|||
19432672|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Disease progression|3|||
19432673|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
19432674|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
19432675|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
19432676|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
19432677|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
19432678|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
19432679|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
19432680|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
19432681|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
19432682|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
19432683|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
19432684|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
19432685|NCT01461928|41679916|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
19432686|NCT01461928|41679917|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
19432687|NCT01461928|41679918|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
19432688|NCT03097991|41679931|FG000|Overall Study|Didn't meet study criteria|8|||
19432689|NCT03097991|41679932|FG001|Overall Study|Didn't meet study criteria|0|||
19432690|NCT03097991|41679931|FG000|Overall Study|Withdrawal by Subject|12|||
19432691|NCT03097991|41679932|FG001|Overall Study|Withdrawal by Subject|6|||
19432692|NCT03097991|41679931|FG000|Overall Study|Death of Baby|3|||
19432693|NCT03097991|41679932|FG001|Overall Study|Death of Baby|1|||
19432694|NCT03097991|41679931|FG000|Overall Study|Lost to Follow-up|24|||
19432695|NCT03097991|41679932|FG001|Overall Study|Lost to Follow-up|38|||
19432696|NCT03097991|41679931|FG000|Overall Study|Adverse Event|3|||
19432697|NCT03097991|41679932|FG001|Overall Study|Adverse Event|5|||
19432698|NCT02623205|41679944|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
19432699|NCT02623205|41679945|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
19432700|NCT01500694|41679954|FG000|Overall Study|Adverse Event|4|||
19432701|NCT01500694|41679955|FG001|Overall Study|Adverse Event|3|||
19432702|NCT01500694|41679954|FG000|Overall Study|Protocol Violation|0|||
19432703|NCT01500694|41679955|FG001|Overall Study|Protocol Violation|1|||
19432704|NCT01500694|41679954|FG000|Overall Study|Withdrawal by Subject|23|||
19432705|NCT01500694|41679955|FG001|Overall Study|Withdrawal by Subject|14|||
19432706|NCT01500694|41679954|FG000|Overall Study|Lost to Follow-up|2|||
19432707|NCT01500694|41679955|FG001|Overall Study|Lost to Follow-up|3|||
19432708|NCT01500694|41679954|FG000|Overall Study|Lack of Efficacy|14|||
19432709|NCT01500694|41679955|FG001|Overall Study|Lack of Efficacy|5|||
19432710|NCT01500694|41679954|FG000|Overall Study|Other|9|||
19432711|NCT01500694|41679955|FG001|Overall Study|Other|3|||
19432712|NCT01500382|41679965|FG000|Washout Period|Study site went out of business|0|||
19432713|NCT01500382|41679966|FG001|Washout Period|Study site went out of business|0|||
19432714|NCT01500382|41679967|FG002|Washout Period|Study site went out of business|1|||
19432715|NCT01500382|41679968|FG003|Washout Period|Study site went out of business|0|||
19432716|NCT02137837|41679981|FG000|Overall Study|Adverse Event|0|||
19432717|NCT02137837|41679982|FG001|Overall Study|Adverse Event|2|||
19432718|NCT02137837|41679983|FG002|Overall Study|Adverse Event|1|||
19432719|NCT02137837|41679981|FG000|Overall Study|Refusal unrelated to adverse event|2|||
19432720|NCT02137837|41679982|FG001|Overall Study|Refusal unrelated to adverse event|2|||
19432721|NCT02137837|41679983|FG002|Overall Study|Refusal unrelated to adverse event|1|||
19432722|NCT02137837|41679981|FG000|Overall Study|Progression/relapse|9|||
19432723|NCT02137837|41679982|FG001|Overall Study|Progression/relapse|7|||
19432724|NCT02137837|41679983|FG002|Overall Study|Progression/relapse|7|||
19432725|NCT02137837|41679981|FG000|Overall Study|Not protocol specified|2|||
19432726|NCT02137837|41679982|FG001|Overall Study|Not protocol specified|1|||
19432727|NCT02137837|41679983|FG002|Overall Study|Not protocol specified|3|||
19432728|NCT01483690|41679998|FG000|Overall Study|Adverse Event|1|||
19432729|NCT01483690|41679999|FG001|Overall Study|Adverse Event|2|||
19432730|NCT01483690|41679998|FG000|Overall Study|clinical deterioration|1|||
19432731|NCT01483690|41679999|FG001|Overall Study|clinical deterioration|0|||
19432732|NCT01483690|41679998|FG000|Overall Study|Physician Decision|0|||
19432733|NCT01483690|41679999|FG001|Overall Study|Physician Decision|2|||
19432734|NCT01483690|41679998|FG000|Overall Study|exclusionary procedure|0|||
19432735|NCT01483690|41679999|FG001|Overall Study|exclusionary procedure|1|||
19432736|NCT02104765|41680012|FG000|Overall Study|Lost to Follow-up|0|||
19432737|NCT02104765|41680013|FG001|Overall Study|Lost to Follow-up|0|||
19432738|NCT02104765|41680014|FG002|Overall Study|Lost to Follow-up|1|||
19432739|NCT02104765|41680015|FG003|Overall Study|Lost to Follow-up|0|||
19432740|NCT02104765|41680016|FG004|Overall Study|Lost to Follow-up|0|||
19432741|NCT02104765|41680017|FG005|Overall Study|Lost to Follow-up|0|||
19432742|NCT02104765|41680018|FG006|Overall Study|Lost to Follow-up|0|||
19432743|NCT02104765|41680012|FG000|Overall Study|Withdrawal by Subject|0|||
19432744|NCT02104765|41680013|FG001|Overall Study|Withdrawal by Subject|0|||
19432745|NCT02104765|41680014|FG002|Overall Study|Withdrawal by Subject|0|||
19432746|NCT02104765|41680015|FG003|Overall Study|Withdrawal by Subject|1|||
19432747|NCT02104765|41680016|FG004|Overall Study|Withdrawal by Subject|1|||
19432748|NCT02104765|41680017|FG005|Overall Study|Withdrawal by Subject|0|||
19432749|NCT02104765|41680018|FG006|Overall Study|Withdrawal by Subject|1|||
19432750|NCT01483144|41680043|FG000|Overall Study|Adverse Event|9|||
19432751|NCT01483144|41680044|FG001|Overall Study|Adverse Event|4|||
19432752|NCT01483144|41680045|FG002|Overall Study|Adverse Event|6|||
19432753|NCT01483144|41680043|FG000|Overall Study|Withdrawal by Subject|0|||
19432754|NCT01483144|41680044|FG001|Overall Study|Withdrawal by Subject|2|||
19432755|NCT01483144|41680045|FG002|Overall Study|Withdrawal by Subject|5|||
19432756|NCT01483144|41680043|FG000|Overall Study|Physician Decision|1|||
19432757|NCT01483144|41680044|FG001|Overall Study|Physician Decision|0|||
19432758|NCT01483144|41680045|FG002|Overall Study|Physician Decision|0|||
19432759|NCT01483144|41680043|FG000|Overall Study|Lost to Follow-up|2|||
19432760|NCT01483144|41680044|FG001|Overall Study|Lost to Follow-up|4|||
19432761|NCT01483144|41680045|FG002|Overall Study|Lost to Follow-up|1|||
19432762|NCT01483144|41680043|FG000|Overall Study|Protocol Violation|3|||
19432763|NCT01483144|41680044|FG001|Overall Study|Protocol Violation|3|||
19432764|NCT01483144|41680045|FG002|Overall Study|Protocol Violation|3|||
19432765|NCT01881789|41680059|FG000|Overall Study|Withdrawal by Subject|0|||
19432766|NCT01881789|41680060|FG001|Overall Study|Withdrawal by Subject|2|||
19432767|NCT01881789|41680061|FG002|Overall Study|Withdrawal by Subject|1|||
19432768|NCT01881789|41680062|FG003|Overall Study|Withdrawal by Subject|0|||
19432769|NCT01881789|41680063|FG004|Overall Study|Withdrawal by Subject|1|||
19432770|NCT01881789|41680064|FG005|Overall Study|Withdrawal by Subject|1|||
19432771|NCT01881789|41680059|FG000|Overall Study|Study Terminated by Sponsor|0|||
19432772|NCT01881789|41680060|FG001|Overall Study|Study Terminated by Sponsor|0|||
19432773|NCT01881789|41680061|FG002|Overall Study|Study Terminated by Sponsor|0|||
19432774|NCT01881789|41680062|FG003|Overall Study|Study Terminated by Sponsor|0|||
19432775|NCT01881789|41680063|FG004|Overall Study|Study Terminated by Sponsor|0|||
19432776|NCT01881789|41680064|FG005|Overall Study|Study Terminated by Sponsor|1|||
19432777|NCT01881789|41680059|FG000|Overall Study|Other|3|||
19432778|NCT01881789|41680060|FG001|Overall Study|Other|5|||
19432779|NCT01881789|41680061|FG002|Overall Study|Other|2|||
19432780|NCT01881789|41680062|FG003|Overall Study|Other|3|||
19432781|NCT01881789|41680063|FG004|Overall Study|Other|1|||
19432782|NCT01881789|41680064|FG005|Overall Study|Other|1|||
19432783|NCT02075203|41680082|FG000|Overall Study|Withdrawal by Subject|1|||
19432784|NCT02075203|41680083|FG001|Overall Study|Withdrawal by Subject|0|||
19432785|NCT02075203|41680084|FG002|Overall Study|Withdrawal by Subject|1|||
19432786|NCT02075203|41680082|FG000|Overall Study|Adverse Event|1|||
19432787|NCT02075203|41680083|FG001|Overall Study|Adverse Event|0|||
19432788|NCT02075203|41680084|FG002|Overall Study|Adverse Event|0|||
19432789|NCT02075203|41680082|FG000|Overall Study|participant refused to use contraception|1|||
19432790|NCT02075203|41680083|FG001|Overall Study|participant refused to use contraception|0|||
19432791|NCT02075203|41680084|FG002|Overall Study|participant refused to use contraception|0|||
19432792|NCT01892163|41680094|FG000|Overall Study|Death|1|||
19432793|NCT01892163|41680095|FG001|Overall Study|Death|1|||
19432794|NCT01892163|41680094|FG000|Overall Study|Lost to Follow-up|1|||
19432795|NCT01892163|41680095|FG001|Overall Study|Lost to Follow-up|0|||
19432796|NCT01881009|41680103|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
19432797|NCT01881009|41680104|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
19432798|NCT01500226|41680113|FG000|Overall Study|Adverse Event|31|||
19432799|NCT01500226|41680114|FG001|Overall Study|Adverse Event|38|||
19432800|NCT01500226|41680113|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
19432801|NCT01500226|41680114|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
19432802|NCT01500226|41680113|FG000|Overall Study|Withdrawal by Subject|93|||
19521713|NCT00637572|41935058|FG000|Overall Study|Physician Decision|1|||
19432803|NCT01500226|41680114|FG001|Overall Study|Withdrawal by Subject|96|||
19432804|NCT01500226|41680113|FG000|Overall Study|Death|12|||
19432805|NCT01500226|41680114|FG001|Overall Study|Death|4|||
19432806|NCT01500226|41680113|FG000|Overall Study|Disease Progression|16|||
19432807|NCT01500226|41680114|FG001|Overall Study|Disease Progression|14|||
19432808|NCT01500226|41680113|FG000|Overall Study|Protocol Violation|53|||
19432809|NCT01500226|41680114|FG001|Overall Study|Protocol Violation|39|||
19432810|NCT01500226|41680113|FG000|Overall Study|Physician Decision|17|||
19432811|NCT01500226|41680114|FG001|Overall Study|Physician Decision|15|||
19432812|NCT01500226|41680113|FG000|Overall Study|Lack of Efficacy|14|||
19432813|NCT01500226|41680114|FG001|Overall Study|Lack of Efficacy|30|||
19432814|NCT01500226|41680113|FG000|Overall Study|Lost to Follow-up|9|||
19432815|NCT01500226|41680114|FG001|Overall Study|Lost to Follow-up|5|||
19432816|NCT01500226|41680113|FG000|Overall Study|Other Reasons|19|||
19432817|NCT01500226|41680114|FG001|Overall Study|Other Reasons|16|||
19432818|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
19432819|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
19432820|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
19432821|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
19432822|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
19432823|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
19432824|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
19432825|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
19432826|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
19432827|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
19432828|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Other|1|||
19432829|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Other|1|||
19432830|NCT02075047|41680122|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
19432831|NCT02075047|41680123|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
19432832|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
19432833|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
19432834|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
19432835|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
19432836|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
19432837|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
19432838|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
19432839|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
19432840|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
19432841|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
19432842|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Other|1|||
19432843|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Other|2|||
19432844|NCT02075047|41680122|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
19432845|NCT02075047|41680123|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
19432846|NCT01859949|41680131|FG000|Overall Study|Family Matters|0|||
19432847|NCT01859949|41680132|FG001|Overall Study|Family Matters|1|||
19432848|NCT01859949|41680131|FG000|Overall Study|Physician Decision|2|||
19432849|NCT01859949|41680132|FG001|Overall Study|Physician Decision|4|||
19432850|NCT01859949|41680131|FG000|Overall Study|Withdrawal by Subject|11|||
19432851|NCT01859949|41680132|FG001|Overall Study|Withdrawal by Subject|10|||
19432852|NCT01859949|41680131|FG000|Overall Study|Protocol Violation|1|||
19432853|NCT01859949|41680132|FG001|Overall Study|Protocol Violation|1|||
19432854|NCT01859949|41680131|FG000|Overall Study|Adverse Event|0|||
19432855|NCT01859949|41680132|FG001|Overall Study|Adverse Event|1|||
19432856|NCT01859793|41680140|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
19432857|NCT01859793|41680141|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
19432858|NCT01859793|41680140|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
19432859|NCT01859793|41680141|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
19432860|NCT01859793|41680140|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
19432861|NCT01859793|41680141|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
19432862|NCT01859793|41680140|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
19432863|NCT01859793|41680141|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
19432864|NCT01859715|41680150|FG000|Overall Study|No 2nd VAS|16|||
19432865|NCT01859715|41680151|FG001|Overall Study|No 2nd VAS|8|||
19432866|NCT01859715|41680152|FG002|Overall Study|No 2nd VAS|23|||
19432867|NCT01890915|41680164|FG000|Overall Study|Adverse Event|1|||
19432868|NCT01890915|41680165|FG001|Overall Study|Adverse Event|0|||
19432869|NCT01890915|41680164|FG000|Overall Study|Protocol Violation|2|||
19432870|NCT01890915|41680165|FG001|Overall Study|Protocol Violation|0|||
19432871|NCT01890915|41680164|FG000|Overall Study|Equipment Malfunction|0|||
19432872|NCT01890915|41680165|FG001|Overall Study|Equipment Malfunction|1|||
19432873|NCT01615263|41680173|FG000|Overall Study|Post-randomization exclusion|0|||
19432874|NCT01615263|41680174|FG001|Overall Study|Post-randomization exclusion|2|||
19432875|NCT01859403|41680191|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
19432876|NCT01859403|41680192|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
19432877|NCT01859403|41680191|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
19432878|NCT01859403|41680192|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
19432879|NCT01859403|41680191|FG000|Primary Endpoint Measure|Physician Decision|0|||
19432880|NCT01859403|41680192|FG001|Primary Endpoint Measure|Physician Decision|1|||
19432881|NCT01859403|41680191|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
19432882|NCT01859403|41680192|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
19432883|NCT01858701|41680198|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
19521714|NCT00637572|41935059|FG001|Overall Study|Physician Decision|1|||
19521715|NCT00637572|41935058|FG000|Overall Study|Withdrawal by Subject|0|||
19432884|NCT01858701|41680199|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
19432885|NCT01858701|41680198|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
19432886|NCT01858701|41680199|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
19432887|NCT01858701|41680198|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
19432888|NCT01858701|41680199|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
19432889|NCT01858701|41680198|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
19432890|NCT01858701|41680199|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
19432891|NCT01461538|41680208|FG000|Overall Study|Death|15|||
19432892|NCT01461538|41680209|FG001|Overall Study|Death|6|||
19432893|NCT01461538|41680210|FG002|Overall Study|Death|2|||
19432894|NCT01461538|41680208|FG000|Overall Study|Study Stopped by Sponsor|2|||
19432895|NCT01461538|41680209|FG001|Overall Study|Study Stopped by Sponsor|1|||
19432896|NCT01461538|41680210|FG002|Overall Study|Study Stopped by Sponsor|0|||
19432897|NCT01461538|41680208|FG000|Overall Study|Withdrawal by Subject|1|||
19432898|NCT01461538|41680209|FG001|Overall Study|Withdrawal by Subject|1|||
19432899|NCT01461538|41680210|FG002|Overall Study|Withdrawal by Subject|0|||
19432900|NCT02117479|41680222|FG000|Overall Study|Death|13|||
19432901|NCT02117479|41680223|FG001|Overall Study|Death|8|||
19432902|NCT02117479|41680222|FG000|Overall Study|Adverse Event|8|||
19432903|NCT02117479|41680223|FG001|Overall Study|Adverse Event|16|||
19432904|NCT02117479|41680222|FG000|Overall Study|Subject decision|8|||
19432905|NCT02117479|41680223|FG001|Overall Study|Subject decision|9|||
19432906|NCT02117479|41680222|FG000|Overall Study|Disease progression|104|||
19432907|NCT02117479|41680223|FG001|Overall Study|Disease progression|108|||
19432908|NCT02117479|41680222|FG000|Overall Study|Noncompliance with study treatment|1|||
19432909|NCT02117479|41680223|FG001|Overall Study|Noncompliance with study treatment|0|||
19432910|NCT02117479|41680222|FG000|Overall Study|Study terminated by the sponsor|4|||
19432911|NCT02117479|41680223|FG001|Overall Study|Study terminated by the sponsor|6|||
19432912|NCT02117479|41680222|FG000|Overall Study|Physician Decision|7|||
19432913|NCT02117479|41680223|FG001|Overall Study|Physician Decision|2|||
19432914|NCT02117479|41680222|FG000|Overall Study|Other unspecified|11|||
19432915|NCT02117479|41680223|FG001|Overall Study|Other unspecified|7|||
19432916|NCT02229851|41680232|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
19432917|NCT02229851|41680233|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
19432918|NCT02229851|41680234|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
19432919|NCT02229851|41680235|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
19432920|NCT02229851|41680236|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
19432921|NCT02229851|41680237|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
19432922|NCT02229851|41680238|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
19432923|NCT02229851|41680232|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432924|NCT02229851|41680233|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
19432925|NCT02229851|41680234|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432926|NCT02229851|41680235|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432927|NCT02229851|41680236|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432928|NCT02229851|41680237|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432929|NCT02229851|41680238|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
19432930|NCT02229851|41680232|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
19432931|NCT02229851|41680233|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
19432932|NCT02229851|41680234|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
19432933|NCT02229851|41680235|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
19432934|NCT02229851|41680236|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
19432935|NCT02229851|41680237|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
19432936|NCT02229851|41680238|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
19432937|NCT02229851|41680232|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432938|NCT02229851|41680233|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432939|NCT02229851|41680234|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
19432940|NCT02229851|41680235|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432941|NCT02229851|41680236|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432942|NCT02229851|41680237|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432943|NCT02229851|41680238|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
19432944|NCT02229851|41680232|FG000|Main Phase (Double-blind Phase)|Death|1|||
19432945|NCT02229851|41680233|FG001|Main Phase (Double-blind Phase)|Death|1|||
19432946|NCT02229851|41680234|FG002|Main Phase (Double-blind Phase)|Death|0|||
19432947|NCT02229851|41680235|FG003|Main Phase (Double-blind Phase)|Death|0|||
19432948|NCT02229851|41680236|FG004|Main Phase (Double-blind Phase)|Death|0|||
19432949|NCT02229851|41680237|FG005|Main Phase (Double-blind Phase)|Death|0|||
19432950|NCT02229851|41680238|FG006|Main Phase (Double-blind Phase)|Death|0|||
19432951|NCT02229851|41680232|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
19432952|NCT02229851|41680233|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
19432953|NCT02229851|41680234|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
19432954|NCT02229851|41680235|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
19628326|NCT00863681|42077760|FG000|Overall Study|Death|40|||
19432955|NCT02229851|41680236|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
19432956|NCT02229851|41680237|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
19432957|NCT02229851|41680238|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
19432958|NCT02229851|41680232|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
19432959|NCT02229851|41680233|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
19432960|NCT02229851|41680234|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
19432961|NCT02229851|41680235|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
19432962|NCT02229851|41680236|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
19432963|NCT02229851|41680237|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
19432964|NCT02229851|41680238|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
19432965|NCT02229851|41680232|FG000|Extension Phase (Open-label Phase)|Death|0|||
19432966|NCT02229851|41680233|FG001|Extension Phase (Open-label Phase)|Death|0|||
19432967|NCT02229851|41680234|FG002|Extension Phase (Open-label Phase)|Death|0|||
19432968|NCT02229851|41680235|FG003|Extension Phase (Open-label Phase)|Death|1|||
19432969|NCT02229851|41680236|FG004|Extension Phase (Open-label Phase)|Death|0|||
19432970|NCT02229851|41680237|FG005|Extension Phase (Open-label Phase)|Death|1|||
19432971|NCT02229851|41680238|FG006|Extension Phase (Open-label Phase)|Death|1|||
19432972|NCT01482910|41680255|FG000|Overall Study|Adverse Event|6|||
19432973|NCT01482910|41680256|FG001|Overall Study|Adverse Event|5|||
19432974|NCT01482910|41680255|FG000|Overall Study|Lost to Follow-up|0|||
19432975|NCT01482910|41680256|FG001|Overall Study|Lost to Follow-up|1|||
19432976|NCT01482910|41680255|FG000|Overall Study|Protocol Violation|1|||
19432977|NCT01482910|41680256|FG001|Overall Study|Protocol Violation|1|||
19432978|NCT01482910|41680255|FG000|Overall Study|Withdrawal by Subject|7|||
19432979|NCT01482910|41680256|FG001|Overall Study|Withdrawal by Subject|2|||
19432980|NCT01482910|41680255|FG000|Overall Study|Death|1|||
19432981|NCT01482910|41680256|FG001|Overall Study|Death|0|||
19432982|NCT01626391|41680266|FG000|Overall Study|Physician Decision|1|||
19432983|NCT01626391|41680267|FG001|Overall Study|Physician Decision|0|||
19432984|NCT01626391|41680266|FG000|Overall Study|Withdrawal by Subject|1|||
19432985|NCT01626391|41680267|FG001|Overall Study|Withdrawal by Subject|0|||
19432986|NCT02103439|41680275|FG000|Overall Study|Adverse Event|0|||
19432987|NCT02103439|41680276|FG001|Overall Study|Adverse Event|2|||
19432988|NCT02103439|41680275|FG000|Overall Study|Withdrawal by Subject|3|||
19432989|NCT02103439|41680276|FG001|Overall Study|Withdrawal by Subject|1|||
19432990|NCT02229539|41680289|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
19432991|NCT02229539|41680290|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
19432992|NCT02229539|41680291|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
19432993|NCT02229539|41680289|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
19432994|NCT02229539|41680290|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
19432995|NCT02229539|41680291|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
19432996|NCT02229539|41680289|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
19432997|NCT02229539|41680290|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
19432998|NCT02229539|41680291|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
19432999|NCT02229539|41680289|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
19433000|NCT02229539|41680290|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
19433001|NCT02229539|41680291|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
19433002|NCT02229539|41680289|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
19433003|NCT02229539|41680290|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
19433004|NCT02229539|41680291|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
19433005|NCT02229539|41680289|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
19433006|NCT02229539|41680290|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
19433007|NCT02229539|41680291|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
19433008|NCT02229539|41680289|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
19433009|NCT02229539|41680290|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
19433010|NCT02229539|41680291|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
19433011|NCT02229539|41680289|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
19433012|NCT02229539|41680290|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
19433013|NCT02229539|41680291|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
19433014|NCT02229539|41680289|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
19433015|NCT02229539|41680290|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
19433016|NCT02229539|41680291|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
19433017|NCT01835223|41680301|FG000|Overall Study|Adverse Event|1|||
19433018|NCT01835223|41680302|FG001|Overall Study|Adverse Event|0|||
19433019|NCT01835223|41680301|FG000|Overall Study|Withdrawal by Subject|2|||
19433020|NCT01835223|41680302|FG001|Overall Study|Withdrawal by Subject|0|||
19433021|NCT01835223|41680301|FG000|Overall Study|Disease progression|2|||
19433022|NCT01835223|41680302|FG001|Overall Study|Disease progression|1|||
19433023|NCT01835223|41680301|FG000|Overall Study|Became Inelligible|4|||
19433024|NCT01835223|41680302|FG001|Overall Study|Became Inelligible|0|||
19433025|NCT01482598|41680312|FG000|Overall Study|Death|7|||
19433026|NCT01482598|41680313|FG001|Overall Study|Death|10|||
19433027|NCT01482598|41680312|FG000|Overall Study|Physician Decision|0|||
19433028|NCT01482598|41680313|FG001|Overall Study|Physician Decision|3|||
19433029|NCT01482598|41680312|FG000|Overall Study|Withdrawal by Subject|4|||
19433030|NCT01482598|41680313|FG001|Overall Study|Withdrawal by Subject|5|||
19433031|NCT01482598|41680312|FG000|Overall Study|Lost to Follow-up|5|||
19433032|NCT01482598|41680313|FG001|Overall Study|Lost to Follow-up|4|||
19433033|NCT01460446|41680321|FG000|Overall Study|Non-compliance|2|||
19433034|NCT01460446|41680322|FG001|Overall Study|Non-compliance|9|||
19433035|NCT01460446|41680321|FG000|Overall Study|Consent Withdrawn|0|||
19433036|NCT01460446|41680322|FG001|Overall Study|Consent Withdrawn|4|||
19433037|NCT01460446|41680321|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
19433038|NCT01460446|41680322|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
19433039|NCT01460446|41680321|FG000|Overall Study|Surgery/Illness|1|||
19433040|NCT01460446|41680322|FG001|Overall Study|Surgery/Illness|1|||
19433041|NCT01460446|41680321|FG000|Overall Study|Pregnancy|1|||
19433042|NCT01460446|41680322|FG001|Overall Study|Pregnancy|0|||
19433043|NCT01460446|41680321|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
19433044|NCT01460446|41680322|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
19433045|NCT02229383|41680331|FG000|Overall Study|Adverse Event|7|||
19433046|NCT02229383|41680332|FG001|Overall Study|Adverse Event|4|||
19433047|NCT02229383|41680331|FG000|Overall Study|Death|0|||
19433048|NCT02229383|41680332|FG001|Overall Study|Death|1|||
19433049|NCT02229383|41680331|FG000|Overall Study|Lost to Follow-up|5|||
19433050|NCT02229383|41680332|FG001|Overall Study|Lost to Follow-up|3|||
19433051|NCT02229383|41680331|FG000|Overall Study|Withdrawal by Subject|4|||
19433052|NCT02229383|41680332|FG001|Overall Study|Withdrawal by Subject|6|||
19433053|NCT02229383|41680331|FG000|Overall Study|Did not receive treatment|1|||
19433054|NCT02229383|41680332|FG001|Overall Study|Did not receive treatment|0|||
19433055|NCT02229383|41680331|FG000|Overall Study|Other|3|||
19433056|NCT02229383|41680332|FG001|Overall Study|Other|8|||
19433057|NCT01499368|41680341|FG000|Overall Study|Did not meet I/E criteria|8|||
19433058|NCT01499368|41680342|FG001|Overall Study|Did not meet I/E criteria|4|||
19433059|NCT01499368|41680343|FG002|Overall Study|Did not meet I/E criteria|4|||
19433060|NCT01499368|41680341|FG000|Overall Study|Prohibited Concomitant medication|1|||
19433061|NCT01499368|41680342|FG001|Overall Study|Prohibited Concomitant medication|1|||
19433062|NCT01499368|41680343|FG002|Overall Study|Prohibited Concomitant medication|0|||
19433063|NCT01499368|41680341|FG000|Overall Study|Withdrawal by Subject|11|||
19433064|NCT01499368|41680342|FG001|Overall Study|Withdrawal by Subject|10|||
19433065|NCT01499368|41680343|FG002|Overall Study|Withdrawal by Subject|8|||
19433066|NCT01499368|41680341|FG000|Overall Study|Lost to Follow-up|3|||
19433067|NCT01499368|41680342|FG001|Overall Study|Lost to Follow-up|2|||
19433068|NCT01499368|41680343|FG002|Overall Study|Lost to Follow-up|5|||
19433069|NCT01499368|41680341|FG000|Overall Study|Adverse Event|4|||
19433070|NCT01499368|41680342|FG001|Overall Study|Adverse Event|0|||
19433071|NCT01499368|41680343|FG002|Overall Study|Adverse Event|2|||
19433072|NCT01499368|41680341|FG000|Overall Study|Physician Decision|0|||
19433073|NCT01499368|41680342|FG001|Overall Study|Physician Decision|1|||
19433074|NCT01499368|41680343|FG002|Overall Study|Physician Decision|0|||
19433075|NCT01499368|41680341|FG000|Overall Study|Deviation from visit window|0|||
19433076|NCT01499368|41680342|FG001|Overall Study|Deviation from visit window|0|||
19433077|NCT01499368|41680343|FG002|Overall Study|Deviation from visit window|1|||
19433078|NCT01499368|41680341|FG000|Overall Study|Error of Prescriptions|0|||
19433079|NCT01499368|41680342|FG001|Overall Study|Error of Prescriptions|0|||
19433080|NCT01499368|41680343|FG002|Overall Study|Error of Prescriptions|1|||
19433081|NCT01835145|41680353|FG000|Overall Study|Ineligible prior to treatment|1|||
19433082|NCT01835145|41680354|FG001|Overall Study|Ineligible prior to treatment|0|||
19433083|NCT02229227|41680364|FG000|Overall Study|Adverse Event|14|||
19433084|NCT02229227|41680365|FG001|Overall Study|Adverse Event|9|||
19433085|NCT02229227|41680364|FG000|Overall Study|Lack of Efficacy|3|||
19433086|NCT02229227|41680365|FG001|Overall Study|Lack of Efficacy|3|||
19433087|NCT02229227|41680364|FG000|Overall Study|Protocol Violation|6|||
19433088|NCT02229227|41680365|FG001|Overall Study|Protocol Violation|8|||
19521716|NCT00637572|41935059|FG001|Overall Study|Withdrawal by Subject|2|||
19433089|NCT02229227|41680364|FG000|Overall Study|Protocol defined stopping criteria|1|||
19433090|NCT02229227|41680365|FG001|Overall Study|Protocol defined stopping criteria|3|||
19433091|NCT02229227|41680364|FG000|Overall Study|Lost to Follow-up|3|||
19433092|NCT02229227|41680365|FG001|Overall Study|Lost to Follow-up|3|||
19433093|NCT02229227|41680364|FG000|Overall Study|Study terminated by sponsor|11|||
19433094|NCT02229227|41680365|FG001|Overall Study|Study terminated by sponsor|11|||
19433095|NCT02229227|41680364|FG000|Overall Study|Withdrawal by Subject|8|||
19433096|NCT02229227|41680365|FG001|Overall Study|Withdrawal by Subject|12|||
19433097|NCT02229227|41680364|FG000|Overall Study|Other|0|||
19433098|NCT02229227|41680365|FG001|Overall Study|Other|1|||
19433099|NCT02229227|41680364|FG000|Overall Study|Physician Decision|5|||
19433100|NCT02229227|41680365|FG001|Overall Study|Physician Decision|12|||
19433101|NCT01499290|41680373|FG000|Overall Study|Withdrawal by Subject|22|||
19433102|NCT01499290|41680374|FG001|Overall Study|Withdrawal by Subject|15|||
19433103|NCT01499290|41680373|FG000|Overall Study|Not specified in study report|11|||
19433104|NCT01499290|41680374|FG001|Overall Study|Not specified in study report|5|||
19433105|NCT01499290|41680373|FG000|Overall Study|Condition improved/subject recovered|1|||
19433106|NCT01499290|41680374|FG001|Overall Study|Condition improved/subject recovered|0|||
19433107|NCT01499290|41680373|FG000|Overall Study|Lack of Efficacy|7|||
19433108|NCT01499290|41680374|FG001|Overall Study|Lack of Efficacy|8|||
19433109|NCT01499290|41680373|FG000|Overall Study|Adverse Event|14|||
19433110|NCT01499290|41680374|FG001|Overall Study|Adverse Event|7|||
19433111|NCT01833897|41680399|FG000|Overall Study|Lack of Efficacy|1|||
19433112|NCT01481896|41680403|FG000|Overall Study|Lost to Follow-up|12|||
19433113|NCT02226653|41680419|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
19433114|NCT02226653|41680420|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
19433115|NCT02226653|41680419|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
19433116|NCT02226653|41680420|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
19433117|NCT02201771|41680436|FG000|Overall Study|Death|3|||
19433118|NCT02201771|41680437|FG001|Overall Study|Death|2|||
19433119|NCT02201771|41680438|FG002|Overall Study|Death|0|||
19433120|NCT02201771|41680436|FG000|Overall Study|Protocol Violation|10|||
19433121|NCT02201771|41680437|FG001|Overall Study|Protocol Violation|8|||
19433122|NCT02201771|41680438|FG002|Overall Study|Protocol Violation|10|||
19433123|NCT02200445|41680449|FG000|Overall Study|Lack of Efficacy|1|||
19433124|NCT02200445|41680450|FG001|Overall Study|Lack of Efficacy|2|||
19433125|NCT02200445|41680451|FG002|Overall Study|Lack of Efficacy|2|||
19433126|NCT02200445|41680449|FG000|Overall Study|Adverse Event|0|||
19433127|NCT02200445|41680450|FG001|Overall Study|Adverse Event|2|||
19433128|NCT02200445|41680451|FG002|Overall Study|Adverse Event|0|||
19433129|NCT01460368|41680461|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433130|NCT01460368|41680462|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433131|NCT01460368|41680463|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433132|NCT01460368|41680464|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433133|NCT01460368|41680465|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
19433134|NCT01460368|41680466|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433135|NCT01460368|41680467|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
19433136|NCT01460368|41680461|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
19433137|NCT01460368|41680462|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
19433138|NCT01460368|41680463|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
19433139|NCT01460368|41680464|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
19433140|NCT01460368|41680465|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
19433141|NCT01460368|41680466|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
19433142|NCT01460368|41680467|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
19433143|NCT01460368|41680461|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433144|NCT01460368|41680462|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
19433145|NCT01460368|41680463|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433146|NCT01460368|41680464|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433147|NCT01460368|41680465|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433148|NCT01460368|41680466|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433149|NCT01460368|41680467|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
19433150|NCT01460368|41680461|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433151|NCT01460368|41680462|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433152|NCT01460368|41680463|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
19433153|NCT01460368|41680464|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433154|NCT01460368|41680465|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433155|NCT01460368|41680466|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433156|NCT01460368|41680467|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
19433157|NCT01460368|41680461|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
19433158|NCT01460368|41680462|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
19433159|NCT01460368|41680463|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
19433160|NCT01460368|41680464|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
19433161|NCT01460368|41680465|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
19433162|NCT01460368|41680466|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
19433163|NCT01460368|41680467|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
19433164|NCT01460290|41680476|FG000|Overall Study|Adverse Event|3|||
19433165|NCT01460290|41680476|FG000|Overall Study|Elevated liver function|1|||
19433166|NCT02200211|41680485|FG000|Overall Study|Lost to Follow-up|7|||
19433167|NCT02200211|41680486|FG001|Overall Study|Lost to Follow-up|7|||
19433168|NCT02200211|41680487|FG002|Overall Study|Lost to Follow-up|1|||
19433169|NCT02200211|41680488|FG003|Overall Study|Lost to Follow-up|2|||
19433170|NCT02200211|41680485|FG000|Overall Study|Withdrawal by Subject|1|||
19433171|NCT02200211|41680486|FG001|Overall Study|Withdrawal by Subject|0|||
19433172|NCT02200211|41680487|FG002|Overall Study|Withdrawal by Subject|0|||
19433173|NCT02200211|41680488|FG003|Overall Study|Withdrawal by Subject|0|||
19433174|NCT01459666|41680508|FG000|Overall Study|PI left institution|5|||
19433175|NCT01459666|41680509|FG001|Overall Study|PI left institution|4|||
19433176|NCT01858389|41680517|FG000|Overall Study|Death|1|||
19433177|NCT01858389|41680518|FG001|Overall Study|Death|3|||
19433178|NCT01858389|41680517|FG000|Overall Study|Study terminated by sponsor|0|||
19433179|NCT01858389|41680518|FG001|Overall Study|Study terminated by sponsor|2|||
19433180|NCT01858389|41680517|FG000|Overall Study|Withdrawal by Subject|0|||
19433181|NCT01858389|41680518|FG001|Overall Study|Withdrawal by Subject|1|||
19433182|NCT01858389|41680517|FG000|Overall Study|Progressive disease|10|||
19433183|NCT01858389|41680518|FG001|Overall Study|Progressive disease|11|||
19433184|NCT01858389|41680517|FG000|Overall Study|Other|2|||
19433185|NCT01858389|41680518|FG001|Overall Study|Other|4|||
19433186|NCT01858389|41680517|FG000|Overall Study|Adverse Event|3|||
19433187|NCT01858389|41680518|FG001|Overall Study|Adverse Event|1|||
19433188|NCT01858389|41680517|FG000|Overall Study|Did not receive treatment|0|||
19433189|NCT01858389|41680518|FG001|Overall Study|Did not receive treatment|3|||
19433190|NCT02199509|41680526|FG000|Overall Study|Suicidal Ideation|0|||
19433191|NCT02199509|41680527|FG001|Overall Study|Suicidal Ideation|1|||
19433192|NCT02199509|41680526|FG000|Overall Study|Misunderstood titration schedule|1|||
19433193|NCT02199509|41680527|FG001|Overall Study|Misunderstood titration schedule|0|||
19433194|NCT01458574|41680540|FG000|Overall Study|Adverse Event|5|||
19433195|NCT01458574|41680541|FG001|Overall Study|Adverse Event|9|||
19433196|NCT01458574|41680542|FG002|Overall Study|Adverse Event|7|||
19433197|NCT01458574|41680540|FG000|Overall Study|Lack of Efficacy|70|||
19433198|NCT01458574|41680541|FG001|Overall Study|Lack of Efficacy|53|||
19433199|NCT01458574|41680542|FG002|Overall Study|Lack of Efficacy|132|||
19433200|NCT01458574|41680540|FG000|Overall Study|Lost to Follow-up|3|||
19433201|NCT01458574|41680541|FG001|Overall Study|Lost to Follow-up|2|||
19433202|NCT01458574|41680542|FG002|Overall Study|Lost to Follow-up|1|||
19433203|NCT01458574|41680540|FG000|Overall Study|Pregnancy|1|||
19433204|NCT01458574|41680541|FG001|Overall Study|Pregnancy|1|||
19433205|NCT01458574|41680542|FG002|Overall Study|Pregnancy|0|||
19433206|NCT01458574|41680540|FG000|Overall Study|Protocol Violation|0|||
19433207|NCT01458574|41680541|FG001|Overall Study|Protocol Violation|1|||
19433208|NCT01458574|41680542|FG002|Overall Study|Protocol Violation|0|||
19433209|NCT01458574|41680540|FG000|Overall Study|Withdrawal by Subject|6|||
19433210|NCT01458574|41680541|FG001|Overall Study|Withdrawal by Subject|3|||
19433211|NCT01458574|41680542|FG002|Overall Study|Withdrawal by Subject|5|||
19433212|NCT01458574|41680540|FG000|Overall Study|Other|2|||
19433213|NCT01458574|41680541|FG001|Overall Study|Other|1|||
19433214|NCT01458574|41680542|FG002|Overall Study|Other|0|||
19433215|NCT01458574|41680540|FG000|Overall Study|Randomized but not treated|0|||
19433216|NCT01458574|41680541|FG001|Overall Study|Randomized but not treated|1|||
19433217|NCT01458574|41680542|FG002|Overall Study|Randomized but not treated|0|||
19433218|NCT02224703|41680553|FG000|Overall Study|Adverse Event|0|||
19433219|NCT02224703|41680554|FG001|Overall Study|Adverse Event|5|||
19433220|NCT02224703|41680555|FG002|Overall Study|Adverse Event|0|||
19433221|NCT02224703|41680553|FG000|Overall Study|Withdrawn by investigator|1|||
19433222|NCT02224703|41680554|FG001|Overall Study|Withdrawn by investigator|0|||
19433223|NCT02224703|41680555|FG002|Overall Study|Withdrawn by investigator|0|||
19433224|NCT02224703|41680553|FG000|Overall Study|Advised by medical monitor|1|||
19433225|NCT02224703|41680554|FG001|Overall Study|Advised by medical monitor|0|||
19433226|NCT02224703|41680555|FG002|Overall Study|Advised by medical monitor|0|||
19433227|NCT02224703|41680553|FG000|Overall Study|Withdrawn by parent/guardian|0|||
19433228|NCT02224703|41680554|FG001|Overall Study|Withdrawn by parent/guardian|1|||
19433229|NCT02224703|41680555|FG002|Overall Study|Withdrawn by parent/guardian|0|||
19433230|NCT02224703|41680553|FG000|Overall Study|Lack of Efficacy|1|||
19433231|NCT02224703|41680554|FG001|Overall Study|Lack of Efficacy|0|||
19433232|NCT02224703|41680555|FG002|Overall Study|Lack of Efficacy|0|||
19433233|NCT02198963|41680564|FG000|Overall Study|Adverse Event|1|||
19433234|NCT02198963|41680564|FG000|Overall Study|Withdrawal by Subject|6|||
19433235|NCT01458106|41680588|FG000|Overall Study|Withdrawal by Subject|2|||
19433236|NCT01458106|41680589|FG001|Overall Study|Withdrawal by Subject|0|||
19433237|NCT01458106|41680588|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
19433238|NCT01458106|41680589|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
19433239|NCT01458106|41680588|FG000|Overall Study|Withdrawn Per Protocol|0|||
19433240|NCT01458106|41680589|FG001|Overall Study|Withdrawn Per Protocol|1|||
19433241|NCT01457950|41680600|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
19433242|NCT01457950|41680601|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
19433243|NCT01457950|41680602|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
19433244|NCT01457950|41680603|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
19433245|NCT01457950|41680600|FG000|Double-Blind Phase|Protocol Violation|2|||
19433246|NCT01457950|41680601|FG001|Double-Blind Phase|Protocol Violation|1|||
19711223|NCT00116805|42154353|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
19433247|NCT01457950|41680602|FG002|Double-Blind Phase|Protocol Violation|0|||
19433248|NCT01457950|41680603|FG003|Double-Blind Phase|Protocol Violation|0|||
19433249|NCT01457950|41680600|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
19433250|NCT01457950|41680601|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
19433251|NCT01457950|41680602|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19433252|NCT01457950|41680603|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19433253|NCT01457950|41680600|FG000|Open-Label Phase|Adverse Event|0|||
19433254|NCT01457950|41680601|FG001|Open-Label Phase|Adverse Event|0|||
19433255|NCT01457950|41680602|FG002|Open-Label Phase|Adverse Event|0|||
19433256|NCT01457950|41680603|FG003|Open-Label Phase|Adverse Event|1|||
19433257|NCT01457950|41680600|FG000|Open-Label Phase|Protocol Violation|0|||
19433258|NCT01457950|41680601|FG001|Open-Label Phase|Protocol Violation|0|||
19433259|NCT01457950|41680602|FG002|Open-Label Phase|Protocol Violation|0|||
19433260|NCT01457950|41680603|FG003|Open-Label Phase|Protocol Violation|1|||
19433261|NCT01457950|41680600|FG000|Open-Label Phase|Withdrawal by Subject|0|||
19433262|NCT01457950|41680601|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19433263|NCT01457950|41680602|FG002|Open-Label Phase|Withdrawal by Subject|2|||
19433264|NCT01457950|41680603|FG003|Open-Label Phase|Withdrawal by Subject|0|||
19433265|NCT01499134|41680616|FG000|Overall Study|Withdrawal by Subject|0|||
19433266|NCT01499134|41680617|FG001|Overall Study|Withdrawal by Subject|1|||
19433267|NCT02198651|41680623|FG000|Lead-in Period|Withdrew consent|13|||
19433268|NCT02198651|41680624|FG001|Lead-in Period|Withdrew consent|0|||
19433269|NCT02198651|41680625|FG002|Lead-in Period|Withdrew consent|0|||
19433270|NCT02198651|41680626|FG003|Lead-in Period|Withdrew consent|0|||
19433271|NCT02198651|41680627|FG004|Lead-in Period|Withdrew consent|0|||
19433272|NCT02198651|41680623|FG000|Lead-in Period|Adverse Event|2|||
19433273|NCT02198651|41680624|FG001|Lead-in Period|Adverse Event|0|||
19433274|NCT02198651|41680625|FG002|Lead-in Period|Adverse Event|0|||
19433275|NCT02198651|41680626|FG003|Lead-in Period|Adverse Event|0|||
19433276|NCT02198651|41680627|FG004|Lead-in Period|Adverse Event|0|||
19433277|NCT02198651|41680623|FG000|Lead-in Period|Other, not specified|22|||
19433278|NCT02198651|41680624|FG001|Lead-in Period|Other, not specified|0|||
19433279|NCT02198651|41680625|FG002|Lead-in Period|Other, not specified|0|||
19433280|NCT02198651|41680626|FG003|Lead-in Period|Other, not specified|0|||
19433281|NCT02198651|41680627|FG004|Lead-in Period|Other, not specified|0|||
19433282|NCT02198651|41680623|FG000|Double-blind Period|Withdrew consent|0|||
19433283|NCT02198651|41680624|FG001|Double-blind Period|Withdrew consent|4|||
19433284|NCT02198651|41680625|FG002|Double-blind Period|Withdrew consent|0|||
19433285|NCT02198651|41680626|FG003|Double-blind Period|Withdrew consent|0|||
19433286|NCT02198651|41680627|FG004|Double-blind Period|Withdrew consent|0|||
19433287|NCT02198651|41680623|FG000|Double-blind Period|Adverse Event|0|||
19433288|NCT02198651|41680624|FG001|Double-blind Period|Adverse Event|1|||
19433289|NCT02198651|41680625|FG002|Double-blind Period|Adverse Event|0|||
19433290|NCT02198651|41680626|FG003|Double-blind Period|Adverse Event|0|||
19433291|NCT02198651|41680627|FG004|Double-blind Period|Adverse Event|0|||
19433292|NCT02198651|41680623|FG000|Double-blind Period|Other, not specified|0|||
19433293|NCT02198651|41680624|FG001|Double-blind Period|Other, not specified|4|||
19433294|NCT02198651|41680625|FG002|Double-blind Period|Other, not specified|1|||
19433295|NCT02198651|41680626|FG003|Double-blind Period|Other, not specified|0|||
19433296|NCT02198651|41680627|FG004|Double-blind Period|Other, not specified|0|||
19433297|NCT02198651|41680623|FG000|Open-label Rescue Period|Withdrew consent|0|||
19433298|NCT02198651|41680624|FG001|Open-label Rescue Period|Withdrew consent|0|||
19433299|NCT02198651|41680625|FG002|Open-label Rescue Period|Withdrew consent|0|||
19433300|NCT02198651|41680626|FG003|Open-label Rescue Period|Withdrew consent|2|||
19433301|NCT02198651|41680627|FG004|Open-label Rescue Period|Withdrew consent|0|||
19433302|NCT02198651|41680623|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
19433303|NCT02198651|41680624|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
19433304|NCT02198651|41680625|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
19433305|NCT02198651|41680626|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
19433306|NCT02198651|41680627|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
19433307|NCT01498822|41680642|FG000|Overall Study|Protocol Violation|8|||
19433308|NCT01498822|41680643|FG001|Overall Study|Protocol Violation|4|||
19433309|NCT01498822|41680642|FG000|Overall Study|Other Reason|5|||
19433310|NCT01498822|41680643|FG001|Overall Study|Other Reason|2|||
19433311|NCT01498822|41680642|FG000|Overall Study|Lack of Efficacy|7|||
19433312|NCT01498822|41680643|FG001|Overall Study|Lack of Efficacy|2|||
19433313|NCT01498822|41680642|FG000|Overall Study|AE, non-serious non-fatal|8|||
19433314|NCT01498822|41680643|FG001|Overall Study|AE, non-serious non-fatal|17|||
19433315|NCT01498822|41680642|FG000|Overall Study|SAE, non-fatal|2|||
19433316|NCT01498822|41680643|FG001|Overall Study|SAE, non-fatal|2|||
19433317|NCT01498822|41680642|FG000|Overall Study|Adverse Event, serious fatal|1|||
19433318|NCT01498822|41680643|FG001|Overall Study|Adverse Event, serious fatal|1|||
19628327|NCT00863681|42077761|FG001|Overall Study|Death|23|||
19628328|NCT00863681|42077762|FG002|Overall Study|Death|6|||
19433319|NCT01498822|41680642|FG000|Overall Study|Withdrawal by Subject|15|||
19433320|NCT01498822|41680643|FG001|Overall Study|Withdrawal by Subject|25|||
19433321|NCT01498822|41680642|FG000|Overall Study|Lost to Follow-up|8|||
19433322|NCT01498822|41680643|FG001|Overall Study|Lost to Follow-up|3|||
19433323|NCT01498120|41680651|FG000|Overall Study|Lost to Follow-up|1|||
19433324|NCT01498120|41680651|FG000|Overall Study|Withdrawal by Subject|5|||
19433325|NCT01498120|41680651|FG000|Overall Study|AE, non-serious non-fatal|3|||
19433326|NCT01498120|41680651|FG000|Overall Study|Other|4|||
19433327|NCT01497262|41680655|FG000|Overall Study|Abnormal Lab Values|4|||
19433328|NCT01497262|41680655|FG000|Overall Study|Abnormal Test Procedure Result|1|||
19433329|NCT01497262|41680655|FG000|Overall Study|Physician Decision|1|||
19433330|NCT01497262|41680655|FG000|Overall Study|Withdrawal by Subject|2|||
19433331|NCT01497262|41680655|FG000|Overall Study|Adverse Event|2|||
19433332|NCT01497262|41680655|FG000|Overall Study|Protocol Violation|1|||
19433333|NCT02224625|41680659|FG000|Irritation|Adverse Event|6|||
19433334|NCT02224625|41680659|FG000|Sensitization|Adverse Event|55|||
19433335|NCT02197247|41680671|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
19433336|NCT02197247|41680671|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
19433337|NCT02197247|41680671|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
19433338|NCT02197247|41680671|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
19433339|NCT02197247|41680671|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
19433340|NCT02197247|41680671|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
19433341|NCT02197247|41680671|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
19433342|NCT02197247|41680671|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
19433343|NCT02224157|41680683|FG000|Overall Study|Severe non-compliance to protocol|2|||
19433344|NCT02224157|41680684|FG001|Overall Study|Severe non-compliance to protocol|2|||
19433345|NCT02224157|41680683|FG000|Overall Study|Other|13|||
19433346|NCT02224157|41680684|FG001|Overall Study|Other|10|||
19433347|NCT02224157|41680683|FG000|Overall Study|Subject decision|58|||
19433348|NCT02224157|41680684|FG001|Overall Study|Subject decision|50|||
19433349|NCT02224157|41680683|FG000|Overall Study|Prematurely closed site|4|||
19433350|NCT02224157|41680684|FG001|Overall Study|Prematurely closed site|2|||
19433351|NCT02224157|41680683|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
19433352|NCT02224157|41680684|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
19433353|NCT02224157|41680683|FG000|Overall Study|Lost to Follow-up|27|||
19433354|NCT02224157|41680684|FG001|Overall Study|Lost to Follow-up|35|||
19433355|NCT02224157|41680683|FG000|Overall Study|Death|1|||
19433356|NCT02224157|41680684|FG001|Overall Study|Death|1|||
19433357|NCT02224157|41680683|FG000|Overall Study|Adverse Event|1|||
19433358|NCT02224157|41680684|FG001|Overall Study|Adverse Event|3|||
19433359|NCT02196701|41680692|FG000|Overall Study|Adverse Event|1|||
19433360|NCT02196701|41680692|FG000|Overall Study|Lost to Follow-up|1|||
19433361|NCT02196701|41680692|FG000|Overall Study|Non-adherence to Protocol|1|||
19433362|NCT01481116|41680702|FG000|Overall Study|Adverse Event|26|||
19433363|NCT01481116|41680703|FG001|Overall Study|Adverse Event|26|||
19433364|NCT01481116|41680704|FG002|Overall Study|Adverse Event|42|||
19433365|NCT01481116|41680702|FG000|Overall Study|Major Protocol Deviation|3|||
19433366|NCT01481116|41680703|FG001|Overall Study|Major Protocol Deviation|7|||
19433367|NCT01481116|41680704|FG002|Overall Study|Major Protocol Deviation|1|||
19433368|NCT01481116|41680702|FG000|Overall Study|Lost to Follow-up|8|||
19433369|NCT01481116|41680703|FG001|Overall Study|Lost to Follow-up|12|||
19433370|NCT01481116|41680704|FG002|Overall Study|Lost to Follow-up|11|||
19433371|NCT01481116|41680702|FG000|Overall Study|Withdrawal by Subject|37|||
19433372|NCT01481116|41680703|FG001|Overall Study|Withdrawal by Subject|33|||
19433373|NCT01481116|41680704|FG002|Overall Study|Withdrawal by Subject|37|||
19433374|NCT01481116|41680702|FG000|Overall Study|Study Termination|730|||
19433375|NCT01481116|41680703|FG001|Overall Study|Study Termination|729|||
19433376|NCT01481116|41680704|FG002|Overall Study|Study Termination|713|||
19433377|NCT01481116|41680702|FG000|Overall Study|Pregnancy|0|||
19433378|NCT01481116|41680703|FG001|Overall Study|Pregnancy|0|||
19433379|NCT01481116|41680704|FG002|Overall Study|Pregnancy|1|||
19433380|NCT01481116|41680702|FG000|Overall Study|Lack of Efficacy|3|||
19433381|NCT01481116|41680703|FG001|Overall Study|Lack of Efficacy|3|||
19433382|NCT01481116|41680704|FG002|Overall Study|Lack of Efficacy|1|||
19433383|NCT01481116|41680702|FG000|Overall Study|Contraindications|1|||
19433384|NCT01481116|41680703|FG001|Overall Study|Contraindications|1|||
19433385|NCT01481116|41680704|FG002|Overall Study|Contraindications|0|||
19433386|NCT01481116|41680702|FG000|Overall Study|Other|1|||
19433387|NCT01481116|41680703|FG001|Overall Study|Other|1|||
19433388|NCT01481116|41680704|FG002|Overall Study|Other|0|||
19433389|NCT01481116|41680702|FG000|Overall Study|Participant Started Taking Glipizide|1|||
19433390|NCT01481116|41680703|FG001|Overall Study|Participant Started Taking Glipizide|0|||
19433391|NCT01481116|41680704|FG002|Overall Study|Participant Started Taking Glipizide|0|||
19433392|NCT01481116|41680702|FG000|Overall Study|Participant Moved Out of Area|2|||
19433393|NCT01481116|41680703|FG001|Overall Study|Participant Moved Out of Area|0|||
19433394|NCT01481116|41680704|FG002|Overall Study|Participant Moved Out of Area|1|||
19433395|NCT01481116|41680702|FG000|Overall Study|Participant Moved Out of Country|1|||
19433396|NCT01481116|41680703|FG001|Overall Study|Participant Moved Out of Country|0|||
19433397|NCT01481116|41680704|FG002|Overall Study|Participant Moved Out of Country|1|||
19433398|NCT01481116|41680702|FG000|Overall Study|Investigator Decision|3|||
19433399|NCT01481116|41680703|FG001|Overall Study|Investigator Decision|2|||
19433400|NCT01481116|41680704|FG002|Overall Study|Investigator Decision|1|||
19433401|NCT01481116|41680702|FG000|Overall Study|Sponsor Decision|0|||
19433402|NCT01481116|41680703|FG001|Overall Study|Sponsor Decision|1|||
19433403|NCT01481116|41680704|FG002|Overall Study|Sponsor Decision|3|||
19433404|NCT01481116|41680702|FG000|Overall Study|Non-Compliant With Study Drug|0|||
19433405|NCT01481116|41680703|FG001|Overall Study|Non-Compliant With Study Drug|1|||
19433406|NCT01481116|41680704|FG002|Overall Study|Non-Compliant With Study Drug|1|||
19433407|NCT01481116|41680702|FG000|Overall Study|Investigator's Discretion|2|||
19433408|NCT01481116|41680703|FG001|Overall Study|Investigator's Discretion|0|||
19433409|NCT01481116|41680704|FG002|Overall Study|Investigator's Discretion|0|||
19433410|NCT01481116|41680702|FG000|Overall Study|Death|2|||
19433411|NCT01481116|41680703|FG001|Overall Study|Death|1|||
19433412|NCT01481116|41680704|FG002|Overall Study|Death|0|||
19433413|NCT01481116|41680702|FG000|Overall Study|Hypoglycemic Event|4|||
19433414|NCT01481116|41680703|FG001|Overall Study|Hypoglycemic Event|0|||
19433415|NCT01481116|41680704|FG002|Overall Study|Hypoglycemic Event|0|||
19433416|NCT02222207|41680712|FG000|Overall Study|Death|1|||
19433417|NCT02222207|41680712|FG000|Overall Study|Other reasons|2|||
19433418|NCT02222207|41680712|FG000|Overall Study|Adverse Event|1|||
19433419|NCT01457014|41680716|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
19433420|NCT01457014|41680717|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
19433421|NCT01457014|41680718|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
19433422|NCT01457014|41680719|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
19433423|NCT01457014|41680716|FG000|First Night|Withdrawal by Subject|3|||
19433424|NCT01457014|41680717|FG001|First Night|Withdrawal by Subject|0|||
19433425|NCT01457014|41680718|FG002|First Night|Withdrawal by Subject|0|||
19433426|NCT01457014|41680719|FG003|First Night|Withdrawal by Subject|0|||
19433427|NCT02254421|41680729|FG000|Overall Study|Randomized but Not Treated|1|||
19433428|NCT02254421|41680730|FG001|Overall Study|Randomized but Not Treated|0|||
19433429|NCT02254421|41680729|FG000|Overall Study|Death|0|||
19433430|NCT02254421|41680730|FG001|Overall Study|Death|2|||
19433431|NCT02254421|41680729|FG000|Overall Study|Withdrew Consent|1|||
19433432|NCT02254421|41680730|FG001|Overall Study|Withdrew Consent|1|||
19433433|NCT02252939|41680736|FG000|Overall Study|Lost to Follow-up|3|||
19433434|NCT02196077|41680745|FG000|Overall Study|Adverse Event|4|||
19433435|NCT02196077|41680745|FG000|Overall Study|Lack of Efficacy|1|||
19433436|NCT02196077|41680745|FG000|Overall Study|Withdrawal by Subject|14|||
19433437|NCT02196077|41680745|FG000|Overall Study|Physician Decision|1|||
19433438|NCT02196077|41680745|FG000|Overall Study|Lost to Follow-up|3|||
19433439|NCT02196077|41680745|FG000|Overall Study|Protocol Violation|24|||
19433440|NCT02195687|41680759|FG000|Overall Study|Personal Reasons|1|||
19433441|NCT02195687|41680760|FG001|Overall Study|Personal Reasons|1|||
19433442|NCT02195687|41680759|FG000|Overall Study|Lost to Follow-up|4|||
19433443|NCT02195687|41680760|FG001|Overall Study|Lost to Follow-up|1|||
19433444|NCT02195531|41680769|FG000|Overall Study|Withdrawal by Subject|1|||
19433445|NCT02195531|41680770|FG001|Overall Study|Withdrawal by Subject|1|||
19433446|NCT02195531|41680771|FG002|Overall Study|Withdrawal by Subject|1|||
19433447|NCT02252081|41680781|FG000|Overall Study|Withdrawal by Subject|2|||
19433448|NCT02252081|41680782|FG001|Overall Study|Withdrawal by Subject|1|||
19433449|NCT02252081|41680781|FG000|Overall Study|Adverse Event|4|||
19433450|NCT02252081|41680782|FG001|Overall Study|Adverse Event|1|||
19433451|NCT02252081|41680781|FG000|Overall Study|non compliance & others|0|||
19433452|NCT02252081|41680782|FG001|Overall Study|non compliance & others|2|||
19433453|NCT01623752|41680796|FG000|Phase 1 (78 Weeks)|No Data|249|||
19433454|NCT01623752|41680797|FG001|Phase 1 (78 Weeks)|No Data|66|||
19433455|NCT01623752|41680798|FG002|Phase 1 (78 Weeks)|No Data|2|||
19433456|NCT01623752|41680796|FG000|Phase 1 (78 Weeks)|Other|33|||
19433457|NCT01623752|41680797|FG001|Phase 1 (78 Weeks)|Other|20|||
19433458|NCT01623752|41680798|FG002|Phase 1 (78 Weeks)|Other|0|||
19433459|NCT01623752|41680796|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
19433460|NCT01623752|41680797|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
19433461|NCT01623752|41680798|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
19433462|NCT01623752|41680796|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
19711224|NCT00116805|42154354|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
19433463|NCT01623752|41680797|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
19433464|NCT01623752|41680798|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
19433465|NCT01623752|41680796|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
19433466|NCT01623752|41680797|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
19433467|NCT01623752|41680798|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
19433468|NCT01623752|41680796|FG000|Phase 2 (78 Weeks)|Other|5|||
19433469|NCT01623752|41680797|FG001|Phase 2 (78 Weeks)|Other|1|||
19433470|NCT01623752|41680798|FG002|Phase 2 (78 Weeks)|Other|0|||
19433471|NCT01623752|41680796|FG000|Phase 2 (78 Weeks)|No Data|43|||
19433472|NCT01623752|41680797|FG001|Phase 2 (78 Weeks)|No Data|11|||
19433473|NCT01623752|41680798|FG002|Phase 2 (78 Weeks)|No Data|0|||
19433474|NCT01623752|41680796|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
19433475|NCT01623752|41680797|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
19433476|NCT01623752|41680798|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
19433477|NCT01623596|41680809|FG000|Overall Study|Abnormal laboratory values|2|||
19433478|NCT01623596|41680810|FG001|Overall Study|Abnormal laboratory values|0|||
19433479|NCT01623596|41680809|FG000|Overall Study|Administrative problems|9|||
19433480|NCT01623596|41680810|FG001|Overall Study|Administrative problems|13|||
19433481|NCT01623596|41680809|FG000|Overall Study|Adverse Event|20|||
19433482|NCT01623596|41680810|FG001|Overall Study|Adverse Event|29|||
19433483|NCT01623596|41680809|FG000|Overall Study|Death|0|||
19433484|NCT01623596|41680810|FG001|Overall Study|Death|2|||
19433485|NCT01623596|41680809|FG000|Overall Study|Lost to Follow-up|12|||
19433486|NCT01623596|41680810|FG001|Overall Study|Lost to Follow-up|16|||
19433487|NCT01623596|41680809|FG000|Overall Study|Withdrawal by Subject|13|||
19433488|NCT01623596|41680810|FG001|Overall Study|Withdrawal by Subject|31|||
19433489|NCT01623596|41680809|FG000|Overall Study|Patient no longer requires study drug|1|||
19433490|NCT01623596|41680810|FG001|Overall Study|Patient no longer requires study drug|0|||
19433491|NCT01623596|41680809|FG000|Overall Study|Protocol Violation|0|||
19433492|NCT01623596|41680810|FG001|Overall Study|Protocol Violation|6|||
19433493|NCT01623596|41680809|FG000|Overall Study|Lack of Efficacy|5|||
19433494|NCT01623596|41680810|FG001|Overall Study|Lack of Efficacy|3|||
19433495|NCT02219477|41680821|FG000|Overall Study|Adverse Event|0|||
19433496|NCT02219477|41680822|FG001|Overall Study|Adverse Event|1|||
19433497|NCT02219477|41680823|FG002|Overall Study|Adverse Event|1|||
19433498|NCT02219477|41680821|FG000|Overall Study|Withdrawal by Subject|0|||
19433499|NCT02219477|41680822|FG001|Overall Study|Withdrawal by Subject|1|||
19433500|NCT02219477|41680823|FG002|Overall Study|Withdrawal by Subject|0|||
19433501|NCT02119286|41680835|FG000|Overall Study|Adverse Event|9|||
19433502|NCT02119286|41680836|FG001|Overall Study|Adverse Event|7|||
19433503|NCT02119286|41680837|FG002|Overall Study|Adverse Event|2|||
19433504|NCT02119286|41680835|FG000|Overall Study|Lack of Efficacy|11|||
19433505|NCT02119286|41680836|FG001|Overall Study|Lack of Efficacy|3|||
19433506|NCT02119286|41680837|FG002|Overall Study|Lack of Efficacy|4|||
19433507|NCT02119286|41680835|FG000|Overall Study|Lost to Follow-up|2|||
19433508|NCT02119286|41680836|FG001|Overall Study|Lost to Follow-up|0|||
19433509|NCT02119286|41680837|FG002|Overall Study|Lost to Follow-up|1|||
19433510|NCT02119286|41680835|FG000|Overall Study|Withdrawal by Subject|4|||
19433511|NCT02119286|41680836|FG001|Overall Study|Withdrawal by Subject|1|||
19433512|NCT02119286|41680837|FG002|Overall Study|Withdrawal by Subject|0|||
19433513|NCT02250443|41680845|FG000|Overall Study|Administrative problems|7|||
19433514|NCT02250443|41680845|FG000|Overall Study|Adverse Event|3|||
19433515|NCT02093390|41680851|FG000|Overall Study|Withdrawal by Subject|0|||
19433516|NCT02093390|41680852|FG001|Overall Study|Withdrawal by Subject|1|||
19433517|NCT02194985|41680859|FG000|Overall Study|Adverse Event|1|||
19433518|NCT02194985|41680859|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
19433519|NCT02194985|41680859|FG000|Overall Study|Physician Decision|4|||
19433520|NCT02194985|41680859|FG000|Overall Study|Lost to Follow-up|1|||
19433521|NCT02194985|41680859|FG000|Overall Study|Withdrawal by Subject|2|||
19433522|NCT02219087|41680865|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
19433523|NCT02219087|41680866|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
19433524|NCT02248961|41680874|FG000|Overall Study|Adverse Event|1|||
19433525|NCT02248961|41680875|FG001|Overall Study|Adverse Event|0|||
19433526|NCT02248961|41680874|FG000|Overall Study|Withdrawal by Subject|1|||
19433527|NCT02248961|41680875|FG001|Overall Study|Withdrawal by Subject|2|||
19433528|NCT02248961|41680874|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
19433529|NCT02248961|41680875|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
19433530|NCT02219009|41680883|FG000|Overall Study|Withdrawal by Subject|5|||
19433531|NCT02219009|41680884|FG001|Overall Study|Withdrawal by Subject|1|||
19433532|NCT02219009|41680883|FG000|Overall Study|Adverse Event|2|||
19433533|NCT02219009|41680884|FG001|Overall Study|Adverse Event|4|||
19433534|NCT02219009|41680883|FG000|Overall Study|Lost to Follow-up|2|||
19433535|NCT02219009|41680884|FG001|Overall Study|Lost to Follow-up|2|||
19433536|NCT02219009|41680883|FG000|Overall Study|Protocol deviation|1|||
19433537|NCT02219009|41680884|FG001|Overall Study|Protocol deviation|0|||
19433538|NCT02219009|41680883|FG000|Overall Study|Physician Decision|0|||
19433539|NCT02219009|41680884|FG001|Overall Study|Physician Decision|1|||
19433540|NCT02248649|41680892|FG000|Overall Study|Death|7|||
19433541|NCT02248649|41680893|FG001|Overall Study|Death|11|||
19433542|NCT02248649|41680892|FG000|Overall Study|Lost to Follow-up|14|||
19433543|NCT02248649|41680893|FG001|Overall Study|Lost to Follow-up|10|||
19433544|NCT02218541|41680901|FG000|Overall Study|Lost to Follow-up|2|||
19433545|NCT02218541|41680902|FG001|Overall Study|Lost to Follow-up|1|||
19433546|NCT02218541|41680901|FG000|Overall Study|Implant Failure|4|||
19433547|NCT02218541|41680902|FG001|Overall Study|Implant Failure|1|||
19433548|NCT02217527|41680911|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
19433549|NCT02217527|41680912|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
19433550|NCT02217527|41680911|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
19433551|NCT02217527|41680912|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
19433552|NCT01456936|41680922|FG000|Overall Study|Other reason|41|||
19433553|NCT01456936|41680923|FG001|Overall Study|Other reason|30|||
19433554|NCT01456936|41680924|FG002|Overall Study|Other reason|36|||
19433555|NCT01456936|41680925|FG003|Overall Study|Other reason|33|||
19433556|NCT01456936|41680922|FG000|Overall Study|No longer meets eligibility criteria|4|||
19433557|NCT01456936|41680923|FG001|Overall Study|No longer meets eligibility criteria|8|||
19433558|NCT01456936|41680924|FG002|Overall Study|No longer meets eligibility criteria|6|||
19433559|NCT01456936|41680925|FG003|Overall Study|No longer meets eligibility criteria|5|||
19433560|NCT01456936|41680922|FG000|Overall Study|Protocol Violation|4|||
19433561|NCT01456936|41680923|FG001|Overall Study|Protocol Violation|2|||
19433562|NCT01456936|41680924|FG002|Overall Study|Protocol Violation|5|||
19433563|NCT01456936|41680925|FG003|Overall Study|Protocol Violation|5|||
19433564|NCT01456936|41680922|FG000|Overall Study|Pregnancy|1|||
19433565|NCT01456936|41680923|FG001|Overall Study|Pregnancy|0|||
19433566|NCT01456936|41680924|FG002|Overall Study|Pregnancy|0|||
19433567|NCT01456936|41680925|FG003|Overall Study|Pregnancy|1|||
19433568|NCT01456936|41680922|FG000|Overall Study|Insufficient clinical response|4|||
19433569|NCT01456936|41680923|FG001|Overall Study|Insufficient clinical response|4|||
19433570|NCT01456936|41680924|FG002|Overall Study|Insufficient clinical response|14|||
19433571|NCT01456936|41680925|FG003|Overall Study|Insufficient clinical response|13|||
19433572|NCT01456936|41680922|FG000|Overall Study|No longer willing to participate|195|||
19433573|NCT01456936|41680923|FG001|Overall Study|No longer willing to participate|218|||
19433574|NCT01456936|41680924|FG002|Overall Study|No longer willing to participate|224|||
19433575|NCT01456936|41680925|FG003|Overall Study|No longer willing to participate|248|||
19433576|NCT01456936|41680922|FG000|Overall Study|Lost to Follow-up|135|||
19433577|NCT01456936|41680923|FG001|Overall Study|Lost to Follow-up|126|||
19433578|NCT01456936|41680924|FG002|Overall Study|Lost to Follow-up|144|||
19433579|NCT01456936|41680925|FG003|Overall Study|Lost to Follow-up|127|||
19433580|NCT01456936|41680922|FG000|Overall Study|Medication error|0|||
19433581|NCT01456936|41680923|FG001|Overall Study|Medication error|1|||
19433582|NCT01456936|41680924|FG002|Overall Study|Medication error|0|||
19433583|NCT01456936|41680925|FG003|Overall Study|Medication error|1|||
19433584|NCT01456936|41680922|FG000|Overall Study|Adverse event (study drug)|25|||
19433585|NCT01456936|41680923|FG001|Overall Study|Adverse event (study drug)|21|||
19433586|NCT01456936|41680924|FG002|Overall Study|Adverse event (study drug)|26|||
19433587|NCT01456936|41680925|FG003|Overall Study|Adverse event (study drug)|17|||
19433588|NCT01456936|41680922|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
19433589|NCT01456936|41680923|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
19433590|NCT01456936|41680924|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
19433591|NCT01456936|41680925|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
19433592|NCT01456936|41680922|FG000|Overall Study|Death|0|||
19433593|NCT01456936|41680923|FG001|Overall Study|Death|3|||
19433594|NCT01456936|41680924|FG002|Overall Study|Death|1|||
19433595|NCT01456936|41680925|FG003|Overall Study|Death|3|||
19433596|NCT01456936|41680922|FG000|Overall Study|Randomized but not treated|21|||
19433597|NCT01456936|41680923|FG001|Overall Study|Randomized but not treated|28|||
19433598|NCT01456936|41680924|FG002|Overall Study|Randomized but not treated|16|||
19433599|NCT01456936|41680925|FG003|Overall Study|Randomized but not treated|21|||
19433600|NCT01456780|41680938|FG000|Overall Study|Lost to Follow-up|3|||
19433601|NCT01456780|41680939|FG001|Overall Study|Lost to Follow-up|3|||
19433602|NCT01456780|41680940|FG002|Overall Study|Lost to Follow-up|0|||
19433603|NCT01480258|41680950|FG000|Infant Series|Protocol Violation|2|||
19433604|NCT01480258|41680951|FG001|Infant Series|Protocol Violation|0|||
19433605|NCT01480258|41680950|FG000|Infant Series|Physician Decision|0|||
19433606|NCT01480258|41680951|FG001|Infant Series|Physician Decision|1|||
19433607|NCT01480258|41680950|FG000|Infant Series|Not Vaccinated|3|||
19433608|NCT01480258|41680951|FG001|Infant Series|Not Vaccinated|0|||
19433609|NCT01480258|41680950|FG000|Infant Series|Adverse Event|1|||
19433610|NCT01480258|41680951|FG001|Infant Series|Adverse Event|1|||
19433611|NCT01480258|41680950|FG000|Infant Series|Withdrawal by Subject|1|||
19433612|NCT01480258|41680951|FG001|Infant Series|Withdrawal by Subject|6|||
19433613|NCT01480258|41680950|FG000|Interim Period|Lost to Follow-up|0|||
19433614|NCT01480258|41680951|FG001|Interim Period|Lost to Follow-up|2|||
19433615|NCT01480258|41680950|FG000|Interim Period|Physician Decision|1|||
19433616|NCT01480258|41680951|FG001|Interim Period|Physician Decision|0|||
19433617|NCT01480258|41680950|FG000|Interim Period|Protocol Violation|0|||
19433618|NCT01480258|41680951|FG001|Interim Period|Protocol Violation|1|||
19433619|NCT01480258|41680950|FG000|Interim Period|Withdrawal by Subject|9|||
19433620|NCT01480258|41680951|FG001|Interim Period|Withdrawal by Subject|6|||
19433621|NCT01479868|41680957|FG000|Overall Study|Adverse Event|1|||
19433622|NCT01479868|41680957|FG000|Overall Study|Lost to Follow-up|4|||
19433623|NCT01479868|41680957|FG000|Overall Study|Protocol Violation|1|||
19433624|NCT01479868|41680957|FG000|Overall Study|Withdrawal by Subject|1|||
19433625|NCT01479868|41680957|FG000|Overall Study|Sponsor's Decision|1|||
19433626|NCT01479868|41680957|FG000|Overall Study|Initiation of new HCV Therapy|1|||
19433627|NCT01478620|41680961|FG000|Overall Study|Lost to Follow-up|6|||
19433628|NCT01455220|41680965|FG000|Overall Study|screen fail|30|||
19433629|NCT01454830|41680974|FG000|Overall Study|Withdrawal by Subject|4|||
19433630|NCT01454830|41680975|FG001|Overall Study|Withdrawal by Subject|4|||
19433631|NCT01454830|41680974|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
19433632|NCT01454830|41680975|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
19433633|NCT01454830|41680974|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
19433634|NCT01454830|41680975|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
19433635|NCT01454830|41680974|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
19433636|NCT01454830|41680975|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
19433637|NCT01454830|41680974|FG000|Overall Study|Withdrawal - no polysomnography|3|||
19433638|NCT01454830|41680975|FG001|Overall Study|Withdrawal - no polysomnography|2|||
19433639|NCT01454596|41680993|FG000|Overall Study|Death|0|||
19433640|NCT01454596|41680994|FG001|Overall Study|Death|0|||
19433641|NCT01454596|41680995|FG002|Overall Study|Death|0|||
19433642|NCT01454596|41680996|FG003|Overall Study|Death|0|||
19433643|NCT01454596|41680997|FG004|Overall Study|Death|0|||
19433644|NCT01454596|41680998|FG005|Overall Study|Death|0|||
19433645|NCT01454596|41680999|FG006|Overall Study|Death|0|||
19433646|NCT01454596|41681000|FG007|Overall Study|Death|0|||
19433647|NCT01454596|41681001|FG008|Overall Study|Death|0|||
19433648|NCT01454596|41681002|FG009|Overall Study|Death|1|||
19433649|NCT01454596|41681003|FG010|Overall Study|Death|1|||
19433650|NCT01454596|41681004|FG011|Overall Study|Death|0|||
19433651|NCT02247479|41681033|FG000|Overall Study|Adverse Event|8|||
19433652|NCT02247479|41681034|FG001|Overall Study|Adverse Event|9|||
19433653|NCT02247479|41681035|FG002|Overall Study|Adverse Event|8|||
19433654|NCT02247479|41681033|FG000|Overall Study|Death|5|||
19433655|NCT02247479|41681034|FG001|Overall Study|Death|4|||
19433656|NCT02247479|41681035|FG002|Overall Study|Death|6|||
19433657|NCT02247479|41681033|FG000|Overall Study|Lost to Follow-up|3|||
19433658|NCT02247479|41681034|FG001|Overall Study|Lost to Follow-up|3|||
19433659|NCT02247479|41681035|FG002|Overall Study|Lost to Follow-up|1|||
19433660|NCT02247479|41681033|FG000|Overall Study|Non-compliance|0|||
19433661|NCT02247479|41681034|FG001|Overall Study|Non-compliance|0|||
19433662|NCT02247479|41681035|FG002|Overall Study|Non-compliance|1|||
19433663|NCT02247479|41681033|FG000|Overall Study|Withdrawal by Subject|25|||
19433664|NCT02247479|41681034|FG001|Overall Study|Withdrawal by Subject|29|||
19433665|NCT02247479|41681035|FG002|Overall Study|Withdrawal by Subject|24|||
19433666|NCT02247479|41681033|FG000|Overall Study|Study Terminated by Sponsor|98|||
19433667|NCT02247479|41681034|FG001|Overall Study|Study Terminated by Sponsor|88|||
19433668|NCT02247479|41681035|FG002|Overall Study|Study Terminated by Sponsor|94|||
19433669|NCT02247479|41681033|FG000|Overall Study|Physician Decision|1|||
19433670|NCT02247479|41681034|FG001|Overall Study|Physician Decision|0|||
19433671|NCT02247479|41681035|FG002|Overall Study|Physician Decision|2|||
19433672|NCT02247479|41681033|FG000|Overall Study|Unspecified Reason|2|||
19433673|NCT02247479|41681034|FG001|Overall Study|Unspecified Reason|5|||
19433674|NCT02247479|41681035|FG002|Overall Study|Unspecified Reason|2|||
19433675|NCT01454284|41681045|FG000|Overall Study|Adverse Event|20|||
19433676|NCT01454284|41681046|FG001|Overall Study|Adverse Event|7|||
19433677|NCT01454284|41681045|FG000|Overall Study|Death|0|||
19433678|NCT01454284|41681046|FG001|Overall Study|Death|3|||
19433679|NCT01454284|41681045|FG000|Overall Study|Lost to Follow-up|13|||
19433680|NCT01454284|41681046|FG001|Overall Study|Lost to Follow-up|8|||
19433681|NCT01454284|41681045|FG000|Overall Study|Protocol Violation|9|||
19433682|NCT01454284|41681046|FG001|Overall Study|Protocol Violation|6|||
19433683|NCT01454284|41681045|FG000|Overall Study|Withdrawal by Subject|58|||
19433684|NCT01454284|41681046|FG001|Overall Study|Withdrawal by Subject|36|||
19433685|NCT01454284|41681045|FG000|Overall Study|Physician Decision|16|||
19433686|NCT01454284|41681046|FG001|Overall Study|Physician Decision|11|||
19433687|NCT01454284|41681045|FG000|Overall Study|Sponsor Decision|0|||
19433688|NCT01454284|41681046|FG001|Overall Study|Sponsor Decision|2|||
19433689|NCT02247401|41681055|FG000|Overall Study|Adverse Event|1|||
19433690|NCT02247401|41681056|FG001|Overall Study|Adverse Event|0|||
19433691|NCT02247401|41681057|FG002|Overall Study|Adverse Event|0|||
19433692|NCT02247401|41681055|FG000|Overall Study|Withdrawal by Subject|4|||
19433693|NCT02247401|41681056|FG001|Overall Study|Withdrawal by Subject|1|||
19433694|NCT02247401|41681057|FG002|Overall Study|Withdrawal by Subject|1|||
19433695|NCT02247401|41681055|FG000|Overall Study|Lost to Follow-up|1|||
19433696|NCT02247401|41681056|FG001|Overall Study|Lost to Follow-up|1|||
19433697|NCT02247401|41681057|FG002|Overall Study|Lost to Follow-up|1|||
19433698|NCT02247011|41681068|FG000|Overall Study|Poor quality of radiological results|125|||
19433699|NCT02246777|41681075|FG000|Overall Study|Adverse Event|2|||
19433700|NCT02246777|41681075|FG000|Overall Study|Change of residence|1|||
19433701|NCT01495702|41681086|FG000|Randomized Phase|Randomized But Not Treated|1|||
19433702|NCT01495702|41681087|FG001|Randomized Phase|Randomized But Not Treated|4|||
19433703|NCT01495702|41681086|FG000|Randomized Phase|Adverse Event|2|||
19433704|NCT01495702|41681087|FG001|Randomized Phase|Adverse Event|2|||
19433705|NCT01495702|41681086|FG000|Randomized Phase|Death|1|||
19433706|NCT01495702|41681087|FG001|Randomized Phase|Death|0|||
19433707|NCT01495702|41681086|FG000|Randomized Phase|Lack of Efficacy|2|||
19433708|NCT01495702|41681087|FG001|Randomized Phase|Lack of Efficacy|0|||
19433709|NCT01495702|41681086|FG000|Randomized Phase|Investigators Discretion|2|||
19433710|NCT01495702|41681087|FG001|Randomized Phase|Investigators Discretion|0|||
19433711|NCT01495702|41681086|FG000|Randomized Phase|Withdrew Consent|10|||
19433712|NCT01495702|41681087|FG001|Randomized Phase|Withdrew Consent|18|||
19433713|NCT01495702|41681086|FG000|Randomized Phase|Lost to Follow-up|4|||
19433714|NCT01495702|41681087|FG001|Randomized Phase|Lost to Follow-up|3|||
19433715|NCT01495702|41681086|FG000|Randomized Phase|Participant Noncompliance|1|||
19433716|NCT01495702|41681087|FG001|Randomized Phase|Participant Noncompliance|0|||
19433717|NCT01495702|41681086|FG000|Randomized Phase|Protocol Violation|3|||
19433718|NCT01495702|41681087|FG001|Randomized Phase|Protocol Violation|1|||
19433719|NCT01630889|41681094|FG000|Overall Study|Death|2|||
19433720|NCT01630889|41681094|FG000|Overall Study|Withdrawal by Subject|1|||
19433721|NCT01630889|41681094|FG000|Overall Study|Other than Specified|2|||
19433722|NCT01630889|41681094|FG000|Overall Study|Lost to Follow-up|4|||
19433723|NCT01630889|41681094|FG000|Overall Study|Other|1|||
19433724|NCT01495000|41681100|FG000|Overall Study|Lost to Follow-up|2|||
19433725|NCT01495000|41681101|FG001|Overall Study|Lost to Follow-up|2|||
19433726|NCT01495000|41681100|FG000|Overall Study|Protocol Violation|1|||
19433727|NCT01495000|41681101|FG001|Overall Study|Protocol Violation|0|||
19433728|NCT01495000|41681100|FG000|Overall Study|Withdrawal by Subject|10|||
19433729|NCT01495000|41681101|FG001|Overall Study|Withdrawal by Subject|10|||
19433730|NCT01494922|41681107|FG000|Overall Study|Adverse Event|1|||
19433731|NCT02192099|41681111|FG000|Overall Study|Adverse Event|1|||
19433732|NCT02192099|41681111|FG000|Overall Study|Lost to Follow-up|2|||
19433733|NCT02192099|41681111|FG000|Overall Study|Physician Decision|1|||
19433734|NCT02192099|41681111|FG000|Overall Study|Pregnancy|1|||
19433735|NCT02192099|41681111|FG000|Overall Study|Protocol Violation|8|||
19433736|NCT02192099|41681111|FG000|Overall Study|Study Terminated by Sponsor|32|||
19433737|NCT02192099|41681111|FG000|Overall Study|Withdrawal by Subject|11|||
19433738|NCT02192099|41681111|FG000|Overall Study|Miscellaneous Reasons|5|||
19433739|NCT01494610|41681115|FG000|Period 1|Withdrawal by Subject|1|||
19433740|NCT01494610|41681116|FG001|Period 1|Withdrawal by Subject|1|||
19433741|NCT01494610|41681115|FG000|Period 3|Adverse Event|1|||
19433742|NCT01494610|41681116|FG001|Period 3|Adverse Event|0|||
19433743|NCT01494610|41681115|FG000|Period 3|Withdrawal by Subject|1|||
19433744|NCT01494610|41681116|FG001|Period 3|Withdrawal by Subject|0|||
19433745|NCT01494610|41681115|FG000|Period 4|Protocol Violation|1|||
19433746|NCT01494610|41681116|FG001|Period 4|Protocol Violation|0|||
19433747|NCT02116777|41681135|FG000|Overall Study|Adverse Event|0|||
19433748|NCT02116777|41681136|FG001|Overall Study|Adverse Event|0|||
19433749|NCT02116777|41681137|FG002|Overall Study|Adverse Event|0|||
19433750|NCT02116777|41681138|FG003|Overall Study|Adverse Event|0|||
19433751|NCT02116777|41681139|FG004|Overall Study|Adverse Event|2|||
19433752|NCT02116777|41681140|FG005|Overall Study|Adverse Event|2|||
19433753|NCT02116777|41681141|FG006|Overall Study|Adverse Event|0|||
19433754|NCT02116777|41681135|FG000|Overall Study|Death|0|||
19433755|NCT02116777|41681136|FG001|Overall Study|Death|0|||
19433756|NCT02116777|41681137|FG002|Overall Study|Death|0|||
19433757|NCT02116777|41681138|FG003|Overall Study|Death|1|||
19433758|NCT02116777|41681139|FG004|Overall Study|Death|0|||
19433759|NCT02116777|41681140|FG005|Overall Study|Death|0|||
19433760|NCT02116777|41681141|FG006|Overall Study|Death|0|||
19433761|NCT02116777|41681135|FG000|Overall Study|Lack of Efficacy|3|||
19433762|NCT02116777|41681136|FG001|Overall Study|Lack of Efficacy|3|||
19433763|NCT02116777|41681137|FG002|Overall Study|Lack of Efficacy|3|||
19433764|NCT02116777|41681138|FG003|Overall Study|Lack of Efficacy|8|||
19433765|NCT02116777|41681139|FG004|Overall Study|Lack of Efficacy|4|||
19433766|NCT02116777|41681140|FG005|Overall Study|Lack of Efficacy|1|||
19433767|NCT02116777|41681141|FG006|Overall Study|Lack of Efficacy|9|||
19433768|NCT02116777|41681135|FG000|Overall Study|Physician Decision|0|||
19433769|NCT02116777|41681136|FG001|Overall Study|Physician Decision|0|||
19711225|NCT00116805|42154353|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
19711226|NCT00116805|42154354|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
19711227|NCT00116805|42154353|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
19711228|NCT00116805|42154354|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
19433770|NCT02116777|41681137|FG002|Overall Study|Physician Decision|0|||
19433771|NCT02116777|41681138|FG003|Overall Study|Physician Decision|2|||
19433772|NCT02116777|41681139|FG004|Overall Study|Physician Decision|0|||
19433773|NCT02116777|41681140|FG005|Overall Study|Physician Decision|0|||
19433774|NCT02116777|41681141|FG006|Overall Study|Physician Decision|0|||
19433775|NCT02116777|41681135|FG000|Overall Study|Protocol Violation|0|||
19433776|NCT02116777|41681136|FG001|Overall Study|Protocol Violation|0|||
19433777|NCT02116777|41681137|FG002|Overall Study|Protocol Violation|0|||
19433778|NCT02116777|41681138|FG003|Overall Study|Protocol Violation|1|||
19433779|NCT02116777|41681139|FG004|Overall Study|Protocol Violation|0|||
19433780|NCT02116777|41681140|FG005|Overall Study|Protocol Violation|0|||
19433781|NCT02116777|41681141|FG006|Overall Study|Protocol Violation|0|||
19433782|NCT02116777|41681135|FG000|Overall Study|Withdrawal by Subject|0|||
19433783|NCT02116777|41681136|FG001|Overall Study|Withdrawal by Subject|0|||
19433784|NCT02116777|41681137|FG002|Overall Study|Withdrawal by Subject|0|||
19433785|NCT02116777|41681138|FG003|Overall Study|Withdrawal by Subject|1|||
19433786|NCT02116777|41681139|FG004|Overall Study|Withdrawal by Subject|0|||
19433787|NCT02116777|41681140|FG005|Overall Study|Withdrawal by Subject|0|||
19433788|NCT02116777|41681141|FG006|Overall Study|Withdrawal by Subject|0|||
19433789|NCT01494532|41681166|FG000|Overall Study|Adverse Event|4|||
19433790|NCT01494532|41681167|FG001|Overall Study|Adverse Event|1|||
19433791|NCT01494532|41681168|FG002|Overall Study|Adverse Event|8|||
19433792|NCT01494532|41681169|FG003|Overall Study|Adverse Event|6|||
19433793|NCT01494532|41681170|FG004|Overall Study|Adverse Event|5|||
19433794|NCT01494532|41681171|FG005|Overall Study|Adverse Event|0|||
19433795|NCT01494532|41681166|FG000|Overall Study|Lack of Efficacy|0|||
19433796|NCT01494532|41681167|FG001|Overall Study|Lack of Efficacy|0|||
19433797|NCT01494532|41681168|FG002|Overall Study|Lack of Efficacy|0|||
19433798|NCT01494532|41681169|FG003|Overall Study|Lack of Efficacy|0|||
19433799|NCT01494532|41681170|FG004|Overall Study|Lack of Efficacy|2|||
19433800|NCT01494532|41681171|FG005|Overall Study|Lack of Efficacy|0|||
19433801|NCT01494532|41681166|FG000|Overall Study|Protocol deviation|2|||
19433802|NCT01494532|41681167|FG001|Overall Study|Protocol deviation|1|||
19433803|NCT01494532|41681168|FG002|Overall Study|Protocol deviation|3|||
19433804|NCT01494532|41681169|FG003|Overall Study|Protocol deviation|2|||
19433805|NCT01494532|41681170|FG004|Overall Study|Protocol deviation|3|||
19433806|NCT01494532|41681171|FG005|Overall Study|Protocol deviation|0|||
19433807|NCT01494532|41681166|FG000|Overall Study|Protocol-defined stopping criteria|0|||
19433808|NCT01494532|41681167|FG001|Overall Study|Protocol-defined stopping criteria|0|||
19433809|NCT01494532|41681168|FG002|Overall Study|Protocol-defined stopping criteria|1|||
19433810|NCT01494532|41681169|FG003|Overall Study|Protocol-defined stopping criteria|0|||
19433811|NCT01494532|41681170|FG004|Overall Study|Protocol-defined stopping criteria|0|||
19433812|NCT01494532|41681171|FG005|Overall Study|Protocol-defined stopping criteria|0|||
19433813|NCT01494532|41681166|FG000|Overall Study|Lost to Follow-up|1|||
19433814|NCT01494532|41681167|FG001|Overall Study|Lost to Follow-up|0|||
19433815|NCT01494532|41681168|FG002|Overall Study|Lost to Follow-up|0|||
19433816|NCT01494532|41681169|FG003|Overall Study|Lost to Follow-up|2|||
19433817|NCT01494532|41681170|FG004|Overall Study|Lost to Follow-up|0|||
19433818|NCT01494532|41681171|FG005|Overall Study|Lost to Follow-up|0|||
19433819|NCT01494532|41681166|FG000|Overall Study|Physician Decision|0|||
19433820|NCT01494532|41681167|FG001|Overall Study|Physician Decision|1|||
19433821|NCT01494532|41681168|FG002|Overall Study|Physician Decision|1|||
19433822|NCT01494532|41681169|FG003|Overall Study|Physician Decision|2|||
19433823|NCT01494532|41681170|FG004|Overall Study|Physician Decision|0|||
19433824|NCT01494532|41681171|FG005|Overall Study|Physician Decision|0|||
19433825|NCT01494532|41681166|FG000|Overall Study|Withdrawal by Subject|3|||
19433826|NCT01494532|41681167|FG001|Overall Study|Withdrawal by Subject|1|||
19433827|NCT01494532|41681168|FG002|Overall Study|Withdrawal by Subject|4|||
19433828|NCT01494532|41681169|FG003|Overall Study|Withdrawal by Subject|3|||
19433829|NCT01494532|41681170|FG004|Overall Study|Withdrawal by Subject|2|||
19433830|NCT01494532|41681171|FG005|Overall Study|Withdrawal by Subject|0|||
19433831|NCT02191397|41681188|FG000|Overall Study|Adverse Event|28|||
19433832|NCT02191397|41681189|FG001|Overall Study|Adverse Event|17|||
19433833|NCT02191397|41681188|FG000|Overall Study|Lack of Efficacy|10|||
19433834|NCT02191397|41681189|FG001|Overall Study|Lack of Efficacy|5|||
19433835|NCT02191397|41681188|FG000|Overall Study|Protocol Violation|0|||
19433836|NCT02191397|41681189|FG001|Overall Study|Protocol Violation|3|||
19433837|NCT02191397|41681188|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
19433838|NCT02191397|41681189|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
19433839|NCT02191397|41681188|FG000|Overall Study|Lost to Follow-up|10|||
19433840|NCT02191397|41681189|FG001|Overall Study|Lost to Follow-up|11|||
19433841|NCT02191397|41681188|FG000|Overall Study|Physician Decision|8|||
19433842|NCT02191397|41681189|FG001|Overall Study|Physician Decision|3|||
19433843|NCT02191397|41681188|FG000|Overall Study|Withdrawal by Subject|22|||
19433844|NCT02191397|41681189|FG001|Overall Study|Withdrawal by Subject|27|||
19433845|NCT01630811|41681195|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
19433846|NCT01630811|41681196|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
19433847|NCT01494298|41681206|FG000|Overall Study|Protocol Violation|2|||
19433848|NCT01494298|41681207|FG001|Overall Study|Protocol Violation|8|||
19433849|NCT02170025|41681217|FG000|Overall Study|Adverse Event|2|||
19433850|NCT02170025|41681218|FG001|Overall Study|Adverse Event|0|||
19433851|NCT01493284|41681224|FG000|Overall Study|Death|29|||
19433852|NCT01493284|41681224|FG000|Overall Study|Withdrawal by Subject|32|||
19433853|NCT02169791|41681228|FG000|Overall Study|Death|6|||
19433854|NCT02169791|41681228|FG000|Overall Study|patient withdrew consent|1|||
19433855|NCT02216591|41681234|FG000|Overall Study|Lost to Follow-up|0|||
19433856|NCT02216591|41681235|FG001|Overall Study|Lost to Follow-up|1|||
19433857|NCT02216357|41681243|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
19433858|NCT02216357|41681244|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
19433859|NCT01492426|41681252|FG000|Treatment|Death|0|||
19433860|NCT01492426|41681253|FG001|Treatment|Death|1|||
19433861|NCT01492426|41681252|FG000|Treatment|Other|1|||
19433862|NCT01492426|41681253|FG001|Treatment|Other|0|||
19433863|NCT01492426|41681252|FG000|Treatment|Adverse Event|25|||
19433864|NCT01492426|41681253|FG001|Treatment|Adverse Event|25|||
19433865|NCT01492426|41681252|FG000|Treatment|Lack of Efficacy|38|||
19433866|NCT01492426|41681253|FG001|Treatment|Lack of Efficacy|5|||
19433867|NCT01492426|41681252|FG000|Treatment|Participant withdrew consent|1|||
19433868|NCT01492426|41681253|FG001|Treatment|Participant withdrew consent|2|||
19433869|NCT01492426|41681252|FG000|Treatment|Poor compliance/noncompliance|1|||
19433870|NCT01492426|41681253|FG001|Treatment|Poor compliance/noncompliance|0|||
19433871|NCT01492426|41681252|FG000|Treatment|Subject requested discontinue study drug|7|||
19433872|NCT01492426|41681253|FG001|Treatment|Subject requested discontinue study drug|3|||
19433873|NCT01492426|41681252|FG000|Treatment|Lost to Follow-up|9|||
19433874|NCT01492426|41681253|FG001|Treatment|Lost to Follow-up|4|||
19433875|NCT01492426|41681252|FG000|Treatment|Participant does not meet study criteria|1|||
19433876|NCT01492426|41681253|FG001|Treatment|Participant does not meet study criteria|0|||
19433877|NCT01492426|41681252|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
19433878|NCT01492426|41681253|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
19433879|NCT01492426|41681252|FG000|Follow-Up|Death|1|||
19433880|NCT01492426|41681253|FG001|Follow-Up|Death|0|||
19433881|NCT01492426|41681252|FG000|Follow-Up|Other|4|||
19433882|NCT01492426|41681253|FG001|Follow-Up|Other|2|||
19433883|NCT01492426|41681252|FG000|Follow-Up|Participant Withdrew Consent|6|||
19433884|NCT01492426|41681253|FG001|Follow-Up|Participant Withdrew Consent|1|||
19433885|NCT01492426|41681252|FG000|Follow-Up|Lost to Follow-up|12|||
19433886|NCT01492426|41681253|FG001|Follow-Up|Lost to Follow-up|6|||
19433887|NCT01453348|41681266|FG000|Overall Study|Death|0|||
19433888|NCT01453348|41681267|FG001|Overall Study|Death|0|||
19433889|NCT01453348|41681268|FG002|Overall Study|Death|1|||
19433890|NCT01453348|41681266|FG000|Overall Study|Withdrawal by Subject|0|||
19433891|NCT01453348|41681267|FG001|Overall Study|Withdrawal by Subject|1|||
19433892|NCT01453348|41681268|FG002|Overall Study|Withdrawal by Subject|0|||
19433893|NCT01453348|41681266|FG000|Overall Study|Protocol Violation|1|||
19433894|NCT01453348|41681267|FG001|Overall Study|Protocol Violation|0|||
19433895|NCT01453348|41681268|FG002|Overall Study|Protocol Violation|0|||
19433896|NCT01453036|41681282|FG000|Overall Study|Lost to Follow-up|26|||
19433897|NCT01453036|41681283|FG001|Overall Study|Lost to Follow-up|115|||
19433898|NCT01453036|41681284|FG002|Overall Study|Lost to Follow-up|31|||
19433899|NCT01475734|41681294|FG000|Overall Study|Withdrawal by Subject|1|||
19433900|NCT01475734|41681295|FG001|Overall Study|Withdrawal by Subject|0|||
19433901|NCT01475734|41681294|FG000|Overall Study|Protocol Violation|1|||
19433902|NCT01475734|41681295|FG001|Overall Study|Protocol Violation|0|||
19433903|NCT01475734|41681294|FG000|Overall Study|Physician Decision|0|||
19433904|NCT01475734|41681295|FG001|Overall Study|Physician Decision|1|||
19433905|NCT01452412|41681303|FG000|Overall Study|Withdrawal by Subject|15|||
19433906|NCT01452412|41681304|FG001|Overall Study|Withdrawal by Subject|11|||
19433907|NCT01452412|41681303|FG000|Overall Study|Adverse Event|4|||
19433908|NCT01452412|41681304|FG001|Overall Study|Adverse Event|3|||
19433909|NCT01452412|41681303|FG000|Overall Study|Lost to Follow-up|5|||
19433910|NCT01452412|41681304|FG001|Overall Study|Lost to Follow-up|3|||
19433911|NCT01452412|41681303|FG000|Overall Study|Death|1|||
19433912|NCT01452412|41681304|FG001|Overall Study|Death|0|||
19433913|NCT01452412|41681303|FG000|Overall Study|Initiated dialysis|1|||
19433914|NCT01452412|41681304|FG001|Overall Study|Initiated dialysis|0|||
19433915|NCT01452412|41681303|FG000|Overall Study|Other|2|||
19433916|NCT01452412|41681304|FG001|Overall Study|Other|0|||
19433917|NCT01474876|41681313|FG000|Overall Study|Adverse Event|11|||
19433918|NCT01474876|41681314|FG001|Overall Study|Adverse Event|5|||
19433919|NCT01474876|41681315|FG002|Overall Study|Adverse Event|0|||
19433920|NCT01474876|41681313|FG000|Overall Study|Serious Adverse Event|2|||
19433921|NCT01474876|41681314|FG001|Overall Study|Serious Adverse Event|3|||
19433922|NCT01474876|41681315|FG002|Overall Study|Serious Adverse Event|0|||
19433923|NCT01474876|41681313|FG000|Overall Study|Lost to Follow-up|5|||
19433924|NCT01474876|41681314|FG001|Overall Study|Lost to Follow-up|4|||
19433925|NCT01474876|41681315|FG002|Overall Study|Lost to Follow-up|0|||
19433926|NCT01474876|41681313|FG000|Overall Study|Investigator's decision|28|||
19433927|NCT01474876|41681314|FG001|Overall Study|Investigator's decision|6|||
19433928|NCT01474876|41681315|FG002|Overall Study|Investigator's decision|0|||
19628329|NCT00863681|42077760|FG000|Overall Study|Withdrawal by Subject|12|||
19433929|NCT01474876|41681313|FG000|Overall Study|Patient's request|19|||
19433930|NCT01474876|41681314|FG001|Overall Study|Patient's request|5|||
19433931|NCT01474876|41681315|FG002|Overall Study|Patient's request|0|||
19433932|NCT01474876|41681313|FG000|Overall Study|Investigator's decision and pt request|1|||
19433933|NCT01474876|41681314|FG001|Overall Study|Investigator's decision and pt request|0|||
19433934|NCT01474876|41681315|FG002|Overall Study|Investigator's decision and pt request|0|||
19433935|NCT01491802|41681321|FG000|Overall Study|Adverse Event|1|||
19628330|NCT00863681|42077761|FG001|Overall Study|Withdrawal by Subject|5|||
19433936|NCT01491802|41681322|FG001|Overall Study|Adverse Event|1|||
19433937|NCT01491802|41681321|FG000|Overall Study|Withdrawal by Subject|0|||
19433938|NCT01491802|41681322|FG001|Overall Study|Withdrawal by Subject|1|||
19433939|NCT02168777|41681332|FG000|Overall Study|Withdrawal by Subject|1|||
19433940|NCT02168777|41681333|FG001|Overall Study|Withdrawal by Subject|0|||
19433941|NCT02168777|41681334|FG002|Overall Study|Withdrawal by Subject|2|||
19433942|NCT02168777|41681332|FG000|Overall Study|Adverse Event|1|||
19433943|NCT02168777|41681333|FG001|Overall Study|Adverse Event|0|||
19433944|NCT02168777|41681334|FG002|Overall Study|Adverse Event|1|||
19433945|NCT02168777|41681332|FG000|Overall Study|Disease recurrence|0|||
19433946|NCT02168777|41681333|FG001|Overall Study|Disease recurrence|0|||
19433947|NCT02168777|41681334|FG002|Overall Study|Disease recurrence|1|||
19433948|NCT02168777|41681332|FG000|Overall Study|Radiological disease progression|0|||
19433949|NCT02168777|41681333|FG001|Overall Study|Radiological disease progression|5|||
19433950|NCT02168777|41681334|FG002|Overall Study|Radiological disease progression|5|||
19433951|NCT02168777|41681332|FG000|Overall Study|Clinical disease progression|0|||
19433952|NCT02168777|41681333|FG001|Overall Study|Clinical disease progression|1|||
19433953|NCT02168777|41681334|FG002|Overall Study|Clinical disease progression|2|||
19433954|NCT02168777|41681332|FG000|Overall Study|Other reason|0|||
19433955|NCT02168777|41681333|FG001|Overall Study|Other reason|1|||
19433956|NCT02168777|41681334|FG002|Overall Study|Other reason|0|||
19433957|NCT01491178|41681345|FG000|Overall Study|Adverse Event|1016|||
19433958|NCT01491178|41681345|FG000|Overall Study|Improvement of NVAF|210|||
19433959|NCT01491178|41681345|FG000|Overall Study|To conduct invasive treatment|59|||
19433960|NCT01491178|41681345|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
19433961|NCT01491178|41681345|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
19433962|NCT01491178|41681345|FG000|Overall Study|To take a contraindication|20|||
19433963|NCT01491178|41681345|FG000|Overall Study|Other than specified above|657|||
19433964|NCT02189837|41681353|FG000|Overall Study|Withdrawal by Subject|2|||
19433965|NCT02189837|41681354|FG001|Overall Study|Withdrawal by Subject|1|||
19433966|NCT02189837|41681355|FG002|Overall Study|Withdrawal by Subject|3|||
19433967|NCT02189837|41681356|FG003|Overall Study|Withdrawal by Subject|1|||
19433968|NCT02189837|41681353|FG000|Overall Study|Sponsor Decision|0|||
19433969|NCT02189837|41681354|FG001|Overall Study|Sponsor Decision|0|||
19433970|NCT02189837|41681355|FG002|Overall Study|Sponsor Decision|0|||
19433971|NCT02189837|41681356|FG003|Overall Study|Sponsor Decision|1|||
19433972|NCT02216123|41681368|FG000|Overall Study|Lost to Follow-up|4|||
19433973|NCT02216123|41681369|FG001|Overall Study|Lost to Follow-up|2|||
19433974|NCT02216123|41681368|FG000|Overall Study|Withdrawal by Subject|2|||
19433975|NCT02216123|41681369|FG001|Overall Study|Withdrawal by Subject|0|||
19433976|NCT02189759|41681383|FG000|Overall Study|Lost to Follow-up|0|||
19433977|NCT02189759|41681384|FG001|Overall Study|Lost to Follow-up|0|||
19433978|NCT02189759|41681385|FG002|Overall Study|Lost to Follow-up|2|||
19433979|NCT02189759|41681386|FG003|Overall Study|Lost to Follow-up|5|||
19433980|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
19628331|NCT00863681|42077762|FG002|Overall Study|Withdrawal by Subject|2|||
19628332|NCT00863681|42077760|FG000|Overall Study|Protocol Violation|2|||
19433981|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
19433982|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
19433983|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
19433984|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
19433985|NCT01490866|41681398|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
19433986|NCT01490866|41681398|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
19433987|NCT01490866|41681398|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
19433988|NCT01490866|41681398|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
19433989|NCT01490866|41681398|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
19433990|NCT01490866|41681398|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
19433991|NCT02215967|41681409|FG000|Overall Study|Patient became ineligible for treatment|0|||
19433992|NCT02215967|41681410|FG001|Overall Study|Patient became ineligible for treatment|0|||
19433993|NCT02215967|41681411|FG002|Overall Study|Patient became ineligible for treatment|0|||
19433994|NCT02215967|41681412|FG003|Overall Study|Patient became ineligible for treatment|3|||
19433995|NCT02215967|41681409|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
19433996|NCT02215967|41681410|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
19433997|NCT02215967|41681411|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
19433998|NCT02215967|41681412|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
19433999|NCT02168387|41681424|FG000|Overall Study|Planned exubation|6|||
19434000|NCT02168387|41681425|FG001|Overall Study|Planned exubation|3|||
19434001|NCT02168387|41681424|FG000|Overall Study|Death|1|||
19434002|NCT02168387|41681425|FG001|Overall Study|Death|0|||
19434003|NCT02188589|41681431|FG000|Overall Study|Withdrawal by Subject|5|||
19434004|NCT02167451|41681436|FG000|Overall Study|Withdrawal by Subject|1|||
19434005|NCT02167139|41681442|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
19434006|NCT02167139|41681443|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
19434007|NCT02167139|41681444|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
19434008|NCT02167139|41681445|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
19434009|NCT02167139|41681442|FG000|Randomised, Double-blind|Adverse Event|2|||
19434010|NCT02167139|41681443|FG001|Randomised, Double-blind|Adverse Event|9|||
19434011|NCT02167139|41681444|FG002|Randomised, Double-blind|Adverse Event|0|||
19434012|NCT02167139|41681445|FG003|Randomised, Double-blind|Adverse Event|0|||
19434013|NCT02167139|41681442|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
19434014|NCT02167139|41681443|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
19434015|NCT02167139|41681444|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
19434016|NCT02167139|41681445|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
19434017|NCT02167139|41681442|FG000|Randomised, Double-blind|Other|3|||
19434018|NCT02167139|41681443|FG001|Randomised, Double-blind|Other|0|||
19434019|NCT02167139|41681444|FG002|Randomised, Double-blind|Other|0|||
19434020|NCT02167139|41681445|FG003|Randomised, Double-blind|Other|0|||
19434021|NCT02167139|41681442|FG000|Transition-extension|Adverse Event|2|||
19434022|NCT02167139|41681443|FG001|Transition-extension|Adverse Event|0|||
19434023|NCT02167139|41681444|FG002|Transition-extension|Adverse Event|2|||
19434024|NCT02167139|41681445|FG003|Transition-extension|Adverse Event|3|||
19434025|NCT02167139|41681442|FG000|Transition-extension|Withdrawal by Subject|2|||
19434026|NCT02167139|41681443|FG001|Transition-extension|Withdrawal by Subject|0|||
19434027|NCT02167139|41681444|FG002|Transition-extension|Withdrawal by Subject|4|||
19434028|NCT02167139|41681445|FG003|Transition-extension|Withdrawal by Subject|1|||
19434029|NCT02167139|41681442|FG000|Transition-extension|Lack of Efficacy|0|||
19434030|NCT02167139|41681443|FG001|Transition-extension|Lack of Efficacy|0|||
19434031|NCT02167139|41681444|FG002|Transition-extension|Lack of Efficacy|1|||
19434032|NCT02167139|41681445|FG003|Transition-extension|Lack of Efficacy|1|||
19434033|NCT02167139|41681442|FG000|Transition-extension|Other|1|||
19434034|NCT02167139|41681443|FG001|Transition-extension|Other|0|||
19434035|NCT02167139|41681444|FG002|Transition-extension|Other|1|||
19434036|NCT02167139|41681445|FG003|Transition-extension|Other|0|||
19434037|NCT02167139|41681442|FG000|Transition-extension|Lost to Follow-up|1|||
19434038|NCT02167139|41681443|FG001|Transition-extension|Lost to Follow-up|0|||
19434039|NCT02167139|41681444|FG002|Transition-extension|Lost to Follow-up|0|||
19434040|NCT02167139|41681445|FG003|Transition-extension|Lost to Follow-up|0|||
19434041|NCT02101021|41681464|FG000|Overall Study|Death|4|||
19434042|NCT02101021|41681465|FG001|Overall Study|Death|3|||
19434043|NCT02101021|41681466|FG002|Overall Study|Death|6|||
19434044|NCT02101021|41681467|FG003|Overall Study|Death|0|||
19434045|NCT02101021|41681468|FG004|Overall Study|Death|3|||
19434046|NCT02101021|41681464|FG000|Overall Study|Withdrew Consent from study|1|||
19434047|NCT02101021|41681465|FG001|Overall Study|Withdrew Consent from study|1|||
19434048|NCT02101021|41681466|FG002|Overall Study|Withdrew Consent from study|0|||
19434049|NCT02101021|41681467|FG003|Overall Study|Withdrew Consent from study|2|||
19434050|NCT02101021|41681468|FG004|Overall Study|Withdrew Consent from study|0|||
19434051|NCT02101021|41681464|FG000|Overall Study|Lost to Follow-up|1|||
19434052|NCT02101021|41681465|FG001|Overall Study|Lost to Follow-up|0|||
19434053|NCT02101021|41681466|FG002|Overall Study|Lost to Follow-up|0|||
19434054|NCT02101021|41681467|FG003|Overall Study|Lost to Follow-up|0|||
19434055|NCT02101021|41681468|FG004|Overall Study|Lost to Follow-up|0|||
19434056|NCT02101021|41681464|FG000|Overall Study|Study Terminated by Sponsor|1|||
19434057|NCT02101021|41681465|FG001|Overall Study|Study Terminated by Sponsor|0|||
19434058|NCT02101021|41681466|FG002|Overall Study|Study Terminated by Sponsor|1|||
19434059|NCT02101021|41681467|FG003|Overall Study|Study Terminated by Sponsor|1|||
19434060|NCT02101021|41681468|FG004|Overall Study|Study Terminated by Sponsor|1|||
19434061|NCT02116621|41681482|FG000|Baseline|Withdrawal by Subject|0|||
19434062|NCT02116621|41681483|FG001|Baseline|Withdrawal by Subject|4|||
19434063|NCT02116621|41681482|FG000|Three Month Follow-up|Death|1|||
19434064|NCT02116621|41681483|FG001|Three Month Follow-up|Death|1|||
19434065|NCT02116621|41681482|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
19434066|NCT02116621|41681483|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
19434067|NCT02116621|41681482|FG000|Three Month Follow-up|Lost to Follow-up|0|||
19434068|NCT02116621|41681483|FG001|Three Month Follow-up|Lost to Follow-up|1|||
19434069|NCT02116621|41681482|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
19434070|NCT02116621|41681483|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
19434071|NCT02116621|41681482|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
19434072|NCT02116621|41681483|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
19434073|NCT02116621|41681482|FG000|Six Month Follow-up|Lost to Follow-up|2|||
19434074|NCT02116621|41681483|FG001|Six Month Follow-up|Lost to Follow-up|1|||
19434075|NCT02116621|41681482|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
19434076|NCT02116621|41681483|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
19434077|NCT02116621|41681482|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
19434078|NCT02116621|41681483|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
19434079|NCT02116621|41681482|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
19434080|NCT02116621|41681483|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
19434081|NCT02116621|41681482|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
19434082|NCT02116621|41681483|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
19434083|NCT02116621|41681482|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
19434084|NCT02116621|41681483|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
19434085|NCT02116309|41681491|FG000|Overall Study|Lost to Follow-up|0|||
19434086|NCT02116309|41681492|FG001|Overall Study|Lost to Follow-up|1|||
19434087|NCT02115607|41681498|FG000|Overall Study|Withdrawal by Subject|1|||
19434088|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
19434089|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
19434090|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
19434091|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
19434092|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
19434093|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
19434094|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
19434095|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
19434096|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
19434097|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
19434098|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
19434099|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
19434100|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
19434101|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
19434102|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
19434103|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
19434104|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
19434105|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
19434106|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
19434107|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
19434108|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
19434109|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
19434110|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
19434111|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
19434112|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434113|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434114|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434115|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434116|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434117|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434118|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434119|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434120|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434121|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434122|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434123|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434124|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434125|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434126|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434127|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
19434128|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434129|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434130|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
19434131|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
19434132|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
19434133|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434134|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434135|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434136|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434137|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434138|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434139|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434140|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434141|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434142|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434143|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434144|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434145|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434146|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434147|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
19434148|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
19434149|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
19434150|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
19434151|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
19434152|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
19434153|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
19711229|NCT00116805|42154353|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
19434154|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
19434155|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
19434156|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
19434157|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
19434158|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
19434159|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
19434160|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
19434161|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
19434162|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
19434163|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
19434164|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
19434165|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
19434166|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
19434167|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
19434168|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
19434169|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434170|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434171|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434172|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434173|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434174|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434175|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434176|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434177|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434178|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434179|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434180|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434181|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434182|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434183|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434184|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434185|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434186|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434187|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
19434188|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
19434189|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
19434190|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434191|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
19434192|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
19434193|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434194|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434195|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434196|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434197|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434198|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434199|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434200|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434201|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434202|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434203|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434204|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434205|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434206|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434207|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
19434208|NCT01490632|41681507|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434209|NCT01490632|41681508|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434210|NCT01490632|41681509|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434211|NCT01490632|41681510|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434212|NCT01490632|41681511|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
19434213|NCT01490632|41681512|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434214|NCT01490632|41681513|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434215|NCT01490632|41681514|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434216|NCT01490632|41681515|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434217|NCT01490632|41681516|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434218|NCT01490632|41681517|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434219|NCT01490632|41681518|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434220|NCT01490632|41681519|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434221|NCT01490632|41681520|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434222|NCT01490632|41681521|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434223|NCT01490632|41681522|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434224|NCT01490632|41681523|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434225|NCT01490632|41681524|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434226|NCT01490632|41681525|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434227|NCT01490632|41681526|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
19434228|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434229|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434230|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434231|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434232|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434233|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
19434234|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
19434235|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434236|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434237|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
19434238|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
19434239|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
19434240|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434241|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434242|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434243|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434244|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434245|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434246|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434247|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
19434248|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434249|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434250|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434251|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434252|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434253|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434254|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
19434255|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434256|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
19434257|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
19434258|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
19434259|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434260|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434261|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434262|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434263|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434264|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434265|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434266|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434267|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
19434268|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434269|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434270|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434271|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434272|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434273|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434274|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
19434275|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434276|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434277|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
19434278|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434279|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434280|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434281|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434282|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19711230|NCT00116805|42154354|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
19711231|NCT00116649|42154369|FG000|Overall Study|Adverse Event|20|||
19434283|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434284|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434285|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434286|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434287|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
19434288|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434289|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434290|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434291|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434292|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434293|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434294|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
19434295|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434296|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434297|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434298|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434299|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434300|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434301|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434302|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434303|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434304|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434305|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434306|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434307|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
19434308|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434309|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434310|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434311|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434312|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434313|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
19434314|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434315|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434316|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434317|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434318|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434319|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434320|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434321|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434322|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434323|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434324|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434325|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434326|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434327|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
19434328|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434329|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434330|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434331|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434332|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434333|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434334|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
19434335|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434336|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
19434337|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434338|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
19434339|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
19434340|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434341|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434342|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434343|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434344|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434345|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434346|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19434347|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
19521717|NCT00637572|41935058|FG000|Overall Study|Illicit Drug Use|1|||
19434348|NCT01490632|41681507|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434349|NCT01490632|41681508|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434350|NCT01490632|41681509|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434351|NCT01490632|41681510|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434352|NCT01490632|41681511|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19521718|NCT00637572|41935059|FG001|Overall Study|Illicit Drug Use|0|||
19521719|NCT00637416|41935067|FG000|Overall Study|Lost to Follow-up|1|||
19521720|NCT00637416|41935068|FG001|Overall Study|Lost to Follow-up|1|||
19521721|NCT00637416|41935067|FG000|Overall Study|Unable to take study drug|0|||
19521722|NCT00637416|41935068|FG001|Overall Study|Unable to take study drug|1|||
19521723|NCT00636792|41935074|FG000|Overall Study|Adverse Event|16|||
19521724|NCT00636792|41935074|FG000|Overall Study|Physician Decision|7|||
19521725|NCT00636792|41935074|FG000|Overall Study|Progressive Disease|4|||
19521726|NCT00636792|41935074|FG000|Overall Study|Withdrawal by Subject|3|||
19521727|NCT00636792|41935074|FG000|Overall Study|Other|3|||
19521728|NCT00636636|41935106|FG000|Overall Study|Other reason|4|||
19521729|NCT00636636|41935107|FG001|Overall Study|Other reason|6|||
19521730|NCT00636636|41935106|FG000|Overall Study|Adverse Event|19|||
19521731|NCT00636636|41935107|FG001|Overall Study|Adverse Event|8|||
19521732|NCT00636636|41935106|FG000|Overall Study|Lack of Efficacy|7|||
19628333|NCT00863681|42077761|FG001|Overall Study|Protocol Violation|0|||
19628334|NCT00863681|42077762|FG002|Overall Study|Protocol Violation|0|||
19628335|NCT00863681|42077760|FG000|Overall Study|Lost to Follow-up|3|||
19628336|NCT00863681|42077761|FG001|Overall Study|Lost to Follow-up|0|||
19628337|NCT00863681|42077762|FG002|Overall Study|Lost to Follow-up|3|||
19628338|NCT00863681|42077760|FG000|Overall Study|Adverse Event|28|||
19434353|NCT01490632|41681512|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
19434354|NCT01490632|41681513|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
19434355|NCT01490632|41681514|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
19434356|NCT01490632|41681515|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
19434357|NCT01490632|41681516|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
19434358|NCT01490632|41681517|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
19434359|NCT01490632|41681518|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
19434360|NCT01490632|41681519|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434361|NCT01490632|41681520|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434362|NCT01490632|41681521|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434363|NCT01490632|41681522|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434364|NCT01490632|41681523|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434365|NCT01490632|41681524|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434366|NCT01490632|41681525|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434367|NCT01490632|41681526|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
19434368|NCT01490632|41681507|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434369|NCT01490632|41681508|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434370|NCT01490632|41681509|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434371|NCT01490632|41681510|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434372|NCT01490632|41681511|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434373|NCT01490632|41681512|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434374|NCT01490632|41681513|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434375|NCT01490632|41681514|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434376|NCT01490632|41681515|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434377|NCT01490632|41681516|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434378|NCT01490632|41681517|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434379|NCT01490632|41681518|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434380|NCT01490632|41681519|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434381|NCT01490632|41681520|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434382|NCT01490632|41681521|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
19434383|NCT01490632|41681522|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
19434384|NCT01490632|41681523|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434385|NCT01490632|41681524|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434386|NCT01490632|41681525|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434387|NCT01490632|41681526|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
19434388|NCT01490632|41681507|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19521733|NCT00636636|41935107|FG001|Overall Study|Lack of Efficacy|12|||
19521734|NCT00636636|41935106|FG000|Overall Study|Protocol Violation|2|||
19521735|NCT00636636|41935107|FG001|Overall Study|Protocol Violation|2|||
19521736|NCT00636636|41935106|FG000|Overall Study|Lost to Follow-up|0|||
19628339|NCT00863681|42077761|FG001|Overall Study|Adverse Event|10|||
19628340|NCT00863681|42077762|FG002|Overall Study|Adverse Event|6|||
19434389|NCT01490632|41681508|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434390|NCT01490632|41681509|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434391|NCT01490632|41681510|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434392|NCT01490632|41681511|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434393|NCT01490632|41681512|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434394|NCT01490632|41681513|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434395|NCT01490632|41681514|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434396|NCT01490632|41681515|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434397|NCT01490632|41681516|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434398|NCT01490632|41681517|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434399|NCT01490632|41681518|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434400|NCT01490632|41681519|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434401|NCT01490632|41681520|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
19434402|NCT01490632|41681521|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434403|NCT01490632|41681522|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434404|NCT01490632|41681523|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434405|NCT01490632|41681524|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434406|NCT01490632|41681525|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434407|NCT01490632|41681526|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
19434408|NCT01490632|41681507|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434409|NCT01490632|41681508|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434410|NCT01490632|41681509|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434411|NCT01490632|41681510|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434412|NCT01490632|41681511|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434413|NCT01490632|41681512|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434414|NCT01490632|41681513|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434415|NCT01490632|41681514|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434416|NCT01490632|41681515|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434417|NCT01490632|41681516|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434418|NCT01490632|41681517|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434419|NCT01490632|41681518|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434420|NCT01490632|41681519|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434421|NCT01490632|41681520|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434422|NCT01490632|41681521|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
19434423|NCT01490632|41681522|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
19434424|NCT01490632|41681523|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434425|NCT01490632|41681524|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434426|NCT01490632|41681525|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434427|NCT01490632|41681526|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
19434428|NCT01490632|41681507|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434429|NCT01490632|41681508|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434430|NCT01490632|41681509|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434431|NCT01490632|41681510|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434432|NCT01490632|41681511|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434433|NCT01490632|41681512|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434434|NCT01490632|41681513|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434435|NCT01490632|41681514|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434436|NCT01490632|41681515|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434437|NCT01490632|41681516|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434438|NCT01490632|41681517|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434439|NCT01490632|41681518|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434440|NCT01490632|41681519|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
19434441|NCT01490632|41681520|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
19434442|NCT01490632|41681521|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
19434443|NCT01490632|41681522|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
19434444|NCT01490632|41681523|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434445|NCT01490632|41681524|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434446|NCT01490632|41681525|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434447|NCT01490632|41681526|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
19434448|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
19434449|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
19434450|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
19434451|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
19434452|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
19434453|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
19434454|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
19434455|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
19434456|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
19434457|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
19521737|NCT00636636|41935107|FG001|Overall Study|Lost to Follow-up|1|||
19521738|NCT00636636|41935106|FG000|Overall Study|Death|0|||
19521739|NCT00636636|41935107|FG001|Overall Study|Death|1|||
19521740|NCT00636636|41935106|FG000|Overall Study|Withdrawal by Subject|4|||
19521741|NCT00636636|41935107|FG001|Overall Study|Withdrawal by Subject|9|||
19521742|NCT00635778|41935120|FG000|Overall Study|Adverse Event|1|||
19521743|NCT00635778|41935121|FG001|Overall Study|Adverse Event|0|||
19521744|NCT00635778|41935122|FG002|Overall Study|Adverse Event|0|||
19521745|NCT00635778|41935123|FG003|Overall Study|Adverse Event|3|||
19521746|NCT00635778|41935124|FG004|Overall Study|Adverse Event|3|||
19521747|NCT00635778|41935125|FG005|Overall Study|Adverse Event|6|||
19521748|NCT00635778|41935126|FG006|Overall Study|Adverse Event|1|||
19521749|NCT00635778|41935120|FG000|Overall Study|Withdrawal by Subject|0|||
19521750|NCT00635778|41935121|FG001|Overall Study|Withdrawal by Subject|0|||
19521751|NCT00635778|41935122|FG002|Overall Study|Withdrawal by Subject|0|||
19521752|NCT00635778|41935123|FG003|Overall Study|Withdrawal by Subject|1|||
19521753|NCT00635778|41935124|FG004|Overall Study|Withdrawal by Subject|0|||
19521754|NCT00635778|41935125|FG005|Overall Study|Withdrawal by Subject|1|||
19521755|NCT00635778|41935126|FG006|Overall Study|Withdrawal by Subject|1|||
19521756|NCT00635778|41935120|FG000|Overall Study|Progressive disease|0|||
19521757|NCT00635778|41935121|FG001|Overall Study|Progressive disease|3|||
19521758|NCT00635778|41935122|FG002|Overall Study|Progressive disease|3|||
19521759|NCT00635778|41935123|FG003|Overall Study|Progressive disease|4|||
19521760|NCT00635778|41935124|FG004|Overall Study|Progressive disease|5|||
19521761|NCT00635778|41935125|FG005|Overall Study|Progressive disease|14|||
19521762|NCT00635778|41935126|FG006|Overall Study|Progressive disease|4|||
19521763|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
19521764|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
19521765|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
19521766|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
19521767|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
19521768|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
19521769|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Rejections|0|||
19521770|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Rejections|0|||
19521771|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Rejections|55|||
19521772|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
19521773|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
19521774|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
19521775|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
19521776|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
19521777|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
19521778|NCT00634920|41935146|FG000|Period 1 - Pre-Randomization|Other issues|0|||
19521779|NCT00634920|41935147|FG001|Period 1 - Pre-Randomization|Other issues|0|||
19521780|NCT00634920|41935148|FG002|Period 1 - Pre-Randomization|Other issues|6|||
19521781|NCT00634920|41935146|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
19521782|NCT00634920|41935147|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
19521783|NCT00634920|41935148|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
19521784|NCT00634920|41935146|FG000|Period 2 - Post-Randomization|Rejection|11|||
19521785|NCT00634920|41935147|FG001|Period 2 - Post-Randomization|Rejection|5|||
19521786|NCT00634920|41935148|FG002|Period 2 - Post-Randomization|Rejection|0|||
19521787|NCT00634920|41935146|FG000|Period 2 - Post-Randomization|Death|2|||
19521788|NCT00634920|41935147|FG001|Period 2 - Post-Randomization|Death|5|||
19521789|NCT00634920|41935148|FG002|Period 2 - Post-Randomization|Death|0|||
19521790|NCT00634920|41935146|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
19521791|NCT00634920|41935147|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
19521792|NCT00634920|41935148|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
19521793|NCT00634920|41935146|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
19521794|NCT00634920|41935147|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
19521795|NCT00634920|41935148|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
19521796|NCT00634842|41935156|FG000|Overall Study|Adverse Event|2|||
19628341|NCT00863681|42077760|FG000|Overall Study|Lack of Efficacy|2|||
19628342|NCT00863681|42077761|FG001|Overall Study|Lack of Efficacy|2|||
19628343|NCT00863681|42077762|FG002|Overall Study|Lack of Efficacy|1|||
19628344|NCT00863681|42077760|FG000|Overall Study|Non-compliance with study drug|1|||
19434458|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
19434459|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
19434460|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
19434461|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
19434462|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
19434463|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
19434464|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
19434465|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
19434466|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
19434467|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
19434468|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Death|0|||
19434469|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Death|0|||
19434470|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Death|0|||
19434471|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Death|0|||
19434472|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Death|0|||
19434473|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Death|0|||
19434474|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Death|0|||
19434475|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Death|0|||
19434476|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Death|0|||
19434477|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Death|0|||
19434478|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Death|0|||
19434479|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Death|0|||
19434480|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Death|0|||
19434481|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Death|0|||
19434482|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Death|0|||
19434483|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Death|0|||
19434484|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Death|0|||
19434485|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Death|0|||
19434486|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Death|1|||
19434487|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Death|0|||
19434488|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434489|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434490|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434491|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434492|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434493|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434494|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434495|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434496|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434497|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434498|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434499|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434500|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434501|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434502|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434503|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434504|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
19434505|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
19434506|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
19434507|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
19434508|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434509|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434510|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434511|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434512|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434513|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434514|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19521797|NCT00634842|41935157|FG001|Overall Study|Adverse Event|3|||
19521798|NCT00634842|41935156|FG000|Overall Study|Protocol Violation|8|||
19521799|NCT00634842|41935157|FG001|Overall Study|Protocol Violation|4|||
19521800|NCT00634842|41935156|FG000|Overall Study|Move to another state|1|||
19521801|NCT00634842|41935157|FG001|Overall Study|Move to another state|0|||
19521802|NCT00634842|41935156|FG000|Overall Study|Inclusion criteria were not met|1|||
19521803|NCT00634842|41935157|FG001|Overall Study|Inclusion criteria were not met|0|||
19521804|NCT00634842|41935156|FG000|Overall Study|Lost to Follow-up|1|||
19521805|NCT00634842|41935157|FG001|Overall Study|Lost to Follow-up|2|||
19521806|NCT00634842|41935156|FG000|Overall Study|Physician Decision|1|||
19521807|NCT00634842|41935157|FG001|Overall Study|Physician Decision|0|||
19521808|NCT00634842|41935156|FG000|Overall Study|Withdrawal by Subject|1|||
19521809|NCT00634842|41935157|FG001|Overall Study|Withdrawal by Subject|3|||
19434515|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434516|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434517|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434518|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434519|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19521810|NCT00634842|41935156|FG000|Overall Study|Lack of time and intolerance to drug|0|||
19521811|NCT00634842|41935157|FG001|Overall Study|Lack of time and intolerance to drug|1|||
19434520|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434521|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434522|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434523|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434524|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434525|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434526|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
19434527|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
19434528|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
19434529|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
19434530|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
19434531|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
19434532|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
19434533|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
19434534|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
19434535|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
19434536|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
19434537|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
19434538|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
19434539|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
19434540|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
19434541|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
19434542|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
19434543|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
19434544|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
19434545|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
19434546|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
19434547|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
19434548|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
19434549|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
19434550|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
19434551|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
19434552|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
19434553|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
19434554|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
19434555|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
19434556|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
19434557|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
19434558|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
19434559|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
19434560|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
19434561|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
19434562|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
19434563|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
19434564|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
19434565|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
19434566|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
19434567|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
19434568|NCT01490632|41681507|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434569|NCT01490632|41681508|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434570|NCT01490632|41681509|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434571|NCT01490632|41681510|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434572|NCT01490632|41681511|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434573|NCT01490632|41681512|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434574|NCT01490632|41681513|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434575|NCT01490632|41681514|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434576|NCT01490632|41681515|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434577|NCT01490632|41681516|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434578|NCT01490632|41681517|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434579|NCT01490632|41681518|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434580|NCT01490632|41681519|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434581|NCT01490632|41681520|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434582|NCT01490632|41681521|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434583|NCT01490632|41681522|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434584|NCT01490632|41681523|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
19434585|NCT01490632|41681524|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
19434586|NCT01490632|41681525|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
19434587|NCT01490632|41681526|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
19434588|NCT02073643|41681569|FG000|Overall Study|Lost to Follow-up|24|||
19434589|NCT01451554|41681575|FG000|Overall Study|Withdrawal by Subject|14|||
19434590|NCT01451554|41681576|FG001|Overall Study|Withdrawal by Subject|9|||
19434591|NCT01474486|41681582|FG000|Overall Study|Death|2|||
19434592|NCT01474486|41681582|FG000|Overall Study|Withdrawal by Subject|4|||
19434593|NCT01474486|41681582|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
19434594|NCT01451398|41681592|FG000|Overall Study|Adverse Event|7|||
19434595|NCT01451398|41681593|FG001|Overall Study|Adverse Event|9|||
19434596|NCT01451398|41681592|FG000|Overall Study|Protocol Violation|1|||
19434597|NCT01451398|41681593|FG001|Overall Study|Protocol Violation|2|||
19434598|NCT01451398|41681592|FG000|Overall Study|Physician Decision|1|||
19434599|NCT01451398|41681593|FG001|Overall Study|Physician Decision|1|||
19434600|NCT01451398|41681592|FG000|Overall Study|Withdrawal by Subject|10|||
19434601|NCT01451398|41681593|FG001|Overall Study|Withdrawal by Subject|14|||
19434602|NCT01451398|41681592|FG000|Overall Study|Lost to Follow-up|6|||
19434603|NCT01451398|41681593|FG001|Overall Study|Lost to Follow-up|4|||
19434604|NCT01451398|41681592|FG000|Overall Study|Non-compliance with study drug|1|||
19434605|NCT01451398|41681593|FG001|Overall Study|Non-compliance with study drug|3|||
19434606|NCT01451398|41681592|FG000|Overall Study|Non-compliance with protocol|1|||
19434607|NCT01451398|41681593|FG001|Overall Study|Non-compliance with protocol|1|||
19434608|NCT01451398|41681592|FG000|Overall Study|Moved out of country|0|||
19434609|NCT01451398|41681593|FG001|Overall Study|Moved out of country|1|||
19434610|NCT01451398|41681592|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
19434611|NCT01451398|41681593|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
19434612|NCT01451398|41681592|FG000|Overall Study|Lack of Efficacy|0|||
19434613|NCT01451398|41681593|FG001|Overall Study|Lack of Efficacy|1|||
19434614|NCT02073565|41681601|FG000|Cohort A|Withdrawal by Subject|1|||
19434615|NCT02073565|41681602|FG001|Cohort A|Withdrawal by Subject|0|||
19434616|NCT02073565|41681601|FG000|Cohort B|Withdrawal by Subject|1|||
19434617|NCT02073565|41681602|FG001|Cohort B|Withdrawal by Subject|2|||
19434618|NCT02073565|41681601|FG000|Cohort C|Withdrawal by Subject|0|||
19434619|NCT02073565|41681602|FG001|Cohort C|Withdrawal by Subject|2|||
19434620|NCT02073565|41681601|FG000|Cohort C|Lost to Follow-up|0|||
19434621|NCT02073565|41681602|FG001|Cohort C|Lost to Follow-up|2|||
19434622|NCT02072941|41681610|FG000|Overall Study|Withdrawal by Subject|29|||
19434623|NCT02072941|41681611|FG001|Overall Study|Withdrawal by Subject|21|||
19434624|NCT02072941|41681610|FG000|Overall Study|Lost to Follow-up|4|||
19434625|NCT02072941|41681611|FG001|Overall Study|Lost to Follow-up|4|||
19434626|NCT02072941|41681610|FG000|Overall Study|Death|3|||
19434627|NCT02072941|41681611|FG001|Overall Study|Death|2|||
19434628|NCT02072941|41681610|FG000|Overall Study|Removed by Study Staff|2|||
19434629|NCT02072941|41681611|FG001|Overall Study|Removed by Study Staff|2|||
19434630|NCT02100631|41681620|FG000|Overall Study|Withdrawal by Subject|1|||
19434631|NCT02100631|41681621|FG001|Overall Study|Withdrawal by Subject|0|||
19434632|NCT02100631|41681622|FG002|Overall Study|Withdrawal by Subject|0|||
19434633|NCT02100631|41681620|FG000|Overall Study|Lost to Follow-up|3|||
19434634|NCT02100631|41681621|FG001|Overall Study|Lost to Follow-up|4|||
19434635|NCT02100631|41681622|FG002|Overall Study|Lost to Follow-up|0|||
19434636|NCT02100631|41681620|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
19434637|NCT02100631|41681621|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
19434638|NCT02100631|41681622|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
19434639|NCT01451164|41681634|FG000|Overall Study|Adverse Event|19|||
19434640|NCT01451164|41681635|FG001|Overall Study|Adverse Event|12|||
19434641|NCT01451164|41681636|FG002|Overall Study|Adverse Event|18|||
19434642|NCT01451164|41681637|FG003|Overall Study|Adverse Event|21|||
19434643|NCT01451164|41681634|FG000|Overall Study|Withdrawal Criteria|1|||
19434644|NCT01451164|41681635|FG001|Overall Study|Withdrawal Criteria|1|||
19434645|NCT01451164|41681636|FG002|Overall Study|Withdrawal Criteria|1|||
19434646|NCT01451164|41681637|FG003|Overall Study|Withdrawal Criteria|1|||
19434647|NCT01451164|41681634|FG000|Overall Study|Physician Decision|2|||
19434648|NCT01451164|41681635|FG001|Overall Study|Physician Decision|0|||
19434649|NCT01451164|41681636|FG002|Overall Study|Physician Decision|1|||
19434650|NCT01451164|41681637|FG003|Overall Study|Physician Decision|0|||
19434651|NCT01451164|41681634|FG000|Overall Study|Withdrawal by Subject|14|||
19434652|NCT01451164|41681635|FG001|Overall Study|Withdrawal by Subject|11|||
19434653|NCT01451164|41681636|FG002|Overall Study|Withdrawal by Subject|16|||
19434654|NCT01451164|41681637|FG003|Overall Study|Withdrawal by Subject|17|||
19434655|NCT01451164|41681634|FG000|Overall Study|Protocol Violation|0|||
19434656|NCT01451164|41681635|FG001|Overall Study|Protocol Violation|1|||
19434657|NCT01451164|41681636|FG002|Overall Study|Protocol Violation|0|||
19434658|NCT01451164|41681637|FG003|Overall Study|Protocol Violation|0|||
19434659|NCT01451164|41681634|FG000|Overall Study|Lack of Efficacy|7|||
19434660|NCT01451164|41681635|FG001|Overall Study|Lack of Efficacy|9|||
19434661|NCT01451164|41681636|FG002|Overall Study|Lack of Efficacy|9|||
19434662|NCT01451164|41681637|FG003|Overall Study|Lack of Efficacy|7|||
19434663|NCT02071849|41681647|FG000|6-month Primary Endpoint|Did not receive device|4|||
19434664|NCT02071849|41681647|FG000|6-month Primary Endpoint|Adverse Event|1|||
19434665|NCT02071849|41681647|FG000|2-year Extended Follow-up|Adverse Event|1|||
19434666|NCT02071771|41681651|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
19434667|NCT02071771|41681652|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
19434668|NCT02071771|41681651|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
19434669|NCT02071771|41681652|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
19434670|NCT02071225|41681658|FG000|Overall Study|Withdrawal of Consent|2|||
19434671|NCT02071225|41681658|FG000|Overall Study|Protocol Deviation|1|||
19434672|NCT02071225|41681658|FG000|Overall Study|Lost to Follow-up|2|||
19434673|NCT02071225|41681658|FG000|Overall Study|Death|25|||
19434674|NCT01450696|41681664|FG000|Overall Study|Never Treated|1|||
19434675|NCT01450696|41681665|FG001|Overall Study|Never Treated|1|||
19434676|NCT01450696|41681664|FG000|Overall Study|Death|77|||
19434677|NCT01450696|41681665|FG001|Overall Study|Death|84|||
19434678|NCT01450696|41681664|FG000|Overall Study|Lost to Follow-up|3|||
19434679|NCT01450696|41681665|FG001|Overall Study|Lost to Follow-up|3|||
19434680|NCT01450696|41681664|FG000|Overall Study|Non-Compliance|1|||
19434681|NCT01450696|41681665|FG001|Overall Study|Non-Compliance|0|||
19434682|NCT01450696|41681664|FG000|Overall Study|Withdrawal by Subject|13|||
19434683|NCT01450696|41681665|FG001|Overall Study|Withdrawal by Subject|2|||
19434684|NCT01450696|41681664|FG000|Overall Study|Study Terminated by Sponsor|53|||
19434685|NCT01450696|41681665|FG001|Overall Study|Study Terminated by Sponsor|58|||
19434686|NCT02070991|41681673|FG000|Overall Study|Death|2|||
19434687|NCT02070991|41681674|FG001|Overall Study|Death|0|||
19434688|NCT02070991|41681673|FG000|Overall Study|Withdrawal by Subject|1|||
19434689|NCT02070991|41681674|FG001|Overall Study|Withdrawal by Subject|0|||
19434690|NCT02114515|41681682|FG000|Overall Study|Lost to Follow-up|52|||
19434691|NCT02114515|41681683|FG001|Overall Study|Lost to Follow-up|55|||
19434692|NCT02114515|41681682|FG000|Overall Study|Death|12|||
19434693|NCT02114515|41681683|FG001|Overall Study|Death|12|||
19434694|NCT02114515|41681682|FG000|Overall Study|Withdrawal by Subject|4|||
19434695|NCT02114515|41681683|FG001|Overall Study|Withdrawal by Subject|22|||
19434696|NCT02114515|41681682|FG000|Overall Study|Other|65|||
19434697|NCT02114515|41681683|FG001|Overall Study|Other|61|||
19434698|NCT01490086|41681694|FG000|Overall Study|Consent withdrawn|4|||
19434699|NCT01490086|41681695|FG001|Overall Study|Consent withdrawn|4|||
19434700|NCT01490086|41681696|FG002|Overall Study|Consent withdrawn|3|||
19434701|NCT01490086|41681697|FG003|Overall Study|Consent withdrawn|0|||
19434702|NCT01490086|41681698|FG004|Overall Study|Consent withdrawn|1|||
19434703|NCT01490086|41681694|FG000|Overall Study|Non-compliance|0|||
19434704|NCT01490086|41681695|FG001|Overall Study|Non-compliance|1|||
19434705|NCT01490086|41681696|FG002|Overall Study|Non-compliance|0|||
19434706|NCT01490086|41681697|FG003|Overall Study|Non-compliance|0|||
19434707|NCT01490086|41681698|FG004|Overall Study|Non-compliance|0|||
19434708|NCT01490086|41681694|FG000|Overall Study|Abnormal laboratory findings|1|||
19434709|NCT01490086|41681695|FG001|Overall Study|Abnormal laboratory findings|0|||
19434710|NCT01490086|41681696|FG002|Overall Study|Abnormal laboratory findings|0|||
19434711|NCT01490086|41681697|FG003|Overall Study|Abnormal laboratory findings|0|||
19434712|NCT01490086|41681698|FG004|Overall Study|Abnormal laboratory findings|0|||
19434713|NCT01490086|41681694|FG000|Overall Study|Lost to Follow-up|0|||
19434714|NCT01490086|41681695|FG001|Overall Study|Lost to Follow-up|0|||
19434715|NCT01490086|41681696|FG002|Overall Study|Lost to Follow-up|0|||
19434716|NCT01490086|41681697|FG003|Overall Study|Lost to Follow-up|0|||
19434717|NCT01490086|41681698|FG004|Overall Study|Lost to Follow-up|1|||
19434718|NCT01490086|41681694|FG000|Overall Study|Physician Decision|3|||
19434719|NCT01490086|41681695|FG001|Overall Study|Physician Decision|4|||
19434720|NCT01490086|41681696|FG002|Overall Study|Physician Decision|2|||
19434721|NCT01490086|41681697|FG003|Overall Study|Physician Decision|3|||
19434722|NCT01490086|41681698|FG004|Overall Study|Physician Decision|1|||
19434723|NCT01490086|41681694|FG000|Overall Study|Adverse Event|0|||
19434724|NCT01490086|41681695|FG001|Overall Study|Adverse Event|0|||
19434725|NCT01490086|41681696|FG002|Overall Study|Adverse Event|1|||
19434726|NCT01490086|41681697|FG003|Overall Study|Adverse Event|2|||
19434727|NCT01490086|41681698|FG004|Overall Study|Adverse Event|0|||
19434728|NCT01490086|41681694|FG000|Overall Study|Lack of Efficacy|0|||
19434729|NCT01490086|41681695|FG001|Overall Study|Lack of Efficacy|3|||
19434730|NCT01490086|41681696|FG002|Overall Study|Lack of Efficacy|1|||
19434731|NCT01490086|41681697|FG003|Overall Study|Lack of Efficacy|0|||
19434732|NCT01490086|41681698|FG004|Overall Study|Lack of Efficacy|8|||
19434733|NCT01490086|41681694|FG000|Overall Study|Worsening of symptoms|0|||
19434734|NCT01490086|41681695|FG001|Overall Study|Worsening of symptoms|1|||
19434735|NCT01490086|41681696|FG002|Overall Study|Worsening of symptoms|0|||
19434736|NCT01490086|41681697|FG003|Overall Study|Worsening of symptoms|1|||
19434737|NCT01490086|41681698|FG004|Overall Study|Worsening of symptoms|0|||
19434738|NCT01490086|41681694|FG000|Overall Study|Subject uncontrollable and abusive|0|||
19434739|NCT01490086|41681695|FG001|Overall Study|Subject uncontrollable and abusive|1|||
19434740|NCT01490086|41681696|FG002|Overall Study|Subject uncontrollable and abusive|0|||
19434741|NCT01490086|41681697|FG003|Overall Study|Subject uncontrollable and abusive|0|||
19434742|NCT01490086|41681698|FG004|Overall Study|Subject uncontrollable and abusive|0|||
19434743|NCT01490086|41681694|FG000|Overall Study|Subject left hospital|0|||
19434744|NCT01490086|41681695|FG001|Overall Study|Subject left hospital|1|||
19434745|NCT01490086|41681696|FG002|Overall Study|Subject left hospital|0|||
19434746|NCT01490086|41681697|FG003|Overall Study|Subject left hospital|1|||
19434747|NCT01490086|41681698|FG004|Overall Study|Subject left hospital|0|||
19434748|NCT02114203|41681713|FG000|Overall Study|Adverse Event|0|||
19434749|NCT02114203|41681714|FG001|Overall Study|Adverse Event|1|||
19434750|NCT02114203|41681715|FG002|Overall Study|Adverse Event|0|||
19434751|NCT02114203|41681713|FG000|Overall Study|Withdrawal by Subject|0|||
19434752|NCT02114203|41681714|FG001|Overall Study|Withdrawal by Subject|1|||
19434753|NCT02114203|41681715|FG002|Overall Study|Withdrawal by Subject|0|||
19434754|NCT02113579|41681725|FG000|Overall Study|Adverse Event|1|||
19434755|NCT02113579|41681726|FG001|Overall Study|Adverse Event|0|||
19434756|NCT02113579|41681725|FG000|Overall Study|Withdrawal by Subject|3|||
19434757|NCT02113579|41681726|FG001|Overall Study|Withdrawal by Subject|2|||
19434758|NCT02113579|41681725|FG000|Overall Study|Lost to Follow-up|6|||
19434759|NCT02113579|41681726|FG001|Overall Study|Lost to Follow-up|2|||
19434760|NCT01474018|41681734|FG000|Overall Study|Lost to Follow-up|0|||
19434761|NCT01474018|41681735|FG001|Overall Study|Lost to Follow-up|1|||
19434762|NCT01474018|41681734|FG000|Overall Study|Withdrawal by Subject|0|||
19434763|NCT01474018|41681735|FG001|Overall Study|Withdrawal by Subject|2|||
19434764|NCT02100475|41681743|FG000|Overall Study|Unclassified|1|||
19434765|NCT02100475|41681744|FG001|Overall Study|Unclassified|2|||
19434766|NCT02100475|41681743|FG000|Overall Study|Withdrawal criteria|1|||
19434767|NCT02100475|41681744|FG001|Overall Study|Withdrawal criteria|0|||
19434768|NCT02113189|41681753|FG000|Overall Study|Lost to follow up|2|||
19434769|NCT02113189|41681754|FG001|Overall Study|Lost to follow up|1|||
19434770|NCT02113189|41681755|FG002|Overall Study|Lost to follow up|3|||
19434771|NCT01440946|41681768|FG000|Overall Study|Lost to Follow-up|1|||
19434772|NCT01440946|41681769|FG001|Overall Study|Lost to Follow-up|1|||
19434773|NCT01440946|41681768|FG000|Overall Study|Physician Decision|1|||
19434774|NCT01440946|41681769|FG001|Overall Study|Physician Decision|0|||
19434775|NCT01450540|41681778|FG000|Overall Study|Withdrawal by Subject|19|||
19434776|NCT01450540|41681779|FG001|Overall Study|Withdrawal by Subject|13|||
19434777|NCT01450540|41681778|FG000|Overall Study|protocol deviation|3|||
19434778|NCT01450540|41681779|FG001|Overall Study|protocol deviation|23|||
19434779|NCT02070757|41681789|FG000|Overall Study|Adverse Event|107|||
19434780|NCT02070757|41681790|FG001|Overall Study|Adverse Event|99|||
19434781|NCT02070757|41681789|FG000|Overall Study|Lost to Follow-up|7|||
19434782|NCT02070757|41681790|FG001|Overall Study|Lost to Follow-up|4|||
19434783|NCT02070757|41681789|FG000|Overall Study|Protocol Violation|0|||
19434784|NCT02070757|41681790|FG001|Overall Study|Protocol Violation|4|||
19434785|NCT02070757|41681789|FG000|Overall Study|Withdrawal by Subject|1|||
19434786|NCT02070757|41681790|FG001|Overall Study|Withdrawal by Subject|3|||
19434787|NCT02070757|41681789|FG000|Overall Study|Investigator Decision|0|||
19434788|NCT02070757|41681790|FG001|Overall Study|Investigator Decision|2|||
19434789|NCT02070757|41681789|FG000|Overall Study|Discharged from Study Hospital|2|||
19434790|NCT02070757|41681790|FG001|Overall Study|Discharged from Study Hospital|2|||
19434791|NCT02100319|41681796|FG000|Overall Study|Case Report Forms Uncollected|11|||
19434792|NCT02100319|41681796|FG000|Overall Study|Protocol Deviation|5|||
19434793|NCT01625845|41681802|FG000|Overall Study|Adverse Event|1|||
19434794|NCT01625845|41681803|FG001|Overall Study|Adverse Event|2|||
19434795|NCT01625845|41681802|FG000|Overall Study|Lost to Follow-up|2|||
19434796|NCT01625845|41681803|FG001|Overall Study|Lost to Follow-up|1|||
19434797|NCT01625845|41681802|FG000|Overall Study|Withdrawal by Subject|2|||
19434798|NCT01625845|41681803|FG001|Overall Study|Withdrawal by Subject|0|||
19434799|NCT01473940|41681813|FG000|Induction Therapy|Death|0|||
19434800|NCT01473940|41681814|FG001|Induction Therapy|Death|0|||
19434801|NCT01473940|41681815|FG002|Induction Therapy|Death|1|||
19434802|NCT01473940|41681816|FG003|Induction Therapy|Death|1|||
19434803|NCT01473940|41681813|FG000|Induction Therapy|Progressive Disease|0|||
19434804|NCT01473940|41681814|FG001|Induction Therapy|Progressive Disease|1|||
19434805|NCT01473940|41681815|FG002|Induction Therapy|Progressive Disease|1|||
19434806|NCT01473940|41681816|FG003|Induction Therapy|Progressive Disease|0|||
19434807|NCT01473940|41681813|FG000|Maintenance Therapy|Progressive Disease|1|||
19434808|NCT01473940|41681814|FG001|Maintenance Therapy|Progressive Disease|2|||
19434809|NCT01473940|41681815|FG002|Maintenance Therapy|Progressive Disease|1|||
19434810|NCT01473940|41681816|FG003|Maintenance Therapy|Progressive Disease|4|||
19434811|NCT01832727|41681838|FG000|Overall Study|Adverse Event|4|||
19434812|NCT01832727|41681839|FG001|Overall Study|Adverse Event|6|||
19434813|NCT01832727|41681840|FG002|Overall Study|Adverse Event|1|||
19434814|NCT01832727|41681841|FG003|Overall Study|Adverse Event|0|||
19434815|NCT01832727|41681842|FG004|Overall Study|Adverse Event|1|||
19434816|NCT01832727|41681843|FG005|Overall Study|Adverse Event|1|||
19434817|NCT01832727|41681844|FG006|Overall Study|Adverse Event|2|||
19434818|NCT01832727|41681845|FG007|Overall Study|Adverse Event|1|||
19434819|NCT01832727|41681846|FG008|Overall Study|Adverse Event|9|||
19434820|NCT01832727|41681838|FG000|Overall Study|Disease progression|3|||
19434821|NCT01832727|41681839|FG001|Overall Study|Disease progression|0|||
19434822|NCT01832727|41681840|FG002|Overall Study|Disease progression|2|||
19434823|NCT01832727|41681841|FG003|Overall Study|Disease progression|1|||
19434824|NCT01832727|41681842|FG004|Overall Study|Disease progression|3|||
19434825|NCT01832727|41681843|FG005|Overall Study|Disease progression|3|||
19434826|NCT01832727|41681844|FG006|Overall Study|Disease progression|6|||
19434827|NCT01832727|41681845|FG007|Overall Study|Disease progression|2|||
19434828|NCT01832727|41681846|FG008|Overall Study|Disease progression|7|||
19434829|NCT01832727|41681838|FG000|Overall Study|Lost to Follow-up|0|||
19434830|NCT01832727|41681839|FG001|Overall Study|Lost to Follow-up|0|||
19434831|NCT01832727|41681840|FG002|Overall Study|Lost to Follow-up|0|||
19434832|NCT01832727|41681841|FG003|Overall Study|Lost to Follow-up|1|||
19434833|NCT01832727|41681842|FG004|Overall Study|Lost to Follow-up|0|||
19434834|NCT01832727|41681843|FG005|Overall Study|Lost to Follow-up|0|||
19434835|NCT01832727|41681844|FG006|Overall Study|Lost to Follow-up|0|||
19434836|NCT01832727|41681845|FG007|Overall Study|Lost to Follow-up|0|||
19434837|NCT01832727|41681846|FG008|Overall Study|Lost to Follow-up|0|||
19434838|NCT01832727|41681838|FG000|Overall Study|Physician Decision|1|||
19434839|NCT01832727|41681839|FG001|Overall Study|Physician Decision|0|||
19434840|NCT01832727|41681840|FG002|Overall Study|Physician Decision|0|||
19434841|NCT01832727|41681841|FG003|Overall Study|Physician Decision|1|||
19434842|NCT01832727|41681842|FG004|Overall Study|Physician Decision|0|||
19434843|NCT01832727|41681843|FG005|Overall Study|Physician Decision|1|||
19434844|NCT01832727|41681844|FG006|Overall Study|Physician Decision|0|||
19434845|NCT01832727|41681845|FG007|Overall Study|Physician Decision|0|||
19434846|NCT01832727|41681846|FG008|Overall Study|Physician Decision|0|||
19434847|NCT01832727|41681838|FG000|Overall Study|Withdrawal by Subject|1|||
19434848|NCT01832727|41681839|FG001|Overall Study|Withdrawal by Subject|1|||
19434849|NCT01832727|41681840|FG002|Overall Study|Withdrawal by Subject|0|||
19434850|NCT01832727|41681841|FG003|Overall Study|Withdrawal by Subject|1|||
19434851|NCT01832727|41681842|FG004|Overall Study|Withdrawal by Subject|0|||
19434852|NCT01832727|41681843|FG005|Overall Study|Withdrawal by Subject|1|||
19434853|NCT01832727|41681844|FG006|Overall Study|Withdrawal by Subject|0|||
19434854|NCT01832727|41681845|FG007|Overall Study|Withdrawal by Subject|2|||
19434855|NCT01832727|41681846|FG008|Overall Study|Withdrawal by Subject|1|||
19434856|NCT01832727|41681838|FG000|Overall Study|Study terminated by sponsor|0|||
19434857|NCT01832727|41681839|FG001|Overall Study|Study terminated by sponsor|0|||
19434858|NCT01832727|41681840|FG002|Overall Study|Study terminated by sponsor|0|||
19434859|NCT01832727|41681841|FG003|Overall Study|Study terminated by sponsor|0|||
19434860|NCT01832727|41681842|FG004|Overall Study|Study terminated by sponsor|0|||
19434861|NCT01832727|41681843|FG005|Overall Study|Study terminated by sponsor|0|||
19434862|NCT01832727|41681844|FG006|Overall Study|Study terminated by sponsor|0|||
19434863|NCT01832727|41681845|FG007|Overall Study|Study terminated by sponsor|1|||
19434864|NCT01832727|41681846|FG008|Overall Study|Study terminated by sponsor|1|||
19434865|NCT01473394|41681877|FG000|Overall Study|Adverse Event|13|||
19434866|NCT01473394|41681878|FG001|Overall Study|Adverse Event|16|||
19434867|NCT01473394|41681877|FG000|Overall Study|Insufficient Therapeutic Response|4|||
19434868|NCT01473394|41681878|FG001|Overall Study|Insufficient Therapeutic Response|1|||
19434869|NCT01473394|41681877|FG000|Overall Study|Protocol Violation|7|||
19434870|NCT01473394|41681878|FG001|Overall Study|Protocol Violation|5|||
19434871|NCT01473394|41681877|FG000|Overall Study|Withdrew Consent|12|||
19434872|NCT01473394|41681878|FG001|Overall Study|Withdrew Consent|10|||
19434873|NCT01473394|41681877|FG000|Overall Study|Lost to Follow-up|9|||
19434874|NCT01473394|41681878|FG001|Overall Study|Lost to Follow-up|11|||
19434875|NCT01449682|41681886|FG000|Overall Study|Death|0|||
19434876|NCT01449682|41681887|FG001|Overall Study|Death|1|||
19434877|NCT01449682|41681886|FG000|Overall Study|Adverse Event|1|||
19434878|NCT01449682|41681887|FG001|Overall Study|Adverse Event|0|||
19434879|NCT01449526|41681895|FG000|Overall Study|Lost to Follow-up|1|||
19434880|NCT01449526|41681896|FG001|Overall Study|Lost to Follow-up|2|||
19434881|NCT01449526|41681895|FG000|Overall Study|Withdrawal by Subject|1|||
19434882|NCT01449526|41681896|FG001|Overall Study|Withdrawal by Subject|1|||
19434883|NCT01449526|41681895|FG000|Overall Study|Symptoms/complaints|0|||
19434884|NCT01449526|41681896|FG001|Overall Study|Symptoms/complaints|1|||
19434885|NCT01449526|41681895|FG000|Overall Study|Lack of Motivation|0|||
19434886|NCT01449526|41681896|FG001|Overall Study|Lack of Motivation|1|||
19434887|NCT01449526|41681895|FG000|Overall Study|Cannot maintain visits|0|||
19434888|NCT01449526|41681896|FG001|Overall Study|Cannot maintain visits|1|||
19434889|NCT01440322|41681904|FG000|Overall Study|Discomfort|2|||
19434890|NCT01440322|41681905|FG001|Overall Study|Discomfort|0|||
19434891|NCT01440322|41681904|FG000|Overall Study|Biomicroscopy|1|||
19434892|NCT01440322|41681905|FG001|Overall Study|Biomicroscopy|0|||
19434893|NCT01440322|41681904|FG000|Overall Study|Symptoms and Problems|1|||
19434894|NCT01440322|41681905|FG001|Overall Study|Symptoms and Problems|0|||
19434895|NCT01440322|41681904|FG000|Overall Study|Unacceptable Subjective Vision|1|||
19434896|NCT01440322|41681905|FG001|Overall Study|Unacceptable Subjective Vision|0|||
19434897|NCT01440322|41681904|FG000|Overall Study|Other Product Related|1|||
19434898|NCT01440322|41681905|FG001|Overall Study|Other Product Related|0|||
19434899|NCT01440322|41681904|FG000|Overall Study|Unrelated Medical Problem|0|||
19434900|NCT01440322|41681905|FG001|Overall Study|Unrelated Medical Problem|1|||
19434901|NCT01440322|41681904|FG000|Overall Study|Other Non-Product Related|1|||
19434902|NCT01440322|41681905|FG001|Overall Study|Other Non-Product Related|0|||
19434903|NCT01832493|41681911|FG000|Overall Study|Physician Decision|2|||
19434904|NCT01832493|41681911|FG000|Overall Study|Protocol Violation|4|||
19434905|NCT01832493|41681911|FG000|Overall Study|Unable to place LV lead|2|||
19434906|NCT01831791|41681915|FG000|Overall Study|Withdrawal by Subject|10|||
19434907|NCT01857531|41681919|FG000|Overall Study|Withdrawal by Subject|4|||
19434908|NCT02166047|41681935|FG000|Overall Study|Withdrawal by Participant|0|||
19434909|NCT02166047|41681936|FG001|Overall Study|Withdrawal by Participant|1|||
19434910|NCT02166047|41681937|FG002|Overall Study|Withdrawal by Participant|2|||
19434911|NCT02166047|41681938|FG003|Overall Study|Withdrawal by Participant|0|||
19434912|NCT02166047|41681939|FG004|Overall Study|Withdrawal by Participant|0|||
19434913|NCT02166047|41681940|FG005|Overall Study|Withdrawal by Participant|0|||
19434914|NCT02166047|41681941|FG006|Overall Study|Withdrawal by Participant|1|||
19434915|NCT02166047|41681942|FG007|Overall Study|Withdrawal by Participant|0|||
19434916|NCT02166047|41681943|FG008|Overall Study|Withdrawal by Participant|0|||
19434917|NCT02166047|41681944|FG009|Overall Study|Withdrawal by Participant|0|||
19434918|NCT02166047|41681945|FG010|Overall Study|Withdrawal by Participant|0|||
19434919|NCT02166047|41681946|FG011|Overall Study|Withdrawal by Participant|0|||
19434920|NCT02166047|41681935|FG000|Overall Study|Adverse Event|0|||
19434921|NCT02166047|41681936|FG001|Overall Study|Adverse Event|0|||
19434922|NCT02166047|41681937|FG002|Overall Study|Adverse Event|0|||
19434923|NCT02166047|41681938|FG003|Overall Study|Adverse Event|0|||
19434924|NCT02166047|41681939|FG004|Overall Study|Adverse Event|1|||
19434925|NCT02166047|41681940|FG005|Overall Study|Adverse Event|0|||
19434926|NCT02166047|41681941|FG006|Overall Study|Adverse Event|1|||
19434927|NCT02166047|41681942|FG007|Overall Study|Adverse Event|0|||
19434928|NCT02166047|41681943|FG008|Overall Study|Adverse Event|0|||
19434929|NCT02166047|41681944|FG009|Overall Study|Adverse Event|0|||
19434930|NCT02166047|41681945|FG010|Overall Study|Adverse Event|2|||
19434931|NCT02166047|41681946|FG011|Overall Study|Adverse Event|0|||
19434932|NCT02165735|41681974|FG000|Overall Study|Lost to Follow-up|12|||
19434933|NCT02165735|41681975|FG001|Overall Study|Lost to Follow-up|10|||
19434934|NCT02165735|41681974|FG000|Overall Study|Withdrawal by Subject|3|||
19434935|NCT02165735|41681975|FG001|Overall Study|Withdrawal by Subject|0|||
19434936|NCT02165735|41681974|FG000|Overall Study|Participant indicated lack of time|1|||
19434937|NCT02165735|41681975|FG001|Overall Study|Participant indicated lack of time|3|||
19434938|NCT02165735|41681974|FG000|Overall Study|Protocol Violation|0|||
19434939|NCT02165735|41681975|FG001|Overall Study|Protocol Violation|1|||
19434940|NCT02069899|41681984|FG000|Overall Study|Adverse Event|6|||
19434941|NCT02069899|41681985|FG001|Overall Study|Adverse Event|0|||
19434942|NCT02069899|41681986|FG002|Overall Study|Adverse Event|1|||
19434943|NCT02069899|41681984|FG000|Overall Study|Withdrawal by Participant|2|||
19434944|NCT02069899|41681985|FG001|Overall Study|Withdrawal by Participant|0|||
19434945|NCT02069899|41681986|FG002|Overall Study|Withdrawal by Participant|0|||
19434946|NCT02069899|41681984|FG000|Overall Study|Lost to Follow-up|1|||
19434947|NCT02069899|41681985|FG001|Overall Study|Lost to Follow-up|0|||
19434948|NCT02069899|41681986|FG002|Overall Study|Lost to Follow-up|1|||
19434949|NCT02069899|41681984|FG000|Overall Study|Other|4|||
19434950|NCT02069899|41681985|FG001|Overall Study|Other|0|||
19434951|NCT02069899|41681986|FG002|Overall Study|Other|0|||
19434952|NCT02069899|41681984|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
19434953|NCT02069899|41681985|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
19434954|NCT02069899|41681986|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
19434955|NCT02069899|41681984|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
19434956|NCT02069899|41681985|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
19434957|NCT02069899|41681986|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
19434958|NCT01831089|41682001|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
19434959|NCT01831089|41682002|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
19434960|NCT01831089|41682003|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
19434961|NCT01831089|41682004|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
19434962|NCT01831089|41682005|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
19434963|NCT01831089|41682006|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
19434964|NCT01831089|41682001|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
19434965|NCT01831089|41682002|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
19434966|NCT01831089|41682003|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
19434967|NCT01831089|41682004|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
19434968|NCT01831089|41682005|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
19434969|NCT01831089|41682006|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
19434970|NCT01831089|41682001|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
19434971|NCT01831089|41682002|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
19434972|NCT01831089|41682003|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
19434973|NCT01831089|41682004|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
19434974|NCT01831089|41682005|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
19434975|NCT01831089|41682006|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
19434976|NCT01831089|41682001|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
19434977|NCT01831089|41682002|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
19434978|NCT01831089|41682003|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
19434979|NCT01831089|41682004|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
19434980|NCT01831089|41682005|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
19434981|NCT01831089|41682006|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
19434982|NCT01831089|41682001|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
19434983|NCT01831089|41682002|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
19434984|NCT01831089|41682003|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
19434985|NCT01831089|41682004|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
19434986|NCT01831089|41682005|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
19434987|NCT01831089|41682006|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
19434988|NCT01831089|41682001|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
19434989|NCT01831089|41682002|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
19434990|NCT01831089|41682003|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
19434991|NCT01831089|41682004|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
19434992|NCT01831089|41682005|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
19434993|NCT01831089|41682006|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
19434994|NCT01831089|41682001|FG000|Cohort III: Dose Level 3|Global end of study|0|||
19434995|NCT01831089|41682002|FG001|Cohort III: Dose Level 3|Global end of study|0|||
19434996|NCT01831089|41682003|FG002|Cohort III: Dose Level 3|Global end of study|1|||
19434997|NCT01831089|41682004|FG003|Cohort III: Dose Level 3|Global end of study|0|||
19434998|NCT01831089|41682005|FG004|Cohort III: Dose Level 3|Global end of study|0|||
19434999|NCT01831089|41682006|FG005|Cohort III: Dose Level 3|Global end of study|0|||
19435000|NCT01831089|41682001|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
19435001|NCT01831089|41682002|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
19435002|NCT01831089|41682003|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
19435003|NCT01831089|41682004|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
19435004|NCT01831089|41682005|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
19435005|NCT01831089|41682006|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
19435006|NCT01831089|41682001|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
19435007|NCT01831089|41682002|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
19435008|NCT01831089|41682003|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
19435009|NCT01831089|41682004|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
19435010|NCT01831089|41682005|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
19435011|NCT01831089|41682006|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
19435012|NCT01831089|41682001|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
19435013|NCT01831089|41682002|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
19435014|NCT01831089|41682003|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
19435015|NCT01831089|41682004|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
19435016|NCT01831089|41682005|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
19435017|NCT01831089|41682006|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
19435018|NCT01831089|41682001|FG000|Cohort V: Dose Level 5|Death|0|||
19435019|NCT01831089|41682002|FG001|Cohort V: Dose Level 5|Death|0|||
19435020|NCT01831089|41682003|FG002|Cohort V: Dose Level 5|Death|0|||
19435021|NCT01831089|41682004|FG003|Cohort V: Dose Level 5|Death|0|||
19435022|NCT01831089|41682005|FG004|Cohort V: Dose Level 5|Death|1|||
19435023|NCT01831089|41682006|FG005|Cohort V: Dose Level 5|Death|0|||
19435024|NCT01831089|41682001|FG000|Cohort V: Dose Level 5|Global end of study|0|||
19435025|NCT01831089|41682002|FG001|Cohort V: Dose Level 5|Global end of study|0|||
19435026|NCT01831089|41682003|FG002|Cohort V: Dose Level 5|Global end of study|0|||
19435027|NCT01831089|41682004|FG003|Cohort V: Dose Level 5|Global end of study|0|||
19435028|NCT01831089|41682005|FG004|Cohort V: Dose Level 5|Global end of study|2|||
19435029|NCT01831089|41682006|FG005|Cohort V: Dose Level 5|Global end of study|0|||
19435030|NCT01831089|41682001|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
19435031|NCT01831089|41682002|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
19435032|NCT01831089|41682003|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
19435033|NCT01831089|41682004|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
19435034|NCT01831089|41682005|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
19435035|NCT01831089|41682006|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
19435036|NCT01831089|41682001|FG000|Cohort B: Arm B|Progressive disease|0|||
19435037|NCT01831089|41682002|FG001|Cohort B: Arm B|Progressive disease|0|||
19435038|NCT01831089|41682003|FG002|Cohort B: Arm B|Progressive disease|0|||
19435039|NCT01831089|41682004|FG003|Cohort B: Arm B|Progressive disease|0|||
19435040|NCT01831089|41682005|FG004|Cohort B: Arm B|Progressive disease|0|||
19435041|NCT01831089|41682006|FG005|Cohort B: Arm B|Progressive disease|8|||
19435042|NCT01831089|41682001|FG000|Cohort B: Arm B|Physician Decision|0|||
19435043|NCT01831089|41682002|FG001|Cohort B: Arm B|Physician Decision|0|||
19435044|NCT01831089|41682003|FG002|Cohort B: Arm B|Physician Decision|0|||
19435045|NCT01831089|41682004|FG003|Cohort B: Arm B|Physician Decision|0|||
19435046|NCT01831089|41682005|FG004|Cohort B: Arm B|Physician Decision|0|||
19435047|NCT01831089|41682006|FG005|Cohort B: Arm B|Physician Decision|2|||
19435048|NCT01831089|41682001|FG000|Cohort B: Arm B|Never treated|0|||
19435049|NCT01831089|41682002|FG001|Cohort B: Arm B|Never treated|0|||
19435050|NCT01831089|41682003|FG002|Cohort B: Arm B|Never treated|0|||
19435051|NCT01831089|41682004|FG003|Cohort B: Arm B|Never treated|0|||
19435052|NCT01831089|41682005|FG004|Cohort B: Arm B|Never treated|0|||
19435053|NCT01831089|41682006|FG005|Cohort B: Arm B|Never treated|2|||
19435054|NCT01831089|41682001|FG000|Cohort B: Arm B|Adverse Event|0|||
19435055|NCT01831089|41682002|FG001|Cohort B: Arm B|Adverse Event|0|||
19435056|NCT01831089|41682003|FG002|Cohort B: Arm B|Adverse Event|0|||
19435057|NCT01831089|41682004|FG003|Cohort B: Arm B|Adverse Event|0|||
19435058|NCT01831089|41682005|FG004|Cohort B: Arm B|Adverse Event|0|||
19435059|NCT01831089|41682006|FG005|Cohort B: Arm B|Adverse Event|1|||
19435060|NCT01831089|41682001|FG000|Cohort B: Arm B|Global end of study|0|||
19435061|NCT01831089|41682002|FG001|Cohort B: Arm B|Global end of study|0|||
19435062|NCT01831089|41682003|FG002|Cohort B: Arm B|Global end of study|0|||
19435063|NCT01831089|41682004|FG003|Cohort B: Arm B|Global end of study|0|||
19435064|NCT01831089|41682005|FG004|Cohort B: Arm B|Global end of study|0|||
19435065|NCT01831089|41682006|FG005|Cohort B: Arm B|Global end of study|1|||
19435066|NCT02112877|41682023|FG000|Overall Study|Withdrawal by Subject|1|||
19435067|NCT02112877|41682024|FG001|Overall Study|Withdrawal by Subject|7|||
19435068|NCT02112877|41682023|FG000|Overall Study|Visit Missed|1|||
19435069|NCT02112877|41682024|FG001|Overall Study|Visit Missed|6|||
19435070|NCT02098369|41682035|FG000|Overall Study|Withdrawal by Subject|1|||
19435071|NCT02098369|41682036|FG001|Overall Study|Withdrawal by Subject|5|||
19435072|NCT02098369|41682037|FG002|Overall Study|Withdrawal by Subject|0|||
19435073|NCT02098369|41682035|FG000|Overall Study|Lost to Follow-up|5|||
19435074|NCT02098369|41682036|FG001|Overall Study|Lost to Follow-up|1|||
19435075|NCT02098369|41682037|FG002|Overall Study|Lost to Follow-up|3|||
19435076|NCT02098369|41682035|FG000|Overall Study|Death|1|||
19435077|NCT02098369|41682036|FG001|Overall Study|Death|1|||
19435078|NCT02098369|41682037|FG002|Overall Study|Death|1|||
19435079|NCT02098369|41682035|FG000|Overall Study|Other|0|||
19435080|NCT02098369|41682036|FG001|Overall Study|Other|2|||
19435081|NCT02098369|41682037|FG002|Overall Study|Other|1|||
19435082|NCT02111785|41682049|FG000|Overall Study|Death|0|||
19435083|NCT02111785|41682050|FG001|Overall Study|Death|1|||
19435084|NCT02111785|41682051|FG002|Overall Study|Death|0|||
19435085|NCT02111785|41682052|FG003|Overall Study|Death|0|||
19435086|NCT02068885|41682069|FG000|Overall Study|Withdrew|3|||
19435087|NCT02068885|41682070|FG001|Overall Study|Withdrew|5|||
19435088|NCT02068885|41682071|FG002|Overall Study|Withdrew|8|||
19435089|NCT02068495|41682080|FG000|Overall Study|Case Report Forms Uncollected|60|||
19435090|NCT02068495|41682080|FG000|Overall Study|Protocol Deviation|49|||
19435091|NCT02097823|41682086|FG000|Overall Study|Withdrawal by Subject|1|||
19435092|NCT02097823|41682087|FG001|Overall Study|Withdrawal by Subject|1|||
19435093|NCT01830855|41682098|FG000|Overall Study|Other|7|||
19435094|NCT01830855|41682099|FG001|Overall Study|Other|1|||
19435095|NCT01830855|41682100|FG002|Overall Study|Other|4|||
19435096|NCT01830855|41682101|FG003|Overall Study|Other|4|||
19435097|NCT01830855|41682098|FG000|Overall Study|Medication error without associated AE|1|||
19435098|NCT01830855|41682099|FG001|Overall Study|Medication error without associated AE|0|||
19435099|NCT01830855|41682100|FG002|Overall Study|Medication error without associated AE|0|||
19435100|NCT01830855|41682101|FG003|Overall Study|Medication error without associated AE|1|||
19435101|NCT01830855|41682098|FG000|Overall Study|Pregnancy|3|||
19435102|NCT01830855|41682099|FG001|Overall Study|Pregnancy|1|||
19435103|NCT01830855|41682100|FG002|Overall Study|Pregnancy|2|||
19435104|NCT01830855|41682101|FG003|Overall Study|Pregnancy|1|||
19435105|NCT01830855|41682098|FG000|Overall Study|No longer meets eligibility criteria|11|||
19435106|NCT01830855|41682099|FG001|Overall Study|No longer meets eligibility criteria|2|||
19435107|NCT01830855|41682100|FG002|Overall Study|No longer meets eligibility criteria|3|||
19435108|NCT01830855|41682101|FG003|Overall Study|No longer meets eligibility criteria|5|||
19711232|NCT00116649|42154369|FG000|Overall Study|Lack of Efficacy|1|||
19435109|NCT01830855|41682098|FG000|Overall Study|Adverse Event|11|||
19435110|NCT01830855|41682099|FG001|Overall Study|Adverse Event|5|||
19435111|NCT01830855|41682100|FG002|Overall Study|Adverse Event|6|||
19435112|NCT01830855|41682101|FG003|Overall Study|Adverse Event|3|||
19435113|NCT01830855|41682098|FG000|Overall Study|Protocol deviation|10|||
19435114|NCT01830855|41682099|FG001|Overall Study|Protocol deviation|5|||
19435115|NCT01830855|41682100|FG002|Overall Study|Protocol deviation|6|||
19435116|NCT01830855|41682101|FG003|Overall Study|Protocol deviation|6|||
19435117|NCT01830855|41682098|FG000|Overall Study|Withdrawal by Subject|33|||
19435118|NCT01830855|41682099|FG001|Overall Study|Withdrawal by Subject|14|||
19435119|NCT01830855|41682100|FG002|Overall Study|Withdrawal by Subject|10|||
19435120|NCT01830855|41682101|FG003|Overall Study|Withdrawal by Subject|12|||
19435121|NCT01830855|41682098|FG000|Overall Study|No longer willing to participate|32|||
19435122|NCT01830855|41682099|FG001|Overall Study|No longer willing to participate|13|||
19435123|NCT01830855|41682100|FG002|Overall Study|No longer willing to participate|12|||
19435124|NCT01830855|41682101|FG003|Overall Study|No longer willing to participate|17|||
19435125|NCT01830855|41682098|FG000|Overall Study|Lost to Follow-up|47|||
19435126|NCT01830855|41682099|FG001|Overall Study|Lost to Follow-up|20|||
19435127|NCT01830855|41682100|FG002|Overall Study|Lost to Follow-up|23|||
19435128|NCT01830855|41682101|FG003|Overall Study|Lost to Follow-up|33|||
19435129|NCT01857063|41682118|FG000|Period 1 (7 Days)|Adverse Event|0|||
19435130|NCT01857063|41682119|FG001|Period 1 (7 Days)|Adverse Event|1|||
19435131|NCT01857063|41682118|FG000|Period 1 (7 Days)|Physician Decision|1|||
19435132|NCT01857063|41682119|FG001|Period 1 (7 Days)|Physician Decision|0|||
19435133|NCT01857063|41682118|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
19435134|NCT01857063|41682119|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
19435135|NCT01857063|41682118|FG000|Period 2 (7 Days)|Adverse Event|2|||
19435136|NCT01857063|41682119|FG001|Period 2 (7 Days)|Adverse Event|1|||
19435137|NCT01857063|41682118|FG000|Period 2 (7 Days)|Physician Decision|1|||
19435138|NCT01857063|41682119|FG001|Period 2 (7 Days)|Physician Decision|1|||
19435139|NCT01857063|41682118|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
19435140|NCT01857063|41682119|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
19435141|NCT01856907|41682128|FG000|Overall Study|Pregnancy|0|||
19435142|NCT01856907|41682129|FG001|Overall Study|Pregnancy|1|||
19435143|NCT01856907|41682130|FG002|Overall Study|Pregnancy|0|||
19435144|NCT01856907|41682128|FG000|Overall Study|Pregnancy|0|||
19435145|NCT01856907|41682129|FG001|Overall Study|Pregnancy|1|||
19435146|NCT01856907|41682130|FG002|Overall Study|Pregnancy|0|||
19435147|NCT01856907|41682128|FG000|Overall Study|Withdrawal by Subject|0|||
19435148|NCT01856907|41682129|FG001|Overall Study|Withdrawal by Subject|1|||
19435149|NCT01856907|41682130|FG002|Overall Study|Withdrawal by Subject|0|||
19435150|NCT02212457|41682147|FG000|Overall Study|Adverse Event|1|||
19435151|NCT02212457|41682148|FG001|Overall Study|Adverse Event|2|||
19435152|NCT02212457|41682149|FG002|Overall Study|Adverse Event|2|||
19435153|NCT02212457|41682150|FG003|Overall Study|Adverse Event|2|||
19435154|NCT02212457|41682151|FG004|Overall Study|Adverse Event|0|||
19435155|NCT02212457|41682152|FG005|Overall Study|Adverse Event|1|||
19435156|NCT02212457|41682147|FG000|Overall Study|Withdrawal by Subject|8|||
19435157|NCT02212457|41682148|FG001|Overall Study|Withdrawal by Subject|10|||
19435158|NCT02212457|41682149|FG002|Overall Study|Withdrawal by Subject|8|||
19435159|NCT02212457|41682150|FG003|Overall Study|Withdrawal by Subject|6|||
19435160|NCT02212457|41682151|FG004|Overall Study|Withdrawal by Subject|5|||
19435161|NCT02212457|41682152|FG005|Overall Study|Withdrawal by Subject|4|||
19435162|NCT02212457|41682147|FG000|Overall Study|Lost to Follow-up|6|||
19435163|NCT02212457|41682148|FG001|Overall Study|Lost to Follow-up|7|||
19435164|NCT02212457|41682149|FG002|Overall Study|Lost to Follow-up|4|||
19435165|NCT02212457|41682150|FG003|Overall Study|Lost to Follow-up|1|||
19435166|NCT02212457|41682151|FG004|Overall Study|Lost to Follow-up|8|||
19435167|NCT02212457|41682152|FG005|Overall Study|Lost to Follow-up|4|||
19435168|NCT02212457|41682147|FG000|Overall Study|Protocol Violation|2|||
19435169|NCT02212457|41682148|FG001|Overall Study|Protocol Violation|1|||
19435170|NCT02212457|41682149|FG002|Overall Study|Protocol Violation|0|||
19435171|NCT02212457|41682150|FG003|Overall Study|Protocol Violation|1|||
19435172|NCT02212457|41682151|FG004|Overall Study|Protocol Violation|2|||
19435173|NCT02212457|41682152|FG005|Overall Study|Protocol Violation|3|||
19435174|NCT02212457|41682147|FG000|Overall Study|Other|2|||
19435175|NCT02212457|41682148|FG001|Overall Study|Other|1|||
19435176|NCT02212457|41682149|FG002|Overall Study|Other|2|||
19435177|NCT02212457|41682150|FG003|Overall Study|Other|1|||
19435178|NCT02212457|41682151|FG004|Overall Study|Other|0|||
19435179|NCT02212457|41682152|FG005|Overall Study|Other|1|||
19435180|NCT02097745|41682173|FG000|Overall Study|Adverse Event|25|||
19435181|NCT02097745|41682173|FG000|Overall Study|Death|16|||
19435182|NCT02097745|41682173|FG000|Overall Study|Failure to Return|14|||
19435183|NCT02097745|41682173|FG000|Overall Study|Administrative/Other|27|||
19435184|NCT02097745|41682173|FG000|Overall Study|Reason Not Specified|96|||
19435185|NCT02111083|41682182|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
19435186|NCT02111083|41682183|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
19435187|NCT01629563|41682191|FG000|Overall Study|Adverse Event|16|||
19435188|NCT01629563|41682192|FG001|Overall Study|Adverse Event|16|||
19435189|NCT01629563|41682191|FG000|Overall Study|Death|2|||
19435190|NCT01629563|41682192|FG001|Overall Study|Death|0|||
19435191|NCT01629563|41682191|FG000|Overall Study|Lack of Efficacy|2|||
19435192|NCT01629563|41682192|FG001|Overall Study|Lack of Efficacy|3|||
19435193|NCT01629563|41682191|FG000|Overall Study|Lost to Follow-up|1|||
19435194|NCT01629563|41682192|FG001|Overall Study|Lost to Follow-up|0|||
19435195|NCT01629563|41682191|FG000|Overall Study|Pregnancy|1|||
19435196|NCT01629563|41682192|FG001|Overall Study|Pregnancy|2|||
19435197|NCT01629563|41682191|FG000|Overall Study|Protocol Violation|0|||
19435198|NCT01629563|41682192|FG001|Overall Study|Protocol Violation|1|||
19435199|NCT01629563|41682191|FG000|Overall Study|Withdrawal by Subject|27|||
19435200|NCT01629563|41682192|FG001|Overall Study|Withdrawal by Subject|20|||
19435201|NCT01629563|41682191|FG000|Overall Study|surgery|0|||
19435202|NCT01629563|41682192|FG001|Overall Study|surgery|3|||
19711233|NCT00116649|42154369|FG000|Overall Study|Lost to Follow-up|32|||
19435203|NCT01629563|41682191|FG000|Overall Study|Lack of return of menses|12|||
19435204|NCT01629563|41682192|FG001|Overall Study|Lack of return of menses|7|||
19435205|NCT01629563|41682191|FG000|Overall Study|Protocol Violation|0|||
19435206|NCT01629563|41682192|FG001|Overall Study|Protocol Violation|1|||
19435207|NCT02097277|41682203|FG000|Overall Study|Subject no longer meets study criteria|0|||
19435208|NCT02097277|41682204|FG001|Overall Study|Subject no longer meets study criteria|1|||
19435209|NCT02097277|41682205|FG002|Overall Study|Subject no longer meets study criteria|0|||
19435210|NCT02097277|41682206|FG003|Overall Study|Subject no longer meets study criteria|1|||
19435211|NCT02097277|41682207|FG004|Overall Study|Subject no longer meets study criteria|0|||
19435212|NCT02097277|41682203|FG000|Overall Study|Subject request to discontinue treatment|0|||
19435213|NCT02097277|41682204|FG001|Overall Study|Subject request to discontinue treatment|0|||
19435214|NCT02097277|41682205|FG002|Overall Study|Subject request to discontinue treatment|0|||
19435215|NCT02097277|41682206|FG003|Overall Study|Subject request to discontinue treatment|0|||
19435216|NCT02097277|41682207|FG004|Overall Study|Subject request to discontinue treatment|1|||
19435217|NCT02097277|41682203|FG000|Overall Study|Lost to Follow-up|0|||
19435218|NCT02097277|41682204|FG001|Overall Study|Lost to Follow-up|1|||
19435219|NCT02097277|41682205|FG002|Overall Study|Lost to Follow-up|1|||
19435220|NCT02097277|41682206|FG003|Overall Study|Lost to Follow-up|0|||
19435221|NCT02097277|41682207|FG004|Overall Study|Lost to Follow-up|0|||
19435222|NCT02097277|41682203|FG000|Overall Study|Withdrawal by Subject|2|||
19435223|NCT02097277|41682204|FG001|Overall Study|Withdrawal by Subject|1|||
19435224|NCT02097277|41682205|FG002|Overall Study|Withdrawal by Subject|0|||
19435225|NCT02097277|41682206|FG003|Overall Study|Withdrawal by Subject|1|||
19435226|NCT02097277|41682207|FG004|Overall Study|Withdrawal by Subject|0|||
19435227|NCT02097277|41682203|FG000|Overall Study|Adverse Event|0|||
19435228|NCT02097277|41682204|FG001|Overall Study|Adverse Event|0|||
19435229|NCT02097277|41682205|FG002|Overall Study|Adverse Event|1|||
19435230|NCT02097277|41682206|FG003|Overall Study|Adverse Event|2|||
19435231|NCT02097277|41682207|FG004|Overall Study|Adverse Event|0|||
19435232|NCT02212379|41682223|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
19435233|NCT02212379|41682223|FG000|From Baseline to Week 48|Adverse Event|7|||
19435234|NCT02212379|41682223|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
19435235|NCT02212379|41682223|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
19435236|NCT02212379|41682223|FG000|From Week 48 to Week 96|Adverse Event|1|||
19435237|NCT02212379|41682223|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
19435238|NCT02110693|41682230|FG000|Overall Study|Withdrawal by Subject|6|||
19435239|NCT02110693|41682231|FG001|Overall Study|Withdrawal by Subject|7|||
19435240|NCT02110693|41682230|FG000|Overall Study|skipped assessment|15|||
19435241|NCT02110693|41682231|FG001|Overall Study|skipped assessment|18|||
19435242|NCT02110693|41682230|FG000|Overall Study|technical difficulties|6|||
19435243|NCT02110693|41682231|FG001|Overall Study|technical difficulties|4|||
19435244|NCT02110693|41682230|FG000|Overall Study|Other|1|||
19435245|NCT02110693|41682231|FG001|Overall Study|Other|0|||
19435246|NCT02212301|41682251|FG000|Period 1|Lost to Follow-up|0|||
19435247|NCT02212301|41682252|FG001|Period 1|Lost to Follow-up|1|||
19435248|NCT02211209|41682261|FG000|Overall Study|Investigator judgment|0|||
19435249|NCT02211209|41682262|FG001|Overall Study|Investigator judgment|1|||
19435250|NCT02211209|41682261|FG000|Overall Study|Voluntary withdrawal|1|||
19435251|NCT02211209|41682262|FG001|Overall Study|Voluntary withdrawal|4|||
19435252|NCT02211209|41682261|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
19435253|NCT02211209|41682262|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
19435254|NCT02211209|41682261|FG000|Overall Study|Reason Not Specified|1|||
19435255|NCT02211209|41682262|FG001|Overall Study|Reason Not Specified|0|||
19435256|NCT02187809|41682268|FG000|Overall Study|The study was terminated|3|||
19435257|NCT02110225|41682275|FG000|Overall Study|Lost to Follow-up|0|||
19435258|NCT02110225|41682276|FG001|Overall Study|Lost to Follow-up|1|||
19435259|NCT02110225|41682277|FG002|Overall Study|Lost to Follow-up|0|||
19435260|NCT02187029|41682290|FG000|Overall Study|Adverse Event|0|||
19435261|NCT02187029|41682291|FG001|Overall Study|Adverse Event|1|||
19435262|NCT02187029|41682292|FG002|Overall Study|Adverse Event|1|||
19435263|NCT02187029|41682293|FG003|Overall Study|Adverse Event|0|||
19435264|NCT02187029|41682290|FG000|Overall Study|Study Terminated by Sponsor|0|||
19435265|NCT02187029|41682291|FG001|Overall Study|Study Terminated by Sponsor|0|||
19435266|NCT02187029|41682292|FG002|Overall Study|Study Terminated by Sponsor|10|||
19435267|NCT02187029|41682293|FG003|Overall Study|Study Terminated by Sponsor|3|||
19435268|NCT02187029|41682290|FG000|Overall Study|Withdrawal by Subject|1|||
19435269|NCT02187029|41682291|FG001|Overall Study|Withdrawal by Subject|0|||
19435270|NCT02187029|41682292|FG002|Overall Study|Withdrawal by Subject|0|||
19435271|NCT02187029|41682293|FG003|Overall Study|Withdrawal by Subject|0|||
19435272|NCT02163395|41682303|FG000|Overall Study|Withdrawal by Subject|1|||
19435273|NCT02163395|41682303|FG000|Overall Study|Lost to Follow-up|3|||
19435274|NCT02163395|41682303|FG000|Overall Study|Adverse Event|1|||
19435275|NCT02162771|41682309|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
19435276|NCT02162771|41682310|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
19435277|NCT02162771|41682309|FG000|Core Study Period (Part 2)|Adverse Event|4|||
19435278|NCT02162771|41682310|FG001|Core Study Period (Part 2)|Adverse Event|1|||
19435279|NCT02162771|41682309|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
19435280|NCT02162771|41682310|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
19435281|NCT02162771|41682309|FG000|Core Study Period (Part 2)|Physician Decision|0|||
19435282|NCT02162771|41682310|FG001|Core Study Period (Part 2)|Physician Decision|2|||
19435283|NCT02162771|41682309|FG000|Core Study Period (Part 2)|Death|1|||
19435284|NCT02162771|41682310|FG001|Core Study Period (Part 2)|Death|0|||
19435285|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
19435286|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
19435287|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
19435288|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
19435289|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Death|2|||
19435290|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Death|1|||
19435291|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
19435292|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
19435293|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
19435294|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
19435295|NCT02162771|41682309|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
19435296|NCT02162771|41682310|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
19435297|NCT02161757|41682319|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
19435298|NCT02161757|41682320|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
19435299|NCT02161757|41682321|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
19435300|NCT02161757|41682319|FG000|Treatment Through Study Completion|Adverse Event|1|||
19435301|NCT02161757|41682320|FG001|Treatment Through Study Completion|Adverse Event|1|||
19435302|NCT02161757|41682321|FG002|Treatment Through Study Completion|Adverse Event|0|||
19435303|NCT02161757|41682319|FG000|Treatment Through Study Completion|Protocol Violation|0|||
19435304|NCT02161757|41682320|FG001|Treatment Through Study Completion|Protocol Violation|1|||
19435305|NCT02161757|41682321|FG002|Treatment Through Study Completion|Protocol Violation|2|||
19435306|NCT02161757|41682319|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
19435307|NCT02161757|41682320|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
19435308|NCT02161757|41682321|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
19435309|NCT02161757|41682319|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
19435310|NCT02161757|41682320|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
19435311|NCT02161757|41682321|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
19435312|NCT02161757|41682319|FG000|Treatment Through Study Completion|Other|20|||
19435313|NCT02161757|41682320|FG001|Treatment Through Study Completion|Other|19|||
19435314|NCT02161757|41682321|FG002|Treatment Through Study Completion|Other|12|||
19435315|NCT02161757|41682319|FG000|Treatment Through Study Completion|Death|2|||
19435316|NCT02161757|41682320|FG001|Treatment Through Study Completion|Death|1|||
19435317|NCT02161757|41682321|FG002|Treatment Through Study Completion|Death|1|||
19435318|NCT02160977|41682331|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
19435319|NCT02160977|41682332|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
19435320|NCT02160977|41682331|FG000|Three Months After Surgery|Lost to Follow-up|0|||
19435321|NCT02160977|41682332|FG001|Three Months After Surgery|Lost to Follow-up|2|||
19435322|NCT02160977|41682331|FG000|Six Months After Surgery|Lost to Follow-up|2|||
19435323|NCT02160977|41682332|FG001|Six Months After Surgery|Lost to Follow-up|1|||
19435324|NCT02160899|41682344|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
19435325|NCT02160899|41682345|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
19435326|NCT02160899|41682346|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
19435327|NCT02160899|41682347|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
19435328|NCT02160899|41682348|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
19435329|NCT02160899|41682349|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
19435330|NCT02160041|41682363|FG000|Overall Study|Adverse Event|11|||
19435331|NCT02160041|41682363|FG000|Overall Study|Death|2|||
19435332|NCT02160041|41682363|FG000|Overall Study|disease progression|57|||
19435333|NCT02160041|41682363|FG000|Overall Study|Protocol Violation|1|||
19435334|NCT02160041|41682363|FG000|Overall Study|non-compliance with study|1|||
19435335|NCT02160041|41682363|FG000|Overall Study|Physician Decision|3|||
19435336|NCT02160041|41682363|FG000|Overall Study|Withdrawal by Subject|8|||
19435337|NCT02160041|41682363|FG000|Overall Study|study terminated by by sponsor|1|||
19435338|NCT02186873|41682369|FG000|Overall Study|Adverse Event|1|||
19435339|NCT02186873|41682370|FG001|Overall Study|Adverse Event|3|||
19435340|NCT02186873|41682369|FG000|Overall Study|Lack of Efficacy|0|||
19435341|NCT02186873|41682370|FG001|Overall Study|Lack of Efficacy|1|||
19521812|NCT00634842|41935156|FG000|Overall Study|Discontinued due to injection|0|||
19628345|NCT00863681|42077761|FG001|Overall Study|Non-compliance with study drug|3|||
19435342|NCT02186873|41682369|FG000|Overall Study|Lost to Follow-up|1|||
19435343|NCT02186873|41682370|FG001|Overall Study|Lost to Follow-up|2|||
19435344|NCT02186873|41682369|FG000|Overall Study|Withdrawal by Subject|7|||
19435345|NCT02186873|41682370|FG001|Overall Study|Withdrawal by Subject|2|||
19435346|NCT02096263|41682380|FG000|Overall Study|Adverse Event|1|||
19435347|NCT02096263|41682381|FG001|Overall Study|Adverse Event|0|||
19435348|NCT02096263|41682382|FG002|Overall Study|Adverse Event|1|||
19435349|NCT02096263|41682380|FG000|Overall Study|Lost to Follow-up|14|||
19435350|NCT02096263|41682381|FG001|Overall Study|Lost to Follow-up|18|||
19435351|NCT02096263|41682382|FG002|Overall Study|Lost to Follow-up|15|||
19435352|NCT02096263|41682380|FG000|Overall Study|Other|7|||
19435353|NCT02096263|41682381|FG001|Overall Study|Other|9|||
19435354|NCT02096263|41682382|FG002|Overall Study|Other|6|||
19435355|NCT02096263|41682380|FG000|Overall Study|Sponsor study termination|0|||
19435356|NCT02096263|41682381|FG001|Overall Study|Sponsor study termination|0|||
19435357|NCT02096263|41682382|FG002|Overall Study|Sponsor study termination|1|||
19435358|NCT02096263|41682380|FG000|Overall Study|Protocol Violation|7|||
19435359|NCT02096263|41682381|FG001|Overall Study|Protocol Violation|2|||
19435360|NCT02096263|41682382|FG002|Overall Study|Protocol Violation|8|||
19435361|NCT02096263|41682380|FG000|Overall Study|Withdrawal by Subject|5|||
19435362|NCT02096263|41682381|FG001|Overall Study|Withdrawal by Subject|7|||
19435363|NCT02096263|41682382|FG002|Overall Study|Withdrawal by Subject|8|||
19435364|NCT01830543|41682393|FG000|Overall Study|Subject Decision|19|||
19435365|NCT01830543|41682394|FG001|Overall Study|Subject Decision|21|||
19435366|NCT01830543|41682395|FG002|Overall Study|Subject Decision|57|||
19435367|NCT01830543|41682393|FG000|Overall Study|Adverse Event|91|||
19435368|NCT01830543|41682394|FG001|Overall Study|Adverse Event|77|||
19435369|NCT01830543|41682395|FG002|Overall Study|Adverse Event|76|||
19435370|NCT01830543|41682393|FG000|Overall Study|Death|20|||
19435371|NCT01830543|41682394|FG001|Overall Study|Death|22|||
19435372|NCT01830543|41682395|FG002|Overall Study|Death|22|||
19435373|NCT01830543|41682393|FG000|Overall Study|Protocol Violation|3|||
19435374|NCT01830543|41682394|FG001|Overall Study|Protocol Violation|7|||
19435375|NCT01830543|41682395|FG002|Overall Study|Protocol Violation|7|||
19435376|NCT01830543|41682393|FG000|Overall Study|Physician Decision|11|||
19435377|NCT01830543|41682394|FG001|Overall Study|Physician Decision|5|||
19435378|NCT01830543|41682395|FG002|Overall Study|Physician Decision|12|||
19435379|NCT01830543|41682393|FG000|Overall Study|Withdrawal by consent|3|||
19435380|NCT01830543|41682394|FG001|Overall Study|Withdrawal by consent|3|||
19435381|NCT01830543|41682395|FG002|Overall Study|Withdrawal by consent|3|||
19435382|NCT01830543|41682393|FG000|Overall Study|Other|12|||
19435383|NCT01830543|41682394|FG001|Overall Study|Other|17|||
19435384|NCT01830543|41682395|FG002|Overall Study|Other|37|||
19435385|NCT02109445|41682403|FG000|Overall Study|Symptomatic deterioration|2|||
19435386|NCT02109445|41682403|FG000|Overall Study|Adverse Event|1|||
19435387|NCT02109133|41682409|FG000|Overall Study|Lost to Follow-up|1|||
19435388|NCT02109133|41682410|FG001|Overall Study|Lost to Follow-up|0|||
19435389|NCT01623271|41682418|FG000|Overall Study|Withdrawal by Subject|2|||
19435390|NCT01856673|41682425|FG000|Overall Study|Withdrawal by Subject|44|||
19435391|NCT01856673|41682426|FG001|Overall Study|Withdrawal by Subject|50|||
19435392|NCT01856673|41682427|FG002|Overall Study|Withdrawal by Subject|33|||
19435393|NCT01856673|41682425|FG000|Overall Study|Lost to Follow-up|31|||
19435394|NCT01856673|41682426|FG001|Overall Study|Lost to Follow-up|34|||
19435395|NCT01856673|41682427|FG002|Overall Study|Lost to Follow-up|0|||
19435396|NCT01856673|41682425|FG000|Overall Study|Unknown reasons|9|||
19435397|NCT01856673|41682426|FG001|Overall Study|Unknown reasons|0|||
19435398|NCT01856673|41682427|FG002|Overall Study|Unknown reasons|0|||
19435399|NCT01856673|41682425|FG000|Overall Study|Psychologist decision|1|||
19435400|NCT01856673|41682426|FG001|Overall Study|Psychologist decision|0|||
19435401|NCT01856673|41682427|FG002|Overall Study|Psychologist decision|0|||
19435402|NCT01856673|41682425|FG000|Overall Study|Paperwork errors|8|||
19435403|NCT01856673|41682426|FG001|Overall Study|Paperwork errors|0|||
19435404|NCT01856673|41682427|FG002|Overall Study|Paperwork errors|0|||
19435405|NCT01856673|41682425|FG000|Overall Study|Death|1|||
19435406|NCT01856673|41682426|FG001|Overall Study|Death|1|||
19435407|NCT01856673|41682427|FG002|Overall Study|Death|0|||
19435408|NCT01856673|41682425|FG000|Overall Study|Protocol Violation|1|||
19435409|NCT01856673|41682426|FG001|Overall Study|Protocol Violation|0|||
19435410|NCT01856673|41682427|FG002|Overall Study|Protocol Violation|1|||
19435411|NCT02095951|41682437|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
19435412|NCT02095951|41682438|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
19435413|NCT02095873|41682450|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
19435414|NCT02095873|41682451|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
19435415|NCT02095873|41682450|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
19435416|NCT02095873|41682451|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
19435417|NCT02095873|41682450|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
19435418|NCT02095873|41682451|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
19435419|NCT02094937|41682459|FG000|8 Weeks in Period 1|Adverse Event|9|||
19435420|NCT02094937|41682460|FG001|8 Weeks in Period 1|Adverse Event|0|||
19435421|NCT02094937|41682461|FG002|8 Weeks in Period 1|Adverse Event|0|||
19435422|NCT02094937|41682462|FG003|8 Weeks in Period 1|Adverse Event|0|||
19435423|NCT02094937|41682459|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
19435424|NCT02094937|41682460|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
19435425|NCT02094937|41682461|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
19435426|NCT02094937|41682462|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
19435427|NCT02094937|41682459|FG000|8 Weeks in Period 1|Protocol Violation|2|||
19435428|NCT02094937|41682460|FG001|8 Weeks in Period 1|Protocol Violation|0|||
19435429|NCT02094937|41682461|FG002|8 Weeks in Period 1|Protocol Violation|0|||
19435430|NCT02094937|41682462|FG003|8 Weeks in Period 1|Protocol Violation|0|||
19435431|NCT02094937|41682459|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
19435432|NCT02094937|41682460|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
19435433|NCT02094937|41682461|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
19435434|NCT02094937|41682462|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
19435435|NCT02094937|41682459|FG000|8 Weeks in Period 1|Physician Decision|1|||
19435436|NCT02094937|41682460|FG001|8 Weeks in Period 1|Physician Decision|0|||
19435437|NCT02094937|41682461|FG002|8 Weeks in Period 1|Physician Decision|0|||
19435438|NCT02094937|41682462|FG003|8 Weeks in Period 1|Physician Decision|0|||
19435439|NCT02094937|41682459|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
19435440|NCT02094937|41682460|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
19435441|NCT02094937|41682461|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
19435442|NCT02094937|41682462|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
19435443|NCT02094937|41682459|FG000|12 Weeks in Period 2|Adverse Event|0|||
19435444|NCT02094937|41682460|FG001|12 Weeks in Period 2|Adverse Event|2|||
19435445|NCT02094937|41682461|FG002|12 Weeks in Period 2|Adverse Event|4|||
19435446|NCT02094937|41682462|FG003|12 Weeks in Period 2|Adverse Event|1|||
19435447|NCT02094937|41682459|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
19435448|NCT02094937|41682460|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
19435449|NCT02094937|41682461|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
19435450|NCT02094937|41682462|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
19435451|NCT02094937|41682459|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
19435452|NCT02094937|41682460|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
19435453|NCT02094937|41682461|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
19435454|NCT02094937|41682462|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
19435455|NCT02094937|41682459|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
19435456|NCT02094937|41682460|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
19435457|NCT02094937|41682461|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
19435458|NCT02094937|41682462|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
19435459|NCT02094937|41682459|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
19435460|NCT02094937|41682460|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
19435461|NCT02094937|41682461|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
19435462|NCT02094937|41682462|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
19435463|NCT02093923|41682476|FG000|Overall Study|Lost to Follow-up|0|||
19435464|NCT02093923|41682477|FG001|Overall Study|Lost to Follow-up|0|||
19435465|NCT02093923|41682478|FG002|Overall Study|Lost to Follow-up|0|||
19435466|NCT02093923|41682479|FG003|Overall Study|Lost to Follow-up|1|||
19435467|NCT02093923|41682480|FG004|Overall Study|Lost to Follow-up|0|||
19435468|NCT02093923|41682476|FG000|Overall Study|Screen failure after randomization|0|||
19435469|NCT02093923|41682477|FG001|Overall Study|Screen failure after randomization|0|||
19435470|NCT02093923|41682478|FG002|Overall Study|Screen failure after randomization|0|||
19435471|NCT02093923|41682479|FG003|Overall Study|Screen failure after randomization|1|||
19435472|NCT02093923|41682480|FG004|Overall Study|Screen failure after randomization|0|||
19435473|NCT02186561|41682496|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
19435474|NCT02186561|41682496|FG000|Enrollment|Enrollment Cap Reached|5|||
19435475|NCT02186561|41682496|FG000|Enrollment|Insurance Denial|2|||
19435476|NCT02186561|41682496|FG000|Enrollment|Withdrawal by Subject|2|||
19435477|NCT02186561|41682496|FG000|Enrollment|Investigator Withdrew Consent|1|||
19435478|NCT02186561|41682496|FG000|30-Day Post Index Procedure Visit|Death|1|||
19435479|NCT02186561|41682496|FG000|1- Year Post Index Procedure Visit|Death|1|||
19521813|NCT00634842|41935157|FG001|Overall Study|Discontinued due to injection|2|||
19521814|NCT00634842|41935156|FG000|Overall Study|No need of study drug to treat diabetes|0|||
19521815|NCT00634842|41935157|FG001|Overall Study|No need of study drug to treat diabetes|1|||
19435480|NCT02186561|41682496|FG000|1- Year Post Index Procedure Visit|Missed|1|||
19435481|NCT02066467|41682502|FG000|Overall Study|Did not undergo implant procedure|24|||
19435482|NCT02066467|41682502|FG000|Overall Study|Attempted to implant withoput success|43|||
19435483|NCT02066467|41682502|FG000|Overall Study|Consent ineligible|1|||
19435484|NCT02066467|41682502|FG000|Overall Study|Death|54|||
19435485|NCT02066467|41682502|FG000|Overall Study|Lost to Follow-up|51|||
19435486|NCT02066467|41682502|FG000|Overall Study|Adverse Event|20|||
19435487|NCT02066467|41682502|FG000|Overall Study|Withdrawal by Subject|16|||
19435488|NCT02066467|41682502|FG000|Overall Study|Physician Decision|2|||
19435489|NCT02066467|41682502|FG000|Overall Study|Not defined|4|||
19435490|NCT02186171|41682508|FG000|Overall Study|Withdrawal by Subject|1|||
19435491|NCT02186171|41682509|FG001|Overall Study|Withdrawal by Subject|9|||
19435492|NCT02186171|41682508|FG000|Overall Study|Lost to Follow-up|2|||
19435493|NCT02186171|41682509|FG001|Overall Study|Lost to Follow-up|2|||
19435494|NCT02186171|41682508|FG000|Overall Study|Death|1|||
19435495|NCT02186171|41682509|FG001|Overall Study|Death|2|||
19435496|NCT02186171|41682508|FG000|Overall Study|Protocol-specified Criteria|0|||
19435497|NCT02186171|41682509|FG001|Overall Study|Protocol-specified Criteria|2|||
19435498|NCT02186015|41682517|FG000|Overall Study|Physician Decision|1|||
19435499|NCT02186015|41682518|FG001|Overall Study|Physician Decision|0|||
19435500|NCT02066389|41682531|FG000|Overall Study|Adverse Event|1|||
19435501|NCT02066389|41682532|FG001|Overall Study|Adverse Event|1|||
19435502|NCT02066389|41682533|FG002|Overall Study|Adverse Event|1|||
19435503|NCT02066389|41682534|FG003|Overall Study|Adverse Event|1|||
19435504|NCT02066389|41682535|FG004|Overall Study|Adverse Event|5|||
19521816|NCT00634842|41935156|FG000|Overall Study|No wish to keep taking Avandia|0|||
19521817|NCT00634842|41935157|FG001|Overall Study|No wish to keep taking Avandia|1|||
19521818|NCT00634842|41935156|FG000|Overall Study|Subject off study drug for too long|0|||
19521819|NCT00634842|41935157|FG001|Overall Study|Subject off study drug for too long|1|||
19521820|NCT00633984|41935165|FG000|Overall Study|Lost to Follow-up|0|||
19521821|NCT00633984|41935166|FG001|Overall Study|Lost to Follow-up|6|||
19521822|NCT00633984|41935165|FG000|Overall Study|Withdrawal by Subject|8|||
19521823|NCT00633984|41935166|FG001|Overall Study|Withdrawal by Subject|7|||
19521824|NCT00633984|41935165|FG000|Overall Study|Hospitalized|1|||
19521825|NCT00633984|41935166|FG001|Overall Study|Hospitalized|0|||
19521826|NCT01921218|41935194|FG000|Overall Study|Death|2|||
19521827|NCT01921218|41935195|FG001|Overall Study|Death|1|||
19521828|NCT01921218|41935194|FG000|Overall Study|Withdrawal by Subject|0|||
19521829|NCT01921218|41935195|FG001|Overall Study|Withdrawal by Subject|2|||
19521830|NCT01921218|41935194|FG000|Overall Study|Kidney transplant|1|||
19521831|NCT01921218|41935195|FG001|Overall Study|Kidney transplant|1|||
19521832|NCT00633750|41935201|FG000|Overall Study|Adverse Event|2|||
19521833|NCT00633750|41935201|FG000|Overall Study|Withdrawal by Subject|3|||
19521834|NCT00633360|41935209|FG000|Overall Study|Lost to Follow-up|1|||
19521835|NCT00633360|41935210|FG001|Overall Study|Lost to Follow-up|1|||
19521836|NCT00633360|41935209|FG000|Overall Study|Adverse Event|3|||
19521837|NCT00633360|41935210|FG001|Overall Study|Adverse Event|1|||
19521838|NCT00633360|41935209|FG000|Overall Study|Protocol Violation|0|||
19521839|NCT00633360|41935210|FG001|Overall Study|Protocol Violation|1|||
19521840|NCT00633126|41935218|FG000|Overall Study|Did not receive full dose|1|||
19521841|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
19435505|NCT02066389|41682536|FG005|Overall Study|Adverse Event|1|||
19435506|NCT02066389|41682531|FG000|Overall Study|Withdrawal by Subject|4|||
19521842|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
19521843|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
19521844|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
19521845|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
19521846|NCT00989664|41935222|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
19521847|NCT00989664|41935222|FG000|Long-Term Follow-Up|Death|3|||
19521848|NCT00632736|41935228|FG000|Overall Study|Adverse Event|104|||
19521849|NCT00632736|41935228|FG000|Overall Study|Lost to Follow-up|15|||
19521850|NCT00632736|41935228|FG000|Overall Study|Protocol Violation|14|||
19521851|NCT00632736|41935228|FG000|Overall Study|Withdrawal by Subject|99|||
19521852|NCT00632736|41935228|FG000|Overall Study|Lack of Efficacy|5|||
19521853|NCT00632736|41935228|FG000|Overall Study|Sponsor terminated study|5|||
19521854|NCT00632736|41935228|FG000|Overall Study|Non-compliance|10|||
19521855|NCT00632736|41935228|FG000|Overall Study|Other|16|||
19521856|NCT00989196|41935232|FG000|Treatment Period|Lost to Follow-up|1|||
19521857|NCT00989196|41935233|FG001|Treatment Period|Lost to Follow-up|0|||
19521858|NCT00632502|41935241|FG000|Overall Study|Adverse Event|0|||
19521859|NCT00632502|41935242|FG001|Overall Study|Adverse Event|1|||
19521860|NCT00632502|41935241|FG000|Overall Study|Randomized not treated|3|||
19521861|NCT00632502|41935242|FG001|Overall Study|Randomized not treated|0|||
19521862|NCT00632424|41935252|FG000|Overall Study|Disease Progression|17|||
19521863|NCT00632424|41935252|FG000|Overall Study|Study Drug Toxicity|1|||
19521864|NCT00631488|41935269|FG000|Overall Study|Adverse Event|1|||
19521865|NCT00631488|41935270|FG001|Overall Study|Adverse Event|0|||
19521866|NCT00631488|41935271|FG002|Overall Study|Adverse Event|0|||
19521867|NCT00631488|41935269|FG000|Overall Study|Lost to Follow-up|2|||
19521868|NCT00631488|41935270|FG001|Overall Study|Lost to Follow-up|2|||
19521869|NCT00631488|41935271|FG002|Overall Study|Lost to Follow-up|0|||
19521870|NCT00631488|41935269|FG000|Overall Study|Physician Decision|1|||
19521871|NCT00631488|41935270|FG001|Overall Study|Physician Decision|0|||
19628346|NCT00863681|42077762|FG002|Overall Study|Non-compliance with study drug|0|||
19521872|NCT00631488|41935271|FG002|Overall Study|Physician Decision|1|||
19521873|NCT00631488|41935269|FG000|Overall Study|Protocol Violation|0|||
19521874|NCT00631488|41935270|FG001|Overall Study|Protocol Violation|0|||
19521875|NCT00631488|41935271|FG002|Overall Study|Protocol Violation|1|||
19628347|NCT00789321|42077772|FG000|Overall Study|Adverse Event|0|||
19628348|NCT00789321|42077773|FG001|Overall Study|Adverse Event|1|||
19628349|NCT00811928|42077781|FG000|Overall Study|AEs and SAEs Including Death|7|||
19628350|NCT00811928|42077782|FG001|Overall Study|AEs and SAEs Including Death|11|||
19628351|NCT00811928|42077781|FG000|Overall Study|Withdrawal by Subject|18|||
19521876|NCT00988884|41935281|FG000|Overall Study|Adverse Event|0|||
19435507|NCT02066389|41682532|FG001|Overall Study|Withdrawal by Subject|0|||
19435508|NCT02066389|41682533|FG002|Overall Study|Withdrawal by Subject|5|||
19435509|NCT02066389|41682534|FG003|Overall Study|Withdrawal by Subject|1|||
19435510|NCT02066389|41682535|FG004|Overall Study|Withdrawal by Subject|1|||
19435511|NCT02066389|41682536|FG005|Overall Study|Withdrawal by Subject|2|||
19435512|NCT02066389|41682531|FG000|Overall Study|Lost to Follow-up|0|||
19435513|NCT02066389|41682532|FG001|Overall Study|Lost to Follow-up|0|||
19435514|NCT02066389|41682533|FG002|Overall Study|Lost to Follow-up|0|||
19435515|NCT02066389|41682534|FG003|Overall Study|Lost to Follow-up|1|||
19435516|NCT02066389|41682535|FG004|Overall Study|Lost to Follow-up|1|||
19435517|NCT02066389|41682536|FG005|Overall Study|Lost to Follow-up|1|||
19435518|NCT02066389|41682531|FG000|Overall Study|Randomized in Error|0|||
19435519|NCT02066389|41682532|FG001|Overall Study|Randomized in Error|0|||
19435520|NCT02066389|41682533|FG002|Overall Study|Randomized in Error|0|||
19435521|NCT02066389|41682534|FG003|Overall Study|Randomized in Error|0|||
19435522|NCT02066389|41682535|FG004|Overall Study|Randomized in Error|0|||
19435523|NCT02066389|41682536|FG005|Overall Study|Randomized in Error|1|||
19435524|NCT02106403|41682550|FG000|Follow-Up Visit 3|Other Reason|0|||
19435525|NCT02106403|41682551|FG001|Follow-Up Visit 3|Other Reason|0|||
19435526|NCT02106403|41682552|FG002|Follow-Up Visit 3|Other Reason|0|||
19435527|NCT02106403|41682553|FG003|Follow-Up Visit 3|Other Reason|0|||
19435528|NCT02106403|41682554|FG004|Follow-Up Visit 3|Other Reason|0|||
19435529|NCT02106403|41682555|FG005|Follow-Up Visit 3|Other Reason|1|||
19435530|NCT02133131|41682572|FG000|Overall Study|Adverse Event|0|||
19435531|NCT02133131|41682573|FG001|Overall Study|Adverse Event|0|||
19435532|NCT02133131|41682574|FG002|Overall Study|Adverse Event|0|||
19435533|NCT02133131|41682575|FG003|Overall Study|Adverse Event|1|||
19435534|NCT02133131|41682576|FG004|Overall Study|Adverse Event|0|||
19435535|NCT02133131|41682577|FG005|Overall Study|Adverse Event|0|||
19435536|NCT02133131|41682578|FG006|Overall Study|Adverse Event|0|||
19435537|NCT02133131|41682572|FG000|Overall Study|Lost to Follow-up|1|||
19435538|NCT02133131|41682573|FG001|Overall Study|Lost to Follow-up|0|||
19435539|NCT02133131|41682574|FG002|Overall Study|Lost to Follow-up|0|||
19435540|NCT02133131|41682575|FG003|Overall Study|Lost to Follow-up|1|||
19435541|NCT02133131|41682576|FG004|Overall Study|Lost to Follow-up|0|||
19435542|NCT02133131|41682577|FG005|Overall Study|Lost to Follow-up|0|||
19435543|NCT02133131|41682578|FG006|Overall Study|Lost to Follow-up|0|||
19435544|NCT02133131|41682572|FG000|Overall Study|Status not recorded|4|||
19435545|NCT02133131|41682573|FG001|Overall Study|Status not recorded|5|||
19435546|NCT02133131|41682574|FG002|Overall Study|Status not recorded|1|||
19435547|NCT02133131|41682575|FG003|Overall Study|Status not recorded|4|||
19435548|NCT02133131|41682576|FG004|Overall Study|Status not recorded|0|||
19435549|NCT02133131|41682577|FG005|Overall Study|Status not recorded|0|||
19435550|NCT02133131|41682578|FG006|Overall Study|Status not recorded|0|||
19435551|NCT02133131|41682572|FG000|Overall Study|Ongoing in study|0|||
19435552|NCT02133131|41682573|FG001|Overall Study|Ongoing in study|0|||
19435553|NCT02133131|41682574|FG002|Overall Study|Ongoing in study|0|||
19435554|NCT02133131|41682575|FG003|Overall Study|Ongoing in study|0|||
19435555|NCT02133131|41682576|FG004|Overall Study|Ongoing in study|15|||
19435556|NCT02133131|41682577|FG005|Overall Study|Ongoing in study|14|||
19435557|NCT02133131|41682578|FG006|Overall Study|Ongoing in study|11|||
19435558|NCT02133131|41682572|FG000|Overall Study|Protocol Violation|0|||
19435559|NCT02133131|41682573|FG001|Overall Study|Protocol Violation|0|||
19435560|NCT02133131|41682574|FG002|Overall Study|Protocol Violation|0|||
19435561|NCT02133131|41682575|FG003|Overall Study|Protocol Violation|0|||
19435562|NCT02133131|41682576|FG004|Overall Study|Protocol Violation|0|||
19435563|NCT02133131|41682577|FG005|Overall Study|Protocol Violation|0|||
19435564|NCT02133131|41682578|FG006|Overall Study|Protocol Violation|1|||
19435565|NCT02106325|41682596|FG000|Phase 1|Lost to Follow-up|2|||
19435566|NCT02106325|41682597|FG001|Phase 1|Lost to Follow-up|2|||
19435567|NCT02106325|41682596|FG000|Phase 2|Lost to Follow-up|2|||
19435568|NCT02106325|41682597|FG001|Phase 2|Lost to Follow-up|3|||
19435569|NCT02106325|41682596|FG000|Phase 3|Lost to Follow-up|2|||
19435570|NCT02106325|41682597|FG001|Phase 3|Lost to Follow-up|1|||
19435571|NCT01625689|41682605|FG000|Overall Study|Migration|2|||
19435572|NCT01625689|41682606|FG001|Overall Study|Migration|1|||
19435573|NCT02184611|41682614|FG000|Overall Study|Lack of Efficacy|11|||
19435574|NCT02184611|41682615|FG001|Overall Study|Lack of Efficacy|15|||
19435575|NCT02184611|41682614|FG000|Overall Study|Withdrawal by Subject|5|||
19435576|NCT02184611|41682615|FG001|Overall Study|Withdrawal by Subject|6|||
19435577|NCT02184611|41682614|FG000|Overall Study|Adverse Event|4|||
19435578|NCT02184611|41682615|FG001|Overall Study|Adverse Event|5|||
19435579|NCT02184611|41682614|FG000|Overall Study|Protocol Violation|1|||
19435580|NCT02184611|41682615|FG001|Overall Study|Protocol Violation|1|||
19435581|NCT02184611|41682614|FG000|Overall Study|Protocol defined stopping criteria|0|||
19435582|NCT02184611|41682615|FG001|Overall Study|Protocol defined stopping criteria|1|||
19435583|NCT02066311|41682621|FG000|Overall Study|Adverse Event|4|||
19435584|NCT02066311|41682621|FG000|Overall Study|Withdrawal by Subject|1|||
19435585|NCT02184455|41682625|FG000|Overall Study|Lost to Follow-up|1|||
19435586|NCT02184143|41682631|FG000|Overall Study|Withdrawal by Subject|4|||
19435587|NCT02184143|41682632|FG001|Overall Study|Withdrawal by Subject|4|||
19435588|NCT02184143|41682631|FG000|Overall Study|Lost to Follow-up|5|||
19435589|NCT02184143|41682632|FG001|Overall Study|Lost to Follow-up|3|||
19435590|NCT02184143|41682631|FG000|Overall Study|Death|1|||
19435591|NCT02184143|41682632|FG001|Overall Study|Death|0|||
19435592|NCT01625611|41682642|FG000|Overall Study|No adlib drinks Lab 1|3|||
19435593|NCT01625611|41682643|FG001|Overall Study|No adlib drinks Lab 1|0|||
19435594|NCT01625611|41682642|FG000|Overall Study|Technical issues with PET|1|||
19435595|NCT01625611|41682643|FG001|Overall Study|Technical issues with PET|0|||
19435596|NCT01625611|41682642|FG000|Overall Study|Unable to complete study procedures|1|||
19435597|NCT01625611|41682643|FG001|Overall Study|Unable to complete study procedures|0|||
19435598|NCT01625611|41682642|FG000|Overall Study|Withdrawal by Subject|3|||
19435599|NCT01625611|41682643|FG001|Overall Study|Withdrawal by Subject|0|||
19435600|NCT02159807|41682653|FG000|Overall Study|Adverse Event|0|||
19435601|NCT02159807|41682654|FG001|Overall Study|Adverse Event|0|||
19435602|NCT02159807|41682655|FG002|Overall Study|Adverse Event|1|||
19435603|NCT02159807|41682653|FG000|Overall Study|No CSF|1|||
19435604|NCT02159807|41682654|FG001|Overall Study|No CSF|1|||
19435605|NCT02159807|41682655|FG002|Overall Study|No CSF|1|||
19435606|NCT02159807|41682653|FG000|Overall Study|elevated blood pressure|0|||
19435607|NCT02159807|41682654|FG001|Overall Study|elevated blood pressure|0|||
19435608|NCT02159807|41682655|FG002|Overall Study|elevated blood pressure|1|||
19435609|NCT02066233|41682665|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
19435610|NCT02066233|41682666|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
19435611|NCT02159729|41682674|FG000|Overall Study|Adverse Event|0|||
19435612|NCT02159729|41682675|FG001|Overall Study|Adverse Event|1|||
19435613|NCT02159729|41682674|FG000|Overall Study|Subject's Request|13|||
19435614|NCT02159729|41682675|FG001|Overall Study|Subject's Request|10|||
19435615|NCT02159729|41682674|FG000|Overall Study|Lost to Follow-up|24|||
19435616|NCT02159729|41682675|FG001|Overall Study|Lost to Follow-up|9|||
19435617|NCT02159729|41682674|FG000|Overall Study|Non compliance|2|||
19435618|NCT02159729|41682675|FG001|Overall Study|Non compliance|0|||
19435619|NCT02159729|41682674|FG000|Overall Study|Other Unspecified|3|||
19435620|NCT02159729|41682675|FG001|Overall Study|Other Unspecified|1|||
19435621|NCT02159183|41682683|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
19435622|NCT02159183|41682684|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
19435623|NCT02159183|41682683|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
19435624|NCT02159183|41682684|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
19435625|NCT02159183|41682683|FG000|Analysis After the 36 Months Follow-up|Death|0|||
19435626|NCT02159183|41682684|FG001|Analysis After the 36 Months Follow-up|Death|1|||
19435627|NCT02159183|41682683|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
19435628|NCT02159183|41682684|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
19435629|NCT02159183|41682683|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
19435630|NCT02159183|41682684|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
19435631|NCT02183675|41682696|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
19435632|NCT02183675|41682697|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
19435633|NCT02183675|41682698|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
19435634|NCT02183675|41682699|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
19435635|NCT02183675|41682700|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
19435636|NCT02183675|41682701|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
19435637|NCT02183519|41682713|FG000|Overall Study|computer error|3|||
19435638|NCT02183519|41682714|FG001|Overall Study|computer error|0|||
19521877|NCT00988884|41935282|FG001|Overall Study|Adverse Event|1|||
19628352|NCT00811928|42077782|FG001|Overall Study|Withdrawal by Subject|12|||
19435639|NCT02183519|41682713|FG000|Overall Study|Did not respond to cough inducter|0|||
19435640|NCT02183519|41682714|FG001|Overall Study|Did not respond to cough inducter|3|||
19435641|NCT02132195|41682723|FG000|Initial Assignment|Relapsed|14|||
19435642|NCT02132195|41682724|FG001|Initial Assignment|Relapsed|0|||
19435643|NCT02132195|41682725|FG002|Initial Assignment|Relapsed|0|||
19435644|NCT02132195|41682723|FG000|Rescue Therapy|Relapsed|0|||
19435645|NCT02132195|41682724|FG001|Rescue Therapy|Relapsed|0|||
19435646|NCT02132195|41682725|FG002|Rescue Therapy|Relapsed|7|||
19435647|NCT02132195|41682723|FG000|Rescue Therapy|Physician Decision|0|||
19435648|NCT02132195|41682724|FG001|Rescue Therapy|Physician Decision|0|||
19435649|NCT02132195|41682725|FG002|Rescue Therapy|Physician Decision|1|||
19435650|NCT02132195|41682723|FG000|Rescue Therapy|Withdrawal by Subject|0|||
19435651|NCT02132195|41682724|FG001|Rescue Therapy|Withdrawal by Subject|0|||
19435652|NCT02132195|41682725|FG002|Rescue Therapy|Withdrawal by Subject|1|||
19435653|NCT02132195|41682723|FG000|Rescue Therapy|Adverse Event|0|||
19435654|NCT02132195|41682724|FG001|Rescue Therapy|Adverse Event|0|||
19435655|NCT02132195|41682725|FG002|Rescue Therapy|Adverse Event|2|||
19435656|NCT02182973|41682735|FG000|Overall Study|Withdrawal by Subject|3|||
19435657|NCT02182973|41682736|FG001|Overall Study|Withdrawal by Subject|0|||
19435658|NCT02182895|41682745|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
19435659|NCT02182895|41682746|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
19435660|NCT01625377|41682754|FG000|Overall Study|Death|1|||
19435661|NCT01625377|41682755|FG001|Overall Study|Death|1|||
19435662|NCT01625377|41682754|FG000|Overall Study|Administrative Problem|1|||
19435663|NCT01625377|41682755|FG001|Overall Study|Administrative Problem|1|||
19435664|NCT01625377|41682754|FG000|Overall Study|Protocol Violation|0|||
19435665|NCT01625377|41682755|FG001|Overall Study|Protocol Violation|3|||
19435666|NCT01625377|41682754|FG000|Overall Study|Adverse Event|3|||
19435667|NCT01625377|41682755|FG001|Overall Study|Adverse Event|16|||
19435668|NCT01625377|41682754|FG000|Overall Study|Graft loss|1|||
19435669|NCT01625377|41682755|FG001|Overall Study|Graft loss|0|||
19435670|NCT01625377|41682754|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19435671|NCT01625377|41682755|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19435672|NCT01625377|41682754|FG000|Overall Study|Abnormal laboratory values|1|||
19435673|NCT01625377|41682755|FG001|Overall Study|Abnormal laboratory values|0|||
19435674|NCT02158949|41682763|FG000|Overall Study|Withdrawal by Subject|1|||
19435675|NCT02158949|41682764|FG001|Overall Study|Withdrawal by Subject|0|||
19435676|NCT02158949|41682763|FG000|Overall Study|Lost to Follow-up|5|||
19435677|NCT02158949|41682764|FG001|Overall Study|Lost to Follow-up|11|||
19435678|NCT02132117|41682772|FG000|Overall Study|Adverse Event|6|||
19435679|NCT02132117|41682773|FG001|Overall Study|Adverse Event|1|||
19435680|NCT02132117|41682772|FG000|Overall Study|Lost to Follow-up|2|||
19435681|NCT02132117|41682773|FG001|Overall Study|Lost to Follow-up|2|||
19435682|NCT02132117|41682772|FG000|Overall Study|Personal Reasons|1|||
19435683|NCT02132117|41682773|FG001|Overall Study|Personal Reasons|2|||
19435684|NCT02132117|41682772|FG000|Overall Study|Other Miscellaneous Reasons|2|||
19435685|NCT02132117|41682773|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19435686|NCT02093689|41682782|FG000|Overall Study|Physician Decision|4|||
19435687|NCT02093689|41682783|FG001|Overall Study|Physician Decision|0|||
19435688|NCT02093689|41682784|FG002|Overall Study|Physician Decision|0|||
19435689|NCT02047045|41682792|FG000|Baseline|Withdrawal by Subject|3|||
19435690|NCT02047045|41682793|FG001|Baseline|Withdrawal by Subject|2|||
19435691|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
19435692|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
19435693|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
19435694|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
19435695|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
19435696|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
19435697|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
19435698|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
19435699|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
19435700|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
19435701|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
19435702|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
19435703|NCT02047045|41682792|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
19435704|NCT02047045|41682793|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
19435705|NCT02047045|41682792|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
19435706|NCT02047045|41682793|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
19435707|NCT02131259|41682799|FG000|Overall Study|Progressive disease|751|||
19435708|NCT02131259|41682799|FG000|Overall Study|Adverse Event|341|||
19435709|NCT02131259|41682799|FG000|Overall Study|Lost to Follow-up|7|||
19435710|NCT02131259|41682799|FG000|Overall Study|Relocation|32|||
19435711|NCT02131259|41682799|FG000|Overall Study|Other|63|||
19435712|NCT02131259|41682799|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
19435713|NCT02131259|41682799|FG000|Overall Study|Progressive disease/relocation|1|||
19435714|NCT02131259|41682799|FG000|Overall Study|Progressive disease/other|2|||
19435715|NCT02131259|41682799|FG000|Overall Study|AE/lost to follow-up|1|||
19435716|NCT02131259|41682799|FG000|Overall Study|AE/other|1|||
19435717|NCT02131259|41682799|FG000|Overall Study|Progressive disease/AE/other|1|||
19435718|NCT02131259|41682799|FG000|Overall Study|Missing|3|||
19435719|NCT01856595|41682812|FG000|Overall Study|Withdrawal by Subject|0|||
19435720|NCT01856595|41682813|FG001|Overall Study|Withdrawal by Subject|1|||
19435721|NCT01856595|41682814|FG002|Overall Study|Withdrawal by Subject|0|||
19435722|NCT01856595|41682815|FG003|Overall Study|Withdrawal by Subject|0|||
19435723|NCT01856595|41682816|FG004|Overall Study|Withdrawal by Subject|0|||
19435724|NCT01856595|41682817|FG005|Overall Study|Withdrawal by Subject|0|||
19435725|NCT01856595|41682818|FG006|Overall Study|Withdrawal by Subject|1|||
19435726|NCT01856595|41682819|FG007|Overall Study|Withdrawal by Subject|0|||
19521878|NCT00988884|41935281|FG000|Overall Study|Lost to Follow-up|20|||
19435727|NCT01856595|41682820|FG008|Overall Study|Withdrawal by Subject|0|||
19435728|NCT02158247|41682857|FG000|Overall Study|Invisible vocal cords|5|||
19435729|NCT01829295|41682879|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
19435730|NCT01829295|41682880|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
19435731|NCT01829295|41682881|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
19435732|NCT01829295|41682882|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
19435733|NCT01829295|41682879|FG000|6-12 Months|Adverse Event|0|||
19435734|NCT01829295|41682880|FG001|6-12 Months|Adverse Event|0|||
19435735|NCT01829295|41682881|FG002|6-12 Months|Adverse Event|3|||
19435736|NCT01829295|41682882|FG003|6-12 Months|Adverse Event|2|||
19435737|NCT01829295|41682879|FG000|6-12 Months|Lost to Follow-up|2|||
19435738|NCT01829295|41682880|FG001|6-12 Months|Lost to Follow-up|0|||
19435739|NCT01829295|41682881|FG002|6-12 Months|Lost to Follow-up|0|||
19435740|NCT01829295|41682882|FG003|6-12 Months|Lost to Follow-up|0|||
19435741|NCT01829295|41682879|FG000|6-12 Months|Withdrawal by Subject|2|||
19435742|NCT01829295|41682880|FG001|6-12 Months|Withdrawal by Subject|2|||
19435743|NCT01829295|41682881|FG002|6-12 Months|Withdrawal by Subject|0|||
19435744|NCT01829295|41682882|FG003|6-12 Months|Withdrawal by Subject|0|||
19435745|NCT02157935|41682894|FG000|Overall Study|Withdrawal by Subject|25|||
19435746|NCT02157935|41682895|FG001|Overall Study|Withdrawal by Subject|39|||
19435747|NCT02157935|41682894|FG000|Overall Study|Screen failure|1|||
19435748|NCT02157935|41682895|FG001|Overall Study|Screen failure|2|||
19435749|NCT02157935|41682894|FG000|Overall Study|Protocol Violation|1|||
19435750|NCT02157935|41682895|FG001|Overall Study|Protocol Violation|0|||
19435751|NCT02157935|41682894|FG000|Overall Study|Progressive disease|0|||
19435752|NCT02157935|41682895|FG001|Overall Study|Progressive disease|2|||
19435753|NCT02157935|41682894|FG000|Overall Study|Other|5|||
19435754|NCT02157935|41682895|FG001|Overall Study|Other|12|||
19435755|NCT02157935|41682894|FG000|Overall Study|Lack of Efficacy|0|||
19435756|NCT02157935|41682895|FG001|Overall Study|Lack of Efficacy|1|||
19435757|NCT02157935|41682894|FG000|Overall Study|Death|4|||
19435758|NCT02157935|41682895|FG001|Overall Study|Death|4|||
19435759|NCT02157935|41682894|FG000|Overall Study|Adverse Event|3|||
19435760|NCT02157935|41682895|FG001|Overall Study|Adverse Event|5|||
19435761|NCT02157779|41682903|FG000|Overall Study|Logistical|9|||
19435762|NCT02157779|41682904|FG001|Overall Study|Logistical|3|||
19435763|NCT02157779|41682903|FG000|Overall Study|Stopped attending, reason unknown|11|||
19435764|NCT02157779|41682904|FG001|Overall Study|Stopped attending, reason unknown|7|||
19435765|NCT02157779|41682903|FG000|Overall Study|No response to outreach after Baseline|1|||
19435766|NCT02157779|41682904|FG001|Overall Study|No response to outreach after Baseline|1|||
19435767|NCT02157779|41682903|FG000|Overall Study|Moved|1|||
19435768|NCT02157779|41682904|FG001|Overall Study|Moved|0|||
19435769|NCT02157779|41682903|FG000|Overall Study|Medical|1|||
19435770|NCT02157779|41682904|FG001|Overall Study|Medical|0|||
19435771|NCT02157779|41682903|FG000|Overall Study|Legal issue|1|||
19435772|NCT02157779|41682904|FG001|Overall Study|Legal issue|0|||
19435773|NCT02093221|41682918|FG000|Overall Study|Adverse Event|1|||
19435774|NCT02093221|41682919|FG001|Overall Study|Adverse Event|0|||
19435775|NCT02093221|41682920|FG002|Overall Study|Adverse Event|0|||
19435776|NCT02093221|41682921|FG003|Overall Study|Adverse Event|0|||
19435777|NCT02093221|41682922|FG004|Overall Study|Adverse Event|0|||
19435778|NCT02093221|41682918|FG000|Overall Study|Withdrawal by Subject|1|||
19435779|NCT02093221|41682919|FG001|Overall Study|Withdrawal by Subject|1|||
19435780|NCT02093221|41682920|FG002|Overall Study|Withdrawal by Subject|4|||
19435781|NCT02093221|41682921|FG003|Overall Study|Withdrawal by Subject|1|||
19435782|NCT02093221|41682922|FG004|Overall Study|Withdrawal by Subject|1|||
19435783|NCT02093221|41682918|FG000|Overall Study|Lost to Follow-up|2|||
19435784|NCT02093221|41682919|FG001|Overall Study|Lost to Follow-up|0|||
19435785|NCT02093221|41682920|FG002|Overall Study|Lost to Follow-up|1|||
19435786|NCT02093221|41682921|FG003|Overall Study|Lost to Follow-up|1|||
19435787|NCT02093221|41682922|FG004|Overall Study|Lost to Follow-up|0|||
19435788|NCT02093221|41682918|FG000|Overall Study|Death|0|||
19435789|NCT02093221|41682919|FG001|Overall Study|Death|1|||
19435790|NCT02093221|41682920|FG002|Overall Study|Death|0|||
19435791|NCT02093221|41682921|FG003|Overall Study|Death|0|||
19435792|NCT02093221|41682922|FG004|Overall Study|Death|0|||
19435793|NCT02093221|41682918|FG000|Overall Study|Protocol Violation|0|||
19435794|NCT02093221|41682919|FG001|Overall Study|Protocol Violation|1|||
19435795|NCT02093221|41682920|FG002|Overall Study|Protocol Violation|0|||
19435796|NCT02093221|41682921|FG003|Overall Study|Protocol Violation|0|||
19435797|NCT02093221|41682922|FG004|Overall Study|Protocol Violation|0|||
19435798|NCT02093221|41682918|FG000|Overall Study|Study termination|6|||
19435799|NCT02093221|41682919|FG001|Overall Study|Study termination|5|||
19435800|NCT02093221|41682920|FG002|Overall Study|Study termination|4|||
19435801|NCT02093221|41682921|FG003|Overall Study|Study termination|6|||
19435802|NCT02093221|41682922|FG004|Overall Study|Study termination|7|||
19435803|NCT02092909|41682938|FG000|Overall Study|Adverse Event|0|||
19435804|NCT02092909|41682939|FG001|Overall Study|Adverse Event|0|||
19435805|NCT02092909|41682940|FG002|Overall Study|Adverse Event|4|||
19435806|NCT02092909|41682941|FG003|Overall Study|Adverse Event|2|||
19435807|NCT02092909|41682938|FG000|Overall Study|Lack of Efficacy|0|||
19435808|NCT02092909|41682939|FG001|Overall Study|Lack of Efficacy|2|||
19435809|NCT02092909|41682940|FG002|Overall Study|Lack of Efficacy|1|||
19435810|NCT02092909|41682941|FG003|Overall Study|Lack of Efficacy|0|||
19435811|NCT02092909|41682938|FG000|Overall Study|Withdrawal by Subject|0|||
19435812|NCT02092909|41682939|FG001|Overall Study|Withdrawal by Subject|0|||
19435813|NCT02092909|41682940|FG002|Overall Study|Withdrawal by Subject|2|||
19435814|NCT02092909|41682941|FG003|Overall Study|Withdrawal by Subject|1|||
19435815|NCT02092909|41682938|FG000|Overall Study|Study terminated by Sponsor|0|||
19435816|NCT02092909|41682939|FG001|Overall Study|Study terminated by Sponsor|0|||
19435817|NCT02092909|41682940|FG002|Overall Study|Study terminated by Sponsor|0|||
19435818|NCT02092909|41682941|FG003|Overall Study|Study terminated by Sponsor|2|||
19435819|NCT02092909|41682938|FG000|Overall Study|Miscellaneous|1|||
19435820|NCT02092909|41682939|FG001|Overall Study|Miscellaneous|1|||
19435821|NCT02092909|41682940|FG002|Overall Study|Miscellaneous|2|||
19435822|NCT02092909|41682941|FG003|Overall Study|Miscellaneous|1|||
19435823|NCT01623115|41682953|FG000|Overall Study|Randomized but not treated|0|||
19435824|NCT01623115|41682954|FG001|Overall Study|Randomized but not treated|1|||
19435825|NCT01623115|41682953|FG000|Overall Study|Physician Decision|1|||
19435826|NCT01623115|41682954|FG001|Overall Study|Physician Decision|0|||
19435827|NCT01623115|41682953|FG000|Overall Study|Participants moved|1|||
19435828|NCT01623115|41682954|FG001|Overall Study|Participants moved|5|||
19435829|NCT01623115|41682953|FG000|Overall Study|Adverse Event|10|||
19435830|NCT01623115|41682954|FG001|Overall Study|Adverse Event|13|||
19435831|NCT01623115|41682953|FG000|Overall Study|Poor compliance to protocol|4|||
19435832|NCT01623115|41682954|FG001|Overall Study|Poor compliance to protocol|10|||
19435833|NCT01623115|41682953|FG000|Overall Study|Consent withdrawn by participant|2|||
19435834|NCT01623115|41682954|FG001|Overall Study|Consent withdrawn by participant|6|||
19435835|NCT01623115|41682953|FG000|Overall Study|Related to study drug administration|0|||
19435836|NCT01623115|41682954|FG001|Overall Study|Related to study drug administration|2|||
19435837|NCT01623115|41682953|FG000|Overall Study|Last visit outside protocol visit window|14|||
19435838|NCT01623115|41682954|FG001|Overall Study|Last visit outside protocol visit window|26|||
19435839|NCT01623115|41682953|FG000|Overall Study|Site closure|1|||
19435840|NCT01623115|41682954|FG001|Overall Study|Site closure|7|||
19435841|NCT01623115|41682953|FG000|Overall Study|Death|0|||
19435842|NCT01623115|41682954|FG001|Overall Study|Death|4|||
19435843|NCT01623115|41682953|FG000|Overall Study|Other than specified above|0|||
19435844|NCT01623115|41682954|FG001|Overall Study|Other than specified above|3|||
19435845|NCT02092285|41682960|FG000|Induction Phase|Adverse Event|7|||
19435846|NCT02092285|41682960|FG000|Induction Phase|Physician Decision|4|||
19435847|NCT02092285|41682960|FG000|Induction Phase|Pregnancy|1|||
19435848|NCT02092285|41682960|FG000|Induction Phase|Relapse/Recurrence|7|||
19435849|NCT02092285|41682960|FG000|Induction Phase|Withdrawal by Subject|2|||
19435850|NCT02092285|41682960|FG000|Induction Phase|Lack of Efficacy|14|||
19435851|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
19435852|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
19435853|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
19435854|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
19435855|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
19435856|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
19435857|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
19435858|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
19435859|NCT02092285|41682960|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
19435860|NCT02091739|41682967|FG000|MP: 16 Weeks|Adverse Event|1|||
19435861|NCT02091739|41682968|FG001|MP: 16 Weeks|Adverse Event|1|||
19435862|NCT02091739|41682969|FG002|MP: 16 Weeks|Adverse Event|1|||
19435863|NCT02091739|41682970|FG003|MP: 16 Weeks|Adverse Event|0|||
19435864|NCT02091739|41682971|FG004|MP: 16 Weeks|Adverse Event|0|||
19435865|NCT02091739|41682967|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
19435866|NCT02091739|41682968|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
19435867|NCT02091739|41682969|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
19435868|NCT02091739|41682970|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
19435869|NCT02091739|41682971|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
19435870|NCT02091739|41682967|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
19435871|NCT02091739|41682968|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
19435872|NCT02091739|41682969|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
19435873|NCT02091739|41682970|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
19435874|NCT02091739|41682971|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
19435875|NCT02091739|41682967|FG000|EP: 48 Weeks|Other|0|||
19435876|NCT02091739|41682968|FG001|EP: 48 Weeks|Other|0|||
19435877|NCT02091739|41682969|FG002|EP: 48 Weeks|Other|0|||
19435878|NCT02091739|41682970|FG003|EP: 48 Weeks|Other|1|||
19435879|NCT02091739|41682971|FG004|EP: 48 Weeks|Other|0|||
19435880|NCT02091739|41682967|FG000|EP: 48 Weeks|Death|0|||
19435881|NCT02091739|41682968|FG001|EP: 48 Weeks|Death|0|||
19435882|NCT02091739|41682969|FG002|EP: 48 Weeks|Death|0|||
19435883|NCT02091739|41682970|FG003|EP: 48 Weeks|Death|3|||
19435884|NCT02091739|41682971|FG004|EP: 48 Weeks|Death|2|||
19435885|NCT02091739|41682967|FG000|EP: 48 Weeks|Adverse Event|0|||
19435886|NCT02091739|41682968|FG001|EP: 48 Weeks|Adverse Event|0|||
19435887|NCT02091739|41682969|FG002|EP: 48 Weeks|Adverse Event|0|||
19435888|NCT02091739|41682970|FG003|EP: 48 Weeks|Adverse Event|2|||
19435889|NCT02091739|41682971|FG004|EP: 48 Weeks|Adverse Event|6|||
19435890|NCT02091739|41682967|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
19435891|NCT02091739|41682968|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
19435892|NCT02091739|41682969|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
19435893|NCT02091739|41682970|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
19435894|NCT02091739|41682971|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
19435895|NCT02045875|41682983|FG000|Overall Study|Lost to Follow-up|3|||
19435896|NCT02045875|41682984|FG001|Overall Study|Lost to Follow-up|0|||
19435897|NCT02045875|41682983|FG000|Overall Study|Withdrawal by Subject|4|||
19435898|NCT02045875|41682984|FG001|Overall Study|Withdrawal by Subject|3|||
19435899|NCT01597635|41682993|FG000|Part A|Adverse Event|3|||
19435900|NCT01597635|41682994|FG001|Part A|Adverse Event|0|||
19435901|NCT01597635|41682995|FG002|Part A|Adverse Event|0|||
19435902|NCT01597635|41682993|FG000|Part B|Adverse Event|0|||
19435903|NCT01597635|41682994|FG001|Part B|Adverse Event|0|||
19435904|NCT01597635|41682995|FG002|Part B|Adverse Event|1|||
19435905|NCT01597635|41682993|FG000|Part B|Protocol Violation|0|||
19435906|NCT01597635|41682994|FG001|Part B|Protocol Violation|1|||
19435907|NCT01597635|41682995|FG002|Part B|Protocol Violation|0|||
19435908|NCT01597635|41682993|FG000|Part B|Protocol-defined stopping criteria|0|||
19435909|NCT01597635|41682994|FG001|Part B|Protocol-defined stopping criteria|4|||
19435910|NCT01597635|41682995|FG002|Part B|Protocol-defined stopping criteria|3|||
19435911|NCT01597635|41682993|FG000|Part B|Withdrawal by Subject|0|||
19435912|NCT01597635|41682994|FG001|Part B|Withdrawal by Subject|1|||
19435913|NCT01597635|41682995|FG002|Part B|Withdrawal by Subject|0|||
19435914|NCT01828281|41683006|FG000|Overall Study|Withdrawal by Subject|1|||
19435915|NCT01828281|41683007|FG001|Overall Study|Withdrawal by Subject|0|||
19435916|NCT01827267|41683016|FG000|Overall Study|Did not receive study drug|1|||
19435917|NCT01827267|41683017|FG001|Overall Study|Did not receive study drug|1|||
19435918|NCT01827267|41683016|FG000|Overall Study|Physician Decision|1|||
19435919|NCT01827267|41683017|FG001|Overall Study|Physician Decision|0|||
19435920|NCT01827267|41683016|FG000|Overall Study|Disease Progression|1|||
19435921|NCT01827267|41683017|FG001|Overall Study|Disease Progression|1|||
19435922|NCT01827267|41683016|FG000|Overall Study|Sponsor Discontinued Study|2|||
19435923|NCT01827267|41683017|FG001|Overall Study|Sponsor Discontinued Study|8|||
19435924|NCT01827267|41683016|FG000|Overall Study|Still on study|0|||
19435925|NCT01827267|41683017|FG001|Overall Study|Still on study|2|||
19435926|NCT01855425|41683024|FG000|Overall Study|Physician Decision|20|||
19435927|NCT01854879|41683028|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
19435928|NCT01854879|41683028|FG000|Overall Study|screen fail|3|||
19435929|NCT01854879|41683028|FG000|Overall Study|incomplete data set|1|||
19435930|NCT01827111|41683032|FG000|Overall Study|Disease Progression|1|||
19435931|NCT02045095|41683036|FG000|Overall Study|Other|0|||
19435932|NCT02045095|41683037|FG001|Overall Study|Other|0|||
19435933|NCT02045095|41683038|FG002|Overall Study|Other|1|||
19435934|NCT02045095|41683039|FG003|Overall Study|Other|0|||
19435935|NCT02045095|41683040|FG004|Overall Study|Other|0|||
19435936|NCT02045095|41683041|FG005|Overall Study|Other|2|||
19435937|NCT02045095|41683042|FG006|Overall Study|Other|0|||
19435938|NCT02045095|41683036|FG000|Overall Study|Progressive Disease|3|||
19435939|NCT02045095|41683037|FG001|Overall Study|Progressive Disease|3|||
19435940|NCT02045095|41683038|FG002|Overall Study|Progressive Disease|2|||
19435941|NCT02045095|41683039|FG003|Overall Study|Progressive Disease|4|||
19435942|NCT02045095|41683040|FG004|Overall Study|Progressive Disease|2|||
19435943|NCT02045095|41683041|FG005|Overall Study|Progressive Disease|4|||
19435944|NCT02045095|41683042|FG006|Overall Study|Progressive Disease|1|||
19435945|NCT02045095|41683036|FG000|Overall Study|Withdrawal by Subject|0|||
19435946|NCT02045095|41683037|FG001|Overall Study|Withdrawal by Subject|0|||
19435947|NCT02045095|41683038|FG002|Overall Study|Withdrawal by Subject|0|||
19435948|NCT02045095|41683039|FG003|Overall Study|Withdrawal by Subject|0|||
19435949|NCT02045095|41683040|FG004|Overall Study|Withdrawal by Subject|3|||
19435950|NCT02045095|41683041|FG005|Overall Study|Withdrawal by Subject|0|||
19435951|NCT02045095|41683042|FG006|Overall Study|Withdrawal by Subject|0|||
19435952|NCT02045095|41683036|FG000|Overall Study|Adverse Event|0|||
19435953|NCT02045095|41683037|FG001|Overall Study|Adverse Event|1|||
19435954|NCT02045095|41683038|FG002|Overall Study|Adverse Event|1|||
19435955|NCT02045095|41683039|FG003|Overall Study|Adverse Event|0|||
19435956|NCT02045095|41683040|FG004|Overall Study|Adverse Event|0|||
19435957|NCT02045095|41683041|FG005|Overall Study|Adverse Event|2|||
19435958|NCT02045095|41683042|FG006|Overall Study|Adverse Event|0|||
19435959|NCT02181803|41683067|FG000|Overall Study|Withdrawal by Subject|0|||
19435960|NCT02181803|41683068|FG001|Overall Study|Withdrawal by Subject|2|||
19435961|NCT02181803|41683069|FG002|Overall Study|Withdrawal by Subject|0|||
19435962|NCT02181803|41683070|FG003|Overall Study|Withdrawal by Subject|0|||
19435963|NCT02181803|41683071|FG004|Overall Study|Withdrawal by Subject|0|||
19435964|NCT02181803|41683072|FG005|Overall Study|Withdrawal by Subject|0|||
19435965|NCT02181803|41683073|FG006|Overall Study|Withdrawal by Subject|0|||
19435966|NCT02181803|41683074|FG007|Overall Study|Withdrawal by Subject|0|||
19435967|NCT02181803|41683075|FG008|Overall Study|Withdrawal by Subject|0|||
19435968|NCT02181803|41683067|FG000|Overall Study|Physician Decision|0|||
19435969|NCT02181803|41683068|FG001|Overall Study|Physician Decision|0|||
19435970|NCT02181803|41683069|FG002|Overall Study|Physician Decision|0|||
19435971|NCT02181803|41683070|FG003|Overall Study|Physician Decision|1|||
19435972|NCT02181803|41683071|FG004|Overall Study|Physician Decision|0|||
19435973|NCT02181803|41683072|FG005|Overall Study|Physician Decision|0|||
19435974|NCT02181803|41683073|FG006|Overall Study|Physician Decision|0|||
19435975|NCT02181803|41683074|FG007|Overall Study|Physician Decision|1|||
19435976|NCT02181803|41683075|FG008|Overall Study|Physician Decision|0|||
19435977|NCT02181803|41683067|FG000|Overall Study|Adverse Event|0|||
19435978|NCT02181803|41683068|FG001|Overall Study|Adverse Event|2|||
19435979|NCT02181803|41683069|FG002|Overall Study|Adverse Event|0|||
19435980|NCT02181803|41683070|FG003|Overall Study|Adverse Event|1|||
19435981|NCT02181803|41683071|FG004|Overall Study|Adverse Event|0|||
19435982|NCT02181803|41683072|FG005|Overall Study|Adverse Event|0|||
19435983|NCT02181803|41683073|FG006|Overall Study|Adverse Event|1|||
19435984|NCT02181803|41683074|FG007|Overall Study|Adverse Event|0|||
19435985|NCT02181803|41683075|FG008|Overall Study|Adverse Event|0|||
19435986|NCT01826487|41683122|FG000|Overall Study|Adverse Event|1|||
19435987|NCT01826487|41683123|FG001|Overall Study|Adverse Event|1|||
19435988|NCT01826487|41683122|FG000|Overall Study|Lost to Follow-up|1|||
19435989|NCT01826487|41683123|FG001|Overall Study|Lost to Follow-up|0|||
19435990|NCT01826487|41683122|FG000|Overall Study|Withdrawal by Subject|1|||
19435991|NCT01826487|41683123|FG001|Overall Study|Withdrawal by Subject|3|||
19435992|NCT01826487|41683122|FG000|Overall Study|Protocol Violation|1|||
19435993|NCT01826487|41683123|FG001|Overall Study|Protocol Violation|1|||
19435994|NCT02064439|41683133|FG000|Overall Study|Adverse Event|51|||
19435995|NCT02064439|41683134|FG001|Overall Study|Adverse Event|47|||
19435996|NCT02064439|41683135|FG002|Overall Study|Adverse Event|46|||
19435997|NCT02064439|41683133|FG000|Overall Study|Death|0|||
19435998|NCT02064439|41683134|FG001|Overall Study|Death|2|||
19435999|NCT02064439|41683135|FG002|Overall Study|Death|3|||
19436000|NCT02064439|41683133|FG000|Overall Study|Withdrawal by Subject|29|||
19436001|NCT02064439|41683134|FG001|Overall Study|Withdrawal by Subject|18|||
19436002|NCT02064439|41683135|FG002|Overall Study|Withdrawal by Subject|26|||
19436003|NCT02064439|41683133|FG000|Overall Study|Protocol Violation|3|||
19436004|NCT02064439|41683134|FG001|Overall Study|Protocol Violation|5|||
19436005|NCT02064439|41683135|FG002|Overall Study|Protocol Violation|3|||
19436006|NCT02064439|41683133|FG000|Overall Study|Lost to Follow-up|1|||
19436007|NCT02064439|41683134|FG001|Overall Study|Lost to Follow-up|3|||
19436008|NCT02064439|41683135|FG002|Overall Study|Lost to Follow-up|4|||
19436009|NCT02064439|41683133|FG000|Overall Study|Non-compliance with study medication|21|||
19436010|NCT02064439|41683134|FG001|Overall Study|Non-compliance with study medication|19|||
19436011|NCT02064439|41683135|FG002|Overall Study|Non-compliance with study medication|23|||
19436012|NCT02064439|41683133|FG000|Overall Study|Physician Decision|0|||
19436013|NCT02064439|41683134|FG001|Overall Study|Physician Decision|1|||
19436014|NCT02064439|41683135|FG002|Overall Study|Physician Decision|1|||
19436015|NCT02064439|41683133|FG000|Overall Study|Logistical difficulties|6|||
19436016|NCT02064439|41683134|FG001|Overall Study|Logistical difficulties|5|||
19436017|NCT02064439|41683135|FG002|Overall Study|Logistical difficulties|2|||
19436018|NCT02064439|41683133|FG000|Overall Study|Efficacy outcome reached|18|||
19436019|NCT02064439|41683134|FG001|Overall Study|Efficacy outcome reached|16|||
19436020|NCT02064439|41683135|FG002|Overall Study|Efficacy outcome reached|57|||
19436021|NCT02064439|41683133|FG000|Overall Study|Safety outcome reached|12|||
19436022|NCT02064439|41683134|FG001|Overall Study|Safety outcome reached|20|||
19436023|NCT02064439|41683135|FG002|Overall Study|Safety outcome reached|10|||
19436024|NCT02064439|41683133|FG000|Overall Study|Other|2|||
19436025|NCT02064439|41683134|FG001|Overall Study|Other|2|||
19436026|NCT02064439|41683135|FG002|Overall Study|Other|7|||
19436027|NCT02130557|41683145|FG000|Overall Study|Withdrawal by Subject|12|||
19436028|NCT02130557|41683146|FG001|Overall Study|Withdrawal by Subject|12|||
19436029|NCT02130557|41683145|FG000|Overall Study|Investigator Request|0|||
19436030|NCT02130557|41683146|FG001|Overall Study|Investigator Request|2|||
19436031|NCT02130557|41683145|FG000|Overall Study|Deceased|14|||
19436032|NCT02130557|41683146|FG001|Overall Study|Deceased|14|||
19436033|NCT02130557|41683145|FG000|Overall Study|Lost to Follow-up|6|||
19436034|NCT02130557|41683146|FG001|Overall Study|Lost to Follow-up|7|||
19436035|NCT02130557|41683145|FG000|Overall Study|Other|2|||
19711234|NCT00116649|42154369|FG000|Overall Study|Withdrawal by Subject|68|||
19711235|NCT00116649|42154369|FG000|Overall Study|Local Skin Reaction|9|||
19436036|NCT02130557|41683146|FG001|Overall Study|Other|1|||
19436037|NCT02130557|41683145|FG000|Overall Study|Missing|2|||
19436038|NCT02130557|41683146|FG001|Overall Study|Missing|1|||
19436039|NCT01854645|41683157|FG000|Overall Study|Protocol-Specified Criteria|13|||
19436040|NCT01854645|41683158|FG001|Overall Study|Protocol-Specified Criteria|10|||
19436041|NCT01854645|41683159|FG002|Overall Study|Protocol-Specified Criteria|8|||
19436042|NCT01854645|41683160|FG003|Overall Study|Protocol-Specified Criteria|5|||
19436043|NCT01854645|41683161|FG004|Overall Study|Protocol-Specified Criteria|7|||
19436044|NCT01854645|41683157|FG000|Overall Study|Administrative Reasons / Missing|0|||
19436045|NCT01854645|41683158|FG001|Overall Study|Administrative Reasons / Missing|0|||
19436046|NCT01854645|41683159|FG002|Overall Study|Administrative Reasons / Missing|0|||
19436047|NCT01854645|41683160|FG003|Overall Study|Administrative Reasons / Missing|1|||
19436048|NCT01854645|41683161|FG004|Overall Study|Administrative Reasons / Missing|1|||
19436049|NCT01854645|41683157|FG000|Overall Study|Protocol Violation|3|||
19436050|NCT01854645|41683158|FG001|Overall Study|Protocol Violation|0|||
19436051|NCT01854645|41683159|FG002|Overall Study|Protocol Violation|5|||
19436052|NCT01854645|41683160|FG003|Overall Study|Protocol Violation|4|||
19436053|NCT01854645|41683161|FG004|Overall Study|Protocol Violation|1|||
19436054|NCT01854645|41683157|FG000|Overall Study|Lost to Follow-up|10|||
19436055|NCT01854645|41683158|FG001|Overall Study|Lost to Follow-up|7|||
19436056|NCT01854645|41683159|FG002|Overall Study|Lost to Follow-up|8|||
19436057|NCT01854645|41683160|FG003|Overall Study|Lost to Follow-up|5|||
19436058|NCT01854645|41683161|FG004|Overall Study|Lost to Follow-up|0|||
19436059|NCT01854645|41683157|FG000|Overall Study|Physician Decision|1|||
19436060|NCT01854645|41683158|FG001|Overall Study|Physician Decision|5|||
19436061|NCT01854645|41683159|FG002|Overall Study|Physician Decision|3|||
19436062|NCT01854645|41683160|FG003|Overall Study|Physician Decision|3|||
19436063|NCT01854645|41683161|FG004|Overall Study|Physician Decision|7|||
19436064|NCT01854645|41683157|FG000|Overall Study|Withdrawal by Subject|31|||
19436065|NCT01854645|41683158|FG001|Overall Study|Withdrawal by Subject|41|||
19436066|NCT01854645|41683159|FG002|Overall Study|Withdrawal by Subject|30|||
19436067|NCT01854645|41683160|FG003|Overall Study|Withdrawal by Subject|21|||
19436068|NCT01854645|41683161|FG004|Overall Study|Withdrawal by Subject|24|||
19436069|NCT01854645|41683157|FG000|Overall Study|Lack of Efficacy|7|||
19436070|NCT01854645|41683158|FG001|Overall Study|Lack of Efficacy|12|||
19436071|NCT01854645|41683159|FG002|Overall Study|Lack of Efficacy|9|||
19436072|NCT01854645|41683160|FG003|Overall Study|Lack of Efficacy|3|||
19436073|NCT01854645|41683161|FG004|Overall Study|Lack of Efficacy|9|||
19436074|NCT01854645|41683157|FG000|Overall Study|Adverse Event|33|||
19436075|NCT01854645|41683158|FG001|Overall Study|Adverse Event|31|||
19436076|NCT01854645|41683159|FG002|Overall Study|Adverse Event|19|||
19436077|NCT01854645|41683160|FG003|Overall Study|Adverse Event|20|||
19436078|NCT01854645|41683161|FG004|Overall Study|Adverse Event|11|||
19436079|NCT01825941|41683175|FG000|Overall Study|Lost to Follow-up|4|||
19436080|NCT01825941|41683176|FG001|Overall Study|Lost to Follow-up|1|||
19436081|NCT02064205|41683182|FG000|Overall Study|Withdrawal by Subject|1|||
19436082|NCT02090959|41683198|FG000|Overall Study|Withdrawal by Subject|10|||
19436083|NCT02090959|41683198|FG000|Overall Study|Adverse Event|1|||
19436084|NCT02090959|41683198|FG000|Overall Study|Investigator decision|2|||
19436085|NCT02090959|41683198|FG000|Overall Study|Study termination|6|||
19436086|NCT02090959|41683198|FG000|Overall Study|Enrolled but not treated|1|||
19436087|NCT02090959|41683198|FG000|Overall Study|Transfer for compassionate use medicine|4|||
19436088|NCT02090959|41683198|FG000|Overall Study|Move to medical need program|3|||
19436089|NCT02090959|41683198|FG000|Overall Study|Entered in to other study|34|||
19436090|NCT02090959|41683198|FG000|Overall Study|Switched to commercial supply|88|||
19436091|NCT02090959|41683198|FG000|Overall Study|Other than specified|2|||
19436092|NCT02044159|41683204|FG000|Overall Study|Consent declined (deferred consent)|2|||
19436093|NCT02044159|41683205|FG001|Overall Study|Consent declined (deferred consent)|4|||
19436094|NCT02044159|41683204|FG000|Overall Study|No longer eligible, drug not given|1|||
19436095|NCT02044159|41683205|FG001|Overall Study|No longer eligible, drug not given|0|||
19436096|NCT02044159|41683204|FG000|Overall Study|Nurse declined to give study drug|1|||
19436097|NCT02044159|41683205|FG001|Overall Study|Nurse declined to give study drug|0|||
19436098|NCT02090725|41683214|FG000|Overall Study|Withdrawal by Subject|1|||
19436099|NCT02090725|41683214|FG000|Overall Study|participants moved from area|3|||
19436100|NCT02180165|41683222|FG000|Overall Study|Not Treated|0|||
19436101|NCT02180165|41683223|FG001|Overall Study|Not Treated|0|||
19436102|NCT02180165|41683224|FG002|Overall Study|Not Treated|1|||
19436103|NCT02180165|41683225|FG003|Overall Study|Not Treated|0|||
19436104|NCT02180165|41683222|FG000|Overall Study|Adverse Event|7|||
19436105|NCT02180165|41683223|FG001|Overall Study|Adverse Event|0|||
19436106|NCT02180165|41683224|FG002|Overall Study|Adverse Event|18|||
19436107|NCT02180165|41683225|FG003|Overall Study|Adverse Event|3|||
19436108|NCT02180165|41683222|FG000|Overall Study|Lack of Efficacy|0|||
19436109|NCT02180165|41683223|FG001|Overall Study|Lack of Efficacy|1|||
19436110|NCT02180165|41683224|FG002|Overall Study|Lack of Efficacy|3|||
19436111|NCT02180165|41683225|FG003|Overall Study|Lack of Efficacy|2|||
19436112|NCT02180165|41683222|FG000|Overall Study|Physician Decision|1|||
19436113|NCT02180165|41683223|FG001|Overall Study|Physician Decision|0|||
19436114|NCT02180165|41683224|FG002|Overall Study|Physician Decision|5|||
19436115|NCT02180165|41683225|FG003|Overall Study|Physician Decision|0|||
19436116|NCT02180165|41683222|FG000|Overall Study|Withdrawal by Subject|3|||
19436117|NCT02180165|41683223|FG001|Overall Study|Withdrawal by Subject|0|||
19436118|NCT02180165|41683224|FG002|Overall Study|Withdrawal by Subject|2|||
19436119|NCT02180165|41683225|FG003|Overall Study|Withdrawal by Subject|1|||
19436120|NCT02155985|41683240|FG000|Overall Study|Withdrawal by Subject|0|||
19436121|NCT02155985|41683241|FG001|Overall Study|Withdrawal by Subject|0|||
19436122|NCT02155985|41683242|FG002|Overall Study|Withdrawal by Subject|1|||
19436123|NCT02155985|41683240|FG000|Overall Study|Lost to Follow-up|1|||
19436124|NCT02155985|41683241|FG001|Overall Study|Lost to Follow-up|0|||
19436125|NCT02155985|41683242|FG002|Overall Study|Lost to Follow-up|0|||
19436126|NCT02155829|41683252|FG000|Overall Study|Adverse Event|1|||
19521879|NCT00988884|41935282|FG001|Overall Study|Lost to Follow-up|16|||
19436127|NCT02155829|41683253|FG001|Overall Study|Adverse Event|0|||
19436128|NCT02155829|41683252|FG000|Overall Study|Withdrawal by Subject|3|||
19436129|NCT02155829|41683253|FG001|Overall Study|Withdrawal by Subject|3|||
19436130|NCT02155829|41683252|FG000|Overall Study|Protocol Violation|2|||
19436131|NCT02155829|41683253|FG001|Overall Study|Protocol Violation|0|||
19436132|NCT02129777|41683265|FG000|Double-Blind Period|Adverse Event|0|||
19436133|NCT02129777|41683266|FG001|Double-Blind Period|Adverse Event|0|||
19436134|NCT02129777|41683267|FG002|Double-Blind Period|Adverse Event|0|||
19436135|NCT02129777|41683268|FG003|Double-Blind Period|Adverse Event|0|||
19436136|NCT02129777|41683269|FG004|Double-Blind Period|Adverse Event|1|||
19436137|NCT02129777|41683270|FG005|Double-Blind Period|Adverse Event|0|||
19436138|NCT02129777|41683271|FG006|Double-Blind Period|Adverse Event|0|||
19436139|NCT02129777|41683265|FG000|Double-Blind Period|Lost to Follow-up|1|||
19436140|NCT02129777|41683266|FG001|Double-Blind Period|Lost to Follow-up|1|||
19436141|NCT02129777|41683267|FG002|Double-Blind Period|Lost to Follow-up|1|||
19436142|NCT02129777|41683268|FG003|Double-Blind Period|Lost to Follow-up|2|||
19436143|NCT02129777|41683269|FG004|Double-Blind Period|Lost to Follow-up|0|||
19436144|NCT02129777|41683270|FG005|Double-Blind Period|Lost to Follow-up|0|||
19436145|NCT02129777|41683271|FG006|Double-Blind Period|Lost to Follow-up|0|||
19436146|NCT02129777|41683265|FG000|Double-Blind Period|Withdrawal by Subject|2|||
19436147|NCT02129777|41683266|FG001|Double-Blind Period|Withdrawal by Subject|4|||
19436148|NCT02129777|41683267|FG002|Double-Blind Period|Withdrawal by Subject|3|||
19436149|NCT02129777|41683268|FG003|Double-Blind Period|Withdrawal by Subject|2|||
19436150|NCT02129777|41683269|FG004|Double-Blind Period|Withdrawal by Subject|3|||
19436151|NCT02129777|41683270|FG005|Double-Blind Period|Withdrawal by Subject|0|||
19436152|NCT02129777|41683271|FG006|Double-Blind Period|Withdrawal by Subject|0|||
19436153|NCT02129777|41683265|FG000|Double-Blind Period|Pregnancy|0|||
19436154|NCT02129777|41683266|FG001|Double-Blind Period|Pregnancy|0|||
19436155|NCT02129777|41683267|FG002|Double-Blind Period|Pregnancy|0|||
19436156|NCT02129777|41683268|FG003|Double-Blind Period|Pregnancy|0|||
19436157|NCT02129777|41683269|FG004|Double-Blind Period|Pregnancy|1|||
19436158|NCT02129777|41683270|FG005|Double-Blind Period|Pregnancy|0|||
19436159|NCT02129777|41683271|FG006|Double-Blind Period|Pregnancy|0|||
19436160|NCT02129777|41683265|FG000|Double-Blind Period|Lack of Efficacy|3|||
19436161|NCT02129777|41683266|FG001|Double-Blind Period|Lack of Efficacy|1|||
19436162|NCT02129777|41683267|FG002|Double-Blind Period|Lack of Efficacy|0|||
19436163|NCT02129777|41683268|FG003|Double-Blind Period|Lack of Efficacy|3|||
19436164|NCT02129777|41683269|FG004|Double-Blind Period|Lack of Efficacy|2|||
19436165|NCT02129777|41683270|FG005|Double-Blind Period|Lack of Efficacy|0|||
19436166|NCT02129777|41683271|FG006|Double-Blind Period|Lack of Efficacy|0|||
19436167|NCT02129777|41683265|FG000|Double-Blind Period|Other|1|||
19436168|NCT02129777|41683266|FG001|Double-Blind Period|Other|2|||
19436169|NCT02129777|41683267|FG002|Double-Blind Period|Other|0|||
19436170|NCT02129777|41683268|FG003|Double-Blind Period|Other|0|||
19436171|NCT02129777|41683269|FG004|Double-Blind Period|Other|0|||
19436172|NCT02129777|41683270|FG005|Double-Blind Period|Other|0|||
19436173|NCT02129777|41683271|FG006|Double-Blind Period|Other|0|||
19436174|NCT02129777|41683265|FG000|Open-Label Period|Lack of Efficacy|0|||
19436175|NCT02129777|41683266|FG001|Open-Label Period|Lack of Efficacy|0|||
19436176|NCT02129777|41683267|FG002|Open-Label Period|Lack of Efficacy|0|||
19436177|NCT02129777|41683268|FG003|Open-Label Period|Lack of Efficacy|0|||
19436178|NCT02129777|41683269|FG004|Open-Label Period|Lack of Efficacy|0|||
19436179|NCT02129777|41683270|FG005|Open-Label Period|Lack of Efficacy|0|||
19436180|NCT02129777|41683271|FG006|Open-Label Period|Lack of Efficacy|5|||
19436181|NCT02129777|41683265|FG000|Open-Label Period|Lost to Follow-up|0|||
19436182|NCT02129777|41683266|FG001|Open-Label Period|Lost to Follow-up|0|||
19436183|NCT02129777|41683267|FG002|Open-Label Period|Lost to Follow-up|0|||
19436184|NCT02129777|41683268|FG003|Open-Label Period|Lost to Follow-up|0|||
19436185|NCT02129777|41683269|FG004|Open-Label Period|Lost to Follow-up|0|||
19436186|NCT02129777|41683270|FG005|Open-Label Period|Lost to Follow-up|1|||
19436187|NCT02129777|41683271|FG006|Open-Label Period|Lost to Follow-up|1|||
19436188|NCT02129777|41683265|FG000|Open-Label Period|Withdrawal by Subject|0|||
19436189|NCT02129777|41683266|FG001|Open-Label Period|Withdrawal by Subject|0|||
19436190|NCT02129777|41683267|FG002|Open-Label Period|Withdrawal by Subject|0|||
19436191|NCT02129777|41683268|FG003|Open-Label Period|Withdrawal by Subject|0|||
19436192|NCT02129777|41683269|FG004|Open-Label Period|Withdrawal by Subject|0|||
19436193|NCT02129777|41683270|FG005|Open-Label Period|Withdrawal by Subject|1|||
19436194|NCT02129777|41683271|FG006|Open-Label Period|Withdrawal by Subject|3|||
19436195|NCT02129777|41683265|FG000|Open-Label Period|Study Termination|0|||
19436196|NCT02129777|41683266|FG001|Open-Label Period|Study Termination|0|||
19436197|NCT02129777|41683267|FG002|Open-Label Period|Study Termination|0|||
19436198|NCT02129777|41683268|FG003|Open-Label Period|Study Termination|0|||
19436199|NCT02129777|41683269|FG004|Open-Label Period|Study Termination|0|||
19436200|NCT02129777|41683270|FG005|Open-Label Period|Study Termination|10|||
19436201|NCT02129777|41683271|FG006|Open-Label Period|Study Termination|39|||
19436202|NCT02178995|41683292|FG000|Double Blind|Adverse Event|0|||
19436203|NCT02178995|41683293|FG001|Double Blind|Adverse Event|0|||
19436204|NCT02178995|41683294|FG002|Double Blind|Adverse Event|0|||
19436205|NCT02178995|41683295|FG003|Double Blind|Adverse Event|0|||
19436206|NCT02178995|41683296|FG004|Double Blind|Adverse Event|0|||
19436207|NCT02178995|41683297|FG005|Double Blind|Adverse Event|1|||
19436208|NCT02178995|41683298|FG006|Double Blind|Adverse Event|0|||
19436209|NCT02178995|41683299|FG007|Double Blind|Adverse Event|1|||
19436210|NCT02178995|41683300|FG008|Double Blind|Adverse Event|1|||
19436211|NCT02178995|41683292|FG000|Double Blind|Lost to Follow-up|0|||
19436212|NCT02178995|41683293|FG001|Double Blind|Lost to Follow-up|1|||
19436213|NCT02178995|41683294|FG002|Double Blind|Lost to Follow-up|0|||
19436214|NCT02178995|41683295|FG003|Double Blind|Lost to Follow-up|0|||
19436215|NCT02178995|41683296|FG004|Double Blind|Lost to Follow-up|0|||
19436216|NCT02178995|41683297|FG005|Double Blind|Lost to Follow-up|0|||
19436217|NCT02178995|41683298|FG006|Double Blind|Lost to Follow-up|0|||
19436218|NCT02178995|41683299|FG007|Double Blind|Lost to Follow-up|1|||
19436219|NCT02178995|41683300|FG008|Double Blind|Lost to Follow-up|0|||
19436220|NCT02178995|41683292|FG000|Open Label|Adverse Event|2|||
19436221|NCT02178995|41683293|FG001|Open Label|Adverse Event|0|||
19436222|NCT02178995|41683294|FG002|Open Label|Adverse Event|0|||
19436223|NCT02178995|41683295|FG003|Open Label|Adverse Event|0|||
19436224|NCT02178995|41683296|FG004|Open Label|Adverse Event|0|||
19436225|NCT02178995|41683297|FG005|Open Label|Adverse Event|0|||
19436226|NCT02178995|41683298|FG006|Open Label|Adverse Event|0|||
19436227|NCT02178995|41683299|FG007|Open Label|Adverse Event|0|||
19436228|NCT02178995|41683300|FG008|Open Label|Adverse Event|0|||
19436229|NCT02128997|41683326|FG000|Overall Study|Lost to Follow-up|6|||
19436230|NCT02128997|41683327|FG001|Overall Study|Lost to Follow-up|11|||
19436231|NCT02155283|41683333|FG000|Overall Study|Lost to Follow-up|3|||
19436232|NCT02155283|41683333|FG000|Overall Study|Withdrawal by Subject|1|||
19436233|NCT02155283|41683333|FG000|Overall Study|Protocol Violation|3|||
19436234|NCT02154581|41683339|FG000|Overall Study|Lost to Follow-up|7|||
19436235|NCT02154581|41683340|FG001|Overall Study|Lost to Follow-up|8|||
19436236|NCT02154425|41683348|FG000|Screening Period|Adverse Event|1|||
19436237|NCT02154347|41683358|FG000|Double-blind Period|Adverse Event|1|||
19436238|NCT02154347|41683359|FG001|Double-blind Period|Adverse Event|2|||
19436239|NCT02154347|41683358|FG000|Double-blind Period|Lack of Efficacy|1|||
19436240|NCT02154347|41683359|FG001|Double-blind Period|Lack of Efficacy|0|||
19436241|NCT02154347|41683358|FG000|Double-blind Period|Physician Decision|0|||
19436242|NCT02154347|41683359|FG001|Double-blind Period|Physician Decision|1|||
19436243|NCT02154347|41683358|FG000|Double-blind Period|Withdrawal by Subject|1|||
19436244|NCT02154347|41683359|FG001|Double-blind Period|Withdrawal by Subject|1|||
19436245|NCT02154347|41683358|FG000|Open-label Period|Adverse Event|3|||
19436246|NCT02154347|41683359|FG001|Open-label Period|Adverse Event|4|||
19436247|NCT02154347|41683358|FG000|Open-label Period|Lack of Efficacy|4|||
19436248|NCT02154347|41683359|FG001|Open-label Period|Lack of Efficacy|19|||
19436249|NCT02154347|41683358|FG000|Open-label Period|Protocol Violation|0|||
19436250|NCT02154347|41683359|FG001|Open-label Period|Protocol Violation|1|||
19436251|NCT02154347|41683358|FG000|Open-label Period|Withdrawal by Subject|0|||
19436252|NCT02154347|41683359|FG001|Open-label Period|Withdrawal by Subject|1|||
19436253|NCT01627067|41683366|FG000|Overall Study|Screen Failure|1|||
19436254|NCT02178059|41683372|FG000|Washout|Physician Decision|1|||
19436255|NCT02178059|41683373|FG001|Washout|Physician Decision|0|||
19436256|NCT01626989|41683379|FG000|Screening Period|Screen Failure|15|||
19436257|NCT01626989|41683380|FG001|Screening Period|Screen Failure|0|||
19436258|NCT01626989|41683381|FG002|Screening Period|Screen Failure|0|||
19436259|NCT01626989|41683379|FG000|Screening Period|Withdrawal by Subject|2|||
19436260|NCT01626989|41683380|FG001|Screening Period|Withdrawal by Subject|0|||
19436261|NCT01626989|41683381|FG002|Screening Period|Withdrawal by Subject|0|||
19436262|NCT02128217|41683392|FG000|Overall Study|Lost to Follow-up|0|||
19436263|NCT02128217|41683393|FG001|Overall Study|Lost to Follow-up|1|||
19436264|NCT01629953|41683406|FG000|Overall Study|Death|3|||
19436265|NCT01629953|41683407|FG001|Overall Study|Death|1|||
19436266|NCT01629953|41683406|FG000|Overall Study|Lost to Follow-up|10|||
19436267|NCT01629953|41683407|FG001|Overall Study|Lost to Follow-up|14|||
19436268|NCT02127281|41683415|FG000|Overall Study|Lost to Follow-up|1|||
19436269|NCT02127281|41683416|FG001|Overall Study|Lost to Follow-up|0|||
19436270|NCT01628549|41683426|FG000|Overall Study|Adverse Event|1|||
19436271|NCT01628549|41683427|FG001|Overall Study|Adverse Event|1|||
19436272|NCT01628549|41683428|FG002|Overall Study|Adverse Event|0|||
19436273|NCT01628549|41683429|FG003|Overall Study|Adverse Event|4|||
19436274|NCT01628549|41683426|FG000|Overall Study|Lost to Follow-up|3|||
19436275|NCT01628549|41683427|FG001|Overall Study|Lost to Follow-up|4|||
19436276|NCT01628549|41683428|FG002|Overall Study|Lost to Follow-up|3|||
19436277|NCT01628549|41683429|FG003|Overall Study|Lost to Follow-up|3|||
19436278|NCT01628549|41683426|FG000|Overall Study|Withdrawal by Subject|3|||
19436279|NCT01628549|41683427|FG001|Overall Study|Withdrawal by Subject|4|||
19436280|NCT01628549|41683428|FG002|Overall Study|Withdrawal by Subject|4|||
19436281|NCT01628549|41683429|FG003|Overall Study|Withdrawal by Subject|1|||
19436282|NCT01628549|41683426|FG000|Overall Study|Protocol Violation|2|||
19436283|NCT01628549|41683427|FG001|Overall Study|Protocol Violation|1|||
19436284|NCT01628549|41683428|FG002|Overall Study|Protocol Violation|1|||
19436285|NCT01628549|41683429|FG003|Overall Study|Protocol Violation|0|||
19436286|NCT01628549|41683426|FG000|Overall Study|withdrawn for noncompliance|0|||
19436287|NCT01628549|41683427|FG001|Overall Study|withdrawn for noncompliance|2|||
19436288|NCT01628549|41683428|FG002|Overall Study|withdrawn for noncompliance|1|||
19436289|NCT01628549|41683429|FG003|Overall Study|withdrawn for noncompliance|0|||
19436290|NCT01628549|41683426|FG000|Overall Study|abnormal laboratory test results|0|||
19436291|NCT01628549|41683427|FG001|Overall Study|abnormal laboratory test results|0|||
19436292|NCT01628549|41683428|FG002|Overall Study|abnormal laboratory test results|1|||
19436293|NCT01628549|41683429|FG003|Overall Study|abnormal laboratory test results|0|||
19436294|NCT01628549|41683426|FG000|Overall Study|positive pregnancy test|0|||
19436295|NCT01628549|41683427|FG001|Overall Study|positive pregnancy test|0|||
19436296|NCT01628549|41683428|FG002|Overall Study|positive pregnancy test|0|||
19436297|NCT01628549|41683429|FG003|Overall Study|positive pregnancy test|1|||
19436298|NCT02127125|41683448|FG000|Overall Study|Lost to Follow-up|0|||
19436299|NCT02127125|41683449|FG001|Overall Study|Lost to Follow-up|0|||
19436300|NCT02127125|41683450|FG002|Overall Study|Lost to Follow-up|0|||
19436301|NCT02127125|41683451|FG003|Overall Study|Lost to Follow-up|0|||
19436302|NCT02127125|41683452|FG004|Overall Study|Lost to Follow-up|2|||
19436303|NCT02127125|41683453|FG005|Overall Study|Lost to Follow-up|1|||
19436304|NCT02127125|41683454|FG006|Overall Study|Lost to Follow-up|0|||
19436305|NCT02127125|41683455|FG007|Overall Study|Lost to Follow-up|0|||
19436306|NCT02127125|41683456|FG008|Overall Study|Lost to Follow-up|0|||
19436307|NCT02127125|41683448|FG000|Overall Study|Withdrawal by Subject|0|||
19436308|NCT02127125|41683449|FG001|Overall Study|Withdrawal by Subject|0|||
19436309|NCT02127125|41683450|FG002|Overall Study|Withdrawal by Subject|0|||
19436310|NCT02127125|41683451|FG003|Overall Study|Withdrawal by Subject|1|||
19436311|NCT02127125|41683452|FG004|Overall Study|Withdrawal by Subject|0|||
19436312|NCT02127125|41683453|FG005|Overall Study|Withdrawal by Subject|0|||
19436313|NCT02127125|41683454|FG006|Overall Study|Withdrawal by Subject|0|||
19436314|NCT02127125|41683455|FG007|Overall Study|Withdrawal by Subject|0|||
19436315|NCT02127125|41683456|FG008|Overall Study|Withdrawal by Subject|0|||
19436316|NCT02127125|41683448|FG000|Overall Study|Physician Decision|0|||
19436317|NCT02127125|41683449|FG001|Overall Study|Physician Decision|0|||
19436318|NCT02127125|41683450|FG002|Overall Study|Physician Decision|1|||
19436319|NCT02127125|41683451|FG003|Overall Study|Physician Decision|0|||
19436320|NCT02127125|41683452|FG004|Overall Study|Physician Decision|1|||
19436321|NCT02127125|41683453|FG005|Overall Study|Physician Decision|2|||
19436322|NCT02127125|41683454|FG006|Overall Study|Physician Decision|0|||
19436323|NCT02127125|41683455|FG007|Overall Study|Physician Decision|0|||
19436324|NCT02127125|41683456|FG008|Overall Study|Physician Decision|0|||
19436325|NCT02090413|41683479|FG000|Overall Study|Adverse Event|11|||
19436326|NCT02090413|41683480|FG001|Overall Study|Adverse Event|15|||
19436327|NCT02090413|41683481|FG002|Overall Study|Adverse Event|20|||
19436328|NCT02090413|41683479|FG000|Overall Study|Flushing event|2|||
19436329|NCT02090413|41683480|FG001|Overall Study|Flushing event|0|||
19436330|NCT02090413|41683481|FG002|Overall Study|Flushing event|1|||
19436331|NCT02090413|41683479|FG000|Overall Study|Withdrawal by Subject|2|||
19436332|NCT02090413|41683480|FG001|Overall Study|Withdrawal by Subject|2|||
19436333|NCT02090413|41683481|FG002|Overall Study|Withdrawal by Subject|2|||
19436334|NCT02090413|41683479|FG000|Overall Study|Investigator Decision|1|||
19436335|NCT02090413|41683480|FG001|Overall Study|Investigator Decision|1|||
19436336|NCT02090413|41683481|FG002|Overall Study|Investigator Decision|0|||
19436337|NCT02090413|41683479|FG000|Overall Study|Other|2|||
19436338|NCT02090413|41683480|FG001|Overall Study|Other|1|||
19436339|NCT02090413|41683481|FG002|Overall Study|Other|0|||
19436340|NCT02090413|41683479|FG000|Overall Study|Lost to Follow-up|1|||
19436341|NCT02090413|41683480|FG001|Overall Study|Lost to Follow-up|1|||
19436342|NCT02090413|41683481|FG002|Overall Study|Lost to Follow-up|0|||
19436343|NCT02063737|41683492|FG000|Overall Study|Lost to Follow-up|11|||
19436344|NCT02063737|41683493|FG001|Overall Study|Lost to Follow-up|4|||
19436345|NCT02125877|41683501|FG000|Overall Study|Physician Decision|1|||
19436346|NCT02125877|41683502|FG001|Overall Study|Physician Decision|0|||
19436347|NCT02125877|41683501|FG000|Overall Study|Death|0|||
19436348|NCT02125877|41683502|FG001|Overall Study|Death|1|||
19436349|NCT02125877|41683501|FG000|Overall Study|Administrative problems|0|||
19436350|NCT02125877|41683502|FG001|Overall Study|Administrative problems|1|||
19436351|NCT02125877|41683501|FG000|Overall Study|Participant/guardian decision|0|||
19436352|NCT02125877|41683502|FG001|Overall Study|Participant/guardian decision|2|||
19436353|NCT02125877|41683501|FG000|Overall Study|Withdrawal by Subject|2|||
19436354|NCT02125877|41683502|FG001|Overall Study|Withdrawal by Subject|1|||
19436355|NCT02125877|41683501|FG000|Overall Study|Protocol deviation|4|||
19436356|NCT02125877|41683502|FG001|Overall Study|Protocol deviation|1|||
19436357|NCT02125877|41683501|FG000|Overall Study|Adverse Event|6|||
19436358|NCT02125877|41683502|FG001|Overall Study|Adverse Event|4|||
19436359|NCT01598987|41683508|FG000|Baseline to Month 12|Administrative problems|2|||
19436360|NCT01598987|41683508|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
19436361|NCT01598987|41683508|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
19436362|NCT01598987|41683508|FG000|Baseline to 24 Month|Administrative problems|2|||
19436363|NCT01598987|41683508|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
19436364|NCT02063659|41683522|FG000|Double-Blind Treatment Period|Adverse Event|1|||
19436365|NCT02063659|41683523|FG001|Double-Blind Treatment Period|Adverse Event|2|||
19436366|NCT02063659|41683524|FG002|Double-Blind Treatment Period|Adverse Event|0|||
19436367|NCT02063659|41683525|FG003|Double-Blind Treatment Period|Adverse Event|0|||
19436368|NCT02063659|41683522|FG000|Double-Blind Treatment Period|Physician Decision|1|||
19436369|NCT02063659|41683523|FG001|Double-Blind Treatment Period|Physician Decision|0|||
19436370|NCT02063659|41683524|FG002|Double-Blind Treatment Period|Physician Decision|0|||
19436371|NCT02063659|41683525|FG003|Double-Blind Treatment Period|Physician Decision|0|||
19436372|NCT02063659|41683522|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
19436373|NCT02063659|41683523|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
19436374|NCT02063659|41683524|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
19436375|NCT02063659|41683525|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
19436376|NCT02063659|41683522|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
19436377|NCT02063659|41683523|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
19436378|NCT02063659|41683524|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
19436379|NCT02063659|41683525|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
19436380|NCT02063659|41683522|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19436381|NCT02063659|41683523|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19436382|NCT02063659|41683524|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
19436383|NCT02063659|41683525|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
19436384|NCT02063659|41683522|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19436385|NCT02063659|41683523|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19436386|NCT02063659|41683524|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
19436387|NCT02063659|41683525|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
19436388|NCT02063659|41683522|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
19436389|NCT02063659|41683523|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
19436390|NCT02063659|41683524|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
19436391|NCT02063659|41683525|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
19436392|NCT02063659|41683522|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19436393|NCT02063659|41683523|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19436394|NCT02063659|41683524|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
19436395|NCT02063659|41683525|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
19436396|NCT02062879|41683541|FG000|Overall Study|Withdrawal by Subject|4|||
19436397|NCT02062879|41683542|FG001|Overall Study|Withdrawal by Subject|1|||
19436398|NCT02062645|41683548|FG000|Overall Study|Adverse Event|2|||
19436399|NCT02062645|41683548|FG000|Overall Study|Protocol Violation|8|||
19436400|NCT02062645|41683548|FG000|Overall Study|Lost to Follow-up|5|||
19436401|NCT02088697|41683554|FG000|Period I|Physician Decision|1|||
19436402|NCT02088697|41683555|FG001|Period I|Physician Decision|4|||
19436403|NCT02088697|41683554|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
19436404|NCT02088697|41683555|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
19436405|NCT01825785|41683568|FG000|Overall Study|Adverse Event|0|||
19436406|NCT01825785|41683569|FG001|Overall Study|Adverse Event|0|||
19436407|NCT01825785|41683570|FG002|Overall Study|Adverse Event|0|||
19436408|NCT01825785|41683571|FG003|Overall Study|Adverse Event|0|||
19436409|NCT01825785|41683572|FG004|Overall Study|Adverse Event|1|||
19436410|NCT01825785|41683573|FG005|Overall Study|Adverse Event|0|||
19436411|NCT01825785|41683574|FG006|Overall Study|Adverse Event|0|||
19436412|NCT01825785|41683568|FG000|Overall Study|Withdrawal by Subject|0|||
19436413|NCT01825785|41683569|FG001|Overall Study|Withdrawal by Subject|0|||
19436414|NCT01825785|41683570|FG002|Overall Study|Withdrawal by Subject|0|||
19436415|NCT01825785|41683571|FG003|Overall Study|Withdrawal by Subject|0|||
19436416|NCT01825785|41683572|FG004|Overall Study|Withdrawal by Subject|1|||
19436417|NCT01825785|41683573|FG005|Overall Study|Withdrawal by Subject|1|||
19436418|NCT01825785|41683574|FG006|Overall Study|Withdrawal by Subject|0|||
19436419|NCT02043301|41683599|FG000|Overall Study|Discontinued|0|||
19436420|NCT02043301|41683600|FG001|Overall Study|Discontinued|1|||
19436421|NCT02043301|41683601|FG002|Overall Study|Discontinued|0|||
19436422|NCT01598753|41683613|FG000|Overall Study|Adverse Event|1|||
19436423|NCT01598753|41683614|FG001|Overall Study|Adverse Event|9|||
19436424|NCT01598753|41683615|FG002|Overall Study|Adverse Event|1|||
19436425|NCT01598753|41683616|FG003|Overall Study|Adverse Event|7|||
19436426|NCT01598753|41683613|FG000|Overall Study|Lost to Follow-up|4|||
19436427|NCT01598753|41683614|FG001|Overall Study|Lost to Follow-up|3|||
19436428|NCT01598753|41683615|FG002|Overall Study|Lost to Follow-up|7|||
19436429|NCT01598753|41683616|FG003|Overall Study|Lost to Follow-up|5|||
19436430|NCT01598753|41683613|FG000|Overall Study|Physician Decision|0|||
19436431|NCT01598753|41683614|FG001|Overall Study|Physician Decision|1|||
19436432|NCT01598753|41683615|FG002|Overall Study|Physician Decision|0|||
19436433|NCT01598753|41683616|FG003|Overall Study|Physician Decision|2|||
19436434|NCT01598753|41683613|FG000|Overall Study|Withdrawal by Subject|7|||
19436435|NCT01598753|41683614|FG001|Overall Study|Withdrawal by Subject|2|||
19436436|NCT01598753|41683615|FG002|Overall Study|Withdrawal by Subject|0|||
19521880|NCT00988884|41935281|FG000|Overall Study|Protocol Violation|0|||
19436437|NCT01598753|41683616|FG003|Overall Study|Withdrawal by Subject|1|||
19436438|NCT02177123|41683626|FG000|Overall Study|Lost to Follow-up|6|||
19436439|NCT02177123|41683626|FG000|Overall Study|Withdrawal by Subject|4|||
19436440|NCT02177123|41683626|FG000|Overall Study|Adverse Event|4|||
19436441|NCT02177123|41683626|FG000|Overall Study|Physician Decision|3|||
19436442|NCT02177123|41683626|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
19436443|NCT02177123|41683626|FG000|Overall Study|Excluded for medical reasons|2|||
19436444|NCT02177123|41683626|FG000|Overall Study|Death|1|||
19436445|NCT02177123|41683626|FG000|Overall Study|Other|1|||
19436446|NCT02177123|41683626|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
19436447|NCT01824693|41683636|FG000|Overall Study|Death|0|||
19436448|NCT01824693|41683637|FG001|Overall Study|Death|1|||
19436449|NCT01824693|41683638|FG002|Overall Study|Death|0|||
19436450|NCT01824693|41683636|FG000|Overall Study|Physician Decision|1|||
19436451|NCT01824693|41683637|FG001|Overall Study|Physician Decision|1|||
19436452|NCT01824693|41683638|FG002|Overall Study|Physician Decision|1|||
19436453|NCT01824693|41683636|FG000|Overall Study|Withdrawal by Subject|0|||
19436454|NCT01824693|41683637|FG001|Overall Study|Withdrawal by Subject|0|||
19436455|NCT01824693|41683638|FG002|Overall Study|Withdrawal by Subject|1|||
19436456|NCT01824693|41683636|FG000|Overall Study|Progressive Disease|0|||
19436457|NCT01824693|41683637|FG001|Overall Study|Progressive Disease|5|||
19436458|NCT01824693|41683638|FG002|Overall Study|Progressive Disease|0|||
19436459|NCT01824693|41683636|FG000|Overall Study|Ineligible|0|||
19436460|NCT01824693|41683637|FG001|Overall Study|Ineligible|0|||
19436461|NCT01824693|41683638|FG002|Overall Study|Ineligible|3|||
19436462|NCT01824693|41683636|FG000|Overall Study|No Transplant Planned|0|||
19436463|NCT01824693|41683637|FG001|Overall Study|No Transplant Planned|0|||
19436464|NCT01824693|41683638|FG002|Overall Study|No Transplant Planned|10|||
19436465|NCT02176655|41683645|FG000|Overall Study|Subjects did not treat|6|||
19436466|NCT02125331|41683652|FG000|Overall Study|Protocol Violation|1|||
19436467|NCT02125331|41683653|FG001|Overall Study|Protocol Violation|0|||
19436468|NCT02125331|41683652|FG000|Overall Study|technical problem|2|||
19436469|NCT02125331|41683653|FG001|Overall Study|technical problem|0|||
19436470|NCT02125331|41683652|FG000|Overall Study|screen failure|2|||
19436471|NCT02125331|41683653|FG001|Overall Study|screen failure|0|||
19436472|NCT01853475|41683662|FG000|Overall Study|Withdrawal by Subject|0|||
19436473|NCT01853475|41683663|FG001|Overall Study|Withdrawal by Subject|1|||
19436474|NCT01853475|41683664|FG002|Overall Study|Withdrawal by Subject|0|||
19436475|NCT01622569|41683676|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
19436476|NCT01622569|41683677|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
19436477|NCT01622569|41683678|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
19436478|NCT01622569|41683679|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
19436479|NCT01622569|41683676|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
19436480|NCT01622569|41683677|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
19436481|NCT01622569|41683678|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
19436482|NCT01622569|41683679|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
19436483|NCT01622569|41683676|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
19436484|NCT01622569|41683677|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
19436485|NCT01622569|41683678|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
19436486|NCT01622569|41683679|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
19436487|NCT01622569|41683676|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
19436488|NCT01622569|41683677|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
19436489|NCT01622569|41683678|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
19436490|NCT01622569|41683679|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
19436491|NCT01622569|41683676|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
19436492|NCT01622569|41683677|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
19436493|NCT01622569|41683678|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
19436494|NCT01622569|41683679|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
19436495|NCT01622569|41683676|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
19436496|NCT01622569|41683677|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
19436497|NCT01622569|41683678|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
19436498|NCT01622569|41683679|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
19436499|NCT01622569|41683676|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
19436500|NCT01622569|41683677|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
19436501|NCT01622569|41683678|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
19436502|NCT01622569|41683679|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
19436503|NCT01622569|41683676|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19436504|NCT01622569|41683677|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19436505|NCT01622569|41683678|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
19436506|NCT01622569|41683679|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
19436507|NCT01824303|41683701|FG000|Randomized Study|Withdrawal by Subject|1|||
19436508|NCT01824303|41683702|FG001|Randomized Study|Withdrawal by Subject|1|||
19436509|NCT01824303|41683701|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
19436510|NCT01824303|41683702|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
19436511|NCT01853397|41683714|FG000|Overall Study|Withdrawal by Subject|0|||
19436512|NCT01853397|41683715|FG001|Overall Study|Withdrawal by Subject|0|||
19436513|NCT01853397|41683716|FG002|Overall Study|Withdrawal by Subject|0|||
19436514|NCT01853397|41683717|FG003|Overall Study|Withdrawal by Subject|1|||
19436515|NCT01853397|41683714|FG000|Overall Study|Subject Noncompliance|0|||
19436516|NCT01853397|41683715|FG001|Overall Study|Subject Noncompliance|0|||
19436517|NCT01853397|41683716|FG002|Overall Study|Subject Noncompliance|0|||
19436518|NCT01853397|41683717|FG003|Overall Study|Subject Noncompliance|1|||
19436519|NCT02088073|41683732|FG000|Acute Phase|Withdrawal by Subject|5|||
19436520|NCT02088073|41683733|FG001|Acute Phase|Withdrawal by Subject|0|||
19436521|NCT02088073|41683734|FG002|Acute Phase|Withdrawal by Subject|0|||
19436522|NCT02088073|41683735|FG003|Acute Phase|Withdrawal by Subject|0|||
19436523|NCT02088073|41683736|FG004|Acute Phase|Withdrawal by Subject|0|||
19436524|NCT02088073|41683732|FG000|Acute Phase|Hyperkalemia|2|||
19436525|NCT02088073|41683733|FG001|Acute Phase|Hyperkalemia|0|||
19436526|NCT02088073|41683734|FG002|Acute Phase|Hyperkalemia|0|||
19436527|NCT02088073|41683735|FG003|Acute Phase|Hyperkalemia|0|||
19436528|NCT02088073|41683736|FG004|Acute Phase|Hyperkalemia|0|||
19436529|NCT02088073|41683732|FG000|Maintanance Phase|Withdrawal by Subject|0|||
19436530|NCT02088073|41683733|FG001|Maintanance Phase|Withdrawal by Subject|2|||
19436531|NCT02088073|41683734|FG002|Maintanance Phase|Withdrawal by Subject|0|||
19436532|NCT02088073|41683735|FG003|Maintanance Phase|Withdrawal by Subject|0|||
19436533|NCT02088073|41683736|FG004|Maintanance Phase|Withdrawal by Subject|0|||
19436534|NCT02088073|41683732|FG000|Maintanance Phase|Adverse Event|0|||
19436535|NCT02088073|41683733|FG001|Maintanance Phase|Adverse Event|0|||
19436536|NCT02088073|41683734|FG002|Maintanance Phase|Adverse Event|3|||
19436537|NCT02088073|41683735|FG003|Maintanance Phase|Adverse Event|0|||
19436538|NCT02088073|41683736|FG004|Maintanance Phase|Adverse Event|1|||
19436539|NCT02088073|41683732|FG000|Maintanance Phase|Physician Decision|0|||
19436540|NCT02088073|41683733|FG001|Maintanance Phase|Physician Decision|0|||
19436541|NCT02088073|41683734|FG002|Maintanance Phase|Physician Decision|0|||
19436542|NCT02088073|41683735|FG003|Maintanance Phase|Physician Decision|0|||
19436543|NCT02088073|41683736|FG004|Maintanance Phase|Physician Decision|1|||
19436544|NCT02088073|41683732|FG000|Maintanance Phase|Sponsor's decision|0|||
19436545|NCT02088073|41683733|FG001|Maintanance Phase|Sponsor's decision|2|||
19436546|NCT02088073|41683734|FG002|Maintanance Phase|Sponsor's decision|0|||
19436547|NCT02088073|41683735|FG003|Maintanance Phase|Sponsor's decision|2|||
19436548|NCT02088073|41683736|FG004|Maintanance Phase|Sponsor's decision|1|||
19436549|NCT02088073|41683732|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
19436550|NCT02088073|41683733|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
19436551|NCT02088073|41683734|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
19436552|NCT02088073|41683735|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
19436553|NCT02088073|41683736|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
19436554|NCT02088073|41683732|FG000|Maintanance Phase|Miscellaneous|0|||
19436555|NCT02088073|41683733|FG001|Maintanance Phase|Miscellaneous|2|||
19436556|NCT02088073|41683734|FG002|Maintanance Phase|Miscellaneous|1|||
19436557|NCT02088073|41683735|FG003|Maintanance Phase|Miscellaneous|2|||
19436558|NCT02088073|41683736|FG004|Maintanance Phase|Miscellaneous|1|||
19436559|NCT02088073|41683732|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
19436560|NCT02088073|41683733|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
19436561|NCT02088073|41683734|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
19436562|NCT02088073|41683735|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
19436563|NCT02088073|41683736|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
19436564|NCT02088073|41683732|FG000|Maintanance Phase|Subject compliance|0|||
19436565|NCT02088073|41683733|FG001|Maintanance Phase|Subject compliance|1|||
19436566|NCT02088073|41683734|FG002|Maintanance Phase|Subject compliance|0|||
19436567|NCT02088073|41683735|FG003|Maintanance Phase|Subject compliance|0|||
19436568|NCT02088073|41683736|FG004|Maintanance Phase|Subject compliance|0|||
19436569|NCT01823991|41683751|FG000|Overall Study|Withdrawal by Subject|8|||
19436570|NCT01823991|41683752|FG001|Overall Study|Withdrawal by Subject|5|||
19436571|NCT02087059|41683762|FG000|Overall Study|Disease Progression|1|||
19436572|NCT02087059|41683762|FG000|Overall Study|Adverse Event|5|||
19436573|NCT02087059|41683762|FG000|Overall Study|Lost to Follow-up|1|||
19436574|NCT02152631|41683768|FG000|Overall Study|Adverse Event|32|||
19436575|NCT02152631|41683769|FG001|Overall Study|Adverse Event|4|||
19436576|NCT02152631|41683768|FG000|Overall Study|Withdrawal by Subject|13|||
19436577|NCT02152631|41683769|FG001|Overall Study|Withdrawal by Subject|16|||
19436578|NCT02152631|41683768|FG000|Overall Study|Noncompliance with study drug|1|||
19436579|NCT02152631|41683769|FG001|Overall Study|Noncompliance with study drug|0|||
19436580|NCT02152631|41683768|FG000|Overall Study|Physician Decision|1|||
19436581|NCT02152631|41683769|FG001|Overall Study|Physician Decision|2|||
19436582|NCT02152631|41683768|FG000|Overall Study|Lost to Follow-up|0|||
19436583|NCT02152631|41683769|FG001|Overall Study|Lost to Follow-up|1|||
19436584|NCT02152631|41683768|FG000|Overall Study|On Treatment|19|||
19436585|NCT02152631|41683769|FG001|Overall Study|On Treatment|3|||
19436586|NCT02152163|41683777|FG000|Overall Study|Physician Decision|12|||
19436587|NCT02152163|41683778|FG001|Overall Study|Physician Decision|13|||
19436588|NCT02152007|41683784|FG000|Overall Study|Withdrawal by Subject|1|||
19436589|NCT02151851|41683791|FG000|Overall Study|Lack of Efficacy|67|||
19436590|NCT02151851|41683792|FG001|Overall Study|Lack of Efficacy|94|||
19436591|NCT02151851|41683791|FG000|Overall Study|Protocol Violation|0|||
19436592|NCT02151851|41683792|FG001|Overall Study|Protocol Violation|1|||
19436593|NCT02151851|41683791|FG000|Overall Study|Withdrawal by Subject|2|||
19436594|NCT02151851|41683792|FG001|Overall Study|Withdrawal by Subject|5|||
19436595|NCT02151851|41683791|FG000|Overall Study|Medical impairment|1|||
19436596|NCT02151851|41683792|FG001|Overall Study|Medical impairment|0|||
19436597|NCT02151851|41683791|FG000|Overall Study|Low compliance to study visits|0|||
19436598|NCT02151851|41683792|FG001|Overall Study|Low compliance to study visits|1|||
19436599|NCT02151851|41683791|FG000|Overall Study|Subject entered into study in error|0|||
19436600|NCT02151851|41683792|FG001|Overall Study|Subject entered into study in error|1|||
19436601|NCT02151851|41683791|FG000|Overall Study|Adverse Event|6|||
19436602|NCT02151851|41683792|FG001|Overall Study|Adverse Event|28|||
19436603|NCT02176421|41683798|FG000|Overall Study|Lost to Follow-up|4|||
19436604|NCT02176421|41683798|FG000|Overall Study|Adverse Event|1|||
19436605|NCT02042443|41683804|FG000|Overall Study|Adverse Event|2|||
19436606|NCT02042443|41683805|FG001|Overall Study|Adverse Event|1|||
19436607|NCT02042443|41683804|FG000|Overall Study|Withdrawal by Subject|0|||
19436608|NCT02042443|41683805|FG001|Overall Study|Withdrawal by Subject|1|||
19436609|NCT02042443|41683804|FG000|Overall Study|Progression|21|||
19436610|NCT02042443|41683805|FG001|Overall Study|Progression|17|||
19436611|NCT02042443|41683804|FG000|Overall Study|not protocol specified|1|||
19436612|NCT02042443|41683805|FG001|Overall Study|not protocol specified|1|||
19436613|NCT02042443|41683804|FG000|Overall Study|Not eligible/not analyzable|3|||
19436614|NCT02042443|41683805|FG001|Overall Study|Not eligible/not analyzable|6|||
19436615|NCT02118896|41683822|FG000|Overall Study|Death|4|||
19436616|NCT02118896|41683823|FG001|Overall Study|Death|0|||
19436617|NCT02118896|41683824|FG002|Overall Study|Death|4|||
19436618|NCT02118896|41683825|FG003|Overall Study|Death|6|||
19521881|NCT00988884|41935282|FG001|Overall Study|Protocol Violation|1|||
19521882|NCT00988884|41935281|FG000|Overall Study|Withdrawal by Subject|15|||
19521883|NCT00988884|41935282|FG001|Overall Study|Withdrawal by Subject|18|||
19521884|NCT00631020|41935288|FG000|Overall Study|Lost to Follow-up|7|||
19521885|NCT00631020|41935288|FG000|Overall Study|Incarcerated|1|||
19521886|NCT00987402|41935294|FG000|Overall Study|Insufficient data entry|86|||
19521887|NCT00987402|41935295|FG001|Overall Study|Insufficient data entry|98|||
19521888|NCT00630864|41935301|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
19521889|NCT00630864|41935301|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
19521890|NCT00630786|41935308|FG000|Overall Study|Physician Decision|0|||
19521891|NCT00630786|41935309|FG001|Overall Study|Physician Decision|0|||
19521892|NCT00630786|41935310|FG002|Overall Study|Physician Decision|1|||
19521893|NCT00630786|41935308|FG000|Overall Study|Withdrawal by Subject|0|||
19521894|NCT00630786|41935309|FG001|Overall Study|Withdrawal by Subject|1|||
19521895|NCT00630786|41935310|FG002|Overall Study|Withdrawal by Subject|1|||
19436619|NCT02118896|41683826|FG004|Overall Study|Death|3|||
19436620|NCT02118896|41683827|FG005|Overall Study|Death|1|||
19436621|NCT02118896|41683828|FG006|Overall Study|Death|0|||
19436622|NCT02118896|41683829|FG007|Overall Study|Death|0|||
19436623|NCT02118896|41683830|FG008|Overall Study|Death|0|||
19436624|NCT02118896|41683831|FG009|Overall Study|Death|0|||
19436625|NCT02118896|41683822|FG000|Overall Study|Adverse Event|5|||
19436626|NCT02118896|41683823|FG001|Overall Study|Adverse Event|4|||
19436627|NCT02118896|41683824|FG002|Overall Study|Adverse Event|4|||
19436628|NCT02118896|41683825|FG003|Overall Study|Adverse Event|5|||
19436629|NCT02118896|41683826|FG004|Overall Study|Adverse Event|5|||
19436630|NCT02118896|41683827|FG005|Overall Study|Adverse Event|9|||
19436631|NCT02118896|41683828|FG006|Overall Study|Adverse Event|1|||
19436632|NCT02118896|41683829|FG007|Overall Study|Adverse Event|1|||
19436633|NCT02118896|41683830|FG008|Overall Study|Adverse Event|4|||
19521896|NCT00630786|41935308|FG000|Overall Study|Lost to Follow-up|0|||
19521897|NCT00630786|41935309|FG001|Overall Study|Lost to Follow-up|1|||
19521898|NCT00630786|41935310|FG002|Overall Study|Lost to Follow-up|0|||
19521899|NCT00630786|41935308|FG000|Overall Study|Other|1|||
19521900|NCT00630786|41935309|FG001|Overall Study|Other|0|||
19521901|NCT00630786|41935310|FG002|Overall Study|Other|0|||
19521902|NCT00630396|41935316|FG000|Overall Study|Death|4|||
19521903|NCT00630396|41935316|FG000|Overall Study|Lost to Follow-up|3|||
19521904|NCT00985686|41935324|FG000|Overall Study|Lost to Follow-up|1|||
19521905|NCT00985686|41935325|FG001|Overall Study|Lost to Follow-up|1|||
19521906|NCT00985686|41935326|FG002|Overall Study|Lost to Follow-up|0|||
19436634|NCT02118896|41683831|FG009|Overall Study|Adverse Event|0|||
19436635|NCT02118896|41683822|FG000|Overall Study|Consent withdrawn|2|||
19436636|NCT02118896|41683823|FG001|Overall Study|Consent withdrawn|0|||
19436637|NCT02118896|41683824|FG002|Overall Study|Consent withdrawn|3|||
19436638|NCT02118896|41683825|FG003|Overall Study|Consent withdrawn|4|||
19436639|NCT02118896|41683826|FG004|Overall Study|Consent withdrawn|1|||
19436640|NCT02118896|41683827|FG005|Overall Study|Consent withdrawn|4|||
19436641|NCT02118896|41683828|FG006|Overall Study|Consent withdrawn|0|||
19436642|NCT02118896|41683829|FG007|Overall Study|Consent withdrawn|0|||
19436643|NCT02118896|41683830|FG008|Overall Study|Consent withdrawn|0|||
19436644|NCT02118896|41683831|FG009|Overall Study|Consent withdrawn|0|||
19436645|NCT02118896|41683822|FG000|Overall Study|Non-compliance|2|||
19436646|NCT02118896|41683823|FG001|Overall Study|Non-compliance|1|||
19436647|NCT02118896|41683824|FG002|Overall Study|Non-compliance|1|||
19436648|NCT02118896|41683825|FG003|Overall Study|Non-compliance|5|||
19436649|NCT02118896|41683826|FG004|Overall Study|Non-compliance|0|||
19436650|NCT02118896|41683827|FG005|Overall Study|Non-compliance|1|||
19436651|NCT02118896|41683828|FG006|Overall Study|Non-compliance|0|||
19436652|NCT02118896|41683829|FG007|Overall Study|Non-compliance|1|||
19436653|NCT02118896|41683830|FG008|Overall Study|Non-compliance|0|||
19436654|NCT02118896|41683831|FG009|Overall Study|Non-compliance|0|||
19436655|NCT02118896|41683822|FG000|Overall Study|Pregnancy|1|||
19436656|NCT02118896|41683823|FG001|Overall Study|Pregnancy|1|||
19436657|NCT02118896|41683824|FG002|Overall Study|Pregnancy|0|||
19436658|NCT02118896|41683825|FG003|Overall Study|Pregnancy|0|||
19436659|NCT02118896|41683826|FG004|Overall Study|Pregnancy|1|||
19436660|NCT02118896|41683827|FG005|Overall Study|Pregnancy|3|||
19436661|NCT02118896|41683828|FG006|Overall Study|Pregnancy|1|||
19436662|NCT02118896|41683829|FG007|Overall Study|Pregnancy|0|||
19436663|NCT02118896|41683830|FG008|Overall Study|Pregnancy|0|||
19436664|NCT02118896|41683831|FG009|Overall Study|Pregnancy|0|||
19436665|NCT02118896|41683822|FG000|Overall Study|Lost to Follow-up|1|||
19436666|NCT02118896|41683823|FG001|Overall Study|Lost to Follow-up|2|||
19436667|NCT02118896|41683824|FG002|Overall Study|Lost to Follow-up|1|||
19436668|NCT02118896|41683825|FG003|Overall Study|Lost to Follow-up|0|||
19436669|NCT02118896|41683826|FG004|Overall Study|Lost to Follow-up|2|||
19436670|NCT02118896|41683827|FG005|Overall Study|Lost to Follow-up|1|||
19436671|NCT02118896|41683828|FG006|Overall Study|Lost to Follow-up|0|||
19436672|NCT02118896|41683829|FG007|Overall Study|Lost to Follow-up|0|||
19436673|NCT02118896|41683830|FG008|Overall Study|Lost to Follow-up|0|||
19436674|NCT02118896|41683831|FG009|Overall Study|Lost to Follow-up|0|||
19436675|NCT02118896|41683822|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
19436676|NCT02118896|41683823|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
19436677|NCT02118896|41683824|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
19436678|NCT02118896|41683825|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
19436679|NCT02118896|41683826|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
19436680|NCT02118896|41683827|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
19436681|NCT02118896|41683828|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
19436682|NCT02118896|41683829|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
19436683|NCT02118896|41683830|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
19436684|NCT02118896|41683831|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
19436685|NCT02118896|41683822|FG000|Overall Study|Prohibited medication|0|||
19436686|NCT02118896|41683823|FG001|Overall Study|Prohibited medication|0|||
19436687|NCT02118896|41683824|FG002|Overall Study|Prohibited medication|0|||
19436688|NCT02118896|41683825|FG003|Overall Study|Prohibited medication|0|||
19436689|NCT02118896|41683826|FG004|Overall Study|Prohibited medication|1|||
19436690|NCT02118896|41683827|FG005|Overall Study|Prohibited medication|3|||
19436691|NCT02118896|41683828|FG006|Overall Study|Prohibited medication|0|||
19436692|NCT02118896|41683829|FG007|Overall Study|Prohibited medication|0|||
19436693|NCT02118896|41683830|FG008|Overall Study|Prohibited medication|0|||
19436694|NCT02118896|41683831|FG009|Overall Study|Prohibited medication|0|||
19436695|NCT02118896|41683822|FG000|Overall Study|Miscellaneous|1|||
19436696|NCT02118896|41683823|FG001|Overall Study|Miscellaneous|2|||
19436697|NCT02118896|41683824|FG002|Overall Study|Miscellaneous|0|||
19436698|NCT02118896|41683825|FG003|Overall Study|Miscellaneous|2|||
19436699|NCT02118896|41683826|FG004|Overall Study|Miscellaneous|0|||
19436700|NCT02118896|41683827|FG005|Overall Study|Miscellaneous|4|||
19436701|NCT02118896|41683828|FG006|Overall Study|Miscellaneous|0|||
19436702|NCT02118896|41683829|FG007|Overall Study|Miscellaneous|0|||
19436703|NCT02118896|41683830|FG008|Overall Study|Miscellaneous|0|||
19436704|NCT02118896|41683831|FG009|Overall Study|Miscellaneous|0|||
19436705|NCT02124707|41683854|FG000|Overall Study|Adverse Event|5|||
19436706|NCT02124707|41683854|FG000|Overall Study|Physician Decision|1|||
19436707|NCT02124707|41683854|FG000|Overall Study|Death|1|||
19436708|NCT02067728|41683861|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
19436709|NCT02067728|41683862|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
19436710|NCT02067728|41683861|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
19436711|NCT02067728|41683862|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
19521907|NCT00985686|41935327|FG003|Overall Study|Lost to Follow-up|2|||
19436712|NCT02067728|41683861|FG000|6 Month Measurements|Unable to attend|114|||
19436713|NCT02067728|41683862|FG001|6 Month Measurements|Unable to attend|97|||
19436714|NCT02118428|41683870|FG000|Overall Study|Physician Decision|0|||
19436715|NCT02118428|41683871|FG001|Overall Study|Physician Decision|1|||
19521908|NCT00984594|41935337|FG000|Overall Study|Lost to Follow-up|1|||
19436716|NCT02118428|41683872|FG002|Overall Study|Physician Decision|0|||
19436717|NCT02118428|41683870|FG000|Overall Study|Withdrawal by Subject|2|||
19436718|NCT02118428|41683871|FG001|Overall Study|Withdrawal by Subject|2|||
19436719|NCT02118428|41683872|FG002|Overall Study|Withdrawal by Subject|0|||
19436720|NCT02118428|41683870|FG000|Overall Study|Death|7|||
19436721|NCT02118428|41683871|FG001|Overall Study|Death|5|||
19436722|NCT02118428|41683872|FG002|Overall Study|Death|0|||
19436723|NCT02118428|41683870|FG000|Overall Study|Lost to Follow-up|3|||
19436724|NCT02118428|41683871|FG001|Overall Study|Lost to Follow-up|1|||
19436725|NCT02118428|41683872|FG002|Overall Study|Lost to Follow-up|0|||
19436726|NCT02118428|41683870|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
19436727|NCT02118428|41683871|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
19436728|NCT02118428|41683872|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
19436729|NCT02067104|41683880|FG000|Overall Study|Study termination due to low accrual|4|||
19436730|NCT02067104|41683881|FG001|Overall Study|Study termination due to low accrual|5|||
19436731|NCT02092220|41683887|FG000|Period 1|Unrelated Illness|0|||
19436732|NCT02092220|41683888|FG001|Period 1|Unrelated Illness|2|||
19436733|NCT02092220|41683887|FG000|Period 2|Severe Hypoglycaemia|1|||
19436734|NCT02092220|41683888|FG001|Period 2|Severe Hypoglycaemia|0|||
19436735|NCT02092220|41683887|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
19436736|NCT02092220|41683888|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
19436737|NCT02066402|41683898|FG000|Overall Study|Adverse Event|1|||
19436738|NCT02066402|41683899|FG001|Overall Study|Adverse Event|2|||
19436739|NCT02066402|41683898|FG000|Overall Study|Lost to Follow-up|11|||
19436740|NCT02066402|41683899|FG001|Overall Study|Lost to Follow-up|8|||
19436741|NCT02066402|41683898|FG000|Overall Study|Withdrawal by Subject|14|||
19436742|NCT02066402|41683899|FG001|Overall Study|Withdrawal by Subject|11|||
19436743|NCT02066402|41683898|FG000|Overall Study|Progressive disease-clinical progression|0|||
19436744|NCT02066402|41683899|FG001|Overall Study|Progressive disease-clinical progression|1|||
19436745|NCT02066402|41683898|FG000|Overall Study|Protocol driven decision point|0|||
19436746|NCT02066402|41683899|FG001|Overall Study|Protocol driven decision point|1|||
19436747|NCT02060383|41683910|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
19436748|NCT02060383|41683911|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
19436749|NCT02060383|41683912|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
19436750|NCT02060383|41683913|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
19436751|NCT02060383|41683914|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
19436752|NCT02060383|41683910|FG000|Core Phase|Adverse Event|2|||
19436753|NCT02060383|41683911|FG001|Core Phase|Adverse Event|0|||
19436754|NCT02060383|41683912|FG002|Core Phase|Adverse Event|0|||
19436755|NCT02060383|41683913|FG003|Core Phase|Adverse Event|2|||
19436756|NCT02060383|41683914|FG004|Core Phase|Adverse Event|6|||
19436757|NCT02060383|41683910|FG000|Core Phase|Administrative problems|0|||
19436758|NCT02060383|41683911|FG001|Core Phase|Administrative problems|1|||
19436759|NCT02060383|41683912|FG002|Core Phase|Administrative problems|0|||
19436760|NCT02060383|41683913|FG003|Core Phase|Administrative problems|0|||
19436761|NCT02060383|41683914|FG004|Core Phase|Administrative problems|0|||
19436762|NCT02060383|41683910|FG000|Core Phase|Protocol Violation|0|||
19436763|NCT02060383|41683911|FG001|Core Phase|Protocol Violation|0|||
19436764|NCT02060383|41683912|FG002|Core Phase|Protocol Violation|0|||
19436765|NCT02060383|41683913|FG003|Core Phase|Protocol Violation|1|||
19436766|NCT02060383|41683914|FG004|Core Phase|Protocol Violation|0|||
19436767|NCT02060383|41683910|FG000|Core Phase|Withdrawal by Subject|0|||
19436768|NCT02060383|41683911|FG001|Core Phase|Withdrawal by Subject|0|||
19436769|NCT02060383|41683912|FG002|Core Phase|Withdrawal by Subject|0|||
19436770|NCT02060383|41683913|FG003|Core Phase|Withdrawal by Subject|4|||
19436771|NCT02060383|41683914|FG004|Core Phase|Withdrawal by Subject|2|||
19436772|NCT02060383|41683910|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
19436773|NCT02060383|41683911|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
19436774|NCT02060383|41683912|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
19436775|NCT02060383|41683913|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
19436776|NCT02060383|41683914|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
19436777|NCT02060383|41683910|FG000|Extension Phase|Adverse Event|1|||
19436778|NCT02060383|41683911|FG001|Extension Phase|Adverse Event|1|||
19711236|NCT00116649|42154369|FG000|Overall Study|Various Reasons|18|||
19711237|NCT00116649|42154369|FG000|Overall Study|Protocol Specified|7|||
19436779|NCT02060383|41683912|FG002|Extension Phase|Adverse Event|2|||
19436780|NCT02060383|41683913|FG003|Extension Phase|Adverse Event|0|||
19436781|NCT02060383|41683914|FG004|Extension Phase|Adverse Event|1|||
19436782|NCT02060383|41683910|FG000|Extension Phase|Withdrawal by Subject|0|||
19436783|NCT02060383|41683911|FG001|Extension Phase|Withdrawal by Subject|1|||
19436784|NCT02060383|41683912|FG002|Extension Phase|Withdrawal by Subject|0|||
19436785|NCT02060383|41683913|FG003|Extension Phase|Withdrawal by Subject|0|||
19436786|NCT02060383|41683914|FG004|Extension Phase|Withdrawal by Subject|2|||
19436787|NCT02060383|41683910|FG000|Extension Phase|Administrative problems|1|||
19436788|NCT02060383|41683911|FG001|Extension Phase|Administrative problems|0|||
19436789|NCT02060383|41683912|FG002|Extension Phase|Administrative problems|0|||
19436790|NCT02060383|41683913|FG003|Extension Phase|Administrative problems|0|||
19436791|NCT02060383|41683914|FG004|Extension Phase|Administrative problems|0|||
19436792|NCT02060383|41683910|FG000|Extension Phase|Death|0|||
19436793|NCT02060383|41683911|FG001|Extension Phase|Death|0|||
19436794|NCT02060383|41683912|FG002|Extension Phase|Death|1|||
19436795|NCT02060383|41683913|FG003|Extension Phase|Death|0|||
19436796|NCT02060383|41683914|FG004|Extension Phase|Death|1|||
19436797|NCT02060383|41683910|FG000|Extension Phase|Protocol Violation|0|||
19436798|NCT02060383|41683911|FG001|Extension Phase|Protocol Violation|0|||
19436799|NCT02060383|41683912|FG002|Extension Phase|Protocol Violation|0|||
19436800|NCT02060383|41683913|FG003|Extension Phase|Protocol Violation|0|||
19436801|NCT02060383|41683914|FG004|Extension Phase|Protocol Violation|1|||
19436802|NCT02086591|41683926|FG000|Overall Study|Adverse Event|1|||
19436803|NCT02086591|41683926|FG000|Overall Study|Withdrawal by Subject|1|||
19436804|NCT02086591|41683926|FG000|Overall Study|protocol terminated|3|||
19436805|NCT02065622|41683932|FG000|Induction Study|Adverse Event|13|||
19436806|NCT02065622|41683933|FG001|Induction Study|Adverse Event|19|||
19436807|NCT02065622|41683934|FG002|Induction Study|Adverse Event|0|||
19436808|NCT02065622|41683935|FG003|Induction Study|Adverse Event|0|||
19436809|NCT02065622|41683936|FG004|Induction Study|Adverse Event|0|||
19436810|NCT02065622|41683932|FG000|Induction Study|Withdrawal by Subject|3|||
19436811|NCT02065622|41683933|FG001|Induction Study|Withdrawal by Subject|5|||
19436812|NCT02065622|41683934|FG002|Induction Study|Withdrawal by Subject|0|||
19436813|NCT02065622|41683935|FG003|Induction Study|Withdrawal by Subject|0|||
19436814|NCT02065622|41683936|FG004|Induction Study|Withdrawal by Subject|0|||
19436815|NCT02065622|41683932|FG000|Induction Study|Lost to Follow-up|1|||
19436816|NCT02065622|41683933|FG001|Induction Study|Lost to Follow-up|0|||
19436817|NCT02065622|41683934|FG002|Induction Study|Lost to Follow-up|0|||
19436818|NCT02065622|41683935|FG003|Induction Study|Lost to Follow-up|0|||
19436819|NCT02065622|41683936|FG004|Induction Study|Lost to Follow-up|0|||
19436820|NCT02065622|41683932|FG000|Induction Study|Lack of Efficacy|22|||
19436821|NCT02065622|41683933|FG001|Induction Study|Lack of Efficacy|27|||
19436822|NCT02065622|41683934|FG002|Induction Study|Lack of Efficacy|0|||
19436823|NCT02065622|41683935|FG003|Induction Study|Lack of Efficacy|0|||
19436824|NCT02065622|41683936|FG004|Induction Study|Lack of Efficacy|0|||
19436825|NCT02065622|41683932|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
19436826|NCT02065622|41683933|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
19436827|NCT02065622|41683934|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
19436828|NCT02065622|41683935|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
19521909|NCT00984594|41935338|FG001|Overall Study|Lost to Follow-up|0|||
19521910|NCT00984594|41935337|FG000|Overall Study|Withdrawal by Subject|0|||
19521911|NCT00984594|41935338|FG001|Overall Study|Withdrawal by Subject|1|||
19521912|NCT00984204|41935346|FG000|Overall Study|Death|1|||
19521913|NCT00984204|41935346|FG000|Overall Study|Lost to Follow-up|4|||
19521914|NCT00984204|41935346|FG000|Overall Study|Lack of Efficacy|10|||
19521915|NCT00983892|41935352|FG000|Overall Study|Withdrawal by Subject|10|||
19521916|NCT00983892|41935353|FG001|Overall Study|Withdrawal by Subject|12|||
19521917|NCT00983580|41935361|FG000|Overall Study|Cancel Prior to treatment|1|||
19521918|NCT00983580|41935362|FG001|Overall Study|Cancel Prior to treatment|3|||
19521919|NCT00983580|41935361|FG000|Overall Study|Protocol Violation|1|||
19521920|NCT00983580|41935362|FG001|Overall Study|Protocol Violation|1|||
19521921|NCT00983580|41935361|FG000|Overall Study|Ineligible|3|||
19521922|NCT00983580|41935362|FG001|Overall Study|Ineligible|0|||
19521923|NCT00982878|41935369|FG000|Overall Study|Physician Decision|1|||
19521924|NCT00982488|41935378|FG000|Overall Study|Administrative reason by sponsor|81|||
19521925|NCT00982488|41935379|FG001|Overall Study|Administrative reason by sponsor|3|||
19521926|NCT00982488|41935380|FG002|Overall Study|Administrative reason by sponsor|11|||
19521927|NCT00982488|41935381|FG003|Overall Study|Administrative reason by sponsor|0|||
19521928|NCT00982488|41935382|FG004|Overall Study|Administrative reason by sponsor|0|||
19521929|NCT00982488|41935378|FG000|Overall Study|Adverse event unrelated to study drug|5|||
19521930|NCT00982488|41935379|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19521931|NCT00982488|41935380|FG002|Overall Study|Adverse event unrelated to study drug|0|||
19521932|NCT00982488|41935381|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19521933|NCT00982488|41935382|FG004|Overall Study|Adverse event unrelated to study drug|0|||
19711238|NCT00083889|42154375|FG000|Overall Study|Adverse Event|76|||
19711239|NCT00083889|42154376|FG001|Overall Study|Adverse Event|86|||
19436829|NCT02065622|41683936|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
19436830|NCT02065622|41683932|FG000|Induction Study|Subject Noncompliance|1|||
19436831|NCT02065622|41683933|FG001|Induction Study|Subject Noncompliance|1|||
19436832|NCT02065622|41683934|FG002|Induction Study|Subject Noncompliance|0|||
19436833|NCT02065622|41683935|FG003|Induction Study|Subject Noncompliance|0|||
19436834|NCT02065622|41683936|FG004|Induction Study|Subject Noncompliance|0|||
19436835|NCT02065622|41683932|FG000|Induction Study|Other, Not Specified|3|||
19436836|NCT02065622|41683933|FG001|Induction Study|Other, Not Specified|2|||
19436837|NCT02065622|41683934|FG002|Induction Study|Other, Not Specified|0|||
19711240|NCT00083889|42154375|FG000|Overall Study|Protocol Violation|2|||
19436838|NCT02065622|41683935|FG003|Induction Study|Other, Not Specified|0|||
19436839|NCT02065622|41683936|FG004|Induction Study|Other, Not Specified|0|||
19436840|NCT02065622|41683932|FG000|Maintenance Study|Adverse Event|0|||
19436841|NCT02065622|41683933|FG001|Maintenance Study|Adverse Event|0|||
19436842|NCT02065622|41683934|FG002|Maintenance Study|Adverse Event|25|||
19436843|NCT02065622|41683935|FG003|Maintenance Study|Adverse Event|22|||
19436844|NCT02065622|41683936|FG004|Maintenance Study|Adverse Event|11|||
19436845|NCT02065622|41683932|FG000|Maintenance Study|Withdrawal by Subject|0|||
19436846|NCT02065622|41683933|FG001|Maintenance Study|Withdrawal by Subject|0|||
19436847|NCT02065622|41683934|FG002|Maintenance Study|Withdrawal by Subject|11|||
19436848|NCT02065622|41683935|FG003|Maintenance Study|Withdrawal by Subject|5|||
19436849|NCT02065622|41683936|FG004|Maintenance Study|Withdrawal by Subject|7|||
19436850|NCT02065622|41683932|FG000|Maintenance Study|Lost to Follow-up|0|||
19436851|NCT02065622|41683933|FG001|Maintenance Study|Lost to Follow-up|0|||
19436852|NCT02065622|41683934|FG002|Maintenance Study|Lost to Follow-up|4|||
19436853|NCT02065622|41683935|FG003|Maintenance Study|Lost to Follow-up|1|||
19436854|NCT02065622|41683936|FG004|Maintenance Study|Lost to Follow-up|1|||
19436855|NCT02065622|41683932|FG000|Maintenance Study|Lack of Efficacy|0|||
19436856|NCT02065622|41683933|FG001|Maintenance Study|Lack of Efficacy|0|||
19436857|NCT02065622|41683934|FG002|Maintenance Study|Lack of Efficacy|70|||
19436858|NCT02065622|41683935|FG003|Maintenance Study|Lack of Efficacy|55|||
19436859|NCT02065622|41683936|FG004|Maintenance Study|Lack of Efficacy|19|||
19436860|NCT02065622|41683932|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
19436861|NCT02065622|41683933|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
19436862|NCT02065622|41683934|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
19436863|NCT02065622|41683935|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
19436864|NCT02065622|41683936|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
19436865|NCT02065622|41683932|FG000|Maintenance Study|Subject Non-Compliance|0|||
19436866|NCT02065622|41683933|FG001|Maintenance Study|Subject Non-Compliance|0|||
19436867|NCT02065622|41683934|FG002|Maintenance Study|Subject Non-Compliance|1|||
19436868|NCT02065622|41683935|FG003|Maintenance Study|Subject Non-Compliance|3|||
19436869|NCT02065622|41683936|FG004|Maintenance Study|Subject Non-Compliance|2|||
19436870|NCT02065622|41683932|FG000|Maintenance Study|Other, Not Specified|0|||
19436871|NCT02065622|41683933|FG001|Maintenance Study|Other, Not Specified|0|||
19436872|NCT02065622|41683934|FG002|Maintenance Study|Other, Not Specified|6|||
19436873|NCT02065622|41683935|FG003|Maintenance Study|Other, Not Specified|14|||
19436874|NCT02065622|41683936|FG004|Maintenance Study|Other, Not Specified|2|||
19436875|NCT02065622|41683932|FG000|Maintenance Study|Unknown Reason|0|||
19436876|NCT02065622|41683933|FG001|Maintenance Study|Unknown Reason|0|||
19436877|NCT02065622|41683934|FG002|Maintenance Study|Unknown Reason|0|||
19436878|NCT02065622|41683935|FG003|Maintenance Study|Unknown Reason|1|||
19436879|NCT02065622|41683936|FG004|Maintenance Study|Unknown Reason|0|||
19436880|NCT02117648|41683951|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
19436881|NCT02117648|41683951|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
19436882|NCT02117648|41683951|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
19436883|NCT02117648|41683951|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
19436884|NCT02117648|41683951|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
19436885|NCT02117648|41683951|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
19436886|NCT02117648|41683951|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
19436887|NCT02117648|41683951|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
19436888|NCT02117648|41683951|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
19436889|NCT02117648|41683951|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
19436890|NCT02117648|41683951|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
19436891|NCT02124161|41683961|FG000|Overall Study|Other unspecified|0|||
19436892|NCT02124161|41683962|FG001|Overall Study|Other unspecified|1|||
19436893|NCT02124161|41683961|FG000|Overall Study|Death|1|||
19436894|NCT02124161|41683962|FG001|Overall Study|Death|0|||
19436895|NCT02124161|41683961|FG000|Overall Study|Protocol Violation|2|||
19436896|NCT02124161|41683962|FG001|Overall Study|Protocol Violation|1|||
19436897|NCT02124161|41683961|FG000|Overall Study|Withdrawal by Subject|1|||
19436898|NCT02124161|41683962|FG001|Overall Study|Withdrawal by Subject|2|||
19436899|NCT02124161|41683961|FG000|Overall Study|Adverse Event|2|||
19436900|NCT02124161|41683962|FG001|Overall Study|Adverse Event|0|||
19436901|NCT02124161|41683961|FG000|Overall Study|Does not meet entrance criteria|2|||
19436902|NCT02124161|41683962|FG001|Overall Study|Does not meet entrance criteria|3|||
19436903|NCT02124161|41683961|FG000|Overall Study|No longer meets eligibility criteria|5|||
19436904|NCT02124161|41683962|FG001|Overall Study|No longer meets eligibility criteria|4|||
19436905|NCT02124161|41683961|FG000|Overall Study|Lost to Follow-up|3|||
19436906|NCT02124161|41683962|FG001|Overall Study|Lost to Follow-up|4|||
19436907|NCT02175641|41683977|FG000|Overall Study|Death|3|||
19436908|NCT02175641|41683978|FG001|Overall Study|Death|4|||
19436909|NCT02175641|41683977|FG000|Overall Study|Lost to Follow-up|4|||
19436910|NCT02175641|41683978|FG001|Overall Study|Lost to Follow-up|4|||
19436911|NCT02175641|41683977|FG000|Overall Study|Withdrawal by Subject|7|||
19436912|NCT02175641|41683978|FG001|Overall Study|Withdrawal by Subject|4|||
19436913|NCT02175641|41683977|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
19436914|NCT02175641|41683978|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
19436915|NCT02175641|41683977|FG000|Overall Study|Developed Contraindicated Condition|8|||
19436916|NCT02175641|41683978|FG001|Overall Study|Developed Contraindicated Condition|0|||
19436917|NCT02117570|41683987|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
19436918|NCT02117570|41683988|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
19436919|NCT02117570|41683989|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
19436920|NCT02117570|41683987|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
19436921|NCT02117570|41683988|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
19436922|NCT02117570|41683989|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
19436923|NCT02117570|41683987|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
19436924|NCT02117570|41683988|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
19436925|NCT02117570|41683989|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
19436926|NCT02117570|41683987|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
19436927|NCT02117570|41683988|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
19436928|NCT02117570|41683989|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
19436929|NCT02117570|41683987|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
19436930|NCT02117570|41683988|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
19436931|NCT02117570|41683989|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
19436932|NCT02117570|41683987|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
19436933|NCT02117570|41683988|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
19436934|NCT02117570|41683989|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
19436935|NCT02117570|41683987|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
19436936|NCT02117570|41683988|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
19436937|NCT02117570|41683989|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
19436938|NCT02123459|41684000|FG000|Washout Period (1 Day)|Adverse Event|1|||
19436939|NCT02123459|41684001|FG001|Washout Period (1 Day)|Adverse Event|0|||
19436940|NCT02151773|41684007|FG000|Overall Study|Protocol Deviation|64|||
19436941|NCT02151461|41684015|FG000|Overall Study|Adverse Event|5|||
19436942|NCT02151461|41684016|FG001|Overall Study|Adverse Event|1|||
19436943|NCT02151461|41684017|FG002|Overall Study|Adverse Event|0|||
19436944|NCT02151461|41684018|FG003|Overall Study|Adverse Event|2|||
19436945|NCT02151461|41684015|FG000|Overall Study|Lost to Follow-up|0|||
19436946|NCT02151461|41684016|FG001|Overall Study|Lost to Follow-up|0|||
19436947|NCT02151461|41684017|FG002|Overall Study|Lost to Follow-up|1|||
19436948|NCT02151461|41684018|FG003|Overall Study|Lost to Follow-up|1|||
19436949|NCT02151461|41684015|FG000|Overall Study|Withdrawal by Subject|1|||
19436950|NCT02151461|41684016|FG001|Overall Study|Withdrawal by Subject|0|||
19436951|NCT02151461|41684017|FG002|Overall Study|Withdrawal by Subject|1|||
19436952|NCT02151461|41684018|FG003|Overall Study|Withdrawal by Subject|1|||
19436953|NCT02151461|41684015|FG000|Overall Study|Treatment discontinuation|0|||
19436954|NCT02151461|41684016|FG001|Overall Study|Treatment discontinuation|0|||
19436955|NCT02151461|41684017|FG002|Overall Study|Treatment discontinuation|1|||
19436956|NCT02151461|41684018|FG003|Overall Study|Treatment discontinuation|0|||
19436957|NCT02117414|41684030|FG000|Overall Study|Death|5|||
19436958|NCT02117414|41684031|FG001|Overall Study|Death|2|||
19436959|NCT02117414|41684030|FG000|Overall Study|Withdrawal by Subject|10|||
19436960|NCT02117414|41684031|FG001|Overall Study|Withdrawal by Subject|4|||
19436961|NCT02091986|41684042|FG000|Overall Study|7 rand in error 1 patient decision|2|||
19436962|NCT02091986|41684043|FG001|Overall Study|7 rand in error 1 patient decision|3|||
19436963|NCT02091986|41684044|FG002|Overall Study|7 rand in error 1 patient decision|3|||
19436964|NCT02091986|41684042|FG000|Overall Study|Lost to Follow-up|1|||
19436965|NCT02091986|41684043|FG001|Overall Study|Lost to Follow-up|0|||
19436966|NCT02091986|41684044|FG002|Overall Study|Lost to Follow-up|0|||
19436967|NCT02091986|41684042|FG000|Overall Study|Withdrawal by Subject|4|||
19436968|NCT02091986|41684043|FG001|Overall Study|Withdrawal by Subject|8|||
19436969|NCT02091986|41684044|FG002|Overall Study|Withdrawal by Subject|3|||
19436970|NCT02091986|41684042|FG000|Overall Study|Adverse Event|0|||
19436971|NCT02091986|41684043|FG001|Overall Study|Adverse Event|0|||
19436972|NCT02091986|41684044|FG002|Overall Study|Adverse Event|2|||
19436973|NCT02091752|41684052|FG000|Overall Study|Study terminated by Sponsor|2|||
19436974|NCT02091752|41684052|FG000|Overall Study|Adverse Event|1|||
19436975|NCT02117024|41684058|FG000|Overall Study|Progressive Disease|26|||
19436976|NCT02117024|41684059|FG001|Overall Study|Progressive Disease|9|||
19436977|NCT02117024|41684058|FG000|Overall Study|Significant Clinical Progression|7|||
19436978|NCT02117024|41684059|FG001|Overall Study|Significant Clinical Progression|4|||
19436979|NCT02117024|41684058|FG000|Overall Study|Death|5|||
19436980|NCT02117024|41684059|FG001|Overall Study|Death|0|||
19436981|NCT02117024|41684058|FG000|Overall Study|Withdrawal by Subject|3|||
19436982|NCT02117024|41684059|FG001|Overall Study|Withdrawal by Subject|1|||
19436983|NCT02117024|41684058|FG000|Overall Study|Protocol Violation|1|||
19436984|NCT02117024|41684059|FG001|Overall Study|Protocol Violation|0|||
19436985|NCT02117024|41684058|FG000|Overall Study|Adverse Event|1|||
19436986|NCT02117024|41684059|FG001|Overall Study|Adverse Event|2|||
19436987|NCT02117024|41684058|FG000|Overall Study|Randomized in Error|1|||
19436988|NCT02117024|41684059|FG001|Overall Study|Randomized in Error|0|||
19436989|NCT02117024|41684058|FG000|Overall Study|Patient returned to primary oncologist|0|||
19436990|NCT02117024|41684059|FG001|Overall Study|Patient returned to primary oncologist|1|||
19436991|NCT02117024|41684058|FG000|Overall Study|Patient took treatment break|0|||
19436992|NCT02117024|41684059|FG001|Overall Study|Patient took treatment break|1|||
19436993|NCT02117024|41684058|FG000|Overall Study|Physician Decision|0|||
19436994|NCT02117024|41684059|FG001|Overall Study|Physician Decision|2|||
19436995|NCT02091440|41684065|FG000|Overall Study|Death|2|||
19436996|NCT02064920|41684071|FG000|Overall Study|Adverse Event|0|||
19436997|NCT02064920|41684072|FG001|Overall Study|Adverse Event|4|||
19436998|NCT02064920|41684071|FG000|Overall Study|Physician Decision|0|||
19436999|NCT02064920|41684072|FG001|Overall Study|Physician Decision|1|||
19437000|NCT02064920|41684071|FG000|Overall Study|Technical Problems|0|||
19437001|NCT02064920|41684072|FG001|Overall Study|Technical Problems|1|||
19437002|NCT02064920|41684071|FG000|Overall Study|Withdrawal by Subject|1|||
19437003|NCT02064920|41684072|FG001|Overall Study|Withdrawal by Subject|3|||
19437004|NCT02151149|41684080|FG000|Treatment Period|Death|2|||
19437005|NCT02151149|41684081|FG001|Treatment Period|Death|3|||
19437006|NCT02151149|41684080|FG000|Treatment Period|Adverse Event|17|||
19437007|NCT02151149|41684081|FG001|Treatment Period|Adverse Event|14|||
19437008|NCT02151149|41684080|FG000|Treatment Period|Progressive Disease|25|||
19437009|NCT02151149|41684081|FG001|Treatment Period|Progressive Disease|24|||
19437010|NCT02151149|41684080|FG000|Treatment Period|Symptomatic Deterioration|2|||
19437011|NCT02151149|41684081|FG001|Treatment Period|Symptomatic Deterioration|10|||
19437012|NCT02151149|41684080|FG000|Treatment Period|Withdrawal by Subject|13|||
19437013|NCT02151149|41684081|FG001|Treatment Period|Withdrawal by Subject|11|||
19437014|NCT02151149|41684080|FG000|Treatment Period|Miscellaneous|8|||
19437015|NCT02151149|41684081|FG001|Treatment Period|Miscellaneous|7|||
19437016|NCT02151149|41684080|FG000|Treatment Period|Participants randomized but not treated|3|||
19437017|NCT02151149|41684081|FG001|Treatment Period|Participants randomized but not treated|2|||
19437018|NCT02151149|41684080|FG000|Follow-Up Period|Lost to Follow-up|2|||
19437019|NCT02151149|41684081|FG001|Follow-Up Period|Lost to Follow-up|3|||
19437020|NCT02151149|41684080|FG000|Follow-Up Period|Death|37|||
19437021|NCT02151149|41684081|FG001|Follow-Up Period|Death|34|||
19437022|NCT02150213|41684087|FG000|Overall Study|Lost to Follow-up|1|||
19437023|NCT02150213|41684087|FG000|Overall Study|Withdrawal by Subject|1|||
19437024|NCT02091362|41684093|FG000|Period 1|Protocol Violation|1|||
19437025|NCT02091362|41684094|FG001|Period 1|Protocol Violation|0|||
19437026|NCT02091362|41684093|FG000|Period 1|Withdrawal by Subject|2|||
19437027|NCT02091362|41684094|FG001|Period 1|Withdrawal by Subject|3|||
19437028|NCT02091362|41684093|FG000|Period 1|Lost to Follow-up|0|||
19437029|NCT02091362|41684094|FG001|Period 1|Lost to Follow-up|1|||
19437030|NCT02091362|41684093|FG000|Period 1|Adverse Event|2|||
19437031|NCT02091362|41684094|FG001|Period 1|Adverse Event|0|||
19437032|NCT02091362|41684093|FG000|Wash-out|Lost to Follow-up|1|||
19437033|NCT02091362|41684094|FG001|Wash-out|Lost to Follow-up|1|||
19437034|NCT02091362|41684093|FG000|Wash-out|Withdrawal by Subject|0|||
19437035|NCT02091362|41684094|FG001|Wash-out|Withdrawal by Subject|2|||
19437036|NCT02091362|41684093|FG000|Period 2|Adverse Event|1|||
19437037|NCT02091362|41684094|FG001|Period 2|Adverse Event|0|||
19437038|NCT02091362|41684093|FG000|Period 2|Lost to Follow-up|0|||
19437039|NCT02091362|41684094|FG001|Period 2|Lost to Follow-up|1|||
19437040|NCT02091362|41684093|FG000|Period 2|Withdrawal by Subject|1|||
19437041|NCT02091362|41684094|FG001|Period 2|Withdrawal by Subject|1|||
19437042|NCT02150057|41684106|FG000|Overall Study|Lost to Follow-up|6|||
19437043|NCT02150057|41684107|FG001|Overall Study|Lost to Follow-up|4|||
19437044|NCT02064296|41684116|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
19437045|NCT02064296|41684117|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
19437046|NCT02064296|41684118|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
19437047|NCT02064296|41684116|FG000|Intervention|Withdrawal by Subject|0|||
19437048|NCT02064296|41684117|FG001|Intervention|Withdrawal by Subject|1|||
19437049|NCT02064296|41684118|FG002|Intervention|Withdrawal by Subject|2|||
19437050|NCT02063984|41684130|FG000|Overall Study|Lost to Follow-up|6|||
19437051|NCT02063984|41684131|FG001|Overall Study|Lost to Follow-up|5|||
19437052|NCT02091284|41684143|FG000|Overall Study|Withdrawal by Subject|2|||
19437053|NCT02091284|41684144|FG001|Overall Study|Withdrawal by Subject|1|||
19437054|NCT02091284|41684143|FG000|Overall Study|unreliable data|1|||
19437055|NCT02091284|41684144|FG001|Overall Study|unreliable data|0|||
19437056|NCT02115386|41684152|FG000|Overall Study|Protocol Violation|1|||
19437057|NCT02115386|41684152|FG000|Overall Study|Administrative - trial was terminated|6|||
19437058|NCT02091206|41684160|FG000|Treatment Period|Adverse Event|0|||
19437059|NCT02091206|41684161|FG001|Treatment Period|Adverse Event|1|||
19437060|NCT02091206|41684162|FG002|Treatment Period|Adverse Event|0|||
19437061|NCT02091206|41684163|FG003|Treatment Period|Adverse Event|0|||
19437062|NCT02091206|41684160|FG000|Treatment Period|Met withdrawal criteria|0|||
19437063|NCT02091206|41684161|FG001|Treatment Period|Met withdrawal criteria|0|||
19437064|NCT02091206|41684162|FG002|Treatment Period|Met withdrawal criteria|1|||
19437065|NCT02091206|41684163|FG003|Treatment Period|Met withdrawal criteria|0|||
19437066|NCT02091206|41684160|FG000|Taper Period|Participant refused study drug|1|||
19437067|NCT02091206|41684161|FG001|Taper Period|Participant refused study drug|0|||
19437068|NCT02091206|41684162|FG002|Taper Period|Participant refused study drug|0|||
19437069|NCT02091206|41684163|FG003|Taper Period|Participant refused study drug|1|||
19437070|NCT02091206|41684160|FG000|Taper Period|Lost to Follow-up|0|||
19437071|NCT02091206|41684161|FG001|Taper Period|Lost to Follow-up|0|||
19437072|NCT02091206|41684162|FG002|Taper Period|Lost to Follow-up|0|||
19437073|NCT02091206|41684163|FG003|Taper Period|Lost to Follow-up|1|||
19437074|NCT02090426|41684175|FG000|Overall Study|Lost to Follow-up|12|||
19437075|NCT02090426|41684176|FG001|Overall Study|Lost to Follow-up|6|||
19437076|NCT02063828|41684185|FG000|Overall Study|Withdrawal by Subject|4|||
19437077|NCT02063828|41684186|FG001|Overall Study|Withdrawal by Subject|6|||
19437078|NCT02063828|41684187|FG002|Overall Study|Withdrawal by Subject|3|||
19437079|NCT02063828|41684185|FG000|Overall Study|Death|0|||
19437080|NCT02063828|41684186|FG001|Overall Study|Death|0|||
19437081|NCT02063828|41684187|FG002|Overall Study|Death|1|||
19437082|NCT02063672|41684197|FG000|Overall Study|Ongoing Follow-up|27|||
19437083|NCT02063672|41684198|FG001|Overall Study|Ongoing Follow-up|14|||
19437084|NCT02063672|41684197|FG000|Overall Study|Death|5|||
19437085|NCT02063672|41684198|FG001|Overall Study|Death|3|||
19437086|NCT02063672|41684197|FG000|Overall Study|Lost to Follow-up|1|||
19437087|NCT02063672|41684198|FG001|Overall Study|Lost to Follow-up|3|||
19437088|NCT02063672|41684197|FG000|Overall Study|Withdrawal by Subject|2|||
19437089|NCT02063672|41684198|FG001|Overall Study|Withdrawal by Subject|2|||
19437090|NCT02062658|41684204|FG000|Overall Study|Withdrawal by Subject|1|||
19437091|NCT02062658|41684204|FG000|Overall Study|Lack of Efficacy|1|||
19437092|NCT02115308|41684210|FG000|Overall Study|Safety Screening|2|||
19437093|NCT02115308|41684211|FG001|Overall Study|Safety Screening|2|||
19437094|NCT02114684|41684223|FG000|Overall Study|Death|6|||
19437095|NCT02114684|41684224|FG001|Overall Study|Death|4|||
19437096|NCT02114684|41684223|FG000|Overall Study|Lost to Follow-up|1|||
19437097|NCT02114684|41684224|FG001|Overall Study|Lost to Follow-up|2|||
19437098|NCT02114684|41684223|FG000|Overall Study|Withdrawal by Subject|1|||
19437099|NCT02114684|41684224|FG001|Overall Study|Withdrawal by Subject|2|||
19437100|NCT02114684|41684223|FG000|Overall Study|Relocation|3|||
19437101|NCT02114684|41684224|FG001|Overall Study|Relocation|1|||
19437102|NCT02114684|41684223|FG000|Overall Study|Rifampicin resistant on culture|0|||
19437103|NCT02114684|41684224|FG001|Overall Study|Rifampicin resistant on culture|1|||
19437104|NCT02114684|41684223|FG000|Overall Study|Patient Incarcerated|1|||
19437105|NCT02114684|41684224|FG001|Overall Study|Patient Incarcerated|0|||
19437106|NCT02090114|41684238|FG000|Overall Study|Withdrawal by Subject|3|||
19437107|NCT02090114|41684239|FG001|Overall Study|Withdrawal by Subject|6|||
19437108|NCT02090114|41684240|FG002|Overall Study|Withdrawal by Subject|2|||
19437109|NCT02090114|41684241|FG003|Overall Study|Withdrawal by Subject|1|||
19437110|NCT02090114|41684238|FG000|Overall Study|Physician Decision|5|||
19437111|NCT02090114|41684239|FG001|Overall Study|Physician Decision|0|||
19437112|NCT02090114|41684240|FG002|Overall Study|Physician Decision|1|||
19437113|NCT02090114|41684241|FG003|Overall Study|Physician Decision|1|||
19437114|NCT02090114|41684238|FG000|Overall Study|Adverse Event|1|||
19437115|NCT02090114|41684239|FG001|Overall Study|Adverse Event|2|||
19437116|NCT02090114|41684240|FG002|Overall Study|Adverse Event|2|||
19437117|NCT02090114|41684241|FG003|Overall Study|Adverse Event|0|||
19437118|NCT02090114|41684238|FG000|Overall Study|Progressive Disease|20|||
19437119|NCT02090114|41684239|FG001|Overall Study|Progressive Disease|21|||
19437120|NCT02090114|41684240|FG002|Overall Study|Progressive Disease|23|||
19437121|NCT02090114|41684241|FG003|Overall Study|Progressive Disease|6|||
19437122|NCT02090114|41684238|FG000|Overall Study|Death|1|||
19437123|NCT02090114|41684239|FG001|Overall Study|Death|0|||
19437124|NCT02090114|41684240|FG002|Overall Study|Death|1|||
19437125|NCT02090114|41684241|FG003|Overall Study|Death|0|||
19437126|NCT01623050|41684251|FG000|Overall Study|Lost to Follow-up|9|||
19437127|NCT02089334|41684259|FG000|Overall Study|Withdrawal by Subject|0|||
19437128|NCT02089334|41684260|FG001|Overall Study|Withdrawal by Subject|0|||
19437129|NCT02089334|41684261|FG002|Overall Study|Withdrawal by Subject|0|||
19437130|NCT02089334|41684262|FG003|Overall Study|Withdrawal by Subject|2|||
19437131|NCT02089334|41684259|FG000|Overall Study|Adverse Event|0|||
19437132|NCT02089334|41684260|FG001|Overall Study|Adverse Event|0|||
19437133|NCT02089334|41684261|FG002|Overall Study|Adverse Event|0|||
19437134|NCT02089334|41684262|FG003|Overall Study|Adverse Event|2|||
19437135|NCT02089334|41684259|FG000|Overall Study|Progressive disease|0|||
19437136|NCT02089334|41684260|FG001|Overall Study|Progressive disease|0|||
19437137|NCT02089334|41684261|FG002|Overall Study|Progressive disease|0|||
19437138|NCT02089334|41684262|FG003|Overall Study|Progressive disease|2|||
19437139|NCT02089334|41684259|FG000|Overall Study|Physician Decision|0|||
19437140|NCT02089334|41684260|FG001|Overall Study|Physician Decision|0|||
19437141|NCT02089334|41684261|FG002|Overall Study|Physician Decision|1|||
19437142|NCT02089334|41684262|FG003|Overall Study|Physician Decision|1|||
19437143|NCT02114606|41684275|FG000|Overall Study|Unable to swallow Cytosponge|6|||
19437144|NCT02113436|41684281|FG000|Period 1: 8 Weeks|Adverse Event|1|||
19437145|NCT02113436|41684282|FG001|Period 1: 8 Weeks|Adverse Event|0|||
19437146|NCT02113436|41684283|FG002|Period 1: 8 Weeks|Adverse Event|0|||
19437147|NCT02113436|41684284|FG003|Period 1: 8 Weeks|Adverse Event|0|||
19437148|NCT02113436|41684281|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
19437149|NCT02113436|41684282|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
19437150|NCT02113436|41684283|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
19437151|NCT02113436|41684284|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
19437152|NCT02113436|41684281|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
19437153|NCT02113436|41684282|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
19437154|NCT02113436|41684283|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
19437155|NCT02113436|41684284|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
19437156|NCT02113436|41684281|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
19437157|NCT02113436|41684282|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
19437158|NCT02113436|41684283|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
19437159|NCT02113436|41684284|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
19437160|NCT02113436|41684281|FG000|Period 2: 16 Weeks|Adverse Event|0|||
19437161|NCT02113436|41684282|FG001|Period 2: 16 Weeks|Adverse Event|0|||
19437162|NCT02113436|41684283|FG002|Period 2: 16 Weeks|Adverse Event|4|||
19437163|NCT02113436|41684284|FG003|Period 2: 16 Weeks|Adverse Event|5|||
19437164|NCT02113436|41684281|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
19437165|NCT02113436|41684282|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
19437166|NCT02113436|41684283|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
19437167|NCT02113436|41684284|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
19437168|NCT02113436|41684281|FG000|Period 2: 16 Weeks|Physician Decision|0|||
19437169|NCT02113436|41684282|FG001|Period 2: 16 Weeks|Physician Decision|0|||
19437170|NCT02113436|41684283|FG002|Period 2: 16 Weeks|Physician Decision|2|||
19437171|NCT02113436|41684284|FG003|Period 2: 16 Weeks|Physician Decision|0|||
19437172|NCT02113436|41684281|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
19437173|NCT02113436|41684282|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
19437174|NCT02113436|41684283|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
19437175|NCT02113436|41684284|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
19437176|NCT02113124|41684295|FG000|Overall Study|Unable to retrieve blood sample|1|||
19437177|NCT02113124|41684296|FG001|Overall Study|Unable to retrieve blood sample|1|||
19437178|NCT02087774|41684304|FG000|Overall Study|Were absent day of data collection|8|||
19437179|NCT02087774|41684305|FG001|Overall Study|Were absent day of data collection|20|||
19437180|NCT02111564|41684313|FG000|Overall Study|Death|109|||
19437181|NCT02111564|41684314|FG001|Overall Study|Death|120|||
19437182|NCT02111564|41684313|FG000|Overall Study|Lost to Follow-up|2|||
19437183|NCT02111564|41684314|FG001|Overall Study|Lost to Follow-up|3|||
19437184|NCT02111564|41684313|FG000|Overall Study|Withdrawal by Subject|20|||
19437185|NCT02111564|41684314|FG001|Overall Study|Withdrawal by Subject|20|||
19437186|NCT02087150|41684323|FG000|Overall Study|Death|0|||
19437187|NCT02087150|41684324|FG001|Overall Study|Death|1|||
19437188|NCT02087150|41684325|FG002|Overall Study|Death|0|||
19437189|NCT02087150|41684323|FG000|Overall Study|Lost to Follow-up|6|||
19437190|NCT02087150|41684324|FG001|Overall Study|Lost to Follow-up|13|||
19437191|NCT02087150|41684325|FG002|Overall Study|Lost to Follow-up|7|||
19437192|NCT02087150|41684323|FG000|Overall Study|Withdrawal by Subject|2|||
19437193|NCT02087150|41684324|FG001|Overall Study|Withdrawal by Subject|5|||
19437194|NCT02087150|41684325|FG002|Overall Study|Withdrawal by Subject|3|||
19437195|NCT02087150|41684323|FG000|Overall Study|Physician Decision|0|||
19437196|NCT02087150|41684324|FG001|Overall Study|Physician Decision|1|||
19437197|NCT02087150|41684325|FG002|Overall Study|Physician Decision|0|||
19437198|NCT02087150|41684323|FG000|Overall Study|Procedure not done|1|||
19437199|NCT02087150|41684324|FG001|Overall Study|Procedure not done|13|||
19437200|NCT02087150|41684325|FG002|Overall Study|Procedure not done|0|||
19437201|NCT02087150|41684323|FG000|Overall Study|F/U not completed w/in study window|0|||
19437202|NCT02087150|41684324|FG001|Overall Study|F/U not completed w/in study window|0|||
19437203|NCT02087150|41684325|FG002|Overall Study|F/U not completed w/in study window|1|||
19437204|NCT02087150|41684323|FG000|Overall Study|Other|1|||
19437205|NCT02087150|41684324|FG001|Overall Study|Other|0|||
19437206|NCT02087150|41684325|FG002|Overall Study|Other|0|||
19437207|NCT02087150|41684323|FG000|Overall Study|Pt moved out of town|0|||
19437208|NCT02087150|41684324|FG001|Overall Study|Pt moved out of town|1|||
19437209|NCT02087150|41684325|FG002|Overall Study|Pt moved out of town|0|||
19437210|NCT02111174|41684336|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
19437211|NCT02111174|41684337|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
19437212|NCT02111174|41684336|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
19437213|NCT02111174|41684337|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
19437214|NCT02111174|41684336|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
19437215|NCT02111174|41684337|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
19437216|NCT02111174|41684336|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
19521934|NCT00982488|41935378|FG000|Overall Study|Death|11|||
19437217|NCT02111174|41684337|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
19437218|NCT02111096|41684346|FG000|Overall Study|Adverse Event|4|||
19437219|NCT02111096|41684347|FG001|Overall Study|Adverse Event|1|||
19437220|NCT02111096|41684348|FG002|Overall Study|Adverse Event|2|||
19437221|NCT02111096|41684346|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19437222|NCT02111096|41684347|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19437223|NCT02111096|41684348|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19437224|NCT02111096|41684346|FG000|Overall Study|Lost to Follow Up|1|||
19437225|NCT02111096|41684347|FG001|Overall Study|Lost to Follow Up|1|||
19437226|NCT02111096|41684348|FG002|Overall Study|Lost to Follow Up|1|||
19437227|NCT02111096|41684346|FG000|Overall Study|Physician Decision|0|||
19437228|NCT02111096|41684347|FG001|Overall Study|Physician Decision|1|||
19437229|NCT02111096|41684348|FG002|Overall Study|Physician Decision|0|||
19437230|NCT02111096|41684346|FG000|Overall Study|Protocol Violation|1|||
19437231|NCT02111096|41684347|FG001|Overall Study|Protocol Violation|0|||
19437232|NCT02111096|41684348|FG002|Overall Study|Protocol Violation|1|||
19437233|NCT02111096|41684346|FG000|Overall Study|Terminated by Sponsor|53|||
19437234|NCT02111096|41684347|FG001|Overall Study|Terminated by Sponsor|35|||
19437235|NCT02111096|41684348|FG002|Overall Study|Terminated by Sponsor|54|||
19437236|NCT02111096|41684346|FG000|Overall Study|Withdrawal by Subject|4|||
19437237|NCT02111096|41684347|FG001|Overall Study|Withdrawal by Subject|2|||
19437238|NCT02111096|41684348|FG002|Overall Study|Withdrawal by Subject|8|||
19437239|NCT02110706|41684361|FG000|Overall Study|Adverse Event|2|||
19437240|NCT02110706|41684362|FG001|Overall Study|Adverse Event|3|||
19437241|NCT02110706|41684361|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
19437242|NCT02110706|41684362|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
19437243|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Adverse Event|3|||
19437244|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Adverse Event|0|||
19437245|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
19437246|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
19437247|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
19437248|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
19437249|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Physician Decision|0|||
19437250|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Physician Decision|2|||
19437251|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
19437252|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
19437253|NCT02110238|41684372|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
19437254|NCT02110238|41684373|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
19437255|NCT02110238|41684372|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
19437256|NCT02110238|41684373|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
19437257|NCT02110238|41684372|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
19437258|NCT02110238|41684373|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
19437259|NCT02110238|41684372|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
19437260|NCT02110238|41684373|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
19437261|NCT02110238|41684372|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
19437262|NCT02110238|41684373|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
19437263|NCT02110238|41684372|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
19437264|NCT02110238|41684373|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
19437265|NCT02108912|41684381|FG000|Overall Study|Lost to Follow-up|1|||
19437266|NCT02108912|41684382|FG001|Overall Study|Lost to Follow-up|1|||
19437267|NCT02108912|41684381|FG000|Overall Study|lack of transportation|1|||
19437268|NCT02108912|41684382|FG001|Overall Study|lack of transportation|0|||
19437269|NCT02108912|41684381|FG000|Overall Study|high blood pressure|1|||
19437270|NCT02108912|41684382|FG001|Overall Study|high blood pressure|0|||
19437271|NCT02108600|41684390|FG000|Overall Study|Withdrawal by Subject|2|||
19437272|NCT02108600|41684391|FG001|Overall Study|Withdrawal by Subject|0|||
19437273|NCT02108600|41684390|FG000|Overall Study|Lost to Follow-up|1|||
19437274|NCT02108600|41684391|FG001|Overall Study|Lost to Follow-up|1|||
19437275|NCT02107898|41684399|FG000|Overall Study|Adverse Event|4|||
19437276|NCT02107898|41684400|FG001|Overall Study|Adverse Event|7|||
19437277|NCT02107898|41684399|FG000|Overall Study|Poor compliance to protocol|0|||
19437278|NCT02107898|41684400|FG001|Overall Study|Poor compliance to protocol|1|||
19437279|NCT02107898|41684399|FG000|Overall Study|Participant moved|0|||
19437280|NCT02107898|41684400|FG001|Overall Study|Participant moved|2|||
19437281|NCT02107898|41684399|FG000|Overall Study|Consent withdrawn by participant|2|||
19437282|NCT02107898|41684400|FG001|Overall Study|Consent withdrawn by participant|1|||
19437283|NCT02107898|41684399|FG000|Overall Study|Randomized but not treated|0|||
19437284|NCT02107898|41684400|FG001|Overall Study|Randomized but not treated|1|||
19437285|NCT02059148|41684406|FG000|Treatment 1|Protocol Violation|0|||
19437286|NCT02059148|41684407|FG001|Treatment 1|Protocol Violation|0|||
19437287|NCT02059148|41684408|FG002|Treatment 1|Protocol Violation|0|||
19437288|NCT02059148|41684409|FG003|Treatment 1|Protocol Violation|0|||
19437289|NCT02059148|41684410|FG004|Treatment 1|Protocol Violation|0|||
19437290|NCT02059148|41684411|FG005|Treatment 1|Protocol Violation|1|||
19437291|NCT02058992|41684422|FG000|Overall Study|Lost to Follow-up|4|||
19437292|NCT02058992|41684422|FG000|Overall Study|Protocol Violation|92|||
19437293|NCT02058992|41684422|FG000|Overall Study|CRF Uncollected|20|||
19437294|NCT02058836|41684428|FG000|Overall Study|Withdrawal by Subject|1|||
19437295|NCT02058836|41684429|FG001|Overall Study|Withdrawal by Subject|1|||
19437296|NCT02107274|41684437|FG000|Treatment vs. Placebo|Adverse Event|3|||
19437297|NCT02107274|41684438|FG001|Treatment vs. Placebo|Adverse Event|0|||
19437298|NCT02107274|41684437|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
19437299|NCT02107274|41684438|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
19437300|NCT02107274|41684437|FG000|Control Phase|Lost to Follow-up|1|||
19437301|NCT02107274|41684438|FG001|Control Phase|Lost to Follow-up|1|||
19437302|NCT02107274|41684437|FG000|Control Phase|Death|2|||
19437303|NCT02107274|41684438|FG001|Control Phase|Death|0|||
19437304|NCT02107274|41684437|FG000|Control Phase|Adverse Event|0|||
19437305|NCT02107274|41684438|FG001|Control Phase|Adverse Event|1|||
19437306|NCT02174627|41684446|FG000|Overall Study|Missing|0|||
19437307|NCT02174627|41684447|FG001|Overall Study|Missing|1|||
19437308|NCT02174627|41684446|FG000|Overall Study|Incorrect enrolment before randomization|0|||
19437309|NCT02174627|41684447|FG001|Overall Study|Incorrect enrolment before randomization|1|||
19437310|NCT02174627|41684446|FG000|Overall Study|Participant decision|84|||
19437311|NCT02174627|41684447|FG001|Overall Study|Participant decision|128|||
19437312|NCT02173769|41684453|FG000|Overall Study|Protocol Violation|4|||
19437313|NCT02121509|41684460|FG000|Washout Period (35 Days)|Adverse Event|1|||
19437314|NCT02121509|41684461|FG001|Washout Period (35 Days)|Adverse Event|1|||
19437315|NCT02121509|41684462|FG002|Washout Period (35 Days)|Adverse Event|0|||
19437316|NCT02121509|41684463|FG003|Washout Period (35 Days)|Adverse Event|0|||
19437317|NCT02121509|41684460|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
19437318|NCT02121509|41684461|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
19437319|NCT02121509|41684462|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
19437320|NCT02121509|41684463|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
19437321|NCT02121509|41684460|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
19437322|NCT02121509|41684461|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
19437323|NCT02121509|41684462|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
19437324|NCT02121509|41684463|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
19437325|NCT02149199|41684476|FG000|Overall Study|Study specific withdrawal criteria|4|||
19437326|NCT02149199|41684477|FG001|Overall Study|Study specific withdrawal criteria|21|||
19437327|NCT02149199|41684478|FG002|Overall Study|Study specific withdrawal criteria|6|||
19437328|NCT02149199|41684476|FG000|Overall Study|Other|20|||
19437329|NCT02149199|41684477|FG001|Overall Study|Other|25|||
19437330|NCT02149199|41684478|FG002|Overall Study|Other|20|||
19437331|NCT02149199|41684476|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
19437332|NCT02149199|41684477|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
19437333|NCT02149199|41684478|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
19437334|NCT02149199|41684476|FG000|Overall Study|Withdrawal by Subject|75|||
19437335|NCT02149199|41684477|FG001|Overall Study|Withdrawal by Subject|93|||
19437336|NCT02149199|41684478|FG002|Overall Study|Withdrawal by Subject|77|||
19437337|NCT02149199|41684476|FG000|Overall Study|Protocol Violation|16|||
19437338|NCT02149199|41684477|FG001|Overall Study|Protocol Violation|13|||
19437339|NCT02149199|41684478|FG002|Overall Study|Protocol Violation|15|||
19437340|NCT02149199|41684476|FG000|Overall Study|Lost to Follow-up|3|||
19437341|NCT02149199|41684477|FG001|Overall Study|Lost to Follow-up|12|||
19437342|NCT02149199|41684478|FG002|Overall Study|Lost to Follow-up|11|||
19437343|NCT02149199|41684476|FG000|Overall Study|Death|0|||
19437344|NCT02149199|41684477|FG001|Overall Study|Death|0|||
19437345|NCT02149199|41684478|FG002|Overall Study|Death|1|||
19437346|NCT02149199|41684476|FG000|Overall Study|Adverse Event|6|||
19437347|NCT02149199|41684477|FG001|Overall Study|Adverse Event|15|||
19437348|NCT02149199|41684478|FG002|Overall Study|Adverse Event|9|||
19437349|NCT02120417|41684488|FG000|Overall Study|Death|5|||
19437350|NCT02120417|41684489|FG001|Overall Study|Death|1|||
19437351|NCT02120417|41684488|FG000|Overall Study|Adverse Event|3|||
19437352|NCT02120417|41684489|FG001|Overall Study|Adverse Event|9|||
19437353|NCT02120417|41684488|FG000|Overall Study|Participant decision|4|||
19437354|NCT02120417|41684489|FG001|Overall Study|Participant decision|4|||
19437355|NCT02120417|41684488|FG000|Overall Study|Disease progression|41|||
19437356|NCT02120417|41684489|FG001|Overall Study|Disease progression|45|||
19437357|NCT02120417|41684488|FG000|Overall Study|Noncompliance with study treatment|0|||
19437358|NCT02120417|41684489|FG001|Overall Study|Noncompliance with study treatment|2|||
19437359|NCT02120417|41684488|FG000|Overall Study|Physician Decision|2|||
19437360|NCT02120417|41684489|FG001|Overall Study|Physician Decision|3|||
19437361|NCT02120417|41684488|FG000|Overall Study|Other unspecified|5|||
19437362|NCT02120417|41684489|FG001|Overall Study|Other unspecified|4|||
19437363|NCT02148263|41684497|FG000|Overall Study|Withdrawal by Subject|3|||
19437364|NCT02148263|41684498|FG001|Overall Study|Withdrawal by Subject|2|||
19437365|NCT02147561|41684504|FG000|Overall Study|Lost to Follow-up|3|||
19437366|NCT02147561|41684504|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
19437367|NCT02058368|41684510|FG000|Overall Study|Adverse Event|15|||
19437368|NCT02058368|41684511|FG001|Overall Study|Adverse Event|20|||
19437369|NCT02058368|41684510|FG000|Overall Study|Lack of Efficacy|0|||
19437370|NCT02058368|41684511|FG001|Overall Study|Lack of Efficacy|1|||
19437371|NCT02058368|41684510|FG000|Overall Study|Protocol Violation|0|||
19437372|NCT02058368|41684511|FG001|Overall Study|Protocol Violation|4|||
19437373|NCT02058368|41684510|FG000|Overall Study|Lost to Follow-up|2|||
19437374|NCT02058368|41684511|FG001|Overall Study|Lost to Follow-up|0|||
19437375|NCT02058368|41684510|FG000|Overall Study|Physician Decision|2|||
19437376|NCT02058368|41684511|FG001|Overall Study|Physician Decision|3|||
19437377|NCT02058368|41684510|FG000|Overall Study|Withdrawal by Subject|22|||
19437378|NCT02058368|41684511|FG001|Overall Study|Withdrawal by Subject|26|||
19437379|NCT02107196|41684519|FG000|12-week Treatment Period|Adverse Event|6|||
19437380|NCT02107196|41684520|FG001|12-week Treatment Period|Adverse Event|3|||
19437381|NCT02107196|41684519|FG000|12-week Treatment Period|Lack of Efficacy|2|||
19437382|NCT02107196|41684520|FG001|12-week Treatment Period|Lack of Efficacy|1|||
19437383|NCT02107196|41684519|FG000|12-week Treatment Period|Lost to Follow-up|3|||
19437384|NCT02107196|41684520|FG001|12-week Treatment Period|Lost to Follow-up|6|||
19437385|NCT02107196|41684519|FG000|12-week Treatment Period|Physician Decision|0|||
19437386|NCT02107196|41684520|FG001|12-week Treatment Period|Physician Decision|1|||
19437387|NCT02107196|41684519|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
19437388|NCT02107196|41684520|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
19437389|NCT02107196|41684519|FG000|12-week Treatment Period|Protocol Violation|7|||
19437390|NCT02107196|41684520|FG001|12-week Treatment Period|Protocol Violation|8|||
19437391|NCT02107196|41684519|FG000|12-week Treatment Period|Reason Missing|11|||
19437392|NCT02107196|41684520|FG001|12-week Treatment Period|Reason Missing|8|||
19437393|NCT02107196|41684519|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
19437394|NCT02107196|41684520|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
19437395|NCT02107196|41684519|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
19437396|NCT02107196|41684520|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
19437397|NCT02107196|41684519|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
19437398|NCT02107196|41684520|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
19437399|NCT02107196|41684519|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
19437400|NCT02107196|41684520|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
19437401|NCT02058290|41684528|FG000|Overall Study|Protocol Violation|2|||
19437402|NCT02058290|41684529|FG001|Overall Study|Protocol Violation|1|||
19437403|NCT02058290|41684528|FG000|Overall Study|Physician Decision|1|||
19437404|NCT02058290|41684529|FG001|Overall Study|Physician Decision|0|||
19437405|NCT02058290|41684528|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
19437406|NCT02058290|41684529|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
19437407|NCT02058290|41684528|FG000|Overall Study|Withdrawal by Subject|0|||
19437408|NCT02058290|41684529|FG001|Overall Study|Withdrawal by Subject|1|||
19437409|NCT02082158|41684541|FG000|Overall Study|Withdrawal by Subject|0|||
19437410|NCT02082158|41684542|FG001|Overall Study|Withdrawal by Subject|0|||
19437411|NCT02082158|41684543|FG002|Overall Study|Withdrawal by Subject|0|||
19437412|NCT02082158|41684544|FG003|Overall Study|Withdrawal by Subject|0|||
19437413|NCT02082158|41684545|FG004|Overall Study|Withdrawal by Subject|1|||
19437414|NCT02082158|41684546|FG005|Overall Study|Withdrawal by Subject|0|||
19437415|NCT02082158|41684541|FG000|Overall Study|Failed Fit-testing|8|||
19437416|NCT02082158|41684542|FG001|Overall Study|Failed Fit-testing|8|||
19437417|NCT02082158|41684543|FG002|Overall Study|Failed Fit-testing|14|||
19437418|NCT02082158|41684544|FG003|Overall Study|Failed Fit-testing|4|||
19437419|NCT02082158|41684545|FG004|Overall Study|Failed Fit-testing|3|||
19437420|NCT02082158|41684546|FG005|Overall Study|Failed Fit-testing|7|||
19437421|NCT02106884|41684568|FG000|Overall Study|Change of diagnosis/exclusion|0|||
19437422|NCT02106884|41684569|FG001|Overall Study|Change of diagnosis/exclusion|1|||
19437423|NCT02081846|41684580|FG000|Overall Study|Withdrawal by Subject|1|||
19437424|NCT02081846|41684581|FG001|Overall Study|Withdrawal by Subject|0|||
19437425|NCT02081846|41684580|FG000|Overall Study|invalid consent|1|||
19437426|NCT02081846|41684581|FG001|Overall Study|invalid consent|0|||
19437427|NCT02081690|41684587|FG000|Overall Study|Death|3|||
19437428|NCT02081690|41684587|FG000|Overall Study|Physician Decision|3|||
19437429|NCT02081690|41684587|FG000|Overall Study|Withdrawal by Subject|1|||
19437430|NCT02057666|41684593|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
19437431|NCT02057666|41684594|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
19437432|NCT02057666|41684593|FG000|Double Blind Treatment Period|Poor tolerability|7|||
19437433|NCT02057666|41684594|FG001|Double Blind Treatment Period|Poor tolerability|2|||
19437434|NCT02057666|41684593|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
19437435|NCT02057666|41684594|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
19437436|NCT02057666|41684593|FG000|Double Blind Treatment Period|Physician Decision|1|||
19437437|NCT02057666|41684594|FG001|Double Blind Treatment Period|Physician Decision|0|||
19437438|NCT02057666|41684593|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
19437439|NCT02057666|41684594|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
19437440|NCT02057666|41684593|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
19437441|NCT02057666|41684594|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
19437442|NCT02057666|41684593|FG000|Double Blind Treatment Period|Sponsor's request|70|||
19437443|NCT02057666|41684594|FG001|Double Blind Treatment Period|Sponsor's request|34|||
19437444|NCT02057666|41684593|FG000|Open-Label Treatment Period|Poor tolerability|0|||
19437445|NCT02057666|41684594|FG001|Open-Label Treatment Period|Poor tolerability|1|||
19437446|NCT02057666|41684593|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
19437447|NCT02057666|41684594|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
19437448|NCT02057666|41684593|FG000|Open-Label Treatment Period|Sponsor's request|0|||
19437449|NCT02057666|41684594|FG001|Open-Label Treatment Period|Sponsor's request|4|||
19437450|NCT01625000|41684605|FG000|Overall Study|Physician Decision|15|||
19437451|NCT01625000|41684606|FG001|Overall Study|Physician Decision|7|||
19437452|NCT01625000|41684607|FG002|Overall Study|Physician Decision|7|||
19437453|NCT01625000|41684608|FG003|Overall Study|Physician Decision|2|||
19437454|NCT01625000|41684609|FG004|Overall Study|Physician Decision|15|||
19437455|NCT01625000|41684605|FG000|Overall Study|Protocol Violation|3|||
19437456|NCT01625000|41684606|FG001|Overall Study|Protocol Violation|10|||
19437457|NCT01625000|41684607|FG002|Overall Study|Protocol Violation|4|||
19437458|NCT01625000|41684608|FG003|Overall Study|Protocol Violation|1|||
19437459|NCT01625000|41684609|FG004|Overall Study|Protocol Violation|2|||
19437460|NCT01625000|41684605|FG000|Overall Study|Withdrawal by Subject|19|||
19437461|NCT01625000|41684606|FG001|Overall Study|Withdrawal by Subject|16|||
19437462|NCT01625000|41684607|FG002|Overall Study|Withdrawal by Subject|11|||
19437463|NCT01625000|41684608|FG003|Overall Study|Withdrawal by Subject|9|||
19437464|NCT01625000|41684609|FG004|Overall Study|Withdrawal by Subject|17|||
19437465|NCT01625000|41684605|FG000|Overall Study|Adverse Event (including Death)|15|||
19437466|NCT01625000|41684606|FG001|Overall Study|Adverse Event (including Death)|19|||
19437467|NCT01625000|41684607|FG002|Overall Study|Adverse Event (including Death)|11|||
19437468|NCT01625000|41684608|FG003|Overall Study|Adverse Event (including Death)|7|||
19437469|NCT01625000|41684609|FG004|Overall Study|Adverse Event (including Death)|21|||
19437470|NCT02081534|41684628|FG000|Overall Study|Adverse Event|5|||
19437471|NCT02081534|41684629|FG001|Overall Study|Adverse Event|4|||
19437472|NCT02081534|41684630|FG002|Overall Study|Adverse Event|3|||
19437473|NCT02081534|41684631|FG003|Overall Study|Adverse Event|10|||
19437474|NCT02081534|41684632|FG004|Overall Study|Adverse Event|2|||
19437475|NCT02081534|41684633|FG005|Overall Study|Adverse Event|8|||
19437476|NCT02081534|41684634|FG006|Overall Study|Adverse Event|2|||
19437477|NCT02081534|41684628|FG000|Overall Study|Withdrawal by Subject|0|||
19437478|NCT02081534|41684629|FG001|Overall Study|Withdrawal by Subject|1|||
19437479|NCT02081534|41684630|FG002|Overall Study|Withdrawal by Subject|1|||
19437480|NCT02081534|41684631|FG003|Overall Study|Withdrawal by Subject|1|||
19437481|NCT02081534|41684632|FG004|Overall Study|Withdrawal by Subject|1|||
19437482|NCT02081534|41684633|FG005|Overall Study|Withdrawal by Subject|0|||
19437483|NCT02081534|41684634|FG006|Overall Study|Withdrawal by Subject|1|||
19437484|NCT02081534|41684628|FG000|Overall Study|Protocol Violation|0|||
19437485|NCT02081534|41684629|FG001|Overall Study|Protocol Violation|3|||
19437486|NCT02081534|41684630|FG002|Overall Study|Protocol Violation|0|||
19437487|NCT02081534|41684631|FG003|Overall Study|Protocol Violation|0|||
19437488|NCT02081534|41684632|FG004|Overall Study|Protocol Violation|0|||
19437489|NCT02081534|41684633|FG005|Overall Study|Protocol Violation|0|||
19437490|NCT02081534|41684634|FG006|Overall Study|Protocol Violation|1|||
19437491|NCT02081534|41684628|FG000|Overall Study|Lost to Follow-up|0|||
19437492|NCT02081534|41684629|FG001|Overall Study|Lost to Follow-up|0|||
19437493|NCT02081534|41684630|FG002|Overall Study|Lost to Follow-up|0|||
19437494|NCT02081534|41684631|FG003|Overall Study|Lost to Follow-up|2|||
19437495|NCT02081534|41684632|FG004|Overall Study|Lost to Follow-up|1|||
19437496|NCT02081534|41684633|FG005|Overall Study|Lost to Follow-up|1|||
19437497|NCT02081534|41684634|FG006|Overall Study|Lost to Follow-up|0|||
19437498|NCT02057198|41684653|FG000|Overall Study|Death|0|||
19437499|NCT02057198|41684654|FG001|Overall Study|Death|0|||
19437500|NCT02057198|41684655|FG002|Overall Study|Death|1|||
19437501|NCT02057198|41684653|FG000|Overall Study|Discharged early; lost to followup|0|||
19437502|NCT02057198|41684654|FG001|Overall Study|Discharged early; lost to followup|1|||
19437503|NCT02057198|41684655|FG002|Overall Study|Discharged early; lost to followup|0|||
19437504|NCT02056652|41684665|FG000|Overall Study|Withdrawal by Subject|1|||
19437505|NCT02056652|41684666|FG001|Overall Study|Withdrawal by Subject|0|||
19437506|NCT02056652|41684665|FG000|Overall Study|Lost to Follow-up|0|||
19437507|NCT02056652|41684666|FG001|Overall Study|Lost to Follow-up|3|||
19437508|NCT02056340|41684674|FG000|Overall Study|Lost to Follow-up|5|||
19437509|NCT02056340|41684675|FG001|Overall Study|Lost to Follow-up|5|||
19437510|NCT02056340|41684674|FG000|Overall Study|Withdrawal by Subject|2|||
19437511|NCT02056340|41684675|FG001|Overall Study|Withdrawal by Subject|6|||
19437512|NCT02046122|41684681|FG000|Overall Study|Physician Decision|8|||
19437513|NCT02046122|41684681|FG000|Overall Study|Withdrawal by Subject|1|||
19437514|NCT02080832|41684688|FG000|Overall Study|Excluded from analysis by MRI|9|||
19437515|NCT02080832|41684689|FG001|Overall Study|Excluded from analysis by MRI|10|||
19437516|NCT02080832|41684690|FG002|Overall Study|Excluded from analysis by MRI|14|||
19437517|NCT02080832|41684688|FG000|Overall Study|Lost to Follow-up|0|||
19437518|NCT02080832|41684689|FG001|Overall Study|Lost to Follow-up|2|||
19437519|NCT02080832|41684690|FG002|Overall Study|Lost to Follow-up|2|||
19437520|NCT02080364|41684704|FG000|Baseline Period|Protocol Violation|2|||
19437521|NCT02080364|41684705|FG001|Baseline Period|Protocol Violation|1|||
19437522|NCT02080364|41684706|FG002|Baseline Period|Protocol Violation|0|||
19437523|NCT02080364|41684707|FG003|Baseline Period|Protocol Violation|0|||
19437524|NCT02080364|41684704|FG000|Baseline Period|Other|0|||
19437525|NCT02080364|41684705|FG001|Baseline Period|Other|1|||
19437526|NCT02080364|41684706|FG002|Baseline Period|Other|1|||
19437527|NCT02080364|41684707|FG003|Baseline Period|Other|0|||
19437528|NCT02080364|41684704|FG000|Treatment Period|Adverse Event|10|||
19437529|NCT02080364|41684705|FG001|Treatment Period|Adverse Event|15|||
19437530|NCT02080364|41684706|FG002|Treatment Period|Adverse Event|11|||
19437531|NCT02080364|41684707|FG003|Treatment Period|Adverse Event|14|||
19437532|NCT02080364|41684704|FG000|Treatment Period|Lost to Follow-up|2|||
19437533|NCT02080364|41684705|FG001|Treatment Period|Lost to Follow-up|3|||
19437534|NCT02080364|41684706|FG002|Treatment Period|Lost to Follow-up|5|||
19437535|NCT02080364|41684707|FG003|Treatment Period|Lost to Follow-up|0|||
19437536|NCT02080364|41684704|FG000|Treatment Period|Protocol Violation|5|||
19437537|NCT02080364|41684705|FG001|Treatment Period|Protocol Violation|3|||
19437538|NCT02080364|41684706|FG002|Treatment Period|Protocol Violation|5|||
19437539|NCT02080364|41684707|FG003|Treatment Period|Protocol Violation|1|||
19437540|NCT02080364|41684704|FG000|Treatment Period|Withdrawal by Subject|16|||
19437541|NCT02080364|41684705|FG001|Treatment Period|Withdrawal by Subject|16|||
19437542|NCT02080364|41684706|FG002|Treatment Period|Withdrawal by Subject|15|||
19437543|NCT02080364|41684707|FG003|Treatment Period|Withdrawal by Subject|10|||
19437544|NCT02080364|41684704|FG000|Treatment Period|Study Terminated by Sponsor|0|||
19437545|NCT02080364|41684705|FG001|Treatment Period|Study Terminated by Sponsor|0|||
19437546|NCT02080364|41684706|FG002|Treatment Period|Study Terminated by Sponsor|180|||
19437547|NCT02080364|41684707|FG003|Treatment Period|Study Terminated by Sponsor|183|||
19437548|NCT02080364|41684704|FG000|Treatment Period|Other|14|||
19437549|NCT02080364|41684705|FG001|Treatment Period|Other|12|||
19437550|NCT02080364|41684706|FG002|Treatment Period|Other|21|||
19437551|NCT02080364|41684707|FG003|Treatment Period|Other|16|||
19437552|NCT02079038|41684719|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
19437553|NCT02079038|41684720|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
19437554|NCT02079038|41684719|FG000|Modified Intent to Treat Population|Death|1|||
19437555|NCT02079038|41684720|FG001|Modified Intent to Treat Population|Death|0|||
19437556|NCT02079038|41684719|FG000|Completed 6 Months|Lost to Follow-up|2|||
19437557|NCT02079038|41684720|FG001|Completed 6 Months|Lost to Follow-up|1|||
19437558|NCT02045732|41684728|FG000|Overall Study|At the discretion of the investigator|1|||
19437559|NCT02045732|41684729|FG001|Overall Study|At the discretion of the investigator|1|||
19437560|NCT02044874|41684738|FG000|Overall Study|Adverse Event|5|||
19437561|NCT02044874|41684739|FG001|Overall Study|Adverse Event|6|||
19437562|NCT02044874|41684740|FG002|Overall Study|Adverse Event|6|||
19437563|NCT02044874|41684738|FG000|Overall Study|Withdrawal by Subject|8|||
19437564|NCT02044874|41684739|FG001|Overall Study|Withdrawal by Subject|16|||
19437565|NCT02044874|41684740|FG002|Overall Study|Withdrawal by Subject|23|||
19437566|NCT02044874|41684738|FG000|Overall Study|Physician Decision|0|||
19437567|NCT02044874|41684739|FG001|Overall Study|Physician Decision|2|||
19437568|NCT02044874|41684740|FG002|Overall Study|Physician Decision|1|||
19437569|NCT02044874|41684738|FG000|Overall Study|Lost to Follow-up|10|||
19437570|NCT02044874|41684739|FG001|Overall Study|Lost to Follow-up|27|||
19437571|NCT02044874|41684740|FG002|Overall Study|Lost to Follow-up|21|||
19437572|NCT02044874|41684738|FG000|Overall Study|Sponsor Decision|0|||
19437573|NCT02044874|41684739|FG001|Overall Study|Sponsor Decision|1|||
19437574|NCT02044874|41684740|FG002|Overall Study|Sponsor Decision|1|||
19437575|NCT02044874|41684738|FG000|Overall Study|Other|7|||
19437576|NCT02044874|41684739|FG001|Overall Study|Other|3|||
19437577|NCT02044874|41684740|FG002|Overall Study|Other|8|||
19437578|NCT02078960|41684753|FG000|Treatment Period|Other|0|||
19437579|NCT02078960|41684754|FG001|Treatment Period|Other|0|||
19437580|NCT02078960|41684755|FG002|Treatment Period|Other|1|||
19437581|NCT02078960|41684753|FG000|Treatment Period|Lack of Efficacy|0|||
19437582|NCT02078960|41684754|FG001|Treatment Period|Lack of Efficacy|1|||
19437583|NCT02078960|41684755|FG002|Treatment Period|Lack of Efficacy|0|||
19437584|NCT02078960|41684753|FG000|Treatment Period|Disease progression - accelerated phase|0|||
19437585|NCT02078960|41684754|FG001|Treatment Period|Disease progression - accelerated phase|1|||
19437586|NCT02078960|41684755|FG002|Treatment Period|Disease progression - accelerated phase|0|||
19437587|NCT02078960|41684753|FG000|Treatment Period|Disease progression - blast phase|1|||
19437588|NCT02078960|41684754|FG001|Treatment Period|Disease progression - blast phase|0|||
19437589|NCT02078960|41684755|FG002|Treatment Period|Disease progression - blast phase|0|||
19437590|NCT02078960|41684753|FG000|Treatment Period|Withdrawal by Subject|0|||
19437591|NCT02078960|41684754|FG001|Treatment Period|Withdrawal by Subject|1|||
19437592|NCT02078960|41684755|FG002|Treatment Period|Withdrawal by Subject|1|||
19437593|NCT02078960|41684753|FG000|Treatment Period|Adverse Event|1|||
19437594|NCT02078960|41684754|FG001|Treatment Period|Adverse Event|0|||
19437595|NCT02078960|41684755|FG002|Treatment Period|Adverse Event|0|||
19437596|NCT02078960|41684753|FG000|Treatment Period|Death|0|||
19521935|NCT00982488|41935379|FG001|Overall Study|Death|0|||
19521936|NCT00982488|41935380|FG002|Overall Study|Death|2|||
19437597|NCT02078960|41684754|FG001|Treatment Period|Death|0|||
19437598|NCT02078960|41684755|FG002|Treatment Period|Death|1|||
19437599|NCT02078960|41684753|FG000|Follow-up Period|Death|2|||
19437600|NCT02078960|41684754|FG001|Follow-up Period|Death|0|||
19437601|NCT02078960|41684755|FG002|Follow-up Period|Death|0|||
19437602|NCT02078960|41684753|FG000|Follow-up Period|Lost to Follow-up|0|||
19437603|NCT02078960|41684754|FG001|Follow-up Period|Lost to Follow-up|1|||
19437604|NCT02078960|41684755|FG002|Follow-up Period|Lost to Follow-up|0|||
19437605|NCT02078102|41684767|FG000|Overall Study|Adverse Event|1|||
19437606|NCT02078102|41684768|FG001|Overall Study|Adverse Event|0|||
19437607|NCT02078102|41684767|FG000|Overall Study|Withdrawal by Subject|1|||
19437608|NCT02078102|41684768|FG001|Overall Study|Withdrawal by Subject|0|||
19437609|NCT02078102|41684767|FG000|Overall Study|Physician Decision|0|||
19437610|NCT02078102|41684768|FG001|Overall Study|Physician Decision|1|||
19437611|NCT02054702|41684777|FG000|Overall Study|Lost to Follow-up|3|||
19437612|NCT02054702|41684778|FG001|Overall Study|Lost to Follow-up|5|||
19437613|NCT02054702|41684777|FG000|Overall Study|Adverse Event|3|||
19437614|NCT02054702|41684778|FG001|Overall Study|Adverse Event|1|||
19437615|NCT02054702|41684777|FG000|Overall Study|Met Withdrawal Criteria|4|||
19437616|NCT02054702|41684778|FG001|Overall Study|Met Withdrawal Criteria|1|||
19437617|NCT02054702|41684777|FG000|Overall Study|Physician Decision|0|||
19437618|NCT02054702|41684778|FG001|Overall Study|Physician Decision|1|||
19437619|NCT02054702|41684777|FG000|Overall Study|Withdrawal by Subject|14|||
19437620|NCT02054702|41684778|FG001|Overall Study|Withdrawal by Subject|4|||
19437621|NCT02044094|41684784|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
19437622|NCT02044094|41684784|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
19437623|NCT02044094|41684784|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
19437624|NCT02044094|41684784|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
19437625|NCT02044094|41684784|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
19437626|NCT02044094|41684784|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
19437627|NCT02044094|41684784|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
19437628|NCT02044094|41684784|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
19437629|NCT02043938|41684799|FG000|Overall Study|Withdrawal by Subject|7|||
19437630|NCT02043938|41684799|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
19437631|NCT02043938|41684799|FG000|Overall Study|No show by subject|1|||
19437632|NCT02043938|41684799|FG000|Overall Study|Investigator decision|1|||
19437633|NCT02053610|41684808|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
19437634|NCT02053610|41684809|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
19437635|NCT02053610|41684808|FG000|Overall Study|Withdrew Consent|2|||
19437636|NCT02053610|41684809|FG001|Overall Study|Withdrew Consent|9|||
19437637|NCT02053610|41684808|FG000|Overall Study|Death|5|||
19437638|NCT02053610|41684809|FG001|Overall Study|Death|5|||
19437639|NCT02053610|41684808|FG000|Overall Study|Administrative/Other|1|||
19437640|NCT02053610|41684809|FG001|Overall Study|Administrative/Other|1|||
19437641|NCT02053610|41684808|FG000|Overall Study|Disease Progression|2|||
19437642|NCT02053610|41684809|FG001|Overall Study|Disease Progression|3|||
19437643|NCT02053610|41684808|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
19437644|NCT02053610|41684809|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
19437645|NCT02053610|41684808|FG000|Overall Study|Did not Receive Treatment|4|||
19437646|NCT02053610|41684809|FG001|Overall Study|Did not Receive Treatment|2|||
19437647|NCT02053610|41684808|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19437648|NCT02053610|41684809|FG001|Overall Study|Insufficient Therapeutic Response|1|||
19437649|NCT02053610|41684808|FG000|Overall Study|Violation of Selection Criteria|1|||
19437650|NCT02053610|41684809|FG001|Overall Study|Violation of Selection Criteria|0|||
19437651|NCT02075606|41684815|FG000|Overall Study|Adverse Event|5|||
19437652|NCT02075606|41684815|FG000|Overall Study|Withdrawal by Subject|1|||
19437653|NCT02075606|41684815|FG000|Overall Study|Death|1|||
19437654|NCT02075606|41684815|FG000|Overall Study|Investigator's decision|1|||
19437655|NCT02075606|41684815|FG000|Overall Study|Symptom management|1|||
19437656|NCT02075606|41684815|FG000|Overall Study|Increasing Symptoms|1|||
19437657|NCT02043782|41684824|FG000|Period 1|Adverse Event|0|||
19437658|NCT02043782|41684825|FG001|Period 1|Adverse Event|0|||
19437659|NCT02043782|41684826|FG002|Period 1|Adverse Event|1|||
19437660|NCT02043782|41684827|FG003|Period 1|Adverse Event|0|||
19437661|NCT02043782|41684828|FG004|Period 1|Adverse Event|0|||
19437662|NCT02043782|41684829|FG005|Period 1|Adverse Event|0|||
19437663|NCT02052596|41684839|FG000|Active Phase|Adverse Event|3|||
19437664|NCT02052596|41684840|FG001|Active Phase|Adverse Event|2|||
19437665|NCT02052596|41684839|FG000|Active Phase|Lost to Follow-up|8|||
19437666|NCT02052596|41684840|FG001|Active Phase|Lost to Follow-up|11|||
19437667|NCT02052596|41684839|FG000|Active Phase|Protocol Violation|1|||
19437668|NCT02052596|41684840|FG001|Active Phase|Protocol Violation|2|||
19437669|NCT02052596|41684839|FG000|Active Phase|Withdrawal by Subject|3|||
19437670|NCT02052596|41684840|FG001|Active Phase|Withdrawal by Subject|4|||
19437671|NCT02052596|41684839|FG000|Active Phase|Enrolled in error|1|||
19437672|NCT02052596|41684840|FG001|Active Phase|Enrolled in error|0|||
19437673|NCT02052596|41684839|FG000|Active Phase|Lost due to Crohn's disease|0|||
19437674|NCT02052596|41684840|FG001|Active Phase|Lost due to Crohn's disease|1|||
19437675|NCT02052596|41684839|FG000|Safety Phase|Adverse Event|6|||
19437676|NCT02052596|41684840|FG001|Safety Phase|Adverse Event|3|||
19437677|NCT02052596|41684839|FG000|Safety Phase|Lost to Follow-up|11|||
19437678|NCT02052596|41684840|FG001|Safety Phase|Lost to Follow-up|18|||
19437679|NCT02052596|41684839|FG000|Safety Phase|Protocol Violation|1|||
19437680|NCT02052596|41684840|FG001|Safety Phase|Protocol Violation|2|||
19437681|NCT02052596|41684839|FG000|Safety Phase|Withdrawal by Subject|8|||
19437682|NCT02052596|41684840|FG001|Safety Phase|Withdrawal by Subject|11|||
19437683|NCT02052596|41684839|FG000|Safety Phase|Enrolled in error|1|||
19437684|NCT02052596|41684840|FG001|Safety Phase|Enrolled in error|0|||
19437685|NCT02052596|41684839|FG000|Safety Phase|Lost due to Crohn's disease|0|||
19437686|NCT02052596|41684840|FG001|Safety Phase|Lost due to Crohn's disease|1|||
19437687|NCT02052440|41684848|FG000|Overall Study|Withdrawal by Subject|0|||
19437688|NCT02052440|41684849|FG001|Overall Study|Withdrawal by Subject|1|||
19437689|NCT02049944|41684855|FG000|Overall Study|Protocol Violation|2|||
19437690|NCT02043548|41684861|FG000|Overall Study|Lack of Efficacy|1|||
19437691|NCT02043548|41684862|FG001|Overall Study|Lack of Efficacy|0|||
19437692|NCT02043548|41684861|FG000|Overall Study|Adverse Event|0|||
19437693|NCT02043548|41684862|FG001|Overall Study|Adverse Event|1|||
19437694|NCT01622348|41684871|FG000|Overall Study|Withdrawal by Subject|1|||
19437695|NCT01622348|41684872|FG001|Overall Study|Withdrawal by Subject|0|||
19437696|NCT01622348|41684873|FG002|Overall Study|Withdrawal by Subject|1|||
19437697|NCT01621880|41684883|FG000|Overall Study|Adverse Event|5|||
19437698|NCT01621880|41684884|FG001|Overall Study|Adverse Event|1|||
19437699|NCT01621880|41684883|FG000|Overall Study|Withdrawal by Subject|5|||
19437700|NCT01621880|41684884|FG001|Overall Study|Withdrawal by Subject|4|||
19437701|NCT01621802|41684897|FG000|Overall Study|Protocol Violation|0|||
19437702|NCT01621802|41684898|FG001|Overall Study|Protocol Violation|0|||
19437703|NCT01621802|41684899|FG002|Overall Study|Protocol Violation|0|||
19437704|NCT01621802|41684900|FG003|Overall Study|Protocol Violation|0|||
19437705|NCT01621802|41684901|FG004|Overall Study|Protocol Violation|0|||
19437706|NCT01621802|41684902|FG005|Overall Study|Protocol Violation|1|||
19437707|NCT01621802|41684897|FG000|Overall Study|Withdrawal by Subject|8|||
19437708|NCT01621802|41684898|FG001|Overall Study|Withdrawal by Subject|4|||
19437709|NCT01621802|41684899|FG002|Overall Study|Withdrawal by Subject|4|||
19437710|NCT01621802|41684900|FG003|Overall Study|Withdrawal by Subject|2|||
19437711|NCT01621802|41684901|FG004|Overall Study|Withdrawal by Subject|2|||
19437712|NCT01621802|41684902|FG005|Overall Study|Withdrawal by Subject|0|||
19437713|NCT01621802|41684897|FG000|Overall Study|Migrated/moved from study area|0|||
19437714|NCT01621802|41684898|FG001|Overall Study|Migrated/moved from study area|0|||
19437715|NCT01621802|41684899|FG002|Overall Study|Migrated/moved from study area|2|||
19437716|NCT01621802|41684900|FG003|Overall Study|Migrated/moved from study area|0|||
19437717|NCT01621802|41684901|FG004|Overall Study|Migrated/moved from study area|1|||
19437718|NCT01621802|41684902|FG005|Overall Study|Migrated/moved from study area|0|||
19437719|NCT01621802|41684897|FG000|Overall Study|Others|3|||
19437720|NCT01621802|41684898|FG001|Overall Study|Others|3|||
19437721|NCT01621802|41684899|FG002|Overall Study|Others|3|||
19437722|NCT01621802|41684900|FG003|Overall Study|Others|2|||
19437723|NCT01621802|41684901|FG004|Overall Study|Others|1|||
19437724|NCT01621802|41684902|FG005|Overall Study|Others|0|||
19437725|NCT01621802|41684897|FG000|Overall Study|Lost to Follow-up|36|||
19437726|NCT01621802|41684898|FG001|Overall Study|Lost to Follow-up|16|||
19437727|NCT01621802|41684899|FG002|Overall Study|Lost to Follow-up|24|||
19437728|NCT01621802|41684900|FG003|Overall Study|Lost to Follow-up|7|||
19437729|NCT01621802|41684901|FG004|Overall Study|Lost to Follow-up|31|||
19437730|NCT01621802|41684902|FG005|Overall Study|Lost to Follow-up|11|||
19437731|NCT02059291|41684928|FG000|Epoch 2|Lack of Efficacy|0|||
19437732|NCT02059291|41684929|FG001|Epoch 2|Lack of Efficacy|0|||
19437733|NCT02059291|41684930|FG002|Epoch 2|Lack of Efficacy|0|||
19437734|NCT02059291|41684931|FG003|Epoch 2|Lack of Efficacy|1|||
19437735|NCT02059291|41684932|FG004|Epoch 2|Lack of Efficacy|0|||
19437736|NCT02059291|41684933|FG005|Epoch 2|Lack of Efficacy|1|||
19437737|NCT02059291|41684934|FG006|Epoch 2|Lack of Efficacy|0|||
19437738|NCT02059291|41684935|FG007|Epoch 2|Lack of Efficacy|0|||
19437739|NCT02059291|41684936|FG008|Epoch 2|Lack of Efficacy|0|||
19437740|NCT02059291|41684937|FG009|Epoch 2|Lack of Efficacy|0|||
19437741|NCT02059291|41684938|FG010|Epoch 2|Lack of Efficacy|0|||
19437742|NCT02059291|41684939|FG011|Epoch 2|Lack of Efficacy|0|||
19437743|NCT02059291|41684940|FG012|Epoch 2|Lack of Efficacy|0|||
19437744|NCT02059291|41684941|FG013|Epoch 2|Lack of Efficacy|0|||
19437745|NCT02059291|41684942|FG014|Epoch 2|Lack of Efficacy|0|||
19437746|NCT02059291|41684943|FG015|Epoch 2|Lack of Efficacy|0|||
19437747|NCT02059291|41684944|FG016|Epoch 2|Lack of Efficacy|0|||
19437748|NCT02059291|41684945|FG017|Epoch 2|Lack of Efficacy|0|||
19437749|NCT02059291|41684946|FG018|Epoch 2|Lack of Efficacy|0|||
19437750|NCT02059291|41684947|FG019|Epoch 2|Lack of Efficacy|0|||
19437751|NCT02059291|41684948|FG020|Epoch 2|Lack of Efficacy|0|||
19437752|NCT02059291|41684949|FG021|Epoch 2|Lack of Efficacy|0|||
19437753|NCT02059291|41684950|FG022|Epoch 2|Lack of Efficacy|0|||
19437754|NCT02059291|41684951|FG023|Epoch 2|Lack of Efficacy|0|||
19437755|NCT02059291|41684952|FG024|Epoch 2|Lack of Efficacy|0|||
19437756|NCT02059291|41684928|FG000|Epoch 2|Adverse Event|0|||
19437757|NCT02059291|41684929|FG001|Epoch 2|Adverse Event|0|||
19437758|NCT02059291|41684930|FG002|Epoch 2|Adverse Event|1|||
19437759|NCT02059291|41684931|FG003|Epoch 2|Adverse Event|1|||
19437760|NCT02059291|41684932|FG004|Epoch 2|Adverse Event|0|||
19437761|NCT02059291|41684933|FG005|Epoch 2|Adverse Event|0|||
19437762|NCT02059291|41684934|FG006|Epoch 2|Adverse Event|0|||
19437763|NCT02059291|41684935|FG007|Epoch 2|Adverse Event|1|||
19437764|NCT02059291|41684936|FG008|Epoch 2|Adverse Event|1|||
19437765|NCT02059291|41684937|FG009|Epoch 2|Adverse Event|0|||
19437766|NCT02059291|41684938|FG010|Epoch 2|Adverse Event|0|||
19437767|NCT02059291|41684939|FG011|Epoch 2|Adverse Event|0|||
19437768|NCT02059291|41684940|FG012|Epoch 2|Adverse Event|0|||
19437769|NCT02059291|41684941|FG013|Epoch 2|Adverse Event|0|||
19437770|NCT02059291|41684942|FG014|Epoch 2|Adverse Event|0|||
19437771|NCT02059291|41684943|FG015|Epoch 2|Adverse Event|0|||
19437772|NCT02059291|41684944|FG016|Epoch 2|Adverse Event|0|||
19437773|NCT02059291|41684945|FG017|Epoch 2|Adverse Event|0|||
19437774|NCT02059291|41684946|FG018|Epoch 2|Adverse Event|0|||
19437775|NCT02059291|41684947|FG019|Epoch 2|Adverse Event|0|||
19437776|NCT02059291|41684948|FG020|Epoch 2|Adverse Event|0|||
19437777|NCT02059291|41684949|FG021|Epoch 2|Adverse Event|0|||
19437778|NCT02059291|41684950|FG022|Epoch 2|Adverse Event|0|||
19437779|NCT02059291|41684951|FG023|Epoch 2|Adverse Event|0|||
19437780|NCT02059291|41684952|FG024|Epoch 2|Adverse Event|0|||
19437781|NCT02059291|41684928|FG000|Epoch 2|Withdrawal by Subject|0|||
19437782|NCT02059291|41684929|FG001|Epoch 2|Withdrawal by Subject|1|||
19437783|NCT02059291|41684930|FG002|Epoch 2|Withdrawal by Subject|0|||
19437784|NCT02059291|41684931|FG003|Epoch 2|Withdrawal by Subject|0|||
19437785|NCT02059291|41684932|FG004|Epoch 2|Withdrawal by Subject|0|||
19437786|NCT02059291|41684933|FG005|Epoch 2|Withdrawal by Subject|1|||
19437787|NCT02059291|41684934|FG006|Epoch 2|Withdrawal by Subject|0|||
19437788|NCT02059291|41684935|FG007|Epoch 2|Withdrawal by Subject|0|||
19437789|NCT02059291|41684936|FG008|Epoch 2|Withdrawal by Subject|1|||
19437790|NCT02059291|41684937|FG009|Epoch 2|Withdrawal by Subject|0|||
19437791|NCT02059291|41684938|FG010|Epoch 2|Withdrawal by Subject|0|||
19437792|NCT02059291|41684939|FG011|Epoch 2|Withdrawal by Subject|0|||
19437793|NCT02059291|41684940|FG012|Epoch 2|Withdrawal by Subject|0|||
19437794|NCT02059291|41684941|FG013|Epoch 2|Withdrawal by Subject|0|||
19437795|NCT02059291|41684942|FG014|Epoch 2|Withdrawal by Subject|0|||
19437796|NCT02059291|41684943|FG015|Epoch 2|Withdrawal by Subject|0|||
19437797|NCT02059291|41684944|FG016|Epoch 2|Withdrawal by Subject|0|||
19437798|NCT02059291|41684945|FG017|Epoch 2|Withdrawal by Subject|0|||
19437799|NCT02059291|41684946|FG018|Epoch 2|Withdrawal by Subject|0|||
19437800|NCT02059291|41684947|FG019|Epoch 2|Withdrawal by Subject|0|||
19437801|NCT02059291|41684948|FG020|Epoch 2|Withdrawal by Subject|0|||
19437802|NCT02059291|41684949|FG021|Epoch 2|Withdrawal by Subject|0|||
19437803|NCT02059291|41684950|FG022|Epoch 2|Withdrawal by Subject|0|||
19437804|NCT02059291|41684951|FG023|Epoch 2|Withdrawal by Subject|0|||
19437805|NCT02059291|41684952|FG024|Epoch 2|Withdrawal by Subject|0|||
19437806|NCT02059291|41684928|FG000|Epoch 3|Physician Decision|0|||
19437807|NCT02059291|41684929|FG001|Epoch 3|Physician Decision|0|||
19437808|NCT02059291|41684930|FG002|Epoch 3|Physician Decision|0|||
19437809|NCT02059291|41684931|FG003|Epoch 3|Physician Decision|0|||
19437810|NCT02059291|41684932|FG004|Epoch 3|Physician Decision|0|||
19437811|NCT02059291|41684933|FG005|Epoch 3|Physician Decision|0|||
19437812|NCT02059291|41684934|FG006|Epoch 3|Physician Decision|0|||
19437813|NCT02059291|41684935|FG007|Epoch 3|Physician Decision|0|||
19437814|NCT02059291|41684936|FG008|Epoch 3|Physician Decision|0|||
19437815|NCT02059291|41684937|FG009|Epoch 3|Physician Decision|0|||
19437816|NCT02059291|41684938|FG010|Epoch 3|Physician Decision|0|||
19437817|NCT02059291|41684939|FG011|Epoch 3|Physician Decision|0|||
19437818|NCT02059291|41684940|FG012|Epoch 3|Physician Decision|0|||
19437819|NCT02059291|41684941|FG013|Epoch 3|Physician Decision|1|||
19437820|NCT02059291|41684942|FG014|Epoch 3|Physician Decision|0|||
19437821|NCT02059291|41684943|FG015|Epoch 3|Physician Decision|1|||
19437822|NCT02059291|41684944|FG016|Epoch 3|Physician Decision|0|||
19437823|NCT02059291|41684945|FG017|Epoch 3|Physician Decision|0|||
19437824|NCT02059291|41684946|FG018|Epoch 3|Physician Decision|0|||
19437825|NCT02059291|41684947|FG019|Epoch 3|Physician Decision|0|||
19437826|NCT02059291|41684948|FG020|Epoch 3|Physician Decision|0|||
19437827|NCT02059291|41684949|FG021|Epoch 3|Physician Decision|0|||
19437828|NCT02059291|41684950|FG022|Epoch 3|Physician Decision|0|||
19437829|NCT02059291|41684951|FG023|Epoch 3|Physician Decision|0|||
19437830|NCT02059291|41684952|FG024|Epoch 3|Physician Decision|0|||
19437831|NCT02059291|41684928|FG000|Epoch 3|Adverse Event|0|||
19437832|NCT02059291|41684929|FG001|Epoch 3|Adverse Event|0|||
19437833|NCT02059291|41684930|FG002|Epoch 3|Adverse Event|0|||
19437834|NCT02059291|41684931|FG003|Epoch 3|Adverse Event|0|||
19437835|NCT02059291|41684932|FG004|Epoch 3|Adverse Event|0|||
19437836|NCT02059291|41684933|FG005|Epoch 3|Adverse Event|0|||
19437837|NCT02059291|41684934|FG006|Epoch 3|Adverse Event|0|||
19437838|NCT02059291|41684935|FG007|Epoch 3|Adverse Event|0|||
19437839|NCT02059291|41684936|FG008|Epoch 3|Adverse Event|0|||
19437840|NCT02059291|41684937|FG009|Epoch 3|Adverse Event|0|||
19437841|NCT02059291|41684938|FG010|Epoch 3|Adverse Event|0|||
19437842|NCT02059291|41684939|FG011|Epoch 3|Adverse Event|0|||
19437843|NCT02059291|41684940|FG012|Epoch 3|Adverse Event|0|||
19437844|NCT02059291|41684941|FG013|Epoch 3|Adverse Event|0|||
19437845|NCT02059291|41684942|FG014|Epoch 3|Adverse Event|0|||
19437846|NCT02059291|41684943|FG015|Epoch 3|Adverse Event|1|||
19437847|NCT02059291|41684944|FG016|Epoch 3|Adverse Event|0|||
19437848|NCT02059291|41684945|FG017|Epoch 3|Adverse Event|0|||
19437849|NCT02059291|41684946|FG018|Epoch 3|Adverse Event|0|||
19437850|NCT02059291|41684947|FG019|Epoch 3|Adverse Event|0|||
19437851|NCT02059291|41684948|FG020|Epoch 3|Adverse Event|0|||
19437852|NCT02059291|41684949|FG021|Epoch 3|Adverse Event|0|||
19437853|NCT02059291|41684950|FG022|Epoch 3|Adverse Event|0|||
19437854|NCT02059291|41684951|FG023|Epoch 3|Adverse Event|0|||
19437855|NCT02059291|41684952|FG024|Epoch 3|Adverse Event|0|||
19437856|NCT02059291|41684928|FG000|Epoch 3|Lack of Efficacy|0|||
19437857|NCT02059291|41684929|FG001|Epoch 3|Lack of Efficacy|0|||
19437858|NCT02059291|41684930|FG002|Epoch 3|Lack of Efficacy|0|||
19437859|NCT02059291|41684931|FG003|Epoch 3|Lack of Efficacy|0|||
19437860|NCT02059291|41684932|FG004|Epoch 3|Lack of Efficacy|0|||
19437861|NCT02059291|41684933|FG005|Epoch 3|Lack of Efficacy|0|||
19437862|NCT02059291|41684934|FG006|Epoch 3|Lack of Efficacy|0|||
19437863|NCT02059291|41684935|FG007|Epoch 3|Lack of Efficacy|0|||
19437864|NCT02059291|41684936|FG008|Epoch 3|Lack of Efficacy|0|||
19437865|NCT02059291|41684937|FG009|Epoch 3|Lack of Efficacy|0|||
19437866|NCT02059291|41684938|FG010|Epoch 3|Lack of Efficacy|0|||
19437867|NCT02059291|41684939|FG011|Epoch 3|Lack of Efficacy|0|||
19437868|NCT02059291|41684940|FG012|Epoch 3|Lack of Efficacy|0|||
19437869|NCT02059291|41684941|FG013|Epoch 3|Lack of Efficacy|0|||
19437870|NCT02059291|41684942|FG014|Epoch 3|Lack of Efficacy|0|||
19437871|NCT02059291|41684943|FG015|Epoch 3|Lack of Efficacy|3|||
19437872|NCT02059291|41684944|FG016|Epoch 3|Lack of Efficacy|0|||
19521937|NCT00982488|41935381|FG003|Overall Study|Death|0|||
19521938|NCT00982488|41935382|FG004|Overall Study|Death|0|||
19521939|NCT00982488|41935378|FG000|Overall Study|Disease progression|30|||
19521940|NCT00982488|41935379|FG001|Overall Study|Disease progression|5|||
19521941|NCT00982488|41935380|FG002|Overall Study|Disease progression|10|||
19521942|NCT00982488|41935381|FG003|Overall Study|Disease progression|1|||
19521943|NCT00982488|41935382|FG004|Overall Study|Disease progression|1|||
19521944|NCT00982488|41935378|FG000|Overall Study|Lost to Follow-up|1|||
19521945|NCT00982488|41935379|FG001|Overall Study|Lost to Follow-up|0|||
19521946|NCT00982488|41935380|FG002|Overall Study|Lost to Follow-up|0|||
19521947|NCT00982488|41935381|FG003|Overall Study|Lost to Follow-up|0|||
19521948|NCT00982488|41935382|FG004|Overall Study|Lost to Follow-up|0|||
19521949|NCT00982488|41935378|FG000|Overall Study|Maximum clinical benefit|1|||
19521950|NCT00982488|41935379|FG001|Overall Study|Maximum clinical benefit|1|||
19521951|NCT00982488|41935380|FG002|Overall Study|Maximum clinical benefit|1|||
19521952|NCT00982488|41935381|FG003|Overall Study|Maximum clinical benefit|0|||
19521953|NCT00982488|41935382|FG004|Overall Study|Maximum clinical benefit|0|||
19521954|NCT00982488|41935378|FG000|Overall Study|Other|15|||
19521955|NCT00982488|41935379|FG001|Overall Study|Other|1|||
19521956|NCT00982488|41935380|FG002|Overall Study|Other|3|||
19437873|NCT02059291|41684945|FG017|Epoch 3|Lack of Efficacy|0|||
19437874|NCT02059291|41684946|FG018|Epoch 3|Lack of Efficacy|0|||
19521957|NCT00982488|41935381|FG003|Overall Study|Other|1|||
19437875|NCT02059291|41684947|FG019|Epoch 3|Lack of Efficacy|0|||
19437876|NCT02059291|41684948|FG020|Epoch 3|Lack of Efficacy|0|||
19437877|NCT02059291|41684949|FG021|Epoch 3|Lack of Efficacy|0|||
19437878|NCT02059291|41684950|FG022|Epoch 3|Lack of Efficacy|0|||
19437879|NCT02059291|41684951|FG023|Epoch 3|Lack of Efficacy|0|||
19521958|NCT00982488|41935382|FG004|Overall Study|Other|0|||
19521959|NCT00982488|41935378|FG000|Overall Study|Poor compliance/noncompliance|0|||
19437880|NCT02059291|41684952|FG024|Epoch 3|Lack of Efficacy|0|||
19437881|NCT02059291|41684928|FG000|Epoch 3|Withdrawal by Subject|0|||
19437882|NCT02059291|41684929|FG001|Epoch 3|Withdrawal by Subject|0|||
19437883|NCT02059291|41684930|FG002|Epoch 3|Withdrawal by Subject|0|||
19437884|NCT02059291|41684931|FG003|Epoch 3|Withdrawal by Subject|0|||
19437885|NCT02059291|41684932|FG004|Epoch 3|Withdrawal by Subject|0|||
19521960|NCT00982488|41935379|FG001|Overall Study|Poor compliance/noncompliance|1|||
19521961|NCT00982488|41935380|FG002|Overall Study|Poor compliance/noncompliance|0|||
19437886|NCT02059291|41684933|FG005|Epoch 3|Withdrawal by Subject|0|||
19437887|NCT02059291|41684934|FG006|Epoch 3|Withdrawal by Subject|0|||
19437888|NCT02059291|41684935|FG007|Epoch 3|Withdrawal by Subject|0|||
19437889|NCT02059291|41684936|FG008|Epoch 3|Withdrawal by Subject|0|||
19437890|NCT02059291|41684937|FG009|Epoch 3|Withdrawal by Subject|0|||
19437891|NCT02059291|41684938|FG010|Epoch 3|Withdrawal by Subject|0|||
19437892|NCT02059291|41684939|FG011|Epoch 3|Withdrawal by Subject|0|||
19437893|NCT02059291|41684940|FG012|Epoch 3|Withdrawal by Subject|0|||
19437894|NCT02059291|41684941|FG013|Epoch 3|Withdrawal by Subject|0|||
19437895|NCT02059291|41684942|FG014|Epoch 3|Withdrawal by Subject|0|||
19437896|NCT02059291|41684943|FG015|Epoch 3|Withdrawal by Subject|1|||
19437897|NCT02059291|41684944|FG016|Epoch 3|Withdrawal by Subject|0|||
19437898|NCT02059291|41684945|FG017|Epoch 3|Withdrawal by Subject|0|||
19437899|NCT02059291|41684946|FG018|Epoch 3|Withdrawal by Subject|0|||
19437900|NCT02059291|41684947|FG019|Epoch 3|Withdrawal by Subject|0|||
19437901|NCT02059291|41684948|FG020|Epoch 3|Withdrawal by Subject|0|||
19437902|NCT02059291|41684949|FG021|Epoch 3|Withdrawal by Subject|0|||
19437903|NCT02059291|41684950|FG022|Epoch 3|Withdrawal by Subject|0|||
19437904|NCT02059291|41684951|FG023|Epoch 3|Withdrawal by Subject|0|||
19437905|NCT02059291|41684952|FG024|Epoch 3|Withdrawal by Subject|0|||
19437906|NCT02059291|41684928|FG000|Epoch 4|Adverse Event|0|||
19437907|NCT02059291|41684929|FG001|Epoch 4|Adverse Event|0|||
19437908|NCT02059291|41684930|FG002|Epoch 4|Adverse Event|0|||
19437909|NCT02059291|41684931|FG003|Epoch 4|Adverse Event|0|||
19437910|NCT02059291|41684932|FG004|Epoch 4|Adverse Event|0|||
19437911|NCT02059291|41684933|FG005|Epoch 4|Adverse Event|0|||
19437912|NCT02059291|41684934|FG006|Epoch 4|Adverse Event|0|||
19437913|NCT02059291|41684935|FG007|Epoch 4|Adverse Event|0|||
19437914|NCT02059291|41684936|FG008|Epoch 4|Adverse Event|0|||
19437915|NCT02059291|41684937|FG009|Epoch 4|Adverse Event|0|||
19437916|NCT02059291|41684938|FG010|Epoch 4|Adverse Event|0|||
19437917|NCT02059291|41684939|FG011|Epoch 4|Adverse Event|0|||
19437918|NCT02059291|41684940|FG012|Epoch 4|Adverse Event|0|||
19437919|NCT02059291|41684941|FG013|Epoch 4|Adverse Event|0|||
19437920|NCT02059291|41684942|FG014|Epoch 4|Adverse Event|0|||
19437921|NCT02059291|41684943|FG015|Epoch 4|Adverse Event|0|||
19437922|NCT02059291|41684944|FG016|Epoch 4|Adverse Event|1|||
19437923|NCT02059291|41684945|FG017|Epoch 4|Adverse Event|0|||
19437924|NCT02059291|41684946|FG018|Epoch 4|Adverse Event|0|||
19437925|NCT02059291|41684947|FG019|Epoch 4|Adverse Event|0|||
19437926|NCT02059291|41684948|FG020|Epoch 4|Adverse Event|0|||
19437927|NCT02059291|41684949|FG021|Epoch 4|Adverse Event|0|||
19437928|NCT02059291|41684950|FG022|Epoch 4|Adverse Event|1|||
19437929|NCT02059291|41684951|FG023|Epoch 4|Adverse Event|0|||
19437930|NCT02059291|41684952|FG024|Epoch 4|Adverse Event|0|||
19437931|NCT02059291|41684928|FG000|Epoch 4|Pregnancy|0|||
19437932|NCT02059291|41684929|FG001|Epoch 4|Pregnancy|0|||
19437933|NCT02059291|41684930|FG002|Epoch 4|Pregnancy|0|||
19437934|NCT02059291|41684931|FG003|Epoch 4|Pregnancy|0|||
19437935|NCT02059291|41684932|FG004|Epoch 4|Pregnancy|0|||
19437936|NCT02059291|41684933|FG005|Epoch 4|Pregnancy|0|||
19437937|NCT02059291|41684934|FG006|Epoch 4|Pregnancy|0|||
19437938|NCT02059291|41684935|FG007|Epoch 4|Pregnancy|0|||
19437939|NCT02059291|41684936|FG008|Epoch 4|Pregnancy|0|||
19437940|NCT02059291|41684937|FG009|Epoch 4|Pregnancy|0|||
19437941|NCT02059291|41684938|FG010|Epoch 4|Pregnancy|0|||
19437942|NCT02059291|41684939|FG011|Epoch 4|Pregnancy|0|||
19437943|NCT02059291|41684940|FG012|Epoch 4|Pregnancy|0|||
19437944|NCT02059291|41684941|FG013|Epoch 4|Pregnancy|0|||
19437945|NCT02059291|41684942|FG014|Epoch 4|Pregnancy|0|||
19437946|NCT02059291|41684943|FG015|Epoch 4|Pregnancy|0|||
19437947|NCT02059291|41684944|FG016|Epoch 4|Pregnancy|1|||
19437948|NCT02059291|41684945|FG017|Epoch 4|Pregnancy|0|||
19437949|NCT02059291|41684946|FG018|Epoch 4|Pregnancy|0|||
19437950|NCT02059291|41684947|FG019|Epoch 4|Pregnancy|0|||
19437951|NCT02059291|41684948|FG020|Epoch 4|Pregnancy|0|||
19437952|NCT02059291|41684949|FG021|Epoch 4|Pregnancy|0|||
19437953|NCT02059291|41684950|FG022|Epoch 4|Pregnancy|0|||
19437954|NCT02059291|41684951|FG023|Epoch 4|Pregnancy|0|||
19437955|NCT02059291|41684952|FG024|Epoch 4|Pregnancy|0|||
19437956|NCT02059291|41684928|FG000|Epoch 4|Withdrawal by Subject|0|||
19437957|NCT02059291|41684929|FG001|Epoch 4|Withdrawal by Subject|0|||
19437958|NCT02059291|41684930|FG002|Epoch 4|Withdrawal by Subject|0|||
19437959|NCT02059291|41684931|FG003|Epoch 4|Withdrawal by Subject|0|||
19437960|NCT02059291|41684932|FG004|Epoch 4|Withdrawal by Subject|0|||
19437961|NCT02059291|41684933|FG005|Epoch 4|Withdrawal by Subject|0|||
19437962|NCT02059291|41684934|FG006|Epoch 4|Withdrawal by Subject|0|||
19437963|NCT02059291|41684935|FG007|Epoch 4|Withdrawal by Subject|0|||
19437964|NCT02059291|41684936|FG008|Epoch 4|Withdrawal by Subject|0|||
19437965|NCT02059291|41684937|FG009|Epoch 4|Withdrawal by Subject|0|||
19437966|NCT02059291|41684938|FG010|Epoch 4|Withdrawal by Subject|0|||
19437967|NCT02059291|41684939|FG011|Epoch 4|Withdrawal by Subject|0|||
19437968|NCT02059291|41684940|FG012|Epoch 4|Withdrawal by Subject|0|||
19437969|NCT02059291|41684941|FG013|Epoch 4|Withdrawal by Subject|0|||
19437970|NCT02059291|41684942|FG014|Epoch 4|Withdrawal by Subject|0|||
19437971|NCT02059291|41684943|FG015|Epoch 4|Withdrawal by Subject|0|||
19437972|NCT02059291|41684944|FG016|Epoch 4|Withdrawal by Subject|0|||
19437973|NCT02059291|41684945|FG017|Epoch 4|Withdrawal by Subject|0|||
19437974|NCT02059291|41684946|FG018|Epoch 4|Withdrawal by Subject|0|||
19437975|NCT02059291|41684947|FG019|Epoch 4|Withdrawal by Subject|0|||
19437976|NCT02059291|41684948|FG020|Epoch 4|Withdrawal by Subject|1|||
19437977|NCT02059291|41684949|FG021|Epoch 4|Withdrawal by Subject|0|||
19437978|NCT02059291|41684950|FG022|Epoch 4|Withdrawal by Subject|0|||
19437979|NCT02059291|41684951|FG023|Epoch 4|Withdrawal by Subject|0|||
19437980|NCT02059291|41684952|FG024|Epoch 4|Withdrawal by Subject|0|||
19437981|NCT02059291|41684928|FG000|Epoch 4|Lack of Efficacy|0|||
19437982|NCT02059291|41684929|FG001|Epoch 4|Lack of Efficacy|0|||
19437983|NCT02059291|41684930|FG002|Epoch 4|Lack of Efficacy|0|||
19437984|NCT02059291|41684931|FG003|Epoch 4|Lack of Efficacy|0|||
19437985|NCT02059291|41684932|FG004|Epoch 4|Lack of Efficacy|0|||
19437986|NCT02059291|41684933|FG005|Epoch 4|Lack of Efficacy|0|||
19437987|NCT02059291|41684934|FG006|Epoch 4|Lack of Efficacy|0|||
19437988|NCT02059291|41684935|FG007|Epoch 4|Lack of Efficacy|0|||
19437989|NCT02059291|41684936|FG008|Epoch 4|Lack of Efficacy|0|||
19437990|NCT02059291|41684937|FG009|Epoch 4|Lack of Efficacy|0|||
19437991|NCT02059291|41684938|FG010|Epoch 4|Lack of Efficacy|0|||
19437992|NCT02059291|41684939|FG011|Epoch 4|Lack of Efficacy|0|||
19437993|NCT02059291|41684940|FG012|Epoch 4|Lack of Efficacy|0|||
19437994|NCT02059291|41684941|FG013|Epoch 4|Lack of Efficacy|0|||
19437995|NCT02059291|41684942|FG014|Epoch 4|Lack of Efficacy|0|||
19437996|NCT02059291|41684943|FG015|Epoch 4|Lack of Efficacy|0|||
19437997|NCT02059291|41684944|FG016|Epoch 4|Lack of Efficacy|0|||
19437998|NCT02059291|41684945|FG017|Epoch 4|Lack of Efficacy|0|||
19437999|NCT02059291|41684946|FG018|Epoch 4|Lack of Efficacy|0|||
19438000|NCT02059291|41684947|FG019|Epoch 4|Lack of Efficacy|0|||
19438001|NCT02059291|41684948|FG020|Epoch 4|Lack of Efficacy|0|||
19438002|NCT02059291|41684949|FG021|Epoch 4|Lack of Efficacy|0|||
19438003|NCT02059291|41684950|FG022|Epoch 4|Lack of Efficacy|0|||
19438004|NCT02059291|41684951|FG023|Epoch 4|Lack of Efficacy|1|||
19438005|NCT02059291|41684952|FG024|Epoch 4|Lack of Efficacy|0|||
19438006|NCT01621568|41684982|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
19438007|NCT01621568|41684983|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
19438008|NCT01621568|41684982|FG000|Week 5-6 No Treatment|Death|1|||
19438009|NCT01621568|41684983|FG001|Week 5-6 No Treatment|Death|0|||
19438010|NCT02042924|41684992|FG000|Overall Study|Early Death|1|||
19438011|NCT02041520|41684998|FG000|Overall Study|Adverse Event|2|||
19438012|NCT02041520|41684999|FG001|Overall Study|Adverse Event|1|||
19438013|NCT02041520|41684998|FG000|Overall Study|Withdrawal by Subject|3|||
19438014|NCT02041520|41684999|FG001|Overall Study|Withdrawal by Subject|4|||
19438015|NCT02041520|41684998|FG000|Overall Study|Protocol Violation|1|||
19438016|NCT02041520|41684999|FG001|Overall Study|Protocol Violation|0|||
19438017|NCT02041520|41684998|FG000|Overall Study|Lost to Follow-up|0|||
19438018|NCT02041520|41684999|FG001|Overall Study|Lost to Follow-up|1|||
19438019|NCT02041520|41684998|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
19438020|NCT02041520|41684999|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
19438021|NCT02041429|41685011|FG000|Overall Study|Progressive Disease|2|||
19438022|NCT02041429|41685012|FG001|Overall Study|Progressive Disease|2|||
19438023|NCT02041429|41685013|FG002|Overall Study|Progressive Disease|3|||
19438024|NCT02041429|41685014|FG003|Overall Study|Progressive Disease|2|||
19438025|NCT02041429|41685011|FG000|Overall Study|Toxicity|0|||
19438026|NCT02041429|41685012|FG001|Overall Study|Toxicity|1|||
19438027|NCT02041429|41685013|FG002|Overall Study|Toxicity|4|||
19438028|NCT02041429|41685014|FG003|Overall Study|Toxicity|2|||
19438029|NCT02041429|41685011|FG000|Overall Study|Withdrawal by Subject|0|||
19438030|NCT02041429|41685012|FG001|Overall Study|Withdrawal by Subject|1|||
19438031|NCT02041429|41685013|FG002|Overall Study|Withdrawal by Subject|0|||
19438032|NCT02041429|41685014|FG003|Overall Study|Withdrawal by Subject|0|||
19438033|NCT02041429|41685011|FG000|Overall Study|On Maintenance Therapy|1|||
19438034|NCT02041429|41685012|FG001|Overall Study|On Maintenance Therapy|0|||
19438035|NCT02041429|41685013|FG002|Overall Study|On Maintenance Therapy|0|||
19438036|NCT02041429|41685014|FG003|Overall Study|On Maintenance Therapy|2|||
19438037|NCT02083783|41685031|FG000|Overall Study|Withdrawal by Subject|1|||
19438038|NCT02083783|41685032|FG001|Overall Study|Withdrawal by Subject|0|||
19438039|NCT02083081|41685042|FG000|Overall Study|Lost to Follow-up|31|||
19438040|NCT02083081|41685043|FG001|Overall Study|Lost to Follow-up|9|||
19438041|NCT02040805|41685051|FG000|Overall Study|Lost to Follow-up|14|||
19438042|NCT02040805|41685052|FG001|Overall Study|Lost to Follow-up|9|||
19438043|NCT02040805|41685051|FG000|Overall Study|Withdrawal by Subject|28|||
19438044|NCT02040805|41685052|FG001|Overall Study|Withdrawal by Subject|41|||
19438045|NCT02040259|41685058|FG000|Overall Study|Death|280|||
19438046|NCT02040259|41685058|FG000|Overall Study|Lost to Follow-up|76|||
19438047|NCT02040259|41685058|FG000|Overall Study|Assessment not completed|3|||
19438048|NCT02040259|41685058|FG000|Overall Study|Withdrawal by Subject|4|||
19438049|NCT02059135|41685066|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
19438050|NCT02059135|41685067|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
19438051|NCT02059135|41685066|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
19438052|NCT02059135|41685067|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
19438053|NCT02059135|41685066|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
19438054|NCT02059135|41685067|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
19438055|NCT02059135|41685066|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
19438056|NCT02059135|41685067|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
19438057|NCT02059135|41685066|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
19438058|NCT02059135|41685067|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
19438059|NCT02059135|41685066|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
19438060|NCT02059135|41685067|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
19438061|NCT02059135|41685066|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
19438062|NCT02059135|41685067|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
19438063|NCT02059135|41685066|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
19438064|NCT02059135|41685067|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
19438065|NCT02081677|41685079|FG000|Overall Study|Adverse Event|0|||
19438066|NCT02081677|41685080|FG001|Overall Study|Adverse Event|0|||
19438067|NCT02081677|41685081|FG002|Overall Study|Adverse Event|1|||
19438068|NCT02081677|41685082|FG003|Overall Study|Adverse Event|0|||
19438069|NCT02081677|41685079|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19438070|NCT02081677|41685080|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19438071|NCT02081677|41685081|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
19438072|NCT02081677|41685082|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
19438073|NCT02081677|41685079|FG000|Overall Study|Not comfortable with lens care system|1|||
19438074|NCT02081677|41685080|FG001|Overall Study|Not comfortable with lens care system|0|||
19438075|NCT02081677|41685081|FG002|Overall Study|Not comfortable with lens care system|0|||
19438076|NCT02081677|41685082|FG003|Overall Study|Not comfortable with lens care system|0|||
19438077|NCT02081677|41685079|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
19438078|NCT02081677|41685080|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
19438079|NCT02081677|41685081|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
19438080|NCT02081677|41685082|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
19438081|NCT02038933|41685094|FG000|Overall Study|Disease progression|104|||
19438082|NCT02038933|41685094|FG000|Overall Study|Study drug toxicity|6|||
19438083|NCT02038933|41685094|FG000|Overall Study|Adverse event unrelated to study drug|6|||
19438084|NCT02038933|41685094|FG000|Overall Study|Participant request to discontinue treatment|2|||
19438085|NCT02038933|41685094|FG000|Overall Study|Lost to Follow-up|1|||
19438086|NCT02038933|41685094|FG000|Overall Study|Other reasons|2|||
19438087|NCT02081599|41685101|FG000|Period 1：Double-blind Period|Adverse Event|3|||
19438088|NCT02081599|41685102|FG001|Period 1：Double-blind Period|Adverse Event|0|||
19438089|NCT02081599|41685101|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
19438090|NCT02081599|41685102|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
19438091|NCT02081599|41685101|FG000|Period 1：Double-blind Period|Physician Decision|1|||
19438092|NCT02081599|41685102|FG001|Period 1：Double-blind Period|Physician Decision|0|||
19438093|NCT02081599|41685101|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
19438094|NCT02081599|41685102|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
19438095|NCT02081599|41685101|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
19438096|NCT02081599|41685102|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
19438097|NCT02081599|41685101|FG000|Period 1：Double-blind Period|stopping criteria|1|||
19438098|NCT02081599|41685102|FG001|Period 1：Double-blind Period|stopping criteria|0|||
19438099|NCT02081599|41685101|FG000|Period 2：Open-label Period|Adverse Event|1|||
19438100|NCT02081599|41685102|FG001|Period 2：Open-label Period|Adverse Event|0|||
19438101|NCT02081599|41685101|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
19438102|NCT02081599|41685102|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
19438103|NCT02081599|41685101|FG000|Period 2：Open-label Period|Physician Decision|1|||
19438104|NCT02081599|41685102|FG001|Period 2：Open-label Period|Physician Decision|0|||
19438105|NCT02081599|41685101|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
19438106|NCT02081599|41685102|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
19438107|NCT02038543|41685114|FG000|Overall Study|Screen Failure|0|||
19438108|NCT02038543|41685115|FG001|Overall Study|Screen Failure|0|||
19438109|NCT02038543|41685116|FG002|Overall Study|Screen Failure|0|||
19438110|NCT02038543|41685117|FG003|Overall Study|Screen Failure|1|||
19438111|NCT02038543|41685114|FG000|Overall Study|Withdrawal by Subject|0|||
19438112|NCT02038543|41685115|FG001|Overall Study|Withdrawal by Subject|0|||
19438113|NCT02038543|41685116|FG002|Overall Study|Withdrawal by Subject|0|||
19438114|NCT02038543|41685117|FG003|Overall Study|Withdrawal by Subject|1|||
19438115|NCT02038153|41685127|FG000|Overall Study|Withdrawal by Subject|1|||
19438116|NCT02038075|41685133|FG000|Overall Study|Withdrawal by Subject|3|||
19438117|NCT02038075|41685134|FG001|Overall Study|Withdrawal by Subject|0|||
19438118|NCT02058589|41685142|FG000|Overall Study|Serious Adverse Event|1|||
19438119|NCT02058589|41685143|FG001|Overall Study|Serious Adverse Event|1|||
19438120|NCT02058589|41685142|FG000|Overall Study|Non-Serious Adverse Event|1|||
19438121|NCT02058589|41685143|FG001|Overall Study|Non-Serious Adverse Event|0|||
19438122|NCT02058589|41685142|FG000|Overall Study|Withdrawal by Subject|0|||
19438123|NCT02058589|41685143|FG001|Overall Study|Withdrawal by Subject|1|||
19438124|NCT02079805|41685153|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
19438125|NCT02079805|41685154|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
19438126|NCT02079805|41685153|FG000|Overall Study|Voluntary Withdrawal|0|||
19438127|NCT02079805|41685154|FG001|Overall Study|Voluntary Withdrawal|1|||
19438128|NCT02037295|41685164|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
19438129|NCT02037295|41685165|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
19438130|NCT02037295|41685166|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
19438131|NCT02037295|41685167|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
19438132|NCT02079649|41685183|FG000|Overall Study|Lost to Follow-up|0|||
19438133|NCT02079649|41685184|FG001|Overall Study|Lost to Follow-up|0|||
19438134|NCT02079649|41685185|FG002|Overall Study|Lost to Follow-up|0|||
19438135|NCT02079649|41685186|FG003|Overall Study|Lost to Follow-up|1|||
19438136|NCT02079649|41685183|FG000|Overall Study|Withdrawal by Subject|0|||
19438137|NCT02079649|41685184|FG001|Overall Study|Withdrawal by Subject|0|||
19438138|NCT02079649|41685185|FG002|Overall Study|Withdrawal by Subject|0|||
19438139|NCT02079649|41685186|FG003|Overall Study|Withdrawal by Subject|1|||
19438140|NCT02079649|41685183|FG000|Overall Study|Randomization error (prior to treatment)|1|||
19438141|NCT02079649|41685184|FG001|Overall Study|Randomization error (prior to treatment)|0|||
19438142|NCT02079649|41685185|FG002|Overall Study|Randomization error (prior to treatment)|1|||
19438143|NCT02079649|41685186|FG003|Overall Study|Randomization error (prior to treatment)|0|||
19438144|NCT02036515|41685200|FG000|Overall Study|Adverse Event|1|||
19438145|NCT02036515|41685201|FG001|Overall Study|Adverse Event|1|||
19438146|NCT02036515|41685202|FG002|Overall Study|Adverse Event|2|||
19438147|NCT02036515|41685200|FG000|Overall Study|Lost to Follow-up|0|||
19438148|NCT02036515|41685201|FG001|Overall Study|Lost to Follow-up|2|||
19438149|NCT02036515|41685202|FG002|Overall Study|Lost to Follow-up|0|||
19438150|NCT02036515|41685200|FG000|Overall Study|Non-compliance with study drug|0|||
19438151|NCT02036515|41685201|FG001|Overall Study|Non-compliance with study drug|0|||
19438152|NCT02036515|41685202|FG002|Overall Study|Non-compliance with study drug|2|||
19438153|NCT02036515|41685200|FG000|Overall Study|Screen failure|0|||
19438154|NCT02036515|41685201|FG001|Overall Study|Screen failure|2|||
19438155|NCT02036515|41685202|FG002|Overall Study|Screen failure|0|||
19438156|NCT02036515|41685200|FG000|Overall Study|Withdrawal by Subject|4|||
19438157|NCT02036515|41685201|FG001|Overall Study|Withdrawal by Subject|7|||
19438158|NCT02036515|41685202|FG002|Overall Study|Withdrawal by Subject|9|||
19438159|NCT02036515|41685200|FG000|Overall Study|Hyperglycemia|0|||
19438160|NCT02036515|41685201|FG001|Overall Study|Hyperglycemia|0|||
19438161|NCT02036515|41685202|FG002|Overall Study|Hyperglycemia|1|||
19438162|NCT02078713|41685214|FG000|Overall Study|Lost to Follow-up|49|||
19438163|NCT02078713|41685215|FG001|Overall Study|Lost to Follow-up|55|||
19438164|NCT02078713|41685216|FG002|Overall Study|Lost to Follow-up|0|||
19438165|NCT02078713|41685217|FG003|Overall Study|Lost to Follow-up|0|||
19438166|NCT02078713|41685214|FG000|Overall Study|Pregnant at baseline|3|||
19438167|NCT02078713|41685215|FG001|Overall Study|Pregnant at baseline|5|||
19438168|NCT02078713|41685216|FG002|Overall Study|Pregnant at baseline|0|||
19438169|NCT02078713|41685217|FG003|Overall Study|Pregnant at baseline|0|||
19438170|NCT02078713|41685214|FG000|Overall Study|Enrolled twice|0|||
19438171|NCT02078713|41685215|FG001|Overall Study|Enrolled twice|1|||
19438172|NCT02078713|41685216|FG002|Overall Study|Enrolled twice|0|||
19438173|NCT02078713|41685217|FG003|Overall Study|Enrolled twice|0|||
19438174|NCT02035267|41685233|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
19438175|NCT02035267|41685234|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
19438176|NCT02035267|41685235|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
19438177|NCT02035267|41685236|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
19438178|NCT02035267|41685233|FG000|Overall Study|Adverse Event|0|||
19438179|NCT02035267|41685234|FG001|Overall Study|Adverse Event|0|||
19438180|NCT02035267|41685235|FG002|Overall Study|Adverse Event|1|||
19438181|NCT02035267|41685236|FG003|Overall Study|Adverse Event|0|||
19438182|NCT02035267|41685233|FG000|Overall Study|Lost to Follow-up|0|||
19438183|NCT02035267|41685234|FG001|Overall Study|Lost to Follow-up|0|||
19438184|NCT02035267|41685235|FG002|Overall Study|Lost to Follow-up|0|||
19438185|NCT02035267|41685236|FG003|Overall Study|Lost to Follow-up|1|||
19438186|NCT02035267|41685233|FG000|Overall Study|Other unspecified|0|||
19438187|NCT02035267|41685234|FG001|Overall Study|Other unspecified|1|||
19438188|NCT02035267|41685235|FG002|Overall Study|Other unspecified|0|||
19438189|NCT02035267|41685236|FG003|Overall Study|Other unspecified|0|||
19438190|NCT02034877|41685250|FG000|Overall Study|Lost to Follow-up|0|||
19438191|NCT02034877|41685251|FG001|Overall Study|Lost to Follow-up|3|||
19438192|NCT02034877|41685250|FG000|Overall Study|No Longer Willing to Participate|0|||
19438193|NCT02034877|41685251|FG001|Overall Study|No Longer Willing to Participate|3|||
19438194|NCT02034799|41685259|FG000|Overall Study|Withdrawal by Subject|0|||
19438195|NCT02034799|41685260|FG001|Overall Study|Withdrawal by Subject|2|||
19438196|NCT02034799|41685259|FG000|Overall Study|Lost to Follow-up|0|||
19438197|NCT02034799|41685260|FG001|Overall Study|Lost to Follow-up|1|||
19438198|NCT02034799|41685259|FG000|Overall Study|Death|2|||
19438199|NCT02034799|41685260|FG001|Overall Study|Death|1|||
19438200|NCT02057575|41685270|FG000|Overall Study|Adverse Event|0|||
19438201|NCT02057575|41685271|FG001|Overall Study|Adverse Event|2|||
19438202|NCT02057575|41685272|FG002|Overall Study|Adverse Event|0|||
19438203|NCT02057575|41685273|FG003|Overall Study|Adverse Event|1|||
19438204|NCT02057575|41685270|FG000|Overall Study|Withdrawal by Subject|1|||
19438205|NCT02057575|41685271|FG001|Overall Study|Withdrawal by Subject|0|||
19438206|NCT02057575|41685272|FG002|Overall Study|Withdrawal by Subject|0|||
19438207|NCT02057575|41685273|FG003|Overall Study|Withdrawal by Subject|0|||
19438208|NCT02057575|41685270|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
19438209|NCT02057575|41685271|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
19438210|NCT02057575|41685272|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
19438211|NCT02057575|41685273|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
19438212|NCT02057575|41685270|FG000|Overall Study|Protocol Violation|0|||
19438213|NCT02057575|41685271|FG001|Overall Study|Protocol Violation|1|||
19438214|NCT02057575|41685272|FG002|Overall Study|Protocol Violation|0|||
19438215|NCT02057575|41685273|FG003|Overall Study|Protocol Violation|0|||
19438216|NCT02077465|41685285|FG000|Overall Study|Withdrew Consent|0|||
19438217|NCT02077465|41685286|FG001|Overall Study|Withdrew Consent|1|||
19438218|NCT02077465|41685285|FG000|Overall Study|Lost to Follow-up|1|||
19438219|NCT02077465|41685286|FG001|Overall Study|Lost to Follow-up|0|||
19438220|NCT02034565|41685292|FG000|Overall Study|Adverse Event|1|||
19438221|NCT02034565|41685293|FG001|Overall Study|Adverse Event|0|||
19438222|NCT02075515|41685304|FG000|Overall Study|Serious Adverse Event|1|||
19438223|NCT02075515|41685305|FG001|Overall Study|Serious Adverse Event|1|||
19438224|NCT02075515|41685306|FG002|Overall Study|Serious Adverse Event|1|||
19438225|NCT02075515|41685304|FG000|Overall Study|Non-Serious Adverse Event|0|||
19438226|NCT02075515|41685305|FG001|Overall Study|Non-Serious Adverse Event|1|||
19438227|NCT02075515|41685306|FG002|Overall Study|Non-Serious Adverse Event|0|||
19438228|NCT02075515|41685304|FG000|Overall Study|Withdrawal by Subject|2|||
19438229|NCT02075515|41685305|FG001|Overall Study|Withdrawal by Subject|0|||
19438230|NCT02075515|41685306|FG002|Overall Study|Withdrawal by Subject|1|||
19438231|NCT02075515|41685304|FG000|Overall Study|Lost to Follow-up|1|||
19438232|NCT02075515|41685305|FG001|Overall Study|Lost to Follow-up|3|||
19438233|NCT02075515|41685306|FG002|Overall Study|Lost to Follow-up|6|||
19438234|NCT02034409|41685317|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
19438235|NCT02034409|41685318|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
19438236|NCT02034409|41685317|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
19438237|NCT02034409|41685318|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
19438238|NCT02034409|41685317|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
19438239|NCT02034409|41685318|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
19438240|NCT02034409|41685317|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
19438241|NCT02034409|41685318|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
19438242|NCT02034409|41685317|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
19438243|NCT02034409|41685318|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
19438244|NCT02034409|41685317|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
19438245|NCT02034409|41685318|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
19438246|NCT02021318|41685326|FG000|Overall Study|Adverse Event|2|||
19438247|NCT02021318|41685327|FG001|Overall Study|Adverse Event|1|||
19438248|NCT02021318|41685326|FG000|Overall Study|Death|33|||
19438249|NCT02021318|41685327|FG001|Overall Study|Death|34|||
19438250|NCT02021318|41685326|FG000|Overall Study|Lost to Follow-up|3|||
19438251|NCT02021318|41685327|FG001|Overall Study|Lost to Follow-up|3|||
19438252|NCT02021318|41685326|FG000|Overall Study|Progressive Disease|0|||
19438253|NCT02021318|41685327|FG001|Overall Study|Progressive Disease|1|||
19438254|NCT02021318|41685326|FG000|Overall Study|Withdrawal by Subject|30|||
19438255|NCT02021318|41685327|FG001|Overall Study|Withdrawal by Subject|18|||
19438256|NCT02021318|41685326|FG000|Overall Study|Physician Decision|3|||
19438257|NCT02021318|41685327|FG001|Overall Study|Physician Decision|3|||
19438258|NCT02021318|41685326|FG000|Overall Study|Miscellaneous|2|||
19438259|NCT02021318|41685327|FG001|Overall Study|Miscellaneous|3|||
19438260|NCT02041286|41685334|FG000|Overall Study|Adverse Event|1|||
19438261|NCT02020616|41685347|FG000|Overall Study|Adverse Event|0|||
19438262|NCT02020616|41685348|FG001|Overall Study|Adverse Event|0|||
19438263|NCT02020616|41685349|FG002|Overall Study|Adverse Event|0|||
19438264|NCT02020616|41685350|FG003|Overall Study|Adverse Event|0|||
19438265|NCT02020616|41685351|FG004|Overall Study|Adverse Event|0|||
19438266|NCT02020616|41685352|FG005|Overall Study|Adverse Event|1|||
19438267|NCT02020616|41685353|FG006|Overall Study|Adverse Event|1|||
19438268|NCT02020616|41685347|FG000|Overall Study|Physician Decision|0|||
19438269|NCT02020616|41685348|FG001|Overall Study|Physician Decision|0|||
19438270|NCT02020616|41685349|FG002|Overall Study|Physician Decision|0|||
19438271|NCT02020616|41685350|FG003|Overall Study|Physician Decision|0|||
19438272|NCT02020616|41685351|FG004|Overall Study|Physician Decision|0|||
19438273|NCT02020616|41685352|FG005|Overall Study|Physician Decision|1|||
19438274|NCT02020616|41685353|FG006|Overall Study|Physician Decision|2|||
19438275|NCT02020616|41685347|FG000|Overall Study|Withdrawal by Subject|0|||
19438276|NCT02020616|41685348|FG001|Overall Study|Withdrawal by Subject|0|||
19438277|NCT02020616|41685349|FG002|Overall Study|Withdrawal by Subject|1|||
19438278|NCT02020616|41685350|FG003|Overall Study|Withdrawal by Subject|0|||
19438279|NCT02020616|41685351|FG004|Overall Study|Withdrawal by Subject|0|||
19438280|NCT02020616|41685352|FG005|Overall Study|Withdrawal by Subject|1|||
19438281|NCT02020616|41685353|FG006|Overall Study|Withdrawal by Subject|1|||
19438282|NCT02020616|41685347|FG000|Overall Study|Lost to Follow-up|0|||
19438283|NCT02020616|41685348|FG001|Overall Study|Lost to Follow-up|1|||
19438284|NCT02020616|41685349|FG002|Overall Study|Lost to Follow-up|0|||
19438285|NCT02020616|41685350|FG003|Overall Study|Lost to Follow-up|1|||
19438286|NCT02020616|41685351|FG004|Overall Study|Lost to Follow-up|1|||
19438287|NCT02020616|41685352|FG005|Overall Study|Lost to Follow-up|1|||
19438288|NCT02020616|41685353|FG006|Overall Study|Lost to Follow-up|0|||
19438289|NCT02020616|41685347|FG000|Overall Study|Early Termination Criteria Met|0|||
19438290|NCT02020616|41685348|FG001|Overall Study|Early Termination Criteria Met|0|||
19438291|NCT02020616|41685349|FG002|Overall Study|Early Termination Criteria Met|1|||
19438292|NCT02020616|41685350|FG003|Overall Study|Early Termination Criteria Met|0|||
19438293|NCT02020616|41685351|FG004|Overall Study|Early Termination Criteria Met|0|||
19521962|NCT00982488|41935381|FG003|Overall Study|Poor compliance/noncompliance|0|||
19521963|NCT00982488|41935382|FG004|Overall Study|Poor compliance/noncompliance|0|||
19521964|NCT00982488|41935378|FG000|Overall Study|Stem cell transplant|2|||
19521965|NCT00982488|41935379|FG001|Overall Study|Stem cell transplant|0|||
19521966|NCT00982488|41935380|FG002|Overall Study|Stem cell transplant|0|||
19521967|NCT00982488|41935381|FG003|Overall Study|Stem cell transplant|1|||
19521968|NCT00982488|41935382|FG004|Overall Study|Stem cell transplant|0|||
19521969|NCT00982488|41935378|FG000|Overall Study|Study drug toxicity|34|||
19521970|NCT00982488|41935379|FG001|Overall Study|Study drug toxicity|1|||
19521971|NCT00982488|41935380|FG002|Overall Study|Study drug toxicity|6|||
19521972|NCT00982488|41935381|FG003|Overall Study|Study drug toxicity|0|||
19521973|NCT00982488|41935382|FG004|Overall Study|Study drug toxicity|0|||
19521974|NCT00982488|41935378|FG000|Overall Study|Withdrawal by Subject|5|||
19521975|NCT00982488|41935379|FG001|Overall Study|Withdrawal by Subject|1|||
19521976|NCT00982488|41935380|FG002|Overall Study|Withdrawal by Subject|1|||
19521977|NCT00982488|41935381|FG003|Overall Study|Withdrawal by Subject|0|||
19521978|NCT00982488|41935382|FG004|Overall Study|Withdrawal by Subject|0|||
19521979|NCT00982410|41935396|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
19521980|NCT00982410|41935397|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
19521981|NCT00982410|41935396|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
19521982|NCT00982410|41935397|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
19521983|NCT00982410|41935396|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
19521984|NCT00982410|41935397|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
19521985|NCT00982410|41935396|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
19521986|NCT00982410|41935397|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
19521987|NCT00982410|41935396|FG000|6-month Follow-up Assessment|participant no transportation|1|||
19521988|NCT00982410|41935397|FG001|6-month Follow-up Assessment|participant no transportation|0|||
19521989|NCT00982410|41935396|FG000|6-month Follow-up Assessment|incarceration|0|||
19521990|NCT00982410|41935397|FG001|6-month Follow-up Assessment|incarceration|2|||
19521991|NCT00982410|41935396|FG000|6-month Follow-up Assessment|patent surgery|0|||
19521992|NCT00982410|41935397|FG001|6-month Follow-up Assessment|patent surgery|1|||
19521993|NCT00982410|41935396|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
19521994|NCT00982410|41935397|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
19521995|NCT00982410|41935396|FG000|12-month Follow-up Assessment|Death|0|||
19521996|NCT00982410|41935397|FG001|12-month Follow-up Assessment|Death|2|||
19521997|NCT00982410|41935396|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
19438294|NCT02020616|41685352|FG005|Overall Study|Early Termination Criteria Met|1|||
19438295|NCT02020616|41685353|FG006|Overall Study|Early Termination Criteria Met|0|||
19438296|NCT02020616|41685347|FG000|Overall Study|Randomized in Error|0|||
19438297|NCT02020616|41685348|FG001|Overall Study|Randomized in Error|0|||
19438298|NCT02020616|41685349|FG002|Overall Study|Randomized in Error|0|||
19438299|NCT02020616|41685350|FG003|Overall Study|Randomized in Error|1|||
19438300|NCT02020616|41685351|FG004|Overall Study|Randomized in Error|0|||
19438301|NCT02020616|41685352|FG005|Overall Study|Randomized in Error|0|||
19438302|NCT02020616|41685353|FG006|Overall Study|Randomized in Error|0|||
19438303|NCT02020616|41685347|FG000|Overall Study|Lack of Efficacy|0|||
19438304|NCT02020616|41685348|FG001|Overall Study|Lack of Efficacy|0|||
19438305|NCT02020616|41685349|FG002|Overall Study|Lack of Efficacy|0|||
19438306|NCT02020616|41685350|FG003|Overall Study|Lack of Efficacy|0|||
19438307|NCT02020616|41685351|FG004|Overall Study|Lack of Efficacy|1|||
19438308|NCT02020616|41685352|FG005|Overall Study|Lack of Efficacy|0|||
19438309|NCT02020616|41685353|FG006|Overall Study|Lack of Efficacy|0|||
19438310|NCT02048072|41685383|FG000|Overall Study|Adverse Event|3|||
19438311|NCT02048072|41685383|FG000|Overall Study|Lost to Follow-up|1|||
19438312|NCT02047604|41685393|FG000|Overall Study|Withdrawal by Subject|0|||
19438313|NCT02047604|41685394|FG001|Overall Study|Withdrawal by Subject|0|||
19438314|NCT02047604|41685395|FG002|Overall Study|Withdrawal by Subject|0|||
19438315|NCT02047604|41685396|FG003|Overall Study|Withdrawal by Subject|0|||
19438316|NCT02047604|41685397|FG004|Overall Study|Withdrawal by Subject|1|||
19438317|NCT02047604|41685398|FG005|Overall Study|Withdrawal by Subject|1|||
19438318|NCT01622660|41685412|FG000|Overall Study|Adverse Event|1|||
19438319|NCT02019602|41685418|FG000|Screening Period|Ineligibility|4|||
19438320|NCT02019602|41685419|FG001|Screening Period|Ineligibility|0|||
19438321|NCT02019602|41685418|FG000|Screening Period|Adverse Event|1|||
19438322|NCT02019602|41685419|FG001|Screening Period|Adverse Event|0|||
19438323|NCT01994954|41685428|FG000|Overall Study|Death|1|||
19438324|NCT01994954|41685429|FG001|Overall Study|Death|0|||
19438325|NCT01994954|41685428|FG000|Overall Study|Withdrawal by Subject|9|||
19438326|NCT01994954|41685429|FG001|Overall Study|Withdrawal by Subject|14|||
19438327|NCT01994954|41685428|FG000|Overall Study|Physician Decision|2|||
19438328|NCT01994954|41685429|FG001|Overall Study|Physician Decision|2|||
19438329|NCT01994954|41685428|FG000|Overall Study|Lost to Follow-up|8|||
19438330|NCT01994954|41685429|FG001|Overall Study|Lost to Follow-up|10|||
19438331|NCT01994954|41685428|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
19438332|NCT01994954|41685429|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
19438333|NCT01994876|41685441|FG000|Test Period 1|Withdrawal by Subject|0|||
19438334|NCT01994876|41685442|FG001|Test Period 1|Withdrawal by Subject|1|||
19438335|NCT01994876|41685441|FG000|Test Period 1|Adverse Event|0|||
19438336|NCT01994876|41685442|FG001|Test Period 1|Adverse Event|1|||
19438337|NCT01994876|41685441|FG000|Test Period 2|Adverse Event|1|||
19438338|NCT01994876|41685442|FG001|Test Period 2|Adverse Event|0|||
19438339|NCT01994876|41685441|FG000|Test Period 2|Protocol Violation|0|||
19438340|NCT01994876|41685442|FG001|Test Period 2|Protocol Violation|1|||
19438341|NCT02040428|41685452|FG000|Overall Study|Death|4|||
19438342|NCT02040428|41685453|FG001|Overall Study|Death|3|||
19438343|NCT02040428|41685452|FG000|Overall Study|Withdrawal by Subject|1|||
19438344|NCT02040428|41685453|FG001|Overall Study|Withdrawal by Subject|1|||
19438345|NCT02018822|41685461|FG000|Overall Study|filling replaced by crown|0|||
19438346|NCT02018822|41685462|FG001|Overall Study|filling replaced by crown|1|||
19438347|NCT02018822|41685463|FG002|Overall Study|filling replaced by crown|0|||
19438348|NCT02018822|41685461|FG000|Overall Study|Physician Decision|0|||
19438349|NCT02018822|41685462|FG001|Overall Study|Physician Decision|1|||
19438350|NCT02018822|41685463|FG002|Overall Study|Physician Decision|1|||
19438351|NCT02018822|41685461|FG000|Overall Study|Lost to Follow-up|6|||
19438352|NCT02018822|41685462|FG001|Overall Study|Lost to Follow-up|6|||
19438353|NCT02018822|41685463|FG002|Overall Study|Lost to Follow-up|5|||
19438354|NCT02055157|41685478|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
19438355|NCT02055157|41685479|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
19438356|NCT02055157|41685480|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
19438357|NCT02055157|41685481|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
19438358|NCT02055157|41685478|FG000|Initial 6 Months|Adverse Event|0|||
19438359|NCT02055157|41685479|FG001|Initial 6 Months|Adverse Event|0|||
19438360|NCT02055157|41685480|FG002|Initial 6 Months|Adverse Event|0|||
19438361|NCT02055157|41685481|FG003|Initial 6 Months|Adverse Event|1|||
19438362|NCT02055157|41685478|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
19438363|NCT02055157|41685479|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
19438364|NCT02055157|41685480|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
19438365|NCT02055157|41685481|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
19711241|NCT00083889|42154376|FG001|Overall Study|Protocol Violation|2|||
19711242|NCT00083889|42154375|FG000|Overall Study|Withdrawal by Subject|22|||
19438366|NCT02055157|41685478|FG000|18-month Extension|Investigator decision|0|||
19438367|NCT02055157|41685479|FG001|18-month Extension|Investigator decision|1|||
19438368|NCT02055157|41685480|FG002|18-month Extension|Investigator decision|0|||
19438369|NCT02055157|41685481|FG003|18-month Extension|Investigator decision|0|||
19438370|NCT02055157|41685478|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
19438371|NCT02055157|41685479|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
19438372|NCT02055157|41685480|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
19438373|NCT02055157|41685481|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
19438374|NCT02022007|41685505|FG000|Overall Study|Withdrawal by Subject|1|||
19438375|NCT02022007|41685506|FG001|Overall Study|Withdrawal by Subject|1|||
19438376|NCT02022007|41685507|FG002|Overall Study|Withdrawal by Subject|1|||
19438377|NCT02022007|41685505|FG000|Overall Study|Noncompliant|0|||
19438378|NCT02022007|41685506|FG001|Overall Study|Noncompliant|0|||
19438379|NCT02022007|41685507|FG002|Overall Study|Noncompliant|1|||
19438380|NCT02031679|41685517|FG000|Overall Study|Protocol Violation|0|||
19438381|NCT02031679|41685518|FG001|Overall Study|Protocol Violation|1|||
19438382|NCT02031679|41685517|FG000|Overall Study|Lack of Efficacy|0|||
19438383|NCT02031679|41685518|FG001|Overall Study|Lack of Efficacy|1|||
19438384|NCT02053753|41685526|FG000|Overall Study|Withdrawal by Subject|2|||
19438385|NCT02053753|41685527|FG001|Overall Study|Withdrawal by Subject|4|||
19438386|NCT02053753|41685526|FG000|Overall Study|Decision by Sponsor|1|||
19438387|NCT02053753|41685527|FG001|Overall Study|Decision by Sponsor|1|||
19438388|NCT02053753|41685526|FG000|Overall Study|Lost to Follow-up|4|||
19438389|NCT02053753|41685527|FG001|Overall Study|Lost to Follow-up|3|||
19438390|NCT02019979|41685533|FG000|Overall Study|study terminated|14|||
19438391|NCT02019667|41685537|FG000|First Intervention (6 Months)|Adverse Event|0|||
19438392|NCT02019667|41685538|FG001|First Intervention (6 Months)|Adverse Event|1|||
19438393|NCT02019667|41685537|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
19438394|NCT02019667|41685538|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
19438395|NCT02019667|41685537|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
19438396|NCT02019667|41685538|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
19438397|NCT02030821|41685550|FG000|Overall Study|Physician Decision|2|||
19438398|NCT02030821|41685551|FG001|Overall Study|Physician Decision|2|||
19438399|NCT02030821|41685552|FG002|Overall Study|Physician Decision|5|||
19438400|NCT02030821|41685553|FG003|Overall Study|Physician Decision|2|||
19438401|NCT02052739|41685565|FG000|Overall Study|Withdrew due to Adverse Event|3|||
19438402|NCT02052739|41685566|FG001|Overall Study|Withdrew due to Adverse Event|0|||
19438403|NCT02052739|41685565|FG000|Overall Study|Participant Died|2|||
19438404|NCT02052739|41685566|FG001|Overall Study|Participant Died|1|||
19438405|NCT02019277|41685574|FG000|Overall Study|Withdrawal by Subject|3|||
19438406|NCT02019277|41685574|FG000|Overall Study|Death|7|||
19438407|NCT02019277|41685574|FG000|Overall Study|Did no Cooperate|1|||
19438408|NCT02019277|41685574|FG000|Overall Study|Adverse Event|1|||
19438409|NCT02030119|41685582|FG000|Overall Study|Withdrawal by Subject|3|||
19438410|NCT02030119|41685583|FG001|Overall Study|Withdrawal by Subject|1|||
19438411|NCT02030119|41685584|FG002|Overall Study|Withdrawal by Subject|5|||
19438412|NCT02030119|41685585|FG003|Overall Study|Withdrawal by Subject|3|||
19438413|NCT02030119|41685582|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
19438414|NCT02030119|41685583|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
19438415|NCT02030119|41685584|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
19438416|NCT02030119|41685585|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
19438417|NCT01823835|41685610|FG000|Overall Study|Adverse Event|0|||
19438418|NCT01823835|41685611|FG001|Overall Study|Adverse Event|0|||
19438419|NCT01823835|41685612|FG002|Overall Study|Adverse Event|0|||
19438420|NCT01823835|41685613|FG003|Overall Study|Adverse Event|0|||
19438421|NCT01823835|41685614|FG004|Overall Study|Adverse Event|1|||
19438422|NCT01823835|41685615|FG005|Overall Study|Adverse Event|0|||
19438423|NCT01823835|41685616|FG006|Overall Study|Adverse Event|1|||
19438424|NCT01823835|41685617|FG007|Overall Study|Adverse Event|0|||
19438425|NCT01823835|41685618|FG008|Overall Study|Adverse Event|0|||
19438426|NCT01823835|41685619|FG009|Overall Study|Adverse Event|0|||
19438427|NCT01823835|41685620|FG010|Overall Study|Adverse Event|1|||
19438428|NCT01823835|41685621|FG011|Overall Study|Adverse Event|2|||
19521998|NCT00982410|41935397|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
19438429|NCT01823835|41685622|FG012|Overall Study|Adverse Event|0|||
19438430|NCT01823835|41685623|FG013|Overall Study|Adverse Event|0|||
19438431|NCT01823835|41685624|FG014|Overall Study|Adverse Event|0|||
19438432|NCT01823835|41685610|FG000|Overall Study|Physician Decision|0|||
19438433|NCT01823835|41685611|FG001|Overall Study|Physician Decision|0|||
19438434|NCT01823835|41685612|FG002|Overall Study|Physician Decision|0|||
19438435|NCT01823835|41685613|FG003|Overall Study|Physician Decision|0|||
19438436|NCT01823835|41685614|FG004|Overall Study|Physician Decision|0|||
19438437|NCT01823835|41685615|FG005|Overall Study|Physician Decision|0|||
19438438|NCT01823835|41685616|FG006|Overall Study|Physician Decision|0|||
19438439|NCT01823835|41685617|FG007|Overall Study|Physician Decision|0|||
19438440|NCT01823835|41685618|FG008|Overall Study|Physician Decision|0|||
19438441|NCT01823835|41685619|FG009|Overall Study|Physician Decision|0|||
19438442|NCT01823835|41685620|FG010|Overall Study|Physician Decision|0|||
19438443|NCT01823835|41685621|FG011|Overall Study|Physician Decision|2|||
19438444|NCT01823835|41685622|FG012|Overall Study|Physician Decision|0|||
19438445|NCT01823835|41685623|FG013|Overall Study|Physician Decision|0|||
19438446|NCT01823835|41685624|FG014|Overall Study|Physician Decision|0|||
19438447|NCT01823835|41685610|FG000|Overall Study|Progressive Disease|3|||
19438448|NCT01823835|41685611|FG001|Overall Study|Progressive Disease|4|||
19438449|NCT01823835|41685612|FG002|Overall Study|Progressive Disease|3|||
19438450|NCT01823835|41685613|FG003|Overall Study|Progressive Disease|6|||
19438451|NCT01823835|41685614|FG004|Overall Study|Progressive Disease|4|||
19438452|NCT01823835|41685615|FG005|Overall Study|Progressive Disease|6|||
19438453|NCT01823835|41685616|FG006|Overall Study|Progressive Disease|5|||
19438454|NCT01823835|41685617|FG007|Overall Study|Progressive Disease|3|||
19438455|NCT01823835|41685618|FG008|Overall Study|Progressive Disease|3|||
19438456|NCT01823835|41685619|FG009|Overall Study|Progressive Disease|18|||
19438457|NCT01823835|41685620|FG010|Overall Study|Progressive Disease|8|||
19438458|NCT01823835|41685621|FG011|Overall Study|Progressive Disease|46|||
19438459|NCT01823835|41685622|FG012|Overall Study|Progressive Disease|18|||
19438460|NCT01823835|41685623|FG013|Overall Study|Progressive Disease|4|||
19438461|NCT01823835|41685624|FG014|Overall Study|Progressive Disease|6|||
19438462|NCT01823835|41685610|FG000|Overall Study|Study Termination|0|||
19438463|NCT01823835|41685611|FG001|Overall Study|Study Termination|0|||
19438464|NCT01823835|41685612|FG002|Overall Study|Study Termination|0|||
19438465|NCT01823835|41685613|FG003|Overall Study|Study Termination|0|||
19438466|NCT01823835|41685614|FG004|Overall Study|Study Termination|1|||
19438467|NCT01823835|41685615|FG005|Overall Study|Study Termination|0|||
19438468|NCT01823835|41685616|FG006|Overall Study|Study Termination|0|||
19438469|NCT01823835|41685617|FG007|Overall Study|Study Termination|0|||
19438470|NCT01823835|41685618|FG008|Overall Study|Study Termination|0|||
19438471|NCT01823835|41685619|FG009|Overall Study|Study Termination|0|||
19438472|NCT01823835|41685620|FG010|Overall Study|Study Termination|0|||
19438473|NCT01823835|41685621|FG011|Overall Study|Study Termination|1|||
19438474|NCT01823835|41685622|FG012|Overall Study|Study Termination|0|||
19438475|NCT01823835|41685623|FG013|Overall Study|Study Termination|0|||
19438476|NCT01823835|41685624|FG014|Overall Study|Study Termination|0|||
19438477|NCT01823835|41685610|FG000|Overall Study|Withdrawal by Subject|0|||
19628353|NCT00811928|42077781|FG000|Overall Study|Did Not Take Study Drug|3|||
19628354|NCT00811928|42077782|FG001|Overall Study|Did Not Take Study Drug|0|||
19628355|NCT00811928|42077781|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
19628356|NCT00811928|42077782|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
19628357|NCT00811928|42077781|FG000|Overall Study|Investigator Decision|2|||
19628358|NCT00811928|42077782|FG001|Overall Study|Investigator Decision|1|||
19628359|NCT00811928|42077781|FG000|Overall Study|Poor Compliance|2|||
19628360|NCT00811928|42077782|FG001|Overall Study|Poor Compliance|5|||
19438478|NCT01823835|41685611|FG001|Overall Study|Withdrawal by Subject|0|||
19438479|NCT01823835|41685612|FG002|Overall Study|Withdrawal by Subject|1|||
19628361|NCT00788775|42077790|FG000|Overall Study|Progressive Disease|8|||
19628362|NCT00788775|42077791|FG001|Overall Study|Progressive Disease|6|||
19438480|NCT01823835|41685613|FG003|Overall Study|Withdrawal by Subject|0|||
19438481|NCT01823835|41685614|FG004|Overall Study|Withdrawal by Subject|0|||
19438482|NCT01823835|41685615|FG005|Overall Study|Withdrawal by Subject|0|||
19438483|NCT01823835|41685616|FG006|Overall Study|Withdrawal by Subject|0|||
19438484|NCT01823835|41685617|FG007|Overall Study|Withdrawal by Subject|0|||
19438485|NCT01823835|41685618|FG008|Overall Study|Withdrawal by Subject|0|||
19438486|NCT01823835|41685619|FG009|Overall Study|Withdrawal by Subject|1|||
19438487|NCT01823835|41685620|FG010|Overall Study|Withdrawal by Subject|1|||
19438488|NCT01823835|41685621|FG011|Overall Study|Withdrawal by Subject|2|||
19438489|NCT01823835|41685622|FG012|Overall Study|Withdrawal by Subject|1|||
19628363|NCT00788775|42077790|FG000|Overall Study|Withdrawal by Subject|0|||
19628364|NCT00788775|42077791|FG001|Overall Study|Withdrawal by Subject|2|||
19628365|NCT00788775|42077790|FG000|Overall Study|Patient Non-Compliance|1|||
19628366|NCT00788775|42077791|FG001|Overall Study|Patient Non-Compliance|0|||
19628367|NCT00788775|42077790|FG000|Overall Study|Patient's measurable disease resected.|1|||
19628368|NCT00788775|42077791|FG001|Overall Study|Patient's measurable disease resected.|0|||
19628369|NCT00448669|42077799|FG000|Overall Study|Lost to Follow-up|52|||
19628370|NCT00448669|42077800|FG001|Overall Study|Lost to Follow-up|63|||
19628371|NCT00448669|42077799|FG000|Overall Study|Withdrawal by Subject|90|||
19628372|NCT00448669|42077800|FG001|Overall Study|Withdrawal by Subject|74|||
19628373|NCT00448669|42077799|FG000|Overall Study|Relocated|49|||
19628374|NCT00448669|42077800|FG001|Overall Study|Relocated|36|||
19628375|NCT00448669|42077799|FG000|Overall Study|Were withdrawn by investigator|10|||
19628376|NCT00448669|42077800|FG001|Overall Study|Were withdrawn by investigator|6|||
19628377|NCT00448669|42077799|FG000|Overall Study|Death|2|||
19628378|NCT00448669|42077800|FG001|Overall Study|Death|4|||
19438490|NCT01823835|41685623|FG013|Overall Study|Withdrawal by Subject|0|||
19438491|NCT01823835|41685624|FG014|Overall Study|Withdrawal by Subject|0|||
19438492|NCT02173379|41685666|FG000|Overall Study|Lost to Follow-up|48|||
19438493|NCT02173379|41685667|FG001|Overall Study|Lost to Follow-up|34|||
19438494|NCT02173379|41685666|FG000|Overall Study|Withdrawal by Subject|14|||
19438495|NCT02173379|41685667|FG001|Overall Study|Withdrawal by Subject|17|||
19628379|NCT00448669|42077799|FG000|Overall Study|Had other reasons|5|||
19628380|NCT00448669|42077800|FG001|Overall Study|Had other reasons|6|||
19628381|NCT00448669|42077799|FG000|Overall Study|HIV-infected at enrollment|1|||
19628382|NCT00448669|42077800|FG001|Overall Study|HIV-infected at enrollment|2|||
19628383|NCT00448669|42077799|FG000|Overall Study|Never started drug|9|||
19628384|NCT00448669|42077800|FG001|Overall Study|Never started drug|7|||
19628385|NCT00591734|42077808|FG000|Overall Study|Lack of Efficacy|35|||
19628386|NCT00591734|42077808|FG000|Overall Study|Adverse Event|5|||
19628387|NCT00591734|42077808|FG000|Overall Study|Physician Decision|5|||
19628388|NCT00591734|42077808|FG000|Overall Study|Intercurrent Illness|8|||
19628389|NCT00788697|42077812|FG000|Overall Study|No study drug administered|12|||
19628390|NCT00788697|42077812|FG000|Overall Study|Training Patients|74|||
19628391|NCT00788697|42077812|FG000|Overall Study|no truth standard procedure available|5|||
19628392|NCT00788697|42077812|FG000|Overall Study|Technically inadequate truth standard|1|||
19628393|NCT00788697|42077812|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
19628394|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
19628395|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
19628396|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
19628397|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
19628398|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
19628399|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
19628400|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
19628401|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
19628402|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
19628403|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
19628404|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
19628405|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
19628406|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
19628407|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
19628408|NCT00848549|42077826|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
19628409|NCT00848549|42077827|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
19628410|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
19628411|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
19628412|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
19628413|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
19628414|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
19628415|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
19628416|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
19628417|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
19628418|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
19628419|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
19628420|NCT00848549|42077826|FG000|E2090-E044-314 (Extension Study)|Other|5|||
19628421|NCT00848549|42077827|FG001|E2090-E044-314 (Extension Study)|Other|6|||
19628422|NCT00788151|42077837|FG000|Overall Study|Other adverse event|0|||
19628423|NCT00788151|42077838|FG001|Overall Study|Other adverse event|2|||
19628424|NCT00788151|42077837|FG000|Overall Study|Protocol Violation|0|||
19628425|NCT00788151|42077838|FG001|Overall Study|Protocol Violation|1|||
19628426|NCT00788151|42077837|FG000|Overall Study|Withdrawal by Subject|13|||
19628427|NCT00788151|42077838|FG001|Overall Study|Withdrawal by Subject|6|||
19628428|NCT00788151|42077837|FG000|Overall Study|Enrolled but not treated|1|||
19628429|NCT00788151|42077838|FG001|Overall Study|Enrolled but not treated|1|||
19628430|NCT00788073|42077846|FG000|STX209 Then Placebo|Adverse Event|1|||
19628431|NCT00788073|42077847|FG001|STX209 Then Placebo|Adverse Event|0|||
19628432|NCT00788073|42077846|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
19628433|NCT00788073|42077847|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
19628434|NCT00788073|42077846|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
19628435|NCT00788073|42077847|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
19628436|NCT00788073|42077846|FG000|STX209 Then Placebo|unable to return due to travel|0|||
19628437|NCT00788073|42077847|FG001|STX209 Then Placebo|unable to return due to travel|1|||
19628438|NCT00788073|42077846|FG000|Placebo Then STX209|Adverse Event|2|||
19628439|NCT00788073|42077847|FG001|Placebo Then STX209|Adverse Event|0|||
19628440|NCT00788073|42077846|FG000|Placebo Then STX209|Protocol Violation|0|||
19628441|NCT00788073|42077847|FG001|Placebo Then STX209|Protocol Violation|1|||
19628442|NCT00848393|42077856|FG000|Overall Study|Protocol Violation|0|||
19628443|NCT00848393|42077857|FG001|Overall Study|Protocol Violation|0|||
19628444|NCT00848393|42077858|FG002|Overall Study|Protocol Violation|1|||
19628445|NCT00848393|42077856|FG000|Overall Study|surgical complications unrelated to stud|0|||
19628446|NCT00848393|42077857|FG001|Overall Study|surgical complications unrelated to stud|0|||
19628447|NCT00848393|42077858|FG002|Overall Study|surgical complications unrelated to stud|2|||
19628448|NCT00815516|42077872|FG000|Overall Study|Death|3|||
19628449|NCT00815516|42077873|FG001|Overall Study|Death|1|||
19628450|NCT00815516|42077872|FG000|Overall Study|Physician Decision|1|||
19628451|NCT00815516|42077873|FG001|Overall Study|Physician Decision|0|||
19628452|NCT00787917|42077881|FG000|Blinded Treatment|Adverse Event|1|||
19628453|NCT00787917|42077882|FG001|Blinded Treatment|Adverse Event|0|||
19628454|NCT00787917|42077881|FG000|Blinded Treatment|Lack of Efficacy|1|||
19628455|NCT00787917|42077882|FG001|Blinded Treatment|Lack of Efficacy|0|||
19628456|NCT00787917|42077881|FG000|Blinded Treatment|Administrative problems|3|||
19628457|NCT00787917|42077882|FG001|Blinded Treatment|Administrative problems|2|||
19628458|NCT00787917|42077881|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
19628459|NCT00787917|42077882|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
19628460|NCT00787917|42077881|FG000|Open Label|Administrative problems|3|||
19628461|NCT00787917|42077882|FG001|Open Label|Administrative problems|0|||
19628462|NCT00814892|42077890|FG000|Overall Study|Disease Progression|1|||
19628463|NCT00814892|42077890|FG000|Overall Study|Study Termination|1|||
19628464|NCT00787839|42077894|FG000|Overall Study|Failure to have the OGTT was most common|404|||
19628465|NCT00829244|42077917|FG000|Overall Study|Adverse Event|1|||
19628466|NCT00829244|42077918|FG001|Overall Study|Adverse Event|3|||
19628467|NCT00829244|42077917|FG000|Overall Study|Protocol Violation|1|||
19628468|NCT00829244|42077918|FG001|Overall Study|Protocol Violation|0|||
19628469|NCT00829244|42077917|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
19628470|NCT00829244|42077918|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
19628471|NCT00829244|42077917|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
19628472|NCT00829244|42077918|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
19628473|NCT00829244|42077917|FG000|Overall Study|No fertilization|2|||
19628474|NCT00829244|42077918|FG001|Overall Study|No fertilization|2|||
19628475|NCT00829244|42077917|FG000|Overall Study|All embryos discarded|0|||
19628476|NCT00829244|42077918|FG001|Overall Study|All embryos discarded|3|||
19628477|NCT00829244|42077917|FG000|Overall Study|No embryo cleavage|0|||
19628478|NCT00829244|42077918|FG001|Overall Study|No embryo cleavage|2|||
19628479|NCT00787605|42077926|FG000|Overall Study|Administrative Problems|3|||
19628480|NCT00787605|42077927|FG001|Overall Study|Administrative Problems|0|||
19628481|NCT00787605|42077926|FG000|Overall Study|Adverse Event|14|||
19628482|NCT00787605|42077927|FG001|Overall Study|Adverse Event|25|||
19628483|NCT00787605|42077926|FG000|Overall Study|Lost to Follow-up|3|||
19628484|NCT00787605|42077927|FG001|Overall Study|Lost to Follow-up|6|||
19628485|NCT00787605|42077926|FG000|Overall Study|Protocol Violation|7|||
19628486|NCT00787605|42077927|FG001|Overall Study|Protocol Violation|3|||
19628487|NCT00787605|42077926|FG000|Overall Study|Withdrawal by Subject|6|||
19628488|NCT00787605|42077927|FG001|Overall Study|Withdrawal by Subject|13|||
19628489|NCT00787605|42077926|FG000|Overall Study|Lack of Efficacy|13|||
19628490|NCT00787605|42077927|FG001|Overall Study|Lack of Efficacy|9|||
19628491|NCT00448591|42077933|FG000|Overall Study|Withdrawal by Subject|178|||
19628492|NCT00448591|42077933|FG000|Overall Study|Progressive Disease|1382|||
19628493|NCT00448591|42077933|FG000|Overall Study|Adverse Event|382|||
19628494|NCT00448591|42077933|FG000|Overall Study|Protocol Violation|41|||
19628495|NCT00448591|42077933|FG000|Overall Study|Lost to Follow-up|19|||
19628496|NCT00448591|42077933|FG000|Overall Study|Treatment Regimen Completed|70|||
19628497|NCT00448591|42077933|FG000|Overall Study|Other|154|||
19628498|NCT00448591|42077933|FG000|Overall Study|Termination of Study|70|||
19628499|NCT00651664|42077949|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
19628500|NCT00651664|42077950|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
19628501|NCT00651664|42077951|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
19628502|NCT00651664|42077952|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
19628503|NCT00651664|42077953|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
19628504|NCT00651664|42077954|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
19628505|NCT00651664|42077955|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
19628506|NCT00651664|42077956|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
19628507|NCT00651664|42077957|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
19628508|NCT00651664|42077958|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
19628509|NCT00651664|42077949|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628510|NCT00651664|42077950|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628511|NCT00651664|42077951|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628512|NCT00651664|42077952|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628513|NCT00651664|42077953|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
19628514|NCT00651664|42077954|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
19628515|NCT00651664|42077955|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628516|NCT00651664|42077956|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
19628517|NCT00651664|42077957|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
19628518|NCT00651664|42077958|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
19628519|NCT00651664|42077949|FG000|Overall Study|Progressive Disease|3|||
19628520|NCT00651664|42077950|FG001|Overall Study|Progressive Disease|3|||
19628521|NCT00651664|42077951|FG002|Overall Study|Progressive Disease|3|||
19628522|NCT00651664|42077952|FG003|Overall Study|Progressive Disease|12|||
19628523|NCT00651664|42077953|FG004|Overall Study|Progressive Disease|4|||
19628524|NCT00651664|42077954|FG005|Overall Study|Progressive Disease|1|||
19628525|NCT00651664|42077955|FG006|Overall Study|Progressive Disease|3|||
19628526|NCT00651664|42077956|FG007|Overall Study|Progressive Disease|6|||
19628527|NCT00651664|42077957|FG008|Overall Study|Progressive Disease|5|||
19628528|NCT00651664|42077958|FG009|Overall Study|Progressive Disease|5|||
19628529|NCT00651664|42077949|FG000|Overall Study|Patient Declined Further Treatment|0|||
19628530|NCT00651664|42077950|FG001|Overall Study|Patient Declined Further Treatment|0|||
19628531|NCT00651664|42077951|FG002|Overall Study|Patient Declined Further Treatment|0|||
19628532|NCT00651664|42077952|FG003|Overall Study|Patient Declined Further Treatment|1|||
19628533|NCT00651664|42077953|FG004|Overall Study|Patient Declined Further Treatment|1|||
19628534|NCT00651664|42077954|FG005|Overall Study|Patient Declined Further Treatment|1|||
19628535|NCT00651664|42077955|FG006|Overall Study|Patient Declined Further Treatment|0|||
19628536|NCT00651664|42077956|FG007|Overall Study|Patient Declined Further Treatment|0|||
19628537|NCT00651664|42077957|FG008|Overall Study|Patient Declined Further Treatment|0|||
19628538|NCT00651664|42077958|FG009|Overall Study|Patient Declined Further Treatment|1|||
19628539|NCT00651664|42077949|FG000|Overall Study|Symptomatic Deterioration|0|||
19628540|NCT00651664|42077950|FG001|Overall Study|Symptomatic Deterioration|0|||
19628541|NCT00651664|42077951|FG002|Overall Study|Symptomatic Deterioration|0|||
19628542|NCT00651664|42077952|FG003|Overall Study|Symptomatic Deterioration|1|||
19628543|NCT00651664|42077953|FG004|Overall Study|Symptomatic Deterioration|0|||
19628544|NCT00651664|42077954|FG005|Overall Study|Symptomatic Deterioration|0|||
19628545|NCT00651664|42077955|FG006|Overall Study|Symptomatic Deterioration|1|||
19628546|NCT00651664|42077956|FG007|Overall Study|Symptomatic Deterioration|0|||
19628547|NCT00651664|42077957|FG008|Overall Study|Symptomatic Deterioration|1|||
19628548|NCT00651664|42077958|FG009|Overall Study|Symptomatic Deterioration|0|||
19628549|NCT00651664|42077949|FG000|Overall Study|Reason not Specified|0|||
19628550|NCT00651664|42077950|FG001|Overall Study|Reason not Specified|0|||
19628551|NCT00651664|42077951|FG002|Overall Study|Reason not Specified|0|||
19628552|NCT00651664|42077952|FG003|Overall Study|Reason not Specified|0|||
19628553|NCT00651664|42077953|FG004|Overall Study|Reason not Specified|0|||
19628554|NCT00651664|42077954|FG005|Overall Study|Reason not Specified|0|||
19628555|NCT00651664|42077955|FG006|Overall Study|Reason not Specified|1|||
19628556|NCT00651664|42077956|FG007|Overall Study|Reason not Specified|0|||
19628557|NCT00651664|42077957|FG008|Overall Study|Reason not Specified|0|||
19628558|NCT00651664|42077958|FG009|Overall Study|Reason not Specified|0|||
19628559|NCT00787527|42077984|FG000|Overall Study|Toxicity|3|||
19628560|NCT00787137|42077995|FG000|Overall Study|Study Termination|0|||
19628561|NCT00787137|42077996|FG001|Overall Study|Study Termination|0|||
19628562|NCT00787137|42077997|FG002|Overall Study|Study Termination|1|||
19628563|NCT00448435|42078005|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
19628564|NCT00448435|42078006|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
19628565|NCT00448279|42078017|FG000|Overall Study|Lost to Follow-up|2|||
19628566|NCT00448279|42078018|FG001|Overall Study|Lost to Follow-up|2|||
19628567|NCT00448279|42078017|FG000|Overall Study|Adverse Event|1|||
19628568|NCT00448279|42078018|FG001|Overall Study|Adverse Event|1|||
19628569|NCT00448279|42078017|FG000|Overall Study|Disease progression|16|||
19628570|NCT00448279|42078018|FG001|Overall Study|Disease progression|18|||
19628571|NCT00448279|42078017|FG000|Overall Study|Withdrawal by Subject|4|||
19628572|NCT00448279|42078018|FG001|Overall Study|Withdrawal by Subject|3|||
19628573|NCT00448279|42078017|FG000|Overall Study|Other|6|||
19628574|NCT00448279|42078018|FG001|Overall Study|Other|4|||
19438496|NCT02173379|41685666|FG000|Overall Study|Physician Decision|7|||
19438497|NCT02173379|41685667|FG001|Overall Study|Physician Decision|4|||
19438498|NCT02173379|41685666|FG000|Overall Study|Death|22|||
19438499|NCT02173379|41685667|FG001|Overall Study|Death|22|||
19438500|NCT01823679|41685674|FG000|Overall Study|Death|1|||
19438501|NCT01823289|41685679|FG000|Overall Study|Lost to Follow-up|5|||
19438502|NCT01823289|41685679|FG000|Overall Study|Adverse Event|5|||
19438503|NCT01823289|41685679|FG000|Overall Study|Lack of Efficacy|1|||
19438504|NCT01823289|41685679|FG000|Overall Study|Physician Decision|9|||
19438505|NCT01823289|41685679|FG000|Overall Study|Administered contraindicated medicine|1|||
19438506|NCT01823289|41685679|FG000|Overall Study|Transaminase increased more than 3 times|1|||
19438507|NCT01823289|41685679|FG000|Overall Study|Drug affected efficacy and safety|1|||
19438508|NCT01823289|41685679|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
19628575|NCT00448279|42078017|FG000|Overall Study|Protocol Violation|0|||
19628576|NCT00448279|42078018|FG001|Overall Study|Protocol Violation|1|||
19628577|NCT00448123|42078026|FG000|Overall Study|Lost to Follow-up|9|||
19628578|NCT00448123|42078027|FG001|Overall Study|Lost to Follow-up|6|||
19628579|NCT00448123|42078026|FG000|Overall Study|Physician Decision|6|||
19628580|NCT00448123|42078027|FG001|Overall Study|Physician Decision|6|||
19628581|NCT00447499|42078036|FG000|Overall Study|Adverse Event|1|||
19628582|NCT00447499|42078036|FG000|Overall Study|Patient Decision|4|||
19628583|NCT00447499|42078036|FG000|Overall Study|Sponsor Decision|1|||
19628584|NCT00447499|42078036|FG000|Overall Study|Physician Decision|1|||
19628585|NCT00800436|42078049|FG000|Overall Study|Withdrawal by Subject|0|||
19628586|NCT00800436|42078050|FG001|Overall Study|Withdrawal by Subject|0|||
19628587|NCT00800436|42078051|FG002|Overall Study|Withdrawal by Subject|1|||
19628588|NCT00800436|42078052|FG003|Overall Study|Withdrawal by Subject|1|||
19628589|NCT00800436|42078053|FG004|Overall Study|Withdrawal by Subject|0|||
19628590|NCT00800436|42078054|FG005|Overall Study|Withdrawal by Subject|0|||
19438509|NCT01822899|41685685|FG000|Overall Study|Adverse Event|6|||
19438510|NCT01822899|41685686|FG001|Overall Study|Adverse Event|5|||
19438511|NCT01822899|41685685|FG000|Overall Study|Lack of Efficacy|6|||
19438512|NCT01822899|41685686|FG001|Overall Study|Lack of Efficacy|3|||
19438513|NCT01822899|41685685|FG000|Overall Study|Protocol Violation|6|||
19438514|NCT01822899|41685686|FG001|Overall Study|Protocol Violation|3|||
19438515|NCT01822899|41685685|FG000|Overall Study|Lost to Follow-up|1|||
19438516|NCT01822899|41685686|FG001|Overall Study|Lost to Follow-up|0|||
19438517|NCT01822899|41685685|FG000|Overall Study|Withdrawal by Subject|5|||
19438518|NCT01822899|41685686|FG001|Overall Study|Withdrawal by Subject|7|||
19438519|NCT01822821|41685694|FG000|Overall Study|Eligible surgery cancelled|1|||
19628591|NCT00800436|42078055|FG006|Overall Study|Withdrawal by Subject|0|||
19628592|NCT00655564|42078071|FG000|Overall Study|Adverse Event|1|||
19628593|NCT00655564|42078071|FG000|Overall Study|Lost to Follow-up|1|||
19628594|NCT00655564|42078071|FG000|Overall Study|Desired Alternate Therapy|1|||
19628595|NCT00447421|42078076|FG000|Overall Study|Lack of Efficacy|1|||
19628596|NCT00447421|42078076|FG000|Overall Study|Adverse Event|3|||
19438520|NCT01822821|41685695|FG001|Overall Study|Eligible surgery cancelled|1|||
19438521|NCT01822821|41685694|FG000|Overall Study|Other reasons|1|||
19438522|NCT01822821|41685695|FG001|Overall Study|Other reasons|0|||
19438523|NCT01822665|41685701|FG000|Overall Study|Adverse Event|3|||
19438524|NCT01822665|41685701|FG000|Overall Study|Other Reason|5|||
19438525|NCT02173301|41685723|FG000|Overall Study|Adverse Event|7|||
19438526|NCT02173301|41685724|FG001|Overall Study|Adverse Event|8|||
19438527|NCT02173301|41685725|FG002|Overall Study|Adverse Event|13|||
19438528|NCT02173301|41685726|FG003|Overall Study|Adverse Event|5|||
19438529|NCT02173301|41685723|FG000|Overall Study|Withdrawal by Subject|8|||
19438530|NCT02173301|41685724|FG001|Overall Study|Withdrawal by Subject|10|||
19438531|NCT02173301|41685725|FG002|Overall Study|Withdrawal by Subject|4|||
19438532|NCT02173301|41685726|FG003|Overall Study|Withdrawal by Subject|8|||
19438533|NCT02173301|41685723|FG000|Overall Study|Lost to Follow-up|4|||
19438534|NCT02173301|41685724|FG001|Overall Study|Lost to Follow-up|4|||
19438535|NCT02173301|41685725|FG002|Overall Study|Lost to Follow-up|2|||
19438536|NCT02173301|41685726|FG003|Overall Study|Lost to Follow-up|2|||
19438537|NCT02173301|41685723|FG000|Overall Study|Protocol Violation|0|||
19438538|NCT02173301|41685724|FG001|Overall Study|Protocol Violation|1|||
19438539|NCT02173301|41685725|FG002|Overall Study|Protocol Violation|0|||
19438540|NCT02173301|41685726|FG003|Overall Study|Protocol Violation|0|||
19438541|NCT02173301|41685723|FG000|Overall Study|Physician Decision|0|||
19438542|NCT02173301|41685724|FG001|Overall Study|Physician Decision|0|||
19438543|NCT02173301|41685725|FG002|Overall Study|Physician Decision|1|||
19438544|NCT02173301|41685726|FG003|Overall Study|Physician Decision|0|||
19438545|NCT02173301|41685723|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
19438546|NCT02173301|41685724|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
19438547|NCT02173301|41685725|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
19438548|NCT02173301|41685726|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
19438549|NCT01822587|41685739|FG000|Overall Study|Lost to Follow-up|7|||
19438550|NCT01822587|41685740|FG001|Overall Study|Lost to Follow-up|9|||
19438551|NCT01822587|41685741|FG002|Overall Study|Lost to Follow-up|12|||
19438552|NCT01822587|41685739|FG000|Overall Study|Physician Decision|9|||
19438553|NCT01822587|41685740|FG001|Overall Study|Physician Decision|6|||
19438554|NCT01822587|41685741|FG002|Overall Study|Physician Decision|6|||
19438555|NCT01822353|41685752|FG000|Overall Study|Adverse Event|1|||
19438556|NCT01822353|41685753|FG001|Overall Study|Adverse Event|3|||
19438557|NCT01822353|41685754|FG002|Overall Study|Adverse Event|1|||
19438558|NCT01822353|41685752|FG000|Overall Study|Pregnancy|0|||
19438559|NCT01822353|41685753|FG001|Overall Study|Pregnancy|1|||
19438560|NCT01822353|41685754|FG002|Overall Study|Pregnancy|0|||
19628597|NCT00447421|42078076|FG000|Overall Study|Sponsor Decision|2|||
19628598|NCT00651118|42078084|FG000|Overall Study|Adverse Event|4|||
19628599|NCT00651118|42078085|FG001|Overall Study|Adverse Event|0|||
19628600|NCT00651118|42078086|FG002|Overall Study|Adverse Event|1|||
19628601|NCT00651118|42078087|FG003|Overall Study|Adverse Event|1|||
19628602|NCT00651118|42078084|FG000|Overall Study|Protocol Violation|2|||
19628603|NCT00651118|42078085|FG001|Overall Study|Protocol Violation|2|||
19628604|NCT00651118|42078086|FG002|Overall Study|Protocol Violation|6|||
19628605|NCT00651118|42078087|FG003|Overall Study|Protocol Violation|2|||
19628606|NCT00651118|42078084|FG000|Overall Study|Lost to Follow-up|2|||
19628607|NCT00651118|42078085|FG001|Overall Study|Lost to Follow-up|0|||
19628608|NCT00651118|42078086|FG002|Overall Study|Lost to Follow-up|1|||
19628609|NCT00651118|42078087|FG003|Overall Study|Lost to Follow-up|2|||
19628610|NCT00651118|42078084|FG000|Overall Study|administrative|1|||
19438561|NCT01822353|41685752|FG000|Overall Study|Withdrawal by Subject|3|||
19521999|NCT00982410|41935396|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
19628611|NCT00651118|42078085|FG001|Overall Study|administrative|4|||
19628612|NCT00651118|42078086|FG002|Overall Study|administrative|2|||
19628613|NCT00651118|42078087|FG003|Overall Study|administrative|1|||
19438562|NCT01822353|41685753|FG001|Overall Study|Withdrawal by Subject|1|||
19438563|NCT01822353|41685754|FG002|Overall Study|Withdrawal by Subject|0|||
19438564|NCT01821963|41685765|FG000|Overall Study|Adverse Event|1|||
19438565|NCT01821807|41685771|FG000|Overall Study|Lost to Follow-up|3|||
19438566|NCT01821807|41685772|FG001|Overall Study|Lost to Follow-up|1|||
19438567|NCT01821729|41685778|FG000|Overall Study|Withdrawal by Subject|1|||
19438568|NCT01820637|41685782|FG000|Overall Study|Death|2|||
19438569|NCT01820637|41685782|FG000|Overall Study|Withdrawal by Subject|1|||
19438570|NCT02172911|41685788|FG000|Overall Study|Serious Adverse Event|0|||
19438571|NCT02172911|41685789|FG001|Overall Study|Serious Adverse Event|1|||
19438572|NCT02172911|41685788|FG000|Overall Study|Progression of Disease|0|||
19438573|NCT02172911|41685789|FG001|Overall Study|Progression of Disease|1|||
19628614|NCT00651118|42078084|FG000|Overall Study|Withdrawal by Subject|0|||
19628615|NCT00651118|42078085|FG001|Overall Study|Withdrawal by Subject|1|||
19628616|NCT00651118|42078086|FG002|Overall Study|Withdrawal by Subject|1|||
19628617|NCT00651118|42078087|FG003|Overall Study|Withdrawal by Subject|1|||
19438574|NCT02172911|41685788|FG000|Overall Study|Loss of insurance coverage|1|||
19438575|NCT02172911|41685789|FG001|Overall Study|Loss of insurance coverage|0|||
19438576|NCT02120027|41685797|FG000|Overall Study|Adverse Event|4|||
19438577|NCT02120027|41685798|FG001|Overall Study|Adverse Event|5|||
19438578|NCT02120027|41685797|FG000|Overall Study|Lack of Efficacy|3|||
19438579|NCT02120027|41685798|FG001|Overall Study|Lack of Efficacy|5|||
19438580|NCT02120027|41685797|FG000|Overall Study|Lost to Follow-up|5|||
19438581|NCT02120027|41685798|FG001|Overall Study|Lost to Follow-up|13|||
19438582|NCT02120027|41685797|FG000|Overall Study|Other|4|||
19438583|NCT02120027|41685798|FG001|Overall Study|Other|0|||
19438584|NCT02120027|41685797|FG000|Overall Study|Physician Decision|4|||
19438585|NCT02120027|41685798|FG001|Overall Study|Physician Decision|3|||
19628618|NCT00447265|42078100|FG000|Overall Study|Physician Decision|1|||
19628619|NCT00447265|42078101|FG001|Overall Study|Physician Decision|0|||
19438586|NCT02120027|41685797|FG000|Overall Study|Protocol Violation|18|||
19438587|NCT02120027|41685798|FG001|Overall Study|Protocol Violation|21|||
19438588|NCT02120027|41685797|FG000|Overall Study|Study terminated by Sponsor|45|||
19438589|NCT02120027|41685798|FG001|Overall Study|Study terminated by Sponsor|47|||
19438590|NCT02120027|41685797|FG000|Overall Study|Withdrawal by Subject|33|||
19438591|NCT02120027|41685798|FG001|Overall Study|Withdrawal by Subject|25|||
19438592|NCT01850823|41685807|FG000|Overall Study|Early Visit Window|0|||
19438593|NCT01850823|41685808|FG001|Overall Study|Early Visit Window|1|||
19438594|NCT01850823|41685809|FG002|Overall Study|Early Visit Window|4|||
19438595|NCT01850823|41685807|FG000|Overall Study|Enrolled in Error|0|||
19438596|NCT01850823|41685808|FG001|Overall Study|Enrolled in Error|1|||
19438597|NCT01850823|41685809|FG002|Overall Study|Enrolled in Error|2|||
19438598|NCT01850823|41685807|FG000|Overall Study|Lack of Efficacy|1|||
19438599|NCT01850823|41685808|FG001|Overall Study|Lack of Efficacy|0|||
19438600|NCT01850823|41685809|FG002|Overall Study|Lack of Efficacy|0|||
19438601|NCT01850823|41685807|FG000|Overall Study|Lost to Follow-up|0|||
19438602|NCT01850823|41685808|FG001|Overall Study|Lost to Follow-up|0|||
19438603|NCT01850823|41685809|FG002|Overall Study|Lost to Follow-up|1|||
19438604|NCT01850823|41685807|FG000|Overall Study|Restricted Medication|0|||
19438605|NCT01850823|41685808|FG001|Overall Study|Restricted Medication|0|||
19438606|NCT01850823|41685809|FG002|Overall Study|Restricted Medication|2|||
19438607|NCT01850823|41685807|FG000|Overall Study|Significant worstening of SAR|0|||
19438608|NCT01850823|41685808|FG001|Overall Study|Significant worstening of SAR|1|||
19438609|NCT01850823|41685809|FG002|Overall Study|Significant worstening of SAR|0|||
19438610|NCT01850823|41685807|FG000|Overall Study|Withdrawal by Subject|2|||
19438611|NCT01850823|41685808|FG001|Overall Study|Withdrawal by Subject|0|||
19438612|NCT01850823|41685809|FG002|Overall Study|Withdrawal by Subject|1|||
19438613|NCT01820559|41685822|FG000|Overall Study|Adverse Event|4|||
19438614|NCT01820559|41685823|FG001|Overall Study|Adverse Event|6|||
19438615|NCT01820559|41685824|FG002|Overall Study|Adverse Event|13|||
19438616|NCT01820559|41685822|FG000|Overall Study|Withdrawal by Subject|1|||
19438617|NCT01820559|41685823|FG001|Overall Study|Withdrawal by Subject|2|||
19438618|NCT01820559|41685824|FG002|Overall Study|Withdrawal by Subject|5|||
19438619|NCT01820559|41685822|FG000|Overall Study|Protocol Violation|2|||
19438620|NCT01820559|41685823|FG001|Overall Study|Protocol Violation|1|||
19438621|NCT01820559|41685824|FG002|Overall Study|Protocol Violation|3|||
19438622|NCT01820559|41685822|FG000|Overall Study|Subject's non-compliance|1|||
19438623|NCT01820559|41685823|FG001|Overall Study|Subject's non-compliance|0|||
19438624|NCT01820559|41685824|FG002|Overall Study|Subject's non-compliance|2|||
19438625|NCT01820559|41685822|FG000|Overall Study|Lost to Follow-up|3|||
19438626|NCT01820559|41685823|FG001|Overall Study|Lost to Follow-up|2|||
19438627|NCT01820559|41685824|FG002|Overall Study|Lost to Follow-up|2|||
19438628|NCT01820559|41685822|FG000|Overall Study|At sponsor request|0|||
19438629|NCT01820559|41685823|FG001|Overall Study|At sponsor request|0|||
19438630|NCT01820559|41685824|FG002|Overall Study|At sponsor request|1|||
19438631|NCT01820559|41685822|FG000|Overall Study|Lack of Efficacy|3|||
19628620|NCT00657358|42078105|FG000|Overall Study|Lack of Efficacy|6|||
19628621|NCT00457639|42078110|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
19438632|NCT01820559|41685823|FG001|Overall Study|Lack of Efficacy|2|||
19438633|NCT01820559|41685824|FG002|Overall Study|Lack of Efficacy|3|||
19438634|NCT01818765|41685832|FG000|Overall Study|Death|2|||
19438635|NCT01850589|41685839|FG000|Overall Study|Withdrawal by Subject|8|||
19438636|NCT01850589|41685840|FG001|Overall Study|Withdrawal by Subject|0|||
19438637|NCT01818531|41685848|FG000|Overall Study|Withdrawn for case delay after block|1|||
19438638|NCT01818531|41685849|FG001|Overall Study|Withdrawn for case delay after block|0|||
19438639|NCT01818531|41685848|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
19438640|NCT01818531|41685849|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
19438641|NCT01818531|41685848|FG000|Overall Study|Withdrawn for failure to place block|0|||
19438642|NCT01818531|41685849|FG001|Overall Study|Withdrawn for failure to place block|1|||
19438643|NCT02171429|41685858|FG000|Overall Study|Other|0|||
19438644|NCT02171429|41685859|FG001|Overall Study|Other|1|||
19438645|NCT02171429|41685860|FG002|Overall Study|Other|1|||
19438646|NCT02171429|41685858|FG000|Overall Study|Non-Compliance|0|||
19438647|NCT02171429|41685859|FG001|Overall Study|Non-Compliance|0|||
19438648|NCT02171429|41685860|FG002|Overall Study|Non-Compliance|1|||
19438649|NCT02171429|41685858|FG000|Overall Study|Physician Decision|0|||
19438650|NCT02171429|41685859|FG001|Overall Study|Physician Decision|0|||
19438651|NCT02171429|41685860|FG002|Overall Study|Physician Decision|1|||
19438652|NCT02171429|41685858|FG000|Overall Study|Withdrawal by Subject|1|||
19438653|NCT02171429|41685859|FG001|Overall Study|Withdrawal by Subject|1|||
19438654|NCT02171429|41685860|FG002|Overall Study|Withdrawal by Subject|1|||
19438655|NCT02171429|41685858|FG000|Overall Study|Lost to Follow-up|0|||
19438656|NCT02171429|41685859|FG001|Overall Study|Lost to Follow-up|1|||
19438657|NCT02171429|41685860|FG002|Overall Study|Lost to Follow-up|0|||
19438658|NCT02171429|41685858|FG000|Overall Study|Death|0|||
19438659|NCT02171429|41685859|FG001|Overall Study|Death|0|||
19438660|NCT02171429|41685860|FG002|Overall Study|Death|1|||
19438661|NCT01818297|41685873|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
19438662|NCT01818297|41685874|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
19438663|NCT01818297|41685873|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
19438664|NCT01818297|41685874|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
19438665|NCT01818297|41685873|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
19438666|NCT01818297|41685874|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
19438667|NCT01818141|41685882|FG000|Overall Study|Withdrawal by Subject|2|||
19438668|NCT01818141|41685883|FG001|Overall Study|Withdrawal by Subject|0|||
19438669|NCT01818141|41685882|FG000|Overall Study|No baseline C.diff colonies|1|||
19438670|NCT01818141|41685883|FG001|Overall Study|No baseline C.diff colonies|1|||
19438671|NCT01818141|41685882|FG000|Overall Study|Lost to Follow-up|0|||
19438672|NCT01818141|41685883|FG001|Overall Study|Lost to Follow-up|2|||
19438673|NCT01849497|41685891|FG000|Overall Study|Withdrawal by Subject|1|||
19438674|NCT01849497|41685892|FG001|Overall Study|Withdrawal by Subject|2|||
19438675|NCT01849497|41685891|FG000|Overall Study|Sponsor Decision|0|||
19438676|NCT01849497|41685892|FG001|Overall Study|Sponsor Decision|1|||
19438677|NCT01849497|41685891|FG000|Overall Study|Lost to Follow-up|0|||
19438678|NCT01849497|41685892|FG001|Overall Study|Lost to Follow-up|1|||
19438679|NCT02147093|41685900|FG000|Period 1|Lost to Follow-up|0|||
19438680|NCT02147093|41685901|FG001|Period 1|Lost to Follow-up|1|||
19438681|NCT02147093|41685900|FG000|Period 2|Protocol Violation|2|||
19438682|NCT02147093|41685901|FG001|Period 2|Protocol Violation|0|||
19438683|NCT02119325|41685907|FG000|Washout Period 1|Adverse Event|0|||
19438684|NCT02119325|41685908|FG001|Washout Period 1|Adverse Event|1|||
19438685|NCT01816893|41685918|FG000|Washout Period|Withdrawal by Subject|2|||
19438686|NCT01816893|41685919|FG001|Washout Period|Withdrawal by Subject|0|||
19438687|NCT01848483|41685927|FG000|Overall Study|Death|2|||
19438688|NCT01848483|41685928|FG001|Overall Study|Death|1|||
19438689|NCT01848483|41685927|FG000|Overall Study|Lost to Follow-up|6|||
19438690|NCT01848483|41685928|FG001|Overall Study|Lost to Follow-up|8|||
19438691|NCT01848483|41685927|FG000|Overall Study|Withdrawal by Subject|1|||
19438692|NCT01848483|41685928|FG001|Overall Study|Withdrawal by Subject|0|||
19438693|NCT01848483|41685927|FG000|Overall Study|Incarceration|2|||
19438694|NCT01848483|41685928|FG001|Overall Study|Incarceration|2|||
19438695|NCT01610271|41685937|FG000|Overall Study|Surgery not complete|0|||
19438696|NCT01610271|41685938|FG001|Overall Study|Surgery not complete|1|||
19438697|NCT01610271|41685937|FG000|Overall Study|Prosthesis not implanted|2|||
19438698|NCT01610271|41685938|FG001|Overall Study|Prosthesis not implanted|3|||
19438699|NCT02170727|41685948|FG000|Overall Study|Lost to Follow-up|1|||
19438700|NCT02170727|41685949|FG001|Overall Study|Lost to Follow-up|0|||
19438701|NCT02170727|41685948|FG000|Overall Study|Withdrawal by Subject|2|||
19438702|NCT02170727|41685949|FG001|Overall Study|Withdrawal by Subject|0|||
19438703|NCT01847313|41685960|FG000|Overall Study|Death|0|||
19438704|NCT01847313|41685961|FG001|Overall Study|Death|1|||
19438705|NCT01847313|41685960|FG000|Overall Study|Withdrawal by Subject|0|||
19438706|NCT01847313|41685961|FG001|Overall Study|Withdrawal by Subject|1|||
19438707|NCT02144285|41685977|FG000|Overall Study|Withdrawal by Subject|0|||
19438708|NCT02144285|41685978|FG001|Overall Study|Withdrawal by Subject|0|||
19438709|NCT02144285|41685979|FG002|Overall Study|Withdrawal by Subject|0|||
19438710|NCT02144285|41685980|FG003|Overall Study|Withdrawal by Subject|0|||
19438711|NCT02144285|41685981|FG004|Overall Study|Withdrawal by Subject|1|||
19438712|NCT02144285|41685982|FG005|Overall Study|Withdrawal by Subject|0|||
19438713|NCT02144285|41685983|FG006|Overall Study|Withdrawal by Subject|0|||
19438714|NCT02144285|41685984|FG007|Overall Study|Withdrawal by Subject|0|||
19438715|NCT02144285|41685985|FG008|Overall Study|Withdrawal by Subject|0|||
19438716|NCT02144285|41685986|FG009|Overall Study|Withdrawal by Subject|0|||
19438717|NCT02117687|41686024|FG000|Overall Study|Lost to Follow-up|0|||
19438718|NCT02117687|41686025|FG001|Overall Study|Lost to Follow-up|1|||
19438719|NCT02117687|41686024|FG000|Overall Study|Adverse Event|0|||
19438720|NCT02117687|41686025|FG001|Overall Study|Adverse Event|2|||
19438721|NCT02117687|41686024|FG000|Overall Study|Other Reasons|1|||
19438722|NCT02117687|41686025|FG001|Overall Study|Other Reasons|1|||
19438723|NCT02143583|41686034|FG000|Overall Study|Withdrawal by Subject|1|||
19628622|NCT00457639|42078111|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
19628623|NCT00457639|42078110|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
19628624|NCT00457639|42078111|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
19628625|NCT00457639|42078110|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
19628626|NCT00457639|42078111|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
19628627|NCT00800202|42078119|FG000|Overall Study|Adverse Event|7|||
19628628|NCT00800202|42078120|FG001|Overall Study|Adverse Event|6|||
19628629|NCT00800202|42078119|FG000|Overall Study|Death|1|||
19628630|NCT00800202|42078120|FG001|Overall Study|Death|0|||
19628631|NCT00800202|42078119|FG000|Overall Study|Other|5|||
19628632|NCT00800202|42078120|FG001|Overall Study|Other|0|||
19628633|NCT00800202|42078119|FG000|Overall Study|Disease Progression|54|||
19628634|NCT00800202|42078120|FG001|Overall Study|Disease Progression|18|||
19628635|NCT00655486|42078126|FG000|Overall Study|Adverse Event|10|||
19628636|NCT00655486|42078126|FG000|Overall Study|Lack of Efficacy|8|||
19628637|NCT00655486|42078126|FG000|Overall Study|Withdrawal by Subject|4|||
19628638|NCT00655486|42078126|FG000|Overall Study|Protocol Violation|1|||
19628639|NCT00655486|42078126|FG000|Overall Study|Unsatisfactory compliance|2|||
19628640|NCT00655486|42078126|FG000|Overall Study|Other: Pregnancy|1|||
19628641|NCT00655486|42078126|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
19628642|NCT00655486|42078126|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
19628643|NCT00457249|42078132|FG000|Overall Study|Lost to Follow-up|3|||
19628644|NCT00457249|42078133|FG001|Overall Study|Lost to Follow-up|0|||
19628645|NCT00457249|42078132|FG000|Overall Study|Protocol Violation|4|||
19628646|NCT00457249|42078133|FG001|Overall Study|Protocol Violation|1|||
19628647|NCT00457249|42078132|FG000|Overall Study|Withdrawal by Subject|3|||
19628648|NCT00457249|42078133|FG001|Overall Study|Withdrawal by Subject|1|||
19628649|NCT00457249|42078132|FG000|Overall Study|Serious Adverse Events|2|||
19628650|NCT00457249|42078133|FG001|Overall Study|Serious Adverse Events|0|||
19628651|NCT00457015|42078143|FG000|Overall Study|Left study site against medical advice|0|||
19628652|NCT00457015|42078144|FG001|Overall Study|Left study site against medical advice|1|||
19628653|NCT00654940|42078152|FG000|Period 1|Adverse Event|0|||
19628654|NCT00654940|42078153|FG001|Period 1|Adverse Event|1|||
19628655|NCT00654940|42078152|FG000|Period 1|Intolerable Pain Level|1|||
19628656|NCT00654940|42078153|FG001|Period 1|Intolerable Pain Level|0|||
19628657|NCT00588666|42078165|FG000|Overall Study|Adverse Event|4|||
19628658|NCT00793182|42078180|FG000|Overall Study|Adverse Event|0|||
19628659|NCT00793182|42078181|FG001|Overall Study|Adverse Event|1|||
19628660|NCT00793104|42078187|FG000|Overall Study|Lost to Follow-up|1|||
19628661|NCT00446797|42078193|FG000|Overall Study|Lack of Efficacy|0|||
19628662|NCT00446797|42078194|FG001|Overall Study|Lack of Efficacy|2|||
19628663|NCT00446797|42078193|FG000|Overall Study|Lost to Follow-up|5|||
19628664|NCT00446797|42078194|FG001|Overall Study|Lost to Follow-up|3|||
19628665|NCT00446797|42078193|FG000|Overall Study|Withdrawal by Subject|2|||
19628666|NCT00446797|42078194|FG001|Overall Study|Withdrawal by Subject|2|||
19628667|NCT00446797|42078193|FG000|Overall Study|Protocol Violation|1|||
19628668|NCT00446797|42078194|FG001|Overall Study|Protocol Violation|3|||
19628669|NCT00446797|42078193|FG000|Overall Study|subject entered at another site|0|||
19628670|NCT00446797|42078194|FG001|Overall Study|subject entered at another site|1|||
19628671|NCT00446797|42078193|FG000|Overall Study|did not meet entrance criteria|0|||
19628672|NCT00446797|42078194|FG001|Overall Study|did not meet entrance criteria|1|||
19628673|NCT00855335|42078205|FG000|Overall Study|Lost to Follow-up|0|||
19628674|NCT00855335|42078206|FG001|Overall Study|Lost to Follow-up|0|||
19628675|NCT00855335|42078207|FG002|Overall Study|Lost to Follow-up|3|||
19628676|NCT00855335|42078208|FG003|Overall Study|Lost to Follow-up|1|||
19628677|NCT00855335|42078209|FG004|Overall Study|Lost to Follow-up|0|||
19628678|NCT00855335|42078205|FG000|Overall Study|Withdrawal by Subject|0|||
19628679|NCT00855335|42078206|FG001|Overall Study|Withdrawal by Subject|0|||
19628680|NCT00855335|42078207|FG002|Overall Study|Withdrawal by Subject|0|||
19628681|NCT00855335|42078208|FG003|Overall Study|Withdrawal by Subject|1|||
19628682|NCT00855335|42078209|FG004|Overall Study|Withdrawal by Subject|0|||
19628683|NCT00855335|42078205|FG000|Overall Study|Adverse Event|2|||
19628684|NCT00855335|42078206|FG001|Overall Study|Adverse Event|0|||
19628685|NCT00855335|42078207|FG002|Overall Study|Adverse Event|0|||
19628686|NCT00855335|42078208|FG003|Overall Study|Adverse Event|0|||
19628687|NCT00855335|42078209|FG004|Overall Study|Adverse Event|0|||
19628688|NCT00855335|42078205|FG000|Overall Study|Physician Decision|1|||
19628689|NCT00855335|42078206|FG001|Overall Study|Physician Decision|1|||
19628690|NCT00855335|42078207|FG002|Overall Study|Physician Decision|0|||
19628691|NCT00855335|42078208|FG003|Overall Study|Physician Decision|0|||
19628692|NCT00855335|42078209|FG004|Overall Study|Physician Decision|0|||
19628693|NCT00855335|42078205|FG000|Overall Study|Other|2|||
19628694|NCT00855335|42078206|FG001|Overall Study|Other|1|||
19628695|NCT00855335|42078207|FG002|Overall Study|Other|2|||
19628696|NCT00855335|42078208|FG003|Overall Study|Other|5|||
19628697|NCT00855335|42078209|FG004|Overall Study|Other|1|||
19628698|NCT00799422|42078234|FG000|First Week of Wear|Lost to Follow-up|0|||
19628699|NCT00799422|42078235|FG001|First Week of Wear|Lost to Follow-up|0|||
19628700|NCT00799422|42078236|FG002|First Week of Wear|Lost to Follow-up|1|||
19628701|NCT00799422|42078237|FG003|First Week of Wear|Lost to Follow-up|0|||
19628702|NCT00799422|42078238|FG004|First Week of Wear|Lost to Follow-up|0|||
19628703|NCT00799422|42078239|FG005|First Week of Wear|Lost to Follow-up|0|||
19628704|NCT00799422|42078234|FG000|First Week of Wear|Adverse Event|0|||
19628705|NCT00799422|42078235|FG001|First Week of Wear|Adverse Event|0|||
19628706|NCT00799422|42078236|FG002|First Week of Wear|Adverse Event|0|||
19628707|NCT00799422|42078237|FG003|First Week of Wear|Adverse Event|1|||
19628708|NCT00799422|42078238|FG004|First Week of Wear|Adverse Event|0|||
19628709|NCT00799422|42078239|FG005|First Week of Wear|Adverse Event|0|||
19628710|NCT00593489|42078249|FG000|Allocation|did not attend workshop; allocation not|2|||
19628711|NCT00593489|42078250|FG001|Allocation|did not attend workshop; allocation not|1|||
19628712|NCT00446641|42078260|FG000|Overall Study|Withdrawal by Subject|8|||
19628713|NCT00446641|42078261|FG001|Overall Study|Withdrawal by Subject|3|||
19628714|NCT00446641|42078260|FG000|Overall Study|poor compliance|8|||
19628715|NCT00446641|42078261|FG001|Overall Study|poor compliance|6|||
19628716|NCT00446641|42078260|FG000|Overall Study|Lost to Follow-up|1|||
19628717|NCT00446641|42078261|FG001|Overall Study|Lost to Follow-up|1|||
19628718|NCT00646282|42078269|FG000|Overall Study|Protocol terminated|4|||
19628719|NCT00646282|42078270|FG001|Overall Study|Protocol terminated|4|||
19628720|NCT00792636|42078279|FG000|Overall Study|Protocol Violation|17|||
19628721|NCT00792636|42078280|FG001|Overall Study|Protocol Violation|23|||
19628722|NCT00792636|42078281|FG002|Overall Study|Protocol Violation|20|||
19628723|NCT00792636|42078279|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
19628724|NCT00792636|42078280|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
19628725|NCT00792636|42078281|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
19628726|NCT00792636|42078279|FG000|Overall Study|Lost to Follow-up|13|||
19628727|NCT00792636|42078280|FG001|Overall Study|Lost to Follow-up|19|||
19628728|NCT00792636|42078281|FG002|Overall Study|Lost to Follow-up|14|||
19628729|NCT00792636|42078279|FG000|Overall Study|Withdrew Consent|10|||
19628730|NCT00792636|42078280|FG001|Overall Study|Withdrew Consent|13|||
19628731|NCT00792636|42078281|FG002|Overall Study|Withdrew Consent|9|||
19628732|NCT00792636|42078279|FG000|Overall Study|Lack of Efficacy|3|||
19628733|NCT00792636|42078280|FG001|Overall Study|Lack of Efficacy|4|||
19628734|NCT00792636|42078281|FG002|Overall Study|Lack of Efficacy|13|||
19628735|NCT00792636|42078279|FG000|Overall Study|Adverse Event|4|||
19628736|NCT00792636|42078280|FG001|Overall Study|Adverse Event|2|||
19628737|NCT00792636|42078281|FG002|Overall Study|Adverse Event|3|||
19628738|NCT00792636|42078279|FG000|Overall Study|Investigator Discretion|2|||
19628739|NCT00792636|42078280|FG001|Overall Study|Investigator Discretion|0|||
19628740|NCT00792636|42078281|FG002|Overall Study|Investigator Discretion|2|||
19628741|NCT00446563|42078293|FG000|Overall Study|Adverse Event|4|||
19628742|NCT00446563|42078294|FG001|Overall Study|Adverse Event|3|||
19628743|NCT00446563|42078293|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19628744|NCT00446563|42078294|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19628745|NCT00446563|42078293|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19628746|NCT00446563|42078294|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19628747|NCT00446563|42078293|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19628748|NCT00446563|42078294|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19628749|NCT00446563|42078293|FG000|Overall Study|Withdrawal by Subject|2|||
19628750|NCT00446563|42078294|FG001|Overall Study|Withdrawal by Subject|1|||
19628751|NCT00446563|42078293|FG000|Overall Study|Administrative problems|0|||
19628752|NCT00446563|42078294|FG001|Overall Study|Administrative problems|1|||
19522000|NCT00982410|41935397|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
19628753|NCT00650806|42078304|FG000|Overall Study|Adverse Event|0|||
19628754|NCT00650806|42078305|FG001|Overall Study|Adverse Event|5|||
19628755|NCT00650806|42078306|FG002|Overall Study|Adverse Event|3|||
19628756|NCT00650806|42078307|FG003|Overall Study|Adverse Event|4|||
19628757|NCT00650806|42078304|FG000|Overall Study|Lost to Follow-up|7|||
19628758|NCT00650806|42078305|FG001|Overall Study|Lost to Follow-up|6|||
19628759|NCT00650806|42078306|FG002|Overall Study|Lost to Follow-up|11|||
19628760|NCT00650806|42078307|FG003|Overall Study|Lost to Follow-up|10|||
19628761|NCT00650806|42078304|FG000|Overall Study|Protocol Violation|0|||
19628762|NCT00650806|42078305|FG001|Overall Study|Protocol Violation|0|||
19628763|NCT00650806|42078306|FG002|Overall Study|Protocol Violation|0|||
19628764|NCT00650806|42078307|FG003|Overall Study|Protocol Violation|1|||
19628765|NCT00650806|42078304|FG000|Overall Study|Pregnancy|0|||
19628766|NCT00650806|42078305|FG001|Overall Study|Pregnancy|0|||
19628767|NCT00650806|42078306|FG002|Overall Study|Pregnancy|0|||
19628768|NCT00650806|42078307|FG003|Overall Study|Pregnancy|1|||
19628769|NCT00650806|42078304|FG000|Overall Study|Withdrawal by Subject|7|||
19628770|NCT00650806|42078305|FG001|Overall Study|Withdrawal by Subject|5|||
19628771|NCT00650806|42078306|FG002|Overall Study|Withdrawal by Subject|8|||
19628772|NCT00650806|42078307|FG003|Overall Study|Withdrawal by Subject|6|||
19628773|NCT00650806|42078304|FG000|Overall Study|Noncompliance with study drug regimen|1|||
19628774|NCT00650806|42078305|FG001|Overall Study|Noncompliance with study drug regimen|1|||
19628775|NCT00650806|42078306|FG002|Overall Study|Noncompliance with study drug regimen|0|||
19628776|NCT00650806|42078307|FG003|Overall Study|Noncompliance with study drug regimen|0|||
19628777|NCT00650806|42078304|FG000|Overall Study|Study terminated by sponsor|2|||
19628778|NCT00650806|42078305|FG001|Overall Study|Study terminated by sponsor|3|||
19628779|NCT00650806|42078306|FG002|Overall Study|Study terminated by sponsor|5|||
19628780|NCT00650806|42078307|FG003|Overall Study|Study terminated by sponsor|4|||
19628781|NCT00650806|42078304|FG000|Overall Study|Other|1|||
19628782|NCT00650806|42078305|FG001|Overall Study|Other|1|||
19628783|NCT00650806|42078306|FG002|Overall Study|Other|2|||
19628784|NCT00650806|42078307|FG003|Overall Study|Other|0|||
19628785|NCT00863057|42078323|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
19628786|NCT00863057|42078324|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
19628787|NCT00863057|42078325|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
19628788|NCT00863057|42078326|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
19628789|NCT00863057|42078323|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
19628790|NCT00863057|42078324|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
19628791|NCT00863057|42078325|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
19628792|NCT00863057|42078326|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
19628793|NCT00863057|42078323|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
19628794|NCT00863057|42078324|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
19628795|NCT00863057|42078325|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
19628796|NCT00863057|42078326|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
19628797|NCT00863057|42078323|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
19628798|NCT00863057|42078324|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
19628799|NCT00863057|42078325|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
19628800|NCT00863057|42078326|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
19628801|NCT00829166|42078344|FG000|Overall Study|Death|305|||
19628802|NCT00829166|42078345|FG001|Overall Study|Death|333|||
19628803|NCT00829166|42078344|FG000|Overall Study|Lost to Follow-up|5|||
19628804|NCT00829166|42078345|FG001|Overall Study|Lost to Follow-up|4|||
19628805|NCT00829166|42078344|FG000|Overall Study|Physician's Decision|4|||
19628806|NCT00829166|42078345|FG001|Overall Study|Physician's Decision|3|||
19628807|NCT00829166|42078344|FG000|Overall Study|Subject's Decision|41|||
19628808|NCT00829166|42078345|FG001|Overall Study|Subject's Decision|55|||
19628809|NCT00829166|42078344|FG000|Overall Study|Sponsor's Decision|137|||
19628810|NCT00829166|42078345|FG001|Overall Study|Sponsor's Decision|98|||
19628811|NCT00829166|42078344|FG000|Overall Study|Reason Not Specified|3|||
19628812|NCT00829166|42078345|FG001|Overall Study|Reason Not Specified|3|||
19628813|NCT00799266|42078354|FG000|Overall Study|Adverse Event|0|||
19628814|NCT00799266|42078355|FG001|Overall Study|Adverse Event|1|||
19628815|NCT00799266|42078354|FG000|Overall Study|Subject withdrew consent|3|||
19628816|NCT00799266|42078355|FG001|Overall Study|Subject withdrew consent|0|||
19628817|NCT00650104|42078361|FG000|Overall Study|Adverse Event|17|||
19522001|NCT00982410|41935396|FG000|12-month Follow-up Assessment|incarceration|2|||
19522002|NCT00982410|41935397|FG001|12-month Follow-up Assessment|incarceration|1|||
19522003|NCT00982410|41935396|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
19522004|NCT00982410|41935397|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
19522005|NCT00982020|41935406|FG000|Overall Study|Adverse Event|19|||
19522006|NCT00982020|41935407|FG001|Overall Study|Adverse Event|15|||
19522007|NCT00982020|41935406|FG000|Overall Study|Withdrawal by Subject|11|||
19522008|NCT00982020|41935407|FG001|Overall Study|Withdrawal by Subject|14|||
19522009|NCT00982020|41935406|FG000|Overall Study|Lost to Follow-up|5|||
19522010|NCT00982020|41935407|FG001|Overall Study|Lost to Follow-up|11|||
19522011|NCT00982020|41935406|FG000|Overall Study|Lack of Efficacy|10|||
19522012|NCT00982020|41935407|FG001|Overall Study|Lack of Efficacy|4|||
19522013|NCT00982020|41935406|FG000|Overall Study|Parent/Caregiver Decision|5|||
19522014|NCT00982020|41935407|FG001|Overall Study|Parent/Caregiver Decision|5|||
19522015|NCT00982020|41935406|FG000|Overall Study|Treatment Non-compliance|3|||
19522016|NCT00982020|41935407|FG001|Overall Study|Treatment Non-compliance|6|||
19522017|NCT00982020|41935406|FG000|Overall Study|Physician Decision|2|||
19628818|NCT00650104|42078361|FG000|Overall Study|Death|2|||
19628819|NCT00650104|42078361|FG000|Overall Study|Withdrawal by Subject|11|||
19628820|NCT00650104|42078361|FG000|Overall Study|Physician Decision|7|||
19628821|NCT00650104|42078361|FG000|Overall Study|Lost to Follow-up|1|||
19628822|NCT00650104|42078361|FG000|Overall Study|Non-compliance|2|||
19628823|NCT00650104|42078361|FG000|Overall Study|Sponsor Terminated Dosing|1|||
19628824|NCT00654238|42078365|FG000|Overall Study|Screen Failures|4|||
19628825|NCT00862979|42078372|FG000|Overall Study|Adverse Event|6|||
19628826|NCT00862979|42078373|FG001|Overall Study|Adverse Event|3|||
19628827|NCT00862979|42078372|FG000|Overall Study|Protocol Violation|0|||
19628828|NCT00862979|42078373|FG001|Overall Study|Protocol Violation|1|||
19628829|NCT00862979|42078372|FG000|Overall Study|Patient withdrew consent|2|||
19628830|NCT00862979|42078373|FG001|Overall Study|Patient withdrew consent|1|||
19628831|NCT00862979|42078372|FG000|Overall Study|Administrative problems|0|||
19628832|NCT00862979|42078373|FG001|Overall Study|Administrative problems|1|||
19628833|NCT00862979|42078372|FG000|Overall Study|Death|0|||
19628834|NCT00862979|42078373|FG001|Overall Study|Death|1|||
19628835|NCT00483379|42078381|FG000|Treatment Period|Adverse Event|1|||
19628836|NCT00483379|42078382|FG001|Treatment Period|Adverse Event|0|||
19628837|NCT00483379|42078381|FG000|Treatment Period|Withdrawal by Subject|1|||
19628838|NCT00483379|42078382|FG001|Treatment Period|Withdrawal by Subject|0|||
19628839|NCT00446251|42078390|FG000|Overall Study|On-study Transplants|2|||
19628840|NCT00446251|42078390|FG000|Overall Study|Rituximab Infusion Reaction|2|||
19628841|NCT00446251|42078390|FG000|Overall Study|Lost to Follow-up|1|||
19628842|NCT00796224|42078396|FG000|Overall Study|Adverse Event|1|||
19628843|NCT00796224|42078397|FG001|Overall Study|Adverse Event|0|||
19628844|NCT00796224|42078396|FG000|Overall Study|Protocol Violation|0|||
19628845|NCT00796224|42078397|FG001|Overall Study|Protocol Violation|1|||
19628846|NCT00791934|42078405|FG000|Overall Study|Withdrawal by Subject|2|||
19628847|NCT00791934|42078405|FG000|Overall Study|Did not consent for extended follow-up|13|||
19628848|NCT00848081|42078411|FG000|Overall Study|Adverse Event|6|||
19628849|NCT00848081|42078412|FG001|Overall Study|Adverse Event|7|||
19628850|NCT00848081|42078411|FG000|Overall Study|Protocol Violation|8|||
19628851|NCT00848081|42078412|FG001|Overall Study|Protocol Violation|5|||
19628852|NCT00848081|42078411|FG000|Overall Study|Lost to Follow-up|1|||
19628853|NCT00848081|42078412|FG001|Overall Study|Lost to Follow-up|0|||
19628854|NCT00848081|42078411|FG000|Overall Study|Physician Decision|0|||
19628855|NCT00848081|42078412|FG001|Overall Study|Physician Decision|3|||
19628856|NCT00848081|42078411|FG000|Overall Study|Withdrawal by Subject|5|||
19628857|NCT00848081|42078412|FG001|Overall Study|Withdrawal by Subject|3|||
19628858|NCT00654004|42078420|FG000|Overall Study|Lost to Follow-up|1|||
19628859|NCT00654004|42078421|FG001|Overall Study|Lost to Follow-up|0|||
19628860|NCT00791778|42078429|FG000|Double-blind Treatment|Adverse Event|49|||
19628861|NCT00791778|42078430|FG001|Double-blind Treatment|Adverse Event|9|||
19628862|NCT00791778|42078429|FG000|Double-blind Treatment|Physician Decision|6|||
19628863|NCT00791778|42078430|FG001|Double-blind Treatment|Physician Decision|26|||
19628864|NCT00791778|42078429|FG000|Double-blind Treatment|Protocol Violation|0|||
19628865|NCT00791778|42078430|FG001|Double-blind Treatment|Protocol Violation|4|||
19628866|NCT00791778|42078429|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
19628867|NCT00791778|42078430|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
19628868|NCT00791778|42078429|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
19628869|NCT00791778|42078430|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
19628870|NCT00791778|42078429|FG000|Follow-up|Withdrawal by Subject|3|||
19628871|NCT00791778|42078430|FG001|Follow-up|Withdrawal by Subject|0|||
19628872|NCT00791778|42078429|FG000|Follow-up|Lost to Follow-up|2|||
19628873|NCT00791778|42078430|FG001|Follow-up|Lost to Follow-up|1|||
19628874|NCT00798174|42078436|FG000|Overall Study|inability to implant azygos coil|3|||
19628875|NCT00798174|42078437|FG001|Overall Study|inability to implant azygos coil|3|||
19628876|NCT00798174|42078436|FG000|Overall Study|Inability to sedate for DFT testing|1|||
19628877|NCT00798174|42078437|FG001|Overall Study|Inability to sedate for DFT testing|0|||
19628878|NCT00798096|42078441|FG000|Overall Study|Ongoing|2|||
19628879|NCT00795600|42078447|FG000|Overall Study|Adverse Event|1|||
19628880|NCT00795600|42078448|FG001|Overall Study|Adverse Event|1|||
19628881|NCT00795600|42078447|FG000|Overall Study|Protocol Violation|1|||
19628882|NCT00795600|42078448|FG001|Overall Study|Protocol Violation|2|||
19628883|NCT00795600|42078447|FG000|Overall Study|Withdrawal by Subject|1|||
19628884|NCT00795600|42078448|FG001|Overall Study|Withdrawal by Subject|0|||
19628885|NCT00795600|42078447|FG000|Overall Study|Unclassified|1|||
19628886|NCT00795600|42078448|FG001|Overall Study|Unclassified|1|||
19628887|NCT00795132|42078454|FG000|Overall Study|Death|1|||
19628888|NCT00795132|42078454|FG000|Overall Study|Relapse|2|||
19628889|NCT00647296|42078470|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
19628890|NCT00647296|42078471|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
19628891|NCT00647296|42078472|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
19628892|NCT00647296|42078473|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
19628893|NCT00647296|42078470|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
19628894|NCT00647296|42078471|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
19628895|NCT00647296|42078472|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
19522018|NCT00982020|41935407|FG001|Overall Study|Physician Decision|5|||
19628896|NCT00647296|42078473|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
19628897|NCT00647296|42078470|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
19628898|NCT00647296|42078471|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
19628899|NCT00647296|42078472|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
19628900|NCT00647296|42078473|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
19628901|NCT00647296|42078470|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
19628902|NCT00647296|42078471|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
19628903|NCT00647296|42078472|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
19628904|NCT00647296|42078473|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
19628905|NCT00647296|42078470|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
19628906|NCT00647296|42078471|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
19628907|NCT00647296|42078472|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
19628908|NCT00647296|42078473|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
19628909|NCT00647296|42078470|FG000|Part 2: 4-week Placebo Washout|Death|3|||
19628910|NCT00647296|42078471|FG001|Part 2: 4-week Placebo Washout|Death|0|||
19628911|NCT00647296|42078472|FG002|Part 2: 4-week Placebo Washout|Death|0|||
19628912|NCT00647296|42078473|FG003|Part 2: 4-week Placebo Washout|Death|0|||
19628913|NCT00647296|42078470|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
19628914|NCT00647296|42078471|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
19628915|NCT00647296|42078472|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
19628916|NCT00647296|42078473|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
19628917|NCT00647296|42078470|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
19628918|NCT00647296|42078471|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
19628919|NCT00647296|42078472|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
19628920|NCT00647296|42078473|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
19628921|NCT00647296|42078470|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
19628922|NCT00647296|42078471|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
19628923|NCT00647296|42078472|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
19628924|NCT00647296|42078473|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
19628925|NCT00647296|42078470|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
19628926|NCT00647296|42078471|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
19628927|NCT00647296|42078472|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
19628928|NCT00647296|42078473|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
19628929|NCT00647296|42078470|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
19628930|NCT00647296|42078471|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
19628931|NCT00647296|42078472|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
19628932|NCT00647296|42078473|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
19628933|NCT00644878|42078495|FG000|Overall Study|Adverse Event|2|||
19628934|NCT00644878|42078495|FG000|Overall Study|Abnormal laboratory value|3|||
19628935|NCT00644878|42078495|FG000|Overall Study|Protocol deviation|2|||
19628936|NCT00644878|42078495|FG000|Overall Study|Treatment duration completed as per protocol|11|||
19628937|NCT00646906|42078503|FG000|Crossover Period 1|Withdrawal by Subject|1|||
19628938|NCT00646906|42078504|FG001|Crossover Period 1|Withdrawal by Subject|0|||
19628939|NCT00646906|42078505|FG002|Crossover Period 1|Withdrawal by Subject|0|||
19628940|NCT00646906|42078506|FG003|Crossover Period 1|Withdrawal by Subject|0|||
19628941|NCT00646906|42078507|FG004|Crossover Period 1|Withdrawal by Subject|0|||
19628942|NCT00646906|42078508|FG005|Crossover Period 1|Withdrawal by Subject|1|||
19628943|NCT00646906|42078509|FG006|Crossover Period 1|Withdrawal by Subject|0|||
19628944|NCT00646906|42078503|FG000|Crossover Period 2|Withdrawal by Subject|0|||
19628945|NCT00646906|42078504|FG001|Crossover Period 2|Withdrawal by Subject|1|||
19628946|NCT00646906|42078505|FG002|Crossover Period 2|Withdrawal by Subject|2|||
19628947|NCT00646906|42078506|FG003|Crossover Period 2|Withdrawal by Subject|1|||
19628948|NCT00646906|42078507|FG004|Crossover Period 2|Withdrawal by Subject|0|||
19628949|NCT00646906|42078508|FG005|Crossover Period 2|Withdrawal by Subject|0|||
19628950|NCT00646906|42078509|FG006|Crossover Period 2|Withdrawal by Subject|0|||
19628951|NCT00646906|42078503|FG000|Crossover Period 2|Physician Decision|0|||
19628952|NCT00646906|42078504|FG001|Crossover Period 2|Physician Decision|0|||
19628953|NCT00646906|42078505|FG002|Crossover Period 2|Physician Decision|0|||
19628954|NCT00646906|42078506|FG003|Crossover Period 2|Physician Decision|0|||
19628955|NCT00646906|42078507|FG004|Crossover Period 2|Physician Decision|0|||
19628956|NCT00646906|42078508|FG005|Crossover Period 2|Physician Decision|0|||
19628957|NCT00646906|42078509|FG006|Crossover Period 2|Physician Decision|1|||
19628958|NCT00642772|42078522|FG000|Overall Study|Lost to Follow-up|3|||
19628959|NCT00642772|42078522|FG000|Overall Study|Withdrawal by Subject|7|||
19628960|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
19628961|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
19628962|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
19628963|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
19628964|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
19628965|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Adverse Event|0|||
19628966|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Adverse Event|1|||
19628967|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Adverse Event|1|||
19628968|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Adverse Event|0|||
19628969|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Adverse Event|0|||
19628970|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
19628971|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
19628972|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
19628973|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
19438724|NCT02143583|41686035|FG001|Overall Study|Withdrawal by Subject|0|||
19438725|NCT02143583|41686036|FG002|Overall Study|Withdrawal by Subject|1|||
19438726|NCT02143583|41686034|FG000|Overall Study|husband illness|0|||
19438727|NCT02143583|41686035|FG001|Overall Study|husband illness|0|||
19438728|NCT02143583|41686036|FG002|Overall Study|husband illness|1|||
19438729|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
19438730|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
19438731|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
19438732|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
19438733|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
19438734|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
19438735|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
19438736|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
19438737|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
19438738|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
19438739|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
19438740|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
19438741|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
19438742|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
19438743|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438744|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438745|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438746|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438747|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
19438748|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
19438749|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438750|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438751|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438752|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438753|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
19438754|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
19438755|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
19438756|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
19438757|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
19438758|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
19438759|NCT02105987|41686046|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
19438760|NCT02105987|41686047|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
19438761|NCT02105987|41686048|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
19438762|NCT02105987|41686049|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
19438763|NCT02105987|41686050|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
19438764|NCT02105987|41686051|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
19438765|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
19438766|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
19438767|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
19438768|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
19438769|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
19438770|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
19438771|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
19438772|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
19438773|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
19438774|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
19438775|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
19438776|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
19438777|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438778|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438779|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
19522019|NCT00982020|41935406|FG000|Overall Study|Entry Criteria Not Met|2|||
19628974|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
19628975|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Physician Decision|1|||
19628976|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Physician Decision|0|||
19628977|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Physician Decision|0|||
19628978|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Physician Decision|0|||
19628979|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Physician Decision|0|||
19628980|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
19628981|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
19628982|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
19628983|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
19628984|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
19628985|NCT00446095|42078531|FG000|Phase II (8 Weeks)|Ongoing|0|||
19628986|NCT00446095|42078532|FG001|Phase II (8 Weeks)|Ongoing|0|||
19628987|NCT00446095|42078533|FG002|Phase II (8 Weeks)|Ongoing|1|||
19628988|NCT00446095|42078534|FG003|Phase II (8 Weeks)|Ongoing|0|||
19438780|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
19438781|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438782|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
19438783|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438784|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438785|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
19438786|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
19438787|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438788|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
19438789|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
19438790|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
19438791|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
19438792|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
19438793|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
19438794|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
19438795|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
19438796|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
19438797|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
19438798|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
19438799|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
19438800|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
19438801|NCT02105987|41686046|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
19438802|NCT02105987|41686047|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
19438803|NCT02105987|41686048|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
19628989|NCT00446095|42078535|FG004|Phase II (8 Weeks)|Ongoing|0|||
19628990|NCT00446095|42078531|FG000|Phase I (28 Days)|Adverse Event|0|||
19438804|NCT02105987|41686049|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
19438805|NCT02105987|41686050|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
19438806|NCT02105987|41686051|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
19438807|NCT02105987|41686046|FG000|Continuation Phase|Protocol Violation|0|||
19438808|NCT02105987|41686047|FG001|Continuation Phase|Protocol Violation|0|||
19438809|NCT02105987|41686048|FG002|Continuation Phase|Protocol Violation|0|||
19438810|NCT02105987|41686049|FG003|Continuation Phase|Protocol Violation|0|||
19438811|NCT02105987|41686050|FG004|Continuation Phase|Protocol Violation|1|||
19438812|NCT02105987|41686051|FG005|Continuation Phase|Protocol Violation|0|||
19438813|NCT02141633|41686059|FG000|Overall Study|Physician Decision|1|||
19438814|NCT02141633|41686060|FG001|Overall Study|Physician Decision|0|||
19438815|NCT01846611|41686068|FG000|Overall Study|Lost to Follow-up|4|||
19438816|NCT01846611|41686069|FG001|Overall Study|Lost to Follow-up|6|||
19438817|NCT01846611|41686068|FG000|Overall Study|Withdrawal by Subject|15|||
19438818|NCT01846611|41686069|FG001|Overall Study|Withdrawal by Subject|19|||
19438819|NCT01846611|41686068|FG000|Overall Study|Other|19|||
19438820|NCT01846611|41686069|FG001|Overall Study|Other|18|||
19438821|NCT02141399|41686075|FG000|Overall Study|Adverse Event|158|||
19438822|NCT02141399|41686075|FG000|Overall Study|Lack of Efficacy|62|||
19438823|NCT02141399|41686075|FG000|Overall Study|Lost to Follow-up|151|||
19522020|NCT00982020|41935407|FG001|Overall Study|Entry Criteria Not Met|1|||
19522021|NCT00982020|41935406|FG000|Overall Study|Protocol Violation|0|||
19522022|NCT00982020|41935407|FG001|Overall Study|Protocol Violation|2|||
19522023|NCT00982020|41935406|FG000|Overall Study|Clinical Relapse|0|||
19522024|NCT00982020|41935407|FG001|Overall Study|Clinical Relapse|1|||
19522025|NCT00981084|41935420|FG000|Post Intervention (Data Analysis)|poor effort|1|||
19522026|NCT00981084|41935421|FG001|Post Intervention (Data Analysis)|poor effort|1|||
19628991|NCT00446095|42078532|FG001|Phase I (28 Days)|Adverse Event|0|||
19628992|NCT00446095|42078533|FG002|Phase I (28 Days)|Adverse Event|0|||
19628993|NCT00446095|42078534|FG003|Phase I (28 Days)|Adverse Event|1|||
19628994|NCT00446095|42078535|FG004|Phase I (28 Days)|Adverse Event|0|||
19628995|NCT00446095|42078531|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
19628996|NCT00446095|42078532|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
19628997|NCT00446095|42078533|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
19438824|NCT02141399|41686075|FG000|Overall Study|Non-compliance with study drug|18|||
19438825|NCT02141399|41686075|FG000|Overall Study|Other|45|||
19522027|NCT00981084|41935420|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
19628998|NCT00446095|42078534|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
19438826|NCT02141399|41686075|FG000|Overall Study|Physician Decision|17|||
19438827|NCT02141399|41686075|FG000|Overall Study|Pregnancy|3|||
19438828|NCT02141399|41686075|FG000|Overall Study|Protocol Violation|38|||
19438829|NCT02141399|41686075|FG000|Overall Study|Withdrawal by Subject|238|||
19438830|NCT02141399|41686075|FG000|Overall Study|Failure to meet eligibility criteria|14|||
19438831|NCT01846299|41686081|FG000|Overall Study|Physician Decision|4|||
19438832|NCT01846299|41686082|FG001|Overall Study|Physician Decision|2|||
19438833|NCT01846299|41686081|FG000|Overall Study|Protocol deviation|1|||
19438834|NCT01846299|41686082|FG001|Overall Study|Protocol deviation|0|||
19438835|NCT01846299|41686081|FG000|Overall Study|Death|1|||
19438836|NCT01846299|41686082|FG001|Overall Study|Death|2|||
19438837|NCT01846299|41686081|FG000|Overall Study|Lost to Follow-up|3|||
19438838|NCT01846299|41686082|FG001|Overall Study|Lost to Follow-up|0|||
19438839|NCT01846299|41686081|FG000|Overall Study|Withdrawal by Subject|1|||
19438840|NCT01846299|41686082|FG001|Overall Study|Withdrawal by Subject|6|||
19438841|NCT01846299|41686081|FG000|Overall Study|Adverse Event|2|||
19438842|NCT01846299|41686082|FG001|Overall Study|Adverse Event|0|||
19438843|NCT01628393|41686093|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
19438844|NCT01628393|41686094|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
19438845|NCT01628393|41686095|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
19438846|NCT01628393|41686096|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
19438847|NCT01628393|41686097|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
19438848|NCT01628393|41686093|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
19438849|NCT01628393|41686094|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
19438850|NCT01628393|41686095|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
19438851|NCT01628393|41686096|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
19438852|NCT01628393|41686097|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
19438853|NCT01628393|41686093|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
19438854|NCT01628393|41686094|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
19438855|NCT01628393|41686095|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
19438856|NCT01628393|41686096|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
19438857|NCT01628393|41686097|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
19438858|NCT01628393|41686093|FG000|Blinded Active Extension Period|Adverse Event|0|||
19438859|NCT01628393|41686094|FG001|Blinded Active Extension Period|Adverse Event|1|||
19438860|NCT01628393|41686095|FG002|Blinded Active Extension Period|Adverse Event|0|||
19438861|NCT01628393|41686096|FG003|Blinded Active Extension Period|Adverse Event|2|||
19438862|NCT01628393|41686097|FG004|Blinded Active Extension Period|Adverse Event|2|||
19438863|NCT01628393|41686093|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
19438864|NCT01628393|41686094|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
19438865|NCT01628393|41686095|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
19438866|NCT01628393|41686096|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
19438867|NCT01628393|41686097|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
19438868|NCT01628393|41686093|FG000|Blinded Active Extension Period|Physician Decision|0|||
19438869|NCT01628393|41686094|FG001|Blinded Active Extension Period|Physician Decision|3|||
19438870|NCT01628393|41686095|FG002|Blinded Active Extension Period|Physician Decision|0|||
19438871|NCT01628393|41686096|FG003|Blinded Active Extension Period|Physician Decision|1|||
19438872|NCT01628393|41686097|FG004|Blinded Active Extension Period|Physician Decision|0|||
19438873|NCT01628393|41686093|FG000|Blinded Active Extension Period|Protocol Violation|0|||
19438874|NCT01628393|41686094|FG001|Blinded Active Extension Period|Protocol Violation|0|||
19438875|NCT01628393|41686095|FG002|Blinded Active Extension Period|Protocol Violation|2|||
19438876|NCT01628393|41686096|FG003|Blinded Active Extension Period|Protocol Violation|1|||
19438877|NCT01628393|41686097|FG004|Blinded Active Extension Period|Protocol Violation|0|||
19438878|NCT01628393|41686093|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
19438879|NCT01628393|41686094|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
19438880|NCT01628393|41686095|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
19438881|NCT01628393|41686096|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
19438882|NCT01628393|41686097|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
19438883|NCT01846221|41686113|FG000|Overall Study|Catheter Failure|2|||
19438884|NCT01846221|41686114|FG001|Overall Study|Catheter Failure|0|||
19438885|NCT01846221|41686113|FG000|Overall Study|Age Exclusion|1|||
19438886|NCT01846221|41686114|FG001|Overall Study|Age Exclusion|0|||
19438887|NCT01815099|41686120|FG000|Overall Study|Lack of Efficacy|1|||
19438888|NCT01815099|41686120|FG000|Overall Study|unable to attend study visits|1|||
19438889|NCT01845831|41686127|FG000|Inpatient Phase|Withdrawal by Subject|1|||
19438890|NCT01845831|41686128|FG001|Inpatient Phase|Withdrawal by Subject|1|||
19438891|NCT01845831|41686129|FG002|Inpatient Phase|Withdrawal by Subject|0|||
19438892|NCT01845831|41686130|FG003|Inpatient Phase|Withdrawal by Subject|0|||
19438893|NCT01845831|41686131|FG004|Inpatient Phase|Withdrawal by Subject|0|||
19438894|NCT01627691|41686142|FG000|Overall Study|Death|11|||
19438895|NCT01627691|41686142|FG000|Overall Study|Lost to Follow-up|3|||
19438896|NCT01627691|41686142|FG000|Overall Study|Withdrawal by Subject|1|||
19438897|NCT01627691|41686142|FG000|Overall Study|Missed the visit|3|||
19438898|NCT01844895|41686146|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
19438899|NCT01844895|41686146|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
19438900|NCT01844895|41686146|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
19438901|NCT01844895|41686146|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
19438902|NCT01844895|41686146|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
19438903|NCT01844895|41686146|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
19438904|NCT01844895|41686146|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
19438905|NCT02116361|41686163|FG000|Overall Study|Pregnancy|0|||
19438906|NCT02116361|41686164|FG001|Overall Study|Pregnancy|0|||
19522028|NCT00981084|41935421|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
19628999|NCT00446095|42078535|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
19629000|NCT00829010|42078551|FG000|Overall Study|Adverse Event|1|||
19629001|NCT00829010|42078552|FG001|Overall Study|Adverse Event|0|||
19629002|NCT00829010|42078553|FG002|Overall Study|Adverse Event|0|||
19629003|NCT00829010|42078554|FG003|Overall Study|Adverse Event|0|||
19629004|NCT00829010|42078555|FG004|Overall Study|Adverse Event|0|||
19629005|NCT00829010|42078551|FG000|Overall Study|Withdrawal by Subject|0|||
19629006|NCT00829010|42078552|FG001|Overall Study|Withdrawal by Subject|1|||
19629007|NCT00829010|42078553|FG002|Overall Study|Withdrawal by Subject|1|||
19629008|NCT00829010|42078554|FG003|Overall Study|Withdrawal by Subject|0|||
19629009|NCT00829010|42078555|FG004|Overall Study|Withdrawal by Subject|2|||
19629010|NCT00829010|42078551|FG000|Overall Study|Lost to Follow-up|1|||
19629011|NCT00829010|42078552|FG001|Overall Study|Lost to Follow-up|0|||
19629012|NCT00829010|42078553|FG002|Overall Study|Lost to Follow-up|2|||
19522029|NCT00980148|41935431|FG000|Overall Study|Discharged from facility|89|||
19522030|NCT00980148|41935432|FG001|Overall Study|Discharged from facility|96|||
19522031|NCT00980148|41935431|FG000|Overall Study|Received other antichlamydia treatment|20|||
19522032|NCT00980148|41935432|FG001|Overall Study|Received other antichlamydia treatment|14|||
19522033|NCT00980148|41935431|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
19522034|NCT00980148|41935432|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
19522035|NCT00980148|41935431|FG000|Overall Study|Various other reasons|8|||
19522036|NCT00980148|41935432|FG001|Overall Study|Various other reasons|9|||
19522037|NCT04553406|41935492|FG000|Overall Study|Study Discontinuation|0|||
19522038|NCT04553406|41935493|FG001|Overall Study|Study Discontinuation|1|||
19522039|NCT04129944|41935511|FG000|Overall Study|Death|0|||
19522040|NCT04129944|41935512|FG001|Overall Study|Death|0|||
19522041|NCT04129944|41935513|FG002|Overall Study|Death|0|||
19522042|NCT04129944|41935514|FG003|Overall Study|Death|1|||
19522043|NCT04129944|41935511|FG000|Overall Study|Lost to Follow-up|1|||
19522044|NCT04129944|41935512|FG001|Overall Study|Lost to Follow-up|0|||
19522045|NCT04129944|41935513|FG002|Overall Study|Lost to Follow-up|0|||
19522046|NCT04129944|41935514|FG003|Overall Study|Lost to Follow-up|0|||
19522047|NCT04129944|41935511|FG000|Overall Study|Withdrawal by Subject|1|||
19522048|NCT04129944|41935512|FG001|Overall Study|Withdrawal by Subject|0|||
19522049|NCT04129944|41935513|FG002|Overall Study|Withdrawal by Subject|1|||
19522050|NCT04129944|41935514|FG003|Overall Study|Withdrawal by Subject|2|||
19522051|NCT03829332|41935578|FG000|Overall Study|Death|145|||
19522052|NCT03829332|41935579|FG001|Overall Study|Death|135|||
19522053|NCT03829332|41935578|FG000|Overall Study|Withdrawal by Subject|10|||
19522054|NCT03829332|41935579|FG001|Overall Study|Withdrawal by Subject|4|||
19522055|NCT03829332|41935578|FG000|Overall Study|Ongoing in Study|154|||
19522056|NCT03829332|41935579|FG001|Overall Study|Ongoing in Study|175|||
19522057|NCT01899144|41937230|FG000|Treatment Period 2|Other|1|||
19522058|NCT01899144|41937230|FG000|Treatment Period 3|Other|2|||
19522059|NCT01899144|41937230|FG000|Treatment Period 5|Other|1|||
19522060|NCT01168219|41940488|FG000|Overall Study|off study before starting treatment|2|||
19522061|NCT01168219|41940488|FG000|Overall Study|withdrew before transplant|1|||
19522062|NCT01168219|41940488|FG000|Overall Study|ineligible due to CML|2|||
19522063|NCT01115803|41940499|FG000|Overall Study|Withdrawal by Subject|0|||
19522064|NCT01115803|41940500|FG001|Overall Study|Withdrawal by Subject|0|||
19522065|NCT01115803|41940501|FG002|Overall Study|Withdrawal by Subject|0|||
19522066|NCT01115803|41940502|FG003|Overall Study|Withdrawal by Subject|0|||
19522067|NCT01115803|41940503|FG004|Overall Study|Withdrawal by Subject|0|||
19522068|NCT01115803|41940504|FG005|Overall Study|Withdrawal by Subject|0|||
19522069|NCT01115803|41940505|FG006|Overall Study|Withdrawal by Subject|1|||
19522070|NCT01115803|41940499|FG000|Overall Study|Lost to Follow-up|0|||
19522071|NCT01115803|41940500|FG001|Overall Study|Lost to Follow-up|0|||
19522072|NCT01115803|41940501|FG002|Overall Study|Lost to Follow-up|1|||
19522073|NCT01115803|41940502|FG003|Overall Study|Lost to Follow-up|0|||
19522074|NCT01115803|41940503|FG004|Overall Study|Lost to Follow-up|0|||
19522075|NCT01115803|41940504|FG005|Overall Study|Lost to Follow-up|0|||
19522076|NCT01115803|41940505|FG006|Overall Study|Lost to Follow-up|0|||
19629013|NCT00829010|42078554|FG003|Overall Study|Lost to Follow-up|0|||
19629014|NCT00829010|42078555|FG004|Overall Study|Lost to Follow-up|0|||
19629015|NCT00829010|42078551|FG000|Overall Study|Fatality|5|||
19629016|NCT00829010|42078552|FG001|Overall Study|Fatality|4|||
19629017|NCT00829010|42078553|FG002|Overall Study|Fatality|0|||
19438907|NCT02116361|41686165|FG002|Overall Study|Pregnancy|0|||
19438908|NCT02116361|41686166|FG003|Overall Study|Pregnancy|1|||
19438909|NCT02116361|41686163|FG000|Overall Study|Protocol Violation|1|||
19438910|NCT02116361|41686164|FG001|Overall Study|Protocol Violation|0|||
19438911|NCT02116361|41686165|FG002|Overall Study|Protocol Violation|0|||
19438912|NCT02116361|41686166|FG003|Overall Study|Protocol Violation|2|||
19438913|NCT02116361|41686163|FG000|Overall Study|Physician Decision|2|||
19438914|NCT02116361|41686164|FG001|Overall Study|Physician Decision|3|||
19438915|NCT02116361|41686165|FG002|Overall Study|Physician Decision|0|||
19438916|NCT02116361|41686166|FG003|Overall Study|Physician Decision|0|||
19438917|NCT02116361|41686163|FG000|Overall Study|Adverse Event|1|||
19438918|NCT02116361|41686164|FG001|Overall Study|Adverse Event|0|||
19438919|NCT02116361|41686165|FG002|Overall Study|Adverse Event|0|||
19438920|NCT02116361|41686166|FG003|Overall Study|Adverse Event|3|||
19438921|NCT02116361|41686163|FG000|Overall Study|Other Reasons|3|||
19438922|NCT02116361|41686164|FG001|Overall Study|Other Reasons|3|||
19438923|NCT02116361|41686165|FG002|Overall Study|Other Reasons|3|||
19438924|NCT02116361|41686166|FG003|Overall Study|Other Reasons|3|||
19438925|NCT02116361|41686163|FG000|Overall Study|Lack of Efficacy|5|||
19438926|NCT02116361|41686164|FG001|Overall Study|Lack of Efficacy|7|||
19438927|NCT02116361|41686165|FG002|Overall Study|Lack of Efficacy|4|||
19438928|NCT02116361|41686166|FG003|Overall Study|Lack of Efficacy|3|||
19438929|NCT02116361|41686163|FG000|Overall Study|Lost to Follow-up|4|||
19438930|NCT02116361|41686164|FG001|Overall Study|Lost to Follow-up|5|||
19438931|NCT02116361|41686165|FG002|Overall Study|Lost to Follow-up|7|||
19438932|NCT02116361|41686166|FG003|Overall Study|Lost to Follow-up|5|||
19438933|NCT02116361|41686163|FG000|Overall Study|Personal Reasons|6|||
19438934|NCT02116361|41686164|FG001|Overall Study|Personal Reasons|6|||
19438935|NCT02116361|41686165|FG002|Overall Study|Personal Reasons|4|||
19438936|NCT02116361|41686166|FG003|Overall Study|Personal Reasons|9|||
19438937|NCT02116361|41686163|FG000|Overall Study|Investigator Decision - Relapse|9|||
19438938|NCT02116361|41686164|FG001|Overall Study|Investigator Decision - Relapse|7|||
19438939|NCT02116361|41686165|FG002|Overall Study|Investigator Decision - Relapse|8|||
19438940|NCT02116361|41686166|FG003|Overall Study|Investigator Decision - Relapse|5|||
19438941|NCT02140775|41686178|FG000|Overall Study|Withdrawal by Subject|30|||
19438942|NCT02140775|41686179|FG001|Overall Study|Withdrawal by Subject|7|||
19438943|NCT01844817|41686189|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
19438944|NCT01844817|41686190|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
19438945|NCT01844817|41686189|FG000|Treatment|Progressive Disease|27|||
19438946|NCT01844817|41686190|FG001|Treatment|Progressive Disease|36|||
19438947|NCT01844817|41686189|FG000|Treatment|Adverse Event|17|||
19438948|NCT01844817|41686190|FG001|Treatment|Adverse Event|9|||
19438949|NCT01844817|41686189|FG000|Treatment|Withdrawal by Subject|10|||
19438950|NCT01844817|41686190|FG001|Treatment|Withdrawal by Subject|6|||
19438951|NCT01844817|41686189|FG000|Treatment|Death|10|||
19438952|NCT01844817|41686190|FG001|Treatment|Death|8|||
19438953|NCT01844817|41686189|FG000|Treatment|Lost to Follow-up|0|||
19438954|NCT01844817|41686190|FG001|Treatment|Lost to Follow-up|1|||
19438955|NCT01844817|41686189|FG000|Treatment|Other|0|||
19438956|NCT01844817|41686190|FG001|Treatment|Other|3|||
19438957|NCT01814553|41686199|FG000|Overall Study|PD per clinical progression|6|||
19438958|NCT01814553|41686200|FG001|Overall Study|PD per clinical progression|8|||
19438959|NCT01814553|41686199|FG000|Overall Study|Other Adverse Event|4|||
19438960|NCT01814553|41686200|FG001|Overall Study|Other Adverse Event|5|||
19438961|NCT01814553|41686199|FG000|Overall Study|Withdrawal by Subject|1|||
19438962|NCT01814553|41686200|FG001|Overall Study|Withdrawal by Subject|1|||
19438963|NCT01814553|41686199|FG000|Overall Study|Other than stated|7|||
19438964|NCT01814553|41686200|FG001|Overall Study|Other than stated|8|||
19438965|NCT02116205|41686210|FG000|Overall Study|Withdrawal by Subject|2|||
19438966|NCT02116205|41686211|FG001|Overall Study|Withdrawal by Subject|4|||
19438967|NCT02116205|41686212|FG002|Overall Study|Withdrawal by Subject|1|||
19438968|NCT02116205|41686213|FG003|Overall Study|Withdrawal by Subject|3|||
19438969|NCT02116205|41686210|FG000|Overall Study|Lost to Follow-up|0|||
19438970|NCT02116205|41686211|FG001|Overall Study|Lost to Follow-up|2|||
19438971|NCT02116205|41686212|FG002|Overall Study|Lost to Follow-up|1|||
19438972|NCT02116205|41686213|FG003|Overall Study|Lost to Follow-up|2|||
19438973|NCT02116205|41686210|FG000|Overall Study|Physician Decision|0|||
19438974|NCT02116205|41686211|FG001|Overall Study|Physician Decision|1|||
19438975|NCT02116205|41686212|FG002|Overall Study|Physician Decision|1|||
19438976|NCT02116205|41686213|FG003|Overall Study|Physician Decision|1|||
19438977|NCT02116205|41686210|FG000|Overall Study|Exclusion criteria|0|||
19438978|NCT02116205|41686211|FG001|Overall Study|Exclusion criteria|0|||
19438979|NCT02116205|41686212|FG002|Overall Study|Exclusion criteria|1|||
19438980|NCT02116205|41686213|FG003|Overall Study|Exclusion criteria|0|||
19438981|NCT01844583|41686225|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
19438982|NCT01844583|41686226|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
19438983|NCT02115815|41686244|FG000|Overall Study|Withdrawal by Subject|2|||
19438984|NCT02115815|41686245|FG001|Overall Study|Withdrawal by Subject|0|||
19438985|NCT02115815|41686246|FG002|Overall Study|Withdrawal by Subject|0|||
19438986|NCT02115815|41686247|FG003|Overall Study|Withdrawal by Subject|0|||
19438987|NCT02115815|41686248|FG004|Overall Study|Withdrawal by Subject|0|||
19438988|NCT02115815|41686249|FG005|Overall Study|Withdrawal by Subject|0|||
19438989|NCT02115815|41686250|FG006|Overall Study|Withdrawal by Subject|0|||
19438990|NCT02115815|41686244|FG000|Overall Study|Not enough drug to dose participant|0|||
19438991|NCT02115815|41686245|FG001|Overall Study|Not enough drug to dose participant|0|||
19438992|NCT02115815|41686246|FG002|Overall Study|Not enough drug to dose participant|0|||
19438993|NCT02115815|41686247|FG003|Overall Study|Not enough drug to dose participant|0|||
19438994|NCT02115815|41686248|FG004|Overall Study|Not enough drug to dose participant|0|||
19522077|NCT01115803|41940499|FG000|Overall Study|Progressive Disease during Cycle1|0|||
19522078|NCT01115803|41940500|FG001|Overall Study|Progressive Disease during Cycle1|0|||
19522079|NCT01115803|41940501|FG002|Overall Study|Progressive Disease during Cycle1|0|||
19522080|NCT01115803|41940502|FG003|Overall Study|Progressive Disease during Cycle1|0|||
19522081|NCT01115803|41940503|FG004|Overall Study|Progressive Disease during Cycle1|0|||
19522082|NCT01115803|41940504|FG005|Overall Study|Progressive Disease during Cycle1|0|||
19522083|NCT01115803|41940505|FG006|Overall Study|Progressive Disease during Cycle1|1|||
19522084|NCT01115569|41940526|FG000|Conversion/Titration Phase|Adverse Event|59|||
19522085|NCT01115569|41940527|FG001|Conversion/Titration Phase|Adverse Event|0|||
19522086|NCT01115569|41940526|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
19522087|NCT01115569|41940527|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
19522088|NCT01115569|41940526|FG000|Conversion/Titration Phase|Physician Decision|5|||
19522089|NCT01115569|41940527|FG001|Conversion/Titration Phase|Physician Decision|0|||
19522090|NCT01115569|41940526|FG000|Conversion/Titration Phase|Protocol Violation|68|||
19522091|NCT01115569|41940527|FG001|Conversion/Titration Phase|Protocol Violation|0|||
19522092|NCT01115569|41940526|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
19522093|NCT01115569|41940527|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
19522094|NCT01115569|41940526|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
19522095|NCT01115569|41940527|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
19522096|NCT01115569|41940526|FG000|Maintenance Phase|Adverse Event|0|||
19522097|NCT01115569|41940527|FG001|Maintenance Phase|Adverse Event|43|||
19522098|NCT01115569|41940526|FG000|Maintenance Phase|Lost to Follow-up|0|||
19522099|NCT01115569|41940527|FG001|Maintenance Phase|Lost to Follow-up|8|||
19522100|NCT01115569|41940526|FG000|Maintenance Phase|Physician Decision|0|||
19522101|NCT01115569|41940527|FG001|Maintenance Phase|Physician Decision|3|||
19522102|NCT01115569|41940526|FG000|Maintenance Phase|Protocol Violation|0|||
19522103|NCT01115569|41940527|FG001|Maintenance Phase|Protocol Violation|9|||
19522104|NCT01115569|41940526|FG000|Maintenance Phase|Withdrawal by Subject|0|||
19522105|NCT01115569|41940527|FG001|Maintenance Phase|Withdrawal by Subject|27|||
19522106|NCT01115569|41940526|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
19522107|NCT01115569|41940527|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
19522108|NCT01115569|41940526|FG000|Maintenance Phase|Administrative|0|||
19522109|NCT01115569|41940527|FG001|Maintenance Phase|Administrative|1|||
19522110|NCT01107886|41940534|FG000|Overall Study|Lost to Follow-up|15|||
19522111|NCT01107886|41940535|FG001|Overall Study|Lost to Follow-up|13|||
19522112|NCT01107886|41940534|FG000|Overall Study|Withdrawal by Subject|180|||
19522113|NCT01107886|41940535|FG001|Overall Study|Withdrawal by Subject|196|||
19522114|NCT01107886|41940534|FG000|Overall Study|Administrative withdrawal of consent|7|||
19522115|NCT01107886|41940535|FG001|Overall Study|Administrative withdrawal of consent|5|||
19522116|NCT01107457|41940546|FG000|Part A|Adverse Event|1|||
19522117|NCT01107457|41940547|FG001|Part A|Adverse Event|2|||
19522118|NCT01107457|41940548|FG002|Part A|Adverse Event|1|||
19522119|NCT01107457|41940549|FG003|Part A|Adverse Event|0|||
19522120|NCT01107457|41940550|FG004|Part A|Adverse Event|0|||
19522121|NCT01107457|41940551|FG005|Part A|Adverse Event|0|||
19522122|NCT01107457|41940546|FG000|Part A|Withdrawal by Subject|3|||
19522123|NCT01107457|41940547|FG001|Part A|Withdrawal by Subject|3|||
19522124|NCT01107457|41940548|FG002|Part A|Withdrawal by Subject|0|||
19522125|NCT01107457|41940549|FG003|Part A|Withdrawal by Subject|3|||
19522126|NCT01107457|41940550|FG004|Part A|Withdrawal by Subject|1|||
19522127|NCT01107457|41940551|FG005|Part A|Withdrawal by Subject|0|||
19522128|NCT01107457|41940546|FG000|Part A|Lost to Follow-up|0|||
19522129|NCT01107457|41940547|FG001|Part A|Lost to Follow-up|1|||
19522130|NCT01107457|41940548|FG002|Part A|Lost to Follow-up|0|||
19522131|NCT01107457|41940549|FG003|Part A|Lost to Follow-up|0|||
19522132|NCT01107457|41940550|FG004|Part A|Lost to Follow-up|0|||
19522133|NCT01107457|41940551|FG005|Part A|Lost to Follow-up|0|||
19522134|NCT01107457|41940546|FG000|Part A|Lack of Efficacy|1|||
19522135|NCT01107457|41940547|FG001|Part A|Lack of Efficacy|0|||
19522136|NCT01107457|41940548|FG002|Part A|Lack of Efficacy|0|||
19522137|NCT01107457|41940549|FG003|Part A|Lack of Efficacy|0|||
19522138|NCT01107457|41940550|FG004|Part A|Lack of Efficacy|0|||
19522139|NCT01107457|41940551|FG005|Part A|Lack of Efficacy|0|||
19522140|NCT01107457|41940546|FG000|Part A|Protocol Violation|0|||
19522141|NCT01107457|41940547|FG001|Part A|Protocol Violation|1|||
19522142|NCT01107457|41940548|FG002|Part A|Protocol Violation|0|||
19522143|NCT01107457|41940549|FG003|Part A|Protocol Violation|0|||
19522144|NCT01107457|41940550|FG004|Part A|Protocol Violation|0|||
19522145|NCT01107457|41940551|FG005|Part A|Protocol Violation|0|||
19438995|NCT02115815|41686249|FG005|Overall Study|Not enough drug to dose participant|1|||
19438996|NCT02115815|41686250|FG006|Overall Study|Not enough drug to dose participant|0|||
19438997|NCT02115815|41686244|FG000|Overall Study|Missed appointment, randomized in error|0|||
19438998|NCT02115815|41686245|FG001|Overall Study|Missed appointment, randomized in error|0|||
19438999|NCT02115815|41686246|FG002|Overall Study|Missed appointment, randomized in error|0|||
19439000|NCT02115815|41686247|FG003|Overall Study|Missed appointment, randomized in error|0|||
19439001|NCT02115815|41686248|FG004|Overall Study|Missed appointment, randomized in error|0|||
19439002|NCT02115815|41686249|FG005|Overall Study|Missed appointment, randomized in error|1|||
19439003|NCT02115815|41686250|FG006|Overall Study|Missed appointment, randomized in error|0|||
19439004|NCT02115269|41686266|FG000|Overall Study|Lost to Follow-up|43|||
19439005|NCT02115269|41686266|FG000|Overall Study|Did not complete patient diary|3|||
19439006|NCT02115269|41686266|FG000|Overall Study|Moved to another city|7|||
19439007|NCT02115269|41686266|FG000|Overall Study|Withdrawal by Subject|2|||
19439008|NCT02115269|41686266|FG000|Overall Study|Didn't take study drug|2|||
19439009|NCT02115113|41686281|FG000|Participants in Run-in Period|Death|0|||
19439010|NCT02115113|41686282|FG001|Participants in Run-in Period|Death|0|||
19439011|NCT02115113|41686283|FG002|Participants in Run-in Period|Death|1|||
19439012|NCT02115113|41686281|FG000|Participants in Run-in Period|Administrative problems|0|||
19439013|NCT02115113|41686282|FG001|Participants in Run-in Period|Administrative problems|0|||
19439014|NCT02115113|41686283|FG002|Participants in Run-in Period|Administrative problems|1|||
19439015|NCT02115113|41686281|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
19439016|NCT02115113|41686282|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
19439017|NCT02115113|41686283|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
19439018|NCT02115113|41686281|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
19439019|NCT02115113|41686282|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
19439020|NCT02115113|41686283|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
19439021|NCT02115113|41686281|FG000|Participants Randomized|Lost to Follow-up|1|||
19439022|NCT02115113|41686282|FG001|Participants Randomized|Lost to Follow-up|0|||
19439023|NCT02115113|41686283|FG002|Participants Randomized|Lost to Follow-up|0|||
19439024|NCT02115113|41686281|FG000|Participants Randomized|Death|1|||
19439025|NCT02115113|41686282|FG001|Participants Randomized|Death|0|||
19439026|NCT02115113|41686283|FG002|Participants Randomized|Death|0|||
19439027|NCT02114879|41686294|FG000|Overall Study|Withdrawal by Subject|9|||
19439028|NCT02114879|41686295|FG001|Overall Study|Withdrawal by Subject|5|||
19439029|NCT02114879|41686294|FG000|Overall Study|Death|6|||
19439030|NCT02114879|41686295|FG001|Overall Study|Death|11|||
19439031|NCT02114879|41686294|FG000|Overall Study|Lost to Follow-up|4|||
19439032|NCT02114879|41686295|FG001|Overall Study|Lost to Follow-up|6|||
19439033|NCT02114879|41686294|FG000|Overall Study|Physician Decision|0|||
19439034|NCT02114879|41686295|FG001|Overall Study|Physician Decision|2|||
19439035|NCT02114177|41686303|FG000|Overall Study|Lost to Follow-up|1|||
19439036|NCT02114177|41686304|FG001|Overall Study|Lost to Follow-up|2|||
19439037|NCT02114177|41686303|FG000|Overall Study|Withdrawal by Subject|6|||
19439038|NCT02114177|41686304|FG001|Overall Study|Withdrawal by Subject|1|||
19439039|NCT02114177|41686303|FG000|Overall Study|Other|2|||
19439040|NCT02114177|41686304|FG001|Overall Study|Other|1|||
19439041|NCT02138825|41686312|FG000|Main Study Treatment|Adverse Event|11|||
19439042|NCT02138825|41686313|FG001|Main Study Treatment|Adverse Event|3|||
19439043|NCT02138825|41686312|FG000|Main Study Treatment|Death|1|||
19439044|NCT02138825|41686313|FG001|Main Study Treatment|Death|2|||
19439045|NCT02138825|41686312|FG000|Main Study Treatment|Protocol Violation|2|||
19439046|NCT02138825|41686313|FG001|Main Study Treatment|Protocol Violation|2|||
19439047|NCT02138825|41686312|FG000|Main Study Treatment|Sponsor decision|12|||
19439048|NCT02138825|41686313|FG001|Main Study Treatment|Sponsor decision|18|||
19439049|NCT02138825|41686312|FG000|Main Study Treatment|Study terminated by sponsor|10|||
19439050|NCT02138825|41686313|FG001|Main Study Treatment|Study terminated by sponsor|9|||
19439051|NCT02138825|41686312|FG000|Main Study Treatment|Withdrawal by Subject|3|||
19439052|NCT02138825|41686313|FG001|Main Study Treatment|Withdrawal by Subject|1|||
19439053|NCT02138825|41686312|FG000|Main Study Treatment|Medical decision|1|||
19439054|NCT02138825|41686313|FG001|Main Study Treatment|Medical decision|0|||
19439055|NCT02138825|41686312|FG000|Long-term Extension|Study termination by sponsor|32|||
19439056|NCT02138825|41686313|FG001|Long-term Extension|Study termination by sponsor|38|||
19439057|NCT02138825|41686312|FG000|Safety Follow-up|Adverse Event|4|||
19522146|NCT01107457|41940546|FG000|Part B and C|Adverse Event|0|||
19439058|NCT02138825|41686313|FG001|Safety Follow-up|Adverse Event|3|||
19439059|NCT02138825|41686312|FG000|Safety Follow-up|Death|11|||
19439060|NCT02138825|41686313|FG001|Safety Follow-up|Death|5|||
19439061|NCT02138825|41686312|FG000|Safety Follow-up|Withdrawal by Subject|5|||
19439062|NCT02138825|41686313|FG001|Safety Follow-up|Withdrawal by Subject|3|||
19439063|NCT02138825|41686312|FG000|Safety Follow-up|clinic worsening|1|||
19439064|NCT02138825|41686313|FG001|Safety Follow-up|clinic worsening|0|||
19439065|NCT02138825|41686312|FG000|Safety Follow-up|withdrawal by PI|1|||
19439066|NCT02138825|41686313|FG001|Safety Follow-up|withdrawal by PI|0|||
19439067|NCT02138825|41686312|FG000|Safety Follow-up|logistical difficulties|0|||
19522147|NCT01107457|41940547|FG001|Part B and C|Adverse Event|0|||
19439068|NCT02138825|41686313|FG001|Safety Follow-up|logistical difficulties|1|||
19439069|NCT02138825|41686312|FG000|Safety Follow-up|progressive disease|0|||
19439070|NCT02138825|41686313|FG001|Safety Follow-up|progressive disease|2|||
19439071|NCT02138825|41686312|FG000|Safety Follow-up|too unwell to attend the visit|0|||
19439072|NCT02138825|41686313|FG001|Safety Follow-up|too unwell to attend the visit|1|||
19439073|NCT02138825|41686312|FG000|Safety Follow-up|treatment unblinded|0|||
19439074|NCT02138825|41686313|FG001|Safety Follow-up|treatment unblinded|1|||
19439075|NCT02138825|41686312|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
19439076|NCT02138825|41686313|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
19439077|NCT02138747|41686328|FG000|Treatment Period 1|Adverse Event|10|||
19439078|NCT02138747|41686329|FG001|Treatment Period 1|Adverse Event|14|||
19439079|NCT02138747|41686330|FG002|Treatment Period 1|Adverse Event|2|||
19439080|NCT02138747|41686331|FG003|Treatment Period 1|Adverse Event|1|||
19439081|NCT02138747|41686328|FG000|Treatment Period 1|Lost to Follow-up|0|||
19439082|NCT02138747|41686329|FG001|Treatment Period 1|Lost to Follow-up|1|||
19439083|NCT02138747|41686330|FG002|Treatment Period 1|Lost to Follow-up|1|||
19439084|NCT02138747|41686331|FG003|Treatment Period 1|Lost to Follow-up|0|||
19439085|NCT02138747|41686328|FG000|Treatment Period 1|Protocol Violation|0|||
19439086|NCT02138747|41686329|FG001|Treatment Period 1|Protocol Violation|2|||
19439087|NCT02138747|41686330|FG002|Treatment Period 1|Protocol Violation|0|||
19439088|NCT02138747|41686331|FG003|Treatment Period 1|Protocol Violation|0|||
19439089|NCT02138747|41686328|FG000|Treatment Period 1|Withdrawal by Subject|8|||
19439090|NCT02138747|41686329|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19439091|NCT02138747|41686330|FG002|Treatment Period 1|Withdrawal by Subject|1|||
19439092|NCT02138747|41686331|FG003|Treatment Period 1|Withdrawal by Subject|3|||
19439093|NCT02138747|41686328|FG000|Treatment Period 1|Other - Miscellaneous|2|||
19439094|NCT02138747|41686329|FG001|Treatment Period 1|Other - Miscellaneous|4|||
19439095|NCT02138747|41686330|FG002|Treatment Period 1|Other - Miscellaneous|0|||
19439096|NCT02138747|41686331|FG003|Treatment Period 1|Other - Miscellaneous|0|||
19439097|NCT02138747|41686328|FG000|Treatment Period 2|Adverse Event|6|||
19439098|NCT02138747|41686329|FG001|Treatment Period 2|Adverse Event|3|||
19439099|NCT02138747|41686330|FG002|Treatment Period 2|Adverse Event|1|||
19439100|NCT02138747|41686331|FG003|Treatment Period 2|Adverse Event|1|||
19439101|NCT02138747|41686328|FG000|Treatment Period 2|Lost to Follow-up|2|||
19439102|NCT02138747|41686329|FG001|Treatment Period 2|Lost to Follow-up|0|||
19439103|NCT02138747|41686330|FG002|Treatment Period 2|Lost to Follow-up|0|||
19439104|NCT02138747|41686331|FG003|Treatment Period 2|Lost to Follow-up|0|||
19439105|NCT02138747|41686328|FG000|Treatment Period 2|Protocol Violation|1|||
19439106|NCT02138747|41686329|FG001|Treatment Period 2|Protocol Violation|0|||
19439107|NCT02138747|41686330|FG002|Treatment Period 2|Protocol Violation|0|||
19439108|NCT02138747|41686331|FG003|Treatment Period 2|Protocol Violation|0|||
19439109|NCT02138747|41686328|FG000|Treatment Period 2|Withdrawal by Subject|5|||
19439110|NCT02138747|41686329|FG001|Treatment Period 2|Withdrawal by Subject|4|||
19439111|NCT02138747|41686330|FG002|Treatment Period 2|Withdrawal by Subject|1|||
19439112|NCT02138747|41686331|FG003|Treatment Period 2|Withdrawal by Subject|2|||
19439113|NCT02138747|41686328|FG000|Treatment Period 2|Other - Miscellaneous|3|||
19439114|NCT02138747|41686329|FG001|Treatment Period 2|Other - Miscellaneous|0|||
19439115|NCT02138747|41686330|FG002|Treatment Period 2|Other - Miscellaneous|0|||
19439116|NCT02138747|41686331|FG003|Treatment Period 2|Other - Miscellaneous|0|||
19439117|NCT02105285|41686344|FG000|Overall Study|Adverse Event|1|||
19439118|NCT02105285|41686345|FG001|Overall Study|Adverse Event|1|||
19439119|NCT02105285|41686346|FG002|Overall Study|Adverse Event|0|||
19439120|NCT02105285|41686344|FG000|Overall Study|Protocol Violation|0|||
19439121|NCT02105285|41686345|FG001|Overall Study|Protocol Violation|1|||
19439122|NCT02105285|41686346|FG002|Overall Study|Protocol Violation|0|||
19439123|NCT02105285|41686344|FG000|Overall Study|Withdrawal by Subject|1|||
19439124|NCT02105285|41686345|FG001|Overall Study|Withdrawal by Subject|0|||
19439125|NCT02105285|41686346|FG002|Overall Study|Withdrawal by Subject|0|||
19439126|NCT02104895|41686355|FG000|Overall Study|Withdrawal by Subject|0|||
19439127|NCT02104895|41686356|FG001|Overall Study|Withdrawal by Subject|14|||
19439128|NCT01621490|41686371|FG000|Overall Study|Participant completed treatment|4|||
19439129|NCT01621490|41686372|FG001|Overall Study|Participant completed treatment|4|||
19439130|NCT01621490|41686373|FG002|Overall Study|Participant completed treatment|1|||
19439131|NCT01621490|41686374|FG003|Overall Study|Participant completed treatment|0|||
19439132|NCT01621490|41686375|FG004|Overall Study|Participant completed treatment|0|||
19522148|NCT01107457|41940548|FG002|Part B and C|Adverse Event|0|||
19439133|NCT01621490|41686376|FG005|Overall Study|Participant completed treatment|0|||
19439134|NCT01621490|41686377|FG006|Overall Study|Participant completed treatment|0|||
19439135|NCT01621490|41686378|FG007|Overall Study|Participant completed treatment|1|||
19439136|NCT01621490|41686379|FG008|Overall Study|Participant completed treatment|0|||
19439137|NCT01621490|41686371|FG000|Overall Study|Patient could not travel|1|||
19439138|NCT01621490|41686372|FG001|Overall Study|Patient could not travel|0|||
19439139|NCT01621490|41686373|FG002|Overall Study|Patient could not travel|0|||
19439140|NCT01621490|41686374|FG003|Overall Study|Patient could not travel|0|||
19439141|NCT01621490|41686375|FG004|Overall Study|Patient could not travel|0|||
19439142|NCT01621490|41686376|FG005|Overall Study|Patient could not travel|0|||
19439143|NCT01621490|41686377|FG006|Overall Study|Patient could not travel|0|||
19439144|NCT01621490|41686378|FG007|Overall Study|Patient could not travel|0|||
19439145|NCT01621490|41686379|FG008|Overall Study|Patient could not travel|0|||
19439146|NCT01621490|41686371|FG000|Overall Study|Subject no longer meets study criteria|0|||
19439147|NCT01621490|41686372|FG001|Overall Study|Subject no longer meets study criteria|0|||
19439148|NCT01621490|41686373|FG002|Overall Study|Subject no longer meets study criteria|0|||
19439149|NCT01621490|41686374|FG003|Overall Study|Subject no longer meets study criteria|0|||
19439150|NCT01621490|41686375|FG004|Overall Study|Subject no longer meets study criteria|1|||
19439151|NCT01621490|41686376|FG005|Overall Study|Subject no longer meets study criteria|0|||
19439152|NCT01621490|41686377|FG006|Overall Study|Subject no longer meets study criteria|0|||
19439153|NCT01621490|41686378|FG007|Overall Study|Subject no longer meets study criteria|0|||
19439154|NCT01621490|41686379|FG008|Overall Study|Subject no longer meets study criteria|0|||
19439155|NCT01621490|41686371|FG000|Overall Study|Maximum clinical benefit|3|||
19439156|NCT01621490|41686372|FG001|Overall Study|Maximum clinical benefit|2|||
19439157|NCT01621490|41686373|FG002|Overall Study|Maximum clinical benefit|0|||
19439158|NCT01621490|41686374|FG003|Overall Study|Maximum clinical benefit|0|||
19439159|NCT01621490|41686375|FG004|Overall Study|Maximum clinical benefit|0|||
19439160|NCT01621490|41686376|FG005|Overall Study|Maximum clinical benefit|0|||
19439161|NCT01621490|41686377|FG006|Overall Study|Maximum clinical benefit|1|||
19711243|NCT00083889|42154376|FG001|Overall Study|Withdrawal by Subject|24|||
19711244|NCT00083889|42154375|FG000|Overall Study|Lack of Efficacy|240|||
19711245|NCT00083889|42154376|FG001|Overall Study|Lack of Efficacy|219|||
19711246|NCT00083889|42154375|FG000|Overall Study|Decision of sponsor|32|||
19711247|NCT00083889|42154376|FG001|Overall Study|Decision of sponsor|4|||
19711248|NCT00083889|42154375|FG000|Overall Study|Randomized: did not take study drug|0|||
19711249|NCT00083889|42154376|FG001|Overall Study|Randomized: did not take study drug|15|||
19711250|NCT00083889|42154375|FG000|Overall Study|Completed on marketed sunitinub|3|||
19711251|NCT00083889|42154376|FG001|Overall Study|Completed on marketed sunitinub|0|||
19711252|NCT00083889|42154375|FG000|Overall Study|Crossover to SU011248|0|||
19439162|NCT01621490|41686378|FG007|Overall Study|Maximum clinical benefit|2|||
19439163|NCT01621490|41686379|FG008|Overall Study|Maximum clinical benefit|0|||
19439164|NCT01621490|41686371|FG000|Overall Study|Withdrawal by Subject|1|||
19439165|NCT01621490|41686372|FG001|Overall Study|Withdrawal by Subject|0|||
19439166|NCT01621490|41686373|FG002|Overall Study|Withdrawal by Subject|0|||
19439167|NCT01621490|41686374|FG003|Overall Study|Withdrawal by Subject|0|||
19439168|NCT01621490|41686375|FG004|Overall Study|Withdrawal by Subject|0|||
19439169|NCT01621490|41686376|FG005|Overall Study|Withdrawal by Subject|3|||
19439170|NCT01621490|41686377|FG006|Overall Study|Withdrawal by Subject|0|||
19439171|NCT01621490|41686378|FG007|Overall Study|Withdrawal by Subject|0|||
19439172|NCT01621490|41686379|FG008|Overall Study|Withdrawal by Subject|0|||
19439173|NCT01621490|41686371|FG000|Overall Study|Subject request to discontinue study|1|||
19439174|NCT01621490|41686372|FG001|Overall Study|Subject request to discontinue study|3|||
19439175|NCT01621490|41686373|FG002|Overall Study|Subject request to discontinue study|1|||
19439176|NCT01621490|41686374|FG003|Overall Study|Subject request to discontinue study|1|||
19439177|NCT01621490|41686375|FG004|Overall Study|Subject request to discontinue study|0|||
19439178|NCT01621490|41686376|FG005|Overall Study|Subject request to discontinue study|2|||
19439179|NCT01621490|41686377|FG006|Overall Study|Subject request to discontinue study|1|||
19439180|NCT01621490|41686378|FG007|Overall Study|Subject request to discontinue study|0|||
19439181|NCT01621490|41686379|FG008|Overall Study|Subject request to discontinue study|1|||
19439182|NCT01621490|41686371|FG000|Overall Study|Adverse event unrelated to study drug|2|||
19439183|NCT01621490|41686372|FG001|Overall Study|Adverse event unrelated to study drug|1|||
19439184|NCT01621490|41686373|FG002|Overall Study|Adverse event unrelated to study drug|0|||
19439185|NCT01621490|41686374|FG003|Overall Study|Adverse event unrelated to study drug|0|||
19439186|NCT01621490|41686375|FG004|Overall Study|Adverse event unrelated to study drug|0|||
19439187|NCT01621490|41686376|FG005|Overall Study|Adverse event unrelated to study drug|0|||
19439188|NCT01621490|41686377|FG006|Overall Study|Adverse event unrelated to study drug|0|||
19439189|NCT01621490|41686378|FG007|Overall Study|Adverse event unrelated to study drug|2|||
19439190|NCT01621490|41686379|FG008|Overall Study|Adverse event unrelated to study drug|1|||
19439191|NCT01621490|41686371|FG000|Overall Study|Disease progression|27|||
19439192|NCT01621490|41686372|FG001|Overall Study|Disease progression|28|||
19439193|NCT01621490|41686373|FG002|Overall Study|Disease progression|1|||
19439194|NCT01621490|41686374|FG003|Overall Study|Disease progression|5|||
19439195|NCT01621490|41686375|FG004|Overall Study|Disease progression|3|||
19439196|NCT01621490|41686376|FG005|Overall Study|Disease progression|8|||
19439197|NCT01621490|41686377|FG006|Overall Study|Disease progression|7|||
19439198|NCT01621490|41686378|FG007|Overall Study|Disease progression|0|||
19522149|NCT01107457|41940549|FG003|Part B and C|Adverse Event|0|||
19439199|NCT01621490|41686379|FG008|Overall Study|Disease progression|4|||
19711253|NCT00083889|42154376|FG001|Overall Study|Crossover to SU011248|25|||
19711254|NCT03572062|42154395|FG000|Overall Study|Adverse Event|0|||
19711255|NCT03572062|42154396|FG001|Overall Study|Adverse Event|0|||
19439200|NCT01621490|41686371|FG000|Overall Study|Study drug toxicity|1|||
19439201|NCT01621490|41686372|FG001|Overall Study|Study drug toxicity|4|||
19439202|NCT01621490|41686373|FG002|Overall Study|Study drug toxicity|5|||
19439203|NCT01621490|41686374|FG003|Overall Study|Study drug toxicity|3|||
19439204|NCT01621490|41686375|FG004|Overall Study|Study drug toxicity|1|||
19439205|NCT01621490|41686376|FG005|Overall Study|Study drug toxicity|10|||
19439206|NCT01621490|41686377|FG006|Overall Study|Study drug toxicity|1|||
19439207|NCT01621490|41686378|FG007|Overall Study|Study drug toxicity|4|||
19439208|NCT01621490|41686379|FG008|Overall Study|Study drug toxicity|1|||
19439209|NCT01621490|41686371|FG000|Overall Study|Death|0|||
19439210|NCT01621490|41686372|FG001|Overall Study|Death|0|||
19439211|NCT01621490|41686373|FG002|Overall Study|Death|0|||
19439212|NCT01621490|41686374|FG003|Overall Study|Death|0|||
19439213|NCT01621490|41686375|FG004|Overall Study|Death|0|||
19439214|NCT01621490|41686376|FG005|Overall Study|Death|0|||
19439215|NCT01621490|41686377|FG006|Overall Study|Death|0|||
19439216|NCT01621490|41686378|FG007|Overall Study|Death|1|||
19439217|NCT01621490|41686379|FG008|Overall Study|Death|0|||
19439218|NCT01621490|41686371|FG000|Overall Study|Grade 4 Lipase elevation|1|||
19439219|NCT01621490|41686372|FG001|Overall Study|Grade 4 Lipase elevation|0|||
19439220|NCT01621490|41686373|FG002|Overall Study|Grade 4 Lipase elevation|0|||
19439221|NCT01621490|41686374|FG003|Overall Study|Grade 4 Lipase elevation|0|||
19439222|NCT01621490|41686375|FG004|Overall Study|Grade 4 Lipase elevation|0|||
19439223|NCT01621490|41686376|FG005|Overall Study|Grade 4 Lipase elevation|0|||
19439224|NCT01621490|41686377|FG006|Overall Study|Grade 4 Lipase elevation|0|||
19439225|NCT01621490|41686378|FG007|Overall Study|Grade 4 Lipase elevation|0|||
19439226|NCT01621490|41686379|FG008|Overall Study|Grade 4 Lipase elevation|0|||
19439227|NCT01621490|41686371|FG000|Overall Study|BMS informed of patient status|0|||
19439228|NCT01621490|41686372|FG001|Overall Study|BMS informed of patient status|0|||
19439229|NCT01621490|41686373|FG002|Overall Study|BMS informed of patient status|1|||
19439230|NCT01621490|41686374|FG003|Overall Study|BMS informed of patient status|0|||
19439231|NCT01621490|41686375|FG004|Overall Study|BMS informed of patient status|0|||
19439232|NCT01621490|41686376|FG005|Overall Study|BMS informed of patient status|0|||
19439233|NCT01621490|41686377|FG006|Overall Study|BMS informed of patient status|0|||
19439234|NCT01621490|41686378|FG007|Overall Study|BMS informed of patient status|0|||
19439235|NCT01621490|41686379|FG008|Overall Study|BMS informed of patient status|0|||
19439236|NCT01621490|41686371|FG000|Overall Study|Investigator decision|0|||
19439237|NCT01621490|41686372|FG001|Overall Study|Investigator decision|0|||
19439238|NCT01621490|41686373|FG002|Overall Study|Investigator decision|1|||
19439239|NCT01621490|41686374|FG003|Overall Study|Investigator decision|0|||
19439240|NCT01621490|41686375|FG004|Overall Study|Investigator decision|1|||
19439241|NCT01621490|41686376|FG005|Overall Study|Investigator decision|0|||
19439242|NCT01621490|41686377|FG006|Overall Study|Investigator decision|1|||
19439243|NCT01621490|41686378|FG007|Overall Study|Investigator decision|0|||
19439244|NCT01621490|41686379|FG008|Overall Study|Investigator decision|0|||
19439245|NCT01621490|41686371|FG000|Overall Study|Documented disease progression|0|||
19439246|NCT01621490|41686372|FG001|Overall Study|Documented disease progression|0|||
19439247|NCT01621490|41686373|FG002|Overall Study|Documented disease progression|1|||
19439248|NCT01621490|41686374|FG003|Overall Study|Documented disease progression|0|||
19439249|NCT01621490|41686375|FG004|Overall Study|Documented disease progression|0|||
19439250|NCT01621490|41686376|FG005|Overall Study|Documented disease progression|0|||
19439251|NCT01621490|41686377|FG006|Overall Study|Documented disease progression|0|||
19439252|NCT01621490|41686378|FG007|Overall Study|Documented disease progression|0|||
19439253|NCT01621490|41686379|FG008|Overall Study|Documented disease progression|0|||
19439254|NCT01621490|41686371|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
19439255|NCT01621490|41686372|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
19439256|NCT01621490|41686373|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
19439257|NCT01621490|41686374|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
19439258|NCT01621490|41686375|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
19439259|NCT01621490|41686376|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
19439260|NCT01621490|41686377|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
19439261|NCT01621490|41686378|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
19439262|NCT01621490|41686379|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
19439263|NCT01621490|41686371|FG000|Overall Study|Clinical deterioration|0|||
19439264|NCT01621490|41686372|FG001|Overall Study|Clinical deterioration|1|||
19439265|NCT01621490|41686373|FG002|Overall Study|Clinical deterioration|0|||
19439266|NCT01621490|41686374|FG003|Overall Study|Clinical deterioration|0|||
19439267|NCT01621490|41686375|FG004|Overall Study|Clinical deterioration|0|||
19439268|NCT01621490|41686376|FG005|Overall Study|Clinical deterioration|0|||
19439269|NCT01621490|41686377|FG006|Overall Study|Clinical deterioration|0|||
19439270|NCT01621490|41686378|FG007|Overall Study|Clinical deterioration|0|||
19439271|NCT01621490|41686379|FG008|Overall Study|Clinical deterioration|0|||
19439272|NCT01621490|41686371|FG000|Overall Study|Complete response|0|||
19439273|NCT01621490|41686372|FG001|Overall Study|Complete response|0|||
19439274|NCT01621490|41686373|FG002|Overall Study|Complete response|0|||
19439275|NCT01621490|41686374|FG003|Overall Study|Complete response|0|||
19439276|NCT01621490|41686375|FG004|Overall Study|Complete response|0|||
19439277|NCT01621490|41686376|FG005|Overall Study|Complete response|0|||
19439278|NCT01621490|41686377|FG006|Overall Study|Complete response|0|||
19439279|NCT01621490|41686378|FG007|Overall Study|Complete response|0|||
19439280|NCT01621490|41686379|FG008|Overall Study|Complete response|1|||
19439281|NCT01621490|41686371|FG000|Overall Study|Patient delayed due to toxicity|0|||
19439282|NCT01621490|41686372|FG001|Overall Study|Patient delayed due to toxicity|0|||
19439283|NCT01621490|41686373|FG002|Overall Study|Patient delayed due to toxicity|0|||
19439284|NCT01621490|41686374|FG003|Overall Study|Patient delayed due to toxicity|0|||
19439285|NCT01621490|41686375|FG004|Overall Study|Patient delayed due to toxicity|0|||
19439286|NCT01621490|41686376|FG005|Overall Study|Patient delayed due to toxicity|1|||
19439287|NCT01621490|41686377|FG006|Overall Study|Patient delayed due to toxicity|0|||
19439288|NCT01621490|41686378|FG007|Overall Study|Patient delayed due to toxicity|0|||
19439289|NCT01621490|41686379|FG008|Overall Study|Patient delayed due to toxicity|0|||
19439290|NCT02018887|41686500|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
19439291|NCT02018887|41686501|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439292|NCT02018887|41686502|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439293|NCT02018887|41686503|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439294|NCT02018887|41686504|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439295|NCT02018887|41686505|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439296|NCT02018887|41686506|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439297|NCT02018887|41686507|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439298|NCT02018887|41686508|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439299|NCT02018887|41686509|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439300|NCT02018887|41686510|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
19439301|NCT02018887|41686500|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439302|NCT02018887|41686501|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439303|NCT02018887|41686502|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439304|NCT02018887|41686503|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439305|NCT02018887|41686504|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
19439306|NCT02018887|41686505|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439307|NCT02018887|41686506|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
19439308|NCT02018887|41686507|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
19439309|NCT02018887|41686508|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439310|NCT02018887|41686509|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439311|NCT02018887|41686510|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
19439312|NCT02018887|41686500|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
19439313|NCT02018887|41686501|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
19439314|NCT02018887|41686502|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
19522150|NCT01107457|41940550|FG004|Part B and C|Adverse Event|0|||
19522151|NCT01107457|41940551|FG005|Part B and C|Adverse Event|12|||
19522152|NCT01107457|41940546|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
19522153|NCT01107457|41940547|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
19522154|NCT01107457|41940548|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
19522155|NCT01107457|41940549|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
19522156|NCT01107457|41940550|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
19522157|NCT01107457|41940551|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
19522158|NCT01107457|41940546|FG000|Part B and C|Physician Decision|0|||
19522159|NCT01107457|41940547|FG001|Part B and C|Physician Decision|0|||
19522160|NCT01107457|41940548|FG002|Part B and C|Physician Decision|0|||
19522161|NCT01107457|41940549|FG003|Part B and C|Physician Decision|0|||
19522162|NCT01107457|41940550|FG004|Part B and C|Physician Decision|0|||
19522163|NCT01107457|41940551|FG005|Part B and C|Physician Decision|3|||
19522164|NCT01107457|41940546|FG000|Part B and C|Lack of Efficacy|0|||
19522165|NCT01107457|41940547|FG001|Part B and C|Lack of Efficacy|0|||
19522166|NCT01107457|41940548|FG002|Part B and C|Lack of Efficacy|0|||
19522167|NCT01107457|41940549|FG003|Part B and C|Lack of Efficacy|0|||
19522168|NCT01107457|41940550|FG004|Part B and C|Lack of Efficacy|0|||
19522169|NCT01107457|41940551|FG005|Part B and C|Lack of Efficacy|7|||
19522170|NCT01107457|41940546|FG000|Part B and C|Lost to Follow-up|0|||
19522171|NCT01107457|41940547|FG001|Part B and C|Lost to Follow-up|0|||
19522172|NCT01107457|41940548|FG002|Part B and C|Lost to Follow-up|0|||
19522173|NCT01107457|41940549|FG003|Part B and C|Lost to Follow-up|0|||
19522174|NCT01107457|41940550|FG004|Part B and C|Lost to Follow-up|0|||
19522175|NCT01107457|41940551|FG005|Part B and C|Lost to Follow-up|10|||
19522176|NCT01107457|41940546|FG000|Part B and C|Protocol Violation|0|||
19522177|NCT01107457|41940547|FG001|Part B and C|Protocol Violation|0|||
19522178|NCT01107457|41940548|FG002|Part B and C|Protocol Violation|0|||
19522179|NCT01107457|41940549|FG003|Part B and C|Protocol Violation|0|||
19522180|NCT01107457|41940550|FG004|Part B and C|Protocol Violation|0|||
19522181|NCT01107457|41940551|FG005|Part B and C|Protocol Violation|1|||
19522182|NCT01107457|41940546|FG000|Part B and C|Sponsor Decision|0|||
19522183|NCT01107457|41940547|FG001|Part B and C|Sponsor Decision|0|||
19522184|NCT01107457|41940548|FG002|Part B and C|Sponsor Decision|0|||
19522185|NCT01107457|41940549|FG003|Part B and C|Sponsor Decision|0|||
19439315|NCT02018887|41686503|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
19439316|NCT02018887|41686504|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
19439317|NCT02018887|41686505|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
19439318|NCT02018887|41686506|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
19439319|NCT02018887|41686507|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
19439320|NCT02018887|41686508|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
19439321|NCT02018887|41686509|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
19439322|NCT02018887|41686510|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
19439323|NCT02018887|41686500|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
19439324|NCT02018887|41686501|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
19439325|NCT02018887|41686502|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
19439326|NCT02018887|41686503|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
19439327|NCT02018887|41686504|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
19439328|NCT02018887|41686505|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
19439329|NCT02018887|41686506|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
19439330|NCT02018887|41686507|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
19439331|NCT02018887|41686508|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
19439332|NCT02018887|41686509|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
19439333|NCT02018887|41686510|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
19439334|NCT02030041|41686579|FG000|Overall Study|Withdrawal by Subject|2|||
19439335|NCT02030041|41686580|FG001|Overall Study|Withdrawal by Subject|2|||
19439336|NCT02030041|41686581|FG002|Overall Study|Withdrawal by Subject|1|||
19439337|NCT01844505|41686592|FG000|Overall Study|Disease progression|170|||
19439338|NCT01844505|41686593|FG001|Overall Study|Disease progression|88|||
19439339|NCT01844505|41686594|FG002|Overall Study|Disease progression|224|||
19439340|NCT01844505|41686592|FG000|Overall Study|Study drug toxicity|40|||
19439341|NCT01844505|41686593|FG001|Overall Study|Study drug toxicity|131|||
19439342|NCT01844505|41686594|FG002|Overall Study|Study drug toxicity|50|||
19439343|NCT01844505|41686592|FG000|Overall Study|Death|1|||
19439344|NCT01844505|41686593|FG001|Overall Study|Death|3|||
19439345|NCT01844505|41686594|FG002|Overall Study|Death|1|||
19439346|NCT01844505|41686592|FG000|Overall Study|Adverse event unrelated to study drug|7|||
19439347|NCT01844505|41686593|FG001|Overall Study|Adverse event unrelated to study drug|15|||
19439348|NCT01844505|41686594|FG002|Overall Study|Adverse event unrelated to study drug|6|||
19439349|NCT01844505|41686592|FG000|Overall Study|Subject request discontinue treatment|17|||
19439350|NCT01844505|41686593|FG001|Overall Study|Subject request discontinue treatment|14|||
19439351|NCT01844505|41686594|FG002|Overall Study|Subject request discontinue treatment|8|||
19439352|NCT01844505|41686592|FG000|Overall Study|Withdrawal by Subject|0|||
19439353|NCT01844505|41686593|FG001|Overall Study|Withdrawal by Subject|3|||
19439354|NCT01844505|41686594|FG002|Overall Study|Withdrawal by Subject|0|||
19439355|NCT01844505|41686592|FG000|Overall Study|Lost to Follow-up|1|||
19439356|NCT01844505|41686593|FG001|Overall Study|Lost to Follow-up|0|||
19439357|NCT01844505|41686594|FG002|Overall Study|Lost to Follow-up|0|||
19439358|NCT01844505|41686592|FG000|Overall Study|Maximum clinical benefit|8|||
19439359|NCT01844505|41686593|FG001|Overall Study|Maximum clinical benefit|11|||
19439360|NCT01844505|41686594|FG002|Overall Study|Maximum clinical benefit|2|||
19439361|NCT01844505|41686592|FG000|Overall Study|Poor/non-compliance|1|||
19439362|NCT01844505|41686593|FG001|Overall Study|Poor/non-compliance|1|||
19439363|NCT01844505|41686594|FG002|Overall Study|Poor/non-compliance|1|||
19439364|NCT01844505|41686592|FG000|Overall Study|Subject no longer meets criteria|0|||
19439365|NCT01844505|41686593|FG001|Overall Study|Subject no longer meets criteria|1|||
19439366|NCT01844505|41686594|FG002|Overall Study|Subject no longer meets criteria|0|||
19439367|NCT01844505|41686592|FG000|Overall Study|Other Reasons|4|||
19439368|NCT01844505|41686593|FG001|Overall Study|Other Reasons|2|||
19439369|NCT01844505|41686594|FG002|Overall Study|Other Reasons|2|||
19439370|NCT01844505|41686592|FG000|Overall Study|Not Reported|0|||
19439371|NCT01844505|41686593|FG001|Overall Study|Not Reported|0|||
19439372|NCT01844505|41686594|FG002|Overall Study|Not Reported|1|||
19439373|NCT01994720|41686604|FG000|Overall Study|Withdrawal by Subject|46|||
19439374|NCT01994720|41686605|FG001|Overall Study|Withdrawal by Subject|56|||
19439375|NCT01814397|41686611|FG000|Overall Study|Adverse Event|7|||
19439376|NCT01814397|41686611|FG000|Overall Study|Withdrawal by Subject|7|||
19439377|NCT01814007|41686615|FG000|Overall Study|Withdrawal by Subject|1|||
19439378|NCT01844115|41686622|FG000|Overall Study|Adverse Event|4|||
19439379|NCT01844115|41686623|FG001|Overall Study|Adverse Event|22|||
19439380|NCT01844115|41686622|FG000|Overall Study|Lack of Efficacy|1|||
19439381|NCT01844115|41686623|FG001|Overall Study|Lack of Efficacy|4|||
19439382|NCT01844115|41686622|FG000|Overall Study|Protocol Violation|12|||
19439383|NCT01844115|41686623|FG001|Overall Study|Protocol Violation|10|||
19439384|NCT01844115|41686622|FG000|Overall Study|Withdrawal by Subject|11|||
19439385|NCT01844115|41686623|FG001|Overall Study|Withdrawal by Subject|11|||
19439386|NCT01844115|41686622|FG000|Overall Study|Lost to Follow-up|11|||
19439387|NCT01844115|41686623|FG001|Overall Study|Lost to Follow-up|10|||
19439388|NCT01844115|41686622|FG000|Overall Study|Pregnancy|0|||
19439389|NCT01844115|41686623|FG001|Overall Study|Pregnancy|1|||
19439390|NCT02018042|41686629|FG000|Overall Study|Withdrawal by Subject|1|||
19439391|NCT01813305|41686635|FG000|Overall Study|Withdrawal by Subject|12|||
19439392|NCT01813305|41686636|FG001|Overall Study|Withdrawal by Subject|5|||
19439393|NCT01813305|41686635|FG000|Overall Study|Safety Concern|4|||
19439394|NCT01813305|41686636|FG001|Overall Study|Safety Concern|0|||
19439395|NCT01813305|41686635|FG000|Overall Study|Ulcer became worse|4|||
19439396|NCT01813305|41686636|FG001|Overall Study|Ulcer became worse|0|||
19439397|NCT01813305|41686635|FG000|Overall Study|Physician Decision|4|||
19439398|NCT01813305|41686636|FG001|Overall Study|Physician Decision|0|||
19439399|NCT01813305|41686635|FG000|Overall Study|Lost to Follow-up|3|||
19439400|NCT01813305|41686636|FG001|Overall Study|Lost to Follow-up|1|||
19439401|NCT01813305|41686635|FG000|Overall Study|Protocol Violation|1|||
19439402|NCT01813305|41686636|FG001|Overall Study|Protocol Violation|0|||
19439403|NCT01813305|41686635|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
19439404|NCT01813305|41686636|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
19439405|NCT01993940|41686646|FG000|Overall Study|Adverse Event|16|||
19439406|NCT01993940|41686647|FG001|Overall Study|Adverse Event|11|||
19439407|NCT01993940|41686646|FG000|Overall Study|Withdrawal by Subject|15|||
19439408|NCT01993940|41686647|FG001|Overall Study|Withdrawal by Subject|19|||
19439409|NCT01993940|41686646|FG000|Overall Study|Lost to Follow-up|2|||
19439410|NCT01993940|41686647|FG001|Overall Study|Lost to Follow-up|5|||
19439411|NCT01993940|41686646|FG000|Overall Study|Protocol Violation|5|||
19439412|NCT01993940|41686647|FG001|Overall Study|Protocol Violation|8|||
19439413|NCT01993940|41686646|FG000|Overall Study|Death|1|||
19439414|NCT01993940|41686647|FG001|Overall Study|Death|0|||
19439415|NCT01993940|41686646|FG000|Overall Study|Other - Miscellaneous|1|||
19439416|NCT01993940|41686647|FG001|Overall Study|Other - Miscellaneous|1|||
19439417|NCT01843803|41686655|FG000|Overall Study|not a Veteran, did not see provider|1|||
19439418|NCT01843803|41686656|FG001|Overall Study|not a Veteran, did not see provider|3|||
19439419|NCT02017171|41686664|FG000|Overall Study|Death|10|||
19439420|NCT02017171|41686665|FG001|Overall Study|Death|4|||
19439421|NCT02017171|41686664|FG000|Overall Study|Withdrawal by Subject|23|||
19439422|NCT02017171|41686665|FG001|Overall Study|Withdrawal by Subject|17|||
19439423|NCT02017171|41686664|FG000|Overall Study|Lost to Follow-up|21|||
19439424|NCT02017171|41686665|FG001|Overall Study|Lost to Follow-up|20|||
19439425|NCT02017171|41686664|FG000|Overall Study|ESKD|6|||
19439426|NCT02017171|41686665|FG001|Overall Study|ESKD|2|||
19439427|NCT02017171|41686664|FG000|Overall Study|Miscellaneous|2|||
19439428|NCT02017171|41686665|FG001|Overall Study|Miscellaneous|3|||
19439429|NCT02029417|41686672|FG000|Overall Study|Death|1|||
19439430|NCT02029417|41686672|FG000|Overall Study|Adverse Event|1|||
19439431|NCT02016716|41686679|FG000|Overall Study|Withdrawal by Subject|5|||
19439432|NCT02016716|41686680|FG001|Overall Study|Withdrawal by Subject|5|||
19439433|NCT02016716|41686681|FG002|Overall Study|Withdrawal by Subject|5|||
19439434|NCT02016716|41686679|FG000|Overall Study|Protocol-specified Criteria|0|||
19439435|NCT02016716|41686680|FG001|Overall Study|Protocol-specified Criteria|1|||
19439436|NCT02016716|41686681|FG002|Overall Study|Protocol-specified Criteria|0|||
19439437|NCT02016716|41686679|FG000|Overall Study|Lost to Follow-up|1|||
19439438|NCT02016716|41686680|FG001|Overall Study|Lost to Follow-up|2|||
19439439|NCT02016716|41686681|FG002|Overall Study|Lost to Follow-up|1|||
19439440|NCT02050321|41686690|FG000|Overall Study|Withdrawal by Subject|1|||
19439441|NCT02050321|41686690|FG000|Overall Study|Adverse Event|1|||
19439442|NCT02039414|41686696|FG000|Overall Study|Delivered|1|||
19439443|NCT02039414|41686697|FG001|Overall Study|Delivered|1|||
19439444|NCT02039414|41686696|FG000|Overall Study|Lost to Follow-up|2|||
19439445|NCT02039414|41686697|FG001|Overall Study|Lost to Follow-up|0|||
19439446|NCT02039414|41686696|FG000|Overall Study|Protocol Violation|3|||
19439447|NCT02039414|41686697|FG001|Overall Study|Protocol Violation|1|||
19439448|NCT02017015|41686703|FG000|Overall Study|Adverse Event|9|||
19439449|NCT02017015|41686703|FG000|Overall Study|Withdrawal by Subject|21|||
19439450|NCT02017015|41686703|FG000|Overall Study|Death|4|||
19439451|NCT02017015|41686703|FG000|Overall Study|Progressive Disease|31|||
19439452|NCT02017015|41686703|FG000|Overall Study|Non-compliance with study drug|2|||
19439453|NCT02017015|41686703|FG000|Overall Study|Physician Decision|2|||
19439454|NCT02016625|41686710|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
19439455|NCT02016625|41686711|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
19439456|NCT02016625|41686710|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
19439457|NCT02016625|41686711|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
19711256|NCT03572062|42154397|FG002|Overall Study|Adverse Event|0|||
19439458|NCT02016625|41686710|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
19439459|NCT02016625|41686711|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
19439460|NCT02016482|41686729|FG000|Period A|Adverse Event|3|||
19439461|NCT02016482|41686730|FG001|Period A|Adverse Event|5|||
19439462|NCT02016482|41686729|FG000|Period A|Withdrawal by Subject|3|||
19439463|NCT02016482|41686730|FG001|Period A|Withdrawal by Subject|4|||
19439464|NCT02016482|41686729|FG000|Period A|Lost to Follow-up|3|||
19439465|NCT02016482|41686730|FG001|Period A|Lost to Follow-up|3|||
19439466|NCT02016482|41686729|FG000|Period A|Lack of Efficacy|2|||
19439467|NCT02016482|41686730|FG001|Period A|Lack of Efficacy|1|||
19439468|NCT02016482|41686729|FG000|Period A|Other|3|||
19439469|NCT02016482|41686730|FG001|Period A|Other|0|||
19439470|NCT02016482|41686729|FG000|Period A|Protocol Violation|0|||
19439471|NCT02016482|41686730|FG001|Period A|Protocol Violation|1|||
19439472|NCT02016482|41686729|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
19439473|NCT02016482|41686730|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
19439474|NCT02016482|41686729|FG000|Period B|Withdrawal by Subject|1|||
19439475|NCT02016482|41686730|FG001|Period B|Withdrawal by Subject|1|||
19439476|NCT02016482|41686729|FG000|Period B|Lost to Follow-up|2|||
19439477|NCT02016482|41686730|FG001|Period B|Lost to Follow-up|0|||
19439478|NCT02016482|41686729|FG000|Period B|Lack of Efficacy|6|||
19439479|NCT02016482|41686730|FG001|Period B|Lack of Efficacy|4|||
19439480|NCT02016482|41686729|FG000|Period B|Other|4|||
19439481|NCT02016482|41686730|FG001|Period B|Other|0|||
19439482|NCT02016482|41686729|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
19439483|NCT02016482|41686730|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
19439484|NCT02028871|41686740|FG000|Overall Study|Positive urine drug screen|1|||
19439485|NCT02028871|41686741|FG001|Overall Study|Positive urine drug screen|1|||
19439486|NCT02028871|41686740|FG000|Overall Study|Withdrawal by Subject|1|||
19439487|NCT02028871|41686741|FG001|Overall Study|Withdrawal by Subject|2|||
19439488|NCT02028871|41686740|FG000|Overall Study|IV placement difficulty|1|||
19439489|NCT02028871|41686741|FG001|Overall Study|IV placement difficulty|0|||
19439490|NCT02028871|41686740|FG000|Overall Study|Current Illness|1|||
19439491|NCT02028871|41686741|FG001|Overall Study|Current Illness|0|||
19439492|NCT02028715|41686752|FG000|Overall Study|Adverse Event|2|||
19439493|NCT02028715|41686753|FG001|Overall Study|Adverse Event|2|||
19439494|NCT02028715|41686752|FG000|Overall Study|Physician Decision|1|||
19439495|NCT02028715|41686753|FG001|Overall Study|Physician Decision|0|||
19439496|NCT02028715|41686752|FG000|Overall Study|Did not complete satisfaction surveys|2|||
19439497|NCT02028715|41686753|FG001|Overall Study|Did not complete satisfaction surveys|2|||
19439498|NCT02016170|41686762|FG000|Overall Study|Adverse Event|1|||
19439499|NCT02016170|41686763|FG001|Overall Study|Adverse Event|1|||
19439500|NCT02016170|41686764|FG002|Overall Study|Adverse Event|0|||
19439501|NCT02016170|41686762|FG000|Overall Study|Protocol Violation|1|||
19439502|NCT02016170|41686763|FG001|Overall Study|Protocol Violation|0|||
19439503|NCT02016170|41686764|FG002|Overall Study|Protocol Violation|0|||
19439504|NCT02028169|41686771|FG000|Overall Study|Lost to Follow-up|21|||
19439505|NCT02028169|41686771|FG000|Overall Study|Lack of Efficacy|2|||
19439506|NCT02028169|41686771|FG000|Overall Study|Withdrawal by Subject|2|||
19439507|NCT02028169|41686771|FG000|Overall Study|Adverse Event|1|||
19439508|NCT02028169|41686771|FG000|Overall Study|Cessation of Drug|1|||
19439509|NCT02028169|41686771|FG000|Overall Study|Concomitant Medication Usage|1|||
19439510|NCT02015546|41686778|FG000|Overall Study|Withdrawal by Subject|1|||
19439511|NCT02015546|41686779|FG001|Overall Study|Withdrawal by Subject|1|||
19439512|NCT02015546|41686780|FG002|Overall Study|Withdrawal by Subject|1|||
19439513|NCT02015546|41686778|FG000|Overall Study|Screem Failure|2|||
19439514|NCT02015546|41686779|FG001|Overall Study|Screem Failure|1|||
19439515|NCT02015546|41686780|FG002|Overall Study|Screem Failure|3|||
19439516|NCT02027701|41686788|FG000|Overall Study|Adverse Event|3|||
19439517|NCT02027701|41686788|FG000|Overall Study|Lack of Efficacy|8|||
19439518|NCT02027701|41686788|FG000|Overall Study|Physician Decision|2|||
19439519|NCT02027701|41686788|FG000|Overall Study|Withdrawal by Subject|3|||
19439520|NCT02038790|41686794|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
19439521|NCT02038790|41686795|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
19439522|NCT02027623|41686804|FG000|Overall Study|Lost to Follow-up|3|||
19439523|NCT02027623|41686805|FG001|Overall Study|Lost to Follow-up|3|||
19439524|NCT02027623|41686804|FG000|Overall Study|Withdrawal by Subject|6|||
19439525|NCT02027623|41686805|FG001|Overall Study|Withdrawal by Subject|9|||
19439526|NCT02027545|41686814|FG000|Overall Study|Failed to sign HIPAA|0|||
19439527|NCT02027545|41686815|FG001|Overall Study|Failed to sign HIPAA|2|||
19439528|NCT02027545|41686814|FG000|Overall Study|Failed to attend study visit|2|||
19439529|NCT02027545|41686815|FG001|Overall Study|Failed to attend study visit|0|||
19439530|NCT02015221|41686823|FG000|Overall Study|Withdrawal by Subject|8|||
19439531|NCT02015221|41686824|FG001|Overall Study|Withdrawal by Subject|6|||
19439532|NCT02015221|41686823|FG000|Overall Study|Lost to Follow-up|1|||
19439533|NCT02015221|41686824|FG001|Overall Study|Lost to Follow-up|0|||
19439534|NCT02027311|41686832|FG000|Overall Study|Protocol Violation|3|||
19439535|NCT02027311|41686833|FG001|Overall Study|Protocol Violation|2|||
19439536|NCT02047903|41686841|FG000|Overall Study|Adverse Event|14|||
19439537|NCT02047903|41686841|FG000|Overall Study|Serious adverse event|10|||
19439538|NCT02047903|41686841|FG000|Overall Study|Withdrawal by Subject|16|||
19439539|NCT02047903|41686841|FG000|Overall Study|Lost to Follow-up|4|||
19439540|NCT02047903|41686841|FG000|Overall Study|Reason not listed|6|||
19711257|NCT03572062|42154398|FG003|Overall Study|Adverse Event|0|||
19439541|NCT02047903|41686841|FG000|Overall Study|Not Treated|9|||
19439542|NCT02015065|41686848|FG000|Overall Study|Death on study|1|||
19439543|NCT02015065|41686849|FG001|Overall Study|Death on study|2|||
19439544|NCT02015065|41686850|FG002|Overall Study|Death on study|1|||
19439545|NCT02026141|41686860|FG000|Overall Study|Protocol Violation|0|||
19439546|NCT02026141|41686861|FG001|Overall Study|Protocol Violation|1|||
19439547|NCT02026063|41686869|FG000|Overall Study|Physician Decision|0|||
19439548|NCT02026063|41686870|FG001|Overall Study|Physician Decision|10|||
19439549|NCT02026063|41686869|FG000|Overall Study|Noncompliance with Study Drug|1|||
19439550|NCT02026063|41686870|FG001|Overall Study|Noncompliance with Study Drug|1|||
19439551|NCT02026063|41686869|FG000|Overall Study|Withdrawal of Consent|1|||
19439552|NCT02026063|41686870|FG001|Overall Study|Withdrawal of Consent|6|||
19439553|NCT02026063|41686869|FG000|Overall Study|Adverse Event|5|||
19439554|NCT02026063|41686870|FG001|Overall Study|Adverse Event|20|||
19439555|NCT02026063|41686869|FG000|Overall Study|Lack of Efficacy|0|||
19439556|NCT02026063|41686870|FG001|Overall Study|Lack of Efficacy|4|||
19439557|NCT02026063|41686869|FG000|Overall Study|Lost to Follow-up|0|||
19439558|NCT02026063|41686870|FG001|Overall Study|Lost to Follow-up|1|||
19439559|NCT02026063|41686869|FG000|Overall Study|Reason not Specified|2|||
19439560|NCT02026063|41686870|FG001|Overall Study|Reason not Specified|7|||
19439561|NCT02025907|41686879|FG000|Overall Study|Lack of Efficacy|1|||
19439562|NCT02025907|41686880|FG001|Overall Study|Lack of Efficacy|0|||
19439563|NCT02025907|41686879|FG000|Overall Study|Withdrawal by Subject|15|||
19439564|NCT02025907|41686880|FG001|Overall Study|Withdrawal by Subject|8|||
19439565|NCT02025907|41686879|FG000|Overall Study|Protocol Violation|2|||
19439566|NCT02025907|41686880|FG001|Overall Study|Protocol Violation|0|||
19439567|NCT02025907|41686879|FG000|Overall Study|Physician Decision|2|||
19439568|NCT02025907|41686880|FG001|Overall Study|Physician Decision|0|||
19439569|NCT02025907|41686879|FG000|Overall Study|Lost to Follow-up|2|||
19439570|NCT02025907|41686880|FG001|Overall Study|Lost to Follow-up|2|||
19439571|NCT02025907|41686879|FG000|Overall Study|Adverse Event|3|||
19439572|NCT02025907|41686880|FG001|Overall Study|Adverse Event|1|||
19439573|NCT02025907|41686879|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
19439574|NCT02025907|41686880|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
19439575|NCT01813071|41686895|FG000|Overall Study|Protocol Violation|0|||
19439576|NCT01813071|41686896|FG001|Overall Study|Protocol Violation|0|||
19439577|NCT01813071|41686897|FG002|Overall Study|Protocol Violation|0|||
19439578|NCT01813071|41686898|FG003|Overall Study|Protocol Violation|0|||
19439579|NCT01813071|41686899|FG004|Overall Study|Protocol Violation|1|||
19439580|NCT01813071|41686900|FG005|Overall Study|Protocol Violation|4|||
19439581|NCT01813071|41686901|FG006|Overall Study|Protocol Violation|2|||
19439582|NCT01813071|41686902|FG007|Overall Study|Protocol Violation|4|||
19439583|NCT01813071|41686903|FG008|Overall Study|Protocol Violation|2|||
19439584|NCT01813071|41686895|FG000|Overall Study|Withdrawal by Subject|0|||
19439585|NCT01813071|41686896|FG001|Overall Study|Withdrawal by Subject|0|||
19439586|NCT01813071|41686897|FG002|Overall Study|Withdrawal by Subject|0|||
19439587|NCT01813071|41686898|FG003|Overall Study|Withdrawal by Subject|0|||
19439588|NCT01813071|41686899|FG004|Overall Study|Withdrawal by Subject|0|||
19439589|NCT01813071|41686900|FG005|Overall Study|Withdrawal by Subject|1|||
19439590|NCT01813071|41686901|FG006|Overall Study|Withdrawal by Subject|0|||
19439591|NCT01813071|41686902|FG007|Overall Study|Withdrawal by Subject|0|||
19439592|NCT01813071|41686903|FG008|Overall Study|Withdrawal by Subject|0|||
19439593|NCT01813071|41686895|FG000|Overall Study|Adverse Event|0|||
19439594|NCT01813071|41686896|FG001|Overall Study|Adverse Event|0|||
19439595|NCT01813071|41686897|FG002|Overall Study|Adverse Event|0|||
19439596|NCT01813071|41686898|FG003|Overall Study|Adverse Event|0|||
19439597|NCT01813071|41686899|FG004|Overall Study|Adverse Event|0|||
19439598|NCT01813071|41686900|FG005|Overall Study|Adverse Event|1|||
19439599|NCT01813071|41686901|FG006|Overall Study|Adverse Event|0|||
19439600|NCT01813071|41686902|FG007|Overall Study|Adverse Event|0|||
19439601|NCT01813071|41686903|FG008|Overall Study|Adverse Event|0|||
19439602|NCT01813071|41686895|FG000|Overall Study|Physician Decision|0|||
19439603|NCT01813071|41686896|FG001|Overall Study|Physician Decision|0|||
19439604|NCT01813071|41686897|FG002|Overall Study|Physician Decision|0|||
19439605|NCT01813071|41686898|FG003|Overall Study|Physician Decision|0|||
19439606|NCT01813071|41686899|FG004|Overall Study|Physician Decision|0|||
19439607|NCT01813071|41686900|FG005|Overall Study|Physician Decision|0|||
19439608|NCT01813071|41686901|FG006|Overall Study|Physician Decision|1|||
19439609|NCT01813071|41686902|FG007|Overall Study|Physician Decision|0|||
19439610|NCT01813071|41686903|FG008|Overall Study|Physician Decision|0|||
19439611|NCT01813071|41686895|FG000|Overall Study|Met inc/exc criteria|0|||
19439612|NCT01813071|41686896|FG001|Overall Study|Met inc/exc criteria|0|||
19439613|NCT01813071|41686897|FG002|Overall Study|Met inc/exc criteria|0|||
19439614|NCT01813071|41686898|FG003|Overall Study|Met inc/exc criteria|0|||
19439615|NCT01813071|41686899|FG004|Overall Study|Met inc/exc criteria|0|||
19439616|NCT01813071|41686900|FG005|Overall Study|Met inc/exc criteria|1|||
19439617|NCT01813071|41686901|FG006|Overall Study|Met inc/exc criteria|0|||
19439618|NCT01813071|41686902|FG007|Overall Study|Met inc/exc criteria|1|||
19439619|NCT01813071|41686903|FG008|Overall Study|Met inc/exc criteria|1|||
19439620|NCT02025751|41686939|FG000|Overall Study|Lost to Follow-up|1|||
19439621|NCT02025751|41686940|FG001|Overall Study|Lost to Follow-up|0|||
19439622|NCT02025751|41686939|FG000|Overall Study|Adverse Event|0|||
19711258|NCT03572062|42154399|FG004|Overall Study|Adverse Event|0|||
19439623|NCT02025751|41686940|FG001|Overall Study|Adverse Event|1|||
19439624|NCT02025751|41686939|FG000|Overall Study|Physician Decision|0|||
19439625|NCT02025751|41686940|FG001|Overall Study|Physician Decision|1|||
19439626|NCT02025751|41686939|FG000|Overall Study|Withdrawal by Subject|0|||
19439627|NCT02025751|41686940|FG001|Overall Study|Withdrawal by Subject|1|||
19439628|NCT02025205|41686948|FG000|Overall Study|Withdrawal by Subject|1|||
19439629|NCT02025205|41686949|FG001|Overall Study|Withdrawal by Subject|1|||
19439630|NCT02025205|41686948|FG000|Overall Study|Protocol Violation|2|||
19439631|NCT02025205|41686949|FG001|Overall Study|Protocol Violation|1|||
19439632|NCT02025205|41686948|FG000|Overall Study|Death|0|||
19439633|NCT02025205|41686949|FG001|Overall Study|Death|1|||
19439634|NCT01812837|41686958|FG000|Overall Study|Lost to Follow-up|1|||
19439635|NCT01812837|41686959|FG001|Overall Study|Lost to Follow-up|1|||
19439636|NCT01812837|41686960|FG002|Overall Study|Lost to Follow-up|0|||
19439637|NCT01812837|41686958|FG000|Overall Study|Protocol Violation|1|||
19439638|NCT01812837|41686959|FG001|Overall Study|Protocol Violation|0|||
19439639|NCT01812837|41686960|FG002|Overall Study|Protocol Violation|0|||
19439640|NCT02024971|41686968|FG000|Overall Study|Data Not Available|30|||
19439641|NCT02024971|41686968|FG000|Overall Study|Lost to Follow-up|6|||
19439642|NCT02014597|41686974|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
19439643|NCT02014597|41686975|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
19439644|NCT01843023|41686983|FG000|Overall Study|Death|1|||
19439645|NCT01843023|41686984|FG001|Overall Study|Death|0|||
19439646|NCT01843023|41686983|FG000|Overall Study|Lost to Follow-up|24|||
19439647|NCT01843023|41686984|FG001|Overall Study|Lost to Follow-up|29|||
19439648|NCT01843023|41686983|FG000|Overall Study|Withdrawal by Subject|8|||
19439649|NCT01843023|41686984|FG001|Overall Study|Withdrawal by Subject|6|||
19439650|NCT01812759|41686993|FG000|Overall Study|Physician Decision|0|||
19439651|NCT01812759|41686994|FG001|Overall Study|Physician Decision|0|||
19439652|NCT01812759|41686995|FG002|Overall Study|Physician Decision|1|||
19439653|NCT01812057|41687005|FG000|Overall Study|Protocol Violation|1|||
19439654|NCT01812057|41687006|FG001|Overall Study|Protocol Violation|0|||
19439655|NCT01812057|41687005|FG000|Overall Study|Physician Decision|1|||
19439656|NCT01812057|41687006|FG001|Overall Study|Physician Decision|0|||
19439657|NCT01842633|41687019|FG000|Overall Study|Screen Failure|1|||
19439658|NCT01842633|41687020|FG001|Overall Study|Screen Failure|0|||
19439659|NCT01842633|41687021|FG002|Overall Study|Screen Failure|0|||
19439660|NCT01842633|41687019|FG000|Overall Study|Adverse Event|1|||
19439661|NCT01842633|41687020|FG001|Overall Study|Adverse Event|1|||
19439662|NCT01842633|41687021|FG002|Overall Study|Adverse Event|0|||
19439663|NCT01842633|41687019|FG000|Overall Study|Withdrawal by Subject|0|||
19439664|NCT01842633|41687020|FG001|Overall Study|Withdrawal by Subject|1|||
19439665|NCT01842633|41687021|FG002|Overall Study|Withdrawal by Subject|0|||
19439666|NCT01842633|41687019|FG000|Overall Study|Technical issues|1|||
19439667|NCT01842633|41687020|FG001|Overall Study|Technical issues|0|||
19439668|NCT01842633|41687021|FG002|Overall Study|Technical issues|0|||
19439669|NCT01810263|41687033|FG000|Overall Study|Lost to Follow-up|8|||
19439670|NCT01810263|41687034|FG001|Overall Study|Lost to Follow-up|7|||
19439671|NCT01841697|41687042|FG000|Overall Study|Death|0|||
19439672|NCT01841697|41687043|FG001|Overall Study|Death|1|||
19439673|NCT01841697|41687042|FG000|Overall Study|Lost to Follow-up|4|||
19439674|NCT01841697|41687043|FG001|Overall Study|Lost to Follow-up|1|||
19439675|NCT01841697|41687042|FG000|Overall Study|Withdrawal by Subject|16|||
19439676|NCT01841697|41687043|FG001|Overall Study|Withdrawal by Subject|16|||
19439677|NCT01841073|41687051|FG000|Overall Study|Adverse Event|1|||
19439678|NCT01841073|41687052|FG001|Overall Study|Adverse Event|1|||
19439679|NCT01841073|41687051|FG000|Overall Study|Physician Decision|1|||
19439680|NCT01841073|41687052|FG001|Overall Study|Physician Decision|0|||
19439681|NCT01841073|41687051|FG000|Overall Study|Lost to Follow-up|0|||
19439682|NCT01841073|41687052|FG001|Overall Study|Lost to Follow-up|2|||
19439683|NCT01809327|41687065|FG000|Overall Study|Lost to Follow-up|5|||
19439684|NCT01809327|41687066|FG001|Overall Study|Lost to Follow-up|2|||
19439685|NCT01809327|41687067|FG002|Overall Study|Lost to Follow-up|4|||
19439686|NCT01809327|41687068|FG003|Overall Study|Lost to Follow-up|2|||
19439687|NCT01809327|41687069|FG004|Overall Study|Lost to Follow-up|3|||
19439688|NCT01809327|41687065|FG000|Overall Study|Withdrawal by Subject|6|||
19439689|NCT01809327|41687066|FG001|Overall Study|Withdrawal by Subject|4|||
19439690|NCT01809327|41687067|FG002|Overall Study|Withdrawal by Subject|4|||
19439691|NCT01809327|41687068|FG003|Overall Study|Withdrawal by Subject|2|||
19439692|NCT01809327|41687069|FG004|Overall Study|Withdrawal by Subject|5|||
19439693|NCT01809327|41687065|FG000|Overall Study|Adverse Event|4|||
19439694|NCT01809327|41687066|FG001|Overall Study|Adverse Event|3|||
19439695|NCT01809327|41687067|FG002|Overall Study|Adverse Event|7|||
19439696|NCT01809327|41687068|FG003|Overall Study|Adverse Event|4|||
19439697|NCT01809327|41687069|FG004|Overall Study|Adverse Event|8|||
19439698|NCT01809327|41687065|FG000|Overall Study|Death|1|||
19439699|NCT01809327|41687066|FG001|Overall Study|Death|0|||
19439700|NCT01809327|41687067|FG002|Overall Study|Death|0|||
19439701|NCT01809327|41687068|FG003|Overall Study|Death|0|||
19439702|NCT01809327|41687069|FG004|Overall Study|Death|0|||
19439703|NCT01809327|41687065|FG000|Overall Study|Protocol Violation|0|||
19439704|NCT01809327|41687066|FG001|Overall Study|Protocol Violation|1|||
19439705|NCT01809327|41687067|FG002|Overall Study|Protocol Violation|0|||
19439706|NCT01809327|41687068|FG003|Overall Study|Protocol Violation|0|||
19439707|NCT01809327|41687069|FG004|Overall Study|Protocol Violation|0|||
19439708|NCT01809327|41687065|FG000|Overall Study|Physician Decision|1|||
19439709|NCT01809327|41687066|FG001|Overall Study|Physician Decision|1|||
19439710|NCT01809327|41687067|FG002|Overall Study|Physician Decision|0|||
19439711|NCT01809327|41687068|FG003|Overall Study|Physician Decision|0|||
19439712|NCT01809327|41687069|FG004|Overall Study|Physician Decision|0|||
19439713|NCT01809327|41687065|FG000|Overall Study|Pregnancy|1|||
19439714|NCT01809327|41687066|FG001|Overall Study|Pregnancy|0|||
19439715|NCT01809327|41687067|FG002|Overall Study|Pregnancy|0|||
19439716|NCT01809327|41687068|FG003|Overall Study|Pregnancy|0|||
19439717|NCT01809327|41687069|FG004|Overall Study|Pregnancy|0|||
19439718|NCT01809327|41687065|FG000|Overall Study|Other|14|||
19439719|NCT01809327|41687066|FG001|Overall Study|Other|15|||
19439720|NCT01809327|41687067|FG002|Overall Study|Other|7|||
19439721|NCT01809327|41687068|FG003|Overall Study|Other|4|||
19439722|NCT01809327|41687069|FG004|Overall Study|Other|9|||
19439723|NCT01808313|41687090|FG000|Overall Study|Adverse Event|5|||
19439724|NCT01808313|41687090|FG000|Overall Study|Protocol Violation|2|||
19439725|NCT01808313|41687090|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19439726|NCT01808313|41687090|FG000|Overall Study|Lost to Follow-up|1|||
19439727|NCT01808313|41687090|FG000|Overall Study|Physician Decision|1|||
19439728|NCT01840605|41687096|FG000|Overall Study|Adverse Event|0|||
19439729|NCT01840605|41687097|FG001|Overall Study|Adverse Event|1|||
19439730|NCT01840605|41687096|FG000|Overall Study|Physician Decision|2|||
19439731|NCT01840605|41687097|FG001|Overall Study|Physician Decision|1|||
19439732|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
19439733|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
19439734|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
19439735|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
19439736|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
19439737|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
19439738|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
19439739|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
19439740|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
19439741|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
19439742|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
19439743|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
19439744|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
19439745|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
19439746|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
19439747|NCT02023879|41687106|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
19439748|NCT02023879|41687107|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
19439749|NCT02023879|41687108|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
19439750|NCT02023879|41687106|FG000|Extension Open Label Treatment|Adverse Event|1|||
19439751|NCT02023879|41687107|FG001|Extension Open Label Treatment|Adverse Event|7|||
19439752|NCT02023879|41687108|FG002|Extension Open Label Treatment|Adverse Event|3|||
19439753|NCT02023879|41687106|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
19439754|NCT02023879|41687107|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
19439755|NCT02023879|41687108|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
19439756|NCT02023879|41687106|FG000|Extension Open Label Treatment|Participant moved|1|||
19439757|NCT02023879|41687107|FG001|Extension Open Label Treatment|Participant moved|2|||
19439758|NCT02023879|41687108|FG002|Extension Open Label Treatment|Participant moved|0|||
19439759|NCT02023879|41687106|FG000|Extension Open Label Treatment|Other than specified above|2|||
19439760|NCT02023879|41687107|FG001|Extension Open Label Treatment|Other than specified above|7|||
19439761|NCT02023879|41687108|FG002|Extension Open Label Treatment|Other than specified above|2|||
19439762|NCT02014441|41687123|FG000|Overall Study|Withdrawal by Subject|12|||
19439763|NCT02013817|41687129|FG000|Overall Study|Adverse Event|12|||
19439764|NCT02013817|41687129|FG000|Overall Study|Withdrawal by Subject|4|||
19439765|NCT02013817|41687129|FG000|Overall Study|Death|2|||
19439766|NCT02013817|41687129|FG000|Overall Study|Other|9|||
19439767|NCT01994863|41687133|FG000|Period 1|Adverse Event|4|||
19439768|NCT01994863|41687134|FG001|Period 1|Adverse Event|0|||
19439769|NCT01994863|41687133|FG000|Period 1|Withdrawal by Subject|1|||
19439770|NCT01994863|41687134|FG001|Period 1|Withdrawal by Subject|0|||
19439771|NCT01994863|41687133|FG000|Period 1|Trial stopped by sponsor|1|||
19439772|NCT01994863|41687134|FG001|Period 1|Trial stopped by sponsor|3|||
19439773|NCT01994863|41687133|FG000|Period 1|Lack of Efficacy|1|||
19439774|NCT01994863|41687134|FG001|Period 1|Lack of Efficacy|0|||
19439775|NCT01994863|41687133|FG000|Period 2|Adverse Event|0|||
19439776|NCT01994863|41687134|FG001|Period 2|Adverse Event|1|||
19439777|NCT01994863|41687133|FG000|Period 2|Lack of Efficacy|0|||
19439778|NCT01994863|41687134|FG001|Period 2|Lack of Efficacy|2|||
19439779|NCT01994863|41687133|FG000|Period 2|Withdrawal by Subject|1|||
19439780|NCT01994863|41687134|FG001|Period 2|Withdrawal by Subject|1|||
19439781|NCT02023099|41687143|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
19439782|NCT02023099|41687144|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
19439783|NCT02023099|41687145|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
19439784|NCT02023099|41687143|FG000|Overall Study|Withdrawn Consent|3|||
19439785|NCT02023099|41687144|FG001|Overall Study|Withdrawn Consent|0|||
19439786|NCT02023099|41687145|FG002|Overall Study|Withdrawn Consent|1|||
19439787|NCT02023099|41687143|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
19439788|NCT02023099|41687144|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
19439789|NCT02023099|41687145|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
19439790|NCT02013037|41687153|FG000|Overall Study|Death|6|||
19439791|NCT02013037|41687153|FG000|Overall Study|Withdrawal by Subject|1|||
19439792|NCT02013037|41687153|FG000|Overall Study|Awaiting Transplantation|7|||
19439793|NCT02013037|41687153|FG000|Overall Study|Transplanted without DSA|2|||
19439794|NCT01967719|41687160|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
19439795|NCT01967719|41687161|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
19439796|NCT01967719|41687162|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
19439797|NCT01967719|41687163|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
19439798|NCT01967719|41687160|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
19439799|NCT01967719|41687161|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
19439800|NCT01967719|41687162|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
19439801|NCT01967719|41687163|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
19439802|NCT01967173|41687181|FG000|Overall Study|Lost to Follow-up|5|||
19439803|NCT01967173|41687182|FG001|Overall Study|Lost to Follow-up|3|||
19439804|NCT01967173|41687183|FG002|Overall Study|Lost to Follow-up|2|||
19439805|NCT01967173|41687184|FG003|Overall Study|Lost to Follow-up|4|||
19439806|NCT01967173|41687185|FG004|Overall Study|Lost to Follow-up|8|||
19439807|NCT01967173|41687186|FG005|Overall Study|Lost to Follow-up|12|||
19439808|NCT01967173|41687187|FG006|Overall Study|Lost to Follow-up|6|||
19439809|NCT01967173|41687188|FG007|Overall Study|Lost to Follow-up|8|||
19439810|NCT01967173|41687181|FG000|Overall Study|Physician Decision|2|||
19439811|NCT01967173|41687182|FG001|Overall Study|Physician Decision|0|||
19439812|NCT01967173|41687183|FG002|Overall Study|Physician Decision|2|||
19439813|NCT01967173|41687184|FG003|Overall Study|Physician Decision|1|||
19439814|NCT01967173|41687185|FG004|Overall Study|Physician Decision|1|||
19439815|NCT01967173|41687186|FG005|Overall Study|Physician Decision|1|||
19439816|NCT01967173|41687187|FG006|Overall Study|Physician Decision|1|||
19439817|NCT01967173|41687188|FG007|Overall Study|Physician Decision|0|||
19439818|NCT01967173|41687181|FG000|Overall Study|Lack of Efficacy|2|||
19439819|NCT01967173|41687182|FG001|Overall Study|Lack of Efficacy|0|||
19439820|NCT01967173|41687183|FG002|Overall Study|Lack of Efficacy|2|||
19439821|NCT01967173|41687184|FG003|Overall Study|Lack of Efficacy|2|||
19439822|NCT01967173|41687185|FG004|Overall Study|Lack of Efficacy|0|||
19439823|NCT01967173|41687186|FG005|Overall Study|Lack of Efficacy|1|||
19439824|NCT01967173|41687187|FG006|Overall Study|Lack of Efficacy|0|||
19439825|NCT01967173|41687188|FG007|Overall Study|Lack of Efficacy|2|||
19439826|NCT01967173|41687181|FG000|Overall Study|Pregnancy|0|||
19439827|NCT01967173|41687182|FG001|Overall Study|Pregnancy|0|||
19439828|NCT01967173|41687183|FG002|Overall Study|Pregnancy|0|||
19439829|NCT01967173|41687184|FG003|Overall Study|Pregnancy|0|||
19439830|NCT01967173|41687185|FG004|Overall Study|Pregnancy|0|||
19439831|NCT01967173|41687186|FG005|Overall Study|Pregnancy|0|||
19439832|NCT01967173|41687187|FG006|Overall Study|Pregnancy|1|||
19439833|NCT01967173|41687188|FG007|Overall Study|Pregnancy|1|||
19439834|NCT01967173|41687181|FG000|Overall Study|Adverse Event|0|||
19439835|NCT01967173|41687182|FG001|Overall Study|Adverse Event|0|||
19439836|NCT01967173|41687183|FG002|Overall Study|Adverse Event|0|||
19439837|NCT01967173|41687184|FG003|Overall Study|Adverse Event|0|||
19439838|NCT01967173|41687185|FG004|Overall Study|Adverse Event|0|||
19439839|NCT01967173|41687186|FG005|Overall Study|Adverse Event|0|||
19439840|NCT01967173|41687187|FG006|Overall Study|Adverse Event|0|||
19439841|NCT01967173|41687188|FG007|Overall Study|Adverse Event|1|||
19439842|NCT01967173|41687181|FG000|Overall Study|Withdrawal by Subject|15|||
19439843|NCT01967173|41687182|FG001|Overall Study|Withdrawal by Subject|14|||
19439844|NCT01967173|41687183|FG002|Overall Study|Withdrawal by Subject|10|||
19439845|NCT01967173|41687184|FG003|Overall Study|Withdrawal by Subject|7|||
19439846|NCT01967173|41687185|FG004|Overall Study|Withdrawal by Subject|8|||
19439847|NCT01967173|41687186|FG005|Overall Study|Withdrawal by Subject|9|||
19439848|NCT01967173|41687187|FG006|Overall Study|Withdrawal by Subject|10|||
19439849|NCT01967173|41687188|FG007|Overall Study|Withdrawal by Subject|12|||
19439850|NCT01994629|41687202|FG000|Overall Study|Withdrawal by Subject|1|||
19439851|NCT01994629|41687203|FG001|Overall Study|Withdrawal by Subject|0|||
19439852|NCT01994629|41687202|FG000|Overall Study|Lost to Follow-up|0|||
19439853|NCT01994629|41687203|FG001|Overall Study|Lost to Follow-up|3|||
19439854|NCT01994395|41687211|FG000|Overall Study|Withdrawal by Subject|1|||
19439855|NCT01994395|41687212|FG001|Overall Study|Withdrawal by Subject|2|||
19439856|NCT01992536|41687228|FG000|Overall Study|Administrative Reason|0|||
19439857|NCT01992536|41687229|FG001|Overall Study|Administrative Reason|0|||
19439858|NCT01992536|41687230|FG002|Overall Study|Administrative Reason|0|||
19439859|NCT01992536|41687231|FG003|Overall Study|Administrative Reason|0|||
19439860|NCT01992536|41687232|FG004|Overall Study|Administrative Reason|0|||
19439861|NCT01992536|41687233|FG005|Overall Study|Administrative Reason|0|||
19439862|NCT01992536|41687234|FG006|Overall Study|Administrative Reason|7|||
19439863|NCT01992536|41687235|FG007|Overall Study|Administrative Reason|0|||
19439864|NCT01992536|41687236|FG008|Overall Study|Administrative Reason|0|||
19439865|NCT01992536|41687237|FG009|Overall Study|Administrative Reason|0|||
19439866|NCT01992536|41687228|FG000|Overall Study|Lost to Follow-up|4|||
19439867|NCT01992536|41687229|FG001|Overall Study|Lost to Follow-up|2|||
19439868|NCT01992536|41687230|FG002|Overall Study|Lost to Follow-up|1|||
19439869|NCT01992536|41687231|FG003|Overall Study|Lost to Follow-up|0|||
19439870|NCT01992536|41687232|FG004|Overall Study|Lost to Follow-up|0|||
19439871|NCT01992536|41687233|FG005|Overall Study|Lost to Follow-up|1|||
19439872|NCT01992536|41687234|FG006|Overall Study|Lost to Follow-up|0|||
19439873|NCT01992536|41687235|FG007|Overall Study|Lost to Follow-up|0|||
19439874|NCT01992536|41687236|FG008|Overall Study|Lost to Follow-up|1|||
19439875|NCT01992536|41687237|FG009|Overall Study|Lost to Follow-up|1|||
19439876|NCT01992536|41687228|FG000|Overall Study|Withdrawal by Subject|0|||
19439877|NCT01992536|41687229|FG001|Overall Study|Withdrawal by Subject|1|||
19439878|NCT01992536|41687230|FG002|Overall Study|Withdrawal by Subject|0|||
19439879|NCT01992536|41687231|FG003|Overall Study|Withdrawal by Subject|2|||
19439880|NCT01992536|41687232|FG004|Overall Study|Withdrawal by Subject|0|||
19439881|NCT01992536|41687233|FG005|Overall Study|Withdrawal by Subject|0|||
19439882|NCT01992536|41687234|FG006|Overall Study|Withdrawal by Subject|0|||
19439883|NCT01992536|41687235|FG007|Overall Study|Withdrawal by Subject|0|||
19439884|NCT01992536|41687236|FG008|Overall Study|Withdrawal by Subject|0|||
19439885|NCT01992536|41687237|FG009|Overall Study|Withdrawal by Subject|0|||
19439886|NCT01993927|41687279|FG000|Overall Study|Case Report Forms Uncollected|18|||
19439887|NCT01993927|41687279|FG000|Overall Study|Protocol Violation|11|||
19439888|NCT02015390|41687285|FG000|Overall Study|Lost to Follow-up|1|||
19439889|NCT02015390|41687286|FG001|Overall Study|Lost to Follow-up|0|||
19439890|NCT02015390|41687285|FG000|Overall Study|Adverse Event|0|||
19439891|NCT02015390|41687286|FG001|Overall Study|Adverse Event|3|||
19439892|NCT02015390|41687285|FG000|Overall Study|Physician Decision|0|||
19439893|NCT02015390|41687286|FG001|Overall Study|Physician Decision|1|||
19439894|NCT02012959|41687293|FG000|Treatment Phase A|Adverse Event|2|||
19439895|NCT02012959|41687294|FG001|Treatment Phase A|Adverse Event|0|||
19439896|NCT02012959|41687295|FG002|Treatment Phase A|Adverse Event|0|||
19439897|NCT02012959|41687296|FG003|Treatment Phase A|Adverse Event|0|||
19439898|NCT02012959|41687297|FG004|Treatment Phase A|Adverse Event|0|||
19439899|NCT01990742|41687309|FG000|Overall Study|Withdrawal by facility|407|||
19439900|NCT01990742|41687310|FG001|Overall Study|Withdrawal by facility|1083|||
19439901|NCT01990742|41687309|FG000|Overall Study|Facility closed|0|||
19439902|NCT01990742|41687310|FG001|Overall Study|Facility closed|270|||
19439903|NCT02012491|41687318|FG000|Overall Study|Lost to Follow-up|1|||
19439904|NCT02012491|41687319|FG001|Overall Study|Lost to Follow-up|0|||
19439905|NCT02012491|41687318|FG000|Overall Study|Protocol Violation|0|||
19439906|NCT02012491|41687319|FG001|Overall Study|Protocol Violation|1|||
19439907|NCT02012491|41687318|FG000|Overall Study|Withdrawal by Subject|1|||
19439908|NCT02012491|41687319|FG001|Overall Study|Withdrawal by Subject|0|||
19439909|NCT01990664|41687327|FG000|Overall Study|Lost to Follow-up|2|||
19439910|NCT01990664|41687328|FG001|Overall Study|Lost to Follow-up|6|||
19439911|NCT01990664|41687327|FG000|Overall Study|Withdrawal by Subject|2|||
19439912|NCT01990664|41687328|FG001|Overall Study|Withdrawal by Subject|3|||
19439913|NCT01990664|41687327|FG000|Overall Study|Protocol Violation|1|||
19439914|NCT01990664|41687328|FG001|Overall Study|Protocol Violation|0|||
19439915|NCT01990664|41687327|FG000|Overall Study|Lens Discomfort|1|||
19439916|NCT01990664|41687328|FG001|Overall Study|Lens Discomfort|1|||
19439917|NCT01990664|41687327|FG000|Overall Study|Lens Handling Difficulties|1|||
19439918|NCT01990664|41687328|FG001|Overall Study|Lens Handling Difficulties|0|||
19439919|NCT01990664|41687327|FG000|Overall Study|Unsatisfactory Visual Response|0|||
19439920|NCT01990664|41687328|FG001|Overall Study|Unsatisfactory Visual Response|1|||
19439921|NCT02038010|41687334|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
19439922|NCT02038010|41687335|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
19439923|NCT02038010|41687336|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
19439924|NCT02038010|41687337|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
19439925|NCT02038010|41687334|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
19439926|NCT02038010|41687335|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
19439927|NCT02038010|41687336|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
19711259|NCT03572062|42154400|FG005|Overall Study|Adverse Event|0|||
19439928|NCT02038010|41687337|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
19711260|NCT03572062|42154401|FG006|Overall Study|Adverse Event|0|||
19439929|NCT02038010|41687334|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
19439930|NCT02038010|41687335|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
19439931|NCT02038010|41687336|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
19439932|NCT02038010|41687337|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
19439933|NCT02038010|41687334|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
19439934|NCT02038010|41687335|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
19439935|NCT02038010|41687336|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
19439936|NCT02038010|41687337|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
19439937|NCT02038010|41687334|FG000|Follow Up|Death|4|||
19439938|NCT02038010|41687335|FG001|Follow Up|Death|3|||
19439939|NCT02038010|41687336|FG002|Follow Up|Death|0|||
19439940|NCT02038010|41687337|FG003|Follow Up|Death|0|||
19439941|NCT02038010|41687334|FG000|Follow Up|Other|3|||
19439942|NCT02038010|41687335|FG001|Follow Up|Other|0|||
19439943|NCT02038010|41687336|FG002|Follow Up|Other|0|||
19439944|NCT02038010|41687337|FG003|Follow Up|Other|0|||
19439945|NCT01989572|41687351|FG000|Overall Study|Lack of Efficacy|35|||
19439946|NCT01989572|41687352|FG001|Overall Study|Lack of Efficacy|48|||
19439947|NCT01989572|41687353|FG002|Overall Study|Lack of Efficacy|48|||
19439948|NCT01989572|41687354|FG003|Overall Study|Lack of Efficacy|43|||
19439949|NCT01989572|41687355|FG004|Overall Study|Lack of Efficacy|71|||
19439950|NCT01989572|41687356|FG005|Overall Study|Lack of Efficacy|79|||
19522186|NCT01107457|41940550|FG004|Part B and C|Sponsor Decision|0|||
19522187|NCT01107457|41940551|FG005|Part B and C|Sponsor Decision|66|||
19522188|NCT01107457|41940546|FG000|Part B and C|Withdrawal by Subject|0|||
19522189|NCT01107457|41940547|FG001|Part B and C|Withdrawal by Subject|0|||
19439951|NCT01989572|41687351|FG000|Overall Study|Adverse Event|2|||
19522190|NCT01107457|41940548|FG002|Part B and C|Withdrawal by Subject|0|||
19522191|NCT01107457|41940549|FG003|Part B and C|Withdrawal by Subject|0|||
19522192|NCT01107457|41940550|FG004|Part B and C|Withdrawal by Subject|0|||
19522193|NCT01107457|41940551|FG005|Part B and C|Withdrawal by Subject|16|||
19522194|NCT01107457|41940546|FG000|Part B and C|Clinical Relapse|0|||
19522195|NCT01107457|41940547|FG001|Part B and C|Clinical Relapse|0|||
19522196|NCT01107457|41940548|FG002|Part B and C|Clinical Relapse|0|||
19522197|NCT01107457|41940549|FG003|Part B and C|Clinical Relapse|0|||
19522198|NCT01107457|41940550|FG004|Part B and C|Clinical Relapse|0|||
19522199|NCT01107457|41940551|FG005|Part B and C|Clinical Relapse|4|||
19522200|NCT05490771|41940569|FG000|Overall Study|Disease progression|18|||
19522201|NCT05490771|41940569|FG000|Overall Study|Adverse Event|3|||
19522202|NCT05490771|41940569|FG000|Overall Study|Other complicating disease|1|||
19522203|NCT05490771|41940569|FG000|Overall Study|Withdrawal by Subject|3|||
19522204|NCT05490771|41940569|FG000|Overall Study|Physician Decision|1|||
19522205|NCT05490771|41940569|FG000|Overall Study|Still on treatment|2|||
19522206|NCT05490771|41940569|FG000|Overall Study|Never start protocol therapy|5|||
19522207|NCT05490771|41940569|FG000|Overall Study|Ineligible|2|||
19522208|NCT04545385|41940585|FG000|Overall Study|Withdrawal by Subject|2|||
19522209|NCT04545385|41940586|FG001|Overall Study|Withdrawal by Subject|0|||
19522210|NCT04545385|41940585|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
19522211|NCT04545385|41940586|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
19522212|NCT04545385|41940585|FG000|Overall Study|Study termination|10|||
19522213|NCT04545385|41940586|FG001|Overall Study|Study termination|10|||
19522214|NCT04545385|41940585|FG000|Overall Study|Sponsor decision|2|||
19522215|NCT04545385|41940586|FG001|Overall Study|Sponsor decision|2|||
19522216|NCT04545385|41940585|FG000|Overall Study|Other than specified|1|||
19522217|NCT04545385|41940586|FG001|Overall Study|Other than specified|0|||
19522218|NCT04439136|41940601|FG000|Overall Study|Ineligible|1|||
19522219|NCT04439136|41940601|FG000|Overall Study|Never Started Treatment|2|||
19522220|NCT04439136|41940601|FG000|Overall Study|Adverse Event|4|||
19522221|NCT04439136|41940601|FG000|Overall Study|Death|3|||
19522222|NCT04439136|41940601|FG000|Overall Study|Disease Progression|27|||
19522223|NCT04439136|41940601|FG000|Overall Study|Alternative Therapy|1|||
19522224|NCT04439136|41940601|FG000|Overall Study|Increased Tumor Burden|1|||
19522225|NCT04439136|41940601|FG000|Overall Study|Symptomatic Detrioration|1|||
19522226|NCT03783026|41940605|FG000|Treatment Phase|Adverse Event|15|||
19522227|NCT03783026|41940605|FG000|Treatment Phase|Lack of Efficacy|11|||
19439952|NCT01989572|41687352|FG001|Overall Study|Adverse Event|1|||
19439953|NCT01989572|41687353|FG002|Overall Study|Adverse Event|3|||
19439954|NCT01989572|41687354|FG003|Overall Study|Adverse Event|0|||
19439955|NCT01989572|41687355|FG004|Overall Study|Adverse Event|3|||
19522228|NCT03783026|41940605|FG000|Treatment Phase|Withdrawal by Subject|6|||
19522229|NCT03783026|41940605|FG000|Treatment Phase|Lost to Follow-up|2|||
19522230|NCT03783026|41940605|FG000|Treatment Phase|Protocol Deviation|8|||
19522231|NCT03783026|41940605|FG000|Treatment Phase|Did Not Receive Treatment|1|||
19522232|NCT03783026|41940605|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
19522233|NCT03635112|41940622|FG000|Overall Study|Adverse Event|5|||
19439956|NCT01989572|41687356|FG005|Overall Study|Adverse Event|0|||
19439957|NCT01989572|41687351|FG000|Overall Study|Death|0|||
19439958|NCT01989572|41687352|FG001|Overall Study|Death|0|||
19439959|NCT01989572|41687353|FG002|Overall Study|Death|0|||
19439960|NCT01989572|41687354|FG003|Overall Study|Death|0|||
19439961|NCT01989572|41687355|FG004|Overall Study|Death|1|||
19439962|NCT01989572|41687356|FG005|Overall Study|Death|0|||
19439963|NCT01989572|41687351|FG000|Overall Study|Withdrawal by Subject|4|||
19439964|NCT01989572|41687352|FG001|Overall Study|Withdrawal by Subject|1|||
19439965|NCT01989572|41687353|FG002|Overall Study|Withdrawal by Subject|5|||
19439966|NCT01989572|41687354|FG003|Overall Study|Withdrawal by Subject|1|||
19439967|NCT01989572|41687355|FG004|Overall Study|Withdrawal by Subject|12|||
19439968|NCT01989572|41687356|FG005|Overall Study|Withdrawal by Subject|4|||
19439969|NCT01989572|41687351|FG000|Overall Study|complicating disease|1|||
19439970|NCT01989572|41687352|FG001|Overall Study|complicating disease|1|||
19439971|NCT01989572|41687353|FG002|Overall Study|complicating disease|2|||
19439972|NCT01989572|41687354|FG003|Overall Study|complicating disease|0|||
19439973|NCT01989572|41687355|FG004|Overall Study|complicating disease|1|||
19439974|NCT01989572|41687356|FG005|Overall Study|complicating disease|0|||
19439975|NCT01989572|41687351|FG000|Overall Study|error|2|||
19439976|NCT01989572|41687352|FG001|Overall Study|error|1|||
19439977|NCT01989572|41687353|FG002|Overall Study|error|1|||
19439978|NCT01989572|41687354|FG003|Overall Study|error|1|||
19439979|NCT01989572|41687355|FG004|Overall Study|error|1|||
19439980|NCT01989572|41687356|FG005|Overall Study|error|1|||
19439981|NCT01989572|41687351|FG000|Overall Study|maximum dose reached|0|||
19439982|NCT01989572|41687352|FG001|Overall Study|maximum dose reached|1|||
19439983|NCT01989572|41687353|FG002|Overall Study|maximum dose reached|0|||
19439984|NCT01989572|41687354|FG003|Overall Study|maximum dose reached|0|||
19439985|NCT01989572|41687355|FG004|Overall Study|maximum dose reached|1|||
19439986|NCT01989572|41687356|FG005|Overall Study|maximum dose reached|0|||
19439987|NCT01989572|41687351|FG000|Overall Study|unknown/not specify|3|||
19439988|NCT01989572|41687352|FG001|Overall Study|unknown/not specify|4|||
19439989|NCT01989572|41687353|FG002|Overall Study|unknown/not specify|1|||
19439990|NCT01989572|41687354|FG003|Overall Study|unknown/not specify|3|||
19439991|NCT01989572|41687355|FG004|Overall Study|unknown/not specify|3|||
19439992|NCT01989572|41687356|FG005|Overall Study|unknown/not specify|5|||
19439993|NCT01989572|41687351|FG000|Overall Study|not start protocol therapy|5|||
19439994|NCT01989572|41687352|FG001|Overall Study|not start protocol therapy|1|||
19439995|NCT01989572|41687353|FG002|Overall Study|not start protocol therapy|2|||
19439996|NCT01989572|41687354|FG003|Overall Study|not start protocol therapy|3|||
19439997|NCT01989572|41687355|FG004|Overall Study|not start protocol therapy|4|||
19439998|NCT01989572|41687356|FG005|Overall Study|not start protocol therapy|18|||
19439999|NCT01989572|41687351|FG000|Overall Study|alternative therapy|3|||
19440000|NCT01989572|41687352|FG001|Overall Study|alternative therapy|0|||
19440001|NCT01989572|41687353|FG002|Overall Study|alternative therapy|0|||
19440002|NCT01989572|41687354|FG003|Overall Study|alternative therapy|0|||
19440003|NCT01989572|41687355|FG004|Overall Study|alternative therapy|1|||
19440004|NCT01989572|41687356|FG005|Overall Study|alternative therapy|3|||
19440005|NCT02036294|41687376|FG000|Overall Study|Death|7|||
19440006|NCT02036294|41687377|FG001|Overall Study|Death|8|||
19440007|NCT02036294|41687376|FG000|Overall Study|Withdrawal by Subject|2|||
19440008|NCT02036294|41687377|FG001|Overall Study|Withdrawal by Subject|3|||
19440009|NCT02035748|41687383|FG000|Overall Study|Adverse Event|5|||
19440010|NCT02035748|41687383|FG000|Overall Study|Death|3|||
19440011|NCT02035748|41687383|FG000|Overall Study|Lost to Follow-up|2|||
19440012|NCT02035748|41687383|FG000|Overall Study|Physician Decision|3|||
19440013|NCT02035748|41687383|FG000|Overall Study|Withdrawal by Subject|6|||
19440014|NCT02035748|41687383|FG000|Overall Study|Progressive Disease|1|||
19711261|NCT03572062|42154402|FG007|Overall Study|Adverse Event|0|||
19629018|NCT00829010|42078554|FG003|Overall Study|Fatality|3|||
19629019|NCT00829010|42078555|FG004|Overall Study|Fatality|0|||
19629020|NCT00829010|42078551|FG000|Overall Study|Migrated/Moved from study area|3|||
19711262|NCT03572062|42154403|FG008|Overall Study|Adverse Event|1|||
19629021|NCT00829010|42078552|FG001|Overall Study|Migrated/Moved from study area|4|||
19629022|NCT00829010|42078553|FG002|Overall Study|Migrated/Moved from study area|0|||
19629023|NCT00829010|42078554|FG003|Overall Study|Migrated/Moved from study area|5|||
19629024|NCT00829010|42078555|FG004|Overall Study|Migrated/Moved from study area|0|||
19440015|NCT02014376|41687391|FG000|Overall Study|Adverse Event|1|||
19440016|NCT02014376|41687392|FG001|Overall Study|Adverse Event|1|||
19440017|NCT02014376|41687393|FG002|Overall Study|Adverse Event|0|||
19629025|NCT00644332|42078567|FG000|Overall Study|Adverse Event|11|||
19711263|NCT03572062|42154404|FG009|Overall Study|Adverse Event|3|||
19440018|NCT02014376|41687391|FG000|Overall Study|Lost to Follow-up|2|||
19440019|NCT02014376|41687392|FG001|Overall Study|Lost to Follow-up|0|||
19440020|NCT02014376|41687393|FG002|Overall Study|Lost to Follow-up|0|||
19440021|NCT02035202|41687404|FG000|Overall Study|Lost to Follow-up|8|||
19440022|NCT02035202|41687405|FG001|Overall Study|Lost to Follow-up|16|||
19440023|NCT02035202|41687406|FG002|Overall Study|Lost to Follow-up|2|||
19440024|NCT01988402|41687416|FG000|Overall Study|Adverse Event|1|||
19440025|NCT01988402|41687417|FG001|Overall Study|Adverse Event|2|||
19629026|NCT00644332|42078567|FG000|Overall Study|Withdrawal by Subject|6|||
19440026|NCT01988402|41687416|FG000|Overall Study|Withdrawal by Subject|1|||
19440027|NCT01988402|41687417|FG001|Overall Study|Withdrawal by Subject|0|||
19440028|NCT01988090|41687425|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
19440029|NCT01988090|41687426|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
19440030|NCT01988090|41687425|FG000|Start Treament After Randomization|Protocol Violation|0|||
19440031|NCT01988090|41687426|FG001|Start Treament After Randomization|Protocol Violation|1|||
19440032|NCT01988090|41687425|FG000|Complete Study After Start|Withdrawal by Subject|2|||
19440033|NCT01988090|41687426|FG001|Complete Study After Start|Withdrawal by Subject|0|||
19440034|NCT01988090|41687425|FG000|Complete Study After Start|Protocol Violation|1|||
19440035|NCT01988090|41687426|FG001|Complete Study After Start|Protocol Violation|1|||
19440036|NCT01988012|41687432|FG000|Overall Study|Adverse Event|5|||
19440037|NCT01988012|41687432|FG000|Overall Study|Insufficient Therapeutic Response|3|||
19440038|NCT01988012|41687432|FG000|Overall Study|Patient Withdrawal of Consent|4|||
19440039|NCT01988012|41687432|FG000|Overall Study|Lost to Follow-up|1|||
19440040|NCT01988012|41687432|FG000|Overall Study|Physician Decision|1|||
19440041|NCT01988012|41687432|FG000|Overall Study|Protocol Violation|1|||
19440042|NCT02011945|41687439|FG000|Overall Study|Participant requested to Discontinue|0|||
19440043|NCT02011945|41687440|FG001|Overall Study|Participant requested to Discontinue|1|||
19440044|NCT02011945|41687441|FG002|Overall Study|Participant requested to Discontinue|1|||
19440045|NCT02011945|41687439|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
19440046|NCT02011945|41687440|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
19440047|NCT02011945|41687441|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
19440048|NCT02011945|41687439|FG000|Overall Study|Study Drug Toxicity|0|||
19440049|NCT02011945|41687440|FG001|Overall Study|Study Drug Toxicity|0|||
19440050|NCT02011945|41687441|FG002|Overall Study|Study Drug Toxicity|1|||
19440051|NCT02011945|41687439|FG000|Overall Study|Treatment Failure|0|||
19440052|NCT02011945|41687440|FG001|Overall Study|Treatment Failure|7|||
19440053|NCT02011945|41687441|FG002|Overall Study|Treatment Failure|6|||
19440054|NCT02011945|41687439|FG000|Overall Study|No Longer Meets Study Criteria|1|||
19440055|NCT02011945|41687440|FG001|Overall Study|No Longer Meets Study Criteria|0|||
19440056|NCT02011945|41687441|FG002|Overall Study|No Longer Meets Study Criteria|0|||
19440057|NCT02011945|41687439|FG000|Overall Study|Proceeded to stem cell transplant|0|||
19440058|NCT02011945|41687440|FG001|Overall Study|Proceeded to stem cell transplant|0|||
19440059|NCT02011945|41687441|FG002|Overall Study|Proceeded to stem cell transplant|1|||
19440060|NCT02011945|41687439|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
19440061|NCT02011945|41687440|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
19440062|NCT02011945|41687441|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
19440063|NCT02013830|41687449|FG000|Overall Study|Adverse Event|3|||
19440064|NCT02013830|41687449|FG000|Overall Study|Death|1|||
19440065|NCT02013830|41687449|FG000|Overall Study|Insufficient therapeutic response|25|||
19440066|NCT02013830|41687449|FG000|Overall Study|Refused treatment|1|||
19440067|NCT02010775|41687458|FG000|Overall Study|Adverse Event|0|||
19440068|NCT02010775|41687459|FG001|Overall Study|Adverse Event|0|||
19440069|NCT02010775|41687460|FG002|Overall Study|Adverse Event|0|||
19440070|NCT02010775|41687461|FG003|Overall Study|Adverse Event|0|||
19440071|NCT02010775|41687462|FG004|Overall Study|Adverse Event|1|||
19440072|NCT02010775|41687458|FG000|Overall Study|Pregnancy|0|||
19440073|NCT02010775|41687459|FG001|Overall Study|Pregnancy|0|||
19440074|NCT02010775|41687460|FG002|Overall Study|Pregnancy|2|||
19440075|NCT02010775|41687461|FG003|Overall Study|Pregnancy|0|||
19440076|NCT02010775|41687462|FG004|Overall Study|Pregnancy|0|||
19522234|NCT03635112|41940623|FG001|Overall Study|Adverse Event|9|||
19522235|NCT03635112|41940624|FG002|Overall Study|Adverse Event|14|||
19522236|NCT03635112|41940622|FG000|Overall Study|Lost to Follow-up|1|||
19522237|NCT03635112|41940623|FG001|Overall Study|Lost to Follow-up|0|||
19522238|NCT03635112|41940624|FG002|Overall Study|Lost to Follow-up|1|||
19522239|NCT03635112|41940622|FG000|Overall Study|Physician Decision|5|||
19522240|NCT03635112|41940623|FG001|Overall Study|Physician Decision|7|||
19522241|NCT03635112|41940624|FG002|Overall Study|Physician Decision|5|||
19522242|NCT03635112|41940622|FG000|Overall Study|Protocol Violation|0|||
19522243|NCT03635112|41940623|FG001|Overall Study|Protocol Violation|0|||
19522244|NCT03635112|41940624|FG002|Overall Study|Protocol Violation|1|||
19440077|NCT02010775|41687458|FG000|Overall Study|Lost to Follow-up|2|||
19440078|NCT02010775|41687459|FG001|Overall Study|Lost to Follow-up|0|||
19440079|NCT02010775|41687460|FG002|Overall Study|Lost to Follow-up|0|||
19440080|NCT02010775|41687461|FG003|Overall Study|Lost to Follow-up|1|||
19440081|NCT02010775|41687462|FG004|Overall Study|Lost to Follow-up|1|||
19440082|NCT02010775|41687458|FG000|Overall Study|Personal Reasons|3|||
19440083|NCT02010775|41687459|FG001|Overall Study|Personal Reasons|3|||
19440084|NCT02010775|41687460|FG002|Overall Study|Personal Reasons|1|||
19440085|NCT02010775|41687461|FG003|Overall Study|Personal Reasons|2|||
19440086|NCT02010775|41687462|FG004|Overall Study|Personal Reasons|4|||
19522245|NCT03635112|41940622|FG000|Overall Study|Study Terminated by Sponsor|11|||
19440087|NCT01993615|41687476|FG000|Overall Study|Death|1|||
19440088|NCT01993615|41687477|FG001|Overall Study|Death|0|||
19440089|NCT02013674|41687485|FG000|Overall Study|Death|0|||
19522246|NCT03635112|41940623|FG001|Overall Study|Study Terminated by Sponsor|17|||
19440090|NCT02013674|41687486|FG001|Overall Study|Death|1|||
19440091|NCT02013674|41687485|FG000|Overall Study|Lost to Follow-up|1|||
19440092|NCT02013674|41687486|FG001|Overall Study|Lost to Follow-up|0|||
19440093|NCT01619059|41687494|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
19440094|NCT01619059|41687495|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
19440095|NCT01619059|41687494|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
19440096|NCT01619059|41687495|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
19440097|NCT01619059|41687494|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
19440098|NCT01619059|41687495|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
19440099|NCT01619059|41687494|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
19440100|NCT01619059|41687495|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
19440101|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
19440102|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
19440103|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
19440104|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
19440105|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
19440106|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
19440107|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Death|1|||
19440108|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Death|0|||
19440109|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
19440110|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
19440111|NCT01619059|41687494|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
19440112|NCT01619059|41687495|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
19440113|NCT02013206|41687503|FG000|Overall Study|Progressive disease (PD)|14|||
19440114|NCT02013206|41687504|FG001|Overall Study|Progressive disease (PD)|17|||
19440115|NCT02013206|41687503|FG000|Overall Study|Symptomatic deterioration|3|||
19440116|NCT02013206|41687504|FG001|Overall Study|Symptomatic deterioration|1|||
19440117|NCT02013206|41687503|FG000|Overall Study|Adverse Event|1|||
19440118|NCT02013206|41687504|FG001|Overall Study|Adverse Event|0|||
19440119|NCT02013206|41687503|FG000|Overall Study|Patient refusal|2|||
19440120|NCT02013206|41687504|FG001|Overall Study|Patient refusal|0|||
19440121|NCT02013206|41687503|FG000|Overall Study|Patient non-compliance|1|||
19440122|NCT02013206|41687504|FG001|Overall Study|Patient non-compliance|0|||
19440123|NCT02013206|41687503|FG000|Overall Study|Death|1|||
19440124|NCT02013206|41687504|FG001|Overall Study|Death|2|||
19440125|NCT02013206|41687503|FG000|Overall Study|Other reasons off treatment|5|||
19440126|NCT02013206|41687504|FG001|Overall Study|Other reasons off treatment|2|||
19440127|NCT01807923|41687513|FG000|Overall Study|Adverse Event|2|||
19440128|NCT01807923|41687514|FG001|Overall Study|Adverse Event|1|||
19440129|NCT01807923|41687515|FG002|Overall Study|Adverse Event|2|||
19440130|NCT01807923|41687513|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
19440131|NCT01807923|41687514|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
19440132|NCT01807923|41687515|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
19440133|NCT01807923|41687513|FG000|Overall Study|Physician Decision|0|||
19440134|NCT01807923|41687514|FG001|Overall Study|Physician Decision|0|||
19440135|NCT01807923|41687515|FG002|Overall Study|Physician Decision|1|||
19440136|NCT01807923|41687513|FG000|Overall Study|Not Eligible (Genotype)|0|||
19440137|NCT01807923|41687514|FG001|Overall Study|Not Eligible (Genotype)|0|||
19440138|NCT01807923|41687515|FG002|Overall Study|Not Eligible (Genotype)|1|||
19440139|NCT01807923|41687513|FG000|Overall Study|Randomized But Not Treated|3|||
19440140|NCT01807923|41687514|FG001|Overall Study|Randomized But Not Treated|2|||
19440141|NCT01807923|41687515|FG002|Overall Study|Randomized But Not Treated|5|||
19440142|NCT01966003|41687527|FG000|Overall Study|Death|43|||
19440143|NCT01966003|41687528|FG001|Overall Study|Death|36|||
19440144|NCT01966003|41687527|FG000|Overall Study|Protocol Violation|6|||
19440145|NCT01966003|41687528|FG001|Overall Study|Protocol Violation|4|||
19440146|NCT01966003|41687527|FG000|Overall Study|Lost to Follow-up|4|||
19440147|NCT01966003|41687528|FG001|Overall Study|Lost to Follow-up|3|||
19440148|NCT01966003|41687527|FG000|Overall Study|Physician Decision|12|||
19440149|NCT01966003|41687528|FG001|Overall Study|Physician Decision|13|||
19440150|NCT01966003|41687527|FG000|Overall Study|Withdrawal by Subject|29|||
19440151|NCT01966003|41687528|FG001|Overall Study|Withdrawal by Subject|19|||
19440152|NCT01966003|41687527|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
19440153|NCT01966003|41687528|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
19440154|NCT01966003|41687527|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
19440155|NCT01966003|41687528|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
19440156|NCT01966003|41687527|FG000|Overall Study|Other|1|||
19440157|NCT01966003|41687528|FG001|Overall Study|Other|1|||
19440158|NCT01839279|41687537|FG000|Overall Study|Adverse Event|4|||
19440159|NCT01839279|41687538|FG001|Overall Study|Adverse Event|1|||
19440160|NCT01839279|41687539|FG002|Overall Study|Adverse Event|1|||
19440161|NCT01839279|41687537|FG000|Overall Study|Withdrawal by Subject|4|||
19440162|NCT01839279|41687538|FG001|Overall Study|Withdrawal by Subject|1|||
19440163|NCT01839279|41687539|FG002|Overall Study|Withdrawal by Subject|1|||
19440164|NCT01839279|41687537|FG000|Overall Study|Classified as 'Other'|5|||
19440165|NCT01839279|41687538|FG001|Overall Study|Classified as 'Other'|0|||
19440166|NCT01839279|41687539|FG002|Overall Study|Classified as 'Other'|0|||
19440167|NCT01807299|41687558|FG000|Overall Study|Protocol Violation|3|||
19440168|NCT01807299|41687559|FG001|Overall Study|Protocol Violation|1|||
19440169|NCT01807299|41687560|FG002|Overall Study|Protocol Violation|0|||
19440170|NCT01807299|41687561|FG003|Overall Study|Protocol Violation|2|||
19440171|NCT01965535|41687573|FG000|Overall Study|Lack of Efficacy|2|||
19440172|NCT01965535|41687574|FG001|Overall Study|Lack of Efficacy|1|||
19440173|NCT01964755|41687580|FG000|Overall Study|Death|2|||
19440174|NCT01964521|41687584|FG000|Overall Study|Lost to Follow-up|4|||
19440175|NCT01992757|41687589|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
19440176|NCT01991743|41687598|FG000|Overall Study|external cephalic version not performed|0|||
19440177|NCT01991743|41687599|FG001|Overall Study|external cephalic version not performed|0|||
19440178|NCT01991743|41687600|FG002|Overall Study|external cephalic version not performed|1|||
19440179|NCT01991743|41687601|FG003|Overall Study|external cephalic version not performed|0|||
19440180|NCT01991197|41687613|FG000|Overall Study|Lost to Follow-up|1|||
19440181|NCT01991197|41687614|FG001|Overall Study|Lost to Follow-up|1|||
19440182|NCT01991197|41687613|FG000|Overall Study|Physician Decision|0|||
19440183|NCT01991197|41687614|FG001|Overall Study|Physician Decision|2|||
19440184|NCT01991197|41687613|FG000|Overall Study|Withdrawal by Subject|2|||
19440185|NCT01991197|41687614|FG001|Overall Study|Withdrawal by Subject|0|||
19440186|NCT01990573|41687628|FG000|Overall Study|Physician Decision|0|||
19440187|NCT01990573|41687629|FG001|Overall Study|Physician Decision|0|||
19440188|NCT01990573|41687630|FG002|Overall Study|Physician Decision|1|||
19440189|NCT01990495|41687640|FG000|Overall Study|Physician Decision|5|||
19440190|NCT01990495|41687641|FG001|Overall Study|Physician Decision|4|||
19440191|NCT01990339|41687649|FG000|Overall Study|Data Not Available|49|||
19440192|NCT01990339|41687649|FG000|Overall Study|Voluntary Withdrawal|1402|||
19440193|NCT01990339|41687649|FG000|Overall Study|Lost to Follow-up|861|||
19440194|NCT02007577|41687655|FG000|Overall Study|Adverse Event|1|||
19440195|NCT02007577|41687656|FG001|Overall Study|Adverse Event|0|||
19440196|NCT02007577|41687655|FG000|Overall Study|Withdrawal by Subject|0|||
19440197|NCT02007577|41687656|FG001|Overall Study|Withdrawal by Subject|1|||
19440198|NCT01990261|41687662|FG000|Overall Study|Death Before Treatment Start|2|||
19440199|NCT01990261|41687662|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
19440200|NCT01990261|41687662|FG000|Overall Study|Death From other Causes|1|||
19440201|NCT01990261|41687662|FG000|Overall Study|Disease Progression (PD)|8|||
19440202|NCT01990261|41687662|FG000|Overall Study|PD Before Treatment Start|1|||
19440203|NCT01990261|41687662|FG000|Overall Study|Dossier not Approved|1|||
19440204|NCT01990261|41687662|FG000|Overall Study|Lost to Follow-up|2|||
19440205|NCT01963117|41687666|FG000|Overall Study|Death|1|||
19440206|NCT02007109|41687670|FG000|Overall Study|Diary not returned or excluded|102|||
19440207|NCT02007109|41687670|FG000|Overall Study|Excluded - Age<7yo|9|||
19440208|NCT02006719|41687679|FG000|Overall Study|Withdrawal by Subject|10|||
19440209|NCT02006719|41687680|FG001|Overall Study|Withdrawal by Subject|2|||
19440210|NCT02006719|41687679|FG000|Overall Study|Lost to Follow-up|5|||
19440211|NCT02006719|41687680|FG001|Overall Study|Lost to Follow-up|1|||
19440212|NCT02006719|41687679|FG000|Overall Study|Protocol Violation|2|||
19440213|NCT02006719|41687680|FG001|Overall Study|Protocol Violation|0|||
19440214|NCT02006719|41687679|FG000|Overall Study|Adverse Event|1|||
19440215|NCT02006719|41687680|FG001|Overall Study|Adverse Event|1|||
19440216|NCT02006719|41687679|FG000|Overall Study|Other/Unknown|0|||
19440217|NCT02006719|41687680|FG001|Overall Study|Other/Unknown|1|||
19440218|NCT01962493|41687688|FG000|Overall Study|Adverse Event|1|||
19440219|NCT01962493|41687689|FG001|Overall Study|Adverse Event|2|||
19440220|NCT01962493|41687688|FG000|Overall Study|Protocol Violation|0|||
19440221|NCT01962493|41687689|FG001|Overall Study|Protocol Violation|1|||
19440222|NCT01962493|41687688|FG000|Overall Study|Withdrawal by Subject|4|||
19440223|NCT01962493|41687689|FG001|Overall Study|Withdrawal by Subject|2|||
19440224|NCT01989169|41687697|FG000|Period 2|Adverse Event|0|||
19440225|NCT01989169|41687698|FG001|Period 2|Adverse Event|1|||
19440226|NCT01988779|41687706|FG000|Overall Study|Withdrawal by Subject|2|||
19440227|NCT01988779|41687707|FG001|Overall Study|Withdrawal by Subject|2|||
19440228|NCT01988779|41687706|FG000|Overall Study|Protocol Violation|1|||
19440229|NCT01988779|41687707|FG001|Overall Study|Protocol Violation|0|||
19440230|NCT01988233|41687715|FG000|Overall Study|Lost to Follow-up|64|||
19440231|NCT01988233|41687716|FG001|Overall Study|Lost to Follow-up|51|||
19440232|NCT01987765|41687722|FG000|Overall Study|Protocol Violation|65|||
19440233|NCT01987765|41687722|FG000|Overall Study|Lost to Follow-up|37|||
19440234|NCT01987609|41687726|FG000|Overall Study|Adverse Event|1|||
19440235|NCT01987232|41687745|FG000|Overall Study|Ongoing in Study|0|||
19440236|NCT01987232|41687746|FG001|Overall Study|Ongoing in Study|0|||
19440237|NCT01987232|41687747|FG002|Overall Study|Ongoing in Study|0|||
19440238|NCT01987232|41687748|FG003|Overall Study|Ongoing in Study|1|||
19440239|NCT01987232|41687749|FG004|Overall Study|Ongoing in Study|0|||
19440240|NCT01986920|41687763|FG000|A- 101 25%|Withdrawal by Subject|1|||
19440241|NCT01986920|41687764|FG001|A- 101 25%|Withdrawal by Subject|0|||
19440242|NCT01986920|41687765|FG002|A- 101 25%|Withdrawal by Subject|0|||
19440243|NCT01986920|41687766|FG003|A- 101 25%|Withdrawal by Subject|0|||
19440244|NCT01986920|41687763|FG000|A-101 32.5%|Withdrawal by Subject|0|||
19440245|NCT01986920|41687764|FG001|A-101 32.5%|Withdrawal by Subject|1|||
19440246|NCT01986920|41687765|FG002|A-101 32.5%|Withdrawal by Subject|0|||
19440247|NCT01986920|41687766|FG003|A-101 32.5%|Withdrawal by Subject|0|||
19440248|NCT01986920|41687763|FG000|A-101 40%|Withdrawal by Subject|0|||
19440249|NCT01986920|41687764|FG001|A-101 40%|Withdrawal by Subject|0|||
19440250|NCT01986920|41687765|FG002|A-101 40%|Withdrawal by Subject|1|||
19440251|NCT01986920|41687766|FG003|A-101 40%|Withdrawal by Subject|0|||
19440252|NCT01986920|41687763|FG000|Placebo|Withdrawal by Subject|0|||
19440253|NCT01986920|41687764|FG001|Placebo|Withdrawal by Subject|0|||
19440254|NCT01986920|41687765|FG002|Placebo|Withdrawal by Subject|0|||
19440255|NCT01986920|41687766|FG003|Placebo|Withdrawal by Subject|1|||
19440256|NCT02010632|41687776|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
19440257|NCT02010632|41687777|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
19440258|NCT01986140|41687785|FG000|Overall Study|Withdrawal by Subject|31|||
19440259|NCT01986140|41687786|FG001|Overall Study|Withdrawal by Subject|25|||
19440260|NCT01986140|41687785|FG000|Overall Study|alternative treatment|1|||
19440261|NCT01986140|41687786|FG001|Overall Study|alternative treatment|1|||
19440262|NCT01986140|41687785|FG000|Overall Study|found not eligible|3|||
19440263|NCT01986140|41687786|FG001|Overall Study|found not eligible|0|||
19440264|NCT01986140|41687785|FG000|Overall Study|Adverse Event|0|||
19440265|NCT01986140|41687786|FG001|Overall Study|Adverse Event|1|||
19440266|NCT01986140|41687785|FG000|Overall Study|progression disease|0|||
19440267|NCT01986140|41687786|FG001|Overall Study|progression disease|1|||
19440268|NCT01986062|41687794|FG000|Overall Study|Lost to Follow-up|1|||
19440269|NCT01986062|41687795|FG001|Overall Study|Lost to Follow-up|0|||
19440270|NCT01986062|41687794|FG000|Overall Study|Withdrawal by Subject|0|||
19440271|NCT01986062|41687795|FG001|Overall Study|Withdrawal by Subject|1|||
19440272|NCT01985360|41687803|FG000|Overall Study|Withdrawal by Subject|4|||
19440273|NCT01985360|41687804|FG001|Overall Study|Withdrawal by Subject|0|||
19440274|NCT01985360|41687803|FG000|Overall Study|Lost to Follow-up|5|||
19440275|NCT01985360|41687804|FG001|Overall Study|Lost to Follow-up|3|||
19440276|NCT02032706|41687810|FG000|Overall Study|Did not qualify|5|||
19440277|NCT02032706|41687810|FG000|Overall Study|Protocol Violation|1|||
19440278|NCT02032238|41687816|FG000|Overall Study|Lost to Follow-up|2|||
19440279|NCT02032238|41687817|FG001|Overall Study|Lost to Follow-up|0|||
19440280|NCT02031536|41687825|FG000|Overall Study|ineligible|1|||
19440281|NCT02031536|41687826|FG001|Overall Study|ineligible|0|||
19440282|NCT02009930|41687832|FG000|Overall Study|withdrawn|5|||
19440283|NCT01985126|41687845|FG000|Overall Study|Death|15|||
19440284|NCT01985126|41687846|FG001|Overall Study|Death|69|||
19440285|NCT01985126|41687845|FG000|Overall Study|Lost to Follow-up|0|||
19440286|NCT01985126|41687846|FG001|Overall Study|Lost to Follow-up|8|||
19440287|NCT01985126|41687845|FG000|Overall Study|Study Terminated By Sponsor|1|||
19440288|NCT01985126|41687846|FG001|Overall Study|Study Terminated By Sponsor|22|||
19440289|NCT01985126|41687845|FG000|Overall Study|Withdrawal by Subject|2|||
19440290|NCT01985126|41687846|FG001|Overall Study|Withdrawal by Subject|7|||
19440291|NCT01984892|41687852|FG000|Overall Study|Progressive disease|7|||
19440292|NCT01807221|41687862|FG000|Overall Study|Progressive disease|1|||
19440293|NCT01807221|41687863|FG001|Overall Study|Progressive disease|0|||
19440294|NCT01807221|41687864|FG002|Overall Study|Progressive disease|1|||
19440295|NCT01807221|41687865|FG003|Overall Study|Progressive disease|0|||
19440296|NCT01807221|41687866|FG004|Overall Study|Progressive disease|0|||
19440297|NCT01807221|41687867|FG005|Overall Study|Progressive disease|0|||
19440298|NCT01807221|41687862|FG000|Overall Study|Death|7|||
19440299|NCT01807221|41687863|FG001|Overall Study|Death|9|||
19440300|NCT01807221|41687864|FG002|Overall Study|Death|4|||
19440301|NCT01807221|41687865|FG003|Overall Study|Death|2|||
19440302|NCT01807221|41687866|FG004|Overall Study|Death|1|||
19440303|NCT01807221|41687867|FG005|Overall Study|Death|6|||
19440304|NCT01807221|41687862|FG000|Overall Study|Physician Decision|2|||
19440305|NCT01807221|41687863|FG001|Overall Study|Physician Decision|1|||
19440306|NCT01807221|41687864|FG002|Overall Study|Physician Decision|0|||
19440307|NCT01807221|41687865|FG003|Overall Study|Physician Decision|0|||
19440308|NCT01807221|41687866|FG004|Overall Study|Physician Decision|0|||
19440309|NCT01807221|41687867|FG005|Overall Study|Physician Decision|0|||
19440310|NCT01807221|41687862|FG000|Overall Study|Adverse Event|33|||
19440311|NCT01807221|41687863|FG001|Overall Study|Adverse Event|22|||
19440312|NCT01807221|41687864|FG002|Overall Study|Adverse Event|26|||
19711264|NCT03572062|42154395|FG000|Overall Study|Death|0|||
19440313|NCT01807221|41687865|FG003|Overall Study|Adverse Event|25|||
19440314|NCT01807221|41687866|FG004|Overall Study|Adverse Event|18|||
19440315|NCT01807221|41687867|FG005|Overall Study|Adverse Event|21|||
19440316|NCT01807221|41687862|FG000|Overall Study|Protocol Violation|0|||
19440317|NCT01807221|41687863|FG001|Overall Study|Protocol Violation|2|||
19440318|NCT01807221|41687864|FG002|Overall Study|Protocol Violation|1|||
19440319|NCT01807221|41687865|FG003|Overall Study|Protocol Violation|2|||
19440320|NCT01807221|41687866|FG004|Overall Study|Protocol Violation|0|||
19440321|NCT01807221|41687867|FG005|Overall Study|Protocol Violation|1|||
19440322|NCT01807221|41687862|FG000|Overall Study|Non-compliance|1|||
19440323|NCT01807221|41687863|FG001|Overall Study|Non-compliance|2|||
19440324|NCT01807221|41687864|FG002|Overall Study|Non-compliance|0|||
19440325|NCT01807221|41687865|FG003|Overall Study|Non-compliance|1|||
19440326|NCT01807221|41687866|FG004|Overall Study|Non-compliance|0|||
19440327|NCT01807221|41687867|FG005|Overall Study|Non-compliance|0|||
19440328|NCT01807221|41687862|FG000|Overall Study|Logistical difficulties|0|||
19440329|NCT01807221|41687863|FG001|Overall Study|Logistical difficulties|1|||
19440330|NCT01807221|41687864|FG002|Overall Study|Logistical difficulties|0|||
19440331|NCT01807221|41687865|FG003|Overall Study|Logistical difficulties|0|||
19440332|NCT01807221|41687866|FG004|Overall Study|Logistical difficulties|1|||
19440333|NCT01807221|41687867|FG005|Overall Study|Logistical difficulties|0|||
19440334|NCT01807221|41687862|FG000|Overall Study|Withdrawal by Subject|33|||
19440335|NCT01807221|41687863|FG001|Overall Study|Withdrawal by Subject|15|||
19440336|NCT01807221|41687864|FG002|Overall Study|Withdrawal by Subject|8|||
19440337|NCT01807221|41687865|FG003|Overall Study|Withdrawal by Subject|14|||
19440338|NCT01807221|41687866|FG004|Overall Study|Withdrawal by Subject|16|||
19440339|NCT01807221|41687867|FG005|Overall Study|Withdrawal by Subject|13|||
19440340|NCT01807221|41687862|FG000|Overall Study|Sponsor decision|2|||
19440341|NCT01807221|41687863|FG001|Overall Study|Sponsor decision|0|||
19440342|NCT01807221|41687864|FG002|Overall Study|Sponsor decision|1|||
19440343|NCT01807221|41687865|FG003|Overall Study|Sponsor decision|1|||
19440344|NCT01807221|41687866|FG004|Overall Study|Sponsor decision|0|||
19440345|NCT01807221|41687867|FG005|Overall Study|Sponsor decision|0|||
19440346|NCT01807221|41687862|FG000|Overall Study|Lost to Follow-up|1|||
19440347|NCT01807221|41687863|FG001|Overall Study|Lost to Follow-up|0|||
19440348|NCT01807221|41687864|FG002|Overall Study|Lost to Follow-up|2|||
19440349|NCT01807221|41687865|FG003|Overall Study|Lost to Follow-up|1|||
19440350|NCT01807221|41687866|FG004|Overall Study|Lost to Follow-up|0|||
19440351|NCT01807221|41687867|FG005|Overall Study|Lost to Follow-up|0|||
19440352|NCT01838499|41687883|FG000|Overall Study|Protocol Violation|0|||
19440353|NCT01838499|41687884|FG001|Overall Study|Protocol Violation|1|||
19440354|NCT01838499|41687883|FG000|Overall Study|Lost to Follow-up|2|||
19440355|NCT01838499|41687884|FG001|Overall Study|Lost to Follow-up|4|||
19440356|NCT01838499|41687883|FG000|Overall Study|Lack of Efficacy|1|||
19440357|NCT01838499|41687884|FG001|Overall Study|Lack of Efficacy|2|||
19440358|NCT01838499|41687883|FG000|Overall Study|Adverse Event|2|||
19440359|NCT01838499|41687884|FG001|Overall Study|Adverse Event|1|||
19440360|NCT01838499|41687883|FG000|Overall Study|Withdrawal by Subject|19|||
19440361|NCT01838499|41687884|FG001|Overall Study|Withdrawal by Subject|9|||
19440362|NCT01807065|41687892|FG000|Overall Study|Receive no sip-T due to IV access|1|||
19440363|NCT01807065|41687893|FG001|Overall Study|Receive no sip-T due to IV access|1|||
19440364|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Death|89|||
19440365|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Death|193|||
19440366|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Death|198|||
19440367|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
19440368|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
19440369|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
19440370|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
19440371|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
19440372|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
19440373|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
19440374|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
19440375|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
19440376|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
19440377|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
19440378|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
19440379|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
19440380|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
19440381|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
19440382|NCT02031458|41687906|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
19440383|NCT02031458|41687907|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
19440384|NCT02031458|41687908|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
19440385|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Death|36|||
19440386|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Death|87|||
19440387|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Death|100|||
19440388|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
19440389|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
19440390|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
19440391|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Physician Decision|0|||
19440392|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Physician Decision|1|||
19522247|NCT03635112|41940624|FG002|Overall Study|Study Terminated by Sponsor|21|||
19522248|NCT03635112|41940622|FG000|Overall Study|Withdrawal by Subject|4|||
19711265|NCT03572062|42154396|FG001|Overall Study|Death|0|||
19440393|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Physician Decision|0|||
19440394|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
19440395|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
19440396|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
19440397|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
19440398|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
19440399|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
19440400|NCT02031458|41687906|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
19440401|NCT02031458|41687907|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
19440402|NCT02031458|41687908|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
19440403|NCT02031458|41687906|FG000|Baseline to May 8, 2015|On Treatment|43|||
19440404|NCT02031458|41687907|FG001|Baseline to May 8, 2015|On Treatment|81|||
19440405|NCT02031458|41687908|FG002|Baseline to May 8, 2015|On Treatment|73|||
19440406|NCT02031458|41687906|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
19440407|NCT02031458|41687907|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
19440408|NCT02031458|41687908|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
19440409|NCT02009696|41687918|FG000|Overall Study|Withdrawal by Subject|2|||
19440410|NCT01806597|41687925|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
19440411|NCT01806597|41687926|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
19440412|NCT01806597|41687927|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
19440413|NCT01806597|41687928|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
19440414|NCT01806597|41687929|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
19440415|NCT01806597|41687930|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
19440416|NCT01806597|41687925|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
19440417|NCT01806597|41687926|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
19440418|NCT01806597|41687927|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
19440419|NCT01806597|41687928|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
19440420|NCT01806597|41687929|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
19440421|NCT01806597|41687930|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
19440422|NCT01806597|41687925|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
19440423|NCT01806597|41687926|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
19440424|NCT01806597|41687927|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
19440425|NCT01806597|41687928|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
19440426|NCT01806597|41687929|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
19440427|NCT01806597|41687930|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
19440428|NCT01806597|41687925|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
19440429|NCT01806597|41687926|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
19440430|NCT01806597|41687927|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
19440431|NCT01806597|41687928|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
19440432|NCT01806597|41687929|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
19440433|NCT01806597|41687930|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
19440434|NCT01806597|41687925|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
19440435|NCT01806597|41687926|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
19440436|NCT01806597|41687927|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
19440437|NCT01806597|41687928|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
19440438|NCT01806597|41687929|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
19440439|NCT01806597|41687930|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
19440440|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
19440441|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
19440442|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
19440443|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
19440444|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
19440445|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
19440446|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
19440447|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
19440448|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
19440449|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
19440450|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
19440451|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
19440452|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
19440453|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
19440454|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
19440455|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
19440456|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
19440457|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
19440458|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
19522249|NCT03635112|41940623|FG001|Overall Study|Withdrawal by Subject|9|||
19522250|NCT03635112|41940624|FG002|Overall Study|Withdrawal by Subject|7|||
19522251|NCT03635112|41940622|FG000|Overall Study|Miscellaneous|0|||
19440459|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
19440460|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
19440461|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
19440462|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
19440463|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
19440464|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
19440465|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
19440466|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
19440467|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
19440468|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
19440469|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
19440470|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
19440471|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
19522252|NCT03635112|41940623|FG001|Overall Study|Miscellaneous|0|||
19522253|NCT03635112|41940624|FG002|Overall Study|Miscellaneous|1|||
19522254|NCT03588728|41940637|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
19522255|NCT03588728|41940638|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
19522256|NCT03588728|41940639|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
19522257|NCT03588728|41940640|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
19522258|NCT03588728|41940637|FG000|Overall Study|Lab shut down due to COVID-19|0|||
19522259|NCT03588728|41940638|FG001|Overall Study|Lab shut down due to COVID-19|0|||
19522260|NCT03588728|41940639|FG002|Overall Study|Lab shut down due to COVID-19|0|||
19522261|NCT03588728|41940640|FG003|Overall Study|Lab shut down due to COVID-19|1|||
19522262|NCT03588728|41940637|FG000|Overall Study|multiple technical issues|1|||
19522263|NCT03588728|41940638|FG001|Overall Study|multiple technical issues|0|||
19522264|NCT03588728|41940639|FG002|Overall Study|multiple technical issues|0|||
19522265|NCT03588728|41940640|FG003|Overall Study|multiple technical issues|0|||
19522266|NCT03588728|41940637|FG000|Overall Study|Hospitalized for COVID|1|||
19522267|NCT03588728|41940638|FG001|Overall Study|Hospitalized for COVID|0|||
19522268|NCT03588728|41940639|FG002|Overall Study|Hospitalized for COVID|0|||
19522269|NCT03588728|41940640|FG003|Overall Study|Hospitalized for COVID|0|||
19629027|NCT00644332|42078567|FG000|Overall Study|Completion Status Unknown|2|||
19629028|NCT00644332|42078567|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
19629029|NCT00644332|42078567|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
19629030|NCT00445939|42078574|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
19629031|NCT00445939|42078575|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
19629032|NCT00445939|42078576|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
19629033|NCT00445939|42078577|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
19629034|NCT00445939|42078574|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
19440472|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
19522270|NCT03588728|41940637|FG000|Overall Study|Schedule change unable to attend sessions|1|||
19522271|NCT03588728|41940638|FG001|Overall Study|Schedule change unable to attend sessions|0|||
19522272|NCT03588728|41940639|FG002|Overall Study|Schedule change unable to attend sessions|0|||
19522273|NCT03588728|41940640|FG003|Overall Study|Schedule change unable to attend sessions|0|||
19522274|NCT02987543|41940662|FG000|Overall Study|Ongoing study at data cut off|49|||
19522275|NCT02987543|41940663|FG001|Overall Study|Ongoing study at data cut off|21|||
19522276|NCT02987543|41940664|FG002|Overall Study|Ongoing study at data cut off|19|||
19522277|NCT02987543|41940665|FG003|Overall Study|Ongoing study at data cut off|12|||
19522278|NCT02987543|41940662|FG000|Overall Study|Death|88|||
19522279|NCT02987543|41940663|FG001|Overall Study|Death|54|||
19522280|NCT02987543|41940664|FG002|Overall Study|Death|67|||
19522281|NCT02987543|41940665|FG003|Overall Study|Death|28|||
19522282|NCT02987543|41940662|FG000|Overall Study|Lost to Follow-up|3|||
19440473|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
19440474|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
19440475|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
19440476|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
19440477|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
19522283|NCT02987543|41940663|FG001|Overall Study|Lost to Follow-up|0|||
19522284|NCT02987543|41940664|FG002|Overall Study|Lost to Follow-up|1|||
19522285|NCT02987543|41940665|FG003|Overall Study|Lost to Follow-up|0|||
19629035|NCT00445939|42078575|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
19440478|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
19440479|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
19440480|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
19440481|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
19629036|NCT00445939|42078576|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
19629037|NCT00445939|42078577|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
19629038|NCT00482053|42078597|FG000|Inter-treatment Period|Disease progression|1|||
19440482|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
19440483|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
19440484|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
19440485|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
19440486|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
19440487|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
19440488|NCT01806597|41687925|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
19440489|NCT01806597|41687926|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
19440490|NCT01806597|41687927|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
19440491|NCT01806597|41687928|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
19440492|NCT01806597|41687929|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
19440493|NCT01806597|41687930|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
19440494|NCT01806597|41687925|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
19440495|NCT01806597|41687926|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
19440496|NCT01806597|41687927|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
19440497|NCT01806597|41687928|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
19440498|NCT01806597|41687929|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
19440499|NCT01806597|41687930|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
19440500|NCT01806597|41687925|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
19440501|NCT01806597|41687926|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
19440502|NCT01806597|41687927|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
19440503|NCT01806597|41687928|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
19440504|NCT01806597|41687929|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
19440505|NCT01806597|41687930|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
19440506|NCT01806597|41687925|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
19440507|NCT01806597|41687926|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
19440508|NCT01806597|41687927|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
19440509|NCT01806597|41687928|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
19440510|NCT01806597|41687929|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
19440511|NCT01806597|41687930|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
19440512|NCT01806597|41687925|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
19440513|NCT01806597|41687926|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
19440514|NCT01806597|41687927|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
19440515|NCT01806597|41687928|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
19440516|NCT01806597|41687929|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
19440517|NCT01806597|41687930|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
19440518|NCT01806597|41687925|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
19440519|NCT01806597|41687926|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
19440520|NCT01806597|41687927|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
19440521|NCT01806597|41687928|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
19440522|NCT01806597|41687929|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
19440523|NCT01806597|41687930|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
19440524|NCT02031302|41687946|FG000|Overall Study|Death|115|||
19440525|NCT02031302|41687947|FG001|Overall Study|Death|0|||
19440526|NCT02031302|41687946|FG000|Overall Study|Not treated with study valve system|18|||
19440527|NCT02031302|41687947|FG001|Overall Study|Not treated with study valve system|0|||
19440528|NCT02031302|41687946|FG000|Overall Study|Missed Follow Up|27|||
19440529|NCT02031302|41687947|FG001|Overall Study|Missed Follow Up|0|||
19440530|NCT02031302|41687946|FG000|Overall Study|Lost to Follow-up|4|||
19440531|NCT02031302|41687947|FG001|Overall Study|Lost to Follow-up|0|||
19440532|NCT01610037|41687957|FG000|All Patients|Adverse Event|27|||
19440533|NCT01610037|41687958|FG001|All Patients|Adverse Event|22|||
19440534|NCT01610037|41687959|FG002|All Patients|Adverse Event|26|||
19440535|NCT01610037|41687957|FG000|All Patients|Withdrawal by Subject|12|||
19440536|NCT01610037|41687958|FG001|All Patients|Withdrawal by Subject|10|||
19440537|NCT01610037|41687959|FG002|All Patients|Withdrawal by Subject|20|||
19440538|NCT01610037|41687957|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
19440539|NCT01610037|41687958|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
19440540|NCT01610037|41687959|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
19440541|NCT01610037|41687957|FG000|All Patients|Death|4|||
19440542|NCT01610037|41687958|FG001|All Patients|Death|2|||
19440543|NCT01610037|41687959|FG002|All Patients|Death|1|||
19440544|NCT01610037|41687957|FG000|All Patients|Protocol deviation|4|||
19440545|NCT01610037|41687958|FG001|All Patients|Protocol deviation|3|||
19440546|NCT01610037|41687959|FG002|All Patients|Protocol deviation|3|||
19440547|NCT01610037|41687957|FG000|All Patients|Abnormal laboratory value|1|||
19440548|NCT01610037|41687958|FG001|All Patients|Abnormal laboratory value|1|||
19440549|NCT01610037|41687959|FG002|All Patients|Abnormal laboratory value|0|||
19440550|NCT01610037|41687957|FG000|All Patients|Administrative problems|1|||
19440551|NCT01610037|41687958|FG001|All Patients|Administrative problems|4|||
19440552|NCT01610037|41687959|FG002|All Patients|Administrative problems|4|||
19440553|NCT01610037|41687957|FG000|All Patients|Lost to Follow-up|1|||
19440554|NCT01610037|41687958|FG001|All Patients|Lost to Follow-up|0|||
19440555|NCT01610037|41687959|FG002|All Patients|Lost to Follow-up|0|||
19440556|NCT01610037|41687957|FG000|All Patients|Abnormal test procedure result(s)|0|||
19440557|NCT01610037|41687958|FG001|All Patients|Abnormal test procedure result(s)|1|||
19440558|NCT01610037|41687959|FG002|All Patients|Abnormal test procedure result(s)|3|||
19440559|NCT01610037|41687957|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
19440560|NCT01610037|41687958|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
19440561|NCT01610037|41687959|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
19440562|NCT01610037|41687957|FG000|Treatment and Follow up Period|Death|10|||
19440563|NCT01610037|41687958|FG001|Treatment and Follow up Period|Death|5|||
19440564|NCT01610037|41687959|FG002|Treatment and Follow up Period|Death|4|||
19440565|NCT01610037|41687957|FG000|Treatment and Follow up Period|Administrative problems|1|||
19440566|NCT01610037|41687958|FG001|Treatment and Follow up Period|Administrative problems|3|||
19440567|NCT01610037|41687959|FG002|Treatment and Follow up Period|Administrative problems|2|||
19440568|NCT01610037|41687957|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
19440569|NCT01610037|41687958|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
19440570|NCT01610037|41687959|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
19440571|NCT01806051|41687967|FG000|Overall Study|Withdrawal by Subject|6|||
19440572|NCT01837797|41687976|FG000|Period 1|Adverse Event|9|||
19440573|NCT01837797|41687977|FG001|Period 1|Adverse Event|0|||
19440574|NCT01837797|41687978|FG002|Period 1|Adverse Event|0|||
19440575|NCT01837797|41687979|FG003|Period 1|Adverse Event|0|||
19440576|NCT01837797|41687980|FG004|Period 1|Adverse Event|0|||
19440577|NCT01837797|41687976|FG000|Period 1|Withdrawal by Subject|6|||
19440578|NCT01837797|41687977|FG001|Period 1|Withdrawal by Subject|0|||
19440579|NCT01837797|41687978|FG002|Period 1|Withdrawal by Subject|0|||
19440580|NCT01837797|41687979|FG003|Period 1|Withdrawal by Subject|0|||
19440581|NCT01837797|41687980|FG004|Period 1|Withdrawal by Subject|0|||
19440582|NCT01837797|41687976|FG000|Period 1|Administrative reasons|76|||
19440583|NCT01837797|41687977|FG001|Period 1|Administrative reasons|0|||
19440584|NCT01837797|41687978|FG002|Period 1|Administrative reasons|0|||
19440585|NCT01837797|41687979|FG003|Period 1|Administrative reasons|0|||
19440586|NCT01837797|41687980|FG004|Period 1|Administrative reasons|0|||
19440587|NCT01837797|41687976|FG000|Period 1|Withdrawal of consent before treatment|1|||
19440588|NCT01837797|41687977|FG001|Period 1|Withdrawal of consent before treatment|0|||
19440589|NCT01837797|41687978|FG002|Period 1|Withdrawal of consent before treatment|0|||
19440590|NCT01837797|41687979|FG003|Period 1|Withdrawal of consent before treatment|0|||
19440591|NCT01837797|41687980|FG004|Period 1|Withdrawal of consent before treatment|0|||
19522286|NCT02987543|41940662|FG000|Overall Study|Screen failure|0|||
19522287|NCT02987543|41940663|FG001|Overall Study|Screen failure|0|||
19522288|NCT02987543|41940664|FG002|Overall Study|Screen failure|0|||
19522289|NCT02987543|41940665|FG003|Overall Study|Screen failure|1|||
19522290|NCT02987543|41940662|FG000|Overall Study|Withdrawal by Subject|21|||
19522291|NCT02987543|41940663|FG001|Overall Study|Withdrawal by Subject|7|||
19522292|NCT02987543|41940664|FG002|Overall Study|Withdrawal by Subject|7|||
19522293|NCT02987543|41940665|FG003|Overall Study|Withdrawal by Subject|6|||
19522294|NCT02987543|41940662|FG000|Overall Study|Study terminated by sponsor|1|||
19522295|NCT02987543|41940663|FG001|Overall Study|Study terminated by sponsor|0|||
19522296|NCT02987543|41940664|FG002|Overall Study|Study terminated by sponsor|0|||
19522297|NCT02987543|41940665|FG003|Overall Study|Study terminated by sponsor|0|||
19522298|NCT02987543|41940662|FG000|Overall Study|Investigator decision|0|||
19522299|NCT02987543|41940663|FG001|Overall Study|Investigator decision|1|||
19522300|NCT02987543|41940664|FG002|Overall Study|Investigator decision|0|||
19522301|NCT02987543|41940665|FG003|Overall Study|Investigator decision|0|||
19522302|NCT02987543|41940662|FG000|Overall Study|Disease progression|0|||
19522303|NCT02987543|41940663|FG001|Overall Study|Disease progression|0|||
19522304|NCT02987543|41940664|FG002|Overall Study|Disease progression|0|||
19522305|NCT02987543|41940665|FG003|Overall Study|Disease progression|1|||
19522306|NCT02983045|41940681|FG000|Overall Study|Withdrawal by Subject|0|||
19522307|NCT02983045|41940682|FG001|Overall Study|Withdrawal by Subject|1|||
19522308|NCT02983045|41940683|FG002|Overall Study|Withdrawal by Subject|0|||
19522309|NCT02983045|41940684|FG003|Overall Study|Withdrawal by Subject|5|||
19522310|NCT02983045|41940685|FG004|Overall Study|Withdrawal by Subject|0|||
19440592|NCT01837797|41687976|FG000|Period 1|Other|10|||
19522311|NCT02983045|41940686|FG005|Overall Study|Withdrawal by Subject|72|||
19522312|NCT02983045|41940687|FG006|Overall Study|Withdrawal by Subject|0|||
19522313|NCT02983045|41940688|FG007|Overall Study|Withdrawal by Subject|0|||
19440593|NCT01837797|41687977|FG001|Period 1|Other|0|||
19440594|NCT01837797|41687978|FG002|Period 1|Other|0|||
19440595|NCT01837797|41687979|FG003|Period 1|Other|0|||
19440596|NCT01837797|41687980|FG004|Period 1|Other|0|||
19522314|NCT02983045|41940689|FG008|Overall Study|Withdrawal by Subject|0|||
19522315|NCT02983045|41940690|FG009|Overall Study|Withdrawal by Subject|2|||
19440597|NCT01837797|41687976|FG000|Period 2|Administrative or other reasons|0|||
19440598|NCT01837797|41687977|FG001|Period 2|Administrative or other reasons|5|||
19440599|NCT01837797|41687978|FG002|Period 2|Administrative or other reasons|2|||
19440600|NCT01837797|41687979|FG003|Period 2|Administrative or other reasons|4|||
19440601|NCT01837797|41687980|FG004|Period 2|Administrative or other reasons|0|||
19440602|NCT01837797|41687976|FG000|Period 2|Adverse Event|0|||
19440603|NCT01837797|41687977|FG001|Period 2|Adverse Event|0|||
19440604|NCT01837797|41687978|FG002|Period 2|Adverse Event|0|||
19440605|NCT01837797|41687979|FG003|Period 2|Adverse Event|1|||
19440606|NCT01837797|41687980|FG004|Period 2|Adverse Event|0|||
19440607|NCT01837797|41687976|FG000|Period 3|Adverse Event|0|||
19440608|NCT01837797|41687977|FG001|Period 3|Adverse Event|0|||
19440609|NCT01837797|41687978|FG002|Period 3|Adverse Event|0|||
19440610|NCT01837797|41687979|FG003|Period 3|Adverse Event|0|||
19440611|NCT01837797|41687980|FG004|Period 3|Adverse Event|1|||
19440612|NCT01837797|41687976|FG000|Period 3|Administrative reasons|0|||
19440613|NCT01837797|41687977|FG001|Period 3|Administrative reasons|0|||
19440614|NCT01837797|41687978|FG002|Period 3|Administrative reasons|0|||
19440615|NCT01837797|41687979|FG003|Period 3|Administrative reasons|0|||
19440616|NCT01837797|41687980|FG004|Period 3|Administrative reasons|20|||
19440617|NCT01837797|41687976|FG000|Period 3|Other|0|||
19440618|NCT01837797|41687977|FG001|Period 3|Other|0|||
19440619|NCT01837797|41687978|FG002|Period 3|Other|0|||
19440620|NCT01837797|41687979|FG003|Period 3|Other|0|||
19440621|NCT01837797|41687980|FG004|Period 3|Other|2|||
19440622|NCT01984424|41687990|FG000|Overall Study|Withdrawal by Subject|3|||
19440623|NCT01984424|41687991|FG001|Overall Study|Withdrawal by Subject|5|||
19440624|NCT01984424|41687990|FG000|Overall Study|Sponsor Decision|0|||
19440625|NCT01984424|41687991|FG001|Overall Study|Sponsor Decision|1|||
19440626|NCT01984424|41687990|FG000|Overall Study|Lost to Follow-up|0|||
19440627|NCT01984424|41687991|FG001|Overall Study|Lost to Follow-up|1|||
19440628|NCT01837719|41687997|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
19440629|NCT01837719|41687997|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
19440630|NCT01984268|41688012|FG000|Overall Study|Study Terminated|15|||
19522316|NCT02983045|41940681|FG000|Overall Study|Lost to Follow-up|0|||
19522317|NCT02983045|41940682|FG001|Overall Study|Lost to Follow-up|0|||
19522318|NCT02983045|41940683|FG002|Overall Study|Lost to Follow-up|0|||
19522319|NCT02983045|41940684|FG003|Overall Study|Lost to Follow-up|0|||
19522320|NCT02983045|41940685|FG004|Overall Study|Lost to Follow-up|0|||
19522321|NCT02983045|41940686|FG005|Overall Study|Lost to Follow-up|10|||
19522322|NCT02983045|41940687|FG006|Overall Study|Lost to Follow-up|0|||
19522323|NCT02983045|41940688|FG007|Overall Study|Lost to Follow-up|0|||
19522324|NCT02983045|41940689|FG008|Overall Study|Lost to Follow-up|0|||
19522325|NCT02983045|41940690|FG009|Overall Study|Lost to Follow-up|0|||
19522326|NCT02564263|41940714|FG000|Overall Study|Adverse Event|31|||
19522327|NCT02564263|41940715|FG001|Overall Study|Adverse Event|29|||
19522328|NCT02564263|41940714|FG000|Overall Study|Death|270|||
19522329|NCT02564263|41940715|FG001|Overall Study|Death|262|||
19522330|NCT02564263|41940714|FG000|Overall Study|Withdrawal by Subject|4|||
19522331|NCT02564263|41940715|FG001|Overall Study|Withdrawal by Subject|19|||
19522332|NCT02564263|41940714|FG000|Overall Study|Sponsor's decision|9|||
19522333|NCT02564263|41940715|FG001|Overall Study|Sponsor's decision|4|||
19522334|NCT02379819|41940722|FG000|Overall Study|Withdrawal by Subject|10|||
19522335|NCT02379819|41940722|FG000|Overall Study|Death|2|||
19522336|NCT02379819|41940722|FG000|Overall Study|Lack of Efficacy|1|||
19522337|NCT02379819|41940722|FG000|Overall Study|Lost to Follow-up|1|||
19522338|NCT02368886|41940730|FG000|Overall Study|Cancel|1|||
19522339|NCT02368886|41940731|FG001|Overall Study|Cancel|1|||
19522340|NCT02368886|41940732|FG002|Overall Study|Cancel|1|||
19522341|NCT02368886|41940733|FG003|Overall Study|Cancel|3|||
19522342|NCT02368886|41940730|FG000|Overall Study|Ineligible|0|||
19522343|NCT02368886|41940731|FG001|Overall Study|Ineligible|0|||
19522344|NCT02368886|41940732|FG002|Overall Study|Ineligible|0|||
19522345|NCT02368886|41940733|FG003|Overall Study|Ineligible|1|||
19522346|NCT02231749|41940743|FG000|Overall Study|Disease progression|229|||
19522347|NCT02231749|41940744|FG001|Overall Study|Disease progression|297|||
19522348|NCT02231749|41940743|FG000|Overall Study|Study Drug Toxicity|134|||
19522349|NCT02231749|41940744|FG001|Overall Study|Study Drug Toxicity|63|||
19522350|NCT02231749|41940743|FG000|Overall Study|Death|1|||
19522351|NCT02231749|41940744|FG001|Overall Study|Death|1|||
19440631|NCT02031146|41688018|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
19440632|NCT02031146|41688019|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
19440633|NCT02031146|41688020|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
19440634|NCT02031146|41688021|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
19440635|NCT02031146|41688022|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
19440636|NCT02031146|41688023|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
19522352|NCT02231749|41940743|FG000|Overall Study|AE unrelated to Study drug|32|||
19522353|NCT02231749|41940744|FG001|Overall Study|AE unrelated to Study drug|31|||
19522354|NCT02231749|41940743|FG000|Overall Study|Participant's request to discontinue|10|||
19629039|NCT00455923|42078603|FG000|Overall Study|Pregnancy|0|||
19440637|NCT02031146|41688024|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
19440638|NCT02009384|41688034|FG000|Overall Study|Death|2|||
19440639|NCT01805037|41688038|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
19440640|NCT01805037|41688039|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
19440641|NCT01805037|41688038|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
19440642|NCT01805037|41688039|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
19440643|NCT01805037|41688038|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
19440644|NCT01805037|41688039|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
19440645|NCT01805037|41688038|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
19440646|NCT01805037|41688039|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
19440647|NCT01805037|41688038|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
19440648|NCT01805037|41688039|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
19440649|NCT01805037|41688038|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
19440650|NCT01805037|41688039|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
19440651|NCT01805037|41688038|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
19440652|NCT01805037|41688039|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
19440653|NCT01805037|41688038|FG000|Follow Up (up to 3 Years)|Death|0|||
19440654|NCT01805037|41688039|FG001|Follow Up (up to 3 Years)|Death|2|||
19440655|NCT01805037|41688038|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
19440656|NCT01805037|41688039|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
19440657|NCT01805037|41688038|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
19440658|NCT01805037|41688039|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
19440659|NCT01803711|41688045|FG000|Overall Study|Adverse Event|1|||
19440660|NCT01803711|41688046|FG001|Overall Study|Adverse Event|1|||
19440661|NCT02030834|41688057|FG000|Overall Study|Death|4|||
19440662|NCT02030834|41688058|FG001|Overall Study|Death|0|||
19440663|NCT02030834|41688059|FG002|Overall Study|Death|0|||
19440664|NCT02030834|41688057|FG000|Overall Study|Manufacturing failure|2|||
19440665|NCT02030834|41688058|FG001|Overall Study|Manufacturing failure|0|||
19440666|NCT02030834|41688059|FG002|Overall Study|Manufacturing failure|1|||
19440667|NCT02030834|41688057|FG000|Overall Study|Disease progression|2|||
19440668|NCT02030834|41688058|FG001|Overall Study|Disease progression|0|||
19440669|NCT02030834|41688059|FG002|Overall Study|Disease progression|2|||
19440670|NCT02030834|41688057|FG000|Overall Study|Lost to Follow-up|1|||
19440671|NCT02030834|41688058|FG001|Overall Study|Lost to Follow-up|0|||
19440672|NCT02030834|41688059|FG002|Overall Study|Lost to Follow-up|0|||
19440673|NCT02030834|41688057|FG000|Overall Study|Withdrawal by Subject|1|||
19440674|NCT02030834|41688058|FG001|Overall Study|Withdrawal by Subject|0|||
19440675|NCT02030834|41688059|FG002|Overall Study|Withdrawal by Subject|0|||
19440676|NCT02030834|41688057|FG000|Overall Study|Lack of funding|1|||
19440677|NCT02030834|41688058|FG001|Overall Study|Lack of funding|0|||
19440678|NCT02030834|41688059|FG002|Overall Study|Lack of funding|0|||
19440679|NCT01836549|41688073|FG000|Overall Study|Did not receive study drug|0|||
19440680|NCT01836549|41688074|FG001|Overall Study|Did not receive study drug|0|||
19440681|NCT01836549|41688075|FG002|Overall Study|Did not receive study drug|1|||
19440682|NCT01836549|41688076|FG003|Overall Study|Did not receive study drug|0|||
19440683|NCT01836549|41688077|FG004|Overall Study|Did not receive study drug|0|||
19440684|NCT01836549|41688078|FG005|Overall Study|Did not receive study drug|0|||
19440685|NCT01836549|41688079|FG006|Overall Study|Did not receive study drug|0|||
19440686|NCT01836549|41688073|FG000|Overall Study|Patient declared ineligible|0|||
19440687|NCT01836549|41688074|FG001|Overall Study|Patient declared ineligible|0|||
19440688|NCT01836549|41688075|FG002|Overall Study|Patient declared ineligible|0|||
19440689|NCT01836549|41688076|FG003|Overall Study|Patient declared ineligible|1|||
19440690|NCT01836549|41688077|FG004|Overall Study|Patient declared ineligible|0|||
19440691|NCT01836549|41688078|FG005|Overall Study|Patient declared ineligible|0|||
19440692|NCT01836549|41688079|FG006|Overall Study|Patient declared ineligible|0|||
19440693|NCT01836549|41688073|FG000|Overall Study|Patient inevaluable to start therapy|0|||
19440694|NCT01836549|41688074|FG001|Overall Study|Patient inevaluable to start therapy|0|||
19440695|NCT01836549|41688075|FG002|Overall Study|Patient inevaluable to start therapy|0|||
19440696|NCT01836549|41688076|FG003|Overall Study|Patient inevaluable to start therapy|0|||
19440697|NCT01836549|41688077|FG004|Overall Study|Patient inevaluable to start therapy|0|||
19440698|NCT01836549|41688078|FG005|Overall Study|Patient inevaluable to start therapy|0|||
19440699|NCT01836549|41688079|FG006|Overall Study|Patient inevaluable to start therapy|1|||
19440700|NCT01836471|41688100|FG000|Overall Study|Pregnancy|1|||
19440701|NCT01836471|41688101|FG001|Overall Study|Pregnancy|0|||
19440702|NCT01836471|41688102|FG002|Overall Study|Pregnancy|0|||
19440703|NCT01836471|41688103|FG003|Overall Study|Pregnancy|0|||
19440704|NCT01836471|41688104|FG004|Overall Study|Pregnancy|0|||
19522355|NCT02231749|41940744|FG001|Overall Study|Participant's request to discontinue|21|||
19522356|NCT02231749|41940743|FG000|Overall Study|Participant withdrew Consent|8|||
19440705|NCT01836471|41688100|FG000|Overall Study|Withdrawal by Subject|3|||
19440706|NCT01836471|41688101|FG001|Overall Study|Withdrawal by Subject|4|||
19440707|NCT01836471|41688102|FG002|Overall Study|Withdrawal by Subject|1|||
19440708|NCT01836471|41688103|FG003|Overall Study|Withdrawal by Subject|0|||
19440709|NCT01836471|41688104|FG004|Overall Study|Withdrawal by Subject|2|||
19440710|NCT01836471|41688100|FG000|Overall Study|Physician Decision|0|||
19440711|NCT01836471|41688101|FG001|Overall Study|Physician Decision|1|||
19440712|NCT01836471|41688102|FG002|Overall Study|Physician Decision|0|||
19440713|NCT01836471|41688103|FG003|Overall Study|Physician Decision|0|||
19440714|NCT01836471|41688104|FG004|Overall Study|Physician Decision|0|||
19440715|NCT01836471|41688100|FG000|Overall Study|Lost to Follow-up|0|||
19440716|NCT01836471|41688101|FG001|Overall Study|Lost to Follow-up|0|||
19440717|NCT01836471|41688102|FG002|Overall Study|Lost to Follow-up|0|||
19440718|NCT01836471|41688103|FG003|Overall Study|Lost to Follow-up|1|||
19440719|NCT01836471|41688104|FG004|Overall Study|Lost to Follow-up|1|||
19440720|NCT01836471|41688100|FG000|Overall Study|Adverse Event|6|||
19440721|NCT01836471|41688101|FG001|Overall Study|Adverse Event|3|||
19440722|NCT01836471|41688102|FG002|Overall Study|Adverse Event|1|||
19440723|NCT01836471|41688103|FG003|Overall Study|Adverse Event|1|||
19440724|NCT01836471|41688104|FG004|Overall Study|Adverse Event|2|||
19440725|NCT01836471|41688100|FG000|Overall Study|Non compliance with tx|1|||
19440726|NCT01836471|41688101|FG001|Overall Study|Non compliance with tx|1|||
19440727|NCT01836471|41688102|FG002|Overall Study|Non compliance with tx|0|||
19440728|NCT01836471|41688103|FG003|Overall Study|Non compliance with tx|0|||
19440729|NCT01836471|41688104|FG004|Overall Study|Non compliance with tx|0|||
19522357|NCT02231749|41940744|FG001|Overall Study|Participant withdrew Consent|15|||
19522358|NCT02231749|41940743|FG000|Overall Study|Lost to Follow-up|1|||
19522359|NCT02231749|41940744|FG001|Overall Study|Lost to Follow-up|2|||
19522360|NCT02231749|41940743|FG000|Overall Study|Maximum Clinical Benefit|5|||
19522361|NCT02231749|41940744|FG001|Overall Study|Maximum Clinical Benefit|8|||
19522362|NCT02231749|41940743|FG000|Overall Study|Poor/Non-Compliance|0|||
19522363|NCT02231749|41940744|FG001|Overall Study|Poor/Non-Compliance|3|||
19522364|NCT02231749|41940743|FG000|Overall Study|Pregnancy|1|||
19522365|NCT02231749|41940744|FG001|Overall Study|Pregnancy|0|||
19522366|NCT02231749|41940743|FG000|Overall Study|other|0|||
19522367|NCT02231749|41940744|FG001|Overall Study|other|8|||
19522368|NCT02231749|41940743|FG000|Overall Study|No longer meets Study Criteria|1|||
19522369|NCT02231749|41940744|FG001|Overall Study|No longer meets Study Criteria|0|||
19522370|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
19522371|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
19522372|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
19522373|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
19522374|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
19522375|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
19522376|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
19522377|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
19522378|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
19522379|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
19522380|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
19522381|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
19522382|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
19522383|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
19522384|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
19522385|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
19522386|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
19522387|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
19522388|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
19522389|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
19522390|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
19522391|NCT02227238|41940752|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
19522392|NCT02227238|41940753|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
19522393|NCT02227238|41940754|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
19522394|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
19522395|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
19522396|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
19522397|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
19522398|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
19522399|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
19522400|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
19522401|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
19629040|NCT00455923|42078604|FG001|Overall Study|Pregnancy|2|||
19440730|NCT02030600|41688119|FG000|Treatment Period 1|Adverse Event|5|||
19440731|NCT02030600|41688120|FG001|Treatment Period 1|Adverse Event|7|||
19440732|NCT02030600|41688119|FG000|Treatment Period 1|Lack of Efficacy|0|||
19440733|NCT02030600|41688120|FG001|Treatment Period 1|Lack of Efficacy|1|||
19440734|NCT02030600|41688119|FG000|Treatment Period 1|Lost to Follow-up|11|||
19440735|NCT02030600|41688120|FG001|Treatment Period 1|Lost to Follow-up|3|||
19440736|NCT02030600|41688119|FG000|Treatment Period 1|Protocol Violation|22|||
19440737|NCT02030600|41688120|FG001|Treatment Period 1|Protocol Violation|17|||
19440738|NCT02030600|41688119|FG000|Treatment Period 1|Withdrawal by Subject|13|||
19440739|NCT02030600|41688120|FG001|Treatment Period 1|Withdrawal by Subject|17|||
19440740|NCT02030600|41688119|FG000|Treatment Period 1|Casebook Unsigned|1|||
19440741|NCT02030600|41688120|FG001|Treatment Period 1|Casebook Unsigned|0|||
19440742|NCT02030600|41688119|FG000|Treatment Period 1|Unclassified|1|||
19440743|NCT02030600|41688120|FG001|Treatment Period 1|Unclassified|0|||
19440744|NCT02030600|41688119|FG000|Treatment Period 2|Adverse Event|4|||
19440745|NCT02030600|41688120|FG001|Treatment Period 2|Adverse Event|4|||
19440746|NCT02030600|41688119|FG000|Treatment Period 2|Lack of Efficacy|2|||
19440747|NCT02030600|41688120|FG001|Treatment Period 2|Lack of Efficacy|1|||
19440748|NCT02030600|41688119|FG000|Treatment Period 2|Lost to Follow-up|4|||
19440749|NCT02030600|41688120|FG001|Treatment Period 2|Lost to Follow-up|2|||
19440750|NCT02030600|41688119|FG000|Treatment Period 2|Protocol Violation|1|||
19440751|NCT02030600|41688120|FG001|Treatment Period 2|Protocol Violation|2|||
19440752|NCT02030600|41688119|FG000|Treatment Period 2|Withdrawal by Subject|13|||
19440753|NCT02030600|41688120|FG001|Treatment Period 2|Withdrawal by Subject|9|||
19440754|NCT02030600|41688119|FG000|Treatment Period 2|Unclassified|1|||
19440755|NCT02030600|41688120|FG001|Treatment Period 2|Unclassified|0|||
19440756|NCT01802775|41688130|FG000|Overall Study|Death|0|||
19440757|NCT01802775|41688131|FG001|Overall Study|Death|3|||
19440758|NCT01802775|41688130|FG000|Overall Study|Reason not provided|0|||
19440759|NCT01802775|41688131|FG001|Overall Study|Reason not provided|1|||
19440760|NCT01802775|41688130|FG000|Overall Study|Physician Decision|1|||
19440761|NCT01802775|41688131|FG001|Overall Study|Physician Decision|0|||
19440762|NCT01802775|41688130|FG000|Overall Study|Adverse Event|1|||
19440763|NCT01802775|41688131|FG001|Overall Study|Adverse Event|1|||
19440764|NCT01802775|41688130|FG000|Overall Study|Withdrawal by Subject|3|||
19440765|NCT01802775|41688131|FG001|Overall Study|Withdrawal by Subject|5|||
19440766|NCT01802775|41688130|FG000|Overall Study|Lost to Follow-up|1|||
19440767|NCT01802775|41688131|FG001|Overall Study|Lost to Follow-up|2|||
19440768|NCT01802385|41688139|FG000|Overall Study|Death|106|||
19440769|NCT01802385|41688140|FG001|Overall Study|Death|120|||
19440770|NCT01773993|41688146|FG000|Overall Study|No Visit After Treatment|35|||
19440771|NCT01802073|41688152|FG000|Overall Study|Lost to Follow-up|0|||
19440772|NCT01802073|41688153|FG001|Overall Study|Lost to Follow-up|1|||
19440773|NCT01802073|41688152|FG000|Overall Study|Non-compliant|4|||
19440774|NCT01802073|41688153|FG001|Overall Study|Non-compliant|2|||
19440775|NCT01802073|41688152|FG000|Overall Study|Withdrawal by Subject|1|||
19440776|NCT01802073|41688153|FG001|Overall Study|Withdrawal by Subject|1|||
19440777|NCT01802073|41688152|FG000|Overall Study|Physician Decision|0|||
19440778|NCT01802073|41688153|FG001|Overall Study|Physician Decision|7|||
19440779|NCT01607073|41688159|FG000|Overall Study|Adverse Event|1|||
19440780|NCT01773291|41688169|FG000|Overall Study|Protocol Violation|1|||
19440781|NCT01773291|41688170|FG001|Overall Study|Protocol Violation|0|||
19440782|NCT01773291|41688171|FG002|Overall Study|Protocol Violation|0|||
19440783|NCT01773291|41688169|FG000|Overall Study|Withdrawal by Subject|0|||
19440784|NCT01773291|41688170|FG001|Overall Study|Withdrawal by Subject|0|||
19440785|NCT01773291|41688171|FG002|Overall Study|Withdrawal by Subject|1|||
19440786|NCT01801917|41688184|FG000|Period 1 - Randomized|Adverse Event|1|||
19440787|NCT01801917|41688185|FG001|Period 1 - Randomized|Adverse Event|0|||
19440788|NCT01801917|41688186|FG002|Period 1 - Randomized|Adverse Event|1|||
19440789|NCT01801917|41688187|FG003|Period 1 - Randomized|Adverse Event|0|||
19440790|NCT02008916|41688201|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
19440791|NCT02008916|41688202|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
19440792|NCT02008916|41688203|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
19440793|NCT02008916|41688201|FG000|Week 16 - 156|Adverse Event|4|||
19440794|NCT02008916|41688202|FG001|Week 16 - 156|Adverse Event|2|||
19440795|NCT02008916|41688203|FG002|Week 16 - 156|Adverse Event|3|||
19440796|NCT02008916|41688201|FG000|Week 16 - 156|Withdrawal by Subject|7|||
19440797|NCT02008916|41688202|FG001|Week 16 - 156|Withdrawal by Subject|3|||
19440798|NCT02008916|41688203|FG002|Week 16 - 156|Withdrawal by Subject|5|||
19440799|NCT02008916|41688201|FG000|Week 16 - 156|No longer requires treatment|0|||
19440800|NCT02008916|41688202|FG001|Week 16 - 156|No longer requires treatment|1|||
19440801|NCT02008916|41688203|FG002|Week 16 - 156|No longer requires treatment|0|||
19440802|NCT02008916|41688201|FG000|Week 16 - 156|Lost to Follow-up|5|||
19440803|NCT02008916|41688202|FG001|Week 16 - 156|Lost to Follow-up|0|||
19440804|NCT02008916|41688203|FG002|Week 16 - 156|Lost to Follow-up|0|||
19440805|NCT02008916|41688201|FG000|Week 16 - 156|Lack of Efficacy|3|||
19440806|NCT02008916|41688202|FG001|Week 16 - 156|Lack of Efficacy|5|||
19522402|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
19440807|NCT02008916|41688203|FG002|Week 16 - 156|Lack of Efficacy|2|||
19440808|NCT02008916|41688201|FG000|Week 16 - 156|Pregnancy|0|||
19440809|NCT02008916|41688202|FG001|Week 16 - 156|Pregnancy|1|||
19440810|NCT02008916|41688203|FG002|Week 16 - 156|Pregnancy|0|||
19440811|NCT02008916|41688201|FG000|Week 16 - 156|Physician Decision|0|||
19440812|NCT02008916|41688202|FG001|Week 16 - 156|Physician Decision|1|||
19440813|NCT02008916|41688203|FG002|Week 16 - 156|Physician Decision|0|||
19440814|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
19440815|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
19440816|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
19440817|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
19440818|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
19440819|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
19440820|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
19440821|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
19440822|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
19440823|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
19440824|NCT01772823|41688214|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
19440825|NCT01772823|41688215|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
19440826|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
19440827|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
19440828|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
19440829|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
19440830|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
19440831|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
19440832|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
19440833|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
19440834|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
19440835|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
19440836|NCT01772823|41688214|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
19522403|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
19522404|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
19522405|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
19522406|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
19522407|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
19522408|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
19522409|NCT02227238|41940752|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
19522410|NCT02227238|41940753|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
19522411|NCT02227238|41940754|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
19522412|NCT02126969|41940775|FG000|Overall Study|Withdrawal by Subject|1|||
19522413|NCT02126969|41940776|FG001|Overall Study|Withdrawal by Subject|2|||
19522414|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
19522415|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
19522416|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
19522417|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
19522418|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
19522419|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
19522420|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
19522421|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
19522422|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
19522423|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
19522424|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
19522425|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
19522426|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
19522427|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
19522428|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
19522429|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
19522430|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
19522431|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
19522432|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
19522433|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
19522434|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
19522435|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
19522436|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
19522437|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
19522438|NCT01715285|41940784|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
19522439|NCT01715285|41940785|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
19522440|NCT01715285|41940786|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
19522441|NCT01715285|41940784|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
19440837|NCT01772823|41688215|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
19440838|NCT01772823|41688214|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
19440839|NCT01772823|41688215|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
19440840|NCT01772823|41688214|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
19440841|NCT01772823|41688215|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
19440842|NCT01772823|41688214|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
19440843|NCT01772823|41688215|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
19440844|NCT01772823|41688214|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
19440845|NCT01772823|41688215|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
19440846|NCT02029976|41688228|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
19440847|NCT02029976|41688229|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
19440848|NCT02029976|41688228|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
19440849|NCT02029976|41688229|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
19440850|NCT02029976|41688228|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
19440851|NCT02029976|41688229|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
19440852|NCT02029976|41688228|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
19440853|NCT02029976|41688229|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
19440854|NCT01983254|41688237|FG000|Overall Study|Death|6|||
19440855|NCT01983254|41688238|FG001|Overall Study|Death|6|||
19440856|NCT01983254|41688237|FG000|Overall Study|Lost to Follow-up|17|||
19440857|NCT01983254|41688238|FG001|Overall Study|Lost to Follow-up|16|||
19440858|NCT01983254|41688237|FG000|Overall Study|too ill|11|||
19440859|NCT01983254|41688238|FG001|Overall Study|too ill|8|||
19440860|NCT01771809|41688246|FG000|Overall Study|Adverse Event|4|||
19440861|NCT01771809|41688247|FG001|Overall Study|Adverse Event|12|||
19440862|NCT01771809|41688246|FG000|Overall Study|Protocol Violation|0|||
19440863|NCT01771809|41688247|FG001|Overall Study|Protocol Violation|1|||
19440864|NCT01771809|41688246|FG000|Overall Study|Withdrawal by Subject|34|||
19440865|NCT01771809|41688247|FG001|Overall Study|Withdrawal by Subject|42|||
19440866|NCT01771809|41688246|FG000|Overall Study|Lost to Follow-up|1|||
19440867|NCT01771809|41688247|FG001|Overall Study|Lost to Follow-up|3|||
19440868|NCT01771809|41688246|FG000|Overall Study|Other (Insufficient clinical response)|22|||
19440869|NCT01771809|41688247|FG001|Overall Study|Other (Insufficient clinical response)|20|||
19440870|NCT01771809|41688246|FG000|Overall Study|Death|1|||
19440871|NCT01771809|41688247|FG001|Overall Study|Death|0|||
19440872|NCT01771809|41688246|FG000|Overall Study|Other (other)|9|||
19440873|NCT01771809|41688247|FG001|Overall Study|Other (other)|5|||
19440874|NCT01771731|41688255|FG000|Overall Study|Physician Decision|1|||
19440875|NCT01771731|41688256|FG001|Overall Study|Physician Decision|0|||
19440876|NCT01771731|41688255|FG000|Overall Study|Protocol Violation|0|||
19440877|NCT01771731|41688256|FG001|Overall Study|Protocol Violation|1|||
19440878|NCT01771731|41688255|FG000|Overall Study|Adverse event: Pain Crisis|1|||
19440879|NCT01771731|41688256|FG001|Overall Study|Adverse event: Pain Crisis|1|||
19440880|NCT01982942|41688264|FG000|Overall Study|Adverse Event|10|||
19440881|NCT01982942|41688265|FG001|Overall Study|Adverse Event|5|||
19440882|NCT01982942|41688264|FG000|Overall Study|Lost to Follow-up|4|||
19440883|NCT01982942|41688265|FG001|Overall Study|Lost to Follow-up|3|||
19440884|NCT01982942|41688264|FG000|Overall Study|Multiple sclerosis progression|3|||
19440885|NCT01982942|41688265|FG001|Overall Study|Multiple sclerosis progression|2|||
19440886|NCT01982942|41688264|FG000|Overall Study|Wanted to try therapy not permitted|1|||
19440887|NCT01982942|41688265|FG001|Overall Study|Wanted to try therapy not permitted|0|||
19440888|NCT01982942|41688264|FG000|Overall Study|Subject declined future visits|0|||
19440889|NCT01982942|41688265|FG001|Overall Study|Subject declined future visits|1|||
19440890|NCT01982942|41688264|FG000|Overall Study|Left geographical area|2|||
19440891|NCT01982942|41688265|FG001|Overall Study|Left geographical area|0|||
19440892|NCT01982942|41688264|FG000|Overall Study|Too many pills|1|||
19440893|NCT01982942|41688265|FG001|Overall Study|Too many pills|0|||
19440894|NCT01982942|41688264|FG000|Overall Study|MS Relapse|0|||
19440895|NCT01982942|41688265|FG001|Overall Study|MS Relapse|1|||
19440896|NCT01982942|41688264|FG000|Overall Study|Chose to join a stem cell trial|0|||
19440897|NCT01982942|41688265|FG001|Overall Study|Chose to join a stem cell trial|1|||
19440898|NCT01982942|41688264|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
19440899|NCT01982942|41688265|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
19440900|NCT01769469|41688271|FG000|Overall Study|Consent Withdrawn|5|||
19440901|NCT01769469|41688271|FG000|Overall Study|Moved Out Of Area|3|||
19440902|NCT01769469|41688271|FG000|Overall Study|Lost to Follow-up|17|||
19440903|NCT01769469|41688271|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
19440904|NCT01769469|41688271|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
19440905|NCT02008526|41688280|FG000|Overall Study|Death|0|||
19440906|NCT02008526|41688281|FG001|Overall Study|Death|2|||
19440907|NCT02008526|41688282|FG002|Overall Study|Death|1|||
19440908|NCT02008526|41688280|FG000|Overall Study|Withdrawal by Subject|3|||
19440909|NCT02008526|41688281|FG001|Overall Study|Withdrawal by Subject|3|||
19440910|NCT02008526|41688282|FG002|Overall Study|Withdrawal by Subject|2|||
19440911|NCT02008526|41688280|FG000|Overall Study|Lost to Follow-up|5|||
19440912|NCT02008526|41688281|FG001|Overall Study|Lost to Follow-up|9|||
19440913|NCT02008526|41688282|FG002|Overall Study|Lost to Follow-up|6|||
19440914|NCT01769391|41688292|FG000|Overall Study|Death|10|||
19440915|NCT01769391|41688293|FG001|Overall Study|Death|1|||
19440916|NCT01769391|41688292|FG000|Overall Study|Adverse Event|0|||
19440917|NCT01769391|41688293|FG001|Overall Study|Adverse Event|3|||
19440918|NCT01769391|41688292|FG000|Overall Study|Progressive Disease|1|||
19440919|NCT01769391|41688293|FG001|Overall Study|Progressive Disease|2|||
19440920|NCT01769391|41688292|FG000|Overall Study|Withdrawal by Subject|4|||
19440921|NCT01769391|41688293|FG001|Overall Study|Withdrawal by Subject|3|||
19440922|NCT01769391|41688292|FG000|Overall Study|Investigator Decision|2|||
19440923|NCT01769391|41688293|FG001|Overall Study|Investigator Decision|0|||
19440924|NCT01800903|41688305|FG000|Second Test Period|unable to catheterise|1|||
19440925|NCT01800903|41688306|FG001|Second Test Period|unable to catheterise|0|||
19440926|NCT01800903|41688307|FG002|Second Test Period|unable to catheterise|0|||
19440927|NCT01800903|41688308|FG003|Second Test Period|unable to catheterise|0|||
19440928|NCT01800903|41688309|FG004|Second Test Period|unable to catheterise|0|||
19440929|NCT01800903|41688310|FG005|Second Test Period|unable to catheterise|0|||
19440930|NCT01767987|41688318|FG000|Overall Study|Physician Decision|4|||
19440931|NCT01767987|41688319|FG001|Overall Study|Physician Decision|1|||
19440932|NCT01800201|41688327|FG000|Overall Study|Withdrawal by Subject|2|||
19440933|NCT01800201|41688328|FG001|Overall Study|Withdrawal by Subject|0|||
19440934|NCT01800201|41688327|FG000|Overall Study|patient privacy concerns|1|||
19440935|NCT01800201|41688328|FG001|Overall Study|patient privacy concerns|1|||
19440936|NCT01800201|41688327|FG000|Overall Study|did not want to use device|0|||
19440937|NCT01800201|41688328|FG001|Overall Study|did not want to use device|1|||
19440938|NCT01800201|41688327|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
19440939|NCT01800201|41688328|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
19440940|NCT01767909|41688337|FG000|Overall Study|Withdrawal by Subject|4|||
19440941|NCT01767909|41688338|FG001|Overall Study|Withdrawal by Subject|7|||
19440942|NCT01767909|41688337|FG000|Overall Study|Adverse Event|3|||
19440943|NCT01767909|41688338|FG001|Overall Study|Adverse Event|1|||
19440944|NCT01767909|41688337|FG000|Overall Study|Withdrawal by Study Partner|3|||
19522442|NCT01715285|41940785|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
19522443|NCT01715285|41940786|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
19522444|NCT01715285|41940784|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
19522445|NCT01715285|41940785|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
19522446|NCT01715285|41940786|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
19522447|NCT01715285|41940784|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
19711266|NCT03572062|42154397|FG002|Overall Study|Death|0|||
19711267|NCT03572062|42154398|FG003|Overall Study|Death|0|||
19711268|NCT03572062|42154399|FG004|Overall Study|Death|0|||
19711269|NCT03572062|42154400|FG005|Overall Study|Death|1|||
19711270|NCT03572062|42154401|FG006|Overall Study|Death|0|||
19711271|NCT03572062|42154402|FG007|Overall Study|Death|0|||
19711272|NCT03572062|42154403|FG008|Overall Study|Death|0|||
19522448|NCT01715285|41940785|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
19522449|NCT01715285|41940786|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
19522450|NCT01715285|41940784|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
19522451|NCT01715285|41940785|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
19522452|NCT01715285|41940786|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
19522453|NCT01715285|41940784|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
19522454|NCT01715285|41940785|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
19522455|NCT01715285|41940786|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
19522456|NCT01250496|41940795|FG000|Overall Study|Study terminated|124|||
19522457|NCT01250496|41940796|FG001|Overall Study|Study terminated|124|||
19522458|NCT01105975|41940812|FG000|Overall Study|Adverse Event|2|||
19522459|NCT01105975|41940813|FG001|Overall Study|Adverse Event|1|||
19522460|NCT01105975|41940814|FG002|Overall Study|Adverse Event|5|||
19522461|NCT01105975|41940815|FG003|Overall Study|Adverse Event|1|||
19522462|NCT01105975|41940816|FG004|Overall Study|Adverse Event|0|||
19522463|NCT01105975|41940817|FG005|Overall Study|Adverse Event|1|||
19522464|NCT01105975|41940818|FG006|Overall Study|Adverse Event|2|||
19522465|NCT01105975|41940819|FG007|Overall Study|Adverse Event|4|||
19522466|NCT01105975|41940820|FG008|Overall Study|Adverse Event|1|||
19522467|NCT01105975|41940821|FG009|Overall Study|Adverse Event|4|||
19711273|NCT03572062|42154404|FG009|Overall Study|Death|0|||
19711274|NCT03572062|42154395|FG000|Overall Study|Lost to Follow-up|0|||
19711275|NCT03572062|42154396|FG001|Overall Study|Lost to Follow-up|0|||
19711276|NCT03572062|42154397|FG002|Overall Study|Lost to Follow-up|0|||
19711277|NCT03572062|42154398|FG003|Overall Study|Lost to Follow-up|0|||
19440945|NCT01767909|41688338|FG001|Overall Study|Withdrawal by Study Partner|1|||
19522468|NCT01105975|41940812|FG000|Overall Study|Withdrawal by Subject|2|||
19522469|NCT01105975|41940813|FG001|Overall Study|Withdrawal by Subject|2|||
19522470|NCT01105975|41940814|FG002|Overall Study|Withdrawal by Subject|2|||
19522471|NCT01105975|41940815|FG003|Overall Study|Withdrawal by Subject|0|||
19711278|NCT03572062|42154399|FG004|Overall Study|Lost to Follow-up|0|||
19440946|NCT01767909|41688337|FG000|Overall Study|Non-Compliance|2|||
19440947|NCT01767909|41688338|FG001|Overall Study|Non-Compliance|0|||
19440948|NCT01767909|41688337|FG000|Overall Study|Perceived Lack of Efficacy|1|||
19440949|NCT01767909|41688338|FG001|Overall Study|Perceived Lack of Efficacy|0|||
19440950|NCT01767909|41688337|FG000|Overall Study|Investigator Recommendation|0|||
19440951|NCT01767909|41688338|FG001|Overall Study|Investigator Recommendation|1|||
19440952|NCT01767909|41688337|FG000|Overall Study|Lost to Follow-up|0|||
19440953|NCT01767909|41688338|FG001|Overall Study|Lost to Follow-up|1|||
19440954|NCT01767909|41688337|FG000|Overall Study|LP uncessessful|0|||
19440955|NCT01767909|41688338|FG001|Overall Study|LP uncessessful|1|||
19440956|NCT02029274|41688350|FG000|Overall Study|Adverse Event|1|||
19440957|NCT02029274|41688351|FG001|Overall Study|Adverse Event|0|||
19440958|NCT02029274|41688352|FG002|Overall Study|Adverse Event|2|||
19440959|NCT02029274|41688353|FG003|Overall Study|Adverse Event|2|||
19440960|NCT02008370|41688367|FG000|Overall Study|Lost to Follow-up|7|||
19440961|NCT01981616|41688373|FG000|Overall Study|Adverse Event|0|||
19440962|NCT01981616|41688374|FG001|Overall Study|Adverse Event|1|||
19440963|NCT01981616|41688373|FG000|Overall Study|Protocol Violation|1|||
19440964|NCT01981616|41688374|FG001|Overall Study|Protocol Violation|0|||
19440965|NCT02104817|41688382|FG000|Overall Study|Death|363|||
19440966|NCT02104817|41688383|FG001|Overall Study|Death|330|||
19440967|NCT02104817|41688382|FG000|Overall Study|Lost to Follow-up|3|||
19440968|NCT02104817|41688383|FG001|Overall Study|Lost to Follow-up|2|||
19440969|NCT02104817|41688382|FG000|Overall Study|Protocol Violation|0|||
19440970|NCT02104817|41688383|FG001|Overall Study|Protocol Violation|1|||
19440971|NCT02104817|41688382|FG000|Overall Study|Study terminated by sponsor|5854|||
19440972|NCT02104817|41688383|FG001|Overall Study|Study terminated by sponsor|5901|||
19440973|NCT02104817|41688382|FG000|Overall Study|Withdrawal by Subject|111|||
19440974|NCT02104817|41688383|FG001|Overall Study|Withdrawal by Subject|78|||
19440975|NCT02104817|41688382|FG000|Overall Study|Other reasons|128|||
19440976|NCT02104817|41688383|FG001|Overall Study|Other reasons|135|||
19440977|NCT01962103|41688398|FG000|Phase 1|Adverse Event|4|||
19440978|NCT01962103|41688399|FG001|Phase 1|Adverse Event|0|||
19440979|NCT01962103|41688400|FG002|Phase 1|Adverse Event|2|||
19440980|NCT01962103|41688401|FG003|Phase 1|Adverse Event|1|||
19440981|NCT01962103|41688402|FG004|Phase 1|Adverse Event|2|||
19440982|NCT01962103|41688403|FG005|Phase 1|Adverse Event|2|||
19440983|NCT01962103|41688404|FG006|Phase 1|Adverse Event|0|||
19440984|NCT01962103|41688405|FG007|Phase 1|Adverse Event|0|||
19440985|NCT01962103|41688406|FG008|Phase 1|Adverse Event|0|||
19440986|NCT01962103|41688398|FG000|Phase 1|Progressive Disease|8|||
19440987|NCT01962103|41688399|FG001|Phase 1|Progressive Disease|6|||
19440988|NCT01962103|41688400|FG002|Phase 1|Progressive Disease|8|||
19440989|NCT01962103|41688401|FG003|Phase 1|Progressive Disease|4|||
19440990|NCT01962103|41688402|FG004|Phase 1|Progressive Disease|5|||
19440991|NCT01962103|41688403|FG005|Phase 1|Progressive Disease|4|||
19440992|NCT01962103|41688404|FG006|Phase 1|Progressive Disease|0|||
19440993|NCT01962103|41688405|FG007|Phase 1|Progressive Disease|0|||
19440994|NCT01962103|41688406|FG008|Phase 1|Progressive Disease|0|||
19440995|NCT01962103|41688398|FG000|Phase 1|Withdrawal by Subject|0|||
19440996|NCT01962103|41688399|FG001|Phase 1|Withdrawal by Subject|0|||
19440997|NCT01962103|41688400|FG002|Phase 1|Withdrawal by Subject|0|||
19440998|NCT01962103|41688401|FG003|Phase 1|Withdrawal by Subject|2|||
19440999|NCT01962103|41688402|FG004|Phase 1|Withdrawal by Subject|0|||
19441000|NCT01962103|41688403|FG005|Phase 1|Withdrawal by Subject|0|||
19441001|NCT01962103|41688404|FG006|Phase 1|Withdrawal by Subject|0|||
19441002|NCT01962103|41688405|FG007|Phase 1|Withdrawal by Subject|0|||
19441003|NCT01962103|41688406|FG008|Phase 1|Withdrawal by Subject|0|||
19441004|NCT01962103|41688398|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
19441005|NCT01962103|41688399|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
19441006|NCT01962103|41688400|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
19441007|NCT01962103|41688401|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
19441008|NCT01962103|41688402|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
19441009|NCT01962103|41688403|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
19441010|NCT01962103|41688404|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
19441011|NCT01962103|41688405|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
19441012|NCT01962103|41688406|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
19441013|NCT01962103|41688398|FG000|Phase 1|Physician Decision|0|||
19441014|NCT01962103|41688399|FG001|Phase 1|Physician Decision|0|||
19441015|NCT01962103|41688400|FG002|Phase 1|Physician Decision|0|||
19441016|NCT01962103|41688401|FG003|Phase 1|Physician Decision|1|||
19441017|NCT01962103|41688402|FG004|Phase 1|Physician Decision|0|||
19441018|NCT01962103|41688403|FG005|Phase 1|Physician Decision|0|||
19441019|NCT01962103|41688404|FG006|Phase 1|Physician Decision|0|||
19441020|NCT01962103|41688405|FG007|Phase 1|Physician Decision|0|||
19441021|NCT01962103|41688406|FG008|Phase 1|Physician Decision|0|||
19441022|NCT01962103|41688398|FG000|Phase 1|Symptomatic Deterioration|3|||
19441023|NCT01962103|41688399|FG001|Phase 1|Symptomatic Deterioration|2|||
19441024|NCT01962103|41688400|FG002|Phase 1|Symptomatic Deterioration|2|||
19441025|NCT01962103|41688401|FG003|Phase 1|Symptomatic Deterioration|2|||
19441026|NCT01962103|41688402|FG004|Phase 1|Symptomatic Deterioration|1|||
19441027|NCT01962103|41688403|FG005|Phase 1|Symptomatic Deterioration|1|||
19441028|NCT01962103|41688404|FG006|Phase 1|Symptomatic Deterioration|0|||
19441029|NCT01962103|41688405|FG007|Phase 1|Symptomatic Deterioration|0|||
19441030|NCT01962103|41688406|FG008|Phase 1|Symptomatic Deterioration|0|||
19441031|NCT01962103|41688398|FG000|Phase 1|Miscellaneous|1|||
19441032|NCT01962103|41688399|FG001|Phase 1|Miscellaneous|0|||
19441033|NCT01962103|41688400|FG002|Phase 1|Miscellaneous|0|||
19441034|NCT01962103|41688401|FG003|Phase 1|Miscellaneous|0|||
19441035|NCT01962103|41688402|FG004|Phase 1|Miscellaneous|0|||
19441036|NCT01962103|41688403|FG005|Phase 1|Miscellaneous|0|||
19441037|NCT01962103|41688404|FG006|Phase 1|Miscellaneous|0|||
19441038|NCT01962103|41688405|FG007|Phase 1|Miscellaneous|0|||
19441039|NCT01962103|41688406|FG008|Phase 1|Miscellaneous|0|||
19441040|NCT01962103|41688398|FG000|Phase 2|Adverse Event|0|||
19441041|NCT01962103|41688399|FG001|Phase 2|Adverse Event|0|||
19441042|NCT01962103|41688400|FG002|Phase 2|Adverse Event|0|||
19441043|NCT01962103|41688401|FG003|Phase 2|Adverse Event|0|||
19441044|NCT01962103|41688402|FG004|Phase 2|Adverse Event|0|||
19441045|NCT01962103|41688403|FG005|Phase 2|Adverse Event|0|||
19441046|NCT01962103|41688404|FG006|Phase 2|Adverse Event|1|||
19441047|NCT01962103|41688405|FG007|Phase 2|Adverse Event|0|||
19441048|NCT01962103|41688406|FG008|Phase 2|Adverse Event|3|||
19441049|NCT01962103|41688398|FG000|Phase 2|Progressive Disease|0|||
19441050|NCT01962103|41688399|FG001|Phase 2|Progressive Disease|0|||
19441051|NCT01962103|41688400|FG002|Phase 2|Progressive Disease|0|||
19441052|NCT01962103|41688401|FG003|Phase 2|Progressive Disease|0|||
19441053|NCT01962103|41688402|FG004|Phase 2|Progressive Disease|0|||
19441054|NCT01962103|41688403|FG005|Phase 2|Progressive Disease|0|||
19441055|NCT01962103|41688404|FG006|Phase 2|Progressive Disease|11|||
19441056|NCT01962103|41688405|FG007|Phase 2|Progressive Disease|12|||
19441057|NCT01962103|41688406|FG008|Phase 2|Progressive Disease|11|||
19441058|NCT01962103|41688398|FG000|Phase 2|Symptomatic Deterioration|0|||
19522472|NCT01105975|41940816|FG004|Overall Study|Withdrawal by Subject|4|||
19522473|NCT01105975|41940817|FG005|Overall Study|Withdrawal by Subject|1|||
19522474|NCT01105975|41940818|FG006|Overall Study|Withdrawal by Subject|2|||
19522475|NCT01105975|41940819|FG007|Overall Study|Withdrawal by Subject|1|||
19522476|NCT01105975|41940820|FG008|Overall Study|Withdrawal by Subject|0|||
19522477|NCT01105975|41940821|FG009|Overall Study|Withdrawal by Subject|3|||
19522478|NCT01105975|41940812|FG000|Overall Study|Lost to Follow-up|1|||
19522479|NCT01105975|41940813|FG001|Overall Study|Lost to Follow-up|0|||
19522480|NCT01105975|41940814|FG002|Overall Study|Lost to Follow-up|0|||
19522481|NCT01105975|41940815|FG003|Overall Study|Lost to Follow-up|1|||
19522482|NCT01105975|41940816|FG004|Overall Study|Lost to Follow-up|1|||
19522483|NCT01105975|41940817|FG005|Overall Study|Lost to Follow-up|0|||
19522484|NCT01105975|41940818|FG006|Overall Study|Lost to Follow-up|0|||
19522485|NCT01105975|41940819|FG007|Overall Study|Lost to Follow-up|0|||
19522486|NCT01105975|41940820|FG008|Overall Study|Lost to Follow-up|1|||
19522487|NCT01105975|41940821|FG009|Overall Study|Lost to Follow-up|0|||
19522488|NCT01105975|41940812|FG000|Overall Study|Physician Decision|0|||
19522489|NCT01105975|41940813|FG001|Overall Study|Physician Decision|0|||
19522490|NCT01105975|41940814|FG002|Overall Study|Physician Decision|0|||
19522491|NCT01105975|41940815|FG003|Overall Study|Physician Decision|0|||
19522492|NCT01105975|41940816|FG004|Overall Study|Physician Decision|0|||
19522493|NCT01105975|41940817|FG005|Overall Study|Physician Decision|0|||
19522494|NCT01105975|41940818|FG006|Overall Study|Physician Decision|2|||
19522495|NCT01105975|41940819|FG007|Overall Study|Physician Decision|0|||
19522496|NCT01105975|41940820|FG008|Overall Study|Physician Decision|0|||
19522497|NCT01105975|41940821|FG009|Overall Study|Physician Decision|0|||
19522498|NCT01105975|41940812|FG000|Overall Study|Protocol Violation|0|||
19522499|NCT01105975|41940813|FG001|Overall Study|Protocol Violation|2|||
19522500|NCT01105975|41940814|FG002|Overall Study|Protocol Violation|2|||
19522501|NCT01105975|41940815|FG003|Overall Study|Protocol Violation|0|||
19441059|NCT01962103|41688399|FG001|Phase 2|Symptomatic Deterioration|0|||
19441060|NCT01962103|41688400|FG002|Phase 2|Symptomatic Deterioration|0|||
19441061|NCT01962103|41688401|FG003|Phase 2|Symptomatic Deterioration|0|||
19441062|NCT01962103|41688402|FG004|Phase 2|Symptomatic Deterioration|0|||
19441063|NCT01962103|41688403|FG005|Phase 2|Symptomatic Deterioration|0|||
19441064|NCT01962103|41688404|FG006|Phase 2|Symptomatic Deterioration|2|||
19441065|NCT01962103|41688405|FG007|Phase 2|Symptomatic Deterioration|2|||
19441066|NCT01962103|41688406|FG008|Phase 2|Symptomatic Deterioration|0|||
19441067|NCT01961323|41688426|FG000|Overall Study|Withdrawal by Subject|7|||
19441068|NCT01961323|41688426|FG000|Overall Study|Lost to Follow-up|8|||
19441069|NCT01961323|41688426|FG000|Overall Study|screen failure|34|||
19441070|NCT01960855|41688435|FG000|Overall Study|Subject noncompliant|1|||
19441071|NCT01960855|41688436|FG001|Overall Study|Subject noncompliant|0|||
19441072|NCT01960855|41688437|FG002|Overall Study|Subject noncompliant|0|||
19522502|NCT01105975|41940816|FG004|Overall Study|Protocol Violation|1|||
19522503|NCT01105975|41940817|FG005|Overall Study|Protocol Violation|1|||
19522504|NCT01105975|41940818|FG006|Overall Study|Protocol Violation|1|||
19522505|NCT01105975|41940819|FG007|Overall Study|Protocol Violation|1|||
19522506|NCT01105975|41940820|FG008|Overall Study|Protocol Violation|2|||
19441073|NCT01960855|41688438|FG003|Overall Study|Subject noncompliant|0|||
19441074|NCT01960855|41688439|FG004|Overall Study|Subject noncompliant|0|||
19441075|NCT01960855|41688435|FG000|Overall Study|Adverse Event|2|||
19441076|NCT01960855|41688436|FG001|Overall Study|Adverse Event|0|||
19441077|NCT01960855|41688437|FG002|Overall Study|Adverse Event|6|||
19441078|NCT01960855|41688438|FG003|Overall Study|Adverse Event|2|||
19441079|NCT01960855|41688439|FG004|Overall Study|Adverse Event|2|||
19441080|NCT01960855|41688435|FG000|Overall Study|Lack of Efficacy|1|||
19441081|NCT01960855|41688436|FG001|Overall Study|Lack of Efficacy|1|||
19441082|NCT01960855|41688437|FG002|Overall Study|Lack of Efficacy|0|||
19441083|NCT01960855|41688438|FG003|Overall Study|Lack of Efficacy|0|||
19441084|NCT01960855|41688439|FG004|Overall Study|Lack of Efficacy|0|||
19441085|NCT01960855|41688435|FG000|Overall Study|Other|2|||
19441086|NCT01960855|41688436|FG001|Overall Study|Other|1|||
19441087|NCT01960855|41688437|FG002|Overall Study|Other|1|||
19441088|NCT01960855|41688438|FG003|Overall Study|Other|1|||
19441089|NCT01960855|41688439|FG004|Overall Study|Other|0|||
19441090|NCT01960855|41688435|FG000|Overall Study|Consent withdrawn by subject|3|||
19441091|NCT01960855|41688436|FG001|Overall Study|Consent withdrawn by subject|1|||
19441092|NCT01960855|41688437|FG002|Overall Study|Consent withdrawn by subject|2|||
19441093|NCT01960855|41688438|FG003|Overall Study|Consent withdrawn by subject|1|||
19441094|NCT01960855|41688439|FG004|Overall Study|Consent withdrawn by subject|1|||
19441095|NCT01960855|41688435|FG000|Overall Study|Lost to Follow-up|2|||
19441096|NCT01960855|41688436|FG001|Overall Study|Lost to Follow-up|1|||
19441097|NCT01960855|41688437|FG002|Overall Study|Lost to Follow-up|0|||
19441098|NCT01960855|41688438|FG003|Overall Study|Lost to Follow-up|0|||
19441099|NCT01960855|41688439|FG004|Overall Study|Lost to Follow-up|2|||
19441100|NCT02007434|41688459|FG000|Overall Study|Lost to Follow-up|0|||
19441101|NCT02007434|41688460|FG001|Overall Study|Lost to Follow-up|1|||
19441102|NCT02007434|41688461|FG002|Overall Study|Lost to Follow-up|0|||
19441103|NCT02007434|41688462|FG003|Overall Study|Lost to Follow-up|0|||
19441104|NCT02007434|41688463|FG004|Overall Study|Lost to Follow-up|0|||
19441105|NCT02007434|41688464|FG005|Overall Study|Lost to Follow-up|0|||
19441106|NCT02007434|41688465|FG006|Overall Study|Lost to Follow-up|0|||
19441107|NCT02007434|41688466|FG007|Overall Study|Lost to Follow-up|0|||
19441108|NCT02007434|41688459|FG000|Overall Study|Non-compliance|1|||
19441109|NCT02007434|41688460|FG001|Overall Study|Non-compliance|0|||
19441110|NCT02007434|41688461|FG002|Overall Study|Non-compliance|1|||
19441111|NCT02007434|41688462|FG003|Overall Study|Non-compliance|0|||
19441112|NCT02007434|41688463|FG004|Overall Study|Non-compliance|0|||
19441113|NCT02007434|41688464|FG005|Overall Study|Non-compliance|0|||
19441114|NCT02007434|41688465|FG006|Overall Study|Non-compliance|0|||
19441115|NCT02007434|41688466|FG007|Overall Study|Non-compliance|0|||
19441116|NCT01987453|41688488|FG000|Overall Study|Death|0|||
19441117|NCT01987453|41688489|FG001|Overall Study|Death|0|||
19441118|NCT01987453|41688490|FG002|Overall Study|Death|1|||
19441119|NCT01987453|41688488|FG000|Overall Study|Lack of Efficacy|1|||
19441120|NCT01987453|41688489|FG001|Overall Study|Lack of Efficacy|12|||
19441121|NCT01987453|41688490|FG002|Overall Study|Lack of Efficacy|0|||
19441122|NCT02006641|41688505|FG000|Overall Study|Withdrawal before treatment|2|||
19441123|NCT02006641|41688506|FG001|Overall Study|Withdrawal before treatment|5|||
19441124|NCT02006641|41688507|FG002|Overall Study|Withdrawal before treatment|3|||
19441125|NCT02006641|41688505|FG000|Overall Study|Adverse Event|15|||
19441126|NCT02006641|41688506|FG001|Overall Study|Adverse Event|11|||
19441127|NCT02006641|41688507|FG002|Overall Study|Adverse Event|15|||
19441128|NCT02006641|41688505|FG000|Overall Study|Protocol Violation|0|||
19441129|NCT02006641|41688506|FG001|Overall Study|Protocol Violation|2|||
19441130|NCT02006641|41688507|FG002|Overall Study|Protocol Violation|2|||
19441131|NCT02006641|41688505|FG000|Overall Study|Lost to Follow-up|0|||
19441132|NCT02006641|41688506|FG001|Overall Study|Lost to Follow-up|1|||
19441133|NCT02006641|41688507|FG002|Overall Study|Lost to Follow-up|0|||
19441134|NCT02006641|41688505|FG000|Overall Study|Withdrawal by Subject|7|||
19441135|NCT02006641|41688506|FG001|Overall Study|Withdrawal by Subject|12|||
19441136|NCT02006641|41688507|FG002|Overall Study|Withdrawal by Subject|11|||
19441137|NCT02006641|41688505|FG000|Overall Study|Other reason: patient didn't show up|1|||
19441138|NCT02006641|41688506|FG001|Overall Study|Other reason: patient didn't show up|0|||
19441139|NCT02006641|41688507|FG002|Overall Study|Other reason: patient didn't show up|0|||
19441140|NCT02006641|41688505|FG000|Overall Study|Other reason:patient didn't want to come|0|||
19441141|NCT02006641|41688506|FG001|Overall Study|Other reason:patient didn't want to come|0|||
19441142|NCT02006641|41688507|FG002|Overall Study|Other reason:patient didn't want to come|1|||
19522507|NCT01105975|41940821|FG009|Overall Study|Protocol Violation|2|||
19522508|NCT01105975|41940812|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19522509|NCT01105975|41940813|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19522510|NCT01105975|41940814|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19522511|NCT01105975|41940815|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19441143|NCT02006641|41688505|FG000|Overall Study|Other reason: patient has moved|1|||
19441144|NCT02006641|41688506|FG001|Overall Study|Other reason: patient has moved|0|||
19629041|NCT00455923|42078603|FG000|Overall Study|Other|3|||
19441145|NCT02006641|41688507|FG002|Overall Study|Other reason: patient has moved|1|||
19441146|NCT02006641|41688505|FG000|Overall Study|Other reason: caregiver in hospital|0|||
19441147|NCT02006641|41688506|FG001|Overall Study|Other reason: caregiver in hospital|1|||
19441148|NCT02006641|41688507|FG002|Overall Study|Other reason: caregiver in hospital|0|||
19441149|NCT02006641|41688505|FG000|Overall Study|Other reason: patient's wife has died|0|||
19441150|NCT02006641|41688506|FG001|Overall Study|Other reason: patient's wife has died|0|||
19441151|NCT02006641|41688507|FG002|Overall Study|Other reason: patient's wife has died|1|||
19441152|NCT02006641|41688505|FG000|Overall Study|Other reason: hospitalisation|0|||
19441153|NCT02006641|41688506|FG001|Overall Study|Other reason: hospitalisation|1|||
19441154|NCT02006641|41688507|FG002|Overall Study|Other reason: hospitalisation|0|||
19522512|NCT01105975|41940816|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19522513|NCT01105975|41940817|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
19522514|NCT01105975|41940818|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19522515|NCT01105975|41940819|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
19522516|NCT01105975|41940820|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
19522517|NCT01105975|41940821|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
19522518|NCT01063517|41940864|FG000|Overall Study|Consent withdrawal|1|||
19522519|NCT01063517|41940865|FG001|Overall Study|Consent withdrawal|0|||
19522520|NCT01063517|41940864|FG000|Overall Study|Study reached data cut-off|19|||
19522521|NCT01063517|41940865|FG001|Overall Study|Study reached data cut-off|7|||
19522522|NCT01063517|41940864|FG000|Overall Study|Lost to Follow-up|4|||
19522523|NCT01063517|41940865|FG001|Overall Study|Lost to Follow-up|3|||
19522524|NCT01063517|41940864|FG000|Overall Study|Withdrawal by Subject|1|||
19522525|NCT01063517|41940865|FG001|Overall Study|Withdrawal by Subject|2|||
19522526|NCT01063517|41940864|FG000|Overall Study|Death|33|||
19522527|NCT01063517|41940865|FG001|Overall Study|Death|48|||
19522528|NCT00831623|41940871|FG000|Overall Study|Withdrawal by Subject|9|||
19522529|NCT00831623|41940871|FG000|Overall Study|Lost to Follow-up|1|||
19522530|NCT00831623|41940871|FG000|Overall Study|Not 2 years post-treatment|12|||
19522531|NCT00079417|41940888|FG000|Overall Study|Physician Decision|2|||
19522532|NCT00079417|41940888|FG000|Overall Study|Ineligible|7|||
19522533|NCT05292755|41945951|FG000|Overall Study|Lost to Follow-up|5|||
19522534|NCT05292755|41945952|FG001|Overall Study|Lost to Follow-up|9|||
19522535|NCT04590781|41945966|FG000|Overall Study|Death|0|||
19522536|NCT04590781|41945967|FG001|Overall Study|Death|2|||
19522537|NCT04590781|41945966|FG000|Overall Study|Withdrawal by Subject|2|||
19522538|NCT04590781|41945967|FG001|Overall Study|Withdrawal by Subject|0|||
19522539|NCT04248868|41945974|FG000|Overall Study|Death|1|||
19522540|NCT04248868|41945974|FG000|Overall Study|Lost to Follow-up|3|||
19522541|NCT04248868|41945974|FG000|Overall Study|Protocol Violation|2|||
19522542|NCT04211831|41945981|FG000|Overall Study|Withdrawal by Subject|4|||
19522543|NCT04211831|41945982|FG001|Overall Study|Withdrawal by Subject|1|||
19522544|NCT04211831|41945983|FG002|Overall Study|Withdrawal by Subject|1|||
19522545|NCT04211831|41945981|FG000|Overall Study|Protocol Violation|0|||
19522546|NCT04211831|41945982|FG001|Overall Study|Protocol Violation|0|||
19522547|NCT04211831|41945983|FG002|Overall Study|Protocol Violation|1|||
19522548|NCT04211831|41945981|FG000|Overall Study|Adverse Event|0|||
19522549|NCT04211831|41945982|FG001|Overall Study|Adverse Event|1|||
19522550|NCT04211831|41945983|FG002|Overall Study|Adverse Event|0|||
19522551|NCT04211831|41945981|FG000|Overall Study|Lack of Efficacy|0|||
19522552|NCT04211831|41945982|FG001|Overall Study|Lack of Efficacy|0|||
19522553|NCT04211831|41945983|FG002|Overall Study|Lack of Efficacy|1|||
19711279|NCT03572062|42154400|FG005|Overall Study|Lost to Follow-up|1|||
19441155|NCT02006641|41688505|FG000|Overall Study|Other reason: caregiver impossibility|0|||
19441156|NCT02006641|41688506|FG001|Overall Study|Other reason: caregiver impossibility|0|||
19441157|NCT02006641|41688507|FG002|Overall Study|Other reason: caregiver impossibility|1|||
19441158|NCT02006641|41688505|FG000|Overall Study|Other reason: protocol non-compliance|0|||
19441159|NCT02006641|41688506|FG001|Overall Study|Other reason: protocol non-compliance|0|||
19441160|NCT02006641|41688507|FG002|Overall Study|Other reason: protocol non-compliance|1|||
19441161|NCT01959919|41688515|FG000|Overall Study|Did not meet the eligibility criteria|2|||
19441162|NCT01986985|41688523|FG000|Overall Study|Withdrawal by Subject|4|||
19441163|NCT01986985|41688523|FG000|Overall Study|Scan not completed due to malfunction|3|||
19441164|NCT01986907|41688527|FG000|Overall Study|Adverse Event|11|||
19441165|NCT01986907|41688527|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
19441166|NCT01986907|41688527|FG000|Overall Study|Protocol Violation|4|||
19522554|NCT04211831|41945981|FG000|Overall Study|Lost to Follow-up|0|||
19522555|NCT04211831|41945982|FG001|Overall Study|Lost to Follow-up|0|||
19522556|NCT04211831|41945983|FG002|Overall Study|Lost to Follow-up|2|||
19522557|NCT04211831|41945981|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
19522558|NCT04211831|41945982|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
19522559|NCT04211831|41945983|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
19522560|NCT04211831|41945981|FG000|Overall Study|Other|0|||
19522561|NCT04211831|41945982|FG001|Overall Study|Other|1|||
19522562|NCT04211831|41945983|FG002|Overall Study|Other|0|||
19522563|NCT04067518|41946041|FG000|Overall Study|Adverse Event|1|||
19441167|NCT01986907|41688527|FG000|Overall Study|Withdrawal by Subject|76|||
19441168|NCT01986907|41688527|FG000|Overall Study|Lost to Follow-up|38|||
19441169|NCT01986907|41688527|FG000|Overall Study|Death|9|||
19441170|NCT01959841|41688537|FG000|Overall Study|Adverse Event|1|||
19441171|NCT01959841|41688538|FG001|Overall Study|Adverse Event|3|||
19441172|NCT01959841|41688539|FG002|Overall Study|Adverse Event|2|||
19441173|NCT01959841|41688537|FG000|Overall Study|Lack of Efficacy|5|||
19441174|NCT01959841|41688538|FG001|Overall Study|Lack of Efficacy|0|||
19441175|NCT01959841|41688539|FG002|Overall Study|Lack of Efficacy|0|||
19441176|NCT01959841|41688537|FG000|Overall Study|Lost to Follow-up|1|||
19441177|NCT01959841|41688538|FG001|Overall Study|Lost to Follow-up|1|||
19441178|NCT01959841|41688539|FG002|Overall Study|Lost to Follow-up|0|||
19441179|NCT01959841|41688537|FG000|Overall Study|Physician Decision|0|||
19441180|NCT01959841|41688538|FG001|Overall Study|Physician Decision|2|||
19441181|NCT01959841|41688539|FG002|Overall Study|Physician Decision|3|||
19441182|NCT01959841|41688537|FG000|Overall Study|Protocol Violation|16|||
19441183|NCT01959841|41688538|FG001|Overall Study|Protocol Violation|23|||
19441184|NCT01959841|41688539|FG002|Overall Study|Protocol Violation|16|||
19441185|NCT01959841|41688537|FG000|Overall Study|Withdrawal by Subject|7|||
19441186|NCT01959841|41688538|FG001|Overall Study|Withdrawal by Subject|7|||
19441187|NCT01959841|41688539|FG002|Overall Study|Withdrawal by Subject|5|||
19441188|NCT01959841|41688537|FG000|Overall Study|Clinical laboratory value|2|||
19441189|NCT01959841|41688538|FG001|Overall Study|Clinical laboratory value|6|||
19441190|NCT01959841|41688539|FG002|Overall Study|Clinical laboratory value|6|||
19441191|NCT01959841|41688537|FG000|Overall Study|Platelet count below on day1 or 4|11|||
19441192|NCT01959841|41688538|FG001|Overall Study|Platelet count below on day1 or 4|15|||
19441193|NCT01959841|41688539|FG002|Overall Study|Platelet count below on day1 or 4|11|||
19441194|NCT02005627|41688549|FG000|Overall Study|Lost to Follow-up|1|||
19441195|NCT02005627|41688550|FG001|Overall Study|Lost to Follow-up|2|||
19441196|NCT02005627|41688549|FG000|Overall Study|Withdrawal by Subject|1|||
19441197|NCT02005627|41688550|FG001|Overall Study|Withdrawal by Subject|2|||
19441198|NCT02104583|41688562|FG000|Overall Study|New ICD or CRT-D implanted|2|||
19441199|NCT02104583|41688563|FG001|Overall Study|New ICD or CRT-D implanted|0|||
19441200|NCT02104583|41688564|FG002|Overall Study|New ICD or CRT-D implanted|1|||
19441201|NCT02104583|41688565|FG003|Overall Study|New ICD or CRT-D implanted|0|||
19441202|NCT02104583|41688566|FG004|Overall Study|New ICD or CRT-D implanted|0|||
19441203|NCT02104583|41688562|FG000|Overall Study|Death|2|||
19441204|NCT02104583|41688563|FG001|Overall Study|Death|1|||
19441205|NCT02104583|41688564|FG002|Overall Study|Death|3|||
19441206|NCT02104583|41688565|FG003|Overall Study|Death|3|||
19441207|NCT02104583|41688566|FG004|Overall Study|Death|5|||
19441208|NCT02104583|41688562|FG000|Overall Study|Subject required cardiac ablation|6|||
19441209|NCT02104583|41688563|FG001|Overall Study|Subject required cardiac ablation|4|||
19441210|NCT02104583|41688564|FG002|Overall Study|Subject required cardiac ablation|4|||
19441211|NCT02104583|41688565|FG003|Overall Study|Subject required cardiac ablation|5|||
19441212|NCT02104583|41688566|FG004|Overall Study|Subject required cardiac ablation|4|||
19441213|NCT02104583|41688562|FG000|Overall Study|Subject required prohibited medication|0|||
19441214|NCT02104583|41688563|FG001|Overall Study|Subject required prohibited medication|1|||
19441215|NCT02104583|41688564|FG002|Overall Study|Subject required prohibited medication|1|||
19441216|NCT02104583|41688565|FG003|Overall Study|Subject required prohibited medication|0|||
19441217|NCT02104583|41688566|FG004|Overall Study|Subject required prohibited medication|1|||
19441218|NCT02104583|41688562|FG000|Overall Study|Withdrew Consent|3|||
19441219|NCT02104583|41688563|FG001|Overall Study|Withdrew Consent|2|||
19441220|NCT02104583|41688564|FG002|Overall Study|Withdrew Consent|0|||
19441221|NCT02104583|41688565|FG003|Overall Study|Withdrew Consent|2|||
19441222|NCT02104583|41688566|FG004|Overall Study|Withdrew Consent|1|||
19441223|NCT02104583|41688562|FG000|Overall Study|Investigator's Discretion|1|||
19441224|NCT02104583|41688563|FG001|Overall Study|Investigator's Discretion|0|||
19441225|NCT02104583|41688564|FG002|Overall Study|Investigator's Discretion|0|||
19441226|NCT02104583|41688565|FG003|Overall Study|Investigator's Discretion|0|||
19441227|NCT02104583|41688566|FG004|Overall Study|Investigator's Discretion|0|||
19441228|NCT02104583|41688562|FG000|Overall Study|Protocol Violation|0|||
19441229|NCT02104583|41688563|FG001|Overall Study|Protocol Violation|0|||
19441230|NCT02104583|41688564|FG002|Overall Study|Protocol Violation|1|||
19441231|NCT02104583|41688565|FG003|Overall Study|Protocol Violation|0|||
19441232|NCT02104583|41688566|FG004|Overall Study|Protocol Violation|0|||
19441233|NCT02104583|41688562|FG000|Overall Study|Adverse Event|3|||
19441234|NCT02104583|41688563|FG001|Overall Study|Adverse Event|3|||
19441235|NCT02104583|41688564|FG002|Overall Study|Adverse Event|6|||
19441236|NCT02104583|41688565|FG003|Overall Study|Adverse Event|6|||
19441237|NCT02104583|41688566|FG004|Overall Study|Adverse Event|1|||
19441238|NCT02104583|41688562|FG000|Overall Study|Lost to Follow-up|1|||
19441239|NCT02104583|41688563|FG001|Overall Study|Lost to Follow-up|0|||
19441240|NCT02104583|41688564|FG002|Overall Study|Lost to Follow-up|0|||
19441241|NCT02104583|41688565|FG003|Overall Study|Lost to Follow-up|0|||
19441242|NCT02104583|41688566|FG004|Overall Study|Lost to Follow-up|0|||
19441243|NCT02104583|41688562|FG000|Overall Study|Randomized but Never Treated|0|||
19522564|NCT04067518|41946042|FG001|Overall Study|Adverse Event|3|||
19441244|NCT02104583|41688563|FG001|Overall Study|Randomized but Never Treated|0|||
19441245|NCT02104583|41688564|FG002|Overall Study|Randomized but Never Treated|0|||
19441246|NCT02104583|41688565|FG003|Overall Study|Randomized but Never Treated|1|||
19441247|NCT02104583|41688566|FG004|Overall Study|Randomized but Never Treated|0|||
19441248|NCT02074553|41688589|FG000|Intervention Period 1|Family Emergency|0|||
19441249|NCT02074553|41688590|FG001|Intervention Period 1|Family Emergency|0|||
19441250|NCT02074553|41688591|FG002|Intervention Period 1|Family Emergency|0|||
19441251|NCT02074553|41688592|FG003|Intervention Period 1|Family Emergency|1|||
19441252|NCT02074553|41688593|FG004|Intervention Period 1|Family Emergency|0|||
19441253|NCT02074553|41688594|FG005|Intervention Period 1|Family Emergency|0|||
19441254|NCT02074553|41688595|FG006|Intervention Period 1|Family Emergency|0|||
19441255|NCT02074553|41688596|FG007|Intervention Period 1|Family Emergency|0|||
19441256|NCT02074553|41688589|FG000|Washout Period 1|Adverse Event|1|||
19441257|NCT02074553|41688590|FG001|Washout Period 1|Adverse Event|0|||
19441258|NCT02074553|41688591|FG002|Washout Period 1|Adverse Event|0|||
19441259|NCT02074553|41688592|FG003|Washout Period 1|Adverse Event|0|||
19441260|NCT02074553|41688593|FG004|Washout Period 1|Adverse Event|0|||
19441261|NCT02074553|41688594|FG005|Washout Period 1|Adverse Event|0|||
19441262|NCT02074553|41688595|FG006|Washout Period 1|Adverse Event|0|||
19441263|NCT02074553|41688596|FG007|Washout Period 1|Adverse Event|0|||
19441264|NCT02074553|41688589|FG000|Washout Period 1|Physician Decision|0|||
19441265|NCT02074553|41688590|FG001|Washout Period 1|Physician Decision|0|||
19441266|NCT02074553|41688591|FG002|Washout Period 1|Physician Decision|0|||
19441267|NCT02074553|41688592|FG003|Washout Period 1|Physician Decision|1|||
19441268|NCT02074553|41688593|FG004|Washout Period 1|Physician Decision|0|||
19441269|NCT02074553|41688594|FG005|Washout Period 1|Physician Decision|0|||
19441270|NCT02074553|41688595|FG006|Washout Period 1|Physician Decision|0|||
19441271|NCT02074553|41688596|FG007|Washout Period 1|Physician Decision|0|||
19441272|NCT02074553|41688589|FG000|Washout Period 1|Other|0|||
19441273|NCT02074553|41688590|FG001|Washout Period 1|Other|0|||
19441274|NCT02074553|41688591|FG002|Washout Period 1|Other|0|||
19441275|NCT02074553|41688592|FG003|Washout Period 1|Other|0|||
19441276|NCT02074553|41688593|FG004|Washout Period 1|Other|0|||
19441277|NCT02074553|41688594|FG005|Washout Period 1|Other|1|||
19441278|NCT02074553|41688595|FG006|Washout Period 1|Other|0|||
19441279|NCT02074553|41688596|FG007|Washout Period 1|Other|0|||
19441280|NCT02074553|41688589|FG000|Washout Period 2|Adverse Event|0|||
19441281|NCT02074553|41688590|FG001|Washout Period 2|Adverse Event|0|||
19441282|NCT02074553|41688591|FG002|Washout Period 2|Adverse Event|0|||
19441283|NCT02074553|41688592|FG003|Washout Period 2|Adverse Event|0|||
19441284|NCT02074553|41688593|FG004|Washout Period 2|Adverse Event|0|||
19441285|NCT02074553|41688594|FG005|Washout Period 2|Adverse Event|0|||
19441286|NCT02074553|41688595|FG006|Washout Period 2|Adverse Event|1|||
19441287|NCT02074553|41688596|FG007|Washout Period 2|Adverse Event|0|||
19441288|NCT02074553|41688589|FG000|Washout Period 2|Physician Decision|0|||
19441289|NCT02074553|41688590|FG001|Washout Period 2|Physician Decision|0|||
19441290|NCT02074553|41688591|FG002|Washout Period 2|Physician Decision|0|||
19441291|NCT02074553|41688592|FG003|Washout Period 2|Physician Decision|0|||
19441292|NCT02074553|41688593|FG004|Washout Period 2|Physician Decision|0|||
19441293|NCT02074553|41688594|FG005|Washout Period 2|Physician Decision|1|||
19441294|NCT02074553|41688595|FG006|Washout Period 2|Physician Decision|0|||
19441295|NCT02074553|41688596|FG007|Washout Period 2|Physician Decision|0|||
19441296|NCT02074553|41688589|FG000|Washout Period 2|Lost to Follow-up|0|||
19441297|NCT02074553|41688590|FG001|Washout Period 2|Lost to Follow-up|0|||
19441298|NCT02074553|41688591|FG002|Washout Period 2|Lost to Follow-up|1|||
19441299|NCT02074553|41688592|FG003|Washout Period 2|Lost to Follow-up|0|||
19441300|NCT02074553|41688593|FG004|Washout Period 2|Lost to Follow-up|0|||
19441301|NCT02074553|41688594|FG005|Washout Period 2|Lost to Follow-up|0|||
19441302|NCT02074553|41688595|FG006|Washout Period 2|Lost to Follow-up|0|||
19522565|NCT04067518|41946041|FG000|Overall Study|Screen failures|0|||
19522566|NCT04067518|41946042|FG001|Overall Study|Screen failures|1|||
19711280|NCT03572062|42154401|FG006|Overall Study|Lost to Follow-up|1|||
19441303|NCT02074553|41688596|FG007|Washout Period 2|Lost to Follow-up|0|||
19441304|NCT02074553|41688589|FG000|Washout Period 3|Physician Decision|0|||
19441305|NCT02074553|41688590|FG001|Washout Period 3|Physician Decision|0|||
19441306|NCT02074553|41688591|FG002|Washout Period 3|Physician Decision|0|||
19441307|NCT02074553|41688592|FG003|Washout Period 3|Physician Decision|0|||
19441308|NCT02074553|41688593|FG004|Washout Period 3|Physician Decision|0|||
19441309|NCT02074553|41688594|FG005|Washout Period 3|Physician Decision|0|||
19441310|NCT02074553|41688595|FG006|Washout Period 3|Physician Decision|0|||
19441311|NCT02074553|41688596|FG007|Washout Period 3|Physician Decision|1|||
19441312|NCT02073929|41688616|FG000|Overall Study|Lost to Follow-up|2|||
19441313|NCT02073929|41688617|FG001|Overall Study|Lost to Follow-up|1|||
19441314|NCT02073929|41688616|FG000|Overall Study|Adverse Event|2|||
19441315|NCT02073929|41688617|FG001|Overall Study|Adverse Event|1|||
19441316|NCT02073929|41688616|FG000|Overall Study|Withdrawal by Subject|0|||
19441317|NCT02073929|41688617|FG001|Overall Study|Withdrawal by Subject|1|||
19441318|NCT02113007|41688623|FG000|Overall Study|Progressive disease|2|||
19441319|NCT02005471|41688629|FG000|Overall Study|Ongoing in Study|144|||
19441320|NCT02005471|41688630|FG001|Overall Study|Ongoing in Study|171|||
19441321|NCT02005471|41688629|FG000|Overall Study|Adverse Event|1|||
19441322|NCT02005471|41688630|FG001|Overall Study|Adverse Event|0|||
19441323|NCT02005471|41688629|FG000|Overall Study|Death|26|||
19441324|NCT02005471|41688630|FG001|Overall Study|Death|15|||
19441325|NCT02005471|41688629|FG000|Overall Study|Lost to Follow-up|1|||
19441326|NCT02005471|41688630|FG001|Overall Study|Lost to Follow-up|0|||
19441327|NCT02005471|41688629|FG000|Overall Study|Physician Decision|2|||
19441328|NCT02005471|41688630|FG001|Overall Study|Physician Decision|1|||
19441329|NCT02005471|41688629|FG000|Overall Study|Progressive Disease|3|||
19441330|NCT02005471|41688630|FG001|Overall Study|Progressive Disease|0|||
19441331|NCT02005471|41688629|FG000|Overall Study|Withdrawal by Subject|18|||
19441332|NCT02005471|41688630|FG001|Overall Study|Withdrawal by Subject|7|||
19441333|NCT02104505|41688641|FG000|First Intervention (14 Days)|Adverse Event|2|||
19441334|NCT02104505|41688642|FG001|First Intervention (14 Days)|Adverse Event|0|||
19441335|NCT02104505|41688641|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
19441336|NCT02104505|41688642|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
19441337|NCT02104505|41688641|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
19441338|NCT02104505|41688642|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
19441339|NCT02104505|41688641|FG000|First Intervention (14 Days)|exclusionary condition|0|||
19441340|NCT02104505|41688642|FG001|First Intervention (14 Days)|exclusionary condition|1|||
19441341|NCT02104505|41688641|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
19441342|NCT02104505|41688642|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
19441343|NCT02104505|41688641|FG000|Second Intervention (14 Days)|Adverse Event|2|||
19441344|NCT02104505|41688642|FG001|Second Intervention (14 Days)|Adverse Event|0|||
19441345|NCT02111993|41688651|FG000|Overall Study|Physician Decision|5|||
19441346|NCT02111993|41688652|FG001|Overall Study|Physician Decision|4|||
19441347|NCT01959607|41688662|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
19441348|NCT01959607|41688663|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
19441349|NCT01959607|41688664|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
19441350|NCT01959607|41688665|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
19441351|NCT02111603|41688674|FG000|Overall Study|Withdrawal by Subject|1|||
19441352|NCT02102399|41688680|FG000|Overall Study|Withdrawal by Subject|6|||
19441353|NCT02102399|41688681|FG001|Overall Study|Withdrawal by Subject|4|||
19441354|NCT02111369|41688692|FG000|Overall Study|Lost to Follow-up|2|||
19711281|NCT03572062|42154402|FG007|Overall Study|Lost to Follow-up|0|||
19711282|NCT03572062|42154403|FG008|Overall Study|Lost to Follow-up|0|||
19711283|NCT03572062|42154404|FG009|Overall Study|Lost to Follow-up|0|||
19711284|NCT03572062|42154395|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711285|NCT03572062|42154396|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711286|NCT03572062|42154397|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711287|NCT03572062|42154398|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711288|NCT03572062|42154399|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711289|NCT03572062|42154400|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711290|NCT03572062|42154401|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711291|NCT03572062|42154402|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711292|NCT03572062|42154403|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
19711293|NCT03572062|42154404|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
19711294|NCT03572062|42154395|FG000|Overall Study|Study Terminated By Sponsor|0|||
19711295|NCT03572062|42154396|FG001|Overall Study|Study Terminated By Sponsor|0|||
19711296|NCT03572062|42154397|FG002|Overall Study|Study Terminated By Sponsor|0|||
19711297|NCT03572062|42154398|FG003|Overall Study|Study Terminated By Sponsor|0|||
19441355|NCT02111369|41688692|FG000|Overall Study|Withdrawal by Subject|1|||
19441356|NCT02111213|41688698|FG000|Overall Study|Withdrawal by Subject|3|||
19441357|NCT02111213|41688699|FG001|Overall Study|Withdrawal by Subject|2|||
19441358|NCT02111213|41688698|FG000|Overall Study|Lost to Follow-up|3|||
19441359|NCT02111213|41688699|FG001|Overall Study|Lost to Follow-up|4|||
19441360|NCT02110901|41688707|FG000|Overall Study|Death|6|||
19441361|NCT02110901|41688708|FG001|Overall Study|Death|3|||
19441362|NCT02110901|41688707|FG000|Overall Study|Lost to Follow-up|12|||
19441363|NCT02110901|41688708|FG001|Overall Study|Lost to Follow-up|8|||
19441364|NCT02110901|41688707|FG000|Overall Study|Withdrawal by Subject|7|||
19441365|NCT02110901|41688708|FG001|Overall Study|Withdrawal by Subject|3|||
19441366|NCT02110901|41688707|FG000|Overall Study|received a kidney transplant|5|||
19441367|NCT02110901|41688708|FG001|Overall Study|received a kidney transplant|0|||
19441368|NCT02070965|41688718|FG000|Overall Study|Lost to Follow-up|0|||
19441369|NCT02070965|41688719|FG001|Overall Study|Lost to Follow-up|1|||
19441370|NCT02070965|41688720|FG002|Overall Study|Lost to Follow-up|0|||
19441371|NCT02070965|41688718|FG000|Overall Study|Withdrawal by Subject|1|||
19441372|NCT02070965|41688719|FG001|Overall Study|Withdrawal by Subject|1|||
19441373|NCT02070965|41688720|FG002|Overall Study|Withdrawal by Subject|1|||
19441374|NCT02070965|41688718|FG000|Overall Study|Subject moved|1|||
19441375|NCT02070965|41688719|FG001|Overall Study|Subject moved|0|||
19441376|NCT02070965|41688720|FG002|Overall Study|Subject moved|0|||
19441377|NCT02109107|41688728|FG000|Overall Study|Lost to Follow-up|2|||
19441378|NCT02100839|41688734|FG000|Multiple Ascending Dose|Adverse Event|2|||
19441379|NCT02100839|41688735|FG001|Multiple Ascending Dose|Adverse Event|0|||
19441380|NCT02100839|41688734|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
19441381|NCT02100839|41688735|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
19441382|NCT02069093|41688741|FG000|Overall Study|Disease progression|14|||
19441383|NCT02069093|41688741|FG000|Overall Study|New cancer therapy|1|||
19441384|NCT02069093|41688741|FG000|Overall Study|Death|1|||
19441385|NCT02069093|41688741|FG000|Overall Study|Administrative problems|1|||
19441386|NCT02069093|41688741|FG000|Overall Study|Withdrawal by Subject|2|||
19441387|NCT02069093|41688741|FG000|Overall Study|Abnormal laboratory values|1|||
19441388|NCT02069093|41688741|FG000|Overall Study|Adverse Event|10|||
19441389|NCT02109029|41688748|FG000|Part B|Adverse Event|0|||
19441390|NCT02109029|41688749|FG001|Part B|Adverse Event|0|||
19441391|NCT02109029|41688750|FG002|Part B|Adverse Event|0|||
19441392|NCT02109029|41688751|FG003|Part B|Adverse Event|0|||
19441393|NCT02109029|41688752|FG004|Part B|Adverse Event|1|||
19441394|NCT02109029|41688753|FG005|Part B|Adverse Event|1|||
19441395|NCT02069015|41688766|FG000|Overall Study|Lost to Follow-up|39|||
19441396|NCT02069015|41688767|FG001|Overall Study|Lost to Follow-up|32|||
19441397|NCT02069015|41688766|FG000|Overall Study|Withdrawal by Subject|1|||
19441398|NCT02069015|41688767|FG001|Overall Study|Withdrawal by Subject|1|||
19441399|NCT01598129|41688774|FG000|Overall Study|Disease progression|6|||
19441400|NCT01598129|41688774|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
19441401|NCT01598129|41688774|FG000|Overall Study|Withdrawal by Subject|1|||
19441402|NCT02068547|41688781|FG000|Overall Study|Lost to Follow-up|3|||
19441403|NCT02068547|41688782|FG001|Overall Study|Lost to Follow-up|3|||
19441404|NCT02068547|41688781|FG000|Overall Study|Physician Decision|1|||
19441405|NCT02068547|41688782|FG001|Overall Study|Physician Decision|0|||
19441406|NCT02108951|41688788|FG000|Overall Study|Lost to Follow-up|1|||
19441407|NCT02108951|41688788|FG000|Overall Study|Patient's/guardian's decision|1|||
19441408|NCT02108951|41688788|FG000|Overall Study|Study Terminated by Sponsor|14|||
19441409|NCT02107859|41688792|FG000|Overall Study|Withdrawal by Subject|14|||
19441410|NCT02107859|41688792|FG000|Overall Study|Adverse Event|3|||
19441411|NCT02107859|41688792|FG000|Overall Study|Study closure|41|||
19441412|NCT02107859|41688792|FG000|Overall Study|Other than specified|3|||
19441413|NCT02007278|41688798|FG000|Overall Study|Failure to comply with an eligibility|0|||
19441414|NCT02007278|41688799|FG001|Overall Study|Failure to comply with an eligibility|1|||
19441415|NCT02007278|41688798|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
19441416|NCT02007278|41688799|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
19441417|NCT02007278|41688798|FG000|Overall Study|Incorrect medication administration|1|||
19441418|NCT02007278|41688799|FG001|Overall Study|Incorrect medication administration|0|||
19441419|NCT02007278|41688798|FG000|Overall Study|Mis-randomization|1|||
19441420|NCT02007278|41688799|FG001|Overall Study|Mis-randomization|1|||
19441421|NCT02107313|41688805|FG000|Overall Study|One participant did not do the FED cohor|0|||
19441422|NCT02107313|41688806|FG001|Overall Study|One participant did not do the FED cohor|1|||
19441423|NCT02028338|41688814|FG000|Overall Study|Withdrawal by Subject|3|||
19441424|NCT02028338|41688815|FG001|Overall Study|Withdrawal by Subject|1|||
19441425|NCT02028338|41688814|FG000|Overall Study|Unable to contact participant|1|||
19441426|NCT02028338|41688815|FG001|Overall Study|Unable to contact participant|0|||
19441427|NCT01625897|41688823|FG000|Overall Study|Adverse Event|27|||
19441428|NCT01625897|41688824|FG001|Overall Study|Adverse Event|10|||
19441429|NCT01625897|41688823|FG000|Overall Study|Physician Decision|0|||
19441430|NCT01625897|41688824|FG001|Overall Study|Physician Decision|1|||
19441431|NCT01625897|41688823|FG000|Overall Study|Withdrawal by Subject|25|||
19441432|NCT01625897|41688824|FG001|Overall Study|Withdrawal by Subject|3|||
19441433|NCT02106923|41688833|FG000|Overall Study|Protocol Violation|0|||
19441434|NCT02106923|41688834|FG001|Overall Study|Protocol Violation|0|||
19441435|NCT02106923|41688835|FG002|Overall Study|Protocol Violation|0|||
19441436|NCT02106923|41688836|FG003|Overall Study|Protocol Violation|0|||
19441437|NCT02106923|41688837|FG004|Overall Study|Protocol Violation|0|||
19441438|NCT02106923|41688838|FG005|Overall Study|Protocol Violation|1|||
19441439|NCT02006732|41688856|FG000|Overall Study|Adverse Event|10|||
19441440|NCT02006732|41688857|FG001|Overall Study|Adverse Event|7|||
19441441|NCT02006732|41688858|FG002|Overall Study|Adverse Event|4|||
19441442|NCT02006732|41688859|FG003|Overall Study|Adverse Event|2|||
19441443|NCT02006732|41688856|FG000|Overall Study|Lack of Efficacy|6|||
19441444|NCT02006732|41688857|FG001|Overall Study|Lack of Efficacy|3|||
19441445|NCT02006732|41688858|FG002|Overall Study|Lack of Efficacy|1|||
19441446|NCT02006732|41688859|FG003|Overall Study|Lack of Efficacy|1|||
19441447|NCT02006732|41688856|FG000|Overall Study|Protocol Violation|1|||
19441448|NCT02006732|41688857|FG001|Overall Study|Protocol Violation|1|||
19441449|NCT02006732|41688858|FG002|Overall Study|Protocol Violation|0|||
19441450|NCT02006732|41688859|FG003|Overall Study|Protocol Violation|0|||
19441451|NCT02006732|41688856|FG000|Overall Study|Lost to Follow-up|0|||
19441452|NCT02006732|41688857|FG001|Overall Study|Lost to Follow-up|1|||
19441453|NCT02006732|41688858|FG002|Overall Study|Lost to Follow-up|0|||
19441454|NCT02006732|41688859|FG003|Overall Study|Lost to Follow-up|0|||
19441455|NCT02006732|41688856|FG000|Overall Study|Withdrawal by Subject|3|||
19441456|NCT02006732|41688857|FG001|Overall Study|Withdrawal by Subject|0|||
19441457|NCT02006732|41688858|FG002|Overall Study|Withdrawal by Subject|4|||
19441458|NCT02006732|41688859|FG003|Overall Study|Withdrawal by Subject|1|||
19441459|NCT02098733|41688869|FG000|Overall Study|Data Not Available|5|||
19441460|NCT02098733|41688869|FG000|Overall Study|Lost to Follow-up|5|||
19441461|NCT02028182|41688873|FG000|Overall Study|Protocol Violation|2|||
19441462|NCT02098109|41688880|FG000|Overall Study|Protocol Violation|3|||
19441463|NCT02098109|41688881|FG001|Overall Study|Protocol Violation|0|||
19441464|NCT02097719|41688889|FG000|Overall Study|Subject Withdrew Consent|1|||
19441465|NCT02097719|41688890|FG001|Overall Study|Subject Withdrew Consent|0|||
19441466|NCT02097719|41688889|FG000|Overall Study|Lost to Follow-up|0|||
19441467|NCT02097719|41688890|FG001|Overall Study|Lost to Follow-up|1|||
19441468|NCT02097719|41688889|FG000|Overall Study|Adverse Event|2|||
19441469|NCT02097719|41688890|FG001|Overall Study|Adverse Event|0|||
19441470|NCT01449370|41688921|FG000|Overall Study|Disease Progression|5|||
19441471|NCT01449370|41688922|FG001|Overall Study|Disease Progression|4|||
19441472|NCT01449370|41688923|FG002|Overall Study|Disease Progression|8|||
19441473|NCT01449370|41688924|FG003|Overall Study|Disease Progression|3|||
19441474|NCT01449370|41688925|FG004|Overall Study|Disease Progression|3|||
19441475|NCT01449370|41688926|FG005|Overall Study|Disease Progression|3|||
19441476|NCT01449370|41688927|FG006|Overall Study|Disease Progression|3|||
19441477|NCT01449370|41688928|FG007|Overall Study|Disease Progression|2|||
19441478|NCT01449370|41688929|FG008|Overall Study|Disease Progression|9|||
19441479|NCT01449370|41688930|FG009|Overall Study|Disease Progression|1|||
19441480|NCT01449370|41688931|FG010|Overall Study|Disease Progression|3|||
19441481|NCT01449370|41688932|FG011|Overall Study|Disease Progression|3|||
19441482|NCT01449370|41688933|FG012|Overall Study|Disease Progression|2|||
19441483|NCT01449370|41688934|FG013|Overall Study|Disease Progression|8|||
19441484|NCT01449370|41688935|FG014|Overall Study|Disease Progression|3|||
19441485|NCT01449370|41688936|FG015|Overall Study|Disease Progression|1|||
19441486|NCT01449370|41688937|FG016|Overall Study|Disease Progression|4|||
19441487|NCT01449370|41688938|FG017|Overall Study|Disease Progression|3|||
19441488|NCT01449370|41688939|FG018|Overall Study|Disease Progression|1|||
19441489|NCT01449370|41688940|FG019|Overall Study|Disease Progression|2|||
19441490|NCT01449370|41688941|FG020|Overall Study|Disease Progression|5|||
19441491|NCT01449370|41688942|FG021|Overall Study|Disease Progression|2|||
19441492|NCT01449370|41688943|FG022|Overall Study|Disease Progression|3|||
19441493|NCT01449370|41688944|FG023|Overall Study|Disease Progression|7|||
19441494|NCT01449370|41688945|FG024|Overall Study|Disease Progression|3|||
19441495|NCT01449370|41688921|FG000|Overall Study|Adverse Event|1|||
19441496|NCT01449370|41688922|FG001|Overall Study|Adverse Event|2|||
19441497|NCT01449370|41688923|FG002|Overall Study|Adverse Event|0|||
19441498|NCT01449370|41688924|FG003|Overall Study|Adverse Event|1|||
19441499|NCT01449370|41688925|FG004|Overall Study|Adverse Event|0|||
19441500|NCT01449370|41688926|FG005|Overall Study|Adverse Event|0|||
19522567|NCT04067518|41946041|FG000|Overall Study|Enrolled but not treated|0|||
19522568|NCT04067518|41946042|FG001|Overall Study|Enrolled but not treated|1|||
19522569|NCT03912233|41946083|FG000|Overall Study|Adverse Event|1|||
19522570|NCT03912233|41946084|FG001|Overall Study|Adverse Event|0|||
19522571|NCT03912233|41946085|FG002|Overall Study|Adverse Event|0|||
19522572|NCT03912233|41946086|FG003|Overall Study|Adverse Event|0|||
19522573|NCT03912233|41946087|FG004|Overall Study|Adverse Event|0|||
19522574|NCT03912233|41946088|FG005|Overall Study|Adverse Event|0|||
19522575|NCT03912233|41946083|FG000|Overall Study|Physician Decision|1|||
19522576|NCT03912233|41946084|FG001|Overall Study|Physician Decision|0|||
19522577|NCT03912233|41946085|FG002|Overall Study|Physician Decision|0|||
19522578|NCT03912233|41946086|FG003|Overall Study|Physician Decision|0|||
19522579|NCT03912233|41946087|FG004|Overall Study|Physician Decision|0|||
19522580|NCT03912233|41946088|FG005|Overall Study|Physician Decision|0|||
19522581|NCT03912233|41946083|FG000|Overall Study|Other|0|||
19522582|NCT03912233|41946084|FG001|Overall Study|Other|0|||
19522583|NCT03912233|41946085|FG002|Overall Study|Other|0|||
19522584|NCT03912233|41946086|FG003|Overall Study|Other|0|||
19522585|NCT03912233|41946087|FG004|Overall Study|Other|7|||
19522586|NCT03912233|41946088|FG005|Overall Study|Other|12|||
19522587|NCT03834519|41946112|FG000|Overall Study|Ongoing|234|||
19522588|NCT03834519|41946113|FG001|Overall Study|Ongoing|111|||
19711298|NCT03572062|42154399|FG004|Overall Study|Study Terminated By Sponsor|0|||
19441501|NCT01449370|41688927|FG006|Overall Study|Adverse Event|0|||
19441502|NCT01449370|41688928|FG007|Overall Study|Adverse Event|0|||
19441503|NCT01449370|41688929|FG008|Overall Study|Adverse Event|1|||
19441504|NCT01449370|41688930|FG009|Overall Study|Adverse Event|1|||
19441505|NCT01449370|41688931|FG010|Overall Study|Adverse Event|0|||
19441506|NCT01449370|41688932|FG011|Overall Study|Adverse Event|0|||
19522589|NCT03834519|41946112|FG000|Overall Study|Withdrawal by Subject|4|||
19522590|NCT03834519|41946113|FG001|Overall Study|Withdrawal by Subject|7|||
19522591|NCT03834519|41946112|FG000|Overall Study|Death|291|||
19522592|NCT03834519|41946113|FG001|Overall Study|Death|146|||
19522593|NCT03755518|41946128|FG000|Overall Study|Adverse Event|6|||
19441507|NCT01449370|41688933|FG012|Overall Study|Adverse Event|0|||
19441508|NCT01449370|41688934|FG013|Overall Study|Adverse Event|2|||
19441509|NCT01449370|41688935|FG014|Overall Study|Adverse Event|0|||
19441510|NCT01449370|41688936|FG015|Overall Study|Adverse Event|1|||
19441511|NCT01449370|41688937|FG016|Overall Study|Adverse Event|0|||
19441512|NCT01449370|41688938|FG017|Overall Study|Adverse Event|0|||
19441513|NCT01449370|41688939|FG018|Overall Study|Adverse Event|1|||
19441514|NCT01449370|41688940|FG019|Overall Study|Adverse Event|1|||
19441515|NCT01449370|41688941|FG020|Overall Study|Adverse Event|0|||
19441516|NCT01449370|41688942|FG021|Overall Study|Adverse Event|1|||
19441517|NCT01449370|41688943|FG022|Overall Study|Adverse Event|0|||
19441518|NCT01449370|41688944|FG023|Overall Study|Adverse Event|1|||
19441519|NCT01449370|41688945|FG024|Overall Study|Adverse Event|3|||
19441520|NCT01449370|41688921|FG000|Overall Study|Participant Decision|0|||
19441521|NCT01449370|41688922|FG001|Overall Study|Participant Decision|0|||
19441522|NCT01449370|41688923|FG002|Overall Study|Participant Decision|0|||
19441523|NCT01449370|41688924|FG003|Overall Study|Participant Decision|0|||
19441524|NCT01449370|41688925|FG004|Overall Study|Participant Decision|0|||
19441525|NCT01449370|41688926|FG005|Overall Study|Participant Decision|0|||
19441526|NCT01449370|41688927|FG006|Overall Study|Participant Decision|0|||
19441527|NCT01449370|41688928|FG007|Overall Study|Participant Decision|1|||
19441528|NCT01449370|41688929|FG008|Overall Study|Participant Decision|1|||
19441529|NCT01449370|41688930|FG009|Overall Study|Participant Decision|0|||
19441530|NCT01449370|41688931|FG010|Overall Study|Participant Decision|0|||
19441531|NCT01449370|41688932|FG011|Overall Study|Participant Decision|0|||
19441532|NCT01449370|41688933|FG012|Overall Study|Participant Decision|1|||
19441533|NCT01449370|41688934|FG013|Overall Study|Participant Decision|1|||
19441534|NCT01449370|41688935|FG014|Overall Study|Participant Decision|0|||
19441535|NCT01449370|41688936|FG015|Overall Study|Participant Decision|1|||
19441536|NCT01449370|41688937|FG016|Overall Study|Participant Decision|3|||
19441537|NCT01449370|41688938|FG017|Overall Study|Participant Decision|0|||
19441538|NCT01449370|41688939|FG018|Overall Study|Participant Decision|1|||
19441539|NCT01449370|41688940|FG019|Overall Study|Participant Decision|0|||
19441540|NCT01449370|41688941|FG020|Overall Study|Participant Decision|0|||
19441541|NCT01449370|41688942|FG021|Overall Study|Participant Decision|1|||
19441542|NCT01449370|41688943|FG022|Overall Study|Participant Decision|0|||
19441543|NCT01449370|41688944|FG023|Overall Study|Participant Decision|0|||
19441544|NCT01449370|41688945|FG024|Overall Study|Participant Decision|1|||
19441545|NCT01449370|41688921|FG000|Overall Study|Lost to Follow-up|0|||
19441546|NCT01449370|41688922|FG001|Overall Study|Lost to Follow-up|0|||
19441547|NCT01449370|41688923|FG002|Overall Study|Lost to Follow-up|0|||
19441548|NCT01449370|41688924|FG003|Overall Study|Lost to Follow-up|0|||
19441549|NCT01449370|41688925|FG004|Overall Study|Lost to Follow-up|0|||
19441550|NCT01449370|41688926|FG005|Overall Study|Lost to Follow-up|0|||
19441551|NCT01449370|41688927|FG006|Overall Study|Lost to Follow-up|0|||
19441552|NCT01449370|41688928|FG007|Overall Study|Lost to Follow-up|0|||
19441553|NCT01449370|41688929|FG008|Overall Study|Lost to Follow-up|0|||
19441554|NCT01449370|41688930|FG009|Overall Study|Lost to Follow-up|0|||
19441555|NCT01449370|41688931|FG010|Overall Study|Lost to Follow-up|0|||
19441556|NCT01449370|41688932|FG011|Overall Study|Lost to Follow-up|0|||
19441557|NCT01449370|41688933|FG012|Overall Study|Lost to Follow-up|0|||
19441558|NCT01449370|41688934|FG013|Overall Study|Lost to Follow-up|0|||
19441559|NCT01449370|41688935|FG014|Overall Study|Lost to Follow-up|0|||
19441560|NCT01449370|41688936|FG015|Overall Study|Lost to Follow-up|0|||
19441561|NCT01449370|41688937|FG016|Overall Study|Lost to Follow-up|0|||
19441562|NCT01449370|41688938|FG017|Overall Study|Lost to Follow-up|0|||
19441563|NCT01449370|41688939|FG018|Overall Study|Lost to Follow-up|0|||
19441564|NCT01449370|41688940|FG019|Overall Study|Lost to Follow-up|0|||
19441565|NCT01449370|41688941|FG020|Overall Study|Lost to Follow-up|1|||
19441566|NCT01449370|41688942|FG021|Overall Study|Lost to Follow-up|0|||
19441567|NCT01449370|41688943|FG022|Overall Study|Lost to Follow-up|0|||
19441568|NCT01449370|41688944|FG023|Overall Study|Lost to Follow-up|0|||
19441569|NCT01449370|41688945|FG024|Overall Study|Lost to Follow-up|0|||
19441570|NCT01449370|41688921|FG000|Overall Study|Other|0|||
19441571|NCT01449370|41688922|FG001|Overall Study|Other|0|||
19441572|NCT01449370|41688923|FG002|Overall Study|Other|0|||
19441573|NCT01449370|41688924|FG003|Overall Study|Other|0|||
19441574|NCT01449370|41688925|FG004|Overall Study|Other|0|||
19441575|NCT01449370|41688926|FG005|Overall Study|Other|0|||
19441576|NCT01449370|41688927|FG006|Overall Study|Other|0|||
19441577|NCT01449370|41688928|FG007|Overall Study|Other|0|||
19522594|NCT03755518|41946128|FG000|Overall Study|Lack of Efficacy|6|||
19522595|NCT03755518|41946128|FG000|Overall Study|Bone Marrow Transplant|4|||
19441578|NCT01449370|41688929|FG008|Overall Study|Other|1|||
19441579|NCT01449370|41688930|FG009|Overall Study|Other|1|||
19441580|NCT01449370|41688931|FG010|Overall Study|Other|0|||
19441581|NCT01449370|41688932|FG011|Overall Study|Other|0|||
19441582|NCT01449370|41688933|FG012|Overall Study|Other|0|||
19441583|NCT01449370|41688934|FG013|Overall Study|Other|0|||
19441584|NCT01449370|41688935|FG014|Overall Study|Other|0|||
19441585|NCT01449370|41688936|FG015|Overall Study|Other|0|||
19441586|NCT01449370|41688937|FG016|Overall Study|Other|0|||
19441587|NCT01449370|41688938|FG017|Overall Study|Other|0|||
19441588|NCT01449370|41688939|FG018|Overall Study|Other|0|||
19441589|NCT01449370|41688940|FG019|Overall Study|Other|0|||
19441590|NCT01449370|41688941|FG020|Overall Study|Other|0|||
19441591|NCT01449370|41688942|FG021|Overall Study|Other|0|||
19441592|NCT01449370|41688943|FG022|Overall Study|Other|1|||
19441593|NCT01449370|41688944|FG023|Overall Study|Other|1|||
19441594|NCT01449370|41688945|FG024|Overall Study|Other|0|||
19441595|NCT01449370|41688921|FG000|Overall Study|Medication Prohibited by Protocol|0|||
19441596|NCT01449370|41688922|FG001|Overall Study|Medication Prohibited by Protocol|0|||
19441597|NCT01449370|41688923|FG002|Overall Study|Medication Prohibited by Protocol|0|||
19441598|NCT01449370|41688924|FG003|Overall Study|Medication Prohibited by Protocol|0|||
19441599|NCT01449370|41688925|FG004|Overall Study|Medication Prohibited by Protocol|0|||
19441600|NCT01449370|41688926|FG005|Overall Study|Medication Prohibited by Protocol|0|||
19441601|NCT01449370|41688927|FG006|Overall Study|Medication Prohibited by Protocol|0|||
19441602|NCT01449370|41688928|FG007|Overall Study|Medication Prohibited by Protocol|0|||
19441603|NCT01449370|41688929|FG008|Overall Study|Medication Prohibited by Protocol|0|||
19441604|NCT01449370|41688930|FG009|Overall Study|Medication Prohibited by Protocol|0|||
19441605|NCT01449370|41688931|FG010|Overall Study|Medication Prohibited by Protocol|0|||
19441606|NCT01449370|41688932|FG011|Overall Study|Medication Prohibited by Protocol|0|||
19441607|NCT01449370|41688933|FG012|Overall Study|Medication Prohibited by Protocol|0|||
19441608|NCT01449370|41688934|FG013|Overall Study|Medication Prohibited by Protocol|0|||
19441609|NCT01449370|41688935|FG014|Overall Study|Medication Prohibited by Protocol|0|||
19441610|NCT01449370|41688936|FG015|Overall Study|Medication Prohibited by Protocol|0|||
19441611|NCT01449370|41688937|FG016|Overall Study|Medication Prohibited by Protocol|0|||
19441612|NCT01449370|41688938|FG017|Overall Study|Medication Prohibited by Protocol|0|||
19441613|NCT01449370|41688939|FG018|Overall Study|Medication Prohibited by Protocol|0|||
19441614|NCT01449370|41688940|FG019|Overall Study|Medication Prohibited by Protocol|0|||
19441615|NCT01449370|41688941|FG020|Overall Study|Medication Prohibited by Protocol|0|||
19441616|NCT01449370|41688942|FG021|Overall Study|Medication Prohibited by Protocol|0|||
19441617|NCT01449370|41688943|FG022|Overall Study|Medication Prohibited by Protocol|0|||
19441618|NCT01449370|41688944|FG023|Overall Study|Medication Prohibited by Protocol|1|||
19441619|NCT01449370|41688945|FG024|Overall Study|Medication Prohibited by Protocol|0|||
19441620|NCT01449370|41688921|FG000|Overall Study|Death|0|||
19441621|NCT01449370|41688922|FG001|Overall Study|Death|0|||
19441622|NCT01449370|41688923|FG002|Overall Study|Death|0|||
19441623|NCT01449370|41688924|FG003|Overall Study|Death|0|||
19441624|NCT01449370|41688925|FG004|Overall Study|Death|0|||
19441625|NCT01449370|41688926|FG005|Overall Study|Death|0|||
19441626|NCT01449370|41688927|FG006|Overall Study|Death|0|||
19441627|NCT01449370|41688928|FG007|Overall Study|Death|0|||
19441628|NCT01449370|41688929|FG008|Overall Study|Death|0|||
19441629|NCT01449370|41688930|FG009|Overall Study|Death|0|||
19441630|NCT01449370|41688931|FG010|Overall Study|Death|0|||
19441631|NCT01449370|41688932|FG011|Overall Study|Death|0|||
19441632|NCT01449370|41688933|FG012|Overall Study|Death|0|||
19441633|NCT01449370|41688934|FG013|Overall Study|Death|0|||
19441634|NCT01449370|41688935|FG014|Overall Study|Death|0|||
19441635|NCT01449370|41688936|FG015|Overall Study|Death|0|||
19441636|NCT01449370|41688937|FG016|Overall Study|Death|0|||
19441637|NCT01449370|41688938|FG017|Overall Study|Death|0|||
19441638|NCT01449370|41688939|FG018|Overall Study|Death|0|||
19441639|NCT01449370|41688940|FG019|Overall Study|Death|0|||
19441640|NCT01449370|41688941|FG020|Overall Study|Death|0|||
19441641|NCT01449370|41688942|FG021|Overall Study|Death|0|||
19441642|NCT01449370|41688943|FG022|Overall Study|Death|0|||
19441643|NCT01449370|41688944|FG023|Overall Study|Death|0|||
19441644|NCT01449370|41688945|FG024|Overall Study|Death|1|||
19522596|NCT03755518|41946128|FG000|Overall Study|Withdrawal by participant|4|||
19522597|NCT03755518|41946128|FG000|Overall Study|Progressive Disease|2|||
19522598|NCT03755518|41946128|FG000|Overall Study|Death|1|||
19522599|NCT03755518|41946128|FG000|Overall Study|Physician Decision|1|||
19522600|NCT03755518|41946128|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
19522601|NCT03546062|41946144|FG000|Overall Study|Adverse Event|6|||
19522602|NCT03546062|41946145|FG001|Overall Study|Adverse Event|5|||
19441645|NCT02067533|41689020|FG000|Overall Study|Lost to Follow-up|4|||
19441646|NCT02067533|41689021|FG001|Overall Study|Lost to Follow-up|2|||
19441647|NCT02066129|41689029|FG000|Overall Study|Lost to Follow-up|13|||
19441648|NCT02066129|41689030|FG001|Overall Study|Lost to Follow-up|12|||
19441649|NCT02066129|41689029|FG000|Overall Study|Withdrawal by Subject|7|||
19441650|NCT02066129|41689030|FG001|Overall Study|Withdrawal by Subject|10|||
19441651|NCT02066129|41689029|FG000|Overall Study|Lack of Efficacy|8|||
19441652|NCT02066129|41689030|FG001|Overall Study|Lack of Efficacy|10|||
19522603|NCT03546062|41946146|FG002|Overall Study|Adverse Event|8|||
19441653|NCT02066129|41689029|FG000|Overall Study|Physician Decision|1|||
19441654|NCT02066129|41689030|FG001|Overall Study|Physician Decision|1|||
19522604|NCT03539952|41946156|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
19441655|NCT02066051|41689036|FG000|Overall Study|Subject developed active GVHD|1|||
19441656|NCT01980992|41689042|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
19441657|NCT01980992|41689043|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
19441658|NCT01980992|41689042|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
19441659|NCT01980992|41689043|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
19441660|NCT01980992|41689042|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
19441661|NCT01980992|41689043|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
19441662|NCT01980992|41689042|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
19441663|NCT01980992|41689043|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
19441664|NCT01980992|41689042|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
19441665|NCT01980992|41689043|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
19441666|NCT01980992|41689042|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
19441667|NCT01980992|41689043|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
19441668|NCT02065895|41689056|FG000|Overall Study|Protocol Violation|1|||
19441669|NCT02065895|41689057|FG001|Overall Study|Protocol Violation|0|||
19441670|NCT02065895|41689058|FG002|Overall Study|Protocol Violation|0|||
19441671|NCT02065895|41689059|FG003|Overall Study|Protocol Violation|1|||
19441672|NCT02065895|41689060|FG004|Overall Study|Protocol Violation|0|||
19441673|NCT02065895|41689061|FG005|Overall Study|Protocol Violation|0|||
19441674|NCT02065895|41689056|FG000|Overall Study|Scheduling conflicts|0|||
19441675|NCT02065895|41689057|FG001|Overall Study|Scheduling conflicts|1|||
19441676|NCT02065895|41689058|FG002|Overall Study|Scheduling conflicts|0|||
19441677|NCT02065895|41689059|FG003|Overall Study|Scheduling conflicts|0|||
19441678|NCT02065895|41689060|FG004|Overall Study|Scheduling conflicts|0|||
19441679|NCT02065895|41689061|FG005|Overall Study|Scheduling conflicts|0|||
19441680|NCT02106455|41689078|FG000|Overall Study|Case Report Form Uncollected|6|||
19441681|NCT02106455|41689078|FG000|Overall Study|Protocol Deviation|2|||
19441682|NCT02006654|41689084|FG000|Overall Study|Withdrawal before treatment|4|||
19441683|NCT02006654|41689085|FG001|Overall Study|Withdrawal before treatment|2|||
19441684|NCT02006654|41689084|FG000|Overall Study|Adverse Event|16|||
19441685|NCT02006654|41689085|FG001|Overall Study|Adverse Event|17|||
19441686|NCT02006654|41689084|FG000|Overall Study|Death|1|||
19441687|NCT02006654|41689085|FG001|Overall Study|Death|0|||
19441688|NCT02006654|41689084|FG000|Overall Study|Withdrawal by Subject|14|||
19441689|NCT02006654|41689085|FG001|Overall Study|Withdrawal by Subject|12|||
19441690|NCT02006654|41689084|FG000|Overall Study|Protocol Violation|5|||
19441691|NCT02006654|41689085|FG001|Overall Study|Protocol Violation|8|||
19441692|NCT02006654|41689084|FG000|Overall Study|Lost to Follow-up|1|||
19441693|NCT02006654|41689085|FG001|Overall Study|Lost to Follow-up|0|||
19441694|NCT02006654|41689084|FG000|Overall Study|patient's will|2|||
19441695|NCT02006654|41689085|FG001|Overall Study|patient's will|1|||
19441696|NCT02006654|41689084|FG000|Overall Study|insufficient compliance|1|||
19441697|NCT02006654|41689085|FG001|Overall Study|insufficient compliance|0|||
19441698|NCT02006654|41689084|FG000|Overall Study|worsening cognitive condition|0|||
19441699|NCT02006654|41689085|FG001|Overall Study|worsening cognitive condition|1|||
19441700|NCT02006654|41689084|FG000|Overall Study|faecal incontinence|0|||
19441701|NCT02006654|41689085|FG001|Overall Study|faecal incontinence|1|||
19441702|NCT02006654|41689084|FG000|Overall Study|mood disorder|0|||
19441703|NCT02006654|41689085|FG001|Overall Study|mood disorder|1|||
19441704|NCT02006654|41689084|FG000|Overall Study|disallowed medication|1|||
19441705|NCT02006654|41689085|FG001|Overall Study|disallowed medication|0|||
19441706|NCT02006654|41689084|FG000|Overall Study|moving out of state|0|||
19441707|NCT02006654|41689085|FG001|Overall Study|moving out of state|1|||
19441708|NCT01980056|41689095|FG000|Overall Study|Death|1|||
19441709|NCT01980056|41689096|FG001|Overall Study|Death|1|||
19441710|NCT01980056|41689097|FG002|Overall Study|Death|0|||
19441711|NCT02027558|41689111|FG000|Overall Study|Death|0|||
19441712|NCT02027558|41689112|FG001|Overall Study|Death|1|||
19441713|NCT02027558|41689111|FG000|Overall Study|Withdrawal by Subject|2|||
19441714|NCT02027558|41689112|FG001|Overall Study|Withdrawal by Subject|0|||
19441715|NCT02027558|41689111|FG000|Overall Study|Lost to Follow-up|4|||
19441716|NCT02027558|41689112|FG001|Overall Study|Lost to Follow-up|1|||
19441717|NCT02027558|41689111|FG000|Overall Study|Refused assessment|3|||
19441718|NCT02027558|41689112|FG001|Overall Study|Refused assessment|0|||
19441719|NCT02006576|41689123|FG000|Overall Study|Withdrawal by Subject|4|||
19441720|NCT02006576|41689124|FG001|Overall Study|Withdrawal by Subject|6|||
19441721|NCT02006576|41689125|FG002|Overall Study|Withdrawal by Subject|2|||
19441722|NCT02006576|41689123|FG000|Overall Study|Death|0|||
19441723|NCT02006576|41689124|FG001|Overall Study|Death|0|||
19441724|NCT02006576|41689125|FG002|Overall Study|Death|1|||
19441725|NCT02006576|41689123|FG000|Overall Study|Lost to Follow-up|1|||
19441726|NCT02006576|41689124|FG001|Overall Study|Lost to Follow-up|0|||
19441727|NCT02006576|41689125|FG002|Overall Study|Lost to Follow-up|1|||
19441728|NCT02006576|41689123|FG000|Overall Study|Screen Failure, too sick, other|13|||
19441729|NCT02006576|41689124|FG001|Overall Study|Screen Failure, too sick, other|1|||
19441730|NCT02006576|41689125|FG002|Overall Study|Screen Failure, too sick, other|13|||
19441731|NCT02027402|41689135|FG000|Overall Study|Withdrawal by Subject|4|||
19441732|NCT02027402|41689136|FG001|Overall Study|Withdrawal by Subject|1|||
19441733|NCT01448824|41689152|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19441734|NCT01448824|41689153|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19441735|NCT01448824|41689154|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19441736|NCT01448824|41689155|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19441737|NCT01448824|41689156|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19522605|NCT03539952|41946157|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
19522606|NCT03539952|41946156|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
19522607|NCT03539952|41946157|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
19522608|NCT03539952|41946156|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
19522609|NCT03539952|41946157|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
19522610|NCT03539952|41946156|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
19522611|NCT03539952|41946157|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
19522612|NCT03539952|41946156|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
19522613|NCT03539952|41946157|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
19522614|NCT03539952|41946156|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
19522615|NCT03539952|41946157|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
19522616|NCT03539952|41946156|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
19522617|NCT03539952|41946157|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
19522618|NCT03471078|41946184|FG000|Overall Study|Withdrawal by Subject|9|||
19522619|NCT03471078|41946185|FG001|Overall Study|Withdrawal by Subject|1|||
19522620|NCT03471078|41946184|FG000|Overall Study|Adverse Event|4|||
19522621|NCT03471078|41946185|FG001|Overall Study|Adverse Event|1|||
19522622|NCT03471078|41946184|FG000|Overall Study|Physician Decision|3|||
19522623|NCT03471078|41946185|FG001|Overall Study|Physician Decision|2|||
19522624|NCT03471078|41946184|FG000|Overall Study|Death|2|||
19522625|NCT03471078|41946185|FG001|Overall Study|Death|0|||
19522626|NCT03471078|41946184|FG000|Overall Study|Other|3|||
19522627|NCT03471078|41946185|FG001|Overall Study|Other|2|||
19522628|NCT03155997|41946193|FG000|Overall Study|Withdrawal by Subject|119|||
19522629|NCT03155997|41946194|FG001|Overall Study|Withdrawal by Subject|134|||
19522630|NCT03155997|41946193|FG000|Overall Study|Lost to Follow-up|12|||
19522631|NCT03155997|41946194|FG001|Overall Study|Lost to Follow-up|13|||
19522632|NCT03155997|41946193|FG000|Overall Study|Missing disposition data|0|||
19522633|NCT03155997|41946194|FG001|Overall Study|Missing disposition data|1|||
19522634|NCT03155997|41946193|FG000|Overall Study|On study treatment|2027|||
19522635|NCT03155997|41946194|FG001|Overall Study|On study treatment|2074|||
19522636|NCT02929108|41946207|FG000|Overall Study|Hospice patient death|100|||
19522637|NCT02929108|41946208|FG001|Overall Study|Hospice patient death|64|||
19522638|NCT02929108|41946209|FG002|Overall Study|Hospice patient death|28|||
19522639|NCT02929108|41946210|FG003|Overall Study|Hospice patient death|46|||
19522640|NCT02929108|41946211|FG004|Overall Study|Hospice patient death|55|||
19522641|NCT02929108|41946212|FG005|Overall Study|Hospice patient death|28|||
19522642|NCT02929108|41946213|FG006|Overall Study|Hospice patient death|78|||
19522643|NCT02661295|41946221|FG000|Overall Study|Death|1|||
19522644|NCT02661295|41946221|FG000|Overall Study|Transferred Out|1|||
19522645|NCT02661295|41946221|FG000|Overall Study|Kidney Transplant|1|||
19522646|NCT02661295|41946221|FG000|Overall Study|Withdrawn due to side effects|8|||
19522647|NCT02661295|41946221|FG000|Overall Study|Withdrawn due to access type|1|||
19522648|NCT02661295|41946221|FG000|Overall Study|Withdrawn due to allergies|1|||
19522649|NCT02661295|41946221|FG000|Overall Study|Withdrawn due to non-compliance|1|||
19522650|NCT02661295|41946221|FG000|Overall Study|Withdrawal by Subject|3|||
19522651|NCT02661295|41946221|FG000|Overall Study|Failed screening|2|||
19522652|NCT02527434|41946228|FG000|Overall Study|Lost to Follow-up|2|||
19522653|NCT02527434|41946229|FG001|Overall Study|Lost to Follow-up|2|||
19522654|NCT02527434|41946230|FG002|Overall Study|Lost to Follow-up|0|||
19522655|NCT02527434|41946228|FG000|Overall Study|Death|19|||
19522656|NCT02527434|41946229|FG001|Overall Study|Death|6|||
19522657|NCT02527434|41946230|FG002|Overall Study|Death|17|||
19522658|NCT02527434|41946228|FG000|Overall Study|Withdrawal by Subject|5|||
19522659|NCT02527434|41946229|FG001|Overall Study|Withdrawal by Subject|3|||
19522660|NCT02527434|41946230|FG002|Overall Study|Withdrawal by Subject|3|||
19441738|NCT01448824|41689157|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19441739|NCT01448824|41689158|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
19441740|NCT01448824|41689159|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
19522661|NCT02527434|41946228|FG000|Overall Study|Reason Not Specified|1|||
19522662|NCT02527434|41946229|FG001|Overall Study|Reason Not Specified|0|||
19522663|NCT02527434|41946230|FG002|Overall Study|Reason Not Specified|0|||
19522664|NCT02527434|41946228|FG000|Overall Study|Site closure|1|||
19522665|NCT02527434|41946229|FG001|Overall Study|Site closure|0|||
19522666|NCT02527434|41946230|FG002|Overall Study|Site closure|0|||
19522667|NCT02412748|41946259|FG000|Overall Study|Lost to Follow-up|38|||
19522668|NCT02412748|41946260|FG001|Overall Study|Lost to Follow-up|39|||
19522669|NCT01844726|41946285|FG000|Overall Study|Withdrawal by Subject|0|||
19441741|NCT01448824|41689152|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
19441742|NCT01448824|41689153|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
19441743|NCT01448824|41689154|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
19441744|NCT01448824|41689155|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
19441745|NCT01448824|41689156|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
19441746|NCT01448824|41689157|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
19441747|NCT01448824|41689158|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
19441748|NCT01448824|41689159|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
19441749|NCT01448824|41689152|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441750|NCT01448824|41689153|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441751|NCT01448824|41689154|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441752|NCT01448824|41689155|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441753|NCT01448824|41689156|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441754|NCT01448824|41689157|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
19441755|NCT01448824|41689158|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441756|NCT01448824|41689159|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
19441757|NCT01448824|41689152|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
19441758|NCT01448824|41689153|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
19441759|NCT01448824|41689154|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
19441760|NCT01448824|41689155|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
19441761|NCT01448824|41689156|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
19441762|NCT01448824|41689157|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
19441763|NCT01448824|41689158|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
19441764|NCT01448824|41689159|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
19441765|NCT01448824|41689152|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441766|NCT01448824|41689153|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441767|NCT01448824|41689154|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441768|NCT01448824|41689155|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441769|NCT01448824|41689156|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441770|NCT01448824|41689157|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441771|NCT01448824|41689158|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
19441772|NCT01448824|41689159|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
19441773|NCT01448824|41689152|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441774|NCT01448824|41689153|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441775|NCT01448824|41689154|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441776|NCT01448824|41689155|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441777|NCT01448824|41689156|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441778|NCT01448824|41689157|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441779|NCT01448824|41689158|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
19441780|NCT01448824|41689159|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
19441781|NCT01448824|41689152|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441782|NCT01448824|41689153|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441783|NCT01448824|41689154|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441784|NCT01448824|41689155|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441785|NCT01448824|41689156|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441786|NCT01448824|41689157|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441787|NCT01448824|41689158|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
19441788|NCT01448824|41689159|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
19441789|NCT01448824|41689152|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441790|NCT01448824|41689153|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441791|NCT01448824|41689154|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441792|NCT01448824|41689155|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441793|NCT01448824|41689156|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441794|NCT01448824|41689157|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441795|NCT01448824|41689158|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
19441796|NCT01448824|41689159|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
19441797|NCT02005562|41689189|FG000|Overall Study|Death|2|||
19441798|NCT02005562|41689190|FG001|Overall Study|Death|2|||
19441799|NCT02005562|41689189|FG000|Overall Study|Graft loss|7|||
19441800|NCT02005562|41689190|FG001|Overall Study|Graft loss|6|||
19441801|NCT02005562|41689189|FG000|Overall Study|Withdrawal by Subject|2|||
19522670|NCT01844726|41946286|FG001|Overall Study|Withdrawal by Subject|1|||
19441802|NCT02005562|41689190|FG001|Overall Study|Withdrawal by Subject|2|||
19441803|NCT02005562|41689189|FG000|Overall Study|No transplant|1|||
19441804|NCT02005562|41689190|FG001|Overall Study|No transplant|4|||
19441805|NCT02005562|41689189|FG000|Overall Study|Physician Decision|0|||
19441806|NCT02005562|41689190|FG001|Overall Study|Physician Decision|1|||
19441807|NCT01448044|41689198|FG000|Treatment Period|Adverse Event|4|||
19441808|NCT01448044|41689199|FG001|Treatment Period|Adverse Event|3|||
19441809|NCT01448044|41689198|FG000|Treatment Period|Lack of Efficacy|5|||
19441810|NCT01448044|41689199|FG001|Treatment Period|Lack of Efficacy|12|||
19441811|NCT01448044|41689198|FG000|Treatment Period|Subject requested discontinue study drug|1|||
19441812|NCT01448044|41689199|FG001|Treatment Period|Subject requested discontinue study drug|0|||
19441813|NCT01448044|41689198|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
19441814|NCT01448044|41689199|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
19441815|NCT01448044|41689198|FG000|Treatment Period|Participant does not meet study criteria|1|||
19441816|NCT01448044|41689199|FG001|Treatment Period|Participant does not meet study criteria|0|||
19441817|NCT01448044|41689198|FG000|Treatment Period|Lost to Follow-up|2|||
19441818|NCT01448044|41689199|FG001|Treatment Period|Lost to Follow-up|1|||
19441819|NCT01448044|41689198|FG000|Treatment Period|Other reason|2|||
19441820|NCT01448044|41689199|FG001|Treatment Period|Other reason|0|||
19441821|NCT01448044|41689198|FG000|Follow Up Period|Withdrawal by Subject|1|||
19441822|NCT01448044|41689199|FG001|Follow Up Period|Withdrawal by Subject|1|||
19441823|NCT01448044|41689198|FG000|Follow Up Period|Lost to Follow-up|6|||
19441824|NCT01448044|41689199|FG001|Follow Up Period|Lost to Follow-up|2|||
19441825|NCT01448044|41689198|FG000|Follow Up Period|Other|5|||
19441826|NCT01448044|41689199|FG001|Follow Up Period|Other|11|||
19441827|NCT02025530|41689207|FG000|Overall Study|No longer met elligibility criteria|5|||
19441828|NCT02025530|41689208|FG001|Overall Study|No longer met elligibility criteria|1|||
19441829|NCT01472380|41689214|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
19441830|NCT01472380|41689214|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
19441831|NCT01978262|41689221|FG000|Overall Study|Withdrawal by Subject|9|||
19441832|NCT01978262|41689221|FG000|Overall Study|Lost to Follow-up|2|||
19441833|NCT01447576|41689226|FG000|Overall Study|Lost to Follow-up|52|||
19441834|NCT01447576|41689226|FG000|Overall Study|Adverse Event|127|||
19441835|NCT01447576|41689226|FG000|Overall Study|Participant met withdrawal criteria|40|||
19441836|NCT01447576|41689226|FG000|Overall Study|Withdrawal by Subject|100|||
19441837|NCT01447576|41689226|FG000|Overall Study|Protocol deviation|83|||
19441838|NCT01447576|41689226|FG000|Overall Study|Lack of Efficacy|68|||
19441839|NCT01447576|41689226|FG000|Overall Study|Physician Decision|6|||
19441840|NCT01447420|41689233|FG000|Overall Study|Adverse Event|2|||
19441841|NCT01447420|41689234|FG001|Overall Study|Adverse Event|4|||
19441842|NCT01447420|41689235|FG002|Overall Study|Adverse Event|2|||
19441843|NCT01447420|41689233|FG000|Overall Study|Protocol Violation|3|||
19441844|NCT01447420|41689234|FG001|Overall Study|Protocol Violation|3|||
19441845|NCT01447420|41689235|FG002|Overall Study|Protocol Violation|0|||
19441846|NCT01447420|41689233|FG000|Overall Study|Withdrawal by Subject|4|||
19441847|NCT01447420|41689234|FG001|Overall Study|Withdrawal by Subject|1|||
19441848|NCT01447420|41689235|FG002|Overall Study|Withdrawal by Subject|0|||
19441849|NCT01447420|41689233|FG000|Overall Study|Lack of Efficacy|1|||
19441850|NCT01447420|41689234|FG001|Overall Study|Lack of Efficacy|19|||
19441851|NCT01447420|41689235|FG002|Overall Study|Lack of Efficacy|8|||
19441852|NCT01471522|41689244|FG000|Overall Study|Withdrawal by Subject|28|||
19441853|NCT01471522|41689245|FG001|Overall Study|Withdrawal by Subject|22|||
19441854|NCT01471522|41689244|FG000|Overall Study|Lost to Follow-up|36|||
19441855|NCT01471522|41689245|FG001|Overall Study|Lost to Follow-up|26|||
19441856|NCT01446874|41689255|FG000|Overall Study|Not eligible|1|||
19441857|NCT01446874|41689256|FG001|Overall Study|Not eligible|0|||
19441858|NCT01446874|41689257|FG002|Overall Study|Not eligible|0|||
19441859|NCT01446874|41689255|FG000|Overall Study|No surgery/No qualifying surgery|1|||
19441860|NCT01446874|41689256|FG001|Overall Study|No surgery/No qualifying surgery|0|||
19441861|NCT01446874|41689257|FG002|Overall Study|No surgery/No qualifying surgery|12|||
19441862|NCT01446874|41689255|FG000|Overall Study|Non-compliance|0|||
19441863|NCT01446874|41689256|FG001|Overall Study|Non-compliance|4|||
19441864|NCT01446874|41689257|FG002|Overall Study|Non-compliance|0|||
19441865|NCT01446874|41689255|FG000|Overall Study|Antibiotics for pre-op infection|0|||
19441866|NCT01446874|41689256|FG001|Overall Study|Antibiotics for pre-op infection|0|||
19441867|NCT01446874|41689257|FG002|Overall Study|Antibiotics for pre-op infection|2|||
19441868|NCT01446874|41689255|FG000|Overall Study|Withdrawal by Subject|0|||
19441869|NCT01446874|41689256|FG001|Overall Study|Withdrawal by Subject|0|||
19441870|NCT01446874|41689257|FG002|Overall Study|Withdrawal by Subject|4|||
19441871|NCT01446796|41689265|FG000|Overall Study|Withdrawal by Subject|1|||
19441872|NCT01446796|41689266|FG001|Overall Study|Withdrawal by Subject|0|||
19441873|NCT01439074|41689276|FG000|Overall Study|Lost to Follow-up|3|||
19441874|NCT01439074|41689277|FG001|Overall Study|Lost to Follow-up|4|||
19441875|NCT01439074|41689276|FG000|Overall Study|Subject shedding|1|||
19441876|NCT01439074|41689277|FG001|Overall Study|Subject shedding|0|||
19441877|NCT01439074|41689276|FG000|Overall Study|Withdrawal by Subject|1|||
19441878|NCT01439074|41689277|FG001|Overall Study|Withdrawal by Subject|5|||
19441879|NCT01439074|41689276|FG000|Overall Study|Other|4|||
19441880|NCT01439074|41689277|FG001|Overall Study|Other|4|||
19441881|NCT01438996|41689286|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
19441882|NCT01438996|41689287|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
19441883|NCT01438996|41689288|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
19441884|NCT01438840|41689298|FG000|Core Study|Adverse Event|0|||
19441885|NCT01438840|41689299|FG001|Core Study|Adverse Event|3|||
19441886|NCT01438840|41689300|FG002|Core Study|Adverse Event|0|||
19441887|NCT01438840|41689298|FG000|Core Study|Lack of Efficacy|15|||
19441888|NCT01438840|41689299|FG001|Core Study|Lack of Efficacy|7|||
19441889|NCT01438840|41689300|FG002|Core Study|Lack of Efficacy|0|||
19441890|NCT01438840|41689298|FG000|Core Study|Withdrawal of consent|1|||
19441891|NCT01438840|41689299|FG001|Core Study|Withdrawal of consent|0|||
19441892|NCT01438840|41689300|FG002|Core Study|Withdrawal of consent|0|||
19441893|NCT01438840|41689298|FG000|Extension Phase|Adverse Event|0|||
19441894|NCT01438840|41689299|FG001|Extension Phase|Adverse Event|0|||
19441895|NCT01438840|41689300|FG002|Extension Phase|Adverse Event|3|||
19441896|NCT01438840|41689298|FG000|Extension Phase|Lost to Follow-up|0|||
19441897|NCT01438840|41689299|FG001|Extension Phase|Lost to Follow-up|0|||
19441898|NCT01438840|41689300|FG002|Extension Phase|Lost to Follow-up|1|||
19441899|NCT01438840|41689298|FG000|Extension Phase|Withdrawal by Subject|0|||
19441900|NCT01438840|41689299|FG001|Extension Phase|Withdrawal by Subject|0|||
19441901|NCT01438840|41689300|FG002|Extension Phase|Withdrawal by Subject|3|||
19441902|NCT01438840|41689298|FG000|Extension Phase|Lack of Efficacy|0|||
19441903|NCT01438840|41689299|FG001|Extension Phase|Lack of Efficacy|0|||
19441904|NCT01438840|41689300|FG002|Extension Phase|Lack of Efficacy|2|||
19441905|NCT01438840|41689298|FG000|Extension Phase|Other|0|||
19441906|NCT01438840|41689299|FG001|Extension Phase|Other|0|||
19441907|NCT01438840|41689300|FG002|Extension Phase|Other|1|||
19441908|NCT01471054|41689309|FG000|Overall Study|Study terminated prematurely|4|||
19441909|NCT01471054|41689310|FG001|Overall Study|Study terminated prematurely|0|||
19441910|NCT01978184|41689328|FG000|Overall Study|Progressive disease|5|||
19441911|NCT01978184|41689329|FG001|Overall Study|Progressive disease|5|||
19441912|NCT01978184|41689328|FG000|Overall Study|Other than PDA|2|||
19441913|NCT01978184|41689329|FG001|Overall Study|Other than PDA|2|||
19441914|NCT01978184|41689328|FG000|Overall Study|Physician Decision|0|||
19441915|NCT01978184|41689329|FG001|Overall Study|Physician Decision|3|||
19441916|NCT01978184|41689328|FG000|Overall Study|Noncompliance|1|||
19441917|NCT01978184|41689329|FG001|Overall Study|Noncompliance|2|||
19441918|NCT01978184|41689328|FG000|Overall Study|Death|1|||
19441919|NCT01978184|41689329|FG001|Overall Study|Death|0|||
19441920|NCT01978184|41689328|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
19441921|NCT01978184|41689329|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
19441922|NCT01445548|41689335|FG000|Overall Study|Adverse Event|1|||
19441923|NCT01977794|41689341|FG000|Overall Study|Adverse Event|2|||
19441924|NCT01977794|41689342|FG001|Overall Study|Adverse Event|2|||
19441925|NCT01977794|41689341|FG000|Overall Study|Lost to Follow-up|2|||
19441926|NCT01977794|41689342|FG001|Overall Study|Lost to Follow-up|1|||
19441927|NCT01977794|41689341|FG000|Overall Study|Protocol Violation|1|||
19441928|NCT01977794|41689342|FG001|Overall Study|Protocol Violation|0|||
19441929|NCT01977794|41689341|FG000|Overall Study|Death|1|||
19441930|NCT01977794|41689342|FG001|Overall Study|Death|1|||
19441931|NCT01977794|41689341|FG000|Overall Study|Withdrew consent|2|||
19441932|NCT01977794|41689342|FG001|Overall Study|Withdrew consent|1|||
19441933|NCT01977794|41689341|FG000|Overall Study|Other|0|||
19441934|NCT01977794|41689342|FG001|Overall Study|Other|1|||
19441935|NCT02005484|41689348|FG000|Overall Study|Death|1|||
19441936|NCT02005484|41689348|FG000|Overall Study|Disease progression|1|||
19441937|NCT02005484|41689348|FG000|Overall Study|Changed to a Different Study|1|||
19441938|NCT02005484|41689348|FG000|Overall Study|Sponsor decision|1|||
19441939|NCT02005250|41689354|FG000|Overall Study|Lost to Follow-up|15|||
19441940|NCT02005250|41689355|FG001|Overall Study|Lost to Follow-up|5|||
19441941|NCT02024750|41689363|FG000|Overall Study|Withdrawal by Subject|2|||
19441942|NCT02024750|41689364|FG001|Overall Study|Withdrawal by Subject|1|||
19441943|NCT01597973|41689372|FG000|Overall Study|Found ineligible before study medication started|4|||
19441944|NCT01597973|41689373|FG001|Overall Study|Found ineligible before study medication started|2|||
19441945|NCT01597973|41689372|FG000|Overall Study|Eligible pathogen not confirmed|14|||
19441946|NCT01597973|41689373|FG001|Overall Study|Eligible pathogen not confirmed|15|||
19441947|NCT01597973|41689372|FG000|Overall Study|LAR not authorized to consent|0|||
19441948|NCT01597973|41689373|FG001|Overall Study|LAR not authorized to consent|1|||
19441949|NCT01597973|41689372|FG000|Overall Study|Ineligible due to early seizures|1|||
19441950|NCT01597973|41689373|FG001|Overall Study|Ineligible due to early seizures|0|||
19441951|NCT01597973|41689372|FG000|Overall Study|Ineligible due to non-target infection|1|||
19522671|NCT01844726|41946285|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
19441952|NCT01597973|41689373|FG001|Overall Study|Ineligible due to non-target infection|1|||
19441953|NCT02023268|41689383|FG000|Overall Study|Lack of Efficacy|0|||
19441954|NCT02023268|41689384|FG001|Overall Study|Lack of Efficacy|1|||
19441955|NCT02023268|41689383|FG000|Overall Study|Adverse Event|0|||
19441956|NCT02023268|41689384|FG001|Overall Study|Adverse Event|2|||
19441957|NCT02023268|41689383|FG000|Overall Study|Withdrawal by Subject|0|||
19441958|NCT02023268|41689384|FG001|Overall Study|Withdrawal by Subject|1|||
19441959|NCT02047253|41689390|FG000|Overall Study|Lost to Follow-up|8|||
19441960|NCT02096705|41689396|FG000|Treatment|Adverse Event|6|||
19441961|NCT02096705|41689397|FG001|Treatment|Adverse Event|3|||
19441962|NCT02096705|41689396|FG000|Treatment|Subject request to discontinue treatment|1|||
19441963|NCT02096705|41689397|FG001|Treatment|Subject request to discontinue treatment|1|||
19441964|NCT02096705|41689396|FG000|Treatment|Withdrawal by Subject|1|||
19441965|NCT02096705|41689397|FG001|Treatment|Withdrawal by Subject|0|||
19441966|NCT02096705|41689396|FG000|Treatment|Other|1|||
19441967|NCT02096705|41689397|FG001|Treatment|Other|1|||
19441968|NCT02096705|41689396|FG000|Follow-up|Withdrawal by Subject|1|||
19441969|NCT02096705|41689397|FG001|Follow-up|Withdrawal by Subject|0|||
19441970|NCT02096705|41689396|FG000|Follow-up|Adverse Event|2|||
19441971|NCT02096705|41689397|FG001|Follow-up|Adverse Event|2|||
19441972|NCT02096705|41689396|FG000|Follow-up|Subjects not reporting status|1|||
19441973|NCT02096705|41689397|FG001|Follow-up|Subjects not reporting status|2|||
19441974|NCT02096471|41689403|FG000|Overall Study|Adverse Event|1|||
19441975|NCT02096471|41689403|FG000|Overall Study|Lack of Efficacy|7|||
19441976|NCT02096471|41689403|FG000|Overall Study|Withdrawal by Subject|3|||
19441977|NCT02096471|41689403|FG000|Overall Study|Non-Compliant|2|||
19441978|NCT02096003|41689409|FG000|Overall Study|Protocol Violation|0|||
19441979|NCT02096003|41689410|FG001|Overall Study|Protocol Violation|2|||
19441980|NCT02096003|41689409|FG000|Overall Study|additional surgery|2|||
19441981|NCT02096003|41689410|FG001|Overall Study|additional surgery|1|||
19441982|NCT02062385|41689420|FG000|Overall Study|Adverse Event|19|||
19441983|NCT02062385|41689421|FG001|Overall Study|Adverse Event|13|||
19441984|NCT02062385|41689422|FG002|Overall Study|Adverse Event|1|||
19441985|NCT02062385|41689423|FG003|Overall Study|Adverse Event|0|||
19441986|NCT02062385|41689420|FG000|Overall Study|Protocol Violation|1|||
19441987|NCT02062385|41689421|FG001|Overall Study|Protocol Violation|0|||
19441988|NCT02062385|41689422|FG002|Overall Study|Protocol Violation|0|||
19441989|NCT02062385|41689423|FG003|Overall Study|Protocol Violation|0|||
19522672|NCT01844726|41946286|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
19441990|NCT02062385|41689420|FG000|Overall Study|Incomplete EPI by database lock|2|||
19441991|NCT02062385|41689421|FG001|Overall Study|Incomplete EPI by database lock|0|||
19441992|NCT02062385|41689422|FG002|Overall Study|Incomplete EPI by database lock|0|||
19441993|NCT02062385|41689423|FG003|Overall Study|Incomplete EPI by database lock|0|||
19441994|NCT02062385|41689420|FG000|Overall Study|Moved|10|||
19441995|NCT02062385|41689421|FG001|Overall Study|Moved|11|||
19441996|NCT02062385|41689422|FG002|Overall Study|Moved|1|||
19441997|NCT02062385|41689423|FG003|Overall Study|Moved|0|||
19441998|NCT02062385|41689420|FG000|Overall Study|Withdrawn by parent/guardian|46|||
19441999|NCT02062385|41689421|FG001|Overall Study|Withdrawn by parent/guardian|41|||
19442000|NCT02062385|41689422|FG002|Overall Study|Withdrawn by parent/guardian|9|||
19442001|NCT02062385|41689423|FG003|Overall Study|Withdrawn by parent/guardian|8|||
19442002|NCT02062385|41689420|FG000|Overall Study|Death|0|||
19442003|NCT02062385|41689421|FG001|Overall Study|Death|0|||
19442004|NCT02062385|41689422|FG002|Overall Study|Death|0|||
19522673|NCT01660451|41946295|FG000|Overall Study|Protocol Violation|0|||
19522674|NCT01660451|41946296|FG001|Overall Study|Protocol Violation|1|||
19522675|NCT01660451|41946297|FG002|Overall Study|Protocol Violation|1|||
19522676|NCT01660451|41946295|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
19522677|NCT01660451|41946296|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
19522678|NCT01660451|41946297|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
19522679|NCT01660451|41946295|FG000|Overall Study|AE with Clinical PD|1|||
19522680|NCT01660451|41946296|FG001|Overall Study|AE with Clinical PD|3|||
19522681|NCT01660451|41946297|FG002|Overall Study|AE with Clinical PD|9|||
19522682|NCT01660451|41946295|FG000|Overall Study|Sponsor Decision|0|||
19522683|NCT01660451|41946296|FG001|Overall Study|Sponsor Decision|0|||
19522684|NCT01660451|41946297|FG002|Overall Study|Sponsor Decision|1|||
19522685|NCT01660451|41946295|FG000|Overall Study|Protocol Deviation|0|||
19522686|NCT01660451|41946296|FG001|Overall Study|Protocol Deviation|0|||
19522687|NCT01660451|41946297|FG002|Overall Study|Protocol Deviation|1|||
19522688|NCT01660451|41946295|FG000|Overall Study|Physician Decision|1|||
19522689|NCT01660451|41946296|FG001|Overall Study|Physician Decision|2|||
19442005|NCT02062385|41689423|FG003|Overall Study|Death|1|||
19442006|NCT02062385|41689420|FG000|Overall Study|Lost to Follow-up|0|||
19442007|NCT02062385|41689421|FG001|Overall Study|Lost to Follow-up|0|||
19442008|NCT02062385|41689422|FG002|Overall Study|Lost to Follow-up|1|||
19442009|NCT02062385|41689423|FG003|Overall Study|Lost to Follow-up|0|||
19442010|NCT02062151|41689431|FG000|Overall Study|screen failure|1|||
19442011|NCT02060903|41689437|FG000|Overall Study|Lost to Follow-up|4|||
19442012|NCT02060903|41689438|FG001|Overall Study|Lost to Follow-up|0|||
19442013|NCT02060903|41689437|FG000|Overall Study|Withdrawal by Subject|0|||
19442014|NCT02060903|41689438|FG001|Overall Study|Withdrawal by Subject|7|||
19442015|NCT02095691|41689444|FG000|Overall Study|Physician Decision|1|||
19442016|NCT02095535|41689460|FG000|Recruitment|Protocol Violation|2|||
19442017|NCT02095223|41689466|FG000|Overall Study|Withdrawal by Subject|1|||
19522690|NCT01660451|41946297|FG002|Overall Study|Physician Decision|5|||
19522691|NCT01660451|41946295|FG000|Overall Study|Withdrawal by Subject|1|||
19522692|NCT01660451|41946296|FG001|Overall Study|Withdrawal by Subject|0|||
19442018|NCT02095223|41689467|FG001|Overall Study|Withdrawal by Subject|0|||
19442019|NCT02095145|41689475|FG000|Overall Study|Withdrawal by Subject|1|||
19442020|NCT02095145|41689476|FG001|Overall Study|Withdrawal by Subject|0|||
19442021|NCT02059187|41689486|FG000|Overall Study|Adverse Event|0|||
19442022|NCT02059187|41689487|FG001|Overall Study|Adverse Event|3|||
19442023|NCT02059187|41689486|FG000|Overall Study|Death|1|||
19442024|NCT02059187|41689487|FG001|Overall Study|Death|1|||
19442025|NCT02059187|41689486|FG000|Overall Study|Lost to Follow-up|9|||
19442026|NCT02059187|41689487|FG001|Overall Study|Lost to Follow-up|8|||
19442027|NCT02059187|41689486|FG000|Overall Study|Non-compliance with study drug|1|||
19442028|NCT02059187|41689487|FG001|Overall Study|Non-compliance with study drug|0|||
19442029|NCT02059187|41689486|FG000|Overall Study|Physician Decision|1|||
19442030|NCT02059187|41689487|FG001|Overall Study|Physician Decision|2|||
19442031|NCT02059187|41689486|FG000|Overall Study|Protocol Violation|1|||
19442032|NCT02059187|41689487|FG001|Overall Study|Protocol Violation|0|||
19442033|NCT02059187|41689486|FG000|Overall Study|Withdrawal by Subject|12|||
19442034|NCT02059187|41689487|FG001|Overall Study|Withdrawal by Subject|8|||
19442035|NCT02043899|41689493|FG000|Overall Study|Adverse Event|3|||
19442036|NCT02043899|41689493|FG000|Overall Study|Physician Decision|1|||
19442037|NCT02043899|41689493|FG000|Overall Study|Withdrawal by Subject|2|||
19442038|NCT02043899|41689493|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
19442039|NCT02043899|41689493|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
19442040|NCT02043899|41689493|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
19442041|NCT02043899|41689493|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
19442042|NCT02043899|41689493|FG000|Overall Study|Treatment delayed|1|||
19442043|NCT02043509|41689499|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
19442044|NCT02043509|41689500|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
19442045|NCT02043509|41689499|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
19442046|NCT02043509|41689500|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
19522693|NCT01660451|41946297|FG002|Overall Study|Withdrawal by Subject|16|||
19522694|NCT01660451|41946295|FG000|Overall Study|Ongoing with treatment|3|||
19522695|NCT01660451|41946296|FG001|Overall Study|Ongoing with treatment|3|||
19522696|NCT01660451|41946297|FG002|Overall Study|Ongoing with treatment|46|||
19522697|NCT03180840|41951900|FG000|Overall Study|Withdrawal by Subject|1|||
19522698|NCT02538666|41951912|FG000|Pre-Treatment|Disease progression|1|||
19522699|NCT02538666|41951913|FG001|Pre-Treatment|Disease progression|0|||
19522700|NCT02538666|41951914|FG002|Pre-Treatment|Disease progression|0|||
19522701|NCT02538666|41951912|FG000|Pre-Treatment|no longer meets study criteria|1|||
19522702|NCT02538666|41951913|FG001|Pre-Treatment|no longer meets study criteria|0|||
19522703|NCT02538666|41951914|FG002|Pre-Treatment|no longer meets study criteria|0|||
19522704|NCT02538666|41951912|FG000|Pre-Treatment|Withdrew Consent|0|||
19522705|NCT02538666|41951913|FG001|Pre-Treatment|Withdrew Consent|1|||
19522706|NCT02538666|41951914|FG002|Pre-Treatment|Withdrew Consent|1|||
19522707|NCT02538666|41951912|FG000|Treatment|Disease progression|270|||
19442047|NCT02043509|41689499|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
19442048|NCT02043509|41689500|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
19442049|NCT02043509|41689499|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
19442050|NCT02043509|41689500|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
19442051|NCT02058563|41689508|FG000|Overall Study|Lost to Follow-up|26|||
19442052|NCT02058563|41689509|FG001|Overall Study|Lost to Follow-up|22|||
19442053|NCT02058563|41689508|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
19442054|NCT02058563|41689509|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
19442055|NCT02058563|41689508|FG000|Overall Study|Consent Withdrawal|1|||
19442056|NCT02058563|41689509|FG001|Overall Study|Consent Withdrawal|1|||
19442057|NCT02058563|41689508|FG000|Overall Study|Other (patient incarcerated)|0|||
19442058|NCT02058563|41689509|FG001|Overall Study|Other (patient incarcerated)|1|||
19442059|NCT01622231|41689515|FG000|Overall Study|Physician Decision|1|||
19522708|NCT02538666|41951913|FG001|Treatment|Disease progression|227|||
19522709|NCT02538666|41951914|FG002|Treatment|Disease progression|165|||
19522710|NCT02538666|41951912|FG000|Treatment|Study drug toxicity|1|||
19442060|NCT01622231|41689515|FG000|Overall Study|Withdrawal by Subject|1|||
19442061|NCT02042183|41689521|FG000|Overall Study|Physician Decision|7|||
19442062|NCT02042183|41689522|FG001|Overall Study|Physician Decision|2|||
19442063|NCT02042183|41689521|FG000|Overall Study|Lack of Efficacy|4|||
19442064|NCT02042183|41689522|FG001|Overall Study|Lack of Efficacy|3|||
19442065|NCT02042183|41689521|FG000|Overall Study|Non-compliance with Study Drug|2|||
19442066|NCT02042183|41689522|FG001|Overall Study|Non-compliance with Study Drug|3|||
19442067|NCT02042183|41689521|FG000|Overall Study|Adverse Event|17|||
19522711|NCT02538666|41951913|FG001|Treatment|Study drug toxicity|29|||
19522712|NCT02538666|41951914|FG002|Treatment|Study drug toxicity|92|||
19522713|NCT02538666|41951912|FG000|Treatment|Death|0|||
19522714|NCT02538666|41951913|FG001|Treatment|Death|2|||
19522715|NCT02538666|41951914|FG002|Treatment|Death|3|||
19522716|NCT02538666|41951912|FG000|Treatment|Adverse event unrelated to study drug|8|||
19522717|NCT02538666|41951913|FG001|Treatment|Adverse event unrelated to study drug|10|||
19522718|NCT02538666|41951914|FG002|Treatment|Adverse event unrelated to study drug|15|||
19522719|NCT02538666|41951912|FG000|Treatment|Participant request to discontinue study treatment|3|||
19522720|NCT02538666|41951913|FG001|Treatment|Participant request to discontinue study treatment|6|||
19522721|NCT02538666|41951914|FG002|Treatment|Participant request to discontinue study treatment|11|||
19522722|NCT02538666|41951912|FG000|Treatment|Participant withdrew consent|2|||
19522723|NCT02538666|41951913|FG001|Treatment|Participant withdrew consent|5|||
19522724|NCT02538666|41951914|FG002|Treatment|Participant withdrew consent|3|||
19442068|NCT02042183|41689522|FG001|Overall Study|Adverse Event|6|||
19442069|NCT02042183|41689521|FG000|Overall Study|Other|3|||
19442070|NCT02042183|41689522|FG001|Overall Study|Other|3|||
19442071|NCT02042183|41689521|FG000|Overall Study|Withdrawal by Subject|21|||
19442072|NCT02042183|41689522|FG001|Overall Study|Withdrawal by Subject|16|||
19442073|NCT02042183|41689521|FG000|Overall Study|Site Terminated by Sponsor|2|||
19442074|NCT02042183|41689522|FG001|Overall Study|Site Terminated by Sponsor|1|||
19442075|NCT02042183|41689521|FG000|Overall Study|Lost to Follow-up|9|||
19442076|NCT02042183|41689522|FG001|Overall Study|Lost to Follow-up|2|||
19442077|NCT01977482|41689536|FG000|Overall Study|Adverse Event|0|||
19442078|NCT01977482|41689537|FG001|Overall Study|Adverse Event|1|||
19442079|NCT01977482|41689538|FG002|Overall Study|Adverse Event|1|||
19442080|NCT01977482|41689539|FG003|Overall Study|Adverse Event|0|||
19442081|NCT01977482|41689540|FG004|Overall Study|Adverse Event|2|||
19442082|NCT01977482|41689541|FG005|Overall Study|Adverse Event|0|||
19442083|NCT01977482|41689536|FG000|Overall Study|Lost to Follow-up|1|||
19442084|NCT01977482|41689537|FG001|Overall Study|Lost to Follow-up|0|||
19442085|NCT01977482|41689538|FG002|Overall Study|Lost to Follow-up|0|||
19442086|NCT01977482|41689539|FG003|Overall Study|Lost to Follow-up|0|||
19442087|NCT01977482|41689540|FG004|Overall Study|Lost to Follow-up|0|||
19442088|NCT01977482|41689541|FG005|Overall Study|Lost to Follow-up|0|||
19522725|NCT02538666|41951912|FG000|Treatment|Lost to Follow-up|0|||
19522726|NCT02538666|41951913|FG001|Treatment|Lost to Follow-up|1|||
19522727|NCT02538666|41951914|FG002|Treatment|Lost to Follow-up|1|||
19522728|NCT02538666|41951912|FG000|Treatment|Maximum clinical benefit|4|||
19522729|NCT02538666|41951913|FG001|Treatment|Maximum clinical benefit|3|||
19522730|NCT02538666|41951914|FG002|Treatment|Maximum clinical benefit|4|||
19442089|NCT01977482|41689536|FG000|Overall Study|Physician Decision|0|||
19442090|NCT01977482|41689537|FG001|Overall Study|Physician Decision|1|||
19442091|NCT01977482|41689538|FG002|Overall Study|Physician Decision|0|||
19442092|NCT01977482|41689539|FG003|Overall Study|Physician Decision|0|||
19442093|NCT01977482|41689540|FG004|Overall Study|Physician Decision|0|||
19442094|NCT01977482|41689541|FG005|Overall Study|Physician Decision|0|||
19442095|NCT01977482|41689536|FG000|Overall Study|Protocol Violation|0|||
19442096|NCT01977482|41689537|FG001|Overall Study|Protocol Violation|0|||
19442097|NCT01977482|41689538|FG002|Overall Study|Protocol Violation|1|||
19442098|NCT01977482|41689539|FG003|Overall Study|Protocol Violation|0|||
19442099|NCT01977482|41689540|FG004|Overall Study|Protocol Violation|0|||
19442100|NCT01977482|41689541|FG005|Overall Study|Protocol Violation|0|||
19442101|NCT01977482|41689536|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
19442102|NCT01977482|41689537|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
19442103|NCT01977482|41689538|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
19442104|NCT01977482|41689539|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
19442105|NCT01977482|41689540|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
19442106|NCT01977482|41689541|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
19442107|NCT01977482|41689536|FG000|Overall Study|Withdrawal by Subject|2|||
19442108|NCT01977482|41689537|FG001|Overall Study|Withdrawal by Subject|4|||
19442109|NCT01977482|41689538|FG002|Overall Study|Withdrawal by Subject|1|||
19442110|NCT01977482|41689539|FG003|Overall Study|Withdrawal by Subject|3|||
19442111|NCT01977482|41689540|FG004|Overall Study|Withdrawal by Subject|1|||
19442112|NCT01977482|41689541|FG005|Overall Study|Withdrawal by Subject|5|||
19442113|NCT02058095|41689562|FG000|Overall Study|Adverse Event|1|||
19442114|NCT02058095|41689563|FG001|Overall Study|Adverse Event|0|||
19442115|NCT02023112|41689571|FG000|Overall Study|Withdrawal by Subject|2|||
19442116|NCT02023112|41689572|FG001|Overall Study|Withdrawal by Subject|1|||
19442117|NCT01977092|41689582|FG000|Overall Study|Death|3|||
19442118|NCT01977092|41689583|FG001|Overall Study|Death|4|||
19442119|NCT01977092|41689582|FG000|Overall Study|Lost to Follow-up|23|||
19442120|NCT01977092|41689583|FG001|Overall Study|Lost to Follow-up|14|||
19442121|NCT01977092|41689582|FG000|Overall Study|Withdrawal by Subject|2|||
19442122|NCT01977092|41689583|FG001|Overall Study|Withdrawal by Subject|1|||
19442123|NCT01977092|41689582|FG000|Overall Study|In prison|3|||
19442124|NCT01977092|41689583|FG001|Overall Study|In prison|11|||
19442125|NCT02004236|41689592|FG000|Overall Study|Lack of Efficacy|0|||
19442126|NCT02004236|41689593|FG001|Overall Study|Lack of Efficacy|0|||
19442127|NCT02004236|41689594|FG002|Overall Study|Lack of Efficacy|16|||
19442128|NCT01976624|41689603|FG000|Overall Study|Participants contraindicated|2|||
19442129|NCT01976624|41689603|FG000|Overall Study|Participants age less than 19 years|12|||
19442130|NCT02041091|41689609|FG000|Treatment|Adverse Event|3|||
19522731|NCT02538666|41951912|FG000|Treatment|Poor/non-compliance|0|||
19442131|NCT02041091|41689610|FG001|Treatment|Adverse Event|3|||
19442132|NCT02041091|41689609|FG000|Treatment|Withdrawal by Subject|2|||
19442133|NCT02041091|41689610|FG001|Treatment|Withdrawal by Subject|4|||
19442134|NCT02041091|41689609|FG000|Treatment|Physician Decision|1|||
19442135|NCT02041091|41689610|FG001|Treatment|Physician Decision|0|||
19442136|NCT02041091|41689609|FG000|Treatment|Sponsor Decision|15|||
19442137|NCT02041091|41689610|FG001|Treatment|Sponsor Decision|16|||
19442138|NCT02041091|41689609|FG000|Treatment|Lost to Follow-up|1|||
19442139|NCT02041091|41689610|FG001|Treatment|Lost to Follow-up|0|||
19442140|NCT02041091|41689609|FG000|Optional Safety Extension Period|Adverse Event|4|||
19442141|NCT02041091|41689610|FG001|Optional Safety Extension Period|Adverse Event|2|||
19522732|NCT02538666|41951913|FG001|Treatment|Poor/non-compliance|1|||
19522733|NCT02538666|41951914|FG002|Treatment|Poor/non-compliance|0|||
19522734|NCT02538666|41951912|FG000|Treatment|Participant no longer meets study criteria|0|||
19522735|NCT02538666|41951913|FG001|Treatment|Participant no longer meets study criteria|2|||
19522736|NCT02538666|41951914|FG002|Treatment|Participant no longer meets study criteria|0|||
19522737|NCT02538666|41951912|FG000|Treatment|Administrative reason by sponsor|0|||
19522738|NCT02538666|41951913|FG001|Treatment|Administrative reason by sponsor|0|||
19522739|NCT02538666|41951914|FG002|Treatment|Administrative reason by sponsor|1|||
19522740|NCT02538666|41951912|FG000|Treatment|Other reasons|8|||
19522741|NCT02538666|41951913|FG001|Treatment|Other reasons|15|||
19522742|NCT02538666|41951914|FG002|Treatment|Other reasons|5|||
19522743|NCT02538666|41951912|FG000|Treatment|Not reported|2|||
19522744|NCT02538666|41951913|FG001|Treatment|Not reported|2|||
19522745|NCT02538666|41951914|FG002|Treatment|Not reported|2|||
19522746|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
19522747|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
19522748|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
19522749|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
19522750|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
19522751|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
19522752|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
19522753|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
19522754|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
19522755|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
19522756|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
19522757|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
19522758|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
19522759|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Death|0|||
19522760|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Death|0|||
19522761|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Death|1|||
19522762|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Death|0|||
19522763|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Death|0|||
19522764|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Death|0|||
19522765|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Death|0|||
19522766|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Death|0|||
19522767|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Death|0|||
19522768|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Death|0|||
19522769|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Death|0|||
19522770|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Death|0|||
19522771|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Death|0|||
19522772|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
19522773|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
19522774|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
19522775|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522776|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522777|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19442142|NCT02041091|41689609|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
19442143|NCT02041091|41689610|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
19442144|NCT02041091|41689609|FG000|Optional Safety Extension Period|Protocol Violation|2|||
19442145|NCT02041091|41689610|FG001|Optional Safety Extension Period|Protocol Violation|0|||
19442146|NCT02041091|41689609|FG000|Optional Safety Extension Period|Physician Decision|2|||
19442147|NCT02041091|41689610|FG001|Optional Safety Extension Period|Physician Decision|1|||
19442148|NCT02041091|41689609|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
19442149|NCT02041091|41689610|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
19442150|NCT02041091|41689609|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
19442151|NCT02041091|41689610|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
19442152|NCT02057549|41689624|FG000|Overall Study|Lost to Follow-up|1|||
19522778|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522779|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522780|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522781|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522782|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522783|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19522784|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
19442153|NCT02057549|41689625|FG001|Overall Study|Lost to Follow-up|0|||
19442154|NCT02057549|41689624|FG000|Overall Study|Physician Decision|1|||
19442155|NCT02057549|41689625|FG001|Overall Study|Physician Decision|0|||
19442156|NCT02057549|41689624|FG000|Overall Study|Withdrawal by Subject|1|||
19442157|NCT02057549|41689625|FG001|Overall Study|Withdrawal by Subject|0|||
19442158|NCT02057393|41689631|FG000|Overall Study|Withdrawal by Subject|1|||
19442159|NCT02057393|41689631|FG000|Overall Study|Patient did not meet criteria|1|||
19442160|NCT02040779|41689638|FG000|Overall Study|Adverse Event|1|||
19442161|NCT02040779|41689639|FG001|Overall Study|Adverse Event|0|||
19442162|NCT02040779|41689640|FG002|Overall Study|Adverse Event|0|||
19442163|NCT02040779|41689638|FG000|Overall Study|Withdrawal by Subject|4|||
19442164|NCT02040779|41689639|FG001|Overall Study|Withdrawal by Subject|1|||
19442165|NCT02040779|41689640|FG002|Overall Study|Withdrawal by Subject|3|||
19442166|NCT02040779|41689638|FG000|Overall Study|Non-compliance|0|||
19442167|NCT02040779|41689639|FG001|Overall Study|Non-compliance|1|||
19442168|NCT02040779|41689640|FG002|Overall Study|Non-compliance|0|||
19442169|NCT02040779|41689638|FG000|Overall Study|Protocol Violation|2|||
19442170|NCT02040779|41689639|FG001|Overall Study|Protocol Violation|1|||
19442171|NCT02040779|41689640|FG002|Overall Study|Protocol Violation|0|||
19442172|NCT02040779|41689638|FG000|Overall Study|Lost to Follow-up|1|||
19442173|NCT02040779|41689639|FG001|Overall Study|Lost to Follow-up|2|||
19442174|NCT02040779|41689640|FG002|Overall Study|Lost to Follow-up|1|||
19442175|NCT02040779|41689638|FG000|Overall Study|Lack of Efficacy|4|||
19442176|NCT02040779|41689639|FG001|Overall Study|Lack of Efficacy|2|||
19442177|NCT02040779|41689640|FG002|Overall Study|Lack of Efficacy|0|||
19442178|NCT02056301|41689650|FG000|Overall Study|Protocol Violation|1|||
19442179|NCT02056301|41689651|FG001|Overall Study|Protocol Violation|2|||
19442180|NCT02056301|41689650|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
19442181|NCT02056301|41689651|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
19442182|NCT02056301|41689650|FG000|Overall Study|Withdrawal by Subject|0|||
19442183|NCT02056301|41689651|FG001|Overall Study|Withdrawal by Subject|1|||
19442184|NCT02056301|41689650|FG000|Overall Study|Issues with epidural|0|||
19442185|NCT02056301|41689651|FG001|Overall Study|Issues with epidural|3|||
19442186|NCT01967888|41689659|FG000|Overall Study|Lost to Follow-up|6|||
19442187|NCT01967888|41689660|FG001|Overall Study|Lost to Follow-up|4|||
19442188|NCT01967888|41689659|FG000|Overall Study|Withdrawal by Subject|1|||
19522785|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522786|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522787|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
19522788|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522789|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522790|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522791|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522792|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522793|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522794|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522795|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522796|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522797|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
19522798|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
19522799|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
19522800|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
19522801|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
19522802|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
19522803|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
19522804|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
19522805|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
19522806|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
19522807|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
19522808|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
19522809|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
19522810|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
19522811|NCT02407236|41951968|FG000|Induction Study (8 Weeks)|Other|2|||
19522812|NCT02407236|41951969|FG001|Induction Study (8 Weeks)|Other|1|||
19442189|NCT01967888|41689660|FG001|Overall Study|Withdrawal by Subject|1|||
19442190|NCT01967888|41689659|FG000|Overall Study|Did Not Have Transplant|1|||
19442191|NCT01967888|41689660|FG001|Overall Study|Did Not Have Transplant|0|||
19442192|NCT01967888|41689659|FG000|Overall Study|Research visit not done, data recorded|1|||
19522813|NCT02407236|41951970|FG002|Induction Study (8 Weeks)|Other|5|||
19522814|NCT02407236|41951971|FG003|Induction Study (8 Weeks)|Other|0|||
19522815|NCT02407236|41951972|FG004|Induction Study (8 Weeks)|Other|0|||
19522816|NCT02407236|41951973|FG005|Induction Study (8 Weeks)|Other|0|||
19522817|NCT02407236|41951974|FG006|Induction Study (8 Weeks)|Other|0|||
19522818|NCT02407236|41951975|FG007|Induction Study (8 Weeks)|Other|0|||
19522819|NCT02407236|41951976|FG008|Induction Study (8 Weeks)|Other|0|||
19442193|NCT01967888|41689660|FG001|Overall Study|Research visit not done, data recorded|0|||
19442194|NCT01967888|41689659|FG000|Overall Study|Subject excluded after randomization|1|||
19442195|NCT01967888|41689660|FG001|Overall Study|Subject excluded after randomization|0|||
19442196|NCT01967888|41689659|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
19442197|NCT01967888|41689660|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
19442198|NCT01967888|41689659|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
19442199|NCT01967888|41689660|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
19442200|NCT01967732|41689668|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
19442201|NCT01967732|41689669|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
19442202|NCT01967732|41689670|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
19442203|NCT01967732|41689671|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
19442204|NCT01967732|41689668|FG000|First Intervention (Day 1)|Poor venous access|0|||
19442205|NCT01967732|41689669|FG001|First Intervention (Day 1)|Poor venous access|1|||
19442206|NCT01967732|41689670|FG002|First Intervention (Day 1)|Poor venous access|0|||
19442207|NCT01967732|41689671|FG003|First Intervention (Day 1)|Poor venous access|0|||
19442208|NCT01967576|41689679|FG000|Overall Study|Withdrawal by Subject|3|||
19522820|NCT02407236|41951977|FG009|Induction Study (8 Weeks)|Other|0|||
19522821|NCT02407236|41951978|FG010|Induction Study (8 Weeks)|Other|0|||
19522822|NCT02407236|41951979|FG011|Induction Study (8 Weeks)|Other|0|||
19522823|NCT02407236|41951980|FG012|Induction Study (8 Weeks)|Other|0|||
19522824|NCT02407236|41951968|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
19522825|NCT02407236|41951969|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
19442209|NCT01967576|41689679|FG000|Overall Study|Progressed/Removed from treatment|1|||
19442210|NCT01967576|41689679|FG000|Overall Study|Study closing at site|1|||
19442211|NCT01967576|41689679|FG000|Overall Study|Adverse Event|1|||
19442212|NCT01967576|41689679|FG000|Overall Study|Refused further treatment|1|||
19442213|NCT02039687|41689687|FG000|Overall Study|Adverse Event|0|||
19442214|NCT02039687|41689688|FG001|Overall Study|Adverse Event|0|||
19442215|NCT02039687|41689689|FG002|Overall Study|Adverse Event|1|||
19442216|NCT02039687|41689690|FG003|Overall Study|Adverse Event|0|||
19522826|NCT02407236|41951970|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
19522827|NCT02407236|41951971|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
19522828|NCT02407236|41951972|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
19522829|NCT02407236|41951973|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
19522830|NCT02407236|41951974|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
19522831|NCT02407236|41951975|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
19522832|NCT02407236|41951976|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
19522833|NCT02407236|41951977|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
19442217|NCT02039687|41689687|FG000|Overall Study|Withdrawal by Subject|0|||
19442218|NCT02039687|41689688|FG001|Overall Study|Withdrawal by Subject|1|||
19442219|NCT02039687|41689689|FG002|Overall Study|Withdrawal by Subject|0|||
19442220|NCT02039687|41689690|FG003|Overall Study|Withdrawal by Subject|0|||
19442221|NCT02039687|41689687|FG000|Overall Study|treatment assignment could not be confir|0|||
19442222|NCT02039687|41689688|FG001|Overall Study|treatment assignment could not be confir|0|||
19442223|NCT02039687|41689689|FG002|Overall Study|treatment assignment could not be confir|2|||
19442224|NCT02039687|41689690|FG003|Overall Study|treatment assignment could not be confir|0|||
19442225|NCT02003534|41689700|FG000|Overall Study|Lost to Follow-up|47|||
19442226|NCT02055365|41689704|FG000|Overall Study|Prematurely Withdrawn|1|||
19442227|NCT02039375|41689715|FG000|Overall Study|Lost to Follow-up|2|||
19442228|NCT02054897|41689722|FG000|Overall Study|Withdrawal by Subject|2|||
19442229|NCT02054897|41689723|FG001|Overall Study|Withdrawal by Subject|0|||
19442230|NCT02054897|41689724|FG002|Overall Study|Withdrawal by Subject|2|||
19442231|NCT02054897|41689722|FG000|Overall Study|Missing follow-up information|3|||
19442232|NCT02054897|41689723|FG001|Overall Study|Missing follow-up information|5|||
19442233|NCT02054897|41689724|FG002|Overall Study|Missing follow-up information|3|||
19442234|NCT02054897|41689722|FG000|Overall Study|Lost to Follow-up|4|||
19442235|NCT02054897|41689723|FG001|Overall Study|Lost to Follow-up|2|||
19442236|NCT02054897|41689724|FG002|Overall Study|Lost to Follow-up|7|||
19442237|NCT02054897|41689722|FG000|Overall Study|Randomized but not exposed|1|||
19442238|NCT02054897|41689723|FG001|Overall Study|Randomized but not exposed|0|||
19442239|NCT02054897|41689724|FG002|Overall Study|Randomized but not exposed|0|||
19442240|NCT01976312|41689734|FG000|Overall Study|Pregnancy|0|||
19442241|NCT01976312|41689735|FG001|Overall Study|Pregnancy|1|||
19442242|NCT01976312|41689734|FG000|Overall Study|Lost to Follow-up|2|||
19442243|NCT01976312|41689735|FG001|Overall Study|Lost to Follow-up|0|||
19442244|NCT01976312|41689734|FG000|Overall Study|Withdrawal by Subject|7|||
19442245|NCT01976312|41689735|FG001|Overall Study|Withdrawal by Subject|2|||
19442246|NCT01976312|41689734|FG000|Overall Study|Adverse Event|6|||
19442247|NCT01976312|41689735|FG001|Overall Study|Adverse Event|6|||
19442248|NCT01976312|41689734|FG000|Overall Study|Protocol Violation|2|||
19442249|NCT01976312|41689735|FG001|Overall Study|Protocol Violation|0|||
19442250|NCT02039219|41689744|FG000|Treatment|Withdrawal by Subject|1|||
19522834|NCT02407236|41951978|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
19442251|NCT02039219|41689745|FG001|Treatment|Withdrawal by Subject|0|||
19442252|NCT02039219|41689744|FG000|Treatment|Adverse Event|0|||
19442253|NCT02039219|41689745|FG001|Treatment|Adverse Event|1|||
19442254|NCT02039219|41689744|FG000|Treatment|Physician Decision|1|||
19442255|NCT02039219|41689745|FG001|Treatment|Physician Decision|0|||
19442256|NCT02039219|41689744|FG000|Treatment|Lost to Follow-up|0|||
19442257|NCT02039219|41689745|FG001|Treatment|Lost to Follow-up|1|||
19442258|NCT02039219|41689744|FG000|Treatment|Protocol Violation|1|||
19442259|NCT02039219|41689745|FG001|Treatment|Protocol Violation|0|||
19442260|NCT02039219|41689744|FG000|Treatment|Death|1|||
19442261|NCT02039219|41689745|FG001|Treatment|Death|0|||
19442262|NCT02039219|41689744|FG000|Follow up|Adverse Event|0|||
19442263|NCT02039219|41689745|FG001|Follow up|Adverse Event|1|||
19442264|NCT02053493|41689753|FG000|Overall Study|Withdrawal by Subject|1|||
19442265|NCT02053493|41689754|FG001|Overall Study|Withdrawal by Subject|1|||
19442266|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Other than specified|2|||
19442267|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Other than specified|4|||
19442268|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
19442269|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
19442270|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Pregnancy|0|||
19442271|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Pregnancy|2|||
19442272|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Physician Decision|1|||
19442273|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Physician Decision|1|||
19442274|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
19442275|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
19442276|NCT02003144|41689762|FG000|Open Label Maintenance Phase|Adverse Event|2|||
19442277|NCT02003144|41689763|FG001|Open Label Maintenance Phase|Adverse Event|1|||
19442278|NCT02001194|41689774|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
19442279|NCT02001194|41689775|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
19442280|NCT02001194|41689776|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
19442281|NCT02001194|41689777|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
19442282|NCT02001194|41689774|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
19442283|NCT02001194|41689775|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
19442284|NCT02001194|41689776|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
19442285|NCT02001194|41689777|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
19442286|NCT02038907|41689801|FG000|Overall Study|Protocol Violation|0|||
19442287|NCT02038907|41689802|FG001|Overall Study|Protocol Violation|0|||
19442288|NCT02038907|41689803|FG002|Overall Study|Protocol Violation|0|||
19442289|NCT02038907|41689804|FG003|Overall Study|Protocol Violation|0|||
19442290|NCT02038907|41689805|FG004|Overall Study|Protocol Violation|0|||
19442291|NCT02038907|41689806|FG005|Overall Study|Protocol Violation|0|||
19442292|NCT02038907|41689807|FG006|Overall Study|Protocol Violation|0|||
19442293|NCT02038907|41689808|FG007|Overall Study|Protocol Violation|0|||
19522835|NCT02407236|41951979|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
19522836|NCT02407236|41951980|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
19522837|NCT02407236|41951968|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522838|NCT02407236|41951969|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522839|NCT02407236|41951970|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522840|NCT02407236|41951971|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
19522841|NCT02407236|41951972|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
19522842|NCT02407236|41951973|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
19522843|NCT02407236|41951974|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
19522844|NCT02407236|41951975|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
19522845|NCT02407236|41951976|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522846|NCT02407236|41951977|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522847|NCT02407236|41951978|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522848|NCT02407236|41951979|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522849|NCT02407236|41951980|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
19522850|NCT02407236|41951968|FG000|Maintenance Study (44 Weeks)|Other|0|||
19522851|NCT02407236|41951969|FG001|Maintenance Study (44 Weeks)|Other|0|||
19522852|NCT02407236|41951970|FG002|Maintenance Study (44 Weeks)|Other|0|||
19522853|NCT02407236|41951971|FG003|Maintenance Study (44 Weeks)|Other|5|||
19522854|NCT02407236|41951972|FG004|Maintenance Study (44 Weeks)|Other|7|||
19522855|NCT02407236|41951973|FG005|Maintenance Study (44 Weeks)|Other|8|||
19522856|NCT02407236|41951974|FG006|Maintenance Study (44 Weeks)|Other|4|||
19522857|NCT02407236|41951975|FG007|Maintenance Study (44 Weeks)|Other|6|||
19522858|NCT02407236|41951976|FG008|Maintenance Study (44 Weeks)|Other|0|||
19522859|NCT02407236|41951977|FG009|Maintenance Study (44 Weeks)|Other|0|||
19442294|NCT02038907|41689809|FG008|Overall Study|Protocol Violation|0|||
19442295|NCT02038907|41689810|FG009|Overall Study|Protocol Violation|0|||
19442296|NCT02038907|41689811|FG010|Overall Study|Protocol Violation|1|||
19442297|NCT02038907|41689812|FG011|Overall Study|Protocol Violation|0|||
19442298|NCT02038907|41689813|FG012|Overall Study|Protocol Violation|0|||
19442299|NCT02038907|41689814|FG013|Overall Study|Protocol Violation|0|||
19442300|NCT02038907|41689801|FG000|Overall Study|Withdrawal by Subject|0|||
19522860|NCT02407236|41951978|FG010|Maintenance Study (44 Weeks)|Other|0|||
19522861|NCT02407236|41951979|FG011|Maintenance Study (44 Weeks)|Other|0|||
19522862|NCT02407236|41951980|FG012|Maintenance Study (44 Weeks)|Other|0|||
19522863|NCT02407236|41951968|FG000|Maintenance Study (44 Weeks)|Death|0|||
19522864|NCT02407236|41951969|FG001|Maintenance Study (44 Weeks)|Death|0|||
19522865|NCT02407236|41951970|FG002|Maintenance Study (44 Weeks)|Death|0|||
19522866|NCT02407236|41951971|FG003|Maintenance Study (44 Weeks)|Death|0|||
19522867|NCT02407236|41951972|FG004|Maintenance Study (44 Weeks)|Death|0|||
19522868|NCT02407236|41951973|FG005|Maintenance Study (44 Weeks)|Death|0|||
19522869|NCT02407236|41951974|FG006|Maintenance Study (44 Weeks)|Death|0|||
19522870|NCT02407236|41951975|FG007|Maintenance Study (44 Weeks)|Death|1|||
19522871|NCT02407236|41951976|FG008|Maintenance Study (44 Weeks)|Death|0|||
19522872|NCT02407236|41951977|FG009|Maintenance Study (44 Weeks)|Death|0|||
19522873|NCT02407236|41951978|FG010|Maintenance Study (44 Weeks)|Death|0|||
19522874|NCT02407236|41951979|FG011|Maintenance Study (44 Weeks)|Death|0|||
19522875|NCT02407236|41951980|FG012|Maintenance Study (44 Weeks)|Death|0|||
19522876|NCT02407236|41951968|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522877|NCT02407236|41951969|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522878|NCT02407236|41951970|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522879|NCT02407236|41951971|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522880|NCT02407236|41951972|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522881|NCT02407236|41951973|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522882|NCT02407236|41951974|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522883|NCT02407236|41951975|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
19522884|NCT02407236|41951976|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
19522885|NCT02407236|41951977|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
19522886|NCT02407236|41951978|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
19522887|NCT02407236|41951979|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
19522888|NCT02407236|41951980|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
19522889|NCT02407236|41951968|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522890|NCT02407236|41951969|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522891|NCT02407236|41951970|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522892|NCT02407236|41951971|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19442301|NCT02038907|41689802|FG001|Overall Study|Withdrawal by Subject|0|||
19442302|NCT02038907|41689803|FG002|Overall Study|Withdrawal by Subject|0|||
19442303|NCT02038907|41689804|FG003|Overall Study|Withdrawal by Subject|0|||
19442304|NCT02038907|41689805|FG004|Overall Study|Withdrawal by Subject|0|||
19442305|NCT02038907|41689806|FG005|Overall Study|Withdrawal by Subject|0|||
19442306|NCT02038907|41689807|FG006|Overall Study|Withdrawal by Subject|0|||
19442307|NCT02038907|41689808|FG007|Overall Study|Withdrawal by Subject|0|||
19442308|NCT02038907|41689809|FG008|Overall Study|Withdrawal by Subject|0|||
19442309|NCT02038907|41689810|FG009|Overall Study|Withdrawal by Subject|0|||
19442310|NCT02038907|41689811|FG010|Overall Study|Withdrawal by Subject|1|||
19442311|NCT02038907|41689812|FG011|Overall Study|Withdrawal by Subject|0|||
19442312|NCT02038907|41689813|FG012|Overall Study|Withdrawal by Subject|0|||
19442313|NCT02038907|41689814|FG013|Overall Study|Withdrawal by Subject|0|||
19442314|NCT02038829|41689846|FG000|Washout Period 1|Death|0|||
19442315|NCT02038829|41689847|FG001|Washout Period 1|Death|0|||
19442316|NCT02038829|41689848|FG002|Washout Period 1|Death|0|||
19442317|NCT02038829|41689849|FG003|Washout Period 1|Death|0|||
19442318|NCT02038829|41689850|FG004|Washout Period 1|Death|1|||
19442319|NCT02038829|41689851|FG005|Washout Period 1|Death|0|||
19442320|NCT02038829|41689852|FG006|Washout Period 1|Death|0|||
19442321|NCT02038829|41689853|FG007|Washout Period 1|Death|0|||
19442322|NCT02038829|41689854|FG008|Washout Period 1|Death|0|||
19442323|NCT02038829|41689855|FG009|Washout Period 1|Death|0|||
19442324|NCT02038829|41689856|FG010|Washout Period 1|Death|0|||
19442325|NCT02038829|41689857|FG011|Washout Period 1|Death|0|||
19442326|NCT02038829|41689846|FG000|Treatment Period 2|Adverse Event|0|||
19442327|NCT02038829|41689847|FG001|Treatment Period 2|Adverse Event|0|||
19442328|NCT02038829|41689848|FG002|Treatment Period 2|Adverse Event|0|||
19442329|NCT02038829|41689849|FG003|Treatment Period 2|Adverse Event|0|||
19442330|NCT02038829|41689850|FG004|Treatment Period 2|Adverse Event|0|||
19442331|NCT02038829|41689851|FG005|Treatment Period 2|Adverse Event|0|||
19442332|NCT02038829|41689852|FG006|Treatment Period 2|Adverse Event|0|||
19442333|NCT02038829|41689853|FG007|Treatment Period 2|Adverse Event|0|||
19442334|NCT02038829|41689854|FG008|Treatment Period 2|Adverse Event|0|||
19442335|NCT02038829|41689855|FG009|Treatment Period 2|Adverse Event|0|||
19442336|NCT02038829|41689856|FG010|Treatment Period 2|Adverse Event|1|||
19442337|NCT02038829|41689857|FG011|Treatment Period 2|Adverse Event|0|||
19442338|NCT02038829|41689846|FG000|Treatment Period 2|Withdrawal by Subject|1|||
19442339|NCT02038829|41689847|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19442340|NCT02038829|41689848|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19442341|NCT02038829|41689849|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19442342|NCT02038829|41689850|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19442343|NCT02038829|41689851|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19442344|NCT02038829|41689852|FG006|Treatment Period 2|Withdrawal by Subject|0|||
19442345|NCT02038829|41689853|FG007|Treatment Period 2|Withdrawal by Subject|0|||
19442346|NCT02038829|41689854|FG008|Treatment Period 2|Withdrawal by Subject|0|||
19442347|NCT02038829|41689855|FG009|Treatment Period 2|Withdrawal by Subject|0|||
19442348|NCT02038829|41689856|FG010|Treatment Period 2|Withdrawal by Subject|0|||
19442349|NCT02038829|41689857|FG011|Treatment Period 2|Withdrawal by Subject|0|||
19442350|NCT02038829|41689846|FG000|Washout Period 2|Adverse Event|0|||
19442351|NCT02038829|41689847|FG001|Washout Period 2|Adverse Event|0|||
19442352|NCT02038829|41689848|FG002|Washout Period 2|Adverse Event|0|||
19442353|NCT02038829|41689849|FG003|Washout Period 2|Adverse Event|0|||
19442354|NCT02038829|41689850|FG004|Washout Period 2|Adverse Event|0|||
19442355|NCT02038829|41689851|FG005|Washout Period 2|Adverse Event|0|||
19442356|NCT02038829|41689852|FG006|Washout Period 2|Adverse Event|0|||
19442357|NCT02038829|41689853|FG007|Washout Period 2|Adverse Event|0|||
19442358|NCT02038829|41689854|FG008|Washout Period 2|Adverse Event|1|||
19442359|NCT02038829|41689855|FG009|Washout Period 2|Adverse Event|0|||
19442360|NCT02038829|41689856|FG010|Washout Period 2|Adverse Event|0|||
19442361|NCT02038829|41689857|FG011|Washout Period 2|Adverse Event|0|||
19442362|NCT02038829|41689846|FG000|Washout Period 2|Withdrawal by Subject|0|||
19442363|NCT02038829|41689847|FG001|Washout Period 2|Withdrawal by Subject|0|||
19442364|NCT02038829|41689848|FG002|Washout Period 2|Withdrawal by Subject|0|||
19442365|NCT02038829|41689849|FG003|Washout Period 2|Withdrawal by Subject|0|||
19442366|NCT02038829|41689850|FG004|Washout Period 2|Withdrawal by Subject|0|||
19442367|NCT02038829|41689851|FG005|Washout Period 2|Withdrawal by Subject|1|||
19442368|NCT02038829|41689852|FG006|Washout Period 2|Withdrawal by Subject|0|||
19442369|NCT02038829|41689853|FG007|Washout Period 2|Withdrawal by Subject|0|||
19442370|NCT02038829|41689854|FG008|Washout Period 2|Withdrawal by Subject|0|||
19442371|NCT02038829|41689855|FG009|Washout Period 2|Withdrawal by Subject|0|||
19442372|NCT02038829|41689856|FG010|Washout Period 2|Withdrawal by Subject|0|||
19442373|NCT02038829|41689857|FG011|Washout Period 2|Withdrawal by Subject|0|||
19442374|NCT02038829|41689846|FG000|Treatment Period 4|Adverse Event|0|||
19442375|NCT02038829|41689847|FG001|Treatment Period 4|Adverse Event|1|||
19442376|NCT02038829|41689848|FG002|Treatment Period 4|Adverse Event|0|||
19442377|NCT02038829|41689849|FG003|Treatment Period 4|Adverse Event|0|||
19442378|NCT02038829|41689850|FG004|Treatment Period 4|Adverse Event|0|||
19442379|NCT02038829|41689851|FG005|Treatment Period 4|Adverse Event|0|||
19442380|NCT02038829|41689852|FG006|Treatment Period 4|Adverse Event|0|||
19442381|NCT02038829|41689853|FG007|Treatment Period 4|Adverse Event|0|||
19442382|NCT02038829|41689854|FG008|Treatment Period 4|Adverse Event|0|||
19442383|NCT02038829|41689855|FG009|Treatment Period 4|Adverse Event|0|||
19442384|NCT02038829|41689856|FG010|Treatment Period 4|Adverse Event|0|||
19442385|NCT02038829|41689857|FG011|Treatment Period 4|Adverse Event|0|||
19442386|NCT02038829|41689846|FG000|Washout Period 4|Adverse Event|0|||
19442387|NCT02038829|41689847|FG001|Washout Period 4|Adverse Event|0|||
19442388|NCT02038829|41689848|FG002|Washout Period 4|Adverse Event|0|||
19442389|NCT02038829|41689849|FG003|Washout Period 4|Adverse Event|0|||
19442390|NCT02038829|41689850|FG004|Washout Period 4|Adverse Event|0|||
19442391|NCT02038829|41689851|FG005|Washout Period 4|Adverse Event|0|||
19442392|NCT02038829|41689852|FG006|Washout Period 4|Adverse Event|1|||
19442393|NCT02038829|41689853|FG007|Washout Period 4|Adverse Event|0|||
19442394|NCT02038829|41689854|FG008|Washout Period 4|Adverse Event|0|||
19442395|NCT02038829|41689855|FG009|Washout Period 4|Adverse Event|0|||
19442396|NCT02038829|41689856|FG010|Washout Period 4|Adverse Event|0|||
19442397|NCT02038829|41689857|FG011|Washout Period 4|Adverse Event|0|||
19442398|NCT02038829|41689846|FG000|Treatment Period 6|Adverse Event|0|||
19442399|NCT02038829|41689847|FG001|Treatment Period 6|Adverse Event|0|||
19442400|NCT02038829|41689848|FG002|Treatment Period 6|Adverse Event|1|||
19522893|NCT02407236|41951972|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19629042|NCT00455923|42078604|FG001|Overall Study|Other|1|||
19442401|NCT02038829|41689849|FG003|Treatment Period 6|Adverse Event|0|||
19442402|NCT02038829|41689850|FG004|Treatment Period 6|Adverse Event|0|||
19442403|NCT02038829|41689851|FG005|Treatment Period 6|Adverse Event|0|||
19442404|NCT02038829|41689852|FG006|Treatment Period 6|Adverse Event|0|||
19442405|NCT02038829|41689853|FG007|Treatment Period 6|Adverse Event|0|||
19442406|NCT02038829|41689854|FG008|Treatment Period 6|Adverse Event|0|||
19442407|NCT02038829|41689855|FG009|Treatment Period 6|Adverse Event|0|||
19442408|NCT02038829|41689856|FG010|Treatment Period 6|Adverse Event|0|||
19442409|NCT02038829|41689857|FG011|Treatment Period 6|Adverse Event|0|||
19442410|NCT02038049|41689874|FG000|Overall Study|Lost to Follow-up|1|||
19442411|NCT02038049|41689875|FG001|Overall Study|Lost to Follow-up|0|||
19442412|NCT02052011|41689887|FG000|Overall Study|Lost to Follow-up|3|||
19442413|NCT02052011|41689888|FG001|Overall Study|Lost to Follow-up|0|||
19442414|NCT02052011|41689887|FG000|Overall Study|Withdrawal by Subject|1|||
19442415|NCT02052011|41689888|FG001|Overall Study|Withdrawal by Subject|2|||
19442416|NCT02036645|41689906|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442417|NCT02036645|41689907|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442418|NCT02036645|41689908|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442419|NCT02036645|41689909|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442420|NCT02036645|41689910|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442421|NCT02036645|41689911|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442422|NCT02036645|41689912|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
19442423|NCT02036645|41689913|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442424|NCT02036645|41689914|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442425|NCT02036645|41689915|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442426|NCT02036645|41689916|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19522894|NCT02407236|41951973|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522895|NCT02407236|41951974|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522896|NCT02407236|41951975|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522897|NCT02407236|41951976|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522898|NCT02407236|41951977|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522899|NCT02407236|41951978|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
19522900|NCT02407236|41951979|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19522901|NCT02407236|41951980|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
19442427|NCT02036645|41689917|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
19442428|NCT02036645|41689906|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442429|NCT02036645|41689907|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442430|NCT02036645|41689908|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19522902|NCT02407236|41951968|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19522903|NCT02407236|41951969|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19522904|NCT02407236|41951970|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19522905|NCT02407236|41951971|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19629043|NCT00642616|42078614|FG000|Overall Study|Adverse Event|2|||
19442431|NCT02036645|41689909|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
19442432|NCT02036645|41689910|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442433|NCT02036645|41689911|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442434|NCT02036645|41689912|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442435|NCT02036645|41689913|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442436|NCT02036645|41689914|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442437|NCT02036645|41689915|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442438|NCT02036645|41689916|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442439|NCT02036645|41689917|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
19442440|NCT02051933|41689957|FG000|Overall Study|Physician Decision|0|||
19442441|NCT02051933|41689958|FG001|Overall Study|Physician Decision|1|||
19442442|NCT02050373|41689971|FG000|Overall Study|Adverse Event|4|||
19442443|NCT02050373|41689972|FG001|Overall Study|Adverse Event|7|||
19442444|NCT02050373|41689971|FG000|Overall Study|Death|3|||
19442445|NCT02050373|41689972|FG001|Overall Study|Death|3|||
19442446|NCT02049437|41689981|FG000|Period 1|Adverse Event|1|||
19442447|NCT02049437|41689982|FG001|Period 1|Adverse Event|1|||
19442448|NCT02049437|41689981|FG000|Period 1|Adverse Event|1|||
19442449|NCT02049437|41689982|FG001|Period 1|Adverse Event|0|||
19442450|NCT02035553|41689990|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
19442451|NCT02035553|41689991|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
19442452|NCT02035553|41689990|FG000|Overall Study|Adverse Event|10|||
19442453|NCT02035553|41689991|FG001|Overall Study|Adverse Event|6|||
19442454|NCT02035553|41689990|FG000|Overall Study|Physician Decision|3|||
19442455|NCT02035553|41689991|FG001|Overall Study|Physician Decision|2|||
19442456|NCT02035553|41689990|FG000|Overall Study|Lack of Efficacy|1|||
19442457|NCT02035553|41689991|FG001|Overall Study|Lack of Efficacy|1|||
19442458|NCT02035553|41689990|FG000|Overall Study|Withdrawal by Subject|4|||
19442459|NCT02035553|41689991|FG001|Overall Study|Withdrawal by Subject|7|||
19442460|NCT02035553|41689990|FG000|Overall Study|Non-compliance with Study Drug|0|||
19442461|NCT02035553|41689991|FG001|Overall Study|Non-compliance with Study Drug|1|||
19442462|NCT02035553|41689990|FG000|Overall Study|Lost to Follow-up|0|||
19442463|NCT02035553|41689991|FG001|Overall Study|Lost to Follow-up|1|||
19442464|NCT02035553|41689990|FG000|Overall Study|Other Reason|0|||
19442465|NCT02035553|41689991|FG001|Overall Study|Other Reason|4|||
19442466|NCT01445080|41690006|FG000|Overall Study|Adverse Event|5|||
19442467|NCT01445080|41690007|FG001|Overall Study|Adverse Event|3|||
19442468|NCT01445080|41690008|FG002|Overall Study|Adverse Event|11|||
19442469|NCT01445080|41690009|FG003|Overall Study|Adverse Event|6|||
19442470|NCT01445080|41690010|FG004|Overall Study|Adverse Event|2|||
19442471|NCT01445080|41690011|FG005|Overall Study|Adverse Event|3|||
19442472|NCT01445080|41690012|FG006|Overall Study|Adverse Event|0|||
19442473|NCT01445080|41690013|FG007|Overall Study|Adverse Event|3|||
19442474|NCT01445080|41690014|FG008|Overall Study|Adverse Event|10|||
19442475|NCT01445080|41690006|FG000|Overall Study|Physician Decision|0|||
19442476|NCT01445080|41690007|FG001|Overall Study|Physician Decision|0|||
19442477|NCT01445080|41690008|FG002|Overall Study|Physician Decision|1|||
19442478|NCT01445080|41690009|FG003|Overall Study|Physician Decision|0|||
19442479|NCT01445080|41690010|FG004|Overall Study|Physician Decision|0|||
19442480|NCT01445080|41690011|FG005|Overall Study|Physician Decision|3|||
19442481|NCT01445080|41690012|FG006|Overall Study|Physician Decision|2|||
19442482|NCT01445080|41690013|FG007|Overall Study|Physician Decision|2|||
19442483|NCT01445080|41690014|FG008|Overall Study|Physician Decision|0|||
19442484|NCT01445080|41690006|FG000|Overall Study|Withdrawal by Subject|1|||
19442485|NCT01445080|41690007|FG001|Overall Study|Withdrawal by Subject|0|||
19442486|NCT01445080|41690008|FG002|Overall Study|Withdrawal by Subject|0|||
19442487|NCT01445080|41690009|FG003|Overall Study|Withdrawal by Subject|1|||
19442488|NCT01445080|41690010|FG004|Overall Study|Withdrawal by Subject|0|||
19442489|NCT01445080|41690011|FG005|Overall Study|Withdrawal by Subject|0|||
19442490|NCT01445080|41690012|FG006|Overall Study|Withdrawal by Subject|0|||
19442491|NCT01445080|41690013|FG007|Overall Study|Withdrawal by Subject|0|||
19442492|NCT01445080|41690014|FG008|Overall Study|Withdrawal by Subject|2|||
19442493|NCT01445080|41690006|FG000|Overall Study|Ineligible/Inevaluable|1|||
19522906|NCT02407236|41951972|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19442494|NCT01445080|41690007|FG001|Overall Study|Ineligible/Inevaluable|2|||
19442495|NCT01445080|41690008|FG002|Overall Study|Ineligible/Inevaluable|0|||
19442496|NCT01445080|41690009|FG003|Overall Study|Ineligible/Inevaluable|1|||
19442497|NCT01445080|41690010|FG004|Overall Study|Ineligible/Inevaluable|2|||
19442498|NCT01445080|41690011|FG005|Overall Study|Ineligible/Inevaluable|3|||
19442499|NCT01445080|41690012|FG006|Overall Study|Ineligible/Inevaluable|0|||
19442500|NCT01445080|41690013|FG007|Overall Study|Ineligible/Inevaluable|0|||
19442501|NCT01445080|41690014|FG008|Overall Study|Ineligible/Inevaluable|6|||
19442502|NCT02035475|41690049|FG000|Overall Study|Withdrawal by Subject|4|||
19442503|NCT02035475|41690049|FG000|Overall Study|Physician Decision|1|||
19442504|NCT02035475|41690049|FG000|Overall Study|Equipment Error|1|||
19442505|NCT01444456|41690055|FG000|Overall Study|Withdrawal by Subject|21|||
19442506|NCT01444456|41690055|FG000|Overall Study|Physician Decision|9|||
19442507|NCT01444456|41690055|FG000|Overall Study|Lost to Follow-up|37|||
19442508|NCT01444456|41690055|FG000|Overall Study|Death|73|||
19442509|NCT01444456|41690055|FG000|Overall Study|Ineligibility determined|23|||
19442510|NCT01444456|41690055|FG000|Overall Study|Other|18|||
19442511|NCT01444456|41690055|FG000|Overall Study|Not treated|104|||
19442512|NCT01438294|41690061|FG000|Overall Study|Lost to Follow-up|3|||
19442513|NCT01438294|41690062|FG001|Overall Study|Lost to Follow-up|7|||
19442514|NCT02033759|41690070|FG000|Overall Study|Withdrawal by Subject|2|||
19442515|NCT02033759|41690071|FG001|Overall Study|Withdrawal by Subject|1|||
19442516|NCT02033759|41690070|FG000|Overall Study|Protocol Violation|1|||
19442517|NCT02033759|41690071|FG001|Overall Study|Protocol Violation|1|||
19442518|NCT01959529|41690079|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
19442519|NCT01959529|41690080|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
19442520|NCT01959529|41690079|FG000|Overall Study|Lost to Follow-up|4|||
19442521|NCT01959529|41690080|FG001|Overall Study|Lost to Follow-up|1|||
19442522|NCT01959529|41690079|FG000|Overall Study|Other|70|||
19442523|NCT01959529|41690080|FG001|Overall Study|Other|68|||
19442524|NCT01959529|41690079|FG000|Overall Study|Hypoglycaemia|1|||
19442525|NCT01959529|41690080|FG001|Overall Study|Hypoglycaemia|1|||
19442526|NCT01959529|41690079|FG000|Overall Study|Lack of glycaemic control|1|||
19442527|NCT01959529|41690080|FG001|Overall Study|Lack of glycaemic control|1|||
19442528|NCT02033369|41690088|FG000|Overall Study|Physician Decision|1|||
19442529|NCT02033369|41690089|FG001|Overall Study|Physician Decision|2|||
19442530|NCT02033369|41690088|FG000|Overall Study|Not a good demographic match|0|||
19442531|NCT02033369|41690089|FG001|Overall Study|Not a good demographic match|2|||
19442532|NCT02033369|41690088|FG000|Overall Study|Withdrawal by Subject|1|||
19442533|NCT02033369|41690089|FG001|Overall Study|Withdrawal by Subject|1|||
19442534|NCT02033369|41690088|FG000|Overall Study|Lost to Follow-up|1|||
19442535|NCT02033369|41690089|FG001|Overall Study|Lost to Follow-up|0|||
19442536|NCT02033369|41690088|FG000|Overall Study|Protocol Violation|2|||
19442537|NCT02033369|41690089|FG001|Overall Study|Protocol Violation|0|||
19442538|NCT02032901|41690095|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
19442539|NCT02032901|41690096|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
19442540|NCT02032901|41690095|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
19442541|NCT02032901|41690096|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
19442542|NCT02020967|41690106|FG000|Overall Study|Withdrawal by Subject|51|||
19442543|NCT01986829|41690112|FG000|Overall Study|Death|1|||
19442544|NCT01986751|41690121|FG000|Overall Study|improperly consented|10|||
19442545|NCT01986751|41690122|FG001|Overall Study|improperly consented|2|||
19522907|NCT02407236|41951973|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19522908|NCT02407236|41951974|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19522909|NCT02407236|41951975|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
19442546|NCT02004847|41690134|FG000|Overall Study|Protocol Violation|1|||
19442547|NCT02004847|41690135|FG001|Overall Study|Protocol Violation|1|||
19442548|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
19442549|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
19442550|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
19442551|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
19442552|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
19442553|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
19522910|NCT02407236|41951976|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
19522911|NCT02407236|41951977|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
19522912|NCT02407236|41951978|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
19522913|NCT02407236|41951979|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
19522914|NCT02407236|41951980|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
19522915|NCT02407236|41951968|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
19522916|NCT02407236|41951969|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
19522917|NCT02407236|41951970|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
19522918|NCT02407236|41951971|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
19522919|NCT02407236|41951972|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
19522920|NCT02407236|41951973|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
19522921|NCT02407236|41951974|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
19522922|NCT02407236|41951975|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
19522923|NCT02407236|41951976|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
19442554|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
19442555|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
19442556|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
19442557|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
19442558|NCT01438060|41690152|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
19442559|NCT01438060|41690153|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
19442560|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
19442561|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
19442562|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
19442563|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
19442564|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
19442565|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
19442566|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
19442567|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
19442568|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
19442569|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
19442570|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
19442571|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
19442572|NCT01438060|41690152|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
19442573|NCT01438060|41690153|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
19442574|NCT01438060|41690152|FG000|On Study Beyond Week 140|Adverse Event|0|||
19442575|NCT01438060|41690153|FG001|On Study Beyond Week 140|Adverse Event|2|||
19442576|NCT01438060|41690152|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
19442577|NCT01438060|41690153|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
19522924|NCT02407236|41951977|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
19522925|NCT02407236|41951978|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
19442578|NCT01438060|41690152|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
19442579|NCT01438060|41690153|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
19442580|NCT01438060|41690152|FG000|On Study Beyond Week 140|Death|0|||
19442581|NCT01438060|41690153|FG001|On Study Beyond Week 140|Death|1|||
19442582|NCT01438060|41690152|FG000|On Study Beyond Week 140|Other Reason|0|||
19442583|NCT01438060|41690153|FG001|On Study Beyond Week 140|Other Reason|3|||
19442584|NCT01469182|41690166|FG000|Overall Study|Adverse Event|21|||
19442585|NCT01469182|41690167|FG001|Overall Study|Adverse Event|3|||
19442586|NCT01469182|41690166|FG000|Overall Study|Lost to Follow-up|3|||
19442587|NCT01469182|41690167|FG001|Overall Study|Lost to Follow-up|0|||
19442588|NCT01469182|41690166|FG000|Overall Study|Withdrawal by Subject|4|||
19442589|NCT01469182|41690167|FG001|Overall Study|Withdrawal by Subject|1|||
19442590|NCT01469182|41690166|FG000|Overall Study|Protocol Violation|4|||
19442591|NCT01469182|41690167|FG001|Overall Study|Protocol Violation|2|||
19442592|NCT01469182|41690166|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
19442593|NCT01469182|41690167|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
19442594|NCT01444378|41690173|FG000|Overall Study|Lost to Follow-up|1|||
19442595|NCT01444378|41690173|FG000|Overall Study|Withdrawal by Subject|1|||
19442596|NCT01444378|41690173|FG000|Overall Study|Death|3|||
19442597|NCT01444378|41690173|FG000|Overall Study|Administrative Closure Of The Study|2|||
19442598|NCT01444378|41690173|FG000|Overall Study|Missed Visits|10|||
19442599|NCT02020889|41690182|FG000|Overall Study|Adverse Event|0|||
19442600|NCT02020889|41690183|FG001|Overall Study|Adverse Event|1|||
19442601|NCT02020889|41690182|FG000|Overall Study|Lack of Efficacy|1|||
19442602|NCT02020889|41690183|FG001|Overall Study|Lack of Efficacy|0|||
19442603|NCT02020889|41690182|FG000|Overall Study|Lost to Follow-up|1|||
19522926|NCT02407236|41951979|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
19522927|NCT02407236|41951980|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
19522928|NCT01893138|41952008|FG000|Double-Blind Period|Withdrawal by Subject|1|||
19522929|NCT01893138|41952009|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19522930|NCT01893138|41952008|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
19442604|NCT02020889|41690183|FG001|Overall Study|Lost to Follow-up|0|||
19442605|NCT02020889|41690182|FG000|Overall Study|Physician Decision|2|||
19442606|NCT02020889|41690183|FG001|Overall Study|Physician Decision|0|||
19442607|NCT02020889|41690182|FG000|Overall Study|Withdrawal by Subject|3|||
19442608|NCT02020889|41690183|FG001|Overall Study|Withdrawal by Subject|2|||
19442609|NCT01444300|41690191|FG000|Overall Study|Adverse Event|4|||
19442610|NCT01444300|41690192|FG001|Overall Study|Adverse Event|0|||
19442611|NCT01443364|41690199|FG000|Overall Study|Lack of Efficacy|14|||
19442612|NCT01443364|41690199|FG000|Overall Study|Lost to Follow-up|3|||
19442613|NCT01443364|41690199|FG000|Overall Study|Withdrawal by Subject|5|||
19442614|NCT01443364|41690199|FG000|Overall Study|Other Reason|4|||
19442615|NCT01443364|41690199|FG000|Overall Study|SAE, non-fatal|6|||
19442616|NCT01443364|41690199|FG000|Overall Study|AE, non-serious non-fatal|8|||
19442617|NCT01443364|41690199|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19442618|NCT02020577|41690205|FG000|Overall Study|Progressive disease|3|||
19442619|NCT02020577|41690206|FG001|Overall Study|Progressive disease|38|||
19442620|NCT02020577|41690205|FG000|Overall Study|Other AE or clinical progression|0|||
19442621|NCT02020577|41690206|FG001|Overall Study|Other AE or clinical progression|15|||
19442622|NCT02020577|41690205|FG000|Overall Study|Withdrawal by Subject|0|||
19442623|NCT02020577|41690206|FG001|Overall Study|Withdrawal by Subject|1|||
19442624|NCT02020577|41690205|FG000|Overall Study|Other than stated above|0|||
19442625|NCT02020577|41690206|FG001|Overall Study|Other than stated above|1|||
19442626|NCT02020031|41690216|FG000|Overall Study|Physician Decision|1|||
19442627|NCT02020031|41690217|FG001|Overall Study|Physician Decision|1|||
19442628|NCT04179305|41690227|FG000|Overall Study|Death|1|||
19442629|NCT04179305|41690228|FG001|Overall Study|Death|1|||
19442630|NCT04179305|41690229|FG002|Overall Study|Death|0|||
19442631|NCT04179305|41690230|FG003|Overall Study|Death|0|||
19442632|NCT04179305|41690227|FG000|Overall Study|Lost to Follow-up|1|||
19442633|NCT04179305|41690228|FG001|Overall Study|Lost to Follow-up|1|||
19442634|NCT04179305|41690229|FG002|Overall Study|Lost to Follow-up|0|||
19442635|NCT04179305|41690230|FG003|Overall Study|Lost to Follow-up|0|||
19442636|NCT04179305|41690227|FG000|Overall Study|Withdrawal by Subject|0|||
19442637|NCT04179305|41690228|FG001|Overall Study|Withdrawal by Subject|1|||
19442638|NCT04179305|41690229|FG002|Overall Study|Withdrawal by Subject|0|||
19442639|NCT04179305|41690230|FG003|Overall Study|Withdrawal by Subject|0|||
19442640|NCT04179305|41690227|FG000|Overall Study|Did not have scan|1|||
19442641|NCT04179305|41690228|FG001|Overall Study|Did not have scan|0|||
19442642|NCT04179305|41690229|FG002|Overall Study|Did not have scan|0|||
19442643|NCT04179305|41690230|FG003|Overall Study|Did not have scan|0|||
19442644|NCT04179305|41690227|FG000|Overall Study|In hospice care|3|||
19442645|NCT04179305|41690228|FG001|Overall Study|In hospice care|0|||
19442646|NCT04179305|41690229|FG002|Overall Study|In hospice care|0|||
19442647|NCT04179305|41690230|FG003|Overall Study|In hospice care|0|||
19442648|NCT02019719|41690246|FG000|Overall Study|Adverse Event|1|||
19442649|NCT02019719|41690247|FG001|Overall Study|Adverse Event|0|||
19442650|NCT02019719|41690248|FG002|Overall Study|Adverse Event|0|||
19442651|NCT02019719|41690249|FG003|Overall Study|Adverse Event|1|||
19442652|NCT02019719|41690250|FG004|Overall Study|Adverse Event|1|||
19442653|NCT02019719|41690246|FG000|Overall Study|Protocol Violation|1|||
19442654|NCT02019719|41690247|FG001|Overall Study|Protocol Violation|1|||
19442655|NCT02019719|41690248|FG002|Overall Study|Protocol Violation|0|||
19442656|NCT02019719|41690249|FG003|Overall Study|Protocol Violation|0|||
19442657|NCT02019719|41690250|FG004|Overall Study|Protocol Violation|0|||
19442658|NCT02019719|41690246|FG000|Overall Study|Protocol defined stopping criteria|2|||
19442659|NCT02019719|41690247|FG001|Overall Study|Protocol defined stopping criteria|0|||
19442660|NCT02019719|41690248|FG002|Overall Study|Protocol defined stopping criteria|0|||
19442661|NCT02019719|41690249|FG003|Overall Study|Protocol defined stopping criteria|1|||
19442662|NCT02019719|41690250|FG004|Overall Study|Protocol defined stopping criteria|1|||
19442663|NCT02019719|41690246|FG000|Overall Study|Physician Decision|2|||
19442664|NCT02019719|41690247|FG001|Overall Study|Physician Decision|0|||
19442665|NCT02019719|41690248|FG002|Overall Study|Physician Decision|0|||
19442666|NCT02019719|41690249|FG003|Overall Study|Physician Decision|0|||
19442667|NCT02019719|41690250|FG004|Overall Study|Physician Decision|0|||
19442668|NCT02030405|41690269|FG000|Overall Study|Withdrawal by Subject|1|||
19442669|NCT02030405|41690269|FG000|Overall Study|Lost to Follow-up|1|||
19442670|NCT01975376|41690276|FG000|Overall Study|Adverse Event|5|||
19442671|NCT01975376|41690277|FG001|Overall Study|Adverse Event|5|||
19442672|NCT01975376|41690276|FG000|Overall Study|Death|65|||
19442673|NCT01975376|41690277|FG001|Overall Study|Death|72|||
19442674|NCT01975376|41690276|FG000|Overall Study|Lost to Follow-up|70|||
19442675|NCT01975376|41690277|FG001|Overall Study|Lost to Follow-up|66|||
19442676|NCT01975376|41690276|FG000|Overall Study|Withdrew consent|68|||
19442677|NCT01975376|41690277|FG001|Overall Study|Withdrew consent|62|||
19442678|NCT01975376|41690276|FG000|Overall Study|Other|2|||
19442679|NCT01975376|41690277|FG001|Overall Study|Other|4|||
19442680|NCT01975376|41690276|FG000|Overall Study|Randomized, Not Treated|16|||
19442681|NCT01975376|41690277|FG001|Overall Study|Randomized, Not Treated|8|||
19442682|NCT01443130|41690289|FG000|Overall Study|Lost to Follow-up|44|||
19442683|NCT01443130|41690290|FG001|Overall Study|Lost to Follow-up|42|||
19442684|NCT01443130|41690291|FG002|Overall Study|Lost to Follow-up|50|||
19442685|NCT01443130|41690292|FG003|Overall Study|Lost to Follow-up|23|||
19442686|NCT01443130|41690293|FG004|Overall Study|Lost to Follow-up|25|||
19442687|NCT01443130|41690294|FG005|Overall Study|Lost to Follow-up|21|||
19442688|NCT01443130|41690289|FG000|Overall Study|Death|0|||
19442689|NCT01443130|41690290|FG001|Overall Study|Death|1|||
19442690|NCT01443130|41690291|FG002|Overall Study|Death|0|||
19442691|NCT01443130|41690292|FG003|Overall Study|Death|7|||
19442692|NCT01443130|41690293|FG004|Overall Study|Death|10|||
19442693|NCT01443130|41690294|FG005|Overall Study|Death|8|||
19442694|NCT01443130|41690289|FG000|Overall Study|Adverse Event|2|||
19442695|NCT01443130|41690290|FG001|Overall Study|Adverse Event|1|||
19442696|NCT01443130|41690291|FG002|Overall Study|Adverse Event|1|||
19442697|NCT01443130|41690292|FG003|Overall Study|Adverse Event|0|||
19442698|NCT01443130|41690293|FG004|Overall Study|Adverse Event|0|||
19442699|NCT01443130|41690294|FG005|Overall Study|Adverse Event|0|||
19442700|NCT01443130|41690289|FG000|Overall Study|Protocol Violation|2|||
19442701|NCT01443130|41690290|FG001|Overall Study|Protocol Violation|1|||
19442702|NCT01443130|41690291|FG002|Overall Study|Protocol Violation|3|||
19442703|NCT01443130|41690292|FG003|Overall Study|Protocol Violation|2|||
19442704|NCT01443130|41690293|FG004|Overall Study|Protocol Violation|2|||
19442705|NCT01443130|41690294|FG005|Overall Study|Protocol Violation|3|||
19442706|NCT01443130|41690289|FG000|Overall Study|Withdrawal by Subject|15|||
19442707|NCT01443130|41690290|FG001|Overall Study|Withdrawal by Subject|14|||
19442708|NCT01443130|41690291|FG002|Overall Study|Withdrawal by Subject|12|||
19442709|NCT01443130|41690292|FG003|Overall Study|Withdrawal by Subject|7|||
19442710|NCT01443130|41690293|FG004|Overall Study|Withdrawal by Subject|7|||
19442711|NCT01443130|41690294|FG005|Overall Study|Withdrawal by Subject|2|||
19442712|NCT01443130|41690289|FG000|Overall Study|Death of Subject's Infant|5|||
19442713|NCT01443130|41690290|FG001|Overall Study|Death of Subject's Infant|10|||
19442714|NCT01443130|41690291|FG002|Overall Study|Death of Subject's Infant|11|||
19442715|NCT01443130|41690292|FG003|Overall Study|Death of Subject's Infant|0|||
19442716|NCT01443130|41690293|FG004|Overall Study|Death of Subject's Infant|0|||
19442717|NCT01443130|41690294|FG005|Overall Study|Death of Subject's Infant|0|||
19442718|NCT01959139|41690312|FG000|Phase II|Disease progression|0|||
19442719|NCT01959139|41690313|FG001|Phase II|Disease progression|0|||
19442720|NCT01959139|41690314|FG002|Phase II|Disease progression|26|||
19442721|NCT01959139|41690315|FG003|Phase II|Disease progression|34|||
19442722|NCT01959139|41690312|FG000|Phase II|Adverse Event|0|||
19442723|NCT01959139|41690313|FG001|Phase II|Adverse Event|0|||
19442724|NCT01959139|41690314|FG002|Phase II|Adverse Event|10|||
19442725|NCT01959139|41690315|FG003|Phase II|Adverse Event|11|||
19442726|NCT01959139|41690312|FG000|Phase II|Patient Refusal|0|||
19442727|NCT01959139|41690313|FG001|Phase II|Patient Refusal|0|||
19442728|NCT01959139|41690314|FG002|Phase II|Patient Refusal|5|||
19442729|NCT01959139|41690315|FG003|Phase II|Patient Refusal|4|||
19442730|NCT01959139|41690312|FG000|Phase II|Death|0|||
19442731|NCT01959139|41690313|FG001|Phase II|Death|0|||
19442732|NCT01959139|41690314|FG002|Phase II|Death|3|||
19442733|NCT01959139|41690315|FG003|Phase II|Death|1|||
19442734|NCT01959139|41690312|FG000|Phase II|Other/Unknown|0|||
19442735|NCT01959139|41690313|FG001|Phase II|Other/Unknown|0|||
19442736|NCT01959139|41690314|FG002|Phase II|Other/Unknown|8|||
19442737|NCT01959139|41690315|FG003|Phase II|Other/Unknown|5|||
19442738|NCT01959139|41690312|FG000|Phase II|On treatment|0|||
19442739|NCT01959139|41690313|FG001|Phase II|On treatment|0|||
19442740|NCT01959139|41690314|FG002|Phase II|On treatment|4|||
19442741|NCT01959139|41690315|FG003|Phase II|On treatment|0|||
19442742|NCT01436500|41690332|FG000|Overall Study|Death|1|||
19442743|NCT01436500|41690333|FG001|Overall Study|Death|0|||
19442744|NCT01436500|41690334|FG002|Overall Study|Death|0|||
19442745|NCT01436500|41690335|FG003|Overall Study|Death|0|||
19442746|NCT01436500|41690336|FG004|Overall Study|Death|0|||
19442747|NCT01436500|41690332|FG000|Overall Study|Adverse Event|0|||
19442748|NCT01436500|41690333|FG001|Overall Study|Adverse Event|2|||
19442749|NCT01436500|41690334|FG002|Overall Study|Adverse Event|2|||
19442750|NCT01436500|41690335|FG003|Overall Study|Adverse Event|0|||
19442751|NCT01436500|41690336|FG004|Overall Study|Adverse Event|1|||
19442752|NCT01436500|41690332|FG000|Overall Study|Withdrawal by Subject|0|||
19442753|NCT01436500|41690333|FG001|Overall Study|Withdrawal by Subject|0|||
19442754|NCT01436500|41690334|FG002|Overall Study|Withdrawal by Subject|2|||
19442755|NCT01436500|41690335|FG003|Overall Study|Withdrawal by Subject|0|||
19442756|NCT01436500|41690336|FG004|Overall Study|Withdrawal by Subject|2|||
19442757|NCT01436500|41690332|FG000|Overall Study|Physician Decision|0|||
19442758|NCT01436500|41690333|FG001|Overall Study|Physician Decision|0|||
19442759|NCT01436500|41690334|FG002|Overall Study|Physician Decision|1|||
19442760|NCT01436500|41690335|FG003|Overall Study|Physician Decision|0|||
19442761|NCT01436500|41690336|FG004|Overall Study|Physician Decision|0|||
19442762|NCT01436500|41690332|FG000|Overall Study|liver transplant|1|||
19442763|NCT01436500|41690333|FG001|Overall Study|liver transplant|0|||
19442764|NCT01436500|41690334|FG002|Overall Study|liver transplant|0|||
19442765|NCT01436500|41690335|FG003|Overall Study|liver transplant|0|||
19442766|NCT01436500|41690336|FG004|Overall Study|liver transplant|0|||
19442767|NCT01436500|41690332|FG000|Overall Study|initiation of dialysis|0|||
19442768|NCT01436500|41690333|FG001|Overall Study|initiation of dialysis|0|||
19442769|NCT01436500|41690334|FG002|Overall Study|initiation of dialysis|0|||
19442770|NCT01436500|41690335|FG003|Overall Study|initiation of dialysis|0|||
19442771|NCT01436500|41690336|FG004|Overall Study|initiation of dialysis|1|||
19442772|NCT01436500|41690332|FG000|Overall Study|discontinued study drug|1|||
19442773|NCT01436500|41690333|FG001|Overall Study|discontinued study drug|0|||
19442774|NCT01436500|41690334|FG002|Overall Study|discontinued study drug|0|||
19442775|NCT01436500|41690335|FG003|Overall Study|discontinued study drug|0|||
19442776|NCT01436500|41690336|FG004|Overall Study|discontinued study drug|0|||
19442777|NCT01436500|41690332|FG000|Overall Study|Other|0|||
19442778|NCT01436500|41690333|FG001|Overall Study|Other|1|||
19442779|NCT01436500|41690334|FG002|Overall Study|Other|0|||
19442780|NCT01436500|41690335|FG003|Overall Study|Other|1|||
19442781|NCT01436500|41690336|FG004|Overall Study|Other|0|||
19442782|NCT01958827|41690349|FG000|Overall Study|Adverse Event|3|||
19442783|NCT01958827|41690349|FG000|Overall Study|Lack of Efficacy|6|||
19442784|NCT01958827|41690349|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
19442785|NCT01620086|41690355|FG000|Overall Study|Withdrawal by Subject|3|||
19442786|NCT01620086|41690356|FG001|Overall Study|Withdrawal by Subject|3|||
19442787|NCT01620086|41690357|FG002|Overall Study|Withdrawal by Subject|0|||
19442788|NCT01620086|41690355|FG000|Overall Study|failed study criteria|1|||
19442789|NCT01620086|41690356|FG001|Overall Study|failed study criteria|4|||
19442790|NCT01620086|41690357|FG002|Overall Study|failed study criteria|0|||
19442791|NCT01620086|41690355|FG000|Overall Study|Physician Decision|1|||
19442792|NCT01620086|41690356|FG001|Overall Study|Physician Decision|0|||
19442793|NCT01620086|41690357|FG002|Overall Study|Physician Decision|0|||
19442794|NCT01436110|41690369|FG000|Overall Study|Lack of Efficacy|23|||
19442795|NCT01436110|41690370|FG001|Overall Study|Lack of Efficacy|14|||
19442796|NCT01436110|41690371|FG002|Overall Study|Lack of Efficacy|9|||
19442797|NCT01436110|41690369|FG000|Overall Study|Withdrawal by Subject|6|||
19442798|NCT01436110|41690370|FG001|Overall Study|Withdrawal by Subject|8|||
19442799|NCT01436110|41690371|FG002|Overall Study|Withdrawal by Subject|4|||
19442800|NCT01436110|41690369|FG000|Overall Study|Adverse Event|2|||
19442801|NCT01436110|41690370|FG001|Overall Study|Adverse Event|1|||
19442802|NCT01436110|41690371|FG002|Overall Study|Adverse Event|2|||
19442803|NCT01436110|41690369|FG000|Overall Study|Physician Decision|3|||
19442804|NCT01436110|41690370|FG001|Overall Study|Physician Decision|1|||
19442805|NCT01436110|41690371|FG002|Overall Study|Physician Decision|1|||
19442806|NCT01436110|41690369|FG000|Overall Study|Lost to Follow-up|1|||
19442807|NCT01436110|41690370|FG001|Overall Study|Lost to Follow-up|1|||
19442808|NCT01436110|41690371|FG002|Overall Study|Lost to Follow-up|3|||
19442809|NCT01436110|41690369|FG000|Overall Study|Protocol Violation|3|||
19442810|NCT01436110|41690370|FG001|Overall Study|Protocol Violation|1|||
19442811|NCT01436110|41690371|FG002|Overall Study|Protocol Violation|1|||
19442812|NCT01436110|41690369|FG000|Overall Study|Did Not Receive Trial Medication|1|||
19442813|NCT01436110|41690370|FG001|Overall Study|Did Not Receive Trial Medication|0|||
19442814|NCT01436110|41690371|FG002|Overall Study|Did Not Receive Trial Medication|3|||
19442815|NCT01619852|41690381|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
19442816|NCT01619852|41690382|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
19442817|NCT01619852|41690381|FG000|3 Month Follow up|Lost to Follow-up|31|||
19442818|NCT01619852|41690382|FG001|3 Month Follow up|Lost to Follow-up|34|||
19442819|NCT02000882|41690389|FG000|Overall Study|Adverse Event|3|||
19442820|NCT02000882|41690389|FG000|Overall Study|Physician Decision|2|||
19442821|NCT02000882|41690389|FG000|Overall Study|Withdrawal by Subject|1|||
19442822|NCT01965938|41690395|FG000|Overall Study|Withdrawal by Subject|1|||
19442823|NCT01965938|41690396|FG001|Overall Study|Withdrawal by Subject|0|||
19442824|NCT01958671|41690407|FG000|Overall Study|Adverse Event|1|||
19442825|NCT01958671|41690408|FG001|Overall Study|Adverse Event|1|||
19442826|NCT01958671|41690409|FG002|Overall Study|Adverse Event|5|||
19442827|NCT01958671|41690407|FG000|Overall Study|Death|1|||
19442828|NCT01958671|41690408|FG001|Overall Study|Death|0|||
19442829|NCT01958671|41690409|FG002|Overall Study|Death|0|||
19442830|NCT01958671|41690407|FG000|Overall Study|Excluded medication|0|||
19442831|NCT01958671|41690408|FG001|Overall Study|Excluded medication|0|||
19442832|NCT01958671|41690409|FG002|Overall Study|Excluded medication|1|||
19442833|NCT01958671|41690407|FG000|Overall Study|Hyperglycemia|0|||
19442834|NCT01958671|41690408|FG001|Overall Study|Hyperglycemia|0|||
19442835|NCT01958671|41690409|FG002|Overall Study|Hyperglycemia|2|||
19442836|NCT01958671|41690407|FG000|Overall Study|Lost to Follow-up|7|||
19442837|NCT01958671|41690408|FG001|Overall Study|Lost to Follow-up|11|||
19442838|NCT01958671|41690409|FG002|Overall Study|Lost to Follow-up|7|||
19442839|NCT01958671|41690407|FG000|Overall Study|Non-compliance with study drug|1|||
19442840|NCT01958671|41690408|FG001|Overall Study|Non-compliance with study drug|1|||
19442841|NCT01958671|41690409|FG002|Overall Study|Non-compliance with study drug|1|||
19442842|NCT01958671|41690407|FG000|Overall Study|Pregnancy|0|||
19442843|NCT01958671|41690408|FG001|Overall Study|Pregnancy|0|||
19442844|NCT01958671|41690409|FG002|Overall Study|Pregnancy|1|||
19442845|NCT01958671|41690407|FG000|Overall Study|Protocol Violation|0|||
19442846|NCT01958671|41690408|FG001|Overall Study|Protocol Violation|1|||
19442847|NCT01958671|41690409|FG002|Overall Study|Protocol Violation|0|||
19442848|NCT01958671|41690407|FG000|Overall Study|Study site terminated by sponsor|1|||
19442849|NCT01958671|41690408|FG001|Overall Study|Study site terminated by sponsor|0|||
19442850|NCT01958671|41690409|FG002|Overall Study|Study site terminated by sponsor|1|||
19442851|NCT01958671|41690407|FG000|Overall Study|Participant moved|0|||
19442852|NCT01958671|41690408|FG001|Overall Study|Participant moved|0|||
19442853|NCT01958671|41690409|FG002|Overall Study|Participant moved|1|||
19442854|NCT01958671|41690407|FG000|Overall Study|Withdrawal by Subject|8|||
19442855|NCT01958671|41690408|FG001|Overall Study|Withdrawal by Subject|10|||
19442856|NCT01958671|41690409|FG002|Overall Study|Withdrawal by Subject|13|||
19442857|NCT01965860|41690424|FG000|Overall Study|Pregnancy|1|||
19442858|NCT01965860|41690425|FG001|Overall Study|Pregnancy|0|||
19442859|NCT01965860|41690426|FG002|Overall Study|Pregnancy|1|||
19442860|NCT01965860|41690424|FG000|Overall Study|Logistics|1|||
19442861|NCT01965860|41690425|FG001|Overall Study|Logistics|0|||
19442862|NCT01965860|41690426|FG002|Overall Study|Logistics|0|||
19442863|NCT01965704|41690447|FG000|Overall Study|Withdrawal by Subject|2|||
19442864|NCT01965704|41690448|FG001|Overall Study|Withdrawal by Subject|2|||
19442865|NCT01965704|41690449|FG002|Overall Study|Withdrawal by Subject|1|||
19442866|NCT01965704|41690450|FG003|Overall Study|Withdrawal by Subject|1|||
19442867|NCT01965704|41690447|FG000|Overall Study|Delivered at home|1|||
19442868|NCT01965704|41690448|FG001|Overall Study|Delivered at home|1|||
19442869|NCT01965704|41690449|FG002|Overall Study|Delivered at home|0|||
19442870|NCT01965704|41690450|FG003|Overall Study|Delivered at home|0|||
19442871|NCT01965704|41690447|FG000|Overall Study|Experienced complications|0|||
19442872|NCT01965704|41690448|FG001|Overall Study|Experienced complications|0|||
19442873|NCT01965704|41690449|FG002|Overall Study|Experienced complications|2|||
19442874|NCT01965704|41690450|FG003|Overall Study|Experienced complications|2|||
19442875|NCT01965704|41690447|FG000|Overall Study|Adverse Event|0|||
19442876|NCT01965704|41690448|FG001|Overall Study|Adverse Event|0|||
19442877|NCT01965704|41690449|FG002|Overall Study|Adverse Event|1|||
19442878|NCT01965704|41690450|FG003|Overall Study|Adverse Event|1|||
19442879|NCT01965704|41690447|FG000|Overall Study|Did not meet inclusion criteria|0|||
19442880|NCT01965704|41690448|FG001|Overall Study|Did not meet inclusion criteria|0|||
19442881|NCT01965704|41690449|FG002|Overall Study|Did not meet inclusion criteria|1|||
19442882|NCT01965704|41690450|FG003|Overall Study|Did not meet inclusion criteria|1|||
19442883|NCT02003365|41690461|FG000|Overall Study|Lost to Follow-up|0|||
19442884|NCT02003365|41690462|FG001|Overall Study|Lost to Follow-up|0|||
19442885|NCT02003365|41690463|FG002|Overall Study|Lost to Follow-up|1|||
19442886|NCT01975220|41690474|FG000|Test Period 1|Not treated|0|||
19442887|NCT01975220|41690475|FG001|Test Period 1|Not treated|1|||
19442888|NCT01975220|41690476|FG002|Test Period 1|Not treated|0|||
19442889|NCT01975220|41690477|FG003|Test Period 1|Not treated|0|||
19442890|NCT01975220|41690478|FG004|Test Period 1|Not treated|0|||
19442891|NCT01975220|41690479|FG005|Test Period 1|Not treated|0|||
19442892|NCT01958437|41690496|FG000|Overall Study|Incidental MRI findings|0|||
19442893|NCT01958437|41690497|FG001|Overall Study|Incidental MRI findings|0|||
19442894|NCT01958437|41690498|FG002|Overall Study|Incidental MRI findings|1|||
19442895|NCT01958437|41690499|FG003|Overall Study|Incidental MRI findings|1|||
19442896|NCT01974752|41690518|FG000|Overall Study|Death|33|||
19442897|NCT01974752|41690519|FG001|Overall Study|Death|11|||
19442898|NCT01974752|41690518|FG000|Overall Study|Lost to Follow-up|2|||
19442899|NCT01974752|41690519|FG001|Overall Study|Lost to Follow-up|0|||
19442900|NCT01974752|41690518|FG000|Overall Study|Withdrawal by Subject|2|||
19442901|NCT01974752|41690519|FG001|Overall Study|Withdrawal by Subject|3|||
19442902|NCT01974752|41690518|FG000|Overall Study|Other Eligibility Criteria|0|||
19442903|NCT01974752|41690519|FG001|Overall Study|Other Eligibility Criteria|1|||
19442904|NCT01999946|41690528|FG000|Overall Study|Participant not released from jail|2|||
19442905|NCT01999946|41690529|FG001|Overall Study|Participant not released from jail|2|||
19442906|NCT01999946|41690530|FG002|Overall Study|Participant not released from jail|0|||
19442907|NCT01999946|41690528|FG000|Overall Study|Not included in primary outcome analysis|0|||
19442908|NCT01999946|41690529|FG001|Overall Study|Not included in primary outcome analysis|0|||
19442909|NCT01999946|41690530|FG002|Overall Study|Not included in primary outcome analysis|79|||
19442910|NCT01958281|41690540|FG000|Overall Study|Lack of Efficacy|5|||
19442911|NCT01958281|41690541|FG001|Overall Study|Lack of Efficacy|2|||
19442912|NCT01958281|41690542|FG002|Overall Study|Lack of Efficacy|0|||
19442913|NCT01958281|41690540|FG000|Overall Study|Adverse Event|0|||
19522931|NCT01893138|41952009|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
19442914|NCT01958281|41690541|FG001|Overall Study|Adverse Event|2|||
19442915|NCT01958281|41690542|FG002|Overall Study|Adverse Event|0|||
19442916|NCT01958281|41690540|FG000|Overall Study|Withdrew Consent|1|||
19442917|NCT01958281|41690541|FG001|Overall Study|Withdrew Consent|0|||
19442918|NCT01958281|41690542|FG002|Overall Study|Withdrew Consent|0|||
19442919|NCT01958125|41690553|FG000|Overall Study|Missing diary data|2|||
19442920|NCT01958125|41690554|FG001|Overall Study|Missing diary data|6|||
19442921|NCT01958125|41690553|FG000|Overall Study|No headache attacks|0|||
19442922|NCT01958125|41690554|FG001|Overall Study|No headache attacks|2|||
19442923|NCT02002975|41690560|FG000|Overall Study|Case Report Forms Uncollected|135|||
19442924|NCT02002975|41690560|FG000|Overall Study|Protocol Deviation|437|||
19442925|NCT02001181|41690566|FG000|Overall Study|Adverse Event|0|||
19442926|NCT02001181|41690567|FG001|Overall Study|Adverse Event|2|||
19442927|NCT02001181|41690566|FG000|Overall Study|Lost to Follow-up|1|||
19442928|NCT02001181|41690567|FG001|Overall Study|Lost to Follow-up|0|||
19442929|NCT02001181|41690566|FG000|Overall Study|Withdrawal by Subject|0|||
19442930|NCT02001181|41690567|FG001|Overall Study|Withdrawal by Subject|1|||
19442931|NCT01999465|41690575|FG000|Overall Study|Lost to Follow-up|0|||
19442932|NCT01999465|41690576|FG001|Overall Study|Lost to Follow-up|2|||
19442933|NCT01999465|41690575|FG000|Overall Study|Protocol Violation|0|||
19442934|NCT01999465|41690576|FG001|Overall Study|Protocol Violation|1|||
19442935|NCT01982773|41690584|FG000|Overall Study|Withdrawal by Subject|1|||
19442936|NCT01982773|41690585|FG001|Overall Study|Withdrawal by Subject|3|||
19442937|NCT01982773|41690584|FG000|Overall Study|Lost to Follow-up|7|||
19442938|NCT01982773|41690585|FG001|Overall Study|Lost to Follow-up|1|||
19442939|NCT01974206|41690593|FG000|Overall Study|Did Not Take Study Drug|0|||
19442940|NCT01974206|41690594|FG001|Overall Study|Did Not Take Study Drug|1|||
19442941|NCT01974206|41690593|FG000|Overall Study|Physician Decision|1|||
19442942|NCT01974206|41690594|FG001|Overall Study|Physician Decision|0|||
19442943|NCT01974206|41690593|FG000|Overall Study|Withdrawal by Subject|3|||
19442944|NCT01974206|41690594|FG001|Overall Study|Withdrawal by Subject|0|||
19442945|NCT01974206|41690593|FG000|Overall Study|Lost to Follow-up|1|||
19442946|NCT01974206|41690594|FG001|Overall Study|Lost to Follow-up|0|||
19442947|NCT01974206|41690593|FG000|Overall Study|Death|1|||
19442948|NCT01974206|41690594|FG001|Overall Study|Death|0|||
19442949|NCT01999868|41690603|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
19442950|NCT01999868|41690604|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
19442951|NCT01999868|41690605|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
19442952|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
19442953|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
19442954|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
19442955|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
19442956|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
19442957|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
19522932|NCT01893138|41952008|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
19522933|NCT01893138|41952009|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
19442958|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
19442959|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
19442960|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
19442961|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
19442962|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
19442963|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
19442964|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
19442965|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
19442966|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
19442967|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
19442968|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
19442969|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
19442970|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
19442971|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
19442972|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
19442973|NCT01999868|41690603|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
19442974|NCT01999868|41690604|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
19442975|NCT01999868|41690605|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
19442976|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
19442977|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
19442978|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
19442979|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
19442980|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
19442981|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
19442982|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
19442983|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
19442984|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
19442985|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
19442986|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
19442987|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
19442988|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
19442989|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
19442990|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
19442991|NCT01999868|41690603|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
19442992|NCT01999868|41690604|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
19442993|NCT01999868|41690605|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
19442994|NCT01957579|41690617|FG000|Overall Study|Withdrawal of concent|0|||
19442995|NCT01957579|41690618|FG001|Overall Study|Withdrawal of concent|1|||
19442996|NCT01957579|41690619|FG002|Overall Study|Withdrawal of concent|0|||
19522934|NCT01893138|41952008|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
19522935|NCT01893138|41952009|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
19522936|NCT01893138|41952008|FG000|Open Label - Unblinded Period|Adverse Event|1|||
19522937|NCT01893138|41952009|FG001|Open Label - Unblinded Period|Adverse Event|0|||
19522938|NCT04309500|41952021|FG000|Overall Study|Lost to Follow-up|1|||
19522939|NCT04309500|41952022|FG001|Overall Study|Lost to Follow-up|0|||
19522940|NCT04309500|41952023|FG002|Overall Study|Lost to Follow-up|0|||
19522941|NCT04309500|41952024|FG003|Overall Study|Lost to Follow-up|0|||
19522942|NCT03671304|41953359|FG000|Overall Study|study terminated|7|||
19522943|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
19522944|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
19522945|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Death|0|||
19522946|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Death|4|||
19522947|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
19522948|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
19522949|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
19522950|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
19522951|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
19522952|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
19442997|NCT01957579|41690620|FG003|Overall Study|Withdrawal of concent|0|||
19442998|NCT01957579|41690617|FG000|Overall Study|Death|0|||
19442999|NCT01957579|41690618|FG001|Overall Study|Death|0|||
19443000|NCT01957579|41690619|FG002|Overall Study|Death|2|||
19443001|NCT01957579|41690620|FG003|Overall Study|Death|0|||
19443002|NCT01999322|41690649|FG000|Overall Study|Adverse Event|1|||
19443003|NCT01999322|41690650|FG001|Overall Study|Adverse Event|0|||
19443004|NCT01996982|41690656|FG000|Overall Study|PI/team left institution|7|||
19443005|NCT01965158|41690662|FG000|Overall Study|Adverse Event|14|||
19443006|NCT01965158|41690663|FG001|Overall Study|Adverse Event|5|||
19443007|NCT01965158|41690662|FG000|Overall Study|Withdrawal by Subject|16|||
19443008|NCT01965158|41690663|FG001|Overall Study|Withdrawal by Subject|24|||
19443009|NCT01965158|41690662|FG000|Overall Study|Lost to Follow-up|7|||
19443010|NCT01965158|41690663|FG001|Overall Study|Lost to Follow-up|5|||
19443011|NCT01965158|41690662|FG000|Overall Study|Protocol Violation|1|||
19443012|NCT01965158|41690663|FG001|Overall Study|Protocol Violation|1|||
19443013|NCT01965158|41690662|FG000|Overall Study|Other - Miscellaneous|3|||
19443014|NCT01965158|41690663|FG001|Overall Study|Other - Miscellaneous|0|||
19443015|NCT01964924|41690669|FG000|Trametinib Monotherapy|Progression|19|||
19443016|NCT01964924|41690670|FG001|Trametinib Monotherapy|Progression|0|||
19443017|NCT01964378|41690681|FG000|Overall Study|Disc. due to death before first dosing|0|||
19443018|NCT01964378|41690682|FG001|Overall Study|Disc. due to death before first dosing|1|||
19443019|NCT01964378|41690681|FG000|Overall Study|Disc. due to AE before first dosing|1|||
19443020|NCT01964378|41690682|FG001|Overall Study|Disc. due to AE before first dosing|0|||
19443021|NCT01964378|41690681|FG000|Overall Study|Death|3|||
19443022|NCT01964378|41690682|FG001|Overall Study|Death|2|||
19443023|NCT01964378|41690681|FG000|Overall Study|Adverse Event|12|||
19443024|NCT01964378|41690682|FG001|Overall Study|Adverse Event|5|||
19443025|NCT01964378|41690681|FG000|Overall Study|Lack of Efficacy|0|||
19443026|NCT01964378|41690682|FG001|Overall Study|Lack of Efficacy|1|||
19443027|NCT01964378|41690681|FG000|Overall Study|Protocol Violation|0|||
19443028|NCT01964378|41690682|FG001|Overall Study|Protocol Violation|1|||
19443029|NCT01964378|41690681|FG000|Overall Study|Lost to Follow-up|0|||
19443030|NCT01964378|41690682|FG001|Overall Study|Lost to Follow-up|1|||
19443031|NCT01964378|41690681|FG000|Overall Study|Withdrawal by Subject|7|||
19443032|NCT01964378|41690682|FG001|Overall Study|Withdrawal by Subject|5|||
19443033|NCT01964378|41690681|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
19443034|NCT01964378|41690682|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
19443035|NCT01964378|41690681|FG000|Overall Study|Other|1|||
19443036|NCT01964378|41690682|FG001|Overall Study|Other|2|||
19443037|NCT01442038|41690690|FG000|Overall Study|Death|35|||
19443038|NCT01442038|41690691|FG001|Overall Study|Death|29|||
19443039|NCT01442038|41690690|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
19443040|NCT01442038|41690691|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
19443041|NCT01442038|41690690|FG000|Overall Study|Participant Withdrew Consent|137|||
19443042|NCT01442038|41690691|FG001|Overall Study|Participant Withdrew Consent|102|||
19522953|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
19629044|NCT00642616|42078615|FG001|Overall Study|Adverse Event|0|||
19443043|NCT01442038|41690690|FG000|Overall Study|Lost to Follow-up|37|||
19443044|NCT01442038|41690691|FG001|Overall Study|Lost to Follow-up|51|||
19443045|NCT01442038|41690690|FG000|Overall Study|Adverse Event|26|||
19443046|NCT01442038|41690691|FG001|Overall Study|Adverse Event|15|||
19443047|NCT01442038|41690690|FG000|Overall Study|Protocol Deviation|9|||
19443048|NCT01442038|41690691|FG001|Overall Study|Protocol Deviation|20|||
19443049|NCT01442038|41690690|FG000|Overall Study|Investigator's Discretion|13|||
19443050|NCT01442038|41690691|FG001|Overall Study|Investigator's Discretion|16|||
19443051|NCT01442038|41690690|FG000|Overall Study|Study Terminated By Sponsor|2|||
19443052|NCT01442038|41690691|FG001|Overall Study|Study Terminated By Sponsor|3|||
19443053|NCT01998919|41690699|FG000|Overall Study|Death|2|||
19443054|NCT01998919|41690700|FG001|Overall Study|Death|2|||
19443055|NCT01998919|41690699|FG000|Overall Study|Adverse Event|0|||
19443056|NCT01998919|41690700|FG001|Overall Study|Adverse Event|5|||
19443057|NCT01998919|41690699|FG000|Overall Study|Disease progression|31|||
19443058|NCT01998919|41690700|FG001|Overall Study|Disease progression|22|||
19443059|NCT01998919|41690699|FG000|Overall Study|Withdrawal by Subject|2|||
19443060|NCT01998919|41690700|FG001|Overall Study|Withdrawal by Subject|4|||
19443061|NCT01998919|41690699|FG000|Overall Study|Lost to Follow-up|2|||
19443062|NCT01998919|41690700|FG001|Overall Study|Lost to Follow-up|0|||
19443063|NCT01998919|41690699|FG000|Overall Study|Other|5|||
19443064|NCT01998919|41690700|FG001|Overall Study|Other|2|||
19443065|NCT01957111|41690708|FG000|Overall Study|Withdrawal by Subject|1|||
19443066|NCT01957111|41690709|FG001|Overall Study|Withdrawal by Subject|1|||
19443067|NCT01964300|41690717|FG000|Overall Study|Ineligible after enrollment|0|||
19443068|NCT01964300|41690718|FG001|Overall Study|Ineligible after enrollment|1|||
19443069|NCT01964300|41690717|FG000|Overall Study|Adverse Event|1|||
19443070|NCT01964300|41690718|FG001|Overall Study|Adverse Event|1|||
19443071|NCT01964300|41690717|FG000|Overall Study|Lack of Efficacy|3|||
19443072|NCT01964300|41690718|FG001|Overall Study|Lack of Efficacy|5|||
19443073|NCT01964300|41690717|FG000|Overall Study|Withdrawal by Subject|0|||
19443074|NCT01964300|41690718|FG001|Overall Study|Withdrawal by Subject|1|||
19443075|NCT01964300|41690717|FG000|Overall Study|To receive alternative therapy|1|||
19443076|NCT01964300|41690718|FG001|Overall Study|To receive alternative therapy|2|||
19443077|NCT01964300|41690717|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
19443078|NCT01964300|41690718|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
19443079|NCT01964300|41690717|FG000|Overall Study|Weight criteria not met|0|||
19443080|NCT01964300|41690718|FG001|Overall Study|Weight criteria not met|1|||
19443081|NCT01964222|41690726|FG000|Overall Study|Lost to Follow-up|7|||
19443082|NCT01964222|41690727|FG001|Overall Study|Lost to Follow-up|5|||
19443083|NCT01964222|41690726|FG000|Overall Study|Withdrawal by Subject|6|||
19443084|NCT01964222|41690727|FG001|Overall Study|Withdrawal by Subject|6|||
19443085|NCT01964222|41690726|FG000|Overall Study|Screening Failure|2|||
19443086|NCT01964222|41690727|FG001|Overall Study|Screening Failure|0|||
19522954|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
19522955|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
19522956|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
19522957|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Other|4|||
19522958|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Other|3|||
19522959|NCT03517722|41953365|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
19522960|NCT03517722|41953366|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
19522961|NCT03517722|41953365|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
19522962|NCT03517722|41953366|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
19522963|NCT03517722|41953365|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
19522964|NCT03517722|41953366|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
19522965|NCT03517722|41953365|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
19522966|NCT03517722|41953366|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
19522967|NCT03517722|41953365|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
19522968|NCT03517722|41953366|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
19522969|NCT03447990|41953380|FG000|Overall Study|Withdrawal by Subject|0|||
19522970|NCT03447990|41953381|FG001|Overall Study|Withdrawal by Subject|0|||
19522971|NCT03447990|41953382|FG002|Overall Study|Withdrawal by Subject|0|||
19522972|NCT03447990|41953383|FG003|Overall Study|Withdrawal by Subject|0|||
19522973|NCT03447990|41953384|FG004|Overall Study|Withdrawal by Subject|0|||
19522974|NCT03447990|41953385|FG005|Overall Study|Withdrawal by Subject|0|||
19522975|NCT03447990|41953386|FG006|Overall Study|Withdrawal by Subject|1|||
19522976|NCT01376778|41953438|FG000|Overall Study|Lost to Follow-up|3|||
19522977|NCT01376778|41953439|FG001|Overall Study|Lost to Follow-up|2|||
19522978|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
19522979|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
19443087|NCT01467700|41690737|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
19443088|NCT01467700|41690738|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
19443089|NCT01467700|41690739|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
19443090|NCT01467700|41690740|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
19522980|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
19522981|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
19522982|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
19522983|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
19522984|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
19522985|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
19522986|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
19522987|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
19522988|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
19522989|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
19522990|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
19522991|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
19522992|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
19522993|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
19522994|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
19522995|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
19522996|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
19522997|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
19522998|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
19522999|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
19523000|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
19523001|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
19523002|NCT01074294|41953448|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
19523003|NCT01074294|41953449|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
19523004|NCT01074294|41953450|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
19523005|NCT01074294|41953451|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
19523006|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
19523007|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
19523008|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
19523009|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
19523010|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
19523011|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
19523012|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
19523013|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
19523014|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
19523015|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
19523016|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
19523017|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
19523018|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
19443091|NCT01467700|41690737|FG000|Overall Study|Major Protocol Deviation|3|||
19443092|NCT01467700|41690738|FG001|Overall Study|Major Protocol Deviation|3|||
19443093|NCT01467700|41690739|FG002|Overall Study|Major Protocol Deviation|2|||
19443094|NCT01467700|41690740|FG003|Overall Study|Major Protocol Deviation|3|||
19443095|NCT01467700|41690737|FG000|Overall Study|Lost to Follow-up|6|||
19443096|NCT01467700|41690738|FG001|Overall Study|Lost to Follow-up|5|||
19443097|NCT01467700|41690739|FG002|Overall Study|Lost to Follow-up|2|||
19443098|NCT01467700|41690740|FG003|Overall Study|Lost to Follow-up|3|||
19443099|NCT01467700|41690737|FG000|Overall Study|Voluntary Withdrawal|5|||
19443100|NCT01467700|41690738|FG001|Overall Study|Voluntary Withdrawal|7|||
19443101|NCT01467700|41690739|FG002|Overall Study|Voluntary Withdrawal|6|||
19443102|NCT01467700|41690740|FG003|Overall Study|Voluntary Withdrawal|2|||
19443103|NCT01467700|41690737|FG000|Overall Study|Study Termination|6|||
19443104|NCT01467700|41690738|FG001|Overall Study|Study Termination|5|||
19443105|NCT01467700|41690739|FG002|Overall Study|Study Termination|10|||
19443106|NCT01467700|41690740|FG003|Overall Study|Study Termination|7|||
19443107|NCT01467700|41690737|FG000|Overall Study|Pregnancy|0|||
19443108|NCT01467700|41690738|FG001|Overall Study|Pregnancy|1|||
19443109|NCT01467700|41690739|FG002|Overall Study|Pregnancy|1|||
19443110|NCT01467700|41690740|FG003|Overall Study|Pregnancy|0|||
19443111|NCT01467700|41690737|FG000|Overall Study|Lack of Efficacy|2|||
19443112|NCT01467700|41690738|FG001|Overall Study|Lack of Efficacy|0|||
19443113|NCT01467700|41690739|FG002|Overall Study|Lack of Efficacy|2|||
19523019|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
19523020|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
19523021|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
19443114|NCT01467700|41690740|FG003|Overall Study|Lack of Efficacy|1|||
19443115|NCT01467700|41690737|FG000|Overall Study|Reason not Specified|1|||
19443116|NCT01467700|41690738|FG001|Overall Study|Reason not Specified|3|||
19443117|NCT01467700|41690739|FG002|Overall Study|Reason not Specified|2|||
19523022|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
19523023|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
19523024|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
19523025|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
19523026|NCT01074294|41953448|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
19523027|NCT01074294|41953449|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
19523028|NCT01074294|41953450|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
19523029|NCT01074294|41953451|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
19523030|NCT04556838|41955268|FG000|Overall Study|Withdrawal by Subject|3|||
19523031|NCT04556838|41955269|FG001|Overall Study|Withdrawal by Subject|1|||
19523032|NCT04556838|41955270|FG002|Overall Study|Withdrawal by Subject|2|||
19523033|NCT04556838|41955268|FG000|Overall Study|Adverse Event|0|||
19523034|NCT04556838|41955269|FG001|Overall Study|Adverse Event|1|||
19523035|NCT04556838|41955270|FG002|Overall Study|Adverse Event|1|||
19443118|NCT01467700|41690740|FG003|Overall Study|Reason not Specified|8|||
19523036|NCT04556838|41955268|FG000|Overall Study|Lost to Follow-up|0|||
19523037|NCT04556838|41955269|FG001|Overall Study|Lost to Follow-up|0|||
19523038|NCT04556838|41955270|FG002|Overall Study|Lost to Follow-up|2|||
19523039|NCT04556838|41955268|FG000|Overall Study|Subject travel|0|||
19523040|NCT04556838|41955269|FG001|Overall Study|Subject travel|1|||
19523041|NCT04556838|41955270|FG002|Overall Study|Subject travel|0|||
19523042|NCT04556838|41955268|FG000|Overall Study|Physician Decision|1|||
19523043|NCT04556838|41955269|FG001|Overall Study|Physician Decision|0|||
19523044|NCT04556838|41955270|FG002|Overall Study|Physician Decision|0|||
19523045|NCT03671148|41955293|FG000|Overall Study|Adverse Event|3|||
19523046|NCT03671148|41955294|FG001|Overall Study|Adverse Event|2|||
19523047|NCT03671148|41955293|FG000|Overall Study|Withdrawal by Subject|8|||
19523048|NCT03671148|41955294|FG001|Overall Study|Withdrawal by Subject|2|||
19523049|NCT03671148|41955293|FG000|Overall Study|Lost to Follow-up|1|||
19523050|NCT03671148|41955294|FG001|Overall Study|Lost to Follow-up|2|||
19523051|NCT03671148|41955293|FG000|Overall Study|Lack of Efficacy|7|||
19523052|NCT03671148|41955294|FG001|Overall Study|Lack of Efficacy|2|||
19523053|NCT03671148|41955293|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
19443119|NCT01972724|41690753|FG000|Double-Blind|Rescue Criteria Met|1|||
19443120|NCT01972724|41690754|FG001|Double-Blind|Rescue Criteria Met|0|||
19443121|NCT01972724|41690755|FG002|Double-Blind|Rescue Criteria Met|0|||
19443122|NCT01972724|41690753|FG000|Double-Blind|Adverse Event|1|||
19443123|NCT01972724|41690754|FG001|Double-Blind|Adverse Event|0|||
19443124|NCT01972724|41690755|FG002|Double-Blind|Adverse Event|0|||
19443125|NCT01972724|41690753|FG000|Double-Blind|Withdrawal of Consent|2|||
19443126|NCT01972724|41690754|FG001|Double-Blind|Withdrawal of Consent|1|||
19443127|NCT01972724|41690755|FG002|Double-Blind|Withdrawal of Consent|0|||
19443128|NCT01972724|41690753|FG000|Double-Blind|Significant Protocol Deviation|5|||
19443129|NCT01972724|41690754|FG001|Double-Blind|Significant Protocol Deviation|8|||
19443130|NCT01972724|41690755|FG002|Double-Blind|Significant Protocol Deviation|0|||
19443131|NCT01972724|41690753|FG000|Open-Label|Withdrew Consent|0|||
19443132|NCT01972724|41690754|FG001|Open-Label|Withdrew Consent|0|||
19443133|NCT01972724|41690755|FG002|Open-Label|Withdrew Consent|3|||
19443134|NCT01972724|41690753|FG000|Open-Label|Significant Protocol Deviation|0|||
19443135|NCT01972724|41690754|FG001|Open-Label|Significant Protocol Deviation|0|||
19443136|NCT01972724|41690755|FG002|Open-Label|Significant Protocol Deviation|2|||
19443137|NCT01441960|41690763|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
19443138|NCT01441960|41690764|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
19443139|NCT01441960|41690763|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
19443140|NCT01441960|41690764|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
19443141|NCT01441960|41690763|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
19443142|NCT01441960|41690764|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
19443143|NCT01955707|41690780|FG000|Overall Study|Adverse Event|1|||
19443144|NCT01955707|41690781|FG001|Overall Study|Adverse Event|2|||
19443145|NCT01955707|41690780|FG000|Overall Study|Lost to Follow-up|2|||
19443146|NCT01955707|41690781|FG001|Overall Study|Lost to Follow-up|1|||
19443147|NCT01955707|41690780|FG000|Overall Study|Withdrawal by Subject|0|||
19523054|NCT03671148|41955294|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
19523055|NCT03671148|41955293|FG000|Overall Study|Other|1|||
19523056|NCT03671148|41955294|FG001|Overall Study|Other|0|||
19523057|NCT03671148|41955293|FG000|Overall Study|Incomplete Randomization Visit|1|||
19523058|NCT03671148|41955294|FG001|Overall Study|Incomplete Randomization Visit|0|||
19443148|NCT01955707|41690781|FG001|Overall Study|Withdrawal by Subject|3|||
19443149|NCT01955707|41690780|FG000|Overall Study|Death|13|||
19443150|NCT01955707|41690781|FG001|Overall Study|Death|14|||
19443151|NCT01955707|41690780|FG000|Overall Study|Other|4|||
19443152|NCT01955707|41690781|FG001|Overall Study|Other|2|||
19443153|NCT01435798|41690787|FG000|Overall Study|Withdrawal by Subject|1|||
19443154|NCT01972568|41690800|FG000|Overall Study|Other events|3|||
19523059|NCT02004522|41955302|FG000|Overall Study|Adverse Event|55|||
19443155|NCT01972568|41690801|FG001|Overall Study|Other events|0|||
19443156|NCT01972568|41690802|FG002|Overall Study|Other events|0|||
19443157|NCT01972568|41690800|FG000|Overall Study|Lack of Efficacy|0|||
19443158|NCT01972568|41690801|FG001|Overall Study|Lack of Efficacy|1|||
19443159|NCT01972568|41690802|FG002|Overall Study|Lack of Efficacy|2|||
19443160|NCT01972568|41690800|FG000|Overall Study|Protocol Violation|1|||
19443161|NCT01972568|41690801|FG001|Overall Study|Protocol Violation|2|||
19443162|NCT01972568|41690802|FG002|Overall Study|Protocol Violation|2|||
19443163|NCT01972568|41690800|FG000|Overall Study|Withdrawal by Subject|6|||
19443164|NCT01972568|41690801|FG001|Overall Study|Withdrawal by Subject|3|||
19443165|NCT01972568|41690802|FG002|Overall Study|Withdrawal by Subject|7|||
19443166|NCT01972568|41690800|FG000|Overall Study|Lost to Follow-up|1|||
19443167|NCT01972568|41690801|FG001|Overall Study|Lost to Follow-up|0|||
19443168|NCT01972568|41690802|FG002|Overall Study|Lost to Follow-up|0|||
19443169|NCT01972568|41690800|FG000|Overall Study|Adverse Event|5|||
19443170|NCT01972568|41690801|FG001|Overall Study|Adverse Event|6|||
19443171|NCT01972568|41690802|FG002|Overall Study|Adverse Event|5|||
19443172|NCT01955161|41690813|FG000|Overall Study|Withdrawal before treatment|2|||
19443173|NCT01955161|41690814|FG001|Overall Study|Withdrawal before treatment|0|||
19443174|NCT01955161|41690815|FG002|Overall Study|Withdrawal before treatment|1|||
19443175|NCT01955161|41690813|FG000|Overall Study|Adverse Event|10|||
19443176|NCT01955161|41690814|FG001|Overall Study|Adverse Event|14|||
19443177|NCT01955161|41690815|FG002|Overall Study|Adverse Event|15|||
19443178|NCT01955161|41690813|FG000|Overall Study|Death|1|||
19443179|NCT01955161|41690814|FG001|Overall Study|Death|1|||
19443180|NCT01955161|41690815|FG002|Overall Study|Death|3|||
19443181|NCT01955161|41690813|FG000|Overall Study|Withdrawal by Subject|9|||
19443182|NCT01955161|41690814|FG001|Overall Study|Withdrawal by Subject|8|||
19523060|NCT02004522|41955303|FG001|Overall Study|Adverse Event|6|||
19523061|NCT02004522|41955302|FG000|Overall Study|Withdrawal by Subject|13|||
19523062|NCT02004522|41955303|FG001|Overall Study|Withdrawal by Subject|7|||
19523063|NCT02004522|41955302|FG000|Overall Study|Death|12|||
19523064|NCT02004522|41955303|FG001|Overall Study|Death|3|||
19523065|NCT02004522|41955302|FG000|Overall Study|Physician Decision|3|||
19523066|NCT02004522|41955303|FG001|Overall Study|Physician Decision|4|||
19523067|NCT02004522|41955302|FG000|Overall Study|Protocol Violation|1|||
19523068|NCT02004522|41955303|FG001|Overall Study|Protocol Violation|0|||
19523069|NCT02004522|41955302|FG000|Overall Study|Other is reason listed by PI|4|||
19523070|NCT02004522|41955303|FG001|Overall Study|Other is reason listed by PI|1|||
19523071|NCT02004522|41955302|FG000|Overall Study|Never Dosed|2|||
19523072|NCT02004522|41955303|FG001|Overall Study|Never Dosed|4|||
19523073|NCT02004522|41955302|FG000|Overall Study|Disease Progression|35|||
19523074|NCT02004522|41955303|FG001|Overall Study|Disease Progression|31|||
19523075|NCT02004522|41955302|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
19523076|NCT02004522|41955303|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
19523077|NCT02000622|41955311|FG000|Overall Study|Withdrawal by Subject|5|||
19523078|NCT02000622|41955312|FG001|Overall Study|Withdrawal by Subject|7|||
19523079|NCT02000622|41955311|FG000|Overall Study|Lost to Follow-up|4|||
19523080|NCT02000622|41955312|FG001|Overall Study|Lost to Follow-up|0|||
19523081|NCT02000622|41955311|FG000|Overall Study|Death|159|||
19523082|NCT02000622|41955312|FG001|Overall Study|Death|73|||
19523083|NCT02000622|41955311|FG000|Overall Study|Withdrawn due to site closure|1|||
19523084|NCT02000622|41955312|FG001|Overall Study|Withdrawn due to site closure|0|||
19523085|NCT01430442|41955330|FG000|Overall Study|Subject Withdrew Consent|3|||
19523086|NCT01430442|41955331|FG001|Overall Study|Subject Withdrew Consent|0|||
19523087|NCT01430442|41955332|FG002|Overall Study|Subject Withdrew Consent|1|||
19523088|NCT01430442|41955333|FG003|Overall Study|Subject Withdrew Consent|0|||
19523089|NCT01430442|41955334|FG004|Overall Study|Subject Withdrew Consent|2|||
19523090|NCT01430442|41955335|FG005|Overall Study|Subject Withdrew Consent|1|||
19523091|NCT01430442|41955336|FG006|Overall Study|Subject Withdrew Consent|5|||
19523092|NCT01430442|41955337|FG007|Overall Study|Subject Withdrew Consent|2|||
19523093|NCT01430442|41955330|FG000|Overall Study|Lost to Follow-up|2|||
19523094|NCT01430442|41955331|FG001|Overall Study|Lost to Follow-up|0|||
19523095|NCT01430442|41955332|FG002|Overall Study|Lost to Follow-up|1|||
19523096|NCT01430442|41955333|FG003|Overall Study|Lost to Follow-up|2|||
19523097|NCT01430442|41955334|FG004|Overall Study|Lost to Follow-up|2|||
19523098|NCT01430442|41955335|FG005|Overall Study|Lost to Follow-up|1|||
19523099|NCT01430442|41955336|FG006|Overall Study|Lost to Follow-up|5|||
19523100|NCT01430442|41955337|FG007|Overall Study|Lost to Follow-up|1|||
19523101|NCT01430442|41955330|FG000|Overall Study|Pregnancy|1|||
19523102|NCT01430442|41955331|FG001|Overall Study|Pregnancy|0|||
19443183|NCT01955161|41690815|FG002|Overall Study|Withdrawal by Subject|12|||
19443184|NCT01955161|41690813|FG000|Overall Study|Protocol Violation|2|||
19443185|NCT01955161|41690814|FG001|Overall Study|Protocol Violation|0|||
19443186|NCT01955161|41690815|FG002|Overall Study|Protocol Violation|0|||
19443187|NCT01955161|41690813|FG000|Overall Study|Other reason: physician decision|0|||
19443188|NCT01955161|41690814|FG001|Overall Study|Other reason: physician decision|1|||
19443189|NCT01955161|41690815|FG002|Overall Study|Other reason: physician decision|1|||
19523103|NCT01430442|41955332|FG002|Overall Study|Pregnancy|0|||
19443190|NCT01955161|41690813|FG000|Overall Study|Other reason: disallowed medication|1|||
19443191|NCT01955161|41690814|FG001|Overall Study|Other reason: disallowed medication|0|||
19443192|NCT01955161|41690815|FG002|Overall Study|Other reason: disallowed medication|1|||
19443193|NCT01955161|41690813|FG000|Overall Study|Other reason: caregiver unavailable|1|||
19443194|NCT01955161|41690814|FG001|Overall Study|Other reason: caregiver unavailable|0|||
19443195|NCT01955161|41690815|FG002|Overall Study|Other reason: caregiver unavailable|0|||
19443196|NCT01955161|41690813|FG000|Overall Study|Other reason: moved to nursing home|0|||
19443197|NCT01955161|41690814|FG001|Overall Study|Other reason: moved to nursing home|1|||
19443198|NCT01955161|41690815|FG002|Overall Study|Other reason: moved to nursing home|0|||
19443199|NCT01955161|41690813|FG000|Overall Study|Other reason: insufficient compliance|0|||
19443200|NCT01955161|41690814|FG001|Overall Study|Other reason: insufficient compliance|0|||
19443201|NCT01955161|41690815|FG002|Overall Study|Other reason: insufficient compliance|1|||
19443202|NCT01955161|41690813|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
19443203|NCT01955161|41690814|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
19443204|NCT01955161|41690815|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
19443205|NCT01955161|41690813|FG000|Overall Study|Other reason: patient's will|0|||
19443206|NCT01955161|41690814|FG001|Overall Study|Other reason: patient's will|0|||
19443207|NCT01955161|41690815|FG002|Overall Study|Other reason: patient's will|1|||
19443208|NCT01441414|41690823|FG000|Overall Study|Participant died|9|||
19443209|NCT01441414|41690823|FG000|Overall Study|Other reasons|3|||
19443210|NCT01441414|41690823|FG000|Overall Study|Study terminated by sponsor|2|||
19443211|NCT01441414|41690823|FG000|Overall Study|Subject refused further follow-up|1|||
19443212|NCT01971554|41690843|FG000|Overall Study|Lost to Follow-up|1|||
19443213|NCT01971554|41690844|FG001|Overall Study|Lost to Follow-up|0|||
19443214|NCT01971554|41690845|FG002|Overall Study|Lost to Follow-up|0|||
19443215|NCT01971554|41690846|FG003|Overall Study|Lost to Follow-up|0|||
19443216|NCT01955083|41690858|FG000|Overall Study|Lost to Follow-up|1|||
19443217|NCT01955083|41690859|FG001|Overall Study|Lost to Follow-up|1|||
19443218|NCT01955005|41690891|FG000|Overall Study|Withdrawal by Subject|3|||
19443219|NCT01955005|41690892|FG001|Overall Study|Withdrawal by Subject|5|||
19443220|NCT01954927|41690900|FG000|Overall Study|Withdrawal by Subject|3|||
19443221|NCT01954927|41690901|FG001|Overall Study|Withdrawal by Subject|1|||
19443222|NCT01954771|41690910|FG000|Overall Study|Missing HbA1c of end-point|1|||
19443223|NCT01954771|41690911|FG001|Overall Study|Missing HbA1c of end-point|1|||
19443224|NCT01954771|41690912|FG002|Overall Study|Missing HbA1c of end-point|0|||
19443225|NCT01954771|41690910|FG000|Overall Study|Missing CGMS of end-point|1|||
19443226|NCT01954771|41690911|FG001|Overall Study|Missing CGMS of end-point|1|||
19443227|NCT01954771|41690912|FG002|Overall Study|Missing CGMS of end-point|0|||
19443228|NCT01954771|41690910|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
19443229|NCT01954771|41690911|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
19443230|NCT01954771|41690912|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
19443231|NCT01997281|41690925|FG000|Overall Study|Withdrawal by Subject|1|||
19443232|NCT01997281|41690926|FG001|Overall Study|Withdrawal by Subject|0|||
19443233|NCT01996033|41690932|FG000|Overall Study|Death|1|||
19443234|NCT01996033|41690932|FG000|Overall Study|Physician Decision|1|||
19443235|NCT01996033|41690932|FG000|Overall Study|Withdrawal by Subject|4|||
19443236|NCT01996033|41690932|FG000|Overall Study|Lost to Follow-up|3|||
19443237|NCT01953913|41690936|FG000|Overall Study|Disease Progression|349|||
19523104|NCT01430442|41955333|FG003|Overall Study|Pregnancy|0|||
19523105|NCT01430442|41955334|FG004|Overall Study|Pregnancy|0|||
19523106|NCT01430442|41955335|FG005|Overall Study|Pregnancy|1|||
19523107|NCT01430442|41955336|FG006|Overall Study|Pregnancy|0|||
19523108|NCT01430442|41955337|FG007|Overall Study|Pregnancy|0|||
19523109|NCT01430442|41955330|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
19523110|NCT01430442|41955331|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
19523111|NCT01430442|41955332|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
19523112|NCT01430442|41955333|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
19523113|NCT01430442|41955334|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
19523114|NCT01430442|41955335|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
19523115|NCT01430442|41955336|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
19523116|NCT01430442|41955337|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
19523117|NCT01420926|41955357|FG000|Overall Study|Adverse Event|6|||
19523118|NCT01420926|41955358|FG001|Overall Study|Adverse Event|4|||
19523119|NCT01420926|41955357|FG000|Overall Study|Death|18|||
19523120|NCT01420926|41955358|FG001|Overall Study|Death|17|||
19523121|NCT01420926|41955357|FG000|Overall Study|Withdrawal by Subject|11|||
19523122|NCT01420926|41955358|FG001|Overall Study|Withdrawal by Subject|17|||
19523123|NCT01420926|41955357|FG000|Overall Study|Non-protocol treatment|17|||
19523124|NCT01420926|41955358|FG001|Overall Study|Non-protocol treatment|20|||
19443238|NCT01953913|41690936|FG000|Overall Study|Worsening of underlying cancer|22|||
19443239|NCT01953913|41690936|FG000|Overall Study|Adverse Event|20|||
19443240|NCT01953913|41690936|FG000|Overall Study|Protocol Violation|6|||
19443241|NCT01953913|41690936|FG000|Overall Study|Lost to Follow-up|4|||
19443242|NCT01953913|41690936|FG000|Overall Study|Withdrawal by Subject|32|||
19443243|NCT01953913|41690936|FG000|Overall Study|Other than listed|108|||
19443244|NCT01953913|41690936|FG000|Overall Study|Not Treated|1|||
19443245|NCT01971476|41690943|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
19443246|NCT01971476|41690944|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
19443247|NCT01971476|41690945|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
19443248|NCT01971476|41690943|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
19443249|NCT01971476|41690944|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
19523125|NCT01420926|41955357|FG000|Overall Study|Physician Decision|8|||
19523126|NCT01420926|41955358|FG001|Overall Study|Physician Decision|5|||
19523127|NCT04303572|41955914|FG000|Overall Study|Study closed due to poor enrollment|1|||
19523128|NCT04150068|41955921|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
19523129|NCT04150068|41955922|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
19523130|NCT04150068|41955923|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
19523131|NCT04150068|41955921|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
19523132|NCT04150068|41955922|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
19523133|NCT04150068|41955923|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
19523134|NCT03551730|41955958|FG000|Overall Study|Adverse Event|1|||
19523135|NCT03551730|41955959|FG001|Overall Study|Adverse Event|0|||
19523136|NCT03551730|41955960|FG002|Overall Study|Adverse Event|0|||
19523137|NCT03551730|41955961|FG003|Overall Study|Adverse Event|0|||
19523138|NCT02656290|41955971|FG000|Overall Study|Subjects Remain On Study|26|||
19523139|NCT02534844|41955977|FG000|Part B|Withdrawal by Subject|0|||
19523140|NCT02534844|41955978|FG001|Part B|Withdrawal by Subject|0|||
19523141|NCT02534844|41955979|FG002|Part B|Withdrawal by Subject|0|||
19523142|NCT02534844|41955980|FG003|Part B|Withdrawal by Subject|0|||
19523143|NCT02534844|41955981|FG004|Part B|Withdrawal by Subject|2|||
19523144|NCT02534844|41955982|FG005|Part B|Withdrawal by Subject|1|||
19523145|NCT01818492|41955999|FG000|Overall Study|Adverse Event|2|||
19523146|NCT01818492|41955999|FG000|Overall Study|Death|3|||
19523147|NCT01818492|41955999|FG000|Overall Study|Withdrawal by Subject|1|||
19523148|NCT01818492|41955999|FG000|Overall Study|Additional therapy when not allowed PP|4|||
19523149|NCT01239030|41956009|FG000|Double Blind|Adverse Event|0|||
19523150|NCT01239030|41956010|FG001|Double Blind|Adverse Event|1|||
19523151|NCT01239030|41956011|FG002|Double Blind|Adverse Event|0|||
19523152|NCT01239030|41956012|FG003|Double Blind|Adverse Event|2|||
19523153|NCT01239030|41956013|FG004|Double Blind|Adverse Event|0|||
19523154|NCT01239030|41956009|FG000|Double Blind|Withdrawal by Subject|0|||
19523155|NCT01239030|41956010|FG001|Double Blind|Withdrawal by Subject|1|||
19523156|NCT01239030|41956011|FG002|Double Blind|Withdrawal by Subject|1|||
19523157|NCT01239030|41956012|FG003|Double Blind|Withdrawal by Subject|0|||
19523158|NCT01239030|41956013|FG004|Double Blind|Withdrawal by Subject|1|||
19523159|NCT01239030|41956009|FG000|Double Blind|Lost to Follow-up|1|||
19523160|NCT01239030|41956010|FG001|Double Blind|Lost to Follow-up|1|||
19523161|NCT01239030|41956011|FG002|Double Blind|Lost to Follow-up|0|||
19523162|NCT01239030|41956012|FG003|Double Blind|Lost to Follow-up|0|||
19523163|NCT01239030|41956013|FG004|Double Blind|Lost to Follow-up|0|||
19523164|NCT01239030|41956009|FG000|Double Blind|Physician Decision|0|||
19523165|NCT01239030|41956010|FG001|Double Blind|Physician Decision|1|||
19523166|NCT01239030|41956011|FG002|Double Blind|Physician Decision|0|||
19523167|NCT01239030|41956012|FG003|Double Blind|Physician Decision|0|||
19523168|NCT01239030|41956013|FG004|Double Blind|Physician Decision|0|||
19523169|NCT01239030|41956009|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
19523170|NCT01239030|41956010|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
19523171|NCT01239030|41956011|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
19523172|NCT01239030|41956012|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
19523173|NCT01239030|41956013|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
19523174|NCT01239030|41956009|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
19523175|NCT01239030|41956010|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
19523176|NCT01239030|41956011|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
19523177|NCT01239030|41956012|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
19523178|NCT01239030|41956013|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
19523179|NCT01239030|41956009|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
19523180|NCT01239030|41956010|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
19523181|NCT01239030|41956011|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
19523182|NCT01239030|41956012|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
19523183|NCT01239030|41956013|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
19523184|NCT01239030|41956009|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
19523185|NCT01239030|41956010|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
19523186|NCT01239030|41956011|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
19523187|NCT01239030|41956012|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
19523188|NCT01239030|41956013|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
19523189|NCT01086540|41956028|FG000|Overall Study|Death|3|||
19523190|NCT01086540|41956029|FG001|Overall Study|Death|1|||
19523191|NCT01086540|41956028|FG000|Overall Study|Physician Decision|2|||
19443250|NCT01971476|41690945|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
19443251|NCT01971476|41690943|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
19443252|NCT01971476|41690944|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
19443253|NCT01971476|41690945|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
19443254|NCT01996904|41690964|FG000|Overall Study|Lost to Follow-up|38|||
19443255|NCT01996904|41690965|FG001|Overall Study|Lost to Follow-up|27|||
19443256|NCT01970540|41690974|FG000|Overall Study|Non-treatment-related AE|0|||
19443257|NCT01970540|41690975|FG001|Overall Study|Non-treatment-related AE|0|||
19443258|NCT01970540|41690976|FG002|Overall Study|Non-treatment-related AE|1|||
19443259|NCT01970540|41690974|FG000|Overall Study|Progressive disease|55|||
19443260|NCT01970540|41690975|FG001|Overall Study|Progressive disease|23|||
19443261|NCT01970540|41690976|FG002|Overall Study|Progressive disease|10|||
19443262|NCT01970540|41690974|FG000|Overall Study|Treatment delay over protocol|0|||
19443263|NCT01970540|41690975|FG001|Overall Study|Treatment delay over protocol|0|||
19443264|NCT01970540|41690976|FG002|Overall Study|Treatment delay over protocol|1|||
19443265|NCT01970540|41690974|FG000|Overall Study|Physician Decision|7|||
19523192|NCT01086540|41956029|FG001|Overall Study|Physician Decision|1|||
19523193|NCT01086540|41956028|FG000|Overall Study|Addition of new therapy for PAH|1|||
19523194|NCT01086540|41956029|FG001|Overall Study|Addition of new therapy for PAH|0|||
19523195|NCT04567524|41959344|FG000|Overall Study|Adverse Event|1|||
19523196|NCT04567524|41959345|FG001|Overall Study|Adverse Event|1|||
19523197|NCT04567524|41959346|FG002|Overall Study|Adverse Event|0|||
19523198|NCT04567524|41959347|FG003|Overall Study|Adverse Event|0|||
19523199|NCT04567524|41959344|FG000|Overall Study|Withdrawal by Subject|2|||
19523200|NCT04567524|41959345|FG001|Overall Study|Withdrawal by Subject|0|||
19523201|NCT04567524|41959346|FG002|Overall Study|Withdrawal by Subject|0|||
19523202|NCT04567524|41959347|FG003|Overall Study|Withdrawal by Subject|1|||
19523203|NCT03370302|41959383|FG000|Dose Escalation Phase|Other|0|||
19523204|NCT03370302|41959384|FG001|Dose Escalation Phase|Other|1|||
19523205|NCT03370302|41959385|FG002|Dose Escalation Phase|Other|1|||
19523206|NCT03370302|41959386|FG003|Dose Escalation Phase|Other|0|||
19523207|NCT03370302|41959387|FG004|Dose Escalation Phase|Other|0|||
19523208|NCT03370302|41959388|FG005|Dose Escalation Phase|Other|0|||
19443266|NCT01970540|41690975|FG001|Overall Study|Physician Decision|2|||
19443267|NCT01970540|41690976|FG002|Overall Study|Physician Decision|0|||
19443268|NCT01970540|41690974|FG000|Overall Study|Clinical progression|0|||
19443269|NCT01970540|41690975|FG001|Overall Study|Clinical progression|1|||
19443270|NCT01970540|41690976|FG002|Overall Study|Clinical progression|1|||
19443271|NCT01970540|41690974|FG000|Overall Study|End of study|2|||
19443272|NCT01970540|41690975|FG001|Overall Study|End of study|0|||
19443273|NCT01970540|41690976|FG002|Overall Study|End of study|2|||
19443274|NCT01970540|41690974|FG000|Overall Study|Adverse Event|0|||
19443275|NCT01970540|41690975|FG001|Overall Study|Adverse Event|2|||
19443276|NCT01970540|41690976|FG002|Overall Study|Adverse Event|1|||
19443277|NCT01970540|41690974|FG000|Overall Study|Treatment-related AE|4|||
19443278|NCT01970540|41690975|FG001|Overall Study|Treatment-related AE|0|||
19443279|NCT01970540|41690976|FG002|Overall Study|Treatment-related AE|2|||
19443280|NCT01970540|41690974|FG000|Overall Study|Withdrawal by Subject|4|||
19443281|NCT01970540|41690975|FG001|Overall Study|Withdrawal by Subject|0|||
19443282|NCT01970540|41690976|FG002|Overall Study|Withdrawal by Subject|1|||
19443283|NCT01970540|41690974|FG000|Overall Study|Clinical deterioration|1|||
19443284|NCT01970540|41690975|FG001|Overall Study|Clinical deterioration|0|||
19443285|NCT01970540|41690976|FG002|Overall Study|Clinical deterioration|0|||
19443286|NCT01963676|41690997|FG000|Overall Study|Withdrawal by Subject|1|||
19443287|NCT01963676|41690998|FG001|Overall Study|Withdrawal by Subject|0|||
19443288|NCT01996826|41691006|FG000|Overall Study|Lost to Follow-up|6|||
19443289|NCT01996826|41691007|FG001|Overall Study|Lost to Follow-up|2|||
19443290|NCT01996826|41691006|FG000|Overall Study|Physician Decision|1|||
19443291|NCT01996826|41691007|FG001|Overall Study|Physician Decision|1|||
19443292|NCT01996748|41691015|FG000|Overall Study|Personal reason|1|||
19443293|NCT01996748|41691016|FG001|Overall Study|Personal reason|0|||
19443294|NCT01996748|41691015|FG000|Overall Study|Physician Decision|2|||
19443295|NCT01996748|41691016|FG001|Overall Study|Physician Decision|0|||
19443296|NCT01996748|41691015|FG000|Overall Study|Adverse Event|1|||
19443297|NCT01996748|41691016|FG001|Overall Study|Adverse Event|4|||
19443298|NCT01996748|41691015|FG000|Overall Study|Withdrawal by Subject|0|||
19443299|NCT01996748|41691016|FG001|Overall Study|Withdrawal by Subject|1|||
19443300|NCT01996748|41691015|FG000|Overall Study|Lost to Follow-up|4|||
19443301|NCT01996748|41691016|FG001|Overall Study|Lost to Follow-up|1|||
19443302|NCT01621178|41691027|FG000|Overall Study|Adverse Event|5|||
19443303|NCT01621178|41691028|FG001|Overall Study|Adverse Event|2|||
19443304|NCT01621178|41691029|FG002|Overall Study|Adverse Event|8|||
19523209|NCT03370302|41959383|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
19443305|NCT01621178|41691027|FG000|Overall Study|Death|6|||
19443306|NCT01621178|41691028|FG001|Overall Study|Death|7|||
19443307|NCT01621178|41691029|FG002|Overall Study|Death|2|||
19443308|NCT01621178|41691027|FG000|Overall Study|Lost to Follow-up|1|||
19443309|NCT01621178|41691028|FG001|Overall Study|Lost to Follow-up|2|||
19443310|NCT01621178|41691029|FG002|Overall Study|Lost to Follow-up|1|||
19443311|NCT01621178|41691027|FG000|Overall Study|Withdrawal by Subject|14|||
19443312|NCT01621178|41691028|FG001|Overall Study|Withdrawal by Subject|17|||
19443313|NCT01621178|41691029|FG002|Overall Study|Withdrawal by Subject|18|||
19443314|NCT01621178|41691027|FG000|Overall Study|Physician Decision|5|||
19443315|NCT01621178|41691028|FG001|Overall Study|Physician Decision|2|||
19443316|NCT01621178|41691029|FG002|Overall Study|Physician Decision|7|||
19443317|NCT01962974|41691041|FG000|Overall Study|Study termination|7|||
19443318|NCT01996592|41691045|FG000|Overall Study|no response to text/no diary entry|32|||
19443319|NCT01996592|41691045|FG000|Overall Study|change in surgical date|4|||
19443320|NCT01996592|41691045|FG000|Overall Study|Withdrawal by Subject|5|||
19443321|NCT01996592|41691045|FG000|Overall Study|change in mode of delivery|4|||
19443322|NCT01962896|41691054|FG000|Overall Study|Lack of Efficacy|4|||
19443323|NCT01970462|41691061|FG000|Overall Study|Lost to Follow-up|0|||
19443324|NCT01970462|41691062|FG001|Overall Study|Lost to Follow-up|2|||
19443325|NCT01995266|41691068|FG000|Overall Study|Death|1|||
19443326|NCT01995266|41691068|FG000|Overall Study|Lack of Efficacy|6|||
19443327|NCT01995266|41691068|FG000|Overall Study|Adverse Event|2|||
19443328|NCT01969058|41691074|FG000|Overall Study|Withdrawal by Subject|2|||
19443329|NCT01969058|41691075|FG001|Overall Study|Withdrawal by Subject|0|||
19443330|NCT01969058|41691074|FG000|Overall Study|Adverse Event|1|||
19443331|NCT01969058|41691075|FG001|Overall Study|Adverse Event|0|||
19443332|NCT01968980|41691083|FG000|Overall Study|Death|0|||
19443333|NCT01968980|41691084|FG001|Overall Study|Death|1|||
19443334|NCT01968980|41691083|FG000|Overall Study|Adverse Event|1|||
19443335|NCT01968980|41691084|FG001|Overall Study|Adverse Event|3|||
19443336|NCT01968980|41691083|FG000|Overall Study|Does not meet entry criteria|1|||
19443337|NCT01968980|41691084|FG001|Overall Study|Does not meet entry criteria|3|||
19443338|NCT01968980|41691083|FG000|Overall Study|Withdrawal by Subject|13|||
19443339|NCT01968980|41691084|FG001|Overall Study|Withdrawal by Subject|5|||
19443340|NCT01968980|41691083|FG000|Overall Study|Other unspecified|1|||
19443341|NCT01968980|41691084|FG001|Overall Study|Other unspecified|2|||
19443342|NCT01961882|41691093|FG000|Overall Study|Adverse Event|3|||
19443343|NCT01961882|41691094|FG001|Overall Study|Adverse Event|2|||
19443344|NCT01961882|41691093|FG000|Overall Study|Physician Decision|1|||
19443345|NCT01961882|41691094|FG001|Overall Study|Physician Decision|0|||
19443346|NCT01961882|41691093|FG000|Overall Study|Withdrawal by Subject|4|||
19443347|NCT01961882|41691094|FG001|Overall Study|Withdrawal by Subject|1|||
19443348|NCT01961882|41691093|FG000|Overall Study|Relapse of AML|39|||
19443349|NCT01961882|41691094|FG001|Overall Study|Relapse of AML|37|||
19443350|NCT01961882|41691093|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
19443351|NCT01961882|41691094|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
19443352|NCT01961882|41691093|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
19443353|NCT01961882|41691094|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
19443354|NCT01968434|41691102|FG000|Overall Study|Lost to Follow-up|3|||
19443355|NCT01968434|41691103|FG001|Overall Study|Lost to Follow-up|6|||
19443356|NCT01946438|41691113|FG000|Overall Study|Adverse Event|0|||
19443357|NCT01946438|41691114|FG001|Overall Study|Adverse Event|0|||
19443358|NCT01946438|41691115|FG002|Overall Study|Adverse Event|0|||
19443359|NCT01946438|41691116|FG003|Overall Study|Adverse Event|1|||
19443360|NCT01946438|41691113|FG000|Overall Study|Serious Adverse event|1|||
19443361|NCT01946438|41691114|FG001|Overall Study|Serious Adverse event|0|||
19443362|NCT01946438|41691115|FG002|Overall Study|Serious Adverse event|0|||
19443363|NCT01946438|41691116|FG003|Overall Study|Serious Adverse event|0|||
19443364|NCT01946438|41691113|FG000|Overall Study|Protocol Violation|0|||
19443365|NCT01946438|41691114|FG001|Overall Study|Protocol Violation|0|||
19443366|NCT01946438|41691115|FG002|Overall Study|Protocol Violation|1|||
19443367|NCT01946438|41691116|FG003|Overall Study|Protocol Violation|0|||
19443368|NCT01946438|41691113|FG000|Overall Study|Withdrawal by Subject|1|||
19443369|NCT01946438|41691114|FG001|Overall Study|Withdrawal by Subject|0|||
19443370|NCT01946438|41691115|FG002|Overall Study|Withdrawal by Subject|0|||
19443371|NCT01946438|41691116|FG003|Overall Study|Withdrawal by Subject|0|||
19443372|NCT01946282|41691135|FG000|Year 1|Did not return FIT kit|4186|||
19443373|NCT01946282|41691136|FG001|Year 1|Did not return FIT kit|608|||
19443374|NCT01946282|41691137|FG002|Year 1|Did not return FIT kit|654|||
19443375|NCT01946282|41691135|FG000|Year 2|Did not return FIT kit|803|||
19711299|NCT03572062|42154400|FG005|Overall Study|Study Terminated By Sponsor|0|||
19443376|NCT01946282|41691136|FG001|Year 2|Did not return FIT kit|131|||
19443377|NCT01946282|41691137|FG002|Year 2|Did not return FIT kit|115|||
19443378|NCT01946282|41691135|FG000|Year 3|Did not return FIT kit|288|||
19443379|NCT01946282|41691136|FG001|Year 3|Did not return FIT kit|43|||
19443380|NCT01946282|41691137|FG002|Year 3|Did not return FIT kit|30|||
19443381|NCT01945580|41691149|FG000|Overall Study|Withdrawal by Subject|13|||
19443382|NCT01945580|41691150|FG001|Overall Study|Withdrawal by Subject|35|||
19443383|NCT01945580|41691149|FG000|Overall Study|Physician Decision|3|||
19443384|NCT01945580|41691150|FG001|Overall Study|Physician Decision|2|||
19443385|NCT01945580|41691149|FG000|Overall Study|Lost to Follow-up|26|||
19443386|NCT01945580|41691150|FG001|Overall Study|Lost to Follow-up|39|||
19443387|NCT01945580|41691149|FG000|Overall Study|Death|7|||
19443388|NCT01945580|41691150|FG001|Overall Study|Death|2|||
19443389|NCT01945580|41691149|FG000|Overall Study|Patient moved out of state|0|||
19443390|NCT01945580|41691150|FG001|Overall Study|Patient moved out of state|1|||
19443391|NCT01945580|41691149|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
19443392|NCT01945580|41691150|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
19443393|NCT01945580|41691149|FG000|Overall Study|Family illness - unable to return|0|||
19443394|NCT01945580|41691150|FG001|Overall Study|Family illness - unable to return|1|||
19443395|NCT01945580|41691149|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
19443396|NCT01945580|41691150|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
19443397|NCT01945580|41691149|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
19443398|NCT01945580|41691150|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
19443399|NCT01945580|41691149|FG000|Overall Study|Noncompliance with 36 month visit|1|||
19443400|NCT01945580|41691150|FG001|Overall Study|Noncompliance with 36 month visit|0|||
19443401|NCT01945580|41691149|FG000|Overall Study|The patient moved.|1|||
19443402|NCT01945580|41691150|FG001|Overall Study|The patient moved.|0|||
19443403|NCT01945580|41691149|FG000|Overall Study|No data available|0|||
19443404|NCT01945580|41691150|FG001|Overall Study|No data available|2|||
19443405|NCT01945034|41691163|FG000|Overall Study|Medication Error|0|||
19443406|NCT01945034|41691164|FG001|Overall Study|Medication Error|1|||
19443407|NCT01945034|41691165|FG002|Overall Study|Medication Error|0|||
19443408|NCT01945034|41691163|FG000|Overall Study|Withdrawal by Subject|0|||
19443409|NCT01945034|41691164|FG001|Overall Study|Withdrawal by Subject|3|||
19443410|NCT01945034|41691165|FG002|Overall Study|Withdrawal by Subject|1|||
19443411|NCT01945034|41691163|FG000|Overall Study|Other|0|||
19443412|NCT01945034|41691164|FG001|Overall Study|Other|1|||
19443413|NCT01945034|41691165|FG002|Overall Study|Other|3|||
19443414|NCT01945034|41691163|FG000|Overall Study|Lost to Follow-up|0|||
19443415|NCT01945034|41691164|FG001|Overall Study|Lost to Follow-up|0|||
19443416|NCT01945034|41691165|FG002|Overall Study|Lost to Follow-up|2|||
19443417|NCT01945034|41691163|FG000|Overall Study|Protocol Violation|1|||
19443418|NCT01945034|41691164|FG001|Overall Study|Protocol Violation|0|||
19443419|NCT01945034|41691165|FG002|Overall Study|Protocol Violation|1|||
19443420|NCT01960790|41691173|FG000|Overall Study|Survey forms could not be recovered|3|||
19443421|NCT01960790|41691173|FG000|Overall Study|Treat with Humira outside survey period|3|||
19443422|NCT01960790|41691173|FG000|Overall Study|Transferred to another hospital|4|||
19443423|NCT01960790|41691173|FG000|Overall Study|Unevaluable for safety|1|||
19443424|NCT01618214|41691179|FG000|Overall Study|Adverse Event|3|||
19443425|NCT01618214|41691180|FG001|Overall Study|Adverse Event|1|||
19443426|NCT01618214|41691179|FG000|Overall Study|Lack of Efficacy|1|||
19443427|NCT01618214|41691180|FG001|Overall Study|Lack of Efficacy|1|||
19443428|NCT01618214|41691179|FG000|Overall Study|Protocol Violation|1|||
19443429|NCT01618214|41691180|FG001|Overall Study|Protocol Violation|4|||
19443430|NCT01618214|41691179|FG000|Overall Study|Withdrawal Criteria|1|||
19443431|NCT01618214|41691180|FG001|Overall Study|Withdrawal Criteria|2|||
19443432|NCT01618214|41691179|FG000|Overall Study|Unclassified|4|||
19443433|NCT01618214|41691180|FG001|Overall Study|Unclassified|5|||
19443434|NCT01917968|41691188|FG000|Overall Study|Death|3|||
19443435|NCT01917968|41691189|FG001|Overall Study|Death|2|||
19443436|NCT01917968|41691188|FG000|Overall Study|Lost to Follow-up|21|||
19443437|NCT01917968|41691189|FG001|Overall Study|Lost to Follow-up|39|||
19523210|NCT03370302|41959384|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
19523211|NCT03370302|41959385|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
19523212|NCT03370302|41959386|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19523213|NCT03370302|41959387|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
19523214|NCT03370302|41959388|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
19523215|NCT03370302|41959383|FG000|Dose Escalation Phase|Adverse Event|1|||
19523216|NCT03370302|41959384|FG001|Dose Escalation Phase|Adverse Event|0|||
19523217|NCT03370302|41959385|FG002|Dose Escalation Phase|Adverse Event|2|||
19523218|NCT03370302|41959386|FG003|Dose Escalation Phase|Adverse Event|0|||
19523219|NCT03370302|41959387|FG004|Dose Escalation Phase|Adverse Event|0|||
19523220|NCT03370302|41959388|FG005|Dose Escalation Phase|Adverse Event|0|||
19523221|NCT03370302|41959383|FG000|Dose Escalation Phase|Progressive Disease|2|||
19523222|NCT03370302|41959384|FG001|Dose Escalation Phase|Progressive Disease|4|||
19523223|NCT03370302|41959385|FG002|Dose Escalation Phase|Progressive Disease|2|||
19523224|NCT03370302|41959386|FG003|Dose Escalation Phase|Progressive Disease|0|||
19523225|NCT03370302|41959387|FG004|Dose Escalation Phase|Progressive Disease|3|||
19523226|NCT03370302|41959388|FG005|Dose Escalation Phase|Progressive Disease|1|||
19523227|NCT03370302|41959383|FG000|Dose Expansion Phase|Progressive Disease|0|||
19523228|NCT03370302|41959384|FG001|Dose Expansion Phase|Progressive Disease|0|||
19523229|NCT03370302|41959385|FG002|Dose Expansion Phase|Progressive Disease|0|||
19443438|NCT01917968|41691188|FG000|Overall Study|Physician Decision|1|||
19443439|NCT01917968|41691189|FG001|Overall Study|Physician Decision|2|||
19443440|NCT01917968|41691188|FG000|Overall Study|Withdrawal by Subject|20|||
19443441|NCT01917968|41691189|FG001|Overall Study|Withdrawal by Subject|35|||
19443442|NCT01917968|41691188|FG000|Overall Study|Subject Relocation|5|||
19443443|NCT01917968|41691189|FG001|Overall Study|Subject Relocation|1|||
19443444|NCT01917968|41691188|FG000|Overall Study|36M Missed Visit|3|||
19443445|NCT01917968|41691189|FG001|Overall Study|36M Missed Visit|2|||
19443446|NCT01917968|41691188|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
19443447|NCT01917968|41691189|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
19443448|NCT01917968|41691188|FG000|Overall Study|Change in Family Circumstances|0|||
19443449|NCT01917968|41691189|FG001|Overall Study|Change in Family Circumstances|1|||
19443450|NCT01917968|41691188|FG000|Overall Study|No Data Available|0|||
19443451|NCT01917968|41691189|FG001|Overall Study|No Data Available|2|||
19443452|NCT01917656|41691204|FG000|Overall Study|Adverse Event|11|||
19443453|NCT01917656|41691205|FG001|Overall Study|Adverse Event|0|||
19443454|NCT01917656|41691204|FG000|Overall Study|Withdrawal criteria|8|||
19443455|NCT01917656|41691205|FG001|Overall Study|Withdrawal criteria|14|||
19443456|NCT01917656|41691204|FG000|Overall Study|Unclassified|0|||
19443457|NCT01917656|41691205|FG001|Overall Study|Unclassified|3|||
19443458|NCT01917656|41691204|FG000|Overall Study|Withdrawal by Subject|4|||
19443459|NCT01917656|41691205|FG001|Overall Study|Withdrawal by Subject|3|||
19443460|NCT01917656|41691204|FG000|Overall Study|Lost to Follow-up|3|||
19443461|NCT01917656|41691205|FG001|Overall Study|Lost to Follow-up|4|||
19443462|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
19443463|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
19443464|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
19443465|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
19443466|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
19443467|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
19443468|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
19443469|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
19443470|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
19443471|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
19443472|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443473|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443474|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443475|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
19443476|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
19443477|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443478|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443479|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443480|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443481|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
19443482|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
19443483|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
19443484|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
19443485|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
19443486|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
19443487|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
19443488|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
19443489|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
19443490|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
19443491|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
19443492|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
19443493|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443494|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443495|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
19443496|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
19443497|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443498|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443499|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443500|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443501|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
19443502|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443503|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443504|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
19443505|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
19443506|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443507|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443508|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443509|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443510|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443511|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
19443512|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443513|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443514|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443515|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443516|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
19443517|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443518|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443519|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443520|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443521|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
19443522|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443523|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443524|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443525|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
19443526|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
19443527|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
19443528|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443529|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443530|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443531|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
19443532|NCT02018861|41691221|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443533|NCT02018861|41691222|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443534|NCT02018861|41691223|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443535|NCT02018861|41691224|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
19443536|NCT02018861|41691225|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
19443537|NCT02018861|41691226|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443538|NCT02018861|41691227|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443539|NCT02018861|41691228|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443540|NCT02018861|41691229|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443541|NCT02018861|41691230|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
19443542|NCT02018861|41691221|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443543|NCT02018861|41691222|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443544|NCT02018861|41691223|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443545|NCT02018861|41691224|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443546|NCT02018861|41691225|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443547|NCT02018861|41691226|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443548|NCT02018861|41691227|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
19443549|NCT02018861|41691228|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
19443550|NCT02018861|41691229|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443551|NCT02018861|41691230|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
19443552|NCT02018861|41691221|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443553|NCT02018861|41691222|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443554|NCT02018861|41691223|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443555|NCT02018861|41691224|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443556|NCT02018861|41691225|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443557|NCT02018861|41691226|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443558|NCT02018861|41691227|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
19443559|NCT02018861|41691228|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
19443560|NCT02018861|41691229|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443561|NCT02018861|41691230|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
19443562|NCT02018861|41691221|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443563|NCT02018861|41691222|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443564|NCT02018861|41691223|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443565|NCT02018861|41691224|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443566|NCT02018861|41691225|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443567|NCT02018861|41691226|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443568|NCT02018861|41691227|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443569|NCT02018861|41691228|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443570|NCT02018861|41691229|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
19443571|NCT02018861|41691230|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
19443572|NCT02018861|41691221|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443573|NCT02018861|41691222|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443574|NCT02018861|41691223|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443575|NCT02018861|41691224|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443576|NCT02018861|41691225|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443577|NCT02018861|41691226|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443578|NCT02018861|41691227|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443579|NCT02018861|41691228|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443580|NCT02018861|41691229|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
19443581|NCT02018861|41691230|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
19443582|NCT02018861|41691221|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443583|NCT02018861|41691222|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443584|NCT02018861|41691223|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443585|NCT02018861|41691224|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443586|NCT02018861|41691225|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443587|NCT02018861|41691226|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443588|NCT02018861|41691227|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443589|NCT02018861|41691228|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443590|NCT02018861|41691229|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
19443591|NCT02018861|41691230|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
19443592|NCT01944722|41691261|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
19443593|NCT01944722|41691261|FG000|Overall Study|Specimen Shipping Issues|34|||
19443594|NCT01944722|41691261|FG000|Overall Study|Improper Storage/Transport|5|||
19443595|NCT01944722|41691261|FG000|Overall Study|Insufficient Volume for Test|1|||
19443596|NCT01944722|41691261|FG000|Overall Study|Missing Specimens|3|||
19443597|NCT01944722|41691261|FG000|Overall Study|Specimens Mislabeled|2|||
19443598|NCT01944722|41691261|FG000|Overall Study|Withdrawal by Subject|8|||
19443599|NCT01944722|41691261|FG000|Overall Study|NILM Subjects <30 years old|8106|||
19443600|NCT01944722|41691261|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
19443601|NCT01944722|41691261|FG000|Overall Study|>ASCUS Cytology|1122|||
19443602|NCT01917344|41691270|FG000|Overall Study|Withdrawal by Subject|1|||
19443603|NCT02017535|41691278|FG000|Overall Study|Withdrawal by Subject|1|||
19443604|NCT02017535|41691279|FG001|Overall Study|Withdrawal by Subject|0|||
19443605|NCT02017535|41691280|FG002|Overall Study|Withdrawal by Subject|0|||
19443606|NCT02017535|41691281|FG003|Overall Study|Withdrawal by Subject|0|||
19443607|NCT01944098|41691293|FG000|Overall Study|Physician Decision|1|||
19443608|NCT01944098|41691294|FG001|Overall Study|Physician Decision|0|||
19443609|NCT02017223|41691300|FG000|Overall Study|Algorithm problems|2|||
19443610|NCT01944020|41691306|FG000|Overall Study|Withdrawal by Subject|5|||
19443611|NCT01944020|41691307|FG001|Overall Study|Withdrawal by Subject|0|||
19443612|NCT01943552|41691315|FG000|Overall Study|Adverse Event|3|||
19443613|NCT01943552|41691316|FG001|Overall Study|Adverse Event|2|||
19443614|NCT01943552|41691315|FG000|Overall Study|Withdrawal by Subject|6|||
19443615|NCT01943552|41691316|FG001|Overall Study|Withdrawal by Subject|6|||
19523230|NCT03370302|41959386|FG003|Dose Expansion Phase|Progressive Disease|6|||
19523231|NCT03370302|41959387|FG004|Dose Expansion Phase|Progressive Disease|0|||
19523232|NCT03370302|41959388|FG005|Dose Expansion Phase|Progressive Disease|0|||
19523233|NCT03327324|41959412|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523234|NCT03327324|41959413|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
19523235|NCT03327324|41959414|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523236|NCT03327324|41959415|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
19523237|NCT03327324|41959416|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19629045|NCT00642616|42078616|FG002|Overall Study|Adverse Event|1|||
19443616|NCT01943552|41691315|FG000|Overall Study|Other Reasons|16|||
19443617|NCT01943552|41691316|FG001|Overall Study|Other Reasons|17|||
19443618|NCT01915940|41691324|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
19443619|NCT01915940|41691325|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
19443620|NCT01915940|41691326|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
19443621|NCT01915940|41691324|FG000|Treatment Period|Decision of Participant|0|||
19443622|NCT01915940|41691325|FG001|Treatment Period|Decision of Participant|1|||
19443623|NCT01915940|41691326|FG002|Treatment Period|Decision of Participant|3|||
19443624|NCT01915940|41691324|FG000|Treatment Period|Adverse Event|0|||
19443625|NCT01915940|41691325|FG001|Treatment Period|Adverse Event|9|||
19443626|NCT01915940|41691326|FG002|Treatment Period|Adverse Event|1|||
19443627|NCT01915940|41691324|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
19443628|NCT01915940|41691325|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
19443629|NCT01915940|41691326|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
19443630|NCT01914926|41691334|FG000|Overall Study|Adverse Event|1|||
19443631|NCT01914926|41691335|FG001|Overall Study|Adverse Event|0|||
19443632|NCT01914926|41691334|FG000|Overall Study|uncooperative, agitated and removed|0|||
19443633|NCT01914926|41691335|FG001|Overall Study|uncooperative, agitated and removed|1|||
19523238|NCT03327324|41959417|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
19523239|NCT03327324|41959412|FG000|Baseline (Month 0-Month 3)|Refused|0|||
19523240|NCT03327324|41959413|FG001|Baseline (Month 0-Month 3)|Refused|0|||
19523241|NCT03327324|41959414|FG002|Baseline (Month 0-Month 3)|Refused|0|||
19523242|NCT03327324|41959415|FG003|Baseline (Month 0-Month 3)|Refused|0|||
19523243|NCT03327324|41959416|FG004|Baseline (Month 0-Month 3)|Refused|1|||
19523244|NCT03327324|41959417|FG005|Baseline (Month 0-Month 3)|Refused|0|||
19523245|NCT03327324|41959412|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
19523246|NCT03327324|41959413|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
19523247|NCT03327324|41959414|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
19523248|NCT03327324|41959415|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
19523249|NCT03327324|41959416|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
19523250|NCT03327324|41959417|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
19523251|NCT03327324|41959412|FG000|Baseline (Month 0-Month 3)|Death|0|||
19523252|NCT03327324|41959413|FG001|Baseline (Month 0-Month 3)|Death|0|||
19523253|NCT03327324|41959414|FG002|Baseline (Month 0-Month 3)|Death|0|||
19523254|NCT03327324|41959415|FG003|Baseline (Month 0-Month 3)|Death|0|||
19523255|NCT03327324|41959416|FG004|Baseline (Month 0-Month 3)|Death|1|||
19523256|NCT03327324|41959417|FG005|Baseline (Month 0-Month 3)|Death|0|||
19443634|NCT02016755|41691341|FG000|Overall Study|Major amputation of index limb|2|||
19443635|NCT02016755|41691341|FG000|Overall Study|Adverse Event|2|||
19443636|NCT02016755|41691341|FG000|Overall Study|Physician Decision|1|||
19443637|NCT02016755|41691341|FG000|Overall Study|Death|2|||
19443638|NCT01942148|41691345|FG000|Overall Study|Adverse Event|4|||
19443639|NCT01942148|41691345|FG000|Overall Study|Lack of Efficacy|2|||
19443640|NCT01942148|41691345|FG000|Overall Study|Physician Decision|11|||
19443641|NCT01942148|41691345|FG000|Overall Study|Protocol Violation|1|||
19443642|NCT01942148|41691345|FG000|Overall Study|Withdrawal by Subject|8|||
19443643|NCT01942148|41691345|FG000|Overall Study|Use of the prohibition medicine|1|||
19443644|NCT02030015|41691349|FG000|Overall Study|Withdrawal by Subject|3|||
19443645|NCT02030015|41691349|FG000|Overall Study|Death|13|||
19443646|NCT02029235|41691355|FG000|Overall Study|Non-compliance with study meds or diary|4|||
19443647|NCT02029235|41691356|FG001|Overall Study|Non-compliance with study meds or diary|1|||
19443648|NCT01617434|41691364|FG000|Overall Study|Adverse Event|12|||
19443649|NCT01617434|41691365|FG001|Overall Study|Adverse Event|3|||
19443650|NCT01617434|41691364|FG000|Overall Study|Protocol Violation|8|||
19443651|NCT01617434|41691365|FG001|Overall Study|Protocol Violation|7|||
19443652|NCT01617434|41691364|FG000|Overall Study|Withdrawal Criteria|12|||
19443653|NCT01617434|41691365|FG001|Overall Study|Withdrawal Criteria|37|||
19443654|NCT01617434|41691364|FG000|Overall Study|Unclassified|3|||
19443655|NCT01617434|41691365|FG001|Overall Study|Unclassified|4|||
19443656|NCT01940900|41691373|FG000|Overall Study|Physician Decision|4|||
19443657|NCT01940900|41691374|FG001|Overall Study|Physician Decision|0|||
19443658|NCT01940900|41691373|FG000|Overall Study|Adverse Event|10|||
19443659|NCT01940900|41691374|FG001|Overall Study|Adverse Event|15|||
19443660|NCT01940900|41691373|FG000|Overall Study|Withdrawal by Subject|11|||
19443661|NCT01940900|41691374|FG001|Overall Study|Withdrawal by Subject|15|||
19443662|NCT01940900|41691373|FG000|Overall Study|Lost to Follow-up|1|||
19443663|NCT01940900|41691374|FG001|Overall Study|Lost to Follow-up|0|||
19443664|NCT01940900|41691373|FG000|Overall Study|Sponsor Decision|1|||
19443665|NCT01940900|41691374|FG001|Overall Study|Sponsor Decision|0|||
19443666|NCT01940900|41691373|FG000|Overall Study|subject non-compliance|1|||
19443667|NCT01940900|41691374|FG001|Overall Study|subject non-compliance|1|||
19443668|NCT01940900|41691373|FG000|Overall Study|other|1|||
19443669|NCT01940900|41691374|FG001|Overall Study|other|0|||
19443670|NCT01940354|41691382|FG000|Overall Study|Withdrawal by Subject|4|||
19443671|NCT01940354|41691383|FG001|Overall Study|Withdrawal by Subject|2|||
19443672|NCT01940120|41691389|FG000|Overall Study|Death|40|||
19443673|NCT01940120|41691389|FG000|Overall Study|Withdrawal by Subject|8|||
19629046|NCT00642616|42078617|FG003|Overall Study|Adverse Event|0|||
19443674|NCT01911260|41691398|FG000|Supplementation Period|transference or evasion of school|7|||
19443675|NCT01911260|41691399|FG001|Supplementation Period|transference or evasion of school|9|||
19443676|NCT01911260|41691400|FG002|Supplementation Period|transference or evasion of school|7|||
19443677|NCT01911260|41691401|FG003|Supplementation Period|transference or evasion of school|6|||
19443678|NCT01911260|41691398|FG000|Supplementation Period|Adverse Event|2|||
19443679|NCT01911260|41691399|FG001|Supplementation Period|Adverse Event|0|||
19443680|NCT01911260|41691400|FG002|Supplementation Period|Adverse Event|1|||
19443681|NCT01911260|41691401|FG003|Supplementation Period|Adverse Event|0|||
19443682|NCT01911260|41691398|FG000|Supplementation Period|refused to receive supplement|1|||
19443683|NCT01911260|41691399|FG001|Supplementation Period|refused to receive supplement|0|||
19443684|NCT01911260|41691400|FG002|Supplementation Period|refused to receive supplement|1|||
19443685|NCT01911260|41691401|FG003|Supplementation Period|refused to receive supplement|0|||
19443686|NCT01911260|41691398|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
19443687|NCT01911260|41691399|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
19443688|NCT01911260|41691400|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
19443689|NCT01911260|41691401|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
19443690|NCT01911260|41691398|FG000|Follow-up Period|transference or evasion of school|13|||
19443691|NCT01911260|41691399|FG001|Follow-up Period|transference or evasion of school|20|||
19443692|NCT01911260|41691400|FG002|Follow-up Period|transference or evasion of school|15|||
19443693|NCT01911260|41691401|FG003|Follow-up Period|transference or evasion of school|12|||
19443694|NCT02015819|41691415|FG000|Overall Study|Rickham catheter was misaligned|0|||
19443695|NCT02015819|41691416|FG001|Overall Study|Rickham catheter was misaligned|0|||
19443696|NCT02015819|41691417|FG002|Overall Study|Rickham catheter was misaligned|0|||
19443697|NCT02015819|41691418|FG003|Overall Study|Rickham catheter was misaligned|1|||
19443698|NCT01939496|41691435|FG000|Overall Study|Adverse Event|2|||
19443699|NCT01939496|41691436|FG001|Overall Study|Adverse Event|0|||
19443700|NCT01939496|41691437|FG002|Overall Study|Adverse Event|0|||
19443701|NCT01939496|41691435|FG000|Overall Study|Lost to Follow-up|1|||
19443702|NCT01939496|41691436|FG001|Overall Study|Lost to Follow-up|1|||
19443703|NCT01939496|41691437|FG002|Overall Study|Lost to Follow-up|0|||
19443704|NCT01939496|41691435|FG000|Overall Study|Physician Decision|1|||
19443705|NCT01939496|41691436|FG001|Overall Study|Physician Decision|0|||
19443706|NCT01939496|41691437|FG002|Overall Study|Physician Decision|0|||
19443707|NCT01939496|41691435|FG000|Overall Study|Protocol Violation|3|||
19443708|NCT01939496|41691436|FG001|Overall Study|Protocol Violation|0|||
19443709|NCT01939496|41691437|FG002|Overall Study|Protocol Violation|0|||
19443710|NCT01939496|41691435|FG000|Overall Study|Withdrawal by Subject|0|||
19443711|NCT01939496|41691436|FG001|Overall Study|Withdrawal by Subject|1|||
19443712|NCT01939496|41691437|FG002|Overall Study|Withdrawal by Subject|1|||
19443713|NCT01939496|41691435|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
19523257|NCT03327324|41959412|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523258|NCT03327324|41959413|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523259|NCT03327324|41959414|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523260|NCT03327324|41959415|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523261|NCT03327324|41959416|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523262|NCT03327324|41959417|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
19523263|NCT03327324|41959412|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523264|NCT03327324|41959413|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523265|NCT03327324|41959414|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
19523266|NCT03327324|41959415|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523267|NCT03327324|41959416|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523268|NCT03327324|41959417|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523269|NCT03327324|41959412|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
19523270|NCT03327324|41959413|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
19523271|NCT03327324|41959414|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
19523272|NCT03327324|41959415|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
19523273|NCT03327324|41959416|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
19443714|NCT01939496|41691436|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
19443715|NCT01939496|41691437|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
19443716|NCT01939496|41691435|FG000|Overall Study|Other|2|||
19443717|NCT01939496|41691436|FG001|Overall Study|Other|0|||
19443718|NCT01939496|41691437|FG002|Overall Study|Other|1|||
19443719|NCT01939028|41691445|FG000|Overall Study|Withdrawal by Subject|5|||
19443720|NCT01939028|41691445|FG000|Overall Study|Physician Decision|7|||
19443721|NCT01938716|41691449|FG000|Overall Study|Physician Decision|2|||
19443722|NCT01938716|41691449|FG000|Overall Study|Withdrawal by Subject|2|||
19443723|NCT01937390|41691453|FG000|Overall Study|Death|2|||
19443724|NCT01937390|41691453|FG000|Overall Study|Lost to Follow-up|7|||
19443725|NCT01937390|41691453|FG000|Overall Study|Withdrawal by Subject|5|||
19443726|NCT01937390|41691453|FG000|Overall Study|Fail to return|21|||
19443727|NCT02015663|41691459|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
19443728|NCT02015663|41691460|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
19443729|NCT02015663|41691459|FG000|Overall Study|Withdrawal by Subject|1|||
19443730|NCT02015663|41691460|FG001|Overall Study|Withdrawal by Subject|0|||
19443731|NCT02015663|41691459|FG000|Overall Study|Protocol Violation|0|||
19443732|NCT02015663|41691460|FG001|Overall Study|Protocol Violation|1|||
19443733|NCT02015663|41691459|FG000|Overall Study|Adverse Event|3|||
19523274|NCT03327324|41959417|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
19523275|NCT03327324|41959412|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
19523276|NCT03327324|41959413|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
19523277|NCT03327324|41959414|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
19523278|NCT03327324|41959415|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
19523279|NCT03327324|41959416|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
19523280|NCT03327324|41959417|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
19523281|NCT03327324|41959412|FG000|Intervention (Month 3-Month 6)|Death|1|||
19523282|NCT03327324|41959413|FG001|Intervention (Month 3-Month 6)|Death|0|||
19443734|NCT02015663|41691460|FG001|Overall Study|Adverse Event|0|||
19443735|NCT02015663|41691459|FG000|Overall Study|Administrative problems|10|||
19443736|NCT02015663|41691460|FG001|Overall Study|Administrative problems|11|||
19443737|NCT02028767|41691467|FG000|Treatment Period 2|Non compliant with protocol|1|||
19443738|NCT02028767|41691468|FG001|Treatment Period 2|Non compliant with protocol|0|||
19443739|NCT02028767|41691467|FG000|Treatment Period 2|Reason other than those specified above|1|||
19443740|NCT02028767|41691468|FG001|Treatment Period 2|Reason other than those specified above|0|||
19443741|NCT01959932|41691477|FG000|Overall Study|Withdrawal by Subject|1|||
19443742|NCT01959932|41691478|FG001|Overall Study|Withdrawal by Subject|0|||
19443743|NCT01959932|41691479|FG002|Overall Study|Withdrawal by Subject|0|||
19443744|NCT02028065|41691491|FG000|Randomization Through Start Treatment|Not treated|1|||
19443745|NCT02028065|41691492|FG001|Randomization Through Start Treatment|Not treated|3|||
19443746|NCT02028065|41691493|FG002|Randomization Through Start Treatment|Not treated|3|||
19443747|NCT02028065|41691491|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
19443748|NCT02028065|41691492|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
19443749|NCT02028065|41691493|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
19443750|NCT02028065|41691491|FG000|Treatment Through Study Completion|Physician Decision|1|||
19443751|NCT02028065|41691492|FG001|Treatment Through Study Completion|Physician Decision|0|||
19443752|NCT02028065|41691493|FG002|Treatment Through Study Completion|Physician Decision|0|||
19443753|NCT02028065|41691491|FG000|Treatment Through Study Completion|Protocol Violation|1|||
19443754|NCT02028065|41691492|FG001|Treatment Through Study Completion|Protocol Violation|4|||
19523283|NCT03327324|41959414|FG002|Intervention (Month 3-Month 6)|Death|1|||
19523284|NCT03327324|41959415|FG003|Intervention (Month 3-Month 6)|Death|1|||
19523285|NCT03327324|41959416|FG004|Intervention (Month 3-Month 6)|Death|1|||
19523286|NCT03327324|41959417|FG005|Intervention (Month 3-Month 6)|Death|0|||
19523287|NCT03327324|41959412|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523288|NCT03327324|41959413|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523289|NCT03327324|41959414|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523290|NCT03327324|41959415|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523291|NCT03327324|41959416|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523292|NCT03327324|41959417|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
19523293|NCT03327324|41959412|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
19523294|NCT03327324|41959413|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523295|NCT03327324|41959414|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523296|NCT03327324|41959415|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523297|NCT03327324|41959416|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19523298|NCT03327324|41959417|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
19443755|NCT02028065|41691493|FG002|Treatment Through Study Completion|Protocol Violation|0|||
19443756|NCT02028065|41691491|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
19443757|NCT02028065|41691492|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
19443758|NCT02028065|41691493|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
19443759|NCT02028065|41691491|FG000|Treatment Through Study Completion|Adverse Event|3|||
19443760|NCT02028065|41691492|FG001|Treatment Through Study Completion|Adverse Event|3|||
19443761|NCT02028065|41691493|FG002|Treatment Through Study Completion|Adverse Event|5|||
19443762|NCT02015195|41691508|FG000|Overall Study|Adverse Event|0|||
19443763|NCT02015195|41691509|FG001|Overall Study|Adverse Event|0|||
19443764|NCT02015195|41691510|FG002|Overall Study|Adverse Event|0|||
19443765|NCT02015195|41691511|FG003|Overall Study|Adverse Event|1|||
19443766|NCT02015195|41691512|FG004|Overall Study|Adverse Event|0|||
19443767|NCT02015195|41691513|FG005|Overall Study|Adverse Event|0|||
19443768|NCT02015195|41691514|FG006|Overall Study|Adverse Event|0|||
19443769|NCT02015039|41691531|FG000|Overall Study|Not eligible|0|||
19443770|NCT02015039|41691532|FG001|Overall Study|Not eligible|1|||
19443771|NCT02025725|41691540|FG000|Overall Study|Adverse Event|5|||
19443772|NCT02025725|41691541|FG001|Overall Study|Adverse Event|0|||
19443773|NCT02025725|41691540|FG000|Overall Study|Lost to Follow-up|2|||
19443774|NCT02025725|41691541|FG001|Overall Study|Lost to Follow-up|0|||
19443775|NCT02025725|41691540|FG000|Overall Study|Protocol Violation|1|||
19443776|NCT02025725|41691541|FG001|Overall Study|Protocol Violation|1|||
19443777|NCT02025725|41691540|FG000|Overall Study|Withdrawal by Subject|3|||
19443778|NCT02025725|41691541|FG001|Overall Study|Withdrawal by Subject|2|||
19443779|NCT02025725|41691540|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
19443780|NCT02025725|41691541|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
19443781|NCT02025179|41691552|FG000|Overall Study|Lost to Follow-up|0|||
19443782|NCT02025179|41691553|FG001|Overall Study|Lost to Follow-up|0|||
19443783|NCT02025179|41691554|FG002|Overall Study|Lost to Follow-up|1|||
19443784|NCT02013791|41691571|FG000|Period 1|Lost to Follow-up|0|||
19443785|NCT02013791|41691572|FG001|Period 1|Lost to Follow-up|0|||
19443786|NCT02013791|41691573|FG002|Period 1|Lost to Follow-up|0|||
19443787|NCT02013791|41691574|FG003|Period 1|Lost to Follow-up|1|||
19443788|NCT02013791|41691575|FG004|Period 1|Lost to Follow-up|0|||
19443789|NCT02013791|41691576|FG005|Period 1|Lost to Follow-up|0|||
19443790|NCT02013791|41691577|FG006|Period 1|Lost to Follow-up|1|||
19443791|NCT02013791|41691578|FG007|Period 1|Lost to Follow-up|1|||
19443792|NCT02013791|41691579|FG008|Period 1|Lost to Follow-up|0|||
19443793|NCT02013791|41691571|FG000|Period 1|Other Miscellaneous Reasons|0|||
19443794|NCT02013791|41691572|FG001|Period 1|Other Miscellaneous Reasons|2|||
19523299|NCT03327324|41959412|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
19523300|NCT03327324|41959413|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
19443795|NCT02013791|41691573|FG002|Period 1|Other Miscellaneous Reasons|0|||
19443796|NCT02013791|41691574|FG003|Period 1|Other Miscellaneous Reasons|0|||
19443797|NCT02013791|41691575|FG004|Period 1|Other Miscellaneous Reasons|0|||
19443798|NCT02013791|41691576|FG005|Period 1|Other Miscellaneous Reasons|0|||
19443799|NCT02013791|41691577|FG006|Period 1|Other Miscellaneous Reasons|0|||
19443800|NCT02013791|41691578|FG007|Period 1|Other Miscellaneous Reasons|0|||
19443801|NCT02013791|41691579|FG008|Period 1|Other Miscellaneous Reasons|0|||
19443802|NCT02024867|41691602|FG000|Overall Study|Protocol Violation|3|||
19443803|NCT02024867|41691603|FG001|Overall Study|Protocol Violation|3|||
19443804|NCT02024867|41691602|FG000|Overall Study|Lost to Follow-up|6|||
19443805|NCT02024867|41691603|FG001|Overall Study|Lost to Follow-up|4|||
19443806|NCT01953601|41691612|FG000|Part 1 (Base Study)|Adverse Event|24|||
19443807|NCT01953601|41691613|FG001|Part 1 (Base Study)|Adverse Event|37|||
19443808|NCT01953601|41691614|FG002|Part 1 (Base Study)|Adverse Event|15|||
19443809|NCT01953601|41691612|FG000|Part 1 (Base Study)|Death|2|||
19443810|NCT01953601|41691613|FG001|Part 1 (Base Study)|Death|0|||
19443811|NCT01953601|41691614|FG002|Part 1 (Base Study)|Death|3|||
19443812|NCT01953601|41691612|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
19443813|NCT01953601|41691613|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
19443814|NCT01953601|41691614|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
19443815|NCT01953601|41691612|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
19443816|NCT01953601|41691613|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
19443817|NCT01953601|41691614|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
19443818|NCT01953601|41691612|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
19443819|NCT01953601|41691613|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
19443820|NCT01953601|41691614|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
19443821|NCT01953601|41691612|FG000|Part 1 (Base Study)|Physician Decision|3|||
19443822|NCT01953601|41691613|FG001|Part 1 (Base Study)|Physician Decision|7|||
19443823|NCT01953601|41691614|FG002|Part 1 (Base Study)|Physician Decision|4|||
19443824|NCT01953601|41691612|FG000|Part 1 (Base Study)|Screen failure|1|||
19443825|NCT01953601|41691613|FG001|Part 1 (Base Study)|Screen failure|0|||
19443826|NCT01953601|41691614|FG002|Part 1 (Base Study)|Screen failure|1|||
19443827|NCT01953601|41691612|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
19443828|NCT01953601|41691613|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
19443829|NCT01953601|41691614|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
19443830|NCT01953601|41691612|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
19443831|NCT01953601|41691613|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
19443832|NCT01953601|41691614|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
19443833|NCT01953601|41691612|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
19443834|NCT01953601|41691613|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
19443835|NCT01953601|41691614|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
19443836|NCT01953601|41691612|FG000|Part 1 (Base Study)|Subject moved|2|||
19443837|NCT01953601|41691613|FG001|Part 1 (Base Study)|Subject moved|2|||
19443838|NCT01953601|41691614|FG002|Part 1 (Base Study)|Subject moved|1|||
19443839|NCT01953601|41691612|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
19443840|NCT01953601|41691613|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
19443841|NCT01953601|41691614|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
19443842|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Adverse Event|1|||
19443843|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Adverse Event|1|||
19443844|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Adverse Event|10|||
19443845|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Death|0|||
19443846|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Death|3|||
19443847|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Death|0|||
19443848|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
19443849|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
19443850|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
19443851|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
19443852|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
19443853|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
19443854|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Physician Decision|2|||
19443855|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Physician Decision|0|||
19443856|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Physician Decision|2|||
19443857|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
19443858|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
19523301|NCT03327324|41959414|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
19523302|NCT03327324|41959415|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
19523303|NCT03327324|41959416|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
19523304|NCT03327324|41959417|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
19443859|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
19443860|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
19443861|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
19443862|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
19443863|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
19443864|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
19443865|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
19443866|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Subject moved|0|||
19443867|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Subject moved|0|||
19443868|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Subject moved|1|||
19443869|NCT01953601|41691612|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
19443870|NCT01953601|41691613|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
19443871|NCT01953601|41691614|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
19443872|NCT01952665|41691627|FG000|Overall Study|Physician Decision|3|||
19443873|NCT01952665|41691628|FG001|Overall Study|Physician Decision|2|||
19443874|NCT01952665|41691627|FG000|Overall Study|Lost to Follow-up|1|||
19443875|NCT01952665|41691628|FG001|Overall Study|Lost to Follow-up|2|||
19443876|NCT01952665|41691627|FG000|Overall Study|Adverse Event|2|||
19443877|NCT01952665|41691628|FG001|Overall Study|Adverse Event|1|||
19443878|NCT01952665|41691627|FG000|Overall Study|Protocol Violation|0|||
19443879|NCT01952665|41691628|FG001|Overall Study|Protocol Violation|1|||
19443880|NCT01952041|41691639|FG000|Overall Study|Lost to Follow-up|9|||
19443881|NCT01952041|41691640|FG001|Overall Study|Lost to Follow-up|16|||
19443882|NCT01952041|41691639|FG000|Overall Study|Withdrawal by Subject|7|||
19443883|NCT01952041|41691640|FG001|Overall Study|Withdrawal by Subject|5|||
19443884|NCT01952041|41691639|FG000|Overall Study|Death|1|||
19443885|NCT01952041|41691640|FG001|Overall Study|Death|0|||
19443886|NCT01951573|41691646|FG000|Washout Period|Adverse Event|0|||
19443887|NCT01951573|41691647|FG001|Washout Period|Adverse Event|1|||
19443888|NCT02023697|41691656|FG000|Treatment Period|Radiological progression|13|||
19443889|NCT02023697|41691657|FG001|Treatment Period|Radiological progression|17|||
19443890|NCT02023697|41691658|FG002|Treatment Period|Radiological progression|26|||
19443891|NCT02023697|41691656|FG000|Treatment Period|Never Treated|5|||
19443892|NCT02023697|41691657|FG001|Treatment Period|Never Treated|6|||
19443893|NCT02023697|41691658|FG002|Treatment Period|Never Treated|10|||
19443894|NCT02023697|41691656|FG000|Treatment Period|Adverse Event|13|||
19443895|NCT02023697|41691657|FG001|Treatment Period|Adverse Event|25|||
19443896|NCT02023697|41691658|FG002|Treatment Period|Adverse Event|23|||
19443897|NCT02023697|41691656|FG000|Treatment Period|Logistical difficulties|1|||
19523305|NCT03327324|41959412|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
19443898|NCT02023697|41691657|FG001|Treatment Period|Logistical difficulties|1|||
19443899|NCT02023697|41691658|FG002|Treatment Period|Logistical difficulties|1|||
19443900|NCT02023697|41691656|FG000|Treatment Period|Clinical progression|10|||
19443901|NCT02023697|41691657|FG001|Treatment Period|Clinical progression|8|||
19443902|NCT02023697|41691658|FG002|Treatment Period|Clinical progression|28|||
19443903|NCT02023697|41691656|FG000|Treatment Period|Withdrawal by Subject|4|||
19443904|NCT02023697|41691657|FG001|Treatment Period|Withdrawal by Subject|5|||
19443905|NCT02023697|41691658|FG002|Treatment Period|Withdrawal by Subject|13|||
19443906|NCT02023697|41691656|FG000|Treatment Period|Safety outcome reached|0|||
19443907|NCT02023697|41691657|FG001|Treatment Period|Safety outcome reached|1|||
19443908|NCT02023697|41691658|FG002|Treatment Period|Safety outcome reached|0|||
19443909|NCT02023697|41691656|FG000|Treatment Period|Physician Decision|0|||
19443910|NCT02023697|41691657|FG001|Treatment Period|Physician Decision|0|||
19443911|NCT02023697|41691658|FG002|Treatment Period|Physician Decision|1|||
19443912|NCT02023697|41691656|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
19443913|NCT02023697|41691657|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
19443914|NCT02023697|41691658|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
19443915|NCT02023697|41691656|FG000|Active Follow-up Period|Lost to Follow-up|1|||
19443916|NCT02023697|41691657|FG001|Active Follow-up Period|Lost to Follow-up|1|||
19443917|NCT02023697|41691658|FG002|Active Follow-up Period|Lost to Follow-up|1|||
19443918|NCT02023697|41691656|FG000|Active Follow-up Period|Deterioration of general condition|1|||
19443919|NCT02023697|41691657|FG001|Active Follow-up Period|Deterioration of general condition|1|||
19443920|NCT02023697|41691658|FG002|Active Follow-up Period|Deterioration of general condition|1|||
19443921|NCT02023697|41691656|FG000|Active Follow-up Period|Other unspecified|2|||
19443922|NCT02023697|41691657|FG001|Active Follow-up Period|Other unspecified|0|||
19443923|NCT02023697|41691658|FG002|Active Follow-up Period|Other unspecified|1|||
19443924|NCT02023697|41691656|FG000|Active Follow-up Period|Clinical progression|0|||
19443925|NCT02023697|41691657|FG001|Active Follow-up Period|Clinical progression|2|||
19443926|NCT02023697|41691658|FG002|Active Follow-up Period|Clinical progression|1|||
19443927|NCT02023697|41691656|FG000|Active Follow-up Period|Radiological progression|0|||
19443928|NCT02023697|41691657|FG001|Active Follow-up Period|Radiological progression|0|||
19443929|NCT02023697|41691658|FG002|Active Follow-up Period|Radiological progression|1|||
19443930|NCT02023697|41691656|FG000|Active Follow-up Period|Death|83|||
19443931|NCT02023697|41691657|FG001|Active Follow-up Period|Death|82|||
19443932|NCT02023697|41691658|FG002|Active Follow-up Period|Death|87|||
19443933|NCT02023697|41691656|FG000|Long-term Follow-up Period|Death|9|||
19443934|NCT02023697|41691657|FG001|Long-term Follow-up Period|Death|6|||
19443935|NCT02023697|41691658|FG002|Long-term Follow-up Period|Death|4|||
19443936|NCT02023697|41691656|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
19443937|NCT02023697|41691657|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
19443938|NCT02023697|41691658|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
19443939|NCT02023697|41691656|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
19443940|NCT02023697|41691657|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
19443941|NCT02023697|41691658|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
19443942|NCT02023697|41691656|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
19443943|NCT02023697|41691657|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
19443944|NCT02023697|41691658|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
19443945|NCT02023697|41691656|FG000|Long-term Follow-up Period|Technical problems|0|||
19443946|NCT02023697|41691657|FG001|Long-term Follow-up Period|Technical problems|0|||
19443947|NCT02023697|41691658|FG002|Long-term Follow-up Period|Technical problems|1|||
19443948|NCT02023697|41691656|FG000|Long-term Follow-up Period|Other unspecified|6|||
19443949|NCT02023697|41691657|FG001|Long-term Follow-up Period|Other unspecified|3|||
19443950|NCT02023697|41691658|FG002|Long-term Follow-up Period|Other unspecified|5|||
19443951|NCT01951417|41691673|FG000|Overall Study|Withdrawal by Subject|1|||
19443952|NCT01951417|41691673|FG000|Overall Study|Protocol Violation|2|||
19443953|NCT01951417|41691673|FG000|Overall Study|Lost to Follow-up|6|||
19443954|NCT01951261|41691683|FG000|Overall Study|Death|1|||
19443955|NCT01951261|41691684|FG001|Overall Study|Death|0|||
19443956|NCT01951261|41691683|FG000|Overall Study|Lost to Follow-up|4|||
19443957|NCT01951261|41691684|FG001|Overall Study|Lost to Follow-up|3|||
19443958|NCT01951261|41691683|FG000|Overall Study|Protocol Violation|4|||
19443959|NCT01951261|41691684|FG001|Overall Study|Protocol Violation|3|||
19443960|NCT02023151|41691690|FG000|Overall Study|Lost to Follow-up|4|||
19443961|NCT01979185|41691696|FG000|Period 2|Other|0|||
19443962|NCT01979185|41691697|FG001|Period 2|Other|1|||
19443963|NCT01946425|41691705|FG000|Overall Study|Protocol Violation|1|||
19443964|NCT01946425|41691706|FG001|Overall Study|Protocol Violation|0|||
19443965|NCT01946425|41691705|FG000|Overall Study|Withdrawal by Subject|1|||
19443966|NCT01946425|41691706|FG001|Overall Study|Withdrawal by Subject|0|||
19443967|NCT01946191|41691715|FG000|Allocation|Did not complete orientation|1|||
19443968|NCT01946191|41691716|FG001|Allocation|Did not complete orientation|1|||
19443969|NCT01946191|41691715|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
19443970|NCT01946191|41691716|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
19443971|NCT01946191|41691715|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
19443972|NCT01946191|41691716|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
19443973|NCT01946191|41691715|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
19443974|NCT01946191|41691716|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
19443975|NCT01959698|41691730|FG000|Overall Study|Adverse Event|0|||
19443976|NCT01959698|41691731|FG001|Overall Study|Adverse Event|0|||
19443977|NCT01959698|41691732|FG002|Overall Study|Adverse Event|0|||
19443978|NCT01959698|41691733|FG003|Overall Study|Adverse Event|0|||
19443979|NCT01959698|41691734|FG004|Overall Study|Adverse Event|0|||
19443980|NCT01959698|41691735|FG005|Overall Study|Adverse Event|0|||
19443981|NCT01959698|41691736|FG006|Overall Study|Adverse Event|1|||
19443982|NCT01959698|41691730|FG000|Overall Study|Physician Decision|1|||
19443983|NCT01959698|41691731|FG001|Overall Study|Physician Decision|0|||
19443984|NCT01959698|41691732|FG002|Overall Study|Physician Decision|1|||
19443985|NCT01959698|41691733|FG003|Overall Study|Physician Decision|2|||
19443986|NCT01959698|41691734|FG004|Overall Study|Physician Decision|0|||
19443987|NCT01959698|41691735|FG005|Overall Study|Physician Decision|3|||
19443988|NCT01959698|41691736|FG006|Overall Study|Physician Decision|3|||
19443989|NCT01910402|41691755|FG000|Randomized Phase|Adverse Event|10|||
19443990|NCT01910402|41691756|FG001|Randomized Phase|Adverse Event|18|||
19443991|NCT01910402|41691755|FG000|Randomized Phase|Physician Decision|1|||
19443992|NCT01910402|41691756|FG001|Randomized Phase|Physician Decision|0|||
19443993|NCT01910402|41691755|FG000|Randomized Phase|Lack of Efficacy|5|||
19443994|NCT01910402|41691756|FG001|Randomized Phase|Lack of Efficacy|4|||
19443995|NCT01910402|41691755|FG000|Randomized Phase|Lost to Follow-up|11|||
19443996|NCT01910402|41691756|FG001|Randomized Phase|Lost to Follow-up|13|||
19443997|NCT01910402|41691755|FG000|Randomized Phase|Protocol Violation|10|||
19443998|NCT01910402|41691756|FG001|Randomized Phase|Protocol Violation|13|||
19443999|NCT01910402|41691755|FG000|Randomized Phase|Withdrawal by Subject|5|||
19444000|NCT01910402|41691756|FG001|Randomized Phase|Withdrawal by Subject|7|||
19444001|NCT01910402|41691755|FG000|Continuation Phase|Ongoing|84|||
19444002|NCT01910402|41691756|FG001|Continuation Phase|Ongoing|0|||
19444003|NCT01910402|41691755|FG000|Continuation Phase|Adverse Event|1|||
19444004|NCT01910402|41691756|FG001|Continuation Phase|Adverse Event|0|||
19444005|NCT01910402|41691755|FG000|Continuation Phase|Protocol Violation|3|||
19444006|NCT01910402|41691756|FG001|Continuation Phase|Protocol Violation|0|||
19444007|NCT01910402|41691755|FG000|Continuation Phase|Withdrawal by Subject|2|||
19444008|NCT01910402|41691756|FG001|Continuation Phase|Withdrawal by Subject|0|||
19444009|NCT01937312|41691766|FG000|Overall Study|Adverse Event|10|||
19444010|NCT01937312|41691767|FG001|Overall Study|Adverse Event|1|||
19444011|NCT01937312|41691766|FG000|Overall Study|Lack of Efficacy|0|||
19444012|NCT01937312|41691767|FG001|Overall Study|Lack of Efficacy|1|||
19444013|NCT01937312|41691766|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
19444014|NCT01937312|41691767|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
19444015|NCT01909934|41691774|FG000|Overall Study|Ongoing|23|||
19444016|NCT01909934|41691774|FG000|Overall Study|Withdrawal by Subject|3|||
19444017|NCT01909934|41691774|FG000|Overall Study|Lost to Follow-up|1|||
19444018|NCT01909934|41691774|FG000|Overall Study|Withdrawal of Informed Consent|1|||
19444019|NCT01909934|41691774|FG000|Overall Study|Death|22|||
19444020|NCT01935128|41691778|FG000|Overall Study|Death|1|||
19444021|NCT01935128|41691778|FG000|Overall Study|Adverse Event|6|||
19444022|NCT01934972|41691784|FG000|Overall Study|Withdrawal by Subject|9|||
19444023|NCT01934972|41691785|FG001|Overall Study|Withdrawal by Subject|6|||
19444024|NCT01959230|41691793|FG000|Overall Study|Failure to follow study procedures|0|||
19444025|NCT01959230|41691794|FG001|Overall Study|Failure to follow study procedures|1|||
19444026|NCT01959230|41691793|FG000|Overall Study|Administrative reasons|2|||
19444027|NCT01959230|41691794|FG001|Overall Study|Administrative reasons|0|||
19444028|NCT01959230|41691793|FG000|Overall Study|Withdrawal by Subject|2|||
19444029|NCT01959230|41691794|FG001|Overall Study|Withdrawal by Subject|0|||
19444030|NCT01909778|41691800|FG000|Overall Study|failed screening|1|||
19444031|NCT01978093|41691808|FG000|Overall Study|Death|1|||
19444032|NCT01978093|41691809|FG001|Overall Study|Death|0|||
19444033|NCT01978093|41691808|FG000|Overall Study|Adverse Event|0|||
19444034|NCT01978093|41691809|FG001|Overall Study|Adverse Event|5|||
19444035|NCT01978093|41691808|FG000|Overall Study|Protocol Violation|8|||
19444036|NCT01978093|41691809|FG001|Overall Study|Protocol Violation|2|||
19444037|NCT01978093|41691808|FG000|Overall Study|Withdrawal by Subject|29|||
19444038|NCT01978093|41691809|FG001|Overall Study|Withdrawal by Subject|25|||
19444039|NCT01978093|41691808|FG000|Overall Study|Lost to Follow-up|11|||
19711300|NCT03572062|42154401|FG006|Overall Study|Study Terminated By Sponsor|0|||
19711301|NCT03572062|42154402|FG007|Overall Study|Study Terminated By Sponsor|0|||
19711302|NCT03572062|42154403|FG008|Overall Study|Study Terminated By Sponsor|29|||
19711303|NCT03572062|42154404|FG009|Overall Study|Study Terminated By Sponsor|27|||
19711304|NCT03572062|42154395|FG000|Overall Study|Physician Decision|0|||
19711305|NCT03572062|42154396|FG001|Overall Study|Physician Decision|0|||
19711306|NCT03572062|42154397|FG002|Overall Study|Physician Decision|0|||
19444040|NCT01978093|41691809|FG001|Overall Study|Lost to Follow-up|15|||
19444041|NCT01978093|41691808|FG000|Overall Study|Migrated/moved from study area|11|||
19444042|NCT01978093|41691809|FG001|Overall Study|Migrated/moved from study area|13|||
19444043|NCT01978093|41691808|FG000|Overall Study|Loss of kaiser coverage|4|||
19711307|NCT03572062|42154398|FG003|Overall Study|Physician Decision|0|||
19444044|NCT01978093|41691809|FG001|Overall Study|Loss of kaiser coverage|10|||
19444045|NCT01978093|41691808|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
19444046|NCT01978093|41691809|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
19444047|NCT01978093|41691808|FG000|Overall Study|Mother lost custody of child|0|||
19444048|NCT01978093|41691809|FG001|Overall Study|Mother lost custody of child|1|||
19444049|NCT01978093|41691808|FG000|Overall Study|Child was in care of grandmother|0|||
19444050|NCT01978093|41691809|FG001|Overall Study|Child was in care of grandmother|1|||
19444051|NCT01978093|41691808|FG000|Overall Study|N/A for vaccine administration|0|||
19444052|NCT01978093|41691809|FG001|Overall Study|N/A for vaccine administration|1|||
19444053|NCT01977937|41691820|FG000|Overall Study|Withdrawal by Subject|2|||
19444054|NCT01977937|41691821|FG001|Overall Study|Withdrawal by Subject|1|||
19444055|NCT01977937|41691820|FG000|Overall Study|Adverse Event|1|||
19444056|NCT01977937|41691821|FG001|Overall Study|Adverse Event|0|||
19444057|NCT01977937|41691820|FG000|Overall Study|Physician Decision|0|||
19444058|NCT01977937|41691821|FG001|Overall Study|Physician Decision|1|||
19444059|NCT01951105|41691830|FG000|Overall Study|Adverse Event|0|||
19444060|NCT01951105|41691831|FG001|Overall Study|Adverse Event|5|||
19444061|NCT01951105|41691832|FG002|Overall Study|Adverse Event|0|||
19444062|NCT01951105|41691830|FG000|Overall Study|Lost to Follow-up|0|||
19444063|NCT01951105|41691831|FG001|Overall Study|Lost to Follow-up|1|||
19444064|NCT01951105|41691832|FG002|Overall Study|Lost to Follow-up|0|||
19444065|NCT01951105|41691830|FG000|Overall Study|Protocol Violation|1|||
19444066|NCT01951105|41691831|FG001|Overall Study|Protocol Violation|1|||
19444067|NCT01951105|41691832|FG002|Overall Study|Protocol Violation|1|||
19444068|NCT01951105|41691830|FG000|Overall Study|Withdrawal by Subject|0|||
19523306|NCT03327324|41959413|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
19444069|NCT01951105|41691831|FG001|Overall Study|Withdrawal by Subject|3|||
19444070|NCT01951105|41691832|FG002|Overall Study|Withdrawal by Subject|1|||
19444071|NCT01958918|41691848|FG000|Overall Study|Death|1|||
19444072|NCT01958918|41691849|FG001|Overall Study|Death|3|||
19444073|NCT01958918|41691848|FG000|Overall Study|Lost to Follow-up|4|||
19444074|NCT01958918|41691849|FG001|Overall Study|Lost to Follow-up|7|||
19444075|NCT01958918|41691848|FG000|Overall Study|Withdrawal by Subject|13|||
19444076|NCT01958918|41691849|FG001|Overall Study|Withdrawal by Subject|8|||
19444077|NCT01958918|41691848|FG000|Overall Study|Lack of Efficacy|13|||
19444078|NCT01958918|41691849|FG001|Overall Study|Lack of Efficacy|10|||
19711308|NCT03572062|42154399|FG004|Overall Study|Physician Decision|0|||
19711309|NCT03572062|42154400|FG005|Overall Study|Physician Decision|0|||
19711310|NCT03572062|42154401|FG006|Overall Study|Physician Decision|0|||
19711311|NCT03572062|42154402|FG007|Overall Study|Physician Decision|0|||
19711312|NCT03572062|42154403|FG008|Overall Study|Physician Decision|1|||
19711313|NCT03572062|42154404|FG009|Overall Study|Physician Decision|0|||
19711314|NCT03572062|42154395|FG000|Overall Study|Withdrawal by Subject|0|||
19711315|NCT03572062|42154396|FG001|Overall Study|Withdrawal by Subject|0|||
19711316|NCT03572062|42154397|FG002|Overall Study|Withdrawal by Subject|0|||
19711317|NCT03572062|42154398|FG003|Overall Study|Withdrawal by Subject|0|||
19711318|NCT03572062|42154399|FG004|Overall Study|Withdrawal by Subject|0|||
19711319|NCT03572062|42154400|FG005|Overall Study|Withdrawal by Subject|0|||
19444079|NCT01958918|41691848|FG000|Overall Study|Adverse Event|12|||
19444080|NCT01958918|41691849|FG001|Overall Study|Adverse Event|12|||
19444081|NCT01958918|41691848|FG000|Overall Study|administrative problems|0|||
19444082|NCT01958918|41691849|FG001|Overall Study|administrative problems|2|||
19444083|NCT01945489|41691857|FG000|Cycle 1|Adverse Event|2|||
19444084|NCT01945489|41691858|FG001|Cycle 1|Adverse Event|0|||
19444085|NCT01945489|41691857|FG000|Cycle 1|Lost to Follow-up|4|||
19444086|NCT01945489|41691858|FG001|Cycle 1|Lost to Follow-up|0|||
19444087|NCT01945489|41691857|FG000|Cycle 1|Personal Reasons|4|||
19444088|NCT01945489|41691858|FG001|Cycle 1|Personal Reasons|2|||
19444089|NCT01945489|41691857|FG000|Cycle 1|Protocol Violation|0|||
19444090|NCT01945489|41691858|FG001|Cycle 1|Protocol Violation|1|||
19523307|NCT03327324|41959414|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
19523308|NCT03327324|41959415|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
19523309|NCT03327324|41959416|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
19523310|NCT03327324|41959417|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
19523311|NCT03327324|41959412|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523312|NCT03327324|41959413|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523313|NCT03327324|41959414|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523314|NCT03327324|41959415|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
19523315|NCT03327324|41959416|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
19523316|NCT03327324|41959417|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
19523317|NCT03327324|41959412|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
19523318|NCT03327324|41959413|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
19523319|NCT03327324|41959414|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
19523320|NCT03327324|41959415|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
19523321|NCT03327324|41959416|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
19523322|NCT03327324|41959417|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
19523323|NCT03327324|41959412|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
19523324|NCT03327324|41959413|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
19523325|NCT03327324|41959414|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
19523326|NCT03327324|41959415|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
19523327|NCT03327324|41959416|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
19523328|NCT03327324|41959417|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
19711320|NCT03572062|42154401|FG006|Overall Study|Withdrawal by Subject|0|||
19444091|NCT01945489|41691857|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
19444092|NCT01945489|41691858|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
19444093|NCT01945489|41691857|FG000|Cycle 2|Adverse Event|1|||
19444094|NCT01945489|41691858|FG001|Cycle 2|Adverse Event|0|||
19444095|NCT01945489|41691857|FG000|Cycle 2|Lost to Follow-up|0|||
19444096|NCT01945489|41691858|FG001|Cycle 2|Lost to Follow-up|1|||
19444097|NCT01934894|41691867|FG000|Overall Study|Adverse Event|1|||
19444098|NCT01934894|41691868|FG001|Overall Study|Adverse Event|2|||
19444099|NCT01934894|41691867|FG000|Overall Study|Death|2|||
19444100|NCT01934894|41691868|FG001|Overall Study|Death|0|||
19444101|NCT01934894|41691867|FG000|Overall Study|Withdrawal by Subject|0|||
19444102|NCT01934894|41691868|FG001|Overall Study|Withdrawal by Subject|1|||
19444103|NCT01934894|41691867|FG000|Overall Study|Progressive Disease|3|||
19444104|NCT01934894|41691868|FG001|Overall Study|Progressive Disease|2|||
19444105|NCT01950169|41691880|FG000|Overall Study|Withdrawal by Subject|2|||
19444106|NCT01950169|41691881|FG001|Overall Study|Withdrawal by Subject|8|||
19444107|NCT01950169|41691882|FG002|Overall Study|Withdrawal by Subject|1|||
19444108|NCT01950169|41691880|FG000|Overall Study|Death|1|||
19444109|NCT01950169|41691881|FG001|Overall Study|Death|0|||
19444110|NCT01950169|41691882|FG002|Overall Study|Death|0|||
19444111|NCT01934504|41691895|FG000|Overall Study|Protocol Deviation|0|||
19444112|NCT01934504|41691896|FG001|Overall Study|Protocol Deviation|0|||
19444113|NCT01934504|41691897|FG002|Overall Study|Protocol Deviation|0|||
19444114|NCT01934504|41691898|FG003|Overall Study|Protocol Deviation|2|||
19444115|NCT01934504|41691895|FG000|Overall Study|Study Terminated by Sponsor|1|||
19444116|NCT01934504|41691896|FG001|Overall Study|Study Terminated by Sponsor|0|||
19444117|NCT01934504|41691897|FG002|Overall Study|Study Terminated by Sponsor|5|||
19444118|NCT01934504|41691898|FG003|Overall Study|Study Terminated by Sponsor|5|||
19444119|NCT01950013|41691911|FG000|Overall Study|Withdrawal by Subject|0|||
19444120|NCT01950013|41691912|FG001|Overall Study|Withdrawal by Subject|2|||
19444121|NCT01950013|41691913|FG002|Overall Study|Withdrawal by Subject|0|||
19444122|NCT01949155|41691923|FG000|Overall Study|Lost to Follow-up|1|||
19444123|NCT01949155|41691924|FG001|Overall Study|Lost to Follow-up|0|||
19444124|NCT01949155|41691923|FG000|Overall Study|Protocol Violation|1|||
19444125|NCT01949155|41691924|FG001|Overall Study|Protocol Violation|0|||
19444126|NCT01909466|41691931|FG000|Overall Study|Lost to Follow-up|5|||
19444127|NCT01909466|41691932|FG001|Overall Study|Lost to Follow-up|7|||
19444128|NCT01909466|41691931|FG000|Overall Study|Adverse Event|3|||
19444129|NCT01909466|41691932|FG001|Overall Study|Adverse Event|4|||
19444130|NCT01909466|41691931|FG000|Overall Study|Met Withdrawal Criteria|0|||
19444131|NCT01909466|41691932|FG001|Overall Study|Met Withdrawal Criteria|3|||
19444132|NCT01909466|41691931|FG000|Overall Study|Physician Decision|2|||
19444133|NCT01909466|41691932|FG001|Overall Study|Physician Decision|0|||
19444134|NCT01909466|41691931|FG000|Overall Study|Withdrawal by Subject|11|||
19444135|NCT01909466|41691932|FG001|Overall Study|Withdrawal by Subject|9|||
19444136|NCT01909466|41691931|FG000|Overall Study|Lack of Efficacy|1|||
19444137|NCT01909466|41691932|FG001|Overall Study|Lack of Efficacy|0|||
19444138|NCT01977625|41691936|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
19444139|NCT01977625|41691937|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
19444140|NCT01977625|41691936|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19444141|NCT01977625|41691937|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
19444142|NCT01944631|41691947|FG000|Overall Study|Adverse Event|1|||
19444143|NCT01944631|41691948|FG001|Overall Study|Adverse Event|0|||
19444144|NCT01944631|41691947|FG000|Overall Study|Lost to Follow-up|3|||
19444145|NCT01944631|41691948|FG001|Overall Study|Lost to Follow-up|1|||
19444146|NCT01944631|41691947|FG000|Overall Study|Withdrawal by Subject|0|||
19444147|NCT01944631|41691948|FG001|Overall Study|Withdrawal by Subject|1|||
19444148|NCT01948063|41691956|FG000|Overall Study|Boston MCI halted research protocol|0|||
19444149|NCT01948063|41691957|FG001|Overall Study|Boston MCI halted research protocol|1|||
19444150|NCT01948063|41691956|FG000|Overall Study|Discovered an enrollment in other study|0|||
19444151|NCT01948063|41691957|FG001|Overall Study|Discovered an enrollment in other study|1|||
19444152|NCT01948063|41691956|FG000|Overall Study|Blood samples were accidentally thawed|1|||
19444153|NCT01948063|41691957|FG001|Overall Study|Blood samples were accidentally thawed|0|||
19444154|NCT01995071|41691975|FG000|Overall Study|Adverse Event|0|||
19444155|NCT01995071|41691976|FG001|Overall Study|Adverse Event|0|||
19444156|NCT01995071|41691977|FG002|Overall Study|Adverse Event|0|||
19444157|NCT01995071|41691978|FG003|Overall Study|Adverse Event|0|||
19444158|NCT01995071|41691979|FG004|Overall Study|Adverse Event|0|||
19444159|NCT01995071|41691980|FG005|Overall Study|Adverse Event|0|||
19444160|NCT01995071|41691981|FG006|Overall Study|Adverse Event|1|||
19444161|NCT01995071|41691982|FG007|Overall Study|Adverse Event|0|||
19444162|NCT01995071|41691983|FG008|Overall Study|Adverse Event|0|||
19444163|NCT01995071|41691984|FG009|Overall Study|Adverse Event|0|||
19444164|NCT01995071|41691985|FG010|Overall Study|Adverse Event|0|||
19444165|NCT01995071|41691986|FG011|Overall Study|Adverse Event|0|||
19444166|NCT01995071|41691975|FG000|Overall Study|Moved|0|||
19444167|NCT01995071|41691976|FG001|Overall Study|Moved|0|||
19444168|NCT01995071|41691977|FG002|Overall Study|Moved|1|||
19444169|NCT01995071|41691978|FG003|Overall Study|Moved|0|||
19444170|NCT01995071|41691979|FG004|Overall Study|Moved|1|||
19444171|NCT01995071|41691980|FG005|Overall Study|Moved|0|||
19444172|NCT01995071|41691981|FG006|Overall Study|Moved|0|||
19444173|NCT01995071|41691982|FG007|Overall Study|Moved|0|||
19523329|NCT03252522|41959423|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
19523330|NCT03252522|41959424|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
19523331|NCT03252522|41959425|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
19523332|NCT03252522|41959423|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
19523333|NCT03252522|41959424|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
19523334|NCT03252522|41959425|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
19523335|NCT03252522|41959423|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
19523336|NCT03252522|41959424|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
19523337|NCT03252522|41959425|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
19523338|NCT03252522|41959423|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
19523339|NCT03252522|41959424|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
19523340|NCT03252522|41959425|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
19523341|NCT03252522|41959423|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
19523342|NCT03252522|41959424|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
19523343|NCT03252522|41959425|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
19444174|NCT01995071|41691983|FG008|Overall Study|Moved|0|||
19444175|NCT01995071|41691984|FG009|Overall Study|Moved|0|||
19444176|NCT01995071|41691985|FG010|Overall Study|Moved|1|||
19444177|NCT01995071|41691986|FG011|Overall Study|Moved|0|||
19444178|NCT01995071|41691975|FG000|Overall Study|Lost to Follow-up|1|||
19444179|NCT01995071|41691976|FG001|Overall Study|Lost to Follow-up|0|||
19444180|NCT01995071|41691977|FG002|Overall Study|Lost to Follow-up|0|||
19444181|NCT01995071|41691978|FG003|Overall Study|Lost to Follow-up|0|||
19444182|NCT01995071|41691979|FG004|Overall Study|Lost to Follow-up|0|||
19444183|NCT01995071|41691980|FG005|Overall Study|Lost to Follow-up|0|||
19444184|NCT01995071|41691981|FG006|Overall Study|Lost to Follow-up|0|||
19444185|NCT01995071|41691982|FG007|Overall Study|Lost to Follow-up|1|||
19444186|NCT01995071|41691983|FG008|Overall Study|Lost to Follow-up|1|||
19444187|NCT01995071|41691984|FG009|Overall Study|Lost to Follow-up|0|||
19444188|NCT01995071|41691985|FG010|Overall Study|Lost to Follow-up|0|||
19444189|NCT01995071|41691986|FG011|Overall Study|Lost to Follow-up|0|||
19444190|NCT01995071|41691975|FG000|Overall Study|Incarcerated|0|||
19444191|NCT01995071|41691976|FG001|Overall Study|Incarcerated|0|||
19444192|NCT01995071|41691977|FG002|Overall Study|Incarcerated|0|||
19444193|NCT01995071|41691978|FG003|Overall Study|Incarcerated|0|||
19444194|NCT01995071|41691979|FG004|Overall Study|Incarcerated|0|||
19444195|NCT01995071|41691980|FG005|Overall Study|Incarcerated|0|||
19444196|NCT01995071|41691981|FG006|Overall Study|Incarcerated|0|||
19444197|NCT01995071|41691982|FG007|Overall Study|Incarcerated|1|||
19444198|NCT01995071|41691983|FG008|Overall Study|Incarcerated|0|||
19444199|NCT01995071|41691984|FG009|Overall Study|Incarcerated|0|||
19444200|NCT01995071|41691985|FG010|Overall Study|Incarcerated|0|||
19444201|NCT01995071|41691986|FG011|Overall Study|Incarcerated|0|||
19444202|NCT01994837|41692018|FG000|Overall Study|Progressive disease per protocol|23|||
19444203|NCT01994837|41692018|FG000|Overall Study|Adv event related to progressive disease|3|||
19444204|NCT01994837|41692018|FG000|Overall Study|Fatal progressive disease|2|||
19444205|NCT01994837|41692018|FG000|Overall Study|Adverse event not related to progression|1|||
19444206|NCT01994837|41692018|FG000|Overall Study|Chose palliative care|1|||
19444207|NCT01994837|41692018|FG000|Overall Study|Proceeded to transplant|1|||
19444208|NCT01994837|41692018|FG000|Overall Study|Removed from study due to no response|1|||
19444209|NCT02010593|41692024|FG000|Overall Study|Lost to Follow-up|1|||
19523344|NCT03252522|41959423|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
19444210|NCT02010593|41692025|FG001|Overall Study|Lost to Follow-up|0|||
19444211|NCT02010593|41692024|FG000|Overall Study|Physician Decision|1|||
19444212|NCT02010593|41692025|FG001|Overall Study|Physician Decision|0|||
19523345|NCT03252522|41959424|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
19444213|NCT02010593|41692024|FG000|Overall Study|Unable to adhere to visit schedule|0|||
19444214|NCT02010593|41692025|FG001|Overall Study|Unable to adhere to visit schedule|2|||
19444215|NCT01994291|41692034|FG000|Overall Study|Adverse Event|4|||
19444216|NCT01994291|41692035|FG001|Overall Study|Adverse Event|1|||
19444217|NCT01994291|41692036|FG002|Overall Study|Adverse Event|3|||
19444218|NCT01994291|41692034|FG000|Overall Study|Lost to Follow-up|1|||
19444219|NCT01994291|41692035|FG001|Overall Study|Lost to Follow-up|1|||
19444220|NCT01994291|41692036|FG002|Overall Study|Lost to Follow-up|0|||
19444221|NCT01994291|41692034|FG000|Overall Study|Does not meet entrance criteria|1|||
19444222|NCT01994291|41692035|FG001|Overall Study|Does not meet entrance criteria|0|||
19444223|NCT01994291|41692036|FG002|Overall Study|Does not meet entrance criteria|0|||
19444224|NCT01994291|41692034|FG000|Overall Study|Medication error without associated AE|1|||
19444225|NCT01994291|41692035|FG001|Overall Study|Medication error without associated AE|0|||
19444226|NCT01994291|41692036|FG002|Overall Study|Medication error without associated AE|1|||
19444227|NCT01994291|41692034|FG000|Overall Study|Protocol Violation|1|||
19444228|NCT01994291|41692035|FG001|Overall Study|Protocol Violation|0|||
19444229|NCT01994291|41692036|FG002|Overall Study|Protocol Violation|0|||
19444230|NCT01994291|41692034|FG000|Overall Study|Withdrawal by Subject|6|||
19444231|NCT01994291|41692035|FG001|Overall Study|Withdrawal by Subject|3|||
19523346|NCT03252522|41959425|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
19523347|NCT03252522|41959423|FG000|Phase 2: Open Label|Adverse Event|0|||
19523348|NCT03252522|41959424|FG001|Phase 2: Open Label|Adverse Event|0|||
19523349|NCT03252522|41959425|FG002|Phase 2: Open Label|Adverse Event|2|||
19523350|NCT03252522|41959423|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
19523351|NCT03252522|41959424|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
19523352|NCT03252522|41959425|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
19523353|NCT02828358|41959439|FG000|Overall Study|Physician Decision|7|||
19523354|NCT02828358|41959440|FG001|Overall Study|Physician Decision|1|||
19523355|NCT02828358|41959439|FG000|Overall Study|Treatment Failure|6|||
19523356|NCT02828358|41959440|FG001|Overall Study|Treatment Failure|0|||
19523357|NCT02828358|41959439|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
19523358|NCT02828358|41959440|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
19523359|NCT02828358|41959439|FG000|Overall Study|Refusal of further protocol therapy|2|||
19523360|NCT02828358|41959440|FG001|Overall Study|Refusal of further protocol therapy|0|||
19523361|NCT02828358|41959439|FG000|Overall Study|Relapse|25|||
19523362|NCT02828358|41959440|FG001|Overall Study|Relapse|0|||
19523363|NCT02828358|41959439|FG000|Overall Study|Still on therapy|5|||
19523364|NCT02828358|41959440|FG001|Overall Study|Still on therapy|0|||
19523365|NCT02756364|41959448|FG000|Overall Study|Site Terminated by Sponsor|24|||
19523366|NCT02756364|41959449|FG001|Overall Study|Site Terminated by Sponsor|30|||
19523367|NCT02756364|41959450|FG002|Overall Study|Site Terminated by Sponsor|21|||
19523368|NCT02756364|41959448|FG000|Overall Study|Death|20|||
19523369|NCT02756364|41959449|FG001|Overall Study|Death|15|||
19629047|NCT00642616|42078614|FG000|Overall Study|Study Terminated by Sponsor|7|||
19629048|NCT00642616|42078615|FG001|Overall Study|Study Terminated by Sponsor|6|||
19629049|NCT00642616|42078616|FG002|Overall Study|Study Terminated by Sponsor|4|||
19629050|NCT00642616|42078617|FG003|Overall Study|Study Terminated by Sponsor|5|||
19629051|NCT00642616|42078614|FG000|Overall Study|Withdrawal by Subject|0|||
19629052|NCT00642616|42078615|FG001|Overall Study|Withdrawal by Subject|1|||
19629053|NCT00642616|42078616|FG002|Overall Study|Withdrawal by Subject|1|||
19629054|NCT00642616|42078617|FG003|Overall Study|Withdrawal by Subject|1|||
19629055|NCT00642616|42078614|FG000|Overall Study|Protocol Violation|0|||
19629056|NCT00642616|42078615|FG001|Overall Study|Protocol Violation|0|||
19629057|NCT00642616|42078616|FG002|Overall Study|Protocol Violation|2|||
19629058|NCT00642616|42078617|FG003|Overall Study|Protocol Violation|0|||
19629059|NCT00642616|42078614|FG000|Overall Study|Physician Decision|0|||
19629060|NCT00642616|42078615|FG001|Overall Study|Physician Decision|0|||
19629061|NCT00642616|42078616|FG002|Overall Study|Physician Decision|1|||
19629062|NCT00642616|42078617|FG003|Overall Study|Physician Decision|1|||
19629063|NCT03844945|42078633|FG000|Overall Study|Adverse Event|1|||
19629064|NCT03844945|42078634|FG001|Overall Study|Adverse Event|1|||
19629065|NCT03844945|42078635|FG002|Overall Study|Adverse Event|4|||
19629066|NCT03844945|42078636|FG003|Overall Study|Adverse Event|0|||
19444232|NCT01994291|41692036|FG002|Overall Study|Withdrawal by Subject|5|||
19444233|NCT01994291|41692034|FG000|Overall Study|Other|1|||
19444234|NCT01994291|41692035|FG001|Overall Study|Other|2|||
19444235|NCT01994291|41692036|FG002|Overall Study|Other|0|||
19523370|NCT02756364|41959450|FG002|Overall Study|Death|18|||
19629067|NCT03844945|42078633|FG000|Overall Study|Withdrawal by Subject|0|||
19629068|NCT03844945|42078634|FG001|Overall Study|Withdrawal by Subject|0|||
19629069|NCT03844945|42078635|FG002|Overall Study|Withdrawal by Subject|1|||
19629070|NCT03844945|42078636|FG003|Overall Study|Withdrawal by Subject|0|||
19444236|NCT02094677|41692047|FG000|Overall Study|Screening|3|||
19444237|NCT02094677|41692048|FG001|Overall Study|Screening|1|||
19444238|NCT01993823|41692063|FG000|Overall Study|Requested by the patient|6|||
19444239|NCT01993823|41692064|FG001|Overall Study|Requested by the patient|11|||
19523371|NCT02756364|41959448|FG000|Overall Study|Withdrawal by Patient|2|||
19523372|NCT02756364|41959449|FG001|Overall Study|Withdrawal by Patient|1|||
19523373|NCT02756364|41959450|FG002|Overall Study|Withdrawal by Patient|8|||
19523374|NCT02756364|41959448|FG000|Overall Study|Lost to Follow-up|0|||
19523375|NCT02756364|41959449|FG001|Overall Study|Lost to Follow-up|1|||
19523376|NCT02756364|41959450|FG002|Overall Study|Lost to Follow-up|1|||
19523377|NCT02272842|41959460|FG000|Overall Study|Lost to Follow-up|8|||
19523378|NCT02272842|41959461|FG001|Overall Study|Lost to Follow-up|8|||
19523379|NCT02272842|41959460|FG000|Overall Study|Withdrawal by Subject|8|||
19523380|NCT02272842|41959461|FG001|Overall Study|Withdrawal by Subject|2|||
19523381|NCT01906476|41959470|FG000|Overall Study|Lost to Follow-up|17|||
19444240|NCT01993823|41692063|FG000|Overall Study|Protocol Violation|0|||
19444241|NCT01993823|41692064|FG001|Overall Study|Protocol Violation|1|||
19444242|NCT01993823|41692063|FG000|Overall Study|Lost to Follow-up|1|||
19523382|NCT01906476|41959471|FG001|Overall Study|Lost to Follow-up|16|||
19523383|NCT05343624|41959477|FG000|Overall Study|Chart review not completed|1|||
19444243|NCT01993823|41692064|FG001|Overall Study|Lost to Follow-up|4|||
19444244|NCT01993667|41692072|FG000|Overall Study|Insufficient data to analyze|16|||
19444245|NCT01993667|41692073|FG001|Overall Study|Insufficient data to analyze|16|||
19444246|NCT01993667|41692072|FG000|Overall Study|Insufficient altitude reached|3|||
19444247|NCT01993667|41692073|FG001|Overall Study|Insufficient altitude reached|1|||
19444248|NCT01993667|41692072|FG000|Overall Study|Lost to Follow-up|2|||
19444249|NCT01993667|41692073|FG001|Overall Study|Lost to Follow-up|2|||
19444250|NCT01992107|41692082|FG000|Overall Study|Administrative reasons|2|||
19444251|NCT01992107|41692083|FG001|Overall Study|Administrative reasons|0|||
19444252|NCT01992107|41692084|FG002|Overall Study|Administrative reasons|0|||
19444253|NCT01992107|41692082|FG000|Overall Study|Adverse Event|0|||
19444254|NCT01992107|41692083|FG001|Overall Study|Adverse Event|1|||
19444255|NCT01992107|41692084|FG002|Overall Study|Adverse Event|0|||
19444256|NCT01992107|41692082|FG000|Overall Study|Lost to Follow-up|46|||
19444257|NCT01992107|41692083|FG001|Overall Study|Lost to Follow-up|22|||
19444258|NCT01992107|41692084|FG002|Overall Study|Lost to Follow-up|26|||
19444259|NCT01992107|41692082|FG000|Overall Study|noncompliance and were unavailable|7|||
19444260|NCT01992107|41692083|FG001|Overall Study|noncompliance and were unavailable|3|||
19444261|NCT01992107|41692084|FG002|Overall Study|noncompliance and were unavailable|2|||
19444262|NCT01992107|41692082|FG000|Overall Study|Withdrawal by Subject|13|||
19444263|NCT01992107|41692083|FG001|Overall Study|Withdrawal by Subject|7|||
19444264|NCT01992107|41692084|FG002|Overall Study|Withdrawal by Subject|8|||
19444265|NCT01934192|41692113|FG000|Overall Study|Protocol Violation|0|||
19444266|NCT01934192|41692114|FG001|Overall Study|Protocol Violation|0|||
19444267|NCT01934192|41692115|FG002|Overall Study|Protocol Violation|0|||
19444268|NCT01934192|41692116|FG003|Overall Study|Protocol Violation|1|||
19444269|NCT01934192|41692113|FG000|Overall Study|Other: reached stopping criteria|6|||
19444270|NCT01934192|41692114|FG001|Overall Study|Other: reached stopping criteria|5|||
19444271|NCT01934192|41692115|FG002|Overall Study|Other: reached stopping criteria|1|||
19444272|NCT01934192|41692116|FG003|Overall Study|Other: reached stopping criteria|0|||
19444273|NCT01934192|41692113|FG000|Overall Study|Physician Decision|3|||
19444274|NCT01934192|41692114|FG001|Overall Study|Physician Decision|2|||
19444275|NCT01934192|41692115|FG002|Overall Study|Physician Decision|0|||
19444276|NCT01934192|41692116|FG003|Overall Study|Physician Decision|0|||
19444277|NCT01933880|41692139|FG000|Overall Study|Withdrawal by Subject|5|||
19444278|NCT01933880|41692140|FG001|Overall Study|Withdrawal by Subject|0|||
19444279|NCT01933880|41692139|FG000|Overall Study|Lack of Efficacy|1|||
19444280|NCT01933880|41692140|FG001|Overall Study|Lack of Efficacy|0|||
19444281|NCT01933880|41692139|FG000|Overall Study|Concomitant medication Interference|0|||
19444282|NCT01933880|41692140|FG001|Overall Study|Concomitant medication Interference|1|||
19444283|NCT01933880|41692139|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
19444284|NCT01933880|41692140|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
19444285|NCT01933880|41692139|FG000|Overall Study|Other|4|||
19444286|NCT01933880|41692140|FG001|Overall Study|Other|0|||
19444287|NCT01933880|41692139|FG000|Overall Study|Protocol Violation|1|||
19444288|NCT01933880|41692140|FG001|Overall Study|Protocol Violation|0|||
19444289|NCT02008877|41692151|FG000|Overall Study|Inevaluable|0|||
19444290|NCT02008877|41692152|FG001|Overall Study|Inevaluable|1|||
19444291|NCT02008877|41692153|FG002|Overall Study|Inevaluable|0|||
19523384|NCT04208412|41959519|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
19523385|NCT04208412|41959520|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
19444292|NCT01933334|41692164|FG000|Overall Study|Adverse Event|5|||
19444293|NCT01933334|41692165|FG001|Overall Study|Adverse Event|1|||
19444294|NCT01933334|41692164|FG000|Overall Study|Withdrawal by Subject|0|||
19444295|NCT01933334|41692165|FG001|Overall Study|Withdrawal by Subject|1|||
19444296|NCT01932788|41692173|FG000|Overall Study|Protocol Violation|18|||
19444297|NCT01932788|41692174|FG001|Overall Study|Protocol Violation|0|||
19444298|NCT01932788|41692173|FG000|Overall Study|Lost to Follow-up|18|||
19444299|NCT01932788|41692174|FG001|Overall Study|Lost to Follow-up|46|||
19444300|NCT01932788|41692173|FG000|Overall Study|Lack of Efficacy|2|||
19444301|NCT01932788|41692174|FG001|Overall Study|Lack of Efficacy|0|||
19444302|NCT01932788|41692173|FG000|Overall Study|Withdrawal by Subject|0|||
19444303|NCT01932788|41692174|FG001|Overall Study|Withdrawal by Subject|5|||
19444304|NCT01908140|41692182|FG000|Overall Study|Other or Progressive Disease|5|||
19444305|NCT01908140|41692183|FG001|Overall Study|Other or Progressive Disease|12|||
19444306|NCT01908140|41692182|FG000|Overall Study|Lack of Efficacy|7|||
19444307|NCT01908140|41692183|FG001|Overall Study|Lack of Efficacy|5|||
19444308|NCT01908140|41692182|FG000|Overall Study|Withdrawal by Subject|23|||
19523386|NCT04208412|41959519|FG000|Overall Study|Withdrawal by Subject|1|||
19523387|NCT04208412|41959520|FG001|Overall Study|Withdrawal by Subject|0|||
19444309|NCT01908140|41692183|FG001|Overall Study|Withdrawal by Subject|24|||
19444310|NCT01908140|41692182|FG000|Overall Study|Lost to Follow-up|1|||
19444311|NCT01908140|41692183|FG001|Overall Study|Lost to Follow-up|6|||
19444312|NCT01908140|41692182|FG000|Overall Study|Protocol Violation|8|||
19444313|NCT01908140|41692183|FG001|Overall Study|Protocol Violation|9|||
19444314|NCT01908140|41692182|FG000|Overall Study|Adverse Event|22|||
19444315|NCT01908140|41692183|FG001|Overall Study|Adverse Event|23|||
19444316|NCT02008565|41692193|FG000|Overall Study|Protocol Violation|1|||
19444317|NCT02008565|41692194|FG001|Overall Study|Protocol Violation|1|||
19444318|NCT02008565|41692195|FG002|Overall Study|Protocol Violation|2|||
19444319|NCT02008565|41692196|FG003|Overall Study|Protocol Violation|0|||
19444320|NCT01907906|41692210|FG000|Overall Study|Withdrawal by Subject|1|||
19444321|NCT01907906|41692211|FG001|Overall Study|Withdrawal by Subject|0|||
19444322|NCT01907906|41692210|FG000|Overall Study|Physician Decision|3|||
19444323|NCT01907906|41692211|FG001|Overall Study|Physician Decision|1|||
19444324|NCT01907828|41692221|FG000|Overall Study|Exclusion criteria not met|0|||
19444325|NCT01907828|41692222|FG001|Overall Study|Exclusion criteria not met|1|||
19444326|NCT01907828|41692221|FG000|Overall Study|Withdrawal by Subject|3|||
19444327|NCT01907828|41692222|FG001|Overall Study|Withdrawal by Subject|4|||
19444328|NCT01907828|41692221|FG000|Overall Study|Lost to Follow-up|3|||
19444329|NCT01907828|41692222|FG001|Overall Study|Lost to Follow-up|0|||
19444330|NCT01907828|41692221|FG000|Overall Study|Participant refused 24-month follow-up|1|||
19444331|NCT01907828|41692222|FG001|Overall Study|Participant refused 24-month follow-up|0|||
19444332|NCT01907828|41692221|FG000|Overall Study|Participant met exclusion criteria|0|||
19444333|NCT01907828|41692222|FG001|Overall Study|Participant met exclusion criteria|1|||
19444334|NCT01907516|41692230|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
19444335|NCT01907516|41692231|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
19444336|NCT01907516|41692230|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
19444337|NCT01907516|41692231|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
19444338|NCT01907516|41692230|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
19444339|NCT01907516|41692231|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
19444340|NCT01907516|41692230|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
19444341|NCT01907516|41692231|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
19444342|NCT01931462|41692238|FG000|Overall Study|Withdrawal by Subject|1|||
19523388|NCT04208412|41959519|FG000|Overall Study|Lost to Follow-up|0|||
19711321|NCT03572062|42154402|FG007|Overall Study|Withdrawal by Subject|0|||
19444343|NCT01931150|41692244|FG000|Overall Study|Withdrawal by Subject|1|||
19444344|NCT01931150|41692245|FG001|Overall Study|Withdrawal by Subject|2|||
19444345|NCT01930214|41692254|FG000|Overall Study|Death|4|||
19444346|NCT01930214|41692255|FG001|Overall Study|Death|4|||
19444347|NCT01930214|41692256|FG002|Overall Study|Death|11|||
19444348|NCT01930214|41692254|FG000|Overall Study|Lost to Follow-up|12|||
19444349|NCT01930214|41692255|FG001|Overall Study|Lost to Follow-up|13|||
19444350|NCT01930214|41692256|FG002|Overall Study|Lost to Follow-up|12|||
19444351|NCT01930214|41692254|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
19444352|NCT01930214|41692255|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
19444353|NCT01930214|41692256|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
19444354|NCT01930214|41692254|FG000|Overall Study|Physician Decision|2|||
19444355|NCT01930214|41692255|FG001|Overall Study|Physician Decision|0|||
19444356|NCT01930214|41692256|FG002|Overall Study|Physician Decision|0|||
19444357|NCT01958294|41692264|FG000|Overall Study|Clinical Circumstances|2|||
19444358|NCT01906346|41692268|FG000|Overall Study|AEs|1|||
19444359|NCT01958060|41692280|FG000|Overall Study|Not treated|2|||
19444360|NCT01958060|41692281|FG001|Overall Study|Not treated|0|||
19444361|NCT01958060|41692282|FG002|Overall Study|Not treated|0|||
19444362|NCT01958060|41692283|FG003|Overall Study|Not treated|0|||
19444363|NCT01958060|41692284|FG004|Overall Study|Not treated|1|||
19444364|NCT01958060|41692285|FG005|Overall Study|Not treated|0|||
19523389|NCT04208412|41959520|FG001|Overall Study|Lost to Follow-up|1|||
19523390|NCT04095858|41959530|FG000|Overall Study|Death|1|||
19444365|NCT01929980|41692304|FG000|Overall Study|Physician Decision|1|||
19523391|NCT04095858|41959531|FG001|Overall Study|Death|0|||
19523392|NCT04095858|41959530|FG000|Overall Study|Study terminated by Sponsor|2|||
19523393|NCT04095858|41959531|FG001|Overall Study|Study terminated by Sponsor|4|||
19523394|NCT03937986|41959537|FG000|Overall Study|COVID-19 Pandemic|1|||
19523395|NCT03738150|41959552|FG000|Base Study|Withdrawal by Subject|1|||
19523396|NCT03738150|41959552|FG000|Extension Study|Withdrawal by Subject|1|||
19523397|NCT03567174|41959568|FG000|Overall Study|Death|24|||
19523398|NCT03567174|41959569|FG001|Overall Study|Death|31|||
19523399|NCT03567174|41959568|FG000|Overall Study|Lost to Follow-up|165|||
19444366|NCT01363076|41692310|FG000|Overall Study|Withdrawal by Subject|0|||
19444367|NCT01363076|41692311|FG001|Overall Study|Withdrawal by Subject|1|||
19444368|NCT01929044|41692319|FG000|Overall Study|Adverse Event|1|||
19444369|NCT01929044|41692320|FG001|Overall Study|Adverse Event|0|||
19444370|NCT01929044|41692319|FG000|Overall Study|Protocol Violation|9|||
19444371|NCT01929044|41692320|FG001|Overall Study|Protocol Violation|14|||
19444372|NCT01929044|41692319|FG000|Overall Study|Not Treated|1|||
19444373|NCT01929044|41692320|FG001|Overall Study|Not Treated|3|||
19444374|NCT01903460|41692330|FG000|Overall Study|Adverse Event|0|||
19444375|NCT01903460|41692331|FG001|Overall Study|Adverse Event|0|||
19444376|NCT01903460|41692332|FG002|Overall Study|Adverse Event|0|||
19444377|NCT01903460|41692333|FG003|Overall Study|Adverse Event|1|||
19444378|NCT01957202|41692342|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444379|NCT01957202|41692343|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
19444380|NCT01957202|41692344|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444381|NCT01957202|41692345|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444382|NCT01957202|41692346|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444383|NCT01957202|41692347|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444384|NCT01957202|41692348|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444385|NCT01957202|41692349|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444386|NCT01957202|41692350|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444387|NCT01957202|41692351|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444388|NCT01957202|41692352|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444389|NCT01957202|41692353|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444390|NCT01957202|41692354|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444391|NCT01957202|41692355|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444392|NCT01957202|41692356|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444393|NCT01957202|41692357|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444394|NCT01957202|41692358|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
19444395|NCT01957202|41692359|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
19444396|NCT01957202|41692342|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444397|NCT01957202|41692343|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444398|NCT01957202|41692344|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444399|NCT01957202|41692345|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444400|NCT01957202|41692346|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444401|NCT01957202|41692347|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444402|NCT01957202|41692348|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444403|NCT01957202|41692349|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444404|NCT01957202|41692350|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444405|NCT01957202|41692351|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444406|NCT01957202|41692352|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444407|NCT01957202|41692353|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444408|NCT01957202|41692354|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444409|NCT01957202|41692355|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444410|NCT01957202|41692356|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444411|NCT01957202|41692357|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444412|NCT01957202|41692358|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
19444413|NCT01957202|41692359|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
19444414|NCT01616654|41692374|FG000|Overall Study|Lack of Efficacy|1|||
19444415|NCT01616654|41692375|FG001|Overall Study|Lack of Efficacy|0|||
19444416|NCT01616654|41692376|FG002|Overall Study|Lack of Efficacy|0|||
19523400|NCT03567174|41959569|FG001|Overall Study|Lost to Follow-up|174|||
19523401|NCT03529110|41959580|FG000|Overall Study|Progressive Disease|66|||
19523402|NCT03529110|41959581|FG001|Overall Study|Progressive Disease|158|||
19523403|NCT03529110|41959580|FG000|Overall Study|Clinical Progression|4|||
19523404|NCT03529110|41959581|FG001|Overall Study|Clinical Progression|12|||
19523405|NCT03529110|41959580|FG000|Overall Study|Adverse Event|35|||
19523406|NCT03529110|41959581|FG001|Overall Study|Adverse Event|17|||
19523407|NCT03529110|41959580|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
19523408|NCT03529110|41959581|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
19523409|NCT03529110|41959580|FG000|Overall Study|Lack of Efficacy|3|||
19444417|NCT01616654|41692377|FG003|Overall Study|Lack of Efficacy|0|||
19444418|NCT01616654|41692378|FG004|Overall Study|Lack of Efficacy|1|||
19444419|NCT01616654|41692374|FG000|Overall Study|Adverse Event|0|||
19444420|NCT01616654|41692375|FG001|Overall Study|Adverse Event|1|||
19523410|NCT03529110|41959581|FG001|Overall Study|Lack of Efficacy|3|||
19523411|NCT03529110|41959580|FG000|Overall Study|Physician Decision|2|||
19523412|NCT03529110|41959581|FG001|Overall Study|Physician Decision|8|||
19523413|NCT03529110|41959580|FG000|Overall Study|Miscellaneous|2|||
19523414|NCT03529110|41959581|FG001|Overall Study|Miscellaneous|5|||
19523415|NCT02663622|41959625|FG000|Overall Study|Death|3|||
19523416|NCT02663622|41959626|FG001|Overall Study|Death|1|||
19523417|NCT02663622|41959627|FG002|Overall Study|Death|1|||
19444421|NCT01616654|41692376|FG002|Overall Study|Adverse Event|2|||
19444422|NCT01616654|41692377|FG003|Overall Study|Adverse Event|1|||
19444423|NCT01616654|41692378|FG004|Overall Study|Adverse Event|0|||
19444424|NCT01616654|41692374|FG000|Overall Study|Withdrawal by Subject|2|||
19444425|NCT01616654|41692375|FG001|Overall Study|Withdrawal by Subject|2|||
19444426|NCT01616654|41692376|FG002|Overall Study|Withdrawal by Subject|3|||
19444427|NCT01616654|41692377|FG003|Overall Study|Withdrawal by Subject|1|||
19444428|NCT01616654|41692378|FG004|Overall Study|Withdrawal by Subject|5|||
19523418|NCT02663622|41959628|FG003|Overall Study|Death|8|||
19523419|NCT02663622|41959625|FG000|Overall Study|Protocol Violation|0|||
19444429|NCT01616654|41692374|FG000|Overall Study|Protocol Violation|0|||
19444430|NCT01616654|41692375|FG001|Overall Study|Protocol Violation|5|||
19444431|NCT01616654|41692376|FG002|Overall Study|Protocol Violation|2|||
19444432|NCT01616654|41692377|FG003|Overall Study|Protocol Violation|4|||
19444433|NCT01616654|41692378|FG004|Overall Study|Protocol Violation|4|||
19523420|NCT02663622|41959626|FG001|Overall Study|Protocol Violation|0|||
19523421|NCT02663622|41959627|FG002|Overall Study|Protocol Violation|0|||
19523422|NCT02663622|41959628|FG003|Overall Study|Protocol Violation|1|||
19523423|NCT02545998|41959654|FG000|Overall Study|Lost to Follow-up|12|||
19523424|NCT02545998|41959655|FG001|Overall Study|Lost to Follow-up|3|||
19523425|NCT02545998|41959654|FG000|Overall Study|Withdrawal by Subject|3|||
19523426|NCT02545998|41959655|FG001|Overall Study|Withdrawal by Subject|2|||
19523427|NCT02257242|41959679|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
19523428|NCT02257242|41959680|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19523429|NCT02257242|41959681|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19523430|NCT02257242|41959682|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19523431|NCT02257242|41959683|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19523432|NCT02257242|41959684|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19444434|NCT01616654|41692374|FG000|Overall Study|Lost to Follow-up|1|||
19444435|NCT01616654|41692375|FG001|Overall Study|Lost to Follow-up|0|||
19444436|NCT01616654|41692376|FG002|Overall Study|Lost to Follow-up|3|||
19444437|NCT01616654|41692377|FG003|Overall Study|Lost to Follow-up|2|||
19444438|NCT01616654|41692378|FG004|Overall Study|Lost to Follow-up|1|||
19444439|NCT01616654|41692374|FG000|Overall Study|Pregnancy|1|||
19444440|NCT01616654|41692375|FG001|Overall Study|Pregnancy|0|||
19444441|NCT01616654|41692376|FG002|Overall Study|Pregnancy|0|||
19444442|NCT01616654|41692377|FG003|Overall Study|Pregnancy|0|||
19444443|NCT01616654|41692378|FG004|Overall Study|Pregnancy|1|||
19444444|NCT01902290|41692393|FG000|Overall Study|Withdrawal by Subject|19|||
19444445|NCT01902290|41692394|FG001|Overall Study|Withdrawal by Subject|27|||
19444446|NCT01902290|41692393|FG000|Overall Study|Lost to Follow-up|2|||
19444447|NCT01902290|41692394|FG001|Overall Study|Lost to Follow-up|2|||
19444448|NCT01902290|41692393|FG000|Overall Study|Death|1|||
19444449|NCT01902290|41692394|FG001|Overall Study|Death|0|||
19523433|NCT02257242|41959685|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19444450|NCT01902290|41692393|FG000|Overall Study|Sponsor Decision|26|||
19444451|NCT01902290|41692394|FG001|Overall Study|Sponsor Decision|24|||
19444452|NCT01927562|41692401|FG000|Overall Study|Lost to Follow-up|30|||
19444453|NCT01927562|41692401|FG000|Overall Study|Withdrawal by Subject|3|||
19444454|NCT01927562|41692401|FG000|Overall Study|Physician Decision|5|||
19444455|NCT01467466|41692409|FG000|Overall Study|Withdrawal by Subject|15|||
19444456|NCT01467466|41692410|FG001|Overall Study|Withdrawal by Subject|18|||
19444457|NCT01467466|41692411|FG002|Overall Study|Withdrawal by Subject|13|||
19444458|NCT01467466|41692412|FG003|Overall Study|Withdrawal by Subject|11|||
19444459|NCT01467466|41692409|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
19444460|NCT01467466|41692410|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
19523434|NCT02257242|41959686|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19523435|NCT02257242|41959687|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
19629071|NCT03844945|42078633|FG000|Overall Study|Lack of Efficacy|0|||
19444461|NCT01467466|41692411|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
19444462|NCT01467466|41692412|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
19444463|NCT01467466|41692409|FG000|Overall Study|Procedure Cancelled|46|||
19444464|NCT01467466|41692410|FG001|Overall Study|Procedure Cancelled|45|||
19444465|NCT01467466|41692411|FG002|Overall Study|Procedure Cancelled|25|||
19629072|NCT03844945|42078634|FG001|Overall Study|Lack of Efficacy|0|||
19444466|NCT01467466|41692412|FG003|Overall Study|Procedure Cancelled|29|||
19444467|NCT01467466|41692409|FG000|Overall Study|No Endpoint Blood Draw|38|||
19444468|NCT01467466|41692410|FG001|Overall Study|No Endpoint Blood Draw|32|||
19444469|NCT01467466|41692411|FG002|Overall Study|No Endpoint Blood Draw|51|||
19523436|NCT01943916|41959717|FG000|Overall Study|Technically invalid images|10|||
19523437|NCT01943916|41959717|FG000|Overall Study|Enrollment Failure|23|||
19523438|NCT01943916|41959717|FG000|Overall Study|Pilot Phase exclusion|100|||
19523439|NCT01943916|41959717|FG000|Overall Study|Quality Assurance Reader Fail|130|||
19523440|NCT01943916|41959717|FG000|Overall Study|Technical Failure|39|||
19523441|NCT01943916|41959717|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
19444470|NCT01467466|41692412|FG003|Overall Study|No Endpoint Blood Draw|43|||
19523442|NCT01943916|41959717|FG000|Overall Study|No Truth Panel Review|38|||
19523443|NCT01943916|41959717|FG000|Overall Study|Protocol Deviation|1|||
19523444|NCT01564368|41959726|FG000|Overall Study|Ineligible|18|||
19523445|NCT01564368|41959726|FG000|Overall Study|Not Randomized in Parent study|116|||
19523446|NCT01564368|41959726|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
19523447|NCT01564368|41959726|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
19523448|NCT00777036|41959735|FG000|On Treatment|Reason Not Specified|4|||
19523449|NCT00777036|41959736|FG001|On Treatment|Reason Not Specified|7|||
19523450|NCT00777036|41959737|FG002|On Treatment|Reason Not Specified|12|||
19444471|NCT01441180|41692425|FG000|Overall Study|Lost to Follow-up|1|||
19444472|NCT01441180|41692426|FG001|Overall Study|Lost to Follow-up|1|||
19444473|NCT01441180|41692427|FG002|Overall Study|Lost to Follow-up|1|||
19444474|NCT01441180|41692425|FG000|Overall Study|Discontinued|0|||
19444475|NCT01441180|41692426|FG001|Overall Study|Discontinued|0|||
19444476|NCT01441180|41692427|FG002|Overall Study|Discontinued|2|||
19444477|NCT01441102|41692438|FG000|Overall Study|Adverse Event|1|||
19444478|NCT01441102|41692438|FG000|Overall Study|Withdrawal by Subject|2|||
19444479|NCT01467076|41692445|FG000|Overall Study|Lost to Follow-up|1|||
19444480|NCT01467076|41692446|FG001|Overall Study|Lost to Follow-up|0|||
19444481|NCT01467076|41692447|FG002|Overall Study|Lost to Follow-up|0|||
19444482|NCT01466062|41692455|FG000|Overall Study|Adverse Event|1|||
19444483|NCT01466062|41692455|FG000|Overall Study|Withdrawal by Subject|1|||
19444484|NCT01435018|41692462|FG000|Overall Study|Death|37|||
19444485|NCT01435018|41692463|FG001|Overall Study|Death|18|||
19444486|NCT01435018|41692464|FG002|Overall Study|Death|25|||
19444487|NCT01435018|41692462|FG000|Overall Study|Site is closing|4|||
19444488|NCT01435018|41692463|FG001|Overall Study|Site is closing|9|||
19444489|NCT01435018|41692464|FG002|Overall Study|Site is closing|7|||
19444490|NCT01435018|41692462|FG000|Overall Study|Withdrew consent|0|||
19444491|NCT01435018|41692463|FG001|Overall Study|Withdrew consent|3|||
19444492|NCT01435018|41692464|FG002|Overall Study|Withdrew consent|1|||
19444493|NCT01435018|41692462|FG000|Overall Study|Not willing to adhere to requirements|0|||
19444494|NCT01435018|41692463|FG001|Overall Study|Not willing to adhere to requirements|2|||
19444495|NCT01435018|41692464|FG002|Overall Study|Not willing to adhere to requirements|3|||
19444496|NCT01435018|41692462|FG000|Overall Study|Not able to get to clinic|2|||
19444497|NCT01435018|41692463|FG001|Overall Study|Not able to get to clinic|0|||
19444498|NCT01435018|41692464|FG002|Overall Study|Not able to get to clinic|2|||
19444499|NCT01435018|41692462|FG000|Overall Study|Severe debilitation, unable to continue|0|||
19444500|NCT01435018|41692463|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19523451|NCT00777036|41959735|FG000|On Treatment|Failure to Meet Study Criteria|0|||
19523452|NCT00777036|41959736|FG001|On Treatment|Failure to Meet Study Criteria|1|||
19523453|NCT00777036|41959737|FG002|On Treatment|Failure to Meet Study Criteria|0|||
19523454|NCT00777036|41959735|FG000|On Treatment|Non-compliance with Study Drug|1|||
19523455|NCT00777036|41959736|FG001|On Treatment|Non-compliance with Study Drug|0|||
19523456|NCT00777036|41959737|FG002|On Treatment|Non-compliance with Study Drug|0|||
19444501|NCT01435018|41692464|FG002|Overall Study|Severe debilitation, unable to continue|1|||
19444502|NCT01435018|41692462|FG000|Overall Study|Unable to contact participant/parent|1|||
19444503|NCT01435018|41692463|FG001|Overall Study|Unable to contact participant/parent|1|||
19444504|NCT01435018|41692464|FG002|Overall Study|Unable to contact participant/parent|1|||
19444505|NCT01435018|41692462|FG000|Overall Study|Enrollment Violation|0|||
19444506|NCT01435018|41692463|FG001|Overall Study|Enrollment Violation|1|||
19444507|NCT01435018|41692464|FG002|Overall Study|Enrollment Violation|0|||
19444508|NCT01435018|41692462|FG000|Overall Study|Never started chemotherapy|3|||
19444509|NCT01435018|41692463|FG001|Overall Study|Never started chemotherapy|0|||
19444510|NCT01435018|41692464|FG002|Overall Study|Never started chemotherapy|1|||
19523457|NCT00777036|41959735|FG000|On Treatment|Maximum Clinical Benefit|2|||
19444511|NCT01419184|41692476|FG000|Overall Study|Site data not available|3|||
19444512|NCT01419184|41692477|FG001|Overall Study|Site data not available|2|||
19444513|NCT01419184|41692476|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
19444514|NCT01419184|41692477|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
19444515|NCT01419184|41692476|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
19523458|NCT00777036|41959736|FG001|On Treatment|Maximum Clinical Benefit|0|||
19523459|NCT00777036|41959737|FG002|On Treatment|Maximum Clinical Benefit|1|||
19523460|NCT00777036|41959735|FG000|On Treatment|Withdrawal by Subject|3|||
19523461|NCT00777036|41959736|FG001|On Treatment|Withdrawal by Subject|2|||
19523462|NCT00777036|41959737|FG002|On Treatment|Withdrawal by Subject|3|||
19444516|NCT01419184|41692477|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
19444517|NCT01419184|41692476|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
19444518|NCT01419184|41692477|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
19444519|NCT01419184|41692476|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
19444520|NCT01419184|41692477|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
19444521|NCT01419184|41692476|FG000|Overall Study|Participant randomized, not treated|1|||
19444522|NCT01419184|41692477|FG001|Overall Study|Participant randomized, not treated|0|||
19444523|NCT01417234|41692483|FG000|Overall Study|Subject non-compliant|3|||
19444524|NCT01417156|41692487|FG000|Overall Study|Adverse Event|12|||
19444525|NCT01417156|41692487|FG000|Overall Study|Protocol Violation|2|||
19444526|NCT01417078|41692491|FG000|Overall Study|Withdrawal by Subject|1|||
19444527|NCT01954394|41692499|FG000|Overall Study|Enrolled but not treated|1|||
19444528|NCT01954394|41692500|FG001|Overall Study|Enrolled but not treated|0|||
19444529|NCT01954394|41692499|FG000|Overall Study|Adverse Event|10|||
19444530|NCT01954394|41692500|FG001|Overall Study|Adverse Event|23|||
19444531|NCT01954394|41692499|FG000|Overall Study|Poor compliance to protocol|7|||
19444532|NCT01954394|41692500|FG001|Overall Study|Poor compliance to protocol|7|||
19444533|NCT01954394|41692499|FG000|Overall Study|Participant Moved|0|||
19444534|NCT01954394|41692500|FG001|Overall Study|Participant Moved|4|||
19444535|NCT01954394|41692499|FG000|Overall Study|Related to Study Drug administration|2|||
19444536|NCT01954394|41692500|FG001|Overall Study|Related to Study Drug administration|2|||
19444537|NCT01954394|41692499|FG000|Overall Study|Other than specified above|10|||
19444538|NCT01954394|41692500|FG001|Overall Study|Other than specified above|21|||
19444539|NCT01464424|41692508|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
19444540|NCT01464424|41692509|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
19444541|NCT01902134|41692521|FG000|Overall Study|Adverse Event|3|||
19444542|NCT01902134|41692522|FG001|Overall Study|Adverse Event|1|||
19444543|NCT01902134|41692523|FG002|Overall Study|Adverse Event|2|||
19444544|NCT01902134|41692524|FG003|Overall Study|Adverse Event|1|||
19444545|NCT01902134|41692525|FG004|Overall Study|Adverse Event|1|||
19444546|NCT01902134|41692526|FG005|Overall Study|Adverse Event|3|||
19444547|NCT01902134|41692521|FG000|Overall Study|Lack of Efficacy|0|||
19444548|NCT01902134|41692522|FG001|Overall Study|Lack of Efficacy|0|||
19444549|NCT01902134|41692523|FG002|Overall Study|Lack of Efficacy|2|||
19444550|NCT01902134|41692524|FG003|Overall Study|Lack of Efficacy|0|||
19444551|NCT01902134|41692525|FG004|Overall Study|Lack of Efficacy|0|||
19444552|NCT01902134|41692526|FG005|Overall Study|Lack of Efficacy|1|||
19444553|NCT01902134|41692521|FG000|Overall Study|Physician Decision|0|||
19444554|NCT01902134|41692522|FG001|Overall Study|Physician Decision|1|||
19444555|NCT01902134|41692523|FG002|Overall Study|Physician Decision|0|||
19444556|NCT01902134|41692524|FG003|Overall Study|Physician Decision|0|||
19444557|NCT01902134|41692525|FG004|Overall Study|Physician Decision|0|||
19444558|NCT01902134|41692526|FG005|Overall Study|Physician Decision|0|||
19444559|NCT01902134|41692521|FG000|Overall Study|Protocol Violation|0|||
19444560|NCT01902134|41692522|FG001|Overall Study|Protocol Violation|0|||
19444561|NCT01902134|41692523|FG002|Overall Study|Protocol Violation|0|||
19444562|NCT01902134|41692524|FG003|Overall Study|Protocol Violation|0|||
19444563|NCT01902134|41692525|FG004|Overall Study|Protocol Violation|0|||
19444564|NCT01902134|41692526|FG005|Overall Study|Protocol Violation|1|||
19444565|NCT01902134|41692521|FG000|Overall Study|Withdrawal by Subject|4|||
19444566|NCT01902134|41692522|FG001|Overall Study|Withdrawal by Subject|8|||
19444567|NCT01902134|41692523|FG002|Overall Study|Withdrawal by Subject|9|||
19444568|NCT01902134|41692524|FG003|Overall Study|Withdrawal by Subject|1|||
19444569|NCT01902134|41692525|FG004|Overall Study|Withdrawal by Subject|5|||
19444570|NCT01902134|41692526|FG005|Overall Study|Withdrawal by Subject|4|||
19444571|NCT01902134|41692521|FG000|Overall Study|no compliance|1|||
19444572|NCT01902134|41692522|FG001|Overall Study|no compliance|0|||
19444573|NCT01902134|41692523|FG002|Overall Study|no compliance|0|||
19444574|NCT01902134|41692524|FG003|Overall Study|no compliance|0|||
19444575|NCT01902134|41692525|FG004|Overall Study|no compliance|0|||
19444576|NCT01902134|41692526|FG005|Overall Study|no compliance|0|||
19444577|NCT01902134|41692521|FG000|Overall Study|Other|0|||
19444578|NCT01902134|41692522|FG001|Overall Study|Other|1|||
19444579|NCT01902134|41692523|FG002|Overall Study|Other|2|||
19444580|NCT01902134|41692524|FG003|Overall Study|Other|0|||
19444581|NCT01902134|41692525|FG004|Overall Study|Other|1|||
19444582|NCT01902134|41692526|FG005|Overall Study|Other|0|||
19444583|NCT01954082|41692544|FG000|Overall Study|Study Suspension|42|||
19444584|NCT01954082|41692545|FG001|Overall Study|Study Suspension|36|||
19444585|NCT01954082|41692544|FG000|Overall Study|Adverse Event|10|||
19444586|NCT01954082|41692545|FG001|Overall Study|Adverse Event|4|||
19444587|NCT01954082|41692544|FG000|Overall Study|Intolerance|0|||
19444588|NCT01954082|41692545|FG001|Overall Study|Intolerance|1|||
19444589|NCT01954082|41692544|FG000|Overall Study|Non-compliance|6|||
19444590|NCT01954082|41692545|FG001|Overall Study|Non-compliance|4|||
19444591|NCT01954082|41692544|FG000|Overall Study|Physician Decision|2|||
19444592|NCT01954082|41692545|FG001|Overall Study|Physician Decision|0|||
19444593|NCT01954082|41692544|FG000|Overall Study|Parent Decision|1|||
19444594|NCT01954082|41692545|FG001|Overall Study|Parent Decision|0|||
19444595|NCT01954082|41692544|FG000|Overall Study|Withdrawal by Subject|0|||
19444596|NCT01954082|41692545|FG001|Overall Study|Withdrawal by Subject|1|||
19444597|NCT01954082|41692544|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
19444598|NCT01954082|41692545|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
19444599|NCT01954082|41692544|FG000|Overall Study|Redirection of Care|0|||
19444600|NCT01954082|41692545|FG001|Overall Study|Redirection of Care|2|||
19444601|NCT01954082|41692544|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
19444602|NCT01954082|41692545|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
19444603|NCT01954082|41692544|FG000|Overall Study|Comfort Care|0|||
19444604|NCT01954082|41692545|FG001|Overall Study|Comfort Care|1|||
19444605|NCT01954082|41692544|FG000|Overall Study|Infant Moved|0|||
19444606|NCT01954082|41692545|FG001|Overall Study|Infant Moved|1|||
19444607|NCT01954082|41692544|FG000|Overall Study|Randomized not Treated|4|||
19444608|NCT01954082|41692545|FG001|Overall Study|Randomized not Treated|2|||
19444609|NCT01417000|41692553|FG000|Overall Study|Death|59|||
19444610|NCT01417000|41692554|FG001|Overall Study|Death|28|||
19444611|NCT01417000|41692553|FG000|Overall Study|Lost to Follow-up|1|||
19444612|NCT01417000|41692554|FG001|Overall Study|Lost to Follow-up|0|||
19444613|NCT01417000|41692553|FG000|Overall Study|Study Terminated by Sponsor|1|||
19444614|NCT01417000|41692554|FG001|Overall Study|Study Terminated by Sponsor|1|||
19444615|NCT01416610|41692560|FG000|Overall Study|Adverse Event|4|||
19444616|NCT01416610|41692560|FG000|Overall Study|Adverse Event -Patient decision|3|||
19444617|NCT01416610|41692560|FG000|Overall Study|Lack of Efficacy|4|||
19444618|NCT01416610|41692560|FG000|Overall Study|No reason given|5|||
19444619|NCT01416610|41692560|FG000|Overall Study|Withdrawal by Subject|13|||
19444620|NCT01416610|41692560|FG000|Overall Study|Lost to Follow-up|7|||
19444621|NCT01416610|41692560|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
19444622|NCT01416142|41692568|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
19444623|NCT01416142|41692569|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
19444624|NCT01416142|41692570|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
19444625|NCT01415986|41692578|FG000|Overall Study|Lost to Follow-up|1|||
19444626|NCT01415908|41692585|FG000|Overall Study|Withdrawal by Subject|1|||
19444627|NCT01415908|41692586|FG001|Overall Study|Withdrawal by Subject|0|||
19444628|NCT01415518|41692594|FG000|Overall Study|Withdrawal by Subject|2|||
19444629|NCT01415518|41692595|FG001|Overall Study|Withdrawal by Subject|12|||
19444630|NCT01415518|41692594|FG000|Overall Study|Protocol Violation|6|||
19444631|NCT01415518|41692595|FG001|Overall Study|Protocol Violation|8|||
19444632|NCT01415518|41692594|FG000|Overall Study|Lost to Follow-up|3|||
19444633|NCT01415518|41692595|FG001|Overall Study|Lost to Follow-up|5|||
19444634|NCT01415518|41692594|FG000|Overall Study|Adverse Event|3|||
19444635|NCT01415518|41692595|FG001|Overall Study|Adverse Event|4|||
19444636|NCT01415518|41692594|FG000|Overall Study|Death|1|||
19444637|NCT01415518|41692595|FG001|Overall Study|Death|1|||
19444638|NCT01415518|41692594|FG000|Overall Study|Condition under Investigation Worsened|1|||
19444639|NCT01415518|41692595|FG001|Overall Study|Condition under Investigation Worsened|1|||
19444640|NCT01393600|41692601|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
19444641|NCT01393600|41692602|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
19444642|NCT01393600|41692603|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
19444643|NCT01393600|41692604|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
19444644|NCT01393600|41692601|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
19444645|NCT01393600|41692602|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
19523463|NCT00777036|41959735|FG000|On Treatment|Death|0|||
19523464|NCT00777036|41959736|FG001|On Treatment|Death|2|||
19523465|NCT00777036|41959737|FG002|On Treatment|Death|0|||
19523466|NCT00777036|41959735|FG000|On Treatment|Study Drug Toxicity|0|||
19523467|NCT00777036|41959736|FG001|On Treatment|Study Drug Toxicity|0|||
19523468|NCT00777036|41959737|FG002|On Treatment|Study Drug Toxicity|1|||
19523469|NCT00777036|41959735|FG000|On Treatment|Progressive Disease|5|||
19523470|NCT00777036|41959736|FG001|On Treatment|Progressive Disease|4|||
19523471|NCT00777036|41959737|FG002|On Treatment|Progressive Disease|6|||
19523472|NCT00777036|41959735|FG000|Follow-Up|Lost to Follow-up|1|||
19523473|NCT00777036|41959736|FG001|Follow-Up|Lost to Follow-up|0|||
19523474|NCT00777036|41959737|FG002|Follow-Up|Lost to Follow-up|0|||
19523475|NCT00777036|41959735|FG000|Follow-Up|Reason Not Specified|2|||
19523476|NCT00777036|41959736|FG001|Follow-Up|Reason Not Specified|0|||
19444646|NCT01393600|41692603|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
19444647|NCT01393600|41692604|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
19444648|NCT01393600|41692601|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
19444649|NCT01393600|41692602|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
19444650|NCT01393600|41692603|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
19444651|NCT01393600|41692604|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
19444652|NCT01393600|41692601|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
19444653|NCT01393600|41692602|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
19523477|NCT00777036|41959737|FG002|Follow-Up|Reason Not Specified|0|||
19523478|NCT00777036|41959735|FG000|Follow-Up|Withdrawal by Subject|1|||
19523479|NCT00777036|41959736|FG001|Follow-Up|Withdrawal by Subject|0|||
19523480|NCT00777036|41959737|FG002|Follow-Up|Withdrawal by Subject|4|||
19523481|NCT00777036|41959735|FG000|Follow-Up|Death|1|||
19523482|NCT00777036|41959736|FG001|Follow-Up|Death|8|||
19523483|NCT00777036|41959737|FG002|Follow-Up|Death|0|||
19523484|NCT00281658|41959754|FG000|Randomized Phase|Adverse Event|0|||
19523485|NCT00281658|41959755|FG001|Randomized Phase|Adverse Event|2|||
19523486|NCT00281658|41959756|FG002|Randomized Phase|Adverse Event|0|||
19523487|NCT00281658|41959757|FG003|Randomized Phase|Adverse Event|0|||
19523488|NCT00281658|41959754|FG000|Randomized Phase|Lost to Follow-up|34|||
19523489|NCT00281658|41959755|FG001|Randomized Phase|Lost to Follow-up|27|||
19523490|NCT00281658|41959756|FG002|Randomized Phase|Lost to Follow-up|0|||
19444654|NCT01393600|41692603|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
19444655|NCT01393600|41692604|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
19444656|NCT01393600|41692601|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
19444657|NCT01393600|41692602|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
19444658|NCT01393600|41692603|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
19444659|NCT01393600|41692604|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
19444660|NCT01393600|41692601|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
19444661|NCT01393600|41692602|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
19444662|NCT01393600|41692603|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
19444663|NCT01393600|41692604|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
19444664|NCT01393600|41692601|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
19444665|NCT01393600|41692602|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
19444666|NCT01393600|41692603|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
19444667|NCT01393600|41692604|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
19444668|NCT01432756|41692620|FG000|Overall Study|Lost to Follow-up|1|||
19444669|NCT01432756|41692621|FG001|Overall Study|Lost to Follow-up|0|||
19444670|NCT01432756|41692622|FG002|Overall Study|Lost to Follow-up|2|||
19444671|NCT01432756|41692623|FG003|Overall Study|Lost to Follow-up|1|||
19444672|NCT01432600|41692634|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
19444673|NCT01432600|41692635|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
19444674|NCT01432600|41692636|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
19444675|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
19444676|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
19444677|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
19444678|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
19444679|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
19444680|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
19444681|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
19444682|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
19444683|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
19444684|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
19444685|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
19444686|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
19444687|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
19444688|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
19444689|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
19444690|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
19444691|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
19444692|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
19444693|NCT01432444|41692646|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
19444694|NCT01432444|41692647|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
19444695|NCT01432444|41692648|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
19444696|NCT01432444|41692646|FG000|Treatment Phase|Lost to Follow-up|0|||
19523491|NCT00281658|41959757|FG003|Randomized Phase|Lost to Follow-up|0|||
19523492|NCT00281658|41959754|FG000|Randomized Phase|Withdrawal by Subject|8|||
19523493|NCT00281658|41959755|FG001|Randomized Phase|Withdrawal by Subject|7|||
19523494|NCT00281658|41959756|FG002|Randomized Phase|Withdrawal by Subject|0|||
19523495|NCT00281658|41959757|FG003|Randomized Phase|Withdrawal by Subject|0|||
19523496|NCT00281658|41959754|FG000|Randomized Phase|Study closed/terminated|1|||
19523497|NCT00281658|41959755|FG001|Randomized Phase|Study closed/terminated|1|||
19523498|NCT00281658|41959756|FG002|Randomized Phase|Study closed/terminated|0|||
19629073|NCT03844945|42078635|FG002|Overall Study|Lack of Efficacy|0|||
19629074|NCT03844945|42078636|FG003|Overall Study|Lack of Efficacy|1|||
19629075|NCT00445549|42078646|FG000|Overall Study|progressive disease|12|||
19444697|NCT01432444|41692647|FG001|Treatment Phase|Lost to Follow-up|33|||
19444698|NCT01432444|41692648|FG002|Treatment Phase|Lost to Follow-up|0|||
19444699|NCT01432444|41692646|FG000|Treatment Phase|Adverse Event|0|||
19444700|NCT01432444|41692647|FG001|Treatment Phase|Adverse Event|37|||
19444701|NCT01432444|41692648|FG002|Treatment Phase|Adverse Event|0|||
19523499|NCT00281658|41959757|FG003|Randomized Phase|Study closed/terminated|0|||
19629076|NCT00445003|42078653|FG000|Overall Study|Death|1|||
19523500|NCT00281658|41959754|FG000|Randomized Phase|Disease progression|36|||
19523501|NCT00281658|41959755|FG001|Randomized Phase|Disease progression|27|||
19523502|NCT00281658|41959756|FG002|Randomized Phase|Disease progression|0|||
19523503|NCT00281658|41959757|FG003|Randomized Phase|Disease progression|0|||
19523504|NCT00281658|41959754|FG000|Randomized Phase|Physician Decision|1|||
19523505|NCT00281658|41959755|FG001|Randomized Phase|Physician Decision|1|||
19523506|NCT00281658|41959756|FG002|Randomized Phase|Physician Decision|0|||
19444702|NCT01432444|41692646|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
19444703|NCT01432444|41692647|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
19444704|NCT01432444|41692648|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
19444705|NCT01432444|41692646|FG000|Treatment Phase|Physician Decision|0|||
19444706|NCT01432444|41692647|FG001|Treatment Phase|Physician Decision|5|||
19444707|NCT01432444|41692648|FG002|Treatment Phase|Physician Decision|0|||
19444708|NCT01432444|41692646|FG000|Treatment Phase|Withdrawal by Subject|0|||
19444709|NCT01432444|41692647|FG001|Treatment Phase|Withdrawal by Subject|41|||
19444710|NCT01432444|41692648|FG002|Treatment Phase|Withdrawal by Subject|0|||
19523507|NCT00281658|41959757|FG003|Randomized Phase|Physician Decision|0|||
19523508|NCT00281658|41959754|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
19523509|NCT00281658|41959755|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
19523510|NCT00281658|41959756|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
19523511|NCT00281658|41959757|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
19523512|NCT00281658|41959754|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
19523513|NCT00281658|41959755|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
19523514|NCT00281658|41959756|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
19523515|NCT00281658|41959757|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
19523516|NCT00281658|41959754|FG000|Randomized Phase|Treatment ongoing|1|||
19444711|NCT01432444|41692646|FG000|Treatment Phase|Protocol Deviation|0|||
19444712|NCT01432444|41692647|FG001|Treatment Phase|Protocol Deviation|3|||
19444713|NCT01432444|41692648|FG002|Treatment Phase|Protocol Deviation|0|||
19444714|NCT01432444|41692646|FG000|Treatment Phase|Lack of Efficacy|0|||
19444715|NCT01432444|41692647|FG001|Treatment Phase|Lack of Efficacy|10|||
19444716|NCT01432444|41692648|FG002|Treatment Phase|Lack of Efficacy|0|||
19444717|NCT01432444|41692646|FG000|Extension Phase|Lost to Follow-up|0|||
19444718|NCT01432444|41692647|FG001|Extension Phase|Lost to Follow-up|0|||
19444719|NCT01432444|41692648|FG002|Extension Phase|Lost to Follow-up|17|||
19444720|NCT01432444|41692646|FG000|Extension Phase|Adverse Event|0|||
19444721|NCT01432444|41692647|FG001|Extension Phase|Adverse Event|0|||
19444722|NCT01432444|41692648|FG002|Extension Phase|Adverse Event|10|||
19444723|NCT01432444|41692646|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
19444724|NCT01432444|41692647|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
19444725|NCT01432444|41692648|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
19444726|NCT01432444|41692646|FG000|Extension Phase|Met Withdrawal Criteria|0|||
19444727|NCT01432444|41692647|FG001|Extension Phase|Met Withdrawal Criteria|0|||
19444728|NCT01432444|41692648|FG002|Extension Phase|Met Withdrawal Criteria|144|||
19444729|NCT01432444|41692646|FG000|Extension Phase|Physician Decision|0|||
19444730|NCT01432444|41692647|FG001|Extension Phase|Physician Decision|0|||
19444731|NCT01432444|41692648|FG002|Extension Phase|Physician Decision|1|||
19444732|NCT01432444|41692646|FG000|Extension Phase|Withdrawal by Subject|0|||
19444733|NCT01432444|41692647|FG001|Extension Phase|Withdrawal by Subject|0|||
19444734|NCT01432444|41692648|FG002|Extension Phase|Withdrawal by Subject|13|||
19444735|NCT01432366|41692653|FG000|Overall Study|Non-Responder|7|||
19444736|NCT01432366|41692653|FG000|Overall Study|Adverse Event|8|||
19444737|NCT01432366|41692653|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
19523517|NCT00281658|41959755|FG001|Randomized Phase|Treatment ongoing|0|||
19629077|NCT00445003|42078654|FG001|Overall Study|Death|2|||
19444738|NCT01432366|41692653|FG000|Overall Study|Pregnancy|1|||
19444739|NCT01432366|41692653|FG000|Overall Study|Lost to Follow-up|13|||
19444740|NCT01432366|41692653|FG000|Overall Study|Lack of Efficacy|1|||
19444741|NCT01432366|41692653|FG000|Overall Study|Site Closed|20|||
19444742|NCT01432366|41692653|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
19444743|NCT01432366|41692653|FG000|Overall Study|Other|14|||
19444744|NCT01415440|41692660|FG000|Overall Study|Lost to Follow-up|0|||
19444745|NCT01415440|41692661|FG001|Overall Study|Lost to Follow-up|1|||
19444746|NCT01415440|41692662|FG002|Overall Study|Lost to Follow-up|2|||
19444747|NCT01415440|41692660|FG000|Overall Study|Physician Decision|3|||
19444748|NCT01415440|41692661|FG001|Overall Study|Physician Decision|0|||
19444749|NCT01415440|41692662|FG002|Overall Study|Physician Decision|0|||
19444750|NCT01415440|41692660|FG000|Overall Study|Withdrawal by Subject|1|||
19523518|NCT00281658|41959756|FG002|Randomized Phase|Treatment ongoing|0|||
19444751|NCT01415440|41692661|FG001|Overall Study|Withdrawal by Subject|0|||
19444752|NCT01415440|41692662|FG002|Overall Study|Withdrawal by Subject|0|||
19444753|NCT01414738|41692678|FG000|Overall Study|Death|26|||
19629078|NCT00445003|42078655|FG002|Overall Study|Death|1|||
19444754|NCT01414738|41692678|FG000|Overall Study|Refused testing|5|||
19444755|NCT01414738|41692678|FG000|Overall Study|Lost to Follow-up|2|||
19444756|NCT01414738|41692678|FG000|Overall Study|Refused, disease progression|8|||
19444757|NCT01414738|41692678|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
19444758|NCT01414114|41692682|FG000|Overall Study|Adverse Event|2|||
19444759|NCT01414114|41692682|FG000|Overall Study|Withdrawal by Subject|1|||
19444760|NCT01414114|41692682|FG000|Overall Study|Other|2|||
19444761|NCT01393444|41692688|FG000|Overall Study|Withdrawal by Subject|1|||
19444762|NCT01393444|41692688|FG000|Overall Study|Determined ineligible during screening.|2|||
19444763|NCT01431976|41692692|FG000|Overall Study|Adverse Event|6|||
19444764|NCT01431976|41692692|FG000|Overall Study|Lack of Efficacy|2|||
19444765|NCT01431976|41692692|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
19444766|NCT01431976|41692692|FG000|Overall Study|Physician Decision|1|||
19444767|NCT01431976|41692692|FG000|Overall Study|Withdrawal by Subject|1|||
19444768|NCT01392742|41692696|FG000|Overall Study|Premature study termination|42|||
19444769|NCT01392742|41692696|FG000|Overall Study|Failure to return|35|||
19444770|NCT01392742|41692696|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
19444771|NCT01392742|41692696|FG000|Overall Study|Lost to Follow-up|34|||
19444772|NCT01392742|41692696|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
19444773|NCT01392742|41692696|FG000|Overall Study|ITR and Protocol deviation|1|||
19444774|NCT01392742|41692696|FG000|Overall Study|Adverse event/intercurrent illness|17|||
19444775|NCT01392742|41692696|FG000|Overall Study|Protocol Violation|14|||
19444776|NCT01392742|41692696|FG000|Overall Study|Other|3|||
19444777|NCT01392742|41692696|FG000|Overall Study|Missing information|13|||
19444778|NCT01413958|41692702|FG000|Overall Study|Lost to Follow-up|0|||
19444779|NCT01413958|41692703|FG001|Overall Study|Lost to Follow-up|1|||
19444780|NCT01413178|41692712|FG000|Overall Study|Toxicity|1|||
19444781|NCT01413178|41692713|FG001|Overall Study|Toxicity|0|||
19444782|NCT01413178|41692712|FG000|Overall Study|Ineligible|0|||
19444783|NCT01413178|41692713|FG001|Overall Study|Ineligible|2|||
19444784|NCT01799889|41692731|FG000|Overall Study|Adverse Event|4|||
19444785|NCT01799889|41692732|FG001|Overall Study|Adverse Event|4|||
19444786|NCT01799889|41692733|FG002|Overall Study|Adverse Event|5|||
19444787|NCT01799889|41692734|FG003|Overall Study|Adverse Event|1|||
19444788|NCT01799889|41692735|FG004|Overall Study|Adverse Event|11|||
19444789|NCT01799889|41692736|FG005|Overall Study|Adverse Event|1|||
19444790|NCT01799889|41692737|FG006|Overall Study|Adverse Event|5|||
19444791|NCT01799889|41692738|FG007|Overall Study|Adverse Event|2|||
19444792|NCT01799889|41692739|FG008|Overall Study|Adverse Event|3|||
19444793|NCT01799889|41692740|FG009|Overall Study|Adverse Event|1|||
19444794|NCT01799889|41692741|FG010|Overall Study|Adverse Event|1|||
19444795|NCT01799889|41692742|FG011|Overall Study|Adverse Event|0|||
19444796|NCT01799889|41692731|FG000|Overall Study|Death|1|||
19444797|NCT01799889|41692732|FG001|Overall Study|Death|0|||
19444798|NCT01799889|41692733|FG002|Overall Study|Death|5|||
19444799|NCT01799889|41692734|FG003|Overall Study|Death|3|||
19444800|NCT01799889|41692735|FG004|Overall Study|Death|1|||
19444801|NCT01799889|41692736|FG005|Overall Study|Death|0|||
19444802|NCT01799889|41692737|FG006|Overall Study|Death|0|||
19444803|NCT01799889|41692738|FG007|Overall Study|Death|0|||
19444804|NCT01799889|41692739|FG008|Overall Study|Death|1|||
19444805|NCT01799889|41692740|FG009|Overall Study|Death|0|||
19444806|NCT01799889|41692741|FG010|Overall Study|Death|1|||
19444807|NCT01799889|41692742|FG011|Overall Study|Death|0|||
19444808|NCT01799889|41692731|FG000|Overall Study|Lack of Efficacy|1|||
19444809|NCT01799889|41692732|FG001|Overall Study|Lack of Efficacy|1|||
19444810|NCT01799889|41692733|FG002|Overall Study|Lack of Efficacy|0|||
19444811|NCT01799889|41692734|FG003|Overall Study|Lack of Efficacy|1|||
19444812|NCT01799889|41692735|FG004|Overall Study|Lack of Efficacy|2|||
19444813|NCT01799889|41692736|FG005|Overall Study|Lack of Efficacy|2|||
19444814|NCT01799889|41692737|FG006|Overall Study|Lack of Efficacy|0|||
19444815|NCT01799889|41692738|FG007|Overall Study|Lack of Efficacy|0|||
19444816|NCT01799889|41692739|FG008|Overall Study|Lack of Efficacy|2|||
19444817|NCT01799889|41692740|FG009|Overall Study|Lack of Efficacy|0|||
19444818|NCT01799889|41692741|FG010|Overall Study|Lack of Efficacy|1|||
19444819|NCT01799889|41692742|FG011|Overall Study|Lack of Efficacy|0|||
19444820|NCT01799889|41692731|FG000|Overall Study|Lost to Follow-up|0|||
19523519|NCT00281658|41959757|FG003|Randomized Phase|Treatment ongoing|0|||
19523520|NCT00281658|41959754|FG000|Open Label Phase|Adverse Event|0|||
19523521|NCT00281658|41959755|FG001|Open Label Phase|Adverse Event|0|||
19523522|NCT00281658|41959756|FG002|Open Label Phase|Adverse Event|1|||
19523523|NCT00281658|41959757|FG003|Open Label Phase|Adverse Event|0|||
19444821|NCT01799889|41692732|FG001|Overall Study|Lost to Follow-up|1|||
19444822|NCT01799889|41692733|FG002|Overall Study|Lost to Follow-up|0|||
19444823|NCT01799889|41692734|FG003|Overall Study|Lost to Follow-up|0|||
19444824|NCT01799889|41692735|FG004|Overall Study|Lost to Follow-up|0|||
19444825|NCT01799889|41692736|FG005|Overall Study|Lost to Follow-up|0|||
19444826|NCT01799889|41692737|FG006|Overall Study|Lost to Follow-up|0|||
19444827|NCT01799889|41692738|FG007|Overall Study|Lost to Follow-up|0|||
19444828|NCT01799889|41692739|FG008|Overall Study|Lost to Follow-up|0|||
19444829|NCT01799889|41692740|FG009|Overall Study|Lost to Follow-up|0|||
19444830|NCT01799889|41692741|FG010|Overall Study|Lost to Follow-up|0|||
19444831|NCT01799889|41692742|FG011|Overall Study|Lost to Follow-up|0|||
19444832|NCT01799889|41692731|FG000|Overall Study|Physician Decision|3|||
19444833|NCT01799889|41692732|FG001|Overall Study|Physician Decision|2|||
19444834|NCT01799889|41692733|FG002|Overall Study|Physician Decision|4|||
19444835|NCT01799889|41692734|FG003|Overall Study|Physician Decision|4|||
19444836|NCT01799889|41692735|FG004|Overall Study|Physician Decision|5|||
19444837|NCT01799889|41692736|FG005|Overall Study|Physician Decision|5|||
19444838|NCT01799889|41692737|FG006|Overall Study|Physician Decision|5|||
19444839|NCT01799889|41692738|FG007|Overall Study|Physician Decision|2|||
19444840|NCT01799889|41692739|FG008|Overall Study|Physician Decision|6|||
19444841|NCT01799889|41692740|FG009|Overall Study|Physician Decision|0|||
19444842|NCT01799889|41692741|FG010|Overall Study|Physician Decision|0|||
19444843|NCT01799889|41692742|FG011|Overall Study|Physician Decision|1|||
19444844|NCT01799889|41692731|FG000|Overall Study|Progressive Disease|30|||
19523524|NCT00281658|41959754|FG000|Open Label Phase|Lost to Follow-up|0|||
19523525|NCT00281658|41959755|FG001|Open Label Phase|Lost to Follow-up|0|||
19523526|NCT00281658|41959756|FG002|Open Label Phase|Lost to Follow-up|16|||
19523527|NCT00281658|41959757|FG003|Open Label Phase|Lost to Follow-up|2|||
19523528|NCT00281658|41959754|FG000|Open Label Phase|Withdrawal by Subject|0|||
19523529|NCT00281658|41959755|FG001|Open Label Phase|Withdrawal by Subject|0|||
19523530|NCT00281658|41959756|FG002|Open Label Phase|Withdrawal by Subject|3|||
19523531|NCT00281658|41959757|FG003|Open Label Phase|Withdrawal by Subject|2|||
19444845|NCT01799889|41692732|FG001|Overall Study|Progressive Disease|26|||
19444846|NCT01799889|41692733|FG002|Overall Study|Progressive Disease|25|||
19444847|NCT01799889|41692734|FG003|Overall Study|Progressive Disease|30|||
19444848|NCT01799889|41692735|FG004|Overall Study|Progressive Disease|23|||
19444849|NCT01799889|41692736|FG005|Overall Study|Progressive Disease|9|||
19444850|NCT01799889|41692737|FG006|Overall Study|Progressive Disease|8|||
19523532|NCT00281658|41959754|FG000|Open Label Phase|Disease progression|0|||
19523533|NCT00281658|41959755|FG001|Open Label Phase|Disease progression|0|||
19444851|NCT01799889|41692738|FG007|Overall Study|Progressive Disease|13|||
19444852|NCT01799889|41692739|FG008|Overall Study|Progressive Disease|18|||
19444853|NCT01799889|41692740|FG009|Overall Study|Progressive Disease|5|||
19444854|NCT01799889|41692741|FG010|Overall Study|Progressive Disease|3|||
19444855|NCT01799889|41692742|FG011|Overall Study|Progressive Disease|1|||
19444856|NCT01799889|41692731|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
19444857|NCT01799889|41692732|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
19444858|NCT01799889|41692733|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
19444859|NCT01799889|41692734|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
19444860|NCT01799889|41692735|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
19444861|NCT01799889|41692736|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
19444862|NCT01799889|41692737|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
19444863|NCT01799889|41692738|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
19444864|NCT01799889|41692739|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
19444865|NCT01799889|41692740|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
19444866|NCT01799889|41692741|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
19444867|NCT01799889|41692742|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
19444868|NCT01799889|41692731|FG000|Overall Study|Study Terminated By Sponsor|1|||
19444869|NCT01799889|41692732|FG001|Overall Study|Study Terminated By Sponsor|0|||
19444870|NCT01799889|41692733|FG002|Overall Study|Study Terminated By Sponsor|0|||
19444871|NCT01799889|41692734|FG003|Overall Study|Study Terminated By Sponsor|0|||
19444872|NCT01799889|41692735|FG004|Overall Study|Study Terminated By Sponsor|2|||
19444873|NCT01799889|41692736|FG005|Overall Study|Study Terminated By Sponsor|1|||
19444874|NCT01799889|41692737|FG006|Overall Study|Study Terminated By Sponsor|0|||
19444875|NCT01799889|41692738|FG007|Overall Study|Study Terminated By Sponsor|2|||
19444876|NCT01799889|41692739|FG008|Overall Study|Study Terminated By Sponsor|1|||
19444877|NCT01799889|41692740|FG009|Overall Study|Study Terminated By Sponsor|1|||
19444878|NCT01799889|41692741|FG010|Overall Study|Study Terminated By Sponsor|0|||
19444879|NCT01799889|41692742|FG011|Overall Study|Study Terminated By Sponsor|0|||
19444880|NCT01799889|41692731|FG000|Overall Study|Withdrawal by Subject|1|||
19444881|NCT01799889|41692732|FG001|Overall Study|Withdrawal by Subject|6|||
19444882|NCT01799889|41692733|FG002|Overall Study|Withdrawal by Subject|4|||
19444883|NCT01799889|41692734|FG003|Overall Study|Withdrawal by Subject|0|||
19444884|NCT01799889|41692735|FG004|Overall Study|Withdrawal by Subject|5|||
19444885|NCT01799889|41692736|FG005|Overall Study|Withdrawal by Subject|1|||
19444886|NCT01799889|41692737|FG006|Overall Study|Withdrawal by Subject|3|||
19444887|NCT01799889|41692738|FG007|Overall Study|Withdrawal by Subject|1|||
19444888|NCT01799889|41692739|FG008|Overall Study|Withdrawal by Subject|2|||
19444889|NCT01799889|41692740|FG009|Overall Study|Withdrawal by Subject|1|||
19444890|NCT01799889|41692741|FG010|Overall Study|Withdrawal by Subject|1|||
19444891|NCT01799889|41692742|FG011|Overall Study|Withdrawal by Subject|1|||
19444892|NCT01799889|41692731|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19444893|NCT01799889|41692732|FG001|Overall Study|Non-Compliance With Study Drug|0|||
19444894|NCT01799889|41692733|FG002|Overall Study|Non-Compliance With Study Drug|0|||
19444895|NCT01799889|41692734|FG003|Overall Study|Non-Compliance With Study Drug|0|||
19444896|NCT01799889|41692735|FG004|Overall Study|Non-Compliance With Study Drug|0|||
19444897|NCT01799889|41692736|FG005|Overall Study|Non-Compliance With Study Drug|1|||
19444898|NCT01799889|41692737|FG006|Overall Study|Non-Compliance With Study Drug|0|||
19444899|NCT01799889|41692738|FG007|Overall Study|Non-Compliance With Study Drug|0|||
19444900|NCT01799889|41692739|FG008|Overall Study|Non-Compliance With Study Drug|0|||
19444901|NCT01799889|41692740|FG009|Overall Study|Non-Compliance With Study Drug|0|||
19444902|NCT01799889|41692741|FG010|Overall Study|Non-Compliance With Study Drug|0|||
19444903|NCT01799889|41692742|FG011|Overall Study|Non-Compliance With Study Drug|0|||
19444904|NCT01412944|41692781|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
19444905|NCT01412944|41692782|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
19444906|NCT01412944|41692783|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
19444907|NCT01412944|41692784|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
19444908|NCT01412944|41692785|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
19444909|NCT01412944|41692786|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
19444910|NCT01412944|41692781|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
19444911|NCT01412944|41692782|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
19444912|NCT01412944|41692783|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
19444913|NCT01412944|41692784|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
19444914|NCT01412944|41692785|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
19444915|NCT01412944|41692786|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
19444916|NCT01412944|41692781|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
19444917|NCT01412944|41692782|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
19523534|NCT00281658|41959756|FG002|Open Label Phase|Disease progression|18|||
19523535|NCT00281658|41959757|FG003|Open Label Phase|Disease progression|0|||
19523536|NCT00281658|41959754|FG000|Open Label Phase|Physician Decision|0|||
19523537|NCT00281658|41959755|FG001|Open Label Phase|Physician Decision|0|||
19523538|NCT00281658|41959756|FG002|Open Label Phase|Physician Decision|1|||
19523539|NCT00281658|41959757|FG003|Open Label Phase|Physician Decision|0|||
19523540|NCT00281658|41959754|FG000|Open Label Phase|Relocation of patient|0|||
19523541|NCT00281658|41959755|FG001|Open Label Phase|Relocation of patient|0|||
19444918|NCT01412944|41692783|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
19523542|NCT00281658|41959756|FG002|Open Label Phase|Relocation of patient|1|||
19523543|NCT00281658|41959757|FG003|Open Label Phase|Relocation of patient|0|||
19444919|NCT01412944|41692784|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
19444920|NCT01412944|41692785|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
19444921|NCT01412944|41692786|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
19444922|NCT01412944|41692781|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
19444923|NCT01412944|41692782|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
19444924|NCT01412944|41692783|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
19444925|NCT01412944|41692784|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
19444926|NCT01412944|41692785|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
19444927|NCT01412944|41692786|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
19444928|NCT01412944|41692781|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
19523544|NCT00281658|41959754|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
19523545|NCT00281658|41959755|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
19444929|NCT01412944|41692782|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
19444930|NCT01412944|41692783|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
19444931|NCT01412944|41692784|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
19444932|NCT01412944|41692785|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
19444933|NCT01412944|41692786|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
19444934|NCT01412944|41692781|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
19444935|NCT01412944|41692782|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
19444936|NCT01412944|41692783|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
19444937|NCT01412944|41692784|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
19523546|NCT00281658|41959756|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
19523547|NCT00281658|41959757|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
19523548|NCT02758626|41961166|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
19444938|NCT01412944|41692785|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
19444939|NCT01412944|41692786|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
19444940|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444941|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444942|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
19444943|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
19444944|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
19444945|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444946|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Adverse Event|0|||
19444947|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Adverse Event|0|||
19444948|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Adverse Event|0|||
19444949|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Adverse Event|0|||
19523549|NCT02758626|41961167|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
19523550|NCT02758626|41961166|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
19523551|NCT02758626|41961167|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
19523552|NCT02758626|41961166|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
19523553|NCT02758626|41961167|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
19523554|NCT02758626|41961166|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
19523555|NCT02758626|41961167|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
19523556|NCT02357784|41961173|FG000|Overall Study|Withdrawal by Subject|1|||
19523557|NCT01448616|41961180|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
19523558|NCT01448616|41961181|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
19523559|NCT01448616|41961182|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
19523560|NCT01448616|41961183|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
19523561|NCT01448616|41961180|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
19523562|NCT01448616|41961181|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
19523563|NCT01448616|41961182|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
19523564|NCT01448616|41961183|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
19523565|NCT01448616|41961180|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
19523566|NCT01448616|41961181|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
19523567|NCT01448616|41961182|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
19523568|NCT01448616|41961183|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
19523569|NCT01448616|41961180|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
19523570|NCT01448616|41961181|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
19523571|NCT01448616|41961182|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
19523572|NCT01448616|41961183|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
19523573|NCT01448616|41961180|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
19523574|NCT01448616|41961181|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
19444950|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Adverse Event|1|||
19444951|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Adverse Event|0|||
19444952|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
19444953|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
19444954|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
19444955|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
19523575|NCT01448616|41961182|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
19444956|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
19444957|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
19444958|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444959|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
19629079|NCT00445003|42078653|FG000|Overall Study|Missed Visit|3|||
19444960|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444961|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444962|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444963|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
19444964|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444965|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444966|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444967|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444968|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
19444969|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444970|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
19444971|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
19444972|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19523576|NCT01448616|41961183|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
19523577|NCT00074412|41961220|FG000|Overall Study|Death|30|||
19444973|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444974|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444975|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
19444976|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
19444977|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
19444978|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
19444979|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
19444980|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
19444981|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
19444982|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444983|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
19444984|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444985|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444986|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444987|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
19444988|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444989|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
19444990|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444991|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444992|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444993|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
19444994|NCT01412944|41692781|FG000|Entire: IV + Maintenance|Adverse Event|0|||
19444995|NCT01412944|41692782|FG001|Entire: IV + Maintenance|Adverse Event|1|||
19444996|NCT01412944|41692783|FG002|Entire: IV + Maintenance|Adverse Event|0|||
19444997|NCT01412944|41692784|FG003|Entire: IV + Maintenance|Adverse Event|0|||
19444998|NCT01412944|41692785|FG004|Entire: IV + Maintenance|Adverse Event|0|||
19444999|NCT01412944|41692786|FG005|Entire: IV + Maintenance|Adverse Event|0|||
19445000|NCT01798485|41692804|FG000|Overall Study|Adverse Event|32|||
19445001|NCT01798485|41692805|FG001|Overall Study|Adverse Event|40|||
19445002|NCT01798485|41692804|FG000|Overall Study|Withdrawal by Subject|27|||
19445003|NCT01798485|41692805|FG001|Overall Study|Withdrawal by Subject|31|||
19445004|NCT01798485|41692804|FG000|Overall Study|Lost to Follow-up|0|||
19445005|NCT01798485|41692805|FG001|Overall Study|Lost to Follow-up|3|||
19445006|NCT01798485|41692804|FG000|Overall Study|Physician Decision|14|||
19629080|NCT00445003|42078654|FG001|Overall Study|Missed Visit|5|||
19629081|NCT00445003|42078655|FG002|Overall Study|Missed Visit|1|||
19629082|NCT00445003|42078653|FG000|Overall Study|Dropped|1|||
19629083|NCT00445003|42078654|FG001|Overall Study|Dropped|3|||
19523578|NCT00074412|41961221|FG001|Overall Study|Death|26|||
19523579|NCT00074412|41961220|FG000|Overall Study|Lost to Follow-up|52|||
19523580|NCT00074412|41961221|FG001|Overall Study|Lost to Follow-up|58|||
19523581|NCT04505592|41962261|FG000|Overall Study|Death|2|||
19523582|NCT04505592|41962262|FG001|Overall Study|Death|1|||
19523583|NCT04521114|41968704|FG000|Overall Study|Lost to Follow-up|1|||
19523584|NCT04521114|41968705|FG001|Overall Study|Lost to Follow-up|2|||
19523585|NCT04521114|41968706|FG002|Overall Study|Lost to Follow-up|0|||
19523586|NCT04521114|41968704|FG000|Overall Study|Withdrawal by Subject|1|||
19523587|NCT04521114|41968705|FG001|Overall Study|Withdrawal by Subject|2|||
19523588|NCT04521114|41968706|FG002|Overall Study|Withdrawal by Subject|2|||
19523589|NCT04521114|41968704|FG000|Overall Study|Adverse Event|1|||
19523590|NCT04521114|41968705|FG001|Overall Study|Adverse Event|0|||
19523591|NCT04521114|41968706|FG002|Overall Study|Adverse Event|0|||
19523592|NCT04521114|41968704|FG000|Overall Study|Sponsor Wish|1|||
19523593|NCT04521114|41968705|FG001|Overall Study|Sponsor Wish|0|||
19523594|NCT04521114|41968706|FG002|Overall Study|Sponsor Wish|0|||
19523595|NCT04521114|41968704|FG000|Overall Study|Withdrawal of Consent|2|||
19523596|NCT04521114|41968705|FG001|Overall Study|Withdrawal of Consent|2|||
19523597|NCT04521114|41968706|FG002|Overall Study|Withdrawal of Consent|0|||
19523598|NCT04360824|41968728|FG000|Overall Study|Withdrawal by Subject|2|||
19523599|NCT04360824|41968729|FG001|Overall Study|Withdrawal by Subject|1|||
19629084|NCT00445003|42078655|FG002|Overall Study|Dropped|2|||
19523600|NCT04360824|41968728|FG000|Overall Study|Did not receive assigned treatment|1|||
19523601|NCT04360824|41968729|FG001|Overall Study|Did not receive assigned treatment|3|||
19523602|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
19445007|NCT01798485|41692805|FG001|Overall Study|Physician Decision|10|||
19445008|NCT01798485|41692804|FG000|Overall Study|Objective Disease Progression|152|||
19445009|NCT01798485|41692805|FG001|Overall Study|Objective Disease Progression|106|||
19445010|NCT01798485|41692804|FG000|Overall Study|Death|25|||
19445011|NCT01798485|41692805|FG001|Overall Study|Death|22|||
19523603|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
19523604|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
19523605|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
19629085|NCT00811070|42078669|FG000|Overall Study|Death|0|||
19445012|NCT01798485|41692804|FG000|Overall Study|Sponsor Decision|61|||
19445013|NCT01798485|41692805|FG001|Overall Study|Sponsor Decision|54|||
19445014|NCT01798485|41692804|FG000|Overall Study|Clinical Progression|35|||
19445015|NCT01798485|41692805|FG001|Overall Study|Clinical Progression|24|||
19445016|NCT01767597|41692813|FG000|Overall Study|Incomplete intervention|3|||
19445017|NCT01767597|41692814|FG001|Overall Study|Incomplete intervention|1|||
19445018|NCT01767597|41692813|FG000|Overall Study|Withdrawal by Subject|1|||
19445019|NCT01767597|41692814|FG001|Overall Study|Withdrawal by Subject|0|||
19445020|NCT01767519|41692823|FG000|Overall Study|Other Reasons|4|||
19445021|NCT01767519|41692824|FG001|Overall Study|Other Reasons|4|||
19445022|NCT01767519|41692825|FG002|Overall Study|Other Reasons|2|||
19445023|NCT01767519|41692823|FG000|Overall Study|Protocol Violation|0|||
19445024|NCT01767519|41692824|FG001|Overall Study|Protocol Violation|3|||
19445025|NCT01767519|41692825|FG002|Overall Study|Protocol Violation|0|||
19445026|NCT01767519|41692823|FG000|Overall Study|Personal Reasons|1|||
19445027|NCT01767519|41692824|FG001|Overall Study|Personal Reasons|0|||
19445028|NCT01767519|41692825|FG002|Overall Study|Personal Reasons|0|||
19445029|NCT01767519|41692823|FG000|Overall Study|Lost to Follow-up|3|||
19445030|NCT01767519|41692824|FG001|Overall Study|Lost to Follow-up|1|||
19445031|NCT01767519|41692825|FG002|Overall Study|Lost to Follow-up|2|||
19445032|NCT01767519|41692823|FG000|Overall Study|Lack of Efficacy|1|||
19445033|NCT01767519|41692824|FG001|Overall Study|Lack of Efficacy|0|||
19445034|NCT01767519|41692825|FG002|Overall Study|Lack of Efficacy|0|||
19445035|NCT01767519|41692823|FG000|Overall Study|Adverse Event|5|||
19445036|NCT01767519|41692824|FG001|Overall Study|Adverse Event|5|||
19445037|NCT01767519|41692825|FG002|Overall Study|Adverse Event|1|||
19445038|NCT01797783|41692835|FG000|Overall Study|Adverse Event|1|||
19445039|NCT01797783|41692836|FG001|Overall Study|Adverse Event|1|||
19445040|NCT01797783|41692835|FG000|Overall Study|Withdrawal by Subject|1|||
19445041|NCT01797783|41692836|FG001|Overall Study|Withdrawal by Subject|0|||
19445042|NCT01766817|41692853|FG000|Overall Study|Drug-related adverse event|1|||
19445043|NCT01766817|41692854|FG001|Overall Study|Drug-related adverse event|2|||
19445044|NCT01766817|41692855|FG002|Overall Study|Drug-related adverse event|1|||
19445045|NCT01766817|41692853|FG000|Overall Study|Drug-unrelated adverse event|3|||
19445046|NCT01766817|41692854|FG001|Overall Study|Drug-unrelated adverse event|3|||
19445047|NCT01766817|41692855|FG002|Overall Study|Drug-unrelated adverse event|3|||
19445048|NCT01766817|41692853|FG000|Overall Study|Death|1|||
19445049|NCT01766817|41692854|FG001|Overall Study|Death|1|||
19523606|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
19523607|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
19523608|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
19523609|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
19523610|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
19523611|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
19523612|NCT03711786|41968738|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
19523613|NCT03711786|41968739|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
19523614|NCT03691974|41968749|FG000|Overall Study|Physician Decision|1|||
19523615|NCT03691974|41968750|FG001|Overall Study|Physician Decision|0|||
19523616|NCT03691974|41968749|FG000|Overall Study|Adverse Event|1|||
19523617|NCT03691974|41968750|FG001|Overall Study|Adverse Event|0|||
19523618|NCT03691974|41968749|FG000|Overall Study|Withdrawal by Subject|11|||
19523619|NCT03691974|41968750|FG001|Overall Study|Withdrawal by Subject|9|||
19523620|NCT03691974|41968749|FG000|Overall Study|Protocol Violation|1|||
19523621|NCT03691974|41968750|FG001|Overall Study|Protocol Violation|0|||
19523622|NCT03691974|41968749|FG000|Overall Study|Lost to Follow-up|8|||
19523623|NCT03691974|41968750|FG001|Overall Study|Lost to Follow-up|7|||
19523624|NCT03525678|41968771|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
19445050|NCT01766817|41692855|FG002|Overall Study|Death|0|||
19445051|NCT01766817|41692853|FG000|Overall Study|Unable to take study drug|0|||
19445052|NCT01766817|41692854|FG001|Overall Study|Unable to take study drug|1|||
19445053|NCT01766817|41692855|FG002|Overall Study|Unable to take study drug|0|||
19445054|NCT01766817|41692853|FG000|Overall Study|Withdrawal by Subject|2|||
19445055|NCT01766817|41692854|FG001|Overall Study|Withdrawal by Subject|0|||
19445056|NCT01766817|41692855|FG002|Overall Study|Withdrawal by Subject|3|||
19445057|NCT01766817|41692853|FG000|Overall Study|Subject non-compliance|0|||
19523625|NCT03525678|41968772|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
19523626|NCT03525678|41968773|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
19445058|NCT01766817|41692854|FG001|Overall Study|Subject non-compliance|1|||
19445059|NCT01766817|41692855|FG002|Overall Study|Subject non-compliance|2|||
19445060|NCT01766817|41692853|FG000|Overall Study|Physician Decision|3|||
19445061|NCT01766817|41692854|FG001|Overall Study|Physician Decision|3|||
19629086|NCT00811070|42078670|FG001|Overall Study|Death|0|||
19445062|NCT01766817|41692855|FG002|Overall Study|Physician Decision|4|||
19445063|NCT01766817|41692853|FG000|Overall Study|Other|1|||
19445064|NCT01766817|41692854|FG001|Overall Study|Other|0|||
19445065|NCT01766817|41692855|FG002|Overall Study|Other|0|||
19523627|NCT03525678|41968771|FG000|Overall Study|Withdrawal by Subject|3|||
19445066|NCT01797705|41692863|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
19445067|NCT01797705|41692863|FG000|Overall Study|Withdrawal by Subject|1|||
19445068|NCT01797081|41692871|FG000|Overall Study|Adverse Event|1|||
19445069|NCT01797081|41692872|FG001|Overall Study|Adverse Event|0|||
19445070|NCT01797081|41692873|FG002|Overall Study|Adverse Event|1|||
19445071|NCT01797081|41692874|FG003|Overall Study|Adverse Event|0|||
19445072|NCT01797081|41692871|FG000|Overall Study|Pregnancy|1|||
19445073|NCT01797081|41692872|FG001|Overall Study|Pregnancy|0|||
19445074|NCT01797081|41692873|FG002|Overall Study|Pregnancy|0|||
19445075|NCT01797081|41692874|FG003|Overall Study|Pregnancy|0|||
19445076|NCT01797081|41692871|FG000|Overall Study|Personal Reasons|12|||
19523628|NCT03525678|41968772|FG001|Overall Study|Withdrawal by Subject|1|||
19523629|NCT03525678|41968773|FG002|Overall Study|Withdrawal by Subject|0|||
19523630|NCT03525678|41968771|FG000|Overall Study|Physician Decision|1|||
19523631|NCT03525678|41968772|FG001|Overall Study|Physician Decision|2|||
19445077|NCT01797081|41692872|FG001|Overall Study|Personal Reasons|4|||
19445078|NCT01797081|41692873|FG002|Overall Study|Personal Reasons|4|||
19445079|NCT01797081|41692874|FG003|Overall Study|Personal Reasons|8|||
19523632|NCT03525678|41968773|FG002|Overall Study|Physician Decision|0|||
19523633|NCT03525678|41968771|FG000|Overall Study|Lost to Follow-up|1|||
19523634|NCT03525678|41968772|FG001|Overall Study|Lost to Follow-up|0|||
19523635|NCT03525678|41968773|FG002|Overall Study|Lost to Follow-up|0|||
19523636|NCT03525678|41968771|FG000|Overall Study|Death|32|||
19523637|NCT03525678|41968772|FG001|Overall Study|Death|31|||
19523638|NCT03525678|41968773|FG002|Overall Study|Death|4|||
19445080|NCT01797081|41692871|FG000|Overall Study|Protocol Violation|0|||
19445081|NCT01797081|41692872|FG001|Overall Study|Protocol Violation|0|||
19445082|NCT01797081|41692873|FG002|Overall Study|Protocol Violation|0|||
19445083|NCT01797081|41692874|FG003|Overall Study|Protocol Violation|1|||
19445084|NCT01794117|41692886|FG000|Overall Study|Adverse Event|1|||
19445085|NCT01794117|41692887|FG001|Overall Study|Adverse Event|0|||
19445086|NCT01794117|41692888|FG002|Overall Study|Adverse Event|0|||
19445087|NCT01794117|41692889|FG003|Overall Study|Adverse Event|0|||
19445088|NCT01794117|41692886|FG000|Overall Study|Participant noncompliance|0|||
19445089|NCT01794117|41692887|FG001|Overall Study|Participant noncompliance|1|||
19445090|NCT01794117|41692888|FG002|Overall Study|Participant noncompliance|0|||
19445091|NCT01794117|41692889|FG003|Overall Study|Participant noncompliance|0|||
19445092|NCT01794117|41692886|FG000|Overall Study|Refused further treatment|0|||
19445093|NCT01794117|41692887|FG001|Overall Study|Refused further treatment|2|||
19445094|NCT01794117|41692888|FG002|Overall Study|Refused further treatment|0|||
19445095|NCT01794117|41692889|FG003|Overall Study|Refused further treatment|0|||
19445096|NCT01766037|41692902|FG000|Overall Study|Adverse Event|1|||
19445097|NCT01766037|41692903|FG001|Overall Study|Adverse Event|0|||
19445098|NCT01766037|41692902|FG000|Overall Study|Lack of Efficacy|1|||
19445099|NCT01766037|41692903|FG001|Overall Study|Lack of Efficacy|0|||
19445100|NCT01766037|41692902|FG000|Overall Study|Lost to Follow-up|0|||
19445101|NCT01766037|41692903|FG001|Overall Study|Lost to Follow-up|10|||
19445102|NCT01766037|41692902|FG000|Overall Study|Physician Decision|0|||
19445103|NCT01766037|41692903|FG001|Overall Study|Physician Decision|1|||
19445104|NCT01766037|41692902|FG000|Overall Study|Withdrawal by Subject|18|||
19445105|NCT01766037|41692903|FG001|Overall Study|Withdrawal by Subject|16|||
19445106|NCT01766037|41692902|FG000|Overall Study|Moved from area|5|||
19445107|NCT01766037|41692903|FG001|Overall Study|Moved from area|0|||
19445108|NCT01766037|41692902|FG000|Overall Study|medical - unrelated|1|||
19445109|NCT01766037|41692903|FG001|Overall Study|medical - unrelated|2|||
19445110|NCT01766037|41692902|FG000|Overall Study|nausea / discomfort|3|||
19445111|NCT01766037|41692903|FG001|Overall Study|nausea / discomfort|0|||
19445112|NCT01765569|41692909|FG000|Period B|Withdrawal by Subject|1|||
19445113|NCT01765569|41692909|FG000|Period C|Death|1|||
19445114|NCT01609257|41692918|FG000|Overall Study|Lost to Follow-up|2|||
19445115|NCT01609257|41692919|FG001|Overall Study|Lost to Follow-up|1|||
19445116|NCT01609257|41692918|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
19445117|NCT01609257|41692919|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
19445118|NCT01609257|41692918|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
19445119|NCT01609257|41692919|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
19445120|NCT01609023|41692928|FG000|Overall Study|Lack of Efficacy|3|||
19445121|NCT01609023|41692928|FG000|Overall Study|Withdrawal by Subject|4|||
19445122|NCT01609023|41692928|FG000|Overall Study|Lost to Follow-up|8|||
19445123|NCT01609023|41692928|FG000|Overall Study|Toxicity|3|||
19445124|NCT01609023|41692928|FG000|Overall Study|Disease progression|10|||
19445125|NCT01609023|41692928|FG000|Overall Study|Physician Decision|2|||
19445126|NCT01609023|41692928|FG000|Overall Study|Death|2|||
19445127|NCT01609023|41692928|FG000|Overall Study|Personal reasons|1|||
19445128|NCT01765179|41692932|FG000|Overall Study|Adverse Event|3|||
19445129|NCT01765179|41692932|FG000|Overall Study|Lost to Follow-up|5|||
19445130|NCT01765179|41692932|FG000|Overall Study|Non-compliance with study drug|2|||
19523639|NCT02829918|41968781|FG000|Overall Study|Death|2|||
19523640|NCT02829918|41968781|FG000|Overall Study|Withdrawal by Subject|4|||
19445131|NCT01765179|41692932|FG000|Overall Study|Protocol Violation|1|||
19523641|NCT02829918|41968781|FG000|Overall Study|Adverse Event|1|||
19445132|NCT01765179|41692932|FG000|Overall Study|Withdrawal by Subject|8|||
19445133|NCT01765179|41692932|FG000|Overall Study|Hematocrit >54%|3|||
19445134|NCT01765179|41692932|FG000|Overall Study|prohibited med|1|||
19445135|NCT01765179|41692932|FG000|Overall Study|Out of country unable to finish study|1|||
19445136|NCT01765179|41692932|FG000|Overall Study|lack of venous access|1|||
19445137|NCT01765179|41692932|FG000|Overall Study|work conflict|1|||
19445138|NCT01765179|41692932|FG000|Overall Study|Ca elevated 10.6|1|||
19445139|NCT01764945|41692944|FG000|Overall Study|Adverse Event|0|||
19445140|NCT01764945|41692945|FG001|Overall Study|Adverse Event|1|||
19445141|NCT01764945|41692946|FG002|Overall Study|Adverse Event|0|||
19445142|NCT01764945|41692947|FG003|Overall Study|Adverse Event|0|||
19445143|NCT01764945|41692948|FG004|Overall Study|Adverse Event|0|||
19445144|NCT01764945|41692949|FG005|Overall Study|Adverse Event|0|||
19445145|NCT01764945|41692950|FG006|Overall Study|Adverse Event|1|||
19445146|NCT01764945|41692951|FG007|Overall Study|Adverse Event|0|||
19445147|NCT01793883|41692972|FG000|Overall Study|Withdrawal by Subject|3|||
19445148|NCT01793883|41692973|FG001|Overall Study|Withdrawal by Subject|7|||
19445149|NCT01793883|41692974|FG002|Overall Study|Withdrawal by Subject|3|||
19445150|NCT01793883|41692972|FG000|Overall Study|Subject noncompliance|0|||
19445151|NCT01793883|41692973|FG001|Overall Study|Subject noncompliance|1|||
19445152|NCT01793883|41692974|FG002|Overall Study|Subject noncompliance|1|||
19445153|NCT01793883|41692972|FG000|Overall Study|Lost to Follow-up|5|||
19445154|NCT01793883|41692973|FG001|Overall Study|Lost to Follow-up|1|||
19445155|NCT01793883|41692974|FG002|Overall Study|Lost to Follow-up|3|||
19523642|NCT02829918|41968781|FG000|Overall Study|Progression|1|||
19523643|NCT02743494|41968787|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
19523644|NCT02743494|41968788|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
19523645|NCT02743494|41968787|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
19523646|NCT02743494|41968788|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
19523647|NCT02743494|41968787|FG000|Treatment Period|Completed treatment|229|||
19445156|NCT01793883|41692972|FG000|Overall Study|Randomized in error|1|||
19445157|NCT01793883|41692973|FG001|Overall Study|Randomized in error|0|||
19445158|NCT01793883|41692974|FG002|Overall Study|Randomized in error|0|||
19445159|NCT01793883|41692972|FG000|Overall Study|Unable to complete spriometry|1|||
19445160|NCT01793883|41692973|FG001|Overall Study|Unable to complete spriometry|0|||
19445161|NCT01793883|41692974|FG002|Overall Study|Unable to complete spriometry|0|||
19445162|NCT01793883|41692972|FG000|Overall Study|Unable to complete measurements|1|||
19445163|NCT01793883|41692973|FG001|Overall Study|Unable to complete measurements|0|||
19445164|NCT01793883|41692974|FG002|Overall Study|Unable to complete measurements|0|||
19445165|NCT01793883|41692972|FG000|Overall Study|Met exclusion criteria|1|||
19445166|NCT01793883|41692973|FG001|Overall Study|Met exclusion criteria|0|||
19445167|NCT01793883|41692974|FG002|Overall Study|Met exclusion criteria|0|||
19445168|NCT01793883|41692972|FG000|Overall Study|Dosing error|0|||
19445169|NCT01793883|41692973|FG001|Overall Study|Dosing error|1|||
19445170|NCT01793883|41692974|FG002|Overall Study|Dosing error|0|||
19445171|NCT01793883|41692972|FG000|Overall Study|Respiratory distress during spirometry|0|||
19445172|NCT01793883|41692973|FG001|Overall Study|Respiratory distress during spirometry|0|||
19523648|NCT02743494|41968788|FG001|Treatment Period|Completed treatment|99|||
19523649|NCT02743494|41968787|FG000|Treatment Period|Disease recurrence|149|||
19523650|NCT02743494|41968788|FG001|Treatment Period|Disease recurrence|113|||
19523651|NCT02743494|41968787|FG000|Treatment Period|Study drug toxicity|57|||
19523652|NCT02743494|41968788|FG001|Treatment Period|Study drug toxicity|8|||
19523653|NCT02743494|41968787|FG000|Treatment Period|Death|1|||
19445173|NCT01793883|41692974|FG002|Overall Study|Respiratory distress during spirometry|1|||
19445174|NCT01792635|41692985|FG000|Part B|Adverse Event|0|||
19445175|NCT01792635|41692986|FG001|Part B|Adverse Event|0|||
19445176|NCT01792635|41692987|FG002|Part B|Adverse Event|1|||
19445177|NCT01792635|41692985|FG000|Part B|Study terminated|0|||
19445178|NCT01792635|41692986|FG001|Part B|Study terminated|4|||
19445179|NCT01792635|41692987|FG002|Part B|Study terminated|3|||
19445180|NCT01953692|41693005|FG000|Overall Study|Adverse Event|5|||
19445181|NCT01953692|41693006|FG001|Overall Study|Adverse Event|2|||
19445182|NCT01953692|41693007|FG002|Overall Study|Adverse Event|4|||
19445183|NCT01953692|41693008|FG003|Overall Study|Adverse Event|2|||
19445184|NCT01953692|41693009|FG004|Overall Study|Adverse Event|1|||
19523654|NCT02743494|41968788|FG001|Treatment Period|Death|0|||
19523655|NCT02743494|41968787|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
19629087|NCT00811070|42078671|FG002|Overall Study|Death|0|||
19445185|NCT01953692|41693010|FG005|Overall Study|Adverse Event|2|||
19445186|NCT01953692|41693011|FG006|Overall Study|Adverse Event|0|||
19445187|NCT01953692|41693012|FG007|Overall Study|Adverse Event|0|||
19445188|NCT01953692|41693013|FG008|Overall Study|Adverse Event|0|||
19445189|NCT01953692|41693005|FG000|Overall Study|Clinical Progression|0|||
19445190|NCT01953692|41693006|FG001|Overall Study|Clinical Progression|15|||
19445191|NCT01953692|41693007|FG002|Overall Study|Clinical Progression|7|||
19445192|NCT01953692|41693008|FG003|Overall Study|Clinical Progression|5|||
19445193|NCT01953692|41693009|FG004|Overall Study|Clinical Progression|0|||
19445194|NCT01953692|41693010|FG005|Overall Study|Clinical Progression|7|||
19445195|NCT01953692|41693011|FG006|Overall Study|Clinical Progression|20|||
19445196|NCT01953692|41693012|FG007|Overall Study|Clinical Progression|3|||
19445197|NCT01953692|41693013|FG008|Overall Study|Clinical Progression|3|||
19445198|NCT01953692|41693005|FG000|Overall Study|Death|5|||
19445199|NCT01953692|41693006|FG001|Overall Study|Death|0|||
19445200|NCT01953692|41693007|FG002|Overall Study|Death|2|||
19445201|NCT01953692|41693008|FG003|Overall Study|Death|2|||
19445202|NCT01953692|41693009|FG004|Overall Study|Death|1|||
19445203|NCT01953692|41693010|FG005|Overall Study|Death|3|||
19445204|NCT01953692|41693011|FG006|Overall Study|Death|6|||
19445205|NCT01953692|41693012|FG007|Overall Study|Death|2|||
19445206|NCT01953692|41693013|FG008|Overall Study|Death|1|||
19445207|NCT01953692|41693005|FG000|Overall Study|Excluded Medication|1|||
19445208|NCT01953692|41693006|FG001|Overall Study|Excluded Medication|0|||
19445209|NCT01953692|41693007|FG002|Overall Study|Excluded Medication|0|||
19445210|NCT01953692|41693008|FG003|Overall Study|Excluded Medication|0|||
19445211|NCT01953692|41693009|FG004|Overall Study|Excluded Medication|0|||
19445212|NCT01953692|41693010|FG005|Overall Study|Excluded Medication|0|||
19445213|NCT01953692|41693011|FG006|Overall Study|Excluded Medication|0|||
19445214|NCT01953692|41693012|FG007|Overall Study|Excluded Medication|0|||
19445215|NCT01953692|41693013|FG008|Overall Study|Excluded Medication|0|||
19445216|NCT01953692|41693005|FG000|Overall Study|Lost to Follow-up|1|||
19445217|NCT01953692|41693006|FG001|Overall Study|Lost to Follow-up|0|||
19445218|NCT01953692|41693007|FG002|Overall Study|Lost to Follow-up|3|||
19445219|NCT01953692|41693008|FG003|Overall Study|Lost to Follow-up|1|||
19445220|NCT01953692|41693009|FG004|Overall Study|Lost to Follow-up|0|||
19445221|NCT01953692|41693010|FG005|Overall Study|Lost to Follow-up|1|||
19445222|NCT01953692|41693011|FG006|Overall Study|Lost to Follow-up|0|||
19445223|NCT01953692|41693012|FG007|Overall Study|Lost to Follow-up|0|||
19445224|NCT01953692|41693013|FG008|Overall Study|Lost to Follow-up|0|||
19445225|NCT01953692|41693005|FG000|Overall Study|Physician Decision|11|||
19445226|NCT01953692|41693006|FG001|Overall Study|Physician Decision|4|||
19445227|NCT01953692|41693007|FG002|Overall Study|Physician Decision|2|||
19445228|NCT01953692|41693008|FG003|Overall Study|Physician Decision|2|||
19445229|NCT01953692|41693009|FG004|Overall Study|Physician Decision|1|||
19445230|NCT01953692|41693010|FG005|Overall Study|Physician Decision|2|||
19445231|NCT01953692|41693011|FG006|Overall Study|Physician Decision|4|||
19445232|NCT01953692|41693012|FG007|Overall Study|Physician Decision|1|||
19445233|NCT01953692|41693013|FG008|Overall Study|Physician Decision|0|||
19445234|NCT01953692|41693005|FG000|Overall Study|Protocol Violation|0|||
19445235|NCT01953692|41693006|FG001|Overall Study|Protocol Violation|2|||
19445236|NCT01953692|41693007|FG002|Overall Study|Protocol Violation|1|||
19445237|NCT01953692|41693008|FG003|Overall Study|Protocol Violation|0|||
19445238|NCT01953692|41693009|FG004|Overall Study|Protocol Violation|0|||
19445239|NCT01953692|41693010|FG005|Overall Study|Protocol Violation|0|||
19445240|NCT01953692|41693011|FG006|Overall Study|Protocol Violation|0|||
19445241|NCT01953692|41693012|FG007|Overall Study|Protocol Violation|1|||
19445242|NCT01953692|41693013|FG008|Overall Study|Protocol Violation|0|||
19445243|NCT01953692|41693005|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445244|NCT01953692|41693006|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445245|NCT01953692|41693007|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445246|NCT01953692|41693008|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445247|NCT01953692|41693009|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445248|NCT01953692|41693010|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445249|NCT01953692|41693011|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445250|NCT01953692|41693012|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
19523656|NCT02743494|41968788|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
19523657|NCT02743494|41968787|FG000|Treatment Period|Participant request to discontinue treatment|30|||
19523658|NCT02743494|41968788|FG001|Treatment Period|Participant request to discontinue treatment|5|||
19445251|NCT01953692|41693013|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
19445252|NCT01953692|41693005|FG000|Overall Study|Withdrawal by Subject|4|||
19445253|NCT01953692|41693006|FG001|Overall Study|Withdrawal by Subject|2|||
19445254|NCT01953692|41693007|FG002|Overall Study|Withdrawal by Subject|1|||
19445255|NCT01953692|41693008|FG003|Overall Study|Withdrawal by Subject|2|||
19445256|NCT01953692|41693009|FG004|Overall Study|Withdrawal by Subject|0|||
19445257|NCT01953692|41693010|FG005|Overall Study|Withdrawal by Subject|3|||
19445258|NCT01953692|41693011|FG006|Overall Study|Withdrawal by Subject|2|||
19445259|NCT01953692|41693012|FG007|Overall Study|Withdrawal by Subject|1|||
19445260|NCT01953692|41693013|FG008|Overall Study|Withdrawal by Subject|1|||
19445261|NCT01791153|41693047|FG000|Part 1: Blinded Period|Adverse Event|7|||
19445262|NCT01791153|41693048|FG001|Part 1: Blinded Period|Adverse Event|3|||
19445263|NCT01791153|41693049|FG002|Part 1: Blinded Period|Adverse Event|2|||
19445264|NCT01791153|41693050|FG003|Part 1: Blinded Period|Adverse Event|0|||
19445265|NCT01791153|41693051|FG004|Part 1: Blinded Period|Adverse Event|0|||
19445266|NCT01791153|41693052|FG005|Part 1: Blinded Period|Adverse Event|0|||
19445267|NCT01791153|41693053|FG006|Part 1: Blinded Period|Adverse Event|0|||
19523659|NCT02743494|41968787|FG000|Treatment Period|Participant withdrew consent|12|||
19523660|NCT02743494|41968788|FG001|Treatment Period|Participant withdrew consent|4|||
19523661|NCT02743494|41968787|FG000|Treatment Period|Lost to Follow-up|0|||
19523662|NCT02743494|41968788|FG001|Treatment Period|Lost to Follow-up|1|||
19523663|NCT02743494|41968787|FG000|Treatment Period|Poor/Non-compliance|1|||
19523664|NCT02743494|41968788|FG001|Treatment Period|Poor/Non-compliance|0|||
19523665|NCT02743494|41968787|FG000|Treatment Period|Other reasons|7|||
19523666|NCT02743494|41968788|FG001|Treatment Period|Other reasons|2|||
19523667|NCT02454972|41968803|FG000|Overall Study|Progressive disease|17|||
19523668|NCT02454972|41968804|FG001|Overall Study|Progressive disease|16|||
19523669|NCT02454972|41968805|FG002|Overall Study|Progressive disease|59|||
19523670|NCT02454972|41968806|FG003|Overall Study|Progressive disease|23|||
19523671|NCT02454972|41968807|FG004|Overall Study|Progressive disease|16|||
19523672|NCT02454972|41968808|FG005|Overall Study|Progressive disease|12|||
19523673|NCT02454972|41968809|FG006|Overall Study|Progressive disease|19|||
19523674|NCT02454972|41968810|FG007|Overall Study|Progressive disease|27|||
19445268|NCT01791153|41693054|FG007|Part 1: Blinded Period|Adverse Event|0|||
19445269|NCT01791153|41693047|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
19523675|NCT02454972|41968811|FG008|Overall Study|Progressive disease|0|||
19523676|NCT02454972|41968803|FG000|Overall Study|Death|0|||
19445270|NCT01791153|41693048|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
19445271|NCT01791153|41693049|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
19445272|NCT01791153|41693050|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
19445273|NCT01791153|41693051|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
19445274|NCT01791153|41693052|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
19445275|NCT01791153|41693053|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
19445276|NCT01791153|41693054|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
19445277|NCT01791153|41693047|FG000|Part 1: Blinded Period|Non-Compliance|1|||
19445278|NCT01791153|41693048|FG001|Part 1: Blinded Period|Non-Compliance|0|||
19445279|NCT01791153|41693049|FG002|Part 1: Blinded Period|Non-Compliance|0|||
19445280|NCT01791153|41693050|FG003|Part 1: Blinded Period|Non-Compliance|0|||
19445281|NCT01791153|41693051|FG004|Part 1: Blinded Period|Non-Compliance|0|||
19523677|NCT02454972|41968804|FG001|Overall Study|Death|0|||
19523678|NCT02454972|41968805|FG002|Overall Study|Death|5|||
19523679|NCT02454972|41968806|FG003|Overall Study|Death|1|||
19523680|NCT02454972|41968807|FG004|Overall Study|Death|0|||
19523681|NCT02454972|41968808|FG005|Overall Study|Death|0|||
19523682|NCT02454972|41968809|FG006|Overall Study|Death|0|||
19523683|NCT02454972|41968810|FG007|Overall Study|Death|0|||
19523684|NCT02454972|41968811|FG008|Overall Study|Death|95|||
19523685|NCT02454972|41968803|FG000|Overall Study|Physician Decision|0|||
19523686|NCT02454972|41968804|FG001|Overall Study|Physician Decision|1|||
19523687|NCT02454972|41968805|FG002|Overall Study|Physician Decision|2|||
19523688|NCT02454972|41968806|FG003|Overall Study|Physician Decision|1|||
19523689|NCT02454972|41968807|FG004|Overall Study|Physician Decision|2|||
19445282|NCT01791153|41693052|FG005|Part 1: Blinded Period|Non-Compliance|0|||
19445283|NCT01791153|41693053|FG006|Part 1: Blinded Period|Non-Compliance|0|||
19445284|NCT01791153|41693054|FG007|Part 1: Blinded Period|Non-Compliance|0|||
19445285|NCT01791153|41693047|FG000|Part 1: Blinded Period|Physician Decision|0|||
19445286|NCT01791153|41693048|FG001|Part 1: Blinded Period|Physician Decision|0|||
19445287|NCT01791153|41693049|FG002|Part 1: Blinded Period|Physician Decision|0|||
19445288|NCT01791153|41693050|FG003|Part 1: Blinded Period|Physician Decision|1|||
19445289|NCT01791153|41693051|FG004|Part 1: Blinded Period|Physician Decision|0|||
19445290|NCT01791153|41693052|FG005|Part 1: Blinded Period|Physician Decision|0|||
19445291|NCT01791153|41693053|FG006|Part 1: Blinded Period|Physician Decision|0|||
19523690|NCT02454972|41968808|FG005|Overall Study|Physician Decision|0|||
19445292|NCT01791153|41693054|FG007|Part 1: Blinded Period|Physician Decision|0|||
19445293|NCT01791153|41693047|FG000|Part 1: Blinded Period|Protocol Violation|0|||
19445294|NCT01791153|41693048|FG001|Part 1: Blinded Period|Protocol Violation|0|||
19445295|NCT01791153|41693049|FG002|Part 1: Blinded Period|Protocol Violation|0|||
19445296|NCT01791153|41693050|FG003|Part 1: Blinded Period|Protocol Violation|1|||
19445297|NCT01791153|41693051|FG004|Part 1: Blinded Period|Protocol Violation|0|||
19445298|NCT01791153|41693052|FG005|Part 1: Blinded Period|Protocol Violation|0|||
19523691|NCT02454972|41968809|FG006|Overall Study|Physician Decision|0|||
19523692|NCT02454972|41968810|FG007|Overall Study|Physician Decision|1|||
19523693|NCT02454972|41968811|FG008|Overall Study|Physician Decision|0|||
19523694|NCT02454972|41968803|FG000|Overall Study|Non treatment-related adverse event|2|||
19523695|NCT02454972|41968804|FG001|Overall Study|Non treatment-related adverse event|0|||
19523696|NCT02454972|41968805|FG002|Overall Study|Non treatment-related adverse event|1|||
19445299|NCT01791153|41693053|FG006|Part 1: Blinded Period|Protocol Violation|0|||
19445300|NCT01791153|41693054|FG007|Part 1: Blinded Period|Protocol Violation|0|||
19445301|NCT01791153|41693047|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
19445302|NCT01791153|41693048|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
19445303|NCT01791153|41693049|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
19445304|NCT01791153|41693050|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
19523697|NCT02454972|41968806|FG003|Overall Study|Non treatment-related adverse event|0|||
19523698|NCT02454972|41968807|FG004|Overall Study|Non treatment-related adverse event|0|||
19523699|NCT02454972|41968808|FG005|Overall Study|Non treatment-related adverse event|1|||
19523700|NCT02454972|41968809|FG006|Overall Study|Non treatment-related adverse event|0|||
19523701|NCT02454972|41968810|FG007|Overall Study|Non treatment-related adverse event|1|||
19523702|NCT02454972|41968811|FG008|Overall Study|Non treatment-related adverse event|0|||
19523703|NCT02454972|41968803|FG000|Overall Study|Treatment-related adverse events|0|||
19523704|NCT02454972|41968804|FG001|Overall Study|Treatment-related adverse events|1|||
19523705|NCT02454972|41968805|FG002|Overall Study|Treatment-related adverse events|1|||
19523706|NCT02454972|41968806|FG003|Overall Study|Treatment-related adverse events|0|||
19523707|NCT02454972|41968807|FG004|Overall Study|Treatment-related adverse events|2|||
19445305|NCT01791153|41693051|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
19445306|NCT01791153|41693052|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
19523708|NCT02454972|41968808|FG005|Overall Study|Treatment-related adverse events|0|||
19523709|NCT02454972|41968809|FG006|Overall Study|Treatment-related adverse events|0|||
19523710|NCT02454972|41968810|FG007|Overall Study|Treatment-related adverse events|2|||
19523711|NCT02454972|41968811|FG008|Overall Study|Treatment-related adverse events|0|||
19523712|NCT02454972|41968803|FG000|Overall Study|Patient moves to compassionate use|0|||
19523713|NCT02454972|41968804|FG001|Overall Study|Patient moves to compassionate use|0|||
19523714|NCT02454972|41968805|FG002|Overall Study|Patient moves to compassionate use|0|||
19523715|NCT02454972|41968806|FG003|Overall Study|Patient moves to compassionate use|0|||
19523716|NCT02454972|41968807|FG004|Overall Study|Patient moves to compassionate use|0|||
19523717|NCT02454972|41968808|FG005|Overall Study|Patient moves to compassionate use|0|||
19523718|NCT02454972|41968809|FG006|Overall Study|Patient moves to compassionate use|2|||
19523719|NCT02454972|41968810|FG007|Overall Study|Patient moves to compassionate use|0|||
19523720|NCT02454972|41968811|FG008|Overall Study|Patient moves to compassionate use|0|||
19523721|NCT02454972|41968803|FG000|Overall Study|Withdrawal by Subject|0|||
19523722|NCT02454972|41968804|FG001|Overall Study|Withdrawal by Subject|1|||
19523723|NCT02454972|41968805|FG002|Overall Study|Withdrawal by Subject|5|||
19523724|NCT02454972|41968806|FG003|Overall Study|Withdrawal by Subject|2|||
19523725|NCT02454972|41968807|FG004|Overall Study|Withdrawal by Subject|3|||
19523726|NCT02454972|41968808|FG005|Overall Study|Withdrawal by Subject|2|||
19523727|NCT02454972|41968809|FG006|Overall Study|Withdrawal by Subject|0|||
19523728|NCT02454972|41968810|FG007|Overall Study|Withdrawal by Subject|1|||
19523729|NCT02454972|41968811|FG008|Overall Study|Withdrawal by Subject|2|||
19523730|NCT02454972|41968803|FG000|Overall Study|Multiple delay/holds on treatment|0|||
19523731|NCT02454972|41968804|FG001|Overall Study|Multiple delay/holds on treatment|0|||
19523732|NCT02454972|41968805|FG002|Overall Study|Multiple delay/holds on treatment|0|||
19523733|NCT02454972|41968806|FG003|Overall Study|Multiple delay/holds on treatment|1|||
19445307|NCT01791153|41693053|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
19445308|NCT01791153|41693054|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
19445309|NCT01791153|41693047|FG000|Part 2: Open-label Period|Adverse Event|0|||
19445310|NCT01791153|41693048|FG001|Part 2: Open-label Period|Adverse Event|0|||
19445311|NCT01791153|41693049|FG002|Part 2: Open-label Period|Adverse Event|0|||
19445312|NCT01791153|41693050|FG003|Part 2: Open-label Period|Adverse Event|0|||
19445313|NCT01791153|41693051|FG004|Part 2: Open-label Period|Adverse Event|0|||
19445314|NCT01791153|41693052|FG005|Part 2: Open-label Period|Adverse Event|1|||
19445315|NCT01791153|41693053|FG006|Part 2: Open-label Period|Adverse Event|1|||
19445316|NCT01791153|41693054|FG007|Part 2: Open-label Period|Adverse Event|2|||
19445317|NCT01791153|41693047|FG000|Part 2: Open-label Period|Death|0|||
19445318|NCT01791153|41693048|FG001|Part 2: Open-label Period|Death|0|||
19445319|NCT01791153|41693049|FG002|Part 2: Open-label Period|Death|0|||
19445320|NCT01791153|41693050|FG003|Part 2: Open-label Period|Death|0|||
19445321|NCT01791153|41693051|FG004|Part 2: Open-label Period|Death|0|||
19445322|NCT01791153|41693052|FG005|Part 2: Open-label Period|Death|1|||
19445323|NCT01791153|41693053|FG006|Part 2: Open-label Period|Death|1|||
19445324|NCT01791153|41693054|FG007|Part 2: Open-label Period|Death|1|||
19445325|NCT01791153|41693047|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
19445326|NCT01791153|41693048|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
19445327|NCT01791153|41693049|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
19445328|NCT01791153|41693050|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
19445329|NCT01791153|41693051|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
19445330|NCT01791153|41693052|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
19523734|NCT02454972|41968807|FG004|Overall Study|Multiple delay/holds on treatment|0|||
19523735|NCT02454972|41968808|FG005|Overall Study|Multiple delay/holds on treatment|0|||
19523736|NCT02454972|41968809|FG006|Overall Study|Multiple delay/holds on treatment|0|||
19523737|NCT02454972|41968810|FG007|Overall Study|Multiple delay/holds on treatment|0|||
19523738|NCT02454972|41968811|FG008|Overall Study|Multiple delay/holds on treatment|0|||
19445331|NCT01791153|41693053|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
19445332|NCT01791153|41693054|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
19523739|NCT02454972|41968803|FG000|Overall Study|Never treated|0|||
19523740|NCT02454972|41968804|FG001|Overall Study|Never treated|0|||
19523741|NCT02454972|41968805|FG002|Overall Study|Never treated|3|||
19523742|NCT02454972|41968806|FG003|Overall Study|Never treated|1|||
19445333|NCT01791153|41693047|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
19445334|NCT01791153|41693048|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
19445335|NCT01791153|41693049|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
19445336|NCT01791153|41693050|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
19445337|NCT01791153|41693051|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
19445338|NCT01791153|41693052|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
19445339|NCT01791153|41693053|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
19445340|NCT01791153|41693054|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
19445341|NCT01791153|41693047|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
19445342|NCT01791153|41693048|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
19445343|NCT01791153|41693049|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
19445344|NCT01791153|41693050|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
19445345|NCT01791153|41693051|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
19445346|NCT01791153|41693052|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
19445347|NCT01791153|41693053|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
19445348|NCT01791153|41693054|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
19445349|NCT01791153|41693047|FG000|Part 2: Open-label Period|Physician Decision|0|||
19445350|NCT01791153|41693048|FG001|Part 2: Open-label Period|Physician Decision|0|||
19445351|NCT01791153|41693049|FG002|Part 2: Open-label Period|Physician Decision|0|||
19445352|NCT01791153|41693050|FG003|Part 2: Open-label Period|Physician Decision|0|||
19445353|NCT01791153|41693051|FG004|Part 2: Open-label Period|Physician Decision|1|||
19445354|NCT01791153|41693052|FG005|Part 2: Open-label Period|Physician Decision|1|||
19445355|NCT01791153|41693053|FG006|Part 2: Open-label Period|Physician Decision|0|||
19445356|NCT01791153|41693054|FG007|Part 2: Open-label Period|Physician Decision|0|||
19445357|NCT01926782|41693075|FG000|Overall Study|Participant moved|2|||
19445358|NCT01926782|41693076|FG001|Overall Study|Participant moved|0|||
19445359|NCT01926782|41693077|FG002|Overall Study|Participant moved|1|||
19445360|NCT01926782|41693078|FG003|Overall Study|Participant moved|1|||
19445361|NCT01926782|41693079|FG004|Overall Study|Participant moved|0|||
19445362|NCT01926782|41693080|FG005|Overall Study|Participant moved|3|||
19445363|NCT01926782|41693075|FG000|Overall Study|Physician Decision|0|||
19445364|NCT01926782|41693076|FG001|Overall Study|Physician Decision|2|||
19445365|NCT01926782|41693077|FG002|Overall Study|Physician Decision|1|||
19445366|NCT01926782|41693078|FG003|Overall Study|Physician Decision|1|||
19445367|NCT01926782|41693079|FG004|Overall Study|Physician Decision|0|||
19445368|NCT01926782|41693080|FG005|Overall Study|Physician Decision|0|||
19523743|NCT02454972|41968807|FG004|Overall Study|Never treated|1|||
19523744|NCT02454972|41968808|FG005|Overall Study|Never treated|0|||
19523745|NCT02454972|41968809|FG006|Overall Study|Never treated|0|||
19523746|NCT02454972|41968810|FG007|Overall Study|Never treated|0|||
19445369|NCT01926782|41693075|FG000|Overall Study|Other than specified|2|||
19445370|NCT01926782|41693076|FG001|Overall Study|Other than specified|3|||
19523747|NCT02454972|41968811|FG008|Overall Study|Never treated|5|||
19523748|NCT02454972|41968803|FG000|Overall Study|Lost to Follow-up|0|||
19523749|NCT02454972|41968804|FG001|Overall Study|Lost to Follow-up|0|||
19523750|NCT02454972|41968805|FG002|Overall Study|Lost to Follow-up|0|||
19523751|NCT02454972|41968806|FG003|Overall Study|Lost to Follow-up|0|||
19445371|NCT01926782|41693077|FG002|Overall Study|Other than specified|5|||
19445372|NCT01926782|41693078|FG003|Overall Study|Other than specified|12|||
19523752|NCT02454972|41968807|FG004|Overall Study|Lost to Follow-up|0|||
19523753|NCT02454972|41968808|FG005|Overall Study|Lost to Follow-up|0|||
19523754|NCT02454972|41968809|FG006|Overall Study|Lost to Follow-up|0|||
19523755|NCT02454972|41968810|FG007|Overall Study|Lost to Follow-up|0|||
19523756|NCT02454972|41968811|FG008|Overall Study|Lost to Follow-up|2|||
19523757|NCT02454972|41968803|FG000|Overall Study|Study termination|0|||
19523758|NCT02454972|41968804|FG001|Overall Study|Study termination|0|||
19523759|NCT02454972|41968805|FG002|Overall Study|Study termination|0|||
19523760|NCT02454972|41968806|FG003|Overall Study|Study termination|0|||
19523761|NCT02454972|41968807|FG004|Overall Study|Study termination|0|||
19523762|NCT02454972|41968808|FG005|Overall Study|Study termination|0|||
19523763|NCT02454972|41968809|FG006|Overall Study|Study termination|0|||
19523764|NCT02454972|41968810|FG007|Overall Study|Study termination|0|||
19523765|NCT02454972|41968811|FG008|Overall Study|Study termination|6|||
19523766|NCT01096368|41968828|FG000|Overall Study|Death|0|||
19523767|NCT01096368|41968829|FG001|Overall Study|Death|1|||
19523768|NCT01096368|41968830|FG002|Overall Study|Death|0|||
19445373|NCT01926782|41693079|FG004|Overall Study|Other than specified|4|||
19445374|NCT01926782|41693080|FG005|Overall Study|Other than specified|11|||
19523769|NCT01096368|41968831|FG003|Overall Study|Death|0|||
19523770|NCT01096368|41968832|FG004|Overall Study|Death|0|||
19523771|NCT01096368|41968828|FG000|Overall Study|Physician Decision|0|||
19523772|NCT01096368|41968829|FG001|Overall Study|Physician Decision|13|||
19523773|NCT01096368|41968830|FG002|Overall Study|Physician Decision|2|||
19523774|NCT01096368|41968831|FG003|Overall Study|Physician Decision|4|||
19523775|NCT01096368|41968832|FG004|Overall Study|Physician Decision|6|||
19523776|NCT01096368|41968828|FG000|Overall Study|Withdrawal by Subject|0|||
19445375|NCT01926782|41693075|FG000|Overall Study|Adverse Event|13|||
19445376|NCT01926782|41693076|FG001|Overall Study|Adverse Event|4|||
19445377|NCT01926782|41693077|FG002|Overall Study|Adverse Event|17|||
19445378|NCT01926782|41693078|FG003|Overall Study|Adverse Event|4|||
19523777|NCT01096368|41968829|FG001|Overall Study|Withdrawal by Subject|52|||
19523778|NCT01096368|41968830|FG002|Overall Study|Withdrawal by Subject|0|||
19523779|NCT01096368|41968831|FG003|Overall Study|Withdrawal by Subject|10|||
19523780|NCT01096368|41968832|FG004|Overall Study|Withdrawal by Subject|14|||
19523781|NCT01096368|41968828|FG000|Overall Study|Ineligible|0|||
19523782|NCT01096368|41968829|FG001|Overall Study|Ineligible|3|||
19445379|NCT01926782|41693079|FG004|Overall Study|Adverse Event|3|||
19445380|NCT01926782|41693080|FG005|Overall Study|Adverse Event|14|||
19445381|NCT01926782|41693075|FG000|Overall Study|Poor compliance to protocol|5|||
19445382|NCT01926782|41693076|FG001|Overall Study|Poor compliance to protocol|3|||
19445383|NCT01926782|41693077|FG002|Overall Study|Poor compliance to protocol|8|||
19445384|NCT01926782|41693078|FG003|Overall Study|Poor compliance to protocol|0|||
19445385|NCT01926782|41693079|FG004|Overall Study|Poor compliance to protocol|1|||
19445386|NCT01926782|41693080|FG005|Overall Study|Poor compliance to protocol|6|||
19445387|NCT01926782|41693075|FG000|Overall Study|Randomized and not treated|0|||
19445388|NCT01926782|41693076|FG001|Overall Study|Randomized and not treated|0|||
19445389|NCT01926782|41693077|FG002|Overall Study|Randomized and not treated|0|||
19445390|NCT01926782|41693078|FG003|Overall Study|Randomized and not treated|1|||
19445391|NCT01926782|41693079|FG004|Overall Study|Randomized and not treated|0|||
19445392|NCT01926782|41693080|FG005|Overall Study|Randomized and not treated|0|||
19445393|NCT01926782|41693075|FG000|Overall Study|Withdrawal by Subject|6|||
19445394|NCT01926782|41693076|FG001|Overall Study|Withdrawal by Subject|1|||
19445395|NCT01926782|41693077|FG002|Overall Study|Withdrawal by Subject|8|||
19445396|NCT01926782|41693078|FG003|Overall Study|Withdrawal by Subject|1|||
19445397|NCT01926782|41693079|FG004|Overall Study|Withdrawal by Subject|0|||
19445398|NCT01926782|41693080|FG005|Overall Study|Withdrawal by Subject|5|||
19445399|NCT01926782|41693075|FG000|Overall Study|Related to study drug administration|0|||
19445400|NCT01926782|41693076|FG001|Overall Study|Related to study drug administration|0|||
19445401|NCT01926782|41693077|FG002|Overall Study|Related to study drug administration|0|||
19445402|NCT01926782|41693078|FG003|Overall Study|Related to study drug administration|0|||
19445403|NCT01926782|41693079|FG004|Overall Study|Related to study drug administration|0|||
19445404|NCT01926782|41693080|FG005|Overall Study|Related to study drug administration|2|||
19445405|NCT01926626|41693095|FG000|Overall Study|Withdrawal by Subject|15|||
19445406|NCT01926626|41693095|FG000|Overall Study|Lost to Follow-up|7|||
19445407|NCT01953224|41693101|FG000|Overall Study|Lost to Follow-up|1|||
19445408|NCT01953224|41693102|FG001|Overall Study|Lost to Follow-up|1|||
19445409|NCT01953224|41693101|FG000|Overall Study|Withdrawal by Subject|1|||
19445410|NCT01953224|41693102|FG001|Overall Study|Withdrawal by Subject|2|||
19445411|NCT01900730|41693110|FG000|Overall Study|Withdrawal by Subject|1|||
19445412|NCT01900730|41693111|FG001|Overall Study|Withdrawal by Subject|0|||
19445413|NCT01900730|41693110|FG000|Overall Study|Screen Failure|1|||
19445414|NCT01900730|41693111|FG001|Overall Study|Screen Failure|0|||
19445415|NCT01952834|41693117|FG000|Overall Study|Adverse Event|1|||
19445416|NCT01952366|41693122|FG000|Overall Study|Death|22|||
19445417|NCT01952366|41693122|FG000|Overall Study|Withdrawal by Subject|9|||
19445418|NCT01952054|41693129|FG000|Overall Study|Physician Decision|1|||
19445419|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
19445420|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19445421|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
19445422|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
19445423|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
19445424|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
19445425|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
19445426|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
19445427|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
19445428|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
19445429|NCT01925768|41693135|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
19445430|NCT01925768|41693136|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
19445431|NCT01925768|41693135|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
19445432|NCT01925768|41693136|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
19445433|NCT01925768|41693135|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
19445434|NCT01925768|41693136|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
19445435|NCT01925768|41693135|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
19523783|NCT01096368|41968830|FG002|Overall Study|Ineligible|2|||
19523784|NCT01096368|41968831|FG003|Overall Study|Ineligible|0|||
19629088|NCT00811070|42078672|FG003|Overall Study|Death|2|||
19523785|NCT01096368|41968832|FG004|Overall Study|Ineligible|25|||
19523786|NCT01096368|41968828|FG000|Overall Study|Did not start treatment|0|||
19523787|NCT01096368|41968829|FG001|Overall Study|Did not start treatment|4|||
19523788|NCT01096368|41968830|FG002|Overall Study|Did not start treatment|4|||
19523789|NCT01096368|41968831|FG003|Overall Study|Did not start treatment|0|||
19523790|NCT01096368|41968832|FG004|Overall Study|Did not start treatment|0|||
19523791|NCT01096368|41968828|FG000|Overall Study|Progressive disease|0|||
19523792|NCT01096368|41968829|FG001|Overall Study|Progressive disease|6|||
19523793|NCT01096368|41968830|FG002|Overall Study|Progressive disease|0|||
19523794|NCT01096368|41968831|FG003|Overall Study|Progressive disease|10|||
19523795|NCT01096368|41968832|FG004|Overall Study|Progressive disease|3|||
19523796|NCT01096368|41968828|FG000|Overall Study|Other|0|||
19523797|NCT01096368|41968829|FG001|Overall Study|Other|0|||
19523798|NCT01096368|41968830|FG002|Overall Study|Other|1|||
19523799|NCT01096368|41968831|FG003|Overall Study|Other|0|||
19523800|NCT01096368|41968832|FG004|Overall Study|Other|0|||
19523801|NCT01096368|41968828|FG000|Overall Study|Treated with institutional review|0|||
19523802|NCT01096368|41968829|FG001|Overall Study|Treated with institutional review|0|||
19523803|NCT01096368|41968830|FG002|Overall Study|Treated with institutional review|0|||
19523804|NCT01096368|41968831|FG003|Overall Study|Treated with institutional review|0|||
19523805|NCT01096368|41968832|FG004|Overall Study|Treated with institutional review|1|||
19523806|NCT00063882|41968853|FG000|Overall Study|Protocol Violation|3|||
19523807|NCT00063882|41968854|FG001|Overall Study|Protocol Violation|3|||
19523808|NCT00063882|41968853|FG000|Overall Study|Withdrawal by Subject|2|||
19445436|NCT01925768|41693136|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
19445437|NCT01925768|41693135|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
19523809|NCT00063882|41968854|FG001|Overall Study|Withdrawal by Subject|1|||
19523810|NCT01279044|41968863|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
19523811|NCT01279044|41968864|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
19523812|NCT01279044|41968865|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
19523813|NCT01279044|41968863|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
19523814|NCT01279044|41968864|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
19523815|NCT01279044|41968865|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
19523816|NCT01279044|41968863|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
19523817|NCT01279044|41968864|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
19523818|NCT01279044|41968865|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
19523819|NCT01278342|41968874|FG000|Overall Study|Physician Decision|0|||
19523820|NCT01278342|41968875|FG001|Overall Study|Physician Decision|1|||
19523821|NCT01278342|41968876|FG002|Overall Study|Physician Decision|0|||
19523822|NCT01278342|41968874|FG000|Overall Study|Lost to Follow-up|1|||
19523823|NCT01278342|41968875|FG001|Overall Study|Lost to Follow-up|0|||
19523824|NCT01278342|41968876|FG002|Overall Study|Lost to Follow-up|0|||
19523825|NCT01278342|41968874|FG000|Overall Study|Administrative problems|2|||
19523826|NCT01278342|41968875|FG001|Overall Study|Administrative problems|0|||
19523827|NCT01278342|41968876|FG002|Overall Study|Administrative problems|0|||
19523828|NCT01278342|41968874|FG000|Overall Study|Other|1|||
19523829|NCT01278342|41968875|FG001|Overall Study|Other|0|||
19523830|NCT01278342|41968876|FG002|Overall Study|Other|0|||
19523831|NCT01278030|41968886|FG000|Overall Study|Withdrawal by Subject|8|||
19523832|NCT01278030|41968887|FG001|Overall Study|Withdrawal by Subject|4|||
19523833|NCT01277718|41968893|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
19523834|NCT01277718|41968894|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
19445438|NCT01925768|41693136|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
19445439|NCT01925768|41693135|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
19445440|NCT01925768|41693136|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
19445441|NCT01431274|41693151|FG000|Overall Study|Adverse Event|51|||
19445442|NCT01431274|41693152|FG001|Overall Study|Adverse Event|37|||
19445443|NCT01431274|41693153|FG002|Overall Study|Adverse Event|43|||
19445444|NCT01431274|41693154|FG003|Overall Study|Adverse Event|30|||
19445445|NCT01431274|41693155|FG004|Overall Study|Adverse Event|37|||
19445446|NCT01431274|41693151|FG000|Overall Study|Consent withdrawn not due to AE|29|||
19445447|NCT01431274|41693152|FG001|Overall Study|Consent withdrawn not due to AE|20|||
19445448|NCT01431274|41693153|FG002|Overall Study|Consent withdrawn not due to AE|17|||
19523835|NCT01277718|41968893|FG000|Period 2 - Second Intervention|Physician Decision|0|||
19523836|NCT01277718|41968894|FG001|Period 2 - Second Intervention|Physician Decision|2|||
19523837|NCT01276236|41968902|FG000|Overall Study|Lack of Efficacy|2|||
19523838|NCT01276236|41968902|FG000|Overall Study|Withdrawal by Subject|4|||
19523839|NCT01275222|41968912|FG000|Phase l by Treatment|Adverse Event|1|||
19523840|NCT01275222|41968913|FG001|Phase l by Treatment|Adverse Event|4|||
19523841|NCT01275222|41968914|FG002|Phase l by Treatment|Adverse Event|2|||
19523842|NCT01275222|41968915|FG003|Phase l by Treatment|Adverse Event|3|||
19523843|NCT01275222|41968916|FG004|Phase l by Treatment|Adverse Event|0|||
19523844|NCT01275222|41968917|FG005|Phase l by Treatment|Adverse Event|0|||
19445449|NCT01431274|41693154|FG003|Overall Study|Consent withdrawn not due to AE|20|||
19445450|NCT01431274|41693155|FG004|Overall Study|Consent withdrawn not due to AE|11|||
19523845|NCT01275222|41968912|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
19523846|NCT01275222|41968913|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
19629089|NCT00811070|42078673|FG004|Overall Study|Death|5|||
19523847|NCT01275222|41968914|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
19523848|NCT01275222|41968915|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
19523849|NCT01275222|41968916|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
19523850|NCT01275222|41968917|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
19523851|NCT01275222|41968912|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
19523852|NCT01275222|41968913|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
19523853|NCT01275222|41968914|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
19523854|NCT01275222|41968915|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
19523855|NCT01275222|41968916|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
19523856|NCT01275222|41968917|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
19523857|NCT01275222|41968912|FG000|Phase l by Treatment|Disease progression|12|||
19445451|NCT01431274|41693151|FG000|Overall Study|Non compliant with protocol|5|||
19445452|NCT01431274|41693152|FG001|Overall Study|Non compliant with protocol|8|||
19445453|NCT01431274|41693153|FG002|Overall Study|Non compliant with protocol|4|||
19445454|NCT01431274|41693154|FG003|Overall Study|Non compliant with protocol|4|||
19445455|NCT01431274|41693155|FG004|Overall Study|Non compliant with protocol|4|||
19445456|NCT01431274|41693151|FG000|Overall Study|Lost to Follow-up|6|||
19445457|NCT01431274|41693152|FG001|Overall Study|Lost to Follow-up|7|||
19445458|NCT01431274|41693153|FG002|Overall Study|Lost to Follow-up|1|||
19445459|NCT01431274|41693154|FG003|Overall Study|Lost to Follow-up|4|||
19445460|NCT01431274|41693155|FG004|Overall Study|Lost to Follow-up|0|||
19445461|NCT01431274|41693151|FG000|Overall Study|Other reason not stated above|6|||
19445462|NCT01431274|41693152|FG001|Overall Study|Other reason not stated above|5|||
19445463|NCT01431274|41693153|FG002|Overall Study|Other reason not stated above|7|||
19445464|NCT01431274|41693154|FG003|Overall Study|Other reason not stated above|2|||
19445465|NCT01431274|41693155|FG004|Overall Study|Other reason not stated above|4|||
19445466|NCT01991795|41693169|FG000|Overall Study|Lost to Follow-up|6|||
19445467|NCT01991795|41693170|FG001|Overall Study|Lost to Follow-up|4|||
19445468|NCT01991795|41693169|FG000|Overall Study|Withdrawal by Subject|117|||
19445469|NCT01991795|41693170|FG001|Overall Study|Withdrawal by Subject|94|||
19445470|NCT01991795|41693169|FG000|Overall Study|Site prematurely closed by sponsor|26|||
19523858|NCT01275222|41968913|FG001|Phase l by Treatment|Disease progression|8|||
19523859|NCT01275222|41968914|FG002|Phase l by Treatment|Disease progression|2|||
19523860|NCT01275222|41968915|FG003|Phase l by Treatment|Disease progression|5|||
19523861|NCT01275222|41968916|FG004|Phase l by Treatment|Disease progression|0|||
19523862|NCT01275222|41968917|FG005|Phase l by Treatment|Disease progression|0|||
19523863|NCT01275222|41968912|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
19523864|NCT01275222|41968913|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
19523865|NCT01275222|41968914|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
19523866|NCT01275222|41968915|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
19523867|NCT01275222|41968916|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
19523868|NCT01275222|41968917|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
19523869|NCT01275222|41968912|FG000|Phase l by Treatment|Death|0|||
19523870|NCT01275222|41968913|FG001|Phase l by Treatment|Death|1|||
19523871|NCT01275222|41968914|FG002|Phase l by Treatment|Death|0|||
19523872|NCT01275222|41968915|FG003|Phase l by Treatment|Death|1|||
19523873|NCT01275222|41968916|FG004|Phase l by Treatment|Death|0|||
19445471|NCT01991795|41693170|FG001|Overall Study|Site prematurely closed by sponsor|25|||
19445472|NCT01411852|41693211|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
19445473|NCT01411852|41693212|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
19445474|NCT01411852|41693211|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
19445475|NCT01411852|41693212|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
19445476|NCT01411852|41693211|FG000|Prehospital Intervention Phase|Found to be under age|0|||
19445477|NCT01411852|41693212|FG001|Prehospital Intervention Phase|Found to be under age|1|||
19445478|NCT01411852|41693211|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
19445479|NCT01411852|41693212|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
19445480|NCT01411852|41693211|FG000|Hospital Intervention Phase|Severe head injury|5|||
19445481|NCT01411852|41693212|FG001|Hospital Intervention Phase|Severe head injury|4|||
19445482|NCT01411852|41693211|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
19445483|NCT01411852|41693212|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
19445484|NCT01411852|41693211|FG000|Hospital Intervention Phase|Miscommunication error|1|||
19445485|NCT01411852|41693212|FG001|Hospital Intervention Phase|Miscommunication error|2|||
19445486|NCT01411852|41693211|FG000|Hospital Intervention Phase|CPR administered|3|||
19445487|NCT01411852|41693212|FG001|Hospital Intervention Phase|CPR administered|1|||
19445488|NCT01411852|41693211|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
19445489|NCT01411852|41693212|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
19445490|NCT01411852|41693211|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
19523874|NCT01275222|41968917|FG005|Phase l by Treatment|Death|0|||
19445491|NCT01411852|41693212|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
19445492|NCT01411852|41693211|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
19445493|NCT01411852|41693212|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
19445494|NCT01411852|41693211|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
19445495|NCT01411852|41693212|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
19445496|NCT01411852|41693211|FG000|Hospital Intervention Phase|Other ineligible|2|||
19445497|NCT01411852|41693212|FG001|Hospital Intervention Phase|Other ineligible|2|||
19445498|NCT01411852|41693211|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
19445499|NCT01411852|41693212|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
19445500|NCT01411852|41693211|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
19445501|NCT01411852|41693212|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
19445502|NCT01411852|41693211|FG000|Hospital Intervention Phase|Vascular access failed|1|||
19445503|NCT01411852|41693212|FG001|Hospital Intervention Phase|Vascular access failed|0|||
19445504|NCT01411774|41693222|FG000|Overall Study|Withdrawal by Subject|0|||
19445505|NCT01411774|41693223|FG001|Overall Study|Withdrawal by Subject|3|||
19445506|NCT01411228|41693232|FG000|Overall Study|Lost to Follow-up|0|||
19445507|NCT01411228|41693233|FG001|Overall Study|Lost to Follow-up|0|||
19445508|NCT01411228|41693234|FG002|Overall Study|Lost to Follow-up|1|||
19445509|NCT01411228|41693232|FG000|Overall Study|Withdrawal by Subject|1|||
19445510|NCT01411228|41693233|FG001|Overall Study|Withdrawal by Subject|0|||
19445511|NCT01411228|41693234|FG002|Overall Study|Withdrawal by Subject|0|||
19445512|NCT01410604|41693244|FG000|Overall Study|Adverse Event|2|||
19445513|NCT01410604|41693245|FG001|Overall Study|Adverse Event|1|||
19445514|NCT01410604|41693244|FG000|Overall Study|Lost to Follow-up|1|||
19523875|NCT01275222|41968912|FG000|Phase ll by Stratum|Adverse Event|0|||
19523876|NCT01275222|41968913|FG001|Phase ll by Stratum|Adverse Event|0|||
19523877|NCT01275222|41968914|FG002|Phase ll by Stratum|Adverse Event|0|||
19445515|NCT01410604|41693245|FG001|Overall Study|Lost to Follow-up|0|||
19445516|NCT01410604|41693244|FG000|Overall Study|Physician Decision|0|||
19445517|NCT01410604|41693245|FG001|Overall Study|Physician Decision|1|||
19445518|NCT01991483|41693255|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
19445519|NCT01991483|41693256|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
19445520|NCT01991483|41693257|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
19445521|NCT01991483|41693258|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
19445522|NCT01991483|41693255|FG000|Dose Level 600 mg|Physician Decision|0|||
19445523|NCT01991483|41693256|FG001|Dose Level 600 mg|Physician Decision|0|||
19445524|NCT01991483|41693257|FG002|Dose Level 600 mg|Physician Decision|1|||
19445525|NCT01991483|41693258|FG003|Dose Level 600 mg|Physician Decision|0|||
19445526|NCT01991483|41693255|FG000|Dose Level 1000 mg|Protocol Violation|0|||
19445527|NCT01991483|41693256|FG001|Dose Level 1000 mg|Protocol Violation|0|||
19445528|NCT01991483|41693257|FG002|Dose Level 1000 mg|Protocol Violation|0|||
19445529|NCT01991483|41693258|FG003|Dose Level 1000 mg|Protocol Violation|1|||
19445530|NCT01410448|41693273|FG000|Overall Study|No conversion to everolimus|0|||
19445531|NCT01410448|41693274|FG001|Overall Study|No conversion to everolimus|24|||
19445532|NCT01410448|41693273|FG000|Overall Study|Graft loss|4|||
19445533|NCT01410448|41693274|FG001|Overall Study|Graft loss|1|||
19445534|NCT01410448|41693273|FG000|Overall Study|Administrative issues|2|||
19445535|NCT01410448|41693274|FG001|Overall Study|Administrative issues|1|||
19445536|NCT01410448|41693273|FG000|Overall Study|Lost to Follow-up|1|||
19445537|NCT01410448|41693274|FG001|Overall Study|Lost to Follow-up|0|||
19445538|NCT01410448|41693273|FG000|Overall Study|Withdrawal by Subject|3|||
19445539|NCT01410448|41693274|FG001|Overall Study|Withdrawal by Subject|2|||
19445540|NCT01410448|41693273|FG000|Overall Study|Protocol Violation|0|||
19445541|NCT01410448|41693274|FG001|Overall Study|Protocol Violation|4|||
19445542|NCT01410448|41693273|FG000|Overall Study|Death|2|||
19445543|NCT01410448|41693274|FG001|Overall Study|Death|3|||
19445544|NCT01943851|41693298|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445545|NCT01943851|41693299|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445546|NCT01943851|41693300|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445547|NCT01943851|41693301|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
19445548|NCT01943851|41693302|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445549|NCT01943851|41693303|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445550|NCT01943851|41693304|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
19445551|NCT01943851|41693305|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
19445552|NCT01943851|41693306|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
19445553|NCT01943851|41693307|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445554|NCT01943851|41693308|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445555|NCT01943851|41693309|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445556|NCT01943851|41693310|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445557|NCT01943851|41693311|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445558|NCT01943851|41693312|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445559|NCT01943851|41693313|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445560|NCT01943851|41693314|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445561|NCT01943851|41693315|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
19445562|NCT01943851|41693298|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445563|NCT01943851|41693299|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445564|NCT01943851|41693300|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445565|NCT01943851|41693301|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445566|NCT01943851|41693302|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
19445567|NCT01943851|41693303|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445568|NCT01943851|41693304|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445569|NCT01943851|41693305|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
19445570|NCT01943851|41693306|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445571|NCT01943851|41693307|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445572|NCT01943851|41693308|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445573|NCT01943851|41693309|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445574|NCT01943851|41693310|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445575|NCT01943851|41693311|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445576|NCT01943851|41693312|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445577|NCT01943851|41693313|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445578|NCT01943851|41693314|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445579|NCT01943851|41693315|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
19445580|NCT01943851|41693298|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445581|NCT01943851|41693299|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445582|NCT01943851|41693300|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445583|NCT01943851|41693301|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445584|NCT01943851|41693302|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445585|NCT01943851|41693303|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445586|NCT01943851|41693304|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445587|NCT01943851|41693305|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445588|NCT01943851|41693306|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445589|NCT01943851|41693307|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445590|NCT01943851|41693308|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445591|NCT01943851|41693309|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445592|NCT01943851|41693310|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445593|NCT01943851|41693311|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
19445594|NCT01943851|41693312|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445595|NCT01943851|41693313|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445596|NCT01943851|41693314|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19523878|NCT01275222|41968915|FG003|Phase ll by Stratum|Adverse Event|0|||
19523879|NCT01275222|41968916|FG004|Phase ll by Stratum|Adverse Event|2|||
19523880|NCT01275222|41968917|FG005|Phase ll by Stratum|Adverse Event|10|||
19523881|NCT01275222|41968912|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
19523882|NCT01275222|41968913|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
19523883|NCT01275222|41968914|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
19523884|NCT01275222|41968915|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
19523885|NCT01275222|41968916|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
19523886|NCT01275222|41968917|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
19445597|NCT01943851|41693315|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
19445598|NCT01943851|41693298|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445599|NCT01943851|41693299|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445600|NCT01943851|41693300|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445601|NCT01943851|41693301|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19523887|NCT01275222|41968912|FG000|Phase ll by Stratum|Disease progression|0|||
19523888|NCT01275222|41968913|FG001|Phase ll by Stratum|Disease progression|0|||
19523889|NCT01275222|41968914|FG002|Phase ll by Stratum|Disease progression|0|||
19523890|NCT01275222|41968915|FG003|Phase ll by Stratum|Disease progression|0|||
19523891|NCT01275222|41968916|FG004|Phase ll by Stratum|Disease progression|23|||
19523892|NCT01275222|41968917|FG005|Phase ll by Stratum|Disease progression|31|||
19523893|NCT01275222|41968912|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
19523894|NCT01275222|41968913|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
19523895|NCT01275222|41968914|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
19523896|NCT01275222|41968915|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
19523897|NCT01275222|41968916|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
19523898|NCT01275222|41968917|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
19523899|NCT01275222|41968912|FG000|Phase ll by Stratum|Death|0|||
19523900|NCT01275222|41968913|FG001|Phase ll by Stratum|Death|0|||
19523901|NCT01275222|41968914|FG002|Phase ll by Stratum|Death|0|||
19523902|NCT01275222|41968915|FG003|Phase ll by Stratum|Death|0|||
19629090|NCT00811070|42078674|FG005|Overall Study|Death|0|||
19629091|NCT00811070|42078669|FG000|Overall Study|Other|1|||
19445602|NCT01943851|41693302|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445603|NCT01943851|41693303|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445604|NCT01943851|41693304|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445605|NCT01943851|41693305|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445606|NCT01943851|41693306|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445607|NCT01943851|41693307|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445608|NCT01943851|41693308|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445609|NCT01943851|41693309|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19629092|NCT00811070|42078670|FG001|Overall Study|Other|0|||
19445610|NCT01943851|41693310|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445611|NCT01943851|41693311|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445612|NCT01943851|41693312|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19523903|NCT01275222|41968916|FG004|Phase ll by Stratum|Death|1|||
19523904|NCT01275222|41968917|FG005|Phase ll by Stratum|Death|1|||
19523905|NCT01275144|41968935|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
19523906|NCT01275144|41968936|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
19523907|NCT01275066|41968947|FG000|Overall Study|Withdrawal by Subject|0|||
19523908|NCT01275066|41968948|FG001|Overall Study|Withdrawal by Subject|0|||
19523909|NCT01275066|41968949|FG002|Overall Study|Withdrawal by Subject|1|||
19523910|NCT01275066|41968947|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
19445613|NCT01943851|41693313|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
19445614|NCT01943851|41693314|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19445615|NCT01943851|41693315|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
19523911|NCT01275066|41968948|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
19523912|NCT01275066|41968949|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
19523913|NCT01273038|41968959|FG000|Second Intervention (14 Days)|Adverse Event|0|||
19523914|NCT01273038|41968960|FG001|Second Intervention (14 Days)|Adverse Event|1|||
19523915|NCT01273038|41968959|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
19523916|NCT01273038|41968960|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
19523917|NCT01272180|41968970|FG000|Overall Study|Adverse Event|0|||
19523918|NCT01272180|41968971|FG001|Overall Study|Adverse Event|0|||
19523919|NCT01272180|41968972|FG002|Overall Study|Adverse Event|1|||
19523920|NCT01272180|41968973|FG003|Overall Study|Adverse Event|0|||
19523921|NCT01272180|41968970|FG000|Overall Study|Withdrawal by Subject|2|||
19523922|NCT01272180|41968971|FG001|Overall Study|Withdrawal by Subject|6|||
19523923|NCT01272180|41968972|FG002|Overall Study|Withdrawal by Subject|3|||
19523924|NCT01272180|41968973|FG003|Overall Study|Withdrawal by Subject|2|||
19523925|NCT01272180|41968970|FG000|Overall Study|Lost to Follow-up|15|||
19523926|NCT01272180|41968971|FG001|Overall Study|Lost to Follow-up|14|||
19523927|NCT01272180|41968972|FG002|Overall Study|Lost to Follow-up|8|||
19523928|NCT01272180|41968973|FG003|Overall Study|Lost to Follow-up|10|||
19523929|NCT01272180|41968970|FG000|Overall Study|Inappropriate enrollment|0|||
19523930|NCT01272180|41968971|FG001|Overall Study|Inappropriate enrollment|0|||
19523931|NCT01272180|41968972|FG002|Overall Study|Inappropriate enrollment|1|||
19523932|NCT01272180|41968973|FG003|Overall Study|Inappropriate enrollment|1|||
19523933|NCT01272180|41968970|FG000|Overall Study|Protocol Violation|0|||
19523934|NCT01272180|41968971|FG001|Overall Study|Protocol Violation|1|||
19523935|NCT01272180|41968972|FG002|Overall Study|Protocol Violation|0|||
19523936|NCT01272180|41968973|FG003|Overall Study|Protocol Violation|1|||
19523937|NCT01271712|41968989|FG000|Double Blind Treatment|Death|2|||
19523938|NCT01271712|41968990|FG001|Double Blind Treatment|Death|0|||
19445616|NCT01943851|41693298|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445617|NCT01943851|41693299|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445618|NCT01943851|41693300|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445619|NCT01943851|41693301|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445620|NCT01943851|41693302|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445621|NCT01943851|41693303|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445622|NCT01943851|41693304|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445623|NCT01943851|41693305|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445624|NCT01943851|41693306|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445625|NCT01943851|41693307|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445626|NCT01943851|41693308|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445627|NCT01943851|41693309|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445628|NCT01943851|41693310|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445629|NCT01943851|41693311|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445630|NCT01943851|41693312|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
19445631|NCT01943851|41693313|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
19445632|NCT01943851|41693314|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
19445633|NCT01943851|41693315|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
19445634|NCT01430104|41693356|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
19445635|NCT01990859|41693363|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
19445636|NCT01990859|41693363|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
19445637|NCT02093897|41693368|FG000|Overall Study|Physician Decision|1|||
19445638|NCT02093897|41693368|FG000|Overall Study|Planned age group closure - no's reached|17|||
19445639|NCT02093897|41693368|FG000|Overall Study|Adverse event, non-fatal|1|||
19445640|NCT01990313|41693379|FG000|Overall Study|Lost to Follow-up|1|||
19445641|NCT01947517|41693385|FG000|Overall Study|Withdrawal by Subject|1|||
19523939|NCT01271712|41968989|FG000|Double Blind Treatment|Lack of Efficacy|1|||
19523940|NCT01271712|41968990|FG001|Double Blind Treatment|Lack of Efficacy|0|||
19523941|NCT01271712|41968989|FG000|Double Blind Treatment|Adverse Event|9|||
19523942|NCT01271712|41968990|FG001|Double Blind Treatment|Adverse Event|4|||
19523943|NCT01271712|41968989|FG000|Double Blind Treatment|Progressive disease|23|||
19445642|NCT01947517|41693386|FG001|Overall Study|Withdrawal by Subject|1|||
19445643|NCT02006927|41693392|FG000|Overall Study|Adverse Event|2|||
19445644|NCT02006927|41693392|FG000|Overall Study|Withdrawal by Subject|1|||
19445645|NCT01947283|41693403|FG000|Overall Study|Death|1|||
19523944|NCT01271712|41968990|FG001|Double Blind Treatment|Progressive disease|3|||
19523945|NCT01271712|41968989|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
19523946|NCT01271712|41968990|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
19523947|NCT01271712|41968989|FG000|Double Blind Treatment|Non compliance with study drug|2|||
19523948|NCT01271712|41968990|FG001|Double Blind Treatment|Non compliance with study drug|0|||
19523949|NCT01271712|41968989|FG000|Double Blind Treatment|receive no study drug|1|||
19523950|NCT01271712|41968990|FG001|Double Blind Treatment|receive no study drug|0|||
19523951|NCT01271712|41968989|FG000|Open Label Treatment|Death|6|||
19523952|NCT01271712|41968990|FG001|Open Label Treatment|Death|5|||
19523953|NCT01271712|41968989|FG000|Open Label Treatment|Withdrawal by Subject|6|||
19523954|NCT01271712|41968990|FG001|Open Label Treatment|Withdrawal by Subject|11|||
19523955|NCT01271712|41968989|FG000|Open Label Treatment|Physician Decision|2|||
19523956|NCT01271712|41968990|FG001|Open Label Treatment|Physician Decision|0|||
19523957|NCT01271712|41968989|FG000|Open Label Treatment|Adverse Event|14|||
19523958|NCT01271712|41968990|FG001|Open Label Treatment|Adverse Event|8|||
19523959|NCT01271712|41968989|FG000|Open Label Treatment|Progressive disease|59|||
19523960|NCT01271712|41968990|FG001|Open Label Treatment|Progressive disease|32|||
19523961|NCT01271712|41968989|FG000|Open Label Treatment|transferred to rollover study|1|||
19523962|NCT01271712|41968990|FG001|Open Label Treatment|transferred to rollover study|0|||
19523963|NCT01271712|41968989|FG000|Open Label Treatment|Non-compliance with study drug|1|||
19523964|NCT01271712|41968990|FG001|Open Label Treatment|Non-compliance with study drug|0|||
19523965|NCT01271712|41968989|FG000|Open Label Treatment|Protocol Violation|0|||
19523966|NCT01271712|41968990|FG001|Open Label Treatment|Protocol Violation|1|||
19523967|NCT01271712|41968989|FG000|Open Label Treatment|Switching to other therapy|2|||
19523968|NCT01271712|41968990|FG001|Open Label Treatment|Switching to other therapy|1|||
19523969|NCT01271712|41968989|FG000|Safety Follow-up|Death|11|||
19523970|NCT01271712|41968990|FG001|Safety Follow-up|Death|7|||
19523971|NCT01271712|41968989|FG000|Safety Follow-up|Withdrawal by Subject|4|||
19523972|NCT01271712|41968990|FG001|Safety Follow-up|Withdrawal by Subject|2|||
19523973|NCT01271712|41968989|FG000|Safety Follow-up|Protocol Violation|1|||
19523974|NCT01271712|41968990|FG001|Safety Follow-up|Protocol Violation|1|||
19523975|NCT01271712|41968989|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
19523976|NCT01271712|41968990|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
19523977|NCT01271712|41968989|FG000|Safety Follow-up|No follow-up|1|||
19445646|NCT01947283|41693404|FG001|Overall Study|Death|1|||
19523978|NCT01271712|41968990|FG001|Safety Follow-up|No follow-up|1|||
19523979|NCT01271712|41968989|FG000|Safety Follow-up|Progressive disease|1|||
19445647|NCT01947283|41693405|FG002|Overall Study|Death|1|||
19445648|NCT01947283|41693406|FG003|Overall Study|Death|0|||
19445649|NCT01947283|41693407|FG004|Overall Study|Death|0|||
19445650|NCT01947283|41693408|FG005|Overall Study|Death|0|||
19445651|NCT01947283|41693409|FG006|Overall Study|Death|0|||
19445652|NCT01947283|41693403|FG000|Overall Study|Lost to Follow-up|4|||
19445653|NCT01947283|41693404|FG001|Overall Study|Lost to Follow-up|6|||
19445654|NCT01947283|41693405|FG002|Overall Study|Lost to Follow-up|5|||
19445655|NCT01947283|41693406|FG003|Overall Study|Lost to Follow-up|5|||
19445656|NCT01947283|41693407|FG004|Overall Study|Lost to Follow-up|0|||
19445657|NCT01947283|41693408|FG005|Overall Study|Lost to Follow-up|2|||
19445658|NCT01947283|41693409|FG006|Overall Study|Lost to Follow-up|5|||
19445659|NCT01947283|41693403|FG000|Overall Study|Withdrawal by Subject|10|||
19445660|NCT01947283|41693404|FG001|Overall Study|Withdrawal by Subject|8|||
19445661|NCT01947283|41693405|FG002|Overall Study|Withdrawal by Subject|4|||
19445662|NCT01947283|41693406|FG003|Overall Study|Withdrawal by Subject|1|||
19445663|NCT01947283|41693407|FG004|Overall Study|Withdrawal by Subject|0|||
19445664|NCT01947283|41693408|FG005|Overall Study|Withdrawal by Subject|0|||
19445665|NCT01947283|41693409|FG006|Overall Study|Withdrawal by Subject|2|||
19445666|NCT01947283|41693403|FG000|Overall Study|No Clinical Recording|12|||
19445667|NCT01947283|41693404|FG001|Overall Study|No Clinical Recording|6|||
19445668|NCT01947283|41693405|FG002|Overall Study|No Clinical Recording|8|||
19445669|NCT01947283|41693406|FG003|Overall Study|No Clinical Recording|10|||
19445670|NCT01947283|41693407|FG004|Overall Study|No Clinical Recording|0|||
19445671|NCT01947283|41693408|FG005|Overall Study|No Clinical Recording|0|||
19445672|NCT01947283|41693409|FG006|Overall Study|No Clinical Recording|0|||
19445673|NCT01947283|41693403|FG000|Overall Study|Non-coding Clinical Recording language|0|||
19523980|NCT01271712|41968990|FG001|Safety Follow-up|Progressive disease|0|||
19629093|NCT00811070|42078671|FG002|Overall Study|Other|0|||
19629094|NCT00811070|42078672|FG003|Overall Study|Other|0|||
19445674|NCT01947283|41693404|FG001|Overall Study|Non-coding Clinical Recording language|0|||
19445675|NCT01947283|41693405|FG002|Overall Study|Non-coding Clinical Recording language|0|||
19445676|NCT01947283|41693406|FG003|Overall Study|Non-coding Clinical Recording language|1|||
19445677|NCT01947283|41693407|FG004|Overall Study|Non-coding Clinical Recording language|0|||
19445678|NCT01947283|41693408|FG005|Overall Study|Non-coding Clinical Recording language|0|||
19445679|NCT01947283|41693409|FG006|Overall Study|Non-coding Clinical Recording language|0|||
19445680|NCT01947283|41693403|FG000|Overall Study|Missing Follow-up Assessment|2|||
19445681|NCT01947283|41693404|FG001|Overall Study|Missing Follow-up Assessment|2|||
19445682|NCT01947283|41693405|FG002|Overall Study|Missing Follow-up Assessment|3|||
19445683|NCT01947283|41693406|FG003|Overall Study|Missing Follow-up Assessment|0|||
19523981|NCT01271712|41968989|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
19523982|NCT01271712|41968990|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
19523983|NCT01271010|41968999|FG000|Overall Study|Reason not specified|11|||
19523984|NCT01271010|41968999|FG000|Overall Study|Start of new CLL therapy|1|||
19523985|NCT01271010|41968999|FG000|Overall Study|Protocol Violation|1|||
19523986|NCT01271010|41968999|FG000|Overall Study|Death|2|||
19523987|NCT01271010|41968999|FG000|Overall Study|Progression and relapse of disease|1|||
19523988|NCT01271010|41968999|FG000|Overall Study|Withdrawal by Subject|18|||
19523989|NCT01271010|41968999|FG000|Overall Study|Disease progression|27|||
19523990|NCT01270620|41969005|FG000|Overall Study|Withdrawal by Subject|1|||
19523991|NCT01270620|41969006|FG001|Overall Study|Withdrawal by Subject|3|||
19523992|NCT01270464|41969021|FG000|Overall Study|Protocol Violation|4|||
19523993|NCT01270464|41969022|FG001|Overall Study|Protocol Violation|3|||
19523994|NCT01270464|41969023|FG002|Overall Study|Protocol Violation|2|||
19523995|NCT01270464|41969021|FG000|Overall Study|Lack of Efficacy|2|||
19523996|NCT01270464|41969022|FG001|Overall Study|Lack of Efficacy|3|||
19523997|NCT01270464|41969023|FG002|Overall Study|Lack of Efficacy|1|||
19523998|NCT01270464|41969021|FG000|Overall Study|Adverse Event|9|||
19523999|NCT01270464|41969022|FG001|Overall Study|Adverse Event|1|||
19524000|NCT01270464|41969023|FG002|Overall Study|Adverse Event|7|||
19524001|NCT01270464|41969021|FG000|Overall Study|Withdrawal by Subject|2|||
19524002|NCT01270464|41969022|FG001|Overall Study|Withdrawal by Subject|1|||
19524003|NCT01270464|41969023|FG002|Overall Study|Withdrawal by Subject|4|||
19524004|NCT01270464|41969021|FG000|Overall Study|Lost to Follow-up|2|||
19524005|NCT01270464|41969022|FG001|Overall Study|Lost to Follow-up|3|||
19524006|NCT01270464|41969023|FG002|Overall Study|Lost to Follow-up|1|||
19524007|NCT01270464|41969021|FG000|Overall Study|Other|1|||
19524008|NCT01270464|41969022|FG001|Overall Study|Other|1|||
19524009|NCT01270464|41969023|FG002|Overall Study|Other|3|||
19524010|NCT00249834|41969039|FG000|Overall Study|Ovarian stimulation failed|1|||
19524011|NCT00249834|41969040|FG001|Overall Study|Ovarian stimulation failed|0|||
19524012|NCT00249834|41969041|FG002|Overall Study|Ovarian stimulation failed|0|||
19524013|NCT00249834|41969042|FG003|Overall Study|Ovarian stimulation failed|0|||
19524014|NCT00249834|41969043|FG004|Overall Study|Ovarian stimulation failed|0|||
19524015|NCT00249834|41969044|FG005|Overall Study|Ovarian stimulation failed|0|||
19524016|NCT00249834|41969045|FG006|Overall Study|Ovarian stimulation failed|0|||
19524017|NCT00249834|41969046|FG007|Overall Study|Ovarian stimulation failed|0|||
19524018|NCT00249834|41969039|FG000|Overall Study|Failure of down-regulation|0|||
19524019|NCT00249834|41969040|FG001|Overall Study|Failure of down-regulation|0|||
19524020|NCT00249834|41969041|FG002|Overall Study|Failure of down-regulation|0|||
19524021|NCT00249834|41969042|FG003|Overall Study|Failure of down-regulation|0|||
19524022|NCT00249834|41969043|FG004|Overall Study|Failure of down-regulation|0|||
19524023|NCT00249834|41969044|FG005|Overall Study|Failure of down-regulation|0|||
19629095|NCT00811070|42078673|FG004|Overall Study|Other|0|||
19629096|NCT00811070|42078674|FG005|Overall Study|Other|0|||
19629097|NCT00811070|42078669|FG000|Overall Study|Withdrawal by Subject|0|||
19629098|NCT00811070|42078670|FG001|Overall Study|Withdrawal by Subject|1|||
19629099|NCT00811070|42078671|FG002|Overall Study|Withdrawal by Subject|0|||
19629100|NCT00811070|42078672|FG003|Overall Study|Withdrawal by Subject|0|||
19629101|NCT00811070|42078673|FG004|Overall Study|Withdrawal by Subject|0|||
19629102|NCT00811070|42078674|FG005|Overall Study|Withdrawal by Subject|0|||
19445684|NCT01947283|41693407|FG004|Overall Study|Missing Follow-up Assessment|0|||
19445685|NCT01947283|41693408|FG005|Overall Study|Missing Follow-up Assessment|2|||
19524024|NCT00249834|41969045|FG006|Overall Study|Failure of down-regulation|1|||
19524025|NCT00249834|41969046|FG007|Overall Study|Failure of down-regulation|0|||
19524026|NCT00249834|41969039|FG000|Overall Study|Protocol Violation|0|||
19524027|NCT00249834|41969040|FG001|Overall Study|Protocol Violation|19|||
19524028|NCT00249834|41969041|FG002|Overall Study|Protocol Violation|14|||
19524029|NCT00249834|41969042|FG003|Overall Study|Protocol Violation|8|||
19524030|NCT00249834|41969043|FG004|Overall Study|Protocol Violation|5|||
19524031|NCT00249834|41969044|FG005|Overall Study|Protocol Violation|2|||
19524032|NCT00249834|41969045|FG006|Overall Study|Protocol Violation|0|||
19524033|NCT00249834|41969046|FG007|Overall Study|Protocol Violation|0|||
19524034|NCT00249444|41969060|FG000|Overall Study|Lost to Follow-up|2|||
19524035|NCT00249444|41969061|FG001|Overall Study|Lost to Follow-up|2|||
19524036|NCT00249444|41969060|FG000|Overall Study|non-compliant|9|||
19524037|NCT00249444|41969061|FG001|Overall Study|non-compliant|11|||
19524038|NCT00249444|41969060|FG000|Overall Study|Adverse Event|1|||
19524039|NCT00249444|41969061|FG001|Overall Study|Adverse Event|1|||
19524040|NCT00249444|41969060|FG000|Overall Study|life event|0|||
19524041|NCT00249444|41969061|FG001|Overall Study|life event|1|||
19445686|NCT01947283|41693409|FG006|Overall Study|Missing Follow-up Assessment|0|||
19445687|NCT01947283|41693403|FG000|Overall Study|No patients were enrolled in study|0|||
19445688|NCT01947283|41693404|FG001|Overall Study|No patients were enrolled in study|0|||
19445689|NCT01947283|41693405|FG002|Overall Study|No patients were enrolled in study|0|||
19445690|NCT01947283|41693406|FG003|Overall Study|No patients were enrolled in study|0|||
19445691|NCT01947283|41693407|FG004|Overall Study|No patients were enrolled in study|0|||
19445692|NCT01947283|41693408|FG005|Overall Study|No patients were enrolled in study|3|||
19445693|NCT01947283|41693409|FG006|Overall Study|No patients were enrolled in study|1|||
19445694|NCT02006693|41693428|FG000|Overall Study|No Reason Specified|6|||
19445695|NCT02006693|41693429|FG001|Overall Study|No Reason Specified|8|||
19445696|NCT02006693|41693428|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
19445697|NCT02006693|41693429|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
19445698|NCT02006693|41693428|FG000|Overall Study|XEN Implant Explantation|0|||
19445699|NCT02006693|41693429|FG001|Overall Study|XEN Implant Explantation|1|||
19445700|NCT02006693|41693428|FG000|Overall Study|Death|2|||
19445701|NCT02006693|41693429|FG001|Overall Study|Death|2|||
19445702|NCT02006693|41693428|FG000|Overall Study|Lost to Follow-up|4|||
19445703|NCT02006693|41693429|FG001|Overall Study|Lost to Follow-up|1|||
19445704|NCT02006693|41693428|FG000|Overall Study|Patient Decision|4|||
19445705|NCT02006693|41693429|FG001|Overall Study|Patient Decision|0|||
19445706|NCT01947127|41693437|FG000|Overall Study|Protocol Violation|18|||
19445707|NCT01947127|41693438|FG001|Overall Study|Protocol Violation|38|||
19445708|NCT01947127|41693437|FG000|Overall Study|Withdrawal by Subject|1|||
19445709|NCT01947127|41693438|FG001|Overall Study|Withdrawal by Subject|1|||
19445710|NCT01947127|41693437|FG000|Overall Study|Data loss|4|||
19445711|NCT01947127|41693438|FG001|Overall Study|Data loss|4|||
19445712|NCT01976845|41693447|FG000|Overall Study|Physician Decision|8|||
19445713|NCT01976845|41693448|FG001|Overall Study|Physician Decision|8|||
19445714|NCT01976845|41693449|FG002|Overall Study|Physician Decision|3|||
19445715|NCT01989689|41693459|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
19445716|NCT01989689|41693460|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
19445717|NCT01989689|41693459|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
19445718|NCT01989689|41693460|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
19445719|NCT01943539|41693468|FG000|Overall Study|Non-compliance with at-home intervention|4|||
19445720|NCT01943539|41693469|FG001|Overall Study|Non-compliance with at-home intervention|0|||
19445721|NCT01942993|41693476|FG000|Overall Study|Lost to Follow-up|1|||
19445722|NCT01942993|41693476|FG000|Overall Study|Physician Decision|1|||
19524042|NCT00249288|41969069|FG000|Overall Study|Lost to Follow-up|3|||
19524043|NCT00249288|41969070|FG001|Overall Study|Lost to Follow-up|3|||
19524044|NCT00249288|41969069|FG000|Overall Study|Withdrawal by Subject|2|||
19524045|NCT00249288|41969070|FG001|Overall Study|Withdrawal by Subject|2|||
19524046|NCT00248040|41969087|FG000|Overall Study|transplantectomy|2|||
19524047|NCT00248040|41969088|FG001|Overall Study|transplantectomy|1|||
19524048|NCT00248040|41969089|FG002|Overall Study|transplantectomy|3|||
19524049|NCT00248040|41969087|FG000|Overall Study|transplant cancelled post treat start|1|||
19524050|NCT00248040|41969088|FG001|Overall Study|transplant cancelled post treat start|0|||
19524051|NCT00248040|41969089|FG002|Overall Study|transplant cancelled post treat start|0|||
19524052|NCT00248040|41969087|FG000|Overall Study|Death|0|||
19524053|NCT00248040|41969088|FG001|Overall Study|Death|0|||
19524054|NCT00248040|41969089|FG002|Overall Study|Death|1|||
19524055|NCT00247962|41969100|FG000|Overall Study|Adverse Event|15|||
19524056|NCT00247962|41969101|FG001|Overall Study|Adverse Event|12|||
19524057|NCT00247962|41969100|FG000|Overall Study|Lost to Follow-up|3|||
19524058|NCT00247962|41969101|FG001|Overall Study|Lost to Follow-up|1|||
19524059|NCT00247962|41969100|FG000|Overall Study|Physician Decision|0|||
19524060|NCT00247962|41969101|FG001|Overall Study|Physician Decision|1|||
19524061|NCT00247962|41969100|FG000|Overall Study|Protocol Violation|1|||
19524062|NCT00247962|41969101|FG001|Overall Study|Protocol Violation|1|||
19524063|NCT00247962|41969100|FG000|Overall Study|Withdrawal by Subject|3|||
19524064|NCT00247962|41969101|FG001|Overall Study|Withdrawal by Subject|2|||
19524065|NCT00247962|41969100|FG000|Overall Study|Lack of Efficacy|4|||
19524066|NCT00247962|41969101|FG001|Overall Study|Lack of Efficacy|2|||
19524067|NCT00247416|41969109|FG000|Overall Study|3 patients were found to be ineligible|1|||
19524068|NCT00247416|41969110|FG001|Overall Study|3 patients were found to be ineligible|2|||
19524069|NCT00246090|41969118|FG000|Overall Study|Adverse Event|25|||
19524070|NCT00246090|41969118|FG000|Overall Study|Withdrawal by Subject|7|||
19524071|NCT00246090|41969118|FG000|Overall Study|Progressive Disease|212|||
19524072|NCT00246090|41969118|FG000|Overall Study|Clinical Progression|30|||
19524073|NCT00246090|41969118|FG000|Overall Study|Physician Decision|11|||
19524074|NCT00246090|41969118|FG000|Overall Study|Not Otherwise Specified|10|||
19524075|NCT00246012|41969131|FG000|Overall Study|Adverse Event|0|||
19524076|NCT00246012|41969132|FG001|Overall Study|Adverse Event|0|||
19524077|NCT00246012|41969133|FG002|Overall Study|Adverse Event|0|||
19524078|NCT00246012|41969134|FG003|Overall Study|Adverse Event|0|||
19445723|NCT01989455|41693485|FG000|Overall Study|Adverse Event|0|||
19445724|NCT01989455|41693486|FG001|Overall Study|Adverse Event|1|||
19445725|NCT01989455|41693487|FG002|Overall Study|Adverse Event|0|||
19524079|NCT00246012|41969135|FG004|Overall Study|Adverse Event|0|||
19524080|NCT00246012|41969136|FG005|Overall Study|Adverse Event|1|||
19524081|NCT00246012|41969137|FG006|Overall Study|Adverse Event|0|||
19524082|NCT00246012|41969138|FG007|Overall Study|Adverse Event|0|||
19445726|NCT01989455|41693488|FG003|Overall Study|Adverse Event|0|||
19445727|NCT01989455|41693489|FG004|Overall Study|Adverse Event|0|||
19445728|NCT01989455|41693485|FG000|Overall Study|Withdrawal by Subject|0|||
19445729|NCT01989455|41693486|FG001|Overall Study|Withdrawal by Subject|1|||
19445730|NCT01989455|41693487|FG002|Overall Study|Withdrawal by Subject|0|||
19445731|NCT01989455|41693488|FG003|Overall Study|Withdrawal by Subject|0|||
19445732|NCT01989455|41693489|FG004|Overall Study|Withdrawal by Subject|0|||
19445733|NCT01989455|41693485|FG000|Overall Study|Technical problems with infusion|0|||
19445734|NCT01989455|41693486|FG001|Overall Study|Technical problems with infusion|0|||
19445735|NCT01989455|41693487|FG002|Overall Study|Technical problems with infusion|1|||
19524083|NCT00246012|41969139|FG008|Overall Study|Adverse Event|2|||
19524084|NCT00246012|41969131|FG000|Overall Study|Withdrawal by Subject|0|||
19524085|NCT00246012|41969132|FG001|Overall Study|Withdrawal by Subject|0|||
19524086|NCT00246012|41969133|FG002|Overall Study|Withdrawal by Subject|0|||
19524087|NCT00246012|41969134|FG003|Overall Study|Withdrawal by Subject|0|||
19524088|NCT00246012|41969135|FG004|Overall Study|Withdrawal by Subject|0|||
19524089|NCT00246012|41969136|FG005|Overall Study|Withdrawal by Subject|1|||
19524090|NCT00246012|41969137|FG006|Overall Study|Withdrawal by Subject|0|||
19524091|NCT00246012|41969138|FG007|Overall Study|Withdrawal by Subject|0|||
19524092|NCT00246012|41969139|FG008|Overall Study|Withdrawal by Subject|0|||
19524093|NCT00246012|41969131|FG000|Overall Study|Disease progression|3|||
19524094|NCT00246012|41969132|FG001|Overall Study|Disease progression|1|||
19524095|NCT00246012|41969133|FG002|Overall Study|Disease progression|2|||
19524096|NCT00246012|41969134|FG003|Overall Study|Disease progression|3|||
19524097|NCT00246012|41969135|FG004|Overall Study|Disease progression|3|||
19524098|NCT00246012|41969136|FG005|Overall Study|Disease progression|25|||
19524099|NCT00246012|41969137|FG006|Overall Study|Disease progression|30|||
19629103|NCT00811070|42078669|FG000|Overall Study|Physician Decision|0|||
19445736|NCT01989455|41693488|FG003|Overall Study|Technical problems with infusion|0|||
19445737|NCT01989455|41693489|FG004|Overall Study|Technical problems with infusion|1|||
19445738|NCT01942837|41693505|FG000|Overall Study|Death|1|||
19445739|NCT01942837|41693505|FG000|Overall Study|Symptomatic or radiographic progression|49|||
19445740|NCT01942837|41693505|FG000|Overall Study|Adverse Event|6|||
19445741|NCT01942837|41693505|FG000|Overall Study|Physician Decision|3|||
19445742|NCT01942837|41693505|FG000|Overall Study|Withdrawal by Subject|2|||
19445743|NCT01942837|41693505|FG000|Overall Study|Intercurrent Illness|1|||
19445744|NCT01942837|41693505|FG000|Overall Study|On treatment|3|||
19445745|NCT01942837|41693505|FG000|Overall Study|Never initiate the treatment|2|||
19445746|NCT01987895|41693512|FG000|Overall Study|Withdrawal by Subject|12|||
19445747|NCT01987895|41693513|FG001|Overall Study|Withdrawal by Subject|7|||
19445748|NCT01987895|41693512|FG000|Overall Study|Physician Decision|8|||
19445749|NCT01987895|41693513|FG001|Overall Study|Physician Decision|10|||
19445750|NCT01987895|41693512|FG000|Overall Study|Death|7|||
19445751|NCT01987895|41693513|FG001|Overall Study|Death|7|||
19445752|NCT01987895|41693512|FG000|Overall Study|Lost to Follow-up|3|||
19445753|NCT01987895|41693513|FG001|Overall Study|Lost to Follow-up|5|||
19445754|NCT01987895|41693512|FG000|Overall Study|randomized before giving IC|0|||
19445755|NCT01987895|41693513|FG001|Overall Study|randomized before giving IC|1|||
19445756|NCT02005445|41693521|FG000|Overall Study|Dual study enrollment|0|||
19445757|NCT02005445|41693522|FG001|Overall Study|Dual study enrollment|1|||
19445758|NCT01618669|41693530|FG000|Overall Study|Lost to Follow-up|1|||
19445759|NCT01618669|41693531|FG001|Overall Study|Lost to Follow-up|1|||
19445760|NCT01618669|41693530|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
19445761|NCT01618669|41693531|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
19445762|NCT01618669|41693530|FG000|Overall Study|Adverse Event|16|||
19445763|NCT01618669|41693531|FG001|Overall Study|Adverse Event|7|||
19445764|NCT01618669|41693530|FG000|Overall Study|Protocol Violation|5|||
19445765|NCT01618669|41693531|FG001|Overall Study|Protocol Violation|3|||
19445766|NCT01618669|41693530|FG000|Overall Study|Withdrawal by Subject|9|||
19445767|NCT01618669|41693531|FG001|Overall Study|Withdrawal by Subject|9|||
19445768|NCT01618669|41693530|FG000|Overall Study|Miscellaneous Reason|0|||
19445769|NCT01618669|41693531|FG001|Overall Study|Miscellaneous Reason|1|||
19445770|NCT01390948|41693552|FG000|Overall Study|End of Study|1|||
19445771|NCT01390948|41693553|FG001|Overall Study|End of Study|0|||
19445772|NCT01390948|41693554|FG002|Overall Study|End of Study|0|||
19445773|NCT01390948|41693552|FG000|Overall Study|Withdrew consent|2|||
19445774|NCT01390948|41693553|FG001|Overall Study|Withdrew consent|2|||
19445775|NCT01390948|41693554|FG002|Overall Study|Withdrew consent|0|||
19445776|NCT01390948|41693552|FG000|Overall Study|Progressive Disease|2|||
19445777|NCT01390948|41693553|FG001|Overall Study|Progressive Disease|5|||
19445778|NCT01390948|41693554|FG002|Overall Study|Progressive Disease|0|||
19445779|NCT01390948|41693552|FG000|Overall Study|Death during follow-up|10|||
19445780|NCT01390948|41693553|FG001|Overall Study|Death during follow-up|11|||
19445781|NCT01390948|41693554|FG002|Overall Study|Death during follow-up|1|||
19445782|NCT02005211|41693568|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19445783|NCT02005211|41693569|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19445784|NCT02005211|41693570|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19445785|NCT02005211|41693571|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19445786|NCT02005211|41693572|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
19445787|NCT02005211|41693573|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19524100|NCT00246012|41969138|FG007|Overall Study|Disease progression|27|||
19445788|NCT02005211|41693574|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
19445789|NCT01429792|41693597|FG000|Overall Study|Other Reasons|67|||
19445790|NCT01429792|41693597|FG000|Overall Study|Unknown Disposition|94|||
19445791|NCT01429792|41693597|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
19445792|NCT01429792|41693597|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
19445793|NCT01429792|41693597|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
19445794|NCT01429792|41693597|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
19445795|NCT01429792|41693597|FG000|Overall Study|Withdrawal by Subject|70|||
19445796|NCT01429792|41693597|FG000|Overall Study|Lost to Follow-up|88|||
19445797|NCT01409434|41693601|FG000|Overall Study|Protocol Violation|4|||
19445798|NCT01940887|41693607|FG000|Year 1|Protocol Violation|0|||
19445799|NCT01940887|41693608|FG001|Year 1|Protocol Violation|1|||
19445800|NCT01940887|41693607|FG000|Year 1|Physician Decision|7|||
19445801|NCT01940887|41693608|FG001|Year 1|Physician Decision|3|||
19445802|NCT01940887|41693607|FG000|Year 1|Death|5|||
19445803|NCT01940887|41693608|FG001|Year 1|Death|3|||
19445804|NCT01940887|41693607|FG000|Year 1|Adverse Event|7|||
19445805|NCT01940887|41693608|FG001|Year 1|Adverse Event|6|||
19445806|NCT01940887|41693607|FG000|Year 1|Withdrawal by Subject|18|||
19445807|NCT01940887|41693608|FG001|Year 1|Withdrawal by Subject|9|||
19445808|NCT01940887|41693607|FG000|Year 1|Lost to Follow-up|2|||
19445809|NCT01940887|41693608|FG001|Year 1|Lost to Follow-up|1|||
19445810|NCT01940887|41693607|FG000|Year 2|Physician Decision|8|||
19445811|NCT01940887|41693608|FG001|Year 2|Physician Decision|1|||
19445812|NCT01940887|41693607|FG000|Year 2|Death|0|||
19445813|NCT01940887|41693608|FG001|Year 2|Death|2|||
19445814|NCT01940887|41693607|FG000|Year 2|Sponsor Decision, early termination|192|||
19445815|NCT01940887|41693608|FG001|Year 2|Sponsor Decision, early termination|203|||
19445816|NCT01940887|41693607|FG000|Year 2|Adverse Event|8|||
19445817|NCT01940887|41693608|FG001|Year 2|Adverse Event|2|||
19445818|NCT01940887|41693607|FG000|Year 2|Withdrawal by Subject|8|||
19524101|NCT00246012|41969139|FG008|Overall Study|Disease progression|26|||
19524102|NCT00246012|41969131|FG000|Overall Study|Other|0|||
19524103|NCT00246012|41969132|FG001|Overall Study|Other|0|||
19524104|NCT00246012|41969133|FG002|Overall Study|Other|0|||
19524105|NCT00246012|41969134|FG003|Overall Study|Other|0|||
19524106|NCT00246012|41969135|FG004|Overall Study|Other|0|||
19524107|NCT00246012|41969136|FG005|Overall Study|Other|0|||
19524108|NCT00246012|41969137|FG006|Overall Study|Other|0|||
19524109|NCT00246012|41969138|FG007|Overall Study|Other|1|||
19524110|NCT00246012|41969139|FG008|Overall Study|Other|0|||
19524111|NCT00246012|41969131|FG000|Overall Study|Randomly assigned but not treated|0|||
19524112|NCT00246012|41969132|FG001|Overall Study|Randomly assigned but not treated|0|||
19524113|NCT00246012|41969133|FG002|Overall Study|Randomly assigned but not treated|0|||
19524114|NCT00246012|41969134|FG003|Overall Study|Randomly assigned but not treated|0|||
19629104|NCT00811070|42078670|FG001|Overall Study|Physician Decision|0|||
19445819|NCT01940887|41693608|FG001|Year 2|Withdrawal by Subject|8|||
19445820|NCT01940887|41693607|FG000|Year 2|Lost to Follow-up|1|||
19445821|NCT01940887|41693608|FG001|Year 2|Lost to Follow-up|6|||
19445822|NCT01925612|41693619|FG000|Overall Study|Progressive Disease|1|||
19445823|NCT01925612|41693620|FG001|Overall Study|Progressive Disease|1|||
19445824|NCT01925612|41693621|FG002|Overall Study|Progressive Disease|1|||
19445825|NCT01925612|41693622|FG003|Overall Study|Progressive Disease|0|||
19445826|NCT01925612|41693623|FG004|Overall Study|Progressive Disease|0|||
19445827|NCT01925612|41693619|FG000|Overall Study|Adverse Event|3|||
19445828|NCT01925612|41693620|FG001|Overall Study|Adverse Event|3|||
19445829|NCT01925612|41693621|FG002|Overall Study|Adverse Event|0|||
19445830|NCT01925612|41693622|FG003|Overall Study|Adverse Event|1|||
19445831|NCT01925612|41693623|FG004|Overall Study|Adverse Event|2|||
19445832|NCT02093663|41693635|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
19445833|NCT02093663|41693636|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
19445834|NCT02093663|41693637|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
19445835|NCT02093663|41693638|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
19445836|NCT02093663|41693639|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
19445837|NCT02093663|41693635|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
19445838|NCT02093663|41693636|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19524115|NCT00246012|41969135|FG004|Overall Study|Randomly assigned but not treated|0|||
19524116|NCT00246012|41969136|FG005|Overall Study|Randomly assigned but not treated|1|||
19524117|NCT00246012|41969137|FG006|Overall Study|Randomly assigned but not treated|1|||
19524118|NCT00246012|41969138|FG007|Overall Study|Randomly assigned but not treated|0|||
19445839|NCT02093663|41693637|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445840|NCT02093663|41693638|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445841|NCT02093663|41693639|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445842|NCT02093663|41693635|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
19445843|NCT02093663|41693636|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
19445844|NCT02093663|41693637|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
19445845|NCT02093663|41693638|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
19445846|NCT02093663|41693639|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
19445847|NCT02093663|41693635|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
19445848|NCT02093663|41693636|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
19445849|NCT02093663|41693637|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
19524119|NCT00246012|41969139|FG008|Overall Study|Randomly assigned but not treated|0|||
19524120|NCT00245856|41969161|FG000|Period Two|Withdrawal by Subject|0|||
19524121|NCT00245856|41969162|FG001|Period Two|Withdrawal by Subject|1|||
19524122|NCT00245466|41969172|FG000|Overall Study|Adverse Event|2|||
19524123|NCT00245466|41969173|FG001|Overall Study|Adverse Event|8|||
19524124|NCT00245466|41969174|FG002|Overall Study|Adverse Event|4|||
19524125|NCT00245466|41969172|FG000|Overall Study|Low prostate specific antigen suppr|16|||
19524126|NCT00245466|41969173|FG001|Overall Study|Low prostate specific antigen suppr|14|||
19524127|NCT00245466|41969174|FG002|Overall Study|Low prostate specific antigen suppr|5|||
19524128|NCT00245466|41969172|FG000|Overall Study|Insufficient testosterone suppr|12|||
19524129|NCT00245466|41969173|FG001|Overall Study|Insufficient testosterone suppr|12|||
19524130|NCT00245466|41969174|FG002|Overall Study|Insufficient testosterone suppr|21|||
19524131|NCT00245466|41969172|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
19524132|NCT00245466|41969173|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
19524133|NCT00245466|41969174|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
19524134|NCT00245466|41969172|FG000|Overall Study|Withdrawal by Subject|2|||
19524135|NCT00245466|41969173|FG001|Overall Study|Withdrawal by Subject|2|||
19524136|NCT00245466|41969174|FG002|Overall Study|Withdrawal by Subject|1|||
19524137|NCT00245466|41969172|FG000|Overall Study|Lost to Follow-up|3|||
19524138|NCT00245466|41969173|FG001|Overall Study|Lost to Follow-up|0|||
19524139|NCT00245466|41969174|FG002|Overall Study|Lost to Follow-up|0|||
19524140|NCT00245466|41969172|FG000|Overall Study|Disease progression|0|||
19524141|NCT00245466|41969173|FG001|Overall Study|Disease progression|3|||
19524142|NCT00245466|41969174|FG002|Overall Study|Disease progression|1|||
19524143|NCT00245466|41969172|FG000|Overall Study|Protocol Violation|1|||
19524144|NCT00245466|41969173|FG001|Overall Study|Protocol Violation|2|||
19524145|NCT00245466|41969174|FG002|Overall Study|Protocol Violation|2|||
19524146|NCT00245466|41969172|FG000|Overall Study|Death|0|||
19524147|NCT00245466|41969173|FG001|Overall Study|Death|2|||
19524148|NCT00245466|41969174|FG002|Overall Study|Death|0|||
19524149|NCT00245466|41969172|FG000|Overall Study|Administrative reasons|0|||
19524150|NCT00245466|41969173|FG001|Overall Study|Administrative reasons|1|||
19524151|NCT00245466|41969174|FG002|Overall Study|Administrative reasons|0|||
19445850|NCT02093663|41693638|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
19445851|NCT02093663|41693639|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
19524152|NCT00244764|41969182|FG000|Overall Study|Adverse Event|37|||
19524153|NCT00244764|41969182|FG000|Overall Study|Lost to Follow-up|23|||
19524154|NCT00244764|41969182|FG000|Overall Study|Withdrawal by Subject|12|||
19524155|NCT00244764|41969182|FG000|Overall Study|Disease Progression|13|||
19524156|NCT00244764|41969182|FG000|Overall Study|Protocol Violation|2|||
19524157|NCT00244764|41969182|FG000|Overall Study|Death|1|||
19524158|NCT00244764|41969182|FG000|Overall Study|Off Study Medication for >21 Days|1|||
19524159|NCT00244764|41969182|FG000|Overall Study|Declining Performance Status|1|||
19524160|NCT00244764|41969182|FG000|Overall Study|Participant was Hospitalized until Death|1|||
19524161|NCT00244764|41969182|FG000|Overall Study|Primary Investigator Discretion|2|||
19524162|NCT00244764|41969182|FG000|Overall Study|Sponsor Terminated Study|2|||
19524163|NCT00244764|41969182|FG000|Overall Study|Developed Secondary Malignancy|1|||
19524164|NCT00244374|41969187|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
19524165|NCT00244374|41969188|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
19524166|NCT00244374|41969189|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
19524167|NCT00244374|41969190|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
19524168|NCT00244374|41969191|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
19445852|NCT02093663|41693635|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445853|NCT02093663|41693636|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445854|NCT02093663|41693637|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
19445855|NCT02093663|41693638|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445856|NCT02093663|41693639|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
19445857|NCT02093663|41693635|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
19524169|NCT00244374|41969187|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
19629105|NCT00811070|42078671|FG002|Overall Study|Physician Decision|0|||
19524170|NCT00244374|41969188|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
19524171|NCT00244374|41969189|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
19524172|NCT00244374|41969190|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
19524173|NCT00244374|41969191|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
19524174|NCT00244374|41969187|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
19524175|NCT00244374|41969188|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
19524176|NCT00244374|41969189|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
19524177|NCT00244374|41969190|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
19445858|NCT02093663|41693636|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
19445859|NCT02093663|41693637|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
19445860|NCT02093663|41693638|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
19445861|NCT02093663|41693639|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
19524178|NCT00244374|41969191|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
19524179|NCT00244374|41969187|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
19524180|NCT00244374|41969188|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
19524181|NCT00244374|41969189|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
19524182|NCT00244374|41969190|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
19524183|NCT00244374|41969191|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
19524184|NCT00244374|41969187|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
19524185|NCT00244374|41969188|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
19524186|NCT00244374|41969189|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
19524187|NCT00244374|41969190|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
19524188|NCT00244374|41969191|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
19524189|NCT00244374|41969187|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
19524190|NCT00244374|41969188|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
19524191|NCT00244374|41969189|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
19524192|NCT00244374|41969190|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
19524193|NCT00244374|41969191|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
19524194|NCT00244374|41969187|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
19445862|NCT02093663|41693635|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
19445863|NCT02093663|41693636|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
19445864|NCT02093663|41693637|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
19445865|NCT02093663|41693638|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
19445866|NCT02093663|41693639|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
19445867|NCT02093663|41693635|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
19445868|NCT02093663|41693636|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
19445869|NCT02093663|41693637|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
19445870|NCT02093663|41693638|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
19445871|NCT02093663|41693639|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
19445872|NCT02093663|41693635|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
19445873|NCT02093663|41693636|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
19445874|NCT02093663|41693637|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
19445875|NCT02093663|41693638|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
19445876|NCT02093663|41693639|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
19445877|NCT01408888|41693656|FG000|First Intervention|Adverse Event|0|||
19445878|NCT01408888|41693657|FG001|First Intervention|Adverse Event|1|||
19445879|NCT01408888|41693656|FG000|First Intervention|Withdrawal by Subject|0|||
19445880|NCT01408888|41693657|FG001|First Intervention|Withdrawal by Subject|2|||
19445881|NCT01408888|41693656|FG000|Second Intervention|Withdrawal by Subject|1|||
19445882|NCT01408888|41693657|FG001|Second Intervention|Withdrawal by Subject|0|||
19445883|NCT01408888|41693656|FG000|Second Intervention|Adverse Event|1|||
19445884|NCT01408888|41693657|FG001|Second Intervention|Adverse Event|0|||
19445885|NCT01918033|41693676|FG000|Overall Study|Adverse Event|1|||
19445886|NCT01918033|41693677|FG001|Overall Study|Adverse Event|0|||
19445887|NCT01918033|41693678|FG002|Overall Study|Adverse Event|2|||
19445888|NCT01918033|41693676|FG000|Overall Study|Lost to Follow-up|0|||
19445889|NCT01918033|41693677|FG001|Overall Study|Lost to Follow-up|1|||
19445890|NCT01918033|41693678|FG002|Overall Study|Lost to Follow-up|0|||
19445891|NCT01918033|41693676|FG000|Overall Study|Protocol Violation|2|||
19445892|NCT01918033|41693677|FG001|Overall Study|Protocol Violation|0|||
19445893|NCT01918033|41693678|FG002|Overall Study|Protocol Violation|1|||
19445894|NCT01918033|41693676|FG000|Overall Study|Withdrawal by Subject|2|||
19445895|NCT01918033|41693677|FG001|Overall Study|Withdrawal by Subject|1|||
19445896|NCT01918033|41693678|FG002|Overall Study|Withdrawal by Subject|0|||
19445897|NCT01408732|41693686|FG000|Overall Study|Withdrawal by Subject|2|||
19445898|NCT01408732|41693687|FG001|Overall Study|Withdrawal by Subject|2|||
19445899|NCT01390402|41693693|FG000|Overall Study|Death|1|||
19445900|NCT01390402|41693693|FG000|Overall Study|Disease Progression|4|||
19445901|NCT01976299|41693699|FG000|Overall Study|Withdrawal by Subject|3|||
19445902|NCT01976299|41693700|FG001|Overall Study|Withdrawal by Subject|1|||
19445903|NCT01976299|41693699|FG000|Overall Study|Death|4|||
19445904|NCT01976299|41693700|FG001|Overall Study|Death|2|||
19445905|NCT01976299|41693699|FG000|Overall Study|Lost to Follow-up|7|||
19445906|NCT01976299|41693700|FG001|Overall Study|Lost to Follow-up|1|||
19445907|NCT01976299|41693699|FG000|Overall Study|See clarification above in comments|9|||
19445908|NCT01976299|41693700|FG001|Overall Study|See clarification above in comments|2|||
19445909|NCT01428076|41693708|FG000|Overall Study|Adverse Event|0|||
19524195|NCT00244374|41969188|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
19524196|NCT00244374|41969189|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
19524197|NCT00244374|41969190|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
19445910|NCT01428076|41693709|FG001|Overall Study|Adverse Event|1|||
19445911|NCT01900652|41693719|FG000|Overall Study|Progressive Disease|1|||
19445912|NCT01900652|41693720|FG001|Overall Study|Progressive Disease|0|||
19445913|NCT01900652|41693719|FG000|Overall Study|Consent withdrawn by subject|1|||
19445914|NCT01900652|41693720|FG001|Overall Study|Consent withdrawn by subject|1|||
19445915|NCT01900652|41693719|FG000|Overall Study|Death|3|||
19445916|NCT01900652|41693720|FG001|Overall Study|Death|0|||
19445917|NCT01900652|41693719|FG000|Overall Study|Adverse Event|2|||
19445918|NCT01900652|41693720|FG001|Overall Study|Adverse Event|1|||
19445919|NCT01900652|41693719|FG000|Overall Study|Physician Decision|1|||
19445920|NCT01900652|41693720|FG001|Overall Study|Physician Decision|1|||
19445921|NCT02093351|41693734|FG000|Part A|Adverse Event|0|||
19445922|NCT02093351|41693735|FG001|Part A|Adverse Event|1|||
19445923|NCT02093351|41693736|FG002|Part A|Adverse Event|1|||
19445924|NCT02093351|41693737|FG003|Part A|Adverse Event|0|||
19445925|NCT02093351|41693734|FG000|Part A|Condition under investigation worsened|2|||
19445926|NCT02093351|41693735|FG001|Part A|Condition under investigation worsened|0|||
19445927|NCT02093351|41693736|FG002|Part A|Condition under investigation worsened|2|||
19445928|NCT02093351|41693737|FG003|Part A|Condition under investigation worsened|0|||
19445929|NCT02093351|41693734|FG000|Part A|Death|0|||
19445930|NCT02093351|41693735|FG001|Part A|Death|1|||
19445931|NCT02093351|41693736|FG002|Part A|Death|0|||
19445932|NCT02093351|41693737|FG003|Part A|Death|0|||
19445933|NCT02093351|41693734|FG000|Part B|Patient decision|0|||
19445934|NCT02093351|41693735|FG001|Part B|Patient decision|0|||
19445935|NCT02093351|41693736|FG002|Part B|Patient decision|0|||
19445936|NCT02093351|41693737|FG003|Part B|Patient decision|3|||
19445937|NCT02093351|41693734|FG000|Part B|Disease progression|0|||
19445938|NCT02093351|41693735|FG001|Part B|Disease progression|0|||
19445939|NCT02093351|41693736|FG002|Part B|Disease progression|0|||
19445940|NCT02093351|41693737|FG003|Part B|Disease progression|4|||
19445941|NCT02093351|41693734|FG000|Part B|Complete response|0|||
19445942|NCT02093351|41693735|FG001|Part B|Complete response|0|||
19445943|NCT02093351|41693736|FG002|Part B|Complete response|0|||
19445944|NCT02093351|41693737|FG003|Part B|Complete response|1|||
19445945|NCT02093351|41693734|FG000|Part B|Adverse event + disease progression|0|||
19445946|NCT02093351|41693735|FG001|Part B|Adverse event + disease progression|0|||
19445947|NCT02093351|41693736|FG002|Part B|Adverse event + disease progression|0|||
19445948|NCT02093351|41693737|FG003|Part B|Adverse event + disease progression|1|||
19445949|NCT02093351|41693734|FG000|Part B|Lack of therapeutic response|0|||
19445950|NCT02093351|41693735|FG001|Part B|Lack of therapeutic response|0|||
19445951|NCT02093351|41693736|FG002|Part B|Lack of therapeutic response|0|||
19445952|NCT02093351|41693737|FG003|Part B|Lack of therapeutic response|12|||
19445953|NCT02093351|41693734|FG000|Part B|Condition under investigation worsened|0|||
19445954|NCT02093351|41693735|FG001|Part B|Condition under investigation worsened|0|||
19445955|NCT02093351|41693736|FG002|Part B|Condition under investigation worsened|0|||
19445956|NCT02093351|41693737|FG003|Part B|Condition under investigation worsened|39|||
19445957|NCT02093351|41693734|FG000|Part B|Adverse Event|0|||
19445958|NCT02093351|41693735|FG001|Part B|Adverse Event|0|||
19445959|NCT02093351|41693736|FG002|Part B|Adverse Event|0|||
19445960|NCT02093351|41693737|FG003|Part B|Adverse Event|2|||
19445961|NCT02093351|41693734|FG000|Part B|Death|0|||
19445962|NCT02093351|41693735|FG001|Part B|Death|0|||
19445963|NCT02093351|41693736|FG002|Part B|Death|0|||
19445964|NCT02093351|41693737|FG003|Part B|Death|1|||
19445965|NCT02092961|41693776|FG000|Overall Study|Not reported|1|||
19445966|NCT02092961|41693777|FG001|Overall Study|Not reported|0|||
19445967|NCT02092961|41693778|FG002|Overall Study|Not reported|1|||
19445968|NCT02092961|41693776|FG000|Overall Study|Study stopped|13|||
19445969|NCT02092961|41693777|FG001|Overall Study|Study stopped|9|||
19445970|NCT02092961|41693778|FG002|Overall Study|Study stopped|12|||
19445971|NCT02092961|41693776|FG000|Overall Study|Lack of therapeutic response|2|||
19445972|NCT02092961|41693777|FG001|Overall Study|Lack of therapeutic response|1|||
19445973|NCT02092961|41693778|FG002|Overall Study|Lack of therapeutic response|3|||
19445974|NCT02092961|41693776|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
19445975|NCT02092961|41693777|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
19445976|NCT02092961|41693778|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
19445977|NCT02092961|41693776|FG000|Overall Study|Adverse Event|2|||
19445978|NCT02092961|41693777|FG001|Overall Study|Adverse Event|4|||
19524198|NCT00244374|41969191|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
19524199|NCT00244374|41969187|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
19524200|NCT00244374|41969188|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
19524201|NCT00244374|41969189|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
19524202|NCT00244374|41969190|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
19524203|NCT00244374|41969191|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
19524204|NCT00244374|41969187|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
19524205|NCT00244374|41969188|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
19524206|NCT00244374|41969189|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
19524207|NCT00244374|41969190|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
19524208|NCT00244374|41969191|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
19524209|NCT00242658|41969209|FG000|Overall Study|Lost to Follow-up|22|||
19524210|NCT00242658|41969210|FG001|Overall Study|Lost to Follow-up|19|||
19524211|NCT00242580|41969219|FG000|Overall Study|Adverse Event|3|||
19524212|NCT00242580|41969220|FG001|Overall Study|Adverse Event|0|||
19524213|NCT00242580|41969221|FG002|Overall Study|Adverse Event|2|||
19524214|NCT00242580|41969219|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19524215|NCT00242580|41969220|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
19524216|NCT00242580|41969221|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
19524217|NCT00242580|41969219|FG000|Overall Study|Protocol Violation|0|||
19524218|NCT00242580|41969220|FG001|Overall Study|Protocol Violation|0|||
19524219|NCT00242580|41969221|FG002|Overall Study|Protocol Violation|1|||
19524220|NCT00242580|41969219|FG000|Overall Study|Subject withdrew consent|2|||
19524221|NCT00242580|41969220|FG001|Overall Study|Subject withdrew consent|2|||
19524222|NCT00242580|41969221|FG002|Overall Study|Subject withdrew consent|5|||
19524223|NCT00242580|41969219|FG000|Overall Study|Lost to Follow-up|0|||
19524224|NCT00242580|41969220|FG001|Overall Study|Lost to Follow-up|3|||
19524225|NCT00242580|41969221|FG002|Overall Study|Lost to Follow-up|0|||
19524226|NCT00242580|41969219|FG000|Overall Study|Death|1|||
19524227|NCT00242580|41969220|FG001|Overall Study|Death|2|||
19524228|NCT00242580|41969221|FG002|Overall Study|Death|1|||
19524229|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
19524230|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
19524231|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
19524232|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
19524233|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
19524234|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
19524235|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
19524236|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
19524237|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
19524238|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
19445979|NCT02092961|41693778|FG002|Overall Study|Adverse Event|0|||
19445980|NCT01898078|41693789|FG000|Overall Study|Progressive Disease|1|||
19445981|NCT01898078|41693790|FG001|Overall Study|Progressive Disease|5|||
19445982|NCT01898078|41693789|FG000|Overall Study|Adverse Event|2|||
19445983|NCT01898078|41693790|FG001|Overall Study|Adverse Event|1|||
19445984|NCT01898078|41693789|FG000|Overall Study|Withdrawal by Subject|1|||
19445985|NCT01898078|41693790|FG001|Overall Study|Withdrawal by Subject|1|||
19445986|NCT01898078|41693789|FG000|Overall Study|Symptomatic Deterioration|2|||
19445987|NCT01898078|41693790|FG001|Overall Study|Symptomatic Deterioration|0|||
19445988|NCT01898078|41693789|FG000|Overall Study|Reason not Specified|0|||
19445989|NCT01898078|41693790|FG001|Overall Study|Reason not Specified|1|||
19445990|NCT01987817|41693800|FG000|Overall Study|Adverse Event|4|||
19445991|NCT01987817|41693801|FG001|Overall Study|Adverse Event|0|||
19445992|NCT01987817|41693800|FG000|Overall Study|Withdrawal by Subject|1|||
19445993|NCT01987817|41693801|FG001|Overall Study|Withdrawal by Subject|1|||
19445994|NCT01987817|41693800|FG000|Overall Study|Physician Decision|1|||
19445995|NCT01987817|41693801|FG001|Overall Study|Physician Decision|0|||
19524239|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
19524240|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
19524241|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
19445996|NCT01940497|41693810|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
19445997|NCT01940497|41693811|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
19445998|NCT01940497|41693810|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
19445999|NCT01940497|41693811|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
19524242|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
19524243|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
19524244|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
19524245|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
19524246|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
19524247|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
19524248|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
19446000|NCT01940497|41693810|FG000|Overall Study|Violation of Entry Criteria|1|||
19446001|NCT01940497|41693811|FG001|Overall Study|Violation of Entry Criteria|1|||
19446002|NCT01940497|41693810|FG000|Overall Study|Refused Treatment|1|||
19446003|NCT01940497|41693811|FG001|Overall Study|Refused Treatment|3|||
19446004|NCT01940497|41693810|FG000|Overall Study|Withdrew Consent|6|||
19446005|NCT01940497|41693811|FG001|Overall Study|Withdrew Consent|2|||
19446006|NCT01940497|41693810|FG000|Overall Study|Administrative/Other|1|||
19446007|NCT01940497|41693811|FG001|Overall Study|Administrative/Other|1|||
19446008|NCT01924754|41693831|FG000|Overall Study|Lost to Follow-up|1|||
19524249|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
19524250|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
19524251|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
19524252|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
19524253|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
19524254|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
19524255|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
19524256|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
19524257|NCT00241644|41969233|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
19524258|NCT00241644|41969234|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
19524259|NCT00241644|41969235|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
19524260|NCT00241644|41969236|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
19524261|NCT00241644|41969233|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
19524262|NCT00241644|41969234|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
19524263|NCT00241644|41969235|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
19524264|NCT00241644|41969236|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
19524265|NCT00241644|41969233|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
19524266|NCT00241644|41969234|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
19524267|NCT00241644|41969235|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
19524268|NCT00241644|41969236|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
19524269|NCT00241644|41969233|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
19524270|NCT00241644|41969234|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
19524271|NCT00241644|41969235|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
19524272|NCT00241644|41969236|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
19524273|NCT00241644|41969233|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
19524274|NCT00241644|41969234|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
19524275|NCT00241644|41969235|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
19524276|NCT00241644|41969236|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
19524277|NCT00241644|41969233|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
19524278|NCT00241644|41969234|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
19524279|NCT00241644|41969235|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
19524280|NCT00241644|41969236|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
19524281|NCT03804684|41969257|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
19524282|NCT03804684|41969258|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
19524283|NCT04295772|41969273|FG000|Overall Study|Protocol Violation|1|||
19524284|NCT04295772|41969274|FG001|Overall Study|Protocol Violation|0|||
19524285|NCT04295772|41969273|FG000|Overall Study|Ongoing for safety monitoring|14|||
19524286|NCT04295772|41969274|FG001|Overall Study|Ongoing for safety monitoring|1|||
19524287|NCT04295772|41969273|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
19524288|NCT04295772|41969274|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
19524289|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #1|24|||
19524290|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #1|0|||
19524291|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
19524292|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
19524293|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524294|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524295|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
19524296|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
19629106|NCT00811070|42078672|FG003|Overall Study|Physician Decision|0|||
19629107|NCT00811070|42078673|FG004|Overall Study|Physician Decision|0|||
19446009|NCT01924754|41693832|FG001|Overall Study|Lost to Follow-up|2|||
19524297|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
19524298|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
19524299|NCT03888066|41969283|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524300|NCT03888066|41969284|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524301|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524302|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524303|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
19524304|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
19524305|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524306|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524307|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
19524308|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524309|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #2|5|||
19524310|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #2|0|||
19524311|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
19524312|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
19524313|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
19524314|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
19524315|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
19524316|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
19524317|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #3|11|||
19524318|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #3|0|||
19524319|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
19524320|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
19524321|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
19524322|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
19524323|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524324|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524325|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #4|3|||
19524326|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #4|0|||
19524327|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
19524328|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
19524329|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
19524330|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
19629108|NCT00811070|42078674|FG005|Overall Study|Physician Decision|1|||
19446010|NCT01924754|41693833|FG002|Overall Study|Lost to Follow-up|1|||
19446011|NCT01924754|41693831|FG000|Overall Study|Pregnancy|0|||
19446012|NCT01924754|41693832|FG001|Overall Study|Pregnancy|1|||
19446013|NCT01924754|41693833|FG002|Overall Study|Pregnancy|2|||
19446014|NCT01924364|41693844|FG000|Overall Study|Physician Decision|3|||
19446015|NCT01987505|41693861|FG000|Overall Study|Other|9|||
19446016|NCT01987505|41693861|FG000|Overall Study|Withdrawal by Subject|2|||
19446017|NCT01987505|41693861|FG000|Overall Study|Other Reason|2|||
19446018|NCT01987505|41693861|FG000|Overall Study|Lost to Follow-up|15|||
19446019|NCT01987505|41693861|FG000|Overall Study|Investigator Decision|2|||
19446020|NCT01987505|41693861|FG000|Overall Study|Death|4|||
19446021|NCT01923896|41693869|FG000|Overall Study|Adverse Event|1|||
19446022|NCT01923896|41693870|FG001|Overall Study|Adverse Event|0|||
19446023|NCT02004353|41693876|FG000|Overall Study|Voluntary participation|1334|||
19446024|NCT01938625|41693882|FG000|Overall Study|Withdrawal by Subject|0|||
19446025|NCT01938625|41693883|FG001|Overall Study|Withdrawal by Subject|1|||
19446026|NCT01938625|41693882|FG000|Overall Study|Adverse Event|0|||
19446027|NCT01938625|41693883|FG001|Overall Study|Adverse Event|1|||
19446028|NCT01975675|41693893|FG000|Overall Study|Death|0|||
19446029|NCT01975675|41693894|FG001|Overall Study|Death|1|||
19446030|NCT01975675|41693895|FG002|Overall Study|Death|0|||
19446031|NCT01975675|41693896|FG003|Overall Study|Death|0|||
19446032|NCT01975285|41693908|FG000|Overall Study|Failed Block and follow up|2|||
19446033|NCT01975285|41693909|FG001|Overall Study|Failed Block and follow up|2|||
19446034|NCT01974895|41693917|FG000|Overall Study|Protocol Violation|1|||
19446035|NCT01974895|41693918|FG001|Overall Study|Protocol Violation|0|||
19446036|NCT01974895|41693917|FG000|Overall Study|Lost to Follow-up|4|||
19446037|NCT01974895|41693918|FG001|Overall Study|Lost to Follow-up|6|||
19446038|NCT01974895|41693917|FG000|Overall Study|Withdrawal by Subject|0|||
19446039|NCT01974895|41693918|FG001|Overall Study|Withdrawal by Subject|1|||
19446040|NCT01974895|41693917|FG000|Overall Study|Other (Missed Visit)|1|||
19446041|NCT01974895|41693918|FG001|Overall Study|Other (Missed Visit)|0|||
19446042|NCT01974895|41693917|FG000|Overall Study|Other (Reason unknown)|9|||
19446043|NCT01974895|41693918|FG001|Overall Study|Other (Reason unknown)|8|||
19446044|NCT01974817|41693924|FG000|Overall Study|Death|4|||
19446045|NCT01974817|41693924|FG000|Overall Study|Lost to Follow-up|2|||
19446046|NCT01974817|41693924|FG000|Overall Study|Protocol Violation|2|||
19446047|NCT01915849|41693932|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
19446048|NCT01915849|41693933|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
19446049|NCT01915849|41693934|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
19446050|NCT01915849|41693935|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
19446051|NCT01915849|41693932|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
19446052|NCT01915849|41693933|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19446053|NCT01915849|41693934|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19446054|NCT01915849|41693935|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
19446055|NCT01915771|41693945|FG000|Day 1|Withdrawal by Subject|1|||
19446056|NCT01915771|41693945|FG000|Day 15|Withdrawal by Subject|1|||
19446057|NCT01938391|41693953|FG000|6 Month Follow up|Withdrawal by Subject|1|||
19446058|NCT01938391|41693953|FG000|12 Month Follow up|Physician Decision|1|||
19446059|NCT01938391|41693953|FG000|12 Month Follow up|Withdrawal by Subject|1|||
19446060|NCT01915303|41693957|FG000|Core Phase|Adverse Event|7|||
19446061|NCT01915303|41693957|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
19446062|NCT01915303|41693957|FG000|Core Phase|Death|2|||
19446063|NCT01915303|41693957|FG000|Core Phase|Protocol Violation|2|||
19446064|NCT01915303|41693957|FG000|Core Phase|Abnormal lab value|1|||
19446065|NCT01915303|41693957|FG000|Core Phase|Withdrawal by Subject|1|||
19446066|NCT01915303|41693957|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
19446067|NCT01915303|41693957|FG000|Extension Phase|Withdrawal by Subject|4|||
19446068|NCT01915303|41693957|FG000|Extension Phase|Adverse Event|3|||
19446069|NCT01915303|41693957|FG000|Extension Phase|Death|1|||
19446070|NCT01915303|41693957|FG000|Extension Phase|Protocol Violation|1|||
19446071|NCT01987427|41693964|FG000|Overall Study|Adverse Event|4|||
19446072|NCT01987427|41693965|FG001|Overall Study|Adverse Event|2|||
19446073|NCT01987427|41693966|FG002|Overall Study|Adverse Event|8|||
19446074|NCT01987427|41693964|FG000|Overall Study|Lost to Follow-up|6|||
19446075|NCT01987427|41693965|FG001|Overall Study|Lost to Follow-up|6|||
19446076|NCT01987427|41693966|FG002|Overall Study|Lost to Follow-up|9|||
19446077|NCT01987427|41693964|FG000|Overall Study|Withdrawal by Subject|2|||
19446078|NCT01987427|41693965|FG001|Overall Study|Withdrawal by Subject|1|||
19446079|NCT01987427|41693966|FG002|Overall Study|Withdrawal by Subject|3|||
19446080|NCT01987427|41693964|FG000|Overall Study|Lack of Efficacy|1|||
19446081|NCT01987427|41693965|FG001|Overall Study|Lack of Efficacy|0|||
19446082|NCT01987427|41693966|FG002|Overall Study|Lack of Efficacy|0|||
19446083|NCT01987427|41693964|FG000|Overall Study|Other|1|||
19446084|NCT01987427|41693965|FG001|Overall Study|Other|1|||
19446085|NCT01987427|41693966|FG002|Overall Study|Other|0|||
19446086|NCT01937299|41693976|FG000|Overall Study|Adverse Event|13|||
19446087|NCT01937299|41693977|FG001|Overall Study|Adverse Event|0|||
19446088|NCT01937299|41693976|FG000|Overall Study|Lack of Efficacy|0|||
19446089|NCT01937299|41693977|FG001|Overall Study|Lack of Efficacy|4|||
19446090|NCT01937299|41693976|FG000|Overall Study|Withdrawal by Subject|1|||
19446091|NCT01937299|41693977|FG001|Overall Study|Withdrawal by Subject|0|||
19446092|NCT02003963|41693986|FG000|Overall Study|Lost to Follow-up|2|||
19446093|NCT02003963|41693987|FG001|Overall Study|Lost to Follow-up|1|||
19446094|NCT01606761|41693998|FG000|Prior to Week 24|Lost to Follow-up|0|||
19446095|NCT01606761|41693999|FG001|Prior to Week 24|Lost to Follow-up|3|||
19446096|NCT01606761|41694000|FG002|Prior to Week 24|Lost to Follow-up|2|||
19446097|NCT01606761|41694001|FG003|Prior to Week 24|Lost to Follow-up|0|||
19524331|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
19524332|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
19524333|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
19524334|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
19524335|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
19524336|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19629109|NCT00642460|42078692|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
19446098|NCT01606761|41694002|FG004|Prior to Week 24|Lost to Follow-up|0|||
19446099|NCT01606761|41693998|FG000|Prior to Week 24|Withdrawal by Subject|12|||
19446100|NCT01606761|41693999|FG001|Prior to Week 24|Withdrawal by Subject|10|||
19446101|NCT01606761|41694000|FG002|Prior to Week 24|Withdrawal by Subject|9|||
19446102|NCT01606761|41694001|FG003|Prior to Week 24|Withdrawal by Subject|0|||
19446103|NCT01606761|41694002|FG004|Prior to Week 24|Withdrawal by Subject|0|||
19446104|NCT01606761|41693998|FG000|Prior to Week 24|Adverse Event|11|||
19446105|NCT01606761|41693999|FG001|Prior to Week 24|Adverse Event|18|||
19446106|NCT01606761|41694000|FG002|Prior to Week 24|Adverse Event|22|||
19446107|NCT01606761|41694001|FG003|Prior to Week 24|Adverse Event|0|||
19446108|NCT01606761|41694002|FG004|Prior to Week 24|Adverse Event|0|||
19446109|NCT01606761|41693998|FG000|Prior to Week 24|Lack of Efficacy|15|||
19446110|NCT01606761|41693999|FG001|Prior to Week 24|Lack of Efficacy|14|||
19446111|NCT01606761|41694000|FG002|Prior to Week 24|Lack of Efficacy|8|||
19524337|NCT03888066|41969283|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
19524338|NCT03888066|41969284|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
19524339|NCT03888066|41969283|FG000|Run-in Phase|AE (Adverse Event)|17|||
19524340|NCT03888066|41969284|FG001|Run-in Phase|AE (Adverse Event)|0|||
19524341|NCT03888066|41969283|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
19524342|NCT03888066|41969284|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
19524343|NCT03888066|41969283|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524344|NCT03888066|41969284|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524345|NCT03888066|41969283|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
19524346|NCT03888066|41969284|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524347|NCT03888066|41969283|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
19524348|NCT03888066|41969284|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
19524349|NCT03888066|41969283|FG000|Run-in Phase|Withdrawal by Subject|43|||
19524350|NCT03888066|41969284|FG001|Run-in Phase|Withdrawal by Subject|0|||
19524351|NCT03888066|41969283|FG000|Run-in Phase|AE; Physician Decision|1|||
19524352|NCT03888066|41969284|FG001|Run-in Phase|AE; Physician Decision|0|||
19524353|NCT03888066|41969283|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
19524354|NCT03888066|41969284|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
19524355|NCT03888066|41969283|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
19524356|NCT03888066|41969284|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
19446112|NCT01606761|41694001|FG003|Prior to Week 24|Lack of Efficacy|0|||
19446113|NCT01606761|41694002|FG004|Prior to Week 24|Lack of Efficacy|0|||
19446114|NCT01606761|41693998|FG000|Prior to Week 24|Physician Decision|0|||
19446115|NCT01606761|41693999|FG001|Prior to Week 24|Physician Decision|3|||
19446116|NCT01606761|41694000|FG002|Prior to Week 24|Physician Decision|1|||
19446117|NCT01606761|41694001|FG003|Prior to Week 24|Physician Decision|0|||
19446118|NCT01606761|41694002|FG004|Prior to Week 24|Physician Decision|0|||
19446119|NCT01606761|41693998|FG000|Prior to Week 24|Other|4|||
19446120|NCT01606761|41693999|FG001|Prior to Week 24|Other|7|||
19446121|NCT01606761|41694000|FG002|Prior to Week 24|Other|5|||
19446122|NCT01606761|41694001|FG003|Prior to Week 24|Other|0|||
19446123|NCT01606761|41694002|FG004|Prior to Week 24|Other|0|||
19446124|NCT01606761|41693998|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
19446125|NCT01606761|41693999|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
19446126|NCT01606761|41694000|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
19446127|NCT01606761|41694001|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
19446128|NCT01606761|41694002|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
19446129|NCT01606761|41693998|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
19446130|NCT01606761|41693999|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
19446131|NCT01606761|41694000|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
19446132|NCT01606761|41694001|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
19446133|NCT01606761|41694002|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
19446134|NCT01606761|41693998|FG000|Week 24 to Week 52|Adverse Event|0|||
19446135|NCT01606761|41693999|FG001|Week 24 to Week 52|Adverse Event|11|||
19446136|NCT01606761|41694000|FG002|Week 24 to Week 52|Adverse Event|14|||
19446137|NCT01606761|41694001|FG003|Week 24 to Week 52|Adverse Event|3|||
19446138|NCT01606761|41694002|FG004|Week 24 to Week 52|Adverse Event|15|||
19446139|NCT01606761|41693998|FG000|Week 24 to Week 52|Death|0|||
19446140|NCT01606761|41693999|FG001|Week 24 to Week 52|Death|0|||
19446141|NCT01606761|41694000|FG002|Week 24 to Week 52|Death|2|||
19446142|NCT01606761|41694001|FG003|Week 24 to Week 52|Death|1|||
19446143|NCT01606761|41694002|FG004|Week 24 to Week 52|Death|0|||
19524357|NCT03888066|41969283|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
19524358|NCT03888066|41969284|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
19524359|NCT03888066|41969283|FG000|Run-in Phase|Death|1|||
19524360|NCT03888066|41969284|FG001|Run-in Phase|Death|0|||
19524361|NCT03888066|41969283|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
19524362|NCT03888066|41969284|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
19524363|NCT03888066|41969283|FG000|Run-in Phase|Physician Decision|1|||
19524364|NCT03888066|41969284|FG001|Run-in Phase|Physician Decision|0|||
19524365|NCT03888066|41969283|FG000|Run-in Phase|Protocol Violation|13|||
19524366|NCT03888066|41969284|FG001|Run-in Phase|Protocol Violation|0|||
19524367|NCT03888066|41969283|FG000|Run-in Phase|Sponsor Request|34|||
19524368|NCT03888066|41969284|FG001|Run-in Phase|Sponsor Request|0|||
19524369|NCT03888066|41969283|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
19446144|NCT01606761|41693998|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
19446145|NCT01606761|41693999|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
19446146|NCT01606761|41694000|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
19446147|NCT01606761|41694001|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
19446148|NCT01606761|41694002|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
19446149|NCT01606761|41693998|FG000|Week 24 to Week 52|Physician Decision|0|||
19446150|NCT01606761|41693999|FG001|Week 24 to Week 52|Physician Decision|1|||
19446151|NCT01606761|41694000|FG002|Week 24 to Week 52|Physician Decision|1|||
19524370|NCT03888066|41969284|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
19524371|NCT03888066|41969283|FG000|Run-in Phase|Withdrawal Of Consent|1|||
19524372|NCT03888066|41969284|FG001|Run-in Phase|Withdrawal Of Consent|0|||
19524373|NCT03888066|41969283|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
19524374|NCT03888066|41969284|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
19524375|NCT03888066|41969283|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
19524376|NCT03888066|41969284|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
19524377|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
19524378|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
19524379|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
19524380|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
19524381|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
19524382|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
19524383|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
19524384|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
19524385|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
19524386|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
19524387|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
19524388|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
19524389|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
19524390|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
19524391|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
19524392|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
19524393|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
19524394|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
19524395|NCT03888066|41969283|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
19524396|NCT03888066|41969284|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
19524397|NCT02017704|41969293|FG000|Overall Study|Withdrawal by Subject|2|||
19524398|NCT02017704|41969294|FG001|Overall Study|Withdrawal by Subject|0|||
19524399|NCT01049334|41969304|FG000|Overall Study|Withdrawal by Subject|5|||
19524400|NCT01049334|41969305|FG001|Overall Study|Withdrawal by Subject|3|||
19524401|NCT01049334|41969304|FG000|Overall Study|Adverse Event|2|||
19524402|NCT01049334|41969305|FG001|Overall Study|Adverse Event|3|||
19524403|NCT01049334|41969304|FG000|Overall Study|Physician Decision|2|||
19524404|NCT01049334|41969305|FG001|Overall Study|Physician Decision|0|||
19524405|NCT01049334|41969304|FG000|Overall Study|Protocol Violation|0|||
19524406|NCT01049334|41969305|FG001|Overall Study|Protocol Violation|1|||
19524407|NCT01048944|41969315|FG000|Overall Study|Protocol Violation|8|||
19446152|NCT01606761|41694001|FG003|Week 24 to Week 52|Physician Decision|0|||
19446153|NCT01606761|41694002|FG004|Week 24 to Week 52|Physician Decision|0|||
19446154|NCT01606761|41693998|FG000|Week 24 to Week 52|Other|0|||
19446155|NCT01606761|41693999|FG001|Week 24 to Week 52|Other|1|||
19446156|NCT01606761|41694000|FG002|Week 24 to Week 52|Other|5|||
19446157|NCT01606761|41694001|FG003|Week 24 to Week 52|Other|2|||
19446158|NCT01606761|41694002|FG004|Week 24 to Week 52|Other|2|||
19446159|NCT01606761|41693998|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
19446160|NCT01606761|41693999|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
19446161|NCT01606761|41694000|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
19524408|NCT01048944|41969316|FG001|Overall Study|Protocol Violation|10|||
19524409|NCT01048944|41969317|FG002|Overall Study|Protocol Violation|10|||
19446162|NCT01606761|41694001|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
19446163|NCT01606761|41694002|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
19446164|NCT01606761|41693998|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
19446165|NCT01606761|41693999|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
19446166|NCT01606761|41694000|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
19524410|NCT01048944|41969318|FG003|Overall Study|Protocol Violation|2|||
19524411|NCT01048866|41969330|FG000|Overall Study|Adverse Event|1|||
19524412|NCT01048866|41969331|FG001|Overall Study|Adverse Event|0|||
19524413|NCT01048866|41969330|FG000|Overall Study|Protocol Violation|1|||
19524414|NCT01048866|41969331|FG001|Overall Study|Protocol Violation|0|||
19524415|NCT01048866|41969330|FG000|Overall Study|Physician Decision|1|||
19524416|NCT01048866|41969331|FG001|Overall Study|Physician Decision|0|||
19524417|NCT01048866|41969330|FG000|Overall Study|Withdrawal by Subject|0|||
19524418|NCT01048866|41969331|FG001|Overall Study|Withdrawal by Subject|2|||
19524419|NCT01048866|41969330|FG000|Overall Study|Lost to Follow-up|0|||
19524420|NCT01048866|41969331|FG001|Overall Study|Lost to Follow-up|2|||
19524421|NCT01048866|41969330|FG000|Overall Study|Other|1|||
19524422|NCT01048866|41969331|FG001|Overall Study|Other|1|||
19524423|NCT01048788|41969340|FG000|Overall Study|Adverse Event|5|||
19524424|NCT01048788|41969341|FG001|Overall Study|Adverse Event|1|||
19524425|NCT01048788|41969342|FG002|Overall Study|Adverse Event|1|||
19446167|NCT01606761|41694001|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
19524426|NCT01048788|41969340|FG000|Overall Study|Lack of Efficacy|0|||
19524427|NCT01048788|41969341|FG001|Overall Study|Lack of Efficacy|0|||
19524428|NCT01048788|41969342|FG002|Overall Study|Lack of Efficacy|1|||
19446168|NCT01606761|41694002|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
19446169|NCT01606761|41693998|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
19446170|NCT01606761|41693999|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
19446171|NCT01606761|41694000|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
19446172|NCT01606761|41694001|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
19446173|NCT01606761|41694002|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
19446174|NCT01606761|41693998|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
19446175|NCT01606761|41693999|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
19446176|NCT01606761|41694000|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
19446177|NCT01606761|41694001|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
19446178|NCT01606761|41694002|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
19446179|NCT01790295|41694017|FG000|Overall Study|Adverse Event|1|||
19446180|NCT01790295|41694017|FG000|Overall Study|Death|4|||
19446181|NCT01790295|41694017|FG000|Overall Study|Lack of Efficacy|2|||
19446182|NCT01790295|41694017|FG000|Overall Study|Study closure|4|||
19446183|NCT01597557|41694024|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
19446184|NCT01597557|41694025|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
19446185|NCT01760733|41694031|FG000|Waiting List|Death|18|||
19446186|NCT01760733|41694031|FG000|Waiting List|Removed from waiting list|41|||
19446187|NCT01760733|41694031|FG000|Waiting List|Not received a transplant yet|13|||
19446188|NCT01760733|41694031|FG000|Transplanted|Not reached 10 years post transplant|184|||
19446189|NCT01760733|41694031|FG000|Transplanted|Death|26|||
19446190|NCT01760733|41694031|FG000|Transplanted|Graft loss|7|||
19446191|NCT01914757|41694039|FG000|Overall Study|Severe non-compliance to protocol|3|||
19446192|NCT01914757|41694040|FG001|Overall Study|Severe non-compliance to protocol|1|||
19446193|NCT01914757|41694041|FG002|Overall Study|Severe non-compliance to protocol|2|||
19446194|NCT01914757|41694039|FG000|Overall Study|Lost to Follow-up|5|||
19446195|NCT01914757|41694040|FG001|Overall Study|Lost to Follow-up|8|||
19446196|NCT01914757|41694041|FG002|Overall Study|Lost to Follow-up|6|||
19446197|NCT01914757|41694039|FG000|Overall Study|Withdrawal by Subject|15|||
19446198|NCT01914757|41694040|FG001|Overall Study|Withdrawal by Subject|27|||
19446199|NCT01914757|41694041|FG002|Overall Study|Withdrawal by Subject|19|||
19446200|NCT01914757|41694039|FG000|Overall Study|Death|2|||
19446201|NCT01914757|41694040|FG001|Overall Study|Death|2|||
19446202|NCT01914757|41694041|FG002|Overall Study|Death|1|||
19446203|NCT01914757|41694039|FG000|Overall Study|Adverse Event|4|||
19446204|NCT01914757|41694040|FG001|Overall Study|Adverse Event|3|||
19446205|NCT01914757|41694041|FG002|Overall Study|Adverse Event|4|||
19446206|NCT01914757|41694039|FG000|Overall Study|Study specific withdrawal criteria|0|||
19446207|NCT01914757|41694040|FG001|Overall Study|Study specific withdrawal criteria|1|||
19446208|NCT01914757|41694041|FG002|Overall Study|Study specific withdrawal criteria|0|||
19446209|NCT01914757|41694039|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19446210|NCT01914757|41694040|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
19446211|NCT01914757|41694041|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
19446212|NCT01914757|41694039|FG000|Overall Study|Other reasons|5|||
19446213|NCT01914757|41694040|FG001|Overall Study|Other reasons|9|||
19446214|NCT01914757|41694041|FG002|Overall Study|Other reasons|4|||
19446215|NCT02003573|41694052|FG000|Overall Study|Progressive disease|2|||
19446216|NCT02003573|41694053|FG001|Overall Study|Progressive disease|0|||
19446217|NCT02003573|41694054|FG002|Overall Study|Progressive disease|1|||
19446218|NCT02003573|41694052|FG000|Overall Study|Other Adverse event|0|||
19446219|NCT02003573|41694053|FG001|Overall Study|Other Adverse event|1|||
19446220|NCT02003573|41694054|FG002|Overall Study|Other Adverse event|1|||
19446221|NCT02003573|41694052|FG000|Overall Study|Refuse to take trial medication|0|||
19446222|NCT02003573|41694053|FG001|Overall Study|Refuse to take trial medication|1|||
19446223|NCT02003573|41694054|FG002|Overall Study|Refuse to take trial medication|1|||
19446224|NCT02003573|41694052|FG000|Overall Study|Other than specified|1|||
19446225|NCT02003573|41694053|FG001|Overall Study|Other than specified|2|||
19446226|NCT02003573|41694054|FG002|Overall Study|Other than specified|3|||
19446227|NCT01914679|41694064|FG000|Overall Study|Lack of Efficacy|1|||
19446228|NCT01914679|41694064|FG000|Overall Study|Sponsor terminated study|4|||
19524429|NCT01048788|41969340|FG000|Overall Study|Withdrawal by Subject|0|||
19524430|NCT01048788|41969341|FG001|Overall Study|Withdrawal by Subject|1|||
19524431|NCT01048788|41969342|FG002|Overall Study|Withdrawal by Subject|0|||
19524432|NCT01048242|41969352|FG000|Overall Study|See study flow chart|4|||
19524433|NCT01048242|41969353|FG001|Overall Study|See study flow chart|2|||
19524434|NCT01047306|41969361|FG000|Overall Study|Withdrawal by Subject|2|||
19524435|NCT01047306|41969362|FG001|Overall Study|Withdrawal by Subject|0|||
19446229|NCT01789281|41694070|FG000|Overall Study|Disease progression|15|||
19446230|NCT01789281|41694071|FG001|Overall Study|Disease progression|4|||
19446231|NCT01789281|41694070|FG000|Overall Study|Adverse Event|5|||
19446232|NCT01789281|41694071|FG001|Overall Study|Adverse Event|5|||
19446233|NCT01789281|41694070|FG000|Overall Study|Withdrawal by Subject|1|||
19524436|NCT01047306|41969361|FG000|Overall Study|Lost to Follow-up|1|||
19524437|NCT01047306|41969362|FG001|Overall Study|Lost to Follow-up|0|||
19524438|NCT01046682|41969372|FG000|Overall Study|Adverse Event|2|||
19524439|NCT01046682|41969373|FG001|Overall Study|Adverse Event|0|||
19524440|NCT01044732|41969381|FG000|Overall Study|Lost to Follow-up|2|||
19524441|NCT01044732|41969382|FG001|Overall Study|Lost to Follow-up|1|||
19524442|NCT01044732|41969381|FG000|Overall Study|Physician Decision|5|||
19524443|NCT01044732|41969382|FG001|Overall Study|Physician Decision|3|||
19524444|NCT01044732|41969381|FG000|Overall Study|Protocol Violation|11|||
19524445|NCT01044732|41969382|FG001|Overall Study|Protocol Violation|12|||
19524446|NCT01044732|41969381|FG000|Overall Study|Withdrawal by Subject|0|||
19524447|NCT01044732|41969382|FG001|Overall Study|Withdrawal by Subject|1|||
19524448|NCT01044732|41969381|FG000|Overall Study|Inadequate bowel preparation|11|||
19524449|NCT01044732|41969382|FG001|Overall Study|Inadequate bowel preparation|17|||
19524450|NCT01044732|41969381|FG000|Overall Study|Inability to reach cecum|5|||
19524451|NCT01044732|41969382|FG001|Overall Study|Inability to reach cecum|2|||
19524452|NCT01044732|41969381|FG000|Overall Study|Technical error or malfunction|15|||
19524453|NCT01044732|41969382|FG001|Overall Study|Technical error or malfunction|14|||
19524454|NCT01044498|41969392|FG000|Overall Study|Withdrew consent|1|||
19524455|NCT01044498|41969393|FG001|Overall Study|Withdrew consent|1|||
19524456|NCT01044498|41969392|FG000|Overall Study|Adverse Event|1|||
19524457|NCT01044498|41969393|FG001|Overall Study|Adverse Event|1|||
19524458|NCT01044498|41969392|FG000|Overall Study|Other|1|||
19524459|NCT01044498|41969393|FG001|Overall Study|Other|0|||
19524460|NCT01043874|41969399|FG000|Overall Study|Adverse Event|3|||
19524461|NCT01043874|41969399|FG000|Overall Study|Withdrawal by Subject|1|||
19524462|NCT01043874|41969399|FG000|Overall Study|Lack of Efficacy|1|||
19524463|NCT01043874|41969399|FG000|Overall Study|Administrative Problems|1|||
19524464|NCT01042938|41969405|FG000|Overall Study|Withdrawal by Subject|1|||
19524465|NCT01042938|41969406|FG001|Overall Study|Withdrawal by Subject|1|||
19524466|NCT01042938|41969405|FG000|Overall Study|Protocol Violation|1|||
19524467|NCT01042938|41969406|FG001|Overall Study|Protocol Violation|1|||
19524468|NCT01042938|41969405|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
19524469|NCT01042938|41969406|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
19524470|NCT01042158|41969414|FG000|Overall Study|Physician Decision|1|||
19524471|NCT03408444|41969422|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
19524472|NCT03408444|41969423|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
19524473|NCT03408444|41969424|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
19524474|NCT03408444|41969425|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
19524475|NCT03408444|41969422|FG000|Overall Study|Lens Discomfort|0|||
19524476|NCT03408444|41969423|FG001|Overall Study|Lens Discomfort|1|||
19524477|NCT03408444|41969424|FG002|Overall Study|Lens Discomfort|0|||
19524478|NCT03408444|41969425|FG003|Overall Study|Lens Discomfort|0|||
19524479|NCT03408444|41969422|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
19524480|NCT03408444|41969423|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
19524481|NCT03408444|41969424|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
19524482|NCT03408444|41969425|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
19524483|NCT03408444|41969422|FG000|Overall Study|Withdrawal by Subject|0|||
19446234|NCT01789281|41694071|FG001|Overall Study|Withdrawal by Subject|0|||
19446235|NCT01789281|41694070|FG000|Overall Study|Lost to Follow-up|1|||
19446236|NCT01789281|41694071|FG001|Overall Study|Lost to Follow-up|0|||
19446237|NCT01789281|41694070|FG000|Overall Study|Administrative problems|0|||
19524484|NCT03408444|41969423|FG001|Overall Study|Withdrawal by Subject|2|||
19524485|NCT03408444|41969424|FG002|Overall Study|Withdrawal by Subject|3|||
19524486|NCT03408444|41969425|FG003|Overall Study|Withdrawal by Subject|0|||
19524487|NCT03408444|41969422|FG000|Overall Study|Lost to Follow-up|0|||
19524488|NCT03408444|41969423|FG001|Overall Study|Lost to Follow-up|0|||
19524489|NCT03408444|41969424|FG002|Overall Study|Lost to Follow-up|1|||
19446238|NCT01789281|41694071|FG001|Overall Study|Administrative problems|1|||
19446239|NCT01923740|41694080|FG000|Overall Study|Lost to Follow-up|4|||
19446240|NCT01923740|41694081|FG001|Overall Study|Lost to Follow-up|9|||
19446241|NCT01923740|41694080|FG000|Overall Study|Withdrawal by Subject|2|||
19524490|NCT03408444|41969425|FG003|Overall Study|Lost to Follow-up|0|||
19524491|NCT03408444|41969422|FG000|Overall Study|Adverse Event|0|||
19524492|NCT03408444|41969423|FG001|Overall Study|Adverse Event|0|||
19524493|NCT03408444|41969424|FG002|Overall Study|Adverse Event|0|||
19629110|NCT00642460|42078693|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
19446242|NCT01923740|41694081|FG001|Overall Study|Withdrawal by Subject|0|||
19446243|NCT01789203|41694089|FG000|Overall Study|Adverse Event|2|||
19446244|NCT01789203|41694090|FG001|Overall Study|Adverse Event|2|||
19524494|NCT03408444|41969425|FG003|Overall Study|Adverse Event|1|||
19524495|NCT03408444|41969422|FG000|Overall Study|Lens Handling Difficulties|0|||
19524496|NCT03408444|41969423|FG001|Overall Study|Lens Handling Difficulties|0|||
19524497|NCT03408444|41969424|FG002|Overall Study|Lens Handling Difficulties|1|||
19446245|NCT01789203|41694089|FG000|Overall Study|Withdrawal by Subject|1|||
19524498|NCT03408444|41969425|FG003|Overall Study|Lens Handling Difficulties|0|||
19524499|NCT03408444|41969422|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
19524500|NCT03408444|41969423|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
19524501|NCT03408444|41969424|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
19524502|NCT03408444|41969425|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
19524503|NCT03400956|41969455|FG000|Treatment Period 1|Adverse Event|0|||
19524504|NCT03400956|41969456|FG001|Treatment Period 1|Adverse Event|1|||
19524505|NCT03400956|41969457|FG002|Treatment Period 1|Adverse Event|0|||
19524506|NCT03400956|41969455|FG000|Treatment Period 1|Lost to Follow-up|0|||
19524507|NCT03400956|41969456|FG001|Treatment Period 1|Lost to Follow-up|0|||
19524508|NCT03400956|41969457|FG002|Treatment Period 1|Lost to Follow-up|1|||
19524509|NCT03400956|41969455|FG000|Treatment Period 1|Protocol Violation|0|||
19524510|NCT03400956|41969456|FG001|Treatment Period 1|Protocol Violation|2|||
19524511|NCT03400956|41969457|FG002|Treatment Period 1|Protocol Violation|0|||
19524512|NCT03400956|41969455|FG000|Treatment Period 1|Study terminated by sponsor|3|||
19524513|NCT03400956|41969456|FG001|Treatment Period 1|Study terminated by sponsor|1|||
19524514|NCT03400956|41969457|FG002|Treatment Period 1|Study terminated by sponsor|1|||
19524515|NCT03400956|41969455|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19524516|NCT03400956|41969456|FG001|Treatment Period 1|Withdrawal by Subject|2|||
19524517|NCT03400956|41969457|FG002|Treatment Period 1|Withdrawal by Subject|4|||
19524518|NCT03400956|41969455|FG000|Treatment Period 1|Other|1|||
19524519|NCT03400956|41969456|FG001|Treatment Period 1|Other|2|||
19524520|NCT03400956|41969457|FG002|Treatment Period 1|Other|3|||
19524521|NCT03400956|41969455|FG000|Post-treatment Period 1|Adverse Event|0|||
19524522|NCT03400956|41969456|FG001|Post-treatment Period 1|Adverse Event|0|||
19524523|NCT03400956|41969457|FG002|Post-treatment Period 1|Adverse Event|1|||
19524524|NCT03400956|41969455|FG000|Post-treatment Period 1|Physician Decision|2|||
19524525|NCT03400956|41969456|FG001|Post-treatment Period 1|Physician Decision|3|||
19524526|NCT03400956|41969457|FG002|Post-treatment Period 1|Physician Decision|0|||
19524527|NCT03400956|41969455|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
19524528|NCT03400956|41969456|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
19446246|NCT01789203|41694090|FG001|Overall Study|Withdrawal by Subject|0|||
19446247|NCT01789203|41694089|FG000|Overall Study|Death|1|||
19446248|NCT01789203|41694090|FG001|Overall Study|Death|0|||
19446249|NCT01789203|41694089|FG000|Overall Study|Protocol Violation|2|||
19446250|NCT01789203|41694090|FG001|Overall Study|Protocol Violation|1|||
19446251|NCT01789203|41694089|FG000|Overall Study|Other|1|||
19446252|NCT01789203|41694090|FG001|Overall Study|Other|1|||
19446253|NCT01789203|41694089|FG000|Overall Study|patient non-adherent|2|||
19446254|NCT01789203|41694090|FG001|Overall Study|patient non-adherent|0|||
19446255|NCT01789047|41694100|FG000|Overall Study|Adverse Event|3|||
19446256|NCT01789047|41694101|FG001|Overall Study|Adverse Event|2|||
19446257|NCT01789047|41694100|FG000|Overall Study|Withdrawal by Subject|1|||
19446258|NCT01789047|41694101|FG001|Overall Study|Withdrawal by Subject|2|||
19446259|NCT01788423|41694110|FG000|Overall Study|See Comments in Completed (above)|0|||
19446260|NCT01788423|41694111|FG001|Overall Study|See Comments in Completed (above)|4|||
19446261|NCT01788423|41694112|FG002|Overall Study|See Comments in Completed (above)|5|||
19446262|NCT01617187|41694124|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
19446263|NCT01617187|41694125|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
19446264|NCT01617187|41694126|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
19446265|NCT01617187|41694127|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
19446266|NCT01617187|41694124|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
19446267|NCT01617187|41694125|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
19446268|NCT01617187|41694126|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
19446269|NCT01617187|41694127|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
19446270|NCT01617187|41694124|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
19446271|NCT01617187|41694125|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
19446272|NCT01617187|41694126|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
19446273|NCT01617187|41694127|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
19446274|NCT01617187|41694124|FG000|Treatment Through Study Completion|Adverse Event|1|||
19446275|NCT01617187|41694125|FG001|Treatment Through Study Completion|Adverse Event|1|||
19524529|NCT03400956|41969457|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
19524530|NCT03400956|41969455|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
19524531|NCT03400956|41969456|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
19524532|NCT03400956|41969457|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
19524533|NCT03400956|41969455|FG000|Post-treatment Period 1|Other|4|||
19524534|NCT03400956|41969456|FG001|Post-treatment Period 1|Other|3|||
19524535|NCT03400956|41969457|FG002|Post-treatment Period 1|Other|4|||
19446276|NCT01617187|41694126|FG002|Treatment Through Study Completion|Adverse Event|0|||
19446277|NCT01617187|41694127|FG003|Treatment Through Study Completion|Adverse Event|1|||
19446278|NCT01617187|41694124|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
19446279|NCT01617187|41694125|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
19446280|NCT01617187|41694126|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
19446281|NCT01617187|41694127|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
19446282|NCT01617187|41694124|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
19446283|NCT01617187|41694125|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
19446284|NCT01617187|41694126|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
19446285|NCT01617187|41694127|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
19446286|NCT01617187|41694124|FG000|Treatment Through Study Completion|Protocol Violation|1|||
19446287|NCT01617187|41694125|FG001|Treatment Through Study Completion|Protocol Violation|0|||
19524536|NCT03400956|41969455|FG000|Treatment Period 2|Adverse Event|2|||
19524537|NCT03400956|41969456|FG001|Treatment Period 2|Adverse Event|1|||
19524538|NCT03400956|41969457|FG002|Treatment Period 2|Adverse Event|1|||
19524539|NCT03400956|41969455|FG000|Treatment Period 2|Lost to Follow-up|1|||
19524540|NCT03400956|41969456|FG001|Treatment Period 2|Lost to Follow-up|1|||
19524541|NCT03400956|41969457|FG002|Treatment Period 2|Lost to Follow-up|0|||
19524542|NCT03400956|41969455|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19524543|NCT03400956|41969456|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19524544|NCT03400956|41969457|FG002|Treatment Period 2|Withdrawal by Subject|3|||
19524545|NCT03400956|41969455|FG000|Treatment Period 2|Other|1|||
19524546|NCT03400956|41969456|FG001|Treatment Period 2|Other|1|||
19524547|NCT03400956|41969457|FG002|Treatment Period 2|Other|0|||
19524548|NCT03400956|41969455|FG000|Follow-up Period|Withdrawal by Subject|0|||
19524549|NCT03400956|41969456|FG001|Follow-up Period|Withdrawal by Subject|0|||
19524550|NCT03400956|41969457|FG002|Follow-up Period|Withdrawal by Subject|1|||
19524551|NCT03400956|41969455|FG000|Follow-up Period|Other|0|||
19524552|NCT03400956|41969456|FG001|Follow-up Period|Other|0|||
19524553|NCT03400956|41969457|FG002|Follow-up Period|Other|1|||
19524554|NCT00012012|41969470|FG000|Overall Study|Protocol Violation|1|||
19524555|NCT00012012|41969471|FG001|Overall Study|Protocol Violation|1|||
19524556|NCT00012012|41969470|FG000|Overall Study|Withdrawal by Subject|0|||
19524557|NCT00012012|41969471|FG001|Overall Study|Withdrawal by Subject|2|||
19524558|NCT00010374|41969477|FG000|Overall Study|False positive phrenic nerve test|1|||
19446288|NCT01617187|41694126|FG002|Treatment Through Study Completion|Protocol Violation|0|||
19446289|NCT01617187|41694127|FG003|Treatment Through Study Completion|Protocol Violation|1|||
19446290|NCT01759407|41694139|FG000|Overall Study|Protocol Violation|0|||
19446291|NCT01759407|41694140|FG001|Overall Study|Protocol Violation|2|||
19446292|NCT01787331|41694146|FG000|Overall Study|Physician Decision|1|||
19446293|NCT01787331|41694146|FG000|Overall Study|Withdrawal by Subject|1|||
19446294|NCT01757847|41694152|FG000|Overall Study|Withdrawal by Subject|3|||
19446295|NCT01757847|41694153|FG001|Overall Study|Withdrawal by Subject|4|||
19446296|NCT01787097|41694159|FG000|Overall Study|Withdrawal by Subject|1|||
19446297|NCT01787097|41694160|FG001|Overall Study|Withdrawal by Subject|0|||
19446298|NCT01787097|41694161|FG002|Overall Study|Withdrawal by Subject|0|||
19446299|NCT01787097|41694162|FG003|Overall Study|Withdrawal by Subject|0|||
19446300|NCT01757691|41694182|FG000|Overall Study|Administrative problems|2|||
19524559|NCT00559962|41969499|FG000|Overall Study|Adverse Event|1|||
19524560|NCT00559962|41969500|FG001|Overall Study|Adverse Event|7|||
19524561|NCT00559962|41969501|FG002|Overall Study|Adverse Event|8|||
19524562|NCT00559962|41969502|FG003|Overall Study|Adverse Event|5|||
19524563|NCT00559962|41969503|FG004|Overall Study|Adverse Event|11|||
19524564|NCT00559962|41969504|FG005|Overall Study|Adverse Event|4|||
19524565|NCT00559962|41969505|FG006|Overall Study|Adverse Event|4|||
19524566|NCT00559962|41969506|FG007|Overall Study|Adverse Event|2|||
19524567|NCT00559962|41969499|FG000|Overall Study|Lost to Follow-up|0|||
19524568|NCT00559962|41969500|FG001|Overall Study|Lost to Follow-up|1|||
19524569|NCT00559962|41969501|FG002|Overall Study|Lost to Follow-up|0|||
19524570|NCT00559962|41969502|FG003|Overall Study|Lost to Follow-up|0|||
19446301|NCT01757691|41694183|FG001|Overall Study|Administrative problems|0|||
19446302|NCT01786707|41694191|FG000|Overall Study|Lost to Follow-up|1|||
19524571|NCT00559962|41969503|FG004|Overall Study|Lost to Follow-up|0|||
19524572|NCT00559962|41969504|FG005|Overall Study|Lost to Follow-up|0|||
19524573|NCT00559962|41969505|FG006|Overall Study|Lost to Follow-up|0|||
19524574|NCT00559962|41969506|FG007|Overall Study|Lost to Follow-up|0|||
19524575|NCT00559962|41969499|FG000|Overall Study|Withdrawal by Subject|1|||
19524576|NCT00559962|41969500|FG001|Overall Study|Withdrawal by Subject|1|||
19524577|NCT00559962|41969501|FG002|Overall Study|Withdrawal by Subject|2|||
19524578|NCT00559962|41969502|FG003|Overall Study|Withdrawal by Subject|0|||
19524579|NCT00559962|41969503|FG004|Overall Study|Withdrawal by Subject|3|||
19524580|NCT00559962|41969504|FG005|Overall Study|Withdrawal by Subject|1|||
19524581|NCT00559962|41969505|FG006|Overall Study|Withdrawal by Subject|0|||
19524582|NCT00559962|41969506|FG007|Overall Study|Withdrawal by Subject|2|||
19524583|NCT00559962|41969499|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
19524584|NCT00559962|41969500|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
19524585|NCT00559962|41969501|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
19524586|NCT00559962|41969502|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
19524587|NCT00559962|41969503|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
19524588|NCT00559962|41969504|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
19524589|NCT00559962|41969505|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
19524590|NCT00559962|41969506|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
19524591|NCT00559104|41969527|FG000|Overall Study|Lack of Efficacy|9|||
19524592|NCT00559104|41969528|FG001|Overall Study|Lack of Efficacy|0|||
19524593|NCT00558636|41969536|FG000|Treatment|Adverse Event|9|||
19524594|NCT00558636|41969537|FG001|Treatment|Adverse Event|2|||
19524595|NCT00558636|41969536|FG000|Treatment|Withdrawal by Subject|2|||
19524596|NCT00558636|41969537|FG001|Treatment|Withdrawal by Subject|0|||
19446303|NCT01786707|41694192|FG001|Overall Study|Lost to Follow-up|1|||
19446304|NCT01786629|41694200|FG000|Overall Study|Lack of Efficacy|0|||
19446305|NCT01786629|41694201|FG001|Overall Study|Lack of Efficacy|4|||
19446306|NCT01786629|41694200|FG000|Overall Study|Adverse Event|0|||
19524597|NCT00558636|41969536|FG000|Treatment|Premature termination of the study|35|||
19524598|NCT00558636|41969537|FG001|Treatment|Premature termination of the study|37|||
19524599|NCT00558636|41969536|FG000|Treatment|Disease progression|1|||
19524600|NCT00558636|41969537|FG001|Treatment|Disease progression|5|||
19524601|NCT00558636|41969536|FG000|Follow-up|Premature termination of the study|12|||
19524602|NCT00558636|41969537|FG001|Follow-up|Premature termination of the study|7|||
19524603|NCT00558558|41969543|FG000|Overall Study|Unable to swallow|1|||
19524604|NCT00558558|41969543|FG000|Overall Study|Withdrawal by Subject|1|||
19524605|NCT00558558|41969543|FG000|Overall Study|Lack of Efficacy|4|||
19524606|NCT00557622|41969549|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
19524607|NCT00557622|41969550|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
19524608|NCT00557622|41969549|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
19524609|NCT00557622|41969550|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
19524610|NCT00557622|41969549|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
19524611|NCT00557622|41969550|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
19524612|NCT00557466|41969562|FG000|Overall Study|Adverse Event|3|||
19524613|NCT00557466|41969563|FG001|Overall Study|Adverse Event|1|||
19524614|NCT00557466|41969564|FG002|Overall Study|Adverse Event|4|||
19524615|NCT00557466|41969565|FG003|Overall Study|Adverse Event|1|||
19524616|NCT00557466|41969566|FG004|Overall Study|Adverse Event|2|||
19524617|NCT00557466|41969567|FG005|Overall Study|Adverse Event|4|||
19629111|NCT00642460|42078694|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
19446307|NCT01786629|41694201|FG001|Overall Study|Adverse Event|1|||
19446308|NCT01786551|41694207|FG000|Overall Study|Participant withdrew consent|2|||
19446309|NCT01973569|41694214|FG000|Overall Study|Adverse Event|9|||
19446310|NCT01973569|41694215|FG001|Overall Study|Adverse Event|2|||
19446311|NCT01973569|41694216|FG002|Overall Study|Adverse Event|4|||
19446312|NCT01973569|41694214|FG000|Overall Study|Protocol Violation|2|||
19446313|NCT01973569|41694215|FG001|Overall Study|Protocol Violation|1|||
19446314|NCT01973569|41694216|FG002|Overall Study|Protocol Violation|3|||
19446315|NCT01973569|41694214|FG000|Overall Study|Withdrawal by Subject|7|||
19446316|NCT01973569|41694215|FG001|Overall Study|Withdrawal by Subject|5|||
19446317|NCT01973569|41694216|FG002|Overall Study|Withdrawal by Subject|2|||
19446318|NCT01973569|41694214|FG000|Overall Study|Invasive dental treatment|3|||
19446319|NCT01973569|41694215|FG001|Overall Study|Invasive dental treatment|5|||
19446320|NCT01973569|41694216|FG002|Overall Study|Invasive dental treatment|6|||
19446321|NCT01973569|41694214|FG000|Overall Study|Prohibited concomitant d|1|||
19446322|NCT01973569|41694215|FG001|Overall Study|Prohibited concomitant d|5|||
19446323|NCT01973569|41694216|FG002|Overall Study|Prohibited concomitant d|0|||
19446324|NCT01973569|41694214|FG000|Overall Study|Disease progression|0|||
19446325|NCT01973569|41694215|FG001|Overall Study|Disease progression|3|||
19446326|NCT01973569|41694216|FG002|Overall Study|Disease progression|0|||
19446327|NCT01973569|41694214|FG000|Overall Study|Other|1|||
19446328|NCT01973569|41694215|FG001|Overall Study|Other|1|||
19446329|NCT01973569|41694216|FG002|Overall Study|Other|0|||
19446330|NCT01973569|41694214|FG000|Overall Study|Did not receive study drug|6|||
19446331|NCT01973569|41694215|FG001|Overall Study|Did not receive study drug|3|||
19446332|NCT01973569|41694216|FG002|Overall Study|Did not receive study drug|3|||
19446333|NCT01973491|41694224|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
19446334|NCT01973491|41694224|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
19446335|NCT01973491|41694224|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
19446336|NCT01913353|41694230|FG000|Overall Study|Adverse Event|2|||
19446337|NCT01913353|41694231|FG001|Overall Study|Adverse Event|0|||
19446338|NCT01913353|41694230|FG000|Overall Study|Physician Decision|0|||
19446339|NCT01913353|41694231|FG001|Overall Study|Physician Decision|2|||
19446340|NCT01913353|41694230|FG000|Overall Study|Withdrawal by Subject|20|||
19446341|NCT01913353|41694231|FG001|Overall Study|Withdrawal by Subject|6|||
19446342|NCT01913353|41694230|FG000|Overall Study|multiple reasons|10|||
19446343|NCT01913353|41694231|FG001|Overall Study|multiple reasons|7|||
19524618|NCT00557466|41969562|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19524619|NCT00557466|41969563|FG001|Overall Study|Abnormal laboratory value(s)|2|||
19446344|NCT01951586|41694246|FG000|Overall Study|Death|61|||
19446345|NCT01951586|41694247|FG001|Overall Study|Death|120|||
19446346|NCT01951586|41694246|FG000|Overall Study|Withdrawal by Subject|8|||
19446347|NCT01951586|41694247|FG001|Overall Study|Withdrawal by Subject|17|||
19446348|NCT01951586|41694246|FG000|Overall Study|Lost to Follow-up|0|||
19446349|NCT01951586|41694247|FG001|Overall Study|Lost to Follow-up|1|||
19446350|NCT01951586|41694246|FG000|Overall Study|Sponsor Decision|9|||
19446351|NCT01951586|41694247|FG001|Overall Study|Sponsor Decision|10|||
19446352|NCT01785849|41694256|FG000|Overall Study|Death|7|||
19446353|NCT01785849|41694257|FG001|Overall Study|Death|9|||
19446354|NCT01785849|41694256|FG000|Overall Study|Protocol Specified Criteria|29|||
19446355|NCT01785849|41694257|FG001|Overall Study|Protocol Specified Criteria|1|||
19446356|NCT01785849|41694256|FG000|Overall Study|Withdrawal by Subject|15|||
19446357|NCT01785849|41694257|FG001|Overall Study|Withdrawal by Subject|12|||
19446358|NCT01785849|41694256|FG000|Overall Study|Sponsor Decision|0|||
19524620|NCT00557466|41969564|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19524621|NCT00557466|41969565|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19524622|NCT00557466|41969566|FG004|Overall Study|Abnormal laboratory value(s)|0|||
19524623|NCT00557466|41969567|FG005|Overall Study|Abnormal laboratory value(s)|0|||
19524624|NCT00557466|41969562|FG000|Overall Study|Protocol deviation|0|||
19524625|NCT00557466|41969563|FG001|Overall Study|Protocol deviation|1|||
19446359|NCT01785849|41694257|FG001|Overall Study|Sponsor Decision|1|||
19446360|NCT01785849|41694256|FG000|Overall Study|Lost to Follow-up|10|||
19446361|NCT01785849|41694257|FG001|Overall Study|Lost to Follow-up|11|||
19446362|NCT01756833|41694265|FG000|Overall Study|Withdrawal by Subject|4|||
19446363|NCT01756833|41694266|FG001|Overall Study|Withdrawal by Subject|3|||
19446364|NCT01617967|41694278|FG000|Overall Study|Protocol Violation|0|||
19446365|NCT01617967|41694279|FG001|Overall Study|Protocol Violation|0|||
19446366|NCT01617967|41694280|FG002|Overall Study|Protocol Violation|0|||
19446367|NCT01617967|41694281|FG003|Overall Study|Protocol Violation|1|||
19446368|NCT01617967|41694282|FG004|Overall Study|Protocol Violation|0|||
19446369|NCT01617967|41694283|FG005|Overall Study|Protocol Violation|0|||
19446370|NCT01617967|41694278|FG000|Overall Study|Withdrawal by Subject|0|||
19446371|NCT01617967|41694279|FG001|Overall Study|Withdrawal by Subject|0|||
19446372|NCT01617967|41694280|FG002|Overall Study|Withdrawal by Subject|0|||
19446373|NCT01617967|41694281|FG003|Overall Study|Withdrawal by Subject|0|||
19446374|NCT01617967|41694282|FG004|Overall Study|Withdrawal by Subject|0|||
19446375|NCT01617967|41694283|FG005|Overall Study|Withdrawal by Subject|1|||
19446376|NCT01617967|41694278|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
19446377|NCT01617967|41694279|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
19446378|NCT01617967|41694280|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
19446379|NCT01617967|41694281|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
19446380|NCT01617967|41694282|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
19446381|NCT01617967|41694283|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
19524626|NCT00557466|41969564|FG002|Overall Study|Protocol deviation|0|||
19524627|NCT00557466|41969565|FG003|Overall Study|Protocol deviation|2|||
19524628|NCT00557466|41969566|FG004|Overall Study|Protocol deviation|0|||
19524629|NCT00557466|41969567|FG005|Overall Study|Protocol deviation|0|||
19524630|NCT00557466|41969562|FG000|Overall Study|Subject withdrew consent|0|||
19524631|NCT00557466|41969563|FG001|Overall Study|Subject withdrew consent|0|||
19524632|NCT00557466|41969564|FG002|Overall Study|Subject withdrew consent|0|||
19524633|NCT00557466|41969565|FG003|Overall Study|Subject withdrew consent|0|||
19524634|NCT00557466|41969566|FG004|Overall Study|Subject withdrew consent|1|||
19524635|NCT00557466|41969567|FG005|Overall Study|Subject withdrew consent|2|||
19524636|NCT00557466|41969562|FG000|Overall Study|Administrative problems|0|||
19524637|NCT00557466|41969563|FG001|Overall Study|Administrative problems|1|||
19524638|NCT00557466|41969564|FG002|Overall Study|Administrative problems|1|||
19524639|NCT00557466|41969565|FG003|Overall Study|Administrative problems|0|||
19524640|NCT00557466|41969566|FG004|Overall Study|Administrative problems|0|||
19524641|NCT00557466|41969567|FG005|Overall Study|Administrative problems|0|||
19524642|NCT00557466|41969562|FG000|Overall Study|Abnormal test procedure results|0|||
19524643|NCT00557466|41969563|FG001|Overall Study|Abnormal test procedure results|0|||
19524644|NCT00557466|41969564|FG002|Overall Study|Abnormal test procedure results|1|||
19524645|NCT00557466|41969565|FG003|Overall Study|Abnormal test procedure results|0|||
19524646|NCT00557466|41969566|FG004|Overall Study|Abnormal test procedure results|0|||
19524647|NCT00557466|41969567|FG005|Overall Study|Abnormal test procedure results|0|||
19524648|NCT00557466|41969562|FG000|Overall Study|Lost to Follow-up|0|||
19524649|NCT00557466|41969563|FG001|Overall Study|Lost to Follow-up|0|||
19524650|NCT00557466|41969564|FG002|Overall Study|Lost to Follow-up|0|||
19524651|NCT00557466|41969565|FG003|Overall Study|Lost to Follow-up|1|||
19524652|NCT00557466|41969566|FG004|Overall Study|Lost to Follow-up|0|||
19446382|NCT01785615|41694301|FG000|Dietary Phase|Lost to Follow-up|0|||
19446383|NCT01785615|41694302|FG001|Dietary Phase|Lost to Follow-up|0|||
19446384|NCT01785615|41694303|FG002|Dietary Phase|Lost to Follow-up|0|||
19446385|NCT01785615|41694304|FG003|Dietary Phase|Lost to Follow-up|24|||
19524653|NCT00557466|41969567|FG005|Overall Study|Lost to Follow-up|0|||
19524654|NCT00557310|41969581|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
19524655|NCT00557310|41969581|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
19524656|NCT00557310|41969581|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
19524657|NCT00557310|41969581|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
19524658|NCT00557310|41969581|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
19524659|NCT00557310|41969581|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
19524660|NCT00555438|41969585|FG000|10 Days Post-operative|Death|4|||
19524661|NCT00555438|41969585|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
19524662|NCT00553644|41969589|FG000|Overall Study|Adverse Event|17|||
19524663|NCT00553644|41969589|FG000|Overall Study|Withdrawal by Subject|4|||
19524664|NCT00553644|41969589|FG000|Overall Study|Physician Decision|1|||
19524665|NCT00553644|41969589|FG000|Overall Study|Alternative therapy|6|||
19524666|NCT00553332|41969593|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
19446386|NCT01913041|41694316|FG000|Overall Study|Protocol Violation|35|||
19446387|NCT01913041|41694316|FG000|Overall Study|Withdrawal by Subject|3|||
19446388|NCT01913041|41694316|FG000|Overall Study|Physician Decision|1|||
19446389|NCT01756053|41694320|FG000|Period 1 (10 Days)|Protocol Violation|1|||
19446390|NCT01756053|41694321|FG001|Period 1 (10 Days)|Protocol Violation|1|||
19446391|NCT01756053|41694320|FG000|Period 2 (10 Days)|Protocol Violation|0|||
19446392|NCT01756053|41694321|FG001|Period 2 (10 Days)|Protocol Violation|2|||
19446393|NCT01785069|41694331|FG000|Overall Study|Implanted with nonstudy device|1|||
19446394|NCT01785069|41694332|FG001|Overall Study|Implanted with nonstudy device|2|||
19446395|NCT01785069|41694333|FG002|Overall Study|Implanted with nonstudy device|1|||
19446396|NCT01785069|41694334|FG003|Overall Study|Implanted with nonstudy device|0|||
19446397|NCT01785069|41694331|FG000|Overall Study|Death|0|||
19446398|NCT01785069|41694332|FG001|Overall Study|Death|0|||
19446399|NCT01785069|41694333|FG002|Overall Study|Death|2|||
19446400|NCT01785069|41694334|FG003|Overall Study|Death|0|||
19446401|NCT01785069|41694331|FG000|Overall Study|Subject choice|2|||
19446402|NCT01785069|41694332|FG001|Overall Study|Subject choice|2|||
19446403|NCT01785069|41694333|FG002|Overall Study|Subject choice|0|||
19446404|NCT01785069|41694334|FG003|Overall Study|Subject choice|1|||
19446405|NCT01785069|41694331|FG000|Overall Study|Lost to Follow-up|1|||
19524667|NCT00552396|41969604|FG000|Overall Study|protocol withdrawal criteria|3|||
19524668|NCT00552396|41969605|FG001|Overall Study|protocol withdrawal criteria|3|||
19524669|NCT00552396|41969606|FG002|Overall Study|protocol withdrawal criteria|3|||
19524670|NCT00552396|41969607|FG003|Overall Study|protocol withdrawal criteria|6|||
19524671|NCT00552396|41969608|FG004|Overall Study|protocol withdrawal criteria|3|||
19524672|NCT00552396|41969609|FG005|Overall Study|protocol withdrawal criteria|3|||
19524673|NCT00552396|41969610|FG006|Overall Study|protocol withdrawal criteria|9|||
19524674|NCT00552240|41969646|FG000|Overall Study|Adverse Event|9|||
19524675|NCT00552240|41969647|FG001|Overall Study|Adverse Event|9|||
19524676|NCT00552240|41969646|FG000|Overall Study|Protocol Violation|1|||
19524677|NCT00552240|41969647|FG001|Overall Study|Protocol Violation|1|||
19524678|NCT00552240|41969646|FG000|Overall Study|Lost to Follow-up|5|||
19446406|NCT01785069|41694332|FG001|Overall Study|Lost to Follow-up|2|||
19446407|NCT01785069|41694333|FG002|Overall Study|Lost to Follow-up|4|||
19446408|NCT01785069|41694334|FG003|Overall Study|Lost to Follow-up|1|||
19446409|NCT01785069|41694331|FG000|Overall Study|Reason not Specified|1|||
19446410|NCT01785069|41694332|FG001|Overall Study|Reason not Specified|2|||
19446411|NCT01785069|41694333|FG002|Overall Study|Reason not Specified|1|||
19446412|NCT01785069|41694334|FG003|Overall Study|Reason not Specified|4|||
19446413|NCT01785069|41694331|FG000|Overall Study|Not evaluable|7|||
19446414|NCT01785069|41694332|FG001|Overall Study|Not evaluable|4|||
19446415|NCT01785069|41694333|FG002|Overall Study|Not evaluable|5|||
19446416|NCT01785069|41694334|FG003|Overall Study|Not evaluable|8|||
19446417|NCT01784523|41694346|FG000|Overall Study|Study closed early|7|||
19446418|NCT01784523|41694347|FG001|Overall Study|Study closed early|4|||
19446419|NCT01784211|41694355|FG000|Part A (Days 1-15)|Adverse Event|1|||
19446420|NCT01784211|41694356|FG001|Part A (Days 1-15)|Adverse Event|1|||
19446421|NCT01784211|41694357|FG002|Part A (Days 1-15)|Adverse Event|0|||
19446422|NCT01784211|41694358|FG003|Part A (Days 1-15)|Adverse Event|0|||
19446423|NCT01784211|41694359|FG004|Part A (Days 1-15)|Adverse Event|0|||
19446424|NCT01784211|41694360|FG005|Part A (Days 1-15)|Adverse Event|0|||
19446425|NCT01784211|41694355|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
19446426|NCT01784211|41694356|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
19446427|NCT01784211|41694357|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
19446428|NCT01784211|41694358|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
19446429|NCT01784211|41694359|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
19446430|NCT01784211|41694360|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
19446431|NCT01783821|41694374|FG000|Overall Study|Screen Failure|1|||
19446432|NCT01783821|41694375|FG001|Overall Study|Screen Failure|1|||
19446433|NCT01783743|41694383|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
19524679|NCT00552240|41969647|FG001|Overall Study|Lost to Follow-up|6|||
19524680|NCT00552240|41969646|FG000|Overall Study|Withdrawal by Subject|2|||
19524681|NCT00552240|41969647|FG001|Overall Study|Withdrawal by Subject|2|||
19524682|NCT00552240|41969646|FG000|Overall Study|Lack of Efficacy|6|||
19446434|NCT01783743|41694384|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
19446435|NCT01783743|41694383|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
19446436|NCT01783743|41694384|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
19446437|NCT01783743|41694383|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
19446438|NCT01783743|41694384|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
19446439|NCT01608321|41694392|FG000|Overall Study|Withdrawal by Subject|1|||
19446440|NCT01608321|41694393|FG001|Overall Study|Withdrawal by Subject|0|||
19446441|NCT01608087|41694402|FG000|Overall Study|Lost to Follow-up|0|||
19446442|NCT01608087|41694403|FG001|Overall Study|Lost to Follow-up|1|||
19446443|NCT01608087|41694404|FG002|Overall Study|Lost to Follow-up|0|||
19446444|NCT01608087|41694402|FG000|Overall Study|Other Reason|0|||
19446445|NCT01608087|41694403|FG001|Overall Study|Other Reason|1|||
19446446|NCT01608087|41694404|FG002|Overall Study|Other Reason|0|||
19446447|NCT01912963|41694415|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
19446448|NCT01912963|41694416|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
19446449|NCT01912963|41694417|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
19446450|NCT01912963|41694415|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
19446451|NCT01912963|41694416|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
19446452|NCT01912963|41694417|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
19446453|NCT01912963|41694415|FG000|Overall Study|Adverse Event|0|||
19446454|NCT01912963|41694416|FG001|Overall Study|Adverse Event|1|||
19446455|NCT01912963|41694417|FG002|Overall Study|Adverse Event|1|||
19446456|NCT01912963|41694415|FG000|Overall Study|Withdrawal by Subject|0|||
19446457|NCT01912963|41694416|FG001|Overall Study|Withdrawal by Subject|1|||
19446458|NCT01912963|41694417|FG002|Overall Study|Withdrawal by Subject|0|||
19446459|NCT01912963|41694415|FG000|Overall Study|Sought treatment locally|0|||
19446460|NCT01912963|41694416|FG001|Overall Study|Sought treatment locally|1|||
19446461|NCT01912963|41694417|FG002|Overall Study|Sought treatment locally|0|||
19446462|NCT01754727|41694425|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
19446463|NCT01912807|41694431|FG000|Overall Study|Did not meet elegibility criteria|6|||
19446464|NCT01912807|41694432|FG001|Overall Study|Did not meet elegibility criteria|4|||
19446465|NCT01912807|41694431|FG000|Overall Study|Lost to Follow-up|36|||
19446466|NCT01912807|41694432|FG001|Overall Study|Lost to Follow-up|37|||
19446467|NCT01782885|41694440|FG000|Overall Study|Lost to Follow-up|4|||
19446468|NCT01782885|41694441|FG001|Overall Study|Lost to Follow-up|6|||
19446469|NCT01912729|41694449|FG000|Overall Study|Withdrawal by Subject|0|||
19446470|NCT01912729|41694450|FG001|Overall Study|Withdrawal by Subject|1|||
19446471|NCT01754493|41694456|FG000|Overall Study|Adverse Event|1|||
19446472|NCT01754493|41694456|FG000|Overall Study|Lost to Follow-up|3|||
19446473|NCT01754493|41694456|FG000|Overall Study|Withdrawal by Subject|1|||
19446474|NCT01754493|41694456|FG000|Overall Study|Moved out of town|1|||
19446475|NCT01754493|41694456|FG000|Overall Study|Scheduling conflict|1|||
19446476|NCT01972789|41694462|FG000|Overall Study|Adverse Event|11|||
19446477|NCT01972789|41694463|FG001|Overall Study|Adverse Event|4|||
19446478|NCT01972789|41694462|FG000|Overall Study|Subject withdrew consent|14|||
19446479|NCT01972789|41694463|FG001|Overall Study|Subject withdrew consent|12|||
19446480|NCT01972789|41694462|FG000|Overall Study|Lost to Follow-up|4|||
19446481|NCT01972789|41694463|FG001|Overall Study|Lost to Follow-up|7|||
19446482|NCT01972789|41694462|FG000|Overall Study|Death|7|||
19446483|NCT01972789|41694463|FG001|Overall Study|Death|5|||
19446484|NCT01972789|41694462|FG000|Overall Study|Protocol deviation|1|||
19446485|NCT01972789|41694463|FG001|Overall Study|Protocol deviation|0|||
19446486|NCT01972789|41694462|FG000|Overall Study|Physician Decision|3|||
19446487|NCT01972789|41694463|FG001|Overall Study|Physician Decision|2|||
19446488|NCT01934335|41694471|FG000|Overall Study|Withdrawal by Subject|1|||
19446489|NCT01934335|41694472|FG001|Overall Study|Withdrawal by Subject|1|||
19446490|NCT01912339|41694480|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
19446491|NCT01912339|41694481|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
19446492|NCT01912339|41694482|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
19446493|NCT01912339|41694480|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
19446494|NCT01912339|41694481|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
19446495|NCT01912339|41694482|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
19446496|NCT01912339|41694480|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
19446497|NCT01912339|41694481|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
19446498|NCT01912339|41694482|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
19446499|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
19446500|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
19629112|NCT00642460|42078695|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
19446501|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
19446502|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
19446503|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
19524683|NCT00552240|41969647|FG001|Overall Study|Lack of Efficacy|0|||
19524684|NCT00552240|41969646|FG000|Overall Study|Other|1|||
19524685|NCT00552240|41969647|FG001|Overall Study|Other|0|||
19524686|NCT00552084|41969655|FG000|Overall Study|Adverse Event|2|||
19524687|NCT00552084|41969656|FG001|Overall Study|Adverse Event|3|||
19524688|NCT00552084|41969655|FG000|Overall Study|Withdrawal by Subject|4|||
19524689|NCT00552084|41969656|FG001|Overall Study|Withdrawal by Subject|5|||
19524690|NCT00552084|41969655|FG000|Overall Study|Protocol Violation|1|||
19524691|NCT00552084|41969656|FG001|Overall Study|Protocol Violation|0|||
19524692|NCT00552084|41969655|FG000|Overall Study|change in anti-arrythmic drug|1|||
19524693|NCT00552084|41969656|FG001|Overall Study|change in anti-arrythmic drug|1|||
19524694|NCT00550836|41969664|FG000|Overall Study|Withdrawal by Subject|3|||
19524695|NCT00550836|41969665|FG001|Overall Study|Withdrawal by Subject|9|||
19524696|NCT00550680|41969671|FG000|Overall Study|Administrative Reasons|1|||
19524697|NCT00550680|41969671|FG000|Overall Study|Adverse Event|5|||
19524698|NCT00550680|41969671|FG000|Overall Study|Death|3|||
19524699|NCT00550680|41969671|FG000|Overall Study|Early Improvement|1|||
19524700|NCT00550680|41969671|FG000|Overall Study|Lost to Follow-up|3|||
19446504|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
19446505|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
19446506|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
19446507|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
19446508|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
19446509|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
19446510|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
19446511|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
19446512|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
19446513|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
19524701|NCT00550680|41969671|FG000|Overall Study|Lack of Efficacy|1|||
19524702|NCT00550680|41969671|FG000|Overall Study|Other|10|||
19524703|NCT00550680|41969671|FG000|Overall Study|Protocol Violation|7|||
19524704|NCT00550680|41969671|FG000|Overall Study|Refused Treatment|19|||
19524705|NCT00550680|41969671|FG000|Overall Study|Screen Failure|6|||
19524706|NCT00554190|41969675|FG000|Overall Study|Termination forms not completed|10|||
19524707|NCT00556374|41969681|FG000|Overall Study|Withdrawal by Subject|190|||
19524708|NCT00556374|41969682|FG001|Overall Study|Withdrawal by Subject|172|||
19524709|NCT00556374|41969681|FG000|Overall Study|Death|50|||
19524710|NCT00556374|41969682|FG001|Overall Study|Death|43|||
19524711|NCT00556374|41969681|FG000|Overall Study|Lost to Follow-up|7|||
19524712|NCT00556374|41969682|FG001|Overall Study|Lost to Follow-up|5|||
19524713|NCT04677959|41969711|FG000|Overall Study|Adverse Event|1|||
19524714|NCT04677959|41969712|FG001|Overall Study|Adverse Event|9|||
19524715|NCT04677959|41969711|FG000|Overall Study|Withdrawal by Subject|2|||
19524716|NCT04677959|41969712|FG001|Overall Study|Withdrawal by Subject|15|||
19524717|NCT04677959|41969711|FG000|Overall Study|Withdrawal by parent/guardian|0|||
19524718|NCT04677959|41969712|FG001|Overall Study|Withdrawal by parent/guardian|1|||
19524719|NCT04677959|41969711|FG000|Overall Study|Non-compliance with study drug|0|||
19524720|NCT04677959|41969712|FG001|Overall Study|Non-compliance with study drug|2|||
19524721|NCT04677959|41969711|FG000|Overall Study|Protocol deviation|0|||
19524722|NCT04677959|41969712|FG001|Overall Study|Protocol deviation|11|||
19524723|NCT04677959|41969711|FG000|Overall Study|Lost to Follow-up|9|||
19524724|NCT04677959|41969712|FG001|Overall Study|Lost to Follow-up|13|||
19524725|NCT04677959|41969711|FG000|Overall Study|Other than specified|0|||
19524726|NCT04677959|41969712|FG001|Overall Study|Other than specified|8|||
19524727|NCT04330638|41969739|FG000|Overall Study|Adverse Event|9|||
19524728|NCT04330638|41969740|FG001|Overall Study|Adverse Event|10|||
19524729|NCT04330638|41969741|FG002|Overall Study|Adverse Event|15|||
19524730|NCT04330638|41969742|FG003|Overall Study|Adverse Event|6|||
19524731|NCT04330638|41969743|FG004|Overall Study|Adverse Event|10|||
19524732|NCT04330638|41969744|FG005|Overall Study|Adverse Event|5|||
19524733|NCT04330638|41969739|FG000|Overall Study|Other|2|||
19446514|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
19446515|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
19524734|NCT04330638|41969740|FG001|Overall Study|Other|2|||
19524735|NCT04330638|41969741|FG002|Overall Study|Other|5|||
19524736|NCT04330638|41969742|FG003|Overall Study|Other|1|||
19524737|NCT04330638|41969743|FG004|Overall Study|Other|3|||
19524738|NCT04330638|41969744|FG005|Overall Study|Other|2|||
19524739|NCT04330638|41969739|FG000|Overall Study|Withdrawal by Subject|4|||
19524740|NCT04330638|41969740|FG001|Overall Study|Withdrawal by Subject|0|||
19524741|NCT04330638|41969741|FG002|Overall Study|Withdrawal by Subject|0|||
19524742|NCT04330638|41969742|FG003|Overall Study|Withdrawal by Subject|0|||
19524743|NCT04330638|41969743|FG004|Overall Study|Withdrawal by Subject|0|||
19524744|NCT04330638|41969744|FG005|Overall Study|Withdrawal by Subject|0|||
19524745|NCT04330638|41969739|FG000|Overall Study|Lost to Follow-up|3|||
19524746|NCT04330638|41969740|FG001|Overall Study|Lost to Follow-up|2|||
19524747|NCT04330638|41969741|FG002|Overall Study|Lost to Follow-up|3|||
19446516|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
19446517|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
19446518|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
19446519|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
19446520|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
19446521|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
19524748|NCT04330638|41969742|FG003|Overall Study|Lost to Follow-up|2|||
19524749|NCT04330638|41969743|FG004|Overall Study|Lost to Follow-up|3|||
19524750|NCT04330638|41969744|FG005|Overall Study|Lost to Follow-up|0|||
19524751|NCT04194541|41969765|FG000|Day 1 Through 13|Lost to Follow-up|3|||
19446522|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
19446523|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
19446524|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
19446525|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
19446526|NCT01912339|41694480|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
19446527|NCT01912339|41694481|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
19446528|NCT01912339|41694482|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
19446529|NCT01911793|41694490|FG000|Overall Study|Physician Decision|1|||
19446530|NCT01911793|41694491|FG001|Overall Study|Physician Decision|5|||
19446531|NCT01933789|41694506|FG000|Overall Study|Death|0|||
19446532|NCT01933789|41694507|FG001|Overall Study|Death|0|||
19446533|NCT01933789|41694508|FG002|Overall Study|Death|0|||
19524752|NCT04194541|41969765|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
19524753|NCT04194541|41969765|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
19524754|NCT04006392|41969783|FG000|Overall Study|Lost to Follow-up|0|||
19524755|NCT04006392|41969784|FG001|Overall Study|Lost to Follow-up|1|||
19524756|NCT03959423|41969792|FG000|Overall Study|Withdrawal by Subject|2|||
19524757|NCT03959423|41969793|FG001|Overall Study|Withdrawal by Subject|3|||
19524758|NCT03959423|41969792|FG000|Overall Study|Physician Decision|0|||
19524759|NCT03959423|41969793|FG001|Overall Study|Physician Decision|1|||
19524760|NCT03959423|41969792|FG000|Overall Study|Lost to Follow-up|1|||
19524761|NCT03959423|41969793|FG001|Overall Study|Lost to Follow-up|0|||
19524762|NCT03959423|41969792|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
19524763|NCT03959423|41969793|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19524764|NCT03786783|41969799|FG000|Overall Study|Death|1|||
19524765|NCT03786783|41969799|FG000|Overall Study|Physician Decision|6|||
19524766|NCT03786783|41969799|FG000|Overall Study|Withdrawal by Subject|2|||
19524767|NCT03786783|41969799|FG000|Overall Study|Disease Progression|7|||
19524768|NCT03786783|41969799|FG000|Overall Study|Patient/Parent Refusal|4|||
19524769|NCT03432494|41969813|FG000|Overall Study|Death|1|||
19524770|NCT03432494|41969813|FG000|Overall Study|Noncompliance|1|||
19524771|NCT03312634|41969819|FG000|Overall Study|Adverse Event|6|||
19524772|NCT03312634|41969820|FG001|Overall Study|Adverse Event|0|||
19524773|NCT03312634|41969819|FG000|Overall Study|Sponsor request|2|||
19524774|NCT03312634|41969820|FG001|Overall Study|Sponsor request|0|||
19524775|NCT03312634|41969819|FG000|Overall Study|Withdrawal by Subject|11|||
19524776|NCT03312634|41969820|FG001|Overall Study|Withdrawal by Subject|9|||
19524777|NCT03312634|41969819|FG000|Overall Study|Ongoing in study at DCO|88|||
19524778|NCT03312634|41969820|FG001|Overall Study|Ongoing in study at DCO|0|||
19524779|NCT03312634|41969819|FG000|Overall Study|Enrolled in an interventional study|0|||
19524780|NCT03312634|41969820|FG001|Overall Study|Enrolled in an interventional study|52|||
19524781|NCT03312634|41969819|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
19524782|NCT03312634|41969820|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
19524783|NCT03312634|41969819|FG000|Overall Study|Death|0|||
19524784|NCT03312634|41969820|FG001|Overall Study|Death|1|||
19524785|NCT03312634|41969819|FG000|Overall Study|Non-compliance|0|||
19524786|NCT03312634|41969820|FG001|Overall Study|Non-compliance|2|||
19524787|NCT03312634|41969819|FG000|Overall Study|Lost to Follow-up|0|||
19524788|NCT03312634|41969820|FG001|Overall Study|Lost to Follow-up|1|||
19524789|NCT03312634|41969819|FG000|Overall Study|Enrolled into non-interventional study|0|||
19524790|NCT03312634|41969820|FG001|Overall Study|Enrolled into non-interventional study|5|||
19524791|NCT03312634|41969819|FG000|Overall Study|Worsening clinical condition|0|||
19524792|NCT03312634|41969820|FG001|Overall Study|Worsening clinical condition|1|||
19524793|NCT03312634|41969819|FG000|Overall Study|Participant did not want to travel|0|||
19524794|NCT03312634|41969820|FG001|Overall Study|Participant did not want to travel|1|||
19524795|NCT03287830|41969831|FG000|Overall Study|Withdrawal by Subject|1|||
19524796|NCT03287830|41969832|FG001|Overall Study|Withdrawal by Subject|1|||
19524797|NCT03287830|41969831|FG000|Overall Study|not meeting inclusion criteria|5|||
19524798|NCT03287830|41969832|FG001|Overall Study|not meeting inclusion criteria|12|||
19524799|NCT03181633|41969842|FG000|Overall Study|Withdrawal by Subject|1|||
19524800|NCT03181633|41969842|FG000|Overall Study|Missing follow-up visit|1|||
19524801|NCT03122223|41969859|FG000|Overall Study|Withdrawal by Subject|2|||
19524802|NCT03122223|41969860|FG001|Overall Study|Withdrawal by Subject|2|||
19524803|NCT03122223|41969861|FG002|Overall Study|Withdrawal by Subject|1|||
19524804|NCT03122223|41969862|FG003|Overall Study|Withdrawal by Subject|0|||
19524805|NCT03122223|41969859|FG000|Overall Study|Lost to Follow-up|0|||
19524806|NCT03122223|41969860|FG001|Overall Study|Lost to Follow-up|2|||
19524807|NCT03122223|41969861|FG002|Overall Study|Lost to Follow-up|2|||
19524808|NCT03122223|41969862|FG003|Overall Study|Lost to Follow-up|0|||
19524809|NCT03122223|41969859|FG000|Overall Study|Participant unable to adhere|1|||
19524810|NCT03122223|41969860|FG001|Overall Study|Participant unable to adhere|1|||
19524811|NCT03122223|41969861|FG002|Overall Study|Participant unable to adhere|1|||
19524812|NCT03122223|41969862|FG003|Overall Study|Participant unable to adhere|0|||
19524813|NCT03077087|41969872|FG000|Overall Study|Physician Decision|2|||
19524814|NCT03075527|41969876|FG000|Overall Study|Ongoing treatment|2|||
19524815|NCT02853604|41969882|FG000|Overall Study|Withdrawal by Subject|12|||
19524816|NCT02853604|41969883|FG001|Overall Study|Withdrawal by Subject|35|||
19524817|NCT02853604|41969882|FG000|Overall Study|Lost to Follow-up|4|||
19524818|NCT02853604|41969883|FG001|Overall Study|Lost to Follow-up|8|||
19524819|NCT02853604|41969882|FG000|Overall Study|Death|1|||
19524820|NCT02853604|41969883|FG001|Overall Study|Death|5|||
19524821|NCT02853604|41969882|FG000|Overall Study|Miscellaneous|11|||
19524822|NCT02853604|41969883|FG001|Overall Study|Miscellaneous|2|||
19524823|NCT02853604|41969882|FG000|Overall Study|Progressive Disease|0|||
19524824|NCT02853604|41969883|FG001|Overall Study|Progressive Disease|2|||
19524825|NCT02632552|41969909|FG000|Overall Study|Lost to Follow-up|14|||
19524826|NCT02632552|41969910|FG001|Overall Study|Lost to Follow-up|8|||
19524827|NCT02632552|41969909|FG000|Overall Study|Withdrawal by Subject|2|||
19524828|NCT02632552|41969910|FG001|Overall Study|Withdrawal by Subject|0|||
19524829|NCT02632552|41969909|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
19524830|NCT02632552|41969910|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
19524831|NCT02525562|41969957|FG000|Overall Study|Death|9|||
19524832|NCT02525562|41969958|FG001|Overall Study|Death|0|||
19524833|NCT02525562|41969959|FG002|Overall Study|Death|0|||
19524834|NCT02525562|41969957|FG000|Overall Study|Lost to Follow-up|19|||
19524835|NCT02525562|41969958|FG001|Overall Study|Lost to Follow-up|0|||
19524836|NCT02525562|41969959|FG002|Overall Study|Lost to Follow-up|0|||
19524837|NCT02525562|41969957|FG000|Overall Study|Withdrawal by Subject|37|||
19524838|NCT02525562|41969958|FG001|Overall Study|Withdrawal by Subject|0|||
19524839|NCT02525562|41969959|FG002|Overall Study|Withdrawal by Subject|0|||
19524840|NCT02525562|41969957|FG000|Overall Study|Revision/Removal of Study Device|4|||
19524841|NCT02525562|41969958|FG001|Overall Study|Revision/Removal of Study Device|0|||
19446534|NCT01933789|41694509|FG003|Overall Study|Death|0|||
19446535|NCT01933789|41694510|FG004|Overall Study|Death|21|||
19446536|NCT01933789|41694511|FG005|Overall Study|Death|32|||
19446537|NCT01933789|41694512|FG006|Overall Study|Death|0|||
19446538|NCT01933789|41694513|FG007|Overall Study|Death|0|||
19446539|NCT01933789|41694514|FG008|Overall Study|Death|0|||
19446540|NCT01933789|41694506|FG000|Overall Study|Lost to Follow-up|0|||
19446541|NCT01933789|41694507|FG001|Overall Study|Lost to Follow-up|0|||
19446542|NCT01933789|41694508|FG002|Overall Study|Lost to Follow-up|0|||
19446543|NCT01933789|41694509|FG003|Overall Study|Lost to Follow-up|1|||
19446544|NCT01933789|41694510|FG004|Overall Study|Lost to Follow-up|8|||
19446545|NCT01933789|41694511|FG005|Overall Study|Lost to Follow-up|9|||
19446546|NCT01933789|41694512|FG006|Overall Study|Lost to Follow-up|1|||
19446547|NCT01933789|41694513|FG007|Overall Study|Lost to Follow-up|4|||
19446548|NCT01933789|41694514|FG008|Overall Study|Lost to Follow-up|0|||
19446549|NCT01933789|41694506|FG000|Overall Study|Withdrawal by Subject|2|||
19446550|NCT01933789|41694507|FG001|Overall Study|Withdrawal by Subject|1|||
19446551|NCT01933789|41694508|FG002|Overall Study|Withdrawal by Subject|0|||
19446552|NCT01933789|41694509|FG003|Overall Study|Withdrawal by Subject|0|||
19446553|NCT01933789|41694510|FG004|Overall Study|Withdrawal by Subject|17|||
19446554|NCT01933789|41694511|FG005|Overall Study|Withdrawal by Subject|16|||
19446555|NCT01933789|41694512|FG006|Overall Study|Withdrawal by Subject|1|||
19446556|NCT01933789|41694513|FG007|Overall Study|Withdrawal by Subject|4|||
19446557|NCT01933789|41694514|FG008|Overall Study|Withdrawal by Subject|0|||
19446558|NCT01933789|41694506|FG000|Overall Study|Became Ineligible|4|||
19446559|NCT01933789|41694507|FG001|Overall Study|Became Ineligible|0|||
19446560|NCT01933789|41694508|FG002|Overall Study|Became Ineligible|0|||
19446561|NCT01933789|41694509|FG003|Overall Study|Became Ineligible|0|||
19524842|NCT02525562|41969959|FG002|Overall Study|Revision/Removal of Study Device|0|||
19524843|NCT02525562|41969957|FG000|Overall Study|Study Closed by Sponsor|154|||
19629113|NCT00642460|42078696|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
19629114|NCT00642460|42078697|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
19629115|NCT00642460|42078692|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
19446562|NCT01933789|41694510|FG004|Overall Study|Became Ineligible|13|||
19446563|NCT01933789|41694511|FG005|Overall Study|Became Ineligible|10|||
19446564|NCT01933789|41694512|FG006|Overall Study|Became Ineligible|13|||
19446565|NCT01933789|41694513|FG007|Overall Study|Became Ineligible|6|||
19446566|NCT01933789|41694514|FG008|Overall Study|Became Ineligible|0|||
19446567|NCT01910389|41694536|FG000|Overall Study|Withdrawal by Subject|2|||
19446568|NCT01910389|41694537|FG001|Overall Study|Withdrawal by Subject|0|||
19446569|NCT01910389|41694536|FG000|Overall Study|Study Closed|13|||
19446570|NCT01910389|41694537|FG001|Overall Study|Study Closed|8|||
19446571|NCT01970995|41694546|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
19446572|NCT01970995|41694547|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
19446573|NCT01970995|41694548|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
19446574|NCT01970995|41694546|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
19446575|NCT01970995|41694547|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
19446576|NCT01970995|41694548|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
19446577|NCT01932697|41694558|FG000|Overall Study|Received a different amount of tx|1|||
19446578|NCT01932697|41694559|FG001|Overall Study|Received a different amount of tx|0|||
19446579|NCT01932697|41694558|FG000|Overall Study|Ineligible|1|||
19446580|NCT01932697|41694559|FG001|Overall Study|Ineligible|0|||
19446581|NCT01970527|41694569|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
19446582|NCT01970527|41694570|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
19446583|NCT01970527|41694569|FG000|Treatment|Disease progression|0|||
19446584|NCT01970527|41694570|FG001|Treatment|Disease progression|1|||
19446585|NCT01970527|41694569|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
19446586|NCT01970527|41694570|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
19446587|NCT01970527|41694569|FG000|Treatment|Death|0|||
19446588|NCT01970527|41694570|FG001|Treatment|Death|1|||
19446589|NCT01970527|41694569|FG000|Follow-up Clinic Visit|Disease progression|1|||
19446590|NCT01970527|41694570|FG001|Follow-up Clinic Visit|Disease progression|1|||
19446591|NCT01970527|41694569|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
19446592|NCT01970527|41694570|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
19446593|NCT01970527|41694569|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
19446594|NCT01970527|41694570|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
19446595|NCT01931995|41694581|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
19446596|NCT01931995|41694582|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
19446597|NCT01931995|41694581|FG000|First Intervention (1 Day)|Physician Decision|1|||
19446598|NCT01931995|41694582|FG001|First Intervention (1 Day)|Physician Decision|1|||
19446599|NCT01931995|41694581|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
19446600|NCT01931995|41694582|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
19446601|NCT01408576|41694591|FG000|Overall Study|Lack of Efficacy|17|||
19446602|NCT01408576|41694592|FG001|Overall Study|Lack of Efficacy|30|||
19446603|NCT01408576|41694593|FG002|Overall Study|Lack of Efficacy|48|||
19524844|NCT02525562|41969958|FG001|Overall Study|Study Closed by Sponsor|0|||
19524845|NCT02525562|41969959|FG002|Overall Study|Study Closed by Sponsor|0|||
19524846|NCT02028455|41969972|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524847|NCT02028455|41969973|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524848|NCT02028455|41969974|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524849|NCT02028455|41969975|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524850|NCT02028455|41969976|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524851|NCT02028455|41969977|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
19524852|NCT02028455|41969978|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
19524853|NCT02028455|41969979|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
19524854|NCT02028455|41969972|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
19524855|NCT02028455|41969973|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
19524856|NCT02028455|41969974|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
19524857|NCT02028455|41969975|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
19524858|NCT02028455|41969976|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
19524859|NCT02028455|41969977|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
19524860|NCT02028455|41969978|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
19524861|NCT02028455|41969979|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
19524862|NCT02028455|41969972|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524863|NCT02028455|41969973|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524864|NCT02028455|41969974|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524865|NCT02028455|41969975|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524866|NCT02028455|41969976|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524867|NCT02028455|41969977|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
19524868|NCT02028455|41969978|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
19524869|NCT02028455|41969979|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
19446604|NCT01408576|41694591|FG000|Overall Study|Protocol Violation|1|||
19446605|NCT01408576|41694592|FG001|Overall Study|Protocol Violation|2|||
19446606|NCT01408576|41694593|FG002|Overall Study|Protocol Violation|2|||
19446607|NCT01408576|41694591|FG000|Overall Study|Lost to Follow-up|10|||
19524870|NCT02028455|41969972|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
19524871|NCT02028455|41969973|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
19446608|NCT01408576|41694592|FG001|Overall Study|Lost to Follow-up|9|||
19446609|NCT01408576|41694593|FG002|Overall Study|Lost to Follow-up|17|||
19446610|NCT01408576|41694591|FG000|Overall Study|Withdrawal by Subject|34|||
19446611|NCT01408576|41694592|FG001|Overall Study|Withdrawal by Subject|60|||
19446612|NCT01408576|41694593|FG002|Overall Study|Withdrawal by Subject|66|||
19446613|NCT01408576|41694591|FG000|Overall Study|Sponsor terminated study|89|||
19446614|NCT01408576|41694592|FG001|Overall Study|Sponsor terminated study|333|||
19446615|NCT01408576|41694593|FG002|Overall Study|Sponsor terminated study|330|||
19446616|NCT01408576|41694591|FG000|Overall Study|AE, serious fatal|4|||
19446617|NCT01408576|41694592|FG001|Overall Study|AE, serious fatal|4|||
19446618|NCT01408576|41694593|FG002|Overall Study|AE, serious fatal|1|||
19446619|NCT01408576|41694591|FG000|Overall Study|SAE, non-fatal|11|||
19446620|NCT01408576|41694592|FG001|Overall Study|SAE, non-fatal|23|||
19446621|NCT01408576|41694593|FG002|Overall Study|SAE, non-fatal|14|||
19524872|NCT02028455|41969974|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
19524873|NCT02028455|41969975|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
19446622|NCT01408576|41694591|FG000|Overall Study|AE, non-serious non-fatal|12|||
19524874|NCT02028455|41969976|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
19524875|NCT02028455|41969977|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
19524876|NCT02028455|41969978|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
19524877|NCT02028455|41969979|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
19524878|NCT01992653|41970009|FG000|Overall Study|Death|0|||
19524879|NCT01992653|41970010|FG001|Overall Study|Death|0|||
19524880|NCT01992653|41970011|FG002|Overall Study|Death|1|||
19446623|NCT01408576|41694592|FG001|Overall Study|AE, non-serious non-fatal|19|||
19446624|NCT01408576|41694593|FG002|Overall Study|AE, non-serious non-fatal|11|||
19524881|NCT01992653|41970012|FG003|Overall Study|Death|0|||
19524882|NCT01992653|41970013|FG004|Overall Study|Death|1|||
19524883|NCT01992653|41970014|FG005|Overall Study|Death|0|||
19524884|NCT01992653|41970015|FG006|Overall Study|Death|4|||
19524885|NCT01992653|41970016|FG007|Overall Study|Death|2|||
19524886|NCT01992653|41970009|FG000|Overall Study|Lost to Follow-up|0|||
19524887|NCT01992653|41970010|FG001|Overall Study|Lost to Follow-up|0|||
19524888|NCT01992653|41970011|FG002|Overall Study|Lost to Follow-up|0|||
19524889|NCT01992653|41970012|FG003|Overall Study|Lost to Follow-up|0|||
19524890|NCT01992653|41970013|FG004|Overall Study|Lost to Follow-up|0|||
19524891|NCT01992653|41970014|FG005|Overall Study|Lost to Follow-up|0|||
19524892|NCT01992653|41970015|FG006|Overall Study|Lost to Follow-up|0|||
19524893|NCT01992653|41970016|FG007|Overall Study|Lost to Follow-up|1|||
19524894|NCT01992653|41970009|FG000|Overall Study|Study Completed|0|||
19524895|NCT01992653|41970010|FG001|Overall Study|Study Completed|0|||
19524896|NCT01992653|41970011|FG002|Overall Study|Study Completed|0|||
19524897|NCT01992653|41970012|FG003|Overall Study|Study Completed|0|||
19524898|NCT01992653|41970013|FG004|Overall Study|Study Completed|0|||
19524899|NCT01992653|41970014|FG005|Overall Study|Study Completed|0|||
19524900|NCT01992653|41970015|FG006|Overall Study|Study Completed|0|||
19524901|NCT01992653|41970016|FG007|Overall Study|Study Completed|1|||
19524902|NCT01992653|41970009|FG000|Overall Study|Disease Progression|0|||
19524903|NCT01992653|41970010|FG001|Overall Study|Disease Progression|0|||
19524904|NCT01992653|41970011|FG002|Overall Study|Disease Progression|0|||
19446625|NCT01408576|41694591|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
19446626|NCT01408576|41694592|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19446627|NCT01408576|41694593|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
19446628|NCT01408576|41694591|FG000|Overall Study|AE, unknown type|0|||
19446629|NCT01408576|41694592|FG001|Overall Study|AE, unknown type|1|||
19446630|NCT01408576|41694593|FG002|Overall Study|AE, unknown type|0|||
19446631|NCT01408576|41694591|FG000|Overall Study|Other|10|||
19446632|NCT01408576|41694592|FG001|Overall Study|Other|16|||
19446633|NCT01408576|41694593|FG002|Overall Study|Other|18|||
19446634|NCT01427920|41694615|FG000|Overall Study|Adverse Event|1|||
19446635|NCT01427920|41694616|FG001|Overall Study|Adverse Event|2|||
19446636|NCT01427920|41694615|FG000|Overall Study|Lack of Efficacy|1|||
19446637|NCT01427920|41694616|FG001|Overall Study|Lack of Efficacy|0|||
19446638|NCT01427920|41694615|FG000|Overall Study|Protocol Violation|1|||
19446639|NCT01427920|41694616|FG001|Overall Study|Protocol Violation|3|||
19524905|NCT01992653|41970012|FG003|Overall Study|Disease Progression|0|||
19524906|NCT01992653|41970013|FG004|Overall Study|Disease Progression|0|||
19524907|NCT01992653|41970014|FG005|Overall Study|Disease Progression|0|||
19524908|NCT01992653|41970015|FG006|Overall Study|Disease Progression|4|||
19524909|NCT01992653|41970016|FG007|Overall Study|Disease Progression|0|||
19524910|NCT01972217|41970038|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
19524911|NCT01972217|41970039|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
19446640|NCT01427920|41694615|FG000|Overall Study|Withdrawal Criteria|4|||
19446641|NCT01427920|41694616|FG001|Overall Study|Withdrawal Criteria|4|||
19446642|NCT01427920|41694615|FG000|Overall Study|Unclassified|2|||
19446643|NCT01427920|41694616|FG001|Overall Study|Unclassified|8|||
19524912|NCT01972217|41970040|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
19524913|NCT01972217|41970041|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
19446644|NCT01427608|41694624|FG000|Overall Study|Death|1|||
19524914|NCT01972217|41970038|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
19524915|NCT01972217|41970039|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
19446645|NCT01427608|41694625|FG001|Overall Study|Death|0|||
19446646|NCT01427608|41694624|FG000|Overall Study|Withdrawal by Subject|7|||
19446647|NCT01427608|41694625|FG001|Overall Study|Withdrawal by Subject|3|||
19524916|NCT01972217|41970040|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
19524917|NCT01972217|41970041|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
19524918|NCT01972217|41970038|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
19524919|NCT01972217|41970039|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
19524920|NCT01972217|41970040|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
19524921|NCT01972217|41970041|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
19524922|NCT01972217|41970038|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
19524923|NCT01972217|41970039|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
19524924|NCT01972217|41970040|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
19446648|NCT01427608|41694624|FG000|Overall Study|Relapsed-all cause|13|||
19446649|NCT01427608|41694625|FG001|Overall Study|Relapsed-all cause|34|||
19446650|NCT01427608|41694624|FG000|Overall Study|Events not attributed to study meds|0|||
19446651|NCT01427608|41694625|FG001|Overall Study|Events not attributed to study meds|1|||
19446652|NCT01408030|41694637|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
19446653|NCT01408030|41694638|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
19446654|NCT01408030|41694639|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
19446655|NCT01408030|41694640|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
19446656|NCT01408030|41694637|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
19446657|NCT01408030|41694638|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
19524925|NCT01972217|41970041|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
19524926|NCT01972217|41970038|FG000|Part B Double-blind, Randomised Period|Death|0|||
19524927|NCT01972217|41970039|FG001|Part B Double-blind, Randomised Period|Death|0|||
19524928|NCT01972217|41970040|FG002|Part B Double-blind, Randomised Period|Death|43|||
19524929|NCT01972217|41970041|FG003|Part B Double-blind, Randomised Period|Death|44|||
19524930|NCT01972217|41970038|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
19524931|NCT01972217|41970039|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
19524932|NCT01972217|41970040|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
19524933|NCT01972217|41970041|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
19524934|NCT01972217|41970038|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
19524935|NCT01972217|41970039|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
19524936|NCT01972217|41970040|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
19524937|NCT01972217|41970041|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
19524938|NCT01972217|41970038|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
19524939|NCT01972217|41970039|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
19446658|NCT01408030|41694639|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
19446659|NCT01408030|41694640|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
19446660|NCT01408030|41694637|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
19446661|NCT01408030|41694638|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
19446662|NCT01408030|41694639|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
19446663|NCT01408030|41694640|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
19446664|NCT01408030|41694637|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
19446665|NCT01408030|41694638|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
19446666|NCT01408030|41694639|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
19446667|NCT01408030|41694640|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
19446668|NCT01408030|41694637|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
19446669|NCT01408030|41694638|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
19446670|NCT01408030|41694639|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
19446671|NCT01408030|41694640|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
19446672|NCT01408030|41694637|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
19446673|NCT01408030|41694638|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
19446674|NCT01408030|41694639|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
19446675|NCT01408030|41694640|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
19446676|NCT01408030|41694637|FG000|Observation Phase (Off Drug)|Other|1|||
19446677|NCT01408030|41694638|FG001|Observation Phase (Off Drug)|Other|1|||
19446678|NCT01408030|41694639|FG002|Observation Phase (Off Drug)|Other|1|||
19446679|NCT01408030|41694640|FG003|Observation Phase (Off Drug)|Other|1|||
19446680|NCT01897532|41694652|FG000|Discontinuation From Treatment|Not Treated|7|||
19446681|NCT01897532|41694653|FG001|Discontinuation From Treatment|Not Treated|5|||
19524940|NCT01972217|41970040|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
19446682|NCT01897532|41694652|FG000|Discontinuation From Treatment|Other reason than specified|196|||
19446683|NCT01897532|41694653|FG001|Discontinuation From Treatment|Other reason than specified|176|||
19446684|NCT01897532|41694652|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
19446685|NCT01897532|41694653|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
19446686|NCT01897532|41694652|FG000|Discontinuation From Treatment|Non compliance|24|||
19446687|NCT01897532|41694653|FG001|Discontinuation From Treatment|Non compliance|15|||
19446688|NCT01897532|41694652|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
19446689|NCT01897532|41694653|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
19446690|NCT01897532|41694652|FG000|Discontinuation From Trial|Not Treated|7|||
19446691|NCT01897532|41694653|FG001|Discontinuation From Trial|Not Treated|5|||
19446692|NCT01897532|41694652|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
19446693|NCT01897532|41694653|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
19446694|NCT01923428|41694663|FG000|Overall Study|Adverse Event|8|||
19446695|NCT01923428|41694664|FG001|Overall Study|Adverse Event|6|||
19446696|NCT01923428|41694665|FG002|Overall Study|Adverse Event|3|||
19446697|NCT01923428|41694666|FG003|Overall Study|Adverse Event|3|||
19446698|NCT01923428|41694663|FG000|Overall Study|Withdrawal by Subject|5|||
19446699|NCT01923428|41694664|FG001|Overall Study|Withdrawal by Subject|3|||
19446700|NCT01923428|41694665|FG002|Overall Study|Withdrawal by Subject|0|||
19446701|NCT01923428|41694666|FG003|Overall Study|Withdrawal by Subject|4|||
19446702|NCT01923428|41694663|FG000|Overall Study|Lost to Follow-up|2|||
19446703|NCT01923428|41694664|FG001|Overall Study|Lost to Follow-up|1|||
19446704|NCT01923428|41694665|FG002|Overall Study|Lost to Follow-up|5|||
19446705|NCT01923428|41694666|FG003|Overall Study|Lost to Follow-up|0|||
19446706|NCT01923428|41694663|FG000|Overall Study|Protocol Violation|3|||
19446707|NCT01923428|41694664|FG001|Overall Study|Protocol Violation|0|||
19446708|NCT01923428|41694665|FG002|Overall Study|Protocol Violation|2|||
19446709|NCT01923428|41694666|FG003|Overall Study|Protocol Violation|1|||
19446710|NCT01923428|41694663|FG000|Overall Study|Non Compliance to treatment|1|||
19446711|NCT01923428|41694664|FG001|Overall Study|Non Compliance to treatment|2|||
19446712|NCT01923428|41694665|FG002|Overall Study|Non Compliance to treatment|0|||
19446713|NCT01923428|41694666|FG003|Overall Study|Non Compliance to treatment|1|||
19446714|NCT01923428|41694663|FG000|Overall Study|Lack of Efficacy|0|||
19446715|NCT01923428|41694664|FG001|Overall Study|Lack of Efficacy|0|||
19446716|NCT01923428|41694665|FG002|Overall Study|Lack of Efficacy|1|||
19446717|NCT01923428|41694666|FG003|Overall Study|Lack of Efficacy|1|||
19446718|NCT01896986|41694678|FG000|Overall Study|samples lost|14|||
19446719|NCT01896986|41694679|FG001|Overall Study|samples lost|23|||
19446720|NCT01896128|41694687|FG000|Overall Study|Withdrawal by Subject|3|||
19446721|NCT01896128|41694688|FG001|Overall Study|Withdrawal by Subject|3|||
19446722|NCT01949870|41694694|FG000|Overall Study|Lack of Efficacy|2|||
19446723|NCT01949870|41694694|FG000|Overall Study|Adverse Event|1|||
19446724|NCT01949870|41694694|FG000|Overall Study|Study termination|1|||
19446725|NCT01949870|41694694|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
19446726|NCT01949480|41694700|FG000|Overall Study|Physician Decision|5|||
19446727|NCT01949480|41694701|FG001|Overall Study|Physician Decision|8|||
19446728|NCT01949090|41694712|FG000|Overall Study|Serious Adverse Event|0|||
19446729|NCT01949090|41694713|FG001|Overall Study|Serious Adverse Event|1|||
19446730|NCT01949090|41694714|FG002|Overall Study|Serious Adverse Event|2|||
19446731|NCT01949090|41694715|FG003|Overall Study|Serious Adverse Event|0|||
19446732|NCT01949090|41694716|FG004|Overall Study|Serious Adverse Event|1|||
19446733|NCT01949090|41694712|FG000|Overall Study|Withdrawal by Subject|2|||
19446734|NCT01949090|41694713|FG001|Overall Study|Withdrawal by Subject|0|||
19446735|NCT01949090|41694714|FG002|Overall Study|Withdrawal by Subject|0|||
19446736|NCT01949090|41694715|FG003|Overall Study|Withdrawal by Subject|0|||
19446737|NCT01949090|41694716|FG004|Overall Study|Withdrawal by Subject|1|||
19446738|NCT01949090|41694712|FG000|Overall Study|Protocol non-compliance|0|||
19446739|NCT01949090|41694713|FG001|Overall Study|Protocol non-compliance|0|||
19446740|NCT01949090|41694714|FG002|Overall Study|Protocol non-compliance|0|||
19446741|NCT01949090|41694715|FG003|Overall Study|Protocol non-compliance|0|||
19446742|NCT01949090|41694716|FG004|Overall Study|Protocol non-compliance|1|||
19446743|NCT01949090|41694712|FG000|Overall Study|Lost to Follow-up|2|||
19446744|NCT01949090|41694713|FG001|Overall Study|Lost to Follow-up|1|||
19446745|NCT01949090|41694714|FG002|Overall Study|Lost to Follow-up|0|||
19446746|NCT01949090|41694715|FG003|Overall Study|Lost to Follow-up|1|||
19446747|NCT01949090|41694716|FG004|Overall Study|Lost to Follow-up|1|||
19446748|NCT01948076|41694731|FG000|Overall Study|Withdrawal by Subject|0|||
19446749|NCT01948076|41694732|FG001|Overall Study|Withdrawal by Subject|1|||
19446750|NCT01922258|41694742|FG000|Overall Study|Lost to Follow-up|1|||
19446751|NCT01922258|41694743|FG001|Overall Study|Lost to Follow-up|1|||
19446752|NCT01922258|41694742|FG000|Overall Study|Adverse Event|9|||
19446753|NCT01922258|41694743|FG001|Overall Study|Adverse Event|2|||
19446754|NCT01922258|41694742|FG000|Overall Study|Met Withdrawal Criteria|0|||
19446755|NCT01922258|41694743|FG001|Overall Study|Met Withdrawal Criteria|4|||
19446756|NCT01922258|41694742|FG000|Overall Study|Withdrawn by the Investigator|1|||
19446757|NCT01922258|41694743|FG001|Overall Study|Withdrawn by the Investigator|4|||
19446758|NCT01922258|41694742|FG000|Overall Study|Withdrawal by participant|5|||
19446759|NCT01922258|41694743|FG001|Overall Study|Withdrawal by participant|5|||
19446760|NCT01406938|41694751|FG000|Induction Period|Subject/guardian decision|6|||
19446761|NCT01406938|41694752|FG001|Induction Period|Subject/guardian decision|8|||
19446762|NCT01406938|41694753|FG002|Induction Period|Subject/guardian decision|0|||
19446763|NCT01406938|41694754|FG003|Induction Period|Subject/guardian decision|0|||
19446764|NCT01406938|41694755|FG004|Induction Period|Subject/guardian decision|0|||
19446765|NCT01406938|41694756|FG005|Induction Period|Subject/guardian decision|0|||
19446766|NCT01406938|41694751|FG000|Induction Period|Protocol deviation|1|||
19446767|NCT01406938|41694752|FG001|Induction Period|Protocol deviation|0|||
19446768|NCT01406938|41694753|FG002|Induction Period|Protocol deviation|0|||
19446769|NCT01406938|41694754|FG003|Induction Period|Protocol deviation|0|||
19446770|NCT01406938|41694755|FG004|Induction Period|Protocol deviation|0|||
19446771|NCT01406938|41694756|FG005|Induction Period|Protocol deviation|0|||
19446772|NCT01406938|41694751|FG000|Induction Period|Adverse Event|8|||
19446773|NCT01406938|41694752|FG001|Induction Period|Adverse Event|9|||
19524941|NCT01972217|41970041|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
19524942|NCT01972217|41970038|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
19524943|NCT01972217|41970039|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
19524944|NCT01972217|41970040|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
19524945|NCT01972217|41970041|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
19524946|NCT01682083|41970072|FG000|Overall Study|Lost to Follow-up|11|||
19524947|NCT01682083|41970073|FG001|Overall Study|Lost to Follow-up|18|||
19524948|NCT01682083|41970072|FG000|Overall Study|Withdrawal by Subject|31|||
19524949|NCT01682083|41970073|FG001|Overall Study|Withdrawal by Subject|40|||
19524950|NCT01682083|41970072|FG000|Overall Study|Death|60|||
19524951|NCT01682083|41970073|FG001|Overall Study|Death|93|||
19524952|NCT01682083|41970072|FG000|Overall Study|Physician Decision|5|||
19524953|NCT01682083|41970073|FG001|Overall Study|Physician Decision|4|||
19524954|NCT01654276|41970079|FG000|Overall Study|Lack of Efficacy|1|||
19524955|NCT01654276|41970079|FG000|Overall Study|Lost to Follow-up|4|||
19524956|NCT01654276|41970079|FG000|Overall Study|Withdrawal by Subject|1|||
19524957|NCT01399658|41970083|FG000|Overall Study|Ineligible|1|||
19524958|NCT01399658|41970083|FG000|Overall Study|Machine Technical Issue|3|||
19524959|NCT01399658|41970083|FG000|Overall Study|Alternative therapy|1|||
19524960|NCT01399658|41970083|FG000|Overall Study|No reason given|1|||
19524961|NCT00590122|41970089|FG000|Overall Study|swallowed oral dissolving dose|1|||
19524962|NCT00590122|41970090|FG001|Overall Study|swallowed oral dissolving dose|0|||
19524963|NCT01386658|41970132|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
19524964|NCT01386658|41970133|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
19524965|NCT01386658|41970132|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
19524966|NCT01386658|41970133|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
19524967|NCT01386684|41970143|FG000|Overall Study|Lost to Follow-up|51|||
19524968|NCT01386684|41970143|FG000|Overall Study|Other|51|||
19524969|NCT01386684|41970143|FG000|Overall Study|Death|47|||
19524970|NCT01386684|41970143|FG000|Overall Study|Withdrawal of Consent|44|||
19524971|NCT01386684|41970143|FG000|Overall Study|Alternative Therapy Required|37|||
19524972|NCT01386684|41970143|FG000|Overall Study|Disease Progression|28|||
19524973|NCT01386684|41970143|FG000|Overall Study|Adverse Event|20|||
19446774|NCT01406938|41694753|FG002|Induction Period|Adverse Event|0|||
19446775|NCT01406938|41694754|FG003|Induction Period|Adverse Event|0|||
19446776|NCT01406938|41694755|FG004|Induction Period|Adverse Event|0|||
19446777|NCT01406938|41694756|FG005|Induction Period|Adverse Event|0|||
19446778|NCT01406938|41694751|FG000|Induction Period|Lack of Efficacy|1|||
19446779|NCT01406938|41694752|FG001|Induction Period|Lack of Efficacy|0|||
19446780|NCT01406938|41694753|FG002|Induction Period|Lack of Efficacy|0|||
19446781|NCT01406938|41694754|FG003|Induction Period|Lack of Efficacy|0|||
19446782|NCT01406938|41694755|FG004|Induction Period|Lack of Efficacy|0|||
19446783|NCT01406938|41694756|FG005|Induction Period|Lack of Efficacy|0|||
19446784|NCT01406938|41694751|FG000|Induction Period|Lost to Follow-up|2|||
19446785|NCT01406938|41694752|FG001|Induction Period|Lost to Follow-up|3|||
19446786|NCT01406938|41694753|FG002|Induction Period|Lost to Follow-up|0|||
19446787|NCT01406938|41694754|FG003|Induction Period|Lost to Follow-up|0|||
19446788|NCT01406938|41694755|FG004|Induction Period|Lost to Follow-up|0|||
19446789|NCT01406938|41694756|FG005|Induction Period|Lost to Follow-up|0|||
19446790|NCT01406938|41694751|FG000|Maintenance Period|Adverse Event|0|||
19446791|NCT01406938|41694752|FG001|Maintenance Period|Adverse Event|0|||
19524974|NCT01386684|41970143|FG000|Overall Study|Noncompliance|8|||
19524975|NCT01386684|41970143|FG000|Overall Study|Protocol Violation|4|||
19524976|NCT01386684|41970143|FG000|Overall Study|Missing|3|||
19446792|NCT01406938|41694753|FG002|Maintenance Period|Adverse Event|2|||
19446793|NCT01406938|41694754|FG003|Maintenance Period|Adverse Event|8|||
19446794|NCT01406938|41694755|FG004|Maintenance Period|Adverse Event|4|||
19446795|NCT01406938|41694756|FG005|Maintenance Period|Adverse Event|2|||
19446796|NCT01406938|41694751|FG000|Maintenance Period|Death|0|||
19446797|NCT01406938|41694752|FG001|Maintenance Period|Death|0|||
19446798|NCT01406938|41694753|FG002|Maintenance Period|Death|0|||
19446799|NCT01406938|41694754|FG003|Maintenance Period|Death|0|||
19446800|NCT01406938|41694755|FG004|Maintenance Period|Death|1|||
19446801|NCT01406938|41694756|FG005|Maintenance Period|Death|0|||
19446802|NCT01406938|41694751|FG000|Maintenance Period|Subject/guardian decision|0|||
19446803|NCT01406938|41694752|FG001|Maintenance Period|Subject/guardian decision|0|||
19446804|NCT01406938|41694753|FG002|Maintenance Period|Subject/guardian decision|11|||
19446805|NCT01406938|41694754|FG003|Maintenance Period|Subject/guardian decision|7|||
19446806|NCT01406938|41694755|FG004|Maintenance Period|Subject/guardian decision|10|||
19446807|NCT01406938|41694756|FG005|Maintenance Period|Subject/guardian decision|7|||
19446808|NCT01406938|41694751|FG000|Maintenance Period|Protocol Violation|0|||
19446809|NCT01406938|41694752|FG001|Maintenance Period|Protocol Violation|0|||
19524977|NCT04980014|41970160|FG000|Overall Study|Participants who are Duplicated|1|||
19524978|NCT04980014|41970160|FG000|Overall Study|Follow-up Failure|13|||
19524979|NCT04980014|41970160|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
19524980|NCT04980014|41970160|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
19524981|NCT04980014|41970160|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
19524982|NCT03735849|41970184|FG000|Overall Study|Lost to Follow-up|1|||
19524983|NCT03735849|41970185|FG001|Overall Study|Lost to Follow-up|0|||
19524984|NCT03735849|41970186|FG002|Overall Study|Lost to Follow-up|0|||
19446810|NCT01406938|41694753|FG002|Maintenance Period|Protocol Violation|2|||
19446811|NCT01406938|41694754|FG003|Maintenance Period|Protocol Violation|2|||
19446812|NCT01406938|41694755|FG004|Maintenance Period|Protocol Violation|2|||
19446813|NCT01406938|41694756|FG005|Maintenance Period|Protocol Violation|2|||
19446814|NCT01406938|41694751|FG000|Maintenance Period|Pregnancy|0|||
19446815|NCT01406938|41694752|FG001|Maintenance Period|Pregnancy|0|||
19446816|NCT01406938|41694753|FG002|Maintenance Period|Pregnancy|0|||
19446817|NCT01406938|41694754|FG003|Maintenance Period|Pregnancy|0|||
19446818|NCT01406938|41694755|FG004|Maintenance Period|Pregnancy|1|||
19446819|NCT01406938|41694756|FG005|Maintenance Period|Pregnancy|0|||
19446820|NCT01406938|41694751|FG000|Maintenance Period|Lost to Follow-up|0|||
19446821|NCT01406938|41694752|FG001|Maintenance Period|Lost to Follow-up|0|||
19446822|NCT01406938|41694753|FG002|Maintenance Period|Lost to Follow-up|0|||
19446823|NCT01406938|41694754|FG003|Maintenance Period|Lost to Follow-up|0|||
19446824|NCT01406938|41694755|FG004|Maintenance Period|Lost to Follow-up|4|||
19446825|NCT01406938|41694756|FG005|Maintenance Period|Lost to Follow-up|0|||
19446826|NCT01406938|41694751|FG000|Maintenance Period|Lack of Efficacy|0|||
19446827|NCT01406938|41694752|FG001|Maintenance Period|Lack of Efficacy|0|||
19446828|NCT01406938|41694753|FG002|Maintenance Period|Lack of Efficacy|2|||
19446829|NCT01406938|41694754|FG003|Maintenance Period|Lack of Efficacy|1|||
19446830|NCT01406938|41694755|FG004|Maintenance Period|Lack of Efficacy|3|||
19446831|NCT01406938|41694756|FG005|Maintenance Period|Lack of Efficacy|5|||
19446832|NCT01406938|41694751|FG000|Follow up|Lack of Efficacy|3|||
19446833|NCT01406938|41694752|FG001|Follow up|Lack of Efficacy|2|||
19446834|NCT01406938|41694753|FG002|Follow up|Lack of Efficacy|1|||
19446835|NCT01406938|41694754|FG003|Follow up|Lack of Efficacy|0|||
19446836|NCT01406938|41694755|FG004|Follow up|Lack of Efficacy|0|||
19446837|NCT01406938|41694756|FG005|Follow up|Lack of Efficacy|0|||
19446838|NCT01406938|41694751|FG000|Follow up|Patient/guardian decision|4|||
19446839|NCT01406938|41694752|FG001|Follow up|Patient/guardian decision|2|||
19446840|NCT01406938|41694753|FG002|Follow up|Patient/guardian decision|4|||
19446841|NCT01406938|41694754|FG003|Follow up|Patient/guardian decision|2|||
19446842|NCT01406938|41694755|FG004|Follow up|Patient/guardian decision|4|||
19446843|NCT01406938|41694756|FG005|Follow up|Patient/guardian decision|1|||
19446844|NCT01406938|41694751|FG000|Follow up|Protocol Violation|0|||
19446845|NCT01406938|41694752|FG001|Follow up|Protocol Violation|0|||
19446846|NCT01406938|41694753|FG002|Follow up|Protocol Violation|1|||
19446847|NCT01406938|41694754|FG003|Follow up|Protocol Violation|0|||
19446848|NCT01406938|41694755|FG004|Follow up|Protocol Violation|0|||
19446849|NCT01406938|41694756|FG005|Follow up|Protocol Violation|0|||
19446850|NCT01406938|41694751|FG000|Follow up|Physician Decision|0|||
19446851|NCT01406938|41694752|FG001|Follow up|Physician Decision|0|||
19446852|NCT01406938|41694753|FG002|Follow up|Physician Decision|2|||
19524985|NCT03735849|41970184|FG000|Overall Study|Participant unable to adhere to visit|1|||
19446853|NCT01406938|41694754|FG003|Follow up|Physician Decision|0|||
19446854|NCT01406938|41694755|FG004|Follow up|Physician Decision|3|||
19446855|NCT01406938|41694756|FG005|Follow up|Physician Decision|1|||
19446856|NCT01406938|41694751|FG000|Follow up|Lost to Follow-up|1|||
19446857|NCT01406938|41694752|FG001|Follow up|Lost to Follow-up|1|||
19446858|NCT01406938|41694753|FG002|Follow up|Lost to Follow-up|0|||
19446859|NCT01406938|41694754|FG003|Follow up|Lost to Follow-up|1|||
19446860|NCT01406938|41694755|FG004|Follow up|Lost to Follow-up|2|||
19446861|NCT01406938|41694756|FG005|Follow up|Lost to Follow-up|1|||
19446862|NCT01405924|41694776|FG000|Overall Study|Protocol Violation|8|||
19446863|NCT01405924|41694776|FG000|Overall Study|Missing/Incomplete Data|2|||
19446864|NCT01426438|41694784|FG000|Overall Study|Lost to Follow-up|1|||
19446865|NCT01426438|41694785|FG001|Overall Study|Lost to Follow-up|3|||
19446866|NCT01426438|41694784|FG000|Overall Study|Off study Treatment|9|||
19446867|NCT01426438|41694785|FG001|Overall Study|Off study Treatment|3|||
19446868|NCT01426438|41694784|FG000|Overall Study|Poor scan quality|3|||
19446869|NCT01426438|41694785|FG001|Overall Study|Poor scan quality|2|||
19446870|NCT01426438|41694784|FG000|Overall Study|Missed Scan|2|||
19446871|NCT01426438|41694785|FG001|Overall Study|Missed Scan|2|||
19446872|NCT01425814|41694791|FG000|Period 1|Stability criteria not fulfilled|0|||
19446873|NCT01425814|41694792|FG001|Period 1|Stability criteria not fulfilled|1|||
19446874|NCT01425814|41694793|FG002|Period 1|Stability criteria not fulfilled|0|||
19446875|NCT01425814|41694794|FG003|Period 1|Stability criteria not fulfilled|0|||
19446876|NCT01425814|41694795|FG004|Period 1|Stability criteria not fulfilled|0|||
19446877|NCT01425814|41694796|FG005|Period 1|Stability criteria not fulfilled|0|||
19446878|NCT01425814|41694791|FG000|Period 2|Stability criteria not fulfilled|0|||
19446879|NCT01425814|41694792|FG001|Period 2|Stability criteria not fulfilled|1|||
19446880|NCT01425814|41694793|FG002|Period 2|Stability criteria not fulfilled|0|||
19446881|NCT01425814|41694794|FG003|Period 2|Stability criteria not fulfilled|0|||
19446882|NCT01425814|41694795|FG004|Period 2|Stability criteria not fulfilled|0|||
19446883|NCT01425814|41694796|FG005|Period 2|Stability criteria not fulfilled|0|||
19446884|NCT01425814|41694791|FG000|Period 3|Adverse Event|0|||
19446885|NCT01425814|41694792|FG001|Period 3|Adverse Event|0|||
19446886|NCT01425814|41694793|FG002|Period 3|Adverse Event|0|||
19446887|NCT01425814|41694794|FG003|Period 3|Adverse Event|0|||
19446888|NCT01425814|41694795|FG004|Period 3|Adverse Event|0|||
19446889|NCT01425814|41694796|FG005|Period 3|Adverse Event|1|||
19446890|NCT01425814|41694791|FG000|Period 4|Adverse Event|1|||
19446891|NCT01425814|41694792|FG001|Period 4|Adverse Event|0|||
19446892|NCT01425814|41694793|FG002|Period 4|Adverse Event|1|||
19446893|NCT01425814|41694794|FG003|Period 4|Adverse Event|0|||
19446894|NCT01425814|41694795|FG004|Period 4|Adverse Event|0|||
19446895|NCT01425814|41694796|FG005|Period 4|Adverse Event|0|||
19446896|NCT01425814|41694791|FG000|Period 5|Stability criteria not fulfilled|0|||
19446897|NCT01425814|41694792|FG001|Period 5|Stability criteria not fulfilled|0|||
19446898|NCT01425814|41694793|FG002|Period 5|Stability criteria not fulfilled|1|||
19446899|NCT01425814|41694794|FG003|Period 5|Stability criteria not fulfilled|0|||
19446900|NCT01425814|41694795|FG004|Period 5|Stability criteria not fulfilled|0|||
19446901|NCT01425814|41694796|FG005|Period 5|Stability criteria not fulfilled|1|||
19446902|NCT01782495|41694821|FG000|Overall Study|Adverse Event|0|||
19446903|NCT01782495|41694822|FG001|Overall Study|Adverse Event|0|||
19446904|NCT01782495|41694823|FG002|Overall Study|Adverse Event|0|||
19446905|NCT01782495|41694824|FG003|Overall Study|Adverse Event|0|||
19446906|NCT01782495|41694825|FG004|Overall Study|Adverse Event|0|||
19446907|NCT01782495|41694826|FG005|Overall Study|Adverse Event|0|||
19446908|NCT01782495|41694827|FG006|Overall Study|Adverse Event|0|||
19446909|NCT01782495|41694828|FG007|Overall Study|Adverse Event|2|||
19446910|NCT01782495|41694829|FG008|Overall Study|Adverse Event|0|||
19446911|NCT01782495|41694830|FG009|Overall Study|Adverse Event|0|||
19446912|NCT01782495|41694831|FG010|Overall Study|Adverse Event|0|||
19446913|NCT01782495|41694821|FG000|Overall Study|Withdrew Consent|0|||
19446914|NCT01782495|41694822|FG001|Overall Study|Withdrew Consent|1|||
19446915|NCT01782495|41694823|FG002|Overall Study|Withdrew Consent|0|||
19446916|NCT01782495|41694824|FG003|Overall Study|Withdrew Consent|0|||
19446917|NCT01782495|41694825|FG004|Overall Study|Withdrew Consent|0|||
19446918|NCT01782495|41694826|FG005|Overall Study|Withdrew Consent|0|||
19446919|NCT01782495|41694827|FG006|Overall Study|Withdrew Consent|0|||
19446920|NCT01782495|41694828|FG007|Overall Study|Withdrew Consent|1|||
19446921|NCT01782495|41694829|FG008|Overall Study|Withdrew Consent|0|||
19446922|NCT01782495|41694830|FG009|Overall Study|Withdrew Consent|0|||
19446923|NCT01782495|41694831|FG010|Overall Study|Withdrew Consent|0|||
19446924|NCT01922102|41694858|FG000|Overall Study|Withdrawal by Subject|7|||
19446925|NCT01922102|41694859|FG001|Overall Study|Withdrawal by Subject|3|||
19446926|NCT01922102|41694860|FG002|Overall Study|Withdrawal by Subject|7|||
19446927|NCT01922102|41694858|FG000|Overall Study|Physician Decision|0|||
19446928|NCT01922102|41694859|FG001|Overall Study|Physician Decision|2|||
19446929|NCT01922102|41694860|FG002|Overall Study|Physician Decision|1|||
19446930|NCT01922102|41694858|FG000|Overall Study|Adverse Event|1|||
19446931|NCT01922102|41694859|FG001|Overall Study|Adverse Event|2|||
19446932|NCT01922102|41694860|FG002|Overall Study|Adverse Event|0|||
19446933|NCT01922102|41694858|FG000|Overall Study|Lost to Follow-up|1|||
19446934|NCT01922102|41694859|FG001|Overall Study|Lost to Follow-up|0|||
19446935|NCT01922102|41694860|FG002|Overall Study|Lost to Follow-up|0|||
19446936|NCT01922102|41694858|FG000|Overall Study|Administrative problems|0|||
19446937|NCT01922102|41694859|FG001|Overall Study|Administrative problems|2|||
19446938|NCT01922102|41694860|FG002|Overall Study|Administrative problems|0|||
19446939|NCT01405768|41694874|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
19446940|NCT01405768|41694875|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
19446941|NCT01754259|41694883|FG000|Overall Study|Withdrawal by Subject|2|||
19446942|NCT01754259|41694884|FG001|Overall Study|Withdrawal by Subject|4|||
19446943|NCT01754259|41694883|FG000|Overall Study|Adverse Event|3|||
19446944|NCT01754259|41694884|FG001|Overall Study|Adverse Event|1|||
19446945|NCT01754259|41694883|FG000|Overall Study|Lost to Follow-up|0|||
19446946|NCT01754259|41694884|FG001|Overall Study|Lost to Follow-up|1|||
19446947|NCT01405456|41694892|FG000|Overall Study|Lost to Follow-up|2|||
19446948|NCT01405456|41694893|FG001|Overall Study|Lost to Follow-up|1|||
19446949|NCT01405456|41694892|FG000|Overall Study|Physician Decision|1|||
19524986|NCT03735849|41970185|FG001|Overall Study|Participant unable to adhere to visit|0|||
19524987|NCT03735849|41970186|FG002|Overall Study|Participant unable to adhere to visit|0|||
19524988|NCT03735849|41970184|FG000|Overall Study|Not Randomized|0|||
19524989|NCT03735849|41970185|FG001|Overall Study|Not Randomized|0|||
19524990|NCT03735849|41970186|FG002|Overall Study|Not Randomized|4|||
19524991|NCT03552393|41970193|FG000|Core Period|Kidney Transplant|1|||
19446950|NCT01405456|41694893|FG001|Overall Study|Physician Decision|0|||
19446951|NCT01404988|41694902|FG000|Overall Study|Death|2|||
19446952|NCT01404988|41694903|FG001|Overall Study|Death|0|||
19446953|NCT01404988|41694904|FG002|Overall Study|Death|2|||
19446954|NCT01404988|41694902|FG000|Overall Study|Adverse Event|1|||
19446955|NCT01404988|41694903|FG001|Overall Study|Adverse Event|0|||
19524992|NCT03552393|41970193|FG000|Core Period|Prohibited Medication|1|||
19524993|NCT03552393|41970193|FG000|Safety Extension Period|Kidney Transplant|4|||
19524994|NCT03333382|41970199|FG000|Overall Study|Lost to Follow-up|1|||
19524995|NCT03333382|41970200|FG001|Overall Study|Lost to Follow-up|0|||
19524996|NCT03107611|41970239|FG000|Overall Study|Adverse Event|1|||
19524997|NCT03107611|41970240|FG001|Overall Study|Adverse Event|0|||
19524998|NCT03107611|41970241|FG002|Overall Study|Adverse Event|2|||
19524999|NCT03107611|41970239|FG000|Overall Study|Lost to Follow-up|3|||
19525000|NCT03107611|41970240|FG001|Overall Study|Lost to Follow-up|3|||
19525001|NCT03107611|41970241|FG002|Overall Study|Lost to Follow-up|3|||
19525002|NCT03107611|41970239|FG000|Overall Study|Protocol Violation|0|||
19525003|NCT03107611|41970240|FG001|Overall Study|Protocol Violation|0|||
19525004|NCT03107611|41970241|FG002|Overall Study|Protocol Violation|1|||
19525005|NCT03107611|41970239|FG000|Overall Study|Withdrawal by Subject|1|||
19525006|NCT03107611|41970240|FG001|Overall Study|Withdrawal by Subject|0|||
19525007|NCT03107611|41970241|FG002|Overall Study|Withdrawal by Subject|1|||
19525008|NCT03107611|41970239|FG000|Overall Study|Worsening signs/symptoms|2|||
19525009|NCT03107611|41970240|FG001|Overall Study|Worsening signs/symptoms|1|||
19525010|NCT03107611|41970241|FG002|Overall Study|Worsening signs/symptoms|2|||
19525011|NCT02720016|41970252|FG000|Overall Study|Separation of couple|6|||
19525012|NCT02720016|41970253|FG001|Overall Study|Separation of couple|8|||
19525013|NCT02720016|41970254|FG002|Overall Study|Separation of couple|2|||
19525014|NCT02720016|41970252|FG000|Overall Study|Withdrawal by Subject|6|||
19525015|NCT02720016|41970253|FG001|Overall Study|Withdrawal by Subject|6|||
19525016|NCT02720016|41970254|FG002|Overall Study|Withdrawal by Subject|4|||
19525017|NCT02720016|41970252|FG000|Overall Study|Scheduling issues|2|||
19525018|NCT02720016|41970253|FG001|Overall Study|Scheduling issues|4|||
19525019|NCT02720016|41970254|FG002|Overall Study|Scheduling issues|7|||
19525020|NCT02720016|41970252|FG000|Overall Study|Childcare|2|||
19525021|NCT02720016|41970253|FG001|Overall Study|Childcare|0|||
19525022|NCT02720016|41970254|FG002|Overall Study|Childcare|2|||
19525023|NCT02720016|41970252|FG000|Overall Study|Withdrawal by PI|2|||
19525024|NCT02720016|41970253|FG001|Overall Study|Withdrawal by PI|2|||
19525025|NCT02720016|41970254|FG002|Overall Study|Withdrawal by PI|0|||
19525026|NCT02720016|41970252|FG000|Overall Study|Moved away|2|||
19525027|NCT02720016|41970253|FG001|Overall Study|Moved away|0|||
19525028|NCT02720016|41970254|FG002|Overall Study|Moved away|0|||
19525029|NCT02720016|41970252|FG000|Overall Study|Not Primary Health Concern|0|||
19446956|NCT01404988|41694904|FG002|Overall Study|Adverse Event|0|||
19446957|NCT01404988|41694902|FG000|Overall Study|Withdrawal by Subject|2|||
19446958|NCT01404988|41694903|FG001|Overall Study|Withdrawal by Subject|2|||
19446959|NCT01404988|41694904|FG002|Overall Study|Withdrawal by Subject|0|||
19446960|NCT01404988|41694902|FG000|Overall Study|Lost to Follow-up|1|||
19446961|NCT01404988|41694903|FG001|Overall Study|Lost to Follow-up|2|||
19446962|NCT01404988|41694904|FG002|Overall Study|Lost to Follow-up|1|||
19446963|NCT01389232|41694915|FG000|Overall Study|Had scaffold removed|15|||
19446964|NCT01389232|41694915|FG000|Overall Study|Personal reasons|2|||
19446965|NCT01389232|41694915|FG000|Overall Study|Adverse Event|1|||
19446966|NCT01389232|41694915|FG000|Overall Study|Death|1|||
19446967|NCT01404208|41694931|FG000|Overall Study|Discontinued|3|||
19525030|NCT02720016|41970253|FG001|Overall Study|Not Primary Health Concern|0|||
19525031|NCT02720016|41970254|FG002|Overall Study|Not Primary Health Concern|2|||
19525032|NCT02720016|41970252|FG000|Overall Study|Transportation issues|0|||
19525033|NCT02720016|41970253|FG001|Overall Study|Transportation issues|0|||
19525034|NCT02720016|41970254|FG002|Overall Study|Transportation issues|1|||
19525035|NCT02720016|41970252|FG000|Overall Study|Other|0|||
19525036|NCT02720016|41970253|FG001|Overall Study|Other|0|||
19446968|NCT01404208|41694932|FG001|Overall Study|Discontinued|0|||
19446969|NCT01617668|41694940|FG000|Overall Study|Adverse Event|7|||
19446970|NCT01617668|41694941|FG001|Overall Study|Adverse Event|0|||
19525037|NCT02720016|41970254|FG002|Overall Study|Other|2|||
19525038|NCT02607956|41970265|FG000|Double-Blinded Phase|Withdrew Consent|17|||
19525039|NCT02607956|41970266|FG001|Double-Blinded Phase|Withdrew Consent|19|||
19446971|NCT01617668|41694942|FG002|Overall Study|Adverse Event|12|||
19446972|NCT01617668|41694943|FG003|Overall Study|Adverse Event|5|||
19446973|NCT01617668|41694940|FG000|Overall Study|Physician Decision|1|||
19446974|NCT01617668|41694941|FG001|Overall Study|Physician Decision|2|||
19446975|NCT01617668|41694942|FG002|Overall Study|Physician Decision|3|||
19446976|NCT01617668|41694943|FG003|Overall Study|Physician Decision|0|||
19446977|NCT01617668|41694940|FG000|Overall Study|Progressive Disease|4|||
19446978|NCT01617668|41694941|FG001|Overall Study|Progressive Disease|4|||
19446979|NCT01617668|41694942|FG002|Overall Study|Progressive Disease|6|||
19446980|NCT01617668|41694943|FG003|Overall Study|Progressive Disease|9|||
19446981|NCT01617668|41694940|FG000|Overall Study|Subject/guardian decision|1|||
19446982|NCT01617668|41694941|FG001|Overall Study|Subject/guardian decision|3|||
19446983|NCT01617668|41694942|FG002|Overall Study|Subject/guardian decision|2|||
19446984|NCT01617668|41694943|FG003|Overall Study|Subject/guardian decision|1|||
19446985|NCT01425268|41694959|FG000|Overall Study|Withdrawal by Subject|2|||
19446986|NCT01425268|41694960|FG001|Overall Study|Withdrawal by Subject|0|||
19446987|NCT01425268|41694959|FG000|Overall Study|Sponsor Decision|5|||
19446988|NCT01425268|41694960|FG001|Overall Study|Sponsor Decision|0|||
19446989|NCT01425268|41694959|FG000|Overall Study|Physician Decision|1|||
19446990|NCT01425268|41694960|FG001|Overall Study|Physician Decision|0|||
19446991|NCT01896050|41694968|FG000|Overall Study|Adverse Event|37|||
19446992|NCT01896050|41694969|FG001|Overall Study|Adverse Event|2|||
19446993|NCT01896050|41694968|FG000|Overall Study|Death|1|||
19446994|NCT01896050|41694969|FG001|Overall Study|Death|0|||
19446995|NCT01425190|41694980|FG000|Overall Study|Full dose not consumed.|1|||
19446996|NCT01425190|41694981|FG001|Overall Study|Full dose not consumed.|0|||
19446997|NCT01425190|41694982|FG002|Overall Study|Full dose not consumed.|0|||
19446998|NCT01388530|41694990|FG000|Overall Study|Lost to Follow-up|5|||
19446999|NCT01895270|41694996|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
19447000|NCT01895270|41694997|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
19447001|NCT01895270|41694996|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
19447002|NCT01895270|41694997|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
19447003|NCT01895270|41694996|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
19447004|NCT01895270|41694997|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
19447005|NCT01895270|41694996|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
19447006|NCT01895270|41694997|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
19447007|NCT01895270|41694996|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
19447008|NCT01895270|41694997|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
19447009|NCT01895270|41694996|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
19447010|NCT01895270|41694997|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
19447011|NCT01895270|41694996|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
19447012|NCT01895270|41694997|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
19447013|NCT01424722|41695003|FG000|Overall Study|Sponsor terminated investigation|2258|||
19447014|NCT01424644|41695009|FG000|Overall Study|Adverse Event|2|||
19447015|NCT01424644|41695010|FG001|Overall Study|Adverse Event|0|||
19447016|NCT01424644|41695009|FG000|Overall Study|Withdrawal by Subject|9|||
19447017|NCT01424644|41695010|FG001|Overall Study|Withdrawal by Subject|12|||
19447018|NCT01424644|41695009|FG000|Overall Study|Lost to Follow-up|16|||
19447019|NCT01424644|41695010|FG001|Overall Study|Lost to Follow-up|12|||
19447020|NCT01424644|41695009|FG000|Overall Study|Protocol Violation|4|||
19447021|NCT01424644|41695010|FG001|Overall Study|Protocol Violation|3|||
19447022|NCT01424644|41695009|FG000|Overall Study|Administrative Reason|1|||
19447023|NCT01424644|41695010|FG001|Overall Study|Administrative Reason|0|||
19447024|NCT01424644|41695009|FG000|Overall Study|Unable to Classify|1|||
19447025|NCT01424644|41695010|FG001|Overall Study|Unable to Classify|0|||
19447026|NCT01920854|41695023|FG000|Overall Study|Withdrawal by Subject|1|||
19447027|NCT01920854|41695024|FG001|Overall Study|Withdrawal by Subject|0|||
19447028|NCT01920854|41695025|FG002|Overall Study|Withdrawal by Subject|0|||
19447029|NCT01920854|41695026|FG003|Overall Study|Withdrawal by Subject|0|||
19447030|NCT01920854|41695027|FG004|Overall Study|Withdrawal by Subject|1|||
19447031|NCT01920854|41695028|FG005|Overall Study|Withdrawal by Subject|0|||
19447032|NCT01920854|41695029|FG006|Overall Study|Withdrawal by Subject|1|||
19447033|NCT01403194|41695064|FG000|Overall Study|Screen Failure|2|||
19447034|NCT01403194|41695064|FG000|Overall Study|Lost to Follow-up|8|||
19447035|NCT01403116|41695070|FG000|Overall Study|Adverse Event|7|||
19525040|NCT02607956|41970267|FG002|Double-Blinded Phase|Withdrew Consent|0|||
19525041|NCT02607956|41970268|FG003|Double-Blinded Phase|Withdrew Consent|0|||
19525042|NCT02607956|41970265|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
19447036|NCT01403116|41695071|FG001|Overall Study|Adverse Event|4|||
19447037|NCT01403116|41695070|FG000|Overall Study|Lost to Follow-up|7|||
19447038|NCT01403116|41695071|FG001|Overall Study|Lost to Follow-up|5|||
19447039|NCT01403116|41695070|FG000|Overall Study|Withdrawal by Subject|12|||
19447040|NCT01403116|41695071|FG001|Overall Study|Withdrawal by Subject|15|||
19447041|NCT01403116|41695070|FG000|Overall Study|Non-compliance of study drug|3|||
19447042|NCT01403116|41695071|FG001|Overall Study|Non-compliance of study drug|0|||
19447043|NCT01403116|41695070|FG000|Overall Study|Protocol Violation|0|||
19447044|NCT01403116|41695071|FG001|Overall Study|Protocol Violation|1|||
19447045|NCT01403116|41695070|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
19447046|NCT01403116|41695071|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
19447047|NCT01403116|41695070|FG000|Overall Study|Hct >54%|2|||
19447048|NCT01403116|41695071|FG001|Overall Study|Hct >54%|0|||
19447049|NCT01403116|41695070|FG000|Overall Study|unable to keep appointments|0|||
19447050|NCT01403116|41695071|FG001|Overall Study|unable to keep appointments|2|||
19447051|NCT01402570|41695077|FG000|Overall Study|Adverse Event|1|||
19447052|NCT01753401|41695084|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
19447053|NCT01753401|41695085|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
19447054|NCT01753401|41695086|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
19447055|NCT01753401|41695087|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
19447056|NCT01753401|41695084|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
19447057|NCT01753401|41695085|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
19447058|NCT01753401|41695086|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
19447059|NCT01753401|41695087|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
19447060|NCT01753401|41695084|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
19447061|NCT01753401|41695085|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
19447062|NCT01753401|41695086|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
19447063|NCT01753401|41695087|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
19447064|NCT01753401|41695084|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
19447065|NCT01753401|41695085|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
19447066|NCT01753401|41695086|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
19447067|NCT01753401|41695087|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
19447068|NCT01753401|41695084|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
19447069|NCT01753401|41695085|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
19447070|NCT01753401|41695086|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
19447071|NCT01753401|41695087|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
19447072|NCT01753401|41695084|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
19447073|NCT01753401|41695085|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
19447074|NCT01753401|41695086|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
19525043|NCT02607956|41970266|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
19525044|NCT02607956|41970267|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
19525045|NCT02607956|41970268|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
19525046|NCT02607956|41970265|FG000|Double-Blinded Phase|Randomized but never treated|7|||
19525047|NCT02607956|41970266|FG001|Double-Blinded Phase|Randomized but never treated|5|||
19525048|NCT02607956|41970267|FG002|Double-Blinded Phase|Randomized but never treated|0|||
19525049|NCT02607956|41970268|FG003|Double-Blinded Phase|Randomized but never treated|0|||
19525050|NCT02607956|41970265|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
19525051|NCT02607956|41970266|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
19525052|NCT02607956|41970267|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
19525053|NCT02607956|41970268|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
19525054|NCT02607956|41970265|FG000|Double-Blinded Phase|Death|4|||
19525055|NCT02607956|41970266|FG001|Double-Blinded Phase|Death|4|||
19525056|NCT02607956|41970267|FG002|Double-Blinded Phase|Death|0|||
19525057|NCT02607956|41970268|FG003|Double-Blinded Phase|Death|0|||
19525058|NCT02607956|41970265|FG000|Double-Blinded Phase|Adverse Event|4|||
19525059|NCT02607956|41970266|FG001|Double-Blinded Phase|Adverse Event|3|||
19525060|NCT02607956|41970267|FG002|Double-Blinded Phase|Adverse Event|0|||
19525061|NCT02607956|41970268|FG003|Double-Blinded Phase|Adverse Event|0|||
19525062|NCT02607956|41970265|FG000|Double-Blinded Phase|Protocol Violation|3|||
19629116|NCT00642460|42078693|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
19447075|NCT01753401|41695087|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
19447076|NCT01753401|41695084|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
19447077|NCT01753401|41695085|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
19447078|NCT01753401|41695086|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
19447079|NCT01753401|41695087|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
19447080|NCT01618916|41695103|FG000|Overall Study|Adverse Event|1|||
19447081|NCT01618916|41695104|FG001|Overall Study|Adverse Event|0|||
19447082|NCT01618916|41695105|FG002|Overall Study|Adverse Event|0|||
19525063|NCT02607956|41970266|FG001|Double-Blinded Phase|Protocol Violation|1|||
19525064|NCT02607956|41970267|FG002|Double-Blinded Phase|Protocol Violation|0|||
19525065|NCT02607956|41970268|FG003|Double-Blinded Phase|Protocol Violation|0|||
19525066|NCT02607956|41970265|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
19447083|NCT01618916|41695106|FG003|Overall Study|Adverse Event|0|||
19447084|NCT01618916|41695107|FG004|Overall Study|Adverse Event|0|||
19447085|NCT01618916|41695108|FG005|Overall Study|Adverse Event|0|||
19447086|NCT01618916|41695103|FG000|Overall Study|Withdrawal by Subject|0|||
19447087|NCT01618916|41695104|FG001|Overall Study|Withdrawal by Subject|1|||
19447088|NCT01618916|41695105|FG002|Overall Study|Withdrawal by Subject|1|||
19447089|NCT01618916|41695106|FG003|Overall Study|Withdrawal by Subject|0|||
19447090|NCT01618916|41695107|FG004|Overall Study|Withdrawal by Subject|1|||
19447091|NCT01618916|41695108|FG005|Overall Study|Withdrawal by Subject|0|||
19447092|NCT01618916|41695103|FG000|Overall Study|Lost to Follow-up|1|||
19447093|NCT01618916|41695104|FG001|Overall Study|Lost to Follow-up|0|||
19447094|NCT01618916|41695105|FG002|Overall Study|Lost to Follow-up|0|||
19447095|NCT01618916|41695106|FG003|Overall Study|Lost to Follow-up|2|||
19447096|NCT01618916|41695107|FG004|Overall Study|Lost to Follow-up|0|||
19447097|NCT01618916|41695108|FG005|Overall Study|Lost to Follow-up|0|||
19447098|NCT01753323|41695124|FG000|Overall Study|Lack of Efficacy|0|||
19447099|NCT01753323|41695125|FG001|Overall Study|Lack of Efficacy|0|||
19447100|NCT01753323|41695126|FG002|Overall Study|Lack of Efficacy|8|||
19447101|NCT01753323|41695124|FG000|Overall Study|Protocol deviation|1|||
19447102|NCT01753323|41695125|FG001|Overall Study|Protocol deviation|0|||
19447103|NCT01753323|41695126|FG002|Overall Study|Protocol deviation|0|||
19447104|NCT01753323|41695124|FG000|Overall Study|Adverse Event|0|||
19447105|NCT01753323|41695125|FG001|Overall Study|Adverse Event|0|||
19447106|NCT01753323|41695126|FG002|Overall Study|Adverse Event|1|||
19447107|NCT01894568|41695137|FG000|Overall Study|Adverse Event|2|||
19447108|NCT01894568|41695138|FG001|Overall Study|Adverse Event|3|||
19447109|NCT01894568|41695137|FG000|Overall Study|Protocol required discontinuation|2|||
19447110|NCT01894568|41695138|FG001|Overall Study|Protocol required discontinuation|1|||
19447111|NCT01894568|41695137|FG000|Overall Study|Withdrawal by Subject|5|||
19447112|NCT01894568|41695138|FG001|Overall Study|Withdrawal by Subject|5|||
19447113|NCT01894568|41695137|FG000|Overall Study|Physician Decision|1|||
19447114|NCT01894568|41695138|FG001|Overall Study|Physician Decision|0|||
19447115|NCT01894568|41695137|FG000|Overall Study|Lost to Follow-up|0|||
19447116|NCT01894568|41695138|FG001|Overall Study|Lost to Follow-up|1|||
19447117|NCT01618838|41695145|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
19447118|NCT01920152|41695152|FG000|Overall Study|Withdrawal by Subject|1|||
19447119|NCT01920152|41695153|FG001|Overall Study|Withdrawal by Subject|2|||
19447120|NCT01752933|41695161|FG000|Treatment|Disease Progression|3|||
19447121|NCT01752933|41695162|FG001|Treatment|Disease Progression|29|||
19447122|NCT01752933|41695161|FG000|Treatment|Withdrawal by Subject|0|||
19447123|NCT01752933|41695162|FG001|Treatment|Withdrawal by Subject|5|||
19447124|NCT01752933|41695161|FG000|Treatment|Adverse Event|1|||
19447125|NCT01752933|41695162|FG001|Treatment|Adverse Event|4|||
19447126|NCT01752933|41695161|FG000|Treatment|Physician Decision|0|||
19447127|NCT01752933|41695162|FG001|Treatment|Physician Decision|3|||
19447128|NCT01752933|41695161|FG000|Treatment|Death|0|||
19447129|NCT01752933|41695162|FG001|Treatment|Death|2|||
19447130|NCT01752933|41695161|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
19447131|NCT01752933|41695162|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
19447132|NCT01752933|41695161|FG000|Treatment|Patient noncompliant|0|||
19447133|NCT01752933|41695162|FG001|Treatment|Patient noncompliant|1|||
19447134|NCT01752933|41695161|FG000|Treatment|Patient unable to travel to appointments|0|||
19447135|NCT01752933|41695162|FG001|Treatment|Patient unable to travel to appointments|1|||
19447136|NCT01752933|41695161|FG000|Overall Study and Follow-up|Death|4|||
19447137|NCT01752933|41695162|FG001|Overall Study and Follow-up|Death|34|||
19447138|NCT01752933|41695161|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
19447139|NCT01752933|41695162|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
19447140|NCT01752933|41695161|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
19447141|NCT01752933|41695162|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
19447142|NCT01752933|41695161|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
19447143|NCT01752933|41695162|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
19447144|NCT01752855|41695171|FG000|Overall Study|Adverse Event|1|||
19447145|NCT01752855|41695172|FG001|Overall Study|Adverse Event|0|||
19447146|NCT01752855|41695171|FG000|Overall Study|Withdrew Consent|0|||
19525067|NCT02607956|41970266|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
19525068|NCT02607956|41970267|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
19525069|NCT02607956|41970268|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
19525070|NCT02607956|41970265|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
19525071|NCT02607956|41970266|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
19525072|NCT02607956|41970267|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
19525073|NCT02607956|41970268|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
19525074|NCT02607956|41970265|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
19447147|NCT01752855|41695172|FG001|Overall Study|Withdrew Consent|2|||
19447148|NCT01752855|41695171|FG000|Overall Study|Lack of Efficacy|0|||
19447149|NCT01752855|41695172|FG001|Overall Study|Lack of Efficacy|2|||
19447150|NCT01402492|41695181|FG000|Overall Study|Withdrawal by Subject|17|||
19447151|NCT01402492|41695182|FG001|Overall Study|Withdrawal by Subject|11|||
19447152|NCT01402492|41695183|FG002|Overall Study|Withdrawal by Subject|11|||
19447153|NCT01402492|41695181|FG000|Overall Study|Adverse Event|2|||
19447154|NCT01402492|41695182|FG001|Overall Study|Adverse Event|3|||
19447155|NCT01402492|41695183|FG002|Overall Study|Adverse Event|4|||
19447156|NCT01402492|41695181|FG000|Overall Study|Physician Decision|0|||
19447157|NCT01402492|41695182|FG001|Overall Study|Physician Decision|3|||
19447158|NCT01402492|41695183|FG002|Overall Study|Physician Decision|0|||
19525075|NCT02607956|41970266|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
19447159|NCT01402492|41695181|FG000|Overall Study|Incarcerated (N=3)|2|||
19447160|NCT01402492|41695182|FG001|Overall Study|Incarcerated (N=3)|0|||
19447161|NCT01402492|41695183|FG002|Overall Study|Incarcerated (N=3)|1|||
19447162|NCT01402102|41695193|FG000|Overall Study|Protocol Violation|1|||
19447163|NCT01402102|41695194|FG001|Overall Study|Protocol Violation|0|||
19447164|NCT01402102|41695193|FG000|Overall Study|Insufficiency of compliance|1|||
19447165|NCT01402102|41695194|FG001|Overall Study|Insufficiency of compliance|1|||
19447166|NCT01402102|41695193|FG000|Overall Study|Withdrawal by Subject|0|||
19447167|NCT01402102|41695194|FG001|Overall Study|Withdrawal by Subject|2|||
19447168|NCT01423084|41695204|FG000|Overall Study|Adverse Event|0|||
19525076|NCT02607956|41970267|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
19447169|NCT01423084|41695205|FG001|Overall Study|Adverse Event|1|||
19447170|NCT01423084|41695204|FG000|Overall Study|Withdrawal by Subject|2|||
19447171|NCT01423084|41695205|FG001|Overall Study|Withdrawal by Subject|3|||
19447172|NCT01894256|41695215|FG000|Part A|Adverse Event|0|||
19447173|NCT01894256|41695216|FG001|Part A|Adverse Event|1|||
19447174|NCT01894256|41695217|FG002|Part A|Adverse Event|0|||
19447175|NCT01894256|41695215|FG000|Part B|Death|0|||
19447176|NCT01894256|41695216|FG001|Part B|Death|1|||
19447177|NCT01894256|41695217|FG002|Part B|Death|1|||
19447178|NCT01894256|41695215|FG000|Part B|Withdrawal by Subject|0|||
19447179|NCT01894256|41695216|FG001|Part B|Withdrawal by Subject|1|||
19447180|NCT01894256|41695217|FG002|Part B|Withdrawal by Subject|0|||
19447181|NCT01894256|41695215|FG000|Part B|Lack of Efficacy|15|||
19447182|NCT01894256|41695216|FG001|Part B|Lack of Efficacy|12|||
19447183|NCT01894256|41695217|FG002|Part B|Lack of Efficacy|13|||
19447184|NCT01780935|41695230|FG000|Overall Study|Admin problems due to early termination|321|||
19525077|NCT02607956|41970268|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
19525078|NCT02607956|41970265|FG000|Open-Label Extension Phase|Death|0|||
19525079|NCT02607956|41970266|FG001|Open-Label Extension Phase|Death|0|||
19525080|NCT02607956|41970267|FG002|Open-Label Extension Phase|Death|1|||
19525081|NCT02607956|41970268|FG003|Open-Label Extension Phase|Death|3|||
19525082|NCT02607956|41970265|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
19525083|NCT02607956|41970266|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
19525084|NCT02607956|41970267|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
19525085|NCT02607956|41970268|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
19525086|NCT02607956|41970265|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
19525087|NCT02607956|41970266|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
19525088|NCT02607956|41970267|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
19525089|NCT02607956|41970268|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
19525090|NCT02607956|41970265|FG000|Open-Label Extension Phase|Protocol Violation|0|||
19525091|NCT02607956|41970266|FG001|Open-Label Extension Phase|Protocol Violation|0|||
19525092|NCT02607956|41970267|FG002|Open-Label Extension Phase|Protocol Violation|0|||
19525093|NCT02607956|41970268|FG003|Open-Label Extension Phase|Protocol Violation|2|||
19525094|NCT02607956|41970265|FG000|Open-Label Extension Phase|Pregnancy|0|||
19525095|NCT02607956|41970266|FG001|Open-Label Extension Phase|Pregnancy|0|||
19525096|NCT02607956|41970267|FG002|Open-Label Extension Phase|Pregnancy|0|||
19525097|NCT02607956|41970268|FG003|Open-Label Extension Phase|Pregnancy|1|||
19525098|NCT02564523|41970298|FG000|Overall Study|Withdrawal by Subject|3|||
19525099|NCT02564523|41970299|FG001|Overall Study|Withdrawal by Subject|0|||
19525100|NCT02564523|41970300|FG002|Overall Study|Withdrawal by Subject|1|||
19525101|NCT02564523|41970301|FG003|Overall Study|Withdrawal by Subject|0|||
19525102|NCT02564523|41970302|FG004|Overall Study|Withdrawal by Subject|1|||
19525103|NCT02564523|41970303|FG005|Overall Study|Withdrawal by Subject|0|||
19525104|NCT02564523|41970304|FG006|Overall Study|Withdrawal by Subject|1|||
19525105|NCT02564523|41970305|FG007|Overall Study|Withdrawal by Subject|0|||
19525106|NCT02564523|41970306|FG008|Overall Study|Withdrawal by Subject|0|||
19525107|NCT02564523|41970307|FG009|Overall Study|Withdrawal by Subject|0|||
19525108|NCT02564523|41970308|FG010|Overall Study|Withdrawal by Subject|1|||
19525109|NCT02564523|41970309|FG011|Overall Study|Withdrawal by Subject|0|||
19525110|NCT02564523|41970310|FG012|Overall Study|Withdrawal by Subject|1|||
19525111|NCT02564523|41970311|FG013|Overall Study|Withdrawal by Subject|0|||
19525112|NCT02564523|41970312|FG014|Overall Study|Withdrawal by Subject|0|||
19525113|NCT02564523|41970313|FG015|Overall Study|Withdrawal by Subject|0|||
19525114|NCT02564523|41970314|FG016|Overall Study|Withdrawal by Subject|0|||
19525115|NCT02564523|41970315|FG017|Overall Study|Withdrawal by Subject|0|||
19447185|NCT01780935|41695231|FG001|Overall Study|Admin problems due to early termination|309|||
19447186|NCT01780935|41695230|FG000|Overall Study|Adverse Event|2|||
19447187|NCT01780935|41695231|FG001|Overall Study|Adverse Event|4|||
19447188|NCT01780935|41695230|FG000|Overall Study|Death|1|||
19447189|NCT01780935|41695231|FG001|Overall Study|Death|6|||
19447190|NCT01780935|41695230|FG000|Overall Study|Lost to Follow-up|2|||
19447191|NCT01780935|41695231|FG001|Overall Study|Lost to Follow-up|6|||
19525116|NCT02564523|41970298|FG000|Overall Study|Adverse Event|0|||
19525117|NCT02564523|41970299|FG001|Overall Study|Adverse Event|0|||
19525118|NCT02564523|41970300|FG002|Overall Study|Adverse Event|0|||
19447192|NCT01780935|41695230|FG000|Overall Study|Physician Decision|1|||
19447193|NCT01780935|41695231|FG001|Overall Study|Physician Decision|1|||
19447194|NCT01780935|41695230|FG000|Overall Study|Protocol deviation|0|||
19447195|NCT01780935|41695231|FG001|Overall Study|Protocol deviation|1|||
19447196|NCT01780935|41695230|FG000|Overall Study|Patient withdrew consent|8|||
19447197|NCT01780935|41695231|FG001|Overall Study|Patient withdrew consent|9|||
19447198|NCT01894100|41695239|FG000|Overall Study|Lost to Follow-up|0|||
19447199|NCT01894100|41695240|FG001|Overall Study|Lost to Follow-up|1|||
19447200|NCT01894100|41695239|FG000|Overall Study|Withdrawal by Subject|3|||
19447201|NCT01894100|41695240|FG001|Overall Study|Withdrawal by Subject|0|||
19447202|NCT01401478|41695286|FG000|Overall Study|Study drug not available|6|||
19447203|NCT01401478|41695286|FG000|Overall Study|Adverse Event|5|||
19447204|NCT01401478|41695286|FG000|Overall Study|Hyperphosphatemia|5|||
19447205|NCT01401478|41695286|FG000|Overall Study|Lost to Follow-up|5|||
19447206|NCT01401478|41695286|FG000|Overall Study|Kidney transplantation|3|||
19447207|NCT01401478|41695286|FG000|Overall Study|Withdrawal by Subject|3|||
19447208|NCT01401478|41695286|FG000|Overall Study|Blood samples not available|1|||
19447209|NCT01401478|41695286|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
19447210|NCT01401478|41695286|FG000|Overall Study|Low intact parathyroid hormone|1|||
19447211|NCT01401478|41695286|FG000|Overall Study|Serious adverse event|1|||
19447212|NCT01422850|41695290|FG000|Overall Study|Physician Decision|3|||
19447213|NCT01422538|41695299|FG000|Overall Study|Lost to Follow-up|0|||
19447214|NCT01422538|41695300|FG001|Overall Study|Lost to Follow-up|1|||
19447215|NCT01422538|41695301|FG002|Overall Study|Lost to Follow-up|1|||
19447216|NCT01422538|41695299|FG000|Overall Study|Missed visit|0|||
19447217|NCT01422538|41695300|FG001|Overall Study|Missed visit|1|||
19447218|NCT01422538|41695301|FG002|Overall Study|Missed visit|1|||
19447219|NCT01422382|41695310|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
19447220|NCT01401322|41695314|FG000|Overall Study|Withdrawal by Subject|1|||
19447221|NCT01401322|41695314|FG000|Overall Study|Physician Decision|1|||
19447222|NCT01387594|41695320|FG000|Overall Study|Withdrawal by Subject|0|||
19447223|NCT01387594|41695321|FG001|Overall Study|Withdrawal by Subject|2|||
19447224|NCT01387594|41695320|FG000|Overall Study|Lost to Follow-up|0|||
19447225|NCT01387594|41695321|FG001|Overall Study|Lost to Follow-up|1|||
19447226|NCT01401010|41695332|FG000|Overall Study|Could not interpret assay results|1|||
19525119|NCT02564523|41970301|FG003|Overall Study|Adverse Event|0|||
19525120|NCT02564523|41970302|FG004|Overall Study|Adverse Event|0|||
19525121|NCT02564523|41970303|FG005|Overall Study|Adverse Event|0|||
19525122|NCT02564523|41970304|FG006|Overall Study|Adverse Event|0|||
19525123|NCT02564523|41970305|FG007|Overall Study|Adverse Event|0|||
19525124|NCT02564523|41970306|FG008|Overall Study|Adverse Event|0|||
19525125|NCT02564523|41970307|FG009|Overall Study|Adverse Event|0|||
19525126|NCT02564523|41970308|FG010|Overall Study|Adverse Event|0|||
19525127|NCT02564523|41970309|FG011|Overall Study|Adverse Event|0|||
19525128|NCT02564523|41970310|FG012|Overall Study|Adverse Event|0|||
19525129|NCT02564523|41970311|FG013|Overall Study|Adverse Event|0|||
19525130|NCT02564523|41970312|FG014|Overall Study|Adverse Event|0|||
19525131|NCT02564523|41970313|FG015|Overall Study|Adverse Event|0|||
19525132|NCT02564523|41970314|FG016|Overall Study|Adverse Event|0|||
19525133|NCT02564523|41970315|FG017|Overall Study|Adverse Event|1|||
19629117|NCT00642460|42078694|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
19629118|NCT00642460|42078695|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
19629119|NCT00642460|42078696|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
19629120|NCT00642460|42078697|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
19525134|NCT02564523|41970298|FG000|Overall Study|Death|0|||
19525135|NCT02564523|41970299|FG001|Overall Study|Death|0|||
19525136|NCT02564523|41970300|FG002|Overall Study|Death|0|||
19525137|NCT02564523|41970301|FG003|Overall Study|Death|0|||
19525138|NCT02564523|41970302|FG004|Overall Study|Death|0|||
19525139|NCT02564523|41970303|FG005|Overall Study|Death|0|||
19629121|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
19629122|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
19629123|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
19629124|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
19629125|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
19629126|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
19525140|NCT02564523|41970304|FG006|Overall Study|Death|1|||
19525141|NCT02564523|41970305|FG007|Overall Study|Death|0|||
19525142|NCT02564523|41970306|FG008|Overall Study|Death|0|||
19525143|NCT02564523|41970307|FG009|Overall Study|Death|0|||
19629127|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Death|0|||
19447227|NCT01401010|41695333|FG001|Overall Study|Could not interpret assay results|0|||
19447228|NCT01400932|41695346|FG000|Overall Study|Adverse Event|10|||
19447229|NCT01400932|41695347|FG001|Overall Study|Adverse Event|5|||
19447230|NCT01400932|41695346|FG000|Overall Study|Lack of Efficacy|0|||
19447231|NCT01400932|41695347|FG001|Overall Study|Lack of Efficacy|3|||
19525144|NCT02564523|41970308|FG010|Overall Study|Death|1|||
19525145|NCT02564523|41970309|FG011|Overall Study|Death|0|||
19525146|NCT02564523|41970310|FG012|Overall Study|Death|0|||
19525147|NCT02564523|41970311|FG013|Overall Study|Death|0|||
19525148|NCT02564523|41970312|FG014|Overall Study|Death|0|||
19525149|NCT02564523|41970313|FG015|Overall Study|Death|0|||
19525150|NCT02564523|41970314|FG016|Overall Study|Death|0|||
19525151|NCT02564523|41970315|FG017|Overall Study|Death|0|||
19525152|NCT02564523|41970298|FG000|Overall Study|Lost to Follow-up|2|||
19525153|NCT02564523|41970299|FG001|Overall Study|Lost to Follow-up|1|||
19525154|NCT02564523|41970300|FG002|Overall Study|Lost to Follow-up|4|||
19525155|NCT02564523|41970301|FG003|Overall Study|Lost to Follow-up|0|||
19525156|NCT02564523|41970302|FG004|Overall Study|Lost to Follow-up|1|||
19525157|NCT02564523|41970303|FG005|Overall Study|Lost to Follow-up|0|||
19525158|NCT02564523|41970304|FG006|Overall Study|Lost to Follow-up|1|||
19525159|NCT02564523|41970305|FG007|Overall Study|Lost to Follow-up|0|||
19525160|NCT02564523|41970306|FG008|Overall Study|Lost to Follow-up|0|||
19525161|NCT02564523|41970307|FG009|Overall Study|Lost to Follow-up|0|||
19525162|NCT02564523|41970308|FG010|Overall Study|Lost to Follow-up|0|||
19525163|NCT02564523|41970309|FG011|Overall Study|Lost to Follow-up|1|||
19525164|NCT02564523|41970310|FG012|Overall Study|Lost to Follow-up|1|||
19525165|NCT02564523|41970311|FG013|Overall Study|Lost to Follow-up|0|||
19525166|NCT02564523|41970312|FG014|Overall Study|Lost to Follow-up|0|||
19525167|NCT02564523|41970313|FG015|Overall Study|Lost to Follow-up|0|||
19525168|NCT02564523|41970314|FG016|Overall Study|Lost to Follow-up|0|||
19525169|NCT02564523|41970315|FG017|Overall Study|Lost to Follow-up|0|||
19447232|NCT01400932|41695346|FG000|Overall Study|Withdrawal by Subject|2|||
19447233|NCT01400932|41695347|FG001|Overall Study|Withdrawal by Subject|6|||
19447234|NCT01400932|41695346|FG000|Overall Study|Lost to Follow-up|1|||
19447235|NCT01400932|41695347|FG001|Overall Study|Lost to Follow-up|0|||
19447236|NCT01400932|41695346|FG000|Overall Study|Protocol Deviation|0|||
19447237|NCT01400932|41695347|FG001|Overall Study|Protocol Deviation|1|||
19525170|NCT02564523|41970298|FG000|Overall Study|Physician Decision|0|||
19447238|NCT01400932|41695346|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19447239|NCT01400932|41695347|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19525171|NCT02564523|41970299|FG001|Overall Study|Physician Decision|0|||
19525172|NCT02564523|41970300|FG002|Overall Study|Physician Decision|0|||
19525173|NCT02564523|41970301|FG003|Overall Study|Physician Decision|0|||
19525174|NCT02564523|41970302|FG004|Overall Study|Physician Decision|1|||
19447240|NCT01400698|41695357|FG000|Overall Study|Lost to Follow-up|2|||
19447241|NCT01400698|41695358|FG001|Overall Study|Lost to Follow-up|5|||
19525175|NCT02564523|41970303|FG005|Overall Study|Physician Decision|0|||
19525176|NCT02564523|41970304|FG006|Overall Study|Physician Decision|0|||
19525177|NCT02564523|41970305|FG007|Overall Study|Physician Decision|0|||
19525178|NCT02564523|41970306|FG008|Overall Study|Physician Decision|0|||
19525179|NCT02564523|41970307|FG009|Overall Study|Physician Decision|0|||
19525180|NCT02564523|41970308|FG010|Overall Study|Physician Decision|1|||
19525181|NCT02564523|41970309|FG011|Overall Study|Physician Decision|0|||
19525182|NCT02564523|41970310|FG012|Overall Study|Physician Decision|0|||
19525183|NCT02564523|41970311|FG013|Overall Study|Physician Decision|0|||
19525184|NCT02564523|41970312|FG014|Overall Study|Physician Decision|0|||
19447242|NCT01400698|41695359|FG002|Overall Study|Lost to Follow-up|2|||
19447243|NCT01400698|41695360|FG003|Overall Study|Lost to Follow-up|1|||
19447244|NCT01400698|41695361|FG004|Overall Study|Lost to Follow-up|4|||
19447245|NCT01400698|41695362|FG005|Overall Study|Lost to Follow-up|3|||
19525185|NCT02564523|41970313|FG015|Overall Study|Physician Decision|0|||
19525186|NCT02564523|41970314|FG016|Overall Study|Physician Decision|0|||
19447246|NCT01400698|41695357|FG000|Overall Study|Withdrawal by Subject|8|||
19447247|NCT01400698|41695358|FG001|Overall Study|Withdrawal by Subject|2|||
19525187|NCT02564523|41970315|FG017|Overall Study|Physician Decision|0|||
19525188|NCT02564523|41970298|FG000|Overall Study|Protocol Violation|2|||
19525189|NCT02564523|41970299|FG001|Overall Study|Protocol Violation|2|||
19525190|NCT02564523|41970300|FG002|Overall Study|Protocol Violation|5|||
19525191|NCT02564523|41970301|FG003|Overall Study|Protocol Violation|0|||
19447248|NCT01400698|41695359|FG002|Overall Study|Withdrawal by Subject|0|||
19447249|NCT01400698|41695360|FG003|Overall Study|Withdrawal by Subject|4|||
19525192|NCT02564523|41970302|FG004|Overall Study|Protocol Violation|1|||
19525193|NCT02564523|41970303|FG005|Overall Study|Protocol Violation|0|||
19525194|NCT02564523|41970304|FG006|Overall Study|Protocol Violation|0|||
19525195|NCT02564523|41970305|FG007|Overall Study|Protocol Violation|0|||
19525196|NCT02564523|41970306|FG008|Overall Study|Protocol Violation|0|||
19525197|NCT02564523|41970307|FG009|Overall Study|Protocol Violation|0|||
19525198|NCT02564523|41970308|FG010|Overall Study|Protocol Violation|0|||
19525199|NCT02564523|41970309|FG011|Overall Study|Protocol Violation|0|||
19525200|NCT02564523|41970310|FG012|Overall Study|Protocol Violation|0|||
19525201|NCT02564523|41970311|FG013|Overall Study|Protocol Violation|0|||
19525202|NCT02564523|41970312|FG014|Overall Study|Protocol Violation|0|||
19447250|NCT01400698|41695361|FG004|Overall Study|Withdrawal by Subject|1|||
19447251|NCT01400698|41695362|FG005|Overall Study|Withdrawal by Subject|3|||
19447252|NCT01400698|41695357|FG000|Overall Study|Protocol Violation|0|||
19525203|NCT02564523|41970313|FG015|Overall Study|Protocol Violation|0|||
19525204|NCT02564523|41970314|FG016|Overall Study|Protocol Violation|0|||
19525205|NCT02564523|41970315|FG017|Overall Study|Protocol Violation|0|||
19525206|NCT02564523|41970298|FG000|Overall Study|Other|3|||
19525207|NCT02564523|41970299|FG001|Overall Study|Other|0|||
19525208|NCT02564523|41970300|FG002|Overall Study|Other|0|||
19447253|NCT01400698|41695358|FG001|Overall Study|Protocol Violation|1|||
19525209|NCT02564523|41970301|FG003|Overall Study|Other|1|||
19447254|NCT01400698|41695359|FG002|Overall Study|Protocol Violation|0|||
19447255|NCT01400698|41695360|FG003|Overall Study|Protocol Violation|0|||
19447256|NCT01400698|41695361|FG004|Overall Study|Protocol Violation|1|||
19447257|NCT01400698|41695362|FG005|Overall Study|Protocol Violation|0|||
19447258|NCT01400698|41695357|FG000|Overall Study|Non-compliance|0|||
19447259|NCT01400698|41695358|FG001|Overall Study|Non-compliance|1|||
19447260|NCT01400698|41695359|FG002|Overall Study|Non-compliance|0|||
19447261|NCT01400698|41695360|FG003|Overall Study|Non-compliance|1|||
19447262|NCT01400698|41695361|FG004|Overall Study|Non-compliance|0|||
19447263|NCT01400698|41695362|FG005|Overall Study|Non-compliance|0|||
19447264|NCT01400698|41695357|FG000|Overall Study|Adverse Event|1|||
19447265|NCT01400698|41695358|FG001|Overall Study|Adverse Event|0|||
19447266|NCT01400698|41695359|FG002|Overall Study|Adverse Event|0|||
19447267|NCT01400698|41695360|FG003|Overall Study|Adverse Event|0|||
19447268|NCT01400698|41695361|FG004|Overall Study|Adverse Event|0|||
19447269|NCT01400698|41695362|FG005|Overall Study|Adverse Event|0|||
19447270|NCT01400698|41695357|FG000|Overall Study|Other|4|||
19447271|NCT01400698|41695358|FG001|Overall Study|Other|2|||
19447272|NCT01400698|41695359|FG002|Overall Study|Other|0|||
19447273|NCT01400698|41695360|FG003|Overall Study|Other|2|||
19447274|NCT01400698|41695361|FG004|Overall Study|Other|1|||
19447275|NCT01400698|41695362|FG005|Overall Study|Other|0|||
19447276|NCT01890746|41695374|FG000|Overall Study|Death|39|||
19447277|NCT01890746|41695375|FG001|Overall Study|Death|30|||
19525210|NCT02564523|41970302|FG004|Overall Study|Other|0|||
19525211|NCT02564523|41970303|FG005|Overall Study|Other|0|||
19525212|NCT02564523|41970304|FG006|Overall Study|Other|0|||
19525213|NCT02564523|41970305|FG007|Overall Study|Other|0|||
19525214|NCT02564523|41970306|FG008|Overall Study|Other|0|||
19525215|NCT02564523|41970307|FG009|Overall Study|Other|0|||
19525216|NCT02564523|41970308|FG010|Overall Study|Other|0|||
19525217|NCT02564523|41970309|FG011|Overall Study|Other|0|||
19525218|NCT02564523|41970310|FG012|Overall Study|Other|0|||
19525219|NCT02564523|41970311|FG013|Overall Study|Other|0|||
19525220|NCT02564523|41970312|FG014|Overall Study|Other|0|||
19525221|NCT02564523|41970313|FG015|Overall Study|Other|0|||
19525222|NCT02564523|41970314|FG016|Overall Study|Other|0|||
19525223|NCT02564523|41970315|FG017|Overall Study|Other|0|||
19525224|NCT01447628|41970422|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
19525225|NCT01447628|41970423|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
19525226|NCT01447628|41970424|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
19525227|NCT01447628|41970425|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
19525228|NCT00515853|41970447|FG000|Overall Study|Lost to Follow-up|9|||
19525229|NCT00515853|41970448|FG001|Overall Study|Lost to Follow-up|13|||
19525230|NCT00515853|41970447|FG000|Overall Study|Withdrawal by Subject|6|||
19525231|NCT00515853|41970448|FG001|Overall Study|Withdrawal by Subject|4|||
19525232|NCT00003458|41970454|FG000|Overall Study|Not evaluable|4|||
19525233|NCT04613739|41970479|FG000|Overall Study|Lost to Follow-up|6|||
19525234|NCT04613739|41970480|FG001|Overall Study|Lost to Follow-up|9|||
19525235|NCT04613739|41970479|FG000|Overall Study|potentially duplicative/fraudulent|1|||
19525236|NCT04613739|41970480|FG001|Overall Study|potentially duplicative/fraudulent|3|||
19525237|NCT04573972|41970488|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
19525238|NCT04573972|41970489|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
19525239|NCT04407806|41970516|FG000|Overall Study|Withdrawal by Subject|1|||
19629128|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Death|1|||
19629129|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Death|0|||
19629130|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Death|2|||
19629131|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Death|0|||
19447278|NCT01890746|41695374|FG000|Overall Study|Adverse Event|1|||
19525240|NCT04407806|41970517|FG001|Overall Study|Withdrawal by Subject|2|||
19525241|NCT04324021|41970526|FG000|Overall Study|Adverse Event|1|||
19525242|NCT04324021|41970527|FG001|Overall Study|Adverse Event|0|||
19525243|NCT04324021|41970528|FG002|Overall Study|Adverse Event|0|||
19525244|NCT04324021|41970526|FG000|Overall Study|Lack of Efficacy|0|||
19525245|NCT04324021|41970527|FG001|Overall Study|Lack of Efficacy|0|||
19525246|NCT04324021|41970528|FG002|Overall Study|Lack of Efficacy|1|||
19447279|NCT01890746|41695375|FG001|Overall Study|Adverse Event|0|||
19447280|NCT01890746|41695374|FG000|Overall Study|Lost to Follow-up|4|||
19447281|NCT01890746|41695375|FG001|Overall Study|Lost to Follow-up|1|||
19447282|NCT01890746|41695374|FG000|Overall Study|Physician Decision|3|||
19447283|NCT01890746|41695375|FG001|Overall Study|Physician Decision|2|||
19447284|NCT01890746|41695374|FG000|Overall Study|Withdrawal by Subject|5|||
19447285|NCT01890746|41695375|FG001|Overall Study|Withdrawal by Subject|8|||
19447286|NCT01422304|41695383|FG000|Overall Study|Adverse Event|0|||
19525247|NCT04324021|41970526|FG000|Overall Study|Death|1|||
19525248|NCT04324021|41970527|FG001|Overall Study|Death|1|||
19525249|NCT04324021|41970528|FG002|Overall Study|Death|0|||
19525250|NCT04209621|41970539|FG000|Overall Study|Death|1|||
19525251|NCT04209621|41970539|FG000|Overall Study|Study Terminated Early|2|||
19525252|NCT04186663|41970544|FG000|Overall Study|Lost to Follow-up|1|||
19525253|NCT04186663|41970544|FG000|Overall Study|Unable to complete blood draw|3|||
19525254|NCT04158219|41970548|FG000|Overall Study|Lost to Follow-up|1|||
19447287|NCT01422304|41695384|FG001|Overall Study|Adverse Event|1|||
19447288|NCT01422304|41695383|FG000|Overall Study|Lost to Follow-up|14|||
19447289|NCT01422304|41695384|FG001|Overall Study|Lost to Follow-up|20|||
19447290|NCT01422304|41695383|FG000|Overall Study|Never Entered Follow-up|2|||
19525255|NCT03954743|41970581|FG000|Overall Study|Adverse Event|1|||
19525256|NCT03954743|41970582|FG001|Overall Study|Adverse Event|0|||
19525257|NCT03954743|41970581|FG000|Overall Study|Lost to Follow-up|6|||
19525258|NCT03954743|41970582|FG001|Overall Study|Lost to Follow-up|4|||
19525259|NCT03954743|41970581|FG000|Overall Study|Protocol Violation|1|||
19447291|NCT01422304|41695384|FG001|Overall Study|Never Entered Follow-up|1|||
19447292|NCT01422304|41695383|FG000|Overall Study|Protocol Violation|1|||
19447293|NCT01422304|41695384|FG001|Overall Study|Protocol Violation|0|||
19447294|NCT01422304|41695383|FG000|Overall Study|Withdrawal by Subject|4|||
19447295|NCT01422304|41695384|FG001|Overall Study|Withdrawal by Subject|2|||
19447296|NCT01422304|41695383|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
19525260|NCT03954743|41970582|FG001|Overall Study|Protocol Violation|0|||
19525261|NCT03954743|41970581|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
19525262|NCT03954743|41970582|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
19525263|NCT03954743|41970581|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
19525264|NCT03954743|41970582|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19525265|NCT03880565|41970603|FG000|Overall Study|Withdrawal by Subject|1|||
19525266|NCT03880565|41970604|FG001|Overall Study|Withdrawal by Subject|0|||
19525267|NCT03782792|41970612|FG000|Overall Study|Patient left the country|0|||
19525268|NCT03782792|41970613|FG001|Overall Study|Patient left the country|1|||
19525269|NCT03782792|41970612|FG000|Overall Study|Withdrawal by Subject|1|||
19525270|NCT03782792|41970613|FG001|Overall Study|Withdrawal by Subject|2|||
19525271|NCT03733119|41970623|FG000|Overall Study|Physician Decision|2|||
19525272|NCT03733119|41970624|FG001|Overall Study|Physician Decision|1|||
19525273|NCT03733119|41970623|FG000|Overall Study|ineligible to treat per protocol|0|||
19525274|NCT03733119|41970624|FG001|Overall Study|ineligible to treat per protocol|1|||
19525275|NCT03661996|41970635|FG000|Overall Study|Adverse Event|0|||
19525276|NCT03661996|41970636|FG001|Overall Study|Adverse Event|0|||
19525277|NCT03661996|41970637|FG002|Overall Study|Adverse Event|1|||
19525278|NCT03661996|41970638|FG003|Overall Study|Adverse Event|1|||
19525279|NCT03661996|41970639|FG004|Overall Study|Adverse Event|0|||
19525280|NCT03661996|41970635|FG000|Overall Study|Lost to Follow-up|5|||
19525281|NCT03661996|41970636|FG001|Overall Study|Lost to Follow-up|1|||
19525282|NCT03661996|41970637|FG002|Overall Study|Lost to Follow-up|2|||
19525283|NCT03661996|41970638|FG003|Overall Study|Lost to Follow-up|2|||
19525284|NCT03661996|41970639|FG004|Overall Study|Lost to Follow-up|6|||
19525285|NCT03661996|41970635|FG000|Overall Study|Physician Decision|1|||
19525286|NCT03661996|41970636|FG001|Overall Study|Physician Decision|1|||
19525287|NCT03661996|41970637|FG002|Overall Study|Physician Decision|1|||
19525288|NCT03661996|41970638|FG003|Overall Study|Physician Decision|2|||
19525289|NCT03661996|41970639|FG004|Overall Study|Physician Decision|0|||
19525290|NCT03661996|41970635|FG000|Overall Study|Protocol Violation|0|||
19525291|NCT03661996|41970636|FG001|Overall Study|Protocol Violation|0|||
19525292|NCT03661996|41970637|FG002|Overall Study|Protocol Violation|0|||
19525293|NCT03661996|41970638|FG003|Overall Study|Protocol Violation|0|||
19525294|NCT03661996|41970639|FG004|Overall Study|Protocol Violation|1|||
19525295|NCT03661996|41970635|FG000|Overall Study|Withdrawal by Subject|3|||
19525296|NCT03661996|41970636|FG001|Overall Study|Withdrawal by Subject|5|||
19525297|NCT03661996|41970637|FG002|Overall Study|Withdrawal by Subject|1|||
19525298|NCT03661996|41970638|FG003|Overall Study|Withdrawal by Subject|7|||
19525299|NCT03661996|41970639|FG004|Overall Study|Withdrawal by Subject|7|||
19525300|NCT03661996|41970635|FG000|Overall Study|Sponsors Decision|2|||
19525301|NCT03661996|41970636|FG001|Overall Study|Sponsors Decision|0|||
19525302|NCT03661996|41970637|FG002|Overall Study|Sponsors Decision|0|||
19525303|NCT03661996|41970638|FG003|Overall Study|Sponsors Decision|0|||
19525304|NCT03661996|41970639|FG004|Overall Study|Sponsors Decision|0|||
19525305|NCT03661996|41970635|FG000|Overall Study|Other|1|||
19525306|NCT03661996|41970636|FG001|Overall Study|Other|1|||
19525307|NCT03661996|41970637|FG002|Overall Study|Other|1|||
19525308|NCT03661996|41970638|FG003|Overall Study|Other|1|||
19525309|NCT03661996|41970639|FG004|Overall Study|Other|0|||
19525310|NCT03633461|41970656|FG000|Overall Study|Lost to Follow-up|0|||
19525311|NCT03633461|41970657|FG001|Overall Study|Lost to Follow-up|1|||
19525312|NCT03499314|41970685|FG000|Overall Study|Time Commitment|1|||
19447297|NCT01422304|41695384|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
19447298|NCT01422304|41695383|FG000|Overall Study|Not Treated|3|||
19447299|NCT01422304|41695384|FG001|Overall Study|Not Treated|11|||
19447300|NCT01387516|41695394|FG000|Overall Study|Lost to Follow-up|4|||
19525313|NCT03499314|41970686|FG001|Overall Study|Time Commitment|2|||
19525314|NCT03499314|41970685|FG000|Overall Study|Medical issue unrelated to research study|1|||
19525315|NCT03499314|41970686|FG001|Overall Study|Medical issue unrelated to research study|1|||
19525316|NCT03439124|41970694|FG000|Overall Study|Adverse Event|2|||
19525317|NCT03439124|41970695|FG001|Overall Study|Adverse Event|0|||
19525318|NCT03439124|41970694|FG000|Overall Study|Lost to Follow-up|1|||
19525319|NCT03439124|41970695|FG001|Overall Study|Lost to Follow-up|0|||
19525320|NCT03439124|41970694|FG000|Overall Study|Other reasons|1|||
19525321|NCT03439124|41970695|FG001|Overall Study|Other reasons|0|||
19525322|NCT03369431|41970703|FG000|Overall Study|Lost to Follow-up|1|||
19525323|NCT03369431|41970704|FG001|Overall Study|Lost to Follow-up|3|||
19525324|NCT03369431|41970703|FG000|Overall Study|Withdrawal by Subject|2|||
19525325|NCT03369431|41970704|FG001|Overall Study|Withdrawal by Subject|3|||
19525326|NCT03369431|41970703|FG000|Overall Study|Protocol Violation|1|||
19525327|NCT03369431|41970704|FG001|Overall Study|Protocol Violation|1|||
19525328|NCT03336866|41970713|FG000|Overall Study|Lost to Follow-up|2|||
19525329|NCT03336866|41970714|FG001|Overall Study|Lost to Follow-up|0|||
19525330|NCT03336866|41970715|FG002|Overall Study|Lost to Follow-up|3|||
19447301|NCT01387516|41695395|FG001|Overall Study|Lost to Follow-up|4|||
19447302|NCT01387516|41695396|FG002|Overall Study|Lost to Follow-up|2|||
19447303|NCT01387516|41695397|FG003|Overall Study|Lost to Follow-up|3|||
19447304|NCT01387516|41695394|FG000|Overall Study|Withdrawal by Subject|1|||
19447305|NCT01387516|41695395|FG001|Overall Study|Withdrawal by Subject|1|||
19447306|NCT01387516|41695396|FG002|Overall Study|Withdrawal by Subject|2|||
19447307|NCT01387516|41695397|FG003|Overall Study|Withdrawal by Subject|0|||
19447308|NCT01387516|41695394|FG000|Overall Study|Death|0|||
19525331|NCT03336866|41970713|FG000|Overall Study|Withdrawal by Subject|1|||
19525332|NCT03336866|41970714|FG001|Overall Study|Withdrawal by Subject|1|||
19525333|NCT03336866|41970715|FG002|Overall Study|Withdrawal by Subject|0|||
19525334|NCT03336866|41970713|FG000|Overall Study|Noncompliance with clinic house rules|0|||
19525335|NCT03336866|41970714|FG001|Overall Study|Noncompliance with clinic house rules|0|||
19525336|NCT03336866|41970715|FG002|Overall Study|Noncompliance with clinic house rules|1|||
19525337|NCT03332173|41970728|FG000|Overall Study|Death|7|||
19525338|NCT03332173|41970728|FG000|Overall Study|Withdrawal by Subject|6|||
19525339|NCT03332173|41970728|FG000|Overall Study|Lost to Follow-up|2|||
19447309|NCT01387516|41695395|FG001|Overall Study|Death|0|||
19447310|NCT01387516|41695396|FG002|Overall Study|Death|0|||
19447311|NCT01387516|41695397|FG003|Overall Study|Death|1|||
19447312|NCT01421134|41695418|FG000|Overall Study|Adverse Event|3|||
19447313|NCT01421134|41695419|FG001|Overall Study|Adverse Event|5|||
19447314|NCT01421134|41695418|FG000|Overall Study|Lack of Efficacy|2|||
19447315|NCT01421134|41695419|FG001|Overall Study|Lack of Efficacy|4|||
19447316|NCT01421134|41695418|FG000|Overall Study|Protocol Violation|0|||
19447317|NCT01421134|41695419|FG001|Overall Study|Protocol Violation|3|||
19447318|NCT01421134|41695418|FG000|Overall Study|Withdrawal by Subject|1|||
19525340|NCT03332173|41970728|FG000|Overall Study|Transferred to long-term extension study|29|||
19525341|NCT03322293|41970735|FG000|Overall Study|Lost to Follow-up|0|||
19525342|NCT03322293|41970736|FG001|Overall Study|Lost to Follow-up|0|||
19525343|NCT03322293|41970737|FG002|Overall Study|Lost to Follow-up|1|||
19525344|NCT03254394|41970759|FG000|Overall Study|Withdrawal by Subject|0|||
19447319|NCT01421134|41695419|FG001|Overall Study|Withdrawal by Subject|1|||
19447320|NCT01421134|41695418|FG000|Overall Study|Administrative|0|||
19447321|NCT01421134|41695419|FG001|Overall Study|Administrative|1|||
19447322|NCT01421134|41695418|FG000|Overall Study|Lost to Follow-up|1|||
19447323|NCT01421134|41695419|FG001|Overall Study|Lost to Follow-up|1|||
19447324|NCT01894022|41695427|FG000|Overall Study|Death|1|||
19447325|NCT01894022|41695428|FG001|Overall Study|Death|0|||
19447326|NCT01894022|41695427|FG000|Overall Study|Adverse Event, non-fatal|1|||
19447327|NCT01894022|41695428|FG001|Overall Study|Adverse Event, non-fatal|0|||
19447328|NCT01894022|41695427|FG000|Overall Study|Study Closed/terminated|7|||
19447329|NCT01894022|41695428|FG001|Overall Study|Study Closed/terminated|10|||
19447330|NCT01615328|41695437|FG000|Overall Study|Lost to Follow-up|3|||
19447331|NCT01615328|41695438|FG001|Overall Study|Lost to Follow-up|5|||
19447332|NCT01890512|41695448|FG000|Overall Study|Physician Decision|1|||
19447333|NCT01890512|41695448|FG000|Overall Study|Withdrawal by Subject|1|||
19525345|NCT03254394|41970760|FG001|Overall Study|Withdrawal by Subject|2|||
19447334|NCT01890512|41695448|FG000|Overall Study|Protocol Violation|1|||
19447335|NCT01387282|41695454|FG000|Overall Study|Death|47|||
19447336|NCT01387282|41695455|FG001|Overall Study|Death|16|||
19447337|NCT01387282|41695454|FG000|Overall Study|Other|5|||
19447338|NCT01387282|41695455|FG001|Overall Study|Other|1|||
19447339|NCT01387282|41695454|FG000|Overall Study|Unrelated AE|6|||
19447340|NCT01387282|41695455|FG001|Overall Study|Unrelated AE|4|||
19447341|NCT01387282|41695454|FG000|Overall Study|Withdrawal by patient|33|||
19447342|NCT01387282|41695455|FG001|Overall Study|Withdrawal by patient|23|||
19447343|NCT01387282|41695454|FG000|Overall Study|Study drug-related AE|2|||
19447344|NCT01387282|41695455|FG001|Overall Study|Study drug-related AE|2|||
19447345|NCT01387282|41695454|FG000|Overall Study|Lost to Follow-up|4|||
19447346|NCT01387282|41695455|FG001|Overall Study|Lost to Follow-up|1|||
19447347|NCT01386970|41695463|FG000|Overall Study|Withdrawal by Subject|0|||
19447348|NCT01386970|41695464|FG001|Overall Study|Withdrawal by Subject|1|||
19447349|NCT01386970|41695463|FG000|Overall Study|Adverse Event|4|||
19447350|NCT01386970|41695464|FG001|Overall Study|Adverse Event|1|||
19447351|NCT01890434|41695472|FG000|Overall Study|Adverse Event|8|||
19447352|NCT01890434|41695472|FG000|Overall Study|PCI at external hospital|1|||
19447353|NCT01890434|41695472|FG000|Overall Study|Assessment discrepancy|1|||
19447354|NCT01890434|41695472|FG000|Overall Study|CRC didn't contact participant for FU|1|||
19447355|NCT01890434|41695472|FG000|Overall Study|Could not get whole set of images|1|||
19447356|NCT01890434|41695472|FG000|Overall Study|Decline to return for GSPECT|1|||
19447357|NCT01890434|41695472|FG000|Overall Study|GSPECT at rest was not done|1|||
19447358|NCT01890434|41695472|FG000|Overall Study|Participant didn't complete MRI|1|||
19447359|NCT01890434|41695472|FG000|Overall Study|Uncontactable by phone|1|||
19447360|NCT01890434|41695472|FG000|Overall Study|Moved out of position|1|||
19447361|NCT01890434|41695472|FG000|Overall Study|Unable to contact|1|||
19447362|NCT01890434|41695472|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
19447363|NCT01385566|41695482|FG000|Overall Study|Lost to Follow-up|1|||
19447364|NCT01385566|41695483|FG001|Overall Study|Lost to Follow-up|0|||
19447365|NCT01385566|41695484|FG002|Overall Study|Lost to Follow-up|0|||
19447366|NCT01385566|41695485|FG003|Overall Study|Lost to Follow-up|0|||
19447367|NCT01385566|41695486|FG004|Overall Study|Lost to Follow-up|0|||
19447368|NCT01385566|41695487|FG005|Overall Study|Lost to Follow-up|0|||
19447369|NCT01385566|41695482|FG000|Overall Study|Withdrawal by Subject|0|||
19447370|NCT01385566|41695483|FG001|Overall Study|Withdrawal by Subject|0|||
19447371|NCT01385566|41695484|FG002|Overall Study|Withdrawal by Subject|0|||
19447372|NCT01385566|41695485|FG003|Overall Study|Withdrawal by Subject|1|||
19447373|NCT01385566|41695486|FG004|Overall Study|Withdrawal by Subject|0|||
19447374|NCT01385566|41695487|FG005|Overall Study|Withdrawal by Subject|0|||
19447375|NCT01780545|41695505|FG000|Overall Study|Withdrawal by Subject|3|||
19447376|NCT01780545|41695506|FG001|Overall Study|Withdrawal by Subject|1|||
19447377|NCT01780545|41695505|FG000|Overall Study|Lost to Follow-up|1|||
19447378|NCT01780545|41695506|FG001|Overall Study|Lost to Follow-up|1|||
19447379|NCT01780389|41695515|FG000|Overall Study|Adverse Event|1|||
19447380|NCT01778985|41695522|FG000|Overall Study|Lost to Follow-up|1|||
19447381|NCT01778985|41695523|FG001|Overall Study|Lost to Follow-up|0|||
19447382|NCT01778985|41695522|FG000|Overall Study|Physician Decision|2|||
19447383|NCT01778985|41695523|FG001|Overall Study|Physician Decision|2|||
19447384|NCT01778985|41695522|FG000|Overall Study|Protocol Violation|4|||
19447385|NCT01778985|41695523|FG001|Overall Study|Protocol Violation|1|||
19447386|NCT01778751|41695531|FG000|Overall Study|Lost to Follow-up|1|||
19447387|NCT01778751|41695532|FG001|Overall Study|Lost to Follow-up|0|||
19447388|NCT01778751|41695531|FG000|Overall Study|Withdrawal by Subject|0|||
19447389|NCT01778751|41695532|FG001|Overall Study|Withdrawal by Subject|2|||
19447390|NCT01778751|41695531|FG000|Overall Study|Transfered care|1|||
19447391|NCT01778751|41695532|FG001|Overall Study|Transfered care|0|||
19447392|NCT01865084|41695541|FG000|Double Blind Period (DB)|Adverse Event|2|||
19447393|NCT01865084|41695542|FG001|Double Blind Period (DB)|Adverse Event|2|||
19447394|NCT01865084|41695543|FG002|Double Blind Period (DB)|Adverse Event|1|||
19447395|NCT01865084|41695541|FG000|Double Blind Period (DB)|Protocol Violation|0|||
19447396|NCT01865084|41695542|FG001|Double Blind Period (DB)|Protocol Violation|0|||
19447397|NCT01865084|41695543|FG002|Double Blind Period (DB)|Protocol Violation|1|||
19447398|NCT01865084|41695541|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
19447399|NCT01865084|41695542|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
19447400|NCT01865084|41695543|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
19447401|NCT01865084|41695541|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
19447402|NCT01865084|41695542|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
19447403|NCT01865084|41695543|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
19447404|NCT01865084|41695541|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
19447405|NCT01865084|41695542|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
19447406|NCT01865084|41695543|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
19447407|NCT01865084|41695541|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
19447408|NCT01865084|41695542|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
19447409|NCT01865084|41695543|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
19447410|NCT01865084|41695541|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
19447411|NCT01865084|41695542|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
19447412|NCT01865084|41695543|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
19447413|NCT01865084|41695541|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
19447414|NCT01865084|41695542|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
19447415|NCT01865084|41695543|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
19447416|NCT01865084|41695541|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
19447417|NCT01865084|41695542|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
19447418|NCT01865084|41695543|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
19447419|NCT01778127|41695558|FG000|Overall Study|Lost to Follow-up|5|||
19447420|NCT01778127|41695559|FG001|Overall Study|Lost to Follow-up|1|||
19447421|NCT01778127|41695560|FG002|Overall Study|Lost to Follow-up|2|||
19525346|NCT03253809|41970766|FG000|Overall Study|Unable to obtain study related data|14|||
19525347|NCT03137173|41970786|FG000|Overall Study|Withdrawal by Subject|8|||
19525348|NCT03137173|41970787|FG001|Overall Study|Withdrawal by Subject|13|||
19525349|NCT03137173|41970786|FG000|Overall Study|Death|1|||
19525350|NCT03137173|41970787|FG001|Overall Study|Death|3|||
19525351|NCT03137173|41970786|FG000|Overall Study|Physician Decision|1|||
19525352|NCT03137173|41970787|FG001|Overall Study|Physician Decision|0|||
19629132|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Death|0|||
19629133|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
19629134|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
19629135|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
19629136|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
19629137|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
19629138|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
19629139|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
19629140|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
19629141|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
19629142|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
19629143|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
19629144|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
19629145|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
19629146|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
19629147|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
19629148|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
19629149|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
19629150|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
19629151|NCT00642460|42078692|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
19525353|NCT03137173|41970786|FG000|Overall Study|Lost to Follow-up|13|||
19629152|NCT00642460|42078693|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
19629153|NCT00642460|42078694|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
19629154|NCT00642460|42078695|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
19629155|NCT00642460|42078696|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
19629156|NCT00642460|42078697|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
19629157|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
19629158|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
19629159|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
19629160|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
19629161|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
19629162|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
19629163|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
19629164|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
19629165|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
19629166|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
19629167|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
19629168|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
19629169|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
19629170|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
19629171|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
19629172|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
19629173|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
19629174|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
19629175|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
19629176|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
19629177|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
19629178|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
19629179|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
19629180|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
19629181|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Other|0|||
19447422|NCT01778127|41695558|FG000|Overall Study|Withdrawal by Subject|3|||
19447423|NCT01778127|41695559|FG001|Overall Study|Withdrawal by Subject|1|||
19447424|NCT01778127|41695560|FG002|Overall Study|Withdrawal by Subject|4|||
19447425|NCT01892540|41695571|FG000|Overall Study|Did not complete PET/MRI|0|||
19447426|NCT01892540|41695572|FG001|Overall Study|Did not complete PET/MRI|0|||
19447427|NCT01892540|41695573|FG002|Overall Study|Did not complete PET/MRI|2|||
19525354|NCT03137173|41970787|FG001|Overall Study|Lost to Follow-up|18|||
19447428|NCT01892540|41695571|FG000|Overall Study|Did not fit in scanner|0|||
19447429|NCT01892540|41695572|FG001|Overall Study|Did not fit in scanner|0|||
19447430|NCT01892540|41695573|FG002|Overall Study|Did not fit in scanner|1|||
19447431|NCT01399372|41695583|FG000|Overall Study|Protocol Violation|3|||
19447432|NCT01399372|41695584|FG001|Overall Study|Protocol Violation|1|||
19447433|NCT01385098|41695590|FG000|Overall Study|Adverse Event|10|||
19447434|NCT01385098|41695590|FG000|Overall Study|Lost to Follow-up|4|||
19447435|NCT01398514|41695598|FG000|Overall Study|Adverse Event|1|||
19447436|NCT01398514|41695599|FG001|Overall Study|Adverse Event|0|||
19447437|NCT01398514|41695598|FG000|Overall Study|Non-compliance with study procedures|2|||
19447438|NCT01398514|41695599|FG001|Overall Study|Non-compliance with study procedures|0|||
19447439|NCT01398514|41695598|FG000|Overall Study|Physiologic non-responsiveness|1|||
19447440|NCT01398514|41695599|FG001|Overall Study|Physiologic non-responsiveness|3|||
19447441|NCT01398514|41695598|FG000|Overall Study|Failure to show a conditioned response|4|||
19447442|NCT01398514|41695599|FG001|Overall Study|Failure to show a conditioned response|3|||
19447443|NCT01398358|41695610|FG000|Overall Study|Lost to Follow-up|11|||
19447444|NCT01398358|41695611|FG001|Overall Study|Lost to Follow-up|21|||
19447445|NCT01398358|41695612|FG002|Overall Study|Lost to Follow-up|18|||
19525355|NCT03137173|41970786|FG000|Overall Study|Other reasons|3|||
19525356|NCT03137173|41970787|FG001|Overall Study|Other reasons|2|||
19525357|NCT02998476|41970855|FG000|Overall Study|Lost to Follow-up|1|||
19525358|NCT02998476|41970856|FG001|Overall Study|Lost to Follow-up|0|||
19525359|NCT02998476|41970855|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
19525360|NCT02998476|41970856|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
19447446|NCT01398358|41695610|FG000|Overall Study|Withdrawal by Subject|3|||
19447447|NCT01398358|41695611|FG001|Overall Study|Withdrawal by Subject|2|||
19447448|NCT01398358|41695612|FG002|Overall Study|Withdrawal by Subject|2|||
19447449|NCT01398358|41695610|FG000|Overall Study|no longer eligible|1|||
19447450|NCT01398358|41695611|FG001|Overall Study|no longer eligible|0|||
19447451|NCT01398358|41695612|FG002|Overall Study|no longer eligible|1|||
19447452|NCT01778049|41695622|FG000|Open Label Treatment Period|Adverse Event|5|||
19447453|NCT01778049|41695623|FG001|Open Label Treatment Period|Adverse Event|15|||
19447454|NCT01778049|41695624|FG002|Open Label Treatment Period|Adverse Event|0|||
19447455|NCT01778049|41695625|FG003|Open Label Treatment Period|Adverse Event|0|||
19447456|NCT01778049|41695626|FG004|Open Label Treatment Period|Adverse Event|0|||
19447457|NCT01778049|41695627|FG005|Open Label Treatment Period|Adverse Event|0|||
19447458|NCT01778049|41695622|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
19447459|NCT01778049|41695623|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
19447460|NCT01778049|41695624|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
19447461|NCT01778049|41695625|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
19447462|NCT01778049|41695626|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
19447463|NCT01778049|41695627|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
19447464|NCT01778049|41695622|FG000|Open Label Treatment Period|Protocol Violation|5|||
19447465|NCT01778049|41695623|FG001|Open Label Treatment Period|Protocol Violation|5|||
19447466|NCT01778049|41695624|FG002|Open Label Treatment Period|Protocol Violation|0|||
19447467|NCT01778049|41695625|FG003|Open Label Treatment Period|Protocol Violation|0|||
19447468|NCT01778049|41695626|FG004|Open Label Treatment Period|Protocol Violation|0|||
19447469|NCT01778049|41695627|FG005|Open Label Treatment Period|Protocol Violation|0|||
19447470|NCT01778049|41695622|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
19447471|NCT01778049|41695623|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
19447472|NCT01778049|41695624|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
19447473|NCT01778049|41695625|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
19447474|NCT01778049|41695626|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
19447475|NCT01778049|41695627|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
19447476|NCT01778049|41695622|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
19447477|NCT01778049|41695623|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
19447478|NCT01778049|41695624|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
19447479|NCT01778049|41695625|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
19447480|NCT01778049|41695626|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
19447481|NCT01778049|41695627|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
19447482|NCT01778049|41695622|FG000|Open Label Treatment Period|Not treated|2|||
19447483|NCT01778049|41695623|FG001|Open Label Treatment Period|Not treated|1|||
19447484|NCT01778049|41695624|FG002|Open Label Treatment Period|Not treated|0|||
19525361|NCT02998476|41970855|FG000|Overall Study|Withdrawal by Subject|1|||
19525362|NCT02998476|41970856|FG001|Overall Study|Withdrawal by Subject|2|||
19447485|NCT01778049|41695625|FG003|Open Label Treatment Period|Not treated|0|||
19447486|NCT01778049|41695626|FG004|Open Label Treatment Period|Not treated|0|||
19447487|NCT01778049|41695627|FG005|Open Label Treatment Period|Not treated|0|||
19447488|NCT01778049|41695622|FG000|Open Label Treatment Period|Other reason not defined above|77|||
19447489|NCT01778049|41695623|FG001|Open Label Treatment Period|Other reason not defined above|94|||
19447490|NCT01778049|41695624|FG002|Open Label Treatment Period|Other reason not defined above|0|||
19447491|NCT01778049|41695625|FG003|Open Label Treatment Period|Other reason not defined above|0|||
19447492|NCT01778049|41695626|FG004|Open Label Treatment Period|Other reason not defined above|0|||
19447493|NCT01778049|41695627|FG005|Open Label Treatment Period|Other reason not defined above|0|||
19629182|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Other|0|||
19629183|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Other|0|||
19629184|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Other|0|||
19525363|NCT02998476|41970855|FG000|Overall Study|Death|45|||
19525364|NCT02998476|41970856|FG001|Overall Study|Death|2|||
19525365|NCT02998476|41970855|FG000|Overall Study|Other|6|||
19525366|NCT02998476|41970856|FG001|Overall Study|Other|1|||
19525367|NCT02924064|41970874|FG000|Overall Study|Adverse Event|2|||
19525368|NCT02924064|41970875|FG001|Overall Study|Adverse Event|2|||
19525369|NCT02924064|41970874|FG000|Overall Study|Lost to Follow-up|0|||
19525370|NCT02924064|41970875|FG001|Overall Study|Lost to Follow-up|2|||
19525371|NCT02924064|41970874|FG000|Overall Study|Physician Decision|0|||
19525372|NCT02924064|41970875|FG001|Overall Study|Physician Decision|2|||
19525373|NCT02924064|41970874|FG000|Overall Study|Protocol Violation|1|||
19525374|NCT02924064|41970875|FG001|Overall Study|Protocol Violation|3|||
19525375|NCT02924064|41970874|FG000|Overall Study|Withdrawal by Subject|4|||
19525376|NCT02924064|41970875|FG001|Overall Study|Withdrawal by Subject|5|||
19525377|NCT02924064|41970874|FG000|Overall Study|Other|17|||
19525378|NCT02924064|41970875|FG001|Overall Study|Other|29|||
19525379|NCT02916706|41970883|FG000|Overall Study|Adverse Event|0|||
19525380|NCT02916706|41970884|FG001|Overall Study|Adverse Event|1|||
19525381|NCT02916706|41970883|FG000|Overall Study|Lost to Follow-up|0|||
19525382|NCT02916706|41970884|FG001|Overall Study|Lost to Follow-up|1|||
19525383|NCT02916706|41970883|FG000|Overall Study|Physician Decision|1|||
19525384|NCT02916706|41970884|FG001|Overall Study|Physician Decision|0|||
19525385|NCT02916706|41970883|FG000|Overall Study|Protocol Violation|3|||
19525386|NCT02916706|41970884|FG001|Overall Study|Protocol Violation|1|||
19525387|NCT02916706|41970883|FG000|Overall Study|Withdrawal by Subject|6|||
19525388|NCT02916706|41970884|FG001|Overall Study|Withdrawal by Subject|9|||
19525389|NCT02916706|41970883|FG000|Overall Study|Other|5|||
19525390|NCT02916706|41970884|FG001|Overall Study|Other|19|||
19525391|NCT02889900|41970890|FG000|Overall Study|Adverse Event|11|||
19525392|NCT02889900|41970890|FG000|Overall Study|Condition under investigation worsened|32|||
19525393|NCT02889900|41970890|FG000|Overall Study|Other|5|||
19525394|NCT02889900|41970890|FG000|Overall Study|Withdrawal by Subject|7|||
19525395|NCT02889900|41970890|FG000|Overall Study|Not treated|2|||
19525396|NCT02866695|41970894|FG000|Overall Study|Adverse Event|1|||
19525397|NCT02866695|41970894|FG000|Overall Study|Lost to Follow-up|1|||
19525398|NCT02834793|41970900|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
19525399|NCT02834793|41970901|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
19525400|NCT02834793|41970902|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
19525401|NCT02834793|41970903|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
19447494|NCT01778049|41695622|FG000|Double Blind Treatment Period|Adverse Event|0|||
19447495|NCT01778049|41695623|FG001|Double Blind Treatment Period|Adverse Event|0|||
19447496|NCT01778049|41695624|FG002|Double Blind Treatment Period|Adverse Event|4|||
19447497|NCT01778049|41695625|FG003|Double Blind Treatment Period|Adverse Event|5|||
19447498|NCT01778049|41695626|FG004|Double Blind Treatment Period|Adverse Event|3|||
19447499|NCT01778049|41695627|FG005|Double Blind Treatment Period|Adverse Event|2|||
19447500|NCT01778049|41695622|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
19447501|NCT01778049|41695623|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
19447502|NCT01778049|41695624|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
19447503|NCT01778049|41695625|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
19447504|NCT01778049|41695626|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
19447505|NCT01778049|41695627|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
19447506|NCT01778049|41695622|FG000|Double Blind Treatment Period|Protocol Violation|0|||
19447507|NCT01778049|41695623|FG001|Double Blind Treatment Period|Protocol Violation|0|||
19447508|NCT01778049|41695624|FG002|Double Blind Treatment Period|Protocol Violation|2|||
19447509|NCT01778049|41695625|FG003|Double Blind Treatment Period|Protocol Violation|0|||
19447510|NCT01778049|41695626|FG004|Double Blind Treatment Period|Protocol Violation|0|||
19447511|NCT01778049|41695627|FG005|Double Blind Treatment Period|Protocol Violation|0|||
19447512|NCT01778049|41695622|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
19447513|NCT01778049|41695623|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
19447514|NCT01778049|41695624|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
19447515|NCT01778049|41695625|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
19447516|NCT01778049|41695626|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
19525402|NCT02834793|41970900|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
19525403|NCT02834793|41970901|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
19629185|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Other|2|||
19629186|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Other|2|||
19447517|NCT01778049|41695627|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
19447518|NCT01778049|41695622|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
19525404|NCT02834793|41970902|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
19525405|NCT02834793|41970903|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
19447519|NCT01778049|41695623|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
19447520|NCT01778049|41695624|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
19447521|NCT01778049|41695625|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
19447522|NCT01778049|41695626|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
19447523|NCT01778049|41695627|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
19447524|NCT01778049|41695622|FG000|Double Blind Treatment Period|Not treated|0|||
19447525|NCT01778049|41695623|FG001|Double Blind Treatment Period|Not treated|0|||
19447526|NCT01778049|41695624|FG002|Double Blind Treatment Period|Not treated|0|||
19447527|NCT01778049|41695625|FG003|Double Blind Treatment Period|Not treated|2|||
19525406|NCT02834793|41970900|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
19525407|NCT02834793|41970901|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
19525408|NCT02834793|41970902|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
19525409|NCT02834793|41970903|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
19525410|NCT02834793|41970900|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
19525411|NCT02834793|41970901|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
19525412|NCT02834793|41970902|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
19525413|NCT02834793|41970903|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
19525414|NCT02834793|41970900|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
19525415|NCT02834793|41970901|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
19525416|NCT02834793|41970902|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
19525417|NCT02834793|41970903|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
19525418|NCT02834793|41970900|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
19525419|NCT02834793|41970901|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
19525420|NCT02834793|41970902|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
19525421|NCT02834793|41970903|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
19525422|NCT02834793|41970900|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
19447528|NCT01778049|41695626|FG004|Double Blind Treatment Period|Not treated|2|||
19447529|NCT01778049|41695627|FG005|Double Blind Treatment Period|Not treated|0|||
19447530|NCT01778049|41695622|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
19447531|NCT01778049|41695623|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
19447532|NCT01778049|41695624|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
19447533|NCT01778049|41695625|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
19525423|NCT02834793|41970901|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
19525424|NCT02834793|41970902|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
19447534|NCT01778049|41695626|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
19447535|NCT01778049|41695627|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
19447536|NCT01777581|41695641|FG000|Overall Study|Lost to Follow-up|1|||
19447537|NCT01777581|41695642|FG001|Overall Study|Lost to Follow-up|1|||
19447538|NCT01777581|41695641|FG000|Overall Study|Adverse Event|2|||
19447539|NCT01777581|41695642|FG001|Overall Study|Adverse Event|0|||
19447540|NCT01777581|41695641|FG000|Overall Study|Lack of Efficacy|0|||
19447541|NCT01777581|41695642|FG001|Overall Study|Lack of Efficacy|1|||
19447542|NCT01864148|41695653|FG000|Overall Study|Other|2|||
19447543|NCT01864148|41695654|FG001|Overall Study|Other|1|||
19447544|NCT01864148|41695655|FG002|Overall Study|Other|1|||
19447545|NCT01864148|41695656|FG003|Overall Study|Other|3|||
19447546|NCT01864148|41695657|FG004|Overall Study|Other|1|||
19447547|NCT01864148|41695653|FG000|Overall Study|Death|0|||
19447548|NCT01864148|41695654|FG001|Overall Study|Death|0|||
19447549|NCT01864148|41695655|FG002|Overall Study|Death|0|||
19525425|NCT02834793|41970903|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
19525426|NCT02834793|41970900|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
19525427|NCT02834793|41970901|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
19525428|NCT02834793|41970902|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
19447550|NCT01864148|41695656|FG003|Overall Study|Death|1|||
19447551|NCT01864148|41695657|FG004|Overall Study|Death|0|||
19447552|NCT01864148|41695653|FG000|Overall Study|Investigator Decision|5|||
19447553|NCT01864148|41695654|FG001|Overall Study|Investigator Decision|0|||
19447554|NCT01864148|41695655|FG002|Overall Study|Investigator Decision|0|||
19447555|NCT01864148|41695656|FG003|Overall Study|Investigator Decision|4|||
19447556|NCT01864148|41695657|FG004|Overall Study|Investigator Decision|6|||
19447557|NCT01864148|41695653|FG000|Overall Study|Withdrawal by Subject|9|||
19525429|NCT02834793|41970903|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
19525430|NCT02834793|41970900|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
19525431|NCT02834793|41970901|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
19525432|NCT02834793|41970902|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
19525433|NCT02834793|41970903|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
19525434|NCT02834793|41970900|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
19447558|NCT01864148|41695654|FG001|Overall Study|Withdrawal by Subject|2|||
19447559|NCT01864148|41695655|FG002|Overall Study|Withdrawal by Subject|6|||
19447560|NCT01864148|41695656|FG003|Overall Study|Withdrawal by Subject|8|||
19447561|NCT01864148|41695657|FG004|Overall Study|Withdrawal by Subject|8|||
19447562|NCT01864148|41695653|FG000|Overall Study|Lost to Follow-up|0|||
19447563|NCT01864148|41695654|FG001|Overall Study|Lost to Follow-up|0|||
19447564|NCT01864148|41695655|FG002|Overall Study|Lost to Follow-up|0|||
19447565|NCT01864148|41695656|FG003|Overall Study|Lost to Follow-up|2|||
19447566|NCT01864148|41695657|FG004|Overall Study|Lost to Follow-up|1|||
19447567|NCT01864148|41695653|FG000|Overall Study|Adverse Event|4|||
19447568|NCT01864148|41695654|FG001|Overall Study|Adverse Event|2|||
19447569|NCT01864148|41695655|FG002|Overall Study|Adverse Event|4|||
19447570|NCT01864148|41695656|FG003|Overall Study|Adverse Event|7|||
19447571|NCT01864148|41695657|FG004|Overall Study|Adverse Event|7|||
19447572|NCT01864148|41695653|FG000|Overall Study|Not Dosed|0|||
19447573|NCT01864148|41695654|FG001|Overall Study|Not Dosed|0|||
19525435|NCT02834793|41970901|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
19525436|NCT02834793|41970902|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
19525437|NCT02834793|41970903|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
19447574|NCT01864148|41695655|FG002|Overall Study|Not Dosed|0|||
19447575|NCT01864148|41695656|FG003|Overall Study|Not Dosed|1|||
19447576|NCT01864148|41695657|FG004|Overall Study|Not Dosed|0|||
19525438|NCT02834793|41970900|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
19525439|NCT02834793|41970901|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
19525440|NCT02834793|41970902|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
19525441|NCT02834793|41970903|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
19525442|NCT02834793|41970900|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
19525443|NCT02834793|41970901|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
19525444|NCT02834793|41970902|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
19525445|NCT02834793|41970903|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
19525446|NCT02834793|41970900|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
19525447|NCT02834793|41970901|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
19525448|NCT02834793|41970902|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
19525449|NCT02834793|41970903|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
19525450|NCT02834793|41970900|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
19525451|NCT02834793|41970901|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
19525452|NCT02834793|41970902|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
19525453|NCT02834793|41970903|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
19525454|NCT02834793|41970900|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
19525455|NCT02834793|41970901|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
19525456|NCT02834793|41970902|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
19525457|NCT02834793|41970903|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
19525458|NCT02810457|41970913|FG000|Overall Study|Randomised but no treatment received|2|||
19525459|NCT02810457|41970914|FG001|Overall Study|Randomised but no treatment received|1|||
19525460|NCT02810457|41970913|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
19525461|NCT02810457|41970914|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
19447577|NCT01751139|41695674|FG000|Overall Study|Other|135|||
19447578|NCT01751139|41695674|FG000|Overall Study|Sponsor study termination|1609|||
19447579|NCT01751139|41695674|FG000|Overall Study|Lost to Follow-up|240|||
19525462|NCT02810457|41970913|FG000|Overall Study|Adverse Event|37|||
19525463|NCT02810457|41970914|FG001|Overall Study|Adverse Event|43|||
19525464|NCT02810457|41970913|FG000|Overall Study|Patient decision|31|||
19447580|NCT01751139|41695674|FG000|Overall Study|Withdrawal by Subject|251|||
19447581|NCT01751139|41695674|FG000|Overall Study|Adverse Event|1|||
19447582|NCT01751139|41695674|FG000|Overall Study|Death|31|||
19447583|NCT01890122|41695682|FG000|Overall Study|Adverse Event|1|||
19447584|NCT01890122|41695683|FG001|Overall Study|Adverse Event|1|||
19447585|NCT01890122|41695684|FG002|Overall Study|Adverse Event|1|||
19447586|NCT01890122|41695685|FG003|Overall Study|Adverse Event|2|||
19447587|NCT01890122|41695682|FG000|Overall Study|Major Protocol Deviation|3|||
19447588|NCT01890122|41695683|FG001|Overall Study|Major Protocol Deviation|1|||
19447589|NCT01890122|41695684|FG002|Overall Study|Major Protocol Deviation|0|||
19447590|NCT01890122|41695685|FG003|Overall Study|Major Protocol Deviation|1|||
19447591|NCT01890122|41695682|FG000|Overall Study|Lost to Follow-up|0|||
19447592|NCT01890122|41695683|FG001|Overall Study|Lost to Follow-up|1|||
19447593|NCT01890122|41695684|FG002|Overall Study|Lost to Follow-up|2|||
19447594|NCT01890122|41695685|FG003|Overall Study|Lost to Follow-up|2|||
19447595|NCT01890122|41695682|FG000|Overall Study|Voluntary Withdrawal|8|||
19447596|NCT01890122|41695683|FG001|Overall Study|Voluntary Withdrawal|8|||
19447597|NCT01890122|41695684|FG002|Overall Study|Voluntary Withdrawal|2|||
19447598|NCT01890122|41695685|FG003|Overall Study|Voluntary Withdrawal|11|||
19447599|NCT01890122|41695682|FG000|Overall Study|Lack of Efficacy|14|||
19447600|NCT01890122|41695683|FG001|Overall Study|Lack of Efficacy|24|||
19447601|NCT01890122|41695684|FG002|Overall Study|Lack of Efficacy|7|||
19447602|NCT01890122|41695685|FG003|Overall Study|Lack of Efficacy|41|||
19447603|NCT01890122|41695682|FG000|Overall Study|Reason not Specified|0|||
19447604|NCT01890122|41695683|FG001|Overall Study|Reason not Specified|1|||
19447605|NCT01890122|41695684|FG002|Overall Study|Reason not Specified|1|||
19447606|NCT01890122|41695685|FG003|Overall Study|Reason not Specified|2|||
19447607|NCT01890122|41695682|FG000|Overall Study|Randomized but not Treated|1|||
19447608|NCT01890122|41695683|FG001|Overall Study|Randomized but not Treated|1|||
19447609|NCT01890122|41695684|FG002|Overall Study|Randomized but not Treated|0|||
19447610|NCT01890122|41695685|FG003|Overall Study|Randomized but not Treated|0|||
19447611|NCT01397890|41695697|FG000|Overall Study|Withdrawal by Subject|7|||
19447612|NCT01397890|41695698|FG001|Overall Study|Withdrawal by Subject|11|||
19629187|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Death|0|||
19629188|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Death|0|||
19629189|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Death|0|||
19629190|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Death|0|||
19629191|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Death|0|||
19629192|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Death|3|||
19629193|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
19629194|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
19629195|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
19629196|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
19629197|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
19629198|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
19629199|NCT00642460|42078692|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
19629200|NCT00642460|42078693|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
19629201|NCT00642460|42078694|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
19629202|NCT00642460|42078695|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
19629203|NCT00642460|42078696|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
19447613|NCT01397890|41695697|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
19447614|NCT01397890|41695698|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
19447615|NCT01397890|41695697|FG000|Overall Study|Death|2|||
19447616|NCT01397890|41695698|FG001|Overall Study|Death|3|||
19447617|NCT01397890|41695697|FG000|Overall Study|Lost to Follow-up|1|||
19447618|NCT01397890|41695698|FG001|Overall Study|Lost to Follow-up|4|||
19447619|NCT01397890|41695697|FG000|Overall Study|Condition under Investigation Worsened|1|||
19447620|NCT01397890|41695698|FG001|Overall Study|Condition under Investigation Worsened|3|||
19447621|NCT01397890|41695697|FG000|Overall Study|Adverse Event|1|||
19447622|NCT01397890|41695698|FG001|Overall Study|Adverse Event|2|||
19447623|NCT01397890|41695697|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
19447624|NCT01397890|41695698|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
19447625|NCT01397890|41695697|FG000|Overall Study|Others|2|||
19447626|NCT01397890|41695698|FG001|Overall Study|Others|1|||
19447627|NCT01777269|41695706|FG000|Overall Study|Adverse Event|24|||
19447628|NCT01777269|41695707|FG001|Overall Study|Adverse Event|33|||
19447629|NCT01777269|41695706|FG000|Overall Study|Lack of Efficacy|8|||
19447630|NCT01777269|41695707|FG001|Overall Study|Lack of Efficacy|10|||
19447631|NCT01777269|41695706|FG000|Overall Study|Protocol Violation|4|||
19447632|NCT01777269|41695707|FG001|Overall Study|Protocol Violation|4|||
19447633|NCT01777269|41695706|FG000|Overall Study|Participants reached stopping criteria|1|||
19447634|NCT01777269|41695707|FG001|Overall Study|Participants reached stopping criteria|1|||
19447635|NCT01777269|41695706|FG000|Overall Study|Lost to Follow-up|4|||
19447636|NCT01777269|41695707|FG001|Overall Study|Lost to Follow-up|0|||
19447637|NCT01777269|41695706|FG000|Overall Study|Physician Decision|5|||
19447638|NCT01777269|41695707|FG001|Overall Study|Physician Decision|2|||
19447639|NCT01777269|41695706|FG000|Overall Study|Withdrawal by Subject|9|||
19447640|NCT01777269|41695707|FG001|Overall Study|Withdrawal by Subject|9|||
19447641|NCT01751061|41695715|FG000|Overall Study|Death|1|||
19447642|NCT01751061|41695716|FG001|Overall Study|Death|0|||
19447643|NCT01751061|41695715|FG000|Overall Study|patient death|5|||
19447644|NCT01751061|41695716|FG001|Overall Study|patient death|0|||
19447645|NCT01751061|41695715|FG000|Overall Study|Lost to Follow-up|40|||
19447646|NCT01751061|41695716|FG001|Overall Study|Lost to Follow-up|25|||
19447647|NCT01751061|41695715|FG000|Overall Study|patient regained decisional capacity|4|||
19447648|NCT01751061|41695716|FG001|Overall Study|patient regained decisional capacity|8|||
19447649|NCT01751061|41695715|FG000|Overall Study|Withdrawal by Subject|4|||
19447650|NCT01751061|41695716|FG001|Overall Study|Withdrawal by Subject|1|||
19447651|NCT01751061|41695715|FG000|Overall Study|Physician Decision|2|||
19447652|NCT01751061|41695716|FG001|Overall Study|Physician Decision|0|||
19525465|NCT02810457|41970914|FG001|Overall Study|Patient decision|35|||
19525466|NCT02810457|41970913|FG000|Overall Study|Patient lost to follow-up|2|||
19525467|NCT02810457|41970914|FG001|Overall Study|Patient lost to follow-up|2|||
19525468|NCT02810457|41970913|FG000|Overall Study|Death|39|||
19525469|NCT02810457|41970914|FG001|Overall Study|Death|28|||
19525470|NCT02810457|41970913|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
19525471|NCT02810457|41970914|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
19525472|NCT02810457|41970913|FG000|Overall Study|Clinical progression|15|||
19525473|NCT02810457|41970914|FG001|Overall Study|Clinical progression|16|||
19525474|NCT02810457|41970913|FG000|Overall Study|Investigator decision|3|||
19525475|NCT02810457|41970914|FG001|Overall Study|Investigator decision|2|||
19525476|NCT02810457|41970913|FG000|Overall Study|Patient ineligibility|3|||
19447653|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
19447654|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
19447655|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
19447656|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
19447657|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
19447658|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
19447659|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
19447660|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
19447661|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
19447662|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
19447663|NCT01777191|41695724|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
19447664|NCT01777191|41695725|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
19447665|NCT01777191|41695724|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
19447666|NCT01777191|41695725|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
19447667|NCT01777191|41695724|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
19447668|NCT01777191|41695725|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
19447669|NCT01777191|41695724|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
19447670|NCT01777191|41695725|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
19447671|NCT01777191|41695724|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
19447672|NCT01777191|41695725|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
19447673|NCT01777191|41695724|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
19447674|NCT01777191|41695725|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
19447675|NCT01775787|41695734|FG000|First 7-10 Days|Adverse Event|0|||
19447676|NCT01775787|41695735|FG001|First 7-10 Days|Adverse Event|1|||
19447677|NCT01775787|41695734|FG000|First 7-10 Days|family emergency|0|||
19447678|NCT01775787|41695735|FG001|First 7-10 Days|family emergency|1|||
19447679|NCT01775787|41695734|FG000|First 7-10 Days|time commitment|0|||
19447680|NCT01775787|41695735|FG001|First 7-10 Days|time commitment|2|||
19447681|NCT01775787|41695734|FG000|First 7-10 Days|concerns with using IV|1|||
19447682|NCT01775787|41695735|FG001|First 7-10 Days|concerns with using IV|2|||
19525477|NCT02810457|41970914|FG001|Overall Study|Patient ineligibility|0|||
19525478|NCT02810457|41970913|FG000|Overall Study|Miscalculated PD|1|||
19525479|NCT02810457|41970914|FG001|Overall Study|Miscalculated PD|0|||
19525480|NCT02810457|41970913|FG000|Overall Study|Physician Decision|0|||
19525481|NCT02810457|41970914|FG001|Overall Study|Physician Decision|1|||
19525482|NCT02745535|41970944|FG000|Overall Study|Death|1|||
19525483|NCT02745535|41970944|FG000|Overall Study|Adverse Event|3|||
19525484|NCT02745535|41970944|FG000|Overall Study|Lost to Follow-up|2|||
19525485|NCT02625090|41970978|FG000|Overall Study|Participant wants to be pregnant|2|||
19525486|NCT02625090|41970978|FG000|Overall Study|For the Promoter|1|||
19525487|NCT02625090|41970978|FG000|Overall Study|Sponsor's Decision|9|||
19525488|NCT02625090|41970978|FG000|Overall Study|Somnolence|1|||
19525489|NCT02625090|41970978|FG000|Overall Study|Study terminated by Sponsor|7|||
19525490|NCT02625090|41970978|FG000|Overall Study|Negative Benefit/Risk|1|||
19525491|NCT02625090|41970978|FG000|Overall Study|Protocol Deviation|2|||
19525492|NCT02625090|41970978|FG000|Overall Study|Lack of Efficacy|16|||
19525493|NCT02625090|41970978|FG000|Overall Study|Adverse Event|3|||
19525494|NCT02539225|41970985|FG000|Part A|Adverse Event|13|||
19525495|NCT02539225|41970986|FG001|Part A|Adverse Event|4|||
19525496|NCT02539225|41970985|FG000|Part A|Withdrawal by Subject|2|||
19525497|NCT02539225|41970986|FG001|Part A|Withdrawal by Subject|4|||
19525498|NCT02539225|41970985|FG000|Part A|Physician Decision|4|||
19525499|NCT02539225|41970986|FG001|Part A|Physician Decision|7|||
19525500|NCT02539225|41970985|FG000|Part A|Did Not Receive study Drug|1|||
19525501|NCT02539225|41970986|FG001|Part A|Did Not Receive study Drug|1|||
19525502|NCT02539225|41970985|FG000|Pre Treatment for Part B|Progressive disease|1|||
19525503|NCT02539225|41970986|FG001|Pre Treatment for Part B|Progressive disease|1|||
19525504|NCT02539225|41970985|FG000|Pre Treatment for Part B|Adverse Event|1|||
19525505|NCT02539225|41970986|FG001|Pre Treatment for Part B|Adverse Event|1|||
19525506|NCT02539225|41970985|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
19525507|NCT02539225|41970986|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
19525508|NCT02539225|41970985|FG000|Pre Treatment for Part B|Physician Decision|2|||
19525509|NCT02539225|41970986|FG001|Pre Treatment for Part B|Physician Decision|0|||
19525510|NCT02539225|41970985|FG000|Part B|Adverse Event|4|||
19447683|NCT01775787|41695734|FG000|Second 7-10 Days|time commitment|0|||
19447684|NCT01775787|41695735|FG001|Second 7-10 Days|time commitment|1|||
19447685|NCT01775787|41695734|FG000|Second 7-10 Days|concerns with using IV|0|||
19447686|NCT01775787|41695735|FG001|Second 7-10 Days|concerns with using IV|1|||
19447687|NCT01775553|41695743|FG000|Overall Study|Adverse Event|1|||
19447688|NCT01775553|41695743|FG000|Overall Study|Disease Progression|12|||
19447689|NCT01775475|41695749|FG000|Overall Study|Death|3|||
19447690|NCT01775475|41695750|FG001|Overall Study|Death|3|||
19525511|NCT02539225|41970986|FG001|Part B|Adverse Event|4|||
19447691|NCT01774929|41695756|FG000|Overall Study|Adverse Event|3|||
19447692|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
19447693|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
19447694|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
19447695|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
19447696|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
19447697|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
19447698|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
19447699|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
19447700|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
19447701|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
19447702|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
19447703|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
19447704|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
19447705|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
19447706|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447707|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447708|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447709|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447710|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447711|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
19447712|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
19447713|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
19447714|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
19447715|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
19447716|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
19447717|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
19447718|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
19447719|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
19525512|NCT02539225|41970985|FG000|Part B|Withdrawal by Subject|0|||
19525513|NCT02539225|41970986|FG001|Part B|Withdrawal by Subject|3|||
19525514|NCT02539225|41970985|FG000|Part B|Physician Decision|0|||
19525515|NCT02539225|41970986|FG001|Part B|Physician Decision|9|||
19525516|NCT02526017|41971010|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525517|NCT02526017|41971011|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525518|NCT02526017|41971012|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525519|NCT02526017|41971013|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525520|NCT02526017|41971014|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
19525521|NCT02526017|41971015|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525522|NCT02526017|41971016|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525523|NCT02526017|41971017|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525524|NCT02526017|41971018|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
19525525|NCT02369653|41971087|FG000|Overall Study|Lost to Follow-up|0|||
19525526|NCT02369653|41971088|FG001|Overall Study|Lost to Follow-up|1|||
19525527|NCT02369653|41971087|FG000|Overall Study|Administrative reason by sponsor|0|||
19525528|NCT02369653|41971088|FG001|Overall Study|Administrative reason by sponsor|1|||
19525529|NCT02369653|41971087|FG000|Overall Study|Death|1|||
19525530|NCT02369653|41971088|FG001|Overall Study|Death|2|||
19525531|NCT02369653|41971087|FG000|Overall Study|Participant withdrew consent|13|||
19525532|NCT02369653|41971088|FG001|Overall Study|Participant withdrew consent|3|||
19525533|NCT02326974|41971098|FG000|Overall Study|Withdrawal by Subject|2|||
19525534|NCT02326974|41971098|FG000|Overall Study|failed heterogenity evaluation|5|||
19525535|NCT02284568|41971109|FG000|Overall Study|Adverse Event|2|||
19525536|NCT02284568|41971110|FG001|Overall Study|Adverse Event|9|||
19525537|NCT02284568|41971111|FG002|Overall Study|Adverse Event|4|||
19525538|NCT02284568|41971109|FG000|Overall Study|Withdrawal by Subject|22|||
19525539|NCT02284568|41971110|FG001|Overall Study|Withdrawal by Subject|21|||
19525540|NCT02284568|41971111|FG002|Overall Study|Withdrawal by Subject|1|||
19525541|NCT02284568|41971109|FG000|Overall Study|Noncompliance with study drug admin|1|||
19525542|NCT02284568|41971110|FG001|Overall Study|Noncompliance with study drug admin|2|||
19525543|NCT02284568|41971111|FG002|Overall Study|Noncompliance with study drug admin|0|||
19525544|NCT02284568|41971109|FG000|Overall Study|Noncompliance|1|||
19525545|NCT02284568|41971110|FG001|Overall Study|Noncompliance|0|||
19525546|NCT02284568|41971111|FG002|Overall Study|Noncompliance|0|||
19525547|NCT02284568|41971109|FG000|Overall Study|Protocol Violation|0|||
19525548|NCT02284568|41971110|FG001|Overall Study|Protocol Violation|1|||
19447720|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19447721|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19447722|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19447723|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19525549|NCT02284568|41971111|FG002|Overall Study|Protocol Violation|0|||
19447724|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
19447725|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19447726|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
19447727|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447728|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
19447729|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447730|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447731|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447732|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447733|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
19447734|NCT01888874|41695767|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
19447735|NCT01888874|41695768|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
19447736|NCT01888874|41695769|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
19447737|NCT01888874|41695770|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
19447738|NCT01888874|41695771|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
19447739|NCT01888874|41695772|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
19447740|NCT01888874|41695773|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
19447741|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
19447742|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
19447743|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
19447744|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19447745|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
19447746|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19447747|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
19447748|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447749|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447750|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447751|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447752|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
19447753|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447754|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
19447755|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
19447756|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
19447757|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
19447758|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
19447759|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
19447760|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
19447761|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
19447762|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19447763|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19447764|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
19447765|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19447766|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19525550|NCT02284568|41971109|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
19525551|NCT02284568|41971110|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
19525552|NCT02284568|41971111|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
19525553|NCT02284568|41971109|FG000|Overall Study|Lost to Follow-up|0|||
19447767|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19447768|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
19447769|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
19447770|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
19447771|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
19447772|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
19447773|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
19447774|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
19447775|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
19447776|NCT01888874|41695767|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
19447777|NCT01888874|41695768|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
19447778|NCT01888874|41695769|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
19447779|NCT01888874|41695770|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
19447780|NCT01888874|41695771|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
19525554|NCT02284568|41971110|FG001|Overall Study|Lost to Follow-up|3|||
19525555|NCT02284568|41971111|FG002|Overall Study|Lost to Follow-up|0|||
19447781|NCT01888874|41695772|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
19447782|NCT01888874|41695773|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
19447783|NCT01749735|41695792|FG000|Overall Study|Withdrawal by Subject|1|||
19447784|NCT01749735|41695793|FG001|Overall Study|Withdrawal by Subject|0|||
19447785|NCT01749033|41695802|FG000|Overall Study|Did not receive allocated intervention|3|||
19447786|NCT01749033|41695803|FG001|Overall Study|Did not receive allocated intervention|3|||
19447787|NCT01749033|41695804|FG002|Overall Study|Did not receive allocated intervention|0|||
19447788|NCT01749033|41695802|FG000|Overall Study|Lost to Follow-up|0|||
19447789|NCT01749033|41695803|FG001|Overall Study|Lost to Follow-up|2|||
19447790|NCT01749033|41695804|FG002|Overall Study|Lost to Follow-up|1|||
19447791|NCT01774305|41695815|FG000|Overall Study|Physician Decision|1|||
19447792|NCT01774305|41695816|FG001|Overall Study|Physician Decision|0|||
19447793|NCT01737021|41695824|FG000|Overall Study|Lost to Follow-up|5|||
19447794|NCT01737021|41695825|FG001|Overall Study|Lost to Follow-up|3|||
19447795|NCT01397422|41695835|FG000|Overall Study|Adverse Event|0|||
19447796|NCT01397422|41695836|FG001|Overall Study|Adverse Event|3|||
19447797|NCT01397422|41695837|FG002|Overall Study|Adverse Event|3|||
19447798|NCT01397422|41695838|FG003|Overall Study|Adverse Event|8|||
19447799|NCT01397422|41695835|FG000|Overall Study|Withdrawal by Subject|1|||
19447800|NCT01397422|41695836|FG001|Overall Study|Withdrawal by Subject|0|||
19447801|NCT01397422|41695837|FG002|Overall Study|Withdrawal by Subject|0|||
19447802|NCT01397422|41695838|FG003|Overall Study|Withdrawal by Subject|0|||
19447803|NCT01397422|41695835|FG000|Overall Study|Increased bradykinesia related to PD|1|||
19447804|NCT01397422|41695836|FG001|Overall Study|Increased bradykinesia related to PD|0|||
19447805|NCT01397422|41695837|FG002|Overall Study|Increased bradykinesia related to PD|0|||
19447806|NCT01397422|41695838|FG003|Overall Study|Increased bradykinesia related to PD|0|||
19447807|NCT01736553|41695852|FG000|Overall Study|Death|12|||
19447808|NCT01736553|41695853|FG001|Overall Study|Death|0|||
19447809|NCT01736553|41695852|FG000|Overall Study|Withdrawal by Subject|5|||
19447810|NCT01736553|41695853|FG001|Overall Study|Withdrawal by Subject|2|||
19447811|NCT01736553|41695852|FG000|Overall Study|Lost to Follow-up|2|||
19447812|NCT01736553|41695853|FG001|Overall Study|Lost to Follow-up|2|||
19447813|NCT01888640|41695880|FG000|Overall Study|Lost to Follow-up|1|||
19447814|NCT01888640|41695881|FG001|Overall Study|Lost to Follow-up|2|||
19447815|NCT01888640|41695882|FG002|Overall Study|Lost to Follow-up|0|||
19447816|NCT01888640|41695880|FG000|Overall Study|Withdrawal by Subject|15|||
19447817|NCT01888640|41695881|FG001|Overall Study|Withdrawal by Subject|11|||
19447818|NCT01888640|41695882|FG002|Overall Study|Withdrawal by Subject|4|||
19447819|NCT01888640|41695880|FG000|Overall Study|Minimum dose not met|10|||
19447820|NCT01888640|41695881|FG001|Overall Study|Minimum dose not met|16|||
19447821|NCT01888640|41695882|FG002|Overall Study|Minimum dose not met|0|||
19447822|NCT01888640|41695880|FG000|Overall Study|Given wrong unit (placebo)|1|||
19447823|NCT01888640|41695881|FG001|Overall Study|Given wrong unit (placebo)|0|||
19447824|NCT01888640|41695882|FG002|Overall Study|Given wrong unit (placebo)|0|||
19447825|NCT01888640|41695880|FG000|Overall Study|Excluded for prior TENS|0|||
19447826|NCT01888640|41695881|FG001|Overall Study|Excluded for prior TENS|1|||
19447827|NCT01888640|41695882|FG002|Overall Study|Excluded for prior TENS|0|||
19447828|NCT01888640|41695880|FG000|Overall Study|Researcher Termination of Participant|0|||
19447829|NCT01888640|41695881|FG001|Overall Study|Researcher Termination of Participant|1|||
19447830|NCT01888640|41695882|FG002|Overall Study|Researcher Termination of Participant|1|||
19447831|NCT01736475|41695895|FG000|Overall Study|Adverse Event|4|||
19447832|NCT01736475|41695896|FG001|Overall Study|Adverse Event|0|||
19447833|NCT01736475|41695895|FG000|Overall Study|Withdrawal by Subject|2|||
19447834|NCT01736475|41695896|FG001|Overall Study|Withdrawal by Subject|0|||
19447835|NCT01736475|41695895|FG000|Overall Study|Protocol Violation|4|||
19447836|NCT01736475|41695896|FG001|Overall Study|Protocol Violation|0|||
19447837|NCT01736475|41695895|FG000|Overall Study|Other - Screen failure|1|||
19447838|NCT01736475|41695896|FG001|Overall Study|Other - Screen failure|0|||
19447839|NCT01736475|41695895|FG000|Overall Study|Other - Surgical procedure|1|||
19447840|NCT01736475|41695896|FG001|Overall Study|Other - Surgical procedure|0|||
19447841|NCT01863758|41695913|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
19525556|NCT02284568|41971109|FG000|Overall Study|Lack of Efficacy|4|||
19525557|NCT02284568|41971110|FG001|Overall Study|Lack of Efficacy|7|||
19447842|NCT01863758|41695913|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
19447843|NCT01863680|41695917|FG000|Overall Study|Adverse Event|17|||
19447844|NCT01863680|41695917|FG000|Overall Study|Risk of OHSS|17|||
19447845|NCT01863680|41695917|FG000|Overall Study|Spontaneous pregnancy|2|||
19447846|NCT01863680|41695917|FG000|Overall Study|Withdrawal by Subject|1|||
19447847|NCT01863680|41695917|FG000|Overall Study|Did not undergo IVF/ET|14|||
19447848|NCT01863680|41695917|FG000|Overall Study|Other|6|||
19447849|NCT01747629|41695923|FG000|Overall Study|Adverse Event|1|||
19447850|NCT01747629|41695924|FG001|Overall Study|Adverse Event|2|||
19447851|NCT01747629|41695923|FG000|Overall Study|Withdrawal by Subject|2|||
19447852|NCT01747629|41695924|FG001|Overall Study|Withdrawal by Subject|2|||
19447853|NCT01747629|41695923|FG000|Overall Study|Noncompliance|1|||
19447854|NCT01747629|41695924|FG001|Overall Study|Noncompliance|1|||
19447855|NCT01747629|41695923|FG000|Overall Study|Inclusion criteria not met|1|||
19447856|NCT01747629|41695924|FG001|Overall Study|Inclusion criteria not met|0|||
19447857|NCT01747629|41695923|FG000|Overall Study|Not treated|1|||
19447858|NCT01747629|41695924|FG001|Overall Study|Not treated|0|||
19447859|NCT01747629|41695923|FG000|Overall Study|Other|2|||
19447860|NCT01747629|41695924|FG001|Overall Study|Other|1|||
19447861|NCT01863368|41695932|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
19447862|NCT01863368|41695933|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
19447863|NCT01863368|41695932|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
19447864|NCT01863368|41695933|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
19447865|NCT01863368|41695932|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
19447866|NCT01863368|41695933|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
19447867|NCT01863368|41695932|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
19447868|NCT01863368|41695933|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
19447869|NCT01863368|41695932|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
19447870|NCT01863368|41695933|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
19447871|NCT01863368|41695932|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
19447872|NCT01863368|41695933|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
19447873|NCT01886690|41695942|FG000|Overall Study|Protocol Violation|0|||
19525558|NCT02284568|41971111|FG002|Overall Study|Lack of Efficacy|0|||
19525559|NCT02284568|41971109|FG000|Overall Study|Other|1|||
19525560|NCT02284568|41971110|FG001|Overall Study|Other|2|||
19525561|NCT02284568|41971111|FG002|Overall Study|Other|0|||
19525562|NCT02284568|41971109|FG000|Overall Study|Withdrew before taking study drug|0|||
19525563|NCT02284568|41971110|FG001|Overall Study|Withdrew before taking study drug|1|||
19525564|NCT02284568|41971111|FG002|Overall Study|Withdrew before taking study drug|0|||
19447874|NCT01886690|41695943|FG001|Overall Study|Protocol Violation|1|||
19447875|NCT01886690|41695942|FG000|Overall Study|Personal Reasons|0|||
19447876|NCT01886690|41695943|FG001|Overall Study|Personal Reasons|1|||
19447877|NCT01886378|41695949|FG000|Overall Study|Adverse Event|1|||
19447878|NCT01886378|41695949|FG000|Overall Study|Withdrawal by Subject|4|||
19447879|NCT01886300|41695953|FG000|Overall Study|Trial terminated by sponsor|16|||
19447880|NCT01885208|41695959|FG000|Overall Study|Unclassified|32|||
19447881|NCT01885208|41695960|FG001|Overall Study|Unclassified|38|||
19447882|NCT01859702|41695966|FG000|Overall Study|Protocol deviation|3|||
19447883|NCT01859702|41695966|FG000|Overall Study|Adverse Event|2|||
19447884|NCT01835132|41695970|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
19447885|NCT01747551|41695976|FG000|Overall Study|Progressive Disease|24|||
19447886|NCT01747551|41695977|FG001|Overall Study|Progressive Disease|17|||
19447887|NCT01747551|41695976|FG000|Overall Study|Death|3|||
19447888|NCT01747551|41695977|FG001|Overall Study|Death|1|||
19447889|NCT01747551|41695976|FG000|Overall Study|Adverse Event|7|||
19447890|NCT01747551|41695977|FG001|Overall Study|Adverse Event|1|||
19447891|NCT01747551|41695976|FG000|Overall Study|Prolonged Treatment Delay|2|||
19525565|NCT02195986|41971126|FG000|Overall Study|Adverse Event|3|||
19525566|NCT02195986|41971127|FG001|Overall Study|Adverse Event|0|||
19525567|NCT02195986|41971128|FG002|Overall Study|Adverse Event|0|||
19525568|NCT02195986|41971126|FG000|Overall Study|Withdrawal by Subject|0|||
19525569|NCT02195986|41971127|FG001|Overall Study|Withdrawal by Subject|3|||
19525570|NCT02195986|41971128|FG002|Overall Study|Withdrawal by Subject|0|||
19525571|NCT02195986|41971126|FG000|Overall Study|Family Emergency|0|||
19447892|NCT01747551|41695977|FG001|Overall Study|Prolonged Treatment Delay|0|||
19447893|NCT01747551|41695976|FG000|Overall Study|Withdrawal by Subject|3|||
19447894|NCT01747551|41695977|FG001|Overall Study|Withdrawal by Subject|1|||
19447895|NCT01747551|41695976|FG000|Overall Study|Physician Decision|2|||
19447896|NCT01747551|41695977|FG001|Overall Study|Physician Decision|1|||
19447897|NCT01747551|41695976|FG000|Overall Study|Other|2|||
19447898|NCT01747551|41695977|FG001|Overall Study|Other|0|||
19447899|NCT01736397|41695985|FG000|Overall Study|Lack of Efficacy|1|||
19447900|NCT01736397|41695986|FG001|Overall Study|Lack of Efficacy|11|||
19447901|NCT01736397|41695985|FG000|Overall Study|Withdrawal by Subject|6|||
19447902|NCT01736397|41695986|FG001|Overall Study|Withdrawal by Subject|5|||
19447903|NCT01736397|41695985|FG000|Overall Study|Lost to Follow-up|0|||
19447904|NCT01736397|41695986|FG001|Overall Study|Lost to Follow-up|1|||
19447905|NCT01736397|41695985|FG000|Overall Study|Adverse Event|6|||
19447906|NCT01736397|41695986|FG001|Overall Study|Adverse Event|3|||
19447907|NCT01736397|41695985|FG000|Overall Study|Not stated|1|||
19447908|NCT01736397|41695986|FG001|Overall Study|Not stated|4|||
19447909|NCT01859390|41695994|FG000|Overall Study|Insufficient Sputum Collected|1|||
19447910|NCT01859390|41695995|FG001|Overall Study|Insufficient Sputum Collected|3|||
19525572|NCT02195986|41971127|FG001|Overall Study|Family Emergency|0|||
19525573|NCT02195986|41971128|FG002|Overall Study|Family Emergency|1|||
19525574|NCT02195986|41971126|FG000|Overall Study|Protocol Violation|0|||
19447911|NCT01859390|41695994|FG000|Overall Study|Sample Missing Collection Date|0|||
19447912|NCT01859390|41695995|FG001|Overall Study|Sample Missing Collection Date|1|||
19447913|NCT01859390|41695994|FG000|Overall Study|Tube Cracked|0|||
19447914|NCT01859390|41695995|FG001|Overall Study|Tube Cracked|2|||
19525575|NCT02195986|41971127|FG001|Overall Study|Protocol Violation|1|||
19525576|NCT02195986|41971128|FG002|Overall Study|Protocol Violation|1|||
19525577|NCT02195986|41971126|FG000|Overall Study|Non-compliance|0|||
19525578|NCT02195986|41971127|FG001|Overall Study|Non-compliance|1|||
19525579|NCT02195986|41971128|FG002|Overall Study|Non-compliance|0|||
19525580|NCT01982630|41971144|FG000|Overall Study|Adverse Event|2|||
19525581|NCT01982630|41971145|FG001|Overall Study|Adverse Event|0|||
19525582|NCT01982630|41971146|FG002|Overall Study|Adverse Event|1|||
19525583|NCT01982630|41971147|FG003|Overall Study|Adverse Event|0|||
19525584|NCT01982630|41971148|FG004|Overall Study|Adverse Event|1|||
19525585|NCT01982630|41971149|FG005|Overall Study|Adverse Event|2|||
19525586|NCT01982630|41971150|FG006|Overall Study|Adverse Event|1|||
19525587|NCT01982630|41971151|FG007|Overall Study|Adverse Event|0|||
19525588|NCT01982630|41971144|FG000|Overall Study|Physician Decision|1|||
19525589|NCT01982630|41971145|FG001|Overall Study|Physician Decision|0|||
19525590|NCT01982630|41971146|FG002|Overall Study|Physician Decision|2|||
19525591|NCT01982630|41971147|FG003|Overall Study|Physician Decision|1|||
19525592|NCT01982630|41971148|FG004|Overall Study|Physician Decision|2|||
19525593|NCT01982630|41971149|FG005|Overall Study|Physician Decision|0|||
19525594|NCT01982630|41971150|FG006|Overall Study|Physician Decision|0|||
19525595|NCT01982630|41971151|FG007|Overall Study|Physician Decision|0|||
19525596|NCT01982630|41971144|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525597|NCT01982630|41971145|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525598|NCT01982630|41971146|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
19525599|NCT01982630|41971147|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525600|NCT01982630|41971148|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525601|NCT01982630|41971149|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525602|NCT01982630|41971150|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525603|NCT01982630|41971151|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
19525604|NCT01982630|41971144|FG000|Overall Study|Withdrawal by Subject|0|||
19525605|NCT01982630|41971145|FG001|Overall Study|Withdrawal by Subject|0|||
19525606|NCT01982630|41971146|FG002|Overall Study|Withdrawal by Subject|0|||
19447915|NCT01859390|41695994|FG000|Overall Study|Shipment Error|0|||
19447916|NCT01859390|41695995|FG001|Overall Study|Shipment Error|1|||
19447917|NCT01746225|41696004|FG000|Overall Study|Death|1|||
19525607|NCT01982630|41971147|FG003|Overall Study|Withdrawal by Subject|0|||
19525608|NCT01982630|41971148|FG004|Overall Study|Withdrawal by Subject|0|||
19525609|NCT01982630|41971149|FG005|Overall Study|Withdrawal by Subject|1|||
19525610|NCT01982630|41971150|FG006|Overall Study|Withdrawal by Subject|0|||
19525611|NCT01982630|41971151|FG007|Overall Study|Withdrawal by Subject|0|||
19525612|NCT01982448|41971206|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
19525613|NCT01982448|41971207|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
19525614|NCT01982448|41971206|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
19525615|NCT01982448|41971207|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
19525616|NCT01982448|41971206|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
19525617|NCT01982448|41971207|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
19525618|NCT01982448|41971206|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
19525619|NCT01982448|41971207|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
19525620|NCT01752920|41971230|FG000|Overall Study|Adverse Event|1|||
19525621|NCT01752920|41971231|FG001|Overall Study|Adverse Event|0|||
19525622|NCT01752920|41971232|FG002|Overall Study|Adverse Event|5|||
19525623|NCT01752920|41971233|FG003|Overall Study|Adverse Event|10|||
19525624|NCT01752920|41971230|FG000|Overall Study|Clinical Disease Progression|6|||
19525625|NCT01752920|41971231|FG001|Overall Study|Clinical Disease Progression|4|||
19525626|NCT01752920|41971232|FG002|Overall Study|Clinical Disease Progression|1|||
19629204|NCT00642460|42078697|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
19629205|NCT00814658|42078709|FG000|Overall Study|Lost to Follow-up|0|||
19525627|NCT01752920|41971233|FG003|Overall Study|Clinical Disease Progression|13|||
19525628|NCT01752920|41971230|FG000|Overall Study|Physician Decision|1|||
19525629|NCT01752920|41971231|FG001|Overall Study|Physician Decision|0|||
19525630|NCT01752920|41971232|FG002|Overall Study|Physician Decision|0|||
19525631|NCT01752920|41971233|FG003|Overall Study|Physician Decision|3|||
19525632|NCT01752920|41971230|FG000|Overall Study|Radiographic Disease Progression|20|||
19629206|NCT00814658|42078710|FG001|Overall Study|Lost to Follow-up|1|||
19447918|NCT01746225|41696005|FG001|Overall Study|Death|0|||
19447919|NCT01746225|41696006|FG002|Overall Study|Death|1|||
19447920|NCT01746225|41696004|FG000|Overall Study|Withdrawal by Subject|5|||
19447921|NCT01746225|41696005|FG001|Overall Study|Withdrawal by Subject|15|||
19447922|NCT01746225|41696006|FG002|Overall Study|Withdrawal by Subject|19|||
19525633|NCT01752920|41971231|FG001|Overall Study|Radiographic Disease Progression|7|||
19447923|NCT01746225|41696004|FG000|Overall Study|Physician Decision|14|||
19447924|NCT01746225|41696005|FG001|Overall Study|Physician Decision|11|||
19447925|NCT01746225|41696006|FG002|Overall Study|Physician Decision|3|||
19447926|NCT01746225|41696004|FG000|Overall Study|Adverse Event|15|||
19525634|NCT01752920|41971232|FG002|Overall Study|Radiographic Disease Progression|12|||
19525635|NCT01752920|41971233|FG003|Overall Study|Radiographic Disease Progression|29|||
19447927|NCT01746225|41696005|FG001|Overall Study|Adverse Event|12|||
19447928|NCT01746225|41696006|FG002|Overall Study|Adverse Event|17|||
19447929|NCT01746225|41696004|FG000|Overall Study|Continuing Treatment|5|||
19447930|NCT01746225|41696005|FG001|Overall Study|Continuing Treatment|8|||
19447931|NCT01746225|41696006|FG002|Overall Study|Continuing Treatment|3|||
19447932|NCT01858766|41696033|FG000|Overall Study|Randomized but Never Treated|0|||
19447933|NCT01858766|41696034|FG001|Overall Study|Randomized but Never Treated|0|||
19447934|NCT01858766|41696035|FG002|Overall Study|Randomized but Never Treated|0|||
19447935|NCT01858766|41696036|FG003|Overall Study|Randomized but Never Treated|0|||
19447936|NCT01858766|41696037|FG004|Overall Study|Randomized but Never Treated|0|||
19447937|NCT01858766|41696038|FG005|Overall Study|Randomized but Never Treated|1|||
19447938|NCT01858766|41696039|FG006|Overall Study|Randomized but Never Treated|0|||
19447939|NCT01858766|41696040|FG007|Overall Study|Randomized but Never Treated|0|||
19447940|NCT01858766|41696041|FG008|Overall Study|Randomized but Never Treated|0|||
19447941|NCT01858766|41696042|FG009|Overall Study|Randomized but Never Treated|0|||
19447942|NCT01858766|41696043|FG010|Overall Study|Randomized but Never Treated|0|||
19447943|NCT01858766|41696044|FG011|Overall Study|Randomized but Never Treated|0|||
19447944|NCT01858766|41696045|FG012|Overall Study|Randomized but Never Treated|0|||
19447945|NCT01858766|41696046|FG013|Overall Study|Randomized but Never Treated|0|||
19447946|NCT01858766|41696047|FG014|Overall Study|Randomized but Never Treated|0|||
19447947|NCT01858766|41696048|FG015|Overall Study|Randomized but Never Treated|0|||
19447948|NCT01858766|41696049|FG016|Overall Study|Randomized but Never Treated|0|||
19447949|NCT01858766|41696050|FG017|Overall Study|Randomized but Never Treated|1|||
19447950|NCT01858766|41696051|FG018|Overall Study|Randomized but Never Treated|0|||
19447951|NCT01858766|41696033|FG000|Overall Study|Death|0|||
19447952|NCT01858766|41696034|FG001|Overall Study|Death|0|||
19525636|NCT01752920|41971230|FG000|Overall Study|Study Terminated by Sponsor|0|||
19525637|NCT01752920|41971231|FG001|Overall Study|Study Terminated by Sponsor|0|||
19525638|NCT01752920|41971232|FG002|Overall Study|Study Terminated by Sponsor|0|||
19525639|NCT01752920|41971233|FG003|Overall Study|Study Terminated by Sponsor|1|||
19525640|NCT01752920|41971230|FG000|Overall Study|Withdrawal by Subject|0|||
19525641|NCT01752920|41971231|FG001|Overall Study|Withdrawal by Subject|1|||
19525642|NCT01752920|41971232|FG002|Overall Study|Withdrawal by Subject|0|||
19525643|NCT01752920|41971233|FG003|Overall Study|Withdrawal by Subject|1|||
19525644|NCT01752920|41971230|FG000|Overall Study|Lack of clinical benefit|1|||
19525645|NCT01752920|41971231|FG001|Overall Study|Lack of clinical benefit|1|||
19525646|NCT01752920|41971232|FG002|Overall Study|Lack of clinical benefit|1|||
19525647|NCT01752920|41971233|FG003|Overall Study|Lack of clinical benefit|1|||
19525648|NCT01740297|41971248|FG000|Overall Study|Withdrawal by Subject|4|||
19525649|NCT01740297|41971249|FG001|Overall Study|Withdrawal by Subject|16|||
19525650|NCT01740297|41971250|FG002|Overall Study|Withdrawal by Subject|17|||
19525651|NCT01740297|41971248|FG000|Overall Study|Death|8|||
19525652|NCT01740297|41971249|FG001|Overall Study|Death|46|||
19525653|NCT01740297|41971250|FG002|Overall Study|Death|40|||
19447953|NCT01858766|41696035|FG002|Overall Study|Death|1|||
19447954|NCT01858766|41696036|FG003|Overall Study|Death|0|||
19447955|NCT01858766|41696037|FG004|Overall Study|Death|0|||
19447956|NCT01858766|41696038|FG005|Overall Study|Death|0|||
19525654|NCT01740297|41971248|FG000|Overall Study|Lost to Follow-up|1|||
19525655|NCT01740297|41971249|FG001|Overall Study|Lost to Follow-up|2|||
19525656|NCT01740297|41971250|FG002|Overall Study|Lost to Follow-up|4|||
19525657|NCT01729754|41971264|FG000|Part 1|Adverse Event|2|||
19447957|NCT01858766|41696039|FG006|Overall Study|Death|0|||
19447958|NCT01858766|41696040|FG007|Overall Study|Death|0|||
19447959|NCT01858766|41696041|FG008|Overall Study|Death|0|||
19525658|NCT01729754|41971265|FG001|Part 1|Adverse Event|0|||
19525659|NCT01729754|41971266|FG002|Part 1|Adverse Event|0|||
19525660|NCT01729754|41971267|FG003|Part 1|Adverse Event|1|||
19525661|NCT01729754|41971268|FG004|Part 1|Adverse Event|0|||
19525662|NCT01729754|41971269|FG005|Part 1|Adverse Event|0|||
19525663|NCT01729754|41971270|FG006|Part 1|Adverse Event|2|||
19525664|NCT01729754|41971271|FG007|Part 1|Adverse Event|0|||
19525665|NCT01729754|41971272|FG008|Part 1|Adverse Event|0|||
19525666|NCT01729754|41971273|FG009|Part 1|Adverse Event|5|||
19525667|NCT01729754|41971264|FG000|Part 1|Lack of Efficacy|1|||
19525668|NCT01729754|41971265|FG001|Part 1|Lack of Efficacy|0|||
19525669|NCT01729754|41971266|FG002|Part 1|Lack of Efficacy|0|||
19525670|NCT01729754|41971267|FG003|Part 1|Lack of Efficacy|0|||
19525671|NCT01729754|41971268|FG004|Part 1|Lack of Efficacy|0|||
19525672|NCT01729754|41971269|FG005|Part 1|Lack of Efficacy|0|||
19525673|NCT01729754|41971270|FG006|Part 1|Lack of Efficacy|2|||
19525674|NCT01729754|41971271|FG007|Part 1|Lack of Efficacy|0|||
19525675|NCT01729754|41971272|FG008|Part 1|Lack of Efficacy|0|||
19525676|NCT01729754|41971273|FG009|Part 1|Lack of Efficacy|0|||
19525677|NCT01729754|41971264|FG000|Part 1|Lost to Follow-up|1|||
19525678|NCT01729754|41971265|FG001|Part 1|Lost to Follow-up|0|||
19629207|NCT00814658|42078709|FG000|Overall Study|Physician Decision|1|||
19525679|NCT01729754|41971266|FG002|Part 1|Lost to Follow-up|0|||
19525680|NCT01729754|41971267|FG003|Part 1|Lost to Follow-up|2|||
19525681|NCT01729754|41971268|FG004|Part 1|Lost to Follow-up|0|||
19447960|NCT01858766|41696042|FG009|Overall Study|Death|0|||
19447961|NCT01858766|41696043|FG010|Overall Study|Death|0|||
19447962|NCT01858766|41696044|FG011|Overall Study|Death|0|||
19447963|NCT01858766|41696045|FG012|Overall Study|Death|0|||
19525682|NCT01729754|41971269|FG005|Part 1|Lost to Follow-up|0|||
19525683|NCT01729754|41971270|FG006|Part 1|Lost to Follow-up|3|||
19525684|NCT01729754|41971271|FG007|Part 1|Lost to Follow-up|0|||
19525685|NCT01729754|41971272|FG008|Part 1|Lost to Follow-up|0|||
19525686|NCT01729754|41971273|FG009|Part 1|Lost to Follow-up|3|||
19525687|NCT01729754|41971264|FG000|Part 1|Non-compliance with Study Drug|1|||
19525688|NCT01729754|41971265|FG001|Part 1|Non-compliance with Study Drug|0|||
19525689|NCT01729754|41971266|FG002|Part 1|Non-compliance with Study Drug|0|||
19525690|NCT01729754|41971267|FG003|Part 1|Non-compliance with Study Drug|0|||
19525691|NCT01729754|41971268|FG004|Part 1|Non-compliance with Study Drug|0|||
19525692|NCT01729754|41971269|FG005|Part 1|Non-compliance with Study Drug|0|||
19525693|NCT01729754|41971270|FG006|Part 1|Non-compliance with Study Drug|0|||
19525694|NCT01729754|41971271|FG007|Part 1|Non-compliance with Study Drug|0|||
19525695|NCT01729754|41971272|FG008|Part 1|Non-compliance with Study Drug|0|||
19525696|NCT01729754|41971273|FG009|Part 1|Non-compliance with Study Drug|0|||
19525697|NCT01729754|41971264|FG000|Part 1|Physician Decision|0|||
19525698|NCT01729754|41971265|FG001|Part 1|Physician Decision|0|||
19525699|NCT01729754|41971266|FG002|Part 1|Physician Decision|0|||
19447964|NCT01858766|41696046|FG013|Overall Study|Death|0|||
19525700|NCT01729754|41971267|FG003|Part 1|Physician Decision|0|||
19525701|NCT01729754|41971268|FG004|Part 1|Physician Decision|0|||
19525702|NCT01729754|41971269|FG005|Part 1|Physician Decision|0|||
19525703|NCT01729754|41971270|FG006|Part 1|Physician Decision|0|||
19525704|NCT01729754|41971271|FG007|Part 1|Physician Decision|0|||
19525705|NCT01729754|41971272|FG008|Part 1|Physician Decision|0|||
19525706|NCT01729754|41971273|FG009|Part 1|Physician Decision|4|||
19525707|NCT01729754|41971264|FG000|Part 1|Pregnancy|0|||
19525708|NCT01729754|41971265|FG001|Part 1|Pregnancy|0|||
19525709|NCT01729754|41971266|FG002|Part 1|Pregnancy|0|||
19525710|NCT01729754|41971267|FG003|Part 1|Pregnancy|1|||
19525711|NCT01729754|41971268|FG004|Part 1|Pregnancy|0|||
19525712|NCT01729754|41971269|FG005|Part 1|Pregnancy|0|||
19525713|NCT01729754|41971270|FG006|Part 1|Pregnancy|0|||
19525714|NCT01729754|41971271|FG007|Part 1|Pregnancy|0|||
19525715|NCT01729754|41971272|FG008|Part 1|Pregnancy|0|||
19525716|NCT01729754|41971273|FG009|Part 1|Pregnancy|1|||
19525717|NCT01729754|41971264|FG000|Part 1|Progressive Disease|0|||
19525718|NCT01729754|41971265|FG001|Part 1|Progressive Disease|0|||
19525719|NCT01729754|41971266|FG002|Part 1|Progressive Disease|0|||
19525720|NCT01729754|41971267|FG003|Part 1|Progressive Disease|0|||
19525721|NCT01729754|41971268|FG004|Part 1|Progressive Disease|0|||
19525722|NCT01729754|41971269|FG005|Part 1|Progressive Disease|0|||
19525723|NCT01729754|41971270|FG006|Part 1|Progressive Disease|0|||
19525724|NCT01729754|41971271|FG007|Part 1|Progressive Disease|0|||
19525725|NCT01729754|41971272|FG008|Part 1|Progressive Disease|0|||
19525726|NCT01729754|41971273|FG009|Part 1|Progressive Disease|1|||
19525727|NCT01729754|41971264|FG000|Part 1|Protocol Violation|2|||
19525728|NCT01729754|41971265|FG001|Part 1|Protocol Violation|0|||
19525729|NCT01729754|41971266|FG002|Part 1|Protocol Violation|0|||
19525730|NCT01729754|41971267|FG003|Part 1|Protocol Violation|1|||
19525731|NCT01729754|41971268|FG004|Part 1|Protocol Violation|0|||
19525732|NCT01729754|41971269|FG005|Part 1|Protocol Violation|0|||
19525733|NCT01729754|41971270|FG006|Part 1|Protocol Violation|1|||
19629208|NCT00814658|42078710|FG001|Overall Study|Physician Decision|0|||
19447965|NCT01858766|41696047|FG014|Overall Study|Death|0|||
19447966|NCT01858766|41696048|FG015|Overall Study|Death|0|||
19447967|NCT01858766|41696049|FG016|Overall Study|Death|0|||
19447968|NCT01858766|41696050|FG017|Overall Study|Death|0|||
19447969|NCT01858766|41696051|FG018|Overall Study|Death|0|||
19447970|NCT01858766|41696033|FG000|Overall Study|Lack of Efficacy|1|||
19447971|NCT01858766|41696034|FG001|Overall Study|Lack of Efficacy|0|||
19447972|NCT01858766|41696035|FG002|Overall Study|Lack of Efficacy|0|||
19447973|NCT01858766|41696036|FG003|Overall Study|Lack of Efficacy|0|||
19447974|NCT01858766|41696037|FG004|Overall Study|Lack of Efficacy|1|||
19447975|NCT01858766|41696038|FG005|Overall Study|Lack of Efficacy|2|||
19447976|NCT01858766|41696039|FG006|Overall Study|Lack of Efficacy|0|||
19447977|NCT01858766|41696040|FG007|Overall Study|Lack of Efficacy|0|||
19447978|NCT01858766|41696041|FG008|Overall Study|Lack of Efficacy|0|||
19447979|NCT01858766|41696042|FG009|Overall Study|Lack of Efficacy|0|||
19447980|NCT01858766|41696043|FG010|Overall Study|Lack of Efficacy|0|||
19447981|NCT01858766|41696044|FG011|Overall Study|Lack of Efficacy|3|||
19447982|NCT01858766|41696045|FG012|Overall Study|Lack of Efficacy|5|||
19525734|NCT01729754|41971271|FG007|Part 1|Protocol Violation|0|||
19447983|NCT01858766|41696046|FG013|Overall Study|Lack of Efficacy|3|||
19447984|NCT01858766|41696047|FG014|Overall Study|Lack of Efficacy|5|||
19447985|NCT01858766|41696048|FG015|Overall Study|Lack of Efficacy|5|||
19525735|NCT01729754|41971272|FG008|Part 1|Protocol Violation|0|||
19525736|NCT01729754|41971273|FG009|Part 1|Protocol Violation|0|||
19525737|NCT01729754|41971264|FG000|Part 1|Withdrawal by Subject|5|||
19525738|NCT01729754|41971265|FG001|Part 1|Withdrawal by Subject|0|||
19525739|NCT01729754|41971266|FG002|Part 1|Withdrawal by Subject|0|||
19525740|NCT01729754|41971267|FG003|Part 1|Withdrawal by Subject|7|||
19525741|NCT01729754|41971268|FG004|Part 1|Withdrawal by Subject|0|||
19525742|NCT01729754|41971269|FG005|Part 1|Withdrawal by Subject|0|||
19525743|NCT01729754|41971270|FG006|Part 1|Withdrawal by Subject|5|||
19447986|NCT01858766|41696049|FG016|Overall Study|Lack of Efficacy|2|||
19447987|NCT01858766|41696050|FG017|Overall Study|Lack of Efficacy|3|||
19447988|NCT01858766|41696051|FG018|Overall Study|Lack of Efficacy|3|||
19525744|NCT01729754|41971271|FG007|Part 1|Withdrawal by Subject|0|||
19525745|NCT01729754|41971272|FG008|Part 1|Withdrawal by Subject|0|||
19447989|NCT01858766|41696033|FG000|Overall Study|Lost to Follow-up|0|||
19447990|NCT01858766|41696034|FG001|Overall Study|Lost to Follow-up|0|||
19447991|NCT01858766|41696035|FG002|Overall Study|Lost to Follow-up|0|||
19525746|NCT01729754|41971273|FG009|Part 1|Withdrawal by Subject|6|||
19525747|NCT01729754|41971264|FG000|Part 1|Other Protocol Specified Criteria|2|||
19525748|NCT01729754|41971265|FG001|Part 1|Other Protocol Specified Criteria|0|||
19525749|NCT01729754|41971266|FG002|Part 1|Other Protocol Specified Criteria|0|||
19525750|NCT01729754|41971267|FG003|Part 1|Other Protocol Specified Criteria|0|||
19525751|NCT01729754|41971268|FG004|Part 1|Other Protocol Specified Criteria|0|||
19525752|NCT01729754|41971269|FG005|Part 1|Other Protocol Specified Criteria|0|||
19525753|NCT01729754|41971270|FG006|Part 1|Other Protocol Specified Criteria|1|||
19447992|NCT01858766|41696036|FG003|Overall Study|Lost to Follow-up|0|||
19447993|NCT01858766|41696037|FG004|Overall Study|Lost to Follow-up|0|||
19447994|NCT01858766|41696038|FG005|Overall Study|Lost to Follow-up|1|||
19447995|NCT01858766|41696039|FG006|Overall Study|Lost to Follow-up|0|||
19447996|NCT01858766|41696040|FG007|Overall Study|Lost to Follow-up|2|||
19447997|NCT01858766|41696041|FG008|Overall Study|Lost to Follow-up|0|||
19447998|NCT01858766|41696042|FG009|Overall Study|Lost to Follow-up|0|||
19447999|NCT01858766|41696043|FG010|Overall Study|Lost to Follow-up|0|||
19448000|NCT01858766|41696044|FG011|Overall Study|Lost to Follow-up|1|||
19448001|NCT01858766|41696045|FG012|Overall Study|Lost to Follow-up|0|||
19448002|NCT01858766|41696046|FG013|Overall Study|Lost to Follow-up|0|||
19448003|NCT01858766|41696047|FG014|Overall Study|Lost to Follow-up|3|||
19448004|NCT01858766|41696048|FG015|Overall Study|Lost to Follow-up|1|||
19448005|NCT01858766|41696049|FG016|Overall Study|Lost to Follow-up|1|||
19448006|NCT01858766|41696050|FG017|Overall Study|Lost to Follow-up|0|||
19525754|NCT01729754|41971271|FG007|Part 1|Other Protocol Specified Criteria|0|||
19525755|NCT01729754|41971272|FG008|Part 1|Other Protocol Specified Criteria|0|||
19448007|NCT01858766|41696051|FG018|Overall Study|Lost to Follow-up|1|||
19448008|NCT01858766|41696033|FG000|Overall Study|Withdrew Consent|0|||
19448009|NCT01858766|41696034|FG001|Overall Study|Withdrew Consent|0|||
19448010|NCT01858766|41696035|FG002|Overall Study|Withdrew Consent|0|||
19525756|NCT01729754|41971273|FG009|Part 1|Other Protocol Specified Criteria|4|||
19525757|NCT01729754|41971264|FG000|Part 2|Adverse Event|2|||
19525758|NCT01729754|41971265|FG001|Part 2|Adverse Event|0|||
19525759|NCT01729754|41971266|FG002|Part 2|Adverse Event|0|||
19525760|NCT01729754|41971267|FG003|Part 2|Adverse Event|0|||
19525761|NCT01729754|41971268|FG004|Part 2|Adverse Event|0|||
19525762|NCT01729754|41971269|FG005|Part 2|Adverse Event|0|||
19525763|NCT01729754|41971270|FG006|Part 2|Adverse Event|0|||
19629209|NCT00814658|42078709|FG000|Overall Study|Adverse Event|3|||
19629210|NCT00814658|42078710|FG001|Overall Study|Adverse Event|3|||
19448011|NCT01858766|41696036|FG003|Overall Study|Withdrew Consent|0|||
19448012|NCT01858766|41696037|FG004|Overall Study|Withdrew Consent|0|||
19448013|NCT01858766|41696038|FG005|Overall Study|Withdrew Consent|0|||
19448014|NCT01858766|41696039|FG006|Overall Study|Withdrew Consent|0|||
19448015|NCT01858766|41696040|FG007|Overall Study|Withdrew Consent|0|||
19448016|NCT01858766|41696041|FG008|Overall Study|Withdrew Consent|0|||
19448017|NCT01858766|41696042|FG009|Overall Study|Withdrew Consent|0|||
19448018|NCT01858766|41696043|FG010|Overall Study|Withdrew Consent|0|||
19448019|NCT01858766|41696044|FG011|Overall Study|Withdrew Consent|1|||
19448020|NCT01858766|41696045|FG012|Overall Study|Withdrew Consent|0|||
19448021|NCT01858766|41696046|FG013|Overall Study|Withdrew Consent|0|||
19448022|NCT01858766|41696047|FG014|Overall Study|Withdrew Consent|0|||
19448023|NCT01858766|41696048|FG015|Overall Study|Withdrew Consent|0|||
19448024|NCT01858766|41696049|FG016|Overall Study|Withdrew Consent|0|||
19448025|NCT01858766|41696050|FG017|Overall Study|Withdrew Consent|0|||
19629211|NCT00642304|42078726|FG000|Overall Study|Adverse Event|1|||
19629212|NCT00642304|42078726|FG000|Overall Study|Death|1|||
19629213|NCT00642304|42078726|FG000|Overall Study|Blood transfusion|2|||
19629214|NCT00642304|42078726|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
19448026|NCT01858766|41696051|FG018|Overall Study|Withdrew Consent|0|||
19448027|NCT01858688|41696084|FG000|Overall Study|Withdrawal by Subject|8|||
19448028|NCT01858688|41696084|FG000|Overall Study|Participant began another therapy|3|||
19448029|NCT01858688|41696084|FG000|Overall Study|Physician Decision|2|||
19448030|NCT01858688|41696084|FG000|Overall Study|Progressive Disease|2|||
19448031|NCT01858688|41696084|FG000|Overall Study|Reason not reproted|5|||
19525764|NCT01729754|41971271|FG007|Part 2|Adverse Event|0|||
19525765|NCT01729754|41971272|FG008|Part 2|Adverse Event|1|||
19525766|NCT01729754|41971273|FG009|Part 2|Adverse Event|2|||
19525767|NCT01729754|41971264|FG000|Part 2|Lack of Efficacy|0|||
19525768|NCT01729754|41971265|FG001|Part 2|Lack of Efficacy|0|||
19448032|NCT01734993|41696088|FG000|Overall Study|Adverse Event|1|||
19525769|NCT01729754|41971266|FG002|Part 2|Lack of Efficacy|0|||
19525770|NCT01729754|41971267|FG003|Part 2|Lack of Efficacy|0|||
19525771|NCT01729754|41971268|FG004|Part 2|Lack of Efficacy|0|||
19525772|NCT01729754|41971269|FG005|Part 2|Lack of Efficacy|0|||
19448033|NCT01734993|41696088|FG000|Overall Study|Lack of Efficacy|1|||
19448034|NCT01745367|41696095|FG000|Overall Study|Death|1|||
19448035|NCT01745367|41696096|FG001|Overall Study|Death|0|||
19448036|NCT01745367|41696095|FG000|Overall Study|Withdrawal by Subject|1|||
19448037|NCT01745367|41696096|FG001|Overall Study|Withdrawal by Subject|2|||
19448038|NCT01745367|41696095|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
19448039|NCT01745367|41696096|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
19448040|NCT01745367|41696095|FG000|Overall Study|Other Reasons Unspecified|0|||
19448041|NCT01745367|41696096|FG001|Overall Study|Other Reasons Unspecified|2|||
19448042|NCT01733121|41696104|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
19448043|NCT01733121|41696105|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
19448044|NCT01733121|41696104|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
19448045|NCT01733121|41696105|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
19448046|NCT01733121|41696104|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
19448047|NCT01733121|41696105|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
19448048|NCT01733121|41696104|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
19448049|NCT01733121|41696105|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
19448050|NCT01744977|41696115|FG000|Overall Study|Withdrawal by Subject|1|||
19448051|NCT01744977|41696116|FG001|Overall Study|Withdrawal by Subject|2|||
19448052|NCT01744977|41696115|FG000|Overall Study|Death|2|||
19448053|NCT01744977|41696116|FG001|Overall Study|Death|3|||
19448054|NCT01744977|41696115|FG000|Overall Study|Lost to Follow-up|2|||
19448055|NCT01744977|41696116|FG001|Overall Study|Lost to Follow-up|0|||
19525773|NCT01729754|41971270|FG006|Part 2|Lack of Efficacy|0|||
19525774|NCT01729754|41971271|FG007|Part 2|Lack of Efficacy|0|||
19525775|NCT01729754|41971272|FG008|Part 2|Lack of Efficacy|2|||
19525776|NCT01729754|41971273|FG009|Part 2|Lack of Efficacy|2|||
19525777|NCT01729754|41971264|FG000|Part 2|Lost to Follow-up|0|||
19525778|NCT01729754|41971265|FG001|Part 2|Lost to Follow-up|0|||
19525779|NCT01729754|41971266|FG002|Part 2|Lost to Follow-up|0|||
19525780|NCT01729754|41971267|FG003|Part 2|Lost to Follow-up|2|||
19525781|NCT01729754|41971268|FG004|Part 2|Lost to Follow-up|0|||
19525782|NCT01729754|41971269|FG005|Part 2|Lost to Follow-up|0|||
19525783|NCT01729754|41971270|FG006|Part 2|Lost to Follow-up|0|||
19525784|NCT01729754|41971271|FG007|Part 2|Lost to Follow-up|1|||
19525785|NCT01729754|41971272|FG008|Part 2|Lost to Follow-up|0|||
19525786|NCT01729754|41971273|FG009|Part 2|Lost to Follow-up|2|||
19525787|NCT01729754|41971264|FG000|Part 2|Non-Compliance with Study Drug|0|||
19525788|NCT01729754|41971265|FG001|Part 2|Non-Compliance with Study Drug|0|||
19525789|NCT01729754|41971266|FG002|Part 2|Non-Compliance with Study Drug|0|||
19525790|NCT01729754|41971267|FG003|Part 2|Non-Compliance with Study Drug|0|||
19525791|NCT01729754|41971268|FG004|Part 2|Non-Compliance with Study Drug|0|||
19525792|NCT01729754|41971269|FG005|Part 2|Non-Compliance with Study Drug|0|||
19525793|NCT01729754|41971270|FG006|Part 2|Non-Compliance with Study Drug|0|||
19448056|NCT01744977|41696115|FG000|Overall Study|No longer meets inclusion|6|||
19448057|NCT01744977|41696116|FG001|Overall Study|No longer meets inclusion|0|||
19448058|NCT01383928|41696125|FG000|Overall Study|Initiation of ASCT|2|||
19448059|NCT01383928|41696126|FG001|Overall Study|Initiation of ASCT|1|||
19448060|NCT01383928|41696127|FG002|Overall Study|Initiation of ASCT|18|||
19448061|NCT01383928|41696125|FG000|Overall Study|Adverse Event|1|||
19448062|NCT01383928|41696126|FG001|Overall Study|Adverse Event|2|||
19448063|NCT01383928|41696127|FG002|Overall Study|Adverse Event|8|||
19448064|NCT01383928|41696125|FG000|Overall Study|Other|1|||
19448065|NCT01383928|41696126|FG001|Overall Study|Other|3|||
19448066|NCT01383928|41696127|FG002|Overall Study|Other|4|||
19525794|NCT01729754|41971271|FG007|Part 2|Non-Compliance with Study Drug|0|||
19448067|NCT01383928|41696125|FG000|Overall Study|Progressive Disease|1|||
19448068|NCT01383928|41696126|FG001|Overall Study|Progressive Disease|1|||
19448069|NCT01383928|41696127|FG002|Overall Study|Progressive Disease|5|||
19525795|NCT01729754|41971272|FG008|Part 2|Non-Compliance with Study Drug|0|||
19525796|NCT01729754|41971273|FG009|Part 2|Non-Compliance with Study Drug|1|||
19448070|NCT01383928|41696125|FG000|Overall Study|Withdrawal by Subject|0|||
19448071|NCT01383928|41696126|FG001|Overall Study|Withdrawal by Subject|0|||
19448072|NCT01383928|41696127|FG002|Overall Study|Withdrawal by Subject|4|||
19448073|NCT01383928|41696125|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
19448074|NCT01383928|41696126|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
19525797|NCT01729754|41971264|FG000|Part 2|Pregnancy|0|||
19525798|NCT01729754|41971265|FG001|Part 2|Pregnancy|0|||
19525799|NCT01729754|41971266|FG002|Part 2|Pregnancy|0|||
19525800|NCT01729754|41971267|FG003|Part 2|Pregnancy|1|||
19525801|NCT01729754|41971268|FG004|Part 2|Pregnancy|0|||
19525802|NCT01729754|41971269|FG005|Part 2|Pregnancy|0|||
19525803|NCT01729754|41971270|FG006|Part 2|Pregnancy|0|||
19525804|NCT01729754|41971271|FG007|Part 2|Pregnancy|0|||
19629215|NCT00642304|42078726|FG000|Overall Study|Transplantation|1|||
19525805|NCT01729754|41971272|FG008|Part 2|Pregnancy|0|||
19525806|NCT01729754|41971273|FG009|Part 2|Pregnancy|1|||
19525807|NCT01729754|41971264|FG000|Part 2|Withdrawal by Subject|3|||
19525808|NCT01729754|41971265|FG001|Part 2|Withdrawal by Subject|0|||
19525809|NCT01729754|41971266|FG002|Part 2|Withdrawal by Subject|0|||
19525810|NCT01729754|41971267|FG003|Part 2|Withdrawal by Subject|2|||
19525811|NCT01729754|41971268|FG004|Part 2|Withdrawal by Subject|0|||
19525812|NCT01729754|41971269|FG005|Part 2|Withdrawal by Subject|0|||
19448075|NCT01383928|41696127|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
19448076|NCT01606137|41696137|FG000|Overall Study|Adverse Event|85|||
19448077|NCT01606137|41696137|FG000|Overall Study|Withdrawal by Subject|74|||
19448078|NCT01606137|41696137|FG000|Overall Study|Lack of Efficacy|56|||
19448079|NCT01606137|41696137|FG000|Overall Study|Lost to Follow-up|15|||
19448080|NCT01606137|41696137|FG000|Overall Study|Protocol Violation|1|||
19448081|NCT01606137|41696137|FG000|Overall Study|Patient non-compliance|9|||
19448082|NCT01606137|41696137|FG000|Overall Study|Death|1|||
19525813|NCT01729754|41971270|FG006|Part 2|Withdrawal by Subject|0|||
19525814|NCT01729754|41971271|FG007|Part 2|Withdrawal by Subject|1|||
19525815|NCT01729754|41971272|FG008|Part 2|Withdrawal by Subject|1|||
19525816|NCT01729754|41971273|FG009|Part 2|Withdrawal by Subject|4|||
19525817|NCT01729754|41971264|FG000|Part 2|Other Protocol Specified Criteria|1|||
19525818|NCT01729754|41971265|FG001|Part 2|Other Protocol Specified Criteria|0|||
19448083|NCT01606137|41696137|FG000|Overall Study|Decreased/no pain|4|||
19448084|NCT01606137|41696137|FG000|Overall Study|Issues with driving|4|||
19448085|NCT01606137|41696137|FG000|Overall Study|multiple sclerosis less stable|1|||
19448086|NCT01606137|41696137|FG000|Overall Study|Increased bilirubin|1|||
19448087|NCT01606137|41696137|FG000|Overall Study|Spray causes nausea|1|||
19448088|NCT01606137|41696137|FG000|Overall Study|Not enough improvement|4|||
19448089|NCT01606137|41696137|FG000|Overall Study|Wanted to try another treatment|1|||
19448090|NCT01606137|41696137|FG000|Overall Study|Patient leaving country|1|||
19448091|NCT01606137|41696137|FG000|Overall Study|Personal reasons|1|||
19448092|NCT01606137|41696137|FG000|Overall Study|Unable to tolerate study med. taste|1|||
19448093|NCT01606137|41696137|FG000|Overall Study|Patient moving|1|||
19448094|NCT01606137|41696137|FG000|Overall Study|Unable to collect consistent data|1|||
19448095|NCT01382602|41696143|FG000|Overall Study|Protocol Violation|0|||
19448096|NCT01382602|41696144|FG001|Overall Study|Protocol Violation|3|||
19448097|NCT01382602|41696143|FG000|Overall Study|Withdrawal by Subject|0|||
19448098|NCT01382602|41696144|FG001|Overall Study|Withdrawal by Subject|1|||
19448099|NCT01382446|41696152|FG000|Overall Study|Withdrawal by Subject|0|||
19448100|NCT01382446|41696153|FG001|Overall Study|Withdrawal by Subject|1|||
19448101|NCT01382446|41696152|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
19525819|NCT01729754|41971266|FG002|Part 2|Other Protocol Specified Criteria|0|||
19525820|NCT01729754|41971267|FG003|Part 2|Other Protocol Specified Criteria|0|||
19525821|NCT01729754|41971268|FG004|Part 2|Other Protocol Specified Criteria|0|||
19525822|NCT01729754|41971269|FG005|Part 2|Other Protocol Specified Criteria|0|||
19525823|NCT01729754|41971270|FG006|Part 2|Other Protocol Specified Criteria|0|||
19525824|NCT01729754|41971271|FG007|Part 2|Other Protocol Specified Criteria|1|||
19525825|NCT01729754|41971272|FG008|Part 2|Other Protocol Specified Criteria|0|||
19525826|NCT01729754|41971273|FG009|Part 2|Other Protocol Specified Criteria|0|||
19525827|NCT01729754|41971264|FG000|Part 3|Adverse Event|0|||
19525828|NCT01729754|41971265|FG001|Part 3|Adverse Event|0|||
19525829|NCT01729754|41971266|FG002|Part 3|Adverse Event|1|||
19525830|NCT01729754|41971267|FG003|Part 3|Adverse Event|0|||
19525831|NCT01729754|41971268|FG004|Part 3|Adverse Event|0|||
19525832|NCT01729754|41971269|FG005|Part 3|Adverse Event|5|||
19525833|NCT01729754|41971270|FG006|Part 3|Adverse Event|0|||
19525834|NCT01729754|41971271|FG007|Part 3|Adverse Event|0|||
19525835|NCT01729754|41971272|FG008|Part 3|Adverse Event|0|||
19525836|NCT01729754|41971273|FG009|Part 3|Adverse Event|3|||
19525837|NCT01729754|41971264|FG000|Part 3|Death|0|||
19525838|NCT01729754|41971265|FG001|Part 3|Death|0|||
19525839|NCT01729754|41971266|FG002|Part 3|Death|0|||
19525840|NCT01729754|41971267|FG003|Part 3|Death|0|||
19525841|NCT01729754|41971268|FG004|Part 3|Death|0|||
19525842|NCT01729754|41971269|FG005|Part 3|Death|2|||
19525843|NCT01729754|41971270|FG006|Part 3|Death|0|||
19525844|NCT01729754|41971271|FG007|Part 3|Death|0|||
19525845|NCT01729754|41971272|FG008|Part 3|Death|0|||
19711322|NCT03572062|42154403|FG008|Overall Study|Withdrawal by Subject|0|||
19525846|NCT01729754|41971273|FG009|Part 3|Death|0|||
19525847|NCT01729754|41971264|FG000|Part 3|Lack of Efficacy|0|||
19525848|NCT01729754|41971265|FG001|Part 3|Lack of Efficacy|0|||
19448102|NCT01382446|41696153|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
19448103|NCT01382212|41696159|FG000|Overall Study|Kidney transplant|1|||
19525849|NCT01729754|41971266|FG002|Part 3|Lack of Efficacy|0|||
19525850|NCT01729754|41971267|FG003|Part 3|Lack of Efficacy|0|||
19525851|NCT01729754|41971268|FG004|Part 3|Lack of Efficacy|2|||
19525852|NCT01729754|41971269|FG005|Part 3|Lack of Efficacy|0|||
19525853|NCT01729754|41971270|FG006|Part 3|Lack of Efficacy|0|||
19525854|NCT01729754|41971271|FG007|Part 3|Lack of Efficacy|0|||
19525855|NCT01729754|41971272|FG008|Part 3|Lack of Efficacy|0|||
19525856|NCT01729754|41971273|FG009|Part 3|Lack of Efficacy|4|||
19525857|NCT01729754|41971264|FG000|Part 3|Lost to Follow-up|0|||
19525858|NCT01729754|41971265|FG001|Part 3|Lost to Follow-up|1|||
19525859|NCT01729754|41971266|FG002|Part 3|Lost to Follow-up|2|||
19448104|NCT01382212|41696159|FG000|Overall Study|Withdrew consent|1|||
19448105|NCT01381900|41696166|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
19525860|NCT01729754|41971267|FG003|Part 3|Lost to Follow-up|0|||
19525861|NCT01729754|41971268|FG004|Part 3|Lost to Follow-up|0|||
19525862|NCT01729754|41971269|FG005|Part 3|Lost to Follow-up|3|||
19525863|NCT01729754|41971270|FG006|Part 3|Lost to Follow-up|0|||
19525864|NCT01729754|41971271|FG007|Part 3|Lost to Follow-up|0|||
19525865|NCT01729754|41971272|FG008|Part 3|Lost to Follow-up|1|||
19525866|NCT01729754|41971273|FG009|Part 3|Lost to Follow-up|0|||
19525867|NCT01729754|41971264|FG000|Part 3|Physician Decision|0|||
19525868|NCT01729754|41971265|FG001|Part 3|Physician Decision|0|||
19525869|NCT01729754|41971266|FG002|Part 3|Physician Decision|1|||
19525870|NCT01729754|41971267|FG003|Part 3|Physician Decision|0|||
19525871|NCT01729754|41971268|FG004|Part 3|Physician Decision|0|||
19525872|NCT01729754|41971269|FG005|Part 3|Physician Decision|0|||
19525873|NCT01729754|41971270|FG006|Part 3|Physician Decision|0|||
19525874|NCT01729754|41971271|FG007|Part 3|Physician Decision|0|||
19525875|NCT01729754|41971272|FG008|Part 3|Physician Decision|0|||
19525876|NCT01729754|41971273|FG009|Part 3|Physician Decision|0|||
19525877|NCT01729754|41971264|FG000|Part 3|Withdrawal by Subject|0|||
19525878|NCT01729754|41971265|FG001|Part 3|Withdrawal by Subject|4|||
19525879|NCT01729754|41971266|FG002|Part 3|Withdrawal by Subject|1|||
19525880|NCT01729754|41971267|FG003|Part 3|Withdrawal by Subject|0|||
19525881|NCT01729754|41971268|FG004|Part 3|Withdrawal by Subject|2|||
19525882|NCT01729754|41971269|FG005|Part 3|Withdrawal by Subject|1|||
19525883|NCT01729754|41971270|FG006|Part 3|Withdrawal by Subject|0|||
19448106|NCT01381900|41696167|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
19448107|NCT01381900|41696168|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
19448108|NCT01381900|41696166|FG000|Overall Study|Adverse Event|4|||
19525884|NCT01729754|41971271|FG007|Part 3|Withdrawal by Subject|2|||
19525885|NCT01729754|41971272|FG008|Part 3|Withdrawal by Subject|0|||
19525886|NCT01729754|41971273|FG009|Part 3|Withdrawal by Subject|0|||
19525887|NCT01729754|41971264|FG000|Part 3|Other Protocol Specified Criteria|0|||
19525888|NCT01729754|41971265|FG001|Part 3|Other Protocol Specified Criteria|0|||
19525889|NCT01729754|41971266|FG002|Part 3|Other Protocol Specified Criteria|0|||
19525890|NCT01729754|41971267|FG003|Part 3|Other Protocol Specified Criteria|0|||
19525891|NCT01729754|41971268|FG004|Part 3|Other Protocol Specified Criteria|0|||
19525892|NCT01729754|41971269|FG005|Part 3|Other Protocol Specified Criteria|2|||
19525893|NCT01729754|41971270|FG006|Part 3|Other Protocol Specified Criteria|0|||
19525894|NCT01729754|41971271|FG007|Part 3|Other Protocol Specified Criteria|1|||
19525895|NCT01729754|41971272|FG008|Part 3|Other Protocol Specified Criteria|0|||
19448109|NCT01381900|41696167|FG001|Overall Study|Adverse Event|6|||
19525896|NCT01729754|41971273|FG009|Part 3|Other Protocol Specified Criteria|0|||
19525897|NCT01515306|41971318|FG000|Overall Study|Adverse Event|3|||
19525898|NCT01515306|41971319|FG001|Overall Study|Adverse Event|2|||
19448110|NCT01381900|41696168|FG002|Overall Study|Adverse Event|7|||
19448111|NCT01381900|41696166|FG000|Overall Study|Noncompliance with study drug|0|||
19448112|NCT01381900|41696167|FG001|Overall Study|Noncompliance with study drug|0|||
19448113|NCT01381900|41696168|FG002|Overall Study|Noncompliance with study drug|1|||
19448114|NCT01381900|41696166|FG000|Overall Study|Physician Decision|0|||
19448115|NCT01381900|41696167|FG001|Overall Study|Physician Decision|1|||
19448116|NCT01381900|41696168|FG002|Overall Study|Physician Decision|1|||
19448117|NCT01381900|41696166|FG000|Overall Study|Protocol Violation|0|||
19448118|NCT01381900|41696167|FG001|Overall Study|Protocol Violation|1|||
19448119|NCT01381900|41696168|FG002|Overall Study|Protocol Violation|1|||
19448120|NCT01381900|41696166|FG000|Overall Study|Withdrawal by Subject|0|||
19448121|NCT01381900|41696167|FG001|Overall Study|Withdrawal by Subject|0|||
19448122|NCT01381900|41696168|FG002|Overall Study|Withdrawal by Subject|1|||
19448123|NCT01381900|41696166|FG000|Overall Study|Early withdraw|3|||
19448124|NCT01381900|41696167|FG001|Overall Study|Early withdraw|1|||
19448125|NCT01381900|41696168|FG002|Overall Study|Early withdraw|1|||
19448126|NCT01744665|41696176|FG000|Monitoring Phase|Adverse Event|4|||
19448127|NCT01744665|41696176|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
19448128|NCT01744665|41696176|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
19448129|NCT01744665|41696176|FG000|Monitoring Phase|Withdrawal by Subject|5|||
19448130|NCT01744665|41696176|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
19448131|NCT01744665|41696176|FG000|Consolidation Phase|Adverse Event|2|||
19448132|NCT01744665|41696176|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
19448133|NCT01744665|41696176|FG000|Consolidation Phase|Withdrawal by Subject|4|||
19448134|NCT01744665|41696176|FG000|Consolidation Phase|Administrative problems|9|||
19525899|NCT01515306|41971318|FG000|Overall Study|Progressive Disease|19|||
19525900|NCT01515306|41971319|FG001|Overall Study|Progressive Disease|9|||
19525901|NCT01515306|41971318|FG000|Overall Study|Withdrawal by Subject|1|||
19525902|NCT01515306|41971319|FG001|Overall Study|Withdrawal by Subject|2|||
19525903|NCT01515306|41971318|FG000|Overall Study|Physician Decision|1|||
19525904|NCT01515306|41971319|FG001|Overall Study|Physician Decision|1|||
19525905|NCT01423851|41971340|FG000|Whole Study|Disease progression|2|||
19448135|NCT01744665|41696176|FG000|Re-initiation Phase|Administrative problems|10|||
19448136|NCT01744665|41696176|FG000|Re-initiation Phase|Adverse Event|1|||
19448137|NCT01744665|41696176|FG000|Re-initiation Phase|No longer required treatment|1|||
19448138|NCT01744665|41696176|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
19448139|NCT01744197|41696185|FG000|Overall Study|Received 1 patch|2|||
19448140|NCT01744197|41696186|FG001|Overall Study|Received 1 patch|1|||
19448141|NCT01744197|41696185|FG000|Overall Study|No patch received|2|||
19448142|NCT01744197|41696186|FG001|Overall Study|No patch received|2|||
19448143|NCT01732107|41696192|FG000|Overall Study|Adverse Event|2|||
19448144|NCT01732107|41696192|FG000|Overall Study|Disease Progression|8|||
19448145|NCT01732107|41696192|FG000|Overall Study|Physician Decision|1|||
19448146|NCT01732107|41696192|FG000|Overall Study|Withdrawal by Subject|2|||
19448147|NCT01743027|41696200|FG000|Overall Study|Adverse Event|2|||
19448148|NCT01743027|41696201|FG001|Overall Study|Adverse Event|0|||
19448149|NCT01743027|41696202|FG002|Overall Study|Adverse Event|0|||
19448150|NCT01743027|41696203|FG003|Overall Study|Adverse Event|0|||
19448151|NCT01743027|41696200|FG000|Overall Study|Lost to Follow-up|0|||
19448152|NCT01743027|41696201|FG001|Overall Study|Lost to Follow-up|0|||
19448153|NCT01743027|41696202|FG002|Overall Study|Lost to Follow-up|2|||
19448154|NCT01743027|41696203|FG003|Overall Study|Lost to Follow-up|0|||
19448155|NCT01743027|41696200|FG000|Overall Study|Progressive Disease|1|||
19448156|NCT01743027|41696201|FG001|Overall Study|Progressive Disease|4|||
19448157|NCT01743027|41696202|FG002|Overall Study|Progressive Disease|3|||
19448158|NCT01743027|41696203|FG003|Overall Study|Progressive Disease|0|||
19448159|NCT01743027|41696200|FG000|Overall Study|Protocol Violation|1|||
19448160|NCT01743027|41696201|FG001|Overall Study|Protocol Violation|1|||
19448161|NCT01743027|41696202|FG002|Overall Study|Protocol Violation|1|||
19448162|NCT01743027|41696203|FG003|Overall Study|Protocol Violation|0|||
19448163|NCT01743027|41696200|FG000|Overall Study|Withdrawal by Subject|1|||
19448164|NCT01743027|41696201|FG001|Overall Study|Withdrawal by Subject|0|||
19448165|NCT01743027|41696202|FG002|Overall Study|Withdrawal by Subject|3|||
19448166|NCT01743027|41696203|FG003|Overall Study|Withdrawal by Subject|1|||
19525906|NCT01423851|41971341|FG001|Whole Study|Disease progression|1|||
19525907|NCT01423851|41971342|FG002|Whole Study|Disease progression|1|||
19448167|NCT01380730|41696221|FG000|Overall Study|Death|0|||
19525908|NCT01423851|41971343|FG003|Whole Study|Disease progression|4|||
19448168|NCT01380730|41696222|FG001|Overall Study|Death|0|||
19448169|NCT01380730|41696223|FG002|Overall Study|Death|0|||
19448170|NCT01380730|41696224|FG003|Overall Study|Death|0|||
19448171|NCT01380730|41696225|FG004|Overall Study|Death|1|||
19448172|NCT01380730|41696226|FG005|Overall Study|Death|0|||
19448173|NCT01380730|41696227|FG006|Overall Study|Death|0|||
19525909|NCT01423851|41971344|FG004|Whole Study|Disease progression|1|||
19525910|NCT01423851|41971345|FG005|Whole Study|Disease progression|3|||
19525911|NCT01423851|41971346|FG006|Whole Study|Disease progression|1|||
19525912|NCT01423851|41971347|FG007|Whole Study|Disease progression|4|||
19525913|NCT01423851|41971348|FG008|Whole Study|Disease progression|0|||
19525914|NCT01423851|41971349|FG009|Whole Study|Disease progression|2|||
19525915|NCT01423851|41971350|FG010|Whole Study|Disease progression|10|||
19525916|NCT01423851|41971340|FG000|Whole Study|Physician Decision|0|||
19525917|NCT01423851|41971341|FG001|Whole Study|Physician Decision|1|||
19525918|NCT01423851|41971342|FG002|Whole Study|Physician Decision|2|||
19525919|NCT01423851|41971343|FG003|Whole Study|Physician Decision|0|||
19525920|NCT01423851|41971344|FG004|Whole Study|Physician Decision|2|||
19525921|NCT01423851|41971345|FG005|Whole Study|Physician Decision|0|||
19525922|NCT01423851|41971346|FG006|Whole Study|Physician Decision|2|||
19525923|NCT01423851|41971347|FG007|Whole Study|Physician Decision|1|||
19525924|NCT01423851|41971348|FG008|Whole Study|Physician Decision|3|||
19525925|NCT01423851|41971349|FG009|Whole Study|Physician Decision|4|||
19525926|NCT01423851|41971350|FG010|Whole Study|Physician Decision|12|||
19525927|NCT01423851|41971340|FG000|Whole Study|Withdrawal by Subject|1|||
19525928|NCT01423851|41971341|FG001|Whole Study|Withdrawal by Subject|1|||
19448174|NCT01380730|41696228|FG007|Overall Study|Death|0|||
19448175|NCT01395784|41696246|FG000|Overall Study|Lost to Follow-up|7|||
19525929|NCT01423851|41971342|FG002|Whole Study|Withdrawal by Subject|0|||
19525930|NCT01423851|41971343|FG003|Whole Study|Withdrawal by Subject|0|||
19525931|NCT01423851|41971344|FG004|Whole Study|Withdrawal by Subject|0|||
19525932|NCT01423851|41971345|FG005|Whole Study|Withdrawal by Subject|0|||
19525933|NCT01423851|41971346|FG006|Whole Study|Withdrawal by Subject|0|||
19525934|NCT01423851|41971347|FG007|Whole Study|Withdrawal by Subject|0|||
19525935|NCT01423851|41971348|FG008|Whole Study|Withdrawal by Subject|2|||
19525936|NCT01423851|41971349|FG009|Whole Study|Withdrawal by Subject|0|||
19525937|NCT01423851|41971350|FG010|Whole Study|Withdrawal by Subject|4|||
19525938|NCT01423851|41971340|FG000|Whole Study|Adverse Event|0|||
19448176|NCT01395784|41696246|FG000|Overall Study|Withdrawal by Subject|3|||
19448177|NCT01395784|41696246|FG000|Overall Study|Physician Decision|5|||
19525939|NCT01423851|41971341|FG001|Whole Study|Adverse Event|0|||
19525940|NCT01423851|41971342|FG002|Whole Study|Adverse Event|0|||
19525941|NCT01423851|41971343|FG003|Whole Study|Adverse Event|2|||
19525942|NCT01423851|41971344|FG004|Whole Study|Adverse Event|0|||
19525943|NCT01423851|41971345|FG005|Whole Study|Adverse Event|0|||
19525944|NCT01423851|41971346|FG006|Whole Study|Adverse Event|0|||
19525945|NCT01423851|41971347|FG007|Whole Study|Adverse Event|3|||
19525946|NCT01423851|41971348|FG008|Whole Study|Adverse Event|3|||
19525947|NCT01423851|41971349|FG009|Whole Study|Adverse Event|2|||
19525948|NCT01423851|41971350|FG010|Whole Study|Adverse Event|3|||
19525949|NCT01334606|41971392|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
19525950|NCT01317875|41971408|FG000|Overall Study|Other|0|||
19525951|NCT01317875|41971409|FG001|Overall Study|Other|0|||
19525952|NCT01317875|41971410|FG002|Overall Study|Other|1|||
19525953|NCT01317875|41971411|FG003|Overall Study|Other|0|||
19525954|NCT01317875|41971412|FG004|Overall Study|Other|0|||
19525955|NCT01317875|41971413|FG005|Overall Study|Other|0|||
19525956|NCT01317875|41971414|FG006|Overall Study|Other|0|||
19525957|NCT01317875|41971415|FG007|Overall Study|Other|0|||
19525958|NCT01317875|41971416|FG008|Overall Study|Other|0|||
19525959|NCT01317875|41971417|FG009|Overall Study|Other|0|||
19525960|NCT01317875|41971408|FG000|Overall Study|Noncompliance with study drug|0|||
19525961|NCT01317875|41971409|FG001|Overall Study|Noncompliance with study drug|0|||
19525962|NCT01317875|41971410|FG002|Overall Study|Noncompliance with study drug|1|||
19525963|NCT01317875|41971411|FG003|Overall Study|Noncompliance with study drug|0|||
19525964|NCT01317875|41971412|FG004|Overall Study|Noncompliance with study drug|0|||
19525965|NCT01317875|41971413|FG005|Overall Study|Noncompliance with study drug|0|||
19525966|NCT01317875|41971414|FG006|Overall Study|Noncompliance with study drug|0|||
19525967|NCT01317875|41971415|FG007|Overall Study|Noncompliance with study drug|0|||
19525968|NCT01317875|41971416|FG008|Overall Study|Noncompliance with study drug|0|||
19525969|NCT01317875|41971417|FG009|Overall Study|Noncompliance with study drug|0|||
19525970|NCT01317875|41971408|FG000|Overall Study|Progressive Disease|1|||
19525971|NCT01317875|41971409|FG001|Overall Study|Progressive Disease|0|||
19448178|NCT01380184|41696250|FG000|Part 1 (19 Days)|Adverse Event|1|||
19448179|NCT01380184|41696250|FG000|Part 2|Adverse Event|5|||
19448180|NCT01380184|41696250|FG000|Part 2|Disease Progression|8|||
19525972|NCT01317875|41971410|FG002|Overall Study|Progressive Disease|2|||
19448181|NCT01380184|41696250|FG000|Part 2|Lost to Follow-up|1|||
19525973|NCT01317875|41971411|FG003|Overall Study|Progressive Disease|0|||
19525974|NCT01317875|41971412|FG004|Overall Study|Progressive Disease|1|||
19525975|NCT01317875|41971413|FG005|Overall Study|Progressive Disease|0|||
19525976|NCT01317875|41971414|FG006|Overall Study|Progressive Disease|0|||
19525977|NCT01317875|41971415|FG007|Overall Study|Progressive Disease|1|||
19525978|NCT01317875|41971416|FG008|Overall Study|Progressive Disease|0|||
19525979|NCT01317875|41971417|FG009|Overall Study|Progressive Disease|0|||
19525980|NCT01317875|41971408|FG000|Overall Study|Withdrawal by Subject|0|||
19448182|NCT01395394|41696257|FG000|Baseline Study Visit|Protocol Violation|1|||
19525981|NCT01317875|41971409|FG001|Overall Study|Withdrawal by Subject|0|||
19525982|NCT01317875|41971410|FG002|Overall Study|Withdrawal by Subject|0|||
19525983|NCT01317875|41971411|FG003|Overall Study|Withdrawal by Subject|0|||
19525984|NCT01317875|41971412|FG004|Overall Study|Withdrawal by Subject|1|||
19525985|NCT01317875|41971413|FG005|Overall Study|Withdrawal by Subject|0|||
19525986|NCT01317875|41971414|FG006|Overall Study|Withdrawal by Subject|0|||
19525987|NCT01317875|41971415|FG007|Overall Study|Withdrawal by Subject|3|||
19525988|NCT01317875|41971416|FG008|Overall Study|Withdrawal by Subject|0|||
19525989|NCT01317875|41971417|FG009|Overall Study|Withdrawal by Subject|0|||
19525990|NCT01317875|41971408|FG000|Overall Study|Physician Decision|0|||
19525991|NCT01317875|41971409|FG001|Overall Study|Physician Decision|1|||
19525992|NCT01317875|41971410|FG002|Overall Study|Physician Decision|1|||
19525993|NCT01317875|41971411|FG003|Overall Study|Physician Decision|0|||
19525994|NCT01317875|41971412|FG004|Overall Study|Physician Decision|2|||
19525995|NCT01317875|41971413|FG005|Overall Study|Physician Decision|0|||
19525996|NCT01317875|41971414|FG006|Overall Study|Physician Decision|0|||
19525997|NCT01317875|41971415|FG007|Overall Study|Physician Decision|2|||
19525998|NCT01317875|41971416|FG008|Overall Study|Physician Decision|0|||
19448183|NCT01395394|41696258|FG001|Baseline Study Visit|Protocol Violation|0|||
19448184|NCT01395394|41696259|FG002|Baseline Study Visit|Protocol Violation|0|||
19448185|NCT01395316|41696267|FG000|Overall Study|Lost to Follow-up|2|||
19448186|NCT01395316|41696267|FG000|Overall Study|poor MRI quality|1|||
19448187|NCT01742091|41696277|FG000|Overall Study|Adverse Event|0|||
19448188|NCT01742091|41696278|FG001|Overall Study|Adverse Event|0|||
19448189|NCT01742091|41696279|FG002|Overall Study|Adverse Event|0|||
19448190|NCT01742091|41696280|FG003|Overall Study|Adverse Event|0|||
19448191|NCT01742091|41696281|FG004|Overall Study|Adverse Event|1|||
19448192|NCT01742091|41696282|FG005|Overall Study|Adverse Event|0|||
19448193|NCT01742091|41696277|FG000|Overall Study|Physician Decision|0|||
19448194|NCT01742091|41696278|FG001|Overall Study|Physician Decision|0|||
19448195|NCT01742091|41696279|FG002|Overall Study|Physician Decision|0|||
19448196|NCT01742091|41696280|FG003|Overall Study|Physician Decision|0|||
19448197|NCT01742091|41696281|FG004|Overall Study|Physician Decision|0|||
19448198|NCT01742091|41696282|FG005|Overall Study|Physician Decision|1|||
19448199|NCT01742091|41696277|FG000|Overall Study|Withdrawal by Subject|0|||
19448200|NCT01742091|41696278|FG001|Overall Study|Withdrawal by Subject|0|||
19448201|NCT01742091|41696279|FG002|Overall Study|Withdrawal by Subject|0|||
19448202|NCT01742091|41696280|FG003|Overall Study|Withdrawal by Subject|1|||
19448203|NCT01742091|41696281|FG004|Overall Study|Withdrawal by Subject|0|||
19448204|NCT01742091|41696282|FG005|Overall Study|Withdrawal by Subject|0|||
19448205|NCT01742091|41696277|FG000|Overall Study|Lost to Follow-up|0|||
19448206|NCT01742091|41696278|FG001|Overall Study|Lost to Follow-up|0|||
19448207|NCT01742091|41696279|FG002|Overall Study|Lost to Follow-up|0|||
19525999|NCT01317875|41971417|FG009|Overall Study|Physician Decision|0|||
19526000|NCT01317875|41971408|FG000|Overall Study|Death|0|||
19526001|NCT01317875|41971409|FG001|Overall Study|Death|0|||
19526002|NCT01317875|41971410|FG002|Overall Study|Death|2|||
19526003|NCT01317875|41971411|FG003|Overall Study|Death|1|||
19526004|NCT01317875|41971412|FG004|Overall Study|Death|0|||
19526005|NCT01317875|41971413|FG005|Overall Study|Death|1|||
19526006|NCT01317875|41971414|FG006|Overall Study|Death|0|||
19526007|NCT01317875|41971415|FG007|Overall Study|Death|4|||
19526008|NCT01317875|41971416|FG008|Overall Study|Death|0|||
19526009|NCT01317875|41971417|FG009|Overall Study|Death|0|||
19526010|NCT01317875|41971408|FG000|Overall Study|Adverse Event|2|||
19526011|NCT01317875|41971409|FG001|Overall Study|Adverse Event|1|||
19526012|NCT01317875|41971410|FG002|Overall Study|Adverse Event|2|||
19526013|NCT01317875|41971411|FG003|Overall Study|Adverse Event|1|||
19526014|NCT01317875|41971412|FG004|Overall Study|Adverse Event|5|||
19526015|NCT01317875|41971413|FG005|Overall Study|Adverse Event|1|||
19526016|NCT01317875|41971414|FG006|Overall Study|Adverse Event|2|||
19526017|NCT01317875|41971415|FG007|Overall Study|Adverse Event|5|||
19526018|NCT01317875|41971416|FG008|Overall Study|Adverse Event|0|||
19526019|NCT01317875|41971417|FG009|Overall Study|Adverse Event|0|||
19526020|NCT00500071|41971493|FG000|Screening and Washout Phase|Protocol Violation|1|||
19526021|NCT00500071|41971493|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
19526022|NCT00500071|41971493|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
19526023|NCT00500071|41971493|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
19526024|NCT00500071|41971493|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
19711323|NCT03572062|42154404|FG009|Overall Study|Withdrawal by Subject|1|||
19711324|NCT03572062|42154395|FG000|Overall Study|Randomized But Not Treated|0|||
19629216|NCT00814580|42078732|FG000|Overall Study|Adverse Event|6|||
19711325|NCT03572062|42154396|FG001|Overall Study|Randomized But Not Treated|0|||
19448208|NCT01742091|41696280|FG003|Overall Study|Lost to Follow-up|0|||
19448209|NCT01742091|41696281|FG004|Overall Study|Lost to Follow-up|0|||
19448210|NCT01742091|41696282|FG005|Overall Study|Lost to Follow-up|1|||
19448211|NCT01731951|41696302|FG000|Overall Study|Documented Disease Progression|1|||
19448212|NCT01731951|41696303|FG001|Overall Study|Documented Disease Progression|0|||
19448213|NCT01731951|41696304|FG002|Overall Study|Documented Disease Progression|0|||
19526025|NCT00500071|41971493|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
19526026|NCT00500071|41971493|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
19526027|NCT00447122|41971501|FG000|Overall Study|worsening medical condition -came off|0|||
19526028|NCT00447122|41971502|FG001|Overall Study|worsening medical condition -came off|1|||
19526029|NCT00447122|41971503|FG002|Overall Study|worsening medical condition -came off|0|||
19526030|NCT00447122|41971504|FG003|Overall Study|worsening medical condition -came off|0|||
19526031|NCT00382252|41971514|FG000|Overall Study|Death|4|||
19526032|NCT00382252|41971514|FG000|Overall Study|Protocol Violation|8|||
19526033|NCT00382252|41971514|FG000|Overall Study|Not treated by RFA|1|||
19526034|NCT00290251|41971521|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
19526035|NCT00290251|41971522|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
19526036|NCT00290251|41971523|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
19526037|NCT00290251|41971524|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
19526038|NCT00290251|41971525|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
19526039|NCT00290251|41971526|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
19526040|NCT00290251|41971521|FG000|Treatment 1 (Months 2-4)|headache|0|||
19526041|NCT00290251|41971522|FG001|Treatment 1 (Months 2-4)|headache|0|||
19526042|NCT00290251|41971523|FG002|Treatment 1 (Months 2-4)|headache|0|||
19526043|NCT00290251|41971524|FG003|Treatment 1 (Months 2-4)|headache|0|||
19526044|NCT00290251|41971525|FG004|Treatment 1 (Months 2-4)|headache|1|||
19526045|NCT00290251|41971526|FG005|Treatment 1 (Months 2-4)|headache|0|||
19526046|NCT00290251|41971521|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
19526047|NCT00290251|41971522|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
19526048|NCT00290251|41971523|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
19526049|NCT00290251|41971524|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
19526050|NCT00290251|41971525|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
19526051|NCT00290251|41971526|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
19526052|NCT01403948|41971562|FG000|Overall Study|Progressive disease|0|||
19526053|NCT01403948|41971563|FG001|Overall Study|Progressive disease|2|||
19526054|NCT01403948|41971564|FG002|Overall Study|Progressive disease|2|||
19526055|NCT01403948|41971565|FG003|Overall Study|Progressive disease|4|||
19526056|NCT01403948|41971566|FG004|Overall Study|Progressive disease|2|||
19526057|NCT01403948|41971567|FG005|Overall Study|Progressive disease|6|||
19526058|NCT01403948|41971568|FG006|Overall Study|Progressive disease|2|||
19526059|NCT01403948|41971569|FG007|Overall Study|Progressive disease|4|||
19526060|NCT01403948|41971570|FG008|Overall Study|Progressive disease|5|||
19526061|NCT01403948|41971571|FG009|Overall Study|Progressive disease|5|||
19526062|NCT01403948|41971562|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526063|NCT01403948|41971563|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526064|NCT01403948|41971564|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526065|NCT01403948|41971565|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526066|NCT01403948|41971566|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
19526067|NCT01403948|41971567|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526068|NCT01403948|41971568|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
19526069|NCT01403948|41971569|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526070|NCT01403948|41971570|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
19526071|NCT01403948|41971571|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
19526072|NCT01403948|41971562|FG000|Overall Study|Lost to Follow-up|0|||
19526073|NCT01403948|41971563|FG001|Overall Study|Lost to Follow-up|0|||
19526074|NCT01403948|41971564|FG002|Overall Study|Lost to Follow-up|0|||
19526075|NCT01403948|41971565|FG003|Overall Study|Lost to Follow-up|0|||
19526076|NCT01403948|41971566|FG004|Overall Study|Lost to Follow-up|0|||
19526077|NCT01403948|41971567|FG005|Overall Study|Lost to Follow-up|0|||
19526078|NCT01403948|41971568|FG006|Overall Study|Lost to Follow-up|0|||
19526079|NCT01403948|41971569|FG007|Overall Study|Lost to Follow-up|0|||
19526080|NCT01403948|41971570|FG008|Overall Study|Lost to Follow-up|0|||
19448214|NCT01731951|41696305|FG003|Overall Study|Documented Disease Progression|0|||
19448215|NCT01731951|41696306|FG004|Overall Study|Documented Disease Progression|0|||
19448216|NCT01731951|41696307|FG005|Overall Study|Documented Disease Progression|0|||
19448217|NCT01731951|41696302|FG000|Overall Study|Lost to Follow-up|2|||
19448218|NCT01731951|41696303|FG001|Overall Study|Lost to Follow-up|0|||
19448219|NCT01731951|41696304|FG002|Overall Study|Lost to Follow-up|0|||
19448220|NCT01731951|41696305|FG003|Overall Study|Lost to Follow-up|1|||
19448221|NCT01731951|41696306|FG004|Overall Study|Lost to Follow-up|3|||
19448222|NCT01731951|41696307|FG005|Overall Study|Lost to Follow-up|1|||
19448223|NCT01731951|41696302|FG000|Overall Study|Withdrawal of Consent|1|||
19448224|NCT01731951|41696303|FG001|Overall Study|Withdrawal of Consent|0|||
19448225|NCT01731951|41696304|FG002|Overall Study|Withdrawal of Consent|0|||
19448226|NCT01731951|41696305|FG003|Overall Study|Withdrawal of Consent|0|||
19526081|NCT01403948|41971571|FG009|Overall Study|Lost to Follow-up|1|||
19526082|NCT01403948|41971562|FG000|Overall Study|Refused cont. medication|0|||
19526083|NCT01403948|41971563|FG001|Overall Study|Refused cont. medication|0|||
19448227|NCT01731951|41696306|FG004|Overall Study|Withdrawal of Consent|0|||
19448228|NCT01731951|41696307|FG005|Overall Study|Withdrawal of Consent|2|||
19448229|NCT01731951|41696302|FG000|Overall Study|Death|13|||
19448230|NCT01731951|41696303|FG001|Overall Study|Death|15|||
19448231|NCT01731951|41696304|FG002|Overall Study|Death|9|||
19448232|NCT01731951|41696305|FG003|Overall Study|Death|8|||
19448233|NCT01731951|41696306|FG004|Overall Study|Death|9|||
19526084|NCT01403948|41971564|FG002|Overall Study|Refused cont. medication|0|||
19526085|NCT01403948|41971565|FG003|Overall Study|Refused cont. medication|0|||
19526086|NCT01403948|41971566|FG004|Overall Study|Refused cont. medication|1|||
19526087|NCT01403948|41971567|FG005|Overall Study|Refused cont. medication|0|||
19526088|NCT01403948|41971568|FG006|Overall Study|Refused cont. medication|0|||
19526089|NCT01403948|41971569|FG007|Overall Study|Refused cont. medication|0|||
19526090|NCT01403948|41971570|FG008|Overall Study|Refused cont. medication|0|||
19526091|NCT01403948|41971571|FG009|Overall Study|Refused cont. medication|1|||
19526092|NCT01403948|41971562|FG000|Overall Study|other than above|1|||
19526093|NCT01403948|41971563|FG001|Overall Study|other than above|2|||
19526094|NCT01403948|41971564|FG002|Overall Study|other than above|1|||
19526095|NCT01403948|41971565|FG003|Overall Study|other than above|0|||
19526096|NCT01403948|41971566|FG004|Overall Study|other than above|1|||
19526097|NCT01403948|41971567|FG005|Overall Study|other than above|1|||
19526098|NCT01403948|41971568|FG006|Overall Study|other than above|2|||
19526099|NCT01403948|41971569|FG007|Overall Study|other than above|0|||
19526100|NCT01403948|41971570|FG008|Overall Study|other than above|0|||
19526101|NCT01403948|41971571|FG009|Overall Study|other than above|0|||
19526102|NCT01404312|41971599|FG000|Overall Study|Death|21|||
19526103|NCT01404312|41971600|FG001|Overall Study|Death|27|||
19526104|NCT01404312|41971599|FG000|Overall Study|Withdrawal by Subject|15|||
19526105|NCT01404312|41971600|FG001|Overall Study|Withdrawal by Subject|18|||
19526106|NCT01404312|41971599|FG000|Overall Study|Participant Unable to get to clinic|93|||
19526107|NCT01404312|41971600|FG001|Overall Study|Participant Unable to get to clinic|103|||
19526108|NCT01404312|41971599|FG000|Overall Study|Lost to Follow-up|115|||
19526109|NCT01404312|41971600|FG001|Overall Study|Lost to Follow-up|111|||
19526110|NCT01404312|41971599|FG000|Overall Study|Site closed|22|||
19526111|NCT01404312|41971600|FG001|Overall Study|Site closed|21|||
19526112|NCT01404312|41971599|FG000|Overall Study|Participant not willing to adhere to req|31|||
19526113|NCT01404312|41971600|FG001|Overall Study|Participant not willing to adhere to req|29|||
19526114|NCT01404312|41971599|FG000|Overall Study|Severe debilitation, unable to continue|1|||
19526115|NCT01404312|41971600|FG001|Overall Study|Severe debilitation, unable to continue|2|||
19526116|NCT01414608|41971609|FG000|Overall Study|Ineligible|5|||
19526117|NCT01414608|41971610|FG001|Overall Study|Ineligible|2|||
19526118|NCT01425008|41971639|FG000|Dose Escalation Phase|Progressive Disease|2|||
19526119|NCT01425008|41971640|FG001|Dose Escalation Phase|Progressive Disease|3|||
19526120|NCT01425008|41971641|FG002|Dose Escalation Phase|Progressive Disease|2|||
19526121|NCT01425008|41971642|FG003|Dose Escalation Phase|Progressive Disease|3|||
19526122|NCT01425008|41971643|FG004|Dose Escalation Phase|Progressive Disease|5|||
19526123|NCT01425008|41971644|FG005|Dose Escalation Phase|Progressive Disease|4|||
19526124|NCT01425008|41971645|FG006|Dose Escalation Phase|Progressive Disease|0|||
19526125|NCT01425008|41971646|FG007|Dose Escalation Phase|Progressive Disease|2|||
19526126|NCT01425008|41971647|FG008|Dose Escalation Phase|Progressive Disease|6|||
19526127|NCT01425008|41971648|FG009|Dose Escalation Phase|Progressive Disease|2|||
19526128|NCT01425008|41971649|FG010|Dose Escalation Phase|Progressive Disease|0|||
19526129|NCT01425008|41971650|FG011|Dose Escalation Phase|Progressive Disease|0|||
19448234|NCT01731951|41696307|FG005|Overall Study|Death|6|||
19448235|NCT01731171|41696327|FG000|Overall Study|Withdrawal by Subject|4|||
19448236|NCT01731171|41696328|FG001|Overall Study|Withdrawal by Subject|1|||
19448237|NCT01731171|41696327|FG000|Overall Study|Lost to Follow-up|3|||
19448238|NCT01731171|41696328|FG001|Overall Study|Lost to Follow-up|2|||
19448239|NCT01731171|41696327|FG000|Overall Study|Moved out of Area|0|||
19448240|NCT01731171|41696328|FG001|Overall Study|Moved out of Area|2|||
19448241|NCT01731171|41696327|FG000|Overall Study|Terminated for Lack of Adherence|0|||
19448242|NCT01731171|41696328|FG001|Overall Study|Terminated for Lack of Adherence|1|||
19448243|NCT01731171|41696327|FG000|Overall Study|Terminated for Safety Reasons|0|||
19448244|NCT01731171|41696328|FG001|Overall Study|Terminated for Safety Reasons|1|||
19448245|NCT01741701|41696336|FG000|Overall Study|Adverse Event|5|||
19448246|NCT01741701|41696337|FG001|Overall Study|Adverse Event|1|||
19448247|NCT01741701|41696336|FG000|Overall Study|Withdrawal by Subject|0|||
19526130|NCT01425008|41971651|FG012|Dose Escalation Phase|Progressive Disease|0|||
19526131|NCT01425008|41971652|FG013|Dose Escalation Phase|Progressive Disease|0|||
19526132|NCT01425008|41971653|FG014|Dose Escalation Phase|Progressive Disease|0|||
19526133|NCT01425008|41971654|FG015|Dose Escalation Phase|Progressive Disease|0|||
19526134|NCT01425008|41971655|FG016|Dose Escalation Phase|Progressive Disease|0|||
19526135|NCT01425008|41971656|FG017|Dose Escalation Phase|Progressive Disease|0|||
19526136|NCT01425008|41971657|FG018|Dose Escalation Phase|Progressive Disease|0|||
19526137|NCT01425008|41971639|FG000|Dose Escalation Phase|Adverse Event|2|||
19448248|NCT01741701|41696337|FG001|Overall Study|Withdrawal by Subject|1|||
19448249|NCT01741545|41696345|FG000|Treatment Period|Lack of Efficacy|0|||
19448250|NCT01741545|41696346|FG001|Treatment Period|Lack of Efficacy|1|||
19448251|NCT01741545|41696345|FG000|Treatment Period|Adverse event, non-fatal|1|||
19448252|NCT01741545|41696346|FG001|Treatment Period|Adverse event, non-fatal|3|||
19448253|NCT01741545|41696345|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
19448254|NCT01741545|41696346|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
19448255|NCT01741545|41696345|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
19448256|NCT01741545|41696346|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
19448257|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
19448258|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
19448259|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
19448260|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
19448261|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
19526138|NCT01425008|41971640|FG001|Dose Escalation Phase|Adverse Event|0|||
19526139|NCT01425008|41971641|FG002|Dose Escalation Phase|Adverse Event|0|||
19448262|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
19448263|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
19526140|NCT01425008|41971642|FG003|Dose Escalation Phase|Adverse Event|0|||
19526141|NCT01425008|41971643|FG004|Dose Escalation Phase|Adverse Event|0|||
19526142|NCT01425008|41971644|FG005|Dose Escalation Phase|Adverse Event|2|||
19526143|NCT01425008|41971645|FG006|Dose Escalation Phase|Adverse Event|0|||
19526144|NCT01425008|41971646|FG007|Dose Escalation Phase|Adverse Event|0|||
19526145|NCT01425008|41971647|FG008|Dose Escalation Phase|Adverse Event|2|||
19526146|NCT01425008|41971648|FG009|Dose Escalation Phase|Adverse Event|0|||
19526147|NCT01425008|41971649|FG010|Dose Escalation Phase|Adverse Event|0|||
19526148|NCT01425008|41971650|FG011|Dose Escalation Phase|Adverse Event|0|||
19526149|NCT01425008|41971651|FG012|Dose Escalation Phase|Adverse Event|0|||
19526150|NCT01425008|41971652|FG013|Dose Escalation Phase|Adverse Event|0|||
19526151|NCT01425008|41971653|FG014|Dose Escalation Phase|Adverse Event|0|||
19526152|NCT01425008|41971654|FG015|Dose Escalation Phase|Adverse Event|0|||
19526153|NCT01425008|41971655|FG016|Dose Escalation Phase|Adverse Event|0|||
19526154|NCT01425008|41971656|FG017|Dose Escalation Phase|Adverse Event|0|||
19526155|NCT01425008|41971657|FG018|Dose Escalation Phase|Adverse Event|0|||
19526156|NCT01425008|41971639|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526157|NCT01425008|41971640|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526158|NCT01425008|41971641|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526159|NCT01425008|41971642|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526160|NCT01425008|41971643|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
19526161|NCT01425008|41971644|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526162|NCT01425008|41971645|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
19526163|NCT01425008|41971646|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
19526164|NCT01425008|41971647|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
19526165|NCT01425008|41971648|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526166|NCT01425008|41971649|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526167|NCT01425008|41971650|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526168|NCT01425008|41971651|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526169|NCT01425008|41971652|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19448264|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
19448265|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
19448266|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
19448267|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
19448268|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
19448269|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
19448270|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
19448271|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
19448272|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
19448273|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
19448274|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
19448275|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
19448276|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
19448277|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
19448278|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
19526170|NCT01425008|41971653|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526171|NCT01425008|41971654|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526172|NCT01425008|41971655|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526173|NCT01425008|41971656|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526174|NCT01425008|41971657|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
19526175|NCT01425008|41971639|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
19526176|NCT01425008|41971640|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
19526177|NCT01425008|41971641|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
19526178|NCT01425008|41971642|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
19526179|NCT01425008|41971643|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
19526180|NCT01425008|41971644|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
19526181|NCT01425008|41971645|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
19526182|NCT01425008|41971646|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
19526183|NCT01425008|41971647|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
19526184|NCT01425008|41971648|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
19526185|NCT01425008|41971649|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
19526186|NCT01425008|41971650|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
19526187|NCT01425008|41971651|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
19526188|NCT01425008|41971652|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
19526189|NCT01425008|41971653|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
19526190|NCT01425008|41971654|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
19526191|NCT01425008|41971655|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
19526192|NCT01425008|41971656|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
19526193|NCT01425008|41971657|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
19526194|NCT01425008|41971639|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526195|NCT01425008|41971640|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526196|NCT01425008|41971641|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
19526197|NCT01425008|41971642|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526198|NCT01425008|41971643|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526199|NCT01425008|41971644|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526200|NCT01425008|41971645|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526201|NCT01425008|41971646|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526202|NCT01425008|41971647|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
19526203|NCT01425008|41971648|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
19526204|NCT01425008|41971649|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526205|NCT01425008|41971650|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526206|NCT01425008|41971651|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526207|NCT01425008|41971652|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526208|NCT01425008|41971653|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526209|NCT01425008|41971654|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526210|NCT01425008|41971655|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526211|NCT01425008|41971656|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526212|NCT01425008|41971657|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
19526213|NCT01425008|41971639|FG000|Dose Escalation Phase|Other|0|||
19526214|NCT01425008|41971640|FG001|Dose Escalation Phase|Other|0|||
19526215|NCT01425008|41971641|FG002|Dose Escalation Phase|Other|0|||
19526216|NCT01425008|41971642|FG003|Dose Escalation Phase|Other|0|||
19526217|NCT01425008|41971643|FG004|Dose Escalation Phase|Other|0|||
19526218|NCT01425008|41971644|FG005|Dose Escalation Phase|Other|0|||
19526219|NCT01425008|41971645|FG006|Dose Escalation Phase|Other|0|||
19526220|NCT01425008|41971646|FG007|Dose Escalation Phase|Other|0|||
19448279|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
19448280|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
19448281|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
19448282|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
19448283|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
19448284|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
19448285|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
19448286|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
19448287|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
19448288|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
19526221|NCT01425008|41971647|FG008|Dose Escalation Phase|Other|1|||
19526222|NCT01425008|41971648|FG009|Dose Escalation Phase|Other|0|||
19526223|NCT01425008|41971649|FG010|Dose Escalation Phase|Other|0|||
19526224|NCT01425008|41971650|FG011|Dose Escalation Phase|Other|0|||
19526225|NCT01425008|41971651|FG012|Dose Escalation Phase|Other|0|||
19526226|NCT01425008|41971652|FG013|Dose Escalation Phase|Other|0|||
19526227|NCT01425008|41971653|FG014|Dose Escalation Phase|Other|0|||
19526228|NCT01425008|41971654|FG015|Dose Escalation Phase|Other|0|||
19526229|NCT01425008|41971655|FG016|Dose Escalation Phase|Other|0|||
19526230|NCT01425008|41971656|FG017|Dose Escalation Phase|Other|0|||
19526231|NCT01425008|41971657|FG018|Dose Escalation Phase|Other|0|||
19526232|NCT01425008|41971639|FG000|Dose Expansion Phase|Progressive Disease|0|||
19526233|NCT01425008|41971640|FG001|Dose Expansion Phase|Progressive Disease|0|||
19526234|NCT01425008|41971641|FG002|Dose Expansion Phase|Progressive Disease|0|||
19526235|NCT01425008|41971642|FG003|Dose Expansion Phase|Progressive Disease|0|||
19526236|NCT01425008|41971643|FG004|Dose Expansion Phase|Progressive Disease|0|||
19526237|NCT01425008|41971644|FG005|Dose Expansion Phase|Progressive Disease|0|||
19526238|NCT01425008|41971645|FG006|Dose Expansion Phase|Progressive Disease|0|||
19629217|NCT00814580|42078733|FG001|Overall Study|Adverse Event|15|||
19526239|NCT01425008|41971646|FG007|Dose Expansion Phase|Progressive Disease|0|||
19526240|NCT01425008|41971647|FG008|Dose Expansion Phase|Progressive Disease|0|||
19526241|NCT01425008|41971648|FG009|Dose Expansion Phase|Progressive Disease|0|||
19526242|NCT01425008|41971649|FG010|Dose Expansion Phase|Progressive Disease|10|||
19526243|NCT01425008|41971650|FG011|Dose Expansion Phase|Progressive Disease|4|||
19526244|NCT01425008|41971651|FG012|Dose Expansion Phase|Progressive Disease|12|||
19526245|NCT01425008|41971652|FG013|Dose Expansion Phase|Progressive Disease|1|||
19526246|NCT01425008|41971653|FG014|Dose Expansion Phase|Progressive Disease|5|||
19526247|NCT01425008|41971654|FG015|Dose Expansion Phase|Progressive Disease|8|||
19526248|NCT01425008|41971655|FG016|Dose Expansion Phase|Progressive Disease|9|||
19526249|NCT01425008|41971656|FG017|Dose Expansion Phase|Progressive Disease|2|||
19526250|NCT01425008|41971657|FG018|Dose Expansion Phase|Progressive Disease|10|||
19526251|NCT01425008|41971639|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
19526252|NCT01425008|41971640|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
19526253|NCT01425008|41971641|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
19526254|NCT01425008|41971642|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
19526255|NCT01425008|41971643|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
19526256|NCT01425008|41971644|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
19526257|NCT01425008|41971645|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
19526258|NCT01425008|41971646|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
19526259|NCT01425008|41971647|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
19526260|NCT01425008|41971648|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
19526261|NCT01425008|41971649|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
19526262|NCT01425008|41971650|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
19526263|NCT01425008|41971651|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
19526264|NCT01425008|41971652|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
19448289|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
19448290|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
19448291|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
19448292|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
19448293|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
19448294|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
19448295|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
19448296|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
19448297|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
19448298|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
19448299|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
19448300|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
19448301|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
19448302|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
19448303|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
19448304|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
19448305|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
19448306|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
19448307|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
19448308|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
19448309|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
19448310|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
19448311|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
19448312|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
19448313|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
19448314|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
19448315|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
19448316|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
19526265|NCT01425008|41971653|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
19526266|NCT01425008|41971654|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
19526267|NCT01425008|41971655|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
19526268|NCT01425008|41971656|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
19526269|NCT01425008|41971657|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
19526270|NCT01425008|41971639|FG000|Dose Expansion Phase|Other|0|||
19526271|NCT01425008|41971640|FG001|Dose Expansion Phase|Other|0|||
19526272|NCT01425008|41971641|FG002|Dose Expansion Phase|Other|0|||
19526273|NCT01425008|41971642|FG003|Dose Expansion Phase|Other|0|||
19526274|NCT01425008|41971643|FG004|Dose Expansion Phase|Other|0|||
19526275|NCT01425008|41971644|FG005|Dose Expansion Phase|Other|0|||
19526276|NCT01425008|41971645|FG006|Dose Expansion Phase|Other|0|||
19526277|NCT01425008|41971646|FG007|Dose Expansion Phase|Other|0|||
19526278|NCT01425008|41971647|FG008|Dose Expansion Phase|Other|0|||
19448317|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
19448318|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
19448319|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
19448320|NCT01884350|41696354|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
19448321|NCT01884350|41696355|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
19448322|NCT01884350|41696356|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
19448323|NCT01614795|41696370|FG000|Overall Study|Adverse Event|0|||
19448324|NCT01614795|41696371|FG001|Overall Study|Adverse Event|0|||
19448325|NCT01614795|41696372|FG002|Overall Study|Adverse Event|1|||
19448326|NCT01614795|41696373|FG003|Overall Study|Adverse Event|1|||
19526279|NCT01425008|41971648|FG009|Dose Expansion Phase|Other|0|||
19526280|NCT01425008|41971649|FG010|Dose Expansion Phase|Other|0|||
19526281|NCT01425008|41971650|FG011|Dose Expansion Phase|Other|0|||
19526282|NCT01425008|41971651|FG012|Dose Expansion Phase|Other|1|||
19526283|NCT01425008|41971652|FG013|Dose Expansion Phase|Other|0|||
19526284|NCT01425008|41971653|FG014|Dose Expansion Phase|Other|0|||
19526285|NCT01425008|41971654|FG015|Dose Expansion Phase|Other|0|||
19526286|NCT01425008|41971655|FG016|Dose Expansion Phase|Other|2|||
19526287|NCT01425008|41971656|FG017|Dose Expansion Phase|Other|0|||
19526288|NCT01425008|41971657|FG018|Dose Expansion Phase|Other|4|||
19526289|NCT01425008|41971639|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
19448327|NCT01614795|41696370|FG000|Overall Study|Lack of Efficacy|10|||
19448328|NCT01614795|41696371|FG001|Overall Study|Lack of Efficacy|10|||
19448329|NCT01614795|41696372|FG002|Overall Study|Lack of Efficacy|9|||
19448330|NCT01614795|41696373|FG003|Overall Study|Lack of Efficacy|8|||
19448331|NCT01614795|41696370|FG000|Overall Study|Physician Decision|1|||
19448332|NCT01614795|41696371|FG001|Overall Study|Physician Decision|0|||
19448333|NCT01614795|41696372|FG002|Overall Study|Physician Decision|1|||
19448334|NCT01614795|41696373|FG003|Overall Study|Physician Decision|1|||
19448335|NCT01614795|41696370|FG000|Overall Study|Withdrawal by Subject|0|||
19448336|NCT01614795|41696371|FG001|Overall Study|Withdrawal by Subject|1|||
19448337|NCT01614795|41696372|FG002|Overall Study|Withdrawal by Subject|0|||
19448338|NCT01614795|41696373|FG003|Overall Study|Withdrawal by Subject|2|||
19448339|NCT01614795|41696370|FG000|Overall Study|Ineligible|0|||
19448340|NCT01614795|41696371|FG001|Overall Study|Ineligible|1|||
19448341|NCT01614795|41696372|FG002|Overall Study|Ineligible|0|||
19448342|NCT01614795|41696373|FG003|Overall Study|Ineligible|0|||
19448343|NCT01834586|41696384|FG000|Overall Study|Adverse Event|1|||
19448344|NCT01614249|41696390|FG000|Overall Study|Lost to Follow-up|11|||
19448345|NCT01614249|41696391|FG001|Overall Study|Lost to Follow-up|23|||
19448346|NCT01597778|41696399|FG000|Overall Study|Death|7|||
19448347|NCT01597778|41696400|FG001|Overall Study|Death|10|||
19448348|NCT01597778|41696399|FG000|Overall Study|Withdrawal by Subject|3|||
19448349|NCT01597778|41696400|FG001|Overall Study|Withdrawal by Subject|4|||
19448350|NCT01597778|41696399|FG000|Overall Study|Adverse Event|1|||
19448351|NCT01597778|41696400|FG001|Overall Study|Adverse Event|1|||
19448352|NCT01597778|41696399|FG000|Overall Study|Protocol Violation|1|||
19448353|NCT01597778|41696400|FG001|Overall Study|Protocol Violation|11|||
19448354|NCT01597778|41696399|FG000|Overall Study|Transplanted off protocol|2|||
19448355|NCT01597778|41696400|FG001|Overall Study|Transplanted off protocol|3|||
19448356|NCT01614093|41696406|FG000|Overall Study|Withdrawal by Subject|1|||
19448357|NCT01834274|41696413|FG000|Overall Study|Study Termination|41|||
19448358|NCT01834274|41696414|FG001|Overall Study|Study Termination|38|||
19448359|NCT01834274|41696413|FG000|Overall Study|Withdrawal by Subject|1|||
19448360|NCT01834274|41696414|FG001|Overall Study|Withdrawal by Subject|1|||
19448361|NCT01834274|41696413|FG000|Overall Study|Lost to Follow-up|3|||
19448362|NCT01834274|41696414|FG001|Overall Study|Lost to Follow-up|1|||
19448363|NCT01834274|41696413|FG000|Overall Study|Other|2|||
19448364|NCT01834274|41696414|FG001|Overall Study|Other|1|||
19448365|NCT01739595|41696423|FG000|Overall Study|Adverse Event|3|||
19448366|NCT01739595|41696424|FG001|Overall Study|Adverse Event|0|||
19448367|NCT01739595|41696425|FG002|Overall Study|Adverse Event|0|||
19526290|NCT01425008|41971640|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526291|NCT01425008|41971641|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
19448368|NCT01739595|41696423|FG000|Overall Study|Lost to Follow-up|2|||
19448369|NCT01739595|41696424|FG001|Overall Study|Lost to Follow-up|0|||
19448370|NCT01739595|41696425|FG002|Overall Study|Lost to Follow-up|0|||
19448371|NCT01739595|41696423|FG000|Overall Study|Withdrawal by Subject|2|||
19448372|NCT01739595|41696424|FG001|Overall Study|Withdrawal by Subject|1|||
19448373|NCT01739595|41696425|FG002|Overall Study|Withdrawal by Subject|2|||
19448374|NCT01739595|41696423|FG000|Overall Study|Eligibility issue|3|||
19448375|NCT01739595|41696424|FG001|Overall Study|Eligibility issue|0|||
19448376|NCT01739595|41696425|FG002|Overall Study|Eligibility issue|0|||
19448377|NCT01739595|41696423|FG000|Overall Study|Protocol Violation|1|||
19448378|NCT01739595|41696424|FG001|Overall Study|Protocol Violation|0|||
19448379|NCT01739595|41696425|FG002|Overall Study|Protocol Violation|0|||
19448380|NCT01739595|41696423|FG000|Overall Study|Lab assessment|1|||
19526292|NCT01425008|41971642|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
19448381|NCT01739595|41696424|FG001|Overall Study|Lab assessment|0|||
19448382|NCT01739595|41696425|FG002|Overall Study|Lab assessment|0|||
19448383|NCT01739595|41696423|FG000|Overall Study|Drug discrepancy|1|||
19448384|NCT01739595|41696424|FG001|Overall Study|Drug discrepancy|0|||
19448385|NCT01739595|41696425|FG002|Overall Study|Drug discrepancy|0|||
19448386|NCT01833494|41696432|FG000|Overall Study|Adverse Event|24|||
19448387|NCT01833494|41696432|FG000|Overall Study|Physician Decision|6|||
19448388|NCT01833494|41696432|FG000|Overall Study|Withdrawal by Subject|6|||
19448389|NCT01833494|41696432|FG000|Overall Study|Decrease in serum phosphorus|4|||
19448390|NCT01833494|41696432|FG000|Overall Study|Decrease in serum calcium|4|||
19448391|NCT01833494|41696432|FG000|Overall Study|Increase in serum ferritin|1|||
19448392|NCT01738971|41696439|FG000|Overall Study|Lost to Follow-up|19|||
19448393|NCT01738971|41696440|FG001|Overall Study|Lost to Follow-up|30|||
19448394|NCT01738971|41696441|FG002|Overall Study|Lost to Follow-up|17|||
19448395|NCT01738581|41696451|FG000|Overall Study|Lost to Follow-up|1|||
19448396|NCT01738581|41696452|FG001|Overall Study|Lost to Follow-up|0|||
19448397|NCT01738503|41696464|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
19448398|NCT01738503|41696465|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448399|NCT01738503|41696466|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448400|NCT01738503|41696467|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448401|NCT01738503|41696468|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448402|NCT01738503|41696469|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448403|NCT01738503|41696470|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
19448404|NCT01738503|41696464|FG000|Treatment Period|Adverse Event|0|||
19448405|NCT01738503|41696465|FG001|Treatment Period|Adverse Event|1|||
19448406|NCT01738503|41696466|FG002|Treatment Period|Adverse Event|0|||
19448407|NCT01738503|41696467|FG003|Treatment Period|Adverse Event|1|||
19448408|NCT01738503|41696468|FG004|Treatment Period|Adverse Event|2|||
19448409|NCT01738503|41696469|FG005|Treatment Period|Adverse Event|2|||
19448410|NCT01738503|41696470|FG006|Treatment Period|Adverse Event|2|||
19448411|NCT01738503|41696464|FG000|Treatment Period|Lost to Follow-up|0|||
19448412|NCT01738503|41696465|FG001|Treatment Period|Lost to Follow-up|0|||
19448413|NCT01738503|41696466|FG002|Treatment Period|Lost to Follow-up|3|||
19448414|NCT01738503|41696467|FG003|Treatment Period|Lost to Follow-up|4|||
19448415|NCT01738503|41696468|FG004|Treatment Period|Lost to Follow-up|1|||
19448416|NCT01738503|41696469|FG005|Treatment Period|Lost to Follow-up|1|||
19448417|NCT01738503|41696470|FG006|Treatment Period|Lost to Follow-up|5|||
19448418|NCT01738503|41696464|FG000|Treatment Period|Withdrawal by Subject|0|||
19448419|NCT01738503|41696465|FG001|Treatment Period|Withdrawal by Subject|1|||
19448420|NCT01738503|41696466|FG002|Treatment Period|Withdrawal by Subject|0|||
19448421|NCT01738503|41696467|FG003|Treatment Period|Withdrawal by Subject|1|||
19448422|NCT01738503|41696468|FG004|Treatment Period|Withdrawal by Subject|1|||
19448423|NCT01738503|41696469|FG005|Treatment Period|Withdrawal by Subject|1|||
19448424|NCT01738503|41696470|FG006|Treatment Period|Withdrawal by Subject|1|||
19448425|NCT01738503|41696464|FG000|Treatment Period|Protocol Violation|0|||
19448426|NCT01738503|41696465|FG001|Treatment Period|Protocol Violation|3|||
19448427|NCT01738503|41696466|FG002|Treatment Period|Protocol Violation|1|||
19448428|NCT01738503|41696467|FG003|Treatment Period|Protocol Violation|0|||
19448429|NCT01738503|41696468|FG004|Treatment Period|Protocol Violation|4|||
19448430|NCT01738503|41696469|FG005|Treatment Period|Protocol Violation|2|||
19448431|NCT01738503|41696470|FG006|Treatment Period|Protocol Violation|0|||
19448432|NCT01738503|41696464|FG000|Treatment Period|Other|0|||
19448433|NCT01738503|41696465|FG001|Treatment Period|Other|0|||
19448434|NCT01738503|41696466|FG002|Treatment Period|Other|1|||
19448435|NCT01738503|41696467|FG003|Treatment Period|Other|0|||
19448436|NCT01738503|41696468|FG004|Treatment Period|Other|0|||
19448437|NCT01738503|41696469|FG005|Treatment Period|Other|0|||
19448438|NCT01738503|41696470|FG006|Treatment Period|Other|0|||
19448439|NCT01738503|41696464|FG000|PET Imaging Sub-study|Adverse Event|0|||
19448440|NCT01738503|41696465|FG001|PET Imaging Sub-study|Adverse Event|0|||
19448441|NCT01738503|41696466|FG002|PET Imaging Sub-study|Adverse Event|0|||
19448442|NCT01738503|41696467|FG003|PET Imaging Sub-study|Adverse Event|0|||
19448443|NCT01738503|41696468|FG004|PET Imaging Sub-study|Adverse Event|0|||
19448444|NCT01738503|41696469|FG005|PET Imaging Sub-study|Adverse Event|1|||
19448445|NCT01738503|41696470|FG006|PET Imaging Sub-study|Adverse Event|0|||
19448446|NCT01738503|41696464|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
19448447|NCT01738503|41696465|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
19448448|NCT01738503|41696466|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
19448449|NCT01738503|41696467|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
19448450|NCT01738503|41696468|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
19448451|NCT01738503|41696469|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
19448452|NCT01738503|41696470|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
19448453|NCT01738191|41696494|FG000|Overall Study|Withdrawal by Subject|4|||
19448454|NCT01738191|41696495|FG001|Overall Study|Withdrawal by Subject|1|||
19448455|NCT01737879|41696501|FG000|Overall Study|Death|1|||
19448456|NCT01737879|41696501|FG000|Overall Study|Sponsor decision|40|||
19448457|NCT01879683|41696505|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
19448458|NCT01605825|41696511|FG000|Overall Study|Adverse Event|4|||
19448459|NCT01605825|41696512|FG001|Overall Study|Adverse Event|2|||
19448460|NCT01605825|41696511|FG000|Overall Study|Withdrawal by Subject|0|||
19448461|NCT01605825|41696512|FG001|Overall Study|Withdrawal by Subject|1|||
19448462|NCT01605825|41696511|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
19448463|NCT01605825|41696512|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
19448464|NCT01605825|41696511|FG000|Overall Study|Non-Compliance with Protocol|3|||
19448465|NCT01605825|41696512|FG001|Overall Study|Non-Compliance with Protocol|0|||
19448466|NCT01727505|41696518|FG000|First 24 Hours|Adverse Event|0|||
19448467|NCT01727505|41696519|FG001|First 24 Hours|Adverse Event|1|||
19448468|NCT01727505|41696518|FG000|Second 24 Hours|Missing data|0|||
19448469|NCT01727505|41696519|FG001|Second 24 Hours|Missing data|1|||
19448470|NCT01726803|41696527|FG000|Overall Study|Lost to Follow-up|6|||
19448471|NCT01726803|41696528|FG001|Overall Study|Lost to Follow-up|1|||
19448472|NCT01726803|41696527|FG000|Overall Study|Withdrawal by Subject|1|||
19448473|NCT01726803|41696528|FG001|Overall Study|Withdrawal by Subject|0|||
19448474|NCT01726335|41696534|FG000|Overall Study|Lost to Follow-up|2|||
19448475|NCT01726335|41696534|FG000|Overall Study|Withdrawal by Subject|15|||
19448476|NCT01726335|41696534|FG000|Overall Study|Adverse Event|4|||
19448477|NCT01726335|41696534|FG000|Overall Study|Lost to Follow-up|2|||
19448478|NCT01726335|41696534|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
19448479|NCT01877421|41696570|FG000|Phase 2|Lost to Follow-up|0|||
19448480|NCT01877421|41696571|FG001|Phase 2|Lost to Follow-up|0|||
19448481|NCT01877421|41696572|FG002|Phase 2|Lost to Follow-up|0|||
19448482|NCT01877421|41696573|FG003|Phase 2|Lost to Follow-up|0|||
19448483|NCT01877421|41696574|FG004|Phase 2|Lost to Follow-up|0|||
19448484|NCT01877421|41696575|FG005|Phase 2|Lost to Follow-up|0|||
19448485|NCT01877421|41696576|FG006|Phase 2|Lost to Follow-up|1|||
19448486|NCT01877421|41696577|FG007|Phase 2|Lost to Follow-up|0|||
19448487|NCT01877421|41696578|FG008|Phase 2|Lost to Follow-up|0|||
19448488|NCT01877421|41696579|FG009|Phase 2|Lost to Follow-up|0|||
19448489|NCT01877421|41696580|FG010|Phase 2|Lost to Follow-up|0|||
19448490|NCT01877421|41696581|FG011|Phase 2|Lost to Follow-up|0|||
19448491|NCT01877421|41696582|FG012|Phase 2|Lost to Follow-up|0|||
19448492|NCT01877421|41696583|FG013|Phase 2|Lost to Follow-up|0|||
19448493|NCT01877421|41696584|FG014|Phase 2|Lost to Follow-up|0|||
19448494|NCT01877421|41696585|FG015|Phase 2|Lost to Follow-up|0|||
19448495|NCT01877421|41696586|FG016|Phase 2|Lost to Follow-up|0|||
19448496|NCT01877421|41696587|FG017|Phase 2|Lost to Follow-up|0|||
19448497|NCT01877421|41696570|FG000|Phase 2|Withdrawal by Subject|0|||
19448498|NCT01877421|41696571|FG001|Phase 2|Withdrawal by Subject|0|||
19448499|NCT01877421|41696572|FG002|Phase 2|Withdrawal by Subject|0|||
19448500|NCT01877421|41696573|FG003|Phase 2|Withdrawal by Subject|0|||
19448501|NCT01877421|41696574|FG004|Phase 2|Withdrawal by Subject|0|||
19448502|NCT01877421|41696575|FG005|Phase 2|Withdrawal by Subject|0|||
19448503|NCT01877421|41696576|FG006|Phase 2|Withdrawal by Subject|0|||
19448504|NCT01877421|41696577|FG007|Phase 2|Withdrawal by Subject|0|||
19448505|NCT01877421|41696578|FG008|Phase 2|Withdrawal by Subject|1|||
19448506|NCT01877421|41696579|FG009|Phase 2|Withdrawal by Subject|0|||
19448507|NCT01877421|41696580|FG010|Phase 2|Withdrawal by Subject|1|||
19448508|NCT01877421|41696581|FG011|Phase 2|Withdrawal by Subject|0|||
19448509|NCT01877421|41696582|FG012|Phase 2|Withdrawal by Subject|1|||
19448510|NCT01877421|41696583|FG013|Phase 2|Withdrawal by Subject|0|||
19448511|NCT01877421|41696584|FG014|Phase 2|Withdrawal by Subject|0|||
19448512|NCT01877421|41696585|FG015|Phase 2|Withdrawal by Subject|1|||
19526293|NCT01425008|41971643|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526294|NCT01425008|41971644|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526295|NCT01425008|41971645|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526296|NCT01425008|41971646|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526297|NCT01425008|41971647|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526298|NCT01425008|41971648|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526299|NCT01425008|41971649|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
19526300|NCT01425008|41971650|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
19526301|NCT01425008|41971651|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526302|NCT01425008|41971652|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526303|NCT01425008|41971653|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526304|NCT01425008|41971654|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
19526305|NCT01425008|41971655|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
19448513|NCT01877421|41696586|FG016|Phase 2|Withdrawal by Subject|0|||
19448514|NCT01877421|41696587|FG017|Phase 2|Withdrawal by Subject|0|||
19448515|NCT01877421|41696570|FG000|Phase 2|Protocol Violation|0|||
19448516|NCT01877421|41696571|FG001|Phase 2|Protocol Violation|0|||
19448517|NCT01877421|41696572|FG002|Phase 2|Protocol Violation|0|||
19448518|NCT01877421|41696573|FG003|Phase 2|Protocol Violation|0|||
19448519|NCT01877421|41696574|FG004|Phase 2|Protocol Violation|0|||
19448520|NCT01877421|41696575|FG005|Phase 2|Protocol Violation|0|||
19448521|NCT01877421|41696576|FG006|Phase 2|Protocol Violation|0|||
19448522|NCT01877421|41696577|FG007|Phase 2|Protocol Violation|0|||
19448523|NCT01877421|41696578|FG008|Phase 2|Protocol Violation|0|||
19448524|NCT01877421|41696579|FG009|Phase 2|Protocol Violation|0|||
19448525|NCT01877421|41696580|FG010|Phase 2|Protocol Violation|1|||
19448526|NCT01877421|41696581|FG011|Phase 2|Protocol Violation|0|||
19448527|NCT01877421|41696582|FG012|Phase 2|Protocol Violation|0|||
19448528|NCT01877421|41696583|FG013|Phase 2|Protocol Violation|0|||
19448529|NCT01877421|41696584|FG014|Phase 2|Protocol Violation|0|||
19448530|NCT01877421|41696585|FG015|Phase 2|Protocol Violation|0|||
19448531|NCT01877421|41696586|FG016|Phase 2|Protocol Violation|0|||
19448532|NCT01877421|41696587|FG017|Phase 2|Protocol Violation|0|||
19448533|NCT01726023|41696669|FG000|Overall Study|Death|1|||
19448534|NCT01726023|41696670|FG001|Overall Study|Death|1|||
19448535|NCT01726023|41696669|FG000|Overall Study|Lost to Follow-up|5|||
19448536|NCT01726023|41696670|FG001|Overall Study|Lost to Follow-up|10|||
19448537|NCT01726023|41696669|FG000|Overall Study|Other Eligibility criteria|7|||
19448538|NCT01726023|41696670|FG001|Overall Study|Other Eligibility criteria|7|||
19448539|NCT01726023|41696669|FG000|Overall Study|Withdrawal by Subject|16|||
19526306|NCT01425008|41971656|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
19526307|NCT01425008|41971657|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
19526308|NCT01425008|41971639|FG000|Dose Expansion Phase|Adverse Event|0|||
19526309|NCT01425008|41971640|FG001|Dose Expansion Phase|Adverse Event|0|||
19526310|NCT01425008|41971641|FG002|Dose Expansion Phase|Adverse Event|0|||
19526311|NCT01425008|41971642|FG003|Dose Expansion Phase|Adverse Event|0|||
19526312|NCT01425008|41971643|FG004|Dose Expansion Phase|Adverse Event|0|||
19526313|NCT01425008|41971644|FG005|Dose Expansion Phase|Adverse Event|0|||
19526314|NCT01425008|41971645|FG006|Dose Expansion Phase|Adverse Event|0|||
19526315|NCT01425008|41971646|FG007|Dose Expansion Phase|Adverse Event|0|||
19526316|NCT01425008|41971647|FG008|Dose Expansion Phase|Adverse Event|0|||
19526317|NCT01425008|41971648|FG009|Dose Expansion Phase|Adverse Event|0|||
19526318|NCT01425008|41971649|FG010|Dose Expansion Phase|Adverse Event|2|||
19526319|NCT01425008|41971650|FG011|Dose Expansion Phase|Adverse Event|3|||
19526320|NCT01425008|41971651|FG012|Dose Expansion Phase|Adverse Event|3|||
19526321|NCT01425008|41971652|FG013|Dose Expansion Phase|Adverse Event|0|||
19526322|NCT01425008|41971653|FG014|Dose Expansion Phase|Adverse Event|1|||
19526323|NCT01425008|41971654|FG015|Dose Expansion Phase|Adverse Event|1|||
19526324|NCT01425008|41971655|FG016|Dose Expansion Phase|Adverse Event|5|||
19526325|NCT01425008|41971656|FG017|Dose Expansion Phase|Adverse Event|0|||
19526326|NCT01425008|41971657|FG018|Dose Expansion Phase|Adverse Event|3|||
19526327|NCT01425008|41971639|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
19526328|NCT01425008|41971640|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
19526329|NCT01425008|41971641|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
19526330|NCT01425008|41971642|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
19526331|NCT01425008|41971643|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
19526332|NCT01425008|41971644|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
19526333|NCT01425008|41971645|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
19526334|NCT01425008|41971646|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
19526335|NCT01425008|41971647|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
19526336|NCT01425008|41971648|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
19526337|NCT01425008|41971649|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
19526338|NCT01425008|41971650|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
19526339|NCT01425008|41971651|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
19526340|NCT01425008|41971652|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
19526341|NCT01425008|41971653|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
19526342|NCT01425008|41971654|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
19526343|NCT01425008|41971655|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
19526344|NCT01425008|41971656|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
19526345|NCT01425008|41971657|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
19526346|NCT01425008|41971639|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19448540|NCT01726023|41696670|FG001|Overall Study|Withdrawal by Subject|8|||
19448541|NCT01877265|41696683|FG000|Treatment Period 1|Sponsor Decision|0|||
19448542|NCT01877265|41696684|FG001|Treatment Period 1|Sponsor Decision|0|||
19448543|NCT01877265|41696685|FG002|Treatment Period 1|Sponsor Decision|1|||
19448544|NCT01877265|41696686|FG003|Treatment Period 1|Sponsor Decision|0|||
19526347|NCT01425008|41971640|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526348|NCT01425008|41971641|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526349|NCT01425008|41971642|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526350|NCT01425008|41971643|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526351|NCT01425008|41971644|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526352|NCT01425008|41971645|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19629218|NCT00814580|42078732|FG000|Overall Study|Lack of Efficacy|18|||
19448545|NCT01877265|41696687|FG004|Treatment Period 1|Sponsor Decision|0|||
19448546|NCT01877265|41696688|FG005|Treatment Period 1|Sponsor Decision|0|||
19448547|NCT01877265|41696683|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
19448548|NCT01877265|41696684|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
19448549|NCT01877265|41696685|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
19526353|NCT01425008|41971646|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526354|NCT01425008|41971647|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526355|NCT01425008|41971648|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526356|NCT01425008|41971649|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526357|NCT01425008|41971650|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526358|NCT01425008|41971651|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526359|NCT01425008|41971652|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526360|NCT01425008|41971653|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526361|NCT01425008|41971654|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526362|NCT01425008|41971655|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526363|NCT01425008|41971656|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
19526364|NCT01425008|41971657|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
19526365|NCT04425902|41971710|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
19526366|NCT04072146|41971723|FG000|Overall Study|Adverse Event|0|||
19526367|NCT04072146|41971724|FG001|Overall Study|Adverse Event|1|||
19526368|NCT03861481|41971738|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
19526369|NCT03861481|41971739|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
19526370|NCT03861481|41971738|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
19526371|NCT03861481|41971739|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
19526372|NCT03861481|41971738|FG000|Overall Study|Relapse|1|||
19526373|NCT03861481|41971739|FG001|Overall Study|Relapse|0|||
19526374|NCT03861481|41971738|FG000|Overall Study|Withdrawal by Subject|0|||
19526375|NCT03861481|41971739|FG001|Overall Study|Withdrawal by Subject|1|||
19526376|NCT03861481|41971738|FG000|Overall Study|Lack of Efficacy|4|||
19526377|NCT03861481|41971739|FG001|Overall Study|Lack of Efficacy|5|||
19526378|NCT03648476|41971751|FG000|Overall Study|Withdrawal by Subject|2|||
19526379|NCT03648476|41971752|FG001|Overall Study|Withdrawal by Subject|1|||
19526380|NCT01231906|41971765|FG000|Overall Study|Lack of Efficacy|75|||
19526381|NCT01231906|41971766|FG001|Overall Study|Lack of Efficacy|68|||
19526382|NCT01231906|41971765|FG000|Overall Study|Lost to Follow-up|1|||
19526383|NCT01231906|41971766|FG001|Overall Study|Lost to Follow-up|0|||
19526384|NCT01231906|41971765|FG000|Overall Study|Physician Decision|34|||
19526385|NCT01231906|41971766|FG001|Overall Study|Physician Decision|24|||
19526386|NCT01231906|41971765|FG000|Overall Study|Withdrawal by Subject|0|||
19526387|NCT01231906|41971766|FG001|Overall Study|Withdrawal by Subject|4|||
19526388|NCT01231906|41971765|FG000|Overall Study|Ineligible|10|||
19526389|NCT01231906|41971766|FG001|Overall Study|Ineligible|3|||
19526390|NCT01231906|41971765|FG000|Overall Study|No treatment|1|||
19526391|NCT01231906|41971766|FG001|Overall Study|No treatment|2|||
19526392|NCT04545060|41971774|FG000|Overall Study|Adverse Event|0|||
19526393|NCT04545060|41971775|FG001|Overall Study|Adverse Event|1|||
19526394|NCT04545060|41971774|FG000|Overall Study|Death|0|||
19526395|NCT04545060|41971775|FG001|Overall Study|Death|5|||
19526396|NCT04545060|41971774|FG000|Overall Study|Lost to Follow-up|10|||
19526397|NCT04545060|41971775|FG001|Overall Study|Lost to Follow-up|13|||
19526398|NCT04545060|41971774|FG000|Overall Study|Physician Decision|3|||
19526399|NCT04545060|41971775|FG001|Overall Study|Physician Decision|0|||
19526400|NCT04545060|41971774|FG000|Overall Study|Withdrawal by Subject|17|||
19526401|NCT04545060|41971775|FG001|Overall Study|Withdrawal by Subject|22|||
19526402|NCT03533660|41971831|FG000|Overall Study|Withdrawal by Subject|2|||
19526403|NCT03533660|41971832|FG001|Overall Study|Withdrawal by Subject|2|||
19526404|NCT03533660|41971831|FG000|Overall Study|Death|2|||
19526405|NCT03533660|41971832|FG001|Overall Study|Death|4|||
19526406|NCT03533660|41971831|FG000|Overall Study|Adverse Event|0|||
19526407|NCT03533660|41971832|FG001|Overall Study|Adverse Event|2|||
19526408|NCT03416127|41971846|FG000|Overall Study|Withdrawal by Subject|0|||
19526409|NCT03416127|41971847|FG001|Overall Study|Withdrawal by Subject|1|||
19526410|NCT03416127|41971848|FG002|Overall Study|Withdrawal by Subject|1|||
19629219|NCT00814580|42078733|FG001|Overall Study|Lack of Efficacy|25|||
19629220|NCT00814580|42078732|FG000|Overall Study|Protocol Violation|2|||
19526411|NCT03260140|41971859|FG000|Overall Study|Death|4|||
19526412|NCT03260140|41971860|FG001|Overall Study|Death|1|||
19526413|NCT03260140|41971859|FG000|Overall Study|Withdrawal by Subject|1|||
19526414|NCT03260140|41971860|FG001|Overall Study|Withdrawal by Subject|4|||
19526415|NCT02986334|41971891|FG000|Overall Study|Withdrawal by Subject|0|||
19526416|NCT02986334|41971892|FG001|Overall Study|Withdrawal by Subject|1|||
19526417|NCT02986334|41971893|FG002|Overall Study|Withdrawal by Subject|2|||
19526418|NCT02986334|41971891|FG000|Overall Study|Lost to Follow-up|1|||
19526419|NCT02986334|41971892|FG001|Overall Study|Lost to Follow-up|2|||
19526420|NCT02986334|41971893|FG002|Overall Study|Lost to Follow-up|1|||
19526421|NCT02986334|41971891|FG000|Overall Study|Adverse Event|0|||
19526422|NCT02986334|41971892|FG001|Overall Study|Adverse Event|2|||
19526423|NCT02986334|41971893|FG002|Overall Study|Adverse Event|1|||
19526424|NCT02986334|41971891|FG000|Overall Study|non compliance in phone ratings|2|||
19526425|NCT02986334|41971892|FG001|Overall Study|non compliance in phone ratings|1|||
19526426|NCT02986334|41971893|FG002|Overall Study|non compliance in phone ratings|2|||
19526427|NCT02986334|41971891|FG000|Overall Study|undisclosed comorbidities|0|||
19526428|NCT02986334|41971892|FG001|Overall Study|undisclosed comorbidities|1|||
19526429|NCT02986334|41971893|FG002|Overall Study|undisclosed comorbidities|1|||
19526430|NCT02210221|41971915|FG000|Overall Study|Lack of Efficacy|7|||
19526431|NCT02210221|41971915|FG000|Overall Study|Withdrawal by Subject|43|||
19526432|NCT02124902|41971928|FG000|Overall Study|Adverse Event|7|||
19526433|NCT02124902|41971929|FG001|Overall Study|Adverse Event|2|||
19526434|NCT02124902|41971928|FG000|Overall Study|Went to alternative treatment|4|||
19526435|NCT02124902|41971929|FG001|Overall Study|Went to alternative treatment|0|||
19526436|NCT02124902|41971928|FG000|Overall Study|Withdrawal by Subject|2|||
19448550|NCT01877265|41696686|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
19448551|NCT01877265|41696687|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
19448552|NCT01877265|41696688|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
19448553|NCT01877265|41696683|FG000|Treatment Period 3|Lost to Follow-up|1|||
19448554|NCT01877265|41696684|FG001|Treatment Period 3|Lost to Follow-up|0|||
19448555|NCT01877265|41696685|FG002|Treatment Period 3|Lost to Follow-up|0|||
19448556|NCT01877265|41696686|FG003|Treatment Period 3|Lost to Follow-up|0|||
19448557|NCT01877265|41696687|FG004|Treatment Period 3|Lost to Follow-up|0|||
19448558|NCT01877265|41696688|FG005|Treatment Period 3|Lost to Follow-up|0|||
19448559|NCT01877187|41696699|FG000|Overall Study|Death|2|||
19448560|NCT01877187|41696699|FG000|Overall Study|Withdrawal by Subject|4|||
19448561|NCT01877187|41696699|FG000|Overall Study|Lost to Follow-up|3|||
19448562|NCT01877187|41696699|FG000|Overall Study|Declining clinical status|11|||
19448563|NCT01877187|41696699|FG000|Overall Study|Liver transplant|2|||
19448564|NCT01858532|41696710|FG000|Overall Study|Adverse Event|58|||
19448565|NCT01858532|41696711|FG001|Overall Study|Adverse Event|50|||
19448566|NCT01858532|41696712|FG002|Overall Study|Adverse Event|23|||
19448567|NCT01858532|41696713|FG003|Overall Study|Adverse Event|28|||
19448568|NCT01858532|41696710|FG000|Overall Study|Withdrew consent|71|||
19448569|NCT01858532|41696711|FG001|Overall Study|Withdrew consent|93|||
19448570|NCT01858532|41696712|FG002|Overall Study|Withdrew consent|46|||
19448571|NCT01858532|41696713|FG003|Overall Study|Withdrew consent|27|||
19448572|NCT01858532|41696710|FG000|Overall Study|Lost to Follow-up|17|||
19448573|NCT01858532|41696711|FG001|Overall Study|Lost to Follow-up|26|||
19448574|NCT01858532|41696712|FG002|Overall Study|Lost to Follow-up|11|||
19448575|NCT01858532|41696713|FG003|Overall Study|Lost to Follow-up|14|||
19448576|NCT01858532|41696710|FG000|Overall Study|Deterioration of medical status|3|||
19448577|NCT01858532|41696711|FG001|Overall Study|Deterioration of medical status|4|||
19448578|NCT01858532|41696712|FG002|Overall Study|Deterioration of medical status|3|||
19448579|NCT01858532|41696713|FG003|Overall Study|Deterioration of medical status|7|||
19448580|NCT01858532|41696710|FG000|Overall Study|Investigator request|3|||
19448581|NCT01858532|41696711|FG001|Overall Study|Investigator request|4|||
19448582|NCT01858532|41696712|FG002|Overall Study|Investigator request|2|||
19448583|NCT01858532|41696713|FG003|Overall Study|Investigator request|6|||
19448584|NCT01858532|41696710|FG000|Overall Study|Other, not specified|29|||
19448585|NCT01858532|41696711|FG001|Overall Study|Other, not specified|15|||
19448586|NCT01858532|41696712|FG002|Overall Study|Other, not specified|13|||
19448587|NCT01858532|41696713|FG003|Overall Study|Other, not specified|11|||
19448588|NCT01883492|41696725|FG000|Overall Study|Lost to Follow-up|3|||
19448589|NCT01883492|41696726|FG001|Overall Study|Lost to Follow-up|4|||
19448590|NCT01883492|41696725|FG000|Overall Study|Surgery on contra-lateral hip|0|||
19448591|NCT01883492|41696726|FG001|Overall Study|Surgery on contra-lateral hip|1|||
19448592|NCT01883492|41696725|FG000|Overall Study|Poor X-ray quality|7|||
19448593|NCT01883492|41696726|FG001|Overall Study|Poor X-ray quality|4|||
19448594|NCT01883492|41696725|FG000|Overall Study|Withdrawal by Subject|1|||
19448595|NCT01883492|41696726|FG001|Overall Study|Withdrawal by Subject|0|||
19448596|NCT01883492|41696725|FG000|Overall Study|inappropriate implant used|1|||
19448597|NCT01883492|41696726|FG001|Overall Study|inappropriate implant used|1|||
19448598|NCT01883492|41696725|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
19448599|NCT01883492|41696726|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
19448600|NCT01832480|41696734|FG000|Overall Study|Lost to Follow-up|33|||
19448601|NCT01832480|41696735|FG001|Overall Study|Lost to Follow-up|30|||
19448602|NCT01832480|41696734|FG000|Overall Study|Withdrawal by Subject|0|||
19448603|NCT01832480|41696735|FG001|Overall Study|Withdrawal by Subject|2|||
19448604|NCT01832480|41696734|FG000|Overall Study|post randomization ineligible|8|||
19526437|NCT02124902|41971929|FG001|Overall Study|Withdrawal by Subject|1|||
19526438|NCT02124902|41971928|FG000|Overall Study|Physician Decision|2|||
19526439|NCT02124902|41971929|FG001|Overall Study|Physician Decision|0|||
19448605|NCT01832480|41696735|FG001|Overall Study|post randomization ineligible|10|||
19526440|NCT02124902|41971928|FG000|Overall Study|Not eligible|1|||
19526441|NCT02124902|41971929|FG001|Overall Study|Not eligible|0|||
19526442|NCT02124902|41971928|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
19448606|NCT01858376|41696741|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
19448607|NCT01831856|41696747|FG000|Overall Study|Adverse Event|5|||
19448608|NCT01831856|41696748|FG001|Overall Study|Adverse Event|8|||
19448609|NCT01831856|41696747|FG000|Overall Study|Lack of Efficacy|13|||
19448610|NCT01831856|41696748|FG001|Overall Study|Lack of Efficacy|11|||
19448611|NCT01831856|41696747|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
19448612|NCT01831856|41696748|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
19448613|NCT01831544|41696754|FG000|Overall Study|Death|1|||
19448614|NCT01831544|41696754|FG000|Overall Study|Still on original MVAD device|2|||
19526443|NCT02124902|41971929|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
19526444|NCT01940341|41971937|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
19526445|NCT01940341|41971938|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
19526446|NCT01940341|41971937|FG000|Double-Blind Phase|Adverse Event|3|||
19526447|NCT01940341|41971938|FG001|Double-Blind Phase|Adverse Event|2|||
19526448|NCT01940341|41971937|FG000|Double-Blind Phase|Withdrew Consent|3|||
19526449|NCT01940341|41971938|FG001|Double-Blind Phase|Withdrew Consent|2|||
19526450|NCT01940341|41971937|FG000|Double-Blind Phase|Lost to Follow-up|4|||
19526451|NCT01940341|41971938|FG001|Double-Blind Phase|Lost to Follow-up|1|||
19526452|NCT01940341|41971937|FG000|Double-Blind Phase|Pregnancy|0|||
19448615|NCT01857206|41696760|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
19448616|NCT01857206|41696761|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
19448617|NCT01857206|41696760|FG000|Overall Study|Lost to Follow-up|9|||
19448618|NCT01857206|41696761|FG001|Overall Study|Lost to Follow-up|6|||
19448619|NCT01857206|41696760|FG000|Overall Study|Unclassified|3|||
19448620|NCT01857206|41696761|FG001|Overall Study|Unclassified|3|||
19448621|NCT01857206|41696760|FG000|Overall Study|Withdrawal by Subject|1|||
19448622|NCT01857206|41696761|FG001|Overall Study|Withdrawal by Subject|0|||
19448623|NCT01882088|41696771|FG000|Overall Study|Intolerance of esophageal manometry|1|||
19448624|NCT01882088|41696771|FG000|Overall Study|no possibility to place the catheter|1|||
19448625|NCT01882088|41696771|FG000|Overall Study|Protocol Violation|1|||
19448626|NCT01882088|41696771|FG000|Overall Study|inadequate pH-impedance tracings|2|||
19448627|NCT01881776|41696778|FG000|Overall Study|Lost to Follow-up|1|||
19448628|NCT01881776|41696779|FG001|Overall Study|Lost to Follow-up|2|||
19448629|NCT01881776|41696780|FG002|Overall Study|Lost to Follow-up|1|||
19448630|NCT01881776|41696778|FG000|Overall Study|Protocol Violation|0|||
19448631|NCT01881776|41696779|FG001|Overall Study|Protocol Violation|2|||
19448632|NCT01881776|41696780|FG002|Overall Study|Protocol Violation|1|||
19448633|NCT01708161|41696794|FG000|Overall Study|Adverse Event|1|||
19448634|NCT01708161|41696795|FG001|Overall Study|Adverse Event|3|||
19448635|NCT01708161|41696796|FG002|Overall Study|Adverse Event|4|||
19448636|NCT01708161|41696797|FG003|Overall Study|Adverse Event|2|||
19448637|NCT01708161|41696798|FG004|Overall Study|Adverse Event|3|||
19448638|NCT01708161|41696799|FG005|Overall Study|Adverse Event|0|||
19448639|NCT01708161|41696794|FG000|Overall Study|Death|0|||
19448640|NCT01708161|41696795|FG001|Overall Study|Death|0|||
19448641|NCT01708161|41696796|FG002|Overall Study|Death|0|||
19448642|NCT01708161|41696797|FG003|Overall Study|Death|1|||
19448643|NCT01708161|41696798|FG004|Overall Study|Death|0|||
19448644|NCT01708161|41696799|FG005|Overall Study|Death|1|||
19448645|NCT01708161|41696794|FG000|Overall Study|Withdrawal by Subject|0|||
19448646|NCT01708161|41696795|FG001|Overall Study|Withdrawal by Subject|1|||
19448647|NCT01708161|41696796|FG002|Overall Study|Withdrawal by Subject|1|||
19448648|NCT01708161|41696797|FG003|Overall Study|Withdrawal by Subject|0|||
19448649|NCT01708161|41696798|FG004|Overall Study|Withdrawal by Subject|0|||
19448650|NCT01708161|41696799|FG005|Overall Study|Withdrawal by Subject|0|||
19448651|NCT01708161|41696794|FG000|Overall Study|Administrative problems|0|||
19448652|NCT01708161|41696795|FG001|Overall Study|Administrative problems|1|||
19448653|NCT01708161|41696796|FG002|Overall Study|Administrative problems|0|||
19448654|NCT01708161|41696797|FG003|Overall Study|Administrative problems|0|||
19448655|NCT01708161|41696798|FG004|Overall Study|Administrative problems|0|||
19448656|NCT01708161|41696799|FG005|Overall Study|Administrative problems|0|||
19448657|NCT01708161|41696794|FG000|Overall Study|Disease progression|3|||
19448658|NCT01708161|41696795|FG001|Overall Study|Disease progression|5|||
19448659|NCT01708161|41696796|FG002|Overall Study|Disease progression|5|||
19448660|NCT01708161|41696797|FG003|Overall Study|Disease progression|13|||
19448661|NCT01708161|41696798|FG004|Overall Study|Disease progression|3|||
19448662|NCT01708161|41696799|FG005|Overall Study|Disease progression|0|||
19448663|NCT01707693|41696815|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
19448664|NCT01707693|41696816|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
19448665|NCT01707693|41696815|FG000|Overall Study Allocation|Protocol Violation|4|||
19448666|NCT01707693|41696816|FG001|Overall Study Allocation|Protocol Violation|3|||
19526453|NCT01940341|41971938|FG001|Double-Blind Phase|Pregnancy|1|||
19526454|NCT01940341|41971937|FG000|Double-Blind Phase|Investigator's Discretion|1|||
19526455|NCT01940341|41971938|FG001|Double-Blind Phase|Investigator's Discretion|0|||
19448667|NCT01707693|41696815|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
19448668|NCT01707693|41696816|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
19448669|NCT01707693|41696815|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
19448670|NCT01707693|41696816|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
19448671|NCT01722669|41696829|FG000|Overall Study|Withdrawal by Subject|0|||
19526456|NCT01940341|41971937|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
19448672|NCT01722669|41696830|FG001|Overall Study|Withdrawal by Subject|0|||
19448673|NCT01722669|41696831|FG002|Overall Study|Withdrawal by Subject|0|||
19448674|NCT01722669|41696832|FG003|Overall Study|Withdrawal by Subject|0|||
19448675|NCT01722669|41696833|FG004|Overall Study|Withdrawal by Subject|0|||
19448676|NCT01722669|41696834|FG005|Overall Study|Withdrawal by Subject|2|||
19448677|NCT01707147|41696854|FG000|Overall Study|Administered Trajenta prior to contract|5|||
19448678|NCT01707147|41696854|FG000|Overall Study|Patients who have not taken Trajenta|1|||
19448679|NCT01707147|41696854|FG000|Overall Study|Follow-up failure|17|||
19448680|NCT01707147|41696854|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
19448681|NCT01876251|41696861|FG000|Overall Study|Clinical progression|1|||
19448682|NCT01876251|41696862|FG001|Overall Study|Clinical progression|0|||
19448683|NCT01876251|41696863|FG002|Overall Study|Clinical progression|0|||
19448684|NCT01876251|41696861|FG000|Overall Study|Death|2|||
19448685|NCT01876251|41696862|FG001|Overall Study|Death|0|||
19448686|NCT01876251|41696863|FG002|Overall Study|Death|1|||
19448687|NCT01876251|41696861|FG000|Overall Study|Participant started new treatment|1|||
19448688|NCT01876251|41696862|FG001|Overall Study|Participant started new treatment|0|||
19448689|NCT01876251|41696863|FG002|Overall Study|Participant started new treatment|1|||
19448690|NCT01876251|41696861|FG000|Overall Study|Participant refused further follow-up|0|||
19448691|NCT01876251|41696862|FG001|Overall Study|Participant refused further follow-up|0|||
19448692|NCT01876251|41696863|FG002|Overall Study|Participant refused further follow-up|1|||
19448693|NCT01876251|41696861|FG000|Overall Study|Study terminated|1|||
19448694|NCT01876251|41696862|FG001|Overall Study|Study terminated|0|||
19448695|NCT01876251|41696863|FG002|Overall Study|Study terminated|0|||
19448696|NCT01876251|41696861|FG000|Overall Study|Objective progression or relapse|10|||
19448697|NCT01876251|41696862|FG001|Overall Study|Objective progression or relapse|3|||
19448698|NCT01876251|41696863|FG002|Overall Study|Objective progression or relapse|8|||
19448699|NCT01875471|41696874|FG000|Overall Study|Adverse Event|0|||
19448700|NCT01875471|41696875|FG001|Overall Study|Adverse Event|1|||
19448701|NCT01875471|41696874|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
19448702|NCT01875471|41696875|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
19448703|NCT01875237|41696883|FG000|Overall Study|GVDH before DLI|1|||
19448704|NCT01875237|41696884|FG001|Overall Study|GVDH before DLI|0|||
19448705|NCT01875237|41696883|FG000|Overall Study|DLI cells could not be produced|1|||
19448706|NCT01875237|41696884|FG001|Overall Study|DLI cells could not be produced|0|||
19629221|NCT00814580|42078733|FG001|Overall Study|Protocol Violation|0|||
19629222|NCT00814580|42078732|FG000|Overall Study|Withdrawal by Subject|2|||
19629223|NCT00814580|42078733|FG001|Overall Study|Withdrawal by Subject|2|||
19629224|NCT00814580|42078732|FG000|Overall Study|Other|1|||
19629225|NCT00814580|42078733|FG001|Overall Study|Other|3|||
19629226|NCT00814580|42078732|FG000|Overall Study|Did Not Take Drug|2|||
19629227|NCT00814580|42078733|FG001|Overall Study|Did Not Take Drug|2|||
19629228|NCT00643162|42078753|FG000|Overall Study|Withdrawal by Subject|1|||
19629229|NCT00643162|42078754|FG001|Overall Study|Withdrawal by Subject|1|||
19629230|NCT00643006|42078762|FG000|Overall Study|Lost to Follow-up|5|||
19629231|NCT00643006|42078763|FG001|Overall Study|Lost to Follow-up|4|||
19629232|NCT00814502|42078773|FG000|Overall Study|Adverse Event|1|||
19629233|NCT00814502|42078774|FG001|Overall Study|Adverse Event|0|||
19629234|NCT00814502|42078773|FG000|Overall Study|Withdrawal by Subject|0|||
19629235|NCT00814502|42078774|FG001|Overall Study|Withdrawal by Subject|2|||
19629236|NCT00653224|42078784|FG000|Overall Study|Adverse Event|2|||
19629237|NCT00653224|42078785|FG001|Overall Study|Adverse Event|1|||
19629238|NCT00653224|42078784|FG000|Overall Study|Lack of Efficacy|1|||
19629239|NCT00653224|42078785|FG001|Overall Study|Lack of Efficacy|2|||
19629240|NCT00653224|42078784|FG000|Overall Study|Loss of efficacy|1|||
19629241|NCT00653224|42078785|FG001|Overall Study|Loss of efficacy|0|||
19629242|NCT00653224|42078784|FG000|Overall Study|Lost to Follow-up|1|||
19629243|NCT00653224|42078785|FG001|Overall Study|Lost to Follow-up|0|||
19629244|NCT00653224|42078784|FG000|Overall Study|Other|2|||
19629245|NCT00653224|42078785|FG001|Overall Study|Other|4|||
19629246|NCT00444925|42078794|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
19629247|NCT00444925|42078795|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
19629248|NCT00444925|42078796|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
19629249|NCT00444925|42078794|FG000|Double-blind Treatment Period|Death|2|||
19448707|NCT01874535|41696894|FG000|Overall Study|Lost to Follow-up|10|||
19448708|NCT01874535|41696895|FG001|Overall Study|Lost to Follow-up|9|||
19448709|NCT01874535|41696894|FG000|Overall Study|incomplete symptom resolution|45|||
19448710|NCT01874535|41696895|FG001|Overall Study|incomplete symptom resolution|35|||
19526457|NCT01940341|41971938|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
19526458|NCT01940341|41971937|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
19526459|NCT01940341|41971938|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
19526460|NCT01940341|41971937|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
19448711|NCT01722045|41696901|FG000|Overall Study|Adverse Event|8|||
19448712|NCT01722045|41696901|FG000|Overall Study|Death|3|||
19629250|NCT00444925|42078795|FG001|Double-blind Treatment Period|Death|0|||
19526461|NCT01940341|41971938|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
19526462|NCT01940341|41971937|FG000|Open-label Extension Phase|Still on Study|4|||
19526463|NCT01940341|41971938|FG001|Open-label Extension Phase|Still on Study|1|||
19526464|NCT01877837|41971946|FG000|Overall Study|Lost to Follow-up|1|||
19526465|NCT01877837|41971946|FG000|Overall Study|Ineligible|4|||
19526466|NCT01624142|41971966|FG000|Overall Study|Withdrawal by Subject|14|||
19526467|NCT01624142|41971967|FG001|Overall Study|Withdrawal by Subject|4|||
19526468|NCT01624142|41971966|FG000|Overall Study|Death|3|||
19526469|NCT01624142|41971967|FG001|Overall Study|Death|6|||
19526470|NCT01624142|41971966|FG000|Overall Study|Study Closure|12|||
19526471|NCT01624142|41971967|FG001|Overall Study|Study Closure|6|||
19526472|NCT01624142|41971966|FG000|Overall Study|Lost to Follow-up|2|||
19526473|NCT01624142|41971967|FG001|Overall Study|Lost to Follow-up|0|||
19526474|NCT01624142|41971966|FG000|Overall Study|Other|1|||
19526475|NCT01624142|41971967|FG001|Overall Study|Other|0|||
19526476|NCT01535807|41971976|FG000|Overall Study|Withdrawal by Subject|1|||
19526477|NCT01535807|41971977|FG001|Overall Study|Withdrawal by Subject|1|||
19526478|NCT01535807|41971976|FG000|Overall Study|Data collection error|1|||
19526479|NCT01535807|41971977|FG001|Overall Study|Data collection error|1|||
19526480|NCT01375764|41971989|FG000|Overall Study|Lost to Follow-up|0|||
19526481|NCT01375764|41971990|FG001|Overall Study|Lost to Follow-up|1|||
19526482|NCT01375764|41971991|FG002|Overall Study|Lost to Follow-up|0|||
19526483|NCT01375764|41971992|FG003|Overall Study|Lost to Follow-up|0|||
19526484|NCT01375764|41971993|FG004|Overall Study|Lost to Follow-up|0|||
19526485|NCT01375764|41971989|FG000|Overall Study|Withdrawal by Subject|2|||
19526486|NCT01375764|41971990|FG001|Overall Study|Withdrawal by Subject|0|||
19526487|NCT01375764|41971991|FG002|Overall Study|Withdrawal by Subject|0|||
19526488|NCT01375764|41971992|FG003|Overall Study|Withdrawal by Subject|0|||
19526489|NCT01375764|41971993|FG004|Overall Study|Withdrawal by Subject|1|||
19526490|NCT01375764|41971989|FG000|Overall Study|Other|0|||
19526491|NCT01375764|41971990|FG001|Overall Study|Other|0|||
19526492|NCT01375764|41971991|FG002|Overall Study|Other|0|||
19526493|NCT01375764|41971992|FG003|Overall Study|Other|1|||
19526494|NCT01375764|41971993|FG004|Overall Study|Other|0|||
19526495|NCT00722046|41972012|FG000|Overall Study|Adverse Event|0|||
19526496|NCT00722046|41972013|FG001|Overall Study|Adverse Event|1|||
19526497|NCT00722046|41972014|FG002|Overall Study|Adverse Event|2|||
19526498|NCT00722046|41972015|FG003|Overall Study|Adverse Event|1|||
19526499|NCT00722046|41972016|FG004|Overall Study|Adverse Event|2|||
19448713|NCT01722045|41696901|FG000|Overall Study|Withdrawal by Subject|8|||
19448714|NCT01722045|41696901|FG000|Overall Study|Lost to Follow-up|4|||
19448715|NCT01722045|41696901|FG000|Overall Study|Protocol Deviation|1|||
19448716|NCT01722045|41696901|FG000|Overall Study|Physician Decision|3|||
19448717|NCT01722045|41696901|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
19448718|NCT01721109|41696905|FG000|Overall Study|Lack of Efficacy|1|||
19448719|NCT01721109|41696905|FG000|Overall Study|Non- Compliance with Study Drug|3|||
19448720|NCT01721109|41696905|FG000|Overall Study|Withdrew Consent|1|||
19448721|NCT01721109|41696905|FG000|Overall Study|Lost to Follow-up|2|||
19448722|NCT01874145|41696911|FG000|Core Period|Non-compliance|1|||
19448723|NCT01874145|41696912|FG001|Core Period|Non-compliance|0|||
19448724|NCT01874145|41696911|FG000|Core Period|Protocol Violation|1|||
19448725|NCT01874145|41696912|FG001|Core Period|Protocol Violation|1|||
19448726|NCT01874145|41696911|FG000|Core Period|Physician Decision|1|||
19448727|NCT01874145|41696912|FG001|Core Period|Physician Decision|1|||
19448728|NCT01874145|41696911|FG000|Core Period|Adverse Event|0|||
19448729|NCT01874145|41696912|FG001|Core Period|Adverse Event|1|||
19448730|NCT01874145|41696911|FG000|Core Period|Withdrawal by Subject|0|||
19448731|NCT01874145|41696912|FG001|Core Period|Withdrawal by Subject|4|||
19448732|NCT01874145|41696911|FG000|Extension Period|Adverse Event|3|||
19448733|NCT01874145|41696912|FG001|Extension Period|Adverse Event|2|||
19448734|NCT01874145|41696911|FG000|Extension Period|Withdrawal by Subject|2|||
19448735|NCT01874145|41696912|FG001|Extension Period|Withdrawal by Subject|1|||
19448736|NCT01874145|41696911|FG000|Extension Period|Lost to Follow-up|1|||
19448737|NCT01874145|41696912|FG001|Extension Period|Lost to Follow-up|1|||
19448738|NCT01720797|41696924|FG000|Overall Study|Withdrawal by Subject|3|||
19526500|NCT00722046|41972017|FG005|Overall Study|Adverse Event|1|||
19526501|NCT00722046|41972018|FG006|Overall Study|Adverse Event|0|||
19526502|NCT00722046|41972012|FG000|Overall Study|Death|0|||
19526503|NCT00722046|41972013|FG001|Overall Study|Death|1|||
19526504|NCT00722046|41972014|FG002|Overall Study|Death|0|||
19526505|NCT00722046|41972015|FG003|Overall Study|Death|0|||
19526506|NCT00722046|41972016|FG004|Overall Study|Death|0|||
19448739|NCT01720797|41696925|FG001|Overall Study|Withdrawal by Subject|0|||
19448740|NCT01831466|41696943|FG000|Overall Study|Protocol Violation|1|||
19448741|NCT01831466|41696944|FG001|Overall Study|Protocol Violation|1|||
19526507|NCT00722046|41972017|FG005|Overall Study|Death|0|||
19526508|NCT00722046|41972018|FG006|Overall Study|Death|2|||
19526509|NCT00722046|41972012|FG000|Overall Study|Protocol Violation|1|||
19448742|NCT01831466|41696945|FG002|Overall Study|Protocol Violation|2|||
19526510|NCT00722046|41972013|FG001|Overall Study|Protocol Violation|0|||
19448743|NCT01831466|41696946|FG003|Overall Study|Protocol Violation|0|||
19448744|NCT01831466|41696947|FG004|Overall Study|Protocol Violation|0|||
19448745|NCT01831466|41696948|FG005|Overall Study|Protocol Violation|1|||
19448746|NCT01831466|41696949|FG006|Overall Study|Protocol Violation|0|||
19448747|NCT01831466|41696950|FG007|Overall Study|Protocol Violation|0|||
19448748|NCT01831466|41696951|FG008|Overall Study|Protocol Violation|0|||
19448749|NCT01831466|41696952|FG009|Overall Study|Protocol Violation|0|||
19448750|NCT01831466|41696953|FG010|Overall Study|Protocol Violation|0|||
19448751|NCT01831466|41696954|FG011|Overall Study|Protocol Violation|0|||
19448752|NCT01831466|41696943|FG000|Overall Study|Other|2|||
19448753|NCT01831466|41696944|FG001|Overall Study|Other|3|||
19448754|NCT01831466|41696945|FG002|Overall Study|Other|2|||
19448755|NCT01831466|41696946|FG003|Overall Study|Other|2|||
19448756|NCT01831466|41696947|FG004|Overall Study|Other|2|||
19448757|NCT01831466|41696948|FG005|Overall Study|Other|1|||
19448758|NCT01831466|41696949|FG006|Overall Study|Other|0|||
19448759|NCT01831466|41696950|FG007|Overall Study|Other|0|||
19448760|NCT01831466|41696951|FG008|Overall Study|Other|0|||
19448761|NCT01831466|41696952|FG009|Overall Study|Other|0|||
19448762|NCT01831466|41696953|FG010|Overall Study|Other|0|||
19448763|NCT01831466|41696954|FG011|Overall Study|Other|0|||
19448764|NCT01831466|41696943|FG000|Overall Study|Non-compliance with study treatment|2|||
19448765|NCT01831466|41696944|FG001|Overall Study|Non-compliance with study treatment|1|||
19448766|NCT01831466|41696945|FG002|Overall Study|Non-compliance with study treatment|1|||
19448767|NCT01831466|41696946|FG003|Overall Study|Non-compliance with study treatment|0|||
19448768|NCT01831466|41696947|FG004|Overall Study|Non-compliance with study treatment|0|||
19448769|NCT01831466|41696948|FG005|Overall Study|Non-compliance with study treatment|1|||
19448770|NCT01831466|41696949|FG006|Overall Study|Non-compliance with study treatment|0|||
19448771|NCT01831466|41696950|FG007|Overall Study|Non-compliance with study treatment|0|||
19448772|NCT01831466|41696951|FG008|Overall Study|Non-compliance with study treatment|0|||
19448773|NCT01831466|41696952|FG009|Overall Study|Non-compliance with study treatment|0|||
19448774|NCT01831466|41696953|FG010|Overall Study|Non-compliance with study treatment|0|||
19448775|NCT01831466|41696954|FG011|Overall Study|Non-compliance with study treatment|0|||
19448776|NCT01831466|41696943|FG000|Overall Study|Death|0|||
19526511|NCT00722046|41972014|FG002|Overall Study|Protocol Violation|0|||
19526512|NCT00722046|41972015|FG003|Overall Study|Protocol Violation|0|||
19526513|NCT00722046|41972016|FG004|Overall Study|Protocol Violation|0|||
19526514|NCT00722046|41972017|FG005|Overall Study|Protocol Violation|1|||
19526515|NCT00722046|41972018|FG006|Overall Study|Protocol Violation|0|||
19526516|NCT00722046|41972012|FG000|Overall Study|Withdrawal by Subject|3|||
19526517|NCT00722046|41972013|FG001|Overall Study|Withdrawal by Subject|3|||
19526518|NCT00722046|41972014|FG002|Overall Study|Withdrawal by Subject|4|||
19526519|NCT00722046|41972015|FG003|Overall Study|Withdrawal by Subject|4|||
19526520|NCT00722046|41972016|FG004|Overall Study|Withdrawal by Subject|4|||
19526521|NCT00722046|41972017|FG005|Overall Study|Withdrawal by Subject|7|||
19526522|NCT00722046|41972018|FG006|Overall Study|Withdrawal by Subject|3|||
19526523|NCT00722046|41972012|FG000|Overall Study|Randomized, but not treated|1|||
19526524|NCT00722046|41972013|FG001|Overall Study|Randomized, but not treated|1|||
19526525|NCT00722046|41972014|FG002|Overall Study|Randomized, but not treated|0|||
19526526|NCT00722046|41972015|FG003|Overall Study|Randomized, but not treated|2|||
19526527|NCT00722046|41972016|FG004|Overall Study|Randomized, but not treated|0|||
19526528|NCT00722046|41972017|FG005|Overall Study|Randomized, but not treated|0|||
19526529|NCT00722046|41972018|FG006|Overall Study|Randomized, but not treated|0|||
19526530|NCT00722046|41972012|FG000|Overall Study|Other|0|||
19526531|NCT00722046|41972013|FG001|Overall Study|Other|0|||
19526532|NCT00722046|41972014|FG002|Overall Study|Other|1|||
19526533|NCT00722046|41972015|FG003|Overall Study|Other|1|||
19629251|NCT00444925|42078796|FG002|Double-blind Treatment Period|Death|0|||
19448777|NCT01831466|41696944|FG001|Overall Study|Death|1|||
19448778|NCT01831466|41696945|FG002|Overall Study|Death|0|||
19448779|NCT01831466|41696946|FG003|Overall Study|Death|0|||
19448780|NCT01831466|41696947|FG004|Overall Study|Death|0|||
19448781|NCT01831466|41696948|FG005|Overall Study|Death|0|||
19448782|NCT01831466|41696949|FG006|Overall Study|Death|0|||
19629252|NCT00444925|42078794|FG000|Double-blind Treatment Period|Adverse Event|6|||
19448783|NCT01831466|41696950|FG007|Overall Study|Death|0|||
19448784|NCT01831466|41696951|FG008|Overall Study|Death|0|||
19448785|NCT01831466|41696952|FG009|Overall Study|Death|0|||
19448786|NCT01831466|41696953|FG010|Overall Study|Death|0|||
19448787|NCT01831466|41696954|FG011|Overall Study|Death|0|||
19526534|NCT00722046|41972016|FG004|Overall Study|Other|3|||
19526535|NCT00722046|41972017|FG005|Overall Study|Other|2|||
19526536|NCT00722046|41972018|FG006|Overall Study|Other|1|||
19526537|NCT00614523|41972038|FG000|Overall Study|Adverse Event|4|||
19448788|NCT01831466|41696943|FG000|Overall Study|Withdrawal by Subject|6|||
19448789|NCT01831466|41696944|FG001|Overall Study|Withdrawal by Subject|3|||
19448790|NCT01831466|41696945|FG002|Overall Study|Withdrawal by Subject|3|||
19448791|NCT01831466|41696946|FG003|Overall Study|Withdrawal by Subject|3|||
19448792|NCT01831466|41696947|FG004|Overall Study|Withdrawal by Subject|3|||
19526538|NCT00614523|41972039|FG001|Overall Study|Adverse Event|20|||
19448793|NCT01831466|41696948|FG005|Overall Study|Withdrawal by Subject|5|||
19448794|NCT01831466|41696949|FG006|Overall Study|Withdrawal by Subject|0|||
19448795|NCT01831466|41696950|FG007|Overall Study|Withdrawal by Subject|0|||
19448796|NCT01831466|41696951|FG008|Overall Study|Withdrawal by Subject|0|||
19448797|NCT01831466|41696952|FG009|Overall Study|Withdrawal by Subject|1|||
19448798|NCT01831466|41696953|FG010|Overall Study|Withdrawal by Subject|0|||
19448799|NCT01831466|41696954|FG011|Overall Study|Withdrawal by Subject|1|||
19448800|NCT01831466|41696943|FG000|Overall Study|Lost to Follow-up|0|||
19448801|NCT01831466|41696944|FG001|Overall Study|Lost to Follow-up|1|||
19448802|NCT01831466|41696945|FG002|Overall Study|Lost to Follow-up|4|||
19448803|NCT01831466|41696946|FG003|Overall Study|Lost to Follow-up|2|||
19448804|NCT01831466|41696947|FG004|Overall Study|Lost to Follow-up|0|||
19448805|NCT01831466|41696948|FG005|Overall Study|Lost to Follow-up|3|||
19448806|NCT01831466|41696949|FG006|Overall Study|Lost to Follow-up|0|||
19448807|NCT01831466|41696950|FG007|Overall Study|Lost to Follow-up|0|||
19448808|NCT01831466|41696951|FG008|Overall Study|Lost to Follow-up|0|||
19448809|NCT01831466|41696952|FG009|Overall Study|Lost to Follow-up|1|||
19448810|NCT01831466|41696953|FG010|Overall Study|Lost to Follow-up|0|||
19448811|NCT01831466|41696954|FG011|Overall Study|Lost to Follow-up|1|||
19448812|NCT01831466|41696943|FG000|Overall Study|Lack of Efficacy|5|||
19448813|NCT01831466|41696944|FG001|Overall Study|Lack of Efficacy|8|||
19448814|NCT01831466|41696945|FG002|Overall Study|Lack of Efficacy|7|||
19448815|NCT01831466|41696946|FG003|Overall Study|Lack of Efficacy|6|||
19448816|NCT01831466|41696947|FG004|Overall Study|Lack of Efficacy|9|||
19448817|NCT01831466|41696948|FG005|Overall Study|Lack of Efficacy|8|||
19448818|NCT01831466|41696949|FG006|Overall Study|Lack of Efficacy|1|||
19448819|NCT01831466|41696950|FG007|Overall Study|Lack of Efficacy|1|||
19448820|NCT01831466|41696951|FG008|Overall Study|Lack of Efficacy|2|||
19448821|NCT01831466|41696952|FG009|Overall Study|Lack of Efficacy|2|||
19448822|NCT01831466|41696953|FG010|Overall Study|Lack of Efficacy|2|||
19448823|NCT01831466|41696954|FG011|Overall Study|Lack of Efficacy|0|||
19448824|NCT01831466|41696943|FG000|Overall Study|Adverse Event|0|||
19448825|NCT01831466|41696944|FG001|Overall Study|Adverse Event|0|||
19448826|NCT01831466|41696945|FG002|Overall Study|Adverse Event|4|||
19448827|NCT01831466|41696946|FG003|Overall Study|Adverse Event|6|||
19448828|NCT01831466|41696947|FG004|Overall Study|Adverse Event|3|||
19448829|NCT01831466|41696948|FG005|Overall Study|Adverse Event|7|||
19448830|NCT01831466|41696949|FG006|Overall Study|Adverse Event|0|||
19448831|NCT01831466|41696950|FG007|Overall Study|Adverse Event|1|||
19448832|NCT01831466|41696951|FG008|Overall Study|Adverse Event|1|||
19448833|NCT01831466|41696952|FG009|Overall Study|Adverse Event|1|||
19448834|NCT01831466|41696953|FG010|Overall Study|Adverse Event|0|||
19448835|NCT01831466|41696954|FG011|Overall Study|Adverse Event|2|||
19448836|NCT01881620|41696974|FG000|Overall Study|Protocol Violation|4|||
19448837|NCT01830920|41696983|FG000|Overall Study|Adverse Event|1|||
19448838|NCT01830920|41696984|FG001|Overall Study|Adverse Event|0|||
19448839|NCT01830920|41696985|FG002|Overall Study|Adverse Event|1|||
19448840|NCT01830920|41696986|FG003|Overall Study|Adverse Event|0|||
19526539|NCT00614523|41972038|FG000|Overall Study|Death|5|||
19526540|NCT00614523|41972039|FG001|Overall Study|Death|8|||
19526541|NCT00614523|41972038|FG000|Overall Study|Lack of Efficacy|9|||
19526542|NCT00614523|41972039|FG001|Overall Study|Lack of Efficacy|11|||
19526543|NCT00614523|41972038|FG000|Overall Study|Lost to Follow-up|0|||
19526544|NCT00614523|41972039|FG001|Overall Study|Lost to Follow-up|1|||
19526545|NCT00614523|41972038|FG000|Overall Study|Protocol Violation|3|||
19526546|NCT00614523|41972039|FG001|Overall Study|Protocol Violation|2|||
19448841|NCT01830920|41696987|FG004|Overall Study|Adverse Event|0|||
19448842|NCT01830920|41696983|FG000|Overall Study|Withdrawal by Subject|2|||
19448843|NCT01830920|41696984|FG001|Overall Study|Withdrawal by Subject|2|||
19448844|NCT01830920|41696985|FG002|Overall Study|Withdrawal by Subject|1|||
19448845|NCT01830920|41696986|FG003|Overall Study|Withdrawal by Subject|7|||
19448846|NCT01830920|41696987|FG004|Overall Study|Withdrawal by Subject|1|||
19448847|NCT01830920|41696983|FG000|Overall Study|Death|3|||
19448848|NCT01830920|41696984|FG001|Overall Study|Death|3|||
19448849|NCT01830920|41696985|FG002|Overall Study|Death|5|||
19448850|NCT01830920|41696986|FG003|Overall Study|Death|4|||
19448851|NCT01830920|41696987|FG004|Overall Study|Death|4|||
19448852|NCT01830920|41696983|FG000|Overall Study|Other|15|||
19448853|NCT01830920|41696984|FG001|Overall Study|Other|1|||
19448854|NCT01830920|41696985|FG002|Overall Study|Other|1|||
19526547|NCT00614523|41972038|FG000|Overall Study|Withdrawal by Subject|12|||
19448855|NCT01830920|41696986|FG003|Overall Study|Other|5|||
19448856|NCT01830920|41696987|FG004|Overall Study|Other|3|||
19448857|NCT01881230|41697002|FG000|Overall Study|Death|2|||
19448858|NCT01881230|41697003|FG001|Overall Study|Death|0|||
19448859|NCT01881230|41697004|FG002|Overall Study|Death|1|||
19448860|NCT01881230|41697002|FG000|Overall Study|Adverse Event|9|||
19448861|NCT01881230|41697003|FG001|Overall Study|Adverse Event|13|||
19448862|NCT01881230|41697004|FG002|Overall Study|Adverse Event|12|||
19448863|NCT01881230|41697002|FG000|Overall Study|Progressive Disease|31|||
19526548|NCT00614523|41972039|FG001|Overall Study|Withdrawal by Subject|22|||
19448864|NCT01881230|41697003|FG001|Overall Study|Progressive Disease|35|||
19448865|NCT01881230|41697004|FG002|Overall Study|Progressive Disease|36|||
19448866|NCT01881230|41697002|FG000|Overall Study|Symptomatic Deterioration|3|||
19448867|NCT01881230|41697003|FG001|Overall Study|Symptomatic Deterioration|3|||
19448868|NCT01881230|41697004|FG002|Overall Study|Symptomatic Deterioration|1|||
19448869|NCT01881230|41697002|FG000|Overall Study|Withdrawal by Subject|6|||
19448870|NCT01881230|41697003|FG001|Overall Study|Withdrawal by Subject|4|||
19448871|NCT01881230|41697004|FG002|Overall Study|Withdrawal by Subject|6|||
19448872|NCT01881230|41697002|FG000|Overall Study|Physician Decision|4|||
19448873|NCT01881230|41697003|FG001|Overall Study|Physician Decision|3|||
19448874|NCT01881230|41697004|FG002|Overall Study|Physician Decision|6|||
19448875|NCT01881230|41697002|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19448876|NCT01881230|41697003|FG001|Overall Study|Non-Compliance with Study Drug|2|||
19448877|NCT01881230|41697004|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19448878|NCT01881230|41697002|FG000|Overall Study|Given Commercially Available Drug|0|||
19448879|NCT01881230|41697003|FG001|Overall Study|Given Commercially Available Drug|0|||
19448880|NCT01881230|41697004|FG002|Overall Study|Given Commercially Available Drug|2|||
19448881|NCT01881230|41697002|FG000|Overall Study|Protocol Violation|1|||
19448882|NCT01881230|41697003|FG001|Overall Study|Protocol Violation|1|||
19448883|NCT01881230|41697004|FG002|Overall Study|Protocol Violation|0|||
19448884|NCT01881230|41697002|FG000|Overall Study|Miscellaneous|3|||
19448885|NCT01881230|41697003|FG001|Overall Study|Miscellaneous|3|||
19448886|NCT01881230|41697004|FG002|Overall Study|Miscellaneous|0|||
19448887|NCT01881230|41697002|FG000|Overall Study|Untreated: Other|0|||
19448888|NCT01881230|41697003|FG001|Overall Study|Untreated: Other|0|||
19448889|NCT01881230|41697004|FG002|Overall Study|Untreated: Other|1|||
19448890|NCT01881230|41697002|FG000|Overall Study|Untreated: Death|0|||
19448891|NCT01881230|41697003|FG001|Overall Study|Untreated: Death|0|||
19448892|NCT01881230|41697004|FG002|Overall Study|Untreated: Death|1|||
19448893|NCT01881230|41697002|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
19448894|NCT01881230|41697003|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
19448895|NCT01881230|41697004|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
19448896|NCT01856582|41697012|FG000|Overall Study|Died prior to Boost infusion|1|||
19448897|NCT01829360|41697020|FG000|Overall Study|Protocol Violation|0|||
19448898|NCT01829360|41697021|FG001|Overall Study|Protocol Violation|0|||
19448899|NCT01829360|41697022|FG002|Overall Study|Protocol Violation|1|||
19448900|NCT01829360|41697023|FG003|Overall Study|Protocol Violation|0|||
19448901|NCT01856114|41697039|FG000|Overall Study|Withdrawal by Subject|1|||
19448902|NCT01856114|41697040|FG001|Overall Study|Withdrawal by Subject|0|||
19448903|NCT01856114|41697039|FG000|Overall Study|Adverse Event|1|||
19448904|NCT01856114|41697040|FG001|Overall Study|Adverse Event|0|||
19448905|NCT01855958|41697048|FG000|Overall Study|Withdrawal by Subject|1|||
19448906|NCT01855958|41697049|FG001|Overall Study|Withdrawal by Subject|0|||
19448907|NCT01855412|41697060|FG000|Overall Study|Death|77|||
19448908|NCT01855412|41697061|FG001|Overall Study|Death|123|||
19448909|NCT01855412|41697062|FG002|Overall Study|Death|30|||
19448910|NCT01855412|41697060|FG000|Overall Study|Lost to Follow-up|28|||
19448911|NCT01855412|41697061|FG001|Overall Study|Lost to Follow-up|46|||
19448912|NCT01855412|41697062|FG002|Overall Study|Lost to Follow-up|15|||
19448913|NCT01855412|41697060|FG000|Overall Study|Withdrawal by Subject|77|||
19448914|NCT01855412|41697061|FG001|Overall Study|Withdrawal by Subject|123|||
19448915|NCT01855412|41697062|FG002|Overall Study|Withdrawal by Subject|24|||
19448916|NCT01855412|41697060|FG000|Overall Study|Physician Decision|25|||
19448917|NCT01855412|41697061|FG001|Overall Study|Physician Decision|31|||
19448918|NCT01855412|41697062|FG002|Overall Study|Physician Decision|3|||
19448919|NCT01855412|41697060|FG000|Overall Study|Site Closure|4|||
19448920|NCT01855412|41697061|FG001|Overall Study|Site Closure|18|||
19448921|NCT01855412|41697062|FG002|Overall Study|Site Closure|1|||
19448922|NCT01855412|41697060|FG000|Overall Study|Reason not Specified|1|||
19448923|NCT01855412|41697061|FG001|Overall Study|Reason not Specified|2|||
19526549|NCT00614523|41972038|FG000|Overall Study|Other|6|||
19526550|NCT00614523|41972039|FG001|Overall Study|Other|11|||
19526551|NCT00614523|41972038|FG000|Overall Study|Ineligibility Determined|1|||
19526552|NCT00614523|41972039|FG001|Overall Study|Ineligibility Determined|2|||
19526553|NCT00614523|41972038|FG000|Overall Study|Disease Progression|0|||
19526554|NCT00614523|41972039|FG001|Overall Study|Disease Progression|8|||
19448924|NCT01855412|41697062|FG002|Overall Study|Reason not Specified|3|||
19448925|NCT01614470|41697078|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
19448926|NCT01614470|41697079|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19448927|NCT01614470|41697080|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
19448928|NCT01614470|41697078|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
19448929|NCT01614470|41697079|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
19448930|NCT01614470|41697080|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
19526555|NCT00614523|41972038|FG000|Overall Study|Administrative Decision|23|||
19448931|NCT01880528|41697091|FG000|Overall Study|Other|1|||
19526556|NCT00614523|41972039|FG001|Overall Study|Administrative Decision|46|||
19526557|NCT00523341|41972047|FG000|Overall Study|Withdrawal by Subject|399|||
19526558|NCT00523341|41972048|FG001|Overall Study|Withdrawal by Subject|427|||
19526559|NCT00523341|41972047|FG000|Overall Study|Other|181|||
19526560|NCT00523341|41972048|FG001|Overall Study|Other|198|||
19526561|NCT00523341|41972047|FG000|Overall Study|Adverse Event|122|||
19526562|NCT00523341|41972048|FG001|Overall Study|Adverse Event|155|||
19526563|NCT00523341|41972047|FG000|Overall Study|Death|101|||
19526564|NCT00523341|41972048|FG001|Overall Study|Death|110|||
19526565|NCT00523341|41972047|FG000|Overall Study|Lost to Follow-up|73|||
19526566|NCT00523341|41972048|FG001|Overall Study|Lost to Follow-up|61|||
19526567|NCT00523341|41972047|FG000|Overall Study|Non-compliance|20|||
19526568|NCT00523341|41972048|FG001|Overall Study|Non-compliance|13|||
19526569|NCT00523341|41972047|FG000|Overall Study|Physician Decision|14|||
19526570|NCT00523341|41972048|FG001|Overall Study|Physician Decision|13|||
19526571|NCT00523341|41972047|FG000|Overall Study|Requirement for Alternative Therapy|4|||
19526572|NCT00523341|41972048|FG001|Overall Study|Requirement for Alternative Therapy|14|||
19526573|NCT00523341|41972047|FG000|Overall Study|Protocol Deviation|6|||
19526574|NCT00523341|41972048|FG001|Overall Study|Protocol Deviation|5|||
19526575|NCT00523341|41972047|FG000|Overall Study|Ineligibility Determined|3|||
19448932|NCT01880528|41697092|FG001|Overall Study|Other|1|||
19448933|NCT01854944|41697101|FG000|Overall Study|Withdrawal by Subject|0|||
19448934|NCT01854944|41697102|FG001|Overall Study|Withdrawal by Subject|0|||
19448935|NCT01854944|41697103|FG002|Overall Study|Withdrawal by Subject|1|||
19448936|NCT01829048|41697130|FG000|Overall Study|Withdrawal by Subject|0|||
19448937|NCT01829048|41697131|FG001|Overall Study|Withdrawal by Subject|0|||
19448938|NCT01829048|41697132|FG002|Overall Study|Withdrawal by Subject|0|||
19526576|NCT00523341|41972048|FG001|Overall Study|Ineligibility Determined|4|||
19526577|NCT00523341|41972047|FG000|Overall Study|Disease Progression|1|||
19526578|NCT00523341|41972048|FG001|Overall Study|Disease Progression|0|||
19526579|NCT00364013|41972056|FG000|Overall Study|Ineligibility determined|4|||
19526580|NCT00364013|41972057|FG001|Overall Study|Ineligibility determined|2|||
19448939|NCT01829048|41697133|FG003|Overall Study|Withdrawal by Subject|2|||
19448940|NCT01829048|41697134|FG004|Overall Study|Withdrawal by Subject|0|||
19448941|NCT01854710|41697147|FG000|Overall Study|Withdrawal by Subject|2|||
19448942|NCT01854710|41697148|FG001|Overall Study|Withdrawal by Subject|1|||
19448943|NCT01854710|41697149|FG002|Overall Study|Withdrawal by Subject|0|||
19448944|NCT01854710|41697150|FG003|Overall Study|Withdrawal by Subject|0|||
19448945|NCT01854710|41697151|FG004|Overall Study|Withdrawal by Subject|0|||
19448946|NCT01854710|41697152|FG005|Overall Study|Withdrawal by Subject|0|||
19448947|NCT01854710|41697147|FG000|Overall Study|CRI procedural error|2|||
19448948|NCT01854710|41697148|FG001|Overall Study|CRI procedural error|2|||
19448949|NCT01854710|41697149|FG002|Overall Study|CRI procedural error|2|||
19526581|NCT00364013|41972056|FG000|Overall Study|Adverse Event|4|||
19526582|NCT00364013|41972057|FG001|Overall Study|Adverse Event|3|||
19526583|NCT00364013|41972056|FG000|Overall Study|Withdrawal by Subject|13|||
19526584|NCT00364013|41972057|FG001|Overall Study|Withdrawal by Subject|18|||
19526585|NCT00364013|41972056|FG000|Overall Study|Physician Decision|3|||
19526586|NCT00364013|41972057|FG001|Overall Study|Physician Decision|3|||
19526587|NCT00364013|41972056|FG000|Overall Study|Lost to Follow-up|10|||
19526588|NCT00364013|41972057|FG001|Overall Study|Lost to Follow-up|3|||
19526589|NCT00364013|41972056|FG000|Overall Study|Protocol-specified criteria|6|||
19526590|NCT00364013|41972057|FG001|Overall Study|Protocol-specified criteria|6|||
19526591|NCT00364013|41972056|FG000|Overall Study|Other|41|||
19526592|NCT00364013|41972057|FG001|Overall Study|Other|47|||
19526593|NCT00364013|41972056|FG000|Overall Study|Ongoing|20|||
19526594|NCT00364013|41972057|FG001|Overall Study|Ongoing|13|||
19526595|NCT00345839|41972069|FG000|Overall Study|Withdrawal by Subject|91|||
19526596|NCT00345839|41972070|FG001|Overall Study|Withdrawal by Subject|98|||
19526597|NCT00345839|41972069|FG000|Overall Study|Lost to Follow-up|58|||
19526598|NCT00345839|41972070|FG001|Overall Study|Lost to Follow-up|61|||
19526599|NCT00330759|41972078|FG000|Overall Study|Death|316|||
19526600|NCT00330759|41972079|FG001|Overall Study|Death|310|||
19526601|NCT00330759|41972078|FG000|Overall Study|Disease progression|104|||
19526602|NCT00330759|41972079|FG001|Overall Study|Disease progression|126|||
19448950|NCT01854710|41697150|FG003|Overall Study|CRI procedural error|2|||
19448951|NCT01854710|41697151|FG004|Overall Study|CRI procedural error|2|||
19448952|NCT01854710|41697152|FG005|Overall Study|CRI procedural error|2|||
19448953|NCT01828034|41697166|FG000|Overall Study|Withdrawal by Subject|0|||
19448954|NCT01828034|41697167|FG001|Overall Study|Withdrawal by Subject|0|||
19526603|NCT00330759|41972078|FG000|Overall Study|Withdrawal by Subject|143|||
19526604|NCT00330759|41972079|FG001|Overall Study|Withdrawal by Subject|124|||
19526605|NCT00330759|41972078|FG000|Overall Study|Adverse Event|48|||
19526606|NCT00330759|41972079|FG001|Overall Study|Adverse Event|36|||
19526607|NCT00330759|41972078|FG000|Overall Study|Participant request|31|||
19526608|NCT00330759|41972079|FG001|Overall Study|Participant request|22|||
19526609|NCT00330759|41972078|FG000|Overall Study|Lost to Follow-up|16|||
19526610|NCT00330759|41972079|FG001|Overall Study|Lost to Follow-up|22|||
19526611|NCT00330759|41972078|FG000|Overall Study|Noncompliance|15|||
19526612|NCT00330759|41972079|FG001|Overall Study|Noncompliance|17|||
19448955|NCT01828034|41697168|FG002|Overall Study|Withdrawal by Subject|0|||
19448956|NCT01828034|41697169|FG003|Overall Study|Withdrawal by Subject|1|||
19629253|NCT00444925|42078795|FG001|Double-blind Treatment Period|Adverse Event|28|||
19629254|NCT00444925|42078796|FG002|Double-blind Treatment Period|Adverse Event|44|||
19629255|NCT00444925|42078794|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
19629256|NCT00444925|42078795|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
19629257|NCT00444925|42078796|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
19629258|NCT00444925|42078794|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
19629259|NCT00444925|42078795|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
19629260|NCT00444925|42078796|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
19629261|NCT00444925|42078794|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
19629262|NCT00444925|42078795|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
19629263|NCT00444925|42078796|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
19629264|NCT00444925|42078794|FG000|Double-blind Treatment Period|Other|7|||
19629265|NCT00444925|42078795|FG001|Double-blind Treatment Period|Other|7|||
19629266|NCT00444925|42078796|FG002|Double-blind Treatment Period|Other|12|||
19629267|NCT00641056|42078806|FG000|Overall Study|Adverse Event|12|||
19629268|NCT00641056|42078807|FG001|Overall Study|Adverse Event|2|||
19629269|NCT00641056|42078806|FG000|Overall Study|Lost to Follow-up|2|||
19448957|NCT01853696|41697178|FG000|Overall Study|Withdrawal by Subject|1|||
19448958|NCT01853696|41697179|FG001|Overall Study|Withdrawal by Subject|1|||
19448959|NCT01853696|41697178|FG000|Overall Study|Lost to Follow-up|5|||
19448960|NCT01853696|41697179|FG001|Overall Study|Lost to Follow-up|4|||
19448961|NCT01871805|41697191|FG000|Phase I|Death|7|||
19526613|NCT00330759|41972078|FG000|Overall Study|Physician Decision|1|||
19526614|NCT00330759|41972079|FG001|Overall Study|Physician Decision|2|||
19526615|NCT00330759|41972078|FG000|Overall Study|Protocol deviation|0|||
19526616|NCT00330759|41972079|FG001|Overall Study|Protocol deviation|2|||
19526617|NCT00330759|41972078|FG000|Overall Study|Ineligibility determined|2|||
19526618|NCT00330759|41972079|FG001|Overall Study|Ineligibility determined|1|||
19526619|NCT00330759|41972078|FG000|Overall Study|Other|36|||
19526620|NCT00330759|41972079|FG001|Overall Study|Other|44|||
19526621|NCT00113763|41972087|FG000|Overall Study|Adverse Event|5|||
19526622|NCT00113763|41972088|FG001|Overall Study|Adverse Event|2|||
19526623|NCT00113763|41972087|FG000|Overall Study|Disease Progression|28|||
19526624|NCT00113763|41972088|FG001|Overall Study|Disease Progression|14|||
19526625|NCT00113763|41972087|FG000|Overall Study|Lost to Follow-up|10|||
19526626|NCT00113763|41972088|FG001|Overall Study|Lost to Follow-up|0|||
19526627|NCT00113763|41972087|FG000|Overall Study|Withdrawal by Subject|1|||
19526628|NCT00113763|41972088|FG001|Overall Study|Withdrawal by Subject|4|||
19526629|NCT00113763|41972087|FG000|Overall Study|Other|27|||
19526630|NCT00113763|41972088|FG001|Overall Study|Other|6|||
19526631|NCT00113763|41972087|FG000|Overall Study|Non-compliance|1|||
19526632|NCT00113763|41972088|FG001|Overall Study|Non-compliance|0|||
19526633|NCT00113763|41972087|FG000|Overall Study|Ongoing|1|||
19526634|NCT00113763|41972088|FG001|Overall Study|Ongoing|0|||
19526635|NCT01470326|41972095|FG000|Overall Study|Protocol Violation|32|||
19526636|NCT01470326|41972095|FG000|Overall Study|No Drug Administration Information|2|||
19526637|NCT01470326|41972095|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
19526638|NCT01480180|41972101|FG000|Main Phase|Withdrawal criteria|12|||
19526639|NCT01480180|41972102|FG001|Main Phase|Withdrawal criteria|1|||
19526640|NCT01480180|41972103|FG002|Main Phase|Withdrawal criteria|0|||
19526641|NCT01480180|41972104|FG003|Main Phase|Withdrawal criteria|0|||
19526642|NCT01480180|41972105|FG004|Main Phase|Withdrawal criteria|0|||
19526643|NCT01480180|41972106|FG005|Main Phase|Withdrawal criteria|0|||
19526644|NCT01480180|41972101|FG000|Main Phase|Lack of Efficacy|1|||
19526645|NCT01480180|41972102|FG001|Main Phase|Lack of Efficacy|0|||
19526646|NCT01480180|41972103|FG002|Main Phase|Lack of Efficacy|0|||
19526647|NCT01480180|41972104|FG003|Main Phase|Lack of Efficacy|0|||
19526648|NCT01480180|41972105|FG004|Main Phase|Lack of Efficacy|0|||
19526649|NCT01480180|41972106|FG005|Main Phase|Lack of Efficacy|0|||
19526650|NCT01480180|41972101|FG000|Main Phase|Non-compliance|3|||
19526651|NCT01480180|41972102|FG001|Main Phase|Non-compliance|0|||
19526652|NCT01480180|41972103|FG002|Main Phase|Non-compliance|0|||
19526653|NCT01480180|41972104|FG003|Main Phase|Non-compliance|0|||
19448962|NCT01871805|41697192|FG001|Phase I|Death|4|||
19448963|NCT01871805|41697193|FG002|Phase I|Death|6|||
19448964|NCT01871805|41697194|FG003|Phase I|Death|2|||
19448965|NCT01871805|41697195|FG004|Phase I|Death|9|||
19526654|NCT01480180|41972105|FG004|Main Phase|Non-compliance|0|||
19526655|NCT01480180|41972106|FG005|Main Phase|Non-compliance|0|||
19526656|NCT01480180|41972101|FG000|Main Phase|Unclassified|3|||
19526657|NCT01480180|41972102|FG001|Main Phase|Unclassified|0|||
19526658|NCT01480180|41972103|FG002|Main Phase|Unclassified|0|||
19526659|NCT01480180|41972104|FG003|Main Phase|Unclassified|0|||
19526660|NCT01480180|41972105|FG004|Main Phase|Unclassified|0|||
19526661|NCT01480180|41972106|FG005|Main Phase|Unclassified|0|||
19526662|NCT01480180|41972101|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
19448966|NCT01871805|41697196|FG005|Phase I|Death|0|||
19526663|NCT01480180|41972102|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
19526664|NCT01480180|41972103|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
19526665|NCT01480180|41972104|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
19526666|NCT01480180|41972105|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
19526667|NCT01480180|41972106|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
19526668|NCT01480180|41972101|FG000|Extension Phase, Part 1|Unclassified|0|||
19526669|NCT01480180|41972102|FG001|Extension Phase, Part 1|Unclassified|0|||
19448967|NCT01871805|41697191|FG000|Phase I|Alive in Survival Follow-up|0|||
19448968|NCT01871805|41697192|FG001|Phase I|Alive in Survival Follow-up|2|||
19526670|NCT01480180|41972103|FG002|Extension Phase, Part 1|Unclassified|1|||
19526671|NCT01480180|41972104|FG003|Extension Phase, Part 1|Unclassified|0|||
19526672|NCT01480180|41972105|FG004|Extension Phase, Part 1|Unclassified|0|||
19526673|NCT01480180|41972106|FG005|Extension Phase, Part 1|Unclassified|0|||
19526674|NCT01480180|41972101|FG000|Extension Phase, Part 1|Adverse Event|0|||
19526675|NCT01480180|41972102|FG001|Extension Phase, Part 1|Adverse Event|0|||
19526676|NCT01480180|41972103|FG002|Extension Phase, Part 1|Adverse Event|4|||
19526677|NCT01480180|41972104|FG003|Extension Phase, Part 1|Adverse Event|1|||
19526678|NCT01480180|41972105|FG004|Extension Phase, Part 1|Adverse Event|0|||
19526679|NCT01480180|41972106|FG005|Extension Phase, Part 1|Adverse Event|0|||
19526680|NCT01480180|41972101|FG000|Extension Phase, Part 1|Change of treatment|0|||
19526681|NCT01480180|41972102|FG001|Extension Phase, Part 1|Change of treatment|0|||
19526682|NCT01480180|41972103|FG002|Extension Phase, Part 1|Change of treatment|0|||
19526683|NCT01480180|41972104|FG003|Extension Phase, Part 1|Change of treatment|9|||
19526684|NCT01480180|41972105|FG004|Extension Phase, Part 1|Change of treatment|0|||
19526685|NCT01480180|41972106|FG005|Extension Phase, Part 1|Change of treatment|0|||
19526686|NCT01480180|41972101|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
19526687|NCT01480180|41972102|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
19526688|NCT01480180|41972103|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
19526689|NCT01480180|41972104|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
19526690|NCT01480180|41972105|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
19526691|NCT01480180|41972106|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
19526692|NCT01480180|41972101|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
19526693|NCT01480180|41972102|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
19526694|NCT01480180|41972103|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
19526695|NCT01480180|41972104|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
19526696|NCT01480180|41972105|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
19526697|NCT01480180|41972106|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
19526698|NCT01480180|41972101|FG000|Extension Phase, Part 2|Unclassified|0|||
19526699|NCT01480180|41972102|FG001|Extension Phase, Part 2|Unclassified|0|||
19448969|NCT01871805|41697193|FG002|Phase I|Alive in Survival Follow-up|4|||
19448970|NCT01871805|41697194|FG003|Phase I|Alive in Survival Follow-up|5|||
19448971|NCT01871805|41697195|FG004|Phase I|Alive in Survival Follow-up|4|||
19448972|NCT01871805|41697196|FG005|Phase I|Alive in Survival Follow-up|0|||
19448973|NCT01871805|41697191|FG000|Phase I|Lost to Follow-up|0|||
19448974|NCT01871805|41697192|FG001|Phase I|Lost to Follow-up|1|||
19448975|NCT01871805|41697193|FG002|Phase I|Lost to Follow-up|3|||
19448976|NCT01871805|41697194|FG003|Phase I|Lost to Follow-up|0|||
19448977|NCT01871805|41697195|FG004|Phase I|Lost to Follow-up|0|||
19448978|NCT01871805|41697196|FG005|Phase I|Lost to Follow-up|0|||
19448979|NCT01871805|41697191|FG000|Phase II|Death|0|||
19448980|NCT01871805|41697192|FG001|Phase II|Death|0|||
19448981|NCT01871805|41697193|FG002|Phase II|Death|0|||
19448982|NCT01871805|41697194|FG003|Phase II|Death|0|||
19448983|NCT01871805|41697195|FG004|Phase II|Death|0|||
19448984|NCT01871805|41697196|FG005|Phase II|Death|45|||
19448985|NCT01871805|41697191|FG000|Phase II|Alive in Survival Follow-up|0|||
19448986|NCT01871805|41697192|FG001|Phase II|Alive in Survival Follow-up|0|||
19448987|NCT01871805|41697193|FG002|Phase II|Alive in Survival Follow-up|0|||
19448988|NCT01871805|41697194|FG003|Phase II|Alive in Survival Follow-up|0|||
19448989|NCT01871805|41697195|FG004|Phase II|Alive in Survival Follow-up|0|||
19448990|NCT01871805|41697196|FG005|Phase II|Alive in Survival Follow-up|29|||
19448991|NCT01871805|41697191|FG000|Phase II|Lost to Follow-up|0|||
19448992|NCT01871805|41697192|FG001|Phase II|Lost to Follow-up|0|||
19448993|NCT01871805|41697193|FG002|Phase II|Lost to Follow-up|0|||
19448994|NCT01871805|41697194|FG003|Phase II|Lost to Follow-up|0|||
19448995|NCT01871805|41697195|FG004|Phase II|Lost to Follow-up|0|||
19448996|NCT01871805|41697196|FG005|Phase II|Lost to Follow-up|13|||
19448997|NCT01719861|41697227|FG000|Cycle 1|Death|4|||
19448998|NCT01719861|41697227|FG000|Cycle 2|Death|1|||
19448999|NCT01853618|41697237|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
19526700|NCT01480180|41972103|FG002|Extension Phase, Part 2|Unclassified|3|||
19526701|NCT01480180|41972104|FG003|Extension Phase, Part 2|Unclassified|1|||
19526702|NCT01480180|41972105|FG004|Extension Phase, Part 2|Unclassified|1|||
19526703|NCT01480180|41972106|FG005|Extension Phase, Part 2|Unclassified|0|||
19449000|NCT01853618|41697238|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
19449001|NCT01853618|41697239|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
19449002|NCT01853618|41697240|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
19449003|NCT01853618|41697241|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
19449004|NCT01853618|41697237|FG000|Overall Study|Progressive disease|1|||
19449005|NCT01853618|41697238|FG001|Overall Study|Progressive disease|1|||
19449006|NCT01853618|41697239|FG002|Overall Study|Progressive disease|1|||
19449007|NCT01853618|41697240|FG003|Overall Study|Progressive disease|1|||
19449008|NCT01853618|41697241|FG004|Overall Study|Progressive disease|2|||
19449009|NCT01853618|41697237|FG000|Overall Study|Physician Decision|0|||
19449010|NCT01853618|41697238|FG001|Overall Study|Physician Decision|1|||
19449011|NCT01853618|41697239|FG002|Overall Study|Physician Decision|1|||
19449012|NCT01853618|41697240|FG003|Overall Study|Physician Decision|0|||
19449013|NCT01853618|41697241|FG004|Overall Study|Physician Decision|0|||
19449014|NCT01853618|41697237|FG000|Overall Study|Refused further treatment|0|||
19449015|NCT01853618|41697238|FG001|Overall Study|Refused further treatment|0|||
19449016|NCT01853618|41697239|FG002|Overall Study|Refused further treatment|0|||
19449017|NCT01853618|41697240|FG003|Overall Study|Refused further treatment|0|||
19449018|NCT01853618|41697241|FG004|Overall Study|Refused further treatment|1|||
19449019|NCT01853462|41697256|FG000|Overall Study|Withdrawal by Subject|1|||
19449020|NCT01853462|41697257|FG001|Overall Study|Withdrawal by Subject|1|||
19526704|NCT01545050|41972142|FG000|Overall Study|Lack of Efficacy|0|||
19526705|NCT01545050|41972143|FG001|Overall Study|Lack of Efficacy|0|||
19526706|NCT01545050|41972144|FG002|Overall Study|Lack of Efficacy|0|||
19526707|NCT01545050|41972145|FG003|Overall Study|Lack of Efficacy|3|||
19526708|NCT01545050|41972146|FG004|Overall Study|Lack of Efficacy|2|||
19526709|NCT01545050|41972142|FG000|Overall Study|Adverse Event|1|||
19526710|NCT01545050|41972143|FG001|Overall Study|Adverse Event|1|||
19526711|NCT01545050|41972144|FG002|Overall Study|Adverse Event|2|||
19526712|NCT01545050|41972145|FG003|Overall Study|Adverse Event|2|||
19526713|NCT01545050|41972146|FG004|Overall Study|Adverse Event|0|||
19526714|NCT01545050|41972142|FG000|Overall Study|Discontinued study treatment|1|||
19526715|NCT01545050|41972143|FG001|Overall Study|Discontinued study treatment|0|||
19526716|NCT01545050|41972144|FG002|Overall Study|Discontinued study treatment|0|||
19526717|NCT01545050|41972145|FG003|Overall Study|Discontinued study treatment|0|||
19526718|NCT01545050|41972146|FG004|Overall Study|Discontinued study treatment|0|||
19526719|NCT01545050|41972142|FG000|Overall Study|Withdrawal by Subject|1|||
19526720|NCT01545050|41972143|FG001|Overall Study|Withdrawal by Subject|0|||
19526721|NCT01545050|41972144|FG002|Overall Study|Withdrawal by Subject|0|||
19526722|NCT01545050|41972145|FG003|Overall Study|Withdrawal by Subject|2|||
19526723|NCT01545050|41972146|FG004|Overall Study|Withdrawal by Subject|1|||
19526724|NCT01545050|41972142|FG000|Overall Study|Participant no longer meets study criteria|0|||
19526725|NCT01545050|41972143|FG001|Overall Study|Participant no longer meets study criteria|2|||
19526726|NCT01545050|41972144|FG002|Overall Study|Participant no longer meets study criteria|0|||
19526727|NCT01545050|41972145|FG003|Overall Study|Participant no longer meets study criteria|0|||
19526728|NCT01545050|41972146|FG004|Overall Study|Participant no longer meets study criteria|1|||
19526729|NCT01545050|41972142|FG000|Overall Study|Administrative reason by sponsor|4|||
19526730|NCT01545050|41972143|FG001|Overall Study|Administrative reason by sponsor|2|||
19526731|NCT01545050|41972144|FG002|Overall Study|Administrative reason by sponsor|3|||
19526732|NCT01545050|41972145|FG003|Overall Study|Administrative reason by sponsor|5|||
19526733|NCT01545050|41972146|FG004|Overall Study|Administrative reason by sponsor|5|||
19526734|NCT01555021|41972173|FG000|Overall Study|Lost to Follow-up|1|||
19526735|NCT01555021|41972174|FG001|Overall Study|Lost to Follow-up|2|||
19526736|NCT04705051|41972186|FG000|Overall Study|Enrolled but not treated|1|||
19526737|NCT04705051|41972186|FG000|Overall Study|Study terminated by sponsor|23|||
19526738|NCT04464421|41972193|FG000|Overall Study|Lost to Follow-up|2|||
19526739|NCT04464421|41972194|FG001|Overall Study|Lost to Follow-up|2|||
19526740|NCT04112784|41972212|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
19526741|NCT04112784|41972212|FG000|Overall Study|Screen Failures|4|||
19526742|NCT04049617|41972222|FG000|Overall Study|Adverse Event|0|||
19526743|NCT04049617|41972223|FG001|Overall Study|Adverse Event|0|||
19526744|NCT04049617|41972224|FG002|Overall Study|Adverse Event|0|||
19526745|NCT04049617|41972225|FG003|Overall Study|Adverse Event|1|||
19526746|NCT04049617|41972226|FG004|Overall Study|Adverse Event|0|||
19526747|NCT04049617|41972227|FG005|Overall Study|Adverse Event|0|||
19526748|NCT04049617|41972222|FG000|Overall Study|Death|0|||
19526749|NCT04049617|41972223|FG001|Overall Study|Death|0|||
19526750|NCT04049617|41972224|FG002|Overall Study|Death|0|||
19526751|NCT04049617|41972225|FG003|Overall Study|Death|0|||
19449021|NCT01719783|41697267|FG000|Dose 2|Physician Decision|1|||
19449022|NCT01719783|41697268|FG001|Dose 2|Physician Decision|0|||
19449023|NCT01719237|41697296|FG000|Overall Study|Physician Decision|0|||
19526752|NCT04049617|41972226|FG004|Overall Study|Death|0|||
19526753|NCT04049617|41972227|FG005|Overall Study|Death|1|||
19526754|NCT04049617|41972222|FG000|Overall Study|Lost to Follow-up|0|||
19526755|NCT04049617|41972223|FG001|Overall Study|Lost to Follow-up|0|||
19526756|NCT04049617|41972224|FG002|Overall Study|Lost to Follow-up|0|||
19526757|NCT04049617|41972225|FG003|Overall Study|Lost to Follow-up|1|||
19449024|NCT01719237|41697297|FG001|Overall Study|Physician Decision|1|||
19449025|NCT01853384|41697305|FG000|Randomized|Adverse Event|5|||
19526758|NCT04049617|41972226|FG004|Overall Study|Lost to Follow-up|0|||
19526759|NCT04049617|41972227|FG005|Overall Study|Lost to Follow-up|0|||
19526760|NCT04049617|41972222|FG000|Overall Study|Withdrew consent|0|||
19526761|NCT04049617|41972223|FG001|Overall Study|Withdrew consent|0|||
19526762|NCT04049617|41972224|FG002|Overall Study|Withdrew consent|1|||
19526763|NCT04049617|41972225|FG003|Overall Study|Withdrew consent|0|||
19526764|NCT04049617|41972226|FG004|Overall Study|Withdrew consent|0|||
19526765|NCT04049617|41972227|FG005|Overall Study|Withdrew consent|0|||
19526766|NCT03911154|41972243|FG000|Overall Study|Withdrawal by Subject|1|||
19526767|NCT03782064|41972259|FG000|Overall Study|Lack of Efficacy|2|||
19526768|NCT03782064|41972259|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
19526769|NCT03781778|41972265|FG000|Overall Study|Withdrawal by Subject|2|||
19526770|NCT03781778|41972266|FG001|Overall Study|Withdrawal by Subject|2|||
19526771|NCT03710590|41972274|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
19449026|NCT01853384|41697306|FG001|Randomized|Adverse Event|3|||
19449027|NCT01853384|41697305|FG000|Randomized|Death|1|||
19449028|NCT01853384|41697306|FG001|Randomized|Death|2|||
19449029|NCT01853384|41697305|FG000|Randomized|Lost to Follow-up|1|||
19449030|NCT01853384|41697306|FG001|Randomized|Lost to Follow-up|1|||
19449031|NCT01853384|41697305|FG000|Randomized|Withdrawal by Subject|5|||
19449032|NCT01853384|41697306|FG001|Randomized|Withdrawal by Subject|3|||
19449033|NCT01853384|41697305|FG000|Randomized|Sponsor Decision|47|||
19449034|NCT01853384|41697306|FG001|Randomized|Sponsor Decision|34|||
19449035|NCT01853384|41697305|FG000|Randomized|Other|3|||
19449036|NCT01853384|41697306|FG001|Randomized|Other|3|||
19449037|NCT01853384|41697305|FG000|Completed Follow up Visit 1|Early Termination|13|||
19449038|NCT01853384|41697306|FG001|Completed Follow up Visit 1|Early Termination|9|||
19449039|NCT01853384|41697305|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
19449040|NCT01853384|41697306|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
19449041|NCT01853384|41697305|FG000|Completed Follow up Visit 2|Adverse Event|1|||
19449042|NCT01853384|41697306|FG001|Completed Follow up Visit 2|Adverse Event|0|||
19449043|NCT01853384|41697305|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
19449044|NCT01853384|41697306|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
19449045|NCT01853384|41697305|FG000|Completed Follow up Visit 2|Death|1|||
19449046|NCT01853384|41697306|FG001|Completed Follow up Visit 2|Death|0|||
19449047|NCT01853384|41697305|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
19449048|NCT01853384|41697306|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
19449049|NCT01878890|41697316|FG000|Overall Study|Protocol Violation|0|||
19449050|NCT01878890|41697317|FG001|Overall Study|Protocol Violation|1|||
19449051|NCT01878890|41697318|FG002|Overall Study|Protocol Violation|0|||
19449052|NCT01878890|41697319|FG003|Overall Study|Protocol Violation|0|||
19449053|NCT01827332|41697332|FG000|Overall Study|Lost to Follow-up|2|||
19449054|NCT01827332|41697333|FG001|Overall Study|Lost to Follow-up|1|||
19449055|NCT01719003|41697347|FG000|Overall Study|Non compliant with protocol|1|||
19449056|NCT01719003|41697348|FG001|Overall Study|Non compliant with protocol|1|||
19449057|NCT01719003|41697349|FG002|Overall Study|Non compliant with protocol|0|||
19449058|NCT01719003|41697350|FG003|Overall Study|Non compliant with protocol|1|||
19449059|NCT01719003|41697351|FG004|Overall Study|Non compliant with protocol|2|||
19449060|NCT01719003|41697352|FG005|Overall Study|Non compliant with protocol|1|||
19449061|NCT01719003|41697353|FG006|Overall Study|Non compliant with protocol|2|||
19449062|NCT01719003|41697354|FG007|Overall Study|Non compliant with protocol|3|||
19449063|NCT01719003|41697355|FG008|Overall Study|Non compliant with protocol|0|||
19449064|NCT01719003|41697347|FG000|Overall Study|Adverse Event|6|||
19449065|NCT01719003|41697348|FG001|Overall Study|Adverse Event|5|||
19449066|NCT01719003|41697349|FG002|Overall Study|Adverse Event|4|||
19449067|NCT01719003|41697350|FG003|Overall Study|Adverse Event|3|||
19449068|NCT01719003|41697351|FG004|Overall Study|Adverse Event|4|||
19449069|NCT01719003|41697352|FG005|Overall Study|Adverse Event|3|||
19449070|NCT01719003|41697353|FG006|Overall Study|Adverse Event|6|||
19449071|NCT01719003|41697354|FG007|Overall Study|Adverse Event|5|||
19449072|NCT01719003|41697355|FG008|Overall Study|Adverse Event|0|||
19449073|NCT01719003|41697347|FG000|Overall Study|Lost to Follow-up|0|||
19449074|NCT01719003|41697348|FG001|Overall Study|Lost to Follow-up|6|||
19526772|NCT03710590|41972275|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
19526773|NCT03470922|41972336|FG000|Overall Study|Death|107|||
19526774|NCT03470922|41972337|FG001|Overall Study|Death|118|||
19526775|NCT03470922|41972336|FG000|Overall Study|Lost to Follow-up|5|||
19526776|NCT03470922|41972337|FG001|Overall Study|Lost to Follow-up|5|||
19526777|NCT03470922|41972336|FG000|Overall Study|Participant Withdrew Consent|4|||
19449075|NCT01719003|41697349|FG002|Overall Study|Lost to Follow-up|7|||
19449076|NCT01719003|41697350|FG003|Overall Study|Lost to Follow-up|2|||
19449077|NCT01719003|41697351|FG004|Overall Study|Lost to Follow-up|3|||
19449078|NCT01719003|41697352|FG005|Overall Study|Lost to Follow-up|4|||
19449079|NCT01719003|41697353|FG006|Overall Study|Lost to Follow-up|3|||
19526778|NCT03470922|41972337|FG001|Overall Study|Participant Withdrew Consent|9|||
19449080|NCT01719003|41697354|FG007|Overall Study|Lost to Follow-up|2|||
19449081|NCT01719003|41697355|FG008|Overall Study|Lost to Follow-up|2|||
19449082|NCT01719003|41697347|FG000|Overall Study|Refusal to continue, not due to AE|2|||
19449083|NCT01719003|41697348|FG001|Overall Study|Refusal to continue, not due to AE|5|||
19526779|NCT03470922|41972336|FG000|Overall Study|Other reasons|1|||
19526780|NCT03470922|41972337|FG001|Overall Study|Other reasons|0|||
19526781|NCT03470922|41972336|FG000|Overall Study|Not reported|1|||
19526782|NCT03470922|41972337|FG001|Overall Study|Not reported|0|||
19526783|NCT03465722|41972345|FG000|Overall Study|Withdrawal by Subject|21|||
19526784|NCT03465722|41972346|FG001|Overall Study|Withdrawal by Subject|14|||
19526785|NCT03465722|41972345|FG000|Overall Study|Death|89|||
19526786|NCT03465722|41972346|FG001|Overall Study|Death|87|||
19526787|NCT03465722|41972345|FG000|Overall Study|Lost to Follow-up|5|||
19526788|NCT03465722|41972346|FG001|Overall Study|Lost to Follow-up|3|||
19526789|NCT03465722|41972345|FG000|Overall Study|Administrative/Other|33|||
19526790|NCT03465722|41972346|FG001|Overall Study|Administrative/Other|32|||
19526791|NCT03465722|41972345|FG000|Overall Study|Not treated|1|||
19526792|NCT03465722|41972346|FG001|Overall Study|Not treated|2|||
19526793|NCT03465722|41972345|FG000|Overall Study|Sponsor decision|91|||
19526794|NCT03465722|41972346|FG001|Overall Study|Sponsor decision|98|||
19526795|NCT03205423|41972352|FG000|Overall Study|Personal|1|||
19526796|NCT03205423|41972353|FG001|Overall Study|Personal|1|||
19526797|NCT03205423|41972352|FG000|Overall Study|Physician Decision|0|||
19526798|NCT03205423|41972353|FG001|Overall Study|Physician Decision|2|||
19526799|NCT03104400|41972364|FG000|Overall Study|Adverse Event|5|||
19526800|NCT03104400|41972365|FG001|Overall Study|Adverse Event|7|||
19526801|NCT03104400|41972366|FG002|Overall Study|Adverse Event|11|||
19526802|NCT03104400|41972367|FG003|Overall Study|Adverse Event|9|||
19526803|NCT03104400|41972368|FG004|Overall Study|Adverse Event|21|||
19526804|NCT03104400|41972364|FG000|Overall Study|Withdrawal by Subject|17|||
19526805|NCT03104400|41972365|FG001|Overall Study|Withdrawal by Subject|19|||
19526806|NCT03104400|41972366|FG002|Overall Study|Withdrawal by Subject|29|||
19526807|NCT03104400|41972367|FG003|Overall Study|Withdrawal by Subject|25|||
19526808|NCT03104400|41972368|FG004|Overall Study|Withdrawal by Subject|24|||
19526809|NCT03104400|41972364|FG000|Overall Study|Lost to Follow-up|4|||
19526810|NCT03104400|41972365|FG001|Overall Study|Lost to Follow-up|1|||
19526811|NCT03104400|41972366|FG002|Overall Study|Lost to Follow-up|4|||
19526812|NCT03104400|41972367|FG003|Overall Study|Lost to Follow-up|8|||
19526813|NCT03104400|41972368|FG004|Overall Study|Lost to Follow-up|7|||
19526814|NCT03104400|41972364|FG000|Overall Study|Lack of Efficacy|6|||
19526815|NCT03104400|41972365|FG001|Overall Study|Lack of Efficacy|3|||
19526816|NCT03104400|41972366|FG002|Overall Study|Lack of Efficacy|8|||
19526817|NCT03104400|41972367|FG003|Overall Study|Lack of Efficacy|2|||
19526818|NCT03104400|41972368|FG004|Overall Study|Lack of Efficacy|1|||
19526819|NCT03104400|41972364|FG000|Overall Study|COVID Logistical Restrictions|0|||
19526820|NCT03104400|41972365|FG001|Overall Study|COVID Logistical Restrictions|0|||
19526821|NCT03104400|41972366|FG002|Overall Study|COVID Logistical Restrictions|0|||
19526822|NCT03104400|41972367|FG003|Overall Study|COVID Logistical Restrictions|1|||
19526823|NCT03104400|41972368|FG004|Overall Study|COVID Logistical Restrictions|0|||
19526824|NCT03104400|41972364|FG000|Overall Study|Other|2|||
19526825|NCT03104400|41972365|FG001|Overall Study|Other|3|||
19526826|NCT03104400|41972366|FG002|Overall Study|Other|7|||
19526827|NCT03104400|41972367|FG003|Overall Study|Other|6|||
19526828|NCT03104400|41972368|FG004|Overall Study|Other|4|||
19526829|NCT03104400|41972364|FG000|Overall Study|Other|0|||
19526830|NCT03104400|41972365|FG001|Overall Study|Other|1|||
19526831|NCT03104400|41972366|FG002|Overall Study|Other|0|||
19449084|NCT01719003|41697349|FG002|Overall Study|Refusal to continue, not due to AE|4|||
19449085|NCT01719003|41697350|FG003|Overall Study|Refusal to continue, not due to AE|4|||
19449086|NCT01719003|41697351|FG004|Overall Study|Refusal to continue, not due to AE|4|||
19449087|NCT01719003|41697352|FG005|Overall Study|Refusal to continue, not due to AE|3|||
19449088|NCT01719003|41697353|FG006|Overall Study|Refusal to continue, not due to AE|8|||
19449089|NCT01719003|41697354|FG007|Overall Study|Refusal to continue, not due to AE|7|||
19449090|NCT01719003|41697355|FG008|Overall Study|Refusal to continue, not due to AE|1|||
19449091|NCT01719003|41697347|FG000|Overall Study|Reason other than those specified|0|||
19449092|NCT01719003|41697348|FG001|Overall Study|Reason other than those specified|0|||
19449093|NCT01719003|41697349|FG002|Overall Study|Reason other than those specified|2|||
19449094|NCT01719003|41697350|FG003|Overall Study|Reason other than those specified|3|||
19449095|NCT01719003|41697351|FG004|Overall Study|Reason other than those specified|4|||
19449096|NCT01719003|41697352|FG005|Overall Study|Reason other than those specified|1|||
19526832|NCT03104400|41972367|FG003|Overall Study|Other|0|||
19526833|NCT03104400|41972368|FG004|Overall Study|Other|0|||
19526834|NCT03104374|41972385|FG000|Overall Study|Adverse Event|7|||
19526835|NCT03104374|41972386|FG001|Overall Study|Adverse Event|6|||
19526836|NCT03104374|41972387|FG002|Overall Study|Adverse Event|12|||
19526837|NCT03104374|41972388|FG003|Overall Study|Adverse Event|15|||
19526838|NCT03104374|41972385|FG000|Overall Study|Withdrawal by Subject|18|||
19526839|NCT03104374|41972386|FG001|Overall Study|Withdrawal by Subject|10|||
19526840|NCT03104374|41972387|FG002|Overall Study|Withdrawal by Subject|10|||
19526841|NCT03104374|41972388|FG003|Overall Study|Withdrawal by Subject|17|||
19526842|NCT03104374|41972385|FG000|Overall Study|Lost to Follow-up|4|||
19526843|NCT03104374|41972386|FG001|Overall Study|Lost to Follow-up|4|||
19526844|NCT03104374|41972387|FG002|Overall Study|Lost to Follow-up|6|||
19526845|NCT03104374|41972388|FG003|Overall Study|Lost to Follow-up|8|||
19526846|NCT03104374|41972385|FG000|Overall Study|Lack of Efficacy|6|||
19526847|NCT03104374|41972386|FG001|Overall Study|Lack of Efficacy|7|||
19526848|NCT03104374|41972387|FG002|Overall Study|Lack of Efficacy|12|||
19526849|NCT03104374|41972388|FG003|Overall Study|Lack of Efficacy|6|||
19526850|NCT03104374|41972385|FG000|Overall Study|Other|2|||
19526851|NCT03104374|41972386|FG001|Overall Study|Other|2|||
19526852|NCT03104374|41972387|FG002|Overall Study|Other|4|||
19526853|NCT03104374|41972388|FG003|Overall Study|Other|7|||
19526854|NCT03073603|41972400|FG000|Overall Study|Noncompliance|3|||
19526855|NCT03073603|41972401|FG001|Overall Study|Noncompliance|1|||
19526856|NCT03073603|41972400|FG000|Overall Study|Adverse Event|5|||
19526857|NCT03073603|41972401|FG001|Overall Study|Adverse Event|3|||
19526858|NCT03073603|41972400|FG000|Overall Study|Physician Decision|1|||
19526859|NCT03073603|41972401|FG001|Overall Study|Physician Decision|2|||
19526860|NCT03073603|41972400|FG000|Overall Study|Required treatment not allowed by protocol|1|||
19526861|NCT03073603|41972401|FG001|Overall Study|Required treatment not allowed by protocol|0|||
19449097|NCT01719003|41697353|FG006|Overall Study|Reason other than those specified|0|||
19449098|NCT01719003|41697354|FG007|Overall Study|Reason other than those specified|3|||
19449099|NCT01719003|41697355|FG008|Overall Study|Reason other than those specified|1|||
19526862|NCT03073603|41972400|FG000|Overall Study|Financial or insurance-related|8|||
19526863|NCT03073603|41972401|FG001|Overall Study|Financial or insurance-related|0|||
19526864|NCT03073603|41972400|FG000|Overall Study|Withdrawal by Subject|0|||
19526865|NCT03073603|41972401|FG001|Overall Study|Withdrawal by Subject|1|||
19526866|NCT03073603|41972400|FG000|Overall Study|Discontinued DMT|4|||
19526867|NCT03073603|41972401|FG001|Overall Study|Discontinued DMT|0|||
19526868|NCT03073603|41972400|FG000|Overall Study|Restarted DMT|0|||
19526869|NCT03073603|41972401|FG001|Overall Study|Restarted DMT|1|||
19526870|NCT03002155|41972413|FG000|Overall Study|Lost to Follow-up|1|||
19526871|NCT03002155|41972414|FG001|Overall Study|Lost to Follow-up|2|||
19526872|NCT03002155|41972413|FG000|Overall Study|Withdrawal by Subject|1|||
19526873|NCT03002155|41972414|FG001|Overall Study|Withdrawal by Subject|0|||
19526874|NCT03002155|41972413|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
19526875|NCT03002155|41972414|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
19526876|NCT02918006|41972424|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
19526877|NCT02918006|41972425|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
19526878|NCT02918006|41972426|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
19526879|NCT02918006|41972424|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
19449100|NCT01719003|41697347|FG000|Overall Study|Lack of Efficacy|0|||
19449101|NCT01719003|41697348|FG001|Overall Study|Lack of Efficacy|0|||
19449102|NCT01719003|41697349|FG002|Overall Study|Lack of Efficacy|0|||
19449103|NCT01719003|41697350|FG003|Overall Study|Lack of Efficacy|0|||
19449104|NCT01719003|41697351|FG004|Overall Study|Lack of Efficacy|0|||
19449105|NCT01719003|41697352|FG005|Overall Study|Lack of Efficacy|0|||
19449106|NCT01719003|41697353|FG006|Overall Study|Lack of Efficacy|1|||
19449107|NCT01719003|41697354|FG007|Overall Study|Lack of Efficacy|0|||
19449108|NCT01719003|41697355|FG008|Overall Study|Lack of Efficacy|0|||
19449109|NCT01853228|41697374|FG000|Phase 1|Lack of Efficacy|8|||
19449110|NCT01853228|41697375|FG001|Phase 1|Lack of Efficacy|0|||
19449111|NCT01853228|41697374|FG000|Phase 1|Other|1|||
19449112|NCT01853228|41697375|FG001|Phase 1|Other|0|||
19449113|NCT01853228|41697374|FG000|Phase 2|Physician Decision|0|||
19449114|NCT01853228|41697375|FG001|Phase 2|Physician Decision|1|||
19449115|NCT01853228|41697374|FG000|Phase 2|Proceed To Transplant|0|||
19449116|NCT01853228|41697375|FG001|Phase 2|Proceed To Transplant|3|||
19449117|NCT01853228|41697374|FG000|Phase 2|Lack of Efficacy|0|||
19449118|NCT01853228|41697375|FG001|Phase 2|Lack of Efficacy|4|||
19449119|NCT01705587|41697382|FG000|Overall Study|Withdrawal by Subject|0|||
19449120|NCT01705587|41697383|FG001|Overall Study|Withdrawal by Subject|1|||
19449121|NCT01718535|41697399|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
19449122|NCT01718535|41697400|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
19449123|NCT01718535|41697401|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
19449124|NCT01718535|41697402|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
19449125|NCT01718535|41697403|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
19449126|NCT01718535|41697404|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
19449127|NCT01718535|41697405|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
19449128|NCT01718535|41697406|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
19449129|NCT01718535|41697407|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
19449130|NCT01718535|41697408|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
19526880|NCT02918006|41972425|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
19526881|NCT02918006|41972426|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
19526882|NCT02918006|41972424|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
19629270|NCT00641056|42078807|FG001|Overall Study|Lost to Follow-up|1|||
19449131|NCT01717989|41697430|FG000|Overall Study|Ineligibility determined|6|||
19449132|NCT01717989|41697430|FG000|Overall Study|Protocol deviation|6|||
19629271|NCT00641056|42078806|FG000|Overall Study|Physician Decision|3|||
19449133|NCT01717989|41697430|FG000|Overall Study|Withdrawal by Subject|11|||
19449134|NCT01717989|41697430|FG000|Overall Study|Physician Decision|2|||
19449135|NCT01717989|41697430|FG000|Overall Study|Lost to Follow-up|11|||
19449136|NCT01717989|41697430|FG000|Overall Study|Death|439|||
19449137|NCT01717989|41697430|FG000|Overall Study|Protocol-specified criteria|551|||
19449138|NCT01717989|41697430|FG000|Overall Study|Other|40|||
19449139|NCT01705509|41697449|FG000|Inclusion CPET|Screen Failure|5|||
19449140|NCT01705509|41697449|FG000|Inclusion CPET|Withdrawal by Subject|2|||
19449141|NCT01705509|41697449|FG000|CPET w/ Ranexa|Screen Failure|2|||
19449142|NCT01853072|41697455|FG000|Overall Study|Adverse event prior to treatment|0|||
19449143|NCT01853072|41697456|FG001|Overall Study|Adverse event prior to treatment|1|||
19449144|NCT01853072|41697455|FG000|Overall Study|Adverse Event|0|||
19449145|NCT01853072|41697456|FG001|Overall Study|Adverse Event|3|||
19449146|NCT01853072|41697455|FG000|Overall Study|Death|1|||
19449147|NCT01853072|41697456|FG001|Overall Study|Death|4|||
19449148|NCT01853072|41697455|FG000|Overall Study|Lost to Follow-up|0|||
19449149|NCT01853072|41697456|FG001|Overall Study|Lost to Follow-up|3|||
19449150|NCT01853072|41697455|FG000|Overall Study|Non-compliance with study drug|0|||
19449151|NCT01853072|41697456|FG001|Overall Study|Non-compliance with study drug|1|||
19449152|NCT01853072|41697455|FG000|Overall Study|Physician Decision|1|||
19449153|NCT01853072|41697456|FG001|Overall Study|Physician Decision|1|||
19449154|NCT01853072|41697455|FG000|Overall Study|Withdrawal by Subject|1|||
19449155|NCT01853072|41697456|FG001|Overall Study|Withdrawal by Subject|2|||
19449156|NCT01853072|41697455|FG000|Overall Study|Reason not specified|9|||
19449157|NCT01853072|41697456|FG001|Overall Study|Reason not specified|6|||
19449158|NCT01877720|41697464|FG000|Overall Study|Adverse Event|1|||
19449159|NCT01877720|41697465|FG001|Overall Study|Adverse Event|0|||
19449160|NCT01870869|41697475|FG000|Overall Study|Implanted with nonstudy device|1|||
19449161|NCT01870869|41697476|FG001|Overall Study|Implanted with nonstudy device|3|||
19449162|NCT01870869|41697477|FG002|Overall Study|Implanted with nonstudy device|14|||
19449163|NCT01870869|41697478|FG003|Overall Study|Implanted with nonstudy device|4|||
19449164|NCT01870869|41697475|FG000|Overall Study|Death|0|||
19449165|NCT01870869|41697476|FG001|Overall Study|Death|0|||
19449166|NCT01870869|41697477|FG002|Overall Study|Death|7|||
19449167|NCT01870869|41697478|FG003|Overall Study|Death|1|||
19449168|NCT01870869|41697475|FG000|Overall Study|Subject choice|6|||
19449169|NCT01870869|41697476|FG001|Overall Study|Subject choice|2|||
19449170|NCT01870869|41697477|FG002|Overall Study|Subject choice|22|||
19449171|NCT01870869|41697478|FG003|Overall Study|Subject choice|8|||
19449172|NCT01870869|41697475|FG000|Overall Study|Lost to Follow-up|10|||
19449173|NCT01870869|41697476|FG001|Overall Study|Lost to Follow-up|2|||
19449174|NCT01870869|41697477|FG002|Overall Study|Lost to Follow-up|25|||
19449175|NCT01870869|41697478|FG003|Overall Study|Lost to Follow-up|3|||
19449176|NCT01870869|41697475|FG000|Overall Study|Reason not Specified|1|||
19449177|NCT01870869|41697476|FG001|Overall Study|Reason not Specified|2|||
19449178|NCT01870869|41697477|FG002|Overall Study|Reason not Specified|20|||
19449179|NCT01870869|41697478|FG003|Overall Study|Reason not Specified|4|||
19449180|NCT01870869|41697475|FG000|Overall Study|Not evaluable|10|||
19449181|NCT01870869|41697476|FG001|Overall Study|Not evaluable|5|||
19449182|NCT01870869|41697477|FG002|Overall Study|Not evaluable|42|||
19449183|NCT01870869|41697478|FG003|Overall Study|Not evaluable|10|||
19449184|NCT01877408|41697490|FG000|Overall Study|Lost to Follow-up|0|||
19449185|NCT01877408|41697491|FG001|Overall Study|Lost to Follow-up|2|||
19449186|NCT01717287|41697500|FG000|Overall Study|Lost to Follow-up|0|||
19449187|NCT01717287|41697501|FG001|Overall Study|Lost to Follow-up|2|||
19449188|NCT01717287|41697500|FG000|Overall Study|Protocol Violation|0|||
19449189|NCT01717287|41697501|FG001|Overall Study|Protocol Violation|1|||
19449190|NCT01827254|41697507|FG000|Overall Study|Death|10|||
19449191|NCT01827254|41697507|FG000|Overall Study|Case report form not completed|4|||
19449192|NCT01827254|41697507|FG000|Overall Study|Invalidated centre|3|||
19449193|NCT01827254|41697507|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
19449194|NCT01827254|41697507|FG000|Overall Study|Did not complete re-challenge|1|||
19449195|NCT01827254|41697507|FG000|Overall Study|Disease progression|36|||
19449196|NCT01827254|41697507|FG000|Overall Study|Intolerance to treatment|4|||
19449197|NCT01824602|41697519|FG000|Overall Study|Withdrawal by Subject|0|||
19449198|NCT01824602|41697520|FG001|Overall Study|Withdrawal by Subject|0|||
19449199|NCT01824602|41697521|FG002|Overall Study|Withdrawal by Subject|1|||
19449200|NCT01824602|41697522|FG003|Overall Study|Withdrawal by Subject|2|||
19449201|NCT01824602|41697519|FG000|Overall Study|Patient non-compliance|0|||
19449202|NCT01824602|41697520|FG001|Overall Study|Patient non-compliance|0|||
19449203|NCT01824602|41697521|FG002|Overall Study|Patient non-compliance|1|||
19449204|NCT01824602|41697522|FG003|Overall Study|Patient non-compliance|0|||
19449205|NCT01824602|41697519|FG000|Overall Study|Adverse Event|1|||
19449206|NCT01824602|41697520|FG001|Overall Study|Adverse Event|0|||
19449207|NCT01824602|41697521|FG002|Overall Study|Adverse Event|2|||
19449208|NCT01824602|41697522|FG003|Overall Study|Adverse Event|2|||
19449209|NCT01824602|41697519|FG000|Overall Study|Treatment failure|0|||
19449210|NCT01824602|41697520|FG001|Overall Study|Treatment failure|0|||
19449211|NCT01824602|41697521|FG002|Overall Study|Treatment failure|0|||
19449212|NCT01824602|41697522|FG003|Overall Study|Treatment failure|1|||
19449213|NCT01704651|41697534|FG000|Overall Study|Pre-op withdrawal by subject|1|||
19449214|NCT01704651|41697535|FG001|Overall Study|Pre-op withdrawal by subject|1|||
19449215|NCT01704651|41697534|FG000|Overall Study|Pre-op change in treatment plan|1|||
19449216|NCT01704651|41697535|FG001|Overall Study|Pre-op change in treatment plan|4|||
19449217|NCT01704651|41697534|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
19449218|NCT01704651|41697535|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
19449219|NCT01704651|41697534|FG000|Overall Study|Post-op did not have laparotomy|2|||
19449220|NCT01704651|41697535|FG001|Overall Study|Post-op did not have laparotomy|1|||
19449221|NCT01876706|41697541|FG000|Overall Study|BPH Intervention|9|||
19449222|NCT01876706|41697541|FG000|Overall Study|Lost to Follow-up|7|||
19449223|NCT01876706|41697541|FG000|Overall Study|Withdrawals|6|||
19449224|NCT01876706|41697541|FG000|Overall Study|Death|3|||
19449225|NCT01876082|41697547|FG000|Overall Study|Withdrawal by Subject|0|||
19449226|NCT01876082|41697548|FG001|Overall Study|Withdrawal by Subject|2|||
19449227|NCT01876082|41697547|FG000|Overall Study|Protocol Violation|1|||
19449228|NCT01876082|41697548|FG001|Overall Study|Protocol Violation|0|||
19449229|NCT01876082|41697547|FG000|Overall Study|Adverse Event|1|||
19449230|NCT01876082|41697548|FG001|Overall Study|Adverse Event|1|||
19449231|NCT01876082|41697547|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
19449232|NCT01876082|41697548|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
19449233|NCT01704495|41697558|FG000|Subjects Randomized|Other Reason|3|||
19449234|NCT01704495|41697559|FG001|Subjects Randomized|Other Reason|2|||
19449235|NCT01704495|41697560|FG002|Subjects Randomized|Other Reason|3|||
19449236|NCT01704495|41697561|FG003|Subjects Randomized|Other Reason|2|||
19449237|NCT01704495|41697558|FG000|Subjects Randomized|Discontinuation criteria met|4|||
19449238|NCT01704495|41697559|FG001|Subjects Randomized|Discontinuation criteria met|2|||
19449239|NCT01704495|41697560|FG002|Subjects Randomized|Discontinuation criteria met|2|||
19449240|NCT01704495|41697561|FG003|Subjects Randomized|Discontinuation criteria met|0|||
19449241|NCT01704495|41697558|FG000|Subjects Randomized|Adverse Event|8|||
19449242|NCT01704495|41697559|FG001|Subjects Randomized|Adverse Event|2|||
19449243|NCT01704495|41697560|FG002|Subjects Randomized|Adverse Event|0|||
19449244|NCT01704495|41697561|FG003|Subjects Randomized|Adverse Event|7|||
19449245|NCT01704495|41697558|FG000|Subjects Randomized|Withdrawal by Subject|5|||
19449246|NCT01704495|41697559|FG001|Subjects Randomized|Withdrawal by Subject|5|||
19449247|NCT01704495|41697560|FG002|Subjects Randomized|Withdrawal by Subject|5|||
19449248|NCT01704495|41697561|FG003|Subjects Randomized|Withdrawal by Subject|5|||
19449249|NCT01704495|41697558|FG000|Subjects Randomized|Protocol Violation|1|||
19449250|NCT01704495|41697559|FG001|Subjects Randomized|Protocol Violation|1|||
19449251|NCT01704495|41697560|FG002|Subjects Randomized|Protocol Violation|2|||
19449252|NCT01704495|41697561|FG003|Subjects Randomized|Protocol Violation|0|||
19449253|NCT01704495|41697558|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
19449254|NCT01704495|41697559|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
19449255|NCT01704495|41697560|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
19449256|NCT01704495|41697561|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
19449257|NCT01704495|41697558|FG000|Optional Safety Extension|Adverse Event|0|||
19449258|NCT01704495|41697559|FG001|Optional Safety Extension|Adverse Event|4|||
19449259|NCT01704495|41697560|FG002|Optional Safety Extension|Adverse Event|0|||
19449260|NCT01704495|41697561|FG003|Optional Safety Extension|Adverse Event|1|||
19449261|NCT01704495|41697558|FG000|Optional Safety Extension|Other reason|27|||
19449262|NCT01704495|41697559|FG001|Optional Safety Extension|Other reason|29|||
19449263|NCT01704495|41697560|FG002|Optional Safety Extension|Other reason|30|||
19449264|NCT01704495|41697561|FG003|Optional Safety Extension|Other reason|28|||
19449265|NCT01704495|41697558|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
19449266|NCT01704495|41697559|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
19449267|NCT01704495|41697560|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
19449268|NCT01704495|41697561|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
19449269|NCT01716663|41697571|FG000|Overall Study|Withdrawn prior to procedure|4|||
19449270|NCT01716663|41697571|FG000|Overall Study|Treated with non-study catheter|2|||
19449271|NCT01716585|41697577|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
19449272|NCT01716585|41697578|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
19449273|NCT01716585|41697577|FG000|Double-blind Treatment|Adverse Event|2|||
19449274|NCT01716585|41697578|FG001|Double-blind Treatment|Adverse Event|1|||
19526883|NCT02918006|41972425|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
19526884|NCT02918006|41972426|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
19526885|NCT02918006|41972424|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
19526886|NCT02918006|41972425|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
19526887|NCT02918006|41972426|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
19526888|NCT02918006|41972424|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
19526889|NCT02918006|41972425|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
19449275|NCT01716585|41697577|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
19449276|NCT01716585|41697578|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
19449277|NCT01716585|41697577|FG000|Double-blind Treatment|Lost to Follow-up|2|||
19449278|NCT01716585|41697578|FG001|Double-blind Treatment|Lost to Follow-up|0|||
19449279|NCT01716585|41697577|FG000|Double-blind Treatment|Subject Noncompliant|1|||
19449280|NCT01716585|41697578|FG001|Double-blind Treatment|Subject Noncompliant|0|||
19449281|NCT01716585|41697577|FG000|Double-blind Treatment|Other|1|||
19449282|NCT01716585|41697578|FG001|Double-blind Treatment|Other|0|||
19449283|NCT01716585|41697577|FG000|Open-label Treatment|Adverse Event|0|||
19449284|NCT01716585|41697578|FG001|Open-label Treatment|Adverse Event|2|||
19449285|NCT01716585|41697577|FG000|Open-label Treatment|Virologic Failure|0|||
19449286|NCT01716585|41697578|FG001|Open-label Treatment|Virologic Failure|2|||
19449287|NCT01716585|41697577|FG000|Open-label Treatment|Withdrawal by Subject|0|||
19449288|NCT01716585|41697578|FG001|Open-label Treatment|Withdrawal by Subject|3|||
19449289|NCT01852292|41697587|FG000|Overall Study|Untreated - did not receive study drug|3|||
19449290|NCT01852292|41697588|FG001|Overall Study|Untreated - did not receive study drug|1|||
19526890|NCT02918006|41972426|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
19526891|NCT02918006|41972424|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
19526892|NCT02918006|41972425|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
19526893|NCT02918006|41972426|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
19526894|NCT02918006|41972424|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
19526895|NCT02918006|41972425|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
19526896|NCT02918006|41972426|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
19526897|NCT02918006|41972424|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
19526898|NCT02918006|41972425|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
19526899|NCT02918006|41972426|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
19526900|NCT02918006|41972424|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
19526901|NCT02918006|41972425|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
19526902|NCT02918006|41972426|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
19526903|NCT02658487|41972451|FG000|Overall Study|Death|2|||
19449291|NCT01852292|41697587|FG000|Overall Study|Death|9|||
19449292|NCT01852292|41697588|FG001|Overall Study|Death|8|||
19449293|NCT01852292|41697587|FG000|Overall Study|Patient/guardian decision|8|||
19449294|NCT01852292|41697588|FG001|Overall Study|Patient/guardian decision|4|||
19449295|NCT01852292|41697587|FG000|Overall Study|Adverse Event|8|||
19449296|NCT01852292|41697588|FG001|Overall Study|Adverse Event|11|||
19449297|NCT01852292|41697587|FG000|Overall Study|Physician Decision|6|||
19449298|NCT01852292|41697588|FG001|Overall Study|Physician Decision|2|||
19449299|NCT01852292|41697587|FG000|Overall Study|Protocol Violation|2|||
19449300|NCT01852292|41697588|FG001|Overall Study|Protocol Violation|0|||
19449301|NCT01852292|41697587|FG000|Overall Study|Non-compliance with study treatment|1|||
19449302|NCT01852292|41697588|FG001|Overall Study|Non-compliance with study treatment|0|||
19449303|NCT01852292|41697587|FG000|Overall Study|Study terminated by Sponsor|0|||
19449304|NCT01852292|41697588|FG001|Overall Study|Study terminated by Sponsor|1|||
19449305|NCT01852292|41697587|FG000|Overall Study|Progressive disease|42|||
19449306|NCT01852292|41697588|FG001|Overall Study|Progressive disease|52|||
19449307|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
19449308|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
19449309|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
19449310|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
19449311|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
19449312|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
19449313|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
19449314|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
19449315|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
19449316|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
19449317|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
19449318|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
19449319|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
19449320|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
19449321|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
19449322|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
19449323|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
19449324|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
19526904|NCT02658487|41972451|FG000|Overall Study|Disease progression|10|||
19526905|NCT02658487|41972451|FG000|Overall Study|Alternative therapy|1|||
19526906|NCT02658487|41972451|FG000|Overall Study|Adverse Event|1|||
19526907|NCT02658487|41972451|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
19526908|NCT02658487|41972451|FG000|Overall Study|Refractory AML|1|||
19449325|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
19449326|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
19449327|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
19449328|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
19449329|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
19449330|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
19449331|NCT01715805|41697594|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
19449332|NCT01715805|41697595|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
19449333|NCT01715805|41697596|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
19449334|NCT01715805|41697597|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
19449335|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
19449336|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
19449337|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
19449338|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
19449339|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
19449340|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
19449341|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
19449342|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
19449343|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
19449344|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
19449345|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
19449346|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
19449347|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
19449348|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
19449349|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
19449350|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
19449351|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
19449352|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
19449353|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
19449354|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
19449355|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
19449356|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
19449357|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
19449358|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
19449359|NCT01715805|41697594|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
19449360|NCT01715805|41697595|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
19449361|NCT01715805|41697596|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
19449362|NCT01715805|41697597|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
19449363|NCT01852214|41697605|FG000|Period 1|Adverse Event|1|||
19449364|NCT01852214|41697606|FG001|Period 1|Adverse Event|2|||
19449365|NCT01852214|41697605|FG000|Period 1|Withdrawal by Subject|0|||
19449366|NCT01852214|41697606|FG001|Period 1|Withdrawal by Subject|1|||
19449367|NCT01852214|41697605|FG000|Washout Period|Withdrawal by Subject|0|||
19449368|NCT01852214|41697606|FG001|Washout Period|Withdrawal by Subject|1|||
19449369|NCT01393990|41697631|FG000|Overall Study|Adverse Event|0|||
19526909|NCT02179749|41972480|FG000|Overall Study|Adverse Event|0|||
19526910|NCT02179749|41972481|FG001|Overall Study|Adverse Event|0|||
19449370|NCT01393990|41697632|FG001|Overall Study|Adverse Event|0|||
19526911|NCT02179749|41972482|FG002|Overall Study|Adverse Event|1|||
19526912|NCT02179749|41972480|FG000|Overall Study|Withdrawal by Subject|0|||
19526913|NCT02179749|41972481|FG001|Overall Study|Withdrawal by Subject|0|||
19526914|NCT02179749|41972482|FG002|Overall Study|Withdrawal by Subject|1|||
19526915|NCT02075593|41972493|FG000|Overall Study|Withdrawal by Subject|1|||
19526916|NCT00700882|41972526|FG000|Overall Study|Never received treatment|6|||
19526917|NCT00700882|41972526|FG000|Overall Study|Ineligible|2|||
19526918|NCT00700882|41972526|FG000|Overall Study|No KIT mutation|51|||
19526919|NCT00641186|41972530|FG000|Overall Study|Adverse Event|3|||
19526920|NCT01595009|41972536|FG000|Core|Patients completed per protocol|85|||
19526921|NCT01595009|41972537|FG001|Core|Patients completed per protocol|44|||
19526922|NCT01595009|41972538|FG002|Core|Patients completed per protocol|0|||
19526923|NCT01595009|41972539|FG003|Core|Patients completed per protocol|0|||
19526924|NCT01595009|41972536|FG000|Core|Adverse Event|19|||
19526925|NCT01595009|41972537|FG001|Core|Adverse Event|23|||
19526926|NCT01595009|41972538|FG002|Core|Adverse Event|0|||
19526927|NCT01595009|41972539|FG003|Core|Adverse Event|0|||
19526928|NCT01595009|41972536|FG000|Core|Disease progression|14|||
19526929|NCT01595009|41972537|FG001|Core|Disease progression|26|||
19526930|NCT01595009|41972538|FG002|Core|Disease progression|0|||
19526931|NCT01595009|41972539|FG003|Core|Disease progression|0|||
19526932|NCT01595009|41972536|FG000|Core|Withdrawal by Subject|4|||
19526933|NCT01595009|41972537|FG001|Core|Withdrawal by Subject|17|||
19526934|NCT01595009|41972538|FG002|Core|Withdrawal by Subject|0|||
19526935|NCT01595009|41972539|FG003|Core|Withdrawal by Subject|0|||
19526936|NCT01595009|41972536|FG000|Core|Death|3|||
19449371|NCT01393990|41697633|FG002|Overall Study|Adverse Event|0|||
19449372|NCT01393990|41697634|FG003|Overall Study|Adverse Event|0|||
19449373|NCT01393990|41697635|FG004|Overall Study|Adverse Event|0|||
19449374|NCT01393990|41697636|FG005|Overall Study|Adverse Event|0|||
19449375|NCT01393990|41697637|FG006|Overall Study|Adverse Event|0|||
19449376|NCT01393990|41697638|FG007|Overall Study|Adverse Event|0|||
19449377|NCT01393990|41697639|FG008|Overall Study|Adverse Event|0|||
19449378|NCT01393990|41697640|FG009|Overall Study|Adverse Event|0|||
19449379|NCT01393990|41697641|FG010|Overall Study|Adverse Event|0|||
19449380|NCT01393990|41697642|FG011|Overall Study|Adverse Event|0|||
19449381|NCT01393990|41697643|FG012|Overall Study|Adverse Event|0|||
19449382|NCT01393990|41697644|FG013|Overall Study|Adverse Event|0|||
19449383|NCT01393990|41697645|FG014|Overall Study|Adverse Event|1|||
19449384|NCT01393990|41697646|FG015|Overall Study|Adverse Event|1|||
19449385|NCT01393990|41697647|FG016|Overall Study|Adverse Event|0|||
19449386|NCT01393990|41697648|FG017|Overall Study|Adverse Event|0|||
19449387|NCT01393990|41697631|FG000|Overall Study|Progressive Disease|1|||
19526937|NCT01595009|41972537|FG001|Core|Death|6|||
19526938|NCT01595009|41972538|FG002|Core|Death|0|||
19526939|NCT01595009|41972539|FG003|Core|Death|0|||
19526940|NCT01595009|41972536|FG000|Core|Lost to Follow-up|1|||
19526941|NCT01595009|41972537|FG001|Core|Lost to Follow-up|2|||
19526942|NCT01595009|41972538|FG002|Core|Lost to Follow-up|0|||
19526943|NCT01595009|41972539|FG003|Core|Lost to Follow-up|0|||
19526944|NCT01595009|41972536|FG000|Core|Protocol deviation|0|||
19449388|NCT01393990|41697632|FG001|Overall Study|Progressive Disease|0|||
19449389|NCT01393990|41697633|FG002|Overall Study|Progressive Disease|0|||
19449390|NCT01393990|41697634|FG003|Overall Study|Progressive Disease|1|||
19449391|NCT01393990|41697635|FG004|Overall Study|Progressive Disease|1|||
19449392|NCT01393990|41697636|FG005|Overall Study|Progressive Disease|1|||
19449393|NCT01393990|41697637|FG006|Overall Study|Progressive Disease|1|||
19449394|NCT01393990|41697638|FG007|Overall Study|Progressive Disease|1|||
19449395|NCT01393990|41697639|FG008|Overall Study|Progressive Disease|3|||
19449396|NCT01393990|41697640|FG009|Overall Study|Progressive Disease|1|||
19449397|NCT01393990|41697641|FG010|Overall Study|Progressive Disease|0|||
19449398|NCT01393990|41697642|FG011|Overall Study|Progressive Disease|0|||
19449399|NCT01393990|41697643|FG012|Overall Study|Progressive Disease|0|||
19449400|NCT01393990|41697644|FG013|Overall Study|Progressive Disease|1|||
19449401|NCT01393990|41697645|FG014|Overall Study|Progressive Disease|6|||
19449402|NCT01393990|41697646|FG015|Overall Study|Progressive Disease|1|||
19449403|NCT01393990|41697647|FG016|Overall Study|Progressive Disease|0|||
19449404|NCT01393990|41697648|FG017|Overall Study|Progressive Disease|0|||
19449405|NCT01393990|41697631|FG000|Overall Study|Death|0|||
19449406|NCT01393990|41697632|FG001|Overall Study|Death|0|||
19449407|NCT01393990|41697633|FG002|Overall Study|Death|0|||
19449408|NCT01393990|41697634|FG003|Overall Study|Death|0|||
19449409|NCT01393990|41697635|FG004|Overall Study|Death|1|||
19449410|NCT01393990|41697636|FG005|Overall Study|Death|0|||
19449411|NCT01393990|41697637|FG006|Overall Study|Death|0|||
19449412|NCT01393990|41697638|FG007|Overall Study|Death|0|||
19449413|NCT01393990|41697639|FG008|Overall Study|Death|0|||
19449414|NCT01393990|41697640|FG009|Overall Study|Death|0|||
19449415|NCT01393990|41697641|FG010|Overall Study|Death|0|||
19449416|NCT01393990|41697642|FG011|Overall Study|Death|0|||
19449417|NCT01393990|41697643|FG012|Overall Study|Death|0|||
19449418|NCT01393990|41697644|FG013|Overall Study|Death|1|||
19449419|NCT01393990|41697645|FG014|Overall Study|Death|1|||
19449420|NCT01393990|41697646|FG015|Overall Study|Death|0|||
19449421|NCT01393990|41697647|FG016|Overall Study|Death|0|||
19449422|NCT01393990|41697648|FG017|Overall Study|Death|0|||
19449423|NCT01393990|41697631|FG000|Overall Study|Withdrawal by Subject|0|||
19526945|NCT01595009|41972537|FG001|Core|Protocol deviation|1|||
19526946|NCT01595009|41972538|FG002|Core|Protocol deviation|0|||
19526947|NCT01595009|41972539|FG003|Core|Protocol deviation|0|||
19526948|NCT01595009|41972536|FG000|Core|Administrative problems|0|||
19629272|NCT00641056|42078807|FG001|Overall Study|Physician Decision|1|||
19449424|NCT01393990|41697632|FG001|Overall Study|Withdrawal by Subject|0|||
19449425|NCT01393990|41697633|FG002|Overall Study|Withdrawal by Subject|0|||
19449426|NCT01393990|41697634|FG003|Overall Study|Withdrawal by Subject|0|||
19449427|NCT01393990|41697635|FG004|Overall Study|Withdrawal by Subject|0|||
19449428|NCT01393990|41697636|FG005|Overall Study|Withdrawal by Subject|0|||
19449429|NCT01393990|41697637|FG006|Overall Study|Withdrawal by Subject|0|||
19449430|NCT01393990|41697638|FG007|Overall Study|Withdrawal by Subject|0|||
19449431|NCT01393990|41697639|FG008|Overall Study|Withdrawal by Subject|0|||
19449432|NCT01393990|41697640|FG009|Overall Study|Withdrawal by Subject|0|||
19449433|NCT01393990|41697641|FG010|Overall Study|Withdrawal by Subject|0|||
19449434|NCT01393990|41697642|FG011|Overall Study|Withdrawal by Subject|0|||
19449435|NCT01393990|41697643|FG012|Overall Study|Withdrawal by Subject|0|||
19526949|NCT01595009|41972537|FG001|Core|Administrative problems|1|||
19526950|NCT01595009|41972538|FG002|Core|Administrative problems|0|||
19526951|NCT01595009|41972539|FG003|Core|Administrative problems|0|||
19526952|NCT01595009|41972536|FG000|Extension|Administrative problems|0|||
19449436|NCT01393990|41697644|FG013|Overall Study|Withdrawal by Subject|0|||
19449437|NCT01393990|41697645|FG014|Overall Study|Withdrawal by Subject|1|||
19449438|NCT01393990|41697646|FG015|Overall Study|Withdrawal by Subject|1|||
19449439|NCT01393990|41697647|FG016|Overall Study|Withdrawal by Subject|0|||
19449440|NCT01393990|41697648|FG017|Overall Study|Withdrawal by Subject|0|||
19526953|NCT01595009|41972537|FG001|Extension|Administrative problems|0|||
19526954|NCT01595009|41972538|FG002|Extension|Administrative problems|0|||
19449441|NCT00210184|41697697|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
19526955|NCT01595009|41972539|FG003|Extension|Administrative problems|1|||
19526956|NCT01595009|41972536|FG000|Extension|Patients completed per protocol|0|||
19526957|NCT01595009|41972537|FG001|Extension|Patients completed per protocol|0|||
19526958|NCT01595009|41972538|FG002|Extension|Patients completed per protocol|0|||
19449442|NCT00210106|41697701|FG000|Overall Study|Death|1|||
19449443|NCT00210106|41697701|FG000|Overall Study|Protocol Violation|13|||
19449444|NCT01852058|41697709|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
19449445|NCT01852058|41697710|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449446|NCT01852058|41697711|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449447|NCT01852058|41697712|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19526959|NCT01595009|41972539|FG003|Extension|Patients completed per protocol|2|||
19526960|NCT01595009|41972536|FG000|Extension|Disease progression|0|||
19526961|NCT01595009|41972537|FG001|Extension|Disease progression|0|||
19526962|NCT01595009|41972538|FG002|Extension|Disease progression|4|||
19526963|NCT01595009|41972539|FG003|Extension|Disease progression|7|||
19526964|NCT01595009|41972536|FG000|Extension|Adverse Event|0|||
19526965|NCT01595009|41972537|FG001|Extension|Adverse Event|0|||
19526966|NCT01595009|41972538|FG002|Extension|Adverse Event|0|||
19526967|NCT01595009|41972539|FG003|Extension|Adverse Event|1|||
19526968|NCT05553808|41972556|FG000|Overall Study|Death|25|||
19526969|NCT05553808|41972557|FG001|Overall Study|Death|62|||
19526970|NCT05553808|41972556|FG000|Overall Study|Site Closed|6|||
19449448|NCT01852058|41697713|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449449|NCT01852058|41697714|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449450|NCT01852058|41697715|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449451|NCT01852058|41697716|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449452|NCT01852058|41697717|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449453|NCT01852058|41697718|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449454|NCT01852058|41697719|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449455|NCT01852058|41697720|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
19449456|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449457|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449458|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449459|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449460|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
19449461|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449462|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449463|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449464|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449465|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449466|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449467|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
19449468|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449469|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449470|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449471|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449472|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
19449473|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
19449474|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449475|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449476|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449477|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449478|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449479|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
19449480|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449481|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19526971|NCT05553808|41972557|FG001|Overall Study|Site Closed|6|||
19526972|NCT05553808|41972556|FG000|Overall Study|Lost to Follow-up|1|||
19526973|NCT05553808|41972557|FG001|Overall Study|Lost to Follow-up|0|||
19526974|NCT05553808|41972556|FG000|Overall Study|Withdrawal by Subject|3|||
19526975|NCT05553808|41972557|FG001|Overall Study|Withdrawal by Subject|2|||
19526976|NCT04997161|41972573|FG000|Overall Study|Study terminated by sponsor|3|||
19449482|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449483|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449484|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
19449485|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449486|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449487|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449488|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449489|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449490|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449491|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
19449492|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449493|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449494|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449495|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449496|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
19449497|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
19449498|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449499|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449500|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449501|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449502|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449503|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
19449504|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449505|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449506|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449507|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
19449508|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449509|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449510|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449511|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449512|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449513|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449514|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449515|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
19449516|NCT01852058|41697709|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449517|NCT01852058|41697710|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449518|NCT01852058|41697711|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449519|NCT01852058|41697712|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449520|NCT01852058|41697713|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
19449521|NCT01852058|41697714|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
19449522|NCT01852058|41697715|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449523|NCT01852058|41697716|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449524|NCT01852058|41697717|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449525|NCT01852058|41697718|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449526|NCT01852058|41697719|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449527|NCT01852058|41697720|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
19449528|NCT01852058|41697709|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449529|NCT01852058|41697710|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449530|NCT01852058|41697711|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449531|NCT01852058|41697712|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449532|NCT01852058|41697713|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449533|NCT01852058|41697714|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449534|NCT01852058|41697715|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449535|NCT01852058|41697716|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
19449536|NCT01852058|41697717|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449537|NCT01852058|41697718|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449538|NCT01852058|41697719|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19449539|NCT01852058|41697720|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
19711326|NCT03572062|42154397|FG002|Overall Study|Randomized But Not Treated|0|||
19711327|NCT03572062|42154398|FG003|Overall Study|Randomized But Not Treated|0|||
19711328|NCT03572062|42154399|FG004|Overall Study|Randomized But Not Treated|1|||
19526977|NCT04753216|41972581|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
19526978|NCT04753216|41972581|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
19526979|NCT04753216|41972581|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
19526980|NCT04530747|41972614|FG000|Overall Study|Withdrawal by Subject|1|||
19526981|NCT04530747|41972615|FG001|Overall Study|Withdrawal by Subject|0|||
19526982|NCT04493242|41972626|FG000|Overall Study|Death|10|||
19526983|NCT04493242|41972627|FG001|Overall Study|Death|14|||
19526984|NCT04493242|41972628|FG002|Overall Study|Death|16|||
19526985|NCT04493242|41972626|FG000|Overall Study|Lost to Follow-up|1|||
19526986|NCT04493242|41972627|FG001|Overall Study|Lost to Follow-up|1|||
19526987|NCT04493242|41972628|FG002|Overall Study|Lost to Follow-up|0|||
19526988|NCT04493242|41972626|FG000|Overall Study|Withdrawal by Subject|1|||
19526989|NCT04493242|41972627|FG001|Overall Study|Withdrawal by Subject|0|||
19526990|NCT04493242|41972628|FG002|Overall Study|Withdrawal by Subject|0|||
19526991|NCT04493242|41972626|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
19526992|NCT04493242|41972627|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
19526993|NCT04493242|41972628|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
19526994|NCT04493242|41972626|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
19526995|NCT04493242|41972627|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
19526996|NCT04493242|41972628|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
19526997|NCT04040751|41972649|FG000|Overall Study|Withdrawal by Subject|2|||
19526998|NCT04040751|41972650|FG001|Overall Study|Withdrawal by Subject|0|||
19526999|NCT04040751|41972651|FG002|Overall Study|Withdrawal by Subject|2|||
19527000|NCT04040751|41972652|FG003|Overall Study|Withdrawal by Subject|0|||
19527001|NCT03997916|41972662|FG000|Overall Study|Protocol Violation|35|||
19527002|NCT03596177|41972700|FG000|Single Blind Period|Withdrawal by Subject|1|||
19527003|NCT03596177|41972701|FG001|Single Blind Period|Withdrawal by Subject|1|||
19527004|NCT03596177|41972700|FG000|Single Blind Period|Other|1|||
19527005|NCT03596177|41972701|FG001|Single Blind Period|Other|0|||
19527006|NCT03596177|41972700|FG000|Double Blind Period|Withdrawal by Subject|0|||
19527007|NCT03596177|41972701|FG001|Double Blind Period|Withdrawal by Subject|1|||
19527008|NCT03596177|41972700|FG000|Double Blind Period|Other|0|||
19527009|NCT03596177|41972701|FG001|Double Blind Period|Other|4|||
19527010|NCT03596177|41972700|FG000|Double Blind Period|Death during safety follow-up|0|||
19629273|NCT00641056|42078806|FG000|Overall Study|Protocol Violation|2|||
19629274|NCT00641056|42078807|FG001|Overall Study|Protocol Violation|0|||
19629275|NCT00641056|42078806|FG000|Overall Study|Entry Criteria Not Met|3|||
19629276|NCT00641056|42078807|FG001|Overall Study|Entry Criteria Not Met|0|||
19629277|NCT00641056|42078806|FG000|Overall Study|Subject Decision|6|||
19629278|NCT00641056|42078807|FG001|Overall Study|Subject Decision|19|||
19629279|NCT00641056|42078806|FG000|Overall Study|Sponsor Decision|1|||
19629280|NCT00641056|42078807|FG001|Overall Study|Sponsor Decision|2|||
19629281|NCT00814346|42078819|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
19629282|NCT00814346|42078820|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
19629283|NCT00814346|42078819|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
19629284|NCT00814346|42078820|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
19629285|NCT00814346|42078819|FG000|Open Phase (17 Months)|Adverse Event|5|||
19629286|NCT00814346|42078820|FG001|Open Phase (17 Months)|Adverse Event|0|||
19629287|NCT00814346|42078819|FG000|Open Phase (17 Months)|Consent|2|||
19629288|NCT00814346|42078820|FG001|Open Phase (17 Months)|Consent|0|||
19629289|NCT00814346|42078819|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
19629290|NCT00814346|42078820|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
19629291|NCT00814346|42078819|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
19629292|NCT00814346|42078820|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
19629293|NCT00569374|42078839|FG000|Overall Study|Withdrawal by Subject|4|||
19629294|NCT00828464|42078843|FG000|Overall Study|Withdrawal by Subject|1|||
19629295|NCT00810602|42078847|FG000|Overall Study|Withdrawal by Subject|8|||
19629296|NCT00810602|42078848|FG001|Overall Study|Withdrawal by Subject|3|||
19629297|NCT00791700|42078856|FG000|Overall Study|Insufficient clinical response|1|||
19629298|NCT00791700|42078857|FG001|Overall Study|Insufficient clinical response|4|||
19629299|NCT00791700|42078858|FG002|Overall Study|Insufficient clinical response|1|||
19629300|NCT00791700|42078859|FG003|Overall Study|Insufficient clinical response|8|||
19629301|NCT00791700|42078856|FG000|Overall Study|No longer willing to participate|1|||
19629302|NCT00791700|42078857|FG001|Overall Study|No longer willing to participate|1|||
19629303|NCT00791700|42078858|FG002|Overall Study|No longer willing to participate|0|||
19629304|NCT00791700|42078859|FG003|Overall Study|No longer willing to participate|8|||
19629305|NCT00791700|42078856|FG000|Overall Study|Non-compliance with study treatment|0|||
19629306|NCT00791700|42078857|FG001|Overall Study|Non-compliance with study treatment|2|||
19629307|NCT00791700|42078858|FG002|Overall Study|Non-compliance with study treatment|0|||
19629308|NCT00791700|42078859|FG003|Overall Study|Non-compliance with study treatment|4|||
19629309|NCT00791700|42078856|FG000|Overall Study|Withdrawn due to pregnancy|0|||
19527011|NCT03596177|41972701|FG001|Double Blind Period|Death during safety follow-up|1|||
19527012|NCT03579459|41972711|FG000|Overall Study|Adverse Event|7|||
19711329|NCT03572062|42154400|FG005|Overall Study|Randomized But Not Treated|2|||
19711330|NCT03572062|42154401|FG006|Overall Study|Randomized But Not Treated|0|||
19711331|NCT03572062|42154402|FG007|Overall Study|Randomized But Not Treated|1|||
19527013|NCT03579459|41972712|FG001|Overall Study|Adverse Event|6|||
19527014|NCT03579459|41972713|FG002|Overall Study|Adverse Event|2|||
19527015|NCT03579459|41972714|FG003|Overall Study|Adverse Event|6|||
19527016|NCT03579459|41972711|FG000|Overall Study|Death|1|||
19527017|NCT03579459|41972712|FG001|Overall Study|Death|0|||
19527018|NCT03579459|41972713|FG002|Overall Study|Death|1|||
19527019|NCT03579459|41972714|FG003|Overall Study|Death|2|||
19527020|NCT03579459|41972711|FG000|Overall Study|Lost to Follow-up|6|||
19527021|NCT03579459|41972712|FG001|Overall Study|Lost to Follow-up|2|||
19527022|NCT03579459|41972713|FG002|Overall Study|Lost to Follow-up|4|||
19527023|NCT03579459|41972714|FG003|Overall Study|Lost to Follow-up|1|||
19527024|NCT03579459|41972711|FG000|Overall Study|Physician Decision|0|||
19527025|NCT03579459|41972712|FG001|Overall Study|Physician Decision|1|||
19527026|NCT03579459|41972713|FG002|Overall Study|Physician Decision|0|||
19527027|NCT03579459|41972714|FG003|Overall Study|Physician Decision|1|||
19527028|NCT03579459|41972711|FG000|Overall Study|Protocol Violation|1|||
19527029|NCT03579459|41972712|FG001|Overall Study|Protocol Violation|2|||
19527030|NCT03579459|41972713|FG002|Overall Study|Protocol Violation|3|||
19527031|NCT03579459|41972714|FG003|Overall Study|Protocol Violation|5|||
19527032|NCT03579459|41972711|FG000|Overall Study|Withdrawal by Subject|12|||
19527033|NCT03579459|41972712|FG001|Overall Study|Withdrawal by Subject|8|||
19527034|NCT03579459|41972713|FG002|Overall Study|Withdrawal by Subject|11|||
19527035|NCT03579459|41972714|FG003|Overall Study|Withdrawal by Subject|8|||
19527036|NCT03579459|41972711|FG000|Overall Study|Medication error without associated adverse event|2|||
19527037|NCT03579459|41972712|FG001|Overall Study|Medication error without associated adverse event|1|||
19527038|NCT03579459|41972713|FG002|Overall Study|Medication error without associated adverse event|1|||
19527039|NCT03579459|41972714|FG003|Overall Study|Medication error without associated adverse event|0|||
19527040|NCT03579459|41972711|FG000|Overall Study|Other|0|||
19527041|NCT03579459|41972712|FG001|Overall Study|Other|1|||
19527042|NCT03579459|41972713|FG002|Overall Study|Other|1|||
19527043|NCT03579459|41972714|FG003|Overall Study|Other|0|||
19527044|NCT03579459|41972711|FG000|Overall Study|Randomized not vaccinated|0|||
19527045|NCT03579459|41972712|FG001|Overall Study|Randomized not vaccinated|2|||
19527046|NCT03579459|41972713|FG002|Overall Study|Randomized not vaccinated|0|||
19527047|NCT03579459|41972714|FG003|Overall Study|Randomized not vaccinated|1|||
19527048|NCT03340766|41972727|FG000|Overall Study|Death|6|||
19527049|NCT03340766|41972728|FG001|Overall Study|Death|6|||
19527050|NCT03340766|41972729|FG002|Overall Study|Death|2|||
19527051|NCT03340766|41972727|FG000|Overall Study|Withdrawal by Subject|2|||
19527052|NCT03340766|41972728|FG001|Overall Study|Withdrawal by Subject|1|||
19527053|NCT03340766|41972729|FG002|Overall Study|Withdrawal by Subject|2|||
19527054|NCT03340766|41972727|FG000|Overall Study|Continuing Study|3|||
19527055|NCT03340766|41972728|FG001|Overall Study|Continuing Study|3|||
19527056|NCT03340766|41972729|FG002|Overall Study|Continuing Study|5|||
19527057|NCT04449276|41972760|FG000|Overall Study|Adverse Event|1|||
19527058|NCT04449276|41972761|FG001|Overall Study|Adverse Event|2|||
19527059|NCT04449276|41972762|FG002|Overall Study|Adverse Event|0|||
19527060|NCT04449276|41972763|FG003|Overall Study|Adverse Event|0|||
19527061|NCT04449276|41972764|FG004|Overall Study|Adverse Event|2|||
19527062|NCT04449276|41972765|FG005|Overall Study|Adverse Event|0|||
19527063|NCT04449276|41972766|FG006|Overall Study|Adverse Event|0|||
19527064|NCT04449276|41972767|FG007|Overall Study|Adverse Event|1|||
19527065|NCT04449276|41972760|FG000|Overall Study|Withdrawal by Subject|2|||
19527066|NCT04449276|41972761|FG001|Overall Study|Withdrawal by Subject|0|||
19527067|NCT04449276|41972762|FG002|Overall Study|Withdrawal by Subject|0|||
19527068|NCT04449276|41972763|FG003|Overall Study|Withdrawal by Subject|1|||
19527069|NCT04449276|41972764|FG004|Overall Study|Withdrawal by Subject|0|||
19527070|NCT04449276|41972765|FG005|Overall Study|Withdrawal by Subject|0|||
19629310|NCT00791700|42078857|FG001|Overall Study|Withdrawn due to pregnancy|0|||
19629311|NCT00791700|42078858|FG002|Overall Study|Withdrawn due to pregnancy|0|||
19629312|NCT00791700|42078859|FG003|Overall Study|Withdrawn due to pregnancy|1|||
19629313|NCT00791700|42078856|FG000|Overall Study|Other|0|||
19629314|NCT00791700|42078857|FG001|Overall Study|Other|1|||
19629315|NCT00791700|42078858|FG002|Overall Study|Other|0|||
19629316|NCT00791700|42078859|FG003|Overall Study|Other|1|||
19629317|NCT00791700|42078856|FG000|Overall Study|Death|0|||
19527071|NCT04449276|41972766|FG006|Overall Study|Withdrawal by Subject|0|||
19527072|NCT04449276|41972767|FG007|Overall Study|Withdrawal by Subject|0|||
19527073|NCT04449276|41972760|FG000|Overall Study|Other|0|||
19629318|NCT00791700|42078857|FG001|Overall Study|Death|0|||
19527074|NCT04449276|41972761|FG001|Overall Study|Other|2|||
19527075|NCT04449276|41972762|FG002|Overall Study|Other|3|||
19527076|NCT04449276|41972763|FG003|Overall Study|Other|2|||
19527077|NCT04449276|41972764|FG004|Overall Study|Other|0|||
19527078|NCT04449276|41972765|FG005|Overall Study|Other|0|||
19527079|NCT04449276|41972766|FG006|Overall Study|Other|0|||
19527080|NCT04449276|41972767|FG007|Overall Study|Other|1|||
19527081|NCT04391894|41972807|FG000|Overall Study|Adverse Event|1|||
19527082|NCT04391894|41972808|FG001|Overall Study|Adverse Event|1|||
19527083|NCT04391894|41972809|FG002|Overall Study|Adverse Event|1|||
19527084|NCT04391894|41972810|FG003|Overall Study|Adverse Event|1|||
19527085|NCT04391894|41972811|FG004|Overall Study|Adverse Event|1|||
19527086|NCT04391894|41972807|FG000|Overall Study|Lost to Follow-up|1|||
19527087|NCT04391894|41972808|FG001|Overall Study|Lost to Follow-up|0|||
19527088|NCT04391894|41972809|FG002|Overall Study|Lost to Follow-up|0|||
19527089|NCT04391894|41972810|FG003|Overall Study|Lost to Follow-up|0|||
19527090|NCT04391894|41972811|FG004|Overall Study|Lost to Follow-up|0|||
19527091|NCT04391894|41972807|FG000|Overall Study|Protocol Violation|0|||
19629319|NCT00791700|42078858|FG002|Overall Study|Death|0|||
19629320|NCT00791700|42078859|FG003|Overall Study|Death|1|||
19629321|NCT00791700|42078856|FG000|Overall Study|Lost to Follow-up|4|||
19711332|NCT03572062|42154403|FG008|Overall Study|Randomized But Not Treated|0|||
19711333|NCT03572062|42154404|FG009|Overall Study|Randomized But Not Treated|0|||
19711334|NCT03571516|42154426|FG000|Overall Study|Severe diarrhea|1|||
19711335|NCT03571516|42154427|FG001|Overall Study|Severe diarrhea|0|||
19711336|NCT03571516|42154426|FG000|Overall Study|Withdrawal by Subject|0|||
19711337|NCT03571516|42154427|FG001|Overall Study|Withdrawal by Subject|1|||
19711338|NCT03600376|42154435|FG000|Overall Study|Adverse Event|1|||
19711339|NCT03600376|42154436|FG001|Overall Study|Adverse Event|1|||
19711340|NCT03600376|42154435|FG000|Overall Study|Transferred to other facility|1|||
19711341|NCT03600376|42154436|FG001|Overall Study|Transferred to other facility|0|||
19711342|NCT03600376|42154435|FG000|Overall Study|Investigator Decision|0|||
19711343|NCT03600376|42154436|FG001|Overall Study|Investigator Decision|4|||
19711344|NCT03600376|42154435|FG000|Overall Study|Determined to be ineligible for study|0|||
19629322|NCT00791700|42078857|FG001|Overall Study|Lost to Follow-up|3|||
19629323|NCT00791700|42078858|FG002|Overall Study|Lost to Follow-up|4|||
19629324|NCT00791700|42078859|FG003|Overall Study|Lost to Follow-up|6|||
19629325|NCT00791700|42078856|FG000|Overall Study|Adverse Event|0|||
19629326|NCT00791700|42078857|FG001|Overall Study|Adverse Event|0|||
19629327|NCT00791700|42078858|FG002|Overall Study|Adverse Event|1|||
19629328|NCT00791700|42078859|FG003|Overall Study|Adverse Event|1|||
19629329|NCT00810368|42078882|FG000|Overall Study|Lost to Follow-up|4|||
19629330|NCT00810368|42078883|FG001|Overall Study|Lost to Follow-up|2|||
19629331|NCT00810368|42078882|FG000|Overall Study|Lack of Efficacy|2|||
19629332|NCT00810368|42078883|FG001|Overall Study|Lack of Efficacy|0|||
19629333|NCT00628108|42078893|FG000|Overall Study|Adverse Event|0|||
19629334|NCT00628108|42078894|FG001|Overall Study|Adverse Event|3|||
19629335|NCT00628108|42078893|FG000|Overall Study|Withdrawal by Subject|1|||
19629336|NCT00628108|42078894|FG001|Overall Study|Withdrawal by Subject|0|||
19629337|NCT00628030|42078902|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
19629338|NCT00628030|42078903|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
19629339|NCT00628030|42078902|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
19629340|NCT00628030|42078903|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
19629341|NCT00628030|42078902|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
19629342|NCT00628030|42078903|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
19629343|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
19629344|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
19629345|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
19629346|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
19629347|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
19629348|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
19629349|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
19711345|NCT03600376|42154436|FG001|Overall Study|Determined to be ineligible for study|1|||
19711346|NCT03599362|42154442|FG000|Overall Study|Screen Failure|3|||
19711347|NCT03598036|42154448|FG000|Overall Study|Withdrawal by Subject|1|||
19711348|NCT03598036|42154449|FG001|Overall Study|Withdrawal by Subject|0|||
19711349|NCT00082407|42154459|FG000|Overall Study|Adverse Event|20|||
19711350|NCT00082407|42154460|FG001|Overall Study|Adverse Event|0|||
19629350|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
19629351|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
19629352|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
19629353|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
19629354|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
19711351|NCT00082407|42154459|FG000|Overall Study|Protocol Violation|14|||
19711352|NCT00082407|42154460|FG001|Overall Study|Protocol Violation|12|||
19711353|NCT00082407|42154459|FG000|Overall Study|Patient Decision|13|||
19711354|NCT00082407|42154460|FG001|Overall Study|Patient Decision|6|||
19711355|NCT00082407|42154459|FG000|Overall Study|Physician Decision|5|||
19527092|NCT04391894|41972808|FG001|Overall Study|Protocol Violation|0|||
19711356|NCT00082407|42154460|FG001|Overall Study|Physician Decision|3|||
19527093|NCT04391894|41972809|FG002|Overall Study|Protocol Violation|0|||
19527094|NCT04391894|41972810|FG003|Overall Study|Protocol Violation|1|||
19527095|NCT04391894|41972811|FG004|Overall Study|Protocol Violation|0|||
19711357|NCT00082407|42154459|FG000|Overall Study|Loss of Glucose Control|2|||
19527096|NCT04391894|41972807|FG000|Overall Study|Withdrawal by Subject|2|||
19527097|NCT04391894|41972808|FG001|Overall Study|Withdrawal by Subject|0|||
19527098|NCT04391894|41972809|FG002|Overall Study|Withdrawal by Subject|3|||
19527099|NCT04391894|41972810|FG003|Overall Study|Withdrawal by Subject|0|||
19527100|NCT04391894|41972811|FG004|Overall Study|Withdrawal by Subject|1|||
19527101|NCT04391894|41972807|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
19527102|NCT04391894|41972808|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
19527103|NCT04391894|41972809|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
19527104|NCT04391894|41972810|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
19527105|NCT04391894|41972811|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
19527106|NCT04166435|41972827|FG000|Overall Study|2 patients ineligible for response|2|||
19527107|NCT03851705|41972833|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
19527108|NCT03851705|41972834|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
19527109|NCT03851705|41972835|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
19527110|NCT03851705|41972836|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
19527111|NCT03851705|41972833|FG000|Part 1: Double-Blind Period|Other reason|1|||
19527112|NCT03851705|41972834|FG001|Part 1: Double-Blind Period|Other reason|0|||
19527113|NCT03851705|41972835|FG002|Part 1: Double-Blind Period|Other reason|0|||
19527114|NCT03851705|41972836|FG003|Part 1: Double-Blind Period|Other reason|0|||
19711358|NCT00082407|42154460|FG001|Overall Study|Loss of Glucose Control|2|||
19711359|NCT00082407|42154459|FG000|Overall Study|Death|2|||
19527115|NCT03851705|41972833|FG000|Part 2: Open-Label Period|Other reason|0|||
19527116|NCT03851705|41972834|FG001|Part 2: Open-Label Period|Other reason|0|||
19527117|NCT03851705|41972835|FG002|Part 2: Open-Label Period|Other reason|0|||
19527118|NCT03851705|41972836|FG003|Part 2: Open-Label Period|Other reason|1|||
19527119|NCT03851705|41972833|FG000|Part 2: Open-Label Period|Death|0|||
19527120|NCT03851705|41972834|FG001|Part 2: Open-Label Period|Death|0|||
19527121|NCT03851705|41972835|FG002|Part 2: Open-Label Period|Death|3|||
19527122|NCT03851705|41972836|FG003|Part 2: Open-Label Period|Death|0|||
19527123|NCT03851705|41972833|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
19527124|NCT03851705|41972834|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
19527125|NCT03851705|41972835|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
19527126|NCT03851705|41972836|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
19527127|NCT03824366|41972849|FG000|Overall Study|Death|1|||
19711360|NCT00082407|42154460|FG001|Overall Study|Death|1|||
19711361|NCT00082407|42154459|FG000|Overall Study|Lost to Follow-up|0|||
19711362|NCT00082407|42154460|FG001|Overall Study|Lost to Follow-up|3|||
19711363|NCT03643432|42154468|FG000|Overall Study|Lost to Follow-up|1|||
19711364|NCT03643432|42154469|FG001|Overall Study|Lost to Follow-up|0|||
19711365|NCT03810183|42154477|FG000|Overall Study|Study terminated by Sponsor|2|||
19711366|NCT03810183|42154478|FG001|Overall Study|Study terminated by Sponsor|1|||
19711367|NCT03597022|42154488|FG000|Overall Study|Premature termination of the study|7|||
19711368|NCT03597022|42154489|FG001|Overall Study|Premature termination of the study|7|||
19711369|NCT03597022|42154490|FG002|Overall Study|Premature termination of the study|8|||
19711370|NCT03597022|42154488|FG000|Overall Study|Serious adverse event|1|||
19449540|NCT01852058|41697709|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449541|NCT01852058|41697710|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449542|NCT01852058|41697711|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449543|NCT01852058|41697712|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449544|NCT01852058|41697713|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449545|NCT01852058|41697714|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449546|NCT01852058|41697715|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449547|NCT01852058|41697716|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449548|NCT01852058|41697717|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
19449549|NCT01852058|41697718|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449550|NCT01852058|41697719|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449551|NCT01852058|41697720|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
19449552|NCT01851590|41697758|FG000|Overall Study|Withdrawal by Subject|0|||
19449553|NCT01851590|41697759|FG001|Overall Study|Withdrawal by Subject|0|||
19449554|NCT01851590|41697760|FG002|Overall Study|Withdrawal by Subject|1|||
19449555|NCT01851590|41697758|FG000|Overall Study|Adverse Event|0|||
19449556|NCT01851590|41697759|FG001|Overall Study|Adverse Event|0|||
19449557|NCT01851590|41697760|FG002|Overall Study|Adverse Event|2|||
19449558|NCT01851590|41697758|FG000|Overall Study|Lack of Efficacy|0|||
19527128|NCT03824366|41972849|FG000|Overall Study|Previously unidentified metal artifact|1|||
19527129|NCT03824366|41972849|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
19527130|NCT03824366|41972849|FG000|Overall Study|Withdrawal by Subject|1|||
19527131|NCT03810313|41972855|FG000|Overall Study|Study terminated by sponsor|164|||
19711371|NCT03597022|42154489|FG001|Overall Study|Serious adverse event|1|||
19711372|NCT03597022|42154490|FG002|Overall Study|Serious adverse event|0|||
19711373|NCT03571204|42154501|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
19711374|NCT03571204|42154502|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
19449559|NCT01851590|41697759|FG001|Overall Study|Lack of Efficacy|1|||
19449560|NCT01851590|41697760|FG002|Overall Study|Lack of Efficacy|0|||
19449561|NCT00218296|41697774|FG000|Overall Study|Lost to Follow-up|9|||
19449562|NCT00218296|41697775|FG001|Overall Study|Lost to Follow-up|7|||
19449563|NCT00218296|41697774|FG000|Overall Study|Withdrawal by Subject|36|||
19449564|NCT00218296|41697775|FG001|Overall Study|Withdrawal by Subject|47|||
19449565|NCT00218296|41697774|FG000|Overall Study|Randomized but did not enter treatment|66|||
19449566|NCT00218296|41697775|FG001|Overall Study|Randomized but did not enter treatment|67|||
19527132|NCT03810313|41972856|FG001|Overall Study|Study terminated by sponsor|159|||
19527133|NCT03810313|41972855|FG000|Overall Study|Subject decision|10|||
19527134|NCT03810313|41972856|FG001|Overall Study|Subject decision|11|||
19527135|NCT03810313|41972855|FG000|Overall Study|Lost to Follow-up|3|||
19527136|NCT03810313|41972856|FG001|Overall Study|Lost to Follow-up|3|||
19527137|NCT03810313|41972855|FG000|Overall Study|Adverse Event|2|||
19527138|NCT03810313|41972856|FG001|Overall Study|Adverse Event|1|||
19527139|NCT03810313|41972855|FG000|Overall Study|Death|2|||
19527140|NCT03810313|41972856|FG001|Overall Study|Death|1|||
19527141|NCT03810313|41972855|FG000|Overall Study|Physician Decision|0|||
19527142|NCT03810313|41972856|FG001|Overall Study|Physician Decision|1|||
19527143|NCT03802630|41972865|FG000|Overall Study|Study terminated by sponsor|130|||
19527144|NCT03802630|41972866|FG001|Overall Study|Study terminated by sponsor|134|||
19527145|NCT03802630|41972865|FG000|Overall Study|Subject decision|16|||
19527146|NCT03802630|41972866|FG001|Overall Study|Subject decision|9|||
19527147|NCT03802630|41972865|FG000|Overall Study|Adverse Event|3|||
19527148|NCT03802630|41972866|FG001|Overall Study|Adverse Event|1|||
19527149|NCT03802630|41972865|FG000|Overall Study|Lost to Follow-up|2|||
19527150|NCT03802630|41972866|FG001|Overall Study|Lost to Follow-up|2|||
19527151|NCT03802630|41972865|FG000|Overall Study|Physician Decision|2|||
19527152|NCT03802630|41972866|FG001|Overall Study|Physician Decision|0|||
19527153|NCT03802630|41972865|FG000|Overall Study|Death|0|||
19629355|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
19629356|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
19629357|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
19629358|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
19629359|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
19629360|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
19629361|NCT00591578|42078912|FG000|Double-Blind Treatment Phase|Other|4|||
19629362|NCT00591578|42078913|FG001|Double-Blind Treatment Phase|Other|9|||
19629363|NCT00591578|42078914|FG002|Double-Blind Treatment Phase|Other|4|||
19629364|NCT00591578|42078912|FG000|Open-Label Extension Phase|Adverse Event|3|||
19629365|NCT00591578|42078913|FG001|Open-Label Extension Phase|Adverse Event|5|||
19629366|NCT00591578|42078914|FG002|Open-Label Extension Phase|Adverse Event|0|||
19629367|NCT00591578|42078912|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
19629368|NCT00591578|42078913|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
19629369|NCT00591578|42078914|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
19629370|NCT00591578|42078912|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
19449567|NCT00217672|41697783|FG000|Allocation|Ineligible|2|||
19449568|NCT00217672|41697784|FG001|Allocation|Ineligible|0|||
19449569|NCT00217672|41697783|FG000|Treatment|disease progression|33|||
19449570|NCT00217672|41697784|FG001|Treatment|disease progression|4|||
19449571|NCT00217672|41697783|FG000|Treatment|Adverse Event|18|||
19449572|NCT00217672|41697784|FG001|Treatment|Adverse Event|2|||
19449573|NCT00217672|41697783|FG000|Treatment|reqd treatment not permitted by protocol|6|||
19449574|NCT00217672|41697784|FG001|Treatment|reqd treatment not permitted by protocol|0|||
19449575|NCT00217672|41697783|FG000|Treatment|Physician Decision|6|||
19449576|NCT00217672|41697784|FG001|Treatment|Physician Decision|0|||
19449577|NCT00217672|41697783|FG000|Treatment|insurance issues|1|||
19449578|NCT00217672|41697784|FG001|Treatment|insurance issues|1|||
19449579|NCT00217672|41697783|FG000|Treatment|Death|2|||
19449580|NCT00217672|41697784|FG001|Treatment|Death|0|||
19449581|NCT00217672|41697783|FG000|Treatment|secondary malignancy|1|||
19449582|NCT00217672|41697784|FG001|Treatment|secondary malignancy|0|||
19449583|NCT00217672|41697783|FG000|Follow-up|Withdrawal by Subject|4|||
19449584|NCT00217672|41697784|FG001|Follow-up|Withdrawal by Subject|0|||
19449585|NCT00217672|41697783|FG000|Follow-up|Lost to Follow-up|1|||
19449586|NCT00217672|41697784|FG001|Follow-up|Lost to Follow-up|0|||
19449587|NCT00216736|41697790|FG000|Overall Study|Lost to Follow-up|1|||
19629371|NCT00591578|42078913|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
19449588|NCT00216736|41697791|FG001|Overall Study|Lost to Follow-up|1|||
19449589|NCT01850030|41697799|FG000|Overall Study|Adverse Event|64|||
19449590|NCT01850030|41697800|FG001|Overall Study|Adverse Event|82|||
19449591|NCT01850030|41697799|FG000|Overall Study|Lack of Efficacy|3|||
19527154|NCT03802630|41972866|FG001|Overall Study|Death|2|||
19527155|NCT03775213|41972875|FG000|Overall Study|Withdrawal by Subject|51|||
19527156|NCT03775213|41972876|FG001|Overall Study|Withdrawal by Subject|53|||
19527157|NCT03775213|41972875|FG000|Overall Study|Incomplete Survey|7|||
19527158|NCT03775213|41972876|FG001|Overall Study|Incomplete Survey|7|||
19527159|NCT03710564|41972884|FG000|Overall Study|Study Terminated by Sponsor|104|||
19449592|NCT01850030|41697800|FG001|Overall Study|Lack of Efficacy|1|||
19449593|NCT01850030|41697799|FG000|Overall Study|Lost to Follow-up|5|||
19449594|NCT01850030|41697800|FG001|Overall Study|Lost to Follow-up|5|||
19449595|NCT01850030|41697799|FG000|Overall Study|Withdrawal by Subject|3|||
19449596|NCT01850030|41697800|FG001|Overall Study|Withdrawal by Subject|4|||
19449597|NCT01850030|41697799|FG000|Overall Study|Protocol Violation|24|||
19449598|NCT01850030|41697800|FG001|Overall Study|Protocol Violation|28|||
19449599|NCT01850030|41697799|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
19449600|NCT01850030|41697800|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
19449601|NCT00215644|41697808|FG000|Overall Study|Disease Progression|28|||
19449602|NCT00215644|41697809|FG001|Overall Study|Disease Progression|10|||
19449603|NCT00215644|41697808|FG000|Overall Study|Adverse Event|2|||
19449604|NCT00215644|41697809|FG001|Overall Study|Adverse Event|9|||
19449605|NCT00215644|41697808|FG000|Overall Study|Death|1|||
19449606|NCT00215644|41697809|FG001|Overall Study|Death|2|||
19449607|NCT00215644|41697808|FG000|Overall Study|Withdrawal by Subject|1|||
19449608|NCT00215644|41697809|FG001|Overall Study|Withdrawal by Subject|0|||
19449609|NCT00215644|41697808|FG000|Overall Study|Other|3|||
19449610|NCT00215644|41697809|FG001|Overall Study|Other|15|||
19449611|NCT00215644|41697808|FG000|Overall Study|Randomized but Not Treated|1|||
19449612|NCT00215644|41697809|FG001|Overall Study|Randomized but Not Treated|0|||
19449613|NCT01870401|41697817|FG000|Overall Study|Death|48|||
19449614|NCT01870401|41697818|FG001|Overall Study|Death|24|||
19449615|NCT01870401|41697817|FG000|Overall Study|Withdrawal by Subject|39|||
19449616|NCT01870401|41697818|FG001|Overall Study|Withdrawal by Subject|26|||
19449617|NCT01870401|41697817|FG000|Overall Study|Lost to Follow-up|19|||
19449618|NCT01870401|41697818|FG001|Overall Study|Lost to Follow-up|14|||
19449619|NCT01870401|41697817|FG000|Overall Study|Other|9|||
19449620|NCT01870401|41697818|FG001|Overall Study|Other|7|||
19449621|NCT01870401|41697817|FG000|Overall Study|On-going in the Study|35|||
19449622|NCT01870401|41697818|FG001|Overall Study|On-going in the Study|25|||
19449623|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
19449624|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
19449625|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
19449626|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
19449627|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
19449628|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
19449629|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
19527160|NCT03710564|41972885|FG001|Overall Study|Study Terminated by Sponsor|55|||
19527161|NCT03710564|41972884|FG000|Overall Study|Withdrawal by Subject|57|||
19527162|NCT03710564|41972885|FG001|Overall Study|Withdrawal by Subject|25|||
19527163|NCT03710564|41972884|FG000|Overall Study|Death|10|||
19527164|NCT03710564|41972885|FG001|Overall Study|Death|4|||
19527165|NCT03710564|41972884|FG000|Overall Study|Lost to Follow-up|5|||
19527166|NCT03710564|41972885|FG001|Overall Study|Lost to Follow-up|4|||
19527167|NCT03710564|41972884|FG000|Overall Study|Protocol Violation|3|||
19527168|NCT03710564|41972885|FG001|Overall Study|Protocol Violation|2|||
19527169|NCT03710564|41972884|FG000|Overall Study|Adverse Event|3|||
19527170|NCT03710564|41972885|FG001|Overall Study|Adverse Event|0|||
19527171|NCT03710564|41972884|FG000|Overall Study|Physician Decision|2|||
19527172|NCT03710564|41972885|FG001|Overall Study|Physician Decision|3|||
19527173|NCT03624127|41972895|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
19527174|NCT03624127|41972896|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
19527175|NCT03624127|41972897|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
19527176|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
19527177|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
19527178|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
19527179|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Death|0|||
19527180|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Death|1|||
19527181|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Death|0|||
19527182|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
19527183|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
19449630|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
19449631|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
19449632|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
19449633|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
19449634|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
19449635|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
19527184|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
19527185|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
19527186|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
19527187|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
19527188|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
19449636|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
19449637|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
19449638|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
19449639|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
19449640|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
19449641|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
19449642|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
19449643|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Other|3|||
19449644|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Other|0|||
19449645|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Other|2|||
19449646|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Other|2|||
19449647|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Other|7|||
19449648|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449649|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449650|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449651|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
19449652|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449653|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449654|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449655|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449656|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449657|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
19449658|NCT00213148|41697830|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
19449659|NCT00213148|41697831|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
19449660|NCT00213148|41697832|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
19449661|NCT00213148|41697833|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
19449662|NCT00213148|41697834|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
19449663|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
19449664|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
19449665|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
19449666|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
19449667|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
19449668|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
19449669|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
19449670|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
19449671|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
19449672|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
19449673|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Other|2|||
19449674|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Other|1|||
19449675|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Other|2|||
19449676|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Other|8|||
19449677|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Other|7|||
19527189|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
19527190|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
19527191|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
19527192|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
19527193|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
19527194|NCT03624127|41972895|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
19527195|NCT03624127|41972896|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
19629372|NCT00591578|42078914|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
19629373|NCT00591578|42078912|FG000|Open-Label Extension Phase|Other|1|||
19449678|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449679|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
19449680|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449681|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449682|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
19449683|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
19449684|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449685|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449686|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449687|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
19449688|NCT00213148|41697830|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
19449689|NCT00213148|41697831|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
19449690|NCT00213148|41697832|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
19449691|NCT00213148|41697833|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
19449692|NCT00213148|41697834|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
19449693|NCT00213148|41697830|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
19449694|NCT00213148|41697831|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
19449695|NCT00213148|41697832|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
19449696|NCT00213148|41697833|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
19449697|NCT00213148|41697834|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
19449698|NCT00213148|41697830|FG000|Cycle 3 (1 Month)|Other|0|||
19449699|NCT00213148|41697831|FG001|Cycle 3 (1 Month)|Other|0|||
19449700|NCT00213148|41697832|FG002|Cycle 3 (1 Month)|Other|1|||
19449701|NCT00213148|41697833|FG003|Cycle 3 (1 Month)|Other|1|||
19527196|NCT03624127|41972897|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
19449702|NCT00213148|41697834|FG004|Cycle 3 (1 Month)|Other|0|||
19449703|NCT01704261|41697856|FG000|Overall Study|Withdrawal by Subject|12|||
19449704|NCT01704261|41697857|FG001|Overall Study|Withdrawal by Subject|15|||
19449705|NCT01704261|41697856|FG000|Overall Study|Lost to Follow-up|1|||
19449706|NCT01704261|41697857|FG001|Overall Study|Lost to Follow-up|0|||
19449707|NCT01715571|41697863|FG000|Overall Study|Lost to Follow-up|8|||
19449708|NCT00212758|41697867|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
19449709|NCT00212758|41697868|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
19449710|NCT00212758|41697867|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
19449711|NCT00212758|41697868|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
19449712|NCT01824290|41697876|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
19449713|NCT01824290|41697877|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
19449714|NCT01824290|41697878|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
19449715|NCT01824290|41697879|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
19449716|NCT01824290|41697876|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
19449717|NCT01824290|41697877|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
19449718|NCT01824290|41697878|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
19449719|NCT01824290|41697879|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
19449720|NCT01824290|41697876|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
19449721|NCT01824290|41697877|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
19449722|NCT01824290|41697878|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
19449723|NCT01824290|41697879|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
19449724|NCT01824290|41697876|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
19449725|NCT01824290|41697877|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
19449726|NCT01824290|41697878|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
19449727|NCT01824290|41697879|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
19449728|NCT01824290|41697876|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
19449729|NCT01824290|41697877|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
19449730|NCT01824290|41697878|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
19449731|NCT01824290|41697879|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
19449732|NCT01824290|41697876|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
19527197|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
19527198|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
19527199|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
19527200|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
19527201|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
19527202|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
19527203|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
19527204|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
19527205|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
19527206|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
19527207|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
19527208|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
19527209|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
19527210|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
19527211|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
19527212|NCT03624127|41972895|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
19527213|NCT03624127|41972896|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
19527214|NCT03624127|41972897|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
19527215|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
19527216|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
19527217|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
19527218|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
19527219|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
19527220|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
19527221|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
19527222|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
19527223|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
19527224|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
19527225|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
19527226|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
19527227|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
19527228|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
19527229|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
19527230|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
19527231|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
19527232|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
19527233|NCT03624127|41972895|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
19527234|NCT03624127|41972896|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
19527235|NCT03624127|41972897|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
19527236|NCT03616912|41972915|FG000|Overall Study|Adverse Event|17|||
19527237|NCT03616912|41972916|FG001|Overall Study|Adverse Event|21|||
19527238|NCT03616912|41972917|FG002|Overall Study|Adverse Event|9|||
19527239|NCT03616912|41972918|FG003|Overall Study|Adverse Event|0|||
19527240|NCT03616912|41972919|FG004|Overall Study|Adverse Event|0|||
19527241|NCT03616912|41972920|FG005|Overall Study|Adverse Event|0|||
19527242|NCT03616912|41972915|FG000|Overall Study|Death|1|||
19527243|NCT03616912|41972916|FG001|Overall Study|Death|1|||
19527244|NCT03616912|41972917|FG002|Overall Study|Death|0|||
19527245|NCT03616912|41972918|FG003|Overall Study|Death|0|||
19527246|NCT03616912|41972919|FG004|Overall Study|Death|0|||
19527247|NCT03616912|41972920|FG005|Overall Study|Death|0|||
19527248|NCT03616912|41972915|FG000|Overall Study|Lack of Efficacy|13|||
19527249|NCT03616912|41972916|FG001|Overall Study|Lack of Efficacy|6|||
19527250|NCT03616912|41972917|FG002|Overall Study|Lack of Efficacy|8|||
19527251|NCT03616912|41972918|FG003|Overall Study|Lack of Efficacy|4|||
19527252|NCT03616912|41972919|FG004|Overall Study|Lack of Efficacy|5|||
19527253|NCT03616912|41972920|FG005|Overall Study|Lack of Efficacy|1|||
19527254|NCT03616912|41972915|FG000|Overall Study|Lost to Follow-up|1|||
19527255|NCT03616912|41972916|FG001|Overall Study|Lost to Follow-up|2|||
19527256|NCT03616912|41972917|FG002|Overall Study|Lost to Follow-up|3|||
19527257|NCT03616912|41972918|FG003|Overall Study|Lost to Follow-up|0|||
19527258|NCT03616912|41972919|FG004|Overall Study|Lost to Follow-up|0|||
19527259|NCT03616912|41972920|FG005|Overall Study|Lost to Follow-up|0|||
19527260|NCT03616912|41972915|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
19527261|NCT03616912|41972916|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
19527262|NCT03616912|41972917|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
19527263|NCT03616912|41972918|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
19527264|NCT03616912|41972919|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
19527265|NCT03616912|41972920|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
19527266|NCT03616912|41972915|FG000|Overall Study|Withdrawal by Subject|12|||
19527267|NCT03616912|41972916|FG001|Overall Study|Withdrawal by Subject|12|||
19527268|NCT03616912|41972917|FG002|Overall Study|Withdrawal by Subject|15|||
19527269|NCT03616912|41972918|FG003|Overall Study|Withdrawal by Subject|2|||
19527270|NCT03616912|41972919|FG004|Overall Study|Withdrawal by Subject|0|||
19527271|NCT03616912|41972920|FG005|Overall Study|Withdrawal by Subject|2|||
19527272|NCT03616912|41972915|FG000|Overall Study|Study Terminated by Sponsor|0|||
19527273|NCT03616912|41972916|FG001|Overall Study|Study Terminated by Sponsor|0|||
19527274|NCT03616912|41972917|FG002|Overall Study|Study Terminated by Sponsor|0|||
19527275|NCT03616912|41972918|FG003|Overall Study|Study Terminated by Sponsor|10|||
19527276|NCT03616912|41972919|FG004|Overall Study|Study Terminated by Sponsor|9|||
19527277|NCT03616912|41972920|FG005|Overall Study|Study Terminated by Sponsor|11|||
19527278|NCT03616912|41972915|FG000|Overall Study|Protocol Deviation|1|||
19527279|NCT03616912|41972916|FG001|Overall Study|Protocol Deviation|1|||
19527280|NCT03616912|41972917|FG002|Overall Study|Protocol Deviation|0|||
19527281|NCT03616912|41972918|FG003|Overall Study|Protocol Deviation|0|||
19527282|NCT03616912|41972919|FG004|Overall Study|Protocol Deviation|0|||
19527283|NCT03616912|41972920|FG005|Overall Study|Protocol Deviation|0|||
19527284|NCT03616912|41972915|FG000|Overall Study|Pregnancy|1|||
19527285|NCT03616912|41972916|FG001|Overall Study|Pregnancy|0|||
19527286|NCT03616912|41972917|FG002|Overall Study|Pregnancy|4|||
19527287|NCT03616912|41972918|FG003|Overall Study|Pregnancy|0|||
19527288|NCT03616912|41972919|FG004|Overall Study|Pregnancy|0|||
19449733|NCT01824290|41697877|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
19449734|NCT01824290|41697878|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
19449735|NCT01824290|41697879|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
19449736|NCT01715415|41697893|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
19449737|NCT01715415|41697894|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
19449738|NCT01715415|41697893|FG000|Double-blind Treatment|Adverse Event|3|||
19449739|NCT01715415|41697894|FG001|Double-blind Treatment|Adverse Event|0|||
19449740|NCT01715415|41697893|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
19449741|NCT01715415|41697894|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
19449742|NCT01715415|41697893|FG000|Double-blind Treatment|Other|1|||
19449743|NCT01715415|41697894|FG001|Double-blind Treatment|Other|0|||
19449744|NCT01715415|41697893|FG000|Open-label Treatment|Adverse Event|0|||
19449745|NCT01715415|41697894|FG001|Open-label Treatment|Adverse Event|1|||
19449746|NCT01715415|41697893|FG000|Open-label Treatment|Subject Noncompliant|0|||
19449747|NCT01715415|41697894|FG001|Open-label Treatment|Subject Noncompliant|1|||
19449748|NCT00211510|41697903|FG000|Overall Study|Physician Decision|3|||
19449749|NCT00211510|41697904|FG001|Overall Study|Physician Decision|1|||
19527289|NCT03616912|41972920|FG005|Overall Study|Pregnancy|0|||
19527290|NCT03616912|41972915|FG000|Overall Study|Protocol Violation|1|||
19527291|NCT03616912|41972916|FG001|Overall Study|Protocol Violation|0|||
19527292|NCT03616912|41972917|FG002|Overall Study|Protocol Violation|2|||
19527293|NCT03616912|41972918|FG003|Overall Study|Protocol Violation|0|||
19527294|NCT03616912|41972919|FG004|Overall Study|Protocol Violation|0|||
19527295|NCT03616912|41972920|FG005|Overall Study|Protocol Violation|0|||
19527296|NCT03616912|41972915|FG000|Overall Study|Physician Decision|2|||
19527297|NCT03616912|41972916|FG001|Overall Study|Physician Decision|0|||
19527298|NCT03616912|41972917|FG002|Overall Study|Physician Decision|0|||
19527299|NCT03616912|41972918|FG003|Overall Study|Physician Decision|0|||
19449750|NCT00211510|41697903|FG000|Overall Study|Withdrawal by Subject|3|||
19449751|NCT00211510|41697904|FG001|Overall Study|Withdrawal by Subject|1|||
19449752|NCT01869777|41697913|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
19449753|NCT01714947|41697917|FG000|Part B|Progressive Disease|3|||
19449754|NCT01869699|41697923|FG000|Overall Study|Withdrawal by Subject|1|||
19449755|NCT01869699|41697924|FG001|Overall Study|Withdrawal by Subject|0|||
19449756|NCT01714635|41697933|FG000|Overall Study|Discontinued|1|||
19449757|NCT01714635|41697934|FG001|Overall Study|Discontinued|0|||
19449758|NCT01714635|41697935|FG002|Overall Study|Discontinued|2|||
19449759|NCT01714635|41697933|FG000|Overall Study|Missed 6-month exam|1|||
19449760|NCT01714635|41697934|FG001|Overall Study|Missed 6-month exam|0|||
19449761|NCT01714635|41697935|FG002|Overall Study|Missed 6-month exam|0|||
19449762|NCT01849874|41697945|FG000|Overall Study|Death|34|||
19449763|NCT01849874|41697946|FG001|Overall Study|Death|16|||
19449764|NCT01849874|41697945|FG000|Overall Study|Withdrawal by Subject|4|||
19449765|NCT01849874|41697946|FG001|Overall Study|Withdrawal by Subject|8|||
19527300|NCT03616912|41972919|FG004|Overall Study|Physician Decision|1|||
19527301|NCT03616912|41972920|FG005|Overall Study|Physician Decision|0|||
19527302|NCT03616912|41972915|FG000|Overall Study|Randomized But Never Treated|0|||
19527303|NCT03616912|41972916|FG001|Overall Study|Randomized But Never Treated|2|||
19527304|NCT03616912|41972917|FG002|Overall Study|Randomized But Never Treated|0|||
19527305|NCT03616912|41972918|FG003|Overall Study|Randomized But Never Treated|0|||
19527306|NCT03616912|41972919|FG004|Overall Study|Randomized But Never Treated|0|||
19527307|NCT03616912|41972920|FG005|Overall Study|Randomized But Never Treated|0|||
19527308|NCT03499899|41972937|FG000|Overall Study|Adverse Event|2|||
19527309|NCT03499899|41972938|FG001|Overall Study|Adverse Event|3|||
19527310|NCT03499899|41972939|FG002|Overall Study|Adverse Event|3|||
19527311|NCT03499899|41972937|FG000|Overall Study|Death|0|||
19527312|NCT03499899|41972938|FG001|Overall Study|Death|0|||
19527313|NCT03499899|41972939|FG002|Overall Study|Death|1|||
19527314|NCT03499899|41972937|FG000|Overall Study|Physician Decision|3|||
19527315|NCT03499899|41972938|FG001|Overall Study|Physician Decision|6|||
19527316|NCT03499899|41972939|FG002|Overall Study|Physician Decision|6|||
19527317|NCT03499899|41972937|FG000|Overall Study|Progressive disease|15|||
19527318|NCT03499899|41972938|FG001|Overall Study|Progressive disease|23|||
19449766|NCT01849874|41697945|FG000|Overall Study|Lost to Follow-up|0|||
19449767|NCT01849874|41697946|FG001|Overall Study|Lost to Follow-up|1|||
19449768|NCT01849874|41697945|FG000|Overall Study|Randomized but Never Treated|1|||
19527319|NCT03499899|41972939|FG002|Overall Study|Progressive disease|23|||
19527320|NCT03499899|41972937|FG000|Overall Study|Patient decision|0|||
19527321|NCT03499899|41972938|FG001|Overall Study|Patient decision|1|||
19527322|NCT03499899|41972939|FG002|Overall Study|Patient decision|1|||
19527323|NCT03499899|41972937|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
19527324|NCT03499899|41972938|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
19527325|NCT03499899|41972939|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
19527326|NCT03481634|41972955|FG000|Overall Study|Withdrawal by Subject|16|||
19527327|NCT03481634|41972956|FG001|Overall Study|Withdrawal by Subject|19|||
19527328|NCT03481634|41972957|FG002|Overall Study|Withdrawal by Subject|14|||
19527329|NCT03481634|41972955|FG000|Overall Study|Protocol Violation|1|||
19527330|NCT03481634|41972956|FG001|Overall Study|Protocol Violation|0|||
19527331|NCT03481634|41972957|FG002|Overall Study|Protocol Violation|1|||
19527332|NCT03481634|41972955|FG000|Overall Study|Progressive disease|0|||
19527333|NCT03481634|41972956|FG001|Overall Study|Progressive disease|1|||
19527334|NCT03481634|41972957|FG002|Overall Study|Progressive disease|0|||
19527335|NCT03481634|41972955|FG000|Overall Study|Physician Decision|3|||
19527336|NCT03481634|41972956|FG001|Overall Study|Physician Decision|0|||
19527337|NCT03481634|41972957|FG002|Overall Study|Physician Decision|1|||
19527338|NCT03481634|41972955|FG000|Overall Study|Lost to Follow-up|3|||
19527339|NCT03481634|41972956|FG001|Overall Study|Lost to Follow-up|4|||
19527340|NCT03481634|41972957|FG002|Overall Study|Lost to Follow-up|4|||
19527341|NCT03481634|41972955|FG000|Overall Study|Death|4|||
19527342|NCT03481634|41972956|FG001|Overall Study|Death|8|||
19527343|NCT03481634|41972957|FG002|Overall Study|Death|7|||
19527344|NCT03481634|41972955|FG000|Overall Study|Adverse Event|6|||
19527345|NCT03481634|41972956|FG001|Overall Study|Adverse Event|3|||
19527346|NCT03481634|41972957|FG002|Overall Study|Adverse Event|7|||
19527347|NCT03460756|41972970|FG000|Overall Study|Adverse Event|0|||
19527348|NCT03460756|41972971|FG001|Overall Study|Adverse Event|0|||
19527349|NCT03460756|41972972|FG002|Overall Study|Adverse Event|0|||
19449769|NCT01849874|41697946|FG001|Overall Study|Randomized but Never Treated|8|||
19449770|NCT01849874|41697945|FG000|Overall Study|Ongoing|162|||
19449771|NCT01849874|41697946|FG001|Overall Study|Ongoing|69|||
19449772|NCT01713933|41697952|FG000|Overall Study|Lost to Follow-up|2|||
19527350|NCT03460756|41972973|FG003|Overall Study|Adverse Event|1|||
19449773|NCT01713933|41697952|FG000|Overall Study|Withdrawal by Subject|3|||
19527351|NCT03460756|41972970|FG000|Overall Study|Lack of Efficacy|0|||
19527352|NCT03460756|41972971|FG001|Overall Study|Lack of Efficacy|0|||
19527353|NCT03460756|41972972|FG002|Overall Study|Lack of Efficacy|0|||
19527354|NCT03460756|41972973|FG003|Overall Study|Lack of Efficacy|2|||
19527355|NCT03460756|41972970|FG000|Overall Study|Lost to Follow-up|0|||
19527356|NCT03460756|41972971|FG001|Overall Study|Lost to Follow-up|1|||
19527357|NCT03460756|41972972|FG002|Overall Study|Lost to Follow-up|2|||
19527358|NCT03460756|41972973|FG003|Overall Study|Lost to Follow-up|1|||
19527359|NCT03460756|41972970|FG000|Overall Study|Pregnancy|0|||
19527360|NCT03460756|41972971|FG001|Overall Study|Pregnancy|0|||
19527361|NCT03460756|41972972|FG002|Overall Study|Pregnancy|0|||
19527362|NCT03460756|41972973|FG003|Overall Study|Pregnancy|1|||
19527363|NCT03460756|41972970|FG000|Overall Study|Protocol Violation|0|||
19527364|NCT03460756|41972971|FG001|Overall Study|Protocol Violation|0|||
19527365|NCT03460756|41972972|FG002|Overall Study|Protocol Violation|0|||
19527366|NCT03460756|41972973|FG003|Overall Study|Protocol Violation|1|||
19527367|NCT03460756|41972970|FG000|Overall Study|Withdrawal by Subject|0|||
19527368|NCT03460756|41972971|FG001|Overall Study|Withdrawal by Subject|4|||
19527369|NCT03460756|41972972|FG002|Overall Study|Withdrawal by Subject|7|||
19527370|NCT03460756|41972973|FG003|Overall Study|Withdrawal by Subject|3|||
19449774|NCT01713933|41697952|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
19449775|NCT01868997|41697958|FG000|Overall Study|Adverse Event|2|||
19527371|NCT03373461|41972990|FG000|Part 2|Adverse Event|0|||
19527372|NCT03373461|41972991|FG001|Part 2|Adverse Event|1|||
19527373|NCT03373461|41972992|FG002|Part 2|Adverse Event|0|||
19527374|NCT03373461|41972993|FG003|Part 2|Adverse Event|0|||
19527375|NCT03373461|41972994|FG004|Part 2|Adverse Event|1|||
19527376|NCT03364751|41973045|FG000|Overall Study|Withdrawal by Subject|1|||
19527377|NCT03364751|41973046|FG001|Overall Study|Withdrawal by Subject|0|||
19527378|NCT03364751|41973047|FG002|Overall Study|Withdrawal by Subject|0|||
19527379|NCT03364751|41973048|FG003|Overall Study|Withdrawal by Subject|0|||
19527380|NCT03364751|41973045|FG000|Overall Study|Lost to Follow-up|0|||
19449776|NCT01868997|41697959|FG001|Overall Study|Adverse Event|5|||
19449777|NCT01868997|41697958|FG000|Overall Study|Lack of Efficacy|2|||
19449778|NCT01868997|41697959|FG001|Overall Study|Lack of Efficacy|0|||
19449779|NCT01868997|41697958|FG000|Overall Study|Other|3|||
19449780|NCT01868997|41697959|FG001|Overall Study|Other|1|||
19449781|NCT01875848|41697967|FG000|Overall Study|Withdrawal by Subject|2|||
19527381|NCT03364751|41973046|FG001|Overall Study|Lost to Follow-up|1|||
19527382|NCT03364751|41973047|FG002|Overall Study|Lost to Follow-up|0|||
19527383|NCT03364751|41973048|FG003|Overall Study|Lost to Follow-up|0|||
19527384|NCT03149003|41973069|FG000|Overall Study|Randomized but not treated|0|||
19527385|NCT03149003|41973070|FG001|Overall Study|Randomized but not treated|1|||
19527386|NCT03149003|41973071|FG002|Overall Study|Randomized but not treated|18|||
19527387|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
19527388|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
19527389|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
19527390|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
19527391|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
19527392|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
19527393|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
19527394|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
19449782|NCT01875848|41697968|FG001|Overall Study|Withdrawal by Subject|0|||
19449783|NCT04191382|41697977|FG000|Overall Study|Withdrawal by Subject|1|||
19449784|NCT04191382|41697978|FG001|Overall Study|Withdrawal by Subject|0|||
19449785|NCT04191382|41697979|FG002|Overall Study|Withdrawal by Subject|0|||
19449786|NCT01703091|41697989|FG000|Overall Study|Adverse Event|5|||
19527395|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
19527396|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
19527397|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
19449787|NCT01703091|41697990|FG001|Overall Study|Adverse Event|3|||
19449788|NCT01703091|41697989|FG000|Overall Study|Physician Decision|2|||
19449789|NCT01703091|41697990|FG001|Overall Study|Physician Decision|1|||
19449790|NCT01703091|41697989|FG000|Overall Study|Withdrawal by Subject|1|||
19449791|NCT01703091|41697990|FG001|Overall Study|Withdrawal by Subject|0|||
19449792|NCT01703091|41697989|FG000|Overall Study|Sponsor Decision|1|||
19449793|NCT01703091|41697990|FG001|Overall Study|Sponsor Decision|0|||
19449794|NCT01712685|41697996|FG000|Overall Study|pt declined to participate before trmt|1|||
19449795|NCT01867671|41698002|FG000|Overall Study|Adverse Event|5|||
19449796|NCT01867671|41698003|FG001|Overall Study|Adverse Event|3|||
19449797|NCT01867671|41698002|FG000|Overall Study|Anaphylaxis|0|||
19449798|NCT01867671|41698003|FG001|Overall Study|Anaphylaxis|1|||
19449799|NCT01867671|41698002|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
19449800|NCT01867671|41698003|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
19449801|NCT01867671|41698002|FG000|Overall Study|Lost to Follow-up|0|||
19449802|NCT01867671|41698003|FG001|Overall Study|Lost to Follow-up|1|||
19527398|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
19527399|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527400|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527401|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
19527402|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
19527403|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
19527404|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
19527405|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
19527406|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
19527407|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
19527408|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
19527409|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
19527410|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
19527411|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
19527412|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
19527413|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
19527414|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
19527415|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Death|0|||
19527416|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Death|1|||
19527417|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Death|0|||
19527418|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Death|0|||
19527419|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
19527420|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
19527421|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
19527422|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
19527423|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
19527424|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
19527425|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
19527426|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
19527427|NCT02990806|41973081|FG000|Stage 1 (22 Weeks)|Other|1|||
19527428|NCT02990806|41973082|FG001|Stage 1 (22 Weeks)|Other|3|||
19527429|NCT02990806|41973083|FG002|Stage 1 (22 Weeks)|Other|0|||
19527430|NCT02990806|41973084|FG003|Stage 1 (22 Weeks)|Other|0|||
19527431|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
19527432|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
19527433|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
19527434|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
19527435|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Death|1|||
19527436|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Death|0|||
19527437|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Death|0|||
19527438|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Death|0|||
19527439|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
19527440|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
19527441|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
19527442|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
19527443|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
19527444|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
19527445|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
19527446|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
19527447|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
19527448|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
19527449|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
19527450|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
19527451|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
19527452|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
19527453|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
19527454|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
19527455|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527456|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
19527457|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
19449803|NCT01867671|41698002|FG000|Overall Study|Non-compliance with Study Drug|1|||
19449804|NCT01867671|41698003|FG001|Overall Study|Non-compliance with Study Drug|2|||
19449805|NCT01867671|41698002|FG000|Overall Study|Withdrawal by Subject|21|||
19449806|NCT01867671|41698003|FG001|Overall Study|Withdrawal by Subject|21|||
19449807|NCT01702311|41698011|FG000|Overall Study|Withdrawal by Subject|3|||
19449808|NCT01702311|41698012|FG001|Overall Study|Withdrawal by Subject|2|||
19449809|NCT01702311|41698011|FG000|Overall Study|Discharge less than 24 hours|10|||
19449810|NCT01702311|41698012|FG001|Overall Study|Discharge less than 24 hours|7|||
19449811|NCT01702311|41698011|FG000|Overall Study|Physician Decision|3|||
19449812|NCT01702311|41698012|FG001|Overall Study|Physician Decision|4|||
19449813|NCT01712061|41698028|FG000|Overall Study|Adverse Event|4|||
19449814|NCT01712061|41698029|FG001|Overall Study|Adverse Event|9|||
19449815|NCT01712061|41698030|FG002|Overall Study|Adverse Event|5|||
19527458|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
19449816|NCT01712061|41698028|FG000|Overall Study|Death|0|||
19449817|NCT01712061|41698029|FG001|Overall Study|Death|0|||
19449818|NCT01712061|41698030|FG002|Overall Study|Death|1|||
19449819|NCT01712061|41698028|FG000|Overall Study|Lost to Follow-up|1|||
19449820|NCT01712061|41698029|FG001|Overall Study|Lost to Follow-up|0|||
19449821|NCT01712061|41698030|FG002|Overall Study|Lost to Follow-up|1|||
19527459|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
19527460|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
19527461|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
19527462|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
19449822|NCT01712061|41698028|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
19449823|NCT01712061|41698029|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
19449824|NCT01712061|41698030|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
19449825|NCT01712061|41698028|FG000|Overall Study|Medication Error Without Associated AE|0|||
19449826|NCT01712061|41698029|FG001|Overall Study|Medication Error Without Associated AE|1|||
19449827|NCT01712061|41698030|FG002|Overall Study|Medication Error Without Associated AE|0|||
19449828|NCT01712061|41698028|FG000|Overall Study|Withdrawal by Subject|1|||
19449829|NCT01712061|41698029|FG001|Overall Study|Withdrawal by Subject|7|||
19449830|NCT01712061|41698030|FG002|Overall Study|Withdrawal by Subject|1|||
19449831|NCT01712061|41698028|FG000|Overall Study|Other|0|||
19449832|NCT01712061|41698029|FG001|Overall Study|Other|3|||
19449833|NCT01712061|41698030|FG002|Overall Study|Other|0|||
19449834|NCT03592186|41698041|FG000|Overall Study|Withdrawal by Subject|1|||
19449835|NCT03592186|41698042|FG001|Overall Study|Withdrawal by Subject|0|||
19449836|NCT03592186|41698041|FG000|Overall Study|Lost to Follow-up|16|||
19449837|NCT03592186|41698042|FG001|Overall Study|Lost to Follow-up|11|||
19527463|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
19527464|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
19527465|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
19527466|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
19527467|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
19527468|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
19527469|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
19527470|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
19527471|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
19527472|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
19527473|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
19527474|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
19527475|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Other|3|||
19527476|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Other|0|||
19449838|NCT03598114|41698050|FG000|Overall Study|Staff turnover/left the program|3|||
19449839|NCT03598114|41698051|FG001|Overall Study|Staff turnover/left the program|39|||
19449840|NCT01711983|41698078|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
19449841|NCT01711983|41698078|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
19449842|NCT01711983|41698078|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
19449843|NCT01711983|41698078|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
19449844|NCT01874288|41698092|FG000|Overall Study|Withdrawal by Subject|1|||
19449845|NCT01874288|41698093|FG001|Overall Study|Withdrawal by Subject|0|||
19449846|NCT01874288|41698094|FG002|Overall Study|Withdrawal by Subject|2|||
19449847|NCT01874288|41698095|FG003|Overall Study|Withdrawal by Subject|1|||
19449848|NCT01874288|41698096|FG004|Overall Study|Withdrawal by Subject|1|||
19449849|NCT01874288|41698092|FG000|Overall Study|Physician Decision|0|||
19449850|NCT01874288|41698093|FG001|Overall Study|Physician Decision|0|||
19449851|NCT01874288|41698094|FG002|Overall Study|Physician Decision|0|||
19449852|NCT01874288|41698095|FG003|Overall Study|Physician Decision|1|||
19449853|NCT01874288|41698096|FG004|Overall Study|Physician Decision|0|||
19449854|NCT01874288|41698092|FG000|Overall Study|Progressive disease|2|||
19449855|NCT01874288|41698093|FG001|Overall Study|Progressive disease|0|||
19449856|NCT01874288|41698094|FG002|Overall Study|Progressive disease|3|||
19449857|NCT01874288|41698095|FG003|Overall Study|Progressive disease|5|||
19449858|NCT01874288|41698096|FG004|Overall Study|Progressive disease|1|||
19449859|NCT01874054|41698125|FG000|Overall Study|Withdrawal by Subject|3|||
19449860|NCT01874054|41698125|FG000|Overall Study|Study Termination by Sponsor|42|||
19449861|NCT01874054|41698125|FG000|Overall Study|Lost to Follow-up|5|||
19449862|NCT01874054|41698125|FG000|Overall Study|Death|5|||
19449863|NCT01873742|41698131|FG000|Overall Study|Lost to Follow-up|68|||
19449864|NCT01873742|41698132|FG001|Overall Study|Lost to Follow-up|76|||
19449865|NCT01873586|41698138|FG000|Overall Study|Lost to Follow-up|3|||
19449866|NCT01849562|41698148|FG000|Overall Study|Lost to Follow-up|1|||
19449867|NCT01849562|41698149|FG001|Overall Study|Lost to Follow-up|0|||
19449868|NCT01849562|41698150|FG002|Overall Study|Lost to Follow-up|0|||
19527477|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Other|4|||
19527478|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Other|1|||
19527479|NCT02990806|41973081|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
19527480|NCT02990806|41973082|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
19527481|NCT02990806|41973083|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
19527482|NCT02990806|41973084|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
19449869|NCT01849562|41698148|FG000|Overall Study|Non-compliance with Study Drug|1|||
19449870|NCT01849562|41698149|FG001|Overall Study|Non-compliance with Study Drug|0|||
19449871|NCT01849562|41698150|FG002|Overall Study|Non-compliance with Study Drug|0|||
19449872|NCT04027348|41698186|FG000|Overall Study|Adverse Event|2|||
19449873|NCT04196686|41698199|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
19449874|NCT04196686|41698200|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
19449875|NCT01611974|41698209|FG000|Overall Study|Death|10|||
19449876|NCT01611974|41698210|FG001|Overall Study|Death|12|||
19449877|NCT01611974|41698211|FG002|Overall Study|Death|10|||
19527483|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
19527484|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
19527485|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
19527486|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
19527487|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
19527488|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
19527489|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
19527490|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
19527491|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527492|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
19527493|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527494|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
19527495|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
19527496|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
19527497|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
19527498|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
19527499|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
19527500|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
19527501|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
19527502|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
19527503|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
19527504|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
19527505|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
19527506|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
19527507|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
19527508|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
19527509|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
19527510|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
19527511|NCT02990806|41973081|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
19527512|NCT02990806|41973082|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
19527513|NCT02990806|41973083|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
19449878|NCT01611974|41698209|FG000|Overall Study|Lost to Follow-up|0|||
19449879|NCT01611974|41698210|FG001|Overall Study|Lost to Follow-up|1|||
19449880|NCT01611974|41698211|FG002|Overall Study|Lost to Follow-up|0|||
19449881|NCT01611974|41698209|FG000|Overall Study|Physician Decision|5|||
19449882|NCT01611974|41698210|FG001|Overall Study|Physician Decision|1|||
19449883|NCT01611974|41698211|FG002|Overall Study|Physician Decision|2|||
19449884|NCT01611974|41698209|FG000|Overall Study|Withdrawal by Subject|0|||
19449885|NCT01611974|41698210|FG001|Overall Study|Withdrawal by Subject|1|||
19449886|NCT01611974|41698211|FG002|Overall Study|Withdrawal by Subject|4|||
19449887|NCT01848938|41698221|FG000|Overall Study|Lost to Follow-up|1|||
19449888|NCT01848938|41698222|FG001|Overall Study|Lost to Follow-up|1|||
19449889|NCT01871870|41698228|FG000|Overall Study|Hardware issues|7|||
19449890|NCT01871870|41698228|FG000|Overall Study|hyperglycemia|2|||
19449891|NCT01871558|41698241|FG000|Overall Study|Other reason|0|||
19449892|NCT01871558|41698242|FG001|Overall Study|Other reason|1|||
19449893|NCT01871558|41698241|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
19449894|NCT01871558|41698242|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
19449895|NCT01871558|41698241|FG000|Overall Study|Withdrawal by Subject|2|||
19449896|NCT01871558|41698242|FG001|Overall Study|Withdrawal by Subject|0|||
19449897|NCT01711359|41698251|FG000|Treatment Period|Withdrawal by Subject|18|||
19449898|NCT01711359|41698252|FG001|Treatment Period|Withdrawal by Subject|7|||
19449899|NCT01711359|41698253|FG002|Treatment Period|Withdrawal by Subject|13|||
19449900|NCT01711359|41698251|FG000|Treatment Period|Lack of Efficacy|13|||
19449901|NCT01711359|41698252|FG001|Treatment Period|Lack of Efficacy|2|||
19449902|NCT01711359|41698253|FG002|Treatment Period|Lack of Efficacy|2|||
19449903|NCT01711359|41698251|FG000|Treatment Period|Adverse Event|8|||
19629374|NCT00591578|42078913|FG001|Open-Label Extension Phase|Other|0|||
19449904|NCT01711359|41698252|FG001|Treatment Period|Adverse Event|10|||
19449905|NCT01711359|41698253|FG002|Treatment Period|Adverse Event|24|||
19449906|NCT01711359|41698251|FG000|Treatment Period|Physician Decision|4|||
19449907|NCT01711359|41698252|FG001|Treatment Period|Physician Decision|3|||
19449908|NCT01711359|41698253|FG002|Treatment Period|Physician Decision|2|||
19449909|NCT01711359|41698251|FG000|Treatment Period|Death|3|||
19449910|NCT01711359|41698252|FG001|Treatment Period|Death|0|||
19449911|NCT01711359|41698253|FG002|Treatment Period|Death|0|||
19449912|NCT01711359|41698251|FG000|Treatment Period|Entry Criteria Not Met|1|||
19449913|NCT01711359|41698252|FG001|Treatment Period|Entry Criteria Not Met|0|||
19449914|NCT01711359|41698253|FG002|Treatment Period|Entry Criteria Not Met|0|||
19449915|NCT01711359|41698251|FG000|Treatment Period|Sponsor Decision|1|||
19449916|NCT01711359|41698252|FG001|Treatment Period|Sponsor Decision|0|||
19449917|NCT01711359|41698253|FG002|Treatment Period|Sponsor Decision|0|||
19449918|NCT01711359|41698251|FG000|Treatment Period|Lost to Follow-up|1|||
19449919|NCT01711359|41698252|FG001|Treatment Period|Lost to Follow-up|1|||
19449920|NCT01711359|41698253|FG002|Treatment Period|Lost to Follow-up|1|||
19449921|NCT01711359|41698251|FG000|Treatment Period|Randomized, Not Treated|3|||
19449922|NCT01711359|41698252|FG001|Treatment Period|Randomized, Not Treated|1|||
19449923|NCT01711359|41698253|FG002|Treatment Period|Randomized, Not Treated|0|||
19449924|NCT01710657|41698280|FG000|Overall Study|Lost to Follow-up|2|||
19449925|NCT01710657|41698281|FG001|Overall Study|Lost to Follow-up|0|||
19449926|NCT01710657|41698282|FG002|Overall Study|Lost to Follow-up|1|||
19449927|NCT01710657|41698280|FG000|Overall Study|Protocol Violation|2|||
19449928|NCT01710657|41698281|FG001|Overall Study|Protocol Violation|2|||
19449929|NCT01710657|41698282|FG002|Overall Study|Protocol Violation|0|||
19449930|NCT01710657|41698280|FG000|Overall Study|Adverse Event|14|||
19449931|NCT01710657|41698281|FG001|Overall Study|Adverse Event|8|||
19449932|NCT01710657|41698282|FG002|Overall Study|Adverse Event|28|||
19449933|NCT01710657|41698280|FG000|Overall Study|Withdrawal by Subject|0|||
19449934|NCT01710657|41698281|FG001|Overall Study|Withdrawal by Subject|1|||
19449935|NCT01710657|41698282|FG002|Overall Study|Withdrawal by Subject|2|||
19449936|NCT01710657|41698280|FG000|Overall Study|Lack of Efficacy|0|||
19449937|NCT01710657|41698281|FG001|Overall Study|Lack of Efficacy|1|||
19449938|NCT01710657|41698282|FG002|Overall Study|Lack of Efficacy|1|||
19449939|NCT01701063|41698293|FG000|Overall Study|Lost to Follow-up|0|||
19449940|NCT01701063|41698294|FG001|Overall Study|Lost to Follow-up|1|||
19449941|NCT01701063|41698295|FG002|Overall Study|Lost to Follow-up|0|||
19449942|NCT01701063|41698293|FG000|Overall Study|Withdrawal by Subject|0|||
19449943|NCT01701063|41698294|FG001|Overall Study|Withdrawal by Subject|0|||
19449944|NCT01701063|41698295|FG002|Overall Study|Withdrawal by Subject|1|||
19449945|NCT01701063|41698293|FG000|Overall Study|Other|0|||
19449946|NCT01701063|41698294|FG001|Overall Study|Other|0|||
19449947|NCT01701063|41698295|FG002|Overall Study|Other|1|||
19449948|NCT01700985|41698306|FG000|Overall Study|Incarcerated|0|||
19449949|NCT01700985|41698307|FG001|Overall Study|Incarcerated|1|||
19449950|NCT01710501|41698316|FG000|Overall Study|Lost to Follow-up|2|||
19449951|NCT01710501|41698317|FG001|Overall Study|Lost to Follow-up|0|||
19449952|NCT01710501|41698318|FG002|Overall Study|Lost to Follow-up|0|||
19449953|NCT01700829|41698328|FG000|Overall Study|Withdrawal by Subject|1|||
19449954|NCT01700829|41698329|FG001|Overall Study|Withdrawal by Subject|1|||
19449955|NCT01710345|41698338|FG000|Overall Study|Adverse Event|0|||
19449956|NCT01710345|41698339|FG001|Overall Study|Adverse Event|2|||
19449957|NCT01710345|41698340|FG002|Overall Study|Adverse Event|0|||
19449958|NCT01710345|41698338|FG000|Overall Study|Lack of Efficacy|2|||
19449959|NCT01710345|41698339|FG001|Overall Study|Lack of Efficacy|3|||
19449960|NCT01710345|41698340|FG002|Overall Study|Lack of Efficacy|1|||
19449961|NCT01710345|41698338|FG000|Overall Study|Drug Dosing Error|1|||
19449962|NCT01710345|41698339|FG001|Overall Study|Drug Dosing Error|0|||
19449963|NCT01710345|41698340|FG002|Overall Study|Drug Dosing Error|0|||
19449964|NCT01710033|41698356|FG000|Stage 2|Adverse Event|0|||
19449965|NCT01710033|41698357|FG001|Stage 2|Adverse Event|0|||
19449966|NCT01710033|41698358|FG002|Stage 2|Adverse Event|0|||
19449967|NCT01710033|41698359|FG003|Stage 2|Adverse Event|0|||
19449968|NCT01710033|41698360|FG004|Stage 2|Adverse Event|1|||
19449969|NCT01822496|41698377|FG000|Overall Study|Protocol Violation|2|||
19527514|NCT02990806|41973084|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
19527515|NCT02420821|41973166|FG000|Overall Study|Lost to Follow-up|6|||
19527516|NCT02420821|41973167|FG001|Overall Study|Lost to Follow-up|6|||
19527517|NCT02420821|41973166|FG000|Overall Study|Non-compliance|0|||
19527518|NCT02420821|41973167|FG001|Overall Study|Non-compliance|2|||
19527519|NCT02420821|41973166|FG000|Overall Study|Physician Decision|6|||
19527520|NCT02420821|41973167|FG001|Overall Study|Physician Decision|2|||
19527521|NCT02420821|41973166|FG000|Overall Study|Withdrawal by Subject|32|||
19527522|NCT02420821|41973167|FG001|Overall Study|Withdrawal by Subject|25|||
19449970|NCT01822496|41698378|FG001|Overall Study|Protocol Violation|2|||
19449971|NCT01822496|41698379|FG002|Overall Study|Protocol Violation|0|||
19527523|NCT02420821|41973166|FG000|Overall Study|Death|270|||
19449972|NCT01822496|41698380|FG003|Overall Study|Protocol Violation|1|||
19449973|NCT01822496|41698377|FG000|Overall Study|Withdrawal by Subject|0|||
19449974|NCT01822496|41698378|FG001|Overall Study|Withdrawal by Subject|0|||
19449975|NCT01822496|41698379|FG002|Overall Study|Withdrawal by Subject|0|||
19527524|NCT02420821|41973167|FG001|Overall Study|Death|263|||
19527525|NCT02420821|41973166|FG000|Overall Study|Study Terminated By Sponsor|145|||
19527526|NCT02420821|41973167|FG001|Overall Study|Study Terminated By Sponsor|149|||
19527527|NCT02420821|41973166|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
19527528|NCT02420821|41973167|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
19527529|NCT02420821|41973166|FG000|Overall Study|Adverse Event|0|||
19527530|NCT02420821|41973167|FG001|Overall Study|Adverse Event|1|||
19449976|NCT01822496|41698380|FG003|Overall Study|Withdrawal by Subject|3|||
19449977|NCT01867047|41698392|FG000|Overall Study|Lost to Follow-up|3|||
19449978|NCT01867047|41698393|FG001|Overall Study|Lost to Follow-up|3|||
19449979|NCT01867047|41698392|FG000|Overall Study|Withdrawal by Subject|2|||
19449980|NCT01867047|41698393|FG001|Overall Study|Withdrawal by Subject|0|||
19449981|NCT01867047|41698392|FG000|Overall Study|Physician Decision|2|||
19449982|NCT01867047|41698393|FG001|Overall Study|Physician Decision|0|||
19527531|NCT02420821|41973166|FG000|Overall Study|Protinuria|0|||
19527532|NCT02420821|41973167|FG001|Overall Study|Protinuria|1|||
19527533|NCT02420821|41973166|FG000|Overall Study|Progressive Disease|1|||
19527534|NCT02420821|41973167|FG001|Overall Study|Progressive Disease|1|||
19527535|NCT02420821|41973166|FG000|Overall Study|Disease Progression|0|||
19527536|NCT02420821|41973167|FG001|Overall Study|Disease Progression|1|||
19527537|NCT02420821|41973166|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
19527538|NCT02420821|41973167|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
19527539|NCT02066181|41973185|FG000|Overall Study|Withdrawal by Subject|1|||
19527540|NCT02066181|41973186|FG001|Overall Study|Withdrawal by Subject|1|||
19527541|NCT02059265|41973195|FG000|Overall Study|Ineligible|4|||
19527542|NCT02039063|41973203|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
19527543|NCT02039063|41973204|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
19527544|NCT02039063|41973205|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
19527545|NCT02039063|41973206|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
19527546|NCT02039063|41973203|FG000|Treatment Phase|Progression of disease|0|||
19527547|NCT02039063|41973204|FG001|Treatment Phase|Progression of disease|0|||
19527548|NCT02039063|41973205|FG002|Treatment Phase|Progression of disease|1|||
19527549|NCT02039063|41973206|FG003|Treatment Phase|Progression of disease|1|||
19527550|NCT02039063|41973203|FG000|Extension Phase|Inadequate therapeutic effect|0|||
19527551|NCT02039063|41973204|FG001|Extension Phase|Inadequate therapeutic effect|1|||
19527552|NCT02039063|41973205|FG002|Extension Phase|Inadequate therapeutic effect|2|||
19527553|NCT02039063|41973206|FG003|Extension Phase|Inadequate therapeutic effect|0|||
19527554|NCT02039063|41973203|FG000|Extension Phase|Progression of disease|0|||
19527555|NCT02039063|41973204|FG001|Extension Phase|Progression of disease|0|||
19527556|NCT02039063|41973205|FG002|Extension Phase|Progression of disease|0|||
19527557|NCT02039063|41973206|FG003|Extension Phase|Progression of disease|1|||
19527558|NCT02039063|41973203|FG000|Extension Phase|Adverse Event|0|||
19527559|NCT02039063|41973204|FG001|Extension Phase|Adverse Event|0|||
19527560|NCT02039063|41973205|FG002|Extension Phase|Adverse Event|1|||
19527561|NCT02039063|41973206|FG003|Extension Phase|Adverse Event|0|||
19527562|NCT01746173|41973227|FG000|Overall Study|Disease Progression|2|||
19629375|NCT00591578|42078914|FG002|Open-Label Extension Phase|Other|0|||
19629376|NCT00797862|42078926|FG000|Overall Study|Adverse Event|86|||
19629377|NCT00797862|42078927|FG001|Overall Study|Adverse Event|44|||
19629378|NCT00797862|42078928|FG002|Overall Study|Adverse Event|58|||
19629379|NCT00797862|42078926|FG000|Overall Study|Abnormal Test Procedure Result|0|||
19629380|NCT00797862|42078927|FG001|Overall Study|Abnormal Test Procedure Result|1|||
19449983|NCT01867047|41698392|FG000|Overall Study|surgery not indicated in protocol|1|||
19449984|NCT01867047|41698393|FG001|Overall Study|surgery not indicated in protocol|2|||
19527563|NCT02995733|41973267|FG000|Overall Study|Study site closed|9|||
19527564|NCT02995733|41973268|FG001|Overall Study|Study site closed|10|||
19527565|NCT02995733|41973267|FG000|Overall Study|Death|3|||
19527566|NCT02995733|41973268|FG001|Overall Study|Death|4|||
19527567|NCT02995733|41973267|FG000|Overall Study|Withdrawal by Subject|6|||
19527568|NCT02995733|41973268|FG001|Overall Study|Withdrawal by Subject|2|||
19527569|NCT02995733|41973267|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
19527570|NCT02995733|41973268|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
19527571|NCT02995733|41973267|FG000|Overall Study|Lost to Follow-up|48|||
19527572|NCT02995733|41973268|FG001|Overall Study|Lost to Follow-up|37|||
19527573|NCT02995733|41973267|FG000|Overall Study|Other|0|||
19449985|NCT01821560|41698405|FG000|Overall Study|Lost to Follow-up|5|||
19449986|NCT01821560|41698406|FG001|Overall Study|Lost to Follow-up|5|||
19449987|NCT01821560|41698405|FG000|Overall Study|Withdrawal by Subject|1|||
19449988|NCT01821560|41698406|FG001|Overall Study|Withdrawal by Subject|1|||
19527574|NCT02995733|41973268|FG001|Overall Study|Other|1|||
19527575|NCT02815566|41973285|FG000|Overall Study|Adverse Event|1|||
19527576|NCT02815566|41973286|FG001|Overall Study|Adverse Event|1|||
19527577|NCT02815566|41973285|FG000|Overall Study|Withdrawal by Subject|1|||
19527578|NCT02815566|41973286|FG001|Overall Study|Withdrawal by Subject|0|||
19527579|NCT02815566|41973285|FG000|Overall Study|Lost to Follow-up|0|||
19629381|NCT00797862|42078928|FG002|Overall Study|Abnormal Test Procedure Result|1|||
19629382|NCT00797862|42078926|FG000|Overall Study|Lack of Efficacy|1|||
19449989|NCT01821560|41698405|FG000|Overall Study|Protocol Violation|0|||
19449990|NCT01821560|41698406|FG001|Overall Study|Protocol Violation|1|||
19449991|NCT01871402|41698414|FG000|Overall Study|Lost to Follow-up|1|||
19449992|NCT01871402|41698415|FG001|Overall Study|Lost to Follow-up|0|||
19449993|NCT01871402|41698414|FG000|Overall Study|Withdrawal by Subject|0|||
19449994|NCT01871402|41698415|FG001|Overall Study|Withdrawal by Subject|2|||
19449995|NCT01871402|41698414|FG000|Overall Study|Non-compliance|0|||
19449996|NCT01871402|41698415|FG001|Overall Study|Non-compliance|1|||
19449997|NCT01846442|41698434|FG000|Overall Study|Adverse Event|2|||
19449998|NCT01846442|41698435|FG001|Overall Study|Adverse Event|4|||
19449999|NCT01846442|41698436|FG002|Overall Study|Adverse Event|2|||
19450000|NCT01846442|41698437|FG003|Overall Study|Adverse Event|1|||
19450001|NCT01846442|41698434|FG000|Overall Study|Lost to Follow-up|0|||
19450002|NCT01846442|41698435|FG001|Overall Study|Lost to Follow-up|0|||
19450003|NCT01846442|41698436|FG002|Overall Study|Lost to Follow-up|1|||
19450004|NCT01846442|41698437|FG003|Overall Study|Lost to Follow-up|0|||
19450005|NCT01846442|41698434|FG000|Overall Study|Withdrawal by Subject|3|||
19450006|NCT01846442|41698435|FG001|Overall Study|Withdrawal by Subject|2|||
19450007|NCT01846442|41698436|FG002|Overall Study|Withdrawal by Subject|0|||
19450008|NCT01846442|41698437|FG003|Overall Study|Withdrawal by Subject|1|||
19450009|NCT01846442|41698434|FG000|Overall Study|Left the city/Lost medication|1|||
19450010|NCT01846442|41698435|FG001|Overall Study|Left the city/Lost medication|0|||
19450011|NCT01846442|41698436|FG002|Overall Study|Left the city/Lost medication|1|||
19450012|NCT01846442|41698437|FG003|Overall Study|Left the city/Lost medication|1|||
19450013|NCT01709721|41698450|FG000|Open Label Phase|Withdrawal by Subject|0|||
19450014|NCT01709721|41698451|FG001|Open Label Phase|Withdrawal by Subject|0|||
19450015|NCT01709721|41698452|FG002|Open Label Phase|Withdrawal by Subject|5|||
19450016|NCT01709721|41698450|FG000|Open Label Phase|Adverse Event|0|||
19450017|NCT01709721|41698451|FG001|Open Label Phase|Adverse Event|0|||
19450018|NCT01709721|41698452|FG002|Open Label Phase|Adverse Event|8|||
19450019|NCT01709721|41698450|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
19450020|NCT01709721|41698451|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
19450021|NCT01709721|41698452|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
19527580|NCT02815566|41973286|FG001|Overall Study|Lost to Follow-up|1|||
19527581|NCT02578680|41973295|FG000|Overall Study|Death|124|||
19527582|NCT02578680|41973296|FG001|Overall Study|Death|104|||
19527583|NCT02578680|41973295|FG000|Overall Study|Protocol Violation|1|||
19527584|NCT02578680|41973296|FG001|Overall Study|Protocol Violation|1|||
19527585|NCT02578680|41973295|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
19527586|NCT02578680|41973296|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
19527587|NCT02578680|41973295|FG000|Overall Study|Withdrawal by Subject|8|||
19527588|NCT02578680|41973296|FG001|Overall Study|Withdrawal by Subject|5|||
19527589|NCT02578680|41973295|FG000|Overall Study|Ongoing in Study|276|||
19527590|NCT02578680|41973296|FG001|Overall Study|Ongoing in Study|96|||
19527591|NCT02525783|41973302|FG000|Overall Study|Lost to Follow-up|10|||
19527592|NCT02466243|41973318|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
19527593|NCT02466243|41973319|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
19527594|NCT02466243|41973318|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
19527595|NCT02466243|41973319|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
19527596|NCT02466243|41973318|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
19527597|NCT02466243|41973319|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
19629383|NCT00797862|42078927|FG001|Overall Study|Lack of Efficacy|7|||
19629384|NCT00797862|42078928|FG002|Overall Study|Lack of Efficacy|6|||
19629385|NCT00797862|42078926|FG000|Overall Study|No longer required study medication|1|||
19527598|NCT02466243|41973318|FG000|Part B Open-label Treatment Period|Missing|2|||
19527599|NCT02466243|41973319|FG001|Part B Open-label Treatment Period|Missing|2|||
19527600|NCT02321098|41973332|FG000|12 Weeks Treament|Lost to Follow-up|1|||
19527601|NCT02321098|41973333|FG001|12 Weeks Treament|Lost to Follow-up|1|||
19629386|NCT00797862|42078927|FG001|Overall Study|No longer required study medication|0|||
19629387|NCT00797862|42078928|FG002|Overall Study|No longer required study medication|0|||
19629388|NCT00797862|42078926|FG000|Overall Study|Withdrawal by Subject|14|||
19629389|NCT00797862|42078927|FG001|Overall Study|Withdrawal by Subject|7|||
19629390|NCT00797862|42078928|FG002|Overall Study|Withdrawal by Subject|7|||
19629391|NCT00797862|42078926|FG000|Overall Study|Lost to Follow-up|11|||
19629392|NCT00797862|42078927|FG001|Overall Study|Lost to Follow-up|0|||
19450022|NCT01709721|41698450|FG000|Open Label Phase|Investigator Decision|0|||
19450023|NCT01709721|41698451|FG001|Open Label Phase|Investigator Decision|0|||
19527602|NCT02321098|41973334|FG002|12 Weeks Treament|Lost to Follow-up|0|||
19527603|NCT02321098|41973332|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
19527604|NCT02321098|41973333|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
19527605|NCT02321098|41973334|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
19527606|NCT02321098|41973332|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
19629393|NCT00797862|42078928|FG002|Overall Study|Lost to Follow-up|5|||
19450024|NCT01709721|41698452|FG002|Open Label Phase|Investigator Decision|1|||
19450025|NCT01709721|41698450|FG000|Open Label Phase|Sponsor Decision|0|||
19450026|NCT01709721|41698451|FG001|Open Label Phase|Sponsor Decision|0|||
19450027|NCT01709721|41698452|FG002|Open Label Phase|Sponsor Decision|2|||
19450028|NCT01709721|41698450|FG000|Open Label Phase|Protocol Violation|0|||
19450029|NCT01709721|41698451|FG001|Open Label Phase|Protocol Violation|0|||
19450030|NCT01709721|41698452|FG002|Open Label Phase|Protocol Violation|1|||
19450031|NCT01709721|41698450|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
19629394|NCT00797862|42078926|FG000|Overall Study|Administrative Problem|4|||
19527607|NCT02321098|41973333|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
19527608|NCT02321098|41973334|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
19527609|NCT02321098|41973332|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
19527610|NCT02321098|41973333|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
19629395|NCT00797862|42078927|FG001|Overall Study|Administrative Problem|0|||
19629396|NCT00797862|42078928|FG002|Overall Study|Administrative Problem|0|||
19629397|NCT00797862|42078926|FG000|Overall Study|Protocol Violation|4|||
19629398|NCT00797862|42078927|FG001|Overall Study|Protocol Violation|6|||
19629399|NCT00797862|42078928|FG002|Overall Study|Protocol Violation|8|||
19629400|NCT00797862|42078926|FG000|Overall Study|Mis-randomized|3|||
19629401|NCT00797862|42078927|FG001|Overall Study|Mis-randomized|3|||
19629402|NCT00797862|42078928|FG002|Overall Study|Mis-randomized|1|||
19629403|NCT00794820|42078936|FG000|Overall Study|Adverse Event|11|||
19629404|NCT00794820|42078936|FG000|Overall Study|Secondary Malignancies|2|||
19629405|NCT00794820|42078936|FG000|Overall Study|Resistant Disease|2|||
19629406|NCT00794820|42078936|FG000|Overall Study|Ineligible/Screen Failure|1|||
19629407|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
19629408|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
19629409|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
19629410|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
19527611|NCT02321098|41973334|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
19527612|NCT02213926|41973343|FG000|Overall Study|Death|59|||
19527613|NCT02213926|41973343|FG000|Overall Study|Withdrawal by Subject|10|||
19527614|NCT02213926|41973343|FG000|Overall Study|study terminated by sponsor|51|||
19527615|NCT02213926|41973343|FG000|Overall Study|Lost to Follow-up|3|||
19527616|NCT02213926|41973343|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
19527617|NCT01966731|41973347|FG000|Overall Study|Death|2|||
19527618|NCT01966731|41973347|FG000|Overall Study|Lost to Follow-up|1|||
19527619|NCT01966731|41973347|FG000|Overall Study|Physician Decision|2|||
19629411|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
19629412|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
19450032|NCT01709721|41698451|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
19450033|NCT01709721|41698452|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
19450034|NCT01709721|41698450|FG000|Open Label Phase|Inadequate Pain Control|0|||
19450035|NCT01709721|41698451|FG001|Open Label Phase|Inadequate Pain Control|0|||
19450036|NCT01709721|41698452|FG002|Open Label Phase|Inadequate Pain Control|37|||
19450037|NCT01709721|41698450|FG000|Open Label Phase|Other, Specify in text field in database|0|||
19450038|NCT01709721|41698451|FG001|Open Label Phase|Other, Specify in text field in database|0|||
19450039|NCT01709721|41698452|FG002|Open Label Phase|Other, Specify in text field in database|14|||
19450040|NCT01709721|41698450|FG000|Randomized Phase|Adverse Event|0|||
19450041|NCT01709721|41698451|FG001|Randomized Phase|Adverse Event|1|||
19450042|NCT01709721|41698452|FG002|Randomized Phase|Adverse Event|0|||
19450043|NCT01709721|41698450|FG000|Randomized Phase|Lost to Follow-up|1|||
19527620|NCT01966731|41973347|FG000|Overall Study|Follow up is not complete|600|||
19527621|NCT01966731|41973347|FG000|Overall Study|Screening Failure|29|||
19527622|NCT01966731|41973347|FG000|Overall Study|Found to be ineligible|1|||
19527623|NCT01843374|41973353|FG000|Overall Study|Death|155|||
19527624|NCT01843374|41973354|FG001|Overall Study|Death|313|||
19527625|NCT01843374|41973353|FG000|Overall Study|Withdrawal by Subject|14|||
19527626|NCT01843374|41973354|FG001|Overall Study|Withdrawal by Subject|20|||
19527627|NCT01843374|41973353|FG000|Overall Study|Withdrawing due to Other reason|20|||
19527628|NCT01843374|41973354|FG001|Overall Study|Withdrawing due to Other reason|46|||
19527629|NCT01620944|41973376|FG000|Overall Study|Early termination of Study|2|||
19527630|NCT01620944|41973377|FG001|Overall Study|Early termination of Study|1|||
19527631|NCT01627561|41973385|FG000|Overall Study|Lost to Follow-up|1|||
19527632|NCT01627561|41973386|FG001|Overall Study|Lost to Follow-up|0|||
19527633|NCT01627561|41973385|FG000|Overall Study|Withdrawal by Subject|0|||
19527634|NCT01627561|41973386|FG001|Overall Study|Withdrawal by Subject|1|||
19527635|NCT01627561|41973385|FG000|Overall Study|Migrated/moved from study area|0|||
19527636|NCT01627561|41973386|FG001|Overall Study|Migrated/moved from study area|2|||
19527637|NCT01652534|41973420|FG000|Overall Study|Lack of Efficacy|1|||
19629413|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
19527638|NCT01652534|41973421|FG001|Overall Study|Lack of Efficacy|0|||
19527639|NCT04709575|41973429|FG000|Overall Study|Withdrawal by Subject|6|||
19450044|NCT01709721|41698451|FG001|Randomized Phase|Lost to Follow-up|0|||
19450045|NCT01709721|41698452|FG002|Randomized Phase|Lost to Follow-up|0|||
19450046|NCT01709721|41698450|FG000|Randomized Phase|Inadequate Pain Control|1|||
19450047|NCT01709721|41698451|FG001|Randomized Phase|Inadequate Pain Control|2|||
19450048|NCT01709721|41698452|FG002|Randomized Phase|Inadequate Pain Control|0|||
19450049|NCT01709721|41698450|FG000|Randomized Phase|Other, Specify text field in database|1|||
19450050|NCT01709721|41698451|FG001|Randomized Phase|Other, Specify text field in database|3|||
19450051|NCT01709721|41698452|FG002|Randomized Phase|Other, Specify text field in database|0|||
19450052|NCT01866657|41698462|FG000|Overall Study|Surgery canceled|2|||
19450053|NCT01866657|41698463|FG001|Overall Study|Surgery canceled|0|||
19450054|NCT01700205|41698471|FG000|Overall Study|Withdrawal by Subject|13|||
19450055|NCT01700205|41698472|FG001|Overall Study|Withdrawal by Subject|13|||
19450056|NCT01700205|41698471|FG000|Overall Study|Protocol Violation|2|||
19450057|NCT01700205|41698472|FG001|Overall Study|Protocol Violation|2|||
19450058|NCT01700049|41698478|FG000|Overall Study|Withdrawal by Subject|1|||
19450059|NCT01699815|41698485|FG000|Overall Study|Protocol Violation|4|||
19450060|NCT01699815|41698486|FG001|Overall Study|Protocol Violation|7|||
19450061|NCT01699815|41698485|FG000|Overall Study|record could not be located|1|||
19450062|NCT01699815|41698486|FG001|Overall Study|record could not be located|0|||
19450063|NCT01699815|41698485|FG000|Overall Study|Adverse Event|0|||
19450064|NCT01699815|41698486|FG001|Overall Study|Adverse Event|1|||
19450065|NCT01866423|41698492|FG000|Overall Study|Lack of Efficacy|3|||
19527640|NCT04709575|41973430|FG001|Overall Study|Withdrawal by Subject|2|||
19527641|NCT04709575|41973429|FG000|Overall Study|Lost to Follow-up|2|||
19527642|NCT04709575|41973430|FG001|Overall Study|Lost to Follow-up|2|||
19527643|NCT04709575|41973429|FG000|Overall Study|Adverse Event|1|||
19527644|NCT04709575|41973430|FG001|Overall Study|Adverse Event|0|||
19527645|NCT04709575|41973429|FG000|Overall Study|Protocol Violation|1|||
19527646|NCT04709575|41973430|FG001|Overall Study|Protocol Violation|1|||
19527647|NCT04450407|41973439|FG000|Overall Study|Withdrawal by Subject|10|||
19527648|NCT04450407|41973440|FG001|Overall Study|Withdrawal by Subject|1|||
19527649|NCT04450407|41973441|FG002|Overall Study|Withdrawal by Subject|4|||
19527650|NCT04450407|41973439|FG000|Overall Study|Adverse Event|0|||
19527651|NCT04450407|41973440|FG001|Overall Study|Adverse Event|0|||
19527652|NCT04450407|41973441|FG002|Overall Study|Adverse Event|1|||
19527653|NCT04450407|41973439|FG000|Overall Study|Lost to Follow-up|1|||
19527654|NCT04450407|41973440|FG001|Overall Study|Lost to Follow-up|0|||
19527655|NCT04450407|41973441|FG002|Overall Study|Lost to Follow-up|0|||
19527656|NCT04450407|41973439|FG000|Overall Study|Physician Decision|0|||
19527657|NCT04450407|41973440|FG001|Overall Study|Physician Decision|0|||
19527658|NCT04450407|41973441|FG002|Overall Study|Physician Decision|1|||
19527659|NCT04450407|41973439|FG000|Overall Study|Pregnancy|1|||
19527660|NCT04450407|41973440|FG001|Overall Study|Pregnancy|0|||
19527661|NCT04450407|41973441|FG002|Overall Study|Pregnancy|0|||
19527662|NCT04450407|41973439|FG000|Overall Study|Protocol Violation|2|||
19527663|NCT04450407|41973440|FG001|Overall Study|Protocol Violation|0|||
19527664|NCT04450407|41973441|FG002|Overall Study|Protocol Violation|0|||
19527665|NCT04450407|41973439|FG000|Overall Study|Investigational site terminated by sponsor|3|||
19527666|NCT04450407|41973440|FG001|Overall Study|Investigational site terminated by sponsor|0|||
19527667|NCT04450407|41973441|FG002|Overall Study|Investigational site terminated by sponsor|2|||
19527668|NCT04418765|41973451|FG000|Overall Study|Adverse Event|1|||
19527669|NCT04418765|41973452|FG001|Overall Study|Adverse Event|1|||
19527670|NCT04418765|41973453|FG002|Overall Study|Adverse Event|6|||
19527671|NCT04418765|41973451|FG000|Overall Study|Lack of Efficacy|1|||
19527672|NCT04418765|41973452|FG001|Overall Study|Lack of Efficacy|3|||
19527673|NCT04418765|41973453|FG002|Overall Study|Lack of Efficacy|0|||
19527674|NCT04418765|41973451|FG000|Overall Study|Protocol Violation|0|||
19527675|NCT04418765|41973452|FG001|Overall Study|Protocol Violation|1|||
19527676|NCT04418765|41973453|FG002|Overall Study|Protocol Violation|1|||
19527677|NCT04418765|41973451|FG000|Overall Study|Withdrawal by Subject|1|||
19527678|NCT04418765|41973452|FG001|Overall Study|Withdrawal by Subject|5|||
19527679|NCT04418765|41973453|FG002|Overall Study|Withdrawal by Subject|2|||
19527680|NCT04418765|41973451|FG000|Overall Study|Lost to Follow-up|0|||
19527681|NCT04418765|41973452|FG001|Overall Study|Lost to Follow-up|1|||
19527682|NCT04418765|41973453|FG002|Overall Study|Lost to Follow-up|0|||
19450066|NCT01866423|41698492|FG000|Overall Study|Sponsor Decision|1|||
19450067|NCT01846208|41698499|FG000|Overall Study|Withdrew prior to treatment|1|||
19450068|NCT01846208|41698500|FG001|Overall Study|Withdrew prior to treatment|1|||
19527683|NCT04418765|41973451|FG000|Overall Study|Other than specified|2|||
19527684|NCT04418765|41973452|FG001|Overall Study|Other than specified|0|||
19527685|NCT04418765|41973453|FG002|Overall Study|Other than specified|1|||
19527686|NCT04418765|41973451|FG000|Overall Study|Randomized but not treated|1|||
19527687|NCT04418765|41973452|FG001|Overall Study|Randomized but not treated|0|||
19527688|NCT04418765|41973453|FG002|Overall Study|Randomized but not treated|0|||
19527689|NCT04388826|41973463|FG000|Overall Study|Lost to Follow-up|3|||
19527690|NCT04388826|41973464|FG001|Overall Study|Lost to Follow-up|2|||
19527691|NCT04388826|41973463|FG000|Overall Study|Adverse Event|1|||
19450069|NCT01846208|41698501|FG002|Overall Study|Withdrew prior to treatment|1|||
19527692|NCT04388826|41973464|FG001|Overall Study|Adverse Event|0|||
19527693|NCT04218266|41973486|FG000|Overall Study|Death|1|||
19527694|NCT04218266|41973487|FG001|Overall Study|Death|2|||
19527695|NCT04218266|41973488|FG002|Overall Study|Death|3|||
19527696|NCT04218266|41973486|FG000|Overall Study|Adverse Event|13|||
19527697|NCT04218266|41973487|FG001|Overall Study|Adverse Event|14|||
19527698|NCT04218266|41973488|FG002|Overall Study|Adverse Event|11|||
19527699|NCT04218266|41973486|FG000|Overall Study|Other|7|||
19527700|NCT04218266|41973487|FG001|Overall Study|Other|5|||
19527701|NCT04218266|41973488|FG002|Overall Study|Other|14|||
19527702|NCT04218266|41973486|FG000|Overall Study|Physician Decision|1|||
19527703|NCT04218266|41973487|FG001|Overall Study|Physician Decision|3|||
19527704|NCT04218266|41973488|FG002|Overall Study|Physician Decision|2|||
19527705|NCT04218266|41973486|FG000|Overall Study|Non-compliance with study drug|0|||
19527706|NCT04218266|41973487|FG001|Overall Study|Non-compliance with study drug|0|||
19527707|NCT04218266|41973488|FG002|Overall Study|Non-compliance with study drug|1|||
19527708|NCT04218266|41973486|FG000|Overall Study|Withdrawal by Subject|1|||
19527709|NCT04218266|41973487|FG001|Overall Study|Withdrawal by Subject|3|||
19527710|NCT04218266|41973488|FG002|Overall Study|Withdrawal by Subject|1|||
19527711|NCT04218266|41973486|FG000|Overall Study|Study drug never administered|2|||
19527712|NCT04218266|41973487|FG001|Overall Study|Study drug never administered|0|||
19527713|NCT04218266|41973488|FG002|Overall Study|Study drug never administered|0|||
19527714|NCT03894904|41973510|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
19527715|NCT03894904|41973511|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
19527716|NCT03894904|41973510|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
19527717|NCT03894904|41973511|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
19527718|NCT03518086|41973528|FG000|Overall Study|Adverse Event|23|||
19527719|NCT03518086|41973529|FG001|Overall Study|Adverse Event|15|||
19527720|NCT03518086|41973530|FG002|Overall Study|Adverse Event|0|||
19527721|NCT03518086|41973531|FG003|Overall Study|Adverse Event|0|||
19629414|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
19629415|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
19629416|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
19629417|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
19629418|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
19527722|NCT03518086|41973528|FG000|Overall Study|Withdrawal by Subject|8|||
19527723|NCT03518086|41973529|FG001|Overall Study|Withdrawal by Subject|5|||
19527724|NCT03518086|41973530|FG002|Overall Study|Withdrawal by Subject|0|||
19527725|NCT03518086|41973531|FG003|Overall Study|Withdrawal by Subject|0|||
19527726|NCT03518086|41973528|FG000|Overall Study|Lack of Efficacy|5|||
19527727|NCT03518086|41973529|FG001|Overall Study|Lack of Efficacy|5|||
19527728|NCT03518086|41973530|FG002|Overall Study|Lack of Efficacy|0|||
19527729|NCT03518086|41973531|FG003|Overall Study|Lack of Efficacy|0|||
19527730|NCT03518086|41973528|FG000|Overall Study|Protocol Violation|1|||
19527731|NCT03518086|41973529|FG001|Overall Study|Protocol Violation|5|||
19527732|NCT03518086|41973530|FG002|Overall Study|Protocol Violation|0|||
19527733|NCT03518086|41973531|FG003|Overall Study|Protocol Violation|0|||
19527734|NCT03518086|41973528|FG000|Overall Study|Lost to Follow-up|0|||
19527735|NCT03518086|41973529|FG001|Overall Study|Lost to Follow-up|3|||
19527736|NCT03518086|41973530|FG002|Overall Study|Lost to Follow-up|0|||
19527737|NCT03518086|41973531|FG003|Overall Study|Lost to Follow-up|0|||
19527738|NCT03518086|41973528|FG000|Overall Study|Insufficient Diary Data|0|||
19527739|NCT03518086|41973529|FG001|Overall Study|Insufficient Diary Data|2|||
19527740|NCT03518086|41973530|FG002|Overall Study|Insufficient Diary Data|0|||
19527741|NCT03518086|41973531|FG003|Overall Study|Insufficient Diary Data|0|||
19527742|NCT03518086|41973528|FG000|Overall Study|Non- compliance to Protocol|0|||
19527743|NCT03518086|41973529|FG001|Overall Study|Non- compliance to Protocol|1|||
19527744|NCT03518086|41973530|FG002|Overall Study|Non- compliance to Protocol|0|||
19527745|NCT03518086|41973531|FG003|Overall Study|Non- compliance to Protocol|0|||
19527746|NCT03518086|41973528|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
19527747|NCT03518086|41973529|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
19527748|NCT03518086|41973530|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
19527749|NCT03518086|41973531|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
19527750|NCT03518086|41973528|FG000|Overall Study|Site Terminated by Sponsor|0|||
19527751|NCT03518086|41973529|FG001|Overall Study|Site Terminated by Sponsor|1|||
19527752|NCT03518086|41973530|FG002|Overall Study|Site Terminated by Sponsor|0|||
19527753|NCT03518086|41973531|FG003|Overall Study|Site Terminated by Sponsor|0|||
19527754|NCT03225287|41973546|FG000|Overall Study|Adverse Event|0|||
19527755|NCT03225287|41973547|FG001|Overall Study|Adverse Event|0|||
19527756|NCT03225287|41973548|FG002|Overall Study|Adverse Event|1|||
19527757|NCT03225287|41973546|FG000|Overall Study|Protocol non-compliance|0|||
19527758|NCT03225287|41973547|FG001|Overall Study|Protocol non-compliance|0|||
19527759|NCT03225287|41973548|FG002|Overall Study|Protocol non-compliance|1|||
19527760|NCT03225287|41973546|FG000|Overall Study|Subject withdraws consent|3|||
19527761|NCT03225287|41973547|FG001|Overall Study|Subject withdraws consent|0|||
19527762|NCT03225287|41973548|FG002|Overall Study|Subject withdraws consent|0|||
19527763|NCT03225287|41973546|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
19527764|NCT03225287|41973547|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
19527765|NCT03225287|41973548|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
19450070|NCT01846208|41698499|FG000|Overall Study|Dosing Symptoms|1|||
19450071|NCT01846208|41698500|FG001|Overall Study|Dosing Symptoms|2|||
19450072|NCT01846208|41698501|FG002|Overall Study|Dosing Symptoms|6|||
19450073|NCT01846208|41698499|FG000|Overall Study|Withdrawal by Subject|5|||
19450074|NCT01846208|41698500|FG001|Overall Study|Withdrawal by Subject|0|||
19450075|NCT01846208|41698501|FG002|Overall Study|Withdrawal by Subject|0|||
19450076|NCT01846208|41698499|FG000|Overall Study|Non-compliance|1|||
19450077|NCT01846208|41698500|FG001|Overall Study|Non-compliance|1|||
19450078|NCT01846208|41698501|FG002|Overall Study|Non-compliance|0|||
19450079|NCT01846208|41698499|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
19450080|NCT01846208|41698500|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
19450081|NCT01846208|41698501|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
19450082|NCT01846208|41698499|FG000|Overall Study|Refused SU OFC|0|||
19450083|NCT01846208|41698500|FG001|Overall Study|Refused SU OFC|0|||
19450084|NCT01846208|41698501|FG002|Overall Study|Refused SU OFC|1|||
19450085|NCT01845974|41698511|FG000|Overall Study|screen failure|1|||
19450086|NCT01845974|41698512|FG001|Overall Study|screen failure|0|||
19450087|NCT01865487|41698524|FG000|Overall Study|Lost to Follow-up|0|||
19527766|NCT03225287|41973546|FG000|Overall Study|Trial drug not effective|0|||
19527767|NCT03225287|41973547|FG001|Overall Study|Trial drug not effective|1|||
19527768|NCT03225287|41973548|FG002|Overall Study|Trial drug not effective|0|||
19527769|NCT03225287|41973546|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
19527770|NCT03225287|41973547|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
19527771|NCT03225287|41973548|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
19527772|NCT03225287|41973546|FG000|Overall Study|Stem cell transplantation|0|||
19527773|NCT03225287|41973547|FG001|Overall Study|Stem cell transplantation|1|||
19527774|NCT03225287|41973548|FG002|Overall Study|Stem cell transplantation|0|||
19527775|NCT03099265|41973556|FG000|Overall Study|Adverse Event|1|||
19527776|NCT02658656|41973574|FG000|Screening|Failed eligibility criteria|0|||
19527777|NCT02658656|41973575|FG001|Screening|Failed eligibility criteria|0|||
19527778|NCT02658656|41973576|FG002|Screening|Failed eligibility criteria|263|||
19527779|NCT02658656|41973574|FG000|Randomization|Withdrawal by Subject|8|||
19527780|NCT02658656|41973575|FG001|Randomization|Withdrawal by Subject|7|||
19527781|NCT02658656|41973576|FG002|Randomization|Withdrawal by Subject|0|||
19527782|NCT02658656|41973574|FG000|Randomization|Lost to Follow-up|1|||
19527783|NCT02658656|41973575|FG001|Randomization|Lost to Follow-up|3|||
19527784|NCT02658656|41973576|FG002|Randomization|Lost to Follow-up|0|||
19527785|NCT02658656|41973574|FG000|Randomization|Adverse Event|4|||
19527786|NCT02658656|41973575|FG001|Randomization|Adverse Event|0|||
19527787|NCT02658656|41973576|FG002|Randomization|Adverse Event|0|||
19527788|NCT02658656|41973574|FG000|Randomization|Administrative Termination|3|||
19527789|NCT02658656|41973575|FG001|Randomization|Administrative Termination|1|||
19527790|NCT02658656|41973576|FG002|Randomization|Administrative Termination|0|||
19527791|NCT02658656|41973574|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
19527792|NCT02658656|41973575|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
19527793|NCT02658656|41973576|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
19527794|NCT02658656|41973574|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
19527795|NCT02658656|41973575|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
19527796|NCT02658656|41973576|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
19527797|NCT02658656|41973574|FG000|Randomization|Not eligible for Randomization|1|||
19527798|NCT02658656|41973575|FG001|Randomization|Not eligible for Randomization|0|||
19527799|NCT02658656|41973576|FG002|Randomization|Not eligible for Randomization|0|||
19527800|NCT02658656|41973574|FG000|Randomization|Protocol Violation|1|||
19527801|NCT02658656|41973575|FG001|Randomization|Protocol Violation|0|||
19527802|NCT02658656|41973576|FG002|Randomization|Protocol Violation|0|||
19527803|NCT02066636|41973623|FG000|Overall Study|Disease progression|51|||
19527804|NCT02066636|41973624|FG001|Overall Study|Disease progression|60|||
19527805|NCT02066636|41973625|FG002|Overall Study|Disease progression|700|||
19527806|NCT02066636|41973623|FG000|Overall Study|Study drug toxicity|13|||
19527807|NCT02066636|41973624|FG001|Overall Study|Study drug toxicity|2|||
19527808|NCT02066636|41973625|FG002|Overall Study|Study drug toxicity|58|||
19527809|NCT02066636|41973623|FG000|Overall Study|Death|4|||
19527810|NCT02066636|41973624|FG001|Overall Study|Death|2|||
19450088|NCT01865487|41698525|FG001|Overall Study|Lost to Follow-up|0|||
19450089|NCT01865487|41698526|FG002|Overall Study|Lost to Follow-up|0|||
19450090|NCT01865487|41698527|FG003|Overall Study|Lost to Follow-up|1|||
19450091|NCT01865487|41698528|FG004|Overall Study|Lost to Follow-up|0|||
19450092|NCT01865487|41698529|FG005|Overall Study|Lost to Follow-up|0|||
19450093|NCT01865487|41698530|FG006|Overall Study|Lost to Follow-up|1|||
19450094|NCT01865487|41698531|FG007|Overall Study|Lost to Follow-up|0|||
19450095|NCT01865487|41698532|FG008|Overall Study|Lost to Follow-up|0|||
19450096|NCT01865487|41698533|FG009|Overall Study|Lost to Follow-up|0|||
19629419|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
19629420|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
19629421|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
19629422|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
19450097|NCT01865487|41698524|FG000|Overall Study|Withdrawal by Subject|0|||
19450098|NCT01865487|41698525|FG001|Overall Study|Withdrawal by Subject|0|||
19450099|NCT01865487|41698526|FG002|Overall Study|Withdrawal by Subject|0|||
19450100|NCT01865487|41698527|FG003|Overall Study|Withdrawal by Subject|0|||
19450101|NCT01865487|41698528|FG004|Overall Study|Withdrawal by Subject|1|||
19450102|NCT01865487|41698529|FG005|Overall Study|Withdrawal by Subject|0|||
19450103|NCT01865487|41698530|FG006|Overall Study|Withdrawal by Subject|0|||
19450104|NCT01865487|41698531|FG007|Overall Study|Withdrawal by Subject|0|||
19450105|NCT01865487|41698532|FG008|Overall Study|Withdrawal by Subject|0|||
19450106|NCT01865487|41698533|FG009|Overall Study|Withdrawal by Subject|0|||
19450107|NCT01699503|41698563|FG000|Overall Study|Death|31|||
19450108|NCT01699503|41698564|FG001|Overall Study|Death|40|||
19450109|NCT01699503|41698563|FG000|Overall Study|Withdrawal by Subject|65|||
19450110|NCT01699503|41698564|FG001|Overall Study|Withdrawal by Subject|57|||
19450111|NCT01699503|41698563|FG000|Overall Study|Lost to Follow-up|121|||
19450112|NCT01699503|41698564|FG001|Overall Study|Lost to Follow-up|117|||
19450113|NCT01699503|41698563|FG000|Overall Study|Excluded due to quality|783|||
19450114|NCT01699503|41698564|FG001|Overall Study|Excluded due to quality|791|||
19450115|NCT01709409|41698572|FG000|Overall Study|Protocol Violation|1|||
19450116|NCT01709409|41698573|FG001|Overall Study|Protocol Violation|0|||
19450117|NCT01698879|41698582|FG000|Overall Study|Withdrawal by Subject|1|||
19450118|NCT01698879|41698583|FG001|Overall Study|Withdrawal by Subject|0|||
19450119|NCT01698879|41698584|FG002|Overall Study|Withdrawal by Subject|0|||
19450120|NCT01698801|41698623|FG000|Treatment Phase|Adverse Event|4|||
19450121|NCT01698801|41698623|FG000|Treatment Phase|Protocol Violation|1|||
19450122|NCT01698801|41698623|FG000|Treatment Phase|Other|4|||
19450123|NCT01698801|41698623|FG000|Treatment Phase|Withdrawal by Subject|1|||
19450124|NCT01698801|41698623|FG000|Treatment Phase|Disease progression|1|||
19450125|NCT01698801|41698623|FG000|Follow Up Phase|Withdrawal by Subject|1|||
19450126|NCT01698801|41698623|FG000|Follow Up Phase|Death|4|||
19450127|NCT01682811|41698635|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450128|NCT01682811|41698636|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450129|NCT01682811|41698637|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450130|NCT01682811|41698638|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450131|NCT01682811|41698639|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
19450132|NCT01682811|41698640|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450133|NCT01682811|41698641|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
19450134|NCT01682811|41698635|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
19450135|NCT01682811|41698636|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
19450136|NCT01682811|41698637|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
19450137|NCT01682811|41698638|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
19450138|NCT01682811|41698639|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
19450139|NCT01682811|41698640|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
19450140|NCT01682811|41698641|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
19450141|NCT01682811|41698635|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450142|NCT01682811|41698636|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450143|NCT01682811|41698637|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450144|NCT01682811|41698638|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450145|NCT01682811|41698639|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
19527811|NCT02066636|41973625|FG002|Overall Study|Death|158|||
19527812|NCT02066636|41973623|FG000|Overall Study|Adverse event unrelated to study drug|6|||
19527813|NCT02066636|41973624|FG001|Overall Study|Adverse event unrelated to study drug|4|||
19527814|NCT02066636|41973625|FG002|Overall Study|Adverse event unrelated to study drug|45|||
19527815|NCT02066636|41973623|FG000|Overall Study|Participant request to discontinue treatment|12|||
19527816|NCT02066636|41973624|FG001|Overall Study|Participant request to discontinue treatment|12|||
19527817|NCT02066636|41973625|FG002|Overall Study|Participant request to discontinue treatment|70|||
19527818|NCT02066636|41973623|FG000|Overall Study|Participant withdrew consent|10|||
19450146|NCT01682811|41698640|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450147|NCT01682811|41698641|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
19450148|NCT01682811|41698635|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450149|NCT01682811|41698636|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450150|NCT01682811|41698637|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450151|NCT01682811|41698638|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450152|NCT01682811|41698639|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450153|NCT01682811|41698640|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
19450154|NCT01682811|41698641|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
19450155|NCT01682031|41698662|FG000|Overall Study|Withdrawal by Subject|0|||
19450156|NCT01682031|41698663|FG001|Overall Study|Withdrawal by Subject|1|||
19450157|NCT01682031|41698662|FG000|Overall Study|Adverse Event|0|||
19450158|NCT01682031|41698663|FG001|Overall Study|Adverse Event|2|||
19450159|NCT01682031|41698662|FG000|Overall Study|MRI results indicate increased nodul|0|||
19450160|NCT01682031|41698663|FG001|Overall Study|MRI results indicate increased nodul|1|||
19450161|NCT01682031|41698662|FG000|Overall Study|Patient could not swallow tablets|1|||
19450162|NCT01682031|41698663|FG001|Overall Study|Patient could not swallow tablets|0|||
19450163|NCT01682031|41698662|FG000|Overall Study|Patient stopped selenium on his own|0|||
19450164|NCT01682031|41698663|FG001|Overall Study|Patient stopped selenium on his own|1|||
19450165|NCT01567527|41698684|FG000|Conversion Phase.|Protocol deviation|3|||
19450166|NCT01567527|41698685|FG001|Conversion Phase.|Protocol deviation|0|||
19450167|NCT01567527|41698686|FG002|Conversion Phase.|Protocol deviation|0|||
19450168|NCT01567527|41698687|FG003|Conversion Phase.|Protocol deviation|0|||
19450169|NCT01567527|41698688|FG004|Conversion Phase.|Protocol deviation|0|||
19450170|NCT01567527|41698684|FG000|Conversion Phase.|Met withdrawal criteria|10|||
19450171|NCT01567527|41698685|FG001|Conversion Phase.|Met withdrawal criteria|0|||
19450172|NCT01567527|41698686|FG002|Conversion Phase.|Met withdrawal criteria|0|||
19450173|NCT01567527|41698687|FG003|Conversion Phase.|Met withdrawal criteria|0|||
19450174|NCT01567527|41698688|FG004|Conversion Phase.|Met withdrawal criteria|0|||
19450175|NCT01567527|41698684|FG000|Conversion Phase.|Withdrawal by Subject|32|||
19450176|NCT01567527|41698685|FG001|Conversion Phase.|Withdrawal by Subject|0|||
19450177|NCT01567527|41698686|FG002|Conversion Phase.|Withdrawal by Subject|0|||
19450178|NCT01567527|41698687|FG003|Conversion Phase.|Withdrawal by Subject|0|||
19450179|NCT01567527|41698688|FG004|Conversion Phase.|Withdrawal by Subject|0|||
19450180|NCT01567527|41698684|FG000|Conversion Phase.|Lost to Follow-up|16|||
19450181|NCT01567527|41698685|FG001|Conversion Phase.|Lost to Follow-up|0|||
19450182|NCT01567527|41698686|FG002|Conversion Phase.|Lost to Follow-up|0|||
19450183|NCT01567527|41698687|FG003|Conversion Phase.|Lost to Follow-up|0|||
19450184|NCT01567527|41698688|FG004|Conversion Phase.|Lost to Follow-up|0|||
19450185|NCT01567527|41698684|FG000|Conversion Phase.|Lack of Efficacy|2|||
19450186|NCT01567527|41698685|FG001|Conversion Phase.|Lack of Efficacy|0|||
19450187|NCT01567527|41698686|FG002|Conversion Phase.|Lack of Efficacy|0|||
19450188|NCT01567527|41698687|FG003|Conversion Phase.|Lack of Efficacy|0|||
19450189|NCT01567527|41698688|FG004|Conversion Phase.|Lack of Efficacy|0|||
19450190|NCT01567527|41698684|FG000|Conversion Phase.|Adverse Event|33|||
19450191|NCT01567527|41698685|FG001|Conversion Phase.|Adverse Event|0|||
19450192|NCT01567527|41698686|FG002|Conversion Phase.|Adverse Event|0|||
19450193|NCT01567527|41698687|FG003|Conversion Phase.|Adverse Event|0|||
19450194|NCT01567527|41698688|FG004|Conversion Phase.|Adverse Event|0|||
19450195|NCT01567527|41698684|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
19450196|NCT01567527|41698685|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
19450197|NCT01567527|41698686|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
19450198|NCT01567527|41698687|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
19450199|NCT01567527|41698688|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
19450200|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
19450201|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
19450202|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
19450203|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
19450204|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
19450205|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
19450206|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
19527819|NCT02066636|41973624|FG001|Overall Study|Participant withdrew consent|18|||
19527820|NCT02066636|41973625|FG002|Overall Study|Participant withdrew consent|61|||
19527821|NCT02066636|41973623|FG000|Overall Study|Lost to Follow-up|0|||
19527822|NCT02066636|41973624|FG001|Overall Study|Lost to Follow-up|2|||
19527823|NCT02066636|41973625|FG002|Overall Study|Lost to Follow-up|2|||
19527824|NCT02066636|41973623|FG000|Overall Study|Maximum clinical benefit|2|||
19527825|NCT02066636|41973624|FG001|Overall Study|Maximum clinical benefit|2|||
19527826|NCT02066636|41973625|FG002|Overall Study|Maximum clinical benefit|3|||
19527827|NCT02066636|41973623|FG000|Overall Study|Poor/non-compliance|2|||
19527828|NCT02066636|41973624|FG001|Overall Study|Poor/non-compliance|1|||
19527829|NCT02066636|41973625|FG002|Overall Study|Poor/non-compliance|1|||
19527830|NCT02066636|41973623|FG000|Overall Study|Participant no loner meets study criteria|3|||
19527831|NCT02066636|41973624|FG001|Overall Study|Participant no loner meets study criteria|2|||
19527832|NCT02066636|41973625|FG002|Overall Study|Participant no loner meets study criteria|28|||
19527833|NCT02066636|41973623|FG000|Overall Study|Administrative reasons by sponsor|8|||
19450207|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
19450208|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
19450209|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
19450210|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
19527834|NCT02066636|41973624|FG001|Overall Study|Administrative reasons by sponsor|5|||
19450211|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
19450212|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
19450213|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
19450214|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
19450215|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
19450216|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
19450217|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
19450218|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
19450219|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
19450220|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
19450221|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
19450222|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
19450223|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
19450224|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
19450225|NCT01567527|41698684|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
19450226|NCT01567527|41698685|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
19450227|NCT01567527|41698686|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
19450228|NCT01567527|41698687|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
19450229|NCT01567527|41698688|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
19450230|NCT01567527|41698684|FG000|IM Depot Stabilization.|Protocol deviation|0|||
19450231|NCT01567527|41698685|FG001|IM Depot Stabilization.|Protocol deviation|0|||
19450232|NCT01567527|41698686|FG002|IM Depot Stabilization.|Protocol deviation|5|||
19450233|NCT01567527|41698687|FG003|IM Depot Stabilization.|Protocol deviation|0|||
19450234|NCT01567527|41698688|FG004|IM Depot Stabilization.|Protocol deviation|0|||
19450235|NCT01567527|41698684|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
19450236|NCT01567527|41698685|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
19450237|NCT01567527|41698686|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
19450238|NCT01567527|41698687|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
19450239|NCT01567527|41698688|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
19527835|NCT02066636|41973625|FG002|Overall Study|Administrative reasons by sponsor|0|||
19527836|NCT02066636|41973623|FG000|Overall Study|Other reasons|16|||
19527837|NCT02066636|41973624|FG001|Overall Study|Other reasons|15|||
19527838|NCT02066636|41973625|FG002|Overall Study|Other reasons|50|||
19527839|NCT01486264|41973637|FG000|Overall Study|Death|1|||
19527840|NCT01486264|41973638|FG001|Overall Study|Death|1|||
19527841|NCT01486264|41973637|FG000|Overall Study|Adverse Event|3|||
19527842|NCT01486264|41973638|FG001|Overall Study|Adverse Event|3|||
19527843|NCT01486264|41973637|FG000|Overall Study|Lack of Efficacy|6|||
19527844|NCT01486264|41973638|FG001|Overall Study|Lack of Efficacy|10|||
19527845|NCT01486264|41973637|FG000|Overall Study|Withdrawal by Subject|7|||
19527846|NCT01486264|41973638|FG001|Overall Study|Withdrawal by Subject|18|||
19527847|NCT01486264|41973637|FG000|Overall Study|Physician Decision|1|||
19527848|NCT01486264|41973638|FG001|Overall Study|Physician Decision|1|||
19527849|NCT01486264|41973637|FG000|Overall Study|Protocol Violation|3|||
19527850|NCT01486264|41973638|FG001|Overall Study|Protocol Violation|0|||
19527851|NCT01486264|41973637|FG000|Overall Study|Lost to Follow-up|3|||
19527852|NCT01486264|41973638|FG001|Overall Study|Lost to Follow-up|2|||
19527853|NCT01486264|41973637|FG000|Overall Study|Other|5|||
19527854|NCT01486264|41973638|FG001|Overall Study|Other|11|||
19527855|NCT01486264|41973637|FG000|Overall Study|Not treated|0|||
19527856|NCT01486264|41973638|FG001|Overall Study|Not treated|1|||
19527857|NCT01323270|41973646|FG000|Overall Study|Withdrawal by Subject|19|||
19527858|NCT01323270|41973647|FG001|Overall Study|Withdrawal by Subject|10|||
19527859|NCT01323270|41973646|FG000|Overall Study|Protocol Violation|9|||
19527860|NCT01323270|41973647|FG001|Overall Study|Protocol Violation|7|||
19527861|NCT01323270|41973646|FG000|Overall Study|Lost to Follow-up|4|||
19527862|NCT01323270|41973647|FG001|Overall Study|Lost to Follow-up|6|||
19527863|NCT01323270|41973646|FG000|Overall Study|Adverse Event|8|||
19527864|NCT01323270|41973647|FG001|Overall Study|Adverse Event|0|||
19527865|NCT01323270|41973646|FG000|Overall Study|Other|0|||
19450240|NCT01567527|41698684|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
19450241|NCT01567527|41698685|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
19450242|NCT01567527|41698686|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
19450243|NCT01567527|41698687|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
19450244|NCT01567527|41698688|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
19450245|NCT01567527|41698684|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
19450246|NCT01567527|41698685|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
19450247|NCT01567527|41698686|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
19450248|NCT01567527|41698687|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
19450249|NCT01567527|41698688|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
19450250|NCT01567527|41698684|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
19527866|NCT01323270|41973647|FG001|Overall Study|Other|3|||
19527867|NCT01323270|41973646|FG000|Overall Study|Physician Decision|0|||
19527868|NCT01323270|41973647|FG001|Overall Study|Physician Decision|2|||
19527869|NCT01323270|41973646|FG000|Overall Study|Not eligible|1|||
19450251|NCT01567527|41698685|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
19450252|NCT01567527|41698686|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
19450253|NCT01567527|41698687|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
19450254|NCT01567527|41698688|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
19450255|NCT01567527|41698684|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
19450256|NCT01567527|41698685|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
19450257|NCT01567527|41698686|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
19450258|NCT01567527|41698687|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
19450259|NCT01567527|41698688|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
19450260|NCT01567527|41698684|FG000|IM Depot Stabilization.|Adverse Event|0|||
19450261|NCT01567527|41698685|FG001|IM Depot Stabilization.|Adverse Event|0|||
19450262|NCT01567527|41698686|FG002|IM Depot Stabilization.|Adverse Event|37|||
19450263|NCT01567527|41698687|FG003|IM Depot Stabilization.|Adverse Event|0|||
19450264|NCT01567527|41698688|FG004|IM Depot Stabilization.|Adverse Event|0|||
19450265|NCT01567527|41698684|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
19450266|NCT01567527|41698685|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
19527870|NCT01323270|41973647|FG001|Overall Study|Not eligible|1|||
19527871|NCT01323270|41973646|FG000|Overall Study|Death|1|||
19527872|NCT01323270|41973647|FG001|Overall Study|Death|0|||
19527873|NCT01323270|41973646|FG000|Overall Study|Randomized, but not vaccinated|1|||
19527874|NCT01323270|41973647|FG001|Overall Study|Randomized, but not vaccinated|0|||
19527875|NCT01300728|41973656|FG000|Overall Study|Withdrawal by Subject|1|||
19527876|NCT01300728|41973657|FG001|Overall Study|Withdrawal by Subject|1|||
19527877|NCT01300728|41973656|FG000|Overall Study|Physician Decision|1|||
19527878|NCT01300728|41973657|FG001|Overall Study|Physician Decision|0|||
19527879|NCT01299480|41973668|FG000|Overall Study|No longer willing to participate|19|||
19527880|NCT01299480|41973669|FG001|Overall Study|No longer willing to participate|17|||
19527881|NCT01299480|41973670|FG002|Overall Study|No longer willing to participate|14|||
19527882|NCT01299480|41973671|FG003|Overall Study|No longer willing to participate|13|||
19629423|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
19629424|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
19629425|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
19629426|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
19711375|NCT03571204|42154503|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
19527883|NCT01299480|41973672|FG004|Overall Study|No longer willing to participate|10|||
19527884|NCT01299480|41973668|FG000|Overall Study|Protocol Violation|7|||
19527885|NCT01299480|41973669|FG001|Overall Study|Protocol Violation|5|||
19527886|NCT01299480|41973670|FG002|Overall Study|Protocol Violation|8|||
19527887|NCT01299480|41973671|FG003|Overall Study|Protocol Violation|1|||
19527888|NCT01299480|41973672|FG004|Overall Study|Protocol Violation|1|||
19527889|NCT01299480|41973668|FG000|Overall Study|Withdrawal by Subject|3|||
19527890|NCT01299480|41973669|FG001|Overall Study|Withdrawal by Subject|4|||
19527891|NCT01299480|41973670|FG002|Overall Study|Withdrawal by Subject|7|||
19527892|NCT01299480|41973671|FG003|Overall Study|Withdrawal by Subject|3|||
19527893|NCT01299480|41973672|FG004|Overall Study|Withdrawal by Subject|4|||
19527894|NCT01299480|41973668|FG000|Overall Study|Adverse Event|6|||
19527895|NCT01299480|41973669|FG001|Overall Study|Adverse Event|4|||
19527896|NCT01299480|41973670|FG002|Overall Study|Adverse Event|5|||
19527897|NCT01299480|41973671|FG003|Overall Study|Adverse Event|4|||
19527898|NCT01299480|41973672|FG004|Overall Study|Adverse Event|0|||
19527899|NCT01299480|41973668|FG000|Overall Study|Withdrawal due to pregnancy|0|||
19527900|NCT01299480|41973669|FG001|Overall Study|Withdrawal due to pregnancy|1|||
19527901|NCT01299480|41973670|FG002|Overall Study|Withdrawal due to pregnancy|1|||
19527902|NCT01299480|41973671|FG003|Overall Study|Withdrawal due to pregnancy|0|||
19527903|NCT01299480|41973672|FG004|Overall Study|Withdrawal due to pregnancy|0|||
19527904|NCT01299480|41973668|FG000|Overall Study|Physician Decision|1|||
19527905|NCT01299480|41973669|FG001|Overall Study|Physician Decision|1|||
19527906|NCT01299480|41973670|FG002|Overall Study|Physician Decision|0|||
19527907|NCT01299480|41973671|FG003|Overall Study|Physician Decision|2|||
19527908|NCT01299480|41973672|FG004|Overall Study|Physician Decision|0|||
19527909|NCT01299480|41973668|FG000|Overall Study|Lost to Follow-up|3|||
19527910|NCT01299480|41973669|FG001|Overall Study|Lost to Follow-up|1|||
19527911|NCT01299480|41973670|FG002|Overall Study|Lost to Follow-up|2|||
19527912|NCT01299480|41973671|FG003|Overall Study|Lost to Follow-up|1|||
19527913|NCT01299480|41973672|FG004|Overall Study|Lost to Follow-up|2|||
19527914|NCT01299480|41973668|FG000|Overall Study|Other|3|||
19527915|NCT01299480|41973669|FG001|Overall Study|Other|2|||
19527916|NCT01299480|41973670|FG002|Overall Study|Other|3|||
19527917|NCT01299480|41973671|FG003|Overall Study|Other|0|||
19527918|NCT01299480|41973672|FG004|Overall Study|Other|3|||
19527919|NCT01299480|41973668|FG000|Overall Study|Started, but not vaccinated|0|||
19527920|NCT01299480|41973669|FG001|Overall Study|Started, but not vaccinated|0|||
19527921|NCT01299480|41973670|FG002|Overall Study|Started, but not vaccinated|1|||
19711376|NCT03571204|42154501|FG000|Overall Study|Physician Decision|0|||
19450267|NCT01567527|41698686|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
19450268|NCT01567527|41698687|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
19527922|NCT01299480|41973671|FG003|Overall Study|Started, but not vaccinated|1|||
19527923|NCT01299480|41973672|FG004|Overall Study|Started, but not vaccinated|0|||
19527924|NCT04799405|41973694|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
19527925|NCT04529499|41973704|FG000|Overall Study|Withdrawal by Subject|9|||
19527926|NCT04529499|41973705|FG001|Overall Study|Withdrawal by Subject|11|||
19527927|NCT04529499|41973704|FG000|Overall Study|Physician Decision|1|||
19527928|NCT04529499|41973705|FG001|Overall Study|Physician Decision|2|||
19527929|NCT04529499|41973704|FG000|Overall Study|Adverse Event|4|||
19527930|NCT04529499|41973705|FG001|Overall Study|Adverse Event|4|||
19527931|NCT04529499|41973704|FG000|Overall Study|Death|14|||
19527932|NCT04529499|41973705|FG001|Overall Study|Death|11|||
19527933|NCT04529499|41973704|FG000|Overall Study|Lost to Follow-up|1|||
19527934|NCT04529499|41973705|FG001|Overall Study|Lost to Follow-up|1|||
19527935|NCT04529499|41973704|FG000|Overall Study|Others|7|||
19450269|NCT01567527|41698688|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
19450270|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
19450271|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
19450272|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
19527936|NCT04529499|41973705|FG001|Overall Study|Others|11|||
19527937|NCT04501094|41973713|FG000|Overall Study|Death (unrelated to research)|1|||
19527938|NCT04501094|41973714|FG001|Overall Study|Death (unrelated to research)|0|||
19527939|NCT04414618|41973722|FG000|Overall Study|Death|3|||
19527940|NCT04414618|41973723|FG001|Overall Study|Death|3|||
19527941|NCT04414618|41973722|FG000|Overall Study|Withdrawal by Subject|2|||
19527942|NCT04414618|41973723|FG001|Overall Study|Withdrawal by Subject|1|||
19450273|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
19450274|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
19450275|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
19450276|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
19450277|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
19450278|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
19450279|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
19450280|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
19450281|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
19450282|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
19450283|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
19450284|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
19450285|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
19450286|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
19450287|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
19450288|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
19450289|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
19527943|NCT04414618|41973722|FG000|Overall Study|Lost to Follow-up|2|||
19527944|NCT04414618|41973723|FG001|Overall Study|Lost to Follow-up|3|||
19527945|NCT04414618|41973722|FG000|Overall Study|Physician Decision|1|||
19527946|NCT04414618|41973723|FG001|Overall Study|Physician Decision|0|||
19527947|NCT04412057|41973732|FG000|Overall Study|Death|3|||
19527948|NCT04412057|41973733|FG001|Overall Study|Death|7|||
19527949|NCT04412057|41973732|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
19527950|NCT04412057|41973733|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
19527951|NCT04402060|41973742|FG000|Overall Study|Death|1|||
19527952|NCT04402060|41973743|FG001|Overall Study|Death|12|||
19450290|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19527953|NCT04402060|41973744|FG002|Overall Study|Death|7|||
19527954|NCT04402060|41973742|FG000|Overall Study|Adverse Event|0|||
19527955|NCT04402060|41973743|FG001|Overall Study|Adverse Event|0|||
19527956|NCT04402060|41973744|FG002|Overall Study|Adverse Event|1|||
19527957|NCT04402060|41973742|FG000|Overall Study|Withdrawal by Subject|0|||
19527958|NCT04402060|41973743|FG001|Overall Study|Withdrawal by Subject|1|||
19527959|NCT04402060|41973744|FG002|Overall Study|Withdrawal by Subject|2|||
19527960|NCT04402060|41973742|FG000|Overall Study|Sponsor Request|0|||
19527961|NCT04402060|41973743|FG001|Overall Study|Sponsor Request|2|||
19527962|NCT04402060|41973744|FG002|Overall Study|Sponsor Request|0|||
19527963|NCT04402060|41973742|FG000|Overall Study|Physician Decision|0|||
19629427|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
19629428|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
19527964|NCT04402060|41973743|FG001|Overall Study|Physician Decision|0|||
19527965|NCT04402060|41973744|FG002|Overall Study|Physician Decision|1|||
19527966|NCT04402060|41973742|FG000|Overall Study|Other|0|||
19527967|NCT04402060|41973743|FG001|Overall Study|Other|1|||
19527968|NCT04402060|41973744|FG002|Overall Study|Other|0|||
19711377|NCT03571204|42154502|FG001|Overall Study|Physician Decision|1|||
19527970|NCT04376684|41973783|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
19527971|NCT04376684|41973784|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
19527972|NCT04376684|41973785|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
19527973|NCT04376684|41973786|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
19527974|NCT04376684|41973783|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
19527975|NCT04376684|41973784|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
19527976|NCT04376684|41973785|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
19527977|NCT04376684|41973786|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
19527978|NCT04376684|41973783|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
19527979|NCT04376684|41973784|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
19527980|NCT04376684|41973785|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
19450291|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19450292|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
19450293|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
19450294|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
19450295|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
19450296|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
19450297|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
19450298|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
19450299|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
19450300|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
19450301|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
19450302|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
19450303|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
19450304|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
19450305|NCT01567527|41698684|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19450306|NCT01567527|41698685|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19450307|NCT01567527|41698686|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
19450308|NCT01567527|41698687|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
19450309|NCT01567527|41698688|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
19450310|NCT01818752|41698699|FG000|Overall Study|Adverse Event|64|||
19450311|NCT01818752|41698700|FG001|Overall Study|Adverse Event|74|||
19450312|NCT01818752|41698699|FG000|Overall Study|Death|14|||
19450313|NCT01818752|41698700|FG001|Overall Study|Death|18|||
19450314|NCT01818752|41698699|FG000|Overall Study|Non-compliance|16|||
19450315|NCT01818752|41698700|FG001|Overall Study|Non-compliance|20|||
19450316|NCT01818752|41698699|FG000|Overall Study|Withdrawal by Subject|15|||
19450317|NCT01818752|41698700|FG001|Overall Study|Withdrawal by Subject|14|||
19450318|NCT01818752|41698699|FG000|Overall Study|Physician Decision|9|||
19450319|NCT01818752|41698700|FG001|Overall Study|Physician Decision|8|||
19450320|NCT01818752|41698699|FG000|Overall Study|Disease Progression|54|||
19450321|NCT01818752|41698700|FG001|Overall Study|Disease Progression|48|||
19450322|NCT01818752|41698699|FG000|Overall Study|Other|7|||
19450323|NCT01818752|41698700|FG001|Overall Study|Other|8|||
19450324|NCT01818752|41698699|FG000|Overall Study|Continuing Treatment|1|||
19450325|NCT01818752|41698700|FG001|Overall Study|Continuing Treatment|4|||
19450326|NCT01818752|41698699|FG000|Overall Study|Randomized but not Dosed|7|||
19450327|NCT01818752|41698700|FG001|Overall Study|Randomized but not Dosed|4|||
19450328|NCT01845818|41698708|FG000|Overall Study|Withdrawal by Subject|0|||
19450329|NCT01845818|41698709|FG001|Overall Study|Withdrawal by Subject|1|||
19450330|NCT01845818|41698708|FG000|Overall Study|Lost to Follow-up|7|||
19450331|NCT01845818|41698709|FG001|Overall Study|Lost to Follow-up|5|||
19450332|NCT01845818|41698708|FG000|Overall Study|Administrative Reasons|3|||
19450333|NCT01845818|41698709|FG001|Overall Study|Administrative Reasons|1|||
19450334|NCT01845818|41698708|FG000|Overall Study|Serious Adverse Event|1|||
19450335|NCT01845818|41698709|FG001|Overall Study|Serious Adverse Event|1|||
19450336|NCT01845818|41698708|FG000|Overall Study|Other|25|||
19450337|NCT01845818|41698709|FG001|Overall Study|Other|8|||
19450338|NCT01845818|41698708|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
19450339|NCT01845818|41698709|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
19450340|NCT01845818|41698708|FG000|Overall Study|No Follow-Up Data Available|4|||
19450341|NCT01845818|41698709|FG001|Overall Study|No Follow-Up Data Available|1|||
19450342|NCT01362608|41698719|FG000|Overall Study|Protocol Violation|0|||
19527981|NCT04376684|41973786|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
19450343|NCT01362608|41698720|FG001|Overall Study|Protocol Violation|1|||
19450344|NCT01362608|41698719|FG000|Overall Study|Lost to Follow-up|3|||
19450345|NCT01362608|41698720|FG001|Overall Study|Lost to Follow-up|1|||
19450346|NCT01362608|41698719|FG000|Overall Study|Withdrawal by Subject|1|||
19450347|NCT01362608|41698720|FG001|Overall Study|Withdrawal by Subject|2|||
19450348|NCT01362608|41698719|FG000|Overall Study|Lack of Efficacy|0|||
19450349|NCT01362608|41698720|FG001|Overall Study|Lack of Efficacy|2|||
19450350|NCT01362608|41698719|FG000|Overall Study|Adverse Event|0|||
19527982|NCT04376684|41973783|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
19527983|NCT04376684|41973784|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
19527984|NCT04376684|41973785|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
19527985|NCT04376684|41973786|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
19527986|NCT04376684|41973783|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
19527987|NCT04376684|41973784|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
19527988|NCT04376684|41973785|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
19527989|NCT04376684|41973786|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
19527990|NCT04376684|41973783|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
19527991|NCT04376684|41973784|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
19527992|NCT04376684|41973785|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
19527993|NCT04376684|41973786|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
19527994|NCT04376684|41973783|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
19527995|NCT04376684|41973784|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
19527996|NCT04376684|41973785|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
19527997|NCT04376684|41973786|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
19527998|NCT04353284|41973798|FG000|Overall Study|Adverse Event|1|||
19527999|NCT04353284|41973799|FG001|Overall Study|Adverse Event|1|||
19528000|NCT04353284|41973798|FG000|Overall Study|Lost to Follow-up|1|||
19528001|NCT04353284|41973799|FG001|Overall Study|Lost to Follow-up|0|||
19528002|NCT04294147|41973807|FG000|Overall Study|Protocol Violation|2|||
19528003|NCT04294147|41973808|FG001|Overall Study|Protocol Violation|0|||
19528004|NCT04231825|41973820|FG000|Overall Study|Protocol Violation|3|||
19528005|NCT04231825|41973821|FG001|Overall Study|Protocol Violation|3|||
19528006|NCT04231825|41973820|FG000|Overall Study|Lost to Follow-up|0|||
19528007|NCT04231825|41973821|FG001|Overall Study|Lost to Follow-up|1|||
19528008|NCT04178772|41973827|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
19528009|NCT04178772|41973827|FG000|Overall Study|study terminated early due to COVID-19|7|||
19528010|NCT04148651|41973831|FG000|Overall Study|Lost to Follow-up|2|||
19528011|NCT03924427|41973844|FG000|Overall Study|Adverse Event|4|||
19528012|NCT03924427|41973844|FG000|Overall Study|Lack of Efficacy|1|||
19528013|NCT03924427|41973844|FG000|Overall Study|Withdrawal by Subject|1|||
19528014|NCT04505722|41973871|FG000|Overall Study|Adverse Event|1|||
19528015|NCT04505722|41973872|FG001|Overall Study|Adverse Event|2|||
19528016|NCT04505722|41973871|FG000|Overall Study|Death|34|||
19528017|NCT04505722|41973872|FG001|Overall Study|Death|63|||
19528018|NCT04505722|41973871|FG000|Overall Study|Lost to Follow-up|271|||
19528019|NCT04505722|41973872|FG001|Overall Study|Lost to Follow-up|333|||
19528020|NCT04505722|41973871|FG000|Overall Study|Physician Decision|17|||
19528021|NCT04505722|41973872|FG001|Overall Study|Physician Decision|17|||
19528022|NCT04505722|41973871|FG000|Overall Study|Protocol Violation|0|||
19528023|NCT04505722|41973872|FG001|Overall Study|Protocol Violation|1|||
19528024|NCT04505722|41973871|FG000|Overall Study|Withdrawal by Subject|376|||
19528025|NCT04505722|41973872|FG001|Overall Study|Withdrawal by Subject|714|||
19528026|NCT04505722|41973871|FG000|Overall Study|Other|61|||
19528027|NCT04505722|41973872|FG001|Overall Study|Other|98|||
19528028|NCT04505722|41973871|FG000|Overall Study|Still ongoing|21138|||
19528029|NCT04505722|41973872|FG001|Overall Study|Still ongoing|20662|||
19528030|NCT04505722|41973871|FG000|Overall Study|Randomized not vaccinated|276|||
19528031|NCT04505722|41973872|FG001|Overall Study|Randomized not vaccinated|260|||
19528032|NCT03642132|41973891|FG000|Chemotherapy Period|Adverse Event|1|||
19528033|NCT03642132|41973892|FG001|Chemotherapy Period|Adverse Event|1|||
19528034|NCT03642132|41973893|FG002|Chemotherapy Period|Adverse Event|0|||
19450351|NCT01362608|41698720|FG001|Overall Study|Adverse Event|2|||
19450352|NCT01871090|41698728|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
19450353|NCT01871090|41698729|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
19450354|NCT01871090|41698728|FG000|Overall Study|Interrogation not completed correctly|1|||
19450355|NCT01871090|41698729|FG001|Overall Study|Interrogation not completed correctly|0|||
19450356|NCT01871090|41698728|FG000|Overall Study|Subject Non-Compliance|0|||
19450357|NCT01871090|41698729|FG001|Overall Study|Subject Non-Compliance|1|||
19450358|NCT01818596|41698737|FG000|Overall Study|Enrolled but Not Treated|4|||
19450359|NCT01818596|41698738|FG001|Overall Study|Enrolled but Not Treated|0|||
19450360|NCT01818596|41698737|FG000|Overall Study|Adverse Event|7|||
19450361|NCT01818596|41698738|FG001|Overall Study|Adverse Event|0|||
19450362|NCT01818596|41698737|FG000|Overall Study|Death|3|||
19450363|NCT01818596|41698738|FG001|Overall Study|Death|0|||
19450364|NCT01818596|41698737|FG000|Overall Study|Investigator's Discretion|4|||
19450365|NCT01818596|41698738|FG001|Overall Study|Investigator's Discretion|0|||
19450366|NCT01818596|41698737|FG000|Overall Study|Protocol Violation|1|||
19450367|NCT01818596|41698738|FG001|Overall Study|Protocol Violation|0|||
19450368|NCT01818596|41698737|FG000|Overall Study|Withdrew Consent|5|||
19450369|NCT01818596|41698738|FG001|Overall Study|Withdrew Consent|0|||
19450370|NCT01818596|41698737|FG000|Overall Study|Lost to Follow-up|7|||
19450371|NCT01818596|41698738|FG001|Overall Study|Lost to Follow-up|0|||
19450372|NCT04577794|41698751|FG000|Overall Study|Adverse Event|1|||
19528035|NCT03642132|41973891|FG000|Chemotherapy Period|Physician's decision|4|||
19528036|NCT03642132|41973892|FG001|Chemotherapy Period|Physician's decision|1|||
19528037|NCT03642132|41973893|FG002|Chemotherapy Period|Physician's decision|0|||
19528038|NCT03642132|41973891|FG000|Chemotherapy Period|Progressive disease|0|||
19528039|NCT03642132|41973892|FG001|Chemotherapy Period|Progressive disease|0|||
19528040|NCT03642132|41973893|FG002|Chemotherapy Period|Progressive disease|1|||
19528041|NCT03642132|41973891|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
19528042|NCT03642132|41973892|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
19528043|NCT03642132|41973893|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
19528044|NCT03642132|41973891|FG000|Chemotherapy Period|Other|1|||
19528045|NCT03642132|41973892|FG001|Chemotherapy Period|Other|0|||
19528046|NCT03642132|41973893|FG002|Chemotherapy Period|Other|2|||
19528047|NCT03642132|41973891|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
19528048|NCT03642132|41973892|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
19528049|NCT03642132|41973893|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
19528050|NCT03642132|41973891|FG000|Maintenance Period|Adverse Event|1|||
19528051|NCT03642132|41973892|FG001|Maintenance Period|Adverse Event|2|||
19528052|NCT03642132|41973893|FG002|Maintenance Period|Adverse Event|0|||
19528053|NCT03642132|41973891|FG000|Maintenance Period|Non-compliance with study drug|0|||
19528054|NCT03642132|41973892|FG001|Maintenance Period|Non-compliance with study drug|0|||
19528055|NCT03642132|41973893|FG002|Maintenance Period|Non-compliance with study drug|1|||
19528056|NCT03642132|41973891|FG000|Maintenance Period|Physician's decision|2|||
19528057|NCT03642132|41973892|FG001|Maintenance Period|Physician's decision|2|||
19528058|NCT03642132|41973893|FG002|Maintenance Period|Physician's decision|2|||
19528059|NCT03642132|41973891|FG000|Maintenance Period|Progressive disease|9|||
19528060|NCT03642132|41973892|FG001|Maintenance Period|Progressive disease|3|||
19528061|NCT03642132|41973893|FG002|Maintenance Period|Progressive disease|6|||
19528062|NCT03642132|41973891|FG000|Maintenance Period|Other|0|||
19528063|NCT03642132|41973892|FG001|Maintenance Period|Other|0|||
19528064|NCT03642132|41973893|FG002|Maintenance Period|Other|3|||
19528065|NCT03642132|41973891|FG000|Maintenance Period|Withdrawal by Subject|1|||
19528066|NCT03642132|41973892|FG001|Maintenance Period|Withdrawal by Subject|1|||
19528067|NCT03642132|41973893|FG002|Maintenance Period|Withdrawal by Subject|2|||
19528068|NCT03642132|41973891|FG000|Follow-up Period|Other|0|||
19528069|NCT03642132|41973892|FG001|Follow-up Period|Other|0|||
19528070|NCT03642132|41973893|FG002|Follow-up Period|Other|1|||
19528071|NCT03642132|41973891|FG000|Follow-up Period|Withdrawal by Subject|1|||
19528072|NCT03642132|41973892|FG001|Follow-up Period|Withdrawal by Subject|2|||
19528073|NCT03642132|41973893|FG002|Follow-up Period|Withdrawal by Subject|0|||
19528074|NCT03642132|41973891|FG000|Follow-up Period|Study terminated by sponsor|1|||
19528075|NCT03642132|41973892|FG001|Follow-up Period|Study terminated by sponsor|0|||
19528076|NCT03642132|41973893|FG002|Follow-up Period|Study terminated by sponsor|1|||
19528077|NCT03642132|41973891|FG000|Follow-up Period|Lack of Efficacy|1|||
19528078|NCT03642132|41973892|FG001|Follow-up Period|Lack of Efficacy|0|||
19528079|NCT03642132|41973893|FG002|Follow-up Period|Lack of Efficacy|0|||
19528080|NCT03642132|41973891|FG000|Follow-up Period|Death|1|||
19528081|NCT03642132|41973892|FG001|Follow-up Period|Death|0|||
19528082|NCT03642132|41973893|FG002|Follow-up Period|Death|2|||
19528083|NCT03642132|41973891|FG000|Follow-up Period|Adverse Event|1|||
19528084|NCT03642132|41973892|FG001|Follow-up Period|Adverse Event|0|||
19528085|NCT03642132|41973893|FG002|Follow-up Period|Adverse Event|0|||
19528086|NCT03635983|41973903|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
19450373|NCT04577794|41698752|FG001|Overall Study|Adverse Event|1|||
19450374|NCT01594281|41698769|FG000|Interventional Core Phase|Protocol Deviation|1|||
19450375|NCT01594281|41698770|FG001|Interventional Core Phase|Protocol Deviation|0|||
19450376|NCT01594281|41698771|FG002|Interventional Core Phase|Protocol Deviation|0|||
19450377|NCT01594281|41698769|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
19450378|NCT01594281|41698770|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
19450379|NCT01594281|41698771|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
19528087|NCT03635983|41973904|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
19528088|NCT03635983|41973903|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
19528089|NCT03635983|41973904|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
19528090|NCT03635983|41973903|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19528091|NCT03635983|41973904|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19528092|NCT03635983|41973903|FG000|Pre-Treatment Period|Other reasons|1|||
19528093|NCT03635983|41973904|FG001|Pre-Treatment Period|Other reasons|2|||
19528094|NCT03635983|41973903|FG000|Pre-Treatment Period|Disease Progression|0|||
19528095|NCT03635983|41973904|FG001|Pre-Treatment Period|Disease Progression|1|||
19528096|NCT03635983|41973903|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
19528097|NCT03635983|41973904|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
19528098|NCT03635983|41973903|FG000|Treatment Period|Completed treatment period|13|||
19528099|NCT03635983|41973904|FG001|Treatment Period|Completed treatment period|20|||
19528100|NCT03635983|41973903|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
19528101|NCT03635983|41973904|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
19450380|NCT01594281|41698769|FG000|Interventional Core Phase|Death|1|||
19528102|NCT03635983|41973903|FG000|Treatment Period|Withdrawal by Subject|2|||
19528103|NCT03635983|41973904|FG001|Treatment Period|Withdrawal by Subject|4|||
19528104|NCT03635983|41973903|FG000|Treatment Period|Death|3|||
19528105|NCT03635983|41973904|FG001|Treatment Period|Death|4|||
19528106|NCT03635983|41973903|FG000|Treatment Period|Poor/Non-compliance|1|||
19528107|NCT03635983|41973904|FG001|Treatment Period|Poor/Non-compliance|0|||
19528108|NCT03635983|41973903|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
19528109|NCT03635983|41973904|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
19528110|NCT03635983|41973903|FG000|Treatment Period|Other reasons|5|||
19528111|NCT03635983|41973904|FG001|Treatment Period|Other reasons|2|||
19528112|NCT03635983|41973903|FG000|Treatment Period|Disease progression|184|||
19528113|NCT03635983|41973904|FG001|Treatment Period|Disease progression|168|||
19528114|NCT03635983|41973903|FG000|Treatment Period|Study drug toxicity|26|||
19528115|NCT03635983|41973904|FG001|Treatment Period|Study drug toxicity|29|||
19528116|NCT03635983|41973903|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
19528117|NCT03635983|41973904|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
19528118|NCT03635983|41973903|FG000|Treatment Period|Maximum clinical benefit|3|||
19528119|NCT03635983|41973904|FG001|Treatment Period|Maximum clinical benefit|2|||
19528120|NCT03008122|41973926|FG000|Overall Study|Physician Decision|3|||
19528121|NCT03008122|41973927|FG001|Overall Study|Physician Decision|2|||
19528122|NCT03008122|41973928|FG002|Overall Study|Physician Decision|0|||
19528123|NCT03008122|41973926|FG000|Overall Study|Withdrawal by Subject|1|||
19528124|NCT03008122|41973927|FG001|Overall Study|Withdrawal by Subject|3|||
19528125|NCT03008122|41973928|FG002|Overall Study|Withdrawal by Subject|0|||
19450381|NCT01594281|41698770|FG001|Interventional Core Phase|Death|1|||
19450382|NCT01594281|41698771|FG002|Interventional Core Phase|Death|2|||
19450383|NCT01594281|41698769|FG000|Interventional Core Phase|Lost to Follow-up|1|||
19450384|NCT01594281|41698770|FG001|Interventional Core Phase|Lost to Follow-up|4|||
19450385|NCT01594281|41698771|FG002|Interventional Core Phase|Lost to Follow-up|1|||
19450386|NCT01594281|41698769|FG000|Interventional Core Phase|Adverse Event|4|||
19450387|NCT01594281|41698770|FG001|Interventional Core Phase|Adverse Event|4|||
19450388|NCT01594281|41698771|FG002|Interventional Core Phase|Adverse Event|4|||
19528126|NCT03008122|41973926|FG000|Overall Study|Lost to Follow-up|4|||
19528127|NCT03008122|41973927|FG001|Overall Study|Lost to Follow-up|8|||
19528128|NCT03008122|41973928|FG002|Overall Study|Lost to Follow-up|3|||
19528129|NCT03008122|41973926|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
19528130|NCT03008122|41973927|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
19528131|NCT03008122|41973928|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
19629429|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
19629430|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
19629431|NCT00455533|42078942|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
19629432|NCT00455533|42078943|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
19629433|NCT00455533|42078944|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
19629434|NCT00455533|42078942|FG000|Period Two: Randomized Period|Death|0|||
19629435|NCT00455533|42078943|FG001|Period Two: Randomized Period|Death|0|||
19629436|NCT00455533|42078944|FG002|Period Two: Randomized Period|Death|3|||
19629437|NCT00455533|42078942|FG000|Period Two: Randomized Period|Disease Progression|0|||
19629438|NCT00455533|42078943|FG001|Period Two: Randomized Period|Disease Progression|1|||
19629439|NCT00455533|42078944|FG002|Period Two: Randomized Period|Disease Progression|1|||
19629440|NCT00455533|42078942|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
19629441|NCT00455533|42078943|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
19629442|NCT00455533|42078944|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
19528132|NCT03008122|41973926|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
19528133|NCT03008122|41973927|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
19528134|NCT03008122|41973928|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
19528135|NCT03008122|41973926|FG000|Overall Study|Death|0|||
19528136|NCT03008122|41973927|FG001|Overall Study|Death|0|||
19528137|NCT03008122|41973928|FG002|Overall Study|Death|1|||
19528138|NCT02879448|41973938|FG000|Overall Study|No implant attempt|17|||
19528139|NCT02879448|41973939|FG001|Overall Study|No implant attempt|28|||
19528140|NCT02879448|41973938|FG000|Overall Study|Withdrawal by Subject|20|||
19528141|NCT02879448|41973939|FG001|Overall Study|Withdrawal by Subject|46|||
19528142|NCT02879448|41973938|FG000|Overall Study|Death|63|||
19528143|NCT02879448|41973939|FG001|Overall Study|Death|85|||
19528144|NCT02879448|41973938|FG000|Overall Study|Lost to Follow-up|3|||
19528145|NCT02879448|41973939|FG001|Overall Study|Lost to Follow-up|4|||
19528146|NCT02879448|41973938|FG000|Overall Study|Missing visit|34|||
19528147|NCT02879448|41973939|FG001|Overall Study|Missing visit|39|||
19528148|NCT02879448|41973938|FG000|Overall Study|Pending evaluation|1|||
19528149|NCT02879448|41973939|FG001|Overall Study|Pending evaluation|0|||
19450389|NCT01594281|41698769|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
19528150|NCT02584634|41973947|FG000|Overall Study|Adverse Event|3|||
19528151|NCT02584634|41973948|FG001|Overall Study|Adverse Event|3|||
19528152|NCT02584634|41973947|FG000|Overall Study|Death|0|||
19450390|NCT01594281|41698770|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
19450391|NCT01594281|41698771|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
19450392|NCT01594281|41698769|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
19450393|NCT01594281|41698770|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
19450394|NCT01594281|41698771|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
19450395|NCT01594281|41698769|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
19450396|NCT01594281|41698770|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
19450397|NCT01594281|41698771|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
19450398|NCT01566981|41698784|FG000|Overall Study|Lost to Follow-up|5|||
19450399|NCT01566981|41698785|FG001|Overall Study|Lost to Follow-up|8|||
19450400|NCT01870778|41698795|FG000|Overall Study|Withdrawal by Subject|8|||
19450401|NCT01870778|41698796|FG001|Overall Study|Withdrawal by Subject|7|||
19450402|NCT01870778|41698795|FG000|Overall Study|Lost to Follow-up|0|||
19528153|NCT02584634|41973948|FG001|Overall Study|Death|1|||
19528154|NCT02584634|41973947|FG000|Overall Study|Lost to Follow-up|0|||
19528155|NCT02584634|41973948|FG001|Overall Study|Lost to Follow-up|1|||
19528156|NCT02584634|41973947|FG000|Overall Study|Physician Decision|1|||
19528157|NCT02584634|41973948|FG001|Overall Study|Physician Decision|1|||
19528158|NCT02584634|41973947|FG000|Overall Study|Progressive disease|7|||
19528159|NCT02584634|41973948|FG001|Overall Study|Progressive disease|14|||
19528160|NCT02584634|41973947|FG000|Overall Study|Withdrawal by Subject|1|||
19528161|NCT02584634|41973948|FG001|Overall Study|Withdrawal by Subject|1|||
19528162|NCT02584634|41973947|FG000|Overall Study|Other|0|||
19528163|NCT02584634|41973948|FG001|Overall Study|Other|2|||
19528164|NCT02584634|41973947|FG000|Overall Study|Ongoing|0|||
19528165|NCT02584634|41973948|FG001|Overall Study|Ongoing|8|||
19528166|NCT02395666|41973984|FG000|Overall Study|Physician Decision|3|||
19528167|NCT02395666|41973985|FG001|Overall Study|Physician Decision|0|||
19528168|NCT02395666|41973984|FG000|Overall Study|Lost to Follow-up|1|||
19528169|NCT02395666|41973985|FG001|Overall Study|Lost to Follow-up|0|||
19528170|NCT02395666|41973984|FG000|Overall Study|Withdrawal by Subject|2|||
19528171|NCT02395666|41973985|FG001|Overall Study|Withdrawal by Subject|1|||
19528172|NCT02125461|41974001|FG000|Overall Study|Withdrawal by Subject|30|||
19528173|NCT02125461|41974002|FG001|Overall Study|Withdrawal by Subject|16|||
19528174|NCT02125461|41974001|FG000|Overall Study|Lost to Follow-up|8|||
19528175|NCT02125461|41974002|FG001|Overall Study|Lost to Follow-up|3|||
19528176|NCT02125461|41974001|FG000|Overall Study|Death|260|||
19528177|NCT02125461|41974002|FG001|Overall Study|Death|149|||
19528178|NCT02125461|41974001|FG000|Overall Study|Missing Termination Reason|0|||
19528179|NCT02125461|41974002|FG001|Overall Study|Missing Termination Reason|1|||
19450403|NCT01870778|41698796|FG001|Overall Study|Lost to Follow-up|2|||
19450404|NCT01818284|41698809|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
19450405|NCT01818284|41698810|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
19450406|NCT01818284|41698809|FG000|Overall Study|Death|0|||
19450407|NCT01818284|41698810|FG001|Overall Study|Death|2|||
19450408|NCT01610492|41698846|FG000|Overall Study|Adverse Event|1|||
19450409|NCT01610492|41698846|FG000|Overall Study|Lack of Efficacy|3|||
19450410|NCT01610492|41698846|FG000|Overall Study|Other: Reached stopping criteria|1|||
19450411|NCT01610492|41698846|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
19528180|NCT02003924|41974010|FG000|Double-blind Phase|Lost to Follow-up|2|||
19528181|NCT02003924|41974011|FG001|Double-blind Phase|Lost to Follow-up|1|||
19528182|NCT02003924|41974012|FG002|Double-blind Phase|Lost to Follow-up|0|||
19528183|NCT02003924|41974010|FG000|Double-blind Phase|Protocol Violation|1|||
19528184|NCT02003924|41974011|FG001|Double-blind Phase|Protocol Violation|2|||
19528185|NCT02003924|41974012|FG002|Double-blind Phase|Protocol Violation|0|||
19528186|NCT02003924|41974010|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
19528187|NCT02003924|41974011|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
19528188|NCT02003924|41974012|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
19528189|NCT02003924|41974010|FG000|Double-blind Phase|Disease Progression|229|||
19528190|NCT02003924|41974011|FG001|Double-blind Phase|Disease Progression|247|||
19528191|NCT02003924|41974012|FG002|Double-blind Phase|Disease Progression|0|||
19528192|NCT02003924|41974010|FG000|Double-blind Phase|Adverse Event|120|||
19528193|NCT02003924|41974011|FG001|Double-blind Phase|Adverse Event|31|||
19528194|NCT02003924|41974012|FG002|Double-blind Phase|Adverse Event|0|||
19528195|NCT02003924|41974010|FG000|Double-blind Phase|Randomized But not Treated|3|||
19528196|NCT02003924|41974011|FG001|Double-blind Phase|Randomized But not Treated|3|||
19528197|NCT02003924|41974012|FG002|Double-blind Phase|Randomized But not Treated|0|||
19528198|NCT02003924|41974010|FG000|Double-blind Phase|Other|29|||
19528199|NCT02003924|41974011|FG001|Double-blind Phase|Other|50|||
19528200|NCT02003924|41974012|FG002|Double-blind Phase|Other|0|||
19528201|NCT02003924|41974010|FG000|Open-label Phase|Lost to Follow-up|0|||
19528202|NCT02003924|41974011|FG001|Open-label Phase|Lost to Follow-up|0|||
19528203|NCT02003924|41974012|FG002|Open-label Phase|Lost to Follow-up|1|||
19528204|NCT02003924|41974010|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
19528205|NCT02003924|41974011|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
19528206|NCT02003924|41974012|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
19528207|NCT02003924|41974010|FG000|Open-label Phase|Disease Progression|59|||
19450412|NCT01817582|41698853|FG000|Overall Study|Withdrawal by Subject|0|||
19450413|NCT01817582|41698854|FG001|Overall Study|Withdrawal by Subject|1|||
19450414|NCT01817582|41698855|FG002|Overall Study|Withdrawal by Subject|0|||
19450415|NCT01817582|41698853|FG000|Overall Study|Participant revealed masked treatment|1|||
19450416|NCT01817582|41698854|FG001|Overall Study|Participant revealed masked treatment|0|||
19450417|NCT01817582|41698855|FG002|Overall Study|Participant revealed masked treatment|0|||
19450418|NCT01817582|41698853|FG000|Overall Study|Randomized but exclusion criteria met|1|||
19450419|NCT01817582|41698854|FG001|Overall Study|Randomized but exclusion criteria met|0|||
19450420|NCT01817582|41698855|FG002|Overall Study|Randomized but exclusion criteria met|0|||
19450421|NCT01594125|41698868|FG000|Overall Study|Withdrawal by Subject|1|||
19450422|NCT01594125|41698869|FG001|Overall Study|Withdrawal by Subject|0|||
19450423|NCT01594125|41698870|FG002|Overall Study|Withdrawal by Subject|0|||
19450424|NCT01594125|41698871|FG003|Overall Study|Withdrawal by Subject|1|||
19450425|NCT01594125|41698872|FG004|Overall Study|Withdrawal by Subject|0|||
19450426|NCT01594125|41698868|FG000|Overall Study|Progressive Disease|3|||
19450427|NCT01594125|41698869|FG001|Overall Study|Progressive Disease|12|||
19450428|NCT01594125|41698870|FG002|Overall Study|Progressive Disease|3|||
19450429|NCT01594125|41698871|FG003|Overall Study|Progressive Disease|3|||
19528208|NCT02003924|41974011|FG001|Open-label Phase|Disease Progression|0|||
19528209|NCT02003924|41974012|FG002|Open-label Phase|Disease Progression|5|||
19528210|NCT02003924|41974010|FG000|Open-label Phase|Adverse Event|25|||
19528211|NCT02003924|41974011|FG001|Open-label Phase|Adverse Event|0|||
19528212|NCT02003924|41974012|FG002|Open-label Phase|Adverse Event|10|||
19528213|NCT02003924|41974010|FG000|Open-label Phase|Other|7|||
19528214|NCT02003924|41974011|FG001|Open-label Phase|Other|0|||
19528215|NCT02003924|41974012|FG002|Open-label Phase|Other|0|||
19528216|NCT02003924|41974010|FG000|Long-term Follow-up Phase|Death|288|||
19528217|NCT02003924|41974011|FG001|Long-term Follow-up Phase|Death|174|||
19450430|NCT01594125|41698872|FG004|Overall Study|Progressive Disease|7|||
19450431|NCT01870076|41698888|FG000|Overall Study|Withdrawal by Subject|1|||
19450432|NCT01870076|41698889|FG001|Overall Study|Withdrawal by Subject|0|||
19450433|NCT01870076|41698890|FG002|Overall Study|Withdrawal by Subject|1|||
19450434|NCT01870076|41698891|FG003|Overall Study|Withdrawal by Subject|0|||
19450435|NCT01592721|41698901|FG000|Long-term Follow-up|Death|1|||
19528218|NCT02003924|41974012|FG002|Long-term Follow-up Phase|Death|4|||
19528219|NCT02003924|41974010|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
19528220|NCT02003924|41974011|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
19528221|NCT02003924|41974012|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
19528222|NCT02003924|41974010|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
19528223|NCT02003924|41974011|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
19528224|NCT02003924|41974012|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
19528225|NCT02003924|41974010|FG000|Long-term Follow-up Phase|Other|5|||
19528226|NCT02003924|41974011|FG001|Long-term Follow-up Phase|Other|2|||
19528227|NCT02003924|41974012|FG002|Long-term Follow-up Phase|Other|1|||
19528228|NCT01817751|41974024|FG000|Overall Study|Physician Decision|1|||
19528229|NCT01349322|41974040|FG000|Overall Study|Protocol Violation|45|||
19528230|NCT01349322|41974041|FG001|Overall Study|Protocol Violation|47|||
19528231|NCT01182415|41974053|FG000|Overall Study|Lost to Follow-up|1|||
19528232|NCT01030523|41974059|FG000|Initial Study (5 Years)|Death|1|||
19528233|NCT01030523|41974060|FG001|Initial Study (5 Years)|Death|0|||
19528234|NCT01030523|41974059|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
19528235|NCT01030523|41974060|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
19528236|NCT01030523|41974059|FG000|Initial Study (5 Years)|Implant failure|1|||
19528237|NCT01030523|41974060|FG001|Initial Study (5 Years)|Implant failure|0|||
19528238|NCT01030523|41974059|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
19528239|NCT01030523|41974060|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
19528240|NCT01030523|41974059|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
19528241|NCT01030523|41974060|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
19528242|NCT01030523|41974059|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
19528243|NCT01030523|41974060|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
19528244|NCT00217425|41974066|FG000|Overall Study|Never started treatment|2|||
19528245|NCT00217425|41974066|FG000|Overall Study|Patient ineligible|5|||
19528246|NCT00217425|41974066|FG000|Overall Study|Lack of Efficacy|13|||
19528247|NCT00217425|41974066|FG000|Overall Study|Adverse Event|8|||
19528248|NCT00217425|41974066|FG000|Overall Study|Withdrawal by Subject|4|||
19528249|NCT00217425|41974066|FG000|Overall Study|Other complicating disease|1|||
19450436|NCT01613378|41698905|FG000|Overall Study|Lack of Efficacy|13|||
19528250|NCT00217425|41974066|FG000|Overall Study|Other|4|||
19528251|NCT03893448|41974072|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
19528252|NCT03893448|41974073|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
19528253|NCT03893448|41974072|FG000|Overall Study|Physician Decision|8|||
19528254|NCT03893448|41974073|FG001|Overall Study|Physician Decision|14|||
19528255|NCT03893448|41974072|FG000|Overall Study|Lost to Follow-up|34|||
19450437|NCT01613378|41698905|FG000|Overall Study|Adverse Event|11|||
19528256|NCT03893448|41974073|FG001|Overall Study|Lost to Follow-up|27|||
19528257|NCT03893448|41974072|FG000|Overall Study|Death|1|||
19528258|NCT03893448|41974073|FG001|Overall Study|Death|0|||
19528259|NCT03811574|41974113|FG000|Overall Study|Withdrawal by Subject|2|||
19528260|NCT03811574|41974114|FG001|Overall Study|Withdrawal by Subject|4|||
19528261|NCT03811574|41974115|FG002|Overall Study|Withdrawal by Subject|0|||
19528262|NCT03727750|41974138|FG000|Overall Study|Death|45|||
19528263|NCT03727750|41974138|FG000|Overall Study|Withdrawal by Subject|2|||
19528264|NCT03727750|41974138|FG000|Overall Study|Lost to Follow-up|1|||
19528265|NCT03727750|41974138|FG000|Overall Study|Other|1|||
19528266|NCT03715829|41974148|FG000|Dose Ranging Period|Adverse Event|2|||
19528267|NCT03715829|41974149|FG001|Dose Ranging Period|Adverse Event|4|||
19528268|NCT03715829|41974150|FG002|Dose Ranging Period|Adverse Event|5|||
19528269|NCT03715829|41974151|FG003|Dose Ranging Period|Adverse Event|2|||
19528270|NCT03715829|41974152|FG004|Dose Ranging Period|Adverse Event|3|||
19528271|NCT03715829|41974153|FG005|Dose Ranging Period|Adverse Event|3|||
19528272|NCT03715829|41974154|FG006|Dose Ranging Period|Adverse Event|0|||
19528273|NCT03715829|41974155|FG007|Dose Ranging Period|Adverse Event|0|||
19528274|NCT03715829|41974156|FG008|Dose Ranging Period|Adverse Event|0|||
19528275|NCT03715829|41974157|FG009|Dose Ranging Period|Adverse Event|0|||
19528276|NCT03715829|41974158|FG010|Dose Ranging Period|Adverse Event|0|||
19528277|NCT03715829|41974148|FG000|Dose Ranging Period|Lack of Efficacy|0|||
19528278|NCT03715829|41974149|FG001|Dose Ranging Period|Lack of Efficacy|1|||
19528279|NCT03715829|41974150|FG002|Dose Ranging Period|Lack of Efficacy|0|||
19528280|NCT03715829|41974151|FG003|Dose Ranging Period|Lack of Efficacy|1|||
19629443|NCT00455533|42078942|FG000|Period Two: Randomized Period|Other - need reasons|0|||
19629444|NCT00455533|42078943|FG001|Period Two: Randomized Period|Other - need reasons|1|||
19629445|NCT00455533|42078944|FG002|Period Two: Randomized Period|Other - need reasons|0|||
19629446|NCT00455533|42078942|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
19629447|NCT00455533|42078943|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
19629448|NCT00455533|42078944|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
19629449|NCT00455533|42078942|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
19629450|NCT00455533|42078943|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
19711378|NCT03571204|42154503|FG002|Overall Study|Physician Decision|0|||
19450438|NCT01613378|41698905|FG000|Overall Study|Withdrawal by Subject|8|||
19450439|NCT01613378|41698905|FG000|Overall Study|Death|2|||
19450440|NCT01613378|41698905|FG000|Overall Study|Lost to Follow-up|1|||
19450441|NCT01613378|41698905|FG000|Overall Study|Other Reason|4|||
19450442|NCT01592409|41698911|FG000|Overall Study|Withdrawal by Subject|0|||
19450443|NCT01592409|41698912|FG001|Overall Study|Withdrawal by Subject|1|||
19450444|NCT01697319|41698931|FG000|Primary Phase|Withdrawal by Subject|1|||
19450445|NCT01697319|41698931|FG000|Extension Phase|Terminated by Sponsor|15|||
19450446|NCT01566435|41698946|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
19450447|NCT01696929|41698954|FG000|Overall Study|Physician Decision|1|||
19450448|NCT01696773|41698964|FG000|Days 15-27, Washout|Adverse Event|1|||
19450449|NCT01696773|41698965|FG001|Days 15-27, Washout|Adverse Event|0|||
19450450|NCT01696695|41698971|FG000|Overall Study|Disease progression|373|||
19450451|NCT01696695|41698971|FG000|Overall Study|Death|29|||
19450452|NCT01696695|41698971|FG000|Overall Study|Adverse Event|74|||
19450453|NCT01696695|41698971|FG000|Overall Study|Withdrawal by Subject|92|||
19450454|NCT01696695|41698971|FG000|Overall Study|Lost to Follow-up|48|||
19450455|NCT01696695|41698971|FG000|Overall Study|Other|74|||
19450456|NCT01696695|41698971|FG000|Overall Study|Major Protocol Violation|192|||
19450457|NCT01565889|41698990|FG000|Part A|Withdrawal by Subject|1|||
19450458|NCT01565889|41698991|FG001|Part A|Withdrawal by Subject|0|||
19450459|NCT01565889|41698992|FG002|Part A|Withdrawal by Subject|0|||
19450460|NCT01565889|41698993|FG003|Part A|Withdrawal by Subject|0|||
19450461|NCT01565889|41698994|FG004|Part A|Withdrawal by Subject|0|||
19450462|NCT01565889|41698995|FG005|Part A|Withdrawal by Subject|0|||
19450463|NCT01565889|41698990|FG000|Part B|Withdrawal by Subject|0|||
19450464|NCT01565889|41698991|FG001|Part B|Withdrawal by Subject|0|||
19450465|NCT01565889|41698992|FG002|Part B|Withdrawal by Subject|0|||
19450466|NCT01565889|41698993|FG003|Part B|Withdrawal by Subject|0|||
19450467|NCT01565889|41698994|FG004|Part B|Withdrawal by Subject|0|||
19450468|NCT01565889|41698995|FG005|Part B|Withdrawal by Subject|1|||
19450469|NCT01565889|41698990|FG000|Part B|Lack of Efficacy|0|||
19450470|NCT01565889|41698991|FG001|Part B|Lack of Efficacy|0|||
19450471|NCT01565889|41698992|FG002|Part B|Lack of Efficacy|0|||
19450472|NCT01565889|41698993|FG003|Part B|Lack of Efficacy|0|||
19450473|NCT01565889|41698994|FG004|Part B|Lack of Efficacy|0|||
19528281|NCT03715829|41974152|FG004|Dose Ranging Period|Lack of Efficacy|0|||
19450474|NCT01565889|41698995|FG005|Part B|Lack of Efficacy|2|||
19450475|NCT01565889|41698990|FG000|Part B|Lost to Follow-up|0|||
19450476|NCT01565889|41698991|FG001|Part B|Lost to Follow-up|0|||
19450477|NCT01565889|41698992|FG002|Part B|Lost to Follow-up|0|||
19528282|NCT03715829|41974153|FG005|Dose Ranging Period|Lack of Efficacy|0|||
19528283|NCT03715829|41974154|FG006|Dose Ranging Period|Lack of Efficacy|0|||
19528284|NCT03715829|41974155|FG007|Dose Ranging Period|Lack of Efficacy|0|||
19528285|NCT03715829|41974156|FG008|Dose Ranging Period|Lack of Efficacy|0|||
19528286|NCT03715829|41974157|FG009|Dose Ranging Period|Lack of Efficacy|0|||
19528287|NCT03715829|41974158|FG010|Dose Ranging Period|Lack of Efficacy|0|||
19528288|NCT03715829|41974148|FG000|Dose Ranging Period|Lost to Follow-up|2|||
19528289|NCT03715829|41974149|FG001|Dose Ranging Period|Lost to Follow-up|0|||
19528290|NCT03715829|41974150|FG002|Dose Ranging Period|Lost to Follow-up|1|||
19528291|NCT03715829|41974151|FG003|Dose Ranging Period|Lost to Follow-up|1|||
19528292|NCT03715829|41974152|FG004|Dose Ranging Period|Lost to Follow-up|1|||
19528293|NCT03715829|41974153|FG005|Dose Ranging Period|Lost to Follow-up|2|||
19528294|NCT03715829|41974154|FG006|Dose Ranging Period|Lost to Follow-up|0|||
19528295|NCT03715829|41974155|FG007|Dose Ranging Period|Lost to Follow-up|0|||
19528296|NCT03715829|41974156|FG008|Dose Ranging Period|Lost to Follow-up|0|||
19528297|NCT03715829|41974157|FG009|Dose Ranging Period|Lost to Follow-up|0|||
19528298|NCT03715829|41974158|FG010|Dose Ranging Period|Lost to Follow-up|0|||
19528299|NCT03715829|41974148|FG000|Dose Ranging Period|Protocol Violation|0|||
19528300|NCT03715829|41974149|FG001|Dose Ranging Period|Protocol Violation|0|||
19528301|NCT03715829|41974150|FG002|Dose Ranging Period|Protocol Violation|0|||
19528302|NCT03715829|41974151|FG003|Dose Ranging Period|Protocol Violation|1|||
19528303|NCT03715829|41974152|FG004|Dose Ranging Period|Protocol Violation|0|||
19528304|NCT03715829|41974153|FG005|Dose Ranging Period|Protocol Violation|0|||
19528305|NCT03715829|41974154|FG006|Dose Ranging Period|Protocol Violation|0|||
19528306|NCT03715829|41974155|FG007|Dose Ranging Period|Protocol Violation|0|||
19528307|NCT03715829|41974156|FG008|Dose Ranging Period|Protocol Violation|0|||
19528308|NCT03715829|41974157|FG009|Dose Ranging Period|Protocol Violation|0|||
19528309|NCT03715829|41974158|FG010|Dose Ranging Period|Protocol Violation|0|||
19528310|NCT03715829|41974148|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
19528311|NCT03715829|41974149|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
19528312|NCT03715829|41974150|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
19528313|NCT03715829|41974151|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
19528314|NCT03715829|41974152|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
19528315|NCT03715829|41974153|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
19528316|NCT03715829|41974154|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
19528317|NCT03715829|41974155|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
19528318|NCT03715829|41974156|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
19528319|NCT03715829|41974157|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
19528320|NCT03715829|41974158|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
19528321|NCT03715829|41974148|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528322|NCT03715829|41974149|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528323|NCT03715829|41974150|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
19528324|NCT03715829|41974151|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528325|NCT03715829|41974152|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528326|NCT03715829|41974153|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528327|NCT03715829|41974154|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528328|NCT03715829|41974155|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528329|NCT03715829|41974156|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528330|NCT03715829|41974157|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528331|NCT03715829|41974158|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
19528332|NCT03715829|41974148|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528333|NCT03715829|41974149|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528334|NCT03715829|41974150|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
19528335|NCT03715829|41974151|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528336|NCT03715829|41974152|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
19528337|NCT03715829|41974153|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528338|NCT03715829|41974154|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528339|NCT03715829|41974155|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528340|NCT03715829|41974156|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528341|NCT03715829|41974157|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528342|NCT03715829|41974158|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
19528343|NCT03715829|41974148|FG000|Dose Ranging Period|Other|0|||
19528344|NCT03715829|41974149|FG001|Dose Ranging Period|Other|0|||
19528345|NCT03715829|41974150|FG002|Dose Ranging Period|Other|2|||
19528346|NCT03715829|41974151|FG003|Dose Ranging Period|Other|0|||
19528347|NCT03715829|41974152|FG004|Dose Ranging Period|Other|0|||
19528348|NCT03715829|41974153|FG005|Dose Ranging Period|Other|3|||
19528349|NCT03715829|41974154|FG006|Dose Ranging Period|Other|0|||
19528350|NCT03715829|41974155|FG007|Dose Ranging Period|Other|0|||
19528351|NCT03715829|41974156|FG008|Dose Ranging Period|Other|0|||
19528352|NCT03715829|41974157|FG009|Dose Ranging Period|Other|0|||
19528353|NCT03715829|41974158|FG010|Dose Ranging Period|Other|0|||
19528354|NCT03715829|41974148|FG000|Extension Period|Adverse Event|0|||
19528355|NCT03715829|41974149|FG001|Extension Period|Adverse Event|0|||
19528356|NCT03715829|41974150|FG002|Extension Period|Adverse Event|0|||
19528357|NCT03715829|41974151|FG003|Extension Period|Adverse Event|0|||
19528358|NCT03715829|41974152|FG004|Extension Period|Adverse Event|0|||
19528359|NCT03715829|41974153|FG005|Extension Period|Adverse Event|0|||
19528360|NCT03715829|41974154|FG006|Extension Period|Adverse Event|3|||
19528361|NCT03715829|41974155|FG007|Extension Period|Adverse Event|1|||
19528362|NCT03715829|41974156|FG008|Extension Period|Adverse Event|6|||
19528363|NCT03715829|41974157|FG009|Extension Period|Adverse Event|0|||
19528364|NCT03715829|41974158|FG010|Extension Period|Adverse Event|0|||
19528365|NCT03715829|41974148|FG000|Extension Period|Lack of Efficacy|0|||
19528366|NCT03715829|41974149|FG001|Extension Period|Lack of Efficacy|0|||
19528367|NCT03715829|41974150|FG002|Extension Period|Lack of Efficacy|0|||
19528368|NCT03715829|41974151|FG003|Extension Period|Lack of Efficacy|0|||
19528369|NCT03715829|41974152|FG004|Extension Period|Lack of Efficacy|0|||
19450478|NCT01565889|41698993|FG003|Part B|Lost to Follow-up|0|||
19450479|NCT01565889|41698994|FG004|Part B|Lost to Follow-up|0|||
19450480|NCT01565889|41698995|FG005|Part B|Lost to Follow-up|1|||
19528370|NCT03715829|41974153|FG005|Extension Period|Lack of Efficacy|0|||
19528371|NCT03715829|41974154|FG006|Extension Period|Lack of Efficacy|1|||
19528372|NCT03715829|41974155|FG007|Extension Period|Lack of Efficacy|9|||
19528373|NCT03715829|41974156|FG008|Extension Period|Lack of Efficacy|2|||
19528374|NCT03715829|41974157|FG009|Extension Period|Lack of Efficacy|0|||
19528375|NCT03715829|41974158|FG010|Extension Period|Lack of Efficacy|0|||
19528376|NCT03715829|41974148|FG000|Extension Period|Lost to Follow-up|0|||
19528377|NCT03715829|41974149|FG001|Extension Period|Lost to Follow-up|0|||
19528378|NCT03715829|41974150|FG002|Extension Period|Lost to Follow-up|0|||
19528379|NCT03715829|41974151|FG003|Extension Period|Lost to Follow-up|0|||
19528380|NCT03715829|41974152|FG004|Extension Period|Lost to Follow-up|0|||
19528381|NCT03715829|41974153|FG005|Extension Period|Lost to Follow-up|0|||
19528382|NCT03715829|41974154|FG006|Extension Period|Lost to Follow-up|0|||
19528383|NCT03715829|41974155|FG007|Extension Period|Lost to Follow-up|0|||
19528384|NCT03715829|41974156|FG008|Extension Period|Lost to Follow-up|2|||
19528385|NCT03715829|41974157|FG009|Extension Period|Lost to Follow-up|0|||
19528386|NCT03715829|41974158|FG010|Extension Period|Lost to Follow-up|0|||
19528387|NCT03715829|41974148|FG000|Extension Period|Protocol Violation|0|||
19450481|NCT01696071|41699010|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
19450482|NCT01696071|41699011|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
19450483|NCT01591863|41699022|FG000|Overall Study|Adverse Event|3|||
19450484|NCT01591863|41699022|FG000|Overall Study|Withdrawal by Subject|1|||
19450485|NCT01591863|41699022|FG000|Overall Study|recurrence|9|||
19450486|NCT01591863|41699022|FG000|Overall Study|Lack of Efficacy|1|||
19450487|NCT01591785|41699028|FG000|Overall Study|worsening condition|1|||
19450488|NCT01591785|41699029|FG001|Overall Study|worsening condition|2|||
19450489|NCT01591785|41699028|FG000|Overall Study|Protocol Violation|2|||
19450490|NCT01591785|41699029|FG001|Overall Study|Protocol Violation|0|||
19450491|NCT01591785|41699028|FG000|Overall Study|Lost to Follow-up|1|||
19450492|NCT01591785|41699029|FG001|Overall Study|Lost to Follow-up|0|||
19450493|NCT01695993|41699038|FG000|Overall Study|Lost to Follow-up|2|||
19450494|NCT01695993|41699039|FG001|Overall Study|Lost to Follow-up|1|||
19450495|NCT01695993|41699040|FG002|Overall Study|Lost to Follow-up|3|||
19450496|NCT01695993|41699038|FG000|Overall Study|Withdrawal by Subject|2|||
19450497|NCT01695993|41699039|FG001|Overall Study|Withdrawal by Subject|2|||
19450498|NCT01695993|41699040|FG002|Overall Study|Withdrawal by Subject|2|||
19450499|NCT01695993|41699038|FG000|Overall Study|To ill to continue|1|||
19450500|NCT01695993|41699039|FG001|Overall Study|To ill to continue|2|||
19450501|NCT01695993|41699040|FG002|Overall Study|To ill to continue|0|||
19450502|NCT01695993|41699038|FG000|Overall Study|Changed Medical Facility|0|||
19450503|NCT01695993|41699039|FG001|Overall Study|Changed Medical Facility|0|||
19450504|NCT01695993|41699040|FG002|Overall Study|Changed Medical Facility|1|||
19528388|NCT03715829|41974149|FG001|Extension Period|Protocol Violation|0|||
19528389|NCT03715829|41974150|FG002|Extension Period|Protocol Violation|0|||
19528390|NCT03715829|41974151|FG003|Extension Period|Protocol Violation|0|||
19528391|NCT03715829|41974152|FG004|Extension Period|Protocol Violation|0|||
19528392|NCT03715829|41974153|FG005|Extension Period|Protocol Violation|0|||
19528393|NCT03715829|41974154|FG006|Extension Period|Protocol Violation|0|||
19528394|NCT03715829|41974155|FG007|Extension Period|Protocol Violation|0|||
19528395|NCT03715829|41974156|FG008|Extension Period|Protocol Violation|1|||
19528396|NCT03715829|41974157|FG009|Extension Period|Protocol Violation|0|||
19528397|NCT03715829|41974158|FG010|Extension Period|Protocol Violation|0|||
19528398|NCT03715829|41974148|FG000|Extension Period|Withdrawal by Subject|0|||
19528399|NCT03715829|41974149|FG001|Extension Period|Withdrawal by Subject|0|||
19528400|NCT03715829|41974150|FG002|Extension Period|Withdrawal by Subject|0|||
19528401|NCT03715829|41974151|FG003|Extension Period|Withdrawal by Subject|0|||
19528402|NCT03715829|41974152|FG004|Extension Period|Withdrawal by Subject|0|||
19450505|NCT01565343|41699051|FG000|Overall Study|Administrative decision/technical issues|1|||
19450506|NCT01565343|41699052|FG001|Overall Study|Administrative decision/technical issues|0|||
19450507|NCT01565343|41699053|FG002|Overall Study|Administrative decision/technical issues|0|||
19528403|NCT03715829|41974153|FG005|Extension Period|Withdrawal by Subject|0|||
19528404|NCT03715829|41974154|FG006|Extension Period|Withdrawal by Subject|3|||
19528405|NCT03715829|41974155|FG007|Extension Period|Withdrawal by Subject|3|||
19528406|NCT03715829|41974156|FG008|Extension Period|Withdrawal by Subject|12|||
19528407|NCT03715829|41974157|FG009|Extension Period|Withdrawal by Subject|3|||
19528408|NCT03715829|41974158|FG010|Extension Period|Withdrawal by Subject|0|||
19528409|NCT03715829|41974148|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528410|NCT03715829|41974149|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528411|NCT03715829|41974150|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528412|NCT03715829|41974151|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528413|NCT03715829|41974152|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528414|NCT03715829|41974153|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528415|NCT03715829|41974154|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528416|NCT03715829|41974155|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
19528417|NCT03715829|41974156|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
19528418|NCT03715829|41974157|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528419|NCT03715829|41974158|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
19528420|NCT03715829|41974148|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528421|NCT03715829|41974149|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528422|NCT03715829|41974150|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528423|NCT03715829|41974151|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528424|NCT03715829|41974152|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528425|NCT03715829|41974153|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528426|NCT03715829|41974154|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528427|NCT03715829|41974155|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528428|NCT03715829|41974156|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
19528429|NCT03715829|41974157|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528430|NCT03715829|41974158|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
19528431|NCT03715829|41974148|FG000|Extension Period|Other|0|||
19528432|NCT03715829|41974149|FG001|Extension Period|Other|0|||
19528433|NCT03715829|41974150|FG002|Extension Period|Other|0|||
19528434|NCT03715829|41974151|FG003|Extension Period|Other|0|||
19528435|NCT03715829|41974152|FG004|Extension Period|Other|0|||
19528436|NCT03715829|41974153|FG005|Extension Period|Other|0|||
19528437|NCT03715829|41974154|FG006|Extension Period|Other|1|||
19528438|NCT03715829|41974155|FG007|Extension Period|Other|2|||
19528439|NCT03715829|41974156|FG008|Extension Period|Other|4|||
19528440|NCT03715829|41974157|FG009|Extension Period|Other|0|||
19528441|NCT03715829|41974158|FG010|Extension Period|Other|0|||
19528442|NCT03575104|41974220|FG000|Overall Study|Adverse Event|4|||
19528443|NCT03575104|41974221|FG001|Overall Study|Adverse Event|3|||
19528444|NCT03575104|41974222|FG002|Overall Study|Adverse Event|4|||
19528445|NCT03575104|41974220|FG000|Overall Study|Withdrawal by Subject|13|||
19528446|NCT03575104|41974221|FG001|Overall Study|Withdrawal by Subject|16|||
19528447|NCT03575104|41974222|FG002|Overall Study|Withdrawal by Subject|11|||
19528448|NCT03575104|41974220|FG000|Overall Study|Other reasons|6|||
19528449|NCT03575104|41974221|FG001|Overall Study|Other reasons|8|||
19528450|NCT03575104|41974222|FG002|Overall Study|Other reasons|6|||
19528451|NCT03575104|41974220|FG000|Overall Study|Lost to Follow-up|1|||
19528452|NCT03575104|41974221|FG001|Overall Study|Lost to Follow-up|2|||
19528453|NCT03575104|41974222|FG002|Overall Study|Lost to Follow-up|1|||
19528454|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
19528455|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
19528456|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
19528457|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
19528458|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
19528459|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
19528460|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
19528461|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
19528462|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
19528463|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
19528464|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
19528465|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
19528466|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
19528467|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
19528468|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
19528469|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
19528470|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
19528471|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
19528472|NCT03569475|41974233|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
19528473|NCT03569475|41974234|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
19528474|NCT03569475|41974235|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
19528475|NCT03569475|41974233|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
19528476|NCT03569475|41974234|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
19528477|NCT03569475|41974235|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
19528478|NCT03569475|41974233|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
19528479|NCT03569475|41974234|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
19528480|NCT03569475|41974235|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
19528481|NCT03545191|41974289|FG000|Overall Study|Death|1|||
19528482|NCT03545191|41974290|FG001|Overall Study|Death|0|||
19528483|NCT03545191|41974291|FG002|Overall Study|Death|0|||
19528484|NCT03545191|41974289|FG000|Overall Study|Adverse Event|4|||
19528485|NCT03545191|41974290|FG001|Overall Study|Adverse Event|2|||
19528486|NCT03545191|41974291|FG002|Overall Study|Adverse Event|7|||
19528487|NCT03545191|41974289|FG000|Overall Study|Other reasons|3|||
19528488|NCT03545191|41974290|FG001|Overall Study|Other reasons|11|||
19528489|NCT03545191|41974291|FG002|Overall Study|Other reasons|8|||
19528490|NCT03545191|41974289|FG000|Overall Study|Withdrawal by Subject|13|||
19528491|NCT03545191|41974290|FG001|Overall Study|Withdrawal by Subject|10|||
19528492|NCT03545191|41974291|FG002|Overall Study|Withdrawal by Subject|12|||
19528493|NCT03545191|41974289|FG000|Overall Study|Lost to Follow-up|1|||
19528494|NCT03545191|41974290|FG001|Overall Study|Lost to Follow-up|2|||
19528495|NCT03545191|41974291|FG002|Overall Study|Lost to Follow-up|3|||
19528496|NCT03500549|41974301|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
19528497|NCT03500549|41974302|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
19528498|NCT03500549|41974301|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
19528499|NCT03500549|41974302|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
19528500|NCT03366792|41974322|FG000|Overall Study|Withdrawal by Subject|7|||
19528501|NCT03366792|41974322|FG000|Overall Study|Lost to Follow-up|2|||
19528502|NCT03366792|41974322|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
19528503|NCT03366792|41974322|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
19528504|NCT03366337|41974330|FG000|Overall Study|Lost to Follow-up|1|||
19528505|NCT03366337|41974331|FG001|Overall Study|Lost to Follow-up|0|||
19528506|NCT03366337|41974332|FG002|Overall Study|Lost to Follow-up|1|||
19528507|NCT03366337|41974333|FG003|Overall Study|Lost to Follow-up|0|||
19528508|NCT03366337|41974330|FG000|Overall Study|Withdrawal by Subject|2|||
19528509|NCT03366337|41974331|FG001|Overall Study|Withdrawal by Subject|0|||
19528510|NCT03366337|41974332|FG002|Overall Study|Withdrawal by Subject|1|||
19629451|NCT00455533|42078944|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
19450508|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Progressive disease|50|||
19450509|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Progressive disease|110|||
19450510|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Progressive disease|0|||
19450511|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Progressive disease|0|||
19450512|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
19450513|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
19450514|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19450515|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
19450516|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Adverse Event|7|||
19450517|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Adverse Event|7|||
19450518|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Adverse Event|0|||
19450519|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Adverse Event|0|||
19450520|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Other|1|||
19450521|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Other|3|||
19450522|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Other|0|||
19450523|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Other|0|||
19450524|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Physician Decision|6|||
19450525|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Physician Decision|3|||
19450526|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Physician Decision|0|||
19450527|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Physician Decision|0|||
19450528|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Death|1|||
19450529|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Death|1|||
19450530|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Death|0|||
19450531|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Death|0|||
19450532|NCT01695135|41699078|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
19450533|NCT01695135|41699079|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
19450534|NCT01695135|41699080|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
19528511|NCT03366337|41974333|FG003|Overall Study|Withdrawal by Subject|1|||
19528512|NCT03342053|41974345|FG000|Overall Study|Adverse Event|2|||
19528513|NCT03342053|41974346|FG001|Overall Study|Adverse Event|0|||
19528514|NCT03342053|41974345|FG000|Overall Study|Withdrawal by Subject|0|||
19528515|NCT03342053|41974346|FG001|Overall Study|Withdrawal by Subject|1|||
19528516|NCT03283241|41974354|FG000|Overall Study|Adverse Event|4|||
19528517|NCT03283241|41974355|FG001|Overall Study|Adverse Event|1|||
19528518|NCT03283241|41974354|FG000|Overall Study|Withdrawal by Subject|0|||
19528519|NCT03283241|41974355|FG001|Overall Study|Withdrawal by Subject|1|||
19528520|NCT03283241|41974354|FG000|Overall Study|Subject relocated to Finland|0|||
19450535|NCT01695135|41699081|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
19450536|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
19450537|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
19450538|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
19450539|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
19450540|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
19450541|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
19450542|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
19450543|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
19528521|NCT03283241|41974355|FG001|Overall Study|Subject relocated to Finland|1|||
19528522|NCT03242772|41974363|FG000|Overall Study|Lost to Follow-up|2|||
19528523|NCT03242772|41974364|FG001|Overall Study|Lost to Follow-up|0|||
19528524|NCT03242772|41974363|FG000|Overall Study|Physician Decision|0|||
19528525|NCT03242772|41974364|FG001|Overall Study|Physician Decision|1|||
19528526|NCT03242772|41974363|FG000|Overall Study|Withdrawal by Subject|1|||
19528527|NCT03242772|41974364|FG001|Overall Study|Withdrawal by Subject|0|||
19528528|NCT03236311|41974372|FG000|Overall Study|Study terminated by sponsor|0|||
19528529|NCT03236311|41974373|FG001|Overall Study|Study terminated by sponsor|2|||
19528530|NCT03236311|41974372|FG000|Overall Study|Adverse Event|0|||
19450544|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
19450545|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
19450546|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
19450547|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
19450548|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Other|0|||
19450549|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Other|0|||
19450550|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Other|4|||
19450551|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Other|7|||
19450552|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
19450553|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
19450554|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
19450555|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
19450556|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Death|0|||
19450557|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Death|0|||
19528531|NCT03236311|41974373|FG001|Overall Study|Adverse Event|1|||
19528532|NCT03192046|41974381|FG000|Overall Study|Withdrawal by Subject|1|||
19528533|NCT03192046|41974382|FG001|Overall Study|Withdrawal by Subject|1|||
19528534|NCT03190369|41974390|FG000|Overall Study|Poor compliance to protocol|0|||
19528535|NCT03190369|41974391|FG001|Overall Study|Poor compliance to protocol|1|||
19528536|NCT03190369|41974390|FG000|Overall Study|Withdraw before treatment|1|||
19528537|NCT03190369|41974391|FG001|Overall Study|Withdraw before treatment|5|||
19528538|NCT03190369|41974390|FG000|Overall Study|Randomized but not treated|0|||
19528539|NCT03190369|41974391|FG001|Overall Study|Randomized but not treated|2|||
19528540|NCT04657198|41974400|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
19528541|NCT04657198|41974401|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
19528542|NCT04657198|41974402|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
19528543|NCT04590586|41974416|FG000|Overall Study|Death|7|||
19528544|NCT04590586|41974417|FG001|Overall Study|Death|1|||
19528545|NCT04590586|41974418|FG002|Overall Study|Death|37|||
19450558|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Death|2|||
19450559|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Death|7|||
19450560|NCT01695135|41699078|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
19450561|NCT01695135|41699079|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
19450562|NCT01695135|41699080|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
19450563|NCT01695135|41699081|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
19450564|NCT01610414|41699091|FG000|Study Start - Month 13|Serious Adverse Event|65|||
19450565|NCT01610414|41699092|FG001|Study Start - Month 13|Serious Adverse Event|67|||
19450566|NCT01610414|41699091|FG000|Study Start - Month 13|Adverse Event|14|||
19450567|NCT01610414|41699092|FG001|Study Start - Month 13|Adverse Event|14|||
19450568|NCT01610414|41699091|FG000|Study Start - Month 13|Protocol Violation|3|||
19450569|NCT01610414|41699092|FG001|Study Start - Month 13|Protocol Violation|1|||
19450570|NCT01610414|41699091|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
19450571|NCT01610414|41699092|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
19450572|NCT01610414|41699091|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
19450573|NCT01610414|41699092|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
19450574|NCT01610414|41699091|FG000|Study Start - Month 13|Lost to Follow-up|4|||
19629452|NCT00627094|42078954|FG000|Overall Study|Adverse Event|8|||
19528546|NCT04590586|41974419|FG003|Overall Study|Death|34|||
19528547|NCT04590586|41974420|FG004|Overall Study|Death|19|||
19528548|NCT04590586|41974421|FG005|Overall Study|Death|3|||
19528549|NCT04590586|41974416|FG000|Overall Study|Lost to Follow-up|3|||
19528550|NCT04590586|41974417|FG001|Overall Study|Lost to Follow-up|0|||
19528551|NCT04590586|41974418|FG002|Overall Study|Lost to Follow-up|11|||
19528552|NCT04590586|41974419|FG003|Overall Study|Lost to Follow-up|11|||
19528553|NCT04590586|41974420|FG004|Overall Study|Lost to Follow-up|6|||
19528554|NCT04590586|41974421|FG005|Overall Study|Lost to Follow-up|0|||
19528555|NCT04590586|41974416|FG000|Overall Study|Withdrawal by Subject|0|||
19528556|NCT04590586|41974417|FG001|Overall Study|Withdrawal by Subject|0|||
19528557|NCT04590586|41974418|FG002|Overall Study|Withdrawal by Subject|6|||
19528558|NCT04590586|41974419|FG003|Overall Study|Withdrawal by Subject|0|||
19528559|NCT04590586|41974420|FG004|Overall Study|Withdrawal by Subject|3|||
19528560|NCT04590586|41974421|FG005|Overall Study|Withdrawal by Subject|0|||
19528561|NCT04590586|41974416|FG000|Overall Study|Other|3|||
19528562|NCT04590586|41974417|FG001|Overall Study|Other|0|||
19528563|NCT04590586|41974418|FG002|Overall Study|Other|1|||
19528564|NCT04590586|41974419|FG003|Overall Study|Other|1|||
19528565|NCT04590586|41974420|FG004|Overall Study|Other|2|||
19528566|NCT04590586|41974421|FG005|Overall Study|Other|1|||
19528567|NCT04312009|41974447|FG000|Overall Study|Withdrawal by Subject|2|||
19528568|NCT04312009|41974448|FG001|Overall Study|Withdrawal by Subject|1|||
19528569|NCT03937466|41974463|FG000|Overall Study|not eligbile after the 2-week diary|9|||
19528570|NCT03937466|41974463|FG000|Overall Study|never returned their diary|6|||
19528571|NCT03937466|41974463|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
19528572|NCT03937466|41974463|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
19528573|NCT03850483|41974476|FG000|Treatment for Stage 1|Adverse Event|1|||
19528574|NCT03850483|41974477|FG001|Treatment for Stage 1|Adverse Event|1|||
19528575|NCT03850483|41974478|FG002|Treatment for Stage 1|Adverse Event|3|||
19528576|NCT03850483|41974479|FG003|Treatment for Stage 1|Adverse Event|0|||
19528577|NCT03850483|41974480|FG004|Treatment for Stage 1|Adverse Event|2|||
19528578|NCT03850483|41974481|FG005|Treatment for Stage 1|Adverse Event|0|||
19528579|NCT03850483|41974482|FG006|Treatment for Stage 1|Adverse Event|2|||
19528580|NCT03850483|41974483|FG007|Treatment for Stage 1|Adverse Event|2|||
19528581|NCT03850483|41974484|FG008|Treatment for Stage 1|Adverse Event|0|||
19528582|NCT03850483|41974485|FG009|Treatment for Stage 1|Adverse Event|0|||
19528583|NCT03850483|41974476|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
19528584|NCT03850483|41974477|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
19528585|NCT03850483|41974478|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
19528586|NCT03850483|41974479|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
19528587|NCT03850483|41974480|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
19528588|NCT03850483|41974481|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
19528589|NCT03850483|41974482|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
19528590|NCT03850483|41974483|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
19450575|NCT01610414|41699092|FG001|Study Start - Month 13|Lost to Follow-up|6|||
19450576|NCT01610414|41699091|FG000|Study Start - Month 13|Suspected HZ episode|1|||
19450577|NCT01610414|41699092|FG001|Study Start - Month 13|Suspected HZ episode|3|||
19450578|NCT01610414|41699091|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
19450579|NCT01610414|41699092|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
19450580|NCT01610414|41699091|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
19450581|NCT01610414|41699092|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
19528591|NCT03850483|41974484|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
19528592|NCT03850483|41974485|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
19528593|NCT03850483|41974476|FG000|Treatment for Stage 1|Protocol Violation|1|||
19528594|NCT03850483|41974477|FG001|Treatment for Stage 1|Protocol Violation|0|||
19528595|NCT03850483|41974478|FG002|Treatment for Stage 1|Protocol Violation|0|||
19528596|NCT03850483|41974479|FG003|Treatment for Stage 1|Protocol Violation|0|||
19528597|NCT03850483|41974480|FG004|Treatment for Stage 1|Protocol Violation|0|||
19528598|NCT03850483|41974481|FG005|Treatment for Stage 1|Protocol Violation|0|||
19528599|NCT03850483|41974482|FG006|Treatment for Stage 1|Protocol Violation|1|||
19528600|NCT03850483|41974483|FG007|Treatment for Stage 1|Protocol Violation|0|||
19528601|NCT03850483|41974484|FG008|Treatment for Stage 1|Protocol Violation|0|||
19450582|NCT01610414|41699091|FG000|Month 13 - Month 25|Adverse Event|8|||
19450583|NCT01610414|41699092|FG001|Month 13 - Month 25|Adverse Event|4|||
19450584|NCT01610414|41699091|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
19450585|NCT01610414|41699092|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
19450586|NCT01610414|41699091|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
19450587|NCT01610414|41699092|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
19450588|NCT01610414|41699091|FG000|Month 13 - Month 25|Protocol Violation|0|||
19528602|NCT03850483|41974485|FG009|Treatment for Stage 1|Protocol Violation|0|||
19528603|NCT03850483|41974476|FG000|Treatment for Stage 1|Physician Decision|0|||
19528604|NCT03850483|41974477|FG001|Treatment for Stage 1|Physician Decision|0|||
19528605|NCT03850483|41974478|FG002|Treatment for Stage 1|Physician Decision|0|||
19528606|NCT03850483|41974479|FG003|Treatment for Stage 1|Physician Decision|0|||
19528607|NCT03850483|41974480|FG004|Treatment for Stage 1|Physician Decision|0|||
19528608|NCT03850483|41974481|FG005|Treatment for Stage 1|Physician Decision|1|||
19528609|NCT03850483|41974482|FG006|Treatment for Stage 1|Physician Decision|0|||
19528610|NCT03850483|41974483|FG007|Treatment for Stage 1|Physician Decision|0|||
19528611|NCT03850483|41974484|FG008|Treatment for Stage 1|Physician Decision|0|||
19528612|NCT03850483|41974485|FG009|Treatment for Stage 1|Physician Decision|0|||
19528613|NCT03850483|41974476|FG000|Treatment for Stage 1|Other|0|||
19528614|NCT03850483|41974477|FG001|Treatment for Stage 1|Other|0|||
19528615|NCT03850483|41974478|FG002|Treatment for Stage 1|Other|0|||
19528616|NCT03850483|41974479|FG003|Treatment for Stage 1|Other|0|||
19528617|NCT03850483|41974480|FG004|Treatment for Stage 1|Other|2|||
19528618|NCT03850483|41974481|FG005|Treatment for Stage 1|Other|1|||
19528619|NCT03850483|41974482|FG006|Treatment for Stage 1|Other|0|||
19528620|NCT03850483|41974483|FG007|Treatment for Stage 1|Other|0|||
19528621|NCT03850483|41974484|FG008|Treatment for Stage 1|Other|0|||
19528622|NCT03850483|41974485|FG009|Treatment for Stage 1|Other|0|||
19450589|NCT01610414|41699092|FG001|Month 13 - Month 25|Protocol Violation|2|||
19450590|NCT01610414|41699091|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
19450591|NCT01610414|41699092|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
19528623|NCT03850483|41974476|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528624|NCT03850483|41974477|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528625|NCT03850483|41974478|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
19528626|NCT03850483|41974479|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19450592|NCT01610414|41699091|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
19450593|NCT01610414|41699092|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
19450594|NCT01610414|41699091|FG000|After Month 25|Study end not reached|48|||
19450595|NCT01610414|41699092|FG001|After Month 25|Study end not reached|53|||
19450596|NCT01564407|41699120|FG000|Overall Study|Lost to Follow-up|0|||
19450597|NCT01564407|41699121|FG001|Overall Study|Lost to Follow-up|1|||
19450598|NCT01564407|41699122|FG002|Overall Study|Lost to Follow-up|0|||
19450599|NCT01564407|41699123|FG003|Overall Study|Lost to Follow-up|0|||
19450600|NCT01564407|41699124|FG004|Overall Study|Lost to Follow-up|0|||
19450601|NCT01564407|41699120|FG000|Overall Study|Withdrawal by Subject|0|||
19450602|NCT01564407|41699121|FG001|Overall Study|Withdrawal by Subject|1|||
19450603|NCT01564407|41699122|FG002|Overall Study|Withdrawal by Subject|0|||
19450604|NCT01564407|41699123|FG003|Overall Study|Withdrawal by Subject|0|||
19450605|NCT01564407|41699124|FG004|Overall Study|Withdrawal by Subject|0|||
19528627|NCT03850483|41974480|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528628|NCT03850483|41974481|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19450606|NCT01564407|41699120|FG000|Overall Study|funding lost, study ended|0|||
19450607|NCT01564407|41699121|FG001|Overall Study|funding lost, study ended|0|||
19450608|NCT01564407|41699122|FG002|Overall Study|funding lost, study ended|0|||
19450609|NCT01564407|41699123|FG003|Overall Study|funding lost, study ended|1|||
19450610|NCT01564407|41699124|FG004|Overall Study|funding lost, study ended|0|||
19450611|NCT01590771|41699147|FG000|Overall Study|Other Protocol Specified Criteria|5|||
19450612|NCT01590771|41699148|FG001|Overall Study|Other Protocol Specified Criteria|14|||
19450613|NCT01590771|41699147|FG000|Overall Study|Withdrawal by Subject|8|||
19450614|NCT01590771|41699148|FG001|Overall Study|Withdrawal by Subject|15|||
19450615|NCT01590771|41699147|FG000|Overall Study|Protocol Violation|1|||
19450616|NCT01590771|41699148|FG001|Overall Study|Protocol Violation|2|||
19528629|NCT03850483|41974482|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528630|NCT03850483|41974483|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528631|NCT03850483|41974484|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528632|NCT03850483|41974485|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
19528633|NCT03850483|41974476|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528634|NCT03850483|41974477|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528635|NCT03850483|41974478|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528636|NCT03850483|41974479|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528637|NCT03850483|41974480|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528638|NCT03850483|41974481|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
19528639|NCT03850483|41974482|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528640|NCT03850483|41974483|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528641|NCT03850483|41974484|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528642|NCT03850483|41974485|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
19528643|NCT03850483|41974476|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
19528644|NCT03850483|41974477|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
19450617|NCT01590771|41699147|FG000|Overall Study|Lost to Follow-up|1|||
19450618|NCT01590771|41699148|FG001|Overall Study|Lost to Follow-up|1|||
19450619|NCT01590771|41699147|FG000|Overall Study|Lack of Efficacy|1|||
19528645|NCT03850483|41974478|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
19528646|NCT03850483|41974479|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
19528647|NCT03850483|41974480|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
19528648|NCT03850483|41974481|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
19528649|NCT03850483|41974482|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
19528650|NCT03850483|41974483|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
19528651|NCT03850483|41974484|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
19528652|NCT03850483|41974485|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
19528653|NCT03850483|41974476|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
19528654|NCT03850483|41974477|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
19528655|NCT03850483|41974478|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
19528656|NCT03850483|41974479|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
19528657|NCT03850483|41974480|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
19528658|NCT03850483|41974481|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
19528659|NCT03850483|41974482|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
19528660|NCT03850483|41974483|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
19528661|NCT03850483|41974484|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
19528662|NCT03850483|41974485|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
19528663|NCT03850483|41974476|FG000|Treatment for Stage 1|Death|0|||
19528664|NCT03850483|41974477|FG001|Treatment for Stage 1|Death|0|||
19528665|NCT03850483|41974478|FG002|Treatment for Stage 1|Death|0|||
19528666|NCT03850483|41974479|FG003|Treatment for Stage 1|Death|0|||
19528667|NCT03850483|41974480|FG004|Treatment for Stage 1|Death|0|||
19528668|NCT03850483|41974481|FG005|Treatment for Stage 1|Death|1|||
19528669|NCT03850483|41974482|FG006|Treatment for Stage 1|Death|0|||
19528670|NCT03850483|41974483|FG007|Treatment for Stage 1|Death|0|||
19528671|NCT03850483|41974484|FG008|Treatment for Stage 1|Death|0|||
19528672|NCT03850483|41974485|FG009|Treatment for Stage 1|Death|0|||
19528673|NCT03850483|41974476|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
19528674|NCT03850483|41974477|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
19528675|NCT03850483|41974478|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
19528676|NCT03850483|41974479|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
19528677|NCT03850483|41974480|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
19528678|NCT03850483|41974481|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
19528679|NCT03850483|41974482|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
19528680|NCT03850483|41974483|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
19528681|NCT03850483|41974484|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
19528682|NCT03850483|41974485|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
19528683|NCT03850483|41974476|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
19528684|NCT03850483|41974477|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
19528685|NCT03850483|41974478|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
19528686|NCT03850483|41974479|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
19528687|NCT03850483|41974480|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
19528688|NCT03850483|41974481|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
19528689|NCT03850483|41974482|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
19528690|NCT03850483|41974483|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
19528691|NCT03850483|41974484|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
19528692|NCT03850483|41974485|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
19528693|NCT03850483|41974476|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
19528694|NCT03850483|41974477|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
19450620|NCT01590771|41699148|FG001|Overall Study|Lack of Efficacy|0|||
19528695|NCT03850483|41974478|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
19450621|NCT01590771|41699147|FG000|Overall Study|Adverse Event|3|||
19450622|NCT01590771|41699148|FG001|Overall Study|Adverse Event|7|||
19528696|NCT03850483|41974479|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
19528697|NCT03850483|41974480|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
19528698|NCT03850483|41974481|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
19629453|NCT00627094|42078955|FG001|Overall Study|Adverse Event|7|||
19450623|NCT01563237|41699154|FG000|Overall Study|Lost to Follow-up|6|||
19450624|NCT01563237|41699155|FG001|Overall Study|Lost to Follow-up|0|||
19450625|NCT01563237|41699154|FG000|Overall Study|Withdrawal by Subject|1|||
19450626|NCT01563237|41699155|FG001|Overall Study|Withdrawal by Subject|0|||
19450627|NCT01563237|41699154|FG000|Overall Study|Adverse Event|1|||
19450628|NCT01563237|41699155|FG001|Overall Study|Adverse Event|0|||
19450629|NCT01563237|41699154|FG000|Overall Study|Medical Reasons|1|||
19450630|NCT01563237|41699155|FG001|Overall Study|Medical Reasons|0|||
19450631|NCT01563237|41699154|FG000|Overall Study|Death|1|||
19450632|NCT01563237|41699155|FG001|Overall Study|Death|0|||
19450633|NCT01694433|41699162|FG000|Overall Study|Adverse Event|7|||
19528699|NCT03850483|41974482|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
19528700|NCT03850483|41974483|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
19528701|NCT03850483|41974484|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
19528702|NCT03850483|41974485|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
19528703|NCT03850483|41974476|FG000|Follow-up for Stage 1|Physician Decision|0|||
19528704|NCT03850483|41974477|FG001|Follow-up for Stage 1|Physician Decision|0|||
19528705|NCT03850483|41974478|FG002|Follow-up for Stage 1|Physician Decision|0|||
19528706|NCT03850483|41974479|FG003|Follow-up for Stage 1|Physician Decision|0|||
19528707|NCT03850483|41974480|FG004|Follow-up for Stage 1|Physician Decision|1|||
19528708|NCT03850483|41974481|FG005|Follow-up for Stage 1|Physician Decision|0|||
19528709|NCT03850483|41974482|FG006|Follow-up for Stage 1|Physician Decision|1|||
19528710|NCT03850483|41974483|FG007|Follow-up for Stage 1|Physician Decision|0|||
19528711|NCT03850483|41974484|FG008|Follow-up for Stage 1|Physician Decision|0|||
19528712|NCT03850483|41974485|FG009|Follow-up for Stage 1|Physician Decision|0|||
19528713|NCT03850483|41974476|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
19528714|NCT03850483|41974477|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
19528715|NCT03850483|41974478|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
19528716|NCT03850483|41974479|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
19528717|NCT03850483|41974480|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
19528718|NCT03850483|41974481|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
19528719|NCT03850483|41974482|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
19528720|NCT03850483|41974483|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
19528721|NCT03850483|41974484|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
19528722|NCT03850483|41974485|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
19528723|NCT03850483|41974476|FG000|Follow-up for Stage 1|Adverse Event|0|||
19528724|NCT03850483|41974477|FG001|Follow-up for Stage 1|Adverse Event|0|||
19528725|NCT03850483|41974478|FG002|Follow-up for Stage 1|Adverse Event|1|||
19528726|NCT03850483|41974479|FG003|Follow-up for Stage 1|Adverse Event|0|||
19528727|NCT03850483|41974480|FG004|Follow-up for Stage 1|Adverse Event|0|||
19528728|NCT03850483|41974481|FG005|Follow-up for Stage 1|Adverse Event|1|||
19528729|NCT03850483|41974482|FG006|Follow-up for Stage 1|Adverse Event|0|||
19528730|NCT03850483|41974483|FG007|Follow-up for Stage 1|Adverse Event|0|||
19528731|NCT03850483|41974484|FG008|Follow-up for Stage 1|Adverse Event|0|||
19528732|NCT03850483|41974485|FG009|Follow-up for Stage 1|Adverse Event|0|||
19528733|NCT03850483|41974476|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528734|NCT03850483|41974477|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
19528735|NCT03850483|41974478|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528736|NCT03850483|41974479|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528737|NCT03850483|41974480|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
19528738|NCT03850483|41974481|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
19528739|NCT03850483|41974482|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528740|NCT03850483|41974483|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19450634|NCT01694433|41699163|FG001|Overall Study|Adverse Event|0|||
19528741|NCT03850483|41974484|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528742|NCT03850483|41974485|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
19528743|NCT03850483|41974476|FG000|Follow-up for Stage 1|Other|0|||
19528744|NCT03850483|41974477|FG001|Follow-up for Stage 1|Other|2|||
19528745|NCT03850483|41974478|FG002|Follow-up for Stage 1|Other|0|||
19528746|NCT03850483|41974479|FG003|Follow-up for Stage 1|Other|2|||
19528747|NCT03850483|41974480|FG004|Follow-up for Stage 1|Other|0|||
19528748|NCT03850483|41974481|FG005|Follow-up for Stage 1|Other|1|||
19528749|NCT03850483|41974482|FG006|Follow-up for Stage 1|Other|0|||
19528750|NCT03850483|41974483|FG007|Follow-up for Stage 1|Other|0|||
19528751|NCT03850483|41974484|FG008|Follow-up for Stage 1|Other|0|||
19528752|NCT03850483|41974485|FG009|Follow-up for Stage 1|Other|0|||
19528753|NCT03850483|41974476|FG000|Treatment for Stage 2|Adverse Event|0|||
19528754|NCT03850483|41974477|FG001|Treatment for Stage 2|Adverse Event|0|||
19528755|NCT03850483|41974478|FG002|Treatment for Stage 2|Adverse Event|0|||
19528756|NCT03850483|41974479|FG003|Treatment for Stage 2|Adverse Event|0|||
19528757|NCT03850483|41974480|FG004|Treatment for Stage 2|Adverse Event|0|||
19528758|NCT03850483|41974481|FG005|Treatment for Stage 2|Adverse Event|0|||
19528759|NCT03850483|41974482|FG006|Treatment for Stage 2|Adverse Event|0|||
19528760|NCT03850483|41974483|FG007|Treatment for Stage 2|Adverse Event|0|||
19528761|NCT03850483|41974484|FG008|Treatment for Stage 2|Adverse Event|0|||
19528762|NCT03850483|41974485|FG009|Treatment for Stage 2|Adverse Event|1|||
19528763|NCT03850483|41974476|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
19528764|NCT03850483|41974477|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
19450635|NCT01694433|41699162|FG000|Overall Study|Physician Decision|1|||
19450636|NCT01694433|41699163|FG001|Overall Study|Physician Decision|0|||
19450637|NCT01694433|41699162|FG000|Overall Study|Withdrawal by Subject|3|||
19450638|NCT01694433|41699163|FG001|Overall Study|Withdrawal by Subject|4|||
19450639|NCT01694121|41699171|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
19450640|NCT01694121|41699172|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
19450641|NCT01562613|41699178|FG000|Overall Study|Lost to Follow-up|2|||
19450642|NCT01562613|41699178|FG000|Overall Study|Withdrawal by Subject|2|||
19528765|NCT03850483|41974478|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
19528766|NCT03850483|41974479|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
19528767|NCT03850483|41974480|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
19528768|NCT03850483|41974481|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
19528769|NCT03850483|41974482|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
19528770|NCT03850483|41974483|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
19528771|NCT03850483|41974484|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
19629454|NCT00627094|42078954|FG000|Overall Study|Lost to Follow-up|1|||
19629455|NCT00627094|42078955|FG001|Overall Study|Lost to Follow-up|0|||
19450643|NCT01693185|41699184|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
19450644|NCT01693185|41699185|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
19450645|NCT01693029|41699200|FG000|Overall Study|Withdrawal by Subject|15|||
19450646|NCT01693029|41699201|FG001|Overall Study|Withdrawal by Subject|22|||
19528772|NCT03850483|41974485|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
19528773|NCT03850483|41974476|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
19528774|NCT03850483|41974477|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
19528775|NCT03850483|41974478|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
19528776|NCT03850483|41974479|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
19528777|NCT03850483|41974480|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
19528778|NCT03850483|41974481|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
19528779|NCT03850483|41974482|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
19528780|NCT03850483|41974483|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
19528781|NCT03850483|41974484|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
19528782|NCT03850483|41974485|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
19528783|NCT03850483|41974476|FG000|Treatment for Stage 2|Physician Decision|0|||
19528784|NCT03850483|41974477|FG001|Treatment for Stage 2|Physician Decision|0|||
19528785|NCT03850483|41974478|FG002|Treatment for Stage 2|Physician Decision|0|||
19528786|NCT03850483|41974479|FG003|Treatment for Stage 2|Physician Decision|0|||
19528787|NCT03850483|41974480|FG004|Treatment for Stage 2|Physician Decision|0|||
19528788|NCT03850483|41974481|FG005|Treatment for Stage 2|Physician Decision|0|||
19528789|NCT03850483|41974482|FG006|Treatment for Stage 2|Physician Decision|0|||
19528790|NCT03850483|41974483|FG007|Treatment for Stage 2|Physician Decision|0|||
19528791|NCT03850483|41974484|FG008|Treatment for Stage 2|Physician Decision|0|||
19528792|NCT03850483|41974485|FG009|Treatment for Stage 2|Physician Decision|1|||
19528793|NCT03850483|41974476|FG000|Treatment for Stage 2|Protocol Violation|0|||
19528794|NCT03850483|41974477|FG001|Treatment for Stage 2|Protocol Violation|0|||
19528795|NCT03850483|41974478|FG002|Treatment for Stage 2|Protocol Violation|0|||
19528796|NCT03850483|41974479|FG003|Treatment for Stage 2|Protocol Violation|0|||
19528797|NCT03850483|41974480|FG004|Treatment for Stage 2|Protocol Violation|0|||
19528798|NCT03850483|41974481|FG005|Treatment for Stage 2|Protocol Violation|0|||
19528799|NCT03850483|41974482|FG006|Treatment for Stage 2|Protocol Violation|0|||
19528800|NCT03850483|41974483|FG007|Treatment for Stage 2|Protocol Violation|0|||
19528801|NCT03850483|41974484|FG008|Treatment for Stage 2|Protocol Violation|1|||
19528802|NCT03850483|41974485|FG009|Treatment for Stage 2|Protocol Violation|0|||
19528803|NCT03850483|41974476|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
19528804|NCT03850483|41974477|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
19528805|NCT03850483|41974478|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
19528806|NCT03850483|41974479|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
19528807|NCT03850483|41974480|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
19528808|NCT03850483|41974481|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
19528809|NCT03850483|41974482|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
19528810|NCT03850483|41974483|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
19528811|NCT03850483|41974484|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
19528812|NCT03850483|41974485|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
19528813|NCT03850483|41974476|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528814|NCT03850483|41974477|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528815|NCT03850483|41974478|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528816|NCT03850483|41974479|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528817|NCT03850483|41974480|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528818|NCT03850483|41974481|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19711379|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
19450647|NCT01693029|41699200|FG000|Overall Study|Kidney transplantation|7|||
19450648|NCT01693029|41699201|FG001|Overall Study|Kidney transplantation|7|||
19450649|NCT01693029|41699200|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
19450650|NCT01693029|41699201|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
19450651|NCT01693029|41699200|FG000|Overall Study|Protocol Violation|6|||
19450652|NCT01693029|41699201|FG001|Overall Study|Protocol Violation|7|||
19450653|NCT01693029|41699200|FG000|Overall Study|Change in dialysis modality|2|||
19450654|NCT01693029|41699201|FG001|Overall Study|Change in dialysis modality|1|||
19450655|NCT01693029|41699200|FG000|Overall Study|Physician Decision|0|||
19450656|NCT01693029|41699201|FG001|Overall Study|Physician Decision|2|||
19450657|NCT01693029|41699200|FG000|Overall Study|Lost to Follow-up|0|||
19450658|NCT01693029|41699201|FG001|Overall Study|Lost to Follow-up|1|||
19450659|NCT01693029|41699200|FG000|Overall Study|Adverse Event|1|||
19450660|NCT01693029|41699201|FG001|Overall Study|Adverse Event|6|||
19450661|NCT01693029|41699200|FG000|Overall Study|Death|5|||
19450662|NCT01693029|41699201|FG001|Overall Study|Death|8|||
19450663|NCT01693029|41699200|FG000|Overall Study|Non-compliance|2|||
19450664|NCT01693029|41699201|FG001|Overall Study|Non-compliance|1|||
19450665|NCT01589445|41699207|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
19450666|NCT01589445|41699207|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
19528819|NCT03850483|41974482|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528820|NCT03850483|41974483|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528821|NCT03850483|41974484|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
19528822|NCT03850483|41974485|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
19528823|NCT03850483|41974476|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
19528824|NCT03850483|41974477|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
19528825|NCT03850483|41974478|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
19528826|NCT03850483|41974479|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
19528827|NCT03850483|41974480|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
19528828|NCT03850483|41974481|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
19528829|NCT03850483|41974482|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
19528830|NCT03850483|41974483|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
19528831|NCT03850483|41974484|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
19528832|NCT03850483|41974485|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
19450667|NCT01589445|41699207|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
19450668|NCT01589445|41699207|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
19450669|NCT01589445|41699207|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
19450670|NCT01589445|41699207|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
19450671|NCT01589445|41699207|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
19450672|NCT01589445|41699207|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
19450673|NCT01589445|41699207|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
19528833|NCT03850483|41974476|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
19528834|NCT03850483|41974477|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
19528835|NCT03850483|41974478|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
19528836|NCT03850483|41974479|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
19528837|NCT03850483|41974480|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
19528838|NCT03850483|41974481|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
19528839|NCT03850483|41974482|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
19528840|NCT03850483|41974483|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
19528841|NCT03850483|41974484|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
19528842|NCT03850483|41974485|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
19528843|NCT03850483|41974476|FG000|Follow-up For Stage 2|Other|0|||
19528844|NCT03850483|41974477|FG001|Follow-up For Stage 2|Other|0|||
19528845|NCT03850483|41974478|FG002|Follow-up For Stage 2|Other|0|||
19528846|NCT03850483|41974479|FG003|Follow-up For Stage 2|Other|0|||
19528847|NCT03850483|41974480|FG004|Follow-up For Stage 2|Other|0|||
19528848|NCT03850483|41974481|FG005|Follow-up For Stage 2|Other|0|||
19528849|NCT03850483|41974482|FG006|Follow-up For Stage 2|Other|0|||
19528850|NCT03850483|41974483|FG007|Follow-up For Stage 2|Other|0|||
19528851|NCT03850483|41974484|FG008|Follow-up For Stage 2|Other|0|||
19528852|NCT03850483|41974485|FG009|Follow-up For Stage 2|Other|1|||
19528853|NCT03473925|41974529|FG000|Overall Study|Death|48|||
19528854|NCT03473925|41974530|FG001|Overall Study|Death|44|||
19528855|NCT03473925|41974529|FG000|Overall Study|Sponsor Decision|2|||
19528856|NCT03473925|41974530|FG001|Overall Study|Sponsor Decision|7|||
19528857|NCT03473925|41974529|FG000|Overall Study|Withdrawal by Subject|1|||
19629456|NCT00627094|42078954|FG000|Overall Study|Withdrawal by Subject|1|||
19629457|NCT00627094|42078955|FG001|Overall Study|Withdrawal by Subject|1|||
19629458|NCT00627094|42078954|FG000|Overall Study|ulcer healed|1|||
19629459|NCT00627094|42078955|FG001|Overall Study|ulcer healed|7|||
19629460|NCT00627094|42078954|FG000|Overall Study|Other reason|1|||
19629461|NCT00627094|42078955|FG001|Overall Study|Other reason|0|||
19629462|NCT00642850|42078963|FG000|Overall Study|Death|7|||
19629463|NCT00642850|42078963|FG000|Overall Study|Adverse Event|2|||
19629464|NCT00642850|42078963|FG000|Overall Study|Lack of Efficacy|1|||
19528858|NCT03473925|41974530|FG001|Overall Study|Withdrawal by Subject|3|||
19528859|NCT03473925|41974529|FG000|Overall Study|Not Treated|1|||
19528860|NCT03473925|41974530|FG001|Overall Study|Not Treated|1|||
19528861|NCT03230097|41974538|FG000|Overall Study|Adverse Event|2|||
19528862|NCT03230097|41974539|FG001|Overall Study|Adverse Event|1|||
19528863|NCT03230097|41974538|FG000|Overall Study|non-compliance|0|||
19528864|NCT03230097|41974539|FG001|Overall Study|non-compliance|1|||
19528865|NCT03230097|41974538|FG000|Overall Study|Lost to Follow-up|2|||
19528866|NCT03230097|41974539|FG001|Overall Study|Lost to Follow-up|4|||
19528867|NCT03230097|41974538|FG000|Overall Study|Withdrawal by Subject|7|||
19528868|NCT03230097|41974539|FG001|Overall Study|Withdrawal by Subject|3|||
19528869|NCT03230097|41974538|FG000|Overall Study|Trial termination|4|||
19528870|NCT03230097|41974539|FG001|Overall Study|Trial termination|5|||
19528871|NCT03230097|41974538|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
19528872|NCT03230097|41974539|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
19528873|NCT03230097|41974538|FG000|Overall Study|outcome event|0|||
19528874|NCT03230097|41974539|FG001|Overall Study|outcome event|1|||
19528875|NCT02803593|41974564|FG000|Overall Study|Lost to Follow-up|17|||
19528876|NCT02803593|41974565|FG001|Overall Study|Lost to Follow-up|35|||
19629465|NCT00642850|42078963|FG000|Overall Study|Protocol Violation|2|||
19629466|NCT00642850|42078963|FG000|Overall Study|Kidney transplantation|8|||
19528877|NCT02663908|41974573|FG000|Overall Study|Withdrawal by Subject|8|||
19528878|NCT02663908|41974574|FG001|Overall Study|Withdrawal by Subject|5|||
19528879|NCT02663908|41974573|FG000|Overall Study|Lost to Follow-up|1|||
19528880|NCT02663908|41974574|FG001|Overall Study|Lost to Follow-up|5|||
19528881|NCT02663908|41974573|FG000|Overall Study|Adverse Event|13|||
19528882|NCT02663908|41974574|FG001|Overall Study|Adverse Event|11|||
19528883|NCT02663908|41974573|FG000|Overall Study|Protocol Violation|1|||
19528884|NCT02663908|41974574|FG001|Overall Study|Protocol Violation|2|||
19528885|NCT02663908|41974573|FG000|Overall Study|Lack of therapeutic response|2|||
19528886|NCT02663908|41974574|FG001|Overall Study|Lack of therapeutic response|0|||
19528887|NCT02663908|41974573|FG000|Overall Study|COVID-19|1|||
19528888|NCT02663908|41974574|FG001|Overall Study|COVID-19|0|||
19528889|NCT02663908|41974573|FG000|Overall Study|Site closed|1|||
19528890|NCT02663908|41974574|FG001|Overall Study|Site closed|0|||
19528891|NCT02663908|41974573|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
19528892|NCT02663908|41974574|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
19528893|NCT02663908|41974573|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
19528894|NCT02663908|41974574|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
19528895|NCT02663908|41974573|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
19528896|NCT02663908|41974574|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
19528897|NCT02663908|41974573|FG000|Overall Study|Death|1|||
19528898|NCT02663908|41974574|FG001|Overall Study|Death|0|||
19528899|NCT02663908|41974573|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
19528900|NCT02663908|41974574|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
19528901|NCT02663908|41974573|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
19528902|NCT02663908|41974574|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
19528903|NCT02650284|41974582|FG000|Overall Study|Lost to Follow-up|3|||
19528904|NCT02650284|41974583|FG001|Overall Study|Lost to Follow-up|3|||
19528905|NCT02650284|41974582|FG000|Overall Study|Consent incorrectly taken|0|||
19528906|NCT02650284|41974583|FG001|Overall Study|Consent incorrectly taken|1|||
19528907|NCT02175030|41974591|FG000|Overall Study|Failed screen after consent|7|||
19528908|NCT02175030|41974592|FG001|Overall Study|Failed screen after consent|6|||
19528909|NCT02175030|41974591|FG000|Overall Study|Failed IUD Insertion|20|||
19528910|NCT02175030|41974592|FG001|Overall Study|Failed IUD Insertion|21|||
19528911|NCT02175030|41974591|FG000|Overall Study|Physician Decision|1|||
19528912|NCT02175030|41974592|FG001|Overall Study|Physician Decision|1|||
19528913|NCT02175030|41974591|FG000|Overall Study|Lost to Follow-up|6|||
19528914|NCT02175030|41974592|FG001|Overall Study|Lost to Follow-up|6|||
19528915|NCT02175030|41974591|FG000|Overall Study|Withdrawal by Subject|1|||
19528916|NCT02175030|41974592|FG001|Overall Study|Withdrawal by Subject|4|||
19528917|NCT02017717|41974607|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528918|NCT02017717|41974608|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528919|NCT02017717|41974609|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528920|NCT02017717|41974610|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
19528921|NCT02017717|41974611|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528922|NCT02017717|41974612|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528923|NCT02017717|41974613|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19450674|NCT01589445|41699207|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
19450675|NCT01588509|41699224|FG000|Overall Study|Lost to Follow-up|1|||
19450676|NCT01588509|41699225|FG001|Overall Study|Lost to Follow-up|0|||
19450677|NCT01588353|41699234|FG000|Step2|Withdrawal by Subject|0|||
19450678|NCT01588353|41699235|FG001|Step2|Withdrawal by Subject|1|||
19450679|NCT01588353|41699236|FG002|Step2|Withdrawal by Subject|0|||
19450680|NCT01588353|41699234|FG000|Step3|Adverse Event|0|||
19450681|NCT01588353|41699235|FG001|Step3|Adverse Event|0|||
19450682|NCT01588353|41699236|FG002|Step3|Adverse Event|2|||
19450683|NCT01588197|41699245|FG000|Overall Study|Lack of Efficacy|0|||
19450684|NCT01588197|41699246|FG001|Overall Study|Lack of Efficacy|1|||
19450685|NCT01588197|41699245|FG000|Overall Study|No MRI|1|||
19450686|NCT01588197|41699246|FG001|Overall Study|No MRI|0|||
19450687|NCT01561989|41699254|FG000|Overall Study|accural target not met.|5|||
19450688|NCT01561989|41699255|FG001|Overall Study|accural target not met.|6|||
19450689|NCT01587885|41699270|FG000|Treatment Period 1|Failure to Return|0|||
19450690|NCT01587885|41699271|FG001|Treatment Period 1|Failure to Return|1|||
19450691|NCT01587885|41699270|FG000|Treatment Period 1|Protocol Violation|0|||
19450692|NCT01587885|41699271|FG001|Treatment Period 1|Protocol Violation|2|||
19450693|NCT01587651|41699281|FG000|Overall Study|Adverse Event|0|||
19450694|NCT01587651|41699282|FG001|Overall Study|Adverse Event|1|||
19450695|NCT01587651|41699283|FG002|Overall Study|Adverse Event|0|||
19450696|NCT01587651|41699281|FG000|Overall Study|Protocol Violation|0|||
19528924|NCT02017717|41974614|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19528925|NCT02017717|41974615|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
19450697|NCT01587651|41699282|FG001|Overall Study|Protocol Violation|1|||
19450698|NCT01587651|41699283|FG002|Overall Study|Protocol Violation|1|||
19528926|NCT02017717|41974607|FG000|Before Treatment Period|Participant request to stop therapy|0|||
19528927|NCT02017717|41974608|FG001|Before Treatment Period|Participant request to stop therapy|0|||
19528928|NCT02017717|41974609|FG002|Before Treatment Period|Participant request to stop therapy|0|||
19528929|NCT02017717|41974610|FG003|Before Treatment Period|Participant request to stop therapy|0|||
19528930|NCT02017717|41974611|FG004|Before Treatment Period|Participant request to stop therapy|5|||
19528931|NCT02017717|41974612|FG005|Before Treatment Period|Participant request to stop therapy|0|||
19528932|NCT02017717|41974613|FG006|Before Treatment Period|Participant request to stop therapy|0|||
19528933|NCT02017717|41974614|FG007|Before Treatment Period|Participant request to stop therapy|0|||
19528934|NCT02017717|41974615|FG008|Before Treatment Period|Participant request to stop therapy|0|||
19528935|NCT02017717|41974607|FG000|Before Treatment Period|Participant withdrew consent|0|||
19528936|NCT02017717|41974608|FG001|Before Treatment Period|Participant withdrew consent|0|||
19528937|NCT02017717|41974609|FG002|Before Treatment Period|Participant withdrew consent|0|||
19528938|NCT02017717|41974610|FG003|Before Treatment Period|Participant withdrew consent|0|||
19528939|NCT02017717|41974611|FG004|Before Treatment Period|Participant withdrew consent|11|||
19528940|NCT02017717|41974612|FG005|Before Treatment Period|Participant withdrew consent|0|||
19528941|NCT02017717|41974613|FG006|Before Treatment Period|Participant withdrew consent|0|||
19528942|NCT02017717|41974614|FG007|Before Treatment Period|Participant withdrew consent|0|||
19528943|NCT02017717|41974615|FG008|Before Treatment Period|Participant withdrew consent|2|||
19450699|NCT01587651|41699281|FG000|Overall Study|Withdrawal by Subject|0|||
19450700|NCT01587651|41699282|FG001|Overall Study|Withdrawal by Subject|1|||
19450701|NCT01587651|41699283|FG002|Overall Study|Withdrawal by Subject|0|||
19450702|NCT01691859|41699305|FG000|Overall Study|Adverse Event|19|||
19450703|NCT01691859|41699305|FG000|Overall Study|Lack of Efficacy|11|||
19450704|NCT01691859|41699305|FG000|Overall Study|Protocol Violation|4|||
19450705|NCT01691859|41699305|FG000|Overall Study|Product commercially available|221|||
19450706|NCT01691859|41699305|FG000|Overall Study|Study closed/terminated|50|||
19450707|NCT01691859|41699305|FG000|Overall Study|Lost to Follow-up|5|||
19450708|NCT01691859|41699305|FG000|Overall Study|Physician Decision|6|||
19450709|NCT01691859|41699305|FG000|Overall Study|Withdrawal by Subject|31|||
19450710|NCT01691781|41699349|FG000|Overall Study|Withdrawal by Subject|4|||
19450711|NCT01691781|41699350|FG001|Overall Study|Withdrawal by Subject|3|||
19450712|NCT01691781|41699349|FG000|Overall Study|Physician Decision|1|||
19528944|NCT02017717|41974607|FG000|Before Treatment Period|Lost to Follow-up|0|||
19528945|NCT02017717|41974608|FG001|Before Treatment Period|Lost to Follow-up|0|||
19528946|NCT02017717|41974609|FG002|Before Treatment Period|Lost to Follow-up|0|||
19528947|NCT02017717|41974610|FG003|Before Treatment Period|Lost to Follow-up|0|||
19528948|NCT02017717|41974611|FG004|Before Treatment Period|Lost to Follow-up|1|||
19528949|NCT02017717|41974612|FG005|Before Treatment Period|Lost to Follow-up|0|||
19528950|NCT02017717|41974613|FG006|Before Treatment Period|Lost to Follow-up|0|||
19528951|NCT02017717|41974614|FG007|Before Treatment Period|Lost to Follow-up|0|||
19528952|NCT02017717|41974615|FG008|Before Treatment Period|Lost to Follow-up|0|||
19528953|NCT02017717|41974607|FG000|Before Treatment Period|Participant no longer met criteria|0|||
19528954|NCT02017717|41974608|FG001|Before Treatment Period|Participant no longer met criteria|0|||
19528955|NCT02017717|41974609|FG002|Before Treatment Period|Participant no longer met criteria|0|||
19450713|NCT01691781|41699350|FG001|Overall Study|Physician Decision|1|||
19450714|NCT01691781|41699349|FG000|Overall Study|Protocol Violation|2|||
19450715|NCT01691781|41699350|FG001|Overall Study|Protocol Violation|2|||
19450716|NCT01691781|41699349|FG000|Overall Study|Adverse Event|0|||
19450717|NCT01691781|41699350|FG001|Overall Study|Adverse Event|1|||
19450718|NCT01561755|41699358|FG000|Overall Study|Lost to Follow-up|0|||
19450719|NCT01561755|41699359|FG001|Overall Study|Lost to Follow-up|1|||
19450720|NCT01560819|41699367|FG000|Overall Study|Physician Decision|1|||
19450721|NCT01560819|41699368|FG001|Overall Study|Physician Decision|0|||
19450722|NCT01585155|41699386|FG000|Overall Study|Adverse Event|1|||
19450723|NCT01585155|41699386|FG000|Overall Study|Lack of Efficacy|2|||
19450724|NCT01585155|41699386|FG000|Overall Study|Worsening ulcerative colitis|2|||
19450725|NCT01560507|41699393|FG000|Overall Study|Lost to Follow-up|3|||
19450726|NCT01560507|41699394|FG001|Overall Study|Lost to Follow-up|1|||
19450727|NCT01560507|41699395|FG002|Overall Study|Lost to Follow-up|2|||
19450728|NCT01560507|41699393|FG000|Overall Study|Withdrawal by Subject|1|||
19450729|NCT01560507|41699394|FG001|Overall Study|Withdrawal by Subject|1|||
19450730|NCT01560507|41699395|FG002|Overall Study|Withdrawal by Subject|0|||
19450731|NCT01584843|41699410|FG000|First Treatment Period|Adverse Event|0|||
19450732|NCT01584843|41699411|FG001|First Treatment Period|Adverse Event|0|||
19450733|NCT01584843|41699412|FG002|First Treatment Period|Adverse Event|1|||
19450734|NCT01584843|41699413|FG003|First Treatment Period|Adverse Event|0|||
19450735|NCT01584843|41699414|FG004|First Treatment Period|Adverse Event|0|||
19450736|NCT01584843|41699415|FG005|First Treatment Period|Adverse Event|0|||
19450737|NCT01584843|41699410|FG000|First Treatment Period|Protocol Violation|0|||
19450738|NCT01584843|41699411|FG001|First Treatment Period|Protocol Violation|0|||
19450739|NCT01584843|41699412|FG002|First Treatment Period|Protocol Violation|0|||
19450740|NCT01584843|41699413|FG003|First Treatment Period|Protocol Violation|0|||
19528956|NCT02017717|41974610|FG003|Before Treatment Period|Participant no longer met criteria|1|||
19528957|NCT02017717|41974611|FG004|Before Treatment Period|Participant no longer met criteria|2|||
19528958|NCT02017717|41974612|FG005|Before Treatment Period|Participant no longer met criteria|0|||
19528959|NCT02017717|41974613|FG006|Before Treatment Period|Participant no longer met criteria|0|||
19528960|NCT02017717|41974614|FG007|Before Treatment Period|Participant no longer met criteria|1|||
19528961|NCT02017717|41974615|FG008|Before Treatment Period|Participant no longer met criteria|0|||
19528962|NCT02017717|41974607|FG000|Before Treatment Period|other reason|0|||
19528963|NCT02017717|41974608|FG001|Before Treatment Period|other reason|0|||
19528964|NCT02017717|41974609|FG002|Before Treatment Period|other reason|0|||
19528965|NCT02017717|41974610|FG003|Before Treatment Period|other reason|0|||
19528966|NCT02017717|41974611|FG004|Before Treatment Period|other reason|1|||
19528967|NCT02017717|41974612|FG005|Before Treatment Period|other reason|0|||
19528968|NCT02017717|41974613|FG006|Before Treatment Period|other reason|0|||
19528969|NCT02017717|41974614|FG007|Before Treatment Period|other reason|0|||
19528970|NCT02017717|41974615|FG008|Before Treatment Period|other reason|0|||
19528971|NCT02017717|41974607|FG000|Treatment Period|Disease progression|7|||
19528972|NCT02017717|41974608|FG001|Treatment Period|Disease progression|9|||
19528973|NCT02017717|41974609|FG002|Treatment Period|Disease progression|12|||
19528974|NCT02017717|41974610|FG003|Treatment Period|Disease progression|165|||
19528975|NCT02017717|41974611|FG004|Treatment Period|Disease progression|134|||
19528976|NCT02017717|41974612|FG005|Treatment Period|Disease progression|20|||
19528977|NCT02017717|41974613|FG006|Treatment Period|Disease progression|26|||
19528978|NCT02017717|41974614|FG007|Treatment Period|Disease progression|17|||
19528979|NCT02017717|41974615|FG008|Treatment Period|Disease progression|22|||
19528980|NCT02017717|41974607|FG000|Treatment Period|Study drug toxicity|3|||
19450741|NCT01584843|41699414|FG004|First Treatment Period|Protocol Violation|0|||
19450742|NCT01584843|41699415|FG005|First Treatment Period|Protocol Violation|1|||
19450743|NCT01584843|41699410|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
19450744|NCT01584843|41699411|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
19528981|NCT02017717|41974608|FG001|Treatment Period|Study drug toxicity|0|||
19528982|NCT02017717|41974609|FG002|Treatment Period|Study drug toxicity|1|||
19528983|NCT02017717|41974610|FG003|Treatment Period|Study drug toxicity|7|||
19528984|NCT02017717|41974611|FG004|Treatment Period|Study drug toxicity|11|||
19528985|NCT02017717|41974612|FG005|Treatment Period|Study drug toxicity|4|||
19528986|NCT02017717|41974613|FG006|Treatment Period|Study drug toxicity|4|||
19450745|NCT01584843|41699412|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
19450746|NCT01584843|41699413|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
19450747|NCT01584843|41699414|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
19450748|NCT01584843|41699415|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
19450749|NCT01584843|41699410|FG000|Second Treatment Period|Withdrawal by Subject|0|||
19450750|NCT01584843|41699411|FG001|Second Treatment Period|Withdrawal by Subject|0|||
19450751|NCT01584843|41699412|FG002|Second Treatment Period|Withdrawal by Subject|0|||
19450752|NCT01584843|41699413|FG003|Second Treatment Period|Withdrawal by Subject|0|||
19450753|NCT01584843|41699414|FG004|Second Treatment Period|Withdrawal by Subject|0|||
19450754|NCT01584843|41699415|FG005|Second Treatment Period|Withdrawal by Subject|1|||
19450755|NCT01560429|41699433|FG000|Overall Study|Protocol Violation|3|||
19450756|NCT01560429|41699434|FG001|Overall Study|Protocol Violation|6|||
19450757|NCT01582971|41699444|FG000|Overall Study|Death|2|||
19450758|NCT01582971|41699445|FG001|Overall Study|Death|1|||
19450759|NCT01582971|41699444|FG000|Overall Study|Lost to Follow-up|18|||
19450760|NCT01582971|41699445|FG001|Overall Study|Lost to Follow-up|21|||
19450761|NCT01582971|41699444|FG000|Overall Study|Withdrawal by Subject|4|||
19450762|NCT01582971|41699445|FG001|Overall Study|Withdrawal by Subject|2|||
19450763|NCT01582971|41699444|FG000|Overall Study|Other|15|||
19450764|NCT01582971|41699445|FG001|Overall Study|Other|13|||
19450765|NCT01690299|41699460|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
19450766|NCT01690299|41699461|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
19450767|NCT01690299|41699462|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
19450768|NCT01690299|41699463|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
19450769|NCT01690299|41699464|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
19450770|NCT01690299|41699465|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
19450771|NCT01690299|41699460|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
19450772|NCT01690299|41699461|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19450773|NCT01690299|41699462|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19450774|NCT01690299|41699463|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19528987|NCT02017717|41974614|FG007|Treatment Period|Study drug toxicity|5|||
19528988|NCT02017717|41974615|FG008|Treatment Period|Study drug toxicity|3|||
19528989|NCT02017717|41974607|FG000|Treatment Period|Death|0|||
19450775|NCT01690299|41699464|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19528990|NCT02017717|41974608|FG001|Treatment Period|Death|0|||
19528991|NCT02017717|41974609|FG002|Treatment Period|Death|1|||
19528992|NCT02017717|41974610|FG003|Treatment Period|Death|0|||
19450776|NCT01690299|41699465|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
19450777|NCT01690299|41699460|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
19450778|NCT01690299|41699461|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
19450779|NCT01690299|41699462|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19450780|NCT01690299|41699463|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19450781|NCT01690299|41699464|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19450782|NCT01690299|41699465|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
19450783|NCT01690299|41699460|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
19450784|NCT01690299|41699461|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
19450785|NCT01690299|41699462|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
19450786|NCT01690299|41699463|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
19450787|NCT01690299|41699464|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
19450788|NCT01690299|41699465|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
19450789|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
19450790|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
19450791|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
19450792|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
19450793|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
19450794|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
19450795|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
19450796|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
19450797|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
19450798|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
19450799|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
19450800|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
19450801|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
19450802|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
19450803|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
19450804|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
19450805|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
19450806|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
19450807|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
19450808|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
19450809|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
19450810|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
19450811|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
19450812|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
19450813|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
19450814|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
19450815|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
19450816|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
19450817|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
19450818|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
19450819|NCT01690299|41699460|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
19450820|NCT01690299|41699461|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
19450821|NCT01690299|41699462|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
19450822|NCT01690299|41699463|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
19450823|NCT01690299|41699464|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
19450824|NCT01690299|41699465|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
19450825|NCT01690143|41699494|FG000|Overall Study|Withdrawal by Subject|1|||
19450826|NCT01559259|41699517|FG000|Overall Study|Withdrawal by Subject|0|||
19450827|NCT01559259|41699518|FG001|Overall Study|Withdrawal by Subject|0|||
19450828|NCT01559259|41699519|FG002|Overall Study|Withdrawal by Subject|0|||
19450829|NCT01559259|41699520|FG003|Overall Study|Withdrawal by Subject|1|||
19450830|NCT01559259|41699521|FG004|Overall Study|Withdrawal by Subject|0|||
19450831|NCT01559259|41699517|FG000|Overall Study|Adverse Event|0|||
19450832|NCT01559259|41699518|FG001|Overall Study|Adverse Event|1|||
19450833|NCT01559259|41699519|FG002|Overall Study|Adverse Event|1|||
19450834|NCT01559259|41699520|FG003|Overall Study|Adverse Event|0|||
19528993|NCT02017717|41974611|FG004|Treatment Period|Death|0|||
19528994|NCT02017717|41974612|FG005|Treatment Period|Death|0|||
19528995|NCT02017717|41974613|FG006|Treatment Period|Death|0|||
19528996|NCT02017717|41974614|FG007|Treatment Period|Death|1|||
19528997|NCT02017717|41974615|FG008|Treatment Period|Death|0|||
19528998|NCT02017717|41974607|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
19629467|NCT00642850|42078963|FG000|Overall Study|Blood transfusion|6|||
19629468|NCT00642850|42078963|FG000|Overall Study|Other reasons|7|||
19528999|NCT02017717|41974608|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
19529000|NCT02017717|41974609|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
19529001|NCT02017717|41974610|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
19529002|NCT02017717|41974611|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
19529003|NCT02017717|41974612|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
19529004|NCT02017717|41974613|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
19529005|NCT02017717|41974614|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
19529006|NCT02017717|41974615|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
19529007|NCT02017717|41974607|FG000|Treatment Period|Participant request to stop therapy|0|||
19529008|NCT02017717|41974608|FG001|Treatment Period|Participant request to stop therapy|0|||
19529009|NCT02017717|41974609|FG002|Treatment Period|Participant request to stop therapy|3|||
19529010|NCT02017717|41974610|FG003|Treatment Period|Participant request to stop therapy|4|||
19529011|NCT02017717|41974611|FG004|Treatment Period|Participant request to stop therapy|7|||
19529012|NCT02017717|41974612|FG005|Treatment Period|Participant request to stop therapy|5|||
19529013|NCT02017717|41974613|FG006|Treatment Period|Participant request to stop therapy|0|||
19529014|NCT02017717|41974614|FG007|Treatment Period|Participant request to stop therapy|2|||
19529015|NCT02017717|41974615|FG008|Treatment Period|Participant request to stop therapy|1|||
19529016|NCT02017717|41974607|FG000|Treatment Period|Participant withdrew consent|0|||
19529017|NCT02017717|41974608|FG001|Treatment Period|Participant withdrew consent|0|||
19529018|NCT02017717|41974609|FG002|Treatment Period|Participant withdrew consent|1|||
19529019|NCT02017717|41974610|FG003|Treatment Period|Participant withdrew consent|1|||
19529020|NCT02017717|41974611|FG004|Treatment Period|Participant withdrew consent|4|||
19529021|NCT02017717|41974612|FG005|Treatment Period|Participant withdrew consent|0|||
19529022|NCT02017717|41974613|FG006|Treatment Period|Participant withdrew consent|0|||
19529023|NCT02017717|41974614|FG007|Treatment Period|Participant withdrew consent|2|||
19529024|NCT02017717|41974615|FG008|Treatment Period|Participant withdrew consent|0|||
19529025|NCT02017717|41974607|FG000|Treatment Period|Participant no longer met criteria|0|||
19529026|NCT02017717|41974608|FG001|Treatment Period|Participant no longer met criteria|0|||
19529027|NCT02017717|41974609|FG002|Treatment Period|Participant no longer met criteria|0|||
19529028|NCT02017717|41974610|FG003|Treatment Period|Participant no longer met criteria|0|||
19529029|NCT02017717|41974611|FG004|Treatment Period|Participant no longer met criteria|1|||
19529030|NCT02017717|41974612|FG005|Treatment Period|Participant no longer met criteria|0|||
19529031|NCT02017717|41974613|FG006|Treatment Period|Participant no longer met criteria|0|||
19529032|NCT02017717|41974614|FG007|Treatment Period|Participant no longer met criteria|0|||
19529033|NCT02017717|41974615|FG008|Treatment Period|Participant no longer met criteria|0|||
19529034|NCT02017717|41974607|FG000|Treatment Period|other reasons|0|||
19529035|NCT02017717|41974608|FG001|Treatment Period|other reasons|0|||
19529036|NCT02017717|41974609|FG002|Treatment Period|other reasons|0|||
19529037|NCT02017717|41974610|FG003|Treatment Period|other reasons|0|||
19529038|NCT02017717|41974611|FG004|Treatment Period|other reasons|1|||
19529039|NCT02017717|41974612|FG005|Treatment Period|other reasons|0|||
19529040|NCT02017717|41974613|FG006|Treatment Period|other reasons|0|||
19529041|NCT02017717|41974614|FG007|Treatment Period|other reasons|1|||
19529042|NCT02017717|41974615|FG008|Treatment Period|other reasons|1|||
19529043|NCT02017717|41974607|FG000|Treatment Period|Maximum clinical benefit|0|||
19529044|NCT02017717|41974608|FG001|Treatment Period|Maximum clinical benefit|0|||
19529045|NCT02017717|41974609|FG002|Treatment Period|Maximum clinical benefit|0|||
19529046|NCT02017717|41974610|FG003|Treatment Period|Maximum clinical benefit|0|||
19529047|NCT02017717|41974611|FG004|Treatment Period|Maximum clinical benefit|1|||
19529048|NCT02017717|41974612|FG005|Treatment Period|Maximum clinical benefit|0|||
19529049|NCT02017717|41974613|FG006|Treatment Period|Maximum clinical benefit|0|||
19529050|NCT02017717|41974614|FG007|Treatment Period|Maximum clinical benefit|0|||
19529051|NCT02017717|41974615|FG008|Treatment Period|Maximum clinical benefit|0|||
19529052|NCT00316888|41974662|FG000|Overall Study|Adverse Event|4|||
19529053|NCT00316888|41974663|FG001|Overall Study|Adverse Event|5|||
19529054|NCT00316888|41974662|FG000|Overall Study|Withdrawal by Subject|2|||
19529055|NCT00316888|41974663|FG001|Overall Study|Withdrawal by Subject|2|||
19529056|NCT00316888|41974662|FG000|Overall Study|Not start protocol therapy|0|||
19529057|NCT00316888|41974663|FG001|Overall Study|Not start protocol therapy|1|||
19529058|NCT03096834|41974671|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
19529059|NCT03096834|41974672|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
19529060|NCT03096834|41974673|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
19529061|NCT03096834|41974674|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
19529062|NCT03096834|41974671|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
19529063|NCT03096834|41974672|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
19529064|NCT03096834|41974673|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
19529065|NCT03096834|41974674|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
19529066|NCT03096834|41974671|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
19529067|NCT03096834|41974672|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
19529068|NCT03096834|41974673|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
19529069|NCT03096834|41974674|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
19529070|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
19529071|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
19529072|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
19529073|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
19529074|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
19529075|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
19529076|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
19529077|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
19529078|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
19529079|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
19529080|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
19529081|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
19529082|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
19529083|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
19529084|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
19529085|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
19529086|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
19529087|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
19529088|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
19529089|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
19529090|NCT03096834|41974671|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
19529091|NCT03096834|41974672|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
19529092|NCT03096834|41974673|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
19529093|NCT03096834|41974674|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
19529094|NCT03096834|41974671|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
19450835|NCT01559259|41699521|FG004|Overall Study|Adverse Event|0|||
19450836|NCT01670500|41699545|FG000|Overall Study|Withdrawal by Subject|1|||
19450837|NCT01670500|41699546|FG001|Overall Study|Withdrawal by Subject|0|||
19450838|NCT02400736|41699554|FG000|Overall Study|Lost to Follow-up|6|||
19450839|NCT02400736|41699555|FG001|Overall Study|Lost to Follow-up|6|||
19450840|NCT02400736|41699554|FG000|Overall Study|Withdrawal by Subject|2|||
19529095|NCT03096834|41974672|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
19529096|NCT03096834|41974673|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
19529097|NCT03096834|41974674|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
19529098|NCT03096834|41974671|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
19529099|NCT03096834|41974672|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
19529100|NCT03096834|41974673|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
19529101|NCT03096834|41974674|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
19529102|NCT03096834|41974671|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
19529103|NCT03096834|41974672|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
19529104|NCT03096834|41974673|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
19529105|NCT03096834|41974674|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
19529106|NCT03015194|41974683|FG000|Overall Study|Death|10|||
19529107|NCT03015194|41974683|FG000|Overall Study|Withdrawal by Subject|2|||
19529108|NCT03012815|41974690|FG000|Overall Study|Lost to Follow-up|1|||
19529109|NCT03012815|41974691|FG001|Overall Study|Lost to Follow-up|0|||
19529110|NCT03012815|41974690|FG000|Overall Study|Physician Decision|3|||
19529111|NCT03012815|41974691|FG001|Overall Study|Physician Decision|2|||
19529112|NCT03012815|41974690|FG000|Overall Study|Adverse Event|1|||
19529113|NCT03012815|41974691|FG001|Overall Study|Adverse Event|0|||
19529114|NCT03001011|41974700|FG000|Overall Study|Adverse Event|9|||
19529115|NCT03001011|41974701|FG001|Overall Study|Adverse Event|3|||
19529116|NCT03001011|41974700|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
19529117|NCT03001011|41974701|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
19529118|NCT03001011|41974700|FG000|Overall Study|Other than specified above|3|||
19529119|NCT03001011|41974701|FG001|Overall Study|Other than specified above|8|||
19529120|NCT02993757|41974710|FG000|Overall Study|Non compliance with the protocol|155|||
19529121|NCT02993757|41974711|FG001|Overall Study|Non compliance with the protocol|170|||
19529122|NCT02993757|41974710|FG000|Overall Study|Lost to Follow-up|1|||
19529123|NCT02993757|41974711|FG001|Overall Study|Lost to Follow-up|0|||
19529124|NCT02993757|41974710|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
19529125|NCT02993757|41974711|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
19529126|NCT02979535|41974719|FG000|Overall Study|Non compliance with the protocol|78|||
19529127|NCT02979535|41974720|FG001|Overall Study|Non compliance with the protocol|82|||
19629469|NCT00455455|42078967|FG000|Washout|Withdrawal by Subject|0|||
19629470|NCT00455455|42078968|FG001|Washout|Withdrawal by Subject|1|||
19450841|NCT02400736|41699555|FG001|Overall Study|Withdrawal by Subject|1|||
19529128|NCT02979535|41974719|FG000|Overall Study|Consent withdrawn by participant|11|||
19529129|NCT02979535|41974720|FG001|Overall Study|Consent withdrawn by participant|18|||
19450842|NCT02400736|41699554|FG000|Overall Study|Moved from the area|3|||
19450843|NCT02400736|41699555|FG001|Overall Study|Moved from the area|1|||
19450844|NCT01689519|41699567|FG000|Intent to Treat|Death|157|||
19450845|NCT01689519|41699568|FG001|Intent to Treat|Death|167|||
19450846|NCT01689519|41699567|FG000|Intent to Treat|Lost to Follow-up|4|||
19450847|NCT01689519|41699568|FG001|Intent to Treat|Lost to Follow-up|8|||
19450848|NCT01689519|41699567|FG000|Intent to Treat|Other|2|||
19450849|NCT01689519|41699568|FG001|Intent to Treat|Other|4|||
19450850|NCT01689519|41699567|FG000|Intent to Treat|Physician Decision|4|||
19450851|NCT01689519|41699568|FG001|Intent to Treat|Physician Decision|1|||
19450852|NCT01689519|41699567|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
19450853|NCT01689519|41699568|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
19450854|NCT01689519|41699567|FG000|Intent to Treat|Withdrawal by Subject|21|||
19450855|NCT01689519|41699568|FG001|Intent to Treat|Withdrawal by Subject|20|||
19450856|NCT01689519|41699567|FG000|Safety Population|Death|158|||
19450857|NCT01689519|41699568|FG001|Safety Population|Death|165|||
19450858|NCT01689519|41699567|FG000|Safety Population|Lost to Follow-up|4|||
19450859|NCT01689519|41699568|FG001|Safety Population|Lost to Follow-up|8|||
19450860|NCT01689519|41699567|FG000|Safety Population|Other|2|||
19450861|NCT01689519|41699568|FG001|Safety Population|Other|4|||
19450862|NCT01689519|41699567|FG000|Safety Population|Physician Decision|4|||
19450863|NCT01689519|41699568|FG001|Safety Population|Physician Decision|1|||
19450864|NCT01689519|41699567|FG000|Safety Population|Study Terminated By Sponsor|60|||
19450865|NCT01689519|41699568|FG001|Safety Population|Study Terminated By Sponsor|47|||
19450866|NCT01689519|41699567|FG000|Safety Population|Withdrawal by Subject|20|||
19450867|NCT01689519|41699568|FG001|Safety Population|Withdrawal by Subject|20|||
19450868|NCT01689363|41699574|FG000|Overall Study|Protocol Violation|0|||
19450869|NCT01689363|41699575|FG001|Overall Study|Protocol Violation|1|||
19529130|NCT02979535|41974719|FG000|Overall Study|Lost to Follow-up|6|||
19529131|NCT02979535|41974720|FG001|Overall Study|Lost to Follow-up|1|||
19529132|NCT02978716|41974729|FG000|Overall Study|Death|25|||
19529133|NCT02978716|41974730|FG001|Overall Study|Death|13|||
19529134|NCT02978716|41974731|FG002|Overall Study|Death|20|||
19529135|NCT02978716|41974729|FG000|Overall Study|Lost to Follow-up|0|||
19529136|NCT02978716|41974730|FG001|Overall Study|Lost to Follow-up|0|||
19529137|NCT02978716|41974731|FG002|Overall Study|Lost to Follow-up|1|||
19529138|NCT02978716|41974729|FG000|Overall Study|Withdrawal by Subject|6|||
19529139|NCT02978716|41974730|FG001|Overall Study|Withdrawal by Subject|4|||
19529140|NCT02978716|41974731|FG002|Overall Study|Withdrawal by Subject|5|||
19529141|NCT02978716|41974729|FG000|Overall Study|Sponsor terminated|2|||
19629471|NCT00455455|42078967|FG000|Washout|Withdrawal by Subject|1|||
19629472|NCT00455455|42078968|FG001|Washout|Withdrawal by Subject|0|||
19629473|NCT03840811|42078980|FG000|Overall Study|Lost to Follow-up|0|||
19629474|NCT03840811|42078981|FG001|Overall Study|Lost to Follow-up|0|||
19629475|NCT03840811|42078982|FG002|Overall Study|Lost to Follow-up|1|||
19629476|NCT00640510|42078992|FG000|Overall Study|Lack of Efficacy|0|||
19629477|NCT00640510|42078993|FG001|Overall Study|Lack of Efficacy|1|||
19629478|NCT00640510|42078992|FG000|Overall Study|Protocol Violation|1|||
19629479|NCT00640510|42078993|FG001|Overall Study|Protocol Violation|0|||
19629480|NCT00640510|42078992|FG000|Overall Study|Physician Decision|0|||
19629481|NCT00640510|42078993|FG001|Overall Study|Physician Decision|1|||
19629482|NCT00813800|42078999|FG000|Overall Study|Screen Failure after Consent|2|||
19629483|NCT00813800|42078999|FG000|Overall Study|Adverse Event|1|||
19629484|NCT00813800|42078999|FG000|Overall Study|Worsening of depression|2|||
19629485|NCT00813800|42078999|FG000|Overall Study|Physician Decision|1|||
19629486|NCT00627016|42079005|FG000|Overall Study|Adverse Event|1|||
19629487|NCT00627016|42079006|FG001|Overall Study|Adverse Event|1|||
19629488|NCT00627016|42079005|FG000|Overall Study|Protocol Violation|0|||
19629489|NCT00627016|42079006|FG001|Overall Study|Protocol Violation|2|||
19629490|NCT00627016|42079005|FG000|Overall Study|Lost to Follow-up|0|||
19629491|NCT00627016|42079006|FG001|Overall Study|Lost to Follow-up|1|||
19629492|NCT00627016|42079005|FG000|Overall Study|Withdrawal by Subject|2|||
19629493|NCT00627016|42079006|FG001|Overall Study|Withdrawal by Subject|1|||
19629494|NCT00627016|42079005|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
19629495|NCT00627016|42079006|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
19629496|NCT00627016|42079005|FG000|Overall Study|Lack of Efficacy|1|||
19629497|NCT00627016|42079006|FG001|Overall Study|Lack of Efficacy|0|||
19629498|NCT00627016|42079005|FG000|Overall Study|Placed on Excluded Drugs|1|||
19629499|NCT00627016|42079006|FG001|Overall Study|Placed on Excluded Drugs|0|||
19629500|NCT00627016|42079005|FG000|Overall Study|Pregnancy|1|||
19629501|NCT00627016|42079006|FG001|Overall Study|Pregnancy|0|||
19629502|NCT00794664|42079014|FG000|Treatment Period|Withdrawal by Subject|0|||
19629503|NCT00794664|42079015|FG001|Treatment Period|Withdrawal by Subject|2|||
19629504|NCT00794664|42079014|FG000|Treatment Period|Protocol non-compliance|0|||
19629505|NCT00794664|42079015|FG001|Treatment Period|Protocol non-compliance|1|||
19629506|NCT00794664|42079014|FG000|Treatment Period|Other|0|||
19629507|NCT00794664|42079015|FG001|Treatment Period|Other|1|||
19450870|NCT01689363|41699576|FG002|Overall Study|Protocol Violation|0|||
19450871|NCT01689363|41699577|FG003|Overall Study|Protocol Violation|0|||
19529142|NCT02978716|41974730|FG001|Overall Study|Sponsor terminated|13|||
19450872|NCT01689363|41699578|FG004|Overall Study|Protocol Violation|0|||
19450873|NCT01689363|41699579|FG005|Overall Study|Protocol Violation|0|||
19529143|NCT02978716|41974731|FG002|Overall Study|Sponsor terminated|9|||
19529144|NCT02978716|41974729|FG000|Overall Study|Other|1|||
19529145|NCT02978716|41974730|FG001|Overall Study|Other|3|||
19529146|NCT02978716|41974731|FG002|Overall Study|Other|0|||
19529147|NCT02973321|41974746|FG000|Overall Study|Other than specified|0|||
19529148|NCT02973321|41974747|FG001|Overall Study|Other than specified|5|||
19529149|NCT02973321|41974748|FG002|Overall Study|Other than specified|3|||
19529150|NCT02973321|41974749|FG003|Overall Study|Other than specified|3|||
19529151|NCT02973321|41974750|FG004|Overall Study|Other than specified|1|||
19529152|NCT02973321|41974746|FG000|Overall Study|Lack of Efficacy|0|||
19529153|NCT02973321|41974747|FG001|Overall Study|Lack of Efficacy|0|||
19529154|NCT02973321|41974748|FG002|Overall Study|Lack of Efficacy|0|||
19529155|NCT02973321|41974749|FG003|Overall Study|Lack of Efficacy|0|||
19529156|NCT02973321|41974750|FG004|Overall Study|Lack of Efficacy|1|||
19529157|NCT02973321|41974746|FG000|Overall Study|Adverse Event|1|||
19529158|NCT02973321|41974747|FG001|Overall Study|Adverse Event|10|||
19529159|NCT02973321|41974748|FG002|Overall Study|Adverse Event|11|||
19450874|NCT01689363|41699580|FG006|Overall Study|Protocol Violation|0|||
19450875|NCT01689363|41699581|FG007|Overall Study|Protocol Violation|0|||
19450876|NCT01558635|41699597|FG000|Overall Study|Death|1|||
19450877|NCT01558635|41699597|FG000|Overall Study|Withdrawal by Subject|2|||
19529160|NCT02973321|41974749|FG003|Overall Study|Adverse Event|13|||
19529161|NCT02973321|41974750|FG004|Overall Study|Adverse Event|3|||
19529162|NCT02943785|41974765|FG000|Overall Study|Adverse Event|112|||
19529163|NCT02943785|41974766|FG001|Overall Study|Adverse Event|97|||
19529164|NCT02943785|41974765|FG000|Overall Study|Withdrawal by Subject|63|||
19529165|NCT02943785|41974766|FG001|Overall Study|Withdrawal by Subject|126|||
19529166|NCT02943785|41974765|FG000|Overall Study|Physician Decision|23|||
19529167|NCT02943785|41974766|FG001|Overall Study|Physician Decision|47|||
19629508|NCT00794664|42079014|FG000|Treatment Period|Adverse Event|1|||
19629509|NCT00794664|42079015|FG001|Treatment Period|Adverse Event|8|||
19629510|NCT00794664|42079014|FG000|Follow-up Period|Other|1|||
19629511|NCT00794664|42079015|FG001|Follow-up Period|Other|2|||
19629512|NCT00794664|42079014|FG000|Follow-up Period|Withdrawal by Subject|0|||
19629513|NCT00794664|42079015|FG001|Follow-up Period|Withdrawal by Subject|2|||
19629514|NCT00794664|42079014|FG000|Follow-up Period|Protocol non-compliance|0|||
19629515|NCT00794664|42079015|FG001|Follow-up Period|Protocol non-compliance|1|||
19629516|NCT00444535|42079021|FG000|Overall Study|Withdrawal by Subject|5|||
19629517|NCT00444535|42079021|FG000|Overall Study|Physician Decision|5|||
19629518|NCT00444535|42079021|FG000|Overall Study|progressive disease|1|||
19629519|NCT00444535|42079021|FG000|Overall Study|Adverse Event|2|||
19629520|NCT00847613|42079029|FG000|Overall Study|Ongoing at cut-off date|250|||
19629521|NCT00847613|42079030|FG001|Overall Study|Ongoing at cut-off date|265|||
19629522|NCT00847613|42079031|FG002|Overall Study|Ongoing at cut-off date|64|||
19629523|NCT00847613|42079032|FG003|Overall Study|Ongoing at cut-off date|64|||
19629524|NCT00847613|42079029|FG000|Overall Study|Death|1|||
19629525|NCT00847613|42079030|FG001|Overall Study|Death|1|||
19629526|NCT00847613|42079031|FG002|Overall Study|Death|0|||
19629527|NCT00847613|42079032|FG003|Overall Study|Death|0|||
19629528|NCT00847613|42079029|FG000|Overall Study|Adverse Event|36|||
19629529|NCT00847613|42079030|FG001|Overall Study|Adverse Event|26|||
19629530|NCT00847613|42079031|FG002|Overall Study|Adverse Event|5|||
19629531|NCT00847613|42079032|FG003|Overall Study|Adverse Event|6|||
19629532|NCT00847613|42079029|FG000|Overall Study|Lack of Efficacy|7|||
19629533|NCT00847613|42079030|FG001|Overall Study|Lack of Efficacy|3|||
19629534|NCT00847613|42079031|FG002|Overall Study|Lack of Efficacy|3|||
19629535|NCT00847613|42079032|FG003|Overall Study|Lack of Efficacy|1|||
19629536|NCT00847613|42079029|FG000|Overall Study|Study terminated by Sponsor|1|||
19629537|NCT00847613|42079030|FG001|Overall Study|Study terminated by Sponsor|0|||
19629538|NCT00847613|42079031|FG002|Overall Study|Study terminated by Sponsor|2|||
19629539|NCT00847613|42079032|FG003|Overall Study|Study terminated by Sponsor|1|||
19629540|NCT00847613|42079029|FG000|Overall Study|Lost to Follow-up|5|||
19629541|NCT00847613|42079030|FG001|Overall Study|Lost to Follow-up|0|||
19629542|NCT00847613|42079031|FG002|Overall Study|Lost to Follow-up|0|||
19629543|NCT00847613|42079032|FG003|Overall Study|Lost to Follow-up|3|||
19450878|NCT01558635|41699597|FG000|Overall Study|Physician Decision|1|||
19450879|NCT01558635|41699597|FG000|Overall Study|Subject received other treatment|1|||
19450880|NCT01558635|41699597|FG000|Overall Study|Reveal XT was explanted|1|||
19450881|NCT00089986|41699611|FG000|Overall Study|Adverse Event|6|||
19629544|NCT00847613|42079029|FG000|Overall Study|Protocol Violation|6|||
19629545|NCT00847613|42079030|FG001|Overall Study|Protocol Violation|6|||
19629546|NCT00847613|42079031|FG002|Overall Study|Protocol Violation|3|||
19629547|NCT00847613|42079032|FG003|Overall Study|Protocol Violation|1|||
19629548|NCT00847613|42079029|FG000|Overall Study|Pregnancy|1|||
19450882|NCT00089986|41699612|FG001|Overall Study|Adverse Event|9|||
19529168|NCT02943785|41974765|FG000|Overall Study|Death|46|||
19529169|NCT02943785|41974766|FG001|Overall Study|Death|46|||
19629549|NCT00847613|42079030|FG001|Overall Study|Pregnancy|1|||
19450883|NCT00089986|41699613|FG002|Overall Study|Adverse Event|6|||
19450884|NCT00089986|41699611|FG000|Overall Study|Lost to Follow-up|3|||
19529170|NCT02943785|41974765|FG000|Overall Study|Lost to Follow-up|1|||
19529171|NCT02943785|41974766|FG001|Overall Study|Lost to Follow-up|0|||
19529172|NCT02943785|41974765|FG000|Overall Study|Other|16|||
19529173|NCT02943785|41974766|FG001|Overall Study|Other|19|||
19529174|NCT02943785|41974765|FG000|Overall Study|Did not receive any study medication|21|||
19529175|NCT02943785|41974766|FG001|Overall Study|Did not receive any study medication|28|||
19529176|NCT02923674|41974775|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
19529177|NCT02923674|41974776|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
19529178|NCT02923674|41974777|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
19529179|NCT02923674|41974775|FG000|Overall Study|Lost to Follow-up|7|||
19529180|NCT02923674|41974776|FG001|Overall Study|Lost to Follow-up|12|||
19529181|NCT02923674|41974777|FG002|Overall Study|Lost to Follow-up|7|||
19529182|NCT02923674|41974775|FG000|Overall Study|Problem with intervention|2|||
19529183|NCT02923674|41974776|FG001|Overall Study|Problem with intervention|2|||
19529184|NCT02923674|41974777|FG002|Overall Study|Problem with intervention|1|||
19529185|NCT02923674|41974775|FG000|Overall Study|Adverse Event|3|||
19529186|NCT02923674|41974776|FG001|Overall Study|Adverse Event|1|||
19529187|NCT02923674|41974777|FG002|Overall Study|Adverse Event|1|||
19529188|NCT02923674|41974775|FG000|Overall Study|Withdrawal by Subject|2|||
19529189|NCT02923674|41974776|FG001|Overall Study|Withdrawal by Subject|2|||
19529190|NCT02923674|41974777|FG002|Overall Study|Withdrawal by Subject|2|||
19529191|NCT02921971|41974787|FG000|Overall Study|Adverse Event|1|||
19529192|NCT02921971|41974788|FG001|Overall Study|Adverse Event|2|||
19529193|NCT02921971|41974787|FG000|Overall Study|Lack of Efficacy|3|||
19529194|NCT02921971|41974788|FG001|Overall Study|Lack of Efficacy|1|||
19529195|NCT02921971|41974787|FG000|Overall Study|Other than specified above|2|||
19529196|NCT02921971|41974788|FG001|Overall Study|Other than specified above|1|||
19529197|NCT02886286|41974796|FG000|Overall Study|pump motor stall|0|||
19529198|NCT02886286|41974797|FG001|Overall Study|pump motor stall|1|||
19529199|NCT02865187|41974805|FG000|Overall Study|Lost to Follow-up|12|||
19529200|NCT02865187|41974806|FG001|Overall Study|Lost to Follow-up|7|||
19529201|NCT02865187|41974805|FG000|Overall Study|Adverse Event|1|||
19529202|NCT02865187|41974806|FG001|Overall Study|Adverse Event|0|||
19529203|NCT02824198|41974814|FG000|Overall Study|Non-compliance with the protocol|5|||
19529204|NCT02824198|41974815|FG001|Overall Study|Non-compliance with the protocol|1|||
19529205|NCT02824198|41974814|FG000|Overall Study|Lost to Follow-up|5|||
19529206|NCT02824198|41974815|FG001|Overall Study|Lost to Follow-up|2|||
19529207|NCT02824198|41974814|FG000|Overall Study|Withdrawal by Subject|5|||
19529208|NCT02824198|41974815|FG001|Overall Study|Withdrawal by Subject|0|||
19529209|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Adverse Event|10|||
19529210|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Adverse Event|0|||
19529211|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
19529212|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
19529213|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
19529214|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
19529215|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
19529216|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
19529217|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
19529218|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
19529219|NCT02787551|41974825|FG000|Core Period: 26 Weeks|Other than specified|3|||
19529220|NCT02787551|41974826|FG001|Core Period: 26 Weeks|Other than specified|1|||
19529221|NCT02787551|41974825|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
19529222|NCT02787551|41974826|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
19529223|NCT02787551|41974825|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
19529224|NCT02787551|41974826|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
19529225|NCT02787551|41974825|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
19529226|NCT02787551|41974826|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
19529227|NCT02735044|41974846|FG000|Overall Study|Adverse Event|3|||
19529228|NCT02735044|41974847|FG001|Overall Study|Adverse Event|3|||
19529229|NCT02735044|41974846|FG000|Overall Study|Lack of Efficacy|1|||
19529230|NCT02735044|41974847|FG001|Overall Study|Lack of Efficacy|0|||
19529231|NCT02735044|41974846|FG000|Overall Study|Poor compliance to protocol|7|||
19529232|NCT02735044|41974847|FG001|Overall Study|Poor compliance to protocol|7|||
19529233|NCT02735044|41974846|FG000|Overall Study|Randomized and not treated|0|||
19629550|NCT00847613|42079031|FG002|Overall Study|Pregnancy|0|||
19450885|NCT00089986|41699612|FG001|Overall Study|Lost to Follow-up|1|||
19450886|NCT00089986|41699613|FG002|Overall Study|Lost to Follow-up|1|||
19450887|NCT00089986|41699611|FG000|Overall Study|Protocol Violation|0|||
19450888|NCT00089986|41699612|FG001|Overall Study|Protocol Violation|1|||
19450889|NCT00089986|41699613|FG002|Overall Study|Protocol Violation|0|||
19450890|NCT00089986|41699611|FG000|Overall Study|Patient transferred to another hospital|2|||
19450891|NCT00089986|41699612|FG001|Overall Study|Patient transferred to another hospital|1|||
19450892|NCT00089986|41699613|FG002|Overall Study|Patient transferred to another hospital|0|||
19450893|NCT00089986|41699611|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
19529234|NCT02735044|41974847|FG001|Overall Study|Randomized and not treated|2|||
19529235|NCT02735044|41974846|FG000|Overall Study|Other, not specified above|5|||
19529236|NCT02735044|41974847|FG001|Overall Study|Other, not specified above|11|||
19529237|NCT02720744|41974855|FG000|Overall Study|Protocol Violation|0|||
19529238|NCT02720744|41974856|FG001|Overall Study|Protocol Violation|2|||
19529239|NCT02720744|41974855|FG000|Overall Study|Pregnancy|2|||
19529240|NCT02720744|41974856|FG001|Overall Study|Pregnancy|0|||
19529241|NCT02720744|41974855|FG000|Overall Study|Lack of Efficacy|2|||
19529242|NCT02720744|41974856|FG001|Overall Study|Lack of Efficacy|8|||
19529243|NCT02720744|41974855|FG000|Overall Study|Adverse Event|21|||
19529244|NCT02720744|41974856|FG001|Overall Study|Adverse Event|3|||
19529245|NCT02720744|41974855|FG000|Overall Study|Withdrawal by Subject|11|||
19529246|NCT02720744|41974856|FG001|Overall Study|Withdrawal by Subject|11|||
19529247|NCT02720744|41974855|FG000|Overall Study|Lost to follow up|2|||
19529248|NCT02720744|41974856|FG001|Overall Study|Lost to follow up|0|||
19629551|NCT00847613|42079032|FG003|Overall Study|Pregnancy|0|||
19629552|NCT00847613|42079029|FG000|Overall Study|Site closure|1|||
19629553|NCT00847613|42079030|FG001|Overall Study|Site closure|0|||
19529249|NCT02720744|41974855|FG000|Overall Study|Non Compliance with Investigational Product|0|||
19529250|NCT02720744|41974856|FG001|Overall Study|Non Compliance with Investigational Product|1|||
19529251|NCT02720744|41974855|FG000|Overall Study|Excluded Concomitant Medication|0|||
19529252|NCT02720744|41974856|FG001|Overall Study|Excluded Concomitant Medication|1|||
19529253|NCT02694185|41974864|FG000|Overall Study|Withdrawal by Subject|45|||
19529254|NCT02694185|41974865|FG001|Overall Study|Withdrawal by Subject|0|||
19529255|NCT02692651|41974873|FG000|Study Treatment|Death|7|||
19529256|NCT02692651|41974874|FG001|Study Treatment|Death|3|||
19529257|NCT02692651|41974873|FG000|Study Treatment|comfort care|1|||
19529258|NCT02692651|41974874|FG001|Study Treatment|comfort care|1|||
19529259|NCT02692651|41974873|FG000|Study Treatment|Protocol violation per treating team preference|8|||
19529260|NCT02692651|41974874|FG001|Study Treatment|Protocol violation per treating team preference|6|||
19529261|NCT02692651|41974873|FG000|Post Study Treatment Follow-up|Death|4|||
19529262|NCT02692651|41974874|FG001|Post Study Treatment Follow-up|Death|4|||
19529263|NCT02674061|41974882|FG000|Overall Study|Death|229|||
19529264|NCT02674061|41974883|FG001|Overall Study|Death|77|||
19529265|NCT02674061|41974882|FG000|Overall Study|Lost to Follow-up|3|||
19529266|NCT02674061|41974883|FG001|Overall Study|Lost to Follow-up|3|||
19529267|NCT02674061|41974882|FG000|Overall Study|Withdrawal by Subject|9|||
19529268|NCT02674061|41974883|FG001|Overall Study|Withdrawal by Subject|1|||
19529269|NCT02674061|41974882|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
19529270|NCT02674061|41974883|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
19529271|NCT02628444|41974903|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
19529272|NCT02628444|41974904|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529273|NCT02628444|41974905|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529274|NCT02628444|41974906|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529275|NCT02628444|41974907|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529276|NCT02628444|41974908|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529277|NCT02628444|41974909|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529278|NCT02628444|41974910|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529279|NCT02628444|41974911|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
19529280|NCT02628444|41974903|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529281|NCT02628444|41974904|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
19529282|NCT02628444|41974905|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
19529283|NCT02628444|41974906|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529284|NCT02628444|41974907|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529285|NCT02628444|41974908|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529286|NCT02628444|41974909|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529287|NCT02628444|41974910|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529288|NCT02628444|41974911|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
19529289|NCT02628444|41974903|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
19529290|NCT02628444|41974904|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
19529291|NCT02628444|41974905|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
19529292|NCT02628444|41974906|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529293|NCT02628444|41974907|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529294|NCT02628444|41974908|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529295|NCT02628444|41974909|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19629554|NCT00847613|42079031|FG002|Overall Study|Site closure|0|||
19629555|NCT00847613|42079032|FG003|Overall Study|Site closure|1|||
19529296|NCT02628444|41974910|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529297|NCT02628444|41974911|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529298|NCT02628444|41974903|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
19529299|NCT02628444|41974904|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
19529300|NCT02628444|41974905|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
19529301|NCT02628444|41974906|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529302|NCT02628444|41974907|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529303|NCT02628444|41974908|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529304|NCT02628444|41974909|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529305|NCT02628444|41974910|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529306|NCT02628444|41974911|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
19529307|NCT02628444|41974903|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
19529308|NCT02628444|41974904|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
19529309|NCT02628444|41974905|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
19529310|NCT02628444|41974906|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529311|NCT02628444|41974907|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529312|NCT02628444|41974908|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529313|NCT02628444|41974909|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529314|NCT02628444|41974910|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529315|NCT02628444|41974911|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
19529316|NCT02628444|41974903|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529317|NCT02628444|41974904|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529318|NCT02628444|41974905|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529319|NCT02628444|41974906|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
19529320|NCT02628444|41974907|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529321|NCT02628444|41974908|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529322|NCT02628444|41974909|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529323|NCT02628444|41974910|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529324|NCT02628444|41974911|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
19529325|NCT02628444|41974903|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
19529326|NCT02628444|41974904|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
19529327|NCT02628444|41974905|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
19529328|NCT02628444|41974906|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
19529329|NCT02628444|41974907|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
19529330|NCT02628444|41974908|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
19529331|NCT02628444|41974909|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
19529332|NCT02628444|41974910|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
19529333|NCT02628444|41974911|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
19529334|NCT02628444|41974903|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529335|NCT02628444|41974904|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529336|NCT02628444|41974905|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
19529337|NCT02628444|41974906|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
19529338|NCT02628444|41974907|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
19529339|NCT02628444|41974908|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
19529340|NCT02628444|41974909|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
19529341|NCT02628444|41974910|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
19529342|NCT02628444|41974911|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
19529343|NCT02628444|41974903|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529344|NCT02628444|41974904|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529345|NCT02628444|41974905|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529346|NCT02628444|41974906|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529347|NCT02628444|41974907|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
19711380|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
19711381|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
19711382|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
19711383|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
19711384|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
19711385|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
19711386|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
19711387|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
19529348|NCT02628444|41974908|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529349|NCT02628444|41974909|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
19529350|NCT02628444|41974910|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
19529351|NCT02628444|41974911|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
19529352|NCT02628444|41974903|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
19529353|NCT02628444|41974904|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
19529354|NCT02628444|41974905|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
19529355|NCT02628444|41974906|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
19529356|NCT02628444|41974907|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
19529357|NCT02628444|41974908|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
19529358|NCT02628444|41974909|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
19529359|NCT02628444|41974910|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
19529360|NCT02628444|41974911|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
19529361|NCT02623725|41974947|FG000|Overall Study|Non compliance with protocol|9|||
19529362|NCT02623725|41974948|FG001|Overall Study|Non compliance with protocol|3|||
19529363|NCT02623725|41974947|FG000|Overall Study|Serious adverse event|0|||
19529364|NCT02623725|41974948|FG001|Overall Study|Serious adverse event|2|||
19529365|NCT02623725|41974947|FG000|Overall Study|Withdrawal by Subject|7|||
19529366|NCT02623725|41974948|FG001|Overall Study|Withdrawal by Subject|1|||
19529367|NCT02608684|41974956|FG000|Overall Study|Physician Decision|2|||
19529368|NCT02608684|41974956|FG000|Overall Study|Withdrawal by Subject|1|||
19529369|NCT02587520|41974978|FG000|Overall Study|Protocol Violation|2|||
19529370|NCT02587520|41974979|FG001|Overall Study|Protocol Violation|0|||
19529371|NCT02587520|41974980|FG002|Overall Study|Protocol Violation|0|||
19529372|NCT02587520|41974981|FG003|Overall Study|Protocol Violation|2|||
19529373|NCT02587520|41974982|FG004|Overall Study|Protocol Violation|0|||
19529374|NCT02587520|41974983|FG005|Overall Study|Protocol Violation|1|||
19529375|NCT02587520|41974984|FG006|Overall Study|Protocol Violation|1|||
19529376|NCT02587520|41974985|FG007|Overall Study|Protocol Violation|1|||
19529377|NCT02587520|41974986|FG008|Overall Study|Protocol Violation|3|||
19529378|NCT02587520|41974987|FG009|Overall Study|Protocol Violation|3|||
19529379|NCT02587520|41974988|FG010|Overall Study|Protocol Violation|1|||
19529380|NCT02587520|41974989|FG011|Overall Study|Protocol Violation|2|||
19529381|NCT02587520|41974990|FG012|Overall Study|Protocol Violation|0|||
19529382|NCT02587520|41974991|FG013|Overall Study|Protocol Violation|0|||
19529383|NCT02587520|41974992|FG014|Overall Study|Protocol Violation|0|||
19529384|NCT02587520|41974993|FG015|Overall Study|Protocol Violation|0|||
19529385|NCT02587520|41974994|FG016|Overall Study|Protocol Violation|0|||
19529386|NCT02587520|41974995|FG017|Overall Study|Protocol Violation|0|||
19529387|NCT02587520|41974978|FG000|Overall Study|Adverse Event|0|||
19529388|NCT02587520|41974979|FG001|Overall Study|Adverse Event|0|||
19529389|NCT02587520|41974980|FG002|Overall Study|Adverse Event|0|||
19529390|NCT02587520|41974981|FG003|Overall Study|Adverse Event|0|||
19529391|NCT02587520|41974982|FG004|Overall Study|Adverse Event|0|||
19529392|NCT02587520|41974983|FG005|Overall Study|Adverse Event|0|||
19529393|NCT02587520|41974984|FG006|Overall Study|Adverse Event|0|||
19529394|NCT02587520|41974985|FG007|Overall Study|Adverse Event|0|||
19529395|NCT02587520|41974986|FG008|Overall Study|Adverse Event|0|||
19529396|NCT02587520|41974987|FG009|Overall Study|Adverse Event|0|||
19529397|NCT02587520|41974988|FG010|Overall Study|Adverse Event|0|||
19529398|NCT02587520|41974989|FG011|Overall Study|Adverse Event|1|||
19529399|NCT02587520|41974990|FG012|Overall Study|Adverse Event|0|||
19529400|NCT02587520|41974991|FG013|Overall Study|Adverse Event|0|||
19529401|NCT02587520|41974992|FG014|Overall Study|Adverse Event|0|||
19529402|NCT02587520|41974993|FG015|Overall Study|Adverse Event|0|||
19529403|NCT02587520|41974994|FG016|Overall Study|Adverse Event|0|||
19529404|NCT02587520|41974995|FG017|Overall Study|Adverse Event|0|||
19529405|NCT02587520|41974978|FG000|Overall Study|Withdrawal by Subject|0|||
19529406|NCT02587520|41974979|FG001|Overall Study|Withdrawal by Subject|0|||
19529407|NCT02587520|41974980|FG002|Overall Study|Withdrawal by Subject|1|||
19529408|NCT02587520|41974981|FG003|Overall Study|Withdrawal by Subject|1|||
19529409|NCT02587520|41974982|FG004|Overall Study|Withdrawal by Subject|0|||
19529410|NCT02587520|41974983|FG005|Overall Study|Withdrawal by Subject|1|||
19529411|NCT02587520|41974984|FG006|Overall Study|Withdrawal by Subject|1|||
19529412|NCT02587520|41974985|FG007|Overall Study|Withdrawal by Subject|0|||
19529413|NCT02587520|41974986|FG008|Overall Study|Withdrawal by Subject|0|||
19529414|NCT02587520|41974987|FG009|Overall Study|Withdrawal by Subject|0|||
19529415|NCT02587520|41974988|FG010|Overall Study|Withdrawal by Subject|0|||
19711388|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
19711389|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
19529416|NCT02587520|41974989|FG011|Overall Study|Withdrawal by Subject|0|||
19529417|NCT02587520|41974990|FG012|Overall Study|Withdrawal by Subject|0|||
19529418|NCT02587520|41974991|FG013|Overall Study|Withdrawal by Subject|1|||
19529419|NCT02587520|41974992|FG014|Overall Study|Withdrawal by Subject|0|||
19529420|NCT02587520|41974993|FG015|Overall Study|Withdrawal by Subject|0|||
19529421|NCT02587520|41974994|FG016|Overall Study|Withdrawal by Subject|0|||
19529422|NCT02587520|41974995|FG017|Overall Study|Withdrawal by Subject|0|||
19529423|NCT02587520|41974978|FG000|Overall Study|Lost to Follow-up|0|||
19529424|NCT02587520|41974979|FG001|Overall Study|Lost to Follow-up|2|||
19529425|NCT02587520|41974980|FG002|Overall Study|Lost to Follow-up|0|||
19529426|NCT02587520|41974981|FG003|Overall Study|Lost to Follow-up|2|||
19529427|NCT02587520|41974982|FG004|Overall Study|Lost to Follow-up|0|||
19529428|NCT02587520|41974983|FG005|Overall Study|Lost to Follow-up|1|||
19529429|NCT02587520|41974984|FG006|Overall Study|Lost to Follow-up|1|||
19529430|NCT02587520|41974985|FG007|Overall Study|Lost to Follow-up|1|||
19529431|NCT02587520|41974986|FG008|Overall Study|Lost to Follow-up|0|||
19529432|NCT02587520|41974987|FG009|Overall Study|Lost to Follow-up|2|||
19529433|NCT02587520|41974988|FG010|Overall Study|Lost to Follow-up|2|||
19529434|NCT02587520|41974989|FG011|Overall Study|Lost to Follow-up|1|||
19529435|NCT02587520|41974990|FG012|Overall Study|Lost to Follow-up|0|||
19529436|NCT02587520|41974991|FG013|Overall Study|Lost to Follow-up|0|||
19529437|NCT02587520|41974992|FG014|Overall Study|Lost to Follow-up|0|||
19529438|NCT02587520|41974993|FG015|Overall Study|Lost to Follow-up|0|||
19529439|NCT02587520|41974994|FG016|Overall Study|Lost to Follow-up|0|||
19529440|NCT02587520|41974995|FG017|Overall Study|Lost to Follow-up|0|||
19529441|NCT02584829|41975035|FG000|Overall Study|Physician Decision|1|||
19529442|NCT02584829|41975036|FG001|Overall Study|Physician Decision|0|||
19529443|NCT02584829|41975035|FG000|Overall Study|Withdrawal by Subject|0|||
19529444|NCT02584829|41975036|FG001|Overall Study|Withdrawal by Subject|1|||
19529445|NCT02584829|41975035|FG000|Overall Study|Progressive Disease|0|||
19529446|NCT02584829|41975036|FG001|Overall Study|Progressive Disease|3|||
19529447|NCT02570308|41975049|FG000|Overall Study|Death|1|||
19529448|NCT02570308|41975050|FG001|Overall Study|Death|5|||
19529449|NCT02570308|41975051|FG002|Overall Study|Death|4|||
19529450|NCT02570308|41975052|FG003|Overall Study|Death|4|||
19529451|NCT02570308|41975053|FG004|Overall Study|Death|69|||
19529452|NCT02570308|41975049|FG000|Overall Study|Lost to Follow-up|0|||
19529453|NCT02570308|41975050|FG001|Overall Study|Lost to Follow-up|0|||
19529454|NCT02570308|41975051|FG002|Overall Study|Lost to Follow-up|0|||
19529455|NCT02570308|41975052|FG003|Overall Study|Lost to Follow-up|0|||
19450894|NCT00089986|41699612|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
19450895|NCT00089986|41699613|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
19450896|NCT00089986|41699611|FG000|Overall Study|Hemohlobin stopping rule|0|||
19450897|NCT00089986|41699612|FG001|Overall Study|Hemohlobin stopping rule|1|||
19450898|NCT00089986|41699613|FG002|Overall Study|Hemohlobin stopping rule|0|||
19450899|NCT00089986|41699611|FG000|Overall Study|Investigator decision to withdrew|0|||
19450900|NCT00089986|41699612|FG001|Overall Study|Investigator decision to withdrew|1|||
19450901|NCT00089986|41699613|FG002|Overall Study|Investigator decision to withdrew|0|||
19450902|NCT00089986|41699611|FG000|Overall Study|Enrollment in another study|0|||
19450903|NCT00089986|41699612|FG001|Overall Study|Enrollment in another study|1|||
19450904|NCT00089986|41699613|FG002|Overall Study|Enrollment in another study|0|||
19450905|NCT00089986|41699611|FG000|Overall Study|Family decision|0|||
19450906|NCT00089986|41699612|FG001|Overall Study|Family decision|1|||
19450907|NCT00089986|41699613|FG002|Overall Study|Family decision|0|||
19450908|NCT00089986|41699611|FG000|Overall Study|Do not resuscitate (DNR)|0|||
19450909|NCT00089986|41699612|FG001|Overall Study|Do not resuscitate (DNR)|0|||
19450910|NCT00089986|41699613|FG002|Overall Study|Do not resuscitate (DNR)|1|||
19450911|NCT00089986|41699611|FG000|Overall Study|Withdrawal by Subject|3|||
19450912|NCT00089986|41699612|FG001|Overall Study|Withdrawal by Subject|6|||
19450913|NCT00089986|41699613|FG002|Overall Study|Withdrawal by Subject|2|||
19450914|NCT01689207|41699636|FG000|Overall Study|Adverse Event|0|||
19450915|NCT01689207|41699637|FG001|Overall Study|Adverse Event|1|||
19450916|NCT01689207|41699638|FG002|Overall Study|Adverse Event|0|||
19450917|NCT01689207|41699639|FG003|Overall Study|Adverse Event|0|||
19450918|NCT01689207|41699640|FG004|Overall Study|Adverse Event|2|||
19450919|NCT01689207|41699641|FG005|Overall Study|Adverse Event|1|||
19450920|NCT01689207|41699642|FG006|Overall Study|Adverse Event|0|||
19450921|NCT01689207|41699643|FG007|Overall Study|Adverse Event|0|||
19450922|NCT01689207|41699644|FG008|Overall Study|Adverse Event|1|||
19450923|NCT01689207|41699645|FG009|Overall Study|Adverse Event|0|||
19450924|NCT01689207|41699646|FG010|Overall Study|Adverse Event|0|||
19450925|NCT00089284|41699681|FG000|Overall Study|Adverse event before starting treatment|0|||
19450926|NCT00089284|41699682|FG001|Overall Study|Adverse event before starting treatment|0|||
19450927|NCT00089284|41699683|FG002|Overall Study|Adverse event before starting treatment|0|||
19450928|NCT00089284|41699684|FG003|Overall Study|Adverse event before starting treatment|0|||
19450929|NCT00089284|41699685|FG004|Overall Study|Adverse event before starting treatment|0|||
19529456|NCT02570308|41975053|FG004|Overall Study|Lost to Follow-up|2|||
19529457|NCT02570308|41975049|FG000|Overall Study|Withdrawal by Subject|0|||
19529458|NCT02570308|41975050|FG001|Overall Study|Withdrawal by Subject|0|||
19529459|NCT02570308|41975051|FG002|Overall Study|Withdrawal by Subject|0|||
19529460|NCT02570308|41975052|FG003|Overall Study|Withdrawal by Subject|0|||
19529461|NCT02570308|41975053|FG004|Overall Study|Withdrawal by Subject|1|||
19529462|NCT02570308|41975049|FG000|Overall Study|Other|0|||
19450930|NCT00089284|41699686|FG005|Overall Study|Adverse event before starting treatment|0|||
19450931|NCT00089284|41699687|FG006|Overall Study|Adverse event before starting treatment|1|||
19450932|NCT01688973|41699711|FG000|Overall Study|Ineligible|2|||
19450933|NCT01688973|41699712|FG001|Overall Study|Ineligible|3|||
19450934|NCT00087646|41699723|FG000|Overall Study|Adverse Event|37|||
19450935|NCT00087646|41699724|FG001|Overall Study|Adverse Event|6|||
19450936|NCT00087646|41699725|FG002|Overall Study|Adverse Event|18|||
19450937|NCT00087646|41699726|FG003|Overall Study|Adverse Event|20|||
19450938|NCT00087646|41699723|FG000|Overall Study|Death|0|||
19450939|NCT00087646|41699724|FG001|Overall Study|Death|1|||
19450940|NCT00087646|41699725|FG002|Overall Study|Death|0|||
19450941|NCT00087646|41699726|FG003|Overall Study|Death|0|||
19450942|NCT00087646|41699723|FG000|Overall Study|Withdrawal by Subject|6|||
19450943|NCT00087646|41699724|FG001|Overall Study|Withdrawal by Subject|1|||
19450944|NCT00087646|41699725|FG002|Overall Study|Withdrawal by Subject|2|||
19450945|NCT00087646|41699726|FG003|Overall Study|Withdrawal by Subject|2|||
19450946|NCT00087646|41699723|FG000|Overall Study|Insufficient therapeutic response|64|||
19450947|NCT00087646|41699724|FG001|Overall Study|Insufficient therapeutic response|24|||
19450948|NCT00087646|41699725|FG002|Overall Study|Insufficient therapeutic response|38|||
19450949|NCT00087646|41699726|FG003|Overall Study|Insufficient therapeutic response|51|||
19450950|NCT00087646|41699723|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
19450951|NCT00087646|41699724|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
19450952|NCT00087646|41699725|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
19529463|NCT02570308|41975050|FG001|Overall Study|Other|0|||
19529464|NCT02570308|41975051|FG002|Overall Study|Other|0|||
19529465|NCT02570308|41975052|FG003|Overall Study|Other|0|||
19529466|NCT02570308|41975053|FG004|Overall Study|Other|2|||
19529467|NCT02497612|41975075|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
19529468|NCT02497612|41975076|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
19529469|NCT02497612|41975077|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
19529470|NCT02497612|41975078|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
19529471|NCT02497612|41975075|FG000|Overall Study|Participant's request|2|||
19529472|NCT02497612|41975076|FG001|Overall Study|Participant's request|3|||
19529473|NCT02497612|41975077|FG002|Overall Study|Participant's request|4|||
19529474|NCT02497612|41975078|FG003|Overall Study|Participant's request|1|||
19529475|NCT02497612|41975075|FG000|Overall Study|Investigator's judgement|1|||
19529476|NCT02497612|41975076|FG001|Overall Study|Investigator's judgement|0|||
19529477|NCT02497612|41975077|FG002|Overall Study|Investigator's judgement|0|||
19529478|NCT02497612|41975078|FG003|Overall Study|Investigator's judgement|2|||
19529479|NCT02497612|41975075|FG000|Overall Study|Adverse Event|3|||
19529480|NCT02497612|41975076|FG001|Overall Study|Adverse Event|1|||
19529481|NCT02497612|41975077|FG002|Overall Study|Adverse Event|4|||
19529482|NCT02497612|41975078|FG003|Overall Study|Adverse Event|1|||
19529483|NCT02497612|41975075|FG000|Overall Study|Lost to Follow-up|1|||
19529484|NCT02497612|41975076|FG001|Overall Study|Lost to Follow-up|1|||
19529485|NCT02497612|41975077|FG002|Overall Study|Lost to Follow-up|0|||
19529486|NCT02497612|41975078|FG003|Overall Study|Lost to Follow-up|1|||
19529487|NCT02497612|41975075|FG000|Overall Study|Other unspecified|1|||
19529488|NCT02497612|41975076|FG001|Overall Study|Other unspecified|1|||
19529489|NCT02497612|41975077|FG002|Overall Study|Other unspecified|2|||
19529490|NCT02497612|41975078|FG003|Overall Study|Other unspecified|0|||
19529491|NCT02497612|41975075|FG000|Overall Study|Not eligible|1|||
19529492|NCT02497612|41975076|FG001|Overall Study|Not eligible|0|||
19529493|NCT02497612|41975077|FG002|Overall Study|Not eligible|0|||
19529494|NCT02497612|41975078|FG003|Overall Study|Not eligible|1|||
19529495|NCT02460458|41975088|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
19529496|NCT02460458|41975088|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
19529497|NCT02460458|41975088|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
19529498|NCT02460458|41975088|FG000|First Prospective Phase|Lost to Follow-up|16|||
19529499|NCT02460458|41975088|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
19529500|NCT02457559|41975103|FG000|Overall Study|Progressive Disease|1|||
19529501|NCT02457559|41975104|FG001|Overall Study|Progressive Disease|2|||
19529502|NCT02457559|41975105|FG002|Overall Study|Progressive Disease|3|||
19529503|NCT02457559|41975106|FG003|Overall Study|Progressive Disease|0|||
19529504|NCT02457559|41975107|FG004|Overall Study|Progressive Disease|0|||
19529505|NCT02457559|41975108|FG005|Overall Study|Progressive Disease|2|||
19450953|NCT00087646|41699726|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
19529506|NCT02457559|41975109|FG006|Overall Study|Progressive Disease|1|||
19529507|NCT02457559|41975110|FG007|Overall Study|Progressive Disease|0|||
19529508|NCT02457559|41975111|FG008|Overall Study|Progressive Disease|1|||
19529509|NCT02457559|41975112|FG009|Overall Study|Progressive Disease|1|||
19529510|NCT02457559|41975113|FG010|Overall Study|Progressive Disease|1|||
19450954|NCT00087646|41699723|FG000|Overall Study|Failure to Return|5|||
19450955|NCT00087646|41699724|FG001|Overall Study|Failure to Return|2|||
19529511|NCT02457559|41975103|FG000|Overall Study|Investigator's Discretion|0|||
19529512|NCT02457559|41975104|FG001|Overall Study|Investigator's Discretion|0|||
19529513|NCT02457559|41975105|FG002|Overall Study|Investigator's Discretion|2|||
19529514|NCT02457559|41975106|FG003|Overall Study|Investigator's Discretion|0|||
19529515|NCT02457559|41975107|FG004|Overall Study|Investigator's Discretion|1|||
19529516|NCT02457559|41975108|FG005|Overall Study|Investigator's Discretion|0|||
19450956|NCT00087646|41699725|FG002|Overall Study|Failure to Return|2|||
19450957|NCT00087646|41699726|FG003|Overall Study|Failure to Return|3|||
19450958|NCT00087646|41699723|FG000|Overall Study|Administrative/Other|6|||
19450959|NCT00087646|41699724|FG001|Overall Study|Administrative/Other|1|||
19450960|NCT00087646|41699725|FG002|Overall Study|Administrative/Other|1|||
19450961|NCT00087646|41699726|FG003|Overall Study|Administrative/Other|2|||
19450962|NCT00087646|41699723|FG000|Overall Study|Other Protocol Violation|3|||
19450963|NCT00087646|41699724|FG001|Overall Study|Other Protocol Violation|1|||
19450964|NCT00087646|41699725|FG002|Overall Study|Other Protocol Violation|0|||
19450965|NCT00087646|41699726|FG003|Overall Study|Other Protocol Violation|0|||
19450966|NCT00087646|41699723|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
19450967|NCT00087646|41699724|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
19450968|NCT00087646|41699725|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
19450969|NCT00087646|41699726|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
19450970|NCT00087568|41699743|FG000|Overall Study|Adverse Event|4|||
19450971|NCT00087568|41699744|FG001|Overall Study|Adverse Event|0|||
19450972|NCT00087568|41699743|FG000|Overall Study|Withdrawal by Subject|1|||
19450973|NCT00087568|41699744|FG001|Overall Study|Withdrawal by Subject|1|||
19529517|NCT02457559|41975109|FG006|Overall Study|Investigator's Discretion|1|||
19529518|NCT02457559|41975110|FG007|Overall Study|Investigator's Discretion|0|||
19529519|NCT02457559|41975111|FG008|Overall Study|Investigator's Discretion|1|||
19529520|NCT02457559|41975112|FG009|Overall Study|Investigator's Discretion|0|||
19529521|NCT02457559|41975113|FG010|Overall Study|Investigator's Discretion|1|||
19529522|NCT02457559|41975103|FG000|Overall Study|Adverse Event|0|||
19529523|NCT02457559|41975104|FG001|Overall Study|Adverse Event|1|||
19529524|NCT02457559|41975105|FG002|Overall Study|Adverse Event|2|||
19529525|NCT02457559|41975106|FG003|Overall Study|Adverse Event|0|||
19529526|NCT02457559|41975107|FG004|Overall Study|Adverse Event|0|||
19529527|NCT02457559|41975108|FG005|Overall Study|Adverse Event|0|||
19529528|NCT02457559|41975109|FG006|Overall Study|Adverse Event|0|||
19450974|NCT00087568|41699743|FG000|Overall Study|Lost to Follow-up|1|||
19450975|NCT00087568|41699744|FG001|Overall Study|Lost to Follow-up|0|||
19450976|NCT00087568|41699743|FG000|Overall Study|Lack of Efficacy|24|||
19450977|NCT00087568|41699744|FG001|Overall Study|Lack of Efficacy|1|||
19450978|NCT00085540|41699756|FG000|Overall Study|Withdrawal by Subject|0|||
19450979|NCT00085540|41699757|FG001|Overall Study|Withdrawal by Subject|1|||
19450980|NCT00085540|41699756|FG000|Overall Study|Protocol Violation|0|||
19450981|NCT00085540|41699757|FG001|Overall Study|Protocol Violation|1|||
19450982|NCT01688739|41699773|FG000|Overall Study|Administrative Decision|1|||
19450983|NCT01688739|41699774|FG001|Overall Study|Administrative Decision|0|||
19450984|NCT01688739|41699775|FG002|Overall Study|Administrative Decision|0|||
19450985|NCT01688739|41699776|FG003|Overall Study|Administrative Decision|0|||
19450986|NCT01688739|41699777|FG004|Overall Study|Administrative Decision|0|||
19450987|NCT01688739|41699778|FG005|Overall Study|Administrative Decision|0|||
19450988|NCT01688739|41699779|FG006|Overall Study|Administrative Decision|0|||
19450989|NCT01688739|41699780|FG007|Overall Study|Administrative Decision|0|||
19450990|NCT01688739|41699781|FG008|Overall Study|Administrative Decision|0|||
19450991|NCT01688739|41699782|FG009|Overall Study|Administrative Decision|0|||
19450992|NCT00084838|41699812|FG000|Overall Study|Death|1|||
19450993|NCT00084838|41699812|FG000|Overall Study|Adverse Event|2|||
19450994|NCT00084838|41699812|FG000|Overall Study|Withdrawal by Subject|1|||
19450995|NCT00084838|41699812|FG000|Overall Study|Progressive Disease|4|||
19450996|NCT00084838|41699812|FG000|Overall Study|Pt Non-Compliance|1|||
19450997|NCT00084838|41699812|FG000|Overall Study|Ineligible|4|||
19450998|NCT01558089|41699818|FG000|Overall Study|Adverse Event|1|||
19450999|NCT01558089|41699818|FG000|Overall Study|Lack of Efficacy|1|||
19529529|NCT02457559|41975110|FG007|Overall Study|Adverse Event|0|||
19529530|NCT02457559|41975111|FG008|Overall Study|Adverse Event|0|||
19529531|NCT02457559|41975112|FG009|Overall Study|Adverse Event|0|||
19529532|NCT02457559|41975113|FG010|Overall Study|Adverse Event|0|||
19529533|NCT02457559|41975103|FG000|Overall Study|Reason not Specified|1|||
19529534|NCT02457559|41975104|FG001|Overall Study|Reason not Specified|0|||
19529535|NCT02457559|41975105|FG002|Overall Study|Reason not Specified|0|||
19529536|NCT02457559|41975106|FG003|Overall Study|Reason not Specified|0|||
19529537|NCT02457559|41975107|FG004|Overall Study|Reason not Specified|0|||
19529538|NCT02457559|41975108|FG005|Overall Study|Reason not Specified|0|||
19529539|NCT02457559|41975109|FG006|Overall Study|Reason not Specified|0|||
19529540|NCT02457559|41975110|FG007|Overall Study|Reason not Specified|0|||
19529541|NCT02457559|41975111|FG008|Overall Study|Reason not Specified|0|||
19529542|NCT02457559|41975112|FG009|Overall Study|Reason not Specified|2|||
19529543|NCT02457559|41975113|FG010|Overall Study|Reason not Specified|0|||
19529544|NCT02457559|41975103|FG000|Overall Study|Death|0|||
19451000|NCT01558089|41699818|FG000|Overall Study|Lost to Follow-up|5|||
19529545|NCT02457559|41975104|FG001|Overall Study|Death|0|||
19529546|NCT02457559|41975105|FG002|Overall Study|Death|0|||
19529547|NCT02457559|41975106|FG003|Overall Study|Death|0|||
19529548|NCT02457559|41975107|FG004|Overall Study|Death|0|||
19529549|NCT02457559|41975108|FG005|Overall Study|Death|0|||
19529550|NCT02457559|41975109|FG006|Overall Study|Death|0|||
19529551|NCT02457559|41975110|FG007|Overall Study|Death|0|||
19529552|NCT02457559|41975111|FG008|Overall Study|Death|1|||
19529553|NCT02457559|41975112|FG009|Overall Study|Death|1|||
19529554|NCT02457559|41975113|FG010|Overall Study|Death|0|||
19529555|NCT02381652|41975163|FG000|Overall Study|Withdrawal by Subject|0|||
19529556|NCT02381652|41975164|FG001|Overall Study|Withdrawal by Subject|0|||
19529557|NCT02381652|41975165|FG002|Overall Study|Withdrawal by Subject|1|||
19529558|NCT02367794|41975174|FG000|Overall Study|Death|252|||
19529559|NCT02367794|41975175|FG001|Overall Study|Death|245|||
19529560|NCT02367794|41975176|FG002|Overall Study|Death|243|||
19529561|NCT02367794|41975174|FG000|Overall Study|Lost to Follow-up|1|||
19529562|NCT02367794|41975175|FG001|Overall Study|Lost to Follow-up|2|||
19529563|NCT02367794|41975176|FG002|Overall Study|Lost to Follow-up|2|||
19529564|NCT02367794|41975174|FG000|Overall Study|Physician Decision|0|||
19529565|NCT02367794|41975175|FG001|Overall Study|Physician Decision|5|||
19529566|NCT02367794|41975176|FG002|Overall Study|Physician Decision|3|||
19529567|NCT02367794|41975174|FG000|Overall Study|Protocol Violation|1|||
19529568|NCT02367794|41975175|FG001|Overall Study|Protocol Violation|0|||
19529569|NCT02367794|41975176|FG002|Overall Study|Protocol Violation|1|||
19529570|NCT02367794|41975174|FG000|Overall Study|Withdrawal by Subject|25|||
19529571|NCT02367794|41975175|FG001|Overall Study|Withdrawal by Subject|12|||
19529572|NCT02367794|41975176|FG002|Overall Study|Withdrawal by Subject|20|||
19529573|NCT02367794|41975174|FG000|Overall Study|Brain metastasis|1|||
19529574|NCT02367794|41975175|FG001|Overall Study|Brain metastasis|0|||
19529575|NCT02367794|41975176|FG002|Overall Study|Brain metastasis|0|||
19529576|NCT02367794|41975174|FG000|Overall Study|Randomized in error|0|||
19529577|NCT02367794|41975175|FG001|Overall Study|Randomized in error|0|||
19529578|NCT02367794|41975176|FG002|Overall Study|Randomized in error|1|||
19529579|NCT02367794|41975174|FG000|Overall Study|Patient unable to receive carboplatin|0|||
19529580|NCT02367794|41975175|FG001|Overall Study|Patient unable to receive carboplatin|0|||
19529581|NCT02367794|41975176|FG002|Overall Study|Patient unable to receive carboplatin|1|||
19529582|NCT02367794|41975174|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
19529583|NCT02367794|41975175|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
19529584|NCT02367794|41975176|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
19529585|NCT02367794|41975174|FG000|Overall Study|Adverse Event|0|||
19529586|NCT02367794|41975175|FG001|Overall Study|Adverse Event|0|||
19529587|NCT02367794|41975176|FG002|Overall Study|Adverse Event|2|||
19529588|NCT02367794|41975174|FG000|Overall Study|Study Terminated By Sponsor|0|||
19529589|NCT02367794|41975175|FG001|Overall Study|Study Terminated By Sponsor|1|||
19529590|NCT02367794|41975176|FG002|Overall Study|Study Terminated By Sponsor|1|||
19529591|NCT02367794|41975174|FG000|Overall Study|Moved to Roll-Over Study|0|||
19529592|NCT02367794|41975175|FG001|Overall Study|Moved to Roll-Over Study|15|||
19529593|NCT02367794|41975176|FG002|Overall Study|Moved to Roll-Over Study|13|||
19529594|NCT02367794|41975174|FG000|Overall Study|Sponsor Request|60|||
19529595|NCT02367794|41975175|FG001|Overall Study|Sponsor Request|57|||
19529596|NCT02367794|41975176|FG002|Overall Study|Sponsor Request|45|||
19529597|NCT02367794|41975174|FG000|Overall Study|Moved into PTAP Study|0|||
19529598|NCT02367794|41975175|FG001|Overall Study|Moved into PTAP Study|2|||
19629556|NCT00847613|42079029|FG000|Overall Study|Withdrawal by Subject|8|||
19629557|NCT00847613|42079030|FG001|Overall Study|Withdrawal by Subject|11|||
19629558|NCT00847613|42079031|FG002|Overall Study|Withdrawal by Subject|2|||
19629559|NCT00847613|42079032|FG003|Overall Study|Withdrawal by Subject|2|||
19629560|NCT00847613|42079029|FG000|Overall Study|Participant moved|4|||
19629561|NCT00847613|42079030|FG001|Overall Study|Participant moved|1|||
19629562|NCT00847613|42079031|FG002|Overall Study|Participant moved|0|||
19529599|NCT02367794|41975176|FG002|Overall Study|Moved into PTAP Study|3|||
19529600|NCT02367794|41975174|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
19529601|NCT02367794|41975175|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
19529602|NCT02367794|41975176|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
19529603|NCT02367794|41975174|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
19529604|NCT02367794|41975175|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
19529605|NCT02367794|41975176|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
19529606|NCT02367794|41975174|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
19529607|NCT02367794|41975175|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
19529608|NCT02367794|41975176|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
19529609|NCT02367794|41975174|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
19529610|NCT02367794|41975175|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
19529611|NCT02367794|41975176|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
19629563|NCT00847613|42079032|FG003|Overall Study|Participant moved|0|||
19629564|NCT00847613|42079029|FG000|Overall Study|Sponsor request|0|||
19529612|NCT02353832|41975209|FG000|Overall Study|Ineligible after enrollment|1|||
19529613|NCT02353832|41975209|FG000|Overall Study|Lost to Follow-up|1|||
19529614|NCT02353728|41975213|FG000|Overall Study|Subject non-compliance|1|||
19529615|NCT02345070|41975220|FG000|Overall Study|Adverse Event|12|||
19529616|NCT02345070|41975221|FG001|Overall Study|Adverse Event|8|||
19529617|NCT02345070|41975222|FG002|Overall Study|Adverse Event|16|||
19529618|NCT02345070|41975220|FG000|Overall Study|Poor compliance to protocol|2|||
19529619|NCT02345070|41975221|FG001|Overall Study|Poor compliance to protocol|0|||
19529620|NCT02345070|41975222|FG002|Overall Study|Poor compliance to protocol|0|||
19529621|NCT02345070|41975220|FG000|Overall Study|Other than specified above|6|||
19529622|NCT02345070|41975221|FG001|Overall Study|Other than specified above|3|||
19529623|NCT02345070|41975222|FG002|Overall Study|Other than specified above|7|||
19529624|NCT02325466|41975230|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
19529625|NCT02325466|41975231|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
19529626|NCT02325466|41975232|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
19529627|NCT02325466|41975230|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
19529628|NCT02325466|41975231|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
19529629|NCT02325466|41975232|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
19529630|NCT02325466|41975230|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
19529631|NCT02325466|41975231|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
19529632|NCT02325466|41975232|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
19529633|NCT02325466|41975230|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
19529634|NCT02325466|41975231|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
19529635|NCT02325466|41975232|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
19529636|NCT02325466|41975230|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
19529637|NCT02325466|41975231|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
19529638|NCT02325466|41975232|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
19529639|NCT02325466|41975230|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
19529640|NCT02325466|41975231|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
19529641|NCT02325466|41975232|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
19529642|NCT02325466|41975230|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
19529643|NCT02325466|41975231|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
19529644|NCT02325466|41975232|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
19529645|NCT02325466|41975230|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
19529646|NCT02325466|41975231|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
19529647|NCT02325466|41975232|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
19529648|NCT02325466|41975230|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
19629565|NCT00847613|42079030|FG001|Overall Study|Sponsor request|1|||
19629566|NCT00847613|42079031|FG002|Overall Study|Sponsor request|0|||
19629567|NCT00847613|42079032|FG003|Overall Study|Sponsor request|0|||
19629568|NCT00847613|42079029|FG000|Overall Study|Randomized, but not treated|0|||
19629569|NCT00847613|42079030|FG001|Overall Study|Randomized, but not treated|3|||
19629570|NCT00847613|42079031|FG002|Overall Study|Randomized, but not treated|0|||
19629571|NCT00847613|42079032|FG003|Overall Study|Randomized, but not treated|0|||
19629572|NCT00847613|42079029|FG000|Overall Study|Other|1|||
19629573|NCT00847613|42079030|FG001|Overall Study|Other|1|||
19629574|NCT00847613|42079031|FG002|Overall Study|Other|2|||
19629575|NCT00847613|42079032|FG003|Overall Study|Other|0|||
19629576|NCT00794196|42079051|FG000|Overall Study|Lost to Follow-up|5|||
19629577|NCT00794196|42079052|FG001|Overall Study|Lost to Follow-up|23|||
19629578|NCT00807092|42079060|FG000|Overall Study|Adverse Event|0|||
19629579|NCT00807092|42079061|FG001|Overall Study|Adverse Event|1|||
19629580|NCT00807092|42079060|FG000|Overall Study|Protocol Violation|0|||
19629581|NCT00807092|42079061|FG001|Overall Study|Protocol Violation|2|||
19629582|NCT00807092|42079060|FG000|Overall Study|Withdrawal by Subject|1|||
19629583|NCT00807092|42079061|FG001|Overall Study|Withdrawal by Subject|0|||
19629584|NCT00807092|42079060|FG000|Overall Study|CGMS data collection failed|0|||
19629585|NCT00807092|42079061|FG001|Overall Study|CGMS data collection failed|1|||
19629586|NCT00794118|42079067|FG000|Overall Study|Lost to Follow-up|16|||
19629587|NCT00794118|42079067|FG000|Overall Study|Withdrawal by Subject|9|||
19629588|NCT00794118|42079067|FG000|Overall Study|Changed hospital center|2|||
19629589|NCT00640042|42079071|FG000|Enrollment|Did not receive study drug|83|||
19629590|NCT00807014|42079077|FG000|Overall Study|Participant Considered Disease Cured|13|||
19629591|NCT00807014|42079078|FG001|Overall Study|Participant Considered Disease Cured|2|||
19629592|NCT00807014|42079077|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
19629593|NCT00807014|42079078|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
19629594|NCT00807014|42079077|FG000|Overall Study|Protocol Violation|2|||
19629595|NCT00807014|42079078|FG001|Overall Study|Protocol Violation|8|||
19629596|NCT00807014|42079077|FG000|Overall Study|Adverse Event|0|||
19629597|NCT00807014|42079078|FG001|Overall Study|Adverse Event|2|||
19629598|NCT00807014|42079077|FG000|Overall Study|Lost to Follow-up|9|||
19629599|NCT00807014|42079078|FG001|Overall Study|Lost to Follow-up|7|||
19529649|NCT02325466|41975231|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
19529650|NCT02325466|41975232|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
19529651|NCT02322710|41975243|FG000|Overall Study|No efficacy assessment post-baseline|0|||
19529652|NCT02322710|41975244|FG001|Overall Study|No efficacy assessment post-baseline|1|||
19529653|NCT02322710|41975243|FG000|Overall Study|Protocol Violation|20|||
19529654|NCT02322710|41975244|FG001|Overall Study|Protocol Violation|25|||
19529655|NCT02234310|41975287|FG000|Overall Study|Physician Decision|1|||
19529656|NCT02234310|41975287|FG000|Overall Study|Adverse Event|1|||
19529657|NCT02234310|41975287|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
19529658|NCT02234310|41975287|FG000|Overall Study|Withdrawal by Subject|2|||
19529659|NCT02106195|41975320|FG000|Overall Study|Adverse Event|2|||
19529660|NCT02106195|41975320|FG000|Overall Study|Protocol Violation|1|||
19529661|NCT02104180|41975332|FG000|Overall Study|Protocol Violation|1|||
19529662|NCT02104180|41975333|FG001|Overall Study|Protocol Violation|0|||
19529663|NCT02040857|41975343|FG000|Overall Study|Adverse Event|14|||
19529664|NCT02040857|41975343|FG000|Overall Study|Physician Decision|5|||
19529665|NCT02040857|41975343|FG000|Overall Study|Withdrawal by Subject|31|||
19529666|NCT02040857|41975343|FG000|Overall Study|patient non-compliance|3|||
19529667|NCT02040857|41975343|FG000|Overall Study|Lost to Follow-up|2|||
19529668|NCT02040857|41975343|FG000|Overall Study|recurrence|4|||
19529669|NCT02040857|41975343|FG000|Overall Study|ineligible|1|||
19529670|NCT01943825|41975363|FG000|Overall Study|Lost to Follow-up|9|||
19529671|NCT01943825|41975364|FG001|Overall Study|Lost to Follow-up|3|||
19529672|NCT01943825|41975365|FG002|Overall Study|Lost to Follow-up|12|||
19529673|NCT01943825|41975366|FG003|Overall Study|Lost to Follow-up|8|||
19529674|NCT01943825|41975363|FG000|Overall Study|Withdrawal by Subject|1|||
19529675|NCT01943825|41975364|FG001|Overall Study|Withdrawal by Subject|0|||
19529676|NCT01943825|41975365|FG002|Overall Study|Withdrawal by Subject|3|||
19529677|NCT01943825|41975366|FG003|Overall Study|Withdrawal by Subject|2|||
19529678|NCT01943825|41975363|FG000|Overall Study|Other than specified above|0|||
19529679|NCT01943825|41975364|FG001|Overall Study|Other than specified above|1|||
19529680|NCT01943825|41975365|FG002|Overall Study|Other than specified above|0|||
19529681|NCT01943825|41975366|FG003|Overall Study|Other than specified above|1|||
19529682|NCT01722331|41975398|FG000|Part 1|Adverse Event|5|||
19529683|NCT01722331|41975399|FG001|Part 1|Adverse Event|0|||
19529684|NCT01722331|41975400|FG002|Part 1|Adverse Event|0|||
19529685|NCT01722331|41975401|FG003|Part 1|Adverse Event|0|||
19529686|NCT01722331|41975402|FG004|Part 1|Adverse Event|0|||
19529687|NCT01722331|41975403|FG005|Part 1|Adverse Event|0|||
19529688|NCT01722331|41975404|FG006|Part 1|Adverse Event|0|||
19529689|NCT01722331|41975398|FG000|Part 1|Lack of Efficacy|0|||
19529690|NCT01722331|41975399|FG001|Part 1|Lack of Efficacy|0|||
19529691|NCT01722331|41975400|FG002|Part 1|Lack of Efficacy|1|||
19529692|NCT01722331|41975401|FG003|Part 1|Lack of Efficacy|0|||
19451001|NCT01558089|41699818|FG000|Overall Study|Withdrawal by Subject|6|||
19451002|NCT01581021|41699824|FG000|Overall Study|Lost to Follow-up|4|||
19451003|NCT01581021|41699825|FG001|Overall Study|Lost to Follow-up|6|||
19451004|NCT01581021|41699824|FG000|Overall Study|More than 2 hooks in thoracic|3|||
19529693|NCT01722331|41975402|FG004|Part 1|Lack of Efficacy|2|||
19529694|NCT01722331|41975403|FG005|Part 1|Lack of Efficacy|0|||
19529695|NCT01722331|41975404|FG006|Part 1|Lack of Efficacy|0|||
19529696|NCT01722331|41975398|FG000|Part 1|Lost to Follow-up|1|||
19529697|NCT01722331|41975399|FG001|Part 1|Lost to Follow-up|0|||
19529698|NCT01722331|41975400|FG002|Part 1|Lost to Follow-up|2|||
19451005|NCT01581021|41699825|FG001|Overall Study|More than 2 hooks in thoracic|0|||
19451006|NCT01581021|41699824|FG000|Overall Study|Neuromuscular|2|||
19451007|NCT01581021|41699825|FG001|Overall Study|Neuromuscular|1|||
19451008|NCT01581021|41699824|FG000|Overall Study|Not Randomized|1|||
19451009|NCT01581021|41699825|FG001|Overall Study|Not Randomized|2|||
19451010|NCT01581021|41699824|FG000|Overall Study|Lenke 6 Classification|0|||
19451011|NCT01581021|41699825|FG001|Overall Study|Lenke 6 Classification|1|||
19451012|NCT01581021|41699824|FG000|Overall Study|Lack of Efficacy|0|||
19451013|NCT01581021|41699825|FG001|Overall Study|Lack of Efficacy|1|||
19451014|NCT00084682|41699831|FG000|Overall Study|Withdrawal by Subject|1|||
19451015|NCT01556997|41699839|FG000|Overall Study|Adverse Event|10|||
19451016|NCT01556997|41699840|FG001|Overall Study|Adverse Event|12|||
19451017|NCT01556997|41699841|FG002|Overall Study|Adverse Event|12|||
19451018|NCT01556997|41699839|FG000|Overall Study|Lost to Follow-up|6|||
19451019|NCT01556997|41699840|FG001|Overall Study|Lost to Follow-up|6|||
19451020|NCT01556997|41699841|FG002|Overall Study|Lost to Follow-up|4|||
19451021|NCT01556997|41699839|FG000|Overall Study|Physician Decision|1|||
19529699|NCT01722331|41975401|FG003|Part 1|Lost to Follow-up|0|||
19529700|NCT01722331|41975402|FG004|Part 1|Lost to Follow-up|1|||
19529701|NCT01722331|41975403|FG005|Part 1|Lost to Follow-up|0|||
19529702|NCT01722331|41975404|FG006|Part 1|Lost to Follow-up|0|||
19529703|NCT01722331|41975398|FG000|Part 1|Physician Decision|0|||
19529704|NCT01722331|41975399|FG001|Part 1|Physician Decision|0|||
19451022|NCT01556997|41699840|FG001|Overall Study|Physician Decision|1|||
19529705|NCT01722331|41975400|FG002|Part 1|Physician Decision|3|||
19529706|NCT01722331|41975401|FG003|Part 1|Physician Decision|0|||
19529707|NCT01722331|41975402|FG004|Part 1|Physician Decision|1|||
19529708|NCT01722331|41975403|FG005|Part 1|Physician Decision|0|||
19451023|NCT01556997|41699841|FG002|Overall Study|Physician Decision|1|||
19451024|NCT01556997|41699839|FG000|Overall Study|Withdrawal by Subject|7|||
19451025|NCT01556997|41699840|FG001|Overall Study|Withdrawal by Subject|6|||
19451026|NCT01556997|41699841|FG002|Overall Study|Withdrawal by Subject|8|||
19451027|NCT01556997|41699839|FG000|Overall Study|Other|2|||
19451028|NCT01556997|41699840|FG001|Overall Study|Other|3|||
19451029|NCT01556997|41699841|FG002|Overall Study|Other|7|||
19451030|NCT00082888|41699852|FG000|Overall Study|Ineligible|1|||
19451031|NCT00082888|41699853|FG001|Overall Study|Ineligible|0|||
19451032|NCT00082888|41699854|FG002|Overall Study|Ineligible|0|||
19451033|NCT00082810|41699863|FG000|Overall Study|Adverse Event|3|||
19451034|NCT00082810|41699863|FG000|Overall Study|Progressive disease|24|||
19451035|NCT00082810|41699863|FG000|Overall Study|Withdrawal by Subject|4|||
19451036|NCT01577745|41699874|FG000|Overall Study|Withdrawal by Subject|0|||
19629600|NCT00807014|42079077|FG000|Overall Study|Recovery|1|||
19629601|NCT00807014|42079078|FG001|Overall Study|Recovery|0|||
19629602|NCT00807014|42079077|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
19629603|NCT00807014|42079078|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
19629604|NCT00847535|42079084|FG000|Overall Study|Withdrawal by Subject|2|||
19629605|NCT00847535|42079085|FG001|Overall Study|Withdrawal by Subject|1|||
19629606|NCT00847535|42079086|FG002|Overall Study|Withdrawal by Subject|1|||
19629607|NCT00847535|42079084|FG000|Overall Study|Lost to Follow-up|0|||
19629608|NCT00847535|42079085|FG001|Overall Study|Lost to Follow-up|1|||
19529709|NCT01722331|41975404|FG006|Part 1|Physician Decision|0|||
19529710|NCT01722331|41975398|FG000|Part 1|Pregnancy|1|||
19529711|NCT01722331|41975399|FG001|Part 1|Pregnancy|0|||
19529712|NCT01722331|41975400|FG002|Part 1|Pregnancy|0|||
19529713|NCT01722331|41975401|FG003|Part 1|Pregnancy|0|||
19529714|NCT01722331|41975402|FG004|Part 1|Pregnancy|0|||
19529715|NCT01722331|41975403|FG005|Part 1|Pregnancy|0|||
19529716|NCT01722331|41975404|FG006|Part 1|Pregnancy|0|||
19529717|NCT01722331|41975398|FG000|Part 1|Progressive Disease|0|||
19529718|NCT01722331|41975399|FG001|Part 1|Progressive Disease|0|||
19529719|NCT01722331|41975400|FG002|Part 1|Progressive Disease|0|||
19529720|NCT01722331|41975401|FG003|Part 1|Progressive Disease|0|||
19529721|NCT01722331|41975402|FG004|Part 1|Progressive Disease|1|||
19529722|NCT01722331|41975403|FG005|Part 1|Progressive Disease|0|||
19629609|NCT00847535|42079086|FG002|Overall Study|Lost to Follow-up|0|||
19629610|NCT00592631|42079093|FG000|Overall Study|Lost to Follow-up|0|||
19629611|NCT00592631|42079094|FG001|Overall Study|Lost to Follow-up|2|||
19629612|NCT00791388|42079105|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
19629613|NCT00791388|42079106|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
19629614|NCT00791388|42079107|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
19629615|NCT00791388|42079108|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
19629616|NCT00791388|42079109|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
19629617|NCT00791388|42079105|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
19629618|NCT00791388|42079106|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
19629619|NCT00791388|42079107|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
19629620|NCT00791388|42079108|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
19629621|NCT00791388|42079109|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
19629622|NCT00791388|42079105|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
19629623|NCT00791388|42079106|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
19629624|NCT00791388|42079107|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
19629625|NCT00791388|42079108|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
19629626|NCT00791388|42079109|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
19629627|NCT00794040|42079123|FG000|Overall Study|Withdrawal by Subject|3|||
19629628|NCT00794040|42079124|FG001|Overall Study|Withdrawal by Subject|4|||
19629629|NCT00794040|42079123|FG000|Overall Study|Physician Decision|0|||
19629630|NCT00794040|42079124|FG001|Overall Study|Physician Decision|1|||
19629631|NCT00813488|42079130|FG000|Titration Period 1|Adverse Event|6|||
19629632|NCT00813488|42079131|FG001|Titration Period 1|Adverse Event|1|||
19451037|NCT01577745|41699875|FG001|Overall Study|Withdrawal by Subject|1|||
19451038|NCT01577745|41699876|FG002|Overall Study|Withdrawal by Subject|0|||
19629633|NCT00813488|42079130|FG000|Titration Period 1|Lack of Efficacy|9|||
19629634|NCT00813488|42079131|FG001|Titration Period 1|Lack of Efficacy|7|||
19711390|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
19451039|NCT01577745|41699877|FG003|Overall Study|Withdrawal by Subject|3|||
19451040|NCT01577745|41699878|FG004|Overall Study|Withdrawal by Subject|2|||
19451041|NCT01577745|41699879|FG005|Overall Study|Withdrawal by Subject|0|||
19529723|NCT01722331|41975404|FG006|Part 1|Progressive Disease|0|||
19529724|NCT01722331|41975398|FG000|Part 1|Protocol Violation|1|||
19529725|NCT01722331|41975399|FG001|Part 1|Protocol Violation|0|||
19629635|NCT00813488|42079130|FG000|Titration Period 1|Withdrawal by Subject|2|||
19629636|NCT00813488|42079131|FG001|Titration Period 1|Withdrawal by Subject|2|||
19629637|NCT00813488|42079130|FG000|Titration Period 1|Protocol Violation|4|||
19629638|NCT00813488|42079131|FG001|Titration Period 1|Protocol Violation|3|||
19451042|NCT01577745|41699874|FG000|Overall Study|Death|3|||
19451043|NCT01577745|41699875|FG001|Overall Study|Death|2|||
19451044|NCT01577745|41699876|FG002|Overall Study|Death|2|||
19451045|NCT01577745|41699877|FG003|Overall Study|Death|1|||
19451046|NCT01577745|41699878|FG004|Overall Study|Death|1|||
19451047|NCT01577745|41699879|FG005|Overall Study|Death|3|||
19451048|NCT01577745|41699874|FG000|Overall Study|Physician Decision|0|||
19451049|NCT01577745|41699875|FG001|Overall Study|Physician Decision|0|||
19451050|NCT01577745|41699876|FG002|Overall Study|Physician Decision|0|||
19451051|NCT01577745|41699877|FG003|Overall Study|Physician Decision|1|||
19451052|NCT01577745|41699878|FG004|Overall Study|Physician Decision|1|||
19451053|NCT01577745|41699879|FG005|Overall Study|Physician Decision|0|||
19451054|NCT01577745|41699874|FG000|Overall Study|Lost to Follow-up|0|||
19451055|NCT01577745|41699875|FG001|Overall Study|Lost to Follow-up|0|||
19451056|NCT01577745|41699876|FG002|Overall Study|Lost to Follow-up|0|||
19451057|NCT01577745|41699877|FG003|Overall Study|Lost to Follow-up|0|||
19451058|NCT01577745|41699878|FG004|Overall Study|Lost to Follow-up|0|||
19451059|NCT01577745|41699879|FG005|Overall Study|Lost to Follow-up|1|||
19451060|NCT01577745|41699874|FG000|Overall Study|Alternative Therapy|0|||
19451061|NCT01577745|41699875|FG001|Overall Study|Alternative Therapy|0|||
19451062|NCT01577745|41699876|FG002|Overall Study|Alternative Therapy|0|||
19451063|NCT01577745|41699877|FG003|Overall Study|Alternative Therapy|1|||
19451064|NCT01577745|41699878|FG004|Overall Study|Alternative Therapy|1|||
19451065|NCT01577745|41699879|FG005|Overall Study|Alternative Therapy|0|||
19451066|NCT00080938|41699898|FG000|Overall Study|Adverse Event|3|||
19451067|NCT00080938|41699898|FG000|Overall Study|Withdrawal by Subject|6|||
19451068|NCT00080938|41699898|FG000|Overall Study|Death|2|||
19451069|NCT00080938|41699898|FG000|Overall Study|Lack of Efficacy|7|||
19451070|NCT00080938|41699898|FG000|Overall Study|other disease|1|||
19451071|NCT00080938|41699898|FG000|Overall Study|Not started protocol therapy|1|||
19451072|NCT00080938|41699898|FG000|Overall Study|Ineligible|4|||
19451073|NCT01688037|41699905|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
19451074|NCT01688037|41699906|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
19451075|NCT01688037|41699907|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
19451076|NCT01688037|41699905|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
19451077|NCT01688037|41699906|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
19451078|NCT01688037|41699907|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
19451079|NCT01688037|41699905|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
19451080|NCT01688037|41699906|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
19451081|NCT01688037|41699907|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
19451082|NCT01688037|41699905|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
19451083|NCT01688037|41699906|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
19529726|NCT01722331|41975400|FG002|Part 1|Protocol Violation|0|||
19529727|NCT01722331|41975401|FG003|Part 1|Protocol Violation|0|||
19529728|NCT01722331|41975402|FG004|Part 1|Protocol Violation|1|||
19529729|NCT01722331|41975403|FG005|Part 1|Protocol Violation|0|||
19529730|NCT01722331|41975404|FG006|Part 1|Protocol Violation|0|||
19529731|NCT01722331|41975398|FG000|Part 1|Withdrawal by Subject|2|||
19529732|NCT01722331|41975399|FG001|Part 1|Withdrawal by Subject|0|||
19529733|NCT01722331|41975400|FG002|Part 1|Withdrawal by Subject|3|||
19529734|NCT01722331|41975401|FG003|Part 1|Withdrawal by Subject|0|||
19529735|NCT01722331|41975402|FG004|Part 1|Withdrawal by Subject|3|||
19529736|NCT01722331|41975403|FG005|Part 1|Withdrawal by Subject|0|||
19529737|NCT01722331|41975404|FG006|Part 1|Withdrawal by Subject|0|||
19529738|NCT01722331|41975398|FG000|Part 2|Adverse Event|3|||
19529739|NCT01722331|41975399|FG001|Part 2|Adverse Event|0|||
19529740|NCT01722331|41975400|FG002|Part 2|Adverse Event|0|||
19529741|NCT01722331|41975401|FG003|Part 2|Adverse Event|0|||
19529742|NCT01722331|41975402|FG004|Part 2|Adverse Event|0|||
19529743|NCT01722331|41975403|FG005|Part 2|Adverse Event|1|||
19629639|NCT00813488|42079130|FG000|Titration Period 1|Non-compliance to study medication|4|||
19629640|NCT00813488|42079131|FG001|Titration Period 1|Non-compliance to study medication|1|||
19629641|NCT00813488|42079130|FG000|Titration Period 1|Non-compliance to study procedures|2|||
19629642|NCT00813488|42079131|FG001|Titration Period 1|Non-compliance to study procedures|2|||
19629643|NCT00813488|42079130|FG000|Titration Period 1|Technical Difficulties|0|||
19629644|NCT00813488|42079131|FG001|Titration Period 1|Technical Difficulties|1|||
19629645|NCT00813488|42079130|FG000|Titration Period 2|Adverse Event|2|||
19629646|NCT00813488|42079131|FG001|Titration Period 2|Adverse Event|3|||
19629647|NCT00813488|42079130|FG000|Titration Period 2|Lack of Efficacy|8|||
19451084|NCT01688037|41699907|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
19451085|NCT01688037|41699905|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
19451086|NCT01688037|41699906|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
19451087|NCT01688037|41699907|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
19529744|NCT01722331|41975404|FG006|Part 2|Adverse Event|0|||
19529745|NCT01722331|41975398|FG000|Part 2|Lack of Efficacy|3|||
19529746|NCT01722331|41975399|FG001|Part 2|Lack of Efficacy|0|||
19529747|NCT01722331|41975400|FG002|Part 2|Lack of Efficacy|11|||
19629648|NCT00813488|42079131|FG001|Titration Period 2|Lack of Efficacy|4|||
19529748|NCT01722331|41975401|FG003|Part 2|Lack of Efficacy|0|||
19529749|NCT01722331|41975402|FG004|Part 2|Lack of Efficacy|0|||
19529750|NCT01722331|41975403|FG005|Part 2|Lack of Efficacy|3|||
19529751|NCT01722331|41975404|FG006|Part 2|Lack of Efficacy|3|||
19529752|NCT01722331|41975398|FG000|Part 2|Lost to Follow-up|0|||
19529753|NCT01722331|41975399|FG001|Part 2|Lost to Follow-up|0|||
19529754|NCT01722331|41975400|FG002|Part 2|Lost to Follow-up|3|||
19529755|NCT01722331|41975401|FG003|Part 2|Lost to Follow-up|0|||
19529756|NCT01722331|41975402|FG004|Part 2|Lost to Follow-up|0|||
19529757|NCT01722331|41975403|FG005|Part 2|Lost to Follow-up|1|||
19529758|NCT01722331|41975404|FG006|Part 2|Lost to Follow-up|1|||
19529759|NCT01722331|41975398|FG000|Part 2|Non-Compliance with Study Drug|1|||
19529760|NCT01722331|41975399|FG001|Part 2|Non-Compliance with Study Drug|0|||
19529761|NCT01722331|41975400|FG002|Part 2|Non-Compliance with Study Drug|1|||
19529762|NCT01722331|41975401|FG003|Part 2|Non-Compliance with Study Drug|0|||
19529763|NCT01722331|41975402|FG004|Part 2|Non-Compliance with Study Drug|0|||
19529764|NCT01722331|41975403|FG005|Part 2|Non-Compliance with Study Drug|0|||
19529765|NCT01722331|41975404|FG006|Part 2|Non-Compliance with Study Drug|0|||
19529766|NCT01722331|41975398|FG000|Part 2|Physician Decision|0|||
19529767|NCT01722331|41975399|FG001|Part 2|Physician Decision|0|||
19529768|NCT01722331|41975400|FG002|Part 2|Physician Decision|2|||
19529769|NCT01722331|41975401|FG003|Part 2|Physician Decision|0|||
19529770|NCT01722331|41975402|FG004|Part 2|Physician Decision|0|||
19529771|NCT01722331|41975403|FG005|Part 2|Physician Decision|0|||
19529772|NCT01722331|41975404|FG006|Part 2|Physician Decision|0|||
19529773|NCT01722331|41975398|FG000|Part 2|Pregnancy|0|||
19529774|NCT01722331|41975399|FG001|Part 2|Pregnancy|0|||
19529775|NCT01722331|41975400|FG002|Part 2|Pregnancy|0|||
19529776|NCT01722331|41975401|FG003|Part 2|Pregnancy|0|||
19529777|NCT01722331|41975402|FG004|Part 2|Pregnancy|0|||
19529778|NCT01722331|41975403|FG005|Part 2|Pregnancy|1|||
19529779|NCT01722331|41975404|FG006|Part 2|Pregnancy|0|||
19629649|NCT00813488|42079130|FG000|Titration Period 2|Protocol Violation|3|||
19629650|NCT00813488|42079131|FG001|Titration Period 2|Protocol Violation|2|||
19629651|NCT00813488|42079130|FG000|Titration Period 2|Lost to Follow-up|1|||
19629652|NCT00813488|42079131|FG001|Titration Period 2|Lost to Follow-up|0|||
19629653|NCT00813488|42079130|FG000|Titration Period 2|Non-compliance with study procedures|2|||
19629654|NCT00813488|42079131|FG001|Titration Period 2|Non-compliance with study procedures|1|||
19529780|NCT01722331|41975398|FG000|Part 2|Progressive Disease|0|||
19529781|NCT01722331|41975399|FG001|Part 2|Progressive Disease|0|||
19529782|NCT01722331|41975400|FG002|Part 2|Progressive Disease|1|||
19529783|NCT01722331|41975401|FG003|Part 2|Progressive Disease|0|||
19529784|NCT01722331|41975402|FG004|Part 2|Progressive Disease|0|||
19529785|NCT01722331|41975403|FG005|Part 2|Progressive Disease|0|||
19529786|NCT01722331|41975404|FG006|Part 2|Progressive Disease|0|||
19529787|NCT01722331|41975398|FG000|Part 2|Protocol Violation|1|||
19529788|NCT01722331|41975399|FG001|Part 2|Protocol Violation|0|||
19529789|NCT01722331|41975400|FG002|Part 2|Protocol Violation|0|||
19629655|NCT00813488|42079130|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
19629656|NCT00813488|42079131|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
19629657|NCT00813488|42079130|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
19629658|NCT00813488|42079131|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
19629659|NCT00813488|42079130|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
19529790|NCT01722331|41975401|FG003|Part 2|Protocol Violation|0|||
19529791|NCT01722331|41975402|FG004|Part 2|Protocol Violation|0|||
19629660|NCT00813488|42079131|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
19629661|NCT00813488|42079130|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
19629662|NCT00813488|42079131|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
19629663|NCT00813488|42079130|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
19629664|NCT00813488|42079131|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
19629665|NCT00813488|42079130|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
19629666|NCT00813488|42079131|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
19629667|NCT00813488|42079130|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
19629668|NCT00813488|42079131|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
19629669|NCT00813488|42079130|FG000|Double-blind Treatment Period 2|Other|1|||
19629670|NCT00813488|42079131|FG001|Double-blind Treatment Period 2|Other|0|||
19629671|NCT00813488|42079130|FG000|Open-label Extension|Adverse Event|1|||
19529792|NCT01722331|41975403|FG005|Part 2|Protocol Violation|0|||
19529793|NCT01722331|41975404|FG006|Part 2|Protocol Violation|0|||
19529794|NCT01722331|41975398|FG000|Part 2|Withdrawal by Subject|5|||
19529795|NCT01722331|41975399|FG001|Part 2|Withdrawal by Subject|0|||
19529796|NCT01722331|41975400|FG002|Part 2|Withdrawal by Subject|3|||
19529797|NCT01722331|41975401|FG003|Part 2|Withdrawal by Subject|0|||
19529798|NCT01722331|41975402|FG004|Part 2|Withdrawal by Subject|0|||
19529799|NCT01722331|41975403|FG005|Part 2|Withdrawal by Subject|2|||
19529800|NCT01722331|41975404|FG006|Part 2|Withdrawal by Subject|2|||
19529801|NCT01722331|41975398|FG000|Part 2|Other Protocol Specified Criteria|6|||
19529802|NCT01722331|41975399|FG001|Part 2|Other Protocol Specified Criteria|0|||
19529803|NCT01722331|41975400|FG002|Part 2|Other Protocol Specified Criteria|10|||
19629672|NCT00813488|42079131|FG001|Open-label Extension|Adverse Event|2|||
19529804|NCT01722331|41975401|FG003|Part 2|Other Protocol Specified Criteria|0|||
19529805|NCT01722331|41975402|FG004|Part 2|Other Protocol Specified Criteria|0|||
19529806|NCT01722331|41975403|FG005|Part 2|Other Protocol Specified Criteria|2|||
19529807|NCT01722331|41975404|FG006|Part 2|Other Protocol Specified Criteria|1|||
19529808|NCT01722331|41975398|FG000|Part 3|Adverse Event|2|||
19529809|NCT01722331|41975399|FG001|Part 3|Adverse Event|2|||
19529810|NCT01722331|41975400|FG002|Part 3|Adverse Event|0|||
19529811|NCT01722331|41975401|FG003|Part 3|Adverse Event|1|||
19529812|NCT01722331|41975402|FG004|Part 3|Adverse Event|0|||
19529813|NCT01722331|41975403|FG005|Part 3|Adverse Event|0|||
19529814|NCT01722331|41975404|FG006|Part 3|Adverse Event|0|||
19529815|NCT01722331|41975398|FG000|Part 3|Death|1|||
19529816|NCT01722331|41975399|FG001|Part 3|Death|0|||
19529817|NCT01722331|41975400|FG002|Part 3|Death|0|||
19529818|NCT01722331|41975401|FG003|Part 3|Death|0|||
19529819|NCT01722331|41975402|FG004|Part 3|Death|0|||
19529820|NCT01722331|41975403|FG005|Part 3|Death|0|||
19529821|NCT01722331|41975404|FG006|Part 3|Death|0|||
19529822|NCT01722331|41975398|FG000|Part 3|Lack of Efficacy|1|||
19529823|NCT01722331|41975399|FG001|Part 3|Lack of Efficacy|0|||
19529824|NCT01722331|41975400|FG002|Part 3|Lack of Efficacy|0|||
19529825|NCT01722331|41975401|FG003|Part 3|Lack of Efficacy|0|||
19529826|NCT01722331|41975402|FG004|Part 3|Lack of Efficacy|0|||
19529827|NCT01722331|41975403|FG005|Part 3|Lack of Efficacy|0|||
19529828|NCT01722331|41975404|FG006|Part 3|Lack of Efficacy|0|||
19529829|NCT01722331|41975398|FG000|Part 3|Lost to Follow-up|3|||
19529830|NCT01722331|41975399|FG001|Part 3|Lost to Follow-up|4|||
19529831|NCT01722331|41975400|FG002|Part 3|Lost to Follow-up|0|||
19529832|NCT01722331|41975401|FG003|Part 3|Lost to Follow-up|0|||
19529833|NCT01722331|41975402|FG004|Part 3|Lost to Follow-up|0|||
19529834|NCT01722331|41975403|FG005|Part 3|Lost to Follow-up|1|||
19529835|NCT01722331|41975404|FG006|Part 3|Lost to Follow-up|0|||
19529836|NCT01722331|41975398|FG000|Part 3|Non-Compliance with Study Drug|0|||
19529837|NCT01722331|41975399|FG001|Part 3|Non-Compliance with Study Drug|1|||
19529838|NCT01722331|41975400|FG002|Part 3|Non-Compliance with Study Drug|0|||
19529839|NCT01722331|41975401|FG003|Part 3|Non-Compliance with Study Drug|0|||
19529840|NCT01722331|41975402|FG004|Part 3|Non-Compliance with Study Drug|0|||
19529841|NCT01722331|41975403|FG005|Part 3|Non-Compliance with Study Drug|0|||
19529842|NCT01722331|41975404|FG006|Part 3|Non-Compliance with Study Drug|0|||
19529843|NCT01722331|41975398|FG000|Part 3|Physician Decision|1|||
19529844|NCT01722331|41975399|FG001|Part 3|Physician Decision|1|||
19529845|NCT01722331|41975400|FG002|Part 3|Physician Decision|0|||
19529846|NCT01722331|41975401|FG003|Part 3|Physician Decision|0|||
19529847|NCT01722331|41975402|FG004|Part 3|Physician Decision|0|||
19529848|NCT01722331|41975403|FG005|Part 3|Physician Decision|0|||
19529849|NCT01722331|41975404|FG006|Part 3|Physician Decision|1|||
19529850|NCT01722331|41975398|FG000|Part 3|Protocol Violation|2|||
19529851|NCT01722331|41975399|FG001|Part 3|Protocol Violation|1|||
19529852|NCT01722331|41975400|FG002|Part 3|Protocol Violation|0|||
19529853|NCT01722331|41975401|FG003|Part 3|Protocol Violation|0|||
19529854|NCT01722331|41975402|FG004|Part 3|Protocol Violation|0|||
19529855|NCT01722331|41975403|FG005|Part 3|Protocol Violation|0|||
19529856|NCT01722331|41975404|FG006|Part 3|Protocol Violation|0|||
19529857|NCT01722331|41975398|FG000|Part 3|Withdrawal by Subject|4|||
19529858|NCT01722331|41975399|FG001|Part 3|Withdrawal by Subject|7|||
19451088|NCT01688037|41699905|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
19451089|NCT01688037|41699906|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
19451090|NCT01688037|41699907|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
19451091|NCT01688037|41699905|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
19451092|NCT01688037|41699906|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
19451093|NCT01688037|41699907|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
19451094|NCT01688037|41699905|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
19451095|NCT01688037|41699906|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
19451096|NCT01688037|41699907|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
19451097|NCT01688037|41699905|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
19451098|NCT01688037|41699906|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
19451099|NCT01688037|41699907|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
19451100|NCT01688037|41699905|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
19451101|NCT01688037|41699906|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
19451102|NCT01688037|41699907|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
19451103|NCT01610336|41699940|FG000|Overall Study|Progressive Disease|4|||
19451104|NCT01610336|41699941|FG001|Overall Study|Progressive Disease|6|||
19451105|NCT01610336|41699942|FG002|Overall Study|Progressive Disease|6|||
19529859|NCT01722331|41975400|FG002|Part 3|Withdrawal by Subject|0|||
19529860|NCT01722331|41975401|FG003|Part 3|Withdrawal by Subject|0|||
19529861|NCT01722331|41975402|FG004|Part 3|Withdrawal by Subject|0|||
19529862|NCT01722331|41975403|FG005|Part 3|Withdrawal by Subject|2|||
19529863|NCT01722331|41975404|FG006|Part 3|Withdrawal by Subject|1|||
19529864|NCT01722331|41975398|FG000|Part 3|Other Protocol Specified Criteria|1|||
19529865|NCT01722331|41975399|FG001|Part 3|Other Protocol Specified Criteria|1|||
19529866|NCT01722331|41975400|FG002|Part 3|Other Protocol Specified Criteria|0|||
19529867|NCT01722331|41975401|FG003|Part 3|Other Protocol Specified Criteria|0|||
19529868|NCT01722331|41975402|FG004|Part 3|Other Protocol Specified Criteria|0|||
19529869|NCT01722331|41975403|FG005|Part 3|Other Protocol Specified Criteria|0|||
19529870|NCT01722331|41975404|FG006|Part 3|Other Protocol Specified Criteria|0|||
19529871|NCT01630590|41975416|FG000|Overall Study|Adverse Event|9|||
19451106|NCT01610336|41699943|FG003|Overall Study|Progressive Disease|5|||
19451107|NCT01610336|41699944|FG004|Overall Study|Progressive Disease|3|||
19451108|NCT01610336|41699945|FG005|Overall Study|Progressive Disease|10|||
19451109|NCT01610336|41699946|FG006|Overall Study|Progressive Disease|1|||
19451110|NCT01610336|41699947|FG007|Overall Study|Progressive Disease|6|||
19451111|NCT01610336|41699948|FG008|Overall Study|Progressive Disease|6|||
19451112|NCT01610336|41699949|FG009|Overall Study|Progressive Disease|40|||
19451113|NCT01610336|41699950|FG010|Overall Study|Progressive Disease|36|||
19451114|NCT01610336|41699940|FG000|Overall Study|Adverse Event|0|||
19451115|NCT01610336|41699941|FG001|Overall Study|Adverse Event|0|||
19451116|NCT01610336|41699942|FG002|Overall Study|Adverse Event|0|||
19451117|NCT01610336|41699943|FG003|Overall Study|Adverse Event|1|||
19451118|NCT01610336|41699944|FG004|Overall Study|Adverse Event|1|||
19451119|NCT01610336|41699945|FG005|Overall Study|Adverse Event|1|||
19451120|NCT01610336|41699946|FG006|Overall Study|Adverse Event|0|||
19451121|NCT01610336|41699947|FG007|Overall Study|Adverse Event|0|||
19451122|NCT01610336|41699948|FG008|Overall Study|Adverse Event|2|||
19451123|NCT01610336|41699949|FG009|Overall Study|Adverse Event|8|||
19529872|NCT01630590|41975416|FG000|Overall Study|Lack of Efficacy|37|||
19529873|NCT01630590|41975416|FG000|Overall Study|Withdrawal by Subject|4|||
19529874|NCT01630590|41975416|FG000|Overall Study|2nd primary tumor|2|||
19529875|NCT01630590|41975416|FG000|Overall Study|Automobile accident|1|||
19529876|NCT01630590|41975416|FG000|Overall Study|Maximum benefit|4|||
19529877|NCT01619085|41975420|FG000|Overall Study|Adverse Event|231|||
19529878|NCT01619085|41975420|FG000|Overall Study|Protocol Violation|4|||
19529879|NCT01619085|41975420|FG000|Overall Study|Lost to Follow-up|3|||
19529880|NCT01619085|41975420|FG000|Overall Study|Withdrawal by Subject|45|||
19529881|NCT01619085|41975420|FG000|Overall Study|Other than specified|96|||
19529882|NCT01619085|41975420|FG000|Overall Study|Not treated|1|||
19529883|NCT01619085|41975420|FG000|Overall Study|Death|145|||
19529884|NCT01499095|41975433|FG000|Overall Study|Randomized But Not Treated|1|||
19529885|NCT01499095|41975434|FG001|Overall Study|Randomized But Not Treated|1|||
19529886|NCT01499095|41975433|FG000|Overall Study|Adverse Event|12|||
19529887|NCT01499095|41975434|FG001|Overall Study|Adverse Event|7|||
19529888|NCT01499095|41975433|FG000|Overall Study|Lack of Efficacy|2|||
19529889|NCT01499095|41975434|FG001|Overall Study|Lack of Efficacy|1|||
19529890|NCT01499095|41975433|FG000|Overall Study|Protocol Violation|6|||
19529891|NCT01499095|41975434|FG001|Overall Study|Protocol Violation|7|||
19529892|NCT01499095|41975433|FG000|Overall Study|Received Rescue Therapy|32|||
19529893|NCT01499095|41975434|FG001|Overall Study|Received Rescue Therapy|40|||
19529894|NCT01499095|41975433|FG000|Overall Study|Diverse Reasons|22|||
19529895|NCT01499095|41975434|FG001|Overall Study|Diverse Reasons|25|||
19529896|NCT01499095|41975433|FG000|Overall Study|Lost to Follow-up|6|||
19529897|NCT01499095|41975434|FG001|Overall Study|Lost to Follow-up|4|||
19529898|NCT01499095|41975433|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
19451124|NCT01610336|41699950|FG010|Overall Study|Adverse Event|6|||
19529899|NCT01499095|41975434|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
19529900|NCT01499095|41975433|FG000|Overall Study|Hypoglycemia|3|||
19629673|NCT00813488|42079130|FG000|Open-label Extension|Lack of Efficacy|3|||
19629674|NCT00813488|42079131|FG001|Open-label Extension|Lack of Efficacy|0|||
19629675|NCT00813488|42079130|FG000|Open-label Extension|Withdrawal by Subject|0|||
19629676|NCT00813488|42079131|FG001|Open-label Extension|Withdrawal by Subject|2|||
19629677|NCT00813488|42079130|FG000|Open-label Extension|Protocol Violation|1|||
19451125|NCT01610336|41699940|FG000|Overall Study|Subject/Guardian decision|1|||
19451126|NCT01610336|41699941|FG001|Overall Study|Subject/Guardian decision|1|||
19451127|NCT01610336|41699942|FG002|Overall Study|Subject/Guardian decision|0|||
19451128|NCT01610336|41699943|FG003|Overall Study|Subject/Guardian decision|1|||
19451129|NCT01610336|41699944|FG004|Overall Study|Subject/Guardian decision|0|||
19451130|NCT01610336|41699945|FG005|Overall Study|Subject/Guardian decision|0|||
19451131|NCT01610336|41699946|FG006|Overall Study|Subject/Guardian decision|0|||
19451132|NCT01610336|41699947|FG007|Overall Study|Subject/Guardian decision|1|||
19451133|NCT01610336|41699948|FG008|Overall Study|Subject/Guardian decision|0|||
19451134|NCT01610336|41699949|FG009|Overall Study|Subject/Guardian decision|2|||
19451135|NCT01610336|41699950|FG010|Overall Study|Subject/Guardian decision|2|||
19451136|NCT01610336|41699940|FG000|Overall Study|Death|0|||
19451137|NCT01610336|41699941|FG001|Overall Study|Death|0|||
19529901|NCT01499095|41975434|FG001|Overall Study|Hypoglycemia|1|||
19529902|NCT01499095|41975433|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
19529903|NCT01499095|41975434|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
19529904|NCT01499095|41975433|FG000|Overall Study|Change in Injection Schedule|2|||
19529905|NCT01499095|41975434|FG001|Overall Study|Change in Injection Schedule|0|||
19629678|NCT00813488|42079131|FG001|Open-label Extension|Protocol Violation|2|||
19629679|NCT00813488|42079130|FG000|Open-label Extension|Non-compliance study medication|4|||
19451138|NCT01610336|41699942|FG002|Overall Study|Death|0|||
19451139|NCT01610336|41699943|FG003|Overall Study|Death|0|||
19451140|NCT01610336|41699944|FG004|Overall Study|Death|0|||
19451141|NCT01610336|41699945|FG005|Overall Study|Death|1|||
19451142|NCT01610336|41699946|FG006|Overall Study|Death|3|||
19451143|NCT01610336|41699947|FG007|Overall Study|Death|0|||
19451144|NCT01610336|41699948|FG008|Overall Study|Death|0|||
19451145|NCT01610336|41699949|FG009|Overall Study|Death|1|||
19451146|NCT01610336|41699950|FG010|Overall Study|Death|2|||
19529906|NCT01499095|41975433|FG000|Overall Study|Perceived Lack of Efficacy|1|||
19529907|NCT01499095|41975434|FG001|Overall Study|Perceived Lack of Efficacy|1|||
19529908|NCT01499082|41975445|FG000|Overall Study|Randomized but not Treated|0|||
19529909|NCT01499082|41975446|FG001|Overall Study|Randomized but not Treated|1|||
19529910|NCT01499082|41975445|FG000|Overall Study|Adverse Event|12|||
19529911|NCT01499082|41975446|FG001|Overall Study|Adverse Event|16|||
19529912|NCT01499082|41975445|FG000|Overall Study|Lack of Efficacy|1|||
19529913|NCT01499082|41975446|FG001|Overall Study|Lack of Efficacy|1|||
19529914|NCT01499082|41975445|FG000|Overall Study|Protocol Violation|6|||
19529915|NCT01499082|41975446|FG001|Overall Study|Protocol Violation|8|||
19529916|NCT01499082|41975445|FG000|Overall Study|Diverse Reasons|18|||
19529917|NCT01499082|41975446|FG001|Overall Study|Diverse Reasons|14|||
19529918|NCT01499082|41975445|FG000|Overall Study|Site Closure for Noncompliance|5|||
19529919|NCT01499082|41975446|FG001|Overall Study|Site Closure for Noncompliance|2|||
19529920|NCT01499082|41975445|FG000|Overall Study|Hypoglycemia|2|||
19529921|NCT01499082|41975446|FG001|Overall Study|Hypoglycemia|3|||
19529922|NCT01499082|41975445|FG000|Overall Study|Lost to Follow-up|1|||
19529923|NCT01499082|41975446|FG001|Overall Study|Lost to Follow-up|3|||
19529924|NCT01488890|41975458|FG000|Overall Study|Serious adverse event|2|||
19529925|NCT01488890|41975459|FG001|Overall Study|Serious adverse event|0|||
19529926|NCT01488890|41975460|FG002|Overall Study|Serious adverse event|0|||
19529927|NCT01488890|41975461|FG003|Overall Study|Serious adverse event|0|||
19529928|NCT01488890|41975458|FG000|Overall Study|Protocol Violation|3|||
19529929|NCT01488890|41975459|FG001|Overall Study|Protocol Violation|0|||
19529930|NCT01488890|41975460|FG002|Overall Study|Protocol Violation|4|||
19529931|NCT01488890|41975461|FG003|Overall Study|Protocol Violation|0|||
19529932|NCT01488890|41975458|FG000|Overall Study|Lost to Follow-up|13|||
19529933|NCT01488890|41975459|FG001|Overall Study|Lost to Follow-up|10|||
19529934|NCT01488890|41975460|FG002|Overall Study|Lost to Follow-up|20|||
19529935|NCT01488890|41975461|FG003|Overall Study|Lost to Follow-up|3|||
19529936|NCT01488890|41975458|FG000|Overall Study|Withdrawal by Subject|14|||
19529937|NCT01488890|41975459|FG001|Overall Study|Withdrawal by Subject|10|||
19529938|NCT01488890|41975460|FG002|Overall Study|Withdrawal by Subject|11|||
19529939|NCT01488890|41975461|FG003|Overall Study|Withdrawal by Subject|2|||
19529940|NCT01436396|41975477|FG000|Overall Study|Protocol Violation|7|||
19529941|NCT01436396|41975478|FG001|Overall Study|Protocol Violation|5|||
19529942|NCT01436396|41975477|FG000|Overall Study|Adverse Event|1|||
19451147|NCT01610336|41699940|FG000|Overall Study|Non-Compliance with study treatment|0|||
19451148|NCT01610336|41699941|FG001|Overall Study|Non-Compliance with study treatment|0|||
19451149|NCT01610336|41699942|FG002|Overall Study|Non-Compliance with study treatment|0|||
19529943|NCT01436396|41975478|FG001|Overall Study|Adverse Event|2|||
19529944|NCT01436396|41975477|FG000|Overall Study|Withdrawal by Subject|19|||
19529945|NCT01436396|41975478|FG001|Overall Study|Withdrawal by Subject|29|||
19529946|NCT01436396|41975477|FG000|Overall Study|Serious adverse event|2|||
19529947|NCT01436396|41975478|FG001|Overall Study|Serious adverse event|3|||
19529948|NCT01436396|41975477|FG000|Overall Study|Lost to Follow-up|3|||
19529949|NCT01436396|41975478|FG001|Overall Study|Lost to Follow-up|3|||
19529950|NCT01411241|41975486|FG000|Overall Study|Protocol Violation|0|||
19529951|NCT01411241|41975487|FG001|Overall Study|Protocol Violation|5|||
19529952|NCT01411241|41975486|FG000|Overall Study|Withdrawal by Subject|9|||
19529953|NCT01411241|41975487|FG001|Overall Study|Withdrawal by Subject|10|||
19529954|NCT01411241|41975486|FG000|Overall Study|Serious Adverse Event|0|||
19529955|NCT01411241|41975487|FG001|Overall Study|Serious Adverse Event|3|||
19529956|NCT01411241|41975486|FG000|Overall Study|Lost to Follow-up|2|||
19529957|NCT01411241|41975487|FG001|Overall Study|Lost to Follow-up|4|||
19529958|NCT01374516|41975495|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
19529959|NCT01374516|41975496|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
19529960|NCT01374516|41975495|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
19529961|NCT01374516|41975496|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
19711391|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
19451150|NCT01610336|41699943|FG003|Overall Study|Non-Compliance with study treatment|0|||
19451151|NCT01610336|41699944|FG004|Overall Study|Non-Compliance with study treatment|0|||
19451152|NCT01610336|41699945|FG005|Overall Study|Non-Compliance with study treatment|0|||
19529962|NCT01374516|41975495|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
19529963|NCT01374516|41975496|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
19529964|NCT01374516|41975495|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
19529965|NCT01374516|41975496|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
19529966|NCT01374516|41975495|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
19529967|NCT01374516|41975496|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
19529968|NCT01374516|41975495|FG000|Surveillance Expansion Period|Protocol Violation|386|||
19529969|NCT01374516|41975496|FG001|Surveillance Expansion Period|Protocol Violation|217|||
19529970|NCT01374516|41975495|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
19529971|NCT01374516|41975496|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
19529972|NCT01374516|41975495|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
19529973|NCT01374516|41975496|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
19529974|NCT01374516|41975495|FG000|Surveillance Expansion Period|Serious adverse event|20|||
19529975|NCT01374516|41975496|FG001|Surveillance Expansion Period|Serious adverse event|5|||
19529976|NCT01373281|41975511|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
19529977|NCT01373281|41975512|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
19529978|NCT01373281|41975511|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
19529979|NCT01373281|41975512|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
19529980|NCT01373281|41975511|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
19529981|NCT01373281|41975512|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
19529982|NCT01373281|41975511|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
19451153|NCT01610336|41699946|FG006|Overall Study|Non-Compliance with study treatment|0|||
19451154|NCT01610336|41699947|FG007|Overall Study|Non-Compliance with study treatment|0|||
19451155|NCT01610336|41699948|FG008|Overall Study|Non-Compliance with study treatment|0|||
19451156|NCT01610336|41699949|FG009|Overall Study|Non-Compliance with study treatment|1|||
19451157|NCT01610336|41699950|FG010|Overall Study|Non-Compliance with study treatment|0|||
19529983|NCT01373281|41975512|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
19529984|NCT01373281|41975511|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
19529985|NCT01373281|41975512|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
19529986|NCT01373281|41975511|FG000|Surveillance Expansion Period|Protocol Violation|9|||
19529987|NCT01373281|41975512|FG001|Surveillance Expansion Period|Protocol Violation|1|||
19529988|NCT01373281|41975511|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
19529989|NCT01373281|41975512|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
19529990|NCT01373281|41975511|FG000|Surveillance Expansion Period|Serious adverse event|3|||
19529991|NCT01373281|41975512|FG001|Surveillance Expansion Period|Serious adverse event|4|||
19529992|NCT01287611|41975527|FG000|Overall Study|Lost to Follow-up|29|||
19529993|NCT01287611|41975528|FG001|Overall Study|Lost to Follow-up|16|||
19529994|NCT01287611|41975527|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
19529995|NCT01287611|41975528|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
19529996|NCT01254422|41975538|FG000|Overall Study|Protocol Violation|1|||
19529997|NCT01254422|41975539|FG001|Overall Study|Protocol Violation|0|||
19529998|NCT01254422|41975538|FG000|Overall Study|Adverse Event|1|||
19529999|NCT01254422|41975539|FG001|Overall Study|Adverse Event|0|||
19530000|NCT01254422|41975538|FG000|Overall Study|Serious adverse event|0|||
19530001|NCT01254422|41975539|FG001|Overall Study|Serious adverse event|1|||
19530002|NCT01254422|41975538|FG000|Overall Study|Lost to Follow-up|1|||
19530003|NCT01254422|41975539|FG001|Overall Study|Lost to Follow-up|0|||
19530004|NCT01187433|41975547|FG000|Overall Study|Protocol Violation|6|||
19711392|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
19530005|NCT01187433|41975548|FG001|Overall Study|Protocol Violation|2|||
19530006|NCT01187433|41975547|FG000|Overall Study|Withdrawal by Subject|5|||
19530007|NCT01187433|41975548|FG001|Overall Study|Withdrawal by Subject|2|||
19530008|NCT01150045|41975558|FG000|Overall Study|Protocol Violation|0|||
19530009|NCT01150045|41975559|FG001|Overall Study|Protocol Violation|1|||
19530010|NCT01150045|41975560|FG002|Overall Study|Protocol Violation|0|||
19530011|NCT01150045|41975561|FG003|Overall Study|Protocol Violation|1|||
19530012|NCT01098032|41975571|FG000|Overall Study|Withdrawal by Subject|1|||
19530013|NCT01098032|41975572|FG001|Overall Study|Withdrawal by Subject|1|||
19530014|NCT01034306|41975580|FG000|Overall Study|Adverse Event|1|||
19451158|NCT01610336|41699940|FG000|Overall Study|Physician Decision|0|||
19451159|NCT01610336|41699941|FG001|Overall Study|Physician Decision|0|||
19451160|NCT01610336|41699942|FG002|Overall Study|Physician Decision|0|||
19451161|NCT01610336|41699943|FG003|Overall Study|Physician Decision|0|||
19451162|NCT01610336|41699944|FG004|Overall Study|Physician Decision|0|||
19451163|NCT01610336|41699945|FG005|Overall Study|Physician Decision|0|||
19451164|NCT01610336|41699946|FG006|Overall Study|Physician Decision|1|||
19451165|NCT01610336|41699947|FG007|Overall Study|Physician Decision|0|||
19451166|NCT01610336|41699948|FG008|Overall Study|Physician Decision|0|||
19451167|NCT01610336|41699949|FG009|Overall Study|Physician Decision|0|||
19451168|NCT01610336|41699950|FG010|Overall Study|Physician Decision|0|||
19451169|NCT01610336|41699940|FG000|Overall Study|Protocol Deviation|0|||
19451170|NCT01610336|41699941|FG001|Overall Study|Protocol Deviation|0|||
19451171|NCT01610336|41699942|FG002|Overall Study|Protocol Deviation|0|||
19451172|NCT01610336|41699943|FG003|Overall Study|Protocol Deviation|0|||
19451173|NCT01610336|41699944|FG004|Overall Study|Protocol Deviation|0|||
19530015|NCT01034306|41975581|FG001|Overall Study|Adverse Event|0|||
19530016|NCT01034306|41975580|FG000|Overall Study|Lost to Follow-up|0|||
19451174|NCT01610336|41699945|FG005|Overall Study|Protocol Deviation|0|||
19451175|NCT01610336|41699946|FG006|Overall Study|Protocol Deviation|0|||
19451176|NCT01610336|41699947|FG007|Overall Study|Protocol Deviation|0|||
19451177|NCT01610336|41699948|FG008|Overall Study|Protocol Deviation|0|||
19451178|NCT01610336|41699949|FG009|Overall Study|Protocol Deviation|1|||
19451179|NCT01610336|41699950|FG010|Overall Study|Protocol Deviation|0|||
19451180|NCT01610336|41699940|FG000|Overall Study|Transfer to another trial|0|||
19451181|NCT01610336|41699941|FG001|Overall Study|Transfer to another trial|0|||
19451182|NCT01610336|41699942|FG002|Overall Study|Transfer to another trial|0|||
19530017|NCT01034306|41975581|FG001|Overall Study|Lost to Follow-up|1|||
19530018|NCT01034306|41975580|FG000|Overall Study|Withdrawal by Subject|2|||
19530019|NCT01034306|41975581|FG001|Overall Study|Withdrawal by Subject|2|||
19530020|NCT01034306|41975580|FG000|Overall Study|hospitalized and decided to stop|1|||
19530021|NCT01034306|41975581|FG001|Overall Study|hospitalized and decided to stop|0|||
19530022|NCT01034306|41975580|FG000|Overall Study|Noncomplience|1|||
19530023|NCT01034306|41975581|FG001|Overall Study|Noncomplience|0|||
19451183|NCT01610336|41699943|FG003|Overall Study|Transfer to another trial|0|||
19451184|NCT01610336|41699944|FG004|Overall Study|Transfer to another trial|0|||
19451185|NCT01610336|41699945|FG005|Overall Study|Transfer to another trial|0|||
19451186|NCT01610336|41699946|FG006|Overall Study|Transfer to another trial|0|||
19451187|NCT01610336|41699947|FG007|Overall Study|Transfer to another trial|0|||
19451188|NCT01610336|41699948|FG008|Overall Study|Transfer to another trial|0|||
19451189|NCT01610336|41699949|FG009|Overall Study|Transfer to another trial|0|||
19451190|NCT01610336|41699950|FG010|Overall Study|Transfer to another trial|1|||
19451191|NCT01613222|41699978|FG000|Overall Study|Physician Decision|1|||
19451192|NCT01613222|41699978|FG000|Overall Study|Unable to place arterial line|1|||
19451193|NCT01613222|41699978|FG000|Overall Study|Reused disposable sensors|10|||
19530024|NCT00993447|41975589|FG000|Overall Study|Withdrawal by Subject|23|||
19530025|NCT00993447|41975590|FG001|Overall Study|Withdrawal by Subject|8|||
19530026|NCT00993447|41975589|FG000|Overall Study|Protocol Violation|12|||
19530027|NCT00993447|41975590|FG001|Overall Study|Protocol Violation|8|||
19530028|NCT00993447|41975589|FG000|Overall Study|Lost to Follow-up|1|||
19530029|NCT00993447|41975590|FG001|Overall Study|Lost to Follow-up|3|||
19530030|NCT00993447|41975589|FG000|Overall Study|Adverse Event|1|||
19530031|NCT00993447|41975590|FG001|Overall Study|Adverse Event|0|||
19530032|NCT00945009|41975599|FG000|Overall Study|Lack of Efficacy|10|||
19530033|NCT00945009|41975600|FG001|Overall Study|Lack of Efficacy|0|||
19530034|NCT00945009|41975601|FG002|Overall Study|Lack of Efficacy|0|||
19530035|NCT00945009|41975599|FG000|Overall Study|Physician Decision|21|||
19530036|NCT00945009|41975600|FG001|Overall Study|Physician Decision|4|||
19530037|NCT00945009|41975601|FG002|Overall Study|Physician Decision|3|||
19530038|NCT00945009|41975599|FG000|Overall Study|Protocol Violation|6|||
19530039|NCT00945009|41975600|FG001|Overall Study|Protocol Violation|1|||
19530040|NCT00945009|41975601|FG002|Overall Study|Protocol Violation|0|||
19530041|NCT00945009|41975599|FG000|Overall Study|Withdrawal by Subject|1|||
19530042|NCT00945009|41975600|FG001|Overall Study|Withdrawal by Subject|0|||
19530043|NCT00945009|41975601|FG002|Overall Study|Withdrawal by Subject|0|||
19530044|NCT00945009|41975599|FG000|Overall Study|Ineligible|6|||
19530045|NCT00945009|41975600|FG001|Overall Study|Ineligible|1|||
19530046|NCT00945009|41975601|FG002|Overall Study|Ineligible|0|||
19530047|NCT00945009|41975599|FG000|Overall Study|Inevaluable|0|||
19530048|NCT00945009|41975600|FG001|Overall Study|Inevaluable|1|||
19530049|NCT00945009|41975601|FG002|Overall Study|Inevaluable|0|||
19530050|NCT00945009|41975599|FG000|Overall Study|Refusal of further protocol|1|||
19530051|NCT00945009|41975600|FG001|Overall Study|Refusal of further protocol|0|||
19530052|NCT00945009|41975601|FG002|Overall Study|Refusal of further protocol|0|||
19530053|NCT00942877|41975611|FG000|Overall Study|Refused further treatment|1|||
19530054|NCT00942877|41975612|FG001|Overall Study|Refused further treatment|1|||
19530055|NCT00942877|41975611|FG000|Overall Study|Patient was not treated|1|||
19530056|NCT00942877|41975612|FG001|Overall Study|Patient was not treated|0|||
19530057|NCT00942877|41975611|FG000|Overall Study|Adverse Event|1|||
19530058|NCT00942877|41975612|FG001|Overall Study|Adverse Event|0|||
19530059|NCT00942877|41975611|FG000|Overall Study|Progressive disease|42|||
19530060|NCT00942877|41975612|FG001|Overall Study|Progressive disease|3|||
19530061|NCT00880893|41975627|FG000|Overall Study|Protocol Violation|13|||
19451194|NCT01612676|41700025|FG000|Overall Study|Adverse Event|2|||
19451195|NCT01612676|41700026|FG001|Overall Study|Adverse Event|3|||
19451196|NCT01612676|41700027|FG002|Overall Study|Adverse Event|1|||
19530062|NCT00880893|41975628|FG001|Overall Study|Protocol Violation|1|||
19530063|NCT00880893|41975627|FG000|Overall Study|Withdrawal by Subject|15|||
19530064|NCT00880893|41975628|FG001|Overall Study|Withdrawal by Subject|11|||
19530065|NCT00880893|41975627|FG000|Overall Study|Lost to Follow-up|76|||
19530066|NCT00880893|41975628|FG001|Overall Study|Lost to Follow-up|33|||
19530067|NCT00880893|41975627|FG000|Overall Study|Serious adverse event|3|||
19530068|NCT00880893|41975628|FG001|Overall Study|Serious adverse event|0|||
19530069|NCT00587301|41975634|FG000|Overall Study|Screen Failure|9|||
19530070|NCT00587301|41975634|FG000|Overall Study|Lost to Follow-up|22|||
19530071|NCT00587301|41975634|FG000|Overall Study|Withdrawal by Subject|7|||
19530072|NCT00587301|41975634|FG000|Overall Study|Protocol Violation|7|||
19451197|NCT01612676|41700028|FG003|Overall Study|Adverse Event|3|||
19451198|NCT01612676|41700025|FG000|Overall Study|Protocol Violation|0|||
19530073|NCT00579527|41975638|FG000|Overall Study|Death|4|||
19530074|NCT00576836|41975643|FG000|Overall Study|Death|0|||
19530075|NCT00576836|41975644|FG001|Overall Study|Death|1|||
19530076|NCT00576836|41975643|FG000|Overall Study|Physician Decision|0|||
19530077|NCT00576836|41975644|FG001|Overall Study|Physician Decision|1|||
19530078|NCT00576407|41975648|FG000|Overall Study|Death|7|||
19530079|NCT00576407|41975648|FG000|Overall Study|Physician Decision|1|||
19530080|NCT00531232|41975656|FG000|Overall Study|Investigator decision|0|||
19530081|NCT00531232|41975657|FG001|Overall Study|Investigator decision|0|||
19530082|NCT00531232|41975658|FG002|Overall Study|Investigator decision|4|||
19530083|NCT00531232|41975656|FG000|Overall Study|Participants refused further treatment|0|||
19530084|NCT00531232|41975657|FG001|Overall Study|Participants refused further treatment|1|||
19530085|NCT00531232|41975658|FG002|Overall Study|Participants refused further treatment|2|||
19530086|NCT00531232|41975656|FG000|Overall Study|Adverse events (AEs)|1|||
19530087|NCT00531232|41975657|FG001|Overall Study|Adverse events (AEs)|2|||
19629680|NCT00813488|42079131|FG001|Open-label Extension|Non-compliance study medication|0|||
19451199|NCT01612676|41700026|FG001|Overall Study|Protocol Violation|1|||
19451200|NCT01612676|41700027|FG002|Overall Study|Protocol Violation|0|||
19451201|NCT01612676|41700028|FG003|Overall Study|Protocol Violation|0|||
19451202|NCT01869764|41700042|FG000|Overall Study|Withdrawal by Subject|0|||
19451203|NCT01869764|41700043|FG001|Overall Study|Withdrawal by Subject|2|||
19451204|NCT01842620|41700049|FG000|Period 1|Withdrawal by Subject|1|||
19451205|NCT01842620|41700050|FG001|Period 1|Withdrawal by Subject|0|||
19451206|NCT01931839|41700076|FG000|Overall Study|Death|0|||
19451207|NCT01931839|41700077|FG001|Overall Study|Death|1|||
19451208|NCT01931839|41700078|FG002|Overall Study|Death|2|||
19451209|NCT01931839|41700079|FG003|Overall Study|Death|0|||
19451210|NCT01931839|41700080|FG004|Overall Study|Death|0|||
19451211|NCT01931839|41700081|FG005|Overall Study|Death|0|||
19451212|NCT01931839|41700082|FG006|Overall Study|Death|0|||
19451213|NCT01931839|41700076|FG000|Overall Study|Physician Decision|1|||
19451214|NCT01931839|41700077|FG001|Overall Study|Physician Decision|0|||
19451215|NCT01931839|41700078|FG002|Overall Study|Physician Decision|1|||
19451216|NCT01931839|41700079|FG003|Overall Study|Physician Decision|0|||
19451217|NCT01931839|41700080|FG004|Overall Study|Physician Decision|0|||
19451218|NCT01931839|41700081|FG005|Overall Study|Physician Decision|0|||
19451219|NCT01931839|41700082|FG006|Overall Study|Physician Decision|1|||
19451220|NCT01931839|41700076|FG000|Overall Study|Withdrawal of consent|0|||
19451221|NCT01931839|41700077|FG001|Overall Study|Withdrawal of consent|0|||
19451222|NCT01931839|41700078|FG002|Overall Study|Withdrawal of consent|0|||
19451223|NCT01931839|41700079|FG003|Overall Study|Withdrawal of consent|0|||
19451224|NCT01931839|41700080|FG004|Overall Study|Withdrawal of consent|1|||
19451225|NCT01931839|41700081|FG005|Overall Study|Withdrawal of consent|0|||
19451226|NCT01931839|41700082|FG006|Overall Study|Withdrawal of consent|0|||
19451227|NCT01931839|41700076|FG000|Overall Study|Adverse Event|9|||
19451228|NCT01931839|41700077|FG001|Overall Study|Adverse Event|4|||
19451229|NCT01931839|41700078|FG002|Overall Study|Adverse Event|1|||
19451230|NCT01931839|41700079|FG003|Overall Study|Adverse Event|3|||
19451231|NCT01931839|41700080|FG004|Overall Study|Adverse Event|0|||
19451232|NCT01931839|41700081|FG005|Overall Study|Adverse Event|0|||
19451233|NCT01931839|41700082|FG006|Overall Study|Adverse Event|1|||
19451234|NCT01931839|41700076|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
19451235|NCT01931839|41700077|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
19451236|NCT01931839|41700078|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
19451237|NCT01931839|41700079|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
19451238|NCT01931839|41700080|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
19451239|NCT01931839|41700081|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
19451240|NCT01931839|41700082|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
19451241|NCT01931839|41700076|FG000|Overall Study|Other non-compliance|15|||
19451242|NCT01931839|41700077|FG001|Overall Study|Other non-compliance|9|||
19451243|NCT01931839|41700078|FG002|Overall Study|Other non-compliance|12|||
19451244|NCT01931839|41700079|FG003|Overall Study|Other non-compliance|3|||
19451245|NCT01931839|41700080|FG004|Overall Study|Other non-compliance|0|||
19451246|NCT01931839|41700081|FG005|Overall Study|Other non-compliance|3|||
19451247|NCT01931839|41700082|FG006|Overall Study|Other non-compliance|0|||
19451248|NCT01931839|41700076|FG000|Overall Study|Lost to Follow-up|1|||
19451249|NCT01931839|41700077|FG001|Overall Study|Lost to Follow-up|2|||
19451250|NCT01931839|41700078|FG002|Overall Study|Lost to Follow-up|4|||
19451251|NCT01931839|41700079|FG003|Overall Study|Lost to Follow-up|5|||
19451252|NCT01931839|41700080|FG004|Overall Study|Lost to Follow-up|0|||
19451253|NCT01931839|41700081|FG005|Overall Study|Lost to Follow-up|0|||
19451254|NCT01931839|41700082|FG006|Overall Study|Lost to Follow-up|0|||
19530088|NCT00531232|41975658|FG002|Overall Study|Adverse events (AEs)|2|||
19530089|NCT00531232|41975656|FG000|Overall Study|Treatment failure|1|||
19530090|NCT00531232|41975657|FG001|Overall Study|Treatment failure|3|||
19451255|NCT01931839|41700076|FG000|Overall Study|Other|4|||
19451256|NCT01931839|41700077|FG001|Overall Study|Other|2|||
19451257|NCT01931839|41700078|FG002|Overall Study|Other|6|||
19451258|NCT01931839|41700079|FG003|Overall Study|Other|0|||
19451259|NCT01931839|41700080|FG004|Overall Study|Other|0|||
19530091|NCT00531232|41975658|FG002|Overall Study|Treatment failure|7|||
19530092|NCT00531232|41975656|FG000|Overall Study|Disease recurrence|0|||
19530093|NCT00531232|41975657|FG001|Overall Study|Disease recurrence|0|||
19530094|NCT00531232|41975658|FG002|Overall Study|Disease recurrence|1|||
19530095|NCT00531232|41975656|FG000|Overall Study|Deceased|2|||
19530096|NCT00531232|41975657|FG001|Overall Study|Deceased|2|||
19530097|NCT00531232|41975658|FG002|Overall Study|Deceased|2|||
19530098|NCT00531232|41975656|FG000|Overall Study|Withdrawal by Subject|0|||
19530099|NCT00531232|41975657|FG001|Overall Study|Withdrawal by Subject|1|||
19530100|NCT00531232|41975658|FG002|Overall Study|Withdrawal by Subject|2|||
19530101|NCT00531232|41975656|FG000|Overall Study|Other|0|||
19530102|NCT00531232|41975657|FG001|Overall Study|Other|0|||
19530103|NCT00531232|41975658|FG002|Overall Study|Other|5|||
19530104|NCT00379340|41975674|FG000|Overall Study|Death|0|||
19530105|NCT00379340|41975675|FG001|Overall Study|Death|0|||
19530106|NCT00379340|41975676|FG002|Overall Study|Death|0|||
19530107|NCT00379340|41975677|FG003|Overall Study|Death|2|||
19530108|NCT00379340|41975678|FG004|Overall Study|Death|0|||
19530109|NCT00379340|41975674|FG000|Overall Study|Lack of Efficacy|6|||
19530110|NCT00379340|41975675|FG001|Overall Study|Lack of Efficacy|1|||
19530111|NCT00379340|41975676|FG002|Overall Study|Lack of Efficacy|0|||
19530112|NCT00379340|41975677|FG003|Overall Study|Lack of Efficacy|4|||
19530113|NCT00379340|41975678|FG004|Overall Study|Lack of Efficacy|3|||
19530114|NCT00379340|41975674|FG000|Overall Study|Physician Decision|6|||
19530115|NCT00379340|41975675|FG001|Overall Study|Physician Decision|2|||
19530116|NCT00379340|41975676|FG002|Overall Study|Physician Decision|1|||
19530117|NCT00379340|41975677|FG003|Overall Study|Physician Decision|2|||
19530118|NCT00379340|41975678|FG004|Overall Study|Physician Decision|3|||
19530119|NCT00379340|41975674|FG000|Overall Study|Withdrawal by Subject|0|||
19530120|NCT00379340|41975675|FG001|Overall Study|Withdrawal by Subject|0|||
19530121|NCT00379340|41975676|FG002|Overall Study|Withdrawal by Subject|0|||
19530122|NCT00379340|41975677|FG003|Overall Study|Withdrawal by Subject|1|||
19530123|NCT00379340|41975678|FG004|Overall Study|Withdrawal by Subject|0|||
19530124|NCT00379340|41975674|FG000|Overall Study|Refusal of further protocol therapy|1|||
19530125|NCT00379340|41975675|FG001|Overall Study|Refusal of further protocol therapy|0|||
19530126|NCT00379340|41975676|FG002|Overall Study|Refusal of further protocol therapy|1|||
19530127|NCT00379340|41975677|FG003|Overall Study|Refusal of further protocol therapy|1|||
19530128|NCT00379340|41975678|FG004|Overall Study|Refusal of further protocol therapy|7|||
19530129|NCT00379340|41975674|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
19530130|NCT00379340|41975675|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
19530131|NCT00379340|41975676|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
19530132|NCT00379340|41975677|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
19530133|NCT00379340|41975678|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
19530134|NCT00379340|41975674|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
19530135|NCT00379340|41975675|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
19530136|NCT00379340|41975676|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
19530137|NCT00379340|41975677|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
19530138|NCT00379340|41975678|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
19530139|NCT01701583|41975693|FG000|Overall Study|Withdrawal by Subject|2|||
19530140|NCT01701583|41975694|FG001|Overall Study|Withdrawal by Subject|0|||
19530141|NCT01714817|41975703|FG000|Year 1 Period|Lack of Efficacy|11|||
19530142|NCT01714817|41975704|FG001|Year 1 Period|Lack of Efficacy|9|||
19530143|NCT01714817|41975703|FG000|Year 1 Period|Adverse Event|20|||
19530144|NCT01714817|41975704|FG001|Year 1 Period|Adverse Event|17|||
19530145|NCT01714817|41975703|FG000|Year 1 Period|Withdrawal by Subject|6|||
19530146|NCT01714817|41975704|FG001|Year 1 Period|Withdrawal by Subject|7|||
19530147|NCT01714817|41975703|FG000|Year 1 Period|Death|1|||
19530148|NCT01714817|41975704|FG001|Year 1 Period|Death|1|||
19451260|NCT01931839|41700081|FG005|Overall Study|Other|0|||
19451261|NCT01931839|41700082|FG006|Overall Study|Other|0|||
19451262|NCT01842308|41700107|FG000|Overall Study|Withdrawal by Subject|0|||
19451263|NCT01842308|41700108|FG001|Overall Study|Withdrawal by Subject|0|||
19451264|NCT01842308|41700109|FG002|Overall Study|Withdrawal by Subject|0|||
19451265|NCT01842308|41700110|FG003|Overall Study|Withdrawal by Subject|0|||
19451266|NCT01842308|41700111|FG004|Overall Study|Withdrawal by Subject|1|||
19451267|NCT01931059|41700126|FG000|Day 1|Pregnancy|0|||
19530149|NCT01714817|41975703|FG000|Year 1 Period|Lost to Follow-up|0|||
19530150|NCT01714817|41975704|FG001|Year 1 Period|Lost to Follow-up|2|||
19530151|NCT01714817|41975703|FG000|Year 1 Period|Poor / non-compliance|0|||
19711393|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
19451268|NCT01931059|41700127|FG001|Day 1|Pregnancy|1|||
19530152|NCT01714817|41975704|FG001|Year 1 Period|Poor / non-compliance|1|||
19530153|NCT01714817|41975703|FG000|Year 1 Period|Pregnancy|2|||
19530154|NCT01714817|41975704|FG001|Year 1 Period|Pregnancy|0|||
19530155|NCT01714817|41975703|FG000|Year 1 Period|Participant no longer meets criteria|6|||
19530156|NCT01714817|41975704|FG001|Year 1 Period|Participant no longer meets criteria|2|||
19530157|NCT01714817|41975703|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
19530158|NCT01714817|41975704|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
19530159|NCT01714817|41975703|FG000|Year 1 Period|Change in Concomitant Medication|0|||
19530160|NCT01714817|41975704|FG001|Year 1 Period|Change in Concomitant Medication|1|||
19530161|NCT01714817|41975703|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
19530162|NCT01714817|41975704|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
19530163|NCT01714817|41975703|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
19530164|NCT01714817|41975704|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
19530165|NCT01714817|41975703|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
19530166|NCT01714817|41975704|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
19530167|NCT01714817|41975703|FG000|Year 2 Period|Lack of Efficacy|4|||
19530168|NCT01714817|41975704|FG001|Year 2 Period|Lack of Efficacy|12|||
19530169|NCT01714817|41975703|FG000|Year 2 Period|Adverse Event|7|||
19530170|NCT01714817|41975704|FG001|Year 2 Period|Adverse Event|6|||
19530171|NCT01714817|41975703|FG000|Year 2 Period|Participant request to stop treatment|4|||
19530172|NCT01714817|41975704|FG001|Year 2 Period|Participant request to stop treatment|4|||
19530173|NCT01714817|41975703|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
19530174|NCT01714817|41975704|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
19530175|NCT01714817|41975703|FG000|Year 2 Period|Participant withdrew consent|1|||
19530176|NCT01714817|41975704|FG001|Year 2 Period|Participant withdrew consent|5|||
19530177|NCT01714817|41975703|FG000|Year 2 Period|Participant no longer meets criteria|1|||
19530178|NCT01714817|41975704|FG001|Year 2 Period|Participant no longer meets criteria|4|||
19530179|NCT01714817|41975703|FG000|Year 2 Period|Lost to Follow-up|2|||
19530180|NCT01714817|41975704|FG001|Year 2 Period|Lost to Follow-up|0|||
19530181|NCT01714817|41975703|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
19530182|NCT01714817|41975704|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
19530183|NCT01714817|41975703|FG000|Year 2 Period|Pregnancy|1|||
19530184|NCT01714817|41975704|FG001|Year 2 Period|Pregnancy|1|||
19530185|NCT01714817|41975703|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
19530186|NCT01714817|41975704|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
19530187|NCT01714817|41975703|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
19530188|NCT01714817|41975704|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
19530189|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
19530190|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
19530191|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
19530192|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
19530193|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
19530194|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
19530195|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
19530196|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
19530197|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
19530198|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
19530199|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
19530200|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
19530201|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
19530202|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
19530203|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
19530204|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
19530205|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
19530206|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
19530207|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
19530208|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
19530209|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
19451269|NCT01931059|41700126|FG000|Day3|Lost to Follow-up|1|||
19451270|NCT01931059|41700127|FG001|Day3|Lost to Follow-up|0|||
19451271|NCT01841762|41700139|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
19451272|NCT01841762|41700139|FG000|Treatment Period|Adverse Event|16|||
19451273|NCT01841762|41700139|FG000|Treatment Period|Death|1|||
19451274|NCT01841762|41700139|FG000|Treatment Period|Withdrawal by Subject|7|||
19451275|NCT01841762|41700139|FG000|Treatment Period|Lost to Follow-up|1|||
19451276|NCT01841762|41700139|FG000|Treatment Period|Physician Decision|2|||
19451277|NCT01841762|41700139|FG000|Treatment Period|Other, including non-compliance|5|||
19451278|NCT01841762|41700139|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
19451279|NCT01841762|41700139|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
19451280|NCT01841762|41700139|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
19451281|NCT01841762|41700139|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
19451282|NCT01841060|41700156|FG000|Overall Study|Protocol Violation|10|||
19451283|NCT01814696|41700162|FG000|Overall Study|Withdrawal by Subject|1|||
19530210|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
19530211|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
19530212|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
19530213|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
19451284|NCT01814696|41700163|FG001|Overall Study|Withdrawal by Subject|0|||
19451285|NCT01814696|41700162|FG000|Overall Study|Randomized to wrong group|1|||
19451286|NCT01814696|41700163|FG001|Overall Study|Randomized to wrong group|0|||
19451287|NCT01970371|41700172|FG000|Overall Study|Death|8|||
19451288|NCT01970371|41700173|FG001|Overall Study|Death|13|||
19451289|NCT01970371|41700174|FG002|Overall Study|Death|12|||
19530214|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
19530215|NCT01714817|41975703|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
19530216|NCT01714817|41975704|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
19530217|NCT01755689|41975728|FG000|Overall Study|Withdrawal by Subject|1|||
19530218|NCT01755689|41975729|FG001|Overall Study|Withdrawal by Subject|3|||
19530219|NCT01755689|41975730|FG002|Overall Study|Withdrawal by Subject|2|||
19530220|NCT01755689|41975731|FG003|Overall Study|Withdrawal by Subject|1|||
19530221|NCT01755689|41975732|FG004|Overall Study|Withdrawal by Subject|1|||
19530222|NCT01755689|41975728|FG000|Overall Study|Migrated/moved from study area|0|||
19530223|NCT01755689|41975729|FG001|Overall Study|Migrated/moved from study area|1|||
19530224|NCT01755689|41975730|FG002|Overall Study|Migrated/moved from study area|1|||
19530225|NCT01755689|41975731|FG003|Overall Study|Migrated/moved from study area|1|||
19530226|NCT01755689|41975732|FG004|Overall Study|Migrated/moved from study area|1|||
19530227|NCT01755689|41975728|FG000|Overall Study|Lost to Follow-up|1|||
19530228|NCT01755689|41975729|FG001|Overall Study|Lost to Follow-up|0|||
19530229|NCT01755689|41975730|FG002|Overall Study|Lost to Follow-up|1|||
19530230|NCT01755689|41975731|FG003|Overall Study|Lost to Follow-up|0|||
19530231|NCT01755689|41975732|FG004|Overall Study|Lost to Follow-up|2|||
19530232|NCT01755689|41975728|FG000|Overall Study|Pregnancy|1|||
19530233|NCT01755689|41975729|FG001|Overall Study|Pregnancy|1|||
19530234|NCT01755689|41975730|FG002|Overall Study|Pregnancy|2|||
19530235|NCT01755689|41975731|FG003|Overall Study|Pregnancy|4|||
19530236|NCT01755689|41975732|FG004|Overall Study|Pregnancy|2|||
19530237|NCT01762761|41975754|FG000|Overall Study|Adverse Event|15|||
19530238|NCT01762761|41975755|FG001|Overall Study|Adverse Event|17|||
19530239|NCT01762761|41975754|FG000|Overall Study|Lack of Efficacy|9|||
19530240|NCT01762761|41975755|FG001|Overall Study|Lack of Efficacy|25|||
19530241|NCT01762761|41975754|FG000|Overall Study|Protocol Violation|1|||
19530242|NCT01762761|41975755|FG001|Overall Study|Protocol Violation|1|||
19530243|NCT01762761|41975754|FG000|Overall Study|Study closed/terminated|0|||
19530244|NCT01762761|41975755|FG001|Overall Study|Study closed/terminated|2|||
19530245|NCT01762761|41975754|FG000|Overall Study|Lost to Follow-up|3|||
19530246|NCT01762761|41975755|FG001|Overall Study|Lost to Follow-up|6|||
19530247|NCT01762761|41975754|FG000|Overall Study|Physician Decision|4|||
19530248|NCT01762761|41975755|FG001|Overall Study|Physician Decision|6|||
19530249|NCT01762761|41975754|FG000|Overall Study|Withdrawal by Subject|7|||
19530250|NCT01762761|41975755|FG001|Overall Study|Withdrawal by Subject|8|||
19530251|NCT01763788|41975766|FG000|Overall Study|Lost to Follow-up|0|||
19530252|NCT01763788|41975767|FG001|Overall Study|Lost to Follow-up|0|||
19530253|NCT01763788|41975768|FG002|Overall Study|Lost to Follow-up|1|||
19530254|NCT01763788|41975769|FG003|Overall Study|Lost to Follow-up|0|||
19530255|NCT01774370|41975779|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
19530256|NCT01774370|41975779|FG000|Overall Study|Administered prior to the contract date|4|||
19530257|NCT01774370|41975779|FG000|Overall Study|Subjects of contraindications|34|||
19530258|NCT01774370|41975779|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
19530259|NCT01774370|41975779|FG000|Overall Study|Follow-up failure|34|||
19530260|NCT01777295|41975785|FG000|Overall Study|Withdrawal by Subject|2|||
19530261|NCT01777295|41975786|FG001|Overall Study|Withdrawal by Subject|2|||
19530262|NCT01777295|41975785|FG000|Overall Study|Pregnancy|0|||
19530263|NCT01777295|41975786|FG001|Overall Study|Pregnancy|1|||
19530264|NCT01777295|41975785|FG000|Overall Study|Personal problem|1|||
19530265|NCT01777295|41975786|FG001|Overall Study|Personal problem|0|||
19530266|NCT01777295|41975785|FG000|Overall Study|Investigator call for AEs check|1|||
19530267|NCT01777295|41975786|FG001|Overall Study|Investigator call for AEs check|0|||
19530268|NCT01787552|41975806|FG000|Overall Study|Withdrawal by Subject|2|||
19530269|NCT01787552|41975807|FG001|Overall Study|Withdrawal by Subject|0|||
19530270|NCT01787552|41975808|FG002|Overall Study|Withdrawal by Subject|0|||
19530271|NCT01787552|41975809|FG003|Overall Study|Withdrawal by Subject|4|||
19530272|NCT01787552|41975806|FG000|Overall Study|Physician Decision|2|||
19530273|NCT01787552|41975807|FG001|Overall Study|Physician Decision|2|||
19530274|NCT01787552|41975808|FG002|Overall Study|Physician Decision|1|||
19711394|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
19451290|NCT01970371|41700172|FG000|Overall Study|Lost to Follow-up|0|||
19451291|NCT01970371|41700173|FG001|Overall Study|Lost to Follow-up|0|||
19530275|NCT01787552|41975809|FG003|Overall Study|Physician Decision|2|||
19451292|NCT01970371|41700174|FG002|Overall Study|Lost to Follow-up|1|||
19530276|NCT01787552|41975806|FG000|Overall Study|Death|0|||
19530277|NCT01787552|41975807|FG001|Overall Study|Death|0|||
19451293|NCT01868594|41700195|FG000|Overall Study|Do not meet inclusion criteria|4|||
19451294|NCT01868594|41700196|FG001|Overall Study|Do not meet inclusion criteria|3|||
19451295|NCT01616953|41700206|FG000|Overall Study|Lost to Follow-up|1|||
19451296|NCT01616953|41700207|FG001|Overall Study|Lost to Follow-up|0|||
19451297|NCT01616953|41700206|FG000|Overall Study|lack of bone and soft tissue|1|||
19451298|NCT01616953|41700207|FG001|Overall Study|lack of bone and soft tissue|0|||
19451299|NCT01867658|41700213|FG000|Overall Study|Withdrawal by Subject|6|||
19451300|NCT01867658|41700213|FG000|Overall Study|Death|2|||
19451301|NCT01867658|41700213|FG000|Overall Study|Subject could not be contacted|1|||
19451302|NCT01867580|41700219|FG000|Overall Study|Withdrawal by Subject|2|||
19530278|NCT01787552|41975808|FG002|Overall Study|Death|0|||
19530279|NCT01787552|41975809|FG003|Overall Study|Death|1|||
19530280|NCT01787552|41975806|FG000|Overall Study|Adverse Event|2|||
19530281|NCT01787552|41975807|FG001|Overall Study|Adverse Event|5|||
19530282|NCT01787552|41975808|FG002|Overall Study|Adverse Event|2|||
19530283|NCT01787552|41975809|FG003|Overall Study|Adverse Event|16|||
19530284|NCT01787552|41975806|FG000|Overall Study|Study terminated by Sponsor|0|||
19530285|NCT01787552|41975807|FG001|Overall Study|Study terminated by Sponsor|0|||
19530286|NCT01787552|41975808|FG002|Overall Study|Study terminated by Sponsor|1|||
19530287|NCT01787552|41975809|FG003|Overall Study|Study terminated by Sponsor|3|||
19530288|NCT01787552|41975806|FG000|Overall Study|Progressive Disease|2|||
19530289|NCT01787552|41975807|FG001|Overall Study|Progressive Disease|2|||
19530290|NCT01787552|41975808|FG002|Overall Study|Progressive Disease|1|||
19530291|NCT01787552|41975809|FG003|Overall Study|Progressive Disease|1|||
19530292|NCT01808261|41975826|FG000|Overall Study|Physician Decision|0|||
19530293|NCT01808261|41975827|FG001|Overall Study|Physician Decision|2|||
19530294|NCT01808261|41975826|FG000|Overall Study|Study Closed/Terminated|25|||
19530295|NCT01808261|41975827|FG001|Overall Study|Study Closed/Terminated|23|||
19530296|NCT01808261|41975826|FG000|Overall Study|Adverse event, non-fatal|2|||
19530297|NCT01808261|41975827|FG001|Overall Study|Adverse event, non-fatal|0|||
19530298|NCT01808261|41975826|FG000|Overall Study|Consent withdrawn by subject|6|||
19530299|NCT01808261|41975827|FG001|Overall Study|Consent withdrawn by subject|7|||
19530300|NCT01808261|41975826|FG000|Overall Study|Lost to Follow-up|3|||
19530301|NCT01808261|41975827|FG001|Overall Study|Lost to Follow-up|1|||
19530302|NCT01814826|41975846|FG000|Overall Study|Other|3|||
19530303|NCT01814826|41975847|FG001|Overall Study|Other|5|||
19530304|NCT01814826|41975848|FG002|Overall Study|Other|0|||
19530305|NCT01814826|41975846|FG000|Overall Study|Death|29|||
19451303|NCT01867580|41700220|FG001|Overall Study|Withdrawal by Subject|3|||
19451304|NCT01867580|41700219|FG000|Overall Study|Physician Decision|17|||
19451305|NCT01867580|41700220|FG001|Overall Study|Physician Decision|12|||
19451306|NCT01867580|41700219|FG000|Overall Study|Lost to Follow-up|3|||
19451307|NCT01867580|41700220|FG001|Overall Study|Lost to Follow-up|5|||
19451308|NCT01867580|41700219|FG000|Overall Study|Sponsor terminated study|1|||
19451309|NCT01867580|41700220|FG001|Overall Study|Sponsor terminated study|0|||
19451310|NCT01867580|41700219|FG000|Overall Study|Missed follow-up assessment|2|||
19451311|NCT01867580|41700220|FG001|Overall Study|Missed follow-up assessment|1|||
19451312|NCT01867580|41700219|FG000|Overall Study|Interruption to therapy|3|||
19451313|NCT01867580|41700220|FG001|Overall Study|Interruption to therapy|0|||
19451314|NCT01867580|41700219|FG000|Overall Study|Osteomyelitis|0|||
19451315|NCT01867580|41700220|FG001|Overall Study|Osteomyelitis|1|||
19451316|NCT01867580|41700219|FG000|Overall Study|Continuation of therapy|0|||
19451317|NCT01867580|41700220|FG001|Overall Study|Continuation of therapy|1|||
19451318|NCT01867580|41700219|FG000|Overall Study|Wound recurrence|0|||
19451319|NCT01867580|41700220|FG001|Overall Study|Wound recurrence|1|||
19451320|NCT01839656|41700234|FG000|Overall Study|Withdrawal by Subject|1|||
19451321|NCT01839656|41700235|FG001|Overall Study|Withdrawal by Subject|1|||
19451322|NCT01839656|41700234|FG000|Overall Study|Adverse event, serious fatal|1|||
19451323|NCT01839656|41700235|FG001|Overall Study|Adverse event, serious fatal|4|||
19451324|NCT01839656|41700234|FG000|Overall Study|Early study closure|0|||
19451325|NCT01839656|41700235|FG001|Overall Study|Early study closure|11|||
19451326|NCT01839656|41700234|FG000|Overall Study|Adverse Event|1|||
19451327|NCT01839656|41700235|FG001|Overall Study|Adverse Event|0|||
19451328|NCT01839188|41700241|FG000|Overall Study|Withdrawal by Subject|1|||
19451329|NCT01838876|41700250|FG000|Overall Study|Adverse Event|49|||
19530306|NCT01814826|41975847|FG001|Overall Study|Death|24|||
19530307|NCT01814826|41975848|FG002|Overall Study|Death|3|||
19530308|NCT01829711|41975857|FG000|Overall Study|Lost to Follow-up|2|||
19451330|NCT01838876|41700250|FG000|Overall Study|Insufficient Therapeutic Response|10|||
19451331|NCT01838876|41700250|FG000|Overall Study|Protocol Violation|34|||
19451332|NCT01838876|41700250|FG000|Overall Study|Withdrawal of Consent|33|||
19451333|NCT01838876|41700250|FG000|Overall Study|Lost to Follow-up|21|||
19451334|NCT01838876|41700250|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
19530309|NCT01829711|41975857|FG000|Overall Study|Withdrawal by Subject|3|||
19530310|NCT01829711|41975857|FG000|Overall Study|Death|4|||
19530311|NCT01829711|41975857|FG000|Overall Study|Started new therapies|17|||
19451335|NCT01838876|41700250|FG000|Overall Study|Reason not Specified|7|||
19451336|NCT01838876|41700250|FG000|Overall Study|Did not meet eligibility criteria|78|||
19451337|NCT01838642|41700265|FG000|Overall Study|Died on study|1|||
19451338|NCT01611194|41700272|FG000|Overall Study|Lost to Follow-up|0|||
19451339|NCT01611194|41700273|FG001|Overall Study|Lost to Follow-up|1|||
19451340|NCT01611194|41700272|FG000|Overall Study|Withdrawal by Subject|0|||
19451341|NCT01611194|41700273|FG001|Overall Study|Withdrawal by Subject|1|||
19451342|NCT01611194|41700272|FG000|Overall Study|drug use|0|||
19451343|NCT01611194|41700273|FG001|Overall Study|drug use|1|||
19451344|NCT01813058|41700281|FG000|Overall Study|Withdrawal by Subject|5|||
19451345|NCT01813058|41700282|FG001|Overall Study|Withdrawal by Subject|4|||
19451346|NCT01867424|41700290|FG000|Overall Study|Patient noncompliance|2|||
19451347|NCT01867424|41700291|FG001|Overall Study|Patient noncompliance|1|||
19451348|NCT01811732|41700299|FG000|Overall Study|Lost to Follow-up|24|||
19451349|NCT01811732|41700300|FG001|Overall Study|Lost to Follow-up|30|||
19451350|NCT01811732|41700299|FG000|Overall Study|Withdrawal by Subject|16|||
19530312|NCT01829711|41975857|FG000|Overall Study|Adverse Event|3|||
19530313|NCT01829711|41975857|FG000|Overall Study|Due to progression of disease|13|||
19530314|NCT01829711|41975857|FG000|Overall Study|Due to lack of response|1|||
19530315|NCT01846273|41975864|FG000|Overall Study|Adverse Event|9|||
19530316|NCT01846273|41975865|FG001|Overall Study|Adverse Event|7|||
19530317|NCT01846273|41975866|FG002|Overall Study|Adverse Event|0|||
19530318|NCT01846273|41975864|FG000|Overall Study|Subject withdrew consent|5|||
19530319|NCT01846273|41975865|FG001|Overall Study|Subject withdrew consent|8|||
19530320|NCT01846273|41975866|FG002|Overall Study|Subject withdrew consent|0|||
19530321|NCT01846273|41975864|FG000|Overall Study|Lost to Follow-up|2|||
19530322|NCT01846273|41975865|FG001|Overall Study|Lost to Follow-up|1|||
19530323|NCT01846273|41975866|FG002|Overall Study|Lost to Follow-up|0|||
19530324|NCT01846273|41975864|FG000|Overall Study|Administrative problems|1|||
19530325|NCT01846273|41975865|FG001|Overall Study|Administrative problems|0|||
19530326|NCT01846273|41975866|FG002|Overall Study|Administrative problems|0|||
19530327|NCT01846273|41975864|FG000|Overall Study|Death|2|||
19530328|NCT01846273|41975865|FG001|Overall Study|Death|1|||
19530329|NCT01846273|41975866|FG002|Overall Study|Death|0|||
19530330|NCT01846273|41975864|FG000|Overall Study|Disease Progression|0|||
19629681|NCT00813488|42079130|FG000|Open-label Extension|Non-compliance study procedures|2|||
19629682|NCT00813488|42079131|FG001|Open-label Extension|Non-compliance study procedures|1|||
19629683|NCT00813488|42079130|FG000|Open-label Extension|Other|1|||
19629684|NCT00813488|42079131|FG001|Open-label Extension|Other|0|||
19629685|NCT00797316|42079143|FG000|Overall Study|Administrative problems|1|||
19629686|NCT00797316|42079144|FG001|Overall Study|Administrative problems|0|||
19629687|NCT00797316|42079143|FG000|Overall Study|Adverse Event|5|||
19629688|NCT00797316|42079144|FG001|Overall Study|Adverse Event|3|||
19629689|NCT00797316|42079143|FG000|Overall Study|Lost to Follow-up|4|||
19629690|NCT00797316|42079144|FG001|Overall Study|Lost to Follow-up|8|||
19629691|NCT00797316|42079143|FG000|Overall Study|Protocol Deviation|1|||
19629692|NCT00797316|42079144|FG001|Overall Study|Protocol Deviation|2|||
19629693|NCT00797316|42079143|FG000|Overall Study|Patient withdrew consent|12|||
19629694|NCT00797316|42079144|FG001|Overall Study|Patient withdrew consent|6|||
19629695|NCT00797316|42079143|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19629696|NCT00797316|42079144|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
19629697|NCT00587964|42079150|FG000|Overall Study|Withdrawal by Subject|1|||
19629698|NCT00587964|42079150|FG000|Overall Study|Lost to Follow-up|1|||
19629699|NCT00587964|42079150|FG000|Overall Study|Patient found to be ineligible|1|||
19629700|NCT00587964|42079150|FG000|Overall Study|Patient did not receive intervention|5|||
19629701|NCT00587964|42079150|FG000|Overall Study|Progression of Disease|4|||
19629702|NCT00590954|42079154|FG000|Overall Study|Inevaluable|2|||
19629703|NCT00791076|42079160|FG000|Overall Study|Study was terminated,PI left institution|8|||
19629704|NCT00590720|42079168|FG000|Overall Study|Lost to Follow-up|1|||
19629705|NCT00590720|42079169|FG001|Overall Study|Lost to Follow-up|0|||
19629706|NCT00590720|42079168|FG000|Overall Study|Withdrawal by Subject|0|||
19451351|NCT01811732|41700300|FG001|Overall Study|Withdrawal by Subject|10|||
19451352|NCT01811732|41700299|FG000|Overall Study|Adverse Event|3|||
19451353|NCT01811732|41700300|FG001|Overall Study|Adverse Event|9|||
19629707|NCT00590720|42079169|FG001|Overall Study|Withdrawal by Subject|1|||
19451354|NCT01811732|41700299|FG000|Overall Study|Lack of Efficacy|3|||
19451355|NCT01811732|41700300|FG001|Overall Study|Lack of Efficacy|1|||
19451356|NCT01811732|41700299|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
19451357|NCT01811732|41700300|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
19530331|NCT01846273|41975865|FG001|Overall Study|Disease Progression|4|||
19530332|NCT01846273|41975866|FG002|Overall Study|Disease Progression|0|||
19530333|NCT01846273|41975864|FG000|Overall Study|Protocol Deviation|2|||
19530334|NCT01846273|41975865|FG001|Overall Study|Protocol Deviation|3|||
19530335|NCT01846273|41975866|FG002|Overall Study|Protocol Deviation|0|||
19530336|NCT01846273|41975864|FG000|Overall Study|Physician Decision|1|||
19629708|NCT00625378|42079177|FG000|Overall Study|Adverse Event|22|||
19629709|NCT00625378|42079178|FG001|Overall Study|Adverse Event|0|||
19451358|NCT01811732|41700299|FG000|Overall Study|Physician Decision|2|||
19451359|NCT01811732|41700300|FG001|Overall Study|Physician Decision|0|||
19451360|NCT01811732|41700299|FG000|Overall Study|Death|1|||
19451361|NCT01811732|41700300|FG001|Overall Study|Death|1|||
19451362|NCT01811732|41700299|FG000|Overall Study|Insufficient venous access|0|||
19451363|NCT01811732|41700300|FG001|Overall Study|Insufficient venous access|1|||
19451364|NCT01811732|41700299|FG000|Overall Study|Protocol Violation|0|||
19451365|NCT01811732|41700300|FG001|Overall Study|Protocol Violation|1|||
19451366|NCT01811732|41700299|FG000|Overall Study|Subject incarcerated|1|||
19451367|NCT01811732|41700300|FG001|Overall Study|Subject incarcerated|2|||
19451368|NCT01811732|41700299|FG000|Overall Study|Admitted to another facility|1|||
19451369|NCT01811732|41700300|FG001|Overall Study|Admitted to another facility|0|||
19451370|NCT01811732|41700299|FG000|Overall Study|Correct study drug not available on site|1|||
19451371|NCT01811732|41700300|FG001|Overall Study|Correct study drug not available on site|0|||
19451372|NCT01836458|41700311|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
19451373|NCT01836458|41700312|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19451374|NCT01836458|41700313|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
19451375|NCT01836458|41700314|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
19451376|NCT01811186|41700326|FG000|Overall Study|Adverse Event|54|||
19451377|NCT01811186|41700327|FG001|Overall Study|Adverse Event|38|||
19451378|NCT01811186|41700326|FG000|Overall Study|Protocol Violation|5|||
19451379|NCT01811186|41700327|FG001|Overall Study|Protocol Violation|6|||
19451380|NCT01811186|41700326|FG000|Overall Study|Withdrawal by Subject|5|||
19451381|NCT01811186|41700327|FG001|Overall Study|Withdrawal by Subject|10|||
19451382|NCT01811186|41700326|FG000|Overall Study|Lack of Efficacy|3|||
19451383|NCT01811186|41700327|FG001|Overall Study|Lack of Efficacy|6|||
19451384|NCT01811186|41700326|FG000|Overall Study|Lost to Follow-up|4|||
19451385|NCT01811186|41700327|FG001|Overall Study|Lost to Follow-up|2|||
19451386|NCT01866098|41700340|FG000|Overall Study|Lost to Follow-up|11|||
19451387|NCT01866098|41700341|FG001|Overall Study|Lost to Follow-up|18|||
19530337|NCT01846273|41975865|FG001|Overall Study|Physician Decision|2|||
19530338|NCT01846273|41975866|FG002|Overall Study|Physician Decision|0|||
19530339|NCT01875185|41975876|FG000|Overall Study|study was terminated|52|||
19530340|NCT01875185|41975877|FG001|Overall Study|study was terminated|48|||
19530341|NCT01901432|41975906|FG000|Overall Study|Adverse Event|0|||
19530342|NCT01901432|41975907|FG001|Overall Study|Adverse Event|1|||
19530343|NCT01901432|41975908|FG002|Overall Study|Adverse Event|1|||
19530344|NCT01901432|41975909|FG003|Overall Study|Adverse Event|0|||
19530345|NCT01901432|41975910|FG004|Overall Study|Adverse Event|1|||
19530346|NCT01901432|41975906|FG000|Overall Study|Withdrawal by Subject|0|||
19530347|NCT01901432|41975907|FG001|Overall Study|Withdrawal by Subject|0|||
19530348|NCT01901432|41975908|FG002|Overall Study|Withdrawal by Subject|1|||
19530349|NCT01901432|41975909|FG003|Overall Study|Withdrawal by Subject|0|||
19530350|NCT01901432|41975910|FG004|Overall Study|Withdrawal by Subject|5|||
19530351|NCT01901432|41975906|FG000|Overall Study|Physician Decision|0|||
19530352|NCT01901432|41975907|FG001|Overall Study|Physician Decision|0|||
19530353|NCT01901432|41975908|FG002|Overall Study|Physician Decision|0|||
19530354|NCT01901432|41975909|FG003|Overall Study|Physician Decision|0|||
19530355|NCT01901432|41975910|FG004|Overall Study|Physician Decision|2|||
19530356|NCT01901432|41975906|FG000|Overall Study|Patient decision to stop study drug|0|||
19530357|NCT01901432|41975907|FG001|Overall Study|Patient decision to stop study drug|0|||
19530358|NCT01901432|41975908|FG002|Overall Study|Patient decision to stop study drug|0|||
19530359|NCT01901432|41975909|FG003|Overall Study|Patient decision to stop study drug|0|||
19530360|NCT01901432|41975910|FG004|Overall Study|Patient decision to stop study drug|1|||
19530361|NCT01904279|41975931|FG000|Overall Study|Lack of Efficacy|2|||
19530362|NCT01904279|41975932|FG001|Overall Study|Lack of Efficacy|3|||
19530363|NCT01904279|41975931|FG000|Overall Study|Withdrawal by Subject|1|||
19530364|NCT01904279|41975932|FG001|Overall Study|Withdrawal by Subject|0|||
19530365|NCT01917318|41975941|FG000|First Treatment|Withdrawal by Subject|0|||
19530366|NCT01917318|41975942|FG001|First Treatment|Withdrawal by Subject|1|||
19530367|NCT01923168|41975951|FG000|Overall Study|Protocol Violation|1|||
19530368|NCT01923168|41975952|FG001|Overall Study|Protocol Violation|1|||
19530369|NCT01923168|41975953|FG002|Overall Study|Protocol Violation|0|||
19530370|NCT01923168|41975951|FG000|Overall Study|Subject/guardian decision|14|||
19530371|NCT01923168|41975952|FG001|Overall Study|Subject/guardian decision|14|||
19530372|NCT01923168|41975953|FG002|Overall Study|Subject/guardian decision|4|||
19530373|NCT01923168|41975951|FG000|Overall Study|Adverse Event|12|||
19530374|NCT01923168|41975952|FG001|Overall Study|Adverse Event|12|||
19530375|NCT01923168|41975953|FG002|Overall Study|Adverse Event|0|||
19530376|NCT01923168|41975951|FG000|Overall Study|Physician Decision|6|||
19451388|NCT01866098|41700342|FG002|Overall Study|Lost to Follow-up|13|||
19451389|NCT01866098|41700340|FG000|Overall Study|Physician Decision|0|||
19451390|NCT01866098|41700341|FG001|Overall Study|Physician Decision|1|||
19451391|NCT01866098|41700342|FG002|Overall Study|Physician Decision|2|||
19530377|NCT01923168|41975952|FG001|Overall Study|Physician Decision|9|||
19530378|NCT01923168|41975953|FG002|Overall Study|Physician Decision|5|||
19530379|NCT01923168|41975951|FG000|Overall Study|Progressive disease|4|||
19530380|NCT01923168|41975952|FG001|Overall Study|Progressive disease|3|||
19530381|NCT01923168|41975953|FG002|Overall Study|Progressive disease|7|||
19530382|NCT01923168|41975951|FG000|Overall Study|Death|0|||
19530383|NCT01923168|41975952|FG001|Overall Study|Death|0|||
19530384|NCT01923168|41975953|FG002|Overall Study|Death|1|||
19530385|NCT01931098|41975963|FG000|Overall Study|Withdrawal by Subject|0|||
19530386|NCT01931098|41975964|FG001|Overall Study|Withdrawal by Subject|1|||
19530387|NCT01931098|41975963|FG000|Overall Study|Enrolled in different protocol|0|||
19530388|NCT01931098|41975964|FG001|Overall Study|Enrolled in different protocol|1|||
19530389|NCT01931098|41975963|FG000|Overall Study|Unable to begin trmt:active infection|0|||
19530390|NCT01931098|41975964|FG001|Overall Study|Unable to begin trmt:active infection|1|||
19530391|NCT01931098|41975963|FG000|Overall Study|Refused further treatment|0|||
19530392|NCT01931098|41975964|FG001|Overall Study|Refused further treatment|1|||
19530393|NCT01945021|41975972|FG000|Overall Study|Adverse Event|1|||
19530394|NCT01945021|41975972|FG000|Overall Study|Withdrawal of consent|12|||
19530395|NCT01945021|41975972|FG000|Overall Study|Lost to Follow-up|5|||
19530396|NCT01945021|41975972|FG000|Overall Study|Death|65|||
19530397|NCT03951077|41976013|FG000|Overall Study|Adverse Event|1|||
19530398|NCT03951077|41976014|FG001|Overall Study|Adverse Event|0|||
19530399|NCT03951077|41976015|FG002|Overall Study|Adverse Event|0|||
19530400|NCT03951077|41976016|FG003|Overall Study|Adverse Event|0|||
19530401|NCT03951077|41976017|FG004|Overall Study|Adverse Event|0|||
19530402|NCT03951077|41976018|FG005|Overall Study|Adverse Event|0|||
19530403|NCT03951077|41976013|FG000|Overall Study|Withdrawal by Subject|3|||
19530404|NCT03951077|41976014|FG001|Overall Study|Withdrawal by Subject|3|||
19530405|NCT03951077|41976015|FG002|Overall Study|Withdrawal by Subject|0|||
19530406|NCT03951077|41976016|FG003|Overall Study|Withdrawal by Subject|3|||
19530407|NCT03951077|41976017|FG004|Overall Study|Withdrawal by Subject|3|||
19530408|NCT03951077|41976018|FG005|Overall Study|Withdrawal by Subject|2|||
19530409|NCT03951077|41976013|FG000|Overall Study|Lost to Follow-up|1|||
19530410|NCT03951077|41976014|FG001|Overall Study|Lost to Follow-up|1|||
19530411|NCT03951077|41976015|FG002|Overall Study|Lost to Follow-up|2|||
19530412|NCT03951077|41976016|FG003|Overall Study|Lost to Follow-up|3|||
19530413|NCT03951077|41976017|FG004|Overall Study|Lost to Follow-up|2|||
19530414|NCT03951077|41976018|FG005|Overall Study|Lost to Follow-up|3|||
19530415|NCT03951077|41976013|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
19530416|NCT03951077|41976014|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
19530417|NCT03951077|41976015|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
19530418|NCT03951077|41976016|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
19530419|NCT03951077|41976017|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
19530420|NCT03951077|41976018|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
19530421|NCT03951077|41976013|FG000|Overall Study|Other, Not Specified|12|||
19530422|NCT03951077|41976014|FG001|Overall Study|Other, Not Specified|10|||
19530423|NCT03951077|41976015|FG002|Overall Study|Other, Not Specified|10|||
19530424|NCT03951077|41976016|FG003|Overall Study|Other, Not Specified|5|||
19530425|NCT03951077|41976017|FG004|Overall Study|Other, Not Specified|9|||
19530426|NCT03951077|41976018|FG005|Overall Study|Other, Not Specified|6|||
19530427|NCT03951077|41976013|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
19530428|NCT03951077|41976014|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
19530429|NCT03951077|41976015|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
19530430|NCT03951077|41976016|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
19530431|NCT03951077|41976017|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
19530432|NCT03951077|41976018|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
19530433|NCT03873246|41976035|FG000|Overall Study|Adverse Event|1|||
19530434|NCT03873246|41976036|FG001|Overall Study|Adverse Event|3|||
19530435|NCT03873246|41976037|FG002|Overall Study|Adverse Event|3|||
19530436|NCT03873246|41976035|FG000|Overall Study|Lost to Follow-up|4|||
19530437|NCT03873246|41976036|FG001|Overall Study|Lost to Follow-up|4|||
19530438|NCT03873246|41976037|FG002|Overall Study|Lost to Follow-up|5|||
19530439|NCT03873246|41976035|FG000|Overall Study|Protocol Violation|0|||
19530440|NCT03873246|41976036|FG001|Overall Study|Protocol Violation|1|||
19530441|NCT03873246|41976037|FG002|Overall Study|Protocol Violation|0|||
19530442|NCT03873246|41976035|FG000|Overall Study|Withdrawal by Subject|0|||
19530443|NCT03873246|41976036|FG001|Overall Study|Withdrawal by Subject|4|||
19530444|NCT03873246|41976037|FG002|Overall Study|Withdrawal by Subject|1|||
19530445|NCT03769649|41976046|FG000|Overall Study|Lost to Follow-up|4|||
19530446|NCT02862548|41976072|FG000|Randomized Phase (Up to Week 48)|Death|0|||
19530447|NCT02862548|41976073|FG001|Randomized Phase (Up to Week 48)|Death|1|||
19530448|NCT02862548|41976072|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
19530449|NCT02862548|41976073|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
19530450|NCT02862548|41976072|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
19530451|NCT02862548|41976073|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
19530452|NCT02862548|41976072|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
19530453|NCT02862548|41976073|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
19530454|NCT02335099|41976092|FG000|Treatment|Withdrawal by Subject|1|||
19530455|NCT02335099|41976093|FG001|Treatment|Withdrawal by Subject|3|||
19530456|NCT02335099|41976092|FG000|Treatment|Lost to Follow-up|2|||
19530457|NCT02335099|41976093|FG001|Treatment|Lost to Follow-up|0|||
19530458|NCT02335099|41976092|FG000|Treatment|Death|1|||
19530459|NCT02335099|41976093|FG001|Treatment|Death|0|||
19530460|NCT02335099|41976092|FG000|Treatment|Adverse Event|1|||
19530461|NCT02335099|41976093|FG001|Treatment|Adverse Event|2|||
19530462|NCT02335099|41976092|FG000|Follow-up|Death|0|||
19530463|NCT02335099|41976093|FG001|Follow-up|Death|1|||
19530464|NCT02330562|41976110|FG000|Overall Study|Adverse Event|0|||
19530465|NCT02330562|41976111|FG001|Overall Study|Adverse Event|0|||
19530466|NCT02330562|41976112|FG002|Overall Study|Adverse Event|3|||
19530467|NCT02330562|41976113|FG003|Overall Study|Adverse Event|0|||
19530468|NCT02330562|41976114|FG004|Overall Study|Adverse Event|3|||
19530469|NCT02330562|41976115|FG005|Overall Study|Adverse Event|1|||
19530470|NCT02330562|41976116|FG006|Overall Study|Adverse Event|0|||
19530471|NCT02330562|41976117|FG007|Overall Study|Adverse Event|0|||
19530472|NCT02330562|41976118|FG008|Overall Study|Adverse Event|0|||
19530473|NCT02330562|41976119|FG009|Overall Study|Adverse Event|1|||
19530474|NCT02330562|41976120|FG010|Overall Study|Adverse Event|1|||
19530475|NCT02330562|41976110|FG000|Overall Study|Participant decision|1|||
19530476|NCT02330562|41976111|FG001|Overall Study|Participant decision|0|||
19530477|NCT02330562|41976112|FG002|Overall Study|Participant decision|4|||
19530478|NCT02330562|41976113|FG003|Overall Study|Participant decision|1|||
19530479|NCT02330562|41976114|FG004|Overall Study|Participant decision|5|||
19530480|NCT02330562|41976115|FG005|Overall Study|Participant decision|2|||
19530481|NCT02330562|41976116|FG006|Overall Study|Participant decision|0|||
19530482|NCT02330562|41976117|FG007|Overall Study|Participant decision|0|||
19530483|NCT02330562|41976118|FG008|Overall Study|Participant decision|0|||
19530484|NCT02330562|41976119|FG009|Overall Study|Participant decision|3|||
19530485|NCT02330562|41976120|FG010|Overall Study|Participant decision|0|||
19530486|NCT02330562|41976110|FG000|Overall Study|Disease progression|5|||
19530487|NCT02330562|41976111|FG001|Overall Study|Disease progression|3|||
19530488|NCT02330562|41976112|FG002|Overall Study|Disease progression|20|||
19530489|NCT02330562|41976113|FG003|Overall Study|Disease progression|28|||
19530490|NCT02330562|41976114|FG004|Overall Study|Disease progression|23|||
19530491|NCT02330562|41976115|FG005|Overall Study|Disease progression|7|||
19530492|NCT02330562|41976116|FG006|Overall Study|Disease progression|1|||
19530493|NCT02330562|41976117|FG007|Overall Study|Disease progression|1|||
19530494|NCT02330562|41976118|FG008|Overall Study|Disease progression|1|||
19530495|NCT02330562|41976119|FG009|Overall Study|Disease progression|0|||
19530496|NCT02330562|41976120|FG010|Overall Study|Disease progression|5|||
19530497|NCT02330562|41976110|FG000|Overall Study|Other reasons|0|||
19530498|NCT02330562|41976111|FG001|Overall Study|Other reasons|0|||
19530499|NCT02330562|41976112|FG002|Overall Study|Other reasons|0|||
19530500|NCT02330562|41976113|FG003|Overall Study|Other reasons|1|||
19530501|NCT02330562|41976114|FG004|Overall Study|Other reasons|0|||
19530502|NCT02330562|41976115|FG005|Overall Study|Other reasons|0|||
19530503|NCT02330562|41976116|FG006|Overall Study|Other reasons|0|||
19530504|NCT02330562|41976117|FG007|Overall Study|Other reasons|0|||
19530505|NCT02330562|41976118|FG008|Overall Study|Other reasons|0|||
19530506|NCT02330562|41976119|FG009|Overall Study|Other reasons|0|||
19530507|NCT02330562|41976120|FG010|Overall Study|Other reasons|0|||
19530508|NCT02330562|41976110|FG000|Overall Study|Withdrawal by Subject|0|||
19530509|NCT02330562|41976111|FG001|Overall Study|Withdrawal by Subject|0|||
19530510|NCT02330562|41976112|FG002|Overall Study|Withdrawal by Subject|0|||
19530511|NCT02330562|41976113|FG003|Overall Study|Withdrawal by Subject|0|||
19530512|NCT02330562|41976114|FG004|Overall Study|Withdrawal by Subject|0|||
19530513|NCT02330562|41976115|FG005|Overall Study|Withdrawal by Subject|0|||
19530514|NCT02330562|41976116|FG006|Overall Study|Withdrawal by Subject|0|||
19530515|NCT02330562|41976117|FG007|Overall Study|Withdrawal by Subject|0|||
19530516|NCT02330562|41976118|FG008|Overall Study|Withdrawal by Subject|0|||
19530517|NCT02330562|41976119|FG009|Overall Study|Withdrawal by Subject|1|||
19451392|NCT01866098|41700340|FG000|Overall Study|Adverse Event|1|||
19451393|NCT01866098|41700341|FG001|Overall Study|Adverse Event|5|||
19451394|NCT01866098|41700342|FG002|Overall Study|Adverse Event|4|||
19451395|NCT01866098|41700340|FG000|Overall Study|Protocol Violation|1|||
19451396|NCT01866098|41700341|FG001|Overall Study|Protocol Violation|0|||
19451397|NCT01866098|41700342|FG002|Overall Study|Protocol Violation|0|||
19451398|NCT01866098|41700340|FG000|Overall Study|Withdrawal by Subject|1|||
19530518|NCT02330562|41976120|FG010|Overall Study|Withdrawal by Subject|0|||
19530519|NCT03703102|41976234|FG000|Overall Study|Adverse Event|4|||
19530520|NCT03703102|41976235|FG001|Overall Study|Adverse Event|3|||
19530521|NCT03703102|41976236|FG002|Overall Study|Adverse Event|7|||
19530522|NCT03703102|41976237|FG003|Overall Study|Adverse Event|3|||
19530523|NCT03703102|41976238|FG004|Overall Study|Adverse Event|13|||
19530524|NCT03703102|41976234|FG000|Overall Study|Lack of Efficacy|4|||
19530525|NCT03703102|41976235|FG001|Overall Study|Lack of Efficacy|0|||
19530526|NCT03703102|41976236|FG002|Overall Study|Lack of Efficacy|1|||
19530527|NCT03703102|41976237|FG003|Overall Study|Lack of Efficacy|4|||
19451399|NCT01866098|41700341|FG001|Overall Study|Withdrawal by Subject|2|||
19451400|NCT01866098|41700342|FG002|Overall Study|Withdrawal by Subject|0|||
19451401|NCT01866098|41700340|FG000|Overall Study|Unrelated Hospitalization|2|||
19451402|NCT01866098|41700341|FG001|Overall Study|Unrelated Hospitalization|0|||
19451403|NCT01866098|41700342|FG002|Overall Study|Unrelated Hospitalization|1|||
19451404|NCT01866098|41700340|FG000|Overall Study|Non-compliance|1|||
19451405|NCT01866098|41700341|FG001|Overall Study|Non-compliance|0|||
19451406|NCT01866098|41700342|FG002|Overall Study|Non-compliance|1|||
19451407|NCT01866098|41700340|FG000|Overall Study|Pregnancy|2|||
19451408|NCT01866098|41700341|FG001|Overall Study|Pregnancy|0|||
19451409|NCT01866098|41700342|FG002|Overall Study|Pregnancy|0|||
19451410|NCT01866098|41700340|FG000|Overall Study|Death|0|||
19451411|NCT01866098|41700341|FG001|Overall Study|Death|1|||
19451412|NCT01866098|41700342|FG002|Overall Study|Death|0|||
19451413|NCT01865552|41700356|FG000|Period 1|Adverse Event|1|||
19451414|NCT01865552|41700357|FG001|Period 1|Adverse Event|0|||
19451415|NCT01865552|41700358|FG002|Period 1|Adverse Event|0|||
19451416|NCT01865552|41700359|FG003|Period 1|Adverse Event|1|||
19451417|NCT01865552|41700360|FG004|Period 1|Adverse Event|1|||
19530528|NCT03703102|41976238|FG004|Overall Study|Lack of Efficacy|1|||
19530529|NCT03703102|41976234|FG000|Overall Study|Lost to Follow-up|0|||
19530530|NCT03703102|41976235|FG001|Overall Study|Lost to Follow-up|0|||
19530531|NCT03703102|41976236|FG002|Overall Study|Lost to Follow-up|1|||
19530532|NCT03703102|41976237|FG003|Overall Study|Lost to Follow-up|2|||
19530533|NCT03703102|41976238|FG004|Overall Study|Lost to Follow-up|2|||
19530534|NCT03703102|41976234|FG000|Overall Study|Physician Decision|2|||
19530535|NCT03703102|41976235|FG001|Overall Study|Physician Decision|2|||
19629710|NCT00625378|42079177|FG000|Overall Study|Withdrawal by Subject|16|||
19629711|NCT00625378|42079178|FG001|Overall Study|Withdrawal by Subject|0|||
19629712|NCT00625378|42079177|FG000|Overall Study|Death|38|||
19629713|NCT00625378|42079178|FG001|Overall Study|Death|0|||
19629714|NCT00625378|42079177|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
19629715|NCT00625378|42079178|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
19629716|NCT00625378|42079177|FG000|Overall Study|Lost to Follow-up|17|||
19629717|NCT00625378|42079178|FG001|Overall Study|Lost to Follow-up|0|||
19629718|NCT00625378|42079177|FG000|Overall Study|Non-compliant with study medication|3|||
19629719|NCT00625378|42079178|FG001|Overall Study|Non-compliant with study medication|0|||
19629720|NCT00625378|42079177|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
19629721|NCT00625378|42079178|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
19629722|NCT00625378|42079177|FG000|Overall Study|Medical decision|1|||
19629723|NCT00625378|42079178|FG001|Overall Study|Medical decision|0|||
19629724|NCT00625378|42079177|FG000|Overall Study|Multiple toxicities|1|||
19629725|NCT00625378|42079178|FG001|Overall Study|Multiple toxicities|0|||
19629726|NCT00625378|42079177|FG000|Overall Study|New cancer|1|||
19629727|NCT00625378|42079178|FG001|Overall Study|New cancer|0|||
19530536|NCT03703102|41976236|FG002|Overall Study|Physician Decision|2|||
19530537|NCT03703102|41976237|FG003|Overall Study|Physician Decision|2|||
19530538|NCT03703102|41976238|FG004|Overall Study|Physician Decision|4|||
19530539|NCT03703102|41976234|FG000|Overall Study|Withdrawal by Subject|7|||
19530540|NCT03703102|41976235|FG001|Overall Study|Withdrawal by Subject|5|||
19530541|NCT03703102|41976236|FG002|Overall Study|Withdrawal by Subject|5|||
19530542|NCT03703102|41976237|FG003|Overall Study|Withdrawal by Subject|5|||
19530543|NCT03703102|41976238|FG004|Overall Study|Withdrawal by Subject|9|||
19530544|NCT03703102|41976234|FG000|Overall Study|Ineligibility|0|||
19530545|NCT03703102|41976235|FG001|Overall Study|Ineligibility|0|||
19530546|NCT03703102|41976236|FG002|Overall Study|Ineligibility|1|||
19530547|NCT03703102|41976237|FG003|Overall Study|Ineligibility|0|||
19530548|NCT03703102|41976238|FG004|Overall Study|Ineligibility|0|||
19530549|NCT03703102|41976234|FG000|Overall Study|Protocol Deviation|4|||
19530550|NCT03703102|41976235|FG001|Overall Study|Protocol Deviation|4|||
19530551|NCT03703102|41976236|FG002|Overall Study|Protocol Deviation|3|||
19530552|NCT03703102|41976237|FG003|Overall Study|Protocol Deviation|0|||
19530553|NCT03703102|41976238|FG004|Overall Study|Protocol Deviation|0|||
19530554|NCT03703102|41976234|FG000|Overall Study|Non-Compliance with Study Drug|1|||
19530555|NCT03703102|41976235|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19530556|NCT03703102|41976236|FG002|Overall Study|Non-Compliance with Study Drug|2|||
19530557|NCT03703102|41976237|FG003|Overall Study|Non-Compliance with Study Drug|1|||
19530558|NCT03703102|41976238|FG004|Overall Study|Non-Compliance with Study Drug|4|||
19530559|NCT03395704|41976257|FG000|Overall Study|Adverse Event|2|||
19530560|NCT03395704|41976258|FG001|Overall Study|Adverse Event|1|||
19530561|NCT03395704|41976257|FG000|Overall Study|Withdrawal by Subject|2|||
19530562|NCT03395704|41976258|FG001|Overall Study|Withdrawal by Subject|1|||
19530563|NCT03395704|41976257|FG000|Overall Study|Physician Decision|0|||
19629728|NCT00625378|42079177|FG000|Overall Study|PTA program|2|||
19629729|NCT00625378|42079178|FG001|Overall Study|PTA program|0|||
19451418|NCT01865552|41700361|FG005|Period 1|Adverse Event|1|||
19451419|NCT01865552|41700356|FG000|Period 1|Pathological lab|0|||
19451420|NCT01865552|41700357|FG001|Period 1|Pathological lab|0|||
19451421|NCT01865552|41700358|FG002|Period 1|Pathological lab|0|||
19451422|NCT01865552|41700359|FG003|Period 1|Pathological lab|0|||
19451423|NCT01865552|41700360|FG004|Period 1|Pathological lab|1|||
19451424|NCT01865552|41700361|FG005|Period 1|Pathological lab|0|||
19451425|NCT01865552|41700356|FG000|Period 1|Other|0|||
19451426|NCT01865552|41700357|FG001|Period 1|Other|0|||
19451427|NCT01865552|41700358|FG002|Period 1|Other|0|||
19451428|NCT01865552|41700359|FG003|Period 1|Other|0|||
19451429|NCT01865552|41700360|FG004|Period 1|Other|1|||
19451430|NCT01865552|41700361|FG005|Period 1|Other|0|||
19451431|NCT01809314|41700375|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
19451432|NCT01809314|41700375|FG000|Overall Study|Adverse Event|6|||
19451433|NCT01809314|41700375|FG000|Overall Study|Insufficient Therapeutic Response|14|||
19451434|NCT01809314|41700375|FG000|Overall Study|Lost to Follow-up|724|||
19451435|NCT01803464|41700383|FG000|Overall Study|Incomplete data|0|||
19451436|NCT01803464|41700384|FG001|Overall Study|Incomplete data|0|||
19451437|NCT01803464|41700385|FG002|Overall Study|Incomplete data|4|||
19451438|NCT01803464|41700386|FG003|Overall Study|Incomplete data|0|||
19451439|NCT01803464|41700383|FG000|Overall Study|Withdrawal by Subject|1|||
19451440|NCT01803464|41700384|FG001|Overall Study|Withdrawal by Subject|0|||
19451441|NCT01803464|41700385|FG002|Overall Study|Withdrawal by Subject|0|||
19451442|NCT01803464|41700386|FG003|Overall Study|Withdrawal by Subject|0|||
19451443|NCT01808690|41700402|FG000|Overall Study|Withdrawal by Subject|1|||
19451444|NCT01808690|41700403|FG001|Overall Study|Withdrawal by Subject|2|||
19451445|NCT01363297|41700414|FG000|Overall Study|Other|0|||
19451446|NCT01363297|41700415|FG001|Overall Study|Other|0|||
19451447|NCT01363297|41700416|FG002|Overall Study|Other|0|||
19451448|NCT01363297|41700417|FG003|Overall Study|Other|0|||
19451449|NCT01363297|41700418|FG004|Overall Study|Other|1|||
19451450|NCT01363297|41700414|FG000|Overall Study|Death|3|||
19451451|NCT01363297|41700415|FG001|Overall Study|Death|6|||
19451452|NCT01363297|41700416|FG002|Overall Study|Death|6|||
19451453|NCT01363297|41700417|FG003|Overall Study|Death|10|||
19451454|NCT01363297|41700418|FG004|Overall Study|Death|30|||
19451455|NCT01908907|41700437|FG000|Overall Study|Physician Decision|1|||
19451456|NCT01908907|41700438|FG001|Overall Study|Physician Decision|0|||
19451457|NCT01908907|41700437|FG000|Overall Study|Protocol Violation|1|||
19451458|NCT01908907|41700438|FG001|Overall Study|Protocol Violation|0|||
19451459|NCT01808612|41700451|FG000|Treatment Period|Adverse Event|8|||
19451460|NCT01808612|41700452|FG001|Treatment Period|Adverse Event|4|||
19451461|NCT01808612|41700453|FG002|Treatment Period|Adverse Event|3|||
19451462|NCT01808612|41700451|FG000|Treatment Period|Lost to Follow-up|2|||
19451463|NCT01808612|41700452|FG001|Treatment Period|Lost to Follow-up|2|||
19451464|NCT01808612|41700453|FG002|Treatment Period|Lost to Follow-up|1|||
19451465|NCT01808612|41700451|FG000|Treatment Period|Protocol Violation|1|||
19451466|NCT01808612|41700452|FG001|Treatment Period|Protocol Violation|0|||
19451467|NCT01808612|41700453|FG002|Treatment Period|Protocol Violation|0|||
19451468|NCT01808612|41700451|FG000|Treatment Period|Withdrawal by Subject|1|||
19451469|NCT01808612|41700452|FG001|Treatment Period|Withdrawal by Subject|0|||
19451470|NCT01808612|41700453|FG002|Treatment Period|Withdrawal by Subject|4|||
19451471|NCT01808612|41700451|FG000|Treatment Period|Physician Decision|1|||
19451472|NCT01808612|41700452|FG001|Treatment Period|Physician Decision|0|||
19451473|NCT01808612|41700453|FG002|Treatment Period|Physician Decision|4|||
19451474|NCT01808612|41700451|FG000|Treatment Period|Sponsor Decision|1|||
19451475|NCT01808612|41700452|FG001|Treatment Period|Sponsor Decision|0|||
19451476|NCT01808612|41700453|FG002|Treatment Period|Sponsor Decision|0|||
19451477|NCT01808612|41700451|FG000|Treatment Period|Lack of Efficacy|1|||
19451478|NCT01808612|41700452|FG001|Treatment Period|Lack of Efficacy|1|||
19451479|NCT01808612|41700453|FG002|Treatment Period|Lack of Efficacy|2|||
19530564|NCT03395704|41976258|FG001|Overall Study|Physician Decision|1|||
19530565|NCT03335813|41976264|FG000|Overall Study|Withdrawal by Subject|1|||
19530566|NCT03246503|41976268|FG000|Overall Study|Lost to Follow-up|23|||
19530567|NCT03246503|41976268|FG000|Overall Study|Withdrawal by Subject|20|||
19530568|NCT03246503|41976268|FG000|Overall Study|Physician Decision|5|||
19530569|NCT03246503|41976268|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
19530570|NCT02514447|41976329|FG000|Overall Study|Withdrawal by Subject|3|||
19530571|NCT02514447|41976330|FG001|Overall Study|Withdrawal by Subject|1|||
19530572|NCT02514447|41976331|FG002|Overall Study|Withdrawal by Subject|1|||
19530573|NCT02514447|41976332|FG003|Overall Study|Withdrawal by Subject|0|||
19530574|NCT02514447|41976333|FG004|Overall Study|Withdrawal by Subject|0|||
19530575|NCT02514447|41976334|FG005|Overall Study|Withdrawal by Subject|0|||
19530576|NCT02514447|41976335|FG006|Overall Study|Withdrawal by Subject|0|||
19530577|NCT02514447|41976336|FG007|Overall Study|Withdrawal by Subject|1|||
19451480|NCT01808612|41700451|FG000|Discontinuation Period|Adverse Event|1|||
19451481|NCT01808612|41700452|FG001|Discontinuation Period|Adverse Event|0|||
19451482|NCT01808612|41700453|FG002|Discontinuation Period|Adverse Event|0|||
19451483|NCT01808612|41700451|FG000|Discontinuation Period|Physician Decision|1|||
19451484|NCT01808612|41700452|FG001|Discontinuation Period|Physician Decision|0|||
19451485|NCT01808612|41700453|FG002|Discontinuation Period|Physician Decision|0|||
19451486|NCT01808612|41700451|FG000|Discontinuation Period|Lost to Follow-up|0|||
19530578|NCT02514447|41976337|FG008|Overall Study|Withdrawal by Subject|1|||
19530579|NCT02514447|41976329|FG000|Overall Study|Death|24|||
19530580|NCT02514447|41976330|FG001|Overall Study|Death|28|||
19530581|NCT02514447|41976331|FG002|Overall Study|Death|29|||
19530582|NCT02514447|41976332|FG003|Overall Study|Death|0|||
19530583|NCT02514447|41976333|FG004|Overall Study|Death|3|||
19530584|NCT02514447|41976334|FG005|Overall Study|Death|4|||
19530585|NCT02514447|41976335|FG006|Overall Study|Death|8|||
19530586|NCT02514447|41976336|FG007|Overall Study|Death|6|||
19530587|NCT02514447|41976337|FG008|Overall Study|Death|5|||
19530588|NCT02514447|41976329|FG000|Overall Study|Lost to Follow-up|1|||
19530589|NCT02514447|41976330|FG001|Overall Study|Lost to Follow-up|0|||
19530590|NCT02514447|41976331|FG002|Overall Study|Lost to Follow-up|0|||
19530591|NCT02514447|41976332|FG003|Overall Study|Lost to Follow-up|0|||
19530592|NCT02514447|41976333|FG004|Overall Study|Lost to Follow-up|0|||
19530593|NCT02514447|41976334|FG005|Overall Study|Lost to Follow-up|0|||
19530594|NCT02514447|41976335|FG006|Overall Study|Lost to Follow-up|0|||
19530595|NCT02514447|41976336|FG007|Overall Study|Lost to Follow-up|0|||
19530596|NCT02514447|41976337|FG008|Overall Study|Lost to Follow-up|1|||
19530597|NCT02514447|41976329|FG000|Overall Study|Sponsor Termination of Study|0|||
19530598|NCT02514447|41976330|FG001|Overall Study|Sponsor Termination of Study|1|||
19530599|NCT02514447|41976331|FG002|Overall Study|Sponsor Termination of Study|1|||
19530600|NCT02514447|41976332|FG003|Overall Study|Sponsor Termination of Study|0|||
19530601|NCT02514447|41976333|FG004|Overall Study|Sponsor Termination of Study|0|||
19530602|NCT02514447|41976334|FG005|Overall Study|Sponsor Termination of Study|0|||
19530603|NCT02514447|41976335|FG006|Overall Study|Sponsor Termination of Study|0|||
19530604|NCT02514447|41976336|FG007|Overall Study|Sponsor Termination of Study|0|||
19530605|NCT02514447|41976337|FG008|Overall Study|Sponsor Termination of Study|0|||
19530606|NCT02514447|41976329|FG000|Overall Study|Study completion per Investigator|1|||
19530607|NCT02514447|41976330|FG001|Overall Study|Study completion per Investigator|0|||
19530608|NCT02514447|41976331|FG002|Overall Study|Study completion per Investigator|1|||
19530609|NCT02514447|41976332|FG003|Overall Study|Study completion per Investigator|2|||
19530610|NCT02514447|41976333|FG004|Overall Study|Study completion per Investigator|0|||
19530611|NCT02514447|41976334|FG005|Overall Study|Study completion per Investigator|0|||
19530612|NCT02514447|41976335|FG006|Overall Study|Study completion per Investigator|0|||
19530613|NCT02514447|41976336|FG007|Overall Study|Study completion per Investigator|0|||
19530614|NCT02514447|41976337|FG008|Overall Study|Study completion per Investigator|1|||
19530615|NCT01785563|41976381|FG000|Overall Study|Physician Decision|10|||
19530616|NCT01785563|41976381|FG000|Overall Study|Withdrawal by Subject|1|||
19530617|NCT01785563|41976381|FG000|Overall Study|Protocol Violation|2|||
19530618|NCT01434290|41976396|FG000|Overall Study|Protocol Violation|6|||
19530619|NCT01434290|41976397|FG001|Overall Study|Protocol Violation|3|||
19530620|NCT01434290|41976396|FG000|Overall Study|No protocol treatment|2|||
19530621|NCT01434290|41976397|FG001|Overall Study|No protocol treatment|4|||
19530622|NCT00750269|41976409|FG000|Overall Study|Protocol Violation|0|||
19530623|NCT00750269|41976410|FG001|Overall Study|Protocol Violation|1|||
19530624|NCT00750269|41976411|FG002|Overall Study|Protocol Violation|1|||
19530625|NCT00750269|41976412|FG003|Overall Study|Protocol Violation|2|||
19530626|NCT00750269|41976413|FG004|Overall Study|Protocol Violation|4|||
19530627|NCT00750269|41976409|FG000|Overall Study|Withdrawal by Subject|0|||
19530628|NCT00750269|41976410|FG001|Overall Study|Withdrawal by Subject|0|||
19530629|NCT00750269|41976411|FG002|Overall Study|Withdrawal by Subject|2|||
19530630|NCT00750269|41976412|FG003|Overall Study|Withdrawal by Subject|2|||
19530631|NCT00750269|41976413|FG004|Overall Study|Withdrawal by Subject|2|||
19530632|NCT00750269|41976409|FG000|Overall Study|Physician Decision|0|||
19530633|NCT00750269|41976410|FG001|Overall Study|Physician Decision|0|||
19530634|NCT00750269|41976411|FG002|Overall Study|Physician Decision|0|||
19530635|NCT00750269|41976412|FG003|Overall Study|Physician Decision|0|||
19530636|NCT00750269|41976413|FG004|Overall Study|Physician Decision|2|||
19530637|NCT00750269|41976409|FG000|Overall Study|Patient too large for positioning|0|||
19530638|NCT00750269|41976410|FG001|Overall Study|Patient too large for positioning|0|||
19530639|NCT00750269|41976411|FG002|Overall Study|Patient too large for positioning|1|||
19530640|NCT00750269|41976412|FG003|Overall Study|Patient too large for positioning|0|||
19530641|NCT00750269|41976413|FG004|Overall Study|Patient too large for positioning|0|||
19530642|NCT00750269|41976409|FG000|Overall Study|Site error|0|||
19530643|NCT00750269|41976410|FG001|Overall Study|Site error|0|||
19530644|NCT00750269|41976411|FG002|Overall Study|Site error|0|||
19530645|NCT00750269|41976412|FG003|Overall Study|Site error|1|||
19530646|NCT00750269|41976413|FG004|Overall Study|Site error|0|||
19530647|NCT00750269|41976409|FG000|Overall Study|SBRT plan could not be drawn|0|||
19530648|NCT00750269|41976410|FG001|Overall Study|SBRT plan could not be drawn|0|||
19530649|NCT00750269|41976411|FG002|Overall Study|SBRT plan could not be drawn|0|||
19530650|NCT00750269|41976412|FG003|Overall Study|SBRT plan could not be drawn|0|||
19530651|NCT00750269|41976413|FG004|Overall Study|SBRT plan could not be drawn|1|||
19530652|NCT00750269|41976409|FG000|Overall Study|Fiducials could not be placed|0|||
19530653|NCT00750269|41976410|FG001|Overall Study|Fiducials could not be placed|0|||
19530654|NCT00750269|41976411|FG002|Overall Study|Fiducials could not be placed|0|||
19530655|NCT00750269|41976412|FG003|Overall Study|Fiducials could not be placed|0|||
19530656|NCT00750269|41976413|FG004|Overall Study|Fiducials could not be placed|1|||
19530657|NCT00712322|41976435|FG000|Overall Study|Protocol deviation|0|||
19530658|NCT00712322|41976436|FG001|Overall Study|Protocol deviation|1|||
19530659|NCT00712322|41976437|FG002|Overall Study|Protocol deviation|0|||
19530660|NCT00323856|41976445|FG000|Overall Study|Withdrawal by Subject|1|||
19530661|NCT00323856|41976445|FG000|Overall Study|Was uncooperative and noncompliant|1|||
19451487|NCT01808612|41700452|FG001|Discontinuation Period|Lost to Follow-up|1|||
19451488|NCT01808612|41700453|FG002|Discontinuation Period|Lost to Follow-up|0|||
19451489|NCT01908829|41700467|FG000|Overall Study|Adverse Event|13|||
19451490|NCT01908829|41700468|FG001|Overall Study|Adverse Event|11|||
19530662|NCT00323856|41976445|FG000|Overall Study|Reason not specified|1|||
19530663|NCT00323856|41976445|FG000|Overall Study|Missing|2|||
19530664|NCT04524663|41976458|FG000|Overall Study|Withdrawal by Subject|0|||
19530665|NCT04524663|41976459|FG001|Overall Study|Withdrawal by Subject|2|||
19530666|NCT03738423|41976488|FG000|Overall Study|Withdrawal by Subject|9|||
19530667|NCT03738423|41976489|FG001|Overall Study|Withdrawal by Subject|12|||
19530668|NCT03738423|41976490|FG002|Overall Study|Withdrawal by Subject|9|||
19530669|NCT03738423|41976491|FG003|Overall Study|Withdrawal by Subject|12|||
19530670|NCT03738423|41976492|FG004|Overall Study|Withdrawal by Subject|10|||
19530671|NCT03738423|41976488|FG000|Overall Study|Lack of Efficacy|3|||
19530672|NCT03738423|41976489|FG001|Overall Study|Lack of Efficacy|1|||
19530673|NCT03738423|41976490|FG002|Overall Study|Lack of Efficacy|1|||
19530674|NCT03738423|41976491|FG003|Overall Study|Lack of Efficacy|1|||
19530675|NCT03738423|41976492|FG004|Overall Study|Lack of Efficacy|2|||
19530676|NCT03738423|41976488|FG000|Overall Study|Lost to Follow-up|1|||
19530677|NCT03738423|41976489|FG001|Overall Study|Lost to Follow-up|0|||
19530678|NCT03738423|41976490|FG002|Overall Study|Lost to Follow-up|1|||
19530679|NCT03738423|41976491|FG003|Overall Study|Lost to Follow-up|1|||
19530680|NCT03738423|41976492|FG004|Overall Study|Lost to Follow-up|0|||
19530681|NCT03738423|41976488|FG000|Overall Study|Protocol Violation|1|||
19530682|NCT03738423|41976489|FG001|Overall Study|Protocol Violation|0|||
19530683|NCT03738423|41976490|FG002|Overall Study|Protocol Violation|0|||
19530684|NCT03738423|41976491|FG003|Overall Study|Protocol Violation|0|||
19530685|NCT03738423|41976492|FG004|Overall Study|Protocol Violation|1|||
19530686|NCT03738423|41976488|FG000|Overall Study|Physician Decision|0|||
19530687|NCT03738423|41976489|FG001|Overall Study|Physician Decision|0|||
19530688|NCT03738423|41976490|FG002|Overall Study|Physician Decision|1|||
19530689|NCT03738423|41976491|FG003|Overall Study|Physician Decision|0|||
19530690|NCT03738423|41976492|FG004|Overall Study|Physician Decision|1|||
19530691|NCT03738423|41976488|FG000|Overall Study|Death|0|||
19451491|NCT01908829|41700469|FG002|Overall Study|Adverse Event|13|||
19451492|NCT01908829|41700467|FG000|Overall Study|Lost to Follow-up|4|||
19451493|NCT01908829|41700468|FG001|Overall Study|Lost to Follow-up|2|||
19451494|NCT01908829|41700469|FG002|Overall Study|Lost to Follow-up|1|||
19451495|NCT01908829|41700467|FG000|Overall Study|Randomized no double-blind drug received|1|||
19451496|NCT01908829|41700468|FG001|Overall Study|Randomized no double-blind drug received|0|||
19451497|NCT01908829|41700469|FG002|Overall Study|Randomized no double-blind drug received|1|||
19451498|NCT01908829|41700467|FG000|Overall Study|Discontinued (no EoT page)|2|||
19451499|NCT01908829|41700468|FG001|Overall Study|Discontinued (no EoT page)|0|||
19451500|NCT01908829|41700469|FG002|Overall Study|Discontinued (no EoT page)|0|||
19451501|NCT01908829|41700467|FG000|Overall Study|Miscellaneous|0|||
19451502|NCT01908829|41700468|FG001|Overall Study|Miscellaneous|2|||
19451503|NCT01908829|41700469|FG002|Overall Study|Miscellaneous|0|||
19530692|NCT03738423|41976489|FG001|Overall Study|Death|0|||
19530693|NCT03738423|41976490|FG002|Overall Study|Death|0|||
19530694|NCT03738423|41976491|FG003|Overall Study|Death|0|||
19530695|NCT03738423|41976492|FG004|Overall Study|Death|1|||
19530696|NCT03738423|41976488|FG000|Overall Study|Randomized but never treated|0|||
19530697|NCT03738423|41976489|FG001|Overall Study|Randomized but never treated|0|||
19530698|NCT03738423|41976490|FG002|Overall Study|Randomized but never treated|1|||
19530699|NCT03738423|41976491|FG003|Overall Study|Randomized but never treated|1|||
19530700|NCT03738423|41976492|FG004|Overall Study|Randomized but never treated|0|||
19530701|NCT03712228|41976510|FG000|Treatment Period 1|Lack of Efficacy|0|||
19530702|NCT03712228|41976511|FG001|Treatment Period 1|Lack of Efficacy|0|||
19530703|NCT03712228|41976512|FG002|Treatment Period 1|Lack of Efficacy|0|||
19530704|NCT03712228|41976513|FG003|Treatment Period 1|Lack of Efficacy|0|||
19530705|NCT03712228|41976514|FG004|Treatment Period 1|Lack of Efficacy|0|||
19530706|NCT03712228|41976515|FG005|Treatment Period 1|Lack of Efficacy|1|||
19451504|NCT01908829|41700467|FG000|Overall Study|Protocol Violation|2|||
19451505|NCT01908829|41700468|FG001|Overall Study|Protocol Violation|2|||
19451506|NCT01908829|41700469|FG002|Overall Study|Protocol Violation|0|||
19451507|NCT01908829|41700467|FG000|Overall Study|Lack of Efficacy|1|||
19451508|NCT01908829|41700468|FG001|Overall Study|Lack of Efficacy|3|||
19451509|NCT01908829|41700469|FG002|Overall Study|Lack of Efficacy|2|||
19451510|NCT01908829|41700467|FG000|Overall Study|Withdrawal by Subject|26|||
19451511|NCT01908829|41700468|FG001|Overall Study|Withdrawal by Subject|29|||
19530707|NCT03712228|41976510|FG000|Treatment Period 2|Pregnancy|0|||
19530708|NCT03712228|41976511|FG001|Treatment Period 2|Pregnancy|0|||
19451512|NCT01908829|41700469|FG002|Overall Study|Withdrawal by Subject|22|||
19451513|NCT01773122|41700481|FG000|Overall Study|Due to amended age eligibility criteria|3|||
19451514|NCT01773122|41700482|FG001|Overall Study|Due to amended age eligibility criteria|1|||
19451515|NCT01773122|41700483|FG002|Overall Study|Due to amended age eligibility criteria|0|||
19451516|NCT01773122|41700484|FG003|Overall Study|Due to amended age eligibility criteria|1|||
19451517|NCT01808534|41700494|FG000|Overall Study|Disease progression|3|||
19451518|NCT01808534|41700494|FG000|Overall Study|Physician Decision|1|||
19451519|NCT01808222|41700498|FG000|Overall Study|mpMR scan was not performed|1|||
19451520|NCT01772576|41700502|FG000|Overall Study|Death|15|||
19451521|NCT01772576|41700502|FG000|Overall Study|Protocol Violation|1|||
19451522|NCT01772576|41700502|FG000|Overall Study|Lost to Follow-up|3|||
19451523|NCT01772576|41700502|FG000|Overall Study|Study device not used|3|||
19530709|NCT03712228|41976512|FG002|Treatment Period 2|Pregnancy|0|||
19530710|NCT03712228|41976513|FG003|Treatment Period 2|Pregnancy|1|||
19530711|NCT03712228|41976514|FG004|Treatment Period 2|Pregnancy|0|||
19530712|NCT03712228|41976515|FG005|Treatment Period 2|Pregnancy|0|||
19530713|NCT03712228|41976510|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19530714|NCT03712228|41976511|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19530715|NCT03712228|41976512|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19530716|NCT03712228|41976513|FG003|Treatment Period 2|Withdrawal by Subject|1|||
19530717|NCT03712228|41976514|FG004|Treatment Period 2|Withdrawal by Subject|0|||
19530718|NCT03712228|41976515|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19530719|NCT03600818|41976534|FG000|Overall Study|Adverse Event|4|||
19530720|NCT03600818|41976535|FG001|Overall Study|Adverse Event|7|||
19530721|NCT03600818|41976534|FG000|Overall Study|Lack of Efficacy|9|||
19530722|NCT03600818|41976535|FG001|Overall Study|Lack of Efficacy|4|||
19530723|NCT03600818|41976534|FG000|Overall Study|Withdrawal by Subject|4|||
19530724|NCT03600818|41976535|FG001|Overall Study|Withdrawal by Subject|3|||
19530725|NCT03600818|41976534|FG000|Overall Study|Other-unspecified|5|||
19530726|NCT03600818|41976535|FG001|Overall Study|Other-unspecified|3|||
19530727|NCT03600818|41976534|FG000|Overall Study|Randomized and not treated|0|||
19530728|NCT03600818|41976535|FG001|Overall Study|Randomized and not treated|1|||
19530729|NCT03578276|41976544|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
19530730|NCT03578276|41976545|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
19530731|NCT02971761|41976560|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
19530732|NCT01627574|41976596|FG000|Overall Study|Withdrawal by Subject|8|||
19530733|NCT01627574|41976597|FG001|Overall Study|Withdrawal by Subject|5|||
19530734|NCT01627574|41976596|FG000|Overall Study|Lost to Follow-up|13|||
19530735|NCT01627574|41976597|FG001|Overall Study|Lost to Follow-up|13|||
19530736|NCT01498458|41976603|FG000|Overall Study|Adverse Event|4|||
19530737|NCT01498458|41976603|FG000|Overall Study|Physician Decision|3|||
19530738|NCT01427712|41976612|FG000|Overall Study|Transfer to a different hospital|2|||
19530739|NCT01427712|41976612|FG000|Overall Study|Lost to Follow-up|1|||
19530740|NCT01427712|41976612|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
19530741|NCT01427712|41976612|FG000|Overall Study|Failure to visit|1|||
19530742|NCT01369147|41976619|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
19530743|NCT01369147|41976620|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
19530744|NCT01369147|41976621|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
19530745|NCT01079780|41976632|FG000|Overall Study|Disease progression|43|||
19530746|NCT01079780|41976633|FG001|Overall Study|Disease progression|7|||
19530747|NCT01079780|41976634|FG002|Overall Study|Disease progression|31|||
19530748|NCT01079780|41976632|FG000|Overall Study|Adverse Event|13|||
19530749|NCT01079780|41976633|FG001|Overall Study|Adverse Event|5|||
19530750|NCT01079780|41976634|FG002|Overall Study|Adverse Event|7|||
19530751|NCT01079780|41976632|FG000|Overall Study|Death|2|||
19530752|NCT01079780|41976633|FG001|Overall Study|Death|0|||
19530753|NCT01079780|41976634|FG002|Overall Study|Death|2|||
19530754|NCT01079780|41976632|FG000|Overall Study|Withdrawal by Subject|6|||
19530755|NCT01079780|41976633|FG001|Overall Study|Withdrawal by Subject|4|||
19530756|NCT01079780|41976634|FG002|Overall Study|Withdrawal by Subject|4|||
19530757|NCT01079780|41976632|FG000|Overall Study|Alternative therapy|2|||
19530758|NCT01079780|41976633|FG001|Overall Study|Alternative therapy|0|||
19530759|NCT01079780|41976634|FG002|Overall Study|Alternative therapy|2|||
19530760|NCT01079780|41976632|FG000|Overall Study|Physician Decision|1|||
19530761|NCT01079780|41976633|FG001|Overall Study|Physician Decision|0|||
19530762|NCT01079780|41976634|FG002|Overall Study|Physician Decision|1|||
19530763|NCT01079780|41976632|FG000|Overall Study|Error made in lesion measurement|1|||
19530764|NCT01079780|41976633|FG001|Overall Study|Error made in lesion measurement|0|||
19629730|NCT00625378|42079177|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
19451524|NCT01772576|41700502|FG000|Overall Study|Adverse Event|6|||
19451525|NCT01772576|41700502|FG000|Overall Study|Withdrawal by Subject|6|||
19451526|NCT01802216|41700529|FG000|4 Month Visit|Participant did not show to visit|3|||
19451527|NCT01802216|41700530|FG001|4 Month Visit|Participant did not show to visit|4|||
19530765|NCT01079780|41976634|FG002|Overall Study|Error made in lesion measurement|0|||
19530766|NCT01079780|41976632|FG000|Overall Study|Patient had surgery|1|||
19530767|NCT01079780|41976633|FG001|Overall Study|Patient had surgery|0|||
19530768|NCT01079780|41976634|FG002|Overall Study|Patient had surgery|0|||
19530769|NCT01079780|41976632|FG000|Overall Study|Treatment cycle delay|0|||
19530770|NCT01079780|41976633|FG001|Overall Study|Treatment cycle delay|0|||
19530771|NCT01079780|41976634|FG002|Overall Study|Treatment cycle delay|1|||
19451528|NCT01802216|41700529|FG000|8 Month Visit|Participant did not show to visit|3|||
19451529|NCT01802216|41700530|FG001|8 Month Visit|Participant did not show to visit|5|||
19451530|NCT01802216|41700529|FG000|12 Month Visit|Participant did not show to visit|3|||
19451531|NCT01802216|41700530|FG001|12 Month Visit|Participant did not show to visit|4|||
19451532|NCT01808144|41700538|FG000|Overall Study|Death|1|||
19451533|NCT01808144|41700539|FG001|Overall Study|Death|0|||
19451534|NCT01808144|41700538|FG000|Overall Study|Withdrawal by Subject|16|||
19451535|NCT01808144|41700539|FG001|Overall Study|Withdrawal by Subject|23|||
19451536|NCT01808144|41700538|FG000|Overall Study|Lost to Follow-up|6|||
19451537|NCT01808144|41700539|FG001|Overall Study|Lost to Follow-up|3|||
19451538|NCT01808144|41700538|FG000|Overall Study|Protocol Violation|6|||
19451539|NCT01808144|41700539|FG001|Overall Study|Protocol Violation|6|||
19451540|NCT01808144|41700538|FG000|Overall Study|Gout flare|0|||
19451541|NCT01808144|41700539|FG001|Overall Study|Gout flare|1|||
19451542|NCT01808144|41700538|FG000|Overall Study|Adverse Event|11|||
19451543|NCT01808144|41700539|FG001|Overall Study|Adverse Event|15|||
19451544|NCT01801982|41700545|FG000|Overall Study|Lost to Follow-up|1|||
19451545|NCT01808066|41700558|FG000|Overall Study|Withdrawal by Subject|15|||
19451546|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
19451547|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
19451548|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
19530772|NCT01079780|41976632|FG000|Overall Study|Never started treatment|1|||
19530773|NCT01079780|41976633|FG001|Overall Study|Never started treatment|0|||
19530774|NCT01079780|41976634|FG002|Overall Study|Never started treatment|2|||
19530775|NCT00075946|41976646|FG000|Overall Study|Path ineligible: undetermined histology|0|||
19530776|NCT00075946|41976647|FG001|Overall Study|Path ineligible: undetermined histology|0|||
19530777|NCT00075946|41976648|FG002|Overall Study|Path ineligible: undetermined histology|0|||
19530778|NCT00075946|41976649|FG003|Overall Study|Path ineligible: undetermined histology|0|||
19530779|NCT00075946|41976650|FG004|Overall Study|Path ineligible: undetermined histology|6|||
19530780|NCT00075946|41976646|FG000|Overall Study|Did not achieve response after induction|0|||
19530781|NCT00075946|41976647|FG001|Overall Study|Did not achieve response after induction|0|||
19530782|NCT00075946|41976648|FG002|Overall Study|Did not achieve response after induction|0|||
19530783|NCT00075946|41976649|FG003|Overall Study|Did not achieve response after induction|0|||
19530784|NCT00075946|41976650|FG004|Overall Study|Did not achieve response after induction|182|||
19530785|NCT00075946|41976646|FG000|Overall Study|Incorrectly randomized (no response)|5|||
19530786|NCT00075946|41976647|FG001|Overall Study|Incorrectly randomized (no response)|5|||
19530787|NCT00075946|41976648|FG002|Overall Study|Incorrectly randomized (no response)|5|||
19530788|NCT00075946|41976649|FG003|Overall Study|Incorrectly randomized (no response)|1|||
19530789|NCT00075946|41976650|FG004|Overall Study|Incorrectly randomized (no response)|0|||
19530790|NCT00075946|41976646|FG000|Overall Study|Still on treatment at time of analysis|52|||
19530791|NCT00075946|41976647|FG001|Overall Study|Still on treatment at time of analysis|19|||
19530792|NCT00075946|41976648|FG002|Overall Study|Still on treatment at time of analysis|3|||
19530793|NCT00075946|41976649|FG003|Overall Study|Still on treatment at time of analysis|9|||
19530794|NCT00075946|41976650|FG004|Overall Study|Still on treatment at time of analysis|0|||
19530795|NCT00075946|41976646|FG000|Overall Study|Adverse Event|2|||
19530796|NCT00075946|41976647|FG001|Overall Study|Adverse Event|10|||
19530797|NCT00075946|41976648|FG002|Overall Study|Adverse Event|0|||
19530798|NCT00075946|41976649|FG003|Overall Study|Adverse Event|2|||
19530799|NCT00075946|41976650|FG004|Overall Study|Adverse Event|0|||
19530800|NCT00075946|41976646|FG000|Overall Study|Death|0|||
19530801|NCT00075946|41976647|FG001|Overall Study|Death|1|||
19530802|NCT00075946|41976648|FG002|Overall Study|Death|0|||
19530803|NCT00075946|41976649|FG003|Overall Study|Death|0|||
19530804|NCT00075946|41976650|FG004|Overall Study|Death|0|||
19530805|NCT00075946|41976646|FG000|Overall Study|Withdrawal by Subject|23|||
19530806|NCT00075946|41976647|FG001|Overall Study|Withdrawal by Subject|58|||
19530807|NCT00075946|41976648|FG002|Overall Study|Withdrawal by Subject|4|||
19451549|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
19530808|NCT00075946|41976649|FG003|Overall Study|Withdrawal by Subject|9|||
19530809|NCT00075946|41976650|FG004|Overall Study|Withdrawal by Subject|0|||
19530810|NCT00075946|41976646|FG000|Overall Study|Alternative therapy|16|||
19530811|NCT00075946|41976647|FG001|Overall Study|Alternative therapy|2|||
19530812|NCT00075946|41976648|FG002|Overall Study|Alternative therapy|5|||
19451550|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
19451551|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
19530813|NCT00075946|41976649|FG003|Overall Study|Alternative therapy|0|||
19530814|NCT00075946|41976650|FG004|Overall Study|Alternative therapy|0|||
19451552|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
19451553|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
19530815|NCT00075946|41976646|FG000|Overall Study|Other complicating disease|7|||
19530816|NCT00075946|41976647|FG001|Overall Study|Other complicating disease|13|||
19530817|NCT00075946|41976648|FG002|Overall Study|Other complicating disease|1|||
19530818|NCT00075946|41976649|FG003|Overall Study|Other complicating disease|4|||
19530819|NCT00075946|41976650|FG004|Overall Study|Other complicating disease|0|||
19530820|NCT00075946|41976646|FG000|Overall Study|No response to retreatment|23|||
19530821|NCT00075946|41976647|FG001|Overall Study|No response to retreatment|0|||
19530822|NCT00075946|41976648|FG002|Overall Study|No response to retreatment|2|||
19530823|NCT00075946|41976649|FG003|Overall Study|No response to retreatment|0|||
19530824|NCT00075946|41976650|FG004|Overall Study|No response to retreatment|0|||
19530825|NCT00075946|41976646|FG000|Overall Study|Time to progression less than 6 months|15|||
19530826|NCT00075946|41976647|FG001|Overall Study|Time to progression less than 6 months|30|||
19530827|NCT00075946|41976648|FG002|Overall Study|Time to progression less than 6 months|8|||
19530828|NCT00075946|41976649|FG003|Overall Study|Time to progression less than 6 months|3|||
19530829|NCT00075946|41976650|FG004|Overall Study|Time to progression less than 6 months|0|||
19530830|NCT00075946|41976646|FG000|Overall Study|Other|5|||
19530831|NCT00075946|41976647|FG001|Overall Study|Other|13|||
19530832|NCT00075946|41976648|FG002|Overall Study|Other|0|||
19530833|NCT00075946|41976649|FG003|Overall Study|Other|2|||
19530834|NCT00075946|41976650|FG004|Overall Study|Other|0|||
19530835|NCT00003641|41976663|FG000|Overall Study|Withdrawal by Subject|0|||
19530836|NCT00003641|41976664|FG001|Overall Study|Withdrawal by Subject|100|||
19530837|NCT00003641|41976663|FG000|Overall Study|Adverse Event|0|||
19530838|NCT00003641|41976664|FG001|Overall Study|Adverse Event|38|||
19530839|NCT00003641|41976663|FG000|Overall Study|Disease progression|0|||
19530840|NCT00003641|41976664|FG001|Overall Study|Disease progression|2|||
19629731|NCT00625378|42079178|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
19629732|NCT00625378|42079177|FG000|Overall Study|Sponsor decision|1|||
19451554|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
19451555|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
19451556|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
19451557|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
19530841|NCT00003641|41976663|FG000|Overall Study|Unknown/missing|0|||
19530842|NCT00003641|41976664|FG001|Overall Study|Unknown/missing|22|||
19629733|NCT00625378|42079178|FG001|Overall Study|Sponsor decision|0|||
19629734|NCT00625378|42079177|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
19629735|NCT00625378|42079178|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
19629736|NCT00625378|42079177|FG000|Overall Study|Switch to commercial drug|6|||
19629737|NCT00625378|42079178|FG001|Overall Study|Switch to commercial drug|1|||
19629738|NCT00625378|42079177|FG000|Overall Study|Missing|2|||
19629739|NCT00625378|42079178|FG001|Overall Study|Missing|0|||
19629740|NCT00625378|42079177|FG000|Overall Study|End of treatment not available|2|||
19629741|NCT00625378|42079178|FG001|Overall Study|End of treatment not available|0|||
19629742|NCT00625378|42079177|FG000|Overall Study|Never treated|2|||
19629743|NCT00625378|42079178|FG001|Overall Study|Never treated|0|||
19629744|NCT00806624|42079187|FG000|Overall Study|Adverse Event|2|||
19629745|NCT00806624|42079188|FG001|Overall Study|Adverse Event|8|||
19629746|NCT00806624|42079189|FG002|Overall Study|Adverse Event|0|||
19629747|NCT00806624|42079187|FG000|Overall Study|Death|0|||
19629748|NCT00806624|42079188|FG001|Overall Study|Death|1|||
19629749|NCT00806624|42079189|FG002|Overall Study|Death|1|||
19629750|NCT00806624|42079187|FG000|Overall Study|Lost to Follow-up|1|||
19629751|NCT00806624|42079188|FG001|Overall Study|Lost to Follow-up|0|||
19629752|NCT00806624|42079189|FG002|Overall Study|Lost to Follow-up|1|||
19629753|NCT00806624|42079187|FG000|Overall Study|Withdrawal by Subject|6|||
19629754|NCT00806624|42079188|FG001|Overall Study|Withdrawal by Subject|3|||
19629755|NCT00806624|42079189|FG002|Overall Study|Withdrawal by Subject|3|||
19629756|NCT00806624|42079187|FG000|Overall Study|discontinued before start of treatment|0|||
19629757|NCT00806624|42079188|FG001|Overall Study|discontinued before start of treatment|0|||
19629758|NCT00806624|42079189|FG002|Overall Study|discontinued before start of treatment|1|||
19629759|NCT00806546|42079197|FG000|Overall Study|Enrolled, not treated|35|||
19629760|NCT00806546|42079197|FG000|Overall Study|Lost to Follow-up|32|||
19629761|NCT00806546|42079197|FG000|Overall Study|Adverse Event|74|||
19629762|NCT00806546|42079197|FG000|Overall Study|Withdrawal by Subject|75|||
19629763|NCT00806546|42079197|FG000|Overall Study|Protocol Violation|49|||
19629764|NCT00806546|42079197|FG000|Overall Study|Various|42|||
19530843|NCT00003641|41976663|FG000|Overall Study|Should not receive interferon therapy|2|||
19629765|NCT00624832|42079205|FG000|Overall Study|Adverse Event|0|||
19629766|NCT00624832|42079206|FG001|Overall Study|Adverse Event|1|||
19530844|NCT00003641|41976664|FG001|Overall Study|Should not receive interferon therapy|0|||
19530845|NCT00003641|41976663|FG000|Overall Study|Never started interferon|567|||
19530846|NCT00003641|41976664|FG001|Overall Study|Never started interferon|12|||
19629767|NCT00624832|42079207|FG002|Overall Study|Adverse Event|0|||
19451558|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
19451559|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
19451560|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
19451561|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Death|5|||
19451562|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Death|0|||
19451563|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Death|2|||
19451564|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Death|0|||
19451565|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Death|4|||
19530847|NCT01956669|41976677|FG000|Overall Study|Disease Progression|12|||
19530848|NCT01956669|41976678|FG001|Overall Study|Disease Progression|7|||
19530849|NCT01956669|41976679|FG002|Overall Study|Disease Progression|7|||
19530850|NCT01956669|41976680|FG003|Overall Study|Disease Progression|8|||
19530851|NCT01956669|41976681|FG004|Overall Study|Disease Progression|4|||
19530852|NCT01956669|41976682|FG005|Overall Study|Disease Progression|3|||
19530853|NCT01956669|41976683|FG006|Overall Study|Disease Progression|5|||
19530854|NCT01956669|41976677|FG000|Overall Study|Adverse Event|0|||
19530855|NCT01956669|41976678|FG001|Overall Study|Adverse Event|2|||
19530856|NCT01956669|41976679|FG002|Overall Study|Adverse Event|2|||
19530857|NCT01956669|41976680|FG003|Overall Study|Adverse Event|1|||
19530858|NCT01956669|41976681|FG004|Overall Study|Adverse Event|0|||
19530859|NCT01956669|41976682|FG005|Overall Study|Adverse Event|0|||
19629768|NCT00624832|42079208|FG003|Overall Study|Adverse Event|1|||
19629769|NCT00624832|42079205|FG000|Overall Study|Abnormal Laboratory Value|2|||
19629770|NCT00624832|42079206|FG001|Overall Study|Abnormal Laboratory Value|0|||
19629771|NCT00624832|42079207|FG002|Overall Study|Abnormal Laboratory Value|0|||
19629772|NCT00624832|42079208|FG003|Overall Study|Abnormal Laboratory Value|0|||
19629773|NCT00633880|42079220|FG000|Open Label Titration|Lack of Efficacy|1|||
19629774|NCT00633880|42079221|FG001|Open Label Titration|Lack of Efficacy|0|||
19629775|NCT00633880|42079222|FG002|Open Label Titration|Lack of Efficacy|0|||
19629776|NCT00633880|42079220|FG000|Open Label Titration|Adverse Event|13|||
19629777|NCT00633880|42079221|FG001|Open Label Titration|Adverse Event|0|||
19629778|NCT00633880|42079222|FG002|Open Label Titration|Adverse Event|0|||
19629779|NCT00633880|42079220|FG000|Open Label Titration|Treatment Failure|55|||
19629780|NCT00633880|42079221|FG001|Open Label Titration|Treatment Failure|0|||
19629781|NCT00633880|42079222|FG002|Open Label Titration|Treatment Failure|0|||
19629782|NCT00633880|42079220|FG000|Open Label Titration|Protocol Violation|6|||
19629783|NCT00633880|42079221|FG001|Open Label Titration|Protocol Violation|0|||
19629784|NCT00633880|42079222|FG002|Open Label Titration|Protocol Violation|0|||
19629785|NCT00633880|42079220|FG000|Open Label Titration|Physician Decision|1|||
19629786|NCT00633880|42079221|FG001|Open Label Titration|Physician Decision|0|||
19629787|NCT00633880|42079222|FG002|Open Label Titration|Physician Decision|0|||
19629788|NCT00633880|42079220|FG000|Open Label Titration|Withdrawal by Subject|4|||
19629789|NCT00633880|42079221|FG001|Open Label Titration|Withdrawal by Subject|0|||
19629790|NCT00633880|42079222|FG002|Open Label Titration|Withdrawal by Subject|0|||
19629791|NCT00590564|42079229|FG000|Overall Study|Withdrawal by Subject|4|||
19629792|NCT00590564|42079229|FG000|Overall Study|Lost to Follow-up|6|||
19629793|NCT00590564|42079229|FG000|Overall Study|Protocol Violation|1|||
19629794|NCT00590564|42079229|FG000|Overall Study|Patient Found to be Ineligible|1|||
19629795|NCT00590564|42079229|FG000|Overall Study|Patient Non-compliance|6|||
19629796|NCT00631696|42079235|FG000|Overall Study|Entered, not randomized to treatment|1|||
19629797|NCT00631696|42079236|FG001|Overall Study|Entered, not randomized to treatment|1|||
19629798|NCT00631696|42079235|FG000|Overall Study|Discontinued after database release date|1|||
19629799|NCT00631696|42079236|FG001|Overall Study|Discontinued after database release date|0|||
19629800|NCT00631696|42079235|FG000|Overall Study|Follow up after database release date|1|||
19629801|NCT00631696|42079236|FG001|Overall Study|Follow up after database release date|0|||
19629802|NCT00631696|42079235|FG000|Overall Study|Lost to Follow-up|7|||
19629803|NCT00631696|42079236|FG001|Overall Study|Lost to Follow-up|10|||
19629804|NCT00631696|42079235|FG000|Overall Study|Withdrawal by Subject|2|||
19629805|NCT00631696|42079236|FG001|Overall Study|Withdrawal by Subject|9|||
19629806|NCT00631696|42079235|FG000|Overall Study|Other|8|||
19629807|NCT00631696|42079236|FG001|Overall Study|Other|8|||
19629808|NCT00631696|42079235|FG000|Overall Study|Protocol Violation|9|||
19451566|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
19451567|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
19530860|NCT01956669|41976683|FG006|Overall Study|Adverse Event|0|||
19530861|NCT01956669|41976677|FG000|Overall Study|Physician Decision|0|||
19530862|NCT01956669|41976678|FG001|Overall Study|Physician Decision|2|||
19629809|NCT00631696|42079236|FG001|Overall Study|Protocol Violation|9|||
19629810|NCT00631696|42079235|FG000|Overall Study|Study terminated by sponsor|3|||
19629811|NCT00631696|42079236|FG001|Overall Study|Study terminated by sponsor|3|||
19629812|NCT00631696|42079235|FG000|Overall Study|Adverse Event|5|||
19629813|NCT00631696|42079236|FG001|Overall Study|Adverse Event|0|||
19629814|NCT00631540|42079242|FG000|Overall Study|Withdrawal by Subject|5|||
19530863|NCT01956669|41976679|FG002|Overall Study|Physician Decision|0|||
19530864|NCT01956669|41976680|FG003|Overall Study|Physician Decision|0|||
19451568|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
19451569|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
19451570|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
19451571|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
19451572|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
19530865|NCT01956669|41976681|FG004|Overall Study|Physician Decision|0|||
19530866|NCT01956669|41976682|FG005|Overall Study|Physician Decision|1|||
19530867|NCT01956669|41976683|FG006|Overall Study|Physician Decision|0|||
19530868|NCT01956669|41976677|FG000|Overall Study|Withdrawal by Subject|0|||
19530869|NCT01956669|41976678|FG001|Overall Study|Withdrawal by Subject|0|||
19530870|NCT01956669|41976679|FG002|Overall Study|Withdrawal by Subject|1|||
19530871|NCT01956669|41976680|FG003|Overall Study|Withdrawal by Subject|1|||
19530872|NCT01956669|41976681|FG004|Overall Study|Withdrawal by Subject|0|||
19451573|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
19451574|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
19451575|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
19451576|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
19451577|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
19451578|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
19451579|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
19451580|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
19451581|NCT01604343|41700566|FG000|Prior to W52 Administration(Through W52)|Other|15|||
19451582|NCT01604343|41700567|FG001|Prior to W52 Administration(Through W52)|Other|0|||
19451583|NCT01604343|41700568|FG002|Prior to W52 Administration(Through W52)|Other|10|||
19451584|NCT01604343|41700569|FG003|Prior to W52 Administration(Through W52)|Other|0|||
19451585|NCT01604343|41700570|FG004|Prior to W52 Administration(Through W52)|Other|6|||
19451586|NCT01604343|41700566|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
19451587|NCT01604343|41700567|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
19451588|NCT01604343|41700568|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
19530873|NCT01956669|41976682|FG005|Overall Study|Withdrawal by Subject|0|||
19530874|NCT01956669|41976683|FG006|Overall Study|Withdrawal by Subject|1|||
19530875|NCT01967823|41976708|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
19530876|NCT01989676|41976718|FG000|Overall Study|Death|52|||
19530877|NCT01989676|41976719|FG001|Overall Study|Death|60|||
19530878|NCT01989676|41976718|FG000|Overall Study|Protocol Violation|2|||
19530879|NCT01989676|41976719|FG001|Overall Study|Protocol Violation|1|||
19530880|NCT01989676|41976718|FG000|Overall Study|Lost to Follow-up|8|||
19530881|NCT01989676|41976719|FG001|Overall Study|Lost to Follow-up|18|||
19530882|NCT01989676|41976718|FG000|Overall Study|No longer willing to participate in study|26|||
19629815|NCT00631540|42079242|FG000|Overall Study|Death|4|||
19629816|NCT00631540|42079242|FG000|Overall Study|Lost to Follow-up|2|||
19629817|NCT00631540|42079242|FG000|Overall Study|Core Lab Data Unavailable|3|||
19629818|NCT00630916|42079246|FG000|Overall Study|Death|110|||
19629819|NCT00630916|42079246|FG000|Overall Study|Explant|8|||
19451589|NCT01604343|41700569|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
19629820|NCT00630916|42079246|FG000|Overall Study|Lost to Follow-up|5|||
19629821|NCT00630916|42079246|FG000|Overall Study|Withdrawal by Subject|30|||
19629822|NCT00630916|42079246|FG000|Overall Study|Protocol Violation|7|||
19629823|NCT00630916|42079246|FG000|Overall Study|Physician Decision|47|||
19629824|NCT00630916|42079246|FG000|Overall Study|Lack of Efficacy|3|||
19629825|NCT00630292|42079250|FG000|Overall Study|Withdrawal by Subject|1|||
19629826|NCT00626548|42079256|FG000|Overall Study|Adverse Event|164|||
19629827|NCT00626548|42079257|FG001|Overall Study|Adverse Event|44|||
19629828|NCT00626548|42079256|FG000|Overall Study|Withdrawal by Subject|42|||
19629829|NCT00626548|42079257|FG001|Overall Study|Withdrawal by Subject|46|||
19629830|NCT00626548|42079256|FG000|Overall Study|Protocol Violation|4|||
19629831|NCT00626548|42079257|FG001|Overall Study|Protocol Violation|11|||
19629832|NCT00626548|42079256|FG000|Overall Study|Lost to Follow-up|2|||
19629833|NCT00626548|42079257|FG001|Overall Study|Lost to Follow-up|2|||
19629834|NCT00626548|42079256|FG000|Overall Study|Other termination reason|493|||
19629835|NCT00626548|42079257|FG001|Overall Study|Other termination reason|613|||
19629836|NCT00847379|42079266|FG000|Overall Study|Study terminated by Sponsor|59|||
19629837|NCT00847379|42079267|FG001|Overall Study|Study terminated by Sponsor|57|||
19629838|NCT00847379|42079268|FG002|Overall Study|Study terminated by Sponsor|57|||
19629839|NCT00847301|42079278|FG000|Overall Study|Adverse Event|35|||
19451590|NCT01604343|41700570|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
19530883|NCT01989676|41976719|FG001|Overall Study|No longer willing to participate in study|26|||
19530884|NCT01989676|41976718|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
19530885|NCT01989676|41976719|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
19629840|NCT00847301|42079278|FG000|Overall Study|Switch to other anticoagulants|16|||
19629841|NCT00847301|42079278|FG000|Overall Study|Lost to Follow-up|1|||
19629842|NCT00847301|42079278|FG000|Overall Study|No prescription after hospital discharge|1|||
19629843|NCT00847301|42079278|FG000|Overall Study|Other reason not defined above|1|||
19451591|NCT01604343|41700566|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
19530886|NCT01989676|41976718|FG000|Overall Study|Other|4|||
19530887|NCT01989676|41976719|FG001|Overall Study|Other|3|||
19530888|NCT02001974|41976729|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
19530889|NCT02001974|41976730|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
19451592|NCT01604343|41700567|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
19451593|NCT01604343|41700568|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
19451594|NCT01604343|41700569|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
19451595|NCT01604343|41700570|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
19451596|NCT01604343|41700566|FG000|Week 52 to Week 104|Adverse Event|0|||
19451597|NCT01604343|41700567|FG001|Week 52 to Week 104|Adverse Event|12|||
19451598|NCT01604343|41700568|FG002|Week 52 to Week 104|Adverse Event|26|||
19530890|NCT02001974|41976731|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
19530891|NCT02001974|41976729|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
19530892|NCT02001974|41976730|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
19530893|NCT02001974|41976731|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
19530894|NCT02001974|41976729|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
19530895|NCT02001974|41976730|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
19451599|NCT01604343|41700569|FG003|Week 52 to Week 104|Adverse Event|21|||
19451600|NCT01604343|41700570|FG004|Week 52 to Week 104|Adverse Event|27|||
19530896|NCT02001974|41976731|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
19530897|NCT02001974|41976729|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
19530898|NCT02001974|41976730|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
19530899|NCT02001974|41976731|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
19530900|NCT04983589|41976741|FG000|Overall Study|Withdrawal by Subject|0|||
19530901|NCT04983589|41976742|FG001|Overall Study|Withdrawal by Subject|3|||
19530902|NCT04983589|41976741|FG000|Overall Study|COVID-19 Infection|1|||
19530903|NCT04983589|41976742|FG001|Overall Study|COVID-19 Infection|0|||
19530904|NCT04983589|41976741|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
19530905|NCT04983589|41976742|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
19530906|NCT04556591|41976762|FG000|Overall Study|Lost to Follow-up|1|||
19451601|NCT01604343|41700566|FG000|Week 52 to Week 104|Death|0|||
19451602|NCT01604343|41700567|FG001|Week 52 to Week 104|Death|4|||
19451603|NCT01604343|41700568|FG002|Week 52 to Week 104|Death|2|||
19451604|NCT01604343|41700569|FG003|Week 52 to Week 104|Death|5|||
19530907|NCT04556591|41976763|FG001|Overall Study|Lost to Follow-up|0|||
19530908|NCT04556591|41976762|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
19530909|NCT04556591|41976763|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
19530910|NCT04428034|41976772|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
19530911|NCT04364984|41976783|FG000|Overall Study|Death|2|||
19530912|NCT04364984|41976784|FG001|Overall Study|Death|2|||
19530913|NCT04364984|41976785|FG002|Overall Study|Death|0|||
19530914|NCT04294095|41976795|FG000|Overall Study|Adverse Event|1|||
19530915|NCT04294095|41976796|FG001|Overall Study|Adverse Event|0|||
19530916|NCT04266028|41976812|FG000|Overall Study|Adverse Event|0|||
19530917|NCT04266028|41976813|FG001|Overall Study|Adverse Event|0|||
19530918|NCT04266028|41976814|FG002|Overall Study|Adverse Event|1|||
19530919|NCT04266028|41976815|FG003|Overall Study|Adverse Event|0|||
19530920|NCT04266028|41976816|FG004|Overall Study|Adverse Event|1|||
19530921|NCT04266028|41976817|FG005|Overall Study|Adverse Event|0|||
19530922|NCT04266028|41976818|FG006|Overall Study|Adverse Event|2|||
19530923|NCT04266028|41976819|FG007|Overall Study|Adverse Event|0|||
19530924|NCT04266028|41976812|FG000|Overall Study|temporary halt of the study|0|||
19530925|NCT04266028|41976813|FG001|Overall Study|temporary halt of the study|0|||
19530926|NCT04266028|41976814|FG002|Overall Study|temporary halt of the study|0|||
19530927|NCT04266028|41976815|FG003|Overall Study|temporary halt of the study|0|||
19530928|NCT04266028|41976816|FG004|Overall Study|temporary halt of the study|0|||
19530929|NCT04266028|41976817|FG005|Overall Study|temporary halt of the study|0|||
19530930|NCT04266028|41976818|FG006|Overall Study|temporary halt of the study|2|||
19530931|NCT04266028|41976819|FG007|Overall Study|temporary halt of the study|1|||
19530932|NCT04266028|41976812|FG000|Overall Study|Onset of birch pollen season|0|||
19530933|NCT04266028|41976813|FG001|Overall Study|Onset of birch pollen season|0|||
19530934|NCT04266028|41976814|FG002|Overall Study|Onset of birch pollen season|0|||
19530935|NCT04266028|41976815|FG003|Overall Study|Onset of birch pollen season|0|||
19530936|NCT04266028|41976816|FG004|Overall Study|Onset of birch pollen season|1|||
19530937|NCT04266028|41976817|FG005|Overall Study|Onset of birch pollen season|0|||
19530938|NCT04266028|41976818|FG006|Overall Study|Onset of birch pollen season|0|||
19530939|NCT04266028|41976819|FG007|Overall Study|Onset of birch pollen season|0|||
19530940|NCT03994731|41976869|FG000|Pegloticase + IMM Period|Death|2|||
19451605|NCT01604343|41700570|FG004|Week 52 to Week 104|Death|0|||
19451606|NCT01604343|41700566|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
19530941|NCT03994731|41976870|FG001|Pegloticase + IMM Period|Death|0|||
19530942|NCT03994731|41976869|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
19530943|NCT03994731|41976870|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
19530944|NCT03994731|41976869|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
19451607|NCT01604343|41700567|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
19451608|NCT01604343|41700568|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
19451609|NCT01604343|41700569|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
19451610|NCT01604343|41700570|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
19451611|NCT01604343|41700566|FG000|Week 52 to Week 104|Physician Decision|0|||
19451612|NCT01604343|41700567|FG001|Week 52 to Week 104|Physician Decision|1|||
19451613|NCT01604343|41700568|FG002|Week 52 to Week 104|Physician Decision|0|||
19451614|NCT01604343|41700569|FG003|Week 52 to Week 104|Physician Decision|0|||
19451615|NCT01604343|41700570|FG004|Week 52 to Week 104|Physician Decision|2|||
19451616|NCT01604343|41700566|FG000|Week 52 to Week 104|Pregnancy|0|||
19451617|NCT01604343|41700567|FG001|Week 52 to Week 104|Pregnancy|0|||
19451618|NCT01604343|41700568|FG002|Week 52 to Week 104|Pregnancy|1|||
19451619|NCT01604343|41700569|FG003|Week 52 to Week 104|Pregnancy|2|||
19451620|NCT01604343|41700570|FG004|Week 52 to Week 104|Pregnancy|1|||
19451621|NCT01604343|41700566|FG000|Week 52 to Week 104|Other|0|||
19451622|NCT01604343|41700567|FG001|Week 52 to Week 104|Other|11|||
19451623|NCT01604343|41700568|FG002|Week 52 to Week 104|Other|11|||
19451624|NCT01604343|41700569|FG003|Week 52 to Week 104|Other|6|||
19451625|NCT01604343|41700570|FG004|Week 52 to Week 104|Other|3|||
19451626|NCT01604343|41700566|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
19451627|NCT01604343|41700567|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
19451628|NCT01604343|41700568|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
19451629|NCT01604343|41700569|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
19451630|NCT01604343|41700570|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
19451631|NCT01604343|41700566|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
19451632|NCT01604343|41700567|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
19451633|NCT01604343|41700568|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
19451634|NCT01604343|41700569|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
19451635|NCT01604343|41700570|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
19451636|NCT01604343|41700566|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
19451637|NCT01604343|41700567|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
19451638|NCT01604343|41700568|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
19451639|NCT01604343|41700569|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
19451640|NCT01604343|41700570|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
19451641|NCT01801436|41700580|FG000|Overall Study|Withdrawal by Subject|3|||
19451642|NCT01801436|41700580|FG000|Overall Study|Adverse Event|2|||
19451643|NCT01801436|41700580|FG000|Overall Study|Progressive disease|4|||
19451644|NCT01771250|41700584|FG000|Period 1|Met exclusion criteria|1|||
19451645|NCT01771250|41700585|FG001|Period 1|Met exclusion criteria|0|||
19451646|NCT01770860|41700591|FG000|Overall Study|Withdrawal by Subject|4|||
19451647|NCT01770860|41700591|FG000|Overall Study|Lost to Follow-up|1|||
19451648|NCT01770860|41700591|FG000|Overall Study|Administrative decision made by the PI|1|||
19451649|NCT01603875|41700602|FG000|Overall Study|Preexisting rabies antibody|3|||
19451650|NCT01603875|41700603|FG001|Overall Study|Preexisting rabies antibody|4|||
19451651|NCT01603875|41700604|FG002|Overall Study|Preexisting rabies antibody|3|||
19451652|NCT01603875|41700602|FG000|Overall Study|Lost to Follow-up|4|||
19451653|NCT01603875|41700603|FG001|Overall Study|Lost to Follow-up|3|||
19451654|NCT01603875|41700604|FG002|Overall Study|Lost to Follow-up|6|||
19451655|NCT01603875|41700602|FG000|Overall Study|Protocol Violation|0|||
19451656|NCT01603875|41700603|FG001|Overall Study|Protocol Violation|1|||
19451657|NCT01603875|41700604|FG002|Overall Study|Protocol Violation|0|||
19451658|NCT01770392|41700612|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
19451659|NCT01603641|41700622|FG000|Overall Study|Did not Receive Treatment|3|||
19451660|NCT01603641|41700622|FG000|Overall Study|Adverse Event|1|||
19451661|NCT01603641|41700622|FG000|Overall Study|Lack of Efficacy|1|||
19451662|NCT01603641|41700622|FG000|Overall Study|Lost to Follow-up|6|||
19451663|NCT01603641|41700622|FG000|Overall Study|Personal Reasons|18|||
19451664|NCT01603641|41700622|FG000|Overall Study|Other Miscellaneous Reasons|6|||
19451665|NCT01556763|41700629|FG000|Overall Study|Withdrawal by Subject|0|||
19451666|NCT01556763|41700630|FG001|Overall Study|Withdrawal by Subject|1|||
19451667|NCT01556763|41700631|FG002|Overall Study|Withdrawal by Subject|0|||
19451668|NCT01576575|41700641|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
19451669|NCT01576575|41700641|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
19451670|NCT01576575|41700641|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
19451671|NCT01555983|41700651|FG000|Overall Study|Withdrawal by Subject|1|||
19451672|NCT01555983|41700652|FG001|Overall Study|Withdrawal by Subject|0|||
19451673|NCT01555983|41700653|FG002|Overall Study|Withdrawal by Subject|0|||
19451674|NCT01555983|41700654|FG003|Overall Study|Withdrawal by Subject|0|||
19451675|NCT01555983|41700655|FG004|Overall Study|Withdrawal by Subject|1|||
19451676|NCT01555983|41700656|FG005|Overall Study|Withdrawal by Subject|1|||
19451677|NCT01576341|41700664|FG000|Overall Study|Withdrawal by Subject|24|||
19451678|NCT01576341|41700664|FG000|Overall Study|Adverse Event|10|||
19451679|NCT01576341|41700664|FG000|Overall Study|Death|21|||
19451680|NCT01576341|41700664|FG000|Overall Study|Physician Decision|2|||
19451681|NCT01576341|41700664|FG000|Overall Study|Lost to Follow-up|2|||
19451682|NCT01576341|41700664|FG000|Overall Study|Kidney transplantation|10|||
19451683|NCT01576341|41700664|FG000|Overall Study|Protocol Violation|12|||
19451684|NCT01576341|41700664|FG000|Overall Study|Other|12|||
19451685|NCT04276090|41700673|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
19451686|NCT04276090|41700674|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
19451687|NCT01892722|41700682|FG000|Overall Study|Protocol deviation|0|||
19451688|NCT01892722|41700683|FG001|Overall Study|Protocol deviation|1|||
19451689|NCT01892722|41700682|FG000|Overall Study|Administrative problems|0|||
19451690|NCT01892722|41700683|FG001|Overall Study|Administrative problems|1|||
19451691|NCT01892722|41700682|FG000|Overall Study|Patient/guardian decision|0|||
19530945|NCT03994731|41976870|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
19530946|NCT03829683|41976894|FG000|Overall Study|Lost to Follow-up|1|||
19530947|NCT03829683|41976895|FG001|Overall Study|Lost to Follow-up|0|||
19530948|NCT03829683|41976894|FG000|Overall Study|Physician Decision|3|||
19530949|NCT03829683|41976895|FG001|Overall Study|Physician Decision|1|||
19530950|NCT03829683|41976894|FG000|Overall Study|Withdrawal by Subject|0|||
19530951|NCT03829683|41976895|FG001|Overall Study|Withdrawal by Subject|1|||
19530952|NCT03829683|41976894|FG000|Overall Study|Discharge from hospital|1|||
19530953|NCT03829683|41976895|FG001|Overall Study|Discharge from hospital|0|||
19530954|NCT03801915|41976904|FG000|Overall Study|Screen failure|0|||
19530955|NCT03801915|41976905|FG001|Overall Study|Screen failure|0|||
19530956|NCT03801915|41976906|FG002|Overall Study|Screen failure|1|||
19530957|NCT03801915|41976904|FG000|Overall Study|Ineligible|1|||
19530958|NCT03801915|41976905|FG001|Overall Study|Ineligible|0|||
19530959|NCT03801915|41976906|FG002|Overall Study|Ineligible|0|||
19530960|NCT03801915|41976904|FG000|Overall Study|Physician Decision|2|||
19530961|NCT03801915|41976905|FG001|Overall Study|Physician Decision|1|||
19530962|NCT03801915|41976906|FG002|Overall Study|Physician Decision|0|||
19530963|NCT03581305|41976920|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
19530964|NCT03581305|41976921|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
19530965|NCT03581305|41976920|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
19530966|NCT03581305|41976921|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
19530967|NCT03581305|41976920|FG000|Serotonergic Study|Withdrawal by Subject|5|||
19530968|NCT03581305|41976921|FG001|Serotonergic Study|Withdrawal by Subject|1|||
19530969|NCT03556202|41976932|FG000|Extension Treatment Period|Adverse Event|18|||
19530970|NCT03556202|41976933|FG001|Extension Treatment Period|Adverse Event|14|||
19530971|NCT03556202|41976934|FG002|Extension Treatment Period|Adverse Event|9|||
19530972|NCT03556202|41976932|FG000|Extension Treatment Period|Death|2|||
19530973|NCT03556202|41976933|FG001|Extension Treatment Period|Death|6|||
19530974|NCT03556202|41976934|FG002|Extension Treatment Period|Death|0|||
19530975|NCT03556202|41976932|FG000|Extension Treatment Period|Lack of Efficacy|5|||
19530976|NCT03556202|41976933|FG001|Extension Treatment Period|Lack of Efficacy|12|||
19530977|NCT03556202|41976934|FG002|Extension Treatment Period|Lack of Efficacy|18|||
19530978|NCT03556202|41976932|FG000|Extension Treatment Period|Lost to Follow-up|9|||
19530979|NCT03556202|41976933|FG001|Extension Treatment Period|Lost to Follow-up|20|||
19530980|NCT03556202|41976934|FG002|Extension Treatment Period|Lost to Follow-up|2|||
19530981|NCT03556202|41976932|FG000|Extension Treatment Period|Pregnancy|2|||
19530982|NCT03556202|41976933|FG001|Extension Treatment Period|Pregnancy|4|||
19530983|NCT03556202|41976934|FG002|Extension Treatment Period|Pregnancy|3|||
19530984|NCT03556202|41976932|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
19530985|NCT03556202|41976933|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
19530986|NCT03556202|41976934|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
19530987|NCT03556202|41976932|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
19530988|NCT03556202|41976933|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
19530989|NCT03556202|41976934|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
19530990|NCT03556202|41976932|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
19530991|NCT03556202|41976933|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
19530992|NCT03556202|41976934|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
19530993|NCT03556202|41976932|FG000|Extension Treatment Period|Physician Decision|0|||
19530994|NCT03556202|41976933|FG001|Extension Treatment Period|Physician Decision|8|||
19530995|NCT03556202|41976934|FG002|Extension Treatment Period|Physician Decision|2|||
19530996|NCT03556202|41976932|FG000|Extension Treatment Period|Protocol Violation|0|||
19451692|NCT01892722|41700683|FG001|Overall Study|Patient/guardian decision|2|||
19451693|NCT01892722|41700682|FG000|Overall Study|Physician Decision|1|||
19451694|NCT01892722|41700683|FG001|Overall Study|Physician Decision|2|||
19451695|NCT01892722|41700682|FG000|Overall Study|Adverse Event|3|||
19451696|NCT01892722|41700683|FG001|Overall Study|Adverse Event|2|||
19451697|NCT01892722|41700682|FG000|Overall Study|Lack of Efficacy|0|||
19451698|NCT01892722|41700683|FG001|Overall Study|Lack of Efficacy|7|||
19451699|NCT01892722|41700682|FG000|Overall Study|Withdrawal by Subject|3|||
19530997|NCT03556202|41976933|FG001|Extension Treatment Period|Protocol Violation|1|||
19530998|NCT03556202|41976934|FG002|Extension Treatment Period|Protocol Violation|1|||
19451700|NCT01892722|41700683|FG001|Overall Study|Withdrawal by Subject|5|||
19451701|NCT01687413|41700700|FG000|Overall Study|Withdrawal by Subject|0|||
19451702|NCT01687413|41700701|FG001|Overall Study|Withdrawal by Subject|2|||
19451703|NCT01687413|41700700|FG000|Overall Study|Not eligible|0|||
19451704|NCT01687413|41700701|FG001|Overall Study|Not eligible|2|||
19451705|NCT01687413|41700700|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
19451706|NCT01687413|41700701|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
19451707|NCT01555671|41700727|FG000|Overall Study|Physician Decision|20|||
19451708|NCT01555671|41700728|FG001|Overall Study|Physician Decision|25|||
19451709|NCT01801358|41700742|FG000|Overall Study|Adverse Event|0|||
19451710|NCT01801358|41700743|FG001|Overall Study|Adverse Event|2|||
19451711|NCT01801358|41700744|FG002|Overall Study|Adverse Event|1|||
19451712|NCT01801358|41700745|FG003|Overall Study|Adverse Event|0|||
19451713|NCT01801358|41700746|FG004|Overall Study|Adverse Event|0|||
19451714|NCT01801358|41700747|FG005|Overall Study|Adverse Event|1|||
19451715|NCT01801358|41700742|FG000|Overall Study|Physician Decision|0|||
19451716|NCT01801358|41700743|FG001|Overall Study|Physician Decision|0|||
19451717|NCT01801358|41700744|FG002|Overall Study|Physician Decision|1|||
19451718|NCT01801358|41700745|FG003|Overall Study|Physician Decision|0|||
19451719|NCT01801358|41700746|FG004|Overall Study|Physician Decision|0|||
19451720|NCT01801358|41700747|FG005|Overall Study|Physician Decision|0|||
19451721|NCT01801358|41700742|FG000|Overall Study|Progressive Disease|6|||
19451722|NCT01801358|41700743|FG001|Overall Study|Progressive Disease|4|||
19530999|NCT03556202|41976932|FG000|Extension Treatment Period|Sponsor Decision|0|||
19531000|NCT03556202|41976933|FG001|Extension Treatment Period|Sponsor Decision|1|||
19531001|NCT03556202|41976934|FG002|Extension Treatment Period|Sponsor Decision|0|||
19531002|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
19531003|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
19531004|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
19531005|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Death|1|||
19531006|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Death|0|||
19531007|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Death|0|||
19531008|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
19531009|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
19531010|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
19531011|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
19531012|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
19531013|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
19531014|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
19531015|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
19531016|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
19531017|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
19531018|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
19531019|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
19531020|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
19531021|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
19531022|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
19531023|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
19531024|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
19531025|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
19531026|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
19531027|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
19531028|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
19531029|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
19531030|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
19531031|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
19531032|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
19531033|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
19531034|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
19531035|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
19531036|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
19531037|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
19531038|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
19531039|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
19531040|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
19451723|NCT01801358|41700744|FG002|Overall Study|Progressive Disease|4|||
19451724|NCT01801358|41700745|FG003|Overall Study|Progressive Disease|5|||
19451725|NCT01801358|41700746|FG004|Overall Study|Progressive Disease|6|||
19451726|NCT01801358|41700747|FG005|Overall Study|Progressive Disease|5|||
19451727|NCT01801358|41700742|FG000|Overall Study|Withdrawal by Subject|0|||
19451728|NCT01801358|41700743|FG001|Overall Study|Withdrawal by Subject|0|||
19531041|NCT03556202|41976932|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
19531042|NCT03556202|41976933|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
19531043|NCT03556202|41976934|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
19531044|NCT03541174|41976948|FG000|Part 1 Double-Blind|Adverse Event|6|||
19531045|NCT03541174|41976949|FG001|Part 1 Double-Blind|Adverse Event|5|||
19531046|NCT03541174|41976950|FG002|Part 1 Double-Blind|Adverse Event|2|||
19531047|NCT03541174|41976951|FG003|Part 1 Double-Blind|Adverse Event|0|||
19531048|NCT03541174|41976952|FG004|Part 1 Double-Blind|Adverse Event|0|||
19531049|NCT03541174|41976953|FG005|Part 1 Double-Blind|Adverse Event|0|||
19531050|NCT03541174|41976948|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
19531051|NCT03541174|41976949|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
19531052|NCT03541174|41976950|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
19531053|NCT03541174|41976951|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
19531054|NCT03541174|41976952|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
19531055|NCT03541174|41976953|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
19531056|NCT03541174|41976948|FG000|Part 1 Double-Blind|Other reasons|3|||
19531057|NCT03541174|41976949|FG001|Part 1 Double-Blind|Other reasons|2|||
19531058|NCT03541174|41976950|FG002|Part 1 Double-Blind|Other reasons|3|||
19531059|NCT03541174|41976951|FG003|Part 1 Double-Blind|Other reasons|0|||
19629844|NCT00624520|42079284|FG000|Overall Study|Withdrawal by Subject|12|||
19451729|NCT01801358|41700744|FG002|Overall Study|Withdrawal by Subject|0|||
19451730|NCT01801358|41700745|FG003|Overall Study|Withdrawal by Subject|1|||
19451731|NCT01801358|41700746|FG004|Overall Study|Withdrawal by Subject|0|||
19451732|NCT01801358|41700747|FG005|Overall Study|Withdrawal by Subject|2|||
19451733|NCT01807598|41700782|FG000|Overall Study|Withdrawal by Subject|4|||
19451734|NCT01807598|41700782|FG000|Overall Study|Adverse Event|1|||
19451735|NCT01807598|41700782|FG000|Overall Study|Other Physician Decision|1|||
19451736|NCT01801280|41700790|FG000|Period 1|Withdrawal by Subject|0|||
19451737|NCT01801280|41700791|FG001|Period 1|Withdrawal by Subject|1|||
19451738|NCT01801280|41700792|FG002|Period 1|Withdrawal by Subject|0|||
19451739|NCT01801280|41700793|FG003|Period 1|Withdrawal by Subject|0|||
19451740|NCT01801280|41700790|FG000|Period 2|Withdrawal by Subject|1|||
19451741|NCT01801280|41700791|FG001|Period 2|Withdrawal by Subject|0|||
19451742|NCT01801280|41700792|FG002|Period 2|Withdrawal by Subject|0|||
19451743|NCT01801280|41700793|FG003|Period 2|Withdrawal by Subject|0|||
19451744|NCT01801280|41700790|FG000|Period 4|Protocol Violation|0|||
19451745|NCT01801280|41700791|FG001|Period 4|Protocol Violation|0|||
19451746|NCT01801280|41700792|FG002|Period 4|Protocol Violation|1|||
19451747|NCT01801280|41700793|FG003|Period 4|Protocol Violation|0|||
19451748|NCT01769456|41700803|FG000|Overall Study|Lost to Follow-up|19|||
19451749|NCT01769456|41700803|FG000|Overall Study|Withdrawal by Subject|3|||
19451750|NCT01769456|41700803|FG000|Overall Study|Did not receive PCC intervention|6|||
19451751|NCT01769456|41700803|FG000|Overall Study|Moved out of the area|3|||
19451752|NCT01769456|41700803|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
19451753|NCT01769456|41700803|FG000|Overall Study|Parental request to youth to withdraw|1|||
19451754|NCT01769378|41700810|FG000|Overall Study|Adverse Event|10|||
19451755|NCT01769378|41700811|FG001|Overall Study|Adverse Event|0|||
19451756|NCT01769378|41700810|FG000|Overall Study|Entry criteria not met|1|||
19451757|NCT01769378|41700811|FG001|Overall Study|Entry criteria not met|0|||
19451758|NCT01769378|41700810|FG000|Overall Study|Protocol Violation|1|||
19451759|NCT01769378|41700811|FG001|Overall Study|Protocol Violation|1|||
19451760|NCT01769378|41700810|FG000|Overall Study|Withdrawal by Subject|10|||
19629845|NCT00624520|42079285|FG001|Overall Study|Withdrawal by Subject|7|||
19629846|NCT00624520|42079284|FG000|Overall Study|Death|0|||
19629847|NCT00624520|42079285|FG001|Overall Study|Death|1|||
19629848|NCT00847145|42079299|FG000|Overall Study|AE or Death|0|||
19629849|NCT00847145|42079300|FG001|Overall Study|AE or Death|1|||
19629850|NCT00847145|42079301|FG002|Overall Study|AE or Death|1|||
19629851|NCT00847145|42079302|FG003|Overall Study|AE or Death|0|||
19629852|NCT00847145|42079303|FG004|Overall Study|AE or Death|0|||
19629853|NCT00847145|42079304|FG005|Overall Study|AE or Death|0|||
19629854|NCT00847145|42079305|FG006|Overall Study|AE or Death|0|||
19451761|NCT01769378|41700811|FG001|Overall Study|Withdrawal by Subject|3|||
19451762|NCT01769378|41700810|FG000|Overall Study|Sponsor Decision|1|||
19451763|NCT01769378|41700811|FG001|Overall Study|Sponsor Decision|0|||
19451764|NCT01769378|41700810|FG000|Overall Study|Lost to Follow-up|2|||
19451765|NCT01769378|41700811|FG001|Overall Study|Lost to Follow-up|0|||
19451766|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
19451767|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
19531060|NCT03541174|41976952|FG004|Part 1 Double-Blind|Other reasons|0|||
19531061|NCT03541174|41976953|FG005|Part 1 Double-Blind|Other reasons|0|||
19531062|NCT03541174|41976948|FG000|Part 2 Single-Blind|Adverse Event|0|||
19531063|NCT03541174|41976949|FG001|Part 2 Single-Blind|Adverse Event|0|||
19629855|NCT00847145|42079306|FG007|Overall Study|AE or Death|0|||
19629856|NCT00847145|42079299|FG000|Overall Study|Withdrawal by Subject|3|||
19629857|NCT00847145|42079300|FG001|Overall Study|Withdrawal by Subject|4|||
19629858|NCT00847145|42079301|FG002|Overall Study|Withdrawal by Subject|6|||
19451768|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
19451769|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
19451770|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
19451771|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
19451772|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
19451773|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
19451774|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
19451775|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
19451776|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
19451777|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
19451778|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
19451779|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
19451780|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451781|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451782|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
19451783|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451784|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451785|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451786|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
19451787|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
19451788|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451789|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451790|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451791|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451792|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451793|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
19451794|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451795|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451796|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
19451797|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451798|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451799|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451800|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
19451801|NCT01807520|41700820|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
19451802|NCT01807520|41700821|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451803|NCT01807520|41700822|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451804|NCT01807520|41700823|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451805|NCT01807520|41700824|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451806|NCT01807520|41700825|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451807|NCT01807520|41700826|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
19451808|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
19451809|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
19451810|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
19451811|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
19451812|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
19451813|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
19451814|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
19451815|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451816|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451817|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451818|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
19451819|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451820|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451821|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
19451822|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
19451823|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19451824|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19531064|NCT03541174|41976950|FG002|Part 2 Single-Blind|Adverse Event|0|||
19531065|NCT03541174|41976951|FG003|Part 2 Single-Blind|Adverse Event|25|||
19531066|NCT03541174|41976952|FG004|Part 2 Single-Blind|Adverse Event|0|||
19531067|NCT03541174|41976953|FG005|Part 2 Single-Blind|Adverse Event|0|||
19531068|NCT03541174|41976948|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
19531069|NCT03541174|41976949|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
19531070|NCT03541174|41976950|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
19531071|NCT03541174|41976951|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
19531072|NCT03541174|41976952|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
19531073|NCT03541174|41976953|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
19531074|NCT03541174|41976948|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
19531075|NCT03541174|41976949|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
19531076|NCT03541174|41976950|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
19531077|NCT03541174|41976951|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
19531078|NCT03541174|41976952|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
19531079|NCT03541174|41976953|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
19531080|NCT03541174|41976948|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
19531081|NCT03541174|41976949|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
19531082|NCT03541174|41976950|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
19531083|NCT03541174|41976951|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
19451825|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19451826|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19451827|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19531084|NCT03541174|41976952|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
19531085|NCT03541174|41976953|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
19531086|NCT03541174|41976948|FG000|Part 2 Single-Blind|Death|0|||
19531087|NCT03541174|41976949|FG001|Part 2 Single-Blind|Death|0|||
19531088|NCT03541174|41976950|FG002|Part 2 Single-Blind|Death|0|||
19531089|NCT03541174|41976951|FG003|Part 2 Single-Blind|Death|5|||
19531090|NCT03541174|41976952|FG004|Part 2 Single-Blind|Death|0|||
19531091|NCT03541174|41976953|FG005|Part 2 Single-Blind|Death|0|||
19531092|NCT03541174|41976948|FG000|Part 2 Single-Blind|Pregnancy|0|||
19531093|NCT03541174|41976949|FG001|Part 2 Single-Blind|Pregnancy|0|||
19531094|NCT03541174|41976950|FG002|Part 2 Single-Blind|Pregnancy|0|||
19531095|NCT03541174|41976951|FG003|Part 2 Single-Blind|Pregnancy|1|||
19531096|NCT03541174|41976952|FG004|Part 2 Single-Blind|Pregnancy|0|||
19531097|NCT03541174|41976953|FG005|Part 2 Single-Blind|Pregnancy|0|||
19531098|NCT03541174|41976948|FG000|Part 2 Single-Blind|Other reasons|0|||
19531099|NCT03541174|41976949|FG001|Part 2 Single-Blind|Other reasons|0|||
19531100|NCT03541174|41976950|FG002|Part 2 Single-Blind|Other reasons|0|||
19531101|NCT03541174|41976951|FG003|Part 2 Single-Blind|Other reasons|32|||
19629859|NCT00847145|42079302|FG003|Overall Study|Withdrawal by Subject|1|||
19629860|NCT00847145|42079303|FG004|Overall Study|Withdrawal by Subject|0|||
19629861|NCT00847145|42079304|FG005|Overall Study|Withdrawal by Subject|0|||
19629862|NCT00847145|42079305|FG006|Overall Study|Withdrawal by Subject|1|||
19629863|NCT00847145|42079306|FG007|Overall Study|Withdrawal by Subject|1|||
19629864|NCT00847145|42079299|FG000|Overall Study|Lost to Follow-up|3|||
19451828|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
19629865|NCT00847145|42079300|FG001|Overall Study|Lost to Follow-up|1|||
19629866|NCT00847145|42079301|FG002|Overall Study|Lost to Follow-up|1|||
19629867|NCT00847145|42079302|FG003|Overall Study|Lost to Follow-up|0|||
19629868|NCT00847145|42079303|FG004|Overall Study|Lost to Follow-up|4|||
19629869|NCT00847145|42079304|FG005|Overall Study|Lost to Follow-up|4|||
19629870|NCT00847145|42079305|FG006|Overall Study|Lost to Follow-up|8|||
19629871|NCT00847145|42079306|FG007|Overall Study|Lost to Follow-up|2|||
19629872|NCT00847145|42079299|FG000|Overall Study|Inappropriate enrollment|0|||
19629873|NCT00847145|42079300|FG001|Overall Study|Inappropriate enrollment|0|||
19629874|NCT00847145|42079301|FG002|Overall Study|Inappropriate enrollment|0|||
19629875|NCT00847145|42079302|FG003|Overall Study|Inappropriate enrollment|0|||
19629876|NCT00847145|42079303|FG004|Overall Study|Inappropriate enrollment|1|||
19629877|NCT00847145|42079304|FG005|Overall Study|Inappropriate enrollment|0|||
19629878|NCT00847145|42079305|FG006|Overall Study|Inappropriate enrollment|0|||
19629879|NCT00847145|42079306|FG007|Overall Study|Inappropriate enrollment|0|||
19629880|NCT00847145|42079299|FG000|Overall Study|Protocol Violation|0|||
19629881|NCT00847145|42079300|FG001|Overall Study|Protocol Violation|0|||
19629882|NCT00847145|42079301|FG002|Overall Study|Protocol Violation|3|||
19629883|NCT00847145|42079302|FG003|Overall Study|Protocol Violation|0|||
19629884|NCT00847145|42079303|FG004|Overall Study|Protocol Violation|1|||
19451829|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451830|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
19451831|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451832|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451833|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451834|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451835|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
19451836|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
19451837|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
19531102|NCT03541174|41976952|FG004|Part 2 Single-Blind|Other reasons|0|||
19531103|NCT03541174|41976953|FG005|Part 2 Single-Blind|Other reasons|0|||
19531104|NCT03541174|41976948|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
19531105|NCT03541174|41976949|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
19531106|NCT03541174|41976950|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
19531107|NCT03541174|41976951|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
19531108|NCT03541174|41976952|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
19531109|NCT03541174|41976953|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
19629885|NCT00847145|42079304|FG005|Overall Study|Protocol Violation|0|||
19629886|NCT00847145|42079305|FG006|Overall Study|Protocol Violation|0|||
19451838|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
19451839|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
19451840|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
19451841|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
19451842|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
19451843|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
19451844|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
19451845|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
19451846|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
19451847|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
19451848|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
19451849|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
19451850|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
19451851|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
19451852|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
19451853|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
19531110|NCT03541174|41976948|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
19531111|NCT03541174|41976949|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
19531112|NCT03541174|41976950|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
19531113|NCT03541174|41976951|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
19531114|NCT03541174|41976952|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
19531115|NCT03541174|41976953|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
19531116|NCT03541174|41976948|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
19531117|NCT03541174|41976949|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
19531118|NCT03541174|41976950|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
19531119|NCT03541174|41976951|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
19451854|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
19451855|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
19451856|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
19451857|NCT01807520|41700820|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
19451858|NCT01807520|41700821|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
19531120|NCT03541174|41976952|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
19531121|NCT03541174|41976953|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
19531122|NCT03541174|41976948|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
19531123|NCT03541174|41976949|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
19531124|NCT03541174|41976950|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
19531125|NCT03541174|41976951|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
19531126|NCT03541174|41976952|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
19531127|NCT03541174|41976953|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
19531128|NCT03541174|41976948|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
19531129|NCT03541174|41976949|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
19531130|NCT03541174|41976950|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
19531131|NCT03541174|41976951|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
19531132|NCT03541174|41976952|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
19531133|NCT03541174|41976953|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
19531134|NCT03459846|41976968|FG000|Overall Study|Death|52|||
19531135|NCT03459846|41976969|FG001|Overall Study|Death|46|||
19531136|NCT03459846|41976968|FG000|Overall Study|Study terminated by sponsor|24|||
19531137|NCT03459846|41976969|FG001|Overall Study|Study terminated by sponsor|28|||
19531138|NCT03459846|41976968|FG000|Overall Study|Withdrawal by Subject|2|||
19531139|NCT03459846|41976969|FG001|Overall Study|Withdrawal by Subject|2|||
19531140|NCT03289039|41977003|FG000|Overall Study|Withdrawal by Subject|0|||
19531141|NCT03289039|41977004|FG001|Overall Study|Withdrawal by Subject|1|||
19531142|NCT03289039|41977003|FG000|Overall Study|Became ineligible prior to treatment start|0|||
19531143|NCT03289039|41977004|FG001|Overall Study|Became ineligible prior to treatment start|1|||
19531144|NCT03289039|41977003|FG000|Overall Study|progressed before treatment start|1|||
19531145|NCT03289039|41977004|FG001|Overall Study|progressed before treatment start|0|||
19531146|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
19451859|NCT01807520|41700822|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
19531147|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
19531148|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
19531149|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
19629887|NCT00847145|42079306|FG007|Overall Study|Protocol Violation|1|||
19451860|NCT01807520|41700823|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
19451861|NCT01807520|41700824|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
19451862|NCT01807520|41700825|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
19451863|NCT01807520|41700826|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
19451864|NCT01807520|41700820|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451865|NCT01807520|41700821|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451866|NCT01807520|41700822|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451867|NCT01807520|41700823|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451868|NCT01807520|41700824|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451869|NCT01807520|41700825|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
19451870|NCT01807520|41700826|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
19451871|NCT01807520|41700820|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19451872|NCT01807520|41700821|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19451873|NCT01807520|41700822|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19451874|NCT01807520|41700823|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19451875|NCT01807520|41700824|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19531150|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
19531151|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
19531152|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
19531153|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
19451876|NCT01807520|41700825|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
19451877|NCT01807520|41700826|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
19451878|NCT01807520|41700820|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
19531154|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Death|0|||
19531155|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Death|1|||
19451879|NCT01807520|41700821|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
19451880|NCT01807520|41700822|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
19451881|NCT01807520|41700823|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
19451882|NCT01807520|41700824|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
19451883|NCT01807520|41700825|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
19451884|NCT01807520|41700826|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
19451885|NCT01806896|41700839|FG000|Overall Study|Adverse Event|2|||
19451886|NCT01806896|41700840|FG001|Overall Study|Adverse Event|0|||
19451887|NCT01806896|41700839|FG000|Overall Study|Other|1|||
19451888|NCT01806896|41700840|FG001|Overall Study|Other|0|||
19451889|NCT01768676|41700848|FG000|Overall Study|Adverse Event|3|||
19451890|NCT01768676|41700849|FG001|Overall Study|Adverse Event|3|||
19531156|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
19531157|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
19531158|NCT03281304|41977012|FG000|Treatment Phase (up to 42 Months)|Other|0|||
19531159|NCT03281304|41977013|FG001|Treatment Phase (up to 42 Months)|Other|2|||
19531160|NCT03281304|41977012|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
19531161|NCT03281304|41977013|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
19531162|NCT03204305|41977022|FG000|Overall Study|Lost to Follow-up|6|||
19531163|NCT03204305|41977023|FG001|Overall Study|Lost to Follow-up|4|||
19531164|NCT03204305|41977024|FG002|Overall Study|Lost to Follow-up|0|||
19531165|NCT03204305|41977025|FG003|Overall Study|Lost to Follow-up|0|||
19531166|NCT03204305|41977022|FG000|Overall Study|Physician Decision|1|||
19531167|NCT03204305|41977023|FG001|Overall Study|Physician Decision|0|||
19531168|NCT03204305|41977024|FG002|Overall Study|Physician Decision|0|||
19531169|NCT03204305|41977025|FG003|Overall Study|Physician Decision|0|||
19531170|NCT03204305|41977022|FG000|Overall Study|failure to place arterial line|2|||
19531171|NCT03204305|41977023|FG001|Overall Study|failure to place arterial line|1|||
19531172|NCT03204305|41977024|FG002|Overall Study|failure to place arterial line|0|||
19531173|NCT03204305|41977025|FG003|Overall Study|failure to place arterial line|0|||
19531174|NCT03204305|41977022|FG000|Overall Study|Withdrawal by Subject|2|||
19531175|NCT03204305|41977023|FG001|Overall Study|Withdrawal by Subject|0|||
19531176|NCT03204305|41977024|FG002|Overall Study|Withdrawal by Subject|0|||
19531177|NCT03204305|41977025|FG003|Overall Study|Withdrawal by Subject|0|||
19531178|NCT03200717|41977037|FG000|Overall Study|Progressive disease|24|||
19531179|NCT03200717|41977038|FG001|Overall Study|Progressive disease|5|||
19531180|NCT03200717|41977037|FG000|Overall Study|Adverse Event|11|||
19531181|NCT03200717|41977038|FG001|Overall Study|Adverse Event|8|||
19531182|NCT03200717|41977037|FG000|Overall Study|Physician Decision|3|||
19531183|NCT03200717|41977038|FG001|Overall Study|Physician Decision|2|||
19531184|NCT03200717|41977037|FG000|Overall Study|Death|2|||
19531185|NCT03200717|41977038|FG001|Overall Study|Death|0|||
19531186|NCT03200717|41977037|FG000|Overall Study|Subject/Guardian Decision|1|||
19531187|NCT03200717|41977038|FG001|Overall Study|Subject/Guardian Decision|0|||
19451891|NCT01768676|41700848|FG000|Overall Study|Lost to Follow-up|13|||
19451892|NCT01768676|41700849|FG001|Overall Study|Lost to Follow-up|16|||
19531188|NCT03105700|41977047|FG000|Overall Study|screen fail|3|||
19531189|NCT03105700|41977047|FG000|Overall Study|Lost to Follow-up|4|||
19531190|NCT02738853|41977081|FG000|Enrollment|Inclusion/Exclusion not met|21|||
19531191|NCT02738853|41977081|FG000|Enrollment|Withdrawal by Subject|3|||
19451893|NCT01768676|41700848|FG000|Overall Study|Protocol Violation|1|||
19451894|NCT01768676|41700849|FG001|Overall Study|Protocol Violation|1|||
19451895|NCT01768676|41700848|FG000|Overall Study|Physician Decision|4|||
19531192|NCT02738853|41977081|FG000|Enrollment|Subject treated with commercially available device|6|||
19531193|NCT02738853|41977081|FG000|Enrollment|Study Enrollment Closed|3|||
19531194|NCT02738853|41977081|FG000|Procedure|Death|1|||
19531195|NCT02738853|41977081|FG000|1 Month|Death|2|||
19531196|NCT02738853|41977081|FG000|6 Month|Death|4|||
19531197|NCT02738853|41977081|FG000|6 Month|Withdrawal by Subject|2|||
19531198|NCT02738853|41977081|FG000|1 Year|Death|6|||
19531199|NCT02738853|41977081|FG000|1 Year|Withdrawal by Subject|1|||
19531200|NCT02738853|41977081|FG000|2 Year|Death|2|||
19451896|NCT01768676|41700849|FG001|Overall Study|Physician Decision|1|||
19451897|NCT01768676|41700848|FG000|Overall Study|Withdrawal by Subject|3|||
19451898|NCT01768676|41700849|FG001|Overall Study|Withdrawal by Subject|10|||
19451899|NCT01555125|41700858|FG000|Induction Period|Lost to Follow-up|0|||
19451900|NCT01555125|41700859|FG001|Induction Period|Lost to Follow-up|2|||
19451901|NCT01555125|41700860|FG002|Induction Period|Lost to Follow-up|0|||
19451902|NCT01555125|41700861|FG003|Induction Period|Lost to Follow-up|0|||
19451903|NCT01555125|41700862|FG004|Induction Period|Lost to Follow-up|0|||
19451904|NCT01555125|41700858|FG000|Induction Period|Adverse Event|0|||
19451905|NCT01555125|41700859|FG001|Induction Period|Adverse Event|1|||
19451906|NCT01555125|41700860|FG002|Induction Period|Adverse Event|0|||
19451907|NCT01555125|41700861|FG003|Induction Period|Adverse Event|0|||
19451908|NCT01555125|41700862|FG004|Induction Period|Adverse Event|1|||
19451909|NCT01555125|41700858|FG000|Induction Period|Subject / guardian decision|0|||
19451910|NCT01555125|41700859|FG001|Induction Period|Subject / guardian decision|0|||
19451911|NCT01555125|41700860|FG002|Induction Period|Subject / guardian decision|0|||
19451912|NCT01555125|41700861|FG003|Induction Period|Subject / guardian decision|0|||
19451913|NCT01555125|41700862|FG004|Induction Period|Subject / guardian decision|2|||
19531201|NCT02738853|41977081|FG000|2 Year|Lost to Follow-up|1|||
19531202|NCT02738853|41977081|FG000|3 Year|Death|2|||
19531203|NCT02738853|41977081|FG000|3 Year|Withdrawal by Subject|1|||
19531204|NCT02738853|41977081|FG000|4 Year|Death|9|||
19531205|NCT02738853|41977081|FG000|5 Year|Lost to Follow-up|4|||
19531206|NCT02358538|41977089|FG000|Through Week 26|Adverse Event|0|||
19531207|NCT02358538|41977090|FG001|Through Week 26|Adverse Event|1|||
19531208|NCT02358538|41977091|FG002|Through Week 26|Adverse Event|1|||
19451914|NCT01555125|41700858|FG000|Induction Period|Death|1|||
19451915|NCT01555125|41700859|FG001|Induction Period|Death|0|||
19451916|NCT01555125|41700860|FG002|Induction Period|Death|0|||
19451917|NCT01555125|41700861|FG003|Induction Period|Death|0|||
19451918|NCT01555125|41700862|FG004|Induction Period|Death|0|||
19451919|NCT01555125|41700858|FG000|Maintenance Period|Adverse Event|1|||
19451920|NCT01555125|41700859|FG001|Maintenance Period|Adverse Event|1|||
19451921|NCT01555125|41700860|FG002|Maintenance Period|Adverse Event|0|||
19451922|NCT01555125|41700861|FG003|Maintenance Period|Adverse Event|0|||
19451923|NCT01555125|41700862|FG004|Maintenance Period|Adverse Event|0|||
19451924|NCT01555125|41700858|FG000|Maintenance Period|Subject / guardian decision|1|||
19451925|NCT01555125|41700859|FG001|Maintenance Period|Subject / guardian decision|2|||
19451926|NCT01555125|41700860|FG002|Maintenance Period|Subject / guardian decision|0|||
19451927|NCT01555125|41700861|FG003|Maintenance Period|Subject / guardian decision|0|||
19451928|NCT01555125|41700862|FG004|Maintenance Period|Subject / guardian decision|0|||
19451929|NCT01555125|41700858|FG000|Maintenance Period|Lost to Follow-up|2|||
19451930|NCT01555125|41700859|FG001|Maintenance Period|Lost to Follow-up|0|||
19451931|NCT01555125|41700860|FG002|Maintenance Period|Lost to Follow-up|0|||
19531209|NCT02358538|41977092|FG003|Through Week 26|Adverse Event|2|||
19531210|NCT02358538|41977089|FG000|Through Week 26|Lack of Efficacy|1|||
19531211|NCT02358538|41977090|FG001|Through Week 26|Lack of Efficacy|1|||
19531212|NCT02358538|41977091|FG002|Through Week 26|Lack of Efficacy|3|||
19531213|NCT02358538|41977092|FG003|Through Week 26|Lack of Efficacy|3|||
19531214|NCT02358538|41977089|FG000|Through Week 26|Withdrawal by Subject|1|||
19451932|NCT01555125|41700861|FG003|Maintenance Period|Lost to Follow-up|1|||
19451933|NCT01555125|41700862|FG004|Maintenance Period|Lost to Follow-up|0|||
19451934|NCT01555125|41700858|FG000|Maintenance Period|Lack of Efficacy|6|||
19451935|NCT01555125|41700859|FG001|Maintenance Period|Lack of Efficacy|1|||
19451936|NCT01555125|41700860|FG002|Maintenance Period|Lack of Efficacy|3|||
19451937|NCT01555125|41700861|FG003|Maintenance Period|Lack of Efficacy|0|||
19451938|NCT01555125|41700862|FG004|Maintenance Period|Lack of Efficacy|0|||
19531215|NCT02358538|41977090|FG001|Through Week 26|Withdrawal by Subject|0|||
19531216|NCT02358538|41977091|FG002|Through Week 26|Withdrawal by Subject|0|||
19531217|NCT02358538|41977092|FG003|Through Week 26|Withdrawal by Subject|0|||
19451939|NCT01555125|41700858|FG000|Maintenance Period|Physician Decision|0|||
19451940|NCT01555125|41700859|FG001|Maintenance Period|Physician Decision|0|||
19451941|NCT01555125|41700860|FG002|Maintenance Period|Physician Decision|1|||
19451942|NCT01555125|41700861|FG003|Maintenance Period|Physician Decision|0|||
19451943|NCT01555125|41700862|FG004|Maintenance Period|Physician Decision|0|||
19531218|NCT02358538|41977089|FG000|Through Week 26|Non-Compliance|0|||
19531219|NCT02358538|41977090|FG001|Through Week 26|Non-Compliance|0|||
19531220|NCT02358538|41977091|FG002|Through Week 26|Non-Compliance|1|||
19531221|NCT02358538|41977092|FG003|Through Week 26|Non-Compliance|0|||
19531222|NCT02358538|41977089|FG000|Through Week 26|Family did not see benefit from IP|1|||
19531223|NCT02358538|41977090|FG001|Through Week 26|Family did not see benefit from IP|0|||
19531224|NCT02358538|41977091|FG002|Through Week 26|Family did not see benefit from IP|0|||
19531225|NCT02358538|41977092|FG003|Through Week 26|Family did not see benefit from IP|0|||
19531226|NCT02358538|41977089|FG000|52 Week Extension Period|Lack of Efficacy|0|||
19531227|NCT02358538|41977090|FG001|52 Week Extension Period|Lack of Efficacy|0|||
19531228|NCT02358538|41977091|FG002|52 Week Extension Period|Lack of Efficacy|2|||
19531229|NCT02358538|41977092|FG003|52 Week Extension Period|Lack of Efficacy|4|||
19531230|NCT02197234|41977125|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
19531231|NCT02197234|41977125|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
19531232|NCT02197234|41977125|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
19531233|NCT02197234|41977125|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
19531234|NCT02197234|41977125|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
19531235|NCT02197234|41977125|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
19531236|NCT02197234|41977125|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
19531237|NCT02157883|41977132|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
19531238|NCT02157883|41977132|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
19531239|NCT02157883|41977132|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
19531240|NCT02157883|41977132|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
19531241|NCT02157883|41977132|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
19531242|NCT02056119|41977141|FG000|Overall Study|Death|1|||
19451944|NCT01555125|41700858|FG000|Maintenance Period|Death|0|||
19451945|NCT01555125|41700859|FG001|Maintenance Period|Death|0|||
19531243|NCT02056119|41977142|FG001|Overall Study|Death|2|||
19531244|NCT02056119|41977141|FG000|Overall Study|Intubated for less than 24 hrs|2|||
19451946|NCT01555125|41700860|FG002|Maintenance Period|Death|0|||
19451947|NCT01555125|41700861|FG003|Maintenance Period|Death|1|||
19451948|NCT01555125|41700862|FG004|Maintenance Period|Death|0|||
19451949|NCT01555125|41700858|FG000|Extension|Adverse Event|1|||
19451950|NCT01555125|41700859|FG001|Extension|Adverse Event|2|||
19451951|NCT01555125|41700860|FG002|Extension|Adverse Event|1|||
19451952|NCT01555125|41700861|FG003|Extension|Adverse Event|1|||
19451953|NCT01555125|41700862|FG004|Extension|Adverse Event|0|||
19451954|NCT01555125|41700858|FG000|Extension|Protocol deviation|1|||
19451955|NCT01555125|41700859|FG001|Extension|Protocol deviation|0|||
19451956|NCT01555125|41700860|FG002|Extension|Protocol deviation|0|||
19451957|NCT01555125|41700861|FG003|Extension|Protocol deviation|0|||
19451958|NCT01555125|41700862|FG004|Extension|Protocol deviation|0|||
19451959|NCT01555125|41700858|FG000|Extension|Lack of Efficacy|7|||
19451960|NCT01555125|41700859|FG001|Extension|Lack of Efficacy|6|||
19451961|NCT01555125|41700860|FG002|Extension|Lack of Efficacy|3|||
19451962|NCT01555125|41700861|FG003|Extension|Lack of Efficacy|0|||
19451963|NCT01555125|41700862|FG004|Extension|Lack of Efficacy|0|||
19451964|NCT01555125|41700858|FG000|Extension|Lost to Follow-up|2|||
19451965|NCT01555125|41700859|FG001|Extension|Lost to Follow-up|1|||
19451966|NCT01555125|41700860|FG002|Extension|Lost to Follow-up|2|||
19451967|NCT01555125|41700861|FG003|Extension|Lost to Follow-up|0|||
19451968|NCT01555125|41700862|FG004|Extension|Lost to Follow-up|0|||
19451969|NCT01555125|41700858|FG000|Extension|Study terminated by sponsor|32|||
19451970|NCT01555125|41700859|FG001|Extension|Study terminated by sponsor|33|||
19451971|NCT01555125|41700860|FG002|Extension|Study terminated by sponsor|16|||
19451972|NCT01555125|41700861|FG003|Extension|Study terminated by sponsor|20|||
19451973|NCT01555125|41700862|FG004|Extension|Study terminated by sponsor|0|||
19451974|NCT01555125|41700858|FG000|Extension|Subject/guardian decision|1|||
19451975|NCT01555125|41700859|FG001|Extension|Subject/guardian decision|9|||
19451976|NCT01555125|41700860|FG002|Extension|Subject/guardian decision|1|||
19451977|NCT01555125|41700861|FG003|Extension|Subject/guardian decision|0|||
19451978|NCT01555125|41700862|FG004|Extension|Subject/guardian decision|0|||
19451979|NCT01555125|41700858|FG000|Extension|Technical Problems|1|||
19451980|NCT01555125|41700859|FG001|Extension|Technical Problems|0|||
19451981|NCT01555125|41700860|FG002|Extension|Technical Problems|0|||
19451982|NCT01555125|41700861|FG003|Extension|Technical Problems|1|||
19451983|NCT01555125|41700862|FG004|Extension|Technical Problems|0|||
19451984|NCT01555125|41700858|FG000|Follow-Up Period|Lost to Follow-up|1|||
19531245|NCT02056119|41977142|FG001|Overall Study|Intubated for less than 24 hrs|7|||
19531246|NCT02056119|41977141|FG000|Overall Study|No aerosol treatments were given.|3|||
19531247|NCT02056119|41977142|FG001|Overall Study|No aerosol treatments were given.|2|||
19531248|NCT02056119|41977141|FG000|Overall Study|Received Metaneb treatment|0|||
19451985|NCT01555125|41700859|FG001|Follow-Up Period|Lost to Follow-up|0|||
19451986|NCT01555125|41700860|FG002|Follow-Up Period|Lost to Follow-up|0|||
19451987|NCT01555125|41700861|FG003|Follow-Up Period|Lost to Follow-up|0|||
19451988|NCT01555125|41700862|FG004|Follow-Up Period|Lost to Follow-up|0|||
19451989|NCT01555125|41700858|FG000|Follow-Up Period|Subject / guardian decision|3|||
19451990|NCT01555125|41700859|FG001|Follow-Up Period|Subject / guardian decision|1|||
19451991|NCT01555125|41700860|FG002|Follow-Up Period|Subject / guardian decision|1|||
19451992|NCT01555125|41700861|FG003|Follow-Up Period|Subject / guardian decision|1|||
19451993|NCT01555125|41700862|FG004|Follow-Up Period|Subject / guardian decision|0|||
19451994|NCT01768286|41700881|FG000|Overall Study|Randomized But Not Treated|0|||
19451995|NCT01768286|41700882|FG001|Overall Study|Randomized But Not Treated|0|||
19451996|NCT01768286|41700883|FG002|Overall Study|Randomized But Not Treated|1|||
19451997|NCT01768286|41700884|FG003|Overall Study|Randomized But Not Treated|0|||
19451998|NCT01768286|41700881|FG000|Overall Study|Lack of Efficacy|7|||
19451999|NCT01768286|41700882|FG001|Overall Study|Lack of Efficacy|4|||
19452000|NCT01768286|41700883|FG002|Overall Study|Lack of Efficacy|0|||
19452001|NCT01768286|41700884|FG003|Overall Study|Lack of Efficacy|1|||
19452002|NCT01768286|41700881|FG000|Overall Study|Withdrew Consent|0|||
19452003|NCT01768286|41700882|FG001|Overall Study|Withdrew Consent|0|||
19452004|NCT01768286|41700883|FG002|Overall Study|Withdrew Consent|1|||
19452005|NCT01768286|41700884|FG003|Overall Study|Withdrew Consent|0|||
19452006|NCT01800968|41700896|FG000|Overall Study|Death|23|||
19452007|NCT01800968|41700897|FG001|Overall Study|Death|16|||
19452008|NCT01800968|41700896|FG000|Overall Study|Lost to Follow-up|5|||
19452009|NCT01800968|41700897|FG001|Overall Study|Lost to Follow-up|7|||
19452010|NCT01800968|41700896|FG000|Overall Study|Withdrawal by Subject|7|||
19452011|NCT01800968|41700897|FG001|Overall Study|Withdrawal by Subject|9|||
19531249|NCT02056119|41977142|FG001|Overall Study|Received Metaneb treatment|2|||
19531250|NCT02056119|41977141|FG000|Overall Study|Protocol Violation|4|||
19531251|NCT02056119|41977142|FG001|Overall Study|Protocol Violation|7|||
19531252|NCT02038452|41977150|FG000|Overall Study|Withdrawal by Subject|7|||
19531253|NCT02038452|41977151|FG001|Overall Study|Withdrawal by Subject|9|||
19531254|NCT02038452|41977150|FG000|Overall Study|Lost to Follow-up|31|||
19531255|NCT02038452|41977151|FG001|Overall Study|Lost to Follow-up|28|||
19531256|NCT01933932|41977163|FG000|Overall Study|Death|173|||
19531257|NCT01933932|41977164|FG001|Overall Study|Death|163|||
19531258|NCT01933932|41977163|FG000|Overall Study|Withdrawal by Subject|11|||
19531259|NCT01933932|41977164|FG001|Overall Study|Withdrawal by Subject|14|||
19531260|NCT01933932|41977163|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19531261|NCT01933932|41977164|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19531262|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
19531263|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
19531264|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
19531265|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
19531266|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
19531267|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
19531268|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
19452012|NCT01800968|41700896|FG000|Overall Study|Physician Decision|1|||
19452013|NCT01800968|41700897|FG001|Overall Study|Physician Decision|0|||
19452014|NCT01799720|41700906|FG000|Overall Study|Withdrawal by Subject|3|||
19452015|NCT01799720|41700907|FG001|Overall Study|Withdrawal by Subject|0|||
19452016|NCT01799720|41700908|FG002|Overall Study|Withdrawal by Subject|0|||
19452017|NCT01799720|41700906|FG000|Overall Study|Protocol Violation|0|||
19452018|NCT01799720|41700907|FG001|Overall Study|Protocol Violation|1|||
19531269|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
19531270|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
19531271|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
19531272|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
19531273|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
19531274|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
19531275|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
19531276|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
19531277|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
19531278|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
19629888|NCT00846521|42079333|FG000|Overall Study|Withdrawal by Subject|5|||
19629889|NCT00846521|42079333|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
19629890|NCT00846521|42079333|FG000|Overall Study|Protocol Violation|1|||
19629891|NCT00862823|42079337|FG000|First Intervention|Withdrawal by Subject|1|||
19629892|NCT00862823|42079338|FG001|First Intervention|Withdrawal by Subject|1|||
19629893|NCT00790842|42079346|FG000|Dose Level 1|Adverse Event|1|||
19629894|NCT00790842|42079347|FG001|Dose Level 1|Adverse Event|0|||
19629895|NCT00790842|42079348|FG002|Dose Level 1|Adverse Event|0|||
19629896|NCT00790842|42079349|FG003|Dose Level 1|Adverse Event|2|||
19629897|NCT00790842|42079350|FG004|Dose Level 1|Adverse Event|0|||
19629898|NCT00790842|42079351|FG005|Dose Level 1|Adverse Event|0|||
19629899|NCT00790842|42079352|FG006|Dose Level 1|Adverse Event|0|||
19629900|NCT00790842|42079353|FG007|Dose Level 1|Adverse Event|1|||
19452019|NCT01799720|41700908|FG002|Overall Study|Protocol Violation|0|||
19452020|NCT01799720|41700906|FG000|Overall Study|Pregnancy|0|||
19629901|NCT00790842|42079354|FG008|Dose Level 1|Adverse Event|0|||
19629902|NCT00790842|42079355|FG009|Dose Level 1|Adverse Event|0|||
19452021|NCT01799720|41700907|FG001|Overall Study|Pregnancy|0|||
19452022|NCT01799720|41700908|FG002|Overall Study|Pregnancy|1|||
19452023|NCT01687257|41700918|FG000|Overall Study|Efficacy Failure|6|||
19531279|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
19531280|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
19531281|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
19531282|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
19531283|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
19531284|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
19629903|NCT00790842|42079356|FG010|Dose Level 1|Adverse Event|0|||
19629904|NCT00790842|42079346|FG000|Dose Level 1|Physician Decision|1|||
19629905|NCT00790842|42079347|FG001|Dose Level 1|Physician Decision|0|||
19629906|NCT00790842|42079348|FG002|Dose Level 1|Physician Decision|0|||
19629907|NCT00790842|42079349|FG003|Dose Level 1|Physician Decision|0|||
19629908|NCT00790842|42079350|FG004|Dose Level 1|Physician Decision|0|||
19629909|NCT00790842|42079351|FG005|Dose Level 1|Physician Decision|0|||
19629910|NCT00790842|42079352|FG006|Dose Level 1|Physician Decision|0|||
19629911|NCT00790842|42079353|FG007|Dose Level 1|Physician Decision|1|||
19629912|NCT00790842|42079354|FG008|Dose Level 1|Physician Decision|0|||
19629913|NCT00790842|42079355|FG009|Dose Level 1|Physician Decision|0|||
19629914|NCT00790842|42079356|FG010|Dose Level 1|Physician Decision|0|||
19629915|NCT00790842|42079346|FG000|Dose Level 1|Withdrawal by Subject|1|||
19629916|NCT00790842|42079347|FG001|Dose Level 1|Withdrawal by Subject|0|||
19629917|NCT00790842|42079348|FG002|Dose Level 1|Withdrawal by Subject|0|||
19629918|NCT00790842|42079349|FG003|Dose Level 1|Withdrawal by Subject|0|||
19452024|NCT01687257|41700919|FG001|Overall Study|Efficacy Failure|0|||
19452025|NCT01687257|41700920|FG002|Overall Study|Efficacy Failure|5|||
19452026|NCT01687257|41700918|FG000|Overall Study|Subject Withdrew Consent|1|||
19452027|NCT01687257|41700919|FG001|Overall Study|Subject Withdrew Consent|1|||
19452028|NCT01687257|41700920|FG002|Overall Study|Subject Withdrew Consent|1|||
19452029|NCT01687257|41700918|FG000|Overall Study|Adverse Event|1|||
19452030|NCT01687257|41700919|FG001|Overall Study|Adverse Event|0|||
19452031|NCT01687257|41700920|FG002|Overall Study|Adverse Event|0|||
19452032|NCT01687257|41700918|FG000|Overall Study|Investigator's Discretion|0|||
19452033|NCT01687257|41700919|FG001|Overall Study|Investigator's Discretion|3|||
19452034|NCT01687257|41700920|FG002|Overall Study|Investigator's Discretion|0|||
19452035|NCT01806740|41700934|FG000|Overall Study|Withdrawal by Subject|4|||
19452036|NCT01806740|41700934|FG000|Overall Study|Physician Decision|1|||
19452037|NCT01806740|41700934|FG000|Overall Study|Patient's refusal of treatment|1|||
19452038|NCT01687101|41700941|FG000|Overall Study|Lost to Follow-up|7|||
19452039|NCT01968967|41700947|FG000|Treatment Period|Other|22|||
19452040|NCT01968967|41700948|FG001|Treatment Period|Other|22|||
19452041|NCT01968967|41700949|FG002|Treatment Period|Other|0|||
19452042|NCT01968967|41700950|FG003|Treatment Period|Other|0|||
19452043|NCT01968967|41700951|FG004|Treatment Period|Other|0|||
19452044|NCT01968967|41700947|FG000|Treatment Period|Withdrawal by Subject|71|||
19452045|NCT01968967|41700948|FG001|Treatment Period|Withdrawal by Subject|61|||
19452046|NCT01968967|41700949|FG002|Treatment Period|Withdrawal by Subject|0|||
19452047|NCT01968967|41700950|FG003|Treatment Period|Withdrawal by Subject|0|||
19452048|NCT01968967|41700951|FG004|Treatment Period|Withdrawal by Subject|0|||
19452049|NCT01968967|41700947|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
19452050|NCT01968967|41700948|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
19452051|NCT01968967|41700949|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
19452052|NCT01968967|41700950|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
19452053|NCT01968967|41700951|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
19452054|NCT01968967|41700947|FG000|Treatment Period|Lost to Follow-up|26|||
19452055|NCT01968967|41700948|FG001|Treatment Period|Lost to Follow-up|31|||
19452056|NCT01968967|41700949|FG002|Treatment Period|Lost to Follow-up|0|||
19452057|NCT01968967|41700950|FG003|Treatment Period|Lost to Follow-up|0|||
19452058|NCT01968967|41700951|FG004|Treatment Period|Lost to Follow-up|0|||
19452059|NCT01968967|41700947|FG000|Treatment Period|Protocol Violation|1|||
19452060|NCT01968967|41700948|FG001|Treatment Period|Protocol Violation|2|||
19452061|NCT01968967|41700949|FG002|Treatment Period|Protocol Violation|0|||
19629919|NCT00790842|42079350|FG004|Dose Level 1|Withdrawal by Subject|0|||
19629920|NCT00790842|42079351|FG005|Dose Level 1|Withdrawal by Subject|0|||
19629921|NCT00790842|42079352|FG006|Dose Level 1|Withdrawal by Subject|0|||
19629922|NCT00790842|42079353|FG007|Dose Level 1|Withdrawal by Subject|0|||
19629923|NCT00790842|42079354|FG008|Dose Level 1|Withdrawal by Subject|0|||
19629924|NCT00790842|42079355|FG009|Dose Level 1|Withdrawal by Subject|0|||
19629925|NCT00790842|42079356|FG010|Dose Level 1|Withdrawal by Subject|0|||
19452062|NCT01968967|41700950|FG003|Treatment Period|Protocol Violation|0|||
19452063|NCT01968967|41700951|FG004|Treatment Period|Protocol Violation|0|||
19452064|NCT01968967|41700947|FG000|Treatment Period|Adverse Event|9|||
19452065|NCT01968967|41700948|FG001|Treatment Period|Adverse Event|8|||
19452066|NCT01968967|41700949|FG002|Treatment Period|Adverse Event|0|||
19452067|NCT01968967|41700950|FG003|Treatment Period|Adverse Event|0|||
19452068|NCT01968967|41700951|FG004|Treatment Period|Adverse Event|0|||
19629926|NCT00790842|42079346|FG000|Dose Level 2|Death|0|||
19629927|NCT00790842|42079347|FG001|Dose Level 2|Death|1|||
19629928|NCT00790842|42079348|FG002|Dose Level 2|Death|0|||
19452069|NCT01968967|41700947|FG000|Treatment Period|Death|9|||
19452070|NCT01968967|41700948|FG001|Treatment Period|Death|2|||
19452071|NCT01968967|41700949|FG002|Treatment Period|Death|0|||
19452072|NCT01968967|41700950|FG003|Treatment Period|Death|0|||
19452073|NCT01968967|41700951|FG004|Treatment Period|Death|0|||
19452074|NCT01968967|41700947|FG000|Treatment Period|Randomized Not Treated|6|||
19452075|NCT01968967|41700948|FG001|Treatment Period|Randomized Not Treated|5|||
19452076|NCT01968967|41700949|FG002|Treatment Period|Randomized Not Treated|0|||
19452077|NCT01968967|41700950|FG003|Treatment Period|Randomized Not Treated|0|||
19452078|NCT01968967|41700951|FG004|Treatment Period|Randomized Not Treated|0|||
19452079|NCT01968967|41700947|FG000|Extension Period|Withdrew Consent|0|||
19452080|NCT01968967|41700948|FG001|Extension Period|Withdrew Consent|0|||
19452081|NCT01968967|41700949|FG002|Extension Period|Withdrew Consent|2|||
19452082|NCT01968967|41700950|FG003|Extension Period|Withdrew Consent|0|||
19452083|NCT01968967|41700951|FG004|Extension Period|Withdrew Consent|5|||
19452084|NCT01554579|41700967|FG000|Overall Study|Adverse Event|6|||
19452085|NCT01554579|41700968|FG001|Overall Study|Adverse Event|25|||
19452086|NCT01554579|41700967|FG000|Overall Study|Lack of Efficacy|2|||
19452087|NCT01554579|41700968|FG001|Overall Study|Lack of Efficacy|1|||
19452088|NCT01554579|41700967|FG000|Overall Study|Withdrawal by Subject|2|||
19452089|NCT01554579|41700968|FG001|Overall Study|Withdrawal by Subject|1|||
19452090|NCT01806662|41700975|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
19452091|NCT01806662|41700976|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
19452092|NCT01806662|41700975|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
19452093|NCT01806662|41700976|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
19452094|NCT01806662|41700975|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
19452095|NCT01806662|41700976|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
19452096|NCT01806662|41700975|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
19452097|NCT01806662|41700976|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
19452098|NCT01930123|41700984|FG000|Overall Study|Adverse Event|1|||
19452099|NCT01930123|41700985|FG001|Overall Study|Adverse Event|0|||
19452100|NCT01930123|41700984|FG000|Overall Study|Physician Decision|21|||
19452101|NCT01930123|41700985|FG001|Overall Study|Physician Decision|8|||
19452102|NCT01930123|41700984|FG000|Overall Study|Withdrawal by Subject|1|||
19452103|NCT01930123|41700985|FG001|Overall Study|Withdrawal by Subject|0|||
19452104|NCT01930045|41700991|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
19452105|NCT01930045|41700992|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
19452106|NCT01930045|41700993|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
19452107|NCT01930045|41700994|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
19452108|NCT01930045|41700995|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
19452109|NCT01930045|41700996|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
19452110|NCT01930045|41700991|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
19629929|NCT00790842|42079349|FG003|Dose Level 2|Death|0|||
19629930|NCT00790842|42079350|FG004|Dose Level 2|Death|1|||
19629931|NCT00790842|42079351|FG005|Dose Level 2|Death|0|||
19629932|NCT00790842|42079352|FG006|Dose Level 2|Death|0|||
19531285|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
19629933|NCT00790842|42079353|FG007|Dose Level 2|Death|0|||
19629934|NCT00790842|42079354|FG008|Dose Level 2|Death|0|||
19531286|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
19531287|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
19531288|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
19531289|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
19531290|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
19531291|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
19531292|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
19531293|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
19531294|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
19531295|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
19531296|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
19531297|NCT01898494|41977174|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
19531298|NCT01898494|41977175|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
19531299|NCT01898494|41977176|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
19629935|NCT00790842|42079355|FG009|Dose Level 2|Death|0|||
19629936|NCT00790842|42079356|FG010|Dose Level 2|Death|0|||
19629937|NCT00790842|42079346|FG000|Dose Level 2|Physician Decision|0|||
19452111|NCT01930045|41700992|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
19452112|NCT01930045|41700993|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
19452113|NCT01930045|41700994|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
19452114|NCT01930045|41700995|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
19629938|NCT00790842|42079347|FG001|Dose Level 2|Physician Decision|1|||
19452115|NCT01930045|41700996|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
19452116|NCT01929343|41701011|FG000|Overall Study|Physician Decision|0|||
19452117|NCT01929343|41701012|FG001|Overall Study|Physician Decision|2|||
19629939|NCT00790842|42079348|FG002|Dose Level 2|Physician Decision|0|||
19452118|NCT01929343|41701013|FG002|Overall Study|Physician Decision|0|||
19452119|NCT01929343|41701011|FG000|Overall Study|Withdrawal by Subject|1|||
19452120|NCT01929343|41701012|FG001|Overall Study|Withdrawal by Subject|0|||
19452121|NCT01929343|41701013|FG002|Overall Study|Withdrawal by Subject|0|||
19452122|NCT01968811|41701021|FG000|Overall Study|Protocol Violation|4|||
19452123|NCT01968811|41701021|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
19452124|NCT01806584|41701027|FG000|Overall Study|Adverse Event|2|||
19452125|NCT01806584|41701028|FG001|Overall Study|Adverse Event|1|||
19452126|NCT01806584|41701027|FG000|Overall Study|Death|1|||
19452127|NCT01806584|41701028|FG001|Overall Study|Death|0|||
19452128|NCT01806584|41701027|FG000|Overall Study|Lost to Follow-up|0|||
19452129|NCT01806584|41701028|FG001|Overall Study|Lost to Follow-up|2|||
19452130|NCT01806584|41701027|FG000|Overall Study|Study terminated by sponsor|9|||
19452131|NCT01806584|41701028|FG001|Overall Study|Study terminated by sponsor|14|||
19452132|NCT01806584|41701027|FG000|Overall Study|Withdrawal by Subject|1|||
19452133|NCT01806584|41701028|FG001|Overall Study|Withdrawal by Subject|1|||
19452134|NCT01806584|41701027|FG000|Overall Study|Other unspecified|1|||
19452135|NCT01806584|41701028|FG001|Overall Study|Other unspecified|0|||
19452136|NCT01798706|41701036|FG000|Overall Study|Adverse Event|15|||
19452137|NCT01798706|41701037|FG001|Overall Study|Adverse Event|10|||
19452138|NCT01798706|41701036|FG000|Overall Study|Lack of Efficacy|0|||
19452139|NCT01798706|41701037|FG001|Overall Study|Lack of Efficacy|2|||
19452140|NCT01798706|41701036|FG000|Overall Study|Poor compliance to protocol|1|||
19452141|NCT01798706|41701037|FG001|Overall Study|Poor compliance to protocol|0|||
19452142|NCT01798706|41701036|FG000|Overall Study|Other than specified above|5|||
19452143|NCT01798706|41701037|FG001|Overall Study|Other than specified above|9|||
19452144|NCT01767194|41701045|FG000|Overall Study|Adverse Event|1|||
19452145|NCT01767194|41701046|FG001|Overall Study|Adverse Event|1|||
19452146|NCT01767194|41701045|FG000|Overall Study|Death|0|||
19452147|NCT01767194|41701046|FG001|Overall Study|Death|1|||
19452148|NCT01767194|41701045|FG000|Overall Study|Lack of Efficacy|12|||
19452149|NCT01767194|41701046|FG001|Overall Study|Lack of Efficacy|11|||
19452150|NCT01767194|41701045|FG000|Overall Study|Physician Decision|2|||
19452151|NCT01767194|41701046|FG001|Overall Study|Physician Decision|23|||
19452152|NCT01767194|41701045|FG000|Overall Study|Withdrawal by Subject|0|||
19452153|NCT01767194|41701046|FG001|Overall Study|Withdrawal by Subject|1|||
19452154|NCT01767194|41701045|FG000|Overall Study|Ineligible|1|||
19452155|NCT01767194|41701046|FG001|Overall Study|Ineligible|1|||
19452156|NCT01767194|41701045|FG000|Overall Study|Refusal by patient/parent|2|||
19452157|NCT01767194|41701046|FG001|Overall Study|Refusal by patient/parent|4|||
19452158|NCT01767194|41701045|FG000|Overall Study|Criteria not met on time for next cycle|0|||
19452159|NCT01767194|41701046|FG001|Overall Study|Criteria not met on time for next cycle|1|||
19452160|NCT01575873|41701057|FG000|Overall Study|Withdrawal by Subject|15|||
19452161|NCT01575873|41701058|FG001|Overall Study|Withdrawal by Subject|20|||
19452162|NCT01575873|41701059|FG002|Overall Study|Withdrawal by Subject|34|||
19452163|NCT01575873|41701060|FG003|Overall Study|Withdrawal by Subject|34|||
19452164|NCT01575873|41701057|FG000|Overall Study|Adverse Event|7|||
19452165|NCT01575873|41701058|FG001|Overall Study|Adverse Event|7|||
19452166|NCT01575873|41701059|FG002|Overall Study|Adverse Event|9|||
19452167|NCT01575873|41701060|FG003|Overall Study|Adverse Event|12|||
19452168|NCT01575873|41701057|FG000|Overall Study|Lost to Follow-up|1|||
19452169|NCT01575873|41701058|FG001|Overall Study|Lost to Follow-up|3|||
19531300|NCT01898494|41977177|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
19531301|NCT01898494|41977178|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
19629940|NCT00790842|42079349|FG003|Dose Level 2|Physician Decision|0|||
19629941|NCT00790842|42079350|FG004|Dose Level 2|Physician Decision|0|||
19629942|NCT00790842|42079351|FG005|Dose Level 2|Physician Decision|0|||
19629943|NCT00790842|42079352|FG006|Dose Level 2|Physician Decision|0|||
19629944|NCT00790842|42079353|FG007|Dose Level 2|Physician Decision|0|||
19629945|NCT00790842|42079354|FG008|Dose Level 2|Physician Decision|0|||
19629946|NCT00790842|42079355|FG009|Dose Level 2|Physician Decision|0|||
19629947|NCT00790842|42079356|FG010|Dose Level 2|Physician Decision|0|||
19629948|NCT00790842|42079346|FG000|Dose Level 2|Withdrawal by Subject|0|||
19629949|NCT00790842|42079347|FG001|Dose Level 2|Withdrawal by Subject|1|||
19452170|NCT01575873|41701059|FG002|Overall Study|Lost to Follow-up|13|||
19452171|NCT01575873|41701060|FG003|Overall Study|Lost to Follow-up|5|||
19452172|NCT01575873|41701057|FG000|Overall Study|Death|3|||
19452173|NCT01575873|41701058|FG001|Overall Study|Death|2|||
19452174|NCT01575873|41701059|FG002|Overall Study|Death|8|||
19452175|NCT01575873|41701060|FG003|Overall Study|Death|9|||
19452176|NCT01575873|41701057|FG000|Overall Study|Noncompliance|1|||
19452177|NCT01575873|41701058|FG001|Overall Study|Noncompliance|2|||
19629950|NCT00790842|42079348|FG002|Dose Level 2|Withdrawal by Subject|0|||
19452178|NCT01575873|41701059|FG002|Overall Study|Noncompliance|4|||
19452179|NCT01575873|41701060|FG003|Overall Study|Noncompliance|3|||
19629951|NCT00790842|42079349|FG003|Dose Level 2|Withdrawal by Subject|0|||
19629952|NCT00790842|42079350|FG004|Dose Level 2|Withdrawal by Subject|0|||
19452180|NCT01575873|41701057|FG000|Overall Study|Administrative decision|1|||
19531302|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
19531303|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
19531304|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
19531305|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
19531306|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
19531307|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
19531308|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
19531309|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
19531310|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
19531311|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
19531312|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
19531313|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
19531314|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
19531315|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
19531316|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
19531317|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
19452181|NCT01575873|41701058|FG001|Overall Study|Administrative decision|1|||
19452182|NCT01575873|41701059|FG002|Overall Study|Administrative decision|1|||
19452183|NCT01575873|41701060|FG003|Overall Study|Administrative decision|0|||
19452184|NCT01575873|41701057|FG000|Overall Study|Protocol deviation|0|||
19452185|NCT01575873|41701058|FG001|Overall Study|Protocol deviation|1|||
19452186|NCT01575873|41701059|FG002|Overall Study|Protocol deviation|0|||
19452187|NCT01575873|41701060|FG003|Overall Study|Protocol deviation|1|||
19452188|NCT01575873|41701057|FG000|Overall Study|Requirement for Alternative Therapy|0|||
19452189|NCT01575873|41701058|FG001|Overall Study|Requirement for Alternative Therapy|0|||
19531318|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
19531319|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
19531320|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
19531321|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
19531322|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
19531323|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
19531324|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
19531325|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
19531326|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
19531327|NCT01898494|41977174|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
19531328|NCT01898494|41977175|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
19531329|NCT01898494|41977176|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
19531330|NCT01898494|41977177|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
19531331|NCT01898494|41977178|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
19531332|NCT01238172|41977219|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
19531333|NCT01238172|41977220|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
19452190|NCT01575873|41701059|FG002|Overall Study|Requirement for Alternative Therapy|1|||
19452191|NCT01575873|41701060|FG003|Overall Study|Requirement for Alternative Therapy|1|||
19452192|NCT01575873|41701057|FG000|Overall Study|Other|0|||
19531334|NCT01238172|41977219|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
19531335|NCT01238172|41977220|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
19531336|NCT00967005|41977228|FG000|Overall Study|Lost to Follow-up|7|||
19531337|NCT00967005|41977229|FG001|Overall Study|Lost to Follow-up|10|||
19629953|NCT00790842|42079351|FG005|Dose Level 2|Withdrawal by Subject|0|||
19629954|NCT00790842|42079352|FG006|Dose Level 2|Withdrawal by Subject|0|||
19629955|NCT00790842|42079353|FG007|Dose Level 2|Withdrawal by Subject|0|||
19629956|NCT00790842|42079354|FG008|Dose Level 2|Withdrawal by Subject|0|||
19629957|NCT00790842|42079355|FG009|Dose Level 2|Withdrawal by Subject|0|||
19629958|NCT00790842|42079356|FG010|Dose Level 2|Withdrawal by Subject|0|||
19629959|NCT00790842|42079346|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629960|NCT00790842|42079347|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629961|NCT00790842|42079348|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629962|NCT00790842|42079349|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629963|NCT00790842|42079350|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629964|NCT00790842|42079351|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629965|NCT00790842|42079352|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19452193|NCT01575873|41701058|FG001|Overall Study|Other|0|||
19452194|NCT01575873|41701059|FG002|Overall Study|Other|4|||
19531338|NCT00203996|41977287|FG000|Overall Study|Lost to Follow-up|0|||
19531339|NCT00203996|41977288|FG001|Overall Study|Lost to Follow-up|0|||
19531340|NCT00203996|41977289|FG002|Overall Study|Lost to Follow-up|0|||
19531341|NCT00203996|41977290|FG003|Overall Study|Lost to Follow-up|1|||
19531342|NCT00203996|41977291|FG004|Overall Study|Lost to Follow-up|0|||
19531343|NCT00203996|41977292|FG005|Overall Study|Lost to Follow-up|0|||
19531344|NCT00203996|41977293|FG006|Overall Study|Lost to Follow-up|0|||
19531345|NCT00203996|41977294|FG007|Overall Study|Lost to Follow-up|0|||
19629966|NCT00790842|42079353|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629967|NCT00790842|42079354|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
19452195|NCT01575873|41701060|FG003|Overall Study|Other|2|||
19452196|NCT01575561|41701068|FG000|Overall Study|Adverse Event|9|||
19452197|NCT01575561|41701068|FG000|Overall Study|Lack of Efficacy|8|||
19531346|NCT00203996|41977295|FG008|Overall Study|Lost to Follow-up|0|||
19531347|NCT00203996|41977296|FG009|Overall Study|Lost to Follow-up|0|||
19531348|NCT00203996|41977287|FG000|Overall Study|Protocol Violation|0|||
19531349|NCT00203996|41977288|FG001|Overall Study|Protocol Violation|0|||
19531350|NCT00203996|41977289|FG002|Overall Study|Protocol Violation|0|||
19531351|NCT00203996|41977290|FG003|Overall Study|Protocol Violation|6|||
19531352|NCT00203996|41977291|FG004|Overall Study|Protocol Violation|1|||
19531353|NCT00203996|41977292|FG005|Overall Study|Protocol Violation|0|||
19531354|NCT00203996|41977293|FG006|Overall Study|Protocol Violation|0|||
19531355|NCT00203996|41977294|FG007|Overall Study|Protocol Violation|0|||
19531356|NCT00203996|41977295|FG008|Overall Study|Protocol Violation|0|||
19531357|NCT00203996|41977296|FG009|Overall Study|Protocol Violation|0|||
19531358|NCT00203996|41977287|FG000|Overall Study|Physician Decision|0|||
19531359|NCT00203996|41977288|FG001|Overall Study|Physician Decision|0|||
19531360|NCT00203996|41977289|FG002|Overall Study|Physician Decision|0|||
19531361|NCT00203996|41977290|FG003|Overall Study|Physician Decision|2|||
19531362|NCT00203996|41977291|FG004|Overall Study|Physician Decision|0|||
19531363|NCT00203996|41977292|FG005|Overall Study|Physician Decision|0|||
19452198|NCT01575561|41701068|FG000|Overall Study|Lost to Follow-up|6|||
19452199|NCT01575561|41701068|FG000|Overall Study|Protocol Violation|4|||
19452200|NCT01575561|41701068|FG000|Overall Study|Withdrawal by Subject|11|||
19452201|NCT01575561|41701068|FG000|Overall Study|administration|1|||
19452202|NCT01609790|41701075|FG000|Overall Study|Protocol Violation|1|||
19452203|NCT01609790|41701076|FG001|Overall Study|Protocol Violation|7|||
19452204|NCT01609790|41701077|FG002|Overall Study|Protocol Violation|8|||
19452205|NCT01767116|41701087|FG000|Overall Study|Lost to Follow-up|2|||
19531364|NCT00203996|41977293|FG006|Overall Study|Physician Decision|0|||
19531365|NCT00203996|41977294|FG007|Overall Study|Physician Decision|0|||
19531366|NCT00203996|41977295|FG008|Overall Study|Physician Decision|0|||
19531367|NCT00203996|41977296|FG009|Overall Study|Physician Decision|1|||
19531368|NCT00203996|41977287|FG000|Overall Study|CPAP machine malfunction|0|||
19531369|NCT00203996|41977288|FG001|Overall Study|CPAP machine malfunction|0|||
19531370|NCT00203996|41977289|FG002|Overall Study|CPAP machine malfunction|0|||
19531371|NCT00203996|41977290|FG003|Overall Study|CPAP machine malfunction|1|||
19531372|NCT00203996|41977291|FG004|Overall Study|CPAP machine malfunction|0|||
19531373|NCT00203996|41977292|FG005|Overall Study|CPAP machine malfunction|0|||
19531374|NCT00203996|41977293|FG006|Overall Study|CPAP machine malfunction|0|||
19531375|NCT00203996|41977294|FG007|Overall Study|CPAP machine malfunction|0|||
19531376|NCT00203996|41977295|FG008|Overall Study|CPAP machine malfunction|0|||
19531377|NCT00203996|41977296|FG009|Overall Study|CPAP machine malfunction|0|||
19531378|NCT00203996|41977287|FG000|Overall Study|Scheduling issue|0|||
19531379|NCT00203996|41977288|FG001|Overall Study|Scheduling issue|0|||
19531380|NCT00203996|41977289|FG002|Overall Study|Scheduling issue|0|||
19452206|NCT01767116|41701088|FG001|Overall Study|Lost to Follow-up|2|||
19531381|NCT00203996|41977290|FG003|Overall Study|Scheduling issue|0|||
19452207|NCT01574703|41701098|FG000|Overall Study|Adverse Event|0|||
19452208|NCT01574703|41701099|FG001|Overall Study|Adverse Event|2|||
19452209|NCT01574703|41701100|FG002|Overall Study|Adverse Event|1|||
19452210|NCT01574703|41701101|FG003|Overall Study|Adverse Event|1|||
19452211|NCT01574703|41701098|FG000|Overall Study|Protocol Violation|0|||
19452212|NCT01574703|41701099|FG001|Overall Study|Protocol Violation|0|||
19452213|NCT01574703|41701100|FG002|Overall Study|Protocol Violation|0|||
19452214|NCT01574703|41701101|FG003|Overall Study|Protocol Violation|1|||
19452215|NCT01574703|41701098|FG000|Overall Study|Unspecified Reason|27|||
19452216|NCT01574703|41701099|FG001|Overall Study|Unspecified Reason|15|||
19452217|NCT01574703|41701100|FG002|Overall Study|Unspecified Reason|20|||
19452218|NCT01574703|41701101|FG003|Overall Study|Unspecified Reason|16|||
19452219|NCT01574703|41701098|FG000|Overall Study|Withdrawal by Subject|53|||
19452220|NCT01574703|41701099|FG001|Overall Study|Withdrawal by Subject|52|||
19452221|NCT01574703|41701100|FG002|Overall Study|Withdrawal by Subject|36|||
19452222|NCT01574703|41701101|FG003|Overall Study|Withdrawal by Subject|61|||
19452223|NCT01574703|41701098|FG000|Overall Study|Met Withdrawal Criteria|0|||
19452224|NCT01574703|41701099|FG001|Overall Study|Met Withdrawal Criteria|1|||
19531382|NCT00203996|41977291|FG004|Overall Study|Scheduling issue|0|||
19531383|NCT00203996|41977292|FG005|Overall Study|Scheduling issue|0|||
19531384|NCT00203996|41977293|FG006|Overall Study|Scheduling issue|0|||
19531385|NCT00203996|41977294|FG007|Overall Study|Scheduling issue|2|||
19531386|NCT00203996|41977295|FG008|Overall Study|Scheduling issue|0|||
19531387|NCT00203996|41977296|FG009|Overall Study|Scheduling issue|0|||
19452225|NCT01574703|41701100|FG002|Overall Study|Met Withdrawal Criteria|1|||
19531388|NCT00099437|41977314|FG000|Overall Study|Lost to Follow-up|30|||
19531389|NCT00099437|41977315|FG001|Overall Study|Lost to Follow-up|33|||
19531390|NCT00099437|41977314|FG000|Overall Study|Death|293|||
19452226|NCT01574703|41701101|FG003|Overall Study|Met Withdrawal Criteria|0|||
19452227|NCT01574703|41701098|FG000|Overall Study|Lost to Follow-up|43|||
19531391|NCT00099437|41977315|FG001|Overall Study|Death|261|||
19531392|NCT00099437|41977314|FG000|Overall Study|Withdrawal by Subject|6|||
19531393|NCT00099437|41977315|FG001|Overall Study|Withdrawal by Subject|10|||
19531394|NCT00099437|41977314|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
19531395|NCT00099437|41977315|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
19531396|NCT02014558|41977334|FG000|Overall Study|Never Received Study Drug|0|||
19531397|NCT02014558|41977335|FG001|Overall Study|Never Received Study Drug|0|||
19531398|NCT02014558|41977336|FG002|Overall Study|Never Received Study Drug|0|||
19531399|NCT02014558|41977337|FG003|Overall Study|Never Received Study Drug|0|||
19531400|NCT02014558|41977338|FG004|Overall Study|Never Received Study Drug|1|||
19531401|NCT02014558|41977339|FG005|Overall Study|Never Received Study Drug|0|||
19531402|NCT02014558|41977340|FG006|Overall Study|Never Received Study Drug|1|||
19531403|NCT02014558|41977341|FG007|Overall Study|Never Received Study Drug|0|||
19531404|NCT02014558|41977342|FG008|Overall Study|Never Received Study Drug|2|||
19531405|NCT02014558|41977343|FG009|Overall Study|Never Received Study Drug|0|||
19531406|NCT02014558|41977344|FG010|Overall Study|Never Received Study Drug|2|||
19531407|NCT02014558|41977345|FG011|Overall Study|Never Received Study Drug|2|||
19531408|NCT02014558|41977346|FG012|Overall Study|Never Received Study Drug|0|||
19531409|NCT02014558|41977334|FG000|Overall Study|Adverse Event|0|||
19531410|NCT02014558|41977335|FG001|Overall Study|Adverse Event|0|||
19531411|NCT02014558|41977336|FG002|Overall Study|Adverse Event|0|||
19531412|NCT02014558|41977337|FG003|Overall Study|Adverse Event|0|||
19531413|NCT02014558|41977338|FG004|Overall Study|Adverse Event|1|||
19531414|NCT02014558|41977339|FG005|Overall Study|Adverse Event|0|||
19531415|NCT02014558|41977340|FG006|Overall Study|Adverse Event|0|||
19531416|NCT02014558|41977341|FG007|Overall Study|Adverse Event|0|||
19531417|NCT02014558|41977342|FG008|Overall Study|Adverse Event|2|||
19531418|NCT02014558|41977343|FG009|Overall Study|Adverse Event|2|||
19531419|NCT02014558|41977344|FG010|Overall Study|Adverse Event|5|||
19531420|NCT02014558|41977345|FG011|Overall Study|Adverse Event|21|||
19531421|NCT02014558|41977346|FG012|Overall Study|Adverse Event|3|||
19531422|NCT02014558|41977334|FG000|Overall Study|Death|1|||
19531423|NCT02014558|41977335|FG001|Overall Study|Death|0|||
19531424|NCT02014558|41977336|FG002|Overall Study|Death|0|||
19531425|NCT02014558|41977337|FG003|Overall Study|Death|0|||
19629968|NCT00790842|42079355|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629969|NCT00790842|42079356|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
19629970|NCT00790842|42079346|FG000|Dose Level 3|Adverse Event|0|||
19629971|NCT00790842|42079347|FG001|Dose Level 3|Adverse Event|0|||
19629972|NCT00790842|42079348|FG002|Dose Level 3|Adverse Event|1|||
19629973|NCT00790842|42079349|FG003|Dose Level 3|Adverse Event|0|||
19629974|NCT00790842|42079350|FG004|Dose Level 3|Adverse Event|0|||
19629975|NCT00790842|42079351|FG005|Dose Level 3|Adverse Event|0|||
19629976|NCT00790842|42079352|FG006|Dose Level 3|Adverse Event|0|||
19629977|NCT00790842|42079353|FG007|Dose Level 3|Adverse Event|0|||
19629978|NCT00790842|42079354|FG008|Dose Level 3|Adverse Event|0|||
19629979|NCT00790842|42079355|FG009|Dose Level 3|Adverse Event|0|||
19711395|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
19711396|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
19711397|NCT03569098|42154515|FG000|Double-Blind Treatment Cycle 1|Other|1|||
19711398|NCT03569098|42154516|FG001|Double-Blind Treatment Cycle 1|Other|0|||
19711399|NCT03569098|42154517|FG002|Double-Blind Treatment Cycle 1|Other|1|||
19711400|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
19711401|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
19711402|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
19711403|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
19711404|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
19711405|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
19711406|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
19711407|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
19711408|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
19711409|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
19711410|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
19711411|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
19711412|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
19531426|NCT02014558|41977338|FG004|Overall Study|Death|0|||
19531427|NCT02014558|41977339|FG005|Overall Study|Death|0|||
19531428|NCT02014558|41977340|FG006|Overall Study|Death|1|||
19531429|NCT02014558|41977341|FG007|Overall Study|Death|1|||
19531430|NCT02014558|41977342|FG008|Overall Study|Death|2|||
19531431|NCT02014558|41977343|FG009|Overall Study|Death|5|||
19531432|NCT02014558|41977344|FG010|Overall Study|Death|5|||
19531433|NCT02014558|41977345|FG011|Overall Study|Death|19|||
19531434|NCT02014558|41977346|FG012|Overall Study|Death|2|||
19629980|NCT00790842|42079356|FG010|Dose Level 3|Adverse Event|0|||
19629981|NCT00790842|42079346|FG000|Dose Level 3|Withdrawal by Subject|0|||
19531435|NCT02014558|41977334|FG000|Overall Study|Lack of Efficacy|1|||
19531436|NCT02014558|41977335|FG001|Overall Study|Lack of Efficacy|2|||
19531437|NCT02014558|41977336|FG002|Overall Study|Lack of Efficacy|1|||
19531438|NCT02014558|41977337|FG003|Overall Study|Lack of Efficacy|1|||
19531439|NCT02014558|41977338|FG004|Overall Study|Lack of Efficacy|0|||
19531440|NCT02014558|41977339|FG005|Overall Study|Lack of Efficacy|0|||
19531441|NCT02014558|41977340|FG006|Overall Study|Lack of Efficacy|1|||
19531442|NCT02014558|41977341|FG007|Overall Study|Lack of Efficacy|3|||
19531443|NCT02014558|41977342|FG008|Overall Study|Lack of Efficacy|3|||
19452228|NCT01574703|41701099|FG001|Overall Study|Lost to Follow-up|41|||
19452229|NCT01574703|41701100|FG002|Overall Study|Lost to Follow-up|46|||
19452230|NCT01574703|41701101|FG003|Overall Study|Lost to Follow-up|35|||
19452231|NCT01574703|41701098|FG000|Overall Study|Death|2|||
19452232|NCT01574703|41701099|FG001|Overall Study|Death|1|||
19452233|NCT01574703|41701100|FG002|Overall Study|Death|1|||
19452234|NCT01574703|41701101|FG003|Overall Study|Death|0|||
19452235|NCT01686633|41701114|FG000|Overall Study|Lack of Efficacy|33|||
19452236|NCT01686633|41701115|FG001|Overall Study|Lack of Efficacy|13|||
19452237|NCT01686633|41701116|FG002|Overall Study|Lack of Efficacy|11|||
19452238|NCT01686633|41701114|FG000|Overall Study|Withdrawal by Subject|8|||
19531444|NCT02014558|41977343|FG009|Overall Study|Lack of Efficacy|3|||
19531445|NCT02014558|41977344|FG010|Overall Study|Lack of Efficacy|16|||
19531446|NCT02014558|41977345|FG011|Overall Study|Lack of Efficacy|8|||
19531447|NCT02014558|41977346|FG012|Overall Study|Lack of Efficacy|5|||
19531448|NCT02014558|41977334|FG000|Overall Study|Lost to Follow-up|0|||
19531449|NCT02014558|41977335|FG001|Overall Study|Lost to Follow-up|0|||
19531450|NCT02014558|41977336|FG002|Overall Study|Lost to Follow-up|0|||
19531451|NCT02014558|41977337|FG003|Overall Study|Lost to Follow-up|0|||
19531452|NCT02014558|41977338|FG004|Overall Study|Lost to Follow-up|0|||
19531453|NCT02014558|41977339|FG005|Overall Study|Lost to Follow-up|0|||
19531454|NCT02014558|41977340|FG006|Overall Study|Lost to Follow-up|0|||
19531455|NCT02014558|41977341|FG007|Overall Study|Lost to Follow-up|0|||
19531456|NCT02014558|41977342|FG008|Overall Study|Lost to Follow-up|0|||
19531457|NCT02014558|41977343|FG009|Overall Study|Lost to Follow-up|0|||
19531458|NCT02014558|41977344|FG010|Overall Study|Lost to Follow-up|1|||
19531459|NCT02014558|41977345|FG011|Overall Study|Lost to Follow-up|0|||
19531460|NCT02014558|41977346|FG012|Overall Study|Lost to Follow-up|0|||
19531461|NCT02014558|41977334|FG000|Overall Study|Progressive Disease|1|||
19531462|NCT02014558|41977335|FG001|Overall Study|Progressive Disease|0|||
19531463|NCT02014558|41977336|FG002|Overall Study|Progressive Disease|1|||
19531464|NCT02014558|41977337|FG003|Overall Study|Progressive Disease|1|||
19531465|NCT02014558|41977338|FG004|Overall Study|Progressive Disease|1|||
19531466|NCT02014558|41977339|FG005|Overall Study|Progressive Disease|2|||
19531467|NCT02014558|41977340|FG006|Overall Study|Progressive Disease|1|||
19531468|NCT02014558|41977341|FG007|Overall Study|Progressive Disease|6|||
19531469|NCT02014558|41977342|FG008|Overall Study|Progressive Disease|5|||
19531470|NCT02014558|41977343|FG009|Overall Study|Progressive Disease|6|||
19531471|NCT02014558|41977344|FG010|Overall Study|Progressive Disease|22|||
19531472|NCT02014558|41977345|FG011|Overall Study|Progressive Disease|31|||
19531473|NCT02014558|41977346|FG012|Overall Study|Progressive Disease|6|||
19531474|NCT02014558|41977334|FG000|Overall Study|Withdrawal by Subject|0|||
19531475|NCT02014558|41977335|FG001|Overall Study|Withdrawal by Subject|0|||
19531476|NCT02014558|41977336|FG002|Overall Study|Withdrawal by Subject|0|||
19531477|NCT02014558|41977337|FG003|Overall Study|Withdrawal by Subject|0|||
19531478|NCT02014558|41977338|FG004|Overall Study|Withdrawal by Subject|1|||
19531479|NCT02014558|41977339|FG005|Overall Study|Withdrawal by Subject|0|||
19531480|NCT02014558|41977340|FG006|Overall Study|Withdrawal by Subject|0|||
19531481|NCT02014558|41977341|FG007|Overall Study|Withdrawal by Subject|0|||
19531482|NCT02014558|41977342|FG008|Overall Study|Withdrawal by Subject|0|||
19531483|NCT02014558|41977343|FG009|Overall Study|Withdrawal by Subject|2|||
19531484|NCT02014558|41977344|FG010|Overall Study|Withdrawal by Subject|6|||
19531485|NCT02014558|41977345|FG011|Overall Study|Withdrawal by Subject|10|||
19711413|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
19711414|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
19531486|NCT02014558|41977346|FG012|Overall Study|Withdrawal by Subject|0|||
19531487|NCT02014558|41977334|FG000|Overall Study|Miscellaneous|2|||
19531488|NCT02014558|41977335|FG001|Overall Study|Miscellaneous|1|||
19531489|NCT02014558|41977336|FG002|Overall Study|Miscellaneous|1|||
19531490|NCT02014558|41977337|FG003|Overall Study|Miscellaneous|1|||
19531491|NCT02014558|41977338|FG004|Overall Study|Miscellaneous|0|||
19531492|NCT02014558|41977339|FG005|Overall Study|Miscellaneous|1|||
19531493|NCT02014558|41977340|FG006|Overall Study|Miscellaneous|0|||
19531494|NCT02014558|41977341|FG007|Overall Study|Miscellaneous|1|||
19531495|NCT02014558|41977342|FG008|Overall Study|Miscellaneous|1|||
19531496|NCT02014558|41977343|FG009|Overall Study|Miscellaneous|3|||
19531497|NCT02014558|41977344|FG010|Overall Study|Miscellaneous|12|||
19531498|NCT02014558|41977345|FG011|Overall Study|Miscellaneous|11|||
19711415|NCT03569098|42154515|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
19452239|NCT01686633|41701115|FG001|Overall Study|Withdrawal by Subject|8|||
19452240|NCT01686633|41701116|FG002|Overall Study|Withdrawal by Subject|5|||
19531499|NCT02014558|41977346|FG012|Overall Study|Miscellaneous|1|||
19531500|NCT02024555|41977401|FG000|Overall Study|Lost to Follow-up|1|||
19531501|NCT02024555|41977402|FG001|Overall Study|Lost to Follow-up|1|||
19531502|NCT02024555|41977401|FG000|Overall Study|Withdrawal by Subject|5|||
19531503|NCT02024555|41977402|FG001|Overall Study|Withdrawal by Subject|1|||
19531504|NCT02040584|41977410|FG000|Overall Study|Adverse Event|13|||
19531505|NCT02040584|41977411|FG001|Overall Study|Adverse Event|6|||
19531506|NCT02040584|41977410|FG000|Overall Study|Protocol Violation|9|||
19531507|NCT02040584|41977411|FG001|Overall Study|Protocol Violation|11|||
19531508|NCT02040584|41977410|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19531509|NCT02040584|41977411|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19531510|NCT02040584|41977410|FG000|Overall Study|Death|6|||
19531511|NCT02040584|41977411|FG001|Overall Study|Death|3|||
19531512|NCT02040584|41977410|FG000|Overall Study|Transplant rejection/retransplant|0|||
19531513|NCT02040584|41977411|FG001|Overall Study|Transplant rejection/retransplant|1|||
19531514|NCT02040584|41977410|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
19531515|NCT02040584|41977411|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
19531516|NCT02045797|41977430|FG000|Overall Study|Adverse Event|3|||
19531517|NCT02045797|41977431|FG001|Overall Study|Adverse Event|1|||
19452241|NCT01686633|41701114|FG000|Overall Study|Physician Decision|3|||
19452242|NCT01686633|41701115|FG001|Overall Study|Physician Decision|4|||
19452243|NCT01686633|41701116|FG002|Overall Study|Physician Decision|4|||
19452244|NCT01686633|41701114|FG000|Overall Study|Adverse Event|4|||
19452245|NCT01686633|41701115|FG001|Overall Study|Adverse Event|3|||
19452246|NCT01686633|41701116|FG002|Overall Study|Adverse Event|3|||
19452247|NCT01686633|41701114|FG000|Overall Study|Protocol Violation|2|||
19452248|NCT01686633|41701115|FG001|Overall Study|Protocol Violation|3|||
19452249|NCT01686633|41701116|FG002|Overall Study|Protocol Violation|0|||
19452250|NCT01686633|41701114|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
19452251|NCT01686633|41701115|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
19452252|NCT01686633|41701116|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
19452253|NCT01686633|41701114|FG000|Overall Study|Lost to Follow-up|0|||
19452254|NCT01686633|41701115|FG001|Overall Study|Lost to Follow-up|1|||
19452255|NCT01686633|41701116|FG002|Overall Study|Lost to Follow-up|1|||
19452256|NCT02511106|41701126|FG000|Overall Study|Lost to Follow-up|1|||
19452257|NCT02511106|41701127|FG001|Overall Study|Lost to Follow-up|2|||
19452258|NCT02511106|41701126|FG000|Overall Study|Withdrawal by Subject|19|||
19452259|NCT02511106|41701127|FG001|Overall Study|Withdrawal by Subject|14|||
19452260|NCT02511106|41701126|FG000|Overall Study|Ongoing study at data cut-off|309|||
19452261|NCT02511106|41701127|FG001|Overall Study|Ongoing study at data cut-off|307|||
19452262|NCT02511106|41701126|FG000|Overall Study|Without specified reason|1|||
19452263|NCT02511106|41701127|FG001|Overall Study|Without specified reason|0|||
19452264|NCT02511106|41701126|FG000|Overall Study|Missing|1|||
19452265|NCT02511106|41701127|FG001|Overall Study|Missing|0|||
19452266|NCT01685697|41701137|FG000|Overall Study|Protocol Violation|3|||
19452267|NCT01685697|41701138|FG001|Overall Study|Protocol Violation|3|||
19452268|NCT02395120|41701149|FG000|Overall Study|Missed follow-up dental exam|57|||
19531518|NCT02045797|41977432|FG002|Overall Study|Adverse Event|0|||
19531519|NCT02045797|41977430|FG000|Overall Study|Lack of Efficacy|1|||
19531520|NCT02045797|41977431|FG001|Overall Study|Lack of Efficacy|0|||
19531521|NCT02045797|41977432|FG002|Overall Study|Lack of Efficacy|0|||
19531522|NCT02045797|41977430|FG000|Overall Study|Lost to Follow-up|2|||
19531523|NCT02045797|41977431|FG001|Overall Study|Lost to Follow-up|3|||
19531524|NCT02045797|41977432|FG002|Overall Study|Lost to Follow-up|1|||
19531525|NCT02045797|41977430|FG000|Overall Study|Physician Decision|0|||
19531526|NCT02045797|41977431|FG001|Overall Study|Physician Decision|1|||
19531527|NCT02045797|41977432|FG002|Overall Study|Physician Decision|0|||
19531528|NCT02045797|41977430|FG000|Overall Study|Withdrawal by Subject|1|||
19531529|NCT02045797|41977431|FG001|Overall Study|Withdrawal by Subject|2|||
19452269|NCT02395120|41701150|FG001|Overall Study|Missed follow-up dental exam|62|||
19531530|NCT02045797|41977432|FG002|Overall Study|Withdrawal by Subject|0|||
19531531|NCT03385239|41977462|FG000|Overall Study|Voluntary Withdrawal|2|||
19531532|NCT03385239|41977463|FG001|Overall Study|Voluntary Withdrawal|3|||
19531533|NCT03385239|41977464|FG002|Overall Study|Voluntary Withdrawal|2|||
19531534|NCT03385239|41977465|FG003|Overall Study|Voluntary Withdrawal|3|||
19531535|NCT03385239|41977466|FG004|Overall Study|Voluntary Withdrawal|0|||
19531536|NCT03385239|41977462|FG000|Overall Study|Adverse Event|0|||
19531537|NCT03385239|41977463|FG001|Overall Study|Adverse Event|0|||
19452270|NCT02395120|41701151|FG002|Overall Study|Missed follow-up dental exam|6|||
19452271|NCT02395120|41701152|FG003|Overall Study|Missed follow-up dental exam|6|||
19452272|NCT02395120|41701153|FG004|Overall Study|Missed follow-up dental exam|51|||
19452273|NCT01685229|41701167|FG000|Overall Study|Subjects missing Study Exit form|3|||
19452274|NCT01685229|41701168|FG001|Overall Study|Subjects missing Study Exit form|1|||
19452275|NCT01685229|41701167|FG000|Overall Study|Lost to Follow-up|16|||
19452276|NCT01685229|41701168|FG001|Overall Study|Lost to Follow-up|10|||
19452277|NCT01685229|41701167|FG000|Overall Study|Withdrawal by Subject|6|||
19452278|NCT01685229|41701168|FG001|Overall Study|Withdrawal by Subject|5|||
19452279|NCT01685229|41701167|FG000|Overall Study|Death|1|||
19531538|NCT03385239|41977464|FG002|Overall Study|Adverse Event|1|||
19531539|NCT03385239|41977465|FG003|Overall Study|Adverse Event|0|||
19452280|NCT01685229|41701168|FG001|Overall Study|Death|0|||
19531540|NCT03385239|41977466|FG004|Overall Study|Adverse Event|0|||
19531541|NCT03385239|41977462|FG000|Overall Study|Other|0|||
19531542|NCT03385239|41977463|FG001|Overall Study|Other|0|||
19531543|NCT03385239|41977464|FG002|Overall Study|Other|0|||
19531544|NCT03385239|41977465|FG003|Overall Study|Other|1|||
19531545|NCT03385239|41977466|FG004|Overall Study|Other|0|||
19531546|NCT03020160|41977484|FG000|Overall Study|Withdrawal by Subject|1|||
19531547|NCT03020160|41977485|FG001|Overall Study|Withdrawal by Subject|0|||
19452281|NCT01551693|41701179|FG000|Overall Study|Disease Progression|1|||
19452282|NCT01551693|41701180|FG001|Overall Study|Disease Progression|0|||
19452283|NCT01551693|41701179|FG000|Overall Study|Adverse Event|0|||
19452284|NCT01551693|41701180|FG001|Overall Study|Adverse Event|1|||
19452285|NCT01551693|41701179|FG000|Overall Study|Withdrawal by Subject|0|||
19452286|NCT01551693|41701180|FG001|Overall Study|Withdrawal by Subject|1|||
19452287|NCT01574157|41701188|FG000|Overall Study|Withdrawal by Subject|4|||
19452288|NCT01574157|41701189|FG001|Overall Study|Withdrawal by Subject|5|||
19452289|NCT01574157|41701188|FG000|Overall Study|Lost to Follow-up|0|||
19531548|NCT02593110|41977496|FG000|Overall Study|Withdrawal by Subject|0|||
19531549|NCT02593110|41977497|FG001|Overall Study|Withdrawal by Subject|3|||
19531550|NCT02593110|41977498|FG002|Overall Study|Withdrawal by Subject|3|||
19531551|NCT02593110|41977499|FG003|Overall Study|Withdrawal by Subject|2|||
19531552|NCT02593110|41977496|FG000|Overall Study|Death|0|||
19531553|NCT02593110|41977497|FG001|Overall Study|Death|0|||
19531554|NCT02593110|41977498|FG002|Overall Study|Death|1|||
19531555|NCT02593110|41977499|FG003|Overall Study|Death|0|||
19531556|NCT02373813|41977512|FG000|Run-In Period|Other, Not Specified|5|||
19531557|NCT02373813|41977513|FG001|Run-In Period|Other, Not Specified|0|||
19531558|NCT02373813|41977514|FG002|Run-In Period|Other, Not Specified|0|||
19531559|NCT02373813|41977515|FG003|Run-In Period|Other, Not Specified|0|||
19531560|NCT02373813|41977512|FG000|Run-In Period|Withdrawal by Subject|16|||
19531561|NCT02373813|41977513|FG001|Run-In Period|Withdrawal by Subject|0|||
19531562|NCT02373813|41977514|FG002|Run-In Period|Withdrawal by Subject|0|||
19531563|NCT02373813|41977515|FG003|Run-In Period|Withdrawal by Subject|0|||
19531564|NCT02373813|41977512|FG000|Run-In Period|Decision by Sponsor|11|||
19531565|NCT02373813|41977513|FG001|Run-In Period|Decision by Sponsor|0|||
19531566|NCT02373813|41977514|FG002|Run-In Period|Decision by Sponsor|0|||
19531567|NCT02373813|41977515|FG003|Run-In Period|Decision by Sponsor|0|||
19531568|NCT02373813|41977512|FG000|Run-In Period|Protocol Violation|75|||
19531569|NCT02373813|41977513|FG001|Run-In Period|Protocol Violation|0|||
19452290|NCT01574157|41701189|FG001|Overall Study|Lost to Follow-up|3|||
19452291|NCT01574079|41701201|FG000|Overall Study|Physician Decision|0|||
19452292|NCT01574079|41701202|FG001|Overall Study|Physician Decision|2|||
19452293|NCT01574079|41701201|FG000|Overall Study|Lost to Follow-up|1|||
19452294|NCT01574079|41701202|FG001|Overall Study|Lost to Follow-up|0|||
19531570|NCT02373813|41977514|FG002|Run-In Period|Protocol Violation|0|||
19531571|NCT02373813|41977515|FG003|Run-In Period|Protocol Violation|0|||
19531572|NCT02373813|41977512|FG000|Run-In Period|Lost to Follow-up|2|||
19629982|NCT00790842|42079347|FG001|Dose Level 3|Withdrawal by Subject|0|||
19629983|NCT00790842|42079348|FG002|Dose Level 3|Withdrawal by Subject|3|||
19629984|NCT00790842|42079349|FG003|Dose Level 3|Withdrawal by Subject|0|||
19629985|NCT00790842|42079350|FG004|Dose Level 3|Withdrawal by Subject|0|||
19629986|NCT00790842|42079351|FG005|Dose Level 3|Withdrawal by Subject|0|||
19629987|NCT00790842|42079352|FG006|Dose Level 3|Withdrawal by Subject|0|||
19629988|NCT00790842|42079353|FG007|Dose Level 3|Withdrawal by Subject|0|||
19629989|NCT00790842|42079354|FG008|Dose Level 3|Withdrawal by Subject|0|||
19629990|NCT00790842|42079355|FG009|Dose Level 3|Withdrawal by Subject|2|||
19629991|NCT00790842|42079356|FG010|Dose Level 3|Withdrawal by Subject|0|||
19629992|NCT00790842|42079346|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19629993|NCT00790842|42079347|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19629994|NCT00790842|42079348|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19629995|NCT00790842|42079349|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19629996|NCT00790842|42079350|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19531573|NCT02373813|41977513|FG001|Run-In Period|Lost to Follow-up|0|||
19531574|NCT02373813|41977514|FG002|Run-In Period|Lost to Follow-up|0|||
19531575|NCT02373813|41977515|FG003|Run-In Period|Lost to Follow-up|0|||
19531576|NCT02373813|41977512|FG000|Run-In Period|Adverse Event|3|||
19531577|NCT02373813|41977513|FG001|Run-In Period|Adverse Event|0|||
19531578|NCT02373813|41977514|FG002|Run-In Period|Adverse Event|0|||
19531579|NCT02373813|41977515|FG003|Run-In Period|Adverse Event|0|||
19629997|NCT00790842|42079351|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
19629998|NCT00790842|42079352|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19452295|NCT01573767|41701212|FG000|Overall Study|Adverse Event|0|||
19452296|NCT01573767|41701213|FG001|Overall Study|Adverse Event|1|||
19452297|NCT01573767|41701214|FG002|Overall Study|Adverse Event|0|||
19531580|NCT02373813|41977512|FG000|Run-In Period|Noncompliance|1|||
19531581|NCT02373813|41977513|FG001|Run-In Period|Noncompliance|0|||
19531582|NCT02373813|41977514|FG002|Run-In Period|Noncompliance|0|||
19629999|NCT00790842|42079353|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19630000|NCT00790842|42079354|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19630001|NCT00790842|42079355|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19630002|NCT00790842|42079356|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
19630003|NCT00790842|42079346|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630004|NCT00790842|42079347|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630005|NCT00790842|42079348|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
19630006|NCT00790842|42079349|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630007|NCT00790842|42079350|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630008|NCT00790842|42079351|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630009|NCT00790842|42079352|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630010|NCT00790842|42079353|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630011|NCT00790842|42079354|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630012|NCT00790842|42079355|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630013|NCT00790842|42079356|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
19630014|NCT00790842|42079346|FG000|Dose Level 4|Adverse Event|0|||
19630015|NCT00790842|42079347|FG001|Dose Level 4|Adverse Event|0|||
19630016|NCT00790842|42079348|FG002|Dose Level 4|Adverse Event|0|||
19630017|NCT00790842|42079349|FG003|Dose Level 4|Adverse Event|0|||
19630018|NCT00790842|42079350|FG004|Dose Level 4|Adverse Event|0|||
19630019|NCT00790842|42079351|FG005|Dose Level 4|Adverse Event|0|||
19630020|NCT00790842|42079352|FG006|Dose Level 4|Adverse Event|1|||
19452298|NCT01573767|41701215|FG003|Overall Study|Adverse Event|1|||
19452299|NCT01573767|41701212|FG000|Overall Study|Lack of Efficacy|18|||
19452300|NCT01573767|41701213|FG001|Overall Study|Lack of Efficacy|15|||
19452301|NCT01573767|41701214|FG002|Overall Study|Lack of Efficacy|12|||
19452302|NCT01573767|41701215|FG003|Overall Study|Lack of Efficacy|17|||
19452303|NCT01573767|41701212|FG000|Overall Study|Protocol Violation|3|||
19452304|NCT01573767|41701213|FG001|Overall Study|Protocol Violation|1|||
19452305|NCT01573767|41701214|FG002|Overall Study|Protocol Violation|1|||
19452306|NCT01573767|41701215|FG003|Overall Study|Protocol Violation|3|||
19452307|NCT01573767|41701212|FG000|Overall Study|Lost to Follow-up|0|||
19452308|NCT01573767|41701213|FG001|Overall Study|Lost to Follow-up|1|||
19452309|NCT01573767|41701214|FG002|Overall Study|Lost to Follow-up|1|||
19452310|NCT01573767|41701215|FG003|Overall Study|Lost to Follow-up|1|||
19452311|NCT01573767|41701212|FG000|Overall Study|Physician Decision|1|||
19452312|NCT01573767|41701213|FG001|Overall Study|Physician Decision|2|||
19452313|NCT01573767|41701214|FG002|Overall Study|Physician Decision|0|||
19452314|NCT01573767|41701215|FG003|Overall Study|Physician Decision|2|||
19452315|NCT01573767|41701212|FG000|Overall Study|Withdrawal by Subject|0|||
19452316|NCT01573767|41701213|FG001|Overall Study|Withdrawal by Subject|1|||
19452317|NCT01573767|41701214|FG002|Overall Study|Withdrawal by Subject|0|||
19452318|NCT01573767|41701215|FG003|Overall Study|Withdrawal by Subject|0|||
19452319|NCT01551303|41701227|FG000|Overall Study|failed awareness check on vision test|4|||
19452320|NCT01551303|41701228|FG001|Overall Study|failed awareness check on vision test|7|||
19452321|NCT00638404|41701236|FG000|Overall Study|Physician Decision|8|||
19452322|NCT00638404|41701237|FG001|Overall Study|Physician Decision|0|||
19452323|NCT01550757|41701251|FG000|Overall Study|Lost to Follow-up|21|||
19452324|NCT01550757|41701252|FG001|Overall Study|Lost to Follow-up|14|||
19452325|NCT01550757|41701253|FG002|Overall Study|Lost to Follow-up|42|||
19452326|NCT01550757|41701254|FG003|Overall Study|Lost to Follow-up|53|||
19452327|NCT01550757|41701251|FG000|Overall Study|Withdrawal by Subject|2|||
19452328|NCT01550757|41701252|FG001|Overall Study|Withdrawal by Subject|0|||
19452329|NCT01550757|41701253|FG002|Overall Study|Withdrawal by Subject|3|||
19452330|NCT01550757|41701254|FG003|Overall Study|Withdrawal by Subject|1|||
19452331|NCT01685073|41701266|FG000|Overall Study|Lost to Follow-up|6|||
19452332|NCT01685073|41701267|FG001|Overall Study|Lost to Follow-up|8|||
19452333|NCT01685073|41701266|FG000|Overall Study|Withdrawal by Subject|24|||
19452334|NCT01685073|41701267|FG001|Overall Study|Withdrawal by Subject|24|||
19452335|NCT01572909|41701275|FG000|Overall Study|Adverse Event|7|||
19531583|NCT02373813|41977515|FG003|Run-In Period|Noncompliance|0|||
19531584|NCT02373813|41977512|FG000|Run-In Period|Ineligibility Determined|3|||
19531585|NCT02373813|41977513|FG001|Run-In Period|Ineligibility Determined|0|||
19531586|NCT02373813|41977514|FG002|Run-In Period|Ineligibility Determined|0|||
19531587|NCT02373813|41977515|FG003|Run-In Period|Ineligibility Determined|0|||
19531588|NCT02373813|41977512|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
19531589|NCT02373813|41977513|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
19531590|NCT02373813|41977514|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
19531591|NCT02373813|41977515|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
19531592|NCT02373813|41977512|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
19630021|NCT00790842|42079353|FG007|Dose Level 4|Adverse Event|0|||
19630022|NCT00790842|42079354|FG008|Dose Level 4|Adverse Event|0|||
19630023|NCT00790842|42079355|FG009|Dose Level 4|Adverse Event|0|||
19452336|NCT01572909|41701276|FG001|Overall Study|Adverse Event|2|||
19531593|NCT02373813|41977513|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
19531594|NCT02373813|41977514|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
19452337|NCT01572909|41701275|FG000|Overall Study|Death|3|||
19452338|NCT01572909|41701276|FG001|Overall Study|Death|1|||
19452339|NCT01572909|41701275|FG000|Overall Study|Lost to Follow-up|8|||
19452340|NCT01572909|41701276|FG001|Overall Study|Lost to Follow-up|7|||
19452341|NCT01572909|41701275|FG000|Overall Study|Physician Decision|1|||
19452342|NCT01572909|41701276|FG001|Overall Study|Physician Decision|1|||
19531595|NCT02373813|41977515|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
19531596|NCT02373813|41977512|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19531597|NCT02373813|41977513|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
19531598|NCT02373813|41977514|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
19531599|NCT02373813|41977515|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
19531600|NCT02373813|41977512|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
19452343|NCT01572909|41701275|FG000|Overall Study|Technical Issues|1|||
19452344|NCT01572909|41701276|FG001|Overall Study|Technical Issues|0|||
19452345|NCT01572909|41701275|FG000|Overall Study|Withdrawal by Subject|12|||
19452346|NCT01572909|41701276|FG001|Overall Study|Withdrawal by Subject|11|||
19452347|NCT01572909|41701275|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
19452348|NCT01572909|41701276|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
19452349|NCT01572675|41701286|FG000|Overall Study|End of prescribed treatment|140|||
19452350|NCT01572675|41701287|FG001|Overall Study|End of prescribed treatment|118|||
19452351|NCT01572675|41701286|FG000|Overall Study|Recovery|16|||
19452352|NCT01572675|41701287|FG001|Overall Study|Recovery|23|||
19452353|NCT01572675|41701286|FG000|Overall Study|Lack of Efficacy|31|||
19452354|NCT01572675|41701287|FG001|Overall Study|Lack of Efficacy|31|||
19452355|NCT01572675|41701286|FG000|Overall Study|Intolerance|6|||
19452356|NCT01572675|41701287|FG001|Overall Study|Intolerance|5|||
19452357|NCT01572675|41701286|FG000|Overall Study|Improved symptoms|8|||
19452358|NCT01572675|41701287|FG001|Overall Study|Improved symptoms|2|||
19452359|NCT01572675|41701286|FG000|Overall Study|Surgical intervention|3|||
19452360|NCT01572675|41701287|FG001|Overall Study|Surgical intervention|6|||
19452361|NCT01572675|41701286|FG000|Overall Study|Withdrawal by Subject|5|||
19452362|NCT01572675|41701287|FG001|Overall Study|Withdrawal by Subject|1|||
19452363|NCT01572675|41701286|FG000|Overall Study|Physician Decision|2|||
19452364|NCT01572675|41701287|FG001|Overall Study|Physician Decision|2|||
19452365|NCT01572675|41701286|FG000|Overall Study|Death unrelated to coxibs|1|||
19452366|NCT01572675|41701287|FG001|Overall Study|Death unrelated to coxibs|1|||
19452367|NCT01572675|41701286|FG000|Overall Study|Other disease detected|1|||
19452368|NCT01572675|41701287|FG001|Overall Study|Other disease detected|1|||
19452369|NCT01572675|41701286|FG000|Overall Study|Unknown reason|1|||
19452370|NCT01572675|41701287|FG001|Overall Study|Unknown reason|1|||
19452371|NCT01572675|41701286|FG000|Overall Study|Rheumatologist new evaluation|0|||
19452372|NCT01572675|41701287|FG001|Overall Study|Rheumatologist new evaluation|1|||
19452373|NCT01572675|41701286|FG000|Overall Study|Missing data|1|||
19452374|NCT01572675|41701287|FG001|Overall Study|Missing data|4|||
19452375|NCT01572675|41701286|FG000|Overall Study|Lost to Follow-up|22|||
19452376|NCT01572675|41701287|FG001|Overall Study|Lost to Follow-up|27|||
19452377|NCT01550289|41701308|FG000|Overall Study|Protocol Violation|1|||
19452378|NCT01550289|41701309|FG001|Overall Study|Protocol Violation|0|||
19452379|NCT01550289|41701308|FG000|Overall Study|Lost to Follow-up|1|||
19452380|NCT01550289|41701309|FG001|Overall Study|Lost to Follow-up|1|||
19452381|NCT01550289|41701308|FG000|Overall Study|Withdrawal by Subject|11|||
19452382|NCT01550289|41701309|FG001|Overall Study|Withdrawal by Subject|3|||
19452383|NCT01968031|41701320|FG000|Overall Study|Adverse Event|13|||
19452384|NCT01968031|41701321|FG001|Overall Study|Adverse Event|10|||
19452385|NCT01968031|41701322|FG002|Overall Study|Adverse Event|22|||
19452386|NCT01968031|41701320|FG000|Overall Study|Withdrawal by Subject|3|||
19452387|NCT01968031|41701321|FG001|Overall Study|Withdrawal by Subject|7|||
19452388|NCT01968031|41701322|FG002|Overall Study|Withdrawal by Subject|3|||
19452389|NCT01968031|41701320|FG000|Overall Study|Did not meet entry criteria|1|||
19452390|NCT01968031|41701321|FG001|Overall Study|Did not meet entry criteria|1|||
19452391|NCT01968031|41701322|FG002|Overall Study|Did not meet entry criteria|1|||
19452392|NCT01968031|41701320|FG000|Overall Study|Noncompliance|0|||
19452393|NCT01968031|41701321|FG001|Overall Study|Noncompliance|0|||
19452394|NCT01968031|41701322|FG002|Overall Study|Noncompliance|2|||
19452395|NCT01968031|41701320|FG000|Overall Study|Failed inclusion criteria|0|||
19452396|NCT01968031|41701321|FG001|Overall Study|Failed inclusion criteria|2|||
19452397|NCT01968031|41701322|FG002|Overall Study|Failed inclusion criteria|0|||
19452398|NCT01968031|41701320|FG000|Overall Study|Death|0|||
19452399|NCT01968031|41701321|FG001|Overall Study|Death|0|||
19452400|NCT01968031|41701322|FG002|Overall Study|Death|1|||
19452401|NCT01968031|41701320|FG000|Overall Study|Prohibited concomitant medication|1|||
19452402|NCT01968031|41701321|FG001|Overall Study|Prohibited concomitant medication|0|||
19452403|NCT01968031|41701322|FG002|Overall Study|Prohibited concomitant medication|0|||
19452404|NCT01684215|41701334|FG000|Phase 1, Part 1|Adverse Event|1|||
19452405|NCT01684215|41701335|FG001|Phase 1, Part 1|Adverse Event|0|||
19452406|NCT01684215|41701336|FG002|Phase 1, Part 1|Adverse Event|0|||
19452407|NCT01684215|41701337|FG003|Phase 1, Part 1|Adverse Event|0|||
19531601|NCT02373813|41977513|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
19452408|NCT01684215|41701334|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
19452409|NCT01684215|41701335|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
19452410|NCT01684215|41701336|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
19452411|NCT01684215|41701337|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
19452412|NCT01684215|41701334|FG000|Phase 1, Part 2|Adverse Event|0|||
19452413|NCT01684215|41701335|FG001|Phase 1, Part 2|Adverse Event|0|||
19452414|NCT01684215|41701336|FG002|Phase 1, Part 2|Adverse Event|1|||
19452415|NCT01684215|41701337|FG003|Phase 1, Part 2|Adverse Event|0|||
19452416|NCT01684215|41701334|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
19452417|NCT01684215|41701335|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
19452418|NCT01684215|41701336|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
19452419|NCT01684215|41701337|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
19452420|NCT01684215|41701334|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
19452421|NCT01684215|41701335|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
19452422|NCT01684215|41701336|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
19452423|NCT01684215|41701337|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
19531602|NCT02373813|41977514|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
19531603|NCT02373813|41977515|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
19531604|NCT01853748|41977532|FG000|Allocation|Withdrawal by Subject|1|||
19531605|NCT01853748|41977533|FG001|Allocation|Withdrawal by Subject|13|||
19531606|NCT01853748|41977532|FG000|Allocation|not sufficient to receive intervention|0|||
19531607|NCT01853748|41977533|FG001|Allocation|not sufficient to receive intervention|1|||
19531608|NCT01853748|41977532|FG000|Follow-Up|Withdrawal by Subject|7|||
19531609|NCT01853748|41977533|FG001|Follow-Up|Withdrawal by Subject|6|||
19531610|NCT01853748|41977532|FG000|Follow-Up|Adverse Event|67|||
19531611|NCT01853748|41977533|FG001|Follow-Up|Adverse Event|7|||
19531612|NCT01853748|41977532|FG000|Follow-Up|not available for data collection|16|||
19531613|NCT01853748|41977533|FG001|Follow-Up|not available for data collection|4|||
19531614|NCT03116347|41977580|FG000|Overall Study|Withdrawal by Subject|1|||
19531615|NCT03116347|41977581|FG001|Overall Study|Withdrawal by Subject|2|||
19531616|NCT01575808|41977589|FG000|Overall Study|Death|2|||
19531617|NCT01575808|41977590|FG001|Overall Study|Death|0|||
19531618|NCT01575808|41977589|FG000|Overall Study|Withdrawal by Subject|1|||
19531619|NCT01575808|41977590|FG001|Overall Study|Withdrawal by Subject|0|||
19531620|NCT00001213|41977638|FG000|Overall Study|Death|18|||
19452424|NCT01684215|41701334|FG000|Phase 2|Death|0|||
19452425|NCT01684215|41701335|FG001|Phase 2|Death|0|||
19452426|NCT01684215|41701336|FG002|Phase 2|Death|0|||
19452427|NCT01684215|41701337|FG003|Phase 2|Death|8|||
19452428|NCT01684215|41701334|FG000|Phase 2|Study terminated by sponsor|0|||
19452429|NCT01684215|41701335|FG001|Phase 2|Study terminated by sponsor|0|||
19452430|NCT01684215|41701336|FG002|Phase 2|Study terminated by sponsor|0|||
19452431|NCT01684215|41701337|FG003|Phase 2|Study terminated by sponsor|30|||
19452432|NCT01684215|41701334|FG000|Phase 2|Enrolled but not treated|0|||
19452433|NCT01684215|41701335|FG001|Phase 2|Enrolled but not treated|0|||
19452434|NCT01684215|41701336|FG002|Phase 2|Enrolled but not treated|0|||
19452435|NCT01684215|41701337|FG003|Phase 2|Enrolled but not treated|1|||
19452436|NCT01684215|41701334|FG000|Phase 2|Lost to Follow-up|0|||
19452437|NCT01684215|41701335|FG001|Phase 2|Lost to Follow-up|0|||
19452438|NCT01684215|41701336|FG002|Phase 2|Lost to Follow-up|0|||
19452439|NCT01684215|41701337|FG003|Phase 2|Lost to Follow-up|4|||
19452440|NCT01549275|41701352|FG000|Overall Study|Lost to Follow-up|1|||
19452441|NCT01549275|41701353|FG001|Overall Study|Lost to Follow-up|0|||
19452442|NCT01908205|41701365|FG000|Overall Study|Lost to Follow-up|2|||
19452443|NCT01908205|41701366|FG001|Overall Study|Lost to Follow-up|0|||
19452444|NCT01908205|41701365|FG000|Overall Study|Withdrawal by Subject|3|||
19452445|NCT01908205|41701366|FG001|Overall Study|Withdrawal by Subject|1|||
19531621|NCT00000135|41977644|FG000|Overall Study|Death|27|||
19531622|NCT00000135|41977645|FG001|Overall Study|Death|14|||
19531623|NCT00001723|41977653|FG000|Overall Study|Lack of Efficacy|6|||
19531624|NCT00001723|41977654|FG001|Overall Study|Lack of Efficacy|7|||
19531625|NCT00001723|41977653|FG000|Overall Study|Lack of family interest|4|||
19531626|NCT00001723|41977654|FG001|Overall Study|Lack of family interest|5|||
19531627|NCT00001723|41977653|FG000|Overall Study|Lost to Follow-up|2|||
19630024|NCT00790842|42079356|FG010|Dose Level 4|Adverse Event|0|||
19452446|NCT01549041|41701387|FG000|Overall Study|Lack of Efficacy|2|||
19452447|NCT01549041|41701388|FG001|Overall Study|Lack of Efficacy|4|||
19452448|NCT01549041|41701387|FG000|Overall Study|Adverse Event|0|||
19452449|NCT01549041|41701388|FG001|Overall Study|Adverse Event|4|||
19452450|NCT01907815|41701396|FG000|Overall Study|Withdrawal by Subject|1|||
19452451|NCT01907815|41701397|FG001|Overall Study|Withdrawal by Subject|0|||
19452452|NCT01548573|41701405|FG000|Overall Study|Death|3|||
19452453|NCT01548573|41701405|FG000|Overall Study|Withdrawal by Subject|2|||
19452454|NCT01907737|41701410|FG000|Overall Study|Withdrawal by Subject|1|||
19531628|NCT00001723|41977654|FG001|Overall Study|Lost to Follow-up|2|||
19531629|NCT00001723|41977653|FG000|Overall Study|medication intolerance|1|||
19531630|NCT00001723|41977654|FG001|Overall Study|medication intolerance|2|||
19531631|NCT00000378|41977676|FG000|Overall Study|Lack of Efficacy|16|||
19531632|NCT00000378|41977677|FG001|Overall Study|Lack of Efficacy|14|||
19531633|NCT01350115|41977685|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
19531634|NCT01350115|41977686|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
19531635|NCT01350115|41977685|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
19531636|NCT01350115|41977686|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
19531637|NCT01350115|41977685|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
19452455|NCT01570491|41701422|FG000|Overall Study|Lost to Follow-up|3|||
19452456|NCT01570491|41701423|FG001|Overall Study|Lost to Follow-up|1|||
19452457|NCT01570491|41701422|FG000|Overall Study|treatment: not given or discontinued|2|||
19452458|NCT01570491|41701423|FG001|Overall Study|treatment: not given or discontinued|0|||
19452459|NCT01929109|41701434|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
19452460|NCT01929109|41701435|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
19452461|NCT01929109|41701436|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
19452462|NCT01929109|41701437|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
19452463|NCT01929109|41701438|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
19452464|NCT01518153|41701453|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
19452465|NCT01518153|41701454|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
19452466|NCT01518153|41701455|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
19452467|NCT01518153|41701453|FG000|Stem Cell Transplant|Death|2|||
19452468|NCT01518153|41701454|FG001|Stem Cell Transplant|Death|0|||
19452469|NCT01518153|41701455|FG002|Stem Cell Transplant|Death|0|||
19452470|NCT01518153|41701453|FG000|Stem Cell Transplant|Secondary graft failure|1|||
19452471|NCT01518153|41701454|FG001|Stem Cell Transplant|Secondary graft failure|0|||
19452472|NCT01518153|41701455|FG002|Stem Cell Transplant|Secondary graft failure|0|||
19452473|NCT01518153|41701453|FG000|Stem Cell Transplant|Adverse Event|1|||
19452474|NCT01518153|41701454|FG001|Stem Cell Transplant|Adverse Event|0|||
19452475|NCT01518153|41701455|FG002|Stem Cell Transplant|Adverse Event|0|||
19452476|NCT01518153|41701453|FG000|Donor Lymphocyte Infusion|Death|0|||
19452477|NCT01518153|41701454|FG001|Donor Lymphocyte Infusion|Death|2|||
19452478|NCT01518153|41701455|FG002|Donor Lymphocyte Infusion|Death|1|||
19452479|NCT01906489|41701465|FG000|Overall Study|Adverse Event|10|||
19452480|NCT01906489|41701466|FG001|Overall Study|Adverse Event|3|||
19452481|NCT01906489|41701465|FG000|Overall Study|Worsening of CKD|6|||
19452482|NCT01906489|41701466|FG001|Overall Study|Worsening of CKD|4|||
19452483|NCT01906489|41701465|FG000|Overall Study|Withdrawal by Subject|5|||
19452484|NCT01906489|41701466|FG001|Overall Study|Withdrawal by Subject|0|||
19452485|NCT01906489|41701465|FG000|Overall Study|Worsening of Anemia|1|||
19452486|NCT01906489|41701466|FG001|Overall Study|Worsening of Anemia|0|||
19452487|NCT01906489|41701465|FG000|Overall Study|Protocol Violation|0|||
19452488|NCT01906489|41701466|FG001|Overall Study|Protocol Violation|1|||
19452489|NCT01906489|41701465|FG000|Overall Study|Non- Compliance|1|||
19452490|NCT01906489|41701466|FG001|Overall Study|Non- Compliance|0|||
19452491|NCT01906489|41701465|FG000|Overall Study|Sponsor Decision|1|||
19452492|NCT01906489|41701466|FG001|Overall Study|Sponsor Decision|0|||
19452493|NCT01906489|41701465|FG000|Overall Study|Lost to Follow-up|1|||
19452494|NCT01906489|41701466|FG001|Overall Study|Lost to Follow-up|1|||
19452495|NCT01906489|41701465|FG000|Overall Study|Other|1|||
19531638|NCT01350115|41977686|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
19531639|NCT04142983|41977694|FG000|Overall Study|Lost to Follow-up|73|||
19531640|NCT04142983|41977694|FG000|Overall Study|Withdrawal by Subject|10|||
19531641|NCT04142983|41977694|FG000|Overall Study|Physician Decision|1|||
19531642|NCT04142983|41977694|FG000|Overall Study|Adverse Event|1|||
19531643|NCT04142983|41977694|FG000|Overall Study|No longer eligible|4|||
19531644|NCT04142983|41977694|FG000|Overall Study|Screen Failure|10|||
19531645|NCT03801031|41977701|FG000|Overall Study|Lost to Follow-up|1|||
19452496|NCT01906489|41701466|FG001|Overall Study|Other|0|||
19452497|NCT01517373|41701477|FG000|Run-in Period|Death|1|||
19452498|NCT01517373|41701478|FG001|Run-in Period|Death|0|||
19452499|NCT01517373|41701479|FG002|Run-in Period|Death|0|||
19452500|NCT01517373|41701480|FG003|Run-in Period|Death|0|||
19452501|NCT01517373|41701481|FG004|Run-in Period|Death|0|||
19531646|NCT03801031|41977702|FG001|Overall Study|Lost to Follow-up|0|||
19531647|NCT03801031|41977701|FG000|Overall Study|Unable to comply|1|||
19531648|NCT03801031|41977702|FG001|Overall Study|Unable to comply|0|||
19531649|NCT03801031|41977701|FG000|Overall Study|Withdrawal by Subject|0|||
19711416|NCT03569098|42154516|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
19452502|NCT01517373|41701482|FG005|Run-in Period|Death|0|||
19452503|NCT01517373|41701477|FG000|Run-in Period|Adverse Event|5|||
19452504|NCT01517373|41701478|FG001|Run-in Period|Adverse Event|0|||
19452505|NCT01517373|41701479|FG002|Run-in Period|Adverse Event|0|||
19452506|NCT01517373|41701480|FG003|Run-in Period|Adverse Event|0|||
19452507|NCT01517373|41701481|FG004|Run-in Period|Adverse Event|0|||
19531650|NCT03801031|41977702|FG001|Overall Study|Withdrawal by Subject|1|||
19531651|NCT03357952|41977710|FG000|Overall Study|Withdrawal by Subject|0|||
19531652|NCT03357952|41977711|FG001|Overall Study|Withdrawal by Subject|1|||
19531653|NCT03357952|41977710|FG000|Overall Study|Sponsor Decision|9|||
19531654|NCT03357952|41977711|FG001|Overall Study|Sponsor Decision|0|||
19452508|NCT01517373|41701482|FG005|Run-in Period|Adverse Event|0|||
19452509|NCT01517373|41701477|FG000|Run-in Period|Did not meet eligibility criteria|34|||
19452510|NCT01517373|41701478|FG001|Run-in Period|Did not meet eligibility criteria|0|||
19531655|NCT03055858|41977717|FG000|Overall Study|Death|9|||
19531656|NCT03055858|41977717|FG000|Overall Study|Withdrawal by Subject|11|||
19531657|NCT03055858|41977717|FG000|Overall Study|Lost to Follow-up|6|||
19531658|NCT03055858|41977717|FG000|Overall Study|Missed Follow-Up Visits|18|||
19531659|NCT02773849|41977744|FG000|Overall Study|Adverse Event|3|||
19531660|NCT02773849|41977744|FG000|Overall Study|Lack of Efficacy|89|||
19452511|NCT01517373|41701479|FG002|Run-in Period|Did not meet eligibility criteria|0|||
19452512|NCT01517373|41701480|FG003|Run-in Period|Did not meet eligibility criteria|0|||
19452513|NCT01517373|41701481|FG004|Run-in Period|Did not meet eligibility criteria|0|||
19452514|NCT01517373|41701482|FG005|Run-in Period|Did not meet eligibility criteria|0|||
19452515|NCT01517373|41701477|FG000|Run-in Period|Lost to Follow-up|1|||
19452516|NCT01517373|41701478|FG001|Run-in Period|Lost to Follow-up|0|||
19452517|NCT01517373|41701479|FG002|Run-in Period|Lost to Follow-up|0|||
19452518|NCT01517373|41701480|FG003|Run-in Period|Lost to Follow-up|0|||
19452519|NCT01517373|41701481|FG004|Run-in Period|Lost to Follow-up|0|||
19452520|NCT01517373|41701482|FG005|Run-in Period|Lost to Follow-up|0|||
19452521|NCT01517373|41701477|FG000|Run-in Period|Withdrawal by Subject|12|||
19452522|NCT01517373|41701478|FG001|Run-in Period|Withdrawal by Subject|0|||
19452523|NCT01517373|41701479|FG002|Run-in Period|Withdrawal by Subject|0|||
19452524|NCT01517373|41701480|FG003|Run-in Period|Withdrawal by Subject|0|||
19452525|NCT01517373|41701481|FG004|Run-in Period|Withdrawal by Subject|0|||
19452526|NCT01517373|41701482|FG005|Run-in Period|Withdrawal by Subject|0|||
19452527|NCT01517373|41701477|FG000|Run-in Period|Sponsor Decision|3|||
19452528|NCT01517373|41701478|FG001|Run-in Period|Sponsor Decision|0|||
19452529|NCT01517373|41701479|FG002|Run-in Period|Sponsor Decision|0|||
19452530|NCT01517373|41701480|FG003|Run-in Period|Sponsor Decision|0|||
19531661|NCT02773849|41977744|FG000|Overall Study|Withdrawal by Subject|1|||
19531662|NCT02773849|41977744|FG000|Overall Study|Withdrawal of Consent|1|||
19531663|NCT02393716|41977752|FG000|Overall Study|Death|29|||
19531664|NCT02393716|41977752|FG000|Overall Study|Withdrawal by Subject|8|||
19531665|NCT02393716|41977752|FG000|Overall Study|Device Explanted|8|||
19531666|NCT02393716|41977752|FG000|Overall Study|Missed visit|16|||
19531667|NCT01804816|41977757|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
19531668|NCT01804816|41977757|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
19531669|NCT00584233|41977764|FG000|Overall Study|Withdrawal by Subject|5|||
19531670|NCT00584233|41977764|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
19531671|NCT00001566|41977776|FG000|Overall Study|patients' choice to discontinue protocol|3|||
19531672|NCT00001566|41977776|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
19531673|NCT00001566|41977776|FG000|Overall Study|Death|13|||
19531674|NCT00001566|41977776|FG000|Overall Study|Lost to Follow-up|1|||
19531675|NCT00001566|41977776|FG000|Overall Study|unable to complete initial apheresis|1|||
19531676|NCT00001575|41977780|FG000|Overall Study|Screening failures-Ph I portion|22|||
19531677|NCT00001575|41977780|FG000|Overall Study|Withdrawn/deaths|23|||
19531678|NCT00001596|41977786|FG000|Overall Study|Death|1|||
19531679|NCT00001596|41977787|FG001|Overall Study|Death|0|||
19531680|NCT00001596|41977786|FG000|Overall Study|Withdrawal by Subject|3|||
19531681|NCT00001596|41977787|FG001|Overall Study|Withdrawal by Subject|1|||
19531682|NCT00001596|41977786|FG000|Overall Study|Study Termination|12|||
19531683|NCT00001596|41977787|FG001|Overall Study|Study Termination|9|||
19531684|NCT00001596|41977786|FG000|Overall Study|Adverse Event|1|||
19531685|NCT00001596|41977787|FG001|Overall Study|Adverse Event|0|||
19531686|NCT01349803|41977828|FG000|Overall Study|Adverse Event|0|||
19531687|NCT01349803|41977829|FG001|Overall Study|Adverse Event|0|||
19531688|NCT01349803|41977830|FG002|Overall Study|Adverse Event|0|||
19531689|NCT01349803|41977831|FG003|Overall Study|Adverse Event|2|||
19531690|NCT01349803|41977828|FG000|Overall Study|Withdrawal by Subject|1|||
19531691|NCT01349803|41977829|FG001|Overall Study|Withdrawal by Subject|0|||
19531692|NCT01349803|41977830|FG002|Overall Study|Withdrawal by Subject|0|||
19531693|NCT01349803|41977831|FG003|Overall Study|Withdrawal by Subject|0|||
19531694|NCT01349803|41977828|FG000|Overall Study|Protocol-specified criteria|0|||
19452531|NCT01517373|41701481|FG004|Run-in Period|Sponsor Decision|0|||
19452532|NCT01517373|41701482|FG005|Run-in Period|Sponsor Decision|0|||
19452533|NCT01517373|41701477|FG000|Run-in Period|Other|1|||
19452534|NCT01517373|41701478|FG001|Run-in Period|Other|0|||
19452535|NCT01517373|41701479|FG002|Run-in Period|Other|0|||
19531695|NCT01349803|41977829|FG001|Overall Study|Protocol-specified criteria|1|||
19531696|NCT01349803|41977830|FG002|Overall Study|Protocol-specified criteria|3|||
19531697|NCT01349803|41977831|FG003|Overall Study|Protocol-specified criteria|0|||
19531698|NCT04059146|41977977|FG000|Overall Study|Withdrawal by Subject|0|||
19531699|NCT04059146|41977978|FG001|Overall Study|Withdrawal by Subject|1|||
19531700|NCT03969641|41977999|FG000|Overall Study|Lost to Follow-up|5|||
19531701|NCT03969641|41978000|FG001|Overall Study|Lost to Follow-up|3|||
19531702|NCT03969641|41977999|FG000|Overall Study|Withdrawal by Subject|1|||
19531703|NCT03969641|41978000|FG001|Overall Study|Withdrawal by Subject|2|||
19531704|NCT03969641|41977999|FG000|Overall Study|Found to be ineligible|1|||
19531705|NCT03969641|41978000|FG001|Overall Study|Found to be ineligible|1|||
19531706|NCT03969641|41977999|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
19531707|NCT03969641|41978000|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
19531708|NCT03969641|41977999|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
19531709|NCT03969641|41978000|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
19531710|NCT03969641|41977999|FG000|Overall Study|Elective termination|0|||
19531711|NCT03969641|41978000|FG001|Overall Study|Elective termination|1|||
19531712|NCT03721172|41978046|FG000|Placebo-controlled Phase|Adverse Event|7|||
19531713|NCT03721172|41978047|FG001|Placebo-controlled Phase|Adverse Event|7|||
19531714|NCT03721172|41978048|FG002|Placebo-controlled Phase|Adverse Event|0|||
19531715|NCT03721172|41978046|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
19531716|NCT03721172|41978047|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
19531717|NCT03721172|41978048|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
19531718|NCT03721172|41978046|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
19531719|NCT03721172|41978047|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
19531720|NCT03721172|41978048|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
19531721|NCT03721172|41978046|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
19531722|NCT03721172|41978047|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
19531723|NCT03721172|41978048|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
19531724|NCT03721172|41978046|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
19531725|NCT03721172|41978047|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
19531726|NCT03721172|41978048|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
19531727|NCT03721172|41978046|FG000|Placebo-controlled Phase|Other|3|||
19531728|NCT03721172|41978047|FG001|Placebo-controlled Phase|Other|0|||
19531729|NCT03721172|41978048|FG002|Placebo-controlled Phase|Other|0|||
19531730|NCT03721172|41978046|FG000|Apremilast Extension Phase|Adverse Event|0|||
19531731|NCT03721172|41978047|FG001|Apremilast Extension Phase|Adverse Event|0|||
19531732|NCT03721172|41978048|FG002|Apremilast Extension Phase|Adverse Event|10|||
19531733|NCT03721172|41978046|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
19531734|NCT03721172|41978047|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
19531735|NCT03721172|41978048|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
19531736|NCT03721172|41978046|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
19531737|NCT03721172|41978047|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
19531738|NCT03721172|41978048|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
19531739|NCT03721172|41978046|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
19531740|NCT03721172|41978047|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
19531741|NCT03721172|41978048|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
19531742|NCT03721172|41978046|FG000|Apremilast Extension Phase|Protocol Violation|0|||
19531743|NCT03721172|41978047|FG001|Apremilast Extension Phase|Protocol Violation|0|||
19531744|NCT03721172|41978048|FG002|Apremilast Extension Phase|Protocol Violation|1|||
19531745|NCT03721172|41978046|FG000|Apremilast Extension Phase|Physician Decision|0|||
19531746|NCT03721172|41978047|FG001|Apremilast Extension Phase|Physician Decision|0|||
19531747|NCT03721172|41978048|FG002|Apremilast Extension Phase|Physician Decision|1|||
19531748|NCT03721172|41978046|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
19531749|NCT03721172|41978047|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
19531750|NCT03721172|41978048|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
19531751|NCT03721172|41978046|FG000|Apremilast Extension Phase|Other|0|||
19531752|NCT03721172|41978047|FG001|Apremilast Extension Phase|Other|0|||
19531753|NCT03721172|41978048|FG002|Apremilast Extension Phase|Other|3|||
19531754|NCT03721172|41978046|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
19531755|NCT03721172|41978047|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
19531756|NCT03721172|41978048|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
19531757|NCT03089606|41978078|FG000|Overall Study|Progression after Cycle 1|1|||
19531758|NCT02337686|41978094|FG000|Overall Study|Adverse Event|1|||
19531759|NCT04540887|41978120|FG000|Overall Study|Withdrawal by Subject|2|||
19531760|NCT04294680|41978131|FG000|Overall Study|Withdrawal by Subject|2|||
19531761|NCT04294680|41978132|FG001|Overall Study|Withdrawal by Subject|1|||
19531762|NCT04294680|41978131|FG000|Overall Study|Follow-up visits completed outside of window|1|||
19531763|NCT04294680|41978132|FG001|Overall Study|Follow-up visits completed outside of window|0|||
19630025|NCT00790842|42079346|FG000|Dose Level 4|Physician Decision|0|||
19630026|NCT00790842|42079347|FG001|Dose Level 4|Physician Decision|0|||
19531764|NCT01350102|41978142|FG000|Overall Study|Adverse Event|0|||
19531765|NCT01350102|41978143|FG001|Overall Study|Adverse Event|0|||
19531766|NCT01350102|41978144|FG002|Overall Study|Adverse Event|1|||
19531767|NCT01350102|41978145|FG003|Overall Study|Adverse Event|0|||
19531768|NCT04059549|41978159|FG000|Overall Study|Withdrawal by Subject|2|||
19531769|NCT04059549|41978160|FG001|Overall Study|Withdrawal by Subject|0|||
19531770|NCT04041570|41978172|FG000|Overall Study|Moved from Area|0|||
19531771|NCT04041570|41978173|FG001|Overall Study|Moved from Area|2|||
19531772|NCT03879408|41978185|FG000|Overall Study|Lost to Follow-up|0|||
19531773|NCT03879408|41978186|FG001|Overall Study|Lost to Follow-up|3|||
19630027|NCT00790842|42079348|FG002|Dose Level 4|Physician Decision|0|||
19531774|NCT03879408|41978187|FG002|Overall Study|Lost to Follow-up|2|||
19531775|NCT03879408|41978188|FG003|Overall Study|Lost to Follow-up|1|||
19531776|NCT03879408|41978189|FG004|Overall Study|Lost to Follow-up|0|||
19531777|NCT03879408|41978185|FG000|Overall Study|Withdrawal by Subject|2|||
19531778|NCT03879408|41978186|FG001|Overall Study|Withdrawal by Subject|1|||
19531779|NCT03879408|41978187|FG002|Overall Study|Withdrawal by Subject|1|||
19452536|NCT01517373|41701480|FG003|Run-in Period|Other|0|||
19452537|NCT01517373|41701481|FG004|Run-in Period|Other|0|||
19452538|NCT01517373|41701482|FG005|Run-in Period|Other|0|||
19452539|NCT01517373|41701477|FG000|Treatment Period|Adverse Event|0|||
19452540|NCT01517373|41701478|FG001|Treatment Period|Adverse Event|0|||
19531780|NCT03879408|41978188|FG003|Overall Study|Withdrawal by Subject|0|||
19531781|NCT03879408|41978189|FG004|Overall Study|Withdrawal by Subject|1|||
19531782|NCT02706873|41978209|FG000|Overall Study|Adverse Event|13|||
19531783|NCT02706873|41978210|FG001|Overall Study|Adverse Event|3|||
19531784|NCT02706873|41978211|FG002|Overall Study|Adverse Event|13|||
19531785|NCT02706873|41978212|FG003|Overall Study|Adverse Event|12|||
19452541|NCT01517373|41701479|FG002|Treatment Period|Adverse Event|0|||
19452542|NCT01517373|41701480|FG003|Treatment Period|Adverse Event|0|||
19452543|NCT01517373|41701481|FG004|Treatment Period|Adverse Event|0|||
19452544|NCT01517373|41701482|FG005|Treatment Period|Adverse Event|2|||
19452545|NCT01517373|41701477|FG000|Treatment Period|Lost to Follow-up|0|||
19452546|NCT01517373|41701478|FG001|Treatment Period|Lost to Follow-up|0|||
19452547|NCT01517373|41701479|FG002|Treatment Period|Lost to Follow-up|1|||
19452548|NCT01517373|41701480|FG003|Treatment Period|Lost to Follow-up|1|||
19531786|NCT02706873|41978209|FG000|Overall Study|Withdrawal by Subject|15|||
19531787|NCT02706873|41978210|FG001|Overall Study|Withdrawal by Subject|0|||
19531788|NCT02706873|41978211|FG002|Overall Study|Withdrawal by Subject|8|||
19531789|NCT02706873|41978212|FG003|Overall Study|Withdrawal by Subject|11|||
19531790|NCT02706873|41978209|FG000|Overall Study|Lost to Follow-up|3|||
19531791|NCT02706873|41978210|FG001|Overall Study|Lost to Follow-up|0|||
19531792|NCT02706873|41978211|FG002|Overall Study|Lost to Follow-up|4|||
19531793|NCT02706873|41978212|FG003|Overall Study|Lost to Follow-up|2|||
19531794|NCT02706873|41978209|FG000|Overall Study|Lack of Efficacy|10|||
19531795|NCT02706873|41978210|FG001|Overall Study|Lack of Efficacy|0|||
19531796|NCT02706873|41978211|FG002|Overall Study|Lack of Efficacy|0|||
19531797|NCT02706873|41978212|FG003|Overall Study|Lack of Efficacy|3|||
19531798|NCT02706873|41978209|FG000|Overall Study|Other|5|||
19531799|NCT02706873|41978210|FG001|Overall Study|Other|1|||
19531800|NCT02706873|41978211|FG002|Overall Study|Other|2|||
19531801|NCT02706873|41978212|FG003|Overall Study|Other|3|||
19531802|NCT02706873|41978209|FG000|Overall Study|Not Dosed|1|||
19531803|NCT02706873|41978210|FG001|Overall Study|Not Dosed|0|||
19531804|NCT02706873|41978211|FG002|Overall Study|Not Dosed|0|||
19531805|NCT02706873|41978212|FG003|Overall Study|Not Dosed|1|||
19531806|NCT02706873|41978209|FG000|Overall Study|Ongoing|0|||
19531807|NCT02706873|41978210|FG001|Overall Study|Ongoing|0|||
19531808|NCT02706873|41978211|FG002|Overall Study|Ongoing|0|||
19531809|NCT02706873|41978212|FG003|Overall Study|Ongoing|1|||
19531810|NCT02454933|41978226|FG000|Overall Study|Progressive disease|7|||
19531811|NCT02454933|41978227|FG001|Overall Study|Progressive disease|5|||
19531812|NCT02454933|41978226|FG000|Overall Study|Adverse Event|1|||
19531813|NCT02454933|41978227|FG001|Overall Study|Adverse Event|1|||
19531814|NCT02454933|41978226|FG000|Overall Study|Withdrawal by Subject|0|||
19531815|NCT02454933|41978227|FG001|Overall Study|Withdrawal by Subject|2|||
19531819|NCT00819780|41978244|FG000|Overall Study|Did not receive study drug|3|||
19531820|NCT00819780|41978245|FG001|Overall Study|Did not receive study drug|4|||
19531821|NCT00819780|41978244|FG000|Overall Study|Still in treatment|25|||
19531822|NCT00819780|41978245|FG001|Overall Study|Still in treatment|17|||
19531823|NCT00000620|41978384|FG000|Overall Study|Death|86|||
19452549|NCT01517373|41701481|FG004|Treatment Period|Lost to Follow-up|0|||
19452550|NCT01517373|41701482|FG005|Treatment Period|Lost to Follow-up|0|||
19452551|NCT01517373|41701477|FG000|Treatment Period|Withdrawal by Subject|0|||
19452552|NCT01517373|41701478|FG001|Treatment Period|Withdrawal by Subject|3|||
19452553|NCT01517373|41701479|FG002|Treatment Period|Withdrawal by Subject|2|||
19452554|NCT01517373|41701480|FG003|Treatment Period|Withdrawal by Subject|2|||
19531824|NCT00000620|41978385|FG001|Overall Study|Death|67|||
19531825|NCT00000620|41978386|FG002|Overall Study|Death|112|||
19531826|NCT00000620|41978387|FG003|Overall Study|Death|126|||
19531827|NCT00000620|41978388|FG004|Overall Study|Death|64|||
19531828|NCT00000620|41978389|FG005|Overall Study|Death|77|||
19531829|NCT00000620|41978390|FG006|Overall Study|Death|91|||
19531830|NCT00000620|41978391|FG007|Overall Study|Death|95|||
19531831|NCT00000620|41978384|FG000|Overall Study|Lost to Follow-up|14|||
19531832|NCT00000620|41978385|FG001|Overall Study|Lost to Follow-up|14|||
19531833|NCT00000620|41978386|FG002|Overall Study|Lost to Follow-up|14|||
19531834|NCT00000620|41978387|FG003|Overall Study|Lost to Follow-up|14|||
19531835|NCT00000620|41978388|FG004|Overall Study|Lost to Follow-up|15|||
19452555|NCT01517373|41701481|FG004|Treatment Period|Withdrawal by Subject|2|||
19452556|NCT01517373|41701482|FG005|Treatment Period|Withdrawal by Subject|3|||
19452557|NCT01517373|41701477|FG000|Treatment Period|Other|0|||
19452558|NCT01517373|41701478|FG001|Treatment Period|Other|0|||
19531836|NCT00000620|41978389|FG005|Overall Study|Lost to Follow-up|15|||
19531837|NCT00000620|41978390|FG006|Overall Study|Lost to Follow-up|13|||
19531838|NCT00000620|41978391|FG007|Overall Study|Lost to Follow-up|14|||
19531839|NCT00000620|41978384|FG000|Overall Study|Withdrawal by Subject|40|||
19531840|NCT00000620|41978385|FG001|Overall Study|Withdrawal by Subject|27|||
19531841|NCT00000620|41978386|FG002|Overall Study|Withdrawal by Subject|28|||
19630028|NCT00790842|42079349|FG003|Dose Level 4|Physician Decision|0|||
19630029|NCT00790842|42079350|FG004|Dose Level 4|Physician Decision|0|||
19531842|NCT00000620|41978387|FG003|Overall Study|Withdrawal by Subject|27|||
19531843|NCT00000620|41978388|FG004|Overall Study|Withdrawal by Subject|30|||
19531844|NCT00000620|41978389|FG005|Overall Study|Withdrawal by Subject|32|||
19531845|NCT00000620|41978390|FG006|Overall Study|Withdrawal by Subject|32|||
19531846|NCT00000620|41978391|FG007|Overall Study|Withdrawal by Subject|21|||
19531847|NCT00000620|41978384|FG000|Overall Study|missed closeout visit|22|||
19531848|NCT00000620|41978385|FG001|Overall Study|missed closeout visit|28|||
19531849|NCT00000620|41978386|FG002|Overall Study|missed closeout visit|16|||
19531850|NCT00000620|41978387|FG003|Overall Study|missed closeout visit|11|||
19531851|NCT00000620|41978388|FG004|Overall Study|missed closeout visit|26|||
19531852|NCT00000620|41978389|FG005|Overall Study|missed closeout visit|28|||
19531853|NCT00000620|41978390|FG006|Overall Study|missed closeout visit|13|||
19531854|NCT00000620|41978391|FG007|Overall Study|missed closeout visit|16|||
19531855|NCT00001262|41978454|FG000|Overall Study|Death|10|||
19531856|NCT00001262|41978455|FG001|Overall Study|Death|11|||
19531857|NCT00001262|41978456|FG002|Overall Study|Death|0|||
19531858|NCT00001262|41978454|FG000|Overall Study|Withdrawal by Subject|0|||
19531859|NCT00001262|41978455|FG001|Overall Study|Withdrawal by Subject|3|||
19531860|NCT00001262|41978456|FG002|Overall Study|Withdrawal by Subject|0|||
19531861|NCT00001277|41978473|FG000|Overall Study|Adverse Event|0|||
19531862|NCT00001277|41978474|FG001|Overall Study|Adverse Event|0|||
19630030|NCT00790842|42079351|FG005|Dose Level 4|Physician Decision|0|||
19630031|NCT00790842|42079352|FG006|Dose Level 4|Physician Decision|1|||
19630032|NCT00790842|42079353|FG007|Dose Level 4|Physician Decision|0|||
19630033|NCT00790842|42079354|FG008|Dose Level 4|Physician Decision|0|||
19630034|NCT00790842|42079355|FG009|Dose Level 4|Physician Decision|0|||
19630035|NCT00790842|42079356|FG010|Dose Level 4|Physician Decision|1|||
19630036|NCT00790842|42079346|FG000|Dose Level 4|Withdrawal by Subject|0|||
19630037|NCT00790842|42079347|FG001|Dose Level 4|Withdrawal by Subject|0|||
19630038|NCT00790842|42079348|FG002|Dose Level 4|Withdrawal by Subject|0|||
19630039|NCT00790842|42079349|FG003|Dose Level 4|Withdrawal by Subject|0|||
19630040|NCT00790842|42079350|FG004|Dose Level 4|Withdrawal by Subject|0|||
19630041|NCT00790842|42079351|FG005|Dose Level 4|Withdrawal by Subject|0|||
19630042|NCT00790842|42079352|FG006|Dose Level 4|Withdrawal by Subject|0|||
19630043|NCT00790842|42079353|FG007|Dose Level 4|Withdrawal by Subject|0|||
19630044|NCT00790842|42079354|FG008|Dose Level 4|Withdrawal by Subject|0|||
19452559|NCT01517373|41701479|FG002|Treatment Period|Other|0|||
19452560|NCT01517373|41701480|FG003|Treatment Period|Other|0|||
19452561|NCT01517373|41701481|FG004|Treatment Period|Other|1|||
19452562|NCT01517373|41701482|FG005|Treatment Period|Other|0|||
19452563|NCT01517373|41701477|FG000|Treatment Period|Protocol Violation|0|||
19452564|NCT01517373|41701478|FG001|Treatment Period|Protocol Violation|0|||
19452565|NCT01517373|41701479|FG002|Treatment Period|Protocol Violation|0|||
19452566|NCT01517373|41701480|FG003|Treatment Period|Protocol Violation|0|||
19452567|NCT01517373|41701481|FG004|Treatment Period|Protocol Violation|1|||
19452568|NCT01517373|41701482|FG005|Treatment Period|Protocol Violation|0|||
19452569|NCT01517373|41701477|FG000|Treatment Period|Lack of Efficacy|0|||
19452570|NCT01517373|41701478|FG001|Treatment Period|Lack of Efficacy|1|||
19452571|NCT01517373|41701479|FG002|Treatment Period|Lack of Efficacy|1|||
19452572|NCT01517373|41701480|FG003|Treatment Period|Lack of Efficacy|3|||
19452573|NCT01517373|41701481|FG004|Treatment Period|Lack of Efficacy|2|||
19452574|NCT01517373|41701482|FG005|Treatment Period|Lack of Efficacy|0|||
19452575|NCT01517373|41701477|FG000|Treatment Period|Medication error without AEs|0|||
19452576|NCT01517373|41701478|FG001|Treatment Period|Medication error without AEs|0|||
19452577|NCT01517373|41701479|FG002|Treatment Period|Medication error without AEs|2|||
19531863|NCT00001277|41978475|FG002|Overall Study|Adverse Event|1|||
19531864|NCT00001277|41978473|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
19531865|NCT00001277|41978474|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
19531866|NCT00001277|41978475|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
19531867|NCT00001703|41978521|FG000|Overall Study|progressed disease|2|||
19531868|NCT00001703|41978521|FG000|Overall Study|No evidence of disease|1|||
19630045|NCT00790842|42079355|FG009|Dose Level 4|Withdrawal by Subject|0|||
19630046|NCT00790842|42079356|FG010|Dose Level 4|Withdrawal by Subject|1|||
19630047|NCT00790842|42079346|FG000|Expansion Cohort|Adverse Event|0|||
19452578|NCT01517373|41701480|FG003|Treatment Period|Medication error without AEs|1|||
19531869|NCT00001703|41978521|FG000|Overall Study|recurrent disease|2|||
19531870|NCT01349907|41978545|FG000|Overall Study|Adverse Event|37|||
19531871|NCT01349907|41978546|FG001|Overall Study|Adverse Event|11|||
19531872|NCT01349907|41978545|FG000|Overall Study|Treatment failure|13|||
19531873|NCT01349907|41978546|FG001|Overall Study|Treatment failure|4|||
19531874|NCT01349907|41978545|FG000|Overall Study|Lost to Follow-up|25|||
19531875|NCT01349907|41978546|FG001|Overall Study|Lost to Follow-up|6|||
19531876|NCT01349907|41978545|FG000|Overall Study|Withdrawal by Subject|30|||
19531877|NCT01349907|41978546|FG001|Overall Study|Withdrawal by Subject|8|||
19531878|NCT01349907|41978545|FG000|Overall Study|Protocol Violation|33|||
19531879|NCT01349907|41978546|FG001|Overall Study|Protocol Violation|13|||
19531880|NCT01349907|41978545|FG000|Overall Study|Administrative|1|||
19531881|NCT01349907|41978546|FG001|Overall Study|Administrative|1|||
19531882|NCT04847141|41978555|FG000|Overall Study|Adverse Event|1|||
19531883|NCT04847141|41978556|FG001|Overall Study|Adverse Event|0|||
19531884|NCT04847141|41978557|FG002|Overall Study|Adverse Event|1|||
19531885|NCT04847141|41978555|FG000|Overall Study|Withdrawal by Subject|2|||
19531886|NCT04847141|41978556|FG001|Overall Study|Withdrawal by Subject|4|||
19531887|NCT04847141|41978557|FG002|Overall Study|Withdrawal by Subject|3|||
19531888|NCT04847141|41978555|FG000|Overall Study|Lost to Follow-up|7|||
19531889|NCT04847141|41978556|FG001|Overall Study|Lost to Follow-up|5|||
19531890|NCT04847141|41978557|FG002|Overall Study|Lost to Follow-up|7|||
19531891|NCT04847141|41978555|FG000|Overall Study|Reason not Specified|0|||
19531892|NCT04847141|41978556|FG001|Overall Study|Reason not Specified|1|||
19531893|NCT04847141|41978557|FG002|Overall Study|Reason not Specified|0|||
19531894|NCT01349829|41978567|FG000|Overall Study|Lost to Follow-up|4|||
19531895|NCT01349829|41978568|FG001|Overall Study|Lost to Follow-up|8|||
19531896|NCT01349829|41978567|FG000|Overall Study|Consent withdrawal|3|||
19531897|NCT01349829|41978568|FG001|Overall Study|Consent withdrawal|8|||
19531898|NCT01349829|41978567|FG000|Overall Study|Migrated/moved|2|||
19531899|NCT01349829|41978568|FG001|Overall Study|Migrated/moved|7|||
19531900|NCT01350128|41978576|FG000|Overall Study|Withdrawal by Subject|3|||
19531901|NCT01350128|41978576|FG000|Overall Study|Protocol discontinuation criteria|8|||
19531902|NCT01350128|41978576|FG000|Overall Study|Physician Decision|1|||
19531903|NCT01350128|41978576|FG000|Overall Study|Lost to Follow-up|2|||
19531904|NCT03893825|41978656|FG000|Overall Study|Death|2|||
19531905|NCT03893825|41978657|FG001|Overall Study|Death|1|||
19531906|NCT03893825|41978656|FG000|Overall Study|Adverse Event|0|||
19531907|NCT03893825|41978657|FG001|Overall Study|Adverse Event|2|||
19531908|NCT03893825|41978656|FG000|Overall Study|Withdrawal by Subject|19|||
19531909|NCT03893825|41978657|FG001|Overall Study|Withdrawal by Subject|21|||
19531910|NCT03893825|41978656|FG000|Overall Study|Protocol deviation|1|||
19531911|NCT03893825|41978657|FG001|Overall Study|Protocol deviation|0|||
19531912|NCT03893825|41978656|FG000|Overall Study|Lost to Follow-up|10|||
19531913|NCT03893825|41978657|FG001|Overall Study|Lost to Follow-up|10|||
19531914|NCT03893825|41978656|FG000|Overall Study|Other than specified|7|||
19531915|NCT03893825|41978657|FG001|Overall Study|Other than specified|6|||
19531916|NCT03890666|41978665|FG000|Overall Study|Withdrawal by Subject|0|||
19531917|NCT03890666|41978666|FG001|Overall Study|Withdrawal by Subject|1|||
19531918|NCT03890666|41978665|FG000|Overall Study|Protocol deviation|1|||
19531919|NCT03890666|41978666|FG001|Overall Study|Protocol deviation|4|||
19531920|NCT03890666|41978665|FG000|Overall Study|Lost to Follow-up|2|||
19531921|NCT03890666|41978666|FG001|Overall Study|Lost to Follow-up|5|||
19531922|NCT03890666|41978665|FG000|Overall Study|Other than specified|1|||
19531923|NCT03890666|41978666|FG001|Overall Study|Other than specified|8|||
19531924|NCT03276572|41978720|FG000|Overall Study|In follow-up|0|||
19531925|NCT03276572|41978721|FG001|Overall Study|In follow-up|0|||
19531926|NCT03276572|41978722|FG002|Overall Study|In follow-up|0|||
19531927|NCT03276572|41978723|FG003|Overall Study|In follow-up|0|||
19531928|NCT03276572|41978724|FG004|Overall Study|In follow-up|0|||
19531929|NCT03276572|41978725|FG005|Overall Study|In follow-up|1|||
19531930|NCT03276572|41978726|FG006|Overall Study|In follow-up|1|||
19531931|NCT03276572|41978720|FG000|Overall Study|Lost to Follow-up|0|||
19531932|NCT03276572|41978721|FG001|Overall Study|Lost to Follow-up|0|||
19531933|NCT03276572|41978722|FG002|Overall Study|Lost to Follow-up|0|||
19531934|NCT03276572|41978723|FG003|Overall Study|Lost to Follow-up|0|||
19531935|NCT03276572|41978724|FG004|Overall Study|Lost to Follow-up|0|||
19531936|NCT03276572|41978725|FG005|Overall Study|Lost to Follow-up|0|||
19531937|NCT03276572|41978726|FG006|Overall Study|Lost to Follow-up|1|||
19531938|NCT03090737|41978751|FG000|Overall Study|Other reasons|1|||
19531939|NCT03090737|41978751|FG000|Overall Study|Completed treatment as per protocol|17|||
19531940|NCT03090737|41978751|FG000|Overall Study|Maximum clinical benefit|2|||
19531941|NCT03090737|41978751|FG000|Overall Study|Adverse event unrelated to study drug|7|||
19531942|NCT03090737|41978751|FG000|Overall Study|Study drug toxicity|4|||
19531943|NCT03090737|41978751|FG000|Overall Study|Disease progression|98|||
19531944|NCT03004976|41978796|FG000|Overall Study|Lost to Follow-up|7|||
19531945|NCT03004976|41978797|FG001|Overall Study|Lost to Follow-up|5|||
19531946|NCT03004976|41978796|FG000|Overall Study|Physician Decision|1|||
19531947|NCT03004976|41978797|FG001|Overall Study|Physician Decision|0|||
19531948|NCT03004976|41978796|FG000|Overall Study|Withdrawal by Subject|1|||
19452579|NCT01517373|41701481|FG004|Treatment Period|Medication error without AEs|0|||
19452580|NCT01517373|41701482|FG005|Treatment Period|Medication error without AEs|2|||
19452581|NCT01517295|41701497|FG000|Overall Study|Physician Decision|1|||
19452582|NCT01517295|41701498|FG001|Overall Study|Physician Decision|0|||
19452583|NCT01541865|41701504|FG000|Overall Study|Lost to Follow-up|11|||
19452584|NCT01541865|41701504|FG000|Overall Study|Withdrawal by Subject|9|||
19452585|NCT01541865|41701504|FG000|Overall Study|Adverse Event|1|||
19452586|NCT01541865|41701504|FG000|Overall Study|Protocol Violation|1|||
19452587|NCT01541397|41701510|FG000|Overall Study|Study ended prior to data collection|4|||
19452588|NCT01541397|41701511|FG001|Overall Study|Study ended prior to data collection|2|||
19452589|NCT01548417|41701519|FG000|Overall Study|Withdrawal by Subject|0|||
19452590|NCT01548417|41701520|FG001|Overall Study|Withdrawal by Subject|2|||
19452591|NCT01546857|41701528|FG000|Overall Study|Withdrawal by Subject|2|||
19452592|NCT01546857|41701529|FG001|Overall Study|Withdrawal by Subject|3|||
19452593|NCT01540851|41701538|FG000|Overall Study|Lost to Follow-up|14|||
19531949|NCT03004976|41978797|FG001|Overall Study|Withdrawal by Subject|0|||
19531950|NCT03004976|41978796|FG000|Overall Study|Death|4|||
19531951|NCT03004976|41978797|FG001|Overall Study|Death|1|||
19531952|NCT02985866|41978805|FG000|Overall Study|Poor CGM data|1|||
19531953|NCT02985866|41978806|FG001|Overall Study|Poor CGM data|1|||
19531954|NCT02762981|41978831|FG000|Overall Study|Adverse Event|2|||
19531955|NCT02762981|41978832|FG001|Overall Study|Adverse Event|3|||
19531956|NCT02762981|41978833|FG002|Overall Study|Adverse Event|1|||
19531957|NCT02762981|41978834|FG003|Overall Study|Adverse Event|1|||
19531958|NCT02762981|41978835|FG004|Overall Study|Adverse Event|3|||
19531959|NCT02762981|41978831|FG000|Overall Study|Physician Decision|0|||
19531960|NCT02762981|41978832|FG001|Overall Study|Physician Decision|1|||
19531961|NCT02762981|41978833|FG002|Overall Study|Physician Decision|0|||
19531962|NCT02762981|41978834|FG003|Overall Study|Physician Decision|0|||
19531963|NCT02762981|41978835|FG004|Overall Study|Physician Decision|1|||
19531964|NCT02762981|41978831|FG000|Overall Study|Disease progression|11|||
19531965|NCT02762981|41978832|FG001|Overall Study|Disease progression|23|||
19531966|NCT02762981|41978833|FG002|Overall Study|Disease progression|4|||
19531967|NCT02762981|41978834|FG003|Overall Study|Disease progression|10|||
19531968|NCT02762981|41978835|FG004|Overall Study|Disease progression|1|||
19531969|NCT02762981|41978831|FG000|Overall Study|Enrolled not treated|1|||
19531970|NCT02762981|41978832|FG001|Overall Study|Enrolled not treated|5|||
19531971|NCT02762981|41978833|FG002|Overall Study|Enrolled not treated|0|||
19531972|NCT02762981|41978834|FG003|Overall Study|Enrolled not treated|2|||
19531973|NCT02762981|41978835|FG004|Overall Study|Enrolled not treated|0|||
19531974|NCT02762981|41978831|FG000|Overall Study|Other|2|||
19531975|NCT02762981|41978832|FG001|Overall Study|Other|3|||
19531976|NCT02762981|41978833|FG002|Overall Study|Other|1|||
19531977|NCT02762981|41978834|FG003|Overall Study|Other|0|||
19531978|NCT02762981|41978835|FG004|Overall Study|Other|0|||
19531979|NCT02762981|41978831|FG000|Overall Study|Missing|1|||
19531980|NCT02762981|41978832|FG001|Overall Study|Missing|0|||
19531981|NCT02762981|41978833|FG002|Overall Study|Missing|0|||
19531982|NCT02762981|41978834|FG003|Overall Study|Missing|0|||
19531983|NCT02762981|41978835|FG004|Overall Study|Missing|0|||
19531984|NCT02762981|41978831|FG000|Overall Study|Withdrawal by Subject|0|||
19531985|NCT02762981|41978832|FG001|Overall Study|Withdrawal by Subject|5|||
19531986|NCT02762981|41978833|FG002|Overall Study|Withdrawal by Subject|1|||
19531987|NCT02762981|41978834|FG003|Overall Study|Withdrawal by Subject|3|||
19630048|NCT00790842|42079347|FG001|Expansion Cohort|Adverse Event|0|||
19630049|NCT00790842|42079348|FG002|Expansion Cohort|Adverse Event|0|||
19630050|NCT00790842|42079349|FG003|Expansion Cohort|Adverse Event|0|||
19452594|NCT01540851|41701539|FG001|Overall Study|Lost to Follow-up|15|||
19531988|NCT02762981|41978835|FG004|Overall Study|Withdrawal by Subject|0|||
19531989|NCT02255435|41978875|FG000|Overall Study|Patient's Limited Time Availability|0|||
19531990|NCT02255435|41978876|FG001|Overall Study|Patient's Limited Time Availability|0|||
19531991|NCT02255435|41978877|FG002|Overall Study|Patient's Limited Time Availability|0|||
19531992|NCT02255435|41978878|FG003|Overall Study|Patient's Limited Time Availability|0|||
19531993|NCT02255435|41978879|FG004|Overall Study|Patient's Limited Time Availability|0|||
19531994|NCT02255435|41978880|FG005|Overall Study|Patient's Limited Time Availability|0|||
19531995|NCT02255435|41978881|FG006|Overall Study|Patient's Limited Time Availability|0|||
19531996|NCT02255435|41978882|FG007|Overall Study|Patient's Limited Time Availability|1|||
19452595|NCT01540851|41701538|FG000|Overall Study|Withdrawal by Subject|7|||
19452596|NCT01540851|41701539|FG001|Overall Study|Withdrawal by Subject|3|||
19531997|NCT02255435|41978883|FG008|Overall Study|Patient's Limited Time Availability|0|||
19531998|NCT02255435|41978884|FG009|Overall Study|Patient's Limited Time Availability|0|||
19531999|NCT02255435|41978875|FG000|Overall Study|Withdrawal by Subject|0|||
19532000|NCT02255435|41978876|FG001|Overall Study|Withdrawal by Subject|0|||
19532001|NCT02255435|41978877|FG002|Overall Study|Withdrawal by Subject|0|||
19532002|NCT02255435|41978878|FG003|Overall Study|Withdrawal by Subject|0|||
19532003|NCT02255435|41978879|FG004|Overall Study|Withdrawal by Subject|0|||
19532004|NCT02255435|41978880|FG005|Overall Study|Withdrawal by Subject|0|||
19532005|NCT02255435|41978881|FG006|Overall Study|Withdrawal by Subject|0|||
19532006|NCT02255435|41978882|FG007|Overall Study|Withdrawal by Subject|0|||
19532007|NCT02255435|41978883|FG008|Overall Study|Withdrawal by Subject|1|||
19532008|NCT02255435|41978884|FG009|Overall Study|Withdrawal by Subject|4|||
19532009|NCT02255435|41978875|FG000|Overall Study|Administrative reasons|0|||
19532010|NCT02255435|41978876|FG001|Overall Study|Administrative reasons|0|||
19532011|NCT02255435|41978877|FG002|Overall Study|Administrative reasons|0|||
19532012|NCT02255435|41978878|FG003|Overall Study|Administrative reasons|0|||
19532013|NCT02255435|41978879|FG004|Overall Study|Administrative reasons|0|||
19532014|NCT02255435|41978880|FG005|Overall Study|Administrative reasons|0|||
19532015|NCT02255435|41978881|FG006|Overall Study|Administrative reasons|0|||
19532016|NCT02255435|41978882|FG007|Overall Study|Administrative reasons|0|||
19532017|NCT02255435|41978883|FG008|Overall Study|Administrative reasons|0|||
19532018|NCT02255435|41978884|FG009|Overall Study|Administrative reasons|2|||
19532019|NCT01902173|41978912|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
19532020|NCT01902173|41978913|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
19532021|NCT01902173|41978914|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
19532022|NCT01902173|41978915|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
19630051|NCT00790842|42079350|FG004|Expansion Cohort|Adverse Event|0|||
19630052|NCT00790842|42079351|FG005|Expansion Cohort|Adverse Event|0|||
19630053|NCT00790842|42079352|FG006|Expansion Cohort|Adverse Event|1|||
19630054|NCT00790842|42079353|FG007|Expansion Cohort|Adverse Event|0|||
19630055|NCT00790842|42079354|FG008|Expansion Cohort|Adverse Event|0|||
19630056|NCT00790842|42079355|FG009|Expansion Cohort|Adverse Event|0|||
19532023|NCT01902173|41978916|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
19532024|NCT01902173|41978917|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
19532025|NCT01902173|41978912|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
19532026|NCT01902173|41978913|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
19532027|NCT01902173|41978914|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
19532028|NCT01902173|41978915|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
19532029|NCT01902173|41978916|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
19532030|NCT01902173|41978917|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
19532031|NCT01902173|41978912|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
19532032|NCT01902173|41978913|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
19532033|NCT01902173|41978914|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
19532034|NCT01902173|41978915|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
19532035|NCT01902173|41978916|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
19532036|NCT01902173|41978917|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
19532037|NCT01902173|41978912|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
19532038|NCT01902173|41978913|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
19532039|NCT01902173|41978914|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
19532040|NCT01902173|41978915|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
19532041|NCT01902173|41978916|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
19532042|NCT01902173|41978917|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
19532043|NCT01902173|41978912|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
19532044|NCT01902173|41978913|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
19532045|NCT01902173|41978914|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
19532046|NCT01902173|41978915|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
19532047|NCT01902173|41978916|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
19532048|NCT01902173|41978917|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
19532049|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
19532050|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
19630057|NCT00790842|42079356|FG010|Expansion Cohort|Adverse Event|0|||
19630058|NCT00790842|42079346|FG000|Expansion Cohort|Death|0|||
19630059|NCT00790842|42079347|FG001|Expansion Cohort|Death|0|||
19630060|NCT00790842|42079348|FG002|Expansion Cohort|Death|2|||
19630061|NCT00790842|42079349|FG003|Expansion Cohort|Death|0|||
19630062|NCT00790842|42079350|FG004|Expansion Cohort|Death|0|||
19630063|NCT00790842|42079351|FG005|Expansion Cohort|Death|0|||
19630064|NCT00790842|42079352|FG006|Expansion Cohort|Death|0|||
19630065|NCT00790842|42079353|FG007|Expansion Cohort|Death|0|||
19630066|NCT00790842|42079354|FG008|Expansion Cohort|Death|0|||
19630067|NCT00790842|42079355|FG009|Expansion Cohort|Death|0|||
19630068|NCT00790842|42079356|FG010|Expansion Cohort|Death|0|||
19630069|NCT00790842|42079346|FG000|Expansion Cohort|Physician Decision|0|||
19630070|NCT00790842|42079347|FG001|Expansion Cohort|Physician Decision|0|||
19630071|NCT00790842|42079348|FG002|Expansion Cohort|Physician Decision|1|||
19630072|NCT00790842|42079349|FG003|Expansion Cohort|Physician Decision|0|||
19630073|NCT00790842|42079350|FG004|Expansion Cohort|Physician Decision|0|||
19630074|NCT00790842|42079351|FG005|Expansion Cohort|Physician Decision|0|||
19630075|NCT00790842|42079352|FG006|Expansion Cohort|Physician Decision|0|||
19630076|NCT00790842|42079353|FG007|Expansion Cohort|Physician Decision|0|||
19630077|NCT00790842|42079354|FG008|Expansion Cohort|Physician Decision|0|||
19630078|NCT00790842|42079355|FG009|Expansion Cohort|Physician Decision|0|||
19532051|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
19532052|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
19532053|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
19532054|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
19532055|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
19532056|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
19532057|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
19532058|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
19532059|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
19532060|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
19532061|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
19532062|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
19532063|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
19532064|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
19532065|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
19532066|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
19532067|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
19532068|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
19532069|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
19532070|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
19532071|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
19532072|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
19532073|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
19532074|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
19532075|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
19532076|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
19532077|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
19532078|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
19532079|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
19532080|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
19532081|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
19532082|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
19532083|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
19532084|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
19532085|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
19532086|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
19532087|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
19532088|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
19532089|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
19452597|NCT01516749|41701547|FG000|Active Therapy|Lost to Follow-up|1|||
19452598|NCT01516749|41701547|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
19452599|NCT01516437|41701555|FG000|Overall Study|Reason not specified|0|||
19452600|NCT01516437|41701556|FG001|Overall Study|Reason not specified|0|||
19452601|NCT01516437|41701557|FG002|Overall Study|Reason not specified|1|||
19452602|NCT01516437|41701558|FG003|Overall Study|Reason not specified|1|||
19452603|NCT01515423|41701572|FG000|Open Label Phase|Adverse Event|57|||
19452604|NCT01515423|41701573|FG001|Open Label Phase|Adverse Event|0|||
19452605|NCT01515423|41701574|FG002|Open Label Phase|Adverse Event|0|||
19452606|NCT01515423|41701572|FG000|Open Label Phase|Death|2|||
19452607|NCT01515423|41701573|FG001|Open Label Phase|Death|0|||
19452608|NCT01515423|41701574|FG002|Open Label Phase|Death|0|||
19452609|NCT01515423|41701572|FG000|Open Label Phase|Lack of Efficacy|117|||
19452610|NCT01515423|41701573|FG001|Open Label Phase|Lack of Efficacy|0|||
19452611|NCT01515423|41701574|FG002|Open Label Phase|Lack of Efficacy|0|||
19452612|NCT01515423|41701572|FG000|Open Label Phase|Lost to Follow-up|21|||
19452613|NCT01515423|41701573|FG001|Open Label Phase|Lost to Follow-up|0|||
19452614|NCT01515423|41701574|FG002|Open Label Phase|Lost to Follow-up|0|||
19452615|NCT01515423|41701572|FG000|Open Label Phase|Withdrawal by Subject|118|||
19452616|NCT01515423|41701573|FG001|Open Label Phase|Withdrawal by Subject|0|||
19452617|NCT01515423|41701574|FG002|Open Label Phase|Withdrawal by Subject|0|||
19452618|NCT01515423|41701572|FG000|Open Label Phase|excluded from DB Phase|70|||
19452619|NCT01515423|41701573|FG001|Open Label Phase|excluded from DB Phase|0|||
19532090|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
19532091|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
19532092|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
19532093|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
19532094|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
19532095|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
19452620|NCT01515423|41701574|FG002|Open Label Phase|excluded from DB Phase|0|||
19452621|NCT01515423|41701572|FG000|Open Label Phase|Other|28|||
19452622|NCT01515423|41701573|FG001|Open Label Phase|Other|0|||
19532096|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
19532097|NCT01902173|41978912|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
19532098|NCT01902173|41978913|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
19532099|NCT01902173|41978914|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
19532100|NCT01902173|41978915|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
19532101|NCT01902173|41978916|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
19532102|NCT01902173|41978917|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
19532103|NCT00640133|41978949|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
19532104|NCT00640133|41978950|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
19532105|NCT00640133|41978949|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
19532106|NCT00640133|41978950|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
19532107|NCT00640133|41978949|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
19532108|NCT00640133|41978950|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
19532109|NCT00001832|41978994|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
19532110|NCT00001832|41978995|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
19532111|NCT00001832|41978996|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
19532112|NCT00001832|41978997|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
19532113|NCT00001832|41978998|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
19532114|NCT00001832|41978999|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
19532115|NCT00001832|41979000|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
19532116|NCT00001832|41979001|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
19532117|NCT00001832|41979002|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
19532118|NCT00001832|41979003|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
19532119|NCT00001832|41979004|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
19532120|NCT00001832|41979005|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
19532121|NCT00001832|41979006|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
19532122|NCT00001832|41979007|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
19532123|NCT00001832|41979008|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
19532124|NCT00001832|41978994|FG000|Treatment Period|Death during treatment|0|||
19532125|NCT00001832|41978995|FG001|Treatment Period|Death during treatment|0|||
19532126|NCT00001832|41978996|FG002|Treatment Period|Death during treatment|0|||
19532127|NCT00001832|41978997|FG003|Treatment Period|Death during treatment|0|||
19532128|NCT00001832|41978998|FG004|Treatment Period|Death during treatment|0|||
19532129|NCT00001832|41978999|FG005|Treatment Period|Death during treatment|1|||
19532130|NCT00001832|41979000|FG006|Treatment Period|Death during treatment|0|||
19532131|NCT00001832|41979001|FG007|Treatment Period|Death during treatment|0|||
19532132|NCT00001832|41979002|FG008|Treatment Period|Death during treatment|0|||
19532133|NCT00001832|41979003|FG009|Treatment Period|Death during treatment|0|||
19532134|NCT00001832|41979004|FG010|Treatment Period|Death during treatment|0|||
19532135|NCT00001832|41979005|FG011|Treatment Period|Death during treatment|0|||
19532136|NCT00001832|41979006|FG012|Treatment Period|Death during treatment|0|||
19532137|NCT00001832|41979007|FG013|Treatment Period|Death during treatment|0|||
19532138|NCT00001832|41979008|FG014|Treatment Period|Death during treatment|0|||
19532139|NCT00001832|41978994|FG000|Treatment Period|Not treated|0|||
19532140|NCT00001832|41978995|FG001|Treatment Period|Not treated|0|||
19532141|NCT00001832|41978996|FG002|Treatment Period|Not treated|0|||
19532142|NCT00001832|41978997|FG003|Treatment Period|Not treated|0|||
19532143|NCT00001832|41978998|FG004|Treatment Period|Not treated|0|||
19532144|NCT00001832|41978999|FG005|Treatment Period|Not treated|0|||
19532145|NCT00001832|41979000|FG006|Treatment Period|Not treated|0|||
19532146|NCT00001832|41979001|FG007|Treatment Period|Not treated|1|||
19532147|NCT00001832|41979002|FG008|Treatment Period|Not treated|0|||
19532148|NCT00001832|41979003|FG009|Treatment Period|Not treated|0|||
19532149|NCT00001832|41979004|FG010|Treatment Period|Not treated|0|||
19532150|NCT00001832|41979005|FG011|Treatment Period|Not treated|0|||
19532151|NCT00001832|41979006|FG012|Treatment Period|Not treated|0|||
19532152|NCT00001832|41979007|FG013|Treatment Period|Not treated|0|||
19532153|NCT00001832|41979008|FG014|Treatment Period|Not treated|0|||
19532154|NCT01349816|41979242|FG000|Overall Study|Withdrawal by Subject|4|||
19532155|NCT01349816|41979242|FG000|Overall Study|Physician Decision|1|||
19532156|NCT01349816|41979242|FG000|Overall Study|Adverse Event|14|||
19532157|NCT01349816|41979242|FG000|Overall Study|Lost to Follow-up|2|||
19532158|NCT01349816|41979242|FG000|Overall Study|Protocol Violation|1|||
19532159|NCT01349816|41979242|FG000|Overall Study|Protocol-specified criteria|8|||
19532160|NCT02971137|41979358|FG000|Overall Study|Lost to Follow-up|44|||
19532161|NCT02971137|41979359|FG001|Overall Study|Lost to Follow-up|56|||
19532162|NCT05201807|41979430|FG000|Overall Study|Adverse Event|1|||
19532163|NCT05201807|41979430|FG000|Overall Study|COVID-19 Related|1|||
19532164|NCT04978337|41979436|FG000|Overall Study|Withdrawal by Subject|0|||
19532165|NCT04978337|41979437|FG001|Overall Study|Withdrawal by Subject|1|||
19532166|NCT04828707|41979446|FG000|Overall Study|Lost to Follow-up|3|||
19532167|NCT04828707|41979447|FG001|Overall Study|Lost to Follow-up|2|||
19532168|NCT04828707|41979446|FG000|Overall Study|Withdrawal by Subject|2|||
19532169|NCT04828707|41979447|FG001|Overall Study|Withdrawal by Subject|1|||
19452623|NCT01515423|41701574|FG002|Open Label Phase|Other|0|||
19452624|NCT01515423|41701572|FG000|DOUBLE BLIND|Adverse Event|0|||
19452625|NCT01515423|41701573|FG001|DOUBLE BLIND|Adverse Event|15|||
19452626|NCT01515423|41701574|FG002|DOUBLE BLIND|Adverse Event|13|||
19452627|NCT01515423|41701572|FG000|DOUBLE BLIND|Death|0|||
19452628|NCT01515423|41701573|FG001|DOUBLE BLIND|Death|1|||
19452629|NCT01515423|41701574|FG002|DOUBLE BLIND|Death|2|||
19452630|NCT01515423|41701572|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
19711417|NCT03569098|42154517|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
19452631|NCT01515423|41701573|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
19452632|NCT01515423|41701574|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
19452633|NCT01515423|41701572|FG000|DOUBLE BLIND|Pregnancy|0|||
19452634|NCT01515423|41701573|FG001|DOUBLE BLIND|Pregnancy|2|||
19452635|NCT01515423|41701574|FG002|DOUBLE BLIND|Pregnancy|0|||
19452636|NCT01515423|41701572|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
19452637|NCT01515423|41701573|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
19452638|NCT01515423|41701574|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
19452639|NCT01515423|41701572|FG000|DOUBLE BLIND|Other|0|||
19452640|NCT01515423|41701573|FG001|DOUBLE BLIND|Other|6|||
19452641|NCT01515423|41701574|FG002|DOUBLE BLIND|Other|12|||
19452642|NCT01515423|41701572|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
19452643|NCT01515423|41701573|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
19452644|NCT01515423|41701574|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
19452645|NCT00637156|41701583|FG000|Overall Study|Withdrawal by Subject|0|||
19452646|NCT00637156|41701584|FG001|Overall Study|Withdrawal by Subject|7|||
19452647|NCT00637156|41701583|FG000|Overall Study|Death|0|||
19452648|NCT00637156|41701584|FG001|Overall Study|Death|1|||
19452649|NCT00637156|41701583|FG000|Overall Study|Lost to Follow-up|10|||
19452650|NCT00637156|41701584|FG001|Overall Study|Lost to Follow-up|16|||
19452651|NCT00637000|41701592|FG000|Overall Study|Withdrawal by Subject|4|||
19452652|NCT00637000|41701593|FG001|Overall Study|Withdrawal by Subject|3|||
19452653|NCT01515189|41701601|FG000|Induction|Disease Progression|109|||
19452654|NCT01515189|41701602|FG001|Induction|Disease Progression|155|||
19452655|NCT01515189|41701601|FG000|Induction|Study drug toxicity|86|||
19452656|NCT01515189|41701602|FG001|Induction|Study drug toxicity|36|||
19452657|NCT01515189|41701601|FG000|Induction|Death|24|||
19452658|NCT01515189|41701602|FG001|Induction|Death|17|||
19452659|NCT01515189|41701601|FG000|Induction|Adverse Event|14|||
19452660|NCT01515189|41701602|FG001|Induction|Adverse Event|9|||
19452661|NCT01515189|41701601|FG000|Induction|Withdrawal by Subject|3|||
19452662|NCT01515189|41701602|FG001|Induction|Withdrawal by Subject|9|||
19452663|NCT01515189|41701601|FG000|Induction|No longer meets study criteria|0|||
19452664|NCT01515189|41701602|FG001|Induction|No longer meets study criteria|2|||
19452665|NCT01515189|41701601|FG000|Induction|Lost to Follow-up|1|||
19452666|NCT01515189|41701602|FG001|Induction|Lost to Follow-up|0|||
19452667|NCT01515189|41701601|FG000|Induction|Other|0|||
19452668|NCT01515189|41701602|FG001|Induction|Other|4|||
19452669|NCT01515189|41701601|FG000|First Re-Induction Phase|Disease progression|6|||
19452670|NCT01515189|41701602|FG001|First Re-Induction Phase|Disease progression|14|||
19452671|NCT01515189|41701601|FG000|First Re-Induction Phase|Study drug toxicity|5|||
19452672|NCT01515189|41701602|FG001|First Re-Induction Phase|Study drug toxicity|0|||
19452673|NCT01515189|41701601|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
19452674|NCT01515189|41701602|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
19452675|NCT01515189|41701601|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
19452676|NCT01515189|41701602|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
19452677|NCT01515189|41701601|FG000|First Re-Induction Phase|Other|1|||
19452678|NCT01515189|41701602|FG001|First Re-Induction Phase|Other|0|||
19452679|NCT01546623|41701610|FG000|Overall Study|Adverse Event|2|||
19452680|NCT01546623|41701611|FG001|Overall Study|Adverse Event|3|||
19452681|NCT01546623|41701610|FG000|Overall Study|Major Protocol Deviation|1|||
19452682|NCT01546623|41701611|FG001|Overall Study|Major Protocol Deviation|1|||
19452683|NCT01546623|41701610|FG000|Overall Study|High Prostate specific antigen|2|||
19452684|NCT01546623|41701611|FG001|Overall Study|High Prostate specific antigen|1|||
19452685|NCT01546623|41701610|FG000|Overall Study|Did Not Receive Study Drug|1|||
19452686|NCT01546623|41701611|FG001|Overall Study|Did Not Receive Study Drug|1|||
19452687|NCT01546155|41701617|FG000|Overall Study|could not tolerate long scan duration|3|||
19452688|NCT00636610|41701623|FG000|Overall Study|Adverse Event|4|||
19452689|NCT00636610|41701624|FG001|Overall Study|Adverse Event|4|||
19452690|NCT00636610|41701623|FG000|Overall Study|Death|6|||
19452691|NCT00636610|41701624|FG001|Overall Study|Death|3|||
19452692|NCT00636610|41701623|FG000|Overall Study|Physician decision to withdraw patient|15|||
19452693|NCT00636610|41701624|FG001|Overall Study|Physician decision to withdraw patient|9|||
19452694|NCT00636610|41701623|FG000|Overall Study|Subject decision to withdraw|15|||
19452695|NCT00636610|41701624|FG001|Overall Study|Subject decision to withdraw|11|||
19452696|NCT00636610|41701623|FG000|Overall Study|Disease progression - radiographic|41|||
19452697|NCT00636610|41701624|FG001|Overall Study|Disease progression - radiographic|51|||
19452698|NCT00636610|41701623|FG000|Overall Study|Disease progression - clinical|8|||
19452699|NCT00636610|41701624|FG001|Overall Study|Disease progression - clinical|3|||
19452700|NCT00636610|41701623|FG000|Overall Study|Reason for discontinuation not available|3|||
19452701|NCT00636610|41701624|FG001|Overall Study|Reason for discontinuation not available|2|||
19452702|NCT00635050|41701632|FG000|Overall Study|Withdrawal by Subject|1|||
19452703|NCT00634504|41701641|FG000|Overall Study|Protocol Violation|1|||
19452704|NCT00634504|41701642|FG001|Overall Study|Protocol Violation|0|||
19452705|NCT00634114|41701651|FG000|Overall Study|Adverse Event|6|||
19452706|NCT00634114|41701652|FG001|Overall Study|Adverse Event|8|||
19452707|NCT00634114|41701653|FG002|Overall Study|Adverse Event|3|||
19452708|NCT00634114|41701651|FG000|Overall Study|Withdrawal by Subject|9|||
19452709|NCT00634114|41701652|FG001|Overall Study|Withdrawal by Subject|6|||
19452710|NCT00634114|41701653|FG002|Overall Study|Withdrawal by Subject|11|||
19452711|NCT00634114|41701651|FG000|Overall Study|Lost to Follow-up|0|||
19452712|NCT00634114|41701652|FG001|Overall Study|Lost to Follow-up|0|||
19452713|NCT00634114|41701653|FG002|Overall Study|Lost to Follow-up|1|||
19452714|NCT00634114|41701651|FG000|Overall Study|Protocol Violation|3|||
19452715|NCT00634114|41701652|FG001|Overall Study|Protocol Violation|3|||
19452716|NCT00634114|41701653|FG002|Overall Study|Protocol Violation|1|||
19452717|NCT00634114|41701651|FG000|Overall Study|Pregnancy|1|||
19452718|NCT00634114|41701652|FG001|Overall Study|Pregnancy|0|||
19452719|NCT00634114|41701653|FG002|Overall Study|Pregnancy|0|||
19452720|NCT00634114|41701651|FG000|Overall Study|Incorrect enrolment|0|||
19452721|NCT00634114|41701652|FG001|Overall Study|Incorrect enrolment|1|||
19452722|NCT00634114|41701653|FG002|Overall Study|Incorrect enrolment|0|||
19452723|NCT00634114|41701651|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
19452724|NCT00634114|41701652|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
19452725|NCT00634114|41701653|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
19452726|NCT00634114|41701651|FG000|Overall Study|Difficult to continue|3|||
19452727|NCT00634114|41701652|FG001|Overall Study|Difficult to continue|1|||
19452728|NCT00634114|41701653|FG002|Overall Study|Difficult to continue|1|||
19452729|NCT00634114|41701651|FG000|Overall Study|Other reason|1|||
19452730|NCT00634114|41701652|FG001|Overall Study|Other reason|1|||
19452731|NCT00634114|41701653|FG002|Overall Study|Other reason|1|||
19452732|NCT00634036|41701663|FG000|Overall Study|Lost to Follow-up|1|||
19452733|NCT00634036|41701664|FG001|Overall Study|Lost to Follow-up|1|||
19532170|NCT04629534|41979466|FG000|Overall Study|Physician Decision|1|||
19532171|NCT04629534|41979467|FG001|Overall Study|Physician Decision|0|||
19532172|NCT04629534|41979466|FG000|Overall Study|Protocol Violation|0|||
19532173|NCT04629534|41979467|FG001|Overall Study|Protocol Violation|2|||
19532174|NCT04481191|41979479|FG000|Overall Study|Withdrawn by parent/guardian|15|||
19532175|NCT04481191|41979480|FG001|Overall Study|Withdrawn by parent/guardian|10|||
19532176|NCT03695185|41979503|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
19532177|NCT03695185|41979503|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
19532178|NCT03695185|41979503|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
19532179|NCT03695185|41979503|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
19532180|NCT03695185|41979503|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
19532181|NCT03695185|41979503|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
19532182|NCT03596164|41979510|FG000|Overall Study|Adverse Event|0|||
19532183|NCT03596164|41979511|FG001|Overall Study|Adverse Event|1|||
19532184|NCT03596164|41979510|FG000|Overall Study|Death|1|||
19532185|NCT03596164|41979511|FG001|Overall Study|Death|0|||
19532186|NCT03547908|41979521|FG000|Overall Study|Still On Study|115|||
19532187|NCT03547908|41979522|FG001|Overall Study|Still On Study|118|||
19532188|NCT03547908|41979521|FG000|Overall Study|Lost to Follow-up|2|||
19532189|NCT03547908|41979522|FG001|Overall Study|Lost to Follow-up|2|||
19532190|NCT03547908|41979521|FG000|Overall Study|Withdrew Consent|2|||
19532191|NCT03547908|41979522|FG001|Overall Study|Withdrew Consent|1|||
19532192|NCT03547908|41979521|FG000|Overall Study|Adverse Event|1|||
19532193|NCT03547908|41979522|FG001|Overall Study|Adverse Event|0|||
19532194|NCT03547908|41979521|FG000|Overall Study|Death|1|||
19532195|NCT03547908|41979522|FG001|Overall Study|Death|0|||
19532196|NCT03547908|41979521|FG000|Overall Study|Investigator's Discretion|0|||
19532197|NCT03547908|41979522|FG001|Overall Study|Investigator's Discretion|1|||
19532198|NCT03547908|41979521|FG000|Overall Study|Randomized But Never Treated|1|||
19532199|NCT03547908|41979522|FG001|Overall Study|Randomized But Never Treated|0|||
19532200|NCT03476798|41979528|FG000|Overall Study|Death|1|||
19532201|NCT03476798|41979528|FG000|Overall Study|Withdrawal by Subject|2|||
19532202|NCT03476798|41979528|FG000|Overall Study|Protocol Violation|2|||
19532203|NCT03240874|41979536|FG000|Overall Study|Lost to Follow-up|0|||
19532204|NCT03240874|41979537|FG001|Overall Study|Lost to Follow-up|2|||
19711418|NCT03568942|42154528|FG000|Overall Study|Family emergency|1|||
19532205|NCT03240874|41979538|FG002|Overall Study|Lost to Follow-up|4|||
19532206|NCT03240874|41979539|FG003|Overall Study|Lost to Follow-up|1|||
19532207|NCT03173560|41979549|FG000|Overall Study|Ongoing on Treatment|38|||
19452734|NCT00634036|41701663|FG000|Overall Study|Withdrawal by Subject|1|||
19452735|NCT00634036|41701664|FG001|Overall Study|Withdrawal by Subject|1|||
19452736|NCT01545375|41701672|FG000|Overall Study|Adverse Event|2|||
19452737|NCT01545375|41701673|FG001|Overall Study|Adverse Event|1|||
19532208|NCT03173560|41979550|FG001|Overall Study|Ongoing on Treatment|50|||
19452738|NCT01545375|41701672|FG000|Overall Study|Lost to Follow-up|34|||
19452739|NCT01545375|41701673|FG001|Overall Study|Lost to Follow-up|31|||
19452740|NCT01545375|41701672|FG000|Overall Study|Protocol Violation|3|||
19452741|NCT01545375|41701673|FG001|Overall Study|Protocol Violation|3|||
19452742|NCT01545375|41701672|FG000|Overall Study|Withdrawal by Subject|58|||
19452743|NCT01545375|41701673|FG001|Overall Study|Withdrawal by Subject|55|||
19452744|NCT01539837|41701682|FG000|Overall Study|reduce neutrophil level|0|||
19452745|NCT01539837|41701683|FG001|Overall Study|reduce neutrophil level|1|||
19452746|NCT01539837|41701684|FG002|Overall Study|reduce neutrophil level|1|||
19452747|NCT01539837|41701682|FG000|Overall Study|bad compliance|0|||
19452748|NCT01539837|41701683|FG001|Overall Study|bad compliance|0|||
19452749|NCT01539837|41701684|FG002|Overall Study|bad compliance|1|||
19452750|NCT01539759|41701694|FG000|Overall Study|Lost to Follow-up|6|||
19452751|NCT01539759|41701695|FG001|Overall Study|Lost to Follow-up|8|||
19452752|NCT00633022|41701704|FG000|Overall Study|Adverse Event|1|||
19452753|NCT00633022|41701705|FG001|Overall Study|Adverse Event|0|||
19452754|NCT00633022|41701706|FG002|Overall Study|Adverse Event|5|||
19452755|NCT00633022|41701704|FG000|Overall Study|Physician Decision|0|||
19452756|NCT00633022|41701705|FG001|Overall Study|Physician Decision|1|||
19452757|NCT00633022|41701706|FG002|Overall Study|Physician Decision|0|||
19452758|NCT00630994|41701714|FG000|Overall Study|Adverse Event|1|||
19452759|NCT00630994|41701714|FG000|Overall Study|Disease Progression|1|||
19452760|NCT00630994|41701714|FG000|Overall Study|Lack of Efficacy|1|||
19452761|NCT00630994|41701714|FG000|Overall Study|Other|1|||
19452762|NCT00630838|41701720|FG000|Overall Study|Death|0|||
19452763|NCT00630838|41701721|FG001|Overall Study|Death|1|||
19532209|NCT03173560|41979549|FG000|Overall Study|Ongoing Survival Follow-up|56|||
19532210|NCT03173560|41979550|FG001|Overall Study|Ongoing Survival Follow-up|57|||
19532211|NCT03173560|41979549|FG000|Overall Study|Lost to Follow-up|1|||
19532212|NCT03173560|41979550|FG001|Overall Study|Lost to Follow-up|4|||
19532213|NCT03173560|41979549|FG000|Overall Study|Withdrawal by Subject|10|||
19532214|NCT03173560|41979550|FG001|Overall Study|Withdrawal by Subject|5|||
19532215|NCT03173560|41979549|FG000|Overall Study|Other|0|||
19532216|NCT03173560|41979550|FG001|Overall Study|Other|1|||
19532217|NCT02990468|41979566|FG000|Phase 2: MTD|Change in treatment|0|||
19532218|NCT02990468|41979567|FG001|Phase 2: MTD|Change in treatment|0|||
19532219|NCT02990468|41979568|FG002|Phase 2: MTD|Change in treatment|1|||
19532220|NCT02899299|41979578|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
19532221|NCT02899299|41979579|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
19532222|NCT02899299|41979578|FG000|Pre-treatment|Participant withdrew consent|1|||
19532223|NCT02899299|41979579|FG001|Pre-treatment|Participant withdrew consent|11|||
19532224|NCT02899299|41979578|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
19532225|NCT02899299|41979579|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
19532226|NCT02899299|41979578|FG000|Pre-treatment|Not reported|0|||
19532227|NCT02899299|41979579|FG001|Pre-treatment|Not reported|1|||
19532228|NCT02899299|41979578|FG000|Treatment|Disease Progression|182|||
19711419|NCT03568942|42154528|FG000|Overall Study|Lost to Follow-up|1|||
19711420|NCT00110019|42154534|FG000|Overall Study|Lack of Efficacy|253|||
19711421|NCT00110019|42154535|FG001|Overall Study|Lack of Efficacy|285|||
19711422|NCT00110019|42154534|FG000|Overall Study|Adverse Event|61|||
19711423|NCT00110019|42154535|FG001|Overall Study|Adverse Event|40|||
19711424|NCT00110019|42154534|FG000|Overall Study|Death|13|||
19711425|NCT00110019|42154535|FG001|Overall Study|Death|15|||
19711426|NCT00110019|42154534|FG000|Overall Study|Withdrawal by Subject|21|||
19711427|NCT00110019|42154535|FG001|Overall Study|Withdrawal by Subject|9|||
19711428|NCT00110019|42154534|FG000|Overall Study|alternative therapy|5|||
19711429|NCT00110019|42154535|FG001|Overall Study|alternative therapy|1|||
19711430|NCT00110019|42154534|FG000|Overall Study|complicating disease|1|||
19711431|NCT00110019|42154535|FG001|Overall Study|complicating disease|1|||
19711432|NCT00110019|42154534|FG000|Overall Study|symptom deterioration|13|||
19711433|NCT00110019|42154535|FG001|Overall Study|symptom deterioration|16|||
19532229|NCT02899299|41979579|FG001|Treatment|Disease Progression|44|||
19532230|NCT02899299|41979578|FG000|Treatment|Study Drug Toxicity|59|||
19532231|NCT02899299|41979579|FG001|Treatment|Study Drug Toxicity|24|||
19532232|NCT02899299|41979578|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
19532233|NCT02899299|41979579|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
19532234|NCT02899299|41979578|FG000|Treatment|Participant request to discontinue Study treatment|4|||
19532235|NCT02899299|41979579|FG001|Treatment|Participant request to discontinue Study treatment|10|||
19711434|NCT00110019|42154534|FG000|Overall Study|Not start protocol therapy|17|||
19711435|NCT00110019|42154535|FG001|Overall Study|Not start protocol therapy|16|||
19711436|NCT00110019|42154534|FG000|Overall Study|other reasons|22|||
19711437|NCT00110019|42154535|FG001|Overall Study|other reasons|30|||
19711438|NCT03595618|42154545|FG000|Overall Study|Adverse Event|16|||
19452764|NCT00630838|41701720|FG000|Overall Study|Lost to Follow-up|0|||
19452765|NCT00630838|41701721|FG001|Overall Study|Lost to Follow-up|1|||
19452766|NCT00630058|41701731|FG000|Overall Study|Adverse Event|1|||
19711439|NCT03595618|42154546|FG001|Overall Study|Adverse Event|17|||
19452767|NCT00630058|41701732|FG001|Overall Study|Adverse Event|1|||
19532236|NCT02899299|41979578|FG000|Treatment|Participant withdrew consent|6|||
19532237|NCT02899299|41979579|FG001|Treatment|Participant withdrew consent|3|||
19532238|NCT02899299|41979578|FG000|Treatment|Lost to Follow-up|0|||
19532239|NCT02899299|41979579|FG001|Treatment|Lost to Follow-up|1|||
19532240|NCT02899299|41979578|FG000|Treatment|Maximum Clinical Benefit|10|||
19532241|NCT02899299|41979579|FG001|Treatment|Maximum Clinical Benefit|2|||
19532242|NCT02899299|41979578|FG000|Treatment|Poor/Non-compliance|1|||
19532243|NCT02899299|41979579|FG001|Treatment|Poor/Non-compliance|0|||
19532244|NCT02899299|41979578|FG000|Treatment|Participant no longer meets Study criteria|4|||
19532245|NCT02899299|41979579|FG001|Treatment|Participant no longer meets Study criteria|0|||
19532246|NCT02899299|41979578|FG000|Treatment|Administrative reason by Sponsor|2|||
19532247|NCT02899299|41979579|FG001|Treatment|Administrative reason by Sponsor|0|||
19532248|NCT02899299|41979578|FG000|Treatment|Other reasons|11|||
19532249|NCT02899299|41979579|FG001|Treatment|Other reasons|2|||
19532250|NCT02899299|41979578|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
19532251|NCT02899299|41979579|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
19532252|NCT02855944|41979587|FG000|Period 1: Treatment|Ongoing|14|||
19532253|NCT02855944|41979588|FG001|Period 1: Treatment|Ongoing|0|||
19532254|NCT02855944|41979587|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
19532255|NCT02855944|41979588|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
19532256|NCT02855944|41979587|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
19532257|NCT02855944|41979588|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
19532258|NCT02681055|41979599|FG000|Weeks 5-12|Adverse Event|1|||
19532259|NCT02577354|41979617|FG000|Overall Study|Lack of Efficacy|4|||
19532260|NCT02577354|41979618|FG001|Overall Study|Lack of Efficacy|4|||
19532261|NCT02577354|41979617|FG000|Overall Study|Lost to Follow-up|3|||
19532262|NCT02577354|41979618|FG001|Overall Study|Lost to Follow-up|1|||
19532263|NCT02577354|41979617|FG000|Overall Study|Missed Visit|4|||
19532264|NCT02577354|41979618|FG001|Overall Study|Missed Visit|3|||
19532265|NCT02577354|41979617|FG000|Overall Study|Adverse Event|4|||
19532266|NCT02577354|41979618|FG001|Overall Study|Adverse Event|5|||
19532267|NCT02477696|41979636|FG000|Overall Study|Adverse Event|40|||
19532268|NCT02477696|41979637|FG001|Overall Study|Adverse Event|59|||
19532269|NCT02477696|41979636|FG000|Overall Study|CLL Disease Progression|82|||
19532270|NCT02477696|41979637|FG001|Overall Study|CLL Disease Progression|68|||
19532271|NCT02477696|41979636|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
19532272|NCT02477696|41979637|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
19532273|NCT02477696|41979636|FG000|Overall Study|Death|5|||
19532274|NCT02477696|41979637|FG001|Overall Study|Death|6|||
19532275|NCT02477696|41979636|FG000|Overall Study|Withdrawal by Subject|7|||
19532276|NCT02477696|41979637|FG001|Overall Study|Withdrawal by Subject|7|||
19532277|NCT02477696|41979636|FG000|Overall Study|Physician Decision|5|||
19532278|NCT02477696|41979637|FG001|Overall Study|Physician Decision|5|||
19532279|NCT02451943|41979645|FG000|Overall Study|On Treatment|4|||
19532280|NCT02451943|41979646|FG001|Overall Study|On Treatment|4|||
19532281|NCT02451943|41979645|FG000|Overall Study|Withdrawal by Subject|13|||
19532282|NCT02451943|41979646|FG001|Overall Study|Withdrawal by Subject|16|||
19532283|NCT02451943|41979645|FG000|Overall Study|Lost to Follow-up|3|||
19532284|NCT02451943|41979646|FG001|Overall Study|Lost to Follow-up|4|||
19532285|NCT02409342|41979654|FG000|Overall Study|Death|211|||
19532286|NCT02409342|41979655|FG001|Overall Study|Death|201|||
19532287|NCT02409342|41979654|FG000|Overall Study|Withdrawal by Subject|24|||
19532288|NCT02409342|41979655|FG001|Overall Study|Withdrawal by Subject|17|||
19532289|NCT02409342|41979654|FG000|Overall Study|Study Terminated By Sponsor|48|||
19532290|NCT02409342|41979655|FG001|Overall Study|Study Terminated By Sponsor|59|||
19532291|NCT02409342|41979654|FG000|Overall Study|Lost to Follow-up|3|||
19532292|NCT02409342|41979655|FG001|Overall Study|Lost to Follow-up|5|||
19532293|NCT02409342|41979654|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
19532294|NCT02409342|41979655|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
19532295|NCT02409342|41979654|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
19532296|NCT02409342|41979655|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
19532297|NCT02409342|41979654|FG000|Overall Study|Sponsor Decision|1|||
19532298|NCT02409342|41979655|FG001|Overall Study|Sponsor Decision|0|||
19532299|NCT02336503|41979671|FG000|Overall Study|Lost to Follow-up|0|||
19532300|NCT02336503|41979672|FG001|Overall Study|Lost to Follow-up|3|||
19532301|NCT02336503|41979673|FG002|Overall Study|Lost to Follow-up|0|||
19532302|NCT02336503|41979674|FG003|Overall Study|Lost to Follow-up|2|||
19532303|NCT02336503|41979671|FG000|Overall Study|Withdrawal by Subject|2|||
19532304|NCT02336503|41979672|FG001|Overall Study|Withdrawal by Subject|0|||
19532305|NCT02336503|41979673|FG002|Overall Study|Withdrawal by Subject|0|||
19532306|NCT02336503|41979674|FG003|Overall Study|Withdrawal by Subject|4|||
19532307|NCT02336503|41979671|FG000|Overall Study|Adverse Event|0|||
19532308|NCT02336503|41979672|FG001|Overall Study|Adverse Event|0|||
19532309|NCT02336503|41979673|FG002|Overall Study|Adverse Event|1|||
19532310|NCT02336503|41979674|FG003|Overall Study|Adverse Event|0|||
19532311|NCT02255409|41979690|FG000|Overall Study|Administrative Reason|3|||
19532312|NCT02255409|41979691|FG001|Overall Study|Administrative Reason|7|||
19452768|NCT00630058|41701731|FG000|Overall Study|Withdrawal by Subject|0|||
19452769|NCT00630058|41701732|FG001|Overall Study|Withdrawal by Subject|1|||
19452770|NCT00630058|41701731|FG000|Overall Study|stopping criteria|3|||
19452771|NCT00630058|41701732|FG001|Overall Study|stopping criteria|2|||
19452772|NCT01925794|41701738|FG000|180 Days|Death|2|||
19452773|NCT01925794|41701738|FG000|180 Days|Withdrawal by Subject|2|||
19452774|NCT01925794|41701738|FG000|270 Days|Death|2|||
19452775|NCT01925794|41701738|FG000|270 Days|Protocol Violation|3|||
19452776|NCT00989950|41701750|FG000|Randomized Phase|Protocol Violation|1|||
19452777|NCT00989950|41701751|FG001|Randomized Phase|Protocol Violation|0|||
19452778|NCT00989950|41701752|FG002|Randomized Phase|Protocol Violation|0|||
19452779|NCT00989950|41701753|FG003|Randomized Phase|Protocol Violation|0|||
19452780|NCT00989950|41701750|FG000|Randomized Phase|Adverse Event|0|||
19452781|NCT00989950|41701751|FG001|Randomized Phase|Adverse Event|1|||
19452782|NCT00989950|41701752|FG002|Randomized Phase|Adverse Event|0|||
19452783|NCT00989950|41701753|FG003|Randomized Phase|Adverse Event|0|||
19532313|NCT02255409|41979690|FG000|Overall Study|Withdrawal by Subject|1|||
19532314|NCT02255409|41979691|FG001|Overall Study|Withdrawal by Subject|5|||
19532315|NCT02255409|41979690|FG000|Overall Study|Lost to Follow-up|10|||
19532316|NCT02255409|41979691|FG001|Overall Study|Lost to Follow-up|19|||
19532317|NCT00630032|41979731|FG000|Overall Study|Death|55|||
19532318|NCT00630032|41979732|FG001|Overall Study|Death|49|||
19532319|NCT00630032|41979731|FG000|Overall Study|Withdrawal by Subject|3|||
19532320|NCT00630032|41979732|FG001|Overall Study|Withdrawal by Subject|2|||
19532321|NCT00630032|41979731|FG000|Overall Study|Lost to Follow-up|18|||
19532322|NCT00630032|41979732|FG001|Overall Study|Lost to Follow-up|31|||
19532323|NCT00630032|41979731|FG000|Overall Study|Protocol Violation|1|||
19532324|NCT00630032|41979732|FG001|Overall Study|Protocol Violation|0|||
19532325|NCT00630032|41979731|FG000|Overall Study|Patient has moved|1|||
19532326|NCT00630032|41979732|FG001|Overall Study|Patient has moved|1|||
19532327|NCT00630032|41979731|FG000|Overall Study|Disease progression|1|||
19532328|NCT00630032|41979732|FG001|Overall Study|Disease progression|1|||
19532329|NCT00630032|41979731|FG000|Overall Study|End of monitoring in US centers|11|||
19532330|NCT00630032|41979732|FG001|Overall Study|End of monitoring in US centers|11|||
19532331|NCT00465517|41979740|FG000|Overall Study|Adverse Event|7|||
19532332|NCT00465517|41979741|FG001|Overall Study|Adverse Event|3|||
19532333|NCT00465517|41979740|FG000|Overall Study|Lost to Follow-up|1|||
19532334|NCT00465517|41979741|FG001|Overall Study|Lost to Follow-up|0|||
19630079|NCT00790842|42079356|FG010|Expansion Cohort|Physician Decision|0|||
19630080|NCT00790842|42079346|FG000|Expansion Cohort|Withdrawal by Subject|0|||
19630081|NCT00790842|42079347|FG001|Expansion Cohort|Withdrawal by Subject|0|||
19630082|NCT00790842|42079348|FG002|Expansion Cohort|Withdrawal by Subject|3|||
19630083|NCT00790842|42079349|FG003|Expansion Cohort|Withdrawal by Subject|0|||
19630084|NCT00790842|42079350|FG004|Expansion Cohort|Withdrawal by Subject|0|||
19630085|NCT00790842|42079351|FG005|Expansion Cohort|Withdrawal by Subject|0|||
19630086|NCT00790842|42079352|FG006|Expansion Cohort|Withdrawal by Subject|0|||
19630087|NCT00790842|42079353|FG007|Expansion Cohort|Withdrawal by Subject|0|||
19630088|NCT00790842|42079354|FG008|Expansion Cohort|Withdrawal by Subject|0|||
19630089|NCT00790842|42079355|FG009|Expansion Cohort|Withdrawal by Subject|0|||
19630090|NCT00790842|42079356|FG010|Expansion Cohort|Withdrawal by Subject|0|||
19452784|NCT01905943|41701763|FG000|Overall Study|Withdrawal of consent|90|||
19452785|NCT01905943|41701763|FG000|Overall Study|Lost to Follow-up|16|||
19452786|NCT01905943|41701763|FG000|Overall Study|Investigator discretion|7|||
19452787|NCT01905943|41701763|FG000|Overall Study|Death|186|||
19452788|NCT01905943|41701763|FG000|Overall Study|Adverse Event|3|||
19630091|NCT00790842|42079346|FG000|Expansion Cohort|Study Closure|0|||
19630092|NCT00790842|42079347|FG001|Expansion Cohort|Study Closure|0|||
19630093|NCT00790842|42079348|FG002|Expansion Cohort|Study Closure|1|||
19630094|NCT00790842|42079349|FG003|Expansion Cohort|Study Closure|0|||
19630095|NCT00790842|42079350|FG004|Expansion Cohort|Study Closure|0|||
19630096|NCT00790842|42079351|FG005|Expansion Cohort|Study Closure|0|||
19630097|NCT00790842|42079352|FG006|Expansion Cohort|Study Closure|0|||
19630098|NCT00790842|42079353|FG007|Expansion Cohort|Study Closure|0|||
19532335|NCT00465517|41979740|FG000|Overall Study|Withdrawal by Subject|4|||
19532336|NCT00465517|41979741|FG001|Overall Study|Withdrawal by Subject|1|||
19532337|NCT05050578|41979749|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
19532338|NCT05050578|41979750|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
19532339|NCT05050578|41979749|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
19630099|NCT00790842|42079354|FG008|Expansion Cohort|Study Closure|0|||
19630100|NCT00790842|42079355|FG009|Expansion Cohort|Study Closure|0|||
19452789|NCT01905943|41701763|FG000|Overall Study|Other|12|||
19452790|NCT01905553|41701784|FG000|Period 2|Adverse Event|1|||
19532340|NCT05050578|41979750|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
19532341|NCT05050578|41979749|FG000|Period 2, 30 Days|Protocol Violation|0|||
19532342|NCT05050578|41979750|FG001|Period 2, 30 Days|Protocol Violation|1|||
19532343|NCT04490278|41979759|FG000|Overall Study|Lost to Follow-up|6|||
19452791|NCT01905553|41701785|FG001|Period 2|Adverse Event|0|||
19532344|NCT04408794|41979763|FG000|Overall Study|Adverse Event|43|||
19532345|NCT04408794|41979763|FG000|Overall Study|Infrequent study drug usage|43|||
19532346|NCT04408794|41979763|FG000|Overall Study|Lack of Efficacy|61|||
19532347|NCT04408794|41979763|FG000|Overall Study|Lost to Follow-up|33|||
19532348|NCT04408794|41979763|FG000|Overall Study|Non-compliance|6|||
19532349|NCT04408794|41979763|FG000|Overall Study|Physician Decision|1|||
19532350|NCT04408794|41979763|FG000|Overall Study|Pregnancy|6|||
19532351|NCT04408794|41979763|FG000|Overall Study|Protocol Deviation|9|||
19532352|NCT04408794|41979763|FG000|Overall Study|Sheehan-STS Result|1|||
19532353|NCT04408794|41979763|FG000|Overall Study|Withdrawal by Subject|57|||
19532354|NCT04408794|41979763|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
19452792|NCT01929031|41701795|FG000|Overall Study|Adverse Event|3|||
19452793|NCT01929031|41701796|FG001|Overall Study|Adverse Event|1|||
19452794|NCT01929031|41701797|FG002|Overall Study|Adverse Event|1|||
19452795|NCT01929031|41701798|FG003|Overall Study|Adverse Event|0|||
19452796|NCT01929031|41701799|FG004|Overall Study|Adverse Event|0|||
19452797|NCT01929031|41701800|FG005|Overall Study|Adverse Event|0|||
19532355|NCT04408794|41979763|FG000|Overall Study|Never Treated Migraine|5|||
19532356|NCT04004221|41979767|FG000|Overall Study|Death|89|||
19532357|NCT04004221|41979767|FG000|Overall Study|Withdrawal by Subject|5|||
19532358|NCT04004221|41979767|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
19532359|NCT04004221|41979767|FG000|Overall Study|Sponsor Decision|9|||
19452798|NCT01929031|41701795|FG000|Overall Study|Protocol Violation|1|||
19452799|NCT01929031|41701796|FG001|Overall Study|Protocol Violation|0|||
19532360|NCT04004221|41979767|FG000|Overall Study|Participant refused to enter LTE|1|||
19532361|NCT03775512|41979777|FG000|Overall Study|Death|1|||
19532362|NCT03775512|41979778|FG001|Overall Study|Death|1|||
19532363|NCT03775512|41979777|FG000|Overall Study|Withdrawal by Subject|7|||
19532364|NCT03775512|41979778|FG001|Overall Study|Withdrawal by Subject|4|||
19532365|NCT03775512|41979777|FG000|Overall Study|Lost to Follow-up|5|||
19532366|NCT03775512|41979778|FG001|Overall Study|Lost to Follow-up|5|||
19532367|NCT03775512|41979777|FG000|Overall Study|Excluded before Catheter insertion|14|||
19532368|NCT03775512|41979778|FG001|Overall Study|Excluded before Catheter insertion|5|||
19532369|NCT03775512|41979777|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
19532370|NCT03775512|41979778|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
19532371|NCT03775512|41979777|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
19532372|NCT03775512|41979778|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
19532373|NCT03620747|41979807|FG000|Overall Study|Participant decision|7|||
19532374|NCT03620747|41979807|FG000|Overall Study|Adverse Event|6|||
19532375|NCT03620747|41979807|FG000|Overall Study|Lack of Efficacy|1|||
19532376|NCT03620747|41979807|FG000|Overall Study|Poor compliance to protocol|2|||
19532377|NCT03620747|41979807|FG000|Overall Study|Other-unspecified|3|||
19452800|NCT01929031|41701797|FG002|Overall Study|Protocol Violation|0|||
19452801|NCT01929031|41701798|FG003|Overall Study|Protocol Violation|0|||
19452802|NCT01929031|41701799|FG004|Overall Study|Protocol Violation|0|||
19452803|NCT01929031|41701800|FG005|Overall Study|Protocol Violation|1|||
19452804|NCT01929031|41701795|FG000|Overall Study|Reason other than specified above|0|||
19452805|NCT01929031|41701796|FG001|Overall Study|Reason other than specified above|1|||
19452806|NCT01929031|41701797|FG002|Overall Study|Reason other than specified above|0|||
19452807|NCT01929031|41701798|FG003|Overall Study|Reason other than specified above|0|||
19452808|NCT01929031|41701799|FG004|Overall Study|Reason other than specified above|1|||
19452809|NCT01929031|41701800|FG005|Overall Study|Reason other than specified above|0|||
19452810|NCT00989092|41701812|FG000|Overall Study|Physician Decision|9|||
19452811|NCT00989092|41701813|FG001|Overall Study|Physician Decision|6|||
19452812|NCT00989092|41701812|FG000|Overall Study|Adverse Event|20|||
19452813|NCT00989092|41701813|FG001|Overall Study|Adverse Event|1|||
19452814|NCT00989092|41701812|FG000|Overall Study|Chemotherapy initiated|12|||
19452815|NCT00989092|41701813|FG001|Overall Study|Chemotherapy initiated|4|||
19452816|NCT00989092|41701812|FG000|Overall Study|Withdrawal by Subject|17|||
19452817|NCT00989092|41701813|FG001|Overall Study|Withdrawal by Subject|9|||
19452818|NCT00989092|41701812|FG000|Overall Study|Death|14|||
19532378|NCT03338790|41979832|FG000|Overall Study|Disease Progression|65|||
19532379|NCT03338790|41979833|FG001|Overall Study|Disease Progression|43|||
19532380|NCT03338790|41979834|FG002|Overall Study|Disease Progression|50|||
19532381|NCT03338790|41979835|FG003|Overall Study|Disease Progression|37|||
19532382|NCT03338790|41979832|FG000|Overall Study|Study Drug Toxicity|9|||
19532383|NCT03338790|41979833|FG001|Overall Study|Study Drug Toxicity|8|||
19532384|NCT03338790|41979834|FG002|Overall Study|Study Drug Toxicity|15|||
19532385|NCT03338790|41979835|FG003|Overall Study|Study Drug Toxicity|0|||
19532386|NCT03338790|41979832|FG000|Overall Study|Death|1|||
19532387|NCT03338790|41979833|FG001|Overall Study|Death|1|||
19532388|NCT03338790|41979834|FG002|Overall Study|Death|1|||
19532389|NCT03338790|41979835|FG003|Overall Study|Death|0|||
19532390|NCT03338790|41979832|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
19711440|NCT03595618|42154547|FG002|Overall Study|Adverse Event|20|||
19452819|NCT00989092|41701813|FG001|Overall Study|Death|2|||
19452820|NCT00989092|41701812|FG000|Overall Study|Ineligibility determined|3|||
19532391|NCT03338790|41979833|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
19532392|NCT03338790|41979834|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
19532393|NCT03338790|41979835|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
19532394|NCT03338790|41979832|FG000|Overall Study|Participant request to discontinue study treatment|3|||
19532395|NCT03338790|41979833|FG001|Overall Study|Participant request to discontinue study treatment|3|||
19532396|NCT03338790|41979834|FG002|Overall Study|Participant request to discontinue study treatment|2|||
19532397|NCT03338790|41979835|FG003|Overall Study|Participant request to discontinue study treatment|1|||
19532398|NCT03338790|41979832|FG000|Overall Study|Poor/non-compliance|0|||
19532399|NCT03338790|41979833|FG001|Overall Study|Poor/non-compliance|1|||
19532400|NCT03338790|41979834|FG002|Overall Study|Poor/non-compliance|0|||
19532401|NCT03338790|41979835|FG003|Overall Study|Poor/non-compliance|0|||
19532402|NCT03338790|41979832|FG000|Overall Study|Participant withdrew consent|1|||
19532403|NCT03338790|41979833|FG001|Overall Study|Participant withdrew consent|0|||
19532404|NCT03338790|41979834|FG002|Overall Study|Participant withdrew consent|1|||
19532405|NCT03338790|41979835|FG003|Overall Study|Participant withdrew consent|1|||
19532406|NCT03338790|41979832|FG000|Overall Study|Other reasons|0|||
19532407|NCT03338790|41979833|FG001|Overall Study|Other reasons|5|||
19532408|NCT03338790|41979834|FG002|Overall Study|Other reasons|0|||
19532409|NCT03338790|41979835|FG003|Overall Study|Other reasons|2|||
19452821|NCT00989092|41701813|FG001|Overall Study|Ineligibility determined|3|||
19452822|NCT00989092|41701812|FG000|Overall Study|Lost to Follow-up|6|||
19452823|NCT00989092|41701813|FG001|Overall Study|Lost to Follow-up|2|||
19532410|NCT03338790|41979832|FG000|Overall Study|Not reported|0|||
19532411|NCT03338790|41979833|FG001|Overall Study|Not reported|0|||
19532412|NCT03338790|41979834|FG002|Overall Study|Not reported|1|||
19532413|NCT03338790|41979835|FG003|Overall Study|Not reported|0|||
19532414|NCT03338790|41979832|FG000|Overall Study|Completed treatment period|1|||
19532415|NCT03338790|41979833|FG001|Overall Study|Completed treatment period|2|||
19532416|NCT03338790|41979834|FG002|Overall Study|Completed treatment period|0|||
19532417|NCT03338790|41979835|FG003|Overall Study|Completed treatment period|0|||
19532418|NCT02954536|41979862|FG000|Overall Study|Adverse Event|2|||
19532419|NCT02954536|41979862|FG000|Overall Study|Death|12|||
19532420|NCT02919670|41979868|FG000|Overall Study|Only 17 participants met compliance|43|||
19532421|NCT02919670|41979869|FG001|Overall Study|Only 17 participants met compliance|39|||
19532422|NCT02250326|41979968|FG000|Treatment Period|Death|1|||
19532423|NCT02250326|41979969|FG001|Treatment Period|Death|12|||
19532424|NCT02250326|41979970|FG002|Treatment Period|Death|2|||
19532425|NCT02250326|41979968|FG000|Treatment Period|Adverse Event|8|||
19532426|NCT02250326|41979969|FG001|Treatment Period|Adverse Event|4|||
19532427|NCT02250326|41979970|FG002|Treatment Period|Adverse Event|8|||
19532428|NCT02250326|41979968|FG000|Treatment Period|Progressive Disease|42|||
19532429|NCT02250326|41979969|FG001|Treatment Period|Progressive Disease|36|||
19532430|NCT02250326|41979970|FG002|Treatment Period|Progressive Disease|45|||
19532431|NCT02250326|41979968|FG000|Treatment Period|Symptomatic Deterioration|9|||
19532432|NCT02250326|41979969|FG001|Treatment Period|Symptomatic Deterioration|4|||
19532433|NCT02250326|41979970|FG002|Treatment Period|Symptomatic Deterioration|10|||
19452824|NCT00989092|41701812|FG000|Overall Study|Other|3|||
19452825|NCT00989092|41701813|FG001|Overall Study|Other|1|||
19532434|NCT02250326|41979968|FG000|Treatment Period|Withdrawal by Subject|11|||
19532435|NCT02250326|41979969|FG001|Treatment Period|Withdrawal by Subject|5|||
19532436|NCT02250326|41979970|FG002|Treatment Period|Withdrawal by Subject|4|||
19532437|NCT02250326|41979968|FG000|Treatment Period|Miscellaneous|8|||
19532438|NCT02250326|41979969|FG001|Treatment Period|Miscellaneous|2|||
19532439|NCT02250326|41979970|FG002|Treatment Period|Miscellaneous|7|||
19532440|NCT02250326|41979968|FG000|Treatment Period|Randomized or assigned; not treated|2|||
19452826|NCT00989092|41701812|FG000|Overall Study|Protocol deviation|2|||
19452827|NCT00989092|41701813|FG001|Overall Study|Protocol deviation|0|||
19452828|NCT00989092|41701812|FG000|Overall Study|Erythropoietin therapy initiated|2|||
19452829|NCT00989092|41701813|FG001|Overall Study|Erythropoietin therapy initiated|0|||
19452830|NCT00989092|41701812|FG000|Overall Study|Did not receive study drug|2|||
19452831|NCT00989092|41701813|FG001|Overall Study|Did not receive study drug|0|||
19452832|NCT00988858|41701820|FG000|Overall Study|Adverse Event|7|||
19452833|NCT00988858|41701820|FG000|Overall Study|Death|1|||
19452834|NCT00988858|41701820|FG000|Overall Study|Physician Decision|1|||
19452835|NCT00988858|41701820|FG000|Overall Study|Sponsor Decision|1|||
19452836|NCT00986986|41701826|FG000|Overall Study|Lost to Follow-up|0|||
19452837|NCT00986986|41701827|FG001|Overall Study|Lost to Follow-up|1|||
19452838|NCT01904773|41701834|FG000|Screen|Screen failure|3|||
19452839|NCT01904773|41701835|FG001|Screen|Screen failure|0|||
19452840|NCT01904773|41701836|FG002|Screen|Screen failure|0|||
19452841|NCT01904773|41701837|FG003|Screen|Screen failure|0|||
19452842|NCT01904773|41701838|FG004|Screen|Screen failure|0|||
19452843|NCT01904773|41701839|FG005|Screen|Screen failure|0|||
19452844|NCT01904773|41701840|FG006|Screen|Screen failure|0|||
19452845|NCT01904773|41701841|FG007|Screen|Screen failure|0|||
19452846|NCT01904773|41701842|FG008|Screen|Screen failure|0|||
19452847|NCT01904773|41701834|FG000|Screen|Withdrawal by Subject|1|||
19532441|NCT02250326|41979969|FG001|Treatment Period|Randomized or assigned; not treated|1|||
19532442|NCT02250326|41979970|FG002|Treatment Period|Randomized or assigned; not treated|1|||
19532443|NCT02250326|41979968|FG000|Follow-Up Period|Death|46|||
19532444|NCT02250326|41979969|FG001|Follow-Up Period|Death|26|||
19532445|NCT02250326|41979970|FG002|Follow-Up Period|Death|32|||
19532446|NCT02250326|41979968|FG000|Follow-Up Period|Unknown or Missing|2|||
19532447|NCT02250326|41979969|FG001|Follow-Up Period|Unknown or Missing|3|||
19532448|NCT02250326|41979970|FG002|Follow-Up Period|Unknown or Missing|3|||
19532449|NCT02250326|41979968|FG000|Follow-Up Period|Lost to Follow-up|1|||
19532450|NCT02250326|41979969|FG001|Follow-Up Period|Lost to Follow-up|1|||
19532451|NCT02250326|41979970|FG002|Follow-Up Period|Lost to Follow-up|3|||
19532452|NCT01567722|41979982|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
19532453|NCT01567722|41979983|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
19532454|NCT01567722|41979984|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
19532455|NCT01567722|41979982|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
19532456|NCT01567722|41979983|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
19532457|NCT01567722|41979984|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
19532458|NCT01567722|41979982|FG000|Overall Study|Protocol closure by the OCG|2|||
19532459|NCT01567722|41979983|FG001|Overall Study|Protocol closure by the OCG|0|||
19532460|NCT01567722|41979984|FG002|Overall Study|Protocol closure by the OCG|0|||
19532461|NCT01567722|41979982|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
19532462|NCT01567722|41979983|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
19532463|NCT01567722|41979984|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
19532464|NCT01194570|41979994|FG000|Overall Study|Death|1|||
19532465|NCT01194570|41979995|FG001|Overall Study|Death|3|||
19532466|NCT01194570|41979994|FG000|Overall Study|Ongoing at CCOD|162|||
19532467|NCT01194570|41979995|FG001|Overall Study|Ongoing at CCOD|387|||
19532468|NCT01194570|41979994|FG000|Overall Study|Physician Decision|2|||
19532469|NCT01194570|41979995|FG001|Overall Study|Physician Decision|6|||
19532470|NCT01194570|41979994|FG000|Overall Study|Reason not specified|13|||
19532471|NCT01194570|41979995|FG001|Overall Study|Reason not specified|20|||
19532472|NCT01194570|41979994|FG000|Overall Study|Protocol Violation|0|||
19532473|NCT01194570|41979995|FG001|Overall Study|Protocol Violation|2|||
19532474|NCT01194570|41979994|FG000|Overall Study|Non-compliance with study drug|2|||
19532475|NCT01194570|41979995|FG001|Overall Study|Non-compliance with study drug|2|||
19532476|NCT01194570|41979994|FG000|Overall Study|Adverse Event|12|||
19532477|NCT01194570|41979995|FG001|Overall Study|Adverse Event|18|||
19532478|NCT01194570|41979994|FG000|Overall Study|Non-compliance|2|||
19532479|NCT01194570|41979995|FG001|Overall Study|Non-compliance|2|||
19532480|NCT01194570|41979994|FG000|Overall Study|Lack of Efficacy|27|||
19532481|NCT01194570|41979995|FG001|Overall Study|Lack of Efficacy|21|||
19532482|NCT01194570|41979994|FG000|Overall Study|Withdrawal by Subject|21|||
19532483|NCT01194570|41979995|FG001|Overall Study|Withdrawal by Subject|22|||
19532484|NCT01194570|41979994|FG000|Overall Study|Pregnancy|1|||
19532485|NCT01194570|41979995|FG001|Overall Study|Pregnancy|1|||
19532486|NCT01194570|41979994|FG000|Overall Study|Lost to Follow-up|1|||
19532487|NCT01194570|41979995|FG001|Overall Study|Lost to Follow-up|4|||
19532488|NCT01124695|41980001|FG000|Overall Study|Disease progression|77|||
19532489|NCT01124695|41980001|FG000|Overall Study|Adverse Event|11|||
19532490|NCT01124695|41980001|FG000|Overall Study|Death|1|||
19532491|NCT01124695|41980001|FG000|Overall Study|Withdrawal by Subject|7|||
19532492|NCT01124695|41980001|FG000|Overall Study|Physician Decision|3|||
19532493|NCT01124695|41980001|FG000|Overall Study|Alternative therapy|9|||
19532494|NCT01124695|41980001|FG000|Overall Study|No documentation that patient went off treatment|4|||
19532495|NCT01124695|41980001|FG000|Overall Study|Ineligible|9|||
19532496|NCT01124695|41980001|FG000|Overall Study|Ineligible and never start treatment|2|||
19532497|NCT01349790|41980029|FG000|Overall Study|Investigator Judgement|3|||
19532498|NCT01349790|41980029|FG000|Overall Study|Death|2|||
19532499|NCT01349790|41980029|FG000|Overall Study|Withdrawal by Patient|2|||
19532500|NCT01349790|41980029|FG000|Overall Study|Adverse Event|1|||
19532501|NCT01349790|41980029|FG000|Overall Study|Lost to Follow-up|1|||
19532502|NCT01349595|41980035|FG000|Overall Study|Lack of funding|2|||
19630101|NCT00790842|42079356|FG010|Expansion Cohort|Study Closure|0|||
19630102|NCT00574288|42079411|FG000|Overall Study|Adverse Event|2|||
19630103|NCT00574288|42079412|FG001|Overall Study|Adverse Event|0|||
19630104|NCT00574288|42079413|FG002|Overall Study|Adverse Event|0|||
19630105|NCT00574288|42079414|FG003|Overall Study|Adverse Event|0|||
19630106|NCT00574288|42079415|FG004|Overall Study|Adverse Event|1|||
19630107|NCT00574288|42079416|FG005|Overall Study|Adverse Event|0|||
19630108|NCT00574288|42079417|FG006|Overall Study|Adverse Event|0|||
19630109|NCT00574288|42079411|FG000|Overall Study|Death|0|||
19630110|NCT00574288|42079412|FG001|Overall Study|Death|0|||
19630111|NCT00574288|42079413|FG002|Overall Study|Death|0|||
19532503|NCT01349595|41980036|FG001|Overall Study|Lack of funding|2|||
19630112|NCT00574288|42079414|FG003|Overall Study|Death|0|||
19532504|NCT01349673|41980046|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
19532505|NCT01349673|41980046|FG000|Overall Study|No Longer Qualified For Study|1|||
19532506|NCT01349673|41980046|FG000|Overall Study|Site Closure|10|||
19452848|NCT01904773|41701835|FG001|Screen|Withdrawal by Subject|0|||
19452849|NCT01904773|41701836|FG002|Screen|Withdrawal by Subject|0|||
19452850|NCT01904773|41701837|FG003|Screen|Withdrawal by Subject|0|||
19452851|NCT01904773|41701838|FG004|Screen|Withdrawal by Subject|0|||
19452852|NCT01904773|41701839|FG005|Screen|Withdrawal by Subject|0|||
19452853|NCT01904773|41701840|FG006|Screen|Withdrawal by Subject|0|||
19532507|NCT01349673|41980046|FG000|Overall Study|Withdrawal by Subject|21|||
19532508|NCT01349673|41980046|FG000|Overall Study|Lost to Follow-up|6|||
19532509|NCT01349673|41980046|FG000|Overall Study|Adverse Event|17|||
19532510|NCT01349673|41980046|FG000|Overall Study|Study Terminated By Sponsor|50|||
19532511|NCT01349673|41980046|FG000|Overall Study|Lack of Efficacy|8|||
19532512|NCT01349660|41980155|FG000|Overall Study|Still Receiving Study Treatment|0|||
19532513|NCT01349660|41980156|FG001|Overall Study|Still Receiving Study Treatment|0|||
19532514|NCT01349660|41980157|FG002|Overall Study|Still Receiving Study Treatment|1|||
19532515|NCT01349660|41980155|FG000|Overall Study|Disease Progression|2|||
19532516|NCT01349660|41980156|FG001|Overall Study|Disease Progression|4|||
19532517|NCT01349660|41980157|FG002|Overall Study|Disease Progression|50|||
19532518|NCT01349660|41980155|FG000|Overall Study|Adverse Event|1|||
19532519|NCT01349660|41980156|FG001|Overall Study|Adverse Event|1|||
19532520|NCT01349660|41980157|FG002|Overall Study|Adverse Event|12|||
19532521|NCT01349660|41980155|FG000|Overall Study|Withdrawal by Subject|2|||
19532522|NCT01349660|41980156|FG001|Overall Study|Withdrawal by Subject|0|||
19532523|NCT01349660|41980157|FG002|Overall Study|Withdrawal by Subject|9|||
19532524|NCT01349660|41980155|FG000|Overall Study|Death|1|||
19532525|NCT01349660|41980156|FG001|Overall Study|Death|1|||
19532526|NCT01349660|41980157|FG002|Overall Study|Death|0|||
19532527|NCT01349660|41980155|FG000|Overall Study|Non-Permitted Interventions|0|||
19532528|NCT01349660|41980156|FG001|Overall Study|Non-Permitted Interventions|0|||
19532529|NCT01349660|41980157|FG002|Overall Study|Non-Permitted Interventions|2|||
19532530|NCT01349660|41980155|FG000|Overall Study|Study Compliance|0|||
19532531|NCT01349660|41980156|FG001|Overall Study|Study Compliance|0|||
19532532|NCT01349660|41980157|FG002|Overall Study|Study Compliance|1|||
19532533|NCT01349660|41980155|FG000|Overall Study|Declining Performance Status|0|||
19532534|NCT01349660|41980156|FG001|Overall Study|Declining Performance Status|0|||
19532535|NCT01349660|41980157|FG002|Overall Study|Declining Performance Status|1|||
19532536|NCT01349569|41980176|FG000|Overall Study|Lack of Efficacy|4|||
19532537|NCT04642079|41980323|FG000|Overall Study|Lost to Follow-up|2|||
19532538|NCT04642079|41980324|FG001|Overall Study|Lost to Follow-up|5|||
19532539|NCT04642079|41980325|FG002|Overall Study|Lost to Follow-up|2|||
19532540|NCT04642079|41980326|FG003|Overall Study|Lost to Follow-up|0|||
19532541|NCT04642079|41980323|FG000|Overall Study|Withdrawal by Subject|0|||
19532542|NCT04642079|41980324|FG001|Overall Study|Withdrawal by Subject|4|||
19532543|NCT04642079|41980325|FG002|Overall Study|Withdrawal by Subject|1|||
19532544|NCT04642079|41980326|FG003|Overall Study|Withdrawal by Subject|2|||
19532545|NCT04642079|41980323|FG000|Overall Study|Other|0|||
19452854|NCT01904773|41701841|FG007|Screen|Withdrawal by Subject|0|||
19452855|NCT01904773|41701842|FG008|Screen|Withdrawal by Subject|0|||
19452856|NCT01904773|41701834|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
19452857|NCT01904773|41701835|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452858|NCT01904773|41701836|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452859|NCT01904773|41701837|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452860|NCT01904773|41701838|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452861|NCT01904773|41701839|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452862|NCT01904773|41701840|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452863|NCT01904773|41701841|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452864|NCT01904773|41701842|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
19452865|NCT01904773|41701834|FG000|First Intervention|Adverse Event|0|||
19452866|NCT01904773|41701835|FG001|First Intervention|Adverse Event|0|||
19452867|NCT01904773|41701836|FG002|First Intervention|Adverse Event|0|||
19452868|NCT01904773|41701837|FG003|First Intervention|Adverse Event|0|||
19452869|NCT01904773|41701838|FG004|First Intervention|Adverse Event|0|||
19452870|NCT01904773|41701839|FG005|First Intervention|Adverse Event|0|||
19452871|NCT01904773|41701840|FG006|First Intervention|Adverse Event|1|||
19452872|NCT01904773|41701841|FG007|First Intervention|Adverse Event|0|||
19452873|NCT01904773|41701842|FG008|First Intervention|Adverse Event|0|||
19452874|NCT01904773|41701834|FG000|Placebo Washout First Intervention|Condition worsened|0|||
19532546|NCT04642079|41980324|FG001|Overall Study|Other|0|||
19532547|NCT04642079|41980325|FG002|Overall Study|Other|0|||
19532548|NCT04642079|41980326|FG003|Overall Study|Other|1|||
19452875|NCT01904773|41701835|FG001|Placebo Washout First Intervention|Condition worsened|1|||
19452876|NCT01904773|41701836|FG002|Placebo Washout First Intervention|Condition worsened|0|||
19532549|NCT04642079|41980323|FG000|Overall Study|No longer met eligibility criteria|1|||
19532550|NCT04642079|41980324|FG001|Overall Study|No longer met eligibility criteria|0|||
19452877|NCT01904773|41701837|FG003|Placebo Washout First Intervention|Condition worsened|0|||
19452878|NCT01904773|41701838|FG004|Placebo Washout First Intervention|Condition worsened|0|||
19452879|NCT01904773|41701839|FG005|Placebo Washout First Intervention|Condition worsened|0|||
19452880|NCT01904773|41701840|FG006|Placebo Washout First Intervention|Condition worsened|0|||
19452881|NCT01904773|41701841|FG007|Placebo Washout First Intervention|Condition worsened|0|||
19452882|NCT01904773|41701842|FG008|Placebo Washout First Intervention|Condition worsened|0|||
19452883|NCT01904773|41701834|FG000|Fifth Intervention|Adverse Event|0|||
19452884|NCT01904773|41701835|FG001|Fifth Intervention|Adverse Event|0|||
19452885|NCT01904773|41701836|FG002|Fifth Intervention|Adverse Event|0|||
19452886|NCT01904773|41701837|FG003|Fifth Intervention|Adverse Event|0|||
19452887|NCT01904773|41701838|FG004|Fifth Intervention|Adverse Event|0|||
19452888|NCT01904773|41701839|FG005|Fifth Intervention|Adverse Event|0|||
19452889|NCT01904773|41701840|FG006|Fifth Intervention|Adverse Event|0|||
19452890|NCT01904773|41701841|FG007|Fifth Intervention|Adverse Event|1|||
19452891|NCT01904773|41701842|FG008|Fifth Intervention|Adverse Event|0|||
19452892|NCT01904773|41701834|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452893|NCT01904773|41701835|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
19532551|NCT04642079|41980325|FG002|Overall Study|No longer met eligibility criteria|1|||
19532552|NCT04642079|41980326|FG003|Overall Study|No longer met eligibility criteria|1|||
19532553|NCT04419493|41980345|FG000|Wash-out After Period 1|Adverse Event|1|||
19532554|NCT04419493|41980346|FG001|Wash-out After Period 1|Adverse Event|2|||
19532555|NCT04419493|41980347|FG002|Wash-out After Period 1|Adverse Event|1|||
19532556|NCT04419493|41980348|FG003|Wash-out After Period 1|Adverse Event|0|||
19532557|NCT04359901|41980361|FG000|Overall Study|Withdrawal by Subject|0|||
19532558|NCT04359901|41980362|FG001|Overall Study|Withdrawal by Subject|1|||
19532559|NCT04359901|41980361|FG000|Overall Study|Death|6|||
19532560|NCT04359901|41980362|FG001|Overall Study|Death|2|||
19532561|NCT04147611|41980385|FG000|Overall Study|Physician Decision|0|||
19532562|NCT04147611|41980386|FG001|Overall Study|Physician Decision|1|||
19532563|NCT03945266|41980419|FG000|Overall Study|Withdrawal by Subject|1|||
19532564|NCT03945266|41980420|FG001|Overall Study|Withdrawal by Subject|0|||
19532565|NCT03945266|41980419|FG000|Overall Study|Miscarriage|0|||
19532566|NCT03945266|41980420|FG001|Overall Study|Miscarriage|2|||
19532567|NCT03945266|41980419|FG000|Overall Study|Lost to Follow-up|1|||
19532568|NCT03945266|41980420|FG001|Overall Study|Lost to Follow-up|0|||
19452894|NCT01904773|41701836|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19532569|NCT03765788|41980432|FG000|Overall Study|Subject decision|2|||
19532570|NCT03765788|41980433|FG001|Overall Study|Subject decision|3|||
19532571|NCT03765788|41980432|FG000|Overall Study|Physician Decision|2|||
19532572|NCT03765788|41980433|FG001|Overall Study|Physician Decision|4|||
19532573|NCT03765788|41980432|FG000|Overall Study|Death|0|||
19532574|NCT03765788|41980433|FG001|Overall Study|Death|1|||
19532575|NCT03765788|41980432|FG000|Overall Study|Lost to Follow-up|1|||
19532576|NCT03765788|41980433|FG001|Overall Study|Lost to Follow-up|0|||
19532577|NCT03635424|41980440|FG000|Overall Study|Adverse Event|1|||
19532578|NCT03635424|41980440|FG000|Overall Study|Death|1|||
19532579|NCT03635424|41980440|FG000|Overall Study|Device not implanted|1|||
19532580|NCT03603964|41980444|FG000|Overall Study|Death|9|||
19532581|NCT03603964|41980444|FG000|Overall Study|Withdrawal by participant|7|||
19532582|NCT03603964|41980444|FG000|Overall Study|Study terminated by Sponsor|19|||
19532583|NCT03462719|41980461|FG000|Overall Study|Withdrawal by Subject|4|||
19532584|NCT03462719|41980462|FG001|Overall Study|Withdrawal by Subject|3|||
19452895|NCT01904773|41701837|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452896|NCT01904773|41701838|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452897|NCT01904773|41701839|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452898|NCT01904773|41701840|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452899|NCT01904773|41701841|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452900|NCT01904773|41701842|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
19452901|NCT01928719|41701856|FG000|Overall Study|Lost to Follow-up|26|||
19452902|NCT01928719|41701857|FG001|Overall Study|Lost to Follow-up|11|||
19452903|NCT01928719|41701856|FG000|Overall Study|Withdrawal by Subject|22|||
19452904|NCT01928719|41701857|FG001|Overall Study|Withdrawal by Subject|7|||
19452905|NCT01928719|41701856|FG000|Overall Study|Protocol Violation|3|||
19452906|NCT01928719|41701857|FG001|Overall Study|Protocol Violation|1|||
19452907|NCT01928719|41701856|FG000|Overall Study|Adverse Event|1|||
19452908|NCT01928719|41701857|FG001|Overall Study|Adverse Event|0|||
19452909|NCT00986674|41701868|FG000|Overall Study|Lack of Efficacy|28|||
19532585|NCT03462719|41980461|FG000|Overall Study|Ongoing|87|||
19532586|NCT03462719|41980462|FG001|Overall Study|Ongoing|72|||
19532587|NCT03456700|41980468|FG000|Overall Study|Withdrawal by Subject|1|||
19630113|NCT00574288|42079415|FG004|Overall Study|Death|0|||
19452910|NCT00986674|41701869|FG001|Overall Study|Lack of Efficacy|25|||
19532588|NCT03191864|41980486|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
19532589|NCT03191864|41980487|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
19532590|NCT03191864|41980488|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
19532591|NCT03191864|41980489|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
19532592|NCT03191864|41980490|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
19532593|NCT03191864|41980491|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
19532594|NCT03191864|41980486|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
19532595|NCT03191864|41980487|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
19452911|NCT00986674|41701870|FG002|Overall Study|Lack of Efficacy|23|||
19452912|NCT00986674|41701868|FG000|Overall Study|Adverse Event|4|||
19452913|NCT00986674|41701869|FG001|Overall Study|Adverse Event|8|||
19452914|NCT00986674|41701870|FG002|Overall Study|Adverse Event|9|||
19452915|NCT00986674|41701868|FG000|Overall Study|Death|5|||
19452916|NCT00986674|41701869|FG001|Overall Study|Death|0|||
19452917|NCT00986674|41701870|FG002|Overall Study|Death|4|||
19452918|NCT00986674|41701868|FG000|Overall Study|Withdrawal by Subject|6|||
19452919|NCT00986674|41701869|FG001|Overall Study|Withdrawal by Subject|2|||
19532596|NCT03191864|41980488|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
19532597|NCT03191864|41980489|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
19532598|NCT03191864|41980490|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
19532599|NCT03191864|41980491|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
19532600|NCT03191864|41980486|FG000|Baseline Symptom Assessment|Adverse Event|0|||
19532601|NCT03191864|41980487|FG001|Baseline Symptom Assessment|Adverse Event|0|||
19532602|NCT03191864|41980488|FG002|Baseline Symptom Assessment|Adverse Event|0|||
19532603|NCT03191864|41980489|FG003|Baseline Symptom Assessment|Adverse Event|0|||
19532604|NCT03191864|41980490|FG004|Baseline Symptom Assessment|Adverse Event|0|||
19532605|NCT03191864|41980491|FG005|Baseline Symptom Assessment|Adverse Event|2|||
19532606|NCT03191864|41980486|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
19532607|NCT03191864|41980487|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
19532608|NCT03191864|41980488|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
19532609|NCT03191864|41980489|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
19532610|NCT03191864|41980490|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
19532611|NCT03191864|41980491|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
19452920|NCT00986674|41701870|FG002|Overall Study|Withdrawal by Subject|1|||
19452921|NCT00986674|41701868|FG000|Overall Study|alternative therapy|0|||
19452922|NCT00986674|41701869|FG001|Overall Study|alternative therapy|0|||
19452923|NCT00986674|41701870|FG002|Overall Study|alternative therapy|1|||
19452924|NCT00986674|41701868|FG000|Overall Study|not start protocol therapy|4|||
19452925|NCT00986674|41701869|FG001|Overall Study|not start protocol therapy|3|||
19452926|NCT00986674|41701870|FG002|Overall Study|not start protocol therapy|1|||
19452927|NCT00986674|41701868|FG000|Overall Study|unknown/not specify|0|||
19452928|NCT00986674|41701869|FG001|Overall Study|unknown/not specify|7|||
19452929|NCT00986674|41701870|FG002|Overall Study|unknown/not specify|9|||
19452930|NCT00986440|41701880|FG000|Overall Study|Progressive disease|27|||
19452931|NCT00986440|41701881|FG001|Overall Study|Progressive disease|37|||
19452932|NCT00986440|41701880|FG000|Overall Study|Serious adverse event or adverse event|9|||
19452933|NCT00986440|41701881|FG001|Overall Study|Serious adverse event or adverse event|2|||
19452934|NCT00986440|41701880|FG000|Overall Study|Withdrawal by Subject|1|||
19452935|NCT00986440|41701881|FG001|Overall Study|Withdrawal by Subject|2|||
19452936|NCT00986440|41701880|FG000|Overall Study|Screen failure (not dosed)|4|||
19452937|NCT00986440|41701881|FG001|Overall Study|Screen failure (not dosed)|2|||
19452938|NCT01904383|41701887|FG000|Overall Study|CRF not collected|117|||
19452939|NCT01904383|41701887|FG000|Overall Study|Reason not listed|147|||
19452940|NCT01904383|41701887|FG000|Overall Study|Lost to Follow-up|674|||
19452941|NCT01904383|41701887|FG000|Overall Study|Lack of Efficacy|370|||
19452942|NCT01904383|41701887|FG000|Overall Study|Improvement|141|||
19452943|NCT01904383|41701887|FG000|Overall Study|Adverse Event|271|||
19452944|NCT01904383|41701887|FG000|Overall Study|No patient visit after entry|54|||
19452945|NCT01904149|41701897|FG000|Overall Study|Adverse Event|3|||
19452946|NCT01904149|41701898|FG001|Overall Study|Adverse Event|4|||
19452947|NCT01904149|41701899|FG002|Overall Study|Adverse Event|0|||
19452948|NCT01904149|41701900|FG003|Overall Study|Adverse Event|1|||
19452949|NCT01904149|41701901|FG004|Overall Study|Adverse Event|1|||
19452950|NCT01904149|41701902|FG005|Overall Study|Adverse Event|2|||
19452951|NCT01904149|41701897|FG000|Overall Study|Lack of Efficacy|0|||
19532612|NCT03191864|41980486|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
19452952|NCT01904149|41701898|FG001|Overall Study|Lack of Efficacy|3|||
19452953|NCT01904149|41701899|FG002|Overall Study|Lack of Efficacy|1|||
19452954|NCT01904149|41701900|FG003|Overall Study|Lack of Efficacy|3|||
19452955|NCT01904149|41701901|FG004|Overall Study|Lack of Efficacy|3|||
19452956|NCT01904149|41701902|FG005|Overall Study|Lack of Efficacy|1|||
19452957|NCT01904149|41701897|FG000|Overall Study|Withdrawal by Subject|1|||
19452958|NCT01904149|41701898|FG001|Overall Study|Withdrawal by Subject|3|||
19452959|NCT01904149|41701899|FG002|Overall Study|Withdrawal by Subject|1|||
19532613|NCT03191864|41980487|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
19630114|NCT00574288|42079416|FG005|Overall Study|Death|25|||
19452960|NCT01904149|41701900|FG003|Overall Study|Withdrawal by Subject|0|||
19452961|NCT01904149|41701901|FG004|Overall Study|Withdrawal by Subject|1|||
19532614|NCT03191864|41980488|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
19532615|NCT03191864|41980489|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
19532616|NCT03191864|41980490|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
19532617|NCT03191864|41980491|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
19532618|NCT03191864|41980486|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
19532619|NCT03191864|41980487|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
19532620|NCT03191864|41980488|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
19532621|NCT03191864|41980489|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
19532622|NCT03191864|41980490|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
19532623|NCT03191864|41980491|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
19532624|NCT03191864|41980486|FG000|Part 1 - Induction|Adverse Event|0|||
19532625|NCT03191864|41980487|FG001|Part 1 - Induction|Adverse Event|2|||
19532626|NCT03191864|41980488|FG002|Part 1 - Induction|Adverse Event|0|||
19532627|NCT03191864|41980489|FG003|Part 1 - Induction|Adverse Event|1|||
19532628|NCT03191864|41980490|FG004|Part 1 - Induction|Adverse Event|0|||
19532629|NCT03191864|41980491|FG005|Part 1 - Induction|Adverse Event|2|||
19532630|NCT03191864|41980486|FG000|Part 1 - Induction|Randomized but never dosed|0|||
19532631|NCT03191864|41980487|FG001|Part 1 - Induction|Randomized but never dosed|0|||
19532632|NCT03191864|41980488|FG002|Part 1 - Induction|Randomized but never dosed|1|||
19532633|NCT03191864|41980489|FG003|Part 1 - Induction|Randomized but never dosed|0|||
19532634|NCT03191864|41980490|FG004|Part 1 - Induction|Randomized but never dosed|0|||
19532635|NCT03191864|41980491|FG005|Part 1 - Induction|Randomized but never dosed|0|||
19532636|NCT03191864|41980486|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
19532637|NCT03191864|41980487|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
19532638|NCT03191864|41980488|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
19532639|NCT03191864|41980489|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
19532640|NCT03191864|41980490|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
19532641|NCT03191864|41980491|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
19532642|NCT03191864|41980486|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
19532643|NCT03191864|41980487|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
19532644|NCT03191864|41980488|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
19532645|NCT03191864|41980489|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
19532646|NCT03191864|41980490|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
19532647|NCT03191864|41980491|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
19452962|NCT01904149|41701902|FG005|Overall Study|Withdrawal by Subject|0|||
19452963|NCT01904149|41701897|FG000|Overall Study|Protocol Violation|0|||
19452964|NCT01904149|41701898|FG001|Overall Study|Protocol Violation|1|||
19452965|NCT01904149|41701899|FG002|Overall Study|Protocol Violation|0|||
19452966|NCT01904149|41701900|FG003|Overall Study|Protocol Violation|0|||
19452967|NCT01904149|41701901|FG004|Overall Study|Protocol Violation|0|||
19452968|NCT01904149|41701902|FG005|Overall Study|Protocol Violation|0|||
19452969|NCT01904149|41701897|FG000|Overall Study|non compliance with study drug|1|||
19452970|NCT01904149|41701898|FG001|Overall Study|non compliance with study drug|0|||
19452971|NCT01904149|41701899|FG002|Overall Study|non compliance with study drug|0|||
19532648|NCT03191864|41980486|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
19532649|NCT03191864|41980487|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
19532650|NCT03191864|41980488|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
19532651|NCT03191864|41980489|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
19532652|NCT03191864|41980490|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
19532653|NCT03191864|41980491|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
19532654|NCT03191864|41980486|FG000|Part 2 - Maintenance|Physician Decision|1|||
19532655|NCT03191864|41980487|FG001|Part 2 - Maintenance|Physician Decision|0|||
19532656|NCT03191864|41980488|FG002|Part 2 - Maintenance|Physician Decision|0|||
19630115|NCT00574288|42079417|FG006|Overall Study|Death|21|||
19630116|NCT00574288|42079411|FG000|Overall Study|Lost to Follow-up|0|||
19630117|NCT00574288|42079412|FG001|Overall Study|Lost to Follow-up|0|||
19630118|NCT00574288|42079413|FG002|Overall Study|Lost to Follow-up|0|||
19630119|NCT00574288|42079414|FG003|Overall Study|Lost to Follow-up|0|||
19630120|NCT00574288|42079415|FG004|Overall Study|Lost to Follow-up|0|||
19630121|NCT00574288|42079416|FG005|Overall Study|Lost to Follow-up|1|||
19630122|NCT00574288|42079417|FG006|Overall Study|Lost to Follow-up|2|||
19630123|NCT00574288|42079411|FG000|Overall Study|Study Terminated By Sponsor|0|||
19630124|NCT00574288|42079412|FG001|Overall Study|Study Terminated By Sponsor|0|||
19452972|NCT01904149|41701900|FG003|Overall Study|non compliance with study drug|0|||
19452973|NCT01904149|41701901|FG004|Overall Study|non compliance with study drug|0|||
19452974|NCT01904149|41701902|FG005|Overall Study|non compliance with study drug|0|||
19452975|NCT00986362|41701920|FG000|Overall Study|Death|2|||
19452976|NCT00986362|41701921|FG001|Overall Study|Death|0|||
19452977|NCT00986362|41701920|FG000|Overall Study|Lost to Follow-up|0|||
19452978|NCT00986362|41701921|FG001|Overall Study|Lost to Follow-up|1|||
19630125|NCT00574288|42079413|FG002|Overall Study|Study Terminated By Sponsor|0|||
19532657|NCT03191864|41980489|FG003|Part 2 - Maintenance|Physician Decision|0|||
19532658|NCT03191864|41980490|FG004|Part 2 - Maintenance|Physician Decision|0|||
19532659|NCT03191864|41980491|FG005|Part 2 - Maintenance|Physician Decision|0|||
19532660|NCT03191864|41980486|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
19532661|NCT03191864|41980487|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
19532662|NCT03191864|41980488|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
19532663|NCT03191864|41980489|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
19532664|NCT03191864|41980490|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
19532665|NCT03191864|41980491|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
19452979|NCT01890421|41701927|FG000|Overall Study|Adverse Event|1|||
19452980|NCT01890421|41701927|FG000|Overall Study|Other reason|10|||
19452981|NCT00985738|41701933|FG000|Overall Study|Study closed prematurely|8|||
19452982|NCT00985738|41701934|FG001|Overall Study|Study closed prematurely|8|||
19452983|NCT01928485|41701942|FG000|Overall Study|Physician Decision|0|||
19452984|NCT01928485|41701943|FG001|Overall Study|Physician Decision|1|||
19452985|NCT00985504|41701951|FG000|Acute Treatment Period|Adverse Event|3|||
19452986|NCT00985504|41701952|FG001|Acute Treatment Period|Adverse Event|4|||
19452987|NCT00985504|41701951|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
19532666|NCT03191864|41980486|FG000|Part 2 - Maintenance|Adverse Event|0|||
19532667|NCT03191864|41980487|FG001|Part 2 - Maintenance|Adverse Event|0|||
19630126|NCT00574288|42079414|FG003|Overall Study|Study Terminated By Sponsor|0|||
19630127|NCT00574288|42079415|FG004|Overall Study|Study Terminated By Sponsor|0|||
19630128|NCT00574288|42079416|FG005|Overall Study|Study Terminated By Sponsor|0|||
19630129|NCT00574288|42079417|FG006|Overall Study|Study Terminated By Sponsor|5|||
19630130|NCT00574288|42079411|FG000|Overall Study|Progressive Disease|17|||
19630131|NCT00574288|42079412|FG001|Overall Study|Progressive Disease|2|||
19630132|NCT00574288|42079413|FG002|Overall Study|Progressive Disease|3|||
19630133|NCT00574288|42079414|FG003|Overall Study|Progressive Disease|2|||
19630134|NCT00574288|42079415|FG004|Overall Study|Progressive Disease|1|||
19630135|NCT00574288|42079416|FG005|Overall Study|Progressive Disease|0|||
19630136|NCT00574288|42079417|FG006|Overall Study|Progressive Disease|0|||
19630137|NCT00574288|42079411|FG000|Overall Study|Other|1|||
19630138|NCT00574288|42079412|FG001|Overall Study|Other|1|||
19630139|NCT00574288|42079413|FG002|Overall Study|Other|0|||
19630140|NCT00574288|42079414|FG003|Overall Study|Other|0|||
19630141|NCT00574288|42079415|FG004|Overall Study|Other|0|||
19630142|NCT00574288|42079416|FG005|Overall Study|Other|0|||
19630143|NCT00574288|42079417|FG006|Overall Study|Other|0|||
19630144|NCT00790452|42079445|FG000|Overall Study|Drug supply issue|1|||
19630145|NCT00790452|42079446|FG001|Overall Study|Drug supply issue|0|||
19630146|NCT00626392|42079458|FG000|Run-in Period|Adverse Event|0|||
19630147|NCT00626392|42079459|FG001|Run-in Period|Adverse Event|0|||
19630148|NCT00626392|42079460|FG002|Run-in Period|Adverse Event|1|||
19630149|NCT00626392|42079461|FG003|Run-in Period|Adverse Event|0|||
19630150|NCT00626392|42079462|FG004|Run-in Period|Adverse Event|1|||
19630151|NCT00626392|42079463|FG005|Run-in Period|Adverse Event|0|||
19630152|NCT00626392|42079458|FG000|Run-in Period|Withdrawal by Subject|0|||
19630153|NCT00626392|42079459|FG001|Run-in Period|Withdrawal by Subject|1|||
19630154|NCT00626392|42079460|FG002|Run-in Period|Withdrawal by Subject|1|||
19630155|NCT00626392|42079461|FG003|Run-in Period|Withdrawal by Subject|1|||
19630156|NCT00626392|42079462|FG004|Run-in Period|Withdrawal by Subject|3|||
19630157|NCT00626392|42079463|FG005|Run-in Period|Withdrawal by Subject|1|||
19630158|NCT00626392|42079458|FG000|Run-in Period|Noncompliance|1|||
19630159|NCT00626392|42079459|FG001|Run-in Period|Noncompliance|0|||
19630160|NCT00626392|42079460|FG002|Run-in Period|Noncompliance|1|||
19630161|NCT00626392|42079461|FG003|Run-in Period|Noncompliance|0|||
19630162|NCT00626392|42079462|FG004|Run-in Period|Noncompliance|0|||
19630163|NCT00626392|42079463|FG005|Run-in Period|Noncompliance|0|||
19630164|NCT00626392|42079458|FG000|Coadministration Period|Adverse Event|3|||
19630165|NCT00626392|42079459|FG001|Coadministration Period|Adverse Event|1|||
19630166|NCT00626392|42079460|FG002|Coadministration Period|Adverse Event|7|||
19630167|NCT00626392|42079461|FG003|Coadministration Period|Adverse Event|4|||
19630168|NCT00626392|42079462|FG004|Coadministration Period|Adverse Event|3|||
19630169|NCT00626392|42079463|FG005|Coadministration Period|Adverse Event|4|||
19630170|NCT00626392|42079458|FG000|Coadministration Period|Withdrawal by Subject|1|||
19630171|NCT00626392|42079459|FG001|Coadministration Period|Withdrawal by Subject|1|||
19630172|NCT00626392|42079460|FG002|Coadministration Period|Withdrawal by Subject|0|||
19630173|NCT00626392|42079461|FG003|Coadministration Period|Withdrawal by Subject|1|||
19630174|NCT00626392|42079462|FG004|Coadministration Period|Withdrawal by Subject|0|||
19630175|NCT00626392|42079463|FG005|Coadministration Period|Withdrawal by Subject|1|||
19630176|NCT00626392|42079458|FG000|Coadministration Period|Protocol Violation|0|||
19452988|NCT00985504|41701952|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
19532668|NCT03191864|41980488|FG002|Part 2 - Maintenance|Adverse Event|0|||
19532669|NCT03191864|41980489|FG003|Part 2 - Maintenance|Adverse Event|0|||
19630177|NCT00626392|42079459|FG001|Coadministration Period|Protocol Violation|1|||
19452989|NCT00985504|41701951|FG000|Acute Treatment Period|Protocol Violation|2|||
19452990|NCT00985504|41701952|FG001|Acute Treatment Period|Protocol Violation|0|||
19452991|NCT00985504|41701951|FG000|Acute Treatment Period|Sponsor Decision|0|||
19452992|NCT00985504|41701952|FG001|Acute Treatment Period|Sponsor Decision|1|||
19452993|NCT00985504|41701951|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
19452994|NCT00985504|41701952|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
19452995|NCT00985504|41701951|FG000|Optimization Period|Adverse Event|7|||
19452996|NCT00985504|41701952|FG001|Optimization Period|Adverse Event|9|||
19452997|NCT00985504|41701951|FG000|Optimization Period|Death|0|||
19452998|NCT00985504|41701952|FG001|Optimization Period|Death|1|||
19452999|NCT00985504|41701951|FG000|Optimization Period|Lack of Efficacy|5|||
19453000|NCT00985504|41701952|FG001|Optimization Period|Lack of Efficacy|3|||
19453001|NCT00985504|41701951|FG000|Optimization Period|Lost to Follow-up|0|||
19453002|NCT00985504|41701952|FG001|Optimization Period|Lost to Follow-up|1|||
19453003|NCT00985504|41701951|FG000|Optimization Period|Physician Decision|1|||
19453004|NCT00985504|41701952|FG001|Optimization Period|Physician Decision|0|||
19453005|NCT00985504|41701951|FG000|Optimization Period|Protocol Violation|3|||
19453006|NCT00985504|41701952|FG001|Optimization Period|Protocol Violation|1|||
19453007|NCT00985504|41701951|FG000|Optimization Period|Withdrawal by Subject|10|||
19453008|NCT00985504|41701952|FG001|Optimization Period|Withdrawal by Subject|8|||
19453009|NCT00985426|41701960|FG000|Overall Study|Adverse Event|0|||
19453010|NCT00985426|41701961|FG001|Overall Study|Adverse Event|1|||
19453011|NCT00985426|41701960|FG000|Overall Study|Subject Non-Compliance|3|||
19453012|NCT00985426|41701961|FG001|Overall Study|Subject Non-Compliance|3|||
19453013|NCT00985426|41701960|FG000|Overall Study|Withdrawal by Subject|12|||
19453014|NCT00985426|41701961|FG001|Overall Study|Withdrawal by Subject|16|||
19453015|NCT00985426|41701960|FG000|Overall Study|Lost to Follow-up|8|||
19453016|NCT00985426|41701961|FG001|Overall Study|Lost to Follow-up|10|||
19453017|NCT00985426|41701960|FG000|Overall Study|Death|7|||
19453018|NCT00985426|41701961|FG001|Overall Study|Death|3|||
19453019|NCT00985426|41701960|FG000|Overall Study|Protocol Violation|2|||
19453020|NCT00985426|41701961|FG001|Overall Study|Protocol Violation|0|||
19453021|NCT00985426|41701960|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
19453022|NCT00985426|41701961|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
19453023|NCT00985192|41701967|FG000|Overall Study|Withdrawal by Subject|1|||
19453024|NCT00985192|41701967|FG000|Overall Study|Disease Progression|1|||
19453025|NCT00985192|41701967|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
19453026|NCT00985114|41701973|FG000|Overall Study|Adverse Event|1|||
19453027|NCT00985114|41701974|FG001|Overall Study|Adverse Event|0|||
19453028|NCT00985114|41701973|FG000|Overall Study|Withdrawal by Subject|0|||
19453029|NCT00985114|41701974|FG001|Overall Study|Withdrawal by Subject|2|||
19453030|NCT00984568|41701982|FG000|Overall Study|Withdrawal by Subject|1|||
19453031|NCT00984568|41701983|FG001|Overall Study|Withdrawal by Subject|2|||
19453032|NCT00984568|41701982|FG000|Overall Study|Lack of Efficacy|2|||
19453033|NCT00984568|41701983|FG001|Overall Study|Lack of Efficacy|0|||
19453034|NCT00984568|41701982|FG000|Overall Study|Adverse Event|2|||
19453035|NCT00984568|41701983|FG001|Overall Study|Adverse Event|0|||
19453036|NCT00984568|41701982|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
19532670|NCT03191864|41980490|FG004|Part 2 - Maintenance|Adverse Event|1|||
19532671|NCT03191864|41980491|FG005|Part 2 - Maintenance|Adverse Event|0|||
19532672|NCT03191864|41980486|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
19532673|NCT03191864|41980487|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
19453037|NCT00984568|41701983|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
19453038|NCT00984568|41701982|FG000|Overall Study|Lost to Follow-up|0|||
19453039|NCT00984568|41701983|FG001|Overall Study|Lost to Follow-up|1|||
19453040|NCT00984568|41701982|FG000|Overall Study|Opportunistic Infection|1|||
19532674|NCT03191864|41980488|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
19532675|NCT03191864|41980489|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
19532676|NCT03191864|41980490|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
19532677|NCT03191864|41980491|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
19532678|NCT03191864|41980486|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
19532679|NCT03191864|41980487|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
19532680|NCT03191864|41980488|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
19532681|NCT03191864|41980489|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
19532682|NCT03191864|41980490|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
19532683|NCT03191864|41980491|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
19532684|NCT02975882|41980523|FG000|Overall Study|Adverse Event|1|||
19532685|NCT02975882|41980524|FG001|Overall Study|Adverse Event|2|||
19532686|NCT02975882|41980525|FG002|Overall Study|Adverse Event|1|||
19532687|NCT02975882|41980526|FG003|Overall Study|Adverse Event|1|||
19453041|NCT00984568|41701983|FG001|Overall Study|Opportunistic Infection|0|||
19453042|NCT00984568|41701982|FG000|Overall Study|Unknown Reason|1|||
19453043|NCT00984568|41701983|FG001|Overall Study|Unknown Reason|3|||
19453044|NCT00984256|41701991|FG000|Overall Study|Withdrawal by Subject|0|||
19453045|NCT00984256|41701992|FG001|Overall Study|Withdrawal by Subject|1|||
19453046|NCT00984022|41702009|FG000|Overall Study|Lost to Follow-up|10|||
19453047|NCT00984022|41702010|FG001|Overall Study|Lost to Follow-up|14|||
19453048|NCT01890265|41702022|FG000|Overall Study|Other (Unspecified reason)|0|||
19453049|NCT01890265|41702023|FG001|Overall Study|Other (Unspecified reason)|1|||
19532688|NCT02975882|41980523|FG000|Overall Study|Death|0|||
19532689|NCT02975882|41980524|FG001|Overall Study|Death|1|||
19532690|NCT02975882|41980525|FG002|Overall Study|Death|0|||
19532691|NCT02975882|41980526|FG003|Overall Study|Death|0|||
19532692|NCT02975882|41980523|FG000|Overall Study|Lack of Efficacy|3|||
19532693|NCT02975882|41980524|FG001|Overall Study|Lack of Efficacy|7|||
19630178|NCT00626392|42079460|FG002|Coadministration Period|Protocol Violation|0|||
19630179|NCT00626392|42079461|FG003|Coadministration Period|Protocol Violation|1|||
19630180|NCT00626392|42079462|FG004|Coadministration Period|Protocol Violation|1|||
19630181|NCT00626392|42079463|FG005|Coadministration Period|Protocol Violation|0|||
19630182|NCT00626392|42079458|FG000|Coadministration Period|Other|0|||
19630183|NCT00626392|42079459|FG001|Coadministration Period|Other|2|||
19630184|NCT00626392|42079460|FG002|Coadministration Period|Other|3|||
19630185|NCT00626392|42079461|FG003|Coadministration Period|Other|1|||
19630186|NCT00626392|42079462|FG004|Coadministration Period|Other|1|||
19630187|NCT00626392|42079463|FG005|Coadministration Period|Other|1|||
19630188|NCT00624286|42079471|FG000|Overall Study|Protocol Deviation|7|||
19630189|NCT00624286|42079472|FG001|Overall Study|Protocol Deviation|9|||
19630190|NCT00624286|42079471|FG000|Overall Study|Adverse Event|6|||
19630191|NCT00624286|42079472|FG001|Overall Study|Adverse Event|3|||
19630192|NCT00624286|42079471|FG000|Overall Study|Withdrawal by Subject|5|||
19630193|NCT00624286|42079472|FG001|Overall Study|Withdrawal by Subject|4|||
19630194|NCT00624286|42079471|FG000|Overall Study|Lost to Follow-up|3|||
19630195|NCT00624286|42079472|FG001|Overall Study|Lost to Follow-up|2|||
19630196|NCT00624286|42079471|FG000|Overall Study|Administrative problems|3|||
19630197|NCT00624286|42079472|FG001|Overall Study|Administrative problems|0|||
19630198|NCT00624286|42079471|FG000|Overall Study|Lack of Efficacy|1|||
19630199|NCT00624286|42079472|FG001|Overall Study|Lack of Efficacy|6|||
19630200|NCT00624286|42079471|FG000|Overall Study|Not stated|0|||
19630201|NCT00624286|42079472|FG001|Overall Study|Not stated|1|||
19630202|NCT00624286|42079471|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19453050|NCT01890265|41702024|FG002|Overall Study|Other (Unspecified reason)|0|||
19453051|NCT01890265|41702025|FG003|Overall Study|Other (Unspecified reason)|0|||
19453052|NCT01890265|41702026|FG004|Overall Study|Other (Unspecified reason)|0|||
19453053|NCT01890265|41702027|FG005|Overall Study|Other (Unspecified reason)|0|||
19453054|NCT01890265|41702022|FG000|Overall Study|Progressive disease|6|||
19453055|NCT01890265|41702023|FG001|Overall Study|Progressive disease|6|||
19453056|NCT01890265|41702024|FG002|Overall Study|Progressive disease|0|||
19453057|NCT01890265|41702025|FG003|Overall Study|Progressive disease|0|||
19453058|NCT01890265|41702026|FG004|Overall Study|Progressive disease|0|||
19453059|NCT01890265|41702027|FG005|Overall Study|Progressive disease|0|||
19453060|NCT01890265|41702022|FG000|Overall Study|Adverse Event|2|||
19453061|NCT01890265|41702023|FG001|Overall Study|Adverse Event|1|||
19453062|NCT01890265|41702024|FG002|Overall Study|Adverse Event|0|||
19453063|NCT01890265|41702025|FG003|Overall Study|Adverse Event|0|||
19453064|NCT01890265|41702026|FG004|Overall Study|Adverse Event|0|||
19453065|NCT01890265|41702027|FG005|Overall Study|Adverse Event|0|||
19453066|NCT01890265|41702022|FG000|Overall Study|Death|2|||
19453067|NCT01890265|41702023|FG001|Overall Study|Death|3|||
19453068|NCT01890265|41702024|FG002|Overall Study|Death|1|||
19453069|NCT01890265|41702025|FG003|Overall Study|Death|0|||
19453070|NCT01890265|41702026|FG004|Overall Study|Death|0|||
19453071|NCT01890265|41702027|FG005|Overall Study|Death|0|||
19453072|NCT01890265|41702022|FG000|Overall Study|Withdrawal by Subject|0|||
19453073|NCT01890265|41702023|FG001|Overall Study|Withdrawal by Subject|2|||
19532694|NCT02975882|41980525|FG002|Overall Study|Lack of Efficacy|4|||
19532695|NCT02975882|41980526|FG003|Overall Study|Lack of Efficacy|3|||
19532696|NCT02975882|41980523|FG000|Overall Study|Physician Decision|0|||
19532697|NCT02975882|41980524|FG001|Overall Study|Physician Decision|2|||
19532698|NCT02975882|41980525|FG002|Overall Study|Physician Decision|4|||
19532699|NCT02975882|41980526|FG003|Overall Study|Physician Decision|2|||
19532700|NCT02975882|41980523|FG000|Overall Study|Ineligible|0|||
19532701|NCT02975882|41980524|FG001|Overall Study|Ineligible|1|||
19532702|NCT02975882|41980525|FG002|Overall Study|Ineligible|0|||
19532703|NCT02975882|41980526|FG003|Overall Study|Ineligible|0|||
19532704|NCT02701283|41980575|FG000|Overall Study|Death|25|||
19532705|NCT02701283|41980576|FG001|Overall Study|Death|29|||
19532706|NCT02701283|41980577|FG002|Overall Study|Death|19|||
19532707|NCT02701283|41980575|FG000|Overall Study|Lost to Follow-up|3|||
19630203|NCT00624286|42079472|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19453074|NCT01890265|41702024|FG002|Overall Study|Withdrawal by Subject|3|||
19532708|NCT02701283|41980576|FG001|Overall Study|Lost to Follow-up|8|||
19532709|NCT02701283|41980577|FG002|Overall Study|Lost to Follow-up|1|||
19532710|NCT02701283|41980575|FG000|Overall Study|Withdrawal by Subject|12|||
19532711|NCT02701283|41980576|FG001|Overall Study|Withdrawal by Subject|41|||
19453075|NCT01890265|41702025|FG003|Overall Study|Withdrawal by Subject|0|||
19453076|NCT01890265|41702026|FG004|Overall Study|Withdrawal by Subject|2|||
19532712|NCT02701283|41980577|FG002|Overall Study|Withdrawal by Subject|1|||
19532713|NCT02701283|41980575|FG000|Overall Study|Missed 2-year visit|22|||
19532714|NCT02701283|41980576|FG001|Overall Study|Missed 2-year visit|27|||
19532715|NCT02701283|41980577|FG002|Overall Study|Missed 2-year visit|0|||
19532716|NCT02701283|41980575|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
19532717|NCT02701283|41980576|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
19532718|NCT02701283|41980577|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
19532719|NCT02636725|41980588|FG000|Baseline|Adverse Event|1|||
19532720|NCT02636725|41980588|FG000|Baseline|Lack of Efficacy|2|||
19532721|NCT02573493|41980596|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
19532722|NCT02573493|41980597|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
19532723|NCT02573493|41980598|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
19532724|NCT02573493|41980599|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
19532725|NCT02327078|41980632|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
19453077|NCT01890265|41702027|FG005|Overall Study|Withdrawal by Subject|0|||
19453078|NCT01928329|41702048|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
19453079|NCT01928329|41702049|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
19453080|NCT01928329|41702048|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
19453081|NCT01928329|41702049|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
19453082|NCT01928329|41702048|FG000|Overall Study|Adverse Event|5|||
19532726|NCT02327078|41980633|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
19532727|NCT02327078|41980634|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
19532728|NCT02327078|41980635|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
19532729|NCT02327078|41980636|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
19532730|NCT02327078|41980637|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
19532731|NCT02327078|41980638|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
19532732|NCT02327078|41980639|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
19532733|NCT02327078|41980640|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
19532734|NCT02327078|41980632|FG000|Overall Study|Death|2|||
19532735|NCT02327078|41980633|FG001|Overall Study|Death|4|||
19532736|NCT02327078|41980634|FG002|Overall Study|Death|10|||
19532737|NCT02327078|41980635|FG003|Overall Study|Death|6|||
19532738|NCT02327078|41980636|FG004|Overall Study|Death|4|||
19453083|NCT01928329|41702049|FG001|Overall Study|Adverse Event|3|||
19532739|NCT02327078|41980637|FG005|Overall Study|Death|3|||
19532740|NCT02327078|41980638|FG006|Overall Study|Death|2|||
19532741|NCT02327078|41980639|FG007|Overall Study|Death|51|||
19532742|NCT02327078|41980640|FG008|Overall Study|Death|97|||
19532743|NCT02327078|41980632|FG000|Overall Study|Lost to Follow-up|0|||
19532744|NCT02327078|41980633|FG001|Overall Study|Lost to Follow-up|1|||
19532745|NCT02327078|41980634|FG002|Overall Study|Lost to Follow-up|1|||
19532746|NCT02327078|41980635|FG003|Overall Study|Lost to Follow-up|0|||
19532747|NCT02327078|41980636|FG004|Overall Study|Lost to Follow-up|0|||
19532748|NCT02327078|41980637|FG005|Overall Study|Lost to Follow-up|0|||
19532749|NCT02327078|41980638|FG006|Overall Study|Lost to Follow-up|0|||
19532750|NCT02327078|41980639|FG007|Overall Study|Lost to Follow-up|2|||
19532751|NCT02327078|41980640|FG008|Overall Study|Lost to Follow-up|5|||
19532752|NCT02327078|41980632|FG000|Overall Study|Site Terminated by Sponsor|1|||
19532753|NCT02327078|41980633|FG001|Overall Study|Site Terminated by Sponsor|0|||
19532754|NCT02327078|41980634|FG002|Overall Study|Site Terminated by Sponsor|1|||
19532755|NCT02327078|41980635|FG003|Overall Study|Site Terminated by Sponsor|4|||
19532756|NCT02327078|41980636|FG004|Overall Study|Site Terminated by Sponsor|0|||
19532757|NCT02327078|41980637|FG005|Overall Study|Site Terminated by Sponsor|0|||
19532758|NCT02327078|41980638|FG006|Overall Study|Site Terminated by Sponsor|0|||
19532759|NCT02327078|41980639|FG007|Overall Study|Site Terminated by Sponsor|11|||
19532760|NCT02327078|41980640|FG008|Overall Study|Site Terminated by Sponsor|25|||
19532761|NCT02327078|41980632|FG000|Overall Study|Physician Decision|0|||
19532762|NCT02327078|41980633|FG001|Overall Study|Physician Decision|0|||
19532763|NCT02327078|41980634|FG002|Overall Study|Physician Decision|0|||
19532764|NCT02327078|41980635|FG003|Overall Study|Physician Decision|1|||
19532765|NCT02327078|41980636|FG004|Overall Study|Physician Decision|0|||
19532766|NCT02327078|41980637|FG005|Overall Study|Physician Decision|0|||
19532767|NCT02327078|41980638|FG006|Overall Study|Physician Decision|0|||
19532768|NCT02327078|41980639|FG007|Overall Study|Physician Decision|0|||
19532769|NCT02327078|41980640|FG008|Overall Study|Physician Decision|1|||
19453084|NCT01928329|41702048|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
19453085|NCT01928329|41702049|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
19532770|NCT02327078|41980632|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
19532771|NCT02327078|41980633|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
19532772|NCT02327078|41980634|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
19630204|NCT00624286|42079471|FG000|Overall Study|Death|0|||
19630205|NCT00624286|42079472|FG001|Overall Study|Death|1|||
19532773|NCT02327078|41980635|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
19532774|NCT02327078|41980636|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
19532775|NCT02327078|41980637|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
19532776|NCT02327078|41980638|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
19532777|NCT02327078|41980639|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
19532778|NCT02327078|41980640|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
19532779|NCT02327078|41980632|FG000|Overall Study|Reason not Specified|0|||
19532780|NCT02327078|41980633|FG001|Overall Study|Reason not Specified|0|||
19532781|NCT02327078|41980634|FG002|Overall Study|Reason not Specified|0|||
19532782|NCT02327078|41980635|FG003|Overall Study|Reason not Specified|0|||
19532783|NCT02327078|41980636|FG004|Overall Study|Reason not Specified|0|||
19532784|NCT02327078|41980637|FG005|Overall Study|Reason not Specified|0|||
19532785|NCT02327078|41980638|FG006|Overall Study|Reason not Specified|0|||
19532786|NCT02327078|41980639|FG007|Overall Study|Reason not Specified|5|||
19532787|NCT02327078|41980640|FG008|Overall Study|Reason not Specified|12|||
19532788|NCT02304458|41980683|FG000|Overall Study|Adverse Event|0|||
19532789|NCT02304458|41980684|FG001|Overall Study|Adverse Event|0|||
19532790|NCT02304458|41980685|FG002|Overall Study|Adverse Event|7|||
19532791|NCT02304458|41980686|FG003|Overall Study|Adverse Event|0|||
19532792|NCT02304458|41980687|FG004|Overall Study|Adverse Event|0|||
19532793|NCT02304458|41980688|FG005|Overall Study|Adverse Event|0|||
19532794|NCT02304458|41980689|FG006|Overall Study|Adverse Event|3|||
19532795|NCT02304458|41980690|FG007|Overall Study|Adverse Event|4|||
19532796|NCT02304458|41980683|FG000|Overall Study|Death|0|||
19532797|NCT02304458|41980684|FG001|Overall Study|Death|0|||
19532798|NCT02304458|41980685|FG002|Overall Study|Death|2|||
19532799|NCT02304458|41980686|FG003|Overall Study|Death|0|||
19532800|NCT02304458|41980687|FG004|Overall Study|Death|0|||
19532801|NCT02304458|41980688|FG005|Overall Study|Death|0|||
19532802|NCT02304458|41980689|FG006|Overall Study|Death|1|||
19532803|NCT02304458|41980690|FG007|Overall Study|Death|0|||
19532804|NCT02304458|41980683|FG000|Overall Study|Lack of Efficacy|4|||
19532805|NCT02304458|41980684|FG001|Overall Study|Lack of Efficacy|6|||
19532806|NCT02304458|41980685|FG002|Overall Study|Lack of Efficacy|38|||
19532807|NCT02304458|41980686|FG003|Overall Study|Lack of Efficacy|5|||
19532808|NCT02304458|41980687|FG004|Overall Study|Lack of Efficacy|6|||
19532809|NCT02304458|41980688|FG005|Overall Study|Lack of Efficacy|6|||
19532810|NCT02304458|41980689|FG006|Overall Study|Lack of Efficacy|21|||
19532811|NCT02304458|41980690|FG007|Overall Study|Lack of Efficacy|4|||
19532812|NCT02304458|41980683|FG000|Overall Study|Physician Decision|2|||
19532813|NCT02304458|41980684|FG001|Overall Study|Physician Decision|0|||
19532814|NCT02304458|41980685|FG002|Overall Study|Physician Decision|16|||
19532815|NCT02304458|41980686|FG003|Overall Study|Physician Decision|1|||
19532816|NCT02304458|41980687|FG004|Overall Study|Physician Decision|0|||
19532817|NCT02304458|41980688|FG005|Overall Study|Physician Decision|0|||
19532818|NCT02304458|41980689|FG006|Overall Study|Physician Decision|3|||
19532819|NCT02304458|41980690|FG007|Overall Study|Physician Decision|0|||
19532820|NCT02304458|41980683|FG000|Overall Study|Protocol Violation|0|||
19532821|NCT02304458|41980684|FG001|Overall Study|Protocol Violation|0|||
19453086|NCT01928329|41702048|FG000|Overall Study|Withdrawal by Subject|1|||
19453087|NCT01928329|41702049|FG001|Overall Study|Withdrawal by Subject|5|||
19453088|NCT01928329|41702048|FG000|Overall Study|Physician Decision|1|||
19453089|NCT01928329|41702049|FG001|Overall Study|Physician Decision|1|||
19453090|NCT01890109|41702057|FG000|Overall Study|Withdrawal by Subject|0|||
19453091|NCT01890109|41702058|FG001|Overall Study|Withdrawal by Subject|3|||
19532822|NCT02304458|41980685|FG002|Overall Study|Protocol Violation|1|||
19532823|NCT02304458|41980686|FG003|Overall Study|Protocol Violation|0|||
19532824|NCT02304458|41980687|FG004|Overall Study|Protocol Violation|0|||
19532825|NCT02304458|41980688|FG005|Overall Study|Protocol Violation|0|||
19532826|NCT02304458|41980689|FG006|Overall Study|Protocol Violation|0|||
19532827|NCT02304458|41980690|FG007|Overall Study|Protocol Violation|0|||
19532828|NCT02304458|41980683|FG000|Overall Study|Withdrawal by Subject|1|||
19532829|NCT02304458|41980684|FG001|Overall Study|Withdrawal by Subject|0|||
19532830|NCT02304458|41980685|FG002|Overall Study|Withdrawal by Subject|7|||
19453092|NCT01890109|41702057|FG000|Overall Study|Lost to Follow-up|1|||
19453093|NCT01890109|41702058|FG001|Overall Study|Lost to Follow-up|2|||
19453094|NCT00982930|41702065|FG000|Overall Study|Adverse Event|1|||
19453095|NCT00982930|41702065|FG000|Overall Study|Withdrawal by Subject|1|||
19453096|NCT00982930|41702065|FG000|Overall Study|Administrative Problems|2|||
19453097|NCT00981682|41702069|FG000|Overall Study|Adverse Event|48|||
19453098|NCT00981682|41702069|FG000|Overall Study|Withdrawal by Subject|52|||
19453099|NCT00981682|41702069|FG000|Overall Study|Lost to Follow-up|14|||
19532831|NCT02304458|41980686|FG003|Overall Study|Withdrawal by Subject|0|||
19532832|NCT02304458|41980687|FG004|Overall Study|Withdrawal by Subject|0|||
19532833|NCT02304458|41980688|FG005|Overall Study|Withdrawal by Subject|0|||
19532834|NCT02304458|41980689|FG006|Overall Study|Withdrawal by Subject|1|||
19532835|NCT02304458|41980690|FG007|Overall Study|Withdrawal by Subject|0|||
19532836|NCT02187224|41980726|FG000|Overall Study|Did not show up for test day|1|||
19453100|NCT00981682|41702069|FG000|Overall Study|Lack of Efficacy|13|||
19453101|NCT00981682|41702069|FG000|Overall Study|Protocol Violation|6|||
19453102|NCT00981682|41702069|FG000|Overall Study|administrative|9|||
19453103|NCT01903993|41702075|FG000|Overall Study|Death|118|||
19453104|NCT01903993|41702076|FG001|Overall Study|Death|121|||
19453105|NCT01903993|41702075|FG000|Overall Study|Withdrawal by Subject|15|||
19453106|NCT01903993|41702076|FG001|Overall Study|Withdrawal by Subject|4|||
19532837|NCT02187224|41980727|FG001|Overall Study|Did not show up for test day|0|||
19532838|NCT02176226|41980737|FG000|Overall Study|Lost to Follow-up|3|||
19532839|NCT02176226|41980737|FG000|Overall Study|Withdrew prior to treatment|6|||
19532840|NCT02032823|41980743|FG000|Overall Study|Death|75|||
19532841|NCT02032823|41980744|FG001|Overall Study|Death|109|||
19453107|NCT01903993|41702075|FG000|Overall Study|Lost to Follow-up|2|||
19453108|NCT01903993|41702076|FG001|Overall Study|Lost to Follow-up|3|||
19532842|NCT02032823|41980743|FG000|Overall Study|Lost to Follow-up|18|||
19532843|NCT02032823|41980744|FG001|Overall Study|Lost to Follow-up|17|||
19532844|NCT02032823|41980743|FG000|Overall Study|Withdrawal by Subject|70|||
19532845|NCT02032823|41980744|FG001|Overall Study|Withdrawal by Subject|53|||
19532846|NCT02032823|41980743|FG000|Overall Study|Ongoing study at data cut-off|755|||
19532847|NCT02032823|41980744|FG001|Overall Study|Ongoing study at data cut-off|731|||
19532848|NCT02032823|41980743|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
19532849|NCT02032823|41980744|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
19532850|NCT01958021|41980752|FG000|Overall Study|Progressive disease|87|||
19532851|NCT01958021|41980753|FG001|Overall Study|Progressive disease|146|||
19532852|NCT01958021|41980752|FG000|Overall Study|Adverse Event|25|||
19532853|NCT01958021|41980753|FG001|Overall Study|Adverse Event|7|||
19532854|NCT01958021|41980752|FG000|Overall Study|Subject/guardian decision|12|||
19532855|NCT01958021|41980753|FG001|Overall Study|Subject/guardian decision|13|||
19532856|NCT01958021|41980752|FG000|Overall Study|Physician Decision|10|||
19532857|NCT01958021|41980753|FG001|Overall Study|Physician Decision|13|||
19532858|NCT01958021|41980752|FG000|Overall Study|Protocol Violation|3|||
19532859|NCT01958021|41980753|FG001|Overall Study|Protocol Violation|1|||
19532860|NCT01958021|41980752|FG000|Overall Study|Death|2|||
19532861|NCT01958021|41980753|FG001|Overall Study|Death|0|||
19532862|NCT00567580|41980762|FG000|Overall Study|Protocol Violation|28|||
19532863|NCT00567580|41980763|FG001|Overall Study|Protocol Violation|24|||
19532864|NCT00567580|41980764|FG002|Overall Study|Protocol Violation|24|||
19630206|NCT00624052|42079482|FG000|Overall Study|Adverse Event|7|||
19630207|NCT00624052|42079483|FG001|Overall Study|Adverse Event|6|||
19630208|NCT00624052|42079484|FG002|Overall Study|Adverse Event|0|||
19630209|NCT00624052|42079485|FG003|Overall Study|Adverse Event|3|||
19630210|NCT00624052|42079482|FG000|Overall Study|Lack of Efficacy|1|||
19630211|NCT00624052|42079483|FG001|Overall Study|Lack of Efficacy|1|||
19630212|NCT00624052|42079484|FG002|Overall Study|Lack of Efficacy|0|||
19630213|NCT00624052|42079485|FG003|Overall Study|Lack of Efficacy|0|||
19630214|NCT00624052|42079482|FG000|Overall Study|Lost to Follow-up|2|||
19630215|NCT00624052|42079483|FG001|Overall Study|Lost to Follow-up|3|||
19630216|NCT00624052|42079484|FG002|Overall Study|Lost to Follow-up|1|||
19630217|NCT00624052|42079485|FG003|Overall Study|Lost to Follow-up|0|||
19630218|NCT00624052|42079482|FG000|Overall Study|Non compliant with the protocol|2|||
19630219|NCT00624052|42079483|FG001|Overall Study|Non compliant with the protocol|1|||
19630220|NCT00624052|42079484|FG002|Overall Study|Non compliant with the protocol|1|||
19630221|NCT00624052|42079485|FG003|Overall Study|Non compliant with the protocol|1|||
19630222|NCT00624052|42079482|FG000|Overall Study|Consent withdrawn|3|||
19630223|NCT00624052|42079483|FG001|Overall Study|Consent withdrawn|1|||
19630224|NCT00624052|42079484|FG002|Overall Study|Consent withdrawn|1|||
19630225|NCT00624052|42079485|FG003|Overall Study|Consent withdrawn|0|||
19630226|NCT00624052|42079482|FG000|Overall Study|Changed job/ran out if meds|0|||
19630227|NCT00624052|42079483|FG001|Overall Study|Changed job/ran out if meds|2|||
19630228|NCT00624052|42079484|FG002|Overall Study|Changed job/ran out if meds|0|||
19630229|NCT00624052|42079485|FG003|Overall Study|Changed job/ran out if meds|0|||
19630230|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
19630231|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
19630232|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
19630233|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
19630234|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
19630235|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
19630236|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
19630237|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
19630238|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
19630239|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
19630240|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
19630241|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
19630242|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
19630243|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
19630244|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
19532865|NCT01058863|41980775|FG000|Overall Study|Lost to Follow-up|1|||
19532866|NCT01058863|41980775|FG000|Overall Study|Withdrawal by Subject|1|||
19532867|NCT01058863|41980775|FG000|Overall Study|Sponsor requested withdrawal|1|||
19532868|NCT01058863|41980775|FG000|Overall Study|Randomized in error|1|||
19532869|NCT01058395|41980790|FG000|Overall Study|Death|2|||
19532870|NCT01058395|41980791|FG001|Overall Study|Death|1|||
19532871|NCT01058395|41980790|FG000|Overall Study|Lost to Follow-up|1|||
19532872|NCT01058395|41980791|FG001|Overall Study|Lost to Follow-up|0|||
19532873|NCT01058356|41980797|FG000|Overall Study|Adverse Event|5|||
19532874|NCT01058356|41980797|FG000|Overall Study|Administration of contraindicated drugs|12|||
19532875|NCT01058356|41980797|FG000|Overall Study|Withdrawal by Subject|21|||
19532876|NCT01058356|41980797|FG000|Overall Study|Lost to Follow-up|4|||
19532877|NCT01058005|41980804|FG000|Overall Study|Adverse Event|0|||
19532878|NCT01058005|41980805|FG001|Overall Study|Adverse Event|2|||
19532879|NCT01058005|41980806|FG002|Overall Study|Adverse Event|1|||
19532880|NCT01058005|41980804|FG000|Overall Study|Physician Decision|2|||
19532881|NCT01058005|41980805|FG001|Overall Study|Physician Decision|2|||
19532882|NCT01058005|41980806|FG002|Overall Study|Physician Decision|0|||
19532883|NCT01058005|41980804|FG000|Overall Study|Withdrawal by Subject|4|||
19532884|NCT01058005|41980805|FG001|Overall Study|Withdrawal by Subject|5|||
19532885|NCT01058005|41980806|FG002|Overall Study|Withdrawal by Subject|11|||
19532886|NCT01058005|41980804|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
19532887|NCT01058005|41980805|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
19532888|NCT01058005|41980806|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
19532889|NCT01058005|41980804|FG000|Overall Study|Reason Missing|5|||
19532890|NCT01058005|41980805|FG001|Overall Study|Reason Missing|3|||
19532891|NCT01058005|41980806|FG002|Overall Study|Reason Missing|1|||
19532892|NCT01056640|41980816|FG000|Overall Study|Withdrawal by Subject|11|||
19532893|NCT01056640|41980817|FG001|Overall Study|Withdrawal by Subject|8|||
19532894|NCT01056640|41980816|FG000|Overall Study|Death|15|||
19532895|NCT01056640|41980817|FG001|Overall Study|Death|4|||
19532896|NCT01056523|41980823|FG000|Overall Study|Death|1|||
19532897|NCT01056523|41980824|FG001|Overall Study|Death|0|||
19532898|NCT01056523|41980825|FG002|Overall Study|Death|2|||
19532899|NCT01056523|41980826|FG003|Overall Study|Death|3|||
19532900|NCT01056523|41980827|FG004|Overall Study|Death|0|||
19532901|NCT01056523|41980828|FG005|Overall Study|Death|0|||
19532902|NCT01056523|41980829|FG006|Overall Study|Death|1|||
19532903|NCT01056484|41980836|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
19532904|NCT01056484|41980837|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
19532905|NCT01056484|41980836|FG000|Randomized Controlled Trial|Physician Decision|1|||
19532906|NCT01056484|41980837|FG001|Randomized Controlled Trial|Physician Decision|0|||
19532907|NCT01056484|41980836|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
19532908|NCT01056484|41980837|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
19532909|NCT01055314|41980846|FG000|Overall Study|Adverse Event|7|||
19532910|NCT01055314|41980847|FG001|Overall Study|Adverse Event|4|||
19532911|NCT01055314|41980846|FG000|Overall Study|Death|2|||
19532912|NCT01055314|41980847|FG001|Overall Study|Death|1|||
19532913|NCT01055314|41980846|FG000|Overall Study|Lack of Efficacy|11|||
19532914|NCT01055314|41980847|FG001|Overall Study|Lack of Efficacy|19|||
19532915|NCT01055314|41980846|FG000|Overall Study|Physician Decision|10|||
19532916|NCT01055314|41980847|FG001|Overall Study|Physician Decision|5|||
19532917|NCT01055314|41980846|FG000|Overall Study|Withdrawal by Subject|1|||
19532918|NCT01055314|41980847|FG001|Overall Study|Withdrawal by Subject|0|||
19532919|NCT01055314|41980846|FG000|Overall Study|Ineligible|3|||
19532920|NCT01055314|41980847|FG001|Overall Study|Ineligible|5|||
19532921|NCT01055314|41980846|FG000|Overall Study|Refusal of further protocol therapy|10|||
19532922|NCT01055314|41980847|FG001|Overall Study|Refusal of further protocol therapy|4|||
19532923|NCT01055314|41980846|FG000|Overall Study|No treatment|1|||
19532924|NCT01055314|41980847|FG001|Overall Study|No treatment|0|||
19532925|NCT01055197|41980856|FG000|Overall Study|Protocol Violation|7|||
19532926|NCT01055197|41980857|FG001|Overall Study|Protocol Violation|2|||
19532927|NCT01055197|41980856|FG000|Overall Study|Withdrawal by Subject|2|||
19532928|NCT01055197|41980857|FG001|Overall Study|Withdrawal by Subject|0|||
19532929|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
19532930|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532931|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532932|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532933|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532934|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532935|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19532936|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
19532937|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
19532938|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
19532939|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
19711441|NCT03595618|42154548|FG003|Overall Study|Adverse Event|8|||
19532940|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
19532941|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
19532942|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
19532943|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
19532944|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532945|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532946|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532947|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532948|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532949|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19532950|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
19532951|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532952|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532953|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532954|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532955|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532956|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19532957|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
19532958|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532959|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532960|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532961|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532962|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532963|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
19532964|NCT01054885|41980869|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
19532965|NCT01054885|41980870|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19532966|NCT01054885|41980871|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19532967|NCT01054885|41980872|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19532968|NCT01054885|41980873|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19453109|NCT01903993|41702075|FG000|Overall Study|Study Terminated by Sponsor|8|||
19453110|NCT01903993|41702076|FG001|Overall Study|Study Terminated by Sponsor|14|||
19453111|NCT01903993|41702075|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
19453112|NCT01903993|41702076|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
19453113|NCT00981292|41702089|FG000|Day 1|Protocol Violation|1|||
19453114|NCT00981292|41702090|FG001|Day 1|Protocol Violation|0|||
19453115|NCT00981292|41702091|FG002|Day 1|Protocol Violation|0|||
19453116|NCT00981292|41702092|FG003|Day 1|Protocol Violation|0|||
19453117|NCT00981292|41702093|FG004|Day 1|Protocol Violation|0|||
19453118|NCT00981292|41702094|FG005|Day 1|Protocol Violation|2|||
19453119|NCT00981292|41702089|FG000|Day 2|Protocol Violation|2|||
19453120|NCT00981292|41702090|FG001|Day 2|Protocol Violation|0|||
19453121|NCT00981292|41702091|FG002|Day 2|Protocol Violation|0|||
19453122|NCT00981292|41702092|FG003|Day 2|Protocol Violation|0|||
19453123|NCT00981292|41702093|FG004|Day 2|Protocol Violation|0|||
19453124|NCT00981292|41702094|FG005|Day 2|Protocol Violation|0|||
19453125|NCT00981292|41702089|FG000|Day 3|Protocol Violation|0|||
19453126|NCT00981292|41702090|FG001|Day 3|Protocol Violation|0|||
19453127|NCT00981292|41702091|FG002|Day 3|Protocol Violation|0|||
19453128|NCT00981292|41702092|FG003|Day 3|Protocol Violation|0|||
19453129|NCT00981292|41702093|FG004|Day 3|Protocol Violation|0|||
19453130|NCT00981292|41702094|FG005|Day 3|Protocol Violation|1|||
19453131|NCT00980044|41702109|FG000|Overall Study|Withdrawal by Subject|5|||
19453132|NCT00980044|41702110|FG001|Overall Study|Withdrawal by Subject|7|||
19453133|NCT00980044|41702111|FG002|Overall Study|Withdrawal by Subject|3|||
19453134|NCT00980044|41702109|FG000|Overall Study|Protocol Violation|0|||
19532969|NCT01054885|41980874|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19532970|NCT01054885|41980875|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19532971|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
19532972|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
19532973|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
19532974|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
19453135|NCT00980044|41702110|FG001|Overall Study|Protocol Violation|0|||
19453136|NCT00980044|41702111|FG002|Overall Study|Protocol Violation|2|||
19453137|NCT01903837|41702126|FG000|Part A|Withdrawal by Subject|4|||
19453138|NCT01903837|41702127|FG001|Part A|Withdrawal by Subject|9|||
19453139|NCT01903837|41702128|FG002|Part A|Withdrawal by Subject|8|||
19453140|NCT01903837|41702129|FG003|Part A|Withdrawal by Subject|5|||
19532975|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
19453141|NCT01903837|41702126|FG000|Part A|Adverse Event|3|||
19453142|NCT01903837|41702127|FG001|Part A|Adverse Event|6|||
19453143|NCT01903837|41702128|FG002|Part A|Adverse Event|9|||
19453144|NCT01903837|41702129|FG003|Part A|Adverse Event|6|||
19453145|NCT01903837|41702126|FG000|Part A|Lost to Follow-up|9|||
19453146|NCT01903837|41702127|FG001|Part A|Lost to Follow-up|7|||
19453147|NCT01903837|41702128|FG002|Part A|Lost to Follow-up|7|||
19453148|NCT01903837|41702129|FG003|Part A|Lost to Follow-up|2|||
19453149|NCT01903837|41702126|FG000|Part A|Non-compliance with study drug|1|||
19453150|NCT01903837|41702127|FG001|Part A|Non-compliance with study drug|4|||
19453151|NCT01903837|41702128|FG002|Part A|Non-compliance with study drug|4|||
19453152|NCT01903837|41702129|FG003|Part A|Non-compliance with study drug|0|||
19453153|NCT01903837|41702126|FG000|Part A|Physician Decision|1|||
19532976|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
19532977|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
19532978|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19532979|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19532980|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
19532981|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
19532982|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19532983|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
19532984|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19532985|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
19532986|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
19532987|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
19532988|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
19532989|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
19532990|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
19532991|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
19532992|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
19532993|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
19532994|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
19532995|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
19532996|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
19532997|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
19532998|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
19532999|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
19533000|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
19533001|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
19533002|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
19533003|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
19533004|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
19533005|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
19533006|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
19533007|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
19533008|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
19533009|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
19533010|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
19533011|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
19533012|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
19533013|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19533014|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
19533015|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
19533016|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19533017|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19533018|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
19533019|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
19533020|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
19533021|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
19533022|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
19533023|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
19533024|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
19533025|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
19533026|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
19533027|NCT01054885|41980869|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19453154|NCT01903837|41702127|FG001|Part A|Physician Decision|1|||
19453155|NCT01903837|41702128|FG002|Part A|Physician Decision|0|||
19453156|NCT01903837|41702129|FG003|Part A|Physician Decision|0|||
19453157|NCT01903837|41702126|FG000|Part A|Protocol Violation|1|||
19533028|NCT01054885|41980870|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
19533029|NCT01054885|41980871|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
19533030|NCT01054885|41980872|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
19533031|NCT01054885|41980873|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
19533032|NCT01054885|41980874|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
19533033|NCT01054885|41980875|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
19533034|NCT01054846|41980892|FG000|Overall Study|Lost to Follow-up|76|||
19533035|NCT01054846|41980893|FG001|Overall Study|Lost to Follow-up|17|||
19533036|NCT01054729|41980902|FG000|Overall Study|Randomized but Not Treated|0|||
19533037|NCT01054729|41980903|FG001|Overall Study|Randomized but Not Treated|1|||
19533038|NCT01054729|41980904|FG002|Overall Study|Randomized but Not Treated|0|||
19533039|NCT01054729|41980905|FG003|Overall Study|Randomized but Not Treated|0|||
19533040|NCT01054729|41980902|FG000|Overall Study|Adverse Event|1|||
19533041|NCT01054729|41980903|FG001|Overall Study|Adverse Event|1|||
19533042|NCT01054729|41980904|FG002|Overall Study|Adverse Event|2|||
19533043|NCT01054729|41980905|FG003|Overall Study|Adverse Event|1|||
19533044|NCT01054729|41980902|FG000|Overall Study|Withdrawal by Subject|1|||
19533045|NCT01054729|41980903|FG001|Overall Study|Withdrawal by Subject|0|||
19533046|NCT01054729|41980904|FG002|Overall Study|Withdrawal by Subject|1|||
19533047|NCT01054729|41980905|FG003|Overall Study|Withdrawal by Subject|0|||
19533048|NCT01054729|41980902|FG000|Overall Study|Lost to Follow-up|0|||
19533049|NCT01054729|41980903|FG001|Overall Study|Lost to Follow-up|1|||
19533050|NCT01054729|41980904|FG002|Overall Study|Lost to Follow-up|0|||
19533051|NCT01054729|41980905|FG003|Overall Study|Lost to Follow-up|0|||
19533052|NCT01054729|41980902|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
19533053|NCT01054729|41980903|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
19533054|NCT01054729|41980904|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
19533055|NCT01054729|41980905|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
19533056|NCT01054729|41980902|FG000|Overall Study|Non-responder|1|||
19533057|NCT01054729|41980903|FG001|Overall Study|Non-responder|0|||
19533058|NCT01054729|41980904|FG002|Overall Study|Non-responder|1|||
19453158|NCT01903837|41702127|FG001|Part A|Protocol Violation|1|||
19453159|NCT01903837|41702128|FG002|Part A|Protocol Violation|0|||
19453160|NCT01903837|41702129|FG003|Part A|Protocol Violation|0|||
19533059|NCT01054729|41980905|FG003|Overall Study|Non-responder|1|||
19533060|NCT01054729|41980902|FG000|Overall Study|PEG/RBV Non-responder|1|||
19533061|NCT01054729|41980903|FG001|Overall Study|PEG/RBV Non-responder|0|||
19533062|NCT01054729|41980904|FG002|Overall Study|PEG/RBV Non-responder|1|||
19533063|NCT01054729|41980905|FG003|Overall Study|PEG/RBV Non-responder|0|||
19630245|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
19630246|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
19630247|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
19630248|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
19630249|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
19630250|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
19630251|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
19630252|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
19630253|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
19630254|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
19630255|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
19630256|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
19630257|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
19630258|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
19630259|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
19630260|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
19630261|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
19630262|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
19630263|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
19630264|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
19630265|NCT00785577|42079504|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
19630266|NCT00785577|42079505|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
19630267|NCT00785577|42079506|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
19630268|NCT00785577|42079507|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
19630269|NCT00785577|42079508|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
19453161|NCT01903837|41702126|FG000|Part B|Lost to Follow-up|0|||
19453162|NCT01903837|41702127|FG001|Part B|Lost to Follow-up|3|||
19453163|NCT01903837|41702128|FG002|Part B|Lost to Follow-up|3|||
19453164|NCT01903837|41702129|FG003|Part B|Lost to Follow-up|4|||
19453165|NCT01903837|41702126|FG000|Part B|Withdrawal by Subject|1|||
19453166|NCT01903837|41702127|FG001|Part B|Withdrawal by Subject|2|||
19453167|NCT01903837|41702128|FG002|Part B|Withdrawal by Subject|0|||
19453168|NCT01903837|41702129|FG003|Part B|Withdrawal by Subject|3|||
19453169|NCT01903837|41702126|FG000|Part B|Adverse Event|3|||
19533064|NCT01054729|41980902|FG000|Overall Study|Personal/Obligations|0|||
19533065|NCT01054729|41980903|FG001|Overall Study|Personal/Obligations|1|||
19533066|NCT01054729|41980904|FG002|Overall Study|Personal/Obligations|0|||
19533067|NCT01054729|41980905|FG003|Overall Study|Personal/Obligations|0|||
19533068|NCT01054729|41980902|FG000|Overall Study|Subject moved|0|||
19533069|NCT01054729|41980903|FG001|Overall Study|Subject moved|0|||
19533070|NCT01054729|41980904|FG002|Overall Study|Subject moved|1|||
19533071|NCT01054729|41980905|FG003|Overall Study|Subject moved|0|||
19533072|NCT01054729|41980902|FG000|Overall Study|Lack of Efficacy|0|||
19533073|NCT01054729|41980903|FG001|Overall Study|Lack of Efficacy|0|||
19533074|NCT01054729|41980904|FG002|Overall Study|Lack of Efficacy|0|||
19533075|NCT01054729|41980905|FG003|Overall Study|Lack of Efficacy|1|||
19533076|NCT01054573|41980919|FG000|Overall Study|Adverse Event|1|||
19533077|NCT01054573|41980920|FG001|Overall Study|Adverse Event|0|||
19533078|NCT01054573|41980921|FG002|Overall Study|Adverse Event|1|||
19533079|NCT01054573|41980922|FG003|Overall Study|Adverse Event|1|||
19453170|NCT01903837|41702127|FG001|Part B|Adverse Event|0|||
19453171|NCT01903837|41702128|FG002|Part B|Adverse Event|2|||
19453172|NCT01903837|41702129|FG003|Part B|Adverse Event|0|||
19453173|NCT01903837|41702126|FG000|Part B|Non-compliance with study drug|2|||
19453174|NCT01903837|41702127|FG001|Part B|Non-compliance with study drug|0|||
19453175|NCT01903837|41702128|FG002|Part B|Non-compliance with study drug|0|||
19453176|NCT01903837|41702129|FG003|Part B|Non-compliance with study drug|1|||
19453177|NCT01903837|41702126|FG000|Part B|Incarceration|2|||
19453178|NCT01903837|41702127|FG001|Part B|Incarceration|0|||
19453179|NCT01903837|41702128|FG002|Part B|Incarceration|0|||
19453180|NCT01903837|41702129|FG003|Part B|Incarceration|1|||
19453181|NCT01903837|41702126|FG000|Part B|Physician Decision|1|||
19453182|NCT01903837|41702127|FG001|Part B|Physician Decision|0|||
19453183|NCT01903837|41702128|FG002|Part B|Physician Decision|0|||
19453184|NCT01903837|41702129|FG003|Part B|Physician Decision|2|||
19453185|NCT01903837|41702126|FG000|Part B|Lack of Efficacy|0|||
19453186|NCT01903837|41702127|FG001|Part B|Lack of Efficacy|1|||
19453187|NCT01903837|41702128|FG002|Part B|Lack of Efficacy|0|||
19453188|NCT01903837|41702129|FG003|Part B|Lack of Efficacy|0|||
19453189|NCT01903525|41702162|FG000|Overall Study|Lost to Follow-up|5|||
19453190|NCT01903525|41702163|FG001|Overall Study|Lost to Follow-up|9|||
19453191|NCT01903525|41702162|FG000|Overall Study|Adverse Event|0|||
19453192|NCT01903525|41702163|FG001|Overall Study|Adverse Event|1|||
19453193|NCT00981526|41702171|FG000|Overall Study|Withdrawal by Subject|0|||
19453194|NCT00981526|41702172|FG001|Overall Study|Withdrawal by Subject|2|||
19453195|NCT00981526|41702171|FG000|Overall Study|Physician Decision|4|||
19453196|NCT00981526|41702172|FG001|Overall Study|Physician Decision|4|||
19453197|NCT01927861|41702182|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
19453198|NCT01927861|41702183|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
19453199|NCT01927861|41702182|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
19453200|NCT01927861|41702183|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
19453201|NCT01927627|41702189|FG000|Overall Study|Adverse Event|3|||
19453202|NCT01927627|41702189|FG000|Overall Study|Lack of Efficacy|1|||
19453203|NCT01927627|41702189|FG000|Overall Study|Financial Concerns|1|||
19453204|NCT01889251|41702195|FG000|Overall Study|Adverse Event|1|||
19453205|NCT01889251|41702196|FG001|Overall Study|Adverse Event|0|||
19533080|NCT01054573|41980919|FG000|Overall Study|Lost to Follow-up|0|||
19533081|NCT01054573|41980920|FG001|Overall Study|Lost to Follow-up|2|||
19533082|NCT01054573|41980921|FG002|Overall Study|Lost to Follow-up|0|||
19533083|NCT01054573|41980922|FG003|Overall Study|Lost to Follow-up|0|||
19453206|NCT01616563|41702202|FG000|Overall Study|Lost to Follow-up|40|||
19453207|NCT01616173|41702210|FG000|Overall Study|Lost to Follow-up|0|||
19453208|NCT01616173|41702211|FG001|Overall Study|Lost to Follow-up|2|||
19453209|NCT01616173|41702212|FG002|Overall Study|Lost to Follow-up|0|||
19453210|NCT01544595|41702226|FG000|Status at Week 68|Adverse Event|3|||
19453211|NCT01544595|41702227|FG001|Status at Week 68|Adverse Event|2|||
19453212|NCT01544595|41702228|FG002|Status at Week 68|Adverse Event|1|||
19453213|NCT01544595|41702229|FG003|Status at Week 68|Adverse Event|0|||
19453214|NCT01544595|41702230|FG004|Status at Week 68|Adverse Event|0|||
19453215|NCT01544595|41702231|FG005|Status at Week 68|Adverse Event|0|||
19453216|NCT01544595|41702226|FG000|Status at Week 68|Lack of Efficacy|1|||
19453217|NCT01544595|41702227|FG001|Status at Week 68|Lack of Efficacy|0|||
19453218|NCT01544595|41702228|FG002|Status at Week 68|Lack of Efficacy|0|||
19453219|NCT01544595|41702229|FG003|Status at Week 68|Lack of Efficacy|0|||
19453220|NCT01544595|41702230|FG004|Status at Week 68|Lack of Efficacy|0|||
19453221|NCT01544595|41702231|FG005|Status at Week 68|Lack of Efficacy|0|||
19453222|NCT01544595|41702226|FG000|Status at Week 68|Lost to Follow-up|1|||
19453223|NCT01544595|41702227|FG001|Status at Week 68|Lost to Follow-up|1|||
19453224|NCT01544595|41702228|FG002|Status at Week 68|Lost to Follow-up|0|||
19533084|NCT01054573|41980919|FG000|Overall Study|Withdrawal by Subject|0|||
19533085|NCT01054573|41980920|FG001|Overall Study|Withdrawal by Subject|2|||
19453225|NCT01544595|41702229|FG003|Status at Week 68|Lost to Follow-up|0|||
19453226|NCT01544595|41702230|FG004|Status at Week 68|Lost to Follow-up|0|||
19453227|NCT01544595|41702231|FG005|Status at Week 68|Lost to Follow-up|0|||
19453228|NCT01544595|41702226|FG000|Status at Week 68|Non-compliance with study treatment|1|||
19453229|NCT01544595|41702227|FG001|Status at Week 68|Non-compliance with study treatment|0|||
19453230|NCT01544595|41702228|FG002|Status at Week 68|Non-compliance with study treatment|0|||
19453231|NCT01544595|41702229|FG003|Status at Week 68|Non-compliance with study treatment|1|||
19453232|NCT01544595|41702230|FG004|Status at Week 68|Non-compliance with study treatment|0|||
19453233|NCT01544595|41702231|FG005|Status at Week 68|Non-compliance with study treatment|0|||
19453234|NCT01544595|41702226|FG000|Status at Week 68|Protocol Violation|2|||
19453235|NCT01544595|41702227|FG001|Status at Week 68|Protocol Violation|0|||
19453236|NCT01544595|41702228|FG002|Status at Week 68|Protocol Violation|1|||
19453237|NCT01544595|41702229|FG003|Status at Week 68|Protocol Violation|1|||
19453238|NCT01544595|41702230|FG004|Status at Week 68|Protocol Violation|0|||
19453239|NCT01544595|41702231|FG005|Status at Week 68|Protocol Violation|0|||
19453240|NCT01544595|41702226|FG000|Status at Week 68|Technical problems|1|||
19453241|NCT01544595|41702227|FG001|Status at Week 68|Technical problems|0|||
19453242|NCT01544595|41702228|FG002|Status at Week 68|Technical problems|0|||
19453243|NCT01544595|41702229|FG003|Status at Week 68|Technical problems|1|||
19453244|NCT01544595|41702230|FG004|Status at Week 68|Technical problems|0|||
19453245|NCT01544595|41702231|FG005|Status at Week 68|Technical problems|0|||
19453246|NCT01544595|41702226|FG000|Status at Week 68|Withdrawal by Subject|0|||
19453247|NCT01544595|41702227|FG001|Status at Week 68|Withdrawal by Subject|1|||
19453248|NCT01544595|41702228|FG002|Status at Week 68|Withdrawal by Subject|1|||
19453249|NCT01544595|41702229|FG003|Status at Week 68|Withdrawal by Subject|2|||
19453250|NCT01544595|41702230|FG004|Status at Week 68|Withdrawal by Subject|0|||
19453251|NCT01544595|41702231|FG005|Status at Week 68|Withdrawal by Subject|0|||
19533086|NCT01054573|41980921|FG002|Overall Study|Withdrawal by Subject|2|||
19533087|NCT01054573|41980922|FG003|Overall Study|Withdrawal by Subject|1|||
19533088|NCT01054456|41980941|FG000|Overall Study|Other|1|||
19533089|NCT01054300|41980947|FG000|Period 1|Adverse Event|1|||
19533090|NCT01054300|41980948|FG001|Period 1|Adverse Event|0|||
19533091|NCT01054300|41980949|FG002|Period 1|Adverse Event|0|||
19533092|NCT01054300|41980950|FG003|Period 1|Adverse Event|0|||
19533093|NCT01054300|41980947|FG000|Period 2|Withdrawal by Subject|0|||
19533094|NCT01054300|41980948|FG001|Period 2|Withdrawal by Subject|0|||
19453252|NCT01544595|41702226|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
19453253|NCT01544595|41702227|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
19453254|NCT01544595|41702228|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
19453255|NCT01544595|41702229|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
19453256|NCT01544595|41702230|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
19453257|NCT01544595|41702231|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
19453258|NCT01544595|41702226|FG000|Status at Week 156|Withdrawal by Subject|9|||
19453259|NCT01544595|41702227|FG001|Status at Week 156|Withdrawal by Subject|10|||
19453260|NCT01544595|41702228|FG002|Status at Week 156|Withdrawal by Subject|4|||
19453261|NCT01544595|41702229|FG003|Status at Week 156|Withdrawal by Subject|9|||
19453262|NCT01544595|41702230|FG004|Status at Week 156|Withdrawal by Subject|20|||
19453263|NCT01544595|41702231|FG005|Status at Week 156|Withdrawal by Subject|6|||
19453264|NCT01544595|41702226|FG000|Status at Week 156|Adverse Event|9|||
19453265|NCT01544595|41702227|FG001|Status at Week 156|Adverse Event|11|||
19453266|NCT01544595|41702228|FG002|Status at Week 156|Adverse Event|1|||
19453267|NCT01544595|41702229|FG003|Status at Week 156|Adverse Event|3|||
19453268|NCT01544595|41702230|FG004|Status at Week 156|Adverse Event|4|||
19453269|NCT01544595|41702231|FG005|Status at Week 156|Adverse Event|2|||
19453270|NCT01544595|41702226|FG000|Status at Week 156|Lost to Follow-up|4|||
19453271|NCT01544595|41702227|FG001|Status at Week 156|Lost to Follow-up|4|||
19453272|NCT01544595|41702228|FG002|Status at Week 156|Lost to Follow-up|0|||
19453273|NCT01544595|41702229|FG003|Status at Week 156|Lost to Follow-up|1|||
19453274|NCT01544595|41702230|FG004|Status at Week 156|Lost to Follow-up|4|||
19453275|NCT01544595|41702231|FG005|Status at Week 156|Lost to Follow-up|1|||
19453276|NCT01544595|41702226|FG000|Status at Week 156|Non-compliance with study treatement|0|||
19453277|NCT01544595|41702227|FG001|Status at Week 156|Non-compliance with study treatement|1|||
19453278|NCT01544595|41702228|FG002|Status at Week 156|Non-compliance with study treatement|0|||
19453279|NCT01544595|41702229|FG003|Status at Week 156|Non-compliance with study treatement|1|||
19453280|NCT01544595|41702230|FG004|Status at Week 156|Non-compliance with study treatement|0|||
19453281|NCT01544595|41702231|FG005|Status at Week 156|Non-compliance with study treatement|1|||
19453282|NCT01544595|41702226|FG000|Status at Week 156|Physician Decision|0|||
19453283|NCT01544595|41702227|FG001|Status at Week 156|Physician Decision|3|||
19453284|NCT01544595|41702228|FG002|Status at Week 156|Physician Decision|1|||
19453285|NCT01544595|41702229|FG003|Status at Week 156|Physician Decision|0|||
19453286|NCT01544595|41702230|FG004|Status at Week 156|Physician Decision|0|||
19453287|NCT01544595|41702231|FG005|Status at Week 156|Physician Decision|0|||
19453288|NCT01544595|41702226|FG000|Status at Week 156|Pregnancy|2|||
19453289|NCT01544595|41702227|FG001|Status at Week 156|Pregnancy|3|||
19453290|NCT01544595|41702228|FG002|Status at Week 156|Pregnancy|0|||
19453291|NCT01544595|41702229|FG003|Status at Week 156|Pregnancy|0|||
19533095|NCT01054300|41980949|FG002|Period 2|Withdrawal by Subject|1|||
19453292|NCT01544595|41702230|FG004|Status at Week 156|Pregnancy|0|||
19453293|NCT01544595|41702231|FG005|Status at Week 156|Pregnancy|0|||
19453294|NCT01544595|41702226|FG000|Status at Week 156|Protocol Violation|3|||
19453295|NCT01544595|41702227|FG001|Status at Week 156|Protocol Violation|1|||
19453296|NCT01544595|41702228|FG002|Status at Week 156|Protocol Violation|2|||
19453297|NCT01544595|41702229|FG003|Status at Week 156|Protocol Violation|2|||
19453298|NCT01544595|41702230|FG004|Status at Week 156|Protocol Violation|0|||
19453299|NCT01544595|41702231|FG005|Status at Week 156|Protocol Violation|0|||
19453300|NCT01544595|41702226|FG000|Status at Week 156|Technical problems|3|||
19453301|NCT01544595|41702227|FG001|Status at Week 156|Technical problems|1|||
19453302|NCT01544595|41702228|FG002|Status at Week 156|Technical problems|0|||
19453303|NCT01544595|41702229|FG003|Status at Week 156|Technical problems|1|||
19453304|NCT01544595|41702230|FG004|Status at Week 156|Technical problems|0|||
19453305|NCT01544595|41702231|FG005|Status at Week 156|Technical problems|0|||
19453306|NCT01544595|41702226|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
19453307|NCT01544595|41702227|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
19453308|NCT01544595|41702228|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
19453309|NCT01544595|41702229|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
19453310|NCT01544595|41702230|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
19453311|NCT01544595|41702231|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
19453312|NCT01544595|41702226|FG000|Status at Week 156|Lack of Efficacy|1|||
19453313|NCT01544595|41702227|FG001|Status at Week 156|Lack of Efficacy|0|||
19453314|NCT01544595|41702228|FG002|Status at Week 156|Lack of Efficacy|1|||
19453315|NCT01544595|41702229|FG003|Status at Week 156|Lack of Efficacy|4|||
19453316|NCT01544595|41702230|FG004|Status at Week 156|Lack of Efficacy|10|||
19453317|NCT01544595|41702231|FG005|Status at Week 156|Lack of Efficacy|5|||
19453318|NCT01539525|41702252|FG000|Overall Study|Lost to Follow-up|19|||
19453319|NCT01539525|41702253|FG001|Overall Study|Lost to Follow-up|12|||
19453320|NCT01539525|41702254|FG002|Overall Study|Lost to Follow-up|11|||
19453321|NCT01539525|41702252|FG000|Overall Study|Withdrawal by Subject|0|||
19453322|NCT01539525|41702253|FG001|Overall Study|Withdrawal by Subject|3|||
19453323|NCT01539525|41702254|FG002|Overall Study|Withdrawal by Subject|2|||
19453324|NCT01539525|41702252|FG000|Overall Study|Protocol Violation|1|||
19453325|NCT01539525|41702253|FG001|Overall Study|Protocol Violation|1|||
19453326|NCT01539525|41702254|FG002|Overall Study|Protocol Violation|4|||
19453327|NCT01513551|41702268|FG000|Overall Study|Death|0|||
19453328|NCT01513551|41702269|FG001|Overall Study|Death|1|||
19453329|NCT01513551|41702270|FG002|Overall Study|Death|0|||
19453330|NCT01513551|41702268|FG000|Overall Study|Lost to Follow-up|3|||
19453331|NCT01513551|41702269|FG001|Overall Study|Lost to Follow-up|5|||
19453332|NCT01513551|41702270|FG002|Overall Study|Lost to Follow-up|2|||
19453333|NCT01513551|41702268|FG000|Overall Study|Withdrawal by Subject|1|||
19453334|NCT01513551|41702269|FG001|Overall Study|Withdrawal by Subject|0|||
19453335|NCT01513551|41702270|FG002|Overall Study|Withdrawal by Subject|2|||
19453336|NCT01513551|41702268|FG000|Overall Study|Randomized but not vaccinated|0|||
19453337|NCT01513551|41702269|FG001|Overall Study|Randomized but not vaccinated|0|||
19453338|NCT01513551|41702270|FG002|Overall Study|Randomized but not vaccinated|1|||
19453339|NCT01513473|41702280|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
19453340|NCT01513473|41702281|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
19453341|NCT01513473|41702280|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
19453342|NCT01513473|41702281|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
19453343|NCT01513473|41702280|FG000|Main Trial (26 Weeks)|Unclassified|0|||
19453344|NCT01513473|41702281|FG001|Main Trial (26 Weeks)|Unclassified|2|||
19453345|NCT01513473|41702280|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
19453346|NCT01513473|41702281|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
19453347|NCT01513473|41702280|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
19453348|NCT01513473|41702281|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
19453349|NCT01513317|41702289|FG000|Overall Study|Withdrawal by Subject|15|||
19453350|NCT01513317|41702290|FG001|Overall Study|Withdrawal by Subject|4|||
19453351|NCT01513317|41702289|FG000|Overall Study|Death|1|||
19453352|NCT01513317|41702290|FG001|Overall Study|Death|1|||
19453353|NCT01513317|41702289|FG000|Overall Study|Study terminated by sponsor|18|||
19453354|NCT01513317|41702290|FG001|Overall Study|Study terminated by sponsor|18|||
19453355|NCT01513317|41702289|FG000|Overall Study|Other|0|||
19453356|NCT01513317|41702290|FG001|Overall Study|Other|1|||
19533096|NCT01054300|41980950|FG003|Period 2|Withdrawal by Subject|0|||
19533097|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
19453357|NCT01901653|41702309|FG000|Overall Study|Death|2|||
19453358|NCT01901653|41702310|FG001|Overall Study|Death|1|||
19453359|NCT01901653|41702311|FG002|Overall Study|Death|8|||
19453360|NCT01901653|41702312|FG003|Overall Study|Death|3|||
19453361|NCT01901653|41702313|FG004|Overall Study|Death|2|||
19453362|NCT01901653|41702314|FG005|Overall Study|Death|2|||
19453363|NCT01901653|41702315|FG006|Overall Study|Death|6|||
19453364|NCT01901653|41702316|FG007|Overall Study|Death|9|||
19453365|NCT01901653|41702317|FG008|Overall Study|Death|1|||
19453366|NCT01901653|41702318|FG009|Overall Study|Death|16|||
19453367|NCT01901653|41702319|FG010|Overall Study|Death|2|||
19453368|NCT01901653|41702320|FG011|Overall Study|Death|15|||
19453369|NCT01901653|41702321|FG012|Overall Study|Death|4|||
19453370|NCT01901653|41702309|FG000|Overall Study|Lost to Follow-up|1|||
19453371|NCT01901653|41702310|FG001|Overall Study|Lost to Follow-up|0|||
19453372|NCT01901653|41702311|FG002|Overall Study|Lost to Follow-up|2|||
19453373|NCT01901653|41702312|FG003|Overall Study|Lost to Follow-up|0|||
19453374|NCT01901653|41702313|FG004|Overall Study|Lost to Follow-up|0|||
19453375|NCT01901653|41702314|FG005|Overall Study|Lost to Follow-up|1|||
19453376|NCT01901653|41702315|FG006|Overall Study|Lost to Follow-up|0|||
19453377|NCT01901653|41702316|FG007|Overall Study|Lost to Follow-up|1|||
19453378|NCT01901653|41702317|FG008|Overall Study|Lost to Follow-up|0|||
19453379|NCT01901653|41702318|FG009|Overall Study|Lost to Follow-up|0|||
19453380|NCT01901653|41702319|FG010|Overall Study|Lost to Follow-up|0|||
19453381|NCT01901653|41702320|FG011|Overall Study|Lost to Follow-up|0|||
19453382|NCT01901653|41702321|FG012|Overall Study|Lost to Follow-up|0|||
19453383|NCT01901653|41702309|FG000|Overall Study|Withdrawal by Subject|0|||
19453384|NCT01901653|41702310|FG001|Overall Study|Withdrawal by Subject|0|||
19453385|NCT01901653|41702311|FG002|Overall Study|Withdrawal by Subject|0|||
19453386|NCT01901653|41702312|FG003|Overall Study|Withdrawal by Subject|0|||
19453387|NCT01901653|41702313|FG004|Overall Study|Withdrawal by Subject|0|||
19453388|NCT01901653|41702314|FG005|Overall Study|Withdrawal by Subject|0|||
19453389|NCT01901653|41702315|FG006|Overall Study|Withdrawal by Subject|1|||
19453390|NCT01901653|41702316|FG007|Overall Study|Withdrawal by Subject|0|||
19453391|NCT01901653|41702317|FG008|Overall Study|Withdrawal by Subject|0|||
19453392|NCT01901653|41702318|FG009|Overall Study|Withdrawal by Subject|0|||
19453393|NCT01901653|41702319|FG010|Overall Study|Withdrawal by Subject|0|||
19453394|NCT01901653|41702320|FG011|Overall Study|Withdrawal by Subject|0|||
19453395|NCT01901653|41702321|FG012|Overall Study|Withdrawal by Subject|0|||
19453396|NCT01901653|41702309|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
19453397|NCT01901653|41702310|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
19453398|NCT01901653|41702311|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
19453399|NCT01901653|41702312|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
19453400|NCT01901653|41702313|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
19453401|NCT01901653|41702314|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
19453402|NCT01901653|41702315|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
19453403|NCT01901653|41702316|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
19453404|NCT01901653|41702317|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
19453405|NCT01901653|41702318|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
19453406|NCT01901653|41702319|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
19453407|NCT01901653|41702320|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
19453408|NCT01901653|41702321|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
19453409|NCT01925989|41702349|FG000|Period 1|Sponsor Decision|1|||
19453410|NCT01925989|41702350|FG001|Period 1|Sponsor Decision|1|||
19453411|NCT01925989|41702351|FG002|Period 1|Sponsor Decision|0|||
19453412|NCT01925989|41702349|FG000|Period 1|Withdrawal by Subject|0|||
19453413|NCT01925989|41702350|FG001|Period 1|Withdrawal by Subject|1|||
19453414|NCT01925989|41702351|FG002|Period 1|Withdrawal by Subject|0|||
19453415|NCT01901419|41702365|FG000|Overall Study|Protocol Violation|2|||
19453416|NCT01901419|41702366|FG001|Overall Study|Protocol Violation|6|||
19453417|NCT01901419|41702365|FG000|Overall Study|unavailable researchers|6|||
19453418|NCT01901419|41702366|FG001|Overall Study|unavailable researchers|3|||
19453419|NCT01901341|41702393|FG000|Overall Study|Adverse Event|4|||
19453420|NCT01901341|41702394|FG001|Overall Study|Adverse Event|2|||
19453421|NCT01901341|41702393|FG000|Overall Study|Lack of Efficacy|0|||
19453422|NCT01901341|41702394|FG001|Overall Study|Lack of Efficacy|2|||
19453423|NCT01901341|41702393|FG000|Overall Study|Lost to Follow-up|0|||
19453424|NCT01901341|41702394|FG001|Overall Study|Lost to Follow-up|1|||
19453425|NCT01901341|41702393|FG000|Overall Study|Protocol Violation|2|||
19453426|NCT01901341|41702394|FG001|Overall Study|Protocol Violation|0|||
19453427|NCT01901341|41702393|FG000|Overall Study|Study Terminated by Sponsor|13|||
19453428|NCT01901341|41702394|FG001|Overall Study|Study Terminated by Sponsor|15|||
19453429|NCT01901341|41702393|FG000|Overall Study|Withdrawal by Subject|1|||
19453430|NCT01901341|41702394|FG001|Overall Study|Withdrawal by Subject|1|||
19453431|NCT01615939|41702403|FG000|Overall Study|Lost to Follow-up|5|||
19453432|NCT01615939|41702404|FG001|Overall Study|Lost to Follow-up|0|||
19453433|NCT01901185|41702410|FG000|Overall Study|Withdrawal by Subject|2|||
19453434|NCT01888003|41702417|FG000|Overall Study|Study Terminated|5|||
19630270|NCT00785577|42079504|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
19453435|NCT01888003|41702418|FG001|Overall Study|Study Terminated|6|||
19453436|NCT01888003|41702419|FG002|Overall Study|Study Terminated|40|||
19453437|NCT01925209|41702485|FG000|Treatment Epoch|Physician Decision|1|||
19453438|NCT01925209|41702486|FG001|Treatment Epoch|Physician Decision|0|||
19453439|NCT01925209|41702487|FG002|Treatment Epoch|Physician Decision|0|||
19453440|NCT01925209|41702488|FG003|Treatment Epoch|Physician Decision|0|||
19453441|NCT01925209|41702485|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
19453442|NCT01925209|41702486|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
19453443|NCT01925209|41702487|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
19453444|NCT01925209|41702488|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
19453445|NCT01925209|41702485|FG000|Treatment Epoch|Death|1|||
19453446|NCT01925209|41702486|FG001|Treatment Epoch|Death|0|||
19453447|NCT01925209|41702487|FG002|Treatment Epoch|Death|0|||
19533098|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19533099|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19533100|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19533101|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19533102|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
19533103|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
19533104|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19533105|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19533106|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19533107|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19533108|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
19533109|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
19453448|NCT01925209|41702488|FG003|Treatment Epoch|Death|0|||
19453449|NCT01925209|41702485|FG000|Treatment Epoch|Protocol deviation|0|||
19453450|NCT01925209|41702486|FG001|Treatment Epoch|Protocol deviation|0|||
19453451|NCT01925209|41702487|FG002|Treatment Epoch|Protocol deviation|1|||
19533110|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19533111|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19533112|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19533113|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19533114|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
19533115|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
19533116|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
19533117|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
19533118|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
19533119|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
19533120|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
19533121|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
19533122|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
19533123|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
19533124|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
19533125|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
19533126|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
19533127|NCT01053988|41980965|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
19533128|NCT01053988|41980966|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19533129|NCT01053988|41980967|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19533130|NCT01053988|41980968|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19533131|NCT01053988|41980969|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19533132|NCT01053988|41980970|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
19533133|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
19533134|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
19533135|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
19533136|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
19533137|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
19533138|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
19533139|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19533140|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
19533141|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
19533142|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
19533143|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
19533144|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
19533145|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
19533146|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
19533147|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
19533148|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
19533149|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
19453452|NCT01925209|41702488|FG003|Treatment Epoch|Protocol deviation|1|||
19453453|NCT01925209|41702485|FG000|Treatment Epoch|Withdrawal by Subject|4|||
19533150|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
19533151|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
19533152|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
19533153|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
19533154|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
19533155|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
19533156|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
19533157|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
19533158|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
19533159|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
19533160|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
19533161|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
19533162|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
19533163|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19533164|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
19533165|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
19533166|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
19630271|NCT00785577|42079505|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
19453454|NCT01925209|41702486|FG001|Treatment Epoch|Withdrawal by Subject|3|||
19453455|NCT01925209|41702487|FG002|Treatment Epoch|Withdrawal by Subject|3|||
19453456|NCT01925209|41702488|FG003|Treatment Epoch|Withdrawal by Subject|2|||
19453457|NCT01925209|41702485|FG000|Treatment Epoch|Adverse Event|3|||
19453458|NCT01925209|41702486|FG001|Treatment Epoch|Adverse Event|5|||
19453459|NCT01925209|41702487|FG002|Treatment Epoch|Adverse Event|3|||
19453460|NCT01925209|41702488|FG003|Treatment Epoch|Adverse Event|1|||
19453461|NCT01925209|41702485|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
19453462|NCT01925209|41702486|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
19453463|NCT01925209|41702487|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
19453464|NCT01925209|41702488|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
19453465|NCT01925209|41702485|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
19453466|NCT01925209|41702486|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
19453467|NCT01925209|41702487|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
19453468|NCT01925209|41702488|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
19453469|NCT01925209|41702485|FG000|Follow-up|Adverse Event|1|||
19453470|NCT01925209|41702486|FG001|Follow-up|Adverse Event|4|||
19453471|NCT01925209|41702487|FG002|Follow-up|Adverse Event|0|||
19453472|NCT01925209|41702488|FG003|Follow-up|Adverse Event|1|||
19453473|NCT01925209|41702485|FG000|Follow-up|Physician Decision|0|||
19453474|NCT01925209|41702486|FG001|Follow-up|Physician Decision|0|||
19453475|NCT01925209|41702487|FG002|Follow-up|Physician Decision|1|||
19453476|NCT01925209|41702488|FG003|Follow-up|Physician Decision|0|||
19453477|NCT01925209|41702485|FG000|Follow-up|Non-compliance with study treatment|0|||
19453478|NCT01925209|41702486|FG001|Follow-up|Non-compliance with study treatment|0|||
19453479|NCT01925209|41702487|FG002|Follow-up|Non-compliance with study treatment|0|||
19453480|NCT01925209|41702488|FG003|Follow-up|Non-compliance with study treatment|1|||
19453481|NCT01925209|41702485|FG000|Follow-up|Withdrawal by Subject|0|||
19453482|NCT01925209|41702486|FG001|Follow-up|Withdrawal by Subject|2|||
19453483|NCT01925209|41702487|FG002|Follow-up|Withdrawal by Subject|0|||
19453484|NCT01925209|41702488|FG003|Follow-up|Withdrawal by Subject|2|||
19453485|NCT01614925|41702500|FG000|Overall Study|Withdrawal by Subject|1|||
19453486|NCT01614925|41702501|FG001|Overall Study|Withdrawal by Subject|0|||
19453487|NCT01614925|41702500|FG000|Overall Study|Protocol Violation|3|||
19453488|NCT01614925|41702501|FG001|Overall Study|Protocol Violation|2|||
19453489|NCT01886833|41702507|FG000|Overall Study|IgA not available from both periods|204|||
19453490|NCT01898923|41702516|FG000|Overall Study|Lack of Efficacy|5|||
19453491|NCT01898923|41702517|FG001|Overall Study|Lack of Efficacy|6|||
19453492|NCT01898923|41702516|FG000|Overall Study|Adverse Event|3|||
19453493|NCT01898923|41702517|FG001|Overall Study|Adverse Event|1|||
19453494|NCT01898923|41702516|FG000|Overall Study|Lost to Follow-up|0|||
19453495|NCT01898923|41702517|FG001|Overall Study|Lost to Follow-up|1|||
19453496|NCT01898923|41702516|FG000|Overall Study|Withdrawal by Subject|4|||
19453497|NCT01898923|41702517|FG001|Overall Study|Withdrawal by Subject|7|||
19453498|NCT01898923|41702516|FG000|Overall Study|Physician Decision|3|||
19453499|NCT01898923|41702517|FG001|Overall Study|Physician Decision|4|||
19453500|NCT01898923|41702516|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
19453501|NCT01898923|41702517|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
19453502|NCT01924429|41702525|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
19453503|NCT01924429|41702526|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
19453504|NCT01898299|41702536|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
19453505|NCT01898299|41702537|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
19453506|NCT01886287|41702543|FG000|Overall Study|Radiographic disease progression|1|||
19453507|NCT01886287|41702543|FG000|Overall Study|Clinical progression due to disease|1|||
19453508|NCT01885195|41702547|FG000|Overall Study|Adverse Event|29|||
19453509|NCT01885195|41702547|FG000|Overall Study|Death|1|||
19453510|NCT01885195|41702547|FG000|Overall Study|Disease Progression|67|||
19453511|NCT01885195|41702547|FG000|Overall Study|Protocol Deviation|2|||
19453512|NCT01885195|41702547|FG000|Overall Study|Physician Decision|3|||
19533167|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
19533168|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
19533169|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
19533170|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
19533171|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
19533172|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
19533173|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
19533174|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
19533175|NCT01053988|41980965|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
19533176|NCT01053988|41980966|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
19533177|NCT01053988|41980967|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
19533178|NCT01053988|41980968|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
19533179|NCT01053988|41980969|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
19533180|NCT01053988|41980970|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
19533181|NCT01053247|41980985|FG000|Overall Study|Withdrawal by Subject|9|||
19533182|NCT01053247|41980986|FG001|Overall Study|Withdrawal by Subject|4|||
19533183|NCT01053247|41980987|FG002|Overall Study|Withdrawal by Subject|15|||
19533184|NCT01053247|41980985|FG000|Overall Study|Lack of Efficacy|1|||
19533185|NCT01053247|41980986|FG001|Overall Study|Lack of Efficacy|0|||
19533186|NCT01053247|41980987|FG002|Overall Study|Lack of Efficacy|1|||
19533187|NCT01053247|41980985|FG000|Overall Study|Protocol Violation|2|||
19533188|NCT01053247|41980986|FG001|Overall Study|Protocol Violation|1|||
19533189|NCT01053247|41980987|FG002|Overall Study|Protocol Violation|2|||
19533190|NCT01053247|41980985|FG000|Overall Study|Lost to Follow-up|8|||
19533191|NCT01053247|41980986|FG001|Overall Study|Lost to Follow-up|5|||
19533192|NCT01053247|41980987|FG002|Overall Study|Lost to Follow-up|7|||
19533193|NCT01053247|41980985|FG000|Overall Study|Adverse Event|0|||
19533194|NCT01053247|41980986|FG001|Overall Study|Adverse Event|9|||
19533195|NCT01053247|41980987|FG002|Overall Study|Adverse Event|3|||
19533196|NCT01052779|41980997|FG000|Overall Study|Adverse Event|1|||
19533197|NCT01052779|41980998|FG001|Overall Study|Adverse Event|4|||
19533198|NCT01052779|41980997|FG000|Overall Study|Withdrawal by Subject|1|||
19533199|NCT01052779|41980998|FG001|Overall Study|Withdrawal by Subject|2|||
19533200|NCT01052779|41980997|FG000|Overall Study|Other-Protocol Violation|1|||
19533201|NCT01052779|41980998|FG001|Overall Study|Other-Protocol Violation|1|||
19533202|NCT01052779|41980997|FG000|Overall Study|Other-Surgery|0|||
19453513|NCT01885195|41702547|FG000|Overall Study|Patient/guardian decision|8|||
19453514|NCT01896895|41702554|FG000|Double-blind MP|Physician Decision|0|||
19453515|NCT01896895|41702555|FG001|Double-blind MP|Physician Decision|0|||
19453516|NCT01896895|41702556|FG002|Double-blind MP|Physician Decision|1|||
19453517|NCT01896895|41702557|FG003|Double-blind MP|Physician Decision|0|||
19453518|NCT01896895|41702554|FG000|Double-blind MP|Withdrawal by Subject|0|||
19453519|NCT01896895|41702555|FG001|Double-blind MP|Withdrawal by Subject|2|||
19453520|NCT01896895|41702556|FG002|Double-blind MP|Withdrawal by Subject|1|||
19453521|NCT01896895|41702557|FG003|Double-blind MP|Withdrawal by Subject|0|||
19453522|NCT01896895|41702554|FG000|Double-blind MP|Lost to Follow-up|1|||
19453523|NCT01896895|41702555|FG001|Double-blind MP|Lost to Follow-up|0|||
19453524|NCT01896895|41702556|FG002|Double-blind MP|Lost to Follow-up|1|||
19453525|NCT01896895|41702557|FG003|Double-blind MP|Lost to Follow-up|0|||
19453526|NCT01923181|41702600|FG000|Overall Study|Protocol Violation|2|||
19453527|NCT01923181|41702601|FG001|Overall Study|Protocol Violation|2|||
19453528|NCT01923181|41702602|FG002|Overall Study|Protocol Violation|0|||
19453529|NCT01923181|41702603|FG003|Overall Study|Protocol Violation|2|||
19453530|NCT01923181|41702604|FG004|Overall Study|Protocol Violation|2|||
19453531|NCT01923181|41702605|FG005|Overall Study|Protocol Violation|1|||
19453532|NCT01923181|41702606|FG006|Overall Study|Protocol Violation|1|||
19453533|NCT01923181|41702607|FG007|Overall Study|Protocol Violation|2|||
19453534|NCT01923181|41702608|FG008|Overall Study|Protocol Violation|1|||
19453535|NCT01923181|41702600|FG000|Overall Study|Withdrawal by Subject|0|||
19453536|NCT01923181|41702601|FG001|Overall Study|Withdrawal by Subject|1|||
19453537|NCT01923181|41702602|FG002|Overall Study|Withdrawal by Subject|0|||
19453538|NCT01923181|41702603|FG003|Overall Study|Withdrawal by Subject|1|||
19453539|NCT01923181|41702604|FG004|Overall Study|Withdrawal by Subject|4|||
19533203|NCT01052779|41980998|FG001|Overall Study|Other-Surgery|2|||
19533204|NCT01052779|41980997|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
19533205|NCT01052779|41980998|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
19533206|NCT01052662|41981007|FG000|Overall Study|Lost to Follow-up|15|||
19533207|NCT01052662|41981008|FG001|Overall Study|Lost to Follow-up|13|||
19533208|NCT01052662|41981009|FG002|Overall Study|Lost to Follow-up|18|||
19453540|NCT01923181|41702605|FG005|Overall Study|Withdrawal by Subject|2|||
19453541|NCT01923181|41702606|FG006|Overall Study|Withdrawal by Subject|4|||
19453542|NCT01923181|41702607|FG007|Overall Study|Withdrawal by Subject|3|||
19453543|NCT01923181|41702608|FG008|Overall Study|Withdrawal by Subject|1|||
19453544|NCT01923181|41702600|FG000|Overall Study|Other|1|||
19453545|NCT01923181|41702601|FG001|Overall Study|Other|0|||
19453546|NCT01923181|41702602|FG002|Overall Study|Other|0|||
19453547|NCT01923181|41702603|FG003|Overall Study|Other|1|||
19453548|NCT01923181|41702604|FG004|Overall Study|Other|0|||
19453549|NCT01923181|41702605|FG005|Overall Study|Other|0|||
19453550|NCT01923181|41702606|FG006|Overall Study|Other|0|||
19453551|NCT01923181|41702607|FG007|Overall Study|Other|0|||
19453552|NCT01923181|41702608|FG008|Overall Study|Other|0|||
19453553|NCT01923181|41702600|FG000|Overall Study|Lost to Follow-up|0|||
19453554|NCT01923181|41702601|FG001|Overall Study|Lost to Follow-up|3|||
19453555|NCT01923181|41702602|FG002|Overall Study|Lost to Follow-up|2|||
19453556|NCT01923181|41702603|FG003|Overall Study|Lost to Follow-up|1|||
19453557|NCT01923181|41702604|FG004|Overall Study|Lost to Follow-up|2|||
19453558|NCT01923181|41702605|FG005|Overall Study|Lost to Follow-up|1|||
19453559|NCT01923181|41702606|FG006|Overall Study|Lost to Follow-up|3|||
19453560|NCT01923181|41702607|FG007|Overall Study|Lost to Follow-up|3|||
19453561|NCT01923181|41702608|FG008|Overall Study|Lost to Follow-up|1|||
19533209|NCT01052662|41981007|FG000|Overall Study|Withdrawal by Subject|3|||
19533210|NCT01052662|41981008|FG001|Overall Study|Withdrawal by Subject|2|||
19533211|NCT01052662|41981009|FG002|Overall Study|Withdrawal by Subject|1|||
19533212|NCT01052662|41981007|FG000|Overall Study|Pharmacy issue|1|||
19533213|NCT01052662|41981008|FG001|Overall Study|Pharmacy issue|3|||
19533214|NCT01052662|41981009|FG002|Overall Study|Pharmacy issue|3|||
19533215|NCT01052662|41981007|FG000|Overall Study|Adverse Event|1|||
19533216|NCT01052662|41981008|FG001|Overall Study|Adverse Event|1|||
19533217|NCT01052662|41981009|FG002|Overall Study|Adverse Event|0|||
19533218|NCT01052662|41981007|FG000|Overall Study|Legal Problem|2|||
19533219|NCT01052662|41981008|FG001|Overall Study|Legal Problem|0|||
19533220|NCT01052662|41981009|FG002|Overall Study|Legal Problem|0|||
19533221|NCT01052662|41981007|FG000|Overall Study|Administrative|0|||
19533222|NCT01052662|41981008|FG001|Overall Study|Administrative|3|||
19533223|NCT01052662|41981009|FG002|Overall Study|Administrative|0|||
19533224|NCT01052116|41981019|FG000|Overall Study|Lost to Follow-up|11|||
19533225|NCT01052116|41981020|FG001|Overall Study|Lost to Follow-up|17|||
19533226|NCT01052116|41981019|FG000|Overall Study|Withdrawal by Subject|3|||
19533227|NCT01052116|41981020|FG001|Overall Study|Withdrawal by Subject|6|||
19533228|NCT01052116|41981019|FG000|Overall Study|Spirometry not performed|0|||
19533229|NCT01052116|41981020|FG001|Overall Study|Spirometry not performed|4|||
19533230|NCT01052077|41981028|FG000|Phase A|Lost to Follow-up|22|||
19533231|NCT01052077|41981029|FG001|Phase A|Lost to Follow-up|0|||
19533232|NCT01052077|41981030|FG002|Phase A|Lost to Follow-up|0|||
19533233|NCT01052077|41981031|FG003|Phase A|Lost to Follow-up|0|||
19533234|NCT01052077|41981028|FG000|Phase A|Adverse Event|32|||
19533235|NCT01052077|41981029|FG001|Phase A|Adverse Event|0|||
19533236|NCT01052077|41981030|FG002|Phase A|Adverse Event|0|||
19533237|NCT01052077|41981031|FG003|Phase A|Adverse Event|0|||
19533238|NCT01052077|41981028|FG000|Phase A|Met Withdrawal Criteria|26|||
19533239|NCT01052077|41981029|FG001|Phase A|Met Withdrawal Criteria|0|||
19533240|NCT01052077|41981030|FG002|Phase A|Met Withdrawal Criteria|0|||
19533241|NCT01052077|41981031|FG003|Phase A|Met Withdrawal Criteria|0|||
19533242|NCT01052077|41981028|FG000|Phase A|Physician Decision|10|||
19533243|NCT01052077|41981029|FG001|Phase A|Physician Decision|0|||
19533244|NCT01052077|41981030|FG002|Phase A|Physician Decision|0|||
19453562|NCT01896271|41702631|FG000|Overall Study|Physician Decision|10|||
19453563|NCT01884571|41702644|FG000|Overall Study|Adverse Event|1|||
19453564|NCT01884571|41702644|FG000|Overall Study|Death|2|||
19453565|NCT01884571|41702644|FG000|Overall Study|Withdrawal by Subject|2|||
19453566|NCT01884571|41702644|FG000|Overall Study|Disease progression|3|||
19453567|NCT01884337|41702650|FG000|Treatment|Adverse Event|2|||
19453568|NCT01884337|41702651|FG001|Treatment|Adverse Event|2|||
19453569|NCT01884337|41702650|FG000|Treatment|Subj. request to discont. treatment|2|||
19533245|NCT01052077|41981031|FG003|Phase A|Physician Decision|0|||
19533246|NCT01052077|41981028|FG000|Phase A|Withdrawal by Subject|29|||
19533247|NCT01052077|41981029|FG001|Phase A|Withdrawal by Subject|0|||
19533248|NCT01052077|41981030|FG002|Phase A|Withdrawal by Subject|0|||
19533249|NCT01052077|41981031|FG003|Phase A|Withdrawal by Subject|0|||
19533250|NCT01052077|41981028|FG000|Phase A|Protocol Deviation|27|||
19533251|NCT01052077|41981029|FG001|Phase A|Protocol Deviation|0|||
19533252|NCT01052077|41981030|FG002|Phase A|Protocol Deviation|0|||
19533253|NCT01052077|41981031|FG003|Phase A|Protocol Deviation|0|||
19533254|NCT01052077|41981028|FG000|Phase B|Lost to Follow-up|0|||
19533255|NCT01052077|41981029|FG001|Phase B|Lost to Follow-up|2|||
19453570|NCT01884337|41702651|FG001|Treatment|Subj. request to discont. treatment|0|||
19533256|NCT01052077|41981030|FG002|Phase B|Lost to Follow-up|3|||
19533257|NCT01052077|41981031|FG003|Phase B|Lost to Follow-up|0|||
19453571|NCT01884337|41702650|FG000|Follow-up Period|Lost to Follow-up|1|||
19533258|NCT01052077|41981028|FG000|Phase B|Adverse Event|0|||
19453572|NCT01884337|41702651|FG001|Follow-up Period|Lost to Follow-up|1|||
19453573|NCT01922089|41702659|FG000|Overall Study|Adverse Event|18|||
19453574|NCT01922089|41702660|FG001|Overall Study|Adverse Event|13|||
19453575|NCT01922089|41702659|FG000|Overall Study|Protocol Deviation|10|||
19453576|NCT01922089|41702660|FG001|Overall Study|Protocol Deviation|7|||
19453577|NCT01922089|41702659|FG000|Overall Study|Withdrawal by Subject|3|||
19453578|NCT01922089|41702660|FG001|Overall Study|Withdrawal by Subject|4|||
19453579|NCT01922089|41702659|FG000|Overall Study|administrative problems|4|||
19453580|NCT01922089|41702660|FG001|Overall Study|administrative problems|1|||
19453581|NCT01922089|41702659|FG000|Overall Study|Physician Decision|2|||
19453582|NCT01922089|41702660|FG001|Overall Study|Physician Decision|3|||
19453583|NCT01922089|41702659|FG000|Overall Study|Death|2|||
19453584|NCT01922089|41702660|FG001|Overall Study|Death|1|||
19453585|NCT01922089|41702659|FG000|Overall Study|Lost to Follow-up|0|||
19453586|NCT01922089|41702660|FG001|Overall Study|Lost to Follow-up|1|||
19453587|NCT01884025|41702668|FG000|Overall Study|Lost to Follow-up|3|||
19453588|NCT01884025|41702669|FG001|Overall Study|Lost to Follow-up|4|||
19453589|NCT01896193|41702679|FG000|Overall Study|Lack of Efficacy|20|||
19453590|NCT01896193|41702680|FG001|Overall Study|Lack of Efficacy|11|||
19453591|NCT01896193|41702679|FG000|Overall Study|Protocol Violation|0|||
19453592|NCT01896193|41702680|FG001|Overall Study|Protocol Violation|1|||
19453593|NCT01896193|41702679|FG000|Overall Study|Withdrew Consent|1|||
19453594|NCT01896193|41702680|FG001|Overall Study|Withdrew Consent|0|||
19453595|NCT01922011|41702690|FG000|Overall Study|Protocol Violation|0|||
19453596|NCT01922011|41702691|FG001|Overall Study|Protocol Violation|1|||
19453597|NCT01922011|41702690|FG000|Overall Study|Physician Decision|0|||
19453598|NCT01922011|41702691|FG001|Overall Study|Physician Decision|1|||
19533259|NCT01052077|41981029|FG001|Phase B|Adverse Event|9|||
19533260|NCT01052077|41981030|FG002|Phase B|Adverse Event|2|||
19533261|NCT01052077|41981031|FG003|Phase B|Adverse Event|0|||
19533262|NCT01052077|41981028|FG000|Phase B|Met Withdrawal Criteria|0|||
19533263|NCT01052077|41981029|FG001|Phase B|Met Withdrawal Criteria|2|||
19533264|NCT01052077|41981030|FG002|Phase B|Met Withdrawal Criteria|1|||
19533265|NCT01052077|41981031|FG003|Phase B|Met Withdrawal Criteria|0|||
19533266|NCT01052077|41981028|FG000|Phase B|Physician Decision|0|||
19533267|NCT01052077|41981029|FG001|Phase B|Physician Decision|1|||
19533268|NCT01052077|41981030|FG002|Phase B|Physician Decision|1|||
19533269|NCT01052077|41981031|FG003|Phase B|Physician Decision|0|||
19533270|NCT01052077|41981028|FG000|Phase B|Withdrawal by Subject|0|||
19533271|NCT01052077|41981029|FG001|Phase B|Withdrawal by Subject|0|||
19533272|NCT01052077|41981030|FG002|Phase B|Withdrawal by Subject|5|||
19533273|NCT01052077|41981031|FG003|Phase B|Withdrawal by Subject|0|||
19533274|NCT01052077|41981028|FG000|Phase B|Protocol Deviation|0|||
19533275|NCT01052077|41981029|FG001|Phase B|Protocol Deviation|3|||
19533276|NCT01052077|41981030|FG002|Phase B|Protocol Deviation|4|||
19533277|NCT01052077|41981031|FG003|Phase B|Protocol Deviation|0|||
19533278|NCT01052077|41981028|FG000|Phase B|Lack of Efficacy|0|||
19533279|NCT01052077|41981029|FG001|Phase B|Lack of Efficacy|1|||
19533280|NCT01052077|41981030|FG002|Phase B|Lack of Efficacy|0|||
19533281|NCT01052077|41981031|FG003|Phase B|Lack of Efficacy|0|||
19533282|NCT01052077|41981028|FG000|Phase A+|Lost to Follow-up|0|||
19533283|NCT01052077|41981029|FG001|Phase A+|Lost to Follow-up|0|||
19533284|NCT01052077|41981030|FG002|Phase A+|Lost to Follow-up|0|||
19533285|NCT01052077|41981031|FG003|Phase A+|Lost to Follow-up|8|||
19533286|NCT01052077|41981028|FG000|Phase A+|Adverse Event|0|||
19533287|NCT01052077|41981029|FG001|Phase A+|Adverse Event|0|||
19533288|NCT01052077|41981030|FG002|Phase A+|Adverse Event|0|||
19533289|NCT01052077|41981031|FG003|Phase A+|Adverse Event|4|||
19533290|NCT01052077|41981028|FG000|Phase A+|Met Withdrawal Criteria|0|||
19533291|NCT01052077|41981029|FG001|Phase A+|Met Withdrawal Criteria|0|||
19533292|NCT01052077|41981030|FG002|Phase A+|Met Withdrawal Criteria|0|||
19533293|NCT01052077|41981031|FG003|Phase A+|Met Withdrawal Criteria|2|||
19533294|NCT01052077|41981028|FG000|Phase A+|Withdrawal by Subject|0|||
19533295|NCT01052077|41981029|FG001|Phase A+|Withdrawal by Subject|0|||
19533296|NCT01052077|41981030|FG002|Phase A+|Withdrawal by Subject|0|||
19533297|NCT01052077|41981031|FG003|Phase A+|Withdrawal by Subject|7|||
19533298|NCT01052038|41981040|FG000|Overall Study|Lost to Follow-up|2|||
19533299|NCT01052038|41981041|FG001|Overall Study|Lost to Follow-up|3|||
19533300|NCT01052038|41981042|FG002|Overall Study|Lost to Follow-up|1|||
19533301|NCT01052038|41981040|FG000|Overall Study|Protocol Violation|2|||
19533302|NCT01052038|41981041|FG001|Overall Study|Protocol Violation|3|||
19533303|NCT01052038|41981042|FG002|Overall Study|Protocol Violation|3|||
19453599|NCT01922011|41702690|FG000|Overall Study|Parent/Guardian Decision|3|||
19453600|NCT01922011|41702691|FG001|Overall Study|Parent/Guardian Decision|0|||
19453601|NCT01922011|41702690|FG000|Overall Study|Lost to Follow-up|0|||
19453602|NCT01922011|41702691|FG001|Overall Study|Lost to Follow-up|1|||
19453603|NCT01922011|41702690|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
19453604|NCT01922011|41702691|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
19533304|NCT01051960|41981050|FG000|Overall Study|Adverse Event|1|||
19533305|NCT01051921|41981054|FG000|Overall Study|Physician Decision|9|||
19533306|NCT01051921|41981054|FG000|Overall Study|Adverse Event|8|||
19533307|NCT01051921|41981054|FG000|Overall Study|Withdrawal by Subject|7|||
19533308|NCT01051921|41981054|FG000|Overall Study|Lost to Follow-up|4|||
19533309|NCT01051921|41981054|FG000|Overall Study|virological failure|1|||
19533310|NCT01051921|41981054|FG000|Overall Study|patient moved|1|||
19533311|NCT01051063|41981060|FG000|Overall Study|Death|2|||
19533312|NCT01051063|41981061|FG001|Overall Study|Death|2|||
19533313|NCT01051063|41981060|FG000|Overall Study|Withdrawal by Subject|1|||
19533314|NCT01051063|41981061|FG001|Overall Study|Withdrawal by Subject|1|||
19533315|NCT01051063|41981060|FG000|Overall Study|Termination of the study|5|||
19533316|NCT01051063|41981061|FG001|Overall Study|Termination of the study|0|||
19533317|NCT01051063|41981060|FG000|Overall Study|Moved from the study site area|1|||
19533318|NCT01051063|41981061|FG001|Overall Study|Moved from the study site area|0|||
19453605|NCT01922011|41702690|FG000|Overall Study|Not Treated|1|||
19453606|NCT01922011|41702691|FG001|Overall Study|Not Treated|0|||
19533319|NCT01051063|41981060|FG000|Overall Study|Other|1|||
19533320|NCT01051063|41981061|FG001|Overall Study|Other|0|||
19533321|NCT01051063|41981060|FG000|Overall Study|Lost to Follow-up|0|||
19533322|NCT01051063|41981061|FG001|Overall Study|Lost to Follow-up|1|||
19533323|NCT01050790|41981068|FG000|Overall Study|Adverse Event|1|||
19533324|NCT01050673|41981075|FG000|Overall Study|Physician Decision|4|||
19533325|NCT01050673|41981076|FG001|Overall Study|Physician Decision|5|||
19533326|NCT01050205|41981084|FG000|Overall Study|Lost to Follow-up|7|||
19533327|NCT01050205|41981085|FG001|Overall Study|Lost to Follow-up|1|||
19533328|NCT01050205|41981084|FG000|Overall Study|Withdrawal by Subject|1|||
19533329|NCT01050205|41981085|FG001|Overall Study|Withdrawal by Subject|1|||
19533330|NCT01050205|41981084|FG000|Overall Study|Relocated from area|1|||
19533331|NCT01050205|41981085|FG001|Overall Study|Relocated from area|2|||
19533332|NCT01050205|41981084|FG000|Overall Study|Discontinued Intervention|2|||
19533333|NCT01050205|41981085|FG001|Overall Study|Discontinued Intervention|0|||
19533334|NCT01059448|41981095|FG000|Overall Study|Adverse Event|1|||
19533335|NCT01059448|41981096|FG001|Overall Study|Adverse Event|3|||
19533336|NCT01059448|41981097|FG002|Overall Study|Adverse Event|0|||
19533337|NCT01059448|41981098|FG003|Overall Study|Adverse Event|1|||
19533338|NCT01059448|41981095|FG000|Overall Study|Withdrawal by Subject|2|||
19533339|NCT01059448|41981096|FG001|Overall Study|Withdrawal by Subject|0|||
19533340|NCT01059448|41981097|FG002|Overall Study|Withdrawal by Subject|2|||
19533341|NCT01059448|41981098|FG003|Overall Study|Withdrawal by Subject|4|||
19533342|NCT01059448|41981095|FG000|Overall Study|Disease Progression|2|||
19533343|NCT01059448|41981096|FG001|Overall Study|Disease Progression|1|||
19533344|NCT01059448|41981097|FG002|Overall Study|Disease Progression|4|||
19533345|NCT01059448|41981098|FG003|Overall Study|Disease Progression|2|||
19533346|NCT01059448|41981095|FG000|Overall Study|Administrative Decision|43|||
19533347|NCT01059448|41981096|FG001|Overall Study|Administrative Decision|49|||
19533348|NCT01059448|41981097|FG002|Overall Study|Administrative Decision|45|||
19533349|NCT01059448|41981098|FG003|Overall Study|Administrative Decision|46|||
19533350|NCT01059448|41981095|FG000|Overall Study|Lost to Follow-up|0|||
19533351|NCT01059448|41981096|FG001|Overall Study|Lost to Follow-up|0|||
19533352|NCT01059448|41981097|FG002|Overall Study|Lost to Follow-up|2|||
19533353|NCT01059448|41981098|FG003|Overall Study|Lost to Follow-up|0|||
19533354|NCT01059448|41981095|FG000|Overall Study|Death|0|||
19533355|NCT01059448|41981096|FG001|Overall Study|Death|1|||
19533356|NCT01059448|41981097|FG002|Overall Study|Death|0|||
19533357|NCT01059448|41981098|FG003|Overall Study|Death|0|||
19533358|NCT01059448|41981095|FG000|Overall Study|Other|1|||
19533359|NCT01059448|41981096|FG001|Overall Study|Other|1|||
19533360|NCT01059448|41981097|FG002|Overall Study|Other|0|||
19533361|NCT01059448|41981098|FG003|Overall Study|Other|1|||
19533362|NCT01058707|41981115|FG000|Overall Study|Disease Progression|15|||
19453607|NCT01922011|41702690|FG000|Overall Study|Lack of willing home health agency|1|||
19453608|NCT01922011|41702691|FG001|Overall Study|Lack of willing home health agency|0|||
19453609|NCT01922011|41702690|FG000|Overall Study|Randomized in error|1|||
19453610|NCT01922011|41702691|FG001|Overall Study|Randomized in error|0|||
19453611|NCT01883635|41702705|FG000|Overall Study|Withdrawal by Subject|4|||
19453612|NCT01883635|41702706|FG001|Overall Study|Withdrawal by Subject|0|||
19453613|NCT01921387|41702714|FG000|Overall Study|Adverse Event|1|||
19453614|NCT01895335|41702718|FG000|Overall Study|Adverse Event|106|||
19453615|NCT01895335|41702718|FG000|Overall Study|Lack of Efficacy|53|||
19533363|NCT01058707|41981116|FG001|Overall Study|Disease Progression|20|||
19533364|NCT01058707|41981117|FG002|Overall Study|Disease Progression|20|||
19533365|NCT01058707|41981118|FG003|Overall Study|Disease Progression|15|||
19533366|NCT01058707|41981119|FG004|Overall Study|Disease Progression|23|||
19533367|NCT01058707|41981120|FG005|Overall Study|Disease Progression|10|||
19533368|NCT01058707|41981121|FG006|Overall Study|Disease Progression|12|||
19533369|NCT01058707|41981115|FG000|Overall Study|Adverse Event|11|||
19533370|NCT01058707|41981116|FG001|Overall Study|Adverse Event|4|||
19533371|NCT01058707|41981117|FG002|Overall Study|Adverse Event|7|||
19533372|NCT01058707|41981118|FG003|Overall Study|Adverse Event|6|||
19533373|NCT01058707|41981119|FG004|Overall Study|Adverse Event|7|||
19533374|NCT01058707|41981120|FG005|Overall Study|Adverse Event|3|||
19533375|NCT01058707|41981121|FG006|Overall Study|Adverse Event|1|||
19533376|NCT01058707|41981115|FG000|Overall Study|Subject Decision|5|||
19533377|NCT01058707|41981116|FG001|Overall Study|Subject Decision|3|||
19533378|NCT01058707|41981117|FG002|Overall Study|Subject Decision|3|||
19533379|NCT01058707|41981118|FG003|Overall Study|Subject Decision|1|||
19533380|NCT01058707|41981119|FG004|Overall Study|Subject Decision|2|||
19533381|NCT01058707|41981120|FG005|Overall Study|Subject Decision|3|||
19533382|NCT01058707|41981121|FG006|Overall Study|Subject Decision|6|||
19453616|NCT01895335|41702718|FG000|Overall Study|Poor Compliance to Protocol|11|||
19453617|NCT01895335|41702718|FG000|Overall Study|Included But Not treated|1|||
19453618|NCT01895335|41702718|FG000|Overall Study|Other than Specified Above|44|||
19453619|NCT01617655|41702724|FG000|Overall Study|Adverse Event|2|||
19453620|NCT01617655|41702725|FG001|Overall Study|Adverse Event|3|||
19453621|NCT01617655|41702724|FG000|Overall Study|Poor compliance to protocol|1|||
19453622|NCT01617655|41702725|FG001|Overall Study|Poor compliance to protocol|4|||
19453623|NCT01617655|41702724|FG000|Overall Study|Participants moved|0|||
19453624|NCT01617655|41702725|FG001|Overall Study|Participants moved|4|||
19453625|NCT01617655|41702724|FG000|Overall Study|Consent withdrawn by participant|1|||
19453626|NCT01617655|41702725|FG001|Overall Study|Consent withdrawn by participant|1|||
19453627|NCT01617655|41702724|FG000|Overall Study|Last visit outside protocol visit window|1|||
19533383|NCT01058707|41981115|FG000|Overall Study|Lost to Follow-up|0|||
19533384|NCT01058707|41981116|FG001|Overall Study|Lost to Follow-up|0|||
19533385|NCT01058707|41981117|FG002|Overall Study|Lost to Follow-up|1|||
19533386|NCT01058707|41981118|FG003|Overall Study|Lost to Follow-up|0|||
19533387|NCT01058707|41981119|FG004|Overall Study|Lost to Follow-up|0|||
19533388|NCT01058707|41981120|FG005|Overall Study|Lost to Follow-up|0|||
19533389|NCT01058707|41981121|FG006|Overall Study|Lost to Follow-up|0|||
19533390|NCT01058707|41981115|FG000|Overall Study|Reason Not Specified|0|||
19533391|NCT01058707|41981116|FG001|Overall Study|Reason Not Specified|3|||
19533392|NCT01058707|41981117|FG002|Overall Study|Reason Not Specified|2|||
19533393|NCT01058707|41981118|FG003|Overall Study|Reason Not Specified|0|||
19533394|NCT01058707|41981119|FG004|Overall Study|Reason Not Specified|7|||
19533395|NCT01058707|41981120|FG005|Overall Study|Reason Not Specified|1|||
19533396|NCT01058707|41981121|FG006|Overall Study|Reason Not Specified|7|||
19533397|NCT01054144|41981159|FG000|Overall Study|Death|2|||
19533398|NCT00105586|41981168|FG000|Overall Study|Adverse Event|4|||
19533399|NCT00105586|41981169|FG001|Overall Study|Adverse Event|3|||
19533400|NCT00105586|41981168|FG000|Overall Study|Physician Decision|13|||
19453628|NCT01617655|41702725|FG001|Overall Study|Last visit outside protocol visit window|10|||
19453629|NCT01617655|41702724|FG000|Overall Study|Site closure|3|||
19533401|NCT00105586|41981169|FG001|Overall Study|Physician Decision|13|||
19533402|NCT01059643|41981177|FG000|Overall Study|Adverse Event|3|||
19533403|NCT01059643|41981177|FG000|Overall Study|Withdrawal by Subject|2|||
19533404|NCT01059643|41981177|FG000|Overall Study|Physician Decision|1|||
19533405|NCT01059565|41981186|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
19533406|NCT01059565|41981187|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
19533407|NCT01059565|41981186|FG000|24-Week Randomized Phase|Adverse Event|5|||
19533408|NCT01059565|41981187|FG001|24-Week Randomized Phase|Adverse Event|0|||
19533409|NCT01059565|41981186|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
19533410|NCT01059565|41981187|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
19533411|NCT01059565|41981186|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
19533412|NCT01059565|41981187|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
19533413|NCT01059565|41981186|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
19533414|NCT01059565|41981187|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
19533415|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Adverse Event|2|||
19533416|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Adverse Event|0|||
19453630|NCT01617655|41702725|FG001|Overall Study|Site closure|5|||
19453631|NCT01617655|41702724|FG000|Overall Study|Other than specified above|1|||
19453632|NCT01617655|41702725|FG001|Overall Study|Other than specified above|2|||
19453633|NCT01895101|41702736|FG000|Overall Study|OPCAB procedure|1|||
19453634|NCT01895101|41702737|FG001|Overall Study|OPCAB procedure|1|||
19453635|NCT01895101|41702738|FG002|Overall Study|OPCAB procedure|3|||
19453636|NCT01895101|41702736|FG000|Overall Study|Withdrawal by Subject|0|||
19453637|NCT01895101|41702737|FG001|Overall Study|Withdrawal by Subject|1|||
19453638|NCT01895101|41702738|FG002|Overall Study|Withdrawal by Subject|2|||
19453639|NCT01895101|41702736|FG000|Overall Study|another study, enrolled in other study|0|||
19453640|NCT01895101|41702737|FG001|Overall Study|another study, enrolled in other study|1|||
19453641|NCT01895101|41702738|FG002|Overall Study|another study, enrolled in other study|0|||
19453642|NCT01895101|41702736|FG000|Overall Study|Death|0|||
19453643|NCT01895101|41702737|FG001|Overall Study|Death|1|||
19453644|NCT01895101|41702738|FG002|Overall Study|Death|0|||
19453645|NCT01895101|41702736|FG000|Overall Study|coagulation disorder|0|||
19533417|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
19533418|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
19533419|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
19533420|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
19453646|NCT01895101|41702737|FG001|Overall Study|coagulation disorder|1|||
19453647|NCT01895101|41702738|FG002|Overall Study|coagulation disorder|0|||
19453648|NCT01894477|41702748|FG000|Overall Study|Protocol Violation|0|||
19453649|NCT01894477|41702749|FG001|Overall Study|Protocol Violation|1|||
19533421|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
19533422|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
19533423|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
19533424|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
19533425|NCT01059565|41981186|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
19533426|NCT01059565|41981187|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
19533427|NCT01059526|41981197|FG000|Overall Study|Patient enrolled but not treated|20|||
19533428|NCT01059526|41981198|FG001|Overall Study|Patient enrolled but not treated|17|||
19533429|NCT01059526|41981197|FG000|Overall Study|Adverse Event|2|||
19533430|NCT01059526|41981198|FG001|Overall Study|Adverse Event|2|||
19533431|NCT01059526|41981197|FG000|Overall Study|Protocol Violation|0|||
19533432|NCT01059526|41981198|FG001|Overall Study|Protocol Violation|1|||
19533433|NCT01059526|41981197|FG000|Overall Study|Withdrawal by Subject|3|||
19533434|NCT01059526|41981198|FG001|Overall Study|Withdrawal by Subject|1|||
19533435|NCT01059526|41981197|FG000|Overall Study|Lost to Follow-up|4|||
19533436|NCT01059526|41981198|FG001|Overall Study|Lost to Follow-up|1|||
19533437|NCT01059526|41981197|FG000|Overall Study|Patient found to be dermatographic|1|||
19453650|NCT01894477|41702748|FG000|Overall Study|protocol changed due SC changed to cord|0|||
19453651|NCT01894477|41702749|FG001|Overall Study|protocol changed due SC changed to cord|1|||
19453652|NCT01894243|41702758|FG000|Overall Study|Adverse Event|0|||
19453653|NCT01894243|41702759|FG001|Overall Study|Adverse Event|1|||
19533438|NCT01059526|41981198|FG001|Overall Study|Patient found to be dermatographic|0|||
19533439|NCT03277261|41981206|FG000|Overall Study|Adverse Event|17|||
19533440|NCT03277261|41981207|FG001|Overall Study|Adverse Event|1|||
19533441|NCT03277261|41981206|FG000|Overall Study|Participant Withdrawal of Consent|6|||
19533442|NCT03277261|41981207|FG001|Overall Study|Participant Withdrawal of Consent|15|||
19533443|NCT03277261|41981206|FG000|Overall Study|Investigator / Sponsor Decision|4|||
19533444|NCT03277261|41981207|FG001|Overall Study|Investigator / Sponsor Decision|2|||
19533445|NCT03277261|41981206|FG000|Overall Study|Pregnancy|2|||
19533446|NCT03277261|41981207|FG001|Overall Study|Pregnancy|0|||
19533447|NCT03277261|41981206|FG000|Overall Study|Lost to Follow-up|2|||
19533448|NCT03277261|41981207|FG001|Overall Study|Lost to Follow-up|2|||
19533449|NCT03277261|41981206|FG000|Overall Study|Lack of Efficacy|2|||
19533450|NCT03277261|41981207|FG001|Overall Study|Lack of Efficacy|2|||
19533451|NCT03277261|41981206|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
19533452|NCT03277261|41981207|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
19533453|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
19533454|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
19533455|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Physician Decision|1|||
19533456|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Physician Decision|0|||
19533457|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
19453654|NCT01894243|41702760|FG002|Overall Study|Adverse Event|2|||
19453655|NCT01894243|41702758|FG000|Overall Study|Death|0|||
19453656|NCT01894243|41702759|FG001|Overall Study|Death|0|||
19453657|NCT01894243|41702760|FG002|Overall Study|Death|3|||
19453658|NCT01894243|41702758|FG000|Overall Study|Lack of Efficacy|3|||
19453659|NCT01894243|41702759|FG001|Overall Study|Lack of Efficacy|3|||
19453660|NCT01894243|41702760|FG002|Overall Study|Lack of Efficacy|1|||
19453661|NCT01894243|41702758|FG000|Overall Study|Condition under investigation worsened|8|||
19453662|NCT01894243|41702759|FG001|Overall Study|Condition under investigation worsened|6|||
19453663|NCT01894243|41702760|FG002|Overall Study|Condition under investigation worsened|2|||
19453664|NCT01894243|41702758|FG000|Overall Study|Subject decision|1|||
19453665|NCT01894243|41702759|FG001|Overall Study|Subject decision|0|||
19453666|NCT01894243|41702760|FG002|Overall Study|Subject decision|0|||
19453667|NCT01894243|41702758|FG000|Overall Study|Other|1|||
19453668|NCT01894243|41702759|FG001|Overall Study|Other|0|||
19453669|NCT01894243|41702760|FG002|Overall Study|Other|0|||
19453670|NCT03822832|41702777|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
19453671|NCT03822832|41702778|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
19453672|NCT03822832|41702777|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
19453673|NCT03822832|41702778|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
19453674|NCT03822832|41702777|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
19453675|NCT03822832|41702778|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
19453676|NCT03822832|41702777|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
19533458|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
19533459|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
19533460|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
19533461|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Adverse Event|15|||
19453677|NCT03822832|41702778|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
19453678|NCT03822832|41702777|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
19453679|NCT03822832|41702778|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
19453680|NCT03822832|41702777|FG000|Re-allocation|Not re-allocated to open label period|2|||
19453681|NCT03822832|41702778|FG001|Re-allocation|Not re-allocated to open label period|6|||
19453682|NCT03822832|41702777|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
19453683|NCT03822832|41702778|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
19453684|NCT03822832|41702777|FG000|Period 2 - Open Label Period|Adverse Event|0|||
19453685|NCT03822832|41702778|FG001|Period 2 - Open Label Period|Adverse Event|3|||
19453686|NCT01513239|41702788|FG000|Period 1: Main Phase|Adverse Event|1|||
19453687|NCT01513239|41702789|FG001|Period 1: Main Phase|Adverse Event|1|||
19453688|NCT01513239|41702790|FG002|Period 1: Main Phase|Adverse Event|2|||
19453689|NCT01513239|41702791|FG003|Period 1: Main Phase|Adverse Event|0|||
19453690|NCT01513239|41702792|FG004|Period 1: Main Phase|Adverse Event|0|||
19453691|NCT01513239|41702793|FG005|Period 1: Main Phase|Adverse Event|0|||
19453692|NCT01513239|41702788|FG000|Period 1: Main Phase|Death|29|||
19453693|NCT01513239|41702789|FG001|Period 1: Main Phase|Death|22|||
19453694|NCT01513239|41702790|FG002|Period 1: Main Phase|Death|32|||
19533462|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Adverse Event|0|||
19533463|NCT03277690|41981229|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
19533464|NCT03277690|41981230|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
19533465|NCT03277690|41981229|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
19533466|NCT03277690|41981230|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
19533467|NCT03271021|41981239|FG000|Overall Study|Adverse Event|3|||
19453695|NCT01513239|41702791|FG003|Period 1: Main Phase|Death|0|||
19453696|NCT01513239|41702792|FG004|Period 1: Main Phase|Death|0|||
19533468|NCT03271021|41981240|FG001|Overall Study|Adverse Event|2|||
19533469|NCT03271021|41981239|FG000|Overall Study|Withdrawal by Subject|36|||
19533470|NCT03271021|41981240|FG001|Overall Study|Withdrawal by Subject|53|||
19533471|NCT03271021|41981239|FG000|Overall Study|Lost to Follow-up|34|||
19533472|NCT03271021|41981240|FG001|Overall Study|Lost to Follow-up|39|||
19533473|NCT03271021|41981239|FG000|Overall Study|Protocol Violation|6|||
19533474|NCT03271021|41981240|FG001|Overall Study|Protocol Violation|4|||
19533475|NCT03271021|41981239|FG000|Overall Study|Abnormal Lab Results|1|||
19533476|NCT03271021|41981240|FG001|Overall Study|Abnormal Lab Results|0|||
19533477|NCT03271021|41981239|FG000|Overall Study|Miscellaneous|9|||
19533478|NCT03271021|41981240|FG001|Overall Study|Miscellaneous|8|||
19533479|NCT01249651|41981261|FG000|Overall Study|Withdrawal by Subject|4|||
19533480|NCT01249651|41981261|FG000|Overall Study|Adverse Event|1|||
19533481|NCT01249651|41981261|FG000|Overall Study|Protocol Violation|1|||
19453697|NCT01513239|41702793|FG005|Period 1: Main Phase|Death|0|||
19453698|NCT01513239|41702788|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
19453699|NCT01513239|41702789|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
19453700|NCT01513239|41702790|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
19453701|NCT01513239|41702791|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
19453702|NCT01513239|41702792|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
19453703|NCT01513239|41702793|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
19453704|NCT01513239|41702788|FG000|Period 1: Main Phase|Physician Decision|4|||
19453705|NCT01513239|41702789|FG001|Period 1: Main Phase|Physician Decision|4|||
19453706|NCT01513239|41702790|FG002|Period 1: Main Phase|Physician Decision|4|||
19453707|NCT01513239|41702791|FG003|Period 1: Main Phase|Physician Decision|0|||
19453708|NCT01513239|41702792|FG004|Period 1: Main Phase|Physician Decision|0|||
19453709|NCT01513239|41702793|FG005|Period 1: Main Phase|Physician Decision|0|||
19453710|NCT01513239|41702788|FG000|Period 1: Main Phase|Protocol Violation|2|||
19453711|NCT01513239|41702789|FG001|Period 1: Main Phase|Protocol Violation|2|||
19453712|NCT01513239|41702790|FG002|Period 1: Main Phase|Protocol Violation|2|||
19453713|NCT01513239|41702791|FG003|Period 1: Main Phase|Protocol Violation|0|||
19453714|NCT01513239|41702792|FG004|Period 1: Main Phase|Protocol Violation|0|||
19453715|NCT01513239|41702793|FG005|Period 1: Main Phase|Protocol Violation|0|||
19453716|NCT01513239|41702788|FG000|Period 1: Main Phase|Technical Problems|1|||
19453717|NCT01513239|41702789|FG001|Period 1: Main Phase|Technical Problems|2|||
19453718|NCT01513239|41702790|FG002|Period 1: Main Phase|Technical Problems|0|||
19453719|NCT01513239|41702791|FG003|Period 1: Main Phase|Technical Problems|0|||
19453720|NCT01513239|41702792|FG004|Period 1: Main Phase|Technical Problems|0|||
19453721|NCT01513239|41702793|FG005|Period 1: Main Phase|Technical Problems|0|||
19453722|NCT01513239|41702788|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
19453723|NCT01513239|41702789|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
19453724|NCT01513239|41702790|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
19453725|NCT01513239|41702791|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
19453726|NCT01513239|41702792|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
19453727|NCT01513239|41702793|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
19453728|NCT01513239|41702788|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
19533482|NCT01249651|41981261|FG000|Overall Study|Sponsor Decision|1|||
19533483|NCT01249417|41981268|FG000|Randomised Population|Study treatment not received|0|||
19533484|NCT01249417|41981269|FG001|Randomised Population|Study treatment not received|0|||
19533485|NCT01249417|41981270|FG002|Randomised Population|Study treatment not received|2|||
19533486|NCT01249417|41981268|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
19533487|NCT01249417|41981269|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
19533488|NCT01249417|41981270|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
19533489|NCT01249417|41981268|FG000|Treatment Phase - ITT Population|Other|0|||
19533490|NCT01249417|41981269|FG001|Treatment Phase - ITT Population|Other|0|||
19533491|NCT01249417|41981270|FG002|Treatment Phase - ITT Population|Other|1|||
19453729|NCT01513239|41702789|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
19453730|NCT01513239|41702790|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
19533492|NCT01249417|41981268|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
19533493|NCT01249417|41981269|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
19533494|NCT01249417|41981270|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
19533495|NCT01249417|41981268|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
19533496|NCT01249417|41981269|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
19533497|NCT01249417|41981270|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
19453731|NCT01513239|41702791|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
19453732|NCT01513239|41702792|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
19453733|NCT01513239|41702793|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
19453734|NCT01513239|41702788|FG000|Period 2: 9 Month Extension Phase|Death|0|||
19453735|NCT01513239|41702789|FG001|Period 2: 9 Month Extension Phase|Death|0|||
19453736|NCT01513239|41702790|FG002|Period 2: 9 Month Extension Phase|Death|0|||
19453737|NCT01513239|41702791|FG003|Period 2: 9 Month Extension Phase|Death|2|||
19453738|NCT01513239|41702792|FG004|Period 2: 9 Month Extension Phase|Death|5|||
19453739|NCT01513239|41702793|FG005|Period 2: 9 Month Extension Phase|Death|2|||
19453740|NCT01513239|41702788|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
19453741|NCT01513239|41702789|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
19453742|NCT01513239|41702790|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
19453743|NCT01513239|41702791|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
19453744|NCT01513239|41702792|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
19453745|NCT01513239|41702793|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
19453746|NCT01513239|41702788|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
19453747|NCT01513239|41702789|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
19453748|NCT01513239|41702790|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
19453749|NCT01513239|41702791|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
19453750|NCT01513239|41702792|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
19453751|NCT01513239|41702793|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
19453752|NCT01513239|41702788|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
19453753|NCT01513239|41702789|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
19453754|NCT01513239|41702790|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
19453755|NCT01513239|41702791|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
19453756|NCT01513239|41702792|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
19453757|NCT01513239|41702793|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
19453758|NCT01544127|41702808|FG000|Overall Study|Lost to Follow-up|4|||
19453759|NCT01544127|41702809|FG001|Overall Study|Lost to Follow-up|2|||
19453760|NCT01544127|41702810|FG002|Overall Study|Lost to Follow-up|9|||
19453761|NCT01544127|41702808|FG000|Overall Study|Withdrawal by Subject|2|||
19453762|NCT01544127|41702809|FG001|Overall Study|Withdrawal by Subject|2|||
19453763|NCT01544127|41702810|FG002|Overall Study|Withdrawal by Subject|1|||
19453764|NCT01544127|41702808|FG000|Overall Study|Discharged out of catchment area|1|||
19453765|NCT01544127|41702809|FG001|Overall Study|Discharged out of catchment area|1|||
19453766|NCT01544127|41702810|FG002|Overall Study|Discharged out of catchment area|1|||
19453767|NCT01544127|41702808|FG000|Overall Study|Death|1|||
19533498|NCT01249417|41981268|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
19533499|NCT01249417|41981269|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
19533500|NCT01249417|41981270|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
19533501|NCT01249261|41981280|FG000|Overall Study|Withdrawal by Subject|1|||
19533502|NCT01249261|41981281|FG001|Overall Study|Withdrawal by Subject|0|||
19533503|NCT01248949|41981301|FG000|Overall Study|Lost to Follow-up|2|||
19533504|NCT01248949|41981302|FG001|Overall Study|Lost to Follow-up|2|||
19533505|NCT01248949|41981303|FG002|Overall Study|Lost to Follow-up|2|||
19533506|NCT01248949|41981304|FG003|Overall Study|Lost to Follow-up|1|||
19533507|NCT01248949|41981305|FG004|Overall Study|Lost to Follow-up|0|||
19630272|NCT00785577|42079506|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
19533508|NCT01248949|41981301|FG000|Overall Study|Withdrawal by Subject|5|||
19533509|NCT01248949|41981302|FG001|Overall Study|Withdrawal by Subject|3|||
19533510|NCT01248949|41981303|FG002|Overall Study|Withdrawal by Subject|11|||
19533511|NCT01248949|41981304|FG003|Overall Study|Withdrawal by Subject|3|||
19533512|NCT01248949|41981305|FG004|Overall Study|Withdrawal by Subject|1|||
19533513|NCT01248949|41981301|FG000|Overall Study|Death|22|||
19533514|NCT01248949|41981302|FG001|Overall Study|Death|7|||
19453768|NCT01544127|41702809|FG001|Overall Study|Death|0|||
19453769|NCT01544127|41702810|FG002|Overall Study|Death|0|||
19453770|NCT01544127|41702808|FG000|Overall Study|Jail or Prison|1|||
19453771|NCT01544127|41702809|FG001|Overall Study|Jail or Prison|1|||
19453772|NCT01544127|41702810|FG002|Overall Study|Jail or Prison|2|||
19453773|NCT01544127|41702808|FG000|Overall Study|Became Psychotic|1|||
19533515|NCT01248949|41981303|FG002|Overall Study|Death|21|||
19533516|NCT01248949|41981304|FG003|Overall Study|Death|6|||
19533517|NCT01248949|41981305|FG004|Overall Study|Death|2|||
19533518|NCT01248949|41981301|FG000|Overall Study|Alternative Therapy|1|||
19453774|NCT01544127|41702809|FG001|Overall Study|Became Psychotic|0|||
19453775|NCT01544127|41702810|FG002|Overall Study|Became Psychotic|0|||
19453776|NCT01544127|41702808|FG000|Overall Study|Researcher withdrew|1|||
19533519|NCT01248949|41981302|FG001|Overall Study|Alternative Therapy|0|||
19533520|NCT01248949|41981303|FG002|Overall Study|Alternative Therapy|0|||
19533521|NCT01248949|41981304|FG003|Overall Study|Alternative Therapy|0|||
19533522|NCT01248949|41981305|FG004|Overall Study|Alternative Therapy|0|||
19533523|NCT01248949|41981301|FG000|Overall Study|Alternative Therapy.|1|||
19533524|NCT01248949|41981302|FG001|Overall Study|Alternative Therapy.|0|||
19533525|NCT01248949|41981303|FG002|Overall Study|Alternative Therapy.|0|||
19533526|NCT01248949|41981304|FG003|Overall Study|Alternative Therapy.|0|||
19533527|NCT01248949|41981305|FG004|Overall Study|Alternative Therapy.|0|||
19533528|NCT01248949|41981301|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
19533529|NCT01248949|41981302|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
19533530|NCT01248949|41981303|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
19533531|NCT01248949|41981304|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
19533532|NCT01248949|41981305|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
19533533|NCT01248949|41981301|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
19533534|NCT01248949|41981302|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
19533535|NCT01248949|41981303|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
19533536|NCT01248949|41981304|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
19533537|NCT01248949|41981305|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
19533538|NCT01248949|41981301|FG000|Overall Study|Participant Went To Hospice|0|||
19533539|NCT01248949|41981302|FG001|Overall Study|Participant Went To Hospice|0|||
19533540|NCT01248949|41981303|FG002|Overall Study|Participant Went To Hospice|1|||
19533541|NCT01248949|41981304|FG003|Overall Study|Participant Went To Hospice|0|||
19533542|NCT01248949|41981305|FG004|Overall Study|Participant Went To Hospice|0|||
19533543|NCT01248949|41981301|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
19533544|NCT01248949|41981302|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
19533545|NCT01248949|41981303|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
19533546|NCT01248949|41981304|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
19533547|NCT01248949|41981305|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
19533548|NCT01248949|41981301|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
19533549|NCT01248949|41981302|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
19533550|NCT01248949|41981303|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
19533551|NCT01248949|41981304|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
19533552|NCT01248949|41981305|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
19533553|NCT01248949|41981301|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
19533554|NCT01248949|41981302|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
19533555|NCT01248949|41981303|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
19533556|NCT01248949|41981304|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
19533557|NCT01248949|41981305|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
19533558|NCT01248949|41981301|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
19533559|NCT01248949|41981302|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
19533560|NCT01248949|41981303|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
19533561|NCT01248949|41981304|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
19533562|NCT01248949|41981305|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
19533563|NCT01248793|41981319|FG000|Overall Study|Lost to Follow-up|0|||
19533564|NCT01248793|41981320|FG001|Overall Study|Lost to Follow-up|1|||
19533565|NCT01248793|41981319|FG000|Overall Study|Adverse Event|1|||
19533566|NCT01248793|41981320|FG001|Overall Study|Adverse Event|1|||
19533567|NCT01248793|41981319|FG000|Overall Study|Protocol Violation|0|||
19453777|NCT01544127|41702809|FG001|Overall Study|Researcher withdrew|0|||
19453778|NCT01544127|41702810|FG002|Overall Study|Researcher withdrew|0|||
19533568|NCT01248793|41981320|FG001|Overall Study|Protocol Violation|1|||
19533569|NCT01248793|41981319|FG000|Overall Study|Withdrawal by Subject|3|||
19533570|NCT01248793|41981320|FG001|Overall Study|Withdrawal by Subject|3|||
19533571|NCT01248715|41981328|FG000|Overall Study|Not influenza positive|501|||
19533572|NCT01248715|41981329|FG001|Overall Study|Not influenza positive|510|||
19533573|NCT01248364|41981339|FG000|Overall Study|Adverse Event|0|||
19533574|NCT01248364|41981340|FG001|Overall Study|Adverse Event|1|||
19533575|NCT01248364|41981341|FG002|Overall Study|Adverse Event|0|||
19533576|NCT01248364|41981342|FG003|Overall Study|Adverse Event|0|||
19453779|NCT01544127|41702808|FG000|Overall Study|Went active duty|0|||
19453780|NCT01544127|41702809|FG001|Overall Study|Went active duty|0|||
19533577|NCT01248130|41981354|FG000|Overall Study|Protocol Violation|1|||
19533578|NCT01248130|41981355|FG001|Overall Study|Protocol Violation|0|||
19533579|NCT01248130|41981354|FG000|Overall Study|Ineligible|1|||
19533580|NCT01248130|41981355|FG001|Overall Study|Ineligible|0|||
19533581|NCT01248013|41981361|FG000|Overall Study|Withdrawal by Subject|14|||
19533582|NCT01247350|41981370|FG000|Overall Study|Adverse Event|0|||
19533583|NCT01247350|41981371|FG001|Overall Study|Adverse Event|0|||
19533584|NCT01247350|41981372|FG002|Overall Study|Adverse Event|1|||
19533585|NCT01247350|41981373|FG003|Overall Study|Adverse Event|0|||
19533586|NCT01247350|41981374|FG004|Overall Study|Adverse Event|0|||
19533587|NCT01247350|41981370|FG000|Overall Study|Withdrawal by Subject|0|||
19533588|NCT01247350|41981371|FG001|Overall Study|Withdrawal by Subject|0|||
19533589|NCT01247350|41981372|FG002|Overall Study|Withdrawal by Subject|0|||
19533590|NCT01247350|41981373|FG003|Overall Study|Withdrawal by Subject|1|||
19533591|NCT01247350|41981374|FG004|Overall Study|Withdrawal by Subject|0|||
19533592|NCT01247350|41981370|FG000|Overall Study|Entry criteria not met|0|||
19533593|NCT01247350|41981371|FG001|Overall Study|Entry criteria not met|0|||
19533594|NCT01247350|41981372|FG002|Overall Study|Entry criteria not met|0|||
19533595|NCT01247350|41981373|FG003|Overall Study|Entry criteria not met|0|||
19533596|NCT01247350|41981374|FG004|Overall Study|Entry criteria not met|1|||
19533597|NCT01246999|41981404|FG000|Overall Study|Lost to Follow-up|0|||
19533598|NCT01246999|41981405|FG001|Overall Study|Lost to Follow-up|1|||
19533599|NCT01246999|41981406|FG002|Overall Study|Lost to Follow-up|0|||
19533600|NCT01246999|41981407|FG003|Overall Study|Lost to Follow-up|0|||
19533601|NCT01246999|41981404|FG000|Overall Study|Withdrawal by Subject|0|||
19533602|NCT01246999|41981405|FG001|Overall Study|Withdrawal by Subject|0|||
19533603|NCT01246999|41981406|FG002|Overall Study|Withdrawal by Subject|0|||
19533604|NCT01246999|41981407|FG003|Overall Study|Withdrawal by Subject|2|||
19533605|NCT01245751|41981429|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
19533606|NCT01245751|41981430|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
19533607|NCT01245751|41981431|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
19533608|NCT01245751|41981432|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
19533609|NCT01245751|41981429|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
19533610|NCT01245751|41981430|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
19533611|NCT01245751|41981431|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
19533612|NCT01245751|41981432|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
19533613|NCT01245751|41981429|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
19533614|NCT01245751|41981430|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
19533615|NCT01245751|41981431|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
19533616|NCT01245751|41981432|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
19533617|NCT01245673|41981443|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
19533618|NCT01245283|41981450|FG000|Overall Study|Lost to Follow-up|14|||
19533619|NCT01245283|41981451|FG001|Overall Study|Lost to Follow-up|11|||
19533620|NCT01245283|41981452|FG002|Overall Study|Lost to Follow-up|11|||
19533621|NCT01245049|41981465|FG000|Overall Study|Migrated/moved from study area|0|||
19533622|NCT01245049|41981466|FG001|Overall Study|Migrated/moved from study area|1|||
19533623|NCT01245049|41981465|FG000|Overall Study|Withdrawal by Subject|0|||
19630273|NCT00785577|42079507|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
19453781|NCT01544127|41702810|FG002|Overall Study|Went active duty|1|||
19453782|NCT01512693|41702821|FG000|Overall Study|Withdrawal by Subject|0|||
19453783|NCT01512693|41702822|FG001|Overall Study|Withdrawal by Subject|1|||
19453784|NCT01458340|41702831|FG000|Overall Study|Adverse Event|5|||
19453785|NCT01458340|41702832|FG001|Overall Study|Adverse Event|4|||
19453786|NCT01458340|41702833|FG002|Overall Study|Adverse Event|2|||
19453787|NCT01458340|41702831|FG000|Overall Study|Lost to Follow-up|3|||
19453788|NCT01458340|41702832|FG001|Overall Study|Lost to Follow-up|3|||
19453789|NCT01458340|41702833|FG002|Overall Study|Lost to Follow-up|10|||
19453790|NCT01458340|41702831|FG000|Overall Study|Miscellaneous|0|||
19453791|NCT01458340|41702832|FG001|Overall Study|Miscellaneous|1|||
19453792|NCT01458340|41702833|FG002|Overall Study|Miscellaneous|0|||
19453793|NCT01458340|41702831|FG000|Overall Study|Physician Decision|1|||
19453794|NCT01458340|41702832|FG001|Overall Study|Physician Decision|1|||
19453795|NCT01458340|41702833|FG002|Overall Study|Physician Decision|2|||
19453796|NCT01458340|41702831|FG000|Overall Study|Protocol Violation|6|||
19453797|NCT01458340|41702832|FG001|Overall Study|Protocol Violation|6|||
19453798|NCT01458340|41702833|FG002|Overall Study|Protocol Violation|5|||
19453799|NCT01458340|41702831|FG000|Overall Study|Withdrawal by Subject|12|||
19453800|NCT01458340|41702832|FG001|Overall Study|Withdrawal by Subject|6|||
19453801|NCT01458340|41702833|FG002|Overall Study|Withdrawal by Subject|4|||
19453802|NCT01539291|41702888|FG000|Study GS-US-312-0116|Adverse Event|9|||
19453803|NCT01539291|41702889|FG001|Study GS-US-312-0116|Adverse Event|0|||
19453804|NCT01539291|41702890|FG002|Study GS-US-312-0116|Adverse Event|0|||
19453805|NCT01539291|41702891|FG003|Study GS-US-312-0116|Adverse Event|0|||
19533624|NCT01245049|41981466|FG001|Overall Study|Withdrawal by Subject|1|||
19533625|NCT01245049|41981465|FG000|Overall Study|Lost to Follow-up|1|||
19533626|NCT01245049|41981466|FG001|Overall Study|Lost to Follow-up|2|||
19533627|NCT01244893|41981472|FG000|Baseline|Protocol Violation|0|||
19533628|NCT01244893|41981473|FG001|Baseline|Protocol Violation|1|||
19533629|NCT01244893|41981472|FG000|1-Week Follow Up|Lost to Follow-up|1|||
19533630|NCT01244893|41981473|FG001|1-Week Follow Up|Lost to Follow-up|0|||
19533631|NCT01244815|41981488|FG000|Overall Study|Not Treated|0|||
19533632|NCT01244815|41981489|FG001|Overall Study|Not Treated|1|||
19533633|NCT01244815|41981490|FG002|Overall Study|Not Treated|0|||
19533634|NCT01244815|41981491|FG003|Overall Study|Not Treated|0|||
19533635|NCT01244815|41981488|FG000|Overall Study|Adverse Event|4|||
19533636|NCT01244815|41981489|FG001|Overall Study|Adverse Event|7|||
19533637|NCT01244815|41981490|FG002|Overall Study|Adverse Event|5|||
19533638|NCT01244815|41981491|FG003|Overall Study|Adverse Event|5|||
19533639|NCT01244815|41981488|FG000|Overall Study|Treatment Failure|0|||
19533640|NCT01244815|41981489|FG001|Overall Study|Treatment Failure|0|||
19533641|NCT01244815|41981490|FG002|Overall Study|Treatment Failure|0|||
19533642|NCT01244815|41981491|FG003|Overall Study|Treatment Failure|1|||
19533643|NCT01244815|41981488|FG000|Overall Study|Lost to Follow-up|3|||
19533644|NCT01244815|41981489|FG001|Overall Study|Lost to Follow-up|2|||
19533645|NCT01244815|41981490|FG002|Overall Study|Lost to Follow-up|3|||
19533646|NCT01244815|41981491|FG003|Overall Study|Lost to Follow-up|2|||
19533647|NCT01244815|41981488|FG000|Overall Study|Withdrawal by Subject|0|||
19533648|NCT01244815|41981489|FG001|Overall Study|Withdrawal by Subject|2|||
19533649|NCT01244815|41981490|FG002|Overall Study|Withdrawal by Subject|0|||
19453806|NCT01539291|41702888|FG000|Study GS-US-312-0116|Physician Decision|1|||
19453807|NCT01539291|41702889|FG001|Study GS-US-312-0116|Physician Decision|0|||
19453808|NCT01539291|41702890|FG002|Study GS-US-312-0116|Physician Decision|0|||
19453809|NCT01539291|41702891|FG003|Study GS-US-312-0116|Physician Decision|0|||
19453810|NCT01539291|41702888|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
19453811|NCT01539291|41702889|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
19453812|NCT01539291|41702890|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
19453813|NCT01539291|41702891|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
19533650|NCT01244815|41981491|FG003|Overall Study|Withdrawal by Subject|3|||
19533651|NCT01244815|41981488|FG000|Overall Study|Protocol Violation|7|||
19533652|NCT01244815|41981489|FG001|Overall Study|Protocol Violation|4|||
19533653|NCT01244815|41981490|FG002|Overall Study|Protocol Violation|3|||
19533654|NCT01244815|41981491|FG003|Overall Study|Protocol Violation|1|||
19533655|NCT01244815|41981488|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
19533656|NCT01244815|41981489|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
19533657|NCT01244815|41981490|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
19533658|NCT01244815|41981491|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
19533659|NCT01244425|41981503|FG000|Overall Study|Withdrawal by Subject|2|||
19533660|NCT01244425|41981504|FG001|Overall Study|Withdrawal by Subject|2|||
19533661|NCT01244425|41981503|FG000|Overall Study|Adverse Event|1|||
19533662|NCT01244425|41981504|FG001|Overall Study|Adverse Event|1|||
19533663|NCT01244191|41981520|FG000|Overall Study|Progressive disease|295|||
19533664|NCT01244191|41981521|FG001|Overall Study|Progressive disease|350|||
19533665|NCT01244191|41981520|FG000|Overall Study|Clinical disease progression|54|||
19533666|NCT01244191|41981521|FG001|Overall Study|Clinical disease progression|36|||
19533667|NCT01244191|41981520|FG000|Overall Study|Adverse Event|65|||
19533668|NCT01244191|41981521|FG001|Overall Study|Adverse Event|48|||
19533669|NCT01244191|41981520|FG000|Overall Study|Death|22|||
19533670|NCT01244191|41981521|FG001|Overall Study|Death|29|||
19533671|NCT01244191|41981520|FG000|Overall Study|Lost to Follow-up|0|||
19533672|NCT01244191|41981521|FG001|Overall Study|Lost to Follow-up|2|||
19533673|NCT01244191|41981520|FG000|Overall Study|Protocol Violation|1|||
19533674|NCT01244191|41981521|FG001|Overall Study|Protocol Violation|2|||
19533675|NCT01244191|41981520|FG000|Overall Study|Withdrawal by Subject|31|||
19533676|NCT01244191|41981521|FG001|Overall Study|Withdrawal by Subject|23|||
19533677|NCT01244191|41981520|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
19533678|NCT01244191|41981521|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
19533679|NCT01244035|41981527|FG000|Part 1: Period 1|Adverse Event|0|||
19533680|NCT01244035|41981528|FG001|Part 1: Period 1|Adverse Event|0|||
19533681|NCT01244035|41981529|FG002|Part 1: Period 1|Adverse Event|0|||
19533682|NCT01244035|41981530|FG003|Part 1: Period 1|Adverse Event|0|||
19533683|NCT01244035|41981531|FG004|Part 1: Period 1|Adverse Event|0|||
19533684|NCT01244035|41981532|FG005|Part 1: Period 1|Adverse Event|1|||
19533685|NCT01244035|41981527|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
19533686|NCT01244035|41981528|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
19533687|NCT01244035|41981529|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
19533688|NCT01244035|41981530|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
19533689|NCT01244035|41981531|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
19533690|NCT01244035|41981532|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
19533691|NCT01244035|41981527|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
19533692|NCT01244035|41981528|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
19533693|NCT01244035|41981529|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
19533694|NCT01244035|41981530|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
19533695|NCT01244035|41981531|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
19533696|NCT01244035|41981532|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
19533697|NCT01244035|41981527|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
19533698|NCT01244035|41981528|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
19533699|NCT01244035|41981529|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
19533700|NCT01244035|41981530|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
19533701|NCT01244035|41981531|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
19533702|NCT01244035|41981532|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
19533703|NCT01244035|41981527|FG000|Part 1: Period 3|Adverse Event|0|||
19533704|NCT01244035|41981528|FG001|Part 1: Period 3|Adverse Event|0|||
19453814|NCT01539291|41702888|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
19453815|NCT01539291|41702889|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
19453816|NCT01539291|41702890|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
19453817|NCT01539291|41702891|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
19453818|NCT01539291|41702888|FG000|Study GS-US-312-0116|Other|1|||
19453819|NCT01539291|41702889|FG001|Study GS-US-312-0116|Other|0|||
19453820|NCT01539291|41702890|FG002|Study GS-US-312-0116|Other|0|||
19453821|NCT01539291|41702891|FG003|Study GS-US-312-0116|Other|0|||
19453822|NCT01539291|41702888|FG000|Study GS-US-312-0117|Adverse Event|22|||
19453823|NCT01539291|41702889|FG001|Study GS-US-312-0117|Adverse Event|1|||
19533705|NCT01244035|41981529|FG002|Part 1: Period 3|Adverse Event|0|||
19533706|NCT01244035|41981530|FG003|Part 1: Period 3|Adverse Event|0|||
19533707|NCT01244035|41981531|FG004|Part 1: Period 3|Adverse Event|0|||
19453824|NCT01539291|41702890|FG002|Study GS-US-312-0117|Adverse Event|9|||
19453825|NCT01539291|41702891|FG003|Study GS-US-312-0117|Adverse Event|12|||
19453826|NCT01539291|41702888|FG000|Study GS-US-312-0117|Physician Decision|9|||
19453827|NCT01539291|41702889|FG001|Study GS-US-312-0117|Physician Decision|0|||
19453828|NCT01539291|41702890|FG002|Study GS-US-312-0117|Physician Decision|6|||
19533708|NCT01244035|41981532|FG005|Part 1: Period 3|Adverse Event|1|||
19533709|NCT01244035|41981527|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
19533710|NCT01244035|41981528|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
19533711|NCT01244035|41981529|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
19533712|NCT01244035|41981530|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
19533713|NCT01244035|41981531|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
19533714|NCT01244035|41981532|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
19533715|NCT01244035|41981527|FG000|Part 1: Period 3|Protocol Deviation|0|||
19533716|NCT01244035|41981528|FG001|Part 1: Period 3|Protocol Deviation|1|||
19533717|NCT01244035|41981529|FG002|Part 1: Period 3|Protocol Deviation|0|||
19533718|NCT01244035|41981530|FG003|Part 1: Period 3|Protocol Deviation|0|||
19533719|NCT01244035|41981531|FG004|Part 1: Period 3|Protocol Deviation|0|||
19533720|NCT01244035|41981532|FG005|Part 1: Period 3|Protocol Deviation|0|||
19533721|NCT01243762|41981568|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
19533722|NCT01243762|41981569|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
19533723|NCT01243762|41981570|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
19533724|NCT01243762|41981571|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
19533725|NCT01243762|41981572|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
19533726|NCT01243762|41981573|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
19533727|NCT01243762|41981574|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
19533728|NCT01243762|41981568|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
19533729|NCT01243762|41981569|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
19533730|NCT01243762|41981570|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
19533731|NCT01243762|41981571|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
19533732|NCT01243762|41981572|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
19533733|NCT01243762|41981573|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
19533734|NCT01243762|41981574|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
19533735|NCT01243762|41981568|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
19533736|NCT01243762|41981569|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
19533737|NCT01243762|41981570|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
19533738|NCT01243762|41981571|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
19533739|NCT01243762|41981572|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
19533740|NCT01243762|41981573|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
19533741|NCT01243762|41981574|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
19533742|NCT01243762|41981568|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533743|NCT01243762|41981569|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
19533744|NCT01243762|41981570|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533745|NCT01243762|41981571|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533746|NCT01243762|41981572|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533747|NCT01243762|41981573|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533748|NCT01243762|41981574|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
19533749|NCT01243762|41981568|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
19533750|NCT01243762|41981569|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
19533751|NCT01243762|41981570|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
19533752|NCT01243762|41981571|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
19533753|NCT01243762|41981572|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
19533754|NCT01243762|41981573|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
19533755|NCT01243762|41981574|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
19533756|NCT01243762|41981568|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
19533757|NCT01243762|41981569|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
19533758|NCT01243762|41981570|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
19453829|NCT01539291|41702891|FG003|Study GS-US-312-0117|Physician Decision|4|||
19453830|NCT01539291|41702888|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
19453831|NCT01539291|41702889|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
19453832|NCT01539291|41702890|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
19533759|NCT01243762|41981571|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
19453833|NCT01539291|41702891|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
19453834|NCT01539291|41702888|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
19453835|NCT01539291|41702889|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
19453836|NCT01539291|41702890|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
19533760|NCT01243762|41981572|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
19533761|NCT01243762|41981573|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
19533762|NCT01243762|41981574|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
19533763|NCT01243762|41981568|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
19533764|NCT01243762|41981569|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
19533765|NCT01243762|41981570|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
19533766|NCT01243762|41981571|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
19533767|NCT01243762|41981572|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
19533768|NCT01243762|41981573|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
19533769|NCT01243762|41981574|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
19533770|NCT01243762|41981568|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
19533771|NCT01243762|41981569|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
19533772|NCT01243762|41981570|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
19533773|NCT01243762|41981571|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
19533774|NCT01243762|41981572|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
19533775|NCT01243762|41981573|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
19533776|NCT01243762|41981574|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
19533777|NCT01243411|41981593|FG000|Overall Study|Withdrawal by Subject|18|||
19533778|NCT01243411|41981593|FG000|Overall Study|Lost to Follow-up|10|||
19533779|NCT01243411|41981593|FG000|Overall Study|Adverse Event|5|||
19533780|NCT01243411|41981593|FG000|Overall Study|Other|8|||
19533781|NCT01243177|41981599|FG000|Overall Study|Lack of Efficacy|47|||
19533782|NCT01243177|41981600|FG001|Overall Study|Lack of Efficacy|31|||
19533783|NCT01243177|41981599|FG000|Overall Study|Protocol Violation|11|||
19533784|NCT01243177|41981600|FG001|Overall Study|Protocol Violation|10|||
19533785|NCT01243177|41981599|FG000|Overall Study|Lost to Follow-up|15|||
19533786|NCT01243177|41981600|FG001|Overall Study|Lost to Follow-up|18|||
19533787|NCT01243177|41981599|FG000|Overall Study|Withdrawal by Subject|46|||
19533788|NCT01243177|41981600|FG001|Overall Study|Withdrawal by Subject|38|||
19533789|NCT01243177|41981599|FG000|Overall Study|AE, serious fatal|0|||
19533790|NCT01243177|41981600|FG001|Overall Study|AE, serious fatal|1|||
19533791|NCT01243177|41981599|FG000|Overall Study|SAE, non-fatal|7|||
19533792|NCT01243177|41981600|FG001|Overall Study|SAE, non-fatal|9|||
19533793|NCT01243177|41981599|FG000|Overall Study|AE, non-serious non-fatal|40|||
19533794|NCT01243177|41981600|FG001|Overall Study|AE, non-serious non-fatal|58|||
19533795|NCT01243177|41981599|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
19533796|NCT01243177|41981600|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
19533797|NCT01243177|41981599|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
19533798|NCT01243177|41981600|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
19533799|NCT01243177|41981599|FG000|Overall Study|Other Reason|11|||
19533800|NCT01243177|41981600|FG001|Overall Study|Other Reason|12|||
19533801|NCT01242748|41981608|FG000|Overall Study|Adverse Event|10|||
19533802|NCT01242748|41981609|FG001|Overall Study|Adverse Event|5|||
19533803|NCT01242748|41981608|FG000|Overall Study|Lost to Follow-up|6|||
19533804|NCT01242748|41981609|FG001|Overall Study|Lost to Follow-up|2|||
19533805|NCT01242748|41981608|FG000|Overall Study|Physician Decision|3|||
19533806|NCT01242748|41981609|FG001|Overall Study|Physician Decision|2|||
19533807|NCT01242748|41981608|FG000|Overall Study|Protocol Violation|1|||
19533808|NCT01242748|41981609|FG001|Overall Study|Protocol Violation|0|||
19533809|NCT01242748|41981608|FG000|Overall Study|Withdrawal by Subject|10|||
19533810|NCT01242748|41981609|FG001|Overall Study|Withdrawal by Subject|2|||
19533811|NCT01242748|41981608|FG000|Overall Study|Miscellaneous reasons|8|||
19533812|NCT01242748|41981609|FG001|Overall Study|Miscellaneous reasons|3|||
19533813|NCT01242514|41981618|FG000|Overall Study|e.g., project closure|1042|||
19533814|NCT01242514|41981619|FG001|Overall Study|e.g., project closure|305|||
19453837|NCT01539291|41702891|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
19453838|NCT01539291|41702888|FG000|Study GS-US-312-0117|Other|2|||
19453839|NCT01539291|41702889|FG001|Study GS-US-312-0117|Other|1|||
19453840|NCT01539291|41702890|FG002|Study GS-US-312-0117|Other|1|||
19453841|NCT01539291|41702891|FG003|Study GS-US-312-0117|Other|1|||
19453842|NCT01538199|41702914|FG000|Overall Study|Lost to Follow-up|1|||
19453843|NCT01538199|41702915|FG001|Overall Study|Lost to Follow-up|2|||
19453844|NCT01538199|41702916|FG002|Overall Study|Lost to Follow-up|1|||
19453845|NCT01538199|41702917|FG003|Overall Study|Lost to Follow-up|0|||
19453846|NCT01538199|41702914|FG000|Overall Study|participant did not have time|1|||
19453847|NCT01538199|41702915|FG001|Overall Study|participant did not have time|0|||
19453848|NCT01538199|41702916|FG002|Overall Study|participant did not have time|0|||
19453849|NCT01538199|41702917|FG003|Overall Study|participant did not have time|2|||
19533815|NCT01242514|41981620|FG002|Overall Study|e.g., project closure|171|||
19533816|NCT01242514|41981618|FG000|Overall Study|Subject decision|33|||
19533817|NCT01242514|41981619|FG001|Overall Study|Subject decision|8|||
19533818|NCT01242514|41981620|FG002|Overall Study|Subject decision|2|||
19533819|NCT01242514|41981618|FG000|Overall Study|Severe non-compliance to protocol|5|||
19533820|NCT01242514|41981619|FG001|Overall Study|Severe non-compliance to protocol|2|||
19533821|NCT01242514|41981620|FG002|Overall Study|Severe non-compliance to protocol|1|||
19533822|NCT01242514|41981618|FG000|Overall Study|Lack of therapeutic response|99|||
19453850|NCT01538199|41702914|FG000|Overall Study|Lack of Efficacy|0|||
19453851|NCT01538199|41702915|FG001|Overall Study|Lack of Efficacy|1|||
19453852|NCT01538199|41702916|FG002|Overall Study|Lack of Efficacy|0|||
19453853|NCT01538199|41702917|FG003|Overall Study|Lack of Efficacy|0|||
19453854|NCT01511445|41702936|FG000|Overall Study|Lost to Follow-up|3|||
19453855|NCT01511445|41702937|FG001|Overall Study|Lost to Follow-up|1|||
19453856|NCT01511445|41702936|FG000|Overall Study|Protocol Violation|1|||
19453857|NCT01511445|41702937|FG001|Overall Study|Protocol Violation|3|||
19453858|NCT01511445|41702936|FG000|Overall Study|Protocol Violation|1|||
19453859|NCT01511445|41702937|FG001|Overall Study|Protocol Violation|0|||
19453860|NCT01543503|41702945|FG000|Overall Study|Lost to Follow-up|32|||
19453861|NCT01543503|41702946|FG001|Overall Study|Lost to Follow-up|36|||
19453862|NCT01543503|41702945|FG000|Overall Study|Adverse Event|9|||
19453863|NCT01543503|41702946|FG001|Overall Study|Adverse Event|13|||
19453864|NCT01543503|41702945|FG000|Overall Study|Lack of Efficacy|4|||
19453865|NCT01543503|41702946|FG001|Overall Study|Lack of Efficacy|16|||
19533823|NCT01242514|41981619|FG001|Overall Study|Lack of therapeutic response|16|||
19533824|NCT01242514|41981620|FG002|Overall Study|Lack of therapeutic response|10|||
19453866|NCT01543503|41702945|FG000|Overall Study|Participant withdrew informed consent|8|||
19453867|NCT01543503|41702946|FG001|Overall Study|Participant withdrew informed consent|10|||
19453868|NCT01543503|41702945|FG000|Overall Study|Change of jobs|0|||
19453869|NCT01543503|41702946|FG001|Overall Study|Change of jobs|1|||
19453870|NCT01543503|41702945|FG000|Overall Study|Intolerance to the biologic treatment|0|||
19533825|NCT01242514|41981618|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
19533826|NCT01242514|41981619|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
19533827|NCT01242514|41981620|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
19533828|NCT01242514|41981618|FG000|Overall Study|Lost to Follow-up|14|||
19453871|NCT01543503|41702946|FG001|Overall Study|Intolerance to the biologic treatment|1|||
19453872|NCT01543503|41702945|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
19453873|NCT01543503|41702946|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
19453874|NCT01543503|41702945|FG000|Overall Study|Participant did not complete last visit|0|||
19533829|NCT01242514|41981619|FG001|Overall Study|Lost to Follow-up|5|||
19533830|NCT01242514|41981620|FG002|Overall Study|Lost to Follow-up|4|||
19533831|NCT01242514|41981618|FG000|Overall Study|Adverse Event|129|||
19533832|NCT01242514|41981619|FG001|Overall Study|Adverse Event|18|||
19533833|NCT01242514|41981620|FG002|Overall Study|Adverse Event|19|||
19533834|NCT01242085|41981631|FG000|Overall Study|Withdrawal by Subject|4|||
19533835|NCT01242085|41981632|FG001|Overall Study|Withdrawal by Subject|2|||
19533836|NCT01242085|41981633|FG002|Overall Study|Withdrawal by Subject|0|||
19533837|NCT01242085|41981631|FG000|Overall Study|medically unable to have surgery|4|||
19533838|NCT01242085|41981632|FG001|Overall Study|medically unable to have surgery|5|||
19533839|NCT01242085|41981633|FG002|Overall Study|medically unable to have surgery|0|||
19533840|NCT01241461|41981641|FG000|Overall Study|Progressive Disease|3|||
19533841|NCT01241461|41981642|FG001|Overall Study|Progressive Disease|6|||
19533842|NCT01240135|41981654|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
19533843|NCT01240135|41981655|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
19533844|NCT01240135|41981654|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
19533845|NCT01240135|41981655|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
19533846|NCT01247701|41981661|FG000|Overall Study|Death|2|||
19453875|NCT01543503|41702946|FG001|Overall Study|Participant did not complete last visit|2|||
19533847|NCT01247701|41981661|FG000|Overall Study|Relapsed|8|||
19533848|NCT01248247|41981669|FG000|Overall Study|Adverse Event|2|||
19453876|NCT01543503|41702945|FG000|Overall Study|Refused to continue treatment|7|||
19453877|NCT01543503|41702946|FG001|Overall Study|Refused to continue treatment|0|||
19533849|NCT01248247|41981670|FG001|Overall Study|Adverse Event|4|||
19533850|NCT01248247|41981671|FG002|Overall Study|Adverse Event|4|||
19533851|NCT01248247|41981672|FG003|Overall Study|Adverse Event|2|||
19533852|NCT01248247|41981669|FG000|Overall Study|Death|0|||
19533853|NCT01248247|41981670|FG001|Overall Study|Death|1|||
19533854|NCT01248247|41981671|FG002|Overall Study|Death|4|||
19533855|NCT01248247|41981672|FG003|Overall Study|Death|7|||
19533856|NCT01248247|41981669|FG000|Overall Study|Lost to Follow-up|0|||
19533857|NCT01248247|41981670|FG001|Overall Study|Lost to Follow-up|1|||
19533858|NCT01248247|41981671|FG002|Overall Study|Lost to Follow-up|1|||
19533859|NCT01248247|41981672|FG003|Overall Study|Lost to Follow-up|0|||
19533860|NCT01248247|41981669|FG000|Overall Study|Alternative treatment|0|||
19533861|NCT01248247|41981670|FG001|Overall Study|Alternative treatment|1|||
19533862|NCT01248247|41981671|FG002|Overall Study|Alternative treatment|0|||
19533863|NCT01248247|41981672|FG003|Overall Study|Alternative treatment|0|||
19533864|NCT01248247|41981669|FG000|Overall Study|Other|2|||
19533865|NCT01248247|41981670|FG001|Overall Study|Other|8|||
19533866|NCT01248247|41981671|FG002|Overall Study|Other|8|||
19533867|NCT01248247|41981672|FG003|Overall Study|Other|5|||
19533868|NCT01248247|41981669|FG000|Overall Study|Progression|18|||
19533869|NCT01248247|41981670|FG001|Overall Study|Progression|27|||
19533870|NCT01248247|41981671|FG002|Overall Study|Progression|56|||
19533871|NCT01248247|41981672|FG003|Overall Study|Progression|44|||
19533872|NCT01248247|41981669|FG000|Overall Study|Refuse further treatment|0|||
19533873|NCT01248247|41981670|FG001|Overall Study|Refuse further treatment|0|||
19533874|NCT01248247|41981671|FG002|Overall Study|Refuse further treatment|1|||
19533875|NCT01248247|41981672|FG003|Overall Study|Refuse further treatment|2|||
19533876|NCT01248247|41981669|FG000|Overall Study|Complicating disease|0|||
19533877|NCT01248247|41981670|FG001|Overall Study|Complicating disease|0|||
19533878|NCT01248247|41981671|FG002|Overall Study|Complicating disease|1|||
19533879|NCT01248247|41981672|FG003|Overall Study|Complicating disease|1|||
19533880|NCT02598583|41981684|FG000|Extension Period|Withdrawal by Subject|1|||
19533881|NCT02598583|41981685|FG001|Extension Period|Withdrawal by Subject|0|||
19533882|NCT04834726|41981722|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
19533883|NCT04834726|41981723|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
19533884|NCT04834726|41981724|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
19533885|NCT04834726|41981725|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
19533886|NCT04834726|41981726|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
19533887|NCT04834726|41981727|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
19533888|NCT04834726|41981728|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
19533889|NCT04834726|41981729|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
19533890|NCT04834726|41981730|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
19533891|NCT04732949|41981746|FG000|Overall Study|Withdrawal by Subject|23|||
19533892|NCT04732949|41981747|FG001|Overall Study|Withdrawal by Subject|27|||
19533893|NCT04732949|41981746|FG000|Overall Study|Protocol Violation|0|||
19533894|NCT04732949|41981747|FG001|Overall Study|Protocol Violation|1|||
19533895|NCT04732949|41981746|FG000|Overall Study|Non-compliance|0|||
19533896|NCT04732949|41981747|FG001|Overall Study|Non-compliance|2|||
19533897|NCT04732949|41981746|FG000|Overall Study|Physician Decision|2|||
19533898|NCT04732949|41981747|FG001|Overall Study|Physician Decision|1|||
19533899|NCT04732949|41981746|FG000|Overall Study|Serious adverse event (Fatal)|16|||
19533900|NCT04732949|41981747|FG001|Overall Study|Serious adverse event (Fatal)|18|||
19453878|NCT01543503|41702945|FG000|Overall Study|Incorrect medication received|1|||
19453879|NCT01543503|41702946|FG001|Overall Study|Incorrect medication received|0|||
19453880|NCT01543503|41702945|FG000|Overall Study|Participant moved to another city|2|||
19453881|NCT01543503|41702946|FG001|Overall Study|Participant moved to another city|0|||
19453882|NCT01543503|41702945|FG000|Overall Study|Participant will not return for visits|0|||
19453883|NCT01543503|41702946|FG001|Overall Study|Participant will not return for visits|2|||
19453884|NCT01543503|41702945|FG000|Overall Study|Participant transferred to another city|1|||
19453885|NCT01543503|41702946|FG001|Overall Study|Participant transferred to another city|0|||
19453886|NCT01543503|41702945|FG000|Overall Study|Participant moved to Scotland|1|||
19453887|NCT01543503|41702946|FG001|Overall Study|Participant moved to Scotland|0|||
19453888|NCT01543503|41702945|FG000|Overall Study|Participant decision to stop treatment|1|||
19453889|NCT01543503|41702946|FG001|Overall Study|Participant decision to stop treatment|0|||
19453890|NCT01543503|41702945|FG000|Overall Study|Investigator did not wish to participate|1|||
19533901|NCT04732949|41981746|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
19533902|NCT04732949|41981747|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
19533903|NCT04732949|41981746|FG000|Overall Study|Non-serious adverse event|1|||
19533904|NCT04732949|41981747|FG001|Overall Study|Non-serious adverse event|3|||
19533905|NCT04732949|41981746|FG000|Overall Study|Lost to Follow-up|26|||
19533906|NCT04732949|41981747|FG001|Overall Study|Lost to Follow-up|27|||
19533907|NCT04732949|41981746|FG000|Overall Study|Other|6|||
19533908|NCT04732949|41981747|FG001|Overall Study|Other|3|||
19453891|NCT01543503|41702946|FG001|Overall Study|Investigator did not wish to participate|1|||
19453892|NCT01543503|41702945|FG000|Overall Study|Participant recruited after closing date|0|||
19453893|NCT01543503|41702946|FG001|Overall Study|Participant recruited after closing date|1|||
19453894|NCT01543503|41702945|FG000|Overall Study|Site stopped participation|5|||
19453895|NCT01543503|41702946|FG001|Overall Study|Site stopped participation|1|||
19453896|NCT01543503|41702945|FG000|Overall Study|Participant did not attend a visit|1|||
19453897|NCT01543503|41702946|FG001|Overall Study|Participant did not attend a visit|0|||
19453898|NCT01543503|41702945|FG000|Overall Study|Moved to other rheumatologic site|0|||
19453899|NCT01543503|41702946|FG001|Overall Study|Moved to other rheumatologic site|1|||
19453900|NCT01543503|41702945|FG000|Overall Study|Participant consented to another study|0|||
19453901|NCT01543503|41702946|FG001|Overall Study|Participant consented to another study|2|||
19453902|NCT01543503|41702945|FG000|Overall Study|Participant went to United States|1|||
19453903|NCT01543503|41702946|FG001|Overall Study|Participant went to United States|0|||
19453904|NCT01543503|41702945|FG000|Overall Study|Screen failure|1|||
19453905|NCT01543503|41702946|FG001|Overall Study|Screen failure|0|||
19453906|NCT01511055|41702952|FG000|Overall Study|Withdrawal by Subject|6|||
19453907|NCT01537887|41702965|FG000|Period 1|Physician Decision|0|||
19453908|NCT01537887|41702966|FG001|Period 1|Physician Decision|0|||
19453909|NCT01537887|41702967|FG002|Period 1|Physician Decision|0|||
19533909|NCT04235504|41981802|FG000|Study Phase|Withdrawal by Subject|5|||
19533910|NCT04235504|41981803|FG001|Study Phase|Withdrawal by Subject|2|||
19533911|NCT04235504|41981804|FG002|Study Phase|Withdrawal by Subject|0|||
19533912|NCT04235504|41981805|FG003|Study Phase|Withdrawal by Subject|0|||
19533913|NCT04235504|41981802|FG000|Continuation Phase|Withdrawal by Subject|0|||
19533914|NCT04235504|41981803|FG001|Continuation Phase|Withdrawal by Subject|4|||
19533915|NCT04235504|41981804|FG002|Continuation Phase|Withdrawal by Subject|0|||
19533916|NCT04235504|41981805|FG003|Continuation Phase|Withdrawal by Subject|0|||
19533917|NCT04235504|41981802|FG000|Continuation Phase|Adverse Event|0|||
19533918|NCT04235504|41981803|FG001|Continuation Phase|Adverse Event|1|||
19533919|NCT04235504|41981804|FG002|Continuation Phase|Adverse Event|0|||
19533920|NCT04235504|41981805|FG003|Continuation Phase|Adverse Event|0|||
19533921|NCT04235504|41981802|FG000|Continuation Phase|Physician Decision|1|||
19533922|NCT04235504|41981803|FG001|Continuation Phase|Physician Decision|2|||
19453910|NCT01537887|41702968|FG003|Period 1|Physician Decision|0|||
19453911|NCT01537887|41702969|FG004|Period 1|Physician Decision|1|||
19453912|NCT01537887|41702970|FG005|Period 1|Physician Decision|1|||
19453913|NCT01537887|41702965|FG000|Period 1|Did not receive treatment|0|||
19453914|NCT01537887|41702966|FG001|Period 1|Did not receive treatment|0|||
19453915|NCT01537887|41702967|FG002|Period 1|Did not receive treatment|1|||
19533923|NCT04235504|41981804|FG002|Continuation Phase|Physician Decision|1|||
19533924|NCT04235504|41981805|FG003|Continuation Phase|Physician Decision|0|||
19533925|NCT04172987|41981820|FG000|Lead In Period|Adverse Event|1|||
19533926|NCT04172987|41981820|FG000|Lead In Period|Protocol Violation|1|||
19533927|NCT04172987|41981820|FG000|Period 1|Physician Decision|1|||
19533928|NCT04172987|41981820|FG000|Period 2|Adverse Event|5|||
19533929|NCT04172987|41981820|FG000|Period 2|Dosing Termination by Sponsor|4|||
19533930|NCT03705832|41981829|FG000|Overall Study|Physician Decision|0|||
19533931|NCT03705832|41981830|FG001|Overall Study|Physician Decision|1|||
19533932|NCT03705832|41981829|FG000|Overall Study|Withdrawal by Subject|1|||
19533933|NCT03705832|41981830|FG001|Overall Study|Withdrawal by Subject|0|||
19533934|NCT03447743|41981836|FG000|Overall Study|Withdrawal by Subject|2|||
19533935|NCT03447743|41981836|FG000|Overall Study|Lost to Follow-up|3|||
19533936|NCT03447743|41981836|FG000|Overall Study|Adverse Event|1|||
19533937|NCT03447743|41981836|FG000|Overall Study|Did not meet criteria to continue|1|||
19533938|NCT03433755|41981844|FG000|Overall Study|Lost to Follow-up|1|||
19533939|NCT03433755|41981845|FG001|Overall Study|Lost to Follow-up|0|||
19533940|NCT03433755|41981846|FG002|Overall Study|Lost to Follow-up|0|||
19533941|NCT03433755|41981847|FG003|Overall Study|Lost to Follow-up|0|||
19533942|NCT03433755|41981844|FG000|Overall Study|Decision by Sponsor|1|||
19533943|NCT03433755|41981845|FG001|Overall Study|Decision by Sponsor|0|||
19533944|NCT03433755|41981846|FG002|Overall Study|Decision by Sponsor|0|||
19533945|NCT03433755|41981847|FG003|Overall Study|Decision by Sponsor|0|||
19533946|NCT03406507|41981870|FG000|Extension Period|Lack of Efficacy|0|||
19533947|NCT03406507|41981871|FG001|Extension Period|Lack of Efficacy|1|||
19453916|NCT01537887|41702968|FG003|Period 1|Did not receive treatment|0|||
19453917|NCT01537887|41702969|FG004|Period 1|Did not receive treatment|0|||
19453918|NCT01537887|41702970|FG005|Period 1|Did not receive treatment|0|||
19453919|NCT01537887|41702965|FG000|Period 2|Withdrawal by Subject|0|||
19453920|NCT01537887|41702966|FG001|Period 2|Withdrawal by Subject|1|||
19453921|NCT01537887|41702967|FG002|Period 2|Withdrawal by Subject|0|||
19453922|NCT01537887|41702968|FG003|Period 2|Withdrawal by Subject|0|||
19533948|NCT03283150|41981880|FG000|Overall Study|Withdrawal by Subject|6|||
19453923|NCT01537887|41702969|FG004|Period 2|Withdrawal by Subject|0|||
19533949|NCT03283150|41981881|FG001|Overall Study|Withdrawal by Subject|0|||
19533950|NCT03283150|41981882|FG002|Overall Study|Withdrawal by Subject|0|||
19533951|NCT03218917|41981893|FG000|Overall Study|Adverse Event|3|||
19533952|NCT03218917|41981894|FG001|Overall Study|Adverse Event|3|||
19453924|NCT01537887|41702970|FG005|Period 2|Withdrawal by Subject|0|||
19453925|NCT01537887|41702965|FG000|Period 3|Adverse Event|0|||
19453926|NCT01537887|41702966|FG001|Period 3|Adverse Event|0|||
19453927|NCT01537887|41702967|FG002|Period 3|Adverse Event|1|||
19453928|NCT01537887|41702968|FG003|Period 3|Adverse Event|0|||
19453929|NCT01537887|41702969|FG004|Period 3|Adverse Event|0|||
19453930|NCT01537887|41702970|FG005|Period 3|Adverse Event|0|||
19453931|NCT01537887|41702965|FG000|Period 3|Withdrawal by Subject|0|||
19453932|NCT01537887|41702966|FG001|Period 3|Withdrawal by Subject|1|||
19533953|NCT03218917|41981895|FG002|Overall Study|Adverse Event|2|||
19533954|NCT03218917|41981893|FG000|Overall Study|Subject withdrew consent|2|||
19533955|NCT03218917|41981894|FG001|Overall Study|Subject withdrew consent|4|||
19533956|NCT03218917|41981895|FG002|Overall Study|Subject withdrew consent|10|||
19533957|NCT03218917|41981893|FG000|Overall Study|Physician Decision|0|||
19533958|NCT03218917|41981894|FG001|Overall Study|Physician Decision|1|||
19533959|NCT03218917|41981895|FG002|Overall Study|Physician Decision|1|||
19533960|NCT03218917|41981893|FG000|Overall Study|Lost to Follow-up|1|||
19533961|NCT03218917|41981894|FG001|Overall Study|Lost to Follow-up|0|||
19533962|NCT03218917|41981895|FG002|Overall Study|Lost to Follow-up|0|||
19533963|NCT03218917|41981893|FG000|Overall Study|Reason Missing|0|||
19533964|NCT03218917|41981894|FG001|Overall Study|Reason Missing|2|||
19533965|NCT03218917|41981895|FG002|Overall Study|Reason Missing|0|||
19533966|NCT03218917|41981893|FG000|Overall Study|Death|0|||
19533967|NCT03218917|41981894|FG001|Overall Study|Death|1|||
19533968|NCT03218917|41981895|FG002|Overall Study|Death|0|||
19533969|NCT03218917|41981893|FG000|Overall Study|Non-Compliance with Study Drug|0|||
19533970|NCT03218917|41981894|FG001|Overall Study|Non-Compliance with Study Drug|1|||
19533971|NCT03218917|41981895|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19533972|NCT03056040|41981906|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
19533973|NCT03056040|41981907|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
19533974|NCT03056040|41981906|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
19533975|NCT03056040|41981907|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
19533976|NCT03056040|41981906|FG000|Primary Evaluation Period|Pregnancy|0|||
19533977|NCT03056040|41981907|FG001|Primary Evaluation Period|Pregnancy|1|||
19533978|NCT03056040|41981906|FG000|Extension Period|Physician Decision|3|||
19533979|NCT03056040|41981907|FG001|Extension Period|Physician Decision|3|||
19533980|NCT03056040|41981906|FG000|Extension Period|Lost to Follow-up|0|||
19533981|NCT03056040|41981907|FG001|Extension Period|Lost to Follow-up|1|||
19533982|NCT03056040|41981906|FG000|Extension Period|Death|0|||
19533983|NCT03056040|41981907|FG001|Extension Period|Death|3|||
19533984|NCT03056040|41981906|FG000|Extension Period|Withdrawal by Subject|1|||
19533985|NCT03056040|41981907|FG001|Extension Period|Withdrawal by Subject|0|||
19533986|NCT03021499|41981918|FG000|Overall Study|Adverse Event|1|||
19533987|NCT03021499|41981919|FG001|Overall Study|Adverse Event|0|||
19533988|NCT03021499|41981918|FG000|Overall Study|Death|1|||
19533989|NCT03021499|41981919|FG001|Overall Study|Death|5|||
19533990|NCT03021499|41981918|FG000|Overall Study|Lack of Efficacy|0|||
19533991|NCT03021499|41981919|FG001|Overall Study|Lack of Efficacy|1|||
19533992|NCT03021499|41981918|FG000|Overall Study|Lost to Follow-up|1|||
19533993|NCT03021499|41981919|FG001|Overall Study|Lost to Follow-up|3|||
19533994|NCT03021499|41981918|FG000|Overall Study|Physician Decision|2|||
19533995|NCT03021499|41981919|FG001|Overall Study|Physician Decision|3|||
19533996|NCT03021499|41981918|FG000|Overall Study|Pregnancy|1|||
19533997|NCT03021499|41981919|FG001|Overall Study|Pregnancy|0|||
19533998|NCT03021499|41981918|FG000|Overall Study|Withdrawal by Subject|7|||
19533999|NCT03021499|41981919|FG001|Overall Study|Withdrawal by Subject|14|||
19534000|NCT03021499|41981918|FG000|Overall Study|Prohibited medication required|1|||
19534001|NCT03021499|41981919|FG001|Overall Study|Prohibited medication required|0|||
19534002|NCT03021499|41981918|FG000|Overall Study|Protocol non-compliance|1|||
19534003|NCT03021499|41981919|FG001|Overall Study|Protocol non-compliance|1|||
19534004|NCT03021499|41981918|FG000|Overall Study|None of the above|0|||
19534005|NCT03021499|41981919|FG001|Overall Study|None of the above|4|||
19534006|NCT03021499|41981918|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
19534007|NCT03021499|41981919|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
19534008|NCT02726581|41981948|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
19453933|NCT01537887|41702967|FG002|Period 3|Withdrawal by Subject|0|||
19453934|NCT01537887|41702968|FG003|Period 3|Withdrawal by Subject|0|||
19453935|NCT01537887|41702969|FG004|Period 3|Withdrawal by Subject|0|||
19453936|NCT01537887|41702970|FG005|Period 3|Withdrawal by Subject|0|||
19534009|NCT02726581|41981949|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
19534010|NCT02726581|41981950|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
19534011|NCT02726581|41981948|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
19534012|NCT02726581|41981949|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
19534013|NCT02726581|41981950|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
19534014|NCT02726581|41981948|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
19534015|NCT02726581|41981949|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19453937|NCT01489527|41702980|FG000|Overall Study|Pregnancy|9|||
19534016|NCT02726581|41981950|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
19534017|NCT02726581|41981948|FG000|Treatment Period|Disease progression|47|||
19534018|NCT02726581|41981949|FG001|Treatment Period|Disease progression|50|||
19534019|NCT02726581|41981950|FG002|Treatment Period|Disease progression|16|||
19534020|NCT02726581|41981948|FG000|Treatment Period|Other reasons|9|||
19534021|NCT02726581|41981949|FG001|Treatment Period|Other reasons|8|||
19534022|NCT02726581|41981950|FG002|Treatment Period|Other reasons|2|||
19534023|NCT02726581|41981948|FG000|Treatment Period|Study drug toxicity|6|||
19534024|NCT02726581|41981949|FG001|Treatment Period|Study drug toxicity|3|||
19534025|NCT02726581|41981950|FG002|Treatment Period|Study drug toxicity|2|||
19534026|NCT02726581|41981948|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
19534027|NCT02726581|41981949|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
19534028|NCT02726581|41981950|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
19534029|NCT02726581|41981948|FG000|Treatment Period|Participant withdrew consent|3|||
19534030|NCT02726581|41981949|FG001|Treatment Period|Participant withdrew consent|1|||
19534031|NCT02726581|41981950|FG002|Treatment Period|Participant withdrew consent|1|||
19534032|NCT02726581|41981948|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
19534033|NCT02726581|41981949|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
19534034|NCT02726581|41981950|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
19534035|NCT02726581|41981948|FG000|Treatment Period|Maximum clinical benefit|0|||
19534036|NCT02726581|41981949|FG001|Treatment Period|Maximum clinical benefit|2|||
19534037|NCT02726581|41981950|FG002|Treatment Period|Maximum clinical benefit|0|||
19534038|NCT02726581|41981948|FG000|Treatment Period|Death|1|||
19534039|NCT02726581|41981949|FG001|Treatment Period|Death|0|||
19534040|NCT02726581|41981950|FG002|Treatment Period|Death|0|||
19534041|NCT02726581|41981948|FG000|Treatment Period|Poor/non-compliance|1|||
19534042|NCT02726581|41981949|FG001|Treatment Period|Poor/non-compliance|0|||
19534043|NCT02726581|41981950|FG002|Treatment Period|Poor/non-compliance|0|||
19534044|NCT02726581|41981948|FG000|Treatment Period|Participant no longer meets study criteria|0|||
19453938|NCT01489527|41702981|FG001|Overall Study|Pregnancy|14|||
19453939|NCT01489527|41702980|FG000|Overall Study|Participant moved|6|||
19453940|NCT01489527|41702981|FG001|Overall Study|Participant moved|7|||
19453941|NCT01489527|41702980|FG000|Overall Study|Withdrawal by Subject|0|||
19534045|NCT02726581|41981949|FG001|Treatment Period|Participant no longer meets study criteria|1|||
19534046|NCT02726581|41981950|FG002|Treatment Period|Participant no longer meets study criteria|0|||
19534047|NCT02700048|41981960|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
19534048|NCT02700048|41981961|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
19534049|NCT02425904|41981978|FG000|Overall Study|Lost to Follow-up|1|||
19534050|NCT02425904|41981979|FG001|Overall Study|Lost to Follow-up|0|||
19453942|NCT01489527|41702981|FG001|Overall Study|Withdrawal by Subject|4|||
19453943|NCT01489527|41702980|FG000|Overall Study|Lost to Follow-up|5|||
19453944|NCT01489527|41702981|FG001|Overall Study|Lost to Follow-up|1|||
19453945|NCT01489527|41702980|FG000|Overall Study|Procedures|1|||
19453946|NCT01489527|41702981|FG001|Overall Study|Procedures|0|||
19453947|NCT01489527|41702980|FG000|Overall Study|Not compliant|1|||
19453948|NCT01489527|41702981|FG001|Overall Study|Not compliant|0|||
19453949|NCT01487577|41702994|FG000|Overall Study|Became ineligible after signing consent|1|||
19453950|NCT01536951|41703000|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453951|NCT01536951|41703001|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453952|NCT01536951|41703002|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
19453953|NCT01536951|41703003|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453954|NCT01536951|41703004|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453955|NCT01536951|41703005|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453956|NCT01536951|41703006|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453957|NCT01536951|41703007|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453958|NCT01536951|41703008|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
19453959|NCT01536951|41703000|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
19453960|NCT01536951|41703001|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
19453961|NCT01536951|41703002|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
19453962|NCT01536951|41703003|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
19453963|NCT01536951|41703004|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
19453964|NCT01536951|41703005|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
19453965|NCT01536951|41703006|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
19453966|NCT01536951|41703007|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
19453967|NCT01536951|41703008|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
19534051|NCT02425904|41981978|FG000|Overall Study|Withdrawal by Subject|2|||
19534052|NCT02425904|41981979|FG001|Overall Study|Withdrawal by Subject|0|||
19453968|NCT01536795|41703033|FG000|Overall Study|Lost to Follow-up|0|||
19453969|NCT01536795|41703034|FG001|Overall Study|Lost to Follow-up|2|||
19534053|NCT02425904|41981978|FG000|Overall Study|Death|0|||
19534054|NCT02425904|41981979|FG001|Overall Study|Death|3|||
19534055|NCT02296125|41982001|FG000|Overall Study|Withdrawal by Subject|18|||
19534056|NCT02296125|41982002|FG001|Overall Study|Withdrawal by Subject|8|||
19534057|NCT02296125|41982003|FG002|Overall Study|Withdrawal by Subject|6|||
19534058|NCT02296125|41982004|FG003|Overall Study|Withdrawal by Subject|2|||
19534059|NCT02296125|41982001|FG000|Overall Study|Adverse Event|41|||
19534060|NCT02296125|41982002|FG001|Overall Study|Adverse Event|52|||
19534061|NCT02296125|41982003|FG002|Overall Study|Adverse Event|9|||
19534062|NCT02296125|41982004|FG003|Overall Study|Adverse Event|4|||
19534063|NCT02296125|41982001|FG000|Overall Study|Severe non-compliance to protocol|0|||
19534064|NCT02296125|41982002|FG001|Overall Study|Severe non-compliance to protocol|1|||
19534065|NCT02296125|41982003|FG002|Overall Study|Severe non-compliance to protocol|0|||
19534066|NCT02296125|41982004|FG003|Overall Study|Severe non-compliance to protocol|0|||
19534067|NCT02296125|41982001|FG000|Overall Study|Condition under investigation worsened|153|||
19534068|NCT02296125|41982002|FG001|Overall Study|Condition under investigation worsened|199|||
19534069|NCT02296125|41982003|FG002|Overall Study|Condition under investigation worsened|39|||
19534070|NCT02296125|41982004|FG003|Overall Study|Condition under investigation worsened|56|||
19534071|NCT02296125|41982001|FG000|Overall Study|Any reason not specifically recorded|6|||
19534072|NCT02296125|41982002|FG001|Overall Study|Any reason not specifically recorded|4|||
19534073|NCT02296125|41982003|FG002|Overall Study|Any reason not specifically recorded|2|||
19534074|NCT02296125|41982004|FG003|Overall Study|Any reason not specifically recorded|0|||
19534075|NCT02242942|41982018|FG000|Overall Study|Death|17|||
19534076|NCT02242942|41982019|FG001|Overall Study|Death|20|||
19534077|NCT02242942|41982020|FG002|Overall Study|Death|2|||
19534078|NCT02242942|41982018|FG000|Overall Study|Physician Decision|1|||
19534079|NCT02242942|41982019|FG001|Overall Study|Physician Decision|0|||
19534080|NCT02242942|41982020|FG002|Overall Study|Physician Decision|0|||
19534081|NCT02242942|41982018|FG000|Overall Study|Withdrawal by Subject|8|||
19534082|NCT02242942|41982019|FG001|Overall Study|Withdrawal by Subject|10|||
19534083|NCT02242942|41982020|FG002|Overall Study|Withdrawal by Subject|0|||
19534084|NCT02242942|41982018|FG000|Overall Study|On-going in Study|190|||
19534085|NCT02242942|41982019|FG001|Overall Study|On-going in Study|186|||
19534086|NCT02242942|41982020|FG002|Overall Study|On-going in Study|11|||
19534087|NCT02097420|41982030|FG000|Overall Study|Death|4|||
19534088|NCT02097420|41982030|FG000|Overall Study|Device explanted|3|||
19534089|NCT02097420|41982030|FG000|Overall Study|Not reached 12-month visit|7|||
19534090|NCT01964989|41982036|FG000|Overall Study|Protocol Violation|3|||
19534091|NCT01964989|41982037|FG001|Overall Study|Protocol Violation|4|||
19534092|NCT01964989|41982036|FG000|Overall Study|Administrative Reason|103|||
19630274|NCT00785577|42079508|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
19630275|NCT00785577|42079504|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
19630276|NCT00785577|42079505|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
19630277|NCT00785577|42079506|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
19630278|NCT00785577|42079507|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
19630279|NCT00785577|42079508|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
19453970|NCT01536795|41703033|FG000|Overall Study|Lack of Efficacy|1|||
19453971|NCT01536795|41703034|FG001|Overall Study|Lack of Efficacy|0|||
19453972|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
19453973|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
19453974|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
19453975|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
19453976|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
19453977|NCT01536561|41703062|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
19453978|NCT01536405|41703080|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
19453979|NCT01536405|41703081|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
19453980|NCT01536405|41703080|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
19453981|NCT01536405|41703081|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
19453982|NCT01536405|41703080|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
19453983|NCT01536405|41703081|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
19453984|NCT01536405|41703080|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
19453985|NCT01536405|41703081|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
19453986|NCT01536405|41703080|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
19453987|NCT01536405|41703081|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
19453988|NCT01536405|41703080|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
19453989|NCT01536405|41703081|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
19453990|NCT01536405|41703080|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
19453991|NCT01536405|41703081|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
19453992|NCT01536405|41703080|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
19630280|NCT00789828|42079532|FG000|Core Period (48 Weeks)|Administrative problems|0|||
19630281|NCT00789828|42079533|FG001|Core Period (48 Weeks)|Administrative problems|1|||
19630282|NCT00789828|42079532|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
19630283|NCT00789828|42079533|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
19453993|NCT01536405|41703081|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
19453994|NCT01536405|41703080|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
19453995|NCT01536405|41703081|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
19453996|NCT01536405|41703080|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
19453997|NCT01536405|41703081|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
19453998|NCT01536405|41703080|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
19453999|NCT01536405|41703081|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
19454000|NCT01536405|41703080|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
19454001|NCT01536405|41703081|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
19454002|NCT01536405|41703080|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
19454003|NCT01536405|41703081|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
19454004|NCT01487265|41703087|FG000|Overall Study|Adverse Event|8|||
19454005|NCT01487265|41703087|FG000|Overall Study|Withdrawal by Subject|5|||
19454006|NCT01487265|41703087|FG000|Overall Study|Disease Progression|21|||
19454007|NCT01487265|41703087|FG000|Overall Study|Death|2|||
19454008|NCT01487265|41703087|FG000|Overall Study|Still on Treatment|1|||
19454009|NCT01485627|41703093|FG000|Overall Study|Patient withdrew|6|||
19454010|NCT01485627|41703094|FG001|Overall Study|Patient withdrew|5|||
19454011|NCT01485627|41703093|FG000|Overall Study|Patient died|3|||
19454012|NCT01485627|41703094|FG001|Overall Study|Patient died|1|||
19454013|NCT01485627|41703093|FG000|Overall Study|Patient lost to followup|0|||
19454014|NCT01485627|41703094|FG001|Overall Study|Patient lost to followup|1|||
19454015|NCT01485627|41703093|FG000|Overall Study|Caregiver withdrew|3|||
19454016|NCT01485627|41703094|FG001|Overall Study|Caregiver withdrew|3|||
19454017|NCT01485627|41703093|FG000|Overall Study|Caregiver lost to follow up|11|||
19454018|NCT01485627|41703094|FG001|Overall Study|Caregiver lost to follow up|12|||
19454019|NCT01485627|41703093|FG000|Overall Study|Caregiver died|1|||
19454020|NCT01485627|41703094|FG001|Overall Study|Caregiver died|0|||
19454021|NCT01485627|41703093|FG000|Overall Study|caregiver was not bereaved|42|||
19454022|NCT01485627|41703094|FG001|Overall Study|caregiver was not bereaved|35|||
19454023|NCT01508325|41703117|FG000|Overall Study|Withdrawal by Subject|8|||
19454024|NCT01508325|41703118|FG001|Overall Study|Withdrawal by Subject|9|||
19454025|NCT01508325|41703117|FG000|Overall Study|Protocol Violation|0|||
19454026|NCT01508325|41703118|FG001|Overall Study|Protocol Violation|3|||
19454027|NCT01508325|41703117|FG000|Overall Study|Physician Decision|2|||
19454028|NCT01508325|41703118|FG001|Overall Study|Physician Decision|1|||
19454029|NCT01508325|41703117|FG000|Overall Study|Adverse Event|1|||
19454030|NCT01508325|41703118|FG001|Overall Study|Adverse Event|0|||
19454031|NCT01508325|41703117|FG000|Overall Study|Lost to Follow-up|5|||
19454032|NCT01508325|41703118|FG001|Overall Study|Lost to Follow-up|6|||
19454033|NCT01508325|41703117|FG000|Overall Study|Other|2|||
19454034|NCT01508325|41703118|FG001|Overall Study|Other|2|||
19454035|NCT01508169|41703126|FG000|Overall Study|Adverse Event|1|||
19454036|NCT01508169|41703127|FG001|Overall Study|Adverse Event|0|||
19454037|NCT01508169|41703126|FG000|Overall Study|Withdrawal by Subject|1|||
19454038|NCT01508169|41703127|FG001|Overall Study|Withdrawal by Subject|0|||
19534093|NCT01964989|41982037|FG001|Overall Study|Administrative Reason|95|||
19534094|NCT01964989|41982036|FG000|Overall Study|Adverse Event|0|||
19534095|NCT01964989|41982037|FG001|Overall Study|Adverse Event|1|||
19534096|NCT01964989|41982036|FG000|Overall Study|Death|1|||
19534097|NCT01964989|41982037|FG001|Overall Study|Death|3|||
19534098|NCT01964989|41982036|FG000|Overall Study|Withdrawal by Subject|156|||
19534099|NCT01964989|41982037|FG001|Overall Study|Withdrawal by Subject|160|||
19534100|NCT01964989|41982036|FG000|Overall Study|Lost to Follow-up|254|||
19534101|NCT01964989|41982037|FG001|Overall Study|Lost to Follow-up|232|||
19534102|NCT01964989|41982036|FG000|Overall Study|Other|267|||
19534103|NCT01964989|41982037|FG001|Overall Study|Other|252|||
19534104|NCT01708941|41982069|FG000|Overall Study|Adverse Event|4|||
19534105|NCT01708941|41982070|FG001|Overall Study|Adverse Event|6|||
19711442|NCT03595618|42154545|FG000|Overall Study|Withdrawal by Subject|12|||
19454039|NCT01508169|41703126|FG000|Overall Study|Lost to Follow-up|1|||
19454040|NCT01508169|41703127|FG001|Overall Study|Lost to Follow-up|2|||
19454041|NCT01536171|41703139|FG000|Overall Study|Withdrawal by Subject|1|||
19454042|NCT01536093|41703146|FG000|Overall Study|Death|1|||
19454043|NCT01536093|41703147|FG001|Overall Study|Death|2|||
19454044|NCT01536093|41703146|FG000|Overall Study|absence of maternal colostrum|2|||
19454045|NCT01536093|41703147|FG001|Overall Study|absence of maternal colostrum|0|||
19534106|NCT01708941|41982071|FG002|Overall Study|Adverse Event|1|||
19534107|NCT01708941|41982072|FG003|Overall Study|Adverse Event|0|||
19711443|NCT03595618|42154546|FG001|Overall Study|Withdrawal by Subject|14|||
19534108|NCT01708941|41982069|FG000|Overall Study|Death|1|||
19534109|NCT01708941|41982070|FG001|Overall Study|Death|1|||
19711444|NCT03595618|42154547|FG002|Overall Study|Withdrawal by Subject|14|||
19454046|NCT01536093|41703146|FG000|Overall Study|Withdrawal by Subject|0|||
19454047|NCT01536093|41703147|FG001|Overall Study|Withdrawal by Subject|1|||
19454048|NCT01536015|41703155|FG000|Overall Study|Adverse Event|1|||
19534110|NCT01708941|41982071|FG002|Overall Study|Death|2|||
19534111|NCT01708941|41982072|FG003|Overall Study|Death|14|||
19454049|NCT01536015|41703156|FG001|Overall Study|Adverse Event|4|||
19454050|NCT01536015|41703155|FG000|Overall Study|Lost to Follow-up|0|||
19534112|NCT01708941|41982069|FG000|Overall Study|Withdrawal by Subject|1|||
19534113|NCT01708941|41982070|FG001|Overall Study|Withdrawal by Subject|0|||
19534114|NCT01708941|41982071|FG002|Overall Study|Withdrawal by Subject|3|||
19534115|NCT01708941|41982072|FG003|Overall Study|Withdrawal by Subject|4|||
19534116|NCT01708941|41982069|FG000|Overall Study|Disease progression|9|||
19534117|NCT01708941|41982070|FG001|Overall Study|Disease progression|10|||
19534118|NCT01708941|41982071|FG002|Overall Study|Disease progression|8|||
19534119|NCT01708941|41982072|FG003|Overall Study|Disease progression|0|||
19534120|NCT01708941|41982069|FG000|Overall Study|Alternative therapy|0|||
19534121|NCT01708941|41982070|FG001|Overall Study|Alternative therapy|0|||
19534122|NCT01708941|41982071|FG002|Overall Study|Alternative therapy|2|||
19534123|NCT01708941|41982072|FG003|Overall Study|Alternative therapy|0|||
19534124|NCT01708941|41982069|FG000|Overall Study|Ineligible and never started treatment|1|||
19534125|NCT01708941|41982070|FG001|Overall Study|Ineligible and never started treatment|0|||
19534126|NCT01708941|41982071|FG002|Overall Study|Ineligible and never started treatment|1|||
19534127|NCT01708941|41982072|FG003|Overall Study|Ineligible and never started treatment|0|||
19534128|NCT01708941|41982069|FG000|Overall Study|Never started treatment|2|||
19534129|NCT01708941|41982070|FG001|Overall Study|Never started treatment|1|||
19534130|NCT01708941|41982071|FG002|Overall Study|Never started treatment|0|||
19534131|NCT01708941|41982072|FG003|Overall Study|Never started treatment|0|||
19534132|NCT01708941|41982069|FG000|Overall Study|Ineligible|0|||
19534133|NCT01708941|41982070|FG001|Overall Study|Ineligible|0|||
19534134|NCT01708941|41982071|FG002|Overall Study|Ineligible|2|||
19534135|NCT01708941|41982072|FG003|Overall Study|Ineligible|0|||
19534136|NCT01575860|41982082|FG000|Overall Study|Withdrawal by Subject|1|||
19534137|NCT01575860|41982082|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
19534138|NCT01416831|41982089|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
19534139|NCT01416831|41982090|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
19534140|NCT01386385|41982101|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
19534141|NCT01386385|41982102|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534142|NCT01386385|41982103|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534143|NCT01386385|41982104|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534144|NCT01386385|41982105|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534145|NCT01386385|41982106|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534146|NCT01386385|41982107|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534147|NCT01386385|41982108|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
19534148|NCT01386385|41982101|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
19534149|NCT01386385|41982102|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534150|NCT01386385|41982103|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534151|NCT01386385|41982104|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534152|NCT01386385|41982105|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534153|NCT01386385|41982106|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534154|NCT01386385|41982107|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534155|NCT01386385|41982108|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
19534156|NCT01386385|41982101|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534157|NCT01386385|41982102|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534158|NCT01386385|41982103|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
19534159|NCT01386385|41982104|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534160|NCT01386385|41982105|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534161|NCT01386385|41982106|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534162|NCT01386385|41982107|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19534163|NCT01386385|41982108|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
19454051|NCT01536015|41703156|FG001|Overall Study|Lost to Follow-up|1|||
19454052|NCT01536015|41703155|FG000|Overall Study|Inclusion Criterion not met|2|||
19454053|NCT01536015|41703156|FG001|Overall Study|Inclusion Criterion not met|0|||
19454054|NCT01536015|41703155|FG000|Overall Study|Study closure|5|||
19454055|NCT01536015|41703156|FG001|Overall Study|Study closure|5|||
19454056|NCT01484691|41703165|FG000|Overall Study|Withdrawal by Subject|1|||
19454057|NCT01484691|41703166|FG001|Overall Study|Withdrawal by Subject|1|||
19454058|NCT01484691|41703167|FG002|Overall Study|Withdrawal by Subject|1|||
19454059|NCT01484691|41703165|FG000|Overall Study|Physician Decision|0|||
19454060|NCT01484691|41703166|FG001|Overall Study|Physician Decision|2|||
19454061|NCT01484691|41703167|FG002|Overall Study|Physician Decision|1|||
19454062|NCT01535235|41703178|FG000|Overall Study|Adverse Event|1|||
19454063|NCT01535235|41703179|FG001|Overall Study|Adverse Event|0|||
19454064|NCT01483599|41703223|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
19454065|NCT01483599|41703224|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19534164|NCT01386385|41982101|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534165|NCT01386385|41982102|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19454066|NCT01483599|41703225|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19534166|NCT01386385|41982103|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534167|NCT01386385|41982104|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534168|NCT01386385|41982105|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
19534169|NCT01386385|41982106|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534170|NCT01386385|41982107|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534171|NCT01386385|41982108|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
19534172|NCT01386385|41982101|FG000|Phase II Concurrent CRT|Adverse Event|0|||
19534173|NCT01386385|41982102|FG001|Phase II Concurrent CRT|Adverse Event|0|||
19534174|NCT01386385|41982103|FG002|Phase II Concurrent CRT|Adverse Event|0|||
19534175|NCT01386385|41982104|FG003|Phase II Concurrent CRT|Adverse Event|0|||
19534176|NCT01386385|41982105|FG004|Phase II Concurrent CRT|Adverse Event|0|||
19534177|NCT01386385|41982106|FG005|Phase II Concurrent CRT|Adverse Event|0|||
19534178|NCT01386385|41982107|FG006|Phase II Concurrent CRT|Adverse Event|3|||
19534179|NCT01386385|41982108|FG007|Phase II Concurrent CRT|Adverse Event|3|||
19534180|NCT01386385|41982101|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534181|NCT01386385|41982102|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534182|NCT01386385|41982103|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534183|NCT01386385|41982104|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534184|NCT01386385|41982105|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534185|NCT01386385|41982106|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534186|NCT01386385|41982107|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
19534187|NCT01386385|41982108|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
19534188|NCT01386385|41982101|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
19534189|NCT01386385|41982102|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
19534190|NCT01386385|41982103|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
19534191|NCT01386385|41982104|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
19534192|NCT01386385|41982105|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
19534193|NCT01386385|41982106|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
19534194|NCT01386385|41982107|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
19454067|NCT01483599|41703226|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
19454068|NCT01483599|41703227|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
19454069|NCT01483599|41703228|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
19454070|NCT01483599|41703229|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
19454071|NCT01483599|41703230|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454072|NCT01483599|41703231|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454073|NCT01483599|41703232|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454074|NCT01483599|41703233|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454075|NCT01483599|41703234|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454076|NCT01483599|41703235|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454077|NCT01483599|41703236|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
19454078|NCT01483599|41703223|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454079|NCT01483599|41703224|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
19454080|NCT01483599|41703225|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454081|NCT01483599|41703226|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
19454082|NCT01483599|41703227|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454083|NCT01483599|41703228|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454084|NCT01483599|41703229|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
19454085|NCT01483599|41703230|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454086|NCT01483599|41703231|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19534195|NCT01386385|41982108|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
19534196|NCT01386385|41982101|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534197|NCT01386385|41982102|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534198|NCT01386385|41982103|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534199|NCT01386385|41982104|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534200|NCT01386385|41982105|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534201|NCT01386385|41982106|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534202|NCT01386385|41982107|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
19534203|NCT01386385|41982108|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
19534204|NCT01386385|41982101|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
19454087|NCT01483599|41703232|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454088|NCT01483599|41703233|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454089|NCT01483599|41703234|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454090|NCT01483599|41703235|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454091|NCT01483599|41703236|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
19454092|NCT01483599|41703223|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
19454093|NCT01483599|41703224|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19630284|NCT00789828|42079532|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
19630285|NCT00789828|42079533|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
19454094|NCT01483599|41703225|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454095|NCT01483599|41703226|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454096|NCT01483599|41703227|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454097|NCT01483599|41703228|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454098|NCT01483599|41703229|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454099|NCT01483599|41703230|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454100|NCT01483599|41703231|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454101|NCT01483599|41703232|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454102|NCT01483599|41703233|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454103|NCT01483599|41703234|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454104|NCT01483599|41703235|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19454105|NCT01483599|41703236|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
19534205|NCT01386385|41982102|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
19534206|NCT01386385|41982103|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
19534207|NCT01386385|41982104|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
19534208|NCT01386385|41982105|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
19534209|NCT01386385|41982106|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
19534210|NCT01386385|41982107|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
19534211|NCT01386385|41982108|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
19534212|NCT01267955|41982129|FG000|Stage 1 (6 Months)|Death|3|||
19534213|NCT01267955|41982129|FG000|Stage 2 (6 Months)|Death|5|||
19534214|NCT01267955|41982129|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
19534215|NCT01065454|41982137|FG000|Treatment|Adverse Event|7|||
19534216|NCT01065454|41982138|FG001|Treatment|Adverse Event|4|||
19534217|NCT01065454|41982139|FG002|Treatment|Adverse Event|3|||
19534218|NCT01065454|41982140|FG003|Treatment|Adverse Event|6|||
19534219|NCT01065454|41982137|FG000|Treatment|Death|1|||
19534220|NCT01065454|41982138|FG001|Treatment|Death|0|||
19534221|NCT01065454|41982139|FG002|Treatment|Death|0|||
19534222|NCT01065454|41982140|FG003|Treatment|Death|0|||
19534223|NCT01065454|41982137|FG000|Treatment|Non-compliance|1|||
19534224|NCT01065454|41982138|FG001|Treatment|Non-compliance|0|||
19534225|NCT01065454|41982139|FG002|Treatment|Non-compliance|0|||
19534226|NCT01065454|41982140|FG003|Treatment|Non-compliance|1|||
19534227|NCT01065454|41982137|FG000|Treatment|Protocol Decision|0|||
19534228|NCT01065454|41982138|FG001|Treatment|Protocol Decision|0|||
19534229|NCT01065454|41982139|FG002|Treatment|Protocol Decision|3|||
19534230|NCT01065454|41982140|FG003|Treatment|Protocol Decision|2|||
19534231|NCT01065454|41982137|FG000|Treatment|Protocol Violation|1|||
19534232|NCT01065454|41982138|FG001|Treatment|Protocol Violation|0|||
19534233|NCT01065454|41982139|FG002|Treatment|Protocol Violation|1|||
19534234|NCT01065454|41982140|FG003|Treatment|Protocol Violation|0|||
19534235|NCT01065454|41982137|FG000|Treatment|Withdrawal by Subject|3|||
19534236|NCT01065454|41982138|FG001|Treatment|Withdrawal by Subject|1|||
19534237|NCT01065454|41982139|FG002|Treatment|Withdrawal by Subject|2|||
19534238|NCT01065454|41982140|FG003|Treatment|Withdrawal by Subject|3|||
19534239|NCT01065454|41982137|FG000|Follow up|Adverse Event|1|||
19534240|NCT01065454|41982138|FG001|Follow up|Adverse Event|0|||
19454106|NCT01483599|41703223|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
19454107|NCT01483599|41703224|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
19454108|NCT01483599|41703225|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
19454109|NCT01483599|41703226|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
19454110|NCT01483599|41703227|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
19454111|NCT01483599|41703228|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
19454112|NCT01483599|41703229|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
19454113|NCT01483599|41703230|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
19534241|NCT01065454|41982139|FG002|Follow up|Adverse Event|0|||
19534242|NCT01065454|41982140|FG003|Follow up|Adverse Event|1|||
19534243|NCT01065454|41982137|FG000|Follow up|Death|0|||
19534244|NCT01065454|41982138|FG001|Follow up|Death|1|||
19534245|NCT01065454|41982139|FG002|Follow up|Death|1|||
19534246|NCT01065454|41982140|FG003|Follow up|Death|0|||
19534247|NCT01065454|41982137|FG000|Follow up|Lost to Follow-up|0|||
19534248|NCT01065454|41982138|FG001|Follow up|Lost to Follow-up|0|||
19534249|NCT01065454|41982139|FG002|Follow up|Lost to Follow-up|0|||
19534250|NCT01065454|41982140|FG003|Follow up|Lost to Follow-up|1|||
19454114|NCT01483599|41703231|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
19454115|NCT01483599|41703232|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
19454116|NCT01483599|41703233|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
19454117|NCT01483599|41703234|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
19534251|NCT01065454|41982137|FG000|Follow up|Progressive disease|0|||
19534252|NCT01065454|41982138|FG001|Follow up|Progressive disease|0|||
19534253|NCT01065454|41982139|FG002|Follow up|Progressive disease|0|||
19534254|NCT01065454|41982140|FG003|Follow up|Progressive disease|1|||
19534255|NCT01065454|41982137|FG000|Follow up|Withdrawal by Subject|1|||
19534256|NCT01065454|41982138|FG001|Follow up|Withdrawal by Subject|1|||
19534257|NCT01065454|41982139|FG002|Follow up|Withdrawal by Subject|1|||
19454118|NCT01483599|41703235|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
19454119|NCT01483599|41703236|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
19454120|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
19454121|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
19454122|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
19454123|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
19454124|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
19454125|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
19454126|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
19454127|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
19454128|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
19454129|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
19454130|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
19534258|NCT01065454|41982140|FG003|Follow up|Withdrawal by Subject|0|||
19534259|NCT01065454|41982137|FG000|Follow up|study ongoing|37|||
19534260|NCT01065454|41982138|FG001|Follow up|study ongoing|22|||
19454131|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
19454132|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
19454133|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
19454134|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454135|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454136|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454137|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454138|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454139|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19711445|NCT03595618|42154548|FG003|Overall Study|Withdrawal by Subject|10|||
19711446|NCT03595618|42154545|FG000|Overall Study|Lost to Follow-up|6|||
19711447|NCT03595618|42154546|FG001|Overall Study|Lost to Follow-up|4|||
19711448|NCT03595618|42154547|FG002|Overall Study|Lost to Follow-up|5|||
19711449|NCT03595618|42154548|FG003|Overall Study|Lost to Follow-up|6|||
19630286|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
19630287|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
19630288|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
19630289|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
19630290|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
19454140|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454141|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
19454142|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
19534261|NCT01065454|41982139|FG002|Follow up|study ongoing|15|||
19534262|NCT01065454|41982140|FG003|Follow up|study ongoing|41|||
19630291|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
19630292|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
19630293|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
19630294|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Death|1|||
19630295|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Death|0|||
19630296|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
19630297|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
19630298|NCT00789828|42079532|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
19630299|NCT00789828|42079533|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
19711450|NCT03595618|42154545|FG000|Overall Study|Protocol Violation|2|||
19534263|NCT01064648|41982153|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
19454143|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454144|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454145|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
19454146|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
19454147|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
19454148|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454149|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454150|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454151|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454152|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454153|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454154|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454155|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454156|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
19454157|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454158|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454159|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
19454160|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
19454161|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
19454162|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454163|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454164|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454165|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454166|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454167|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454168|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454169|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454170|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
19454171|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454172|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
19454173|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454174|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
19454175|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
19454176|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454177|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454178|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454179|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454180|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454181|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454182|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454183|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454184|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
19454185|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454186|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454187|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
19454188|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
19454189|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
19454190|NCT01483599|41703223|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
19454191|NCT01483599|41703224|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
19454192|NCT01483599|41703225|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
19454193|NCT01483599|41703226|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
19454194|NCT01483599|41703227|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
19454195|NCT01483599|41703228|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
19454196|NCT01483599|41703229|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
19454197|NCT01483599|41703230|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
19454198|NCT01483599|41703231|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
19454199|NCT01483599|41703232|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
19454200|NCT01483599|41703233|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
19534264|NCT01064648|41982154|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
19534265|NCT01064648|41982155|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
19454201|NCT01483599|41703234|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
19454202|NCT01483599|41703235|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
19454203|NCT01483599|41703236|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
19454204|NCT01507545|41703329|FG000|Overall Study|Withdrawal by Subject|6|||
19534266|NCT01064648|41982156|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
19454205|NCT01507545|41703330|FG001|Overall Study|Withdrawal by Subject|2|||
19454206|NCT01507545|41703329|FG000|Overall Study|Lost to Follow-up|1|||
19454207|NCT01507545|41703330|FG001|Overall Study|Lost to Follow-up|0|||
19454208|NCT01507545|41703329|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
19454209|NCT01507545|41703330|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
19454210|NCT01507545|41703329|FG000|Overall Study|Progressive disease|60|||
19454211|NCT01507545|41703330|FG001|Overall Study|Progressive disease|27|||
19454212|NCT01507545|41703329|FG000|Overall Study|Other|6|||
19454213|NCT01507545|41703330|FG001|Overall Study|Other|4|||
19454214|NCT01482819|41703336|FG000|Overall Study|Lost to Follow-up|2|||
19454215|NCT01534533|41703348|FG000|Overall Study|Lost to Follow-up|3|||
19454216|NCT01534533|41703349|FG001|Overall Study|Lost to Follow-up|0|||
19534267|NCT01064648|41982153|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
19454217|NCT01534533|41703350|FG002|Overall Study|Lost to Follow-up|4|||
19454218|NCT01534533|41703351|FG003|Overall Study|Lost to Follow-up|3|||
19454219|NCT01534533|41703348|FG000|Overall Study|Withdrawal by Subject|5|||
19454220|NCT01534533|41703349|FG001|Overall Study|Withdrawal by Subject|3|||
19534268|NCT01064648|41982154|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
19534269|NCT01064648|41982155|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
19534270|NCT01064648|41982156|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
19534271|NCT01064648|41982153|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
19534272|NCT01064648|41982154|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
19534273|NCT01064648|41982155|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
19534274|NCT01064648|41982156|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
19534275|NCT01064648|41982153|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
19454221|NCT01534533|41703350|FG002|Overall Study|Withdrawal by Subject|4|||
19454222|NCT01534533|41703351|FG003|Overall Study|Withdrawal by Subject|1|||
19454223|NCT01506609|41703485|FG000|Overall Study|Adverse Event Related to Progression|0|||
19454224|NCT01506609|41703486|FG001|Overall Study|Adverse Event Related to Progression|0|||
19454225|NCT01506609|41703487|FG002|Overall Study|Adverse Event Related to Progression|0|||
19454226|NCT01506609|41703488|FG003|Overall Study|Adverse Event Related to Progression|3|||
19454227|NCT01506609|41703489|FG004|Overall Study|Adverse Event Related to Progression|7|||
19454228|NCT01506609|41703490|FG005|Overall Study|Adverse Event Related to Progression|3|||
19454229|NCT01506609|41703485|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
19454230|NCT01506609|41703486|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
19454231|NCT01506609|41703487|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
19454232|NCT01506609|41703488|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
19454233|NCT01506609|41703489|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
19454234|NCT01506609|41703490|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
19454235|NCT01506609|41703485|FG000|Overall Study|Withdrawal by Subject|0|||
19454236|NCT01506609|41703486|FG001|Overall Study|Withdrawal by Subject|0|||
19454237|NCT01506609|41703487|FG002|Overall Study|Withdrawal by Subject|0|||
19534276|NCT01064648|41982154|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
19534277|NCT01064648|41982155|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
19534278|NCT01064648|41982156|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
19534279|NCT01064648|41982153|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
19534280|NCT01064648|41982154|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
19534281|NCT01064648|41982155|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
19534282|NCT01064648|41982156|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
19534283|NCT01064648|41982153|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
19454238|NCT01506609|41703488|FG003|Overall Study|Withdrawal by Subject|9|||
19454239|NCT01506609|41703489|FG004|Overall Study|Withdrawal by Subject|7|||
19454240|NCT01506609|41703490|FG005|Overall Study|Withdrawal by Subject|7|||
19454241|NCT01506609|41703485|FG000|Overall Study|Lost to Follow-up|0|||
19454242|NCT01506609|41703486|FG001|Overall Study|Lost to Follow-up|0|||
19454243|NCT01506609|41703487|FG002|Overall Study|Lost to Follow-up|0|||
19454244|NCT01506609|41703488|FG003|Overall Study|Lost to Follow-up|1|||
19454245|NCT01506609|41703489|FG004|Overall Study|Lost to Follow-up|2|||
19454246|NCT01506609|41703490|FG005|Overall Study|Lost to Follow-up|0|||
19454247|NCT01506609|41703485|FG000|Overall Study|Sponsor Discontinued Study|0|||
19454248|NCT01506609|41703486|FG001|Overall Study|Sponsor Discontinued Study|0|||
19454249|NCT01506609|41703487|FG002|Overall Study|Sponsor Discontinued Study|0|||
19454250|NCT01506609|41703488|FG003|Overall Study|Sponsor Discontinued Study|2|||
19454251|NCT01506609|41703489|FG004|Overall Study|Sponsor Discontinued Study|2|||
19454252|NCT01506609|41703490|FG005|Overall Study|Sponsor Discontinued Study|0|||
19454253|NCT01506609|41703485|FG000|Overall Study|Progressive Disease per Protocol|1|||
19454254|NCT01506609|41703486|FG001|Overall Study|Progressive Disease per Protocol|0|||
19454255|NCT01506609|41703487|FG002|Overall Study|Progressive Disease per Protocol|0|||
19454256|NCT01506609|41703488|FG003|Overall Study|Progressive Disease per Protocol|64|||
19454257|NCT01506609|41703489|FG004|Overall Study|Progressive Disease per Protocol|57|||
19454258|NCT01506609|41703490|FG005|Overall Study|Progressive Disease per Protocol|74|||
19454259|NCT01506609|41703485|FG000|Overall Study|Other, Not Specified|0|||
19454260|NCT01506609|41703486|FG001|Overall Study|Other, Not Specified|0|||
19454261|NCT01506609|41703487|FG002|Overall Study|Other, Not Specified|0|||
19454262|NCT01506609|41703488|FG003|Overall Study|Other, Not Specified|10|||
19454263|NCT01506609|41703489|FG004|Overall Study|Other, Not Specified|7|||
19454264|NCT01506609|41703490|FG005|Overall Study|Other, Not Specified|3|||
19454265|NCT01506609|41703485|FG000|Overall Study|Missing / Unknown Reason|1|||
19454266|NCT01506609|41703486|FG001|Overall Study|Missing / Unknown Reason|0|||
19454267|NCT01506609|41703487|FG002|Overall Study|Missing / Unknown Reason|1|||
19454268|NCT01506609|41703488|FG003|Overall Study|Missing / Unknown Reason|4|||
19454269|NCT01506609|41703489|FG004|Overall Study|Missing / Unknown Reason|4|||
19454270|NCT01506609|41703490|FG005|Overall Study|Missing / Unknown Reason|2|||
19454271|NCT01506453|41703514|FG000|Overall Study|Withdrawal prior to treatment|0|||
19454272|NCT01506453|41703515|FG001|Overall Study|Withdrawal prior to treatment|2|||
19454273|NCT01482429|41703523|FG000|Care Usual|Protocol Violation|0|||
19454274|NCT01482429|41703524|FG001|Care Usual|Protocol Violation|172|||
19454275|NCT01482429|41703523|FG000|Care Usual|Lost to Follow-up|0|||
19454276|NCT01482429|41703524|FG001|Care Usual|Lost to Follow-up|1|||
19454277|NCT01482429|41703523|FG000|Protocol|Protocol Violation|275|||
19454278|NCT01482429|41703524|FG001|Protocol|Protocol Violation|0|||
19454279|NCT01504971|41703530|FG000|Overall Study|Physician Decision|13|||
19454280|NCT01479777|41703538|FG000|Overall Study|Physician Decision|2|||
19454281|NCT01479621|41703548|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
19454282|NCT01479621|41703549|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454283|NCT01479621|41703550|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454284|NCT01479621|41703551|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454285|NCT01479621|41703552|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454286|NCT01479621|41703553|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454287|NCT01479621|41703554|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
19454288|NCT01479621|41703548|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
19454289|NCT01479621|41703549|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19454290|NCT01479621|41703550|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19454291|NCT01479621|41703551|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19454292|NCT01479621|41703552|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19534284|NCT01064648|41982154|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
19534285|NCT01064648|41982155|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
19534286|NCT01064648|41982156|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
19534287|NCT01064648|41982153|FG000|Phase II|Adverse Event|0|||
19454293|NCT01479621|41703553|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19454294|NCT01479621|41703554|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
19454295|NCT01479621|41703548|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
19454296|NCT01479621|41703549|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19454297|NCT01479621|41703550|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19454298|NCT01479621|41703551|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19534288|NCT01064648|41982154|FG001|Phase II|Adverse Event|0|||
19534289|NCT01064648|41982155|FG002|Phase II|Adverse Event|15|||
19534290|NCT01064648|41982156|FG003|Phase II|Adverse Event|8|||
19534291|NCT01064648|41982153|FG000|Phase II|Death|0|||
19534292|NCT01064648|41982154|FG001|Phase II|Death|0|||
19534293|NCT01064648|41982155|FG002|Phase II|Death|4|||
19534294|NCT01064648|41982156|FG003|Phase II|Death|5|||
19534295|NCT01064648|41982153|FG000|Phase II|Withdrawal by Subject|0|||
19534296|NCT01064648|41982154|FG001|Phase II|Withdrawal by Subject|0|||
19534297|NCT01064648|41982155|FG002|Phase II|Withdrawal by Subject|2|||
19534298|NCT01064648|41982156|FG003|Phase II|Withdrawal by Subject|5|||
19534299|NCT01064648|41982153|FG000|Phase II|Progression|0|||
19534300|NCT01064648|41982154|FG001|Phase II|Progression|0|||
19534301|NCT01064648|41982155|FG002|Phase II|Progression|21|||
19534302|NCT01064648|41982156|FG003|Phase II|Progression|27|||
19534303|NCT01064648|41982153|FG000|Phase II|Non-protocol specified|0|||
19534304|NCT01064648|41982154|FG001|Phase II|Non-protocol specified|0|||
19534305|NCT01064648|41982155|FG002|Phase II|Non-protocol specified|5|||
19534306|NCT01064648|41982156|FG003|Phase II|Non-protocol specified|3|||
19534307|NCT01064648|41982153|FG000|Phase II|Under Review|0|||
19534308|NCT01064648|41982154|FG001|Phase II|Under Review|0|||
19534309|NCT01064648|41982155|FG002|Phase II|Under Review|2|||
19534310|NCT01064648|41982156|FG003|Phase II|Under Review|0|||
19534311|NCT00542451|41982182|FG000|Overall Study|Adverse Event|31|||
19534312|NCT00542451|41982182|FG000|Overall Study|Withdrawal by Subject|30|||
19534313|NCT00542451|41982182|FG000|Overall Study|Physician Decision|4|||
19534314|NCT00542451|41982182|FG000|Overall Study|Recurrent disease|1|||
19534315|NCT00542451|41982182|FG000|Overall Study|unknown reason|1|||
19534316|NCT00542451|41982182|FG000|Overall Study|Death|2|||
19534317|NCT00542451|41982182|FG000|Overall Study|Lost to Follow-up|10|||
19454299|NCT01479621|41703552|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19534318|NCT00382070|41982191|FG000|Overall Study|No follow up data mapped to Other|17|||
19534319|NCT00382070|41982192|FG001|Overall Study|No follow up data mapped to Other|19|||
19534320|NCT00382070|41982191|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
19534321|NCT00382070|41982192|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
19534322|NCT00382070|41982191|FG000|Overall Study|No clinical assessment|9|||
19534323|NCT00382070|41982192|FG001|Overall Study|No clinical assessment|11|||
19534324|NCT02921269|41982215|FG000|Overall Study|Did not complete DLT period|1|||
19534325|NCT04303559|41982263|FG000|Overall Study|Study closed due to poor enrollment.|1|||
19534326|NCT04152200|41982269|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
19534327|NCT04152200|41982270|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
19534328|NCT03905694|41982278|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
19534329|NCT03784820|41982284|FG000|Overall Study|Lost to Follow-up|5|||
19534330|NCT03784820|41982285|FG001|Overall Study|Lost to Follow-up|5|||
19534331|NCT03784820|41982286|FG002|Overall Study|Lost to Follow-up|3|||
19534332|NCT03784820|41982287|FG003|Overall Study|Lost to Follow-up|3|||
19534333|NCT03769675|41982295|FG000|Overall Study|Lost to Follow-up|1|||
19534334|NCT03729245|41982301|FG000|Overall Study|Lost to Follow-up|5|||
19534335|NCT03729245|41982302|FG001|Overall Study|Lost to Follow-up|6|||
19534336|NCT03729245|41982301|FG000|Overall Study|Withdrawal by Subject|16|||
19534337|NCT03729245|41982302|FG001|Overall Study|Withdrawal by Subject|19|||
19534338|NCT03729245|41982301|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
19534339|NCT03729245|41982302|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
19534340|NCT03681184|41982310|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
19534341|NCT03681184|41982311|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
19454300|NCT01479621|41703553|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19454301|NCT01479621|41703554|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
19454302|NCT01479621|41703548|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
19454303|NCT01479621|41703549|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454304|NCT01479621|41703550|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454305|NCT01479621|41703551|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454306|NCT01479621|41703552|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454307|NCT01479621|41703553|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454308|NCT01479621|41703554|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
19454309|NCT01479621|41703548|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
19454310|NCT01479621|41703549|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454311|NCT01479621|41703550|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454312|NCT01479621|41703551|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454313|NCT01479621|41703552|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454314|NCT01479621|41703553|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454315|NCT01479621|41703554|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
19454316|NCT01479621|41703548|FG000|Treatment Period|Adverse Event|0|||
19454317|NCT01479621|41703549|FG001|Treatment Period|Adverse Event|0|||
19454318|NCT01479621|41703550|FG002|Treatment Period|Adverse Event|0|||
19454319|NCT01479621|41703551|FG003|Treatment Period|Adverse Event|0|||
19454320|NCT01479621|41703552|FG004|Treatment Period|Adverse Event|1|||
19454321|NCT01479621|41703553|FG005|Treatment Period|Adverse Event|2|||
19454322|NCT01479621|41703554|FG006|Treatment Period|Adverse Event|2|||
19454323|NCT01479621|41703548|FG000|Treatment Period|Withdrawal by Subject|0|||
19454324|NCT01479621|41703549|FG001|Treatment Period|Withdrawal by Subject|4|||
19454325|NCT01479621|41703550|FG002|Treatment Period|Withdrawal by Subject|2|||
19454326|NCT01479621|41703551|FG003|Treatment Period|Withdrawal by Subject|2|||
19454327|NCT01479621|41703552|FG004|Treatment Period|Withdrawal by Subject|5|||
19454328|NCT01479621|41703553|FG005|Treatment Period|Withdrawal by Subject|5|||
19454329|NCT01479621|41703554|FG006|Treatment Period|Withdrawal by Subject|1|||
19454330|NCT01479621|41703548|FG000|Treatment Period|Physician Decision|0|||
19454331|NCT01479621|41703549|FG001|Treatment Period|Physician Decision|0|||
19454332|NCT01479621|41703550|FG002|Treatment Period|Physician Decision|0|||
19454333|NCT01479621|41703551|FG003|Treatment Period|Physician Decision|0|||
19454334|NCT01479621|41703552|FG004|Treatment Period|Physician Decision|1|||
19454335|NCT01479621|41703553|FG005|Treatment Period|Physician Decision|1|||
19454336|NCT01479621|41703554|FG006|Treatment Period|Physician Decision|0|||
19454337|NCT01479621|41703548|FG000|Treatment Period|Non-compliance to study drug|0|||
19534342|NCT03681184|41982310|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
19534343|NCT03681184|41982311|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
19711451|NCT03595618|42154546|FG001|Overall Study|Protocol Violation|0|||
19454338|NCT01479621|41703549|FG001|Treatment Period|Non-compliance to study drug|1|||
19454339|NCT01479621|41703550|FG002|Treatment Period|Non-compliance to study drug|0|||
19534344|NCT03681184|41982310|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
19534345|NCT03681184|41982311|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
19534346|NCT03311711|41982331|FG000|Overall Study|Death|1|||
19534347|NCT03311711|41982332|FG001|Overall Study|Death|0|||
19534348|NCT03311711|41982333|FG002|Overall Study|Death|0|||
19534349|NCT03311711|41982334|FG003|Overall Study|Death|0|||
19454340|NCT01479621|41703551|FG003|Treatment Period|Non-compliance to study drug|0|||
19454341|NCT01479621|41703552|FG004|Treatment Period|Non-compliance to study drug|0|||
19454342|NCT01479621|41703553|FG005|Treatment Period|Non-compliance to study drug|0|||
19454343|NCT01479621|41703554|FG006|Treatment Period|Non-compliance to study drug|1|||
19454344|NCT01479621|41703548|FG000|Treatment Period|Protocol Violation|0|||
19454345|NCT01479621|41703549|FG001|Treatment Period|Protocol Violation|9|||
19454346|NCT01479621|41703550|FG002|Treatment Period|Protocol Violation|6|||
19454347|NCT01479621|41703551|FG003|Treatment Period|Protocol Violation|5|||
19454348|NCT01479621|41703552|FG004|Treatment Period|Protocol Violation|2|||
19454349|NCT01479621|41703553|FG005|Treatment Period|Protocol Violation|10|||
19454350|NCT01479621|41703554|FG006|Treatment Period|Protocol Violation|6|||
19454351|NCT01479621|41703548|FG000|Treatment Period|Pregnancy|0|||
19454352|NCT01479621|41703549|FG001|Treatment Period|Pregnancy|0|||
19454353|NCT01479621|41703550|FG002|Treatment Period|Pregnancy|2|||
19454354|NCT01479621|41703551|FG003|Treatment Period|Pregnancy|0|||
19454355|NCT01479621|41703552|FG004|Treatment Period|Pregnancy|0|||
19454356|NCT01479621|41703553|FG005|Treatment Period|Pregnancy|0|||
19454357|NCT01479621|41703554|FG006|Treatment Period|Pregnancy|0|||
19454358|NCT01479621|41703548|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
19454359|NCT01479621|41703549|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
19454360|NCT01479621|41703550|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
19454361|NCT01479621|41703551|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
19454362|NCT01479621|41703552|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
19454363|NCT01479621|41703553|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
19454364|NCT01479621|41703554|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
19454365|NCT01479621|41703548|FG000|Treatment Period|Lost to Follow-up|0|||
19534350|NCT03311711|41982335|FG004|Overall Study|Death|0|||
19534351|NCT03311711|41982336|FG005|Overall Study|Death|0|||
19534352|NCT03311711|41982337|FG006|Overall Study|Death|1|||
19534353|NCT03311711|41982338|FG007|Overall Study|Death|0|||
19534354|NCT03311711|41982339|FG008|Overall Study|Death|1|||
19630300|NCT00790296|42079544|FG000|Overall Study|Did not meet study eligibility criteria|1|||
19630301|NCT00790296|42079545|FG001|Overall Study|Did not meet study eligibility criteria|1|||
19630302|NCT00790296|42079544|FG000|Overall Study|Adverse Event|0|||
19630303|NCT00790296|42079545|FG001|Overall Study|Adverse Event|1|||
19630304|NCT00623194|42079551|FG000|Overall Study|Lack of Efficacy|1|||
19630305|NCT00623194|42079551|FG000|Overall Study|Protocol Violation|3|||
19630306|NCT00623194|42079551|FG000|Overall Study|Unclassified|1|||
19630307|NCT00784368|42079558|FG000|Overall Study|Physician Decision|0|||
19630308|NCT00784368|42079559|FG001|Overall Study|Physician Decision|0|||
19630309|NCT00784368|42079560|FG002|Overall Study|Physician Decision|6|||
19630310|NCT00784368|42079558|FG000|Overall Study|Lack of Efficacy|2|||
19630311|NCT00784368|42079559|FG001|Overall Study|Lack of Efficacy|0|||
19630312|NCT00784368|42079560|FG002|Overall Study|Lack of Efficacy|1|||
19630313|NCT00784368|42079558|FG000|Overall Study|Adverse Event|6|||
19630314|NCT00784368|42079559|FG001|Overall Study|Adverse Event|9|||
19630315|NCT00784368|42079560|FG002|Overall Study|Adverse Event|2|||
19630316|NCT00784368|42079558|FG000|Overall Study|Diagnosis of fever|0|||
19630317|NCT00784368|42079559|FG001|Overall Study|Diagnosis of fever|0|||
19630318|NCT00784368|42079560|FG002|Overall Study|Diagnosis of fever|1|||
19630319|NCT00784368|42079558|FG000|Overall Study|Worsening of complications|0|||
19630320|NCT00784368|42079559|FG001|Overall Study|Worsening of complications|0|||
19630321|NCT00784368|42079560|FG002|Overall Study|Worsening of complications|1|||
19630322|NCT00784368|42079558|FG000|Overall Study|Worsening of symptoms|0|||
19630323|NCT00784368|42079559|FG001|Overall Study|Worsening of symptoms|1|||
19630324|NCT00784368|42079560|FG002|Overall Study|Worsening of symptoms|0|||
19630325|NCT00784368|42079558|FG000|Overall Study|Withdrawal of informed consent|0|||
19630326|NCT00784368|42079559|FG001|Overall Study|Withdrawal of informed consent|1|||
19630327|NCT00784368|42079560|FG002|Overall Study|Withdrawal of informed consent|0|||
19454366|NCT01479621|41703549|FG001|Treatment Period|Lost to Follow-up|0|||
19454367|NCT01479621|41703550|FG002|Treatment Period|Lost to Follow-up|1|||
19454368|NCT01479621|41703551|FG003|Treatment Period|Lost to Follow-up|0|||
19454369|NCT01479621|41703552|FG004|Treatment Period|Lost to Follow-up|2|||
19534355|NCT03311711|41982340|FG009|Overall Study|Death|0|||
19534356|NCT03311711|41982331|FG000|Overall Study|Death of dyad partner|0|||
19534357|NCT03311711|41982332|FG001|Overall Study|Death of dyad partner|1|||
19534358|NCT03311711|41982333|FG002|Overall Study|Death of dyad partner|0|||
19630328|NCT00622726|42079573|FG000|March, 2008 to August, 2010|Death|5|||
19630329|NCT00622726|42079574|FG001|March, 2008 to August, 2010|Death|2|||
19630330|NCT00622726|42079573|FG000|August, 2010 to April, 2013|Death|1|||
19454370|NCT01479621|41703553|FG005|Treatment Period|Lost to Follow-up|2|||
19454371|NCT01479621|41703554|FG006|Treatment Period|Lost to Follow-up|1|||
19454372|NCT01479621|41703548|FG000|Treatment Period|Met stopping criteria|0|||
19454373|NCT01479621|41703549|FG001|Treatment Period|Met stopping criteria|8|||
19454374|NCT01479621|41703550|FG002|Treatment Period|Met stopping criteria|7|||
19454375|NCT01479621|41703551|FG003|Treatment Period|Met stopping criteria|4|||
19454376|NCT01479621|41703552|FG004|Treatment Period|Met stopping criteria|9|||
19454377|NCT01479621|41703553|FG005|Treatment Period|Met stopping criteria|20|||
19454378|NCT01479621|41703554|FG006|Treatment Period|Met stopping criteria|6|||
19454379|NCT01479465|41703602|FG000|Overall Study|Disease Progression|9|||
19534359|NCT03311711|41982334|FG003|Overall Study|Death of dyad partner|0|||
19534360|NCT03311711|41982335|FG004|Overall Study|Death of dyad partner|0|||
19534361|NCT03311711|41982336|FG005|Overall Study|Death of dyad partner|0|||
19534362|NCT03311711|41982337|FG006|Overall Study|Death of dyad partner|0|||
19534363|NCT03311711|41982338|FG007|Overall Study|Death of dyad partner|1|||
19534364|NCT03311711|41982339|FG008|Overall Study|Death of dyad partner|0|||
19534365|NCT03311711|41982340|FG009|Overall Study|Death of dyad partner|1|||
19534366|NCT03311711|41982331|FG000|Overall Study|Lost to Follow-up|2|||
19534367|NCT03311711|41982332|FG001|Overall Study|Lost to Follow-up|2|||
19534368|NCT03311711|41982333|FG002|Overall Study|Lost to Follow-up|0|||
19534369|NCT03311711|41982334|FG003|Overall Study|Lost to Follow-up|0|||
19534370|NCT03311711|41982335|FG004|Overall Study|Lost to Follow-up|0|||
19534371|NCT03311711|41982336|FG005|Overall Study|Lost to Follow-up|0|||
19534372|NCT03311711|41982337|FG006|Overall Study|Lost to Follow-up|1|||
19534373|NCT03311711|41982338|FG007|Overall Study|Lost to Follow-up|1|||
19534374|NCT03311711|41982339|FG008|Overall Study|Lost to Follow-up|0|||
19534375|NCT03311711|41982340|FG009|Overall Study|Lost to Follow-up|0|||
19534376|NCT03311711|41982331|FG000|Overall Study|Withdrawal by Subject|1|||
19534377|NCT03311711|41982332|FG001|Overall Study|Withdrawal by Subject|1|||
19534378|NCT03311711|41982333|FG002|Overall Study|Withdrawal by Subject|0|||
19534379|NCT03311711|41982334|FG003|Overall Study|Withdrawal by Subject|0|||
19534380|NCT03311711|41982335|FG004|Overall Study|Withdrawal by Subject|0|||
19534381|NCT03311711|41982336|FG005|Overall Study|Withdrawal by Subject|0|||
19534382|NCT03311711|41982337|FG006|Overall Study|Withdrawal by Subject|3|||
19534383|NCT03311711|41982338|FG007|Overall Study|Withdrawal by Subject|3|||
19534384|NCT03311711|41982339|FG008|Overall Study|Withdrawal by Subject|0|||
19534385|NCT03311711|41982340|FG009|Overall Study|Withdrawal by Subject|0|||
19534386|NCT03270891|41982370|FG000|Overall Study|Lost to Follow-up|3|||
19534387|NCT03270891|41982371|FG001|Overall Study|Lost to Follow-up|6|||
19534388|NCT03270891|41982372|FG002|Overall Study|Lost to Follow-up|0|||
19534389|NCT03270891|41982370|FG000|Overall Study|Withdrawal by Subject|1|||
19454380|NCT01479465|41703603|FG001|Overall Study|Disease Progression|61|||
19534390|NCT03270891|41982371|FG001|Overall Study|Withdrawal by Subject|0|||
19534391|NCT03270891|41982372|FG002|Overall Study|Withdrawal by Subject|0|||
19534392|NCT03270891|41982370|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
19534393|NCT03270891|41982371|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
19534394|NCT03270891|41982372|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
19534395|NCT02992743|41982384|FG000|Overall Study|Withdrawal by Subject|1|||
19454381|NCT01479465|41703604|FG002|Overall Study|Disease Progression|65|||
19454382|NCT01479465|41703605|FG003|Overall Study|Disease Progression|70|||
19534396|NCT02992743|41982385|FG001|Overall Study|Withdrawal by Subject|1|||
19534397|NCT02992743|41982384|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
19534398|NCT02992743|41982385|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
19534399|NCT02992743|41982384|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
19534400|NCT02992743|41982385|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
19534401|NCT02992743|41982384|FG000|Overall Study|No measurable disease|1|||
19534402|NCT02992743|41982385|FG001|Overall Study|No measurable disease|0|||
19534403|NCT02992743|41982384|FG000|Overall Study|Lost to Follow-up|0|||
19534404|NCT02992743|41982385|FG001|Overall Study|Lost to Follow-up|1|||
19534405|NCT02853344|41982393|FG000|Overall Study|Lost to Follow-up|1|||
19534406|NCT02853344|41982394|FG001|Overall Study|Lost to Follow-up|1|||
19534407|NCT02853344|41982393|FG000|Overall Study|Withdrawal by Subject|2|||
19534408|NCT02853344|41982394|FG001|Overall Study|Withdrawal by Subject|4|||
19534409|NCT02853344|41982393|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
19534410|NCT02853344|41982394|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
19534411|NCT02853344|41982393|FG000|Overall Study|Death|70|||
19534412|NCT02853344|41982394|FG001|Overall Study|Death|112|||
19534413|NCT02739620|41982405|FG000|Overall Study|Lost to Follow-up|3|||
19454383|NCT01479465|41703602|FG000|Overall Study|Study Discontinued by Sponsor|0|||
19454384|NCT01479465|41703603|FG001|Overall Study|Study Discontinued by Sponsor|7|||
19454385|NCT01479465|41703604|FG002|Overall Study|Study Discontinued by Sponsor|5|||
19534414|NCT02739620|41982406|FG001|Overall Study|Lost to Follow-up|1|||
19534415|NCT02739620|41982405|FG000|Overall Study|Adverse Event|0|||
19534416|NCT02739620|41982406|FG001|Overall Study|Adverse Event|1|||
19454386|NCT01479465|41703605|FG003|Overall Study|Study Discontinued by Sponsor|3|||
19534417|NCT02675426|41982415|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
19534418|NCT02675426|41982416|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
19534419|NCT02675426|41982417|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
19534420|NCT02675426|41982418|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
19534421|NCT02675426|41982415|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
19534422|NCT02675426|41982416|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
19534423|NCT02675426|41982417|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
19534424|NCT02675426|41982418|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
19534425|NCT02675426|41982415|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
19534426|NCT02675426|41982416|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
19534427|NCT02675426|41982417|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
19534428|NCT02675426|41982418|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
19534429|NCT02675426|41982415|FG000|Period 1: Week 1 to Week 12|Other|2|||
19534430|NCT02675426|41982416|FG001|Period 1: Week 1 to Week 12|Other|1|||
19454387|NCT01479465|41703602|FG000|Overall Study|Adverse Event|0|||
19454388|NCT01479465|41703603|FG001|Overall Study|Adverse Event|3|||
19534431|NCT02675426|41982417|FG002|Period 1: Week 1 to Week 12|Other|0|||
19534432|NCT02675426|41982418|FG003|Period 1: Week 1 to Week 12|Other|2|||
19534433|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
19534434|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
19534435|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
19534436|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
19454389|NCT01479465|41703604|FG002|Overall Study|Adverse Event|6|||
19454390|NCT01479465|41703605|FG003|Overall Study|Adverse Event|4|||
19454391|NCT01479465|41703602|FG000|Overall Study|Investigator Discretion|1|||
19454392|NCT01479465|41703603|FG001|Overall Study|Investigator Discretion|4|||
19454393|NCT01479465|41703604|FG002|Overall Study|Investigator Discretion|2|||
19454394|NCT01479465|41703605|FG003|Overall Study|Investigator Discretion|4|||
19454395|NCT01479465|41703602|FG000|Overall Study|Subject Request|1|||
19534437|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
19534438|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
19454396|NCT01479465|41703603|FG001|Overall Study|Subject Request|3|||
19454397|NCT01479465|41703604|FG002|Overall Study|Subject Request|4|||
19454398|NCT01479465|41703605|FG003|Overall Study|Subject Request|2|||
19454399|NCT01479465|41703602|FG000|Overall Study|Subject Withdrew Consent|0|||
19454400|NCT01479465|41703603|FG001|Overall Study|Subject Withdrew Consent|5|||
19454401|NCT01479465|41703604|FG002|Overall Study|Subject Withdrew Consent|2|||
19454402|NCT01479465|41703605|FG003|Overall Study|Subject Withdrew Consent|1|||
19454403|NCT01479465|41703602|FG000|Overall Study|Protocol Violation|0|||
19454404|NCT01479465|41703603|FG001|Overall Study|Protocol Violation|1|||
19454405|NCT01479465|41703604|FG002|Overall Study|Protocol Violation|1|||
19454406|NCT01479465|41703605|FG003|Overall Study|Protocol Violation|0|||
19454407|NCT01479465|41703602|FG000|Overall Study|Death|0|||
19534439|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
19534440|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
19534441|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
19534442|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
19534443|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
19534444|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
19534445|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
19534446|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
19534447|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
19534448|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
19534449|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
19534450|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
19534451|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
19534452|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
19534453|NCT02675426|41982415|FG000|Period 2: Week 12 to Week 260|Other|8|||
19534454|NCT02675426|41982416|FG001|Period 2: Week 12 to Week 260|Other|12|||
19534455|NCT02675426|41982417|FG002|Period 2: Week 12 to Week 260|Other|23|||
19534456|NCT02675426|41982418|FG003|Period 2: Week 12 to Week 260|Other|15|||
19534457|NCT02513394|41982444|FG000|Overall Study|Withdrawal by Subject|11|||
19534458|NCT02513394|41982445|FG001|Overall Study|Withdrawal by Subject|23|||
19534459|NCT02513394|41982444|FG000|Overall Study|Ineligible|1|||
19534460|NCT02513394|41982445|FG001|Overall Study|Ineligible|0|||
19534461|NCT02152982|41982474|FG000|Overall Study|Ineligible|4|||
19534462|NCT02152982|41982475|FG001|Overall Study|Ineligible|4|||
19534463|NCT02152982|41982474|FG000|Overall Study|Did not start treatment|12|||
19534464|NCT02152982|41982475|FG001|Overall Study|Did not start treatment|6|||
19454408|NCT01479465|41703603|FG001|Overall Study|Death|0|||
19454409|NCT01479465|41703604|FG002|Overall Study|Death|0|||
19454410|NCT01479465|41703605|FG003|Overall Study|Death|1|||
19454411|NCT01479465|41703602|FG000|Overall Study|Lost to Follow-up|0|||
19534465|NCT02112916|41982491|FG000|Overall Study|Adverse Event|6|||
19534466|NCT02112916|41982492|FG001|Overall Study|Adverse Event|9|||
19534467|NCT02112916|41982493|FG002|Overall Study|Adverse Event|3|||
19534468|NCT02112916|41982494|FG003|Overall Study|Adverse Event|2|||
19534469|NCT02112916|41982491|FG000|Overall Study|Death|9|||
19534470|NCT02112916|41982492|FG001|Overall Study|Death|9|||
19534471|NCT02112916|41982493|FG002|Overall Study|Death|3|||
19534472|NCT02112916|41982494|FG003|Overall Study|Death|4|||
19534473|NCT02112916|41982491|FG000|Overall Study|Lost to Follow-up|1|||
19534474|NCT02112916|41982492|FG001|Overall Study|Lost to Follow-up|0|||
19534475|NCT02112916|41982493|FG002|Overall Study|Lost to Follow-up|0|||
19534476|NCT02112916|41982494|FG003|Overall Study|Lost to Follow-up|0|||
19534477|NCT02112916|41982491|FG000|Overall Study|Physician Decision|94|||
19534478|NCT02112916|41982492|FG001|Overall Study|Physician Decision|72|||
19534479|NCT02112916|41982493|FG002|Overall Study|Physician Decision|24|||
19534480|NCT02112916|41982494|FG003|Overall Study|Physician Decision|15|||
19534481|NCT02112916|41982491|FG000|Overall Study|Withdrawal by Subject|5|||
19534482|NCT02112916|41982492|FG001|Overall Study|Withdrawal by Subject|3|||
19534483|NCT02112916|41982493|FG002|Overall Study|Withdrawal by Subject|1|||
19534484|NCT02112916|41982494|FG003|Overall Study|Withdrawal by Subject|1|||
19534485|NCT02112916|41982491|FG000|Overall Study|Ineligible|4|||
19534486|NCT02112916|41982492|FG001|Overall Study|Ineligible|8|||
19534487|NCT02112916|41982493|FG002|Overall Study|Ineligible|3|||
19534488|NCT02112916|41982494|FG003|Overall Study|Ineligible|8|||
19534489|NCT02112916|41982491|FG000|Overall Study|Inevaluable|6|||
19534490|NCT02112916|41982492|FG001|Overall Study|Inevaluable|4|||
19630331|NCT00622726|42079574|FG001|August, 2010 to April, 2013|Death|5|||
19630332|NCT00623428|42079586|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
19630333|NCT00623428|42079587|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
19630334|NCT00623428|42079586|FG000|Treatment Period|Death|0|||
19630335|NCT00623428|42079587|FG001|Treatment Period|Death|1|||
19630336|NCT00623428|42079586|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
19630337|NCT00623428|42079587|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
19630338|NCT00623428|42079586|FG000|Treatment Period|Insufficient therapeutic response|0|||
19630339|NCT00623428|42079587|FG001|Treatment Period|Insufficient therapeutic response|2|||
19630340|NCT00623428|42079586|FG000|Treatment Period|Other|0|||
19630341|NCT00623428|42079587|FG001|Treatment Period|Other|1|||
19630342|NCT00623428|42079586|FG000|Treatment Period|Withdrawal by Subject|0|||
19630343|NCT00623428|42079587|FG001|Treatment Period|Withdrawal by Subject|1|||
19630344|NCT00623428|42079586|FG000|Follow-up Period|Relapse post-treatment|11|||
19630345|NCT00623428|42079587|FG001|Follow-up Period|Relapse post-treatment|3|||
19630346|NCT00623428|42079586|FG000|Follow-up Period|Failure to return|10|||
19630347|NCT00623428|42079587|FG001|Follow-up Period|Failure to return|2|||
19630348|NCT00623428|42079586|FG000|Follow-up Period|Patient withdrew consent|5|||
19630349|NCT00623428|42079587|FG001|Follow-up Period|Patient withdrew consent|4|||
19630350|NCT00623428|42079586|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
19454412|NCT01479465|41703603|FG001|Overall Study|Lost to Follow-up|0|||
19454413|NCT01479465|41703604|FG002|Overall Study|Lost to Follow-up|1|||
19454414|NCT01479465|41703605|FG003|Overall Study|Lost to Follow-up|0|||
19454415|NCT01503021|41703669|FG000|Overall Study|Adverse Event|7|||
19454416|NCT01503021|41703670|FG001|Overall Study|Adverse Event|6|||
19454417|NCT01503021|41703669|FG000|Overall Study|Death|0|||
19454418|NCT01503021|41703670|FG001|Overall Study|Death|2|||
19454419|NCT01503021|41703669|FG000|Overall Study|Lost to Follow-up|2|||
19454420|NCT01503021|41703670|FG001|Overall Study|Lost to Follow-up|0|||
19454421|NCT01503021|41703669|FG000|Overall Study|Physician Decision|3|||
19454422|NCT01503021|41703670|FG001|Overall Study|Physician Decision|0|||
19454423|NCT01503021|41703669|FG000|Overall Study|Protocol Violation|1|||
19454424|NCT01503021|41703670|FG001|Overall Study|Protocol Violation|3|||
19454425|NCT01503021|41703669|FG000|Overall Study|Withdrawal by Subject|9|||
19454426|NCT01503021|41703670|FG001|Overall Study|Withdrawal by Subject|8|||
19454427|NCT01503021|41703669|FG000|Overall Study|Moved, received transplant, etc.|5|||
19454428|NCT01503021|41703670|FG001|Overall Study|Moved, received transplant, etc.|7|||
19454429|NCT01531725|41703681|FG000|Overall Study|Protocol Violation|5|||
19454430|NCT01478373|41703685|FG000|Treatment Phase|Protocol Violation|1|||
19454431|NCT01478373|41703685|FG000|Survival Phase|Adverse Event|8|||
19454432|NCT01478373|41703685|FG000|Survival Phase|Protocol Violation|1|||
19454433|NCT01478373|41703685|FG000|Survival Phase|crossover to another study|2|||
19454434|NCT01478373|41703685|FG000|Survival Phase|Progressive Disease|27|||
19534491|NCT02112916|41982493|FG002|Overall Study|Inevaluable|5|||
19711452|NCT03595618|42154547|FG002|Overall Study|Protocol Violation|6|||
19454435|NCT01502709|41703691|FG000|Overall Study|Lost to Follow-up|4|||
19454436|NCT01502709|41703692|FG001|Overall Study|Lost to Follow-up|0|||
19454437|NCT01477749|41703699|FG000|Overall Study|Physician Decision|4|||
19454438|NCT01502631|41703729|FG000|Overall Study|Adverse Event|5|||
19534492|NCT02112916|41982494|FG003|Overall Study|Inevaluable|5|||
19534493|NCT02112916|41982491|FG000|Overall Study|Refusal of further protocol therapy|19|||
19534494|NCT02112916|41982492|FG001|Overall Study|Refusal of further protocol therapy|16|||
19534495|NCT02112916|41982493|FG002|Overall Study|Refusal of further protocol therapy|1|||
19534496|NCT02112916|41982494|FG003|Overall Study|Refusal of further protocol therapy|7|||
19534497|NCT02112916|41982491|FG000|Overall Study|Development of SMN|1|||
19534498|NCT02112916|41982492|FG001|Overall Study|Development of SMN|0|||
19534499|NCT02112916|41982493|FG002|Overall Study|Development of SMN|0|||
19534500|NCT02112916|41982494|FG003|Overall Study|Development of SMN|1|||
19534501|NCT02112916|41982491|FG000|Overall Study|Relapse/Progression|10|||
19534502|NCT02112916|41982492|FG001|Overall Study|Relapse/Progression|18|||
19534503|NCT02112916|41982493|FG002|Overall Study|Relapse/Progression|15|||
19534504|NCT02112916|41982494|FG003|Overall Study|Relapse/Progression|2|||
19534505|NCT02112916|41982491|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
19534506|NCT02112916|41982492|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
19534507|NCT02112916|41982493|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
19534508|NCT02112916|41982494|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
19534509|NCT02112916|41982491|FG000|Overall Study|Still on Therapy|44|||
19534510|NCT02112916|41982492|FG001|Overall Study|Still on Therapy|47|||
19534511|NCT02112916|41982493|FG002|Overall Study|Still on Therapy|3|||
19534512|NCT02112916|41982494|FG003|Overall Study|Still on Therapy|2|||
19534513|NCT02112916|41982491|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
19534514|NCT02112916|41982492|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
19534515|NCT02112916|41982493|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
19534516|NCT02112916|41982494|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
19534517|NCT02112916|41982491|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
19534518|NCT02112916|41982492|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
19534519|NCT02112916|41982493|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
19534520|NCT02112916|41982494|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
19534521|NCT02091960|41982509|FG000|Overall Study|Death|7|||
19534522|NCT02091960|41982509|FG000|Overall Study|Withdrawal by Subject|1|||
19534523|NCT02091960|41982509|FG000|Overall Study|Miscellaneous Reasons|31|||
19534524|NCT02091960|41982509|FG000|Overall Study|On Study at Data Cut-off|12|||
19534525|NCT02060721|41982513|FG000|Overall Study|Lost to Follow-up|1|||
19534526|NCT02060721|41982513|FG000|Overall Study|Physician Decision|2|||
19534527|NCT02060721|41982513|FG000|Overall Study|Death|14|||
19534528|NCT02060721|41982513|FG000|Overall Study|Withdrawal by Subject|2|||
19534529|NCT02060721|41982513|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
19534530|NCT01527149|41982517|FG000|Overall Study|Death|2|||
19534531|NCT01359956|41982525|FG000|Overall Study|Death|58|||
19534532|NCT01359956|41982526|FG001|Overall Study|Death|60|||
19534533|NCT01359956|41982527|FG002|Overall Study|Death|66|||
19534534|NCT01359956|41982528|FG003|Overall Study|Death|57|||
19534535|NCT01359956|41982525|FG000|Overall Study|Lost to Follow-up|3|||
19534536|NCT01359956|41982526|FG001|Overall Study|Lost to Follow-up|4|||
19534537|NCT01359956|41982527|FG002|Overall Study|Lost to Follow-up|1|||
19454439|NCT01502631|41703730|FG001|Overall Study|Adverse Event|8|||
19454440|NCT01502631|41703729|FG000|Overall Study|Lost to Follow-up|2|||
19454441|NCT01502631|41703730|FG001|Overall Study|Lost to Follow-up|2|||
19454442|NCT01502631|41703729|FG000|Overall Study|Participant withdrew consent|2|||
19454443|NCT01502631|41703730|FG001|Overall Study|Participant withdrew consent|4|||
19454444|NCT01502631|41703729|FG000|Overall Study|Participant non-compliant|1|||
19454445|NCT01502631|41703730|FG001|Overall Study|Participant non-compliant|0|||
19454446|NCT01502631|41703729|FG000|Overall Study|Investigator's decision|0|||
19454447|NCT01502631|41703730|FG001|Overall Study|Investigator's decision|1|||
19454448|NCT01502631|41703729|FG000|Overall Study|Other|10|||
19534538|NCT01359956|41982528|FG003|Overall Study|Lost to Follow-up|1|||
19534539|NCT01306045|41982541|FG000|Met General Eligibility Criteria|Screen failures|193|||
19534540|NCT01306045|41982542|FG001|Met General Eligibility Criteria|Screen failures|11|||
19534541|NCT01306045|41982543|FG002|Met General Eligibility Criteria|Screen failures|8|||
19534542|NCT00324805|41982599|FG000|Overall Study|Adverse Event|62|||
19534543|NCT00324805|41982600|FG001|Overall Study|Adverse Event|203|||
19534544|NCT00324805|41982599|FG000|Overall Study|Progression|7|||
19534545|NCT00324805|41982600|FG001|Overall Study|Progression|35|||
19534546|NCT00324805|41982599|FG000|Overall Study|Withdrawal by Subject|51|||
19534547|NCT00324805|41982600|FG001|Overall Study|Withdrawal by Subject|174|||
19534548|NCT00324805|41982599|FG000|Overall Study|Death|6|||
19534549|NCT00324805|41982600|FG001|Overall Study|Death|9|||
19534550|NCT00324805|41982599|FG000|Overall Study|Alternative therapy|4|||
19454449|NCT01502631|41703730|FG001|Overall Study|Other|5|||
19454450|NCT01475721|41703790|FG000|Overall Study|Death|3|||
19454451|NCT01475721|41703791|FG001|Overall Study|Death|6|||
19454452|NCT01475721|41703790|FG000|Overall Study|Withdrawal by Subject|8|||
19454453|NCT01475721|41703791|FG001|Overall Study|Withdrawal by Subject|8|||
19454454|NCT01530087|41703815|FG000|Overall Study|Physician Decision|2|||
19454455|NCT01475487|41703833|FG000|Overall Study|had to leave early for personal reasons|2|||
19630351|NCT00623428|42079587|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
19454456|NCT01475487|41703834|FG001|Overall Study|had to leave early for personal reasons|1|||
19534551|NCT00324805|41982600|FG001|Overall Study|Alternative therapy|8|||
19454457|NCT01475331|41703842|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
19454458|NCT01475331|41703843|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
19454459|NCT01475331|41703842|FG000|Overall Study|excessive main duct communication|1|||
19454460|NCT01475331|41703843|FG001|Overall Study|excessive main duct communication|1|||
19454461|NCT01475331|41703842|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
19454462|NCT01475331|41703843|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
19454463|NCT01475331|41703842|FG000|Overall Study|Sign of malignancy during the procedure|2|||
19454464|NCT01475331|41703843|FG001|Overall Study|Sign of malignancy during the procedure|0|||
19454465|NCT01475331|41703842|FG000|Overall Study|cyst found to be prohibitively small|0|||
19454466|NCT01475331|41703843|FG001|Overall Study|cyst found to be prohibitively small|1|||
19454467|NCT01500213|41703851|FG000|Overall Study|Adverse Event|35|||
19454468|NCT01500213|41703852|FG001|Overall Study|Adverse Event|35|||
19454469|NCT01500213|41703851|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
19454470|NCT01500213|41703852|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
19454471|NCT01500213|41703851|FG000|Overall Study|Withdrawal by Subject|28|||
19454472|NCT01500213|41703852|FG001|Overall Study|Withdrawal by Subject|37|||
19454473|NCT01500213|41703851|FG000|Overall Study|Death|7|||
19454474|NCT01500213|41703852|FG001|Overall Study|Death|3|||
19454475|NCT01500213|41703851|FG000|Overall Study|Disease Progression|13|||
19454476|NCT01500213|41703852|FG001|Overall Study|Disease Progression|21|||
19454477|NCT01500213|41703851|FG000|Overall Study|Protocol Violation|19|||
19454478|NCT01500213|41703852|FG001|Overall Study|Protocol Violation|19|||
19454479|NCT01500213|41703851|FG000|Overall Study|Physician Decision|12|||
19454480|NCT01500213|41703852|FG001|Overall Study|Physician Decision|10|||
19454481|NCT01500213|41703851|FG000|Overall Study|Lack of Efficacy|9|||
19454482|NCT01500213|41703852|FG001|Overall Study|Lack of Efficacy|7|||
19454483|NCT01500213|41703851|FG000|Overall Study|Lost to Follow-up|3|||
19454484|NCT01500213|41703852|FG001|Overall Study|Lost to Follow-up|6|||
19454485|NCT01500213|41703851|FG000|Overall Study|Other Reasons|7|||
19454486|NCT01500213|41703852|FG001|Overall Study|Other Reasons|5|||
19454487|NCT01475253|41703882|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
19454488|NCT01475253|41703883|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
19454489|NCT01475253|41703884|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
19454490|NCT01475253|41703885|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
19454491|NCT01475253|41703882|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
19534552|NCT00324805|41982599|FG000|Overall Study|Other complicating disease|1|||
19534553|NCT00324805|41982600|FG001|Overall Study|Other complicating disease|9|||
19454492|NCT01475253|41703883|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
19454493|NCT01475253|41703884|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
19454494|NCT01475253|41703885|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
19534554|NCT00324805|41982599|FG000|Overall Study|Other reasons|7|||
19534555|NCT00324805|41982600|FG001|Overall Study|Other reasons|26|||
19534556|NCT00324805|41982599|FG000|Overall Study|Other|0|||
19534557|NCT00324805|41982600|FG001|Overall Study|Other|2|||
19534558|NCT00324805|41982599|FG000|Overall Study|Did not start therapy|12|||
19534559|NCT00324805|41982600|FG001|Overall Study|Did not start therapy|17|||
19534560|NCT01356940|41982633|FG000|First Intervention (28 Days)|Adverse Event|1|||
19534561|NCT01356940|41982634|FG001|First Intervention (28 Days)|Adverse Event|0|||
19630352|NCT00623428|42079586|FG000|Follow-up Period|Did not cooperate|0|||
19630353|NCT00623428|42079587|FG001|Follow-up Period|Did not cooperate|3|||
19630354|NCT00623428|42079586|FG000|Follow-up Period|Reason not specified|1|||
19630355|NCT00623428|42079587|FG001|Follow-up Period|Reason not specified|1|||
19630356|NCT00623428|42079586|FG000|Follow-up Period|Death|0|||
19630357|NCT00623428|42079587|FG001|Follow-up Period|Death|1|||
19630358|NCT00784134|42079595|FG000|Overall Study|Lost to Follow-up|3|||
19630359|NCT00784134|42079596|FG001|Overall Study|Lost to Follow-up|6|||
19630360|NCT00776100|42079604|FG000|Overall Study|Disease Progression|1|||
19630361|NCT00776100|42079605|FG001|Overall Study|Disease Progression|0|||
19630362|NCT00783432|42079613|FG000|Overall Study|Adverse Event|22|||
19630363|NCT00783432|42079614|FG001|Overall Study|Adverse Event|17|||
19630364|NCT00783432|42079613|FG000|Overall Study|Lack of Efficacy|20|||
19630365|NCT00783432|42079614|FG001|Overall Study|Lack of Efficacy|21|||
19630366|NCT00783432|42079613|FG000|Overall Study|Lost to Follow-up|11|||
19630367|NCT00783432|42079614|FG001|Overall Study|Lost to Follow-up|6|||
19630368|NCT00783432|42079613|FG000|Overall Study|Withdrawal by Subject|23|||
19534562|NCT01356940|41982633|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
19534563|NCT01356940|41982634|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
19534564|NCT01330030|41982653|FG000|Overall Study|Lost to Follow-up|16|||
19534565|NCT01330030|41982654|FG001|Overall Study|Lost to Follow-up|17|||
19630369|NCT00783432|42079614|FG001|Overall Study|Withdrawal by Subject|20|||
19630370|NCT00783432|42079613|FG000|Overall Study|subject moved|3|||
19630371|NCT00783432|42079614|FG001|Overall Study|subject moved|5|||
19454495|NCT01500135|41703943|FG000|Overall Study|Withdrawal of Consent|4|||
19534566|NCT00477295|41982774|FG000|Overall Study|Adverse Event|31|||
19534567|NCT00477295|41982775|FG001|Overall Study|Adverse Event|35|||
19630372|NCT00783432|42079613|FG000|Overall Study|Protocol Violation|6|||
19454496|NCT01500135|41703944|FG001|Overall Study|Withdrawal of Consent|0|||
19454497|NCT01500135|41703943|FG000|Overall Study|Lost to Follow-up|6|||
19454498|NCT01500135|41703944|FG001|Overall Study|Lost to Follow-up|4|||
19454499|NCT01500135|41703943|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
19630373|NCT00783432|42079614|FG001|Overall Study|Protocol Violation|9|||
19630374|NCT00783198|42079623|FG000|Overall Study|Adverse Event|15|||
19630375|NCT00783198|42079624|FG001|Overall Study|Adverse Event|19|||
19630376|NCT00783198|42079625|FG002|Overall Study|Adverse Event|3|||
19630377|NCT00783198|42079623|FG000|Overall Study|Lost to Follow-up|11|||
19630378|NCT00783198|42079624|FG001|Overall Study|Lost to Follow-up|1|||
19630379|NCT00783198|42079625|FG002|Overall Study|Lost to Follow-up|7|||
19630380|NCT00783198|42079623|FG000|Overall Study|Withdrawal by Subject|22|||
19630381|NCT00783198|42079624|FG001|Overall Study|Withdrawal by Subject|14|||
19630382|NCT00783198|42079625|FG002|Overall Study|Withdrawal by Subject|20|||
19630383|NCT00783198|42079623|FG000|Overall Study|Noncompliance with protocol|7|||
19630384|NCT00783198|42079624|FG001|Overall Study|Noncompliance with protocol|7|||
19630385|NCT00783198|42079625|FG002|Overall Study|Noncompliance with protocol|10|||
19630386|NCT00783198|42079623|FG000|Overall Study|Did not meet protocol eligibility|0|||
19630387|NCT00783198|42079624|FG001|Overall Study|Did not meet protocol eligibility|1|||
19630388|NCT00783198|42079625|FG002|Overall Study|Did not meet protocol eligibility|0|||
19630389|NCT00783198|42079623|FG000|Overall Study|Administrative|2|||
19630390|NCT00783198|42079624|FG001|Overall Study|Administrative|1|||
19630391|NCT00783198|42079625|FG002|Overall Study|Administrative|2|||
19630392|NCT00789360|42079635|FG000|Overall Study|Protocol Violation|3|||
19630393|NCT00789360|42079636|FG001|Overall Study|Protocol Violation|1|||
19630394|NCT00782496|42079645|FG000|Overall Study|Lost to Follow-up|14|||
19630395|NCT00782496|42079646|FG001|Overall Study|Lost to Follow-up|15|||
19630396|NCT00782418|42079653|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
19630397|NCT00782418|42079654|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630398|NCT00782418|42079655|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630399|NCT00782418|42079656|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630400|NCT00782418|42079657|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630401|NCT00782418|42079658|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630402|NCT00782418|42079659|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
19630403|NCT00782418|42079653|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
19630404|NCT00782418|42079654|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
19630405|NCT00782418|42079655|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
19630406|NCT00782418|42079656|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
19630407|NCT00782418|42079657|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
19630408|NCT00782418|42079658|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
19630409|NCT00782418|42079659|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
19630410|NCT00782340|42079676|FG000|Open Label Titration|Adverse Event|12|||
19630411|NCT00782340|42079677|FG001|Open Label Titration|Adverse Event|0|||
19630412|NCT00782340|42079678|FG002|Open Label Titration|Adverse Event|0|||
19630413|NCT00782340|42079676|FG000|Open Label Titration|Treatment failure|50|||
19630414|NCT00782340|42079677|FG001|Open Label Titration|Treatment failure|0|||
19630415|NCT00782340|42079678|FG002|Open Label Titration|Treatment failure|0|||
19454500|NCT01500135|41703944|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
19454501|NCT01500135|41703943|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
19534568|NCT00477295|41982774|FG000|Overall Study|Withdrawal by Subject|35|||
19534569|NCT00477295|41982775|FG001|Overall Study|Withdrawal by Subject|24|||
19534570|NCT00477295|41982774|FG000|Overall Study|Lack of Efficacy|23|||
19534571|NCT00477295|41982775|FG001|Overall Study|Lack of Efficacy|23|||
19534572|NCT00477295|41982774|FG000|Overall Study|Protocol Violation|3|||
19534573|NCT00477295|41982775|FG001|Overall Study|Protocol Violation|8|||
19454502|NCT01500135|41703944|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
19454503|NCT01500135|41703943|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
19454504|NCT01500135|41703944|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
19454505|NCT01500135|41703943|FG000|Overall Study|Participant was a Safety Concern|1|||
19454506|NCT01500135|41703944|FG001|Overall Study|Participant was a Safety Concern|0|||
19454507|NCT01500135|41703943|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
19454508|NCT01500135|41703944|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
19454509|NCT01475097|41703956|FG000|Overall Study|Protocol Violation|1|||
19454510|NCT01475097|41703957|FG001|Overall Study|Protocol Violation|1|||
19454511|NCT01529385|41703965|FG000|Overall Study|Lost to Follow-up|2|||
19534574|NCT00477295|41982774|FG000|Overall Study|Physician Decision|4|||
19534575|NCT00477295|41982775|FG001|Overall Study|Physician Decision|5|||
19454512|NCT01529385|41703966|FG001|Overall Study|Lost to Follow-up|1|||
19454513|NCT01474551|41703972|FG000|Overall Study|Death|1|||
19454514|NCT01500057|41704007|FG000|Overall Study|Lost to Follow-up|6|||
19630416|NCT00782340|42079676|FG000|Open Label Titration|Protocol Violation|5|||
19630417|NCT00782340|42079677|FG001|Open Label Titration|Protocol Violation|0|||
19534576|NCT00477295|41982774|FG000|Overall Study|Lost to Follow-up|21|||
19534577|NCT00477295|41982775|FG001|Overall Study|Lost to Follow-up|11|||
19534578|NCT00477295|41982774|FG000|Overall Study|Other|4|||
19534579|NCT00477295|41982775|FG001|Overall Study|Other|3|||
19534580|NCT00476593|41982787|FG000|Overall Study|Lost to Follow-up|10|||
19534581|NCT00476593|41982788|FG001|Overall Study|Lost to Follow-up|2|||
19534582|NCT00476593|41982789|FG002|Overall Study|Lost to Follow-up|8|||
19534583|NCT00476593|41982790|FG003|Overall Study|Lost to Follow-up|22|||
19534584|NCT00476476|41982802|FG000|Overall Study|Adverse Event|2|||
19534585|NCT00476476|41982803|FG001|Overall Study|Adverse Event|7|||
19534586|NCT00476476|41982802|FG000|Overall Study|Progressive Disease|0|||
19534587|NCT00476476|41982803|FG001|Overall Study|Progressive Disease|17|||
19534588|NCT00476086|41982808|FG000|Overall Study|Alternative therapy|1|||
19534589|NCT00476086|41982808|FG000|Overall Study|Progressive Disease|4|||
19534590|NCT00476047|41982814|FG000|Overall Study|Lost to Follow-up|1|||
19534591|NCT00476008|41982822|FG000|Overall Study|Adverse Event|4|||
19534592|NCT00476008|41982823|FG001|Overall Study|Adverse Event|4|||
19534593|NCT00476008|41982822|FG000|Overall Study|Placebo concerns|2|||
19534594|NCT00476008|41982823|FG001|Overall Study|Placebo concerns|2|||
19534595|NCT00476008|41982822|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
19534596|NCT00476008|41982823|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
19534597|NCT00476008|41982822|FG000|Overall Study|Withdrawal by Subject|0|||
19534598|NCT00476008|41982823|FG001|Overall Study|Withdrawal by Subject|1|||
19534599|NCT00476008|41982822|FG000|Overall Study|Death|1|||
19534600|NCT00476008|41982823|FG001|Overall Study|Death|0|||
19534601|NCT00475735|41982839|FG000|Treatment Period 1|Adverse Event|2|||
19534602|NCT00475735|41982840|FG001|Treatment Period 1|Adverse Event|0|||
19534603|NCT00475735|41982841|FG002|Treatment Period 1|Adverse Event|0|||
19534604|NCT00475735|41982842|FG003|Treatment Period 1|Adverse Event|0|||
19534605|NCT00475735|41982843|FG004|Treatment Period 1|Adverse Event|0|||
19534606|NCT00475735|41982844|FG005|Treatment Period 1|Adverse Event|0|||
19534607|NCT00475735|41982839|FG000|Treatment Period 1|Lack of Efficacy|1|||
19534608|NCT00475735|41982840|FG001|Treatment Period 1|Lack of Efficacy|0|||
19534609|NCT00475735|41982841|FG002|Treatment Period 1|Lack of Efficacy|0|||
19454515|NCT01500057|41704008|FG001|Overall Study|Lost to Follow-up|4|||
19454516|NCT01499667|41704026|FG000|Overall Study|administrative problems|4|||
19454517|NCT01499667|41704027|FG001|Overall Study|administrative problems|5|||
19454518|NCT01499667|41704028|FG002|Overall Study|administrative problems|5|||
19534610|NCT00475735|41982842|FG003|Treatment Period 1|Lack of Efficacy|0|||
19534611|NCT00475735|41982843|FG004|Treatment Period 1|Lack of Efficacy|0|||
19454519|NCT01499667|41704026|FG000|Overall Study|Protocol Violation|1|||
19454520|NCT01499667|41704027|FG001|Overall Study|Protocol Violation|3|||
19454521|NCT01499667|41704028|FG002|Overall Study|Protocol Violation|2|||
19454522|NCT01499667|41704026|FG000|Overall Study|Adverse Event|0|||
19454523|NCT01499667|41704027|FG001|Overall Study|Adverse Event|2|||
19454524|NCT01499667|41704028|FG002|Overall Study|Adverse Event|2|||
19454525|NCT01499667|41704026|FG000|Overall Study|Withdrawal by Subject|2|||
19454526|NCT01499667|41704027|FG001|Overall Study|Withdrawal by Subject|1|||
19454527|NCT01499667|41704028|FG002|Overall Study|Withdrawal by Subject|1|||
19534612|NCT00475735|41982844|FG005|Treatment Period 1|Lack of Efficacy|0|||
19534613|NCT00475735|41982839|FG000|Treatment Period 1|Lost to Follow-up|0|||
19454528|NCT01499667|41704026|FG000|Overall Study|Lack of Efficacy|2|||
19454529|NCT01499667|41704027|FG001|Overall Study|Lack of Efficacy|0|||
19454530|NCT01499667|41704028|FG002|Overall Study|Lack of Efficacy|0|||
19534614|NCT00475735|41982840|FG001|Treatment Period 1|Lost to Follow-up|0|||
19534615|NCT00475735|41982841|FG002|Treatment Period 1|Lost to Follow-up|0|||
19534616|NCT00475735|41982842|FG003|Treatment Period 1|Lost to Follow-up|0|||
19534617|NCT00475735|41982843|FG004|Treatment Period 1|Lost to Follow-up|0|||
19534618|NCT00475735|41982844|FG005|Treatment Period 1|Lost to Follow-up|1|||
19534619|NCT00475735|41982839|FG000|Treatment Period 1|Protocol Violation|0|||
19534620|NCT00475735|41982840|FG001|Treatment Period 1|Protocol Violation|0|||
19534621|NCT00475735|41982841|FG002|Treatment Period 1|Protocol Violation|0|||
19534622|NCT00475735|41982842|FG003|Treatment Period 1|Protocol Violation|1|||
19534623|NCT00475735|41982843|FG004|Treatment Period 1|Protocol Violation|0|||
19534624|NCT00475735|41982844|FG005|Treatment Period 1|Protocol Violation|0|||
19534625|NCT00475735|41982839|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19534626|NCT00475735|41982840|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19534627|NCT00475735|41982841|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19534628|NCT00475735|41982842|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19534629|NCT00475735|41982843|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19534630|NCT00475735|41982844|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19534631|NCT00475735|41982839|FG000|Treatment Period 1|DC due to AE but continuing|0|||
19534632|NCT00475735|41982840|FG001|Treatment Period 1|DC due to AE but continuing|0|||
19454531|NCT01499511|41704038|FG000|Overall Study|Death|1|||
19454532|NCT01499511|41704039|FG001|Overall Study|Death|0|||
19454533|NCT01474317|41704059|FG000|Overall Study|Adverse Event|1|||
19454534|NCT01474317|41704059|FG000|Overall Study|Subject ineligible for study|1|||
19711453|NCT03595618|42154548|FG003|Overall Study|Protocol Violation|2|||
19454535|NCT01499355|41704155|FG000|Run-In Period|Study Termination|15|||
19454536|NCT01499355|41704156|FG001|Run-In Period|Study Termination|0|||
19454537|NCT01499355|41704157|FG002|Run-In Period|Study Termination|0|||
19454538|NCT01499355|41704158|FG003|Run-In Period|Study Termination|0|||
19454539|NCT01499355|41704155|FG000|Run-In Period|Other|3|||
19454540|NCT01499355|41704156|FG001|Run-In Period|Other|0|||
19454541|NCT01499355|41704157|FG002|Run-In Period|Other|0|||
19454542|NCT01499355|41704158|FG003|Run-In Period|Other|0|||
19454543|NCT01499355|41704155|FG000|Run-In Period|Death|2|||
19454544|NCT01499355|41704156|FG001|Run-In Period|Death|0|||
19454545|NCT01499355|41704157|FG002|Run-In Period|Death|0|||
19454546|NCT01499355|41704158|FG003|Run-In Period|Death|0|||
19454547|NCT01499355|41704155|FG000|Run-In Period|Investigator Decision|2|||
19534633|NCT00475735|41982841|FG002|Treatment Period 1|DC due to AE but continuing|0|||
19534634|NCT00475735|41982842|FG003|Treatment Period 1|DC due to AE but continuing|1|||
19534635|NCT00475735|41982843|FG004|Treatment Period 1|DC due to AE but continuing|2|||
19534636|NCT00475735|41982844|FG005|Treatment Period 1|DC due to AE but continuing|2|||
19534637|NCT00475735|41982839|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
19534638|NCT00475735|41982840|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
19534639|NCT00475735|41982841|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
19534640|NCT00475735|41982842|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
19534641|NCT00475735|41982843|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
19534642|NCT00475735|41982844|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
19534643|NCT00475735|41982839|FG000|Treatment Washout|Lost to Follow-up|0|||
19534644|NCT00475735|41982840|FG001|Treatment Washout|Lost to Follow-up|1|||
19534645|NCT00475735|41982841|FG002|Treatment Washout|Lost to Follow-up|0|||
19534646|NCT00475735|41982842|FG003|Treatment Washout|Lost to Follow-up|0|||
19454548|NCT01499355|41704156|FG001|Run-In Period|Investigator Decision|0|||
19534647|NCT00475735|41982843|FG004|Treatment Washout|Lost to Follow-up|0|||
19454549|NCT01499355|41704157|FG002|Run-In Period|Investigator Decision|0|||
19454550|NCT01499355|41704158|FG003|Run-In Period|Investigator Decision|0|||
19534648|NCT00475735|41982844|FG005|Treatment Washout|Lost to Follow-up|0|||
19534649|NCT00475735|41982839|FG000|Treatment Washout|Protocol Violation|0|||
19534650|NCT00475735|41982840|FG001|Treatment Washout|Protocol Violation|1|||
19534651|NCT00475735|41982841|FG002|Treatment Washout|Protocol Violation|0|||
19534652|NCT00475735|41982842|FG003|Treatment Washout|Protocol Violation|0|||
19534653|NCT00475735|41982843|FG004|Treatment Washout|Protocol Violation|0|||
19534654|NCT00475735|41982844|FG005|Treatment Washout|Protocol Violation|0|||
19534655|NCT00475735|41982839|FG000|Treatment Period 2|Adverse Event|0|||
19534656|NCT00475735|41982840|FG001|Treatment Period 2|Adverse Event|1|||
19534657|NCT00475735|41982841|FG002|Treatment Period 2|Adverse Event|0|||
19534658|NCT00475735|41982842|FG003|Treatment Period 2|Adverse Event|2|||
19534659|NCT00475735|41982843|FG004|Treatment Period 2|Adverse Event|0|||
19534660|NCT00475735|41982844|FG005|Treatment Period 2|Adverse Event|0|||
19534661|NCT00475735|41982839|FG000|Treatment Period 2|Lack of Efficacy|0|||
19534662|NCT00475735|41982840|FG001|Treatment Period 2|Lack of Efficacy|0|||
19534663|NCT00475735|41982841|FG002|Treatment Period 2|Lack of Efficacy|0|||
19534664|NCT00475735|41982842|FG003|Treatment Period 2|Lack of Efficacy|0|||
19534665|NCT00475735|41982843|FG004|Treatment Period 2|Lack of Efficacy|0|||
19534666|NCT00475735|41982844|FG005|Treatment Period 2|Lack of Efficacy|1|||
19534667|NCT00475735|41982839|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19534668|NCT00475735|41982840|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19534669|NCT00475735|41982841|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19534670|NCT00475735|41982842|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19534671|NCT00475735|41982843|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19534672|NCT00475735|41982844|FG005|Treatment Period 2|Withdrawal by Subject|0|||
19534673|NCT00475657|41982852|FG000|Overall Study|Death|1|||
19534674|NCT00475657|41982852|FG000|Overall Study|Sponsor's Decision|3|||
19534675|NCT00475423|41982856|FG000|Overall Study|Protocol Violation|5|||
19534676|NCT00475423|41982856|FG000|Overall Study|Adverse Event|4|||
19534677|NCT00475423|41982856|FG000|Overall Study|Withdrawal by Subject|6|||
19534678|NCT00475423|41982856|FG000|Overall Study|Lack of Efficacy|8|||
19534679|NCT00475423|41982856|FG000|Overall Study|Death|1|||
19534680|NCT00475423|41982856|FG000|Overall Study|Reason not specified|1|||
19534681|NCT00475423|41982856|FG000|Overall Study|Lost to Follow-up|7|||
19534682|NCT00475306|41982864|FG000|Overall Study|Protocol Violation|1|||
19534683|NCT00475306|41982865|FG001|Overall Study|Protocol Violation|1|||
19534684|NCT00475306|41982866|FG002|Overall Study|Protocol Violation|0|||
19534685|NCT00475306|41982867|FG003|Overall Study|Protocol Violation|1|||
19534686|NCT00475228|41982879|FG000|Overall Study|Lost to Follow-up|17|||
19534687|NCT00475228|41982880|FG001|Overall Study|Lost to Follow-up|17|||
19534688|NCT00475033|41982892|FG000|Infant Series|Failed to return|3|||
19534689|NCT00475033|41982893|FG001|Infant Series|Failed to return|4|||
19534690|NCT00475033|41982892|FG000|Infant Series|Parent or legal guardian request|1|||
19534691|NCT00475033|41982893|FG001|Infant Series|Parent or legal guardian request|5|||
19454551|NCT01499355|41704155|FG000|Run-In Period|Consent Withdrawn|1|||
19454552|NCT01499355|41704156|FG001|Run-In Period|Consent Withdrawn|0|||
19454553|NCT01499355|41704157|FG002|Run-In Period|Consent Withdrawn|0|||
19534692|NCT00475033|41982892|FG000|Infant Series|Protocol Violation|1|||
19534693|NCT00475033|41982893|FG001|Infant Series|Protocol Violation|2|||
19534694|NCT00475033|41982892|FG000|Infant Series|Lost to Follow-up|2|||
19534695|NCT00475033|41982893|FG001|Infant Series|Lost to Follow-up|0|||
19534696|NCT00475033|41982892|FG000|Infant Series|Adverse Event|0|||
19534697|NCT00475033|41982893|FG001|Infant Series|Adverse Event|2|||
19534698|NCT00475033|41982892|FG000|After the Infant Series|Adverse Event|0|||
19534699|NCT00475033|41982893|FG001|After the Infant Series|Adverse Event|4|||
19534700|NCT00475033|41982892|FG000|After the Infant Series|Parent or legal guardian request|2|||
19534701|NCT00475033|41982893|FG001|After the Infant Series|Parent or legal guardian request|2|||
19534702|NCT00475033|41982892|FG000|After the Infant Series|Failed to return|2|||
19534703|NCT00475033|41982893|FG001|After the Infant Series|Failed to return|1|||
19534704|NCT00475033|41982892|FG000|After the Infant Series|Protocol Violation|1|||
19534705|NCT00475033|41982893|FG001|After the Infant Series|Protocol Violation|0|||
19534706|NCT00475033|41982892|FG000|After the Infant Series|Lost to Follow-up|1|||
19534707|NCT00475033|41982893|FG001|After the Infant Series|Lost to Follow-up|0|||
19630418|NCT00782340|42079678|FG002|Open Label Titration|Protocol Violation|0|||
19630419|NCT00782340|42079676|FG000|Open Label Titration|Withdrawal by Subject|5|||
19630420|NCT00782340|42079677|FG001|Open Label Titration|Withdrawal by Subject|0|||
19630421|NCT00782340|42079678|FG002|Open Label Titration|Withdrawal by Subject|0|||
19630422|NCT00782340|42079676|FG000|Open Label Titration|Enrollment capped|16|||
19630423|NCT00782340|42079677|FG001|Open Label Titration|Enrollment capped|0|||
19630424|NCT00782340|42079678|FG002|Open Label Titration|Enrollment capped|0|||
19630425|NCT00782340|42079676|FG000|Open Label Titration|Did not meet responder criteria|2|||
19630426|NCT00782340|42079677|FG001|Open Label Titration|Did not meet responder criteria|0|||
19630427|NCT00782340|42079678|FG002|Open Label Titration|Did not meet responder criteria|0|||
19630428|NCT00782340|42079676|FG000|Open Label Titration|Lost to Follow-up|5|||
19630429|NCT00782340|42079677|FG001|Open Label Titration|Lost to Follow-up|0|||
19630430|NCT00782340|42079678|FG002|Open Label Titration|Lost to Follow-up|0|||
19630431|NCT00782340|42079676|FG000|Open Label Titration|Randomized in error|6|||
19630432|NCT00782340|42079677|FG001|Open Label Titration|Randomized in error|0|||
19630433|NCT00782340|42079678|FG002|Open Label Titration|Randomized in error|0|||
19630434|NCT00774852|42079687|FG000|Overall Study|Adverse Event|9|||
19630435|NCT00774852|42079688|FG001|Overall Study|Adverse Event|6|||
19630436|NCT00774852|42079687|FG000|Overall Study|Death|2|||
19630437|NCT00774852|42079688|FG001|Overall Study|Death|1|||
19630438|NCT00774852|42079687|FG000|Overall Study|Lack of Efficacy|3|||
19630439|NCT00774852|42079688|FG001|Overall Study|Lack of Efficacy|7|||
19630440|NCT00774852|42079687|FG000|Overall Study|Lost to Follow-up|9|||
19630441|NCT00774852|42079688|FG001|Overall Study|Lost to Follow-up|5|||
19630442|NCT00774852|42079687|FG000|Overall Study|Physician Decision|2|||
19630443|NCT00774852|42079688|FG001|Overall Study|Physician Decision|6|||
19630444|NCT00774852|42079687|FG000|Overall Study|Pregnancy|1|||
19630445|NCT00774852|42079688|FG001|Overall Study|Pregnancy|2|||
19630446|NCT00774852|42079687|FG000|Overall Study|Withdrawal by Subject|2|||
19630447|NCT00774852|42079688|FG001|Overall Study|Withdrawal by Subject|2|||
19630448|NCT00774852|42079687|FG000|Overall Study|Non-responder|15|||
19630449|NCT00774852|42079688|FG001|Overall Study|Non-responder|11|||
19630450|NCT00774852|42079687|FG000|Overall Study|Subject non-compliance|0|||
19630451|NCT00774852|42079688|FG001|Overall Study|Subject non-compliance|1|||
19630452|NCT00774852|42079687|FG000|Overall Study|Protocol Violation|1|||
19630453|NCT00774852|42079688|FG001|Overall Study|Protocol Violation|0|||
19630454|NCT00774852|42079687|FG000|Overall Study|Subject received prohibited medication|1|||
19630455|NCT00774852|42079688|FG001|Overall Study|Subject received prohibited medication|0|||
19630456|NCT00774306|42079708|FG000|Overall Study|Adverse Event|3|||
19630457|NCT00774306|42079709|FG001|Overall Study|Adverse Event|0|||
19630458|NCT00774306|42079710|FG002|Overall Study|Adverse Event|0|||
19630459|NCT00774306|42079711|FG003|Overall Study|Adverse Event|0|||
19630460|NCT00774306|42079708|FG000|Overall Study|Protocol Violation|2|||
19630461|NCT00774306|42079709|FG001|Overall Study|Protocol Violation|0|||
19630462|NCT00774306|42079710|FG002|Overall Study|Protocol Violation|3|||
19630463|NCT00774306|42079711|FG003|Overall Study|Protocol Violation|0|||
19630464|NCT00774306|42079708|FG000|Overall Study|Withdrawal by Subject|6|||
19630465|NCT00774306|42079709|FG001|Overall Study|Withdrawal by Subject|1|||
19630466|NCT00774306|42079710|FG002|Overall Study|Withdrawal by Subject|1|||
19630467|NCT00774306|42079711|FG003|Overall Study|Withdrawal by Subject|0|||
19630468|NCT00774306|42079708|FG000|Overall Study|Lost to Follow-up|6|||
19630469|NCT00774306|42079709|FG001|Overall Study|Lost to Follow-up|0|||
19630470|NCT00774306|42079710|FG002|Overall Study|Lost to Follow-up|4|||
19630471|NCT00774306|42079711|FG003|Overall Study|Lost to Follow-up|5|||
19630472|NCT00774306|42079708|FG000|Overall Study|Death|1|||
19534708|NCT00475033|41982892|FG000|After the Infant Series|Other|0|||
19630473|NCT00774306|42079709|FG001|Overall Study|Death|1|||
19630474|NCT00774306|42079710|FG002|Overall Study|Death|0|||
19630475|NCT00774306|42079711|FG003|Overall Study|Death|0|||
19630476|NCT00781326|42079721|FG000|Phase I|Adverse Event|1|||
19534709|NCT00475033|41982893|FG001|After the Infant Series|Other|1|||
19534710|NCT00475033|41982892|FG000|Toddler Dose|Parent or legal guardian request|2|||
19534711|NCT00475033|41982893|FG001|Toddler Dose|Parent or legal guardian request|0|||
19534712|NCT00475033|41982892|FG000|Toddler Dose|Failed to return|1|||
19534713|NCT00475033|41982893|FG001|Toddler Dose|Failed to return|0|||
19534714|NCT00475033|41982892|FG000|Toddler Dose|Lost to Follow-up|1|||
19534715|NCT00475033|41982893|FG001|Toddler Dose|Lost to Follow-up|0|||
19534716|NCT00474994|41982906|FG000|Overall Study|Patient Not treated|1|||
19534717|NCT00474994|41982906|FG000|Overall Study|Patient evaluable for toxicity only|3|||
19630477|NCT00781326|42079721|FG000|Phase I|Withdrawal by Subject|1|||
19630478|NCT00781326|42079721|FG000|Phase I|Physician Decision|2|||
19630479|NCT00787800|42079727|FG000|Overall Study|Withdrawal by Subject|3|||
19630480|NCT00787800|42079728|FG001|Overall Study|Withdrawal by Subject|5|||
19630481|NCT00787800|42079727|FG000|Overall Study|Death|0|||
19630482|NCT00787800|42079728|FG001|Overall Study|Death|2|||
19630483|NCT00773838|42079735|FG000|Overall Study|Adverse Event|29|||
19630484|NCT00773838|42079735|FG000|Overall Study|Lost to Follow-up|1|||
19630485|NCT00773838|42079735|FG000|Overall Study|Physician Decision|8|||
19630486|NCT00773838|42079735|FG000|Overall Study|Progressive Disease|82|||
19630487|NCT00773838|42079735|FG000|Overall Study|Protocol Violation|2|||
19630488|NCT00773838|42079735|FG000|Overall Study|Withdrawal by Subject|21|||
19630489|NCT00787644|42079741|FG000|Overall Study|Lost to Follow-up|1|||
19711454|NCT03595618|42154545|FG000|Overall Study|Physician Decision|0|||
19711455|NCT03595618|42154546|FG001|Overall Study|Physician Decision|0|||
19711456|NCT03595618|42154547|FG002|Overall Study|Physician Decision|1|||
19711457|NCT03595618|42154548|FG003|Overall Study|Physician Decision|2|||
19711458|NCT03595618|42154545|FG000|Overall Study|Miscellaneous|7|||
19711459|NCT03595618|42154546|FG001|Overall Study|Miscellaneous|5|||
19711460|NCT03595618|42154547|FG002|Overall Study|Miscellaneous|10|||
19711461|NCT03595618|42154548|FG003|Overall Study|Miscellaneous|6|||
19711462|NCT02954848|42154560|FG000|Overall Study|Randomized but Not Treated|0|||
19711463|NCT02954848|42154561|FG001|Overall Study|Randomized but Not Treated|1|||
19711464|NCT02954848|42154560|FG000|Overall Study|Adverse Event|2|||
19711465|NCT02954848|42154561|FG001|Overall Study|Adverse Event|3|||
19711466|NCT02954848|42154560|FG000|Overall Study|Withdrawal by Participant|0|||
19711467|NCT02954848|42154561|FG001|Overall Study|Withdrawal by Participant|1|||
19711468|NCT03642262|42154567|FG000|Period 1|Withdrawal by Subject|1|||
19711469|NCT03642262|42154568|FG001|Period 1|Withdrawal by Subject|1|||
19711470|NCT03642262|42154567|FG000|Period 1|Adverse Event|0|||
19711471|NCT03642262|42154568|FG001|Period 1|Adverse Event|1|||
19711472|NCT00109707|42154578|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
19711473|NCT00109707|42154579|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
19711474|NCT00109707|42154580|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
19711475|NCT00109707|42154578|FG000|Overall Study|Abnormal laboratory values|1|||
19711476|NCT00109707|42154579|FG001|Overall Study|Abnormal laboratory values|0|||
19711477|NCT00109707|42154580|FG002|Overall Study|Abnormal laboratory values|0|||
19711478|NCT00109707|42154578|FG000|Overall Study|Administrative problems|2|||
19711479|NCT00109707|42154579|FG001|Overall Study|Administrative problems|0|||
19711480|NCT00109707|42154580|FG002|Overall Study|Administrative problems|1|||
19711481|NCT00109707|42154578|FG000|Overall Study|Adverse Event|10|||
19711482|NCT00109707|42154579|FG001|Overall Study|Adverse Event|2|||
19711483|NCT00109707|42154580|FG002|Overall Study|Adverse Event|3|||
19711484|NCT00109707|42154578|FG000|Overall Study|Death|4|||
19711485|NCT00109707|42154579|FG001|Overall Study|Death|0|||
19711486|NCT00109707|42154580|FG002|Overall Study|Death|0|||
19711487|NCT00109707|42154578|FG000|Overall Study|Disease progression|12|||
19711488|NCT00109707|42154579|FG001|Overall Study|Disease progression|4|||
19711489|NCT00109707|42154580|FG002|Overall Study|Disease progression|3|||
19711490|NCT00109707|42154578|FG000|Overall Study|Lost to Follow-up|3|||
19711491|NCT00109707|42154579|FG001|Overall Study|Lost to Follow-up|0|||
19711492|NCT00109707|42154580|FG002|Overall Study|Lost to Follow-up|0|||
19711493|NCT00109707|42154578|FG000|Overall Study|Protocol Violation|1|||
19711494|NCT00109707|42154579|FG001|Overall Study|Protocol Violation|0|||
19711495|NCT00109707|42154580|FG002|Overall Study|Protocol Violation|0|||
19711496|NCT00109707|42154578|FG000|Overall Study|Patient withdrew consent|6|||
19711497|NCT00109707|42154579|FG001|Overall Study|Patient withdrew consent|1|||
19711498|NCT00109707|42154580|FG002|Overall Study|Patient withdrew consent|0|||
19711499|NCT00095979|42154592|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
19711500|NCT00082173|42154603|FG000|Overall Study|Withdrawal by Subject|3|||
19711501|NCT00082173|42154604|FG001|Overall Study|Withdrawal by Subject|5|||
19711502|NCT00082173|42154603|FG000|Overall Study|Lost to Follow-up|1|||
19711503|NCT00082173|42154604|FG001|Overall Study|Lost to Follow-up|0|||
19534718|NCT00474994|41982906|FG000|Overall Study|Patient found to be ineligible|1|||
19534719|NCT00474955|41982910|FG000|Overall Study|Adverse Event|2|||
19534720|NCT00474955|41982910|FG000|Overall Study|Drug unavailability|1|||
19630490|NCT00787644|42079742|FG001|Overall Study|Lost to Follow-up|1|||
19711504|NCT00082173|42154603|FG000|Overall Study|Adverse Event|1|||
19711505|NCT00082173|42154604|FG001|Overall Study|Adverse Event|0|||
19534721|NCT00474955|41982910|FG000|Overall Study|Personal reasons|5|||
19534722|NCT00474487|41982918|FG000|Overall Study|Withdrawal by Subject|6|||
19534723|NCT00474487|41982919|FG001|Overall Study|Withdrawal by Subject|0|||
19534724|NCT00474487|41982920|FG002|Overall Study|Withdrawal by Subject|0|||
19534725|NCT00474487|41982921|FG003|Overall Study|Withdrawal by Subject|0|||
19534726|NCT00474487|41982918|FG000|Overall Study|Lost to Follow-up|20|||
19534727|NCT00474487|41982919|FG001|Overall Study|Lost to Follow-up|1|||
19534728|NCT00474487|41982920|FG002|Overall Study|Lost to Follow-up|7|||
19534729|NCT00474487|41982921|FG003|Overall Study|Lost to Follow-up|0|||
19534730|NCT00474487|41982918|FG000|Overall Study|Inappropriate enrollment|4|||
19534731|NCT00474487|41982919|FG001|Overall Study|Inappropriate enrollment|0|||
19534732|NCT00474487|41982920|FG002|Overall Study|Inappropriate enrollment|7|||
19534733|NCT00474487|41982921|FG003|Overall Study|Inappropriate enrollment|0|||
19534734|NCT00474487|41982918|FG000|Overall Study|Death|0|||
19534735|NCT00474487|41982919|FG001|Overall Study|Death|1|||
19534736|NCT00474487|41982920|FG002|Overall Study|Death|0|||
19534737|NCT00474487|41982921|FG003|Overall Study|Death|0|||
19534738|NCT00474253|41982933|FG000|Overall Study|Withdrew consent|2|||
19534739|NCT00474253|41982934|FG001|Overall Study|Withdrew consent|0|||
19534740|NCT00474253|41982933|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
19534741|NCT00474253|41982934|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
19534742|NCT00474253|41982933|FG000|Overall Study|Lost to Follow-up|1|||
19534743|NCT00474253|41982934|FG001|Overall Study|Lost to Follow-up|0|||
19534744|NCT00474253|41982933|FG000|Overall Study|Discharged prior to study completion|0|||
19534745|NCT00474253|41982934|FG001|Overall Study|Discharged prior to study completion|1|||
19534746|NCT00474058|41982942|FG000|Overall Study|Adverse Event|11|||
19534747|NCT00474058|41982943|FG001|Overall Study|Adverse Event|6|||
19534748|NCT00474058|41982942|FG000|Overall Study|Lack of Efficacy|0|||
19534749|NCT00474058|41982943|FG001|Overall Study|Lack of Efficacy|4|||
19534750|NCT00474058|41982942|FG000|Overall Study|Withdrawal by Subject|11|||
19534751|NCT00474058|41982943|FG001|Overall Study|Withdrawal by Subject|7|||
19534752|NCT00474058|41982942|FG000|Overall Study|Other|2|||
19534753|NCT00474058|41982943|FG001|Overall Study|Other|0|||
19534754|NCT00473824|41982951|FG000|Overall Study|Virologic Breakthrough|1|||
19534755|NCT00473824|41982952|FG001|Overall Study|Virologic Breakthrough|0|||
19534756|NCT00473824|41982951|FG000|Overall Study|Adverse Event|1|||
19534757|NCT00473824|41982952|FG001|Overall Study|Adverse Event|0|||
19534758|NCT00473824|41982951|FG000|Overall Study|Death|1|||
19534759|NCT00473824|41982952|FG001|Overall Study|Death|0|||
19534760|NCT00473824|41982951|FG000|Overall Study|Lost to Follow-up|1|||
19534761|NCT00473824|41982952|FG001|Overall Study|Lost to Follow-up|0|||
19534762|NCT00473824|41982951|FG000|Overall Study|Withdrawal by physician|1|||
19534763|NCT00473824|41982952|FG001|Overall Study|Withdrawal by physician|0|||
19534764|NCT00473746|41982963|FG000|Period 1 (Phase 1)|Adverse Event|1|||
19534765|NCT00473746|41982964|FG001|Period 1 (Phase 1)|Adverse Event|0|||
19534766|NCT00473746|41982965|FG002|Period 1 (Phase 1)|Adverse Event|0|||
19534767|NCT00473746|41982966|FG003|Period 1 (Phase 1)|Adverse Event|0|||
19534768|NCT00473746|41982967|FG004|Period 1 (Phase 1)|Adverse Event|0|||
19534769|NCT00473746|41982963|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
19534770|NCT00473746|41982964|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
19534771|NCT00473746|41982965|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
19534772|NCT00473746|41982966|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
19534773|NCT00473746|41982967|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
19534774|NCT00473746|41982963|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
19534775|NCT00473746|41982964|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
19534776|NCT00473746|41982965|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
19534777|NCT00473746|41982966|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
19534778|NCT00473746|41982967|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
19534779|NCT00473746|41982963|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
19534780|NCT00473746|41982964|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
19534781|NCT00473746|41982965|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
19534782|NCT00473746|41982966|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
19534783|NCT00473746|41982967|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
19534784|NCT00473746|41982963|FG000|Period 1 (Phase 1)|Reason not specified|0|||
19534785|NCT00473746|41982964|FG001|Period 1 (Phase 1)|Reason not specified|1|||
19534786|NCT00473746|41982965|FG002|Period 1 (Phase 1)|Reason not specified|0|||
19534787|NCT00473746|41982966|FG003|Period 1 (Phase 1)|Reason not specified|0|||
19534788|NCT00473746|41982967|FG004|Period 1 (Phase 1)|Reason not specified|0|||
19534789|NCT00473746|41982963|FG000|Period 2 (Phase 2)|Adverse Event|0|||
19534790|NCT00473746|41982964|FG001|Period 2 (Phase 2)|Adverse Event|0|||
19534791|NCT00473746|41982965|FG002|Period 2 (Phase 2)|Adverse Event|0|||
19534792|NCT00473746|41982966|FG003|Period 2 (Phase 2)|Adverse Event|0|||
19534793|NCT00473746|41982967|FG004|Period 2 (Phase 2)|Adverse Event|3|||
19534794|NCT00473746|41982963|FG000|Period 2 (Phase 2)|Death|0|||
19534795|NCT00473746|41982964|FG001|Period 2 (Phase 2)|Death|0|||
19534796|NCT00473746|41982965|FG002|Period 2 (Phase 2)|Death|0|||
19534797|NCT00473746|41982966|FG003|Period 2 (Phase 2)|Death|0|||
19534798|NCT00473746|41982967|FG004|Period 2 (Phase 2)|Death|1|||
19534799|NCT00473746|41982963|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
19534800|NCT00473746|41982964|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
19534801|NCT00473746|41982965|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
19534802|NCT00473746|41982966|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
19534803|NCT00473746|41982967|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
19534804|NCT00473746|41982963|FG000|Period 2 (Phase 2)|Reason not specified|0|||
19534805|NCT00473746|41982964|FG001|Period 2 (Phase 2)|Reason not specified|0|||
19534806|NCT00473746|41982965|FG002|Period 2 (Phase 2)|Reason not specified|0|||
19534807|NCT00473746|41982966|FG003|Period 2 (Phase 2)|Reason not specified|0|||
19534808|NCT00473746|41982967|FG004|Period 2 (Phase 2)|Reason not specified|3|||
19534809|NCT00473668|41982984|FG000|Overall Study|Withdrawal by Subject|0|||
19534810|NCT00473668|41982985|FG001|Overall Study|Withdrawal by Subject|2|||
19534811|NCT00473668|41982986|FG002|Overall Study|Withdrawal by Subject|0|||
19534812|NCT00473668|41982984|FG000|Overall Study|Migrated/moved from study area|3|||
19534813|NCT00473668|41982985|FG001|Overall Study|Migrated/moved from study area|2|||
19534814|NCT00473668|41982986|FG002|Overall Study|Migrated/moved from study area|0|||
19534815|NCT00473668|41982984|FG000|Overall Study|Lost to Follow-up|0|||
19534816|NCT00473668|41982985|FG001|Overall Study|Lost to Follow-up|4|||
19534817|NCT00473668|41982986|FG002|Overall Study|Lost to Follow-up|6|||
19534818|NCT00473668|41982984|FG000|Overall Study|Other|2|||
19534819|NCT00473668|41982985|FG001|Overall Study|Other|3|||
19534820|NCT00473668|41982986|FG002|Overall Study|Other|4|||
19534821|NCT00473590|41982996|FG000|Overall Study|Adverse Event|3|||
19534822|NCT00473590|41982997|FG001|Overall Study|Adverse Event|3|||
19534823|NCT00473590|41982996|FG000|Overall Study|Death|4|||
19534824|NCT00473590|41982997|FG001|Overall Study|Death|2|||
19534825|NCT00473590|41982996|FG000|Overall Study|Progression not resulting in death|24|||
19630491|NCT00787644|42079741|FG000|Overall Study|Withdrawal by Subject|1|||
19630492|NCT00787644|42079742|FG001|Overall Study|Withdrawal by Subject|1|||
19630493|NCT00787566|42079751|FG000|Overall Study|AE related to chemotherapy|0|||
19630494|NCT00787566|42079752|FG001|Overall Study|AE related to chemotherapy|1|||
19630495|NCT00787566|42079753|FG002|Overall Study|AE related to chemotherapy|0|||
19630496|NCT00787254|42079763|FG000|Overall Study|Adverse Event|24|||
19630497|NCT00787254|42079764|FG001|Overall Study|Adverse Event|23|||
19630498|NCT00787254|42079763|FG000|Overall Study|Protocol Violation|26|||
19630499|NCT00787254|42079764|FG001|Overall Study|Protocol Violation|23|||
19630500|NCT00787254|42079763|FG000|Overall Study|Withdrawal by Subject|16|||
19630501|NCT00787254|42079764|FG001|Overall Study|Withdrawal by Subject|11|||
19630502|NCT00787254|42079763|FG000|Overall Study|Lack of Efficacy|4|||
19630503|NCT00787254|42079764|FG001|Overall Study|Lack of Efficacy|15|||
19630504|NCT00787254|42079763|FG000|Overall Study|NSAIDs discontinuation|1|||
19630505|NCT00787254|42079764|FG001|Overall Study|NSAIDs discontinuation|2|||
19630506|NCT00787254|42079763|FG000|Overall Study|Institution closed|1|||
19630507|NCT00787254|42079764|FG001|Overall Study|Institution closed|0|||
19630508|NCT00787254|42079763|FG000|Overall Study|Physician Decision|4|||
19630509|NCT00787254|42079764|FG001|Overall Study|Physician Decision|8|||
19630510|NCT00625846|42079774|FG000|Overall Study|Withdrawal by Subject|2|||
19630511|NCT00625846|42079775|FG001|Overall Study|Withdrawal by Subject|0|||
19630512|NCT00625846|42079776|FG002|Overall Study|Withdrawal by Subject|1|||
19630513|NCT00625846|42079777|FG003|Overall Study|Withdrawal by Subject|2|||
19630514|NCT00773292|42079791|FG000|Treatment 48 Weeks|Adverse Event|1|||
19630515|NCT00773292|42079791|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
19630516|NCT00786864|42079797|FG000|Overall Study|Lost to Follow-up|0|||
19630517|NCT00786864|42079798|FG001|Overall Study|Lost to Follow-up|1|||
19630518|NCT00786864|42079797|FG000|Overall Study|Sustained serious back injury|1|||
19630519|NCT00786864|42079798|FG001|Overall Study|Sustained serious back injury|0|||
19630520|NCT00621322|42079810|FG000|Overall Study|Lost to Follow-up|0|||
19630521|NCT00621322|42079811|FG001|Overall Study|Lost to Follow-up|0|||
19630522|NCT00621322|42079812|FG002|Overall Study|Lost to Follow-up|0|||
19630523|NCT00621322|42079813|FG003|Overall Study|Lost to Follow-up|0|||
19630524|NCT00621322|42079814|FG004|Overall Study|Lost to Follow-up|1|||
19534826|NCT00473590|41982997|FG001|Overall Study|Progression not resulting in death|20|||
19534827|NCT00473590|41982996|FG000|Overall Study|Non-protocol-specified therapy|7|||
19630525|NCT00621322|42079815|FG005|Overall Study|Lost to Follow-up|0|||
19630526|NCT00621322|42079810|FG000|Overall Study|Physician Decision|0|||
19630527|NCT00621322|42079811|FG001|Overall Study|Physician Decision|0|||
19630528|NCT00621322|42079812|FG002|Overall Study|Physician Decision|1|||
19630529|NCT00621322|42079813|FG003|Overall Study|Physician Decision|1|||
19630530|NCT00621322|42079814|FG004|Overall Study|Physician Decision|0|||
19630531|NCT00621322|42079815|FG005|Overall Study|Physician Decision|0|||
19630532|NCT00621322|42079810|FG000|Overall Study|Withdrawal by Subject|0|||
19630533|NCT00621322|42079811|FG001|Overall Study|Withdrawal by Subject|0|||
19630534|NCT00621322|42079812|FG002|Overall Study|Withdrawal by Subject|0|||
19630535|NCT00621322|42079813|FG003|Overall Study|Withdrawal by Subject|1|||
19534828|NCT00473590|41982997|FG001|Overall Study|Non-protocol-specified therapy|5|||
19534829|NCT00473590|41982996|FG000|Overall Study|Physician Decision|2|||
19534830|NCT00473590|41982997|FG001|Overall Study|Physician Decision|4|||
19534831|NCT00473590|41982996|FG000|Overall Study|Withdrawal by Subject|5|||
19534832|NCT00473590|41982997|FG001|Overall Study|Withdrawal by Subject|3|||
19534833|NCT00473590|41982996|FG000|Overall Study|Other|0|||
19534834|NCT00473590|41982997|FG001|Overall Study|Other|1|||
19534835|NCT00473512|41983008|FG000|Period 1 (Phase 1)|Adverse Event|0|||
19534836|NCT00473512|41983009|FG001|Period 1 (Phase 1)|Adverse Event|0|||
19534837|NCT00473512|41983010|FG002|Period 1 (Phase 1)|Adverse Event|0|||
19534838|NCT00473512|41983011|FG003|Period 1 (Phase 1)|Adverse Event|5|||
19534839|NCT00473512|41983012|FG004|Period 1 (Phase 1)|Adverse Event|0|||
19534840|NCT00473512|41983008|FG000|Period 1 (Phase 1)|Death|0|||
19534841|NCT00473512|41983009|FG001|Period 1 (Phase 1)|Death|0|||
19534842|NCT00473512|41983010|FG002|Period 1 (Phase 1)|Death|0|||
19534843|NCT00473512|41983011|FG003|Period 1 (Phase 1)|Death|1|||
19534844|NCT00473512|41983012|FG004|Period 1 (Phase 1)|Death|0|||
19534845|NCT00473512|41983008|FG000|Period 1 (Phase 1)|Disease Progression|1|||
19534846|NCT00473512|41983009|FG001|Period 1 (Phase 1)|Disease Progression|1|||
19534847|NCT00473512|41983010|FG002|Period 1 (Phase 1)|Disease Progression|0|||
19534848|NCT00473512|41983011|FG003|Period 1 (Phase 1)|Disease Progression|10|||
19534849|NCT00473512|41983012|FG004|Period 1 (Phase 1)|Disease Progression|1|||
19534850|NCT00473512|41983008|FG000|Period 1 (Phase 1)|Other|0|||
19534851|NCT00473512|41983009|FG001|Period 1 (Phase 1)|Other|0|||
19534852|NCT00473512|41983010|FG002|Period 1 (Phase 1)|Other|0|||
19534853|NCT00473512|41983011|FG003|Period 1 (Phase 1)|Other|1|||
19534854|NCT00473512|41983012|FG004|Period 1 (Phase 1)|Other|0|||
19534855|NCT00473512|41983008|FG000|Period 2 (Phase 2)|Adverse Event|0|||
19534856|NCT00473512|41983009|FG001|Period 2 (Phase 2)|Adverse Event|0|||
19534857|NCT00473512|41983010|FG002|Period 2 (Phase 2)|Adverse Event|0|||
19534858|NCT00473512|41983011|FG003|Period 2 (Phase 2)|Adverse Event|1|||
19534859|NCT00473512|41983012|FG004|Period 2 (Phase 2)|Adverse Event|0|||
19534860|NCT00473512|41983008|FG000|Period 2 (Phase 2)|Death|0|||
19534861|NCT00473512|41983009|FG001|Period 2 (Phase 2)|Death|0|||
19454554|NCT01499355|41704158|FG003|Run-In Period|Consent Withdrawn|0|||
19454555|NCT01499355|41704155|FG000|Run-In Period|Adverse Event|8|||
19454556|NCT01499355|41704156|FG001|Run-In Period|Adverse Event|0|||
19454557|NCT01499355|41704157|FG002|Run-In Period|Adverse Event|0|||
19454558|NCT01499355|41704158|FG003|Run-In Period|Adverse Event|0|||
19454559|NCT01499355|41704155|FG000|Double-Blind Period|Adverse Event|0|||
19454560|NCT01499355|41704156|FG001|Double-Blind Period|Adverse Event|2|||
19454561|NCT01499355|41704157|FG002|Double-Blind Period|Adverse Event|3|||
19534862|NCT00473512|41983010|FG002|Period 2 (Phase 2)|Death|0|||
19630536|NCT00621322|42079814|FG004|Overall Study|Withdrawal by Subject|0|||
19630537|NCT00621322|42079815|FG005|Overall Study|Withdrawal by Subject|2|||
19630538|NCT00621322|42079810|FG000|Overall Study|Migrated/moved from study area|1|||
19630539|NCT00621322|42079811|FG001|Overall Study|Migrated/moved from study area|0|||
19630540|NCT00621322|42079812|FG002|Overall Study|Migrated/moved from study area|1|||
19630541|NCT00621322|42079813|FG003|Overall Study|Migrated/moved from study area|1|||
19630542|NCT00621322|42079814|FG004|Overall Study|Migrated/moved from study area|0|||
19630543|NCT00621322|42079815|FG005|Overall Study|Migrated/moved from study area|2|||
19630544|NCT00853385|42079834|FG000|Overall Study|Death|0|||
19630545|NCT00853385|42079835|FG001|Overall Study|Death|0|||
19630546|NCT00853385|42079836|FG002|Overall Study|Death|0|||
19630547|NCT00853385|42079837|FG003|Overall Study|Death|0|||
19630548|NCT00853385|42079838|FG004|Overall Study|Death|1|||
19630549|NCT00853385|42079834|FG000|Overall Study|Adverse Event|24|||
19630550|NCT00853385|42079835|FG001|Overall Study|Adverse Event|24|||
19630551|NCT00853385|42079836|FG002|Overall Study|Adverse Event|2|||
19630552|NCT00853385|42079837|FG003|Overall Study|Adverse Event|5|||
19630553|NCT00853385|42079838|FG004|Overall Study|Adverse Event|22|||
19630554|NCT00853385|42079834|FG000|Overall Study|Lack of Efficacy|6|||
19630555|NCT00853385|42079835|FG001|Overall Study|Lack of Efficacy|7|||
19630556|NCT00853385|42079836|FG002|Overall Study|Lack of Efficacy|3|||
19630557|NCT00853385|42079837|FG003|Overall Study|Lack of Efficacy|3|||
19630558|NCT00853385|42079838|FG004|Overall Study|Lack of Efficacy|6|||
19630559|NCT00853385|42079834|FG000|Overall Study|Lost to Follow-up|2|||
19630560|NCT00853385|42079835|FG001|Overall Study|Lost to Follow-up|1|||
19630561|NCT00853385|42079836|FG002|Overall Study|Lost to Follow-up|0|||
19630562|NCT00853385|42079837|FG003|Overall Study|Lost to Follow-up|0|||
19534863|NCT00473512|41983011|FG003|Period 2 (Phase 2)|Death|1|||
19534864|NCT00473512|41983012|FG004|Period 2 (Phase 2)|Death|1|||
19630563|NCT00853385|42079838|FG004|Overall Study|Lost to Follow-up|0|||
19630564|NCT00853385|42079834|FG000|Overall Study|Withdrawal by Subject|4|||
19630565|NCT00853385|42079835|FG001|Overall Study|Withdrawal by Subject|2|||
19534865|NCT00473512|41983008|FG000|Period 2 (Phase 2)|Disease Progression|0|||
19630566|NCT00853385|42079836|FG002|Overall Study|Withdrawal by Subject|0|||
19630567|NCT00853385|42079837|FG003|Overall Study|Withdrawal by Subject|1|||
19534866|NCT00473512|41983009|FG001|Period 2 (Phase 2)|Disease Progression|2|||
19630568|NCT00853385|42079838|FG004|Overall Study|Withdrawal by Subject|1|||
19630569|NCT00853385|42079834|FG000|Overall Study|Other|18|||
19454562|NCT01499355|41704158|FG003|Double-Blind Period|Adverse Event|2|||
19534867|NCT00473512|41983010|FG002|Period 2 (Phase 2)|Disease Progression|2|||
19534868|NCT00473512|41983011|FG003|Period 2 (Phase 2)|Disease Progression|17|||
19630570|NCT00853385|42079835|FG001|Overall Study|Other|9|||
19454563|NCT01499355|41704155|FG000|Double-Blind Period|Study Termination|0|||
19454564|NCT01499355|41704156|FG001|Double-Blind Period|Study Termination|18|||
19454565|NCT01499355|41704157|FG002|Double-Blind Period|Study Termination|16|||
19534869|NCT00473512|41983012|FG004|Period 2 (Phase 2)|Disease Progression|1|||
19534870|NCT00473512|41983008|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
19534871|NCT00473512|41983009|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
19534872|NCT00473512|41983010|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
19534873|NCT00473512|41983011|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
19534874|NCT00473512|41983012|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
19534875|NCT00473512|41983008|FG000|Period 2 (Phase 2)|Other|1|||
19534876|NCT00473512|41983009|FG001|Period 2 (Phase 2)|Other|0|||
19534877|NCT00473512|41983010|FG002|Period 2 (Phase 2)|Other|0|||
19534878|NCT00473512|41983011|FG003|Period 2 (Phase 2)|Other|3|||
19454566|NCT01499355|41704158|FG003|Double-Blind Period|Study Termination|14|||
19454567|NCT01499355|41704155|FG000|Double-Blind Period|Other|0|||
19454568|NCT01499355|41704156|FG001|Double-Blind Period|Other|1|||
19454569|NCT01499355|41704157|FG002|Double-Blind Period|Other|2|||
19454570|NCT01499355|41704158|FG003|Double-Blind Period|Other|2|||
19454571|NCT01499355|41704155|FG000|Double-Blind Period|Death|0|||
19454572|NCT01499355|41704156|FG001|Double-Blind Period|Death|1|||
19454573|NCT01499355|41704157|FG002|Double-Blind Period|Death|0|||
19454574|NCT01499355|41704158|FG003|Double-Blind Period|Death|0|||
19454575|NCT01499355|41704155|FG000|Double-Blind Period|Investigator Decision|0|||
19534879|NCT00473512|41983012|FG004|Period 2 (Phase 2)|Other|0|||
19534880|NCT00473434|41983032|FG000|Overall Study|Physician Decision|3|||
19534881|NCT00473434|41983032|FG000|Overall Study|Withdrawal by Subject|9|||
19534882|NCT00473434|41983032|FG000|Overall Study|Compliance|3|||
19534883|NCT00473434|41983032|FG000|Overall Study|Lack of Efficacy|3|||
19534884|NCT00473434|41983032|FG000|Overall Study|Adverse Event|3|||
19534885|NCT00473434|41983032|FG000|Overall Study|Patient was selling medication to others|1|||
19534886|NCT00473434|41983032|FG000|Overall Study|Safety evaluation|1|||
19534887|NCT00473434|41983032|FG000|Overall Study|Reason not specified|6|||
19534888|NCT00473434|41983032|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
19534889|NCT00473434|41983032|FG000|Overall Study|Switching to trial medication|1|||
19534890|NCT00473434|41983032|FG000|Overall Study|No longer required|1|||
19630571|NCT00853385|42079836|FG002|Overall Study|Other|4|||
19454576|NCT01499355|41704156|FG001|Double-Blind Period|Investigator Decision|0|||
19454577|NCT01499355|41704157|FG002|Double-Blind Period|Investigator Decision|3|||
19454578|NCT01499355|41704158|FG003|Double-Blind Period|Investigator Decision|3|||
19454579|NCT01499355|41704155|FG000|Double-Blind Period|Consent Withdrawn|0|||
19454580|NCT01499355|41704156|FG001|Double-Blind Period|Consent Withdrawn|0|||
19630572|NCT00853385|42079837|FG003|Overall Study|Other|4|||
19630573|NCT00853385|42079838|FG004|Overall Study|Other|12|||
19630574|NCT00622336|42079860|FG000|Treatment Phase|Progression of Disease|181|||
19630575|NCT00622336|42079860|FG000|Treatment Phase|Adverse Event|46|||
19630576|NCT00622336|42079860|FG000|Treatment Phase|Other|40|||
19630577|NCT00622336|42079860|FG000|Treatment Phase|Death|14|||
19630578|NCT00622336|42079860|FG000|Treatment Phase|Lack of therapeutic effect|13|||
19630579|NCT00622336|42079860|FG000|Treatment Phase|Withdrawal by Subject|13|||
19630580|NCT00622336|42079860|FG000|Treatment Phase|Lost to Follow-up|2|||
19630581|NCT00622336|42079860|FG000|Extension Phase|Adverse Event|2|||
19630582|NCT00622336|42079860|FG000|Extension Phase|Progressive Disease|6|||
19630583|NCT00622336|42079860|FG000|Extension Phase|Lack of therapeutic effect|2|||
19630584|NCT00622336|42079860|FG000|Extension Phase|Withdrawal by Subject|1|||
19630585|NCT00622336|42079860|FG000|Extension Phase|Lost to Follow-up|1|||
19630586|NCT00622336|42079860|FG000|Extension Phase|Other|9|||
19630587|NCT00779766|42079868|FG000|Month 24|Serious Adverse Event|2|||
19630588|NCT00779766|42079869|FG001|Month 24|Serious Adverse Event|3|||
19630589|NCT00779766|42079868|FG000|Month 24|Adverse Event|3|||
19630590|NCT00779766|42079869|FG001|Month 24|Adverse Event|3|||
19630591|NCT00779766|42079868|FG000|Month 24|Protocol Violation|3|||
19630592|NCT00779766|42079869|FG001|Month 24|Protocol Violation|1|||
19630593|NCT00779766|42079868|FG000|Month 24|Withdrawal by Subject|159|||
19630594|NCT00779766|42079869|FG001|Month 24|Withdrawal by Subject|127|||
19630595|NCT00779766|42079868|FG000|Month 24|Migrated/moved from study area|138|||
19630596|NCT00779766|42079869|FG001|Month 24|Migrated/moved from study area|162|||
19630597|NCT00779766|42079868|FG000|Month 24|Lost to Follow-up|9|||
19630598|NCT00779766|42079869|FG001|Month 24|Lost to Follow-up|9|||
19630599|NCT00779766|42079868|FG000|Month 24|Other|18|||
19630600|NCT00779766|42079869|FG001|Month 24|Other|27|||
19534891|NCT00473083|41983052|FG000|Overall Study|Adverse Event|1|||
19534892|NCT00473083|41983053|FG001|Overall Study|Adverse Event|0|||
19630601|NCT00779766|42079868|FG000|Month 48|Withdrawal by Subject|68|||
19630602|NCT00779766|42079869|FG001|Month 48|Withdrawal by Subject|63|||
19630603|NCT00779766|42079868|FG000|Month 48|Migrated/moved from study area|76|||
19630604|NCT00779766|42079869|FG001|Month 48|Migrated/moved from study area|75|||
19630605|NCT00779766|42079868|FG000|Month 48|Lost to Follow-up|29|||
19454581|NCT01499355|41704157|FG002|Double-Blind Period|Consent Withdrawn|1|||
19454582|NCT01499355|41704158|FG003|Double-Blind Period|Consent Withdrawn|2|||
19454583|NCT01499355|41704155|FG000|Double-Blind Period|Lost to Follow-up|0|||
19454584|NCT01499355|41704156|FG001|Double-Blind Period|Lost to Follow-up|1|||
19454585|NCT01499355|41704157|FG002|Double-Blind Period|Lost to Follow-up|0|||
19454586|NCT01499355|41704158|FG003|Double-Blind Period|Lost to Follow-up|0|||
19454587|NCT01474239|41704179|FG000|Overall Study|Disease Progression|37|||
19454588|NCT01474239|41704180|FG001|Overall Study|Disease Progression|25|||
19454589|NCT01474239|41704179|FG000|Overall Study|Adverse Event|12|||
19454590|NCT01474239|41704180|FG001|Overall Study|Adverse Event|3|||
19454591|NCT01474239|41704179|FG000|Overall Study|Withdrawal by Subject|1|||
19454592|NCT01474239|41704180|FG001|Overall Study|Withdrawal by Subject|2|||
19454593|NCT01474239|41704179|FG000|Overall Study|Death|1|||
19534893|NCT00473083|41983054|FG002|Overall Study|Adverse Event|0|||
19534894|NCT00472420|41983065|FG000|Induction Treatment Period|Physician Decision|9|||
19534895|NCT00472420|41983065|FG000|Induction Treatment Period|Adverse Event|3|||
19534896|NCT00472420|41983065|FG000|Induction Treatment Period|Non-compliance|1|||
19534897|NCT00472420|41983065|FG000|Induction Treatment Period|Death|3|||
19534898|NCT00472420|41983065|FG000|Follow-up Period|Death|5|||
19534899|NCT00472420|41983065|FG000|Follow-up Period|Physician Decision|9|||
19534900|NCT00472420|41983065|FG000|Follow-up Period|Lost to Follow-up|2|||
19534901|NCT00472420|41983065|FG000|Follow-up Period|Protocol Violation|1|||
19534902|NCT00472303|41983071|FG000|Titration Phase|Adverse Event|22|||
19534903|NCT00472303|41983072|FG001|Titration Phase|Adverse Event|12|||
19534904|NCT00472303|41983073|FG002|Titration Phase|Adverse Event|0|||
19534905|NCT00472303|41983071|FG000|Titration Phase|Death|4|||
19534906|NCT00472303|41983072|FG001|Titration Phase|Death|2|||
19534907|NCT00472303|41983073|FG002|Titration Phase|Death|0|||
19534908|NCT00472303|41983071|FG000|Titration Phase|Lack of Efficacy|10|||
19534909|NCT00472303|41983072|FG001|Titration Phase|Lack of Efficacy|0|||
19534910|NCT00472303|41983073|FG002|Titration Phase|Lack of Efficacy|0|||
19534911|NCT00472303|41983071|FG000|Titration Phase|Withdrawal by Subject|16|||
19534912|NCT00472303|41983072|FG001|Titration Phase|Withdrawal by Subject|13|||
19534913|NCT00472303|41983073|FG002|Titration Phase|Withdrawal by Subject|0|||
19534914|NCT00472303|41983071|FG000|Titration Phase|Trial Medication non-compliant|4|||
19534915|NCT00472303|41983072|FG001|Titration Phase|Trial Medication non-compliant|1|||
19534916|NCT00472303|41983073|FG002|Titration Phase|Trial Medication non-compliant|0|||
19534917|NCT00472303|41983071|FG000|Titration Phase|Other|3|||
19534918|NCT00472303|41983072|FG001|Titration Phase|Other|1|||
19534919|NCT00472303|41983073|FG002|Titration Phase|Other|0|||
19534920|NCT00472303|41983071|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
19534921|NCT00472303|41983072|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
19534922|NCT00472303|41983073|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
19534923|NCT00472303|41983071|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
19534924|NCT00472303|41983072|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
19534925|NCT00472303|41983073|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
19534926|NCT00472303|41983071|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
19534927|NCT00472303|41983072|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
19534928|NCT00472303|41983073|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
19534929|NCT00472303|41983071|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
19534930|NCT00472303|41983072|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
19534931|NCT00472303|41983073|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
19534932|NCT00472303|41983071|FG000|Discontinuations After Titration Phase|Other|5|||
19454594|NCT01474239|41704180|FG001|Overall Study|Death|1|||
19454595|NCT01474239|41704179|FG000|Overall Study|Clinical Disease Progression|7|||
19454596|NCT01474239|41704180|FG001|Overall Study|Clinical Disease Progression|1|||
19454597|NCT01474239|41704179|FG000|Overall Study|Withdrawal for Economic Reason|1|||
19454598|NCT01474239|41704180|FG001|Overall Study|Withdrawal for Economic Reason|0|||
19454599|NCT01473381|41704190|FG000|Overall Study|Adverse Event|8|||
19454600|NCT01473381|41704191|FG001|Overall Study|Adverse Event|20|||
19454601|NCT01473381|41704192|FG002|Overall Study|Adverse Event|25|||
19454602|NCT01473381|41704193|FG003|Overall Study|Adverse Event|17|||
19454603|NCT01473381|41704190|FG000|Overall Study|Insufficient Therapeutic Response|10|||
19454604|NCT01473381|41704191|FG001|Overall Study|Insufficient Therapeutic Response|1|||
19454605|NCT01473381|41704192|FG002|Overall Study|Insufficient Therapeutic Response|2|||
19454606|NCT01473381|41704193|FG003|Overall Study|Insufficient Therapeutic Response|3|||
19454607|NCT01473381|41704190|FG000|Overall Study|Protocol Violation|17|||
19454608|NCT01473381|41704191|FG001|Overall Study|Protocol Violation|23|||
19454609|NCT01473381|41704192|FG002|Overall Study|Protocol Violation|19|||
19454610|NCT01473381|41704193|FG003|Overall Study|Protocol Violation|17|||
19454611|NCT01473381|41704190|FG000|Overall Study|Withdrawal of Consent|20|||
19454612|NCT01473381|41704191|FG001|Overall Study|Withdrawal of Consent|21|||
19534933|NCT00472303|41983072|FG001|Discontinuations After Titration Phase|Other|0|||
19454613|NCT01473381|41704192|FG002|Overall Study|Withdrawal of Consent|20|||
19454614|NCT01473381|41704193|FG003|Overall Study|Withdrawal of Consent|26|||
19630606|NCT00779766|42079869|FG001|Month 48|Lost to Follow-up|30|||
19534934|NCT00472303|41983073|FG002|Discontinuations After Titration Phase|Other|0|||
19630607|NCT00779766|42079868|FG000|Month 48|Other|1|||
19534935|NCT00472303|41983071|FG000|Maintenance Phase|Adverse Event|5|||
19534936|NCT00472303|41983072|FG001|Maintenance Phase|Adverse Event|6|||
19534937|NCT00472303|41983073|FG002|Maintenance Phase|Adverse Event|6|||
19534938|NCT00472303|41983071|FG000|Maintenance Phase|Death|3|||
19534939|NCT00472303|41983072|FG001|Maintenance Phase|Death|0|||
19534940|NCT00472303|41983073|FG002|Maintenance Phase|Death|2|||
19534941|NCT00472303|41983071|FG000|Maintenance Phase|Lack of Efficacy|2|||
19534942|NCT00472303|41983072|FG001|Maintenance Phase|Lack of Efficacy|2|||
19534943|NCT00472303|41983073|FG002|Maintenance Phase|Lack of Efficacy|4|||
19534944|NCT00472303|41983071|FG000|Maintenance Phase|Withdrawal by Subject|6|||
19454615|NCT01473381|41704190|FG000|Overall Study|Lost to Follow-up|25|||
19454616|NCT01473381|41704191|FG001|Overall Study|Lost to Follow-up|28|||
19454617|NCT01473381|41704192|FG002|Overall Study|Lost to Follow-up|35|||
19454618|NCT01473381|41704193|FG003|Overall Study|Lost to Follow-up|23|||
19454619|NCT01473381|41704190|FG000|Overall Study|Other Reasons|0|||
19454620|NCT01473381|41704191|FG001|Overall Study|Other Reasons|0|||
19454621|NCT01473381|41704192|FG002|Overall Study|Other Reasons|1|||
19454622|NCT01473381|41704193|FG003|Overall Study|Other Reasons|3|||
19534945|NCT00472303|41983072|FG001|Maintenance Phase|Withdrawal by Subject|7|||
19534946|NCT00472303|41983073|FG002|Maintenance Phase|Withdrawal by Subject|3|||
19534947|NCT00472303|41983071|FG000|Maintenance Phase|Trial medication non-compliant|0|||
19534948|NCT00472303|41983072|FG001|Maintenance Phase|Trial medication non-compliant|0|||
19534949|NCT00472303|41983073|FG002|Maintenance Phase|Trial medication non-compliant|1|||
19534950|NCT00472303|41983071|FG000|Maintenance Phase|Resolution of pain|0|||
19534951|NCT00472303|41983072|FG001|Maintenance Phase|Resolution of pain|0|||
19534952|NCT00472303|41983073|FG002|Maintenance Phase|Resolution of pain|1|||
19534953|NCT00472303|41983071|FG000|Maintenance Phase|Other|1|||
19534954|NCT00472303|41983072|FG001|Maintenance Phase|Other|1|||
19534955|NCT00472303|41983073|FG002|Maintenance Phase|Other|0|||
19534956|NCT00471718|41983101|FG000|Overall Study|Adverse Event|3|||
19534957|NCT00471718|41983101|FG000|Overall Study|other complicating disease|1|||
19534958|NCT00471718|41983101|FG000|Overall Study|disease progression|22|||
19534959|NCT00471718|41983101|FG000|Overall Study|Withdrawal by Subject|1|||
19534960|NCT00471445|41983111|FG000|Overall Study|Withdrawal by Subject|1|||
19534961|NCT00471445|41983112|FG001|Overall Study|Withdrawal by Subject|1|||
19534962|NCT00471445|41983111|FG000|Overall Study|Ineligible|1|||
19534963|NCT00471445|41983112|FG001|Overall Study|Ineligible|0|||
19534964|NCT00471445|41983111|FG000|Overall Study|Protocol Violation|0|||
19534965|NCT00471445|41983112|FG001|Overall Study|Protocol Violation|1|||
19534966|NCT00471328|41983120|FG000|Core Phase|Adverse Event|18|||
19534967|NCT00471328|41983121|FG001|Core Phase|Adverse Event|6|||
19534968|NCT00471328|41983120|FG000|Core Phase|Death|8|||
19534969|NCT00471328|41983121|FG001|Core Phase|Death|4|||
19534970|NCT00471328|41983120|FG000|Core Phase|Withdrawal by Subject|2|||
19454623|NCT01499277|41704235|FG000|Overall Study|Adverse Event|3|||
19454624|NCT01499277|41704236|FG001|Overall Study|Adverse Event|6|||
19454625|NCT01499277|41704235|FG000|Overall Study|Death|3|||
19454626|NCT01499277|41704236|FG001|Overall Study|Death|2|||
19454627|NCT01499277|41704235|FG000|Overall Study|Lost to Follow-up|15|||
19454628|NCT01499277|41704236|FG001|Overall Study|Lost to Follow-up|8|||
19454629|NCT01499277|41704235|FG000|Overall Study|Protocol Violation|2|||
19454630|NCT01499277|41704236|FG001|Overall Study|Protocol Violation|3|||
19454631|NCT01499277|41704235|FG000|Overall Study|Withdrawal by Subject|16|||
19454632|NCT01499277|41704236|FG001|Overall Study|Withdrawal by Subject|6|||
19454633|NCT01499277|41704235|FG000|Overall Study|Lack of therapeutic response and other|8|||
19454634|NCT01499277|41704236|FG001|Overall Study|Lack of therapeutic response and other|7|||
19534971|NCT00471328|41983121|FG001|Core Phase|Withdrawal by Subject|2|||
19534972|NCT00471328|41983120|FG000|Core Phase|Abnormal laboratory value|1|||
19630608|NCT00779766|42079869|FG001|Month 48|Other|0|||
19454635|NCT01499199|41704261|FG000|Overall Study|Adverse Event|1|||
19454636|NCT01499199|41704261|FG000|Overall Study|Lack of Efficacy|1|||
19454637|NCT01499043|41704265|FG000|Overall Study|Progressive disease (radiographic)|2|||
19454638|NCT01499043|41704265|FG000|Overall Study|Progressive disease (clinical)|1|||
19454639|NCT01499043|41704265|FG000|Overall Study|Withdrawal by Subject|2|||
19454640|NCT01499043|41704265|FG000|Overall Study|Adverse Event|1|||
19454641|NCT01498887|41704349|FG000|Overall Study|Administrative problems|1|||
19454642|NCT01498887|41704350|FG001|Overall Study|Administrative problems|0|||
19454643|NCT01498887|41704349|FG000|Overall Study|Lost to Follow-up|1|||
19454644|NCT01498887|41704350|FG001|Overall Study|Lost to Follow-up|1|||
19454645|NCT01498887|41704349|FG000|Overall Study|Withdrawal by Subject|1|||
19454646|NCT01498887|41704350|FG001|Overall Study|Withdrawal by Subject|0|||
19454647|NCT01498887|41704349|FG000|Overall Study|Protocol Violation|1|||
19534973|NCT00471328|41983121|FG001|Core Phase|Abnormal laboratory value|0|||
19534974|NCT00471328|41983120|FG000|Core Phase|Disease Progression|78|||
19534975|NCT00471328|41983121|FG001|Core Phase|Disease Progression|53|||
19534976|NCT00471328|41983120|FG000|Core Phase|Administrative Problem|0|||
19534977|NCT00471328|41983121|FG001|Core Phase|Administrative Problem|1|||
19534978|NCT00471328|41983120|FG000|Core Phase|Protocol Deviation|0|||
19534979|NCT00471328|41983121|FG001|Core Phase|Protocol Deviation|1|||
19630609|NCT00779766|42079868|FG000|Month 72|Withdrawal by Subject|55|||
19534980|NCT00471328|41983120|FG000|Extension Phase|Adverse Event|3|||
19534981|NCT00471328|41983121|FG001|Extension Phase|Adverse Event|12|||
19534982|NCT00471328|41983120|FG000|Extension Phase|Withdrawal by Subject|0|||
19534983|NCT00471328|41983121|FG001|Extension Phase|Withdrawal by Subject|2|||
19534984|NCT00471328|41983120|FG000|Extension Phase|Death|1|||
19534985|NCT00471328|41983121|FG001|Extension Phase|Death|7|||
19534986|NCT00471328|41983120|FG000|Extension Phase|Protocol Deviation|3|||
19534987|NCT00471328|41983121|FG001|Extension Phase|Protocol Deviation|1|||
19534988|NCT00471328|41983120|FG000|Extension Phase|Treatment duration as per protocol|0|||
19534989|NCT00471328|41983121|FG001|Extension Phase|Treatment duration as per protocol|1|||
19534990|NCT00471328|41983120|FG000|Extension Phase|Disease Progression|32|||
19534991|NCT00471328|41983121|FG001|Extension Phase|Disease Progression|44|||
19534992|NCT00471328|41983120|FG000|Extension Phase|New cancer Therapy|1|||
19534993|NCT00471328|41983121|FG001|Extension Phase|New cancer Therapy|0|||
19534994|NCT00471328|41983120|FG000|Extension Phase|Administrative Problem|1|||
19534995|NCT00471328|41983121|FG001|Extension Phase|Administrative Problem|0|||
19630610|NCT00779766|42079869|FG001|Month 72|Withdrawal by Subject|71|||
19630611|NCT00779766|42079868|FG000|Month 72|Migrated/moved from study area|124|||
19454648|NCT01498887|41704350|FG001|Overall Study|Protocol Violation|3|||
19454649|NCT01498887|41704349|FG000|Overall Study|Lack of Efficacy|5|||
19454650|NCT01498887|41704350|FG001|Overall Study|Lack of Efficacy|3|||
19454651|NCT01498887|41704349|FG000|Overall Study|Abnormal result from test procedure|1|||
19454652|NCT01498887|41704350|FG001|Overall Study|Abnormal result from test procedure|1|||
19454653|NCT01498887|41704349|FG000|Overall Study|Abnormal laboratory value|2|||
19454654|NCT01498887|41704350|FG001|Overall Study|Abnormal laboratory value|2|||
19454655|NCT01498887|41704349|FG000|Overall Study|Adverse Event|4|||
19454656|NCT01498887|41704350|FG001|Overall Study|Adverse Event|1|||
19454657|NCT01498653|41704359|FG000|Overall Study|Adverse Event|2|||
19454658|NCT01498653|41704360|FG001|Overall Study|Adverse Event|2|||
19454659|NCT01498653|41704359|FG000|Overall Study|Lack of Efficacy|12|||
19454660|NCT01498653|41704360|FG001|Overall Study|Lack of Efficacy|26|||
19454661|NCT01498653|41704359|FG000|Overall Study|Protocol Violation|0|||
19454662|NCT01498653|41704360|FG001|Overall Study|Protocol Violation|4|||
19454663|NCT01498653|41704359|FG000|Overall Study|Lost to Follow-up|1|||
19454664|NCT01498653|41704360|FG001|Overall Study|Lost to Follow-up|0|||
19454665|NCT01498653|41704359|FG000|Overall Study|Physician Decision|2|||
19454666|NCT01498653|41704360|FG001|Overall Study|Physician Decision|0|||
19454667|NCT01498653|41704359|FG000|Overall Study|Withdrawal by Subject|2|||
19454668|NCT01498653|41704360|FG001|Overall Study|Withdrawal by Subject|3|||
19454669|NCT01498575|41704368|FG000|Overall Sample|Withdrawal by Subject|60|||
19454670|NCT01498575|41704369|FG001|Overall Sample|Withdrawal by Subject|14|||
19454671|NCT01498575|41704368|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
19454672|NCT01498575|41704369|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
19454673|NCT01498575|41704368|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
19454674|NCT01498575|41704369|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
19454675|NCT01498185|41704380|FG000|Overall Study|Adverse Event|0|||
19454676|NCT01498185|41704381|FG001|Overall Study|Adverse Event|0|||
19454677|NCT01498185|41704382|FG002|Overall Study|Adverse Event|0|||
19454678|NCT01498185|41704383|FG003|Overall Study|Adverse Event|1|||
19454679|NCT01498185|41704384|FG004|Overall Study|Adverse Event|0|||
19454680|NCT01498185|41704380|FG000|Overall Study|Withdrawal by Subject|1|||
19454681|NCT01498185|41704381|FG001|Overall Study|Withdrawal by Subject|1|||
19454682|NCT01498185|41704382|FG002|Overall Study|Withdrawal by Subject|0|||
19454683|NCT01498185|41704383|FG003|Overall Study|Withdrawal by Subject|2|||
19454684|NCT01498185|41704384|FG004|Overall Study|Withdrawal by Subject|1|||
19454685|NCT01498185|41704380|FG000|Overall Study|No longer met criteria, etc|0|||
19454686|NCT01498185|41704381|FG001|Overall Study|No longer met criteria, etc|0|||
19454687|NCT01498185|41704382|FG002|Overall Study|No longer met criteria, etc|0|||
19454688|NCT01498185|41704383|FG003|Overall Study|No longer met criteria, etc|0|||
19454689|NCT01498185|41704384|FG004|Overall Study|No longer met criteria, etc|2|||
19454690|NCT01528605|41704406|FG000|Overall Study|Lost to Follow-up|1|||
19454691|NCT01528605|41704407|FG001|Overall Study|Lost to Follow-up|0|||
19534996|NCT00470704|41983131|FG000|Overall Study|Withdrawal by Subject|4|||
19534997|NCT00470704|41983132|FG001|Overall Study|Withdrawal by Subject|3|||
19534998|NCT00470704|41983131|FG000|Overall Study|Relapse/Progression|37|||
19534999|NCT00470704|41983132|FG001|Overall Study|Relapse/Progression|42|||
19535000|NCT00470704|41983131|FG000|Overall Study|toxicity|0|||
19535001|NCT00470704|41983132|FG001|Overall Study|toxicity|1|||
19535002|NCT00470470|41983138|FG000|Overall Study|Adverse Event|2|||
19454692|NCT01528605|41704408|FG002|Overall Study|Lost to Follow-up|1|||
19454693|NCT01528605|41704409|FG003|Overall Study|Lost to Follow-up|1|||
19454694|NCT01528605|41704410|FG004|Overall Study|Lost to Follow-up|0|||
19454695|NCT01528605|41704411|FG005|Overall Study|Lost to Follow-up|0|||
19454696|NCT01528605|41704406|FG000|Overall Study|Death|1|||
19454697|NCT01528605|41704407|FG001|Overall Study|Death|0|||
19454698|NCT01528605|41704408|FG002|Overall Study|Death|0|||
19535003|NCT00470470|41983138|FG000|Overall Study|Death|2|||
19535004|NCT00470470|41983138|FG000|Overall Study|Not treated|1|||
19535005|NCT00470275|41983142|FG000|Overall Study|Death|1|||
19535006|NCT00470275|41983142|FG000|Overall Study|Lack of Efficacy|7|||
19535007|NCT00470275|41983142|FG000|Overall Study|Withdrawal by Subject|2|||
19535008|NCT00470158|41983151|FG000|Overall Study|Death|0|||
19535009|NCT00470158|41983152|FG001|Overall Study|Death|0|||
19535010|NCT00470158|41983153|FG002|Overall Study|Death|0|||
19535011|NCT00470158|41983154|FG003|Overall Study|Death|0|||
19535012|NCT00470158|41983155|FG004|Overall Study|Death|2|||
19535013|NCT00470158|41983151|FG000|Overall Study|Lost to Follow-up|7|||
19535014|NCT00470158|41983152|FG001|Overall Study|Lost to Follow-up|8|||
19535015|NCT00470158|41983153|FG002|Overall Study|Lost to Follow-up|8|||
19535016|NCT00470158|41983154|FG003|Overall Study|Lost to Follow-up|5|||
19535017|NCT00470158|41983155|FG004|Overall Study|Lost to Follow-up|4|||
19535018|NCT00470158|41983151|FG000|Overall Study|Protocol Violation|1|||
19535019|NCT00470158|41983152|FG001|Overall Study|Protocol Violation|0|||
19535020|NCT00470158|41983153|FG002|Overall Study|Protocol Violation|0|||
19535021|NCT00470158|41983154|FG003|Overall Study|Protocol Violation|0|||
19535022|NCT00470158|41983155|FG004|Overall Study|Protocol Violation|0|||
19535023|NCT00475540|41983169|FG000|36 Months|Lost to Follow-up|4|||
19535024|NCT00475540|41983170|FG001|36 Months|Lost to Follow-up|4|||
19535025|NCT00475540|41983169|FG000|36 Months|Death|1|||
19535026|NCT00475540|41983170|FG001|36 Months|Death|2|||
19535027|NCT00475540|41983169|FG000|36 Months|Censored due to reoperation|3|||
19535028|NCT00475540|41983170|FG001|36 Months|Censored due to reoperation|0|||
19711506|NCT00082173|42154603|FG000|Overall Study|Culture negative or resistant at baselin|5|||
19454699|NCT01528605|41704409|FG003|Overall Study|Death|0|||
19454700|NCT01528605|41704410|FG004|Overall Study|Death|0|||
19454701|NCT01528605|41704411|FG005|Overall Study|Death|0|||
19454702|NCT01528215|41704427|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
19535029|NCT00472186|41983178|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
19535030|NCT00472186|41983179|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
19535031|NCT00479713|41983189|FG000|Overall Study|Adverse Event|8|||
19535032|NCT00479713|41983190|FG001|Overall Study|Adverse Event|6|||
19535033|NCT00479713|41983189|FG000|Overall Study|Death|1|||
19535034|NCT00479713|41983190|FG001|Overall Study|Death|0|||
19454703|NCT01528215|41704428|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
19535035|NCT00479713|41983189|FG000|Overall Study|Lost to Follow-up|0|||
19535036|NCT00479713|41983190|FG001|Overall Study|Lost to Follow-up|1|||
19535037|NCT00479713|41983189|FG000|Overall Study|Protocol Violation|0|||
19535038|NCT00479713|41983190|FG001|Overall Study|Protocol Violation|1|||
19535039|NCT00479713|41983189|FG000|Overall Study|Withdrawal by Subject|4|||
19535040|NCT00479713|41983190|FG001|Overall Study|Withdrawal by Subject|1|||
19535041|NCT00474526|41983222|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
19535042|NCT00474526|41983223|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
19535043|NCT00474526|41983224|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
19535044|NCT00474526|41983225|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
19535045|NCT00474526|41983226|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
19535046|NCT00474526|41983227|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
19535047|NCT00474526|41983228|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
19535048|NCT00474526|41983229|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
19535049|NCT00474526|41983230|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
19535050|NCT00474526|41983231|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
19535051|NCT00474526|41983232|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
19535052|NCT00474526|41983233|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
19535053|NCT00474526|41983234|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
19535054|NCT00474526|41983235|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
19535055|NCT00474526|41983236|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
19535056|NCT00474526|41983237|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
19535057|NCT00474526|41983238|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
19535058|NCT00474526|41983222|FG000|Overall Study|Adverse Event|2|||
19535059|NCT00474526|41983223|FG001|Overall Study|Adverse Event|0|||
19535060|NCT00474526|41983224|FG002|Overall Study|Adverse Event|2|||
19454704|NCT01528215|41704427|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
19454705|NCT01528215|41704428|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
19454706|NCT01528215|41704427|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
19454707|NCT01528215|41704428|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
19454708|NCT01528215|41704427|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
19454709|NCT01528215|41704428|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
19454710|NCT01527357|41704436|FG000|Overall Study|Death|8|||
19454711|NCT01527357|41704437|FG001|Overall Study|Death|2|||
19454712|NCT01527357|41704436|FG000|Overall Study|Lost to Follow-up|6|||
19454713|NCT01527357|41704437|FG001|Overall Study|Lost to Follow-up|4|||
19454714|NCT01527357|41704436|FG000|Overall Study|Withdrew Consent|1|||
19454715|NCT01527357|41704437|FG001|Overall Study|Withdrew Consent|1|||
19454716|NCT01527357|41704436|FG000|Overall Study|Non-compliance|0|||
19454717|NCT01527357|41704437|FG001|Overall Study|Non-compliance|1|||
19454718|NCT01527357|41704436|FG000|Overall Study|No Day 29 Visit|0|||
19454719|NCT01527357|41704437|FG001|Overall Study|No Day 29 Visit|1|||
19454720|NCT01527357|41704436|FG000|Overall Study|Did Not Receive Treatment|2|||
19454721|NCT01527357|41704437|FG001|Overall Study|Did Not Receive Treatment|0|||
19454722|NCT01526889|41704456|FG000|Treatment Period|Adverse Event|2|||
19454723|NCT01526889|41704457|FG001|Treatment Period|Adverse Event|0|||
19454724|NCT01526889|41704456|FG000|Treatment Extension Period|Administrative problems|1|||
19454725|NCT01526889|41704457|FG001|Treatment Extension Period|Administrative problems|0|||
19454726|NCT01472835|41704469|FG000|Overall Study|Lost to Follow-up|2|||
19454727|NCT01472835|41704470|FG001|Overall Study|Lost to Follow-up|0|||
19454728|NCT01526733|41704483|FG000|Phase 1|Protocol Violation|1|||
19454729|NCT01526733|41704484|FG001|Phase 1|Protocol Violation|0|||
19454730|NCT01526733|41704483|FG000|Phase 1|Withdrawal by Subject|1|||
19454731|NCT01526733|41704484|FG001|Phase 1|Withdrawal by Subject|1|||
19454732|NCT01472757|41704529|FG000|Overall Study|Withdrawal by Subject|1|||
19454733|NCT01472757|41704530|FG001|Overall Study|Withdrawal by Subject|2|||
19454734|NCT01472757|41704531|FG002|Overall Study|Withdrawal by Subject|2|||
19454735|NCT01472757|41704532|FG003|Overall Study|Withdrawal by Subject|0|||
19454736|NCT01472757|41704529|FG000|Overall Study|Asthma exacerbation|4|||
19454737|NCT01472757|41704530|FG001|Overall Study|Asthma exacerbation|1|||
19454738|NCT01472757|41704531|FG002|Overall Study|Asthma exacerbation|2|||
19454739|NCT01472757|41704532|FG003|Overall Study|Asthma exacerbation|1|||
19454740|NCT01472757|41704529|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
19454741|NCT01472757|41704530|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
19454742|NCT01472757|41704531|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
19454743|NCT01472757|41704532|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
19535061|NCT00474526|41983225|FG003|Overall Study|Adverse Event|4|||
19535062|NCT00474526|41983226|FG004|Overall Study|Adverse Event|2|||
19535063|NCT00474526|41983227|FG005|Overall Study|Adverse Event|1|||
19535064|NCT00474526|41983228|FG006|Overall Study|Adverse Event|1|||
19454744|NCT01472757|41704529|FG000|Overall Study|Protocol Violation|3|||
19454745|NCT01472757|41704530|FG001|Overall Study|Protocol Violation|2|||
19454746|NCT01472757|41704531|FG002|Overall Study|Protocol Violation|4|||
19454747|NCT01472757|41704532|FG003|Overall Study|Protocol Violation|4|||
19454748|NCT01472757|41704529|FG000|Overall Study|Other reasons|1|||
19454749|NCT01472757|41704530|FG001|Overall Study|Other reasons|0|||
19454750|NCT01472757|41704531|FG002|Overall Study|Other reasons|2|||
19454751|NCT01472757|41704532|FG003|Overall Study|Other reasons|2|||
19535065|NCT00474526|41983229|FG007|Overall Study|Adverse Event|0|||
19535066|NCT00474526|41983230|FG008|Overall Study|Adverse Event|0|||
19535067|NCT00474526|41983231|FG009|Overall Study|Adverse Event|0|||
19535068|NCT00474526|41983232|FG010|Overall Study|Adverse Event|0|||
19535069|NCT00474526|41983233|FG011|Overall Study|Adverse Event|0|||
19535070|NCT00474526|41983234|FG012|Overall Study|Adverse Event|0|||
19535071|NCT00474526|41983235|FG013|Overall Study|Adverse Event|0|||
19535072|NCT00474526|41983236|FG014|Overall Study|Adverse Event|1|||
19535073|NCT00474526|41983237|FG015|Overall Study|Adverse Event|1|||
19535074|NCT00474526|41983238|FG016|Overall Study|Adverse Event|0|||
19535075|NCT00474526|41983222|FG000|Overall Study|Death|0|||
19535076|NCT00474526|41983223|FG001|Overall Study|Death|0|||
19535077|NCT00474526|41983224|FG002|Overall Study|Death|0|||
19535078|NCT00474526|41983225|FG003|Overall Study|Death|0|||
19535079|NCT00474526|41983226|FG004|Overall Study|Death|0|||
19535080|NCT00474526|41983227|FG005|Overall Study|Death|0|||
19535081|NCT00474526|41983228|FG006|Overall Study|Death|0|||
19535082|NCT00474526|41983229|FG007|Overall Study|Death|0|||
19535083|NCT00474526|41983230|FG008|Overall Study|Death|0|||
19535084|NCT00474526|41983231|FG009|Overall Study|Death|0|||
19535085|NCT00474526|41983232|FG010|Overall Study|Death|0|||
19535086|NCT00474526|41983233|FG011|Overall Study|Death|0|||
19535087|NCT00474526|41983234|FG012|Overall Study|Death|0|||
19535088|NCT00474526|41983235|FG013|Overall Study|Death|3|||
19535089|NCT00474526|41983236|FG014|Overall Study|Death|0|||
19535090|NCT00474526|41983237|FG015|Overall Study|Death|0|||
19535091|NCT00474526|41983238|FG016|Overall Study|Death|0|||
19535092|NCT00474526|41983222|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535093|NCT00474526|41983223|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
19535094|NCT00474526|41983224|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19454752|NCT01472289|41704551|FG000|Overall Study|Death|2|||
19454753|NCT01525875|41704570|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
19454754|NCT01525875|41704571|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
19454755|NCT01525875|41704570|FG000|Open-label Period|Lost to Follow-up|0|||
19454756|NCT01525875|41704571|FG001|Open-label Period|Lost to Follow-up|2|||
19454757|NCT01525641|41704577|FG000|Overall Study|Case report form not collected|25|||
19535095|NCT00474526|41983225|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
19535096|NCT00474526|41983226|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
19535097|NCT00474526|41983227|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19454758|NCT01525641|41704577|FG000|Overall Study|No visit since the first visit|16|||
19454759|NCT01525641|41704577|FG000|Overall Study|Adverse Event|73|||
19454760|NCT01525641|41704577|FG000|Overall Study|Lack of Efficacy|24|||
19454761|NCT01525641|41704577|FG000|Overall Study|Improvement|5|||
19454762|NCT01525641|41704577|FG000|Overall Study|Lost to follow-up (relocation)|1|||
19454763|NCT01525641|41704577|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
19454764|NCT01525641|41704577|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
19454765|NCT01525641|41704577|FG000|Overall Study|Other than stated above|7|||
19454766|NCT01496469|41704592|FG000|Overall Study|Adverse Event|1|||
19454767|NCT01496469|41704593|FG001|Overall Study|Adverse Event|0|||
19535098|NCT00474526|41983228|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535099|NCT00474526|41983229|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535100|NCT00474526|41983230|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535101|NCT00474526|41983231|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19630612|NCT00779766|42079869|FG001|Month 72|Migrated/moved from study area|109|||
19630613|NCT00779766|42079868|FG000|Month 72|Lost to Follow-up|6|||
19630614|NCT00779766|42079869|FG001|Month 72|Lost to Follow-up|8|||
19454768|NCT01496469|41704592|FG000|Overall Study|Protocol Violation|2|||
19454769|NCT01496469|41704593|FG001|Overall Study|Protocol Violation|0|||
19454770|NCT01496469|41704592|FG000|Overall Study|Lost to Follow-up|1|||
19454771|NCT01496469|41704593|FG001|Overall Study|Lost to Follow-up|1|||
19454772|NCT01496469|41704592|FG000|Overall Study|Withdrawal by Subject|4|||
19454773|NCT01496469|41704593|FG001|Overall Study|Withdrawal by Subject|4|||
19535102|NCT00474526|41983232|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535103|NCT00474526|41983233|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535104|NCT00474526|41983234|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535105|NCT00474526|41983235|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
19535106|NCT00474526|41983236|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
19535107|NCT00474526|41983237|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535108|NCT00474526|41983238|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
19535109|NCT00474526|41983222|FG000|Overall Study|Lost to Follow-up|8|||
19535110|NCT00474526|41983223|FG001|Overall Study|Lost to Follow-up|6|||
19630615|NCT00779766|42079868|FG000|Month 72|Other|0|||
19454774|NCT01496469|41704592|FG000|Overall Study|BP exceeds protocol limits|1|||
19454775|NCT01496469|41704593|FG001|Overall Study|BP exceeds protocol limits|2|||
19454776|NCT01496469|41704592|FG000|Overall Study|Other|1|||
19535111|NCT00474526|41983224|FG002|Overall Study|Lost to Follow-up|13|||
19535112|NCT00474526|41983225|FG003|Overall Study|Lost to Follow-up|29|||
19535113|NCT00474526|41983226|FG004|Overall Study|Lost to Follow-up|11|||
19535114|NCT00474526|41983227|FG005|Overall Study|Lost to Follow-up|5|||
19454777|NCT01496469|41704593|FG001|Overall Study|Other|1|||
19454778|NCT01471353|41704608|FG000|Overall Study|remain on study|3|||
19454779|NCT01525407|41704614|FG000|Overall Study|Change in recipient treatment plan|2|||
19454780|NCT01525407|41704615|FG001|Overall Study|Change in recipient treatment plan|2|||
19454781|NCT01525407|41704614|FG000|Overall Study|Withdrawal by Subject|0|||
19454782|NCT01525407|41704615|FG001|Overall Study|Withdrawal by Subject|1|||
19454783|NCT01525407|41704614|FG000|Overall Study|Transplant was delayed|0|||
19454784|NCT01525407|41704615|FG001|Overall Study|Transplant was delayed|1|||
19454785|NCT01525407|41704614|FG000|Overall Study|Delay in Transplant|1|||
19454786|NCT01525407|41704615|FG001|Overall Study|Delay in Transplant|0|||
19454787|NCT01471197|41704623|FG000|Overall Study|Disease Progression|4|||
19454788|NCT01471197|41704624|FG001|Overall Study|Disease Progression|2|||
19454789|NCT01471197|41704623|FG000|Overall Study|Death|1|||
19535115|NCT00474526|41983228|FG006|Overall Study|Lost to Follow-up|8|||
19535116|NCT00474526|41983229|FG007|Overall Study|Lost to Follow-up|1|||
19535117|NCT00474526|41983230|FG008|Overall Study|Lost to Follow-up|0|||
19454790|NCT01471197|41704624|FG001|Overall Study|Death|0|||
19454791|NCT01471197|41704623|FG000|Overall Study|Study Drug Toxicity|1|||
19454792|NCT01471197|41704624|FG001|Overall Study|Study Drug Toxicity|0|||
19454793|NCT01524783|41704658|FG000|Blinded Period|Adverse Event|64|||
19454794|NCT01524783|41704659|FG001|Blinded Period|Adverse Event|7|||
19454795|NCT01524783|41704660|FG002|Blinded Period|Adverse Event|0|||
19454796|NCT01524783|41704658|FG000|Blinded Period|Disease Progression|89|||
19454797|NCT01524783|41704659|FG001|Blinded Period|Disease Progression|75|||
19454798|NCT01524783|41704660|FG002|Blinded Period|Disease Progression|0|||
19454799|NCT01524783|41704658|FG000|Blinded Period|Withdrawal by Subject|19|||
19454800|NCT01524783|41704659|FG001|Blinded Period|Withdrawal by Subject|6|||
19454801|NCT01524783|41704660|FG002|Blinded Period|Withdrawal by Subject|0|||
19535118|NCT00474526|41983231|FG009|Overall Study|Lost to Follow-up|6|||
19454802|NCT01524783|41704658|FG000|Blinded Period|Protocol deviation|2|||
19454803|NCT01524783|41704659|FG001|Blinded Period|Protocol deviation|1|||
19454804|NCT01524783|41704660|FG002|Blinded Period|Protocol deviation|0|||
19454805|NCT01524783|41704658|FG000|Blinded Period|Death|5|||
19454806|NCT01524783|41704659|FG001|Blinded Period|Death|2|||
19454807|NCT01524783|41704660|FG002|Blinded Period|Death|0|||
19454808|NCT01524783|41704658|FG000|Open-label Period|Disease progression|13|||
19454809|NCT01524783|41704659|FG001|Open-label Period|Disease progression|0|||
19535119|NCT00474526|41983232|FG010|Overall Study|Lost to Follow-up|2|||
19535120|NCT00474526|41983233|FG011|Overall Study|Lost to Follow-up|4|||
19535121|NCT00474526|41983234|FG012|Overall Study|Lost to Follow-up|6|||
19454810|NCT01524783|41704660|FG002|Open-label Period|Disease progression|2|||
19454811|NCT01524783|41704658|FG000|Open-label Period|Administrative problems|5|||
19454812|NCT01524783|41704659|FG001|Open-label Period|Administrative problems|0|||
19454813|NCT01524783|41704660|FG002|Open-label Period|Administrative problems|2|||
19454814|NCT01524783|41704658|FG000|Open-label Period|Adverse Event|5|||
19454815|NCT01524783|41704659|FG001|Open-label Period|Adverse Event|0|||
19454816|NCT01524783|41704660|FG002|Open-label Period|Adverse Event|1|||
19454817|NCT01524783|41704658|FG000|Open-label Period|Withdrawal by Subject|2|||
19454818|NCT01524783|41704659|FG001|Open-label Period|Withdrawal by Subject|0|||
19454819|NCT01524783|41704660|FG002|Open-label Period|Withdrawal by Subject|1|||
19454820|NCT01524783|41704658|FG000|Open-label Period|Protocol deviation|1|||
19454821|NCT01524783|41704659|FG001|Open-label Period|Protocol deviation|0|||
19454822|NCT01524783|41704660|FG002|Open-label Period|Protocol deviation|0|||
19454823|NCT01494987|41704674|FG000|Overall Study|Adverse Event|6|||
19454824|NCT01494987|41704675|FG001|Overall Study|Adverse Event|5|||
19454825|NCT01494987|41704674|FG000|Overall Study|Hyperglycemia|6|||
19454826|NCT01494987|41704675|FG001|Overall Study|Hyperglycemia|4|||
19454827|NCT01494987|41704674|FG000|Overall Study|Investigator's Discretion|1|||
19454828|NCT01494987|41704675|FG001|Overall Study|Investigator's Discretion|2|||
19535122|NCT00474526|41983235|FG013|Overall Study|Lost to Follow-up|74|||
19454829|NCT01494987|41704674|FG000|Overall Study|Lost to Follow-up|1|||
19454830|NCT01494987|41704675|FG001|Overall Study|Lost to Follow-up|1|||
19454831|NCT01494987|41704674|FG000|Overall Study|Protocol Violation|3|||
19454832|NCT01494987|41704675|FG001|Overall Study|Protocol Violation|3|||
19454833|NCT01494987|41704674|FG000|Overall Study|Subject Non-Compliance|9|||
19454834|NCT01494987|41704675|FG001|Overall Study|Subject Non-Compliance|10|||
19454835|NCT01494987|41704674|FG000|Overall Study|Subject Withdrew Consent|2|||
19535123|NCT00474526|41983236|FG014|Overall Study|Lost to Follow-up|29|||
19535124|NCT00474526|41983237|FG015|Overall Study|Lost to Follow-up|4|||
19535125|NCT00474526|41983238|FG016|Overall Study|Lost to Follow-up|5|||
19535126|NCT00474526|41983222|FG000|Overall Study|Protocol Violation|2|||
19535127|NCT00474526|41983223|FG001|Overall Study|Protocol Violation|6|||
19535128|NCT00474526|41983224|FG002|Overall Study|Protocol Violation|4|||
19535129|NCT00474526|41983225|FG003|Overall Study|Protocol Violation|12|||
19535130|NCT00474526|41983226|FG004|Overall Study|Protocol Violation|3|||
19535131|NCT00474526|41983227|FG005|Overall Study|Protocol Violation|1|||
19535132|NCT00474526|41983228|FG006|Overall Study|Protocol Violation|3|||
19535133|NCT00474526|41983229|FG007|Overall Study|Protocol Violation|0|||
19535134|NCT00474526|41983230|FG008|Overall Study|Protocol Violation|0|||
19454836|NCT01494987|41704675|FG001|Overall Study|Subject Withdrew Consent|3|||
19454837|NCT01470417|41704683|FG000|Overall Study|Disease progression|0|||
19454838|NCT01470417|41704684|FG001|Overall Study|Disease progression|2|||
19454839|NCT01524627|41704692|FG000|Overall Study|Physician Decision|0|||
19454840|NCT01524627|41704693|FG001|Overall Study|Physician Decision|1|||
19454841|NCT01524627|41704692|FG000|Overall Study|Lost to Follow-up|1|||
19454842|NCT01524627|41704693|FG001|Overall Study|Lost to Follow-up|1|||
19454843|NCT01469637|41704701|FG000|First Intervention|Unacceptable behavior|0|||
19454844|NCT01469637|41704702|FG001|First Intervention|Unacceptable behavior|1|||
19454845|NCT01469637|41704701|FG000|Second Intervention|Incarcerated|1|||
19454846|NCT01469637|41704702|FG001|Second Intervention|Incarcerated|0|||
19454847|NCT04842747|41705122|FG000|Overall Study|Withdrawal by Subject|6|||
19454848|NCT04842747|41705123|FG001|Overall Study|Withdrawal by Subject|2|||
19454849|NCT04842747|41705122|FG000|Overall Study|Lost to Follow-up|1|||
19535135|NCT00474526|41983231|FG009|Overall Study|Protocol Violation|4|||
19535136|NCT00474526|41983232|FG010|Overall Study|Protocol Violation|2|||
19535137|NCT00474526|41983233|FG011|Overall Study|Protocol Violation|2|||
19535138|NCT00474526|41983234|FG012|Overall Study|Protocol Violation|4|||
19535139|NCT00474526|41983235|FG013|Overall Study|Protocol Violation|19|||
19535140|NCT00474526|41983236|FG014|Overall Study|Protocol Violation|9|||
19535141|NCT00474526|41983237|FG015|Overall Study|Protocol Violation|6|||
19535142|NCT00474526|41983238|FG016|Overall Study|Protocol Violation|2|||
19535143|NCT00474526|41983222|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
19535144|NCT00474526|41983223|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
19535145|NCT00474526|41983224|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
19535146|NCT00474526|41983225|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
19535147|NCT00474526|41983226|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
19535148|NCT00474526|41983227|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
19535149|NCT00474526|41983228|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
19535150|NCT00474526|41983229|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
19535151|NCT00474526|41983230|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
19535152|NCT00474526|41983231|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
19535153|NCT00474526|41983232|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
19535154|NCT00474526|41983233|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
19535155|NCT00474526|41983234|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
19535156|NCT00474526|41983235|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
19535157|NCT00474526|41983236|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
19535158|NCT00474526|41983237|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
19535159|NCT00474526|41983238|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
19535160|NCT00474526|41983222|FG000|Overall Study|Withdrawal by Subject|9|||
19535161|NCT00474526|41983223|FG001|Overall Study|Withdrawal by Subject|24|||
19535162|NCT00474526|41983224|FG002|Overall Study|Withdrawal by Subject|21|||
19535163|NCT00474526|41983225|FG003|Overall Study|Withdrawal by Subject|52|||
19535164|NCT00474526|41983226|FG004|Overall Study|Withdrawal by Subject|38|||
19535165|NCT00474526|41983227|FG005|Overall Study|Withdrawal by Subject|6|||
19535166|NCT00474526|41983228|FG006|Overall Study|Withdrawal by Subject|12|||
19535167|NCT00474526|41983229|FG007|Overall Study|Withdrawal by Subject|4|||
19535168|NCT00474526|41983230|FG008|Overall Study|Withdrawal by Subject|4|||
19535169|NCT00474526|41983231|FG009|Overall Study|Withdrawal by Subject|13|||
19535170|NCT00474526|41983232|FG010|Overall Study|Withdrawal by Subject|5|||
19535171|NCT00474526|41983233|FG011|Overall Study|Withdrawal by Subject|4|||
19535172|NCT00474526|41983234|FG012|Overall Study|Withdrawal by Subject|4|||
19535173|NCT00474526|41983235|FG013|Overall Study|Withdrawal by Subject|37|||
19535174|NCT00474526|41983236|FG014|Overall Study|Withdrawal by Subject|22|||
19535175|NCT00474526|41983237|FG015|Overall Study|Withdrawal by Subject|1|||
19535176|NCT00474526|41983238|FG016|Overall Study|Withdrawal by Subject|1|||
19535177|NCT00478426|41983324|FG000|Overall Study|Withdrawal by Subject|1|||
19535178|NCT00477412|41983332|FG000|Overall Study|Death|0|||
19535179|NCT00477412|41983333|FG001|Overall Study|Death|0|||
19454850|NCT04842747|41705123|FG001|Overall Study|Lost to Follow-up|2|||
19535180|NCT00477412|41983334|FG002|Overall Study|Death|0|||
19535181|NCT00477412|41983335|FG003|Overall Study|Death|4|||
19535182|NCT00477412|41983332|FG000|Overall Study|Lost to Follow-up|0|||
19535183|NCT00477412|41983333|FG001|Overall Study|Lost to Follow-up|0|||
19535184|NCT00477412|41983334|FG002|Overall Study|Lost to Follow-up|0|||
19535185|NCT00477412|41983335|FG003|Overall Study|Lost to Follow-up|1|||
19535186|NCT00477412|41983332|FG000|Overall Study|Withdrawal by Subject|0|||
19535187|NCT00477412|41983333|FG001|Overall Study|Withdrawal by Subject|0|||
19535188|NCT00477412|41983334|FG002|Overall Study|Withdrawal by Subject|0|||
19454851|NCT04842747|41705122|FG000|Overall Study|Physician Decision|1|||
19535189|NCT00477412|41983335|FG003|Overall Study|Withdrawal by Subject|2|||
19535190|NCT00477412|41983332|FG000|Overall Study|Second Malignancy|0|||
19535191|NCT00477412|41983333|FG001|Overall Study|Second Malignancy|0|||
19535192|NCT00477412|41983334|FG002|Overall Study|Second Malignancy|0|||
19454852|NCT04842747|41705123|FG001|Overall Study|Physician Decision|0|||
19454853|NCT04842747|41705122|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
19535193|NCT00477412|41983335|FG003|Overall Study|Second Malignancy|1|||
19454854|NCT04842747|41705123|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
19454855|NCT04810481|41705131|FG000|Overall Study|Disqualified data sets|10|||
19454856|NCT04810481|41705132|FG001|Overall Study|Disqualified data sets|28|||
19454857|NCT04664400|41705151|FG000|Overall Study|Withdrawal by Subject|2|||
19454858|NCT04657770|41705156|FG000|Overall Study|Withdrawal by Subject|3|||
19454859|NCT04657770|41705156|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
19454860|NCT04496453|41705160|FG000|Overall Study|Lost to Follow-up|6|||
19535194|NCT00477412|41983332|FG000|Overall Study|Adverse Event|1|||
19535195|NCT00477412|41983333|FG001|Overall Study|Adverse Event|0|||
19454861|NCT04482647|41705164|FG000|Overall Study|Time constraints|2|||
19454862|NCT04482647|41705164|FG000|Overall Study|Health issues|1|||
19454863|NCT04482647|41705164|FG000|Overall Study|Death in the family|1|||
19454864|NCT04482647|41705164|FG000|Overall Study|Disliked the intervention|1|||
19454865|NCT04482647|41705164|FG000|Overall Study|No reasons specified|7|||
19454866|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
19454867|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
19454868|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
19454869|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
19454870|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
19454871|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
19454872|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
19454873|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
19454874|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19454875|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19454876|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19454877|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
19535196|NCT00477412|41983334|FG002|Overall Study|Adverse Event|1|||
19535197|NCT00477412|41983335|FG003|Overall Study|Adverse Event|0|||
19630616|NCT00779766|42079869|FG001|Month 72|Other|1|||
19630617|NCT00846365|42079879|FG000|Overall Study|Adverse Event|20|||
19630618|NCT00846365|42079880|FG001|Overall Study|Adverse Event|30|||
19630619|NCT00846365|42079881|FG002|Overall Study|Adverse Event|11|||
19630620|NCT00846365|42079879|FG000|Overall Study|Protocol Violation|5|||
19630621|NCT00846365|42079880|FG001|Overall Study|Protocol Violation|4|||
19630622|NCT00846365|42079881|FG002|Overall Study|Protocol Violation|0|||
19630623|NCT00846365|42079879|FG000|Overall Study|Lost to Follow-up|8|||
19630624|NCT00846365|42079880|FG001|Overall Study|Lost to Follow-up|2|||
19630625|NCT00846365|42079881|FG002|Overall Study|Lost to Follow-up|5|||
19630626|NCT00846365|42079879|FG000|Overall Study|Withdrawal by Subject|11|||
19630627|NCT00846365|42079880|FG001|Overall Study|Withdrawal by Subject|11|||
19630628|NCT00846365|42079881|FG002|Overall Study|Withdrawal by Subject|9|||
19630629|NCT00846365|42079879|FG000|Overall Study|Pregnancy|1|||
19630630|NCT00846365|42079880|FG001|Overall Study|Pregnancy|0|||
19630631|NCT00846365|42079881|FG002|Overall Study|Pregnancy|0|||
19630632|NCT00846365|42079879|FG000|Overall Study|Lack of Efficacy|1|||
19630633|NCT00846365|42079880|FG001|Overall Study|Lack of Efficacy|1|||
19630634|NCT00846365|42079881|FG002|Overall Study|Lack of Efficacy|2|||
19630635|NCT00846365|42079879|FG000|Overall Study|Other|9|||
19630636|NCT00846365|42079880|FG001|Overall Study|Other|1|||
19630637|NCT00846365|42079881|FG002|Overall Study|Other|6|||
19630638|NCT00779142|42079889|FG000|Overall Study|Screen Failures|3|||
19630639|NCT00622180|42079894|FG000|Overall Study|Lost to Follow-up|1|||
19630640|NCT00622180|42079895|FG001|Overall Study|Lost to Follow-up|2|||
19630641|NCT00773136|42079901|FG000|Overall Study|Physician Decision|2|||
19630642|NCT00853307|42079908|FG000|Overall Study|Adverse Event|1|||
19630643|NCT00853307|42079909|FG001|Overall Study|Adverse Event|2|||
19630644|NCT00853307|42079908|FG000|Overall Study|Withdrawal by Subject|1|||
19630645|NCT00853307|42079909|FG001|Overall Study|Withdrawal by Subject|2|||
19630646|NCT00853307|42079908|FG000|Overall Study|Reason Not Specified|0|||
19630647|NCT00853307|42079909|FG001|Overall Study|Reason Not Specified|1|||
19630648|NCT00778830|42079917|FG000|Overall Study|Ongoing at data cut-off|0|||
19630649|NCT00778830|42079918|FG001|Overall Study|Ongoing at data cut-off|1|||
19630650|NCT00772668|42079924|FG000|Overall Study|Physician Decision|3|||
19630651|NCT00786474|42079931|FG000|Overall Study|Death|5|||
19630652|NCT00786474|42079932|FG001|Overall Study|Death|4|||
19630653|NCT00786474|42079931|FG000|Overall Study|Withdrawal by Subject|23|||
19630654|NCT00786474|42079932|FG001|Overall Study|Withdrawal by Subject|31|||
19535198|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
19454878|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
19454879|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19454880|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19454881|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
19535199|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
19535200|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
19535201|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
19535202|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
19535203|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
19535204|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
19535205|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
19535206|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
19535207|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
19535208|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
19535209|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
19535210|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
19535211|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
19535212|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
19535213|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
19535214|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
19535215|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
19535216|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
19535217|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
19535218|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
19535219|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
19535220|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
19535221|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
19535222|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
19535223|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
19535224|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
19535225|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
19535226|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
19535227|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
19535228|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
19535229|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
19535230|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
19535231|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
19535232|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
19535233|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
19535234|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
19535235|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
19535236|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
19535237|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
19535238|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
19535239|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
19535240|NCT01089556|41983345|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
19535241|NCT01089556|41983346|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
19454882|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
19454883|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
19454884|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
19454885|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
19454886|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
19454887|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
19454888|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
19454889|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
19454890|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
19454891|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
19454892|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
19535242|NCT01089556|41983347|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
19535243|NCT01089556|41983348|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
19535244|NCT01089556|41983349|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
19535245|NCT01089556|41983350|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
19535246|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
19535247|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
19535248|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
19630655|NCT00786474|42079931|FG000|Overall Study|Lost to Follow-up|3|||
19454893|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
19454894|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
19454895|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
19454896|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
19454897|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
19454898|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
19454899|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
19454900|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
19454901|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
19454902|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
19535249|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
19535250|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
19535251|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
19535252|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
19535253|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
19454903|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
19535254|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
19535255|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
19535256|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
19535257|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
19535258|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
19535259|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
19535260|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
19535261|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
19535262|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
19535263|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
19535264|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
19535265|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
19535266|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
19535267|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
19535268|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
19535269|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
19535270|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
19535271|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
19535272|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
19535273|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
19535274|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
19535275|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
19535276|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
19535277|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
19535278|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
19535279|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
19535280|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
19535281|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
19535282|NCT01089556|41983345|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
19535283|NCT01089556|41983346|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
19535284|NCT01089556|41983347|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
19535285|NCT01089556|41983348|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
19535286|NCT01089556|41983349|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
19535287|NCT01089556|41983350|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
19535288|NCT01089127|41983368|FG000|Overall Study|Adverse Event|5|||
19535289|NCT01089127|41983369|FG001|Overall Study|Adverse Event|1|||
19535290|NCT01089127|41983370|FG002|Overall Study|Adverse Event|1|||
19535291|NCT01089127|41983371|FG003|Overall Study|Adverse Event|0|||
19535292|NCT01089127|41983372|FG004|Overall Study|Adverse Event|0|||
19535293|NCT01089127|41983373|FG005|Overall Study|Adverse Event|1|||
19535294|NCT01089127|41983368|FG000|Overall Study|Subject withdrew consent|0|||
19535295|NCT01089127|41983369|FG001|Overall Study|Subject withdrew consent|1|||
19535296|NCT01089127|41983370|FG002|Overall Study|Subject withdrew consent|1|||
19535297|NCT01089127|41983371|FG003|Overall Study|Subject withdrew consent|1|||
19535298|NCT01089127|41983372|FG004|Overall Study|Subject withdrew consent|0|||
19535299|NCT01089127|41983373|FG005|Overall Study|Subject withdrew consent|2|||
19535300|NCT01089127|41983368|FG000|Overall Study|Abnormal test procedure result(s)|2|||
19535301|NCT01089127|41983369|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19535302|NCT01089127|41983370|FG002|Overall Study|Abnormal test procedure result(s)|0|||
19535303|NCT01089127|41983371|FG003|Overall Study|Abnormal test procedure result(s)|0|||
19535304|NCT01089127|41983372|FG004|Overall Study|Abnormal test procedure result(s)|0|||
19454904|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
19535305|NCT01089127|41983373|FG005|Overall Study|Abnormal test procedure result(s)|0|||
19535306|NCT01089127|41983368|FG000|Overall Study|Lost to Follow-up|1|||
19535307|NCT01089127|41983369|FG001|Overall Study|Lost to Follow-up|1|||
19535308|NCT01089127|41983370|FG002|Overall Study|Lost to Follow-up|0|||
19535309|NCT01089127|41983371|FG003|Overall Study|Lost to Follow-up|0|||
19535310|NCT01089127|41983372|FG004|Overall Study|Lost to Follow-up|1|||
19535311|NCT01089127|41983373|FG005|Overall Study|Lost to Follow-up|0|||
19535312|NCT01089127|41983368|FG000|Overall Study|Protocol deviation|0|||
19535313|NCT01089127|41983369|FG001|Overall Study|Protocol deviation|1|||
19535314|NCT01089127|41983370|FG002|Overall Study|Protocol deviation|0|||
19535315|NCT01089127|41983371|FG003|Overall Study|Protocol deviation|0|||
19535316|NCT01089127|41983372|FG004|Overall Study|Protocol deviation|1|||
19535317|NCT01089127|41983373|FG005|Overall Study|Protocol deviation|0|||
19535318|NCT01087957|41983389|FG000|Overall Study|Death|2|||
19535319|NCT01087957|41983390|FG001|Overall Study|Death|2|||
19535320|NCT01087957|41983389|FG000|Overall Study|Lost to Follow-up|3|||
19535321|NCT01087957|41983390|FG001|Overall Study|Lost to Follow-up|4|||
19535322|NCT01087957|41983389|FG000|Overall Study|Protocol Violation|13|||
19535323|NCT01087957|41983390|FG001|Overall Study|Protocol Violation|25|||
19535324|NCT01087957|41983389|FG000|Overall Study|Withdrawal by Subject|18|||
19535325|NCT01087957|41983390|FG001|Overall Study|Withdrawal by Subject|15|||
19535326|NCT01087957|41983389|FG000|Overall Study|Physician Decision|5|||
19535327|NCT01087957|41983390|FG001|Overall Study|Physician Decision|9|||
19535328|NCT01087723|41983398|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
19535329|NCT01087723|41983399|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
19535330|NCT01087723|41983398|FG000|Overall Study|Withdrawal by Subject|10|||
19535331|NCT01087723|41983399|FG001|Overall Study|Withdrawal by Subject|13|||
19535332|NCT01087723|41983398|FG000|Overall Study|Physician Decision|2|||
19535333|NCT01087723|41983399|FG001|Overall Study|Physician Decision|0|||
19535334|NCT01087723|41983398|FG000|Overall Study|Lost to Follow-up|1|||
19535335|NCT01087723|41983399|FG001|Overall Study|Lost to Follow-up|4|||
19535336|NCT01087723|41983398|FG000|Overall Study|Reason Not Specified|1|||
19535337|NCT01087723|41983399|FG001|Overall Study|Reason Not Specified|2|||
19535338|NCT01087528|41983405|FG000|Overall Study|Withdrawal by Subject|1|||
19535339|NCT01087528|41983405|FG000|Overall Study|Incomplete CE procedure|6|||
19535340|NCT01085812|41983411|FG000|Open-Label Period|Adverse Event|0|||
19535341|NCT01085812|41983412|FG001|Open-Label Period|Adverse Event|80|||
19535342|NCT01085812|41983411|FG000|Open-Label Period|Lack of Efficacy|0|||
19535343|NCT01085812|41983412|FG001|Open-Label Period|Lack of Efficacy|26|||
19535344|NCT01085812|41983411|FG000|Open-Label Period|Protocol Violation|0|||
19535345|NCT01085812|41983412|FG001|Open-Label Period|Protocol Violation|39|||
19535346|NCT01085812|41983411|FG000|Open-Label Period|Withdrawal by Subject|0|||
19535347|NCT01085812|41983412|FG001|Open-Label Period|Withdrawal by Subject|53|||
19535348|NCT01085812|41983411|FG000|Open-Label Period|Lost to Follow-up|0|||
19535349|NCT01085812|41983412|FG001|Open-Label Period|Lost to Follow-up|42|||
19535350|NCT01085812|41983411|FG000|Double-Blind Period|Adverse Event|3|||
19535351|NCT01085812|41983412|FG001|Double-Blind Period|Adverse Event|8|||
19535352|NCT01085812|41983411|FG000|Double-Blind Period|Protocol Violation|2|||
19535353|NCT01085812|41983412|FG001|Double-Blind Period|Protocol Violation|7|||
19535354|NCT01085812|41983411|FG000|Double-Blind Period|Withdrawal by Subject|11|||
19535355|NCT01085812|41983412|FG001|Double-Blind Period|Withdrawal by Subject|24|||
19535356|NCT01085812|41983411|FG000|Double-Blind Period|Lost to Follow-up|5|||
19535357|NCT01085812|41983412|FG001|Double-Blind Period|Lost to Follow-up|17|||
19535358|NCT01085812|41983411|FG000|Double-Blind Period|Other Reasons|0|||
19535359|NCT01085812|41983412|FG001|Double-Blind Period|Other Reasons|2|||
19535360|NCT01085812|41983411|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
19535361|NCT01085812|41983412|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
19535362|NCT01085812|41983411|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
19535363|NCT01085812|41983412|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
19535364|NCT01085812|41983411|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
19535365|NCT01085812|41983412|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
19535366|NCT01085812|41983411|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
19535367|NCT01085812|41983412|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
19535368|NCT01085812|41983411|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
19535369|NCT01085812|41983412|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
19535370|NCT01085734|41983421|FG000|Overall Study|Adverse Event|0|||
19535371|NCT01085734|41983422|FG001|Overall Study|Adverse Event|2|||
19535372|NCT01085734|41983421|FG000|Overall Study|Death|1|||
19535373|NCT01085734|41983422|FG001|Overall Study|Death|0|||
19535374|NCT01085734|41983421|FG000|Overall Study|Lost to Follow-up|0|||
19535375|NCT01085734|41983422|FG001|Overall Study|Lost to Follow-up|1|||
19535376|NCT01085734|41983421|FG000|Overall Study|Withdrawal by Subject|0|||
19535377|NCT01085734|41983422|FG001|Overall Study|Withdrawal by Subject|1|||
19535378|NCT01084603|41983429|FG000|Baseline|Withdrawal by Subject|2|||
19535379|NCT01084603|41983429|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
19535380|NCT01084603|41983429|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
19535381|NCT01084603|41983429|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
19535382|NCT01084603|41983429|FG000|Washout Period 4|Adverse Event|1|||
19535383|NCT01084174|41983444|FG000|Overall Study|gastrointestinal symptoms|1|||
19535384|NCT01084174|41983445|FG001|Overall Study|gastrointestinal symptoms|1|||
19535385|NCT01084174|41983444|FG000|Overall Study|Eosinophilic esophagitis|0|||
19535386|NCT01084174|41983445|FG001|Overall Study|Eosinophilic esophagitis|1|||
19535387|NCT01084174|41983444|FG000|Overall Study|Anaphylaxis|0|||
19535388|NCT01084174|41983445|FG001|Overall Study|Anaphylaxis|1|||
19535389|NCT01084174|41983444|FG000|Overall Study|Participant noncompliance|0|||
19535390|NCT01084174|41983445|FG001|Overall Study|Participant noncompliance|1|||
19535391|NCT01084135|41983455|FG000|20 Week|Physician Decision|0|||
19535392|NCT01084135|41983456|FG001|20 Week|Physician Decision|1|||
19535393|NCT01083316|41983464|FG000|Overall Study|Adverse Event|2|||
19535394|NCT01083316|41983464|FG000|Overall Study|Withdrawal by Subject|1|||
19535395|NCT01083160|41983469|FG000|Overall Study|Adverse Event|1|||
19535396|NCT01083121|41983473|FG000|Overall Study|Use of Humira outside the approved label|81|||
19535397|NCT01082614|41983483|FG000|Overall Study|Adverse Event|1|||
19535398|NCT01082614|41983484|FG001|Overall Study|Adverse Event|4|||
19454905|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
19535399|NCT01082614|41983483|FG000|Overall Study|Equipment Malfunction|0|||
19535400|NCT01082614|41983484|FG001|Overall Study|Equipment Malfunction|1|||
19535401|NCT01082614|41983483|FG000|Overall Study|Physician Decision|2|||
19535402|NCT01082614|41983484|FG001|Overall Study|Physician Decision|0|||
19535403|NCT01081873|41983490|FG000|Overall Study|Death|86|||
19535404|NCT01081873|41983490|FG000|Overall Study|Withdrawal by Subject|10|||
19535405|NCT01081873|41983490|FG000|Overall Study|Lost to Follow-up|142|||
19454906|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
19454907|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
19454908|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
19454909|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
19454910|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
19454911|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
19535406|NCT01081873|41983490|FG000|Overall Study|Progression of prostate cancer|13|||
19535407|NCT01081873|41983490|FG000|Overall Study|Other|47|||
19535408|NCT01081795|41983522|FG000|Overall Study|Adverse Event|18|||
19535409|NCT01081795|41983523|FG001|Overall Study|Adverse Event|23|||
19535410|NCT01081795|41983524|FG002|Overall Study|Adverse Event|6|||
19535411|NCT01081795|41983522|FG000|Overall Study|Lack of Efficacy|7|||
19535412|NCT01081795|41983523|FG001|Overall Study|Lack of Efficacy|5|||
19535413|NCT01081795|41983524|FG002|Overall Study|Lack of Efficacy|19|||
19535414|NCT01081795|41983522|FG000|Overall Study|Subject's schedule|1|||
19535415|NCT01081795|41983523|FG001|Overall Study|Subject's schedule|1|||
19535416|NCT01081795|41983524|FG002|Overall Study|Subject's schedule|2|||
19535417|NCT01081795|41983522|FG000|Overall Study|Revocation of informed consent|2|||
19535418|NCT01081795|41983523|FG001|Overall Study|Revocation of informed consent|0|||
19535419|NCT01081795|41983524|FG002|Overall Study|Revocation of informed consent|0|||
19535420|NCT01081795|41983522|FG000|Overall Study|Ineligible for participation|1|||
19535421|NCT01081795|41983523|FG001|Overall Study|Ineligible for participation|0|||
19535422|NCT01081795|41983524|FG002|Overall Study|Ineligible for participation|0|||
19535423|NCT01081795|41983522|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
19535424|NCT01081795|41983523|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
19535425|NCT01081795|41983524|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
19535426|NCT01081795|41983522|FG000|Overall Study|Using drug with restricted days of use|2|||
19535427|NCT01081795|41983523|FG001|Overall Study|Using drug with restricted days of use|3|||
19535428|NCT01081795|41983524|FG002|Overall Study|Using drug with restricted days of use|2|||
19535429|NCT01081795|41983522|FG000|Overall Study|Other|1|||
19535430|NCT01081795|41983523|FG001|Overall Study|Other|2|||
19535431|NCT01081795|41983524|FG002|Overall Study|Other|0|||
19535432|NCT01081678|41983536|FG000|Overall Study|Ineligibility Determined|0|||
19535433|NCT01081678|41983537|FG001|Overall Study|Ineligibility Determined|0|||
19535434|NCT01081678|41983538|FG002|Overall Study|Ineligibility Determined|1|||
19454912|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
19454913|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
19454914|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
19535435|NCT01081678|41983539|FG003|Overall Study|Ineligibility Determined|1|||
19535436|NCT01081678|41983536|FG000|Overall Study|Noncompliance|3|||
19535437|NCT01081678|41983537|FG001|Overall Study|Noncompliance|4|||
19535438|NCT01081678|41983538|FG002|Overall Study|Noncompliance|5|||
19535439|NCT01081678|41983539|FG003|Overall Study|Noncompliance|2|||
19535440|NCT01081678|41983536|FG000|Overall Study|Adverse Event|2|||
19535441|NCT01081678|41983537|FG001|Overall Study|Adverse Event|1|||
19535442|NCT01081678|41983538|FG002|Overall Study|Adverse Event|2|||
19535443|NCT01081678|41983539|FG003|Overall Study|Adverse Event|2|||
19535444|NCT01081678|41983536|FG000|Overall Study|Withdrawal by Subject|15|||
19535445|NCT01081678|41983537|FG001|Overall Study|Withdrawal by Subject|7|||
19535446|NCT01081678|41983538|FG002|Overall Study|Withdrawal by Subject|17|||
19535447|NCT01081678|41983539|FG003|Overall Study|Withdrawal by Subject|14|||
19535448|NCT01081678|41983536|FG000|Overall Study|Administrative Decision|1|||
19454915|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
19454916|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
19454917|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
19454918|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
19454919|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
19454920|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
19454921|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
19454922|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
19535449|NCT01081678|41983537|FG001|Overall Study|Administrative Decision|0|||
19535450|NCT01081678|41983538|FG002|Overall Study|Administrative Decision|0|||
19535451|NCT01081678|41983539|FG003|Overall Study|Administrative Decision|1|||
19535452|NCT01081678|41983536|FG000|Overall Study|Lost to Follow-up|4|||
19535453|NCT01081678|41983537|FG001|Overall Study|Lost to Follow-up|1|||
19535454|NCT01081678|41983538|FG002|Overall Study|Lost to Follow-up|4|||
19535455|NCT01081678|41983539|FG003|Overall Study|Lost to Follow-up|3|||
19535456|NCT01081678|41983536|FG000|Overall Study|Death|2|||
19535457|NCT01081678|41983537|FG001|Overall Study|Death|2|||
19535458|NCT01081678|41983538|FG002|Overall Study|Death|2|||
19535459|NCT01081678|41983539|FG003|Overall Study|Death|6|||
19535460|NCT01081678|41983536|FG000|Overall Study|Other|0|||
19535461|NCT01081678|41983537|FG001|Overall Study|Other|1|||
19535462|NCT01081678|41983538|FG002|Overall Study|Other|0|||
19454923|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
19454924|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
19454925|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
19454926|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
19535463|NCT01081678|41983539|FG003|Overall Study|Other|0|||
19535464|NCT01081249|41983549|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
19535465|NCT01081249|41983550|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
19535466|NCT01081132|41983558|FG000|Overall Study|Lack of Efficacy|25|||
19535467|NCT01081132|41983559|FG001|Overall Study|Lack of Efficacy|9|||
19535468|NCT01081132|41983558|FG000|Overall Study|Withdrawal by Subject|13|||
19535469|NCT01081132|41983559|FG001|Overall Study|Withdrawal by Subject|16|||
19535470|NCT01081132|41983558|FG000|Overall Study|Lost to Follow-up|4|||
19535471|NCT01081132|41983559|FG001|Overall Study|Lost to Follow-up|11|||
19535472|NCT01081132|41983558|FG000|Overall Study|Adverse Event|3|||
19535473|NCT01081132|41983559|FG001|Overall Study|Adverse Event|9|||
19535474|NCT01081132|41983558|FG000|Overall Study|Non Compliance|4|||
19535475|NCT01081132|41983559|FG001|Overall Study|Non Compliance|2|||
19535476|NCT01081132|41983558|FG000|Overall Study|Lack Of Compliance|0|||
19535477|NCT01081132|41983559|FG001|Overall Study|Lack Of Compliance|1|||
19535478|NCT01081132|41983558|FG000|Overall Study|Missed Visits|1|||
19535479|NCT01081132|41983559|FG001|Overall Study|Missed Visits|1|||
19535480|NCT01081132|41983558|FG000|Overall Study|Stopped Taking Meds|2|||
19535481|NCT01081132|41983559|FG001|Overall Study|Stopped Taking Meds|0|||
19535482|NCT01081132|41983558|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
19535483|NCT01081132|41983559|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
19535484|NCT01081132|41983558|FG000|Overall Study|Declined Taper Phase|0|||
19535485|NCT01081132|41983559|FG001|Overall Study|Declined Taper Phase|1|||
19535486|NCT01081132|41983558|FG000|Overall Study|Protocol Violation|3|||
19535487|NCT01081132|41983559|FG001|Overall Study|Protocol Violation|1|||
19535488|NCT01080625|41983568|FG000|Overall Study|Physician Decision|0|||
19535489|NCT01080625|41983569|FG001|Overall Study|Physician Decision|2|||
19535490|NCT01080625|41983570|FG002|Overall Study|Physician Decision|1|||
19535491|NCT01059903|41983580|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
19535492|NCT01059903|41983581|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
19535493|NCT00199888|41983637|FG000|Overall Study|Lost to Follow-up|1|||
19535494|NCT00199849|41983644|FG000|Overall Study|Unrelated illness or complication|0|||
19535495|NCT00199849|41983645|FG001|Overall Study|Unrelated illness or complication|1|||
19535496|NCT00199849|41983646|FG002|Overall Study|Unrelated illness or complication|0|||
19535497|NCT00199849|41983644|FG000|Overall Study|Progressive disease requiring intervention|0|||
19535498|NCT00199849|41983645|FG001|Overall Study|Progressive disease requiring intervention|0|||
19535499|NCT00199849|41983646|FG002|Overall Study|Progressive disease requiring intervention|1|||
19535500|NCT00199849|41983644|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
19535501|NCT00199849|41983645|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
19535502|NCT00199849|41983646|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
19535503|NCT00199381|41983654|FG000|Overall Study|Withdrawal by Subject|38|||
19535504|NCT00199381|41983654|FG000|Overall Study|Adverse Event|73|||
19535505|NCT00199381|41983654|FG000|Overall Study|Protocol Violation|6|||
19535506|NCT00199381|41983654|FG000|Overall Study|Lack of Efficacy|27|||
19535507|NCT00199381|41983654|FG000|Overall Study|Not including due to early termination|37|||
19535508|NCT00199381|41983654|FG000|Overall Study|Study termination by Sponsor|323|||
19535509|NCT00198133|41983660|FG000|Overall Study|Disease progression|2|||
19535510|NCT00198133|41983661|FG001|Overall Study|Disease progression|5|||
19535511|NCT00198133|41983660|FG000|Overall Study|Adverse Event|1|||
19535512|NCT00198133|41983661|FG001|Overall Study|Adverse Event|3|||
19535513|NCT00198133|41983660|FG000|Overall Study|Withdrawal by Subject|1|||
19535514|NCT00198133|41983661|FG001|Overall Study|Withdrawal by Subject|0|||
19535515|NCT00198133|41983660|FG000|Overall Study|Physician Decision|1|||
19535516|NCT00198133|41983661|FG001|Overall Study|Physician Decision|0|||
19535517|NCT00197236|41983670|FG000|Overall Study|Adverse Event|1|||
19535518|NCT00197236|41983671|FG001|Overall Study|Adverse Event|0|||
19535519|NCT00197236|41983672|FG002|Overall Study|Adverse Event|1|||
19535520|NCT00197236|41983670|FG000|Overall Study|Lost to Follow-up|5|||
19535521|NCT00197236|41983671|FG001|Overall Study|Lost to Follow-up|14|||
19535522|NCT00197236|41983672|FG002|Overall Study|Lost to Follow-up|6|||
19535523|NCT00197236|41983670|FG000|Overall Study|Protocol Violation|0|||
19535524|NCT00197236|41983671|FG001|Overall Study|Protocol Violation|0|||
19535525|NCT00197236|41983672|FG002|Overall Study|Protocol Violation|1|||
19535526|NCT00197236|41983670|FG000|Overall Study|Withdrawal by Subject|7|||
19535527|NCT00197236|41983671|FG001|Overall Study|Withdrawal by Subject|3|||
19535528|NCT00197236|41983672|FG002|Overall Study|Withdrawal by Subject|11|||
19535529|NCT00197236|41983670|FG000|Overall Study|Study drug/medication expiration|1|||
19535530|NCT00197236|41983671|FG001|Overall Study|Study drug/medication expiration|0|||
19454927|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
19454928|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
19454929|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
19454930|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
19454931|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
19454932|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
19454933|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
19535531|NCT00197236|41983672|FG002|Overall Study|Study drug/medication expiration|3|||
19535532|NCT00197236|41983670|FG000|Overall Study|Returned out of specified time window|0|||
19535533|NCT00197236|41983671|FG001|Overall Study|Returned out of specified time window|0|||
19535534|NCT00197236|41983672|FG002|Overall Study|Returned out of specified time window|1|||
19535535|NCT00197002|41983686|FG000|Overall Study|Adverse Event|0|||
19535536|NCT00197002|41983687|FG001|Overall Study|Adverse Event|1|||
19535537|NCT00197002|41983688|FG002|Overall Study|Adverse Event|0|||
19535538|NCT00197002|41983686|FG000|Overall Study|Protocol Violation|1|||
19535539|NCT00197002|41983687|FG001|Overall Study|Protocol Violation|0|||
19535540|NCT00197002|41983688|FG002|Overall Study|Protocol Violation|2|||
19535541|NCT00197002|41983686|FG000|Overall Study|Withdrawal by Subject|9|||
19535542|NCT00197002|41983687|FG001|Overall Study|Withdrawal by Subject|5|||
19535543|NCT00197002|41983688|FG002|Overall Study|Withdrawal by Subject|7|||
19535544|NCT00197002|41983686|FG000|Overall Study|Migrated/moved from study area|3|||
19535545|NCT00197002|41983687|FG001|Overall Study|Migrated/moved from study area|5|||
19454934|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
19454935|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
19535546|NCT00197002|41983688|FG002|Overall Study|Migrated/moved from study area|1|||
19535547|NCT00197002|41983686|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
19535548|NCT00197002|41983687|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
19535549|NCT00197002|41983688|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
19535550|NCT00197002|41983686|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
19535551|NCT00197002|41983687|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
19535552|NCT00197002|41983688|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
19535553|NCT00197002|41983686|FG000|Overall Study|Others|3|||
19535554|NCT00197002|41983687|FG001|Overall Study|Others|1|||
19535555|NCT00197002|41983688|FG002|Overall Study|Others|1|||
19535556|NCT00196105|41983702|FG000|Overall Study|Lost to Follow-up|4|||
19535557|NCT00196105|41983703|FG001|Overall Study|Lost to Follow-up|5|||
19535558|NCT00196105|41983704|FG002|Overall Study|Lost to Follow-up|7|||
19630656|NCT00786474|42079932|FG001|Overall Study|Lost to Follow-up|3|||
19630657|NCT00786474|42079931|FG000|Overall Study|Physician Decision|2|||
19630658|NCT00786474|42079932|FG001|Overall Study|Physician Decision|1|||
19630659|NCT00786474|42079931|FG000|Overall Study|Other|4|||
19630660|NCT00786474|42079932|FG001|Overall Study|Other|4|||
19535559|NCT00195715|41983712|FG000|Overall Study|Adverse Event|122|||
19535560|NCT00195715|41983712|FG000|Overall Study|Withdrawal by Subject|58|||
19535561|NCT00195715|41983712|FG000|Overall Study|Lost to Follow-up|27|||
19535562|NCT00195715|41983712|FG000|Overall Study|Protocol Violation|13|||
19535563|NCT00195715|41983712|FG000|Overall Study|Lack of Efficacy|93|||
19535564|NCT00195715|41983712|FG000|Overall Study|Pregnancy|14|||
19535565|NCT00195715|41983712|FG000|Overall Study|Investigative site closure|8|||
19630661|NCT00784875|42079942|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
19630662|NCT00784875|42079943|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
19535566|NCT00195715|41983712|FG000|Overall Study|Subject moved/relocated|7|||
19535567|NCT00195715|41983712|FG000|Overall Study|Subject non-compliance|6|||
19535568|NCT00195715|41983712|FG000|Overall Study|Subject started commercial Humira|5|||
19535569|NCT00195715|41983712|FG000|Overall Study|Subject choice|3|||
19535570|NCT00195715|41983712|FG000|Overall Study|Loss of response/no improvement|3|||
19535571|NCT00195715|41983712|FG000|Overall Study|Sponsor stopped study|1|||
19535572|NCT00195715|41983712|FG000|Overall Study|Administrative reasons|2|||
19535573|NCT00195715|41983712|FG000|Overall Study|Investigator's decision|2|||
19535574|NCT00195715|41983712|FG000|Overall Study|Subject wants to get pregnant|4|||
19535575|NCT00195715|41983712|FG000|Overall Study|Use of prohibited medication|2|||
19535576|NCT00195715|41983712|FG000|Overall Study|Planned surgery|2|||
19535577|NCT00195715|41983712|FG000|Overall Study|Increased infection rate|1|||
19535578|NCT00195715|41983712|FG000|Overall Study|Ineligible|1|||
19535579|NCT00195715|41983712|FG000|Overall Study|Colonic stricture|1|||
19535580|NCT00195715|41983712|FG000|Overall Study|Sponsor discontinued trial|1|||
19535581|NCT00195715|41983712|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
19454936|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
19454937|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
19454938|NCT04440163|41705176|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
19454939|NCT04440163|41705177|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
19454940|NCT04440163|41705178|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
19454941|NCT04440163|41705179|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
19535582|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Adverse Event|82|||
19535583|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Death|6|||
19535584|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
19535585|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
19535586|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
19535587|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
19535588|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
19535589|NCT00195676|41983716|FG000|Period O - Open-label Treatment|Other reasons|68|||
19535590|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
19535591|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
19535592|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
19535593|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
19535594|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
19535595|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
19535596|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
19535597|NCT00195676|41983716|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
19535598|NCT00195676|41983716|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
19535599|NCT00195676|41983716|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
19535600|NCT00195676|41983716|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
19535601|NCT00195676|41983716|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
19535602|NCT00195676|41983716|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
19535603|NCT00194077|41983726|FG000|Overall Study|Lack of Efficacy|22|||
19535604|NCT00194077|41983727|FG001|Overall Study|Lack of Efficacy|29|||
19535605|NCT00194077|41983726|FG000|Overall Study|Study nonadherence|1|||
19454942|NCT04440163|41705180|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
19454943|NCT04440163|41705181|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
19454944|NCT04440163|41705182|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
19454945|NCT04440163|41705183|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
19454946|NCT04440163|41705176|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
19454947|NCT04440163|41705177|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
19454948|NCT04440163|41705178|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
19454949|NCT04440163|41705179|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
19454950|NCT04440163|41705180|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
19454951|NCT04440163|41705181|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
19454952|NCT04440163|41705182|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
19454953|NCT04440163|41705183|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
19454954|NCT04440163|41705176|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454955|NCT04440163|41705177|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19535606|NCT00194077|41983727|FG001|Overall Study|Study nonadherence|0|||
19535607|NCT00194077|41983726|FG000|Overall Study|Withdrawal by Subject|1|||
19535608|NCT00194077|41983727|FG001|Overall Study|Withdrawal by Subject|1|||
19535609|NCT00193609|41983733|FG000|Overall Study|Lack of Efficacy|2|||
19535610|NCT00193609|41983733|FG000|Overall Study|Adverse Event|2|||
19535611|NCT00193180|41983737|FG000|Overall Study|Lack of Efficacy|1|||
19535612|NCT00193180|41983737|FG000|Overall Study|Adverse Event|8|||
19535613|NCT00193180|41983737|FG000|Overall Study|Protocol Violation|1|||
19535614|NCT00193063|41983742|FG000|Overall Study|Lack of Efficacy|3|||
19535615|NCT00193063|41983742|FG000|Overall Study|Adverse Event|1|||
19454956|NCT04440163|41705178|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454957|NCT04440163|41705179|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
19454958|NCT04440163|41705180|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454959|NCT04440163|41705181|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454960|NCT04440163|41705182|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454961|NCT04440163|41705183|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
19454962|NCT04304508|41705214|FG000|Overall Study|Subject Decision|29|||
19454963|NCT04304508|41705215|FG001|Overall Study|Subject Decision|39|||
19454964|NCT04304508|41705216|FG002|Overall Study|Subject Decision|37|||
19454965|NCT04304508|41705217|FG003|Overall Study|Subject Decision|48|||
19535616|NCT00191854|41983749|FG000|Overall Study|Death|26|||
19535617|NCT00191854|41983750|FG001|Overall Study|Death|23|||
19535618|NCT00191854|41983751|FG002|Overall Study|Death|29|||
19535619|NCT00191854|41983749|FG000|Overall Study|Lost to Follow-up|7|||
19535620|NCT00191854|41983750|FG001|Overall Study|Lost to Follow-up|5|||
19535621|NCT00191854|41983751|FG002|Overall Study|Lost to Follow-up|5|||
19535622|NCT00191854|41983749|FG000|Overall Study|Withdrawal by Subject|4|||
19535623|NCT00191854|41983750|FG001|Overall Study|Withdrawal by Subject|2|||
19535624|NCT00191854|41983751|FG002|Overall Study|Withdrawal by Subject|3|||
19535625|NCT00191854|41983749|FG000|Overall Study|Sponsor Decision|0|||
19535626|NCT00191854|41983750|FG001|Overall Study|Sponsor Decision|0|||
19535627|NCT00191854|41983751|FG002|Overall Study|Sponsor Decision|1|||
19535628|NCT00191854|41983749|FG000|Overall Study|Screen Failure|0|||
19535629|NCT00191854|41983750|FG001|Overall Study|Screen Failure|0|||
19535630|NCT00191854|41983751|FG002|Overall Study|Screen Failure|1|||
19535631|NCT00191815|41983759|FG000|Overall Study|Adverse Event|2|||
19535632|NCT00191815|41983759|FG000|Overall Study|Disease progression or relapse|24|||
19535633|NCT00191815|41983759|FG000|Overall Study|Death|2|||
19630663|NCT00784875|42079944|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
19454966|NCT04304508|41705214|FG000|Overall Study|Death|6|||
19454967|NCT04304508|41705215|FG001|Overall Study|Death|1|||
19454968|NCT04304508|41705216|FG002|Overall Study|Death|8|||
19454969|NCT04304508|41705217|FG003|Overall Study|Death|5|||
19454970|NCT04304508|41705214|FG000|Overall Study|Non-compliance With Study Drug|3|||
19454971|NCT04304508|41705215|FG001|Overall Study|Non-compliance With Study Drug|1|||
19454972|NCT04304508|41705216|FG002|Overall Study|Non-compliance With Study Drug|2|||
19454973|NCT04304508|41705217|FG003|Overall Study|Non-compliance With Study Drug|0|||
19454974|NCT04304508|41705214|FG000|Overall Study|Switching To Other Therapy|1|||
19454975|NCT04304508|41705215|FG001|Overall Study|Switching To Other Therapy|1|||
19454976|NCT04304508|41705216|FG002|Overall Study|Switching To Other Therapy|1|||
19454977|NCT04304508|41705217|FG003|Overall Study|Switching To Other Therapy|2|||
19454978|NCT04304508|41705214|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
19454979|NCT04304508|41705215|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
19454980|NCT04304508|41705216|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
19454981|NCT04304508|41705217|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
19454982|NCT04304508|41705214|FG000|Overall Study|Withdrawal by Subject|7|||
19454983|NCT04304508|41705215|FG001|Overall Study|Withdrawal by Subject|5|||
19454984|NCT04304508|41705216|FG002|Overall Study|Withdrawal by Subject|11|||
19454985|NCT04304508|41705217|FG003|Overall Study|Withdrawal by Subject|6|||
19454986|NCT04304508|41705214|FG000|Overall Study|Logistical Difficulties|2|||
19454987|NCT04304508|41705215|FG001|Overall Study|Logistical Difficulties|2|||
19454988|NCT04304508|41705216|FG002|Overall Study|Logistical Difficulties|3|||
19454989|NCT04304508|41705217|FG003|Overall Study|Logistical Difficulties|2|||
19454990|NCT04304508|41705214|FG000|Overall Study|Missing Information|1|||
19454991|NCT04304508|41705215|FG001|Overall Study|Missing Information|2|||
19454992|NCT04304508|41705216|FG002|Overall Study|Missing Information|1|||
19454993|NCT04304508|41705217|FG003|Overall Study|Missing Information|3|||
19454994|NCT04304508|41705214|FG000|Overall Study|Other|7|||
19454995|NCT04304508|41705215|FG001|Overall Study|Other|6|||
19454996|NCT04304508|41705216|FG002|Overall Study|Other|5|||
19454997|NCT04304508|41705217|FG003|Overall Study|Other|4|||
19454998|NCT04304508|41705214|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
19454999|NCT04304508|41705215|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
19455000|NCT04304508|41705216|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
19455001|NCT04304508|41705217|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
19535634|NCT00191815|41983759|FG000|Overall Study|Protocol Violation|3|||
19535635|NCT00191815|41983759|FG000|Overall Study|Physician Decision|2|||
19535636|NCT00191815|41983759|FG000|Overall Study|Withdrawal by Subject|7|||
19535637|NCT00191386|41983763|FG000|Overall Study|Adverse Event|16|||
19535638|NCT00191386|41983763|FG000|Overall Study|Lost to Follow-up|1|||
19535639|NCT00191386|41983763|FG000|Overall Study|Entry Criteria Exclusion|3|||
19535640|NCT00191386|41983763|FG000|Overall Study|Protocol Violation|18|||
19455002|NCT04304508|41705214|FG000|Overall Study|Physician Decision|3|||
19455003|NCT04304508|41705215|FG001|Overall Study|Physician Decision|4|||
19455004|NCT04304508|41705216|FG002|Overall Study|Physician Decision|9|||
19535641|NCT00191386|41983763|FG000|Overall Study|Withdrawal by Subject|96|||
19455005|NCT04304508|41705217|FG003|Overall Study|Physician Decision|7|||
19455006|NCT04304508|41705214|FG000|Overall Study|Study drug never administered|10|||
19455007|NCT04304508|41705215|FG001|Overall Study|Study drug never administered|4|||
19455008|NCT04304508|41705216|FG002|Overall Study|Study drug never administered|4|||
19455009|NCT04304508|41705217|FG003|Overall Study|Study drug never administered|4|||
19455010|NCT04304508|41705214|FG000|Overall Study|Adverse Event|49|||
19455011|NCT04304508|41705215|FG001|Overall Study|Adverse Event|50|||
19455012|NCT04304508|41705216|FG002|Overall Study|Adverse Event|51|||
19455013|NCT04304508|41705217|FG003|Overall Study|Adverse Event|56|||
19455014|NCT04304508|41705214|FG000|Overall Study|Lost to Follow-up|1|||
19455015|NCT04304508|41705215|FG001|Overall Study|Lost to Follow-up|5|||
19455016|NCT04304508|41705216|FG002|Overall Study|Lost to Follow-up|2|||
19455017|NCT04304508|41705217|FG003|Overall Study|Lost to Follow-up|3|||
19535642|NCT00191386|41983763|FG000|Overall Study|Physician Decision|11|||
19535643|NCT00191386|41983763|FG000|Overall Study|Lack of Efficacy|15|||
19535644|NCT00191308|41983767|FG000|Overall Study|Adverse Event|1|||
19535645|NCT00191269|41983773|FG000|Overall Study|Protocol Violation|0|||
19535646|NCT00191269|41983774|FG001|Overall Study|Protocol Violation|2|||
19535647|NCT00191269|41983773|FG000|Overall Study|Adverse Event|1|||
19535648|NCT00191269|41983774|FG001|Overall Study|Adverse Event|4|||
19535649|NCT00191269|41983773|FG000|Overall Study|Progression of Disease|4|||
19535650|NCT00191269|41983774|FG001|Overall Study|Progression of Disease|42|||
19535651|NCT00191269|41983773|FG000|Overall Study|Lack of Efficacy|1|||
19535652|NCT00191269|41983774|FG001|Overall Study|Lack of Efficacy|5|||
19535653|NCT00191269|41983773|FG000|Overall Study|Withdrawal by Subject|0|||
19535654|NCT00191269|41983774|FG001|Overall Study|Withdrawal by Subject|1|||
19535655|NCT00191269|41983773|FG000|Overall Study|Pathologic Aggrevation|0|||
19535656|NCT00191269|41983774|FG001|Overall Study|Pathologic Aggrevation|1|||
19535657|NCT00191269|41983773|FG000|Overall Study|Physician Decision|0|||
19535658|NCT00191269|41983774|FG001|Overall Study|Physician Decision|3|||
19535659|NCT00191191|41983783|FG000|Overall Study|Entry Criteria Exclusion|2|||
19535660|NCT00191191|41983784|FG001|Overall Study|Entry Criteria Exclusion|0|||
19535661|NCT00191191|41983783|FG000|Overall Study|Treated with Another Systemic Agent|1|||
19535662|NCT00191191|41983784|FG001|Overall Study|Treated with Another Systemic Agent|1|||
19535663|NCT00191191|41983783|FG000|Overall Study|Adverse Event|11|||
19535664|NCT00191191|41983784|FG001|Overall Study|Adverse Event|21|||
19535665|NCT00191191|41983783|FG000|Overall Study|Progressive Disease|84|||
19535666|NCT00191191|41983784|FG001|Overall Study|Progressive Disease|72|||
19535667|NCT00191191|41983783|FG000|Overall Study|Toxicity After Dose Reduction|7|||
19535668|NCT00191191|41983784|FG001|Overall Study|Toxicity After Dose Reduction|8|||
19535669|NCT00191191|41983783|FG000|Overall Study|Family/Caregiver Decision|5|||
19535670|NCT00191191|41983784|FG001|Overall Study|Family/Caregiver Decision|7|||
19535671|NCT00191191|41983783|FG000|Overall Study|Lost to Follow-up|1|||
19535672|NCT00191191|41983784|FG001|Overall Study|Lost to Follow-up|0|||
19535673|NCT00191191|41983783|FG000|Overall Study|Physician Decision|3|||
19535674|NCT00191191|41983784|FG001|Overall Study|Physician Decision|2|||
19535675|NCT00191191|41983783|FG000|Overall Study|Good Clinical Practice Violation|0|||
19535676|NCT00191191|41983784|FG001|Overall Study|Good Clinical Practice Violation|1|||
19535677|NCT00191152|41983792|FG000|Initial Treatment|Adverse Event|43|||
19535678|NCT00191152|41983793|FG001|Initial Treatment|Adverse Event|67|||
19535679|NCT00191152|41983792|FG000|Initial Treatment|Physician Decision|40|||
19535680|NCT00191152|41983793|FG001|Initial Treatment|Physician Decision|31|||
19535681|NCT00191152|41983792|FG000|Initial Treatment|Withdrawal by Subject|40|||
19535682|NCT00191152|41983793|FG001|Initial Treatment|Withdrawal by Subject|28|||
19535683|NCT00191152|41983792|FG000|Initial Treatment|Lost to Follow-up|0|||
19535684|NCT00191152|41983793|FG001|Initial Treatment|Lost to Follow-up|6|||
19535685|NCT00191152|41983792|FG000|Initial Treatment|Other|18|||
19535686|NCT00191152|41983793|FG001|Initial Treatment|Other|21|||
19535687|NCT00191152|41983792|FG000|Crossover Treatment|Adverse Event|8|||
19535688|NCT00191152|41983793|FG001|Crossover Treatment|Adverse Event|8|||
19535689|NCT00191152|41983792|FG000|Crossover Treatment|Physician Decision|7|||
19535690|NCT00191152|41983793|FG001|Crossover Treatment|Physician Decision|7|||
19535691|NCT00191152|41983792|FG000|Crossover Treatment|Withdrawal by Subject|6|||
19535692|NCT00191152|41983793|FG001|Crossover Treatment|Withdrawal by Subject|9|||
19535693|NCT00191152|41983792|FG000|Crossover Treatment|Lost to Follow-up|2|||
19535694|NCT00191152|41983793|FG001|Crossover Treatment|Lost to Follow-up|1|||
19535695|NCT00191152|41983792|FG000|Crossover Treatment|Other|4|||
19455018|NCT04206332|41705246|FG000|Part A|Lost to Follow-up|0|||
19455019|NCT04206332|41705247|FG001|Part A|Lost to Follow-up|1|||
19455020|NCT04206332|41705248|FG002|Part A|Lost to Follow-up|0|||
19455021|NCT04206332|41705249|FG003|Part A|Lost to Follow-up|0|||
19455022|NCT04206332|41705250|FG004|Part A|Lost to Follow-up|0|||
19535696|NCT00191152|41983793|FG001|Crossover Treatment|Other|3|||
19535697|NCT00190684|41983811|FG000|Overall Study|Adverse Event|86|||
19535698|NCT00190684|41983811|FG000|Overall Study|Satisfactory response|80|||
19535699|NCT00190684|41983811|FG000|Overall Study|Lack of efficacy|204|||
19535700|NCT00190684|41983811|FG000|Overall Study|Lost to Follow-up|232|||
19455023|NCT04206332|41705251|FG005|Part A|Lost to Follow-up|0|||
19455024|NCT04206332|41705252|FG006|Part A|Lost to Follow-up|0|||
19455025|NCT04206332|41705253|FG007|Part A|Lost to Follow-up|0|||
19455026|NCT04206332|41705254|FG008|Part A|Lost to Follow-up|0|||
19455027|NCT04206332|41705255|FG009|Part A|Lost to Follow-up|0|||
19455028|NCT04206332|41705256|FG010|Part A|Lost to Follow-up|0|||
19455029|NCT04206332|41705257|FG011|Part A|Lost to Follow-up|0|||
19455030|NCT04206332|41705258|FG012|Part A|Lost to Follow-up|0|||
19455031|NCT04206332|41705259|FG013|Part A|Lost to Follow-up|0|||
19455032|NCT04206332|41705260|FG014|Part A|Lost to Follow-up|0|||
19535701|NCT00190684|41983811|FG000|Overall Study|Patient moved|60|||
19535702|NCT00190684|41983811|FG000|Overall Study|Patient Decision|432|||
19535703|NCT00190684|41983811|FG000|Overall Study|Clinical relapse|67|||
19535704|NCT00190684|41983811|FG000|Overall Study|Sponsor's decision|17|||
19535705|NCT00190684|41983811|FG000|Overall Study|Physician Decision|84|||
19535706|NCT00190684|41983811|FG000|Overall Study|Protocol Violation|123|||
19535707|NCT00190684|41983811|FG000|Overall Study|Study Period III Completed|103|||
19535708|NCT00190684|41983811|FG000|Overall Study|Study Period V Completed|1|||
19535709|NCT00179959|41983822|FG000|Overall Study|Lost to Follow-up|3|||
19535710|NCT00179959|41983823|FG001|Overall Study|Lost to Follow-up|1|||
19535711|NCT00179959|41983822|FG000|Overall Study|Withdrawal by Subject|3|||
19535712|NCT00179959|41983823|FG001|Overall Study|Withdrawal by Subject|2|||
19535713|NCT00179647|41983829|FG000|Overall Study|Adverse Event|294|||
19535714|NCT00179647|41983829|FG000|Overall Study|Lack of Efficacy|478|||
19535715|NCT00179647|41983829|FG000|Overall Study|Withdrawal by Subject|83|||
19535716|NCT00179647|41983829|FG000|Overall Study|Lost to Follow-up|4|||
19535717|NCT00179647|41983829|FG000|Overall Study|Death|94|||
19535718|NCT00179647|41983829|FG000|Overall Study|Other|960|||
19535719|NCT00179413|41983835|FG000|Overall Study|Adverse Event|38|||
19535720|NCT00179413|41983836|FG001|Overall Study|Adverse Event|20|||
19535721|NCT00179413|41983835|FG000|Overall Study|Withdrawal by Subject|87|||
19535722|NCT00179413|41983836|FG001|Overall Study|Withdrawal by Subject|95|||
19535723|NCT00178633|41983842|FG000|Overall Study|Lost to Follow-up|6|||
19535724|NCT00178399|41983847|FG000|Overall Study|Physician Decision|4|||
19535725|NCT00178399|41983847|FG000|Overall Study|Withdrawal by Subject|8|||
19535726|NCT00178399|41983847|FG000|Overall Study|Lost to Follow-up|1|||
19535727|NCT00178126|41983854|FG000|Overall Study|Lost to Follow-up|21|||
19535728|NCT00178126|41983855|FG001|Overall Study|Lost to Follow-up|21|||
19535729|NCT00178126|41983854|FG000|Overall Study|did not receive intervention|4|||
19535730|NCT00178126|41983855|FG001|Overall Study|did not receive intervention|6|||
19455033|NCT04206332|41705261|FG015|Part A|Lost to Follow-up|0|||
19455034|NCT04206332|41705262|FG016|Part A|Lost to Follow-up|0|||
19455035|NCT04206332|41705246|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455036|NCT04206332|41705247|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455037|NCT04206332|41705248|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455038|NCT04206332|41705249|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455039|NCT04206332|41705250|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455040|NCT04206332|41705251|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
19455041|NCT04206332|41705252|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455042|NCT04206332|41705253|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455043|NCT04206332|41705254|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455044|NCT04206332|41705255|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455045|NCT04206332|41705256|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455046|NCT04206332|41705257|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455047|NCT04206332|41705258|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455048|NCT04206332|41705259|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455049|NCT04206332|41705260|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455050|NCT04206332|41705261|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455051|NCT04206332|41705262|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
19455052|NCT04206332|41705246|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455053|NCT04206332|41705247|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19535731|NCT00177307|41983861|FG000|Overall Study|Withdrawal by Subject|1|||
19535732|NCT00176644|41983865|FG000|Overall Study|Withdrawal by Subject|1|||
19535733|NCT00176605|41983873|FG000|Overall Study|Withdrawal by Subject|2|||
19535734|NCT00176488|41983877|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
19535735|NCT00176254|41983881|FG000|Overall Study|Lost to Follow-up|1|||
19535736|NCT00175825|41983889|FG000|Overall Study|Adverse Event|3|||
19535737|NCT00175825|41983890|FG001|Overall Study|Adverse Event|2|||
19455054|NCT04206332|41705248|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455055|NCT04206332|41705249|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455056|NCT04206332|41705250|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455057|NCT04206332|41705251|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455058|NCT04206332|41705252|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455059|NCT04206332|41705253|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
19455060|NCT04206332|41705254|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455061|NCT04206332|41705255|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455062|NCT04206332|41705256|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
19455063|NCT04206332|41705257|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455064|NCT04206332|41705258|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455065|NCT04206332|41705259|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455066|NCT04206332|41705260|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455067|NCT04206332|41705261|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455068|NCT04206332|41705262|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455069|NCT04206332|41705246|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455070|NCT04206332|41705247|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455071|NCT04206332|41705248|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455072|NCT04206332|41705249|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455073|NCT04206332|41705250|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455074|NCT04206332|41705251|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455075|NCT04206332|41705252|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455076|NCT04206332|41705253|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455077|NCT04206332|41705254|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455078|NCT04206332|41705255|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455079|NCT04206332|41705256|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455080|NCT04206332|41705257|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455081|NCT04206332|41705258|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455082|NCT04206332|41705259|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455083|NCT04206332|41705260|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455084|NCT04206332|41705261|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
19455085|NCT04206332|41705262|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
19455086|NCT04206332|41705246|FG000|Part C|Withdrawal by Subject|0|||
19455087|NCT04206332|41705247|FG001|Part C|Withdrawal by Subject|0|||
19455088|NCT04206332|41705248|FG002|Part C|Withdrawal by Subject|0|||
19455089|NCT04206332|41705249|FG003|Part C|Withdrawal by Subject|0|||
19455090|NCT04206332|41705250|FG004|Part C|Withdrawal by Subject|0|||
19455091|NCT04206332|41705251|FG005|Part C|Withdrawal by Subject|0|||
19455092|NCT04206332|41705252|FG006|Part C|Withdrawal by Subject|0|||
19455093|NCT04206332|41705253|FG007|Part C|Withdrawal by Subject|0|||
19455094|NCT04206332|41705254|FG008|Part C|Withdrawal by Subject|0|||
19455095|NCT04206332|41705255|FG009|Part C|Withdrawal by Subject|0|||
19455096|NCT04206332|41705256|FG010|Part C|Withdrawal by Subject|0|||
19455097|NCT04206332|41705257|FG011|Part C|Withdrawal by Subject|0|||
19455098|NCT04206332|41705258|FG012|Part C|Withdrawal by Subject|0|||
19455099|NCT04206332|41705259|FG013|Part C|Withdrawal by Subject|0|||
19455100|NCT04206332|41705260|FG014|Part C|Withdrawal by Subject|2|||
19455101|NCT04206332|41705261|FG015|Part C|Withdrawal by Subject|0|||
19455102|NCT04206332|41705262|FG016|Part C|Withdrawal by Subject|0|||
19455103|NCT03830866|41705347|FG000|Overall Study|Ongoing study at DCO|312|||
19455104|NCT03830866|41705348|FG001|Overall Study|Ongoing study at DCO|295|||
19455105|NCT03830866|41705347|FG000|Overall Study|Death|58|||
19455106|NCT03830866|41705348|FG001|Overall Study|Death|74|||
19455107|NCT03830866|41705347|FG000|Overall Study|Lost to Follow-up|0|||
19455108|NCT03830866|41705348|FG001|Overall Study|Lost to Follow-up|1|||
19455109|NCT03830866|41705347|FG000|Overall Study|Withdrawal by Subject|15|||
19455110|NCT03830866|41705348|FG001|Overall Study|Withdrawal by Subject|13|||
19455111|NCT03830866|41705347|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
19455112|NCT03830866|41705348|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
19455113|NCT03830866|41705347|FG000|Overall Study|Other|0|||
19455114|NCT03830866|41705348|FG001|Overall Study|Other|1|||
19455115|NCT03790111|41705354|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
19535738|NCT00175825|41983891|FG002|Overall Study|Adverse Event|1|||
19535739|NCT00175825|41983892|FG003|Overall Study|Adverse Event|1|||
19535740|NCT00175825|41983889|FG000|Overall Study|Lost to Follow-up|1|||
19535741|NCT00175825|41983890|FG001|Overall Study|Lost to Follow-up|2|||
19535742|NCT00175825|41983891|FG002|Overall Study|Lost to Follow-up|0|||
19535743|NCT00175825|41983892|FG003|Overall Study|Lost to Follow-up|0|||
19535744|NCT00175825|41983889|FG000|Overall Study|Withdrawal by Subject|1|||
19535745|NCT00175825|41983890|FG001|Overall Study|Withdrawal by Subject|0|||
19535746|NCT00175825|41983891|FG002|Overall Study|Withdrawal by Subject|0|||
19535747|NCT00175825|41983892|FG003|Overall Study|Withdrawal by Subject|0|||
19535748|NCT00174967|41983906|FG000|Overall Study|Adverse Event|1|||
19535749|NCT00174967|41983907|FG001|Overall Study|Adverse Event|2|||
19535750|NCT00174967|41983908|FG002|Overall Study|Adverse Event|2|||
19535751|NCT00174967|41983909|FG003|Overall Study|Adverse Event|1|||
19535752|NCT00174967|41983906|FG000|Overall Study|Gout Flare|0|||
19535753|NCT00174967|41983907|FG001|Overall Study|Gout Flare|0|||
19535754|NCT00174967|41983908|FG002|Overall Study|Gout Flare|0|||
19535755|NCT00174967|41983909|FG003|Overall Study|Gout Flare|1|||
19535756|NCT00174967|41983906|FG000|Overall Study|Other|0|||
19535757|NCT00174967|41983907|FG001|Overall Study|Other|1|||
19535758|NCT00174967|41983908|FG002|Overall Study|Other|0|||
19535759|NCT00174967|41983909|FG003|Overall Study|Other|0|||
19535760|NCT00174265|41983921|FG000|Overall Study|Adverse Event|7|||
19535761|NCT00174265|41983922|FG001|Overall Study|Adverse Event|4|||
19535762|NCT00174265|41983921|FG000|Overall Study|Lack of Efficacy|2|||
19535763|NCT00174265|41983922|FG001|Overall Study|Lack of Efficacy|2|||
19535764|NCT00174265|41983921|FG000|Overall Study|Withdrawal by Subject|3|||
19535765|NCT00174265|41983922|FG001|Overall Study|Withdrawal by Subject|5|||
19535766|NCT00174265|41983921|FG000|Overall Study|Lost to Follow-up|1|||
19535767|NCT00174265|41983922|FG001|Overall Study|Lost to Follow-up|0|||
19535768|NCT00174265|41983921|FG000|Overall Study|Other (Not specified)|16|||
19535769|NCT00174265|41983922|FG001|Overall Study|Other (Not specified)|10|||
19535770|NCT00172042|41983930|FG000|Overall Study|Adverse Event|27|||
19535771|NCT00172042|41983931|FG001|Overall Study|Adverse Event|13|||
19535772|NCT00172042|41983930|FG000|Overall Study|Abnormal laboratory value(s)|5|||
19535773|NCT00172042|41983931|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19535774|NCT00172042|41983930|FG000|Overall Study|Abnormal test procedure(s)|0|||
19535775|NCT00172042|41983931|FG001|Overall Study|Abnormal test procedure(s)|3|||
19535776|NCT00172042|41983930|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
19535777|NCT00172042|41983931|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
19535778|NCT00172042|41983930|FG000|Overall Study|Patient no longer requires study drug|10|||
19535779|NCT00172042|41983931|FG001|Overall Study|Patient no longer requires study drug|8|||
19535780|NCT00172042|41983930|FG000|Overall Study|Protocol Violation|8|||
19535781|NCT00172042|41983931|FG001|Overall Study|Protocol Violation|7|||
19535782|NCT00172042|41983930|FG000|Overall Study|Withdrawal by Subject|37|||
19535783|NCT00172042|41983931|FG001|Overall Study|Withdrawal by Subject|25|||
19535784|NCT00172042|41983930|FG000|Overall Study|Lost to Follow-up|3|||
19535785|NCT00172042|41983931|FG001|Overall Study|Lost to Follow-up|5|||
19535786|NCT00172042|41983930|FG000|Overall Study|Administrative problems|13|||
19535787|NCT00172042|41983931|FG001|Overall Study|Administrative problems|10|||
19535788|NCT00172042|41983930|FG000|Overall Study|Death|42|||
19535789|NCT00172042|41983931|FG001|Overall Study|Death|42|||
19630664|NCT00784875|42079945|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
19630665|NCT00784875|42079942|FG000|Period A - Baseline|Adverse Event|0|||
19455116|NCT03780543|41705361|FG000|Overall Study|Adverse Event|1|||
19455117|NCT03780543|41705362|FG001|Overall Study|Adverse Event|0|||
19455118|NCT03780543|41705363|FG002|Overall Study|Adverse Event|2|||
19455119|NCT03780543|41705361|FG000|Overall Study|Lost to Follow-up|2|||
19455120|NCT03780543|41705362|FG001|Overall Study|Lost to Follow-up|0|||
19455121|NCT03780543|41705363|FG002|Overall Study|Lost to Follow-up|1|||
19455122|NCT03780543|41705361|FG000|Overall Study|Study terminated by Sponsor|8|||
19455123|NCT03780543|41705362|FG001|Overall Study|Study terminated by Sponsor|7|||
19535790|NCT00171925|41983939|FG000|Overall Study|Adverse Event|10|||
19535791|NCT00171925|41983940|FG001|Overall Study|Adverse Event|6|||
19535792|NCT00171925|41983939|FG000|Overall Study|Protocol Violation|1|||
19535793|NCT00171925|41983940|FG001|Overall Study|Protocol Violation|1|||
19535794|NCT00171925|41983939|FG000|Overall Study|Withdrawal by Subject|6|||
19535795|NCT00171925|41983940|FG001|Overall Study|Withdrawal by Subject|9|||
19535796|NCT00171925|41983939|FG000|Overall Study|Lost to Follow-up|2|||
19535797|NCT00171925|41983940|FG001|Overall Study|Lost to Follow-up|2|||
19535798|NCT00171925|41983939|FG000|Overall Study|Administrative problems|10|||
19535799|NCT00171925|41983940|FG001|Overall Study|Administrative problems|11|||
19535800|NCT00171925|41983939|FG000|Overall Study|Death|1|||
19535801|NCT00171925|41983940|FG001|Overall Study|Death|2|||
19535802|NCT00171340|41983948|FG000|Overall Study|Adverse Event|46|||
19535803|NCT00171340|41983949|FG001|Overall Study|Adverse Event|42|||
19535804|NCT00171340|41983948|FG000|Overall Study|Lack of Efficacy|29|||
19455124|NCT03780543|41705363|FG002|Overall Study|Study terminated by Sponsor|13|||
19455125|NCT03780543|41705361|FG000|Overall Study|Withdrawal by Subject|1|||
19455126|NCT03780543|41705362|FG001|Overall Study|Withdrawal by Subject|8|||
19455127|NCT03780543|41705363|FG002|Overall Study|Withdrawal by Subject|1|||
19455128|NCT03780543|41705361|FG000|Overall Study|Noncompliance with study drug|1|||
19455129|NCT03780543|41705362|FG001|Overall Study|Noncompliance with study drug|0|||
19455130|NCT03780543|41705363|FG002|Overall Study|Noncompliance with study drug|0|||
19455131|NCT03745820|41705376|FG000|Overall Study|Adverse Event|0|||
19455132|NCT03745820|41705377|FG001|Overall Study|Adverse Event|3|||
19455133|NCT03745820|41705378|FG002|Overall Study|Adverse Event|2|||
19455134|NCT03745820|41705376|FG000|Overall Study|Non-Compliance with Study Drug|4|||
19455135|NCT03745820|41705377|FG001|Overall Study|Non-Compliance with Study Drug|3|||
19455136|NCT03745820|41705378|FG002|Overall Study|Non-Compliance with Study Drug|0|||
19455137|NCT03745820|41705376|FG000|Overall Study|Withdrawal by Subject|4|||
19455138|NCT03745820|41705377|FG001|Overall Study|Withdrawal by Subject|4|||
19455139|NCT03745820|41705378|FG002|Overall Study|Withdrawal by Subject|4|||
19455140|NCT03745820|41705376|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
19455141|NCT03745820|41705377|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
19455142|NCT03745820|41705378|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
19455143|NCT03745820|41705376|FG000|Overall Study|Lost to Follow-up|2|||
19455144|NCT03745820|41705377|FG001|Overall Study|Lost to Follow-up|0|||
19455145|NCT03745820|41705378|FG002|Overall Study|Lost to Follow-up|3|||
19455146|NCT03745820|41705376|FG000|Overall Study|Reason not Specified|2|||
19455147|NCT03745820|41705377|FG001|Overall Study|Reason not Specified|4|||
19455148|NCT03745820|41705378|FG002|Overall Study|Reason not Specified|1|||
19455149|NCT03699631|41705386|FG000|Overall Study|Adverse Event|3|||
19455150|NCT03686150|41705400|FG000|Overall Study|Withdrawal by Subject|1|||
19455151|NCT03686150|41705401|FG001|Overall Study|Withdrawal by Subject|1|||
19455152|NCT03686150|41705402|FG002|Overall Study|Withdrawal by Subject|1|||
19455153|NCT03686150|41705403|FG003|Overall Study|Withdrawal by Subject|0|||
19455154|NCT03686150|41705404|FG004|Overall Study|Withdrawal by Subject|1|||
19455155|NCT03686150|41705405|FG005|Overall Study|Withdrawal by Subject|2|||
19455156|NCT03686150|41705400|FG000|Overall Study|Physician Decision|1|||
19455157|NCT03686150|41705401|FG001|Overall Study|Physician Decision|0|||
19455158|NCT03686150|41705402|FG002|Overall Study|Physician Decision|0|||
19455159|NCT03686150|41705403|FG003|Overall Study|Physician Decision|0|||
19455160|NCT03686150|41705404|FG004|Overall Study|Physician Decision|0|||
19455161|NCT03686150|41705405|FG005|Overall Study|Physician Decision|1|||
19455162|NCT03686150|41705400|FG000|Overall Study|Lost to Follow-up|0|||
19455163|NCT03686150|41705401|FG001|Overall Study|Lost to Follow-up|1|||
19455164|NCT03686150|41705402|FG002|Overall Study|Lost to Follow-up|0|||
19455165|NCT03686150|41705403|FG003|Overall Study|Lost to Follow-up|0|||
19455166|NCT03686150|41705404|FG004|Overall Study|Lost to Follow-up|0|||
19455167|NCT03686150|41705405|FG005|Overall Study|Lost to Follow-up|0|||
19455168|NCT03604172|41705422|FG000|Overall Study|Lost to Follow-up|1|||
19455169|NCT03604172|41705423|FG001|Overall Study|Lost to Follow-up|2|||
19455170|NCT03530124|41705448|FG000|Overall Study|Withdrawal by Subject|0|||
19455171|NCT03530124|41705449|FG001|Overall Study|Withdrawal by Subject|1|||
19455172|NCT03530124|41705448|FG000|Overall Study|Protocol Violation|1|||
19455173|NCT03530124|41705449|FG001|Overall Study|Protocol Violation|0|||
19455174|NCT03530124|41705448|FG000|Overall Study|Discharged prior to study completion|1|||
19455175|NCT03530124|41705449|FG001|Overall Study|Discharged prior to study completion|0|||
19455176|NCT03496207|41705458|FG000|Base Study|Adverse Event|0|||
19455177|NCT03496207|41705459|FG001|Base Study|Adverse Event|0|||
19455178|NCT03496207|41705460|FG002|Base Study|Adverse Event|1|||
19455179|NCT03496207|41705461|FG003|Base Study|Adverse Event|1|||
19455180|NCT03496207|41705462|FG004|Base Study|Adverse Event|4|||
19455181|NCT03496207|41705458|FG000|Base Study|Death|0|||
19455182|NCT03496207|41705459|FG001|Base Study|Death|0|||
19455183|NCT03496207|41705460|FG002|Base Study|Death|0|||
19455184|NCT03496207|41705461|FG003|Base Study|Death|0|||
19455185|NCT03496207|41705462|FG004|Base Study|Death|1|||
19455186|NCT03496207|41705458|FG000|Base Study|Withdrawal by Subject|0|||
19455187|NCT03496207|41705459|FG001|Base Study|Withdrawal by Subject|0|||
19455188|NCT03496207|41705460|FG002|Base Study|Withdrawal by Subject|1|||
19455189|NCT03496207|41705461|FG003|Base Study|Withdrawal by Subject|0|||
19455190|NCT03496207|41705462|FG004|Base Study|Withdrawal by Subject|1|||
19455191|NCT03496207|41705458|FG000|Extension Period|Adverse Event|0|||
19455192|NCT03496207|41705459|FG001|Extension Period|Adverse Event|0|||
19455193|NCT03496207|41705460|FG002|Extension Period|Adverse Event|0|||
19455194|NCT03496207|41705461|FG003|Extension Period|Adverse Event|1|||
19455195|NCT03496207|41705462|FG004|Extension Period|Adverse Event|1|||
19455196|NCT03496207|41705458|FG000|Extension Period|Death|1|||
19455197|NCT03496207|41705459|FG001|Extension Period|Death|0|||
19455198|NCT03496207|41705460|FG002|Extension Period|Death|0|||
19455199|NCT03496207|41705461|FG003|Extension Period|Death|1|||
19455200|NCT03496207|41705462|FG004|Extension Period|Death|2|||
19455201|NCT03496207|41705458|FG000|Extension Period|Withdrawal by Subject|1|||
19455202|NCT03496207|41705459|FG001|Extension Period|Withdrawal by Subject|0|||
19455203|NCT03496207|41705460|FG002|Extension Period|Withdrawal by Subject|0|||
19535805|NCT00171340|41983949|FG001|Overall Study|Lack of Efficacy|41|||
19535806|NCT00171340|41983948|FG000|Overall Study|Protocol Violation|7|||
19535807|NCT00171340|41983949|FG001|Overall Study|Protocol Violation|8|||
19535808|NCT00171340|41983948|FG000|Overall Study|Withdrawal by Subject|22|||
19535809|NCT00171340|41983949|FG001|Overall Study|Withdrawal by Subject|19|||
19535810|NCT00171340|41983948|FG000|Overall Study|Lost to Follow-up|0|||
19535811|NCT00171340|41983949|FG001|Overall Study|Lost to Follow-up|5|||
19455204|NCT03496207|41705461|FG003|Extension Period|Withdrawal by Subject|1|||
19455205|NCT03496207|41705462|FG004|Extension Period|Withdrawal by Subject|1|||
19455206|NCT03496207|41705458|FG000|Extension Period|Elevated hemoglobin levels|0|||
19455207|NCT03496207|41705459|FG001|Extension Period|Elevated hemoglobin levels|0|||
19455208|NCT03496207|41705460|FG002|Extension Period|Elevated hemoglobin levels|0|||
19455209|NCT03496207|41705461|FG003|Extension Period|Elevated hemoglobin levels|0|||
19455210|NCT03496207|41705462|FG004|Extension Period|Elevated hemoglobin levels|1|||
19535812|NCT00171340|41983948|FG000|Overall Study|Abnormal Laboratory Results|2|||
19535813|NCT00171340|41983949|FG001|Overall Study|Abnormal Laboratory Results|0|||
19455211|NCT03492177|41705486|FG000|Overall Study|Adverse Event|1|||
19455212|NCT03492177|41705487|FG001|Overall Study|Adverse Event|0|||
19535814|NCT00171340|41983948|FG000|Overall Study|Abnormal Test Procedure Results|6|||
19535815|NCT00171340|41983949|FG001|Overall Study|Abnormal Test Procedure Results|11|||
19535816|NCT00171340|41983948|FG000|Overall Study|No Longer Required Study Drug|1|||
19535817|NCT00171340|41983949|FG001|Overall Study|No Longer Required Study Drug|1|||
19535818|NCT00171340|41983948|FG000|Overall Study|Administrative Problems|5|||
19535819|NCT00171340|41983949|FG001|Overall Study|Administrative Problems|2|||
19535820|NCT00171340|41983948|FG000|Overall Study|Death|6|||
19535821|NCT00171340|41983949|FG001|Overall Study|Death|6|||
19535822|NCT00171301|41983959|FG000|Overall Study|Death|1|||
19535823|NCT00171301|41983960|FG001|Overall Study|Death|2|||
19535824|NCT00171301|41983959|FG000|Overall Study|Adverse Event|1|||
19535825|NCT00171301|41983960|FG001|Overall Study|Adverse Event|2|||
19535826|NCT00171301|41983959|FG000|Overall Study|Lost to Follow-up|6|||
19535827|NCT00171301|41983960|FG001|Overall Study|Lost to Follow-up|2|||
19535828|NCT00171301|41983959|FG000|Overall Study|Protocol Violation|0|||
19535829|NCT00171301|41983960|FG001|Overall Study|Protocol Violation|2|||
19535830|NCT00171301|41983959|FG000|Overall Study|Withdrawal by Subject|0|||
19535831|NCT00171301|41983960|FG001|Overall Study|Withdrawal by Subject|1|||
19535832|NCT00171223|41983970|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
19535833|NCT00171223|41983971|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
19535834|NCT00171223|41983972|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
19535835|NCT00171223|41983970|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
19535836|NCT00171223|41983971|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
19535837|NCT00171223|41983972|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
19535838|NCT00171223|41983970|FG000|Overall Study|Abnormal Procedure|1|||
19535839|NCT00171223|41983971|FG001|Overall Study|Abnormal Procedure|0|||
19535840|NCT00171223|41983972|FG002|Overall Study|Abnormal Procedure|0|||
19535841|NCT00171223|41983970|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
19630666|NCT00784875|42079943|FG001|Period A - Baseline|Adverse Event|0|||
19630667|NCT00784875|42079944|FG002|Period A - Baseline|Adverse Event|0|||
19630668|NCT00784875|42079945|FG003|Period A - Baseline|Adverse Event|8|||
19630669|NCT00784875|42079942|FG000|Period A - Baseline|Protocol Violation|0|||
19630670|NCT00784875|42079943|FG001|Period A - Baseline|Protocol Violation|0|||
19630671|NCT00784875|42079944|FG002|Period A - Baseline|Protocol Violation|0|||
19630672|NCT00784875|42079945|FG003|Period A - Baseline|Protocol Violation|25|||
19630673|NCT00784875|42079942|FG000|Period A - Baseline|Withdrawal by Subject|0|||
19630674|NCT00784875|42079943|FG001|Period A - Baseline|Withdrawal by Subject|0|||
19455213|NCT03492177|41705488|FG002|Overall Study|Adverse Event|0|||
19455214|NCT03492177|41705486|FG000|Overall Study|Death|3|||
19455215|NCT03492177|41705487|FG001|Overall Study|Death|0|||
19455216|NCT03492177|41705488|FG002|Overall Study|Death|3|||
19455217|NCT03492177|41705486|FG000|Overall Study|Lack of Efficacy|1|||
19455218|NCT03492177|41705487|FG001|Overall Study|Lack of Efficacy|2|||
19535842|NCT00171223|41983971|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
19630675|NCT00784875|42079944|FG002|Period A - Baseline|Withdrawal by Subject|0|||
19455219|NCT03492177|41705488|FG002|Overall Study|Lack of Efficacy|0|||
19535843|NCT00171223|41983972|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
19535844|NCT00171223|41983970|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
19535845|NCT00171223|41983971|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
19455220|NCT03492177|41705486|FG000|Overall Study|Other|1|||
19455221|NCT03492177|41705487|FG001|Overall Study|Other|0|||
19455222|NCT03492177|41705488|FG002|Overall Study|Other|0|||
19455223|NCT03492177|41705486|FG000|Overall Study|Ongoing|16|||
19535846|NCT00171223|41983972|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
19535847|NCT00171223|41983970|FG000|Overall Study|Protocol Violation|2|||
19630676|NCT00784875|42079945|FG003|Period A - Baseline|Withdrawal by Subject|27|||
19630677|NCT00784875|42079942|FG000|Period A - Baseline|Physician Decision|0|||
19630678|NCT00784875|42079943|FG001|Period A - Baseline|Physician Decision|0|||
19455224|NCT03492177|41705487|FG001|Overall Study|Ongoing|19|||
19455225|NCT03492177|41705488|FG002|Overall Study|Ongoing|17|||
19455226|NCT03204188|41705526|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
19455227|NCT03204188|41705526|FG000|Immunotherapy Phase (1 Year)|Death|1|||
19455228|NCT03204188|41705526|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
19455229|NCT03204188|41705526|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
19455230|NCT03113500|41705530|FG000|Overall Study|Withdrawal by Subject|1|||
19455231|NCT03112590|41705537|FG000|Overall Study|Adverse Event|0|||
19455232|NCT03112590|41705538|FG001|Overall Study|Adverse Event|1|||
19455233|NCT03112590|41705539|FG002|Overall Study|Adverse Event|0|||
19455234|NCT03060629|41705549|FG000|Overall Study|Death|4|||
19455235|NCT03060629|41705550|FG001|Overall Study|Death|5|||
19455236|NCT03060629|41705549|FG000|Overall Study|Withdrawal by Subject|50|||
19455237|NCT03060629|41705550|FG001|Overall Study|Withdrawal by Subject|35|||
19455238|NCT03060629|41705549|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
19455239|NCT03060629|41705550|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
19455240|NCT03060629|41705549|FG000|Overall Study|Participant Relocate|15|||
19455241|NCT03060629|41705550|FG001|Overall Study|Participant Relocate|15|||
19455242|NCT03060629|41705549|FG000|Overall Study|Unable to Contact Participant|34|||
19455243|NCT03060629|41705550|FG001|Overall Study|Unable to Contact Participant|23|||
19455244|NCT03060629|41705549|FG000|Overall Study|Investigator Decision|7|||
19455245|NCT03060629|41705550|FG001|Overall Study|Investigator Decision|7|||
19455246|NCT03060629|41705549|FG000|Overall Study|Study Terminated by Sponsor|1100|||
19455247|NCT03060629|41705550|FG001|Overall Study|Study Terminated by Sponsor|1123|||
19455248|NCT03060629|41705549|FG000|Overall Study|Other|4|||
19455249|NCT03060629|41705550|FG001|Overall Study|Other|4|||
19455250|NCT03021486|41705559|FG000|Overall Study|Withdrawal by Subject|1|||
19455251|NCT03021486|41705560|FG001|Overall Study|Withdrawal by Subject|1|||
19455252|NCT03021486|41705561|FG002|Overall Study|Withdrawal by Subject|3|||
19455253|NCT03021486|41705559|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
19455254|NCT03021486|41705560|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
19455255|NCT03021486|41705561|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
19455256|NCT02999789|41705573|FG000|Overall Study|Withdrawal by Subject|0|||
19455257|NCT02999789|41705574|FG001|Overall Study|Withdrawal by Subject|1|||
19455258|NCT02999789|41705573|FG000|Overall Study|Became ineligible|1|||
19455259|NCT02999789|41705574|FG001|Overall Study|Became ineligible|2|||
19455260|NCT02949128|41705581|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
19455261|NCT02949128|41705581|FG000|Initial Evaluation Period|Adverse Event|3|||
19455262|NCT02949128|41705581|FG000|Initial Evaluation Period|Death|2|||
19455263|NCT02949128|41705581|FG000|Initial Evaluation Period|Physician Decision|1|||
19455264|NCT02949128|41705581|FG000|Initial Evaluation Period|Protocol Violation|1|||
19455265|NCT02949128|41705581|FG000|Extension Period|Withdrawal by Subject|5|||
19455266|NCT02949128|41705581|FG000|Extension Period|Protocol Violation|1|||
19455267|NCT02949128|41705581|FG000|Extension Period|Physician Decision|2|||
19535848|NCT00171223|41983971|FG001|Overall Study|Protocol Violation|2|||
19535849|NCT00171223|41983972|FG002|Overall Study|Protocol Violation|3|||
19535850|NCT00171223|41983970|FG000|Overall Study|Participant Withdrew Consent|12|||
19535851|NCT00171223|41983971|FG001|Overall Study|Participant Withdrew Consent|21|||
19535852|NCT00171223|41983972|FG002|Overall Study|Participant Withdrew Consent|15|||
19535853|NCT00171223|41983970|FG000|Overall Study|Lost to Follow-up|5|||
19535854|NCT00171223|41983971|FG001|Overall Study|Lost to Follow-up|2|||
19535855|NCT00171223|41983972|FG002|Overall Study|Lost to Follow-up|3|||
19630679|NCT00784875|42079944|FG002|Period A - Baseline|Physician Decision|0|||
19630680|NCT00784875|42079945|FG003|Period A - Baseline|Physician Decision|2|||
19630681|NCT00784875|42079942|FG000|Period A - Baseline|Sponsor Decision|0|||
19630682|NCT00784875|42079943|FG001|Period A - Baseline|Sponsor Decision|0|||
19630683|NCT00784875|42079944|FG002|Period A - Baseline|Sponsor Decision|0|||
19630684|NCT00784875|42079945|FG003|Period A - Baseline|Sponsor Decision|113|||
19630685|NCT00784875|42079942|FG000|Period A - Baseline|Lost to Follow-up|0|||
19630686|NCT00784875|42079943|FG001|Period A - Baseline|Lost to Follow-up|0|||
19630687|NCT00784875|42079944|FG002|Period A - Baseline|Lost to Follow-up|0|||
19630688|NCT00784875|42079945|FG003|Period A - Baseline|Lost to Follow-up|2|||
19455268|NCT02949128|41705581|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
19455269|NCT02923115|41705600|FG000|Overall Study|Lost to Follow-up|0|||
19455270|NCT02923115|41705601|FG001|Overall Study|Lost to Follow-up|0|||
19535856|NCT00171223|41983970|FG000|Overall Study|Administrative Problems|4|||
19535857|NCT00171223|41983971|FG001|Overall Study|Administrative Problems|7|||
19455271|NCT02923115|41705602|FG002|Overall Study|Lost to Follow-up|0|||
19535858|NCT00171223|41983972|FG002|Overall Study|Administrative Problems|6|||
19535859|NCT00171223|41983970|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
19455272|NCT02923115|41705603|FG003|Overall Study|Lost to Follow-up|1|||
19455273|NCT02923115|41705604|FG004|Overall Study|Lost to Follow-up|0|||
19455274|NCT02923115|41705605|FG005|Overall Study|Lost to Follow-up|0|||
19630689|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
19630690|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
19535860|NCT00171223|41983971|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
19535861|NCT00171223|41983972|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
19535862|NCT00171223|41983970|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
19535863|NCT00171223|41983971|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
19535864|NCT00171223|41983972|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
19535865|NCT00479674|41983978|FG000|Overall Study|Adverse Event|18|||
19535866|NCT00479674|41983978|FG000|Overall Study|Withdrawal by Subject|6|||
19535867|NCT00479674|41983978|FG000|Overall Study|Physician Decision|14|||
19535868|NCT00479674|41983978|FG000|Overall Study|none provided|3|||
19535869|NCT00479401|41983985|FG000|Overall Study|Adverse Event|24|||
19535870|NCT00479401|41983986|FG001|Overall Study|Adverse Event|20|||
19535871|NCT00479401|41983987|FG002|Overall Study|Adverse Event|4|||
19535872|NCT00479401|41983985|FG000|Overall Study|Lack of Efficacy|2|||
19535873|NCT00479401|41983986|FG001|Overall Study|Lack of Efficacy|2|||
19535874|NCT00479401|41983987|FG002|Overall Study|Lack of Efficacy|4|||
19535875|NCT00479401|41983985|FG000|Overall Study|Protocol Violation|2|||
19535876|NCT00479401|41983986|FG001|Overall Study|Protocol Violation|1|||
19535877|NCT00479401|41983987|FG002|Overall Study|Protocol Violation|1|||
19535878|NCT00479401|41983985|FG000|Overall Study|Lost to Follow-up|1|||
19535879|NCT00479401|41983986|FG001|Overall Study|Lost to Follow-up|1|||
19535880|NCT00479401|41983987|FG002|Overall Study|Lost to Follow-up|1|||
19535881|NCT00479401|41983985|FG000|Overall Study|Withdrawal by Subject|16|||
19535882|NCT00479401|41983986|FG001|Overall Study|Withdrawal by Subject|10|||
19535883|NCT00479401|41983987|FG002|Overall Study|Withdrawal by Subject|2|||
19535884|NCT00479401|41983985|FG000|Overall Study|Exclusion criteria, relocation|4|||
19535885|NCT00479401|41983986|FG001|Overall Study|Exclusion criteria, relocation|3|||
19535886|NCT00479401|41983987|FG002|Overall Study|Exclusion criteria, relocation|0|||
19535887|NCT00478777|41983995|FG000|Overall Study|Adverse Event|29|||
19535888|NCT00478777|41983995|FG000|Overall Study|Lack of Efficacy|23|||
19535889|NCT00478777|41983995|FG000|Overall Study|Withdrawal by Subject|4|||
19535890|NCT00478777|41983995|FG000|Overall Study|Death|3|||
19535891|NCT00478777|41983995|FG000|Overall Study|Protocol Violation|3|||
19535892|NCT00478777|41983995|FG000|Overall Study|Lost to Follow-up|3|||
19455275|NCT02923115|41705600|FG000|Overall Study|Withdrawal by Subject|0|||
19455276|NCT02923115|41705601|FG001|Overall Study|Withdrawal by Subject|1|||
19455277|NCT02923115|41705602|FG002|Overall Study|Withdrawal by Subject|0|||
19455278|NCT02923115|41705603|FG003|Overall Study|Withdrawal by Subject|0|||
19535893|NCT00478777|41983995|FG000|Overall Study|Physician Decision|1|||
19535894|NCT00478777|41983995|FG000|Overall Study|Intolerance of therapy|1|||
19535895|NCT00478777|41983995|FG000|Overall Study|Lack of compliance|1|||
19535896|NCT00478777|41983995|FG000|Overall Study|Lymphocytes infusion|1|||
19630691|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
19630692|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
19630693|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
19630694|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
19630695|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
19630696|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
19630697|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
19630698|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
19630699|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
19630700|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
19630701|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
19630702|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
19630703|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
19455279|NCT02923115|41705604|FG004|Overall Study|Withdrawal by Subject|0|||
19455280|NCT02923115|41705605|FG005|Overall Study|Withdrawal by Subject|0|||
19455281|NCT02923115|41705600|FG000|Overall Study|Randomized, but not dosed|0|||
19455282|NCT02923115|41705601|FG001|Overall Study|Randomized, but not dosed|0|||
19455283|NCT02923115|41705602|FG002|Overall Study|Randomized, but not dosed|3|||
19455284|NCT02923115|41705603|FG003|Overall Study|Randomized, but not dosed|1|||
19455285|NCT02923115|41705604|FG004|Overall Study|Randomized, but not dosed|5|||
19455286|NCT02923115|41705605|FG005|Overall Study|Randomized, but not dosed|0|||
19455287|NCT02910583|41705621|FG000|Overall Study|Withdrawal by Subject|6|||
19455288|NCT02910583|41705622|FG001|Overall Study|Withdrawal by Subject|7|||
19455289|NCT02910583|41705621|FG000|Overall Study|Other, Not Specified|1|||
19535897|NCT00478777|41983995|FG000|Overall Study|End of therapy|2|||
19535898|NCT00478777|41983995|FG000|Overall Study|Not treated with lenalidomide|6|||
19535899|NCT00477607|41984001|FG000|Overall Study|Lost to Follow-up|7|||
19535900|NCT00477607|41984002|FG001|Overall Study|Lost to Follow-up|7|||
19535901|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
19535902|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
19535903|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
19535904|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
19535905|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
19630704|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
19535906|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
19455290|NCT02910583|41705622|FG001|Overall Study|Other, Not Specified|0|||
19455291|NCT02779855|41705659|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
19455292|NCT02779855|41705660|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
19455293|NCT02779855|41705661|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
19455294|NCT02562235|41705679|FG000|Overall Study|Adverse Event|3|||
19455295|NCT02487394|41705690|FG000|Phase 1|Withdrawal by Subject|0|||
19455296|NCT02487394|41705691|FG001|Phase 1|Withdrawal by Subject|1|||
19455297|NCT02388906|41705699|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
19455298|NCT02388906|41705700|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
19455299|NCT02388906|41705699|FG000|Treatment Period|Disease progression|121|||
19535907|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
19535908|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
19535909|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
19535910|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
19535911|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535912|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535913|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
19535914|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
19535915|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535916|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535917|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535918|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
19535919|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
19535920|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535921|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535922|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535923|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
19535924|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535925|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535926|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535927|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
19535928|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
19535929|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
19535930|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
19535931|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
19535932|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
19535933|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
19535934|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
19535935|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
19535936|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
19535937|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
19535938|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
19535939|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
19535940|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
19535941|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
19535942|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
19455300|NCT02388906|41705700|FG001|Treatment Period|Disease progression|101|||
19535943|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
19535944|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
19535945|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
19535946|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
19535947|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
19535948|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
19535949|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
19535950|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
19535951|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
19535952|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
19455301|NCT02388906|41705699|FG000|Treatment Period|Study drug toxicity|41|||
19455302|NCT02388906|41705700|FG001|Treatment Period|Study drug toxicity|208|||
19455303|NCT02388906|41705699|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
19535953|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
19535954|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
19535955|NCT00477490|41984013|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
19535956|NCT00477490|41984014|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
19535957|NCT00477490|41984015|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
19535958|NCT00477490|41984016|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
19535959|NCT00477490|41984017|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
19535960|NCT00477490|41984018|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
19535961|NCT00477490|41984019|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
19535962|NCT00477490|41984020|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
19455304|NCT02388906|41705700|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
19455305|NCT02388906|41705699|FG000|Treatment Period|Participant request to stop treatment|5|||
19535963|NCT00477490|41984021|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
19535964|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
19535965|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
19535966|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
19535967|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
19535968|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
19455306|NCT02388906|41705700|FG001|Treatment Period|Participant request to stop treatment|9|||
19455307|NCT02388906|41705699|FG000|Treatment Period|Participant withdrew consent|2|||
19455308|NCT02388906|41705700|FG001|Treatment Period|Participant withdrew consent|3|||
19455309|NCT02388906|41705699|FG000|Treatment Period|Poor/non-compliance|0|||
19455310|NCT02388906|41705700|FG001|Treatment Period|Poor/non-compliance|1|||
19455311|NCT02388906|41705699|FG000|Treatment Period|Participant no longer meets study criteria|0|||
19455312|NCT02388906|41705700|FG001|Treatment Period|Participant no longer meets study criteria|1|||
19455313|NCT02388906|41705699|FG000|Treatment Period|Other reasons|3|||
19455314|NCT02388906|41705700|FG001|Treatment Period|Other reasons|3|||
19455315|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
19535969|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
19535970|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
19535971|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
19535972|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
19535973|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
19535974|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
19535975|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
19535976|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
19535977|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
19535978|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
19535979|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
19535980|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
19535981|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
19455316|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
19455317|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
19455318|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
19455319|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
19455320|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
19455321|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
19455322|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
19455323|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
19455324|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
19455325|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
19455326|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
19455327|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
19455328|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
19455329|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
19535982|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
19535983|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
19535984|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
19535985|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
19535986|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
19535987|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
19535988|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
19455330|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
19535989|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
19535990|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
19535991|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535992|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535993|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535994|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535995|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
19535996|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535997|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
19535998|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
19535999|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
19536000|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536001|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
19536002|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536003|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536004|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536005|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536006|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536007|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536008|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
19536009|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
19536010|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
19536011|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
19536012|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
19536013|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
19536014|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
19536015|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
19536016|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
19536017|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
19536018|NCT00477490|41984013|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536019|NCT00477490|41984014|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
19536020|NCT00477490|41984015|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
19536021|NCT00477490|41984016|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536022|NCT00477490|41984017|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
19536023|NCT00477490|41984018|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536024|NCT00477490|41984019|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536025|NCT00477490|41984020|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536026|NCT00477490|41984021|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
19536027|NCT00477334|41984051|FG000|Overall Study|Discontinued prior to taking study drug|106|||
19536028|NCT00477334|41984052|FG001|Overall Study|Discontinued prior to taking study drug|53|||
19536029|NCT00477334|41984051|FG000|Overall Study|Adverse Event|1|||
19536030|NCT00477334|41984052|FG001|Overall Study|Adverse Event|2|||
19536031|NCT00477334|41984051|FG000|Overall Study|Withdrawal by Subject|2|||
19536032|NCT00477334|41984052|FG001|Overall Study|Withdrawal by Subject|1|||
19536033|NCT00477334|41984051|FG000|Overall Study|Lost to Follow-up|15|||
19536034|NCT00477334|41984052|FG001|Overall Study|Lost to Follow-up|4|||
19536035|NCT00477334|41984051|FG000|Overall Study|Administrative Problems|39|||
19536036|NCT00477334|41984052|FG001|Overall Study|Administrative Problems|15|||
19536037|NCT00477334|41984051|FG000|Overall Study|Protocol Violation|7|||
19536038|NCT00477334|41984052|FG001|Overall Study|Protocol Violation|1|||
19536039|NCT02277106|41984194|FG000|Stage 2|Adverse Event|0|||
19455331|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455332|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455333|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455334|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455335|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455336|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
19455337|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
19536040|NCT02277106|41984195|FG001|Stage 2|Adverse Event|0|||
19536041|NCT02277106|41984196|FG002|Stage 2|Adverse Event|1|||
19536042|NCT02215096|41984219|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
19536043|NCT02215096|41984220|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
19536044|NCT02215096|41984221|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
19536045|NCT02215096|41984222|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
19536046|NCT02215096|41984223|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
19536047|NCT02215096|41984219|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
19536048|NCT02215096|41984220|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
19536049|NCT02215096|41984221|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
19536050|NCT02215096|41984222|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
19536051|NCT02215096|41984223|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
19536052|NCT02215096|41984219|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
19536053|NCT02215096|41984220|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
19536054|NCT02215096|41984221|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
19536055|NCT02215096|41984222|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
19536056|NCT02215096|41984223|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
19536057|NCT02215096|41984219|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
19536058|NCT02215096|41984220|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
19536059|NCT02215096|41984221|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
19536060|NCT02215096|41984222|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
19536061|NCT02215096|41984223|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
19455338|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
19455339|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455340|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455341|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455342|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455343|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455344|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455345|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
19455346|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
19455347|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
19455348|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
19455349|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
19630705|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
19630706|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
19630707|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
19630708|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
19630709|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
19630710|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
19630711|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
19630712|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
19630713|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
19630714|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
19630715|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
19630716|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
19630717|NCT00784875|42079942|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
19630718|NCT00784875|42079943|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
19630719|NCT00784875|42079944|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
19630720|NCT00784875|42079945|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
19630721|NCT00784875|42079942|FG000|Period C|Adverse Event|1|||
19630722|NCT00784875|42079943|FG001|Period C|Adverse Event|0|||
19630723|NCT00784875|42079944|FG002|Period C|Adverse Event|4|||
19630724|NCT00784875|42079945|FG003|Period C|Adverse Event|2|||
19630725|NCT00784875|42079942|FG000|Period C|Protocol Violation|0|||
19630726|NCT00784875|42079943|FG001|Period C|Protocol Violation|0|||
19630727|NCT00784875|42079944|FG002|Period C|Protocol Violation|1|||
19630728|NCT00784875|42079945|FG003|Period C|Protocol Violation|2|||
19630729|NCT00784875|42079942|FG000|Period C|Lack of Efficacy|0|||
19630730|NCT00784875|42079943|FG001|Period C|Lack of Efficacy|0|||
19630731|NCT00784875|42079944|FG002|Period C|Lack of Efficacy|1|||
19630732|NCT00784875|42079945|FG003|Period C|Lack of Efficacy|0|||
19630733|NCT00784875|42079942|FG000|Period C|Withdrawal by Subject|1|||
19630734|NCT00784875|42079943|FG001|Period C|Withdrawal by Subject|1|||
19630735|NCT00784875|42079944|FG002|Period C|Withdrawal by Subject|2|||
19630736|NCT00784875|42079945|FG003|Period C|Withdrawal by Subject|0|||
19630737|NCT00784875|42079942|FG000|Period C|Physician Decision|0|||
19630738|NCT00784875|42079943|FG001|Period C|Physician Decision|0|||
19630739|NCT00784875|42079944|FG002|Period C|Physician Decision|1|||
19630740|NCT00784875|42079945|FG003|Period C|Physician Decision|1|||
19630741|NCT00784875|42079942|FG000|Period C|Sponsor Decision|5|||
19630742|NCT00784875|42079943|FG001|Period C|Sponsor Decision|5|||
19630743|NCT00784875|42079944|FG002|Period C|Sponsor Decision|4|||
19630744|NCT00784875|42079945|FG003|Period C|Sponsor Decision|2|||
19630745|NCT00784875|42079942|FG000|Period D|Adverse Event|0|||
19630746|NCT00784875|42079943|FG001|Period D|Adverse Event|2|||
19536062|NCT02214160|41984242|FG000|Overall Study|Withdrawal by Subject|1|||
19536063|NCT02214160|41984243|FG001|Overall Study|Withdrawal by Subject|0|||
19536064|NCT02214160|41984244|FG002|Overall Study|Withdrawal by Subject|6|||
19536065|NCT02214160|41984242|FG000|Overall Study|Death|2|||
19536066|NCT02214160|41984243|FG001|Overall Study|Death|2|||
19536067|NCT02214160|41984244|FG002|Overall Study|Death|1|||
19536068|NCT02214160|41984242|FG000|Overall Study|Subject Non-Compliance|0|||
19536069|NCT02214160|41984243|FG001|Overall Study|Subject Non-Compliance|3|||
19536070|NCT02214160|41984244|FG002|Overall Study|Subject Non-Compliance|1|||
19536071|NCT02214160|41984242|FG000|Overall Study|Adverse Event|0|||
19536072|NCT02214160|41984243|FG001|Overall Study|Adverse Event|1|||
19630747|NCT00784875|42079944|FG002|Period D|Adverse Event|2|||
19630748|NCT00784875|42079945|FG003|Period D|Adverse Event|0|||
19630749|NCT00784875|42079942|FG000|Period D|Protocol Violation|1|||
19630750|NCT00784875|42079943|FG001|Period D|Protocol Violation|0|||
19630751|NCT00784875|42079944|FG002|Period D|Protocol Violation|0|||
19630752|NCT00784875|42079945|FG003|Period D|Protocol Violation|0|||
19630753|NCT00784875|42079942|FG000|Period D|Withdrawal by Subject|2|||
19630754|NCT00784875|42079943|FG001|Period D|Withdrawal by Subject|0|||
19630755|NCT00784875|42079944|FG002|Period D|Withdrawal by Subject|2|||
19455350|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
19536073|NCT02214160|41984244|FG002|Overall Study|Adverse Event|1|||
19536074|NCT02214160|41984242|FG000|Overall Study|Sponsor Decision|0|||
19536075|NCT02214160|41984243|FG001|Overall Study|Sponsor Decision|2|||
19536076|NCT02214160|41984244|FG002|Overall Study|Sponsor Decision|0|||
19536077|NCT02214160|41984242|FG000|Overall Study|Protocol Violation|1|||
19536078|NCT02214160|41984243|FG001|Overall Study|Protocol Violation|0|||
19536079|NCT02214160|41984244|FG002|Overall Study|Protocol Violation|0|||
19536080|NCT02214160|41984242|FG000|Overall Study|Physician Decision|0|||
19536081|NCT02214160|41984243|FG001|Overall Study|Physician Decision|0|||
19536082|NCT02214160|41984244|FG002|Overall Study|Physician Decision|1|||
19536083|NCT03189862|41984262|FG000|Overall Study|Withdrawal by Subject|1|||
19536084|NCT03189862|41984263|FG001|Overall Study|Withdrawal by Subject|0|||
19536085|NCT03189862|41984262|FG000|Overall Study|Lost to Follow-up|54|||
19536086|NCT03189862|41984263|FG001|Overall Study|Lost to Follow-up|62|||
19536087|NCT00107614|41984295|FG000|Overall Study|Physician Decision|10|||
19455351|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
19455352|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
19455353|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
19455354|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
19455355|NCT02315703|41705714|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
19455356|NCT02315703|41705715|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
19455357|NCT02315703|41705716|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
19455358|NCT02315703|41705717|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
19455359|NCT02315703|41705718|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
19455360|NCT02315703|41705719|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
19455361|NCT02315703|41705720|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
19455362|NCT02315703|41705721|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
19536088|NCT00107614|41984295|FG000|Overall Study|Death|2|||
19536089|NCT00107380|41984299|FG000|Overall Study|Adverse Event|7|||
19536090|NCT00107380|41984299|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
19536091|NCT00107380|41984299|FG000|Overall Study|Progression/relapse|4|||
19536092|NCT00107380|41984299|FG000|Overall Study|Death|3|||
19536093|NCT00107380|41984299|FG000|Overall Study|Other - not protocol specified|7|||
19536094|NCT00107380|41984299|FG000|Overall Study|Ineligible|2|||
19536095|NCT01340014|41984306|FG000|Period 1, First 7 Days|Adverse Event|1|||
19536096|NCT01340014|41984307|FG001|Period 1, First 7 Days|Adverse Event|0|||
19536097|NCT01340014|41984306|FG000|Period 1, First 7 Days|Personal Reasons|1|||
19536098|NCT01340014|41984307|FG001|Period 1, First 7 Days|Personal Reasons|0|||
19536099|NCT01340014|41984306|FG000|Period 2, Second 7 Days|Adverse Event|0|||
19536100|NCT01340014|41984307|FG001|Period 2, Second 7 Days|Adverse Event|1|||
19536101|NCT01339897|41984317|FG000|Overall Study|Adverse Event|1|||
19536102|NCT01339897|41984318|FG001|Overall Study|Adverse Event|0|||
19536103|NCT01339897|41984319|FG002|Overall Study|Adverse Event|0|||
19536104|NCT01339897|41984320|FG003|Overall Study|Adverse Event|1|||
19536105|NCT01339429|41984332|FG000|Overall Study|Withdrawal by Subject|1|||
19536106|NCT01339429|41984332|FG000|Overall Study|Physician Decision|3|||
19536107|NCT01339390|41984338|FG000|Overall Study|Death|32|||
19536108|NCT01339390|41984339|FG001|Overall Study|Death|29|||
19536109|NCT01339390|41984338|FG000|Overall Study|Lost to Follow-up|125|||
19536110|NCT01339390|41984339|FG001|Overall Study|Lost to Follow-up|127|||
19536111|NCT01339273|41984347|FG000|Overall Study|Lost to Follow-up|8|||
19536112|NCT01339273|41984348|FG001|Overall Study|Lost to Follow-up|8|||
19536113|NCT01334866|41984354|FG000|Overall Study|Withdrawal by Subject|10|||
19536114|NCT01334866|41984354|FG000|Overall Study|Lost to Follow-up|3|||
19455363|NCT02315703|41705714|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
19455364|NCT02315703|41705715|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
19455365|NCT02315703|41705716|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455366|NCT02315703|41705717|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455367|NCT02315703|41705718|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455368|NCT02315703|41705719|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455369|NCT02315703|41705720|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455370|NCT02315703|41705721|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
19455371|NCT02315703|41705714|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19455372|NCT02315703|41705715|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
19455373|NCT02315703|41705716|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19536115|NCT01334866|41984354|FG000|Overall Study|Physician Decision|3|||
19536116|NCT01334866|41984354|FG000|Overall Study|medically necessary prior to procedure|2|||
19536117|NCT01334866|41984354|FG000|Overall Study|medically necessary post-procedure|1|||
19536118|NCT01334710|41984360|FG000|Overall Study|Trial was terminated|3|||
19536119|NCT01334554|41984367|FG000|Overall Study|Adverse Event|4|||
19536120|NCT01334554|41984368|FG001|Overall Study|Adverse Event|2|||
19536121|NCT01332799|41984378|FG000|Overall Study|Insufficient funding|10|||
19536122|NCT01332799|41984379|FG001|Overall Study|Insufficient funding|10|||
19455374|NCT02315703|41705717|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19455375|NCT02315703|41705718|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19630756|NCT00784875|42079945|FG003|Period D|Withdrawal by Subject|0|||
19630757|NCT00784875|42079942|FG000|Period D|Physician Decision|0|||
19630758|NCT00784875|42079943|FG001|Period D|Physician Decision|1|||
19536123|NCT01332331|41984387|FG000|Overall Study|Lost to Follow-up|0|||
19536124|NCT01332331|41984388|FG001|Overall Study|Lost to Follow-up|1|||
19536125|NCT01332331|41984387|FG000|Overall Study|Adverse Event|1|||
19536126|NCT01332331|41984388|FG001|Overall Study|Adverse Event|1|||
19536127|NCT01332331|41984387|FG000|Overall Study|Physician Decision|1|||
19536128|NCT01332331|41984388|FG001|Overall Study|Physician Decision|0|||
19536129|NCT01332292|41984395|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
19536130|NCT01332292|41984396|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
19536131|NCT01332292|41984395|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
19536132|NCT01332292|41984396|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
19536133|NCT01332292|41984395|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
19536134|NCT01332292|41984396|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
19630759|NCT00784875|42079944|FG002|Period D|Physician Decision|0|||
19630760|NCT00784875|42079945|FG003|Period D|Physician Decision|0|||
19630761|NCT00784875|42079942|FG000|Period D|Sponsor Decision|1|||
19630762|NCT00784875|42079943|FG001|Period D|Sponsor Decision|1|||
19630763|NCT00784875|42079944|FG002|Period D|Sponsor Decision|1|||
19630764|NCT00784875|42079945|FG003|Period D|Sponsor Decision|0|||
19630765|NCT00784875|42079942|FG000|Period D|Lost to Follow-up|1|||
19630766|NCT00784875|42079943|FG001|Period D|Lost to Follow-up|0|||
19630767|NCT00784875|42079944|FG002|Period D|Lost to Follow-up|1|||
19630768|NCT00784875|42079945|FG003|Period D|Lost to Follow-up|1|||
19630769|NCT00592553|42079971|FG000|Overall Study|Protocol Noncompliance|1|||
19455376|NCT02315703|41705719|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19455377|NCT02315703|41705720|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19455378|NCT02315703|41705721|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
19455379|NCT02315703|41705714|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
19455380|NCT02315703|41705715|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
19455381|NCT02315703|41705716|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
19455382|NCT02315703|41705717|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
19455383|NCT02315703|41705718|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
19455384|NCT02315703|41705719|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
19455385|NCT02315703|41705720|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
19455386|NCT02315703|41705721|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
19455387|NCT02063724|41705765|FG000|Overall Study|Disease progression|1|||
19455388|NCT02043678|41705771|FG000|Overall Study|Never treated|11|||
19455389|NCT02043678|41705772|FG001|Overall Study|Never treated|9|||
19455390|NCT02043678|41705771|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
19455391|NCT02043678|41705772|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
19455392|NCT02043678|41705771|FG000|Overall Study|AE without clinical PD|51|||
19455393|NCT02043678|41705772|FG001|Overall Study|AE without clinical PD|34|||
19455394|NCT02043678|41705771|FG000|Overall Study|Lost to Follow-up|1|||
19455395|NCT02043678|41705772|FG001|Overall Study|Lost to Follow-up|1|||
19455396|NCT02043678|41705771|FG000|Overall Study|Other|19|||
19455397|NCT02043678|41705772|FG001|Overall Study|Other|16|||
19455398|NCT02043678|41705771|FG000|Overall Study|Clinical PD|108|||
19455399|NCT02043678|41705772|FG001|Overall Study|Clinical PD|138|||
19455400|NCT02043678|41705771|FG000|Overall Study|Radiological PD|91|||
19455401|NCT02043678|41705772|FG001|Overall Study|Radiological PD|80|||
19455402|NCT02043678|41705771|FG000|Overall Study|Protocol-driven decision point|56|||
19455403|NCT02043678|41705772|FG001|Overall Study|Protocol-driven decision point|56|||
19455404|NCT02043678|41705771|FG000|Overall Study|Withdrawal by Subject|12|||
19455405|NCT02043678|41705772|FG001|Overall Study|Withdrawal by Subject|15|||
19455406|NCT02043678|41705771|FG000|Overall Study|Ongoing with treatment|34|||
19455407|NCT02043678|41705772|FG001|Overall Study|Ongoing with treatment|38|||
19455408|NCT02029846|41705780|FG000|Overall Study|n=1 each arm|1|||
19455409|NCT02029846|41705781|FG001|Overall Study|n=1 each arm|1|||
19455410|NCT02028884|41705790|FG000|Double-blind Period|Adverse Event|5|||
19455411|NCT02028884|41705791|FG001|Double-blind Period|Adverse Event|3|||
19455412|NCT02028884|41705792|FG002|Double-blind Period|Adverse Event|0|||
19455413|NCT02028884|41705790|FG000|Double-blind Period|Eligibility Violation|1|||
19455414|NCT02028884|41705791|FG001|Double-blind Period|Eligibility Violation|0|||
19455415|NCT02028884|41705792|FG002|Double-blind Period|Eligibility Violation|0|||
19455416|NCT02028884|41705790|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
19455417|NCT02028884|41705791|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
19536135|NCT01332019|41984406|FG000|Overall Study|Was Not Dosed|1|||
19536136|NCT01332019|41984407|FG001|Overall Study|Was Not Dosed|0|||
19536137|NCT01332019|41984406|FG000|Overall Study|Other|16|||
19630770|NCT00592553|42079972|FG001|Overall Study|Protocol Noncompliance|0|||
19630771|NCT00592553|42079973|FG002|Overall Study|Protocol Noncompliance|0|||
19630772|NCT00853229|42079983|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
19536138|NCT01332019|41984407|FG001|Overall Study|Other|18|||
19536139|NCT01332019|41984406|FG000|Overall Study|Death|2|||
19536140|NCT01332019|41984407|FG001|Overall Study|Death|1|||
19536141|NCT01332019|41984406|FG000|Overall Study|Physician Decision|4|||
19536142|NCT01332019|41984407|FG001|Overall Study|Physician Decision|3|||
19536143|NCT01332019|41984406|FG000|Overall Study|Withdrawal by Subject|73|||
19536144|NCT01332019|41984407|FG001|Overall Study|Withdrawal by Subject|71|||
19536145|NCT01332019|41984406|FG000|Overall Study|Lost to Follow-up|4|||
19536146|NCT01332019|41984407|FG001|Overall Study|Lost to Follow-up|7|||
19536147|NCT01332019|41984406|FG000|Overall Study|Adverse Event|13|||
19536148|NCT01332019|41984407|FG001|Overall Study|Adverse Event|22|||
19536149|NCT01331239|41984415|FG000|Part II: Core Study|Adverse Event|0|||
19536150|NCT01331239|41984416|FG001|Part II: Core Study|Adverse Event|3|||
19536151|NCT01331239|41984417|FG002|Part II: Core Study|Adverse Event|0|||
19455418|NCT02028884|41705792|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
19455419|NCT02028884|41705790|FG000|Double-blind Period|Withdrawal by Subject|2|||
19455420|NCT02028884|41705791|FG001|Double-blind Period|Withdrawal by Subject|0|||
19455421|NCT02028884|41705792|FG002|Double-blind Period|Withdrawal by Subject|0|||
19455422|NCT02028884|41705790|FG000|Open-label Extension Period|Adverse Event|3|||
19455423|NCT02028884|41705791|FG001|Open-label Extension Period|Adverse Event|1|||
19536152|NCT01331239|41984415|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
19536153|NCT01331239|41984416|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
19536154|NCT01331239|41984417|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
19536155|NCT01331239|41984415|FG000|Part II: Core Study|Withdrawal by Subject|0|||
19536156|NCT01331239|41984416|FG001|Part II: Core Study|Withdrawal by Subject|2|||
19536157|NCT01331239|41984417|FG002|Part II: Core Study|Withdrawal by Subject|0|||
19536158|NCT01331239|41984415|FG000|Part II: Core Study|Administrative problems|0|||
19536159|NCT01331239|41984416|FG001|Part II: Core Study|Administrative problems|1|||
19536160|NCT01331239|41984417|FG002|Part II: Core Study|Administrative problems|0|||
19536161|NCT01331161|41984435|FG000|Overall Study|Physician Decision|1|||
19536162|NCT01331161|41984436|FG001|Overall Study|Physician Decision|0|||
19536163|NCT01331161|41984435|FG000|Overall Study|Lost to Follow-up|0|||
19536164|NCT01331161|41984436|FG001|Overall Study|Lost to Follow-up|1|||
19536165|NCT01331161|41984435|FG000|Overall Study|Pregnancy|0|||
19455424|NCT02028884|41705792|FG002|Open-label Extension Period|Adverse Event|0|||
19455425|NCT02028884|41705790|FG000|Open-label Extension Period|Lack of Efficacy|3|||
19455426|NCT02028884|41705791|FG001|Open-label Extension Period|Lack of Efficacy|0|||
19455427|NCT02028884|41705792|FG002|Open-label Extension Period|Lack of Efficacy|0|||
19455428|NCT02028884|41705790|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
19455429|NCT02028884|41705791|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
19455430|NCT02028884|41705792|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
19455431|NCT02028884|41705790|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
19455432|NCT02028884|41705791|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
19455433|NCT02028884|41705792|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
19455434|NCT02028884|41705790|FG000|Open-label Extension Period|Switched to another treatment option|3|||
19455435|NCT02028884|41705791|FG001|Open-label Extension Period|Switched to another treatment option|0|||
19455436|NCT02028884|41705792|FG002|Open-label Extension Period|Switched to another treatment option|0|||
19455437|NCT02025010|41705802|FG000|Overall Study|Symptomatic or radiographic progression|36|||
19455438|NCT02025010|41705802|FG000|Overall Study|Adverse Event|6|||
19455439|NCT02025010|41705802|FG000|Overall Study|Physician Decision|7|||
19455440|NCT02025010|41705802|FG000|Overall Study|Withdrawal by Subject|3|||
19455441|NCT02025010|41705802|FG000|Overall Study|Intercurrent illness|3|||
19455442|NCT02025010|41705802|FG000|Overall Study|Patients still on treatment|3|||
19455443|NCT02025010|41705802|FG000|Overall Study|Never initiate the treatment|2|||
19455444|NCT01928394|41705868|FG000|Treatment Period|Disease progression|17|||
19455445|NCT01928394|41705869|FG001|Treatment Period|Disease progression|2|||
19455446|NCT01928394|41705870|FG002|Treatment Period|Disease progression|12|||
19455447|NCT01928394|41705871|FG003|Treatment Period|Disease progression|48|||
19455448|NCT01928394|41705872|FG004|Treatment Period|Disease progression|3|||
19455449|NCT01928394|41705873|FG005|Treatment Period|Disease progression|25|||
19455450|NCT01928394|41705874|FG006|Treatment Period|Disease progression|38|||
19455451|NCT01928394|41705875|FG007|Treatment Period|Disease progression|16|||
19455452|NCT01928394|41705876|FG008|Treatment Period|Disease progression|3|||
19455453|NCT01928394|41705877|FG009|Treatment Period|Disease progression|11|||
19455454|NCT01928394|41705878|FG010|Treatment Period|Disease progression|22|||
19455455|NCT01928394|41705879|FG011|Treatment Period|Disease progression|73|||
19455456|NCT01928394|41705880|FG012|Treatment Period|Disease progression|38|||
19455457|NCT01928394|41705881|FG013|Treatment Period|Disease progression|118|||
19455458|NCT01928394|41705882|FG014|Treatment Period|Disease progression|59|||
19455459|NCT01928394|41705883|FG015|Treatment Period|Disease progression|1|||
19455460|NCT01928394|41705884|FG016|Treatment Period|Disease progression|43|||
19455461|NCT01928394|41705885|FG017|Treatment Period|Disease progression|56|||
19536166|NCT01331161|41984436|FG001|Overall Study|Pregnancy|1|||
19536167|NCT01331005|41984446|FG000|Overall Study|Lost to Follow-up|2|||
19455462|NCT01928394|41705886|FG018|Treatment Period|Disease progression|50|||
19455463|NCT01928394|41705887|FG019|Treatment Period|Disease progression|71|||
19455464|NCT01928394|41705888|FG020|Treatment Period|Disease progression|30|||
19455465|NCT01928394|41705889|FG021|Treatment Period|Disease progression|31|||
19455466|NCT01928394|41705890|FG022|Treatment Period|Disease progression|31|||
19455467|NCT01928394|41705868|FG000|Treatment Period|Study drug toxicity|1|||
19455468|NCT01928394|41705869|FG001|Treatment Period|Study drug toxicity|1|||
19455469|NCT01928394|41705870|FG002|Treatment Period|Study drug toxicity|3|||
19455470|NCT01928394|41705871|FG003|Treatment Period|Study drug toxicity|3|||
19455471|NCT01928394|41705872|FG004|Treatment Period|Study drug toxicity|0|||
19455472|NCT01928394|41705873|FG005|Treatment Period|Study drug toxicity|9|||
19455473|NCT01928394|41705874|FG006|Treatment Period|Study drug toxicity|7|||
19455474|NCT01928394|41705875|FG007|Treatment Period|Study drug toxicity|1|||
19455475|NCT01928394|41705876|FG008|Treatment Period|Study drug toxicity|0|||
19455476|NCT01928394|41705877|FG009|Treatment Period|Study drug toxicity|5|||
19455477|NCT01928394|41705878|FG010|Treatment Period|Study drug toxicity|2|||
19455478|NCT01928394|41705879|FG011|Treatment Period|Study drug toxicity|3|||
19455479|NCT01928394|41705880|FG012|Treatment Period|Study drug toxicity|7|||
19455480|NCT01928394|41705881|FG013|Treatment Period|Study drug toxicity|5|||
19455481|NCT01928394|41705882|FG014|Treatment Period|Study drug toxicity|12|||
19455482|NCT01928394|41705883|FG015|Treatment Period|Study drug toxicity|0|||
19455483|NCT01928394|41705884|FG016|Treatment Period|Study drug toxicity|3|||
19455484|NCT01928394|41705885|FG017|Treatment Period|Study drug toxicity|3|||
19455485|NCT01928394|41705886|FG018|Treatment Period|Study drug toxicity|12|||
19455486|NCT01928394|41705887|FG019|Treatment Period|Study drug toxicity|15|||
19455487|NCT01928394|41705888|FG020|Treatment Period|Study drug toxicity|4|||
19455488|NCT01928394|41705889|FG021|Treatment Period|Study drug toxicity|7|||
19455489|NCT01928394|41705890|FG022|Treatment Period|Study drug toxicity|4|||
19455490|NCT01928394|41705868|FG000|Treatment Period|AE unrelated to study drug|0|||
19455491|NCT01928394|41705869|FG001|Treatment Period|AE unrelated to study drug|0|||
19455492|NCT01928394|41705870|FG002|Treatment Period|AE unrelated to study drug|2|||
19455493|NCT01928394|41705871|FG003|Treatment Period|AE unrelated to study drug|3|||
19455494|NCT01928394|41705872|FG004|Treatment Period|AE unrelated to study drug|0|||
19455495|NCT01928394|41705873|FG005|Treatment Period|AE unrelated to study drug|5|||
19455496|NCT01928394|41705874|FG006|Treatment Period|AE unrelated to study drug|1|||
19455497|NCT01928394|41705875|FG007|Treatment Period|AE unrelated to study drug|0|||
19455498|NCT01928394|41705876|FG008|Treatment Period|AE unrelated to study drug|0|||
19455499|NCT01928394|41705877|FG009|Treatment Period|AE unrelated to study drug|2|||
19455500|NCT01928394|41705878|FG010|Treatment Period|AE unrelated to study drug|0|||
19455501|NCT01928394|41705879|FG011|Treatment Period|AE unrelated to study drug|12|||
19455502|NCT01928394|41705880|FG012|Treatment Period|AE unrelated to study drug|6|||
19455503|NCT01928394|41705881|FG013|Treatment Period|AE unrelated to study drug|13|||
19455504|NCT01928394|41705882|FG014|Treatment Period|AE unrelated to study drug|6|||
19455505|NCT01928394|41705883|FG015|Treatment Period|AE unrelated to study drug|1|||
19455506|NCT01928394|41705884|FG016|Treatment Period|AE unrelated to study drug|1|||
19455507|NCT01928394|41705885|FG017|Treatment Period|AE unrelated to study drug|6|||
19455508|NCT01928394|41705886|FG018|Treatment Period|AE unrelated to study drug|3|||
19455509|NCT01928394|41705887|FG019|Treatment Period|AE unrelated to study drug|5|||
19455510|NCT01928394|41705888|FG020|Treatment Period|AE unrelated to study drug|1|||
19455511|NCT01928394|41705889|FG021|Treatment Period|AE unrelated to study drug|1|||
19455512|NCT01928394|41705890|FG022|Treatment Period|AE unrelated to study drug|0|||
19455513|NCT01928394|41705868|FG000|Treatment Period|Participant request to stop therapy|0|||
19455514|NCT01928394|41705869|FG001|Treatment Period|Participant request to stop therapy|0|||
19455515|NCT01928394|41705870|FG002|Treatment Period|Participant request to stop therapy|0|||
19455516|NCT01928394|41705871|FG003|Treatment Period|Participant request to stop therapy|0|||
19455517|NCT01928394|41705872|FG004|Treatment Period|Participant request to stop therapy|0|||
19455518|NCT01928394|41705873|FG005|Treatment Period|Participant request to stop therapy|3|||
19455519|NCT01928394|41705874|FG006|Treatment Period|Participant request to stop therapy|3|||
19455520|NCT01928394|41705875|FG007|Treatment Period|Participant request to stop therapy|0|||
19455521|NCT01928394|41705876|FG008|Treatment Period|Participant request to stop therapy|0|||
19455522|NCT01928394|41705877|FG009|Treatment Period|Participant request to stop therapy|0|||
19455523|NCT01928394|41705878|FG010|Treatment Period|Participant request to stop therapy|3|||
19455524|NCT01928394|41705879|FG011|Treatment Period|Participant request to stop therapy|2|||
19455525|NCT01928394|41705880|FG012|Treatment Period|Participant request to stop therapy|1|||
19455526|NCT01928394|41705881|FG013|Treatment Period|Participant request to stop therapy|2|||
19455527|NCT01928394|41705882|FG014|Treatment Period|Participant request to stop therapy|4|||
19455528|NCT01928394|41705883|FG015|Treatment Period|Participant request to stop therapy|0|||
19455529|NCT01928394|41705884|FG016|Treatment Period|Participant request to stop therapy|1|||
19455530|NCT01928394|41705885|FG017|Treatment Period|Participant request to stop therapy|3|||
19455531|NCT01928394|41705886|FG018|Treatment Period|Participant request to stop therapy|1|||
19536168|NCT01331005|41984447|FG001|Overall Study|Lost to Follow-up|1|||
19455532|NCT01928394|41705887|FG019|Treatment Period|Participant request to stop therapy|1|||
19455533|NCT01928394|41705888|FG020|Treatment Period|Participant request to stop therapy|3|||
19455534|NCT01928394|41705889|FG021|Treatment Period|Participant request to stop therapy|1|||
19536169|NCT01331005|41984446|FG000|Overall Study|Withdrawal by Subject|2|||
19536170|NCT01331005|41984447|FG001|Overall Study|Withdrawal by Subject|3|||
19536171|NCT01330459|41984455|FG000|Overall Study|Physician Decision|0|||
19536172|NCT01330459|41984456|FG001|Overall Study|Physician Decision|2|||
19536173|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
19536174|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
19536175|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
19536176|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
19536177|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
19536178|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
19536179|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
19536180|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
19536181|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
19536182|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
19536183|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
19536184|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
19536185|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
19536186|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
19536187|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
19536188|NCT01330381|41984466|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
19536189|NCT01330381|41984467|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
19536190|NCT01330381|41984468|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
19536191|NCT01330381|41984466|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
19536192|NCT01330381|41984467|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
19536193|NCT01330381|41984468|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
19536194|NCT01330381|41984466|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
19536195|NCT01330381|41984467|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
19536196|NCT01330381|41984468|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
19536197|NCT01330381|41984466|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
19536198|NCT01330381|41984467|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
19536199|NCT01330381|41984468|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
19536200|NCT01330381|41984466|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
19536201|NCT01330381|41984467|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
19536202|NCT01330381|41984468|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
19536203|NCT01330303|41984477|FG000|Period 1|Adverse Event|1|||
19536204|NCT01330303|41984478|FG001|Period 1|Adverse Event|0|||
19536205|NCT01330303|41984477|FG000|Period 1|Protocol Violation|0|||
19536206|NCT01330303|41984478|FG001|Period 1|Protocol Violation|1|||
19536207|NCT01330303|41984477|FG000|Period 1|Withdrawal by Subject|0|||
19536208|NCT01330303|41984478|FG001|Period 1|Withdrawal by Subject|1|||
19536209|NCT01330108|41984485|FG000|Overall Study|Withdrawal by Subject|4|||
19536210|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536211|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536212|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536213|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536214|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536215|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
19536216|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
19536217|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536218|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536219|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536220|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536221|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536222|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
19536223|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
19536224|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
19455535|NCT01928394|41705890|FG022|Treatment Period|Participant request to stop therapy|3|||
19455536|NCT01928394|41705868|FG000|Treatment Period|Participant withdrew consent|0|||
19455537|NCT01928394|41705869|FG001|Treatment Period|Participant withdrew consent|0|||
19455538|NCT01928394|41705870|FG002|Treatment Period|Participant withdrew consent|1|||
19455539|NCT01928394|41705871|FG003|Treatment Period|Participant withdrew consent|1|||
19455540|NCT01928394|41705872|FG004|Treatment Period|Participant withdrew consent|0|||
19455541|NCT01928394|41705873|FG005|Treatment Period|Participant withdrew consent|1|||
19536225|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
19536226|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
19536227|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
19536228|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
19536229|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
19536230|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
19536231|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536232|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536233|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536234|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536235|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536236|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
19536237|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
19536238|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
19536239|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
19536240|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
19536241|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
19536242|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
19536243|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
19536244|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
19536245|NCT01059825|41984495|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
19536246|NCT01059825|41984496|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
19536247|NCT01059825|41984497|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
19536248|NCT01059825|41984498|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
19536249|NCT01059825|41984499|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
19536250|NCT01059825|41984500|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
19536251|NCT01059825|41984501|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
19536252|NCT01059825|41984495|FG000|Treatment Period|Lost to Follow-up|2|||
19536253|NCT01059825|41984496|FG001|Treatment Period|Lost to Follow-up|1|||
19536254|NCT01059825|41984497|FG002|Treatment Period|Lost to Follow-up|0|||
19536255|NCT01059825|41984498|FG003|Treatment Period|Lost to Follow-up|1|||
19630773|NCT00853229|42079984|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
19630774|NCT00853151|42079996|FG000|Overall Study|Adverse Event|1|||
19536256|NCT01059825|41984499|FG004|Treatment Period|Lost to Follow-up|2|||
19536257|NCT01059825|41984500|FG005|Treatment Period|Lost to Follow-up|0|||
19536258|NCT01059825|41984501|FG006|Treatment Period|Lost to Follow-up|0|||
19536259|NCT01059825|41984495|FG000|Treatment Period|Withdrawal by Subject|3|||
19536260|NCT01059825|41984496|FG001|Treatment Period|Withdrawal by Subject|0|||
19536261|NCT01059825|41984497|FG002|Treatment Period|Withdrawal by Subject|1|||
19536262|NCT01059825|41984498|FG003|Treatment Period|Withdrawal by Subject|5|||
19536263|NCT01059825|41984499|FG004|Treatment Period|Withdrawal by Subject|4|||
19536264|NCT01059825|41984500|FG005|Treatment Period|Withdrawal by Subject|1|||
19536265|NCT01059825|41984501|FG006|Treatment Period|Withdrawal by Subject|0|||
19536266|NCT01059825|41984495|FG000|Treatment Period|Other reason not specified|1|||
19536267|NCT01059825|41984496|FG001|Treatment Period|Other reason not specified|2|||
19536268|NCT01059825|41984497|FG002|Treatment Period|Other reason not specified|1|||
19536269|NCT01059825|41984498|FG003|Treatment Period|Other reason not specified|2|||
19536270|NCT01059825|41984499|FG004|Treatment Period|Other reason not specified|0|||
19536271|NCT01059825|41984500|FG005|Treatment Period|Other reason not specified|0|||
19536272|NCT01059825|41984501|FG006|Treatment Period|Other reason not specified|0|||
19536273|NCT01059825|41984495|FG000|Treatment Period|Protocol Violation|0|||
19536274|NCT01059825|41984496|FG001|Treatment Period|Protocol Violation|0|||
19536275|NCT01059825|41984497|FG002|Treatment Period|Protocol Violation|1|||
19536276|NCT01059825|41984498|FG003|Treatment Period|Protocol Violation|1|||
19536277|NCT01059825|41984499|FG004|Treatment Period|Protocol Violation|1|||
19536278|NCT01059825|41984500|FG005|Treatment Period|Protocol Violation|1|||
19536279|NCT01059825|41984501|FG006|Treatment Period|Protocol Violation|0|||
19536280|NCT01059825|41984495|FG000|Treatment Period|Adverse event related to study drug|1|||
19536281|NCT01059825|41984496|FG001|Treatment Period|Adverse event related to study drug|0|||
19536282|NCT01059825|41984497|FG002|Treatment Period|Adverse event related to study drug|1|||
19536283|NCT01059825|41984498|FG003|Treatment Period|Adverse event related to study drug|1|||
19536284|NCT01059825|41984499|FG004|Treatment Period|Adverse event related to study drug|0|||
19536285|NCT01059825|41984500|FG005|Treatment Period|Adverse event related to study drug|0|||
19536286|NCT01059825|41984501|FG006|Treatment Period|Adverse event related to study drug|0|||
19536287|NCT01059825|41984495|FG000|Treatment Period|Insufficient clinical response|3|||
19536288|NCT01059825|41984496|FG001|Treatment Period|Insufficient clinical response|0|||
19536289|NCT01059825|41984497|FG002|Treatment Period|Insufficient clinical response|0|||
19536290|NCT01059825|41984498|FG003|Treatment Period|Insufficient clinical response|0|||
19536291|NCT01059825|41984499|FG004|Treatment Period|Insufficient clinical response|0|||
19536292|NCT01059825|41984500|FG005|Treatment Period|Insufficient clinical response|0|||
19536293|NCT01059825|41984501|FG006|Treatment Period|Insufficient clinical response|0|||
19536294|NCT01059825|41984495|FG000|Treatment Period|Adverse event not related to study drug|0|||
19536295|NCT01059825|41984496|FG001|Treatment Period|Adverse event not related to study drug|1|||
19536296|NCT01059825|41984497|FG002|Treatment Period|Adverse event not related to study drug|2|||
19536297|NCT01059825|41984498|FG003|Treatment Period|Adverse event not related to study drug|1|||
19536298|NCT01059825|41984499|FG004|Treatment Period|Adverse event not related to study drug|1|||
19536299|NCT01059825|41984500|FG005|Treatment Period|Adverse event not related to study drug|1|||
19536300|NCT01059825|41984501|FG006|Treatment Period|Adverse event not related to study drug|0|||
19536301|NCT01059773|41984560|FG000|Overall Study|Adverse Event|2|||
19536302|NCT01059773|41984561|FG001|Overall Study|Adverse Event|2|||
19536303|NCT01059773|41984560|FG000|Overall Study|Withdrawal by Subject|1|||
19536304|NCT01059773|41984561|FG001|Overall Study|Withdrawal by Subject|5|||
19536305|NCT01059773|41984560|FG000|Overall Study|Lost to Follow-up|1|||
19536306|NCT01059773|41984561|FG001|Overall Study|Lost to Follow-up|1|||
19536307|NCT01059773|41984560|FG000|Overall Study|Pregnancy|1|||
19536308|NCT01059773|41984561|FG001|Overall Study|Pregnancy|1|||
19536309|NCT01059773|41984560|FG000|Overall Study|Protocol Violation|6|||
19536310|NCT01059773|41984561|FG001|Overall Study|Protocol Violation|2|||
19536311|NCT01059773|41984560|FG000|Overall Study|Physician Decision|5|||
19536312|NCT01059773|41984561|FG001|Overall Study|Physician Decision|4|||
19536313|NCT01059773|41984560|FG000|Overall Study|Lack of Efficacy|3|||
19536314|NCT01059773|41984561|FG001|Overall Study|Lack of Efficacy|3|||
19536315|NCT01059773|41984560|FG000|Overall Study|Death|0|||
19536316|NCT01059773|41984561|FG001|Overall Study|Death|1|||
19536317|NCT01059773|41984560|FG000|Overall Study|Malignancy including squamous cell skin|0|||
19536318|NCT01059773|41984561|FG001|Overall Study|Malignancy including squamous cell skin|1|||
19536319|NCT01059773|41984560|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
19536320|NCT01059773|41984561|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
19536321|NCT01059773|41984560|FG000|Overall Study|Other|1|||
19536322|NCT01059773|41984561|FG001|Overall Study|Other|3|||
19536323|NCT01059318|41984572|FG000|Core Study (26 Week)|Adverse Event|3|||
19536324|NCT01059318|41984572|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
19536325|NCT01059318|41984572|FG000|Extension (36 Week)|Adverse Event|3|||
19536326|NCT01058655|41984583|FG000|Overall Study|Withdrawal by Subject|1|||
19536327|NCT01058655|41984584|FG001|Overall Study|Withdrawal by Subject|0|||
19536328|NCT01058655|41984585|FG002|Overall Study|Withdrawal by Subject|3|||
19536329|NCT01058655|41984586|FG003|Overall Study|Withdrawal by Subject|4|||
19536330|NCT01058655|41984583|FG000|Overall Study|Prolonged Treatment Delay|0|||
19536331|NCT01058655|41984584|FG001|Overall Study|Prolonged Treatment Delay|0|||
19536332|NCT01058655|41984585|FG002|Overall Study|Prolonged Treatment Delay|0|||
19536333|NCT01058655|41984586|FG003|Overall Study|Prolonged Treatment Delay|2|||
19536334|NCT01058655|41984583|FG000|Overall Study|Symptomatic Deterioration|0|||
19536335|NCT01058655|41984584|FG001|Overall Study|Symptomatic Deterioration|0|||
19536336|NCT01058655|41984585|FG002|Overall Study|Symptomatic Deterioration|0|||
19536337|NCT01058655|41984586|FG003|Overall Study|Symptomatic Deterioration|1|||
19536338|NCT01058655|41984583|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
19536339|NCT01058655|41984584|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
19536340|NCT01058655|41984585|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
19536341|NCT01058655|41984586|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
19455542|NCT01928394|41705874|FG006|Treatment Period|Participant withdrew consent|0|||
19455543|NCT01928394|41705875|FG007|Treatment Period|Participant withdrew consent|1|||
19455544|NCT01928394|41705876|FG008|Treatment Period|Participant withdrew consent|0|||
19455545|NCT01928394|41705877|FG009|Treatment Period|Participant withdrew consent|0|||
19455546|NCT01928394|41705878|FG010|Treatment Period|Participant withdrew consent|1|||
19455547|NCT01928394|41705879|FG011|Treatment Period|Participant withdrew consent|1|||
19455548|NCT01928394|41705880|FG012|Treatment Period|Participant withdrew consent|1|||
19455549|NCT01928394|41705881|FG013|Treatment Period|Participant withdrew consent|0|||
19455550|NCT01928394|41705882|FG014|Treatment Period|Participant withdrew consent|2|||
19455551|NCT01928394|41705883|FG015|Treatment Period|Participant withdrew consent|0|||
19455552|NCT01928394|41705884|FG016|Treatment Period|Participant withdrew consent|2|||
19455553|NCT01928394|41705885|FG017|Treatment Period|Participant withdrew consent|1|||
19455554|NCT01928394|41705886|FG018|Treatment Period|Participant withdrew consent|1|||
19455555|NCT01928394|41705887|FG019|Treatment Period|Participant withdrew consent|1|||
19455556|NCT01928394|41705888|FG020|Treatment Period|Participant withdrew consent|0|||
19455557|NCT01928394|41705889|FG021|Treatment Period|Participant withdrew consent|2|||
19455558|NCT01928394|41705890|FG022|Treatment Period|Participant withdrew consent|0|||
19455559|NCT01928394|41705868|FG000|Treatment Period|Poor/non-compliance|0|||
19455560|NCT01928394|41705869|FG001|Treatment Period|Poor/non-compliance|0|||
19455561|NCT01928394|41705870|FG002|Treatment Period|Poor/non-compliance|0|||
19536342|NCT01058655|41984583|FG000|Overall Study|Death|0|||
19536343|NCT01058655|41984584|FG001|Overall Study|Death|1|||
19536344|NCT01058655|41984585|FG002|Overall Study|Death|1|||
19536345|NCT01058655|41984586|FG003|Overall Study|Death|0|||
19536346|NCT01058655|41984583|FG000|Overall Study|Disease Progression|1|||
19536347|NCT01058655|41984584|FG001|Overall Study|Disease Progression|2|||
19455562|NCT01928394|41705871|FG003|Treatment Period|Poor/non-compliance|1|||
19455563|NCT01928394|41705872|FG004|Treatment Period|Poor/non-compliance|0|||
19455564|NCT01928394|41705873|FG005|Treatment Period|Poor/non-compliance|0|||
19455565|NCT01928394|41705874|FG006|Treatment Period|Poor/non-compliance|0|||
19455566|NCT01928394|41705875|FG007|Treatment Period|Poor/non-compliance|0|||
19455567|NCT01928394|41705876|FG008|Treatment Period|Poor/non-compliance|0|||
19455568|NCT01928394|41705877|FG009|Treatment Period|Poor/non-compliance|0|||
19455569|NCT01928394|41705878|FG010|Treatment Period|Poor/non-compliance|0|||
19455570|NCT01928394|41705879|FG011|Treatment Period|Poor/non-compliance|0|||
19455571|NCT01928394|41705880|FG012|Treatment Period|Poor/non-compliance|1|||
19455572|NCT01928394|41705881|FG013|Treatment Period|Poor/non-compliance|0|||
19455573|NCT01928394|41705882|FG014|Treatment Period|Poor/non-compliance|1|||
19455574|NCT01928394|41705883|FG015|Treatment Period|Poor/non-compliance|0|||
19455575|NCT01928394|41705884|FG016|Treatment Period|Poor/non-compliance|0|||
19455576|NCT01928394|41705885|FG017|Treatment Period|Poor/non-compliance|1|||
19455577|NCT01928394|41705886|FG018|Treatment Period|Poor/non-compliance|0|||
19455578|NCT01928394|41705887|FG019|Treatment Period|Poor/non-compliance|1|||
19455579|NCT01928394|41705888|FG020|Treatment Period|Poor/non-compliance|0|||
19455580|NCT01928394|41705889|FG021|Treatment Period|Poor/non-compliance|0|||
19455581|NCT01928394|41705890|FG022|Treatment Period|Poor/non-compliance|0|||
19536348|NCT01058655|41984585|FG002|Overall Study|Disease Progression|4|||
19536349|NCT01058655|41984586|FG003|Overall Study|Disease Progression|24|||
19536350|NCT01058655|41984583|FG000|Overall Study|Other|0|||
19536351|NCT01058655|41984584|FG001|Overall Study|Other|0|||
19536352|NCT01058655|41984585|FG002|Overall Study|Other|0|||
19536353|NCT01058655|41984586|FG003|Overall Study|Other|4|||
19536354|NCT01058421|41984599|FG000|1 Month Outcomes|Death|10|||
19536355|NCT01058421|41984600|FG001|1 Month Outcomes|Death|6|||
19536356|NCT01058421|41984599|FG000|1 Month Outcomes|Lost to Follow-up|8|||
19536357|NCT01058421|41984600|FG001|1 Month Outcomes|Lost to Follow-up|7|||
19536358|NCT01058421|41984599|FG000|1 Month Outcomes|Remained in Hospital|5|||
19536359|NCT01058421|41984600|FG001|1 Month Outcomes|Remained in Hospital|12|||
19536360|NCT01058421|41984599|FG000|1 Month Outcomes|Remained in Other Facility|16|||
19536361|NCT01058421|41984600|FG001|1 Month Outcomes|Remained in Other Facility|17|||
19536362|NCT01058421|41984599|FG000|3 Month Outcomes|Death|3|||
19536363|NCT01058421|41984600|FG001|3 Month Outcomes|Death|5|||
19536364|NCT01058421|41984599|FG000|3 Month Outcomes|Lost to Follow-up|12|||
19536365|NCT01058421|41984600|FG001|3 Month Outcomes|Lost to Follow-up|11|||
19536366|NCT01058421|41984599|FG000|3 Month Outcomes|Remained in Hospital|0|||
19536367|NCT01058421|41984600|FG001|3 Month Outcomes|Remained in Hospital|2|||
19536368|NCT01058421|41984599|FG000|3 Month Outcomes|Remained in Other Facility|5|||
19536369|NCT01058421|41984600|FG001|3 Month Outcomes|Remained in Other Facility|8|||
19536370|NCT01058421|41984599|FG000|6 Month Outcomes|Death|2|||
19536371|NCT01058421|41984600|FG001|6 Month Outcomes|Death|2|||
19536372|NCT01058421|41984599|FG000|6 Month Outcomes|Lost to Follow-up|16|||
19536373|NCT01058421|41984600|FG001|6 Month Outcomes|Lost to Follow-up|21|||
19536374|NCT01058421|41984599|FG000|6 Month Outcomes|Remained in Other Facility|1|||
19455582|NCT01928394|41705868|FG000|Treatment Period|other reason|0|||
19455583|NCT01928394|41705869|FG001|Treatment Period|other reason|0|||
19455584|NCT01928394|41705870|FG002|Treatment Period|other reason|0|||
19455585|NCT01928394|41705871|FG003|Treatment Period|other reason|0|||
19536375|NCT01058421|41984600|FG001|6 Month Outcomes|Remained in Other Facility|3|||
19536376|NCT01058304|41984608|FG000|Overall Study|Withdrawal by Subject|8|||
19536377|NCT01058304|41984609|FG001|Overall Study|Withdrawal by Subject|5|||
19536378|NCT01058304|41984608|FG000|Overall Study|Lost to Follow-up|13|||
19536379|NCT01058304|41984609|FG001|Overall Study|Lost to Follow-up|16|||
19536380|NCT01058304|41984608|FG000|Overall Study|Developed exclusion criterion|6|||
19536381|NCT01058304|41984609|FG001|Overall Study|Developed exclusion criterion|12|||
19455586|NCT01928394|41705872|FG004|Treatment Period|other reason|0|||
19455587|NCT01928394|41705873|FG005|Treatment Period|other reason|0|||
19455588|NCT01928394|41705874|FG006|Treatment Period|other reason|0|||
19455589|NCT01928394|41705875|FG007|Treatment Period|other reason|0|||
19455590|NCT01928394|41705876|FG008|Treatment Period|other reason|0|||
19536382|NCT01058265|41984617|FG000|Overall Study|Lost to Follow-up|11|||
19536383|NCT01058265|41984618|FG001|Overall Study|Lost to Follow-up|12|||
19536384|NCT01057251|41984626|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
19536385|NCT01057251|41984627|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
19536386|NCT01057251|41984626|FG000|Overall Study|Adverse Event|4|||
19536387|NCT01057251|41984627|FG001|Overall Study|Adverse Event|2|||
19536388|NCT01057251|41984626|FG000|Overall Study|Lack of Efficacy|2|||
19455591|NCT01928394|41705877|FG009|Treatment Period|other reason|0|||
19455592|NCT01928394|41705878|FG010|Treatment Period|other reason|1|||
19455593|NCT01928394|41705879|FG011|Treatment Period|other reason|1|||
19536389|NCT01057251|41984627|FG001|Overall Study|Lack of Efficacy|11|||
19536390|NCT01057251|41984626|FG000|Overall Study|Protocol Violation|6|||
19536391|NCT01057251|41984627|FG001|Overall Study|Protocol Violation|2|||
19536392|NCT01057251|41984626|FG000|Overall Study|Withdrawal by Subject|4|||
19536393|NCT01057251|41984627|FG001|Overall Study|Withdrawal by Subject|5|||
19536394|NCT01057251|41984626|FG000|Overall Study|Lost to Follow-up|7|||
19536395|NCT01057251|41984627|FG001|Overall Study|Lost to Follow-up|6|||
19536396|NCT01057251|41984626|FG000|Overall Study|Other Reason|1|||
19536397|NCT01057251|41984627|FG001|Overall Study|Other Reason|1|||
19536398|NCT01056822|41984635|FG000|Overall Study|Adverse Event|0|||
19455594|NCT01928394|41705880|FG012|Treatment Period|other reason|1|||
19455595|NCT01928394|41705881|FG013|Treatment Period|other reason|0|||
19455596|NCT01928394|41705882|FG014|Treatment Period|other reason|1|||
19455597|NCT01928394|41705883|FG015|Treatment Period|other reason|0|||
19455598|NCT01928394|41705884|FG016|Treatment Period|other reason|0|||
19536399|NCT01056822|41984636|FG001|Overall Study|Adverse Event|1|||
19536400|NCT01056822|41984635|FG000|Overall Study|Protocol Violation|6|||
19536401|NCT01056822|41984636|FG001|Overall Study|Protocol Violation|5|||
19536402|NCT01056822|41984635|FG000|Overall Study|Withdrawal by Subject|1|||
19536403|NCT01056822|41984636|FG001|Overall Study|Withdrawal by Subject|1|||
19536404|NCT01056822|41984635|FG000|Overall Study|Lost to Follow-up|1|||
19536405|NCT01056822|41984636|FG001|Overall Study|Lost to Follow-up|0|||
19536406|NCT01051791|41984643|FG000|Overall Study|Failed screening|3|||
19536407|NCT01051791|41984643|FG000|Overall Study|Withdrawal by Subject|1|||
19536408|NCT01056510|41984655|FG000|Overall Study|Dropout Before Start of Treatment|1|||
19536409|NCT01056510|41984656|FG001|Overall Study|Dropout Before Start of Treatment|1|||
19536410|NCT01056510|41984655|FG000|Overall Study|Withdrawal by Subject|4|||
19536411|NCT01056510|41984656|FG001|Overall Study|Withdrawal by Subject|2|||
19536412|NCT01056510|41984655|FG000|Overall Study|Death|29|||
19536413|NCT01056510|41984656|FG001|Overall Study|Death|34|||
19536414|NCT01056510|41984655|FG000|Overall Study|Noncompliance|1|||
19536415|NCT01056510|41984656|FG001|Overall Study|Noncompliance|3|||
19536416|NCT01056510|41984655|FG000|Overall Study|Physician Decision|4|||
19536417|NCT01056510|41984656|FG001|Overall Study|Physician Decision|5|||
19536418|NCT01056510|41984655|FG000|Overall Study|Lost to Follow-up|5|||
19536419|NCT01056510|41984656|FG001|Overall Study|Lost to Follow-up|6|||
19536420|NCT01056510|41984655|FG000|Overall Study|Other|10|||
19536421|NCT01056510|41984656|FG001|Overall Study|Other|12|||
19536422|NCT01056510|41984655|FG000|Overall Study|Missing|0|||
19536423|NCT01056510|41984656|FG001|Overall Study|Missing|1|||
19536424|NCT01051323|41984664|FG000|Overall Study|Discontinuation of treatment|103|||
19536425|NCT01051323|41984664|FG000|Overall Study|Transplantation|28|||
19536426|NCT01051323|41984664|FG000|Overall Study|Dialysis dependency|22|||
19536427|NCT01051323|41984664|FG000|Overall Study|Withdrawal by Subject|13|||
19536428|NCT01051323|41984664|FG000|Overall Study|Lost to Follow-up|31|||
19536429|NCT01051323|41984664|FG000|Overall Study|Death|129|||
19536430|NCT01051323|41984664|FG000|Overall Study|Hospitalization|28|||
19536431|NCT01051323|41984664|FG000|Overall Study|Other|148|||
19536432|NCT01051323|41984664|FG000|Overall Study|Missing|37|||
19536433|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
19536434|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
19536435|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
19536436|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
19536437|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
19536438|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
19536439|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
19455599|NCT01928394|41705885|FG017|Treatment Period|other reason|0|||
19455600|NCT01928394|41705886|FG018|Treatment Period|other reason|2|||
19455601|NCT01928394|41705887|FG019|Treatment Period|other reason|2|||
19455602|NCT01928394|41705888|FG020|Treatment Period|other reason|0|||
19455603|NCT01928394|41705889|FG021|Treatment Period|other reason|0|||
19455604|NCT01928394|41705890|FG022|Treatment Period|other reason|0|||
19536440|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
19536441|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
19536442|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
19536443|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Death|3|||
19536444|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Death|1|||
19536445|NCT01056276|41984674|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
19536446|NCT01056276|41984675|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
19536447|NCT01056276|41984674|FG000|Maintenance Therapy|Toxicity|0|||
19536448|NCT01056276|41984675|FG001|Maintenance Therapy|Toxicity|2|||
19536449|NCT01056276|41984674|FG000|Maintenance Therapy|Progressive Disease|0|||
19536450|NCT01056276|41984675|FG001|Maintenance Therapy|Progressive Disease|9|||
19536451|NCT01056276|41984674|FG000|Maintenance Therapy|Physician Decision|0|||
19536452|NCT01056276|41984675|FG001|Maintenance Therapy|Physician Decision|1|||
19455605|NCT01928394|41705868|FG000|Treatment Period|Maximum clinical benefit|0|||
19536453|NCT01056276|41984674|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
19536454|NCT01056276|41984675|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
19536455|NCT01056276|41984674|FG000|Maintenance Therapy|Intercurrent Illness|0|||
19536456|NCT01056276|41984675|FG001|Maintenance Therapy|Intercurrent Illness|1|||
19455606|NCT01928394|41705869|FG001|Treatment Period|Maximum clinical benefit|0|||
19536457|NCT01056276|41984674|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
19536458|NCT01056276|41984675|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
19536459|NCT01055886|41984688|FG000|Overall Study|Withdrawal by Subject|4|||
19536460|NCT01055886|41984689|FG001|Overall Study|Withdrawal by Subject|9|||
19536461|NCT01055886|41984688|FG000|Overall Study|Lost to Follow-up|1|||
19536462|NCT01055886|41984689|FG001|Overall Study|Lost to Follow-up|1|||
19536463|NCT01055886|41984688|FG000|Overall Study|Withdrawal by PI|0|||
19536464|NCT01055886|41984689|FG001|Overall Study|Withdrawal by PI|1|||
19536465|NCT01055613|41984697|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
19536466|NCT01055613|41984698|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
19536467|NCT01055613|41984697|FG000|Overall Study|Unacceptable lens fit|1|||
19536468|NCT01055613|41984698|FG001|Overall Study|Unacceptable lens fit|0|||
19455607|NCT01928394|41705870|FG002|Treatment Period|Maximum clinical benefit|0|||
19455608|NCT01928394|41705871|FG003|Treatment Period|Maximum clinical benefit|0|||
19455609|NCT01928394|41705872|FG004|Treatment Period|Maximum clinical benefit|0|||
19455610|NCT01928394|41705873|FG005|Treatment Period|Maximum clinical benefit|0|||
19455611|NCT01928394|41705874|FG006|Treatment Period|Maximum clinical benefit|0|||
19455612|NCT01928394|41705875|FG007|Treatment Period|Maximum clinical benefit|0|||
19455613|NCT01928394|41705876|FG008|Treatment Period|Maximum clinical benefit|0|||
19455614|NCT01928394|41705877|FG009|Treatment Period|Maximum clinical benefit|0|||
19536469|NCT01055613|41984697|FG000|Overall Study|Discomfort|2|||
19536470|NCT01055613|41984698|FG001|Overall Study|Discomfort|1|||
19536471|NCT01055613|41984697|FG000|Overall Study|Lost to Follow-up|1|||
19536472|NCT01055613|41984698|FG001|Overall Study|Lost to Follow-up|1|||
19536473|NCT01055613|41984697|FG000|Overall Study|Protocol Violation|1|||
19536474|NCT01055613|41984698|FG001|Overall Study|Protocol Violation|1|||
19536475|NCT01055613|41984697|FG000|Overall Study|Subject Disinterest|1|||
19536476|NCT01055613|41984698|FG001|Overall Study|Subject Disinterest|1|||
19536477|NCT01055457|41984714|FG000|Overall Study|Lost to Follow-up|0|||
19536478|NCT01055457|41984715|FG001|Overall Study|Lost to Follow-up|1|||
19630775|NCT00853151|42079997|FG001|Overall Study|Adverse Event|4|||
19630776|NCT00853151|42079998|FG002|Overall Study|Adverse Event|2|||
19630777|NCT00853151|42079999|FG003|Overall Study|Adverse Event|0|||
19630778|NCT00853151|42079996|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
19630779|NCT00853151|42079997|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19630780|NCT00853151|42079998|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19630781|NCT00853151|42079999|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
19630782|NCT00853151|42079996|FG000|Overall Study|Lost to Follow-up|2|||
19630783|NCT00853151|42079997|FG001|Overall Study|Lost to Follow-up|0|||
19630784|NCT00853151|42079998|FG002|Overall Study|Lost to Follow-up|3|||
19630785|NCT00853151|42079999|FG003|Overall Study|Lost to Follow-up|0|||
19630786|NCT00853151|42079996|FG000|Overall Study|Death|1|||
19630787|NCT00853151|42079997|FG001|Overall Study|Death|0|||
19630788|NCT00853151|42079998|FG002|Overall Study|Death|0|||
19630789|NCT00853151|42079999|FG003|Overall Study|Death|1|||
19630790|NCT00853151|42079996|FG000|Overall Study|Protocol Violation|0|||
19630791|NCT00853151|42079997|FG001|Overall Study|Protocol Violation|0|||
19630792|NCT00853151|42079998|FG002|Overall Study|Protocol Violation|0|||
19630793|NCT00853151|42079999|FG003|Overall Study|Protocol Violation|1|||
19630794|NCT00853151|42079996|FG000|Overall Study|Withdrawal by Subject|5|||
19630795|NCT00853151|42079997|FG001|Overall Study|Withdrawal by Subject|4|||
19630796|NCT00853151|42079998|FG002|Overall Study|Withdrawal by Subject|2|||
19630797|NCT00853151|42079999|FG003|Overall Study|Withdrawal by Subject|1|||
19630798|NCT00853151|42079996|FG000|Overall Study|Physician Decision|0|||
19630799|NCT00853151|42079997|FG001|Overall Study|Physician Decision|2|||
19630800|NCT00853151|42079998|FG002|Overall Study|Physician Decision|1|||
19630801|NCT00853151|42079999|FG003|Overall Study|Physician Decision|0|||
19630802|NCT00853151|42079996|FG000|Overall Study|Sponsor Decision|0|||
19630803|NCT00853151|42079997|FG001|Overall Study|Sponsor Decision|3|||
19630804|NCT00853151|42079998|FG002|Overall Study|Sponsor Decision|0|||
19630805|NCT00853151|42079999|FG003|Overall Study|Sponsor Decision|0|||
19630806|NCT00853073|42080014|FG000|Overall Study|Withdrawal by Subject|3|||
19630807|NCT00853073|42080015|FG001|Overall Study|Withdrawal by Subject|2|||
19630808|NCT00846053|42080023|FG000|Overall Study|Physician Decision|3|||
19630809|NCT00846053|42080024|FG001|Overall Study|Physician Decision|0|||
19630810|NCT00845897|42080035|FG000|Overall Study|Lost to Follow-up|1|||
19630811|NCT00845897|42080036|FG001|Overall Study|Lost to Follow-up|1|||
19630812|NCT00845897|42080037|FG002|Overall Study|Lost to Follow-up|0|||
19455615|NCT01928394|41705878|FG010|Treatment Period|Maximum clinical benefit|1|||
19455616|NCT01928394|41705879|FG011|Treatment Period|Maximum clinical benefit|1|||
19536479|NCT01055457|41984716|FG002|Overall Study|Lost to Follow-up|0|||
19536480|NCT01055457|41984717|FG003|Overall Study|Lost to Follow-up|0|||
19536481|NCT01055457|41984718|FG004|Overall Study|Lost to Follow-up|0|||
19536482|NCT01055457|41984719|FG005|Overall Study|Lost to Follow-up|1|||
19536483|NCT01055457|41984720|FG006|Overall Study|Lost to Follow-up|0|||
19630813|NCT00845897|42080035|FG000|Overall Study|Withdrawal by Subject|0|||
19630814|NCT00845897|42080036|FG001|Overall Study|Withdrawal by Subject|3|||
19630815|NCT00845897|42080037|FG002|Overall Study|Withdrawal by Subject|2|||
19630816|NCT00845897|42080035|FG000|Overall Study|Ulcer did not heal|1|||
19630817|NCT00845897|42080036|FG001|Overall Study|Ulcer did not heal|0|||
19455617|NCT01928394|41705880|FG012|Treatment Period|Maximum clinical benefit|0|||
19455618|NCT01928394|41705881|FG013|Treatment Period|Maximum clinical benefit|0|||
19536484|NCT01055457|41984721|FG007|Overall Study|Lost to Follow-up|0|||
19536485|NCT01055457|41984722|FG008|Overall Study|Lost to Follow-up|0|||
19536486|NCT01055457|41984723|FG009|Overall Study|Lost to Follow-up|0|||
19536487|NCT01055457|41984714|FG000|Overall Study|Protocol Violation|0|||
19536488|NCT01055457|41984715|FG001|Overall Study|Protocol Violation|0|||
19536489|NCT01055457|41984716|FG002|Overall Study|Protocol Violation|1|||
19536490|NCT01055457|41984717|FG003|Overall Study|Protocol Violation|1|||
19536491|NCT01055457|41984718|FG004|Overall Study|Protocol Violation|1|||
19630818|NCT00845897|42080037|FG002|Overall Study|Ulcer did not heal|1|||
19630819|NCT00845897|42080035|FG000|Overall Study|Too ill to participate|0|||
19630820|NCT00845897|42080036|FG001|Overall Study|Too ill to participate|1|||
19630821|NCT00845897|42080037|FG002|Overall Study|Too ill to participate|0|||
19630822|NCT00862277|42080048|FG000|Overall Study|Protocol Violation|1|||
19630823|NCT00862277|42080049|FG001|Overall Study|Protocol Violation|2|||
19630824|NCT00862277|42080050|FG002|Overall Study|Protocol Violation|5|||
19630825|NCT00852995|42080063|FG000|Overall Study|Adverse Event|1|||
19630826|NCT00852995|42080064|FG001|Overall Study|Adverse Event|0|||
19630827|NCT00852995|42080065|FG002|Overall Study|Adverse Event|4|||
19630828|NCT00852995|42080066|FG003|Overall Study|Adverse Event|0|||
19630829|NCT00852995|42080067|FG004|Overall Study|Adverse Event|0|||
19630830|NCT00852995|42080063|FG000|Overall Study|Lost to Follow-up|0|||
19630831|NCT00852995|42080064|FG001|Overall Study|Lost to Follow-up|1|||
19630832|NCT00852995|42080065|FG002|Overall Study|Lost to Follow-up|1|||
19630833|NCT00852995|42080066|FG003|Overall Study|Lost to Follow-up|0|||
19630834|NCT00852995|42080067|FG004|Overall Study|Lost to Follow-up|0|||
19630835|NCT00852995|42080063|FG000|Overall Study|Withdrawal by Subject|4|||
19630836|NCT00852995|42080064|FG001|Overall Study|Withdrawal by Subject|0|||
19630837|NCT00852995|42080065|FG002|Overall Study|Withdrawal by Subject|0|||
19630838|NCT00852995|42080066|FG003|Overall Study|Withdrawal by Subject|1|||
19630839|NCT00852995|42080067|FG004|Overall Study|Withdrawal by Subject|2|||
19630840|NCT00852995|42080063|FG000|Overall Study|Non-Compliance|0|||
19630841|NCT00852995|42080064|FG001|Overall Study|Non-Compliance|0|||
19630842|NCT00852995|42080065|FG002|Overall Study|Non-Compliance|0|||
19630843|NCT00852995|42080066|FG003|Overall Study|Non-Compliance|2|||
19630844|NCT00852995|42080067|FG004|Overall Study|Non-Compliance|0|||
19630845|NCT00852995|42080063|FG000|Overall Study|Progressive Disease|1|||
19630846|NCT00852995|42080064|FG001|Overall Study|Progressive Disease|0|||
19630847|NCT00852995|42080065|FG002|Overall Study|Progressive Disease|0|||
19630848|NCT00852995|42080066|FG003|Overall Study|Progressive Disease|2|||
19630849|NCT00852995|42080067|FG004|Overall Study|Progressive Disease|1|||
19630850|NCT00852995|42080063|FG000|Overall Study|Physician Decision|1|||
19630851|NCT00852995|42080064|FG001|Overall Study|Physician Decision|0|||
19630852|NCT00852995|42080065|FG002|Overall Study|Physician Decision|0|||
19630853|NCT00852995|42080066|FG003|Overall Study|Physician Decision|0|||
19630854|NCT00852995|42080067|FG004|Overall Study|Physician Decision|0|||
19536492|NCT01055457|41984719|FG005|Overall Study|Protocol Violation|2|||
19536493|NCT01055457|41984720|FG006|Overall Study|Protocol Violation|1|||
19630855|NCT00852995|42080063|FG000|Overall Study|Protocol Violation|0|||
19630856|NCT00852995|42080064|FG001|Overall Study|Protocol Violation|0|||
19630857|NCT00852995|42080065|FG002|Overall Study|Protocol Violation|0|||
19630858|NCT00852995|42080066|FG003|Overall Study|Protocol Violation|0|||
19630859|NCT00852995|42080067|FG004|Overall Study|Protocol Violation|1|||
19630860|NCT00852995|42080063|FG000|Overall Study|Moved Out of Area|1|||
19630861|NCT00852995|42080064|FG001|Overall Study|Moved Out of Area|0|||
19630862|NCT00852995|42080065|FG002|Overall Study|Moved Out of Area|0|||
19455619|NCT01928394|41705882|FG014|Treatment Period|Maximum clinical benefit|1|||
19455620|NCT01928394|41705883|FG015|Treatment Period|Maximum clinical benefit|0|||
19455621|NCT01928394|41705884|FG016|Treatment Period|Maximum clinical benefit|0|||
19455622|NCT01928394|41705885|FG017|Treatment Period|Maximum clinical benefit|1|||
19455623|NCT01928394|41705886|FG018|Treatment Period|Maximum clinical benefit|1|||
19455624|NCT01928394|41705887|FG019|Treatment Period|Maximum clinical benefit|0|||
19455625|NCT01928394|41705888|FG020|Treatment Period|Maximum clinical benefit|2|||
19455626|NCT01928394|41705889|FG021|Treatment Period|Maximum clinical benefit|0|||
19455627|NCT01928394|41705890|FG022|Treatment Period|Maximum clinical benefit|0|||
19455628|NCT01928394|41705868|FG000|Treatment Period|Lost to Follow-up|0|||
19536494|NCT01055457|41984721|FG007|Overall Study|Protocol Violation|0|||
19536495|NCT01055457|41984722|FG008|Overall Study|Protocol Violation|0|||
19536496|NCT01055457|41984723|FG009|Overall Study|Protocol Violation|1|||
19536497|NCT01055457|41984714|FG000|Overall Study|Subject Disinterest|0|||
19630863|NCT00852995|42080066|FG003|Overall Study|Moved Out of Area|0|||
19630864|NCT00852995|42080067|FG004|Overall Study|Moved Out of Area|0|||
19630865|NCT00592319|42080086|FG000|Overall Study|Lost to Follow-up|0|||
19630866|NCT00592319|42080087|FG001|Overall Study|Lost to Follow-up|3|||
19630867|NCT00862121|42080097|FG000|Overall Study|Adverse Event|1|||
19630868|NCT00862121|42080098|FG001|Overall Study|Adverse Event|2|||
19630869|NCT00862121|42080097|FG000|Overall Study|Lack of Efficacy|0|||
19630870|NCT00862121|42080098|FG001|Overall Study|Lack of Efficacy|3|||
19630871|NCT00862121|42080097|FG000|Overall Study|Protocol Violation|0|||
19536498|NCT01055457|41984715|FG001|Overall Study|Subject Disinterest|0|||
19536499|NCT01055457|41984716|FG002|Overall Study|Subject Disinterest|0|||
19536500|NCT01055457|41984717|FG003|Overall Study|Subject Disinterest|0|||
19536501|NCT01055457|41984718|FG004|Overall Study|Subject Disinterest|0|||
19536502|NCT01055457|41984719|FG005|Overall Study|Subject Disinterest|0|||
19536503|NCT01055457|41984720|FG006|Overall Study|Subject Disinterest|0|||
19536504|NCT01055457|41984721|FG007|Overall Study|Subject Disinterest|1|||
19536505|NCT01055457|41984722|FG008|Overall Study|Subject Disinterest|0|||
19536506|NCT01055457|41984723|FG009|Overall Study|Subject Disinterest|0|||
19536507|NCT01055457|41984714|FG000|Overall Study|Subject Ineligible|1|||
19536508|NCT01055457|41984715|FG001|Overall Study|Subject Ineligible|0|||
19455629|NCT01928394|41705869|FG001|Treatment Period|Lost to Follow-up|0|||
19455630|NCT01928394|41705870|FG002|Treatment Period|Lost to Follow-up|0|||
19455631|NCT01928394|41705871|FG003|Treatment Period|Lost to Follow-up|0|||
19455632|NCT01928394|41705872|FG004|Treatment Period|Lost to Follow-up|0|||
19455633|NCT01928394|41705873|FG005|Treatment Period|Lost to Follow-up|0|||
19455634|NCT01928394|41705874|FG006|Treatment Period|Lost to Follow-up|0|||
19455635|NCT01928394|41705875|FG007|Treatment Period|Lost to Follow-up|0|||
19455636|NCT01928394|41705876|FG008|Treatment Period|Lost to Follow-up|0|||
19455637|NCT01928394|41705877|FG009|Treatment Period|Lost to Follow-up|0|||
19455638|NCT01928394|41705878|FG010|Treatment Period|Lost to Follow-up|0|||
19455639|NCT01928394|41705879|FG011|Treatment Period|Lost to Follow-up|0|||
19455640|NCT01928394|41705880|FG012|Treatment Period|Lost to Follow-up|0|||
19455641|NCT01928394|41705881|FG013|Treatment Period|Lost to Follow-up|0|||
19455642|NCT01928394|41705882|FG014|Treatment Period|Lost to Follow-up|0|||
19536509|NCT01055457|41984716|FG002|Overall Study|Subject Ineligible|1|||
19536510|NCT01055457|41984717|FG003|Overall Study|Subject Ineligible|0|||
19536511|NCT01055457|41984718|FG004|Overall Study|Subject Ineligible|1|||
19536512|NCT01055457|41984719|FG005|Overall Study|Subject Ineligible|0|||
19536513|NCT01055457|41984720|FG006|Overall Study|Subject Ineligible|0|||
19536514|NCT01055457|41984721|FG007|Overall Study|Subject Ineligible|0|||
19536515|NCT01055457|41984722|FG008|Overall Study|Subject Ineligible|0|||
19536516|NCT01055457|41984723|FG009|Overall Study|Subject Ineligible|0|||
19536517|NCT01055457|41984714|FG000|Overall Study|Discomfort|0|||
19536518|NCT01055457|41984715|FG001|Overall Study|Discomfort|0|||
19536519|NCT01055457|41984716|FG002|Overall Study|Discomfort|0|||
19536520|NCT01055457|41984717|FG003|Overall Study|Discomfort|0|||
19536521|NCT01055457|41984718|FG004|Overall Study|Discomfort|1|||
19536522|NCT01055457|41984719|FG005|Overall Study|Discomfort|0|||
19536523|NCT01055457|41984720|FG006|Overall Study|Discomfort|0|||
19536524|NCT01055457|41984721|FG007|Overall Study|Discomfort|0|||
19536525|NCT01055457|41984722|FG008|Overall Study|Discomfort|0|||
19536526|NCT01055457|41984723|FG009|Overall Study|Discomfort|0|||
19536527|NCT01055457|41984714|FG000|Overall Study|Pregnancy|0|||
19536528|NCT01055457|41984715|FG001|Overall Study|Pregnancy|0|||
19536529|NCT01055457|41984716|FG002|Overall Study|Pregnancy|0|||
19536530|NCT01055457|41984717|FG003|Overall Study|Pregnancy|1|||
19536531|NCT01055457|41984718|FG004|Overall Study|Pregnancy|0|||
19536532|NCT01055457|41984719|FG005|Overall Study|Pregnancy|0|||
19536533|NCT01055457|41984720|FG006|Overall Study|Pregnancy|0|||
19536534|NCT01055457|41984721|FG007|Overall Study|Pregnancy|0|||
19536535|NCT01055457|41984722|FG008|Overall Study|Pregnancy|0|||
19536536|NCT01055457|41984723|FG009|Overall Study|Pregnancy|0|||
19536537|NCT01055457|41984714|FG000|Overall Study|Adverse Event|0|||
19536538|NCT01055457|41984715|FG001|Overall Study|Adverse Event|0|||
19536539|NCT01055457|41984716|FG002|Overall Study|Adverse Event|0|||
19455643|NCT01928394|41705883|FG015|Treatment Period|Lost to Follow-up|0|||
19455644|NCT01928394|41705884|FG016|Treatment Period|Lost to Follow-up|0|||
19455645|NCT01928394|41705885|FG017|Treatment Period|Lost to Follow-up|0|||
19455646|NCT01928394|41705886|FG018|Treatment Period|Lost to Follow-up|0|||
19536540|NCT01055457|41984717|FG003|Overall Study|Adverse Event|1|||
19536541|NCT01055457|41984718|FG004|Overall Study|Adverse Event|0|||
19536542|NCT01055457|41984719|FG005|Overall Study|Adverse Event|0|||
19536543|NCT01055457|41984720|FG006|Overall Study|Adverse Event|0|||
19630872|NCT00862121|42080098|FG001|Overall Study|Protocol Violation|1|||
19455647|NCT01928394|41705887|FG019|Treatment Period|Lost to Follow-up|0|||
19455648|NCT01928394|41705888|FG020|Treatment Period|Lost to Follow-up|0|||
19455649|NCT01928394|41705889|FG021|Treatment Period|Lost to Follow-up|0|||
19536544|NCT01055457|41984721|FG007|Overall Study|Adverse Event|0|||
19536545|NCT01055457|41984722|FG008|Overall Study|Adverse Event|0|||
19536546|NCT01055457|41984723|FG009|Overall Study|Adverse Event|0|||
19536547|NCT01055028|41984747|FG000|Screening|Screen Failure|1|||
19536548|NCT01055028|41984748|FG001|Screening|Screen Failure|1|||
19536549|NCT01055028|41984747|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
19536550|NCT01055028|41984748|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
19455650|NCT01928394|41705890|FG022|Treatment Period|Lost to Follow-up|1|||
19455651|NCT01928394|41705868|FG000|Treatment Period|Death|0|||
19455652|NCT01928394|41705869|FG001|Treatment Period|Death|0|||
19455653|NCT01928394|41705870|FG002|Treatment Period|Death|0|||
19455654|NCT01928394|41705871|FG003|Treatment Period|Death|0|||
19536551|NCT01055028|41984747|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
19455655|NCT01928394|41705872|FG004|Treatment Period|Death|0|||
19455656|NCT01928394|41705873|FG005|Treatment Period|Death|0|||
19455657|NCT01928394|41705874|FG006|Treatment Period|Death|0|||
19536552|NCT01055028|41984748|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
19536553|NCT01055028|41984747|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
19536554|NCT01055028|41984748|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
19536555|NCT01050816|41984780|FG000|Overall Study|Lost to Follow-up|2|||
19536556|NCT01050816|41984780|FG000|Overall Study|patient's refusal|2|||
19536557|NCT01054560|41984786|FG000|Overall Study|Death|10|||
19536558|NCT01054560|41984787|FG001|Overall Study|Death|21|||
19536559|NCT01054560|41984786|FG000|Overall Study|Lost to Follow-up|2|||
19536560|NCT01054560|41984787|FG001|Overall Study|Lost to Follow-up|5|||
19536561|NCT01054560|41984786|FG000|Overall Study|Withdrawal by Subject|0|||
19536562|NCT01054560|41984787|FG001|Overall Study|Withdrawal by Subject|2|||
19536563|NCT01054560|41984786|FG000|Overall Study|Physician Decision|1|||
19536564|NCT01054560|41984787|FG001|Overall Study|Physician Decision|0|||
19536565|NCT01054443|41984799|FG000|Overall Study|Withdrawal by Subject|0|||
19536566|NCT01054443|41984800|FG001|Overall Study|Withdrawal by Subject|0|||
19536567|NCT01054443|41984801|FG002|Overall Study|Withdrawal by Subject|0|||
19536568|NCT01054443|41984802|FG003|Overall Study|Withdrawal by Subject|1|||
19536569|NCT01050543|41984817|FG000|Overall Study|Withdrawal by Subject|0|||
19536570|NCT01050543|41984818|FG001|Overall Study|Withdrawal by Subject|2|||
19536571|NCT01050543|41984817|FG000|Overall Study|Protocol Violation|0|||
19536572|NCT01050543|41984818|FG001|Overall Study|Protocol Violation|1|||
19536573|NCT01050543|41984817|FG000|Overall Study|Administrative|4|||
19536574|NCT01050543|41984818|FG001|Overall Study|Administrative|1|||
19536575|NCT01051557|41984831|FG000|Overall Study|Physician Decision|1|||
19536576|NCT01051557|41984832|FG001|Overall Study|Physician Decision|0|||
19536577|NCT01051557|41984833|FG002|Overall Study|Physician Decision|0|||
19455658|NCT01928394|41705875|FG007|Treatment Period|Death|0|||
19455659|NCT01928394|41705876|FG008|Treatment Period|Death|0|||
19455660|NCT01928394|41705877|FG009|Treatment Period|Death|0|||
19455661|NCT01928394|41705878|FG010|Treatment Period|Death|0|||
19455662|NCT01928394|41705879|FG011|Treatment Period|Death|0|||
19455663|NCT01928394|41705880|FG012|Treatment Period|Death|0|||
19455664|NCT01928394|41705881|FG013|Treatment Period|Death|1|||
19455665|NCT01928394|41705882|FG014|Treatment Period|Death|2|||
19455666|NCT01928394|41705883|FG015|Treatment Period|Death|0|||
19455667|NCT01928394|41705884|FG016|Treatment Period|Death|0|||
19455668|NCT01928394|41705885|FG017|Treatment Period|Death|0|||
19455669|NCT01928394|41705886|FG018|Treatment Period|Death|0|||
19455670|NCT01928394|41705887|FG019|Treatment Period|Death|0|||
19455671|NCT01928394|41705888|FG020|Treatment Period|Death|0|||
19455672|NCT01928394|41705889|FG021|Treatment Period|Death|0|||
19455673|NCT01928394|41705890|FG022|Treatment Period|Death|0|||
19455674|NCT01928394|41705868|FG000|Follow-up Period|Participant withdrew consent|3|||
19455675|NCT01928394|41705869|FG001|Follow-up Period|Participant withdrew consent|0|||
19455676|NCT01928394|41705870|FG002|Follow-up Period|Participant withdrew consent|1|||
19455677|NCT01928394|41705871|FG003|Follow-up Period|Participant withdrew consent|4|||
19536578|NCT01051557|41984834|FG003|Overall Study|Physician Decision|0|||
19536579|NCT01051557|41984835|FG004|Overall Study|Physician Decision|0|||
19536580|NCT01051557|41984836|FG005|Overall Study|Physician Decision|0|||
19536581|NCT01051557|41984837|FG006|Overall Study|Physician Decision|0|||
19536582|NCT01051557|41984831|FG000|Overall Study|disease progression|3|||
19536583|NCT01051557|41984832|FG001|Overall Study|disease progression|3|||
19536584|NCT01051557|41984833|FG002|Overall Study|disease progression|5|||
19536585|NCT01051557|41984834|FG003|Overall Study|disease progression|2|||
19536586|NCT01051557|41984835|FG004|Overall Study|disease progression|4|||
19536587|NCT01051557|41984836|FG005|Overall Study|disease progression|3|||
19536588|NCT01051557|41984837|FG006|Overall Study|disease progression|1|||
19536589|NCT01051557|41984831|FG000|Overall Study|Withdrawal by Subject|0|||
19536590|NCT01051557|41984832|FG001|Overall Study|Withdrawal by Subject|0|||
19536591|NCT01051557|41984833|FG002|Overall Study|Withdrawal by Subject|1|||
19536592|NCT01051557|41984834|FG003|Overall Study|Withdrawal by Subject|0|||
19536593|NCT01051557|41984835|FG004|Overall Study|Withdrawal by Subject|2|||
19536594|NCT01051557|41984836|FG005|Overall Study|Withdrawal by Subject|0|||
19536595|NCT01051557|41984837|FG006|Overall Study|Withdrawal by Subject|1|||
19711507|NCT00082173|42154604|FG001|Overall Study|Culture negative or resistant at baselin|6|||
19711508|NCT03568318|42154616|FG000|Overall Study|Adverse Event|3|||
19455678|NCT01928394|41705872|FG004|Follow-up Period|Participant withdrew consent|0|||
19455679|NCT01928394|41705873|FG005|Follow-up Period|Participant withdrew consent|2|||
19455680|NCT01928394|41705874|FG006|Follow-up Period|Participant withdrew consent|5|||
19455681|NCT01928394|41705875|FG007|Follow-up Period|Participant withdrew consent|1|||
19455682|NCT01928394|41705876|FG008|Follow-up Period|Participant withdrew consent|0|||
19455683|NCT01928394|41705877|FG009|Follow-up Period|Participant withdrew consent|0|||
19455684|NCT01928394|41705878|FG010|Follow-up Period|Participant withdrew consent|5|||
19455685|NCT01928394|41705879|FG011|Follow-up Period|Participant withdrew consent|8|||
19536596|NCT01051557|41984831|FG000|Overall Study|Adverse Event|0|||
19536597|NCT01051557|41984832|FG001|Overall Study|Adverse Event|0|||
19536598|NCT01051557|41984833|FG002|Overall Study|Adverse Event|0|||
19536599|NCT01051557|41984834|FG003|Overall Study|Adverse Event|1|||
19536600|NCT01051557|41984835|FG004|Overall Study|Adverse Event|1|||
19536601|NCT01051557|41984836|FG005|Overall Study|Adverse Event|3|||
19536602|NCT01051557|41984837|FG006|Overall Study|Adverse Event|4|||
19536603|NCT01054170|41984856|FG000|Overall Study|Protocol Violation|1|||
19536604|NCT01054170|41984857|FG001|Overall Study|Protocol Violation|0|||
19536605|NCT01054170|41984856|FG000|Overall Study|Withdrawal by Subject|3|||
19536606|NCT01054170|41984857|FG001|Overall Study|Withdrawal by Subject|2|||
19536607|NCT01054170|41984856|FG000|Overall Study|Adverse Event|0|||
19536608|NCT01054170|41984857|FG001|Overall Study|Adverse Event|4|||
19536609|NCT01053741|41984865|FG000|2nd Study Intervention|Physician Decision|0|||
19536610|NCT01053741|41984866|FG001|2nd Study Intervention|Physician Decision|1|||
19536611|NCT01052493|41984872|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
19536612|NCT01052493|41984873|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
19536613|NCT01052493|41984874|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
19536614|NCT01052103|41984889|FG000|Overall Study|Adverse Event|10|||
19536615|NCT01052103|41984890|FG001|Overall Study|Adverse Event|6|||
19536616|NCT01052103|41984889|FG000|Overall Study|Entry Criteria Not Met|3|||
19536617|NCT01052103|41984890|FG001|Overall Study|Entry Criteria Not Met|1|||
19536618|NCT01052103|41984889|FG000|Overall Study|Lost to Follow-up|3|||
19536619|NCT01052103|41984890|FG001|Overall Study|Lost to Follow-up|5|||
19536620|NCT01052103|41984889|FG000|Overall Study|Protocol Violation|10|||
19536621|NCT01052103|41984890|FG001|Overall Study|Protocol Violation|4|||
19536622|NCT01052103|41984889|FG000|Overall Study|Scheduling conflict|2|||
19536623|NCT01052103|41984890|FG001|Overall Study|Scheduling conflict|1|||
19536624|NCT01052103|41984889|FG000|Overall Study|Sponsor Decision|2|||
19536625|NCT01052103|41984890|FG001|Overall Study|Sponsor Decision|0|||
19536626|NCT01052103|41984889|FG000|Overall Study|Withdrawal by Subject|3|||
19536627|NCT01052103|41984890|FG001|Overall Study|Withdrawal by Subject|6|||
19536628|NCT01052103|41984889|FG000|Overall Study|Perceived Lack of Efficacy|1|||
19536629|NCT01052103|41984890|FG001|Overall Study|Perceived Lack of Efficacy|0|||
19536630|NCT01051986|41984899|FG000|Overall Study|Death|1|||
19536631|NCT01051986|41984900|FG001|Overall Study|Death|0|||
19536632|NCT01051986|41984899|FG000|Overall Study|Withdrawal by Subject|2|||
19536633|NCT01051986|41984900|FG001|Overall Study|Withdrawal by Subject|1|||
19536634|NCT01051986|41984899|FG000|Overall Study|Protocol Violation|2|||
19536635|NCT01051986|41984900|FG001|Overall Study|Protocol Violation|3|||
19536636|NCT00105534|41984912|FG000|Overall Study|Adverse Event|2|||
19536637|NCT00105534|41984913|FG001|Overall Study|Adverse Event|5|||
19536638|NCT00105534|41984912|FG000|Overall Study|Protocol Violation|1|||
19536639|NCT00105534|41984913|FG001|Overall Study|Protocol Violation|4|||
19536640|NCT00105534|41984912|FG000|Overall Study|Withdrawal by Subject|6|||
19536641|NCT00105534|41984913|FG001|Overall Study|Withdrawal by Subject|6|||
19536642|NCT00105534|41984912|FG000|Overall Study|Lost to Follow-up|5|||
19536643|NCT00105534|41984913|FG001|Overall Study|Lost to Follow-up|1|||
19536644|NCT00105534|41984912|FG000|Overall Study|Lack of Efficacy|7|||
19536645|NCT00105534|41984913|FG001|Overall Study|Lack of Efficacy|15|||
19536646|NCT00105534|41984912|FG000|Overall Study|Treatment unmasked|1|||
19536647|NCT00105534|41984913|FG001|Overall Study|Treatment unmasked|0|||
19536648|NCT00105534|41984912|FG000|Overall Study|Other Reason|0|||
19536649|NCT00105534|41984913|FG001|Overall Study|Other Reason|2|||
19536650|NCT00105183|41984922|FG000|Overall Study|Death|19|||
19536651|NCT00105183|41984923|FG001|Overall Study|Death|13|||
19536652|NCT00105183|41984924|FG002|Overall Study|Death|15|||
19536653|NCT00105183|41984922|FG000|Overall Study|Withdrawal by Subject|1|||
19536654|NCT00105183|41984923|FG001|Overall Study|Withdrawal by Subject|1|||
19536655|NCT00105183|41984924|FG002|Overall Study|Withdrawal by Subject|4|||
19536656|NCT00105183|41984922|FG000|Overall Study|Physician Decision|1|||
19536657|NCT00105183|41984923|FG001|Overall Study|Physician Decision|2|||
19536658|NCT00105183|41984924|FG002|Overall Study|Physician Decision|3|||
19536659|NCT00105183|41984922|FG000|Overall Study|Lost to Follow-up|0|||
19536660|NCT00105183|41984923|FG001|Overall Study|Lost to Follow-up|1|||
19536661|NCT00105183|41984924|FG002|Overall Study|Lost to Follow-up|1|||
19536662|NCT00105183|41984922|FG000|Overall Study|Other reason|1|||
19536663|NCT00105183|41984923|FG001|Overall Study|Other reason|2|||
19536664|NCT00105183|41984924|FG002|Overall Study|Other reason|0|||
19536665|NCT01059617|41984936|FG000|Overall Study|Other|7|||
19536666|NCT01059617|41984937|FG001|Overall Study|Other|1|||
19536667|NCT01059617|41984938|FG002|Overall Study|Other|8|||
19536668|NCT01059617|41984939|FG003|Overall Study|Other|6|||
19536669|NCT01059344|41984959|FG000|Overall Study|Adverse Event|12|||
19536670|NCT01059344|41984960|FG001|Overall Study|Adverse Event|30|||
19536671|NCT01059344|41984959|FG000|Overall Study|Withdrawal by Subject|6|||
19536672|NCT01059344|41984960|FG001|Overall Study|Withdrawal by Subject|9|||
19536673|NCT01059344|41984959|FG000|Overall Study|Lost to Follow-up|1|||
19536674|NCT01059344|41984960|FG001|Overall Study|Lost to Follow-up|1|||
19536675|NCT01059344|41984959|FG000|Overall Study|Other|3|||
19536676|NCT01059344|41984960|FG001|Overall Study|Other|6|||
19536677|NCT01059071|41984968|FG000|Overall Study|Lack of Efficacy|1|||
19536678|NCT01059071|41984969|FG001|Overall Study|Lack of Efficacy|4|||
19536679|NCT01059071|41984970|FG002|Overall Study|Lack of Efficacy|2|||
19536680|NCT01059071|41984971|FG003|Overall Study|Lack of Efficacy|3|||
19536681|NCT01059071|41984968|FG000|Overall Study|Withdrawal by Subject|1|||
19536682|NCT01059071|41984969|FG001|Overall Study|Withdrawal by Subject|0|||
19536683|NCT01059071|41984970|FG002|Overall Study|Withdrawal by Subject|0|||
19536684|NCT01059071|41984971|FG003|Overall Study|Withdrawal by Subject|2|||
19536685|NCT01059071|41984968|FG000|Overall Study|Physician Decision|0|||
19536686|NCT01059071|41984969|FG001|Overall Study|Physician Decision|0|||
19536687|NCT01059071|41984970|FG002|Overall Study|Physician Decision|0|||
19536688|NCT01059071|41984971|FG003|Overall Study|Physician Decision|1|||
19536689|NCT01058642|41984983|FG000|Treatment Period 1|Adverse Event|0|||
19536690|NCT01058642|41984984|FG001|Treatment Period 1|Adverse Event|1|||
19536691|NCT01058642|41984985|FG002|Treatment Period 1|Adverse Event|1|||
19536692|NCT01058642|41984986|FG003|Treatment Period 1|Adverse Event|0|||
19536693|NCT01058642|41984983|FG000|Treatment Period 1|Physician Decision|0|||
19536694|NCT01058642|41984984|FG001|Treatment Period 1|Physician Decision|0|||
19536695|NCT01058642|41984985|FG002|Treatment Period 1|Physician Decision|1|||
19536696|NCT01058642|41984986|FG003|Treatment Period 1|Physician Decision|0|||
19536697|NCT01058642|41984983|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19536698|NCT01058642|41984984|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19536699|NCT01058642|41984985|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19536700|NCT01058642|41984986|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19536701|NCT01058642|41984983|FG000|Treatment Period 1|Lack of Efficacy|0|||
19536702|NCT01058642|41984984|FG001|Treatment Period 1|Lack of Efficacy|0|||
19536703|NCT01058642|41984985|FG002|Treatment Period 1|Lack of Efficacy|0|||
19536704|NCT01058642|41984986|FG003|Treatment Period 1|Lack of Efficacy|1|||
19536705|NCT01058642|41984983|FG000|Treatment Period 1|Protocol Violation|0|||
19536706|NCT01058642|41984984|FG001|Treatment Period 1|Protocol Violation|0|||
19536707|NCT01058642|41984985|FG002|Treatment Period 1|Protocol Violation|0|||
19536708|NCT01058642|41984986|FG003|Treatment Period 1|Protocol Violation|1|||
19536709|NCT01058642|41984983|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
19536710|NCT01058642|41984984|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
19536711|NCT01058642|41984985|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
19536712|NCT01058642|41984986|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
19536713|NCT01058369|41984994|FG000|Overall Study|Adverse Event|1|||
19536714|NCT01058369|41984994|FG000|Overall Study|Early termination study|1|||
19536715|NCT01057433|41984998|FG000|Overall Study|Adverse Event|1|||
19536716|NCT01057394|41985002|FG000|Overall Study|Not eligible|0|||
19536717|NCT01057394|41985003|FG001|Overall Study|Not eligible|2|||
19536718|NCT01056653|41985010|FG000|Overall Study|Lost to Follow-up|0|||
19536719|NCT01056653|41985011|FG001|Overall Study|Lost to Follow-up|0|||
19536720|NCT01056653|41985012|FG002|Overall Study|Lost to Follow-up|2|||
19536721|NCT01056536|41985024|FG000|Overall Study|Lost to Follow-up|202|||
19536722|NCT01056536|41985025|FG001|Overall Study|Lost to Follow-up|116|||
19536723|NCT01056536|41985026|FG002|Overall Study|Lost to Follow-up|248|||
19536724|NCT01056380|41985036|FG000|Overall Study|Lost to Follow-up|2|||
19536725|NCT01056380|41985037|FG001|Overall Study|Lost to Follow-up|3|||
19536726|NCT01055834|41985047|FG000|Treatment Period I|Adverse Event|1|||
19536727|NCT01055834|41985048|FG001|Treatment Period I|Adverse Event|0|||
19536728|NCT01055639|41985059|FG000|Overall Study|Adverse Event|0|||
19536729|NCT01055639|41985060|FG001|Overall Study|Adverse Event|1|||
19536730|NCT01055639|41985059|FG000|Overall Study|Lack of Efficacy|0|||
19536731|NCT01055639|41985060|FG001|Overall Study|Lack of Efficacy|1|||
19536732|NCT01055639|41985059|FG000|Overall Study|Lost to Follow-up|8|||
19536733|NCT01055639|41985060|FG001|Overall Study|Lost to Follow-up|11|||
19536734|NCT01055639|41985059|FG000|Overall Study|Protocol Violation|5|||
19536735|NCT01055639|41985060|FG001|Overall Study|Protocol Violation|5|||
19536736|NCT01055639|41985059|FG000|Overall Study|Withdrawal by Subject|8|||
19536737|NCT01055639|41985060|FG001|Overall Study|Withdrawal by Subject|11|||
19536738|NCT01055132|41985075|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
19536739|NCT01055132|41985076|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
19536740|NCT01055132|41985075|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
19536741|NCT01055132|41985076|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
19536742|NCT01054976|41985086|FG000|Overall Study|Adverse Event|16|||
19536743|NCT01054976|41985086|FG000|Overall Study|Uncooperative participations to study|7|||
19536744|NCT01054976|41985086|FG000|Overall Study|Withdrawal by Subject|4|||
19536745|NCT01054976|41985086|FG000|Overall Study|Other|8|||
19536746|NCT01053962|41985095|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
19536747|NCT01053962|41985096|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
19536748|NCT01053962|41985097|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
19536749|NCT01053962|41985098|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
19536750|NCT01053962|41985099|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
19536751|NCT01053962|41985095|FG000|Pretreatment Period|Venipuncture Failure|0|||
19536752|NCT01053962|41985096|FG001|Pretreatment Period|Venipuncture Failure|0|||
19536753|NCT01053962|41985097|FG002|Pretreatment Period|Venipuncture Failure|1|||
19536754|NCT01053962|41985098|FG003|Pretreatment Period|Venipuncture Failure|0|||
19536755|NCT01053962|41985099|FG004|Pretreatment Period|Venipuncture Failure|0|||
19630873|NCT00862121|42080097|FG000|Overall Study|Exclusion criterion violation|0|||
19536756|NCT01053962|41985095|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
19536757|NCT01053962|41985096|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
19536758|NCT01053962|41985097|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
19536759|NCT01053962|41985098|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
19536760|NCT01053962|41985099|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
19536761|NCT01053962|41985095|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
19536762|NCT01053962|41985096|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
19536763|NCT01053962|41985097|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
19536764|NCT01053962|41985098|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
19536765|NCT01053962|41985099|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
19536766|NCT01053962|41985095|FG000|Treatment Period|Lack of Efficacy|0|||
19536767|NCT01053962|41985096|FG001|Treatment Period|Lack of Efficacy|0|||
19536768|NCT01053962|41985097|FG002|Treatment Period|Lack of Efficacy|0|||
19536769|NCT01053962|41985098|FG003|Treatment Period|Lack of Efficacy|0|||
19536770|NCT01053962|41985099|FG004|Treatment Period|Lack of Efficacy|1|||
19536771|NCT01053962|41985095|FG000|Treatment Period|Adverse Event|0|||
19536772|NCT01053962|41985096|FG001|Treatment Period|Adverse Event|0|||
19536773|NCT01053962|41985097|FG002|Treatment Period|Adverse Event|0|||
19536774|NCT01053962|41985098|FG003|Treatment Period|Adverse Event|0|||
19536775|NCT01053962|41985099|FG004|Treatment Period|Adverse Event|1|||
19536776|NCT01053962|41985095|FG000|Treatment Period|Withdrawal by Subject|0|||
19536777|NCT01053962|41985096|FG001|Treatment Period|Withdrawal by Subject|0|||
19536778|NCT01053962|41985097|FG002|Treatment Period|Withdrawal by Subject|0|||
19536779|NCT01053962|41985098|FG003|Treatment Period|Withdrawal by Subject|0|||
19536780|NCT01053962|41985099|FG004|Treatment Period|Withdrawal by Subject|1|||
19536781|NCT01053962|41985095|FG000|Treatment Period|Noncompliance with protocol|1|||
19536782|NCT01053962|41985096|FG001|Treatment Period|Noncompliance with protocol|0|||
19536783|NCT01053962|41985097|FG002|Treatment Period|Noncompliance with protocol|0|||
19536784|NCT01053962|41985098|FG003|Treatment Period|Noncompliance with protocol|0|||
19536785|NCT01053962|41985099|FG004|Treatment Period|Noncompliance with protocol|0|||
19536786|NCT01053221|41985118|FG000|Overall Study|The study was closed prematurely|5|||
19536787|NCT01053221|41985119|FG001|Overall Study|The study was closed prematurely|9|||
19536788|NCT01052012|41985131|FG000|Overall Study|Not treated|2|||
19536789|NCT01052012|41985132|FG001|Overall Study|Not treated|5|||
19536790|NCT01052012|41985133|FG002|Overall Study|Not treated|0|||
19536791|NCT01052012|41985134|FG003|Overall Study|Not treated|0|||
19536792|NCT01052012|41985135|FG004|Overall Study|Not treated|11|||
19536793|NCT01052012|41985136|FG005|Overall Study|Not treated|8|||
19536794|NCT01052012|41985131|FG000|Overall Study|Adverse Event|1|||
19536795|NCT01052012|41985132|FG001|Overall Study|Adverse Event|0|||
19536796|NCT01052012|41985133|FG002|Overall Study|Adverse Event|0|||
19536797|NCT01052012|41985134|FG003|Overall Study|Adverse Event|1|||
19536798|NCT01052012|41985135|FG004|Overall Study|Adverse Event|0|||
19536799|NCT01052012|41985136|FG005|Overall Study|Adverse Event|0|||
19536800|NCT01052012|41985131|FG000|Overall Study|Lost to Follow-up|0|||
19536801|NCT01052012|41985132|FG001|Overall Study|Lost to Follow-up|0|||
19536802|NCT01052012|41985133|FG002|Overall Study|Lost to Follow-up|0|||
19536803|NCT01052012|41985134|FG003|Overall Study|Lost to Follow-up|0|||
19536804|NCT01052012|41985135|FG004|Overall Study|Lost to Follow-up|1|||
19536805|NCT01052012|41985136|FG005|Overall Study|Lost to Follow-up|0|||
19536806|NCT01052012|41985131|FG000|Overall Study|Withdrawal by Subject|1|||
19536807|NCT01052012|41985132|FG001|Overall Study|Withdrawal by Subject|1|||
19536808|NCT01052012|41985133|FG002|Overall Study|Withdrawal by Subject|0|||
19536809|NCT01052012|41985134|FG003|Overall Study|Withdrawal by Subject|0|||
19536810|NCT01052012|41985135|FG004|Overall Study|Withdrawal by Subject|3|||
19536811|NCT01052012|41985136|FG005|Overall Study|Withdrawal by Subject|1|||
19536812|NCT01052012|41985131|FG000|Overall Study|Physician Decision|0|||
19536813|NCT01052012|41985132|FG001|Overall Study|Physician Decision|0|||
19536814|NCT01052012|41985133|FG002|Overall Study|Physician Decision|0|||
19536815|NCT01052012|41985134|FG003|Overall Study|Physician Decision|0|||
19536816|NCT01052012|41985135|FG004|Overall Study|Physician Decision|0|||
19536817|NCT01052012|41985136|FG005|Overall Study|Physician Decision|1|||
19536818|NCT01052012|41985131|FG000|Overall Study|Other|0|||
19536819|NCT01052012|41985132|FG001|Overall Study|Other|0|||
19536820|NCT01052012|41985133|FG002|Overall Study|Other|0|||
19536821|NCT01052012|41985134|FG003|Overall Study|Other|0|||
19536822|NCT01052012|41985135|FG004|Overall Study|Other|1|||
19536823|NCT01052012|41985136|FG005|Overall Study|Other|0|||
19536824|NCT01051856|41985152|FG000|Overall Study|Withdrawal by Subject|1|||
19536825|NCT01051856|41985153|FG001|Overall Study|Withdrawal by Subject|0|||
19536826|NCT01051817|41985161|FG000|Overall Study|Adverse Event|0|||
19536827|NCT01051817|41985162|FG001|Overall Study|Adverse Event|2|||
19536828|NCT01051817|41985161|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
19536829|NCT01051817|41985162|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
19536830|NCT01051817|41985161|FG000|Overall Study|Withdrawal by Subject|3|||
19536831|NCT01051817|41985162|FG001|Overall Study|Withdrawal by Subject|5|||
19536832|NCT01051817|41985161|FG000|Overall Study|Protocol Violation|0|||
19536833|NCT01051817|41985162|FG001|Overall Study|Protocol Violation|1|||
19536834|NCT01327846|41985172|FG000|Core Phase|Subject decision (vital status: missing)|1|||
19536835|NCT01327846|41985173|FG001|Core Phase|Subject decision (vital status: missing)|2|||
19536836|NCT01327846|41985174|FG002|Core Phase|Subject decision (vital status: missing)|2|||
19536837|NCT01327846|41985175|FG003|Core Phase|Subject decision (vital status: missing)|1|||
19536838|NCT01327846|41985172|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
19536839|NCT01327846|41985173|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
19536840|NCT01327846|41985174|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
19536841|NCT01327846|41985175|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
19536842|NCT01327846|41985172|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
19536843|NCT01327846|41985173|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
19536844|NCT01327846|41985174|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
19536845|NCT01327846|41985175|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
19536846|NCT01327846|41985172|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
19536847|NCT01327846|41985173|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
19536848|NCT01327846|41985174|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
19536849|NCT01327846|41985175|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
19536850|NCT01327846|41985172|FG000|Core Phase|Lost to Follow-up|3|||
19536851|NCT01327846|41985173|FG001|Core Phase|Lost to Follow-up|3|||
19536852|NCT01327846|41985174|FG002|Core Phase|Lost to Follow-up|4|||
19536853|NCT01327846|41985175|FG003|Core Phase|Lost to Follow-up|5|||
19536854|NCT01327846|41985172|FG000|Extension Phase|Study terminated by sponsor|1073|||
19536855|NCT01327846|41985173|FG001|Extension Phase|Study terminated by sponsor|1124|||
19536856|NCT01327846|41985174|FG002|Extension Phase|Study terminated by sponsor|1067|||
19536857|NCT01327846|41985175|FG003|Extension Phase|Study terminated by sponsor|1660|||
19536858|NCT01327846|41985172|FG000|Extension Phase|Withdrawal by Subject|20|||
19536859|NCT01327846|41985173|FG001|Extension Phase|Withdrawal by Subject|13|||
19536860|NCT01327846|41985174|FG002|Extension Phase|Withdrawal by Subject|19|||
19536861|NCT01327846|41985175|FG003|Extension Phase|Withdrawal by Subject|37|||
19536862|NCT01327846|41985172|FG000|Extension Phase|Lost to Follow-up|4|||
19536863|NCT01327846|41985173|FG001|Extension Phase|Lost to Follow-up|3|||
19536864|NCT01327846|41985174|FG002|Extension Phase|Lost to Follow-up|4|||
19536865|NCT01327846|41985175|FG003|Extension Phase|Lost to Follow-up|7|||
19536866|NCT01327846|41985172|FG000|Extension Phase|Technical Problems|2|||
19630874|NCT00862121|42080098|FG001|Overall Study|Exclusion criterion violation|1|||
19630875|NCT00862121|42080097|FG000|Overall Study|Incorrect randomisation|0|||
19630876|NCT00862121|42080098|FG001|Overall Study|Incorrect randomisation|1|||
19630877|NCT00784719|42080111|FG000|Overall Study|Adverse Event|0|||
19630878|NCT00784719|42080112|FG001|Overall Study|Adverse Event|2|||
19630879|NCT00784719|42080113|FG002|Overall Study|Adverse Event|0|||
19630880|NCT00784719|42080114|FG003|Overall Study|Adverse Event|0|||
19630881|NCT00784719|42080115|FG004|Overall Study|Adverse Event|1|||
19630882|NCT00784719|42080116|FG005|Overall Study|Adverse Event|1|||
19630883|NCT00784719|42080117|FG006|Overall Study|Adverse Event|1|||
19630884|NCT00784719|42080111|FG000|Overall Study|Lost to Follow-up|0|||
19630885|NCT00784719|42080112|FG001|Overall Study|Lost to Follow-up|0|||
19630886|NCT00784719|42080113|FG002|Overall Study|Lost to Follow-up|0|||
19630887|NCT00784719|42080114|FG003|Overall Study|Lost to Follow-up|0|||
19630888|NCT00784719|42080115|FG004|Overall Study|Lost to Follow-up|1|||
19630889|NCT00784719|42080116|FG005|Overall Study|Lost to Follow-up|1|||
19630890|NCT00784719|42080117|FG006|Overall Study|Lost to Follow-up|0|||
19630891|NCT00784719|42080111|FG000|Overall Study|Other|2|||
19630892|NCT00784719|42080112|FG001|Overall Study|Other|1|||
19630893|NCT00784719|42080113|FG002|Overall Study|Other|1|||
19630894|NCT00784719|42080114|FG003|Overall Study|Other|0|||
19630895|NCT00784719|42080115|FG004|Overall Study|Other|2|||
19630896|NCT00784719|42080116|FG005|Overall Study|Other|1|||
19630897|NCT00784719|42080117|FG006|Overall Study|Other|3|||
19630898|NCT00784719|42080111|FG000|Overall Study|Withdrawal by Subject|1|||
19630899|NCT00784719|42080112|FG001|Overall Study|Withdrawal by Subject|0|||
19630900|NCT00784719|42080113|FG002|Overall Study|Withdrawal by Subject|0|||
19630901|NCT00784719|42080114|FG003|Overall Study|Withdrawal by Subject|0|||
19630902|NCT00784719|42080115|FG004|Overall Study|Withdrawal by Subject|2|||
19630903|NCT00784719|42080116|FG005|Overall Study|Withdrawal by Subject|0|||
19630904|NCT00784719|42080117|FG006|Overall Study|Withdrawal by Subject|1|||
19630905|NCT00852917|42080137|FG000|Overall Study|Adverse Event|13|||
19630906|NCT00852917|42080138|FG001|Overall Study|Adverse Event|20|||
19630907|NCT00852917|42080139|FG002|Overall Study|Adverse Event|35|||
19630908|NCT00852917|42080140|FG003|Overall Study|Adverse Event|17|||
19630909|NCT00852917|42080137|FG000|Overall Study|Lack of Efficacy|21|||
19630910|NCT00852917|42080138|FG001|Overall Study|Lack of Efficacy|11|||
19630911|NCT00852917|42080139|FG002|Overall Study|Lack of Efficacy|11|||
19630912|NCT00852917|42080140|FG003|Overall Study|Lack of Efficacy|47|||
19630913|NCT00852917|42080137|FG000|Overall Study|Withdrawal by Subject|4|||
19536867|NCT01327846|41985173|FG001|Extension Phase|Technical Problems|4|||
19455686|NCT01928394|41705880|FG012|Follow-up Period|Participant withdrew consent|2|||
19455687|NCT01928394|41705881|FG013|Follow-up Period|Participant withdrew consent|12|||
19536868|NCT01327846|41985174|FG002|Extension Phase|Technical Problems|2|||
19455688|NCT01928394|41705882|FG014|Follow-up Period|Participant withdrew consent|7|||
19455689|NCT01928394|41705883|FG015|Follow-up Period|Participant withdrew consent|0|||
19455690|NCT01928394|41705884|FG016|Follow-up Period|Participant withdrew consent|5|||
19455691|NCT01928394|41705885|FG017|Follow-up Period|Participant withdrew consent|3|||
19455692|NCT01928394|41705886|FG018|Follow-up Period|Participant withdrew consent|2|||
19455693|NCT01928394|41705887|FG019|Follow-up Period|Participant withdrew consent|7|||
19455694|NCT01928394|41705888|FG020|Follow-up Period|Participant withdrew consent|4|||
19536869|NCT01327846|41985175|FG003|Extension Phase|Technical Problems|2|||
19536870|NCT01051739|41985188|FG000|Overall Study|Death|3|||
19536871|NCT01051739|41985189|FG001|Overall Study|Death|3|||
19536872|NCT01051739|41985188|FG000|Overall Study|Withdrawal by Subject|25|||
19536873|NCT01051739|41985189|FG001|Overall Study|Withdrawal by Subject|10|||
19536874|NCT01051661|41985201|FG000|Overall Study|Adverse Event|1|||
19536875|NCT01051661|41985202|FG001|Overall Study|Adverse Event|1|||
19536876|NCT01051661|41985203|FG002|Overall Study|Adverse Event|1|||
19536877|NCT01051661|41985204|FG003|Overall Study|Adverse Event|1|||
19536878|NCT01051661|41985205|FG004|Overall Study|Adverse Event|0|||
19536879|NCT01051661|41985206|FG005|Overall Study|Adverse Event|0|||
19536880|NCT01051661|41985201|FG000|Overall Study|Lost to Follow-up|13|||
19536881|NCT01051661|41985202|FG001|Overall Study|Lost to Follow-up|22|||
19536882|NCT01051661|41985203|FG002|Overall Study|Lost to Follow-up|15|||
19536883|NCT01051661|41985204|FG003|Overall Study|Lost to Follow-up|17|||
19536884|NCT01051661|41985205|FG004|Overall Study|Lost to Follow-up|10|||
19536885|NCT01051661|41985206|FG005|Overall Study|Lost to Follow-up|24|||
19536886|NCT01051661|41985201|FG000|Overall Study|Migrated/moved from study area|1|||
19536887|NCT01051661|41985202|FG001|Overall Study|Migrated/moved from study area|6|||
19536888|NCT01051661|41985203|FG002|Overall Study|Migrated/moved from study area|6|||
19536889|NCT01051661|41985204|FG003|Overall Study|Migrated/moved from study area|8|||
19536890|NCT01051661|41985205|FG004|Overall Study|Migrated/moved from study area|7|||
19536891|NCT01051661|41985206|FG005|Overall Study|Migrated/moved from study area|3|||
19455695|NCT01928394|41705889|FG021|Follow-up Period|Participant withdrew consent|6|||
19455696|NCT01928394|41705890|FG022|Follow-up Period|Participant withdrew consent|2|||
19455697|NCT01928394|41705868|FG000|Follow-up Period|Death|0|||
19455698|NCT01928394|41705869|FG001|Follow-up Period|Death|0|||
19455699|NCT01928394|41705870|FG002|Follow-up Period|Death|2|||
19455700|NCT01928394|41705871|FG003|Follow-up Period|Death|6|||
19455701|NCT01928394|41705872|FG004|Follow-up Period|Death|0|||
19455702|NCT01928394|41705873|FG005|Follow-up Period|Death|6|||
19455703|NCT01928394|41705874|FG006|Follow-up Period|Death|6|||
19455704|NCT01928394|41705875|FG007|Follow-up Period|Death|2|||
19455705|NCT01928394|41705876|FG008|Follow-up Period|Death|1|||
19455706|NCT01928394|41705877|FG009|Follow-up Period|Death|2|||
19455707|NCT01928394|41705878|FG010|Follow-up Period|Death|4|||
19455708|NCT01928394|41705879|FG011|Follow-up Period|Death|12|||
19455709|NCT01928394|41705880|FG012|Follow-up Period|Death|11|||
19455710|NCT01928394|41705881|FG013|Follow-up Period|Death|25|||
19455711|NCT01928394|41705882|FG014|Follow-up Period|Death|18|||
19455712|NCT01928394|41705883|FG015|Follow-up Period|Death|0|||
19455713|NCT01928394|41705884|FG016|Follow-up Period|Death|6|||
19455714|NCT01928394|41705885|FG017|Follow-up Period|Death|5|||
19455715|NCT01928394|41705886|FG018|Follow-up Period|Death|13|||
19455716|NCT01928394|41705887|FG019|Follow-up Period|Death|13|||
19455717|NCT01928394|41705888|FG020|Follow-up Period|Death|5|||
19455718|NCT01928394|41705889|FG021|Follow-up Period|Death|3|||
19455719|NCT01928394|41705890|FG022|Follow-up Period|Death|2|||
19455720|NCT01928394|41705868|FG000|Follow-up Period|other reason|0|||
19455721|NCT01928394|41705869|FG001|Follow-up Period|other reason|0|||
19455722|NCT01928394|41705870|FG002|Follow-up Period|other reason|0|||
19455723|NCT01928394|41705871|FG003|Follow-up Period|other reason|0|||
19455724|NCT01928394|41705872|FG004|Follow-up Period|other reason|0|||
19455725|NCT01928394|41705873|FG005|Follow-up Period|other reason|0|||
19455726|NCT01928394|41705874|FG006|Follow-up Period|other reason|1|||
19455727|NCT01928394|41705875|FG007|Follow-up Period|other reason|3|||
19455728|NCT01928394|41705876|FG008|Follow-up Period|other reason|0|||
19455729|NCT01928394|41705877|FG009|Follow-up Period|other reason|0|||
19455730|NCT01928394|41705878|FG010|Follow-up Period|other reason|2|||
19536892|NCT01051661|41985201|FG000|Overall Study|Refused blood sampling|0|||
19536893|NCT01051661|41985202|FG001|Overall Study|Refused blood sampling|0|||
19536894|NCT01051661|41985203|FG002|Overall Study|Refused blood sampling|0|||
19455731|NCT01928394|41705879|FG011|Follow-up Period|other reason|1|||
19455732|NCT01928394|41705880|FG012|Follow-up Period|other reason|0|||
19455733|NCT01928394|41705881|FG013|Follow-up Period|other reason|1|||
19455734|NCT01928394|41705882|FG014|Follow-up Period|other reason|4|||
19455735|NCT01928394|41705883|FG015|Follow-up Period|other reason|0|||
19455736|NCT01928394|41705884|FG016|Follow-up Period|other reason|2|||
19455737|NCT01928394|41705885|FG017|Follow-up Period|other reason|0|||
19455738|NCT01928394|41705886|FG018|Follow-up Period|other reason|1|||
19455739|NCT01928394|41705887|FG019|Follow-up Period|other reason|1|||
19455740|NCT01928394|41705888|FG020|Follow-up Period|other reason|0|||
19455741|NCT01928394|41705889|FG021|Follow-up Period|other reason|0|||
19455742|NCT01928394|41705890|FG022|Follow-up Period|other reason|1|||
19455743|NCT01928394|41705868|FG000|Follow-up Period|Lost to Follow-up|0|||
19455744|NCT01928394|41705869|FG001|Follow-up Period|Lost to Follow-up|0|||
19455745|NCT01928394|41705870|FG002|Follow-up Period|Lost to Follow-up|0|||
19455746|NCT01928394|41705871|FG003|Follow-up Period|Lost to Follow-up|0|||
19455747|NCT01928394|41705872|FG004|Follow-up Period|Lost to Follow-up|0|||
19455748|NCT01928394|41705873|FG005|Follow-up Period|Lost to Follow-up|0|||
19455749|NCT01928394|41705874|FG006|Follow-up Period|Lost to Follow-up|0|||
19455750|NCT01928394|41705875|FG007|Follow-up Period|Lost to Follow-up|0|||
19455751|NCT01928394|41705876|FG008|Follow-up Period|Lost to Follow-up|0|||
19455752|NCT01928394|41705877|FG009|Follow-up Period|Lost to Follow-up|0|||
19455753|NCT01928394|41705878|FG010|Follow-up Period|Lost to Follow-up|0|||
19455754|NCT01928394|41705879|FG011|Follow-up Period|Lost to Follow-up|1|||
19455755|NCT01928394|41705880|FG012|Follow-up Period|Lost to Follow-up|1|||
19455756|NCT01928394|41705881|FG013|Follow-up Period|Lost to Follow-up|0|||
19455757|NCT01928394|41705882|FG014|Follow-up Period|Lost to Follow-up|1|||
19455758|NCT01928394|41705883|FG015|Follow-up Period|Lost to Follow-up|0|||
19455759|NCT01928394|41705884|FG016|Follow-up Period|Lost to Follow-up|1|||
19455760|NCT01928394|41705885|FG017|Follow-up Period|Lost to Follow-up|0|||
19455761|NCT01928394|41705886|FG018|Follow-up Period|Lost to Follow-up|0|||
19455762|NCT01928394|41705887|FG019|Follow-up Period|Lost to Follow-up|0|||
19455763|NCT01928394|41705888|FG020|Follow-up Period|Lost to Follow-up|0|||
19455764|NCT01928394|41705889|FG021|Follow-up Period|Lost to Follow-up|0|||
19455765|NCT01928394|41705890|FG022|Follow-up Period|Lost to Follow-up|1|||
19455766|NCT01701674|41705938|FG000|Overall Study|Unable to safely complete treatment|1|||
19455767|NCT01467427|41705959|FG000|Overall Study|Withdrawal by Subject|1|||
19455768|NCT01467427|41705960|FG001|Overall Study|Withdrawal by Subject|0|||
19455769|NCT01467427|41705959|FG000|Overall Study|Entered extension phase|11|||
19455770|NCT01467427|41705960|FG001|Overall Study|Entered extension phase|11|||
19455771|NCT01467427|41705959|FG000|Overall Study|Not continuing in extension phase|0|||
19455772|NCT01467427|41705960|FG001|Overall Study|Not continuing in extension phase|2|||
19455773|NCT01422187|41705969|FG000|Overall Study|Personal reason|1|||
19455774|NCT01422187|41705970|FG001|Overall Study|Personal reason|0|||
19455775|NCT01422187|41705971|FG002|Overall Study|Personal reason|0|||
19455776|NCT01422187|41705969|FG000|Overall Study|Lost to Follow-up|0|||
19455777|NCT01422187|41705970|FG001|Overall Study|Lost to Follow-up|1|||
19455778|NCT01422187|41705971|FG002|Overall Study|Lost to Follow-up|0|||
19455779|NCT00920621|41705983|FG000|Overall Study|Lost to Follow-up|16|||
19455780|NCT00920621|41705984|FG001|Overall Study|Lost to Follow-up|17|||
19455781|NCT00920621|41705985|FG002|Overall Study|Lost to Follow-up|19|||
19455782|NCT00920621|41705986|FG003|Overall Study|Lost to Follow-up|21|||
19455783|NCT00920621|41705983|FG000|Overall Study|Fetal/neonatal deaths|16|||
19455784|NCT00920621|41705984|FG001|Overall Study|Fetal/neonatal deaths|14|||
19455785|NCT00920621|41705985|FG002|Overall Study|Fetal/neonatal deaths|16|||
19455786|NCT00920621|41705986|FG003|Overall Study|Fetal/neonatal deaths|14|||
19455787|NCT00920621|41705983|FG000|Overall Study|Blood sample not collected|22|||
19536895|NCT01051661|41985204|FG003|Overall Study|Refused blood sampling|0|||
19536896|NCT01051661|41985205|FG004|Overall Study|Refused blood sampling|0|||
19536897|NCT01051661|41985206|FG005|Overall Study|Refused blood sampling|1|||
19536898|NCT01051661|41985201|FG000|Overall Study|Data not reliable|1|||
19536899|NCT01051661|41985202|FG001|Overall Study|Data not reliable|0|||
19536900|NCT01051661|41985203|FG002|Overall Study|Data not reliable|0|||
19536901|NCT01051661|41985204|FG003|Overall Study|Data not reliable|0|||
19536902|NCT01051661|41985205|FG004|Overall Study|Data not reliable|0|||
19536903|NCT01051661|41985206|FG005|Overall Study|Data not reliable|1|||
19536904|NCT01051661|41985201|FG000|Overall Study|Unable to attend visit(s)|2|||
19536905|NCT01051661|41985202|FG001|Overall Study|Unable to attend visit(s)|4|||
19536906|NCT01051661|41985203|FG002|Overall Study|Unable to attend visit(s)|2|||
19536907|NCT01051661|41985204|FG003|Overall Study|Unable to attend visit(s)|1|||
19536908|NCT01051661|41985205|FG004|Overall Study|Unable to attend visit(s)|3|||
19630914|NCT00852917|42080138|FG001|Overall Study|Withdrawal by Subject|8|||
19630915|NCT00852917|42080139|FG002|Overall Study|Withdrawal by Subject|10|||
19455788|NCT00920621|41705984|FG001|Overall Study|Blood sample not collected|14|||
19455789|NCT00920621|41705985|FG002|Overall Study|Blood sample not collected|0|||
19455790|NCT00920621|41705986|FG003|Overall Study|Blood sample not collected|0|||
19455791|NCT00837616|41705999|FG000|Overall Study|Withdrawal by Subject|0|||
19455792|NCT00837616|41706000|FG001|Overall Study|Withdrawal by Subject|1|||
19455793|NCT00472212|41706008|FG000|Overall Study|Lost to Follow-up|6|||
19455794|NCT00472212|41706009|FG001|Overall Study|Lost to Follow-up|4|||
19455795|NCT00378105|41706017|FG000|Overall Study|Adverse Event|3|||
19455796|NCT00378105|41706018|FG001|Overall Study|Adverse Event|1|||
19455797|NCT00378105|41706017|FG000|Overall Study|Withdrawal by Subject|3|||
19536909|NCT01051661|41985206|FG005|Overall Study|Unable to attend visit(s)|2|||
19536910|NCT01051661|41985201|FG000|Overall Study|Consent not received from both parents|0|||
19536911|NCT01051661|41985202|FG001|Overall Study|Consent not received from both parents|0|||
19536912|NCT01051661|41985203|FG002|Overall Study|Consent not received from both parents|0|||
19536913|NCT01051661|41985204|FG003|Overall Study|Consent not received from both parents|0|||
19536914|NCT01051661|41985205|FG004|Overall Study|Consent not received from both parents|0|||
19536915|NCT01051661|41985206|FG005|Overall Study|Consent not received from both parents|1|||
19536916|NCT01051661|41985201|FG000|Overall Study|Failure to comply with protocol|0|||
19536917|NCT01051661|41985202|FG001|Overall Study|Failure to comply with protocol|0|||
19536918|NCT01051661|41985203|FG002|Overall Study|Failure to comply with protocol|2|||
19536919|NCT01051661|41985204|FG003|Overall Study|Failure to comply with protocol|0|||
19536920|NCT01051661|41985205|FG004|Overall Study|Failure to comply with protocol|0|||
19536921|NCT01051661|41985206|FG005|Overall Study|Failure to comply with protocol|0|||
19455798|NCT00378105|41706018|FG001|Overall Study|Withdrawal by Subject|3|||
19536922|NCT01051661|41985201|FG000|Overall Study|Subject lost legal representation|0|||
19536923|NCT01051661|41985202|FG001|Overall Study|Subject lost legal representation|0|||
19536924|NCT01051661|41985203|FG002|Overall Study|Subject lost legal representation|0|||
19536925|NCT01051661|41985204|FG003|Overall Study|Subject lost legal representation|0|||
19536926|NCT01051661|41985205|FG004|Overall Study|Subject lost legal representation|1|||
19536927|NCT01051661|41985206|FG005|Overall Study|Subject lost legal representation|0|||
19536928|NCT01051661|41985201|FG000|Overall Study|Protocol Violation|0|||
19536929|NCT01051661|41985202|FG001|Overall Study|Protocol Violation|0|||
19536930|NCT01051661|41985203|FG002|Overall Study|Protocol Violation|0|||
19536931|NCT01051661|41985204|FG003|Overall Study|Protocol Violation|1|||
19536932|NCT01051661|41985205|FG004|Overall Study|Protocol Violation|2|||
19536933|NCT01051661|41985206|FG005|Overall Study|Protocol Violation|1|||
19630916|NCT00852917|42080140|FG003|Overall Study|Withdrawal by Subject|9|||
19630917|NCT00852917|42080137|FG000|Overall Study|Physician Decision|6|||
19630918|NCT00852917|42080138|FG001|Overall Study|Physician Decision|7|||
19630919|NCT00852917|42080139|FG002|Overall Study|Physician Decision|2|||
19630920|NCT00852917|42080140|FG003|Overall Study|Physician Decision|19|||
19630921|NCT00852917|42080137|FG000|Overall Study|Death|0|||
19630922|NCT00852917|42080138|FG001|Overall Study|Death|0|||
19630923|NCT00852917|42080139|FG002|Overall Study|Death|0|||
19630924|NCT00852917|42080140|FG003|Overall Study|Death|1|||
19630925|NCT00845429|42080153|FG000|Overall Study|Protocol Violation|5|||
19630926|NCT00845429|42080154|FG001|Overall Study|Protocol Violation|4|||
19630927|NCT00845429|42080155|FG002|Overall Study|Protocol Violation|7|||
19630928|NCT00845429|42080153|FG000|Overall Study|Lost to Follow-up|7|||
19630929|NCT00845429|42080154|FG001|Overall Study|Lost to Follow-up|9|||
19630930|NCT00845429|42080155|FG002|Overall Study|Lost to Follow-up|10|||
19630931|NCT00845429|42080153|FG000|Overall Study|Withdrawal by Subject|2|||
19630932|NCT00845429|42080154|FG001|Overall Study|Withdrawal by Subject|2|||
19630933|NCT00845429|42080155|FG002|Overall Study|Withdrawal by Subject|2|||
19630934|NCT00845429|42080153|FG000|Overall Study|Serious adverse event|0|||
19630935|NCT00845429|42080154|FG001|Overall Study|Serious adverse event|0|||
19630936|NCT00845429|42080155|FG002|Overall Study|Serious adverse event|1|||
19630937|NCT00593333|42080165|FG000|Overall Study|Lost to Follow-up|10|||
19630938|NCT00593333|42080166|FG001|Overall Study|Lost to Follow-up|11|||
19630939|NCT00844883|42080172|FG000|Overall Study|Bridged to liver transplant|3|||
19630940|NCT00844883|42080172|FG000|Overall Study|Bridged to resection|1|||
19630941|NCT00851903|42080176|FG000|Overall Study|Withdrawal by Subject|2|||
19630942|NCT00587457|42080183|FG000|Overall Study|Adverse Event|1|||
19630943|NCT00587457|42080184|FG001|Overall Study|Adverse Event|2|||
19630944|NCT00587457|42080185|FG002|Overall Study|Adverse Event|1|||
19455799|NCT00378105|41706017|FG000|Overall Study|Death|1|||
19455800|NCT00378105|41706018|FG001|Overall Study|Death|0|||
19455801|NCT00378105|41706017|FG000|Overall Study|Going to transplant|7|||
19455802|NCT00378105|41706018|FG001|Overall Study|Going to transplant|8|||
19455803|NCT00378105|41706017|FG000|Overall Study|Progressive disease|3|||
19455804|NCT00378105|41706018|FG001|Overall Study|Progressive disease|3|||
19455805|NCT00378105|41706017|FG000|Overall Study|remain on study|3|||
19455806|NCT00378105|41706018|FG001|Overall Study|remain on study|11|||
19455807|NCT00378105|41706017|FG000|Overall Study|Physician Decision|0|||
19455808|NCT00378105|41706018|FG001|Overall Study|Physician Decision|2|||
19455809|NCT00378105|41706017|FG000|Overall Study|Going non-protocol therapy|0|||
19455810|NCT00378105|41706018|FG001|Overall Study|Going non-protocol therapy|1|||
19455811|NCT00378105|41706017|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
19455812|NCT00378105|41706018|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
19630945|NCT00587457|42080183|FG000|Overall Study|Disease progression|2|||
19630946|NCT00587457|42080184|FG001|Overall Study|Disease progression|0|||
19630947|NCT00587457|42080185|FG002|Overall Study|Disease progression|2|||
19630948|NCT00587457|42080183|FG000|Overall Study|Initiation of alternative therapy|0|||
19630949|NCT00587457|42080184|FG001|Overall Study|Initiation of alternative therapy|1|||
19630950|NCT00587457|42080185|FG002|Overall Study|Initiation of alternative therapy|0|||
19630951|NCT00587457|42080183|FG000|Overall Study|Undefined|0|||
19630952|NCT00587457|42080184|FG001|Overall Study|Undefined|0|||
19630953|NCT00587457|42080185|FG002|Overall Study|Undefined|1|||
19455813|NCT00139477|41706027|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
19455814|NCT00139477|41706028|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
19455815|NCT00139477|41706027|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
19455816|NCT00139477|41706028|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
19455817|NCT00139477|41706027|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
19455818|NCT00139477|41706028|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
19455819|NCT00139477|41706027|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
19455820|NCT00139477|41706028|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
19455821|NCT00139477|41706027|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
19455822|NCT00139477|41706028|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
19455823|NCT00139477|41706027|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
19455824|NCT00139477|41706028|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
19455825|NCT00139477|41706027|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
19455826|NCT00139477|41706028|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
19455827|NCT01469013|41706348|FG000|Part A (Treatment Period)|Adverse Event|1|||
19455828|NCT01469013|41706349|FG001|Part A (Treatment Period)|Adverse Event|0|||
19455829|NCT01469013|41706350|FG002|Part A (Treatment Period)|Adverse Event|0|||
19455830|NCT01469013|41706351|FG003|Part A (Treatment Period)|Adverse Event|0|||
19455831|NCT01469013|41706352|FG004|Part A (Treatment Period)|Adverse Event|1|||
19455832|NCT01469013|41706353|FG005|Part A (Treatment Period)|Adverse Event|0|||
19455833|NCT01469013|41706354|FG006|Part A (Treatment Period)|Adverse Event|0|||
19455834|NCT01469013|41706355|FG007|Part A (Treatment Period)|Adverse Event|0|||
19455835|NCT01469013|41706356|FG008|Part A (Treatment Period)|Adverse Event|0|||
19455836|NCT01469013|41706357|FG009|Part A (Treatment Period)|Adverse Event|0|||
19455837|NCT01469013|41706358|FG010|Part A (Treatment Period)|Adverse Event|0|||
19455838|NCT01469013|41706359|FG011|Part A (Treatment Period)|Adverse Event|0|||
19455839|NCT01469013|41706360|FG012|Part A (Treatment Period)|Adverse Event|0|||
19455840|NCT01469013|41706348|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455841|NCT01469013|41706349|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455842|NCT01469013|41706350|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
19455843|NCT01469013|41706351|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
19536934|NCT01051661|41985201|FG000|Overall Study|Withdrawal by Subject|16|||
19536935|NCT01051661|41985202|FG001|Overall Study|Withdrawal by Subject|30|||
19536936|NCT01051661|41985203|FG002|Overall Study|Withdrawal by Subject|13|||
19536937|NCT01051661|41985204|FG003|Overall Study|Withdrawal by Subject|28|||
19536938|NCT01051661|41985205|FG004|Overall Study|Withdrawal by Subject|12|||
19536939|NCT01051661|41985206|FG005|Overall Study|Withdrawal by Subject|34|||
19536940|NCT01051466|41985243|FG000|Overall Study|Adverse Event|1|||
19455844|NCT01469013|41706352|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455845|NCT01469013|41706353|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455846|NCT01469013|41706354|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455847|NCT01469013|41706355|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455848|NCT01469013|41706356|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455849|NCT01469013|41706357|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455850|NCT01469013|41706358|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
19536941|NCT01051466|41985244|FG001|Overall Study|Adverse Event|0|||
19536942|NCT01051466|41985243|FG000|Overall Study|Lost to Follow-up|1|||
19536943|NCT01051466|41985244|FG001|Overall Study|Lost to Follow-up|1|||
19536944|NCT01051466|41985243|FG000|Overall Study|Withdrawal by Subject|5|||
19536945|NCT01051466|41985244|FG001|Overall Study|Withdrawal by Subject|1|||
19536946|NCT01051466|41985243|FG000|Overall Study|Entry Criteria Not Met|0|||
19536947|NCT01051466|41985244|FG001|Overall Study|Entry Criteria Not Met|3|||
19536948|NCT01051466|41985243|FG000|Overall Study|Physician Decision|1|||
19536949|NCT01051466|41985244|FG001|Overall Study|Physician Decision|0|||
19536950|NCT01051349|41985258|FG000|Overall Study|Adverse Event|88|||
19536951|NCT01051349|41985258|FG000|Overall Study|Consent Withdrawn|54|||
19455851|NCT01469013|41706359|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455852|NCT01469013|41706360|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
19455853|NCT01469013|41706348|FG000|Part B (Extension Period)|Adverse Event|0|||
19455854|NCT01469013|41706349|FG001|Part B (Extension Period)|Adverse Event|0|||
19455855|NCT01469013|41706350|FG002|Part B (Extension Period)|Adverse Event|0|||
19455856|NCT01469013|41706351|FG003|Part B (Extension Period)|Adverse Event|0|||
19455857|NCT01469013|41706352|FG004|Part B (Extension Period)|Adverse Event|0|||
19455858|NCT01469013|41706353|FG005|Part B (Extension Period)|Adverse Event|2|||
19536952|NCT01051349|41985258|FG000|Overall Study|Investigator Decision|6|||
19536953|NCT01051349|41985258|FG000|Overall Study|Lost to Follow-up|6|||
19536954|NCT01051349|41985258|FG000|Overall Study|Subject non-compliance|7|||
19536955|NCT01051349|41985258|FG000|Overall Study|Reason not Specified|12|||
19536956|NCT01050998|41985270|FG000|Overall Study|Adverse Event|1|||
19536957|NCT01050998|41985271|FG001|Overall Study|Adverse Event|0|||
19536958|NCT01050998|41985272|FG002|Overall Study|Adverse Event|1|||
19536959|NCT01050998|41985273|FG003|Overall Study|Adverse Event|0|||
19536960|NCT01050998|41985274|FG004|Overall Study|Adverse Event|2|||
19536961|NCT01050998|41985270|FG000|Overall Study|Withdrawal by Subject|0|||
19536962|NCT01050998|41985271|FG001|Overall Study|Withdrawal by Subject|0|||
19536963|NCT01050998|41985272|FG002|Overall Study|Withdrawal by Subject|0|||
19536964|NCT01050998|41985273|FG003|Overall Study|Withdrawal by Subject|1|||
19536965|NCT01050998|41985274|FG004|Overall Study|Withdrawal by Subject|3|||
19536966|NCT01050998|41985270|FG000|Overall Study|Other|3|||
19536967|NCT01050998|41985271|FG001|Overall Study|Other|2|||
19536968|NCT01050998|41985272|FG002|Overall Study|Other|1|||
19536969|NCT01050998|41985273|FG003|Overall Study|Other|1|||
19536970|NCT01050998|41985274|FG004|Overall Study|Other|5|||
19536971|NCT01050998|41985270|FG000|Overall Study|Data integrity issues|0|||
19536972|NCT01050998|41985271|FG001|Overall Study|Data integrity issues|0|||
19536973|NCT01050998|41985272|FG002|Overall Study|Data integrity issues|1|||
19536974|NCT01050998|41985273|FG003|Overall Study|Data integrity issues|1|||
19536975|NCT01050998|41985274|FG004|Overall Study|Data integrity issues|4|||
19536976|NCT00106028|41985292|FG000|Overall Study|Adverse Event|3|||
19536977|NCT00106028|41985293|FG001|Overall Study|Adverse Event|2|||
19455859|NCT01469013|41706354|FG006|Part B (Extension Period)|Adverse Event|5|||
19455860|NCT01469013|41706355|FG007|Part B (Extension Period)|Adverse Event|5|||
19455861|NCT01469013|41706356|FG008|Part B (Extension Period)|Adverse Event|3|||
19455862|NCT01469013|41706357|FG009|Part B (Extension Period)|Adverse Event|3|||
19455863|NCT01469013|41706358|FG010|Part B (Extension Period)|Adverse Event|1|||
19455864|NCT01469013|41706359|FG011|Part B (Extension Period)|Adverse Event|6|||
19536978|NCT00106028|41985292|FG000|Overall Study|Protocol Violation|1|||
19536979|NCT00106028|41985293|FG001|Overall Study|Protocol Violation|1|||
19536980|NCT00106028|41985292|FG000|Overall Study|Withdrawal by Subject|2|||
19536981|NCT00106028|41985293|FG001|Overall Study|Withdrawal by Subject|8|||
19536982|NCT00106028|41985292|FG000|Overall Study|Lost to Follow-up|0|||
19536983|NCT00106028|41985293|FG001|Overall Study|Lost to Follow-up|1|||
19536984|NCT01050764|41985301|FG000|Overall Study|Death, before HSCT|1|||
19536985|NCT01050764|41985301|FG000|Overall Study|Donor mobilization failure, death|1|||
19536986|NCT01050764|41985301|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
19536987|NCT01050569|41985308|FG000|Overall Study|Lost to Follow-up|20|||
19536988|NCT01050569|41985309|FG001|Overall Study|Lost to Follow-up|14|||
19536989|NCT01050569|41985310|FG002|Overall Study|Lost to Follow-up|16|||
19536990|NCT01050569|41985308|FG000|Overall Study|Withdrawal by Subject|9|||
19536991|NCT01050569|41985309|FG001|Overall Study|Withdrawal by Subject|3|||
19536992|NCT01050569|41985310|FG002|Overall Study|Withdrawal by Subject|11|||
19536993|NCT01050569|41985308|FG000|Overall Study|Lack of Efficacy|5|||
19536994|NCT01050569|41985309|FG001|Overall Study|Lack of Efficacy|4|||
19536995|NCT01050569|41985310|FG002|Overall Study|Lack of Efficacy|3|||
19536996|NCT01050569|41985308|FG000|Overall Study|Adverse Event|1|||
19536997|NCT01050569|41985309|FG001|Overall Study|Adverse Event|0|||
19455865|NCT01469013|41706360|FG012|Part B (Extension Period)|Adverse Event|3|||
19455866|NCT01469013|41706348|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
19455867|NCT01469013|41706349|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
19455868|NCT01469013|41706350|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
19455869|NCT01469013|41706351|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
19455870|NCT01469013|41706352|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
19455871|NCT01469013|41706353|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
19455872|NCT01469013|41706354|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
19455873|NCT01469013|41706355|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
19455874|NCT01469013|41706356|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
19455875|NCT01469013|41706357|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
19536998|NCT01050569|41985310|FG002|Overall Study|Adverse Event|0|||
19536999|NCT01050569|41985308|FG000|Overall Study|Physician Decision|3|||
19537000|NCT01050569|41985309|FG001|Overall Study|Physician Decision|3|||
19537001|NCT01050569|41985310|FG002|Overall Study|Physician Decision|3|||
19537002|NCT01050530|41985324|FG000|Overall Study|Adverse Event|6|||
19537003|NCT01050530|41985325|FG001|Overall Study|Adverse Event|3|||
19537004|NCT01050530|41985324|FG000|Overall Study|Lack of Efficacy|1|||
19537005|NCT01050530|41985325|FG001|Overall Study|Lack of Efficacy|4|||
19537006|NCT01050530|41985324|FG000|Overall Study|Withdrawal by Subject|0|||
19537007|NCT01050530|41985325|FG001|Overall Study|Withdrawal by Subject|3|||
19630954|NCT00587457|42080183|FG000|Overall Study|Development of neutralizing Abs|0|||
19630955|NCT00587457|42080184|FG001|Overall Study|Development of neutralizing Abs|0|||
19630956|NCT00587457|42080185|FG002|Overall Study|Development of neutralizing Abs|1|||
19630957|NCT00851747|42080196|FG000|Overall Study|Physician Decision|6|||
19537008|NCT01050530|41985324|FG000|Overall Study|Protocol Violation|1|||
19537009|NCT01050530|41985325|FG001|Overall Study|Protocol Violation|0|||
19537010|NCT01050257|41985334|FG000|Overall Study|Adverse Event|4|||
19537011|NCT01050257|41985335|FG001|Overall Study|Adverse Event|4|||
19537012|NCT01050257|41985336|FG002|Overall Study|Adverse Event|2|||
19537013|NCT01050257|41985334|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
19537014|NCT01050257|41985335|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
19630958|NCT00851747|42080197|FG001|Overall Study|Physician Decision|6|||
19537015|NCT01050257|41985336|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
19537016|NCT01050257|41985334|FG000|Overall Study|Withdrawal by Subject|0|||
19537017|NCT01050257|41985335|FG001|Overall Study|Withdrawal by Subject|3|||
19537018|NCT01050257|41985336|FG002|Overall Study|Withdrawal by Subject|0|||
19537019|NCT01050257|41985334|FG000|Overall Study|No reason specified|0|||
19537020|NCT01050257|41985335|FG001|Overall Study|No reason specified|0|||
19537021|NCT01050257|41985336|FG002|Overall Study|No reason specified|2|||
19537022|NCT01050257|41985334|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
19537023|NCT01050257|41985335|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
19537024|NCT01050257|41985336|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
19537025|NCT01050257|41985334|FG000|Overall Study|Violation criteria|0|||
19455876|NCT01469013|41706358|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
19455877|NCT01469013|41706359|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
19537026|NCT01050257|41985335|FG001|Overall Study|Violation criteria|1|||
19537027|NCT01050257|41985336|FG002|Overall Study|Violation criteria|0|||
19537028|NCT01050257|41985334|FG000|Overall Study|Failure to return|0|||
19537029|NCT01050257|41985335|FG001|Overall Study|Failure to return|2|||
19537030|NCT01050257|41985336|FG002|Overall Study|Failure to return|0|||
19537031|NCT01050257|41985334|FG000|Overall Study|Death|0|||
19455878|NCT01469013|41706360|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
19455879|NCT01493427|41706387|FG000|Overall Study|Adverse Event|10|||
19455880|NCT01493427|41706387|FG000|Overall Study|Personal Reasons|4|||
19455881|NCT01493427|41706387|FG000|Overall Study|Lost to Follow-up|2|||
19455882|NCT01493427|41706387|FG000|Overall Study|Inability to Follow Instructions|2|||
19455883|NCT01493427|41706387|FG000|Overall Study|Other|2|||
19455884|NCT01523457|41706393|FG000|Overall Study|Withdrawal by Subject|7|||
19455885|NCT01523457|41706394|FG001|Overall Study|Withdrawal by Subject|2|||
19455886|NCT01523301|41706402|FG000|Overall Study|Adverse Event|25|||
19455887|NCT01523301|41706403|FG001|Overall Study|Adverse Event|16|||
19455888|NCT01523301|41706402|FG000|Overall Study|Lack of Efficacy|0|||
19455889|NCT01523301|41706403|FG001|Overall Study|Lack of Efficacy|2|||
19455890|NCT01523301|41706402|FG000|Overall Study|Protocol Violation|3|||
19455891|NCT01523301|41706403|FG001|Overall Study|Protocol Violation|4|||
19455892|NCT01523301|41706402|FG000|Overall Study|Lost to Follow-up|1|||
19455893|NCT01523301|41706403|FG001|Overall Study|Lost to Follow-up|0|||
19455894|NCT01523301|41706402|FG000|Overall Study|Withdrawal by Subject|6|||
19455895|NCT01523301|41706403|FG001|Overall Study|Withdrawal by Subject|8|||
19455896|NCT01523301|41706402|FG000|Overall Study|Other Reason|0|||
19455897|NCT01523301|41706403|FG001|Overall Study|Other Reason|2|||
19455898|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455899|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455900|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455901|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19537032|NCT01050257|41985335|FG001|Overall Study|Death|0|||
19537033|NCT01050257|41985336|FG002|Overall Study|Death|1|||
19537034|NCT01050218|41985344|FG000|Overall Study|Adverse Event|37|||
19537035|NCT01050218|41985344|FG000|Overall Study|Lack of Efficacy|8|||
19537036|NCT01050218|41985344|FG000|Overall Study|Protocol Violation|3|||
19537037|NCT01050218|41985344|FG000|Overall Study|Withdrawal by Subject|18|||
19537038|NCT01050218|41985344|FG000|Overall Study|Discontinued by sponsor|18|||
19537039|NCT01050218|41985344|FG000|Overall Study|Compliance|2|||
19537040|NCT01050218|41985344|FG000|Overall Study|Failed to return|7|||
19537041|NCT01050218|41985344|FG000|Overall Study|Serious Adverse Event|1|||
19455902|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
19537042|NCT01050218|41985344|FG000|Overall Study|Family emergency|1|||
19537043|NCT01050062|41985350|FG000|Overall Study|Adverse Event|75|||
19537044|NCT01050062|41985351|FG001|Overall Study|Adverse Event|22|||
19537045|NCT01050062|41985350|FG000|Overall Study|Lost to Follow-up|83|||
19537046|NCT01050062|41985351|FG001|Overall Study|Lost to Follow-up|35|||
19537047|NCT01050062|41985350|FG000|Overall Study|Lack of Efficacy|22|||
19537048|NCT01050062|41985351|FG001|Overall Study|Lack of Efficacy|35|||
19537049|NCT01050062|41985350|FG000|Overall Study|Physician Decision|74|||
19537050|NCT01050062|41985351|FG001|Overall Study|Physician Decision|9|||
19537051|NCT01050062|41985350|FG000|Overall Study|Others|17|||
19455903|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455904|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455905|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
19537052|NCT01050062|41985351|FG001|Overall Study|Others|11|||
19537053|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
19537054|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
19537055|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
19537056|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
19537057|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
19537058|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
19455906|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
19537059|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
19537060|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
19537061|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
19537062|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
19537063|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
19537064|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
19537065|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
19537066|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
19537067|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Death|1|||
19537068|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Death|0|||
19537069|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
19537070|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
19537071|NCT00105989|41985369|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
19537072|NCT00105989|41985370|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
19537073|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
19537074|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
19537075|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
19537076|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
19537077|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
19537078|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
19537079|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
19455907|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455908|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
19455909|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
19455910|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455911|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455912|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455913|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
19455914|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
19455915|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
19455916|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
19455917|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
19455918|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
19455919|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
19537080|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
19537081|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
19537082|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
19537083|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
19537084|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
19537085|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
19537086|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
19537087|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Death|0|||
19537088|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Death|0|||
19537089|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
19537090|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
19537091|NCT00105989|41985369|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
19537092|NCT00105989|41985370|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
19537093|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
19537094|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
19537095|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
19537096|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
19537097|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
19537098|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
19537099|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
19537100|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
19537101|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
19537102|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
19537103|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
19537104|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
19537105|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
19537106|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
19537107|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
19537108|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
19537109|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
19537110|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
19537111|NCT00105989|41985369|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
19537112|NCT00105989|41985370|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
19537113|NCT03277248|41985388|FG000|Overall Study|Adverse Event|3|||
19537114|NCT03277248|41985389|FG001|Overall Study|Adverse Event|1|||
19455920|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
19455921|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
19455922|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
19537115|NCT03277248|41985388|FG000|Overall Study|Subject Withdrawal of Consent|6|||
19537116|NCT03277248|41985389|FG001|Overall Study|Subject Withdrawal of Consent|23|||
19537117|NCT03277248|41985388|FG000|Overall Study|Investigator/Sponsor Decision|2|||
19537118|NCT03277248|41985389|FG001|Overall Study|Investigator/Sponsor Decision|2|||
19537119|NCT03277248|41985388|FG000|Overall Study|Pregnancy|4|||
19537120|NCT03277248|41985389|FG001|Overall Study|Pregnancy|1|||
19537121|NCT03277248|41985388|FG000|Overall Study|Lost to Follow-up|0|||
19537122|NCT03277248|41985389|FG001|Overall Study|Lost to Follow-up|2|||
19537123|NCT03277248|41985388|FG000|Overall Study|Lack of Efficacy|0|||
19537124|NCT03277248|41985389|FG001|Overall Study|Lack of Efficacy|2|||
19537125|NCT03277248|41985388|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
19537126|NCT03277248|41985389|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
19537127|NCT03276780|41985397|FG000|Overall Study|Withdrawal by Subject|5|||
19537128|NCT03276780|41985398|FG001|Overall Study|Withdrawal by Subject|3|||
19537129|NCT03276780|41985397|FG000|Overall Study|Lost to Follow-up|3|||
19537130|NCT03276780|41985398|FG001|Overall Study|Lost to Follow-up|5|||
19537131|NCT03276780|41985397|FG000|Overall Study|Moved out of state|1|||
19537132|NCT03276780|41985398|FG001|Overall Study|Moved out of state|1|||
19537133|NCT03276780|41985397|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
19537134|NCT03276780|41985398|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
19537135|NCT03276780|41985397|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
19537136|NCT03276780|41985398|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
19537137|NCT03271047|41985414|FG000|Phase 1b: Dose Finding Period|Death|8|||
19537138|NCT03271047|41985415|FG001|Phase 1b: Dose Finding Period|Death|8|||
19537139|NCT03271047|41985416|FG002|Phase 1b: Dose Finding Period|Death|0|||
19537140|NCT03271047|41985417|FG003|Phase 1b: Dose Finding Period|Death|0|||
19537141|NCT03271047|41985414|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
19537142|NCT03271047|41985415|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
19537143|NCT03271047|41985416|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
19537144|NCT03271047|41985417|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
19537145|NCT03271047|41985414|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
19537146|NCT03271047|41985415|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
19537147|NCT03271047|41985416|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
19537148|NCT03271047|41985417|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
19537149|NCT03271047|41985414|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
19537150|NCT03271047|41985415|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
19630959|NCT00851747|42080198|FG002|Overall Study|Physician Decision|6|||
19630960|NCT00767325|42080205|FG000|Overall Study|Lack of Efficacy|2|||
19630961|NCT00767325|42080205|FG000|Overall Study|Adverse Event|7|||
19455923|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
19455924|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
19630962|NCT00767325|42080205|FG000|Overall Study|Lost to Follow-up|3|||
19630963|NCT00767325|42080205|FG000|Overall Study|No longer met study criteria|2|||
19630964|NCT00767325|42080205|FG000|Overall Study|Missed visit due to family reasons|1|||
19630965|NCT00851591|42080211|FG000|Overall Study|Withdrawal by Subject|2|||
19630966|NCT00851591|42080212|FG001|Overall Study|Withdrawal by Subject|0|||
19630967|NCT00861341|42080218|FG000|Overall Study|Withdrawal by Subject|2|||
19630968|NCT00766467|42080224|FG000|Overall Study|Withdrawal by Subject|7|||
19630969|NCT00766467|42080225|FG001|Overall Study|Withdrawal by Subject|2|||
19630970|NCT00766467|42080224|FG000|Overall Study|Adverse Event|1|||
19630971|NCT00766467|42080225|FG001|Overall Study|Adverse Event|1|||
19630972|NCT00766467|42080224|FG000|Overall Study|Protocol Violation|2|||
19630973|NCT00766467|42080225|FG001|Overall Study|Protocol Violation|4|||
19630974|NCT00766467|42080224|FG000|Overall Study|Tumor Progression on Study|0|||
19630975|NCT00766467|42080225|FG001|Overall Study|Tumor Progression on Study|1|||
19630976|NCT00766467|42080224|FG000|Overall Study|Physician Decision|1|||
19630977|NCT00766467|42080225|FG001|Overall Study|Physician Decision|0|||
19630978|NCT00850499|42080233|FG000|Overall Study|Adverse Event|3|||
19455925|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
19455926|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
19455927|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
19455928|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
19455929|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
19455930|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19630979|NCT00850499|42080234|FG001|Overall Study|Adverse Event|1|||
19537151|NCT03271047|41985416|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
19537152|NCT03271047|41985417|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
19537153|NCT03271047|41985414|FG000|Randomized Phase 2 Period|Other|0|||
19537154|NCT03271047|41985415|FG001|Randomized Phase 2 Period|Other|0|||
19537155|NCT03271047|41985416|FG002|Randomized Phase 2 Period|Other|0|||
19537156|NCT03271047|41985417|FG003|Randomized Phase 2 Period|Other|1|||
19537157|NCT03271047|41985414|FG000|Randomized Phase 2 Period|Death|0|||
19537158|NCT03271047|41985415|FG001|Randomized Phase 2 Period|Death|0|||
19537159|NCT03271047|41985416|FG002|Randomized Phase 2 Period|Death|20|||
19537160|NCT03271047|41985417|FG003|Randomized Phase 2 Period|Death|21|||
19537161|NCT03271047|41985414|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
19537162|NCT03271047|41985415|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
19537163|NCT03271047|41985416|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
19537164|NCT03271047|41985417|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
19537165|NCT03271047|41985414|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
19537166|NCT03271047|41985415|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
19537167|NCT03271047|41985416|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
19537168|NCT03271047|41985417|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
19537169|NCT03271047|41985414|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
19537170|NCT03271047|41985415|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
19630980|NCT00850499|42080233|FG000|Overall Study|Lack of Efficacy|0|||
19630981|NCT00850499|42080234|FG001|Overall Study|Lack of Efficacy|1|||
19630982|NCT00860951|42080240|FG000|Overall Study|Withdrawal by Subject|2|||
19630983|NCT00860951|42080240|FG000|Overall Study|Lost to Follow-up|5|||
19630984|NCT00844805|42080258|FG000|Treatment Phase|Adverse Event|5|||
19630985|NCT00844805|42080259|FG001|Treatment Phase|Adverse Event|1|||
19630986|NCT00844805|42080260|FG002|Treatment Phase|Adverse Event|0|||
19630987|NCT00844805|42080261|FG003|Treatment Phase|Adverse Event|0|||
19630988|NCT00844805|42080258|FG000|Treatment Phase|Withdrawal by Subject|3|||
19630989|NCT00844805|42080259|FG001|Treatment Phase|Withdrawal by Subject|4|||
19630990|NCT00844805|42080260|FG002|Treatment Phase|Withdrawal by Subject|0|||
19630991|NCT00844805|42080261|FG003|Treatment Phase|Withdrawal by Subject|0|||
19630992|NCT00844805|42080258|FG000|Treatment Phase|Noncompliance With Protocol|1|||
19630993|NCT00844805|42080259|FG001|Treatment Phase|Noncompliance With Protocol|0|||
19630994|NCT00844805|42080260|FG002|Treatment Phase|Noncompliance With Protocol|0|||
19630995|NCT00844805|42080261|FG003|Treatment Phase|Noncompliance With Protocol|0|||
19630996|NCT00844805|42080258|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
19630997|NCT00844805|42080259|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
19630998|NCT00844805|42080260|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
19630999|NCT00844805|42080261|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
19631000|NCT00844805|42080258|FG000|Follow-Up Phase|Adverse Event|0|||
19631001|NCT00844805|42080259|FG001|Follow-Up Phase|Adverse Event|0|||
19631002|NCT00844805|42080260|FG002|Follow-Up Phase|Adverse Event|1|||
19631003|NCT00844805|42080261|FG003|Follow-Up Phase|Adverse Event|0|||
19631004|NCT00844805|42080258|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
19631005|NCT00844805|42080259|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
19631006|NCT00844805|42080260|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
19631007|NCT00844805|42080261|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
19631008|NCT00844805|42080258|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
19631009|NCT00844805|42080259|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
19631010|NCT00844805|42080260|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
19631011|NCT00844805|42080261|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
19631012|NCT00844805|42080258|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
19631013|NCT00844805|42080259|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
19631014|NCT00844805|42080260|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
19631015|NCT00844805|42080261|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
19631016|NCT00844805|42080258|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
19631017|NCT00844805|42080259|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
19631018|NCT00844805|42080260|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
19631019|NCT00844805|42080261|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
19631020|NCT00765999|42080272|FG000|Overall Study|Adverse Event|203|||
19631021|NCT00765999|42080272|FG000|Overall Study|Insufficient Therapeutic Response|100|||
19631022|NCT00765999|42080272|FG000|Overall Study|Protocol Violation|95|||
19631023|NCT00765999|42080272|FG000|Overall Study|Consent Withdrawn|202|||
19631024|NCT00765999|42080272|FG000|Overall Study|Lost to Follow-up|131|||
19711509|NCT03568318|42154617|FG001|Overall Study|Adverse Event|1|||
19711510|NCT03568318|42154618|FG002|Overall Study|Adverse Event|1|||
19631025|NCT00765999|42080272|FG000|Overall Study|Study Terminated by Sponsor|2|||
19455931|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455932|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455933|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455934|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19631026|NCT00765999|42080272|FG000|Overall Study|Other Miscellaneous Reasons|51|||
19631027|NCT00765843|42080281|FG000|Overall Study|Lost to Follow-up|1|||
19537171|NCT03271047|41985416|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
19537172|NCT03271047|41985417|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
19537173|NCT03276936|41985431|FG000|Overall Study|Adverse Event|4|||
19537174|NCT03276936|41985432|FG001|Overall Study|Adverse Event|2|||
19537175|NCT03276936|41985431|FG000|Overall Study|Lost to Follow-up|16|||
19537176|NCT03276936|41985432|FG001|Overall Study|Lost to Follow-up|13|||
19537177|NCT03276936|41985431|FG000|Overall Study|Withdrawal by Subject|30|||
19537178|NCT03276936|41985432|FG001|Overall Study|Withdrawal by Subject|20|||
19537179|NCT03276936|41985431|FG000|Overall Study|Not mentioned|6|||
19537180|NCT03276936|41985432|FG001|Overall Study|Not mentioned|3|||
19537181|NCT00106002|41985438|FG000|Overall Study|Did not take any study drug|1|||
19537182|NCT00106002|41985438|FG000|Overall Study|Ineligible after Registration|1|||
19537183|NCT00105482|41985456|FG000|Overall Study|Adverse Event|1|||
19537184|NCT00105482|41985457|FG001|Overall Study|Adverse Event|1|||
19537185|NCT00105482|41985456|FG000|Overall Study|Lost to Follow-up|26|||
19537186|NCT00105482|41985457|FG001|Overall Study|Lost to Follow-up|17|||
19537187|NCT00105482|41985456|FG000|Overall Study|Withdrawal by Subject|0|||
19537188|NCT00105482|41985457|FG001|Overall Study|Withdrawal by Subject|1|||
19537189|NCT00105482|41985456|FG000|Overall Study|Lost Interest|29|||
19537190|NCT00105482|41985457|FG001|Overall Study|Lost Interest|32|||
19537191|NCT00105482|41985456|FG000|Overall Study|Scheduling Conflict|2|||
19537192|NCT00105482|41985457|FG001|Overall Study|Scheduling Conflict|3|||
19537193|NCT00105482|41985456|FG000|Overall Study|Withdrawn by PI|1|||
19537194|NCT00105482|41985457|FG001|Overall Study|Withdrawn by PI|1|||
19537195|NCT01327651|41985472|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
19537196|NCT01327651|41985473|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
19537197|NCT01327651|41985474|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
19537198|NCT01327651|41985475|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
19537199|NCT01327651|41985476|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
19537200|NCT01327651|41985477|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
19537201|NCT01327651|41985478|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
19537202|NCT01327651|41985479|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
19537203|NCT01327651|41985480|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
19537204|NCT01327651|41985472|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
19537205|NCT01327651|41985473|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537206|NCT01327651|41985474|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537207|NCT01327651|41985475|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537208|NCT01327651|41985476|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537209|NCT01327651|41985477|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537210|NCT01327651|41985478|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537211|NCT01327651|41985479|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537212|NCT01327651|41985480|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
19537213|NCT01327651|41985472|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
19537214|NCT01327651|41985473|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
19537215|NCT01327651|41985474|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
19537216|NCT01327651|41985475|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
19631028|NCT00765843|42080282|FG001|Overall Study|Lost to Follow-up|3|||
19631029|NCT00765843|42080283|FG002|Overall Study|Lost to Follow-up|2|||
19631030|NCT00765843|42080281|FG000|Overall Study|did not return to receive intervention|0|||
19631031|NCT00765843|42080282|FG001|Overall Study|did not return to receive intervention|1|||
19631032|NCT00765843|42080283|FG002|Overall Study|did not return to receive intervention|0|||
19631033|NCT00765843|42080281|FG000|Overall Study|Adverse Event|0|||
19631034|NCT00765843|42080282|FG001|Overall Study|Adverse Event|0|||
19631035|NCT00765843|42080283|FG002|Overall Study|Adverse Event|1|||
19631036|NCT00765063|42080291|FG000|Overall Study|Lack of Efficacy|5|||
19631037|NCT00765063|42080291|FG000|Overall Study|Withdrawal by Subject|1|||
19631038|NCT00765063|42080291|FG000|Overall Study|Other|16|||
19631039|NCT00765063|42080291|FG000|Overall Study|Protocol Violation|6|||
19455935|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
19455936|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
19455937|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455938|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455939|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
19455940|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
19455941|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
19455942|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19537217|NCT01327651|41985476|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
19537218|NCT01327651|41985477|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
19631040|NCT00765063|42080291|FG000|Overall Study|Adverse Event|4|||
19631041|NCT00764751|42080297|FG000|Overall Study|Adverse Event|1|||
19631042|NCT00764751|42080298|FG001|Overall Study|Adverse Event|1|||
19711511|NCT03568318|42154619|FG003|Overall Study|Adverse Event|0|||
19455943|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455944|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19537219|NCT01327651|41985478|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
19537220|NCT01327651|41985479|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
19537221|NCT01327651|41985480|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
19455945|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
19455946|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455947|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455948|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455949|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455950|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455951|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
19455952|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455953|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455954|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455955|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455956|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455957|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
19455958|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455959|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455960|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455961|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
19455962|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455963|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455964|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455965|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455966|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455967|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
19455968|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19537222|NCT01327651|41985472|FG000|Post Study Follow-up|Lost to Follow-up|0|||
19537223|NCT01327651|41985473|FG001|Post Study Follow-up|Lost to Follow-up|1|||
19537224|NCT01327651|41985474|FG002|Post Study Follow-up|Lost to Follow-up|1|||
19537225|NCT01327651|41985475|FG003|Post Study Follow-up|Lost to Follow-up|0|||
19455969|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455970|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455971|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455972|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19537226|NCT01327651|41985476|FG004|Post Study Follow-up|Lost to Follow-up|0|||
19537227|NCT01327651|41985477|FG005|Post Study Follow-up|Lost to Follow-up|0|||
19537228|NCT01327651|41985478|FG006|Post Study Follow-up|Lost to Follow-up|4|||
19537229|NCT01327651|41985479|FG007|Post Study Follow-up|Lost to Follow-up|1|||
19537230|NCT01327651|41985480|FG008|Post Study Follow-up|Lost to Follow-up|2|||
19537231|NCT00105443|41985521|FG000|Double-Blind Treatment|Adverse Event|1|||
19537232|NCT00105443|41985522|FG001|Double-Blind Treatment|Adverse Event|0|||
19537233|NCT00105443|41985523|FG002|Double-Blind Treatment|Adverse Event|0|||
19537234|NCT00105443|41985524|FG003|Double-Blind Treatment|Adverse Event|0|||
19537235|NCT00105443|41985521|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
19537236|NCT00105443|41985522|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
19537237|NCT00105443|41985523|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
19537238|NCT00105443|41985524|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
19537239|NCT00105443|41985521|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
19537240|NCT00105443|41985522|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
19631043|NCT00764751|42080297|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
19631044|NCT00764751|42080298|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
19631045|NCT00764673|42080309|FG000|Overall Study|Death|1|||
19455973|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19537241|NCT00105443|41985523|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
19537242|NCT00105443|41985524|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
19631046|NCT00764673|42080309|FG000|Overall Study|Lost to Follow-up|3|||
19631047|NCT00764673|42080309|FG000|Overall Study|Withdrawal by Subject|6|||
19631048|NCT00764673|42080309|FG000|Overall Study|Revision of Device|2|||
19631049|NCT00764517|42080315|FG000|Overall Study|Adverse Event|9|||
19631050|NCT00764517|42080316|FG001|Overall Study|Adverse Event|3|||
19631051|NCT00764517|42080315|FG000|Overall Study|Death|3|||
19631052|NCT00764517|42080316|FG001|Overall Study|Death|11|||
19631053|NCT00764517|42080315|FG000|Overall Study|Physician Decision|3|||
19631054|NCT00764517|42080316|FG001|Overall Study|Physician Decision|0|||
19631055|NCT00764361|42080324|FG000|Overall Study|Withdrawal by Subject|2|||
19711512|NCT03568318|42154620|FG004|Overall Study|Adverse Event|1|||
19455974|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455975|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455976|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455977|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
19455978|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455979|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455980|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455981|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455982|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455983|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455984|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455985|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455986|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
19455987|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455988|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455989|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455990|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455991|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455992|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455993|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
19455994|NCT01609556|41706425|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
19455995|NCT01609556|41706426|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19455996|NCT01609556|41706427|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19455997|NCT01609556|41706428|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19455998|NCT01609556|41706429|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19455999|NCT01609556|41706430|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
19456000|NCT01609556|41706431|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456001|NCT01609556|41706432|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456002|NCT01609556|41706433|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456003|NCT01609556|41706434|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456004|NCT01609556|41706435|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
19456005|NCT01609556|41706436|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456006|NCT01609556|41706437|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456007|NCT01609556|41706438|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456008|NCT01609556|41706439|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456009|NCT01609556|41706440|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
19456010|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456011|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456012|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456013|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456014|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456015|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456016|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456017|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456018|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456019|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456020|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456021|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
19456022|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
19456023|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
19456024|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
19456025|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
19456026|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456027|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456028|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456029|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456030|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456031|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19631056|NCT00764361|42080325|FG001|Overall Study|Withdrawal by Subject|3|||
19631057|NCT00764361|42080324|FG000|Overall Study|Adverse Event|0|||
19631058|NCT00764361|42080325|FG001|Overall Study|Adverse Event|1|||
19631059|NCT00763971|42080334|FG000|Overall Study|Adverse Event|5|||
19631060|NCT00763971|42080335|FG001|Overall Study|Adverse Event|2|||
19631061|NCT00763971|42080336|FG002|Overall Study|Adverse Event|4|||
19456032|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456033|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456034|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456035|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456036|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456037|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
19456038|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
19456039|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
19456040|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
19456041|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
19456042|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456043|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456044|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456045|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456046|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456047|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456048|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456049|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456050|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456051|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456052|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456053|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
19456054|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
19456055|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
19456056|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
19456057|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
19537243|NCT00105443|41985521|FG000|Double-Blind Treatment|Physician Decision|1|||
19537244|NCT00105443|41985522|FG001|Double-Blind Treatment|Physician Decision|0|||
19537245|NCT00105443|41985523|FG002|Double-Blind Treatment|Physician Decision|2|||
19537246|NCT00105443|41985524|FG003|Double-Blind Treatment|Physician Decision|0|||
19537247|NCT00105443|41985521|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
19537248|NCT00105443|41985522|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
19537249|NCT00105443|41985523|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
19537250|NCT00105443|41985524|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
19537251|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
19537252|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
19456058|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456059|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456060|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456061|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456062|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456063|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456064|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456065|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456066|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456067|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456068|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456069|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19537253|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
19537254|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
19537255|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
19537256|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
19537257|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
19537258|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
19537259|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
19537260|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
19537261|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
19537262|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
19537263|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
19537264|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
19537265|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
19537266|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
19537267|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
19537268|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
19537269|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
19537270|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
19537271|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
19537272|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
19456070|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
19537273|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
19537274|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
19537275|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
19537276|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
19537277|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
19537278|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
19537279|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
19537280|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
19537281|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
19537282|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
19537283|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
19537284|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
19537285|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
19537286|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
19537287|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
19537288|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
19537289|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
19537290|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
19537291|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
19537292|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
19537293|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
19537294|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
19537295|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
19537296|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
19537297|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
19537298|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
19537299|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
19537300|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
19537301|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
19537302|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
19537303|NCT00105443|41985521|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
19537304|NCT00105443|41985522|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
19537305|NCT00105443|41985523|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
19537306|NCT00105443|41985524|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
19537307|NCT01327612|41985540|FG000|Overall Study|Withdrawal by Subject|0|||
19537308|NCT01327612|41985541|FG001|Overall Study|Withdrawal by Subject|0|||
19537309|NCT01327612|41985542|FG002|Overall Study|Withdrawal by Subject|0|||
19537310|NCT01327612|41985543|FG003|Overall Study|Withdrawal by Subject|0|||
19537311|NCT01327612|41985544|FG004|Overall Study|Withdrawal by Subject|0|||
19537312|NCT01327612|41985545|FG005|Overall Study|Withdrawal by Subject|1|||
19537313|NCT01327612|41985546|FG006|Overall Study|Withdrawal by Subject|0|||
19537314|NCT01327612|41985540|FG000|Overall Study|Disease Progression|1|||
19537315|NCT01327612|41985541|FG001|Overall Study|Disease Progression|1|||
19537316|NCT01327612|41985542|FG002|Overall Study|Disease Progression|1|||
19537317|NCT01327612|41985543|FG003|Overall Study|Disease Progression|0|||
19537318|NCT01327612|41985544|FG004|Overall Study|Disease Progression|1|||
19537319|NCT01327612|41985545|FG005|Overall Study|Disease Progression|2|||
19537320|NCT01327612|41985546|FG006|Overall Study|Disease Progression|2|||
19537321|NCT01327612|41985540|FG000|Overall Study|Administrative Decision|0|||
19537322|NCT01327612|41985541|FG001|Overall Study|Administrative Decision|0|||
19537323|NCT01327612|41985542|FG002|Overall Study|Administrative Decision|0|||
19537324|NCT01327612|41985543|FG003|Overall Study|Administrative Decision|1|||
19537325|NCT01327612|41985544|FG004|Overall Study|Administrative Decision|0|||
19537326|NCT01327612|41985545|FG005|Overall Study|Administrative Decision|0|||
19537327|NCT01327612|41985546|FG006|Overall Study|Administrative Decision|0|||
19537328|NCT01327612|41985540|FG000|Overall Study|Death|0|||
19537329|NCT01327612|41985541|FG001|Overall Study|Death|0|||
19537330|NCT01327612|41985542|FG002|Overall Study|Death|0|||
19537331|NCT01327612|41985543|FG003|Overall Study|Death|0|||
19537332|NCT01327612|41985544|FG004|Overall Study|Death|1|||
19537333|NCT01327612|41985545|FG005|Overall Study|Death|0|||
19537334|NCT01327612|41985546|FG006|Overall Study|Death|0|||
19537335|NCT01327573|41985565|FG000|Overall Study|Physician Decision|3|||
19537336|NCT01327573|41985566|FG001|Overall Study|Physician Decision|1|||
19537337|NCT01327495|41985579|FG000|Overall Study|Adverse Event|2|||
19537338|NCT01327495|41985580|FG001|Overall Study|Adverse Event|1|||
19537339|NCT01327495|41985581|FG002|Overall Study|Adverse Event|1|||
19537340|NCT01327495|41985582|FG003|Overall Study|Adverse Event|0|||
19537341|NCT01327495|41985583|FG004|Overall Study|Adverse Event|0|||
19537342|NCT01327495|41985584|FG005|Overall Study|Adverse Event|2|||
19537343|NCT01327495|41985579|FG000|Overall Study|Withdrawal by Subject|0|||
19537344|NCT01327495|41985580|FG001|Overall Study|Withdrawal by Subject|1|||
19537345|NCT01327495|41985581|FG002|Overall Study|Withdrawal by Subject|1|||
19537346|NCT01327495|41985582|FG003|Overall Study|Withdrawal by Subject|0|||
19537347|NCT01327495|41985583|FG004|Overall Study|Withdrawal by Subject|1|||
19537348|NCT01327495|41985584|FG005|Overall Study|Withdrawal by Subject|0|||
19537349|NCT01327495|41985579|FG000|Overall Study|Physician Decision|0|||
19537350|NCT01327495|41985580|FG001|Overall Study|Physician Decision|0|||
19537351|NCT01327495|41985581|FG002|Overall Study|Physician Decision|0|||
19537352|NCT01327495|41985582|FG003|Overall Study|Physician Decision|0|||
19537353|NCT01327495|41985583|FG004|Overall Study|Physician Decision|2|||
19537354|NCT01327495|41985584|FG005|Overall Study|Physician Decision|0|||
19537355|NCT01327339|41985604|FG000|Overall Study|Protocol Violation|8|||
19537356|NCT01327300|41985608|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
19537357|NCT01327300|41985609|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
19537358|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Adverse Event|3|||
19537359|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Adverse Event|0|||
19537360|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
19537361|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
19537362|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Disease Progression|23|||
19537363|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Disease Progression|22|||
19537364|NCT01379521|41985627|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
19537365|NCT01379521|41985628|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
19537366|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
19537367|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
19537368|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
19537369|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
19537370|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
19537371|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
19537372|NCT01379521|41985627|FG000|Overall Study -Treatment Period|Death|2|||
19537373|NCT01379521|41985628|FG001|Overall Study -Treatment Period|Death|1|||
19537374|NCT01379521|41985627|FG000|Post-Treatment Evaluations|Disease Progression|22|||
19537375|NCT01379521|41985628|FG001|Post-Treatment Evaluations|Disease Progression|20|||
19537376|NCT01379521|41985627|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
19537377|NCT01379521|41985628|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
19537378|NCT01379521|41985627|FG000|Post-Treatment Evaluations|Death|1|||
19537379|NCT01379521|41985628|FG001|Post-Treatment Evaluations|Death|0|||
19537380|NCT01371994|41985636|FG000|Overall Study|Adverse Event|3|||
19537381|NCT01371994|41985637|FG001|Overall Study|Adverse Event|6|||
19537382|NCT01371994|41985636|FG000|Overall Study|Lack of Efficacy|3|||
19537383|NCT01371994|41985637|FG001|Overall Study|Lack of Efficacy|0|||
19537384|NCT01371994|41985636|FG000|Overall Study|Withdrawal by Subject|13|||
19537385|NCT01371994|41985637|FG001|Overall Study|Withdrawal by Subject|7|||
19537386|NCT01371994|41985636|FG000|Overall Study|Lost to Follow-up|1|||
19537387|NCT01371994|41985637|FG001|Overall Study|Lost to Follow-up|1|||
19537388|NCT01371994|41985636|FG000|Overall Study|Protocol Violation|24|||
19537389|NCT01371994|41985637|FG001|Overall Study|Protocol Violation|17|||
19537390|NCT01371994|41985636|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
19537391|NCT01371994|41985637|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
19537392|NCT01371994|41985636|FG000|Overall Study|Physician Decision|1|||
19537393|NCT01371994|41985637|FG001|Overall Study|Physician Decision|1|||
19456071|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456072|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456073|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
19456074|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456075|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19537394|NCT01371994|41985636|FG000|Overall Study|Miscellaneous Reasons|6|||
19456076|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456077|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456078|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456079|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456080|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456081|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456082|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456083|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456084|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19456085|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
19537395|NCT01371994|41985637|FG001|Overall Study|Miscellaneous Reasons|4|||
19537396|NCT01371877|41985645|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
19631062|NCT00763971|42080334|FG000|Overall Study|Protocol Violation|3|||
19537397|NCT01371877|41985646|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
19537398|NCT01371838|41985654|FG000|Overall Study|Withdrawal by Subject|27|||
19537399|NCT01371838|41985655|FG001|Overall Study|Withdrawal by Subject|33|||
19537400|NCT01371838|41985654|FG000|Overall Study|Lost to Follow-up|10|||
19537401|NCT01371838|41985655|FG001|Overall Study|Lost to Follow-up|20|||
19537402|NCT01371838|41985654|FG000|Overall Study|Death|3|||
19537403|NCT01371838|41985655|FG001|Overall Study|Death|4|||
19456086|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
19456087|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
19456088|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
19456089|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
19456090|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19537404|NCT01371838|41985654|FG000|Overall Study|Protocol Violation|3|||
19537405|NCT01371838|41985655|FG001|Overall Study|Protocol Violation|0|||
19537406|NCT01371838|41985654|FG000|Overall Study|Investigator Decision|3|||
19537407|NCT01371838|41985655|FG001|Overall Study|Investigator Decision|8|||
19537408|NCT01371838|41985654|FG000|Overall Study|Last follow-up visit not conducted|2|||
19537409|NCT01371838|41985655|FG001|Overall Study|Last follow-up visit not conducted|0|||
19537410|NCT01371838|41985654|FG000|Overall Study|Lack of therapeutic response|0|||
19537411|NCT01371838|41985655|FG001|Overall Study|Lack of therapeutic response|1|||
19537412|NCT01371838|41985654|FG000|Overall Study|Surgery|1|||
19537413|NCT01371838|41985655|FG001|Overall Study|Surgery|0|||
19537414|NCT01371721|41985664|FG000|Overall Study|Adverse Event|5|||
19537415|NCT01371721|41985665|FG001|Overall Study|Adverse Event|4|||
19537416|NCT01371721|41985666|FG002|Overall Study|Adverse Event|5|||
19537417|NCT01371721|41985664|FG000|Overall Study|Protocol Violation|6|||
19537418|NCT01371721|41985665|FG001|Overall Study|Protocol Violation|4|||
19537419|NCT01371721|41985666|FG002|Overall Study|Protocol Violation|5|||
19537420|NCT01371721|41985664|FG000|Overall Study|Lost to Follow-up|8|||
19537421|NCT01371721|41985665|FG001|Overall Study|Lost to Follow-up|2|||
19537422|NCT01371721|41985666|FG002|Overall Study|Lost to Follow-up|6|||
19537423|NCT01371721|41985664|FG000|Overall Study|Withdrawal by Subject|5|||
19537424|NCT01371721|41985665|FG001|Overall Study|Withdrawal by Subject|7|||
19537425|NCT01371721|41985666|FG002|Overall Study|Withdrawal by Subject|11|||
19537426|NCT01371721|41985664|FG000|Overall Study|Other|2|||
19537427|NCT01371721|41985665|FG001|Overall Study|Other|3|||
19537428|NCT01371721|41985666|FG002|Overall Study|Other|0|||
19537429|NCT01371721|41985664|FG000|Overall Study|Lack of Efficacy|2|||
19537430|NCT01371721|41985665|FG001|Overall Study|Lack of Efficacy|4|||
19537431|NCT01371721|41985666|FG002|Overall Study|Lack of Efficacy|3|||
19537432|NCT01371721|41985664|FG000|Overall Study|Randomized but not treated|1|||
19537433|NCT01371721|41985665|FG001|Overall Study|Randomized but not treated|0|||
19537434|NCT01371721|41985666|FG002|Overall Study|Randomized but not treated|0|||
19537435|NCT01366534|41985679|FG000|Overall Study|Lost to Follow-up|1|||
19537436|NCT01366534|41985680|FG001|Overall Study|Lost to Follow-up|0|||
19537437|NCT01366534|41985681|FG002|Overall Study|Lost to Follow-up|0|||
19537438|NCT01366534|41985679|FG000|Overall Study|Migrated|1|||
19537439|NCT01366534|41985680|FG001|Overall Study|Migrated|1|||
19537440|NCT01366534|41985681|FG002|Overall Study|Migrated|0|||
19537441|NCT01366534|41985679|FG000|Overall Study|Declined challenged|0|||
19537442|NCT01366534|41985680|FG001|Overall Study|Declined challenged|1|||
19537443|NCT01366534|41985681|FG002|Overall Study|Declined challenged|0|||
19537444|NCT01365910|41985689|FG000|Overall Study|Withdrawal by Subject|7|||
19537445|NCT01365910|41985689|FG000|Overall Study|disease progression|18|||
19537446|NCT01365910|41985689|FG000|Overall Study|Adverse Event|3|||
19537447|NCT01365910|41985689|FG000|Overall Study|other complicating disease|1|||
19537448|NCT01365910|41985689|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
19537449|NCT01365481|41985697|FG000|Overall Study|Adverse Event|6|||
19537450|NCT01365481|41985698|FG001|Overall Study|Adverse Event|9|||
19537451|NCT01365481|41985699|FG002|Overall Study|Adverse Event|0|||
19537452|NCT01365481|41985700|FG003|Overall Study|Adverse Event|2|||
19537453|NCT01365481|41985697|FG000|Overall Study|Withdrawal by Subject|0|||
19537454|NCT01365481|41985698|FG001|Overall Study|Withdrawal by Subject|2|||
19631063|NCT00763971|42080335|FG001|Overall Study|Protocol Violation|3|||
19456091|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456092|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456093|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456094|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19537455|NCT01365481|41985699|FG002|Overall Study|Withdrawal by Subject|1|||
19537456|NCT01365481|41985700|FG003|Overall Study|Withdrawal by Subject|1|||
19537457|NCT01365481|41985697|FG000|Overall Study|Lost to Follow-up|1|||
19537458|NCT01365481|41985698|FG001|Overall Study|Lost to Follow-up|1|||
19537459|NCT01365481|41985699|FG002|Overall Study|Lost to Follow-up|2|||
19537460|NCT01365481|41985700|FG003|Overall Study|Lost to Follow-up|3|||
19537461|NCT01365481|41985697|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19537462|NCT01365481|41985698|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19537463|NCT01365481|41985699|FG002|Overall Study|Abnormal laboratory value(s)|0|||
19537464|NCT01365481|41985700|FG003|Overall Study|Abnormal laboratory value(s)|0|||
19537465|NCT01365481|41985697|FG000|Overall Study|Administrative problems|0|||
19537466|NCT01365481|41985698|FG001|Overall Study|Administrative problems|1|||
19537467|NCT01365481|41985699|FG002|Overall Study|Administrative problems|0|||
19537468|NCT01365481|41985700|FG003|Overall Study|Administrative problems|0|||
19537469|NCT01365481|41985697|FG000|Overall Study|Protocol deviation|0|||
19537470|NCT01365481|41985698|FG001|Overall Study|Protocol deviation|1|||
19537471|NCT01365481|41985699|FG002|Overall Study|Protocol deviation|0|||
19537472|NCT01365481|41985700|FG003|Overall Study|Protocol deviation|1|||
19537473|NCT01365481|41985697|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19537474|NCT01365481|41985698|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19537475|NCT01365481|41985699|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
19537476|NCT01365481|41985700|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
19537477|NCT01357915|41985712|FG000|Overall Study|Lost to Follow-up|3|||
19537478|NCT01357915|41985713|FG001|Overall Study|Lost to Follow-up|0|||
19537479|NCT01350973|41985722|FG000|Overall Study|Adverse Event|4|||
19537480|NCT01350973|41985723|FG001|Overall Study|Adverse Event|7|||
19537481|NCT01350973|41985724|FG002|Overall Study|Adverse Event|7|||
19537482|NCT01350973|41985722|FG000|Overall Study|Voluntary Withdrawal|2|||
19537483|NCT01350973|41985723|FG001|Overall Study|Voluntary Withdrawal|1|||
19537484|NCT01350973|41985724|FG002|Overall Study|Voluntary Withdrawal|1|||
19537485|NCT01350544|41985734|FG000|Overall Study|Administrative Withdrawal|0|||
19537486|NCT01350544|41985735|FG001|Overall Study|Administrative Withdrawal|1|||
19537487|NCT01350544|41985734|FG000|Overall Study|Death|1|||
19537488|NCT01350544|41985735|FG001|Overall Study|Death|2|||
19537489|NCT01350544|41985734|FG000|Overall Study|Moved out of LA County|2|||
19537490|NCT01350544|41985735|FG001|Overall Study|Moved out of LA County|2|||
19537491|NCT01350544|41985734|FG000|Overall Study|Medical Issues|1|||
19537492|NCT01350544|41985735|FG001|Overall Study|Medical Issues|1|||
19537493|NCT01350544|41985734|FG000|Overall Study|Withdrawal by Subject|0|||
19537494|NCT01350544|41985735|FG001|Overall Study|Withdrawal by Subject|1|||
19537495|NCT01350544|41985734|FG000|Overall Study|Incarceration|1|||
19537496|NCT01350544|41985735|FG001|Overall Study|Incarceration|0|||
19537497|NCT01350544|41985734|FG000|Overall Study|Lost to Follow-up|18|||
19537498|NCT01350544|41985735|FG001|Overall Study|Lost to Follow-up|15|||
19537499|NCT01350505|41985741|FG000|Overall Study|Lost to Follow-up|4|||
19537500|NCT01350271|41985748|FG000|Overall Study|Lost to Follow-up|21|||
19537501|NCT01350271|41985749|FG001|Overall Study|Lost to Follow-up|17|||
19537502|NCT01350271|41985750|FG002|Overall Study|Lost to Follow-up|26|||
19537503|NCT01348828|41985761|FG000|Overall Study|Death|20|||
19537504|NCT01348828|41985761|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
19537505|NCT01348828|41985761|FG000|Overall Study|Conversion|2|||
19537506|NCT01348828|41985761|FG000|Overall Study|missed visit|1|||
19537507|NCT01348789|41985765|FG000|Overall Study|Protocol Violation|2|||
19537508|NCT01348789|41985765|FG000|Overall Study|Withdrawal by Subject|2|||
19537509|NCT01342510|41985780|FG000|Overall Study|Protocol Violation|12|||
19537510|NCT01342510|41985781|FG001|Overall Study|Protocol Violation|6|||
19537511|NCT01342510|41985782|FG002|Overall Study|Protocol Violation|13|||
19537512|NCT01342510|41985783|FG003|Overall Study|Protocol Violation|11|||
19537513|NCT01340872|41985803|FG000|Double-blind Phase|Adverse Event|6|||
19537514|NCT01340872|41985804|FG001|Double-blind Phase|Adverse Event|4|||
19537515|NCT01340872|41985805|FG002|Double-blind Phase|Adverse Event|0|||
19537516|NCT01340872|41985806|FG003|Double-blind Phase|Adverse Event|0|||
19537517|NCT01340872|41985803|FG000|Double-blind Phase|Withdrawal by Subject|3|||
19537518|NCT01340872|41985804|FG001|Double-blind Phase|Withdrawal by Subject|5|||
19537519|NCT01340872|41985805|FG002|Double-blind Phase|Withdrawal by Subject|0|||
19537520|NCT01340872|41985806|FG003|Double-blind Phase|Withdrawal by Subject|0|||
19537521|NCT01340872|41985803|FG000|Double-blind Phase|Lost to Follow-up|0|||
19537522|NCT01340872|41985804|FG001|Double-blind Phase|Lost to Follow-up|1|||
19537523|NCT01340872|41985805|FG002|Double-blind Phase|Lost to Follow-up|0|||
19537524|NCT01340872|41985806|FG003|Double-blind Phase|Lost to Follow-up|0|||
19537525|NCT01340872|41985803|FG000|Double-blind Phase|Protocol Violation|0|||
19537526|NCT01340872|41985804|FG001|Double-blind Phase|Protocol Violation|1|||
19537527|NCT01340872|41985805|FG002|Double-blind Phase|Protocol Violation|0|||
19537528|NCT01340872|41985806|FG003|Double-blind Phase|Protocol Violation|0|||
19537529|NCT01340872|41985803|FG000|Open-label Phase|Physician Decision|0|||
19537530|NCT01340872|41985804|FG001|Open-label Phase|Physician Decision|0|||
19537531|NCT01340872|41985805|FG002|Open-label Phase|Physician Decision|2|||
19537532|NCT01340872|41985806|FG003|Open-label Phase|Physician Decision|1|||
19537533|NCT01340872|41985803|FG000|Open-label Phase|Pregnancy|0|||
19537534|NCT01340872|41985804|FG001|Open-label Phase|Pregnancy|0|||
19537535|NCT01340872|41985805|FG002|Open-label Phase|Pregnancy|1|||
19537536|NCT01340872|41985806|FG003|Open-label Phase|Pregnancy|0|||
19537537|NCT01340872|41985803|FG000|Open-label Phase|Adverse Event|0|||
19537538|NCT01340872|41985804|FG001|Open-label Phase|Adverse Event|0|||
19537539|NCT01340872|41985805|FG002|Open-label Phase|Adverse Event|8|||
19537540|NCT01340872|41985806|FG003|Open-label Phase|Adverse Event|4|||
19537541|NCT01340872|41985803|FG000|Open-label Phase|Withdrawal by Subject|0|||
19537542|NCT01340872|41985804|FG001|Open-label Phase|Withdrawal by Subject|0|||
19537543|NCT01340872|41985805|FG002|Open-label Phase|Withdrawal by Subject|1|||
19537544|NCT01340872|41985806|FG003|Open-label Phase|Withdrawal by Subject|6|||
19537545|NCT01340872|41985803|FG000|Open-label Phase|Worsening of IBD|0|||
19537546|NCT01340872|41985804|FG001|Open-label Phase|Worsening of IBD|0|||
19631064|NCT00763971|42080336|FG002|Overall Study|Protocol Violation|2|||
19631065|NCT00763971|42080334|FG000|Overall Study|Withdrawal by Subject|4|||
19631066|NCT00763971|42080335|FG001|Overall Study|Withdrawal by Subject|5|||
19631067|NCT00763971|42080336|FG002|Overall Study|Withdrawal by Subject|5|||
19631068|NCT00763971|42080334|FG000|Overall Study|Lost to Follow-up|0|||
19631069|NCT00763971|42080335|FG001|Overall Study|Lost to Follow-up|1|||
19631070|NCT00763971|42080336|FG002|Overall Study|Lost to Follow-up|0|||
19631071|NCT00763971|42080334|FG000|Overall Study|Lack of Efficacy|11|||
19631072|NCT00763971|42080335|FG001|Overall Study|Lack of Efficacy|22|||
19631073|NCT00763971|42080336|FG002|Overall Study|Lack of Efficacy|54|||
19631074|NCT00763971|42080334|FG000|Overall Study|Unable to swallow capsule|2|||
19631075|NCT00763971|42080335|FG001|Overall Study|Unable to swallow capsule|1|||
19631076|NCT00763971|42080336|FG002|Overall Study|Unable to swallow capsule|1|||
19631077|NCT00763971|42080334|FG000|Overall Study|Personal reason|3|||
19456095|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456096|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456097|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19631078|NCT00763971|42080335|FG001|Overall Study|Personal reason|0|||
19631079|NCT00763971|42080336|FG002|Overall Study|Personal reason|0|||
19631080|NCT00763971|42080334|FG000|Overall Study|Exclusion criteria met|1|||
19631081|NCT00763971|42080335|FG001|Overall Study|Exclusion criteria met|0|||
19631082|NCT00763971|42080336|FG002|Overall Study|Exclusion criteria met|0|||
19631083|NCT00763971|42080334|FG000|Overall Study|Sponsor decision|1|||
19631084|NCT00763971|42080335|FG001|Overall Study|Sponsor decision|0|||
19631085|NCT00763971|42080336|FG002|Overall Study|Sponsor decision|0|||
19631086|NCT00763971|42080334|FG000|Overall Study|Due to holiday season|2|||
19631087|NCT00763971|42080335|FG001|Overall Study|Due to holiday season|0|||
19631088|NCT00763971|42080336|FG002|Overall Study|Due to holiday season|1|||
19631089|NCT00763971|42080334|FG000|Overall Study|Randomization error|0|||
19631090|NCT00763971|42080335|FG001|Overall Study|Randomization error|0|||
19631091|NCT00763971|42080336|FG002|Overall Study|Randomization error|1|||
19631092|NCT00763971|42080334|FG000|Overall Study|Medical monitor decision|0|||
19631093|NCT00763971|42080335|FG001|Overall Study|Medical monitor decision|0|||
19631094|NCT00763971|42080336|FG002|Overall Study|Medical monitor decision|1|||
19631095|NCT00763971|42080334|FG000|Overall Study|Moved to another country|0|||
19631096|NCT00763971|42080335|FG001|Overall Study|Moved to another country|1|||
19631097|NCT00763971|42080336|FG002|Overall Study|Moved to another country|0|||
19631098|NCT00763971|42080334|FG000|Overall Study|Subject wanted dose reduction|0|||
19631099|NCT00763971|42080335|FG001|Overall Study|Subject wanted dose reduction|1|||
19631100|NCT00763971|42080336|FG002|Overall Study|Subject wanted dose reduction|0|||
19631101|NCT00763971|42080334|FG000|Overall Study|Lack of availability|0|||
19456098|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456099|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456100|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456101|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456102|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456103|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456104|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
19456105|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
19456106|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456107|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456108|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456109|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456110|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456111|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456112|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456113|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456114|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456115|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
19537547|NCT01340872|41985805|FG002|Open-label Phase|Worsening of IBD|1|||
19537548|NCT01340872|41985806|FG003|Open-label Phase|Worsening of IBD|0|||
19537549|NCT01340794|41985820|FG000|Overall Study|Withdrawal by Subject|0|||
19537550|NCT01340794|41985821|FG001|Overall Study|Withdrawal by Subject|1|||
19537551|NCT01340482|41985832|FG000|Overall Study|Adverse Event|2|||
19537552|NCT01340482|41985833|FG001|Overall Study|Adverse Event|0|||
19537553|NCT01340482|41985834|FG002|Overall Study|Adverse Event|0|||
19537554|NCT01340209|41985847|FG000|Overall Study|Adverse Event|1|||
19631102|NCT00763971|42080335|FG001|Overall Study|Lack of availability|1|||
19631103|NCT00763971|42080336|FG002|Overall Study|Lack of availability|0|||
19537555|NCT01340209|41985848|FG001|Overall Study|Adverse Event|1|||
19537556|NCT01340209|41985849|FG002|Overall Study|Adverse Event|2|||
19537557|NCT01340209|41985847|FG000|Overall Study|Protocol Violation|1|||
19537558|NCT01340209|41985848|FG001|Overall Study|Protocol Violation|2|||
19537559|NCT01340209|41985849|FG002|Overall Study|Protocol Violation|1|||
19537560|NCT01340209|41985847|FG000|Overall Study|Withdrawal by Subject|0|||
19537561|NCT01340209|41985848|FG001|Overall Study|Withdrawal by Subject|0|||
19537562|NCT01340209|41985849|FG002|Overall Study|Withdrawal by Subject|1|||
19537563|NCT01340209|41985847|FG000|Overall Study|Other reason not defined above|3|||
19537564|NCT01340209|41985848|FG001|Overall Study|Other reason not defined above|5|||
19537565|NCT01340209|41985849|FG002|Overall Study|Other reason not defined above|4|||
19537566|NCT01326910|41985859|FG000|Overall Study|Withdrawal by Subject|3|||
19537567|NCT01326910|41985860|FG001|Overall Study|Withdrawal by Subject|2|||
19537568|NCT01326910|41985859|FG000|Overall Study|Protocol Violation|1|||
19537569|NCT01326910|41985860|FG001|Overall Study|Protocol Violation|1|||
19537570|NCT01326481|41985866|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
19537571|NCT01325701|41985874|FG000|Overall Study|Adverse Event|12|||
19537572|NCT01325701|41985875|FG001|Overall Study|Adverse Event|0|||
19537573|NCT01325701|41985874|FG000|Overall Study|Protocol Violation|1|||
19537574|NCT01325701|41985875|FG001|Overall Study|Protocol Violation|0|||
19537575|NCT01325701|41985874|FG000|Overall Study|Physician Decision|2|||
19537576|NCT01325701|41985875|FG001|Overall Study|Physician Decision|2|||
19537577|NCT01325701|41985874|FG000|Overall Study|Withdrawal by Subject|2|||
19537578|NCT01325701|41985875|FG001|Overall Study|Withdrawal by Subject|1|||
19537579|NCT01325701|41985874|FG000|Overall Study|Rollerover Extension Study|4|||
19537580|NCT01325701|41985875|FG001|Overall Study|Rollerover Extension Study|0|||
19537581|NCT01325623|41985882|FG000|Overall Study|Withdrawal by Subject|3|||
19537582|NCT01325584|41985919|FG000|Overall Study|Death|1|||
19537583|NCT01325428|41985923|FG000|Part A|Progressive disease according to RECIST|9|||
19537584|NCT01325428|41985923|FG000|Part A|Clinical signs, symptoms of progression|2|||
19537585|NCT01325428|41985923|FG000|Part A|Other adverse event|1|||
19537586|NCT01325428|41985923|FG000|Part A|Refused continue taking trial medication|2|||
19537587|NCT01325428|41985923|FG000|Part A|Other reason not defined above|2|||
19537588|NCT01325428|41985923|FG000|Part B|Refused continue taking trial medication|2|||
19537589|NCT01325428|41985923|FG000|Part B|Other reason not defined above|1|||
19537590|NCT01325350|41985937|FG000|Overall Study|Adverse Event|3|||
19537591|NCT01325350|41985938|FG001|Overall Study|Adverse Event|3|||
19537592|NCT01325350|41985939|FG002|Overall Study|Adverse Event|3|||
19456116|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456117|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456118|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
19456119|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
19456120|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
19456121|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
19456122|NCT01609556|41706425|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456123|NCT01609556|41706426|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456124|NCT01609556|41706427|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456125|NCT01609556|41706428|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456126|NCT01609556|41706429|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456127|NCT01609556|41706430|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456128|NCT01609556|41706431|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456129|NCT01609556|41706432|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456130|NCT01609556|41706433|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456131|NCT01609556|41706434|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456132|NCT01609556|41706435|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456133|NCT01609556|41706436|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19537593|NCT01325350|41985940|FG003|Overall Study|Adverse Event|1|||
19537594|NCT01325350|41985941|FG004|Overall Study|Adverse Event|2|||
19537595|NCT01325350|41985937|FG000|Overall Study|Pregnancy|0|||
19537596|NCT01325350|41985938|FG001|Overall Study|Pregnancy|0|||
19537597|NCT01325350|41985939|FG002|Overall Study|Pregnancy|1|||
19537598|NCT01325350|41985940|FG003|Overall Study|Pregnancy|0|||
19537599|NCT01325350|41985941|FG004|Overall Study|Pregnancy|1|||
19537600|NCT01325350|41985937|FG000|Overall Study|Lost to Follow-up|1|||
19537601|NCT01325350|41985938|FG001|Overall Study|Lost to Follow-up|0|||
19537602|NCT01325350|41985939|FG002|Overall Study|Lost to Follow-up|5|||
19537603|NCT01325350|41985940|FG003|Overall Study|Lost to Follow-up|1|||
19537604|NCT01325350|41985941|FG004|Overall Study|Lost to Follow-up|5|||
19537605|NCT01325350|41985937|FG000|Overall Study|Personal Reasons|2|||
19537606|NCT01325350|41985938|FG001|Overall Study|Personal Reasons|1|||
19456134|NCT01609556|41706437|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
19537607|NCT01325350|41985939|FG002|Overall Study|Personal Reasons|6|||
19537608|NCT01325350|41985940|FG003|Overall Study|Personal Reasons|5|||
19537609|NCT01325350|41985941|FG004|Overall Study|Personal Reasons|3|||
19537610|NCT01325350|41985937|FG000|Overall Study|Protocol Violation|0|||
19537611|NCT01325350|41985938|FG001|Overall Study|Protocol Violation|0|||
19537612|NCT01325350|41985939|FG002|Overall Study|Protocol Violation|0|||
19537613|NCT01325350|41985940|FG003|Overall Study|Protocol Violation|1|||
19537614|NCT01325350|41985941|FG004|Overall Study|Protocol Violation|0|||
19537615|NCT01325350|41985937|FG000|Overall Study|Withdrawal by Subject|0|||
19537616|NCT01325350|41985938|FG001|Overall Study|Withdrawal by Subject|0|||
19537617|NCT01325350|41985939|FG002|Overall Study|Withdrawal by Subject|1|||
19537618|NCT01325350|41985940|FG003|Overall Study|Withdrawal by Subject|1|||
19537619|NCT01325350|41985941|FG004|Overall Study|Withdrawal by Subject|0|||
19537620|NCT01325350|41985937|FG000|Overall Study|Did Not Receive Treatment|0|||
19537621|NCT01325350|41985938|FG001|Overall Study|Did Not Receive Treatment|1|||
19537622|NCT01325350|41985939|FG002|Overall Study|Did Not Receive Treatment|1|||
19537623|NCT01325350|41985940|FG003|Overall Study|Did Not Receive Treatment|0|||
19537624|NCT01325350|41985941|FG004|Overall Study|Did Not Receive Treatment|1|||
19537625|NCT01324999|41985953|FG000|Overall Study|Adverse Event|3|||
19537626|NCT01324999|41985953|FG000|Overall Study|Withdrawal by Subject|2|||
19537627|NCT01324570|41985959|FG000|Overall Study|Adverse Event|4|||
19537628|NCT01324570|41985960|FG001|Overall Study|Adverse Event|7|||
19537629|NCT01324570|41985959|FG000|Overall Study|Withdrawal by Subject|0|||
19537630|NCT01324570|41985960|FG001|Overall Study|Withdrawal by Subject|3|||
19537631|NCT01324570|41985959|FG000|Overall Study|Lack of Efficacy|0|||
19537632|NCT01324570|41985960|FG001|Overall Study|Lack of Efficacy|1|||
19537633|NCT01324570|41985959|FG000|Overall Study|Confirmed or suspected diversion|0|||
19537634|NCT01324570|41985960|FG001|Overall Study|Confirmed or suspected diversion|1|||
19537635|NCT01324570|41985959|FG000|Overall Study|Administrative|0|||
19537636|NCT01324570|41985960|FG001|Overall Study|Administrative|2|||
19537637|NCT01324141|41985968|FG000|Overall Study|Declined to participate before treatment started|1|||
19537638|NCT01324141|41985968|FG000|Overall Study|Disease progression on study|1|||
19537639|NCT01324102|41985984|FG000|Overall Study|illness|1|||
19537640|NCT01324102|41985985|FG001|Overall Study|illness|6|||
19537641|NCT01324024|41985992|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
19537642|NCT01324024|41985993|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
19537643|NCT01323946|41986006|FG000|Overall Study|Lost to Follow-up|0|||
19537644|NCT01323946|41986007|FG001|Overall Study|Lost to Follow-up|1|||
19537645|NCT01323946|41986008|FG002|Overall Study|Lost to Follow-up|0|||
19537646|NCT01323946|41986006|FG000|Overall Study|Parents refused the last blood draw|1|||
19456135|NCT01609556|41706438|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456136|NCT01609556|41706439|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456137|NCT01609556|41706440|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
19456138|NCT01806506|41706483|FG000|Overall Study|Lost to Follow-up|2|||
19456139|NCT01806506|41706484|FG001|Overall Study|Lost to Follow-up|1|||
19456140|NCT01766336|41706492|FG000|Overall Study|Adverse Event|11|||
19456141|NCT01766336|41706493|FG001|Overall Study|Adverse Event|8|||
19456142|NCT01766336|41706492|FG000|Overall Study|Death|4|||
19456143|NCT01766336|41706493|FG001|Overall Study|Death|3|||
19456144|NCT01766336|41706492|FG000|Overall Study|Lost to Follow-up|1|||
19456145|NCT01766336|41706493|FG001|Overall Study|Lost to Follow-up|3|||
19537647|NCT01323946|41986007|FG001|Overall Study|Parents refused the last blood draw|0|||
19537648|NCT01323946|41986008|FG002|Overall Study|Parents refused the last blood draw|0|||
19537649|NCT01323946|41986006|FG000|Overall Study|Withdrawal by Subject|2|||
19537650|NCT01323946|41986007|FG001|Overall Study|Withdrawal by Subject|2|||
19537651|NCT01323946|41986008|FG002|Overall Study|Withdrawal by Subject|0|||
19537652|NCT01323790|41986021|FG000|Overall Study|Other|3|||
19537653|NCT01323790|41986022|FG001|Overall Study|Other|2|||
19537654|NCT01323790|41986023|FG002|Overall Study|Other|1|||
19537655|NCT01323790|41986021|FG000|Overall Study|Lost to Follow-up|11|||
19456146|NCT01766336|41706492|FG000|Overall Study|Physician Decision|4|||
19456147|NCT01766336|41706493|FG001|Overall Study|Physician Decision|2|||
19456148|NCT01766336|41706492|FG000|Overall Study|Protocol Violation|0|||
19456149|NCT01766336|41706493|FG001|Overall Study|Protocol Violation|1|||
19456150|NCT01766336|41706492|FG000|Overall Study|Sponsor Decision|52|||
19456151|NCT01766336|41706493|FG001|Overall Study|Sponsor Decision|43|||
19456152|NCT01766336|41706492|FG000|Overall Study|Withdrawal by Subject|18|||
19456153|NCT01766336|41706493|FG001|Overall Study|Withdrawal by Subject|15|||
19456154|NCT01797536|41706503|FG000|Overall Study|Adverse Event|0|||
19456155|NCT01797536|41706504|FG001|Overall Study|Adverse Event|1|||
19456156|NCT01797536|41706505|FG002|Overall Study|Adverse Event|0|||
19456157|NCT01797536|41706506|FG003|Overall Study|Adverse Event|0|||
19456158|NCT01797302|41706519|FG000|Overall Study|Lost to Follow-up|16|||
19456159|NCT01797302|41706520|FG001|Overall Study|Lost to Follow-up|23|||
19456160|NCT01797302|41706521|FG002|Overall Study|Lost to Follow-up|22|||
19456161|NCT01797302|41706519|FG000|Overall Study|Withdrawal by Subject|1|||
19456162|NCT01797302|41706520|FG001|Overall Study|Withdrawal by Subject|3|||
19456163|NCT01797302|41706521|FG002|Overall Study|Withdrawal by Subject|4|||
19537656|NCT01323790|41986022|FG001|Overall Study|Lost to Follow-up|9|||
19537657|NCT01323790|41986023|FG002|Overall Study|Lost to Follow-up|9|||
19537658|NCT01323790|41986021|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
19537659|NCT01323790|41986022|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
19537660|NCT01323790|41986023|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
19456164|NCT01805180|41706531|FG000|Lead-in Donor Phase|screen failure|1|||
19456165|NCT01805180|41706532|FG001|Lead-in Donor Phase|screen failure|0|||
19456166|NCT01805180|41706533|FG002|Lead-in Donor Phase|screen failure|0|||
19456167|NCT01804946|41706543|FG000|Overall Study|Protocol Violation|1|||
19456168|NCT01804946|41706544|FG001|Overall Study|Protocol Violation|0|||
19456169|NCT01804946|41706543|FG000|Overall Study|Adverse Event|0|||
19456170|NCT01804946|41706544|FG001|Overall Study|Adverse Event|1|||
19456171|NCT01804946|41706543|FG000|Overall Study|Insufficient data available|0|||
19456172|NCT01804946|41706544|FG001|Overall Study|Insufficient data available|1|||
19456173|NCT01804946|41706543|FG000|Overall Study|Do not meet inclusion criteria|1|||
19456174|NCT01804946|41706544|FG001|Overall Study|Do not meet inclusion criteria|2|||
19456175|NCT01737398|41706554|FG000|Overall Study|Adverse event or SAE|16|||
19456176|NCT01737398|41706555|FG001|Overall Study|Adverse event or SAE|1|||
19456177|NCT01737398|41706554|FG000|Overall Study|Stopping rule met|2|||
19456178|NCT01737398|41706555|FG001|Overall Study|Stopping rule met|1|||
19456179|NCT01737398|41706554|FG000|Overall Study|Voluntary withdrawal|2|||
19456180|NCT01737398|41706555|FG001|Overall Study|Voluntary withdrawal|3|||
19456181|NCT01737398|41706554|FG000|Overall Study|Ineligibility|1|||
19537661|NCT01323790|41986021|FG000|Overall Study|Lack of Efficacy|3|||
19537662|NCT01323790|41986022|FG001|Overall Study|Lack of Efficacy|0|||
19537663|NCT01323790|41986023|FG002|Overall Study|Lack of Efficacy|3|||
19537664|NCT01323790|41986021|FG000|Overall Study|Adverse Event|11|||
19537665|NCT01323790|41986022|FG001|Overall Study|Adverse Event|24|||
19537666|NCT01323790|41986023|FG002|Overall Study|Adverse Event|12|||
19537667|NCT01323790|41986021|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19537668|NCT01323790|41986022|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
19456182|NCT01737398|41706555|FG001|Overall Study|Ineligibility|0|||
19537669|NCT01323790|41986023|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
19537670|NCT01323790|41986021|FG000|Overall Study|Withdrawal by Subject|23|||
19537671|NCT01323790|41986022|FG001|Overall Study|Withdrawal by Subject|20|||
19537672|NCT01323790|41986023|FG002|Overall Study|Withdrawal by Subject|13|||
19537673|NCT01323790|41986021|FG000|Overall Study|Did Not Receive Treatment|2|||
19537674|NCT01323790|41986022|FG001|Overall Study|Did Not Receive Treatment|0|||
19537675|NCT01323790|41986023|FG002|Overall Study|Did Not Receive Treatment|1|||
19537676|NCT01323790|41986021|FG000|Overall Study|Severe non-compliance with protocol|2|||
19537677|NCT01323790|41986022|FG001|Overall Study|Severe non-compliance with protocol|2|||
19537678|NCT01323790|41986023|FG002|Overall Study|Severe non-compliance with protocol|2|||
19537679|NCT01323673|41986033|FG000|Overall Study|Adverse Event|0|||
19537680|NCT01323673|41986034|FG001|Overall Study|Adverse Event|1|||
19456183|NCT01737398|41706554|FG000|Overall Study|Liver transplant|1|||
19456184|NCT01737398|41706555|FG001|Overall Study|Liver transplant|0|||
19456185|NCT01737398|41706554|FG000|Overall Study|Disease progression|2|||
19456186|NCT01737398|41706555|FG001|Overall Study|Disease progression|3|||
19456187|NCT01737398|41706554|FG000|Overall Study|Sponsor's decision|2|||
19456188|NCT01737398|41706555|FG001|Overall Study|Sponsor's decision|0|||
19456189|NCT01795898|41706564|FG000|Overall Study|Adverse Event|27|||
19537681|NCT01323673|41986033|FG000|Overall Study|Lost to Follow-up|0|||
19537682|NCT01323673|41986034|FG001|Overall Study|Lost to Follow-up|1|||
19537683|NCT01323673|41986033|FG000|Overall Study|Protocol Violation|1|||
19537684|NCT01323673|41986034|FG001|Overall Study|Protocol Violation|0|||
19537685|NCT01323673|41986033|FG000|Overall Study|Withdrawal by Subject|2|||
19537686|NCT01323673|41986034|FG001|Overall Study|Withdrawal by Subject|3|||
19537687|NCT01323634|41986042|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
19537688|NCT01323634|41986043|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
19537689|NCT01323634|41986044|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
19537690|NCT01323634|41986042|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
19537691|NCT01323634|41986043|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
19537692|NCT01323634|41986044|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
19537693|NCT01323634|41986042|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
19537694|NCT01323634|41986043|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
19537695|NCT01323634|41986044|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
19537696|NCT01323634|41986042|FG000|2-week Run-in Period|Physician Decision|5|||
19537697|NCT01323634|41986043|FG001|2-week Run-in Period|Physician Decision|0|||
19537698|NCT01323634|41986044|FG002|2-week Run-in Period|Physician Decision|0|||
19537699|NCT01323634|41986042|FG000|2-week Run-in Period|Protocol Violation|1|||
19537700|NCT01323634|41986043|FG001|2-week Run-in Period|Protocol Violation|0|||
19456190|NCT01795898|41706564|FG000|Overall Study|Lost to Follow-up|20|||
19456191|NCT01795898|41706564|FG000|Overall Study|Withdrawal of consent|6|||
19456192|NCT01795898|41706564|FG000|Overall Study|Diagnosed with metastasis|1|||
19456193|NCT01795898|41706564|FG000|Overall Study|No pain|1|||
19537701|NCT01323634|41986044|FG002|2-week Run-in Period|Protocol Violation|0|||
19537702|NCT01323634|41986042|FG000|2-week Run-in Period|Adverse Event|1|||
19537703|NCT01323634|41986043|FG001|2-week Run-in Period|Adverse Event|0|||
19456194|NCT01795898|41706564|FG000|Overall Study|Death|1|||
19456195|NCT01795898|41706564|FG000|Overall Study|Withdrew consent & had adverse events|3|||
19537704|NCT01323634|41986044|FG002|2-week Run-in Period|Adverse Event|0|||
19537705|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
19537706|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
19537707|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
19537708|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19537709|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
19537710|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
19537711|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
19537712|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
19537713|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
19537714|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
19537715|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
19537716|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
19537717|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
19537718|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
19537719|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
19537720|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
19537721|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
19537722|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
19537723|NCT01323634|41986042|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
19537724|NCT01323634|41986043|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
19537725|NCT01323634|41986044|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
19537726|NCT01323478|41986050|FG000|Overall Study|Adverse Event|7|||
19537727|NCT01323478|41986050|FG000|Overall Study|Lack of Efficacy|4|||
19537728|NCT01323478|41986050|FG000|Overall Study|Non-compliance With Study Product|3|||
19537729|NCT01323478|41986050|FG000|Overall Study|Protocol Violation|1|||
19537730|NCT01323478|41986050|FG000|Overall Study|Withdrawal of Consent|1|||
19537731|NCT01323478|41986050|FG000|Overall Study|Administrative or Other Reasons|8|||
19537732|NCT01322386|41986056|FG000|Overall Study|Protocol Violation|0|||
19537733|NCT01322386|41986057|FG001|Overall Study|Protocol Violation|1|||
19537734|NCT01322386|41986056|FG000|Overall Study|Physician Decision|0|||
19631104|NCT00763971|42080334|FG000|Overall Study|Performed final visit on phone|0|||
19631105|NCT00763971|42080335|FG001|Overall Study|Performed final visit on phone|1|||
19631106|NCT00763971|42080336|FG002|Overall Study|Performed final visit on phone|0|||
19631107|NCT00763971|42080334|FG000|Overall Study|Participation in 489-326 required|1|||
19631108|NCT00763971|42080335|FG001|Overall Study|Participation in 489-326 required|0|||
19631109|NCT00763971|42080336|FG002|Overall Study|Participation in 489-326 required|0|||
19631110|NCT00763815|42080346|FG000|Overall Study|Adverse Event|14|||
19631111|NCT00763815|42080347|FG001|Overall Study|Adverse Event|29|||
19631112|NCT00763815|42080346|FG000|Overall Study|Lack of Efficacy|10|||
19631113|NCT00763815|42080347|FG001|Overall Study|Lack of Efficacy|11|||
19631114|NCT00763815|42080346|FG000|Overall Study|Poor Compliance to Protocol|6|||
19631115|NCT00763815|42080347|FG001|Overall Study|Poor Compliance to Protocol|6|||
19631116|NCT00763815|42080346|FG000|Overall Study|Lost to Follow-up|2|||
19631117|NCT00763815|42080347|FG001|Overall Study|Lost to Follow-up|4|||
19631118|NCT00763815|42080346|FG000|Overall Study|Early Termination|1|||
19631119|NCT00763815|42080347|FG001|Overall Study|Early Termination|0|||
19631120|NCT00763815|42080346|FG000|Overall Study|Familial and Personal Reasons|9|||
19631121|NCT00763815|42080347|FG001|Overall Study|Familial and Personal Reasons|16|||
19631122|NCT00763815|42080346|FG000|Overall Study|Physician Decision|1|||
19537735|NCT01322386|41986057|FG001|Overall Study|Physician Decision|1|||
19537736|NCT01322347|41986067|FG000|Overall Study|Adverse Event|7|||
19537737|NCT01322347|41986068|FG001|Overall Study|Adverse Event|2|||
19631123|NCT00763815|42080347|FG001|Overall Study|Physician Decision|0|||
19631124|NCT00763815|42080346|FG000|Overall Study|Withdrawal by Subject|7|||
19631125|NCT00763815|42080347|FG001|Overall Study|Withdrawal by Subject|12|||
19631126|NCT00763815|42080346|FG000|Overall Study|Protocol Violation|2|||
19631127|NCT00763815|42080347|FG001|Overall Study|Protocol Violation|5|||
19631128|NCT00763815|42080346|FG000|Overall Study|Sponsor's Decision|0|||
19631129|NCT00763815|42080347|FG001|Overall Study|Sponsor's Decision|1|||
19631130|NCT00763269|42080355|FG000|Overall Study|Lost to Follow-up|12|||
19631131|NCT00763269|42080356|FG001|Overall Study|Lost to Follow-up|13|||
19631132|NCT00763035|42080362|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
19631133|NCT00763035|42080363|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
19631134|NCT00763035|42080362|FG000|First Intervention|Adverse Event|0|||
19631135|NCT00763035|42080363|FG001|First Intervention|Adverse Event|1|||
19631136|NCT00763035|42080362|FG000|Second Intervention|Adverse Event|1|||
19631137|NCT00763035|42080363|FG001|Second Intervention|Adverse Event|0|||
19631138|NCT00763035|42080362|FG000|Second Intervention|Physician Decision|2|||
19631139|NCT00763035|42080363|FG001|Second Intervention|Physician Decision|0|||
19631140|NCT00844649|42080371|FG000|Overall Study|Progressive Disease|196|||
19631141|NCT00844649|42080372|FG001|Overall Study|Progressive Disease|245|||
19537738|NCT01322347|41986067|FG000|Overall Study|Death|5|||
19631142|NCT00844649|42080371|FG000|Overall Study|Adverse Event|128|||
19537739|NCT01322347|41986068|FG001|Overall Study|Death|3|||
19537740|NCT01322347|41986067|FG000|Overall Study|Physician Decision|2|||
19537741|NCT01322347|41986068|FG001|Overall Study|Physician Decision|1|||
19537742|NCT01322347|41986067|FG000|Overall Study|Protocol Violation|5|||
19537743|NCT01322347|41986068|FG001|Overall Study|Protocol Violation|2|||
19537744|NCT01322347|41986067|FG000|Overall Study|Withdrawal by Subject|1|||
19537745|NCT01322347|41986068|FG001|Overall Study|Withdrawal by Subject|4|||
19537746|NCT01322347|41986067|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
19456196|NCT01795898|41706564|FG000|Overall Study|Physician Decision|1|||
19456197|NCT01736696|41706575|FG000|Overall Study|Withdrawal by Subject|0|||
19456198|NCT01736696|41706576|FG001|Overall Study|Withdrawal by Subject|0|||
19456199|NCT01736696|41706577|FG002|Overall Study|Withdrawal by Subject|1|||
19456200|NCT01736696|41706578|FG003|Overall Study|Withdrawal by Subject|0|||
19456201|NCT01736696|41706579|FG004|Overall Study|Withdrawal by Subject|0|||
19456202|NCT01736696|41706580|FG005|Overall Study|Withdrawal by Subject|0|||
19456203|NCT01736696|41706581|FG006|Overall Study|Withdrawal by Subject|0|||
19456204|NCT01736540|41706605|FG000|Overall Study|Did not complete scan within 45 days|2|||
19456205|NCT01736540|41706605|FG000|Overall Study|Death|1|||
19456206|NCT01736540|41706605|FG000|Overall Study|Abnormal test procedure|1|||
19456207|NCT01736540|41706605|FG000|Overall Study|Withdrawal by Subject|5|||
19456208|NCT01736540|41706605|FG000|Overall Study|Protocol Violation|1|||
19456209|NCT01736540|41706605|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
19456210|NCT01736540|41706605|FG000|Overall Study|No show for MRI appointment|1|||
19456211|NCT01736540|41706605|FG000|Overall Study|Unable to make MRI appointment|3|||
19456212|NCT01794338|41706618|FG000|Overall Study|Death|2|||
19456213|NCT01794338|41706619|FG001|Overall Study|Death|0|||
19456214|NCT01794338|41706618|FG000|Overall Study|Lost to Follow-up|6|||
19456215|NCT01794338|41706619|FG001|Overall Study|Lost to Follow-up|9|||
19456216|NCT01609478|41706628|FG000|Overall Study|Adverse Event|3|||
19456217|NCT01609478|41706629|FG001|Overall Study|Adverse Event|1|||
19456218|NCT01609478|41706630|FG002|Overall Study|Adverse Event|5|||
19456219|NCT01609478|41706628|FG000|Overall Study|Protocol Deviation|0|||
19456220|NCT01609478|41706629|FG001|Overall Study|Protocol Deviation|1|||
19456221|NCT01609478|41706630|FG002|Overall Study|Protocol Deviation|1|||
19456222|NCT01609478|41706628|FG000|Overall Study|Non-Compliance with study treatment|1|||
19456223|NCT01609478|41706629|FG001|Overall Study|Non-Compliance with study treatment|0|||
19456224|NCT01609478|41706630|FG002|Overall Study|Non-Compliance with study treatment|0|||
19456225|NCT01609478|41706628|FG000|Overall Study|Physician Decision|1|||
19456226|NCT01609478|41706629|FG001|Overall Study|Physician Decision|0|||
19456227|NCT01609478|41706630|FG002|Overall Study|Physician Decision|1|||
19456228|NCT01609478|41706628|FG000|Overall Study|Withdrawal by Subject|2|||
19456229|NCT01609478|41706629|FG001|Overall Study|Withdrawal by Subject|0|||
19456230|NCT01609478|41706630|FG002|Overall Study|Withdrawal by Subject|2|||
19456231|NCT01764854|41706642|FG000|Overall Study|Adverse Event|0|||
19456232|NCT01764854|41706643|FG001|Overall Study|Adverse Event|0|||
19456233|NCT01764854|41706644|FG002|Overall Study|Adverse Event|2|||
19456234|NCT01764854|41706645|FG003|Overall Study|Adverse Event|0|||
19456235|NCT01764854|41706642|FG000|Overall Study|Withdrawal by Subject|0|||
19456236|NCT01764854|41706643|FG001|Overall Study|Withdrawal by Subject|0|||
19456237|NCT01764854|41706644|FG002|Overall Study|Withdrawal by Subject|1|||
19456238|NCT01764854|41706645|FG003|Overall Study|Withdrawal by Subject|0|||
19456239|NCT01764854|41706642|FG000|Overall Study|relocation|0|||
19456240|NCT01764854|41706643|FG001|Overall Study|relocation|0|||
19456241|NCT01764854|41706644|FG002|Overall Study|relocation|2|||
19537747|NCT01322347|41986068|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
19537748|NCT01322347|41986067|FG000|Overall Study|blood transfusion|5|||
19537749|NCT01322347|41986068|FG001|Overall Study|blood transfusion|5|||
19537750|NCT01322347|41986067|FG000|Overall Study|sponsor decision|1|||
19537751|NCT01322347|41986068|FG001|Overall Study|sponsor decision|3|||
19537752|NCT01322347|41986067|FG000|Overall Study|ineligible|6|||
19537753|NCT01322347|41986068|FG001|Overall Study|ineligible|3|||
19711513|NCT03568318|42154621|FG005|Overall Study|Adverse Event|0|||
19456242|NCT01764854|41706645|FG003|Overall Study|relocation|0|||
19456243|NCT01764854|41706642|FG000|Overall Study|Protocol Violation|0|||
19456244|NCT01764854|41706643|FG001|Overall Study|Protocol Violation|0|||
19456245|NCT01764854|41706644|FG002|Overall Study|Protocol Violation|1|||
19456246|NCT01764854|41706645|FG003|Overall Study|Protocol Violation|2|||
19456247|NCT01764464|41706657|FG000|First Intervention|Withdrawal by Subject|1|||
19456248|NCT01764464|41706658|FG001|First Intervention|Withdrawal by Subject|0|||
19456249|NCT01764464|41706657|FG000|First Intervention|Lost to Follow-up|1|||
19456250|NCT01764464|41706658|FG001|First Intervention|Lost to Follow-up|0|||
19456251|NCT01764464|41706657|FG000|First Intervention|Adverse Event|0|||
19456252|NCT01764464|41706658|FG001|First Intervention|Adverse Event|2|||
19537754|NCT01322347|41986067|FG000|Overall Study|kidney transplant|3|||
19537755|NCT01322347|41986068|FG001|Overall Study|kidney transplant|1|||
19456253|NCT01764464|41706657|FG000|First Intervention|did not receive study drug|0|||
19537756|NCT01322347|41986067|FG000|Overall Study|study drug withheld > 12 wks|0|||
19537757|NCT01322347|41986068|FG001|Overall Study|study drug withheld > 12 wks|1|||
19456254|NCT01764464|41706658|FG001|First Intervention|did not receive study drug|1|||
19456255|NCT01764464|41706657|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
19456256|NCT01764464|41706658|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
19456257|NCT01764386|41706666|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
19456258|NCT01764386|41706667|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
19456259|NCT01764386|41706666|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
19456260|NCT01764386|41706667|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
19456261|NCT01764386|41706666|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
19456262|NCT01764386|41706667|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
19537758|NCT01322347|41986067|FG000|Overall Study|moved/changed dialysis|2|||
19537759|NCT01322347|41986068|FG001|Overall Study|moved/changed dialysis|4|||
19537760|NCT01321879|41986075|FG000|Overall Study|Lack of Efficacy|5|||
19537761|NCT01321879|41986075|FG000|Overall Study|Adverse Event|5|||
19537762|NCT01321879|41986075|FG000|Overall Study|Death|3|||
19537763|NCT01321879|41986075|FG000|Overall Study|Withdrawal by Subject|1|||
19537764|NCT01321723|41986082|FG000|Overall Study|Adverse Event|3|||
19537765|NCT01321723|41986083|FG001|Overall Study|Adverse Event|5|||
19631143|NCT00844649|42080372|FG001|Overall Study|Adverse Event|73|||
19631144|NCT00844649|42080371|FG000|Overall Study|Physician Decision|25|||
19631145|NCT00844649|42080372|FG001|Overall Study|Physician Decision|18|||
19631146|NCT00844649|42080371|FG000|Overall Study|Protocol Violation|10|||
19631147|NCT00844649|42080372|FG001|Overall Study|Protocol Violation|6|||
19631148|NCT00844649|42080371|FG000|Overall Study|Withdrawal by Subject|28|||
19631149|NCT00844649|42080372|FG001|Overall Study|Withdrawal by Subject|39|||
19631150|NCT00844649|42080371|FG000|Overall Study|Other|7|||
19631151|NCT00844649|42080372|FG001|Overall Study|Other|10|||
19631152|NCT00844649|42080371|FG000|Overall Study|Withdrew prior to starting treatment|11|||
19631153|NCT00844649|42080372|FG001|Overall Study|Withdrew prior to starting treatment|27|||
19631154|NCT00762723|42080383|FG000|Overall Study|Study Terminated slow enrollement|5|||
19631155|NCT00762723|42080384|FG001|Overall Study|Study Terminated slow enrollement|5|||
19631156|NCT00762723|42080385|FG002|Overall Study|Study Terminated slow enrollement|3|||
19631157|NCT00850343|42080397|FG000|Overall Study|Withdrawal by Subject|11|||
19631158|NCT00850343|42080398|FG001|Overall Study|Withdrawal by Subject|0|||
19631159|NCT00850343|42080399|FG002|Overall Study|Withdrawal by Subject|3|||
19631160|NCT00850343|42080400|FG003|Overall Study|Withdrawal by Subject|2|||
19631161|NCT00850343|42080397|FG000|Overall Study|Adverse Event|15|||
19631162|NCT00850343|42080398|FG001|Overall Study|Adverse Event|2|||
19631163|NCT00850343|42080399|FG002|Overall Study|Adverse Event|6|||
19631164|NCT00850343|42080400|FG003|Overall Study|Adverse Event|6|||
19631165|NCT00850343|42080397|FG000|Overall Study|Pregnancy|0|||
19631166|NCT00850343|42080398|FG001|Overall Study|Pregnancy|0|||
19631167|NCT00850343|42080399|FG002|Overall Study|Pregnancy|0|||
19631168|NCT00850343|42080400|FG003|Overall Study|Pregnancy|1|||
19631169|NCT00850343|42080397|FG000|Overall Study|Lack of Efficacy|17|||
19631170|NCT00850343|42080398|FG001|Overall Study|Lack of Efficacy|0|||
19631171|NCT00850343|42080399|FG002|Overall Study|Lack of Efficacy|3|||
19631172|NCT00850343|42080400|FG003|Overall Study|Lack of Efficacy|2|||
19631173|NCT00850343|42080397|FG000|Overall Study|Non-compliance with Study Procedures|1|||
19631174|NCT00850343|42080398|FG001|Overall Study|Non-compliance with Study Procedures|0|||
19631175|NCT00850343|42080399|FG002|Overall Study|Non-compliance with Study Procedures|1|||
19631176|NCT00850343|42080400|FG003|Overall Study|Non-compliance with Study Procedures|1|||
19631177|NCT00850343|42080397|FG000|Overall Study|Physician Decision|2|||
19631178|NCT00850343|42080398|FG001|Overall Study|Physician Decision|1|||
19456263|NCT01764386|41706666|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
19456264|NCT01764386|41706667|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
19456265|NCT01764386|41706666|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
19456266|NCT01764386|41706667|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
19456267|NCT01764386|41706666|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
19456268|NCT01764386|41706667|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
19456269|NCT01764386|41706666|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
19456270|NCT01764386|41706667|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
19456271|NCT01764386|41706666|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
19456272|NCT01764386|41706667|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
19456273|NCT01763996|41706674|FG000|Treatment Period 2|Adverse Event|0|||
19456274|NCT01763996|41706675|FG001|Treatment Period 2|Adverse Event|1|||
19456275|NCT01763918|41706685|FG000|Overall Study|Withdrawal by Subject|2|||
19456276|NCT01763918|41706686|FG001|Overall Study|Withdrawal by Subject|1|||
19456277|NCT01763918|41706687|FG002|Overall Study|Withdrawal by Subject|1|||
19537766|NCT01321723|41986084|FG002|Overall Study|Adverse Event|2|||
19537767|NCT01321723|41986082|FG000|Overall Study|Withdrawal by Subject|2|||
19631179|NCT00850343|42080399|FG002|Overall Study|Physician Decision|1|||
19631180|NCT00850343|42080400|FG003|Overall Study|Physician Decision|1|||
19631181|NCT00849875|42080413|FG000|Overall Study|Death|28|||
19456278|NCT01763918|41706688|FG003|Overall Study|Withdrawal by Subject|2|||
19456279|NCT01763918|41706685|FG000|Overall Study|Sponsor Decision|4|||
19456280|NCT01763918|41706686|FG001|Overall Study|Sponsor Decision|0|||
19456281|NCT01763918|41706687|FG002|Overall Study|Sponsor Decision|9|||
19456282|NCT01763918|41706688|FG003|Overall Study|Sponsor Decision|0|||
19456283|NCT01763684|41706700|FG000|Overall Study|Study terminated early due to low enrollment|126|||
19456284|NCT01763684|41706701|FG001|Overall Study|Study terminated early due to low enrollment|127|||
19456285|NCT01763684|41706700|FG000|Overall Study|Study surgery not performed|7|||
19456286|NCT01763684|41706701|FG001|Overall Study|Study surgery not performed|6|||
19456287|NCT01606748|41706709|FG000|Overall Study|Adverse Event|1|||
19456288|NCT01606748|41706710|FG001|Overall Study|Adverse Event|0|||
19456289|NCT01606748|41706709|FG000|Overall Study|Progressive Disease|1|||
19456290|NCT01606748|41706710|FG001|Overall Study|Progressive Disease|0|||
19456291|NCT01606748|41706709|FG000|Overall Study|Withdrawal by Subject|1|||
19456292|NCT01606748|41706710|FG001|Overall Study|Withdrawal by Subject|0|||
19456293|NCT01597622|41706728|FG000|Overall Study|Adverse Event|7|||
19456294|NCT01597622|41706728|FG000|Overall Study|Lack of Efficacy|3|||
19537768|NCT01321723|41986083|FG001|Overall Study|Withdrawal by Subject|0|||
19537769|NCT01321723|41986084|FG002|Overall Study|Withdrawal by Subject|2|||
19537770|NCT01321606|41986094|FG000|Overall Study|Lost to Follow-up|0|||
19537771|NCT01321606|41986095|FG001|Overall Study|Lost to Follow-up|0|||
19537772|NCT01321606|41986096|FG002|Overall Study|Lost to Follow-up|0|||
19537773|NCT01321606|41986097|FG003|Overall Study|Lost to Follow-up|1|||
19456295|NCT01597622|41706728|FG000|Overall Study|Protocol Violation|1|||
19456296|NCT01597622|41706728|FG000|Overall Study|Lost to Follow-up|1|||
19456297|NCT01597622|41706728|FG000|Overall Study|Investigator Discretion|5|||
19456298|NCT01597622|41706728|FG000|Overall Study|Withdrawal by Subject|20|||
19456299|NCT01597622|41706728|FG000|Overall Study|Death|1|||
19456300|NCT01761266|41706734|FG000|Overall Study|Death|415|||
19456301|NCT01761266|41706735|FG001|Overall Study|Death|402|||
19456302|NCT01761266|41706734|FG000|Overall Study|Lost to Follow-up|8|||
19456303|NCT01761266|41706735|FG001|Overall Study|Lost to Follow-up|12|||
19456304|NCT01761266|41706734|FG000|Overall Study|Withdrawal by Subject|14|||
19456305|NCT01761266|41706735|FG001|Overall Study|Withdrawal by Subject|10|||
19456306|NCT01761266|41706734|FG000|Overall Study|Sponsor Decision|41|||
19456307|NCT01761266|41706735|FG001|Overall Study|Sponsor Decision|52|||
19456308|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
19456309|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
19456310|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
19456311|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
19456312|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Adverse Event|5|||
19537774|NCT01320943|41986109|FG000|Overall Study|Lost to Follow-up|1|||
19537775|NCT01320943|41986110|FG001|Overall Study|Lost to Follow-up|0|||
19537776|NCT01320943|41986109|FG000|Overall Study|Physician Decision|0|||
19537777|NCT01320943|41986110|FG001|Overall Study|Physician Decision|1|||
19631182|NCT00849875|42080413|FG000|Overall Study|Ongoing (unknown completion status)|11|||
19631183|NCT00849875|42080413|FG000|Overall Study|Others|6|||
19631184|NCT00849875|42080413|FG000|Overall Study|Lost to Follow-up|2|||
19537778|NCT01320943|41986109|FG000|Overall Study|Randomized but not Treated|0|||
19537779|NCT01320943|41986110|FG001|Overall Study|Randomized but not Treated|1|||
19537780|NCT02482233|41986125|FG000|Overall Study|Lost to Follow-up|1|||
19537781|NCT02482233|41986126|FG001|Overall Study|Lost to Follow-up|1|||
19537782|NCT01320202|41986136|FG000|Overall Study|Adverse Event|5|||
19537783|NCT01320202|41986137|FG001|Overall Study|Adverse Event|5|||
19537784|NCT01320202|41986136|FG000|Overall Study|Death|5|||
19537785|NCT01320202|41986137|FG001|Overall Study|Death|3|||
19537786|NCT01320202|41986136|FG000|Overall Study|Lost to Follow-up|1|||
19537787|NCT01320202|41986137|FG001|Overall Study|Lost to Follow-up|0|||
19537788|NCT01320202|41986136|FG000|Overall Study|Physician Decision|3|||
19537789|NCT01320202|41986137|FG001|Overall Study|Physician Decision|1|||
19537790|NCT01320202|41986136|FG000|Overall Study|Protocol Violation|2|||
19631185|NCT00844415|42080424|FG000|Overall Study|Withdrawal by Subject|1|||
19631186|NCT00843635|42080432|FG000|Overall Study|Adverse Event|2|||
19631187|NCT00843635|42080433|FG001|Overall Study|Adverse Event|2|||
19631188|NCT00843635|42080434|FG002|Overall Study|Adverse Event|0|||
19631189|NCT00843167|42080448|FG000|Treatment Period|Adverse Event|1|||
19631190|NCT00843167|42080449|FG001|Treatment Period|Adverse Event|5|||
19631191|NCT00843167|42080448|FG000|Treatment Period|Withdrawal by Subject|2|||
19456313|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Adverse Event|3|||
19456314|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Adverse Event|4|||
19537791|NCT01320202|41986137|FG001|Overall Study|Protocol Violation|1|||
19537792|NCT01320202|41986136|FG000|Overall Study|Withdrawal by Subject|10|||
19537793|NCT01320202|41986137|FG001|Overall Study|Withdrawal by Subject|3|||
19537794|NCT01320202|41986136|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
19631192|NCT00843167|42080449|FG001|Treatment Period|Withdrawal by Subject|3|||
19631193|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
19631194|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
19631195|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
19456315|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Adverse Event|10|||
19456316|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
19456317|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
19456318|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
19456319|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
19456320|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
19456321|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
19631196|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
19631197|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
19631198|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
19631199|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
19631200|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
19631201|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
19631202|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
19631203|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
19631204|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
19631205|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
19631206|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
19631207|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
19631208|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
19631209|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
19631210|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
19631211|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
19631212|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
19537795|NCT01320202|41986137|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
19537796|NCT01320202|41986136|FG000|Overall Study|kidney transplant|1|||
19537797|NCT01320202|41986137|FG001|Overall Study|kidney transplant|2|||
19537798|NCT01320202|41986136|FG000|Overall Study|blood transfusion|1|||
19537799|NCT01320202|41986137|FG001|Overall Study|blood transfusion|7|||
19537800|NCT01320202|41986136|FG000|Overall Study|moved/changed dialysis|5|||
19537801|NCT01320202|41986137|FG001|Overall Study|moved/changed dialysis|2|||
19537802|NCT01320202|41986136|FG000|Overall Study|sponsor request|2|||
19537803|NCT01320202|41986137|FG001|Overall Study|sponsor request|0|||
19537804|NCT01320202|41986136|FG000|Overall Study|ineligible|3|||
19537805|NCT01320202|41986137|FG001|Overall Study|ineligible|0|||
19537806|NCT01320202|41986136|FG000|Overall Study|regained renal function|1|||
19537807|NCT01320202|41986137|FG001|Overall Study|regained renal function|0|||
19537808|NCT01319383|41986146|FG000|Overall Study|No ex vivo or in vivo response|4|||
19537809|NCT01319383|41986147|FG001|Overall Study|No ex vivo or in vivo response|0|||
19537810|NCT01319383|41986146|FG000|Overall Study|Physician Decision|3|||
19537811|NCT01319383|41986147|FG001|Overall Study|Physician Decision|0|||
19537812|NCT01319383|41986146|FG000|Overall Study|Lack of Efficacy|5|||
19537813|NCT01319383|41986147|FG001|Overall Study|Lack of Efficacy|9|||
19537814|NCT01319383|41986146|FG000|Overall Study|No in vivo response to interval doses|0|||
19537815|NCT01319383|41986147|FG001|Overall Study|No in vivo response to interval doses|1|||
19537816|NCT01316614|41986164|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
19537817|NCT01316614|41986164|FG000|Overall Study|Cytology slides not available for review|4|||
19537818|NCT01316614|41986164|FG000|Overall Study|Cystic lesion|5|||
19537819|NCT01316614|41986164|FG000|Overall Study|Inadequate number of passes|2|||
19537820|NCT01316614|41986164|FG000|Overall Study|Medically unstable|1|||
19537821|NCT01316575|41986171|FG000|Overall Study|Withdrawal by Subject|2|||
19537822|NCT01316575|41986172|FG001|Overall Study|Withdrawal by Subject|0|||
19537823|NCT01316575|41986171|FG000|Overall Study|Required alternate treatment|0|||
19537824|NCT01316575|41986172|FG001|Overall Study|Required alternate treatment|1|||
19537825|NCT01315678|41986180|FG000|Overall Study|Withdrawal by Subject|7|||
19537826|NCT01315678|41986181|FG001|Overall Study|Withdrawal by Subject|3|||
19537827|NCT01315678|41986180|FG000|Overall Study|Adverse Event|3|||
19537828|NCT01315678|41986181|FG001|Overall Study|Adverse Event|1|||
19537829|NCT01315678|41986180|FG000|Overall Study|Lost to Follow-up|1|||
19537830|NCT01315678|41986181|FG001|Overall Study|Lost to Follow-up|0|||
19537831|NCT01315678|41986180|FG000|Overall Study|similar reason to those listed above|3|||
19537832|NCT01315678|41986181|FG001|Overall Study|similar reason to those listed above|2|||
19537833|NCT01315249|41986191|FG000|Overall Study|Adverse Event|22|||
19537834|NCT01315249|41986192|FG001|Overall Study|Adverse Event|26|||
19537835|NCT01315249|41986191|FG000|Overall Study|Withdrawal by Subject|11|||
19537836|NCT01315249|41986192|FG001|Overall Study|Withdrawal by Subject|10|||
19537837|NCT01315249|41986191|FG000|Overall Study|Protocol Violation|8|||
19537838|NCT01315249|41986192|FG001|Overall Study|Protocol Violation|5|||
19537839|NCT01315249|41986191|FG000|Overall Study|Abnormal test results|1|||
19537840|NCT01315249|41986192|FG001|Overall Study|Abnormal test results|2|||
19537841|NCT01315249|41986191|FG000|Overall Study|Administrative problems|1|||
19631213|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
19456322|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
19456323|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
19456324|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Pregnancy|5|||
19456325|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Pregnancy|0|||
19456326|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Pregnancy|3|||
19456327|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Pregnancy|2|||
19456328|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Non-compliance|1|||
19456329|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Non-compliance|4|||
19456330|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Non-compliance|0|||
19537842|NCT01315249|41986192|FG001|Overall Study|Administrative problems|0|||
19537843|NCT01315249|41986191|FG000|Overall Study|inability to use device|1|||
19537844|NCT01315249|41986192|FG001|Overall Study|inability to use device|0|||
19537845|NCT01315249|41986191|FG000|Overall Study|Lack of Efficacy|0|||
19537846|NCT01315249|41986192|FG001|Overall Study|Lack of Efficacy|1|||
19537847|NCT01315249|41986191|FG000|Overall Study|Lost to Follow-up|0|||
19537848|NCT01315249|41986192|FG001|Overall Study|Lost to Follow-up|2|||
19537849|NCT01315249|41986191|FG000|Overall Study|Death|0|||
19537850|NCT01315249|41986192|FG001|Overall Study|Death|1|||
19537851|NCT01315132|41986198|FG000|Overall Study|not treated due to disease progression|1|||
19537852|NCT01313767|41986204|FG000|Overall Study|Adverse Event|1|||
19537853|NCT01313767|41986205|FG001|Overall Study|Adverse Event|0|||
19537854|NCT01313767|41986204|FG000|Overall Study|Lost to Follow-up|1|||
19537855|NCT01313767|41986205|FG001|Overall Study|Lost to Follow-up|0|||
19537856|NCT01313767|41986204|FG000|Overall Study|Withdrawal by Subject|2|||
19537857|NCT01313767|41986205|FG001|Overall Study|Withdrawal by Subject|1|||
19537858|NCT01313767|41986204|FG000|Overall Study|Protocol Violation|3|||
19537859|NCT01313767|41986205|FG001|Overall Study|Protocol Violation|1|||
19537860|NCT01313728|41986211|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
19537861|NCT01313650|41986220|FG000|Overall Study|Adverse Event|9|||
19537862|NCT01313650|41986221|FG001|Overall Study|Adverse Event|34|||
19537863|NCT01313650|41986222|FG002|Overall Study|Adverse Event|24|||
19537864|NCT01313650|41986223|FG003|Overall Study|Adverse Event|23|||
19537865|NCT01313650|41986220|FG000|Overall Study|Lack of Efficacy|37|||
19537866|NCT01313650|41986221|FG001|Overall Study|Lack of Efficacy|20|||
19537867|NCT01313650|41986222|FG002|Overall Study|Lack of Efficacy|32|||
19537868|NCT01313650|41986223|FG003|Overall Study|Lack of Efficacy|20|||
19537869|NCT01313650|41986220|FG000|Overall Study|Lost to Follow-up|1|||
19537870|NCT01313650|41986221|FG001|Overall Study|Lost to Follow-up|0|||
19537871|NCT01313650|41986222|FG002|Overall Study|Lost to Follow-up|3|||
19537872|NCT01313650|41986223|FG003|Overall Study|Lost to Follow-up|2|||
19537873|NCT01313650|41986220|FG000|Overall Study|Withdrawal by Subject|16|||
19537874|NCT01313650|41986221|FG001|Overall Study|Withdrawal by Subject|20|||
19537875|NCT01313650|41986222|FG002|Overall Study|Withdrawal by Subject|15|||
19537876|NCT01313650|41986223|FG003|Overall Study|Withdrawal by Subject|15|||
19537877|NCT01313650|41986220|FG000|Overall Study|Protocol Violation|4|||
19537878|NCT01313650|41986221|FG001|Overall Study|Protocol Violation|7|||
19537879|NCT01313650|41986222|FG002|Overall Study|Protocol Violation|5|||
19537880|NCT01313650|41986223|FG003|Overall Study|Protocol Violation|6|||
19537881|NCT01313650|41986220|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
19537882|NCT01313650|41986221|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
19537883|NCT01313650|41986222|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
19537884|NCT01313650|41986223|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
19537885|NCT01313299|41986236|FG000|Overall Study|Adverse Event|3|||
19537886|NCT01313299|41986237|FG001|Overall Study|Adverse Event|1|||
19537887|NCT01313299|41986238|FG002|Overall Study|Adverse Event|1|||
19537888|NCT01313299|41986236|FG000|Overall Study|Lost to Follow-up|1|||
19537889|NCT01313299|41986237|FG001|Overall Study|Lost to Follow-up|0|||
19537890|NCT01313299|41986238|FG002|Overall Study|Lost to Follow-up|0|||
19537891|NCT01313299|41986236|FG000|Overall Study|Protocol Violation|2|||
19537892|NCT01313299|41986237|FG001|Overall Study|Protocol Violation|0|||
19537893|NCT01313299|41986238|FG002|Overall Study|Protocol Violation|0|||
19537894|NCT01313299|41986236|FG000|Overall Study|Withdrawal by Subject|1|||
19537895|NCT01313299|41986237|FG001|Overall Study|Withdrawal by Subject|0|||
19537896|NCT01313299|41986238|FG002|Overall Study|Withdrawal by Subject|2|||
19537897|NCT01313299|41986236|FG000|Overall Study|Family reason and moved out of state|0|||
19537898|NCT01313299|41986237|FG001|Overall Study|Family reason and moved out of state|2|||
19537899|NCT01313299|41986238|FG002|Overall Study|Family reason and moved out of state|0|||
19537900|NCT01313299|41986236|FG000|Overall Study|Lack of subject compliance|0|||
19537901|NCT01313299|41986237|FG001|Overall Study|Lack of subject compliance|0|||
19456331|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Non-compliance|3|||
19537902|NCT01313299|41986238|FG002|Overall Study|Lack of subject compliance|1|||
19537903|NCT01313221|41986249|FG000|Overall Study|Protocol Violation|0|||
19537904|NCT01313221|41986250|FG001|Overall Study|Protocol Violation|1|||
19537905|NCT01313221|41986251|FG002|Overall Study|Protocol Violation|1|||
19537906|NCT01313221|41986249|FG000|Overall Study|Non-compliance|3|||
19537907|NCT01313221|41986250|FG001|Overall Study|Non-compliance|0|||
19456332|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Other|0|||
19456333|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Other|3|||
19456334|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Other|3|||
19456335|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Other|1|||
19456336|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
19456337|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
19456338|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
19456339|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
19456340|NCT01760954|41706748|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
19456341|NCT01760954|41706749|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
19456342|NCT01760954|41706750|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
19456343|NCT01760954|41706751|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
19456344|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
19456345|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
19456346|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
19537908|NCT01313221|41986251|FG002|Overall Study|Non-compliance|2|||
19537909|NCT01313221|41986249|FG000|Overall Study|Withdrawal by Subject|2|||
19537910|NCT01313221|41986250|FG001|Overall Study|Withdrawal by Subject|3|||
19537911|NCT01313221|41986251|FG002|Overall Study|Withdrawal by Subject|5|||
19537912|NCT01313221|41986249|FG000|Overall Study|Requirement for alternative therapy|0|||
19537913|NCT01313221|41986250|FG001|Overall Study|Requirement for alternative therapy|1|||
19537914|NCT01313221|41986251|FG002|Overall Study|Requirement for alternative therapy|1|||
19537915|NCT01313221|41986249|FG000|Overall Study|Lost to Follow-up|6|||
19537916|NCT01313221|41986250|FG001|Overall Study|Lost to Follow-up|3|||
19537917|NCT01313221|41986251|FG002|Overall Study|Lost to Follow-up|1|||
19537918|NCT01313221|41986249|FG000|Overall Study|Other|1|||
19537919|NCT01313221|41986250|FG001|Overall Study|Other|0|||
19537920|NCT01313221|41986251|FG002|Overall Study|Other|0|||
19537921|NCT01313221|41986249|FG000|Overall Study|Adverse Event|0|||
19537922|NCT01313221|41986250|FG001|Overall Study|Adverse Event|0|||
19537923|NCT01313221|41986251|FG002|Overall Study|Adverse Event|7|||
19537924|NCT01313221|41986249|FG000|Overall Study|Disease progression|0|||
19537925|NCT01313221|41986250|FG001|Overall Study|Disease progression|0|||
19537926|NCT01313221|41986251|FG002|Overall Study|Disease progression|2|||
19537927|NCT01313221|41986249|FG000|Overall Study|Physician Decision|0|||
19537928|NCT01313221|41986250|FG001|Overall Study|Physician Decision|0|||
19537929|NCT01313221|41986251|FG002|Overall Study|Physician Decision|2|||
19537930|NCT01313221|41986249|FG000|Overall Study|Pregnancy|0|||
19537931|NCT01313221|41986250|FG001|Overall Study|Pregnancy|0|||
19537932|NCT01313221|41986251|FG002|Overall Study|Pregnancy|2|||
19537933|NCT01313182|41986261|FG000|Overall Study|Protocol Violation|66|||
19537934|NCT01313182|41986262|FG001|Overall Study|Protocol Violation|92|||
19537935|NCT01312909|41986271|FG000|Overall Study|Randomized but not treated|1|||
19537936|NCT01312909|41986272|FG001|Overall Study|Randomized but not treated|3|||
19537937|NCT01312909|41986273|FG002|Overall Study|Randomized but not treated|1|||
19537938|NCT01312909|41986271|FG000|Overall Study|Adverse Event|1|||
19537939|NCT01312909|41986272|FG001|Overall Study|Adverse Event|0|||
19537940|NCT01312909|41986273|FG002|Overall Study|Adverse Event|3|||
19537941|NCT01312909|41986271|FG000|Overall Study|Protocol Violation|2|||
19537942|NCT01312909|41986272|FG001|Overall Study|Protocol Violation|0|||
19537943|NCT01312909|41986273|FG002|Overall Study|Protocol Violation|2|||
19537944|NCT01312909|41986271|FG000|Overall Study|Other|9|||
19537945|NCT01312909|41986272|FG001|Overall Study|Other|6|||
19537946|NCT01312909|41986273|FG002|Overall Study|Other|11|||
19537947|NCT01312909|41986271|FG000|Overall Study|Withdrawal by Subject|8|||
19537948|NCT01312909|41986272|FG001|Overall Study|Withdrawal by Subject|10|||
19537949|NCT01312909|41986273|FG002|Overall Study|Withdrawal by Subject|7|||
19537950|NCT01312909|41986271|FG000|Overall Study|Lost to Follow-up|21|||
19537951|NCT01312909|41986272|FG001|Overall Study|Lost to Follow-up|17|||
19537952|NCT01312909|41986273|FG002|Overall Study|Lost to Follow-up|20|||
19537953|NCT01312909|41986271|FG000|Overall Study|Insufficient clinical response|0|||
19537954|NCT01312909|41986272|FG001|Overall Study|Insufficient clinical response|0|||
19537955|NCT01312909|41986273|FG002|Overall Study|Insufficient clinical response|1|||
19537956|NCT01312909|41986271|FG000|Overall Study|Entrance criteria not met|0|||
19537957|NCT01312909|41986272|FG001|Overall Study|Entrance criteria not met|0|||
19537958|NCT01312909|41986273|FG002|Overall Study|Entrance criteria not met|2|||
19537959|NCT01312129|41986283|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
19537960|NCT01312129|41986284|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
19537961|NCT01311661|41986290|FG000|Overall Study|Adverse Event|2|||
19537962|NCT01311661|41986290|FG000|Overall Study|Protocol Violation|3|||
19537963|NCT01311661|41986290|FG000|Overall Study|Withdrawal by Subject|2|||
19537964|NCT01311505|41986302|FG000|First Intervention Period|Protocol Violation|0|||
19711514|NCT03568318|42154616|FG000|Overall Study|Withdrawal by Subject|6|||
19537965|NCT01311505|41986303|FG001|First Intervention Period|Protocol Violation|1|||
19537966|NCT01310803|41986314|FG000|Overall Study|Subject terminated by Sponsor|1|||
19537967|NCT01310803|41986315|FG001|Overall Study|Subject terminated by Sponsor|0|||
19537968|NCT01310413|41986327|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
19456347|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
19456348|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
19456349|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
19456350|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
19456351|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
19456352|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
19456353|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
19456354|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
19456355|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
19537969|NCT01310413|41986328|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
19537970|NCT01310413|41986329|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
19537971|NCT01310413|41986330|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
19537972|NCT01310413|41986331|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
19537973|NCT01310413|41986332|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
19537974|NCT01310413|41986333|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
19537975|NCT01310413|41986327|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
19537976|NCT01310413|41986328|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
19537977|NCT01310413|41986329|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
19537978|NCT01310413|41986330|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
19537979|NCT01310413|41986331|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
19537980|NCT01310413|41986332|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
19537981|NCT01310413|41986333|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
19537982|NCT01310413|41986327|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
19537983|NCT01310413|41986328|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
19537984|NCT01310413|41986329|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
19537985|NCT01310413|41986330|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
19537986|NCT01310413|41986331|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
19537987|NCT01310413|41986332|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
19537988|NCT01310413|41986333|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
19537989|NCT01310413|41986327|FG000|Day 0 to Day 385|Other|1|||
19537990|NCT01310413|41986328|FG001|Day 0 to Day 385|Other|0|||
19537991|NCT01310413|41986329|FG002|Day 0 to Day 385|Other|3|||
19537992|NCT01310413|41986330|FG003|Day 0 to Day 385|Other|0|||
19537993|NCT01310413|41986331|FG004|Day 0 to Day 385|Other|0|||
19537994|NCT01310413|41986332|FG005|Day 0 to Day 385|Other|0|||
19537995|NCT01310413|41986333|FG006|Day 0 to Day 385|Other|0|||
19537996|NCT01310413|41986327|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
19537997|NCT01310413|41986328|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
19537998|NCT01310413|41986329|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
19537999|NCT01310413|41986330|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
19538000|NCT01310413|41986331|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
19456356|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
19456357|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
19456358|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
19456359|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
19456360|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
19456361|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
19456362|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
19456363|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
19456364|NCT01760954|41706748|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
19456365|NCT01760954|41706749|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
19456366|NCT01760954|41706750|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
19456367|NCT01760954|41706751|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
19456368|NCT01760876|41706761|FG000|Overall Study|Non-cardiac death (head injury)|1|||
19456369|NCT01760876|41706761|FG000|Overall Study|Carcinoma of prostate|1|||
19456370|NCT01760876|41706761|FG000|Overall Study|Impaired renal function|1|||
19456371|NCT01760876|41706761|FG000|Overall Study|Major depression|1|||
19456372|NCT01760876|41706761|FG000|Overall Study|Very poor baseline OCT quality|2|||
19456373|NCT01759862|41706767|FG000|Overall Study|Physician Decision|3|||
19456374|NCT01759862|41706768|FG001|Overall Study|Physician Decision|1|||
19456375|NCT01759862|41706767|FG000|Overall Study|Adverse Event|0|||
19456376|NCT01759862|41706768|FG001|Overall Study|Adverse Event|1|||
19456377|NCT01606670|41706774|FG000|Overall Study|Adverse Event|6|||
19456378|NCT01606670|41706774|FG000|Overall Study|Lack of Efficacy|2|||
19538001|NCT01310413|41986332|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
19456379|NCT01606670|41706774|FG000|Overall Study|Lost to Follow-up|3|||
19538002|NCT01310413|41986333|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
19538003|NCT01310413|41986327|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
19538004|NCT01310413|41986328|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
19538005|NCT01310413|41986329|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
19538006|NCT01310413|41986330|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
19538007|NCT01310413|41986331|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
19538008|NCT01310413|41986332|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
19538009|NCT01310413|41986333|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
19538010|NCT01309828|41986364|FG000|Overall Study|Adverse Event|10|||
19538011|NCT01309828|41986365|FG001|Overall Study|Adverse Event|11|||
19538012|NCT01309828|41986364|FG000|Overall Study|Voluntary Withdrawal|5|||
19538013|NCT01309828|41986365|FG001|Overall Study|Voluntary Withdrawal|4|||
19538014|NCT01309828|41986364|FG000|Overall Study|Major Protocol Deviation|0|||
19538015|NCT01309828|41986365|FG001|Overall Study|Major Protocol Deviation|1|||
19538016|NCT01309828|41986364|FG000|Overall Study|Other|1|||
19538017|NCT01309828|41986365|FG001|Overall Study|Other|0|||
19538018|NCT01309282|41986371|FG000|Overall Study|Lost to Follow-up|1|||
19538019|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
19538020|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
19538021|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
19538022|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
19538023|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Death|0|||
19538024|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Death|1|||
19538025|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
19538026|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
19538027|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
19538028|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
19538029|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
19538030|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
19538031|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
19538032|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
19538033|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
19538034|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
19538035|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
19538036|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
19538037|NCT01309243|41986377|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
19538038|NCT01309243|41986378|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
19538039|NCT01309243|41986377|FG000|Extension Phase|Lost to Follow-up|6|||
19538040|NCT01309243|41986378|FG001|Extension Phase|Lost to Follow-up|0|||
19538041|NCT01309204|41986386|FG000|Overall Study|Adverse Event|48|||
19538042|NCT01309204|41986387|FG001|Overall Study|Adverse Event|58|||
19538043|NCT01309204|41986386|FG000|Overall Study|Lost to Follow-up|2|||
19538044|NCT01309204|41986387|FG001|Overall Study|Lost to Follow-up|2|||
19538045|NCT01309204|41986386|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
19538046|NCT01309204|41986387|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
19538047|NCT01309204|41986386|FG000|Overall Study|Inadequate control of IOP|4|||
19538048|NCT01309204|41986387|FG001|Overall Study|Inadequate control of IOP|4|||
19538049|NCT01309204|41986386|FG000|Overall Study|Other|4|||
19538050|NCT01309204|41986387|FG001|Overall Study|Other|1|||
19538051|NCT01309165|41986395|FG000|Overall Study|Lost to Follow-up|4|||
19538052|NCT01309165|41986396|FG001|Overall Study|Lost to Follow-up|3|||
19538053|NCT01309165|41986395|FG000|Overall Study|Return to work|1|||
19538054|NCT01309165|41986396|FG001|Overall Study|Return to work|2|||
19538055|NCT01309165|41986395|FG000|Overall Study|Left country|0|||
19538056|NCT01309165|41986396|FG001|Overall Study|Left country|1|||
19538057|NCT01309165|41986395|FG000|Overall Study|No transportation|0|||
19538058|NCT01309165|41986396|FG001|Overall Study|No transportation|1|||
19538059|NCT01309165|41986395|FG000|Overall Study|Admitted to hospital for second stroke|1|||
19538060|NCT01309165|41986396|FG001|Overall Study|Admitted to hospital for second stroke|0|||
19538061|NCT01308853|41986403|FG000|Overall Study|Adverse Event|1|||
19538062|NCT01308853|41986403|FG000|Overall Study|Lost to Follow-up|2|||
19538063|NCT01308853|41986403|FG000|Overall Study|Insertion of permanent implants|1|||
19538064|NCT01308736|41986409|FG000|Overall Study|Did not attend a single session|6|||
19538065|NCT01308736|41986410|FG001|Overall Study|Did not attend a single session|5|||
19456380|NCT01606670|41706774|FG000|Overall Study|Withdrawal by Subject|3|||
19456381|NCT01606670|41706774|FG000|Overall Study|Other Reason|2|||
19456382|NCT01793792|41706778|FG000|Overall Study|Death|5|||
19456383|NCT01793792|41706778|FG000|Overall Study|Lost to Follow-up|5|||
19456384|NCT01793792|41706778|FG000|Overall Study|Withdrawal by Subject|1|||
19456385|NCT01793792|41706778|FG000|Overall Study|Device Not Implanted|1|||
19456386|NCT01790984|41706784|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
19456387|NCT01790984|41706785|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
19456388|NCT01790984|41706786|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
19456389|NCT01790984|41706787|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
19456390|NCT01735994|41706812|FG000|Overall Study|Withdrawal by Subject|6|||
19456391|NCT01735994|41706813|FG001|Overall Study|Withdrawal by Subject|4|||
19538066|NCT01308580|41986418|FG000|Overall Study|Lost to Follow-up|12|||
19538067|NCT01308580|41986419|FG001|Overall Study|Lost to Follow-up|7|||
19538068|NCT01308463|41986426|FG000|Overall Study|Study Discontinued|23|||
19538069|NCT01308463|41986426|FG000|Overall Study|Death|4|||
19538070|NCT01308463|41986426|FG000|Overall Study|Revision|2|||
19538071|NCT01308424|41986432|FG000|Baseline Eligibility|Screen Failures|71|||
19538072|NCT01308424|41986433|FG001|Baseline Eligibility|Screen Failures|0|||
19538073|NCT01308424|41986434|FG002|Baseline Eligibility|Screen Failures|0|||
19538074|NCT01308424|41986432|FG000|Randomization|Adverse Event|0|||
19538075|NCT01308424|41986433|FG001|Randomization|Adverse Event|1|||
19538076|NCT01308424|41986434|FG002|Randomization|Adverse Event|1|||
19538077|NCT01308424|41986432|FG000|Randomization|Lost to Follow-up|0|||
19538078|NCT01308424|41986433|FG001|Randomization|Lost to Follow-up|1|||
19538079|NCT01308424|41986434|FG002|Randomization|Lost to Follow-up|0|||
19538080|NCT01308424|41986432|FG000|Randomization|Physician Decision|0|||
19538081|NCT01308424|41986433|FG001|Randomization|Physician Decision|1|||
19538082|NCT01308424|41986434|FG002|Randomization|Physician Decision|1|||
19538083|NCT01307800|41986445|FG000|Overall Study|Adverse Event|9|||
19538084|NCT01307800|41986446|FG001|Overall Study|Adverse Event|8|||
19538085|NCT01307800|41986447|FG002|Overall Study|Adverse Event|10|||
19538086|NCT01307800|41986448|FG003|Overall Study|Adverse Event|14|||
19538087|NCT01307800|41986445|FG000|Overall Study|Entry Criteria Not Met|0|||
19538088|NCT01307800|41986446|FG001|Overall Study|Entry Criteria Not Met|0|||
19538089|NCT01307800|41986447|FG002|Overall Study|Entry Criteria Not Met|0|||
19538090|NCT01307800|41986448|FG003|Overall Study|Entry Criteria Not Met|2|||
19538091|NCT01307800|41986445|FG000|Overall Study|Lost to Follow-up|5|||
19538092|NCT01307800|41986446|FG001|Overall Study|Lost to Follow-up|6|||
19538093|NCT01307800|41986447|FG002|Overall Study|Lost to Follow-up|2|||
19538094|NCT01307800|41986448|FG003|Overall Study|Lost to Follow-up|8|||
19538095|NCT01307800|41986445|FG000|Overall Study|Perceived Lack of Efficacy|24|||
19538096|NCT01307800|41986446|FG001|Overall Study|Perceived Lack of Efficacy|23|||
19538097|NCT01307800|41986447|FG002|Overall Study|Perceived Lack of Efficacy|20|||
19538098|NCT01307800|41986448|FG003|Overall Study|Perceived Lack of Efficacy|33|||
19538099|NCT01307800|41986445|FG000|Overall Study|Protocol Violation|0|||
19538100|NCT01307800|41986446|FG001|Overall Study|Protocol Violation|3|||
19538101|NCT01307800|41986447|FG002|Overall Study|Protocol Violation|4|||
19538102|NCT01307800|41986448|FG003|Overall Study|Protocol Violation|5|||
19538103|NCT01307800|41986445|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
19456392|NCT01735994|41706812|FG000|Overall Study|Injury|2|||
19456393|NCT01735994|41706813|FG001|Overall Study|Injury|0|||
19456394|NCT01735994|41706812|FG000|Overall Study|Kicked off team|5|||
19538104|NCT01307800|41986446|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
19538105|NCT01307800|41986447|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
19538106|NCT01307800|41986448|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
19538107|NCT01307800|41986445|FG000|Overall Study|Sponsor Decision|6|||
19538108|NCT01307800|41986446|FG001|Overall Study|Sponsor Decision|9|||
19538109|NCT01307800|41986447|FG002|Overall Study|Sponsor Decision|12|||
19538110|NCT01307800|41986448|FG003|Overall Study|Sponsor Decision|28|||
19538111|NCT01307800|41986445|FG000|Overall Study|Withdrawal by Subject|10|||
19538112|NCT01307800|41986446|FG001|Overall Study|Withdrawal by Subject|11|||
19538113|NCT01307800|41986447|FG002|Overall Study|Withdrawal by Subject|8|||
19538114|NCT01307800|41986448|FG003|Overall Study|Withdrawal by Subject|15|||
19538115|NCT01307800|41986445|FG000|Overall Study|Participant Moved|0|||
19538116|NCT01307800|41986446|FG001|Overall Study|Participant Moved|2|||
19538117|NCT01307800|41986447|FG002|Overall Study|Participant Moved|1|||
19538118|NCT01307800|41986448|FG003|Overall Study|Participant Moved|3|||
19538119|NCT01307449|41986462|FG000|Overall Study|Adverse Event|1|||
19538120|NCT01307449|41986463|FG001|Overall Study|Adverse Event|0|||
19538121|NCT01307449|41986464|FG002|Overall Study|Adverse Event|0|||
19538122|NCT01307449|41986465|FG003|Overall Study|Adverse Event|0|||
19538123|NCT01307020|41986485|FG000|Overall Study|Lost to Follow-up|0|||
19538124|NCT01307020|41986486|FG001|Overall Study|Lost to Follow-up|0|||
19631214|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
19456395|NCT01735994|41706813|FG001|Overall Study|Kicked off team|0|||
19456396|NCT01735994|41706812|FG000|Overall Study|Lost to Follow-up|50|||
19456397|NCT01735994|41706813|FG001|Overall Study|Lost to Follow-up|62|||
19456398|NCT01790828|41706819|FG000|Overall Study|Other|34|||
19456399|NCT01790594|41706825|FG000|Overall Study|Death|1|||
19456400|NCT01790594|41706826|FG001|Overall Study|Death|0|||
19456401|NCT01790594|41706827|FG002|Overall Study|Death|0|||
19538125|NCT01307020|41986487|FG002|Overall Study|Lost to Follow-up|1|||
19538126|NCT01307020|41986488|FG003|Overall Study|Lost to Follow-up|1|||
19538127|NCT01307020|41986489|FG004|Overall Study|Lost to Follow-up|0|||
19538128|NCT01307020|41986490|FG005|Overall Study|Lost to Follow-up|0|||
19538129|NCT01307020|41986491|FG006|Overall Study|Lost to Follow-up|1|||
19538130|NCT01307020|41986492|FG007|Overall Study|Lost to Follow-up|0|||
19538131|NCT01307020|41986493|FG008|Overall Study|Lost to Follow-up|0|||
19456402|NCT01790594|41706825|FG000|Overall Study|Physician Decision|2|||
19538132|NCT01307020|41986494|FG009|Overall Study|Lost to Follow-up|0|||
19456403|NCT01790594|41706826|FG001|Overall Study|Physician Decision|1|||
19456404|NCT01790594|41706827|FG002|Overall Study|Physician Decision|0|||
19456405|NCT01790594|41706825|FG000|Overall Study|Withdrawal by Subject|2|||
19456406|NCT01790594|41706826|FG001|Overall Study|Withdrawal by Subject|0|||
19456407|NCT01790594|41706827|FG002|Overall Study|Withdrawal by Subject|0|||
19456408|NCT01790594|41706825|FG000|Overall Study|Transplant was not done|0|||
19456409|NCT01790594|41706826|FG001|Overall Study|Transplant was not done|0|||
19456410|NCT01790594|41706827|FG002|Overall Study|Transplant was not done|3|||
19456411|NCT01790594|41706825|FG000|Overall Study|Terminated prior to week 76|0|||
19456412|NCT01790594|41706826|FG001|Overall Study|Terminated prior to week 76|2|||
19456413|NCT01790594|41706827|FG002|Overall Study|Terminated prior to week 76|0|||
19456414|NCT01790516|41706836|FG000|Overall Study|Physician Decision|1|||
19456415|NCT01790516|41706837|FG001|Overall Study|Physician Decision|0|||
19456416|NCT01790438|41706845|FG000|Overall Study|Adverse Event|3|||
19456417|NCT01790438|41706846|FG001|Overall Study|Adverse Event|2|||
19456418|NCT01790438|41706845|FG000|Overall Study|Death|4|||
19456419|NCT01790438|41706846|FG001|Overall Study|Death|0|||
19456420|NCT01790438|41706845|FG000|Overall Study|Lost to Follow-up|5|||
19456421|NCT01790438|41706846|FG001|Overall Study|Lost to Follow-up|2|||
19456422|NCT01790438|41706845|FG000|Overall Study|Withdrawal by Subject|13|||
19456423|NCT01790438|41706846|FG001|Overall Study|Withdrawal by Subject|2|||
19456424|NCT01790438|41706845|FG000|Overall Study|Physician Decision|3|||
19456425|NCT01790438|41706846|FG001|Overall Study|Physician Decision|1|||
19456426|NCT01790438|41706845|FG000|Overall Study|Sponsor Decision|0|||
19456427|NCT01790438|41706846|FG001|Overall Study|Sponsor Decision|3|||
19456428|NCT01790438|41706845|FG000|Overall Study|Protocol Required Discontinuation|7|||
19456429|NCT01790438|41706846|FG001|Overall Study|Protocol Required Discontinuation|1|||
19456430|NCT01735916|41706857|FG000|Overall Study|Subject not eligible to be randomized|11|||
19456431|NCT01735916|41706858|FG001|Overall Study|Subject not eligible to be randomized|0|||
19456432|NCT01735916|41706859|FG002|Overall Study|Subject not eligible to be randomized|0|||
19456433|NCT01735916|41706857|FG000|Overall Study|Early termination of study by sponsor|4|||
19456434|NCT01735916|41706858|FG001|Overall Study|Early termination of study by sponsor|19|||
19456435|NCT01735916|41706859|FG002|Overall Study|Early termination of study by sponsor|7|||
19456436|NCT01735916|41706857|FG000|Overall Study|Withdrawal by Subject|3|||
19456437|NCT01735916|41706858|FG001|Overall Study|Withdrawal by Subject|0|||
19456438|NCT01735916|41706859|FG002|Overall Study|Withdrawal by Subject|0|||
19456439|NCT01790126|41706869|FG000|Overall Study|PSA Progression|12|||
19456440|NCT01790126|41706870|FG001|Overall Study|PSA Progression|16|||
19456441|NCT01790126|41706871|FG002|Overall Study|PSA Progression|16|||
19456442|NCT01790126|41706869|FG000|Overall Study|Other|5|||
19456443|NCT01790126|41706870|FG001|Overall Study|Other|4|||
19456444|NCT01790126|41706871|FG002|Overall Study|Other|8|||
19456445|NCT01790126|41706869|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
19456446|NCT01790126|41706870|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
19456447|NCT01790126|41706871|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
19456448|NCT01790126|41706869|FG000|Overall Study|Withdrawal by Physician|1|||
19456449|NCT01790126|41706870|FG001|Overall Study|Withdrawal by Physician|1|||
19456450|NCT01790126|41706871|FG002|Overall Study|Withdrawal by Physician|2|||
19456451|NCT01790126|41706869|FG000|Overall Study|Withdrawal by Subject|3|||
19456452|NCT01790126|41706870|FG001|Overall Study|Withdrawal by Subject|1|||
19456453|NCT01790126|41706871|FG002|Overall Study|Withdrawal by Subject|2|||
19456454|NCT01790126|41706869|FG000|Overall Study|Lost to Follow-up|1|||
19456455|NCT01790126|41706870|FG001|Overall Study|Lost to Follow-up|0|||
19456456|NCT01790126|41706871|FG002|Overall Study|Lost to Follow-up|1|||
19456457|NCT01790126|41706869|FG000|Overall Study|Adverse Event|0|||
19456458|NCT01790126|41706870|FG001|Overall Study|Adverse Event|2|||
19456459|NCT01790126|41706871|FG002|Overall Study|Adverse Event|0|||
19456460|NCT01790126|41706869|FG000|Overall Study|Death|2|||
19456461|NCT01790126|41706870|FG001|Overall Study|Death|0|||
19456462|NCT01790126|41706871|FG002|Overall Study|Death|0|||
19456463|NCT01790126|41706869|FG000|Overall Study|Radiographic Progression|3|||
19456464|NCT01790126|41706870|FG001|Overall Study|Radiographic Progression|1|||
19456465|NCT01790126|41706871|FG002|Overall Study|Radiographic Progression|0|||
19456466|NCT01734902|41706882|FG000|Overall Study|Other than listed|0|||
19456467|NCT01734902|41706883|FG001|Overall Study|Other than listed|2|||
19456468|NCT01790048|41706891|FG000|Overall Study|Incorrect Age|9|||
19456469|NCT01790048|41706892|FG001|Overall Study|Incorrect Age|14|||
19456470|NCT01790048|41706891|FG000|Overall Study|data entry error|0|||
19456471|NCT01790048|41706892|FG001|Overall Study|data entry error|1|||
19456472|NCT01790048|41706891|FG000|Overall Study|Other|0|||
19456473|NCT01790048|41706892|FG001|Overall Study|Other|2|||
19456474|NCT01790048|41706891|FG000|Overall Study|SAM at Enrollment|2|||
19456475|NCT01790048|41706892|FG001|Overall Study|SAM at Enrollment|0|||
19456476|NCT01790048|41706891|FG000|Overall Study|Measurement error|1|||
19456477|NCT01790048|41706892|FG001|Overall Study|Measurement error|0|||
19456478|NCT01789970|41706902|FG000|Open-label Titration Period|Adverse Event|68|||
19456479|NCT01789970|41706903|FG001|Open-label Titration Period|Adverse Event|0|||
19456480|NCT01789970|41706904|FG002|Open-label Titration Period|Adverse Event|0|||
19456481|NCT01789970|41706902|FG000|Open-label Titration Period|Lack of Efficacy|31|||
19456482|NCT01789970|41706903|FG001|Open-label Titration Period|Lack of Efficacy|0|||
19456483|NCT01789970|41706904|FG002|Open-label Titration Period|Lack of Efficacy|0|||
19456484|NCT01789970|41706902|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
19456485|NCT01789970|41706903|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
19456486|NCT01789970|41706904|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
19456487|NCT01789970|41706902|FG000|Open-label Titration Period|Protocol Violation|18|||
19456488|NCT01789970|41706903|FG001|Open-label Titration Period|Protocol Violation|0|||
19456489|NCT01789970|41706904|FG002|Open-label Titration Period|Protocol Violation|0|||
19456490|NCT01789970|41706902|FG000|Open-label Titration Period|Lost to Follow-up|5|||
19456491|NCT01789970|41706903|FG001|Open-label Titration Period|Lost to Follow-up|0|||
19456492|NCT01789970|41706904|FG002|Open-label Titration Period|Lost to Follow-up|0|||
19456493|NCT01789970|41706902|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
19456494|NCT01789970|41706903|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
19456495|NCT01789970|41706904|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
19456496|NCT01789970|41706902|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
19538133|NCT01307020|41986485|FG000|Overall Study|Electronic data capture failure|0|||
19538134|NCT01307020|41986486|FG001|Overall Study|Electronic data capture failure|1|||
19538135|NCT01307020|41986487|FG002|Overall Study|Electronic data capture failure|0|||
19538136|NCT01307020|41986488|FG003|Overall Study|Electronic data capture failure|0|||
19538137|NCT01307020|41986489|FG004|Overall Study|Electronic data capture failure|0|||
19538138|NCT01307020|41986490|FG005|Overall Study|Electronic data capture failure|0|||
19538139|NCT01307020|41986491|FG006|Overall Study|Electronic data capture failure|0|||
19538140|NCT01307020|41986492|FG007|Overall Study|Electronic data capture failure|0|||
19538141|NCT01307020|41986493|FG008|Overall Study|Electronic data capture failure|0|||
19538142|NCT01307020|41986494|FG009|Overall Study|Electronic data capture failure|0|||
19538143|NCT01306201|41986516|FG000|Overall Study|Arrhythmia|4|||
19538144|NCT01306201|41986516|FG000|Overall Study|Files could not be processed|3|||
19456497|NCT01789970|41706903|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
19456498|NCT01789970|41706904|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
19456499|NCT01789970|41706902|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
19456500|NCT01789970|41706903|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
19538145|NCT01306201|41986516|FG000|Overall Study|Files unreadable|3|||
19538146|NCT01306162|41986528|FG000|Period 1|Adverse Event|0|||
19538147|NCT01306162|41986529|FG001|Period 1|Adverse Event|0|||
19538148|NCT01306162|41986530|FG002|Period 1|Adverse Event|0|||
19538149|NCT01306162|41986531|FG003|Period 1|Adverse Event|1|||
19538150|NCT01306162|41986528|FG000|Washout 1|Non-compliance to protocol|0|||
19538151|NCT01306162|41986529|FG001|Washout 1|Non-compliance to protocol|1|||
19538152|NCT01306162|41986530|FG002|Washout 1|Non-compliance to protocol|0|||
19538153|NCT01306162|41986531|FG003|Washout 1|Non-compliance to protocol|0|||
19538154|NCT01305577|41986547|FG000|Overall Study|Adverse Event|2|||
19538155|NCT01305577|41986548|FG001|Overall Study|Adverse Event|2|||
19538156|NCT01305577|41986549|FG002|Overall Study|Adverse Event|1|||
19538157|NCT01305577|41986547|FG000|Overall Study|Withdrawal by Subject|7|||
19538158|NCT01305577|41986548|FG001|Overall Study|Withdrawal by Subject|5|||
19538159|NCT01305577|41986549|FG002|Overall Study|Withdrawal by Subject|6|||
19456501|NCT01789970|41706904|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
19456502|NCT01789970|41706902|FG000|Open-label Titration Period|Pregnancy|2|||
19456503|NCT01789970|41706903|FG001|Open-label Titration Period|Pregnancy|0|||
19456504|NCT01789970|41706904|FG002|Open-label Titration Period|Pregnancy|0|||
19456505|NCT01789970|41706902|FG000|Open-label Titration Period|Other|76|||
19456506|NCT01789970|41706903|FG001|Open-label Titration Period|Other|0|||
19456507|NCT01789970|41706904|FG002|Open-label Titration Period|Other|0|||
19456508|NCT01789970|41706902|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
19456509|NCT01789970|41706903|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
19538160|NCT01305577|41986547|FG000|Overall Study|Lost to Follow-up|4|||
19538161|NCT01305577|41986548|FG001|Overall Study|Lost to Follow-up|3|||
19538162|NCT01305577|41986549|FG002|Overall Study|Lost to Follow-up|2|||
19538163|NCT01305577|41986547|FG000|Overall Study|Protocol Deviation|0|||
19538164|NCT01305577|41986548|FG001|Overall Study|Protocol Deviation|1|||
19538165|NCT01305577|41986549|FG002|Overall Study|Protocol Deviation|1|||
19538166|NCT01304329|41986557|FG000|Third Intervention (3 Days)|Adverse Event|0|||
19538167|NCT01304329|41986558|FG001|Third Intervention (3 Days)|Adverse Event|1|||
19538168|NCT01304329|41986559|FG002|Third Intervention (3 Days)|Adverse Event|0|||
19538169|NCT01304329|41986560|FG003|Third Intervention (3 Days)|Adverse Event|0|||
19538170|NCT01304329|41986561|FG004|Third Intervention (3 Days)|Adverse Event|0|||
19538171|NCT01304329|41986562|FG005|Third Intervention (3 Days)|Adverse Event|0|||
19538172|NCT01303861|41986575|FG000|Overall Study|Lost to Follow-up|34|||
19538173|NCT01303861|41986576|FG001|Overall Study|Lost to Follow-up|14|||
19538174|NCT01303861|41986577|FG002|Overall Study|Lost to Follow-up|27|||
19538175|NCT01303861|41986578|FG003|Overall Study|Lost to Follow-up|31|||
19538176|NCT01303861|41986575|FG000|Overall Study|Lack of Efficacy|3|||
19538177|NCT01303861|41986576|FG001|Overall Study|Lack of Efficacy|2|||
19538178|NCT01303861|41986577|FG002|Overall Study|Lack of Efficacy|1|||
19538179|NCT01303861|41986578|FG003|Overall Study|Lack of Efficacy|0|||
19538180|NCT01303861|41986575|FG000|Overall Study|Withdrawal by Subject|16|||
19538181|NCT01303861|41986576|FG001|Overall Study|Withdrawal by Subject|8|||
19538182|NCT01303861|41986577|FG002|Overall Study|Withdrawal by Subject|8|||
19538183|NCT01303861|41986578|FG003|Overall Study|Withdrawal by Subject|23|||
19538184|NCT01303861|41986575|FG000|Overall Study|Adverse Event|4|||
19538185|NCT01303861|41986576|FG001|Overall Study|Adverse Event|1|||
19538186|NCT01303861|41986577|FG002|Overall Study|Adverse Event|0|||
19538187|NCT01303861|41986578|FG003|Overall Study|Adverse Event|5|||
19538188|NCT01303861|41986575|FG000|Overall Study|Pregnancy|1|||
19538189|NCT01303861|41986576|FG001|Overall Study|Pregnancy|0|||
19538190|NCT01303861|41986577|FG002|Overall Study|Pregnancy|0|||
19538191|NCT01303861|41986578|FG003|Overall Study|Pregnancy|0|||
19538192|NCT01303627|41986591|FG000|Overall Study|the failure while performing URS|0|||
19538193|NCT01303627|41986592|FG001|Overall Study|the failure while performing URS|1|||
19538194|NCT01303510|41986600|FG000|Overall Study|Lost to Follow-up|1|||
19538195|NCT01303510|41986601|FG001|Overall Study|Lost to Follow-up|0|||
19538196|NCT01303159|41986607|FG000|Overall Study|Death|16|||
19538197|NCT01303159|41986607|FG000|Overall Study|Study Termination|7|||
19538198|NCT01302964|41986613|FG000|Overall Study|Adverse Event|1|||
19538199|NCT01302964|41986614|FG001|Overall Study|Adverse Event|0|||
19538200|NCT01302691|41986622|FG000|Overall Study|Adverse Event|2|||
19538201|NCT01302691|41986623|FG001|Overall Study|Adverse Event|0|||
19538202|NCT01302691|41986622|FG000|Overall Study|Death|0|||
19538203|NCT01302691|41986623|FG001|Overall Study|Death|1|||
19538204|NCT01302691|41986622|FG000|Overall Study|Lost to Follow-up|1|||
19538205|NCT01302691|41986623|FG001|Overall Study|Lost to Follow-up|0|||
19538206|NCT01302691|41986622|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
19538207|NCT01302691|41986623|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
19538208|NCT01302691|41986622|FG000|Overall Study|Physician Decision|0|||
19538209|NCT01302691|41986623|FG001|Overall Study|Physician Decision|1|||
19538210|NCT01302691|41986622|FG000|Overall Study|Protocol Violation|1|||
19538211|NCT01302691|41986623|FG001|Overall Study|Protocol Violation|0|||
19538212|NCT01302418|41986629|FG000|Overall Study|Protocol Violation|9|||
19538213|NCT01302418|41986629|FG000|Overall Study|Non-evaluable|9|||
19456510|NCT01789970|41706904|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
19456511|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
19538214|NCT01302067|41986636|FG000|Overall Study|Death|0|||
19538215|NCT01302067|41986637|FG001|Overall Study|Death|0|||
19456512|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
19456513|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
19456514|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
19456515|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
19456516|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
19456517|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19456518|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
19456519|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
19456520|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
19456521|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
19456522|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
19456523|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
19456524|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
19456525|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
19456526|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
19456527|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
19456528|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
19456529|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
19456530|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
19456531|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
19456532|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
19456533|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
19456534|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
19456535|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
19538216|NCT01302067|41986638|FG002|Overall Study|Death|1|||
19538217|NCT01302067|41986636|FG000|Overall Study|Physician Decision|9|||
19538218|NCT01302067|41986637|FG001|Overall Study|Physician Decision|5|||
19538219|NCT01302067|41986638|FG002|Overall Study|Physician Decision|14|||
19538220|NCT01302067|41986636|FG000|Overall Study|Lack of Efficacy|8|||
19538221|NCT01302067|41986637|FG001|Overall Study|Lack of Efficacy|4|||
19538222|NCT01302067|41986638|FG002|Overall Study|Lack of Efficacy|2|||
19538223|NCT01302067|41986636|FG000|Overall Study|Lost to Follow-up|9|||
19538224|NCT01302067|41986637|FG001|Overall Study|Lost to Follow-up|4|||
19538225|NCT01302067|41986638|FG002|Overall Study|Lost to Follow-up|15|||
19538226|NCT01302067|41986636|FG000|Overall Study|Withdrawal by Subject|13|||
19538227|NCT01302067|41986637|FG001|Overall Study|Withdrawal by Subject|6|||
19538228|NCT01302067|41986638|FG002|Overall Study|Withdrawal by Subject|10|||
19538229|NCT01302067|41986636|FG000|Overall Study|Other|1|||
19538230|NCT01302067|41986637|FG001|Overall Study|Other|1|||
19538231|NCT01302067|41986638|FG002|Overall Study|Other|3|||
19538232|NCT01302067|41986636|FG000|Overall Study|Protocol Violation|11|||
19538233|NCT01302067|41986637|FG001|Overall Study|Protocol Violation|0|||
19538234|NCT01302067|41986638|FG002|Overall Study|Protocol Violation|8|||
19538235|NCT01302067|41986636|FG000|Overall Study|Adverse Event|27|||
19538236|NCT01302067|41986637|FG001|Overall Study|Adverse Event|14|||
19538237|NCT01302067|41986638|FG002|Overall Study|Adverse Event|45|||
19538238|NCT01301950|41986648|FG000|Overall Study|Surgery was cancelled by patient|0|||
19538239|NCT01301950|41986649|FG001|Overall Study|Surgery was cancelled by patient|1|||
19538240|NCT01301833|41986659|FG000|Overall Study|Adverse Event|7|||
19538241|NCT01301833|41986660|FG001|Overall Study|Adverse Event|5|||
19538242|NCT01301833|41986661|FG002|Overall Study|Adverse Event|5|||
19538243|NCT01301833|41986662|FG003|Overall Study|Adverse Event|5|||
19538244|NCT01301833|41986659|FG000|Overall Study|Lack of Efficacy|1|||
19456536|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
19456537|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
19456538|NCT01789970|41706902|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
19456539|NCT01789970|41706903|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
19456540|NCT01789970|41706904|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
19456541|NCT01734434|41706922|FG000|Overall Study|Death Infant|3|||
19456542|NCT01734434|41706923|FG001|Overall Study|Death Infant|1|||
19456543|NCT01734434|41706924|FG002|Overall Study|Death Infant|17|||
19538245|NCT01301833|41986660|FG001|Overall Study|Lack of Efficacy|1|||
19538246|NCT01301833|41986661|FG002|Overall Study|Lack of Efficacy|0|||
19538247|NCT01301833|41986662|FG003|Overall Study|Lack of Efficacy|0|||
19538248|NCT01301833|41986659|FG000|Overall Study|Physician Decision|3|||
19538249|NCT01301833|41986660|FG001|Overall Study|Physician Decision|1|||
19538250|NCT01301833|41986661|FG002|Overall Study|Physician Decision|1|||
19538251|NCT01301833|41986662|FG003|Overall Study|Physician Decision|0|||
19538252|NCT01301833|41986659|FG000|Overall Study|Withdrawal by Subject|3|||
19538253|NCT01301833|41986660|FG001|Overall Study|Withdrawal by Subject|1|||
19538254|NCT01301833|41986661|FG002|Overall Study|Withdrawal by Subject|1|||
19456544|NCT01734434|41706925|FG003|Overall Study|Death Infant|5|||
19456545|NCT01734434|41706922|FG000|Overall Study|Lost to Follow-up|2|||
19456546|NCT01734434|41706923|FG001|Overall Study|Lost to Follow-up|9|||
19456547|NCT01734434|41706924|FG002|Overall Study|Lost to Follow-up|67|||
19456548|NCT01734434|41706925|FG003|Overall Study|Lost to Follow-up|11|||
19456549|NCT01734434|41706922|FG000|Overall Study|No Live Birth|1|||
19456550|NCT01734434|41706923|FG001|Overall Study|No Live Birth|2|||
19456551|NCT01734434|41706924|FG002|Overall Study|No Live Birth|32|||
19456552|NCT01734434|41706925|FG003|Overall Study|No Live Birth|6|||
19456553|NCT01734434|41706922|FG000|Overall Study|Withdrawal by Subject|4|||
19538255|NCT01301833|41986662|FG003|Overall Study|Withdrawal by Subject|2|||
19538256|NCT01301833|41986659|FG000|Overall Study|Personal matter|1|||
19538257|NCT01301833|41986660|FG001|Overall Study|Personal matter|0|||
19538258|NCT01301833|41986661|FG002|Overall Study|Personal matter|0|||
19538259|NCT01301833|41986662|FG003|Overall Study|Personal matter|0|||
19538260|NCT01301092|41986675|FG000|Overall Study|Lost to Follow-up|0|||
19538261|NCT01301092|41986676|FG001|Overall Study|Lost to Follow-up|0|||
19538262|NCT01301092|41986677|FG002|Overall Study|Lost to Follow-up|1|||
19538263|NCT01300819|41986692|FG000|Overall Study|Adverse Event|9|||
19538264|NCT01300819|41986693|FG001|Overall Study|Adverse Event|27|||
19538265|NCT01300819|41986692|FG000|Overall Study|Lack of Efficacy|2|||
19538266|NCT01300819|41986693|FG001|Overall Study|Lack of Efficacy|1|||
19538267|NCT01300819|41986692|FG000|Overall Study|Withdrawal by Subject|10|||
19711515|NCT03568318|42154617|FG001|Overall Study|Withdrawal by Subject|5|||
19456554|NCT01734434|41706923|FG001|Overall Study|Withdrawal by Subject|0|||
19456555|NCT01734434|41706924|FG002|Overall Study|Withdrawal by Subject|8|||
19538268|NCT01300819|41986693|FG001|Overall Study|Withdrawal by Subject|12|||
19538269|NCT01300819|41986692|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
19538270|NCT01300819|41986693|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
19538271|NCT01300819|41986692|FG000|Overall Study|Refusal to down titrate study drug|0|||
19538272|NCT01300819|41986693|FG001|Overall Study|Refusal to down titrate study drug|1|||
19538273|NCT01300819|41986692|FG000|Overall Study|Administrative reason|0|||
19538274|NCT01300819|41986693|FG001|Overall Study|Administrative reason|1|||
19538275|NCT01300819|41986692|FG000|Overall Study|Safety follow up not done by mistake|0|||
19538276|NCT01300819|41986693|FG001|Overall Study|Safety follow up not done by mistake|1|||
19538277|NCT01300819|41986692|FG000|Overall Study|Follow up call was not done|1|||
19538278|NCT01300819|41986693|FG001|Overall Study|Follow up call was not done|0|||
19538279|NCT01300741|41986699|FG000|Overall Study|Lens deposits|1|||
19456556|NCT01734434|41706925|FG003|Overall Study|Withdrawal by Subject|1|||
19456557|NCT01734434|41706922|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
19456558|NCT01734434|41706923|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
19456559|NCT01734434|41706924|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
19456560|NCT01734434|41706925|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
19456561|NCT01734434|41706922|FG000|Overall Study|Subject Not Reachable|0|||
19456562|NCT01734434|41706923|FG001|Overall Study|Subject Not Reachable|0|||
19456563|NCT01734434|41706924|FG002|Overall Study|Subject Not Reachable|1|||
19456564|NCT01734434|41706925|FG003|Overall Study|Subject Not Reachable|0|||
19456565|NCT01734434|41706922|FG000|Overall Study|Treatment Defaulter|0|||
19456566|NCT01734434|41706923|FG001|Overall Study|Treatment Defaulter|0|||
19456567|NCT01734434|41706924|FG002|Overall Study|Treatment Defaulter|1|||
19456568|NCT01734434|41706925|FG003|Overall Study|Treatment Defaulter|0|||
19456569|NCT01734434|41706922|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
19456570|NCT01734434|41706923|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
19456571|NCT01734434|41706924|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
19456572|NCT01734434|41706925|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
19456573|NCT01734434|41706922|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
19456574|NCT01734434|41706923|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
19456575|NCT01734434|41706924|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
19538280|NCT01300741|41986699|FG000|Overall Study|Lost to Follow-up|1|||
19538281|NCT01300741|41986699|FG000|Overall Study|Discomfort|1|||
19538282|NCT01300546|41986707|FG000|Overall Study|Withdrawal by Subject|1|||
19538283|NCT01300546|41986708|FG001|Overall Study|Withdrawal by Subject|0|||
19538284|NCT01300546|41986707|FG000|Overall Study|Lost to Follow-up|0|||
19538285|NCT01300546|41986708|FG001|Overall Study|Lost to Follow-up|2|||
19538286|NCT01300546|41986707|FG000|Overall Study|Lack of Efficacy|0|||
19538287|NCT01300546|41986708|FG001|Overall Study|Lack of Efficacy|3|||
19538288|NCT01300546|41986707|FG000|Overall Study|Adverse Event|0|||
19538289|NCT01300546|41986708|FG001|Overall Study|Adverse Event|1|||
19538290|NCT01300351|41986716|FG000|Overall Study|Did not receive treatment|2|||
19538291|NCT01300351|41986717|FG001|Overall Study|Did not receive treatment|0|||
19538292|NCT01300351|41986716|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
19538293|NCT01300351|41986717|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
19538294|NCT01300351|41986716|FG000|Overall Study|Lost to Follow-up|0|||
19538295|NCT01300351|41986717|FG001|Overall Study|Lost to Follow-up|1|||
19538296|NCT01300351|41986716|FG000|Overall Study|Adverse Event|0|||
19538297|NCT01300351|41986717|FG001|Overall Study|Adverse Event|4|||
19538298|NCT01300351|41986716|FG000|Overall Study|Withdrawal by Subject|7|||
19538299|NCT01300351|41986717|FG001|Overall Study|Withdrawal by Subject|10|||
19538300|NCT01300234|41986725|FG000|Overall Study|Adverse Event|1|||
19538301|NCT01300234|41986726|FG001|Overall Study|Adverse Event|1|||
19538302|NCT01300234|41986725|FG000|Overall Study|Protocol Violation|2|||
19538303|NCT01300234|41986726|FG001|Overall Study|Protocol Violation|3|||
19538304|NCT01300234|41986725|FG000|Overall Study|Withdrawal by Subject|5|||
19538305|NCT01300234|41986726|FG001|Overall Study|Withdrawal by Subject|9|||
19538306|NCT01300234|41986725|FG000|Overall Study|Lost to Follow-up|14|||
19538307|NCT01300234|41986726|FG001|Overall Study|Lost to Follow-up|12|||
19538308|NCT01300234|41986725|FG000|Overall Study|Pregnancy|2|||
19538309|NCT01300234|41986726|FG001|Overall Study|Pregnancy|1|||
19538310|NCT01300234|41986725|FG000|Overall Study|Participant reached stopping critera|2|||
19538311|NCT01300234|41986726|FG001|Overall Study|Participant reached stopping critera|0|||
19538312|NCT01300234|41986725|FG000|Overall Study|Participant stopped medication|1|||
19538313|NCT01300234|41986726|FG001|Overall Study|Participant stopped medication|1|||
19538314|NCT01300234|41986725|FG000|Overall Study|Participant refused return to hospital|1|||
19538315|NCT01300234|41986726|FG001|Overall Study|Participant refused return to hospital|0|||
19538316|NCT01299961|41986743|FG000|Overall Study|Adverse Event|3|||
19538317|NCT01299961|41986743|FG000|Overall Study|Lack of Efficacy|2|||
19538318|NCT01299961|41986743|FG000|Overall Study|Lost to Follow-up|1|||
19538319|NCT01299805|41986749|FG000|Overall Study|Adverse Event|2|||
19538320|NCT01299805|41986750|FG001|Overall Study|Adverse Event|0|||
19538321|NCT01299766|41986758|FG000|Overall Study|Death|5|||
19538322|NCT01299766|41986759|FG001|Overall Study|Death|4|||
19538323|NCT01299766|41986758|FG000|Overall Study|Withdrawal by Subject|29|||
19538324|NCT01299766|41986759|FG001|Overall Study|Withdrawal by Subject|19|||
19538325|NCT01299727|41986768|FG000|Overall Study|Withdrawal by Subject|1|||
19538326|NCT01299727|41986769|FG001|Overall Study|Withdrawal by Subject|0|||
19538327|NCT01299727|41986770|FG002|Overall Study|Withdrawal by Subject|0|||
19538328|NCT01299727|41986768|FG000|Overall Study|Adverse Event|0|||
19538329|NCT01299727|41986769|FG001|Overall Study|Adverse Event|0|||
19538330|NCT01299727|41986770|FG002|Overall Study|Adverse Event|1|||
19538331|NCT01299727|41986768|FG000|Overall Study|Completed the Treatment Period|3|||
19538332|NCT01299727|41986769|FG001|Overall Study|Completed the Treatment Period|4|||
19538333|NCT01299727|41986770|FG002|Overall Study|Completed the Treatment Period|3|||
19538334|NCT01299571|41986778|FG000|Overall Study|Protocol Violation|107|||
19538335|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
19538336|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
19538337|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
19538338|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
19538339|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
19538340|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
19538341|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
19538342|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
19538343|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
19538344|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
19456576|NCT01734434|41706925|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
19456577|NCT01788566|41706943|FG000|Overall Study|Death|4|||
19538345|NCT01299376|41986785|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
19538346|NCT01299376|41986786|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
19538347|NCT01299376|41986785|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
19538348|NCT01299376|41986786|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
19538349|NCT01299376|41986785|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
19538350|NCT01299376|41986786|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
19538351|NCT01299376|41986785|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
19538352|NCT01299376|41986786|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
19538353|NCT01299376|41986785|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
19538354|NCT01299376|41986786|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
19538355|NCT01299376|41986785|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
19538356|NCT01299376|41986786|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
19538357|NCT01299025|41986798|FG000|Overall Study|Withdrawal by Subject|2|||
19538358|NCT01299025|41986799|FG001|Overall Study|Withdrawal by Subject|1|||
19456578|NCT01788566|41706943|FG000|Overall Study|Adverse Event|1|||
19456579|NCT01788566|41706943|FG000|Overall Study|Clinical Progressive Disease|3|||
19456580|NCT01733732|41706949|FG000|Overall Study|Adverse Event|1|||
19456581|NCT01733732|41706950|FG001|Overall Study|Adverse Event|0|||
19456582|NCT01733732|41706949|FG000|Overall Study|Did not attend all study visits|1|||
19456583|NCT01733732|41706950|FG001|Overall Study|Did not attend all study visits|0|||
19456584|NCT01732874|41706968|FG000|Overall Study|Withdrawal by Subject|5|||
19456585|NCT01732874|41706969|FG001|Overall Study|Withdrawal by Subject|1|||
19456586|NCT01732874|41706968|FG000|Overall Study|Death of Infant|3|||
19456587|NCT01732874|41706969|FG001|Overall Study|Death of Infant|2|||
19456588|NCT01732796|41706978|FG000|Overall Study|Adverse Event|16|||
19456589|NCT01732796|41706979|FG001|Overall Study|Adverse Event|16|||
19456590|NCT01732796|41706980|FG002|Overall Study|Adverse Event|4|||
19456591|NCT01732796|41706978|FG000|Overall Study|Lack of Efficacy|21|||
19456592|NCT01732796|41706979|FG001|Overall Study|Lack of Efficacy|18|||
19456593|NCT01732796|41706980|FG002|Overall Study|Lack of Efficacy|5|||
19456594|NCT01732796|41706978|FG000|Overall Study|Lost to Follow-up|2|||
19456595|NCT01732796|41706979|FG001|Overall Study|Lost to Follow-up|0|||
19456596|NCT01732796|41706980|FG002|Overall Study|Lost to Follow-up|0|||
19456597|NCT01732796|41706978|FG000|Overall Study|Withdrawal by Subject|6|||
19456598|NCT01732796|41706979|FG001|Overall Study|Withdrawal by Subject|8|||
19456599|NCT01732796|41706980|FG002|Overall Study|Withdrawal by Subject|2|||
19456600|NCT01732796|41706978|FG000|Overall Study|Other reason not defined above|1|||
19456601|NCT01732796|41706979|FG001|Overall Study|Other reason not defined above|0|||
19456602|NCT01732796|41706980|FG002|Overall Study|Other reason not defined above|2|||
19456603|NCT01732640|41706990|FG000|Overall Study|Adverse Event|0|||
19456604|NCT01732640|41706991|FG001|Overall Study|Adverse Event|1|||
19456605|NCT01732640|41706990|FG000|Overall Study|Death|0|||
19456606|NCT01732640|41706991|FG001|Overall Study|Death|1|||
19456607|NCT01732484|41707001|FG000|Overall Study|Death|7|||
19456608|NCT01732484|41707001|FG000|Overall Study|Lost to Follow-up|14|||
19456609|NCT01732484|41707001|FG000|Overall Study|chronical illness|5|||
19456610|NCT01786148|41707009|FG000|Overall Study|Lost to Follow-up|21|||
19456611|NCT01786148|41707010|FG001|Overall Study|Lost to Follow-up|13|||
19456612|NCT01786148|41707009|FG000|Overall Study|Death|0|||
19456613|NCT01786148|41707010|FG001|Overall Study|Death|1|||
19538359|NCT01299025|41986798|FG000|Overall Study|Lost to Follow-up|1|||
19538360|NCT01299025|41986799|FG001|Overall Study|Lost to Follow-up|0|||
19538361|NCT01298596|41986807|FG000|Overall Study|Withdrawal by Subject|1|||
19538362|NCT01298596|41986808|FG001|Overall Study|Withdrawal by Subject|1|||
19456614|NCT01786148|41707009|FG000|Overall Study|Withdrawal by Subject|0|||
19456615|NCT01786148|41707010|FG001|Overall Study|Withdrawal by Subject|7|||
19456616|NCT01786148|41707009|FG000|Overall Study|Incarceration|1|||
19456617|NCT01786148|41707010|FG001|Overall Study|Incarceration|1|||
19456618|NCT01785602|41707022|FG000|Overall Study|Withdrawal by Subject|2|||
19456619|NCT01785602|41707023|FG001|Overall Study|Withdrawal by Subject|0|||
19456620|NCT01785602|41707022|FG000|Overall Study|Lost to Follow-up|1|||
19456621|NCT01785602|41707023|FG001|Overall Study|Lost to Follow-up|1|||
19538363|NCT01298596|41986807|FG000|Overall Study|Death|5|||
19538364|NCT01298596|41986808|FG001|Overall Study|Death|3|||
19538365|NCT01298596|41986807|FG000|Overall Study|Lost to Follow-up|6|||
19538366|NCT01298596|41986808|FG001|Overall Study|Lost to Follow-up|14|||
19538367|NCT01298596|41986807|FG000|Overall Study|Referred for further management|16|||
19538368|NCT01298596|41986808|FG001|Overall Study|Referred for further management|15|||
19538369|NCT01298518|41986817|FG000|Overall Study|Withdrawal by Subject|0|||
19538370|NCT01298518|41986818|FG001|Overall Study|Withdrawal by Subject|0|||
19538371|NCT01298518|41986819|FG002|Overall Study|Withdrawal by Subject|1|||
19538372|NCT01298362|41986829|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
19538373|NCT01298362|41986830|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
19538374|NCT01298323|41986840|FG000|Overall Study|Adverse Event|2|||
19538375|NCT01298323|41986841|FG001|Overall Study|Adverse Event|4|||
19538376|NCT01298323|41986840|FG000|Overall Study|Death|11|||
19538377|NCT01298323|41986841|FG001|Overall Study|Death|16|||
19538378|NCT01298323|41986840|FG000|Overall Study|Lost to Follow-up|1|||
19456622|NCT01785602|41707022|FG000|Overall Study|Adverse Event|3|||
19456623|NCT01785602|41707023|FG001|Overall Study|Adverse Event|5|||
19456624|NCT01785602|41707022|FG000|Overall Study|Administrative problems|7|||
19456625|NCT01785602|41707023|FG001|Overall Study|Administrative problems|3|||
19538379|NCT01298323|41986841|FG001|Overall Study|Lost to Follow-up|0|||
19538380|NCT01298323|41986840|FG000|Overall Study|Withdrawal by Subject|6|||
19538381|NCT01298323|41986841|FG001|Overall Study|Withdrawal by Subject|3|||
19538382|NCT01298323|41986840|FG000|Overall Study|Protocol Violation|1|||
19538383|NCT01298323|41986841|FG001|Overall Study|Protocol Violation|0|||
19538384|NCT01298323|41986840|FG000|Overall Study|Other|10|||
19538385|NCT01298323|41986841|FG001|Overall Study|Other|9|||
19538386|NCT01298323|41986840|FG000|Overall Study|Ongoing|55|||
19538387|NCT01298323|41986841|FG001|Overall Study|Ongoing|55|||
19538388|NCT01298323|41986840|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19538389|NCT01298323|41986841|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19538390|NCT01297504|41986847|FG000|Overall Study|Invalid Consent|1|||
19538391|NCT01297504|41986847|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
19538392|NCT01297504|41986847|FG000|Overall Study|No Study Visits|4|||
19538393|NCT01297504|41986847|FG000|Overall Study|Death|3|||
19538394|NCT01297504|41986847|FG000|Overall Study|Lost to Follow-up|43|||
19538395|NCT01297504|41986847|FG000|Overall Study|Withdrawal by Subject|9|||
19631215|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
19456626|NCT01785524|41707031|FG000|Overall Study|Withdrawal by Subject|2|||
19456627|NCT01785524|41707032|FG001|Overall Study|Withdrawal by Subject|2|||
19456628|NCT01757288|41707041|FG000|Overall Study|Consent withdrawal|0|||
19538396|NCT01297504|41986847|FG000|Overall Study|Site Closure|3|||
19631216|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
19456629|NCT01757288|41707042|FG001|Overall Study|Consent withdrawal|4|||
19456630|NCT01757288|41707043|FG002|Overall Study|Consent withdrawal|4|||
19456631|NCT01757288|41707041|FG000|Overall Study|Patient off study, IRB hold.|0|||
19456632|NCT01757288|41707042|FG001|Overall Study|Patient off study, IRB hold.|0|||
19456633|NCT01757288|41707043|FG002|Overall Study|Patient off study, IRB hold.|1|||
19456634|NCT01757288|41707041|FG000|Overall Study|Patient death prior to starting treatment|0|||
19456635|NCT01757288|41707042|FG001|Overall Study|Patient death prior to starting treatment|0|||
19538397|NCT01297504|41986847|FG000|Overall Study|Protocol Violation|3|||
19538398|NCT01297465|41986857|FG000|Overall Study|Lack of Ovarian Response|1|||
19456636|NCT01757288|41707043|FG002|Overall Study|Patient death prior to starting treatment|1|||
19456637|NCT01757288|41707041|FG000|Overall Study|Wrong medication administered|0|||
19456638|NCT01757288|41707042|FG001|Overall Study|Wrong medication administered|1|||
19456639|NCT01757288|41707043|FG002|Overall Study|Wrong medication administered|0|||
19456640|NCT01757288|41707041|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
19456641|NCT01757288|41707042|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
19456642|NCT01757288|41707043|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
19456643|NCT01757288|41707041|FG000|Overall Study|Not meeting protocol constraints|0|||
19456644|NCT01757288|41707042|FG001|Overall Study|Not meeting protocol constraints|1|||
19456645|NCT01757288|41707043|FG002|Overall Study|Not meeting protocol constraints|1|||
19456646|NCT01757288|41707041|FG000|Overall Study|Multiple missed appointments|0|||
19456647|NCT01757288|41707042|FG001|Overall Study|Multiple missed appointments|1|||
19456648|NCT01757288|41707043|FG002|Overall Study|Multiple missed appointments|0|||
19456649|NCT01757288|41707041|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
19456650|NCT01757288|41707042|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
19456651|NCT01757288|41707043|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
19456652|NCT01757288|41707041|FG000|Overall Study|>2 weeks treatment break|0|||
19456653|NCT01757288|41707042|FG001|Overall Study|>2 weeks treatment break|0|||
19538399|NCT01297465|41986858|FG001|Overall Study|Lack of Ovarian Response|1|||
19538400|NCT01297465|41986857|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
19538401|NCT01297465|41986858|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
19631217|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
19631218|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
19631219|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
19631220|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
19631221|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
19631222|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
19631223|NCT00849017|42080462|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
19631224|NCT00849017|42080463|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
19631225|NCT00849017|42080464|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
19631226|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
19538402|NCT01297465|41986857|FG000|Overall Study|No Oocytes Retrieved|1|||
19538403|NCT01297465|41986858|FG001|Overall Study|No Oocytes Retrieved|1|||
19538404|NCT01297465|41986857|FG000|Overall Study|Poor oocyte quality|0|||
19538405|NCT01297465|41986858|FG001|Overall Study|Poor oocyte quality|1|||
19538406|NCT01297465|41986857|FG000|Overall Study|No Fertilization|6|||
19538407|NCT01297465|41986858|FG001|Overall Study|No Fertilization|4|||
19538408|NCT01297465|41986857|FG000|Overall Study|All Embryos Discarded|0|||
19538409|NCT01297465|41986858|FG001|Overall Study|All Embryos Discarded|1|||
19538410|NCT01297465|41986857|FG000|Overall Study|Intention to Freeze all Embryos|0|||
19538411|NCT01297465|41986858|FG001|Overall Study|Intention to Freeze all Embryos|1|||
19538412|NCT01297309|41986864|FG000|Overall Study|Eligibility failure|2|||
19538413|NCT01297309|41986864|FG000|Overall Study|Screen failure|2|||
19538414|NCT01297309|41986864|FG000|Overall Study|Withdrawal by Subject|5|||
19538415|NCT01297309|41986864|FG000|Overall Study|Adverse Event|1|||
19538416|NCT01297309|41986864|FG000|Overall Study|Investigator Decision|2|||
19631227|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
19631228|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
19631229|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
19631230|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
19631231|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
19631232|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
19631233|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
19631234|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
19631235|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
19631236|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
19631237|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
19631238|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
19631239|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
19631240|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
19631241|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
19631242|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
19631243|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
19631244|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
19631245|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
19631246|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
19631247|NCT00849017|42080462|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
19631248|NCT00849017|42080463|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
19631249|NCT00849017|42080464|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
19538417|NCT01297309|41986864|FG000|Overall Study|Death|1|||
19538418|NCT01297309|41986864|FG000|Overall Study|Participant not entering extensionperiod|1|||
19538419|NCT04518462|41986871|FG000|Overall Study|Withdrawal by Subject|0|||
19538420|NCT04518462|41986872|FG001|Overall Study|Withdrawal by Subject|0|||
19538421|NCT04518462|41986873|FG002|Overall Study|Withdrawal by Subject|1|||
19538422|NCT04518462|41986871|FG000|Overall Study|Physician Decision|1|||
19538423|NCT04518462|41986872|FG001|Overall Study|Physician Decision|1|||
19538424|NCT04518462|41986873|FG002|Overall Study|Physician Decision|0|||
19538425|NCT01297270|41986884|FG000|Overall Study|Adverse Event|19|||
19538426|NCT01297270|41986885|FG001|Overall Study|Adverse Event|32|||
19538427|NCT01297270|41986886|FG002|Overall Study|Adverse Event|5|||
19538428|NCT01297270|41986884|FG000|Overall Study|Lack of Efficacy|15|||
19538429|NCT01297270|41986885|FG001|Overall Study|Lack of Efficacy|17|||
19538430|NCT01297270|41986886|FG002|Overall Study|Lack of Efficacy|15|||
19538431|NCT01297270|41986884|FG000|Overall Study|Lost to Follow-up|1|||
19538432|NCT01297270|41986885|FG001|Overall Study|Lost to Follow-up|2|||
19538433|NCT01297270|41986886|FG002|Overall Study|Lost to Follow-up|1|||
19538434|NCT01297270|41986884|FG000|Overall Study|Protocol Violation|0|||
19538435|NCT01297270|41986885|FG001|Overall Study|Protocol Violation|2|||
19538436|NCT01297270|41986886|FG002|Overall Study|Protocol Violation|0|||
19538437|NCT01297270|41986884|FG000|Overall Study|Withdrawal by Subject|7|||
19538438|NCT01297270|41986885|FG001|Overall Study|Withdrawal by Subject|15|||
19538439|NCT01297270|41986886|FG002|Overall Study|Withdrawal by Subject|7|||
19538440|NCT01297270|41986884|FG000|Overall Study|Other reason not defined above|3|||
19538441|NCT01297270|41986885|FG001|Overall Study|Other reason not defined above|3|||
19538442|NCT01297270|41986886|FG002|Overall Study|Other reason not defined above|1|||
19538443|NCT01297270|41986884|FG000|Overall Study|Not treated|0|||
19538444|NCT01297270|41986885|FG001|Overall Study|Not treated|1|||
19538445|NCT01297270|41986886|FG002|Overall Study|Not treated|0|||
19538446|NCT01296568|41986894|FG000|Continued Access Phase|Lost to Follow-up|1|||
19538447|NCT01296568|41986894|FG000|Continued Access Phase|Withdrawal by Subject|1|||
19538448|NCT01296568|41986894|FG000|Continued Access Phase|Disease Progression|1|||
19538449|NCT01296412|41986902|FG000|Overall Study|Adverse Event|8|||
19538450|NCT01296412|41986903|FG001|Overall Study|Adverse Event|29|||
19538451|NCT01296412|41986902|FG000|Overall Study|Lack of Efficacy|1|||
19538452|NCT01296412|41986903|FG001|Overall Study|Lack of Efficacy|0|||
19538453|NCT01296412|41986902|FG000|Overall Study|Lost to Follow-up|10|||
19538454|NCT01296412|41986903|FG001|Overall Study|Lost to Follow-up|7|||
19538455|NCT01296412|41986902|FG000|Overall Study|Non-compliance with study drug|1|||
19631250|NCT00842543|42080480|FG000|Overall Study|Withdrawal by Subject|2|||
19631251|NCT00842543|42080481|FG001|Overall Study|Withdrawal by Subject|0|||
19631252|NCT00842543|42080482|FG002|Overall Study|Withdrawal by Subject|3|||
19631253|NCT00842543|42080483|FG003|Overall Study|Withdrawal by Subject|4|||
19631254|NCT00785928|42080502|FG000|Treatment Phase|Adverse Event|1|||
19631255|NCT00785928|42080503|FG001|Treatment Phase|Adverse Event|1|||
19631256|NCT00785928|42080504|FG002|Treatment Phase|Adverse Event|2|||
19631257|NCT00785928|42080505|FG003|Treatment Phase|Adverse Event|0|||
19631258|NCT00785928|42080506|FG004|Treatment Phase|Adverse Event|0|||
19631259|NCT00785928|42080507|FG005|Treatment Phase|Adverse Event|0|||
19538456|NCT01296412|41986903|FG001|Overall Study|Non-compliance with study drug|2|||
19538457|NCT01296412|41986902|FG000|Overall Study|Other reason not specified|20|||
19538458|NCT01296412|41986903|FG001|Overall Study|Other reason not specified|15|||
19538459|NCT01296412|41986902|FG000|Overall Study|Physician Decision|1|||
19631260|NCT00785928|42080508|FG006|Treatment Phase|Adverse Event|2|||
19631261|NCT00785928|42080502|FG000|Treatment Phase|Inadequate Response|0|||
19538460|NCT01296412|41986903|FG001|Overall Study|Physician Decision|3|||
19538461|NCT01296412|41986902|FG000|Overall Study|Pregnancy|0|||
19538462|NCT01296412|41986903|FG001|Overall Study|Pregnancy|1|||
19538463|NCT01296412|41986902|FG000|Overall Study|Withdrawal by Subject|10|||
19631262|NCT00785928|42080503|FG001|Treatment Phase|Inadequate Response|1|||
19456654|NCT01757288|41707043|FG002|Overall Study|>2 weeks treatment break|1|||
19538464|NCT01296412|41986903|FG001|Overall Study|Withdrawal by Subject|13|||
19538465|NCT01295905|41986911|FG000|Overall Study|Did not meet inclusion criteria|1|||
19538466|NCT01295905|41986912|FG001|Overall Study|Did not meet inclusion criteria|0|||
19538467|NCT01295905|41986911|FG000|Overall Study|Met exclusion criteria|1|||
19538468|NCT01295905|41986912|FG001|Overall Study|Met exclusion criteria|0|||
19538469|NCT02596035|41986921|FG000|Overall Study|Disease Progression|64|||
19456655|NCT01756898|41707056|FG000|Overall Study|Adverse Event|7|||
19538470|NCT02596035|41986922|FG001|Overall Study|Disease Progression|32|||
19538471|NCT02596035|41986923|FG002|Overall Study|Disease Progression|1|||
19538472|NCT02596035|41986921|FG000|Overall Study|study drug toxicity|12|||
19631263|NCT00785928|42080504|FG002|Treatment Phase|Inadequate Response|0|||
19456656|NCT01756898|41707057|FG001|Overall Study|Adverse Event|1|||
19456657|NCT01756898|41707058|FG002|Overall Study|Adverse Event|0|||
19456658|NCT01756898|41707059|FG003|Overall Study|Adverse Event|0|||
19456659|NCT01756898|41707056|FG000|Overall Study|Lack of Efficacy|4|||
19456660|NCT01756898|41707057|FG001|Overall Study|Lack of Efficacy|7|||
19456661|NCT01756898|41707058|FG002|Overall Study|Lack of Efficacy|6|||
19538473|NCT02596035|41986922|FG001|Overall Study|study drug toxicity|3|||
19538474|NCT02596035|41986923|FG002|Overall Study|study drug toxicity|0|||
19538475|NCT02596035|41986921|FG000|Overall Study|AE unrelated to study drug|5|||
19538476|NCT02596035|41986922|FG001|Overall Study|AE unrelated to study drug|2|||
19538477|NCT02596035|41986923|FG002|Overall Study|AE unrelated to study drug|0|||
19538478|NCT02596035|41986921|FG000|Overall Study|participant request to discontinue study treatment|2|||
19538479|NCT02596035|41986922|FG001|Overall Study|participant request to discontinue study treatment|0|||
19538480|NCT02596035|41986923|FG002|Overall Study|participant request to discontinue study treatment|0|||
19538481|NCT02596035|41986921|FG000|Overall Study|participant withdrew consent|2|||
19538482|NCT02596035|41986922|FG001|Overall Study|participant withdrew consent|2|||
19538483|NCT02596035|41986923|FG002|Overall Study|participant withdrew consent|0|||
19538484|NCT02596035|41986921|FG000|Overall Study|Poor/Non Comlpiance|0|||
19538485|NCT02596035|41986922|FG001|Overall Study|Poor/Non Comlpiance|1|||
19538486|NCT02596035|41986923|FG002|Overall Study|Poor/Non Comlpiance|0|||
19538487|NCT02596035|41986921|FG000|Overall Study|participant no longer meets study criteria|1|||
19538488|NCT02596035|41986922|FG001|Overall Study|participant no longer meets study criteria|0|||
19538489|NCT02596035|41986923|FG002|Overall Study|participant no longer meets study criteria|0|||
19538490|NCT02596035|41986921|FG000|Overall Study|other reasons|11|||
19538491|NCT02596035|41986922|FG001|Overall Study|other reasons|4|||
19456662|NCT01756898|41707059|FG003|Overall Study|Lack of Efficacy|6|||
19456663|NCT01756898|41707056|FG000|Overall Study|Lost to Follow-up|2|||
19456664|NCT01756898|41707057|FG001|Overall Study|Lost to Follow-up|4|||
19456665|NCT01756898|41707058|FG002|Overall Study|Lost to Follow-up|2|||
19456666|NCT01756898|41707059|FG003|Overall Study|Lost to Follow-up|3|||
19456667|NCT01756898|41707056|FG000|Overall Study|Protocol Violation|1|||
19538492|NCT02596035|41986923|FG002|Overall Study|other reasons|0|||
19538493|NCT02595372|41986932|FG000|Overall Study|Adverse Event|6|||
19538494|NCT02595372|41986932|FG000|Overall Study|Physician Decision|2|||
19538495|NCT02595372|41986932|FG000|Overall Study|Disease Progression|1|||
19538496|NCT01248962|41986952|FG000|Overall Study|Withdrawal by Subject|1|||
19456668|NCT01756898|41707057|FG001|Overall Study|Protocol Violation|2|||
19456669|NCT01756898|41707058|FG002|Overall Study|Protocol Violation|2|||
19456670|NCT01756898|41707059|FG003|Overall Study|Protocol Violation|1|||
19456671|NCT01756898|41707056|FG000|Overall Study|Withdrew Consent|5|||
19456672|NCT01756898|41707057|FG001|Overall Study|Withdrew Consent|3|||
19456673|NCT01756898|41707058|FG002|Overall Study|Withdrew Consent|5|||
19456674|NCT01756898|41707059|FG003|Overall Study|Withdrew Consent|6|||
19456675|NCT01756898|41707056|FG000|Overall Study|Other|0|||
19456676|NCT01756898|41707057|FG001|Overall Study|Other|2|||
19456677|NCT01756898|41707058|FG002|Overall Study|Other|2|||
19456678|NCT01756898|41707059|FG003|Overall Study|Other|0|||
19456679|NCT01731938|41707076|FG000|Preliminary Part I|Withdrawal by Subject|2|||
19456680|NCT01731938|41707077|FG001|Preliminary Part I|Withdrawal by Subject|2|||
19456681|NCT01731938|41707076|FG000|Preliminary Part I|Physician Decision|1|||
19456682|NCT01731938|41707077|FG001|Preliminary Part I|Physician Decision|0|||
19456683|NCT01731938|41707076|FG000|Preliminary Part I|Lost to Follow-up|0|||
19538497|NCT01248962|41986953|FG001|Overall Study|Withdrawal by Subject|1|||
19538498|NCT01248962|41986952|FG000|Overall Study|Adverse Event|2|||
19538499|NCT01248962|41986953|FG001|Overall Study|Adverse Event|1|||
19538500|NCT01248962|41986952|FG000|Overall Study|Complete Response after 4 Cycles|1|||
19538501|NCT01248962|41986953|FG001|Overall Study|Complete Response after 4 Cycles|0|||
19538502|NCT01248962|41986952|FG000|Overall Study|Complete Response after 3 Cycles|0|||
19538503|NCT01248962|41986953|FG001|Overall Study|Complete Response after 3 Cycles|1|||
19538504|NCT01248962|41986952|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
19538505|NCT01248962|41986953|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
19538506|NCT01248455|41986960|FG000|Overall Study|switched to alternate treatment|1|||
19538507|NCT01247090|41986967|FG000|Overall Study|Physician Decision|1|||
19538508|NCT01247090|41986968|FG001|Overall Study|Physician Decision|0|||
19538509|NCT01247090|41986969|FG002|Overall Study|Physician Decision|0|||
19538510|NCT01247090|41986967|FG000|Overall Study|Withdrawal by Subject|0|||
19538511|NCT01247090|41986968|FG001|Overall Study|Withdrawal by Subject|1|||
19538512|NCT01247090|41986969|FG002|Overall Study|Withdrawal by Subject|0|||
19456684|NCT01731938|41707077|FG001|Preliminary Part I|Lost to Follow-up|3|||
19456685|NCT01731938|41707076|FG000|Preliminary Part I|Missed Week 6 visit|0|||
19456686|NCT01731938|41707077|FG001|Preliminary Part I|Missed Week 6 visit|3|||
19456687|NCT01731938|41707076|FG000|Primary Part II|Withdrawal by Subject|5|||
19456688|NCT01731938|41707077|FG001|Primary Part II|Withdrawal by Subject|4|||
19538513|NCT01249664|41986979|FG000|Overall Study|Withdrawal by Subject|5|||
19538514|NCT01249664|41986980|FG001|Overall Study|Withdrawal by Subject|0|||
19538515|NCT01249664|41986979|FG000|Overall Study|Adverse Event|1|||
19538516|NCT01249664|41986980|FG001|Overall Study|Adverse Event|0|||
19538517|NCT01249274|41986990|FG000|Overall Study|Lost to Follow-up|3|||
19538518|NCT01249274|41986991|FG001|Overall Study|Lost to Follow-up|4|||
19538519|NCT01249274|41986990|FG000|Overall Study|Received inpatient substance treatment|1|||
19538520|NCT01249274|41986991|FG001|Overall Study|Received inpatient substance treatment|2|||
19538521|NCT01249157|41986999|FG000|Overall Study|Withdrawal by Subject|1|||
19538522|NCT01249118|41987003|FG000|First Washout Period|Physician Decision|0|||
19538523|NCT01249118|41987004|FG001|First Washout Period|Physician Decision|1|||
19538524|NCT01249118|41987005|FG002|First Washout Period|Physician Decision|0|||
19538525|NCT01248884|41987015|FG000|Overall Study|Withdrawal by Subject|1|||
19538526|NCT01248884|41987016|FG001|Overall Study|Withdrawal by Subject|3|||
19538527|NCT01248884|41987017|FG002|Overall Study|Withdrawal by Subject|1|||
19538528|NCT01248884|41987015|FG000|Overall Study|Adverse Event|1|||
19538529|NCT01248884|41987016|FG001|Overall Study|Adverse Event|0|||
19538530|NCT01248884|41987017|FG002|Overall Study|Adverse Event|0|||
19538531|NCT01248728|41987029|FG000|Overall Study|Adverse Event|1|||
19538532|NCT01248728|41987030|FG001|Overall Study|Adverse Event|1|||
19538533|NCT01248728|41987029|FG000|Overall Study|Withdrawal by Subject|2|||
19538534|NCT01248728|41987030|FG001|Overall Study|Withdrawal by Subject|1|||
19538535|NCT01248728|41987029|FG000|Overall Study|Lack of Efficacy|1|||
19538536|NCT01248728|41987030|FG001|Overall Study|Lack of Efficacy|0|||
19538537|NCT01246973|41987040|FG000|Overall Study|Other|38|||
19538538|NCT01246973|41987041|FG001|Overall Study|Other|25|||
19538539|NCT01246973|41987040|FG000|Overall Study|Adverse Event|16|||
19538540|NCT01246973|41987041|FG001|Overall Study|Adverse Event|9|||
19538541|NCT01246973|41987040|FG000|Overall Study|Withdrawal by Subject|7|||
19538542|NCT01246973|41987041|FG001|Overall Study|Withdrawal by Subject|13|||
19538543|NCT01246466|41987047|FG000|Overall Study|Death|1|||
19538544|NCT01246466|41987047|FG000|Overall Study|Withdrawal by Subject|1|||
19538545|NCT01245764|41987056|FG000|Study Phase A|Other|3|||
19538546|NCT01245764|41987057|FG001|Study Phase A|Other|2|||
19538547|NCT01245764|41987058|FG002|Study Phase A|Other|3|||
19538548|NCT01245764|41987059|FG003|Study Phase A|Other|1|||
19538549|NCT01245764|41987056|FG000|Study Phase A|Protocol Violation|6|||
19631264|NCT00785928|42080505|FG003|Treatment Phase|Inadequate Response|0|||
19631265|NCT00785928|42080506|FG004|Treatment Phase|Inadequate Response|0|||
19631266|NCT00785928|42080507|FG005|Treatment Phase|Inadequate Response|0|||
19631267|NCT00785928|42080508|FG006|Treatment Phase|Inadequate Response|0|||
19631268|NCT00785928|42080502|FG000|Treatment Phase|Lack of Efficacy|0|||
19631269|NCT00785928|42080503|FG001|Treatment Phase|Lack of Efficacy|1|||
19631270|NCT00785928|42080504|FG002|Treatment Phase|Lack of Efficacy|1|||
19631271|NCT00785928|42080505|FG003|Treatment Phase|Lack of Efficacy|0|||
19631272|NCT00785928|42080506|FG004|Treatment Phase|Lack of Efficacy|0|||
19631273|NCT00785928|42080507|FG005|Treatment Phase|Lack of Efficacy|0|||
19631274|NCT00785928|42080508|FG006|Treatment Phase|Lack of Efficacy|0|||
19631275|NCT00785928|42080502|FG000|Treatment Phase|Physician Decision|0|||
19631276|NCT00785928|42080503|FG001|Treatment Phase|Physician Decision|0|||
19631277|NCT00785928|42080504|FG002|Treatment Phase|Physician Decision|0|||
19631278|NCT00785928|42080505|FG003|Treatment Phase|Physician Decision|0|||
19631279|NCT00785928|42080506|FG004|Treatment Phase|Physician Decision|1|||
19631280|NCT00785928|42080507|FG005|Treatment Phase|Physician Decision|0|||
19631281|NCT00785928|42080508|FG006|Treatment Phase|Physician Decision|0|||
19631282|NCT00785928|42080502|FG000|Treatment Phase|Sponsor Decision|1|||
19631283|NCT00785928|42080503|FG001|Treatment Phase|Sponsor Decision|0|||
19538550|NCT01245764|41987057|FG001|Study Phase A|Protocol Violation|3|||
19631284|NCT00785928|42080504|FG002|Treatment Phase|Sponsor Decision|0|||
19631285|NCT00785928|42080505|FG003|Treatment Phase|Sponsor Decision|0|||
19631286|NCT00785928|42080506|FG004|Treatment Phase|Sponsor Decision|0|||
19631287|NCT00785928|42080507|FG005|Treatment Phase|Sponsor Decision|0|||
19631288|NCT00785928|42080508|FG006|Treatment Phase|Sponsor Decision|1|||
19631289|NCT00785928|42080502|FG000|Treatment Phase|Withdrawal by Subject|1|||
19631290|NCT00785928|42080503|FG001|Treatment Phase|Withdrawal by Subject|2|||
19631291|NCT00785928|42080504|FG002|Treatment Phase|Withdrawal by Subject|0|||
19631292|NCT00785928|42080505|FG003|Treatment Phase|Withdrawal by Subject|0|||
19631293|NCT00785928|42080506|FG004|Treatment Phase|Withdrawal by Subject|1|||
19631294|NCT00785928|42080507|FG005|Treatment Phase|Withdrawal by Subject|0|||
19631295|NCT00785928|42080508|FG006|Treatment Phase|Withdrawal by Subject|0|||
19631296|NCT00842309|42080548|FG000|Overall Study|Withdrawal by Subject|3|||
19631297|NCT00842309|42080549|FG001|Overall Study|Withdrawal by Subject|1|||
19631298|NCT00842153|42080557|FG000|Overall Study|Adverse Event|0|||
19631299|NCT00842153|42080558|FG001|Overall Study|Adverse Event|1|||
19631300|NCT00842153|42080557|FG000|Overall Study|Lost to Follow-up|1|||
19631301|NCT00842153|42080558|FG001|Overall Study|Lost to Follow-up|2|||
19631302|NCT00762411|42080566|FG000|Initial Treatment|Death|7|||
19631303|NCT00762411|42080567|FG001|Initial Treatment|Death|6|||
19631304|NCT00762411|42080566|FG000|Initial Treatment|Adverse Event|132|||
19631305|NCT00762411|42080567|FG001|Initial Treatment|Adverse Event|40|||
19538551|NCT01245764|41987058|FG002|Study Phase A|Protocol Violation|2|||
19538552|NCT01245764|41987059|FG003|Study Phase A|Protocol Violation|2|||
19538553|NCT01245764|41987056|FG000|Study Phase A|Lost to Follow-up|0|||
19538554|NCT01245764|41987057|FG001|Study Phase A|Lost to Follow-up|0|||
19538555|NCT01245764|41987058|FG002|Study Phase A|Lost to Follow-up|5|||
19538556|NCT01245764|41987059|FG003|Study Phase A|Lost to Follow-up|0|||
19631306|NCT00762411|42080566|FG000|Initial Treatment|Protocol Violation|4|||
19538557|NCT01245140|41987079|FG000|Overall Study|Adverse Event|1|||
19538558|NCT01245140|41987080|FG001|Overall Study|Adverse Event|3|||
19538559|NCT01245140|41987079|FG000|Overall Study|Lack of Efficacy|2|||
19538560|NCT01245140|41987080|FG001|Overall Study|Lack of Efficacy|4|||
19538561|NCT01245140|41987079|FG000|Overall Study|Protocol Violation|0|||
19538562|NCT01245140|41987080|FG001|Overall Study|Protocol Violation|1|||
19538563|NCT01245140|41987079|FG000|Overall Study|Withdrawal by Subject|0|||
19538564|NCT01245140|41987080|FG001|Overall Study|Withdrawal by Subject|1|||
19538565|NCT01245140|41987079|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
19538566|NCT01245140|41987080|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
19538567|NCT01245101|41987088|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
19631307|NCT00762411|42080567|FG001|Initial Treatment|Protocol Violation|1|||
19631308|NCT00762411|42080566|FG000|Initial Treatment|Withdrawal by Subject|65|||
19631309|NCT00762411|42080567|FG001|Initial Treatment|Withdrawal by Subject|52|||
19631310|NCT00762411|42080566|FG000|Initial Treatment|Physician Decision|1|||
19631311|NCT00762411|42080567|FG001|Initial Treatment|Physician Decision|0|||
19631312|NCT00762411|42080566|FG000|Initial Treatment|Sponsor Decision|293|||
19631313|NCT00762411|42080567|FG001|Initial Treatment|Sponsor Decision|401|||
19631314|NCT00762411|42080566|FG000|Initial Treatment|Lost to Follow-up|5|||
19631315|NCT00762411|42080567|FG001|Initial Treatment|Lost to Follow-up|0|||
19631316|NCT00762411|42080566|FG000|Initial Treatment|Caregiver Decision|21|||
19631317|NCT00762411|42080567|FG001|Initial Treatment|Caregiver Decision|16|||
19631318|NCT00762411|42080566|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
19631319|NCT00762411|42080567|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
19631320|NCT00762411|42080566|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
19631321|NCT00762411|42080567|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
19631322|NCT00762411|42080566|FG000|Delayed Start|Adverse Event|0|||
19631323|NCT00762411|42080567|FG001|Delayed Start|Adverse Event|4|||
19631324|NCT00762411|42080566|FG000|Delayed Start|Protocol Violation|0|||
19631325|NCT00762411|42080567|FG001|Delayed Start|Protocol Violation|1|||
19631326|NCT00762411|42080566|FG000|Delayed Start|Sponsor Decision|16|||
19631327|NCT00762411|42080567|FG001|Delayed Start|Sponsor Decision|20|||
19631328|NCT00762411|42080566|FG000|Delayed Start|Caregiver Decision|1|||
19631329|NCT00762411|42080567|FG001|Delayed Start|Caregiver Decision|1|||
19631330|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
19631331|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
19631332|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
19631333|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
19631334|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
19631335|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
19631336|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
19631337|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
19631338|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
19631339|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
19631340|NCT00762411|42080566|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
19631341|NCT00762411|42080567|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
19631342|NCT00761865|42080579|FG000|Overall Study|Lost to Follow-up|8|||
19631343|NCT00761865|42080580|FG001|Overall Study|Lost to Follow-up|7|||
19631344|NCT00841763|42080588|FG000|Overall Study|Withdrawal by Subject|60|||
19631345|NCT00841763|42080589|FG001|Overall Study|Withdrawal by Subject|17|||
19631346|NCT00841763|42080590|FG002|Overall Study|Withdrawal by Subject|4|||
19631347|NCT00841763|42080591|FG003|Overall Study|Withdrawal by Subject|1|||
19631348|NCT00841763|42080588|FG000|Overall Study|Adverse Event|9|||
19631349|NCT00841763|42080589|FG001|Overall Study|Adverse Event|10|||
19631350|NCT00841763|42080590|FG002|Overall Study|Adverse Event|3|||
19538568|NCT01245101|41987089|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
19538569|NCT01245101|41987088|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
19538570|NCT01245101|41987089|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
19538571|NCT01245101|41987088|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
19538572|NCT01245101|41987089|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
19538573|NCT01245062|41987097|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
19538574|NCT01245062|41987098|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
19538575|NCT01245062|41987099|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
19538576|NCT01245062|41987097|FG000|Randomization and Crossover Phase|Physician Decision|2|||
19631351|NCT00841763|42080591|FG003|Overall Study|Adverse Event|2|||
19538577|NCT01245062|41987098|FG001|Randomization and Crossover Phase|Physician Decision|4|||
19538578|NCT01245062|41987099|FG002|Randomization and Crossover Phase|Physician Decision|0|||
19631352|NCT00841763|42080588|FG000|Overall Study|Lost to Follow-up|63|||
19631353|NCT00841763|42080589|FG001|Overall Study|Lost to Follow-up|25|||
19631354|NCT00841763|42080590|FG002|Overall Study|Lost to Follow-up|0|||
19631355|NCT00841763|42080591|FG003|Overall Study|Lost to Follow-up|0|||
19631356|NCT00841763|42080588|FG000|Overall Study|Protocol Violation|20|||
19538579|NCT01245062|41987097|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
19538580|NCT01245062|41987098|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
19538581|NCT01245062|41987099|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
19538582|NCT01245062|41987097|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
19538583|NCT01245062|41987098|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
19538584|NCT01245062|41987099|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
19538585|NCT01245062|41987097|FG000|Cross-over Phase|Lost to Follow-up|0|||
19538586|NCT01245062|41987098|FG001|Cross-over Phase|Lost to Follow-up|0|||
19538587|NCT01245062|41987099|FG002|Cross-over Phase|Lost to Follow-up|1|||
19538588|NCT01245062|41987097|FG000|Cross-over Phase|Physician Decision|0|||
19538589|NCT01245062|41987098|FG001|Cross-over Phase|Physician Decision|0|||
19538590|NCT01245062|41987099|FG002|Cross-over Phase|Physician Decision|1|||
19538591|NCT01245062|41987097|FG000|Cross-over Phase|Withdrew Consent|0|||
19538592|NCT01245062|41987098|FG001|Cross-over Phase|Withdrew Consent|0|||
19538593|NCT01245062|41987099|FG002|Cross-over Phase|Withdrew Consent|4|||
19538594|NCT01245062|41987097|FG000|Cross-over Phase|Study closed/ terminated|0|||
19538595|NCT01245062|41987098|FG001|Cross-over Phase|Study closed/ terminated|0|||
19538596|NCT01245062|41987099|FG002|Cross-over Phase|Study closed/ terminated|11|||
19538597|NCT01244984|41987110|FG000|Overall Study|Adverse Event|2|||
19538598|NCT01244984|41987111|FG001|Overall Study|Adverse Event|11|||
19538599|NCT01244984|41987112|FG002|Overall Study|Adverse Event|2|||
19538600|NCT01244984|41987110|FG000|Overall Study|Protocol Violation|1|||
19538601|NCT01244984|41987111|FG001|Overall Study|Protocol Violation|0|||
19538602|NCT01244984|41987112|FG002|Overall Study|Protocol Violation|0|||
19538603|NCT01244984|41987110|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
19538604|NCT01244984|41987111|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
19538605|NCT01244984|41987112|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
19538606|NCT01244984|41987110|FG000|Overall Study|Withdrawal by Subject|1|||
19538607|NCT01244984|41987111|FG001|Overall Study|Withdrawal by Subject|2|||
19538608|NCT01244984|41987112|FG002|Overall Study|Withdrawal by Subject|2|||
19538609|NCT01244516|41987124|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
19538610|NCT01244516|41987125|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
19538611|NCT01244516|41987126|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
19538612|NCT01244516|41987124|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
19538613|NCT01244516|41987125|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
19538614|NCT01244516|41987126|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
19538615|NCT01244516|41987124|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
19538616|NCT01244516|41987125|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
19538617|NCT01244516|41987126|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
19538618|NCT01244516|41987124|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
19538619|NCT01244516|41987125|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
19538620|NCT01244516|41987126|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
19538621|NCT01244516|41987124|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
19538622|NCT01244516|41987125|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
19538623|NCT01244516|41987126|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
19538624|NCT01244516|41987124|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
19538625|NCT01244516|41987125|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
19538626|NCT01244516|41987126|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
19538627|NCT01244516|41987124|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
19538628|NCT01244516|41987125|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
19538629|NCT01244516|41987126|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
19538630|NCT01244126|41987138|FG000|Overall Study|Protocol Violation|3|||
19538631|NCT01244126|41987139|FG001|Overall Study|Protocol Violation|3|||
19538632|NCT01244126|41987140|FG002|Overall Study|Protocol Violation|9|||
19538633|NCT01243892|41987150|FG000|Overall Study|Did not meet eligibility criteria|2|||
19538634|NCT01243892|41987151|FG001|Overall Study|Did not meet eligibility criteria|0|||
19538635|NCT01243775|41987157|FG000|Overall Study|Withdrawal by Subject|2|||
19538636|NCT01243268|41987161|FG000|Overall Study|Lost to Follow-up|4|||
19538637|NCT01243268|41987161|FG000|Overall Study|Protocol Violation|51|||
19456689|NCT01731938|41707076|FG000|Primary Part II|Lost to Follow-up|4|||
19456690|NCT01731938|41707077|FG001|Primary Part II|Lost to Follow-up|5|||
19456691|NCT01731938|41707076|FG000|Primary Part II|Death|2|||
19456692|NCT01731938|41707077|FG001|Primary Part II|Death|1|||
19456693|NCT01731938|41707076|FG000|Primary Part II|Missed Week 6 visit|2|||
19456694|NCT01731938|41707077|FG001|Primary Part II|Missed Week 6 visit|3|||
19456695|NCT01731470|41707084|FG000|Overall Study|Withdrawal by Subject|1|||
19456696|NCT01731470|41707084|FG000|Overall Study|Did not meet study criteria|1|||
19456697|NCT01756352|41707088|FG000|Overall Study|moved away and lost to followup|1|||
19538638|NCT01243268|41987161|FG000|Overall Study|Deviation with contract date|7|||
19538639|NCT01243268|41987161|FG000|Overall Study|Duplicate subject|2|||
19538640|NCT01242371|41987167|FG000|Overall Study|Withdrawal by Subject|2|||
19538641|NCT01242371|41987168|FG001|Overall Study|Withdrawal by Subject|2|||
19538642|NCT01242371|41987167|FG000|Overall Study|Protocol Violation|0|||
19456698|NCT01756274|41707092|FG000|Overall Study|Protocol Violation|2|||
19456699|NCT01756274|41707092|FG000|Overall Study|Laboratory error|1|||
19456700|NCT01731002|41707100|FG000|Overall Study|Adverse Event|0|||
19456701|NCT01731002|41707101|FG001|Overall Study|Adverse Event|2|||
19456702|NCT01731002|41707102|FG002|Overall Study|Adverse Event|2|||
19456703|NCT01731002|41707100|FG000|Overall Study|Non-Compliant|0|||
19456704|NCT01731002|41707101|FG001|Overall Study|Non-Compliant|1|||
19456705|NCT01731002|41707102|FG002|Overall Study|Non-Compliant|0|||
19456706|NCT01731002|41707100|FG000|Overall Study|Lost to Follow-up|1|||
19456707|NCT01731002|41707101|FG001|Overall Study|Lost to Follow-up|0|||
19456708|NCT01731002|41707102|FG002|Overall Study|Lost to Follow-up|0|||
19456709|NCT01731002|41707100|FG000|Overall Study|Test Agent Discontinuation|0|||
19456710|NCT01731002|41707101|FG001|Overall Study|Test Agent Discontinuation|1|||
19538643|NCT01242371|41987168|FG001|Overall Study|Protocol Violation|3|||
19538644|NCT01242176|41987174|FG000|Washout Period of 7 Days|Adverse Event|0|||
19538645|NCT01242176|41987175|FG001|Washout Period of 7 Days|Adverse Event|2|||
19538646|NCT01242176|41987174|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
19538647|NCT01242176|41987175|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
19538648|NCT01242020|41987183|FG000|Overall Study|Withdrawal by Subject|2|||
19538649|NCT01242020|41987184|FG001|Overall Study|Withdrawal by Subject|0|||
19538650|NCT01242020|41987183|FG000|Overall Study|Failed screening|1|||
19538651|NCT01242020|41987184|FG001|Overall Study|Failed screening|0|||
19538652|NCT01241786|41987190|FG000|Overall Study|Lack of Efficacy|5|||
19538653|NCT01241318|41987197|FG000|Overall Study|Woman: false pregnancies|27|||
19538654|NCT01241318|41987198|FG001|Overall Study|Woman: false pregnancies|15|||
19538655|NCT01241318|41987197|FG000|Overall Study|Woman: miscarriage/abortion|46|||
19538656|NCT01241318|41987198|FG001|Overall Study|Woman: miscarriage/abortion|38|||
19538657|NCT01241318|41987197|FG000|Overall Study|Withdrawal by Subject|175|||
19538658|NCT01241318|41987198|FG001|Overall Study|Withdrawal by Subject|46|||
19538659|NCT01241318|41987197|FG000|Overall Study|Lost to Follow-up|740|||
19538660|NCT01241318|41987198|FG001|Overall Study|Lost to Follow-up|455|||
19538661|NCT01241318|41987197|FG000|Overall Study|Death|2|||
19538662|NCT01241318|41987198|FG001|Overall Study|Death|4|||
19538663|NCT01241318|41987197|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
19538664|NCT01241318|41987198|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
19538665|NCT01241318|41987197|FG000|Overall Study|Woman: Stillborn infant|129|||
19538666|NCT01241318|41987198|FG001|Overall Study|Woman: Stillborn infant|146|||
19538667|NCT01241279|41987209|FG000|Overall Study|Lost to Follow-up|0|||
19538668|NCT01241279|41987210|FG001|Overall Study|Lost to Follow-up|1|||
19538669|NCT01241240|41987218|FG000|Overall Study|Adverse Event|5|||
19538670|NCT01241240|41987219|FG001|Overall Study|Adverse Event|4|||
19538671|NCT01241240|41987218|FG000|Overall Study|Lost to Follow-up|2|||
19538672|NCT01241240|41987219|FG001|Overall Study|Lost to Follow-up|4|||
19538673|NCT01241240|41987218|FG000|Overall Study|Personal Reasons|1|||
19538674|NCT01241240|41987219|FG001|Overall Study|Personal Reasons|1|||
19538675|NCT01240811|41987228|FG000|Overall Study|Physician Decision|0|||
19456711|NCT01731002|41707102|FG002|Overall Study|Test Agent Discontinuation|0|||
19456712|NCT01731002|41707100|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
19538676|NCT01240811|41987229|FG001|Overall Study|Physician Decision|1|||
19538677|NCT01240811|41987230|FG002|Overall Study|Physician Decision|0|||
19538678|NCT01240811|41987228|FG000|Overall Study|Withdrawal by Subject|0|||
19538679|NCT01240811|41987229|FG001|Overall Study|Withdrawal by Subject|0|||
19538680|NCT01240811|41987230|FG002|Overall Study|Withdrawal by Subject|1|||
19538681|NCT01240382|41987242|FG000|Overall Study|Adverse Event|2|||
19538682|NCT01240382|41987243|FG001|Overall Study|Adverse Event|1|||
19538683|NCT01240382|41987242|FG000|Overall Study|Lack of Efficacy|0|||
19538684|NCT01240382|41987243|FG001|Overall Study|Lack of Efficacy|2|||
19538685|NCT01240382|41987242|FG000|Overall Study|Fear of adverse events|0|||
19538686|NCT01240382|41987243|FG001|Overall Study|Fear of adverse events|1|||
19538687|NCT01244828|41987249|FG000|Overall Study|Adverse Event|37|||
19538688|NCT01244828|41987249|FG000|Overall Study|Withdrawal by Subject|31|||
19538689|NCT01244828|41987249|FG000|Overall Study|Lack of Efficacy|7|||
19631357|NCT00841763|42080589|FG001|Overall Study|Protocol Violation|3|||
19631358|NCT00841763|42080590|FG002|Overall Study|Protocol Violation|1|||
19631359|NCT00841763|42080591|FG003|Overall Study|Protocol Violation|0|||
19375336|NCT02279524|41617212|FG001|Overall Study|Withdrawal by Subject|6|||
19375337|NCT02279524|41617213|FG002|Overall Study|Withdrawal by Subject|3|||
19375338|NCT02279524|41617211|FG000|Overall Study|Adverse Event|4|||
19375339|NCT02279524|41617212|FG001|Overall Study|Adverse Event|3|||
19375340|NCT02279524|41617213|FG002|Overall Study|Adverse Event|2|||
19375341|NCT02279524|41617211|FG000|Overall Study|Lost to Follow-up|1|||
19375342|NCT02279524|41617212|FG001|Overall Study|Lost to Follow-up|1|||
19375343|NCT02279524|41617213|FG002|Overall Study|Lost to Follow-up|0|||
19375344|NCT02279524|41617211|FG000|Overall Study|Disallowed medication|1|||
19375345|NCT02279524|41617212|FG001|Overall Study|Disallowed medication|1|||
19538690|NCT01244828|41987249|FG000|Overall Study|Lost to Follow-up|2|||
19631360|NCT00841763|42080588|FG000|Overall Study|Administrative Reasons|3|||
19375346|NCT02279524|41617213|FG002|Overall Study|Disallowed medication|2|||
19538691|NCT01244828|41987249|FG000|Overall Study|Other reason (not specified)|1|||
19538692|NCT01249833|41987255|FG000|Overall Study|Lost to Follow-up|0|||
19538693|NCT01249833|41987256|FG001|Overall Study|Lost to Follow-up|1|||
19538694|NCT01249404|41987265|FG000|Overall Study|Study treatment not received|0|||
19538695|NCT01249404|41987266|FG001|Overall Study|Study treatment not received|1|||
19538696|NCT01249404|41987267|FG002|Overall Study|Study treatment not received|2|||
19538697|NCT01249404|41987265|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
19538698|NCT01249404|41987266|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
19538699|NCT01249404|41987267|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
19538700|NCT01249404|41987265|FG000|Overall Study|Adverse Event|2|||
19538701|NCT01249404|41987266|FG001|Overall Study|Adverse Event|2|||
19538702|NCT01249404|41987267|FG002|Overall Study|Adverse Event|2|||
19538703|NCT01249404|41987265|FG000|Overall Study|Withdrawal by Subject|2|||
19538704|NCT01249404|41987266|FG001|Overall Study|Withdrawal by Subject|2|||
19538705|NCT01249404|41987267|FG002|Overall Study|Withdrawal by Subject|0|||
19456713|NCT01731002|41707101|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
19456714|NCT01731002|41707102|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
19456715|NCT01731002|41707100|FG000|Overall Study|Elevated IOP|1|||
19456716|NCT01731002|41707101|FG001|Overall Study|Elevated IOP|0|||
19456717|NCT01731002|41707102|FG002|Overall Study|Elevated IOP|0|||
19456718|NCT01731002|41707100|FG000|Overall Study|Inappropriate use of study medications|0|||
19456719|NCT01731002|41707101|FG001|Overall Study|Inappropriate use of study medications|0|||
19456720|NCT01731002|41707102|FG002|Overall Study|Inappropriate use of study medications|1|||
19456721|NCT01783886|41707113|FG000|Overall Study|Lost to Follow-up|0|||
19456722|NCT01783886|41707114|FG001|Overall Study|Lost to Follow-up|3|||
19456723|NCT01783886|41707115|FG002|Overall Study|Lost to Follow-up|0|||
19456724|NCT01783886|41707113|FG000|Overall Study|Protocol deviation|0|||
19538706|NCT01249404|41987265|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
19538707|NCT01249404|41987266|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
19538708|NCT01249404|41987267|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
19538709|NCT01249404|41987265|FG000|Overall Study|Non compliance to visit schedule|0|||
19538710|NCT01249404|41987266|FG001|Overall Study|Non compliance to visit schedule|1|||
19538711|NCT01249404|41987267|FG002|Overall Study|Non compliance to visit schedule|0|||
19538712|NCT01249365|41987275|FG000|Overall Study|Lost to Follow-up|1|||
19538713|NCT01249131|41987279|FG000|Washout Period of 10 Days|Adverse Event|0|||
19538714|NCT01249131|41987280|FG001|Washout Period of 10 Days|Adverse Event|0|||
19538715|NCT01249131|41987281|FG002|Washout Period of 10 Days|Adverse Event|0|||
19538716|NCT01249131|41987282|FG003|Washout Period of 10 Days|Adverse Event|0|||
19538717|NCT01249131|41987283|FG004|Washout Period of 10 Days|Adverse Event|1|||
19538718|NCT01249131|41987284|FG005|Washout Period of 10 Days|Adverse Event|0|||
19538719|NCT01249092|41987292|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
19538720|NCT01249092|41987292|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
19538721|NCT01248936|41987298|FG000|Overall Study|Sponsor Decision|259|||
19538722|NCT01248936|41987298|FG000|Overall Study|Progression of Disease|50|||
19538723|NCT01248936|41987298|FG000|Overall Study|Death|26|||
19538724|NCT01248936|41987298|FG000|Overall Study|Withdrawal of Consent|20|||
19538725|NCT01248936|41987298|FG000|Overall Study|Adverse Event|8|||
19456725|NCT01783886|41707114|FG001|Overall Study|Protocol deviation|0|||
19456726|NCT01783886|41707115|FG002|Overall Study|Protocol deviation|2|||
19456727|NCT01783886|41707113|FG000|Overall Study|Withdrawal of consent by participant|1|||
19456728|NCT01783886|41707114|FG001|Overall Study|Withdrawal of consent by participant|3|||
19456729|NCT01783886|41707115|FG002|Overall Study|Withdrawal of consent by participant|4|||
19456730|NCT01783886|41707113|FG000|Overall Study|Adverse Event|4|||
19456731|NCT01783886|41707114|FG001|Overall Study|Adverse Event|5|||
19456732|NCT01783886|41707115|FG002|Overall Study|Adverse Event|4|||
19456733|NCT01468701|41707893|FG000|Overall Study|Not eligible|91|||
19456734|NCT01468701|41707894|FG001|Overall Study|Not eligible|140|||
19456735|NCT01468701|41707895|FG002|Overall Study|Not eligible|29|||
19538726|NCT01248936|41987298|FG000|Overall Study|Lost to Follow-up|7|||
19538727|NCT01248936|41987298|FG000|Overall Study|Refused Treatment|1|||
19538728|NCT01248936|41987298|FG000|Overall Study|Other reason|3|||
19538729|NCT01248780|41987305|FG000|Overall Study|Lack of Efficacy|2|||
19538730|NCT01248780|41987306|FG001|Overall Study|Lack of Efficacy|0|||
19538731|NCT01248780|41987305|FG000|Overall Study|Lost to Follow-up|0|||
19538732|NCT01248780|41987306|FG001|Overall Study|Lost to Follow-up|1|||
19538733|NCT01248780|41987305|FG000|Overall Study|Death|0|||
19538734|NCT01248780|41987306|FG001|Overall Study|Death|1|||
19456736|NCT01468701|41707896|FG003|Overall Study|Not eligible|12|||
19538735|NCT01248780|41987305|FG000|Overall Study|Adverse Event|2|||
19538736|NCT01248780|41987306|FG001|Overall Study|Adverse Event|7|||
19538737|NCT01248780|41987305|FG000|Overall Study|Protocol Violation|1|||
19538738|NCT01248780|41987306|FG001|Overall Study|Protocol Violation|1|||
19538739|NCT01248780|41987305|FG000|Overall Study|Withdrawal by Subject|4|||
19538740|NCT01248780|41987306|FG001|Overall Study|Withdrawal by Subject|4|||
19538741|NCT01248780|41987305|FG000|Overall Study|Not treated|0|||
19538742|NCT01248780|41987306|FG001|Overall Study|Not treated|1|||
19538743|NCT01248468|41987315|FG000|Overall Study|Administrative problem|1|||
19538744|NCT01248468|41987316|FG001|Overall Study|Administrative problem|0|||
19538745|NCT01248468|41987317|FG002|Overall Study|Administrative problem|0|||
19538746|NCT01248468|41987315|FG000|Overall Study|Lost to Follow-up|9|||
19538747|NCT01248468|41987316|FG001|Overall Study|Lost to Follow-up|12|||
19538748|NCT01248468|41987317|FG002|Overall Study|Lost to Follow-up|4|||
19538749|NCT01248468|41987315|FG000|Overall Study|Pregnancy|1|||
19538750|NCT01248468|41987316|FG001|Overall Study|Pregnancy|0|||
19538751|NCT01248468|41987317|FG002|Overall Study|Pregnancy|0|||
19538752|NCT01248468|41987315|FG000|Overall Study|Withdrawal by Subject|4|||
19538753|NCT01248468|41987316|FG001|Overall Study|Withdrawal by Subject|2|||
19538754|NCT01248468|41987317|FG002|Overall Study|Withdrawal by Subject|0|||
19538755|NCT01247922|41987325|FG000|Overall Study|Disease progression|4|||
19538756|NCT01246206|41987329|FG000|Overall Study|Patient did not receive study regiments.|1|||
19538757|NCT01246011|41987336|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
19538758|NCT01246011|41987337|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
19538759|NCT01246011|41987338|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
19538760|NCT01246011|41987336|FG000|Overall Study|Withdrawal by Subject|0|||
19538761|NCT01246011|41987337|FG001|Overall Study|Withdrawal by Subject|0|||
19538762|NCT01246011|41987338|FG002|Overall Study|Withdrawal by Subject|1|||
19538763|NCT01244490|41987350|FG000|Overall Study|Lack of Efficacy|14|||
19538764|NCT01244490|41987351|FG001|Overall Study|Lack of Efficacy|5|||
19538765|NCT01244490|41987352|FG002|Overall Study|Lack of Efficacy|5|||
19538766|NCT01244490|41987350|FG000|Overall Study|Withdrawal by Subject|4|||
19538767|NCT01244490|41987351|FG001|Overall Study|Withdrawal by Subject|4|||
19538768|NCT01244490|41987352|FG002|Overall Study|Withdrawal by Subject|9|||
19538769|NCT01244490|41987350|FG000|Overall Study|Adverse Event|1|||
19538770|NCT01244490|41987351|FG001|Overall Study|Adverse Event|9|||
19538771|NCT01244490|41987352|FG002|Overall Study|Adverse Event|5|||
19538772|NCT01244490|41987350|FG000|Overall Study|Lost to Follow-up|0|||
19538773|NCT01244490|41987351|FG001|Overall Study|Lost to Follow-up|6|||
19538774|NCT01244490|41987352|FG002|Overall Study|Lost to Follow-up|3|||
19538775|NCT01244490|41987350|FG000|Overall Study|Other|0|||
19538776|NCT01244490|41987351|FG001|Overall Study|Other|0|||
19538777|NCT01244490|41987352|FG002|Overall Study|Other|1|||
19538778|NCT01243944|41987362|FG000|Overall Study|Adverse Event|15|||
19538779|NCT01243944|41987363|FG001|Overall Study|Adverse Event|13|||
19538780|NCT01243944|41987362|FG000|Overall Study|Lost to Follow-up|2|||
19538781|NCT01243944|41987363|FG001|Overall Study|Lost to Follow-up|1|||
19538782|NCT01243944|41987362|FG000|Overall Study|Physician Decision|2|||
19538783|NCT01243944|41987363|FG001|Overall Study|Physician Decision|7|||
19538784|NCT01243944|41987362|FG000|Overall Study|Disease progression|12|||
19538785|NCT01243944|41987363|FG001|Overall Study|Disease progression|11|||
19538786|NCT01243944|41987362|FG000|Overall Study|Protocol deviation|1|||
19538787|NCT01243944|41987363|FG001|Overall Study|Protocol deviation|1|||
19538788|NCT01243944|41987362|FG000|Overall Study|Participant decision|10|||
19538789|NCT01243944|41987363|FG001|Overall Study|Participant decision|15|||
19538790|NCT01243944|41987362|FG000|Overall Study|Death|2|||
19538791|NCT01243944|41987363|FG001|Overall Study|Death|3|||
19538792|NCT01243944|41987362|FG000|Overall Study|Non-compliance with study treatment|1|||
19538793|NCT01243944|41987363|FG001|Overall Study|Non-compliance with study treatment|0|||
19538794|NCT01243242|41987372|FG000|Overall Study|Adverse Event|1|||
19538795|NCT01243242|41987373|FG001|Overall Study|Adverse Event|1|||
19538796|NCT01243242|41987372|FG000|Overall Study|Withdrawal by Subject|1|||
19538797|NCT01243242|41987373|FG001|Overall Study|Withdrawal by Subject|1|||
19538798|NCT01243242|41987372|FG000|Overall Study|Physician Decision|0|||
19538799|NCT01243242|41987373|FG001|Overall Study|Physician Decision|1|||
19538800|NCT01243242|41987372|FG000|Overall Study|sponsor decision|0|||
19538801|NCT01243242|41987373|FG001|Overall Study|sponsor decision|1|||
19456737|NCT01468701|41707897|FG004|Overall Study|Not eligible|22|||
19456738|NCT01468701|41707898|FG005|Overall Study|Not eligible|2|||
19456739|NCT01468701|41707899|FG006|Overall Study|Not eligible|39|||
19456740|NCT01468701|41707900|FG007|Overall Study|Not eligible|1|||
19456741|NCT01468701|41707901|FG008|Overall Study|Not eligible|40|||
19456742|NCT01468701|41707902|FG009|Overall Study|Not eligible|126|||
19456743|NCT01468701|41707903|FG010|Overall Study|Not eligible|39|||
19538802|NCT01243242|41987372|FG000|Overall Study|non compliance|1|||
19538803|NCT01243242|41987373|FG001|Overall Study|non compliance|0|||
19538804|NCT01242813|41987379|FG000|Overall Study|Lost to Follow-up|2|||
19456744|NCT01468701|41707904|FG011|Overall Study|Not eligible|33|||
19456745|NCT01468701|41707905|FG012|Overall Study|Not eligible|1|||
19456746|NCT01468701|41707906|FG013|Overall Study|Not eligible|19|||
19538805|NCT01242111|41987383|FG000|Overall Study|Adverse Event|1|||
19538806|NCT01242111|41987383|FG000|Overall Study|Withdrawal by Subject|1|||
19538807|NCT01242111|41987383|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
19538808|NCT01241604|41987387|FG000|Screening Period|Screen Failure|3|||
19538809|NCT01241604|41987388|FG001|Screening Period|Screen Failure|0|||
19538810|NCT01241604|41987389|FG002|Screening Period|Screen Failure|0|||
19538811|NCT01241292|41987398|FG000|Overall Study|Administrative Reason by Sponsor|1|||
19456747|NCT01468701|41707907|FG014|Overall Study|Not eligible|1|||
19456748|NCT01468701|41707908|FG015|Overall Study|Not eligible|32|||
19456749|NCT01468701|41707909|FG016|Overall Study|Not eligible|0|||
19456750|NCT01468701|41707893|FG000|Overall Study|Lost to Follow-up|306|||
19456751|NCT01468701|41707894|FG001|Overall Study|Lost to Follow-up|0|||
19456752|NCT01468701|41707895|FG002|Overall Study|Lost to Follow-up|0|||
19456753|NCT01468701|41707896|FG003|Overall Study|Lost to Follow-up|0|||
19456754|NCT01468701|41707897|FG004|Overall Study|Lost to Follow-up|0|||
19538812|NCT01241292|41987399|FG001|Overall Study|Administrative Reason by Sponsor|0|||
19538813|NCT01241292|41987398|FG000|Overall Study|Disease Progression|2|||
19538814|NCT01241292|41987399|FG001|Overall Study|Disease Progression|0|||
19538815|NCT01241292|41987398|FG000|Overall Study|Study Drug Toxicity|0|||
19538816|NCT01241292|41987399|FG001|Overall Study|Study Drug Toxicity|1|||
19538817|NCT01241292|41987398|FG000|Overall Study|Participant Discontinued Treatment|0|||
19538818|NCT01241292|41987399|FG001|Overall Study|Participant Discontinued Treatment|2|||
19538819|NCT01240863|41987411|FG000|Open-label Titration Period|Adverse Event|47|||
19538820|NCT01240863|41987412|FG001|Open-label Titration Period|Adverse Event|0|||
19538821|NCT01240863|41987413|FG002|Open-label Titration Period|Adverse Event|0|||
19538822|NCT01240863|41987411|FG000|Open-label Titration Period|Lack of Efficacy|19|||
19538823|NCT01240863|41987412|FG001|Open-label Titration Period|Lack of Efficacy|0|||
19538824|NCT01240863|41987413|FG002|Open-label Titration Period|Lack of Efficacy|0|||
19538825|NCT01240863|41987411|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
19538826|NCT01240863|41987412|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
19538827|NCT01240863|41987413|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
19538828|NCT01240863|41987411|FG000|Open-label Titration Period|Protocol Violation|7|||
19538829|NCT01240863|41987412|FG001|Open-label Titration Period|Protocol Violation|0|||
19538830|NCT01240863|41987413|FG002|Open-label Titration Period|Protocol Violation|0|||
19538831|NCT01240863|41987411|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
19538832|NCT01240863|41987412|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
19538833|NCT01240863|41987413|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
19538834|NCT01240863|41987411|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
19538835|NCT01240863|41987412|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
19538836|NCT01240863|41987413|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
19538837|NCT01240863|41987411|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
19538838|NCT01240863|41987412|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
19538839|NCT01240863|41987413|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
19538840|NCT01240863|41987411|FG000|Open-label Titration Period|Other|7|||
19538841|NCT01240863|41987412|FG001|Open-label Titration Period|Other|0|||
19538842|NCT01240863|41987413|FG002|Open-label Titration Period|Other|0|||
19538843|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
19538844|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
19538845|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
19538846|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
19538847|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
19456755|NCT01468701|41707898|FG005|Overall Study|Lost to Follow-up|0|||
19456756|NCT01468701|41707899|FG006|Overall Study|Lost to Follow-up|0|||
19456757|NCT01468701|41707900|FG007|Overall Study|Lost to Follow-up|0|||
19456758|NCT01468701|41707901|FG008|Overall Study|Lost to Follow-up|215|||
19456759|NCT01468701|41707902|FG009|Overall Study|Lost to Follow-up|309|||
19456760|NCT01468701|41707903|FG010|Overall Study|Lost to Follow-up|224|||
19456761|NCT01468701|41707904|FG011|Overall Study|Lost to Follow-up|212|||
19456762|NCT01468701|41707905|FG012|Overall Study|Lost to Follow-up|11|||
19456763|NCT01468701|41707906|FG013|Overall Study|Lost to Follow-up|164|||
19456764|NCT01468701|41707907|FG014|Overall Study|Lost to Follow-up|17|||
19456765|NCT01468701|41707908|FG015|Overall Study|Lost to Follow-up|127|||
19456766|NCT01468701|41707909|FG016|Overall Study|Lost to Follow-up|1|||
19456767|NCT01468701|41707893|FG000|Overall Study|Withdrawal by Subject|165|||
19456768|NCT01468701|41707894|FG001|Overall Study|Withdrawal by Subject|0|||
19456769|NCT01468701|41707895|FG002|Overall Study|Withdrawal by Subject|0|||
19538848|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
19538849|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
19538850|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
19538851|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
19538852|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
19538853|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
19456770|NCT01468701|41707896|FG003|Overall Study|Withdrawal by Subject|0|||
19456771|NCT01468701|41707897|FG004|Overall Study|Withdrawal by Subject|0|||
19456772|NCT01468701|41707898|FG005|Overall Study|Withdrawal by Subject|0|||
19456773|NCT01468701|41707899|FG006|Overall Study|Withdrawal by Subject|0|||
19538854|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
19538855|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
19538856|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
19538857|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
19538858|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
19538859|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
19538860|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
19538861|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
19538862|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
19538863|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
19538864|NCT01240863|41987411|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
19538865|NCT01240863|41987412|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
19538866|NCT01240863|41987413|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
19538867|NCT01240746|41987428|FG000|Overall Study|Adverse Event|2|||
19538868|NCT01240746|41987429|FG001|Overall Study|Adverse Event|0|||
19538869|NCT01240746|41987430|FG002|Overall Study|Adverse Event|10|||
19538870|NCT01240746|41987428|FG000|Overall Study|Lost to Follow-up|23|||
19538871|NCT01240746|41987429|FG001|Overall Study|Lost to Follow-up|20|||
19538872|NCT01240746|41987430|FG002|Overall Study|Lost to Follow-up|102|||
19538873|NCT01240746|41987428|FG000|Overall Study|Protocol Violation|24|||
19538874|NCT01240746|41987429|FG001|Overall Study|Protocol Violation|15|||
19538875|NCT01240746|41987430|FG002|Overall Study|Protocol Violation|72|||
19538876|NCT01240746|41987428|FG000|Overall Study|Withdrawal by Subject|10|||
19538877|NCT01240746|41987429|FG001|Overall Study|Withdrawal by Subject|13|||
19538878|NCT01240746|41987430|FG002|Overall Study|Withdrawal by Subject|59|||
19538879|NCT01240590|41987443|FG000|Phase I|Refused further treatment|0|||
19538880|NCT01240590|41987444|FG001|Phase I|Refused further treatment|0|||
19538881|NCT01240590|41987445|FG002|Phase I|Refused further treatment|3|||
19538882|NCT01240590|41987446|FG003|Phase I|Refused further treatment|0|||
19538883|NCT01240590|41987447|FG004|Phase I|Refused further treatment|0|||
19538884|NCT01240590|41987443|FG000|Phase II|Refused further treatment|0|||
19538885|NCT01240590|41987444|FG001|Phase II|Refused further treatment|0|||
19538886|NCT01240590|41987445|FG002|Phase II|Refused further treatment|0|||
19538887|NCT01240590|41987446|FG003|Phase II|Refused further treatment|2|||
19538888|NCT01240590|41987447|FG004|Phase II|Refused further treatment|1|||
19456774|NCT01468701|41707900|FG007|Overall Study|Withdrawal by Subject|0|||
19456775|NCT01468701|41707901|FG008|Overall Study|Withdrawal by Subject|83|||
19456776|NCT01468701|41707902|FG009|Overall Study|Withdrawal by Subject|88|||
19538889|NCT01240200|41987475|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
19538890|NCT01240200|41987476|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
19538891|NCT01356966|41987487|FG000|Overall Study|Withdrawal by Subject|1|||
19538892|NCT01356966|41987488|FG001|Overall Study|Withdrawal by Subject|2|||
19538893|NCT01356966|41987487|FG000|Overall Study|Physician Decision|1|||
19538894|NCT01356966|41987488|FG001|Overall Study|Physician Decision|0|||
19538895|NCT01295827|41987517|FG000|Overall Study|Adverse Event|1|||
19538896|NCT01295827|41987518|FG001|Overall Study|Adverse Event|2|||
19538897|NCT01295827|41987519|FG002|Overall Study|Adverse Event|2|||
19538898|NCT01295827|41987520|FG003|Overall Study|Adverse Event|1|||
19538899|NCT01295827|41987521|FG004|Overall Study|Adverse Event|1|||
19538900|NCT01295827|41987522|FG005|Overall Study|Adverse Event|4|||
19538901|NCT01295827|41987523|FG006|Overall Study|Adverse Event|15|||
19538902|NCT01295827|41987524|FG007|Overall Study|Adverse Event|49|||
19538903|NCT01295827|41987525|FG008|Overall Study|Adverse Event|22|||
19538904|NCT01295827|41987526|FG009|Overall Study|Adverse Event|7|||
19538905|NCT01295827|41987527|FG010|Overall Study|Adverse Event|50|||
19538906|NCT01295827|41987528|FG011|Overall Study|Adverse Event|21|||
19538907|NCT01295827|41987529|FG012|Overall Study|Adverse Event|0|||
19538908|NCT01295827|41987530|FG013|Overall Study|Adverse Event|0|||
19538909|NCT01295827|41987531|FG014|Overall Study|Adverse Event|0|||
19538910|NCT01295827|41987517|FG000|Overall Study|Lost to Follow-up|0|||
19631361|NCT00841763|42080589|FG001|Overall Study|Administrative Reasons|1|||
19631362|NCT00841763|42080590|FG002|Overall Study|Administrative Reasons|0|||
19456777|NCT01468701|41707903|FG010|Overall Study|Withdrawal by Subject|100|||
19456778|NCT01468701|41707904|FG011|Overall Study|Withdrawal by Subject|114|||
19456779|NCT01468701|41707905|FG012|Overall Study|Withdrawal by Subject|9|||
19456780|NCT01468701|41707906|FG013|Overall Study|Withdrawal by Subject|47|||
19456781|NCT01468701|41707907|FG014|Overall Study|Withdrawal by Subject|6|||
19456782|NCT01468701|41707908|FG015|Overall Study|Withdrawal by Subject|31|||
19538911|NCT01295827|41987518|FG001|Overall Study|Lost to Follow-up|0|||
19538912|NCT01295827|41987519|FG002|Overall Study|Lost to Follow-up|3|||
19538913|NCT01295827|41987520|FG003|Overall Study|Lost to Follow-up|0|||
19631363|NCT00841763|42080591|FG003|Overall Study|Administrative Reasons|0|||
19631364|NCT00841763|42080588|FG000|Overall Study|Unable to Classify|7|||
19631365|NCT00841763|42080589|FG001|Overall Study|Unable to Classify|1|||
19631366|NCT00841763|42080590|FG002|Overall Study|Unable to Classify|0|||
19631367|NCT00841763|42080591|FG003|Overall Study|Unable to Classify|0|||
19631368|NCT00838331|42080636|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
19631369|NCT00785538|42080644|FG000|Treatment Period|Adverse Event|1|||
19456783|NCT01468701|41707909|FG016|Overall Study|Withdrawal by Subject|0|||
19456784|NCT01468701|41707893|FG000|Overall Study|Other reasons than listed|437|||
19456785|NCT01468701|41707894|FG001|Overall Study|Other reasons than listed|0|||
19456786|NCT01468701|41707895|FG002|Overall Study|Other reasons than listed|0|||
19456787|NCT01468701|41707896|FG003|Overall Study|Other reasons than listed|0|||
19456788|NCT01468701|41707897|FG004|Overall Study|Other reasons than listed|0|||
19456789|NCT01468701|41707898|FG005|Overall Study|Other reasons than listed|0|||
19456790|NCT01468701|41707899|FG006|Overall Study|Other reasons than listed|0|||
19456791|NCT01468701|41707900|FG007|Overall Study|Other reasons than listed|0|||
19538914|NCT01295827|41987521|FG004|Overall Study|Lost to Follow-up|1|||
19538915|NCT01295827|41987522|FG005|Overall Study|Lost to Follow-up|0|||
19538916|NCT01295827|41987523|FG006|Overall Study|Lost to Follow-up|4|||
19538917|NCT01295827|41987524|FG007|Overall Study|Lost to Follow-up|8|||
19538918|NCT01295827|41987525|FG008|Overall Study|Lost to Follow-up|7|||
19538919|NCT01295827|41987526|FG009|Overall Study|Lost to Follow-up|4|||
19538920|NCT01295827|41987527|FG010|Overall Study|Lost to Follow-up|7|||
19538921|NCT01295827|41987528|FG011|Overall Study|Lost to Follow-up|3|||
19538922|NCT01295827|41987529|FG012|Overall Study|Lost to Follow-up|0|||
19538923|NCT01295827|41987530|FG013|Overall Study|Lost to Follow-up|0|||
19538924|NCT01295827|41987531|FG014|Overall Study|Lost to Follow-up|0|||
19538925|NCT01295827|41987517|FG000|Overall Study|Not Reported|0|||
19538926|NCT01295827|41987518|FG001|Overall Study|Not Reported|0|||
19538927|NCT01295827|41987519|FG002|Overall Study|Not Reported|0|||
19538928|NCT01295827|41987520|FG003|Overall Study|Not Reported|1|||
19538929|NCT01295827|41987521|FG004|Overall Study|Not Reported|0|||
19538930|NCT01295827|41987522|FG005|Overall Study|Not Reported|0|||
19538931|NCT01295827|41987523|FG006|Overall Study|Not Reported|24|||
19538932|NCT01295827|41987524|FG007|Overall Study|Not Reported|58|||
19631370|NCT00785538|42080645|FG001|Treatment Period|Adverse Event|2|||
19631371|NCT00785538|42080646|FG002|Treatment Period|Adverse Event|2|||
19631372|NCT00785538|42080647|FG003|Treatment Period|Adverse Event|0|||
19631373|NCT00785538|42080644|FG000|Treatment Period|Withdrawal by Subject|0|||
19631374|NCT00785538|42080645|FG001|Treatment Period|Withdrawal by Subject|0|||
19631375|NCT00785538|42080646|FG002|Treatment Period|Withdrawal by Subject|0|||
19631376|NCT00785538|42080647|FG003|Treatment Period|Withdrawal by Subject|1|||
19631377|NCT00860405|42080660|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
19631378|NCT00860405|42080661|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
19631379|NCT00838097|42080667|FG000|Overall Study|Ineligibility determined|6|||
19631380|NCT00838097|42080667|FG000|Overall Study|Adverse Event|2|||
19631381|NCT00838097|42080667|FG000|Overall Study|Withdrawal by Subject|3|||
19631382|NCT00838097|42080667|FG000|Overall Study|Requirement for alternative therapy|2|||
19631383|NCT00838097|42080667|FG000|Overall Study|Physician Decision|4|||
19631384|NCT00838097|42080667|FG000|Overall Study|Lost to Follow-up|11|||
19631385|NCT00838097|42080667|FG000|Overall Study|Death|6|||
19631386|NCT00838097|42080667|FG000|Overall Study|Protocol-specified criteria|142|||
19631387|NCT00840827|42080671|FG000|Overall Study|Adverse Event|1|||
19631388|NCT00840827|42080671|FG000|Overall Study|Lack of Efficacy|4|||
19631389|NCT00840827|42080671|FG000|Overall Study|Physician Decision|1|||
19631390|NCT00860249|42080678|FG000|Overall Study|trial was terminated prior to completion|21|||
19631391|NCT00860249|42080679|FG001|Overall Study|trial was terminated prior to completion|18|||
19631392|NCT00860249|42080680|FG002|Overall Study|trial was terminated prior to completion|21|||
19631393|NCT00840749|42080690|FG000|Overall Study|Death|1|||
19631394|NCT00840749|42080691|FG001|Overall Study|Death|2|||
19631395|NCT00840749|42080690|FG000|Overall Study|not treated on study arm|11|||
19631396|NCT00840749|42080691|FG001|Overall Study|not treated on study arm|11|||
19631397|NCT00840749|42080690|FG000|Overall Study|study closed|19|||
19631398|NCT00840749|42080691|FG001|Overall Study|study closed|14|||
19631399|NCT00859937|42080699|FG000|Overall Study|Protocol Violation|1|||
19538933|NCT01295827|41987525|FG008|Overall Study|Not Reported|41|||
19538934|NCT01295827|41987526|FG009|Overall Study|Not Reported|2|||
19538935|NCT01295827|41987527|FG010|Overall Study|Not Reported|23|||
19631400|NCT00859937|42080700|FG001|Overall Study|Protocol Violation|0|||
19631401|NCT00592007|42080706|FG000|Overall Study|Withdrawal by Subject|1|||
19631402|NCT00592007|42080706|FG000|Overall Study|patient ineligible (out of lab range)|1|||
19631403|NCT00591851|42080710|FG000|Overall Study|Withdrawal by Subject|3|||
19631404|NCT00591851|42080710|FG000|Overall Study|Adverse Event|2|||
19456792|NCT01468701|41707901|FG008|Overall Study|Other reasons than listed|318|||
19538936|NCT01295827|41987528|FG011|Overall Study|Not Reported|13|||
19538937|NCT01295827|41987529|FG012|Overall Study|Not Reported|0|||
19538938|NCT01295827|41987530|FG013|Overall Study|Not Reported|0|||
19538939|NCT01295827|41987531|FG014|Overall Study|Not Reported|0|||
19538940|NCT01295827|41987517|FG000|Overall Study|Progressive Disease|2|||
19631405|NCT00591851|42080710|FG000|Overall Study|Progressive Disease|1|||
19631406|NCT00837473|42080714|FG000|Overall Study|Lost to Follow-up|1|||
19631407|NCT00837473|42080714|FG000|Overall Study|Withdrawal by Subject|2|||
19631408|NCT00839423|42080722|FG000|Overall Study|Adverse Event|4|||
19538941|NCT01295827|41987518|FG001|Overall Study|Progressive Disease|1|||
19538942|NCT01295827|41987519|FG002|Overall Study|Progressive Disease|5|||
19456793|NCT01468701|41707902|FG009|Overall Study|Other reasons than listed|658|||
19456794|NCT01468701|41707903|FG010|Overall Study|Other reasons than listed|433|||
19631409|NCT00839423|42080723|FG001|Overall Study|Adverse Event|3|||
19631410|NCT00839423|42080724|FG002|Overall Study|Adverse Event|7|||
19711516|NCT03568318|42154618|FG002|Overall Study|Withdrawal by Subject|2|||
19711517|NCT03568318|42154619|FG003|Overall Study|Withdrawal by Subject|1|||
19711518|NCT03568318|42154620|FG004|Overall Study|Withdrawal by Subject|0|||
19711519|NCT03568318|42154621|FG005|Overall Study|Withdrawal by Subject|0|||
19711520|NCT03568318|42154616|FG000|Overall Study|Lost to Follow-up|3|||
19711521|NCT03568318|42154617|FG001|Overall Study|Lost to Follow-up|2|||
19711522|NCT03568318|42154618|FG002|Overall Study|Lost to Follow-up|2|||
19711523|NCT03568318|42154619|FG003|Overall Study|Lost to Follow-up|2|||
19711524|NCT03568318|42154620|FG004|Overall Study|Lost to Follow-up|1|||
19711525|NCT03568318|42154621|FG005|Overall Study|Lost to Follow-up|0|||
19711526|NCT03568318|42154616|FG000|Overall Study|Other|3|||
19711527|NCT03568318|42154617|FG001|Overall Study|Other|1|||
19711528|NCT03568318|42154618|FG002|Overall Study|Other|3|||
19711529|NCT03568318|42154619|FG003|Overall Study|Other|0|||
19711530|NCT03568318|42154620|FG004|Overall Study|Other|0|||
19711531|NCT03568318|42154621|FG005|Overall Study|Other|0|||
19711532|NCT03568318|42154616|FG000|Overall Study|Ongoing at Time of Analysis|5|||
19711533|NCT03568318|42154617|FG001|Overall Study|Ongoing at Time of Analysis|3|||
19711534|NCT03568318|42154618|FG002|Overall Study|Ongoing at Time of Analysis|2|||
19711535|NCT03568318|42154619|FG003|Overall Study|Ongoing at Time of Analysis|1|||
19711536|NCT03568318|42154620|FG004|Overall Study|Ongoing at Time of Analysis|0|||
19711537|NCT03568318|42154621|FG005|Overall Study|Ongoing at Time of Analysis|0|||
19711538|NCT00108069|42154637|FG000|Overall Study|Never rec'd study drug|0|||
19711539|NCT00108069|42154638|FG001|Overall Study|Never rec'd study drug|1|||
19711540|NCT00108069|42154637|FG000|Overall Study|Adverse Event|1|||
19711541|NCT00108069|42154638|FG001|Overall Study|Adverse Event|1|||
19711542|NCT00108069|42154637|FG000|Overall Study|Withdrawal by Subject|1|||
19711543|NCT00108069|42154638|FG001|Overall Study|Withdrawal by Subject|0|||
19711544|NCT00108069|42154637|FG000|Overall Study|Death|1|||
19456795|NCT01468701|41707904|FG011|Overall Study|Other reasons than listed|504|||
19631411|NCT00839423|42080725|FG003|Overall Study|Adverse Event|16|||
19631412|NCT00839423|42080722|FG000|Overall Study|Lack of Efficacy|6|||
19631413|NCT00839423|42080723|FG001|Overall Study|Lack of Efficacy|6|||
19631414|NCT00839423|42080724|FG002|Overall Study|Lack of Efficacy|3|||
19631415|NCT00839423|42080725|FG003|Overall Study|Lack of Efficacy|2|||
19631416|NCT00839423|42080722|FG000|Overall Study|Non-compliance|0|||
19456796|NCT01468701|41707905|FG012|Overall Study|Other reasons than listed|28|||
19456797|NCT01468701|41707906|FG013|Overall Study|Other reasons than listed|239|||
19456798|NCT01468701|41707907|FG014|Overall Study|Other reasons than listed|39|||
19711545|NCT00108069|42154638|FG001|Overall Study|Death|0|||
19711546|NCT00108069|42154637|FG000|Overall Study|Progessive disease|27|||
19456799|NCT01468701|41707908|FG015|Overall Study|Other reasons than listed|172|||
19456800|NCT01468701|41707909|FG016|Overall Study|Other reasons than listed|0|||
19456801|NCT01468701|41707893|FG000|Overall Study|No end of study case report form|0|||
19456802|NCT01468701|41707894|FG001|Overall Study|No end of study case report form|0|||
19456803|NCT01468701|41707895|FG002|Overall Study|No end of study case report form|0|||
19456804|NCT01468701|41707896|FG003|Overall Study|No end of study case report form|0|||
19456805|NCT01468701|41707897|FG004|Overall Study|No end of study case report form|0|||
19456806|NCT01468701|41707898|FG005|Overall Study|No end of study case report form|0|||
19456807|NCT01468701|41707899|FG006|Overall Study|No end of study case report form|0|||
19456808|NCT01468701|41707900|FG007|Overall Study|No end of study case report form|0|||
19456809|NCT01468701|41707901|FG008|Overall Study|No end of study case report form|4|||
19631417|NCT00839423|42080723|FG001|Overall Study|Non-compliance|0|||
19711547|NCT00108069|42154638|FG001|Overall Study|Progessive disease|11|||
19711548|NCT00079274|42154657|FG000|Overall Study|Withdrawal by Subject|111|||
19711549|NCT00079274|42154658|FG001|Overall Study|Withdrawal by Subject|10|||
19711550|NCT00079274|42154659|FG002|Overall Study|Withdrawal by Subject|12|||
19711551|NCT00079274|42154660|FG003|Overall Study|Withdrawal by Subject|163|||
19711552|NCT00079274|42154661|FG004|Overall Study|Withdrawal by Subject|7|||
19711553|NCT00079274|42154662|FG005|Overall Study|Withdrawal by Subject|8|||
19711554|NCT00079274|42154663|FG006|Overall Study|Withdrawal by Subject|0|||
19711555|NCT00079274|42154657|FG000|Overall Study|Adverse Event|130|||
19711556|NCT00079274|42154658|FG001|Overall Study|Adverse Event|8|||
19375347|NCT02279524|41617211|FG000|Overall Study|Bariatric surgery|1|||
19375348|NCT02279524|41617212|FG001|Overall Study|Bariatric surgery|0|||
19375349|NCT02279524|41617213|FG002|Overall Study|Bariatric surgery|0|||
19375350|NCT02283268|41617221|FG000|Overall Study|Withdrawal by Subject|1|||
19375351|NCT00857285|41617235|FG000|Overall Study|Adverse Event|4|||
19375352|NCT00857285|41617236|FG001|Overall Study|Adverse Event|2|||
19375353|NCT00857285|41617235|FG000|Overall Study|Lack of Efficacy|0|||
19375354|NCT00857285|41617236|FG001|Overall Study|Lack of Efficacy|2|||
19375355|NCT00857285|41617235|FG000|Overall Study|Protocol Violation|3|||
19375356|NCT00857285|41617236|FG001|Overall Study|Protocol Violation|1|||
19631418|NCT00839423|42080724|FG002|Overall Study|Non-compliance|0|||
19456810|NCT01468701|41707902|FG009|Overall Study|No end of study case report form|1|||
19538943|NCT01295827|41987520|FG003|Overall Study|Progressive Disease|2|||
19538944|NCT01295827|41987521|FG004|Overall Study|Progressive Disease|0|||
19538945|NCT01295827|41987522|FG005|Overall Study|Progressive Disease|1|||
19538946|NCT01295827|41987523|FG006|Overall Study|Progressive Disease|87|||
19538947|NCT01295827|41987524|FG007|Overall Study|Progressive Disease|144|||
19538948|NCT01295827|41987525|FG008|Overall Study|Progressive Disease|85|||
19538949|NCT01295827|41987526|FG009|Overall Study|Progressive Disease|40|||
19538950|NCT01295827|41987527|FG010|Overall Study|Progressive Disease|175|||
19538951|NCT01295827|41987528|FG011|Overall Study|Progressive Disease|136|||
19538952|NCT01295827|41987529|FG012|Overall Study|Progressive Disease|0|||
19538953|NCT01295827|41987530|FG013|Overall Study|Progressive Disease|0|||
19538954|NCT01295827|41987531|FG014|Overall Study|Progressive Disease|0|||
19538955|NCT01295827|41987517|FG000|Overall Study|Screen Failure|0|||
19538956|NCT01295827|41987518|FG001|Overall Study|Screen Failure|0|||
19538957|NCT01295827|41987519|FG002|Overall Study|Screen Failure|0|||
19538958|NCT01295827|41987520|FG003|Overall Study|Screen Failure|0|||
19538959|NCT01295827|41987521|FG004|Overall Study|Screen Failure|0|||
19538960|NCT01295827|41987522|FG005|Overall Study|Screen Failure|0|||
19538961|NCT01295827|41987523|FG006|Overall Study|Screen Failure|2|||
19538962|NCT01295827|41987524|FG007|Overall Study|Screen Failure|2|||
19538963|NCT01295827|41987525|FG008|Overall Study|Screen Failure|2|||
19538964|NCT01295827|41987526|FG009|Overall Study|Screen Failure|0|||
19538965|NCT01295827|41987527|FG010|Overall Study|Screen Failure|1|||
19538966|NCT01295827|41987528|FG011|Overall Study|Screen Failure|0|||
19538967|NCT01295827|41987529|FG012|Overall Study|Screen Failure|0|||
19538968|NCT01295827|41987530|FG013|Overall Study|Screen Failure|0|||
19538969|NCT01295827|41987531|FG014|Overall Study|Screen Failure|0|||
19538970|NCT01295827|41987517|FG000|Overall Study|Withdrawal by Subject|1|||
19538971|NCT01295827|41987518|FG001|Overall Study|Withdrawal by Subject|0|||
19538972|NCT01295827|41987519|FG002|Overall Study|Withdrawal by Subject|2|||
19538973|NCT01295827|41987520|FG003|Overall Study|Withdrawal by Subject|0|||
19538974|NCT01295827|41987521|FG004|Overall Study|Withdrawal by Subject|0|||
19538975|NCT01295827|41987522|FG005|Overall Study|Withdrawal by Subject|1|||
19538976|NCT01295827|41987523|FG006|Overall Study|Withdrawal by Subject|13|||
19538977|NCT01295827|41987524|FG007|Overall Study|Withdrawal by Subject|35|||
19538978|NCT01295827|41987525|FG008|Overall Study|Withdrawal by Subject|11|||
19538979|NCT01295827|41987526|FG009|Overall Study|Withdrawal by Subject|2|||
19538980|NCT01295827|41987527|FG010|Overall Study|Withdrawal by Subject|18|||
19538981|NCT01295827|41987528|FG011|Overall Study|Withdrawal by Subject|13|||
19456811|NCT01468701|41707903|FG010|Overall Study|No end of study case report form|2|||
19456812|NCT01468701|41707904|FG011|Overall Study|No end of study case report form|3|||
19456813|NCT01468701|41707905|FG012|Overall Study|No end of study case report form|0|||
19456814|NCT01468701|41707906|FG013|Overall Study|No end of study case report form|1|||
19456815|NCT01468701|41707907|FG014|Overall Study|No end of study case report form|0|||
19456816|NCT01468701|41707908|FG015|Overall Study|No end of study case report form|0|||
19456817|NCT01468701|41707909|FG016|Overall Study|No end of study case report form|0|||
19456818|NCT01468701|41707893|FG000|Overall Study|Not being followed up|0|||
19456819|NCT01468701|41707894|FG001|Overall Study|Not being followed up|4963|||
19456820|NCT01468701|41707895|FG002|Overall Study|Not being followed up|1755|||
19456821|NCT01468701|41707896|FG003|Overall Study|Not being followed up|703|||
19456822|NCT01468701|41707897|FG004|Overall Study|Not being followed up|1714|||
19456823|NCT01468701|41707898|FG005|Overall Study|Not being followed up|126|||
19456824|NCT01468701|41707899|FG006|Overall Study|Not being followed up|1170|||
19456825|NCT01468701|41707900|FG007|Overall Study|Not being followed up|4|||
19456826|NCT01468701|41707901|FG008|Overall Study|Not being followed up|0|||
19456827|NCT01468701|41707902|FG009|Overall Study|Not being followed up|0|||
19456828|NCT01468701|41707903|FG010|Overall Study|Not being followed up|0|||
19456829|NCT01468701|41707904|FG011|Overall Study|Not being followed up|0|||
19456830|NCT01468701|41707905|FG012|Overall Study|Not being followed up|0|||
19456831|NCT01468701|41707906|FG013|Overall Study|Not being followed up|0|||
19456832|NCT01468701|41707907|FG014|Overall Study|Not being followed up|0|||
19456833|NCT01468701|41707908|FG015|Overall Study|Not being followed up|0|||
19456834|NCT01468701|41707909|FG016|Overall Study|Not being followed up|0|||
19456835|NCT01492101|41707924|FG000|Overall Study|Death|323|||
19456836|NCT01492101|41707925|FG001|Overall Study|Death|322|||
19538982|NCT01295827|41987529|FG012|Overall Study|Withdrawal by Subject|0|||
19538983|NCT01295827|41987530|FG013|Overall Study|Withdrawal by Subject|0|||
19456837|NCT01492101|41707924|FG000|Overall Study|Withdrawal by Subject|14|||
19538984|NCT01295827|41987531|FG014|Overall Study|Withdrawal by Subject|0|||
19538985|NCT01295827|41987517|FG000|Overall Study|Other|0|||
19538986|NCT01295827|41987518|FG001|Overall Study|Other|0|||
19538987|NCT01295827|41987519|FG002|Overall Study|Other|0|||
19538988|NCT01295827|41987520|FG003|Overall Study|Other|0|||
19538989|NCT01295827|41987521|FG004|Overall Study|Other|0|||
19538990|NCT01295827|41987522|FG005|Overall Study|Other|0|||
19538991|NCT01295827|41987523|FG006|Overall Study|Other|1|||
19538992|NCT01295827|41987524|FG007|Overall Study|Other|1|||
19538993|NCT01295827|41987525|FG008|Overall Study|Other|1|||
19538994|NCT01295827|41987526|FG009|Overall Study|Other|0|||
19538995|NCT01295827|41987527|FG010|Overall Study|Other|2|||
19538996|NCT01295827|41987528|FG011|Overall Study|Other|0|||
19538997|NCT01295827|41987529|FG012|Overall Study|Other|0|||
19538998|NCT01295827|41987530|FG013|Overall Study|Other|0|||
19538999|NCT01295827|41987531|FG014|Overall Study|Other|0|||
19539000|NCT01295671|41987587|FG000|Overall Study|Lost to Follow-up|4|||
19539001|NCT01295671|41987588|FG001|Overall Study|Lost to Follow-up|6|||
19539002|NCT01295671|41987589|FG002|Overall Study|Lost to Follow-up|3|||
19539003|NCT01295671|41987587|FG000|Overall Study|Withdrawal by Subject|3|||
19539004|NCT01295671|41987588|FG001|Overall Study|Withdrawal by Subject|1|||
19539005|NCT01295671|41987589|FG002|Overall Study|Withdrawal by Subject|0|||
19539006|NCT01295320|41987597|FG000|Overall Study|Adverse Event|2|||
19539007|NCT01295320|41987597|FG000|Overall Study|Lost to Follow-up|4|||
19539008|NCT01295320|41987597|FG000|Overall Study|Withdrawal by Subject|2|||
19539009|NCT01295320|41987597|FG000|Overall Study|Subject was bedridden|1|||
19539010|NCT01295320|41987597|FG000|Overall Study|Unable to travel|1|||
19539011|NCT01295281|41987603|FG000|First Intervention (7 Days)|Death|0|||
19539012|NCT01295281|41987604|FG001|First Intervention (7 Days)|Death|1|||
19539013|NCT01294696|41987612|FG000|Overall Study|Screening failures|7|||
19539014|NCT01294696|41987612|FG000|Overall Study|Protocol Violation|8|||
19539015|NCT01294696|41987612|FG000|Overall Study|Missing BPI Response|7|||
19539016|NCT01294696|41987612|FG000|Overall Study|Site closure|52|||
19539017|NCT01294579|41987617|FG000|Overall Study|Disease progression|12|||
19539018|NCT01294579|41987617|FG000|Overall Study|Adverse Event|11|||
19539019|NCT01294579|41987617|FG000|Overall Study|Study closed/terminated|3|||
19539020|NCT01294579|41987617|FG000|Overall Study|Lost to Follow-up|1|||
19539021|NCT01294579|41987617|FG000|Overall Study|Physician Decision|3|||
19539022|NCT01294579|41987617|FG000|Overall Study|Withdrawal by Subject|5|||
19539023|NCT01294462|41987623|FG000|Overall Study|Lost to Follow-up|1|||
19539024|NCT01294462|41987624|FG001|Overall Study|Lost to Follow-up|0|||
19539025|NCT01294462|41987623|FG000|Overall Study|Withdrawal by Subject|65|||
19539026|NCT01294462|41987624|FG001|Overall Study|Withdrawal by Subject|63|||
19539027|NCT01294423|41987633|FG000|Overall Study|Adverse Event|1|||
19539028|NCT01294423|41987634|FG001|Overall Study|Adverse Event|2|||
19539029|NCT01294423|41987635|FG002|Overall Study|Adverse Event|3|||
19539030|NCT01294423|41987633|FG000|Overall Study|Withdrawal by Subject|1|||
19539031|NCT01294423|41987634|FG001|Overall Study|Withdrawal by Subject|2|||
19539032|NCT01294423|41987635|FG002|Overall Study|Withdrawal by Subject|2|||
19539033|NCT01294423|41987633|FG000|Overall Study|subject no longer meets study criteria|2|||
19539034|NCT01294423|41987634|FG001|Overall Study|subject no longer meets study criteria|5|||
19539035|NCT01294423|41987635|FG002|Overall Study|subject no longer meets study criteria|2|||
19539036|NCT01294423|41987633|FG000|Overall Study|poor/non-compliance|1|||
19539037|NCT01294423|41987634|FG001|Overall Study|poor/non-compliance|0|||
19539038|NCT01294423|41987635|FG002|Overall Study|poor/non-compliance|1|||
19539039|NCT01294150|41987645|FG000|Overall Study|Physician Decision|2|||
19539040|NCT01294150|41987646|FG001|Overall Study|Physician Decision|2|||
19539041|NCT01292473|41987658|FG000|Overall Study|Adverse Event|1|||
19539042|NCT01292473|41987659|FG001|Overall Study|Adverse Event|0|||
19539043|NCT01292473|41987660|FG002|Overall Study|Adverse Event|1|||
19539044|NCT01292473|41987661|FG003|Overall Study|Adverse Event|1|||
19539045|NCT01292473|41987658|FG000|Overall Study|Lost to Follow-up|1|||
19539046|NCT01292473|41987659|FG001|Overall Study|Lost to Follow-up|1|||
19539047|NCT01292473|41987660|FG002|Overall Study|Lost to Follow-up|2|||
19539048|NCT01292473|41987661|FG003|Overall Study|Lost to Follow-up|2|||
19539049|NCT01292473|41987658|FG000|Overall Study|Withdrawal by Subject|3|||
19539050|NCT01292473|41987659|FG001|Overall Study|Withdrawal by Subject|4|||
19539051|NCT01292473|41987660|FG002|Overall Study|Withdrawal by Subject|3|||
19539052|NCT01292473|41987661|FG003|Overall Study|Withdrawal by Subject|3|||
19539053|NCT01292473|41987658|FG000|Overall Study|Physician Decision|0|||
19539054|NCT01292473|41987659|FG001|Overall Study|Physician Decision|1|||
19539055|NCT01292473|41987660|FG002|Overall Study|Physician Decision|0|||
19539056|NCT01292473|41987661|FG003|Overall Study|Physician Decision|0|||
19539057|NCT01292473|41987658|FG000|Overall Study|Disease Progression|0|||
19539058|NCT01292473|41987659|FG001|Overall Study|Disease Progression|1|||
19539059|NCT01292473|41987660|FG002|Overall Study|Disease Progression|3|||
19539060|NCT01292473|41987661|FG003|Overall Study|Disease Progression|6|||
19539061|NCT01292239|41987677|FG000|Overall Study|Other|1|||
19539062|NCT01292239|41987678|FG001|Overall Study|Other|1|||
19539063|NCT01292239|41987677|FG000|Overall Study|Withdrawal by Subject|3|||
19539064|NCT01292239|41987678|FG001|Overall Study|Withdrawal by Subject|6|||
19539065|NCT01291225|41987686|FG000|Overall Study|Lost to Follow-up|85|||
19539066|NCT01291225|41987687|FG001|Overall Study|Lost to Follow-up|39|||
19539067|NCT01290796|41987697|FG000|Overall Study|Lost to Follow-up|21|||
19539068|NCT01290796|41987697|FG000|Overall Study|Withdrawal by Subject|4|||
19539069|NCT01290796|41987697|FG000|Overall Study|Physician Decision|2|||
19539070|NCT01290796|41987697|FG000|Overall Study|Secondary Surgical Intervention|2|||
19539071|NCT01290796|41987697|FG000|Overall Study|Withdrawal by Sponsor|1|||
19539072|NCT01290757|41987703|FG000|Overall Study|Adverse Event|1|||
19539073|NCT01290757|41987704|FG001|Overall Study|Adverse Event|0|||
19539074|NCT01290757|41987703|FG000|Overall Study|Protocol Violation|1|||
19539075|NCT01290757|41987704|FG001|Overall Study|Protocol Violation|1|||
19539076|NCT01290757|41987703|FG000|Overall Study|Other|0|||
19539077|NCT01290757|41987704|FG001|Overall Study|Other|1|||
19539078|NCT01290718|41987710|FG000|Overall Study|Early termination of the study|4|||
19539079|NCT01290679|41987716|FG000|Overall Study|Adverse Event|2|||
19539080|NCT01290679|41987717|FG001|Overall Study|Adverse Event|0|||
19539081|NCT01290679|41987716|FG000|Overall Study|Lost to Follow-up|8|||
19539082|NCT01290679|41987717|FG001|Overall Study|Lost to Follow-up|10|||
19539083|NCT01290679|41987716|FG000|Overall Study|Protocol Violation|0|||
19539084|NCT01290679|41987717|FG001|Overall Study|Protocol Violation|1|||
19539085|NCT01290679|41987716|FG000|Overall Study|Withdrawal by Subject|6|||
19539086|NCT01290679|41987717|FG001|Overall Study|Withdrawal by Subject|5|||
19539087|NCT01290679|41987716|FG000|Overall Study|Subject Entered Another Trial|0|||
19539088|NCT01290679|41987717|FG001|Overall Study|Subject Entered Another Trial|5|||
19539089|NCT01290601|41987725|FG000|Overall Study|Adverse Event|0|||
19539090|NCT01290601|41987726|FG001|Overall Study|Adverse Event|2|||
19539091|NCT01290601|41987727|FG002|Overall Study|Adverse Event|0|||
19539092|NCT01290601|41987728|FG003|Overall Study|Adverse Event|0|||
19539093|NCT01290601|41987725|FG000|Overall Study|Lack of Efficacy|2|||
19539094|NCT01290601|41987726|FG001|Overall Study|Lack of Efficacy|1|||
19539095|NCT01290601|41987727|FG002|Overall Study|Lack of Efficacy|0|||
19539096|NCT01290601|41987728|FG003|Overall Study|Lack of Efficacy|0|||
19539097|NCT01290601|41987725|FG000|Overall Study|Lost to Follow-up|7|||
19539098|NCT01290601|41987726|FG001|Overall Study|Lost to Follow-up|2|||
19539099|NCT01290601|41987727|FG002|Overall Study|Lost to Follow-up|0|||
19539100|NCT01290601|41987728|FG003|Overall Study|Lost to Follow-up|0|||
19539101|NCT01290601|41987725|FG000|Overall Study|Other|1|||
19539102|NCT01290601|41987726|FG001|Overall Study|Other|0|||
19539103|NCT01290601|41987727|FG002|Overall Study|Other|0|||
19539104|NCT01290601|41987728|FG003|Overall Study|Other|0|||
19539105|NCT01290601|41987725|FG000|Overall Study|Protocol Violation|1|||
19539106|NCT01290601|41987726|FG001|Overall Study|Protocol Violation|0|||
19539107|NCT01290601|41987727|FG002|Overall Study|Protocol Violation|0|||
19539108|NCT01290601|41987728|FG003|Overall Study|Protocol Violation|0|||
19539109|NCT01290523|41987734|FG000|Overall Study|Death|3|||
19539110|NCT01290094|41987738|FG000|Overall Study|Withdrawal by Subject|1|||
19539111|NCT01290094|41987738|FG000|Overall Study|Lost to Follow-up|5|||
19539112|NCT01289821|41987751|FG000|Treatment Period|Withdrawal by Subject|1|||
19539113|NCT01289821|41987751|FG000|Treatment Period|Physician Decision|3|||
19456838|NCT01492101|41707925|FG001|Overall Study|Withdrawal by Subject|18|||
19456839|NCT01492101|41707924|FG000|Overall Study|Lost to Follow-up|0|||
19456840|NCT01492101|41707925|FG001|Overall Study|Lost to Follow-up|2|||
19456841|NCT01468311|41707931|FG000|Overall Study|mobilization failure|1|||
19539114|NCT01289821|41987751|FG000|Treatment Period|Adverse Event|4|||
19539115|NCT01289821|41987751|FG000|Treatment Period|Radiological Progression|43|||
19539116|NCT01289821|41987751|FG000|Treatment Period|Clinical Progression|2|||
19539117|NCT01289821|41987751|FG000|Treatment Period|Therapeutic procedure required|1|||
19539118|NCT01289821|41987751|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
19539119|NCT01289821|41987751|FG000|Safety Follow-up Period|Protocol Violation|3|||
19539120|NCT01289821|41987751|FG000|Safety Follow-up Period|Unspecified reason|1|||
19539121|NCT01289821|41987751|FG000|Survival Follow-up Period|Protocol Violation|1|||
19539122|NCT01289821|41987751|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
19539123|NCT01289821|41987751|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
19539124|NCT01289782|41987761|FG000|Overall Study|Lost to Follow-up|14|||
19539125|NCT01289782|41987762|FG001|Overall Study|Lost to Follow-up|7|||
19539126|NCT01289782|41987761|FG000|Overall Study|Protocol Violation|1|||
19539127|NCT01289782|41987762|FG001|Overall Study|Protocol Violation|1|||
19539128|NCT01289782|41987761|FG000|Overall Study|Withdrawal by Subject|8|||
19539129|NCT01289782|41987762|FG001|Overall Study|Withdrawal by Subject|2|||
19631419|NCT00839423|42080725|FG003|Overall Study|Non-compliance|1|||
19631420|NCT00839423|42080722|FG000|Overall Study|Protocol Violation|0|||
19456842|NCT01468311|41707931|FG000|Overall Study|Withdrawal by Subject|1|||
19456843|NCT01730534|41708042|FG000|Overall Study|Withdrawal by Subject|97|||
19456844|NCT01730534|41708043|FG001|Overall Study|Withdrawal by Subject|127|||
19456845|NCT01730534|41708042|FG000|Overall Study|Lost to Follow-up|12|||
19456846|NCT01730534|41708043|FG001|Overall Study|Lost to Follow-up|18|||
19456847|NCT01783730|41708063|FG000|Overall Study|Failed to meet inclusion criteria|6|||
19456848|NCT01730378|41708069|FG000|Overall Study|Lost to Follow-up|1|||
19456849|NCT01730378|41708070|FG001|Overall Study|Lost to Follow-up|0|||
19456850|NCT01783496|41708083|FG000|Overall Study|Lost to Follow-up|0|||
19456851|NCT01783496|41708084|FG001|Overall Study|Lost to Follow-up|0|||
19539130|NCT01289782|41987761|FG000|Overall Study|Sponsor's Decision|1|||
19539131|NCT01289782|41987762|FG001|Overall Study|Sponsor's Decision|0|||
19539132|NCT01289782|41987761|FG000|Overall Study|Reason not specified|1|||
19539133|NCT01289782|41987762|FG001|Overall Study|Reason not specified|2|||
19539134|NCT01289353|41987768|FG000|Overall Study|Lost to Follow-up|2|||
19539135|NCT01289119|41987778|FG000|Overall Study|Adverse Event|2|||
19539136|NCT01289119|41987779|FG001|Overall Study|Adverse Event|1|||
19539137|NCT01289119|41987780|FG002|Overall Study|Adverse Event|0|||
19539138|NCT01289119|41987781|FG003|Overall Study|Adverse Event|2|||
19539139|NCT01289119|41987782|FG004|Overall Study|Adverse Event|1|||
19539140|NCT01289119|41987783|FG005|Overall Study|Adverse Event|0|||
19539141|NCT01289119|41987778|FG000|Overall Study|Major Protocol Deviation|2|||
19539142|NCT01289119|41987779|FG001|Overall Study|Major Protocol Deviation|1|||
19539143|NCT01289119|41987780|FG002|Overall Study|Major Protocol Deviation|3|||
19539144|NCT01289119|41987781|FG003|Overall Study|Major Protocol Deviation|0|||
19539145|NCT01289119|41987782|FG004|Overall Study|Major Protocol Deviation|2|||
19539146|NCT01289119|41987783|FG005|Overall Study|Major Protocol Deviation|1|||
19539147|NCT01289119|41987778|FG000|Overall Study|Lost to Follow-up|0|||
19539148|NCT01289119|41987779|FG001|Overall Study|Lost to Follow-up|3|||
19539149|NCT01289119|41987780|FG002|Overall Study|Lost to Follow-up|0|||
19539150|NCT01289119|41987781|FG003|Overall Study|Lost to Follow-up|0|||
19539151|NCT01289119|41987782|FG004|Overall Study|Lost to Follow-up|0|||
19539152|NCT01289119|41987783|FG005|Overall Study|Lost to Follow-up|1|||
19539153|NCT01289119|41987778|FG000|Overall Study|Withdrawal by Subject|4|||
19539154|NCT01289119|41987779|FG001|Overall Study|Withdrawal by Subject|2|||
19539155|NCT01289119|41987780|FG002|Overall Study|Withdrawal by Subject|4|||
19539156|NCT01289119|41987781|FG003|Overall Study|Withdrawal by Subject|3|||
19539157|NCT01289119|41987782|FG004|Overall Study|Withdrawal by Subject|1|||
19539158|NCT01289119|41987783|FG005|Overall Study|Withdrawal by Subject|1|||
19539159|NCT01289119|41987778|FG000|Overall Study|Pregnancy|0|||
19539160|NCT01289119|41987779|FG001|Overall Study|Pregnancy|1|||
19539161|NCT01289119|41987780|FG002|Overall Study|Pregnancy|0|||
19539162|NCT01289119|41987781|FG003|Overall Study|Pregnancy|0|||
19539163|NCT01289119|41987782|FG004|Overall Study|Pregnancy|0|||
19539164|NCT01289119|41987783|FG005|Overall Study|Pregnancy|0|||
19539165|NCT01289119|41987778|FG000|Overall Study|Lack of Efficacy|0|||
19539166|NCT01289119|41987779|FG001|Overall Study|Lack of Efficacy|1|||
19539167|NCT01289119|41987780|FG002|Overall Study|Lack of Efficacy|1|||
19539168|NCT01289119|41987781|FG003|Overall Study|Lack of Efficacy|1|||
19539169|NCT01289119|41987782|FG004|Overall Study|Lack of Efficacy|1|||
19539170|NCT01289119|41987783|FG005|Overall Study|Lack of Efficacy|1|||
19539171|NCT01289119|41987778|FG000|Overall Study|Other|1|||
19456852|NCT01783496|41708085|FG002|Overall Study|Lost to Follow-up|0|||
19456853|NCT01783496|41708086|FG003|Overall Study|Lost to Follow-up|2|||
19456854|NCT01783496|41708087|FG004|Overall Study|Lost to Follow-up|0|||
19456855|NCT01783496|41708088|FG005|Overall Study|Lost to Follow-up|1|||
19456856|NCT01783496|41708083|FG000|Overall Study|Withdrawal by Subject|1|||
19456857|NCT01783496|41708084|FG001|Overall Study|Withdrawal by Subject|0|||
19456858|NCT01783496|41708085|FG002|Overall Study|Withdrawal by Subject|0|||
19456859|NCT01783496|41708086|FG003|Overall Study|Withdrawal by Subject|0|||
19456860|NCT01783496|41708087|FG004|Overall Study|Withdrawal by Subject|0|||
19456861|NCT01783496|41708088|FG005|Overall Study|Withdrawal by Subject|0|||
19456862|NCT01729208|41708113|FG000|Baseline|Physician Decision|5|||
19456863|NCT01729208|41708114|FG001|Baseline|Physician Decision|4|||
19456864|NCT01729208|41708113|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
19456865|NCT01729208|41708114|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
19456866|NCT01729208|41708113|FG000|12 Months Follow-up|Lost to Follow-up|3|||
19456867|NCT01729208|41708114|FG001|12 Months Follow-up|Lost to Follow-up|3|||
19456868|NCT01729208|41708113|FG000|24 Months Follow-up|Lost to Follow-up|3|||
19456869|NCT01729208|41708114|FG001|24 Months Follow-up|Lost to Follow-up|0|||
19456870|NCT01729208|41708113|FG000|36 Months Follow-up|Physician Decision|1|||
19539172|NCT01289119|41987779|FG001|Overall Study|Other|0|||
19539173|NCT01289119|41987780|FG002|Overall Study|Other|1|||
19539174|NCT01289119|41987781|FG003|Overall Study|Other|0|||
19539175|NCT01289119|41987782|FG004|Overall Study|Other|0|||
19539176|NCT01289119|41987783|FG005|Overall Study|Other|0|||
19539177|NCT01289041|41987797|FG000|Overall Study|Adverse Event|24|||
19539178|NCT01289041|41987797|FG000|Overall Study|Physician Decision|1|||
19539179|NCT01289041|41987797|FG000|Overall Study|Progressive Disease|41|||
19539180|NCT01289041|41987797|FG000|Overall Study|Withdrawal by Subject|3|||
19539181|NCT01289041|41987797|FG000|Overall Study|Death|1|||
19539182|NCT01288729|41987805|FG000|Overall Study|Withdrawal by Subject|1|||
19539183|NCT01288729|41987806|FG001|Overall Study|Withdrawal by Subject|0|||
19539184|NCT01288612|41987815|FG000|Overall Study|Unable to contact|11|||
19539185|NCT01288612|41987816|FG001|Overall Study|Unable to contact|16|||
19539186|NCT01288612|41987817|FG002|Overall Study|Unable to contact|20|||
19539187|NCT01288612|41987815|FG000|Overall Study|Declined|78|||
19539188|NCT01288612|41987816|FG001|Overall Study|Declined|63|||
19539189|NCT01288612|41987817|FG002|Overall Study|Declined|62|||
19456871|NCT01729208|41708114|FG001|36 Months Follow-up|Physician Decision|0|||
19456872|NCT01729208|41708113|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
19456873|NCT01729208|41708114|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
19539190|NCT01288612|41987815|FG000|Overall Study|Unable to intubate|0|||
19539191|NCT01288612|41987816|FG001|Overall Study|Unable to intubate|3|||
19539192|NCT01288612|41987817|FG002|Overall Study|Unable to intubate|0|||
19539193|NCT01287832|41987827|FG000|Overall Study|Adverse Event|1|||
19539194|NCT01287832|41987828|FG001|Overall Study|Adverse Event|0|||
19539195|NCT01287832|41987827|FG000|Overall Study|Death|0|||
19539196|NCT01287832|41987828|FG001|Overall Study|Death|1|||
19539197|NCT01287754|41987836|FG000|Overall Study|Death|2|||
19539198|NCT01287754|41987837|FG001|Overall Study|Death|12|||
19539199|NCT01287754|41987836|FG000|Overall Study|Lost to Follow-up|1|||
19539200|NCT01287754|41987837|FG001|Overall Study|Lost to Follow-up|6|||
19539201|NCT01287754|41987836|FG000|Overall Study|Protocol Violation|0|||
19539202|NCT01287754|41987837|FG001|Overall Study|Protocol Violation|3|||
19539203|NCT01287520|41987857|FG000|Overall Study|Adverse Event|2|||
19539204|NCT01287520|41987858|FG001|Overall Study|Adverse Event|2|||
19539205|NCT01287520|41987859|FG002|Overall Study|Adverse Event|2|||
19539206|NCT01287520|41987860|FG003|Overall Study|Adverse Event|1|||
19539207|NCT01287520|41987861|FG004|Overall Study|Adverse Event|1|||
19456874|NCT01609010|41708131|FG000|Overall Study|Stable disease (SD)|22|||
19456875|NCT01609010|41708132|FG001|Overall Study|Stable disease (SD)|16|||
19456876|NCT01609010|41708131|FG000|Overall Study|Progressive disease (PD)|8|||
19456877|NCT01609010|41708132|FG001|Overall Study|Progressive disease (PD)|10|||
19456878|NCT01609010|41708131|FG000|Overall Study|Adverse Event|3|||
19539208|NCT01287520|41987862|FG005|Overall Study|Adverse Event|2|||
19539209|NCT01287520|41987863|FG006|Overall Study|Adverse Event|0|||
19539210|NCT01287520|41987864|FG007|Overall Study|Adverse Event|2|||
19456879|NCT01609010|41708132|FG001|Overall Study|Adverse Event|6|||
19456880|NCT01609010|41708131|FG000|Overall Study|Withdrawal by Subject|2|||
19456881|NCT01609010|41708132|FG001|Overall Study|Withdrawal by Subject|2|||
19456882|NCT01609010|41708131|FG000|Overall Study|Other|2|||
19456883|NCT01609010|41708132|FG001|Overall Study|Other|0|||
19456884|NCT01609010|41708131|FG000|Overall Study|Other malignancy|1|||
19456885|NCT01609010|41708132|FG001|Overall Study|Other malignancy|0|||
19456886|NCT01609010|41708131|FG000|Overall Study|Pathology review|2|||
19456887|NCT01609010|41708132|FG001|Overall Study|Pathology review|1|||
19456888|NCT01609010|41708131|FG000|Overall Study|Protocol Violation|1|||
19456889|NCT01609010|41708132|FG001|Overall Study|Protocol Violation|1|||
19456890|NCT01609010|41708131|FG000|Overall Study|New cancer|1|||
19456891|NCT01609010|41708132|FG001|Overall Study|New cancer|0|||
19456892|NCT01609010|41708131|FG000|Overall Study|Lost to Follow-up|1|||
19456893|NCT01609010|41708132|FG001|Overall Study|Lost to Follow-up|1|||
19456894|NCT01608308|41708140|FG000|Overall Study|pretreatment medical and billing reasons|0|||
19539211|NCT01287520|41987865|FG008|Overall Study|Adverse Event|0|||
19539212|NCT01287520|41987857|FG000|Overall Study|Physician Decision|1|||
19539213|NCT01287520|41987858|FG001|Overall Study|Physician Decision|1|||
19539214|NCT01287520|41987859|FG002|Overall Study|Physician Decision|2|||
19539215|NCT01287520|41987860|FG003|Overall Study|Physician Decision|0|||
19539216|NCT01287520|41987861|FG004|Overall Study|Physician Decision|1|||
19539217|NCT01287520|41987862|FG005|Overall Study|Physician Decision|1|||
19539218|NCT01287520|41987863|FG006|Overall Study|Physician Decision|0|||
19539219|NCT01287520|41987864|FG007|Overall Study|Physician Decision|1|||
19539220|NCT01287520|41987865|FG008|Overall Study|Physician Decision|0|||
19539221|NCT01287520|41987857|FG000|Overall Study|Progressive disease|0|||
19539222|NCT01287520|41987858|FG001|Overall Study|Progressive disease|4|||
19539223|NCT01287520|41987859|FG002|Overall Study|Progressive disease|1|||
19539224|NCT01287520|41987860|FG003|Overall Study|Progressive disease|6|||
19539225|NCT01287520|41987861|FG004|Overall Study|Progressive disease|1|||
19539226|NCT01287520|41987862|FG005|Overall Study|Progressive disease|0|||
19539227|NCT01287520|41987863|FG006|Overall Study|Progressive disease|2|||
19539228|NCT01287520|41987864|FG007|Overall Study|Progressive disease|2|||
19539229|NCT01287520|41987865|FG008|Overall Study|Progressive disease|4|||
19539230|NCT01287520|41987857|FG000|Overall Study|Withdrawal by Subject|0|||
19539231|NCT01287520|41987858|FG001|Overall Study|Withdrawal by Subject|0|||
19539232|NCT01287520|41987859|FG002|Overall Study|Withdrawal by Subject|0|||
19539233|NCT01287520|41987860|FG003|Overall Study|Withdrawal by Subject|0|||
19539234|NCT01287520|41987861|FG004|Overall Study|Withdrawal by Subject|0|||
19539235|NCT01287520|41987862|FG005|Overall Study|Withdrawal by Subject|1|||
19539236|NCT01287520|41987863|FG006|Overall Study|Withdrawal by Subject|0|||
19539237|NCT01287520|41987864|FG007|Overall Study|Withdrawal by Subject|0|||
19539238|NCT01287520|41987865|FG008|Overall Study|Withdrawal by Subject|1|||
19539239|NCT01287403|41987914|FG000|1st Intervention (1 Day)|Adverse Event|1|||
19539240|NCT01287364|41987930|FG000|Overall Study|Adverse Event|0|||
19539241|NCT01287364|41987931|FG001|Overall Study|Adverse Event|3|||
19539242|NCT01287364|41987930|FG000|Overall Study|Protocol Violation|5|||
19539243|NCT01287364|41987931|FG001|Overall Study|Protocol Violation|5|||
19539244|NCT01287364|41987930|FG000|Overall Study|Other Reason|4|||
19456895|NCT01608308|41708141|FG001|Overall Study|pretreatment medical and billing reasons|2|||
19456896|NCT01755416|41708172|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
19456897|NCT01755416|41708173|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
19456898|NCT01755026|41708181|FG000|Overall Study|Adverse Event|1|||
19456899|NCT01755026|41708182|FG001|Overall Study|Adverse Event|0|||
19539245|NCT01287364|41987931|FG001|Overall Study|Other Reason|2|||
19456900|NCT01755026|41708181|FG000|Overall Study|Withdrawal by Subject|1|||
19456901|NCT01755026|41708182|FG001|Overall Study|Withdrawal by Subject|1|||
19456902|NCT01491945|41708197|FG000|Overall Study|Death|30|||
19631421|NCT00839423|42080723|FG001|Overall Study|Protocol Violation|1|||
19631422|NCT00839423|42080724|FG002|Overall Study|Protocol Violation|2|||
19631423|NCT00839423|42080725|FG003|Overall Study|Protocol Violation|0|||
19631424|NCT00839423|42080722|FG000|Overall Study|Withdrawal of consent|4|||
19631425|NCT00839423|42080723|FG001|Overall Study|Withdrawal of consent|0|||
19631426|NCT00839423|42080724|FG002|Overall Study|Withdrawal of consent|4|||
19631427|NCT00839423|42080725|FG003|Overall Study|Withdrawal of consent|1|||
19631428|NCT00839423|42080722|FG000|Overall Study|Lost to Follow-up|1|||
19631429|NCT00839423|42080723|FG001|Overall Study|Lost to Follow-up|0|||
19631430|NCT00839423|42080724|FG002|Overall Study|Lost to Follow-up|1|||
19631431|NCT00839423|42080725|FG003|Overall Study|Lost to Follow-up|0|||
19631432|NCT00839423|42080722|FG000|Overall Study|Administrative or other reasons|3|||
19631433|NCT00839423|42080723|FG001|Overall Study|Administrative or other reasons|0|||
19631434|NCT00839423|42080724|FG002|Overall Study|Administrative or other reasons|1|||
19631435|NCT00839423|42080725|FG003|Overall Study|Administrative or other reasons|0|||
19631436|NCT00837161|42080735|FG000|Overall Study|refused hysterectomy|2|||
19631437|NCT00859547|42080739|FG000|Overall Study|Lost to Follow-up|1|||
19631438|NCT00859547|42080739|FG000|Overall Study|Parent withdrew consent|1|||
19631439|NCT00859469|42080743|FG000|Overall Study|Adverse Event|2|||
19631440|NCT00859469|42080743|FG000|Overall Study|Lack of Efficacy|9|||
19631441|NCT00859469|42080743|FG000|Overall Study|Withdrawal by Subject|1|||
19631442|NCT00859469|42080743|FG000|Overall Study|Death|16|||
19631443|NCT00859313|42080747|FG000|Overall Study|Lack of Efficacy|2|||
19631444|NCT00859313|42080747|FG000|Overall Study|Adverse Event|1|||
19631445|NCT00859313|42080747|FG000|Overall Study|staff error|1|||
19631446|NCT00771810|42080754|FG000|Overall Study|Adverse Event|3|||
19631447|NCT00771810|42080755|FG001|Overall Study|Adverse Event|0|||
19631448|NCT00771810|42080756|FG002|Overall Study|Adverse Event|2|||
19631449|NCT00771810|42080754|FG000|Overall Study|Lost to Follow-up|0|||
19631450|NCT00771810|42080755|FG001|Overall Study|Lost to Follow-up|0|||
19631451|NCT00771810|42080756|FG002|Overall Study|Lost to Follow-up|1|||
19631452|NCT00771810|42080754|FG000|Overall Study|Physician Decision|1|||
19631453|NCT00771810|42080755|FG001|Overall Study|Physician Decision|2|||
19631454|NCT00771810|42080756|FG002|Overall Study|Physician Decision|2|||
19631455|NCT00771810|42080754|FG000|Overall Study|Protocol Violation|0|||
19631456|NCT00771810|42080755|FG001|Overall Study|Protocol Violation|1|||
19631457|NCT00771810|42080756|FG002|Overall Study|Protocol Violation|1|||
19631458|NCT00771810|42080754|FG000|Overall Study|Withdrawal by Subject|1|||
19456903|NCT01491945|41708197|FG000|Overall Study|Withdrwan/LTF|16|||
19456904|NCT01491945|41708197|FG000|Overall Study|Conversion|4|||
19456905|NCT01491945|41708197|FG000|Overall Study|Missed Visit|1|||
19456906|NCT01728584|41708219|FG000|Overall Study|Adverse Event|1|||
19456907|NCT01728584|41708220|FG001|Overall Study|Adverse Event|0|||
19456908|NCT01728584|41708221|FG002|Overall Study|Adverse Event|0|||
19539246|NCT01287013|41987953|FG000|Overall Study|Non-evaluable|3|||
19539247|NCT01287013|41987954|FG001|Overall Study|Non-evaluable|5|||
19539248|NCT01287013|41987955|FG002|Overall Study|Non-evaluable|21|||
19539249|NCT01286779|41987963|FG000|Overall Study|Withdrawal by Subject|9|||
19539250|NCT01286779|41987963|FG000|Overall Study|Protocol Violation|5|||
19539251|NCT01286779|41987963|FG000|Overall Study|Physician Decision|2|||
19539252|NCT01286779|41987963|FG000|Overall Study|Participant had scheduled surgery|1|||
19539253|NCT01286779|41987963|FG000|Overall Study|Participant moved to another country|1|||
19539254|NCT01286779|41987963|FG000|Overall Study|Discontinued by sponsor|1|||
19539255|NCT01286740|41987977|FG000|Overall Study|Enrolled but not treated|1|||
19539256|NCT01286740|41987977|FG000|Overall Study|Protocol Violation|1|||
19539257|NCT01286311|41987983|FG000|Overall Study|Physician did not want outreach sent|14|||
19539258|NCT01286311|41987984|FG001|Overall Study|Physician did not want outreach sent|0|||
19539259|NCT01286077|41987992|FG000|Overall Study|Adverse Event|2|||
19456909|NCT01728584|41708222|FG003|Overall Study|Adverse Event|0|||
19456910|NCT01728584|41708219|FG000|Overall Study|Physician Decision|4|||
19456911|NCT01728584|41708220|FG001|Overall Study|Physician Decision|0|||
19456912|NCT01728584|41708221|FG002|Overall Study|Physician Decision|1|||
19539260|NCT01286077|41987993|FG001|Overall Study|Adverse Event|0|||
19539261|NCT01286077|41987992|FG000|Overall Study|Death|1|||
19631459|NCT00771810|42080755|FG001|Overall Study|Withdrawal by Subject|2|||
19631460|NCT00771810|42080756|FG002|Overall Study|Withdrawal by Subject|0|||
19631461|NCT00771810|42080754|FG000|Overall Study|Other|0|||
19631462|NCT00771810|42080755|FG001|Overall Study|Other|0|||
19631463|NCT00771810|42080756|FG002|Overall Study|Other|1|||
19631464|NCT00836927|42080770|FG000|Overall Study|Progressive disease|2|||
19631465|NCT00836927|42080771|FG001|Overall Study|Progressive disease|0|||
19631466|NCT00836927|42080772|FG002|Overall Study|Progressive disease|0|||
19631467|NCT00836927|42080773|FG003|Overall Study|Progressive disease|1|||
19631468|NCT00836927|42080774|FG004|Overall Study|Progressive disease|1|||
19456913|NCT01728584|41708222|FG003|Overall Study|Physician Decision|0|||
19456914|NCT01728584|41708219|FG000|Overall Study|Withdrawal by Subject|1|||
19456915|NCT01728584|41708220|FG001|Overall Study|Withdrawal by Subject|0|||
19456916|NCT01728584|41708221|FG002|Overall Study|Withdrawal by Subject|0|||
19456917|NCT01728584|41708222|FG003|Overall Study|Withdrawal by Subject|0|||
19456918|NCT01728584|41708219|FG000|Overall Study|Screen failure|1|||
19456919|NCT01728584|41708220|FG001|Overall Study|Screen failure|0|||
19456920|NCT01728584|41708221|FG002|Overall Study|Screen failure|0|||
19456921|NCT01728584|41708222|FG003|Overall Study|Screen failure|0|||
19456922|NCT01728584|41708219|FG000|Overall Study|Other reason (not specified)|1|||
19456923|NCT01728584|41708220|FG001|Overall Study|Other reason (not specified)|0|||
19456924|NCT01728584|41708221|FG002|Overall Study|Other reason (not specified)|0|||
19456925|NCT01728584|41708222|FG003|Overall Study|Other reason (not specified)|1|||
19456926|NCT01522443|41708255|FG000|Overall Study|No longer receiving clinical benefit|36|||
19456927|NCT01522443|41708256|FG001|Overall Study|No longer receiving clinical benefit|28|||
19456928|NCT01522443|41708255|FG000|Overall Study|Adverse Event|10|||
19456929|NCT01522443|41708256|FG001|Overall Study|Adverse Event|15|||
19539262|NCT01286077|41987993|FG001|Overall Study|Death|0|||
19539263|NCT01286077|41987992|FG000|Overall Study|Protocol Violation|1|||
19539264|NCT01286077|41987993|FG001|Overall Study|Protocol Violation|1|||
19539265|NCT01286077|41987992|FG000|Overall Study|Withdrawal by Subject|0|||
19539266|NCT01286077|41987993|FG001|Overall Study|Withdrawal by Subject|2|||
19539267|NCT01286077|41987992|FG000|Overall Study|Intercurrent illness|1|||
19539268|NCT01286077|41987993|FG001|Overall Study|Intercurrent illness|0|||
19539269|NCT01286077|41987992|FG000|Overall Study|Non-compliance|1|||
19539270|NCT01286077|41987993|FG001|Overall Study|Non-compliance|0|||
19539271|NCT01286077|41987992|FG000|Overall Study|The subject starts with alternative MMY|0|||
19539272|NCT01286077|41987993|FG001|Overall Study|The subject starts with alternative MMY|3|||
19539273|NCT01286077|41987992|FG000|Overall Study|Patient's decision to stop treatment|3|||
19539274|NCT01286077|41987993|FG001|Overall Study|Patient's decision to stop treatment|0|||
19539275|NCT01286077|41987992|FG000|Overall Study|Progression of disease|0|||
19539276|NCT01286077|41987993|FG001|Overall Study|Progression of disease|1|||
19539277|NCT01286077|41987992|FG000|Overall Study|refill medication not received in time|1|||
19539278|NCT01286077|41987993|FG001|Overall Study|refill medication not received in time|0|||
19539279|NCT01285960|41987999|FG000|Overall Study|Withdrawal by Subject|2|||
19539280|NCT01285960|41987999|FG000|Overall Study|Lost to Follow-up|2|||
19456930|NCT01522443|41708255|FG000|Overall Study|Withdrawal by Subject|5|||
19456931|NCT01522443|41708256|FG001|Overall Study|Withdrawal by Subject|8|||
19456932|NCT01522443|41708255|FG000|Overall Study|No study treatment given|1|||
19456933|NCT01522443|41708256|FG001|Overall Study|No study treatment given|1|||
19456934|NCT01522443|41708255|FG000|Overall Study|Other|1|||
19456935|NCT01522443|41708256|FG001|Overall Study|Other|3|||
19456936|NCT01468233|41708277|FG000|Treatment Period 1|Adverse Event|5|||
19456937|NCT01468233|41708278|FG001|Treatment Period 1|Adverse Event|3|||
19456938|NCT01468233|41708279|FG002|Treatment Period 1|Adverse Event|0|||
19456939|NCT01468233|41708280|FG003|Treatment Period 1|Adverse Event|0|||
19539281|NCT01285960|41987999|FG000|Overall Study|2 subjects received less 10 sonications|2|||
19539282|NCT01285609|41988011|FG000|Randomized|Progressive Disease|41|||
19539283|NCT01285609|41988012|FG001|Randomized|Progressive Disease|61|||
19539284|NCT01285609|41988011|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
19539285|NCT01285609|41988012|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
19539286|NCT01285609|41988011|FG000|Randomized|Study Drug Toxicity|13|||
19539287|NCT01285609|41988012|FG001|Randomized|Study Drug Toxicity|14|||
19539288|NCT01285609|41988011|FG000|Randomized|Death|5|||
19539289|NCT01285609|41988012|FG001|Randomized|Death|7|||
19539290|NCT01285609|41988011|FG000|Randomized|Withdrawal by Subject|8|||
19539291|NCT01285609|41988012|FG001|Randomized|Withdrawal by Subject|11|||
19539292|NCT01285609|41988011|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
19539293|NCT01285609|41988012|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
19539294|NCT01285609|41988011|FG000|Randomized|Undisclosed Reasons|1|||
19539295|NCT01285609|41988012|FG001|Randomized|Undisclosed Reasons|0|||
19539296|NCT01285609|41988011|FG000|Randomized|Randomized but not Treated|4|||
19539297|NCT01285609|41988012|FG001|Randomized|Randomized but not Treated|4|||
19539298|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
19539299|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
19539300|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
19456940|NCT01468233|41708281|FG004|Treatment Period 1|Adverse Event|0|||
19456941|NCT01468233|41708282|FG005|Treatment Period 1|Adverse Event|0|||
19456942|NCT01468233|41708277|FG000|Treatment Period 1|Withdrawal by Subject|3|||
19539301|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
19539302|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
19539303|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
19456943|NCT01468233|41708278|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19456944|NCT01468233|41708279|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19539304|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
19539305|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
19539306|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Death|11|||
19539307|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Death|3|||
19539308|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
19539309|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
19539310|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Not Reported|0|||
19539311|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Not Reported|2|||
19539312|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
19539313|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
19539314|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
19539315|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
19539316|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
19539317|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
19539318|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
19539319|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
19539320|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
19539321|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
19539322|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
19539323|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
19539324|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
19539325|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
19539326|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
19539327|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
19539328|NCT01285609|41988011|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
19539329|NCT01285609|41988012|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
19539330|NCT01285609|41988011|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
19539331|NCT01285609|41988012|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
19539332|NCT01285492|41988022|FG000|Overall Study|Adverse Event|11|||
19539333|NCT01285492|41988023|FG001|Overall Study|Adverse Event|0|||
19539334|NCT01285492|41988022|FG000|Overall Study|Protocol Violation|3|||
19631469|NCT00836927|42080770|FG000|Overall Study|Withdrawal by Subject|1|||
19631470|NCT00836927|42080771|FG001|Overall Study|Withdrawal by Subject|0|||
19631471|NCT00836927|42080772|FG002|Overall Study|Withdrawal by Subject|0|||
19631472|NCT00836927|42080773|FG003|Overall Study|Withdrawal by Subject|0|||
19631473|NCT00836927|42080774|FG004|Overall Study|Withdrawal by Subject|0|||
19631474|NCT00771030|42080795|FG000|Overall Study|Adverse Event|0|||
19631475|NCT00771030|42080796|FG001|Overall Study|Adverse Event|1|||
19631476|NCT00771030|42080797|FG002|Overall Study|Adverse Event|0|||
19631477|NCT00771030|42080798|FG003|Overall Study|Adverse Event|0|||
19631478|NCT00771030|42080799|FG004|Overall Study|Adverse Event|0|||
19631479|NCT00771030|42080800|FG005|Overall Study|Adverse Event|0|||
19631480|NCT00771030|42080801|FG006|Overall Study|Adverse Event|0|||
19631481|NCT00768300|42080824|FG000|Overall Study|Randomized but not treated|1|||
19631482|NCT00768300|42080825|FG001|Overall Study|Randomized but not treated|1|||
19631483|NCT00768300|42080824|FG000|Overall Study|Adverse Event|10|||
19631484|NCT00768300|42080825|FG001|Overall Study|Adverse Event|2|||
19631485|NCT00768300|42080824|FG000|Overall Study|Protocol Violation|6|||
19631486|NCT00768300|42080825|FG001|Overall Study|Protocol Violation|1|||
19631487|NCT00768300|42080824|FG000|Overall Study|Withdrawal by Subject|13|||
19631488|NCT00768300|42080825|FG001|Overall Study|Withdrawal by Subject|7|||
19631489|NCT00768300|42080824|FG000|Overall Study|Physician Decision|2|||
19539335|NCT01285492|41988023|FG001|Overall Study|Protocol Violation|0|||
19539336|NCT01285492|41988022|FG000|Overall Study|Withdrawal by Subject|2|||
19539337|NCT01285492|41988023|FG001|Overall Study|Withdrawal by Subject|1|||
19539338|NCT01285492|41988022|FG000|Overall Study|Death|1|||
19539339|NCT01285492|41988023|FG001|Overall Study|Death|0|||
19539340|NCT01284634|41988033|FG000|Overall Study|Adverse Event|1|||
19539341|NCT01284634|41988034|FG001|Overall Study|Adverse Event|0|||
19539342|NCT01284634|41988035|FG002|Overall Study|Adverse Event|2|||
19539343|NCT01284634|41988036|FG003|Overall Study|Adverse Event|1|||
19539344|NCT01284361|41988046|FG000|Overall Study|Withdrawal by Subject|1|||
19539345|NCT01284361|41988046|FG000|Overall Study|Protocol Violation|5|||
19539346|NCT01284361|41988046|FG000|Overall Study|Adverse Event|1|||
19539347|NCT01284361|41988046|FG000|Overall Study|Lost to Follow-up|2|||
19539348|NCT01284127|41988053|FG000|Overall Study|Adverse Event|2|||
19539349|NCT01284127|41988053|FG000|Overall Study|Withdrawal by Subject|4|||
19631490|NCT00768300|42080825|FG001|Overall Study|Physician Decision|3|||
19539350|NCT01284127|41988053|FG000|Overall Study|Physician Decision|1|||
19539351|NCT01283971|41988059|FG000|Overall Study|Adverse Event|3|||
19539352|NCT01283971|41988060|FG001|Overall Study|Adverse Event|5|||
19631491|NCT00768300|42080824|FG000|Overall Study|Study discontinued by Sponsor|271|||
19631492|NCT00768300|42080825|FG001|Overall Study|Study discontinued by Sponsor|140|||
19631493|NCT00768300|42080824|FG000|Overall Study|Death|21|||
19631494|NCT00768300|42080825|FG001|Overall Study|Death|5|||
19631495|NCT00768300|42080824|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
19711557|NCT00079274|42154659|FG002|Overall Study|Adverse Event|8|||
19456945|NCT01468233|41708280|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19539353|NCT01283971|41988059|FG000|Overall Study|Insufficient therapeutic responses|3|||
19539354|NCT01283971|41988060|FG001|Overall Study|Insufficient therapeutic responses|3|||
19539355|NCT01283971|41988059|FG000|Overall Study|Protocol Violation|5|||
19539356|NCT01283971|41988060|FG001|Overall Study|Protocol Violation|1|||
19539357|NCT01283971|41988059|FG000|Overall Study|Refused treatment|3|||
19539358|NCT01283971|41988060|FG001|Overall Study|Refused treatment|1|||
19539359|NCT01283971|41988059|FG000|Overall Study|Failure to return|0|||
19539360|NCT01283971|41988060|FG001|Overall Study|Failure to return|1|||
19539361|NCT01283971|41988059|FG000|Overall Study|Administrative reasons|1|||
19539362|NCT01283971|41988060|FG001|Overall Study|Administrative reasons|1|||
19539363|NCT01283581|41988069|FG000|Overall Study|Lost to Follow-up|8|||
19539364|NCT01283581|41988070|FG001|Overall Study|Lost to Follow-up|6|||
19539365|NCT01283581|41988071|FG002|Overall Study|Lost to Follow-up|8|||
19539366|NCT01283581|41988069|FG000|Overall Study|Withdrawal by Subject|2|||
19539367|NCT01283581|41988070|FG001|Overall Study|Withdrawal by Subject|5|||
19539368|NCT01283581|41988071|FG002|Overall Study|Withdrawal by Subject|2|||
19539369|NCT01283581|41988069|FG000|Overall Study|Adverse Event|1|||
19539370|NCT01283581|41988070|FG001|Overall Study|Adverse Event|1|||
19539371|NCT01283581|41988071|FG002|Overall Study|Adverse Event|4|||
19539372|NCT01283581|41988069|FG000|Overall Study|Physician Decision|0|||
19539373|NCT01283581|41988070|FG001|Overall Study|Physician Decision|1|||
19539374|NCT01283581|41988071|FG002|Overall Study|Physician Decision|2|||
19539375|NCT01283581|41988069|FG000|Overall Study|Protocol Violation|0|||
19539376|NCT01283581|41988070|FG001|Overall Study|Protocol Violation|1|||
19539377|NCT01283581|41988071|FG002|Overall Study|Protocol Violation|2|||
19539378|NCT01283581|41988069|FG000|Overall Study|Noncompliance|1|||
19539379|NCT01283581|41988070|FG001|Overall Study|Noncompliance|0|||
19539380|NCT01283581|41988071|FG002|Overall Study|Noncompliance|0|||
19539381|NCT01283581|41988069|FG000|Overall Study|Investigator unblinded|0|||
19539382|NCT01283581|41988070|FG001|Overall Study|Investigator unblinded|0|||
19539383|NCT01283581|41988071|FG002|Overall Study|Investigator unblinded|1|||
19539384|NCT01283581|41988069|FG000|Overall Study|"Early termination"|0|||
19539385|NCT01283581|41988070|FG001|Overall Study|"Early termination"|0|||
19539386|NCT01283581|41988071|FG002|Overall Study|"Early termination"|1|||
19456946|NCT01468233|41708281|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19456947|NCT01468233|41708282|FG005|Treatment Period 1|Withdrawal by Subject|0|||
19456948|NCT01468233|41708277|FG000|Treatment Period 1|Lost to Follow-up|3|||
19456949|NCT01468233|41708278|FG001|Treatment Period 1|Lost to Follow-up|0|||
19456950|NCT01468233|41708279|FG002|Treatment Period 1|Lost to Follow-up|0|||
19456951|NCT01468233|41708280|FG003|Treatment Period 1|Lost to Follow-up|0|||
19456952|NCT01468233|41708281|FG004|Treatment Period 1|Lost to Follow-up|0|||
19456953|NCT01468233|41708282|FG005|Treatment Period 1|Lost to Follow-up|0|||
19456954|NCT01468233|41708277|FG000|Treatment Period 1|Other|1|||
19456955|NCT01468233|41708278|FG001|Treatment Period 1|Other|1|||
19456956|NCT01468233|41708279|FG002|Treatment Period 1|Other|0|||
19456957|NCT01468233|41708280|FG003|Treatment Period 1|Other|0|||
19456958|NCT01468233|41708281|FG004|Treatment Period 1|Other|0|||
19456959|NCT01468233|41708282|FG005|Treatment Period 1|Other|0|||
19456960|NCT01468233|41708277|FG000|Treatment Period 2|Adverse Event|0|||
19456961|NCT01468233|41708278|FG001|Treatment Period 2|Adverse Event|0|||
19456962|NCT01468233|41708279|FG002|Treatment Period 2|Adverse Event|3|||
19456963|NCT01468233|41708280|FG003|Treatment Period 2|Adverse Event|0|||
19456964|NCT01468233|41708281|FG004|Treatment Period 2|Adverse Event|2|||
19456965|NCT01468233|41708282|FG005|Treatment Period 2|Adverse Event|1|||
19456966|NCT01468233|41708277|FG000|Treatment Period 2|Lack of Efficacy|0|||
19456967|NCT01468233|41708278|FG001|Treatment Period 2|Lack of Efficacy|0|||
19456968|NCT01468233|41708279|FG002|Treatment Period 2|Lack of Efficacy|9|||
19456969|NCT01468233|41708280|FG003|Treatment Period 2|Lack of Efficacy|2|||
19456970|NCT01468233|41708281|FG004|Treatment Period 2|Lack of Efficacy|0|||
19456971|NCT01468233|41708282|FG005|Treatment Period 2|Lack of Efficacy|1|||
19456972|NCT01468233|41708277|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19456973|NCT01468233|41708278|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19456974|NCT01468233|41708279|FG002|Treatment Period 2|Withdrawal by Subject|9|||
19456975|NCT01468233|41708280|FG003|Treatment Period 2|Withdrawal by Subject|1|||
19456976|NCT01468233|41708281|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19456977|NCT01468233|41708282|FG005|Treatment Period 2|Withdrawal by Subject|1|||
19456978|NCT01468233|41708277|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
19456979|NCT01468233|41708278|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
19456980|NCT01468233|41708279|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
19456981|NCT01468233|41708280|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
19456982|NCT01468233|41708281|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
19456983|NCT01468233|41708282|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
19539387|NCT01283542|41988082|FG000|Main Phase|Acute or progressive vision loss|1|||
19539388|NCT01283542|41988082|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
19539389|NCT01283542|41988082|FG000|Main Phase|abnormal laboratory values|5|||
19539390|NCT01283542|41988082|FG000|Extension Phase|Physician Decision|1|||
19456984|NCT01468233|41708277|FG000|Treatment Period 2|Lost to Follow-up|0|||
19456985|NCT01468233|41708278|FG001|Treatment Period 2|Lost to Follow-up|0|||
19456986|NCT01468233|41708279|FG002|Treatment Period 2|Lost to Follow-up|3|||
19456987|NCT01468233|41708280|FG003|Treatment Period 2|Lost to Follow-up|0|||
19456988|NCT01468233|41708281|FG004|Treatment Period 2|Lost to Follow-up|2|||
19456989|NCT01468233|41708282|FG005|Treatment Period 2|Lost to Follow-up|0|||
19456990|NCT01468233|41708277|FG000|Treatment Period 2|Other|0|||
19456991|NCT01468233|41708278|FG001|Treatment Period 2|Other|0|||
19456992|NCT01468233|41708279|FG002|Treatment Period 2|Other|3|||
19539391|NCT01283542|41988082|FG000|Extension Phase|Adverse Event|1|||
19539392|NCT01283542|41988082|FG000|Extension Phase|Administrative problems|1|||
19539393|NCT01283464|41988106|FG000|Overall Study|Lost to Follow-up|0|||
19539394|NCT01283464|41988107|FG001|Overall Study|Lost to Follow-up|1|||
19539395|NCT01283464|41988106|FG000|Overall Study|Withdrawal by Subject|1|||
19539396|NCT01283464|41988107|FG001|Overall Study|Withdrawal by Subject|0|||
19539397|NCT01283464|41988106|FG000|Overall Study|Physician Decision|1|||
19539398|NCT01283464|41988107|FG001|Overall Study|Physician Decision|0|||
19539399|NCT01283386|41988115|FG000|Overall Study|Death|2|||
19539400|NCT01283386|41988116|FG001|Overall Study|Death|0|||
19539401|NCT01283386|41988115|FG000|Overall Study|Withdrawal by Subject|2|||
19539402|NCT01283386|41988116|FG001|Overall Study|Withdrawal by Subject|1|||
19539403|NCT01283386|41988115|FG000|Overall Study|Relapse of underlying disease|1|||
19539404|NCT01283386|41988116|FG001|Overall Study|Relapse of underlying disease|3|||
19539405|NCT01283386|41988115|FG000|Overall Study|Progression of underlying disease|2|||
19539406|NCT01283386|41988116|FG001|Overall Study|Progression of underlying disease|7|||
19539407|NCT01283386|41988115|FG000|Overall Study|Reason not specified|1|||
19539408|NCT01283386|41988116|FG001|Overall Study|Reason not specified|0|||
19539409|NCT01283386|41988115|FG000|Overall Study|Protocol Violation|0|||
19539410|NCT01283386|41988116|FG001|Overall Study|Protocol Violation|1|||
19539411|NCT01283152|41988124|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
19539412|NCT01283152|41988125|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
19539413|NCT01283152|41988124|FG000|Overall Study|Refused HESA|1|||
19539414|NCT01283152|41988125|FG001|Overall Study|Refused HESA|0|||
19539415|NCT01283035|41988131|FG000|Overall Study|Subject later found ineligible|1|||
19539416|NCT01282801|41988137|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
19539417|NCT01282801|41988138|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
19539418|NCT01282372|41988144|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
19539419|NCT01282372|41988144|FG000|Overall Study|Lost to Follow-up|23|||
19539420|NCT01282372|41988144|FG000|Overall Study|Withdrawal by Subject|11|||
19539421|NCT01282372|41988144|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
19539422|NCT01282372|41988144|FG000|Overall Study|Death|1|||
19539423|NCT01282372|41988144|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
19539424|NCT01282372|41988144|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
19539425|NCT01282372|41988144|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
19539426|NCT01282372|41988144|FG000|Overall Study|Adverse Event|12|||
19539427|NCT01282294|41988155|FG000|Overall Study|Lost to Follow-up|14|||
19539428|NCT01282294|41988155|FG000|Overall Study|Screening failure|1|||
19539429|NCT01282294|41988155|FG000|Overall Study|Adverse Event|1|||
19539430|NCT01282294|41988155|FG000|Overall Study|Patient non-compliance|2|||
19539431|NCT01282294|41988155|FG000|Overall Study|Physician Decision|1|||
19539432|NCT01282216|41988161|FG000|Overall Study|Graft failure|0|||
19539433|NCT01282216|41988162|FG001|Overall Study|Graft failure|0|||
19539434|NCT01282216|41988163|FG002|Overall Study|Graft failure|3|||
19539435|NCT01282216|41988164|FG003|Overall Study|Graft failure|2|||
19539436|NCT01282216|41988161|FG000|Overall Study|Physician Decision|0|||
19539437|NCT01282216|41988162|FG001|Overall Study|Physician Decision|0|||
19539438|NCT01282216|41988163|FG002|Overall Study|Physician Decision|11|||
19539439|NCT01282216|41988164|FG003|Overall Study|Physician Decision|0|||
19539440|NCT01282216|41988161|FG000|Overall Study|Relapse|0|||
19539441|NCT01282216|41988162|FG001|Overall Study|Relapse|0|||
19539442|NCT01282216|41988163|FG002|Overall Study|Relapse|17|||
19539443|NCT01282216|41988164|FG003|Overall Study|Relapse|6|||
19539444|NCT01282216|41988161|FG000|Overall Study|Death|0|||
19539445|NCT01282216|41988162|FG001|Overall Study|Death|0|||
19539446|NCT01282216|41988163|FG002|Overall Study|Death|2|||
19539447|NCT01282216|41988164|FG003|Overall Study|Death|0|||
19539448|NCT01281865|41988172|FG000|Overall Study|Adverse Event|1|||
19539449|NCT01281865|41988173|FG001|Overall Study|Adverse Event|1|||
19456993|NCT01468233|41708280|FG003|Treatment Period 2|Other|0|||
19456994|NCT01468233|41708281|FG004|Treatment Period 2|Other|1|||
19539450|NCT01281865|41988172|FG000|Overall Study|Withdrawal by Subject|1|||
19539451|NCT01281865|41988173|FG001|Overall Study|Withdrawal by Subject|0|||
19539452|NCT01281865|41988172|FG000|Overall Study|Lack of Efficacy|1|||
19539453|NCT01281865|41988173|FG001|Overall Study|Lack of Efficacy|0|||
19539454|NCT01281202|41988181|FG000|Overall Study|Adverse Event|2|||
19539455|NCT01281202|41988182|FG001|Overall Study|Adverse Event|0|||
19539456|NCT01281202|41988181|FG000|Overall Study|Withdrawal by Subject|2|||
19456995|NCT01468233|41708282|FG005|Treatment Period 2|Other|0|||
19539457|NCT01281202|41988182|FG001|Overall Study|Withdrawal by Subject|2|||
19539458|NCT01281202|41988181|FG000|Overall Study|Protocol Violation|11|||
19539459|NCT01281202|41988182|FG001|Overall Study|Protocol Violation|10|||
19539460|NCT01281202|41988181|FG000|Overall Study|Administrative|2|||
19539461|NCT01281202|41988182|FG001|Overall Study|Administrative|8|||
19539462|NCT01281202|41988181|FG000|Overall Study|Lost to Follow-up|11|||
19539463|NCT01281202|41988182|FG001|Overall Study|Lost to Follow-up|13|||
19539464|NCT01281202|41988181|FG000|Overall Study|Incarceration|0|||
19539465|NCT01281202|41988182|FG001|Overall Study|Incarceration|3|||
19539466|NCT01281124|41988190|FG000|Overall Study|Death|1|||
19539467|NCT01280968|41988198|FG000|Overall Study|Lost to Follow-up|8|||
19539468|NCT01280968|41988199|FG001|Overall Study|Lost to Follow-up|2|||
19539469|NCT01280968|41988198|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
19539470|NCT01280968|41988199|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
19539471|NCT01280968|41988198|FG000|Overall Study|Commuting Problems|2|||
19539472|NCT01280968|41988199|FG001|Overall Study|Commuting Problems|0|||
19539473|NCT01280968|41988198|FG000|Overall Study|Anxiety|2|||
19539474|NCT01280968|41988199|FG001|Overall Study|Anxiety|0|||
19539475|NCT01280968|41988198|FG000|Overall Study|Adverse Event|1|||
19539476|NCT01280968|41988199|FG001|Overall Study|Adverse Event|0|||
19539477|NCT01280968|41988198|FG000|Overall Study|Scheduling Conflicts|1|||
19539478|NCT01280968|41988199|FG001|Overall Study|Scheduling Conflicts|1|||
19539479|NCT01280968|41988198|FG000|Overall Study|Pre-existing Neurological Condition|1|||
19539480|NCT01280968|41988199|FG001|Overall Study|Pre-existing Neurological Condition|0|||
19539481|NCT01280968|41988198|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
19539482|NCT01280968|41988199|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
19539483|NCT01280812|41988209|FG000|Overall Study|Withdrawal by Subject|2|||
19539484|NCT01280812|41988210|FG001|Overall Study|Withdrawal by Subject|1|||
19539485|NCT01280812|41988211|FG002|Overall Study|Withdrawal by Subject|0|||
19456996|NCT01468077|41708302|FG000|Overall Study|Adverse Event|2|||
19456997|NCT01468077|41708303|FG001|Overall Study|Adverse Event|2|||
19456998|NCT01468077|41708302|FG000|Overall Study|Lack of Efficacy|1|||
19456999|NCT01468077|41708303|FG001|Overall Study|Lack of Efficacy|1|||
19457000|NCT01468077|41708302|FG000|Overall Study|Physician Decision|1|||
19457001|NCT01468077|41708303|FG001|Overall Study|Physician Decision|0|||
19539486|NCT01280812|41988209|FG000|Overall Study|Lost to Follow-up|1|||
19539487|NCT01280812|41988210|FG001|Overall Study|Lost to Follow-up|1|||
19539488|NCT01280812|41988211|FG002|Overall Study|Lost to Follow-up|1|||
19539489|NCT01280656|41988223|FG000|Overall Study|Adverse Event|1|||
19539490|NCT01280656|41988224|FG001|Overall Study|Adverse Event|14|||
19539491|NCT01280656|41988225|FG002|Overall Study|Adverse Event|13|||
19539492|NCT01280656|41988223|FG000|Overall Study|Lack of Efficacy|1|||
19539493|NCT01280656|41988224|FG001|Overall Study|Lack of Efficacy|22|||
19539494|NCT01280656|41988225|FG002|Overall Study|Lack of Efficacy|38|||
19539495|NCT01280656|41988223|FG000|Overall Study|Treatment shortening (RGT)|0|||
19539496|NCT01280656|41988224|FG001|Overall Study|Treatment shortening (RGT)|4|||
19539497|NCT01280656|41988225|FG002|Overall Study|Treatment shortening (RGT)|5|||
19539498|NCT01280656|41988223|FG000|Overall Study|Other|1|||
19457002|NCT01522365|41708311|FG000|Overall Study|Withdrawal by Subject|1|||
19457003|NCT01522365|41708312|FG001|Overall Study|Withdrawal by Subject|1|||
19457004|NCT01522365|41708311|FG000|Overall Study|Lost to Follow-up|1|||
19457005|NCT01522365|41708312|FG001|Overall Study|Lost to Follow-up|1|||
19457006|NCT01754402|41708322|FG000|Overall Study|Death|0|||
19457007|NCT01754402|41708323|FG001|Overall Study|Death|0|||
19457008|NCT01754402|41708324|FG002|Overall Study|Death|1|||
19457009|NCT01754402|41708322|FG000|Overall Study|Adverse Event|2|||
19457010|NCT01754402|41708323|FG001|Overall Study|Adverse Event|2|||
19457011|NCT01754402|41708324|FG002|Overall Study|Adverse Event|1|||
19457012|NCT01754402|41708322|FG000|Overall Study|Withdrawal by Subject|0|||
19457013|NCT01754402|41708323|FG001|Overall Study|Withdrawal by Subject|0|||
19457014|NCT01754402|41708324|FG002|Overall Study|Withdrawal by Subject|1|||
19457015|NCT01754402|41708322|FG000|Overall Study|Lack of Efficacy|0|||
19457016|NCT01754402|41708323|FG001|Overall Study|Lack of Efficacy|0|||
19457017|NCT01754402|41708324|FG002|Overall Study|Lack of Efficacy|1|||
19457018|NCT01783418|41708335|FG000|Overall Study|Withdrawal by Subject|1|||
19457019|NCT01783418|41708336|FG001|Overall Study|Withdrawal by Subject|0|||
19457020|NCT01521897|41708342|FG000|Overall Study|Protocol Violation|18|||
19457021|NCT01521897|41708342|FG000|Overall Study|Lost to Follow-up|5|||
19457022|NCT01782872|41708350|FG000|Overall Study|Protocol Violation|0|||
19539499|NCT01280656|41988224|FG001|Overall Study|Other|7|||
19539500|NCT01280656|41988225|FG002|Overall Study|Other|7|||
19539501|NCT01280617|41988235|FG000|Overall Study|Adverse Event|0|||
19457023|NCT01782872|41708351|FG001|Overall Study|Protocol Violation|0|||
19457024|NCT01782872|41708352|FG002|Overall Study|Protocol Violation|0|||
19457025|NCT01782872|41708353|FG003|Overall Study|Protocol Violation|1|||
19457026|NCT01782872|41708350|FG000|Overall Study|Withdrawal by Subject|0|||
19457027|NCT01782872|41708351|FG001|Overall Study|Withdrawal by Subject|1|||
19457028|NCT01782872|41708352|FG002|Overall Study|Withdrawal by Subject|0|||
19457029|NCT01782872|41708353|FG003|Overall Study|Withdrawal by Subject|0|||
19539502|NCT01280617|41988236|FG001|Overall Study|Adverse Event|1|||
19539503|NCT01280266|41988244|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
19539504|NCT01280266|41988245|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
19539505|NCT01280266|41988244|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
19457030|NCT01490697|41708365|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
19457031|NCT01490697|41708366|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
19457032|NCT01728194|41708374|FG000|Overall Study|Lost to Follow-up|4|||
19457033|NCT01728194|41708375|FG001|Overall Study|Lost to Follow-up|3|||
19457034|NCT01728194|41708374|FG000|Overall Study|Physician Decision|4|||
19457035|NCT01728194|41708375|FG001|Overall Study|Physician Decision|0|||
19457036|NCT01728194|41708374|FG000|Overall Study|Withdrawal by Subject|7|||
19457037|NCT01728194|41708375|FG001|Overall Study|Withdrawal by Subject|3|||
19457038|NCT01728194|41708374|FG000|Overall Study|Perceived Medication Side Effects|4|||
19539506|NCT01280266|41988245|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
19539507|NCT01279447|41988257|FG000|Overall Study|Lost to Follow-up|3|||
19539508|NCT01279447|41988258|FG001|Overall Study|Lost to Follow-up|1|||
19539509|NCT01276639|41988280|FG000|Week 0 to 16|Death|1|||
19539510|NCT01276639|41988281|FG001|Week 0 to 16|Death|0|||
19539511|NCT01276639|41988282|FG002|Week 0 to 16|Death|0|||
19539512|NCT01276639|41988283|FG003|Week 0 to 16|Death|0|||
19539513|NCT01276639|41988284|FG004|Week 0 to 16|Death|0|||
19539514|NCT01276639|41988280|FG000|Week 0 to 16|Adverse Event|11|||
19539515|NCT01276639|41988281|FG001|Week 0 to 16|Adverse Event|8|||
19539516|NCT01276639|41988282|FG002|Week 0 to 16|Adverse Event|11|||
19539517|NCT01276639|41988283|FG003|Week 0 to 16|Adverse Event|0|||
19539518|NCT01276639|41988284|FG004|Week 0 to 16|Adverse Event|0|||
19539519|NCT01276639|41988280|FG000|Week 0 to 16|Lack of Efficacy|20|||
19539520|NCT01276639|41988281|FG001|Week 0 to 16|Lack of Efficacy|15|||
19539521|NCT01276639|41988282|FG002|Week 0 to 16|Lack of Efficacy|25|||
19539522|NCT01276639|41988283|FG003|Week 0 to 16|Lack of Efficacy|0|||
19539523|NCT01276639|41988284|FG004|Week 0 to 16|Lack of Efficacy|0|||
19539524|NCT01276639|41988280|FG000|Week 0 to 16|Lost to Follow-up|3|||
19539525|NCT01276639|41988281|FG001|Week 0 to 16|Lost to Follow-up|5|||
19539526|NCT01276639|41988282|FG002|Week 0 to 16|Lost to Follow-up|3|||
19539527|NCT01276639|41988283|FG003|Week 0 to 16|Lost to Follow-up|0|||
19539528|NCT01276639|41988284|FG004|Week 0 to 16|Lost to Follow-up|0|||
19539529|NCT01276639|41988280|FG000|Week 0 to 16|Withdrawal by Subject|8|||
19539530|NCT01276639|41988281|FG001|Week 0 to 16|Withdrawal by Subject|5|||
19539531|NCT01276639|41988282|FG002|Week 0 to 16|Withdrawal by Subject|4|||
19539532|NCT01276639|41988283|FG003|Week 0 to 16|Withdrawal by Subject|0|||
19539533|NCT01276639|41988284|FG004|Week 0 to 16|Withdrawal by Subject|0|||
19539534|NCT01276639|41988280|FG000|Week 0 to 16|Other|7|||
19539535|NCT01276639|41988281|FG001|Week 0 to 16|Other|7|||
19539536|NCT01276639|41988282|FG002|Week 0 to 16|Other|2|||
19539537|NCT01276639|41988283|FG003|Week 0 to 16|Other|0|||
19539538|NCT01276639|41988284|FG004|Week 0 to 16|Other|0|||
19539539|NCT01276639|41988280|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
19539540|NCT01276639|41988281|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
19539541|NCT01276639|41988282|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
19539542|NCT01276639|41988283|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
19539543|NCT01276639|41988284|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
19539544|NCT01276639|41988280|FG000|Week 16 to 52|Death|1|||
19539545|NCT01276639|41988281|FG001|Week 16 to 52|Death|0|||
19539546|NCT01276639|41988282|FG002|Week 16 to 52|Death|0|||
19539547|NCT01276639|41988283|FG003|Week 16 to 52|Death|0|||
19539548|NCT01276639|41988284|FG004|Week 16 to 52|Death|0|||
19539549|NCT01276639|41988280|FG000|Week 16 to 52|Adverse Event|10|||
19375357|NCT00857285|41617235|FG000|Overall Study|Withdrawal by Subject|4|||
19539550|NCT01276639|41988281|FG001|Week 16 to 52|Adverse Event|13|||
19539551|NCT01276639|41988282|FG002|Week 16 to 52|Adverse Event|0|||
19539552|NCT01276639|41988283|FG003|Week 16 to 52|Adverse Event|1|||
19375358|NCT00857285|41617236|FG001|Overall Study|Withdrawal by Subject|0|||
19375359|NCT00857285|41617235|FG000|Overall Study|Randomization criteria not met|1|||
19375360|NCT00857285|41617236|FG001|Overall Study|Randomization criteria not met|1|||
19375361|NCT02278354|41617242|FG000|Overall Study|Lost to Follow-up|2|||
19375362|NCT02278354|41617243|FG001|Overall Study|Lost to Follow-up|2|||
19375363|NCT02278354|41617242|FG000|Overall Study|Withdrawal by Subject|0|||
19375364|NCT02278354|41617243|FG001|Overall Study|Withdrawal by Subject|1|||
19375365|NCT02278354|41617242|FG000|Overall Study|<10 professional fights|2|||
19375366|NCT02278354|41617243|FG001|Overall Study|<10 professional fights|0|||
19375367|NCT01657370|41617262|FG000|Overall Study|Withdrawal by Subject|0|||
19375368|NCT01657370|41617263|FG001|Overall Study|Withdrawal by Subject|0|||
19375369|NCT01657370|41617264|FG002|Overall Study|Withdrawal by Subject|1|||
19375370|NCT01657370|41617265|FG003|Overall Study|Withdrawal by Subject|0|||
19457039|NCT01728194|41708375|FG001|Overall Study|Perceived Medication Side Effects|0|||
19457040|NCT01728194|41708374|FG000|Overall Study|Family Member Request|1|||
19539553|NCT01276639|41988284|FG004|Week 16 to 52|Adverse Event|3|||
19539554|NCT01276639|41988280|FG000|Week 16 to 52|Lack of Efficacy|99|||
19539555|NCT01276639|41988281|FG001|Week 16 to 52|Lack of Efficacy|71|||
19539556|NCT01276639|41988282|FG002|Week 16 to 52|Lack of Efficacy|0|||
19539557|NCT01276639|41988283|FG003|Week 16 to 52|Lack of Efficacy|14|||
19539558|NCT01276639|41988284|FG004|Week 16 to 52|Lack of Efficacy|13|||
19539559|NCT01276639|41988280|FG000|Week 16 to 52|Lost to Follow-up|3|||
19539560|NCT01276639|41988281|FG001|Week 16 to 52|Lost to Follow-up|1|||
19539561|NCT01276639|41988282|FG002|Week 16 to 52|Lost to Follow-up|0|||
19457041|NCT01728194|41708375|FG001|Overall Study|Family Member Request|0|||
19457042|NCT01782482|41708383|FG000|Overall Study|Adverse Event|2|||
19457043|NCT01782482|41708384|FG001|Overall Study|Adverse Event|1|||
19457044|NCT01782482|41708383|FG000|Overall Study|Lost to Follow-up|2|||
19457045|NCT01782482|41708384|FG001|Overall Study|Lost to Follow-up|3|||
19457046|NCT01782482|41708383|FG000|Overall Study|Physician Decision|1|||
19457047|NCT01782482|41708384|FG001|Overall Study|Physician Decision|0|||
19457048|NCT01782482|41708383|FG000|Overall Study|Protocol Violation|1|||
19457049|NCT01782482|41708384|FG001|Overall Study|Protocol Violation|0|||
19457050|NCT01782482|41708383|FG000|Overall Study|Withdrawal by Subject|2|||
19539562|NCT01276639|41988283|FG003|Week 16 to 52|Lost to Follow-up|0|||
19539563|NCT01276639|41988284|FG004|Week 16 to 52|Lost to Follow-up|1|||
19539564|NCT01276639|41988280|FG000|Week 16 to 52|Withdrawal by Subject|4|||
19539565|NCT01276639|41988281|FG001|Week 16 to 52|Withdrawal by Subject|4|||
19539566|NCT01276639|41988282|FG002|Week 16 to 52|Withdrawal by Subject|0|||
19539567|NCT01276639|41988283|FG003|Week 16 to 52|Withdrawal by Subject|0|||
19539568|NCT01276639|41988284|FG004|Week 16 to 52|Withdrawal by Subject|1|||
19539569|NCT01276639|41988280|FG000|Week 16 to 52|Other|10|||
19539570|NCT01276639|41988281|FG001|Week 16 to 52|Other|12|||
19539571|NCT01276639|41988282|FG002|Week 16 to 52|Other|0|||
19539572|NCT01276639|41988283|FG003|Week 16 to 52|Other|1|||
19539573|NCT01276639|41988284|FG004|Week 16 to 52|Other|3|||
19539574|NCT01275625|41988299|FG000|Overall Study|Death|1|||
19539575|NCT01275625|41988299|FG000|Overall Study|Lack of Efficacy|2|||
19539576|NCT01275625|41988299|FG000|Overall Study|Lost to Follow-up|1|||
19539577|NCT01275625|41988299|FG000|Overall Study|Withdrawal by Subject|3|||
19539578|NCT01275625|41988299|FG000|Overall Study|Protocol Violation|1|||
19539579|NCT01275625|41988299|FG000|Overall Study|Adverse Event|4|||
19539580|NCT01275625|41988299|FG000|Overall Study|Other|1|||
19539581|NCT01272193|41988305|FG000|Overall Study|Adverse Event|1|||
19539582|NCT01272193|41988306|FG001|Overall Study|Adverse Event|1|||
19539583|NCT01272193|41988305|FG000|Overall Study|Lack of Efficacy|0|||
19539584|NCT01272193|41988306|FG001|Overall Study|Lack of Efficacy|3|||
19539585|NCT01272193|41988305|FG000|Overall Study|Withdrawal Criteria|1|||
19539586|NCT01272193|41988306|FG001|Overall Study|Withdrawal Criteria|1|||
19539587|NCT01272193|41988305|FG000|Overall Study|Unclassified|8|||
19539588|NCT01272193|41988306|FG001|Overall Study|Unclassified|7|||
19539589|NCT01270828|41988318|FG000|Pregabalin CR SB|Reason Unspecified|0|||
19539590|NCT01270828|41988319|FG001|Pregabalin CR SB|Reason Unspecified|0|||
19539591|NCT01270828|41988320|FG002|Pregabalin CR SB|Reason Unspecified|8|||
19539592|NCT01270828|41988318|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
19539593|NCT01270828|41988319|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
19539594|NCT01270828|41988320|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
19539595|NCT01270828|41988318|FG000|Pregabalin CR SB|Related adverse event|0|||
19539596|NCT01270828|41988319|FG001|Pregabalin CR SB|Related adverse event|0|||
19539597|NCT01270828|41988320|FG002|Pregabalin CR SB|Related adverse event|46|||
19539598|NCT01270828|41988318|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
19539599|NCT01270828|41988319|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
19539600|NCT01270828|41988320|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
19539601|NCT01270828|41988318|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
19539602|NCT01270828|41988319|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
19539603|NCT01270828|41988320|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
19539604|NCT01270828|41988318|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
19539605|NCT01270828|41988319|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
19539606|NCT01270828|41988320|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
19539607|NCT01270828|41988318|FG000|Pregabalin CR SB|Unrelated AE|0|||
19539608|NCT01270828|41988319|FG001|Pregabalin CR SB|Unrelated AE|0|||
19539609|NCT01270828|41988320|FG002|Pregabalin CR SB|Unrelated AE|8|||
19539610|NCT01270828|41988318|FG000|Pregabalin CR SB|Protocol Violation|0|||
19539611|NCT01270828|41988319|FG001|Pregabalin CR SB|Protocol Violation|0|||
19539612|NCT01270828|41988320|FG002|Pregabalin CR SB|Protocol Violation|8|||
19539613|NCT01270828|41988318|FG000|Double Blind Phase|Death|0|||
19457051|NCT01782482|41708384|FG001|Overall Study|Withdrawal by Subject|3|||
19457052|NCT01782482|41708383|FG000|Overall Study|Randomized in Error|2|||
19539614|NCT01270828|41988319|FG001|Double Blind Phase|Death|1|||
19539615|NCT01270828|41988320|FG002|Double Blind Phase|Death|0|||
19539616|NCT01270828|41988318|FG000|Double Blind Phase|Protocol Violation|0|||
19539617|NCT01270828|41988319|FG001|Double Blind Phase|Protocol Violation|1|||
19539618|NCT01270828|41988320|FG002|Double Blind Phase|Protocol Violation|0|||
19539619|NCT01270828|41988318|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
19539620|NCT01270828|41988319|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
19539621|NCT01270828|41988320|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
19539622|NCT01270828|41988318|FG000|Double Blind Phase|Reason Unspecified|7|||
19539623|NCT01270828|41988319|FG001|Double Blind Phase|Reason Unspecified|4|||
19539624|NCT01270828|41988320|FG002|Double Blind Phase|Reason Unspecified|0|||
19539625|NCT01270828|41988318|FG000|Double Blind Phase|Withdrawal by Subject|6|||
19539626|NCT01270828|41988319|FG001|Double Blind Phase|Withdrawal by Subject|15|||
19539627|NCT01270828|41988320|FG002|Double Blind Phase|Withdrawal by Subject|0|||
19539628|NCT01270828|41988318|FG000|Double Blind Phase|Lost to Follow-up|1|||
19539629|NCT01270828|41988319|FG001|Double Blind Phase|Lost to Follow-up|2|||
19539630|NCT01270828|41988320|FG002|Double Blind Phase|Lost to Follow-up|0|||
19539631|NCT01270828|41988318|FG000|Double Blind Phase|Lack of Efficacy|2|||
19539632|NCT01270828|41988319|FG001|Double Blind Phase|Lack of Efficacy|11|||
19539633|NCT01270828|41988320|FG002|Double Blind Phase|Lack of Efficacy|0|||
19539634|NCT01270828|41988318|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
19539635|NCT01270828|41988319|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
19539636|NCT01270828|41988320|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
19539637|NCT01270828|41988318|FG000|Double Blind Phase|Adverse event related to study drug|5|||
19539638|NCT01270828|41988319|FG001|Double Blind Phase|Adverse event related to study drug|7|||
19539639|NCT01270828|41988320|FG002|Double Blind Phase|Adverse event related to study drug|0|||
19539640|NCT01269385|41988328|FG000|Overall Study|Adverse Event|1|||
19539641|NCT01269385|41988329|FG001|Overall Study|Adverse Event|1|||
19539642|NCT01269385|41988330|FG002|Overall Study|Adverse Event|0|||
19539643|NCT01269385|41988331|FG003|Overall Study|Adverse Event|0|||
19539644|NCT01269346|41988354|FG000|Treatment Phase|Disease progression|3|||
19539645|NCT01269346|41988354|FG000|Treatment Phase|Adverse Event|3|||
19539646|NCT01269346|41988354|FG000|Treatment Phase|Withdrawal by Subject|1|||
19539647|NCT01269346|41988354|FG000|Treatment Phase|Other|2|||
19539648|NCT01269346|41988354|FG000|Extension Phase|Adverse Event|6|||
19539649|NCT01269346|41988354|FG000|Extension Phase|Withdrawal by Subject|4|||
19539650|NCT01269346|41988354|FG000|Extension Phase|Disease progression|22|||
19539651|NCT01269346|41988354|FG000|Extension Phase|Physician decision or participant choice|9|||
19539652|NCT01269346|41988354|FG000|Extension Phase|Clinical progression|1|||
19539653|NCT01269346|41988354|FG000|Extension Phase|Started a prohibited con med|1|||
19457053|NCT01782482|41708384|FG001|Overall Study|Randomized in Error|2|||
19457054|NCT01782482|41708383|FG000|Overall Study|Habitually wearing toric lens OS|0|||
19457055|NCT01782482|41708384|FG001|Overall Study|Habitually wearing toric lens OS|1|||
19457056|NCT01466673|41708392|FG000|Overall Study|Non-compliance with study treatment|2|||
19539654|NCT01268683|41988359|FG000|Overall Study|Lost to Follow-up|1|||
19457057|NCT01466673|41708393|FG001|Overall Study|Non-compliance with study treatment|0|||
19457058|NCT01466673|41708392|FG000|Overall Study|Lost to Follow-up|3|||
19457059|NCT01466673|41708393|FG001|Overall Study|Lost to Follow-up|5|||
19457060|NCT01466673|41708392|FG000|Overall Study|Adverse Event|2|||
19457061|NCT01466673|41708393|FG001|Overall Study|Adverse Event|1|||
19457062|NCT01753856|41708401|FG000|Overall Study|Adverse Event|1|||
19539655|NCT01268683|41988359|FG000|Overall Study|Death|1|||
19539656|NCT01268566|41988363|FG000|Overall Study|Lost to Follow-up|1|||
19539657|NCT01268566|41988363|FG000|Overall Study|Withdrawal by Subject|12|||
19539658|NCT01268566|41988363|FG000|Overall Study|Death|30|||
19539659|NCT01268488|41988367|FG000|Overall Study|Adverse Event|3|||
19539660|NCT01268488|41988367|FG000|Overall Study|Physician Decision|2|||
19539661|NCT01268293|41988372|FG000|Overall Study|Disease progression|7|||
19539662|NCT01268293|41988372|FG000|Overall Study|Adverse Event|1|||
19539663|NCT01268293|41988372|FG000|Overall Study|Subject choice|1|||
19539664|NCT01268098|41988378|FG000|Overall Study|Adverse Event|1|||
19539665|NCT01268098|41988379|FG001|Overall Study|Adverse Event|0|||
19539666|NCT01268059|41988389|FG000|Overall Study|Lost to Follow-up|0|||
19539667|NCT01268059|41988390|FG001|Overall Study|Lost to Follow-up|1|||
19539668|NCT01268059|41988391|FG002|Overall Study|Lost to Follow-up|0|||
19539669|NCT01268059|41988392|FG003|Overall Study|Lost to Follow-up|0|||
19539670|NCT01268059|41988389|FG000|Overall Study|Withdrawal by Subject|7|||
19539671|NCT01268059|41988390|FG001|Overall Study|Withdrawal by Subject|4|||
19539672|NCT01268059|41988391|FG002|Overall Study|Withdrawal by Subject|0|||
19539673|NCT01268059|41988392|FG003|Overall Study|Withdrawal by Subject|0|||
19539674|NCT01268059|41988389|FG000|Overall Study|Death|20|||
19539675|NCT01268059|41988390|FG001|Overall Study|Death|30|||
19539676|NCT01268059|41988391|FG002|Overall Study|Death|3|||
19539677|NCT01268059|41988392|FG003|Overall Study|Death|5|||
19631496|NCT00768300|42080825|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
19631497|NCT00768300|42080824|FG000|Overall Study|Screen failure following randomization|1|||
19631498|NCT00768300|42080825|FG001|Overall Study|Screen failure following randomization|0|||
19631499|NCT00768300|42080824|FG000|Overall Study|Received lung transplant|1|||
19631500|NCT00768300|42080825|FG001|Overall Study|Received lung transplant|1|||
19631501|NCT00768300|42080824|FG000|Overall Study|Lost to Follow-up|0|||
19631502|NCT00768300|42080825|FG001|Overall Study|Lost to Follow-up|1|||
19631503|NCT00768300|42080824|FG000|Overall Study|Began prohibited concomitant medication|0|||
19457063|NCT01753856|41708402|FG001|Overall Study|Adverse Event|0|||
19457064|NCT01753856|41708401|FG000|Overall Study|Withdrawal by Subject|0|||
19539678|NCT01268059|41988389|FG000|Overall Study|Progression of disease|1|||
19539679|NCT01268059|41988390|FG001|Overall Study|Progression of disease|0|||
19539680|NCT01268059|41988391|FG002|Overall Study|Progression of disease|0|||
19539681|NCT01268059|41988392|FG003|Overall Study|Progression of disease|0|||
19539682|NCT01267825|41988407|FG000|Overall Study|study terminated. no data collected.|1|||
19539683|NCT01267825|41988408|FG001|Overall Study|study terminated. no data collected.|0|||
19539684|NCT01260181|41988414|FG000|Overall Study|Decision of Investigator|1|||
19539685|NCT01260142|41988424|FG000|Treatment Period 1|Study on hold|1|||
19539686|NCT01260142|41988425|FG001|Treatment Period 1|Study on hold|1|||
19539687|NCT01260142|41988426|FG002|Treatment Period 1|Study on hold|0|||
19539688|NCT01260142|41988427|FG003|Treatment Period 1|Study on hold|0|||
19539689|NCT01260142|41988428|FG004|Treatment Period 1|Study on hold|1|||
19539690|NCT01260142|41988429|FG005|Treatment Period 1|Study on hold|2|||
19539691|NCT01260142|41988424|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
19539692|NCT01260142|41988425|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
19539693|NCT01260142|41988426|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
19539694|NCT01260142|41988427|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
19539695|NCT01260142|41988428|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
19539696|NCT01260142|41988429|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
19539697|NCT01260142|41988424|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19539698|NCT01260142|41988425|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19539699|NCT01260142|41988426|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19539700|NCT01260142|41988427|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19539701|NCT01260142|41988428|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19539702|NCT01260142|41988429|FG005|Treatment Period 1|Withdrawal by Subject|1|||
19539703|NCT01259869|41988449|FG000|Overall Study|Duplicated registration|1|||
19539704|NCT01259713|41988465|FG000|Overall Study|Adverse Event|54|||
19539705|NCT01259713|41988466|FG001|Overall Study|Adverse Event|23|||
19539706|NCT01259713|41988465|FG000|Overall Study|Death Not Related to IFI|8|||
19539707|NCT01259713|41988466|FG001|Overall Study|Death Not Related to IFI|1|||
19539708|NCT01259713|41988465|FG000|Overall Study|Investigators Discretion|14|||
19539709|NCT01259713|41988466|FG001|Overall Study|Investigators Discretion|6|||
19539710|NCT01259713|41988465|FG000|Overall Study|Lack of Efficacy|2|||
19539711|NCT01259713|41988466|FG001|Overall Study|Lack of Efficacy|0|||
19539712|NCT01259713|41988465|FG000|Overall Study|Protocol Violation|5|||
19539713|NCT01259713|41988466|FG001|Overall Study|Protocol Violation|4|||
19539714|NCT01259713|41988465|FG000|Overall Study|Subject Withdrew Consent|12|||
19539715|NCT01259713|41988466|FG001|Overall Study|Subject Withdrew Consent|7|||
19539716|NCT01259401|41988474|FG000|4-month Follow-up|Death|0|||
19539717|NCT01259401|41988475|FG001|4-month Follow-up|Death|1|||
19539718|NCT01259401|41988474|FG000|4-month Follow-up|Lost to Follow-up|0|||
19539719|NCT01259401|41988475|FG001|4-month Follow-up|Lost to Follow-up|1|||
19539720|NCT02438722|41988492|FG000|Overall Study|Adverse Event|12|||
19539721|NCT02438722|41988493|FG001|Overall Study|Adverse Event|9|||
19539722|NCT02438722|41988492|FG000|Overall Study|Refusal unrelated to AE|2|||
19457065|NCT01753856|41708402|FG001|Overall Study|Withdrawal by Subject|2|||
19457066|NCT01753856|41708401|FG000|Overall Study|Sponsor Decision|2|||
19457067|NCT01753856|41708402|FG001|Overall Study|Sponsor Decision|0|||
19457068|NCT01464333|41708411|FG000|Overall Study|Adverse Event|34|||
19457069|NCT01464333|41708411|FG000|Overall Study|Lack of Efficacy|72|||
19457070|NCT01464333|41708411|FG000|Overall Study|Withdrawal by Subject|11|||
19457071|NCT01464333|41708411|FG000|Overall Study|Other|4|||
19457072|NCT01464333|41708411|FG000|Overall Study|No Hospital Visit|42|||
19457073|NCT01464255|41708417|FG000|Overall Study|unresolve corneal staining|0|||
19457074|NCT01464255|41708418|FG001|Overall Study|unresolve corneal staining|1|||
19457075|NCT01464021|41708425|FG000|Overall Study|Withdrawal by Subject|13|||
19457076|NCT01464021|41708425|FG000|Overall Study|Lost to Follow-up|1|||
19457077|NCT01464021|41708425|FG000|Overall Study|Lack of Efficacy|1|||
19457078|NCT01464021|41708425|FG000|Overall Study|various|11|||
19457079|NCT01753310|41708431|FG000|Overall Study|Entered into open label extension study|25|||
19457080|NCT01753310|41708432|FG001|Overall Study|Entered into open label extension study|22|||
19457081|NCT01753310|41708431|FG000|Overall Study|Adverse Event|1|||
19457082|NCT01753310|41708432|FG001|Overall Study|Adverse Event|0|||
19457083|NCT01753310|41708431|FG000|Overall Study|Lost to Follow-up|2|||
19457084|NCT01753310|41708432|FG001|Overall Study|Lost to Follow-up|0|||
19539723|NCT02438722|41988493|FG001|Overall Study|Refusal unrelated to AE|5|||
19539724|NCT02438722|41988492|FG000|Overall Study|Disease progression/relapse|46|||
19539725|NCT02438722|41988493|FG001|Overall Study|Disease progression/relapse|51|||
19539726|NCT02438722|41988492|FG000|Overall Study|Death|0|||
19539727|NCT02438722|41988493|FG001|Overall Study|Death|3|||
19539728|NCT02438722|41988492|FG000|Overall Study|Physician Decision|2|||
19539729|NCT02438722|41988493|FG001|Overall Study|Physician Decision|2|||
19457085|NCT01753310|41708431|FG000|Overall Study|Subject decision|2|||
19457086|NCT01753310|41708432|FG001|Overall Study|Subject decision|2|||
19457087|NCT01753310|41708431|FG000|Overall Study|Sponsor decision|1|||
19457088|NCT01753310|41708432|FG001|Overall Study|Sponsor decision|0|||
19457089|NCT01753310|41708431|FG000|Overall Study|Withdrawal by Subject|1|||
19539730|NCT02438722|41988492|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
19539731|NCT02438722|41988493|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
19539732|NCT02438722|41988492|FG000|Overall Study|Withdrawal by Subject|0|||
19539733|NCT02438722|41988493|FG001|Overall Study|Withdrawal by Subject|1|||
19539734|NCT02438722|41988492|FG000|Overall Study|On protocol treatment|15|||
19539735|NCT02438722|41988493|FG001|Overall Study|On protocol treatment|14|||
19539736|NCT02438722|41988492|FG000|Overall Study|Did not receive protocol treatment|5|||
19457090|NCT01753310|41708432|FG001|Overall Study|Withdrawal by Subject|0|||
19457091|NCT01463631|41708442|FG000|Overall Study|Withdrawal by Subject|0|||
19457092|NCT01463631|41708443|FG001|Overall Study|Withdrawal by Subject|0|||
19457093|NCT01463631|41708444|FG002|Overall Study|Withdrawal by Subject|0|||
19457094|NCT01463631|41708445|FG003|Overall Study|Withdrawal by Subject|1|||
19457095|NCT01463631|41708442|FG000|Overall Study|Death|0|||
19457096|NCT01463631|41708443|FG001|Overall Study|Death|0|||
19631504|NCT00768300|42080825|FG001|Overall Study|Began prohibited concomitant medication|1|||
19631505|NCT00768300|42080824|FG000|Overall Study|Treated but never dosed with Study drug|1|||
19631506|NCT00768300|42080825|FG001|Overall Study|Treated but never dosed with Study drug|0|||
19457097|NCT01463631|41708444|FG002|Overall Study|Death|1|||
19457098|NCT01463631|41708445|FG003|Overall Study|Death|0|||
19457099|NCT01463631|41708442|FG000|Overall Study|Progressive Disease|0|||
19457100|NCT01463631|41708443|FG001|Overall Study|Progressive Disease|0|||
19457101|NCT01463631|41708444|FG002|Overall Study|Progressive Disease|0|||
19457102|NCT01463631|41708445|FG003|Overall Study|Progressive Disease|5|||
19457103|NCT01521507|41708459|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
19457104|NCT01521507|41708460|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
19457105|NCT01521507|41708459|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
19457106|NCT01521507|41708460|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
19539737|NCT02438722|41988493|FG001|Overall Study|Did not receive protocol treatment|0|||
19539738|NCT01313923|41988508|FG000|Overall Study|Physician Decision|3|||
19539739|NCT01313884|41988512|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
19539740|NCT01135459|41988518|FG000|Overall Study|Adverse Event|8|||
19539741|NCT01135459|41988519|FG001|Overall Study|Adverse Event|10|||
19539742|NCT01135459|41988518|FG000|Overall Study|Lack of Efficacy|3|||
19539743|NCT01135459|41988519|FG001|Overall Study|Lack of Efficacy|1|||
19539744|NCT01135459|41988518|FG000|Overall Study|Withdrawal by Subject|2|||
19457107|NCT01521507|41708459|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
19457108|NCT01521507|41708460|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
19457109|NCT01521507|41708459|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
19457110|NCT01521507|41708460|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
19457111|NCT01521507|41708459|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
19457112|NCT01521507|41708460|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
19457113|NCT01521507|41708459|FG000|Stage 2: Observational Design|Physician Decision|1|||
19457114|NCT01521507|41708460|FG001|Stage 2: Observational Design|Physician Decision|0|||
19457115|NCT01521117|41708473|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
19457116|NCT01521117|41708474|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
19457117|NCT01521117|41708473|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
19457118|NCT01521117|41708474|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
19457119|NCT01521117|41708473|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
19457120|NCT01521117|41708474|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
19457121|NCT01466595|41708482|FG000|Overall Study|Withdrawal by Subject|0|||
19457122|NCT01466595|41708483|FG001|Overall Study|Withdrawal by Subject|1|||
19457123|NCT01728116|41708500|FG000|Overall Study|Sponsor Terminated Study|106|||
19457124|NCT01728116|41708501|FG001|Overall Study|Sponsor Terminated Study|35|||
19457125|NCT01728116|41708500|FG000|Overall Study|Withdrawal by Subject|16|||
19457126|NCT01728116|41708501|FG001|Overall Study|Withdrawal by Subject|9|||
19457127|NCT01728116|41708500|FG000|Overall Study|Adverse Event|13|||
19457128|NCT01728116|41708501|FG001|Overall Study|Adverse Event|0|||
19457129|NCT01728116|41708500|FG000|Overall Study|Procedure/device failure|7|||
19457130|NCT01728116|41708501|FG001|Overall Study|Procedure/device failure|0|||
19457131|NCT01728116|41708500|FG000|Overall Study|Lost to Follow-up|9|||
19457132|NCT01728116|41708501|FG001|Overall Study|Lost to Follow-up|2|||
19457133|NCT01728116|41708500|FG000|Overall Study|Physician Decision|2|||
19457134|NCT01728116|41708501|FG001|Overall Study|Physician Decision|0|||
19457135|NCT01728116|41708500|FG000|Overall Study|Subject Non-Compliance|2|||
19457136|NCT01728116|41708501|FG001|Overall Study|Subject Non-Compliance|0|||
19457137|NCT01728116|41708500|FG000|Overall Study|Inter-current finding at procedure|1|||
19457138|NCT01728116|41708501|FG001|Overall Study|Inter-current finding at procedure|0|||
19457139|NCT01728116|41708500|FG000|Overall Study|Incorrectly enrolled in Study|0|||
19539745|NCT01135459|41988519|FG001|Overall Study|Withdrawal by Subject|3|||
19457140|NCT01728116|41708501|FG001|Overall Study|Incorrectly enrolled in Study|1|||
19539746|NCT01135459|41988518|FG000|Overall Study|Protocol Violation|5|||
19539747|NCT01135459|41988519|FG001|Overall Study|Protocol Violation|3|||
19457141|NCT01728116|41708500|FG000|Overall Study|various not noted previously|5|||
19457142|NCT01728116|41708501|FG001|Overall Study|various not noted previously|0|||
19539748|NCT01135459|41988518|FG000|Overall Study|Lost to Follow-up|2|||
19539749|NCT01135459|41988519|FG001|Overall Study|Lost to Follow-up|1|||
19539750|NCT01135459|41988518|FG000|Overall Study|Non-compliance to study procedures|0|||
19539751|NCT01135459|41988519|FG001|Overall Study|Non-compliance to study procedures|1|||
19539752|NCT01135459|41988518|FG000|Overall Study|Other than specified|1|||
19539753|NCT01135459|41988519|FG001|Overall Study|Other than specified|1|||
19539754|NCT01259284|41988528|FG000|Overall Study|Study Termination|2|||
19539755|NCT01259284|41988529|FG001|Overall Study|Study Termination|0|||
19539756|NCT01259284|41988530|FG002|Overall Study|Study Termination|0|||
19539757|NCT01259245|41988540|FG000|Overall Study|Withdrawal by Subject|27|||
19539758|NCT01259245|41988541|FG001|Overall Study|Withdrawal by Subject|24|||
19539759|NCT01259245|41988540|FG000|Overall Study|Death|1|||
19539760|NCT01259245|41988541|FG001|Overall Study|Death|2|||
19539761|NCT01259089|41988549|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
19539762|NCT01259089|41988550|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
19539763|NCT01259089|41988551|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
19539764|NCT01259089|41988552|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
19539765|NCT01259089|41988553|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
19539766|NCT01259089|41988554|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
19539767|NCT01259089|41988549|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
19539768|NCT01259089|41988550|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
19539769|NCT01259089|41988551|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
19539770|NCT01259089|41988552|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
19539771|NCT01259089|41988553|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
19539772|NCT01259089|41988554|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
19539773|NCT01259089|41988549|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
19539774|NCT01259089|41988550|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
19539775|NCT01259089|41988551|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
19539776|NCT01259089|41988552|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
19539777|NCT01259089|41988553|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
19539778|NCT01259089|41988554|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
19539779|NCT01259089|41988549|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
19539780|NCT01259089|41988550|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
19539781|NCT01259089|41988551|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
19539782|NCT01259089|41988552|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
19457143|NCT01465659|41708512|FG000|Completed 1 Cycle of Treatment|Death|0|||
19457144|NCT01465659|41708513|FG001|Completed 1 Cycle of Treatment|Death|1|||
19457145|NCT01465659|41708514|FG002|Completed 1 Cycle of Treatment|Death|0|||
19457146|NCT01465659|41708515|FG003|Completed 1 Cycle of Treatment|Death|0|||
19457147|NCT01465659|41708512|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
19457148|NCT01465659|41708513|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
19457149|NCT01465659|41708514|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
19457150|NCT01465659|41708515|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
19539783|NCT01259089|41988553|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
19539784|NCT01259089|41988554|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
19539785|NCT01259089|41988549|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
19539786|NCT01259089|41988550|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
19539787|NCT01259089|41988551|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
19539788|NCT01259089|41988552|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
19539789|NCT01259089|41988553|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
19539790|NCT01259089|41988554|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
19539791|NCT01259089|41988549|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
19539792|NCT01259089|41988550|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
19539793|NCT01259089|41988551|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
19539794|NCT01259089|41988552|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
19539795|NCT01259089|41988553|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
19539796|NCT01259089|41988554|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
19539797|NCT01259089|41988549|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
19539798|NCT01259089|41988550|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
19539799|NCT01259089|41988551|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
19539800|NCT01259089|41988552|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
19539801|NCT01259089|41988553|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
19539802|NCT01259089|41988554|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
19539803|NCT01259089|41988549|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
19539804|NCT01259089|41988550|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
19539805|NCT01259089|41988551|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
19457151|NCT01465659|41708512|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
19457152|NCT01465659|41708513|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
19539806|NCT01259089|41988552|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
19539807|NCT01259089|41988553|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
19539808|NCT01259089|41988554|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
19457153|NCT01465659|41708514|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
19457154|NCT01465659|41708515|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
19457155|NCT01465659|41708512|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
19457156|NCT01465659|41708513|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
19457157|NCT01465659|41708514|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
19457158|NCT01465659|41708515|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
19457159|NCT01465659|41708512|FG000|Completed Follow for 1 Year|Death|6|||
19457160|NCT01465659|41708513|FG001|Completed Follow for 1 Year|Death|3|||
19539809|NCT01259089|41988549|FG000|Survival Follow up for Two Years|Death|3|||
19539810|NCT01259089|41988550|FG001|Survival Follow up for Two Years|Death|2|||
19539811|NCT01259089|41988551|FG002|Survival Follow up for Two Years|Death|2|||
19539812|NCT01259089|41988552|FG003|Survival Follow up for Two Years|Death|3|||
19539813|NCT01259089|41988553|FG004|Survival Follow up for Two Years|Death|6|||
19539814|NCT01259089|41988554|FG005|Survival Follow up for Two Years|Death|13|||
19539815|NCT01259089|41988549|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
19539816|NCT01259089|41988550|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
19539817|NCT01259089|41988551|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
19539818|NCT01259089|41988552|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
19539819|NCT01259089|41988553|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
19539820|NCT01259089|41988554|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
19539821|NCT01259089|41988549|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
19539822|NCT01259089|41988550|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
19539823|NCT01259089|41988551|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
19539824|NCT01259089|41988552|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
19539825|NCT01259089|41988553|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
19539826|NCT01259089|41988554|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
19539827|NCT01258738|41988570|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
19539828|NCT01258738|41988571|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
19539829|NCT01258738|41988570|FG000|Double-blind Period|Withdrawal by Subject|2|||
19539830|NCT01258738|41988571|FG001|Double-blind Period|Withdrawal by Subject|2|||
19539831|NCT01258738|41988570|FG000|Double-blind Period|Protocol Violation|1|||
19539832|NCT01258738|41988571|FG001|Double-blind Period|Protocol Violation|1|||
19539833|NCT01258738|41988570|FG000|Double-blind Period|Adverse Event|3|||
19539834|NCT01258738|41988571|FG001|Double-blind Period|Adverse Event|1|||
19539835|NCT01258738|41988570|FG000|Open-label Period|Did not meet inclusion criteria|0|||
19539836|NCT01258738|41988571|FG001|Open-label Period|Did not meet inclusion criteria|1|||
19539837|NCT01258738|41988570|FG000|Open-label Period|Insufficient clinical response|5|||
19539838|NCT01258738|41988571|FG001|Open-label Period|Insufficient clinical response|3|||
19539839|NCT01258738|41988570|FG000|Open-label Period|Lost to Follow-up|0|||
19539840|NCT01258738|41988571|FG001|Open-label Period|Lost to Follow-up|2|||
19539841|NCT01258738|41988570|FG000|Open-label Period|Withdrawal by Subject|5|||
19539842|NCT01258738|41988571|FG001|Open-label Period|Withdrawal by Subject|6|||
19539843|NCT01258738|41988570|FG000|Open-label Period|Protocol Violation|2|||
19539844|NCT01258738|41988571|FG001|Open-label Period|Protocol Violation|2|||
19539845|NCT01258738|41988570|FG000|Open-label Period|Adverse Event|4|||
19539846|NCT01258738|41988571|FG001|Open-label Period|Adverse Event|5|||
19539847|NCT01258738|41988570|FG000|Open-label Period|Other Reasons|0|||
19539848|NCT01258738|41988571|FG001|Open-label Period|Other Reasons|1|||
19457161|NCT01465659|41708514|FG002|Completed Follow for 1 Year|Death|2|||
19457162|NCT01465659|41708515|FG003|Completed Follow for 1 Year|Death|4|||
19457163|NCT01753076|41708530|FG000|Overall Study|Adverse Event|17|||
19457164|NCT01753076|41708531|FG001|Overall Study|Adverse Event|18|||
19457165|NCT01753076|41708530|FG000|Overall Study|Lack of Efficacy|3|||
19457166|NCT01753076|41708531|FG001|Overall Study|Lack of Efficacy|1|||
19457167|NCT01753076|41708530|FG000|Overall Study|Lost to Follow-up|2|||
19457168|NCT01753076|41708531|FG001|Overall Study|Lost to Follow-up|1|||
19457169|NCT01753076|41708530|FG000|Overall Study|Physician Decision|4|||
19457170|NCT01753076|41708531|FG001|Overall Study|Physician Decision|2|||
19539849|NCT01258738|41988570|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
19539850|NCT01258738|41988571|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
19539851|NCT01258660|41988579|FG000|Overall Study|Adverse Event|2|||
19539852|NCT01258660|41988580|FG001|Overall Study|Adverse Event|4|||
19539853|NCT01258660|41988579|FG000|Overall Study|Withdrawal by Subject|3|||
19631507|NCT00768300|42080824|FG000|Overall Study|Missing data|1|||
19457171|NCT01753076|41708530|FG000|Overall Study|Withdrawal by Subject|14|||
19457172|NCT01753076|41708531|FG001|Overall Study|Withdrawal by Subject|24|||
19539854|NCT01258660|41988580|FG001|Overall Study|Withdrawal by Subject|0|||
19539855|NCT01258660|41988579|FG000|Overall Study|due to relocation|2|||
19539856|NCT01258660|41988580|FG001|Overall Study|due to relocation|0|||
19457173|NCT01753076|41708530|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
19457174|NCT01753076|41708531|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
19457175|NCT01463007|41708539|FG000|Overall Study|Physician Decision|1|||
19457176|NCT01462929|41708547|FG000|Overall Study|Adverse Event|3|||
19457177|NCT01462929|41708548|FG001|Overall Study|Adverse Event|3|||
19457178|NCT01462929|41708549|FG002|Overall Study|Adverse Event|4|||
19457179|NCT01462929|41708547|FG000|Overall Study|Withdrawal by Subject|2|||
19457180|NCT01462929|41708548|FG001|Overall Study|Withdrawal by Subject|1|||
19457181|NCT01462929|41708549|FG002|Overall Study|Withdrawal by Subject|0|||
19457182|NCT01462929|41708547|FG000|Overall Study|Lack of Efficacy|0|||
19539857|NCT01258660|41988579|FG000|Overall Study|Protocol Violation|0|||
19539858|NCT01258660|41988580|FG001|Overall Study|Protocol Violation|1|||
19539859|NCT01258660|41988579|FG000|Overall Study|Invalid for primary analysis data set|4|||
19539860|NCT01258660|41988580|FG001|Overall Study|Invalid for primary analysis data set|6|||
19539861|NCT01258348|41988587|FG000|Overall Study|Adverse Event|1|||
19539862|NCT01258348|41988588|FG001|Overall Study|Adverse Event|1|||
19539863|NCT01258348|41988589|FG002|Overall Study|Adverse Event|3|||
19539864|NCT01258348|41988590|FG003|Overall Study|Adverse Event|2|||
19539865|NCT01258348|41988591|FG004|Overall Study|Adverse Event|4|||
19539866|NCT01258348|41988587|FG000|Overall Study|Progressive Disease|0|||
19539867|NCT01258348|41988588|FG001|Overall Study|Progressive Disease|3|||
19539868|NCT01258348|41988589|FG002|Overall Study|Progressive Disease|0|||
19539869|NCT01258348|41988590|FG003|Overall Study|Progressive Disease|2|||
19539870|NCT01258348|41988591|FG004|Overall Study|Progressive Disease|2|||
19539871|NCT01258348|41988587|FG000|Overall Study|Physician Decision|0|||
19539872|NCT01258348|41988588|FG001|Overall Study|Physician Decision|0|||
19457183|NCT01462929|41708548|FG001|Overall Study|Lack of Efficacy|0|||
19457184|NCT01462929|41708549|FG002|Overall Study|Lack of Efficacy|1|||
19457185|NCT01462695|41708559|FG000|Overall Study|Adverse Event|1|||
19457186|NCT01462695|41708560|FG001|Overall Study|Adverse Event|1|||
19457187|NCT01462695|41708559|FG000|Overall Study|Death|2|||
19457188|NCT01462695|41708560|FG001|Overall Study|Death|0|||
19539873|NCT01258348|41988589|FG002|Overall Study|Physician Decision|0|||
19539874|NCT01258348|41988590|FG003|Overall Study|Physician Decision|2|||
19539875|NCT01258348|41988591|FG004|Overall Study|Physician Decision|0|||
19539876|NCT01258348|41988587|FG000|Overall Study|Withdrawal by Subject|0|||
19539877|NCT01258348|41988588|FG001|Overall Study|Withdrawal by Subject|1|||
19539878|NCT01258348|41988589|FG002|Overall Study|Withdrawal by Subject|0|||
19539879|NCT01258348|41988590|FG003|Overall Study|Withdrawal by Subject|0|||
19539880|NCT01258348|41988591|FG004|Overall Study|Withdrawal by Subject|0|||
19539881|NCT01258075|41988607|FG000|Overall Study|Adverse Event|8|||
19539882|NCT01258075|41988608|FG001|Overall Study|Adverse Event|3|||
19539883|NCT01258075|41988607|FG000|Overall Study|Lost to Follow-up|11|||
19539884|NCT01258075|41988608|FG001|Overall Study|Lost to Follow-up|6|||
19539885|NCT01258075|41988607|FG000|Overall Study|Withdrawal by Subject|10|||
19539886|NCT01258075|41988608|FG001|Overall Study|Withdrawal by Subject|7|||
19539887|NCT01258075|41988607|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
19539888|NCT01258075|41988608|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
19539889|NCT01258075|41988607|FG000|Overall Study|Other|12|||
19711558|NCT00079274|42154660|FG003|Overall Study|Adverse Event|184|||
19375371|NCT01657370|41617266|FG004|Overall Study|Withdrawal by Subject|0|||
19457189|NCT01462695|41708559|FG000|Overall Study|Lack of Efficacy|6|||
19457190|NCT01462695|41708560|FG001|Overall Study|Lack of Efficacy|12|||
19457191|NCT01462695|41708559|FG000|Overall Study|Physician Decision|5|||
19457192|NCT01462695|41708560|FG001|Overall Study|Physician Decision|0|||
19457193|NCT01462695|41708559|FG000|Overall Study|Withdrawal by Subject|2|||
19457194|NCT01462695|41708560|FG001|Overall Study|Withdrawal by Subject|0|||
19457195|NCT01462695|41708559|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
19457196|NCT01462695|41708560|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
19457197|NCT01465347|41708566|FG000|Overall Study|Withdrawal by Subject|1|||
19539890|NCT01258075|41988608|FG001|Overall Study|Other|5|||
19539891|NCT01257568|41988614|FG000|Overall Study|Lost to Follow-up|2|||
19375372|NCT01657370|41617267|FG005|Overall Study|Withdrawal by Subject|1|||
19375373|NCT01657370|41617262|FG000|Overall Study|Physician Decision|2|||
19375374|NCT01657370|41617263|FG001|Overall Study|Physician Decision|3|||
19375375|NCT01657370|41617264|FG002|Overall Study|Physician Decision|1|||
19375376|NCT01657370|41617265|FG003|Overall Study|Physician Decision|2|||
19375377|NCT01657370|41617266|FG004|Overall Study|Physician Decision|5|||
19375378|NCT01657370|41617267|FG005|Overall Study|Physician Decision|0|||
19375379|NCT01657370|41617262|FG000|Overall Study|Lack of Qualifying Event|1|||
19375380|NCT01657370|41617263|FG001|Overall Study|Lack of Qualifying Event|0|||
19375381|NCT01657370|41617264|FG002|Overall Study|Lack of Qualifying Event|3|||
19539892|NCT01257568|41988614|FG000|Overall Study|Withdrawal by Subject|6|||
19539893|NCT01257568|41988614|FG000|Overall Study|Terminated|1|||
19539894|NCT01257568|41988614|FG000|Overall Study|Component Revision|24|||
19539895|NCT01256788|41988623|FG000|Overall Study|Lost to Follow-up|5|||
19539896|NCT01256788|41988624|FG001|Overall Study|Lost to Follow-up|8|||
19539897|NCT01256788|41988625|FG002|Overall Study|Lost to Follow-up|3|||
19457198|NCT01465347|41708567|FG001|Overall Study|Withdrawal by Subject|1|||
19457199|NCT01465347|41708566|FG000|Overall Study|Physician Decision|0|||
19457200|NCT01465347|41708567|FG001|Overall Study|Physician Decision|1|||
19457201|NCT01465347|41708566|FG000|Overall Study|Admitted to hospice|0|||
19457202|NCT01465347|41708567|FG001|Overall Study|Admitted to hospice|1|||
19457203|NCT01465191|41708579|FG000|Overall Study|Protocol Violation|6|||
19457204|NCT01465191|41708580|FG001|Overall Study|Protocol Violation|3|||
19457205|NCT01465191|41708581|FG002|Overall Study|Protocol Violation|3|||
19457206|NCT01465191|41708579|FG000|Overall Study|Lost to Follow-up|3|||
19539898|NCT01256671|41988633|FG000|Overall Study|Adverse Event|29|||
19539899|NCT01256671|41988633|FG000|Overall Study|Lost to Follow-up|16|||
19539900|NCT01256671|41988633|FG000|Overall Study|Withdrawal by Subject|31|||
19539901|NCT01256671|41988633|FG000|Overall Study|Physician Decision|3|||
19539902|NCT01256671|41988633|FG000|Overall Study|Lack of Efficacy|4|||
19539903|NCT01256671|41988633|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
19539904|NCT01256593|41988637|FG000|Overall Study|Protocol Violation|26|||
19539905|NCT01256593|41988637|FG000|Overall Study|No Drug Administration Information|2|||
19539906|NCT01256593|41988637|FG000|Overall Study|No Visit After Treatment|186|||
19539907|NCT01256476|41988643|FG000|Overall Study|Adverse Event|2|||
19539908|NCT01256476|41988644|FG001|Overall Study|Adverse Event|1|||
19539909|NCT01256476|41988643|FG000|Overall Study|Withdrawal by Subject|2|||
19539910|NCT01256476|41988644|FG001|Overall Study|Withdrawal by Subject|1|||
19539911|NCT01256476|41988643|FG000|Overall Study|Lost to Follow-up|1|||
19539912|NCT01256476|41988644|FG001|Overall Study|Lost to Follow-up|2|||
19539913|NCT01256476|41988643|FG000|Overall Study|Persistent ALT or AST elevation|1|||
19539914|NCT01256476|41988644|FG001|Overall Study|Persistent ALT or AST elevation|0|||
19539915|NCT01256476|41988643|FG000|Overall Study|Physician Decision|0|||
19539916|NCT01256476|41988644|FG001|Overall Study|Physician Decision|1|||
19457207|NCT01465191|41708580|FG001|Overall Study|Lost to Follow-up|6|||
19457208|NCT01465191|41708581|FG002|Overall Study|Lost to Follow-up|4|||
19457209|NCT01519947|41708596|FG000|Overall Study|Death|0|||
19457210|NCT01519947|41708597|FG001|Overall Study|Death|0|||
19457211|NCT01519947|41708598|FG002|Overall Study|Death|0|||
19457212|NCT01519947|41708599|FG003|Overall Study|Death|1|||
19539917|NCT01256476|41988643|FG000|Overall Study|Subject non-compliance|0|||
19539918|NCT01256476|41988644|FG001|Overall Study|Subject non-compliance|1|||
19539919|NCT01256476|41988643|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
19539920|NCT01256476|41988644|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
19539921|NCT01256008|41988653|FG000|Overall Study|Lost to Follow-up|6|||
19539922|NCT01256008|41988654|FG001|Overall Study|Lost to Follow-up|4|||
19539923|NCT01256008|41988655|FG002|Overall Study|Lost to Follow-up|11|||
19539924|NCT01256008|41988653|FG000|Overall Study|Withdrawal by Subject|2|||
19539925|NCT01256008|41988654|FG001|Overall Study|Withdrawal by Subject|3|||
19539926|NCT01256008|41988655|FG002|Overall Study|Withdrawal by Subject|10|||
19539927|NCT01255423|41988667|FG000|Overall Study|Abnormal Laboratory value|3|||
19539928|NCT01255423|41988668|FG001|Overall Study|Abnormal Laboratory value|2|||
19539929|NCT01255423|41988667|FG000|Overall Study|Use of prohibited medications|0|||
19539930|NCT01255423|41988668|FG001|Overall Study|Use of prohibited medications|1|||
19539931|NCT01255306|41988676|FG000|Overall Study|Physician Decision|1|||
19539932|NCT01255306|41988677|FG001|Overall Study|Physician Decision|1|||
19539933|NCT01254721|41988688|FG000|Overall Study|Lost to Follow-up|0|||
19539934|NCT01254721|41988689|FG001|Overall Study|Lost to Follow-up|4|||
19539935|NCT01254721|41988688|FG000|Overall Study|Lack of Efficacy|4|||
19539936|NCT01254721|41988689|FG001|Overall Study|Lack of Efficacy|2|||
19539937|NCT01254721|41988688|FG000|Overall Study|Death|0|||
19539938|NCT01254721|41988689|FG001|Overall Study|Death|1|||
19539939|NCT01254721|41988688|FG000|Overall Study|technical problum|1|||
19539940|NCT01254721|41988689|FG001|Overall Study|technical problum|0|||
19539941|NCT01254721|41988688|FG000|Overall Study|Adverse Event|2|||
19539942|NCT01254721|41988689|FG001|Overall Study|Adverse Event|3|||
19539943|NCT01254721|41988688|FG000|Overall Study|Withdrawal by Subject|8|||
19539944|NCT01254721|41988689|FG001|Overall Study|Withdrawal by Subject|11|||
19539945|NCT01254721|41988688|FG000|Overall Study|Wrongly randomization|0|||
19375382|NCT01657370|41617265|FG003|Overall Study|Lack of Qualifying Event|2|||
19375383|NCT01657370|41617266|FG004|Overall Study|Lack of Qualifying Event|1|||
19375384|NCT01657370|41617267|FG005|Overall Study|Lack of Qualifying Event|2|||
19375385|NCT01657370|41617262|FG000|Overall Study|Adverse Event|0|||
19375386|NCT01657370|41617263|FG001|Overall Study|Adverse Event|0|||
19375387|NCT01657370|41617264|FG002|Overall Study|Adverse Event|0|||
19375388|NCT01657370|41617265|FG003|Overall Study|Adverse Event|0|||
19375389|NCT01657370|41617266|FG004|Overall Study|Adverse Event|1|||
19457213|NCT01519947|41708596|FG000|Overall Study|Protocol Violation|0|||
19457214|NCT01519947|41708597|FG001|Overall Study|Protocol Violation|0|||
19539946|NCT01254721|41988689|FG001|Overall Study|Wrongly randomization|1|||
19539947|NCT01254643|41988695|FG000|Overall Study|Withdrawal by Subject|1|||
19539948|NCT01254604|41988701|FG000|Overall Study|Lost to Follow-up|1|||
19539949|NCT01254604|41988702|FG001|Overall Study|Lost to Follow-up|1|||
19539950|NCT01254604|41988701|FG000|Overall Study|Protocol Violation|2|||
19539951|NCT01254604|41988702|FG001|Overall Study|Protocol Violation|2|||
19539952|NCT01254604|41988701|FG000|Overall Study|Withdrawal by Subject|2|||
19539953|NCT01254604|41988702|FG001|Overall Study|Withdrawal by Subject|4|||
19539954|NCT01254604|41988701|FG000|Overall Study|Adverse Event|3|||
19539955|NCT01254604|41988702|FG001|Overall Study|Adverse Event|2|||
19539956|NCT01254565|41988714|FG000|Overall Study|Non-compliance to Study Procedures|0|||
19539957|NCT01254565|41988715|FG001|Overall Study|Non-compliance to Study Procedures|0|||
19539958|NCT01254565|41988716|FG002|Overall Study|Non-compliance to Study Procedures|0|||
19539959|NCT01254565|41988717|FG003|Overall Study|Non-compliance to Study Procedures|0|||
19539960|NCT01254565|41988718|FG004|Overall Study|Non-compliance to Study Procedures|1|||
19539961|NCT01254565|41988719|FG005|Overall Study|Non-compliance to Study Procedures|0|||
19539962|NCT01254565|41988714|FG000|Overall Study|Did not Receive Treatment|1|||
19539963|NCT01254565|41988715|FG001|Overall Study|Did not Receive Treatment|1|||
19539964|NCT01254565|41988716|FG002|Overall Study|Did not Receive Treatment|0|||
19457215|NCT01519947|41708598|FG002|Overall Study|Protocol Violation|2|||
19457216|NCT01519947|41708599|FG003|Overall Study|Protocol Violation|1|||
19457217|NCT01519947|41708596|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
19539965|NCT01254565|41988717|FG003|Overall Study|Did not Receive Treatment|0|||
19539966|NCT01254565|41988718|FG004|Overall Study|Did not Receive Treatment|3|||
19539967|NCT01254565|41988719|FG005|Overall Study|Did not Receive Treatment|4|||
19539968|NCT01254565|41988714|FG000|Overall Study|Other|0|||
19539969|NCT01254565|41988715|FG001|Overall Study|Other|0|||
19539970|NCT01254565|41988716|FG002|Overall Study|Other|0|||
19539971|NCT01254565|41988717|FG003|Overall Study|Other|1|||
19539972|NCT01254565|41988718|FG004|Overall Study|Other|0|||
19539973|NCT01254565|41988719|FG005|Overall Study|Other|0|||
19539974|NCT01254409|41988751|FG000|Overall Study|Adverse Event|0|||
19539975|NCT01254409|41988752|FG001|Overall Study|Adverse Event|1|||
19539976|NCT01254409|41988753|FG002|Overall Study|Adverse Event|0|||
19539977|NCT01254409|41988754|FG003|Overall Study|Adverse Event|0|||
19539978|NCT01254331|41988767|FG000|Initial Phase|Adverse Event|3|||
19539979|NCT01254331|41988767|FG000|Initial Phase|Withdrawal by Subject|1|||
19539980|NCT01254331|41988767|FG000|Initial Phase|Pregnancy|1|||
19539981|NCT01254331|41988767|FG000|Extension Phase|Lack of Efficacy|1|||
19539982|NCT01254331|41988767|FG000|Extension Phase|Lost to Follow-up|3|||
19539983|NCT01254292|41988782|FG000|Comparative Phase|Adverse Event|25|||
19539984|NCT01254292|41988783|FG001|Comparative Phase|Adverse Event|25|||
19539985|NCT01254292|41988782|FG000|Comparative Phase|Lost to Follow-up|3|||
19539986|NCT01254292|41988783|FG001|Comparative Phase|Lost to Follow-up|21|||
19539987|NCT01254292|41988782|FG000|Comparative Phase|Pregnancy|2|||
19539988|NCT01254292|41988783|FG001|Comparative Phase|Pregnancy|6|||
19539989|NCT01254292|41988782|FG000|Comparative Phase|Withdrawal by Subject|20|||
19539990|NCT01254292|41988783|FG001|Comparative Phase|Withdrawal by Subject|21|||
19539991|NCT01254292|41988782|FG000|Comparative Phase|Protocol Violation|1|||
19539992|NCT01254292|41988783|FG001|Comparative Phase|Protocol Violation|2|||
19539993|NCT01254292|41988782|FG000|Comparative Phase|Wish for pregnancy|4|||
19539994|NCT01254292|41988783|FG001|Comparative Phase|Wish for pregnancy|6|||
19539995|NCT01254292|41988782|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
19539996|NCT01254292|41988783|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
19539997|NCT01254292|41988782|FG000|LCS12 Extension Phase|Adverse Event|9|||
19457218|NCT01519947|41708597|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
19539998|NCT01254292|41988783|FG001|LCS12 Extension Phase|Adverse Event|0|||
19539999|NCT01254292|41988782|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
19540000|NCT01254292|41988783|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
19540001|NCT01254292|41988782|FG000|LCS12 Extension Phase|Other unknown|4|||
19540002|NCT01254292|41988783|FG001|LCS12 Extension Phase|Other unknown|0|||
19540003|NCT01254292|41988782|FG000|LCS12 Extension Phase|Pregnancy|2|||
19540004|NCT01254292|41988783|FG001|LCS12 Extension Phase|Pregnancy|0|||
19540005|NCT01254292|41988782|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
19540006|NCT01254292|41988783|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
19540007|NCT01254019|41988792|FG000|Overall Study|Adverse Event|0|||
19540008|NCT01254019|41988793|FG001|Overall Study|Adverse Event|2|||
19540009|NCT01254019|41988792|FG000|Overall Study|Protocol Violation|1|||
19711559|NCT00079274|42154661|FG004|Overall Study|Adverse Event|7|||
19457219|NCT01519947|41708598|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
19457220|NCT01519947|41708599|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
19457221|NCT01519947|41708596|FG000|Overall Study|Development of Anemia|0|||
19457222|NCT01519947|41708597|FG001|Overall Study|Development of Anemia|1|||
19540010|NCT01254019|41988793|FG001|Overall Study|Protocol Violation|0|||
19540011|NCT01254019|41988792|FG000|Overall Study|Withdrawal by Subject|0|||
19540012|NCT01254019|41988793|FG001|Overall Study|Withdrawal by Subject|2|||
19540013|NCT01253317|41988802|FG000|Overall Study|Adverse Event|2|||
19540014|NCT01253200|41988815|FG000|Overall Study|Death|1|||
19457223|NCT01519947|41708598|FG002|Overall Study|Development of Anemia|0|||
19540015|NCT01253200|41988816|FG001|Overall Study|Death|0|||
19540016|NCT01253200|41988817|FG002|Overall Study|Death|0|||
19540017|NCT01253200|41988818|FG003|Overall Study|Death|0|||
19540018|NCT01253200|41988819|FG004|Overall Study|Death|0|||
19540019|NCT01253200|41988815|FG000|Overall Study|Lost to Follow-up|1|||
19540020|NCT01253200|41988816|FG001|Overall Study|Lost to Follow-up|1|||
19540021|NCT01253200|41988817|FG002|Overall Study|Lost to Follow-up|0|||
19540022|NCT01253200|41988818|FG003|Overall Study|Lost to Follow-up|0|||
19540023|NCT01253200|41988819|FG004|Overall Study|Lost to Follow-up|0|||
19540024|NCT01253200|41988815|FG000|Overall Study|Withdrawal by Subject|2|||
19540025|NCT01253200|41988816|FG001|Overall Study|Withdrawal by Subject|0|||
19540026|NCT01253200|41988817|FG002|Overall Study|Withdrawal by Subject|0|||
19540027|NCT01253200|41988818|FG003|Overall Study|Withdrawal by Subject|0|||
19540028|NCT01253200|41988819|FG004|Overall Study|Withdrawal by Subject|0|||
19457224|NCT01519947|41708599|FG003|Overall Study|Development of Anemia|1|||
19540029|NCT01253200|41988815|FG000|Overall Study|Protocol Violation|1|||
19540030|NCT01253200|41988816|FG001|Overall Study|Protocol Violation|4|||
19540031|NCT01253200|41988817|FG002|Overall Study|Protocol Violation|0|||
19540032|NCT01253200|41988818|FG003|Overall Study|Protocol Violation|0|||
19540033|NCT01253200|41988819|FG004|Overall Study|Protocol Violation|5|||
19540034|NCT01253200|41988815|FG000|Overall Study|intents|10|||
19540035|NCT01253200|41988816|FG001|Overall Study|intents|10|||
19540036|NCT01253200|41988817|FG002|Overall Study|intents|1|||
19540037|NCT01253200|41988818|FG003|Overall Study|intents|3|||
19540038|NCT01253200|41988819|FG004|Overall Study|intents|0|||
19540039|NCT01253200|41988815|FG000|Overall Study|Attempts|6|||
19540040|NCT01253200|41988816|FG001|Overall Study|Attempts|4|||
19540041|NCT01253200|41988817|FG002|Overall Study|Attempts|1|||
19540042|NCT01253200|41988818|FG003|Overall Study|Attempts|2|||
19540043|NCT01253200|41988819|FG004|Overall Study|Attempts|0|||
19540044|NCT01253044|41988830|FG000|Overall Study|Lost to Follow-up|38|||
19540045|NCT01253044|41988831|FG001|Overall Study|Lost to Follow-up|29|||
19540046|NCT01252966|41988839|FG000|Overall Study|Lost to Follow-up|16|||
19457225|NCT01519947|41708596|FG000|Overall Study|Blood Transfusion|0|||
19457226|NCT01519947|41708597|FG001|Overall Study|Blood Transfusion|1|||
19457227|NCT01519947|41708598|FG002|Overall Study|Blood Transfusion|1|||
19457228|NCT01519947|41708599|FG003|Overall Study|Blood Transfusion|0|||
19457229|NCT01519947|41708596|FG000|Overall Study|Withdrawal by Subject|0|||
19457230|NCT01519947|41708597|FG001|Overall Study|Withdrawal by Subject|1|||
19457231|NCT01519947|41708598|FG002|Overall Study|Withdrawal by Subject|0|||
19540047|NCT01252966|41988840|FG001|Overall Study|Lost to Follow-up|10|||
19540048|NCT01252966|41988839|FG000|Overall Study|Withdrawal by Subject|7|||
19540049|NCT01252966|41988840|FG001|Overall Study|Withdrawal by Subject|3|||
19540050|NCT01252810|41988850|FG000|Overall Study|Withdrawal by Subject|4|||
19540051|NCT01252810|41988851|FG001|Overall Study|Withdrawal by Subject|1|||
19375390|NCT01657370|41617267|FG005|Overall Study|Adverse Event|0|||
19375391|NCT01657370|41617262|FG000|Overall Study|Protocol Violation|1|||
19375392|NCT01657370|41617263|FG001|Overall Study|Protocol Violation|1|||
19375393|NCT01657370|41617264|FG002|Overall Study|Protocol Violation|1|||
19375394|NCT01657370|41617265|FG003|Overall Study|Protocol Violation|1|||
19375395|NCT01657370|41617266|FG004|Overall Study|Protocol Violation|0|||
19375396|NCT01657370|41617267|FG005|Overall Study|Protocol Violation|0|||
19375397|NCT01657370|41617262|FG000|Overall Study|Lost to Follow-up|2|||
19375398|NCT01657370|41617263|FG001|Overall Study|Lost to Follow-up|0|||
19375399|NCT01657370|41617264|FG002|Overall Study|Lost to Follow-up|1|||
19375400|NCT01657370|41617265|FG003|Overall Study|Lost to Follow-up|0|||
19375401|NCT01657370|41617266|FG004|Overall Study|Lost to Follow-up|0|||
19375402|NCT01657370|41617267|FG005|Overall Study|Lost to Follow-up|1|||
19375403|NCT00849797|41617309|FG000|First Intervention|bad veins|1|||
19375404|NCT00849797|41617310|FG001|First Intervention|bad veins|0|||
19375405|NCT00849797|41617309|FG000|First Intervention|Adverse Event|0|||
19375406|NCT00849797|41617310|FG001|First Intervention|Adverse Event|1|||
19375407|NCT00849797|41617309|FG000|Washout: One Week|Withdrawal by Subject|0|||
19375408|NCT00849797|41617310|FG001|Washout: One Week|Withdrawal by Subject|2|||
19375409|NCT00840203|41617331|FG000|First Intervention|Protocol Violation|1|||
19375410|NCT00840203|41617332|FG001|First Intervention|Protocol Violation|1|||
19375411|NCT00840203|41617331|FG000|Washout|Protocol Violation|1|||
19375412|NCT00840203|41617332|FG001|Washout|Protocol Violation|0|||
19375413|NCT00835991|41617338|FG000|First Intervention|Adverse Event|0|||
19375414|NCT00835991|41617339|FG001|First Intervention|Adverse Event|1|||
19375415|NCT00835991|41617338|FG000|Washout|Protocol Violation|0|||
19375416|NCT00835991|41617339|FG001|Washout|Protocol Violation|2|||
19375417|NCT00835991|41617338|FG000|Washout|Withdrawal by Subject|3|||
19375418|NCT00835991|41617339|FG001|Washout|Withdrawal by Subject|1|||
19375419|NCT02276872|41617346|FG000|Overall Study|Adverse Event|1|||
19375420|NCT02276872|41617347|FG001|Overall Study|Adverse Event|0|||
19457232|NCT01519947|41708599|FG003|Overall Study|Withdrawal by Subject|1|||
19457233|NCT01519947|41708596|FG000|Overall Study|Lost to Follow-up|0|||
19457234|NCT01519947|41708597|FG001|Overall Study|Lost to Follow-up|0|||
19457235|NCT01519947|41708598|FG002|Overall Study|Lost to Follow-up|3|||
19457236|NCT01519947|41708599|FG003|Overall Study|Lost to Follow-up|2|||
19457237|NCT01519947|41708596|FG000|Overall Study|Poor Response|1|||
19457238|NCT01519947|41708597|FG001|Overall Study|Poor Response|0|||
19457239|NCT01519947|41708598|FG002|Overall Study|Poor Response|0|||
19457240|NCT01519947|41708599|FG003|Overall Study|Poor Response|1|||
19457241|NCT01519947|41708596|FG000|Overall Study|Adverse Event|1|||
19457242|NCT01519947|41708597|FG001|Overall Study|Adverse Event|0|||
19457243|NCT01519947|41708598|FG002|Overall Study|Adverse Event|1|||
19457244|NCT01519947|41708599|FG003|Overall Study|Adverse Event|1|||
19457245|NCT01462227|41708611|FG000|Second Assignment|Lost to Follow-up|1|||
19457246|NCT01462227|41708612|FG001|Second Assignment|Lost to Follow-up|0|||
19457247|NCT01462227|41708613|FG002|Second Assignment|Lost to Follow-up|0|||
19457248|NCT01462227|41708614|FG003|Second Assignment|Lost to Follow-up|0|||
19457249|NCT01462227|41708611|FG000|Second Assignment|Protocol Violation|0|||
19457250|NCT01462227|41708612|FG001|Second Assignment|Protocol Violation|1|||
19457251|NCT01462227|41708613|FG002|Second Assignment|Protocol Violation|1|||
19457252|NCT01462227|41708614|FG003|Second Assignment|Protocol Violation|0|||
19457253|NCT01464879|41708622|FG000|Overall Study|Physician Decision|1|||
19457254|NCT01464879|41708622|FG000|Overall Study|Non-compliance|1|||
19457255|NCT01519869|41708632|FG000|Overall Study|Lost to Follow-up|1|||
19457256|NCT01519791|41708638|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
19457257|NCT01519791|41708639|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
19457258|NCT01519791|41708638|FG000|Overall Study|Protocol Violation|6|||
19457259|NCT01519791|41708639|FG001|Overall Study|Protocol Violation|19|||
19457260|NCT01519791|41708638|FG000|Overall Study|Other Reason|87|||
19457261|NCT01519791|41708639|FG001|Overall Study|Other Reason|222|||
19457262|NCT01519791|41708638|FG000|Overall Study|subjects randomized in error|2|||
19457263|NCT01519791|41708639|FG001|Overall Study|subjects randomized in error|0|||
19457264|NCT01519791|41708638|FG000|Overall Study|Lack of Efficacy|16|||
19457265|NCT01519791|41708639|FG001|Overall Study|Lack of Efficacy|20|||
19457266|NCT01519791|41708638|FG000|Overall Study|SAE, non-fatal|6|||
19457267|NCT01519791|41708639|FG001|Overall Study|SAE, non-fatal|22|||
19457268|NCT01519791|41708638|FG000|Overall Study|AE, serious fatal|0|||
19457269|NCT01519791|41708639|FG001|Overall Study|AE, serious fatal|1|||
19457270|NCT01519791|41708638|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
19457271|NCT01519791|41708639|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
19457272|NCT01519791|41708638|FG000|Overall Study|AE, non-serious non-fatal|12|||
19457273|NCT01519791|41708639|FG001|Overall Study|AE, non-serious non-fatal|31|||
19457274|NCT01519791|41708638|FG000|Overall Study|Withdrawal by Subject|15|||
19457275|NCT01519791|41708639|FG001|Overall Study|Withdrawal by Subject|37|||
19457276|NCT01519791|41708638|FG000|Overall Study|Lost to Follow-up|6|||
19457277|NCT01519791|41708639|FG001|Overall Study|Lost to Follow-up|14|||
19457278|NCT01461993|41708650|FG000|Overall Study|Withdrawal by Subject|60|||
19457279|NCT01461993|41708651|FG001|Overall Study|Withdrawal by Subject|53|||
19457280|NCT01461993|41708652|FG002|Overall Study|Withdrawal by Subject|16|||
19457281|NCT01461993|41708650|FG000|Overall Study|Lost to Follow-up|44|||
19457282|NCT01461993|41708651|FG001|Overall Study|Lost to Follow-up|48|||
19457283|NCT01461993|41708652|FG002|Overall Study|Lost to Follow-up|22|||
19457284|NCT01461993|41708650|FG000|Overall Study|Protocol Violation|10|||
19457285|NCT01461993|41708651|FG001|Overall Study|Protocol Violation|9|||
19540052|NCT01252810|41988850|FG000|Overall Study|Lost to Follow-up|0|||
19540053|NCT01252810|41988851|FG001|Overall Study|Lost to Follow-up|1|||
19540054|NCT01252810|41988850|FG000|Overall Study|Physician Decision|2|||
19540055|NCT01252810|41988851|FG001|Overall Study|Physician Decision|1|||
19540056|NCT01252810|41988850|FG000|Overall Study|Various reasons|8|||
19540057|NCT01252810|41988851|FG001|Overall Study|Various reasons|0|||
19540058|NCT01252186|41988860|FG000|Overall Study|Adverse Event|9|||
19540059|NCT01252186|41988861|FG001|Overall Study|Adverse Event|6|||
19540060|NCT01252186|41988862|FG002|Overall Study|Adverse Event|8|||
19540061|NCT01252186|41988860|FG000|Overall Study|Withdrawal by Subject|2|||
19540062|NCT01252186|41988861|FG001|Overall Study|Withdrawal by Subject|5|||
19540063|NCT01252186|41988862|FG002|Overall Study|Withdrawal by Subject|2|||
19540064|NCT01252186|41988860|FG000|Overall Study|Physician Decision|0|||
19540065|NCT01252186|41988861|FG001|Overall Study|Physician Decision|0|||
19540066|NCT01252186|41988862|FG002|Overall Study|Physician Decision|1|||
19540067|NCT01252186|41988860|FG000|Overall Study|Non-compliance|0|||
19540068|NCT01252186|41988861|FG001|Overall Study|Non-compliance|3|||
19540069|NCT01252186|41988862|FG002|Overall Study|Non-compliance|4|||
19540070|NCT01252186|41988860|FG000|Overall Study|Protocol Violation|0|||
19540071|NCT01252186|41988861|FG001|Overall Study|Protocol Violation|0|||
19540072|NCT01252186|41988862|FG002|Overall Study|Protocol Violation|1|||
19457286|NCT01461993|41708652|FG002|Overall Study|Protocol Violation|7|||
19457287|NCT01461993|41708650|FG000|Overall Study|Adverse Event|9|||
19457288|NCT01461993|41708651|FG001|Overall Study|Adverse Event|11|||
19457289|NCT01461993|41708652|FG002|Overall Study|Adverse Event|3|||
19457290|NCT01461993|41708650|FG000|Overall Study|No longer met eligibility criteria|13|||
19457291|NCT01461993|41708651|FG001|Overall Study|No longer met eligibility criteria|18|||
19457292|NCT01461993|41708652|FG002|Overall Study|No longer met eligibility criteria|10|||
19457293|NCT01461993|41708650|FG000|Overall Study|Did not meet entrance criteria|2|||
19457294|NCT01461993|41708651|FG001|Overall Study|Did not meet entrance criteria|3|||
19457295|NCT01461993|41708652|FG002|Overall Study|Did not meet entrance criteria|0|||
19457296|NCT01461993|41708650|FG000|Overall Study|Other|13|||
19457297|NCT01461993|41708651|FG001|Overall Study|Other|15|||
19457298|NCT01461993|41708652|FG002|Overall Study|Other|6|||
19457299|NCT01782326|41708663|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
19540073|NCT01252186|41988860|FG000|Overall Study|Pregnancy|2|||
19540074|NCT01252186|41988861|FG001|Overall Study|Pregnancy|2|||
19540075|NCT01252186|41988862|FG002|Overall Study|Pregnancy|0|||
19540076|NCT01252186|41988860|FG000|Overall Study|Sponsor Request|2|||
19540077|NCT01252186|41988861|FG001|Overall Study|Sponsor Request|1|||
19540078|NCT01252186|41988862|FG002|Overall Study|Sponsor Request|0|||
19540079|NCT01252186|41988860|FG000|Overall Study|Lost to Follow-up|10|||
19540080|NCT01252186|41988861|FG001|Overall Study|Lost to Follow-up|10|||
19540081|NCT01252186|41988862|FG002|Overall Study|Lost to Follow-up|11|||
19540082|NCT01252186|41988860|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
19540083|NCT01252186|41988861|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
19540084|NCT01252186|41988862|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
19540085|NCT01251952|41988897|FG000|Overall Study|Adverse Event|1|||
19540086|NCT01251367|41988901|FG000|Overall Study|Protocol Violation|1|||
19540087|NCT01251367|41988901|FG000|Overall Study|Lack of Efficacy|2|||
19540088|NCT01251367|41988901|FG000|Overall Study|Adverse Event|19|||
19540089|NCT01251367|41988901|FG000|Overall Study|Withdrawal by Subject|36|||
19540090|NCT01251367|41988901|FG000|Overall Study|Lost to Follow-up|5|||
19540091|NCT01251367|41988901|FG000|Overall Study|Subject Required Alternative Treatment|7|||
19540092|NCT01251367|41988901|FG000|Overall Study|No Study Drug Available|1|||
19540093|NCT01251367|41988901|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
19540094|NCT01251367|41988901|FG000|Overall Study|End of Study Visit Performed in Error|1|||
19540095|NCT01250509|41988907|FG000|Overall Study|Lost to Follow-up|5|||
19540096|NCT01250509|41988908|FG001|Overall Study|Lost to Follow-up|2|||
19540097|NCT01250119|41988916|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
19540098|NCT01250119|41988917|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
19540099|NCT01250119|41988916|FG000|Diagnostic Phase|Participants Not Tested|44|||
19540100|NCT01250119|41988917|FG001|Diagnostic Phase|Participants Not Tested|0|||
19540101|NCT01250119|41988916|FG000|Treatment Phase|Progressive Disease|0|||
19540102|NCT01250119|41988917|FG001|Treatment Phase|Progressive Disease|32|||
19540103|NCT01250119|41988916|FG000|Treatment Phase|Death|0|||
19540104|NCT01250119|41988917|FG001|Treatment Phase|Death|2|||
19540105|NCT01250119|41988916|FG000|Treatment Phase|Withdrawal by Subject|0|||
19540106|NCT01250119|41988917|FG001|Treatment Phase|Withdrawal by Subject|1|||
19540107|NCT01250119|41988916|FG000|Treatment Phase|Adverse Event|0|||
19540108|NCT01250119|41988917|FG001|Treatment Phase|Adverse Event|2|||
19540109|NCT01250119|41988916|FG000|Treatment Phase|Unknown reason|0|||
19540110|NCT01250119|41988917|FG001|Treatment Phase|Unknown reason|4|||
19540111|NCT01250002|41988926|FG000|Overall Study|Change to open surgical procedure|4|||
19540112|NCT01250002|41988927|FG001|Overall Study|Change to open surgical procedure|3|||
19540113|NCT01246960|41988935|FG000|Overall Study|Lost to Follow-up|3|||
19540114|NCT01246960|41988936|FG001|Overall Study|Lost to Follow-up|1|||
19540115|NCT01246960|41988935|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
19540116|NCT01246960|41988936|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
19540117|NCT01244620|41988942|FG000|Overall Study|Study terminated|4|||
19540118|NCT01244620|41988943|FG001|Overall Study|Study terminated|4|||
19540119|NCT01244620|41988944|FG002|Overall Study|Study terminated|4|||
19540120|NCT01244620|41988945|FG003|Overall Study|Study terminated|4|||
19540121|NCT01267201|41988955|FG000|First Intervention Period|Withdrawal by Subject|1|||
19540122|NCT01267201|41988956|FG001|First Intervention Period|Withdrawal by Subject|0|||
19540123|NCT01267201|41988957|FG002|First Intervention Period|Withdrawal by Subject|0|||
19540124|NCT01267201|41988958|FG003|First Intervention Period|Withdrawal by Subject|0|||
19540125|NCT01267201|41988959|FG004|First Intervention Period|Withdrawal by Subject|0|||
19540126|NCT01267201|41988960|FG005|First Intervention Period|Withdrawal by Subject|0|||
19540127|NCT01267201|41988955|FG000|Second Intervention Period|Withdrawal by Subject|0|||
19540128|NCT01267201|41988956|FG001|Second Intervention Period|Withdrawal by Subject|1|||
19540129|NCT01267201|41988957|FG002|Second Intervention Period|Withdrawal by Subject|0|||
19540130|NCT01267201|41988958|FG003|Second Intervention Period|Withdrawal by Subject|0|||
19540131|NCT01267201|41988959|FG004|Second Intervention Period|Withdrawal by Subject|0|||
19540132|NCT01267201|41988960|FG005|Second Intervention Period|Withdrawal by Subject|0|||
19540133|NCT01266967|41988970|FG000|Overall Study|Death|69|||
19540134|NCT01266967|41988971|FG001|Overall Study|Death|61|||
19540135|NCT01266967|41988970|FG000|Overall Study|Study Closed/Terminated|15|||
19457300|NCT01782326|41708664|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
19540136|NCT01266967|41988971|FG001|Overall Study|Study Closed/Terminated|17|||
19540137|NCT01266967|41988970|FG000|Overall Study|Lost to Follow-up|2|||
19540138|NCT01266967|41988971|FG001|Overall Study|Lost to Follow-up|1|||
19540139|NCT01266967|41988970|FG000|Overall Study|Physician Decision|0|||
19540140|NCT01266967|41988971|FG001|Overall Study|Physician Decision|1|||
19540141|NCT01266967|41988970|FG000|Overall Study|Withdrawal by Subject|3|||
19540142|NCT01266967|41988971|FG001|Overall Study|Withdrawal by Subject|3|||
19540143|NCT01266850|41988985|FG000|Overall Study|Lost to Follow-up|19|||
19540144|NCT01266850|41988986|FG001|Overall Study|Lost to Follow-up|19|||
19540145|NCT01266850|41988987|FG002|Overall Study|Lost to Follow-up|13|||
19540146|NCT01266850|41988988|FG003|Overall Study|Lost to Follow-up|13|||
19540147|NCT01266850|41988989|FG004|Overall Study|Lost to Follow-up|12|||
19540148|NCT01266850|41988985|FG000|Overall Study|Withdrawal by Subject|8|||
19540149|NCT01266850|41988986|FG001|Overall Study|Withdrawal by Subject|9|||
19540150|NCT01266850|41988987|FG002|Overall Study|Withdrawal by Subject|6|||
19540151|NCT01266850|41988988|FG003|Overall Study|Withdrawal by Subject|9|||
19540152|NCT01266850|41988989|FG004|Overall Study|Withdrawal by Subject|12|||
19540153|NCT01266850|41988985|FG000|Overall Study|Physician Decision|3|||
19540154|NCT01266850|41988986|FG001|Overall Study|Physician Decision|6|||
19540155|NCT01266850|41988987|FG002|Overall Study|Physician Decision|4|||
19540156|NCT01266850|41988988|FG003|Overall Study|Physician Decision|4|||
19540157|NCT01266850|41988989|FG004|Overall Study|Physician Decision|3|||
19540158|NCT01266850|41988985|FG000|Overall Study|Protocol Violation|0|||
19540159|NCT01266850|41988986|FG001|Overall Study|Protocol Violation|1|||
19540160|NCT01266850|41988987|FG002|Overall Study|Protocol Violation|0|||
19540161|NCT01266850|41988988|FG003|Overall Study|Protocol Violation|1|||
19540162|NCT01266850|41988989|FG004|Overall Study|Protocol Violation|2|||
19540163|NCT01266850|41988985|FG000|Overall Study|Adverse Event|0|||
19540164|NCT01266850|41988986|FG001|Overall Study|Adverse Event|0|||
19540165|NCT01266850|41988987|FG002|Overall Study|Adverse Event|0|||
19540166|NCT01266850|41988988|FG003|Overall Study|Adverse Event|0|||
19540167|NCT01266850|41988989|FG004|Overall Study|Adverse Event|1|||
19540168|NCT01266850|41988985|FG000|Overall Study|Site Closure|0|||
19540169|NCT01266850|41988986|FG001|Overall Study|Site Closure|1|||
19540170|NCT01266850|41988987|FG002|Overall Study|Site Closure|1|||
19540171|NCT01266850|41988988|FG003|Overall Study|Site Closure|1|||
19540172|NCT01266850|41988989|FG004|Overall Study|Site Closure|0|||
19540173|NCT01266460|41989001|FG000|Overall Study|Adverse Event|3|||
19540174|NCT01266460|41989001|FG000|Overall Study|Withdrawal by Subject|5|||
19540175|NCT01266460|41989001|FG000|Overall Study|Disease Progression|18|||
19540176|NCT01266460|41989001|FG000|Overall Study|Not otherwise specified|8|||
19540177|NCT01266265|41989007|FG000|Overall Study|Death|95|||
19540178|NCT01266265|41989008|FG001|Overall Study|Death|73|||
19540179|NCT01266265|41989007|FG000|Overall Study|Lost to Follow-up|23|||
19540180|NCT01266265|41989008|FG001|Overall Study|Lost to Follow-up|28|||
19540181|NCT01266265|41989007|FG000|Overall Study|Withdrawal by Subject|13|||
19540182|NCT01266265|41989008|FG001|Overall Study|Withdrawal by Subject|11|||
19540183|NCT01266265|41989007|FG000|Overall Study|Respiratory-related adverse event|2|||
19540184|NCT01266265|41989008|FG001|Overall Study|Respiratory-related adverse event|1|||
19540185|NCT01266265|41989007|FG000|Overall Study|Transferred care to another provider|22|||
19540186|NCT01266265|41989008|FG001|Overall Study|Transferred care to another provider|28|||
19540187|NCT01266265|41989007|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
19540188|NCT01266265|41989008|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
19540189|NCT01266265|41989007|FG000|Overall Study|Enrolled in another clinical study|15|||
19540190|NCT01266265|41989008|FG001|Overall Study|Enrolled in another clinical study|26|||
19540191|NCT01266265|41989007|FG000|Overall Study|Non-compliance|8|||
19540192|NCT01266265|41989008|FG001|Overall Study|Non-compliance|5|||
19540193|NCT01266265|41989007|FG000|Overall Study|Lung transplant|6|||
19540194|NCT01266265|41989008|FG001|Overall Study|Lung transplant|5|||
19540195|NCT01266265|41989007|FG000|Overall Study|Site closed early|4|||
19540196|NCT01266265|41989008|FG001|Overall Study|Site closed early|3|||
19540197|NCT01266265|41989007|FG000|Overall Study|Clinical worsening|1|||
19540198|NCT01266265|41989008|FG001|Overall Study|Clinical worsening|1|||
19540199|NCT01266148|41989033|FG000|Overall Study|Adverse Event|2|||
19540200|NCT01266148|41989034|FG001|Overall Study|Adverse Event|0|||
19540201|NCT01266148|41989033|FG000|Overall Study|Ongoing rejection|1|||
19540202|NCT01266148|41989034|FG001|Overall Study|Ongoing rejection|0|||
19540203|NCT01266148|41989033|FG000|Overall Study|2 2R rejections|1|||
19540204|NCT01266148|41989034|FG001|Overall Study|2 2R rejections|0|||
19540205|NCT01266148|41989033|FG000|Overall Study|Death|2|||
19540206|NCT01266148|41989034|FG001|Overall Study|Death|3|||
19540207|NCT01266148|41989033|FG000|Overall Study|missing mGFR value + AE|1|||
19540208|NCT01266148|41989034|FG001|Overall Study|missing mGFR value + AE|0|||
19540209|NCT01266070|41989040|FG000|Overall Study|Adverse Event|3|||
19540210|NCT01266070|41989040|FG000|Overall Study|Protocol Violation|1|||
19540211|NCT01265992|41989044|FG000|Overall Study|Lost to Follow-up|1|||
19540212|NCT01265992|41989044|FG000|Overall Study|Withdrawal by Subject|1|||
19540213|NCT01265992|41989044|FG000|Overall Study|Adverse Event|1|||
19540214|NCT01265992|41989044|FG000|Overall Study|Administrative reasons|2|||
19540215|NCT01265992|41989044|FG000|Overall Study|Stopped treatment|3|||
19540216|NCT01265992|41989044|FG000|Overall Study|Did not receive treatment|1|||
19540217|NCT01265953|41989050|FG000|Overall Study|Non compliance|5|||
19540218|NCT01265953|41989051|FG001|Overall Study|Non compliance|3|||
19540219|NCT01265875|41989057|FG000|Overall Study|Uncooperative/unreliable|1|||
19540220|NCT01265797|41989068|FG000|Run-in Month|Withdrawal by Subject|0|||
19540221|NCT01265797|41989069|FG001|Run-in Month|Withdrawal by Subject|4|||
19540222|NCT01265797|41989068|FG000|Run-in Month|1st seizure during run-in month|0|||
19540223|NCT01265797|41989069|FG001|Run-in Month|1st seizure during run-in month|1|||
19540224|NCT01265797|41989068|FG000|Blinded Month|Lack of Efficacy|5|||
19540225|NCT01265797|41989069|FG001|Blinded Month|Lack of Efficacy|0|||
19540226|NCT01265797|41989068|FG000|Blinded Month|Lost to Follow-up|1|||
19540227|NCT01265797|41989069|FG001|Blinded Month|Lost to Follow-up|0|||
19540228|NCT01265797|41989068|FG000|Blinded Month|Protocol Violation|2|||
19540229|NCT01265797|41989069|FG001|Blinded Month|Protocol Violation|1|||
19540230|NCT01265797|41989068|FG000|Blinded Month|Adverse Event|2|||
19540231|NCT01265797|41989069|FG001|Blinded Month|Adverse Event|0|||
19540232|NCT01265797|41989068|FG000|Blinded Month|Diary data incomplete|0|||
19540233|NCT01265797|41989069|FG001|Blinded Month|Diary data incomplete|1|||
19540234|NCT01265797|41989068|FG000|Open Label Month|Lost to Follow-up|0|||
19457301|NCT01782326|41708663|FG000|Planned Treatment Epoch|Death|29|||
19457302|NCT01782326|41708664|FG001|Planned Treatment Epoch|Death|30|||
19457303|NCT01782326|41708663|FG000|Planned Treatment Epoch|Physician Decision|18|||
19457304|NCT01782326|41708664|FG001|Planned Treatment Epoch|Physician Decision|16|||
19457305|NCT01782326|41708663|FG000|Planned Treatment Epoch|Protocol deviation|2|||
19457306|NCT01782326|41708664|FG001|Planned Treatment Epoch|Protocol deviation|3|||
19457307|NCT01782326|41708663|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
19457308|NCT01782326|41708664|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
19457309|NCT01782326|41708663|FG000|Planned Treatment Epoch|Technical problems|0|||
19457310|NCT01782326|41708664|FG001|Planned Treatment Epoch|Technical problems|4|||
19457311|NCT01782326|41708663|FG000|Double-blind Treatment|Adverse Event|129|||
19457312|NCT01782326|41708664|FG001|Double-blind Treatment|Adverse Event|145|||
19457313|NCT01782326|41708663|FG000|Double-blind Treatment|Subject/guardian decision|111|||
19457314|NCT01782326|41708664|FG001|Double-blind Treatment|Subject/guardian decision|125|||
19457315|NCT01782326|41708663|FG000|Double-blind Treatment|Lack of Efficacy|17|||
19457316|NCT01782326|41708664|FG001|Double-blind Treatment|Lack of Efficacy|22|||
19457317|NCT01782326|41708663|FG000|Double-blind Treatment|Physician Decision|13|||
19457318|NCT01782326|41708664|FG001|Double-blind Treatment|Physician Decision|16|||
19457319|NCT01782326|41708663|FG000|Double-blind Treatment|Protocol deviation|8|||
19457320|NCT01782326|41708664|FG001|Double-blind Treatment|Protocol deviation|7|||
19457321|NCT01782326|41708663|FG000|Double-blind Treatment|Technical problems|0|||
19457322|NCT01782326|41708664|FG001|Double-blind Treatment|Technical problems|5|||
19457323|NCT01439373|41708672|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
19457324|NCT01439373|41708673|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
19457325|NCT01439373|41708672|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
19457326|NCT01439373|41708673|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
19457327|NCT01461369|41708686|FG000|Overall Study|Lack of Efficacy|2|||
19457328|NCT01461369|41708687|FG001|Overall Study|Lack of Efficacy|0|||
19457329|NCT01461369|41708688|FG002|Overall Study|Lack of Efficacy|6|||
19457330|NCT01461369|41708686|FG000|Overall Study|Lost to Follow-up|0|||
19457331|NCT01461369|41708687|FG001|Overall Study|Lost to Follow-up|0|||
19457332|NCT01461369|41708688|FG002|Overall Study|Lost to Follow-up|3|||
19540235|NCT01265797|41989069|FG001|Open Label Month|Lost to Follow-up|1|||
19540236|NCT01265719|41989079|FG000|Overall Study|Does not meet entrance criteria|0|||
19540237|NCT01265719|41989080|FG001|Overall Study|Does not meet entrance criteria|3|||
19457333|NCT01461369|41708686|FG000|Overall Study|Adverse Event|9|||
19457334|NCT01461369|41708687|FG001|Overall Study|Adverse Event|12|||
19540238|NCT01265719|41989079|FG000|Overall Study|Other reasons|2|||
19540239|NCT01265719|41989080|FG001|Overall Study|Other reasons|0|||
19540240|NCT01265719|41989079|FG000|Overall Study|Withdrawal by Subject|8|||
19540241|NCT01265719|41989080|FG001|Overall Study|Withdrawal by Subject|3|||
19540242|NCT01265719|41989079|FG000|Overall Study|Lost to Follow-up|2|||
19540243|NCT01265719|41989080|FG001|Overall Study|Lost to Follow-up|7|||
19540244|NCT01265719|41989079|FG000|Overall Study|Adverse Event|2|||
19540245|NCT01265719|41989080|FG001|Overall Study|Adverse Event|0|||
19540246|NCT01265563|41989112|FG000|Overall Study|Withdrawal by Subject|0|||
19540247|NCT01265563|41989113|FG001|Overall Study|Withdrawal by Subject|1|||
19711560|NCT00079274|42154662|FG005|Overall Study|Adverse Event|8|||
19457335|NCT01461369|41708688|FG002|Overall Study|Adverse Event|4|||
19457336|NCT01461369|41708686|FG000|Overall Study|Protocol Violation|1|||
19457337|NCT01461369|41708687|FG001|Overall Study|Protocol Violation|2|||
19457338|NCT01461369|41708688|FG002|Overall Study|Protocol Violation|2|||
19457339|NCT01461369|41708686|FG000|Overall Study|Withdrawal by Subject|1|||
19457340|NCT01461369|41708687|FG001|Overall Study|Withdrawal by Subject|3|||
19457341|NCT01461369|41708688|FG002|Overall Study|Withdrawal by Subject|2|||
19457342|NCT01727258|41708699|FG000|Overall Study|Adverse Event|0|||
19457343|NCT01727258|41708700|FG001|Overall Study|Adverse Event|2|||
19540248|NCT01265563|41989114|FG002|Overall Study|Withdrawal by Subject|1|||
19540249|NCT01265563|41989115|FG003|Overall Study|Withdrawal by Subject|0|||
19540250|NCT01265563|41989116|FG004|Overall Study|Withdrawal by Subject|2|||
19540251|NCT01265056|41989135|FG000|Initial Study Period|Withdrawal by Subject|1|||
19540252|NCT01265056|41989136|FG001|Initial Study Period|Withdrawal by Subject|1|||
19540253|NCT01265056|41989135|FG000|Initial Study Period|Withdrawal by Subject|1|||
19540254|NCT01265056|41989136|FG001|Initial Study Period|Withdrawal by Subject|1|||
19540255|NCT01265056|41989135|FG000|Follow up|Lost to Follow-up|7|||
19540256|NCT01265056|41989136|FG001|Follow up|Lost to Follow-up|3|||
19540257|NCT01264939|41989144|FG000|Overall Study|Adverse Event|1|||
19540258|NCT01264939|41989145|FG001|Overall Study|Adverse Event|3|||
19540259|NCT01264939|41989144|FG000|Overall Study|Lost to Follow-up|0|||
19540260|NCT01264939|41989145|FG001|Overall Study|Lost to Follow-up|3|||
19540261|NCT01264939|41989144|FG000|Overall Study|Physician Decision|1|||
19540262|NCT01264939|41989145|FG001|Overall Study|Physician Decision|1|||
19540263|NCT01264939|41989144|FG000|Overall Study|Patient/Guardian Decision|8|||
19540264|NCT01264939|41989145|FG001|Overall Study|Patient/Guardian Decision|10|||
19540265|NCT01264939|41989144|FG000|Overall Study|Disease Progression|8|||
19540266|NCT01264939|41989145|FG001|Overall Study|Disease Progression|11|||
19540267|NCT01264081|41989151|FG000|Participants Screened|Screening failures|30|||
19540268|NCT01264081|41989151|FG000|Started Treatment|Withdrawal by Subject|1|||
19540269|NCT01264081|41989151|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
19540270|NCT01263925|41989157|FG000|Overall Study|Protocol Violation|1|||
19540271|NCT01263925|41989158|FG001|Overall Study|Protocol Violation|0|||
19540272|NCT01263925|41989157|FG000|Overall Study|Lack of Efficacy|0|||
19457344|NCT01727258|41708701|FG002|Overall Study|Adverse Event|0|||
19457345|NCT01727258|41708699|FG000|Overall Study|Noncompliance with Study Drug|0|||
19457346|NCT01727258|41708700|FG001|Overall Study|Noncompliance with Study Drug|0|||
19457347|NCT01727258|41708701|FG002|Overall Study|Noncompliance with Study Drug|1|||
19457348|NCT01727258|41708699|FG000|Overall Study|Withdrawal by Subject|1|||
19457349|NCT01727258|41708700|FG001|Overall Study|Withdrawal by Subject|1|||
19540273|NCT01263925|41989158|FG001|Overall Study|Lack of Efficacy|1|||
19540274|NCT01263925|41989157|FG000|Overall Study|Adverse Event|23|||
19540275|NCT01263925|41989158|FG001|Overall Study|Adverse Event|22|||
19540276|NCT01263925|41989157|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
19540277|NCT01263925|41989158|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
19540278|NCT01263925|41989157|FG000|Overall Study|Withdrawal by Subject|6|||
19540279|NCT01263925|41989158|FG001|Overall Study|Withdrawal by Subject|8|||
19540280|NCT01263925|41989157|FG000|Overall Study|Other|4|||
19457350|NCT01727258|41708701|FG002|Overall Study|Withdrawal by Subject|0|||
19457351|NCT01727258|41708699|FG000|Overall Study|Lost to Follow-up|1|||
19457352|NCT01727258|41708700|FG001|Overall Study|Lost to Follow-up|0|||
19457353|NCT01727258|41708701|FG002|Overall Study|Lost to Follow-up|0|||
19540281|NCT01263925|41989158|FG001|Overall Study|Other|4|||
19540282|NCT01263925|41989157|FG000|Overall Study|Lost to Follow-up|3|||
19540283|NCT01263925|41989158|FG001|Overall Study|Lost to Follow-up|1|||
19540284|NCT01263925|41989157|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
19457354|NCT01781390|41708712|FG000|Overall Study|Withdrawal of Consent|0|||
19540285|NCT01263925|41989158|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
19540286|NCT01263925|41989157|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
19540287|NCT01263925|41989158|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
19540288|NCT01263925|41989157|FG000|Overall Study|AE/ Withdrawal|1|||
19540289|NCT01263925|41989158|FG001|Overall Study|AE/ Withdrawal|4|||
19540290|NCT01263925|41989157|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
19540291|NCT01263925|41989158|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
19540292|NCT01263925|41989157|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
19457355|NCT01781390|41708713|FG001|Overall Study|Withdrawal of Consent|3|||
19457356|NCT01781390|41708714|FG002|Overall Study|Withdrawal of Consent|1|||
19457357|NCT01781390|41708712|FG000|Overall Study|Lost to Follow-up|1|||
19457358|NCT01781390|41708713|FG001|Overall Study|Lost to Follow-up|1|||
19457359|NCT01781390|41708714|FG002|Overall Study|Lost to Follow-up|1|||
19457360|NCT01781390|41708712|FG000|Overall Study|Adverse Event|1|||
19457361|NCT01781390|41708713|FG001|Overall Study|Adverse Event|2|||
19457362|NCT01781390|41708714|FG002|Overall Study|Adverse Event|1|||
19540293|NCT01263925|41989158|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
19457363|NCT01781390|41708712|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
19457364|NCT01781390|41708713|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
19457365|NCT01781390|41708714|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
19457366|NCT01781234|41708724|FG000|Overall Study|Adverse Event|2|||
19457367|NCT01781234|41708725|FG001|Overall Study|Adverse Event|0|||
19540294|NCT01263925|41989157|FG000|Overall Study|Withdrawal/ Not specified|0|||
19540295|NCT01263925|41989158|FG001|Overall Study|Withdrawal/ Not specified|1|||
19540296|NCT01263769|41989164|FG000|Overall Study|Non-Compliant with treatment|1|||
19540297|NCT01263691|41989174|FG000|Overall Study|Lost to Follow-up|1|||
19540298|NCT01263691|41989175|FG001|Overall Study|Lost to Follow-up|0|||
19540299|NCT01263691|41989176|FG002|Overall Study|Lost to Follow-up|1|||
19540300|NCT01263691|41989177|FG003|Overall Study|Lost to Follow-up|1|||
19540301|NCT01263691|41989178|FG004|Overall Study|Lost to Follow-up|0|||
19540302|NCT01263691|41989179|FG005|Overall Study|Lost to Follow-up|0|||
19540303|NCT01263691|41989174|FG000|Overall Study|Withdrawal by Subject|1|||
19540304|NCT01263691|41989175|FG001|Overall Study|Withdrawal by Subject|0|||
19540305|NCT01263691|41989176|FG002|Overall Study|Withdrawal by Subject|0|||
19540306|NCT01263691|41989177|FG003|Overall Study|Withdrawal by Subject|0|||
19540307|NCT01263691|41989178|FG004|Overall Study|Withdrawal by Subject|0|||
19540308|NCT01263691|41989179|FG005|Overall Study|Withdrawal by Subject|0|||
19540309|NCT01263691|41989174|FG000|Overall Study|Adverse Event|1|||
19540310|NCT01263691|41989175|FG001|Overall Study|Adverse Event|0|||
19540311|NCT01263691|41989176|FG002|Overall Study|Adverse Event|0|||
19540312|NCT01263691|41989177|FG003|Overall Study|Adverse Event|0|||
19540313|NCT01263691|41989178|FG004|Overall Study|Adverse Event|0|||
19540314|NCT01263691|41989179|FG005|Overall Study|Adverse Event|0|||
19540315|NCT01263496|41989256|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
19540316|NCT01263496|41989257|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540317|NCT01263496|41989258|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540318|NCT01263496|41989259|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540319|NCT01263496|41989260|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540320|NCT01263496|41989261|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540321|NCT01263496|41989262|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540322|NCT01263496|41989263|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540323|NCT01263496|41989264|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
19540324|NCT01263496|41989256|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540325|NCT01263496|41989257|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540326|NCT01263496|41989258|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540327|NCT01263496|41989259|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
19540328|NCT01263496|41989260|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
19540329|NCT01263496|41989261|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540330|NCT01263496|41989262|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540331|NCT01263496|41989263|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540332|NCT01263496|41989264|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
19540333|NCT01263496|41989256|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
19540334|NCT01263496|41989257|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
19540335|NCT01263496|41989258|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
19540336|NCT01263496|41989259|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
19540337|NCT01263496|41989260|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
19540338|NCT01263496|41989261|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
19540339|NCT01263496|41989262|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
19540340|NCT01263496|41989263|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
19540341|NCT01263496|41989264|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
19540342|NCT01263496|41989256|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540343|NCT01263496|41989257|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
19540344|NCT01263496|41989258|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540345|NCT01263496|41989259|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540346|NCT01263496|41989260|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540347|NCT01263496|41989261|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540348|NCT01263496|41989262|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540349|NCT01263496|41989263|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540350|NCT01263496|41989264|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
19540351|NCT01263496|41989256|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19540352|NCT01263496|41989257|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19540353|NCT01263496|41989258|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19540354|NCT01263496|41989259|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
19540355|NCT01263496|41989260|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
19540356|NCT01263496|41989261|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19540357|NCT01263496|41989262|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19540358|NCT01263496|41989263|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
19540359|NCT01263496|41989264|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
19540360|NCT01263496|41989256|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
19540361|NCT01263496|41989257|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
19540362|NCT01263496|41989258|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
19631508|NCT00768300|42080825|FG001|Overall Study|Missing data|0|||
19540363|NCT01263496|41989259|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19540364|NCT01263496|41989260|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
19540365|NCT01263496|41989261|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19540366|NCT01263496|41989262|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19540367|NCT01263496|41989263|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
19540368|NCT01263496|41989264|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
19540369|NCT01263496|41989256|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540370|NCT01263496|41989257|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540371|NCT01263496|41989258|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540372|NCT01263496|41989259|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540373|NCT01263496|41989260|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19457368|NCT01781234|41708724|FG000|Overall Study|Protocol Violation|3|||
19457369|NCT01781234|41708725|FG001|Overall Study|Protocol Violation|0|||
19457370|NCT01781234|41708724|FG000|Overall Study|Withdrawal by Subject|4|||
19457371|NCT01781234|41708725|FG001|Overall Study|Withdrawal by Subject|3|||
19457372|NCT01752842|41708735|FG000|Overall Study|Adverse Event|3|||
19540374|NCT01263496|41989261|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540375|NCT01263496|41989262|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19457373|NCT01752842|41708736|FG001|Overall Study|Adverse Event|0|||
19457374|NCT01752842|41708735|FG000|Overall Study|Withdrawal by Subject|0|||
19540376|NCT01263496|41989263|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
19540377|NCT01263496|41989264|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
19540378|NCT01263223|41989276|FG000|Period 2|Withdrawal by Subject|0|||
19540379|NCT01263223|41989277|FG001|Period 2|Withdrawal by Subject|1|||
19540380|NCT01263223|41989276|FG000|7-day Follow-up|Withdrawal by Subject|0|||
19540381|NCT01263223|41989277|FG001|7-day Follow-up|Withdrawal by Subject|1|||
19540382|NCT01263223|41989276|FG000|7-day Follow-up|Lost to Follow-up|1|||
19540383|NCT01263223|41989277|FG001|7-day Follow-up|Lost to Follow-up|0|||
19540384|NCT01263106|41989286|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
19540385|NCT01263106|41989287|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
19540386|NCT01263028|41989296|FG000|Overall Study|Withdrawal by Subject|1|||
19540387|NCT01263028|41989296|FG000|Overall Study|Adverse Event|1|||
19540388|NCT01263028|41989296|FG000|Overall Study|Study terminated due to low enrollment.|4|||
19540389|NCT01262989|41989300|FG000|Period 1|Lost to Follow-up|1|||
19540390|NCT01262989|41989301|FG001|Period 1|Lost to Follow-up|1|||
19540391|NCT01262989|41989300|FG000|Period 1|Intercurrent disease|0|||
19540392|NCT01262989|41989301|FG001|Period 1|Intercurrent disease|1|||
19540393|NCT01262989|41989300|FG000|Period 1|Positive answer for exclusion criteria|0|||
19540394|NCT01262989|41989301|FG001|Period 1|Positive answer for exclusion criteria|1|||
19540395|NCT01262989|41989300|FG000|Period 2|Intercurrent disease|0|||
19540396|NCT01262989|41989301|FG001|Period 2|Intercurrent disease|1|||
19540397|NCT01262872|41989315|FG000|Step 2|Death|0|||
19540398|NCT01262872|41989316|FG001|Step 2|Death|0|||
19540399|NCT01262872|41989317|FG002|Step 2|Death|0|||
19540400|NCT01262872|41989318|FG003|Step 2|Death|1|||
19540401|NCT01262872|41989319|FG004|Step 2|Death|0|||
19540402|NCT01262872|41989320|FG005|Step 2|Death|2|||
19540403|NCT01262872|41989321|FG006|Step 2|Death|2|||
19540404|NCT01262872|41989322|FG007|Step 2|Death|1|||
19540405|NCT01262872|41989315|FG000|Step 2|Protocol Violation|0|||
19540406|NCT01262872|41989316|FG001|Step 2|Protocol Violation|0|||
19540407|NCT01262872|41989317|FG002|Step 2|Protocol Violation|1|||
19540408|NCT01262872|41989318|FG003|Step 2|Protocol Violation|0|||
19540409|NCT01262872|41989319|FG004|Step 2|Protocol Violation|0|||
19540410|NCT01262872|41989320|FG005|Step 2|Protocol Violation|0|||
19540411|NCT01262872|41989321|FG006|Step 2|Protocol Violation|3|||
19540412|NCT01262872|41989322|FG007|Step 2|Protocol Violation|1|||
19540413|NCT01262872|41989315|FG000|Step 2|Withdrawal by Subject|0|||
19540414|NCT01262872|41989316|FG001|Step 2|Withdrawal by Subject|0|||
19540415|NCT01262872|41989317|FG002|Step 2|Withdrawal by Subject|4|||
19540416|NCT01262872|41989318|FG003|Step 2|Withdrawal by Subject|6|||
19540417|NCT01262872|41989319|FG004|Step 2|Withdrawal by Subject|3|||
19540418|NCT01262872|41989320|FG005|Step 2|Withdrawal by Subject|1|||
19540419|NCT01262872|41989321|FG006|Step 2|Withdrawal by Subject|2|||
19540420|NCT01262872|41989322|FG007|Step 2|Withdrawal by Subject|1|||
19540421|NCT01262872|41989315|FG000|Step 2|Migrated/moved from study area|0|||
19540422|NCT01262872|41989316|FG001|Step 2|Migrated/moved from study area|0|||
19540423|NCT01262872|41989317|FG002|Step 2|Migrated/moved from study area|4|||
19457375|NCT01752842|41708736|FG001|Overall Study|Withdrawal by Subject|2|||
19457376|NCT01461057|41708744|FG000|Overall Study|Death|10|||
19540424|NCT01262872|41989318|FG003|Step 2|Migrated/moved from study area|3|||
19540425|NCT01262872|41989319|FG004|Step 2|Migrated/moved from study area|2|||
19540426|NCT01262872|41989320|FG005|Step 2|Migrated/moved from study area|6|||
19540427|NCT01262872|41989321|FG006|Step 2|Migrated/moved from study area|2|||
19540428|NCT01262872|41989322|FG007|Step 2|Migrated/moved from study area|3|||
19457377|NCT01461057|41708745|FG001|Overall Study|Death|9|||
19457378|NCT01461057|41708744|FG000|Overall Study|Withdrawal by Subject|2|||
19540429|NCT01262677|41989359|FG000|Overall Study|Does not meet entrance criteria|0|||
19540430|NCT01262677|41989360|FG001|Overall Study|Does not meet entrance criteria|2|||
19457379|NCT01461057|41708745|FG001|Overall Study|Withdrawal by Subject|3|||
19457380|NCT01461057|41708744|FG000|Overall Study|Physician Decision|0|||
19540431|NCT01262677|41989361|FG002|Overall Study|Does not meet entrance criteria|0|||
19540432|NCT01262677|41989359|FG000|Overall Study|Insufficient clinical response|0|||
19540433|NCT01262677|41989360|FG001|Overall Study|Insufficient clinical response|0|||
19540434|NCT01262677|41989361|FG002|Overall Study|Insufficient clinical response|1|||
19540435|NCT01262677|41989359|FG000|Overall Study|Lost to Follow-up|1|||
19540436|NCT01262677|41989360|FG001|Overall Study|Lost to Follow-up|0|||
19540437|NCT01262677|41989361|FG002|Overall Study|Lost to Follow-up|2|||
19540438|NCT01262677|41989359|FG000|Overall Study|No longer willing to participate|3|||
19540439|NCT01262677|41989360|FG001|Overall Study|No longer willing to participate|3|||
19540440|NCT01262677|41989361|FG002|Overall Study|No longer willing to participate|2|||
19540441|NCT01262677|41989359|FG000|Overall Study|Reason not provided|2|||
19540442|NCT01262677|41989360|FG001|Overall Study|Reason not provided|1|||
19540443|NCT01262677|41989361|FG002|Overall Study|Reason not provided|3|||
19457381|NCT01461057|41708745|FG001|Overall Study|Physician Decision|2|||
19457382|NCT01461057|41708744|FG000|Overall Study|Adverse Event|0|||
19457383|NCT01461057|41708745|FG001|Overall Study|Adverse Event|1|||
19457384|NCT01461057|41708744|FG000|Overall Study|Progression of Disease|1|||
19457385|NCT01461057|41708745|FG001|Overall Study|Progression of Disease|0|||
19457386|NCT01461057|41708744|FG000|Overall Study|Study Terminated by Sponsor|2|||
19540444|NCT01262677|41989359|FG000|Overall Study|Protocol Violation|0|||
19540445|NCT01262677|41989360|FG001|Overall Study|Protocol Violation|1|||
19540446|NCT01262677|41989361|FG002|Overall Study|Protocol Violation|1|||
19540447|NCT01262677|41989359|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
19540448|NCT01262677|41989360|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
19540449|NCT01262677|41989361|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
19540450|NCT01262638|41989373|FG000|Overall Study|Adverse Event|3|||
19540451|NCT01262638|41989374|FG001|Overall Study|Adverse Event|4|||
19540452|NCT01262638|41989375|FG002|Overall Study|Adverse Event|3|||
19540453|NCT01262638|41989376|FG003|Overall Study|Adverse Event|4|||
19540454|NCT01262638|41989373|FG000|Overall Study|Protocol Violation|1|||
19540455|NCT01262638|41989374|FG001|Overall Study|Protocol Violation|0|||
19540456|NCT01262638|41989375|FG002|Overall Study|Protocol Violation|0|||
19540457|NCT01262638|41989376|FG003|Overall Study|Protocol Violation|1|||
19457387|NCT01461057|41708745|FG001|Overall Study|Study Terminated by Sponsor|0|||
19457388|NCT01460901|41708751|FG000|Overall Study|Withdrawal by Subject|2|||
19457389|NCT01519635|41708760|FG000|Overall Study|Withdrawal by Subject|0|||
19457390|NCT01519635|41708761|FG001|Overall Study|Withdrawal by Subject|1|||
19457391|NCT01519635|41708760|FG000|Overall Study|No possibility to put a catheter|1|||
19540458|NCT01262638|41989373|FG000|Overall Study|Withdrawal by Subject|2|||
19540459|NCT01262638|41989374|FG001|Overall Study|Withdrawal by Subject|1|||
19540460|NCT01262638|41989375|FG002|Overall Study|Withdrawal by Subject|0|||
19540461|NCT01262638|41989376|FG003|Overall Study|Withdrawal by Subject|1|||
19540462|NCT01262638|41989373|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
19540463|NCT01262638|41989374|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
19540464|NCT01262638|41989375|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
19540465|NCT01262638|41989376|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
19540466|NCT01262638|41989373|FG000|Overall Study|Lost to Follow-up|1|||
19540467|NCT01262638|41989374|FG001|Overall Study|Lost to Follow-up|1|||
19540468|NCT01262638|41989375|FG002|Overall Study|Lost to Follow-up|1|||
19540469|NCT01262638|41989376|FG003|Overall Study|Lost to Follow-up|1|||
19540470|NCT01262638|41989373|FG000|Overall Study|Participant Went Out of Town|0|||
19540471|NCT01262638|41989374|FG001|Overall Study|Participant Went Out of Town|0|||
19540472|NCT01262638|41989375|FG002|Overall Study|Participant Went Out of Town|1|||
19540473|NCT01262638|41989376|FG003|Overall Study|Participant Went Out of Town|0|||
19540474|NCT01262560|41989392|FG000|Overall Study|Protocol Violation|0|||
19540475|NCT01262560|41989393|FG001|Overall Study|Protocol Violation|1|||
19540476|NCT01262560|41989394|FG002|Overall Study|Protocol Violation|2|||
19540477|NCT01262365|41989405|FG000|Overall Study|Lack of Efficacy|35|||
19540478|NCT01262365|41989406|FG001|Overall Study|Lack of Efficacy|30|||
19540479|NCT01262365|41989407|FG002|Overall Study|Lack of Efficacy|47|||
19540480|NCT01262365|41989405|FG000|Overall Study|Protocol Violation|3|||
19540481|NCT01262365|41989406|FG001|Overall Study|Protocol Violation|1|||
19540482|NCT01262365|41989407|FG002|Overall Study|Protocol Violation|1|||
19540483|NCT01262365|41989405|FG000|Overall Study|Lost to Follow-up|3|||
19540484|NCT01262365|41989406|FG001|Overall Study|Lost to Follow-up|7|||
19540485|NCT01262365|41989407|FG002|Overall Study|Lost to Follow-up|6|||
19540486|NCT01262365|41989405|FG000|Overall Study|Withdrawal by Subject|17|||
19540487|NCT01262365|41989406|FG001|Overall Study|Withdrawal by Subject|22|||
19540488|NCT01262365|41989407|FG002|Overall Study|Withdrawal by Subject|22|||
19540489|NCT01262365|41989405|FG000|Overall Study|Death|1|||
19540490|NCT01262365|41989406|FG001|Overall Study|Death|2|||
19457392|NCT01519635|41708761|FG001|Overall Study|No possibility to put a catheter|2|||
19540491|NCT01262365|41989407|FG002|Overall Study|Death|1|||
19540492|NCT01262365|41989405|FG000|Overall Study|Adverse Event|26|||
19540493|NCT01262365|41989406|FG001|Overall Study|Adverse Event|16|||
19540494|NCT01262365|41989407|FG002|Overall Study|Adverse Event|11|||
19540495|NCT01262365|41989405|FG000|Overall Study|sponsor decision|1|||
19540496|NCT01262365|41989406|FG001|Overall Study|sponsor decision|1|||
19540497|NCT01262365|41989407|FG002|Overall Study|sponsor decision|0|||
19540498|NCT01262365|41989405|FG000|Overall Study|Randomization error|1|||
19540499|NCT01262365|41989406|FG001|Overall Study|Randomization error|0|||
19540500|NCT01262365|41989407|FG002|Overall Study|Randomization error|2|||
19540501|NCT01262365|41989405|FG000|Overall Study|Non-compliance|1|||
19540502|NCT01262365|41989406|FG001|Overall Study|Non-compliance|0|||
19540503|NCT01262365|41989407|FG002|Overall Study|Non-compliance|2|||
19540504|NCT01262365|41989405|FG000|Overall Study|Suspected pregnancy|1|||
19540505|NCT01262365|41989406|FG001|Overall Study|Suspected pregnancy|0|||
19540506|NCT01262365|41989407|FG002|Overall Study|Suspected pregnancy|0|||
19540507|NCT01262365|41989405|FG000|Overall Study|Patient pregnant|1|||
19540508|NCT01262365|41989406|FG001|Overall Study|Patient pregnant|0|||
19540509|NCT01262365|41989407|FG002|Overall Study|Patient pregnant|1|||
19540510|NCT01262365|41989405|FG000|Overall Study|Toxicity related to study drug|0|||
19540511|NCT01262365|41989406|FG001|Overall Study|Toxicity related to study drug|1|||
19540512|NCT01262365|41989407|FG002|Overall Study|Toxicity related to study drug|0|||
19540513|NCT01262365|41989405|FG000|Overall Study|Cannot tolerate the protocol|0|||
19540514|NCT01262365|41989406|FG001|Overall Study|Cannot tolerate the protocol|1|||
19540515|NCT01262365|41989407|FG002|Overall Study|Cannot tolerate the protocol|0|||
19540516|NCT01262365|41989405|FG000|Overall Study|Patient unavailable|0|||
19540517|NCT01262365|41989406|FG001|Overall Study|Patient unavailable|0|||
19540518|NCT01262365|41989407|FG002|Overall Study|Patient unavailable|1|||
19540519|NCT03932812|41989417|FG000|Overall Study|Lost to Follow-up|12|||
19540520|NCT03932812|41989418|FG001|Overall Study|Lost to Follow-up|14|||
19540521|NCT03932812|41989417|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
19540522|NCT03932812|41989418|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
19540523|NCT01262287|41989427|FG000|Overall Study|Lost to Follow-up|2|||
19540524|NCT01262287|41989428|FG001|Overall Study|Lost to Follow-up|1|||
19540525|NCT01262092|41989440|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
19540526|NCT01262092|41989441|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
19540527|NCT01262092|41989440|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
19540528|NCT01262092|41989441|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
19540529|NCT01262092|41989440|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
19540530|NCT01262092|41989441|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
19540531|NCT01262092|41989440|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
19540532|NCT01262092|41989441|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
19540533|NCT01261975|41989447|FG000|Overall Study|Surgical complication|1|||
19540534|NCT01261780|41989456|FG000|Overall Study|Withdrawal by Subject|1|||
19540535|NCT01261780|41989457|FG001|Overall Study|Withdrawal by Subject|0|||
19540536|NCT01261780|41989456|FG000|Overall Study|Event not related to subject|1|||
19540537|NCT01261780|41989457|FG001|Overall Study|Event not related to subject|2|||
19540538|NCT01261624|41989465|FG000|Week 0 to Week 12|Disease Progression|1|||
19540539|NCT01261624|41989466|FG001|Week 0 to Week 12|Disease Progression|1|||
19631509|NCT00768222|42080833|FG000|Overall Study|Lost to Follow-up|1|||
19631510|NCT00768222|42080834|FG001|Overall Study|Lost to Follow-up|1|||
19631511|NCT00768222|42080833|FG000|Overall Study|Withdrawal by Subject|3|||
19631512|NCT00768222|42080834|FG001|Overall Study|Withdrawal by Subject|1|||
19540540|NCT01261624|41989465|FG000|Week 0 to Week 12|Insufficient Response|0|||
19540541|NCT01261624|41989466|FG001|Week 0 to Week 12|Insufficient Response|2|||
19540542|NCT01261624|41989465|FG000|Week 13 to Week 24|Insufficient Response|0|||
19540543|NCT01261624|41989466|FG001|Week 13 to Week 24|Insufficient Response|1|||
19540544|NCT03694522|41989480|FG000|Overall Study|Withdrawal by Subject|8|||
19540545|NCT03694522|41989481|FG001|Overall Study|Withdrawal by Subject|10|||
19540546|NCT03694522|41989480|FG000|Overall Study|Physician Decision|53|||
19540547|NCT03694522|41989481|FG001|Overall Study|Physician Decision|54|||
19540548|NCT03694522|41989480|FG000|Overall Study|Other|1|||
19540549|NCT03694522|41989481|FG001|Overall Study|Other|1|||
19540550|NCT03694522|41989480|FG000|Overall Study|Lost to Follow-up|0|||
19540551|NCT03694522|41989481|FG001|Overall Study|Lost to Follow-up|1|||
19540552|NCT01261390|41989491|FG000|Overall Study|Significant Concurrent Illness|1|||
19540553|NCT01261390|41989492|FG001|Overall Study|Significant Concurrent Illness|0|||
19540554|NCT01261390|41989493|FG002|Overall Study|Significant Concurrent Illness|1|||
19540555|NCT01261390|41989494|FG003|Overall Study|Significant Concurrent Illness|0|||
19540556|NCT01261390|41989491|FG000|Overall Study|Dissatisfaction with Treatment|2|||
19540557|NCT01261390|41989492|FG001|Overall Study|Dissatisfaction with Treatment|1|||
19540558|NCT01261390|41989493|FG002|Overall Study|Dissatisfaction with Treatment|1|||
19540559|NCT01261390|41989494|FG003|Overall Study|Dissatisfaction with Treatment|2|||
19540560|NCT01261390|41989491|FG000|Overall Study|Relocation|0|||
19540561|NCT01261390|41989492|FG001|Overall Study|Relocation|1|||
19540562|NCT01261390|41989493|FG002|Overall Study|Relocation|0|||
19540563|NCT01261390|41989494|FG003|Overall Study|Relocation|0|||
19540564|NCT01261390|41989491|FG000|Overall Study|Loss of Interest in the Study|3|||
19540565|NCT01261390|41989492|FG001|Overall Study|Loss of Interest in the Study|1|||
19540566|NCT01261390|41989493|FG002|Overall Study|Loss of Interest in the Study|0|||
19540567|NCT01261390|41989494|FG003|Overall Study|Loss of Interest in the Study|0|||
19540568|NCT01261390|41989491|FG000|Overall Study|Lost to Follow-up|1|||
19540569|NCT01261390|41989492|FG001|Overall Study|Lost to Follow-up|6|||
19540570|NCT01261390|41989493|FG002|Overall Study|Lost to Follow-up|5|||
19540571|NCT01261390|41989494|FG003|Overall Study|Lost to Follow-up|6|||
19540572|NCT03391882|41989515|FG000|Study Overall|Adverse Event|3|||
19540573|NCT03391882|41989516|FG001|Study Overall|Adverse Event|6|||
19540574|NCT03391882|41989517|FG002|Study Overall|Adverse Event|1|||
19540575|NCT03391882|41989518|FG003|Study Overall|Adverse Event|1|||
19540576|NCT03391882|41989519|FG004|Study Overall|Adverse Event|3|||
19540577|NCT03391882|41989520|FG005|Study Overall|Adverse Event|1|||
19540578|NCT03391882|41989515|FG000|Study Overall|Lack of Efficacy|13|||
19540579|NCT03391882|41989516|FG001|Study Overall|Lack of Efficacy|9|||
19540580|NCT03391882|41989517|FG002|Study Overall|Lack of Efficacy|0|||
19540581|NCT03391882|41989518|FG003|Study Overall|Lack of Efficacy|0|||
19540582|NCT03391882|41989519|FG004|Study Overall|Lack of Efficacy|0|||
19540583|NCT03391882|41989520|FG005|Study Overall|Lack of Efficacy|0|||
19540584|NCT03391882|41989515|FG000|Study Overall|Withdrawal by Subject|3|||
19540585|NCT03391882|41989516|FG001|Study Overall|Withdrawal by Subject|3|||
19540586|NCT03391882|41989517|FG002|Study Overall|Withdrawal by Subject|2|||
19457393|NCT01519323|41708767|FG000|Overall Study|Death|3|||
19457394|NCT01519323|41708768|FG001|Overall Study|Death|2|||
19457395|NCT01519323|41708767|FG000|Overall Study|Study terminated by sponsor|0|||
19457396|NCT01519323|41708768|FG001|Overall Study|Study terminated by sponsor|1|||
19457397|NCT01519245|41708776|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
19457398|NCT01519245|41708777|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
19540587|NCT03391882|41989518|FG003|Study Overall|Withdrawal by Subject|2|||
19540588|NCT03391882|41989519|FG004|Study Overall|Withdrawal by Subject|1|||
19540589|NCT03391882|41989520|FG005|Study Overall|Withdrawal by Subject|3|||
19540590|NCT03391882|41989515|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
19540591|NCT03391882|41989516|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
19540592|NCT03391882|41989517|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
19540593|NCT03391882|41989518|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
19540594|NCT03391882|41989519|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
19540595|NCT03391882|41989520|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
19540596|NCT03391882|41989515|FG000|Study Overall|Protocol Violation|1|||
19540597|NCT03391882|41989516|FG001|Study Overall|Protocol Violation|0|||
19540598|NCT03391882|41989517|FG002|Study Overall|Protocol Violation|0|||
19540599|NCT03391882|41989518|FG003|Study Overall|Protocol Violation|0|||
19540600|NCT03391882|41989519|FG004|Study Overall|Protocol Violation|0|||
19540601|NCT03391882|41989520|FG005|Study Overall|Protocol Violation|0|||
19540602|NCT03391882|41989515|FG000|Part A - Titration Phase|Adverse Event|3|||
19540603|NCT03391882|41989516|FG001|Part A - Titration Phase|Adverse Event|6|||
19457399|NCT01519167|41708787|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
19457400|NCT01519167|41708788|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
19457401|NCT01519167|41708787|FG000|Overall Study|Adverse Event|0|||
19457402|NCT01519167|41708788|FG001|Overall Study|Adverse Event|1|||
19457403|NCT01519167|41708787|FG000|Overall Study|Lack of Efficacy|0|||
19457404|NCT01519167|41708788|FG001|Overall Study|Lack of Efficacy|1|||
19457405|NCT01519167|41708787|FG000|Overall Study|Medical condition changes&deep sedation|0|||
19457406|NCT01519167|41708788|FG001|Overall Study|Medical condition changes&deep sedation|2|||
19457407|NCT01519167|41708787|FG000|Overall Study|Physician Decision|0|||
19457408|NCT01519167|41708788|FG001|Overall Study|Physician Decision|1|||
19457409|NCT01519089|41709029|FG000|Overall Study|Adverse Event|4|||
19457410|NCT01519089|41709030|FG001|Overall Study|Adverse Event|4|||
19457411|NCT01519089|41709029|FG000|Overall Study|Lack of Efficacy|0|||
19457412|NCT01519089|41709030|FG001|Overall Study|Lack of Efficacy|2|||
19457413|NCT01519089|41709029|FG000|Overall Study|Lost to Follow-up|1|||
19457414|NCT01519089|41709030|FG001|Overall Study|Lost to Follow-up|0|||
19457415|NCT01519089|41709029|FG000|Overall Study|Withdrawal by Subject|0|||
19457416|NCT01519089|41709030|FG001|Overall Study|Withdrawal by Subject|2|||
19457417|NCT01519089|41709029|FG000|Overall Study|Other|2|||
19540604|NCT03391882|41989517|FG002|Part A - Titration Phase|Adverse Event|0|||
19540605|NCT03391882|41989518|FG003|Part A - Titration Phase|Adverse Event|0|||
19540606|NCT03391882|41989519|FG004|Part A - Titration Phase|Adverse Event|0|||
19540607|NCT03391882|41989520|FG005|Part A - Titration Phase|Adverse Event|0|||
19540608|NCT03391882|41989515|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
19540609|NCT03391882|41989516|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
19540610|NCT03391882|41989517|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
19540611|NCT03391882|41989518|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
19457418|NCT01519089|41709030|FG001|Overall Study|Other|6|||
19457419|NCT01519089|41709029|FG000|Overall Study|Not received study drug|0|||
19457420|NCT01519089|41709030|FG001|Overall Study|Not received study drug|1|||
19457421|NCT01518699|41709052|FG000|Period 2|Protocol Violation|1|||
19457422|NCT01518699|41709053|FG001|Period 2|Protocol Violation|1|||
19457423|NCT01518699|41709054|FG002|Period 2|Protocol Violation|0|||
19457424|NCT01518699|41709055|FG003|Period 2|Protocol Violation|0|||
19457425|NCT01518699|41709056|FG004|Period 2|Protocol Violation|0|||
19457426|NCT01518699|41709057|FG005|Period 2|Protocol Violation|0|||
19540612|NCT03391882|41989519|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
19540613|NCT03391882|41989520|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
19457427|NCT01518699|41709052|FG000|Period 2|Lost to Follow-up|0|||
19457428|NCT01518699|41709053|FG001|Period 2|Lost to Follow-up|1|||
19457429|NCT01518699|41709054|FG002|Period 2|Lost to Follow-up|0|||
19457430|NCT01518699|41709055|FG003|Period 2|Lost to Follow-up|0|||
19457431|NCT01518699|41709056|FG004|Period 2|Lost to Follow-up|0|||
19457432|NCT01518699|41709057|FG005|Period 2|Lost to Follow-up|0|||
19457433|NCT01518699|41709052|FG000|Period 2|Adverse Event|1|||
19457434|NCT01518699|41709053|FG001|Period 2|Adverse Event|0|||
19457435|NCT01518699|41709054|FG002|Period 2|Adverse Event|0|||
19457436|NCT01518699|41709055|FG003|Period 2|Adverse Event|0|||
19457437|NCT01518699|41709056|FG004|Period 2|Adverse Event|0|||
19457438|NCT01518699|41709057|FG005|Period 2|Adverse Event|0|||
19457439|NCT01518309|41709065|FG000|Overall Study|Adverse Event|6|||
19457440|NCT01518309|41709065|FG000|Overall Study|Death|6|||
19457441|NCT01518309|41709065|FG000|Overall Study|Lack of Efficacy|7|||
19457442|NCT01518309|41709065|FG000|Overall Study|Withdrawal by Subject|6|||
19457443|NCT01518309|41709065|FG000|Overall Study|Physician Decision|3|||
19457444|NCT01518309|41709065|FG000|Overall Study|Sponsor Decision|2|||
19457445|NCT01518309|41709065|FG000|Overall Study|Not in Predefined Categories|9|||
19457446|NCT01419717|41709069|FG000|Overall Study|Protocol-specified Criteria|62|||
19457447|NCT01419717|41709069|FG000|Overall Study|Adverse Event|19|||
19457448|NCT01419717|41709069|FG000|Overall Study|Death|17|||
19457449|NCT01419717|41709069|FG000|Overall Study|Withdrawal by Subject|10|||
19457450|NCT01419717|41709069|FG000|Overall Study|Disease Progression|9|||
19457451|NCT01419717|41709069|FG000|Overall Study|Other|4|||
19457452|NCT01419717|41709069|FG000|Overall Study|Lost to Follow-up|2|||
19457453|NCT01419717|41709069|FG000|Overall Study|Administrative Decision|1|||
19457454|NCT01419717|41709069|FG000|Overall Study|Noncompliance|1|||
19457455|NCT01458951|41709076|FG000|Overall Study|Other|1|||
19457456|NCT01458951|41709077|FG001|Overall Study|Other|0|||
19457457|NCT01458951|41709078|FG002|Overall Study|Other|0|||
19457458|NCT01458951|41709076|FG000|Overall Study|Protocol Violation|5|||
19457459|NCT01458951|41709077|FG001|Overall Study|Protocol Violation|1|||
19457460|NCT01458951|41709078|FG002|Overall Study|Protocol Violation|0|||
19457461|NCT01458951|41709076|FG000|Overall Study|Withdrawal by Subject|2|||
19457462|NCT01458951|41709077|FG001|Overall Study|Withdrawal by Subject|0|||
19457463|NCT01458951|41709078|FG002|Overall Study|Withdrawal by Subject|2|||
19457464|NCT01458951|41709076|FG000|Overall Study|Adverse Event|7|||
19457465|NCT01458951|41709077|FG001|Overall Study|Adverse Event|0|||
19457466|NCT01458951|41709078|FG002|Overall Study|Adverse Event|2|||
19457467|NCT01458951|41709076|FG000|Overall Study|Insufficient Clinical Response|17|||
19457468|NCT01458951|41709077|FG001|Overall Study|Insufficient Clinical Response|0|||
19540614|NCT03391882|41989515|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
19540615|NCT03391882|41989516|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
19540616|NCT03391882|41989517|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
19540617|NCT03391882|41989518|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
19540618|NCT03391882|41989519|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
19540619|NCT03391882|41989520|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
19540620|NCT03391882|41989515|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
19540621|NCT03391882|41989516|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
19540622|NCT03391882|41989517|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
19540623|NCT03391882|41989518|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
19540624|NCT03391882|41989519|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
19540625|NCT03391882|41989520|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
19540626|NCT03391882|41989515|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
19540627|NCT03391882|41989516|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
19540628|NCT03391882|41989517|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
19540629|NCT03391882|41989518|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
19540630|NCT03391882|41989519|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
19457469|NCT01458951|41709078|FG002|Overall Study|Insufficient Clinical Response|11|||
19457470|NCT01458639|41709085|FG000|Overall Study|Physician Decision|4|||
19457471|NCT01458639|41709085|FG000|Overall Study|Equipment issue|1|||
19457472|NCT01458639|41709085|FG000|Overall Study|Inability to obtain subject blood sample|1|||
19457473|NCT01437423|41709089|FG000|Overall Study|Lost to Follow-up|12|||
19457474|NCT01437423|41709089|FG000|Overall Study|Off label usage|3|||
19457475|NCT01458249|41709120|FG000|Overall Study|Not treated|1|||
19457476|NCT01458249|41709120|FG000|Overall Study|Adverse Event|4|||
19457477|NCT01458249|41709120|FG000|Overall Study|Other|2|||
19540631|NCT03391882|41989520|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
19540632|NCT03391882|41989515|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
19540633|NCT03391882|41989516|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
19540634|NCT03391882|41989517|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
19540635|NCT03391882|41989518|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
19540636|NCT03391882|41989519|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
19540637|NCT03391882|41989520|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
19540638|NCT03391882|41989515|FG000|Part B - Treatment Phase|Adverse Event|0|||
19540639|NCT03391882|41989516|FG001|Part B - Treatment Phase|Adverse Event|0|||
19540640|NCT03391882|41989517|FG002|Part B - Treatment Phase|Adverse Event|1|||
19540641|NCT03391882|41989518|FG003|Part B - Treatment Phase|Adverse Event|1|||
19540642|NCT03391882|41989519|FG004|Part B - Treatment Phase|Adverse Event|3|||
19540643|NCT03391882|41989520|FG005|Part B - Treatment Phase|Adverse Event|1|||
19540644|NCT03391882|41989515|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
19540645|NCT03391882|41989516|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
19540646|NCT03391882|41989517|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
19540647|NCT03391882|41989518|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
19540648|NCT03391882|41989519|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
19540649|NCT03391882|41989520|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
19540650|NCT01261000|41989530|FG000|Overall Study|Screen failure|1|||
19540651|NCT01234402|41989563|FG000|Overall Study|Lost to Follow-up|0|||
19540652|NCT01234402|41989564|FG001|Overall Study|Lost to Follow-up|1|||
19540653|NCT01234402|41989565|FG002|Overall Study|Lost to Follow-up|3|||
19540654|NCT01234402|41989563|FG000|Overall Study|Withdrawal by Subject|1|||
19540655|NCT01234402|41989564|FG001|Overall Study|Withdrawal by Subject|3|||
19540656|NCT01234402|41989565|FG002|Overall Study|Withdrawal by Subject|4|||
19540657|NCT01234402|41989563|FG000|Overall Study|Never treated: Death|0|||
19540658|NCT01234402|41989564|FG001|Overall Study|Never treated: Death|0|||
19540659|NCT01234402|41989565|FG002|Overall Study|Never treated: Death|1|||
19540660|NCT01234402|41989563|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
19540661|NCT01234402|41989564|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
19540662|NCT01234402|41989565|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
19540663|NCT01234402|41989563|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
19540664|NCT01234402|41989564|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
19540665|NCT01234402|41989565|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
19540666|NCT01260922|41989577|FG000|First Intervention|Withdrawal by Subject|0|||
19540667|NCT01260922|41989578|FG001|First Intervention|Withdrawal by Subject|1|||
19540668|NCT01260922|41989577|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
19540669|NCT01260922|41989578|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
19540670|NCT01260922|41989577|FG000|Second Intervention|Emesis|0|||
19540671|NCT01260922|41989578|FG001|Second Intervention|Emesis|2|||
19540672|NCT01233817|41989584|FG000|Overall Study|Lost to Follow-up|1|||
19540673|NCT01233817|41989584|FG000|Overall Study|Withdrawal by Subject|2|||
19540674|NCT01233232|41989591|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
19540675|NCT01233232|41989592|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
19540676|NCT01233232|41989593|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
19540677|NCT01233076|41989603|FG000|Period 2, One Week|Lost to Follow-up|1|||
19540678|NCT01233076|41989604|FG001|Period 2, One Week|Lost to Follow-up|0|||
19540679|NCT01212094|41989613|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
19540680|NCT01212094|41989614|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
19540681|NCT01212094|41989615|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
19540682|NCT01212094|41989613|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
19540683|NCT01212094|41989614|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
19540684|NCT01212094|41989615|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
19540685|NCT01212094|41989613|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
19540686|NCT01212094|41989614|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
19540687|NCT01212094|41989615|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
19540688|NCT01212094|41989613|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
19540689|NCT01212094|41989614|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
19540690|NCT01212094|41989615|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
19540691|NCT01212094|41989613|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
19540692|NCT01212094|41989614|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
19540693|NCT01212094|41989615|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
19540694|NCT01212094|41989613|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
19540695|NCT01212094|41989614|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
19540696|NCT01212094|41989615|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
19540697|NCT01232569|41989624|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
19540698|NCT01232569|41989625|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
19540699|NCT01232569|41989626|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19540700|NCT01232569|41989627|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
19540701|NCT01232569|41989624|FG000|Double-blind Treatment Period|Escape|2|||
19540702|NCT01232569|41989625|FG001|Double-blind Treatment Period|Escape|2|||
19457478|NCT01458249|41709120|FG000|Overall Study|Ongoing|1|||
19540703|NCT01232569|41989626|FG002|Double-blind Treatment Period|Escape|0|||
19540704|NCT01232569|41989627|FG003|Double-blind Treatment Period|Escape|0|||
19540705|NCT01232569|41989624|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
19540706|NCT01232569|41989625|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
19540707|NCT01232569|41989626|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
19540708|NCT01232569|41989627|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
19540709|NCT01232569|41989624|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
19540710|NCT01232569|41989625|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
19540711|NCT01232569|41989626|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
19540712|NCT01232569|41989627|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
19540713|NCT01232569|41989624|FG000|Double-blind Treatment Period|Physician Decision|1|||
19540714|NCT01232569|41989625|FG001|Double-blind Treatment Period|Physician Decision|0|||
19540715|NCT01232569|41989626|FG002|Double-blind Treatment Period|Physician Decision|0|||
19540716|NCT01232569|41989627|FG003|Double-blind Treatment Period|Physician Decision|0|||
19540717|NCT01232569|41989624|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
19540718|NCT01232569|41989625|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
19631513|NCT00768222|42080833|FG000|Overall Study|Protocol Violation|0|||
19631514|NCT00768222|42080834|FG001|Overall Study|Protocol Violation|2|||
19631515|NCT00768144|42080840|FG000|Overall Study|Adverse Event|13|||
19631516|NCT00768144|42080840|FG000|Overall Study|Progressive Disease|21|||
19631517|NCT00768144|42080840|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
19631518|NCT00768144|42080840|FG000|Overall Study|Pt Withdrew Consent|1|||
19631519|NCT00784836|42080844|FG000|Overall Study|Early Study Termination|3|||
19631520|NCT00784758|42080850|FG000|Overall Study|Withdrawal by Subject|3|||
19631521|NCT00784758|42080851|FG001|Overall Study|Withdrawal by Subject|0|||
19631522|NCT00784758|42080850|FG000|Overall Study|Adverse Event|1|||
19631523|NCT00784758|42080851|FG001|Overall Study|Adverse Event|0|||
19631524|NCT00768066|42080862|FG000|Overall Study|Did not receive study product injection.|3|||
19631525|NCT00768066|42080863|FG001|Overall Study|Did not receive study product injection.|3|||
19631526|NCT00768066|42080864|FG002|Overall Study|Did not receive study product injection.|0|||
19631527|NCT00767676|42080872|FG000|Overall Study|Investigator error|54|||
19631528|NCT00767520|42080878|FG000|Overall Study|Participants still on treatment|11|||
19631529|NCT00767520|42080879|FG001|Overall Study|Participants still on treatment|15|||
19631530|NCT00767520|42080878|FG000|Overall Study|Randomized in error and Never treated|0|||
19631531|NCT00767520|42080879|FG001|Overall Study|Randomized in error and Never treated|2|||
19631532|NCT00838565|42080891|FG000|Overall Study|Withdrawal by Subject|0|||
19631533|NCT00838565|42080892|FG001|Overall Study|Withdrawal by Subject|0|||
19631534|NCT00838565|42080893|FG002|Overall Study|Withdrawal by Subject|1|||
19631535|NCT00838565|42080894|FG003|Overall Study|Withdrawal by Subject|0|||
19631536|NCT00838565|42080895|FG004|Overall Study|Withdrawal by Subject|0|||
19631537|NCT00838565|42080896|FG005|Overall Study|Withdrawal by Subject|2|||
19631538|NCT00838565|42080891|FG000|Overall Study|Other|0|||
19631539|NCT00838565|42080892|FG001|Overall Study|Other|2|||
19631540|NCT00838565|42080893|FG002|Overall Study|Other|0|||
19631541|NCT00838565|42080894|FG003|Overall Study|Other|0|||
19631542|NCT00838565|42080895|FG004|Overall Study|Other|0|||
19631543|NCT00838565|42080896|FG005|Overall Study|Other|0|||
19631544|NCT00838565|42080891|FG000|Overall Study|Randomized but not Treated|0|||
19631545|NCT00838565|42080892|FG001|Overall Study|Randomized but not Treated|1|||
19457479|NCT01458171|41709136|FG000|Overall Study|Adverse Event|1|||
19457480|NCT01457703|41709153|FG000|Overall Study|Screen Failure|5|||
19457481|NCT01457703|41709154|FG001|Overall Study|Screen Failure|7|||
19457482|NCT01457703|41709153|FG000|Overall Study|Withdrawal by Subject|1|||
19457483|NCT01457703|41709154|FG001|Overall Study|Withdrawal by Subject|4|||
19457484|NCT01419015|41709172|FG000|Overall Study|Death|2|||
19457485|NCT01418937|41709193|FG000|Overall Study|Lost to Follow-up|5|||
19457486|NCT01418937|41709193|FG000|Overall Study|Protocol Violation|1|||
19457487|NCT01418937|41709193|FG000|Overall Study|Pregnancy|1|||
19457488|NCT01418937|41709193|FG000|Overall Study|Withdrawal by Subject|1|||
19457489|NCT01417377|41709206|FG000|Overall Study|Lost to Follow-up|12|||
19457490|NCT01417377|41709206|FG000|Overall Study|Enrolled, but not treated|1|||
19457491|NCT01437267|41709253|FG000|Overall Study|Withdrawal by Subject|0|||
19457492|NCT01437267|41709254|FG001|Overall Study|Withdrawal by Subject|0|||
19457493|NCT01437267|41709255|FG002|Overall Study|Withdrawal by Subject|0|||
19457494|NCT01437267|41709256|FG003|Overall Study|Withdrawal by Subject|1|||
19457495|NCT01437267|41709257|FG004|Overall Study|Withdrawal by Subject|0|||
19457496|NCT01437267|41709258|FG005|Overall Study|Withdrawal by Subject|0|||
19457497|NCT01437267|41709253|FG000|Overall Study|Protocol Violation|0|||
19457498|NCT01437267|41709254|FG001|Overall Study|Protocol Violation|1|||
19631546|NCT00838565|42080893|FG002|Overall Study|Randomized but not Treated|0|||
19631547|NCT00838565|42080894|FG003|Overall Study|Randomized but not Treated|0|||
19457499|NCT01437267|41709255|FG002|Overall Study|Protocol Violation|0|||
19457500|NCT01437267|41709256|FG003|Overall Study|Protocol Violation|0|||
19540719|NCT01232569|41989626|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
19540720|NCT01232569|41989627|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
19457501|NCT01437267|41709257|FG004|Overall Study|Protocol Violation|0|||
19457502|NCT01437267|41709258|FG005|Overall Study|Protocol Violation|0|||
19540721|NCT01232569|41989624|FG000|Double-blind Treatment Period|Death|2|||
19540722|NCT01232569|41989625|FG001|Double-blind Treatment Period|Death|0|||
19540723|NCT01232569|41989626|FG002|Double-blind Treatment Period|Death|0|||
19540724|NCT01232569|41989627|FG003|Double-blind Treatment Period|Death|0|||
19540725|NCT01211665|41989638|FG000|Overall Study|Withdrawal by Subject|1|||
19540726|NCT01211665|41989639|FG001|Overall Study|Withdrawal by Subject|0|||
19540727|NCT01211665|41989638|FG000|Overall Study|Death|1|||
19540728|NCT01211665|41989639|FG001|Overall Study|Death|0|||
19540729|NCT01232491|41989647|FG000|Overall Study|Adverse Event|13|||
19540730|NCT01232491|41989648|FG001|Overall Study|Adverse Event|8|||
19540731|NCT01232491|41989647|FG000|Overall Study|Lack of Efficacy|1|||
19540732|NCT01232491|41989648|FG001|Overall Study|Lack of Efficacy|5|||
19540733|NCT01232491|41989647|FG000|Overall Study|Protocol Violation|13|||
19540734|NCT01232491|41989648|FG001|Overall Study|Protocol Violation|11|||
19540735|NCT01232491|41989647|FG000|Overall Study|Withdrawal Criteria|12|||
19540736|NCT01232491|41989648|FG001|Overall Study|Withdrawal Criteria|21|||
19540737|NCT01232491|41989647|FG000|Overall Study|Other|21|||
19540738|NCT01232491|41989648|FG001|Overall Study|Other|18|||
19540739|NCT01232452|41989656|FG000|Overall Study|Adverse Event|17|||
19540740|NCT01232452|41989657|FG001|Overall Study|Adverse Event|15|||
19540741|NCT01232452|41989656|FG000|Overall Study|Withdrawal by Subject|11|||
19540742|NCT01232452|41989657|FG001|Overall Study|Withdrawal by Subject|8|||
19540743|NCT01232452|41989656|FG000|Overall Study|Physician Decision|8|||
19540744|NCT01232452|41989657|FG001|Overall Study|Physician Decision|12|||
19540745|NCT01232452|41989656|FG000|Overall Study|Protocol entry criterion not met|0|||
19540746|NCT01232452|41989657|FG001|Overall Study|Protocol entry criterion not met|2|||
19540747|NCT01232452|41989656|FG000|Overall Study|Sponsor Decision|3|||
19540748|NCT01232452|41989657|FG001|Overall Study|Sponsor Decision|1|||
19540749|NCT01232452|41989656|FG000|Overall Study|Protocol Violation|0|||
19540750|NCT01232452|41989657|FG001|Overall Study|Protocol Violation|1|||
19540751|NCT01211197|41989663|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19540752|NCT01211197|41989664|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19540753|NCT01211197|41989665|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
19540754|NCT01211197|41989666|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19540755|NCT01211197|41989667|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19540756|NCT01211197|41989668|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
19540757|NCT01211197|41989663|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
19540758|NCT01211197|41989664|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
19540759|NCT01211197|41989665|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
19540760|NCT01211197|41989666|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
19540761|NCT01211197|41989667|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
19631548|NCT00838565|42080895|FG004|Overall Study|Randomized but not Treated|0|||
19631549|NCT00838565|42080896|FG005|Overall Study|Randomized but not Treated|0|||
19631550|NCT00858845|42080917|FG000|Overall Study|Patient underwent heart transplant.|0|||
19631551|NCT00858845|42080918|FG001|Overall Study|Patient underwent heart transplant.|1|||
19631552|NCT00770562|42080926|FG000|Overall Study|Did not take treatment|1|||
19631553|NCT00770562|42080927|FG001|Overall Study|Did not take treatment|1|||
19631554|NCT00836693|42080936|FG000|Overall Study|Adverse Event|4|||
19631555|NCT00836693|42080937|FG001|Overall Study|Adverse Event|1|||
19631556|NCT00836693|42080936|FG000|Overall Study|Sponsor Decision|0|||
19631557|NCT00836693|42080937|FG001|Overall Study|Sponsor Decision|1|||
19631558|NCT00836693|42080936|FG000|Overall Study|Physician Decision|2|||
19631559|NCT00836693|42080937|FG001|Overall Study|Physician Decision|0|||
19631560|NCT00836693|42080936|FG000|Overall Study|Withdrawal by Subject|9|||
19631561|NCT00836693|42080937|FG001|Overall Study|Withdrawal by Subject|4|||
19631562|NCT00836693|42080936|FG000|Overall Study|Protocol Violation|1|||
19540762|NCT01211197|41989668|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
19540763|NCT01232296|41989678|FG000|Overall Study|Adverse Event|24|||
19540764|NCT01232296|41989679|FG001|Overall Study|Adverse Event|12|||
19457503|NCT01456221|41709287|FG000|Overall Study|Withdrawal by Subject|56|||
19457504|NCT01456221|41709288|FG001|Overall Study|Withdrawal by Subject|49|||
19457505|NCT01456221|41709287|FG000|Overall Study|Lost to Follow-up|1|||
19457506|NCT01456221|41709288|FG001|Overall Study|Lost to Follow-up|4|||
19457507|NCT01456221|41709287|FG000|Overall Study|Received medication|3|||
19457508|NCT01456221|41709288|FG001|Overall Study|Received medication|2|||
19457509|NCT01456221|41709287|FG000|Overall Study|Incomplete data|4|||
19457510|NCT01456221|41709288|FG001|Overall Study|Incomplete data|2|||
19457511|NCT01437111|41709294|FG000|Overall Study|Adverse Event|2|||
19457512|NCT01437111|41709294|FG000|Overall Study|Withdrawal by Subject|4|||
19540765|NCT01232296|41989678|FG000|Overall Study|Physician Decision|1|||
19631563|NCT00836693|42080937|FG001|Overall Study|Protocol Violation|0|||
19631564|NCT00836693|42080936|FG000|Overall Study|Lost to Follow-up|1|||
19457513|NCT01437111|41709294|FG000|Overall Study|Not reported|5|||
19540766|NCT01232296|41989679|FG001|Overall Study|Physician Decision|1|||
19540767|NCT01232296|41989678|FG000|Overall Study|Progressive disease|43|||
19540768|NCT01232296|41989679|FG001|Overall Study|Progressive disease|61|||
19540769|NCT01232296|41989678|FG000|Overall Study|Study terminated by sponsor|0|||
19540770|NCT01232296|41989679|FG001|Overall Study|Study terminated by sponsor|1|||
19540771|NCT01232296|41989678|FG000|Overall Study|Technical problems|3|||
19540772|NCT01232296|41989679|FG001|Overall Study|Technical problems|0|||
19540773|NCT01232296|41989678|FG000|Overall Study|Subject/guardian decision|10|||
19540774|NCT01232296|41989679|FG001|Overall Study|Subject/guardian decision|2|||
19540775|NCT01232296|41989678|FG000|Overall Study|Death|1|||
19540776|NCT01232296|41989679|FG001|Overall Study|Death|6|||
19540777|NCT01231984|41989687|FG000|Study Period 1|Withdrawal by Subject|0|||
19457514|NCT01437111|41709294|FG000|Overall Study|Physician Decision|1|||
19457515|NCT01437111|41709294|FG000|Overall Study|Lost to Follow-up|5|||
19457516|NCT01437111|41709294|FG000|Overall Study|Protocol Violation|1|||
19457517|NCT01436643|41709342|FG000|2-week Pre-treatment|Abnormal test result|0|||
19457518|NCT01436643|41709343|FG001|2-week Pre-treatment|Abnormal test result|0|||
19457519|NCT01436643|41709344|FG002|2-week Pre-treatment|Abnormal test result|0|||
19457520|NCT01436643|41709345|FG003|2-week Pre-treatment|Abnormal test result|1|||
19457521|NCT01436643|41709342|FG000|2-week Pre-treatment|Adverse Event|0|||
19457522|NCT01436643|41709343|FG001|2-week Pre-treatment|Adverse Event|0|||
19457523|NCT01436643|41709344|FG002|2-week Pre-treatment|Adverse Event|0|||
19457524|NCT01436643|41709345|FG003|2-week Pre-treatment|Adverse Event|5|||
19457525|NCT01436643|41709342|FG000|2-week Pre-treatment|Protocol Violation|0|||
19457526|NCT01436643|41709343|FG001|2-week Pre-treatment|Protocol Violation|0|||
19457527|NCT01436643|41709344|FG002|2-week Pre-treatment|Protocol Violation|0|||
19457528|NCT01436643|41709345|FG003|2-week Pre-treatment|Protocol Violation|4|||
19457529|NCT01436643|41709342|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
19457530|NCT01436643|41709343|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
19457531|NCT01436643|41709344|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
19457532|NCT01436643|41709345|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
19457533|NCT01436643|41709342|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
19457534|NCT01436643|41709343|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
19457535|NCT01436643|41709344|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
19457536|NCT01436643|41709345|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
19457537|NCT01436643|41709342|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
19457538|NCT01436643|41709343|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
19457539|NCT01436643|41709344|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
19457540|NCT01436643|41709345|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
19457541|NCT01454739|41709443|FG000|Overall Study|Protocol Violation|2|||
19457542|NCT01454739|41709444|FG001|Overall Study|Protocol Violation|3|||
19457543|NCT01454739|41709443|FG000|Overall Study|Withdrawal by Subject|2|||
19457544|NCT01454739|41709444|FG001|Overall Study|Withdrawal by Subject|6|||
19457545|NCT01454739|41709443|FG000|Overall Study|Other|3|||
19457546|NCT01454739|41709444|FG001|Overall Study|Other|5|||
19457547|NCT01454739|41709443|FG000|Overall Study|Physician Decision|0|||
19457548|NCT01454739|41709444|FG001|Overall Study|Physician Decision|5|||
19457549|NCT01454739|41709443|FG000|Overall Study|Lost to Follow-up|0|||
19457550|NCT01454739|41709444|FG001|Overall Study|Lost to Follow-up|1|||
19540778|NCT01231984|41989688|FG001|Study Period 1|Withdrawal by Subject|0|||
19540779|NCT01231984|41989689|FG002|Study Period 1|Withdrawal by Subject|0|||
19540780|NCT01231984|41989690|FG003|Study Period 1|Withdrawal by Subject|1|||
19540781|NCT01231984|41989687|FG000|Study Period 1|Lost to Follow-up|1|||
19540782|NCT01231984|41989688|FG001|Study Period 1|Lost to Follow-up|1|||
19540783|NCT01231984|41989689|FG002|Study Period 1|Lost to Follow-up|1|||
19540784|NCT01231984|41989690|FG003|Study Period 1|Lost to Follow-up|0|||
19540785|NCT01231984|41989687|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
19540786|NCT01231984|41989688|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
19540787|NCT01231984|41989689|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
19540788|NCT01231984|41989690|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
19540789|NCT01231984|41989687|FG000|Study Period 1|Screen Failure|0|||
19540790|NCT01231984|41989688|FG001|Study Period 1|Screen Failure|0|||
19540791|NCT01231984|41989689|FG002|Study Period 1|Screen Failure|0|||
19540792|NCT01231984|41989690|FG003|Study Period 1|Screen Failure|1|||
19540793|NCT01231984|41989687|FG000|Study Period 1|Non-compliance with study requirements|5|||
19540794|NCT01231984|41989688|FG001|Study Period 1|Non-compliance with study requirements|0|||
19540795|NCT01231984|41989689|FG002|Study Period 1|Non-compliance with study requirements|2|||
19540796|NCT01231984|41989690|FG003|Study Period 1|Non-compliance with study requirements|1|||
19540797|NCT01231984|41989687|FG000|Study Period 1|Protocol Violation|3|||
19540798|NCT01231984|41989688|FG001|Study Period 1|Protocol Violation|4|||
19540799|NCT01231984|41989689|FG002|Study Period 1|Protocol Violation|2|||
19457551|NCT01454739|41709443|FG000|Overall Study|Adverse Event|0|||
19457552|NCT01454739|41709444|FG001|Overall Study|Adverse Event|1|||
19457553|NCT01416441|41709482|FG000|Overall Study|Lost to Follow-up|5|||
19457554|NCT01416441|41709482|FG000|Overall Study|Adverse Event|6|||
19457555|NCT01416441|41709482|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
19540800|NCT01231984|41989690|FG003|Study Period 1|Protocol Violation|3|||
19540801|NCT01231984|41989687|FG000|Study Period 1|Adverse Event|1|||
19540802|NCT01231984|41989688|FG001|Study Period 1|Adverse Event|0|||
19540803|NCT01231984|41989689|FG002|Study Period 1|Adverse Event|0|||
19540804|NCT01231984|41989690|FG003|Study Period 1|Adverse Event|0|||
19540805|NCT01231984|41989687|FG000|Study Period 1|Other|0|||
19540806|NCT01231984|41989688|FG001|Study Period 1|Other|0|||
19540807|NCT01231984|41989689|FG002|Study Period 1|Other|0|||
19540808|NCT01231984|41989690|FG003|Study Period 1|Other|1|||
19540809|NCT01231984|41989687|FG000|Study Period 2|Withdrawal by Subject|1|||
19540810|NCT01231984|41989688|FG001|Study Period 2|Withdrawal by Subject|1|||
19540811|NCT01231984|41989689|FG002|Study Period 2|Withdrawal by Subject|0|||
19540812|NCT01231984|41989690|FG003|Study Period 2|Withdrawal by Subject|0|||
19540813|NCT01231984|41989687|FG000|Study Period 2|Lost to Follow-up|1|||
19540814|NCT01231984|41989688|FG001|Study Period 2|Lost to Follow-up|0|||
19540815|NCT01231984|41989689|FG002|Study Period 2|Lost to Follow-up|0|||
19540816|NCT01231984|41989690|FG003|Study Period 2|Lost to Follow-up|3|||
19540817|NCT01231984|41989687|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
19540818|NCT01231984|41989688|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
19540819|NCT01231984|41989689|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
19540820|NCT01231984|41989690|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
19540821|NCT01210807|41989710|FG000|Overall Study|Lost to Follow-up|1|||
19540822|NCT01210807|41989711|FG001|Overall Study|Lost to Follow-up|2|||
19540823|NCT01210807|41989710|FG000|Overall Study|Not implanted bilaterally|2|||
19540824|NCT01210807|41989711|FG001|Overall Study|Not implanted bilaterally|1|||
19540825|NCT01231555|41989720|FG000|Overall Study|Study terminated|8|||
19540826|NCT01231555|41989721|FG001|Overall Study|Study terminated|5|||
19540827|NCT01231555|41989722|FG002|Overall Study|Study terminated|8|||
19540828|NCT01231555|41989720|FG000|Overall Study|Withdrawal by Subject|0|||
19540829|NCT01231555|41989721|FG001|Overall Study|Withdrawal by Subject|2|||
19457556|NCT01416441|41709482|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
19457557|NCT01416441|41709482|FG000|Overall Study|Investigator Withdrew Subject|2|||
19457558|NCT01416441|41709482|FG000|Overall Study|Subject Withdrew Consent|12|||
19457559|NCT01416441|41709482|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
19457560|NCT01436253|41709491|FG000|Overall Study|Lost to Follow-up|182|||
19457561|NCT01436253|41709491|FG000|Overall Study|Not meeting all eligibility criteria|117|||
19457562|NCT01454583|41710404|FG000|1st Year|Lost to Follow-up|1057|||
19457563|NCT01454583|41710405|FG001|1st Year|Lost to Follow-up|318|||
19540830|NCT01231555|41989722|FG002|Overall Study|Withdrawal by Subject|0|||
19540831|NCT01210690|41989730|FG000|Overall Study|Adverse Event|7|||
19540832|NCT01210690|41989730|FG000|Overall Study|Lack of Efficacy|12|||
19540833|NCT01210690|41989730|FG000|Overall Study|Lost to Follow-up|3|||
19540834|NCT01210690|41989730|FG000|Overall Study|Disease Remission|1|||
19540835|NCT01210690|41989730|FG000|Overall Study|Withdrawal by Subject|1|||
19540836|NCT01210690|41989730|FG000|Overall Study|Patient refused to swallow|1|||
19540837|NCT01210690|41989730|FG000|Overall Study|Patient could not take glucose|1|||
19540838|NCT01210651|41989737|FG000|Overall Study|Lost to Follow-up|1|||
19540839|NCT01210651|41989738|FG001|Overall Study|Lost to Follow-up|1|||
19540840|NCT01210651|41989737|FG000|Overall Study|schedule conflicts|1|||
19540841|NCT01210651|41989738|FG001|Overall Study|schedule conflicts|5|||
19540842|NCT01210651|41989737|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
19540843|NCT01210651|41989738|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
19540844|NCT01210651|41989737|FG000|Overall Study|Withdrawal by Subject|1|||
19540845|NCT01210651|41989738|FG001|Overall Study|Withdrawal by Subject|1|||
19540846|NCT01210651|41989737|FG000|Overall Study|Injury outside study|2|||
19540847|NCT01210651|41989738|FG001|Overall Study|Injury outside study|0|||
19540848|NCT01210495|41989817|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
19540849|NCT01210495|41989818|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
19540850|NCT01210495|41989819|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
19540851|NCT01210495|41989820|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
19540852|NCT01210495|41989817|FG000|Overall Study|Death|14|||
19540853|NCT01210495|41989818|FG001|Overall Study|Death|7|||
19457564|NCT01454583|41710406|FG002|1st Year|Lost to Follow-up|180|||
19457565|NCT01454583|41710404|FG000|2nd Year|Lost to Follow-up|3965|||
19457566|NCT01454583|41710405|FG001|2nd Year|Lost to Follow-up|1049|||
19457567|NCT01454583|41710406|FG002|2nd Year|Lost to Follow-up|737|||
19457568|NCT01454583|41710404|FG000|3rd Year|Lost to Follow-up|1959|||
19457569|NCT01454583|41710405|FG001|3rd Year|Lost to Follow-up|512|||
19457570|NCT01454583|41710406|FG002|3rd Year|Lost to Follow-up|297|||
19457571|NCT01436175|41710429|FG000|Overall Study|Adverse Event|111|||
19457572|NCT01436175|41710429|FG000|Overall Study|Protocol Violation|49|||
19457573|NCT01436175|41710429|FG000|Overall Study|Withdrawal by Subject|108|||
19457574|NCT01436175|41710429|FG000|Overall Study|Lost to Follow-up|89|||
19540854|NCT01210495|41989819|FG002|Overall Study|Death|112|||
19540855|NCT01210495|41989820|FG003|Overall Study|Death|54|||
19457575|NCT01436175|41710429|FG000|Overall Study|Lack of Efficacy|24|||
19457576|NCT01436175|41710429|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
19457577|NCT01436175|41710429|FG000|Overall Study|Other|826|||
19540856|NCT01210495|41989817|FG000|Overall Study|Study Terminated by Sponsor|0|||
19540857|NCT01210495|41989818|FG001|Overall Study|Study Terminated by Sponsor|0|||
19540858|NCT01210495|41989819|FG002|Overall Study|Study Terminated by Sponsor|4|||
19540859|NCT01210495|41989820|FG003|Overall Study|Study Terminated by Sponsor|11|||
19540860|NCT01210495|41989817|FG000|Overall Study|Lost to Follow-up|0|||
19540861|NCT01210495|41989818|FG001|Overall Study|Lost to Follow-up|0|||
19540862|NCT01210495|41989819|FG002|Overall Study|Lost to Follow-up|1|||
19540863|NCT01210495|41989820|FG003|Overall Study|Lost to Follow-up|1|||
19540864|NCT01210495|41989817|FG000|Overall Study|Other unspecified|0|||
19540865|NCT01210495|41989818|FG001|Overall Study|Other unspecified|0|||
19540866|NCT01210495|41989819|FG002|Overall Study|Other unspecified|6|||
19540867|NCT01210495|41989820|FG003|Overall Study|Other unspecified|0|||
19540868|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
19540869|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
19540870|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
19540871|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
19540872|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
19540873|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
19540874|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
19540875|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
19540876|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
19540877|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
19540878|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
19540879|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
19540880|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
19540881|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
19540882|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
19540883|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
19540884|NCT01231516|41989832|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
19540885|NCT01231516|41989833|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
19540886|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
19540887|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
19540888|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
19540889|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
19540890|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
19540891|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
19540892|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
19540893|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
19540894|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
19540895|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
19540896|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
19540897|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
19540898|NCT01231516|41989832|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
19540899|NCT01231516|41989833|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
19540900|NCT01231321|41989839|FG000|Overall Study|Adverse Event|3|||
19540901|NCT01231321|41989839|FG000|Overall Study|Lack of Efficacy|2|||
19540902|NCT01210222|41989849|FG000|Overall Study|Ineligible|2|||
19540903|NCT01210222|41989849|FG000|Overall Study|Never treated|1|||
19540904|NCT01210144|41989861|FG000|Overall Study|Lack of ovarian response|1|||
19540905|NCT01210144|41989862|FG001|Overall Study|Lack of ovarian response|0|||
19540906|NCT01210144|41989861|FG000|Overall Study|No fertilization|1|||
19540907|NCT01210144|41989862|FG001|Overall Study|No fertilization|0|||
19540908|NCT01210144|41989861|FG000|Overall Study|No transfer|1|||
19457578|NCT01453725|41710457|FG000|Overall Study|Adverse Event|3|||
19457579|NCT01453725|41710458|FG001|Overall Study|Adverse Event|3|||
19457580|NCT01453725|41710457|FG000|Overall Study|Lost to Follow-up|4|||
19457581|NCT01453725|41710458|FG001|Overall Study|Lost to Follow-up|0|||
19457582|NCT01453725|41710457|FG000|Overall Study|Non-compliance With Protocol|1|||
19457583|NCT01453725|41710458|FG001|Overall Study|Non-compliance With Protocol|2|||
19540909|NCT01210144|41989862|FG001|Overall Study|No transfer|0|||
19540910|NCT01209949|41989869|FG000|Overall Study|Lost to Follow-up|3|||
19540911|NCT01209832|41989873|FG000|Period 1|Sponsor Decision and was not dosed|1|||
19540912|NCT01209832|41989873|FG000|Period 2|Sponsor Decision|1|||
19457584|NCT01453725|41710457|FG000|Overall Study|Protocol Violation|1|||
19457585|NCT01453725|41710458|FG001|Overall Study|Protocol Violation|0|||
19457586|NCT01453725|41710457|FG000|Overall Study|Withdrawal by Subject|2|||
19457587|NCT01453725|41710458|FG001|Overall Study|Withdrawal by Subject|3|||
19457588|NCT01453725|41710457|FG000|Overall Study|Pregnancy Wish|0|||
19540913|NCT01230892|41989886|FG000|Overall Study|Withdrawal by Subject|1|||
19540914|NCT01230892|41989887|FG001|Overall Study|Withdrawal by Subject|1|||
19540915|NCT01230892|41989886|FG000|Overall Study|Lost to Follow-up|2|||
19540916|NCT01230892|41989887|FG001|Overall Study|Lost to Follow-up|0|||
19540917|NCT01230814|41989895|FG000|Overall Study|Lost to Follow-up|11|||
19540918|NCT01230814|41989896|FG001|Overall Study|Lost to Follow-up|3|||
19540919|NCT01230814|41989895|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
19540920|NCT01230814|41989896|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
19540921|NCT01230307|41989904|FG000|Overall Study|LVAD Placement|0|||
19540922|NCT01230307|41989905|FG001|Overall Study|LVAD Placement|2|||
19540923|NCT01209598|41989913|FG000|Overall Study|Withdrawal by Subject|1|||
19540924|NCT01209598|41989914|FG001|Overall Study|Withdrawal by Subject|0|||
19540925|NCT01209520|41989921|FG000|Overall Study|Withdrawal by Subject|3|||
19540926|NCT01209325|41989925|FG000|Overall Study|Lost to Follow-up|24|||
19540927|NCT01209325|41989925|FG000|Overall Study|Adverse Event|1|||
19540928|NCT01209325|41989925|FG000|Overall Study|Relocated|3|||
19540929|NCT01209325|41989925|FG000|Overall Study|Refusal after starting therapy|8|||
19540930|NCT01209325|41989925|FG000|Overall Study|Protocol Violation|4|||
19540931|NCT01209325|41989925|FG000|Overall Study|Refusal prior to therapy|1|||
19540932|NCT01209325|41989925|FG000|Overall Study|Incarceration|2|||
19540933|NCT01209286|41989963|FG000|Overall Study|Adverse Event|4|||
19540934|NCT01209286|41989964|FG001|Overall Study|Adverse Event|3|||
19540935|NCT01209286|41989965|FG002|Overall Study|Adverse Event|1|||
19540936|NCT01209286|41989963|FG000|Overall Study|Hematological Relapse After Remission|0|||
19540937|NCT01209286|41989964|FG001|Overall Study|Hematological Relapse After Remission|1|||
19540938|NCT01209286|41989965|FG002|Overall Study|Hematological Relapse After Remission|1|||
19540939|NCT01209286|41989963|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
19540940|NCT01209286|41989964|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
19540941|NCT01209286|41989965|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
19540942|NCT01209286|41989963|FG000|Overall Study|Physician Decision|0|||
19540943|NCT01209286|41989964|FG001|Overall Study|Physician Decision|2|||
19540944|NCT01209286|41989965|FG002|Overall Study|Physician Decision|0|||
19540945|NCT01209286|41989963|FG000|Overall Study|Other|0|||
19540946|NCT01209286|41989964|FG001|Overall Study|Other|1|||
19540947|NCT01209286|41989965|FG002|Overall Study|Other|0|||
19540948|NCT01208233|41989988|FG000|Overall Study|Adverse Event|0|||
19540949|NCT01208233|41989989|FG001|Overall Study|Adverse Event|1|||
19540950|NCT01208233|41989990|FG002|Overall Study|Adverse Event|2|||
19540951|NCT01208233|41989991|FG003|Overall Study|Adverse Event|0|||
19540952|NCT01208233|41989992|FG004|Overall Study|Adverse Event|3|||
19540953|NCT01208233|41989993|FG005|Overall Study|Adverse Event|5|||
19540954|NCT01208233|41989988|FG000|Overall Study|Death|0|||
19540955|NCT01208233|41989989|FG001|Overall Study|Death|0|||
19540956|NCT01208233|41989990|FG002|Overall Study|Death|0|||
19540957|NCT01208233|41989991|FG003|Overall Study|Death|0|||
19540958|NCT01208233|41989992|FG004|Overall Study|Death|3|||
19540959|NCT01208233|41989993|FG005|Overall Study|Death|5|||
19540960|NCT01208233|41989988|FG000|Overall Study|Did not meet entrance criteria|2|||
19540961|NCT01208233|41989989|FG001|Overall Study|Did not meet entrance criteria|1|||
19540962|NCT01208233|41989990|FG002|Overall Study|Did not meet entrance criteria|1|||
19540963|NCT01208233|41989991|FG003|Overall Study|Did not meet entrance criteria|0|||
19540964|NCT01208233|41989992|FG004|Overall Study|Did not meet entrance criteria|1|||
19540965|NCT01208233|41989993|FG005|Overall Study|Did not meet entrance criteria|0|||
19540966|NCT01208233|41989988|FG000|Overall Study|Medication error without adverse event|0|||
19540967|NCT01208233|41989989|FG001|Overall Study|Medication error without adverse event|0|||
19540968|NCT01208233|41989990|FG002|Overall Study|Medication error without adverse event|0|||
19540969|NCT01208233|41989991|FG003|Overall Study|Medication error without adverse event|0|||
19540970|NCT01208233|41989992|FG004|Overall Study|Medication error without adverse event|0|||
19540971|NCT01208233|41989993|FG005|Overall Study|Medication error without adverse event|1|||
19540972|NCT01208233|41989988|FG000|Overall Study|Study terminated by sponsor|0|||
19540973|NCT01208233|41989989|FG001|Overall Study|Study terminated by sponsor|0|||
19631565|NCT00836693|42080937|FG001|Overall Study|Lost to Follow-up|0|||
19631566|NCT00770484|42080945|FG000|Overall Study|Withdrawal by Subject|1|||
19631567|NCT00770484|42080946|FG001|Overall Study|Withdrawal by Subject|0|||
19631568|NCT00835679|42080956|FG000|Overall Study|Withdrawal by Subject|1|||
19631569|NCT00835679|42080957|FG001|Overall Study|Withdrawal by Subject|0|||
19631570|NCT00835679|42080958|FG002|Overall Study|Withdrawal by Subject|0|||
19631571|NCT00835679|42080959|FG003|Overall Study|Withdrawal by Subject|0|||
19540974|NCT01208233|41989990|FG002|Overall Study|Study terminated by sponsor|0|||
19540975|NCT01208233|41989991|FG003|Overall Study|Study terminated by sponsor|0|||
19540976|NCT01208233|41989992|FG004|Overall Study|Study terminated by sponsor|10|||
19540977|NCT01208233|41989993|FG005|Overall Study|Study terminated by sponsor|7|||
19540978|NCT01208233|41989988|FG000|Overall Study|Protocol Violation|0|||
19540979|NCT01208233|41989989|FG001|Overall Study|Protocol Violation|0|||
19540980|NCT01208233|41989990|FG002|Overall Study|Protocol Violation|0|||
19631572|NCT00766506|42080975|FG000|Overall Study|Use rescue medication after 3 hours|3|||
19540981|NCT01208233|41989991|FG003|Overall Study|Protocol Violation|0|||
19540982|NCT01208233|41989992|FG004|Overall Study|Protocol Violation|3|||
19540983|NCT01208233|41989993|FG005|Overall Study|Protocol Violation|0|||
19540984|NCT01208233|41989988|FG000|Overall Study|Other|2|||
19540985|NCT01208233|41989989|FG001|Overall Study|Other|1|||
19540986|NCT01208233|41989990|FG002|Overall Study|Other|0|||
19540987|NCT01208233|41989991|FG003|Overall Study|Other|0|||
19540988|NCT01208233|41989992|FG004|Overall Study|Other|0|||
19540989|NCT01208233|41989993|FG005|Overall Study|Other|1|||
19540990|NCT01208233|41989988|FG000|Overall Study|Withdrawal by Subject|1|||
19631573|NCT00766506|42080976|FG001|Overall Study|Use rescue medication after 3 hours|0|||
19631574|NCT00766506|42080975|FG000|Overall Study|Other|2|||
19631575|NCT00766506|42080976|FG001|Overall Study|Other|2|||
19631576|NCT00770328|42080984|FG000|Overall Study|Adverse Event|11|||
19631577|NCT00770328|42080985|FG001|Overall Study|Adverse Event|2|||
19631578|NCT00770328|42080984|FG000|Overall Study|Lost to Follow-up|2|||
19631579|NCT00770328|42080985|FG001|Overall Study|Lost to Follow-up|2|||
19631580|NCT00766038|42080993|FG000|Overall Study|Lost to Follow-up|15|||
19631581|NCT00766038|42080994|FG001|Overall Study|Lost to Follow-up|14|||
19631582|NCT00765882|42081005|FG000|Overall Study|Adverse Event|10|||
19631583|NCT00765882|42081006|FG001|Overall Study|Adverse Event|21|||
19631584|NCT00765882|42081007|FG002|Overall Study|Adverse Event|20|||
19631585|NCT00765882|42081005|FG000|Overall Study|Lack of Efficacy|4|||
19631586|NCT00765882|42081006|FG001|Overall Study|Lack of Efficacy|0|||
19631587|NCT00765882|42081007|FG002|Overall Study|Lack of Efficacy|1|||
19631588|NCT00765882|42081005|FG000|Overall Study|Protocol Violation|4|||
19631589|NCT00765882|42081006|FG001|Overall Study|Protocol Violation|3|||
19631590|NCT00765882|42081007|FG002|Overall Study|Protocol Violation|1|||
19631591|NCT00765882|42081005|FG000|Overall Study|Withdrawal by Subject|2|||
19631592|NCT00765882|42081006|FG001|Overall Study|Withdrawal by Subject|6|||
19631593|NCT00765882|42081007|FG002|Overall Study|Withdrawal by Subject|6|||
19631594|NCT00765882|42081005|FG000|Overall Study|Lost to Follow-up|1|||
19631595|NCT00765882|42081006|FG001|Overall Study|Lost to Follow-up|9|||
19631596|NCT00765882|42081007|FG002|Overall Study|Lost to Follow-up|6|||
19631597|NCT00765882|42081005|FG000|Overall Study|Other Reason|3|||
19631598|NCT00765882|42081006|FG001|Overall Study|Other Reason|1|||
19631599|NCT00765882|42081007|FG002|Overall Study|Other Reason|2|||
19631600|NCT00769860|42081017|FG000|Overall Study|Withdrawal by Subject|2|||
19631601|NCT00769860|42081018|FG001|Overall Study|Withdrawal by Subject|0|||
19631602|NCT00858143|42081024|FG000|Overall Study|Adverse Event|16|||
19631603|NCT00858143|42081024|FG000|Overall Study|Lack of Efficacy|4|||
19631604|NCT00858143|42081024|FG000|Overall Study|Death|7|||
19631605|NCT00858143|42081024|FG000|Overall Study|Other|23|||
19631606|NCT00828113|42081030|FG000|Overall Study|Withdrawal by Subject|27|||
19631607|NCT00828113|42081031|FG001|Overall Study|Withdrawal by Subject|26|||
19631608|NCT00828113|42081030|FG000|Overall Study|Lost to Follow-up|3|||
19631609|NCT00828113|42081031|FG001|Overall Study|Lost to Follow-up|5|||
19631610|NCT00769704|42081039|FG000|Overall Study|Lost to Follow-up|3|||
19631611|NCT00769704|42081040|FG001|Overall Study|Lost to Follow-up|2|||
19631612|NCT00769704|42081039|FG000|Overall Study|Death|95|||
19631613|NCT00769704|42081040|FG001|Overall Study|Death|190|||
19631614|NCT00769704|42081039|FG000|Overall Study|Withdrawal by Subject|12|||
19631615|NCT00769704|42081040|FG001|Overall Study|Withdrawal by Subject|5|||
19631616|NCT00769704|42081039|FG000|Overall Study|Other|1|||
19631617|NCT00769704|42081040|FG001|Overall Study|Other|2|||
19631618|NCT00818753|42081050|FG000|Overall Study|Protocol Violation|1|||
19711561|NCT00079274|42154663|FG006|Overall Study|Adverse Event|0|||
19711562|NCT00079274|42154657|FG000|Overall Study|Recurrence|21|||
19631619|NCT00818753|42081051|FG001|Overall Study|Protocol Violation|0|||
19631620|NCT00818753|42081052|FG002|Overall Study|Protocol Violation|0|||
19711563|NCT00079274|42154658|FG001|Overall Study|Recurrence|0|||
19711564|NCT00079274|42154659|FG002|Overall Study|Recurrence|1|||
19711565|NCT00079274|42154660|FG003|Overall Study|Recurrence|15|||
19711566|NCT00079274|42154661|FG004|Overall Study|Recurrence|0|||
19711567|NCT00079274|42154662|FG005|Overall Study|Recurrence|2|||
19711568|NCT00079274|42154663|FG006|Overall Study|Recurrence|0|||
19540991|NCT01208233|41989989|FG001|Overall Study|Withdrawal by Subject|0|||
19540992|NCT01208233|41989990|FG002|Overall Study|Withdrawal by Subject|1|||
19540993|NCT01208233|41989991|FG003|Overall Study|Withdrawal by Subject|1|||
19631621|NCT00818753|42081050|FG000|Overall Study|Other reason (not specified)|0|||
19631622|NCT00818753|42081051|FG001|Overall Study|Other reason (not specified)|0|||
19631623|NCT00818753|42081052|FG002|Overall Study|Other reason (not specified)|1|||
19631624|NCT00818753|42081050|FG000|Overall Study|Randomised and not treated|2|||
19631625|NCT00818753|42081051|FG001|Overall Study|Randomised and not treated|0|||
19631626|NCT00818753|42081052|FG002|Overall Study|Randomised and not treated|0|||
19631627|NCT00765726|42081060|FG000|Overall Study|Withdrawal by Subject|1|||
19631628|NCT00765726|42081060|FG000|Overall Study|Discontinuation of study by sponsor|8|||
19540994|NCT01208233|41989992|FG004|Overall Study|Withdrawal by Subject|4|||
19631629|NCT00765336|42081066|FG000|Overall Study|Protocol Violation|4|||
19631630|NCT00765336|42081067|FG001|Overall Study|Protocol Violation|2|||
19711569|NCT00079274|42154657|FG000|Overall Study|Alternate Treatment|6|||
19540995|NCT01208233|41989993|FG005|Overall Study|Withdrawal by Subject|2|||
19540996|NCT01208038|41990013|FG000|Overall Study|Withdrawal by Subject|1|||
19540997|NCT01207687|41990017|FG000|Overall Study|Adverse Event|1|||
19540998|NCT01207687|41990017|FG000|Overall Study|Withdrawal by Subject|1|||
19540999|NCT01207453|41990029|FG000|First Intervention|Adverse Event|2|||
19541000|NCT01207453|41990030|FG001|First Intervention|Adverse Event|1|||
19541001|NCT01207453|41990029|FG000|Washout|Adverse Event|1|||
19541002|NCT01207453|41990030|FG001|Washout|Adverse Event|0|||
19541003|NCT01207453|41990029|FG000|Washout|Lost to Follow-up|1|||
19541004|NCT01207453|41990030|FG001|Washout|Lost to Follow-up|0|||
19541005|NCT01207453|41990029|FG000|2nd Intervention|Adverse Event|1|||
19541006|NCT01207453|41990030|FG001|2nd Intervention|Adverse Event|2|||
19541007|NCT01207453|41990029|FG000|2nd Intervention|Lost to Follow-up|1|||
19541008|NCT01207453|41990030|FG001|2nd Intervention|Lost to Follow-up|0|||
19541009|NCT01207414|41990041|FG000|Overall Study|Adverse Event|25|||
19541010|NCT01207414|41990042|FG001|Overall Study|Adverse Event|39|||
19541011|NCT01207414|41990041|FG000|Overall Study|Abnormal test procedure results|0|||
19541012|NCT01207414|41990042|FG001|Overall Study|Abnormal test procedure results|1|||
19541013|NCT01207414|41990041|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
19631631|NCT00765336|42081066|FG000|Overall Study|Withdrawal by Subject|6|||
19631632|NCT00765336|42081067|FG001|Overall Study|Withdrawal by Subject|4|||
19631633|NCT00765336|42081066|FG000|Overall Study|Lost to Follow-up|7|||
19631634|NCT00765336|42081067|FG001|Overall Study|Lost to Follow-up|9|||
19631635|NCT00765336|42081066|FG000|Overall Study|Adverse Event|2|||
19631636|NCT00765336|42081067|FG001|Overall Study|Adverse Event|1|||
19631637|NCT00818519|42081075|FG000|Overall Study|Adverse Event|2|||
19631638|NCT00818519|42081076|FG001|Overall Study|Adverse Event|2|||
19631639|NCT00818519|42081075|FG000|Overall Study|Lost to Follow-up|4|||
19631640|NCT00818519|42081076|FG001|Overall Study|Lost to Follow-up|6|||
19631641|NCT00818519|42081075|FG000|Overall Study|Protocol Violation|2|||
19631642|NCT00818519|42081076|FG001|Overall Study|Protocol Violation|1|||
19631643|NCT00818519|42081075|FG000|Overall Study|Pregnancy|0|||
19631644|NCT00818519|42081076|FG001|Overall Study|Pregnancy|1|||
19631645|NCT00818519|42081075|FG000|Overall Study|Withdrawal by Subject|4|||
19631646|NCT00818519|42081076|FG001|Overall Study|Withdrawal by Subject|9|||
19631647|NCT00818519|42081075|FG000|Overall Study|participant recovered completely|1|||
19631648|NCT00818519|42081076|FG001|Overall Study|participant recovered completely|0|||
19631649|NCT00818519|42081075|FG000|Overall Study|participant will leave for long tme|1|||
19631650|NCT00818519|42081076|FG001|Overall Study|participant will leave for long tme|0|||
19631651|NCT00827567|42081082|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
19631652|NCT00765102|42081086|FG000|Overall Study|Progressive disease|18|||
19631653|NCT00765102|42081086|FG000|Overall Study|Adverse Event|6|||
19631654|NCT00765102|42081086|FG000|Overall Study|Physician Decision|4|||
19631655|NCT00765102|42081086|FG000|Overall Study|Withdrawal by Subject|2|||
19631656|NCT00765102|42081086|FG000|Overall Study|Protocol Violation|1|||
19631657|NCT00809354|42081102|FG000|Overall Study|Adverse Event|32|||
19631658|NCT00809354|42081103|FG001|Overall Study|Adverse Event|45|||
19631659|NCT00809354|42081104|FG002|Overall Study|Adverse Event|37|||
19631660|NCT00809354|42081105|FG003|Overall Study|Adverse Event|53|||
19631661|NCT00809354|42081106|FG004|Overall Study|Adverse Event|26|||
19631662|NCT00809354|42081107|FG005|Overall Study|Adverse Event|33|||
19631663|NCT00809354|42081108|FG006|Overall Study|Adverse Event|44|||
19631664|NCT00809354|42081109|FG007|Overall Study|Adverse Event|40|||
19631665|NCT00809354|42081110|FG008|Overall Study|Adverse Event|46|||
19631666|NCT00809354|42081111|FG009|Overall Study|Adverse Event|26|||
19631667|NCT00809354|42081102|FG000|Overall Study|Lack of Efficacy|23|||
19631668|NCT00809354|42081103|FG001|Overall Study|Lack of Efficacy|23|||
19631669|NCT00809354|42081104|FG002|Overall Study|Lack of Efficacy|22|||
19631670|NCT00809354|42081105|FG003|Overall Study|Lack of Efficacy|15|||
19631671|NCT00809354|42081106|FG004|Overall Study|Lack of Efficacy|40|||
19631672|NCT00809354|42081107|FG005|Overall Study|Lack of Efficacy|19|||
19631673|NCT00809354|42081108|FG006|Overall Study|Lack of Efficacy|21|||
19631674|NCT00809354|42081109|FG007|Overall Study|Lack of Efficacy|15|||
19631675|NCT00809354|42081110|FG008|Overall Study|Lack of Efficacy|18|||
19631676|NCT00809354|42081111|FG009|Overall Study|Lack of Efficacy|38|||
19631677|NCT00809354|42081102|FG000|Overall Study|Lost to Follow-up|10|||
19631678|NCT00809354|42081103|FG001|Overall Study|Lost to Follow-up|11|||
19541014|NCT01207414|41990042|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
19541015|NCT01207414|41990041|FG000|Overall Study|Patient withdrew consent|14|||
19631679|NCT00809354|42081104|FG002|Overall Study|Lost to Follow-up|8|||
19541016|NCT01207414|41990042|FG001|Overall Study|Patient withdrew consent|11|||
19541017|NCT01207414|41990041|FG000|Overall Study|Lost to Follow-up|15|||
19541018|NCT01207414|41990042|FG001|Overall Study|Lost to Follow-up|17|||
19541019|NCT01207414|41990041|FG000|Overall Study|Administrative problems|1|||
19631680|NCT00809354|42081105|FG003|Overall Study|Lost to Follow-up|13|||
19631681|NCT00809354|42081106|FG004|Overall Study|Lost to Follow-up|6|||
19631682|NCT00809354|42081107|FG005|Overall Study|Lost to Follow-up|2|||
19631683|NCT00809354|42081108|FG006|Overall Study|Lost to Follow-up|0|||
19541020|NCT01207414|41990042|FG001|Overall Study|Administrative problems|1|||
19541021|NCT01207414|41990041|FG000|Overall Study|Protocol deviation|12|||
19541022|NCT01207414|41990042|FG001|Overall Study|Protocol deviation|9|||
19541023|NCT01207414|41990041|FG000|Overall Study|Randomized in error|1|||
19541024|NCT01207414|41990042|FG001|Overall Study|Randomized in error|0|||
19541025|NCT01207219|41990051|FG000|Overall Study|changed diagnosis during study period|5|||
19541026|NCT01207219|41990052|FG001|Overall Study|changed diagnosis during study period|3|||
19541027|NCT01207219|41990053|FG002|Overall Study|changed diagnosis during study period|1|||
19541028|NCT01207219|41990051|FG000|Overall Study|Lost to Follow-up|6|||
19541029|NCT01207219|41990052|FG001|Overall Study|Lost to Follow-up|8|||
19541030|NCT01207219|41990053|FG002|Overall Study|Lost to Follow-up|6|||
19541031|NCT01207102|41990061|FG000|Overall Study|Withdrawal by Subject|5|||
19541032|NCT01207102|41990061|FG000|Overall Study|Adverse Event|2|||
19541033|NCT01207102|41990061|FG000|Overall Study|progression|2|||
19541034|NCT01207102|41990061|FG000|Overall Study|Withdrawal by Treating Physician|1|||
19541035|NCT01206517|41990071|FG000|Overall Study|Withdrawal by Subject|0|||
19541036|NCT01206517|41990072|FG001|Overall Study|Withdrawal by Subject|0|||
19541037|NCT01206517|41990073|FG002|Overall Study|Withdrawal by Subject|2|||
19541038|NCT01206517|41990074|FG003|Overall Study|Withdrawal by Subject|0|||
19541039|NCT01206517|41990075|FG004|Overall Study|Withdrawal by Subject|1|||
19541040|NCT01206517|41990076|FG005|Overall Study|Withdrawal by Subject|0|||
19541041|NCT01206439|41990087|FG000|Overall Study|subject did not meet inclusion criteria|1|||
19541042|NCT01206322|41990093|FG000|Overall Study|Adverse Event|0|||
19541043|NCT01206322|41990094|FG001|Overall Study|Adverse Event|0|||
19541044|NCT01206322|41990095|FG002|Overall Study|Adverse Event|0|||
19541045|NCT01206322|41990096|FG003|Overall Study|Adverse Event|1|||
19541046|NCT01206166|41990108|FG000|Overall Study|No evaluable data|2|||
19541047|NCT01206166|41990109|FG001|Overall Study|No evaluable data|3|||
19541048|NCT01205776|41990130|FG000|Overall Study|Lost to Follow-up|53|||
19541049|NCT01205776|41990131|FG001|Overall Study|Lost to Follow-up|61|||
19541050|NCT01205776|41990130|FG000|Overall Study|Withdrawal by Subject|11|||
19541051|NCT01205776|41990131|FG001|Overall Study|Withdrawal by Subject|34|||
19541052|NCT01205581|41990143|FG000|Overall Study|Withdrawal by Subject|1|||
19541053|NCT01205581|41990144|FG001|Overall Study|Withdrawal by Subject|0|||
19541054|NCT01205581|41990145|FG002|Overall Study|Withdrawal by Subject|0|||
19457589|NCT01453725|41710458|FG001|Overall Study|Pregnancy Wish|2|||
19457590|NCT01453725|41710457|FG000|Overall Study|Pregnancy|1|||
19457591|NCT01453725|41710458|FG001|Overall Study|Pregnancy|0|||
19541055|NCT01205581|41990146|FG003|Overall Study|Withdrawal by Subject|0|||
19541056|NCT01205581|41990147|FG004|Overall Study|Withdrawal by Subject|0|||
19541057|NCT01205581|41990148|FG005|Overall Study|Withdrawal by Subject|0|||
19541058|NCT01205269|41990179|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
19541059|NCT01205269|41990180|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
19457592|NCT01453725|41710457|FG000|Overall Study|Physician Decision|1|||
19457593|NCT01453725|41710458|FG001|Overall Study|Physician Decision|1|||
19457594|NCT01415349|41710497|FG000|Treatment Period 1|Adverse Event|0|||
19457595|NCT01415349|41710498|FG001|Treatment Period 1|Adverse Event|1|||
19457596|NCT01415349|41710497|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19457597|NCT01415349|41710498|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19457598|NCT01453023|41710552|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
19457599|NCT01453023|41710553|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
19457600|NCT01453023|41710552|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
19457601|NCT01453023|41710553|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
19457602|NCT01453023|41710552|FG000|Treatment Period 2|Protocol Violation|0|||
19457603|NCT01453023|41710553|FG001|Treatment Period 2|Protocol Violation|1|||
19457604|NCT01452789|41710561|FG000|Overall Study|Withdrawal by Subject|3|||
19457605|NCT01452789|41710562|FG001|Overall Study|Withdrawal by Subject|2|||
19457606|NCT01451931|41710571|FG000|Overall Study|Lost to Follow-up|17|||
19457607|NCT01451931|41710572|FG001|Overall Study|Lost to Follow-up|36|||
19457608|NCT01451931|41710573|FG002|Overall Study|Lost to Follow-up|21|||
19457609|NCT01451931|41710571|FG000|Overall Study|Withdrawal by Subject|16|||
19457610|NCT01451931|41710572|FG001|Overall Study|Withdrawal by Subject|22|||
19457611|NCT01451931|41710573|FG002|Overall Study|Withdrawal by Subject|22|||
19457612|NCT01414257|41710596|FG000|Overall Study|No Visit After First Day of Treatment|12|||
19457613|NCT01414257|41710596|FG000|Overall Study|Protocol Violation|10|||
19457614|NCT01434693|41710639|FG000|Overall Study|Adverse Event|1|||
19457615|NCT01434693|41710640|FG001|Overall Study|Adverse Event|0|||
19457616|NCT01434693|41710641|FG002|Overall Study|Adverse Event|0|||
19541060|NCT01205269|41990181|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
19541061|NCT01205269|41990182|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
19541062|NCT01205269|41990183|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
19541063|NCT01205269|41990184|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
19541064|NCT01240915|41990209|FG000|Overall Study|Adverse Event|0|||
19541065|NCT01240915|41990210|FG001|Overall Study|Adverse Event|0|||
19541066|NCT01240915|41990211|FG002|Overall Study|Adverse Event|0|||
19541067|NCT01240915|41990212|FG003|Overall Study|Adverse Event|1|||
19541068|NCT01240915|41990213|FG004|Overall Study|Adverse Event|0|||
19541069|NCT01240915|41990214|FG005|Overall Study|Adverse Event|2|||
19541070|NCT01240915|41990215|FG006|Overall Study|Adverse Event|0|||
19541071|NCT01240915|41990216|FG007|Overall Study|Adverse Event|0|||
19541072|NCT01240915|41990217|FG008|Overall Study|Adverse Event|1|||
19541073|NCT01240915|41990209|FG000|Overall Study|Lost to Follow-up|0|||
19541074|NCT01240915|41990210|FG001|Overall Study|Lost to Follow-up|0|||
19541075|NCT01240915|41990211|FG002|Overall Study|Lost to Follow-up|0|||
19541076|NCT01240915|41990212|FG003|Overall Study|Lost to Follow-up|0|||
19541077|NCT01240915|41990213|FG004|Overall Study|Lost to Follow-up|1|||
19541078|NCT01240915|41990214|FG005|Overall Study|Lost to Follow-up|1|||
19541079|NCT01240915|41990215|FG006|Overall Study|Lost to Follow-up|0|||
19541080|NCT01240915|41990216|FG007|Overall Study|Lost to Follow-up|1|||
19541081|NCT01240915|41990217|FG008|Overall Study|Lost to Follow-up|1|||
19541082|NCT01240915|41990209|FG000|Overall Study|Withdrawal by Subject|2|||
19541083|NCT01240915|41990210|FG001|Overall Study|Withdrawal by Subject|1|||
19541084|NCT01240915|41990211|FG002|Overall Study|Withdrawal by Subject|0|||
19541085|NCT01240915|41990212|FG003|Overall Study|Withdrawal by Subject|2|||
19541086|NCT01240915|41990213|FG004|Overall Study|Withdrawal by Subject|0|||
19541087|NCT01240915|41990214|FG005|Overall Study|Withdrawal by Subject|4|||
19541088|NCT01240915|41990215|FG006|Overall Study|Withdrawal by Subject|2|||
19541089|NCT01240915|41990216|FG007|Overall Study|Withdrawal by Subject|3|||
19541090|NCT01240915|41990217|FG008|Overall Study|Withdrawal by Subject|3|||
19541091|NCT01240915|41990209|FG000|Overall Study|Other|0|||
19541092|NCT01240915|41990210|FG001|Overall Study|Other|0|||
19541093|NCT01240915|41990211|FG002|Overall Study|Other|0|||
19541094|NCT01240915|41990212|FG003|Overall Study|Other|0|||
19541095|NCT01240915|41990213|FG004|Overall Study|Other|2|||
19541096|NCT01240915|41990214|FG005|Overall Study|Other|0|||
19541097|NCT01240915|41990215|FG006|Overall Study|Other|0|||
19541098|NCT01240915|41990216|FG007|Overall Study|Other|0|||
19541099|NCT01240915|41990217|FG008|Overall Study|Other|0|||
19541100|NCT01240915|41990209|FG000|Overall Study|Insufficient Clinical Response|0|||
19541101|NCT01240915|41990210|FG001|Overall Study|Insufficient Clinical Response|0|||
19541102|NCT01240915|41990211|FG002|Overall Study|Insufficient Clinical Response|0|||
19541103|NCT01240915|41990212|FG003|Overall Study|Insufficient Clinical Response|0|||
19541104|NCT01240915|41990213|FG004|Overall Study|Insufficient Clinical Response|1|||
19541105|NCT01240915|41990214|FG005|Overall Study|Insufficient Clinical Response|3|||
19541106|NCT01240915|41990215|FG006|Overall Study|Insufficient Clinical Response|6|||
19541107|NCT01240915|41990216|FG007|Overall Study|Insufficient Clinical Response|0|||
19541108|NCT01240915|41990217|FG008|Overall Study|Insufficient Clinical Response|3|||
19631684|NCT00809354|42081109|FG007|Overall Study|Lost to Follow-up|5|||
19631685|NCT00809354|42081110|FG008|Overall Study|Lost to Follow-up|4|||
19631686|NCT00809354|42081111|FG009|Overall Study|Lost to Follow-up|0|||
19631687|NCT00809354|42081102|FG000|Overall Study|Protocol Violation|7|||
19631688|NCT00809354|42081103|FG001|Overall Study|Protocol Violation|14|||
19631689|NCT00809354|42081104|FG002|Overall Study|Protocol Violation|14|||
19631690|NCT00809354|42081105|FG003|Overall Study|Protocol Violation|12|||
19631691|NCT00809354|42081106|FG004|Overall Study|Protocol Violation|14|||
19631692|NCT00809354|42081107|FG005|Overall Study|Protocol Violation|6|||
19631693|NCT00809354|42081108|FG006|Overall Study|Protocol Violation|4|||
19631694|NCT00809354|42081109|FG007|Overall Study|Protocol Violation|6|||
19631695|NCT00809354|42081110|FG008|Overall Study|Protocol Violation|9|||
19631696|NCT00809354|42081111|FG009|Overall Study|Protocol Violation|3|||
19631697|NCT00809354|42081102|FG000|Overall Study|Withdrawal by Subject|32|||
19631698|NCT00809354|42081103|FG001|Overall Study|Withdrawal by Subject|27|||
19631699|NCT00809354|42081104|FG002|Overall Study|Withdrawal by Subject|31|||
19631700|NCT00809354|42081105|FG003|Overall Study|Withdrawal by Subject|33|||
19631701|NCT00809354|42081106|FG004|Overall Study|Withdrawal by Subject|34|||
19631702|NCT00809354|42081107|FG005|Overall Study|Withdrawal by Subject|29|||
19631703|NCT00809354|42081108|FG006|Overall Study|Withdrawal by Subject|27|||
19631704|NCT00809354|42081109|FG007|Overall Study|Withdrawal by Subject|19|||
19631705|NCT00809354|42081110|FG008|Overall Study|Withdrawal by Subject|18|||
19631706|NCT00809354|42081111|FG009|Overall Study|Withdrawal by Subject|20|||
19631707|NCT00809354|42081102|FG000|Overall Study|Other|10|||
19631708|NCT00809354|42081103|FG001|Overall Study|Other|2|||
19631709|NCT00809354|42081104|FG002|Overall Study|Other|7|||
19631710|NCT00809354|42081105|FG003|Overall Study|Other|10|||
19631711|NCT00809354|42081106|FG004|Overall Study|Other|5|||
19541109|NCT01239745|41990239|FG000|Overall Study|Study terminated by sponsor|45|||
19541110|NCT01239745|41990239|FG000|Overall Study|Adverse Event|1|||
19541111|NCT01239472|41990245|FG000|Overall Study|Withdrawal by Subject|5|||
19541112|NCT01239472|41990246|FG001|Overall Study|Withdrawal by Subject|1|||
19541113|NCT01239472|41990245|FG000|Overall Study|Adverse Event|0|||
19541114|NCT01239472|41990246|FG001|Overall Study|Adverse Event|1|||
19541115|NCT01239472|41990245|FG000|Overall Study|Lack of Efficacy|0|||
19541116|NCT01239472|41990246|FG001|Overall Study|Lack of Efficacy|1|||
19541117|NCT01239394|41990254|FG000|Overall Study|Adverse Event|1|||
19541118|NCT01229449|41990263|FG000|Overall Study|Withdrawal by Subject|0|||
19631712|NCT00809354|42081107|FG005|Overall Study|Other|3|||
19541119|NCT01229449|41990264|FG001|Overall Study|Withdrawal by Subject|3|||
19541120|NCT01229449|41990265|FG002|Overall Study|Withdrawal by Subject|0|||
19541121|NCT01229449|41990266|FG003|Overall Study|Withdrawal by Subject|1|||
19541122|NCT01229449|41990267|FG004|Overall Study|Withdrawal by Subject|1|||
19541123|NCT01229449|41990263|FG000|Overall Study|Lost to Follow-up|1|||
19541124|NCT01229449|41990264|FG001|Overall Study|Lost to Follow-up|1|||
19541125|NCT01229449|41990265|FG002|Overall Study|Lost to Follow-up|1|||
19541126|NCT01229449|41990266|FG003|Overall Study|Lost to Follow-up|0|||
19541127|NCT01229449|41990267|FG004|Overall Study|Lost to Follow-up|0|||
19541128|NCT01229449|41990263|FG000|Overall Study|Physician Decision|0|||
19541129|NCT01229449|41990264|FG001|Overall Study|Physician Decision|0|||
19541130|NCT01229449|41990265|FG002|Overall Study|Physician Decision|1|||
19541131|NCT01229449|41990266|FG003|Overall Study|Physician Decision|0|||
19541132|NCT01229449|41990267|FG004|Overall Study|Physician Decision|0|||
19541133|NCT01239316|41990279|FG000|Overall Study|Progression/Relapse|11|||
19541134|NCT01239316|41990279|FG000|Overall Study|Adverse Event|1|||
19541135|NCT01239160|41990285|FG000|Overall Study|Lost to Follow-up|3|||
19541136|NCT01239160|41990286|FG001|Overall Study|Lost to Follow-up|5|||
19541137|NCT01239160|41990287|FG002|Overall Study|Lost to Follow-up|0|||
19541138|NCT01239160|41990285|FG000|Overall Study|Withdrawal by Subject|17|||
19541139|NCT01239160|41990286|FG001|Overall Study|Withdrawal by Subject|6|||
19541140|NCT01239160|41990287|FG002|Overall Study|Withdrawal by Subject|2|||
19541141|NCT01239160|41990285|FG000|Overall Study|Physician Decision|5|||
19541142|NCT01239160|41990286|FG001|Overall Study|Physician Decision|7|||
19541143|NCT01239160|41990287|FG002|Overall Study|Physician Decision|2|||
19541144|NCT01239160|41990285|FG000|Overall Study|Early Termination Due to Study Closure|0|||
19541145|NCT01239160|41990286|FG001|Overall Study|Early Termination Due to Study Closure|1|||
19541146|NCT01239160|41990287|FG002|Overall Study|Early Termination Due to Study Closure|6|||
19541147|NCT01239121|41990296|FG000|Overall Study|Withdrawal by Subject|2|||
19541148|NCT01239121|41990297|FG001|Overall Study|Withdrawal by Subject|4|||
19541149|NCT01239121|41990298|FG002|Overall Study|Withdrawal by Subject|0|||
19541150|NCT01239043|41990308|FG000|Overall Study|Protocol Violation|2|||
19541151|NCT01239043|41990309|FG001|Overall Study|Protocol Violation|1|||
19541152|NCT01238848|41990317|FG000|Overall Study|Physician Decision|13|||
19541153|NCT01238848|41990318|FG001|Overall Study|Physician Decision|5|||
19541154|NCT01238575|41990326|FG000|Overall Study|Lack of Efficacy|2|||
19541155|NCT01238575|41990327|FG001|Overall Study|Lack of Efficacy|4|||
19541156|NCT01238575|41990326|FG000|Overall Study|Adverse Event|2|||
19541157|NCT01238575|41990327|FG001|Overall Study|Adverse Event|0|||
19541158|NCT01237951|41990333|FG000|Overall Study|Death|1|||
19541159|NCT01237678|41990340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
19541160|NCT01237678|41990341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
19541161|NCT01237678|41990342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
19541162|NCT01237678|41990340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
19631713|NCT00809354|42081108|FG006|Overall Study|Other|2|||
19631714|NCT00809354|42081109|FG007|Overall Study|Other|3|||
19631715|NCT00809354|42081110|FG008|Overall Study|Other|4|||
19631716|NCT00809354|42081111|FG009|Overall Study|Other|3|||
19631717|NCT00809354|42081102|FG000|Overall Study|Study terminated by sponsor|138|||
19631718|NCT00809354|42081103|FG001|Overall Study|Study terminated by sponsor|134|||
19631719|NCT00809354|42081104|FG002|Overall Study|Study terminated by sponsor|129|||
19631720|NCT00809354|42081105|FG003|Overall Study|Study terminated by sponsor|120|||
19631721|NCT00809354|42081106|FG004|Overall Study|Study terminated by sponsor|126|||
19631722|NCT00809354|42081107|FG005|Overall Study|Study terminated by sponsor|133|||
19631723|NCT00809354|42081108|FG006|Overall Study|Study terminated by sponsor|124|||
19631724|NCT00809354|42081109|FG007|Overall Study|Study terminated by sponsor|148|||
19631725|NCT00809354|42081110|FG008|Overall Study|Study terminated by sponsor|127|||
19631726|NCT00809354|42081111|FG009|Overall Study|Study terminated by sponsor|135|||
19631727|NCT00809354|42081102|FG000|Overall Study|Withdrawn due to pregnancy|0|||
19631728|NCT00809354|42081103|FG001|Overall Study|Withdrawn due to pregnancy|1|||
19631729|NCT00809354|42081104|FG002|Overall Study|Withdrawn due to pregnancy|0|||
19631730|NCT00809354|42081105|FG003|Overall Study|Withdrawn due to pregnancy|0|||
19631731|NCT00809354|42081106|FG004|Overall Study|Withdrawn due to pregnancy|0|||
19631732|NCT00809354|42081107|FG005|Overall Study|Withdrawn due to pregnancy|0|||
19631733|NCT00809354|42081108|FG006|Overall Study|Withdrawn due to pregnancy|0|||
19631734|NCT00809354|42081109|FG007|Overall Study|Withdrawn due to pregnancy|0|||
19631735|NCT00809354|42081110|FG008|Overall Study|Withdrawn due to pregnancy|0|||
19631736|NCT00809354|42081111|FG009|Overall Study|Withdrawn due to pregnancy|0|||
19631737|NCT00809354|42081102|FG000|Overall Study|Randomized but not Treated|3|||
19631738|NCT00809354|42081103|FG001|Overall Study|Randomized but not Treated|1|||
19631739|NCT00809354|42081104|FG002|Overall Study|Randomized but not Treated|6|||
19541163|NCT01237678|41990341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
19541164|NCT01237678|41990342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
19541165|NCT01237678|41990340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
19541166|NCT01237678|41990341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
19541167|NCT01237678|41990342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
19541168|NCT01237678|41990340|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
19541169|NCT01237678|41990341|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
19541170|NCT01237678|41990342|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
19541171|NCT01237678|41990340|FG000|Phase II|Adverse Event|0|||
19541172|NCT01237678|41990341|FG001|Phase II|Adverse Event|39|||
19541173|NCT01237678|41990342|FG002|Phase II|Adverse Event|9|||
19541174|NCT01237678|41990340|FG000|Phase II|Death|0|||
19541175|NCT01237678|41990341|FG001|Phase II|Death|0|||
19541176|NCT01237678|41990342|FG002|Phase II|Death|2|||
19541177|NCT01237678|41990340|FG000|Phase II|Lack of Efficacy|0|||
19541178|NCT01237678|41990341|FG001|Phase II|Lack of Efficacy|25|||
19541179|NCT01237678|41990342|FG002|Phase II|Lack of Efficacy|3|||
19541180|NCT01237678|41990340|FG000|Phase II|Withdrawal by Subject|0|||
19541181|NCT01237678|41990341|FG001|Phase II|Withdrawal by Subject|1|||
19541182|NCT01237678|41990342|FG002|Phase II|Withdrawal by Subject|5|||
19541183|NCT01237678|41990340|FG000|Phase II|Completed Cycles 4-6|0|||
19541184|NCT01237678|41990341|FG001|Phase II|Completed Cycles 4-6|11|||
19541185|NCT01237678|41990342|FG002|Phase II|Completed Cycles 4-6|21|||
19541186|NCT01237678|41990340|FG000|Phase II|Sponsor Decision/Study Closed|0|||
19541187|NCT01237678|41990341|FG001|Phase II|Sponsor Decision/Study Closed|18|||
19541188|NCT01237678|41990342|FG002|Phase II|Sponsor Decision/Study Closed|7|||
19541189|NCT01237678|41990340|FG000|Phase II|Randomized but were not treated|0|||
19541190|NCT01237678|41990341|FG001|Phase II|Randomized but were not treated|4|||
19541191|NCT01237678|41990342|FG002|Phase II|Randomized but were not treated|3|||
19541192|NCT01229371|41990365|FG000|Overall Study|Withdrawal by Subject|0|||
19541193|NCT01229371|41990366|FG001|Overall Study|Withdrawal by Subject|1|||
19541194|NCT01229371|41990367|FG002|Overall Study|Withdrawal by Subject|0|||
19541195|NCT01229371|41990368|FG003|Overall Study|Withdrawal by Subject|0|||
19541196|NCT01237327|41990380|FG000|Overall Study|Protocol Violation: Core Study|1|||
19541197|NCT01237327|41990381|FG001|Overall Study|Protocol Violation: Core Study|0|||
19457617|NCT01434693|41710642|FG003|Overall Study|Adverse Event|0|||
19457618|NCT01434693|41710639|FG000|Overall Study|Withdrawal by Subject|1|||
19457619|NCT01434693|41710640|FG001|Overall Study|Withdrawal by Subject|0|||
19457620|NCT01434693|41710641|FG002|Overall Study|Withdrawal by Subject|1|||
19457621|NCT01434693|41710642|FG003|Overall Study|Withdrawal by Subject|1|||
19457622|NCT01434693|41710639|FG000|Overall Study|Lost to Follow-up|1|||
19457623|NCT01434693|41710640|FG001|Overall Study|Lost to Follow-up|0|||
19457624|NCT01434693|41710641|FG002|Overall Study|Lost to Follow-up|0|||
19541198|NCT01237327|41990380|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
19541199|NCT01237327|41990381|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
19541200|NCT01237327|41990380|FG000|Overall Study|Progression of Disease: Core Study|18|||
19541201|NCT01237327|41990381|FG001|Overall Study|Progression of Disease: Core Study|22|||
19541202|NCT01237327|41990380|FG000|Overall Study|Progression of Disease: Extension Study|15|||
19541203|NCT01237327|41990381|FG001|Overall Study|Progression of Disease: Extension Study|13|||
19541204|NCT01237327|41990380|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
19541205|NCT01237327|41990381|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
19541206|NCT01237327|41990380|FG000|Overall Study|Withdrawal by Subject|1|||
19541207|NCT01237327|41990381|FG001|Overall Study|Withdrawal by Subject|3|||
19541208|NCT01237327|41990380|FG000|Overall Study|Lost to Follow-up|3|||
19541209|NCT01237327|41990381|FG001|Overall Study|Lost to Follow-up|0|||
19541210|NCT01237054|41990387|FG000|Overall Study|imaging 10C0096|1|||
19541211|NCT01236352|41990424|FG000|Overall Study|Death|0|||
19541212|NCT01236352|41990425|FG001|Overall Study|Death|0|||
19541213|NCT01236352|41990426|FG002|Overall Study|Death|0|||
19541214|NCT01236352|41990427|FG003|Overall Study|Death|0|||
19541215|NCT01236352|41990428|FG004|Overall Study|Death|0|||
19541216|NCT01236352|41990429|FG005|Overall Study|Death|0|||
19541217|NCT01236352|41990430|FG006|Overall Study|Death|0|||
19541218|NCT01236352|41990431|FG007|Overall Study|Death|1|||
19541219|NCT01236352|41990432|FG008|Overall Study|Death|0|||
19541220|NCT01236352|41990433|FG009|Overall Study|Death|0|||
19541221|NCT01236352|41990434|FG010|Overall Study|Death|0|||
19541222|NCT01236352|41990424|FG000|Overall Study|Withdrawal by Subject|0|||
19541223|NCT01236352|41990425|FG001|Overall Study|Withdrawal by Subject|0|||
19541224|NCT01236352|41990426|FG002|Overall Study|Withdrawal by Subject|0|||
19541225|NCT01236352|41990427|FG003|Overall Study|Withdrawal by Subject|0|||
19541226|NCT01236352|41990428|FG004|Overall Study|Withdrawal by Subject|0|||
19541227|NCT01236352|41990429|FG005|Overall Study|Withdrawal by Subject|0|||
19541228|NCT01236352|41990430|FG006|Overall Study|Withdrawal by Subject|0|||
19541229|NCT01236352|41990431|FG007|Overall Study|Withdrawal by Subject|0|||
19541230|NCT01236352|41990432|FG008|Overall Study|Withdrawal by Subject|0|||
19457625|NCT01434693|41710642|FG003|Overall Study|Lost to Follow-up|0|||
19457626|NCT01451541|41710659|FG000|Overall Study|Adverse Event|4|||
19457627|NCT01451541|41710660|FG001|Overall Study|Adverse Event|3|||
19541231|NCT01236352|41990433|FG009|Overall Study|Withdrawal by Subject|2|||
19541232|NCT01236352|41990434|FG010|Overall Study|Withdrawal by Subject|1|||
19457628|NCT01451541|41710661|FG002|Overall Study|Adverse Event|6|||
19541233|NCT01236352|41990424|FG000|Overall Study|Adverse Event|0|||
19541234|NCT01236352|41990425|FG001|Overall Study|Adverse Event|0|||
19541235|NCT01236352|41990426|FG002|Overall Study|Adverse Event|0|||
19541236|NCT01236352|41990427|FG003|Overall Study|Adverse Event|0|||
19541237|NCT01236352|41990428|FG004|Overall Study|Adverse Event|0|||
19541238|NCT01236352|41990429|FG005|Overall Study|Adverse Event|0|||
19541239|NCT01236352|41990430|FG006|Overall Study|Adverse Event|2|||
19541240|NCT01236352|41990431|FG007|Overall Study|Adverse Event|0|||
19541241|NCT01236352|41990432|FG008|Overall Study|Adverse Event|0|||
19541242|NCT01236352|41990433|FG009|Overall Study|Adverse Event|4|||
19541243|NCT01236352|41990434|FG010|Overall Study|Adverse Event|1|||
19541244|NCT01236352|41990424|FG000|Overall Study|Study drug toxicity|0|||
19541245|NCT01236352|41990425|FG001|Overall Study|Study drug toxicity|0|||
19541246|NCT01236352|41990426|FG002|Overall Study|Study drug toxicity|0|||
19541247|NCT01236352|41990427|FG003|Overall Study|Study drug toxicity|0|||
19541248|NCT01236352|41990428|FG004|Overall Study|Study drug toxicity|0|||
19541249|NCT01236352|41990429|FG005|Overall Study|Study drug toxicity|1|||
19541250|NCT01236352|41990430|FG006|Overall Study|Study drug toxicity|1|||
19541251|NCT01236352|41990431|FG007|Overall Study|Study drug toxicity|0|||
19541252|NCT01236352|41990432|FG008|Overall Study|Study drug toxicity|0|||
19541253|NCT01236352|41990433|FG009|Overall Study|Study drug toxicity|2|||
19541254|NCT01236352|41990434|FG010|Overall Study|Study drug toxicity|2|||
19541255|NCT01236352|41990424|FG000|Overall Study|Disease progression|1|||
19541256|NCT01236352|41990425|FG001|Overall Study|Disease progression|2|||
19541257|NCT01236352|41990426|FG002|Overall Study|Disease progression|1|||
19541258|NCT01236352|41990427|FG003|Overall Study|Disease progression|2|||
19541259|NCT01236352|41990428|FG004|Overall Study|Disease progression|2|||
19541260|NCT01236352|41990429|FG005|Overall Study|Disease progression|2|||
19541261|NCT01236352|41990430|FG006|Overall Study|Disease progression|1|||
19541262|NCT01236352|41990431|FG007|Overall Study|Disease progression|3|||
19457629|NCT01451541|41710659|FG000|Overall Study|Lack of Efficacy|2|||
19457630|NCT01451541|41710660|FG001|Overall Study|Lack of Efficacy|0|||
19457631|NCT01451541|41710661|FG002|Overall Study|Lack of Efficacy|0|||
19457632|NCT01451541|41710659|FG000|Overall Study|Lost to Follow-up|4|||
19457633|NCT01451541|41710660|FG001|Overall Study|Lost to Follow-up|4|||
19457634|NCT01451541|41710661|FG002|Overall Study|Lost to Follow-up|7|||
19541263|NCT01236352|41990432|FG008|Overall Study|Disease progression|2|||
19541264|NCT01236352|41990433|FG009|Overall Study|Disease progression|2|||
19541265|NCT01236352|41990434|FG010|Overall Study|Disease progression|2|||
19541266|NCT01236352|41990424|FG000|Overall Study|Poor/Non-compliance|1|||
19541267|NCT01236352|41990425|FG001|Overall Study|Poor/Non-compliance|0|||
19541268|NCT01236352|41990426|FG002|Overall Study|Poor/Non-compliance|0|||
19541269|NCT01236352|41990427|FG003|Overall Study|Poor/Non-compliance|0|||
19541270|NCT01236352|41990428|FG004|Overall Study|Poor/Non-compliance|0|||
19541271|NCT01236352|41990429|FG005|Overall Study|Poor/Non-compliance|0|||
19541272|NCT01236352|41990430|FG006|Overall Study|Poor/Non-compliance|0|||
19541273|NCT01236352|41990431|FG007|Overall Study|Poor/Non-compliance|0|||
19541274|NCT01236352|41990432|FG008|Overall Study|Poor/Non-compliance|0|||
19541275|NCT01236352|41990433|FG009|Overall Study|Poor/Non-compliance|0|||
19541276|NCT01236352|41990434|FG010|Overall Study|Poor/Non-compliance|0|||
19541277|NCT01236352|41990424|FG000|Overall Study|Maximum clinical benefit|1|||
19541278|NCT01236352|41990425|FG001|Overall Study|Maximum clinical benefit|1|||
19541279|NCT01236352|41990426|FG002|Overall Study|Maximum clinical benefit|1|||
19541280|NCT01236352|41990427|FG003|Overall Study|Maximum clinical benefit|0|||
19541281|NCT01236352|41990428|FG004|Overall Study|Maximum clinical benefit|2|||
19711570|NCT00079274|42154658|FG001|Overall Study|Alternate Treatment|1|||
19457635|NCT01451541|41710659|FG000|Overall Study|Withdrawal by Subject|15|||
19457636|NCT01451541|41710660|FG001|Overall Study|Withdrawal by Subject|8|||
19457637|NCT01451541|41710661|FG002|Overall Study|Withdrawal by Subject|6|||
19457638|NCT01451541|41710659|FG000|Overall Study|randomization error, noncompliance|11|||
19457639|NCT01451541|41710660|FG001|Overall Study|randomization error, noncompliance|10|||
19457640|NCT01451541|41710661|FG002|Overall Study|randomization error, noncompliance|8|||
19457641|NCT01450761|41710789|FG000|Randomization|Subject no longer meets study criteria|1|||
19457642|NCT01450761|41710790|FG001|Randomization|Subject no longer meets study criteria|2|||
19457643|NCT01450761|41710789|FG000|Randomization|Withdrawal by Subject|2|||
19457644|NCT01450761|41710790|FG001|Randomization|Withdrawal by Subject|0|||
19457645|NCT01450761|41710789|FG000|Randomization|Disease progression|0|||
19457646|NCT01450761|41710790|FG001|Randomization|Disease progression|2|||
19457647|NCT01450761|41710789|FG000|Randomization|Adverse Event unrelated to study drug|1|||
19457648|NCT01450761|41710790|FG001|Randomization|Adverse Event unrelated to study drug|0|||
19457649|NCT01450761|41710789|FG000|Randomization|Other|0|||
19457650|NCT01450761|41710790|FG001|Randomization|Other|1|||
19457651|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Disease progression|33|||
19457652|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Disease progression|32|||
19541282|NCT01236352|41990429|FG005|Overall Study|Maximum clinical benefit|0|||
19541283|NCT01236352|41990430|FG006|Overall Study|Maximum clinical benefit|3|||
19541284|NCT01236352|41990431|FG007|Overall Study|Maximum clinical benefit|1|||
19541285|NCT01236352|41990432|FG008|Overall Study|Maximum clinical benefit|1|||
19541286|NCT01236352|41990433|FG009|Overall Study|Maximum clinical benefit|4|||
19541287|NCT01236352|41990434|FG010|Overall Study|Maximum clinical benefit|2|||
19541288|NCT01236352|41990424|FG000|Overall Study|Subject request to discontinue treatment|0|||
19541289|NCT01236352|41990425|FG001|Overall Study|Subject request to discontinue treatment|0|||
19541290|NCT01236352|41990426|FG002|Overall Study|Subject request to discontinue treatment|1|||
19541291|NCT01236352|41990427|FG003|Overall Study|Subject request to discontinue treatment|1|||
19541292|NCT01236352|41990428|FG004|Overall Study|Subject request to discontinue treatment|0|||
19541293|NCT01236352|41990429|FG005|Overall Study|Subject request to discontinue treatment|1|||
19541294|NCT01236352|41990430|FG006|Overall Study|Subject request to discontinue treatment|0|||
19541295|NCT01236352|41990431|FG007|Overall Study|Subject request to discontinue treatment|0|||
19541296|NCT01236352|41990432|FG008|Overall Study|Subject request to discontinue treatment|0|||
19541297|NCT01236352|41990433|FG009|Overall Study|Subject request to discontinue treatment|1|||
19541298|NCT01236352|41990434|FG010|Overall Study|Subject request to discontinue treatment|4|||
19541299|NCT01236352|41990424|FG000|Overall Study|Subject to receive drug via EAP|1|||
19541300|NCT01236352|41990425|FG001|Overall Study|Subject to receive drug via EAP|1|||
19541301|NCT01236352|41990426|FG002|Overall Study|Subject to receive drug via EAP|1|||
19541302|NCT01236352|41990427|FG003|Overall Study|Subject to receive drug via EAP|0|||
19541303|NCT01236352|41990428|FG004|Overall Study|Subject to receive drug via EAP|0|||
19541304|NCT01236352|41990429|FG005|Overall Study|Subject to receive drug via EAP|0|||
19541305|NCT01236352|41990430|FG006|Overall Study|Subject to receive drug via EAP|0|||
19541306|NCT01236352|41990431|FG007|Overall Study|Subject to receive drug via EAP|2|||
19541307|NCT01236352|41990432|FG008|Overall Study|Subject to receive drug via EAP|0|||
19541308|NCT01236352|41990433|FG009|Overall Study|Subject to receive drug via EAP|4|||
19541309|NCT01236352|41990434|FG010|Overall Study|Subject to receive drug via EAP|0|||
19541310|NCT01236352|41990424|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
19541311|NCT01236352|41990425|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
19541312|NCT01236352|41990426|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
19541313|NCT01236352|41990427|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
19541314|NCT01236352|41990428|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
19541315|NCT01236352|41990429|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
19541316|NCT01236352|41990430|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
19541317|NCT01236352|41990431|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
19541318|NCT01236352|41990432|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
19541319|NCT01236352|41990433|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
19541320|NCT01236352|41990434|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
19541321|NCT01236352|41990424|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541322|NCT01236352|41990425|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541323|NCT01236352|41990426|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541324|NCT01236352|41990427|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541325|NCT01236352|41990428|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541326|NCT01236352|41990429|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541327|NCT01236352|41990430|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541328|NCT01236352|41990431|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541329|NCT01236352|41990432|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541330|NCT01236352|41990433|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
19541331|NCT01236352|41990434|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
19541332|NCT01236352|41990424|FG000|Overall Study|Lack of response to drug|0|||
19541333|NCT01236352|41990425|FG001|Overall Study|Lack of response to drug|0|||
19541334|NCT01236352|41990426|FG002|Overall Study|Lack of response to drug|0|||
19541335|NCT01236352|41990427|FG003|Overall Study|Lack of response to drug|0|||
19541336|NCT01236352|41990428|FG004|Overall Study|Lack of response to drug|0|||
19541337|NCT01236352|41990429|FG005|Overall Study|Lack of response to drug|0|||
19541338|NCT01236352|41990430|FG006|Overall Study|Lack of response to drug|0|||
19541339|NCT01236352|41990431|FG007|Overall Study|Lack of response to drug|0|||
19541340|NCT01236352|41990432|FG008|Overall Study|Lack of response to drug|0|||
19541341|NCT01236352|41990433|FG009|Overall Study|Lack of response to drug|1|||
19541342|NCT01236352|41990434|FG010|Overall Study|Lack of response to drug|1|||
19541343|NCT01236352|41990424|FG000|Overall Study|Patient transferred to IST|0|||
19541344|NCT01236352|41990425|FG001|Overall Study|Patient transferred to IST|0|||
19541345|NCT01236352|41990426|FG002|Overall Study|Patient transferred to IST|0|||
19541346|NCT01236352|41990427|FG003|Overall Study|Patient transferred to IST|0|||
19541347|NCT01236352|41990428|FG004|Overall Study|Patient transferred to IST|0|||
19541348|NCT01236352|41990429|FG005|Overall Study|Patient transferred to IST|0|||
19541349|NCT01236352|41990430|FG006|Overall Study|Patient transferred to IST|0|||
19541350|NCT01236352|41990431|FG007|Overall Study|Patient transferred to IST|0|||
19541351|NCT01236352|41990432|FG008|Overall Study|Patient transferred to IST|0|||
19541352|NCT01236352|41990433|FG009|Overall Study|Patient transferred to IST|2|||
19541353|NCT01236352|41990434|FG010|Overall Study|Patient transferred to IST|6|||
19541354|NCT01236118|41990461|FG000|Overall Study|Adverse Event|2|||
19541355|NCT01236118|41990462|FG001|Overall Study|Adverse Event|0|||
19541356|NCT01236118|41990463|FG002|Overall Study|Adverse Event|2|||
19541357|NCT01236118|41990461|FG000|Overall Study|Physician Decision|0|||
19541358|NCT01236118|41990462|FG001|Overall Study|Physician Decision|1|||
19541359|NCT01236118|41990463|FG002|Overall Study|Physician Decision|0|||
19541360|NCT01236118|41990461|FG000|Overall Study|Withdrawal by Subject|0|||
19541361|NCT01236118|41990462|FG001|Overall Study|Withdrawal by Subject|0|||
19541362|NCT01236118|41990463|FG002|Overall Study|Withdrawal by Subject|1|||
19541363|NCT01236001|41990473|FG000|Overall Study|Adverse Event|5|||
19541364|NCT01236001|41990474|FG001|Overall Study|Adverse Event|14|||
19541365|NCT01236001|41990473|FG000|Overall Study|Lack of Efficacy|6|||
19541366|NCT01236001|41990474|FG001|Overall Study|Lack of Efficacy|6|||
19541367|NCT01236001|41990473|FG000|Overall Study|Lost to Follow-up|6|||
19541368|NCT01236001|41990474|FG001|Overall Study|Lost to Follow-up|1|||
19541369|NCT01236001|41990473|FG000|Overall Study|Incompliance|1|||
19541370|NCT01236001|41990474|FG001|Overall Study|Incompliance|0|||
19541371|NCT01236001|41990473|FG000|Overall Study|Planned Visit After End of Study|0|||
19541372|NCT01236001|41990474|FG001|Overall Study|Planned Visit After End of Study|1|||
19541373|NCT01229254|41990484|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
19541374|NCT01229254|41990485|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
19541375|NCT01229254|41990486|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
19541376|NCT01229254|41990484|FG000|Overall Study|Adverse Event|4|||
19541377|NCT01229254|41990485|FG001|Overall Study|Adverse Event|5|||
19541378|NCT01229254|41990486|FG002|Overall Study|Adverse Event|3|||
19541379|NCT01229254|41990484|FG000|Overall Study|Lost to Follow-up|3|||
19541380|NCT01229254|41990485|FG001|Overall Study|Lost to Follow-up|0|||
19541381|NCT01229254|41990486|FG002|Overall Study|Lost to Follow-up|1|||
19541382|NCT01229254|41990484|FG000|Overall Study|Physician Decision|0|||
19541383|NCT01229254|41990485|FG001|Overall Study|Physician Decision|3|||
19541384|NCT01229254|41990486|FG002|Overall Study|Physician Decision|0|||
19541385|NCT01229254|41990484|FG000|Overall Study|Protocol Violation|4|||
19541386|NCT01229254|41990485|FG001|Overall Study|Protocol Violation|6|||
19541387|NCT01229254|41990486|FG002|Overall Study|Protocol Violation|5|||
19541388|NCT01229254|41990484|FG000|Overall Study|Withdrawal by Subject|1|||
19541389|NCT01229254|41990485|FG001|Overall Study|Withdrawal by Subject|0|||
19541390|NCT01229254|41990486|FG002|Overall Study|Withdrawal by Subject|1|||
19541391|NCT01229254|41990484|FG000|Overall Study|Non-compliance with Study Drug|0|||
19541392|NCT01229254|41990485|FG001|Overall Study|Non-compliance with Study Drug|1|||
19541393|NCT01229254|41990486|FG002|Overall Study|Non-compliance with Study Drug|1|||
19541394|NCT01235728|41990495|FG000|Overall Study|Protocol Violation|0|||
19541395|NCT01235728|41990496|FG001|Overall Study|Protocol Violation|0|||
19457653|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
19457654|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
19457655|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
19457656|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
19457657|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
19457658|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
19457659|NCT01450761|41710789|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
19457660|NCT01450761|41710790|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
19457661|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Death|3|||
19457662|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Death|3|||
19457663|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Other|2|||
19457664|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Other|2|||
19457665|NCT01450761|41710789|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
19457666|NCT01450761|41710790|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
19457667|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
19457668|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
19457669|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
19457670|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
19457671|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
19457672|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
19457673|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
19457674|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
19541396|NCT01235728|41990497|FG002|Overall Study|Protocol Violation|0|||
19541397|NCT01235728|41990498|FG003|Overall Study|Protocol Violation|1|||
19541398|NCT01235728|41990499|FG004|Overall Study|Protocol Violation|0|||
19541399|NCT01235728|41990500|FG005|Overall Study|Protocol Violation|0|||
19541400|NCT01235728|41990501|FG006|Overall Study|Protocol Violation|0|||
19457675|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
19541401|NCT01235728|41990502|FG007|Overall Study|Protocol Violation|0|||
19541402|NCT01235689|41990512|FG000|Overall Study|Adverse Event|12|||
19541403|NCT01235689|41990513|FG001|Overall Study|Adverse Event|16|||
19541404|NCT01235689|41990512|FG000|Overall Study|Lack of Efficacy|12|||
19541405|NCT01235689|41990513|FG001|Overall Study|Lack of Efficacy|5|||
19541406|NCT01235689|41990512|FG000|Overall Study|Withdrawal by Subject|3|||
19541407|NCT01235689|41990513|FG001|Overall Study|Withdrawal by Subject|4|||
19541408|NCT01235689|41990512|FG000|Overall Study|Lost to Follow-up|1|||
19541409|NCT01235689|41990513|FG001|Overall Study|Lost to Follow-up|2|||
19541410|NCT01235689|41990512|FG000|Overall Study|Miscellaneous|1|||
19541411|NCT01235689|41990513|FG001|Overall Study|Miscellaneous|5|||
19541412|NCT01229176|41990527|FG000|Overall Study|Withdrawal by Subject|0|||
19541413|NCT01229176|41990528|FG001|Overall Study|Withdrawal by Subject|0|||
19541414|NCT01229176|41990529|FG002|Overall Study|Withdrawal by Subject|0|||
19541415|NCT01229176|41990530|FG003|Overall Study|Withdrawal by Subject|1|||
19541416|NCT01229176|41990531|FG004|Overall Study|Withdrawal by Subject|1|||
19541417|NCT01229176|41990532|FG005|Overall Study|Withdrawal by Subject|1|||
19541418|NCT01229176|41990533|FG006|Overall Study|Withdrawal by Subject|0|||
19541419|NCT01229176|41990534|FG007|Overall Study|Withdrawal by Subject|1|||
19541420|NCT01229176|41990527|FG000|Overall Study|Lost to Follow-up|0|||
19541421|NCT01229176|41990528|FG001|Overall Study|Lost to Follow-up|3|||
19541422|NCT01229176|41990529|FG002|Overall Study|Lost to Follow-up|0|||
19631740|NCT00809354|42081105|FG003|Overall Study|Randomized but not Treated|0|||
19631741|NCT00809354|42081106|FG004|Overall Study|Randomized but not Treated|5|||
19631742|NCT00809354|42081107|FG005|Overall Study|Randomized but not Treated|0|||
19631743|NCT00809354|42081108|FG006|Overall Study|Randomized but not Treated|1|||
19631744|NCT00809354|42081109|FG007|Overall Study|Randomized but not Treated|1|||
19631745|NCT00809354|42081110|FG008|Overall Study|Randomized but not Treated|2|||
19631746|NCT00809354|42081111|FG009|Overall Study|Randomized but not Treated|1|||
19631747|NCT00809354|42081102|FG000|Overall Study|Death|0|||
19457676|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
19457677|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Death|5|||
19457678|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Death|6|||
19457679|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
19457680|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
19457681|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
19457682|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
19457683|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
19457684|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
19457685|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
19457686|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
19457687|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
19457688|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
19457689|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
19457690|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
19457691|NCT01450761|41710789|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
19457692|NCT01450761|41710790|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
19457693|NCT01433991|41710840|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
19457694|NCT01433991|41710841|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
19457695|NCT01433991|41710842|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
19457696|NCT01433991|41710843|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
19457697|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
19457698|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
19457699|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
19457700|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
19457701|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
19457702|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
19457703|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
19457704|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
19457705|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
19457706|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
19457707|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
19457708|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
19457709|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
19457710|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
19457711|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
19457712|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
19457713|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
19457714|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
19541423|NCT01229176|41990530|FG003|Overall Study|Lost to Follow-up|0|||
19541424|NCT01229176|41990531|FG004|Overall Study|Lost to Follow-up|1|||
19541425|NCT01229176|41990532|FG005|Overall Study|Lost to Follow-up|1|||
19541426|NCT01229176|41990533|FG006|Overall Study|Lost to Follow-up|0|||
19541427|NCT01229176|41990534|FG007|Overall Study|Lost to Follow-up|2|||
19541428|NCT01228747|41990554|FG000|Overall Study|Adverse Event|8|||
19631748|NCT00809354|42081103|FG001|Overall Study|Death|0|||
19631749|NCT00809354|42081104|FG002|Overall Study|Death|0|||
19541429|NCT01228747|41990555|FG001|Overall Study|Adverse Event|4|||
19541430|NCT01228747|41990554|FG000|Overall Study|Lack of Efficacy|40|||
19541431|NCT01228747|41990555|FG001|Overall Study|Lack of Efficacy|27|||
19541432|NCT01228747|41990554|FG000|Overall Study|Protocol Violation|6|||
19457715|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
19457716|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
19457717|NCT01433991|41710840|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
19457718|NCT01433991|41710841|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
19457719|NCT01433991|41710842|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
19457720|NCT01433991|41710843|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
19457721|NCT01450683|41710859|FG000|Overall Study|Adverse Event|2|||
19457722|NCT01433055|41710865|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
19457723|NCT01433055|41710866|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
19457724|NCT01433055|41710865|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
19457725|NCT01433055|41710866|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
19457726|NCT01450137|41710874|FG000|Up to Week 12|Adverse Event|2|||
19457727|NCT01450137|41710875|FG001|Up to Week 12|Adverse Event|1|||
19457728|NCT01450137|41710874|FG000|Up to Week 12|Withdrawal by Subject|0|||
19457729|NCT01450137|41710875|FG001|Up to Week 12|Withdrawal by Subject|2|||
19457730|NCT01450137|41710874|FG000|Week 12 to Study End|Death|0|||
19457731|NCT01450137|41710875|FG001|Week 12 to Study End|Death|1|||
19457732|NCT01450137|41710874|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
19457733|NCT01450137|41710875|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
19457734|NCT01412229|41710881|FG000|Overall Study|Physician Decision|1|||
19457735|NCT01412151|41710886|FG000|Week 0 - 306 - Treatment Period|Death|1|||
19457736|NCT01412151|41710886|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
19457737|NCT01412151|41710886|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
19457738|NCT01412151|41710886|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
19457739|NCT01432275|41710892|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
19457740|NCT01432275|41710893|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
19457741|NCT01432275|41710892|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
19457742|NCT01432275|41710893|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
19457743|NCT01432275|41710892|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
19457744|NCT01432275|41710893|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
19457745|NCT01432275|41710892|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
19457746|NCT01432275|41710893|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
19457747|NCT01432275|41710892|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
19457748|NCT01432275|41710893|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
19457749|NCT01432275|41710892|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
19457750|NCT01432275|41710893|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
19457751|NCT01432275|41710892|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
19457752|NCT01432275|41710893|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
19457753|NCT01432275|41710892|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
19457754|NCT01432275|41710893|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
19541433|NCT01228747|41990555|FG001|Overall Study|Protocol Violation|5|||
19541434|NCT01228747|41990554|FG000|Overall Study|Lost to Follow-up|4|||
19541435|NCT01228747|41990555|FG001|Overall Study|Lost to Follow-up|3|||
19457755|NCT01432275|41710892|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
19457756|NCT01432275|41710893|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
19457757|NCT01411995|41710901|FG000|Overall Study|Failed IUD insertion|0|||
19457758|NCT01411995|41710902|FG001|Overall Study|Failed IUD insertion|1|||
19457759|NCT01411917|41710910|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
19457760|NCT01411917|41710911|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
19457761|NCT01411839|41710919|FG000|Overall Study|Lost to Follow-up|4|||
19457762|NCT01411839|41710920|FG001|Overall Study|Lost to Follow-up|3|||
19457763|NCT01411215|41710928|FG000|Overall Study|Adverse Event|1|||
19457764|NCT01411215|41710929|FG001|Overall Study|Adverse Event|2|||
19541436|NCT01228747|41990554|FG000|Overall Study|Withdrawal by Subject|5|||
19541437|NCT01228747|41990555|FG001|Overall Study|Withdrawal by Subject|1|||
19541438|NCT01228747|41990554|FG000|Overall Study|Other Reason|2|||
19541439|NCT01228747|41990555|FG001|Overall Study|Other Reason|5|||
19541440|NCT01228591|41990561|FG000|Baseline|Lack of Efficacy|1|||
19541441|NCT01228591|41990562|FG001|Baseline|Lack of Efficacy|2|||
19541442|NCT01235338|41990574|FG000|Overall Study|Adverse Event|3|||
19541443|NCT01235338|41990575|FG001|Overall Study|Adverse Event|2|||
19541444|NCT01235338|41990574|FG000|Overall Study|Protocol Violation|1|||
19541445|NCT01235338|41990575|FG001|Overall Study|Protocol Violation|1|||
19541446|NCT01235338|41990574|FG000|Overall Study|Withdrawal by Subject|5|||
19541447|NCT01235338|41990575|FG001|Overall Study|Withdrawal by Subject|0|||
19457765|NCT01411215|41710928|FG000|Overall Study|Lack of Efficacy|2|||
19457766|NCT01411215|41710929|FG001|Overall Study|Lack of Efficacy|4|||
19457767|NCT01411215|41710928|FG000|Overall Study|Lost to Follow-up|12|||
19541448|NCT01235338|41990574|FG000|Overall Study|Exclusion criteria violations|1|||
19541449|NCT01235338|41990575|FG001|Overall Study|Exclusion criteria violations|1|||
19541450|NCT01235338|41990574|FG000|Overall Study|Positive drug screen|0|||
19541451|NCT01235338|41990575|FG001|Overall Study|Positive drug screen|1|||
19541452|NCT01235338|41990574|FG000|Overall Study|Prohibited meds|1|||
19541453|NCT01235338|41990575|FG001|Overall Study|Prohibited meds|0|||
19541454|NCT01234675|41990583|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
19541455|NCT01234675|41990584|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
19541456|NCT01234675|41990583|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
19541457|NCT01234675|41990584|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
19541458|NCT01228318|41990592|FG000|Overall Study|Clinic no show to receive intervention|1|||
19541459|NCT01228318|41990593|FG001|Overall Study|Clinic no show to receive intervention|0|||
19541460|NCT01228318|41990592|FG000|Overall Study|Unable to contact|2|||
19541461|NCT01228318|41990593|FG001|Overall Study|Unable to contact|5|||
19541462|NCT01228318|41990592|FG000|Overall Study|Moved|0|||
19541463|NCT01228318|41990593|FG001|Overall Study|Moved|2|||
19541464|NCT01228318|41990592|FG000|Overall Study|Incarcerated|1|||
19541465|NCT01228318|41990593|FG001|Overall Study|Incarcerated|0|||
19541466|NCT01234480|41990599|FG000|Overall Study|Pregnancy|88|||
19541467|NCT01234480|41990599|FG000|Overall Study|>36/Normal History|50|||
19541468|NCT01234480|41990599|FG000|Overall Study|Age|3|||
19541469|NCT01234480|41990599|FG000|Overall Study|HPV Vaccine History|28|||
19541470|NCT01234480|41990599|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
19541471|NCT01234480|41990599|FG000|Overall Study|Hysterectomy|2|||
19541472|NCT01234480|41990599|FG000|Overall Study|Hysterectomy post enrollment|1|||
19541473|NCT01234480|41990599|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
19541474|NCT01234480|41990599|FG000|Overall Study|Informed Consent Form Violation|30|||
19541475|NCT01234480|41990599|FG000|Overall Study|Incorrect Visit|3|||
19541476|NCT01234480|41990599|FG000|Overall Study|No Florida Lab License|20|||
19541477|NCT01234480|41990599|FG000|Overall Study|Out of Window|42|||
19541478|NCT01234480|41990599|FG000|Overall Study|Sample Processing/Storage|92|||
19541479|NCT01234480|41990599|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
19541480|NCT01234480|41990599|FG000|Overall Study|Site/Subject non-compliance|44|||
19541481|NCT01234480|41990599|FG000|Overall Study|Missing Sample|9|||
19541482|NCT01227967|41990608|FG000|Overall Study|Protocol Violation|3|||
19541483|NCT01227967|41990609|FG001|Overall Study|Protocol Violation|1|||
19541484|NCT01227967|41990608|FG000|Overall Study|Death|0|||
19541485|NCT01227967|41990609|FG001|Overall Study|Death|1|||
19541486|NCT01227967|41990608|FG000|Overall Study|Lost to Follow-up|8|||
19541487|NCT01227967|41990609|FG001|Overall Study|Lost to Follow-up|3|||
19541488|NCT01227967|41990608|FG000|Overall Study|Withdrawal by Subject|4|||
19541489|NCT01227967|41990609|FG001|Overall Study|Withdrawal by Subject|3|||
19541490|NCT01227967|41990608|FG000|Overall Study|Physician Decision|0|||
19541491|NCT01227967|41990609|FG001|Overall Study|Physician Decision|1|||
19541492|NCT01227967|41990608|FG000|Overall Study|Never Started Treatment|0|||
19541493|NCT01227967|41990609|FG001|Overall Study|Never Started Treatment|4|||
19541494|NCT01227967|41990608|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
19541495|NCT01227967|41990609|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
19541496|NCT01227928|41990617|FG000|Overall Study|Lost to Follow-up|4|||
19541497|NCT01227928|41990618|FG001|Overall Study|Lost to Follow-up|2|||
19541498|NCT01227928|41990617|FG000|Overall Study|Withdrawal by Subject|4|||
19541499|NCT01227928|41990618|FG001|Overall Study|Withdrawal by Subject|3|||
19541500|NCT01227928|41990617|FG000|Overall Study|Death|14|||
19541501|NCT01227928|41990618|FG001|Overall Study|Death|12|||
19541502|NCT01227889|41990626|FG000|Randomized Phase (RP)|Adverse Event|13|||
19541503|NCT01227889|41990627|FG001|Randomized Phase (RP)|Adverse Event|0|||
19541504|NCT01227889|41990626|FG000|Randomized Phase (RP)|Physician Decision|13|||
19541505|NCT01227889|41990627|FG001|Randomized Phase (RP)|Physician Decision|5|||
19541506|NCT01227889|41990626|FG000|Randomized Phase (RP)|Progressive Disease|135|||
19541507|NCT01227889|41990627|FG001|Randomized Phase (RP)|Progressive Disease|52|||
19541508|NCT01227889|41990626|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
19541509|NCT01227889|41990627|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
19541510|NCT01227889|41990626|FG000|Randomized Phase (RP)|Missing|1|||
19541511|NCT01227889|41990627|FG001|Randomized Phase (RP)|Missing|3|||
19541512|NCT01227889|41990626|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
19541513|NCT01227889|41990627|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
19541514|NCT01227889|41990626|FG000|Crossover Phase|Adverse Event|0|||
19541515|NCT01227889|41990627|FG001|Crossover Phase|Adverse Event|1|||
19541516|NCT01227889|41990626|FG000|Crossover Phase|Physician Decision|0|||
19541517|NCT01227889|41990627|FG001|Crossover Phase|Physician Decision|3|||
19541518|NCT01227889|41990626|FG000|Crossover Phase|Progressive Disease|0|||
19541519|NCT01227889|41990627|FG001|Crossover Phase|Progressive Disease|31|||
19541520|NCT01227889|41990626|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
19541521|NCT01227889|41990627|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
19541522|NCT01227889|41990626|FG000|Crossover Phase|Withdrawal by Subject|0|||
19541523|NCT01227889|41990627|FG001|Crossover Phase|Withdrawal by Subject|1|||
19541524|NCT01227577|41990641|FG000|Overall Study|Protocol deviation|3|||
19457768|NCT01411215|41710929|FG001|Overall Study|Lost to Follow-up|18|||
19457769|NCT01411215|41710928|FG000|Overall Study|Did not meet entrance criteria|0|||
19457770|NCT01411215|41710929|FG001|Overall Study|Did not meet entrance criteria|1|||
19457771|NCT01411215|41710928|FG000|Overall Study|Study terminated by sponsor|2|||
19457772|NCT01411215|41710929|FG001|Overall Study|Study terminated by sponsor|15|||
19457773|NCT01411215|41710928|FG000|Overall Study|Protocol Violation|3|||
19457774|NCT01411215|41710929|FG001|Overall Study|Protocol Violation|5|||
19541525|NCT01227577|41990641|FG000|Overall Study|Death|3|||
19541526|NCT01227577|41990641|FG000|Overall Study|Administrative problems|2|||
19541527|NCT01227577|41990641|FG000|Overall Study|Lost to Follow-up|1|||
19541528|NCT01227577|41990641|FG000|Overall Study|Withdrawal by Subject|4|||
19541529|NCT01227577|41990641|FG000|Overall Study|Lack of Efficacy|5|||
19541530|NCT01227577|41990641|FG000|Overall Study|Adverse Event|17|||
19541531|NCT01227421|41990661|FG000|Overall Study|Lost to Follow-up|6|||
19541532|NCT01227421|41990662|FG001|Overall Study|Lost to Follow-up|7|||
19541533|NCT01227421|41990663|FG002|Overall Study|Lost to Follow-up|5|||
19541534|NCT01227421|41990661|FG000|Overall Study|Adverse Event|2|||
19541535|NCT01227421|41990662|FG001|Overall Study|Adverse Event|7|||
19541536|NCT01227421|41990663|FG002|Overall Study|Adverse Event|2|||
19541537|NCT01227421|41990661|FG000|Overall Study|Withdrawal by Subject|1|||
19541538|NCT01227421|41990662|FG001|Overall Study|Withdrawal by Subject|2|||
19541539|NCT01227421|41990663|FG002|Overall Study|Withdrawal by Subject|1|||
19541540|NCT01227421|41990661|FG000|Overall Study|Protocol Violation|1|||
19541541|NCT01227421|41990662|FG001|Overall Study|Protocol Violation|1|||
19541542|NCT01227421|41990663|FG002|Overall Study|Protocol Violation|2|||
19541543|NCT01227421|41990661|FG000|Overall Study|Randomized in error|1|||
19541544|NCT01227421|41990662|FG001|Overall Study|Randomized in error|1|||
19541545|NCT01227421|41990663|FG002|Overall Study|Randomized in error|0|||
19541546|NCT01227265|41990674|FG000|Overall Study|Did Not Receive Treatment|1|||
19541547|NCT01227265|41990675|FG001|Overall Study|Did Not Receive Treatment|2|||
19541548|NCT01227265|41990676|FG002|Overall Study|Did Not Receive Treatment|0|||
19541549|NCT01227265|41990674|FG000|Overall Study|Administrative|1|||
19541550|NCT01227265|41990675|FG001|Overall Study|Administrative|0|||
19541551|NCT01227265|41990676|FG002|Overall Study|Administrative|2|||
19541552|NCT01227265|41990674|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
19541553|NCT01227265|41990675|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
19541554|NCT01227265|41990676|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
19541555|NCT01227265|41990674|FG000|Overall Study|Protocol Violation|2|||
19541556|NCT01227265|41990675|FG001|Overall Study|Protocol Violation|1|||
19541557|NCT01227265|41990676|FG002|Overall Study|Protocol Violation|0|||
19541558|NCT01227265|41990674|FG000|Overall Study|Withdrawal by Subject|7|||
19541559|NCT01227265|41990675|FG001|Overall Study|Withdrawal by Subject|7|||
19541560|NCT01227265|41990676|FG002|Overall Study|Withdrawal by Subject|3|||
19541561|NCT01227265|41990674|FG000|Overall Study|Lost to Follow-up|2|||
19541562|NCT01227265|41990675|FG001|Overall Study|Lost to Follow-up|0|||
19541563|NCT01227265|41990676|FG002|Overall Study|Lost to Follow-up|3|||
19541564|NCT01227265|41990674|FG000|Overall Study|Adverse Event|6|||
19541565|NCT01227265|41990675|FG001|Overall Study|Adverse Event|10|||
19541566|NCT01227265|41990676|FG002|Overall Study|Adverse Event|5|||
19541567|NCT01226095|41990684|FG000|Overall Study|Poor compliance|1|||
19541568|NCT01225822|41990700|FG000|Overall Study|Adverse Event|13|||
19541569|NCT01225822|41990701|FG001|Overall Study|Adverse Event|31|||
19541570|NCT01225822|41990702|FG002|Overall Study|Adverse Event|18|||
19541571|NCT01225822|41990703|FG003|Overall Study|Adverse Event|23|||
19541572|NCT01225822|41990704|FG004|Overall Study|Adverse Event|14|||
19541573|NCT01225822|41990700|FG000|Overall Study|Protocol Violation|6|||
19541574|NCT01225822|41990701|FG001|Overall Study|Protocol Violation|8|||
19541575|NCT01225822|41990702|FG002|Overall Study|Protocol Violation|6|||
19541576|NCT01225822|41990703|FG003|Overall Study|Protocol Violation|7|||
19541577|NCT01225822|41990704|FG004|Overall Study|Protocol Violation|4|||
19541578|NCT01225822|41990700|FG000|Overall Study|Lost to Follow-up|0|||
19541579|NCT01225822|41990701|FG001|Overall Study|Lost to Follow-up|0|||
19541580|NCT01225822|41990702|FG002|Overall Study|Lost to Follow-up|0|||
19541581|NCT01225822|41990703|FG003|Overall Study|Lost to Follow-up|1|||
19541582|NCT01225822|41990704|FG004|Overall Study|Lost to Follow-up|0|||
19541583|NCT01225822|41990700|FG000|Overall Study|Withdrawal by Subject|6|||
19541584|NCT01225822|41990701|FG001|Overall Study|Withdrawal by Subject|7|||
19541585|NCT01225822|41990702|FG002|Overall Study|Withdrawal by Subject|7|||
19541586|NCT01225822|41990703|FG003|Overall Study|Withdrawal by Subject|11|||
19457775|NCT01411215|41710928|FG000|Overall Study|Withdrawal by Subject|34|||
19457776|NCT01411215|41710929|FG001|Overall Study|Withdrawal by Subject|21|||
19457777|NCT01411215|41710928|FG000|Overall Study|Other|12|||
19457778|NCT01411215|41710929|FG001|Overall Study|Other|17|||
19457779|NCT01411215|41710928|FG000|Overall Study|Screen failure|0|||
19541587|NCT01225822|41990704|FG004|Overall Study|Withdrawal by Subject|6|||
19541588|NCT01225822|41990700|FG000|Overall Study|Other|13|||
19457780|NCT01411215|41710929|FG001|Overall Study|Screen failure|1|||
19457781|NCT01449279|41710935|FG000|Overall Study|Lack of Efficacy|5|||
19541589|NCT01225822|41990701|FG001|Overall Study|Other|10|||
19541590|NCT01225822|41990702|FG002|Overall Study|Other|7|||
19541591|NCT01225822|41990703|FG003|Overall Study|Other|10|||
19541592|NCT01225822|41990704|FG004|Overall Study|Other|7|||
19541593|NCT01225549|41990719|FG000|Period 4 - Washout|Disallowed medication|0|||
19541594|NCT01225549|41990720|FG001|Period 4 - Washout|Disallowed medication|1|||
19541595|NCT01225549|41990721|FG002|Period 4 - Washout|Disallowed medication|0|||
19541596|NCT01225549|41990722|FG003|Period 4 - Washout|Disallowed medication|0|||
19541597|NCT01225549|41990723|FG004|Period 4 - Washout|Disallowed medication|0|||
19541598|NCT01225549|41990724|FG005|Period 4 - Washout|Disallowed medication|0|||
19541599|NCT01225549|41990725|FG006|Period 4 - Washout|Disallowed medication|0|||
19541600|NCT01225549|41990726|FG007|Period 4 - Washout|Disallowed medication|0|||
19541601|NCT01225549|41990727|FG008|Period 4 - Washout|Disallowed medication|0|||
19541602|NCT01225549|41990728|FG009|Period 4 - Washout|Disallowed medication|0|||
19541603|NCT01225549|41990719|FG000|Period 6 - Washout|Disallowed medication|0|||
19541604|NCT01225549|41990720|FG001|Period 6 - Washout|Disallowed medication|0|||
19541605|NCT01225549|41990721|FG002|Period 6 - Washout|Disallowed medication|0|||
19541606|NCT01225549|41990722|FG003|Period 6 - Washout|Disallowed medication|1|||
19541607|NCT01225549|41990723|FG004|Period 6 - Washout|Disallowed medication|0|||
19541608|NCT01225549|41990724|FG005|Period 6 - Washout|Disallowed medication|0|||
19541609|NCT01225549|41990725|FG006|Period 6 - Washout|Disallowed medication|0|||
19541610|NCT01225549|41990726|FG007|Period 6 - Washout|Disallowed medication|0|||
19457782|NCT01449279|41710935|FG000|Overall Study|Toxicity|2|||
19457783|NCT01447719|41710939|FG000|Overall Study|Image acquisition failure|2|||
19457784|NCT01447719|41710939|FG000|Overall Study|Invalid image or not imaged|3|||
19457785|NCT01447719|41710939|FG000|Overall Study|Subject still living at end of study|79|||
19457786|NCT01447719|41710939|FG000|Overall Study|Withdrawal by Subject|2|||
19457787|NCT01447719|41710939|FG000|Overall Study|Family withdrew autopsy consent|7|||
19457788|NCT01431963|41710948|FG000|Overall Study|Adverse Event|18|||
19457789|NCT01431963|41710948|FG000|Overall Study|Lack of Efficacy|7|||
19457790|NCT01431963|41710948|FG000|Overall Study|Protocol Violation|1|||
19457791|NCT01431963|41710948|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
19457792|NCT01431963|41710948|FG000|Overall Study|Physician Decision|4|||
19457793|NCT01431963|41710948|FG000|Overall Study|Withdrawal by Subject|3|||
19457794|NCT01447407|41710956|FG000|Overall Study|Withdrawal by Subject|2|||
19457795|NCT01447407|41710957|FG001|Overall Study|Withdrawal by Subject|0|||
19541611|NCT01225549|41990727|FG008|Period 6 - Washout|Disallowed medication|0|||
19541612|NCT01225549|41990728|FG009|Period 6 - Washout|Disallowed medication|0|||
19541613|NCT01225159|41990740|FG000|Overall Study|Change operation|1|||
19541614|NCT01225159|41990741|FG001|Overall Study|Change operation|0|||
19541615|NCT01224925|41990749|FG000|Overall Study|Lost to Follow-up|3|||
19541616|NCT01224925|41990750|FG001|Overall Study|Lost to Follow-up|2|||
19541617|NCT01223404|41990758|FG000|First Intervention (1 Day)|Adverse Event|0|||
19541618|NCT01223404|41990759|FG001|First Intervention (1 Day)|Adverse Event|0|||
19541619|NCT01223404|41990760|FG002|First Intervention (1 Day)|Adverse Event|0|||
19541620|NCT01223404|41990761|FG003|First Intervention (1 Day)|Adverse Event|1|||
19541621|NCT01223404|41990762|FG004|First Intervention (1 Day)|Adverse Event|0|||
19541622|NCT01223404|41990763|FG005|First Intervention (1 Day)|Adverse Event|0|||
19541623|NCT01223404|41990758|FG000|Second Intervention (1 Day)|Adverse Event|1|||
19541624|NCT01223404|41990759|FG001|Second Intervention (1 Day)|Adverse Event|0|||
19541625|NCT01223404|41990760|FG002|Second Intervention (1 Day)|Adverse Event|0|||
19541626|NCT01223404|41990761|FG003|Second Intervention (1 Day)|Adverse Event|0|||
19541627|NCT01223404|41990762|FG004|Second Intervention (1 Day)|Adverse Event|0|||
19541628|NCT01223404|41990763|FG005|Second Intervention (1 Day)|Adverse Event|0|||
19541629|NCT01223404|41990758|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
19541630|NCT01223404|41990759|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
19541631|NCT01223404|41990760|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
19541632|NCT01223404|41990761|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
19541633|NCT01223404|41990762|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
19541634|NCT01223404|41990763|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
19541635|NCT01223365|41990811|FG000|Open-label Titration Period|Enrolled but not treated|1|||
19457796|NCT01447407|41710958|FG002|Overall Study|Withdrawal by Subject|0|||
19457797|NCT01447407|41710959|FG003|Overall Study|Withdrawal by Subject|1|||
19457798|NCT01447407|41710956|FG000|Overall Study|Physician Decision|0|||
19541636|NCT01223365|41990811|FG000|Open-label Titration Period|Adverse Event|23|||
19541637|NCT01223365|41990811|FG000|Open-label Titration Period|Lack of Efficacy|3|||
19541638|NCT01223365|41990811|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
19541639|NCT01223365|41990811|FG000|Open-label Titration Period|Protocol Violation|1|||
19541640|NCT01223365|41990811|FG000|Open-label Titration Period|Lost to Follow-up|2|||
19541641|NCT01223365|41990811|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
19457799|NCT01447407|41710957|FG001|Overall Study|Physician Decision|0|||
19457800|NCT01447407|41710958|FG002|Overall Study|Physician Decision|1|||
19457801|NCT01447407|41710959|FG003|Overall Study|Physician Decision|1|||
19457802|NCT01446237|41710969|FG000|Overall Study|Adverse Event|1|||
19457803|NCT01446237|41710969|FG000|Overall Study|Lost to Follow-up|2|||
19541642|NCT01223365|41990811|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
19541643|NCT01223365|41990811|FG000|Open-label Titration Period|Starting physical therapy|1|||
19541644|NCT01223365|41990811|FG000|Open-label Treatment Period|Adverse Event|39|||
19541645|NCT01223365|41990811|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
19541646|NCT01223365|41990811|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
19541647|NCT01223365|41990811|FG000|Open-label Treatment Period|Protocol Violation|15|||
19541648|NCT01223365|41990811|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
19541649|NCT01223365|41990811|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
19541650|NCT01223365|41990811|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
19541651|NCT01223365|41990811|FG000|Open-label Treatment Period|Moved out of area|2|||
19541652|NCT01223365|41990811|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
19541653|NCT01223365|41990811|FG000|Open-label Treatment Period|"Out of window"|1|||
19541654|NCT01223365|41990811|FG000|Open-label Treatment Period|Starting physical therapy|1|||
19541655|NCT01223365|41990811|FG000|Open-label Treatment Period|Physician Decision|2|||
19541656|NCT01222507|41990820|FG000|Overall Study|Physician Decision|1|||
19541657|NCT01222507|41990820|FG000|Overall Study|Withdrawal by Subject|1|||
19541658|NCT01222078|41990824|FG000|Overall Study|Early termination of the study|1|||
19541659|NCT01221727|41990831|FG000|Overall Study|Physician Decision|2|||
19541660|NCT01221727|41990832|FG001|Overall Study|Physician Decision|0|||
19541661|NCT01221727|41990831|FG000|Overall Study|Withdrawal by Subject|1|||
19541662|NCT01221727|41990832|FG001|Overall Study|Withdrawal by Subject|1|||
19541663|NCT01221181|41990844|FG000|Overall Study|Lost to Follow-up|1|||
19541664|NCT01220557|41990850|FG000|Overall Study|Lost to Follow-up|5|||
19541665|NCT01220557|41990851|FG001|Overall Study|Lost to Follow-up|3|||
19541666|NCT01220557|41990850|FG000|Overall Study|attended less than 6 lessons|1|||
19541667|NCT01220557|41990851|FG001|Overall Study|attended less than 6 lessons|2|||
19541668|NCT01220401|41990857|FG000|Overall Study|Withdrawal by Subject|2|||
19541669|NCT01220401|41990857|FG000|Overall Study|Protocol Violation|1|||
19541670|NCT01220167|41990864|FG000|Period 3|Urine positive for substance abuse|0|||
19541671|NCT01220167|41990865|FG001|Period 3|Urine positive for substance abuse|1|||
19541672|NCT01220167|41990866|FG002|Period 3|Urine positive for substance abuse|0|||
19541673|NCT01220128|41990879|FG000|Overall Study|Progressive disease|0|||
19541674|NCT01220128|41990880|FG001|Overall Study|Progressive disease|0|||
19541675|NCT01220128|41990881|FG002|Overall Study|Progressive disease|2|||
19541676|NCT01220128|41990882|FG003|Overall Study|Progressive disease|0|||
19541677|NCT01220128|41990883|FG004|Overall Study|Progressive disease|0|||
19541678|NCT01220128|41990884|FG005|Overall Study|Progressive disease|0|||
19541679|NCT01220128|41990885|FG006|Overall Study|Progressive disease|0|||
19541680|NCT01220128|41990879|FG000|Overall Study|Sponsor study termination|0|||
19541681|NCT01220128|41990880|FG001|Overall Study|Sponsor study termination|1|||
19541682|NCT01220128|41990881|FG002|Overall Study|Sponsor study termination|0|||
19541683|NCT01220128|41990882|FG003|Overall Study|Sponsor study termination|0|||
19541684|NCT01220128|41990883|FG004|Overall Study|Sponsor study termination|0|||
19541685|NCT01220128|41990884|FG005|Overall Study|Sponsor study termination|0|||
19541686|NCT01220128|41990885|FG006|Overall Study|Sponsor study termination|1|||
19541687|NCT01220128|41990879|FG000|Overall Study|Adverse event, serious fatal|2|||
19541688|NCT01220128|41990880|FG001|Overall Study|Adverse event, serious fatal|0|||
19541689|NCT01220128|41990881|FG002|Overall Study|Adverse event, serious fatal|0|||
19541690|NCT01220128|41990882|FG003|Overall Study|Adverse event, serious fatal|0|||
19541691|NCT01220128|41990883|FG004|Overall Study|Adverse event, serious fatal|0|||
19541692|NCT01220128|41990884|FG005|Overall Study|Adverse event, serious fatal|0|||
19541693|NCT01220128|41990885|FG006|Overall Study|Adverse event, serious fatal|1|||
19541694|NCT01220128|41990879|FG000|Overall Study|Adverse event, non-fatal|1|||
19541695|NCT01220128|41990880|FG001|Overall Study|Adverse event, non-fatal|0|||
19541696|NCT01220128|41990881|FG002|Overall Study|Adverse event, non-fatal|0|||
19541697|NCT01220128|41990882|FG003|Overall Study|Adverse event, non-fatal|0|||
19541698|NCT01220128|41990883|FG004|Overall Study|Adverse event, non-fatal|0|||
19541699|NCT01220128|41990884|FG005|Overall Study|Adverse event, non-fatal|0|||
19541700|NCT01220128|41990885|FG006|Overall Study|Adverse event, non-fatal|3|||
19541701|NCT01220128|41990879|FG000|Overall Study|Other|0|||
19541702|NCT01220128|41990880|FG001|Overall Study|Other|0|||
19541703|NCT01220128|41990881|FG002|Overall Study|Other|1|||
19541704|NCT01220128|41990882|FG003|Overall Study|Other|0|||
19541705|NCT01220128|41990883|FG004|Overall Study|Other|0|||
19541706|NCT01220128|41990884|FG005|Overall Study|Other|0|||
19541707|NCT01220128|41990885|FG006|Overall Study|Other|0|||
19541708|NCT01220128|41990879|FG000|Overall Study|Consent withdrawn by subject|1|||
19541709|NCT01220128|41990880|FG001|Overall Study|Consent withdrawn by subject|0|||
19541710|NCT01220128|41990881|FG002|Overall Study|Consent withdrawn by subject|0|||
19541711|NCT01220128|41990882|FG003|Overall Study|Consent withdrawn by subject|0|||
19541712|NCT01220128|41990883|FG004|Overall Study|Consent withdrawn by subject|0|||
19541713|NCT01220128|41990884|FG005|Overall Study|Consent withdrawn by subject|0|||
19541714|NCT01220128|41990885|FG006|Overall Study|Consent withdrawn by subject|0|||
19541715|NCT01219933|41990902|FG000|Overall Study|Adverse Event|8|||
19541716|NCT01219933|41990902|FG000|Overall Study|No LDA reached|5|||
19541717|NCT01219933|41990902|FG000|Overall Study|No LDA maintained|7|||
19541718|NCT01219933|41990902|FG000|Overall Study|Lost to Follow-up|3|||
19541719|NCT01219933|41990902|FG000|Overall Study|GC free|1|||
19541720|NCT01219933|41990902|FG000|Overall Study|Withdrawal by Subject|5|||
19541721|NCT01219933|41990902|FG000|Overall Study|Protocol Violation|8|||
19541722|NCT01219933|41990902|FG000|Overall Study|Lack of Efficacy|1|||
19541723|NCT01218802|41990909|FG000|Overall Study|Lost to Follow-up|5|||
19541724|NCT01218802|41990910|FG001|Overall Study|Lost to Follow-up|6|||
19541725|NCT01218802|41990909|FG000|Overall Study|Withdrawal by Subject|3|||
19541726|NCT01218802|41990910|FG001|Overall Study|Withdrawal by Subject|10|||
19541727|NCT01218802|41990909|FG000|Overall Study|Adverse Event|0|||
19541728|NCT01218802|41990910|FG001|Overall Study|Adverse Event|2|||
19541729|NCT01218802|41990909|FG000|Overall Study|Incarcerated|2|||
19541730|NCT01218802|41990910|FG001|Overall Study|Incarcerated|0|||
19541731|NCT01218646|41990920|FG000|Overall Study|Adverse Event|0|||
19541732|NCT01218646|41990921|FG001|Overall Study|Adverse Event|0|||
19541733|NCT01218646|41990922|FG002|Overall Study|Adverse Event|1|||
19457804|NCT01446237|41710969|FG000|Overall Study|Withdrawal by Subject|7|||
19541734|NCT01218646|41990923|FG003|Overall Study|Adverse Event|0|||
19541735|NCT01218646|41990920|FG000|Overall Study|Lost to Follow-up|1|||
19541736|NCT01218646|41990921|FG001|Overall Study|Lost to Follow-up|0|||
19541737|NCT01218646|41990922|FG002|Overall Study|Lost to Follow-up|0|||
19541738|NCT01218646|41990923|FG003|Overall Study|Lost to Follow-up|0|||
19541739|NCT01218646|41990920|FG000|Overall Study|Protocol Violation|0|||
19541740|NCT01218646|41990921|FG001|Overall Study|Protocol Violation|0|||
19541741|NCT01218646|41990922|FG002|Overall Study|Protocol Violation|1|||
19541742|NCT01218646|41990923|FG003|Overall Study|Protocol Violation|1|||
19541743|NCT01188772|41990937|FG000|Overall Study|Randomized but Not Treated|0|||
19541744|NCT01188772|41990938|FG001|Overall Study|Randomized but Not Treated|1|||
19541745|NCT01188772|41990939|FG002|Overall Study|Randomized but Not Treated|0|||
19541746|NCT01188772|41990940|FG003|Overall Study|Randomized but Not Treated|0|||
19541747|NCT01188772|41990937|FG000|Overall Study|Adverse Event|0|||
19457805|NCT01446159|41711117|FG000|Overall Study|Withdrawal by Subject|1|||
19457806|NCT01446159|41711118|FG001|Overall Study|Withdrawal by Subject|0|||
19457807|NCT01446159|41711119|FG002|Overall Study|Withdrawal by Subject|14|||
19457808|NCT01446159|41711120|FG003|Overall Study|Withdrawal by Subject|11|||
19457809|NCT01446159|41711117|FG000|Overall Study|Lost to Follow-up|0|||
19457810|NCT01446159|41711118|FG001|Overall Study|Lost to Follow-up|0|||
19457811|NCT01446159|41711119|FG002|Overall Study|Lost to Follow-up|1|||
19457812|NCT01446159|41711120|FG003|Overall Study|Lost to Follow-up|2|||
19457813|NCT01446159|41711117|FG000|Overall Study|Death|2|||
19541748|NCT01188772|41990938|FG001|Overall Study|Adverse Event|1|||
19541749|NCT01188772|41990939|FG002|Overall Study|Adverse Event|2|||
19541750|NCT01188772|41990940|FG003|Overall Study|Adverse Event|0|||
19541751|NCT01188772|41990937|FG000|Overall Study|Lost to Follow-up|4|||
19541752|NCT01188772|41990938|FG001|Overall Study|Lost to Follow-up|1|||
19541753|NCT01188772|41990939|FG002|Overall Study|Lost to Follow-up|1|||
19541754|NCT01188772|41990940|FG003|Overall Study|Lost to Follow-up|1|||
19541755|NCT01188772|41990937|FG000|Overall Study|Non-responder|0|||
19541756|NCT01188772|41990938|FG001|Overall Study|Non-responder|0|||
19541757|NCT01188772|41990939|FG002|Overall Study|Non-responder|3|||
19457814|NCT01446159|41711118|FG001|Overall Study|Death|3|||
19457815|NCT01446159|41711119|FG002|Overall Study|Death|43|||
19457816|NCT01446159|41711120|FG003|Overall Study|Death|36|||
19457817|NCT01446159|41711117|FG000|Overall Study|Other|0|||
19457818|NCT01446159|41711118|FG001|Overall Study|Other|0|||
19457819|NCT01446159|41711119|FG002|Overall Study|Other|13|||
19457820|NCT01446159|41711120|FG003|Overall Study|Other|13|||
19457821|NCT01446003|41711156|FG000|Period 1|Protocol Violation|2|||
19457822|NCT01446003|41711157|FG001|Period 1|Protocol Violation|0|||
19457823|NCT01446003|41711156|FG000|Period 2|Adverse Event|1|||
19541758|NCT01188772|41990940|FG003|Overall Study|Non-responder|0|||
19631750|NCT00809354|42081105|FG003|Overall Study|Death|0|||
19631751|NCT00809354|42081106|FG004|Overall Study|Death|0|||
19631752|NCT00809354|42081107|FG005|Overall Study|Death|0|||
19457824|NCT01446003|41711157|FG001|Period 2|Adverse Event|0|||
19457825|NCT01430559|41711174|FG000|Overall Study|Adverse Event|7|||
19457826|NCT01430559|41711175|FG001|Overall Study|Adverse Event|3|||
19457827|NCT01430559|41711174|FG000|Overall Study|Entry criteria not met|1|||
19457828|NCT01430559|41711175|FG001|Overall Study|Entry criteria not met|1|||
19541759|NCT01188772|41990937|FG000|Overall Study|Physician Decision|0|||
19541760|NCT01188772|41990938|FG001|Overall Study|Physician Decision|0|||
19541761|NCT01188772|41990939|FG002|Overall Study|Physician Decision|1|||
19541762|NCT01188772|41990940|FG003|Overall Study|Physician Decision|0|||
19541763|NCT01188772|41990937|FG000|Overall Study|Terminated by Sponsor|0|||
19541764|NCT01188772|41990938|FG001|Overall Study|Terminated by Sponsor|0|||
19541765|NCT01188772|41990939|FG002|Overall Study|Terminated by Sponsor|1|||
19631753|NCT00809354|42081108|FG006|Overall Study|Death|0|||
19541766|NCT01188772|41990940|FG003|Overall Study|Terminated by Sponsor|0|||
19541767|NCT01188772|41990937|FG000|Overall Study|Treatment Failure|0|||
19541768|NCT01188772|41990938|FG001|Overall Study|Treatment Failure|0|||
19541769|NCT01188772|41990939|FG002|Overall Study|Treatment Failure|1|||
19541770|NCT01188772|41990940|FG003|Overall Study|Treatment Failure|0|||
19541771|NCT01188772|41990937|FG000|Overall Study|Virologic Failure|1|||
19541772|NCT01188772|41990938|FG001|Overall Study|Virologic Failure|0|||
19541773|NCT01188772|41990939|FG002|Overall Study|Virologic Failure|0|||
19541774|NCT01188772|41990940|FG003|Overall Study|Virologic Failure|0|||
19541775|NCT01188772|41990937|FG000|Overall Study|Withdrawal by Subject|0|||
19541776|NCT01188772|41990938|FG001|Overall Study|Withdrawal by Subject|0|||
19541777|NCT01188772|41990939|FG002|Overall Study|Withdrawal by Subject|2|||
19711571|NCT00079274|42154659|FG002|Overall Study|Alternate Treatment|0|||
19711572|NCT00079274|42154660|FG003|Overall Study|Alternate Treatment|3|||
19711573|NCT00079274|42154661|FG004|Overall Study|Alternate Treatment|0|||
19711574|NCT00079274|42154662|FG005|Overall Study|Alternate Treatment|0|||
19711575|NCT00079274|42154663|FG006|Overall Study|Alternate Treatment|0|||
19711576|NCT00079274|42154657|FG000|Overall Study|Other Medical Problems|6|||
19711577|NCT00079274|42154658|FG001|Overall Study|Other Medical Problems|1|||
19457829|NCT01430559|41711174|FG000|Overall Study|Lost to Follow-up|1|||
19457830|NCT01430559|41711175|FG001|Overall Study|Lost to Follow-up|0|||
19541778|NCT01188772|41990940|FG003|Overall Study|Withdrawal by Subject|0|||
19541779|NCT01188655|41990953|FG000|Overall Study|Lack of Efficacy|1|||
19541780|NCT01188655|41990953|FG000|Overall Study|Lost to Follow-up|1|||
19541781|NCT01188655|41990953|FG000|Overall Study|Other|11|||
19541782|NCT01188538|41990959|FG000|Overall Study|Lost to Follow-up|0|||
19541783|NCT01188538|41990960|FG001|Overall Study|Lost to Follow-up|1|||
19541784|NCT01188343|41990971|FG000|Overall Study|Not vaccinated|0|||
19541785|NCT01188343|41990972|FG001|Overall Study|Not vaccinated|2|||
19541786|NCT01188343|41990973|FG002|Overall Study|Not vaccinated|1|||
19541787|NCT01188343|41990971|FG000|Overall Study|Withdrawal by Subject|1|||
19541788|NCT01188343|41990972|FG001|Overall Study|Withdrawal by Subject|24|||
19541789|NCT01188343|41990973|FG002|Overall Study|Withdrawal by Subject|0|||
19541790|NCT01188226|41990984|FG000|Overall Study|Withdrawal by Subject|4|||
19541791|NCT01218100|41991002|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
19541792|NCT01218100|41991003|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
19541793|NCT01218100|41991004|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
19541794|NCT01218100|41991005|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
19541795|NCT01218100|41991002|FG000|Overall Study|Adverse Event|4|||
19541796|NCT01218100|41991003|FG001|Overall Study|Adverse Event|6|||
19541797|NCT01218100|41991004|FG002|Overall Study|Adverse Event|6|||
19541798|NCT01218100|41991005|FG003|Overall Study|Adverse Event|7|||
19541799|NCT01218100|41991002|FG000|Overall Study|Lack of Efficacy|9|||
19541800|NCT01218100|41991003|FG001|Overall Study|Lack of Efficacy|6|||
19541801|NCT01218100|41991004|FG002|Overall Study|Lack of Efficacy|5|||
19541802|NCT01218100|41991005|FG003|Overall Study|Lack of Efficacy|12|||
19541803|NCT01218100|41991002|FG000|Overall Study|Protocol Violation|0|||
19711578|NCT00079274|42154659|FG002|Overall Study|Other Medical Problems|0|||
19711579|NCT00079274|42154660|FG003|Overall Study|Other Medical Problems|7|||
19457831|NCT01430559|41711174|FG000|Overall Study|Medication error|1|||
19457832|NCT01430559|41711175|FG001|Overall Study|Medication error|0|||
19457833|NCT01430559|41711174|FG000|Overall Study|Withdrawal by Subject|3|||
19457834|NCT01430559|41711175|FG001|Overall Study|Withdrawal by Subject|2|||
19457835|NCT01430559|41711174|FG000|Overall Study|Protocol Violation|1|||
19457836|NCT01430559|41711175|FG001|Overall Study|Protocol Violation|0|||
19457837|NCT01430559|41711174|FG000|Overall Study|Other|3|||
19457838|NCT01430559|41711175|FG001|Overall Study|Other|3|||
19457839|NCT01430559|41711174|FG000|Overall Study|Randomized, Not Treated|3|||
19457840|NCT01430559|41711175|FG001|Overall Study|Randomized, Not Treated|3|||
19457841|NCT01410357|41711188|FG000|Overall Study|Death|2|||
19457842|NCT01410357|41711189|FG001|Overall Study|Death|1|||
19457843|NCT01410357|41711188|FG000|Overall Study|Withdrawal by Subject|1|||
19457844|NCT01410357|41711189|FG001|Overall Study|Withdrawal by Subject|2|||
19457845|NCT01410357|41711188|FG000|Overall Study|Lost to Follow-up|23|||
19541804|NCT01218100|41991003|FG001|Overall Study|Protocol Violation|0|||
19541805|NCT01218100|41991004|FG002|Overall Study|Protocol Violation|1|||
19541806|NCT01218100|41991005|FG003|Overall Study|Protocol Violation|1|||
19541807|NCT01218100|41991002|FG000|Overall Study|Withdrawal by Subject|5|||
19541808|NCT01218100|41991003|FG001|Overall Study|Withdrawal by Subject|2|||
19541809|NCT01218100|41991004|FG002|Overall Study|Withdrawal by Subject|6|||
19541810|NCT01218100|41991005|FG003|Overall Study|Withdrawal by Subject|7|||
19541811|NCT01218100|41991002|FG000|Overall Study|Lost to Follow-up|3|||
19457846|NCT01410357|41711189|FG001|Overall Study|Lost to Follow-up|21|||
19457847|NCT01409811|41711214|FG000|Overall Study|Insurance denial|1|||
19541812|NCT01218100|41991003|FG001|Overall Study|Lost to Follow-up|8|||
19541813|NCT01218100|41991004|FG002|Overall Study|Lost to Follow-up|2|||
19541814|NCT01218100|41991005|FG003|Overall Study|Lost to Follow-up|1|||
19541815|NCT01218100|41991002|FG000|Overall Study|Other Reason|2|||
19711580|NCT00079274|42154661|FG004|Overall Study|Other Medical Problems|0|||
19457848|NCT01445847|41711220|FG000|Overall Study|Protocol Violation|13|||
19457849|NCT01445847|41711221|FG001|Overall Study|Protocol Violation|14|||
19457850|NCT01445847|41711220|FG000|Overall Study|Missed Data|1|||
19457851|NCT01445847|41711221|FG001|Overall Study|Missed Data|0|||
19457852|NCT01445769|41711240|FG000|Overall Study|Consent Withdrawn|2|||
19457853|NCT01445769|41711240|FG000|Overall Study|Disease Progression|1|||
19457854|NCT01445769|41711240|FG000|Overall Study|Lost to Follow-up|5|||
19457855|NCT01445613|41711322|FG000|30-day Follow-up|Withdrawal by Subject|6|||
19457856|NCT01445613|41711322|FG000|30-day Follow-up|Physician Decision|3|||
19457857|NCT01445613|41711322|FG000|30-day Follow-up|Missed visit|23|||
19541816|NCT01218100|41991003|FG001|Overall Study|Other Reason|2|||
19541817|NCT01218100|41991004|FG002|Overall Study|Other Reason|6|||
19457858|NCT01445613|41711322|FG000|30-day Follow-up|Death|3|||
19457859|NCT01445613|41711322|FG000|1-year Follow-up|Withdrawal by Subject|12|||
19541818|NCT01218100|41991005|FG003|Overall Study|Other Reason|4|||
19541819|NCT01187953|41991051|FG000|Overall Study|Death|11|||
19541820|NCT01187953|41991052|FG001|Overall Study|Death|13|||
19541821|NCT01187953|41991051|FG000|Overall Study|Adverse Event|1|||
19541822|NCT01187953|41991052|FG001|Overall Study|Adverse Event|2|||
19541823|NCT01187953|41991051|FG000|Overall Study|Lost to Follow-up|0|||
19541824|NCT01187953|41991052|FG001|Overall Study|Lost to Follow-up|3|||
19541825|NCT01187953|41991051|FG000|Overall Study|Withdrawal by Subject|3|||
19541826|NCT01187953|41991052|FG001|Overall Study|Withdrawal by Subject|3|||
19541827|NCT01217944|41991061|FG000|Overall Study|Protocol Violation|1|||
19541828|NCT01217944|41991062|FG001|Overall Study|Protocol Violation|1|||
19541829|NCT01217944|41991063|FG002|Overall Study|Protocol Violation|0|||
19541830|NCT01217944|41991061|FG000|Overall Study|Lost to Follow-up|3|||
19541831|NCT01217944|41991062|FG001|Overall Study|Lost to Follow-up|1|||
19541832|NCT01217944|41991063|FG002|Overall Study|Lost to Follow-up|0|||
19631754|NCT00809354|42081109|FG007|Overall Study|Death|1|||
19631755|NCT00809354|42081110|FG008|Overall Study|Death|0|||
19631756|NCT00809354|42081111|FG009|Overall Study|Death|0|||
19631757|NCT00834899|42081140|FG000|Overall Study|Withdrawal by Subject|1|||
19631758|NCT00834899|42081141|FG001|Overall Study|Withdrawal by Subject|1|||
19631759|NCT00764946|42081150|FG000|Overall Study|Lack of Efficacy|1|||
19631760|NCT00764946|42081151|FG001|Overall Study|Lack of Efficacy|0|||
19631761|NCT00764946|42081152|FG002|Overall Study|Lack of Efficacy|0|||
19631762|NCT00764946|42081150|FG000|Overall Study|Lost to Follow-up|3|||
19631763|NCT00764946|42081151|FG001|Overall Study|Lost to Follow-up|4|||
19631764|NCT00764946|42081152|FG002|Overall Study|Lost to Follow-up|0|||
19631765|NCT00764946|42081150|FG000|Overall Study|Physician Decision|2|||
19631766|NCT00764946|42081151|FG001|Overall Study|Physician Decision|4|||
19631767|NCT00764946|42081152|FG002|Overall Study|Physician Decision|0|||
19631768|NCT00764946|42081150|FG000|Overall Study|Adverse Event|3|||
19631769|NCT00764946|42081151|FG001|Overall Study|Adverse Event|2|||
19631770|NCT00764946|42081152|FG002|Overall Study|Adverse Event|1|||
19631771|NCT00764946|42081150|FG000|Overall Study|Withdrawal by Subject|3|||
19631772|NCT00764946|42081151|FG001|Overall Study|Withdrawal by Subject|6|||
19631773|NCT00764946|42081152|FG002|Overall Study|Withdrawal by Subject|2|||
19631774|NCT00764946|42081150|FG000|Overall Study|Never Treated|1|||
19631775|NCT00764946|42081151|FG001|Overall Study|Never Treated|1|||
19631776|NCT00764946|42081152|FG002|Overall Study|Never Treated|1|||
19631777|NCT00764868|42081166|FG000|Overall Study|Adverse Event|18|||
19631778|NCT00764868|42081166|FG000|Overall Study|Withdrawal by Subject|31|||
19631779|NCT00764868|42081166|FG000|Overall Study|Non-compliance|16|||
19631780|NCT00764868|42081166|FG000|Overall Study|Lost to Follow-up|25|||
19631781|NCT00764868|42081166|FG000|Overall Study|Lack of Efficacy|5|||
19631782|NCT00764868|42081166|FG000|Overall Study|Subject moved|7|||
19631783|NCT00764868|42081166|FG000|Overall Study|Pregnancy|3|||
19631784|NCT00764868|42081166|FG000|Overall Study|Prohibited medication|1|||
19631785|NCT00764868|42081166|FG000|Overall Study|Out of town|1|||
19631786|NCT00764868|42081166|FG000|Overall Study|Misuse and compliance of study drug|1|||
19631787|NCT00764868|42081166|FG000|Overall Study|Subject sent to boarding school|1|||
19631788|NCT00764868|42081166|FG000|Overall Study|Met an exclusion criteria|1|||
19631789|NCT00764868|42081166|FG000|Overall Study|Positive drug screen|2|||
19631790|NCT00764868|42081166|FG000|Overall Study|Sponsor requested withdrawal|1|||
19631791|NCT00764790|42081173|FG000|Overall Study|Protocol Violation|0|||
19457860|NCT01445613|41711322|FG000|1-year Follow-up|Missed visit|29|||
19457861|NCT01445613|41711322|FG000|1-year Follow-up|Lost to Follow-up|2|||
19541833|NCT01217944|41991061|FG000|Overall Study|Withdrawal by Subject|1|||
19541834|NCT01217944|41991062|FG001|Overall Study|Withdrawal by Subject|2|||
19541835|NCT01217944|41991063|FG002|Overall Study|Withdrawal by Subject|0|||
19457862|NCT01445613|41711322|FG000|1-year Follow-up|Death|30|||
19457863|NCT01445613|41711322|FG000|1-year Follow-up|Physician Decision|2|||
19457864|NCT01445613|41711322|FG000|1-year Follow-up|Received a non-study stent|2|||
19541836|NCT01217944|41991061|FG000|Overall Study|Lack of Efficacy|1|||
19541837|NCT01217944|41991062|FG001|Overall Study|Lack of Efficacy|0|||
19631792|NCT00764790|42081174|FG001|Overall Study|Protocol Violation|0|||
19631793|NCT00764790|42081175|FG002|Overall Study|Protocol Violation|1|||
19631794|NCT00764790|42081173|FG000|Overall Study|Withdrawal by Subject|10|||
19457865|NCT01445535|41711426|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
19457866|NCT01445535|41711427|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
19457867|NCT01445535|41711428|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
19457868|NCT01445535|41711429|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
19457869|NCT01445535|41711426|FG000|Overall Study|Disease progression|1|||
19457870|NCT01445535|41711427|FG001|Overall Study|Disease progression|0|||
19457871|NCT01445535|41711428|FG002|Overall Study|Disease progression|1|||
19457872|NCT01445535|41711429|FG003|Overall Study|Disease progression|0|||
19457873|NCT01445535|41711426|FG000|Overall Study|PI discretion|0|||
19457874|NCT01445535|41711427|FG001|Overall Study|PI discretion|0|||
19457875|NCT01445535|41711428|FG002|Overall Study|PI discretion|0|||
19457876|NCT01445535|41711429|FG003|Overall Study|PI discretion|1|||
19457877|NCT01445301|41711443|FG000|Overall Study|Adverse Event|15|||
19457878|NCT01445301|41711444|FG001|Overall Study|Adverse Event|25|||
19457879|NCT01445301|41711445|FG002|Overall Study|Adverse Event|4|||
19457880|NCT01445301|41711443|FG000|Overall Study|Lack of Efficacy|0|||
19457881|NCT01445301|41711444|FG001|Overall Study|Lack of Efficacy|1|||
19457882|NCT01445301|41711445|FG002|Overall Study|Lack of Efficacy|0|||
19457883|NCT01445301|41711443|FG000|Overall Study|Protocol Violation|1|||
19457884|NCT01445301|41711444|FG001|Overall Study|Protocol Violation|0|||
19457885|NCT01445301|41711445|FG002|Overall Study|Protocol Violation|0|||
19457886|NCT01445301|41711443|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
19541838|NCT01217944|41991063|FG002|Overall Study|Lack of Efficacy|0|||
19541839|NCT01187446|41991075|FG000|Overall Study|Patient started non-protocol therapy|0|||
19541840|NCT01187446|41991076|FG001|Overall Study|Patient started non-protocol therapy|1|||
19541841|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
19541842|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19541843|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19541844|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19541845|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19541846|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
19541847|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19541848|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19541849|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19541850|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19541851|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
19541852|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19541853|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19541854|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19541855|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19541856|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
19541857|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19541858|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19541859|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19541860|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19541861|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
19541862|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19541863|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19631795|NCT00764790|42081174|FG001|Overall Study|Withdrawal by Subject|12|||
19631796|NCT00764790|42081175|FG002|Overall Study|Withdrawal by Subject|6|||
19631797|NCT00764790|42081173|FG000|Overall Study|Lost to Follow-up|28|||
19631798|NCT00764790|42081174|FG001|Overall Study|Lost to Follow-up|29|||
19631799|NCT00764790|42081175|FG002|Overall Study|Lost to Follow-up|23|||
19631800|NCT00756444|42081185|FG000|Overall Study|Adverse Event|1|||
19631801|NCT00756444|42081186|FG001|Overall Study|Adverse Event|1|||
19631802|NCT00756444|42081185|FG000|Overall Study|Withdrawal by Subject|6|||
19631803|NCT00756444|42081186|FG001|Overall Study|Withdrawal by Subject|8|||
19631804|NCT00756444|42081185|FG000|Overall Study|Lost to Follow-up|0|||
19631805|NCT00756444|42081186|FG001|Overall Study|Lost to Follow-up|1|||
19631806|NCT00756444|42081185|FG000|Overall Study|Death|5|||
19631807|NCT00756444|42081186|FG001|Overall Study|Death|4|||
19631808|NCT00756444|42081185|FG000|Overall Study|Disease Progression|2|||
19631809|NCT00756444|42081186|FG001|Overall Study|Disease Progression|7|||
19631810|NCT00756444|42081185|FG000|Overall Study|Ineligibility Determined|1|||
19631811|NCT00756444|42081186|FG001|Overall Study|Ineligibility Determined|0|||
19541864|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19541865|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19631812|NCT00769002|42081197|FG000|Overall Study|Study was not completed, no data|9|||
19541866|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
19631813|NCT00769002|42081198|FG001|Overall Study|Study was not completed, no data|9|||
19631814|NCT00753012|42081205|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
19711581|NCT00079274|42154662|FG005|Overall Study|Other Medical Problems|0|||
19457887|NCT01445301|41711444|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
19457888|NCT01445301|41711445|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
19457889|NCT01445301|41711443|FG000|Overall Study|Physician Decision|0|||
19457890|NCT01445301|41711444|FG001|Overall Study|Physician Decision|2|||
19457891|NCT01445301|41711445|FG002|Overall Study|Physician Decision|0|||
19457892|NCT01445301|41711443|FG000|Overall Study|Withdrawal by Subject|5|||
19457893|NCT01445301|41711444|FG001|Overall Study|Withdrawal by Subject|6|||
19457894|NCT01445301|41711445|FG002|Overall Study|Withdrawal by Subject|4|||
19457895|NCT01409031|41711455|FG000|Overall Study|transferred to other hosp|1|||
19541867|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19541868|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19541869|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19541870|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19541871|NCT01187407|41991086|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
19541872|NCT01187407|41991087|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19457896|NCT01409031|41711456|FG001|Overall Study|transferred to other hosp|0|||
19457897|NCT01430403|41711465|FG000|Overall Study|Lost to Follow-up|5|||
19457898|NCT01430403|41711466|FG001|Overall Study|Lost to Follow-up|5|||
19457899|NCT01430403|41711467|FG002|Overall Study|Lost to Follow-up|3|||
19457900|NCT01430403|41711465|FG000|Overall Study|Physician Decision|1|||
19457901|NCT01430403|41711466|FG001|Overall Study|Physician Decision|0|||
19457902|NCT01430403|41711467|FG002|Overall Study|Physician Decision|0|||
19457903|NCT01430403|41711465|FG000|Overall Study|Protocol Violation|2|||
19457904|NCT01430403|41711466|FG001|Overall Study|Protocol Violation|3|||
19457905|NCT01430403|41711467|FG002|Overall Study|Protocol Violation|2|||
19457906|NCT01430403|41711465|FG000|Overall Study|Withdrawal by Subject|9|||
19457907|NCT01430403|41711466|FG001|Overall Study|Withdrawal by Subject|1|||
19457908|NCT01430403|41711467|FG002|Overall Study|Withdrawal by Subject|3|||
19457909|NCT01429623|41711482|FG000|Overall Study|Death|1|||
19457910|NCT01429623|41711483|FG001|Overall Study|Death|0|||
19457911|NCT01429623|41711482|FG000|Overall Study|Adverse Event|7|||
19541873|NCT01187407|41991088|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19541874|NCT01187407|41991089|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19631815|NCT00753012|42081206|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
19631816|NCT00753012|42081205|FG000|Overall Study|Adverse Event|2|||
19631817|NCT00753012|42081206|FG001|Overall Study|Adverse Event|0|||
19631818|NCT00753012|42081205|FG000|Overall Study|Withdrawal by Subject|0|||
19631819|NCT00753012|42081206|FG001|Overall Study|Withdrawal by Subject|1|||
19631820|NCT00753012|42081205|FG000|Overall Study|Lost to Follow-up|4|||
19631821|NCT00753012|42081206|FG001|Overall Study|Lost to Follow-up|0|||
19631822|NCT00753012|42081205|FG000|Overall Study|Confounded endpoint data|1|||
19631823|NCT00753012|42081206|FG001|Overall Study|Confounded endpoint data|0|||
19631824|NCT00806156|42081215|FG000|Overall Study|Death|35|||
19631825|NCT00806156|42081216|FG001|Overall Study|Death|95|||
19631826|NCT00806156|42081215|FG000|Overall Study|Did not meet eligibility criteria|1|||
19631827|NCT00806156|42081216|FG001|Overall Study|Did not meet eligibility criteria|0|||
19631828|NCT00806156|42081215|FG000|Overall Study|Study terminated by Sponsor|2|||
19631829|NCT00806156|42081216|FG001|Overall Study|Study terminated by Sponsor|40|||
19631830|NCT00806156|42081215|FG000|Overall Study|Consent withdrawn by subject|1|||
19631831|NCT00806156|42081216|FG001|Overall Study|Consent withdrawn by subject|3|||
19631832|NCT00806156|42081215|FG000|Overall Study|Lost to Follow-up|0|||
19631833|NCT00806156|42081216|FG001|Overall Study|Lost to Follow-up|1|||
19631834|NCT00764478|42081237|FG000|Overall Study|Adverse Event|1|||
19631835|NCT00764478|42081238|FG001|Overall Study|Adverse Event|1|||
19631836|NCT00764478|42081239|FG002|Overall Study|Adverse Event|1|||
19631837|NCT00764478|42081237|FG000|Overall Study|Withdrawal by Subject|7|||
19631838|NCT00764478|42081238|FG001|Overall Study|Withdrawal by Subject|12|||
19631839|NCT00764478|42081239|FG002|Overall Study|Withdrawal by Subject|1|||
19631840|NCT00764478|42081237|FG000|Overall Study|Lost to Follow-up|7|||
19631841|NCT00764478|42081238|FG001|Overall Study|Lost to Follow-up|8|||
19631842|NCT00764478|42081239|FG002|Overall Study|Lost to Follow-up|5|||
19631843|NCT00764478|42081237|FG000|Overall Study|Protocol Violation|0|||
19631844|NCT00764478|42081238|FG001|Overall Study|Protocol Violation|1|||
19631845|NCT00764478|42081239|FG002|Overall Study|Protocol Violation|1|||
19631846|NCT00805766|42081247|FG000|Screening Period|Adverse Event|1|||
19631847|NCT00805766|42081247|FG000|Screening Period|Lack of Efficacy|2|||
19631848|NCT00805766|42081247|FG000|Screening Period|Pregnancy|1|||
19631849|NCT00805766|42081247|FG000|Screening Period|Responder|2|||
19631850|NCT00805766|42081247|FG000|Increased Dose Period|Adverse Event|4|||
19711582|NCT00079274|42154663|FG006|Overall Study|Other Medical Problems|0|||
19457912|NCT01429623|41711483|FG001|Overall Study|Adverse Event|14|||
19457913|NCT01429623|41711482|FG000|Overall Study|Withdrawal by Subject|19|||
19457914|NCT01429623|41711483|FG001|Overall Study|Withdrawal by Subject|13|||
19631851|NCT00805766|42081247|FG000|Increased Dose Period|Lack of Efficacy|7|||
19631852|NCT00805766|42081247|FG000|Increased Dose Period|Pregnancy|1|||
19631853|NCT00805766|42081247|FG000|Increased Dose Period|Withdrawal by Subject|1|||
19631854|NCT00805532|42081257|FG000|Overall Study|invalid data|0|||
19631855|NCT00805532|42081258|FG001|Overall Study|invalid data|1|||
19541875|NCT01187407|41991090|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19541876|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
19541877|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
19541878|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
19541879|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
19541880|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
19541881|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
19541882|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
19541883|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
19541884|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
19541885|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
19541886|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
19541887|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
19541888|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
19541889|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
19541890|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
19541891|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19541892|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19541893|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19541894|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
19541895|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
19541896|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
19541897|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
19541898|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
19541899|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
19541900|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
19541901|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
19541902|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
19541903|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
19541904|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
19541905|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
19541906|NCT01187407|41991086|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19541907|NCT01187407|41991087|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
19541908|NCT01187407|41991088|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
19541909|NCT01187407|41991089|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
19541910|NCT01187407|41991090|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
19541911|NCT01186978|41991107|FG000|Overall Study|Withdrawal by Subject|1|||
19541912|NCT01186939|41991111|FG000|Overall Study|Death|7|||
19541913|NCT01186939|41991111|FG000|Overall Study|Withdrawal by Subject|2|||
19541914|NCT01186939|41991111|FG000|Overall Study|No longer receiving clinical benefit|17|||
19541915|NCT01186939|41991111|FG000|Overall Study|Program closed|5|||
19541916|NCT01186939|41991111|FG000|Overall Study|Sponsor decision|4|||
19541917|NCT01186939|41991111|FG000|Overall Study|Started additional treatment|1|||
19541918|NCT01186939|41991111|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
19541919|NCT01186939|41991111|FG000|Overall Study|Myocardial infarction|1|||
19541920|NCT01186939|41991111|FG000|Overall Study|Bone marrow transplant|1|||
19541921|NCT01186939|41991111|FG000|Overall Study|Transformation to AML|1|||
19541922|NCT01658826|41991171|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
19541923|NCT01658826|41991172|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
19541924|NCT01658826|41991171|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
19541925|NCT01658826|41991172|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
19541926|NCT01658826|41991171|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
19541927|NCT01658826|41991172|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
19541928|NCT01658826|41991171|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
19541929|NCT01658826|41991172|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
19541930|NCT01658826|41991171|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
19541931|NCT01658826|41991172|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
19541932|NCT01658826|41991171|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
19541933|NCT01658826|41991172|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
19541934|NCT01658826|41991171|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
19541935|NCT01658826|41991172|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
19541936|NCT01658826|41991171|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
19541937|NCT01658826|41991172|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
19711583|NCT00079274|42154657|FG000|Overall Study|Death|4|||
19541938|NCT01658826|41991171|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
19541939|NCT01658826|41991172|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
19541940|NCT01186744|41991188|FG000|Overall Study|Lack of Efficacy|156|||
19631856|NCT00764322|42081268|FG000|Overall Study|Withdrawal by Subject|11|||
19631857|NCT00764322|42081268|FG000|Overall Study|No CYP2D6 genotyping|9|||
19631858|NCT00752856|42081287|FG000|Overall Study|randomized but did not do viral kinetics|0|||
19631859|NCT00752856|42081288|FG001|Overall Study|randomized but did not do viral kinetics|1|||
19631860|NCT00755196|42081294|FG000|Overall Study|Lost to Follow-up|1|||
19631861|NCT00755196|42081294|FG000|Overall Study|Lack of Efficiency|1|||
19631862|NCT00805142|42081301|FG000|Titration Period|Adverse Event|3|||
19631863|NCT00805142|42081302|FG001|Titration Period|Adverse Event|3|||
19631864|NCT00805142|42081301|FG000|Titration Period|Lack of Efficacy|1|||
19631865|NCT00805142|42081302|FG001|Titration Period|Lack of Efficacy|1|||
19631866|NCT00805142|42081301|FG000|Titration Period|Lost to Follow-up|0|||
19631867|NCT00805142|42081302|FG001|Titration Period|Lost to Follow-up|1|||
19631868|NCT00805142|42081301|FG000|Titration Period|Disease Progression|2|||
19631869|NCT00805142|42081302|FG001|Titration Period|Disease Progression|1|||
19631870|NCT00805142|42081301|FG000|Titration Period|Withdrawal of consent|0|||
19631871|NCT00805142|42081302|FG001|Titration Period|Withdrawal of consent|1|||
19631872|NCT00805142|42081301|FG000|Titration Period|Other|0|||
19631873|NCT00805142|42081302|FG001|Titration Period|Other|3|||
19631874|NCT00805142|42081301|FG000|Maintenance Period|Adverse Event|0|||
19631875|NCT00805142|42081302|FG001|Maintenance Period|Adverse Event|1|||
19631876|NCT00805142|42081301|FG000|Maintenance Period|Other|0|||
19631877|NCT00805142|42081302|FG001|Maintenance Period|Other|1|||
19631878|NCT00761631|42081319|FG000|Overall Study|Parent/legal guardian request|8|||
19631879|NCT00761631|42081320|FG001|Overall Study|Parent/legal guardian request|3|||
19631880|NCT00761631|42081321|FG002|Overall Study|Parent/legal guardian request|8|||
19631881|NCT00761631|42081322|FG003|Overall Study|Parent/legal guardian request|0|||
19631882|NCT00761631|42081323|FG004|Overall Study|Parent/legal guardian request|5|||
19631883|NCT00761631|42081324|FG005|Overall Study|Parent/legal guardian request|0|||
19631884|NCT00761631|42081319|FG000|Overall Study|Lost to Follow-up|2|||
19631885|NCT00761631|42081320|FG001|Overall Study|Lost to Follow-up|4|||
19631886|NCT00761631|42081321|FG002|Overall Study|Lost to Follow-up|7|||
19631887|NCT00761631|42081322|FG003|Overall Study|Lost to Follow-up|1|||
19631888|NCT00761631|42081323|FG004|Overall Study|Lost to Follow-up|6|||
19631889|NCT00761631|42081324|FG005|Overall Study|Lost to Follow-up|1|||
19631890|NCT00761631|42081319|FG000|Overall Study|Protocol Violation|2|||
19631891|NCT00761631|42081320|FG001|Overall Study|Protocol Violation|0|||
19631892|NCT00761631|42081321|FG002|Overall Study|Protocol Violation|0|||
19631893|NCT00761631|42081322|FG003|Overall Study|Protocol Violation|1|||
19631894|NCT00761631|42081323|FG004|Overall Study|Protocol Violation|5|||
19631895|NCT00761631|42081324|FG005|Overall Study|Protocol Violation|1|||
19631896|NCT00761631|42081319|FG000|Overall Study|Randomized, not treated|1|||
19631897|NCT00761631|42081320|FG001|Overall Study|Randomized, not treated|0|||
19631898|NCT00761631|42081321|FG002|Overall Study|Randomized, not treated|0|||
19631899|NCT00761631|42081322|FG003|Overall Study|Randomized, not treated|0|||
19631900|NCT00761631|42081323|FG004|Overall Study|Randomized, not treated|0|||
19631901|NCT00761631|42081324|FG005|Overall Study|Randomized, not treated|0|||
19631902|NCT00761631|42081319|FG000|Overall Study|Failed to return|1|||
19631903|NCT00761631|42081320|FG001|Overall Study|Failed to return|0|||
19631904|NCT00761631|42081321|FG002|Overall Study|Failed to return|1|||
19631905|NCT00761631|42081322|FG003|Overall Study|Failed to return|1|||
19631906|NCT00761631|42081323|FG004|Overall Study|Failed to return|5|||
19631907|NCT00761631|42081324|FG005|Overall Study|Failed to return|2|||
19631908|NCT00761631|42081319|FG000|Overall Study|Physician Decision|1|||
19631909|NCT00761631|42081320|FG001|Overall Study|Physician Decision|0|||
19631910|NCT00761631|42081321|FG002|Overall Study|Physician Decision|0|||
19631911|NCT00761631|42081322|FG003|Overall Study|Physician Decision|0|||
19631912|NCT00761631|42081323|FG004|Overall Study|Physician Decision|0|||
19541941|NCT01186744|41991189|FG001|Overall Study|Lack of Efficacy|99|||
19541942|NCT01186744|41991190|FG002|Overall Study|Lack of Efficacy|0|||
19541943|NCT01186744|41991191|FG003|Overall Study|Lack of Efficacy|2|||
19631913|NCT00761631|42081324|FG005|Overall Study|Physician Decision|0|||
19631914|NCT00761631|42081319|FG000|Overall Study|Other|0|||
19631915|NCT00761631|42081320|FG001|Overall Study|Other|0|||
19631916|NCT00761631|42081321|FG002|Overall Study|Other|0|||
19631917|NCT00761631|42081322|FG003|Overall Study|Other|0|||
19631918|NCT00761631|42081323|FG004|Overall Study|Other|1|||
19631919|NCT00761631|42081324|FG005|Overall Study|Other|1|||
19631920|NCT00763698|42081347|FG000|Overall Study|Unsuccessful Implant|5|||
19457915|NCT01429623|41711482|FG000|Overall Study|Physician Decision|2|||
19457916|NCT01429623|41711483|FG001|Overall Study|Physician Decision|3|||
19457917|NCT01429623|41711482|FG000|Overall Study|Protocol Violation|3|||
19457918|NCT01429623|41711483|FG001|Overall Study|Protocol Violation|2|||
19457919|NCT01429623|41711482|FG000|Overall Study|Assorted|1|||
19457920|NCT01429623|41711483|FG001|Overall Study|Assorted|2|||
19457921|NCT01429623|41711482|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
19541944|NCT01186744|41991192|FG004|Overall Study|Lack of Efficacy|2|||
19541945|NCT01186744|41991193|FG005|Overall Study|Lack of Efficacy|5|||
19541946|NCT01186744|41991188|FG000|Overall Study|Protocol Violation|1|||
19541947|NCT01186744|41991189|FG001|Overall Study|Protocol Violation|2|||
19541948|NCT01186744|41991190|FG002|Overall Study|Protocol Violation|0|||
19541949|NCT01186744|41991191|FG003|Overall Study|Protocol Violation|1|||
19541950|NCT01186744|41991192|FG004|Overall Study|Protocol Violation|1|||
19541951|NCT01186744|41991193|FG005|Overall Study|Protocol Violation|2|||
19541952|NCT01186744|41991188|FG000|Overall Study|Lost to Follow-up|15|||
19541953|NCT01186744|41991189|FG001|Overall Study|Lost to Follow-up|16|||
19541954|NCT01186744|41991190|FG002|Overall Study|Lost to Follow-up|2|||
19541955|NCT01186744|41991191|FG003|Overall Study|Lost to Follow-up|1|||
19541956|NCT01186744|41991192|FG004|Overall Study|Lost to Follow-up|1|||
19541957|NCT01186744|41991193|FG005|Overall Study|Lost to Follow-up|4|||
19541958|NCT01186744|41991188|FG000|Overall Study|Screen failure|1|||
19541959|NCT01186744|41991189|FG001|Overall Study|Screen failure|1|||
19541960|NCT01186744|41991190|FG002|Overall Study|Screen failure|0|||
19541961|NCT01186744|41991191|FG003|Overall Study|Screen failure|1|||
19541962|NCT01186744|41991192|FG004|Overall Study|Screen failure|0|||
19541963|NCT01186744|41991193|FG005|Overall Study|Screen failure|0|||
19541964|NCT01186744|41991188|FG000|Overall Study|Withdrawal by Subject|14|||
19541965|NCT01186744|41991189|FG001|Overall Study|Withdrawal by Subject|10|||
19541966|NCT01186744|41991190|FG002|Overall Study|Withdrawal by Subject|2|||
19541967|NCT01186744|41991191|FG003|Overall Study|Withdrawal by Subject|5|||
19541968|NCT01186744|41991192|FG004|Overall Study|Withdrawal by Subject|0|||
19541969|NCT01186744|41991193|FG005|Overall Study|Withdrawal by Subject|6|||
19541970|NCT01186744|41991188|FG000|Overall Study|Study terminated by Sponsor|1|||
19541971|NCT01186744|41991189|FG001|Overall Study|Study terminated by Sponsor|0|||
19541972|NCT01186744|41991190|FG002|Overall Study|Study terminated by Sponsor|0|||
19541973|NCT01186744|41991191|FG003|Overall Study|Study terminated by Sponsor|0|||
19541974|NCT01186744|41991192|FG004|Overall Study|Study terminated by Sponsor|0|||
19541975|NCT01186744|41991193|FG005|Overall Study|Study terminated by Sponsor|0|||
19541976|NCT01186744|41991188|FG000|Overall Study|Other|9|||
19541977|NCT01186744|41991189|FG001|Overall Study|Other|10|||
19541978|NCT01186744|41991190|FG002|Overall Study|Other|1|||
19541979|NCT01186744|41991191|FG003|Overall Study|Other|2|||
19541980|NCT01186744|41991192|FG004|Overall Study|Other|1|||
19541981|NCT01186744|41991193|FG005|Overall Study|Other|5|||
19541982|NCT01186744|41991188|FG000|Overall Study|Adverse Event|10|||
19541983|NCT01186744|41991189|FG001|Overall Study|Adverse Event|14|||
19541984|NCT01186744|41991190|FG002|Overall Study|Adverse Event|1|||
19541985|NCT01186744|41991191|FG003|Overall Study|Adverse Event|0|||
19541986|NCT01186744|41991192|FG004|Overall Study|Adverse Event|1|||
19541987|NCT01186744|41991193|FG005|Overall Study|Adverse Event|4|||
19541988|NCT01186744|41991188|FG000|Overall Study|Death|1|||
19541989|NCT01186744|41991189|FG001|Overall Study|Death|0|||
19541990|NCT01186744|41991190|FG002|Overall Study|Death|0|||
19541991|NCT01186744|41991191|FG003|Overall Study|Death|0|||
19541992|NCT01186744|41991192|FG004|Overall Study|Death|0|||
19541993|NCT01186744|41991193|FG005|Overall Study|Death|0|||
19541994|NCT01185964|41991231|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
19541995|NCT01185964|41991232|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
19541996|NCT01185964|41991233|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
19541997|NCT01185964|41991234|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
19541998|NCT01185964|41991231|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
19541999|NCT01185964|41991232|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
19542000|NCT01185964|41991233|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
19542001|NCT01185964|41991234|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
19457922|NCT01429623|41711483|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
19457923|NCT01429623|41711482|FG000|Overall Study|No post baseline data|4|||
19457924|NCT01429623|41711483|FG001|Overall Study|No post baseline data|4|||
19457925|NCT01408641|41711491|FG000|Overall Study|Physician Decision|1|||
19457926|NCT01408641|41711492|FG001|Overall Study|Physician Decision|0|||
19457927|NCT01429077|41711500|FG000|Overall Study|Lost to Follow-up|0|||
19457928|NCT01429077|41711501|FG001|Overall Study|Lost to Follow-up|3|||
19457929|NCT01428453|41711509|FG000|Overall Study|Adverse Event|2|||
19457930|NCT01428453|41711510|FG001|Overall Study|Adverse Event|7|||
19457931|NCT01428453|41711509|FG000|Overall Study|Protocol Violation|1|||
19457932|NCT01428453|41711510|FG001|Overall Study|Protocol Violation|0|||
19457933|NCT01428453|41711509|FG000|Overall Study|Lost to Follow-up|0|||
19542002|NCT01185964|41991231|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
19542003|NCT01185964|41991232|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
19542004|NCT01185964|41991233|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
19542005|NCT01185964|41991234|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
19542006|NCT01185964|41991231|FG000|Phase 1b and Phase 2|Adverse Event|1|||
19542007|NCT01185964|41991232|FG001|Phase 1b and Phase 2|Adverse Event|0|||
19542008|NCT01185964|41991233|FG002|Phase 1b and Phase 2|Adverse Event|2|||
19542009|NCT01185964|41991234|FG003|Phase 1b and Phase 2|Adverse Event|0|||
19457934|NCT01428453|41711510|FG001|Overall Study|Lost to Follow-up|1|||
19457935|NCT01428453|41711509|FG000|Overall Study|Withdrawal by Subject|3|||
19542010|NCT01185964|41991231|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
19542011|NCT01185964|41991232|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
19542012|NCT01185964|41991233|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
19542013|NCT01185964|41991234|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
19542014|NCT01185964|41991231|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
19542015|NCT01185964|41991232|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
19542016|NCT01185964|41991233|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
19542017|NCT01185964|41991234|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
19542018|NCT01185964|41991231|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
19542019|NCT01185964|41991232|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
19542020|NCT01185964|41991233|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
19542021|NCT01185964|41991234|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
19542022|NCT01185964|41991231|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
19542023|NCT01185964|41991232|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
19542024|NCT01185964|41991233|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
19542025|NCT01185964|41991234|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
19542026|NCT01217476|41991252|FG000|Overall Study|Adverse Event|6|||
19542027|NCT01217476|41991253|FG001|Overall Study|Adverse Event|1|||
19542028|NCT01217476|41991252|FG000|Overall Study|Physician Decision|0|||
19542029|NCT01217476|41991253|FG001|Overall Study|Physician Decision|1|||
19542030|NCT01217476|41991252|FG000|Overall Study|Withdrawal by Subject|3|||
19542031|NCT01217476|41991253|FG001|Overall Study|Withdrawal by Subject|3|||
19542032|NCT01217476|41991252|FG000|Overall Study|Surgery on the Target Limb|0|||
19542033|NCT01217476|41991253|FG001|Overall Study|Surgery on the Target Limb|2|||
19542034|NCT01217476|41991252|FG000|Overall Study|Protocol Deviation|1|||
19542035|NCT01217476|41991253|FG001|Overall Study|Protocol Deviation|0|||
19542036|NCT01217476|41991252|FG000|Overall Study|Other|2|||
19542037|NCT01217476|41991253|FG001|Overall Study|Other|0|||
19542038|NCT01217437|41991274|FG000|Overall Study|Adverse Event|0|||
19542039|NCT01217437|41991275|FG001|Overall Study|Adverse Event|8|||
19542040|NCT01217437|41991274|FG000|Overall Study|Death|5|||
19542041|NCT01217437|41991275|FG001|Overall Study|Death|0|||
19542042|NCT01217437|41991274|FG000|Overall Study|Lack of Efficacy|29|||
19542043|NCT01217437|41991275|FG001|Overall Study|Lack of Efficacy|25|||
19542044|NCT01217437|41991274|FG000|Overall Study|Physician Decision|8|||
19542045|NCT01217437|41991275|FG001|Overall Study|Physician Decision|5|||
19542046|NCT01217437|41991274|FG000|Overall Study|Withdrawal by Subject|0|||
19542047|NCT01217437|41991275|FG001|Overall Study|Withdrawal by Subject|2|||
19542048|NCT01217437|41991274|FG000|Overall Study|Ineligible|1|||
19542049|NCT01217437|41991275|FG001|Overall Study|Ineligible|1|||
19542050|NCT01217047|41991285|FG000|Overall Study|Lost to Follow-up|0|||
19542051|NCT01217047|41991286|FG001|Overall Study|Lost to Follow-up|1|||
19542052|NCT01217047|41991287|FG002|Overall Study|Lost to Follow-up|0|||
19542053|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
19542054|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19542055|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19542056|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19542057|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
19542058|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19542059|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19542060|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19542061|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
19542062|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19542063|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19542064|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19542065|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
19542066|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19542067|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19542068|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19542069|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
19542070|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19542071|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19457936|NCT01428453|41711510|FG001|Overall Study|Withdrawal by Subject|1|||
19457937|NCT01408563|41711518|FG000|Overall Study|Ineligible after consent/ registration|2|||
19457938|NCT01442493|41711524|FG000|Overall Study|withdrawn from study|3|||
19457939|NCT01442493|41711525|FG001|Overall Study|withdrawn from study|2|||
19457940|NCT01442181|41711533|FG000|Overall Study|patient refused surgery|1|||
19457941|NCT01442181|41711534|FG001|Overall Study|patient refused surgery|0|||
19375421|NCT02276872|41617348|FG002|Overall Study|Adverse Event|0|||
19631921|NCT00763698|42081347|FG000|Overall Study|Death|4|||
19631922|NCT00763698|42081347|FG000|Overall Study|Withdrawal by Subject|1|||
19631923|NCT00763386|42081354|FG000|Overall Study|Adverse Event|43|||
19631924|NCT00763386|42081355|FG001|Overall Study|Adverse Event|33|||
19631925|NCT00763386|42081354|FG000|Overall Study|Death|1|||
19631926|NCT00763386|42081355|FG001|Overall Study|Death|2|||
19631927|NCT00763386|42081354|FG000|Overall Study|Lost to Follow-up|3|||
19631928|NCT00763386|42081355|FG001|Overall Study|Lost to Follow-up|3|||
19631929|NCT00763386|42081354|FG000|Overall Study|Withdrawal by Subject|0|||
19631930|NCT00763386|42081355|FG001|Overall Study|Withdrawal by Subject|1|||
19631931|NCT00763386|42081354|FG000|Overall Study|CRF missing|0|||
19542072|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19542073|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
19631932|NCT00763386|42081355|FG001|Overall Study|CRF missing|1|||
19631933|NCT00763386|42081354|FG000|Overall Study|Study Prosthesis Removed|1|||
19631934|NCT00763386|42081355|FG001|Overall Study|Study Prosthesis Removed|0|||
19542074|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19542075|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19631935|NCT00761319|42081363|FG000|Overall Study|Protocol Violation|21|||
19631936|NCT00761319|42081364|FG001|Overall Study|Protocol Violation|14|||
19631937|NCT00761319|42081363|FG000|Overall Study|Adverse Event|11|||
19631938|NCT00761319|42081364|FG001|Overall Study|Adverse Event|7|||
19631939|NCT00761319|42081363|FG000|Overall Study|Withdrawal by Subject|8|||
19631940|NCT00761319|42081364|FG001|Overall Study|Withdrawal by Subject|7|||
19631941|NCT00761319|42081363|FG000|Overall Study|Noncompliance|4|||
19631942|NCT00761319|42081364|FG001|Overall Study|Noncompliance|3|||
19631943|NCT00761319|42081363|FG000|Overall Study|Lost to Follow-up|1|||
19631944|NCT00761319|42081364|FG001|Overall Study|Lost to Follow-up|1|||
19631945|NCT00761319|42081363|FG000|Overall Study|Nonspecified|2|||
19631946|NCT00761319|42081364|FG001|Overall Study|Nonspecified|2|||
19631947|NCT00761319|42081363|FG000|Overall Study|Missing|1|||
19631948|NCT00761319|42081364|FG001|Overall Study|Missing|0|||
19631949|NCT00762996|42081370|FG000|Period One|Protocol Violation|0|||
19631950|NCT00762996|42081371|FG001|Period One|Protocol Violation|0|||
19631951|NCT00762996|42081372|FG002|Period One|Protocol Violation|1|||
19631952|NCT00762996|42081373|FG003|Period One|Protocol Violation|0|||
19542076|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19542077|NCT01185340|41991299|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
19542078|NCT01185340|41991300|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19542079|NCT01185340|41991301|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19542080|NCT01185340|41991302|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19542081|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
19631953|NCT00762996|42081370|FG000|Period One|ineligible|0|||
19631954|NCT00762996|42081371|FG001|Period One|ineligible|0|||
19631955|NCT00762996|42081372|FG002|Period One|ineligible|1|||
19631956|NCT00762996|42081373|FG003|Period One|ineligible|1|||
19631957|NCT00762996|42081370|FG000|Period One|Adverse Event|0|||
19631958|NCT00762996|42081371|FG001|Period One|Adverse Event|0|||
19631959|NCT00762996|42081372|FG002|Period One|Adverse Event|1|||
19631960|NCT00762996|42081373|FG003|Period One|Adverse Event|0|||
19631961|NCT00762996|42081370|FG000|Period One|Withdrawal by Subject|0|||
19631962|NCT00762996|42081371|FG001|Period One|Withdrawal by Subject|0|||
19631963|NCT00762996|42081372|FG002|Period One|Withdrawal by Subject|1|||
19631964|NCT00762996|42081373|FG003|Period One|Withdrawal by Subject|0|||
19631965|NCT00762606|42081383|FG000|Overall Study|Lost to Follow-up|18|||
19631966|NCT00762606|42081384|FG001|Overall Study|Lost to Follow-up|13|||
19631967|NCT00818441|42081392|FG000|Overall Study|Death|69|||
19631968|NCT00818441|42081393|FG001|Overall Study|Death|26|||
19631969|NCT00818441|42081392|FG000|Overall Study|Other|5|||
19631970|NCT00818441|42081393|FG001|Overall Study|Other|0|||
19631971|NCT00818441|42081392|FG000|Overall Study|Lost to Follow-up|2|||
19631972|NCT00818441|42081393|FG001|Overall Study|Lost to Follow-up|1|||
19631973|NCT00818441|42081392|FG000|Overall Study|Withdrawal by Subject|2|||
19631974|NCT00818441|42081393|FG001|Overall Study|Withdrawal by Subject|0|||
19631975|NCT00818441|42081392|FG000|Overall Study|Adverse Event|0|||
19631976|NCT00818441|42081393|FG001|Overall Study|Adverse Event|1|||
19631977|NCT00818441|42081392|FG000|Overall Study|Study terminated by sponsor|11|||
19631978|NCT00818441|42081393|FG001|Overall Study|Study terminated by sponsor|2|||
19711584|NCT00079274|42154658|FG001|Overall Study|Death|0|||
19631979|NCT00826943|42081400|FG000|Overall Study|Withdrawal by Subject|0|||
19631980|NCT00826943|42081401|FG001|Overall Study|Withdrawal by Subject|0|||
19631981|NCT00826943|42081402|FG002|Overall Study|Withdrawal by Subject|0|||
19631982|NCT00826943|42081403|FG003|Overall Study|Withdrawal by Subject|0|||
19631983|NCT00826943|42081404|FG004|Overall Study|Withdrawal by Subject|1|||
19631984|NCT00826943|42081405|FG005|Overall Study|Withdrawal by Subject|0|||
19711585|NCT00079274|42154659|FG002|Overall Study|Death|1|||
19542082|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
19631985|NCT00834041|42081415|FG000|Overall Study|Withdrawal by Subject|1|||
19711586|NCT00079274|42154660|FG003|Overall Study|Death|15|||
19631986|NCT00834041|42081416|FG001|Overall Study|Withdrawal by Subject|0|||
19631987|NCT00834041|42081415|FG000|Overall Study|Lost to Follow-up|0|||
19631988|NCT00834041|42081416|FG001|Overall Study|Lost to Follow-up|1|||
19631989|NCT00760929|42081426|FG000|Overall Study|Adverse Event|2|||
19631990|NCT00760929|42081427|FG001|Overall Study|Adverse Event|0|||
19631991|NCT00760929|42081428|FG002|Overall Study|Adverse Event|6|||
19631992|NCT00760929|42081429|FG003|Overall Study|Adverse Event|10|||
19631993|NCT00760929|42081426|FG000|Overall Study|Lack of Efficacy|0|||
19631994|NCT00760929|42081427|FG001|Overall Study|Lack of Efficacy|2|||
19631995|NCT00760929|42081428|FG002|Overall Study|Lack of Efficacy|1|||
19631996|NCT00760929|42081429|FG003|Overall Study|Lack of Efficacy|0|||
19631997|NCT00760929|42081426|FG000|Overall Study|Withdrawal by Subject|1|||
19631998|NCT00760929|42081427|FG001|Overall Study|Withdrawal by Subject|0|||
19631999|NCT00760929|42081428|FG002|Overall Study|Withdrawal by Subject|9|||
19632000|NCT00760929|42081429|FG003|Overall Study|Withdrawal by Subject|1|||
19632001|NCT00760929|42081426|FG000|Overall Study|Lost to Follow-up|0|||
19632002|NCT00760929|42081427|FG001|Overall Study|Lost to Follow-up|0|||
19632003|NCT00760929|42081428|FG002|Overall Study|Lost to Follow-up|1|||
19632004|NCT00760929|42081429|FG003|Overall Study|Lost to Follow-up|0|||
19632005|NCT00760929|42081426|FG000|Overall Study|Progression of Disease|21|||
19632006|NCT00760929|42081427|FG001|Overall Study|Progression of Disease|26|||
19632007|NCT00760929|42081428|FG002|Overall Study|Progression of Disease|38|||
19632008|NCT00760929|42081429|FG003|Overall Study|Progression of Disease|42|||
19632009|NCT00760929|42081426|FG000|Overall Study|Other|2|||
19632010|NCT00760929|42081427|FG001|Overall Study|Other|0|||
19632011|NCT00760929|42081428|FG002|Overall Study|Other|2|||
19632012|NCT00760929|42081429|FG003|Overall Study|Other|1|||
19632013|NCT00760929|42081426|FG000|Overall Study|Death|0|||
19632014|NCT00760929|42081427|FG001|Overall Study|Death|0|||
19632015|NCT00760929|42081428|FG002|Overall Study|Death|1|||
19632016|NCT00760929|42081429|FG003|Overall Study|Death|0|||
19632017|NCT00760929|42081426|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
19632018|NCT00760929|42081427|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
19632019|NCT00760929|42081428|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
19632020|NCT00760929|42081429|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
19632021|NCT00818207|42081440|FG000|Overall Study|Adverse Event|6|||
19632022|NCT00818207|42081441|FG001|Overall Study|Adverse Event|0|||
19632023|NCT00818207|42081440|FG000|Overall Study|Lost to Follow-up|160|||
19632024|NCT00818207|42081441|FG001|Overall Study|Lost to Follow-up|146|||
19632025|NCT00818207|42081440|FG000|Overall Study|Multiple reasons|11|||
19632026|NCT00818207|42081441|FG001|Overall Study|Multiple reasons|12|||
19632027|NCT00818207|42081440|FG000|Overall Study|Withdrawal by Subject|42|||
19632028|NCT00818207|42081441|FG001|Overall Study|Withdrawal by Subject|104|||
19632029|NCT00818207|42081440|FG000|Overall Study|Death|3|||
19632030|NCT00818207|42081441|FG001|Overall Study|Death|5|||
19632031|NCT00760617|42081450|FG000|Overall Study|Adverse Event|5|||
19632032|NCT00760617|42081451|FG001|Overall Study|Adverse Event|2|||
19632033|NCT00760617|42081452|FG002|Overall Study|Adverse Event|0|||
19632034|NCT00760617|42081450|FG000|Overall Study|Lost to Follow-up|0|||
19632035|NCT00760617|42081451|FG001|Overall Study|Lost to Follow-up|0|||
19632036|NCT00760617|42081452|FG002|Overall Study|Lost to Follow-up|5|||
19632037|NCT00760383|42081462|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
19632038|NCT00760383|42081463|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
19632039|NCT00759915|42081471|FG000|Overall Study|Withdrawal by Subject|1|||
19632040|NCT00759915|42081472|FG001|Overall Study|Withdrawal by Subject|0|||
19632041|NCT00759915|42081471|FG000|Overall Study|Adverse Event|0|||
19632042|NCT00759915|42081472|FG001|Overall Study|Adverse Event|1|||
19632043|NCT00759759|42081480|FG000|Overall Study|didn't return for period 2|1|||
19632044|NCT00759759|42081481|FG001|Overall Study|didn't return for period 2|0|||
19632045|NCT00759759|42081480|FG000|Overall Study|Didn't receive drug in period 2|1|||
19632046|NCT00759759|42081481|FG001|Overall Study|Didn't receive drug in period 2|0|||
19632047|NCT00759759|42081480|FG000|Overall Study|Withdrawal by Subject|2|||
19632048|NCT00759759|42081481|FG001|Overall Study|Withdrawal by Subject|1|||
19632049|NCT00759681|42081489|FG000|Overall Study|Death|2|||
19632050|NCT00759681|42081490|FG001|Overall Study|Death|5|||
19632051|NCT00759681|42081489|FG000|Overall Study|Lost to Follow-up|8|||
19632052|NCT00759681|42081490|FG001|Overall Study|Lost to Follow-up|5|||
19632053|NCT00826241|42081497|FG000|Overall Study|Withdrawal from Follow-up|1|||
19632054|NCT00826241|42081497|FG000|Overall Study|Withdrew consent|2|||
19632055|NCT00826241|42081497|FG000|Overall Study|Death|4|||
19632056|NCT00826241|42081497|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
19632057|NCT00826241|42081497|FG000|Overall Study|Non-compliance|1|||
19632058|NCT00826241|42081497|FG000|Overall Study|Progression of disease|1|||
19632059|NCT00826241|42081497|FG000|Overall Study|Patient refused follow-up|3|||
19632060|NCT00826241|42081497|FG000|Overall Study|Lost to Follow-up|9|||
19632061|NCT00826241|42081497|FG000|Overall Study|Could not obtain records|1|||
19632062|NCT00826241|42081497|FG000|Overall Study|Screen failure|2|||
19632063|NCT00826241|42081497|FG000|Overall Study|Pt unable to proceed to registration|1|||
19632064|NCT00826241|42081497|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
19632065|NCT00758589|42081505|FG000|Overall Study|Adverse Event|3|||
19632066|NCT00758589|42081506|FG001|Overall Study|Adverse Event|2|||
19632067|NCT00758589|42081507|FG002|Overall Study|Adverse Event|5|||
19632068|NCT00758589|42081508|FG003|Overall Study|Adverse Event|4|||
19632069|NCT00758589|42081505|FG000|Overall Study|Withdrawal by Subject|0|||
19632070|NCT00758589|42081506|FG001|Overall Study|Withdrawal by Subject|1|||
19632071|NCT00758589|42081507|FG002|Overall Study|Withdrawal by Subject|1|||
19632072|NCT00758589|42081508|FG003|Overall Study|Withdrawal by Subject|1|||
19632073|NCT00758589|42081505|FG000|Overall Study|Palm stopped to work|0|||
19542083|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
19542084|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
19542085|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
19542086|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
19542087|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
19542088|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
19542089|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
19542090|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
19542091|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
19542092|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
19542093|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19542094|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
19542095|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19542096|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
19542097|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
19542098|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
19542099|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
19542100|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
19542101|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
19542102|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
19542103|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
19542104|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
19542105|NCT01185340|41991299|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19542106|NCT01185340|41991300|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19542107|NCT01185340|41991301|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
19542108|NCT01185340|41991302|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
19542109|NCT01216189|41991316|FG000|Overall Study|Lost to Follow-up|21|||
19542110|NCT01216189|41991317|FG001|Overall Study|Lost to Follow-up|3|||
19542111|NCT01216189|41991316|FG000|Overall Study|Death|4|||
19542112|NCT01216189|41991317|FG001|Overall Study|Death|2|||
19542113|NCT01185301|41991327|FG000|Overall Study|Adverse Event|3|||
19542114|NCT01185301|41991328|FG001|Overall Study|Adverse Event|0|||
19542115|NCT01185301|41991329|FG002|Overall Study|Adverse Event|2|||
19542116|NCT01185301|41991330|FG003|Overall Study|Adverse Event|3|||
19542117|NCT01185301|41991327|FG000|Overall Study|Withdrawal by Subject|7|||
19542118|NCT01185301|41991328|FG001|Overall Study|Withdrawal by Subject|5|||
19542119|NCT01185301|41991329|FG002|Overall Study|Withdrawal by Subject|2|||
19542120|NCT01185301|41991330|FG003|Overall Study|Withdrawal by Subject|3|||
19542121|NCT01185301|41991327|FG000|Overall Study|Lost to Follow-up|2|||
19542122|NCT01185301|41991328|FG001|Overall Study|Lost to Follow-up|0|||
19542123|NCT01185301|41991329|FG002|Overall Study|Lost to Follow-up|0|||
19542124|NCT01185301|41991330|FG003|Overall Study|Lost to Follow-up|1|||
19542125|NCT01185301|41991327|FG000|Overall Study|Other Reason|3|||
19542126|NCT01185301|41991328|FG001|Overall Study|Other Reason|2|||
19542127|NCT01185301|41991329|FG002|Overall Study|Other Reason|2|||
19542128|NCT01185301|41991330|FG003|Overall Study|Other Reason|2|||
19542129|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
19542130|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
19542131|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
19542132|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
19542133|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
19542134|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
19542135|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
19542136|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
19542137|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
19542138|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
19542139|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
19632074|NCT00758589|42081506|FG001|Overall Study|Palm stopped to work|0|||
19632075|NCT00758589|42081507|FG002|Overall Study|Palm stopped to work|0|||
19632076|NCT00758589|42081508|FG003|Overall Study|Palm stopped to work|1|||
19632077|NCT00833417|42081520|FG000|Overall Study|Adverse Event|5|||
19632078|NCT00833417|42081521|FG001|Overall Study|Adverse Event|16|||
19632079|NCT00833417|42081520|FG000|Overall Study|Death|1|||
19632080|NCT00833417|42081521|FG001|Overall Study|Death|3|||
19632081|NCT00833417|42081520|FG000|Overall Study|Lost to Follow-up|1|||
19632082|NCT00833417|42081521|FG001|Overall Study|Lost to Follow-up|2|||
19632083|NCT00833417|42081520|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
19632084|NCT00833417|42081521|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
19632085|NCT00833417|42081520|FG000|Overall Study|Patient Decision to Withdraw|4|||
19632086|NCT00833417|42081521|FG001|Overall Study|Patient Decision to Withdraw|23|||
19632087|NCT00833417|42081520|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
19632088|NCT00833417|42081521|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
19632089|NCT00833417|42081520|FG000|Overall Study|Disease Progression|18|||
19632090|NCT00833417|42081521|FG001|Overall Study|Disease Progression|17|||
19632091|NCT00833417|42081520|FG000|Overall Study|Reason Not Specified|0|||
19632092|NCT00833417|42081521|FG001|Overall Study|Reason Not Specified|1|||
19632093|NCT00762372|42081531|FG000|Overall Study|Adverse Event|1|||
19632094|NCT00762372|42081532|FG001|Overall Study|Adverse Event|0|||
19632095|NCT00762372|42081533|FG002|Overall Study|Adverse Event|0|||
19632096|NCT00833261|42081547|FG000|Overall Study|Withdrawal by Subject|4|||
19632097|NCT00833105|42081551|FG000|Overall Study|Withdrawal by Subject|1|||
19632098|NCT00833105|42081551|FG000|Overall Study|Adverse Event|2|||
19632099|NCT00833027|42081557|FG000|Overall Study|Adverse Event|33|||
19632100|NCT00833027|42081557|FG000|Overall Study|Death|1|||
19632101|NCT00833027|42081557|FG000|Overall Study|Lack of Efficacy|12|||
19632102|NCT00833027|42081557|FG000|Overall Study|Lost to Follow-up|24|||
19632103|NCT00833027|42081557|FG000|Overall Study|Protocol Violation|115|||
19632104|NCT00833027|42081557|FG000|Overall Study|Withdrawal by Subject|16|||
19632105|NCT00833027|42081557|FG000|Overall Study|Missing|10|||
19632106|NCT00752622|42081561|FG000|Induction Phase|Adverse Event|3|||
19632107|NCT00752622|42081561|FG000|Induction Phase|Other|3|||
19632108|NCT00752622|42081561|FG000|Induction Phase|Non-responder|14|||
19632109|NCT00752622|42081561|FG000|Induction Phase|Withdrawal by Subject|1|||
19632110|NCT00752622|42081561|FG000|Induction Phase|Premature study termination|14|||
19632111|NCT00752622|42081561|FG000|Observational Phase|Premature Study Termination|36|||
19632112|NCT00752622|42081561|FG000|Observational Phase|Non-responder|2|||
19632113|NCT00752622|42081561|FG000|Observational Phase|Withdrawal by Subject|2|||
19632114|NCT00752622|42081561|FG000|Observational Phase|Adverse Event|1|||
19632115|NCT00752622|42081561|FG000|Observational Phase|Other|2|||
19632116|NCT00752622|42081561|FG000|Interventional Phase|Non-responder|2|||
19632117|NCT00752622|42081561|FG000|Interventional Phase|Physician Decision|1|||
19632118|NCT00752622|42081561|FG000|Interventional Phase|Premature Study Termination|5|||
19632119|NCT00754650|42081566|FG000|Overall Study|Disease Progression|2|||
19632120|NCT00761748|42081570|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
19632121|NCT00761748|42081571|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
19632122|NCT00761748|42081570|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
19632123|NCT00761748|42081571|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
19632124|NCT00825305|42081579|FG000|Overall Study|Adverse Event|1|||
19632125|NCT00825305|42081580|FG001|Overall Study|Adverse Event|1|||
19632126|NCT00825305|42081579|FG000|Overall Study|Withdrawal by Subject|6|||
19632127|NCT00825305|42081580|FG001|Overall Study|Withdrawal by Subject|12|||
19632128|NCT00825305|42081579|FG000|Overall Study|Inappropriate inclusion|1|||
19632129|NCT00825305|42081580|FG001|Overall Study|Inappropriate inclusion|0|||
19632130|NCT00825305|42081579|FG000|Overall Study|Protocol Violation|9|||
19632131|NCT00825305|42081580|FG001|Overall Study|Protocol Violation|9|||
19632132|NCT00825305|42081579|FG000|Overall Study|Can not be classified|0|||
19632133|NCT00825305|42081580|FG001|Overall Study|Can not be classified|1|||
19632134|NCT00754572|42081586|FG000|Overall Study|Adverse Event|19|||
19632135|NCT00754572|42081586|FG000|Overall Study|Other|39|||
19632136|NCT00754572|42081586|FG000|Overall Study|Protocol Violation|3|||
19632137|NCT00754572|42081586|FG000|Overall Study|Withdrawal by Subject|3|||
19632138|NCT00754572|42081586|FG000|Overall Study|Lack of Efficacy|2|||
19632139|NCT00754572|42081586|FG000|Overall Study|Death|1|||
19632140|NCT00754572|42081586|FG000|Overall Study|Administrative Reason|3|||
19632141|NCT00754572|42081586|FG000|Overall Study|Lost to Follow-up|1|||
19632142|NCT00824993|42081592|FG000|Overall Study|Withdrawal by Subject|1|||
19632143|NCT00824993|42081593|FG001|Overall Study|Withdrawal by Subject|1|||
19632144|NCT00824993|42081592|FG000|Overall Study|Malignancy Relapse|9|||
19632145|NCT00824993|42081593|FG001|Overall Study|Malignancy Relapse|10|||
19632146|NCT00824993|42081592|FG000|Overall Study|Rapid Bone Loss|0|||
19632147|NCT00824993|42081593|FG001|Overall Study|Rapid Bone Loss|1|||
19632148|NCT00824993|42081592|FG000|Overall Study|Non-Compliant|2|||
19632149|NCT00824993|42081593|FG001|Overall Study|Non-Compliant|1|||
19632150|NCT00824993|42081592|FG000|Overall Study|Insurance Issue|2|||
19632151|NCT00824993|42081593|FG001|Overall Study|Insurance Issue|1|||
19632152|NCT00824993|42081592|FG000|Overall Study|Death|0|||
19632153|NCT00824993|42081593|FG001|Overall Study|Death|3|||
19632154|NCT00832091|42081601|FG000|Overall Study|Adverse Event|1|||
19632155|NCT00832091|42081602|FG001|Overall Study|Adverse Event|1|||
19711587|NCT00079274|42154661|FG004|Overall Study|Death|0|||
19632156|NCT00832091|42081601|FG000|Overall Study|Protocol Violation|1|||
19632157|NCT00832091|42081602|FG001|Overall Study|Protocol Violation|0|||
19632158|NCT00832091|42081601|FG000|Overall Study|Withdrawal by Subject|2|||
19632159|NCT00832091|42081602|FG001|Overall Study|Withdrawal by Subject|1|||
19632160|NCT00832091|42081601|FG000|Overall Study|Prohibited Medication|1|||
19632161|NCT00832091|42081602|FG001|Overall Study|Prohibited Medication|0|||
19632162|NCT00754338|42081612|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
19632163|NCT00754338|42081613|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
19632164|NCT00754338|42081614|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
19632165|NCT00754338|42081615|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
19632166|NCT00754338|42081612|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
19632167|NCT00754338|42081613|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
19632168|NCT00754338|42081614|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
19632169|NCT00754338|42081615|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
19632170|NCT00761514|42081627|FG000|Overall Study|Adverse Event|1|||
19632171|NCT00761514|42081627|FG000|Overall Study|Withdrawal by Subject|2|||
19632172|NCT00761514|42081627|FG000|Overall Study|Lost to Follow-up|1|||
19632173|NCT00761514|42081627|FG000|Overall Study|Health insurance didn't cover study drug|1|||
19632174|NCT00761514|42081627|FG000|Overall Study|Problem complying with study visit|1|||
19632175|NCT00761514|42081627|FG000|Overall Study|Unable to pay for medications|1|||
19632176|NCT00831779|42081633|FG000|Overall Study|Lost to Follow-up|1|||
19632177|NCT00831779|42081634|FG001|Overall Study|Lost to Follow-up|0|||
19711588|NCT00079274|42154662|FG005|Overall Study|Death|0|||
19711589|NCT00079274|42154663|FG006|Overall Study|Death|0|||
19711590|NCT00079274|42154657|FG000|Overall Study|Cytogenetic resistance|0|||
19711591|NCT00079274|42154658|FG001|Overall Study|Cytogenetic resistance|0|||
19632178|NCT00831779|42081633|FG000|Overall Study|No longer met criteria|0|||
19632179|NCT00831779|42081634|FG001|Overall Study|No longer met criteria|1|||
19632180|NCT00758043|42081644|FG000|Overall Study|Adverse Event|1|||
19632181|NCT00758043|42081645|FG001|Overall Study|Adverse Event|20|||
19632182|NCT00758043|42081646|FG002|Overall Study|Adverse Event|12|||
19632183|NCT00758043|42081647|FG003|Overall Study|Adverse Event|62|||
19632184|NCT00758043|42081644|FG000|Overall Study|Lack of Efficacy|0|||
19632185|NCT00758043|42081645|FG001|Overall Study|Lack of Efficacy|6|||
19632186|NCT00758043|42081646|FG002|Overall Study|Lack of Efficacy|18|||
19632187|NCT00758043|42081647|FG003|Overall Study|Lack of Efficacy|12|||
19632188|NCT00758043|42081644|FG000|Overall Study|Refused Further Treatment|0|||
19632189|NCT00758043|42081645|FG001|Overall Study|Refused Further Treatment|11|||
19632190|NCT00758043|42081646|FG002|Overall Study|Refused Further Treatment|5|||
19632191|NCT00758043|42081647|FG003|Overall Study|Refused Further Treatment|8|||
19632192|NCT00758043|42081644|FG000|Overall Study|Lost to Follow-up|0|||
19632193|NCT00758043|42081645|FG001|Overall Study|Lost to Follow-up|2|||
19632194|NCT00758043|42081646|FG002|Overall Study|Lost to Follow-up|2|||
19632195|NCT00758043|42081647|FG003|Overall Study|Lost to Follow-up|5|||
19632196|NCT00758043|42081644|FG000|Overall Study|Withdrawal by Subject|0|||
19632197|NCT00758043|42081645|FG001|Overall Study|Withdrawal by Subject|1|||
19632198|NCT00758043|42081646|FG002|Overall Study|Withdrawal by Subject|1|||
19632199|NCT00758043|42081647|FG003|Overall Study|Withdrawal by Subject|4|||
19632200|NCT00758043|42081644|FG000|Overall Study|Required Prohibited Medication|0|||
19632201|NCT00758043|42081645|FG001|Overall Study|Required Prohibited Medication|0|||
19632202|NCT00758043|42081646|FG002|Overall Study|Required Prohibited Medication|1|||
19632203|NCT00758043|42081647|FG003|Overall Study|Required Prohibited Medication|3|||
19632204|NCT00758043|42081644|FG000|Overall Study|Non-Compliant With study Drug|0|||
19632205|NCT00758043|42081645|FG001|Overall Study|Non-Compliant With study Drug|0|||
19632206|NCT00758043|42081646|FG002|Overall Study|Non-Compliant With study Drug|0|||
19632207|NCT00758043|42081647|FG003|Overall Study|Non-Compliant With study Drug|1|||
19632208|NCT00758043|42081644|FG000|Overall Study|Other Reasons|0|||
19632209|NCT00758043|42081645|FG001|Overall Study|Other Reasons|1|||
19632210|NCT00758043|42081646|FG002|Overall Study|Other Reasons|0|||
19632211|NCT00758043|42081647|FG003|Overall Study|Other Reasons|5|||
19632212|NCT00831701|42081665|FG000|Overall Study|Withdrawal by Subject|2|||
19632213|NCT00831701|42081666|FG001|Overall Study|Withdrawal by Subject|0|||
19632214|NCT00831701|42081665|FG000|Overall Study|Stone expulsion before first medication|2|||
19632215|NCT00831701|42081666|FG001|Overall Study|Stone expulsion before first medication|2|||
19632216|NCT00831701|42081665|FG000|Overall Study|Lost to Follow-up|1|||
19632217|NCT00831701|42081666|FG001|Overall Study|Lost to Follow-up|3|||
19632218|NCT00752895|42081674|FG000|Overall Study|Withdrawal by Subject|8|||
19632219|NCT00752895|42081675|FG001|Overall Study|Withdrawal by Subject|3|||
19632220|NCT00831389|42081683|FG000|Overall Study|Withdrawal by Subject|0|||
19632221|NCT00831389|42081684|FG001|Overall Study|Withdrawal by Subject|1|||
19632222|NCT00831311|42081692|FG000|Overall Study|Definitive Contraindication|3|||
19632223|NCT00831311|42081693|FG001|Overall Study|Definitive Contraindication|3|||
19632224|NCT00831311|42081692|FG000|Overall Study|Lost to Follow-up|3|||
19632225|NCT00831311|42081693|FG001|Overall Study|Lost to Follow-up|0|||
19632226|NCT00831311|42081692|FG000|Overall Study|Physician Decision|0|||
19632227|NCT00831311|42081693|FG001|Overall Study|Physician Decision|1|||
19632228|NCT00831311|42081692|FG000|Overall Study|Withdrawal by Subject|6|||
19632229|NCT00831311|42081693|FG001|Overall Study|Withdrawal by Subject|4|||
19632230|NCT00831233|42081702|FG000|Overall Study|Adverse Event|0|||
19632231|NCT00831233|42081703|FG001|Overall Study|Adverse Event|1|||
19632232|NCT00831233|42081702|FG000|Overall Study|Protocol Violation|1|||
19632233|NCT00831233|42081703|FG001|Overall Study|Protocol Violation|0|||
19632234|NCT00831233|42081702|FG000|Overall Study|Selection Criteria Not Met|2|||
19632235|NCT00831233|42081703|FG001|Overall Study|Selection Criteria Not Met|0|||
19632236|NCT00761280|42081720|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
19632237|NCT00761280|42081721|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
19632238|NCT00761280|42081720|FG000|Randomization to First Dose|Sponsor decision|1|||
19632239|NCT00761280|42081721|FG001|Randomization to First Dose|Sponsor decision|0|||
19632240|NCT00761280|42081720|FG000|Randomization to First Dose|Other|1|||
19632241|NCT00761280|42081721|FG001|Randomization to First Dose|Other|0|||
19632242|NCT00761280|42081720|FG000|First Dose to End of Study|End of trial|5|||
19632243|NCT00761280|42081721|FG001|First Dose to End of Study|End of trial|5|||
19632244|NCT00761280|42081720|FG000|First Dose to End of Study|Progressive disease|5|||
19632245|NCT00761280|42081721|FG001|First Dose to End of Study|Progressive disease|3|||
19632246|NCT00761280|42081720|FG000|First Dose to End of Study|Sponsor decision|1|||
19632247|NCT00761280|42081721|FG001|First Dose to End of Study|Sponsor decision|2|||
19632248|NCT00761280|42081720|FG000|First Dose to End of Study|Death|1|||
19632249|NCT00761280|42081721|FG001|First Dose to End of Study|Death|0|||
19632250|NCT00761280|42081720|FG000|First Dose to End of Study|Lost to Follow-up|0|||
19632251|NCT00761280|42081721|FG001|First Dose to End of Study|Lost to Follow-up|1|||
19632252|NCT00824369|42081733|FG000|Overall Study|Nolonger willing to participate in study|1|||
19632253|NCT00824369|42081734|FG001|Overall Study|Nolonger willing to participate in study|0|||
19632254|NCT00824369|42081735|FG002|Overall Study|Nolonger willing to participate in study|1|||
19632255|NCT00824369|42081736|FG003|Overall Study|Nolonger willing to participate in study|2|||
19632256|NCT00824369|42081737|FG004|Overall Study|Nolonger willing to participate in study|0|||
19632257|NCT00824369|42081738|FG005|Overall Study|Nolonger willing to participate in study|1|||
19632258|NCT00824369|42081733|FG000|Overall Study|Lost to Follow-up|0|||
19632259|NCT00824369|42081734|FG001|Overall Study|Lost to Follow-up|0|||
19632260|NCT00824369|42081735|FG002|Overall Study|Lost to Follow-up|0|||
19632261|NCT00824369|42081736|FG003|Overall Study|Lost to Follow-up|0|||
19632262|NCT00824369|42081737|FG004|Overall Study|Lost to Follow-up|1|||
19632263|NCT00824369|42081738|FG005|Overall Study|Lost to Follow-up|0|||
19632264|NCT00824291|42081754|FG000|Overall Study|Adverse Event|15|||
19542140|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
19542141|NCT01216072|41991342|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
19542142|NCT01216072|41991343|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
19542143|NCT01216072|41991342|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
19542144|NCT01216072|41991343|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
19542145|NCT01216072|41991342|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
19542146|NCT01216072|41991343|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
19542147|NCT01216072|41991342|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
19542148|NCT01216072|41991343|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
19542149|NCT01184989|41991352|FG000|Overall Study|Adverse Event|11|||
19542150|NCT01184989|41991352|FG000|Overall Study|Withdrawal by Subject|1|||
19542151|NCT01215955|41991360|FG000|Overall Study|Adverse Event|1|||
19542152|NCT01215955|41991361|FG001|Overall Study|Adverse Event|4|||
19542153|NCT01215955|41991362|FG002|Overall Study|Adverse Event|2|||
19542154|NCT01215955|41991363|FG003|Overall Study|Adverse Event|3|||
19542155|NCT01215955|41991360|FG000|Overall Study|Death|2|||
19542156|NCT01215955|41991361|FG001|Overall Study|Death|0|||
19542157|NCT01215955|41991362|FG002|Overall Study|Death|1|||
19542158|NCT01215955|41991363|FG003|Overall Study|Death|3|||
19542159|NCT01215955|41991360|FG000|Overall Study|Entry Criteria Not Met|1|||
19542160|NCT01215955|41991361|FG001|Overall Study|Entry Criteria Not Met|3|||
19542161|NCT01215955|41991362|FG002|Overall Study|Entry Criteria Not Met|4|||
19542162|NCT01215955|41991363|FG003|Overall Study|Entry Criteria Not Met|7|||
19542163|NCT01215955|41991360|FG000|Overall Study|Lack of Efficacy|1|||
19542164|NCT01215955|41991361|FG001|Overall Study|Lack of Efficacy|2|||
19632265|NCT00824291|42081755|FG001|Overall Study|Adverse Event|6|||
19632266|NCT00824291|42081754|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
19632267|NCT00824291|42081755|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
19632268|NCT00824291|42081754|FG000|Overall Study|Lost to Follow-up|11|||
19542165|NCT01215955|41991362|FG002|Overall Study|Lack of Efficacy|1|||
19542166|NCT01215955|41991363|FG003|Overall Study|Lack of Efficacy|0|||
19542167|NCT01215955|41991360|FG000|Overall Study|Lost to Follow-up|4|||
19542168|NCT01215955|41991361|FG001|Overall Study|Lost to Follow-up|4|||
19542169|NCT01215955|41991362|FG002|Overall Study|Lost to Follow-up|8|||
19542170|NCT01215955|41991363|FG003|Overall Study|Lost to Follow-up|9|||
19542171|NCT01215955|41991360|FG000|Overall Study|Physician Decision|4|||
19542172|NCT01215955|41991361|FG001|Overall Study|Physician Decision|10|||
19542173|NCT01215955|41991362|FG002|Overall Study|Physician Decision|8|||
19542174|NCT01215955|41991363|FG003|Overall Study|Physician Decision|11|||
19542175|NCT01215955|41991360|FG000|Overall Study|Protocol Violation|17|||
19542176|NCT01215955|41991361|FG001|Overall Study|Protocol Violation|13|||
19542177|NCT01215955|41991362|FG002|Overall Study|Protocol Violation|8|||
19542178|NCT01215955|41991363|FG003|Overall Study|Protocol Violation|8|||
19542179|NCT01215955|41991360|FG000|Overall Study|Sponsor Decision|1|||
19542180|NCT01215955|41991361|FG001|Overall Study|Sponsor Decision|2|||
19542181|NCT01215955|41991362|FG002|Overall Study|Sponsor Decision|0|||
19542182|NCT01215955|41991363|FG003|Overall Study|Sponsor Decision|1|||
19542183|NCT01215955|41991360|FG000|Overall Study|Withdrawal by Subject|14|||
19542184|NCT01215955|41991361|FG001|Overall Study|Withdrawal by Subject|15|||
19542185|NCT01215955|41991362|FG002|Overall Study|Withdrawal by Subject|13|||
19542186|NCT01215955|41991363|FG003|Overall Study|Withdrawal by Subject|9|||
19542187|NCT01215955|41991360|FG000|Overall Study|Quality Issues|0|||
19542188|NCT01215955|41991361|FG001|Overall Study|Quality Issues|0|||
19542189|NCT01215955|41991362|FG002|Overall Study|Quality Issues|3|||
19542190|NCT01215955|41991363|FG003|Overall Study|Quality Issues|2|||
19542191|NCT01215916|41991402|FG000|Overall Study|Progressive Disease|0|||
19542192|NCT01215916|41991403|FG001|Overall Study|Progressive Disease|2|||
19542193|NCT01215916|41991404|FG002|Overall Study|Progressive Disease|1|||
19542194|NCT01215916|41991405|FG003|Overall Study|Progressive Disease|2|||
19542195|NCT01215916|41991406|FG004|Overall Study|Progressive Disease|5|||
19542196|NCT01215916|41991407|FG005|Overall Study|Progressive Disease|4|||
19542197|NCT01215916|41991408|FG006|Overall Study|Progressive Disease|5|||
19542198|NCT01215916|41991409|FG007|Overall Study|Progressive Disease|3|||
19542199|NCT01215916|41991410|FG008|Overall Study|Progressive Disease|1|||
19542200|NCT01215916|41991402|FG000|Overall Study|Adverse Event|1|||
19542201|NCT01215916|41991403|FG001|Overall Study|Adverse Event|1|||
19542202|NCT01215916|41991404|FG002|Overall Study|Adverse Event|0|||
19542203|NCT01215916|41991405|FG003|Overall Study|Adverse Event|1|||
19542204|NCT01215916|41991406|FG004|Overall Study|Adverse Event|0|||
19542205|NCT01215916|41991407|FG005|Overall Study|Adverse Event|0|||
19542206|NCT01215916|41991408|FG006|Overall Study|Adverse Event|3|||
19542207|NCT01215916|41991409|FG007|Overall Study|Adverse Event|0|||
19542208|NCT01215916|41991410|FG008|Overall Study|Adverse Event|0|||
19542209|NCT01215916|41991402|FG000|Overall Study|Withdrawal by Subject|0|||
19542210|NCT01215916|41991403|FG001|Overall Study|Withdrawal by Subject|1|||
19542211|NCT01215916|41991404|FG002|Overall Study|Withdrawal by Subject|1|||
19542212|NCT01215916|41991405|FG003|Overall Study|Withdrawal by Subject|2|||
19542213|NCT01215916|41991406|FG004|Overall Study|Withdrawal by Subject|0|||
19542214|NCT01215916|41991407|FG005|Overall Study|Withdrawal by Subject|0|||
19542215|NCT01215916|41991408|FG006|Overall Study|Withdrawal by Subject|1|||
19542216|NCT01215916|41991409|FG007|Overall Study|Withdrawal by Subject|0|||
19542217|NCT01215916|41991410|FG008|Overall Study|Withdrawal by Subject|0|||
19542218|NCT01215916|41991402|FG000|Overall Study|Death|0|||
19542219|NCT01215916|41991403|FG001|Overall Study|Death|1|||
19542220|NCT01215916|41991404|FG002|Overall Study|Death|0|||
19542221|NCT01215916|41991405|FG003|Overall Study|Death|0|||
19542222|NCT01215916|41991406|FG004|Overall Study|Death|1|||
19542223|NCT01215916|41991407|FG005|Overall Study|Death|0|||
19542224|NCT01215916|41991408|FG006|Overall Study|Death|0|||
19542225|NCT01215916|41991409|FG007|Overall Study|Death|0|||
19542226|NCT01215916|41991410|FG008|Overall Study|Death|1|||
19632269|NCT00824291|42081755|FG001|Overall Study|Lost to Follow-up|9|||
19632270|NCT00824291|42081754|FG000|Overall Study|Non-compliance|1|||
19632271|NCT00824291|42081755|FG001|Overall Study|Non-compliance|1|||
19632272|NCT00824291|42081754|FG000|Overall Study|Protocol Violation|4|||
19632273|NCT00824291|42081755|FG001|Overall Study|Protocol Violation|1|||
19632274|NCT00824291|42081754|FG000|Overall Study|Withdrawal by Subject|14|||
19632275|NCT00824291|42081755|FG001|Overall Study|Withdrawal by Subject|8|||
19711592|NCT00079274|42154659|FG002|Overall Study|Cytogenetic resistance|0|||
19542227|NCT01215916|41991402|FG000|Overall Study|Physician Decision|0|||
19542228|NCT01215916|41991403|FG001|Overall Study|Physician Decision|0|||
19711593|NCT00079274|42154660|FG003|Overall Study|Cytogenetic resistance|2|||
19711594|NCT00079274|42154661|FG004|Overall Study|Cytogenetic resistance|0|||
19375422|NCT00835367|41617363|FG000|Washout|Adverse Event|2|||
19632276|NCT00824291|42081754|FG000|Overall Study|Lack of Efficacy|7|||
19542229|NCT01215916|41991404|FG002|Overall Study|Physician Decision|1|||
19542230|NCT01215916|41991405|FG003|Overall Study|Physician Decision|1|||
19542231|NCT01215916|41991406|FG004|Overall Study|Physician Decision|0|||
19542232|NCT01215916|41991407|FG005|Overall Study|Physician Decision|0|||
19542233|NCT01215916|41991408|FG006|Overall Study|Physician Decision|0|||
19542234|NCT01215916|41991409|FG007|Overall Study|Physician Decision|0|||
19542235|NCT01215916|41991410|FG008|Overall Study|Physician Decision|0|||
19542236|NCT01184872|41991436|FG000|Overall Study|Adverse Event|3|||
19542237|NCT01184872|41991437|FG001|Overall Study|Adverse Event|4|||
19542238|NCT01184872|41991436|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
19542239|NCT01184872|41991437|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19542240|NCT01184872|41991436|FG000|Overall Study|Withdrawal by Subject|2|||
19542241|NCT01184872|41991437|FG001|Overall Study|Withdrawal by Subject|0|||
19542242|NCT01184872|41991436|FG000|Overall Study|Lost to Follow-up|0|||
19542243|NCT01184872|41991437|FG001|Overall Study|Lost to Follow-up|1|||
19542244|NCT01184872|41991436|FG000|Overall Study|Administrative problems|1|||
19542245|NCT01184872|41991437|FG001|Overall Study|Administrative problems|1|||
19542246|NCT01184872|41991436|FG000|Overall Study|Protocol deviation|1|||
19542247|NCT01184872|41991437|FG001|Overall Study|Protocol deviation|0|||
19542248|NCT01215721|41991443|FG000|Overall Study|Adverse Event|2|||
19542249|NCT01184326|41991450|FG000|Overall Study|Adverse Event|1|||
19542250|NCT01184326|41991451|FG001|Overall Study|Adverse Event|2|||
19542251|NCT01184326|41991452|FG002|Overall Study|Adverse Event|0|||
19542252|NCT01184326|41991450|FG000|Overall Study|Death|0|||
19542253|NCT01184326|41991451|FG001|Overall Study|Death|0|||
19542254|NCT01184326|41991452|FG002|Overall Study|Death|1|||
19542255|NCT01184326|41991450|FG000|Overall Study|Withdrawal by Subject|0|||
19542256|NCT01184326|41991451|FG001|Overall Study|Withdrawal by Subject|0|||
19542257|NCT01184326|41991452|FG002|Overall Study|Withdrawal by Subject|1|||
19542258|NCT01184326|41991450|FG000|Overall Study|Physician Decision|1|||
19542259|NCT01184326|41991451|FG001|Overall Study|Physician Decision|1|||
19542260|NCT01184326|41991452|FG002|Overall Study|Physician Decision|0|||
19542261|NCT01184326|41991450|FG000|Overall Study|Disease Progression|1|||
19542262|NCT01184326|41991451|FG001|Overall Study|Disease Progression|3|||
19542263|NCT01184326|41991452|FG002|Overall Study|Disease Progression|12|||
19542264|NCT01215253|41991465|FG000|Overall Study|Withdrawal by Subject|57|||
19542265|NCT01215253|41991466|FG001|Overall Study|Withdrawal by Subject|35|||
19542266|NCT01215253|41991465|FG000|Overall Study|Physician Decision|9|||
19542267|NCT01215253|41991466|FG001|Overall Study|Physician Decision|12|||
19542268|NCT01215253|41991465|FG000|Overall Study|Lost to Follow-up|6|||
19542269|NCT01215253|41991466|FG001|Overall Study|Lost to Follow-up|4|||
19542270|NCT01215253|41991465|FG000|Overall Study|Other|14|||
19542271|NCT01215253|41991466|FG001|Overall Study|Other|12|||
19542272|NCT01184053|41991473|FG000|Overall Study|progression while on treatment|3|||
19542273|NCT01183975|41991478|FG000|Overall Study|Lost to Follow-up|73|||
19542274|NCT01183858|41991484|FG000|Overall Study|Death not related to Progressive Disease|5|||
19542275|NCT01183858|41991485|FG001|Overall Study|Death not related to Progressive Disease|6|||
19542276|NCT01183858|41991484|FG000|Overall Study|Adverse Event|14|||
19542277|NCT01183858|41991485|FG001|Overall Study|Adverse Event|11|||
19542278|NCT01183858|41991484|FG000|Overall Study|Investigator's Decision|0|||
19632277|NCT00824291|42081755|FG001|Overall Study|Lack of Efficacy|8|||
19632278|NCT00824291|42081754|FG000|Overall Study|Participant on prohibited medication|1|||
19632279|NCT00824291|42081755|FG001|Overall Study|Participant on prohibited medication|0|||
19632280|NCT00804986|42081767|FG000|Overall Study|Adverse Event|0|||
19632281|NCT00804986|42081768|FG001|Overall Study|Adverse Event|1|||
19632282|NCT00804986|42081769|FG002|Overall Study|Adverse Event|2|||
19632283|NCT00804986|42081770|FG003|Overall Study|Adverse Event|1|||
19632284|NCT00804986|42081771|FG004|Overall Study|Adverse Event|3|||
19632285|NCT00804986|42081772|FG005|Overall Study|Adverse Event|0|||
19632286|NCT00804986|42081767|FG000|Overall Study|Lack of Efficacy|0|||
19632287|NCT00804986|42081768|FG001|Overall Study|Lack of Efficacy|0|||
19632288|NCT00804986|42081769|FG002|Overall Study|Lack of Efficacy|0|||
19632289|NCT00804986|42081770|FG003|Overall Study|Lack of Efficacy|1|||
19632290|NCT00804986|42081771|FG004|Overall Study|Lack of Efficacy|0|||
19632291|NCT00804986|42081772|FG005|Overall Study|Lack of Efficacy|3|||
19632292|NCT00804986|42081767|FG000|Overall Study|Lost to Follow-up|0|||
19632293|NCT00804986|42081768|FG001|Overall Study|Lost to Follow-up|0|||
19632294|NCT00804986|42081769|FG002|Overall Study|Lost to Follow-up|0|||
19632295|NCT00804986|42081770|FG003|Overall Study|Lost to Follow-up|1|||
19632296|NCT00804986|42081771|FG004|Overall Study|Lost to Follow-up|1|||
19632297|NCT00804986|42081772|FG005|Overall Study|Lost to Follow-up|3|||
19632298|NCT00804986|42081767|FG000|Overall Study|Protocol Violation|0|||
19632299|NCT00804986|42081768|FG001|Overall Study|Protocol Violation|1|||
19632300|NCT00804986|42081769|FG002|Overall Study|Protocol Violation|0|||
19632301|NCT00804986|42081770|FG003|Overall Study|Protocol Violation|1|||
19632302|NCT00804986|42081771|FG004|Overall Study|Protocol Violation|0|||
19711595|NCT00079274|42154662|FG005|Overall Study|Cytogenetic resistance|0|||
19542279|NCT01183858|41991485|FG001|Overall Study|Investigator's Decision|3|||
19632303|NCT00804986|42081772|FG005|Overall Study|Protocol Violation|0|||
19632304|NCT00804986|42081767|FG000|Overall Study|Withdrawal by Subject|0|||
19632305|NCT00804986|42081768|FG001|Overall Study|Withdrawal by Subject|3|||
19632306|NCT00804986|42081769|FG002|Overall Study|Withdrawal by Subject|0|||
19632307|NCT00804986|42081770|FG003|Overall Study|Withdrawal by Subject|3|||
19632308|NCT00804986|42081771|FG004|Overall Study|Withdrawal by Subject|5|||
19542280|NCT01183858|41991484|FG000|Overall Study|Insufficient Therapeutic Response|2|||
19542281|NCT01183858|41991485|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19632309|NCT00804986|42081772|FG005|Overall Study|Withdrawal by Subject|3|||
19632310|NCT00804986|42081767|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
19632311|NCT00804986|42081768|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
19632312|NCT00804986|42081769|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
19632313|NCT00804986|42081770|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
19632314|NCT00804986|42081771|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
19632315|NCT00804986|42081772|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
19632316|NCT00804986|42081767|FG000|Overall Study|Sponsor Decision|0|||
19632317|NCT00804986|42081768|FG001|Overall Study|Sponsor Decision|1|||
19632318|NCT00804986|42081769|FG002|Overall Study|Sponsor Decision|0|||
19632319|NCT00804986|42081770|FG003|Overall Study|Sponsor Decision|0|||
19632320|NCT00804986|42081771|FG004|Overall Study|Sponsor Decision|0|||
19632321|NCT00804986|42081772|FG005|Overall Study|Sponsor Decision|0|||
19632322|NCT00804986|42081767|FG000|Overall Study|Physician Decision|1|||
19632323|NCT00804986|42081768|FG001|Overall Study|Physician Decision|0|||
19632324|NCT00804986|42081769|FG002|Overall Study|Physician Decision|0|||
19632325|NCT00804986|42081770|FG003|Overall Study|Physician Decision|0|||
19632326|NCT00804986|42081771|FG004|Overall Study|Physician Decision|0|||
19632327|NCT00804986|42081772|FG005|Overall Study|Physician Decision|0|||
19632328|NCT00752232|42081793|FG000|Overall Study|Protocol Violation|0|||
19632329|NCT00752232|42081794|FG001|Overall Study|Protocol Violation|0|||
19632330|NCT00752232|42081795|FG002|Overall Study|Protocol Violation|0|||
19632331|NCT00752232|42081796|FG003|Overall Study|Protocol Violation|0|||
19632332|NCT00752232|42081797|FG004|Overall Study|Protocol Violation|0|||
19632333|NCT00752232|42081798|FG005|Overall Study|Protocol Violation|1|||
19632334|NCT00752232|42081799|FG006|Overall Study|Protocol Violation|0|||
19632335|NCT00752232|42081793|FG000|Overall Study|Caregiver request|2|||
19632336|NCT00752232|42081794|FG001|Overall Study|Caregiver request|0|||
19632337|NCT00752232|42081795|FG002|Overall Study|Caregiver request|0|||
19632338|NCT00752232|42081796|FG003|Overall Study|Caregiver request|0|||
19632339|NCT00752232|42081797|FG004|Overall Study|Caregiver request|1|||
19632340|NCT00752232|42081798|FG005|Overall Study|Caregiver request|0|||
19632341|NCT00752232|42081799|FG006|Overall Study|Caregiver request|0|||
19375423|NCT00835367|41617364|FG001|Washout|Adverse Event|0|||
19542282|NCT01183858|41991484|FG000|Overall Study|Refused Treatment|1|||
19542283|NCT01183858|41991485|FG001|Overall Study|Refused Treatment|4|||
19542284|NCT01183858|41991484|FG000|Overall Study|Withdrew Consent|4|||
19542285|NCT01183858|41991485|FG001|Overall Study|Withdrew Consent|4|||
19542286|NCT01183858|41991484|FG000|Overall Study|Discontinued Smoking|3|||
19542287|NCT01183858|41991485|FG001|Overall Study|Discontinued Smoking|1|||
19542288|NCT01183858|41991484|FG000|Overall Study|Protocol Violation|1|||
19542289|NCT01183858|41991485|FG001|Overall Study|Protocol Violation|0|||
19542290|NCT01183858|41991484|FG000|Overall Study|Administrative/Other|6|||
19542291|NCT01183858|41991485|FG001|Overall Study|Administrative/Other|6|||
19542292|NCT01183858|41991484|FG000|Overall Study|Progressive Disease|112|||
19542293|NCT01183858|41991485|FG001|Overall Study|Progressive Disease|115|||
19542294|NCT01183858|41991484|FG000|Overall Study|Death related to Progressive Disease|4|||
19542295|NCT01183858|41991485|FG001|Overall Study|Death related to Progressive Disease|5|||
19542296|NCT01183858|41991484|FG000|Overall Study|Lost to Follow-up|1|||
19542297|NCT01183858|41991485|FG001|Overall Study|Lost to Follow-up|1|||
19542298|NCT01215175|41991496|FG000|Overall Study|Lost to Follow-up|0|||
19542299|NCT01215175|41991497|FG001|Overall Study|Lost to Follow-up|1|||
19542300|NCT01215175|41991498|FG002|Overall Study|Lost to Follow-up|0|||
19542301|NCT01215175|41991499|FG003|Overall Study|Lost to Follow-up|1|||
19542302|NCT01215175|41991500|FG004|Overall Study|Lost to Follow-up|0|||
19542303|NCT01215097|41991514|FG000|Overall Study|Adverse Event|1|||
19542304|NCT01215097|41991515|FG001|Overall Study|Adverse Event|3|||
19542305|NCT01215097|41991514|FG000|Overall Study|Protocol Violation|0|||
19542306|NCT01215097|41991515|FG001|Overall Study|Protocol Violation|2|||
19542307|NCT01215097|41991514|FG000|Overall Study|Lost to Follow-up|2|||
19542308|NCT01215097|41991515|FG001|Overall Study|Lost to Follow-up|0|||
19542309|NCT01215097|41991514|FG000|Overall Study|Withdrawal by Subject|6|||
19542310|NCT01215097|41991515|FG001|Overall Study|Withdrawal by Subject|3|||
19542311|NCT01215097|41991514|FG000|Overall Study|Lack of Efficacy|0|||
19632342|NCT00752232|42081793|FG000|Overall Study|Investigator request|0|||
19632343|NCT00752232|42081794|FG001|Overall Study|Investigator request|0|||
19632344|NCT00752232|42081795|FG002|Overall Study|Investigator request|0|||
19632345|NCT00752232|42081796|FG003|Overall Study|Investigator request|0|||
19632346|NCT00752232|42081797|FG004|Overall Study|Investigator request|1|||
19632347|NCT00752232|42081798|FG005|Overall Study|Investigator request|0|||
19375424|NCT00835367|41617363|FG000|Washout|Withdrawal by Subject|1|||
19542312|NCT01215097|41991515|FG001|Overall Study|Lack of Efficacy|3|||
19542313|NCT01215097|41991514|FG000|Overall Study|patient's refusal to come|2|||
19542314|NCT01215097|41991515|FG001|Overall Study|patient's refusal to come|2|||
19542315|NCT01215097|41991514|FG000|Overall Study|patient's private reason|1|||
19542316|NCT01215097|41991515|FG001|Overall Study|patient's private reason|1|||
19542317|NCT03303339|41991533|FG000|Overall Study|Death|2|||
19632348|NCT00752232|42081799|FG006|Overall Study|Investigator request|0|||
19632349|NCT00752232|42081793|FG000|Overall Study|Subject request|0|||
19632350|NCT00752232|42081794|FG001|Overall Study|Subject request|0|||
19632351|NCT00752232|42081795|FG002|Overall Study|Subject request|1|||
19632352|NCT00752232|42081796|FG003|Overall Study|Subject request|0|||
19632353|NCT00752232|42081797|FG004|Overall Study|Subject request|0|||
19632354|NCT00752232|42081798|FG005|Overall Study|Subject request|0|||
19632355|NCT00752232|42081799|FG006|Overall Study|Subject request|0|||
19632356|NCT00752232|42081793|FG000|Overall Study|Group home admission|0|||
19632357|NCT00752232|42081794|FG001|Overall Study|Group home admission|0|||
19632358|NCT00752232|42081795|FG002|Overall Study|Group home admission|0|||
19632359|NCT00752232|42081796|FG003|Overall Study|Group home admission|1|||
19632360|NCT00752232|42081797|FG004|Overall Study|Group home admission|0|||
19632361|NCT00752232|42081798|FG005|Overall Study|Group home admission|0|||
19632362|NCT00752232|42081799|FG006|Overall Study|Group home admission|0|||
19632363|NCT00752232|42081793|FG000|Overall Study|Caregiver could not attend the subject|0|||
19632364|NCT00752232|42081794|FG001|Overall Study|Caregiver could not attend the subject|0|||
19632365|NCT00752232|42081795|FG002|Overall Study|Caregiver could not attend the subject|0|||
19632366|NCT00752232|42081796|FG003|Overall Study|Caregiver could not attend the subject|0|||
19632367|NCT00752232|42081797|FG004|Overall Study|Caregiver could not attend the subject|1|||
19632368|NCT00752232|42081798|FG005|Overall Study|Caregiver could not attend the subject|0|||
19632369|NCT00752232|42081799|FG006|Overall Study|Caregiver could not attend the subject|0|||
19632370|NCT00760266|42081818|FG000|Overall Study|Adverse Event|13|||
19632371|NCT00760266|42081819|FG001|Overall Study|Adverse Event|7|||
19632372|NCT00760266|42081818|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19632373|NCT00760266|42081819|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19632374|NCT00760266|42081818|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19632375|NCT00760266|42081819|FG001|Overall Study|Abnormal test procedure result(s)|0|||
19632376|NCT00760266|42081818|FG000|Overall Study|Lack of Efficacy|2|||
19632377|NCT00760266|42081819|FG001|Overall Study|Lack of Efficacy|2|||
19632378|NCT00760266|42081818|FG000|Overall Study|Protocol deviation|2|||
19632379|NCT00760266|42081819|FG001|Overall Study|Protocol deviation|4|||
19632380|NCT00760266|42081818|FG000|Overall Study|Patient withdrew consent|3|||
19632381|NCT00760266|42081819|FG001|Overall Study|Patient withdrew consent|3|||
19632382|NCT00760266|42081818|FG000|Overall Study|Lost to Follow-up|2|||
19632383|NCT00760266|42081819|FG001|Overall Study|Lost to Follow-up|1|||
19632384|NCT00760266|42081818|FG000|Overall Study|Administrative Problems|0|||
19632385|NCT00760266|42081819|FG001|Overall Study|Administrative Problems|1|||
19632386|NCT00753714|42081827|FG000|Overall Study|Lack of Efficacy|21|||
19632387|NCT00753714|42081828|FG001|Overall Study|Lack of Efficacy|34|||
19632388|NCT00753714|42081827|FG000|Overall Study|Adverse Event|26|||
19542318|NCT03303339|41991534|FG001|Overall Study|Death|2|||
19542319|NCT03303339|41991535|FG002|Overall Study|Death|2|||
19542320|NCT03303339|41991536|FG003|Overall Study|Death|1|||
19542321|NCT03303339|41991537|FG004|Overall Study|Death|4|||
19542322|NCT03303339|41991538|FG005|Overall Study|Death|2|||
19542323|NCT03303339|41991539|FG006|Overall Study|Death|2|||
19542324|NCT03303339|41991540|FG007|Overall Study|Death|2|||
19542325|NCT03303339|41991541|FG008|Overall Study|Death|3|||
19542326|NCT03303339|41991542|FG009|Overall Study|Death|3|||
19632389|NCT00753714|42081828|FG001|Overall Study|Adverse Event|18|||
19632390|NCT00753714|42081827|FG000|Overall Study|Protocol Violation|1|||
19632391|NCT00753714|42081828|FG001|Overall Study|Protocol Violation|0|||
19632392|NCT00753714|42081827|FG000|Overall Study|Lost to Follow-up|0|||
19632393|NCT00753714|42081828|FG001|Overall Study|Lost to Follow-up|1|||
19632394|NCT00753714|42081827|FG000|Overall Study|Withdrawal by Subject|2|||
19632395|NCT00753714|42081828|FG001|Overall Study|Withdrawal by Subject|1|||
19632396|NCT00753714|42081827|FG000|Overall Study|Death|3|||
19632397|NCT00753714|42081828|FG001|Overall Study|Death|3|||
19632398|NCT00753714|42081827|FG000|Overall Study|Other|7|||
19632399|NCT00753714|42081828|FG001|Overall Study|Other|5|||
19632400|NCT00759954|42081839|FG000|Overall Study|Personal reason|1|||
19632401|NCT00759954|42081840|FG001|Overall Study|Personal reason|0|||
19632402|NCT00759954|42081839|FG000|Overall Study|Adverse Event|1|||
19632403|NCT00759954|42081840|FG001|Overall Study|Adverse Event|2|||
19632404|NCT00804908|42081849|FG000|Overall Study|Other|115|||
19632405|NCT00804908|42081850|FG001|Overall Study|Other|116|||
19711596|NCT00079274|42154663|FG006|Overall Study|Cytogenetic resistance|0|||
19711597|NCT00079274|42154657|FG000|Overall Study|Other|43|||
19711598|NCT00079274|42154658|FG001|Overall Study|Other|7|||
19632406|NCT00804908|42081851|FG002|Overall Study|Other|114|||
19632407|NCT00808808|42081862|FG000|Overall Study|Vaccinated; survey not completed|131|||
19632408|NCT00808808|42081863|FG001|Overall Study|Vaccinated; survey not completed|169|||
19632409|NCT00808808|42081864|FG002|Overall Study|Vaccinated; survey not completed|302|||
19632410|NCT00808808|42081862|FG000|Overall Study|Employee was not vaccinated.|2686|||
19542327|NCT03303339|41991543|FG010|Overall Study|Death|4|||
19542328|NCT03303339|41991544|FG011|Overall Study|Death|24|||
19542329|NCT03303339|41991533|FG000|Overall Study|Study Terminated by Sponsor|0|||
19632411|NCT00808808|42081863|FG001|Overall Study|Employee was not vaccinated.|2268|||
19632412|NCT00808808|42081864|FG002|Overall Study|Employee was not vaccinated.|2255|||
19632413|NCT00589784|42081880|FG000|Overall Study|Withdrawal by Subject|0|||
19632414|NCT00589784|42081881|FG001|Overall Study|Withdrawal by Subject|6|||
19632415|NCT00589784|42081880|FG000|Overall Study|Patient inevaluable|1|||
19632416|NCT00589784|42081881|FG001|Overall Study|Patient inevaluable|0|||
19632417|NCT00589784|42081880|FG000|Overall Study|Adverse Event|0|||
19632418|NCT00589784|42081881|FG001|Overall Study|Adverse Event|4|||
19632419|NCT00759876|42081886|FG000|Overall Study|Sponsor terminated study early|36|||
19632420|NCT00823979|42081893|FG000|Overall Study|Lack of Efficacy|13|||
19632421|NCT00823979|42081894|FG001|Overall Study|Lack of Efficacy|16|||
19632422|NCT00823979|42081895|FG002|Overall Study|Lack of Efficacy|9|||
19632423|NCT00823979|42081893|FG000|Overall Study|Lost to Follow-up|2|||
19632424|NCT00823979|42081894|FG001|Overall Study|Lost to Follow-up|1|||
19632425|NCT00823979|42081895|FG002|Overall Study|Lost to Follow-up|0|||
19632426|NCT00823979|42081893|FG000|Overall Study|Withdrawal by Subject|2|||
19632427|NCT00823979|42081894|FG001|Overall Study|Withdrawal by Subject|3|||
19632428|NCT00823979|42081895|FG002|Overall Study|Withdrawal by Subject|2|||
19632429|NCT00823979|42081893|FG000|Overall Study|Protocol Violation|1|||
19632430|NCT00823979|42081894|FG001|Overall Study|Protocol Violation|1|||
19632431|NCT00823979|42081895|FG002|Overall Study|Protocol Violation|0|||
19632432|NCT00823979|42081893|FG000|Overall Study|Pregnancy|0|||
19632433|NCT00823979|42081894|FG001|Overall Study|Pregnancy|1|||
19632434|NCT00823979|42081895|FG002|Overall Study|Pregnancy|0|||
19632435|NCT00823979|42081893|FG000|Overall Study|Adverse Event|0|||
19632436|NCT00823979|42081894|FG001|Overall Study|Adverse Event|2|||
19632437|NCT00823979|42081895|FG002|Overall Study|Adverse Event|4|||
19457942|NCT01442181|41711533|FG000|Overall Study|no insurance for surgery|1|||
19457943|NCT01442181|41711534|FG001|Overall Study|no insurance for surgery|0|||
19457944|NCT01442181|41711533|FG000|Overall Study|low ejection factor|0|||
19457945|NCT01442181|41711534|FG001|Overall Study|low ejection factor|1|||
19457946|NCT01442181|41711533|FG000|Overall Study|Lost to Follow-up|1|||
19457947|NCT01442181|41711534|FG001|Overall Study|Lost to Follow-up|1|||
19457948|NCT01442181|41711533|FG000|Overall Study|patient in an additional study|1|||
19457949|NCT01442181|41711534|FG001|Overall Study|patient in an additional study|0|||
19457950|NCT01442181|41711533|FG000|Overall Study|atrial fibrillation not noted|0|||
19542330|NCT03303339|41991534|FG001|Overall Study|Study Terminated by Sponsor|0|||
19542331|NCT03303339|41991535|FG002|Overall Study|Study Terminated by Sponsor|0|||
19542332|NCT03303339|41991536|FG003|Overall Study|Study Terminated by Sponsor|0|||
19542333|NCT03303339|41991537|FG004|Overall Study|Study Terminated by Sponsor|0|||
19542334|NCT03303339|41991538|FG005|Overall Study|Study Terminated by Sponsor|0|||
19542335|NCT03303339|41991539|FG006|Overall Study|Study Terminated by Sponsor|0|||
19542336|NCT03303339|41991540|FG007|Overall Study|Study Terminated by Sponsor|0|||
19542337|NCT03303339|41991541|FG008|Overall Study|Study Terminated by Sponsor|1|||
19542338|NCT03303339|41991542|FG009|Overall Study|Study Terminated by Sponsor|0|||
19542339|NCT03303339|41991543|FG010|Overall Study|Study Terminated by Sponsor|1|||
19542340|NCT03303339|41991544|FG011|Overall Study|Study Terminated by Sponsor|1|||
19542341|NCT03303339|41991533|FG000|Overall Study|Withdrawal by Subject|1|||
19542342|NCT03303339|41991534|FG001|Overall Study|Withdrawal by Subject|0|||
19542343|NCT03303339|41991535|FG002|Overall Study|Withdrawal by Subject|0|||
19542344|NCT03303339|41991536|FG003|Overall Study|Withdrawal by Subject|0|||
19542345|NCT03303339|41991537|FG004|Overall Study|Withdrawal by Subject|0|||
19542346|NCT03303339|41991538|FG005|Overall Study|Withdrawal by Subject|1|||
19542347|NCT03303339|41991539|FG006|Overall Study|Withdrawal by Subject|1|||
19542348|NCT03303339|41991540|FG007|Overall Study|Withdrawal by Subject|0|||
19542349|NCT03303339|41991541|FG008|Overall Study|Withdrawal by Subject|0|||
19542350|NCT03303339|41991542|FG009|Overall Study|Withdrawal by Subject|0|||
19542351|NCT03303339|41991543|FG010|Overall Study|Withdrawal by Subject|0|||
19542352|NCT03303339|41991544|FG011|Overall Study|Withdrawal by Subject|2|||
19542353|NCT03303339|41991533|FG000|Overall Study|Physician Decision|0|||
19542354|NCT03303339|41991534|FG001|Overall Study|Physician Decision|0|||
19542355|NCT03303339|41991535|FG002|Overall Study|Physician Decision|0|||
19542356|NCT03303339|41991536|FG003|Overall Study|Physician Decision|0|||
19542357|NCT03303339|41991537|FG004|Overall Study|Physician Decision|1|||
19542358|NCT03303339|41991538|FG005|Overall Study|Physician Decision|0|||
19542359|NCT03303339|41991539|FG006|Overall Study|Physician Decision|0|||
19542360|NCT03303339|41991540|FG007|Overall Study|Physician Decision|0|||
19542361|NCT03303339|41991541|FG008|Overall Study|Physician Decision|0|||
19542362|NCT03303339|41991542|FG009|Overall Study|Physician Decision|0|||
19542363|NCT03303339|41991543|FG010|Overall Study|Physician Decision|0|||
19542364|NCT03303339|41991544|FG011|Overall Study|Physician Decision|0|||
19542365|NCT03303339|41991533|FG000|Overall Study|Safety/Non-compliance|0|||
19632438|NCT00823979|42081893|FG000|Overall Study|Other|2|||
19632439|NCT00823979|42081894|FG001|Overall Study|Other|0|||
19632440|NCT00823979|42081895|FG002|Overall Study|Other|1|||
19632441|NCT00823979|42081893|FG000|Overall Study|Randomized but not Treated|4|||
19632442|NCT00823979|42081894|FG001|Overall Study|Randomized but not Treated|3|||
19542366|NCT03303339|41991534|FG001|Overall Study|Safety/Non-compliance|0|||
19632443|NCT00823979|42081895|FG002|Overall Study|Randomized but not Treated|1|||
19632444|NCT00823979|42081893|FG000|Overall Study|Study Terminated by Sponsor|5|||
19632445|NCT00823979|42081894|FG001|Overall Study|Study Terminated by Sponsor|5|||
19632446|NCT00823979|42081895|FG002|Overall Study|Study Terminated by Sponsor|7|||
19632447|NCT00823901|42081905|FG000|Overall Study|Adverse Event|1|||
19632448|NCT00823901|42081906|FG001|Overall Study|Adverse Event|1|||
19632449|NCT00823901|42081905|FG000|Overall Study|Lack of Efficacy|1|||
19632450|NCT00823901|42081906|FG001|Overall Study|Lack of Efficacy|0|||
19632451|NCT00823901|42081905|FG000|Overall Study|Lost to Follow-up|2|||
19632452|NCT00823901|42081906|FG001|Overall Study|Lost to Follow-up|1|||
19632453|NCT00823823|42081914|FG000|Overall Study|Lost to Follow-up|3|||
19632454|NCT00823823|42081915|FG001|Overall Study|Lost to Follow-up|1|||
19632455|NCT00823823|42081914|FG000|Overall Study|Protocol Violation|5|||
19632456|NCT00823823|42081915|FG001|Overall Study|Protocol Violation|5|||
19632457|NCT00759564|42081935|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
19632458|NCT00759564|42081936|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
19632459|NCT00759564|42081937|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
19632460|NCT00759564|42081938|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
19632461|NCT00759564|42081939|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
19632462|NCT00816023|42081975|FG000|Overall Study|Lost to Follow-up|1|||
19632463|NCT00816023|42081976|FG001|Overall Study|Lost to Follow-up|1|||
19632464|NCT00816023|42081977|FG002|Overall Study|Lost to Follow-up|0|||
19542367|NCT03303339|41991535|FG002|Overall Study|Safety/Non-compliance|0|||
19542368|NCT03303339|41991536|FG003|Overall Study|Safety/Non-compliance|0|||
19632465|NCT00816023|42081978|FG003|Overall Study|Lost to Follow-up|0|||
19711599|NCT00079274|42154659|FG002|Overall Study|Other|5|||
19632466|NCT00816023|42081975|FG000|Overall Study|Withdrawal by Subject|1|||
19632467|NCT00816023|42081976|FG001|Overall Study|Withdrawal by Subject|0|||
19632468|NCT00816023|42081977|FG002|Overall Study|Withdrawal by Subject|0|||
19632469|NCT00816023|42081978|FG003|Overall Study|Withdrawal by Subject|0|||
19632470|NCT00816023|42081975|FG000|Overall Study|Physician Decision|0|||
19632471|NCT00816023|42081976|FG001|Overall Study|Physician Decision|0|||
19632472|NCT00816023|42081977|FG002|Overall Study|Physician Decision|1|||
19632473|NCT00816023|42081978|FG003|Overall Study|Physician Decision|0|||
19632474|NCT00816023|42081975|FG000|Overall Study|assessments complete prior to window|1|||
19632475|NCT00816023|42081976|FG001|Overall Study|assessments complete prior to window|1|||
19632476|NCT00816023|42081977|FG002|Overall Study|assessments complete prior to window|2|||
19632477|NCT00816023|42081978|FG003|Overall Study|assessments complete prior to window|1|||
19632478|NCT00816023|42081975|FG000|Overall Study|Randomized Not Treated|6|||
19632479|NCT00816023|42081976|FG001|Overall Study|Randomized Not Treated|4|||
19632480|NCT00816023|42081977|FG002|Overall Study|Randomized Not Treated|6|||
19632481|NCT00816023|42081978|FG003|Overall Study|Randomized Not Treated|11|||
19632482|NCT00759174|42081990|FG000|Overall Study|Other|0|||
19632483|NCT00759174|42081991|FG001|Overall Study|Other|2|||
19632484|NCT00815633|42081998|FG000|Overall Study|study terminated|1|||
19632485|NCT03631784|42082004|FG000|Overall Study|Death|48|||
19632486|NCT03631784|42082005|FG001|Overall Study|Death|28|||
19632487|NCT03631784|42082004|FG000|Overall Study|Lost to Follow-up|1|||
19632488|NCT03631784|42082005|FG001|Overall Study|Lost to Follow-up|0|||
19632489|NCT03631784|42082004|FG000|Overall Study|Withdrawal by Subject|0|||
19632490|NCT03631784|42082005|FG001|Overall Study|Withdrawal by Subject|3|||
19632491|NCT03631784|42082004|FG000|Overall Study|Participants Ongoing|63|||
19632492|NCT03631784|42082005|FG001|Overall Study|Participants Ongoing|71|||
19632493|NCT00830765|42082013|FG000|Overall Study|Protocol Violation|3|||
19542369|NCT03303339|41991537|FG004|Overall Study|Safety/Non-compliance|0|||
19542370|NCT03303339|41991538|FG005|Overall Study|Safety/Non-compliance|0|||
19542371|NCT03303339|41991539|FG006|Overall Study|Safety/Non-compliance|0|||
19542372|NCT03303339|41991540|FG007|Overall Study|Safety/Non-compliance|0|||
19542373|NCT03303339|41991541|FG008|Overall Study|Safety/Non-compliance|0|||
19542374|NCT03303339|41991542|FG009|Overall Study|Safety/Non-compliance|0|||
19542375|NCT03303339|41991543|FG010|Overall Study|Safety/Non-compliance|0|||
19542376|NCT03303339|41991544|FG011|Overall Study|Safety/Non-compliance|1|||
19542377|NCT01183780|41991589|FG000|Overall Study|Withdrawal by Subject|25|||
19542378|NCT01183780|41991590|FG001|Overall Study|Withdrawal by Subject|14|||
19542379|NCT01183780|41991589|FG000|Overall Study|Lost to Follow-up|6|||
19542380|NCT01183780|41991590|FG001|Overall Study|Lost to Follow-up|11|||
19542381|NCT01183468|41991600|FG000|Overall Study|Lost to Follow-up|2|||
19542382|NCT01183468|41991601|FG001|Overall Study|Lost to Follow-up|1|||
19542383|NCT01183468|41991602|FG002|Overall Study|Lost to Follow-up|0|||
19542384|NCT01183468|41991603|FG003|Overall Study|Lost to Follow-up|0|||
19542385|NCT01183468|41991600|FG000|Overall Study|Physician Decision|1|||
19542386|NCT01183468|41991601|FG001|Overall Study|Physician Decision|0|||
19542387|NCT01183468|41991602|FG002|Overall Study|Physician Decision|0|||
19542388|NCT01183468|41991603|FG003|Overall Study|Physician Decision|0|||
19632494|NCT00830765|42082014|FG001|Overall Study|Protocol Violation|2|||
19632495|NCT00830375|42082020|FG000|Overall Study|Lost to Follow-up|1|||
19632496|NCT00803270|42082026|FG000|Overall Study|Lost to Follow-up|1|||
19632497|NCT00803270|42082027|FG001|Overall Study|Lost to Follow-up|2|||
19632498|NCT00751998|42082033|FG000|Overall Study|Lost to Follow-up|7|||
19632499|NCT00751998|42082033|FG000|Overall Study|Death|11|||
19542389|NCT01183468|41991600|FG000|Overall Study|Withdrawal by Subject|0|||
19542390|NCT01183468|41991601|FG001|Overall Study|Withdrawal by Subject|1|||
19542391|NCT01183468|41991602|FG002|Overall Study|Withdrawal by Subject|0|||
19542392|NCT01183468|41991603|FG003|Overall Study|Withdrawal by Subject|0|||
19542393|NCT01183390|41991613|FG000|First Intervention|Adverse Event|0|||
19542394|NCT01183390|41991614|FG001|First Intervention|Adverse Event|1|||
19542395|NCT01214668|41991643|FG000|Overall Study|Adverse Event|0|||
19542396|NCT01214668|41991644|FG001|Overall Study|Adverse Event|1|||
19542397|NCT01214668|41991645|FG002|Overall Study|Adverse Event|0|||
19542398|NCT01214668|41991646|FG003|Overall Study|Adverse Event|2|||
19632500|NCT00751998|42082033|FG000|Overall Study|Withdrawal by Subject|2|||
19632501|NCT00803738|42082039|FG000|Overall Study|Adverse Event|3|||
19632502|NCT00803738|42082040|FG001|Overall Study|Adverse Event|5|||
19632503|NCT00803738|42082039|FG000|Overall Study|Lost to Follow-up|4|||
19632504|NCT00803738|42082040|FG001|Overall Study|Lost to Follow-up|4|||
19632505|NCT00803738|42082039|FG000|Overall Study|Protocol Violation|18|||
19632506|NCT00803738|42082040|FG001|Overall Study|Protocol Violation|10|||
19632507|NCT00803738|42082039|FG000|Overall Study|Withdrawal by Subject|1|||
19632508|NCT00803738|42082040|FG001|Overall Study|Withdrawal by Subject|4|||
19632509|NCT00803738|42082039|FG000|Overall Study|Lack of Efficacy|10|||
19632510|NCT00803738|42082040|FG001|Overall Study|Lack of Efficacy|16|||
19632511|NCT00803738|42082039|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
19632512|NCT00803738|42082040|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
19632513|NCT00803738|42082039|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
19632514|NCT00803738|42082040|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
19632515|NCT00758706|42082048|FG000|Overall Study|Adverse Event|4|||
19632516|NCT00758706|42082049|FG001|Overall Study|Adverse Event|4|||
19632517|NCT00591266|42082058|FG000|Overall Study|Adverse Event|2|||
19632518|NCT00591266|42082059|FG001|Overall Study|Adverse Event|2|||
19632519|NCT00591266|42082060|FG002|Overall Study|Adverse Event|3|||
19632520|NCT00591266|42082058|FG000|Overall Study|Lost to Follow-up|0|||
19632521|NCT00591266|42082059|FG001|Overall Study|Lost to Follow-up|1|||
19632522|NCT00591266|42082060|FG002|Overall Study|Lost to Follow-up|0|||
19632523|NCT00591266|42082058|FG000|Overall Study|Protocol Violation|0|||
19457951|NCT01442181|41711534|FG001|Overall Study|atrial fibrillation not noted|1|||
19457952|NCT01442103|41711541|FG000|Overall Study|Lost to Follow-up|2|||
19457953|NCT01428219|41711545|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
19457954|NCT01428063|41711552|FG000|Overall Study|Lack of Efficacy|8|||
19457955|NCT01428063|41711553|FG001|Overall Study|Lack of Efficacy|4|||
19457956|NCT01428063|41711554|FG002|Overall Study|Lack of Efficacy|1|||
19457957|NCT01428063|41711552|FG000|Overall Study|Adverse Event|2|||
19457958|NCT01428063|41711553|FG001|Overall Study|Adverse Event|3|||
19542399|NCT01214668|41991647|FG004|Overall Study|Adverse Event|1|||
19542400|NCT01214668|41991648|FG005|Overall Study|Adverse Event|1|||
19457959|NCT01428063|41711554|FG002|Overall Study|Adverse Event|0|||
19542401|NCT01214668|41991643|FG000|Overall Study|Death|0|||
19542402|NCT01214668|41991644|FG001|Overall Study|Death|0|||
19542403|NCT01214668|41991645|FG002|Overall Study|Death|1|||
19542404|NCT01214668|41991646|FG003|Overall Study|Death|0|||
19542405|NCT01214668|41991647|FG004|Overall Study|Death|0|||
19542406|NCT01214668|41991648|FG005|Overall Study|Death|0|||
19542407|NCT01214668|41991643|FG000|Overall Study|Progressive Disease|4|||
19542408|NCT01214668|41991644|FG001|Overall Study|Progressive Disease|2|||
19542409|NCT01214668|41991645|FG002|Overall Study|Progressive Disease|5|||
19542410|NCT01214668|41991646|FG003|Overall Study|Progressive Disease|4|||
19542411|NCT01214668|41991647|FG004|Overall Study|Progressive Disease|4|||
19542412|NCT01214668|41991648|FG005|Overall Study|Progressive Disease|5|||
19542413|NCT01214668|41991643|FG000|Overall Study|Withdrawal by Subject|0|||
19542414|NCT01214668|41991644|FG001|Overall Study|Withdrawal by Subject|0|||
19542415|NCT01214668|41991645|FG002|Overall Study|Withdrawal by Subject|0|||
19542416|NCT01214668|41991646|FG003|Overall Study|Withdrawal by Subject|0|||
19542417|NCT01214668|41991647|FG004|Overall Study|Withdrawal by Subject|1|||
19542418|NCT01214668|41991648|FG005|Overall Study|Withdrawal by Subject|0|||
19542419|NCT01191268|41991666|FG000|Overall Study|Withdrawal by Subject|19|||
19542420|NCT01191268|41991667|FG001|Overall Study|Withdrawal by Subject|25|||
19542421|NCT01191268|41991668|FG002|Overall Study|Withdrawal by Subject|21|||
19542422|NCT01191268|41991666|FG000|Overall Study|Adverse Event|21|||
19542423|NCT01191268|41991667|FG001|Overall Study|Adverse Event|13|||
19542424|NCT01191268|41991668|FG002|Overall Study|Adverse Event|8|||
19542425|NCT01191268|41991666|FG000|Overall Study|Physician Decision|6|||
19542426|NCT01191268|41991667|FG001|Overall Study|Physician Decision|8|||
19542427|NCT01191268|41991668|FG002|Overall Study|Physician Decision|9|||
19542428|NCT01191268|41991666|FG000|Overall Study|Lost to Follow-up|8|||
19542429|NCT01191268|41991667|FG001|Overall Study|Lost to Follow-up|5|||
19542430|NCT01191268|41991668|FG002|Overall Study|Lost to Follow-up|9|||
19542431|NCT01191268|41991666|FG000|Overall Study|Entry Criteria Not Met|3|||
19632524|NCT00591266|42082059|FG001|Overall Study|Protocol Violation|0|||
19632525|NCT00591266|42082060|FG002|Overall Study|Protocol Violation|1|||
19542432|NCT01191268|41991667|FG001|Overall Study|Entry Criteria Not Met|1|||
19632526|NCT00591266|42082058|FG000|Overall Study|Withdrawal by Subject|6|||
19632527|NCT00591266|42082059|FG001|Overall Study|Withdrawal by Subject|2|||
19632528|NCT00591266|42082060|FG002|Overall Study|Withdrawal by Subject|5|||
19632529|NCT00591266|42082058|FG000|Overall Study|Lack of Efficacy|0|||
19632530|NCT00591266|42082059|FG001|Overall Study|Lack of Efficacy|2|||
19632531|NCT00591266|42082060|FG002|Overall Study|Lack of Efficacy|0|||
19632532|NCT00591266|42082058|FG000|Overall Study|Other|1|||
19632533|NCT00591266|42082059|FG001|Overall Study|Other|4|||
19632534|NCT00591266|42082060|FG002|Overall Study|Other|5|||
19632535|NCT00758394|42082072|FG000|2nd Intervention Order|Lost to Follow-up|0|||
19632536|NCT00758394|42082073|FG001|2nd Intervention Order|Lost to Follow-up|1|||
19632537|NCT00758394|42082074|FG002|2nd Intervention Order|Lost to Follow-up|0|||
19632538|NCT00758394|42082075|FG003|2nd Intervention Order|Lost to Follow-up|0|||
19632539|NCT00758394|42082072|FG000|3rd Intervention|Lost to Follow-up|1|||
19632540|NCT00758394|42082073|FG001|3rd Intervention|Lost to Follow-up|0|||
19632541|NCT00758394|42082074|FG002|3rd Intervention|Lost to Follow-up|0|||
19632542|NCT00758394|42082075|FG003|3rd Intervention|Lost to Follow-up|1|||
19632543|NCT04450394|42082088|FG000|Overall Study|Adverse Event|2|||
19632544|NCT04450394|42082089|FG001|Overall Study|Adverse Event|0|||
19632545|NCT04450394|42082090|FG002|Overall Study|Adverse Event|0|||
19632546|NCT04450394|42082088|FG000|Overall Study|Death|0|||
19632547|NCT04450394|42082089|FG001|Overall Study|Death|1|||
19632548|NCT04450394|42082090|FG002|Overall Study|Death|0|||
19632549|NCT04450394|42082088|FG000|Overall Study|Lost to Follow-up|0|||
19632550|NCT04450394|42082089|FG001|Overall Study|Lost to Follow-up|3|||
19632551|NCT04450394|42082090|FG002|Overall Study|Lost to Follow-up|0|||
19632552|NCT04450394|42082088|FG000|Overall Study|Physician Decision|0|||
19632553|NCT04450394|42082089|FG001|Overall Study|Physician Decision|1|||
19632554|NCT04450394|42082090|FG002|Overall Study|Physician Decision|0|||
19632555|NCT04450394|42082088|FG000|Overall Study|Protocol Violation|2|||
19632556|NCT04450394|42082089|FG001|Overall Study|Protocol Violation|0|||
19632557|NCT04450394|42082090|FG002|Overall Study|Protocol Violation|0|||
19632558|NCT04450394|42082088|FG000|Overall Study|Withdrawal by Subject|6|||
19632559|NCT04450394|42082089|FG001|Overall Study|Withdrawal by Subject|9|||
19632560|NCT04450394|42082090|FG002|Overall Study|Withdrawal by Subject|0|||
19632561|NCT00758160|42082097|FG000|Overall Study|No Longer Requires Study Medication|4|||
19632562|NCT00758160|42082097|FG000|Overall Study|Administration Problems|3|||
19632563|NCT00758160|42082097|FG000|Overall Study|Adverse Event|15|||
19632564|NCT00758160|42082097|FG000|Overall Study|Lack of Efficacy|10|||
19632565|NCT00758160|42082097|FG000|Overall Study|Lost to Follow-up|14|||
19632566|NCT00758160|42082097|FG000|Overall Study|Protocol Violation|12|||
19632567|NCT00758160|42082097|FG000|Overall Study|Withdrawal by Subject|8|||
19632568|NCT00757848|42082107|FG000|Overall Study|Voluntary discontinuation|1|||
19632569|NCT00757848|42082108|FG001|Overall Study|Voluntary discontinuation|0|||
19632570|NCT00757848|42082107|FG000|Overall Study|Adverse Event|1|||
19632571|NCT00757848|42082108|FG001|Overall Study|Adverse Event|2|||
19632572|NCT00757848|42082107|FG000|Overall Study|Incorrect enrolment|1|||
19632573|NCT00757848|42082108|FG001|Overall Study|Incorrect enrolment|0|||
19632574|NCT00751296|42082114|FG000|Overall Study|Adverse Event|2|||
19632575|NCT00751140|42082118|FG000|Overall Study|benign angioma excluded from analysis|1|||
19632576|NCT00751881|42082129|FG000|Core Treatment Period|Not treated|1|||
19632577|NCT00751881|42082130|FG001|Core Treatment Period|Not treated|1|||
19632578|NCT00751881|42082131|FG002|Core Treatment Period|Not treated|2|||
19632579|NCT00751881|42082129|FG000|Core Treatment Period|Adverse Event|26|||
19632580|NCT00751881|42082130|FG001|Core Treatment Period|Adverse Event|54|||
19711600|NCT00079274|42154660|FG003|Overall Study|Other|55|||
19711601|NCT00079274|42154661|FG004|Overall Study|Other|1|||
19711602|NCT00079274|42154662|FG005|Overall Study|Other|2|||
19711603|NCT00079274|42154663|FG006|Overall Study|Other|0|||
19711604|NCT00079040|42154676|FG000|Overall Study|Withdrew before treatment|1|||
19711605|NCT00079040|42154676|FG000|Overall Study|Ineligible|1|||
19711606|NCT00078806|42154680|FG000|Part 1A|Adverse Event|2|||
19711607|NCT00078806|42154681|FG001|Part 1A|Adverse Event|0|||
19711608|NCT00078806|42154682|FG002|Part 1A|Adverse Event|0|||
19711609|NCT00078806|42154683|FG003|Part 1A|Adverse Event|0|||
19711610|NCT00078806|42154680|FG000|Part 1A|Lack of Efficacy|7|||
19711611|NCT00078806|42154681|FG001|Part 1A|Lack of Efficacy|0|||
19711612|NCT00078806|42154682|FG002|Part 1A|Lack of Efficacy|0|||
19711613|NCT00078806|42154683|FG003|Part 1A|Lack of Efficacy|0|||
19711614|NCT00078806|42154680|FG000|Part 1A|Other|1|||
19711615|NCT00078806|42154681|FG001|Part 1A|Other|0|||
19711616|NCT00078806|42154682|FG002|Part 1A|Other|0|||
19711617|NCT00078806|42154683|FG003|Part 1A|Other|0|||
19711618|NCT00078806|42154680|FG000|Part 1B|Adverse Event|1|||
19711619|NCT00078806|42154681|FG001|Part 1B|Adverse Event|0|||
19711620|NCT00078806|42154682|FG002|Part 1B|Adverse Event|0|||
19711621|NCT00078806|42154683|FG003|Part 1B|Adverse Event|0|||
19711622|NCT00078806|42154680|FG000|Part 1B|Lack of Efficacy|7|||
19711623|NCT00078806|42154681|FG001|Part 1B|Lack of Efficacy|0|||
19711624|NCT00078806|42154682|FG002|Part 1B|Lack of Efficacy|0|||
19711625|NCT00078806|42154683|FG003|Part 1B|Lack of Efficacy|0|||
19711626|NCT00078806|42154680|FG000|Part 2|Adverse Event|0|||
19632581|NCT00751881|42082131|FG002|Core Treatment Period|Adverse Event|58|||
19632582|NCT00751881|42082129|FG000|Core Treatment Period|Lack of Efficacy|37|||
19632583|NCT00751881|42082130|FG001|Core Treatment Period|Lack of Efficacy|30|||
19632584|NCT00751881|42082131|FG002|Core Treatment Period|Lack of Efficacy|20|||
19632585|NCT00751881|42082129|FG000|Core Treatment Period|Poor compliance to protocol|15|||
19632586|NCT00751881|42082130|FG001|Core Treatment Period|Poor compliance to protocol|3|||
19632587|NCT00751881|42082131|FG002|Core Treatment Period|Poor compliance to protocol|4|||
19632588|NCT00751881|42082129|FG000|Core Treatment Period|Lost to Follow-up|6|||
19632589|NCT00751881|42082130|FG001|Core Treatment Period|Lost to Follow-up|4|||
19632590|NCT00751881|42082131|FG002|Core Treatment Period|Lost to Follow-up|3|||
19632591|NCT00751881|42082129|FG000|Core Treatment Period|Other: protocol deviation|3|||
19632592|NCT00751881|42082130|FG001|Core Treatment Period|Other: protocol deviation|3|||
19632593|NCT00751881|42082131|FG002|Core Treatment Period|Other: protocol deviation|7|||
19632594|NCT00751881|42082129|FG000|Core Treatment Period|Other: wish to parent|5|||
19632595|NCT00751881|42082130|FG001|Core Treatment Period|Other: wish to parent|7|||
19632596|NCT00751881|42082131|FG002|Core Treatment Period|Other: wish to parent|4|||
19632597|NCT00751881|42082129|FG000|Core Treatment Period|Other: personal/family constraints|6|||
19632598|NCT00751881|42082130|FG001|Core Treatment Period|Other: personal/family constraints|7|||
19632599|NCT00751881|42082131|FG002|Core Treatment Period|Other: personal/family constraints|10|||
19632600|NCT00751881|42082129|FG000|Core Treatment Period|Other: MS treatment change|6|||
19632601|NCT00751881|42082130|FG001|Core Treatment Period|Other: MS treatment change|4|||
19632602|NCT00751881|42082131|FG002|Core Treatment Period|Other: MS treatment change|4|||
19632603|NCT00751881|42082129|FG000|Core Treatment Period|Other: tolerability complaints|2|||
19632604|NCT00751881|42082130|FG001|Core Treatment Period|Other: tolerability complaints|0|||
19632605|NCT00751881|42082131|FG002|Core Treatment Period|Other: tolerability complaints|0|||
19632606|NCT00751881|42082129|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
19632607|NCT00751881|42082130|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
19632608|NCT00751881|42082131|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
19632609|NCT00751881|42082129|FG000|Extension Study Period|Adverse Event|18|||
19632610|NCT00751881|42082130|FG001|Extension Study Period|Adverse Event|20|||
19632611|NCT00751881|42082131|FG002|Extension Study Period|Adverse Event|21|||
19632612|NCT00751881|42082129|FG000|Extension Study Period|Lack of Efficacy|14|||
19632613|NCT00751881|42082130|FG001|Extension Study Period|Lack of Efficacy|10|||
19632614|NCT00751881|42082131|FG002|Extension Study Period|Lack of Efficacy|20|||
19632615|NCT00751881|42082129|FG000|Extension Study Period|Lost to Follow-up|4|||
19632616|NCT00751881|42082130|FG001|Extension Study Period|Lost to Follow-up|9|||
19632617|NCT00751881|42082131|FG002|Extension Study Period|Lost to Follow-up|6|||
19632618|NCT00751881|42082129|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
19632619|NCT00751881|42082130|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
19632620|NCT00751881|42082131|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
19632621|NCT00751881|42082129|FG000|Extension Study Period|Other than specified above|26|||
19632622|NCT00751881|42082130|FG001|Extension Study Period|Other than specified above|30|||
19632623|NCT00751881|42082131|FG002|Extension Study Period|Other than specified above|18|||
19632624|NCT00747474|42082145|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632625|NCT00747474|42082146|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632626|NCT00747474|42082147|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632627|NCT00747474|42082148|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632628|NCT00747474|42082149|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632629|NCT00747474|42082150|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632630|NCT00747474|42082151|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632631|NCT00747474|42082152|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
19632632|NCT00747474|42082153|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632633|NCT00747474|42082154|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632634|NCT00747474|42082155|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632635|NCT00747474|42082156|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
19632636|NCT00830063|42082165|FG000|Overall Study|Adverse Event|7|||
19632637|NCT00830063|42082166|FG001|Overall Study|Adverse Event|13|||
19632638|NCT00830063|42082167|FG002|Overall Study|Adverse Event|16|||
19632639|NCT00830063|42082168|FG003|Overall Study|Adverse Event|13|||
19632640|NCT00830063|42082165|FG000|Overall Study|Death|1|||
19632641|NCT00830063|42082166|FG001|Overall Study|Death|0|||
19632642|NCT00830063|42082167|FG002|Overall Study|Death|0|||
19632643|NCT00830063|42082168|FG003|Overall Study|Death|0|||
19632644|NCT00830063|42082165|FG000|Overall Study|Lost to Follow-up|0|||
19632645|NCT00830063|42082166|FG001|Overall Study|Lost to Follow-up|0|||
19632646|NCT00830063|42082167|FG002|Overall Study|Lost to Follow-up|3|||
19632647|NCT00830063|42082168|FG003|Overall Study|Lost to Follow-up|1|||
19632648|NCT00830063|42082165|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
19632649|NCT00830063|42082166|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
19711627|NCT00078806|42154681|FG001|Part 2|Adverse Event|1|||
19711628|NCT00078806|42154682|FG002|Part 2|Adverse Event|0|||
19632650|NCT00830063|42082167|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
19457960|NCT01428063|41711552|FG000|Overall Study|Lost to Follow-up|0|||
19542433|NCT01191268|41991668|FG002|Overall Study|Entry Criteria Not Met|1|||
19542434|NCT01191268|41991666|FG000|Overall Study|Death|0|||
19542435|NCT01191268|41991667|FG001|Overall Study|Death|1|||
19542436|NCT01191268|41991668|FG002|Overall Study|Death|3|||
19542437|NCT01191268|41991666|FG000|Overall Study|Protocol Violation|1|||
19542438|NCT01191268|41991667|FG001|Overall Study|Protocol Violation|0|||
19542439|NCT01191268|41991668|FG002|Overall Study|Protocol Violation|1|||
19542440|NCT01191268|41991666|FG000|Overall Study|Sponsor Decision|0|||
19542441|NCT01191268|41991667|FG001|Overall Study|Sponsor Decision|2|||
19542442|NCT01191268|41991668|FG002|Overall Study|Sponsor Decision|0|||
19542443|NCT01191190|41991677|FG000|Overall Study|Withdrawal by Subject|1|||
19542444|NCT05751629|41991681|FG000|Overall Study|Withdrawal by Subject|6|||
19542445|NCT05751629|41991681|FG000|Overall Study|Death|25|||
19542446|NCT05751629|41991681|FG000|Overall Study|Study Site Closed|9|||
19542447|NCT05751629|41991681|FG000|Overall Study|Physician Decision|1|||
19542448|NCT05306977|41991685|FG000|Overall Study|Withdrawal by Subject|1|||
19542449|NCT05086276|41991691|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
19542450|NCT05086276|41991692|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
19542451|NCT05062759|41991700|FG000|Overall Study|Death|0|||
19542452|NCT05062759|41991701|FG001|Overall Study|Death|1|||
19542453|NCT05062759|41991700|FG000|Overall Study|Lost to Follow-up|1|||
19542454|NCT05062759|41991701|FG001|Overall Study|Lost to Follow-up|0|||
19542455|NCT04870710|41991707|FG000|Overall Study|Lost to Follow-up|3|||
19542456|NCT04858802|41991713|FG000|Overall Study|Lost to Follow-up|1|||
19542457|NCT04858802|41991714|FG001|Overall Study|Lost to Follow-up|1|||
19542458|NCT04858802|41991713|FG000|Overall Study|Withdrawal by Subject|1|||
19542459|NCT04858802|41991714|FG001|Overall Study|Withdrawal by Subject|1|||
19542460|NCT04562090|41991753|FG000|Overall Study|Withdrawal by Subject|3|||
19542461|NCT04562090|41991754|FG001|Overall Study|Withdrawal by Subject|4|||
19542462|NCT04562090|41991753|FG000|Overall Study|Protocol Violation|2|||
19542463|NCT04562090|41991754|FG001|Overall Study|Protocol Violation|0|||
19542464|NCT04562090|41991753|FG000|Overall Study|Lack of Efficacy|0|||
19542465|NCT04562090|41991754|FG001|Overall Study|Lack of Efficacy|1|||
19542466|NCT04562090|41991753|FG000|Overall Study|Adverse Event|1|||
19542467|NCT04562090|41991754|FG001|Overall Study|Adverse Event|4|||
19542468|NCT04562090|41991753|FG000|Overall Study|Miscellaneous|0|||
19542469|NCT04562090|41991754|FG001|Overall Study|Miscellaneous|3|||
19542470|NCT04557189|41991765|FG000|Overall Study|Adverse Event|0|||
19542471|NCT04557189|41991766|FG001|Overall Study|Adverse Event|1|||
19542472|NCT04557189|41991765|FG000|Overall Study|Lost to Follow-up|1|||
19542473|NCT04557189|41991766|FG001|Overall Study|Lost to Follow-up|1|||
19542474|NCT04557189|41991765|FG000|Overall Study|Withdrawal by Subject|2|||
19542475|NCT04557189|41991766|FG001|Overall Study|Withdrawal by Subject|1|||
19542476|NCT04557189|41991765|FG000|Overall Study|Reason not Specified|3|||
19542477|NCT04557189|41991766|FG001|Overall Study|Reason not Specified|6|||
19542478|NCT04530838|41991779|FG000|Overall Study|Other|2|||
19542479|NCT04530838|41991780|FG001|Overall Study|Other|1|||
19542480|NCT04530838|41991781|FG002|Overall Study|Other|0|||
19542481|NCT04530838|41991779|FG000|Overall Study|Physician Decision|0|||
19542482|NCT04530838|41991780|FG001|Overall Study|Physician Decision|0|||
19542483|NCT04530838|41991781|FG002|Overall Study|Physician Decision|1|||
19542484|NCT04530838|41991779|FG000|Overall Study|Death|0|||
19542485|NCT04530838|41991780|FG001|Overall Study|Death|0|||
19542486|NCT04530838|41991781|FG002|Overall Study|Death|1|||
19542487|NCT04530838|41991779|FG000|Overall Study|Adverse Event|0|||
19542488|NCT04530838|41991780|FG001|Overall Study|Adverse Event|1|||
19542489|NCT04530838|41991781|FG002|Overall Study|Adverse Event|0|||
19542490|NCT04530838|41991779|FG000|Overall Study|No longer meets eligibility criteria|1|||
19542491|NCT04530838|41991780|FG001|Overall Study|No longer meets eligibility criteria|0|||
19542492|NCT04530838|41991781|FG002|Overall Study|No longer meets eligibility criteria|2|||
19542493|NCT04530838|41991779|FG000|Overall Study|Withdrawal by parent/guardian|5|||
19542494|NCT04530838|41991780|FG001|Overall Study|Withdrawal by parent/guardian|2|||
19542495|NCT04530838|41991781|FG002|Overall Study|Withdrawal by parent/guardian|2|||
19457961|NCT01428063|41711553|FG001|Overall Study|Lost to Follow-up|2|||
19457962|NCT01428063|41711554|FG002|Overall Study|Lost to Follow-up|0|||
19457963|NCT01428063|41711552|FG000|Overall Study|No longer meets study criteria|0|||
19457964|NCT01428063|41711553|FG001|Overall Study|No longer meets study criteria|1|||
19457965|NCT01428063|41711554|FG002|Overall Study|No longer meets study criteria|0|||
19457966|NCT01441635|41711718|FG000|Overall Study|Adverse Event|4|||
19457967|NCT01441635|41711719|FG001|Overall Study|Adverse Event|3|||
19457968|NCT01441635|41711720|FG002|Overall Study|Adverse Event|1|||
19542496|NCT04424901|41991795|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
19542497|NCT04424901|41991796|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
19542498|NCT04410445|41991804|FG000|Overall Study|Lost to Follow-up|3|||
19542499|NCT04410445|41991805|FG001|Overall Study|Lost to Follow-up|9|||
19542500|NCT04410445|41991804|FG000|Overall Study|Withdrawal by Subject|27|||
19632651|NCT00830063|42082168|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
19632652|NCT00830063|42082165|FG000|Overall Study|Lack of Efficacy|51|||
19632653|NCT00830063|42082166|FG001|Overall Study|Lack of Efficacy|23|||
19632654|NCT00830063|42082167|FG002|Overall Study|Lack of Efficacy|25|||
19632655|NCT00830063|42082168|FG003|Overall Study|Lack of Efficacy|32|||
19632656|NCT00830063|42082165|FG000|Overall Study|Other|5|||
19632657|NCT00830063|42082166|FG001|Overall Study|Other|5|||
19632658|NCT00830063|42082167|FG002|Overall Study|Other|8|||
19632659|NCT00830063|42082168|FG003|Overall Study|Other|6|||
19632660|NCT00830063|42082165|FG000|Overall Study|Withdrawal by Subject|16|||
19632661|NCT00830063|42082166|FG001|Overall Study|Withdrawal by Subject|10|||
19711629|NCT00078806|42154683|FG003|Part 2|Adverse Event|0|||
19542501|NCT04410445|41991805|FG001|Overall Study|Withdrawal by Subject|15|||
19542502|NCT04062448|41991834|FG000|Overall Study|Lost to Follow-up|1|||
19542503|NCT04062448|41991834|FG000|Overall Study|Withdrawal by Subject|1|||
19542504|NCT04062448|41991834|FG000|Overall Study|Ongoing|14|||
19542505|NCT03970733|41991841|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
19542506|NCT03970733|41991842|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
19542507|NCT03970733|41991843|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
19542508|NCT03970733|41991844|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
19542509|NCT03970733|41991845|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
19542510|NCT03970733|41991841|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
19542511|NCT03970733|41991842|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
19542512|NCT03970733|41991843|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
19542513|NCT03970733|41991844|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
19542514|NCT03970733|41991845|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
19542515|NCT03970733|41991841|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
19542516|NCT03970733|41991842|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
19542517|NCT03970733|41991843|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
19542518|NCT03970733|41991844|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
19542519|NCT03970733|41991845|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
19542520|NCT03970733|41991841|FG000|Main Study Phase (18 Months)|Other|1|||
19542521|NCT03970733|41991842|FG001|Main Study Phase (18 Months)|Other|1|||
19542522|NCT03970733|41991843|FG002|Main Study Phase (18 Months)|Other|0|||
19542523|NCT03970733|41991844|FG003|Main Study Phase (18 Months)|Other|0|||
19542524|NCT03970733|41991845|FG004|Main Study Phase (18 Months)|Other|0|||
19542525|NCT03970733|41991841|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
19542526|NCT03970733|41991842|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
19542527|NCT03970733|41991843|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
19542528|NCT03970733|41991844|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
19542529|NCT03970733|41991845|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
19542530|NCT03921411|41991857|FG000|Overall Study|Withdrawal by Subject|1|||
19542531|NCT03921411|41991857|FG000|Overall Study|Protocol Deviation|2|||
19542532|NCT03921411|41991857|FG000|Overall Study|Enrolled, but never treated|2|||
19542533|NCT03728582|41991861|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
19542534|NCT03728582|41991862|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
19542535|NCT03728582|41991861|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
19542536|NCT03728582|41991862|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
19542537|NCT03721016|41991871|FG000|Overall Study|Adverse Event|0|||
19542538|NCT03721016|41991872|FG001|Overall Study|Adverse Event|1|||
19542539|NCT03721016|41991873|FG002|Overall Study|Adverse Event|1|||
19542540|NCT03721016|41991871|FG000|Overall Study|Withdrawal by Subject|8|||
19542541|NCT03721016|41991872|FG001|Overall Study|Withdrawal by Subject|16|||
19542542|NCT03721016|41991873|FG002|Overall Study|Withdrawal by Subject|13|||
19542543|NCT03721016|41991871|FG000|Overall Study|Lost to Follow-up|4|||
19542544|NCT03721016|41991872|FG001|Overall Study|Lost to Follow-up|6|||
19542545|NCT03721016|41991873|FG002|Overall Study|Lost to Follow-up|5|||
19542546|NCT03721016|41991871|FG000|Overall Study|Physician Decision|0|||
19542547|NCT03721016|41991872|FG001|Overall Study|Physician Decision|1|||
19542548|NCT03721016|41991873|FG002|Overall Study|Physician Decision|2|||
19542549|NCT03721016|41991871|FG000|Overall Study|Protocol Violation|0|||
19542550|NCT03721016|41991872|FG001|Overall Study|Protocol Violation|1|||
19542551|NCT03721016|41991873|FG002|Overall Study|Protocol Violation|0|||
19542552|NCT03721016|41991871|FG000|Overall Study|Site terminated by sponsor|3|||
19542553|NCT03721016|41991872|FG001|Overall Study|Site terminated by sponsor|7|||
19542554|NCT03721016|41991873|FG002|Overall Study|Site terminated by sponsor|6|||
19542555|NCT03721016|41991871|FG000|Overall Study|Subject exited early due to COVID-19|1|||
19542556|NCT03721016|41991872|FG001|Overall Study|Subject exited early due to COVID-19|0|||
19542557|NCT03721016|41991873|FG002|Overall Study|Subject exited early due to COVID-19|0|||
19542558|NCT03459729|41991881|FG000|Overall Study|Physician Decision|2|||
19542559|NCT03416179|41991898|FG000|Overall Study|Death|90|||
19542560|NCT03416179|41991899|FG001|Overall Study|Death|87|||
19542561|NCT03416179|41991900|FG002|Overall Study|Death|117|||
19711630|NCT00078338|42154700|FG000|Overall Study|Adverse Event|31|||
19542562|NCT03416179|41991901|FG003|Overall Study|Death|113|||
19542563|NCT03416179|41991898|FG000|Overall Study|Withdrawal by Subject|15|||
19542564|NCT03416179|41991899|FG001|Overall Study|Withdrawal by Subject|20|||
19542565|NCT03416179|41991900|FG002|Overall Study|Withdrawal by Subject|6|||
19542566|NCT03416179|41991901|FG003|Overall Study|Withdrawal by Subject|9|||
19542567|NCT03416179|41991898|FG000|Overall Study|Lost to Follow-up|1|||
19542568|NCT03416179|41991899|FG001|Overall Study|Lost to Follow-up|1|||
19542569|NCT03416179|41991900|FG002|Overall Study|Lost to Follow-up|0|||
19542570|NCT03416179|41991901|FG003|Overall Study|Lost to Follow-up|3|||
19542571|NCT03416179|41991898|FG000|Overall Study|Study participation terminated by Sponsor|93|||
19542572|NCT03416179|41991899|FG001|Overall Study|Study participation terminated by Sponsor|91|||
19542573|NCT03416179|41991900|FG002|Overall Study|Study participation terminated by Sponsor|26|||
19542574|NCT03416179|41991901|FG003|Overall Study|Study participation terminated by Sponsor|31|||
19542575|NCT03416179|41991898|FG000|Overall Study|Other|2|||
19542576|NCT03416179|41991899|FG001|Overall Study|Other|3|||
19542577|NCT03416179|41991900|FG002|Overall Study|Other|1|||
19542578|NCT03416179|41991901|FG003|Overall Study|Other|0|||
19542579|NCT03186638|41991913|FG000|Overall Study|Withdrawal by Subject|4|||
19542580|NCT03186638|41991914|FG001|Overall Study|Withdrawal by Subject|4|||
19542581|NCT03186638|41991913|FG000|Overall Study|Withdrawn due to medical problem|3|||
19542582|NCT03186638|41991914|FG001|Overall Study|Withdrawn due to medical problem|2|||
19542583|NCT03186638|41991913|FG000|Overall Study|Lost to Follow-up|1|||
19542584|NCT03186638|41991914|FG001|Overall Study|Lost to Follow-up|0|||
19542585|NCT03064126|41991937|FG000|Overall Study|Death|6|||
19542586|NCT03064126|41991938|FG001|Overall Study|Death|2|||
19542587|NCT03064126|41991939|FG002|Overall Study|Death|2|||
19542588|NCT03064126|41991940|FG003|Overall Study|Death|1|||
19542589|NCT03064126|41991937|FG000|Overall Study|Investigator Discretion|1|||
19542590|NCT03064126|41991938|FG001|Overall Study|Investigator Discretion|0|||
19542591|NCT03064126|41991939|FG002|Overall Study|Investigator Discretion|0|||
19542592|NCT03064126|41991940|FG003|Overall Study|Investigator Discretion|0|||
19542593|NCT03064126|41991937|FG000|Overall Study|Withdrawal by Subject|7|||
19542594|NCT03064126|41991938|FG001|Overall Study|Withdrawal by Subject|4|||
19542595|NCT03064126|41991939|FG002|Overall Study|Withdrawal by Subject|0|||
19542596|NCT03064126|41991940|FG003|Overall Study|Withdrawal by Subject|0|||
19542597|NCT03064126|41991937|FG000|Overall Study|Subject moved|1|||
19542598|NCT03064126|41991938|FG001|Overall Study|Subject moved|0|||
19542599|NCT03064126|41991939|FG002|Overall Study|Subject moved|0|||
19542600|NCT03064126|41991940|FG003|Overall Study|Subject moved|0|||
19542601|NCT03064126|41991937|FG000|Overall Study|Protocol Violation|11|||
19542602|NCT03064126|41991938|FG001|Overall Study|Protocol Violation|1|||
19542603|NCT03064126|41991939|FG002|Overall Study|Protocol Violation|1|||
19542604|NCT03064126|41991940|FG003|Overall Study|Protocol Violation|0|||
19542605|NCT03043872|41991954|FG000|Overall Study|Withdrawal by Subject|6|||
19542606|NCT03043872|41991955|FG001|Overall Study|Withdrawal by Subject|6|||
19542607|NCT03043872|41991956|FG002|Overall Study|Withdrawal by Subject|15|||
19542608|NCT03043872|41991954|FG000|Overall Study|Lost to Follow-up|2|||
19542609|NCT03043872|41991955|FG001|Overall Study|Lost to Follow-up|1|||
19542610|NCT03043872|41991956|FG002|Overall Study|Lost to Follow-up|1|||
19542611|NCT03043872|41991954|FG000|Overall Study|Death|270|||
19542612|NCT03043872|41991955|FG001|Overall Study|Death|269|||
19542613|NCT03043872|41991956|FG002|Overall Study|Death|296|||
19542614|NCT02990338|41991998|FG000|Overall Study|Ongoing|30|||
19542615|NCT02990338|41991999|FG001|Overall Study|Ongoing|36|||
19542616|NCT02932332|41992012|FG000|Overall Study|Withdrawal by Subject|1|||
19542617|NCT02932332|41992013|FG001|Overall Study|Withdrawal by Subject|1|||
19542618|NCT02932332|41992014|FG002|Overall Study|Withdrawal by Subject|0|||
19542619|NCT02932332|41992015|FG003|Overall Study|Withdrawal by Subject|1|||
19542620|NCT02932332|41992012|FG000|Overall Study|Chest pain|0|||
19542621|NCT02932332|41992013|FG001|Overall Study|Chest pain|0|||
19542622|NCT02932332|41992014|FG002|Overall Study|Chest pain|0|||
19542623|NCT02932332|41992015|FG003|Overall Study|Chest pain|1|||
19542624|NCT02932332|41992012|FG000|Overall Study|Not Dyspneic cough|1|||
19542625|NCT02932332|41992013|FG001|Overall Study|Not Dyspneic cough|2|||
19542626|NCT02932332|41992014|FG002|Overall Study|Not Dyspneic cough|1|||
19457969|NCT01441635|41711721|FG003|Overall Study|Adverse Event|5|||
19457970|NCT01441635|41711722|FG004|Overall Study|Adverse Event|1|||
19457971|NCT01441635|41711723|FG005|Overall Study|Adverse Event|2|||
19457972|NCT01441635|41711724|FG006|Overall Study|Adverse Event|2|||
19457973|NCT01441635|41711725|FG007|Overall Study|Adverse Event|2|||
19457974|NCT01441635|41711726|FG008|Overall Study|Adverse Event|1|||
19457975|NCT01441635|41711727|FG009|Overall Study|Adverse Event|0|||
19457976|NCT01441635|41711718|FG000|Overall Study|Withdrawal by Subject|1|||
19457977|NCT01441635|41711719|FG001|Overall Study|Withdrawal by Subject|1|||
19542627|NCT02932332|41992015|FG003|Overall Study|Not Dyspneic cough|0|||
19457978|NCT01441635|41711720|FG002|Overall Study|Withdrawal by Subject|0|||
19542628|NCT02820623|41992049|FG000|Overall Study|Withdrawal by Subject|1|||
19542629|NCT02820623|41992050|FG001|Overall Study|Withdrawal by Subject|3|||
19542630|NCT02820623|41992051|FG002|Overall Study|Withdrawal by Subject|3|||
19542631|NCT02820623|41992049|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
19542632|NCT02820623|41992050|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
19542633|NCT02820623|41992051|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
19542634|NCT02820623|41992049|FG000|Overall Study|Therapist unable to enroll clients|1|||
19542635|NCT02820623|41992050|FG001|Overall Study|Therapist unable to enroll clients|1|||
19542636|NCT02820623|41992051|FG002|Overall Study|Therapist unable to enroll clients|3|||
19542637|NCT02820623|41992049|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
19542638|NCT02820623|41992050|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
19542639|NCT02820623|41992051|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
19542640|NCT02774005|41992059|FG000|Overall Study|Adverse Event|8|||
19542641|NCT02774005|41992059|FG000|Overall Study|Withdrawal by Subject|23|||
19542642|NCT02774005|41992059|FG000|Overall Study|Lost to Follow-up|7|||
19542643|NCT02774005|41992059|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
19542644|NCT02774005|41992059|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
19542645|NCT02774005|41992059|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
19542646|NCT02774005|41992059|FG000|Overall Study|Death|1|||
19542647|NCT02774005|41992059|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
19542648|NCT02774005|41992059|FG000|Overall Study|Lack of compliance with study medication|4|||
19542649|NCT02774005|41992059|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
19542650|NCT02774005|41992059|FG000|Overall Study|another study|1|||
19542651|NCT02774005|41992059|FG000|Overall Study|cardiologist imposed travel restriction|1|||
19542652|NCT01975428|41992093|FG000|Overall Study|Lost to Follow-up|17|||
19542653|NCT01975428|41992094|FG001|Overall Study|Lost to Follow-up|4|||
19542654|NCT01975428|41992093|FG000|Overall Study|Withdrawal by Subject|3|||
19542655|NCT01975428|41992094|FG001|Overall Study|Withdrawal by Subject|10|||
19542656|NCT01047540|41992135|FG000|Overall Study|Protocol Violation|1|||
19542657|NCT01047540|41992136|FG001|Overall Study|Protocol Violation|0|||
19542658|NCT01047540|41992137|FG002|Overall Study|Protocol Violation|0|||
19542659|NCT01047540|41992138|FG003|Overall Study|Protocol Violation|0|||
19542660|NCT01047540|41992139|FG004|Overall Study|Protocol Violation|0|||
19542661|NCT01047540|41992135|FG000|Overall Study|Lost to Follow-up|1|||
19542662|NCT01047540|41992136|FG001|Overall Study|Lost to Follow-up|0|||
19542663|NCT01047540|41992137|FG002|Overall Study|Lost to Follow-up|0|||
19542664|NCT01047540|41992138|FG003|Overall Study|Lost to Follow-up|0|||
19542665|NCT01047540|41992139|FG004|Overall Study|Lost to Follow-up|0|||
19542666|NCT01047540|41992135|FG000|Overall Study|Withdrawal by Subject|1|||
19542667|NCT01047540|41992136|FG001|Overall Study|Withdrawal by Subject|0|||
19542668|NCT01047540|41992137|FG002|Overall Study|Withdrawal by Subject|3|||
19542669|NCT01047540|41992138|FG003|Overall Study|Withdrawal by Subject|0|||
19542670|NCT01047540|41992139|FG004|Overall Study|Withdrawal by Subject|1|||
19542671|NCT01047540|41992135|FG000|Overall Study|Pregnancy|1|||
19542672|NCT01047540|41992136|FG001|Overall Study|Pregnancy|0|||
19542673|NCT01047540|41992137|FG002|Overall Study|Pregnancy|0|||
19542674|NCT01047540|41992138|FG003|Overall Study|Pregnancy|0|||
19542675|NCT01047540|41992139|FG004|Overall Study|Pregnancy|0|||
19542676|NCT01047540|41992135|FG000|Overall Study|Adverse Event|1|||
19542677|NCT01047540|41992136|FG001|Overall Study|Adverse Event|0|||
19542678|NCT01047540|41992137|FG002|Overall Study|Adverse Event|0|||
19542679|NCT01047540|41992138|FG003|Overall Study|Adverse Event|0|||
19542680|NCT01047540|41992139|FG004|Overall Study|Adverse Event|0|||
19542681|NCT00521222|41992155|FG000|Overall Study|Lost to Follow-up|0|||
19542682|NCT00521222|41992156|FG001|Overall Study|Lost to Follow-up|0|||
19542683|NCT00521222|41992157|FG002|Overall Study|Lost to Follow-up|1|||
19542684|NCT00521222|41992158|FG003|Overall Study|Lost to Follow-up|1|||
19542685|NCT00521222|41992155|FG000|Overall Study|Withdrawal by Subject|0|||
19542686|NCT00521222|41992156|FG001|Overall Study|Withdrawal by Subject|0|||
19542687|NCT00521222|41992157|FG002|Overall Study|Withdrawal by Subject|2|||
19542688|NCT00521222|41992158|FG003|Overall Study|Withdrawal by Subject|0|||
19542689|NCT00521222|41992155|FG000|Overall Study|Physician Decision|0|||
19542690|NCT00521222|41992156|FG001|Overall Study|Physician Decision|1|||
19542691|NCT00521222|41992157|FG002|Overall Study|Physician Decision|0|||
19542692|NCT00521222|41992158|FG003|Overall Study|Physician Decision|1|||
19542693|NCT00378482|41992168|FG000|Overall Study|Lost to Follow-up|1|||
19542694|NCT00378482|41992168|FG000|Overall Study|Lack of Efficacy|8|||
19542695|NCT00378482|41992168|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
19542696|NCT00378482|41992168|FG000|Overall Study|Withdrawal by Subject|4|||
19542697|NCT00378482|41992168|FG000|Overall Study|Adverse Event|9|||
19542698|NCT01214629|41992196|FG000|Overall Study|Progressive Disease|1|||
19542699|NCT01214629|41992197|FG001|Overall Study|Progressive Disease|1|||
19542700|NCT01214629|41992198|FG002|Overall Study|Progressive Disease|0|||
19542701|NCT01214629|41992199|FG003|Overall Study|Progressive Disease|1|||
19542702|NCT01214629|41992200|FG004|Overall Study|Progressive Disease|2|||
19632662|NCT00830063|42082167|FG002|Overall Study|Withdrawal by Subject|16|||
19632663|NCT00830063|42082168|FG003|Overall Study|Withdrawal by Subject|13|||
19542703|NCT01214629|41992201|FG005|Overall Study|Progressive Disease|3|||
19542704|NCT01214629|41992202|FG006|Overall Study|Progressive Disease|1|||
19542705|NCT01214629|41992203|FG007|Overall Study|Progressive Disease|1|||
19542706|NCT01214629|41992204|FG008|Overall Study|Progressive Disease|1|||
19542707|NCT01214629|41992205|FG009|Overall Study|Progressive Disease|5|||
19542708|NCT01214629|41992206|FG010|Overall Study|Progressive Disease|1|||
19542709|NCT01214629|41992196|FG000|Overall Study|Adverse Event|0|||
19542710|NCT01214629|41992197|FG001|Overall Study|Adverse Event|0|||
19542711|NCT01214629|41992198|FG002|Overall Study|Adverse Event|0|||
19542712|NCT01214629|41992199|FG003|Overall Study|Adverse Event|1|||
19542713|NCT01214629|41992200|FG004|Overall Study|Adverse Event|0|||
19542714|NCT01214629|41992201|FG005|Overall Study|Adverse Event|1|||
19542715|NCT01214629|41992202|FG006|Overall Study|Adverse Event|0|||
19542716|NCT01214629|41992203|FG007|Overall Study|Adverse Event|0|||
19542717|NCT01214629|41992204|FG008|Overall Study|Adverse Event|0|||
19542718|NCT01214629|41992205|FG009|Overall Study|Adverse Event|1|||
19542719|NCT01214629|41992206|FG010|Overall Study|Adverse Event|0|||
19542720|NCT01214629|41992196|FG000|Overall Study|Physician Decision|0|||
19542721|NCT01214629|41992197|FG001|Overall Study|Physician Decision|0|||
19542722|NCT01214629|41992198|FG002|Overall Study|Physician Decision|0|||
19542723|NCT01214629|41992199|FG003|Overall Study|Physician Decision|0|||
19542724|NCT01214629|41992200|FG004|Overall Study|Physician Decision|0|||
19542725|NCT01214629|41992201|FG005|Overall Study|Physician Decision|0|||
19542726|NCT01214629|41992202|FG006|Overall Study|Physician Decision|0|||
19542727|NCT01214629|41992203|FG007|Overall Study|Physician Decision|0|||
19542728|NCT01214629|41992204|FG008|Overall Study|Physician Decision|0|||
19542729|NCT01214629|41992205|FG009|Overall Study|Physician Decision|0|||
19542730|NCT01214629|41992206|FG010|Overall Study|Physician Decision|1|||
19542731|NCT01214629|41992196|FG000|Overall Study|Withdrawal by Subject|0|||
19542732|NCT01214629|41992197|FG001|Overall Study|Withdrawal by Subject|0|||
19542733|NCT01214629|41992198|FG002|Overall Study|Withdrawal by Subject|0|||
19542734|NCT01214629|41992199|FG003|Overall Study|Withdrawal by Subject|0|||
19542735|NCT01214629|41992200|FG004|Overall Study|Withdrawal by Subject|0|||
19542736|NCT01214629|41992201|FG005|Overall Study|Withdrawal by Subject|0|||
19542737|NCT01214629|41992202|FG006|Overall Study|Withdrawal by Subject|0|||
19542738|NCT01214629|41992203|FG007|Overall Study|Withdrawal by Subject|0|||
19542739|NCT01214629|41992204|FG008|Overall Study|Withdrawal by Subject|0|||
19542740|NCT01214629|41992205|FG009|Overall Study|Withdrawal by Subject|1|||
19542741|NCT01214629|41992206|FG010|Overall Study|Withdrawal by Subject|0|||
19542742|NCT01214434|41992246|FG000|Overall Study|Withdrawal by Subject|1|||
19542743|NCT01214434|41992247|FG001|Overall Study|Withdrawal by Subject|0|||
19542744|NCT01214434|41992246|FG000|Overall Study|Lost to Follow-up|2|||
19542745|NCT01214434|41992247|FG001|Overall Study|Lost to Follow-up|2|||
19542746|NCT01214434|41992246|FG000|Overall Study|Site error|1|||
19542747|NCT01214434|41992247|FG001|Overall Study|Site error|0|||
19542748|NCT01214395|41992253|FG000|Overall Study|All patients had infection|5|||
19542749|NCT01214239|41992260|FG000|Overall Study|Adverse Event|3|||
19542750|NCT01214239|41992261|FG001|Overall Study|Adverse Event|4|||
19542751|NCT01214239|41992260|FG000|Overall Study|Protocol Violation|2|||
19542752|NCT01214239|41992261|FG001|Overall Study|Protocol Violation|1|||
19542753|NCT01214239|41992260|FG000|Overall Study|Lost to Follow-up|1|||
19542754|NCT01214239|41992261|FG001|Overall Study|Lost to Follow-up|1|||
19542755|NCT01214239|41992260|FG000|Overall Study|Withdrawal by Subject|4|||
19542756|NCT01214239|41992261|FG001|Overall Study|Withdrawal by Subject|9|||
19542757|NCT01214239|41992260|FG000|Overall Study|Lack of Efficacy|1|||
19542758|NCT01214239|41992261|FG001|Overall Study|Lack of Efficacy|2|||
19542759|NCT01214239|41992260|FG000|Overall Study|patient's private reason|1|||
19542760|NCT01214239|41992261|FG001|Overall Study|patient's private reason|1|||
19542761|NCT01214200|41992267|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
19542762|NCT01214200|41992267|FG000|Overall Study|Withdrawal by Subject|2|||
19542763|NCT01214044|41992273|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
19542764|NCT01214044|41992273|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
19542765|NCT01214044|41992273|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
19542766|NCT01214044|41992273|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
19542767|NCT01214044|41992273|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
19542768|NCT01214044|41992273|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
19542769|NCT01213966|41992285|FG000|Overall Study|Protocol Violation|1|||
19542770|NCT01213966|41992286|FG001|Overall Study|Protocol Violation|0|||
19542771|NCT01213966|41992287|FG002|Overall Study|Protocol Violation|3|||
19542772|NCT01213966|41992288|FG003|Overall Study|Protocol Violation|1|||
19542773|NCT01213264|41992301|FG000|Overall Study|Adverse Event|1|||
19542774|NCT01213264|41992302|FG001|Overall Study|Adverse Event|0|||
19542775|NCT01213264|41992303|FG002|Overall Study|Adverse Event|0|||
19542776|NCT01213264|41992301|FG000|Overall Study|Lost to Follow-up|1|||
19542777|NCT01213264|41992302|FG001|Overall Study|Lost to Follow-up|2|||
19542778|NCT01213264|41992303|FG002|Overall Study|Lost to Follow-up|6|||
19542779|NCT01212991|41992316|FG000|Double-blind|Lost to Follow-up|8|||
19542780|NCT01212991|41992317|FG001|Double-blind|Lost to Follow-up|4|||
19542781|NCT01212991|41992318|FG002|Double-blind|Lost to Follow-up|0|||
19542782|NCT01212991|41992316|FG000|Double-blind|Death|699|||
19542783|NCT01212991|41992317|FG001|Double-blind|Death|550|||
19542784|NCT01212991|41992318|FG002|Double-blind|Death|0|||
19542785|NCT01212991|41992316|FG000|Double-blind|Withdrawal by Subject|16|||
19542786|NCT01212991|41992317|FG001|Double-blind|Withdrawal by Subject|19|||
19542787|NCT01212991|41992318|FG002|Double-blind|Withdrawal by Subject|0|||
19542788|NCT01212991|41992316|FG000|Double-blind|Other|7|||
19542789|NCT01212991|41992317|FG001|Double-blind|Other|0|||
19542790|NCT01212991|41992318|FG002|Double-blind|Other|0|||
19542791|NCT01212991|41992316|FG000|Double-blind|Sponsor decision|142|||
19542792|NCT01212991|41992317|FG001|Double-blind|Sponsor decision|38|||
19542793|NCT01212991|41992318|FG002|Double-blind|Sponsor decision|0|||
19542794|NCT01212991|41992316|FG000|Open-label|Death|0|||
19542795|NCT01212991|41992317|FG001|Open-label|Death|0|||
19542796|NCT01212991|41992318|FG002|Open-label|Death|166|||
19542797|NCT01212991|41992316|FG000|Open-label|Lost to Follow-up|0|||
19542798|NCT01212991|41992317|FG001|Open-label|Lost to Follow-up|0|||
19542799|NCT01212991|41992318|FG002|Open-label|Lost to Follow-up|5|||
19542800|NCT01212991|41992316|FG000|Open-label|Withdrawal by Subject|0|||
19542801|NCT01212991|41992317|FG001|Open-label|Withdrawal by Subject|0|||
19542802|NCT01212991|41992318|FG002|Open-label|Withdrawal by Subject|7|||
19542803|NCT01212991|41992316|FG000|Open-label|Sponsor decision|0|||
19542804|NCT01212991|41992317|FG001|Open-label|Sponsor decision|0|||
19542805|NCT01212991|41992318|FG002|Open-label|Sponsor decision|53|||
19542806|NCT01212991|41992316|FG000|Open-label|Other|0|||
19542807|NCT01212991|41992317|FG001|Open-label|Other|0|||
19542808|NCT01212991|41992318|FG002|Open-label|Other|3|||
19542809|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
19542810|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
19542811|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
19542812|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542813|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542814|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542815|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542816|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542817|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
19542818|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
19542819|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
19542820|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
19542821|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542822|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542823|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542824|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542825|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542826|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
19542827|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
19542828|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
19542829|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
19542830|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19542831|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19542832|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19542833|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19542834|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19542835|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
19632664|NCT00830063|42082165|FG000|Overall Study|Protocol Violation|1|||
19632665|NCT00830063|42082166|FG001|Overall Study|Protocol Violation|0|||
19632666|NCT00830063|42082167|FG002|Overall Study|Protocol Violation|3|||
19632667|NCT00830063|42082168|FG003|Overall Study|Protocol Violation|2|||
19632668|NCT00830063|42082165|FG000|Overall Study|Randomized But Not Treated|0|||
19632669|NCT00830063|42082166|FG001|Overall Study|Randomized But Not Treated|2|||
19632670|NCT00830063|42082167|FG002|Overall Study|Randomized But Not Treated|0|||
19457979|NCT01441635|41711721|FG003|Overall Study|Withdrawal by Subject|1|||
19457980|NCT01441635|41711722|FG004|Overall Study|Withdrawal by Subject|0|||
19457981|NCT01441635|41711723|FG005|Overall Study|Withdrawal by Subject|0|||
19457982|NCT01441635|41711724|FG006|Overall Study|Withdrawal by Subject|2|||
19457983|NCT01441635|41711725|FG007|Overall Study|Withdrawal by Subject|0|||
19457984|NCT01441635|41711726|FG008|Overall Study|Withdrawal by Subject|1|||
19457985|NCT01441635|41711727|FG009|Overall Study|Withdrawal by Subject|1|||
19457986|NCT01441635|41711718|FG000|Overall Study|Lost to Follow-up|0|||
19457987|NCT01441635|41711719|FG001|Overall Study|Lost to Follow-up|1|||
19457988|NCT01441635|41711720|FG002|Overall Study|Lost to Follow-up|1|||
19457989|NCT01441635|41711721|FG003|Overall Study|Lost to Follow-up|1|||
19457990|NCT01441635|41711722|FG004|Overall Study|Lost to Follow-up|1|||
19632671|NCT00830063|42082168|FG003|Overall Study|Randomized But Not Treated|2|||
19632672|NCT00750438|42082182|FG000|Overall Study|Protocol Violation|4|||
19632673|NCT00750438|42082183|FG001|Overall Study|Protocol Violation|1|||
19632674|NCT00750438|42082182|FG000|Overall Study|Physician Decision|2|||
19632675|NCT00750438|42082183|FG001|Overall Study|Physician Decision|2|||
19632676|NCT00750438|42082182|FG000|Overall Study|Withdrawal by Subject|1|||
19632677|NCT00750438|42082183|FG001|Overall Study|Withdrawal by Subject|1|||
19632678|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
19632679|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
19632680|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
19632681|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
19632682|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
19632683|NCT00586326|42082189|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
19632684|NCT00586326|42082189|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
19632685|NCT00586326|42082189|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
19632686|NCT00586326|42082189|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
19632687|NCT00586326|42082189|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
19632688|NCT00586326|42082189|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
19632689|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
19632690|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
19632691|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
19632692|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
19632693|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
19632694|NCT00586326|42082189|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
19632695|NCT00751101|42082199|FG000|Overall Study|Withdrawal by Subject|1|||
19632696|NCT00751101|42082200|FG001|Overall Study|Withdrawal by Subject|0|||
19632697|NCT00751101|42082199|FG000|Overall Study|No HFS / Never Started Patch/|0|||
19632698|NCT00751101|42082200|FG001|Overall Study|No HFS / Never Started Patch/|4|||
19632699|NCT00751101|42082199|FG000|Overall Study|Never began capecitabine|1|||
19632700|NCT00751101|42082200|FG001|Overall Study|Never began capecitabine|0|||
19632701|NCT00751101|42082199|FG000|Overall Study|Physician Decision|0|||
19632702|NCT00751101|42082200|FG001|Overall Study|Physician Decision|1|||
19632703|NCT00750204|42082212|FG000|Overall Study|study halted prematurely|1|||
19632704|NCT00750204|42082213|FG001|Overall Study|study halted prematurely|1|||
19632705|NCT00751023|42082221|FG000|Overall Study|Lost to Follow-up|11|||
19632706|NCT00751023|42082222|FG001|Overall Study|Lost to Follow-up|7|||
19632707|NCT00591773|42082231|FG000|Overall Study|Adverse Event|9|||
19632708|NCT00591773|42082232|FG001|Overall Study|Adverse Event|9|||
19711631|NCT00078338|42154701|FG001|Overall Study|Adverse Event|24|||
19711632|NCT00078338|42154700|FG000|Overall Study|Lost to Follow-up|17|||
19711633|NCT00078338|42154701|FG001|Overall Study|Lost to Follow-up|2|||
19711634|NCT00078338|42154700|FG000|Overall Study|Protocol Violation|2|||
19711635|NCT00078338|42154701|FG001|Overall Study|Protocol Violation|2|||
19711636|NCT00078338|42154700|FG000|Overall Study|Disease Progression|4|||
19711637|NCT00078338|42154701|FG001|Overall Study|Disease Progression|7|||
19711638|NCT00078338|42154700|FG000|Overall Study|Other|28|||
19711639|NCT00078338|42154701|FG001|Overall Study|Other|16|||
19711640|NCT00078338|42154700|FG000|Overall Study|Subjects randomized, but not treated|3|||
19711641|NCT00078338|42154701|FG001|Overall Study|Subjects randomized, but not treated|3|||
19711642|NCT03808688|42154709|FG000|Overall Study|Adverse Event|13|||
19711643|NCT03808688|42154710|FG001|Overall Study|Adverse Event|17|||
19711644|NCT03808688|42154709|FG000|Overall Study|Lack of Efficacy|2|||
19711645|NCT03808688|42154710|FG001|Overall Study|Lack of Efficacy|0|||
19711646|NCT03808688|42154709|FG000|Overall Study|Lost to Follow-up|0|||
19711647|NCT03808688|42154710|FG001|Overall Study|Lost to Follow-up|2|||
19711648|NCT03808688|42154709|FG000|Overall Study|Withdrawal by Subject|1|||
19711649|NCT03808688|42154710|FG001|Overall Study|Withdrawal by Subject|0|||
19711650|NCT03808688|42154709|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
19711651|NCT03808688|42154710|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
19711652|NCT03808688|42154709|FG000|Overall Study|IOP Too High|1|||
19711653|NCT03808688|42154710|FG001|Overall Study|IOP Too High|1|||
19711654|NCT03808688|42154709|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
19711655|NCT03808688|42154710|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
19457991|NCT01441635|41711723|FG005|Overall Study|Lost to Follow-up|3|||
19457992|NCT01441635|41711724|FG006|Overall Study|Lost to Follow-up|1|||
19711656|NCT03808688|42154709|FG000|Overall Study|Visit Out of Window|0|||
19711657|NCT03808688|42154710|FG001|Overall Study|Visit Out of Window|1|||
19711658|NCT03808688|42154709|FG000|Overall Study|Medication Non-Compliance|0|||
19711659|NCT03808688|42154710|FG001|Overall Study|Medication Non-Compliance|1|||
19711660|NCT03808298|42154718|FG000|Overall Study|Adverse Event|3|||
19711661|NCT03808298|42154718|FG000|Overall Study|Physician Decision|1|||
19632709|NCT00591773|42082233|FG002|Overall Study|Adverse Event|6|||
19632710|NCT00591773|42082231|FG000|Overall Study|Protocol Violation|2|||
19711662|NCT03808298|42154718|FG000|Overall Study|Withdrawal by Subject|1|||
19632711|NCT00591773|42082232|FG001|Overall Study|Protocol Violation|3|||
19632712|NCT00591773|42082233|FG002|Overall Study|Protocol Violation|0|||
19632713|NCT00591773|42082231|FG000|Overall Study|Lost to Follow-up|1|||
19632714|NCT00591773|42082232|FG001|Overall Study|Lost to Follow-up|4|||
19632715|NCT00591773|42082233|FG002|Overall Study|Lost to Follow-up|1|||
19632716|NCT00591773|42082231|FG000|Overall Study|Withdrawal by Subject|2|||
19632717|NCT00591773|42082232|FG001|Overall Study|Withdrawal by Subject|5|||
19632718|NCT00591773|42082233|FG002|Overall Study|Withdrawal by Subject|3|||
19632719|NCT00591773|42082231|FG000|Overall Study|Lack of Efficacy|1|||
19632720|NCT00591773|42082232|FG001|Overall Study|Lack of Efficacy|2|||
19632721|NCT00591773|42082233|FG002|Overall Study|Lack of Efficacy|2|||
19632722|NCT00591773|42082231|FG000|Overall Study|Other|1|||
19632723|NCT00591773|42082232|FG001|Overall Study|Other|1|||
19632724|NCT00591773|42082233|FG002|Overall Study|Other|4|||
19632725|NCT00750867|42082241|FG000|Overall Study|Adverse Event|2|||
19632726|NCT00744042|42082245|FG000|Overall Study|Withdrawal by Subject|1|||
19632727|NCT00829829|42082258|FG000|Overall Study|Protocol Violation|0|||
19632728|NCT00829829|42082259|FG001|Overall Study|Protocol Violation|3|||
19632729|NCT00829829|42082260|FG002|Overall Study|Protocol Violation|0|||
19632730|NCT00829829|42082258|FG000|Overall Study|Adverse Event|4|||
19632731|NCT00829829|42082259|FG001|Overall Study|Adverse Event|4|||
19632732|NCT00829829|42082260|FG002|Overall Study|Adverse Event|3|||
19542836|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
19542837|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542838|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
19542839|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542840|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542841|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542842|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542843|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542844|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
19542845|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
19542846|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
19542847|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
19542848|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542849|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542850|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542851|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542852|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542853|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
19542854|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542855|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
19542856|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
19542857|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542858|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542859|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542860|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542861|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542862|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
19542863|NCT01212757|41992329|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
19542864|NCT01212757|41992330|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
19632733|NCT00829829|42082258|FG000|Overall Study|Withdrawal by Subject|8|||
19632734|NCT00829829|42082259|FG001|Overall Study|Withdrawal by Subject|4|||
19632735|NCT00829829|42082260|FG002|Overall Study|Withdrawal by Subject|2|||
19632736|NCT00829829|42082258|FG000|Overall Study|Decision by the Sponsor|1|||
19632737|NCT00829829|42082259|FG001|Overall Study|Decision by the Sponsor|0|||
19632738|NCT00829829|42082260|FG002|Overall Study|Decision by the Sponsor|2|||
19632739|NCT00829829|42082258|FG000|Overall Study|Lost to Follow-up|7|||
19632740|NCT00829829|42082259|FG001|Overall Study|Lost to Follow-up|3|||
19632741|NCT00829829|42082260|FG002|Overall Study|Lost to Follow-up|3|||
19632742|NCT00829829|42082258|FG000|Overall Study|Other than specified above|2|||
19632743|NCT00829829|42082259|FG001|Overall Study|Other than specified above|2|||
19632744|NCT00829829|42082260|FG002|Overall Study|Other than specified above|1|||
19632745|NCT00823199|42082269|FG000|Overall Study|Withdrawal by Subject|2|||
19632746|NCT00829439|42082274|FG000|Overall Study|Adverse Event|0|||
19711663|NCT03808298|42154718|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
19711664|NCT00077636|42154749|FG000|Overall Study|Refused Treatment|9|||
19632747|NCT00829439|42082275|FG001|Overall Study|Adverse Event|0|||
19632748|NCT00829439|42082276|FG002|Overall Study|Adverse Event|1|||
19632749|NCT00829439|42082277|FG003|Overall Study|Adverse Event|0|||
19632750|NCT00749775|42082281|FG000|Overall Study|Protocol Violation|24|||
19632751|NCT00749775|42082281|FG000|Overall Study|Lost to Follow-up|36|||
19711665|NCT00077636|42154750|FG001|Overall Study|Refused Treatment|31|||
19632752|NCT00749775|42082281|FG000|Overall Study|No visit after first day of treatment|44|||
19632753|NCT00749775|42082281|FG000|Overall Study|No drug administration|3|||
19632754|NCT00829283|42082297|FG000|Overall Study|Lost to Follow-up|7|||
19632755|NCT00829283|42082298|FG001|Overall Study|Lost to Follow-up|25|||
19632756|NCT00821873|42082304|FG000|Overall Study|Lost to Follow-up|4|||
19632757|NCT00749463|42082311|FG000|Overall Study|Adverse Event|0|||
19632758|NCT00749463|42082312|FG001|Overall Study|Adverse Event|4|||
19632759|NCT00749463|42082313|FG002|Overall Study|Adverse Event|1|||
19632760|NCT00749463|42082311|FG000|Overall Study|Withdrawal by Subject|1|||
19632761|NCT00749463|42082312|FG001|Overall Study|Withdrawal by Subject|0|||
19632762|NCT00749463|42082313|FG002|Overall Study|Withdrawal by Subject|0|||
19632763|NCT00821327|42082321|FG000|Overall Study|Adverse Event|13|||
19632764|NCT00821327|42082321|FG000|Overall Study|Patient Request|1|||
19632765|NCT00821327|42082321|FG000|Overall Study|Investigator Request|2|||
19632766|NCT00821327|42082321|FG000|Overall Study|Sponsor Request|1|||
19632767|NCT00821327|42082321|FG000|Overall Study|Disease Progression|13|||
19632768|NCT00821327|42082321|FG000|Overall Study|Other/Unknown|5|||
19632769|NCT00821093|42082327|FG000|Overall Study|Adverse Event|20|||
19632770|NCT00821093|42082328|FG001|Overall Study|Adverse Event|12|||
19632771|NCT00821093|42082327|FG000|Overall Study|Withdrawal by Subject|9|||
19632772|NCT00821093|42082328|FG001|Overall Study|Withdrawal by Subject|13|||
19632773|NCT00821093|42082327|FG000|Overall Study|Lost to Follow-up|9|||
19542865|NCT01212757|41992331|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542866|NCT01212757|41992332|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542867|NCT01212757|41992333|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542868|NCT01212757|41992334|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542869|NCT01212757|41992335|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542870|NCT01212757|41992336|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542871|NCT01212757|41992337|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
19542872|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
19542873|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
19542874|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
19542875|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
19542876|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
19542877|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
19542878|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
19542879|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
19542880|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
19542881|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
19542882|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
19542883|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
19542884|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
19542885|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
19542886|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
19542887|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
19542888|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
19542889|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
19542890|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542891|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542892|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
19542893|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542894|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542895|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542896|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542897|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542898|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
19542899|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19542900|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
19542901|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
19542902|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
19542903|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
19542904|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
19542905|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19542906|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19542907|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
19632774|NCT00821093|42082328|FG001|Overall Study|Lost to Follow-up|3|||
19632775|NCT00821093|42082327|FG000|Overall Study|Protocol deviation|3|||
19542908|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542909|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
19542910|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542911|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542912|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
19542913|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542914|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542915|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19542916|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
19632776|NCT00821093|42082328|FG001|Overall Study|Protocol deviation|6|||
19632777|NCT00821093|42082327|FG000|Overall Study|Abnormal laboratory value(s)|2|||
19632778|NCT00821093|42082328|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19632779|NCT00821093|42082327|FG000|Overall Study|Lack of Efficacy|2|||
19632780|NCT00821093|42082328|FG001|Overall Study|Lack of Efficacy|2|||
19711666|NCT00077636|42154749|FG000|Overall Study|Admin|3|||
19711667|NCT00077636|42154750|FG001|Overall Study|Admin|3|||
19711668|NCT00077636|42154749|FG000|Overall Study|Withdrawal by Subject|2|||
19711669|NCT00077636|42154750|FG001|Overall Study|Withdrawal by Subject|2|||
19711670|NCT00077636|42154749|FG000|Overall Study|Adverse Event|17|||
19711671|NCT00077636|42154750|FG001|Overall Study|Adverse Event|34|||
19711672|NCT00077636|42154749|FG000|Overall Study|Protocol Violation|0|||
19711673|NCT00077636|42154750|FG001|Overall Study|Protocol Violation|2|||
19711674|NCT00077636|42154749|FG000|Overall Study|Lost to Follow-up|10|||
19632781|NCT00821093|42082327|FG000|Overall Study|Death|2|||
19632782|NCT00821093|42082328|FG001|Overall Study|Death|1|||
19632783|NCT00821093|42082327|FG000|Overall Study|Abnormal test procedure result(s)|1|||
19632784|NCT00821093|42082328|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19632785|NCT00821093|42082327|FG000|Overall Study|Administrative problems|1|||
19632786|NCT00821093|42082328|FG001|Overall Study|Administrative problems|2|||
19632787|NCT00821015|42082334|FG000|Overall Study|Lost to Follow-up|12|||
19632788|NCT00814463|42082338|FG000|Overall Study|Lost to Follow-up|1|||
19632789|NCT00743652|42082348|FG000|Overall Study|Parent/Legal Guardian Request|3|||
19632790|NCT00743652|42082349|FG001|Overall Study|Parent/Legal Guardian Request|2|||
19632791|NCT00743652|42082350|FG002|Overall Study|Parent/Legal Guardian Request|2|||
19632792|NCT00743652|42082351|FG003|Overall Study|Parent/Legal Guardian Request|2|||
19632793|NCT00743652|42082352|FG004|Overall Study|Parent/Legal Guardian Request|0|||
19632794|NCT00743652|42082348|FG000|Overall Study|Adverse Event|3|||
19632795|NCT00743652|42082349|FG001|Overall Study|Adverse Event|0|||
19632796|NCT00743652|42082350|FG002|Overall Study|Adverse Event|0|||
19632797|NCT00743652|42082351|FG003|Overall Study|Adverse Event|0|||
19632798|NCT00743652|42082352|FG004|Overall Study|Adverse Event|0|||
19632799|NCT00743652|42082348|FG000|Overall Study|Death|2|||
19632800|NCT00743652|42082349|FG001|Overall Study|Death|0|||
19632801|NCT00743652|42082350|FG002|Overall Study|Death|0|||
19632802|NCT00743652|42082351|FG003|Overall Study|Death|0|||
19632803|NCT00743652|42082352|FG004|Overall Study|Death|0|||
19632804|NCT00743652|42082348|FG000|Overall Study|Investigator Request|0|||
19632805|NCT00743652|42082349|FG001|Overall Study|Investigator Request|0|||
19632806|NCT00743652|42082350|FG002|Overall Study|Investigator Request|0|||
19632807|NCT00743652|42082351|FG003|Overall Study|Investigator Request|2|||
19632808|NCT00743652|42082352|FG004|Overall Study|Investigator Request|0|||
19632809|NCT00743652|42082348|FG000|Overall Study|Other|1|||
19632810|NCT00743652|42082349|FG001|Overall Study|Other|1|||
19632811|NCT00743652|42082350|FG002|Overall Study|Other|0|||
19632812|NCT00743652|42082351|FG003|Overall Study|Other|0|||
19632813|NCT00743652|42082352|FG004|Overall Study|Other|0|||
19632814|NCT00743652|42082348|FG000|Overall Study|Lost to Follow-up|1|||
19632815|NCT00743652|42082349|FG001|Overall Study|Lost to Follow-up|0|||
19632816|NCT00743652|42082350|FG002|Overall Study|Lost to Follow-up|0|||
19632817|NCT00743652|42082351|FG003|Overall Study|Lost to Follow-up|0|||
19632818|NCT00743652|42082352|FG004|Overall Study|Lost to Follow-up|0|||
19632819|NCT00748215|42082370|FG000|Overall Study|Withdrawal by Subject|7|||
19632820|NCT00748215|42082371|FG001|Overall Study|Withdrawal by Subject|7|||
19632821|NCT00748215|42082370|FG000|Overall Study|Treatment change|2|||
19632822|NCT00748215|42082371|FG001|Overall Study|Treatment change|1|||
19632823|NCT00748215|42082370|FG000|Overall Study|Change in patient condition|0|||
19632824|NCT00748215|42082371|FG001|Overall Study|Change in patient condition|3|||
19632825|NCT00748215|42082370|FG000|Overall Study|Non-compliant|0|||
19632826|NCT00748215|42082371|FG001|Overall Study|Non-compliant|2|||
19711675|NCT00077636|42154750|FG001|Overall Study|Lost to Follow-up|18|||
19711676|NCT00077636|42154749|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
19542917|NCT01212757|41992329|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542918|NCT01212757|41992330|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
19632827|NCT00748215|42082370|FG000|Overall Study|Adverse Event|0|||
19632828|NCT00748215|42082371|FG001|Overall Study|Adverse Event|5|||
19632829|NCT00749892|42082377|FG000|Overall Study|Withdrawal by Subject|3|||
19711677|NCT00077636|42154750|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
19375425|NCT00835367|41617364|FG001|Washout|Withdrawal by Subject|0|||
19542919|NCT01212757|41992331|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
19542920|NCT01212757|41992332|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542921|NCT01212757|41992333|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19632830|NCT00749580|42082383|FG000|Overall Study|Lost to Follow-up|4|||
19632831|NCT00749580|42082384|FG001|Overall Study|Lost to Follow-up|8|||
19632832|NCT00749580|42082383|FG000|Overall Study|Adverse Event|0|||
19632833|NCT00749580|42082384|FG001|Overall Study|Adverse Event|1|||
19632834|NCT00747006|42082393|FG000|Overall Study|Adverse Event|1|||
19632835|NCT00747006|42082394|FG001|Overall Study|Adverse Event|0|||
19632836|NCT00747006|42082395|FG002|Overall Study|Adverse Event|0|||
19632837|NCT00747006|42082393|FG000|Overall Study|Lost to Follow-up|0|||
19632838|NCT00747006|42082394|FG001|Overall Study|Lost to Follow-up|1|||
19632839|NCT00747006|42082395|FG002|Overall Study|Lost to Follow-up|0|||
19632840|NCT00747006|42082393|FG000|Overall Study|Physician Decision|2|||
19632841|NCT00747006|42082394|FG001|Overall Study|Physician Decision|0|||
19632842|NCT00747006|42082395|FG002|Overall Study|Physician Decision|1|||
19632843|NCT00743340|42082406|FG000|Overall Study|Study medication non-compliance|1|||
19632844|NCT00743340|42082406|FG000|Overall Study|Lost to Follow-up|1|||
19632845|NCT00743340|42082406|FG000|Overall Study|Withdrawal from the Study|5|||
19632846|NCT00743340|42082406|FG000|Overall Study|Protocol Violation|1|||
19632847|NCT00743340|42082406|FG000|Overall Study|Virologic failure|8|||
19632848|NCT00743340|42082406|FG000|Overall Study|Pregnancy|1|||
19632849|NCT00743340|42082406|FG000|Overall Study|Rolled over to other Gilead Study|23|||
19542922|NCT01212757|41992334|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542923|NCT01212757|41992335|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542924|NCT01212757|41992336|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542925|NCT01212757|41992337|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
19542926|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542927|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542928|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542929|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542930|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542931|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542932|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19542933|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
19457993|NCT01441635|41711725|FG007|Overall Study|Lost to Follow-up|1|||
19457994|NCT01441635|41711726|FG008|Overall Study|Lost to Follow-up|0|||
19457995|NCT01441635|41711727|FG009|Overall Study|Lost to Follow-up|1|||
19457996|NCT01441635|41711718|FG000|Overall Study|Noncompliance|0|||
19457997|NCT01441635|41711719|FG001|Overall Study|Noncompliance|1|||
19457998|NCT01441635|41711720|FG002|Overall Study|Noncompliance|0|||
19457999|NCT01441635|41711721|FG003|Overall Study|Noncompliance|0|||
19458000|NCT01441635|41711722|FG004|Overall Study|Noncompliance|0|||
19458001|NCT01441635|41711723|FG005|Overall Study|Noncompliance|0|||
19458002|NCT01441635|41711724|FG006|Overall Study|Noncompliance|1|||
19458003|NCT01441635|41711725|FG007|Overall Study|Noncompliance|0|||
19458004|NCT01441635|41711726|FG008|Overall Study|Noncompliance|0|||
19458005|NCT01441635|41711727|FG009|Overall Study|Noncompliance|0|||
19458006|NCT01441635|41711718|FG000|Overall Study|Surgery or Invasive Intervention|0|||
19458007|NCT01441635|41711719|FG001|Overall Study|Surgery or Invasive Intervention|0|||
19458008|NCT01441635|41711720|FG002|Overall Study|Surgery or Invasive Intervention|1|||
19458009|NCT01441635|41711721|FG003|Overall Study|Surgery or Invasive Intervention|0|||
19458010|NCT01441635|41711722|FG004|Overall Study|Surgery or Invasive Intervention|0|||
19458011|NCT01441635|41711723|FG005|Overall Study|Surgery or Invasive Intervention|0|||
19458012|NCT01441635|41711724|FG006|Overall Study|Surgery or Invasive Intervention|0|||
19458013|NCT01441635|41711725|FG007|Overall Study|Surgery or Invasive Intervention|0|||
19458014|NCT01441635|41711726|FG008|Overall Study|Surgery or Invasive Intervention|0|||
19458015|NCT01441635|41711727|FG009|Overall Study|Surgery or Invasive Intervention|0|||
19458016|NCT01441635|41711718|FG000|Overall Study|Received Exclusionary Medication|1|||
19458017|NCT01441635|41711719|FG001|Overall Study|Received Exclusionary Medication|0|||
19458018|NCT01441635|41711720|FG002|Overall Study|Received Exclusionary Medication|0|||
19458019|NCT01441635|41711721|FG003|Overall Study|Received Exclusionary Medication|0|||
19458020|NCT01441635|41711722|FG004|Overall Study|Received Exclusionary Medication|0|||
19458021|NCT01441635|41711723|FG005|Overall Study|Received Exclusionary Medication|0|||
19458022|NCT01441635|41711724|FG006|Overall Study|Received Exclusionary Medication|0|||
19458023|NCT01441635|41711725|FG007|Overall Study|Received Exclusionary Medication|0|||
19458024|NCT01441635|41711726|FG008|Overall Study|Received Exclusionary Medication|0|||
19632850|NCT00743340|42082406|FG000|Overall Study|Participant Relocated|1|||
19542934|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
19542935|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
19632851|NCT00749190|42082417|FG000|Overall Study|Adverse Event|0|||
19632852|NCT00749190|42082418|FG001|Overall Study|Adverse Event|2|||
19632853|NCT00749190|42082419|FG002|Overall Study|Adverse Event|0|||
19632854|NCT00749190|42082420|FG003|Overall Study|Adverse Event|4|||
19632855|NCT00749190|42082421|FG004|Overall Study|Adverse Event|0|||
19632856|NCT00749190|42082422|FG005|Overall Study|Adverse Event|3|||
19632857|NCT00749190|42082423|FG006|Overall Study|Adverse Event|0|||
19632858|NCT00749190|42082417|FG000|Overall Study|Lack of Efficacy|3|||
19632859|NCT00749190|42082418|FG001|Overall Study|Lack of Efficacy|1|||
19632860|NCT00749190|42082419|FG002|Overall Study|Lack of Efficacy|1|||
19632861|NCT00749190|42082420|FG003|Overall Study|Lack of Efficacy|0|||
19632862|NCT00749190|42082421|FG004|Overall Study|Lack of Efficacy|0|||
19632863|NCT00749190|42082422|FG005|Overall Study|Lack of Efficacy|1|||
19632864|NCT00749190|42082423|FG006|Overall Study|Lack of Efficacy|0|||
19632865|NCT00749190|42082417|FG000|Overall Study|Withdrawal by Subject|2|||
19632866|NCT00749190|42082418|FG001|Overall Study|Withdrawal by Subject|1|||
19632867|NCT00749190|42082419|FG002|Overall Study|Withdrawal by Subject|0|||
19632868|NCT00749190|42082420|FG003|Overall Study|Withdrawal by Subject|0|||
19632869|NCT00749190|42082421|FG004|Overall Study|Withdrawal by Subject|0|||
19632870|NCT00749190|42082422|FG005|Overall Study|Withdrawal by Subject|1|||
19632871|NCT00749190|42082423|FG006|Overall Study|Withdrawal by Subject|0|||
19632872|NCT00749190|42082417|FG000|Overall Study|Protocol Violation|0|||
19632873|NCT00749190|42082418|FG001|Overall Study|Protocol Violation|1|||
19632874|NCT00749190|42082419|FG002|Overall Study|Protocol Violation|0|||
19632875|NCT00749190|42082420|FG003|Overall Study|Protocol Violation|0|||
19632876|NCT00749190|42082421|FG004|Overall Study|Protocol Violation|0|||
19632877|NCT00749190|42082422|FG005|Overall Study|Protocol Violation|0|||
19632878|NCT00749190|42082423|FG006|Overall Study|Protocol Violation|1|||
19632879|NCT00749190|42082417|FG000|Overall Study|Other reason not defined above|0|||
19632880|NCT00749190|42082418|FG001|Overall Study|Other reason not defined above|0|||
19632881|NCT00749190|42082419|FG002|Overall Study|Other reason not defined above|0|||
19632882|NCT00749190|42082420|FG003|Overall Study|Other reason not defined above|1|||
19632883|NCT00749190|42082421|FG004|Overall Study|Other reason not defined above|0|||
19632884|NCT00749190|42082422|FG005|Overall Study|Other reason not defined above|0|||
19632885|NCT00749190|42082423|FG006|Overall Study|Other reason not defined above|0|||
19632886|NCT00748566|42082444|FG000|Overall Study|Adverse Event|49|||
19632887|NCT00748566|42082444|FG000|Overall Study|Death|1|||
19632888|NCT00748566|42082444|FG000|Overall Study|Lack of Efficacy|12|||
19632889|NCT00748566|42082444|FG000|Overall Study|Lost to Follow-up|1|||
19632890|NCT00748566|42082444|FG000|Overall Study|Protocol Violation|13|||
19632891|NCT00748566|42082444|FG000|Overall Study|Withdrawal by Subject|22|||
19632892|NCT00748566|42082444|FG000|Overall Study|Study terminated by sponsor|5|||
19632893|NCT00748566|42082444|FG000|Overall Study|Other|9|||
19632894|NCT00743106|42082450|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
19632895|NCT00743106|42082451|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
19632896|NCT00738699|42082459|FG000|Overall Study|Withdrawal by Subject|5|||
19632897|NCT00738699|42082460|FG001|Overall Study|Withdrawal by Subject|0|||
19632898|NCT00738699|42082459|FG000|Overall Study|Lost to Follow-up|1|||
19632899|NCT00738699|42082460|FG001|Overall Study|Lost to Follow-up|0|||
19632900|NCT00738699|42082459|FG000|Overall Study|Death|144|||
19632901|NCT00738699|42082460|FG001|Overall Study|Death|68|||
19632902|NCT00738699|42082459|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
19632903|NCT00738699|42082460|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
19632904|NCT00738699|42082459|FG000|Overall Study|Other|2|||
19632905|NCT00738699|42082460|FG001|Overall Study|Other|0|||
19632906|NCT00814307|42082470|FG000|Overall Study|Randomized but not treated|1|||
19632907|NCT00814307|42082471|FG001|Overall Study|Randomized but not treated|0|||
19632908|NCT00814307|42082472|FG002|Overall Study|Randomized but not treated|0|||
19632909|NCT00814307|42082473|FG003|Overall Study|Randomized but not treated|0|||
19632910|NCT00814307|42082470|FG000|Overall Study|Adverse Event|3|||
19632911|NCT00814307|42082471|FG001|Overall Study|Adverse Event|9|||
19632912|NCT00814307|42082472|FG002|Overall Study|Adverse Event|3|||
19632913|NCT00814307|42082473|FG003|Overall Study|Adverse Event|2|||
19632914|NCT00814307|42082470|FG000|Overall Study|Lack of Efficacy|1|||
19632915|NCT00814307|42082471|FG001|Overall Study|Lack of Efficacy|1|||
19632916|NCT00814307|42082472|FG002|Overall Study|Lack of Efficacy|3|||
19632917|NCT00814307|42082473|FG003|Overall Study|Lack of Efficacy|4|||
19632918|NCT00814307|42082470|FG000|Overall Study|Other|1|||
19632919|NCT00814307|42082471|FG001|Overall Study|Other|2|||
19632920|NCT00814307|42082472|FG002|Overall Study|Other|0|||
19632921|NCT00814307|42082473|FG003|Overall Study|Other|1|||
19632922|NCT00814307|42082470|FG000|Overall Study|Protocol Violation|2|||
19632923|NCT00814307|42082471|FG001|Overall Study|Protocol Violation|8|||
19632924|NCT00814307|42082472|FG002|Overall Study|Protocol Violation|1|||
19632925|NCT00814307|42082473|FG003|Overall Study|Protocol Violation|1|||
19632926|NCT00814307|42082470|FG000|Overall Study|Withdrawal by Subject|4|||
19632927|NCT00814307|42082471|FG001|Overall Study|Withdrawal by Subject|6|||
19632928|NCT00814307|42082472|FG002|Overall Study|Withdrawal by Subject|0|||
19632929|NCT00814307|42082473|FG003|Overall Study|Withdrawal by Subject|2|||
19632930|NCT00814307|42082470|FG000|Overall Study|Death|0|||
19632931|NCT00814307|42082471|FG001|Overall Study|Death|1|||
19632932|NCT00814307|42082472|FG002|Overall Study|Death|0|||
19632933|NCT00814307|42082473|FG003|Overall Study|Death|0|||
19632934|NCT00748098|42082485|FG000|First Treatment Intervention Period|Adverse Event|1|||
19632935|NCT00748098|42082486|FG001|First Treatment Intervention Period|Adverse Event|1|||
19632936|NCT00748098|42082485|FG000|First Treatment Intervention Period|Protocol Violation|1|||
19632937|NCT00748098|42082486|FG001|First Treatment Intervention Period|Protocol Violation|0|||
19632938|NCT00748098|42082485|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
19632939|NCT00748098|42082486|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
19632940|NCT00748098|42082485|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
19632941|NCT00748098|42082486|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
19632942|NCT00748098|42082485|FG000|First Taper Period|Protocol Violation|1|||
19632943|NCT00748098|42082486|FG001|First Taper Period|Protocol Violation|0|||
19632944|NCT00748098|42082485|FG000|First Taper Period|Withdrawal by Subject|2|||
19632945|NCT00748098|42082486|FG001|First Taper Period|Withdrawal by Subject|0|||
19632946|NCT00748098|42082485|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
19632947|NCT00748098|42082486|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
19632948|NCT00748098|42082485|FG000|1-Week Washout Period|Adverse Event|0|||
19632949|NCT00748098|42082486|FG001|1-Week Washout Period|Adverse Event|1|||
19632950|NCT00748098|42082485|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
19458025|NCT01441635|41711727|FG009|Overall Study|Received Exclusionary Medication|0|||
19458026|NCT01441635|41711718|FG000|Overall Study|Other|0|||
19542936|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
19542937|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
19458027|NCT01441635|41711719|FG001|Overall Study|Other|0|||
19458028|NCT01441635|41711720|FG002|Overall Study|Other|0|||
19458029|NCT01441635|41711721|FG003|Overall Study|Other|0|||
19458030|NCT01441635|41711722|FG004|Overall Study|Other|0|||
19458031|NCT01441635|41711723|FG005|Overall Study|Other|0|||
19458032|NCT01441635|41711724|FG006|Overall Study|Other|0|||
19458033|NCT01441635|41711725|FG007|Overall Study|Other|1|||
19458034|NCT01441635|41711726|FG008|Overall Study|Other|0|||
19458035|NCT01441635|41711727|FG009|Overall Study|Other|0|||
19458036|NCT01408485|41711749|FG000|Overall Study|Withdrawal by Subject|21|||
19458037|NCT01427907|41711755|FG000|Overall Study|Withdrawal by Subject|3|||
19458038|NCT01427907|41711756|FG001|Overall Study|Withdrawal by Subject|4|||
19458039|NCT01427751|41711764|FG000|Overall Study|Adverse Event|18|||
19458040|NCT01427751|41711765|FG001|Overall Study|Adverse Event|2|||
19458041|NCT01427751|41711764|FG000|Overall Study|No further treatment benefit expected|5|||
19458042|NCT01427751|41711765|FG001|Overall Study|No further treatment benefit expected|1|||
19458043|NCT01427751|41711764|FG000|Overall Study|Lost to Follow-up|3|||
19458044|NCT01427751|41711765|FG001|Overall Study|Lost to Follow-up|1|||
19458045|NCT01427751|41711764|FG000|Overall Study|Withdrawal of consent|2|||
19458046|NCT01427751|41711765|FG001|Overall Study|Withdrawal of consent|2|||
19458047|NCT01427751|41711764|FG000|Overall Study|Protocol Violation|6|||
19458048|NCT01427751|41711765|FG001|Overall Study|Protocol Violation|4|||
19458049|NCT01427751|41711764|FG000|Overall Study|Death|2|||
19458050|NCT01427751|41711765|FG001|Overall Study|Death|0|||
19458051|NCT01427751|41711764|FG000|Overall Study|Other miscellaneous reasons|6|||
19458052|NCT01427751|41711765|FG001|Overall Study|Other miscellaneous reasons|4|||
19458053|NCT01920061|41711791|FG000|Overall Study|Death|1|||
19458054|NCT01920061|41711792|FG001|Overall Study|Death|1|||
19458055|NCT01920061|41711793|FG002|Overall Study|Death|0|||
19458056|NCT01920061|41711794|FG003|Overall Study|Death|1|||
19458057|NCT01920061|41711795|FG004|Overall Study|Death|1|||
19458058|NCT01920061|41711796|FG005|Overall Study|Death|0|||
19458059|NCT01920061|41711797|FG006|Overall Study|Death|0|||
19458060|NCT01920061|41711798|FG007|Overall Study|Death|1|||
19458061|NCT01920061|41711799|FG008|Overall Study|Death|0|||
19458062|NCT01920061|41711800|FG009|Overall Study|Death|1|||
19458063|NCT01920061|41711801|FG010|Overall Study|Death|0|||
19458064|NCT01920061|41711802|FG011|Overall Study|Death|1|||
19458065|NCT01920061|41711803|FG012|Overall Study|Death|0|||
19542938|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
19542939|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
19542940|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
19542941|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
19542942|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
19542943|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
19542944|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19542945|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
19542946|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
19542947|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19458066|NCT01920061|41711804|FG013|Overall Study|Death|2|||
19458067|NCT01920061|41711805|FG014|Overall Study|Death|0|||
19458068|NCT01920061|41711806|FG015|Overall Study|Death|0|||
19458069|NCT01920061|41711807|FG016|Overall Study|Death|0|||
19458070|NCT01920061|41711808|FG017|Overall Study|Death|0|||
19458071|NCT01920061|41711809|FG018|Overall Study|Death|1|||
19458072|NCT01920061|41711810|FG019|Overall Study|Death|0|||
19542948|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19542949|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19632951|NCT00748098|42082486|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
19632952|NCT00748098|42082485|FG000|Second Treatment Intervention Period|Adverse Event|4|||
19632953|NCT00748098|42082486|FG001|Second Treatment Intervention Period|Adverse Event|1|||
19632954|NCT00748098|42082485|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
19632955|NCT00748098|42082486|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
19632956|NCT00748098|42082485|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
19632957|NCT00748098|42082486|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
19632958|NCT00813995|42082495|FG000|Overall Study|Clinical adverse event|9|||
19632959|NCT00813995|42082496|FG001|Overall Study|Clinical adverse event|3|||
19632960|NCT00813995|42082495|FG000|Overall Study|Laboratory adverse event|0|||
19632961|NCT00813995|42082496|FG001|Overall Study|Laboratory adverse event|2|||
19632962|NCT00813995|42082495|FG000|Overall Study|Lack of Efficacy|1|||
19632963|NCT00813995|42082496|FG001|Overall Study|Lack of Efficacy|0|||
19632964|NCT00813995|42082495|FG000|Overall Study|Lost to Follow-up|4|||
19542950|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19542951|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
19542952|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
19542953|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19542954|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
19542955|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
19542956|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19542957|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19542958|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19542959|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
19542960|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
19542961|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
19542962|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542963|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542964|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
19542965|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542966|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542967|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542968|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19632965|NCT00813995|42082496|FG001|Overall Study|Lost to Follow-up|2|||
19632966|NCT00813995|42082495|FG000|Overall Study|Other reason|2|||
19632967|NCT00813995|42082496|FG001|Overall Study|Other reason|2|||
19632968|NCT00813995|42082495|FG000|Overall Study|Protocol Violation|3|||
19632969|NCT00813995|42082496|FG001|Overall Study|Protocol Violation|2|||
19632970|NCT00813995|42082495|FG000|Overall Study|Subject moved|4|||
19632971|NCT00813995|42082496|FG001|Overall Study|Subject moved|0|||
19632972|NCT00813995|42082495|FG000|Overall Study|Withdrawal by Subject|0|||
19632973|NCT00813995|42082496|FG001|Overall Study|Withdrawal by Subject|5|||
19632974|NCT00737529|42082506|FG000|Overall Study|Disease Progression|95|||
19632975|NCT00737529|42082506|FG000|Overall Study|Adverse Event|24|||
19632976|NCT00737529|42082506|FG000|Overall Study|Withdrawal by Subject|5|||
19632977|NCT00737529|42082506|FG000|Overall Study|Death|4|||
19632978|NCT00737529|42082506|FG000|Overall Study|Protocol Violation|1|||
19632979|NCT00737529|42082506|FG000|Overall Study|Other|4|||
19632980|NCT00813917|42082512|FG000|Overall Study|Adverse Event|0|||
19711678|NCT00095199|42154761|FG000|Overall Study|Adverse Event|40|||
19711679|NCT00095199|42154762|FG001|Overall Study|Adverse Event|22|||
19711680|NCT00095199|42154763|FG002|Overall Study|Adverse Event|26|||
19711681|NCT00095199|42154764|FG003|Overall Study|Adverse Event|11|||
19711682|NCT00095199|42154761|FG000|Overall Study|Progressive disease|213|||
19711683|NCT00095199|42154762|FG001|Overall Study|Progressive disease|179|||
19711684|NCT00095199|42154763|FG002|Overall Study|Progressive disease|105|||
19711685|NCT00095199|42154764|FG003|Overall Study|Progressive disease|98|||
19711686|NCT00095199|42154761|FG000|Overall Study|Death|10|||
19711687|NCT00095199|42154762|FG001|Overall Study|Death|6|||
19711688|NCT00095199|42154763|FG002|Overall Study|Death|11|||
19711689|NCT00095199|42154764|FG003|Overall Study|Death|9|||
19711690|NCT00095199|42154761|FG000|Overall Study|Withdrawal by Subject|21|||
19711691|NCT00095199|42154762|FG001|Overall Study|Withdrawal by Subject|16|||
19711692|NCT00095199|42154763|FG002|Overall Study|Withdrawal by Subject|13|||
19711693|NCT00095199|42154764|FG003|Overall Study|Withdrawal by Subject|22|||
19632981|NCT00813917|42082513|FG001|Overall Study|Adverse Event|1|||
19711694|NCT00095199|42154761|FG000|Overall Study|Protocol Violation|4|||
19711695|NCT00095199|42154762|FG001|Overall Study|Protocol Violation|4|||
19711696|NCT00095199|42154763|FG002|Overall Study|Protocol Violation|2|||
19711697|NCT00095199|42154764|FG003|Overall Study|Protocol Violation|0|||
19711698|NCT00095199|42154761|FG000|Overall Study|Liver function test results elevated|0|||
19632982|NCT00813917|42082512|FG000|Overall Study|Withdrawal by Subject|3|||
19711699|NCT00095199|42154762|FG001|Overall Study|Liver function test results elevated|0|||
19375426|NCT00835367|41617363|FG000|Second Intervention|Adverse Event|1|||
19542969|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19632983|NCT00813917|42082513|FG001|Overall Study|Withdrawal by Subject|4|||
19632984|NCT00813917|42082512|FG000|Overall Study|Lost to Follow-up|3|||
19632985|NCT00813917|42082513|FG001|Overall Study|Lost to Follow-up|1|||
19632986|NCT00737061|42082519|FG000|Waiting Period|Lost to Follow-up|6|||
19632987|NCT00737061|42082519|FG000|Waiting Period|Withdrawal by Subject|1|||
19632988|NCT00737061|42082519|FG000|Waiting Period|Bilateral placement failure|34|||
19632989|NCT00737061|42082519|FG000|Waiting Period|Deemed patent following HSG|26|||
19632990|NCT00737061|42082519|FG000|Waiting Period|Alternative contraception failure|3|||
19632991|NCT00737061|42082519|FG000|Waiting Period|Elected surgical tubal ligation|5|||
19632992|NCT00737061|42082519|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
19632993|NCT00737061|42082519|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
19632994|NCT00737061|42082519|FG000|1 Year Wearing Period|Discontinued reilance|3|||
19632995|NCT00737061|42082519|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
19632996|NCT00585975|42082525|FG000|Overall Study|Withdrawal by Subject|3|||
19632997|NCT00585975|42082526|FG001|Overall Study|Withdrawal by Subject|3|||
19632998|NCT00585975|42082525|FG000|Overall Study|Lost to Follow-up|2|||
19632999|NCT00585975|42082526|FG001|Overall Study|Lost to Follow-up|1|||
19633000|NCT00585975|42082525|FG000|Overall Study|Enrollment met/over-enrolled|10|||
19633001|NCT00585975|42082526|FG001|Overall Study|Enrollment met/over-enrolled|9|||
19633002|NCT00585585|42082532|FG000|Overall Study|Adverse Event|1|||
19633003|NCT00734097|42082536|FG000|Screening|Protocol Violation|12|||
19633004|NCT00734097|42082536|FG000|Screening|Withdrawal by Subject|5|||
19633005|NCT00734097|42082536|FG000|Screening|Lost to Follow-up|2|||
19633006|NCT00734097|42082536|FG000|Screening|Unconfirmed pregnancy|1|||
19633007|NCT00734097|42082536|FG000|Open Label|Lost to Follow-up|7|||
19633008|NCT00734097|42082536|FG000|Open Label|Withdrawal by Subject|5|||
19633009|NCT00734097|42082536|FG000|Open Label|Protocol Violation|4|||
19633010|NCT00819767|42082542|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19633011|NCT00819767|42082543|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19633012|NCT00733005|42082551|FG000|Overall Study|Adverse Event|0|||
19633013|NCT00733005|42082552|FG001|Overall Study|Adverse Event|1|||
19633014|NCT00733005|42082551|FG000|Overall Study|Treatment Failure|0|||
19633015|NCT00733005|42082552|FG001|Overall Study|Treatment Failure|1|||
19633016|NCT00733005|42082551|FG000|Overall Study|Withdrawal by Subject|0|||
19633017|NCT00733005|42082552|FG001|Overall Study|Withdrawal by Subject|1|||
19633018|NCT00733005|42082551|FG000|Overall Study|Protocol Violation|2|||
19633019|NCT00733005|42082552|FG001|Overall Study|Protocol Violation|0|||
19633020|NCT00812981|42082560|FG000|Overall Study|Other|0|||
19633021|NCT00812981|42082561|FG001|Overall Study|Other|1|||
19542970|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
19542971|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19542972|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
19542973|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
19542974|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19542975|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19458073|NCT01920061|41711791|FG000|Overall Study|Lost to Follow-up|0|||
19458074|NCT01920061|41711792|FG001|Overall Study|Lost to Follow-up|2|||
19458075|NCT01920061|41711793|FG002|Overall Study|Lost to Follow-up|0|||
19458076|NCT01920061|41711794|FG003|Overall Study|Lost to Follow-up|0|||
19458077|NCT01920061|41711795|FG004|Overall Study|Lost to Follow-up|0|||
19458078|NCT01920061|41711796|FG005|Overall Study|Lost to Follow-up|0|||
19458079|NCT01920061|41711797|FG006|Overall Study|Lost to Follow-up|1|||
19633022|NCT00732615|42082569|FG000|Overall Study|Withdrawal by Subject|3|||
19633023|NCT00732615|42082570|FG001|Overall Study|Withdrawal by Subject|1|||
19633024|NCT00732615|42082569|FG000|Overall Study|Lost to Follow-up|0|||
19633025|NCT00732615|42082570|FG001|Overall Study|Lost to Follow-up|1|||
19633026|NCT00732615|42082569|FG000|Overall Study|Adverse Event|0|||
19633027|NCT00732615|42082570|FG001|Overall Study|Adverse Event|2|||
19633028|NCT00732615|42082569|FG000|Overall Study|Physician Decision|3|||
19633029|NCT00732615|42082570|FG001|Overall Study|Physician Decision|0|||
19458080|NCT01920061|41711798|FG007|Overall Study|Lost to Follow-up|0|||
19458081|NCT01920061|41711799|FG008|Overall Study|Lost to Follow-up|0|||
19458082|NCT01920061|41711800|FG009|Overall Study|Lost to Follow-up|0|||
19458083|NCT01920061|41711801|FG010|Overall Study|Lost to Follow-up|3|||
19458084|NCT01920061|41711802|FG011|Overall Study|Lost to Follow-up|0|||
19542976|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19633030|NCT00732615|42082569|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
19633031|NCT00732615|42082570|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
19633032|NCT00732381|42082579|FG000|Overall Study|Adverse Event|1|||
19633033|NCT00732381|42082580|FG001|Overall Study|Adverse Event|0|||
19633034|NCT00732381|42082579|FG000|Overall Study|Treatment Failure|1|||
19458085|NCT01920061|41711803|FG012|Overall Study|Lost to Follow-up|0|||
19458086|NCT01920061|41711804|FG013|Overall Study|Lost to Follow-up|0|||
19542977|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19633035|NCT00732381|42082580|FG001|Overall Study|Treatment Failure|1|||
19633036|NCT00732303|42082586|FG000|Overall Study|Study Terminated|2|||
19633037|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
19542978|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
19542979|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
19542980|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
19542981|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
19542982|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
19542983|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
19542984|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
19542985|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
19542986|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
19542987|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
19542988|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
19542989|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19633038|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
19633039|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
19633040|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
19633041|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
19633042|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
19633043|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
19633044|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
19633045|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
19633046|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
19633047|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
19633048|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
19633049|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
19633050|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
19633051|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
19633052|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
19633053|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
19633054|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
19633055|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
19633056|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
19633057|NCT00813761|42082592|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
19633058|NCT00813761|42082593|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
19633059|NCT00813761|42082594|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
19633060|NCT00813761|42082595|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
19633061|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
19633062|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
19633063|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
19633064|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
19633065|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
19633066|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
19633067|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
19633068|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
19633069|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
19633070|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
19633071|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
19633072|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
19633073|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
19633074|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
19633075|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
19633076|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
19633077|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
19633078|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
19633079|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
19633080|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
19542990|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542991|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
19633081|NCT00813761|42082592|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
19542992|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542993|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542994|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542995|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542996|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542997|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
19542998|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19542999|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
19543000|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
19543001|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19543002|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19633082|NCT00813761|42082593|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
19633083|NCT00813761|42082594|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
19633084|NCT00813761|42082595|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
19633085|NCT00732069|42082611|FG000|Washout After First Study Drug|Adverse Event|1|||
19633086|NCT00732069|42082612|FG001|Washout After First Study Drug|Adverse Event|0|||
19633087|NCT00732069|42082613|FG002|Washout After First Study Drug|Adverse Event|0|||
19633088|NCT00732069|42082614|FG003|Washout After First Study Drug|Adverse Event|0|||
19633089|NCT00732069|42082615|FG004|Washout After First Study Drug|Adverse Event|0|||
19633090|NCT00732069|42082616|FG005|Washout After First Study Drug|Adverse Event|0|||
19633091|NCT00731679|42082626|FG000|Overall Study|Adverse Event|7|||
19633092|NCT00731679|42082627|FG001|Overall Study|Adverse Event|8|||
19633093|NCT00731679|42082626|FG000|Overall Study|Withdrawal by Subject|8|||
19633094|NCT00731679|42082627|FG001|Overall Study|Withdrawal by Subject|8|||
19633095|NCT00731679|42082626|FG000|Overall Study|Lost to Follow-up|7|||
19633096|NCT00731679|42082627|FG001|Overall Study|Lost to Follow-up|8|||
19633097|NCT00731679|42082626|FG000|Overall Study|Noncompliance|0|||
19633098|NCT00731679|42082627|FG001|Overall Study|Noncompliance|1|||
19711700|NCT00095199|42154763|FG002|Overall Study|Liver function test results elevated|1|||
19711701|NCT00095199|42154764|FG003|Overall Study|Liver function test results elevated|1|||
19711702|NCT00095199|42154761|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
19711703|NCT00095199|42154762|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
19711704|NCT00095199|42154763|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
19543003|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19543004|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
19543005|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
19543006|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
19543007|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543008|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543009|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543010|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543011|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543012|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543013|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543014|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
19543015|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
19543016|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543017|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
19543018|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543019|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543020|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543021|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543022|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543023|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543024|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
19543025|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543026|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543027|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
19543028|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543029|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543030|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543031|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543032|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
19543033|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
19543034|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543035|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
19543036|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543037|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543038|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543039|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543040|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543041|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
19543042|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
19543043|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
19543044|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
19633099|NCT00731679|42082626|FG000|Overall Study|Pregnancy|0|||
19633100|NCT00731679|42082627|FG001|Overall Study|Pregnancy|1|||
19633101|NCT00731133|42082633|FG000|Overall Study|Withdrawal by Subject|10|||
19711705|NCT00095199|42154764|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
19711706|NCT00095199|42154761|FG000|Overall Study|Physician Decision|5|||
19711707|NCT00095199|42154762|FG001|Overall Study|Physician Decision|6|||
19633102|NCT00730275|42082641|FG000|Overall Study|Withdrawal by Subject|0|||
19633103|NCT00730275|42082642|FG001|Overall Study|Withdrawal by Subject|0|||
19633104|NCT00730275|42082643|FG002|Overall Study|Withdrawal by Subject|0|||
19633105|NCT00730275|42082644|FG003|Overall Study|Withdrawal by Subject|1|||
19633106|NCT00730041|42082662|FG000|Overall Study|Lost to Follow-up|0|||
19633107|NCT00730041|42082663|FG001|Overall Study|Lost to Follow-up|2|||
19633108|NCT00729651|42082671|FG000|Overall Study|Withdrawal by Subject|5|||
19633109|NCT00729651|42082672|FG001|Overall Study|Withdrawal by Subject|6|||
19633110|NCT00729651|42082671|FG000|Overall Study|Lost to Follow-up|5|||
19633111|NCT00729651|42082672|FG001|Overall Study|Lost to Follow-up|4|||
19633112|NCT00729651|42082671|FG000|Overall Study|Protocol Violation|0|||
19633113|NCT00729651|42082672|FG001|Overall Study|Protocol Violation|1|||
19633114|NCT00729651|42082671|FG000|Overall Study|Adverse Event|7|||
19633115|NCT00729651|42082672|FG001|Overall Study|Adverse Event|3|||
19633116|NCT00729651|42082671|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
19633117|NCT00729651|42082672|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
19633118|NCT00729651|42082671|FG000|Overall Study|Subject's private reason|2|||
19633119|NCT00729651|42082672|FG001|Overall Study|Subject's private reason|0|||
19633120|NCT00729183|42082680|FG000|Overall Study|Adverse Event|11|||
19633121|NCT00729183|42082681|FG001|Overall Study|Adverse Event|5|||
19633122|NCT00729183|42082680|FG000|Overall Study|Lack of Efficacy|0|||
19633123|NCT00729183|42082681|FG001|Overall Study|Lack of Efficacy|1|||
19633124|NCT00729183|42082680|FG000|Overall Study|Lost to Follow-up|3|||
19633125|NCT00729183|42082681|FG001|Overall Study|Lost to Follow-up|1|||
19633126|NCT00729183|42082680|FG000|Overall Study|Physician Decision|1|||
19633127|NCT00729183|42082681|FG001|Overall Study|Physician Decision|1|||
19633128|NCT00729183|42082680|FG000|Overall Study|Protocol Violation|1|||
19633129|NCT00729183|42082681|FG001|Overall Study|Protocol Violation|0|||
19633130|NCT00729183|42082680|FG000|Overall Study|Withdrawal by Subject|9|||
19633131|NCT00729183|42082681|FG001|Overall Study|Withdrawal by Subject|7|||
19633132|NCT00811733|42082689|FG000|Overall Study|Investigator Discretion|10|||
19633133|NCT00811733|42082690|FG001|Overall Study|Investigator Discretion|8|||
19633134|NCT00811733|42082689|FG000|Overall Study|Withdrawal by Subject|1|||
19633135|NCT00811733|42082690|FG001|Overall Study|Withdrawal by Subject|2|||
19633136|NCT00728949|42082698|FG000|Overall Study|Adverse Event|8|||
19633137|NCT00728949|42082699|FG001|Overall Study|Adverse Event|0|||
19633138|NCT00728949|42082698|FG000|Overall Study|Withdrawal by Subject|2|||
19633139|NCT00728949|42082699|FG001|Overall Study|Withdrawal by Subject|2|||
19633140|NCT00728949|42082698|FG000|Overall Study|Abnormal Lab Results|0|||
19633141|NCT00728949|42082699|FG001|Overall Study|Abnormal Lab Results|2|||
19633142|NCT00728949|42082698|FG000|Overall Study|On treatment at cutoff date|1|||
19633143|NCT00728949|42082699|FG001|Overall Study|On treatment at cutoff date|0|||
19633144|NCT00728481|42082707|FG000|Overall Study|Withdrawal by Subject|0|||
19633145|NCT00728481|42082708|FG001|Overall Study|Withdrawal by Subject|1|||
19633146|NCT00728481|42082707|FG000|Overall Study|Adverse Event|0|||
19633147|NCT00728481|42082708|FG001|Overall Study|Adverse Event|1|||
19633148|NCT00728481|42082707|FG000|Overall Study|Study medication non-compliance|0|||
19633149|NCT00728481|42082708|FG001|Overall Study|Study medication non-compliance|2|||
19633150|NCT00728481|42082707|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
19543045|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
19543046|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
19543047|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
19543048|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
19543049|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
19543050|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
19543051|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
19543052|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
19543053|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
19543054|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
19543055|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
19543056|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
19543057|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
19543058|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
19543059|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
19633151|NCT00728481|42082708|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
19633152|NCT00811655|42082714|FG000|Overall Study|Physician Decision|1|||
19633153|NCT00727311|42082718|FG000|Overall Study|Did not receive drug|316|||
19633154|NCT00727311|42082718|FG000|Overall Study|Missing end of therapy data|205|||
19543060|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
19543061|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19543062|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
19543063|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
19543064|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19543065|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19543066|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19543067|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
19543068|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
19543069|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
19543070|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
19543071|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
19543072|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
19543073|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
19543074|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
19543075|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
19543076|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
19543077|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
19543078|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
19633155|NCT00727311|42082718|FG000|Overall Study|Adverse Event|58|||
19633156|NCT00727311|42082718|FG000|Overall Study|Lack of Efficacy|242|||
19633157|NCT00727311|42082718|FG000|Overall Study|Lost to Follow-up|73|||
19633158|NCT00727311|42082718|FG000|Overall Study|Withdrawal by Subject|77|||
19633159|NCT00727311|42082718|FG000|Overall Study|Other|97|||
19633160|NCT00727311|42082718|FG000|Overall Study|Multiple reasons|39|||
19633161|NCT00726999|42082724|FG000|Overall Study|Physician Decision|0|||
19543079|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543080|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543081|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543082|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543083|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543084|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543085|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543086|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
19543087|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
19543088|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19543089|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
19543090|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
19543091|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19633162|NCT00726999|42082725|FG001|Overall Study|Physician Decision|1|||
19633163|NCT00726999|42082724|FG000|Overall Study|Withdrawal by Subject|2|||
19633164|NCT00726999|42082725|FG001|Overall Study|Withdrawal by Subject|0|||
19633165|NCT00726999|42082724|FG000|Overall Study|Protocol Violation|1|||
19633166|NCT00726999|42082725|FG001|Overall Study|Protocol Violation|0|||
19633167|NCT00585351|42082739|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
19633168|NCT00585351|42082740|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
19633169|NCT00585351|42082741|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
19633170|NCT00585351|42082742|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
19633171|NCT00585351|42082743|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
19633172|NCT00585351|42082744|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
19633173|NCT00585351|42082745|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
19633174|NCT00585351|42082746|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
19633175|NCT00585351|42082739|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
19633176|NCT00585351|42082740|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
19633177|NCT00585351|42082741|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
19633178|NCT00585351|42082742|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
19633179|NCT00585351|42082743|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
19633180|NCT00585351|42082744|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
19633181|NCT00585351|42082745|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
19633182|NCT00585351|42082746|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
19633183|NCT00585351|42082739|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
19633184|NCT00585351|42082740|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
19633185|NCT00585351|42082741|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
19633186|NCT00585351|42082742|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
19543092|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19543093|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19543094|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
19543095|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
19543096|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
19543097|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19543098|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
19543099|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
19543100|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19543101|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19543102|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19633187|NCT00585351|42082743|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
19633188|NCT00585351|42082744|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
19633189|NCT00585351|42082745|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
19633190|NCT00585351|42082746|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
19633191|NCT00585351|42082739|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
19633192|NCT00585351|42082740|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
19633193|NCT00585351|42082741|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633194|NCT00585351|42082742|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633195|NCT00585351|42082743|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633196|NCT00585351|42082744|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633197|NCT00585351|42082745|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633198|NCT00585351|42082746|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
19633199|NCT00585351|42082739|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633200|NCT00585351|42082740|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633201|NCT00585351|42082741|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633202|NCT00585351|42082742|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633203|NCT00585351|42082743|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633204|NCT00585351|42082744|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
19633205|NCT00585351|42082745|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
19633206|NCT00585351|42082746|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
19633207|NCT00585351|42082739|FG000|Enrollment Period (Intervention)|Death|0|||
19633208|NCT00585351|42082740|FG001|Enrollment Period (Intervention)|Death|0|||
19633209|NCT00585351|42082741|FG002|Enrollment Period (Intervention)|Death|0|||
19633210|NCT00585351|42082742|FG003|Enrollment Period (Intervention)|Death|0|||
19633211|NCT00585351|42082743|FG004|Enrollment Period (Intervention)|Death|1|||
19633212|NCT00585351|42082744|FG005|Enrollment Period (Intervention)|Death|0|||
19633213|NCT00585351|42082745|FG006|Enrollment Period (Intervention)|Death|1|||
19633214|NCT00585351|42082746|FG007|Enrollment Period (Intervention)|Death|0|||
19633215|NCT00585351|42082739|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633216|NCT00585351|42082740|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633217|NCT00585351|42082741|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633218|NCT00585351|42082742|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633219|NCT00585351|42082743|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
19633220|NCT00585351|42082744|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
19633221|NCT00585351|42082745|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633222|NCT00585351|42082746|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
19633223|NCT00813293|42082762|FG000|Overall Study|Intercurrent illness|1|||
19633224|NCT00813293|42082763|FG001|Overall Study|Intercurrent illness|0|||
19633225|NCT00813293|42082762|FG000|Overall Study|Adverse Event|0|||
19633226|NCT00813293|42082763|FG001|Overall Study|Adverse Event|1|||
19633227|NCT00726609|42082769|FG000|Overall Study|Adverse Event|10|||
19633228|NCT00726609|42082769|FG000|Overall Study|Withdrawal by Subject|2|||
19633229|NCT00726609|42082769|FG000|Overall Study|Lack of Efficacy|25|||
19633230|NCT00726609|42082769|FG000|Overall Study|Other|16|||
19633231|NCT00726609|42082769|FG000|Overall Study|Missing|42|||
19633232|NCT00726609|42082769|FG000|Overall Study|Other|3|||
19633233|NCT00726453|42082775|FG000|Primary Enrollment Group|Death|18|||
19633234|NCT00726453|42082776|FG001|Primary Enrollment Group|Death|0|||
19633235|NCT00726453|42082775|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
19543103|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19543104|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
19543105|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
19543106|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
19543107|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
19543108|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
19543109|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
19543110|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
19543111|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
19543112|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
19543113|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
19543114|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
19543115|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543116|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
19633236|NCT00726453|42082776|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
19543117|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543118|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19633237|NCT00726453|42082775|FG000|38 mm Length Group|Death|0|||
19633238|NCT00726453|42082776|FG001|38 mm Length Group|Death|3|||
19633239|NCT00726063|42082783|FG000|Overall Study|Adverse Event|9|||
19633240|NCT00726063|42082784|FG001|Overall Study|Adverse Event|7|||
19633241|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
19633242|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
19633243|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
19633244|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
19633245|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Other|1|||
19633246|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Other|0|||
19633247|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Other|2|||
19633248|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Other|4|||
19633249|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
19633250|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
19633251|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
19633252|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
19633253|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Adverse Event|0|||
19633254|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Adverse Event|0|||
19633255|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Adverse Event|1|||
19633256|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Adverse Event|2|||
19633257|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
19633258|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
19633259|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
19633260|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
19633261|NCT00808028|42082794|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
19633262|NCT00808028|42082795|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
19633263|NCT00808028|42082796|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
19633264|NCT00808028|42082797|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
19633265|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
19633266|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
19633267|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
19633268|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
19633269|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
19633270|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
19633271|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
19633272|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
19633273|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
19633274|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
19633275|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
19633276|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
19633277|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
19633278|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
19633279|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
19633280|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
19633281|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
19633282|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
19543119|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19633283|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
19633284|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
19633285|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
19633286|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
19633287|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
19633288|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
19633289|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
19633290|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
19633291|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
19633292|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
19633293|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
19633294|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
19633295|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
19633296|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
19633297|NCT00808028|42082794|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
19633298|NCT00808028|42082795|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
19633299|NCT00808028|42082796|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
19633300|NCT00808028|42082797|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
19633301|NCT00809783|42082820|FG000|Overall Study|Death|1|||
19633302|NCT00809783|42082821|FG001|Overall Study|Death|0|||
19633303|NCT00809783|42082822|FG002|Overall Study|Death|0|||
19633304|NCT00809783|42082820|FG000|Overall Study|Adverse Event|34|||
19633305|NCT00809783|42082821|FG001|Overall Study|Adverse Event|52|||
19633306|NCT00809783|42082822|FG002|Overall Study|Adverse Event|71|||
19633307|NCT00809783|42082820|FG000|Overall Study|Lack of Efficacy|39|||
19633308|NCT00809783|42082821|FG001|Overall Study|Lack of Efficacy|52|||
19633309|NCT00809783|42082822|FG002|Overall Study|Lack of Efficacy|63|||
19633310|NCT00809783|42082820|FG000|Overall Study|Lost to Follow-up|0|||
19633311|NCT00809783|42082821|FG001|Overall Study|Lost to Follow-up|3|||
19633312|NCT00809783|42082822|FG002|Overall Study|Lost to Follow-up|4|||
19633313|NCT00809783|42082820|FG000|Overall Study|Withdrawal by Subject|47|||
19633314|NCT00809783|42082821|FG001|Overall Study|Withdrawal by Subject|72|||
19633315|NCT00809783|42082822|FG002|Overall Study|Withdrawal by Subject|64|||
19633316|NCT00809783|42082820|FG000|Overall Study|Protocol Violation|2|||
19633317|NCT00809783|42082821|FG001|Overall Study|Protocol Violation|6|||
19633318|NCT00809783|42082822|FG002|Overall Study|Protocol Violation|5|||
19633319|NCT00809783|42082820|FG000|Overall Study|Randomized, but not treated|3|||
19633320|NCT00809783|42082821|FG001|Overall Study|Randomized, but not treated|0|||
19633321|NCT00809783|42082822|FG002|Overall Study|Randomized, but not treated|2|||
19543120|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543121|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543122|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543123|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
19543124|NCT01212757|41992329|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543125|NCT01212757|41992330|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
19543126|NCT01212757|41992331|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
19543127|NCT01212757|41992332|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543128|NCT01212757|41992333|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543129|NCT01212757|41992334|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543130|NCT01212757|41992335|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543131|NCT01212757|41992336|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543132|NCT01212757|41992337|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
19543133|NCT01190410|41992357|FG000|Overall Study|Adverse Event|0|||
19543134|NCT01190410|41992358|FG001|Overall Study|Adverse Event|3|||
19543135|NCT01190410|41992357|FG000|Overall Study|Lack of Efficacy|0|||
19543136|NCT01190410|41992358|FG001|Overall Study|Lack of Efficacy|2|||
19543137|NCT01190410|41992357|FG000|Overall Study|Withdrawal by Subject|0|||
19543138|NCT01190410|41992358|FG001|Overall Study|Withdrawal by Subject|2|||
19543139|NCT01190410|41992357|FG000|Overall Study|Administrative decision|1|||
19543140|NCT01190410|41992358|FG001|Overall Study|Administrative decision|0|||
19543141|NCT01190410|41992357|FG000|Overall Study|PI discretion|0|||
19543142|NCT01190410|41992358|FG001|Overall Study|PI discretion|2|||
19543143|NCT01190254|41992373|FG000|Overall Study|Adverse Event|3|||
19543144|NCT01190254|41992374|FG001|Overall Study|Adverse Event|6|||
19543145|NCT01190254|41992375|FG002|Overall Study|Adverse Event|8|||
19543146|NCT01190254|41992373|FG000|Overall Study|Lack of Efficacy|7|||
19543147|NCT01190254|41992374|FG001|Overall Study|Lack of Efficacy|4|||
19543148|NCT01190254|41992375|FG002|Overall Study|Lack of Efficacy|5|||
19543149|NCT01190254|41992373|FG000|Overall Study|Lost to Follow-up|4|||
19633322|NCT00809783|42082820|FG000|Overall Study|Study Terminated by Sponsor|378|||
19633323|NCT00809783|42082821|FG001|Overall Study|Study Terminated by Sponsor|626|||
19633324|NCT00809783|42082822|FG002|Overall Study|Study Terminated by Sponsor|565|||
19633325|NCT00809783|42082820|FG000|Overall Study|Other|21|||
19633326|NCT00809783|42082821|FG001|Overall Study|Other|21|||
19633327|NCT00809783|42082822|FG002|Overall Study|Other|16|||
19633328|NCT00809471|42082833|FG000|Overall Study|Protocol non-compliance|15|||
19633329|NCT00809471|42082834|FG001|Overall Study|Protocol non-compliance|15|||
19633330|NCT00809471|42082835|FG002|Overall Study|Protocol non-compliance|6|||
19543150|NCT01190254|41992374|FG001|Overall Study|Lost to Follow-up|2|||
19543151|NCT01190254|41992375|FG002|Overall Study|Lost to Follow-up|0|||
19543152|NCT01190254|41992373|FG000|Overall Study|Withdrawal by Subject|4|||
19543153|NCT01190254|41992374|FG001|Overall Study|Withdrawal by Subject|5|||
19543154|NCT01190254|41992375|FG002|Overall Study|Withdrawal by Subject|7|||
19543155|NCT01190254|41992373|FG000|Overall Study|Protocol Violation|2|||
19543156|NCT01190254|41992374|FG001|Overall Study|Protocol Violation|0|||
19543157|NCT01190254|41992375|FG002|Overall Study|Protocol Violation|2|||
19543158|NCT01190254|41992373|FG000|Overall Study|Did not meet protocol eligibility|1|||
19543159|NCT01190254|41992374|FG001|Overall Study|Did not meet protocol eligibility|0|||
19543160|NCT01190254|41992375|FG002|Overall Study|Did not meet protocol eligibility|0|||
19543161|NCT01190839|41992385|FG000|Overall Study|Adverse Event|32|||
19543162|NCT01190839|41992386|FG001|Overall Study|Adverse Event|41|||
19543163|NCT01190839|41992385|FG000|Overall Study|Protocol Violation|2|||
19543164|NCT01190839|41992386|FG001|Overall Study|Protocol Violation|2|||
19543165|NCT01190839|41992385|FG000|Overall Study|Lost to Follow-up|7|||
19543166|NCT01190839|41992386|FG001|Overall Study|Lost to Follow-up|1|||
19543167|NCT01190839|41992385|FG000|Overall Study|Death|1|||
19543168|NCT01190839|41992386|FG001|Overall Study|Death|0|||
19543169|NCT01190839|41992385|FG000|Overall Study|Trial stopped by Sponsor|71|||
19543170|NCT01190839|41992386|FG001|Overall Study|Trial stopped by Sponsor|68|||
19543171|NCT01190839|41992385|FG000|Overall Study|Undefined|35|||
19543172|NCT01190839|41992386|FG001|Overall Study|Undefined|31|||
19543173|NCT01190839|41992385|FG000|Overall Study|Randomized but not treated|2|||
19711708|NCT00095199|42154763|FG002|Overall Study|Physician Decision|1|||
19711709|NCT00095199|42154764|FG003|Overall Study|Physician Decision|1|||
19711710|NCT00095199|42154761|FG000|Overall Study|Not eligible|1|||
19375427|NCT00835367|41617364|FG001|Second Intervention|Adverse Event|1|||
19543174|NCT01190839|41992386|FG001|Overall Study|Randomized but not treated|4|||
19543175|NCT01190215|41992396|FG000|Up to Month 6|Lost to Follow-up|2|||
19543176|NCT01190215|41992397|FG001|Up to Month 6|Lost to Follow-up|0|||
19543177|NCT01190449|41992405|FG000|Overall Study|Ineligible|0|||
19543178|NCT01190449|41992406|FG001|Overall Study|Ineligible|4|||
19543179|NCT01190176|41992412|FG000|Overall Study|Withdrawal by Subject|1|||
19543180|NCT01190176|41992412|FG000|Overall Study|Lost to Follow-up|1|||
19543181|NCT01190098|41992418|FG000|Overall Study|Adverse Event|2|||
19543182|NCT01190098|41992419|FG001|Overall Study|Adverse Event|0|||
19543183|NCT01190098|41992418|FG000|Overall Study|Patient coomorbidity|0|||
19543184|NCT01190098|41992419|FG001|Overall Study|Patient coomorbidity|1|||
19543185|NCT01190098|41992418|FG000|Overall Study|Lack of transportation|1|||
19543186|NCT01190098|41992419|FG001|Overall Study|Lack of transportation|0|||
19543187|NCT01190098|41992418|FG000|Overall Study|Other|0|||
19543188|NCT01190098|41992419|FG001|Overall Study|Other|1|||
19543189|NCT01190020|41992427|FG000|Overall Study|Adverse Event|2|||
19543190|NCT01190020|41992428|FG001|Overall Study|Adverse Event|0|||
19543191|NCT01190020|41992427|FG000|Overall Study|Lost to Follow-up|2|||
19543192|NCT01190020|41992428|FG001|Overall Study|Lost to Follow-up|0|||
19543193|NCT01190020|41992427|FG000|Overall Study|Withdrawal by Subject|3|||
19543194|NCT01190020|41992428|FG001|Overall Study|Withdrawal by Subject|0|||
19543195|NCT01189435|41992434|FG000|Overall Study|Withdrawal by Subject|1|||
19543196|NCT01189435|41992434|FG000|Overall Study|Physician Decision|1|||
19543197|NCT01165996|41992438|FG000|Overall Study|Death|1|||
19543198|NCT01165996|41992438|FG000|Overall Study|Physician Decision|1|||
19543199|NCT01165684|41992445|FG000|Overall Study|Adverse Event|1|||
19543200|NCT01165684|41992446|FG001|Overall Study|Adverse Event|1|||
19543201|NCT01165684|41992445|FG000|Overall Study|Lack of Efficacy|2|||
19543202|NCT01165684|41992446|FG001|Overall Study|Lack of Efficacy|1|||
19543203|NCT01165684|41992445|FG000|Overall Study|Protocol Violation|7|||
19543204|NCT01165684|41992446|FG001|Overall Study|Protocol Violation|15|||
19633331|NCT00809471|42082833|FG000|Overall Study|Lost to Follow-up|4|||
19633332|NCT00809471|42082834|FG001|Overall Study|Lost to Follow-up|2|||
19633333|NCT00809471|42082835|FG002|Overall Study|Lost to Follow-up|9|||
19543205|NCT01165684|41992445|FG000|Overall Study|Withdrawal Criteria|2|||
19543206|NCT01165684|41992446|FG001|Overall Study|Withdrawal Criteria|13|||
19543207|NCT01165684|41992445|FG000|Overall Study|Unclassified|16|||
19633334|NCT00809471|42082833|FG000|Overall Study|Adverse Event|0|||
19633335|NCT00809471|42082834|FG001|Overall Study|Adverse Event|2|||
19633336|NCT00809471|42082835|FG002|Overall Study|Adverse Event|2|||
19633337|NCT00809471|42082833|FG000|Overall Study|Requirement for restricted medication|1|||
19633338|NCT00809471|42082834|FG001|Overall Study|Requirement for restricted medication|1|||
19633339|NCT00809471|42082835|FG002|Overall Study|Requirement for restricted medication|0|||
19633340|NCT00807248|42082847|FG000|Overall Study|Adverse Event|1|||
19633341|NCT00807248|42082848|FG001|Overall Study|Adverse Event|2|||
19633342|NCT00807248|42082849|FG002|Overall Study|Adverse Event|2|||
19633343|NCT00807248|42082850|FG003|Overall Study|Adverse Event|6|||
19543208|NCT01165684|41992446|FG001|Overall Study|Unclassified|22|||
19543209|NCT01189201|41992452|FG000|Overall Study|Adverse Event|1|||
19543210|NCT01188967|41992469|FG000|Overall Study|Withdrawal by Subject|1|||
19633344|NCT00807248|42082847|FG000|Overall Study|Lack of Efficacy|14|||
19633345|NCT00807248|42082848|FG001|Overall Study|Lack of Efficacy|4|||
19633346|NCT00807248|42082849|FG002|Overall Study|Lack of Efficacy|8|||
19633347|NCT00807248|42082850|FG003|Overall Study|Lack of Efficacy|3|||
19633348|NCT00807248|42082847|FG000|Overall Study|Protocol Violation|0|||
19633349|NCT00807248|42082848|FG001|Overall Study|Protocol Violation|1|||
19633350|NCT00807248|42082849|FG002|Overall Study|Protocol Violation|1|||
19633351|NCT00807248|42082850|FG003|Overall Study|Protocol Violation|0|||
19633352|NCT00807248|42082847|FG000|Overall Study|Withdrawal of Consent|5|||
19633353|NCT00807248|42082848|FG001|Overall Study|Withdrawal of Consent|5|||
19633354|NCT00807248|42082849|FG002|Overall Study|Withdrawal of Consent|5|||
19633355|NCT00807248|42082850|FG003|Overall Study|Withdrawal of Consent|5|||
19633356|NCT00807248|42082847|FG000|Overall Study|Lost to Follow-up|1|||
19633357|NCT00807248|42082848|FG001|Overall Study|Lost to Follow-up|0|||
19633358|NCT00807248|42082849|FG002|Overall Study|Lost to Follow-up|0|||
19633359|NCT00807248|42082850|FG003|Overall Study|Lost to Follow-up|0|||
19633360|NCT00807248|42082847|FG000|Overall Study|Other Reason|0|||
19633361|NCT00807248|42082848|FG001|Overall Study|Other Reason|0|||
19633362|NCT00807248|42082849|FG002|Overall Study|Other Reason|2|||
19633363|NCT00807248|42082850|FG003|Overall Study|Other Reason|0|||
19633364|NCT00589628|42082862|FG000|Overall Study|Lost to Follow-up|0|||
19633365|NCT00589628|42082863|FG001|Overall Study|Lost to Follow-up|1|||
19633366|NCT00588848|42082871|FG000|Overall Study|Physician Decision|0|||
19633367|NCT00588848|42082872|FG001|Overall Study|Physician Decision|3|||
19633368|NCT00797108|42082883|FG000|Overall Study|Adverse Event|1|||
19633369|NCT00797108|42082884|FG001|Overall Study|Adverse Event|0|||
19633370|NCT00797108|42082885|FG002|Overall Study|Adverse Event|3|||
19633371|NCT00797108|42082883|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
19633372|NCT00797108|42082884|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
19633373|NCT00797108|42082885|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
19633374|NCT00797108|42082883|FG000|Overall Study|Global Deterioration of Health Status|0|||
19633375|NCT00797108|42082884|FG001|Overall Study|Global Deterioration of Health Status|1|||
19633376|NCT00797108|42082885|FG002|Overall Study|Global Deterioration of Health Status|0|||
19633377|NCT00797108|42082883|FG000|Overall Study|Lack of Efficacy|1|||
19633378|NCT00797108|42082884|FG001|Overall Study|Lack of Efficacy|0|||
19633379|NCT00797108|42082885|FG002|Overall Study|Lack of Efficacy|1|||
19633380|NCT00797108|42082883|FG000|Overall Study|Other|0|||
19633381|NCT00797108|42082884|FG001|Overall Study|Other|0|||
19633382|NCT00797108|42082885|FG002|Overall Study|Other|2|||
19633383|NCT00797108|42082883|FG000|Overall Study|Randomized but not Treated|2|||
19633384|NCT00797108|42082884|FG001|Overall Study|Randomized but not Treated|0|||
19633385|NCT00797108|42082885|FG002|Overall Study|Randomized but not Treated|0|||
19633386|NCT00742560|42082898|FG000|Overall Study|Adverse Event|0|||
19633387|NCT00742560|42082899|FG001|Overall Study|Adverse Event|0|||
19633388|NCT00742560|42082900|FG002|Overall Study|Adverse Event|1|||
19633389|NCT00742560|42082901|FG003|Overall Study|Adverse Event|1|||
19633390|NCT00742560|42082902|FG004|Overall Study|Adverse Event|1|||
19633391|NCT00742560|42082898|FG000|Overall Study|Death|0|||
19633392|NCT00742560|42082899|FG001|Overall Study|Death|2|||
19633393|NCT00742560|42082900|FG002|Overall Study|Death|0|||
19633394|NCT00742560|42082901|FG003|Overall Study|Death|2|||
19633395|NCT00742560|42082902|FG004|Overall Study|Death|3|||
19633396|NCT00742560|42082898|FG000|Overall Study|Subject's Decision|1|||
19633397|NCT00742560|42082899|FG001|Overall Study|Subject's Decision|0|||
19633398|NCT00742560|42082900|FG002|Overall Study|Subject's Decision|2|||
19633399|NCT00742560|42082901|FG003|Overall Study|Subject's Decision|3|||
19633400|NCT00742560|42082902|FG004|Overall Study|Subject's Decision|3|||
19633401|NCT00742560|42082898|FG000|Overall Study|Investigator's Decision|0|||
19633402|NCT00742560|42082899|FG001|Overall Study|Investigator's Decision|0|||
19633403|NCT00742560|42082900|FG002|Overall Study|Investigator's Decision|4|||
19633404|NCT00742560|42082901|FG003|Overall Study|Investigator's Decision|1|||
19633405|NCT00742560|42082902|FG004|Overall Study|Investigator's Decision|0|||
19633406|NCT00742560|42082898|FG000|Overall Study|Disease Progression|1|||
19633407|NCT00742560|42082899|FG001|Overall Study|Disease Progression|0|||
19633408|NCT00742560|42082900|FG002|Overall Study|Disease Progression|5|||
19633409|NCT00742560|42082901|FG003|Overall Study|Disease Progression|17|||
19633410|NCT00742560|42082902|FG004|Overall Study|Disease Progression|16|||
19633411|NCT00742560|42082898|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
19633412|NCT00742560|42082899|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
19633413|NCT00742560|42082900|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
19633414|NCT00742560|42082901|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
19633415|NCT00742560|42082902|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
19633416|NCT00742560|42082898|FG000|Overall Study|Other|0|||
19633417|NCT00742560|42082899|FG001|Overall Study|Other|1|||
19633418|NCT00742560|42082900|FG002|Overall Study|Other|8|||
19633419|NCT00742560|42082901|FG003|Overall Study|Other|9|||
19633420|NCT00742560|42082902|FG004|Overall Study|Other|9|||
19633421|NCT00742560|42082898|FG000|Overall Study|MIssing|0|||
19633422|NCT00742560|42082899|FG001|Overall Study|MIssing|0|||
19633423|NCT00742560|42082900|FG002|Overall Study|MIssing|0|||
19633424|NCT00742560|42082901|FG003|Overall Study|MIssing|0|||
19633425|NCT00742560|42082902|FG004|Overall Study|MIssing|1|||
19633426|NCT00740220|42082933|FG000|Overall Study|screen failures (non-COPD patients)|9|||
19633427|NCT00796718|42082937|FG000|Overall Study|Adverse Event|2|||
19633428|NCT00796718|42082937|FG000|Overall Study|Exclusion Criteria|1|||
19633429|NCT00796718|42082937|FG000|Overall Study|Lost to Follow-up|5|||
19633430|NCT00796718|42082937|FG000|Overall Study|Withdrawal by Informed Consent|1|||
19633431|NCT00809159|42082945|FG000|Part 1|Adverse Event|1|||
19633432|NCT00809159|42082946|FG001|Part 1|Adverse Event|1|||
19633433|NCT00809159|42082947|FG002|Part 1|Adverse Event|0|||
19633434|NCT00809159|42082948|FG003|Part 1|Adverse Event|0|||
19633435|NCT00809159|42082949|FG004|Part 1|Adverse Event|0|||
19633436|NCT00809159|42082950|FG005|Part 1|Adverse Event|0|||
19633437|NCT00809159|42082945|FG000|Part 1|Lost to Follow-up|1|||
19633438|NCT00809159|42082946|FG001|Part 1|Lost to Follow-up|0|||
19633439|NCT00809159|42082947|FG002|Part 1|Lost to Follow-up|0|||
19633440|NCT00809159|42082948|FG003|Part 1|Lost to Follow-up|0|||
19633441|NCT00809159|42082949|FG004|Part 1|Lost to Follow-up|0|||
19633442|NCT00809159|42082950|FG005|Part 1|Lost to Follow-up|0|||
19633443|NCT00809159|42082945|FG000|Part 1|Withdrawal by Subject|3|||
19633444|NCT00809159|42082946|FG001|Part 1|Withdrawal by Subject|1|||
19633445|NCT00809159|42082947|FG002|Part 1|Withdrawal by Subject|0|||
19633446|NCT00809159|42082948|FG003|Part 1|Withdrawal by Subject|0|||
19633447|NCT00809159|42082949|FG004|Part 1|Withdrawal by Subject|0|||
19633448|NCT00809159|42082950|FG005|Part 1|Withdrawal by Subject|0|||
19633449|NCT00809159|42082945|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
19633450|NCT00809159|42082946|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
19633451|NCT00809159|42082947|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
19633452|NCT00809159|42082948|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
19633453|NCT00809159|42082949|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
19633454|NCT00809159|42082950|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
19633455|NCT00809159|42082945|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
19633456|NCT00809159|42082946|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
19633457|NCT00809159|42082947|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
19633458|NCT00809159|42082948|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
19633459|NCT00809159|42082949|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
19633460|NCT00809159|42082950|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
19633461|NCT00809159|42082945|FG000|Part 1 and 2|Administrative problems|0|||
19633462|NCT00809159|42082946|FG001|Part 1 and 2|Administrative problems|0|||
19633463|NCT00809159|42082947|FG002|Part 1 and 2|Administrative problems|0|||
19633464|NCT00809159|42082948|FG003|Part 1 and 2|Administrative problems|1|||
19633465|NCT00809159|42082949|FG004|Part 1 and 2|Administrative problems|0|||
19633466|NCT00809159|42082950|FG005|Part 1 and 2|Administrative problems|0|||
19633467|NCT00809159|42082945|FG000|Part 1 and 2|Adverse Event|0|||
19633468|NCT00809159|42082946|FG001|Part 1 and 2|Adverse Event|0|||
19633469|NCT00809159|42082947|FG002|Part 1 and 2|Adverse Event|1|||
19633470|NCT00809159|42082948|FG003|Part 1 and 2|Adverse Event|0|||
19633471|NCT00809159|42082949|FG004|Part 1 and 2|Adverse Event|1|||
19633472|NCT00809159|42082950|FG005|Part 1 and 2|Adverse Event|1|||
19633473|NCT00809159|42082945|FG000|Part 1 and 2|Lost to Follow-up|0|||
19633474|NCT00809159|42082946|FG001|Part 1 and 2|Lost to Follow-up|0|||
19633475|NCT00809159|42082947|FG002|Part 1 and 2|Lost to Follow-up|1|||
19633476|NCT00809159|42082948|FG003|Part 1 and 2|Lost to Follow-up|1|||
19633477|NCT00809159|42082949|FG004|Part 1 and 2|Lost to Follow-up|0|||
19633478|NCT00809159|42082950|FG005|Part 1 and 2|Lost to Follow-up|0|||
19633479|NCT00809159|42082945|FG000|Part 1 and 2|Withdrawal by Subject|0|||
19633480|NCT00809159|42082946|FG001|Part 1 and 2|Withdrawal by Subject|0|||
19633481|NCT00809159|42082947|FG002|Part 1 and 2|Withdrawal by Subject|4|||
19633482|NCT00809159|42082948|FG003|Part 1 and 2|Withdrawal by Subject|0|||
19633483|NCT00809159|42082949|FG004|Part 1 and 2|Withdrawal by Subject|0|||
19633484|NCT00809159|42082950|FG005|Part 1 and 2|Withdrawal by Subject|1|||
19633485|NCT00745368|42082964|FG000|Overall Study|Unable to provide sample|3|||
19633486|NCT00589472|42082968|FG000|Overall Study|Adverse Event|1|||
19633487|NCT00811577|42082974|FG000|Overall Study|Lost to Follow-up|7|||
19633488|NCT00811577|42082975|FG001|Overall Study|Lost to Follow-up|1|||
19633489|NCT00811577|42082974|FG000|Overall Study|Withdrawal by Subject|3|||
19633490|NCT00811577|42082975|FG001|Overall Study|Withdrawal by Subject|0|||
19633491|NCT00802178|42083024|FG000|Overall Study|Lack of Efficacy|36|||
19633492|NCT00802178|42083024|FG000|Overall Study|Insufficient tolerability (IT)|17|||
19633493|NCT00802178|42083024|FG000|Overall Study|Withdrawal by Subject|18|||
19633494|NCT00802178|42083024|FG000|Overall Study|Other|32|||
19633495|NCT00802178|42083024|FG000|Overall Study|Lack of efficacy and patient wish|1|||
19633496|NCT00802178|42083024|FG000|Overall Study|IT and patient wish|8|||
19633497|NCT00802178|42083024|FG000|Overall Study|Patients wish and other reason|1|||
19633498|NCT00744978|42083030|FG000|Period 1|Lost to Follow-up|1|||
19633499|NCT00744978|42083031|FG001|Period 1|Lost to Follow-up|0|||
19633500|NCT00744978|42083030|FG000|Period 1|Withdrawal by Subject|0|||
19633501|NCT00744978|42083031|FG001|Period 1|Withdrawal by Subject|2|||
19633502|NCT00744978|42083030|FG000|Period 1|Other|0|||
19633503|NCT00744978|42083031|FG001|Period 1|Other|2|||
19633504|NCT00744978|42083030|FG000|Period 1|Adverse Event|4|||
19633505|NCT00744978|42083031|FG001|Period 1|Adverse Event|0|||
19633506|NCT00744978|42083030|FG000|Period 1|Randomized but not Treated|1|||
19633507|NCT00744978|42083031|FG001|Period 1|Randomized but not Treated|1|||
19633508|NCT00744978|42083030|FG000|Period 2|Adverse Event|0|||
19633509|NCT00744978|42083031|FG001|Period 2|Adverse Event|1|||
19633510|NCT00739908|42083039|FG000|Overall Study|Adverse Event|5|||
19633511|NCT00739908|42083040|FG001|Overall Study|Adverse Event|6|||
19633512|NCT00739908|42083039|FG000|Overall Study|Withdrawal by Subject|4|||
19633513|NCT00739908|42083040|FG001|Overall Study|Withdrawal by Subject|2|||
19633514|NCT00739908|42083039|FG000|Overall Study|Lost to Follow-up|14|||
19633515|NCT00739908|42083040|FG001|Overall Study|Lost to Follow-up|9|||
19633516|NCT00739908|42083039|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
19633517|NCT00739908|42083040|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
19633518|NCT00739908|42083039|FG000|Overall Study|Non-Compliance With Study Medication|0|||
19633519|NCT00739908|42083040|FG001|Overall Study|Non-Compliance With Study Medication|3|||
19633520|NCT00739908|42083039|FG000|Overall Study|Lack of Efficacy|0|||
19633521|NCT00739908|42083040|FG001|Overall Study|Lack of Efficacy|1|||
19633522|NCT00739908|42083039|FG000|Overall Study|Relocation|0|||
19633523|NCT00739908|42083040|FG001|Overall Study|Relocation|1|||
19633524|NCT00739596|42083050|FG000|Overall Study|Adverse Event|12|||
19633525|NCT00739596|42083051|FG001|Overall Study|Adverse Event|6|||
19633526|NCT00739596|42083050|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
19633527|NCT00739596|42083051|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19633528|NCT00739596|42083050|FG000|Overall Study|Patient Withdrew Consent|8|||
19633529|NCT00739596|42083051|FG001|Overall Study|Patient Withdrew Consent|8|||
19633530|NCT00739596|42083050|FG000|Overall Study|Lost to Follow-up|0|||
19633531|NCT00739596|42083051|FG001|Overall Study|Lost to Follow-up|2|||
19633532|NCT00739596|42083050|FG000|Overall Study|Protocol Deviation|1|||
19633533|NCT00739596|42083051|FG001|Overall Study|Protocol Deviation|1|||
19633534|NCT00742326|42083059|FG000|Overall Study|Physician Decision|0|||
19633535|NCT00742326|42083060|FG001|Overall Study|Physician Decision|1|||
19633536|NCT00741936|42083068|FG000|Overall Study|Lost to Follow-up|1|||
19633537|NCT00741936|42083069|FG001|Overall Study|Lost to Follow-up|1|||
19633538|NCT00741936|42083068|FG000|Overall Study|Adverse Event|3|||
19633539|NCT00741936|42083069|FG001|Overall Study|Adverse Event|4|||
19633540|NCT00741936|42083068|FG000|Overall Study|Pregnancy|0|||
19633541|NCT00741936|42083069|FG001|Overall Study|Pregnancy|1|||
19633542|NCT00741936|42083068|FG000|Overall Study|Protocol Violation|2|||
19633543|NCT00741936|42083069|FG001|Overall Study|Protocol Violation|0|||
19633544|NCT00741936|42083068|FG000|Overall Study|Lack of Efficacy|0|||
19633545|NCT00741936|42083069|FG001|Overall Study|Lack of Efficacy|2|||
19633546|NCT00741936|42083068|FG000|Overall Study|Low compliance|3|||
19633547|NCT00741936|42083069|FG001|Overall Study|Low compliance|0|||
19633548|NCT00811187|42083077|FG000|Overall Study|Unable to place device / procedure abort|3|||
19633549|NCT00811187|42083078|FG001|Overall Study|Unable to place device / procedure abort|3|||
19633550|NCT00591149|42083084|FG000|Overall Study|Adverse Event|4|||
19633551|NCT00591149|42083084|FG000|Overall Study|Withdrawal by Subject|1|||
19633552|NCT00735072|42083090|FG000|Overall Study|interrupted study med during ARV change|1|||
19633553|NCT00735072|42083091|FG001|Overall Study|interrupted study med during ARV change|0|||
19633554|NCT00735072|42083090|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
19633555|NCT00735072|42083091|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
19633556|NCT00810641|42083102|FG000|Overall Study|Withdrawal by Subject|0|||
19633557|NCT00810641|42083103|FG001|Overall Study|Withdrawal by Subject|1|||
19633558|NCT00810641|42083104|FG002|Overall Study|Withdrawal by Subject|2|||
19633559|NCT00793598|42083117|FG000|Overall Study|Patient Request|0|||
19633560|NCT00793598|42083118|FG001|Overall Study|Patient Request|1|||
19633561|NCT00793598|42083119|FG002|Overall Study|Patient Request|0|||
19633562|NCT00793598|42083120|FG003|Overall Study|Patient Request|0|||
19633563|NCT00793598|42083121|FG004|Overall Study|Patient Request|0|||
19633564|NCT00793598|42083122|FG005|Overall Study|Patient Request|0|||
19633565|NCT00793598|42083123|FG006|Overall Study|Patient Request|0|||
19633566|NCT00793598|42083124|FG007|Overall Study|Patient Request|0|||
19633567|NCT00793598|42083117|FG000|Overall Study|Protocol Violation|0|||
19633568|NCT00793598|42083118|FG001|Overall Study|Protocol Violation|0|||
19633569|NCT00793598|42083119|FG002|Overall Study|Protocol Violation|0|||
19633570|NCT00793598|42083120|FG003|Overall Study|Protocol Violation|0|||
19633571|NCT00793598|42083121|FG004|Overall Study|Protocol Violation|0|||
19633572|NCT00793598|42083122|FG005|Overall Study|Protocol Violation|0|||
19633573|NCT00793598|42083123|FG006|Overall Study|Protocol Violation|0|||
19633574|NCT00793598|42083124|FG007|Overall Study|Protocol Violation|1|||
19633575|NCT00793598|42083117|FG000|Overall Study|Subject not dosed|0|||
19633576|NCT00793598|42083118|FG001|Overall Study|Subject not dosed|0|||
19633577|NCT00793598|42083119|FG002|Overall Study|Subject not dosed|0|||
19633578|NCT00793598|42083120|FG003|Overall Study|Subject not dosed|0|||
19633579|NCT00793598|42083121|FG004|Overall Study|Subject not dosed|0|||
19633580|NCT00793598|42083122|FG005|Overall Study|Subject not dosed|1|||
19633581|NCT00793598|42083123|FG006|Overall Study|Subject not dosed|0|||
19633582|NCT00793598|42083124|FG007|Overall Study|Subject not dosed|0|||
19633583|NCT00796562|42083146|FG000|Overall Study|Death|49|||
19633584|NCT00801632|42083150|FG000|Overall Study|Re-transplant|1|||
19633585|NCT00806819|42083156|FG000|Overall Study|progressive disease (modified RECIST )|217|||
19633586|NCT00806819|42083157|FG001|Overall Study|progressive disease (modified RECIST )|216|||
19633587|NCT00806819|42083156|FG000|Overall Study|Worsening or AE of underlying disease|18|||
19633588|NCT00806819|42083157|FG001|Overall Study|Worsening or AE of underlying disease|25|||
19633589|NCT00806819|42083156|FG000|Overall Study|Other AE|38|||
19633590|NCT00806819|42083157|FG001|Overall Study|Other AE|40|||
19633591|NCT00806819|42083156|FG000|Overall Study|Protocol Violation|9|||
19633592|NCT00806819|42083157|FG001|Overall Study|Protocol Violation|4|||
19633593|NCT00806819|42083156|FG000|Overall Study|Lost to Follow-up|1|||
19633594|NCT00806819|42083157|FG001|Overall Study|Lost to Follow-up|0|||
19633595|NCT00806819|42083156|FG000|Overall Study|Withdrawal by Subject|32|||
19633596|NCT00806819|42083157|FG001|Overall Study|Withdrawal by Subject|29|||
19633597|NCT00806819|42083156|FG000|Overall Study|Not treated|6|||
19633598|NCT00806819|42083157|FG001|Overall Study|Not treated|3|||
19633599|NCT00806819|42083156|FG000|Overall Study|Reasons other than stated above|25|||
19633600|NCT00806819|42083157|FG001|Overall Study|Reasons other than stated above|41|||
19633601|NCT00801242|42083164|FG000|Overall Study|Adverse Event|10|||
19633602|NCT00801242|42083164|FG000|Overall Study|Withdrawal by Subject|13|||
19633603|NCT00801242|42083164|FG000|Overall Study|Protocol Violation|5|||
19633604|NCT00801242|42083164|FG000|Overall Study|Physician Decision|3|||
19633605|NCT00801242|42083164|FG000|Overall Study|Lost to Follow-up|1|||
19543211|NCT01188967|41992470|FG001|Overall Study|Withdrawal by Subject|1|||
19543212|NCT01188967|41992469|FG000|Overall Study|Physician Decision|1|||
19543213|NCT01188967|41992470|FG001|Overall Study|Physician Decision|1|||
19543214|NCT01188967|41992469|FG000|Overall Study|Lost to Follow-up|3|||
19633606|NCT00801242|42083164|FG000|Overall Study|Miscellaneous reasons|20|||
19633607|NCT00800540|42083168|FG000|Period One: 6 Weeks|Noncompliance|1|||
19633608|NCT00800540|42083169|FG001|Period One: 6 Weeks|Noncompliance|0|||
19633609|NCT00800540|42083168|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
19633610|NCT00800540|42083169|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
19633611|NCT00800540|42083168|FG000|Period 2: 6 Weeks|Adverse Event|0|||
19633612|NCT00800540|42083169|FG001|Period 2: 6 Weeks|Adverse Event|1|||
19633613|NCT00800384|42083177|FG000|Overall Study|Withdrawal by Subject|24|||
19633614|NCT00800384|42083178|FG001|Overall Study|Withdrawal by Subject|17|||
19633615|NCT00800384|42083177|FG000|Overall Study|Lost to Follow-up|17|||
19633616|NCT00800384|42083178|FG001|Overall Study|Lost to Follow-up|26|||
19633617|NCT00796328|42083185|FG000|Overall Study|experienced hypotension requiring tx|6|||
19633618|NCT00588692|42083191|FG000|Overall Study|Withdrawal by Subject|4|||
19633619|NCT00588692|42083192|FG001|Overall Study|Withdrawal by Subject|2|||
19711711|NCT00095199|42154762|FG001|Overall Study|Not eligible|7|||
19711712|NCT00095199|42154763|FG002|Overall Study|Not eligible|0|||
19711713|NCT00095199|42154764|FG003|Overall Study|Not eligible|1|||
19711714|NCT00095199|42154761|FG000|Overall Study|Started Palliative Radiotherapy|1|||
19711715|NCT00095199|42154762|FG001|Overall Study|Started Palliative Radiotherapy|0|||
19711716|NCT00095199|42154763|FG002|Overall Study|Started Palliative Radiotherapy|0|||
19711717|NCT00095199|42154764|FG003|Overall Study|Started Palliative Radiotherapy|0|||
19711718|NCT00095199|42154761|FG000|Overall Study|Started radiotherapy regimen|0|||
19711719|NCT00095199|42154762|FG001|Overall Study|Started radiotherapy regimen|1|||
19711720|NCT00095199|42154763|FG002|Overall Study|Started radiotherapy regimen|0|||
19711721|NCT00095199|42154764|FG003|Overall Study|Started radiotherapy regimen|0|||
19711722|NCT00095199|42154761|FG000|Overall Study|Primary tumor removed in other surgery|0|||
19711723|NCT00095199|42154762|FG001|Overall Study|Primary tumor removed in other surgery|1|||
19633620|NCT00588692|42083191|FG000|Overall Study|Hip Surgery|0|||
19633621|NCT00588692|42083192|FG001|Overall Study|Hip Surgery|1|||
19633622|NCT00588692|42083191|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
19633623|NCT00588692|42083192|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
19633624|NCT00588692|42083191|FG000|Overall Study|Cancer|1|||
19633625|NCT00588692|42083192|FG001|Overall Study|Cancer|0|||
19633626|NCT00588692|42083191|FG000|Overall Study|Death|1|||
19633627|NCT00588692|42083192|FG001|Overall Study|Death|0|||
19633628|NCT00588146|42083200|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
19633629|NCT00588146|42083201|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
19633630|NCT00795704|42083209|FG000|Overall Study|Withdrawal by Subject|3|||
19633631|NCT00795704|42083210|FG001|Overall Study|Withdrawal by Subject|2|||
19711724|NCT00095199|42154763|FG002|Overall Study|Primary tumor removed in other surgery|0|||
19711725|NCT00095199|42154764|FG003|Overall Study|Primary tumor removed in other surgery|0|||
19711726|NCT00095199|42154761|FG000|Overall Study|Data inadvertently lost by site|1|||
19633632|NCT00795704|42083209|FG000|Overall Study|Adverse Event|1|||
19633633|NCT00795704|42083210|FG001|Overall Study|Adverse Event|1|||
19711727|NCT00095199|42154762|FG001|Overall Study|Data inadvertently lost by site|0|||
19711728|NCT00095199|42154763|FG002|Overall Study|Data inadvertently lost by site|0|||
19711729|NCT00095199|42154764|FG003|Overall Study|Data inadvertently lost by site|0|||
19633634|NCT00444457|42083220|FG000|Infant Series|Other|0|||
19633635|NCT00444457|42083221|FG001|Infant Series|Other|1|||
19633636|NCT00444457|42083222|FG002|Infant Series|Other|0|||
19633637|NCT00444457|42083223|FG003|Infant Series|Other|0|||
19633638|NCT00444457|42083220|FG000|Infant Series|Parent or legal guardian request|18|||
19633639|NCT00444457|42083221|FG001|Infant Series|Parent or legal guardian request|29|||
19633640|NCT00444457|42083222|FG002|Infant Series|Parent or legal guardian request|34|||
19633641|NCT00444457|42083223|FG003|Infant Series|Parent or legal guardian request|14|||
19633642|NCT00444457|42083220|FG000|Infant Series|Lost to Follow-up|10|||
19633643|NCT00444457|42083221|FG001|Infant Series|Lost to Follow-up|11|||
19633644|NCT00444457|42083222|FG002|Infant Series|Lost to Follow-up|7|||
19633645|NCT00444457|42083223|FG003|Infant Series|Lost to Follow-up|6|||
19633646|NCT00444457|42083220|FG000|Infant Series|Protocol Violation|16|||
19633647|NCT00444457|42083221|FG001|Infant Series|Protocol Violation|8|||
19633648|NCT00444457|42083222|FG002|Infant Series|Protocol Violation|6|||
19633649|NCT00444457|42083223|FG003|Infant Series|Protocol Violation|3|||
19633650|NCT00444457|42083220|FG000|Infant Series|Failed to return|5|||
19633651|NCT00444457|42083221|FG001|Infant Series|Failed to return|4|||
19633652|NCT00444457|42083222|FG002|Infant Series|Failed to return|4|||
19633653|NCT00444457|42083223|FG003|Infant Series|Failed to return|2|||
19633654|NCT00444457|42083220|FG000|Infant Series|Investigator request|4|||
19633655|NCT00444457|42083221|FG001|Infant Series|Investigator request|3|||
19633656|NCT00444457|42083222|FG002|Infant Series|Investigator request|3|||
19633657|NCT00444457|42083223|FG003|Infant Series|Investigator request|2|||
19633658|NCT00444457|42083220|FG000|Infant Series|Other|0|||
19633659|NCT00444457|42083221|FG001|Infant Series|Other|2|||
19633660|NCT00444457|42083222|FG002|Infant Series|Other|4|||
19633661|NCT00444457|42083223|FG003|Infant Series|Other|0|||
19633662|NCT00444457|42083220|FG000|Infant Series|Adverse Event|1|||
19633663|NCT00444457|42083221|FG001|Infant Series|Adverse Event|2|||
19633664|NCT00444457|42083222|FG002|Infant Series|Adverse Event|2|||
19633665|NCT00444457|42083223|FG003|Infant Series|Adverse Event|0|||
19633666|NCT00444457|42083220|FG000|Infant Series|Death|0|||
19633667|NCT00444457|42083221|FG001|Infant Series|Death|1|||
19633668|NCT00444457|42083222|FG002|Infant Series|Death|1|||
19633669|NCT00444457|42083223|FG003|Infant Series|Death|1|||
19633670|NCT00444457|42083220|FG000|After Infant Series|Other|0|||
19633671|NCT00444457|42083221|FG001|After Infant Series|Other|1|||
19633672|NCT00444457|42083222|FG002|After Infant Series|Other|1|||
19633673|NCT00444457|42083223|FG003|After Infant Series|Other|1|||
19633674|NCT00444457|42083220|FG000|After Infant Series|Parent or legal guardian request|4|||
19633675|NCT00444457|42083221|FG001|After Infant Series|Parent or legal guardian request|11|||
19633676|NCT00444457|42083222|FG002|After Infant Series|Parent or legal guardian request|6|||
19633677|NCT00444457|42083223|FG003|After Infant Series|Parent or legal guardian request|3|||
19633678|NCT00444457|42083220|FG000|After Infant Series|Failed to return|7|||
19633679|NCT00444457|42083221|FG001|After Infant Series|Failed to return|6|||
19633680|NCT00444457|42083222|FG002|After Infant Series|Failed to return|5|||
19633681|NCT00444457|42083223|FG003|After Infant Series|Failed to return|1|||
19633682|NCT00444457|42083220|FG000|After Infant Series|Lost to Follow-up|5|||
19633683|NCT00444457|42083221|FG001|After Infant Series|Lost to Follow-up|5|||
19633684|NCT00444457|42083222|FG002|After Infant Series|Lost to Follow-up|5|||
19633685|NCT00444457|42083223|FG003|After Infant Series|Lost to Follow-up|2|||
19633686|NCT00444457|42083220|FG000|After Infant Series|Protocol Violation|2|||
19633687|NCT00444457|42083221|FG001|After Infant Series|Protocol Violation|4|||
19633688|NCT00444457|42083222|FG002|After Infant Series|Protocol Violation|2|||
19633689|NCT00444457|42083223|FG003|After Infant Series|Protocol Violation|2|||
19633690|NCT00444457|42083220|FG000|After Infant Series|Adverse Event|2|||
19633691|NCT00444457|42083221|FG001|After Infant Series|Adverse Event|2|||
19633692|NCT00444457|42083222|FG002|After Infant Series|Adverse Event|0|||
19633693|NCT00444457|42083223|FG003|After Infant Series|Adverse Event|0|||
19633694|NCT00444457|42083220|FG000|After Infant Series|Investigator request|0|||
19633695|NCT00444457|42083221|FG001|After Infant Series|Investigator request|0|||
19633696|NCT00444457|42083222|FG002|After Infant Series|Investigator request|0|||
19633697|NCT00444457|42083223|FG003|After Infant Series|Investigator request|1|||
19633698|NCT00444457|42083220|FG000|After Infant Series|Other|0|||
19633699|NCT00444457|42083221|FG001|After Infant Series|Other|1|||
19633700|NCT00444457|42083222|FG002|After Infant Series|Other|0|||
19633701|NCT00444457|42083223|FG003|After Infant Series|Other|0|||
19633702|NCT00444457|42083220|FG000|Toddler Dose|Lost to Follow-up|4|||
19633703|NCT00444457|42083221|FG001|Toddler Dose|Lost to Follow-up|1|||
19633704|NCT00444457|42083222|FG002|Toddler Dose|Lost to Follow-up|1|||
19633705|NCT00444457|42083223|FG003|Toddler Dose|Lost to Follow-up|3|||
19633706|NCT00444457|42083220|FG000|Toddler Dose|Failed to return|2|||
19633707|NCT00444457|42083221|FG001|Toddler Dose|Failed to return|2|||
19633708|NCT00444457|42083222|FG002|Toddler Dose|Failed to return|1|||
19543215|NCT01188967|41992470|FG001|Overall Study|Lost to Follow-up|2|||
19633709|NCT00444457|42083223|FG003|Toddler Dose|Failed to return|3|||
19633710|NCT00444457|42083220|FG000|Toddler Dose|Parent or legal guardian request|0|||
19633711|NCT00444457|42083221|FG001|Toddler Dose|Parent or legal guardian request|3|||
19633712|NCT00444457|42083222|FG002|Toddler Dose|Parent or legal guardian request|2|||
19633713|NCT00444457|42083223|FG003|Toddler Dose|Parent or legal guardian request|1|||
19633714|NCT00444457|42083220|FG000|Toddler Dose|Protocol Violation|1|||
19633715|NCT00444457|42083221|FG001|Toddler Dose|Protocol Violation|0|||
19633716|NCT00444457|42083222|FG002|Toddler Dose|Protocol Violation|0|||
19633717|NCT00444457|42083223|FG003|Toddler Dose|Protocol Violation|1|||
19633718|NCT00799058|42083247|FG000|Overall Study|Withdrawal by Subject|2|||
19633719|NCT00799058|42083248|FG001|Overall Study|Withdrawal by Subject|2|||
19633720|NCT00799058|42083249|FG002|Overall Study|Withdrawal by Subject|2|||
19633721|NCT00799058|42083247|FG000|Overall Study|Lost to Follow-up|1|||
19633722|NCT00799058|42083248|FG001|Overall Study|Lost to Follow-up|2|||
19633723|NCT00799058|42083249|FG002|Overall Study|Lost to Follow-up|1|||
19633724|NCT00799058|42083247|FG000|Overall Study|Adverse Event|0|||
19633725|NCT00799058|42083248|FG001|Overall Study|Adverse Event|2|||
19633726|NCT00799058|42083249|FG002|Overall Study|Adverse Event|0|||
19633727|NCT00799058|42083247|FG000|Overall Study|Pregnancy|1|||
19633728|NCT00799058|42083248|FG001|Overall Study|Pregnancy|0|||
19633729|NCT00799058|42083249|FG002|Overall Study|Pregnancy|0|||
19633730|NCT00799058|42083247|FG000|Overall Study|Not adherent|3|||
19633731|NCT00799058|42083248|FG001|Overall Study|Not adherent|2|||
19633732|NCT00799058|42083249|FG002|Overall Study|Not adherent|1|||
19633733|NCT00799058|42083247|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
19633734|NCT00799058|42083248|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
19633735|NCT00799058|42083249|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
19633736|NCT00799058|42083247|FG000|Overall Study|IP dispensing error|1|||
19633737|NCT00799058|42083248|FG001|Overall Study|IP dispensing error|0|||
19633738|NCT00799058|42083249|FG002|Overall Study|IP dispensing error|0|||
19633739|NCT00799058|42083247|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
19711730|NCT00075764|42154781|FG000|Overall Study|Adverse Event|5|||
19711731|NCT00075764|42154782|FG001|Overall Study|Adverse Event|12|||
19711732|NCT00075764|42154781|FG000|Overall Study|Death|4|||
19711733|NCT00075764|42154782|FG001|Overall Study|Death|8|||
19711734|NCT00075764|42154781|FG000|Overall Study|Withdrawal by Subject|28|||
19711735|NCT00075764|42154782|FG001|Overall Study|Withdrawal by Subject|18|||
19711736|NCT00075764|42154781|FG000|Overall Study|Progression|269|||
19711737|NCT00075764|42154782|FG001|Overall Study|Progression|274|||
19711738|NCT00075764|42154781|FG000|Overall Study|Still on treatment|8|||
19711739|NCT00075764|42154782|FG001|Overall Study|Still on treatment|15|||
19711740|NCT00075764|42154781|FG000|Overall Study|Delinquent|4|||
19711741|NCT00075764|42154782|FG001|Overall Study|Delinquent|2|||
19711742|NCT00075764|42154781|FG000|Overall Study|Not protocol specified|27|||
19711743|NCT00075764|42154782|FG001|Overall Study|Not protocol specified|19|||
19711744|NCT00075764|42154781|FG000|Overall Study|Under review|0|||
19711745|NCT00075764|42154782|FG001|Overall Study|Under review|1|||
19711746|NCT03568162|42154796|FG000|Overall Study|Adverse Event|0|||
19711747|NCT03568162|42154797|FG001|Overall Study|Adverse Event|1|||
19711748|NCT03568162|42154798|FG002|Overall Study|Adverse Event|2|||
19711749|NCT03568162|42154799|FG003|Overall Study|Adverse Event|0|||
19711750|NCT03568162|42154800|FG004|Overall Study|Adverse Event|0|||
19711751|NCT03568162|42154801|FG005|Overall Study|Adverse Event|1|||
19633740|NCT00799058|42083248|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
19633741|NCT00799058|42083249|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
19633742|NCT00799058|42083247|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
19633743|NCT00799058|42083248|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
19633744|NCT00799058|42083249|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
19633745|NCT00799058|42083247|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
19633746|NCT00799058|42083248|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
19633747|NCT00799058|42083249|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
19633748|NCT00799058|42083247|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
19633749|NCT00799058|42083248|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
19633750|NCT00799058|42083249|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
19633751|NCT00725985|42083262|FG000|ITP- Treatment Disposition|Adverse Event|20|||
19633752|NCT00725985|42083263|FG001|ITP- Treatment Disposition|Adverse Event|10|||
19633753|NCT00725985|42083264|FG002|ITP- Treatment Disposition|Adverse Event|5|||
19633754|NCT00725985|42083265|FG003|ITP- Treatment Disposition|Adverse Event|0|||
19711752|NCT03568162|42154796|FG000|Overall Study|Death|0|||
19711753|NCT03568162|42154797|FG001|Overall Study|Death|0|||
19711754|NCT03568162|42154798|FG002|Overall Study|Death|0|||
19711755|NCT03568162|42154799|FG003|Overall Study|Death|0|||
19711756|NCT03568162|42154800|FG004|Overall Study|Death|1|||
19711757|NCT03568162|42154801|FG005|Overall Study|Death|0|||
19711758|NCT03568162|42154796|FG000|Overall Study|Lost to Follow-up|3|||
19711759|NCT03568162|42154797|FG001|Overall Study|Lost to Follow-up|2|||
19711760|NCT03568162|42154798|FG002|Overall Study|Lost to Follow-up|4|||
19375428|NCT02276560|41617371|FG000|Overall Study|Adverse Event|1|||
19633755|NCT00725985|42083266|FG004|ITP- Treatment Disposition|Adverse Event|0|||
19633756|NCT00725985|42083267|FG005|ITP- Treatment Disposition|Adverse Event|0|||
19633757|NCT00725985|42083268|FG006|ITP- Treatment Disposition|Adverse Event|0|||
19633758|NCT00725985|42083269|FG007|ITP- Treatment Disposition|Adverse Event|0|||
19633759|NCT00725985|42083270|FG008|ITP- Treatment Disposition|Adverse Event|0|||
19633760|NCT00725985|42083271|FG009|ITP- Treatment Disposition|Adverse Event|0|||
19633761|NCT00725985|42083272|FG010|ITP- Treatment Disposition|Adverse Event|0|||
19633762|NCT00725985|42083273|FG011|ITP- Treatment Disposition|Adverse Event|0|||
19633763|NCT00725985|42083262|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633764|NCT00725985|42083263|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633765|NCT00725985|42083264|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
19633766|NCT00725985|42083265|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633767|NCT00725985|42083266|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633768|NCT00725985|42083267|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633769|NCT00725985|42083268|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633770|NCT00725985|42083269|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633771|NCT00725985|42083270|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633772|NCT00725985|42083271|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633773|NCT00725985|42083272|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633774|NCT00725985|42083273|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
19633775|NCT00725985|42083262|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
19633776|NCT00725985|42083263|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
19633777|NCT00725985|42083264|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
19633778|NCT00725985|42083265|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
19633779|NCT00725985|42083266|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
19633780|NCT00725985|42083267|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
19633781|NCT00725985|42083268|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
19633782|NCT00725985|42083269|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
19633783|NCT00725985|42083270|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
19633784|NCT00725985|42083271|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
19633785|NCT00725985|42083272|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
19633786|NCT00725985|42083273|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
19633787|NCT00725985|42083262|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
19633788|NCT00725985|42083263|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
19633789|NCT00725985|42083264|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
19633790|NCT00725985|42083265|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
19633791|NCT00725985|42083266|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
19633792|NCT00725985|42083267|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
19633793|NCT00725985|42083268|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
19543216|NCT01188811|41992480|FG000|Overall Study|Withdrawal by Subject|0|||
19543217|NCT01188811|41992481|FG001|Overall Study|Withdrawal by Subject|2|||
19543218|NCT01188811|41992480|FG000|Overall Study|Adverse Event|6|||
19543219|NCT01188811|41992481|FG001|Overall Study|Adverse Event|0|||
19543220|NCT01183234|41992489|FG000|First Intervention|Adverse Event|1|||
19543221|NCT01183234|41992490|FG001|First Intervention|Adverse Event|0|||
19633794|NCT00725985|42083269|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
19633795|NCT00725985|42083270|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
19633796|NCT00725985|42083271|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
19633797|NCT00725985|42083272|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
19633798|NCT00725985|42083273|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
19633799|NCT00725985|42083262|FG000|ITP- Treatment Disposition|Other|50|||
19543222|NCT01165216|41992498|FG000|Overall Study|Adverse Event|6|||
19543223|NCT01165216|41992499|FG001|Overall Study|Adverse Event|3|||
19543224|NCT01165216|41992498|FG000|Overall Study|Withdrawal by Subject|1|||
19543225|NCT01165216|41992499|FG001|Overall Study|Withdrawal by Subject|1|||
19543226|NCT01165216|41992498|FG000|Overall Study|Disease progression|1|||
19543227|NCT01165216|41992499|FG001|Overall Study|Disease progression|3|||
19543228|NCT01165177|41992522|FG000|Overall Study|Serious Adverse Event|227|||
19543229|NCT01165177|41992523|FG001|Overall Study|Serious Adverse Event|235|||
19543230|NCT01165177|41992522|FG000|Overall Study|Withdrawal by Subject|368|||
19543231|NCT01165177|41992523|FG001|Overall Study|Withdrawal by Subject|354|||
19543232|NCT01165177|41992522|FG000|Overall Study|Protocol Violation|19|||
19543233|NCT01165177|41992523|FG001|Overall Study|Protocol Violation|21|||
19543234|NCT01165177|41992522|FG000|Overall Study|Non-serious adverse event|30|||
19543235|NCT01165177|41992523|FG001|Overall Study|Non-serious adverse event|18|||
19543236|NCT01165177|41992522|FG000|Overall Study|Other unspecified reasons|47|||
19543237|NCT01165177|41992523|FG001|Overall Study|Other unspecified reasons|35|||
19543238|NCT01165177|41992522|FG000|Overall Study|Suspected HZ episode|0|||
19543239|NCT01165177|41992523|FG001|Overall Study|Suspected HZ episode|2|||
19543240|NCT01165177|41992522|FG000|Overall Study|Lost to Follow-up|183|||
19543241|NCT01165177|41992523|FG001|Overall Study|Lost to Follow-up|194|||
19543242|NCT01165177|41992522|FG000|Overall Study|Migrated/ moved from study area|48|||
19633800|NCT00725985|42083263|FG001|ITP- Treatment Disposition|Other|38|||
19633801|NCT00725985|42083264|FG002|ITP- Treatment Disposition|Other|24|||
19633802|NCT00725985|42083265|FG003|ITP- Treatment Disposition|Other|0|||
19633803|NCT00725985|42083266|FG004|ITP- Treatment Disposition|Other|0|||
19633804|NCT00725985|42083267|FG005|ITP- Treatment Disposition|Other|0|||
19633805|NCT00725985|42083268|FG006|ITP- Treatment Disposition|Other|0|||
19633806|NCT00725985|42083269|FG007|ITP- Treatment Disposition|Other|0|||
19633807|NCT00725985|42083270|FG008|ITP- Treatment Disposition|Other|0|||
19633808|NCT00725985|42083271|FG009|ITP- Treatment Disposition|Other|0|||
19633809|NCT00725985|42083272|FG010|ITP- Treatment Disposition|Other|0|||
19633810|NCT00725985|42083273|FG011|ITP- Treatment Disposition|Other|0|||
19711761|NCT03568162|42154799|FG003|Overall Study|Lost to Follow-up|2|||
19711762|NCT03568162|42154800|FG004|Overall Study|Lost to Follow-up|3|||
19711763|NCT03568162|42154801|FG005|Overall Study|Lost to Follow-up|2|||
19711764|NCT03568162|42154796|FG000|Overall Study|Physician Decision|0|||
19711765|NCT03568162|42154797|FG001|Overall Study|Physician Decision|1|||
19711766|NCT03568162|42154798|FG002|Overall Study|Physician Decision|1|||
19711767|NCT03568162|42154799|FG003|Overall Study|Physician Decision|0|||
19711768|NCT03568162|42154800|FG004|Overall Study|Physician Decision|1|||
19711769|NCT03568162|42154801|FG005|Overall Study|Physician Decision|0|||
19711770|NCT03568162|42154796|FG000|Overall Study|Pregnancy|0|||
19711771|NCT03568162|42154797|FG001|Overall Study|Pregnancy|0|||
19711772|NCT03568162|42154798|FG002|Overall Study|Pregnancy|0|||
19711773|NCT03568162|42154799|FG003|Overall Study|Pregnancy|1|||
19711774|NCT03568162|42154800|FG004|Overall Study|Pregnancy|0|||
19711775|NCT03568162|42154801|FG005|Overall Study|Pregnancy|0|||
19711776|NCT03568162|42154796|FG000|Overall Study|Protocol Violation|1|||
19711777|NCT03568162|42154797|FG001|Overall Study|Protocol Violation|0|||
19711778|NCT03568162|42154798|FG002|Overall Study|Protocol Violation|1|||
19711779|NCT03568162|42154799|FG003|Overall Study|Protocol Violation|1|||
19711780|NCT03568162|42154800|FG004|Overall Study|Protocol Violation|1|||
19711781|NCT03568162|42154801|FG005|Overall Study|Protocol Violation|1|||
19711782|NCT03568162|42154796|FG000|Overall Study|Withdrawal by Subject|15|||
19711783|NCT03568162|42154797|FG001|Overall Study|Withdrawal by Subject|15|||
19711784|NCT03568162|42154798|FG002|Overall Study|Withdrawal by Subject|26|||
19711785|NCT03568162|42154799|FG003|Overall Study|Withdrawal by Subject|22|||
19711786|NCT03568162|42154800|FG004|Overall Study|Withdrawal by Subject|6|||
19711787|NCT03568162|42154801|FG005|Overall Study|Withdrawal by Subject|9|||
19711788|NCT03568162|42154796|FG000|Overall Study|Others|3|||
19711789|NCT03568162|42154797|FG001|Overall Study|Others|4|||
19711790|NCT03568162|42154798|FG002|Overall Study|Others|1|||
19711791|NCT03568162|42154799|FG003|Overall Study|Others|4|||
19711792|NCT03568162|42154800|FG004|Overall Study|Others|2|||
19711793|NCT03568162|42154801|FG005|Overall Study|Others|1|||
19711794|NCT03567616|42154820|FG000|Overall Study|Disease progression|4|||
19711795|NCT03567616|42154820|FG000|Overall Study|Withdrawal by Subject|1|||
19711796|NCT03567616|42154820|FG000|Overall Study|Physician Decision|1|||
19711797|NCT03567616|42154820|FG000|Overall Study|Death|1|||
19711798|NCT03567616|42154820|FG000|Overall Study|Adverse Event|1|||
19711799|NCT03567382|42154829|FG000|Overall Study|Lost to Follow-up|1|||
19711800|NCT03567382|42154830|FG001|Overall Study|Lost to Follow-up|21|||
19711801|NCT03567382|42154831|FG002|Overall Study|Lost to Follow-up|1|||
19711802|NCT03567382|42154832|FG003|Overall Study|Lost to Follow-up|21|||
19633811|NCT00725985|42083262|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633812|NCT00725985|42083263|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633813|NCT00725985|42083264|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633814|NCT00725985|42083265|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
19633815|NCT00725985|42083266|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
19633816|NCT00725985|42083267|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
19633817|NCT00725985|42083268|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633818|NCT00725985|42083269|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633819|NCT00725985|42083270|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633820|NCT00725985|42083271|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633821|NCT00725985|42083272|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633822|NCT00725985|42083273|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
19633823|NCT00725985|42083262|FG000|OLMP (Up to 96 Weeks)|Death|0|||
19633824|NCT00725985|42083263|FG001|OLMP (Up to 96 Weeks)|Death|0|||
19633825|NCT00725985|42083264|FG002|OLMP (Up to 96 Weeks)|Death|0|||
19633826|NCT00725985|42083265|FG003|OLMP (Up to 96 Weeks)|Death|0|||
19711803|NCT03567382|42154829|FG000|Overall Study|Withdrawal by Subject|2|||
19711804|NCT03567382|42154830|FG001|Overall Study|Withdrawal by Subject|14|||
19711805|NCT03567382|42154831|FG002|Overall Study|Withdrawal by Subject|1|||
19711806|NCT03567382|42154832|FG003|Overall Study|Withdrawal by Subject|12|||
19711807|NCT03595384|42154843|FG000|Overall Study|Other time commitments|8|||
19711808|NCT03595384|42154843|FG000|Overall Study|Changes to session time|7|||
19711809|NCT03595384|42154843|FG000|Overall Study|Relocation out of country|1|||
19711810|NCT03591874|42154849|FG000|Overall Study|Adverse Event|4|||
19711811|NCT03591874|42154850|FG001|Overall Study|Adverse Event|0|||
19633827|NCT00725985|42083266|FG004|OLMP (Up to 96 Weeks)|Death|1|||
19711812|NCT03591874|42154849|FG000|Overall Study|Withdrawal by Subject|2|||
19633828|NCT00725985|42083267|FG005|OLMP (Up to 96 Weeks)|Death|0|||
19633829|NCT00725985|42083268|FG006|OLMP (Up to 96 Weeks)|Death|0|||
19633830|NCT00725985|42083269|FG007|OLMP (Up to 96 Weeks)|Death|0|||
19633831|NCT00725985|42083270|FG008|OLMP (Up to 96 Weeks)|Death|0|||
19633832|NCT00725985|42083271|FG009|OLMP (Up to 96 Weeks)|Death|0|||
19633833|NCT00725985|42083272|FG010|OLMP (Up to 96 Weeks)|Death|0|||
19633834|NCT00725985|42083273|FG011|OLMP (Up to 96 Weeks)|Death|0|||
19633835|NCT00725985|42083262|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633836|NCT00725985|42083263|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633837|NCT00725985|42083264|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633838|NCT00725985|42083265|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
19633839|NCT00725985|42083266|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19711813|NCT03591874|42154850|FG001|Overall Study|Withdrawal by Subject|1|||
19711814|NCT03591874|42154849|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
19711815|NCT03591874|42154850|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
19711816|NCT03591874|42154849|FG000|Overall Study|On Study at Time of Study Termination|12|||
19711817|NCT03591874|42154850|FG001|Overall Study|On Study at Time of Study Termination|6|||
19711818|NCT03566680|42154856|FG000|Overall Study|Pregnancy|1|||
19711819|NCT03566680|42154856|FG000|Overall Study|Lost to Follow-up|13|||
19711820|NCT03566680|42154856|FG000|Overall Study|Withdrawal by Subject|3|||
19711821|NCT00106353|42154862|FG000|Part 1|Disease progression|3|||
19711822|NCT00106353|42154863|FG001|Part 1|Disease progression|4|||
19633840|NCT00725985|42083267|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633841|NCT00725985|42083268|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633842|NCT00725985|42083269|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633843|NCT00725985|42083270|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633844|NCT00725985|42083271|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633845|NCT00725985|42083272|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633846|NCT00725985|42083273|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
19633847|NCT00725985|42083262|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633848|NCT00725985|42083263|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633849|NCT00725985|42083264|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633850|NCT00725985|42083265|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633851|NCT00725985|42083266|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633852|NCT00725985|42083267|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
19633853|NCT00725985|42083268|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633854|NCT00725985|42083269|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633855|NCT00725985|42083270|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633856|NCT00725985|42083271|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633857|NCT00725985|42083272|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633858|NCT00725985|42083273|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
19633859|NCT00725985|42083262|FG000|OLMP (Up to 96 Weeks)|Other|0|||
19633860|NCT00725985|42083263|FG001|OLMP (Up to 96 Weeks)|Other|0|||
19633861|NCT00725985|42083264|FG002|OLMP (Up to 96 Weeks)|Other|0|||
19633862|NCT00725985|42083265|FG003|OLMP (Up to 96 Weeks)|Other|15|||
19633863|NCT00725985|42083266|FG004|OLMP (Up to 96 Weeks)|Other|20|||
19633864|NCT00725985|42083267|FG005|OLMP (Up to 96 Weeks)|Other|44|||
19633865|NCT00725985|42083268|FG006|OLMP (Up to 96 Weeks)|Other|0|||
19711823|NCT00106353|42154864|FG002|Part 1|Disease progression|1|||
19711824|NCT00106353|42154865|FG003|Part 1|Disease progression|3|||
19711825|NCT00106353|42154866|FG004|Part 1|Disease progression|0|||
19711826|NCT00106353|42154867|FG005|Part 1|Disease progression|0|||
19711827|NCT00106353|42154868|FG006|Part 1|Disease progression|0|||
19711828|NCT00106353|42154862|FG000|Part 1|Withdrawal by Subject|0|||
19711829|NCT00106353|42154863|FG001|Part 1|Withdrawal by Subject|0|||
19711830|NCT00106353|42154864|FG002|Part 1|Withdrawal by Subject|1|||
19711831|NCT00106353|42154865|FG003|Part 1|Withdrawal by Subject|2|||
19711832|NCT00106353|42154866|FG004|Part 1|Withdrawal by Subject|0|||
19711833|NCT00106353|42154867|FG005|Part 1|Withdrawal by Subject|0|||
19711834|NCT00106353|42154868|FG006|Part 1|Withdrawal by Subject|0|||
19711835|NCT00106353|42154862|FG000|Part 1|Symptomatic deterioration|0|||
19458087|NCT01920061|41711805|FG014|Overall Study|Lost to Follow-up|0|||
19458088|NCT01920061|41711806|FG015|Overall Study|Lost to Follow-up|0|||
19458089|NCT01920061|41711807|FG016|Overall Study|Lost to Follow-up|0|||
19633866|NCT00725985|42083269|FG007|OLMP (Up to 96 Weeks)|Other|0|||
19633867|NCT00725985|42083270|FG008|OLMP (Up to 96 Weeks)|Other|0|||
19633868|NCT00725985|42083271|FG009|OLMP (Up to 96 Weeks)|Other|0|||
19633869|NCT00725985|42083272|FG010|OLMP (Up to 96 Weeks)|Other|0|||
19633870|NCT00725985|42083273|FG011|OLMP (Up to 96 Weeks)|Other|0|||
19633871|NCT00725985|42083262|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633872|NCT00725985|42083263|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633873|NCT00725985|42083264|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19711836|NCT00106353|42154863|FG001|Part 1|Symptomatic deterioration|0|||
19711837|NCT00106353|42154864|FG002|Part 1|Symptomatic deterioration|1|||
19711838|NCT00106353|42154865|FG003|Part 1|Symptomatic deterioration|0|||
19633874|NCT00725985|42083265|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633875|NCT00725985|42083266|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633876|NCT00725985|42083267|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633877|NCT00725985|42083268|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633878|NCT00725985|42083269|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
19633879|NCT00725985|42083270|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633880|NCT00725985|42083271|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633881|NCT00725985|42083272|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633882|NCT00725985|42083273|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
19633883|NCT00725985|42083262|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633884|NCT00725985|42083263|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633885|NCT00725985|42083264|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633886|NCT00725985|42083265|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633887|NCT00725985|42083266|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633888|NCT00725985|42083267|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633889|NCT00725985|42083268|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633890|NCT00725985|42083269|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633891|NCT00725985|42083270|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
19633892|NCT00725985|42083271|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633893|NCT00725985|42083272|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633894|NCT00725985|42083273|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
19633895|NCT00725985|42083262|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633896|NCT00725985|42083263|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19543243|NCT01165177|41992523|FG001|Overall Study|Migrated/ moved from study area|43|||
19543244|NCT01165138|41992540|FG000|Overall Study|Adverse Event|0|||
19543245|NCT01165138|41992541|FG001|Overall Study|Adverse Event|1|||
19543246|NCT01165138|41992542|FG002|Overall Study|Adverse Event|0|||
19633897|NCT00725985|42083264|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633898|NCT00725985|42083265|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633899|NCT00725985|42083266|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633900|NCT00725985|42083267|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633901|NCT00725985|42083268|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
19633902|NCT00725985|42083269|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
19633903|NCT00725985|42083270|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
19633904|NCT00725985|42083271|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19633905|NCT00725985|42083272|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19458090|NCT01920061|41711808|FG017|Overall Study|Lost to Follow-up|1|||
19633906|NCT00725985|42083273|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
19711839|NCT00106353|42154866|FG004|Part 1|Symptomatic deterioration|0|||
19711840|NCT00106353|42154867|FG005|Part 1|Symptomatic deterioration|0|||
19711841|NCT00106353|42154868|FG006|Part 1|Symptomatic deterioration|0|||
19711842|NCT00106353|42154862|FG000|Part 1|Entered follow-up phase|1|||
19711843|NCT00106353|42154863|FG001|Part 1|Entered follow-up phase|1|||
19711844|NCT00106353|42154864|FG002|Part 1|Entered follow-up phase|0|||
19711845|NCT00106353|42154865|FG003|Part 1|Entered follow-up phase|1|||
19711846|NCT00106353|42154866|FG004|Part 1|Entered follow-up phase|0|||
19711847|NCT00106353|42154867|FG005|Part 1|Entered follow-up phase|0|||
19711848|NCT00106353|42154868|FG006|Part 1|Entered follow-up phase|0|||
19711849|NCT00106353|42154862|FG000|Part 1|Adverse Event|0|||
19711850|NCT00106353|42154863|FG001|Part 1|Adverse Event|0|||
19711851|NCT00106353|42154864|FG002|Part 1|Adverse Event|0|||
19711852|NCT00106353|42154865|FG003|Part 1|Adverse Event|1|||
19711853|NCT00106353|42154866|FG004|Part 1|Adverse Event|0|||
19711854|NCT00106353|42154867|FG005|Part 1|Adverse Event|0|||
19711855|NCT00106353|42154868|FG006|Part 1|Adverse Event|0|||
19711856|NCT00106353|42154862|FG000|Part 2|Disease progression|0|||
19711857|NCT00106353|42154863|FG001|Part 2|Disease progression|0|||
19711858|NCT00106353|42154864|FG002|Part 2|Disease progression|0|||
19711859|NCT00106353|42154865|FG003|Part 2|Disease progression|0|||
19711860|NCT00106353|42154866|FG004|Part 2|Disease progression|8|||
19711861|NCT00106353|42154867|FG005|Part 2|Disease progression|14|||
19458091|NCT01920061|41711809|FG018|Overall Study|Lost to Follow-up|4|||
19458092|NCT01920061|41711810|FG019|Overall Study|Lost to Follow-up|3|||
19458093|NCT01920061|41711791|FG000|Overall Study|Other|1|||
19711862|NCT00106353|42154868|FG006|Part 2|Disease progression|13|||
19711863|NCT00106353|42154862|FG000|Part 2|Death|0|||
19711864|NCT00106353|42154863|FG001|Part 2|Death|0|||
19711865|NCT00106353|42154864|FG002|Part 2|Death|0|||
19711866|NCT00106353|42154865|FG003|Part 2|Death|0|||
19711867|NCT00106353|42154866|FG004|Part 2|Death|3|||
19711868|NCT00106353|42154867|FG005|Part 2|Death|0|||
19711869|NCT00106353|42154868|FG006|Part 2|Death|1|||
19375429|NCT02276560|41617372|FG001|Overall Study|Adverse Event|0|||
19375430|NCT02276560|41617373|FG002|Overall Study|Adverse Event|0|||
19375431|NCT02276482|41617383|FG000|Overall Study|Adverse Event|1|||
19375432|NCT02276482|41617384|FG001|Overall Study|Adverse Event|0|||
19375433|NCT02276482|41617383|FG000|Overall Study|Withdrawal by Subject|1|||
19375434|NCT02276482|41617384|FG001|Overall Study|Withdrawal by Subject|0|||
19543247|NCT01165138|41992543|FG003|Overall Study|Adverse Event|2|||
19543248|NCT01165138|41992540|FG000|Overall Study|Lack of Efficacy|0|||
19543249|NCT01165138|41992541|FG001|Overall Study|Lack of Efficacy|32|||
19633907|NCT00725985|42083262|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633908|NCT00725985|42083263|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633909|NCT00725985|42083264|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633910|NCT00725985|42083265|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633911|NCT00725985|42083266|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633912|NCT00725985|42083267|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633913|NCT00725985|42083268|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19458094|NCT01920061|41711792|FG001|Overall Study|Other|1|||
19458095|NCT01920061|41711793|FG002|Overall Study|Other|2|||
19458096|NCT01920061|41711794|FG003|Overall Study|Other|1|||
19458097|NCT01920061|41711795|FG004|Overall Study|Other|0|||
19458098|NCT01920061|41711796|FG005|Overall Study|Other|1|||
19633914|NCT00725985|42083269|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633915|NCT00725985|42083270|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
19633916|NCT00725985|42083271|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
19633917|NCT00725985|42083272|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
19633918|NCT00725985|42083273|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
19633919|NCT00793910|42083301|FG000|Overall Study|discarded study pills|0|||
19633920|NCT00793910|42083302|FG001|Overall Study|discarded study pills|1|||
19633921|NCT00793910|42083301|FG000|Overall Study|did not pick up medications|1|||
19633922|NCT00793910|42083302|FG001|Overall Study|did not pick up medications|1|||
19633923|NCT00793910|42083301|FG000|Overall Study|ineligible based on entry criteria|2|||
19633924|NCT00793910|42083302|FG001|Overall Study|ineligible based on entry criteria|3|||
19458099|NCT01920061|41711797|FG006|Overall Study|Other|0|||
19458100|NCT01920061|41711798|FG007|Overall Study|Other|0|||
19458101|NCT01920061|41711799|FG008|Overall Study|Other|0|||
19543250|NCT01165138|41992542|FG002|Overall Study|Lack of Efficacy|6|||
19543251|NCT01165138|41992543|FG003|Overall Study|Lack of Efficacy|7|||
19543252|NCT01165138|41992540|FG000|Overall Study|Protocol Violation|0|||
19543253|NCT01165138|41992541|FG001|Overall Study|Protocol Violation|7|||
19543254|NCT01165138|41992542|FG002|Overall Study|Protocol Violation|0|||
19543255|NCT01165138|41992543|FG003|Overall Study|Protocol Violation|2|||
19543256|NCT01165138|41992540|FG000|Overall Study|Lost to Follow-up|0|||
19543257|NCT01165138|41992541|FG001|Overall Study|Lost to Follow-up|0|||
19543258|NCT01165138|41992542|FG002|Overall Study|Lost to Follow-up|1|||
19543259|NCT01165138|41992543|FG003|Overall Study|Lost to Follow-up|2|||
19543260|NCT01165138|41992540|FG000|Overall Study|Physician Decision|0|||
19543261|NCT01165138|41992541|FG001|Overall Study|Physician Decision|6|||
19543262|NCT01165138|41992542|FG002|Overall Study|Physician Decision|7|||
19543263|NCT01165138|41992543|FG003|Overall Study|Physician Decision|6|||
19543264|NCT01165138|41992540|FG000|Overall Study|Withdrawal by Subject|0|||
19543265|NCT01165138|41992541|FG001|Overall Study|Withdrawal by Subject|6|||
19543266|NCT01165138|41992542|FG002|Overall Study|Withdrawal by Subject|6|||
19543267|NCT01165138|41992543|FG003|Overall Study|Withdrawal by Subject|3|||
19543268|NCT01165021|41992551|FG000|Overall Study|Death|1|||
19543269|NCT01182844|41992557|FG000|Overall Study|Withdrawal by Subject|0|||
19543270|NCT01182844|41992558|FG001|Overall Study|Withdrawal by Subject|2|||
19543271|NCT01164865|41992566|FG000|Overall Study|Lost to Follow-up|2|||
19543272|NCT01164865|41992567|FG001|Overall Study|Lost to Follow-up|1|||
19543273|NCT01164475|41992575|FG000|Overall Study|Lack of Efficacy|1|||
19543274|NCT01164475|41992576|FG001|Overall Study|Lack of Efficacy|0|||
19543275|NCT01164475|41992575|FG000|Overall Study|Other|0|||
19543276|NCT01164475|41992576|FG001|Overall Study|Other|1|||
19543277|NCT01164475|41992575|FG000|Overall Study|Progressive disease|0|||
19543278|NCT01164475|41992576|FG001|Overall Study|Progressive disease|1|||
19543279|NCT01164475|41992575|FG000|Overall Study|Protocol Violation|1|||
19543280|NCT01164475|41992576|FG001|Overall Study|Protocol Violation|0|||
19543281|NCT01164007|41992582|FG000|Overall Study|Adverse Event|5|||
19543282|NCT01164007|41992582|FG000|Overall Study|Progression of Disease|30|||
19543283|NCT01164007|41992582|FG000|Overall Study|Protocol Violation|1|||
19543284|NCT01164007|41992582|FG000|Overall Study|Withdrawal by Subject|1|||
19543285|NCT01164007|41992582|FG000|Overall Study|Medical Decision|3|||
19543286|NCT01163851|41992588|FG000|Overall Study|Site Closure|0|||
19543287|NCT01163851|41992589|FG001|Overall Study|Site Closure|1|||
19543288|NCT01163851|41992588|FG000|Overall Study|Enrolled but not treated|1|||
19543289|NCT01163851|41992589|FG001|Overall Study|Enrolled but not treated|0|||
19543290|NCT01163617|41992595|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19543291|NCT01163617|41992596|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
19543292|NCT01163617|41992597|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19711870|NCT00106353|42154862|FG000|Part 2|Symptomatic deterioration|0|||
19458102|NCT01920061|41711800|FG009|Overall Study|Other|1|||
19458103|NCT01920061|41711801|FG010|Overall Study|Other|1|||
19458104|NCT01920061|41711802|FG011|Overall Study|Other|2|||
19458105|NCT01920061|41711803|FG012|Overall Study|Other|1|||
19543293|NCT01163617|41992598|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19543294|NCT01163617|41992599|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19633925|NCT00793910|42083301|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
19633926|NCT00793910|42083302|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
19633927|NCT00793910|42083301|FG000|Overall Study|Withdrawal by Subject|0|||
19633928|NCT00793910|42083302|FG001|Overall Study|Withdrawal by Subject|1|||
19633929|NCT00444145|42083308|FG000|Overall Study|Withdrawal by Subject|2|||
19633930|NCT00444145|42083308|FG000|Overall Study|Lost to Follow-up|1|||
19633931|NCT00444145|42083308|FG000|Overall Study|non-compliant|11|||
19633932|NCT00444145|42083308|FG000|Overall Study|Screen Failures|5|||
19633933|NCT00725283|42083312|FG000|Overall Study|Missing Code|3|||
19633934|NCT00725283|42083312|FG000|Overall Study|Death|5|||
19633935|NCT00725283|42083312|FG000|Overall Study|Other|6|||
19633936|NCT00725283|42083312|FG000|Overall Study|Withdrawal by Subject|10|||
19633937|NCT00444067|42083318|FG000|Overall Study|Lost to Follow-up|0|||
19633938|NCT00444067|42083319|FG001|Overall Study|Lost to Follow-up|1|||
19633939|NCT00789854|42083328|FG000|Overall Study|Adverse Event|28|||
19633940|NCT00789854|42083329|FG001|Overall Study|Adverse Event|23|||
19633941|NCT00789854|42083330|FG002|Overall Study|Adverse Event|18|||
19633942|NCT00789854|42083328|FG000|Overall Study|Lost to Follow-up|1|||
19633943|NCT00789854|42083329|FG001|Overall Study|Lost to Follow-up|1|||
19633944|NCT00789854|42083330|FG002|Overall Study|Lost to Follow-up|4|||
19633945|NCT00789854|42083328|FG000|Overall Study|Withdrawal by Subject|9|||
19633946|NCT00789854|42083329|FG001|Overall Study|Withdrawal by Subject|6|||
19633947|NCT00789854|42083330|FG002|Overall Study|Withdrawal by Subject|17|||
19633948|NCT00789854|42083328|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
19633949|NCT00789854|42083329|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
19633950|NCT00789854|42083330|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
19633951|NCT00789854|42083328|FG000|Overall Study|Severe non-compliance to the protocol|3|||
19633952|NCT00789854|42083329|FG001|Overall Study|Severe non-compliance to the protocol|0|||
19633953|NCT00789854|42083330|FG002|Overall Study|Severe non-compliance to the protocol|0|||
19633954|NCT00789854|42083328|FG000|Overall Study|Safety reasons|0|||
19633955|NCT00789854|42083329|FG001|Overall Study|Safety reasons|0|||
19633956|NCT00789854|42083330|FG002|Overall Study|Safety reasons|2|||
19633957|NCT00789854|42083328|FG000|Overall Study|Other|6|||
19633958|NCT00789854|42083329|FG001|Overall Study|Other|0|||
19633959|NCT00789854|42083330|FG002|Overall Study|Other|5|||
19633960|NCT00725205|42083338|FG000|Overall Study|Adverse Event|22|||
19633961|NCT00725205|42083338|FG000|Overall Study|Investigator Discontinued|1|||
19633962|NCT00725205|42083338|FG000|Overall Study|Non-compliance With Protocol|14|||
19633963|NCT00725205|42083338|FG000|Overall Study|Other|8|||
19633964|NCT00725205|42083338|FG000|Overall Study|Protocol Defined Clinical Event|1|||
19633965|NCT00725205|42083338|FG000|Overall Study|Treatment Failure|41|||
19543295|NCT01163617|41992600|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19543296|NCT01163617|41992601|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19543297|NCT01163617|41992602|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
19543298|NCT01163617|41992595|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543299|NCT01163617|41992596|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
19543300|NCT01163617|41992597|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543301|NCT01163617|41992598|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543302|NCT01163617|41992599|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543303|NCT01163617|41992600|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19633966|NCT00443755|42083344|FG000|Overall Study|Withdrawal by Subject|2|||
19633967|NCT00443755|42083345|FG001|Overall Study|Withdrawal by Subject|1|||
19633968|NCT00724971|42083351|FG000|Overall Study|Adverse Event|5|||
19633969|NCT00724971|42083351|FG000|Overall Study|Withdrawal by Subject|1|||
19633970|NCT00443599|42083357|FG000|Overall Study|Physician Decision|2|||
19633971|NCT00443599|42083358|FG001|Overall Study|Physician Decision|1|||
19633972|NCT00443599|42083357|FG000|Overall Study|Death|1|||
19633973|NCT00443599|42083358|FG001|Overall Study|Death|1|||
19633974|NCT00443599|42083357|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
19633975|NCT00443599|42083358|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
19633976|NCT00455143|42083364|FG000|Overall Study|Physician Decision|1|||
19633977|NCT00455143|42083364|FG000|Overall Study|Withdrawal by Subject|1|||
19633978|NCT00455143|42083364|FG000|Overall Study|Staff was not avail to follow patient|2|||
19633979|NCT00455143|42083364|FG000|Overall Study|No longer met Inclusion Criteria|1|||
19633980|NCT00455143|42083364|FG000|Overall Study|Surgical time, staff not available|1|||
19633981|NCT00454987|42083372|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
19633982|NCT00454987|42083373|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
19633983|NCT00454987|42083374|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
19633984|NCT00454987|42083372|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
19633985|NCT00454987|42083373|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
19633986|NCT00454987|42083374|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
19633987|NCT00454987|42083372|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
19633988|NCT00454987|42083373|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
19633989|NCT00454987|42083374|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
19633990|NCT00724893|42083385|FG000|Overall Study|Adverse Event|76|||
19633991|NCT00724893|42083386|FG001|Overall Study|Adverse Event|142|||
19633992|NCT00724893|42083385|FG000|Overall Study|Withdrawal by Subject|0|||
19633993|NCT00724893|42083386|FG001|Overall Study|Withdrawal by Subject|1|||
19633994|NCT00724893|42083385|FG000|Overall Study|Lack of virologic response|94|||
19633995|NCT00724893|42083386|FG001|Overall Study|Lack of virologic response|202|||
19633996|NCT00724893|42083385|FG000|Overall Study|Reason not specified|193|||
19633997|NCT00724893|42083386|FG001|Overall Study|Reason not specified|7|||
19633998|NCT00724893|42083385|FG000|Overall Study|Patient choice|0|||
19633999|NCT00724893|42083386|FG001|Overall Study|Patient choice|26|||
19634000|NCT00724893|42083385|FG000|Overall Study|Geographic reasons|0|||
19634001|NCT00724893|42083386|FG001|Overall Study|Geographic reasons|11|||
19634002|NCT00724893|42083385|FG000|Overall Study|Incarceration|0|||
19634003|NCT00724893|42083386|FG001|Overall Study|Incarceration|9|||
19634004|NCT00724893|42083385|FG000|Overall Study|Substance abuse|0|||
19634005|NCT00724893|42083386|FG001|Overall Study|Substance abuse|3|||
19634006|NCT00724893|42083385|FG000|Overall Study|Financial reasons|0|||
19634007|NCT00724893|42083386|FG001|Overall Study|Financial reasons|2|||
19634008|NCT00724893|42083385|FG000|Overall Study|Assigned shorter treatment|0|||
19634009|NCT00724893|42083386|FG001|Overall Study|Assigned shorter treatment|2|||
19634010|NCT00724893|42083385|FG000|Overall Study|Lost to Follow-up|0|||
19634011|NCT00724893|42083386|FG001|Overall Study|Lost to Follow-up|52|||
19634012|NCT00724893|42083385|FG000|Overall Study|Unknown, missing data|1|||
19634013|NCT00724893|42083386|FG001|Overall Study|Unknown, missing data|1|||
19634014|NCT00789698|42083411|FG000|Overall Study|Lack of Efficacy|10|||
19634015|NCT00789698|42083412|FG001|Overall Study|Lack of Efficacy|4|||
19634016|NCT00789698|42083413|FG002|Overall Study|Lack of Efficacy|5|||
19634017|NCT00789698|42083414|FG003|Overall Study|Lack of Efficacy|18|||
19634018|NCT00789698|42083411|FG000|Overall Study|Adverse Event|5|||
19634019|NCT00789698|42083412|FG001|Overall Study|Adverse Event|5|||
19634020|NCT00789698|42083413|FG002|Overall Study|Adverse Event|3|||
19634021|NCT00789698|42083414|FG003|Overall Study|Adverse Event|4|||
19634022|NCT00789698|42083411|FG000|Overall Study|Lost to Follow-up|5|||
19634023|NCT00789698|42083412|FG001|Overall Study|Lost to Follow-up|5|||
19634024|NCT00789698|42083413|FG002|Overall Study|Lost to Follow-up|2|||
19634025|NCT00789698|42083414|FG003|Overall Study|Lost to Follow-up|9|||
19543304|NCT01163617|41992601|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543305|NCT01163617|41992602|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
19543306|NCT01163617|41992595|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543307|NCT01163617|41992596|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543308|NCT01163617|41992597|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
19543309|NCT01163617|41992598|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543310|NCT01163617|41992599|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543311|NCT01163617|41992600|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543312|NCT01163617|41992601|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19543313|NCT01163617|41992602|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
19634026|NCT00789698|42083411|FG000|Overall Study|Protocol Violation|6|||
19634027|NCT00789698|42083412|FG001|Overall Study|Protocol Violation|1|||
19634028|NCT00789698|42083413|FG002|Overall Study|Protocol Violation|2|||
19634029|NCT00789698|42083414|FG003|Overall Study|Protocol Violation|1|||
19634030|NCT00789698|42083411|FG000|Overall Study|Withdrawal by Subject|14|||
19634031|NCT00789698|42083412|FG001|Overall Study|Withdrawal by Subject|15|||
19634032|NCT00789698|42083413|FG002|Overall Study|Withdrawal by Subject|12|||
19458106|NCT01920061|41711804|FG013|Overall Study|Other|4|||
19458107|NCT01920061|41711805|FG014|Overall Study|Other|0|||
19458108|NCT01920061|41711806|FG015|Overall Study|Other|1|||
19458109|NCT01920061|41711807|FG016|Overall Study|Other|1|||
19458110|NCT01920061|41711808|FG017|Overall Study|Other|0|||
19458111|NCT01920061|41711809|FG018|Overall Study|Other|1|||
19458112|NCT01920061|41711810|FG019|Overall Study|Other|1|||
19458113|NCT01920061|41711791|FG000|Overall Study|Participant refused further follow-up|0|||
19458114|NCT01920061|41711792|FG001|Overall Study|Participant refused further follow-up|0|||
19634033|NCT00789698|42083414|FG003|Overall Study|Withdrawal by Subject|19|||
19634034|NCT00789698|42083411|FG000|Overall Study|Administrative|0|||
19634035|NCT00789698|42083412|FG001|Overall Study|Administrative|3|||
19634036|NCT00789698|42083413|FG002|Overall Study|Administrative|3|||
19634037|NCT00789698|42083414|FG003|Overall Study|Administrative|1|||
19634038|NCT00724815|42083425|FG000|Overall Study|Randomized, not treated|31|||
19634039|NCT00724815|42083426|FG001|Overall Study|Randomized, not treated|30|||
19634040|NCT00724815|42083425|FG000|Overall Study|Adverse Event|5|||
19634041|NCT00724815|42083426|FG001|Overall Study|Adverse Event|3|||
19458115|NCT01920061|41711793|FG002|Overall Study|Participant refused further follow-up|0|||
19634042|NCT00724815|42083425|FG000|Overall Study|Lost to Follow-up|4|||
19543314|NCT01182337|41992624|FG000|Overall Study|Withdrawal by Subject|3|||
19543315|NCT01182337|41992625|FG001|Overall Study|Withdrawal by Subject|1|||
19634043|NCT00724815|42083426|FG001|Overall Study|Lost to Follow-up|1|||
19634044|NCT00724815|42083425|FG000|Overall Study|Other Various|3|||
19634045|NCT00724815|42083426|FG001|Overall Study|Other Various|5|||
19634046|NCT00454909|42083435|FG000|Overall Study|Withdrawal by Subject|1|||
19634047|NCT00454909|42083436|FG001|Overall Study|Withdrawal by Subject|0|||
19634048|NCT00454909|42083437|FG002|Overall Study|Withdrawal by Subject|0|||
19634049|NCT00454909|42083435|FG000|Overall Study|Migrated/moved from study area|0|||
19634050|NCT00454909|42083436|FG001|Overall Study|Migrated/moved from study area|0|||
19543316|NCT01182337|41992624|FG000|Overall Study|Lost to Follow-up|0|||
19543317|NCT01182337|41992625|FG001|Overall Study|Lost to Follow-up|1|||
19543318|NCT01182298|41992632|FG000|Overall Study|Lack of Efficacy|4|||
19543319|NCT01182298|41992632|FG000|Overall Study|Withdrawal by Subject|2|||
19634051|NCT00454909|42083437|FG002|Overall Study|Migrated/moved from study area|1|||
19634052|NCT00454909|42083435|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
19634053|NCT00454909|42083436|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
19634054|NCT00454909|42083437|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
19634055|NCT00454909|42083435|FG000|Overall Study|Others|1|||
19634056|NCT00454909|42083436|FG001|Overall Study|Others|0|||
19634057|NCT00454909|42083437|FG002|Overall Study|Others|0|||
19634058|NCT00798590|42083448|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
19634059|NCT00798590|42083449|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
19634060|NCT00481195|42083457|FG000|Overall Study|Adverse Event|16|||
19634061|NCT00481195|42083458|FG001|Overall Study|Adverse Event|11|||
19634062|NCT00481195|42083457|FG000|Overall Study|Lack of Efficacy|1|||
19634063|NCT00481195|42083458|FG001|Overall Study|Lack of Efficacy|3|||
19634064|NCT00481195|42083457|FG000|Overall Study|Lost to Follow-up|4|||
19634065|NCT00481195|42083458|FG001|Overall Study|Lost to Follow-up|6|||
19634066|NCT00481195|42083457|FG000|Overall Study|Physician Decision|3|||
19634067|NCT00481195|42083458|FG001|Overall Study|Physician Decision|1|||
19634068|NCT00481195|42083457|FG000|Overall Study|Protocol Violation|10|||
19634069|NCT00481195|42083458|FG001|Overall Study|Protocol Violation|7|||
19634070|NCT00481195|42083457|FG000|Overall Study|Withdrawal by Subject|3|||
19634071|NCT00481195|42083458|FG001|Overall Study|Withdrawal by Subject|9|||
19634072|NCT00481195|42083457|FG000|Overall Study|Miscellaneous|2|||
19634073|NCT00481195|42083458|FG001|Overall Study|Miscellaneous|2|||
19543320|NCT01163266|41992639|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
19543321|NCT01163266|41992640|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
19543322|NCT01163266|41992641|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
19543323|NCT01163266|41992639|FG000|Overall Study|Lack of Efficacy|1|||
19543324|NCT01163266|41992640|FG001|Overall Study|Lack of Efficacy|3|||
19543325|NCT01163266|41992641|FG002|Overall Study|Lack of Efficacy|1|||
19543326|NCT01163266|41992639|FG000|Overall Study|Noncompliance with Study Drug|0|||
19543327|NCT01163266|41992640|FG001|Overall Study|Noncompliance with Study Drug|2|||
19543328|NCT01163266|41992641|FG002|Overall Study|Noncompliance with Study Drug|0|||
19543329|NCT01163266|41992639|FG000|Overall Study|Protocol Deviations|2|||
19543330|NCT01163266|41992640|FG001|Overall Study|Protocol Deviations|2|||
19543331|NCT01163266|41992641|FG002|Overall Study|Protocol Deviations|5|||
19543332|NCT01163266|41992639|FG000|Overall Study|Withdrawal of Consent|5|||
19543333|NCT01163266|41992640|FG001|Overall Study|Withdrawal of Consent|7|||
19543334|NCT01163266|41992641|FG002|Overall Study|Withdrawal of Consent|3|||
19543335|NCT01163266|41992639|FG000|Overall Study|Lost to Follow-up|7|||
19543336|NCT01163266|41992640|FG001|Overall Study|Lost to Follow-up|7|||
19543337|NCT01163266|41992641|FG002|Overall Study|Lost to Follow-up|10|||
19543338|NCT01163266|41992639|FG000|Overall Study|Other|1|||
19543339|NCT01163266|41992640|FG001|Overall Study|Other|1|||
19543340|NCT01163266|41992641|FG002|Overall Study|Other|2|||
19543341|NCT01163149|41992703|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
19543342|NCT01163149|41992704|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
19543343|NCT01163149|41992705|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
19543344|NCT01163149|41992703|FG000|Extension Treatment Period|Adverse Event|0|||
19543345|NCT01163149|41992704|FG001|Extension Treatment Period|Adverse Event|1|||
19543346|NCT01163149|41992705|FG002|Extension Treatment Period|Adverse Event|0|||
19543347|NCT01163149|41992703|FG000|Extension Treatment Period|Noncompliance|0|||
19543348|NCT01163149|41992704|FG001|Extension Treatment Period|Noncompliance|0|||
19634074|NCT00454363|42083475|FG000|Overall Study|Adverse Event|1|||
19634075|NCT00454363|42083476|FG001|Overall Study|Adverse Event|2|||
19634076|NCT00454363|42083475|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
19634077|NCT00454363|42083476|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
19634078|NCT00454207|42083483|FG000|Overall Study|Adverse Event|3|||
19634079|NCT00454207|42083484|FG001|Overall Study|Adverse Event|1|||
19634080|NCT00454207|42083483|FG000|Overall Study|Lack of Efficacy|1|||
19543349|NCT01163149|41992705|FG002|Extension Treatment Period|Noncompliance|1|||
19543350|NCT01163032|41992730|FG000|Randomization Phase|Withdrawal by Subject|2|||
19543351|NCT01163032|41992731|FG001|Randomization Phase|Withdrawal by Subject|3|||
19543352|NCT01163032|41992732|FG002|Randomization Phase|Withdrawal by Subject|0|||
19543353|NCT01163032|41992730|FG000|Randomization Phase|Adverse Event|3|||
19543354|NCT01163032|41992731|FG001|Randomization Phase|Adverse Event|3|||
19543355|NCT01163032|41992732|FG002|Randomization Phase|Adverse Event|0|||
19543356|NCT01163032|41992730|FG000|Randomization Phase|Protocol Violation|0|||
19543357|NCT01163032|41992731|FG001|Randomization Phase|Protocol Violation|1|||
19543358|NCT01163032|41992732|FG002|Randomization Phase|Protocol Violation|0|||
19543359|NCT01163032|41992730|FG000|Randomization Phase|Various*|5|||
19634081|NCT00454207|42083484|FG001|Overall Study|Lack of Efficacy|0|||
19634082|NCT00454207|42083483|FG000|Overall Study|Protocol Violation|0|||
19634083|NCT00454207|42083484|FG001|Overall Study|Protocol Violation|1|||
19634084|NCT00738894|42083504|FG000|Overall Study|Lost to Follow-up|23|||
19634085|NCT00738894|42083505|FG001|Overall Study|Lost to Follow-up|13|||
19634086|NCT00738894|42083504|FG000|Overall Study|Withdrawal by Subject|10|||
19634087|NCT00738894|42083505|FG001|Overall Study|Withdrawal by Subject|15|||
19634088|NCT00738894|42083504|FG000|Overall Study|Physician Decision|4|||
19634089|NCT00738894|42083505|FG001|Overall Study|Physician Decision|5|||
19634090|NCT00738894|42083504|FG000|Overall Study|Death|2|||
19634091|NCT00738894|42083505|FG001|Overall Study|Death|0|||
19634092|NCT00480493|42083513|FG000|Overall Study|moved|2|||
19634093|NCT00480493|42083514|FG001|Overall Study|moved|7|||
19634094|NCT00734994|42083522|FG000|Overall Study|Withdrawal by Subject|1|||
19634095|NCT00798434|42083529|FG000|Double-Blind|Adverse Event|22|||
19634096|NCT00798434|42083530|FG001|Double-Blind|Adverse Event|46|||
19634097|NCT00798434|42083529|FG000|Double-Blind|Death|0|||
19634098|NCT00798434|42083530|FG001|Double-Blind|Death|1|||
19634099|NCT00798434|42083529|FG000|Double-Blind|Lost to Follow-up|1|||
19634100|NCT00798434|42083530|FG001|Double-Blind|Lost to Follow-up|0|||
19634101|NCT00798434|42083529|FG000|Double-Blind|Lack of Efficacy|8|||
19634102|NCT00798434|42083530|FG001|Double-Blind|Lack of Efficacy|12|||
19634103|NCT00798434|42083529|FG000|Double-Blind|Withdrawal by Subject|17|||
19634104|NCT00798434|42083530|FG001|Double-Blind|Withdrawal by Subject|14|||
19634105|NCT00798434|42083529|FG000|Double-Blind|Protocol Violation|1|||
19634106|NCT00798434|42083530|FG001|Double-Blind|Protocol Violation|4|||
19634107|NCT00798434|42083529|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
19634108|NCT00798434|42083530|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
19634109|NCT00798434|42083529|FG000|Double-Blind|Other|1|||
19634110|NCT00798434|42083530|FG001|Double-Blind|Other|0|||
19634111|NCT00798434|42083529|FG000|Double-Blind|Not Treated|3|||
19634112|NCT00798434|42083530|FG001|Double-Blind|Not Treated|6|||
19634113|NCT00798434|42083529|FG000|Open-Label|Adverse Event|33|||
19634114|NCT00798434|42083530|FG001|Open-Label|Adverse Event|11|||
19634115|NCT00798434|42083529|FG000|Open-Label|Lack of Efficacy|5|||
19634116|NCT00798434|42083530|FG001|Open-Label|Lack of Efficacy|11|||
19634117|NCT00798434|42083529|FG000|Open-Label|Withdrawal by Subject|2|||
19634118|NCT00798434|42083530|FG001|Open-Label|Withdrawal by Subject|7|||
19634119|NCT00798434|42083529|FG000|Open-Label|Protocol Violation|1|||
19634120|NCT00798434|42083530|FG001|Open-Label|Protocol Violation|0|||
19634121|NCT00798434|42083529|FG000|Open-Label|Other|1|||
19634122|NCT00798434|42083530|FG001|Open-Label|Other|2|||
19634123|NCT00798434|42083529|FG000|Open-Label|Not Treated|0|||
19634124|NCT00798434|42083530|FG001|Open-Label|Not Treated|1|||
19634125|NCT00724503|42083543|FG000|Overall Study|Lost to Follow-up|4|||
19634126|NCT00724503|42083544|FG001|Overall Study|Lost to Follow-up|8|||
19634127|NCT00724503|42083543|FG000|Overall Study|Withdrawal by Subject|11|||
19634128|NCT00724503|42083544|FG001|Overall Study|Withdrawal by Subject|23|||
19634129|NCT00724503|42083543|FG000|Overall Study|Death|190|||
19634130|NCT00724503|42083544|FG001|Overall Study|Death|182|||
19634131|NCT00724503|42083543|FG000|Overall Study|Adverse Event|1|||
19634132|NCT00724503|42083544|FG001|Overall Study|Adverse Event|0|||
19634133|NCT00724503|42083543|FG000|Overall Study|Not otherwise specified|4|||
19634134|NCT00724503|42083544|FG001|Overall Study|Not otherwise specified|7|||
19634135|NCT00791648|42083554|FG000|Overall Study|Physician Decision|0|||
19634136|NCT00791648|42083555|FG001|Overall Study|Physician Decision|1|||
19634137|NCT00791648|42083554|FG000|Overall Study|Withdrawal by Subject|0|||
19634138|NCT00791648|42083555|FG001|Overall Study|Withdrawal by Subject|1|||
19634139|NCT00791492|42083563|FG000|Overall Study|Withdrawal by Subject|1|||
19634140|NCT00791492|42083564|FG001|Overall Study|Withdrawal by Subject|2|||
19711871|NCT00106353|42154863|FG001|Part 2|Symptomatic deterioration|0|||
19634141|NCT00791492|42083563|FG000|Overall Study|Liver transplantation|5|||
19634142|NCT00791492|42083564|FG001|Overall Study|Liver transplantation|1|||
19634143|NCT00723957|42083572|FG000|Overall Study|Adverse event unrelated to study drug|1|||
19634144|NCT00723957|42083573|FG001|Overall Study|Adverse event unrelated to study drug|4|||
19543360|NCT01163032|41992731|FG001|Randomization Phase|Various*|4|||
19543361|NCT01163032|41992732|FG002|Randomization Phase|Various*|0|||
19634145|NCT00723957|42083572|FG000|Overall Study|Death|3|||
19634146|NCT00723957|42083573|FG001|Overall Study|Death|4|||
19634147|NCT00723957|42083572|FG000|Overall Study|Disease progression|27|||
19634148|NCT00723957|42083573|FG001|Overall Study|Disease progression|25|||
19634149|NCT00723957|42083572|FG000|Overall Study|Maximum clinical benefit|4|||
19634150|NCT00723957|42083573|FG001|Overall Study|Maximum clinical benefit|5|||
19634151|NCT00723957|42083572|FG000|Overall Study|Investigator decision|1|||
19634152|NCT00723957|42083573|FG001|Overall Study|Investigator decision|1|||
19634153|NCT00723957|42083572|FG000|Overall Study|Study drug toxicity|4|||
19634154|NCT00723957|42083573|FG001|Overall Study|Study drug toxicity|6|||
19634155|NCT00723957|42083572|FG000|Overall Study|Withdrawal by Subject|7|||
19634156|NCT00723957|42083573|FG001|Overall Study|Withdrawal by Subject|5|||
19634157|NCT00723957|42083572|FG000|Overall Study|Reason not analyzed|1|||
19634158|NCT00723957|42083573|FG001|Overall Study|Reason not analyzed|0|||
19634159|NCT00723957|42083572|FG000|Overall Study|Never received treatment|3|||
19634160|NCT00723957|42083573|FG001|Overall Study|Never received treatment|3|||
19634161|NCT00723801|42083581|FG000|Overall Study|Lost to Follow-up|1|||
19634162|NCT00723801|42083582|FG001|Overall Study|Lost to Follow-up|2|||
19634163|NCT00723801|42083581|FG000|Overall Study|Protocol Violation|2|||
19634164|NCT00723801|42083582|FG001|Overall Study|Protocol Violation|1|||
19634165|NCT00797966|42083592|FG000|Phase A|Lost to Follow-up|0|||
19634166|NCT00797966|42083593|FG001|Phase A|Lost to Follow-up|0|||
19634167|NCT00797966|42083594|FG002|Phase A|Lost to Follow-up|0|||
19634168|NCT00797966|42083595|FG003|Phase A|Lost to Follow-up|0|||
19634169|NCT00797966|42083596|FG004|Phase A|Lost to Follow-up|33|||
19634170|NCT00797966|42083597|FG005|Phase A|Lost to Follow-up|0|||
19634171|NCT00797966|42083592|FG000|Phase A|Adverse Event|0|||
19634172|NCT00797966|42083593|FG001|Phase A|Adverse Event|0|||
19634173|NCT00797966|42083594|FG002|Phase A|Adverse Event|0|||
19634174|NCT00797966|42083595|FG003|Phase A|Adverse Event|0|||
19634175|NCT00797966|42083596|FG004|Phase A|Adverse Event|46|||
19634176|NCT00797966|42083597|FG005|Phase A|Adverse Event|0|||
19634177|NCT00797966|42083592|FG000|Phase A|Met withdrawal criteria|0|||
19634178|NCT00797966|42083593|FG001|Phase A|Met withdrawal criteria|0|||
19634179|NCT00797966|42083594|FG002|Phase A|Met withdrawal criteria|0|||
19634180|NCT00797966|42083595|FG003|Phase A|Met withdrawal criteria|0|||
19543362|NCT01163032|41992730|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
19543363|NCT01163032|41992731|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
19634181|NCT00797966|42083596|FG004|Phase A|Met withdrawal criteria|4|||
19543364|NCT01163032|41992732|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
19543365|NCT01163032|41992730|FG000|Open Label Extension Phase|Adverse Event|0|||
19543366|NCT01163032|41992731|FG001|Open Label Extension Phase|Adverse Event|0|||
19543367|NCT01163032|41992732|FG002|Open Label Extension Phase|Adverse Event|3|||
19543368|NCT01163032|41992730|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
19543369|NCT01163032|41992731|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
19634182|NCT00797966|42083597|FG005|Phase A|Met withdrawal criteria|0|||
19634183|NCT00797966|42083592|FG000|Phase A|Physician Decision|0|||
19634184|NCT00797966|42083593|FG001|Phase A|Physician Decision|0|||
19634185|NCT00797966|42083594|FG002|Phase A|Physician Decision|0|||
19634186|NCT00797966|42083595|FG003|Phase A|Physician Decision|0|||
19634187|NCT00797966|42083596|FG004|Phase A|Physician Decision|13|||
19634188|NCT00797966|42083597|FG005|Phase A|Physician Decision|0|||
19634189|NCT00797966|42083592|FG000|Phase A|Withdrawal by Subject|0|||
19634190|NCT00797966|42083593|FG001|Phase A|Withdrawal by Subject|0|||
19634191|NCT00797966|42083594|FG002|Phase A|Withdrawal by Subject|0|||
19634192|NCT00797966|42083595|FG003|Phase A|Withdrawal by Subject|0|||
19634193|NCT00797966|42083596|FG004|Phase A|Withdrawal by Subject|33|||
19634194|NCT00797966|42083597|FG005|Phase A|Withdrawal by Subject|0|||
19634195|NCT00797966|42083592|FG000|Phase A|Protocol deviation|0|||
19634196|NCT00797966|42083593|FG001|Phase A|Protocol deviation|0|||
19634197|NCT00797966|42083594|FG002|Phase A|Protocol deviation|0|||
19634198|NCT00797966|42083595|FG003|Phase A|Protocol deviation|0|||
19634199|NCT00797966|42083596|FG004|Phase A|Protocol deviation|56|||
19634200|NCT00797966|42083597|FG005|Phase A|Protocol deviation|0|||
19634201|NCT00797966|42083592|FG000|Phase B|Lost to Follow-up|0|||
19543370|NCT01163032|41992732|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
19543371|NCT01163032|41992730|FG000|Open Label Extension Phase|Protocol Violation|0|||
19634202|NCT00797966|42083593|FG001|Phase B|Lost to Follow-up|1|||
19634203|NCT00797966|42083594|FG002|Phase B|Lost to Follow-up|3|||
19634204|NCT00797966|42083595|FG003|Phase B|Lost to Follow-up|0|||
19634205|NCT00797966|42083596|FG004|Phase B|Lost to Follow-up|0|||
19634206|NCT00797966|42083597|FG005|Phase B|Lost to Follow-up|0|||
19634207|NCT00797966|42083592|FG000|Phase B|Adverse Event|2|||
19634208|NCT00797966|42083593|FG001|Phase B|Adverse Event|1|||
19634209|NCT00797966|42083594|FG002|Phase B|Adverse Event|3|||
19634210|NCT00797966|42083595|FG003|Phase B|Adverse Event|1|||
19634211|NCT00797966|42083596|FG004|Phase B|Adverse Event|0|||
19634212|NCT00797966|42083597|FG005|Phase B|Adverse Event|0|||
19634213|NCT00797966|42083592|FG000|Phase B|Met Withdrawal Criteria|3|||
19634214|NCT00797966|42083593|FG001|Phase B|Met Withdrawal Criteria|3|||
19634215|NCT00797966|42083594|FG002|Phase B|Met Withdrawal Criteria|6|||
19634216|NCT00797966|42083595|FG003|Phase B|Met Withdrawal Criteria|1|||
19634217|NCT00797966|42083596|FG004|Phase B|Met Withdrawal Criteria|0|||
19634218|NCT00797966|42083597|FG005|Phase B|Met Withdrawal Criteria|0|||
19634219|NCT00797966|42083592|FG000|Phase B|Physician Decision|1|||
19634220|NCT00797966|42083593|FG001|Phase B|Physician Decision|0|||
19634221|NCT00797966|42083594|FG002|Phase B|Physician Decision|3|||
19634222|NCT00797966|42083595|FG003|Phase B|Physician Decision|1|||
19634223|NCT00797966|42083596|FG004|Phase B|Physician Decision|0|||
19634224|NCT00797966|42083597|FG005|Phase B|Physician Decision|0|||
19634225|NCT00797966|42083592|FG000|Phase B|Withdrawal by Subject|1|||
19634226|NCT00797966|42083593|FG001|Phase B|Withdrawal by Subject|4|||
19634227|NCT00797966|42083594|FG002|Phase B|Withdrawal by Subject|3|||
19634228|NCT00797966|42083595|FG003|Phase B|Withdrawal by Subject|3|||
19634229|NCT00797966|42083596|FG004|Phase B|Withdrawal by Subject|0|||
19634230|NCT00797966|42083597|FG005|Phase B|Withdrawal by Subject|0|||
19634231|NCT00797966|42083592|FG000|Phase B|Protocol Deviation|4|||
19634232|NCT00797966|42083593|FG001|Phase B|Protocol Deviation|8|||
19634233|NCT00797966|42083594|FG002|Phase B|Protocol Deviation|2|||
19634234|NCT00797966|42083595|FG003|Phase B|Protocol Deviation|6|||
19634235|NCT00797966|42083596|FG004|Phase B|Protocol Deviation|0|||
19634236|NCT00797966|42083597|FG005|Phase B|Protocol Deviation|0|||
19634237|NCT00797966|42083592|FG000|Phase B|Lack of Efficacy|0|||
19634238|NCT00797966|42083593|FG001|Phase B|Lack of Efficacy|1|||
19711872|NCT00106353|42154864|FG002|Part 2|Symptomatic deterioration|0|||
19711873|NCT00106353|42154865|FG003|Part 2|Symptomatic deterioration|0|||
19711874|NCT00106353|42154866|FG004|Part 2|Symptomatic deterioration|3|||
19711875|NCT00106353|42154867|FG005|Part 2|Symptomatic deterioration|0|||
19711876|NCT00106353|42154868|FG006|Part 2|Symptomatic deterioration|0|||
19711877|NCT00106353|42154862|FG000|Part 2|Adverse Event|0|||
19711878|NCT00106353|42154863|FG001|Part 2|Adverse Event|0|||
19711879|NCT00106353|42154864|FG002|Part 2|Adverse Event|0|||
19634239|NCT00797966|42083594|FG002|Phase B|Lack of Efficacy|1|||
19634240|NCT00797966|42083595|FG003|Phase B|Lack of Efficacy|4|||
19634241|NCT00797966|42083596|FG004|Phase B|Lack of Efficacy|0|||
19634242|NCT00797966|42083597|FG005|Phase B|Lack of Efficacy|0|||
19634243|NCT00797966|42083592|FG000|Phase A+|Lost to Follow-up|0|||
19634244|NCT00797966|42083593|FG001|Phase A+|Lost to Follow-up|0|||
19634245|NCT00797966|42083594|FG002|Phase A+|Lost to Follow-up|0|||
19634246|NCT00797966|42083595|FG003|Phase A+|Lost to Follow-up|0|||
19634247|NCT00797966|42083596|FG004|Phase A+|Lost to Follow-up|0|||
19634248|NCT00797966|42083597|FG005|Phase A+|Lost to Follow-up|9|||
19634249|NCT00797966|42083592|FG000|Phase A+|Met withdrawal criteria|0|||
19634250|NCT00797966|42083593|FG001|Phase A+|Met withdrawal criteria|0|||
19634251|NCT00797966|42083594|FG002|Phase A+|Met withdrawal criteria|0|||
19634252|NCT00797966|42083595|FG003|Phase A+|Met withdrawal criteria|0|||
19634253|NCT00797966|42083596|FG004|Phase A+|Met withdrawal criteria|0|||
19634254|NCT00797966|42083597|FG005|Phase A+|Met withdrawal criteria|5|||
19634255|NCT00797966|42083592|FG000|Phase A+|Withdrawal by Subject|0|||
19634256|NCT00797966|42083593|FG001|Phase A+|Withdrawal by Subject|0|||
19634257|NCT00797966|42083594|FG002|Phase A+|Withdrawal by Subject|0|||
19634258|NCT00797966|42083595|FG003|Phase A+|Withdrawal by Subject|0|||
19634259|NCT00797966|42083596|FG004|Phase A+|Withdrawal by Subject|0|||
19634260|NCT00797966|42083597|FG005|Phase A+|Withdrawal by Subject|6|||
19634261|NCT00797966|42083592|FG000|Phase A+|Adverse Event|0|||
19634262|NCT00797966|42083593|FG001|Phase A+|Adverse Event|0|||
19711880|NCT00106353|42154865|FG003|Part 2|Adverse Event|0|||
19711881|NCT00106353|42154866|FG004|Part 2|Adverse Event|0|||
19634263|NCT00797966|42083594|FG002|Phase A+|Adverse Event|0|||
19634264|NCT00797966|42083595|FG003|Phase A+|Adverse Event|0|||
19711882|NCT00106353|42154867|FG005|Part 2|Adverse Event|2|||
19711883|NCT00106353|42154868|FG006|Part 2|Adverse Event|1|||
19711884|NCT00106353|42154862|FG000|Part 2|Other|0|||
19711885|NCT00106353|42154863|FG001|Part 2|Other|0|||
19711886|NCT00106353|42154864|FG002|Part 2|Other|0|||
19711887|NCT00106353|42154865|FG003|Part 2|Other|0|||
19711888|NCT00106353|42154866|FG004|Part 2|Other|1|||
19711889|NCT00106353|42154867|FG005|Part 2|Other|1|||
19711890|NCT00106353|42154868|FG006|Part 2|Other|1|||
19711891|NCT00106353|42154862|FG000|Part 2|Withdrawal by Subject|0|||
19634265|NCT00797966|42083596|FG004|Phase A+|Adverse Event|0|||
19634266|NCT00797966|42083597|FG005|Phase A+|Adverse Event|4|||
19634267|NCT00797966|42083592|FG000|Phase A+|Protocol deviation|0|||
19711892|NCT00106353|42154863|FG001|Part 2|Withdrawal by Subject|0|||
19711893|NCT00106353|42154864|FG002|Part 2|Withdrawal by Subject|0|||
19711894|NCT00106353|42154865|FG003|Part 2|Withdrawal by Subject|0|||
19711895|NCT00106353|42154866|FG004|Part 2|Withdrawal by Subject|1|||
19711896|NCT00106353|42154867|FG005|Part 2|Withdrawal by Subject|0|||
19711897|NCT00106353|42154868|FG006|Part 2|Withdrawal by Subject|0|||
19711898|NCT00106353|42154862|FG000|Part 2|Physician Decision|0|||
19634268|NCT00797966|42083593|FG001|Phase A+|Protocol deviation|0|||
19634269|NCT00797966|42083594|FG002|Phase A+|Protocol deviation|0|||
19634270|NCT00797966|42083595|FG003|Phase A+|Protocol deviation|0|||
19634271|NCT00797966|42083596|FG004|Phase A+|Protocol deviation|0|||
19634272|NCT00797966|42083597|FG005|Phase A+|Protocol deviation|4|||
19634273|NCT00723489|42083613|FG000|Overall Study|Physician Decision|0|||
19634274|NCT00723489|42083614|FG001|Overall Study|Physician Decision|1|||
19711899|NCT00106353|42154863|FG001|Part 2|Physician Decision|0|||
19711900|NCT00106353|42154864|FG002|Part 2|Physician Decision|0|||
19634275|NCT00723489|42083615|FG002|Overall Study|Physician Decision|0|||
19634276|NCT00723489|42083616|FG003|Overall Study|Physician Decision|0|||
19634277|NCT00723489|42083613|FG000|Overall Study|Pregnancy|0|||
19634278|NCT00723489|42083614|FG001|Overall Study|Pregnancy|0|||
19634279|NCT00723489|42083615|FG002|Overall Study|Pregnancy|0|||
19634280|NCT00723489|42083616|FG003|Overall Study|Pregnancy|1|||
19634281|NCT00723489|42083613|FG000|Overall Study|Withdrawal by Subject|0|||
19543372|NCT01163032|41992731|FG001|Open Label Extension Phase|Protocol Violation|0|||
19543373|NCT01163032|41992732|FG002|Open Label Extension Phase|Protocol Violation|1|||
19543374|NCT01163032|41992730|FG000|Open Label Extension Phase|Study Termination|0|||
19543375|NCT01163032|41992731|FG001|Open Label Extension Phase|Study Termination|0|||
19543376|NCT01163032|41992732|FG002|Open Label Extension Phase|Study Termination|7|||
19543377|NCT01163032|41992730|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
19543378|NCT01163032|41992731|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
19543379|NCT01163032|41992732|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
19634282|NCT00723489|42083614|FG001|Overall Study|Withdrawal by Subject|0|||
19458116|NCT01920061|41711794|FG003|Overall Study|Participant refused further follow-up|0|||
19458117|NCT01920061|41711795|FG004|Overall Study|Participant refused further follow-up|1|||
19458118|NCT01920061|41711796|FG005|Overall Study|Participant refused further follow-up|1|||
19458119|NCT01920061|41711797|FG006|Overall Study|Participant refused further follow-up|0|||
19458120|NCT01920061|41711798|FG007|Overall Study|Participant refused further follow-up|0|||
19458121|NCT01920061|41711799|FG008|Overall Study|Participant refused further follow-up|1|||
19458122|NCT01920061|41711800|FG009|Overall Study|Participant refused further follow-up|0|||
19458123|NCT01920061|41711801|FG010|Overall Study|Participant refused further follow-up|1|||
19458124|NCT01920061|41711802|FG011|Overall Study|Participant refused further follow-up|0|||
19458125|NCT01920061|41711803|FG012|Overall Study|Participant refused further follow-up|1|||
19458126|NCT01920061|41711804|FG013|Overall Study|Participant refused further follow-up|0|||
19458127|NCT01920061|41711805|FG014|Overall Study|Participant refused further follow-up|1|||
19458128|NCT01920061|41711806|FG015|Overall Study|Participant refused further follow-up|2|||
19458129|NCT01920061|41711807|FG016|Overall Study|Participant refused further follow-up|1|||
19458130|NCT01920061|41711808|FG017|Overall Study|Participant refused further follow-up|1|||
19458131|NCT01920061|41711809|FG018|Overall Study|Participant refused further follow-up|0|||
19458132|NCT01920061|41711810|FG019|Overall Study|Participant refused further follow-up|0|||
19458133|NCT01426425|41711873|FG000|Overall Study|Exited prior to EP study|22|||
19458134|NCT01426425|41711873|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
19458135|NCT01426425|41711873|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
19458136|NCT01426347|41711886|FG000|Overall Study|Lost to Follow-up|0|||
19458137|NCT01426347|41711887|FG001|Overall Study|Lost to Follow-up|3|||
19458138|NCT01426347|41711886|FG000|Overall Study|Protocol Violation|2|||
19458139|NCT01426347|41711887|FG001|Overall Study|Protocol Violation|0|||
19458140|NCT01426347|41711886|FG000|Overall Study|Withdrawal by Subject|5|||
19458141|NCT01426347|41711887|FG001|Overall Study|Withdrawal by Subject|0|||
19458142|NCT01882465|41711893|FG000|Period 1|Lens Discomfort|0|||
19458143|NCT01882465|41711894|FG001|Period 1|Lens Discomfort|0|||
19458144|NCT01882465|41711895|FG002|Period 1|Lens Discomfort|0|||
19458145|NCT01882465|41711896|FG003|Period 1|Lens Discomfort|1|||
19458146|NCT01882465|41711897|FG004|Period 1|Lens Discomfort|0|||
19458147|NCT01882465|41711898|FG005|Period 1|Lens Discomfort|0|||
19458148|NCT01882465|41711899|FG006|Period 1|Lens Discomfort|0|||
19458149|NCT01882465|41711893|FG000|Period 1|Withdrawal by Subject|0|||
19458150|NCT01882465|41711894|FG001|Period 1|Withdrawal by Subject|0|||
19458151|NCT01882465|41711895|FG002|Period 1|Withdrawal by Subject|0|||
19458152|NCT01882465|41711896|FG003|Period 1|Withdrawal by Subject|0|||
19458153|NCT01882465|41711897|FG004|Period 1|Withdrawal by Subject|0|||
19458154|NCT01882465|41711898|FG005|Period 1|Withdrawal by Subject|0|||
19458155|NCT01882465|41711899|FG006|Period 1|Withdrawal by Subject|1|||
19458156|NCT01882465|41711893|FG000|Period 2|Protocol Violation|0|||
19458157|NCT01882465|41711894|FG001|Period 2|Protocol Violation|0|||
19458158|NCT01882465|41711895|FG002|Period 2|Protocol Violation|0|||
19543380|NCT01162486|41992745|FG000|Overall Study|low ANC|1|||
19543381|NCT01162486|41992746|FG001|Overall Study|low ANC|0|||
19543382|NCT01162486|41992747|FG002|Overall Study|low ANC|0|||
19458159|NCT01882465|41711896|FG003|Period 2|Protocol Violation|0|||
19458160|NCT01882465|41711897|FG004|Period 2|Protocol Violation|1|||
19458161|NCT01882465|41711898|FG005|Period 2|Protocol Violation|0|||
19458162|NCT01882465|41711899|FG006|Period 2|Protocol Violation|0|||
19458163|NCT01426269|41711907|FG000|Period 1: 12 Weeks|Adverse Event|5|||
19458164|NCT01426269|41711908|FG001|Period 1: 12 Weeks|Adverse Event|0|||
19634283|NCT00723489|42083615|FG002|Overall Study|Withdrawal by Subject|0|||
19634284|NCT00723489|42083616|FG003|Overall Study|Withdrawal by Subject|1|||
19458165|NCT01426269|41711909|FG002|Period 1: 12 Weeks|Adverse Event|0|||
19458166|NCT01426269|41711907|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
19458167|NCT01426269|41711908|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
19543383|NCT01162486|41992748|FG003|Overall Study|low ANC|0|||
19543384|NCT01162486|41992749|FG004|Overall Study|low ANC|0|||
19543385|NCT01162486|41992745|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
19543386|NCT01162486|41992746|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
19543387|NCT01162486|41992747|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
19543388|NCT01162486|41992748|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
19634285|NCT00723489|42083613|FG000|Overall Study|Seropositive at baseline|1|||
19634286|NCT00723489|42083614|FG001|Overall Study|Seropositive at baseline|0|||
19634287|NCT00723489|42083615|FG002|Overall Study|Seropositive at baseline|0|||
19634288|NCT00723489|42083616|FG003|Overall Study|Seropositive at baseline|0|||
19543389|NCT01162486|41992749|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
19543390|NCT01162486|41992745|FG000|Overall Study|elevated LFTs|0|||
19543391|NCT01162486|41992746|FG001|Overall Study|elevated LFTs|0|||
19543392|NCT01162486|41992747|FG002|Overall Study|elevated LFTs|1|||
19543393|NCT01162486|41992748|FG003|Overall Study|elevated LFTs|0|||
19634289|NCT00723489|42083613|FG000|Overall Study|Prohibited Medication|0|||
19634290|NCT00723489|42083614|FG001|Overall Study|Prohibited Medication|0|||
19634291|NCT00723489|42083615|FG002|Overall Study|Prohibited Medication|0|||
19634292|NCT00723489|42083616|FG003|Overall Study|Prohibited Medication|1|||
19634293|NCT00723489|42083613|FG000|Overall Study|Samples Collected Out of Window|0|||
19634294|NCT00723489|42083614|FG001|Overall Study|Samples Collected Out of Window|3|||
19634295|NCT00723489|42083615|FG002|Overall Study|Samples Collected Out of Window|0|||
19634296|NCT00723489|42083616|FG003|Overall Study|Samples Collected Out of Window|0|||
19634297|NCT00587990|42083629|FG000|Overall Study|Death|0|||
19634298|NCT00587990|42083630|FG001|Overall Study|Death|0|||
19634299|NCT00587990|42083631|FG002|Overall Study|Death|1|||
19634300|NCT00723255|42083639|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
19634301|NCT00723255|42083639|FG000|Overall Study|Ineligible: Second primary|1|||
19634302|NCT00723255|42083639|FG000|Overall Study|Ineligible: Wrong Primary|2|||
19634303|NCT00791258|42083655|FG000|Overall Study|Adverse Event|87|||
19634304|NCT00791258|42083655|FG000|Overall Study|Lost to Follow-up|18|||
19634305|NCT00791258|42083655|FG000|Overall Study|Protocol Violation|109|||
19634306|NCT00791258|42083655|FG000|Overall Study|Withdrawal by Subject|40|||
19634307|NCT00791258|42083655|FG000|Overall Study|Did not take medication for >3 days|1|||
19634308|NCT00791258|42083655|FG000|Overall Study|subject left area|2|||
19634309|NCT00791258|42083655|FG000|Overall Study|non-compliance|3|||
19634310|NCT00791258|42083655|FG000|Overall Study|Subject incarcerated|1|||
19634311|NCT00791258|42083655|FG000|Overall Study|Subject required restricted medication|1|||
19634312|NCT00791258|42083655|FG000|Overall Study|Lack of Efficacy|1|||
19634313|NCT00808067|42083661|FG000|Overall Study|Major/minor bleed|30|||
19634314|NCT00808067|42083662|FG001|Overall Study|Major/minor bleed|44|||
19634315|NCT00808067|42083661|FG000|Overall Study|Outcome event - other|33|||
19634316|NCT00808067|42083662|FG001|Overall Study|Outcome event - other|25|||
19634317|NCT00808067|42083661|FG000|Overall Study|Adverse Event|111|||
19634318|NCT00808067|42083662|FG001|Overall Study|Adverse Event|121|||
19634319|NCT00808067|42083661|FG000|Overall Study|Hospitalization (not including surgery)|18|||
19634320|NCT00808067|42083662|FG001|Overall Study|Hospitalization (not including surgery)|17|||
19634321|NCT00808067|42083661|FG000|Overall Study|Hospitalization due to surgery|37|||
19634322|NCT00808067|42083662|FG001|Overall Study|Hospitalization due to surgery|40|||
19634323|NCT00808067|42083661|FG000|Overall Study|Reduced creatinine clearance|53|||
19634324|NCT00808067|42083662|FG001|Overall Study|Reduced creatinine clearance|55|||
19634325|NCT00808067|42083661|FG000|Overall Study|Elevated LFT results|7|||
19634326|NCT00808067|42083662|FG001|Overall Study|Elevated LFT results|3|||
19634327|NCT00808067|42083661|FG000|Overall Study|Patient refused to take study medication|65|||
19634328|NCT00808067|42083662|FG001|Overall Study|Patient refused to take study medication|76|||
19634329|NCT00808067|42083661|FG000|Overall Study|Missing|1|||
19634330|NCT00808067|42083662|FG001|Overall Study|Missing|0|||
19634331|NCT00808067|42083661|FG000|Overall Study|Death|1|||
19634332|NCT00808067|42083662|FG001|Overall Study|Death|1|||
19634333|NCT00808067|42083661|FG000|Overall Study|Procedure|6|||
19634334|NCT00808067|42083662|FG001|Overall Study|Procedure|7|||
19634335|NCT00808067|42083661|FG000|Overall Study|Withdrawal by Subject|21|||
19634336|NCT00808067|42083662|FG001|Overall Study|Withdrawal by Subject|25|||
19634337|NCT00808067|42083661|FG000|Overall Study|Site closed|4|||
19634338|NCT00808067|42083662|FG001|Overall Study|Site closed|3|||
19634339|NCT00808067|42083661|FG000|Overall Study|Physician Decision|47|||
19634340|NCT00808067|42083662|FG001|Overall Study|Physician Decision|38|||
19634341|NCT00808067|42083661|FG000|Overall Study|Protocol Violation|3|||
19634342|NCT00808067|42083662|FG001|Overall Study|Protocol Violation|11|||
19634343|NCT00808067|42083661|FG000|Overall Study|Patient elected|7|||
19634344|NCT00808067|42083662|FG001|Overall Study|Patient elected|9|||
19634345|NCT00808067|42083661|FG000|Overall Study|Site closed for cause|19|||
19634346|NCT00808067|42083662|FG001|Overall Study|Site closed for cause|19|||
19634347|NCT00808067|42083661|FG000|Overall Study|Other reason not defined above|5|||
19543394|NCT01162486|41992749|FG004|Overall Study|elevated LFTs|0|||
19634348|NCT00808067|42083662|FG001|Overall Study|Other reason not defined above|5|||
19634349|NCT00808067|42083661|FG000|Overall Study|Excluded from analysis|13|||
19634350|NCT00808067|42083662|FG001|Overall Study|Excluded from analysis|19|||
19634351|NCT00723021|42083668|FG000|Intervention Period 4|Adverse Event|0|||
19634352|NCT00723021|42083669|FG001|Intervention Period 4|Adverse Event|0|||
19634353|NCT00723021|42083670|FG002|Intervention Period 4|Adverse Event|0|||
19634354|NCT00723021|42083671|FG003|Intervention Period 4|Adverse Event|0|||
19634355|NCT00723021|42083672|FG004|Intervention Period 4|Adverse Event|1|||
19634356|NCT00721227|42083693|FG000|Overall Study|Lost to Follow-up|3|||
19634357|NCT00721227|42083694|FG001|Overall Study|Lost to Follow-up|0|||
19634358|NCT00721227|42083693|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
19634359|NCT00721227|42083694|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
19634360|NCT00807599|42083702|FG000|Overall Study|Not treated on protocol study|0|||
19634361|NCT00807599|42083703|FG001|Overall Study|Not treated on protocol study|0|||
19634362|NCT00807599|42083704|FG002|Overall Study|Not treated on protocol study|2|||
19634363|NCT00807599|42083702|FG000|Overall Study|Adverse Event|0|||
19634364|NCT00807599|42083703|FG001|Overall Study|Adverse Event|0|||
19634365|NCT00807599|42083704|FG002|Overall Study|Adverse Event|5|||
19634366|NCT00807599|42083702|FG000|Overall Study|Inadequate response to induction|0|||
19634367|NCT00807599|42083703|FG001|Overall Study|Inadequate response to induction|0|||
19634368|NCT00807599|42083704|FG002|Overall Study|Inadequate response to induction|9|||
19634369|NCT00807599|42083702|FG000|Overall Study|Withdrawal by Subject|0|||
19634370|NCT00807599|42083703|FG001|Overall Study|Withdrawal by Subject|0|||
19634371|NCT00807599|42083704|FG002|Overall Study|Withdrawal by Subject|1|||
19634372|NCT00721149|42083710|FG000|Overall Study|Physician Decision|1|||
19634373|NCT00788372|42083714|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
19634374|NCT00788372|42083714|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
19634375|NCT00788372|42083714|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
19634376|NCT00788372|42083714|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
19634377|NCT00788372|42083714|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
19634378|NCT00788372|42083714|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
19634379|NCT00788372|42083714|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
19634380|NCT00738582|42083718|FG000|Combination Therapy|Completed Combination Therapy|1|||
19634381|NCT00738582|42083719|FG001|Combination Therapy|Completed Combination Therapy|0|||
19634382|NCT00738582|42083718|FG000|Combination Therapy|Physician Decision|1|||
19634383|NCT00738582|42083719|FG001|Combination Therapy|Physician Decision|0|||
19634384|NCT00738582|42083718|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
19634385|NCT00738582|42083719|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
19634386|NCT00738582|42083718|FG000|Combination Therapy|Other|5|||
19634387|NCT00738582|42083719|FG001|Combination Therapy|Other|0|||
19634388|NCT00738582|42083718|FG000|Combination Therapy|Adverse Event|16|||
19634389|NCT00738582|42083719|FG001|Combination Therapy|Adverse Event|0|||
19634390|NCT00738582|42083718|FG000|Combination Therapy|Progressive Disease|9|||
19634391|NCT00738582|42083719|FG001|Combination Therapy|Progressive Disease|0|||
19634392|NCT00738582|42083718|FG000|Maintenance Therapy|Other|0|||
19634393|NCT00738582|42083719|FG001|Maintenance Therapy|Other|2|||
19634394|NCT00738582|42083718|FG000|Maintenance Therapy|Adverse Event|0|||
19634395|NCT00738582|42083719|FG001|Maintenance Therapy|Adverse Event|6|||
19634396|NCT00738582|42083718|FG000|Maintenance Therapy|Progressive Disease|0|||
19634397|NCT00738582|42083719|FG001|Maintenance Therapy|Progressive Disease|47|||
19634398|NCT00738582|42083718|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
19634399|NCT00738582|42083719|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
19634400|NCT00720759|42083730|FG000|Overall Study|Lost to Follow-up|0|||
19634401|NCT00720759|42083731|FG001|Overall Study|Lost to Follow-up|1|||
19634402|NCT00720759|42083732|FG002|Overall Study|Lost to Follow-up|1|||
19634403|NCT00720759|42083733|FG003|Overall Study|Lost to Follow-up|0|||
19634404|NCT00720213|42083743|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
19634405|NCT00720213|42083744|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
19634406|NCT00720213|42083745|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
19634407|NCT00810407|42083753|FG000|Overall Study|Protocol Violation|3|||
19634408|NCT00810407|42083753|FG000|Overall Study|No Visit After First Day of Treatment|3|||
19634409|NCT00720057|42083759|FG000|Overall Study|Lost to Follow-up|0|||
19634410|NCT00720057|42083760|FG001|Overall Study|Lost to Follow-up|2|||
19634411|NCT00720057|42083759|FG000|Overall Study|Protocol Violation|1|||
19634412|NCT00720057|42083760|FG001|Overall Study|Protocol Violation|0|||
19634413|NCT00720057|42083759|FG000|Overall Study|Withdrawal by Subject|0|||
19634414|NCT00720057|42083760|FG001|Overall Study|Withdrawal by Subject|1|||
19634415|NCT00790868|42083768|FG000|Overall Study|Withdrawal by Subject|4|||
19634416|NCT00790868|42083769|FG001|Overall Study|Withdrawal by Subject|5|||
19634417|NCT00790868|42083768|FG000|Overall Study|Lost to Follow-up|2|||
19634418|NCT00790868|42083769|FG001|Overall Study|Lost to Follow-up|12|||
19711901|NCT00106353|42154865|FG003|Part 2|Physician Decision|0|||
19634419|NCT00719901|42083777|FG000|Overall Study|Adverse Event|5|||
19634420|NCT00719901|42083777|FG000|Overall Study|Withdrawal by Subject|1|||
19711902|NCT00106353|42154866|FG004|Part 2|Physician Decision|0|||
19634421|NCT00719901|42083777|FG000|Overall Study|Alternate Treatment|1|||
19634422|NCT00719901|42083777|FG000|Overall Study|Disease Progression|3|||
19634423|NCT00719901|42083777|FG000|Overall Study|Availability of Study Drug|1|||
19634424|NCT00807365|42083781|FG000|Overall Study|Study Terminated|5|||
19634425|NCT00719355|42083787|FG000|Overall Study|Death|0|||
19634426|NCT00719355|42083788|FG001|Overall Study|Death|1|||
19634427|NCT00719355|42083787|FG000|Overall Study|Medical|14|||
19634428|NCT00719355|42083788|FG001|Overall Study|Medical|5|||
19634429|NCT00719355|42083787|FG000|Overall Study|Compliance|4|||
19634430|NCT00719355|42083788|FG001|Overall Study|Compliance|6|||
19634431|NCT00719355|42083787|FG000|Overall Study|Moved|0|||
19634432|NCT00719355|42083788|FG001|Overall Study|Moved|1|||
19634433|NCT00590759|42083794|FG000|Overall Study|Death|52|||
19634434|NCT00590759|42083794|FG000|Overall Study|Lost to Follow-up|28|||
19634435|NCT00734604|42083804|FG000|Overall Study|Adverse Event|0|||
19634436|NCT00734604|42083805|FG001|Overall Study|Adverse Event|2|||
19634437|NCT00734604|42083806|FG002|Overall Study|Adverse Event|0|||
19634438|NCT00734604|42083807|FG003|Overall Study|Adverse Event|2|||
19634439|NCT00734604|42083808|FG004|Overall Study|Adverse Event|1|||
19634440|NCT00734604|42083809|FG005|Overall Study|Adverse Event|1|||
19634441|NCT00734604|42083804|FG000|Overall Study|Serious Adverse Event|1|||
19634442|NCT00734604|42083805|FG001|Overall Study|Serious Adverse Event|0|||
19634443|NCT00734604|42083806|FG002|Overall Study|Serious Adverse Event|1|||
19634444|NCT00734604|42083807|FG003|Overall Study|Serious Adverse Event|2|||
19634445|NCT00734604|42083808|FG004|Overall Study|Serious Adverse Event|0|||
19634446|NCT00734604|42083809|FG005|Overall Study|Serious Adverse Event|1|||
19634447|NCT00734604|42083804|FG000|Overall Study|Lost to Follow-up|1|||
19634448|NCT00734604|42083805|FG001|Overall Study|Lost to Follow-up|2|||
19634449|NCT00734604|42083806|FG002|Overall Study|Lost to Follow-up|2|||
19634450|NCT00734604|42083807|FG003|Overall Study|Lost to Follow-up|4|||
19634451|NCT00734604|42083808|FG004|Overall Study|Lost to Follow-up|2|||
19634452|NCT00734604|42083809|FG005|Overall Study|Lost to Follow-up|3|||
19634453|NCT00734604|42083804|FG000|Overall Study|Physician Decision|0|||
19634454|NCT00734604|42083805|FG001|Overall Study|Physician Decision|1|||
19634455|NCT00734604|42083806|FG002|Overall Study|Physician Decision|1|||
19634456|NCT00734604|42083807|FG003|Overall Study|Physician Decision|0|||
19634457|NCT00734604|42083808|FG004|Overall Study|Physician Decision|0|||
19634458|NCT00734604|42083809|FG005|Overall Study|Physician Decision|0|||
19634459|NCT00734604|42083804|FG000|Overall Study|Protocol Violation|0|||
19634460|NCT00734604|42083805|FG001|Overall Study|Protocol Violation|2|||
19634461|NCT00734604|42083806|FG002|Overall Study|Protocol Violation|0|||
19634462|NCT00734604|42083807|FG003|Overall Study|Protocol Violation|0|||
19634463|NCT00734604|42083808|FG004|Overall Study|Protocol Violation|1|||
19634464|NCT00734604|42083809|FG005|Overall Study|Protocol Violation|0|||
19634465|NCT00734604|42083804|FG000|Overall Study|Sponsor Decision|1|||
19634466|NCT00734604|42083805|FG001|Overall Study|Sponsor Decision|2|||
19634467|NCT00734604|42083806|FG002|Overall Study|Sponsor Decision|1|||
19634468|NCT00734604|42083807|FG003|Overall Study|Sponsor Decision|0|||
19634469|NCT00734604|42083808|FG004|Overall Study|Sponsor Decision|2|||
19634470|NCT00734604|42083809|FG005|Overall Study|Sponsor Decision|0|||
19634471|NCT00734604|42083804|FG000|Overall Study|Withdrawal by Subject|0|||
19634472|NCT00734604|42083805|FG001|Overall Study|Withdrawal by Subject|2|||
19634473|NCT00734604|42083806|FG002|Overall Study|Withdrawal by Subject|0|||
19634474|NCT00734604|42083807|FG003|Overall Study|Withdrawal by Subject|1|||
19458168|NCT01426269|41711909|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
19458169|NCT01426269|41711907|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
19458170|NCT01426269|41711908|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
19458171|NCT01426269|41711909|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
19458172|NCT01426269|41711907|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
19711903|NCT00106353|42154867|FG005|Part 2|Physician Decision|1|||
19458173|NCT01426269|41711908|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
19458174|NCT01426269|41711909|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
19458175|NCT01426269|41711907|FG000|Period 1: 12 Weeks|Pregnancy|1|||
19458176|NCT01426269|41711908|FG001|Period 1: 12 Weeks|Pregnancy|0|||
19458177|NCT01426269|41711909|FG002|Period 1: 12 Weeks|Pregnancy|0|||
19458178|NCT01426269|41711907|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
19458179|NCT01426269|41711908|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
19458180|NCT01426269|41711909|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
19634475|NCT00734604|42083808|FG004|Overall Study|Withdrawal by Subject|2|||
19634476|NCT00734604|42083809|FG005|Overall Study|Withdrawal by Subject|1|||
19634477|NCT00734604|42083804|FG000|Overall Study|Lack of Efficacy|0|||
19634478|NCT00734604|42083805|FG001|Overall Study|Lack of Efficacy|1|||
19634479|NCT00734604|42083806|FG002|Overall Study|Lack of Efficacy|1|||
19634480|NCT00734604|42083807|FG003|Overall Study|Lack of Efficacy|0|||
19634481|NCT00734604|42083808|FG004|Overall Study|Lack of Efficacy|0|||
19634482|NCT00734604|42083809|FG005|Overall Study|Lack of Efficacy|0|||
19543395|NCT01162486|41992745|FG000|Overall Study|Pregnancy|0|||
19634483|NCT00590681|42083820|FG000|Overall Study|Withdrawal by Subject|7|||
19634484|NCT00590681|42083820|FG000|Overall Study|Adverse Event|8|||
19634485|NCT00590681|42083820|FG000|Overall Study|Death|3|||
19711904|NCT00106353|42154868|FG006|Part 2|Physician Decision|0|||
19634486|NCT00590681|42083820|FG000|Overall Study|Lost to Follow-up|1|||
19634487|NCT00590681|42083820|FG000|Overall Study|disease progression|1|||
19634488|NCT00727272|42083824|FG000|Washout Period A|Adverse Event|0|||
19634489|NCT00727272|42083825|FG001|Washout Period A|Adverse Event|0|||
19634490|NCT00727272|42083826|FG002|Washout Period A|Adverse Event|1|||
19634491|NCT00727272|42083824|FG000|Washout Period B|Withdrawal by Subject|0|||
19634492|NCT00727272|42083825|FG001|Washout Period B|Withdrawal by Subject|0|||
19634493|NCT00727272|42083826|FG002|Washout Period B|Withdrawal by Subject|1|||
19634494|NCT00805025|42083836|FG000|Overall Study|Screened but not enrolled/treated|42|||
19634495|NCT00805025|42083836|FG000|Overall Study|Adverse Event|4|||
19634496|NCT00805025|42083836|FG000|Overall Study|Withdrawal by Subject|2|||
19634497|NCT00805025|42083836|FG000|Overall Study|Physician Decision|1|||
19634498|NCT00734214|42083842|FG000|Overall Study|Withdrawal by Subject|3|||
19543396|NCT01162486|41992746|FG001|Overall Study|Pregnancy|0|||
19543397|NCT01162486|41992747|FG002|Overall Study|Pregnancy|0|||
19543398|NCT01162486|41992748|FG003|Overall Study|Pregnancy|1|||
19543399|NCT01162486|41992749|FG004|Overall Study|Pregnancy|0|||
19543400|NCT01162135|41992765|FG000|Overall Study|Withdrawal by Subject|1|||
19543401|NCT01162135|41992765|FG000|Overall Study|Severe back pain|1|||
19543402|NCT01162135|41992765|FG000|Overall Study|Ineligible|1|||
19543403|NCT01161628|41992769|FG000|Overall Study|Death|6|||
19543404|NCT01161628|41992769|FG000|Overall Study|Lack of Efficacy|2|||
19543405|NCT01161472|41992773|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
19543406|NCT01161472|41992774|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
19543407|NCT01161472|41992775|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
19543408|NCT01161472|41992776|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
19543409|NCT01161043|41992786|FG000|Overall Study|Withdrawal by Subject|3|||
19543410|NCT01160770|41992790|FG000|Overall Study|Adverse Event|10|||
19543411|NCT01160770|41992790|FG000|Overall Study|Protocol Violation|2|||
19543412|NCT01160770|41992790|FG000|Overall Study|Subject/parent/caregiver request|33|||
19543413|NCT01160770|41992790|FG000|Overall Study|Physician Decision|1|||
19543414|NCT01160770|41992790|FG000|Overall Study|Lost to Follow-up|7|||
19543415|NCT01160770|41992790|FG000|Overall Study|Study termination or sponsor request|1|||
19543416|NCT01160770|41992790|FG000|Overall Study|Death|9|||
19543417|NCT01160770|41992790|FG000|Overall Study|Lack of Efficacy|15|||
19543418|NCT01160770|41992790|FG000|Overall Study|Other Reasons|1|||
19543419|NCT01160614|41992796|FG000|Overall Study|Withdrawal by Subject|0|||
19543420|NCT01160614|41992797|FG001|Overall Study|Withdrawal by Subject|2|||
19543421|NCT01159912|41992824|FG000|Overall Study|Adverse Event|2|||
19543422|NCT01159912|41992825|FG001|Overall Study|Adverse Event|2|||
19543423|NCT01159912|41992826|FG002|Overall Study|Adverse Event|3|||
19543424|NCT01159912|41992824|FG000|Overall Study|Lack of Efficacy|23|||
19543425|NCT01159912|41992825|FG001|Overall Study|Lack of Efficacy|15|||
19543426|NCT01159912|41992826|FG002|Overall Study|Lack of Efficacy|14|||
19543427|NCT01159912|41992824|FG000|Overall Study|Protocol Violation|1|||
19543428|NCT01159912|41992825|FG001|Overall Study|Protocol Violation|2|||
19543429|NCT01159912|41992826|FG002|Overall Study|Protocol Violation|3|||
19543430|NCT01159912|41992824|FG000|Overall Study|Lost to Follow-up|4|||
19543431|NCT01159912|41992825|FG001|Overall Study|Lost to Follow-up|0|||
19543432|NCT01159912|41992826|FG002|Overall Study|Lost to Follow-up|0|||
19543433|NCT01159912|41992824|FG000|Overall Study|Physician Decision|0|||
19543434|NCT01159912|41992825|FG001|Overall Study|Physician Decision|0|||
19543435|NCT01159912|41992826|FG002|Overall Study|Physician Decision|3|||
19543436|NCT01159912|41992824|FG000|Overall Study|Withdrawal by Subject|10|||
19543437|NCT01159912|41992825|FG001|Overall Study|Withdrawal by Subject|3|||
19543438|NCT01159912|41992826|FG002|Overall Study|Withdrawal by Subject|3|||
19543439|NCT01159600|41992842|FG000|Overall Study|Not treated|0|||
19543440|NCT01159600|41992843|FG001|Overall Study|Not treated|0|||
19543441|NCT01159600|41992844|FG002|Overall Study|Not treated|1|||
19543442|NCT01159600|41992845|FG003|Overall Study|Not treated|0|||
19543443|NCT01159600|41992846|FG004|Overall Study|Not treated|0|||
19543444|NCT01159600|41992847|FG005|Overall Study|Not treated|1|||
19543445|NCT01159600|41992848|FG006|Overall Study|Not treated|2|||
19543446|NCT01159600|41992849|FG007|Overall Study|Not treated|2|||
19543447|NCT01159600|41992842|FG000|Overall Study|Adverse Event|7|||
19543448|NCT01159600|41992843|FG001|Overall Study|Adverse Event|2|||
19543449|NCT01159600|41992844|FG002|Overall Study|Adverse Event|5|||
19543450|NCT01159600|41992845|FG003|Overall Study|Adverse Event|1|||
19543451|NCT01159600|41992846|FG004|Overall Study|Adverse Event|8|||
19543452|NCT01159600|41992847|FG005|Overall Study|Adverse Event|6|||
19543453|NCT01159600|41992848|FG006|Overall Study|Adverse Event|7|||
19543454|NCT01159600|41992849|FG007|Overall Study|Adverse Event|5|||
19543455|NCT01159600|41992842|FG000|Overall Study|Lack of Efficacy|0|||
19543456|NCT01159600|41992843|FG001|Overall Study|Lack of Efficacy|0|||
19543457|NCT01159600|41992844|FG002|Overall Study|Lack of Efficacy|0|||
19543458|NCT01159600|41992845|FG003|Overall Study|Lack of Efficacy|0|||
19543459|NCT01159600|41992846|FG004|Overall Study|Lack of Efficacy|2|||
19543460|NCT01159600|41992847|FG005|Overall Study|Lack of Efficacy|0|||
19543461|NCT01159600|41992848|FG006|Overall Study|Lack of Efficacy|0|||
19543462|NCT01159600|41992849|FG007|Overall Study|Lack of Efficacy|1|||
19634499|NCT00734214|42083843|FG001|Overall Study|Withdrawal by Subject|4|||
19634500|NCT00734214|42083842|FG000|Overall Study|MD withdrawal|1|||
19543463|NCT01159600|41992842|FG000|Overall Study|Non compliant with protocol|2|||
19543464|NCT01159600|41992843|FG001|Overall Study|Non compliant with protocol|1|||
19543465|NCT01159600|41992844|FG002|Overall Study|Non compliant with protocol|0|||
19543466|NCT01159600|41992845|FG003|Overall Study|Non compliant with protocol|0|||
19543467|NCT01159600|41992846|FG004|Overall Study|Non compliant with protocol|2|||
19543468|NCT01159600|41992847|FG005|Overall Study|Non compliant with protocol|0|||
19543469|NCT01159600|41992848|FG006|Overall Study|Non compliant with protocol|2|||
19543470|NCT01159600|41992849|FG007|Overall Study|Non compliant with protocol|0|||
19543471|NCT01159600|41992842|FG000|Overall Study|Lost to Follow-up|2|||
19543472|NCT01159600|41992843|FG001|Overall Study|Lost to Follow-up|3|||
19543473|NCT01159600|41992844|FG002|Overall Study|Lost to Follow-up|4|||
19711905|NCT00080301|42154891|FG000|Overall Study|Randomized but Never Treated|5|||
19711906|NCT00080301|42154892|FG001|Overall Study|Randomized but Never Treated|10|||
19711907|NCT00080301|42154891|FG000|Overall Study|Still on Treatment as of CSR date|0|||
19711908|NCT00080301|42154892|FG001|Overall Study|Still on Treatment as of CSR date|1|||
19711909|NCT00079677|42154901|FG000|Overall Study|Adverse Event|5|||
19711910|NCT00079677|42154902|FG001|Overall Study|Adverse Event|6|||
19711911|NCT00079677|42154901|FG000|Overall Study|Lack of Efficacy|1|||
19711912|NCT00079677|42154902|FG001|Overall Study|Lack of Efficacy|0|||
19711913|NCT00079677|42154901|FG000|Overall Study|Lost to Follow-up|2|||
19711914|NCT00079677|42154902|FG001|Overall Study|Lost to Follow-up|2|||
19711915|NCT00079677|42154901|FG000|Overall Study|Physician Decision|3|||
19711916|NCT00079677|42154902|FG001|Overall Study|Physician Decision|0|||
19711917|NCT00079677|42154901|FG000|Overall Study|Protocol Violation|2|||
19711918|NCT00079677|42154902|FG001|Overall Study|Protocol Violation|3|||
19711919|NCT00079677|42154901|FG000|Overall Study|Withdrawal by Subject|5|||
19711920|NCT00079677|42154902|FG001|Overall Study|Withdrawal by Subject|3|||
19711921|NCT00079677|42154901|FG000|Overall Study|Miscellaneous|2|||
19711922|NCT00079677|42154902|FG001|Overall Study|Miscellaneous|0|||
19711923|NCT00095121|42154910|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
19711924|NCT00095121|42154911|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
19711925|NCT00095121|42154910|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
19711926|NCT00095121|42154911|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
19711927|NCT00094809|42154929|FG000|Overall Study|Protocol deviation|2|||
19711928|NCT00094809|42154930|FG001|Overall Study|Protocol deviation|2|||
19711929|NCT00094809|42154929|FG000|Overall Study|Noncompliance|1|||
19711930|NCT00094809|42154930|FG001|Overall Study|Noncompliance|0|||
19711931|NCT00094809|42154929|FG000|Overall Study|Adverse Event|3|||
19711932|NCT00094809|42154930|FG001|Overall Study|Adverse Event|1|||
19711933|NCT00094809|42154929|FG000|Overall Study|Withdrawal by Subject|8|||
19711934|NCT00094809|42154930|FG001|Overall Study|Withdrawal by Subject|9|||
19711935|NCT00094809|42154929|FG000|Overall Study|Disease progression|3|||
19634501|NCT00734214|42083843|FG001|Overall Study|MD withdrawal|0|||
19634502|NCT00787202|42083854|FG000|Overall Study|Adverse Event|3|||
19634503|NCT00787202|42083855|FG001|Overall Study|Adverse Event|2|||
19634504|NCT00787202|42083856|FG002|Overall Study|Adverse Event|0|||
19634505|NCT00787202|42083857|FG003|Overall Study|Adverse Event|0|||
19634506|NCT00787202|42083858|FG004|Overall Study|Adverse Event|2|||
19634507|NCT00787202|42083854|FG000|Overall Study|Lack of Efficacy|5|||
19634508|NCT00787202|42083855|FG001|Overall Study|Lack of Efficacy|6|||
19634509|NCT00787202|42083856|FG002|Overall Study|Lack of Efficacy|5|||
19634510|NCT00787202|42083857|FG003|Overall Study|Lack of Efficacy|2|||
19634511|NCT00787202|42083858|FG004|Overall Study|Lack of Efficacy|1|||
19634512|NCT00787202|42083854|FG000|Overall Study|Lost to Follow-up|1|||
19634513|NCT00787202|42083855|FG001|Overall Study|Lost to Follow-up|0|||
19634514|NCT00787202|42083856|FG002|Overall Study|Lost to Follow-up|0|||
19634515|NCT00787202|42083857|FG003|Overall Study|Lost to Follow-up|0|||
19634516|NCT00787202|42083858|FG004|Overall Study|Lost to Follow-up|0|||
19634517|NCT00787202|42083854|FG000|Overall Study|Withdrawal by Subject|2|||
19634518|NCT00787202|42083855|FG001|Overall Study|Withdrawal by Subject|2|||
19634519|NCT00787202|42083856|FG002|Overall Study|Withdrawal by Subject|2|||
19634520|NCT00787202|42083857|FG003|Overall Study|Withdrawal by Subject|0|||
19634521|NCT00787202|42083858|FG004|Overall Study|Withdrawal by Subject|0|||
19634522|NCT00787202|42083854|FG000|Overall Study|Protocol Violation|2|||
19634523|NCT00787202|42083855|FG001|Overall Study|Protocol Violation|1|||
19711936|NCT00094809|42154930|FG001|Overall Study|Disease progression|3|||
19711937|NCT00094809|42154929|FG000|Overall Study|Physician Decision|3|||
19711938|NCT00094809|42154930|FG001|Overall Study|Physician Decision|5|||
19711939|NCT00094809|42154929|FG000|Overall Study|Lost to Follow-up|6|||
19711940|NCT00094809|42154930|FG001|Overall Study|Lost to Follow-up|6|||
19711941|NCT00094809|42154929|FG000|Overall Study|Death|19|||
19711942|NCT00094809|42154930|FG001|Overall Study|Death|25|||
19543474|NCT01159600|41992845|FG003|Overall Study|Lost to Follow-up|3|||
19543475|NCT01159600|41992846|FG004|Overall Study|Lost to Follow-up|3|||
19634524|NCT00787202|42083856|FG002|Overall Study|Protocol Violation|0|||
19634525|NCT00787202|42083857|FG003|Overall Study|Protocol Violation|0|||
19634526|NCT00787202|42083858|FG004|Overall Study|Protocol Violation|1|||
19634527|NCT00787202|42083854|FG000|Overall Study|Randomized, not treated|1|||
19543476|NCT01159600|41992847|FG005|Overall Study|Lost to Follow-up|0|||
19543477|NCT01159600|41992848|FG006|Overall Study|Lost to Follow-up|3|||
19543478|NCT01159600|41992849|FG007|Overall Study|Lost to Follow-up|2|||
19543479|NCT01159600|41992842|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
19543480|NCT01159600|41992843|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
19543481|NCT01159600|41992844|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
19543482|NCT01159600|41992845|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
19543483|NCT01159600|41992846|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
19543484|NCT01159600|41992847|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
19543485|NCT01159600|41992848|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
19543486|NCT01159600|41992849|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
19543487|NCT01159600|41992842|FG000|Overall Study|Other reason not defined above|3|||
19543488|NCT01159600|41992843|FG001|Overall Study|Other reason not defined above|0|||
19543489|NCT01159600|41992844|FG002|Overall Study|Other reason not defined above|4|||
19543490|NCT01159600|41992845|FG003|Overall Study|Other reason not defined above|2|||
19543491|NCT01159600|41992846|FG004|Overall Study|Other reason not defined above|5|||
19543492|NCT01159600|41992847|FG005|Overall Study|Other reason not defined above|7|||
19543493|NCT01159600|41992848|FG006|Overall Study|Other reason not defined above|3|||
19543494|NCT01159600|41992849|FG007|Overall Study|Other reason not defined above|3|||
19543495|NCT01159171|41992868|FG000|Overall Study|Adverse Event|11|||
19543496|NCT01159171|41992868|FG000|Overall Study|Progression of Disease|28|||
19543497|NCT01159171|41992868|FG000|Overall Study|Protocol Violation|1|||
19543498|NCT01159171|41992868|FG000|Overall Study|Need for Surgery|5|||
19543499|NCT01159171|41992868|FG000|Overall Study|Medical Decision|4|||
19543500|NCT01159171|41992868|FG000|Overall Study|Death|1|||
19543501|NCT01158118|41992875|FG000|Overall Study|Screen failure|1|||
19543502|NCT01158118|41992876|FG001|Overall Study|Screen failure|0|||
19543503|NCT01158118|41992875|FG000|Overall Study|Donor match was a screen failure|0|||
19543504|NCT01158118|41992876|FG001|Overall Study|Donor match was a screen failure|1|||
19543505|NCT01158118|41992875|FG000|Overall Study|Suffered stroke prior to transplant|0|||
19543506|NCT01158118|41992876|FG001|Overall Study|Suffered stroke prior to transplant|1|||
19543507|NCT01158118|41992875|FG000|Overall Study|Death|0|||
19543508|NCT01158118|41992876|FG001|Overall Study|Death|1|||
19543509|NCT01157845|41992882|FG000|Overall Study|Lost to Follow-up|5|||
19543510|NCT01157845|41992882|FG000|Overall Study|Withdrawal by Subject|12|||
19543511|NCT01157845|41992882|FG000|Overall Study|Physician Decision|3|||
19543512|NCT01157845|41992882|FG000|Overall Study|Protocol Violation|13|||
19543513|NCT01157845|41992882|FG000|Overall Study|Study was ended|1|||
19543514|NCT01157845|41992882|FG000|Overall Study|Device malfunction|1|||
19543515|NCT01157377|41992893|FG000|Overall Study|Lost to Follow-up|0|||
19543516|NCT01157377|41992894|FG001|Overall Study|Lost to Follow-up|0|||
19543517|NCT01157377|41992895|FG002|Overall Study|Lost to Follow-up|1|||
19543518|NCT01157377|41992896|FG003|Overall Study|Lost to Follow-up|0|||
19543519|NCT01157377|41992897|FG004|Overall Study|Lost to Follow-up|1|||
19543520|NCT01157377|41992898|FG005|Overall Study|Lost to Follow-up|1|||
19543521|NCT01157377|41992899|FG006|Overall Study|Lost to Follow-up|0|||
19543522|NCT01157377|41992893|FG000|Overall Study|Personal Reasons|2|||
19543523|NCT01157377|41992894|FG001|Overall Study|Personal Reasons|1|||
19543524|NCT01157377|41992895|FG002|Overall Study|Personal Reasons|0|||
19543525|NCT01157377|41992896|FG003|Overall Study|Personal Reasons|1|||
19543526|NCT01157377|41992897|FG004|Overall Study|Personal Reasons|0|||
19543527|NCT01157377|41992898|FG005|Overall Study|Personal Reasons|0|||
19543528|NCT01157377|41992899|FG006|Overall Study|Personal Reasons|0|||
19543529|NCT01157377|41992893|FG000|Overall Study|Protocol Violation|0|||
19543530|NCT01157377|41992894|FG001|Overall Study|Protocol Violation|0|||
19543531|NCT01157377|41992895|FG002|Overall Study|Protocol Violation|0|||
19543532|NCT01157377|41992896|FG003|Overall Study|Protocol Violation|0|||
19543533|NCT01157377|41992897|FG004|Overall Study|Protocol Violation|0|||
19543534|NCT01157377|41992898|FG005|Overall Study|Protocol Violation|1|||
19543535|NCT01157377|41992899|FG006|Overall Study|Protocol Violation|0|||
19543536|NCT01157377|41992893|FG000|Overall Study|Lack of Efficacy|0|||
19543537|NCT01157377|41992894|FG001|Overall Study|Lack of Efficacy|0|||
19543538|NCT01157377|41992895|FG002|Overall Study|Lack of Efficacy|0|||
19543539|NCT01157377|41992896|FG003|Overall Study|Lack of Efficacy|0|||
19543540|NCT01157377|41992897|FG004|Overall Study|Lack of Efficacy|0|||
19543541|NCT01157377|41992898|FG005|Overall Study|Lack of Efficacy|0|||
19543542|NCT01157377|41992899|FG006|Overall Study|Lack of Efficacy|1|||
19543543|NCT01157377|41992893|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19543544|NCT01157377|41992894|FG001|Overall Study|Other Miscellaneous Reasons|2|||
19543545|NCT01157377|41992895|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19543546|NCT01157377|41992896|FG003|Overall Study|Other Miscellaneous Reasons|0|||
19543547|NCT01157377|41992897|FG004|Overall Study|Other Miscellaneous Reasons|1|||
19543548|NCT01157377|41992898|FG005|Overall Study|Other Miscellaneous Reasons|1|||
19543549|NCT01157377|41992899|FG006|Overall Study|Other Miscellaneous Reasons|1|||
19543550|NCT01157182|41992917|FG000|Washout of 28 Days|Adverse Event|2|||
19543551|NCT01157182|41992918|FG001|Washout of 28 Days|Adverse Event|0|||
19543552|NCT01157065|41992926|FG000|Overall Study|Death|0|||
19543553|NCT01157065|41992927|FG001|Overall Study|Death|1|||
19543554|NCT01156792|41992933|FG000|Overall Study|Adverse Event|1|||
19634528|NCT00787202|42083855|FG001|Overall Study|Randomized, not treated|0|||
19634529|NCT00787202|42083856|FG002|Overall Study|Randomized, not treated|0|||
19634530|NCT00787202|42083857|FG003|Overall Study|Randomized, not treated|0|||
19634531|NCT00787202|42083858|FG004|Overall Study|Randomized, not treated|0|||
19634532|NCT04033367|42083876|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
19634533|NCT04033367|42083877|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
19711943|NCT00094809|42154929|FG000|Overall Study|Protocol-specified criteria|1|||
19711944|NCT00094809|42154930|FG001|Overall Study|Protocol-specified criteria|1|||
19711945|NCT00094809|42154929|FG000|Overall Study|Other|2|||
19711946|NCT00094809|42154930|FG001|Overall Study|Other|4|||
19711947|NCT00094809|42154929|FG000|Overall Study|Informed consent signed after treatment|1|||
19711948|NCT00094809|42154930|FG001|Overall Study|Informed consent signed after treatment|0|||
19711949|NCT00094809|42154929|FG000|Overall Study|Study drug not received|2|||
19711950|NCT00094809|42154930|FG001|Overall Study|Study drug not received|8|||
19634534|NCT04033367|42083876|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
19634535|NCT04033367|42083877|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
19634536|NCT04033367|42083876|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
19711951|NCT00094809|42154929|FG000|Overall Study|Other|1|||
19711952|NCT00094809|42154930|FG001|Overall Study|Other|1|||
19711953|NCT00075218|42154938|FG000|Double-Blind Treatment|Adverse Event|23|||
19711954|NCT00075218|42154939|FG001|Double-Blind Treatment|Adverse Event|4|||
19711955|NCT00075218|42154940|FG002|Double-Blind Treatment|Adverse Event|0|||
19543555|NCT01156792|41992933|FG000|Overall Study|Lack of Efficacy|36|||
19543556|NCT01156792|41992933|FG000|Overall Study|Protocol Violation|6|||
19543557|NCT01156792|41992933|FG000|Overall Study|Lost to Follow-up|3|||
19634537|NCT04033367|42083877|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
19634538|NCT04033367|42083876|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
19634539|NCT04033367|42083877|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
19634540|NCT00733980|42083889|FG000|Overall Study|Adverse Event|5|||
19634541|NCT00733980|42083890|FG001|Overall Study|Adverse Event|2|||
19634542|NCT00733980|42083889|FG000|Overall Study|Lack of Efficacy|0|||
19634543|NCT00733980|42083890|FG001|Overall Study|Lack of Efficacy|1|||
19634544|NCT00733980|42083889|FG000|Overall Study|Protocol Violation|2|||
19634545|NCT00733980|42083890|FG001|Overall Study|Protocol Violation|1|||
19634546|NCT00733980|42083889|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
19634547|NCT00733980|42083890|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
19634548|NCT00733980|42083889|FG000|Overall Study|Lost to Follow-up|6|||
19634549|NCT00733980|42083890|FG001|Overall Study|Lost to Follow-up|11|||
19634550|NCT00733980|42083889|FG000|Overall Study|Physician Decision|2|||
19634551|NCT00733980|42083890|FG001|Overall Study|Physician Decision|3|||
19634552|NCT00733980|42083889|FG000|Overall Study|Withdrawal by Subject|6|||
19634553|NCT00733980|42083890|FG001|Overall Study|Withdrawal by Subject|2|||
19634554|NCT00806585|42083902|FG000|Overall Study|Study terminated by Sponsor|0|||
19634555|NCT00806585|42083903|FG001|Overall Study|Study terminated by Sponsor|0|||
19634556|NCT00806585|42083904|FG002|Overall Study|Study terminated by Sponsor|1|||
19634557|NCT00806585|42083905|FG003|Overall Study|Study terminated by Sponsor|2|||
19634558|NCT00806585|42083906|FG004|Overall Study|Study terminated by Sponsor|0|||
19634559|NCT00806585|42083902|FG000|Overall Study|Protocol Violation|3|||
19634560|NCT00806585|42083903|FG001|Overall Study|Protocol Violation|1|||
19634561|NCT00806585|42083904|FG002|Overall Study|Protocol Violation|2|||
19634562|NCT00806585|42083905|FG003|Overall Study|Protocol Violation|0|||
19634563|NCT00806585|42083906|FG004|Overall Study|Protocol Violation|0|||
19634564|NCT00806585|42083902|FG000|Overall Study|Physician Decision|0|||
19634565|NCT00806585|42083903|FG001|Overall Study|Physician Decision|2|||
19634566|NCT00806585|42083904|FG002|Overall Study|Physician Decision|3|||
19634567|NCT00806585|42083905|FG003|Overall Study|Physician Decision|0|||
19634568|NCT00806585|42083906|FG004|Overall Study|Physician Decision|1|||
19634569|NCT00806585|42083902|FG000|Overall Study|Lost to Follow-up|2|||
19634570|NCT00806585|42083903|FG001|Overall Study|Lost to Follow-up|1|||
19543558|NCT01156792|41992933|FG000|Overall Study|Physician Decision|3|||
19543559|NCT01156792|41992933|FG000|Overall Study|Withdrawal by Subject|9|||
19543560|NCT01156792|41992933|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
19634571|NCT00806585|42083904|FG002|Overall Study|Lost to Follow-up|2|||
19634572|NCT00806585|42083905|FG003|Overall Study|Lost to Follow-up|2|||
19634573|NCT00806585|42083906|FG004|Overall Study|Lost to Follow-up|5|||
19634574|NCT00806585|42083902|FG000|Overall Study|Lack of Efficacy|1|||
19634575|NCT00806585|42083903|FG001|Overall Study|Lack of Efficacy|0|||
19634576|NCT00806585|42083904|FG002|Overall Study|Lack of Efficacy|0|||
19634577|NCT00806585|42083905|FG003|Overall Study|Lack of Efficacy|0|||
19711956|NCT00075218|42154938|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
19711957|NCT00075218|42154939|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
19711958|NCT00075218|42154940|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
19711959|NCT00075218|42154938|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
19711960|NCT00075218|42154939|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
19543561|NCT01156714|41992951|FG000|Overall Study|Withdrawal by Subject|9|||
19634578|NCT00806585|42083906|FG004|Overall Study|Lack of Efficacy|0|||
19634579|NCT00806585|42083902|FG000|Overall Study|Adverse Event|1|||
19634580|NCT00806585|42083903|FG001|Overall Study|Adverse Event|5|||
19634581|NCT00806585|42083904|FG002|Overall Study|Adverse Event|3|||
19634582|NCT00806585|42083905|FG003|Overall Study|Adverse Event|4|||
19634583|NCT00806585|42083906|FG004|Overall Study|Adverse Event|2|||
19634584|NCT00806585|42083902|FG000|Overall Study|Withdrawal by Subject|10|||
19634585|NCT00806585|42083903|FG001|Overall Study|Withdrawal by Subject|8|||
19634586|NCT00806585|42083904|FG002|Overall Study|Withdrawal by Subject|9|||
19634587|NCT00806585|42083905|FG003|Overall Study|Withdrawal by Subject|3|||
19634588|NCT00806585|42083906|FG004|Overall Study|Withdrawal by Subject|11|||
19634589|NCT00806585|42083902|FG000|Overall Study|Completion status unknown|15|||
19634590|NCT00806585|42083903|FG001|Overall Study|Completion status unknown|14|||
19634591|NCT00806585|42083904|FG002|Overall Study|Completion status unknown|12|||
19634592|NCT00806585|42083905|FG003|Overall Study|Completion status unknown|4|||
19634593|NCT00806585|42083906|FG004|Overall Study|Completion status unknown|12|||
19634594|NCT00480025|42083920|FG000|Overall Study|Protocol Violation|12|||
19634595|NCT00480025|42083921|FG001|Overall Study|Protocol Violation|7|||
19634596|NCT00480025|42083920|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
19634597|NCT00480025|42083921|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
19634598|NCT00480025|42083920|FG000|Overall Study|Disease Progression / Recurrence|449|||
19634599|NCT00480025|42083921|FG001|Overall Study|Disease Progression / Recurrence|224|||
19634600|NCT00480025|42083920|FG000|Overall Study|Adverse Event|44|||
19634601|NCT00480025|42083921|FG001|Overall Study|Adverse Event|12|||
19634602|NCT00480025|42083920|FG000|Overall Study|Other|70|||
19543562|NCT01156714|41992952|FG001|Overall Study|Withdrawal by Subject|4|||
19543563|NCT01156714|41992953|FG002|Overall Study|Withdrawal by Subject|3|||
19543564|NCT01156675|41992967|FG000|Overall Study|Death|5|||
19543565|NCT01156675|41992968|FG001|Overall Study|Death|3|||
19543566|NCT01156675|41992969|FG002|Overall Study|Death|0|||
19543567|NCT01156675|41992967|FG000|Overall Study|No data|29|||
19634603|NCT00480025|42083921|FG001|Overall Study|Other|29|||
19634604|NCT00480025|42083920|FG000|Overall Study|SAE including intercurrent illness|76|||
19634605|NCT00480025|42083921|FG001|Overall Study|SAE including intercurrent illness|42|||
19634606|NCT00806351|42083935|FG000|Overall Study|Death|5|||
19634607|NCT00806351|42083936|FG001|Overall Study|Death|4|||
19634608|NCT00733902|42083946|FG000|Overall Study|Death|0|||
19634609|NCT00733902|42083947|FG001|Overall Study|Death|0|||
19543568|NCT01156675|41992968|FG001|Overall Study|No data|22|||
19543569|NCT01156675|41992969|FG002|Overall Study|No data|2|||
19634610|NCT00733902|42083948|FG002|Overall Study|Death|0|||
19634611|NCT00733902|42083949|FG003|Overall Study|Death|1|||
19634612|NCT00733902|42083946|FG000|Overall Study|Adverse Event|3|||
19634613|NCT00733902|42083947|FG001|Overall Study|Adverse Event|4|||
19634614|NCT00733902|42083948|FG002|Overall Study|Adverse Event|7|||
19634615|NCT00733902|42083949|FG003|Overall Study|Adverse Event|11|||
19543570|NCT01156480|41992980|FG000|Overall Study|change in diagnosis|0|||
19543571|NCT01156480|41992981|FG001|Overall Study|change in diagnosis|1|||
19543572|NCT01156363|41992989|FG000|Overall Study|Adverse Event|6|||
19543573|NCT01156363|41992989|FG000|Overall Study|Insufficient Therapeutic Response|5|||
19543574|NCT01156363|41992989|FG000|Overall Study|Failure to Return|1|||
19543575|NCT01156363|41992989|FG000|Overall Study|Refused Treatment|4|||
19543576|NCT01156363|41992989|FG000|Overall Study|Other|6|||
19543577|NCT01156051|41993002|FG000|Overall Study|Lost to Follow-up|1|||
19543578|NCT01156051|41993003|FG001|Overall Study|Lost to Follow-up|0|||
19634616|NCT00733902|42083946|FG000|Overall Study|Lack of Efficacy|56|||
19634617|NCT00733902|42083947|FG001|Overall Study|Lack of Efficacy|21|||
19634618|NCT00733902|42083948|FG002|Overall Study|Lack of Efficacy|34|||
19634619|NCT00733902|42083949|FG003|Overall Study|Lack of Efficacy|23|||
19543579|NCT01156051|41993002|FG000|Overall Study|patient not compliant with protocol|0|||
19543580|NCT01156051|41993003|FG001|Overall Study|patient not compliant with protocol|1|||
19543581|NCT01156012|41993011|FG000|Overall Study|Adverse Event|3|||
19543582|NCT01156012|41993012|FG001|Overall Study|Adverse Event|1|||
19543583|NCT01156012|41993011|FG000|Overall Study|Lost to Follow-up|1|||
19543584|NCT01156012|41993012|FG001|Overall Study|Lost to Follow-up|0|||
19543585|NCT01156012|41993011|FG000|Overall Study|Withdrawal by Subject|1|||
19543586|NCT01156012|41993012|FG001|Overall Study|Withdrawal by Subject|0|||
19543587|NCT01156012|41993011|FG000|Overall Study|use of commercial drug instead of study|0|||
19634620|NCT00733902|42083946|FG000|Overall Study|Protocol Violation|4|||
19634621|NCT00733902|42083947|FG001|Overall Study|Protocol Violation|6|||
19634622|NCT00733902|42083948|FG002|Overall Study|Protocol Violation|3|||
19634623|NCT00733902|42083949|FG003|Overall Study|Protocol Violation|3|||
19634624|NCT00733902|42083946|FG000|Overall Study|Withdrawal by Subject|10|||
19543588|NCT01156012|41993012|FG001|Overall Study|use of commercial drug instead of study|1|||
19543589|NCT01156012|41993011|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
19543590|NCT01156012|41993012|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
19543591|NCT01155661|41993018|FG000|Overall Study|Adverse Event|101|||
19634625|NCT00733902|42083947|FG001|Overall Study|Withdrawal by Subject|5|||
19543592|NCT01155661|41993018|FG000|Overall Study|Death|1|||
19543593|NCT01155661|41993018|FG000|Overall Study|Lack of Efficacy|32|||
19543594|NCT01155661|41993018|FG000|Overall Study|Lost to Follow-up|22|||
19543595|NCT01155661|41993018|FG000|Overall Study|Physician Decision|3|||
19543596|NCT01155661|41993018|FG000|Overall Study|Protocol Violation|35|||
19543597|NCT01155661|41993018|FG000|Overall Study|Withdrawal by Subject|73|||
19543598|NCT01155661|41993018|FG000|Overall Study|Sponsor Decision|13|||
19634626|NCT00733902|42083948|FG002|Overall Study|Withdrawal by Subject|4|||
19634627|NCT00733902|42083949|FG003|Overall Study|Withdrawal by Subject|16|||
19634628|NCT00733902|42083946|FG000|Overall Study|Entered extension study|89|||
19634629|NCT00733902|42083947|FG001|Overall Study|Entered extension study|124|||
19634630|NCT00733902|42083948|FG002|Overall Study|Entered extension study|111|||
19634631|NCT00733902|42083949|FG003|Overall Study|Entered extension study|109|||
19634632|NCT00733902|42083946|FG000|Overall Study|Randomized but not treated|2|||
19634633|NCT00733902|42083947|FG001|Overall Study|Randomized but not treated|2|||
19634634|NCT00733902|42083948|FG002|Overall Study|Randomized but not treated|2|||
19634635|NCT00733902|42083949|FG003|Overall Study|Randomized but not treated|1|||
19634636|NCT00790790|42083962|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
19634637|NCT00790790|42083963|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
19634638|NCT00790790|42083964|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
19634639|NCT00790790|42083962|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
19634640|NCT00790790|42083963|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
19634641|NCT00790790|42083964|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
19634642|NCT00790790|42083962|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
19634643|NCT00790790|42083963|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
19634644|NCT00790790|42083964|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
19634645|NCT00790790|42083962|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
19543599|NCT01155583|41993033|FG000|Phase I|Screen failure - did not start treatment|0|||
19543600|NCT01155583|41993034|FG001|Phase I|Screen failure - did not start treatment|0|||
19634646|NCT00790790|42083963|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
19634647|NCT00790790|42083964|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
19634648|NCT00790790|42083962|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
19634649|NCT00790790|42083963|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
19634650|NCT00790790|42083964|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
19634651|NCT00719043|42083984|FG000|Overall Study|Adverse Event|5|||
19634652|NCT00719043|42083985|FG001|Overall Study|Adverse Event|1|||
19634653|NCT00719043|42083986|FG002|Overall Study|Adverse Event|2|||
19634654|NCT00719043|42083987|FG003|Overall Study|Adverse Event|2|||
19634655|NCT00719043|42083988|FG004|Overall Study|Adverse Event|1|||
19634656|NCT00719043|42083989|FG005|Overall Study|Adverse Event|4|||
19634657|NCT00719043|42083990|FG006|Overall Study|Adverse Event|4|||
19634658|NCT00719043|42083984|FG000|Overall Study|Lost to Follow-up|14|||
19634659|NCT00719043|42083985|FG001|Overall Study|Lost to Follow-up|10|||
19634660|NCT00719043|42083986|FG002|Overall Study|Lost to Follow-up|8|||
19634661|NCT00719043|42083987|FG003|Overall Study|Lost to Follow-up|9|||
19634662|NCT00719043|42083988|FG004|Overall Study|Lost to Follow-up|10|||
19634663|NCT00719043|42083989|FG005|Overall Study|Lost to Follow-up|9|||
19634664|NCT00719043|42083990|FG006|Overall Study|Lost to Follow-up|9|||
19634665|NCT00719043|42083984|FG000|Overall Study|Protocol Violation|0|||
19634666|NCT00719043|42083985|FG001|Overall Study|Protocol Violation|0|||
19634667|NCT00719043|42083986|FG002|Overall Study|Protocol Violation|0|||
19634668|NCT00719043|42083987|FG003|Overall Study|Protocol Violation|0|||
19634669|NCT00719043|42083988|FG004|Overall Study|Protocol Violation|0|||
19634670|NCT00719043|42083989|FG005|Overall Study|Protocol Violation|1|||
19634671|NCT00719043|42083990|FG006|Overall Study|Protocol Violation|0|||
19634672|NCT00719043|42083984|FG000|Overall Study|Other|1|||
19634673|NCT00719043|42083985|FG001|Overall Study|Other|0|||
19634674|NCT00719043|42083986|FG002|Overall Study|Other|1|||
19634675|NCT00719043|42083987|FG003|Overall Study|Other|2|||
19634676|NCT00719043|42083988|FG004|Overall Study|Other|0|||
19634677|NCT00719043|42083989|FG005|Overall Study|Other|2|||
19634678|NCT00719043|42083990|FG006|Overall Study|Other|1|||
19634679|NCT00719043|42083984|FG000|Overall Study|Withdrawal by Subject|12|||
19711961|NCT00075218|42154940|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
19711962|NCT00075218|42154938|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
19634680|NCT00719043|42083985|FG001|Overall Study|Withdrawal by Subject|14|||
19634681|NCT00719043|42083986|FG002|Overall Study|Withdrawal by Subject|9|||
19634682|NCT00719043|42083987|FG003|Overall Study|Withdrawal by Subject|10|||
19634683|NCT00719043|42083988|FG004|Overall Study|Withdrawal by Subject|16|||
19634684|NCT00719043|42083989|FG005|Overall Study|Withdrawal by Subject|18|||
19634685|NCT00719043|42083990|FG006|Overall Study|Withdrawal by Subject|14|||
19634686|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Death|2|||
19711963|NCT00075218|42154939|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
19711964|NCT00075218|42154940|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
19543601|NCT01155583|41993035|FG002|Phase I|Screen failure - did not start treatment|0|||
19543602|NCT01155583|41993036|FG003|Phase I|Screen failure - did not start treatment|0|||
19634687|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
19634688|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
19634689|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Physician Decision|1|||
19634690|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
19634691|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
19634692|NCT00786422|42084018|FG000|Rivaroxaban Treatment|Adverse Event|2|||
19634693|NCT00786422|42084018|FG000|Follow-up Period|Death|1|||
19634694|NCT00786422|42084018|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
19634695|NCT00718887|42084026|FG000|Overall Study|Withdrawal by Subject|3|||
19634696|NCT00718887|42084027|FG001|Overall Study|Withdrawal by Subject|2|||
19634697|NCT00718887|42084026|FG000|Overall Study|Not identified|2|||
19634698|NCT00718887|42084027|FG001|Overall Study|Not identified|7|||
19634699|NCT00786188|42084041|FG000|Overall Study|Adverse Event|3|||
19634700|NCT00786188|42084042|FG001|Overall Study|Adverse Event|1|||
19634701|NCT00786188|42084041|FG000|Overall Study|Withdrawal by Subject|2|||
19634702|NCT00786188|42084042|FG001|Overall Study|Withdrawal by Subject|0|||
19634703|NCT00790556|42084050|FG000|Treatment Period 1|Physician Decision|1|||
19634704|NCT00790556|42084051|FG001|Treatment Period 1|Physician Decision|0|||
19634705|NCT00790556|42084050|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19634706|NCT00790556|42084051|FG001|Treatment Period 1|Withdrawal by Subject|0|||
19634707|NCT00733824|42084062|FG000|Phase I|Withdrawal by Subject|1|||
19634708|NCT00733824|42084063|FG001|Phase I|Withdrawal by Subject|0|||
19634709|NCT00733824|42084064|FG002|Phase I|Withdrawal by Subject|0|||
19634710|NCT00733824|42084065|FG003|Phase I|Withdrawal by Subject|0|||
19634711|NCT00733824|42084066|FG004|Phase I|Withdrawal by Subject|0|||
19634712|NCT00718809|42084082|FG000|Overall Study|Disease progression|9|||
19634713|NCT00718809|42084083|FG001|Overall Study|Disease progression|7|||
19634714|NCT00718809|42084082|FG000|Overall Study|Adverse Event|1|||
19634715|NCT00718809|42084083|FG001|Overall Study|Adverse Event|1|||
19634716|NCT00718809|42084082|FG000|Overall Study|Withdrawal by Subject|0|||
19634717|NCT00718809|42084083|FG001|Overall Study|Withdrawal by Subject|1|||
19634718|NCT00718809|42084082|FG000|Overall Study|Lost to Follow-up|1|||
19634719|NCT00718809|42084083|FG001|Overall Study|Lost to Follow-up|0|||
19634720|NCT00718809|42084082|FG000|Overall Study|Noncompliance|1|||
19634721|NCT00718809|42084083|FG001|Overall Study|Noncompliance|0|||
19634722|NCT00585039|42084091|FG000|Overall Study|medication spilled|2|||
19634723|NCT00585039|42084092|FG001|Overall Study|medication spilled|0|||
19634724|NCT00806195|42084104|FG000|Overall Study|Death|6|||
19634725|NCT00806195|42084105|FG001|Overall Study|Death|0|||
19634726|NCT00806195|42084106|FG002|Overall Study|Death|1|||
19634727|NCT00806195|42084107|FG003|Overall Study|Death|0|||
19634728|NCT00806195|42084104|FG000|Overall Study|Adverse Event|25|||
19634729|NCT00806195|42084105|FG001|Overall Study|Adverse Event|5|||
19634730|NCT00806195|42084106|FG002|Overall Study|Adverse Event|11|||
19634731|NCT00806195|42084107|FG003|Overall Study|Adverse Event|2|||
19634732|NCT00806195|42084104|FG000|Overall Study|Withdrawal by Subject|119|||
19634733|NCT00806195|42084105|FG001|Overall Study|Withdrawal by Subject|31|||
19634734|NCT00806195|42084106|FG002|Overall Study|Withdrawal by Subject|76|||
19634735|NCT00806195|42084107|FG003|Overall Study|Withdrawal by Subject|35|||
19634736|NCT00806195|42084104|FG000|Overall Study|Lost to Follow-up|217|||
19634737|NCT00806195|42084105|FG001|Overall Study|Lost to Follow-up|66|||
19634738|NCT00806195|42084106|FG002|Overall Study|Lost to Follow-up|90|||
19634739|NCT00806195|42084107|FG003|Overall Study|Lost to Follow-up|34|||
19634740|NCT00806195|42084104|FG000|Overall Study|Inappropriate Enrollment|0|||
19634741|NCT00806195|42084105|FG001|Overall Study|Inappropriate Enrollment|1|||
19634742|NCT00806195|42084106|FG002|Overall Study|Inappropriate Enrollment|0|||
19634743|NCT00806195|42084107|FG003|Overall Study|Inappropriate Enrollment|0|||
19634744|NCT00806195|42084104|FG000|Overall Study|Administrative Reason|113|||
19634745|NCT00806195|42084105|FG001|Overall Study|Administrative Reason|35|||
19634746|NCT00806195|42084106|FG002|Overall Study|Administrative Reason|66|||
19634747|NCT00806195|42084107|FG003|Overall Study|Administrative Reason|26|||
19634748|NCT00806195|42084104|FG000|Overall Study|Protocol Violation|34|||
19634749|NCT00806195|42084105|FG001|Overall Study|Protocol Violation|24|||
19634750|NCT00806195|42084106|FG002|Overall Study|Protocol Violation|26|||
19634751|NCT00806195|42084107|FG003|Overall Study|Protocol Violation|9|||
19634752|NCT00733746|42084119|FG000|Overall Study|Ineligible|5|||
19634753|NCT00718419|42084125|FG000|Overall Study|Adverse Event|2|||
19634754|NCT00718419|42084126|FG001|Overall Study|Adverse Event|1|||
19634755|NCT00718419|42084125|FG000|Overall Study|Physician Decision|1|||
19634756|NCT00718419|42084126|FG001|Overall Study|Physician Decision|6|||
19634757|NCT00718419|42084125|FG000|Overall Study|Sponsor decision|0|||
19634758|NCT00718419|42084126|FG001|Overall Study|Sponsor decision|1|||
19634759|NCT00718419|42084125|FG000|Overall Study|Withdrawal by Subject|0|||
19634760|NCT00718419|42084126|FG001|Overall Study|Withdrawal by Subject|5|||
19634761|NCT00718419|42084125|FG000|Overall Study|Progressive Disease|7|||
19634762|NCT00718419|42084126|FG001|Overall Study|Progressive Disease|25|||
19634763|NCT00718419|42084125|FG000|Overall Study|Death Due to Progressive Disease|2|||
19634764|NCT00718419|42084126|FG001|Overall Study|Death Due to Progressive Disease|0|||
19634765|NCT00718419|42084125|FG000|Overall Study|Death Due to Study Drug Related|0|||
19634766|NCT00718419|42084126|FG001|Overall Study|Death Due to Study Drug Related|1|||
19634767|NCT00718419|42084125|FG000|Overall Study|Death Due to Adverse Events|1|||
19634768|NCT00718419|42084126|FG001|Overall Study|Death Due to Adverse Events|0|||
19634769|NCT00717249|42084134|FG000|Overall Study|Lens Discomfort|4|||
19634770|NCT00717249|42084135|FG001|Overall Study|Lens Discomfort|1|||
19634771|NCT00717249|42084134|FG000|Overall Study|Unsatisfactory visual Response|0|||
19634772|NCT00717249|42084135|FG001|Overall Study|Unsatisfactory visual Response|2|||
19634773|NCT00717249|42084134|FG000|Overall Study|Adverse Event|4|||
19543603|NCT01155583|41993037|FG004|Phase I|Screen failure - did not start treatment|1|||
19543604|NCT01155583|41993038|FG005|Phase I|Screen failure - did not start treatment|0|||
19543605|NCT01155583|41993039|FG006|Phase I|Screen failure - did not start treatment|0|||
19543606|NCT01155583|41993040|FG007|Phase I|Screen failure - did not start treatment|2|||
19543607|NCT01155583|41993041|FG008|Phase I|Screen failure - did not start treatment|0|||
19543608|NCT01155583|41993033|FG000|Phase I|Withdrawal by Subject|0|||
19543609|NCT01155583|41993034|FG001|Phase I|Withdrawal by Subject|0|||
19543610|NCT01155583|41993035|FG002|Phase I|Withdrawal by Subject|0|||
19543611|NCT01155583|41993036|FG003|Phase I|Withdrawal by Subject|0|||
19543612|NCT01155583|41993037|FG004|Phase I|Withdrawal by Subject|0|||
19543613|NCT01155583|41993038|FG005|Phase I|Withdrawal by Subject|0|||
19543614|NCT01155583|41993039|FG006|Phase I|Withdrawal by Subject|0|||
19543615|NCT01155583|41993040|FG007|Phase I|Withdrawal by Subject|1|||
19543616|NCT01155583|41993041|FG008|Phase I|Withdrawal by Subject|0|||
19543617|NCT01155466|41993062|FG000|Overall Study|Adverse Event|13|||
19543618|NCT01155466|41993063|FG001|Overall Study|Adverse Event|15|||
19543619|NCT01155466|41993064|FG002|Overall Study|Adverse Event|6|||
19543620|NCT01155466|41993065|FG003|Overall Study|Adverse Event|17|||
19543621|NCT01155466|41993066|FG004|Overall Study|Adverse Event|18|||
19543622|NCT01155466|41993062|FG000|Overall Study|Lost to Follow-up|0|||
19634774|NCT00717249|42084135|FG001|Overall Study|Adverse Event|2|||
19634775|NCT00717249|42084134|FG000|Overall Study|Lost to Follow-up|2|||
19634776|NCT00717249|42084135|FG001|Overall Study|Lost to Follow-up|0|||
19634777|NCT00717249|42084134|FG000|Overall Study|Withdrawal by Subject|1|||
19634778|NCT00717249|42084135|FG001|Overall Study|Withdrawal by Subject|2|||
19634779|NCT00717249|42084134|FG000|Overall Study|Pregnancy|6|||
19634780|NCT00717249|42084135|FG001|Overall Study|Pregnancy|3|||
19634781|NCT00717249|42084134|FG000|Overall Study|Protocol Violation|0|||
19634782|NCT00717249|42084135|FG001|Overall Study|Protocol Violation|2|||
19634783|NCT00717249|42084134|FG000|Overall Study|Subject became Ineligible|1|||
19634784|NCT00717249|42084135|FG001|Overall Study|Subject became Ineligible|1|||
19543623|NCT01155466|41993063|FG001|Overall Study|Lost to Follow-up|0|||
19543624|NCT01155466|41993064|FG002|Overall Study|Lost to Follow-up|0|||
19543625|NCT01155466|41993065|FG003|Overall Study|Lost to Follow-up|0|||
19543626|NCT01155466|41993066|FG004|Overall Study|Lost to Follow-up|2|||
19543627|NCT01155466|41993062|FG000|Overall Study|Withdrawal by Subject|7|||
19543628|NCT01155466|41993063|FG001|Overall Study|Withdrawal by Subject|5|||
19543629|NCT01155466|41993064|FG002|Overall Study|Withdrawal by Subject|9|||
19543630|NCT01155466|41993065|FG003|Overall Study|Withdrawal by Subject|4|||
19543631|NCT01155466|41993066|FG004|Overall Study|Withdrawal by Subject|4|||
19634785|NCT00717249|42084134|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
19634786|NCT00717249|42084135|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
19634787|NCT00717249|42084134|FG000|Overall Study|Gastric Surgery|0|||
19634788|NCT00717249|42084135|FG001|Overall Study|Gastric Surgery|1|||
19634789|NCT00717249|42084134|FG000|Overall Study|Diagnosed with Diabetes|1|||
19634790|NCT00717249|42084135|FG001|Overall Study|Diagnosed with Diabetes|0|||
19634791|NCT00717249|42084134|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
19634792|NCT00717249|42084135|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
19634793|NCT00717249|42084134|FG000|Overall Study|Subject relocated|1|||
19634794|NCT00717249|42084135|FG001|Overall Study|Subject relocated|0|||
19634795|NCT00717249|42084134|FG000|Overall Study|Headaches|1|||
19634796|NCT00717249|42084135|FG001|Overall Study|Headaches|0|||
19634797|NCT00727194|42084141|FG000|Screening Period|Low QMG scores|0|||
19634798|NCT00727194|42084142|FG001|Screening Period|Low QMG scores|0|||
19634799|NCT00727194|42084143|FG002|Screening Period|Low QMG scores|6|||
19634800|NCT00727194|42084141|FG000|Screening Period|Lacked AChR antibodies|0|||
19634801|NCT00727194|42084142|FG001|Screening Period|Lacked AChR antibodies|0|||
19634802|NCT00727194|42084143|FG002|Screening Period|Lacked AChR antibodies|5|||
19634803|NCT00727194|42084141|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
19375435|NCT02276482|41617383|FG000|Overall Study|Gram-negative infection|1|||
19543632|NCT01155466|41993062|FG000|Overall Study|Protocol Violation|0|||
19543633|NCT01155466|41993063|FG001|Overall Study|Protocol Violation|0|||
19543634|NCT01155466|41993064|FG002|Overall Study|Protocol Violation|2|||
19543635|NCT01155466|41993065|FG003|Overall Study|Protocol Violation|0|||
19543636|NCT01155466|41993066|FG004|Overall Study|Protocol Violation|1|||
19543637|NCT01155466|41993062|FG000|Overall Study|Administrative|0|||
19543638|NCT01155466|41993063|FG001|Overall Study|Administrative|3|||
19543639|NCT01155466|41993064|FG002|Overall Study|Administrative|0|||
19543640|NCT01155466|41993065|FG003|Overall Study|Administrative|0|||
19634804|NCT00727194|42084142|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
19634805|NCT00727194|42084143|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
19634806|NCT00727194|42084141|FG000|Screening Period|Severe infections|0|||
19634807|NCT00727194|42084142|FG001|Screening Period|Severe infections|0|||
19634808|NCT00727194|42084143|FG002|Screening Period|Severe infections|2|||
19634809|NCT00727194|42084141|FG000|Screening Period|History of thymoma|0|||
19634810|NCT00727194|42084142|FG001|Screening Period|History of thymoma|0|||
19634811|NCT00727194|42084143|FG002|Screening Period|History of thymoma|1|||
19634812|NCT00727194|42084141|FG000|Treatment Period 2|Lack of Efficacy|0|||
19634813|NCT00727194|42084142|FG001|Treatment Period 2|Lack of Efficacy|1|||
19634814|NCT00727194|42084143|FG002|Treatment Period 2|Lack of Efficacy|0|||
19634815|NCT00717093|42084159|FG000|Overall Study|Adverse Event|19|||
19634816|NCT00717093|42084160|FG001|Overall Study|Adverse Event|9|||
19634817|NCT00717093|42084159|FG000|Overall Study|Lack of Efficacy|3|||
19634818|NCT00717093|42084160|FG001|Overall Study|Lack of Efficacy|13|||
19634819|NCT00717093|42084159|FG000|Overall Study|Lost to Follow-up|9|||
19634820|NCT00717093|42084160|FG001|Overall Study|Lost to Follow-up|6|||
19634821|NCT00717093|42084159|FG000|Overall Study|Withdrawal by Subject|12|||
19634822|NCT00717093|42084160|FG001|Overall Study|Withdrawal by Subject|19|||
19634823|NCT00717093|42084159|FG000|Overall Study|Other|0|||
19634824|NCT00717093|42084160|FG001|Overall Study|Other|1|||
19634825|NCT00717093|42084159|FG000|Overall Study|Randomized but not treated|1|||
19634826|NCT00717093|42084160|FG001|Overall Study|Randomized but not treated|0|||
19634827|NCT00716859|42084168|FG000|Overall Study|Adverse Event|4|||
19634828|NCT00716859|42084169|FG001|Overall Study|Adverse Event|1|||
19634829|NCT00716859|42084168|FG000|Overall Study|Lack of Efficacy|3|||
19634830|NCT00716859|42084169|FG001|Overall Study|Lack of Efficacy|0|||
19634831|NCT00716859|42084168|FG000|Overall Study|Withdrawal by Subject|1|||
19634832|NCT00716859|42084169|FG001|Overall Study|Withdrawal by Subject|3|||
19634833|NCT00716859|42084168|FG000|Overall Study|Not treated|1|||
19634834|NCT00716859|42084169|FG001|Overall Study|Not treated|1|||
19634835|NCT00589121|42084177|FG000|Overall Study|Protocol Violation|2|||
19634836|NCT00589121|42084178|FG001|Overall Study|Protocol Violation|6|||
19634837|NCT00589121|42084177|FG000|Overall Study|No protocol treatment received|0|||
19634838|NCT00589121|42084178|FG001|Overall Study|No protocol treatment received|1|||
19634839|NCT00590135|42084187|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
19634840|NCT00589667|42084192|FG000|Overall Study|Adverse Event|2|||
19634841|NCT00589667|42084192|FG000|Overall Study|Withdrawal by Subject|1|||
19634842|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
19634843|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
19634844|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
19634845|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
19634846|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
19634847|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
19634848|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
19634849|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
19634850|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
19634851|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
19634852|NCT00737568|42084198|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
19634853|NCT00737568|42084199|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
19634854|NCT00737568|42084198|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
19634855|NCT00737568|42084199|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
19634856|NCT00737568|42084198|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
19634857|NCT00737568|42084199|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
19634858|NCT00737568|42084198|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
19634859|NCT00737568|42084199|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
19634860|NCT00737100|42084208|FG000|Overall Study|Adverse Event|6|||
19634861|NCT00737100|42084209|FG001|Overall Study|Adverse Event|5|||
19634862|NCT00737100|42084210|FG002|Overall Study|Adverse Event|3|||
19634863|NCT00737100|42084208|FG000|Overall Study|Lost to Follow-up|0|||
19634864|NCT00737100|42084209|FG001|Overall Study|Lost to Follow-up|1|||
19634865|NCT00737100|42084210|FG002|Overall Study|Lost to Follow-up|0|||
19634866|NCT00737100|42084208|FG000|Overall Study|Withdrawal by Subject|0|||
19634867|NCT00737100|42084209|FG001|Overall Study|Withdrawal by Subject|0|||
19634868|NCT00737100|42084210|FG002|Overall Study|Withdrawal by Subject|3|||
19634869|NCT00737100|42084208|FG000|Overall Study|Reason discontinued not explained above|1|||
19634870|NCT00737100|42084209|FG001|Overall Study|Reason discontinued not explained above|1|||
19634871|NCT00737100|42084210|FG002|Overall Study|Reason discontinued not explained above|1|||
19458181|NCT01426269|41711907|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
19634872|NCT00732498|42084220|FG000|Overall Study|Ineligible|1|||
19458182|NCT01426269|41711908|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
19634873|NCT00732498|42084220|FG000|Overall Study|Adverse Event|2|||
19634874|NCT00732498|42084220|FG000|Overall Study|Physician Decision|3|||
19634875|NCT00726882|42084224|FG000|Overall Study|Withdrawal by Subject|5|||
19634876|NCT00726882|42084224|FG000|Overall Study|Lost to Follow-up|7|||
19634877|NCT00726882|42084224|FG000|Overall Study|Other|10|||
19634878|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
19634879|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
19634880|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
19634881|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
19634882|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
19634883|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
19634884|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
19634885|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
19634886|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
19634887|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
19634888|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
19634889|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
19634890|NCT00790400|42084232|FG000|Double-blind Period (Core Phase)|Death|1|||
19634891|NCT00790400|42084233|FG001|Double-blind Period (Core Phase)|Death|0|||
19634892|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
19634893|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
19634894|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
19634895|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
19634896|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
19634897|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
19634898|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
19634899|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
19634900|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
19634901|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
19634902|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Death|1|||
19634903|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Death|0|||
19634904|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
19634905|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
19634906|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
19634907|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
19634908|NCT00790400|42084232|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
19634909|NCT00790400|42084233|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
19634910|NCT00786032|42084242|FG000|Overall Study|Death|4|||
19634911|NCT00786032|42084242|FG000|Overall Study|Withdrawal by Subject|14|||
19634912|NCT00786032|42084242|FG000|Overall Study|Did not complete in the timeframe|6|||
19634913|NCT00716625|42084248|FG000|Overall Study|Safety was not Assessable|1|||
19634914|NCT00785486|42084266|FG000|Midazolam Alone|Withdrawal by Subject|1|||
19634915|NCT00589979|42084289|FG000|Run-In Period|Adverse Event|5|||
19634916|NCT00589979|42084290|FG001|Run-In Period|Adverse Event|0|||
19634917|NCT00589979|42084291|FG002|Run-In Period|Adverse Event|0|||
19634918|NCT00589979|42084289|FG000|Run-In Period|Protocol Violation|3|||
19634919|NCT00589979|42084290|FG001|Run-In Period|Protocol Violation|0|||
19634920|NCT00589979|42084291|FG002|Run-In Period|Protocol Violation|0|||
19634921|NCT00589979|42084289|FG000|Run-In Period|Did not qualify for randomization|54|||
19634922|NCT00589979|42084290|FG001|Run-In Period|Did not qualify for randomization|0|||
19634923|NCT00589979|42084291|FG002|Run-In Period|Did not qualify for randomization|0|||
19634924|NCT00589979|42084289|FG000|Run-In Period|Withdrawal by Subject|10|||
19634925|NCT00589979|42084290|FG001|Run-In Period|Withdrawal by Subject|0|||
19458183|NCT01426269|41711909|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
19458184|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Adverse Event|0|||
19458185|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Adverse Event|1|||
19458186|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Adverse Event|2|||
19458187|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
19458188|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
19458189|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
19458190|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
19458191|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
19543641|NCT01155466|41993066|FG004|Overall Study|Administrative|0|||
19543642|NCT01155466|41993062|FG000|Overall Study|Randomized not treated|2|||
19543643|NCT01155466|41993063|FG001|Overall Study|Randomized not treated|2|||
19543644|NCT01155466|41993064|FG002|Overall Study|Randomized not treated|3|||
19543645|NCT01155466|41993065|FG003|Overall Study|Randomized not treated|0|||
19543646|NCT01155466|41993066|FG004|Overall Study|Randomized not treated|2|||
19543647|NCT01155388|41993080|FG000|Overall Study|Adverse Event|1|||
19543648|NCT01155388|41993081|FG001|Overall Study|Adverse Event|0|||
19543649|NCT01154452|41993092|FG000|Phase Ib|Not Treated|1|||
19458192|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
19543650|NCT01154452|41993093|FG001|Phase Ib|Not Treated|0|||
19634926|NCT00589979|42084291|FG002|Run-In Period|Withdrawal by Subject|0|||
19634927|NCT00589979|42084289|FG000|Run-In Period|Informed Consent Withdrawn|4|||
19634928|NCT00589979|42084290|FG001|Run-In Period|Informed Consent Withdrawn|0|||
19634929|NCT00589979|42084291|FG002|Run-In Period|Informed Consent Withdrawn|0|||
19634930|NCT00589979|42084289|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
19634931|NCT00589979|42084290|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
19634932|NCT00589979|42084291|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
19634933|NCT00589979|42084289|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
19634934|NCT00589979|42084290|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
19634935|NCT00589979|42084291|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
19634936|NCT00589979|42084289|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
19634937|NCT00589979|42084290|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
19634938|NCT00589979|42084291|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
19634939|NCT00589979|42084289|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
19634940|NCT00589979|42084290|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
19634941|NCT00589979|42084291|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
19634942|NCT00589979|42084289|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
19634943|NCT00589979|42084290|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
19634944|NCT00589979|42084291|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
19634945|NCT00589979|42084289|FG000|Double-Blind Treatment Period 2|Other|0|||
19634946|NCT00589979|42084290|FG001|Double-Blind Treatment Period 2|Other|0|||
19634947|NCT00589979|42084291|FG002|Double-Blind Treatment Period 2|Other|1|||
19634948|NCT00589979|42084289|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
19634949|NCT00589979|42084290|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
19634950|NCT00589979|42084291|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
19634951|NCT00589979|42084289|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
19634952|NCT00589979|42084290|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
19634953|NCT00589979|42084291|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
19634954|NCT00797732|42084305|FG000|Overall Study|Withdrawal by Subject|3|||
19458193|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
19458194|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
19458195|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
19458196|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Site closed|0|||
19458197|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Site closed|6|||
19458198|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Site closed|5|||
19458199|NCT01426269|41711907|FG000|Period 2: 40 Weeks|Relapsed|0|||
19458200|NCT01426269|41711908|FG001|Period 2: 40 Weeks|Relapsed|9|||
19458201|NCT01426269|41711909|FG002|Period 2: 40 Weeks|Relapsed|18|||
19458202|NCT01426113|41711922|FG000|Overall Study|Study Discontinued|1|||
19458203|NCT01426113|41711923|FG001|Overall Study|Study Discontinued|1|||
19458204|NCT01426113|41711922|FG000|Overall Study|Adverse Event|0|||
19543651|NCT01154452|41993094|FG002|Phase Ib|Not Treated|0|||
19543652|NCT01154452|41993095|FG003|Phase Ib|Not Treated|0|||
19543653|NCT01154452|41993092|FG000|Phase Ib|Adverse Event|2|||
19543654|NCT01154452|41993093|FG001|Phase Ib|Adverse Event|1|||
19543655|NCT01154452|41993094|FG002|Phase Ib|Adverse Event|0|||
19543656|NCT01154452|41993095|FG003|Phase Ib|Adverse Event|0|||
19543657|NCT01154452|41993092|FG000|Phase II|Withdrawal by Subject|0|||
19543658|NCT01154452|41993093|FG001|Phase II|Withdrawal by Subject|0|||
19543659|NCT01154452|41993094|FG002|Phase II|Withdrawal by Subject|1|||
19543660|NCT01154452|41993095|FG003|Phase II|Withdrawal by Subject|2|||
19543661|NCT01154452|41993092|FG000|Phase II|Adverse Event|0|||
19543662|NCT01154452|41993093|FG001|Phase II|Adverse Event|0|||
19543663|NCT01154452|41993094|FG002|Phase II|Adverse Event|4|||
19543664|NCT01154452|41993095|FG003|Phase II|Adverse Event|4|||
19543665|NCT01154296|41993110|FG000|Randomization and Intervention|Decided to decline|1|||
19543666|NCT01154296|41993111|FG001|Randomization and Intervention|Decided to decline|1|||
19543667|NCT01154296|41993110|FG000|Randomization and Intervention|Declined by staff|1|||
19543668|NCT01154296|41993111|FG001|Randomization and Intervention|Declined by staff|0|||
19543669|NCT01154296|41993110|FG000|Randomization and Intervention|Did not return|1|||
19543670|NCT01154296|41993111|FG001|Randomization and Intervention|Did not return|0|||
19543671|NCT01154296|41993110|FG000|Randomization and Intervention|Left before test|0|||
19543672|NCT01154296|41993111|FG001|Randomization and Intervention|Left before test|1|||
19543673|NCT01154296|41993110|FG000|Randomization and Intervention|Left clinic early|2|||
19543674|NCT01154296|41993111|FG001|Randomization and Intervention|Left clinic early|0|||
19543675|NCT01154296|41993110|FG000|6-month Follow-up|Lost contact|269|||
19543676|NCT01154296|41993111|FG001|6-month Follow-up|Lost contact|275|||
19543677|NCT01154296|41993110|FG000|6-month Follow-up|Incarcerated|37|||
19543678|NCT01154296|41993111|FG001|6-month Follow-up|Incarcerated|32|||
19458205|NCT01426113|41711923|FG001|Overall Study|Adverse Event|1|||
19458206|NCT01864603|41711931|FG000|Stage 2|DSMB design modification|86056|||
19543679|NCT01154296|41993110|FG000|6-month Follow-up|Withdrew consent|14|||
19543680|NCT01154296|41993111|FG001|6-month Follow-up|Withdrew consent|15|||
19543681|NCT01154296|41993110|FG000|6-month Follow-up|Death|3|||
19634955|NCT00797732|42084306|FG001|Overall Study|Withdrawal by Subject|3|||
19634956|NCT00797732|42084307|FG002|Overall Study|Withdrawal by Subject|0|||
19634957|NCT00797732|42084305|FG000|Overall Study|Lost to Follow-up|1|||
19634958|NCT00797732|42084306|FG001|Overall Study|Lost to Follow-up|0|||
19634959|NCT00797732|42084307|FG002|Overall Study|Lost to Follow-up|0|||
19634960|NCT00797732|42084305|FG000|Overall Study|Death|1|||
19634961|NCT00797732|42084306|FG001|Overall Study|Death|0|||
19634962|NCT00797732|42084307|FG002|Overall Study|Death|0|||
19634963|NCT00797732|42084305|FG000|Overall Study|Not meet inclusion criteria|0|||
19634964|NCT00797732|42084306|FG001|Overall Study|Not meet inclusion criteria|0|||
19634965|NCT00797732|42084307|FG002|Overall Study|Not meet inclusion criteria|7|||
19634966|NCT00797732|42084305|FG000|Overall Study|Excluded due to time constraints|0|||
19634967|NCT00797732|42084306|FG001|Overall Study|Excluded due to time constraints|0|||
19634968|NCT00797732|42084307|FG002|Overall Study|Excluded due to time constraints|24|||
19634969|NCT00797732|42084305|FG000|Overall Study|Refused to Participate|0|||
19634970|NCT00797732|42084306|FG001|Overall Study|Refused to Participate|0|||
19634971|NCT00797732|42084307|FG002|Overall Study|Refused to Participate|123|||
19634972|NCT00790088|42084313|FG000|Overall Study|Protocol Violation|11|||
19634973|NCT00790088|42084313|FG000|Overall Study|Withdrawal by Subject|17|||
19634974|NCT00790088|42084313|FG000|Overall Study|Lost to Follow-up|7|||
19634975|NCT00790088|42084313|FG000|Overall Study|Physician Decision|4|||
19634976|NCT00736944|42084319|FG000|Induction|Death|1|||
19634977|NCT00736944|42084319|FG000|Definitive Treatment|Physician Decision|1|||
19634978|NCT00736476|42084328|FG000|Overall Study|Adverse Event|1|||
19634979|NCT00736476|42084329|FG001|Overall Study|Adverse Event|0|||
19634980|NCT00715299|42084341|FG000|Overall Study|Withdrawal by Subject|1|||
19634981|NCT00715299|42084341|FG000|Overall Study|Adverse Event|3|||
19634982|NCT00715299|42084341|FG000|Overall Study|failed the pre-screen exercise test|2|||
19634983|NCT00730236|42084345|FG000|Overall Study|Adverse Event|4|||
19634984|NCT00730236|42084345|FG000|Overall Study|Withdrawal by Subject|1|||
19711965|NCT00075218|42154938|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
19711966|NCT00075218|42154939|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
19711967|NCT00075218|42154940|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
19711968|NCT00075218|42154938|FG000|Double-Blind Treatment|No study medication taken|2|||
19711969|NCT00075218|42154939|FG001|Double-Blind Treatment|No study medication taken|0|||
19711970|NCT00075218|42154940|FG002|Double-Blind Treatment|No study medication taken|0|||
19711971|NCT00075218|42154938|FG000|Open-Label Treatment|Lack of Efficacy|0|||
19711972|NCT00075218|42154939|FG001|Open-Label Treatment|Lack of Efficacy|0|||
19711973|NCT00075218|42154940|FG002|Open-Label Treatment|Lack of Efficacy|174|||
19711974|NCT00075218|42154938|FG000|Open-Label Treatment|Adverse Event|0|||
19711975|NCT00075218|42154939|FG001|Open-Label Treatment|Adverse Event|0|||
19711976|NCT00075218|42154940|FG002|Open-Label Treatment|Adverse Event|51|||
19634985|NCT00730236|42084345|FG000|Overall Study|Non-compliance|1|||
19711977|NCT00075218|42154938|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
19711978|NCT00075218|42154939|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
19711979|NCT00075218|42154940|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
19458207|NCT01864603|41711932|FG001|Stage 2|DSMB design modification|92558|||
19458208|NCT01892293|41711943|FG000|Overall Study|Apheresed but not treated|4|||
19634986|NCT00714285|42084353|FG000|Overall Study|Lost to Follow-up|0|||
19458209|NCT01393899|41711950|FG000|Overall Study|Study terminated by sponsor|1|||
19458210|NCT01393899|41711951|FG001|Overall Study|Study terminated by sponsor|0|||
19458211|NCT01393899|41711952|FG002|Overall Study|Study terminated by sponsor|1|||
19458212|NCT01393899|41711950|FG000|Overall Study|Other|1|||
19458213|NCT01393899|41711951|FG001|Overall Study|Other|0|||
19458214|NCT01393899|41711952|FG002|Overall Study|Other|0|||
19458215|NCT01393899|41711950|FG000|Overall Study|Withdrawal by Subject|2|||
19458216|NCT01393899|41711951|FG001|Overall Study|Withdrawal by Subject|2|||
19458217|NCT01393899|41711952|FG002|Overall Study|Withdrawal by Subject|1|||
19458218|NCT01393899|41711950|FG000|Overall Study|Lost to Follow-up|0|||
19458219|NCT01393899|41711951|FG001|Overall Study|Lost to Follow-up|0|||
19458220|NCT01393899|41711952|FG002|Overall Study|Lost to Follow-up|1|||
19458221|NCT01393899|41711950|FG000|Overall Study|Does not meet entrance criteria|1|||
19634987|NCT00714285|42084354|FG001|Overall Study|Lost to Follow-up|2|||
19634988|NCT00714285|42084355|FG002|Overall Study|Lost to Follow-up|0|||
19634989|NCT00714285|42084356|FG003|Overall Study|Lost to Follow-up|1|||
19634990|NCT00714285|42084353|FG000|Overall Study|Migrated/moved from study area|0|||
19634991|NCT00714285|42084354|FG001|Overall Study|Migrated/moved from study area|1|||
19634992|NCT00714285|42084355|FG002|Overall Study|Migrated/moved from study area|0|||
19634993|NCT00714285|42084356|FG003|Overall Study|Migrated/moved from study area|0|||
19634994|NCT00776984|42084370|FG000|Overall Study|Adverse Event|8|||
19634995|NCT00776984|42084371|FG001|Overall Study|Adverse Event|2|||
19711980|NCT00075218|42154938|FG000|Open-Label Treatment|Decision of Sponsor|0|||
19711981|NCT00075218|42154939|FG001|Open-Label Treatment|Decision of Sponsor|0|||
19711982|NCT00075218|42154940|FG002|Open-Label Treatment|Decision of Sponsor|8|||
19711983|NCT00075218|42154938|FG000|Open-Label Treatment|Protocol Violation|0|||
19711984|NCT00075218|42154939|FG001|Open-Label Treatment|Protocol Violation|0|||
19634996|NCT00776984|42084370|FG000|Overall Study|Protocol Violation|4|||
19634997|NCT00776984|42084371|FG001|Overall Study|Protocol Violation|2|||
19634998|NCT00776984|42084370|FG000|Overall Study|Lost to Follow-up|2|||
19634999|NCT00776984|42084371|FG001|Overall Study|Lost to Follow-up|0|||
19635000|NCT00776984|42084370|FG000|Overall Study|Withdrawal by Subject|12|||
19635001|NCT00776984|42084371|FG001|Overall Study|Withdrawal by Subject|7|||
19635002|NCT00776984|42084370|FG000|Overall Study|Lack of Efficacy|0|||
19635003|NCT00776984|42084371|FG001|Overall Study|Lack of Efficacy|1|||
19635004|NCT00776984|42084370|FG000|Overall Study|Other|5|||
19635005|NCT00776984|42084371|FG001|Overall Study|Other|9|||
19635006|NCT00714051|42084379|FG000|Overall Study|Withdrawal by Subject|1|||
19635007|NCT00714051|42084380|FG001|Overall Study|Withdrawal by Subject|0|||
19635008|NCT00714051|42084379|FG000|Overall Study|Death|0|||
19635009|NCT00714051|42084380|FG001|Overall Study|Death|1|||
19635010|NCT00784784|42084388|FG000|Overall Study|Withdrawal by Subject|2|||
19635011|NCT00784784|42084389|FG001|Overall Study|Withdrawal by Subject|2|||
19635012|NCT00801983|42084397|FG000|Period 1|Lost to Follow-up|2|||
19635013|NCT00801983|42084398|FG001|Period 1|Lost to Follow-up|0|||
19635014|NCT00801983|42084397|FG000|Period 1|Withdrawal by Subject|2|||
19635015|NCT00801983|42084398|FG001|Period 1|Withdrawal by Subject|8|||
19635016|NCT00801983|42084397|FG000|Period 2|Withdrawal by Subject|2|||
19635017|NCT00801983|42084398|FG001|Period 2|Withdrawal by Subject|1|||
19635018|NCT00587288|42084406|FG000|Overall Study|Adverse Event|0|||
19635019|NCT00587288|42084407|FG001|Overall Study|Adverse Event|1|||
19635020|NCT00587288|42084406|FG000|Overall Study|Lack of Efficacy|2|||
19635021|NCT00587288|42084407|FG001|Overall Study|Lack of Efficacy|8|||
19635022|NCT00587288|42084406|FG000|Overall Study|Protocol Violation|1|||
19635023|NCT00587288|42084407|FG001|Overall Study|Protocol Violation|0|||
19635024|NCT00800735|42084415|FG000|Overall Study|Administrative/Other|2|||
19635025|NCT00800735|42084415|FG000|Overall Study|Insufficient Therapeutic Response|2|||
19635026|NCT00800735|42084415|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
19635027|NCT00800735|42084415|FG000|Overall Study|Withdrew Consent|3|||
19635028|NCT00730158|42084421|FG000|Overall Study|Withdrawal by Subject|1|||
19635029|NCT00730158|42084422|FG001|Overall Study|Withdrawal by Subject|1|||
19635030|NCT00784550|42084434|FG000|Overall Study|Adverse Event|12|||
19635031|NCT00784550|42084435|FG001|Overall Study|Adverse Event|10|||
19635032|NCT00784550|42084434|FG000|Overall Study|Lack of Efficacy|0|||
19635033|NCT00784550|42084435|FG001|Overall Study|Lack of Efficacy|1|||
19635034|NCT00784550|42084434|FG000|Overall Study|Protocol Violation|10|||
19635035|NCT00784550|42084435|FG001|Overall Study|Protocol Violation|10|||
19635036|NCT00784550|42084434|FG000|Overall Study|Lost to Follow-up|8|||
19635037|NCT00784550|42084435|FG001|Overall Study|Lost to Follow-up|5|||
19635038|NCT00784550|42084434|FG000|Overall Study|Physician Decision|2|||
19635039|NCT00784550|42084435|FG001|Overall Study|Physician Decision|3|||
19635040|NCT00784550|42084434|FG000|Overall Study|Withdrawal by Subject|4|||
19635041|NCT00784550|42084435|FG001|Overall Study|Withdrawal by Subject|13|||
19635042|NCT00729690|42084444|FG000|Overall Study|IT Catheter Malfunction|0|||
19635043|NCT00729690|42084445|FG001|Overall Study|IT Catheter Malfunction|2|||
19635044|NCT00729690|42084446|FG002|Overall Study|IT Catheter Malfunction|2|||
19635045|NCT00784238|42084454|FG000|Overall Study|Adverse Event|14|||
19635046|NCT00784238|42084454|FG000|Overall Study|Death|2|||
19635047|NCT00784238|42084454|FG000|Overall Study|Lack of Efficacy|33|||
19635048|NCT00784238|42084454|FG000|Overall Study|Lost to Follow-up|29|||
19635049|NCT00784238|42084454|FG000|Overall Study|Pregnancy|1|||
19635050|NCT00784238|42084454|FG000|Overall Study|Withdrawal by Subject|26|||
19635051|NCT00784238|42084454|FG000|Overall Study|Other|14|||
19635052|NCT00729612|42084461|FG000|Overall Study|Non evaluable for response|10|||
19635053|NCT00585546|42084465|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
19635054|NCT00585546|42084465|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
19635055|NCT00768248|42084471|FG000|Overall Study|Research coordinator didn't collect data|1|||
19635056|NCT00768248|42084472|FG001|Overall Study|Research coordinator didn't collect data|1|||
19635057|NCT00775268|42084480|FG000|Baseline|Drug not synthesize dose|1|||
19635058|NCT00775268|42084481|FG001|Baseline|Drug not synthesize dose|0|||
19635059|NCT00775268|42084480|FG000|Baseline|Not treated-ineligible per CT|0|||
19635060|NCT00775268|42084481|FG001|Baseline|Not treated-ineligible per CT|1|||
19635061|NCT00775268|42084480|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
19635062|NCT00775268|42084481|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
19635063|NCT00775268|42084480|FG000|After Completion|Participant missed scan appointment|1|||
19635064|NCT00775268|42084481|FG001|After Completion|Participant missed scan appointment|0|||
19635065|NCT00775190|42084500|FG000|Overall Study|Lost to Follow-up|2|||
19635066|NCT00775190|42084501|FG001|Overall Study|Lost to Follow-up|3|||
19635067|NCT00775190|42084500|FG000|Overall Study|Withdrawal by Subject|1|||
19635068|NCT00775190|42084501|FG001|Overall Study|Withdrawal by Subject|2|||
19635069|NCT00775190|42084500|FG000|Overall Study|Protocol Violation|1|||
19635070|NCT00775190|42084501|FG001|Overall Study|Protocol Violation|0|||
19635071|NCT00479557|42084514|FG000|Overall Study|Death|0|||
19635072|NCT00479557|42084515|FG001|Overall Study|Death|0|||
19635073|NCT00479557|42084516|FG002|Overall Study|Death|0|||
19635074|NCT00479557|42084517|FG003|Overall Study|Death|0|||
19635075|NCT00479557|42084518|FG004|Overall Study|Death|0|||
19635076|NCT00479557|42084519|FG005|Overall Study|Death|1|||
19635077|NCT00479557|42084520|FG006|Overall Study|Death|0|||
19635078|NCT00479557|42084514|FG000|Overall Study|Lack of Efficacy|1|||
19635079|NCT00479557|42084515|FG001|Overall Study|Lack of Efficacy|0|||
19635080|NCT00479557|42084516|FG002|Overall Study|Lack of Efficacy|0|||
19635081|NCT00479557|42084517|FG003|Overall Study|Lack of Efficacy|0|||
19635082|NCT00479557|42084518|FG004|Overall Study|Lack of Efficacy|0|||
19635083|NCT00479557|42084519|FG005|Overall Study|Lack of Efficacy|0|||
19635084|NCT00479557|42084520|FG006|Overall Study|Lack of Efficacy|0|||
19635085|NCT00479557|42084514|FG000|Overall Study|Lost to Follow-up|0|||
19635086|NCT00479557|42084515|FG001|Overall Study|Lost to Follow-up|2|||
19635087|NCT00479557|42084516|FG002|Overall Study|Lost to Follow-up|0|||
19635088|NCT00479557|42084517|FG003|Overall Study|Lost to Follow-up|2|||
19458222|NCT01393899|41711951|FG001|Overall Study|Does not meet entrance criteria|0|||
19635089|NCT00479557|42084518|FG004|Overall Study|Lost to Follow-up|0|||
19635090|NCT00479557|42084519|FG005|Overall Study|Lost to Follow-up|0|||
19635091|NCT00479557|42084520|FG006|Overall Study|Lost to Follow-up|0|||
19635092|NCT00479557|42084514|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
19635093|NCT00479557|42084515|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19635094|NCT00479557|42084516|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
19635095|NCT00479557|42084517|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
19635096|NCT00479557|42084518|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19635097|NCT00479557|42084519|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
19635098|NCT00479557|42084520|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
19635099|NCT00479557|42084514|FG000|Overall Study|AE not related to Study Drug|1|||
19635100|NCT00479557|42084515|FG001|Overall Study|AE not related to Study Drug|3|||
19635101|NCT00479557|42084516|FG002|Overall Study|AE not related to Study Drug|0|||
19635102|NCT00479557|42084517|FG003|Overall Study|AE not related to Study Drug|0|||
19635103|NCT00479557|42084518|FG004|Overall Study|AE not related to Study Drug|2|||
19635104|NCT00479557|42084519|FG005|Overall Study|AE not related to Study Drug|2|||
19635105|NCT00479557|42084520|FG006|Overall Study|AE not related to Study Drug|1|||
19635106|NCT00479557|42084514|FG000|Overall Study|Caregiver Request|2|||
19635107|NCT00479557|42084515|FG001|Overall Study|Caregiver Request|2|||
19635108|NCT00479557|42084516|FG002|Overall Study|Caregiver Request|2|||
19635109|NCT00479557|42084517|FG003|Overall Study|Caregiver Request|0|||
19635110|NCT00479557|42084518|FG004|Overall Study|Caregiver Request|1|||
19635111|NCT00479557|42084519|FG005|Overall Study|Caregiver Request|2|||
19635112|NCT00479557|42084520|FG006|Overall Study|Caregiver Request|0|||
19635113|NCT00479557|42084514|FG000|Overall Study|Investigator Request|0|||
19635114|NCT00479557|42084515|FG001|Overall Study|Investigator Request|0|||
19635115|NCT00479557|42084516|FG002|Overall Study|Investigator Request|1|||
19635116|NCT00479557|42084517|FG003|Overall Study|Investigator Request|0|||
19635117|NCT00479557|42084518|FG004|Overall Study|Investigator Request|0|||
19635118|NCT00479557|42084519|FG005|Overall Study|Investigator Request|0|||
19635119|NCT00479557|42084520|FG006|Overall Study|Investigator Request|0|||
19635120|NCT00479557|42084514|FG000|Overall Study|Subject Request|3|||
19635121|NCT00479557|42084515|FG001|Overall Study|Subject Request|0|||
19711985|NCT00075218|42154940|FG002|Open-Label Treatment|Protocol Violation|1|||
19711986|NCT00075218|42154938|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
19711987|NCT00075218|42154939|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
19543682|NCT01154296|41993111|FG001|6-month Follow-up|Death|2|||
19543683|NCT01154296|41993110|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
19543684|NCT01154296|41993111|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
19543685|NCT01154218|41993117|FG000|Third Intervention Period|Adverse Event|0|||
19543686|NCT01154218|41993118|FG001|Third Intervention Period|Adverse Event|1|||
19543687|NCT01154218|41993119|FG002|Third Intervention Period|Adverse Event|0|||
19543688|NCT01154218|41993120|FG003|Third Intervention Period|Adverse Event|0|||
19458223|NCT01393899|41711952|FG002|Overall Study|Does not meet entrance criteria|1|||
19458224|NCT01393899|41711950|FG000|Overall Study|Lack of Efficacy|26|||
19458225|NCT01393899|41711951|FG001|Overall Study|Lack of Efficacy|21|||
19458226|NCT01393899|41711952|FG002|Overall Study|Lack of Efficacy|16|||
19458227|NCT01393899|41711950|FG000|Overall Study|Adverse Event|1|||
19458228|NCT01393899|41711951|FG001|Overall Study|Adverse Event|5|||
19458229|NCT01393899|41711952|FG002|Overall Study|Adverse Event|3|||
19458230|NCT01393743|41711964|FG000|Core Study|Adverse Event|5|||
19635122|NCT00479557|42084516|FG002|Overall Study|Subject Request|1|||
19635123|NCT00479557|42084517|FG003|Overall Study|Subject Request|1|||
19635124|NCT00479557|42084518|FG004|Overall Study|Subject Request|1|||
19635125|NCT00479557|42084519|FG005|Overall Study|Subject Request|4|||
19635126|NCT00479557|42084520|FG006|Overall Study|Subject Request|1|||
19635127|NCT00479557|42084514|FG000|Overall Study|Other|2|||
19635128|NCT00479557|42084515|FG001|Overall Study|Other|3|||
19635129|NCT00479557|42084516|FG002|Overall Study|Other|1|||
19458231|NCT01393743|41711965|FG001|Core Study|Adverse Event|9|||
19458232|NCT01393743|41711966|FG002|Core Study|Adverse Event|0|||
19635130|NCT00479557|42084517|FG003|Overall Study|Other|0|||
19635131|NCT00479557|42084518|FG004|Overall Study|Other|0|||
19635132|NCT00479557|42084519|FG005|Overall Study|Other|3|||
19635133|NCT00479557|42084520|FG006|Overall Study|Other|0|||
19543689|NCT01154218|41993117|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19635134|NCT00774800|42084542|FG000|Intervention 4|Withdrawal by Subject|1|||
19635135|NCT00439309|42084554|FG000|Follow-Up|Death|1|||
19543690|NCT01154218|41993118|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19543691|NCT01154218|41993119|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
19543692|NCT01154218|41993120|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
19543693|NCT01154218|41993117|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
19543694|NCT01154218|41993118|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
19543695|NCT01154218|41993119|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
19543696|NCT01154218|41993120|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
19543697|NCT01154140|41993145|FG000|Overall Study|Death|71|||
19635136|NCT00439309|42084555|FG001|Follow-Up|Death|0|||
19635137|NCT00439309|42084554|FG000|Follow-Up|Lost to Follow-up|2|||
19543698|NCT01154140|41993146|FG001|Overall Study|Death|81|||
19543699|NCT01154140|41993145|FG000|Overall Study|Lost to Follow-up|4|||
19543700|NCT01154140|41993146|FG001|Overall Study|Lost to Follow-up|5|||
19543701|NCT01154140|41993145|FG000|Overall Study|Withdrawal by Subject|12|||
19543702|NCT01154140|41993146|FG001|Overall Study|Withdrawal by Subject|13|||
19543703|NCT01154140|41993145|FG000|Overall Study|Other|3|||
19543704|NCT01154140|41993146|FG001|Overall Study|Other|1|||
19543705|NCT01154140|41993145|FG000|Overall Study|Randomized but not treated|1|||
19543706|NCT01154140|41993146|FG001|Overall Study|Randomized but not treated|2|||
19543707|NCT01154101|41993157|FG000|Overall Study|Adverse Event|0|||
19543708|NCT01154101|41993158|FG001|Overall Study|Adverse Event|2|||
19543709|NCT01154101|41993159|FG002|Overall Study|Adverse Event|1|||
19635138|NCT00439309|42084555|FG001|Follow-Up|Lost to Follow-up|0|||
19635139|NCT00439309|42084554|FG000|Follow-Up|Withdrawal by Subject|0|||
19635140|NCT00439309|42084555|FG001|Follow-Up|Withdrawal by Subject|1|||
19635141|NCT00439309|42084554|FG000|Follow-Up|Late response by subject|0|||
19635142|NCT00439309|42084555|FG001|Follow-Up|Late response by subject|1|||
19635143|NCT00479167|42084561|FG000|Overall Study|Withdrawal by Subject|1|||
19635144|NCT00725712|42084568|FG000|Overall Study|Withdrawal by Subject|2|||
19635145|NCT00725712|42084569|FG001|Overall Study|Withdrawal by Subject|1|||
19635146|NCT00725712|42084568|FG000|Overall Study|Protocol Violation|1|||
19635147|NCT00725712|42084569|FG001|Overall Study|Protocol Violation|0|||
19635148|NCT00725712|42084568|FG000|Overall Study|Progressive disease|37|||
19635149|NCT00725712|42084569|FG001|Overall Study|Progressive disease|16|||
19635150|NCT00725712|42084568|FG000|Overall Study|Clinical progression not based on RECIST|0|||
19635151|NCT00725712|42084569|FG001|Overall Study|Clinical progression not based on RECIST|3|||
19635152|NCT00725712|42084568|FG000|Overall Study|Adverse Event|5|||
19635153|NCT00725712|42084569|FG001|Overall Study|Adverse Event|5|||
19635154|NCT00725712|42084568|FG000|Overall Study|Death|2|||
19635155|NCT00725712|42084569|FG001|Overall Study|Death|0|||
19635156|NCT00725712|42084568|FG000|Overall Study|Other: Death|1|||
19635157|NCT00725712|42084569|FG001|Overall Study|Other: Death|0|||
19635158|NCT00725712|42084568|FG000|Overall Study|Hospitalized, unable to continue|0|||
19635159|NCT00725712|42084569|FG001|Overall Study|Hospitalized, unable to continue|1|||
19635160|NCT00729378|42084581|FG000|Baseline|Did not complete study measurements|72|||
19635161|NCT00729378|42084582|FG001|Baseline|Did not complete study measurements|33|||
19635162|NCT00729378|42084581|FG000|Baseline|Withdrawal by Subject|66|||
19635163|NCT00729378|42084582|FG001|Baseline|Withdrawal by Subject|59|||
19635164|NCT00729378|42084581|FG000|12-months|Lost to Follow-up|100|||
19635165|NCT00729378|42084582|FG001|12-months|Lost to Follow-up|65|||
19635166|NCT00729378|42084581|FG000|24-months|Lost to Follow-up|72|||
19635167|NCT00729378|42084582|FG001|24-months|Lost to Follow-up|51|||
19543710|NCT01154101|41993160|FG003|Overall Study|Adverse Event|1|||
19543711|NCT01154101|41993161|FG004|Overall Study|Adverse Event|0|||
19543712|NCT01154101|41993157|FG000|Overall Study|Lost to Follow-up|0|||
19543713|NCT01154101|41993158|FG001|Overall Study|Lost to Follow-up|1|||
19543714|NCT01154101|41993159|FG002|Overall Study|Lost to Follow-up|0|||
19635168|NCT00729378|42084581|FG000|36-months|Lost to Follow-up|15|||
19711988|NCT00075218|42154940|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
19711989|NCT00094653|42154950|FG000|Overall Study|Death|306|||
19711990|NCT00094653|42154951|FG001|Overall Study|Death|100|||
19458233|NCT01393743|41711964|FG000|Core Study|Lost to Follow-up|1|||
19543715|NCT01154101|41993160|FG003|Overall Study|Lost to Follow-up|1|||
19543716|NCT01154101|41993161|FG004|Overall Study|Lost to Follow-up|0|||
19543717|NCT01154101|41993157|FG000|Overall Study|Withdrawal by Subject|0|||
19543718|NCT01154101|41993158|FG001|Overall Study|Withdrawal by Subject|1|||
19543719|NCT01154101|41993159|FG002|Overall Study|Withdrawal by Subject|2|||
19635169|NCT00729378|42084582|FG001|36-months|Lost to Follow-up|6|||
19635170|NCT00478933|42084591|FG000|Overall Study|Protocol Violation|22|||
19635171|NCT00478933|42084591|FG000|Overall Study|Informed consent not verified|3|||
19711991|NCT00094653|42154952|FG002|Overall Study|Death|119|||
19543720|NCT01154101|41993160|FG003|Overall Study|Withdrawal by Subject|0|||
19635172|NCT00478933|42084591|FG000|Overall Study|Inadequate data available|53|||
19635173|NCT00725322|42084617|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
19635174|NCT00725322|42084618|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
19635175|NCT00725322|42084617|FG000|Washout (28 Days)|Protocol Violation|0|||
19543721|NCT01154101|41993161|FG004|Overall Study|Withdrawal by Subject|1|||
19543722|NCT01153984|41993178|FG000|Overall Study|Withdrawal by Subject|1|||
19543723|NCT01153984|41993178|FG000|Overall Study|Adverse Event|1|||
19543724|NCT01153633|41993184|FG000|Overall Study|Protocol Violation|1|||
19543725|NCT01153633|41993185|FG001|Overall Study|Protocol Violation|1|||
19543726|NCT01153633|41993184|FG000|Overall Study|Therapeutic failure|3|||
19543727|NCT01153633|41993185|FG001|Overall Study|Therapeutic failure|3|||
19543728|NCT01153516|41993195|FG000|Overall Study|Both subjects refused surgery|2|||
19543729|NCT01153516|41993196|FG001|Overall Study|Both subjects refused surgery|0|||
19543730|NCT01153321|41993204|FG000|Overall Study|Development of study withdrawal criteria|0|||
19543731|NCT01153321|41993205|FG001|Overall Study|Development of study withdrawal criteria|1|||
19543732|NCT01153321|41993204|FG000|Overall Study|Withdrawal by Subject|0|||
19543733|NCT01153321|41993205|FG001|Overall Study|Withdrawal by Subject|1|||
19543734|NCT01153321|41993204|FG000|Overall Study|Adverse Event|1|||
19543735|NCT01153321|41993205|FG001|Overall Study|Adverse Event|1|||
19543736|NCT01153009|41993215|FG000|Overall Study|Adverse Event|4|||
19543737|NCT01153009|41993216|FG001|Overall Study|Adverse Event|14|||
19543738|NCT01153009|41993217|FG002|Overall Study|Adverse Event|14|||
19543739|NCT01153009|41993218|FG003|Overall Study|Adverse Event|10|||
19543740|NCT01153009|41993215|FG000|Overall Study|Lack of Efficacy|9|||
19543741|NCT01153009|41993216|FG001|Overall Study|Lack of Efficacy|0|||
19543742|NCT01153009|41993217|FG002|Overall Study|Lack of Efficacy|2|||
19543743|NCT01153009|41993218|FG003|Overall Study|Lack of Efficacy|1|||
19543744|NCT01153009|41993215|FG000|Overall Study|Noncompliance with Study Medication|1|||
19543745|NCT01153009|41993216|FG001|Overall Study|Noncompliance with Study Medication|3|||
19543746|NCT01153009|41993217|FG002|Overall Study|Noncompliance with Study Medication|4|||
19543747|NCT01153009|41993218|FG003|Overall Study|Noncompliance with Study Medication|1|||
19543748|NCT01153009|41993215|FG000|Overall Study|Protocol Deviations|4|||
19543749|NCT01153009|41993216|FG001|Overall Study|Protocol Deviations|3|||
19543750|NCT01153009|41993217|FG002|Overall Study|Protocol Deviations|3|||
19543751|NCT01153009|41993218|FG003|Overall Study|Protocol Deviations|2|||
19543752|NCT01153009|41993215|FG000|Overall Study|Withdrawal of Consent|5|||
19635176|NCT00725322|42084618|FG001|Washout (28 Days)|Protocol Violation|1|||
19635177|NCT00725010|42084624|FG000|Overall Study|Toxicity|9|||
19635178|NCT00725010|42084624|FG000|Overall Study|Tumor Progression|7|||
19635179|NCT00725010|42084624|FG000|Overall Study|Withdrawal by Subject|2|||
19635180|NCT00725010|42084624|FG000|Overall Study|Death|1|||
19635181|NCT00725010|42084624|FG000|Overall Study|Lost to Follow-up|1|||
19543753|NCT01153009|41993216|FG001|Overall Study|Withdrawal of Consent|5|||
19543754|NCT01153009|41993217|FG002|Overall Study|Withdrawal of Consent|4|||
19543755|NCT01153009|41993218|FG003|Overall Study|Withdrawal of Consent|6|||
19543756|NCT01153009|41993215|FG000|Overall Study|Lost to Follow-up|8|||
19543757|NCT01153009|41993216|FG001|Overall Study|Lost to Follow-up|8|||
19543758|NCT01153009|41993217|FG002|Overall Study|Lost to Follow-up|11|||
19543759|NCT01153009|41993218|FG003|Overall Study|Lost to Follow-up|15|||
19543760|NCT01153009|41993215|FG000|Overall Study|Other|1|||
19543761|NCT01153009|41993216|FG001|Overall Study|Other|1|||
19543762|NCT01153009|41993217|FG002|Overall Study|Other|3|||
19543763|NCT01153009|41993218|FG003|Overall Study|Other|2|||
19543764|NCT01152814|41993228|FG000|Overall Study|Lost to Follow-up|2|||
19543765|NCT01152580|41993234|FG000|Overall Study|Withdrawal by Subject|0|||
19543766|NCT01152580|41993235|FG001|Overall Study|Withdrawal by Subject|1|||
19543767|NCT01152385|41993245|FG000|Overall Study|Withdrawal by Subject|3|||
19543768|NCT01152385|41993246|FG001|Overall Study|Withdrawal by Subject|1|||
19635182|NCT00725010|42084624|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
19635183|NCT00725010|42084624|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
19635184|NCT00725010|42084624|FG000|Overall Study|No further documentation|1|||
19635185|NCT00725010|42084624|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
19543769|NCT01152385|41993247|FG002|Overall Study|Withdrawal by Subject|1|||
19543770|NCT01152385|41993248|FG003|Overall Study|Withdrawal by Subject|1|||
19543771|NCT01152385|41993245|FG000|Overall Study|Protocol Violation|0|||
19543772|NCT01152385|41993246|FG001|Overall Study|Protocol Violation|0|||
19543773|NCT01152385|41993247|FG002|Overall Study|Protocol Violation|0|||
19543774|NCT01152385|41993248|FG003|Overall Study|Protocol Violation|1|||
19543775|NCT01152385|41993245|FG000|Overall Study|Adverse Event|1|||
19543776|NCT01152385|41993246|FG001|Overall Study|Adverse Event|1|||
19543777|NCT01152385|41993247|FG002|Overall Study|Adverse Event|0|||
19543778|NCT01152385|41993248|FG003|Overall Study|Adverse Event|0|||
19543779|NCT01152385|41993245|FG000|Overall Study|Study-specific withdrawal criteria|1|||
19543780|NCT01152385|41993246|FG001|Overall Study|Study-specific withdrawal criteria|1|||
19543781|NCT01152385|41993247|FG002|Overall Study|Study-specific withdrawal criteria|2|||
19635186|NCT00767000|42084635|FG000|54-week Study|Adverse Event|4|||
19635187|NCT00767000|42084636|FG001|54-week Study|Adverse Event|6|||
19543782|NCT01152385|41993248|FG003|Overall Study|Study-specific withdrawal criteria|0|||
19543783|NCT01152385|41993245|FG000|Overall Study|Other|4|||
19635188|NCT00767000|42084637|FG002|54-week Study|Adverse Event|6|||
19635189|NCT00767000|42084638|FG003|54-week Study|Adverse Event|8|||
19635190|NCT00767000|42084639|FG004|54-week Study|Adverse Event|4|||
19635191|NCT00767000|42084635|FG000|54-week Study|Creaninine/creatinine clearance|2|||
19635192|NCT00767000|42084636|FG001|54-week Study|Creaninine/creatinine clearance|1|||
19635193|NCT00767000|42084637|FG002|54-week Study|Creaninine/creatinine clearance|2|||
19635194|NCT00767000|42084638|FG003|54-week Study|Creaninine/creatinine clearance|2|||
19635195|NCT00767000|42084639|FG004|54-week Study|Creaninine/creatinine clearance|4|||
19635196|NCT00767000|42084635|FG000|54-week Study|Hyperglycemia|0|||
19635197|NCT00767000|42084636|FG001|54-week Study|Hyperglycemia|0|||
19635198|NCT00767000|42084637|FG002|54-week Study|Hyperglycemia|1|||
19635199|NCT00767000|42084638|FG003|54-week Study|Hyperglycemia|0|||
19635200|NCT00767000|42084639|FG004|54-week Study|Hyperglycemia|1|||
19635201|NCT00767000|42084635|FG000|54-week Study|Hypoglycemia|0|||
19635202|NCT00767000|42084636|FG001|54-week Study|Hypoglycemia|1|||
19635203|NCT00767000|42084637|FG002|54-week Study|Hypoglycemia|0|||
19635204|NCT00767000|42084638|FG003|54-week Study|Hypoglycemia|0|||
19635205|NCT00767000|42084639|FG004|54-week Study|Hypoglycemia|0|||
19635206|NCT00767000|42084635|FG000|54-week Study|Interruption of study medication|0|||
19635207|NCT00767000|42084636|FG001|54-week Study|Interruption of study medication|0|||
19635208|NCT00767000|42084637|FG002|54-week Study|Interruption of study medication|1|||
19635209|NCT00767000|42084638|FG003|54-week Study|Interruption of study medication|0|||
19635210|NCT00767000|42084639|FG004|54-week Study|Interruption of study medication|0|||
19635211|NCT00767000|42084635|FG000|54-week Study|Lack of Efficacy|2|||
19635212|NCT00767000|42084636|FG001|54-week Study|Lack of Efficacy|0|||
19635213|NCT00767000|42084637|FG002|54-week Study|Lack of Efficacy|1|||
19635214|NCT00767000|42084638|FG003|54-week Study|Lack of Efficacy|0|||
19635215|NCT00767000|42084639|FG004|54-week Study|Lack of Efficacy|5|||
19635216|NCT00767000|42084635|FG000|54-week Study|Lost to Follow-up|4|||
19635217|NCT00767000|42084636|FG001|54-week Study|Lost to Follow-up|0|||
19635218|NCT00767000|42084637|FG002|54-week Study|Lost to Follow-up|1|||
19635219|NCT00767000|42084638|FG003|54-week Study|Lost to Follow-up|4|||
19635220|NCT00767000|42084639|FG004|54-week Study|Lost to Follow-up|2|||
19635221|NCT00767000|42084635|FG000|54-week Study|Physician Decision|4|||
19635222|NCT00767000|42084636|FG001|54-week Study|Physician Decision|0|||
19635223|NCT00767000|42084637|FG002|54-week Study|Physician Decision|1|||
19635224|NCT00767000|42084638|FG003|54-week Study|Physician Decision|1|||
19635225|NCT00767000|42084639|FG004|54-week Study|Physician Decision|1|||
19635226|NCT00767000|42084635|FG000|54-week Study|Progressive disease|0|||
19635227|NCT00767000|42084636|FG001|54-week Study|Progressive disease|0|||
19635228|NCT00767000|42084637|FG002|54-week Study|Progressive disease|1|||
19635229|NCT00767000|42084638|FG003|54-week Study|Progressive disease|0|||
19635230|NCT00767000|42084639|FG004|54-week Study|Progressive disease|0|||
19635231|NCT00767000|42084635|FG000|54-week Study|Protocol Violation|0|||
19635232|NCT00767000|42084636|FG001|54-week Study|Protocol Violation|0|||
19635233|NCT00767000|42084637|FG002|54-week Study|Protocol Violation|1|||
19635234|NCT00767000|42084638|FG003|54-week Study|Protocol Violation|2|||
19635235|NCT00767000|42084639|FG004|54-week Study|Protocol Violation|0|||
19635236|NCT00767000|42084635|FG000|54-week Study|Withdrawal by Subject|2|||
19635237|NCT00767000|42084636|FG001|54-week Study|Withdrawal by Subject|3|||
19635238|NCT00767000|42084637|FG002|54-week Study|Withdrawal by Subject|5|||
19635239|NCT00767000|42084638|FG003|54-week Study|Withdrawal by Subject|11|||
19635240|NCT00767000|42084639|FG004|54-week Study|Withdrawal by Subject|13|||
19635241|NCT00767000|42084635|FG000|54-week Study|Study terminated by sponsor|90|||
19635242|NCT00767000|42084636|FG001|54-week Study|Study terminated by sponsor|102|||
19543784|NCT01152385|41993246|FG001|Overall Study|Other|3|||
19543785|NCT01152385|41993247|FG002|Overall Study|Other|2|||
19543786|NCT01152385|41993248|FG003|Overall Study|Other|3|||
19543787|NCT01152190|41993264|FG000|Overall Study|Adverse Event|2|||
19543788|NCT01152190|41993265|FG001|Overall Study|Adverse Event|4|||
19543789|NCT01152190|41993264|FG000|Overall Study|Death|1|||
19543790|NCT01152190|41993265|FG001|Overall Study|Death|0|||
19635243|NCT00767000|42084637|FG002|54-week Study|Study terminated by sponsor|89|||
19635244|NCT00767000|42084638|FG003|54-week Study|Study terminated by sponsor|196|||
19635245|NCT00767000|42084639|FG004|54-week Study|Study terminated by sponsor|194|||
19635246|NCT00767000|42084635|FG000|54-week Study|Reason not reported|0|||
19635247|NCT00767000|42084636|FG001|54-week Study|Reason not reported|0|||
19635248|NCT00767000|42084637|FG002|54-week Study|Reason not reported|0|||
19635249|NCT00767000|42084638|FG003|54-week Study|Reason not reported|1|||
19635250|NCT00767000|42084639|FG004|54-week Study|Reason not reported|0|||
19635251|NCT00767000|42084635|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
19635252|NCT00767000|42084636|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
19543791|NCT01152190|41993264|FG000|Overall Study|Protocol Violation|1|||
19635253|NCT00767000|42084637|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
19543792|NCT01152190|41993265|FG001|Overall Study|Protocol Violation|1|||
19635254|NCT00767000|42084638|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
19635255|NCT00767000|42084639|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
19635256|NCT00724932|42084653|FG000|Overall Study|Lost to Follow-up|1|||
19635257|NCT00724932|42084654|FG001|Overall Study|Lost to Follow-up|0|||
19635258|NCT00724932|42084653|FG000|Overall Study|Not treated|4|||
19635259|NCT00724932|42084654|FG001|Overall Study|Not treated|3|||
19635260|NCT00766532|42084662|FG000|Overall Study|Protocol Violation|2|||
19543793|NCT01152190|41993264|FG000|Overall Study|Withdrawal by Subject|1|||
19543794|NCT01152190|41993265|FG001|Overall Study|Withdrawal by Subject|3|||
19543795|NCT01151410|41993273|FG000|Overall Study|Withdrawal by Subject|3|||
19543796|NCT01151410|41993274|FG001|Overall Study|Withdrawal by Subject|5|||
19543797|NCT01151410|41993273|FG000|Overall Study|Lost to Follow-up|3|||
19543798|NCT01151410|41993274|FG001|Overall Study|Lost to Follow-up|4|||
19543799|NCT01151410|41993273|FG000|Overall Study|Adverse Event|1|||
19543800|NCT01151410|41993274|FG001|Overall Study|Adverse Event|2|||
19543801|NCT01151410|41993273|FG000|Overall Study|Protocol deviation|2|||
19543802|NCT01151410|41993274|FG001|Overall Study|Protocol deviation|1|||
19543803|NCT01151410|41993273|FG000|Overall Study|Administrative problems|1|||
19543804|NCT01151410|41993274|FG001|Overall Study|Administrative problems|1|||
19543805|NCT01151410|41993273|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19635261|NCT00774566|42084668|FG000|Overall Study|Protocol Violation|18|||
19635262|NCT00774566|42084669|FG001|Overall Study|Protocol Violation|15|||
19635263|NCT00766376|42084675|FG000|Overall Study|Withdrawal by Subject|27|||
19635264|NCT00587054|42084679|FG000|Overall Study|Patient not treated|9|||
19635265|NCT00766142|42084683|FG000|Overall Study|Protocol Violation|4|||
19635266|NCT00724854|42084689|FG000|Overall Study|Lack of Efficacy|187|||
19635267|NCT00724854|42084690|FG001|Overall Study|Lack of Efficacy|13|||
19635268|NCT00724854|42084689|FG000|Overall Study|Lost to Follow-up|87|||
19635269|NCT00724854|42084690|FG001|Overall Study|Lost to Follow-up|10|||
19635270|NCT00724854|42084689|FG000|Overall Study|Adverse Event|62|||
19635271|NCT00724854|42084690|FG001|Overall Study|Adverse Event|4|||
19635272|NCT00724854|42084689|FG000|Overall Study|Other|42|||
19635273|NCT00724854|42084690|FG001|Overall Study|Other|3|||
19635274|NCT00724854|42084689|FG000|Overall Study|Death|11|||
19635275|NCT00724854|42084690|FG001|Overall Study|Death|0|||
19635276|NCT00724854|42084689|FG000|Overall Study|Change of treatment|7|||
19635277|NCT00724854|42084690|FG001|Overall Study|Change of treatment|0|||
19635278|NCT00724854|42084689|FG000|Overall Study|Withdrawal by Subject|5|||
19635279|NCT00724854|42084690|FG001|Overall Study|Withdrawal by Subject|0|||
19635280|NCT00724854|42084689|FG000|Overall Study|Adverse event + lack of efficacy|2|||
19635281|NCT00724854|42084690|FG001|Overall Study|Adverse event + lack of efficacy|1|||
19635282|NCT00728988|42084699|FG000|Overall Study|Not Treated|2|||
19635283|NCT00728988|42084700|FG001|Overall Study|Not Treated|2|||
19635284|NCT00728988|42084699|FG000|Overall Study|Death|1|||
19635285|NCT00728988|42084700|FG001|Overall Study|Death|1|||
19635286|NCT00728988|42084699|FG000|Overall Study|Adverse Event|3|||
19635287|NCT00728988|42084700|FG001|Overall Study|Adverse Event|2|||
19635288|NCT00728988|42084699|FG000|Overall Study|Other|85|||
19635289|NCT00728988|42084700|FG001|Overall Study|Other|77|||
19635290|NCT00728988|42084699|FG000|Overall Study|Withdrawal by Subject|2|||
19635291|NCT00728988|42084700|FG001|Overall Study|Withdrawal by Subject|6|||
19635292|NCT00728754|42084709|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
19635293|NCT00728754|42084710|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
19635294|NCT00728754|42084709|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
19635295|NCT00728754|42084710|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
19635296|NCT00728754|42084709|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
19635297|NCT00728754|42084710|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
19635298|NCT00728130|42084716|FG000|Overall Study|Withdrawal by Subject|1|||
19635299|NCT00728130|42084716|FG000|Overall Study|Paperwork not completed in time|1|||
19635300|NCT00728130|42084716|FG000|Overall Study|Physician Decision|1|||
19635301|NCT00735696|42084720|FG000|Overall Study|Withdrawal by Subject|1|||
19635302|NCT00735696|42084720|FG000|Overall Study|Enrolled but never Treated|1|||
19635303|NCT00478231|42084724|FG000|Overall Study|Death|7|||
19635304|NCT00478231|42084724|FG000|Overall Study|Lack of Efficacy|47|||
19635305|NCT00478231|42084724|FG000|Overall Study|Lost to Follow-up|7|||
19635306|NCT00478231|42084724|FG000|Overall Study|Withdrawal by Subject|6|||
19635307|NCT00478231|42084724|FG000|Overall Study|Other|9|||
19635308|NCT00478231|42084724|FG000|Overall Study|Adverse Event|5|||
19635309|NCT00478231|42084724|FG000|Overall Study|Randomized, not treated|3|||
19635310|NCT00474175|42084731|FG000|Overall Study|Lack of Efficacy|0|||
19635311|NCT00474175|42084732|FG001|Overall Study|Lack of Efficacy|0|||
19635312|NCT00474175|42084733|FG002|Overall Study|Lack of Efficacy|1|||
19635313|NCT00474175|42084731|FG000|Overall Study|Withdrawal by Subject|0|||
19635314|NCT00474175|42084732|FG001|Overall Study|Withdrawal by Subject|1|||
19635315|NCT00474175|42084733|FG002|Overall Study|Withdrawal by Subject|1|||
19635316|NCT00474175|42084731|FG000|Overall Study|Ineligible|1|||
19635317|NCT00474175|42084732|FG001|Overall Study|Ineligible|3|||
19635318|NCT00474175|42084733|FG002|Overall Study|Ineligible|1|||
19635319|NCT00474175|42084731|FG000|Overall Study|Protocol Violation|0|||
19635320|NCT00474175|42084732|FG001|Overall Study|Protocol Violation|2|||
19635321|NCT00474175|42084733|FG002|Overall Study|Protocol Violation|1|||
19635322|NCT00474175|42084731|FG000|Overall Study|Administrative|0|||
19635323|NCT00474175|42084732|FG001|Overall Study|Administrative|1|||
19635324|NCT00474175|42084733|FG002|Overall Study|Administrative|0|||
19635325|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
19635326|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
19635327|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
19635328|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
19635329|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
19635330|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
19635331|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
19635332|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
19543806|NCT01151410|41993274|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
19543807|NCT01151410|41993273|FG000|Overall Study|Abnormal laboratory value(s)|0|||
19543808|NCT01151410|41993274|FG001|Overall Study|Abnormal laboratory value(s)|1|||
19543809|NCT01151215|41993283|FG000|Overall Study|Worsening of condition under study|1|||
19543810|NCT01151215|41993284|FG001|Overall Study|Worsening of condition under study|1|||
19543811|NCT01151215|41993285|FG002|Overall Study|Worsening of condition under study|1|||
19543812|NCT01151215|41993283|FG000|Overall Study|Death|16|||
19543813|NCT01151215|41993284|FG001|Overall Study|Death|20|||
19543814|NCT01151215|41993285|FG002|Overall Study|Death|11|||
19635333|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
19635334|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
19635335|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
19635336|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
19635337|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
19635338|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
19635339|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
19635340|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
19635341|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
19635342|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
19635343|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Missing|2|||
19635344|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Missing|1|||
19635345|NCT00443209|42084764|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
19458234|NCT01393743|41711965|FG001|Core Study|Lost to Follow-up|1|||
19458235|NCT01393743|41711966|FG002|Core Study|Lost to Follow-up|0|||
19458236|NCT01393743|41711964|FG000|Core Study|Participant's Choice|2|||
19458237|NCT01393743|41711965|FG001|Core Study|Participant's Choice|3|||
19458238|NCT01393743|41711966|FG002|Core Study|Participant's Choice|0|||
19543815|NCT01151215|41993283|FG000|Overall Study|Lost to Follow-up|0|||
19543816|NCT01151215|41993284|FG001|Overall Study|Lost to Follow-up|0|||
19458239|NCT01393743|41711964|FG000|Core Study|Inadequate therapeutic effect|2|||
19458240|NCT01393743|41711965|FG001|Core Study|Inadequate therapeutic effect|0|||
19458241|NCT01393743|41711966|FG002|Core Study|Inadequate therapeutic effect|0|||
19458242|NCT01393743|41711964|FG000|Extension Phase|Adverse Event|0|||
19458243|NCT01393743|41711965|FG001|Extension Phase|Adverse Event|0|||
19458244|NCT01393743|41711966|FG002|Extension Phase|Adverse Event|12|||
19458245|NCT01393743|41711964|FG000|Extension Phase|Lost to Follow-up|0|||
19458246|NCT01393743|41711965|FG001|Extension Phase|Lost to Follow-up|0|||
19458247|NCT01393743|41711966|FG002|Extension Phase|Lost to Follow-up|2|||
19458248|NCT01393743|41711964|FG000|Extension Phase|Participant choice|0|||
19458249|NCT01393743|41711965|FG001|Extension Phase|Participant choice|0|||
19458250|NCT01393743|41711966|FG002|Extension Phase|Participant choice|16|||
19458251|NCT01393743|41711964|FG000|Extension Phase|Inadequate therapeutic effect|0|||
19458252|NCT01393743|41711965|FG001|Extension Phase|Inadequate therapeutic effect|0|||
19458253|NCT01393743|41711966|FG002|Extension Phase|Inadequate therapeutic effect|7|||
19458254|NCT01393743|41711964|FG000|Extension Phase|Withdrawal by Subject|0|||
19458255|NCT01393743|41711965|FG001|Extension Phase|Withdrawal by Subject|0|||
19458256|NCT01393743|41711966|FG002|Extension Phase|Withdrawal by Subject|8|||
19458257|NCT01393743|41711964|FG000|Extension Phase|Pregnancy|0|||
19458258|NCT01393743|41711965|FG001|Extension Phase|Pregnancy|0|||
19458259|NCT01393743|41711966|FG002|Extension Phase|Pregnancy|1|||
19458260|NCT01393743|41711964|FG000|Extension Phase|Other|0|||
19458261|NCT01393743|41711965|FG001|Extension Phase|Other|0|||
19458262|NCT01393743|41711966|FG002|Extension Phase|Other|14|||
19635346|NCT00443209|42084765|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
19635347|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
19458263|NCT01405911|41711985|FG000|Overall Study|Pre-treatment lab AE|0|||
19543817|NCT01151215|41993285|FG002|Overall Study|Lost to Follow-up|3|||
19543818|NCT01151215|41993283|FG000|Overall Study|Withdrawal by Subject|3|||
19543819|NCT01151215|41993284|FG001|Overall Study|Withdrawal by Subject|1|||
19543820|NCT01151215|41993285|FG002|Overall Study|Withdrawal by Subject|2|||
19635348|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
19635349|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
19635350|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
19635351|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
19635352|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
19635353|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
19635354|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
19635355|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
19635356|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
19635357|NCT00443209|42084764|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
19635358|NCT00443209|42084765|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
19635359|NCT00439231|42084771|FG000|Overall Study|Lack of Efficacy|28|||
19635360|NCT00437983|42084777|FG000|Overall Study|Adverse Event|6|||
19635361|NCT00437983|42084778|FG001|Overall Study|Adverse Event|6|||
19635362|NCT00437983|42084777|FG000|Overall Study|Protocol Violation|2|||
19635363|NCT00437983|42084778|FG001|Overall Study|Protocol Violation|1|||
19635364|NCT00437983|42084777|FG000|Overall Study|Withdrawal by Subject|5|||
19635365|NCT00437983|42084778|FG001|Overall Study|Withdrawal by Subject|6|||
19635366|NCT00783692|42084787|FG000|Induction Phase|Adverse Event|7|||
19635367|NCT00783692|42084788|FG001|Induction Phase|Adverse Event|9|||
19635368|NCT00783692|42084789|FG002|Induction Phase|Adverse Event|24|||
19635369|NCT00783692|42084790|FG003|Induction Phase|Adverse Event|0|||
19635370|NCT00783692|42084791|FG004|Induction Phase|Adverse Event|0|||
19635371|NCT00783692|42084792|FG005|Induction Phase|Adverse Event|0|||
19635372|NCT00783692|42084793|FG006|Induction Phase|Adverse Event|0|||
19635373|NCT00783692|42084787|FG000|Induction Phase|Protocol Violation|0|||
19635374|NCT00783692|42084788|FG001|Induction Phase|Protocol Violation|0|||
19635375|NCT00783692|42084789|FG002|Induction Phase|Protocol Violation|1|||
19635376|NCT00783692|42084790|FG003|Induction Phase|Protocol Violation|0|||
19635377|NCT00783692|42084791|FG004|Induction Phase|Protocol Violation|0|||
19635378|NCT00783692|42084792|FG005|Induction Phase|Protocol Violation|0|||
19635379|NCT00783692|42084793|FG006|Induction Phase|Protocol Violation|0|||
19635380|NCT00783692|42084787|FG000|Induction Phase|Lack of Efficacy|1|||
19635381|NCT00783692|42084788|FG001|Induction Phase|Lack of Efficacy|3|||
19635382|NCT00783692|42084789|FG002|Induction Phase|Lack of Efficacy|28|||
19635383|NCT00783692|42084790|FG003|Induction Phase|Lack of Efficacy|0|||
19635384|NCT00783692|42084791|FG004|Induction Phase|Lack of Efficacy|0|||
19635385|NCT00783692|42084792|FG005|Induction Phase|Lack of Efficacy|0|||
19635386|NCT00783692|42084793|FG006|Induction Phase|Lack of Efficacy|0|||
19635387|NCT00783692|42084787|FG000|Induction Phase|Withdrawal by Subject|3|||
19635388|NCT00783692|42084788|FG001|Induction Phase|Withdrawal by Subject|9|||
19635389|NCT00783692|42084789|FG002|Induction Phase|Withdrawal by Subject|16|||
19635390|NCT00783692|42084790|FG003|Induction Phase|Withdrawal by Subject|0|||
19635391|NCT00783692|42084791|FG004|Induction Phase|Withdrawal by Subject|0|||
19635392|NCT00783692|42084792|FG005|Induction Phase|Withdrawal by Subject|0|||
19635393|NCT00783692|42084793|FG006|Induction Phase|Withdrawal by Subject|0|||
19635394|NCT00783692|42084787|FG000|Induction Phase|Lost to Follow-up|0|||
19543821|NCT01151215|41993283|FG000|Overall Study|Disease progression|0|||
19543822|NCT01151215|41993284|FG001|Overall Study|Disease progression|1|||
19543823|NCT01151215|41993285|FG002|Overall Study|Disease progression|1|||
19635395|NCT00783692|42084788|FG001|Induction Phase|Lost to Follow-up|0|||
19635396|NCT00783692|42084789|FG002|Induction Phase|Lost to Follow-up|3|||
19635397|NCT00783692|42084790|FG003|Induction Phase|Lost to Follow-up|0|||
19543824|NCT01151215|41993283|FG000|Overall Study|Safety as judged by the investigator|0|||
19543825|NCT01151215|41993284|FG001|Overall Study|Safety as judged by the investigator|0|||
19543826|NCT01151215|41993285|FG002|Overall Study|Safety as judged by the investigator|1|||
19543827|NCT01151137|41993295|FG000|Overall Study|Death|15|||
19543828|NCT01151137|41993296|FG001|Overall Study|Death|27|||
19543829|NCT01151137|41993295|FG000|Overall Study|Lost to Follow-up|1|||
19543830|NCT01151137|41993296|FG001|Overall Study|Lost to Follow-up|1|||
19543831|NCT01151098|41993302|FG000|Overall Study|Adverse Event|82|||
19543832|NCT01151098|41993302|FG000|Overall Study|Lost to Follow-up|6|||
19543833|NCT01151098|41993302|FG000|Overall Study|Lack of Efficacy|15|||
19543834|NCT01151098|41993302|FG000|Overall Study|Protocol Violation|1|||
19543835|NCT01151098|41993302|FG000|Overall Study|Miscellaneous|13|||
19635398|NCT00783692|42084791|FG004|Induction Phase|Lost to Follow-up|0|||
19543836|NCT01151020|41993306|FG000|Overall Study|Death|25|||
19635399|NCT00783692|42084792|FG005|Induction Phase|Lost to Follow-up|0|||
19635400|NCT00783692|42084793|FG006|Induction Phase|Lost to Follow-up|0|||
19635401|NCT00783692|42084787|FG000|Induction Phase|Other|0|||
19635402|NCT00783692|42084788|FG001|Induction Phase|Other|0|||
19635403|NCT00783692|42084789|FG002|Induction Phase|Other|2|||
19635404|NCT00783692|42084790|FG003|Induction Phase|Other|0|||
19635405|NCT00783692|42084791|FG004|Induction Phase|Other|0|||
19635406|NCT00783692|42084792|FG005|Induction Phase|Other|0|||
19635407|NCT00783692|42084793|FG006|Induction Phase|Other|0|||
19635408|NCT00783692|42084787|FG000|Maintenance Phase|Adverse Event|7|||
19635409|NCT00783692|42084788|FG001|Maintenance Phase|Adverse Event|0|||
19635410|NCT00783692|42084789|FG002|Maintenance Phase|Adverse Event|0|||
19635411|NCT00783692|42084790|FG003|Maintenance Phase|Adverse Event|15|||
19635412|NCT00783692|42084791|FG004|Maintenance Phase|Adverse Event|12|||
19635413|NCT00783692|42084792|FG005|Maintenance Phase|Adverse Event|9|||
19635414|NCT00783692|42084793|FG006|Maintenance Phase|Adverse Event|38|||
19635415|NCT00783692|42084787|FG000|Maintenance Phase|Protocol Violation|0|||
19635416|NCT00783692|42084788|FG001|Maintenance Phase|Protocol Violation|0|||
19635417|NCT00783692|42084789|FG002|Maintenance Phase|Protocol Violation|0|||
19635418|NCT00783692|42084790|FG003|Maintenance Phase|Protocol Violation|1|||
19635419|NCT00783692|42084791|FG004|Maintenance Phase|Protocol Violation|2|||
19635420|NCT00783692|42084792|FG005|Maintenance Phase|Protocol Violation|3|||
19635421|NCT00783692|42084793|FG006|Maintenance Phase|Protocol Violation|4|||
19635422|NCT00783692|42084787|FG000|Maintenance Phase|Lack of Efficacy|79|||
19635423|NCT00783692|42084788|FG001|Maintenance Phase|Lack of Efficacy|0|||
19635424|NCT00783692|42084789|FG002|Maintenance Phase|Lack of Efficacy|0|||
19635425|NCT00783692|42084790|FG003|Maintenance Phase|Lack of Efficacy|64|||
19635426|NCT00783692|42084791|FG004|Maintenance Phase|Lack of Efficacy|58|||
19635427|NCT00783692|42084792|FG005|Maintenance Phase|Lack of Efficacy|48|||
19635428|NCT00783692|42084793|FG006|Maintenance Phase|Lack of Efficacy|177|||
19711992|NCT00094653|42154950|FG000|Overall Study|Subject Withdrew Consent|10|||
19711993|NCT00094653|42154951|FG001|Overall Study|Subject Withdrew Consent|2|||
19711994|NCT00094653|42154952|FG002|Overall Study|Subject Withdrew Consent|3|||
19711995|NCT00094653|42154950|FG000|Overall Study|Other|2|||
19711996|NCT00094653|42154951|FG001|Overall Study|Other|2|||
19711997|NCT00094653|42154952|FG002|Overall Study|Other|2|||
19711998|NCT00094653|42154950|FG000|Overall Study|Lost to Follow-up|3|||
19711999|NCT00094653|42154951|FG001|Overall Study|Lost to Follow-up|2|||
19712000|NCT00094653|42154952|FG002|Overall Study|Lost to Follow-up|1|||
19712001|NCT00094653|42154950|FG000|Overall Study|Protocol Violation|0|||
19712002|NCT00094653|42154951|FG001|Overall Study|Protocol Violation|0|||
19712003|NCT00094653|42154952|FG002|Overall Study|Protocol Violation|1|||
19712004|NCT00104247|42154963|FG000|Overall Study|Withdrawal by Subject|1|||
19712005|NCT00104247|42154964|FG001|Overall Study|Withdrawal by Subject|0|||
19712006|NCT00104247|42154963|FG000|Overall Study|Noncompliant with dosing|0|||
19712007|NCT00104247|42154964|FG001|Overall Study|Noncompliant with dosing|1|||
19712008|NCT03565900|42154972|FG000|Overall Study|Disposition Unknown|4|||
19712009|NCT03565900|42154973|FG001|Overall Study|Disposition Unknown|1|||
19712010|NCT03565900|42154972|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
19712011|NCT03565900|42154973|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
19712012|NCT03565900|42154972|FG000|Overall Study|Withdrawal by Subject|4|||
19543837|NCT01151020|41993306|FG000|Overall Study|Conversion to open repair|1|||
19543838|NCT01151020|41993306|FG000|Overall Study|Lost to Follow-up|4|||
19543839|NCT01151020|41993306|FG000|Overall Study|Withdrawal by Subject|22|||
19543840|NCT01151020|41993306|FG000|Overall Study|Patients did not receive the device|2|||
19543841|NCT01150474|41993312|FG000|Overall Study|Withdrawal by Subject|5|||
19543842|NCT01150474|41993313|FG001|Overall Study|Withdrawal by Subject|2|||
19543843|NCT01150474|41993312|FG000|Overall Study|Cancer found|1|||
19543844|NCT01150474|41993313|FG001|Overall Study|Cancer found|0|||
19543845|NCT01150474|41993312|FG000|Overall Study|Multiple Studies|0|||
19543846|NCT01150474|41993313|FG001|Overall Study|Multiple Studies|1|||
19543847|NCT01150474|41993312|FG000|Overall Study|Rectotomy|1|||
19543848|NCT01150474|41993313|FG001|Overall Study|Rectotomy|0|||
19543849|NCT01150474|41993312|FG000|Overall Study|Drug did not arrive in time|1|||
19543850|NCT01150474|41993313|FG001|Overall Study|Drug did not arrive in time|0|||
19543851|NCT01150474|41993312|FG000|Overall Study|Drug not administered|1|||
19543852|NCT01150474|41993313|FG001|Overall Study|Drug not administered|0|||
19543853|NCT01150474|41993312|FG000|Overall Study|Surgery Changed|1|||
19543854|NCT01150474|41993313|FG001|Overall Study|Surgery Changed|0|||
19543855|NCT01150357|41993322|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
19543856|NCT01150357|41993323|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
19543857|NCT01150357|41993324|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
19543858|NCT01150357|41993322|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
19543859|NCT01150357|41993323|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
19543860|NCT01150357|41993324|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
19543861|NCT01150357|41993322|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
19543862|NCT01150357|41993323|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
19543863|NCT01150357|41993324|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
19635429|NCT00783692|42084787|FG000|Maintenance Phase|Withdrawal by Subject|7|||
19635430|NCT00783692|42084788|FG001|Maintenance Phase|Withdrawal by Subject|0|||
19712013|NCT03565900|42154973|FG001|Overall Study|Withdrawal by Subject|5|||
19712014|NCT03565900|42154972|FG000|Overall Study|Randomized By Mistake|0|||
19712015|NCT03565900|42154973|FG001|Overall Study|Randomized By Mistake|2|||
19712016|NCT03565900|42154972|FG000|Overall Study|Physician Decision|7|||
19712017|NCT03565900|42154973|FG001|Overall Study|Physician Decision|11|||
19712018|NCT03565900|42154972|FG000|Overall Study|Death|9|||
19712019|NCT03565900|42154973|FG001|Overall Study|Death|7|||
19712020|NCT03591406|42154997|FG000|Overall Study|Adverse Event|5|||
19712021|NCT03591406|42154998|FG001|Overall Study|Adverse Event|3|||
19543864|NCT01150357|41993322|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
19543865|NCT01150357|41993323|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
19543866|NCT01150357|41993324|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
19543867|NCT01150357|41993322|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
19543868|NCT01150357|41993323|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
19635431|NCT00783692|42084789|FG002|Maintenance Phase|Withdrawal by Subject|0|||
19635432|NCT00783692|42084790|FG003|Maintenance Phase|Withdrawal by Subject|7|||
19635433|NCT00783692|42084791|FG004|Maintenance Phase|Withdrawal by Subject|6|||
19635434|NCT00783692|42084792|FG005|Maintenance Phase|Withdrawal by Subject|9|||
19635435|NCT00783692|42084793|FG006|Maintenance Phase|Withdrawal by Subject|24|||
19635436|NCT00783692|42084787|FG000|Maintenance Phase|Lost to Follow-up|2|||
19635437|NCT00783692|42084788|FG001|Maintenance Phase|Lost to Follow-up|0|||
19635438|NCT00783692|42084789|FG002|Maintenance Phase|Lost to Follow-up|0|||
19635439|NCT00783692|42084790|FG003|Maintenance Phase|Lost to Follow-up|1|||
19635440|NCT00783692|42084791|FG004|Maintenance Phase|Lost to Follow-up|3|||
19635441|NCT00783692|42084792|FG005|Maintenance Phase|Lost to Follow-up|2|||
19635442|NCT00783692|42084793|FG006|Maintenance Phase|Lost to Follow-up|5|||
19635443|NCT00783692|42084787|FG000|Maintenance Phase|Other|0|||
19635444|NCT00783692|42084788|FG001|Maintenance Phase|Other|0|||
19635445|NCT00783692|42084789|FG002|Maintenance Phase|Other|0|||
19635446|NCT00783692|42084790|FG003|Maintenance Phase|Other|1|||
19635447|NCT00783692|42084791|FG004|Maintenance Phase|Other|0|||
19635448|NCT00783692|42084792|FG005|Maintenance Phase|Other|1|||
19635449|NCT00783692|42084793|FG006|Maintenance Phase|Other|1|||
19635450|NCT04992273|42084808|FG000|Overall Study|Lost to Follow-up|0|||
19635451|NCT04992273|42084809|FG001|Overall Study|Lost to Follow-up|1|||
19635452|NCT00783302|42084816|FG000|Overall Study|Lost to Follow-up|17|||
19635453|NCT00783302|42084816|FG000|Overall Study|Technical Problems|11|||
19635454|NCT00783302|42084816|FG000|Overall Study|Protocol Violation|3|||
19635455|NCT00783302|42084816|FG000|Overall Study|Physician Decision|1|||
19635456|NCT00783302|42084816|FG000|Overall Study|Withdrawal by Subject|3|||
19635457|NCT00783224|42084838|FG000|Overall Study|Adverse Event|0|||
19635458|NCT00783224|42084839|FG001|Overall Study|Adverse Event|0|||
19635459|NCT00783224|42084840|FG002|Overall Study|Adverse Event|1|||
19712022|NCT03591406|42154997|FG000|Overall Study|Protocol Violation|2|||
19712023|NCT03591406|42154998|FG001|Overall Study|Protocol Violation|1|||
19712024|NCT03591406|42154997|FG000|Overall Study|Withdrawal by Subject|0|||
19712025|NCT03591406|42154998|FG001|Overall Study|Withdrawal by Subject|5|||
19712026|NCT03560986|42155006|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
19712027|NCT03560986|42155007|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
19712028|NCT03560986|42155006|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
19712029|NCT03560986|42155007|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
19712030|NCT03560986|42155006|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
19712031|NCT03560986|42155007|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
19712032|NCT03560986|42155006|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
19712033|NCT03560986|42155007|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
19712034|NCT03560986|42155006|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
19712035|NCT03560986|42155007|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
19543869|NCT01150357|41993324|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
19543870|NCT01150357|41993322|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
19543871|NCT01150357|41993323|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
19543872|NCT01150357|41993324|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
19543873|NCT01150357|41993322|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
19543874|NCT01150357|41993323|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
19543875|NCT01150357|41993324|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
19635460|NCT00783224|42084841|FG003|Overall Study|Adverse Event|0|||
19635461|NCT00783224|42084838|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
19635462|NCT00783224|42084839|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
19635463|NCT00783224|42084840|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
19635464|NCT00783224|42084841|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
19635465|NCT00783224|42084838|FG000|Overall Study|Inappropriate as a study subject|0|||
19635466|NCT00783224|42084839|FG001|Overall Study|Inappropriate as a study subject|0|||
19635467|NCT00783224|42084840|FG002|Overall Study|Inappropriate as a study subject|0|||
19635468|NCT00783224|42084841|FG003|Overall Study|Inappropriate as a study subject|1|||
19635469|NCT00782834|42084850|FG000|Treatment Phase|fibrous tumor not GIST|1|||
19635470|NCT00584805|42084854|FG000|Overall Study|No longer at risk of exposure|39|||
19635471|NCT00584805|42084854|FG000|Overall Study|Relocation|36|||
19635472|NCT00584805|42084854|FG000|Overall Study|Withdrawal by Subject|18|||
19712036|NCT03560986|42155006|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
19712037|NCT03560986|42155007|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
19635473|NCT00584805|42084854|FG000|Overall Study|Non-compliance|1|||
19635474|NCT00584805|42084854|FG000|Overall Study|Lost to follow up|3|||
19635475|NCT00584805|42084854|FG000|Overall Study|Screen failures|2|||
19635476|NCT00765674|42084864|FG000|Overall Study|Adverse Event|7|||
19635477|NCT00765674|42084865|FG001|Overall Study|Adverse Event|2|||
19635478|NCT00765674|42084866|FG002|Overall Study|Adverse Event|8|||
19635479|NCT00765674|42084867|FG003|Overall Study|Adverse Event|11|||
19635480|NCT00765674|42084864|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
19635481|NCT00765674|42084865|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
19635482|NCT00765674|42084866|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
19635483|NCT00765674|42084867|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
19635484|NCT00765674|42084864|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
19635485|NCT00765674|42084865|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
19635486|NCT00765674|42084866|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
19635487|NCT00765674|42084867|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
19635488|NCT00765674|42084864|FG000|Overall Study|Lack of Efficacy|2|||
19635489|NCT00765674|42084865|FG001|Overall Study|Lack of Efficacy|3|||
19635490|NCT00765674|42084866|FG002|Overall Study|Lack of Efficacy|1|||
19635491|NCT00765674|42084867|FG003|Overall Study|Lack of Efficacy|2|||
19635492|NCT00765674|42084864|FG000|Overall Study|Protocol Violation|2|||
19635493|NCT00765674|42084865|FG001|Overall Study|Protocol Violation|0|||
19635494|NCT00765674|42084866|FG002|Overall Study|Protocol Violation|1|||
19635495|NCT00765674|42084867|FG003|Overall Study|Protocol Violation|0|||
19635496|NCT00765674|42084864|FG000|Overall Study|Withdrawal by Subject|5|||
19635497|NCT00765674|42084865|FG001|Overall Study|Withdrawal by Subject|7|||
19635498|NCT00765674|42084866|FG002|Overall Study|Withdrawal by Subject|3|||
19635499|NCT00765674|42084867|FG003|Overall Study|Withdrawal by Subject|8|||
19635500|NCT00765674|42084864|FG000|Overall Study|Lost to Follow-up|4|||
19635501|NCT00765674|42084865|FG001|Overall Study|Lost to Follow-up|6|||
19635502|NCT00765674|42084866|FG002|Overall Study|Lost to Follow-up|2|||
19635503|NCT00765674|42084867|FG003|Overall Study|Lost to Follow-up|1|||
19635504|NCT00765674|42084864|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
19635505|NCT00765674|42084865|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
19635506|NCT00765674|42084866|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
19635507|NCT00765674|42084867|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
19635508|NCT00765362|42084877|FG000|Overall Study|Death|9|||
19635509|NCT00765362|42084877|FG000|Overall Study|Adverse Event|2|||
19635510|NCT00765362|42084877|FG000|Overall Study|Protocol Violation|18|||
19635511|NCT00765362|42084877|FG000|Overall Study|Withdrawal by Subject|13|||
19635512|NCT00765362|42084877|FG000|Overall Study|Lost to Follow-up|95|||
19635513|NCT00586898|42084881|FG000|Overall Study|Adverse Event|1|||
19635514|NCT00586898|42084881|FG000|Overall Study|Patiemt Non-compliance|1|||
19635515|NCT00586898|42084881|FG000|Overall Study|Evaluable for Toxicity Only|5|||
19635516|NCT04912245|42084885|FG000|Overall Study|Withdrawal by Subject|21|||
19635517|NCT04912245|42084886|FG001|Overall Study|Withdrawal by Subject|4|||
19635518|NCT04912245|42084885|FG000|Overall Study|Lost to Follow-up|5|||
19635519|NCT04912245|42084886|FG001|Overall Study|Lost to Follow-up|11|||
19635520|NCT00796991|42084893|FG000|Overall Study|Adverse Event|0|||
19635521|NCT00796991|42084894|FG001|Overall Study|Adverse Event|0|||
19635522|NCT00796991|42084895|FG002|Overall Study|Adverse Event|1|||
19635523|NCT00796991|42084893|FG000|Overall Study|Death|2|||
19635524|NCT00796991|42084894|FG001|Overall Study|Death|0|||
19635525|NCT00796991|42084895|FG002|Overall Study|Death|0|||
19635526|NCT00796991|42084893|FG000|Overall Study|Disease Progression|10|||
19635527|NCT00796991|42084894|FG001|Overall Study|Disease Progression|9|||
19635528|NCT00796991|42084895|FG002|Overall Study|Disease Progression|7|||
19635529|NCT00796991|42084893|FG000|Overall Study|Study Drug Toxicity|3|||
19635530|NCT00796991|42084894|FG001|Overall Study|Study Drug Toxicity|3|||
19635531|NCT00796991|42084895|FG002|Overall Study|Study Drug Toxicity|5|||
19635532|NCT00796991|42084893|FG000|Overall Study|Withdrawal by Subject|0|||
19635533|NCT00796991|42084894|FG001|Overall Study|Withdrawal by Subject|0|||
19635534|NCT00796991|42084895|FG002|Overall Study|Withdrawal by Subject|1|||
19635535|NCT00799487|42084906|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
19635536|NCT00799487|42084907|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
19635537|NCT00799487|42084908|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
19635538|NCT00799487|42084906|FG000|Dose Adjustment Period|Adverse Event|2|||
19635539|NCT00799487|42084907|FG001|Dose Adjustment Period|Adverse Event|0|||
19635540|NCT00799487|42084908|FG002|Dose Adjustment Period|Adverse Event|0|||
19635541|NCT00799487|42084906|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
19635542|NCT00799487|42084907|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
19712038|NCT03560986|42155006|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
19712039|NCT03560986|42155007|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
19635543|NCT00799487|42084908|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
19635544|NCT00799487|42084906|FG000|Dose Adjustment Period|Investigator Discretion|2|||
19635545|NCT00799487|42084907|FG001|Dose Adjustment Period|Investigator Discretion|0|||
19635546|NCT00799487|42084908|FG002|Dose Adjustment Period|Investigator Discretion|0|||
19635547|NCT00799487|42084906|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
19635548|NCT00799487|42084907|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
19635549|NCT00799487|42084908|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
19543876|NCT01150123|41993374|FG000|Overall Study|Withdrawal by Subject|1|||
19543877|NCT01150123|41993375|FG001|Overall Study|Withdrawal by Subject|1|||
19543878|NCT01150123|41993376|FG002|Overall Study|Withdrawal by Subject|2|||
19543879|NCT01150123|41993377|FG003|Overall Study|Withdrawal by Subject|1|||
19543880|NCT01150123|41993378|FG004|Overall Study|Withdrawal by Subject|1|||
19543881|NCT01150123|41993379|FG005|Overall Study|Withdrawal by Subject|1|||
19543882|NCT01150123|41993380|FG006|Overall Study|Withdrawal by Subject|0|||
19543883|NCT01150123|41993381|FG007|Overall Study|Withdrawal by Subject|3|||
19543884|NCT01150123|41993382|FG008|Overall Study|Withdrawal by Subject|2|||
19543885|NCT01150123|41993383|FG009|Overall Study|Withdrawal by Subject|0|||
19543886|NCT01150123|41993384|FG010|Overall Study|Withdrawal by Subject|1|||
19543887|NCT01150123|41993385|FG011|Overall Study|Withdrawal by Subject|0|||
19543888|NCT01150123|41993386|FG012|Overall Study|Withdrawal by Subject|1|||
19543889|NCT01150123|41993387|FG013|Overall Study|Withdrawal by Subject|0|||
19543890|NCT01150123|41993388|FG014|Overall Study|Withdrawal by Subject|0|||
19543891|NCT01150123|41993389|FG015|Overall Study|Withdrawal by Subject|1|||
19543892|NCT01150123|41993390|FG016|Overall Study|Withdrawal by Subject|0|||
19543893|NCT01150123|41993391|FG017|Overall Study|Withdrawal by Subject|1|||
19543894|NCT01150123|41993374|FG000|Overall Study|Lost to Follow-up|2|||
19543895|NCT01150123|41993375|FG001|Overall Study|Lost to Follow-up|1|||
19543896|NCT01150123|41993376|FG002|Overall Study|Lost to Follow-up|2|||
19543897|NCT01150123|41993377|FG003|Overall Study|Lost to Follow-up|2|||
19543898|NCT01150123|41993378|FG004|Overall Study|Lost to Follow-up|2|||
19543899|NCT01150123|41993379|FG005|Overall Study|Lost to Follow-up|5|||
19635550|NCT00799487|42084906|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
19635551|NCT00799487|42084907|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
19635552|NCT00799487|42084908|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
19635553|NCT00799487|42084906|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
19635554|NCT00799487|42084907|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
19635555|NCT00799487|42084908|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
19635556|NCT00799487|42084906|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
19635557|NCT00799487|42084907|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
19635558|NCT00799487|42084908|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
19635559|NCT00799487|42084906|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
19635560|NCT00799487|42084907|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
19635561|NCT00799487|42084908|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
19635562|NCT00799487|42084906|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
19635563|NCT00799487|42084907|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
19635564|NCT00799487|42084908|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
19635565|NCT00799487|42084906|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
19635566|NCT00799487|42084907|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
19635567|NCT00799487|42084908|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
19635568|NCT00799487|42084906|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
19635569|NCT00799487|42084907|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
19635570|NCT00799487|42084908|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
19635571|NCT00584727|42084919|FG000|First Intervention|Discontinuation|0|||
19635572|NCT00584727|42084920|FG001|First Intervention|Discontinuation|0|||
19635573|NCT00584727|42084921|FG002|First Intervention|Discontinuation|1|||
19635574|NCT00584727|42084922|FG003|First Intervention|Discontinuation|0|||
19635575|NCT00584727|42084923|FG004|First Intervention|Discontinuation|0|||
19635576|NCT00584727|42084924|FG005|First Intervention|Discontinuation|0|||
19635577|NCT00584727|42084919|FG000|Third Intervention|Protocol Violation|0|||
19635578|NCT00584727|42084920|FG001|Third Intervention|Protocol Violation|0|||
19635579|NCT00584727|42084921|FG002|Third Intervention|Protocol Violation|1|||
19635580|NCT00584727|42084922|FG003|Third Intervention|Protocol Violation|0|||
19635581|NCT00584727|42084923|FG004|Third Intervention|Protocol Violation|4|||
19635582|NCT00584727|42084924|FG005|Third Intervention|Protocol Violation|2|||
19635583|NCT00799409|42084938|FG000|Overall Study|Withdrawal by Subject|1|||
19635584|NCT00799409|42084939|FG001|Overall Study|Withdrawal by Subject|0|||
19635585|NCT00799409|42084940|FG002|Overall Study|Withdrawal by Subject|0|||
19635586|NCT00799409|42084938|FG000|Overall Study|Lost to Follow-up|1|||
19635587|NCT00799409|42084939|FG001|Overall Study|Lost to Follow-up|0|||
19635588|NCT00799409|42084940|FG002|Overall Study|Lost to Follow-up|0|||
19635589|NCT00799409|42084938|FG000|Overall Study|Optimal Dose Not Achieved|2|||
19635590|NCT00799409|42084939|FG001|Overall Study|Optimal Dose Not Achieved|0|||
19635591|NCT00799409|42084940|FG002|Overall Study|Optimal Dose Not Achieved|0|||
19635592|NCT00799409|42084938|FG000|Overall Study|Failure to follow study protocol)|1|||
19635593|NCT00799409|42084939|FG001|Overall Study|Failure to follow study protocol)|0|||
19635594|NCT00799409|42084940|FG002|Overall Study|Failure to follow study protocol)|0|||
19635595|NCT00799409|42084938|FG000|Overall Study|Did not attend lab school day 1|1|||
19543900|NCT01150123|41993380|FG006|Overall Study|Lost to Follow-up|0|||
19635596|NCT00799409|42084939|FG001|Overall Study|Did not attend lab school day 1|0|||
19635597|NCT00799409|42084940|FG002|Overall Study|Did not attend lab school day 1|0|||
19635598|NCT00799409|42084938|FG000|Overall Study|medication compliance|1|||
19635599|NCT00799409|42084939|FG001|Overall Study|medication compliance|0|||
19635600|NCT00799409|42084940|FG002|Overall Study|medication compliance|0|||
19635601|NCT00782210|42084951|FG000|Overall Study|Adverse Event|21|||
19635602|NCT00782210|42084952|FG001|Overall Study|Adverse Event|17|||
19635603|NCT00782210|42084953|FG002|Overall Study|Adverse Event|16|||
19635604|NCT00782210|42084951|FG000|Overall Study|Lost to Follow-up|2|||
19635605|NCT00782210|42084952|FG001|Overall Study|Lost to Follow-up|1|||
19635606|NCT00782210|42084953|FG002|Overall Study|Lost to Follow-up|2|||
19635607|NCT00782210|42084951|FG000|Overall Study|Withdrawal by Subject|11|||
19635608|NCT00782210|42084952|FG001|Overall Study|Withdrawal by Subject|8|||
19635609|NCT00782210|42084953|FG002|Overall Study|Withdrawal by Subject|11|||
19635610|NCT00782210|42084951|FG000|Overall Study|Non compliance with protocol|0|||
19635611|NCT00782210|42084952|FG001|Overall Study|Non compliance with protocol|3|||
19635612|NCT00782210|42084953|FG002|Overall Study|Non compliance with protocol|2|||
19635613|NCT00782210|42084951|FG000|Overall Study|Lack of Efficacy|13|||
19635614|NCT00782210|42084952|FG001|Overall Study|Lack of Efficacy|4|||
19635615|NCT00782210|42084953|FG002|Overall Study|Lack of Efficacy|1|||
19635616|NCT00782210|42084951|FG000|Overall Study|Other reason not described above|3|||
19635617|NCT00782210|42084952|FG001|Overall Study|Other reason not described above|2|||
19635618|NCT00782210|42084953|FG002|Overall Study|Other reason not described above|3|||
19635619|NCT01558115|42084970|FG000|Overall Study|Withdrawal by Subject|3|||
19635620|NCT01558115|42084970|FG000|Overall Study|Study closed due to poor enrollment|4|||
19635621|NCT00764660|42084993|FG000|Overall Study|Adverse Event|6|||
19635622|NCT00764660|42084994|FG001|Overall Study|Adverse Event|3|||
19635623|NCT00764660|42084993|FG000|Overall Study|Lost to Follow-up|3|||
19635624|NCT00764660|42084994|FG001|Overall Study|Lost to Follow-up|4|||
19635625|NCT00764660|42084993|FG000|Overall Study|Withdrawal by Subject|7|||
19375436|NCT02276482|41617384|FG001|Overall Study|Gram-negative infection|0|||
19375437|NCT02276482|41617383|FG000|Overall Study|Reason not specified|0|||
19375438|NCT02276482|41617384|FG001|Overall Study|Reason not specified|1|||
19635626|NCT00764660|42084994|FG001|Overall Study|Withdrawal by Subject|3|||
19635627|NCT00764660|42084993|FG000|Overall Study|Noncompliance With Protocol|5|||
19635628|NCT00764660|42084994|FG001|Overall Study|Noncompliance With Protocol|1|||
19635629|NCT00764660|42084993|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
19635630|NCT00764660|42084994|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
19635631|NCT00584415|42085000|FG000|Overall Study|Adverse Event|7|||
19635632|NCT00764504|42085008|FG000|Overall Study|Death|12|||
19635633|NCT00764504|42085009|FG001|Overall Study|Death|6|||
19635634|NCT00764504|42085010|FG002|Overall Study|Death|13|||
19635635|NCT00764504|42085008|FG000|Overall Study|Revision of Device|12|||
19635636|NCT00764504|42085009|FG001|Overall Study|Revision of Device|23|||
19635637|NCT00764504|42085010|FG002|Overall Study|Revision of Device|14|||
19635638|NCT00764504|42085008|FG000|Overall Study|Physician Decision|1|||
19635639|NCT00764504|42085009|FG001|Overall Study|Physician Decision|0|||
19635640|NCT00764504|42085010|FG002|Overall Study|Physician Decision|0|||
19635641|NCT00764504|42085008|FG000|Overall Study|Withdrawal by Subject|1|||
19635642|NCT00764504|42085009|FG001|Overall Study|Withdrawal by Subject|7|||
19635643|NCT00764504|42085010|FG002|Overall Study|Withdrawal by Subject|4|||
19635644|NCT00764504|42085008|FG000|Overall Study|Lost to Follow-up|40|||
19635645|NCT00764504|42085009|FG001|Overall Study|Lost to Follow-up|34|||
19635646|NCT00764504|42085010|FG002|Overall Study|Lost to Follow-up|72|||
19635647|NCT00763958|42085020|FG000|Overall Study|did not meet final criteria|4|||
19635648|NCT00763958|42085021|FG001|Overall Study|did not meet final criteria|4|||
19635649|NCT00763958|42085020|FG000|Overall Study|Lost to Follow-up|10|||
19635650|NCT00763958|42085021|FG001|Overall Study|Lost to Follow-up|2|||
19635651|NCT00763958|42085020|FG000|Overall Study|Believed they were receiving placebo|0|||
19635652|NCT00763958|42085021|FG001|Overall Study|Believed they were receiving placebo|5|||
19635653|NCT00763256|42085030|FG000|Overall Study|Didn't return for appointments|7|||
19635654|NCT00763256|42085031|FG001|Overall Study|Didn't return for appointments|10|||
19635655|NCT00762788|42085043|FG000|Overall Study|Lost to Follow-up|26|||
19635656|NCT00762788|42085044|FG001|Overall Study|Lost to Follow-up|37|||
19635657|NCT00762788|42085045|FG002|Overall Study|Lost to Follow-up|21|||
19635658|NCT00762788|42085046|FG003|Overall Study|Lost to Follow-up|26|||
19635659|NCT00762788|42085047|FG004|Overall Study|Lost to Follow-up|13|||
19635660|NCT00762788|42085048|FG005|Overall Study|Lost to Follow-up|21|||
19635661|NCT00583947|42085064|FG000|Cross-over Period|Adverse Event|2|||
19635662|NCT00583947|42085065|FG001|Cross-over Period|Adverse Event|0|||
19635663|NCT00583947|42085064|FG000|Cross-over Period|Withdrawal by Subject|2|||
19635664|NCT00583947|42085065|FG001|Cross-over Period|Withdrawal by Subject|0|||
19635665|NCT00583947|42085064|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
19635666|NCT00583947|42085065|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
19635667|NCT00583947|42085064|FG000|Cross-over Period|Other|1|||
19635668|NCT00583947|42085065|FG001|Cross-over Period|Other|1|||
19635669|NCT00772928|42085075|FG000|Overall Study|Lost to Follow-up|9|||
19635670|NCT00772928|42085076|FG001|Overall Study|Lost to Follow-up|6|||
19635671|NCT00772928|42085075|FG000|Overall Study|Protocol Violation|10|||
19635672|NCT00772928|42085076|FG001|Overall Study|Protocol Violation|12|||
19635673|NCT00772928|42085075|FG000|Overall Study|Withdrawal by Subject|25|||
19635674|NCT00772928|42085076|FG001|Overall Study|Withdrawal by Subject|22|||
19635675|NCT00772928|42085075|FG000|Overall Study|Did not receive vaccine|0|||
19635676|NCT00772928|42085076|FG001|Overall Study|Did not receive vaccine|1|||
19635677|NCT00762476|42085084|FG000|Overall Study|Adverse Event|7|||
19635678|NCT00762476|42085085|FG001|Overall Study|Adverse Event|1|||
19635679|NCT00762476|42085084|FG000|Overall Study|Lost to Follow-up|2|||
19635680|NCT00762476|42085085|FG001|Overall Study|Lost to Follow-up|0|||
19635681|NCT00762476|42085084|FG000|Overall Study|Protocol Violation|5|||
19635682|NCT00762476|42085085|FG001|Overall Study|Protocol Violation|6|||
19635683|NCT00762476|42085084|FG000|Overall Study|Physician Decision|2|||
19635684|NCT00762476|42085085|FG001|Overall Study|Physician Decision|14|||
19635685|NCT00762476|42085084|FG000|Overall Study|Withdrawal by Subject|6|||
19635686|NCT00762476|42085085|FG001|Overall Study|Withdrawal by Subject|12|||
19635687|NCT00762476|42085084|FG000|Overall Study|antibiotic use|0|||
19635688|NCT00762476|42085085|FG001|Overall Study|antibiotic use|1|||
19635689|NCT00762476|42085084|FG000|Overall Study|non-compliance with study visits|0|||
19635690|NCT00762476|42085085|FG001|Overall Study|non-compliance with study visits|2|||
19635691|NCT00762476|42085084|FG000|Overall Study|Seasonal allergies|1|||
19635692|NCT00762476|42085085|FG001|Overall Study|Seasonal allergies|0|||
19635693|NCT00762164|42085094|FG000|Overall Study|Lost to Follow-up|1|||
19635694|NCT00762164|42085095|FG001|Overall Study|Lost to Follow-up|1|||
19635695|NCT00762164|42085094|FG000|Overall Study|Discontinued medication|2|||
19543901|NCT01150123|41993381|FG007|Overall Study|Lost to Follow-up|0|||
19543902|NCT01150123|41993382|FG008|Overall Study|Lost to Follow-up|3|||
19543903|NCT01150123|41993383|FG009|Overall Study|Lost to Follow-up|1|||
19543904|NCT01150123|41993384|FG010|Overall Study|Lost to Follow-up|1|||
19635696|NCT00762164|42085095|FG001|Overall Study|Discontinued medication|0|||
19635697|NCT00762164|42085094|FG000|Overall Study|Withdrawal by Subject|0|||
19635698|NCT00762164|42085095|FG001|Overall Study|Withdrawal by Subject|1|||
19635699|NCT00762086|42085103|FG000|Overall Study|Adverse Event|2|||
19635700|NCT00762086|42085104|FG001|Overall Study|Adverse Event|0|||
19635701|NCT00762086|42085103|FG000|Overall Study|Lost to Follow-up|0|||
19635702|NCT00762086|42085104|FG001|Overall Study|Lost to Follow-up|2|||
19635703|NCT00762086|42085103|FG000|Overall Study|Non compliance|1|||
19635704|NCT00762086|42085104|FG001|Overall Study|Non compliance|0|||
19635705|NCT00762086|42085103|FG000|Overall Study|Withdrawal by Subject|2|||
19635706|NCT00762086|42085104|FG001|Overall Study|Withdrawal by Subject|2|||
19635707|NCT00762086|42085103|FG000|Overall Study|Ineligible to participate in the study|1|||
19635708|NCT00762086|42085104|FG001|Overall Study|Ineligible to participate in the study|0|||
19635709|NCT00761774|42085110|FG000|Overall Study|Adverse Event|17|||
19635710|NCT00761774|42085110|FG000|Overall Study|Lack of Efficacy|37|||
19635711|NCT00761774|42085110|FG000|Overall Study|Lost to Follow-up|2|||
19635712|NCT00761774|42085110|FG000|Overall Study|Withdrawal by Subject|9|||
19635713|NCT00761774|42085110|FG000|Overall Study|Non-compliance|4|||
19635714|NCT00761774|42085110|FG000|Overall Study|End of study|2|||
19635715|NCT00761774|42085110|FG000|Overall Study|Reclassification of seizures|1|||
19635716|NCT00761774|42085110|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
19635717|NCT00761774|42085110|FG000|Overall Study|Sponsor decision|1|||
19635718|NCT00761774|42085110|FG000|Overall Study|Investigator clinical judgement|1|||
19635719|NCT00761774|42085110|FG000|Overall Study|Patient moved out of study area|1|||
19635720|NCT00761774|42085110|FG000|Overall Study|Coordinator leaving site|1|||
19635721|NCT00761774|42085110|FG000|Overall Study|Subject IP non-compliance|1|||
19635722|NCT00761774|42085110|FG000|Overall Study|IP stopped by hospital physician|1|||
19635723|NCT00583791|42085116|FG000|Overall Study|Other|67|||
19635724|NCT00583791|42085116|FG000|Overall Study|Death|6|||
19635725|NCT00781274|42085120|FG000|Overall Study|Withdrawal by Subject|2|||
19635726|NCT00780416|42085126|FG000|Overall Study|Physician Decision|3|||
19635727|NCT00780416|42085127|FG001|Overall Study|Physician Decision|3|||
19635728|NCT00780416|42085126|FG000|Overall Study|Protocol Violation|1|||
19635729|NCT00780416|42085127|FG001|Overall Study|Protocol Violation|0|||
19635730|NCT00780416|42085126|FG000|Overall Study|Withdrawal by Subject|8|||
19635731|NCT00780416|42085127|FG001|Overall Study|Withdrawal by Subject|6|||
19635732|NCT00761462|42085135|FG000|Treatment|Subjects never received study medication|23|||
19635733|NCT00761462|42085136|FG001|Treatment|Subjects never received study medication|12|||
19543905|NCT01150123|41993385|FG011|Overall Study|Lost to Follow-up|1|||
19543906|NCT01150123|41993386|FG012|Overall Study|Lost to Follow-up|2|||
19543907|NCT01150123|41993387|FG013|Overall Study|Lost to Follow-up|0|||
19543908|NCT01150123|41993388|FG014|Overall Study|Lost to Follow-up|0|||
19635734|NCT00761462|42085135|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
19635735|NCT00761462|42085136|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
19635736|NCT00761462|42085135|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
19635737|NCT00761462|42085136|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
19635738|NCT00761462|42085135|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
19635739|NCT00761462|42085136|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
19635740|NCT00761306|42085142|FG000|Overall Study|Adverse Event|5|||
19635741|NCT00761306|42085142|FG000|Overall Study|Lack of Efficacy|4|||
19635742|NCT00761306|42085142|FG000|Overall Study|Protocol Violation|2|||
19635743|NCT00761306|42085142|FG000|Overall Study|Withdrawal of Consent|3|||
19635744|NCT00761306|42085142|FG000|Overall Study|Lost to Follow-up|1|||
19635745|NCT00761306|42085142|FG000|Overall Study|Administrative or Other Reasons|5|||
19635746|NCT00772538|42085148|FG000|Overall Study|Adverse Event|6|||
19635747|NCT00772538|42085149|FG001|Overall Study|Adverse Event|6|||
19635748|NCT00772538|42085148|FG000|Overall Study|Protocol Violation|3|||
19635749|NCT00772538|42085149|FG001|Overall Study|Protocol Violation|3|||
19635750|NCT00772538|42085148|FG000|Overall Study|Lost to Follow-up|1|||
19635751|NCT00772538|42085149|FG001|Overall Study|Lost to Follow-up|1|||
19635752|NCT00772538|42085148|FG000|Overall Study|Withdrawal by Subject|3|||
19635753|NCT00772538|42085149|FG001|Overall Study|Withdrawal by Subject|8|||
19635754|NCT00772538|42085148|FG000|Overall Study|Lack of Efficacy|0|||
19635755|NCT00772538|42085149|FG001|Overall Study|Lack of Efficacy|1|||
19635756|NCT00772538|42085148|FG000|Overall Study|Other|7|||
19635757|NCT00772538|42085149|FG001|Overall Study|Other|7|||
19635758|NCT00761150|42085158|FG000|Open-label Period|Adverse Event|36|||
19635759|NCT00761150|42085159|FG001|Open-label Period|Adverse Event|0|||
19635760|NCT00761150|42085160|FG002|Open-label Period|Adverse Event|0|||
19635761|NCT00761150|42085158|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
19635762|NCT00761150|42085159|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
19635763|NCT00761150|42085160|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
19635764|NCT00761150|42085158|FG000|Open-label Period|Lost to Follow-up|7|||
19635765|NCT00761150|42085159|FG001|Open-label Period|Lost to Follow-up|0|||
19635766|NCT00761150|42085160|FG002|Open-label Period|Lost to Follow-up|0|||
19635767|NCT00761150|42085158|FG000|Open-label Period|Lack of Efficacy|4|||
19635768|NCT00761150|42085159|FG001|Open-label Period|Lack of Efficacy|0|||
19635769|NCT00761150|42085160|FG002|Open-label Period|Lack of Efficacy|0|||
19635770|NCT00761150|42085158|FG000|Open-label Period|Withdrawal by Subject|5|||
19635771|NCT00761150|42085159|FG001|Open-label Period|Withdrawal by Subject|0|||
19635772|NCT00761150|42085160|FG002|Open-label Period|Withdrawal by Subject|0|||
19635773|NCT00761150|42085158|FG000|Open-label Period|Noncompliance|2|||
19635774|NCT00761150|42085159|FG001|Open-label Period|Noncompliance|0|||
19635775|NCT00761150|42085160|FG002|Open-label Period|Noncompliance|0|||
19635776|NCT00761150|42085158|FG000|Open-label Period|Other|5|||
19635777|NCT00761150|42085159|FG001|Open-label Period|Other|0|||
19635778|NCT00761150|42085160|FG002|Open-label Period|Other|0|||
19635779|NCT00761150|42085158|FG000|Double-blind Period|Lack of Efficacy|0|||
19635780|NCT00761150|42085159|FG001|Double-blind Period|Lack of Efficacy|2|||
19635781|NCT00761150|42085160|FG002|Double-blind Period|Lack of Efficacy|19|||
19635782|NCT00761150|42085158|FG000|Double-blind Period|Adverse Event|0|||
19635783|NCT00761150|42085159|FG001|Double-blind Period|Adverse Event|3|||
19635784|NCT00761150|42085160|FG002|Double-blind Period|Adverse Event|3|||
19635785|NCT00761150|42085158|FG000|Double-blind Period|Withdrawal by Subject|0|||
19635786|NCT00761150|42085159|FG001|Double-blind Period|Withdrawal by Subject|3|||
19635787|NCT00761150|42085160|FG002|Double-blind Period|Withdrawal by Subject|2|||
19635788|NCT00761150|42085158|FG000|Double-blind Period|Lost to Follow-up|0|||
19635789|NCT00761150|42085159|FG001|Double-blind Period|Lost to Follow-up|2|||
19635790|NCT00761150|42085160|FG002|Double-blind Period|Lost to Follow-up|1|||
19635791|NCT00761150|42085158|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
19635792|NCT00761150|42085159|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
19635793|NCT00761150|42085160|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
19635794|NCT00761150|42085158|FG000|Double-blind Period|Noncompliance|0|||
19635795|NCT00761150|42085159|FG001|Double-blind Period|Noncompliance|1|||
19635796|NCT00761150|42085160|FG002|Double-blind Period|Noncompliance|0|||
19635797|NCT00761150|42085158|FG000|Double-blind Period|Other|0|||
19635798|NCT00761150|42085159|FG001|Double-blind Period|Other|3|||
19635799|NCT00761150|42085160|FG002|Double-blind Period|Other|3|||
19635800|NCT00760994|42085170|FG000|Overall Study|Lost to Follow-up|4|||
19635801|NCT00760994|42085171|FG001|Overall Study|Lost to Follow-up|4|||
19635802|NCT00760994|42085172|FG002|Overall Study|Lost to Follow-up|3|||
19635803|NCT00583557|42085182|FG000|Overall Study|Withdrawal by Subject|18|||
19635804|NCT00583557|42085182|FG000|Overall Study|Adverse Event|9|||
19635805|NCT00583557|42085182|FG000|Overall Study|Lack of Efficacy|31|||
19635806|NCT00583557|42085182|FG000|Overall Study|Lack of Compliance|5|||
19635807|NCT00583557|42085182|FG000|Overall Study|Other|5|||
19635808|NCT00583557|42085182|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
19635809|NCT00586820|42085188|FG000|Overall Study|Unsuccessful PCI|1|||
19635810|NCT00586820|42085189|FG001|Overall Study|Unsuccessful PCI|0|||
19635811|NCT00760838|42085197|FG000|Overall Study|Adverse Event|1|||
19543909|NCT01150123|41993389|FG015|Overall Study|Lost to Follow-up|0|||
19635812|NCT00760838|42085198|FG001|Overall Study|Adverse Event|1|||
19635813|NCT00760838|42085197|FG000|Overall Study|Lack of Efficacy|1|||
19635814|NCT00760838|42085198|FG001|Overall Study|Lack of Efficacy|0|||
19635815|NCT00760838|42085197|FG000|Overall Study|Lost to Follow-up|2|||
19543910|NCT01150123|41993390|FG016|Overall Study|Lost to Follow-up|0|||
19543911|NCT01150123|41993391|FG017|Overall Study|Lost to Follow-up|0|||
19543912|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
19543913|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
19543914|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
19543915|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
19543916|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
19543917|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
19543918|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
19543919|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
19543920|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
19543921|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
19543922|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
19543923|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
19635816|NCT00760838|42085198|FG001|Overall Study|Lost to Follow-up|0|||
19635817|NCT00760838|42085197|FG000|Overall Study|Withdrawal by Subject|1|||
19635818|NCT00760838|42085198|FG001|Overall Study|Withdrawal by Subject|1|||
19635819|NCT00586664|42085207|FG000|Overall Study|Withdrawal by Subject|3|||
19635820|NCT00586664|42085208|FG001|Overall Study|Withdrawal by Subject|7|||
19635821|NCT00586664|42085209|FG002|Overall Study|Withdrawal by Subject|1|||
19635822|NCT00586664|42085207|FG000|Overall Study|Exclusion criteria met|2|||
19635823|NCT00586664|42085208|FG001|Overall Study|Exclusion criteria met|0|||
19635824|NCT00586664|42085209|FG002|Overall Study|Exclusion criteria met|0|||
19635825|NCT00437281|42085237|FG000|Overall Study|Adverse Event|0|||
19635826|NCT00437281|42085238|FG001|Overall Study|Adverse Event|0|||
19635827|NCT00437281|42085239|FG002|Overall Study|Adverse Event|0|||
19635828|NCT00437281|42085240|FG003|Overall Study|Adverse Event|1|||
19635829|NCT00437281|42085241|FG004|Overall Study|Adverse Event|0|||
19635830|NCT00437281|42085242|FG005|Overall Study|Adverse Event|1|||
19635831|NCT00437281|42085243|FG006|Overall Study|Adverse Event|0|||
19635832|NCT00437281|42085244|FG007|Overall Study|Adverse Event|0|||
19635833|NCT00437281|42085245|FG008|Overall Study|Adverse Event|0|||
19635834|NCT00437281|42085246|FG009|Overall Study|Adverse Event|1|||
19635835|NCT00437281|42085247|FG010|Overall Study|Adverse Event|0|||
19635836|NCT00437281|42085248|FG011|Overall Study|Adverse Event|0|||
19635837|NCT00437281|42085249|FG012|Overall Study|Adverse Event|0|||
19635838|NCT00437281|42085250|FG013|Overall Study|Adverse Event|1|||
19635839|NCT00437281|42085251|FG014|Overall Study|Adverse Event|1|||
19635840|NCT00437281|42085252|FG015|Overall Study|Adverse Event|0|||
19635841|NCT00437281|42085253|FG016|Overall Study|Adverse Event|0|||
19635842|NCT00437281|42085254|FG017|Overall Study|Adverse Event|0|||
19635843|NCT00437281|42085255|FG018|Overall Study|Adverse Event|1|||
19635844|NCT00437281|42085256|FG019|Overall Study|Adverse Event|0|||
19635845|NCT00437281|42085237|FG000|Overall Study|Lost to Follow-up|0|||
19635846|NCT00437281|42085238|FG001|Overall Study|Lost to Follow-up|0|||
19635847|NCT00437281|42085239|FG002|Overall Study|Lost to Follow-up|0|||
19635848|NCT00437281|42085240|FG003|Overall Study|Lost to Follow-up|0|||
19635849|NCT00437281|42085241|FG004|Overall Study|Lost to Follow-up|0|||
19635850|NCT00437281|42085242|FG005|Overall Study|Lost to Follow-up|0|||
19635851|NCT00437281|42085243|FG006|Overall Study|Lost to Follow-up|0|||
19635852|NCT00437281|42085244|FG007|Overall Study|Lost to Follow-up|0|||
19635853|NCT00437281|42085245|FG008|Overall Study|Lost to Follow-up|0|||
19635854|NCT00437281|42085246|FG009|Overall Study|Lost to Follow-up|0|||
19635855|NCT00437281|42085247|FG010|Overall Study|Lost to Follow-up|0|||
19635856|NCT00437281|42085248|FG011|Overall Study|Lost to Follow-up|0|||
19635857|NCT00437281|42085249|FG012|Overall Study|Lost to Follow-up|0|||
19635858|NCT00437281|42085250|FG013|Overall Study|Lost to Follow-up|0|||
19635859|NCT00437281|42085251|FG014|Overall Study|Lost to Follow-up|0|||
19635860|NCT00437281|42085252|FG015|Overall Study|Lost to Follow-up|0|||
19635861|NCT00437281|42085253|FG016|Overall Study|Lost to Follow-up|0|||
19635862|NCT00437281|42085254|FG017|Overall Study|Lost to Follow-up|0|||
19635863|NCT00437281|42085255|FG018|Overall Study|Lost to Follow-up|0|||
19635864|NCT00437281|42085256|FG019|Overall Study|Lost to Follow-up|1|||
19635865|NCT00741039|42085330|FG000|Overall Study|Patient non-compliance|2|||
19635866|NCT00741039|42085331|FG001|Overall Study|Patient non-compliance|0|||
19635867|NCT00772382|42085337|FG000|Overall Study|Adverse Event|19|||
19635868|NCT00772382|42085337|FG000|Overall Study|Death|6|||
19543924|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
19543925|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
19635869|NCT00772382|42085337|FG000|Overall Study|Lack of Efficacy|4|||
19635870|NCT00772382|42085337|FG000|Overall Study|Physician Decision|5|||
19635871|NCT00772382|42085337|FG000|Overall Study|Protocol Violation|1|||
19635872|NCT00772382|42085337|FG000|Overall Study|Withdrawal by Subject|10|||
19635873|NCT00772382|42085337|FG000|Overall Study|Other Reasons|10|||
19635874|NCT00798707|42085344|FG000|Overall Study|Adverse Event|6|||
19635875|NCT00798707|42085345|FG001|Overall Study|Adverse Event|8|||
19635876|NCT00798707|42085346|FG002|Overall Study|Adverse Event|8|||
19635877|NCT00798707|42085344|FG000|Overall Study|Failed to return|2|||
19543926|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
19543927|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
19543928|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
19543929|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
19543930|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
19543931|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
19543932|NCT01149655|41993450|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
19543933|NCT01149655|41993451|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
19543934|NCT01149655|41993452|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
19543935|NCT01149655|41993453|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
19543936|NCT01149655|41993450|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
19543937|NCT01149655|41993451|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
19543938|NCT01149655|41993452|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
19543939|NCT01149655|41993453|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
19543940|NCT01149655|41993450|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
19543941|NCT01149655|41993451|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
19543942|NCT01149655|41993452|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
19543943|NCT01149655|41993453|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
19543944|NCT01149655|41993450|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
19543945|NCT01149655|41993451|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
19543946|NCT01149655|41993452|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
19543947|NCT01149655|41993453|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
19543948|NCT01149655|41993450|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
19543949|NCT01149655|41993451|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
19543950|NCT01149655|41993452|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
19543951|NCT01149655|41993453|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
19543952|NCT01149655|41993450|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
19543953|NCT01149655|41993451|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
19543954|NCT01149655|41993452|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
19543955|NCT01149655|41993453|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
19543956|NCT01149655|41993450|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
19543957|NCT01149655|41993451|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
19543958|NCT01149655|41993452|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
19543959|NCT01149655|41993453|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
19543960|NCT01149655|41993450|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
19543961|NCT01149655|41993451|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
19543962|NCT01149655|41993452|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
19543963|NCT01149655|41993453|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
19543964|NCT01149655|41993450|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
19543965|NCT01149655|41993451|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
19543966|NCT01149655|41993452|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
19543967|NCT01149655|41993453|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
19543968|NCT01149655|41993450|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
19543969|NCT01149655|41993451|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
19543970|NCT01149655|41993452|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
19543971|NCT01149655|41993453|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
19543972|NCT01149655|41993450|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
19543973|NCT01149655|41993451|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
19543974|NCT01149655|41993452|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
19543975|NCT01149655|41993453|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
19543976|NCT01149538|41993463|FG000|Overall Study|Lost to Follow-up|0|||
19543977|NCT01149538|41993464|FG001|Overall Study|Lost to Follow-up|1|||
19543978|NCT01149538|41993463|FG000|Overall Study|Withdrawal by Subject|5|||
19543979|NCT01149538|41993464|FG001|Overall Study|Withdrawal by Subject|3|||
19543980|NCT01149460|41993472|FG000|Overall Study|Withdrawal by Subject|0|||
19543981|NCT01149460|41993473|FG001|Overall Study|Withdrawal by Subject|2|||
19635878|NCT00798707|42085345|FG001|Overall Study|Failed to return|2|||
19635879|NCT00798707|42085346|FG002|Overall Study|Failed to return|0|||
19635880|NCT00798707|42085344|FG000|Overall Study|Investigator|0|||
19635881|NCT00798707|42085345|FG001|Overall Study|Investigator|1|||
19635882|NCT00798707|42085346|FG002|Overall Study|Investigator|2|||
19635883|NCT00798707|42085344|FG000|Overall Study|Lack of Efficacy|2|||
19635884|NCT00798707|42085345|FG001|Overall Study|Lack of Efficacy|2|||
19635885|NCT00798707|42085346|FG002|Overall Study|Lack of Efficacy|1|||
19635886|NCT00798707|42085344|FG000|Overall Study|Lost to Follow-up|5|||
19635887|NCT00798707|42085345|FG001|Overall Study|Lost to Follow-up|6|||
19635888|NCT00798707|42085346|FG002|Overall Study|Lost to Follow-up|6|||
19635889|NCT00798707|42085344|FG000|Overall Study|Other|0|||
19635890|NCT00798707|42085345|FG001|Overall Study|Other|1|||
19635891|NCT00798707|42085346|FG002|Overall Study|Other|0|||
19635892|NCT00798707|42085344|FG000|Overall Study|Protocol Violation|4|||
19635893|NCT00798707|42085345|FG001|Overall Study|Protocol Violation|0|||
19635894|NCT00798707|42085346|FG002|Overall Study|Protocol Violation|2|||
19635895|NCT00798707|42085344|FG000|Overall Study|Withdrawal by Subject|3|||
19635896|NCT00798707|42085345|FG001|Overall Study|Withdrawal by Subject|8|||
19635897|NCT00798707|42085346|FG002|Overall Study|Withdrawal by Subject|2|||
19635898|NCT00798707|42085344|FG000|Overall Study|Randomized not treated|4|||
19635899|NCT00798707|42085345|FG001|Overall Study|Randomized not treated|5|||
19635900|NCT00798707|42085346|FG002|Overall Study|Randomized not treated|1|||
19635901|NCT00760214|42085357|FG000|Overall Study|Adverse Event|8|||
19635902|NCT00760214|42085358|FG001|Overall Study|Adverse Event|9|||
19635903|NCT00760214|42085359|FG002|Overall Study|Adverse Event|12|||
19635904|NCT00760214|42085357|FG000|Overall Study|Protocol Violation|3|||
19635905|NCT00760214|42085358|FG001|Overall Study|Protocol Violation|0|||
19635906|NCT00760214|42085359|FG002|Overall Study|Protocol Violation|3|||
19635907|NCT00760214|42085357|FG000|Overall Study|Lost to Follow-up|0|||
19635908|NCT00760214|42085358|FG001|Overall Study|Lost to Follow-up|0|||
19635909|NCT00760214|42085359|FG002|Overall Study|Lost to Follow-up|1|||
19635910|NCT00760214|42085357|FG000|Overall Study|Withdrawal by Subject|12|||
19635911|NCT00760214|42085358|FG001|Overall Study|Withdrawal by Subject|14|||
19635912|NCT00760214|42085359|FG002|Overall Study|Withdrawal by Subject|13|||
19635913|NCT00760214|42085357|FG000|Overall Study|Lack of Efficacy|3|||
19635914|NCT00760214|42085358|FG001|Overall Study|Lack of Efficacy|2|||
19635915|NCT00760214|42085359|FG002|Overall Study|Lack of Efficacy|4|||
19635916|NCT00760214|42085357|FG000|Overall Study|Pregnancy|0|||
19635917|NCT00760214|42085358|FG001|Overall Study|Pregnancy|0|||
19635918|NCT00760214|42085359|FG002|Overall Study|Pregnancy|1|||
19635919|NCT00760214|42085357|FG000|Overall Study|Physician Decision|1|||
19635920|NCT00760214|42085358|FG001|Overall Study|Physician Decision|1|||
19635921|NCT00760214|42085359|FG002|Overall Study|Physician Decision|1|||
19635922|NCT00760214|42085357|FG000|Overall Study|Other|3|||
19635923|NCT00760214|42085358|FG001|Overall Study|Other|4|||
19635924|NCT00760214|42085359|FG002|Overall Study|Other|6|||
19635925|NCT00802841|42085369|FG000|Overall Study|Administrative problems|1|||
19635926|NCT00802841|42085370|FG001|Overall Study|Administrative problems|0|||
19635927|NCT00802841|42085369|FG000|Overall Study|Lost to Follow-up|2|||
19635928|NCT00802841|42085370|FG001|Overall Study|Lost to Follow-up|1|||
19635929|NCT00802841|42085369|FG000|Overall Study|Death|1|||
19635930|NCT00802841|42085370|FG001|Overall Study|Death|2|||
19635931|NCT00802841|42085369|FG000|Overall Study|Adverse Event|8|||
19635932|NCT00802841|42085370|FG001|Overall Study|Adverse Event|2|||
19635933|NCT00802841|42085369|FG000|Overall Study|Disease progression|7|||
19635934|NCT00802841|42085370|FG001|Overall Study|Disease progression|3|||
19635935|NCT00802841|42085369|FG000|Overall Study|Withdrawal by Subject|9|||
19635936|NCT00802841|42085370|FG001|Overall Study|Withdrawal by Subject|5|||
19635937|NCT00802841|42085369|FG000|Overall Study|Protocol deviation|2|||
19635938|NCT00802841|42085370|FG001|Overall Study|Protocol deviation|6|||
19635939|NCT00802841|42085369|FG000|Overall Study|Treatment duration completed|66|||
19635940|NCT00802841|42085370|FG001|Overall Study|Treatment duration completed|76|||
19635941|NCT00772148|42085380|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
19635942|NCT00772148|42085381|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
19635943|NCT00772148|42085380|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
19635944|NCT00772148|42085381|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
19635945|NCT00772148|42085380|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
19635946|NCT00772148|42085381|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
19635947|NCT00772148|42085380|FG000|Maintenance Phase (Week 52)|Death|2|||
19635948|NCT00772148|42085381|FG001|Maintenance Phase (Week 52)|Death|2|||
19635949|NCT00772148|42085380|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
19635950|NCT00772148|42085381|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
19635951|NCT00772148|42085380|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
19635952|NCT00772148|42085381|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
19635953|NCT00772148|42085380|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
19635954|NCT00772148|42085381|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
19635955|NCT00759902|42085389|FG000|Overall Study|Adverse Event|0|||
19635956|NCT00759902|42085390|FG001|Overall Study|Adverse Event|1|||
19635957|NCT00772070|42085398|FG000|Overall Study|Lost to Follow-up|0|||
19635958|NCT00772070|42085399|FG001|Overall Study|Lost to Follow-up|8|||
19635959|NCT00772070|42085398|FG000|Overall Study|Withdrawal by Subject|0|||
19635960|NCT00772070|42085399|FG001|Overall Study|Withdrawal by Subject|2|||
19635961|NCT00772070|42085398|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
19635962|NCT00772070|42085399|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
19635963|NCT00796757|42085405|FG000|Overall Study|Withdrawal by Subject|14|||
19635964|NCT00796757|42085405|FG000|Overall Study|Death|61|||
19635965|NCT00796757|42085405|FG000|Overall Study|Protocol Violation|1|||
19635966|NCT00796757|42085405|FG000|Overall Study|Participant noncompliance|1|||
19635967|NCT00796757|42085405|FG000|Overall Study|Investigator's decision|2|||
19635968|NCT00796757|42085405|FG000|Overall Study|Other|7|||
19635969|NCT00759356|42085411|FG000|Overall Study|Adverse Event|0|||
19635970|NCT00759356|42085412|FG001|Overall Study|Adverse Event|1|||
19635971|NCT00759356|42085411|FG000|Overall Study|Withdrawal by Subject|0|||
19635972|NCT00759356|42085412|FG001|Overall Study|Withdrawal by Subject|2|||
19635973|NCT00759356|42085411|FG000|Overall Study|Subject was unable to return|1|||
19635974|NCT00759356|42085412|FG001|Overall Study|Subject was unable to return|0|||
19635975|NCT00721734|42085423|FG000|Overall Study|Progressive Disease|3|||
19635976|NCT00721734|42085424|FG001|Overall Study|Progressive Disease|10|||
19635977|NCT00721734|42085425|FG002|Overall Study|Progressive Disease|4|||
19635978|NCT00721734|42085426|FG003|Overall Study|Progressive Disease|5|||
19635979|NCT00721734|42085427|FG004|Overall Study|Progressive Disease|2|||
19635980|NCT00721734|42085423|FG000|Overall Study|Adverse Event|3|||
19635981|NCT00721734|42085424|FG001|Overall Study|Adverse Event|1|||
19635982|NCT00721734|42085425|FG002|Overall Study|Adverse Event|4|||
19635983|NCT00721734|42085426|FG003|Overall Study|Adverse Event|0|||
19635984|NCT00721734|42085427|FG004|Overall Study|Adverse Event|3|||
19635985|NCT00721734|42085423|FG000|Overall Study|Withdrawal by Subject|2|||
19635986|NCT00721734|42085424|FG001|Overall Study|Withdrawal by Subject|1|||
19635987|NCT00721734|42085425|FG002|Overall Study|Withdrawal by Subject|0|||
19635988|NCT00721734|42085426|FG003|Overall Study|Withdrawal by Subject|0|||
19635989|NCT00721734|42085427|FG004|Overall Study|Withdrawal by Subject|1|||
19635990|NCT00721734|42085423|FG000|Overall Study|Other|0|||
19635991|NCT00721734|42085424|FG001|Overall Study|Other|0|||
19635992|NCT00721734|42085425|FG002|Overall Study|Other|0|||
19635993|NCT00721734|42085426|FG003|Overall Study|Other|1|||
19635994|NCT00721734|42085427|FG004|Overall Study|Other|0|||
19635995|NCT00798317|42085441|FG000|Overall Study|Physician Decision|0|||
19635996|NCT00798317|42085442|FG001|Overall Study|Physician Decision|1|||
19635997|NCT00798317|42085441|FG000|Overall Study|Withdrawal by Subject|5|||
19635998|NCT00798317|42085442|FG001|Overall Study|Withdrawal by Subject|4|||
19635999|NCT00798317|42085441|FG000|Overall Study|Lost to Follow-up|2|||
19636000|NCT00798317|42085442|FG001|Overall Study|Lost to Follow-up|2|||
19636001|NCT00798317|42085441|FG000|Overall Study|Adverse Event|2|||
19636002|NCT00798317|42085442|FG001|Overall Study|Adverse Event|0|||
19636003|NCT00798317|42085441|FG000|Overall Study|Death|1|||
19636004|NCT00798317|42085442|FG001|Overall Study|Death|0|||
19636005|NCT00779402|42085450|FG000|Treatment Phase 1|Disease Progression|1|||
19636006|NCT00779402|42085451|FG001|Treatment Phase 1|Disease Progression|0|||
19636007|NCT00779402|42085450|FG000|Treatment Phase 1|Adverse Event|2|||
19636008|NCT00779402|42085451|FG001|Treatment Phase 1|Adverse Event|0|||
19636009|NCT00779402|42085450|FG000|Treatment Phase 1|Protocol Violation|1|||
19636010|NCT00779402|42085451|FG001|Treatment Phase 1|Protocol Violation|0|||
19636011|NCT00779402|42085450|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
19636012|NCT00779402|42085451|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
19636013|NCT00779402|42085450|FG000|Treatment Phase 1|Lost to Follow-up|0|||
19636014|NCT00779402|42085451|FG001|Treatment Phase 1|Lost to Follow-up|1|||
19636015|NCT00779402|42085450|FG000|Treatment Phase 1|Death|0|||
19636016|NCT00779402|42085451|FG001|Treatment Phase 1|Death|1|||
19636017|NCT00779402|42085450|FG000|Treatment Phase 1|Intercurrent Illness|1|||
19636018|NCT00779402|42085451|FG001|Treatment Phase 1|Intercurrent Illness|1|||
19636019|NCT00779402|42085450|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
19636020|NCT00779402|42085451|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
19636021|NCT00779402|42085450|FG000|Treatment Phase 1|Other|4|||
19636022|NCT00779402|42085451|FG001|Treatment Phase 1|Other|2|||
19636023|NCT00779402|42085450|FG000|Treatment Phase 1|Closure of Study|3|||
19636024|NCT00779402|42085451|FG001|Treatment Phase 1|Closure of Study|2|||
19636025|NCT00779402|42085450|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
19636026|NCT00779402|42085451|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
19636027|NCT00779402|42085450|FG000|Surveillance Phase|Protocol Violation|0|||
19636028|NCT00779402|42085451|FG001|Surveillance Phase|Protocol Violation|1|||
19636029|NCT00779402|42085450|FG000|Surveillance Phase|Patient refused to continue|22|||
19636030|NCT00779402|42085451|FG001|Surveillance Phase|Patient refused to continue|14|||
19636031|NCT00779402|42085450|FG000|Surveillance Phase|Lost to Follow-up|2|||
19636032|NCT00779402|42085451|FG001|Surveillance Phase|Lost to Follow-up|1|||
19636033|NCT00779402|42085450|FG000|Surveillance Phase|Death|0|||
19636034|NCT00779402|42085451|FG001|Surveillance Phase|Death|1|||
19636035|NCT00779402|42085450|FG000|Surveillance Phase|Intercurrent Illness|2|||
19636036|NCT00779402|42085451|FG001|Surveillance Phase|Intercurrent Illness|0|||
19636037|NCT00779402|42085450|FG000|Surveillance Phase|Other|5|||
19636038|NCT00779402|42085451|FG001|Surveillance Phase|Other|5|||
19636039|NCT00779402|42085450|FG000|Surveillance Phase|Withdrawal by Subject|4|||
19636040|NCT00779402|42085451|FG001|Surveillance Phase|Withdrawal by Subject|1|||
19636041|NCT00779402|42085450|FG000|Surveillance Phase|Closure of study|5|||
19636042|NCT00779402|42085451|FG001|Surveillance Phase|Closure of study|6|||
19636043|NCT00779402|42085450|FG000|Surveillance Phase|Completed Protocol Visits|3|||
19636044|NCT00779402|42085451|FG001|Surveillance Phase|Completed Protocol Visits|2|||
19636045|NCT00779402|42085450|FG000|Long-term Follow-up|Patient refused to continue|2|||
19636046|NCT00779402|42085451|FG001|Long-term Follow-up|Patient refused to continue|0|||
19636047|NCT00779402|42085450|FG000|Long-term Follow-up|Other|5|||
19636048|NCT00779402|42085451|FG001|Long-term Follow-up|Other|0|||
19636049|NCT00779402|42085450|FG000|Long-term Follow-up|Closure of Study|8|||
19636050|NCT00779402|42085451|FG001|Long-term Follow-up|Closure of Study|4|||
19636051|NCT00779402|42085450|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
19636052|NCT00779402|42085451|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
19636053|NCT00771914|42085461|FG000|Overall Study|Physician Decision|0|||
19636054|NCT00771914|42085462|FG001|Overall Study|Physician Decision|0|||
19636055|NCT00771914|42085463|FG002|Overall Study|Physician Decision|0|||
19636056|NCT00771914|42085464|FG003|Overall Study|Physician Decision|1|||
19636057|NCT00771914|42085461|FG000|Overall Study|Lost to Follow-up|0|||
19636058|NCT00771914|42085462|FG001|Overall Study|Lost to Follow-up|0|||
19636059|NCT00771914|42085463|FG002|Overall Study|Lost to Follow-up|0|||
19636060|NCT00771914|42085464|FG003|Overall Study|Lost to Follow-up|1|||
19636061|NCT00779324|42085476|FG000|Overall Study|Lost to Follow-up|2|||
19636062|NCT00779324|42085477|FG001|Overall Study|Lost to Follow-up|1|||
19636063|NCT00779324|42085476|FG000|Overall Study|Withdrawal by Subject|4|||
19636064|NCT00779324|42085477|FG001|Overall Study|Withdrawal by Subject|2|||
19636065|NCT00779324|42085476|FG000|Overall Study|Missed visit|1|||
19636066|NCT00779324|42085477|FG001|Overall Study|Missed visit|1|||
19636067|NCT00779246|42085485|FG000|Overall Study|Missing sufficient data for analysis|33|||
19636068|NCT00779246|42085486|FG001|Overall Study|Missing sufficient data for analysis|53|||
19636069|NCT00771758|42085495|FG000|Overall Study|Adverse Event|2|||
19636070|NCT00771758|42085496|FG001|Overall Study|Adverse Event|8|||
19636071|NCT00771758|42085497|FG002|Overall Study|Adverse Event|1|||
19636072|NCT00771758|42085495|FG000|Overall Study|Lack of Efficacy|0|||
19636073|NCT00771758|42085496|FG001|Overall Study|Lack of Efficacy|2|||
19636074|NCT00771758|42085497|FG002|Overall Study|Lack of Efficacy|1|||
19636075|NCT00771758|42085495|FG000|Overall Study|Lost to Follow-up|1|||
19543982|NCT01149421|41993482|FG000|Overall Study|Adverse Event|22|||
19543983|NCT01149421|41993483|FG001|Overall Study|Adverse Event|6|||
19543984|NCT01149421|41993484|FG002|Overall Study|Adverse Event|11|||
19543985|NCT01149421|41993482|FG000|Overall Study|Withdrawal by Subject|20|||
19543986|NCT01149421|41993483|FG001|Overall Study|Withdrawal by Subject|12|||
19543987|NCT01149421|41993484|FG002|Overall Study|Withdrawal by Subject|13|||
19543988|NCT01149421|41993482|FG000|Overall Study|Sponsor Decision|0|||
19543989|NCT01149421|41993483|FG001|Overall Study|Sponsor Decision|1|||
19543990|NCT01149421|41993484|FG002|Overall Study|Sponsor Decision|1|||
19543991|NCT01149421|41993482|FG000|Overall Study|Lost to Follow-up|2|||
19543992|NCT01149421|41993483|FG001|Overall Study|Lost to Follow-up|4|||
19636076|NCT00771758|42085496|FG001|Overall Study|Lost to Follow-up|0|||
19712040|NCT03560518|42155022|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
19712041|NCT03560518|42155023|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
19712042|NCT03560518|42155024|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
19712043|NCT03560518|42155022|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
19712044|NCT03560518|42155023|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
19712045|NCT03560518|42155024|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
19712046|NCT03560518|42155022|FG000|Double Blind Treatment Period|Protocol Violation|1|||
19712047|NCT03560518|42155023|FG001|Double Blind Treatment Period|Protocol Violation|2|||
19712048|NCT03560518|42155024|FG002|Double Blind Treatment Period|Protocol Violation|0|||
19712049|NCT03560518|42155022|FG000|Double Blind Treatment Period|Pregnancy|0|||
19712050|NCT03560518|42155023|FG001|Double Blind Treatment Period|Pregnancy|2|||
19712051|NCT03560518|42155024|FG002|Double Blind Treatment Period|Pregnancy|0|||
19712052|NCT03560518|42155022|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
19712053|NCT03560518|42155023|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
19712054|NCT03560518|42155024|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
19712055|NCT03560518|42155022|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
19712056|NCT03560518|42155023|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
19712057|NCT03560518|42155024|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
19712058|NCT03560518|42155022|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
19458264|NCT01405911|41711986|FG001|Overall Study|Pre-treatment lab AE|1|||
19458265|NCT01405911|41711987|FG002|Overall Study|Pre-treatment lab AE|0|||
19458266|NCT01405911|41711985|FG000|Overall Study|Lost to Follow-up|0|||
19458267|NCT01405911|41711986|FG001|Overall Study|Lost to Follow-up|1|||
19458268|NCT01405911|41711987|FG002|Overall Study|Lost to Follow-up|0|||
19458269|NCT01405911|41711985|FG000|Overall Study|Protocol Violation|1|||
19458270|NCT01405911|41711986|FG001|Overall Study|Protocol Violation|0|||
19458271|NCT01405911|41711987|FG002|Overall Study|Protocol Violation|0|||
19458272|NCT01405911|41711985|FG000|Overall Study|Withdrawal by Subject|3|||
19458273|NCT01405911|41711986|FG001|Overall Study|Withdrawal by Subject|1|||
19458274|NCT01405911|41711987|FG002|Overall Study|Withdrawal by Subject|1|||
19458275|NCT01425801|41711995|FG000|Period 1|Withdrawal by Subject|0|||
19458276|NCT01425801|41711996|FG001|Period 1|Withdrawal by Subject|0|||
19458277|NCT01425801|41711997|FG002|Period 1|Withdrawal by Subject|0|||
19543993|NCT01149421|41993484|FG002|Overall Study|Lost to Follow-up|5|||
19543994|NCT01149421|41993482|FG000|Overall Study|Physician Decision|5|||
19543995|NCT01149421|41993483|FG001|Overall Study|Physician Decision|3|||
19543996|NCT01149421|41993484|FG002|Overall Study|Physician Decision|6|||
19636077|NCT00771758|42085497|FG002|Overall Study|Lost to Follow-up|0|||
19636078|NCT00771758|42085495|FG000|Overall Study|Protocol Violation|1|||
19636079|NCT00771758|42085496|FG001|Overall Study|Protocol Violation|0|||
19636080|NCT00771758|42085497|FG002|Overall Study|Protocol Violation|0|||
19636081|NCT00771758|42085495|FG000|Overall Study|Withdrawal by Subject|1|||
19636082|NCT00771758|42085496|FG001|Overall Study|Withdrawal by Subject|0|||
19458278|NCT01425801|41711998|FG003|Period 1|Withdrawal by Subject|0|||
19458279|NCT01425801|41711999|FG004|Period 1|Withdrawal by Subject|1|||
19458280|NCT01425801|41712000|FG005|Period 1|Withdrawal by Subject|0|||
19458281|NCT01425801|41711995|FG000|Period 2|Withdrawal by Subject|0|||
19458282|NCT01425801|41711996|FG001|Period 2|Withdrawal by Subject|0|||
19458283|NCT01425801|41711997|FG002|Period 2|Withdrawal by Subject|0|||
19458284|NCT01425801|41711998|FG003|Period 2|Withdrawal by Subject|0|||
19458285|NCT01425801|41711999|FG004|Period 2|Withdrawal by Subject|1|||
19458286|NCT01425801|41712000|FG005|Period 2|Withdrawal by Subject|0|||
19458287|NCT01425801|41711995|FG000|Period 3|Stability criteria not fullfilled|0|||
19458288|NCT01425801|41711996|FG001|Period 3|Stability criteria not fullfilled|0|||
19458289|NCT01425801|41711997|FG002|Period 3|Stability criteria not fullfilled|1|||
19458290|NCT01425801|41711998|FG003|Period 3|Stability criteria not fullfilled|0|||
19458291|NCT01425801|41711999|FG004|Period 3|Stability criteria not fullfilled|0|||
19458292|NCT01425801|41712000|FG005|Period 3|Stability criteria not fullfilled|0|||
19543997|NCT01149421|41993482|FG000|Overall Study|Entry Criteria Not Met|1|||
19543998|NCT01149421|41993483|FG001|Overall Study|Entry Criteria Not Met|1|||
19543999|NCT01149421|41993484|FG002|Overall Study|Entry Criteria Not Met|2|||
19544000|NCT01149421|41993482|FG000|Overall Study|Protocol Violation|2|||
19712059|NCT03560518|42155023|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
19712060|NCT03560518|42155024|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
19712061|NCT03560518|42155022|FG000|Double Blind Treatment Period|Adverse Event|0|||
19712062|NCT03560518|42155023|FG001|Double Blind Treatment Period|Adverse Event|3|||
19712063|NCT03560518|42155024|FG002|Double Blind Treatment Period|Adverse Event|1|||
19712064|NCT03635320|42155034|FG000|Overall Study|not implanted the device|1|||
19712065|NCT03635320|42155035|FG001|Overall Study|not implanted the device|2|||
19712066|NCT03635320|42155034|FG000|Overall Study|Withdrawal by Subject|11|||
19712067|NCT03635320|42155035|FG001|Overall Study|Withdrawal by Subject|6|||
19712068|NCT03560206|42155043|FG000|Overall Study|Lost to Follow-up|19|||
19712069|NCT03560206|42155044|FG001|Overall Study|Lost to Follow-up|11|||
19712070|NCT03560206|42155043|FG000|Overall Study|Withdrawal by Subject|2|||
19636083|NCT00771758|42085497|FG002|Overall Study|Withdrawal by Subject|0|||
19636084|NCT00771758|42085495|FG000|Overall Study|Other|3|||
19636085|NCT00771758|42085496|FG001|Overall Study|Other|2|||
19636086|NCT00771758|42085497|FG002|Overall Study|Other|0|||
19636087|NCT00758498|42085525|FG000|Overall Study|Adverse Event|2|||
19636088|NCT00758498|42085526|FG001|Overall Study|Adverse Event|2|||
19636089|NCT00758498|42085527|FG002|Overall Study|Adverse Event|3|||
19636090|NCT00758498|42085525|FG000|Overall Study|Subject legally detained out of state|1|||
19712071|NCT03560206|42155044|FG001|Overall Study|Withdrawal by Subject|4|||
19712072|NCT03560206|42155043|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
19458293|NCT01425801|41711995|FG000|Period 4|Not able to maintain visit schedule|0|||
19458294|NCT01425801|41711996|FG001|Period 4|Not able to maintain visit schedule|0|||
19458295|NCT01425801|41711997|FG002|Period 4|Not able to maintain visit schedule|1|||
19458296|NCT01425801|41711998|FG003|Period 4|Not able to maintain visit schedule|0|||
19458297|NCT01425801|41711999|FG004|Period 4|Not able to maintain visit schedule|0|||
19544001|NCT01149421|41993483|FG001|Overall Study|Protocol Violation|2|||
19712073|NCT03560206|42155044|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
19636091|NCT00758498|42085526|FG001|Overall Study|Subject legally detained out of state|0|||
19636092|NCT00758498|42085527|FG002|Overall Study|Subject legally detained out of state|0|||
19636093|NCT00758498|42085525|FG000|Overall Study|Withdrawal by Subject|0|||
19636094|NCT00758498|42085526|FG001|Overall Study|Withdrawal by Subject|0|||
19636095|NCT00758498|42085527|FG002|Overall Study|Withdrawal by Subject|1|||
19636096|NCT00758498|42085525|FG000|Overall Study|Noncompliance to study procedures|0|||
19636097|NCT00758498|42085526|FG001|Overall Study|Noncompliance to study procedures|0|||
19636098|NCT00758498|42085527|FG002|Overall Study|Noncompliance to study procedures|1|||
19636099|NCT00798161|42085542|FG000|Overall Study|Adverse Event|3|||
19636100|NCT00798161|42085543|FG001|Overall Study|Adverse Event|4|||
19636101|NCT00798161|42085544|FG002|Overall Study|Adverse Event|6|||
19636102|NCT00798161|42085545|FG003|Overall Study|Adverse Event|6|||
19636103|NCT00798161|42085546|FG004|Overall Study|Adverse Event|5|||
19636104|NCT00798161|42085547|FG005|Overall Study|Adverse Event|2|||
19636105|NCT00798161|42085548|FG006|Overall Study|Adverse Event|4|||
19636106|NCT00798161|42085542|FG000|Overall Study|Protocol Violation|2|||
19636107|NCT00798161|42085543|FG001|Overall Study|Protocol Violation|1|||
19636108|NCT00798161|42085544|FG002|Overall Study|Protocol Violation|3|||
19636109|NCT00798161|42085545|FG003|Overall Study|Protocol Violation|3|||
19636110|NCT00798161|42085546|FG004|Overall Study|Protocol Violation|3|||
19636111|NCT00798161|42085547|FG005|Overall Study|Protocol Violation|2|||
19636112|NCT00798161|42085548|FG006|Overall Study|Protocol Violation|0|||
19636113|NCT00798161|42085542|FG000|Overall Study|Lost to Follow-up|1|||
19636114|NCT00798161|42085543|FG001|Overall Study|Lost to Follow-up|3|||
19636115|NCT00798161|42085544|FG002|Overall Study|Lost to Follow-up|4|||
19636116|NCT00798161|42085545|FG003|Overall Study|Lost to Follow-up|3|||
19636117|NCT00798161|42085546|FG004|Overall Study|Lost to Follow-up|4|||
19636118|NCT00798161|42085547|FG005|Overall Study|Lost to Follow-up|0|||
19636119|NCT00798161|42085548|FG006|Overall Study|Lost to Follow-up|0|||
19636120|NCT00798161|42085542|FG000|Overall Study|Withdrawal by Subject|5|||
19636121|NCT00798161|42085543|FG001|Overall Study|Withdrawal by Subject|4|||
19636122|NCT00798161|42085544|FG002|Overall Study|Withdrawal by Subject|5|||
19636123|NCT00798161|42085545|FG003|Overall Study|Withdrawal by Subject|4|||
19636124|NCT00798161|42085546|FG004|Overall Study|Withdrawal by Subject|2|||
19636125|NCT00798161|42085547|FG005|Overall Study|Withdrawal by Subject|3|||
19636126|NCT00798161|42085548|FG006|Overall Study|Withdrawal by Subject|1|||
19636127|NCT00798161|42085542|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
19636128|NCT00798161|42085543|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
19636129|NCT00798161|42085544|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
19636130|NCT00798161|42085545|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
19636131|NCT00798161|42085546|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
19636132|NCT00798161|42085547|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
19636133|NCT00798161|42085548|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
19636134|NCT00588341|42085564|FG000|Overall Study|Withdrawal by Subject|3|||
19636135|NCT00588341|42085564|FG000|Overall Study|Not treated due to metastatic disease|1|||
19636136|NCT00588341|42085564|FG000|Overall Study|Patient ineligible|1|||
19636137|NCT00802529|42085570|FG000|Overall Study|Lost to Follow-up|0|||
19636138|NCT00802529|42085571|FG001|Overall Study|Lost to Follow-up|1|||
19636139|NCT00758264|42085580|FG000|Active Phase|Withdrawal by Subject|0|||
19636140|NCT00758264|42085581|FG001|Active Phase|Withdrawal by Subject|0|||
19636141|NCT00758264|42085582|FG002|Active Phase|Withdrawal by Subject|1|||
19636142|NCT00758264|42085580|FG000|Active Phase|Lost to Follow-up|1|||
19636143|NCT00758264|42085581|FG001|Active Phase|Lost to Follow-up|0|||
19636144|NCT00758264|42085582|FG002|Active Phase|Lost to Follow-up|0|||
19636145|NCT00758264|42085580|FG000|Active Phase|Other|0|||
19636146|NCT00758264|42085581|FG001|Active Phase|Other|0|||
19636147|NCT00758264|42085582|FG002|Active Phase|Other|4|||
19636148|NCT00588731|42085592|FG000|Overall Study|Withdrawal by Subject|3|||
19636149|NCT00588731|42085593|FG001|Overall Study|Withdrawal by Subject|2|||
19636150|NCT00757172|42085599|FG000|Overall Study|Withdrawal by Subject|4|||
19636151|NCT00757172|42085599|FG000|Overall Study|Physician Decision|3|||
19636152|NCT00757172|42085599|FG000|Overall Study|Progression|4|||
19636153|NCT00797225|42085607|FG000|Weeks 1 to 12|Adverse Event|0|||
19636154|NCT00797225|42085608|FG001|Weeks 1 to 12|Adverse Event|0|||
19636155|NCT00797225|42085609|FG002|Weeks 1 to 12|Adverse Event|1|||
19636156|NCT00797225|42085610|FG003|Weeks 1 to 12|Adverse Event|0|||
19636157|NCT00797225|42085611|FG004|Weeks 1 to 12|Adverse Event|0|||
19636158|NCT00797225|42085612|FG005|Weeks 1 to 12|Adverse Event|0|||
19636159|NCT00797225|42085613|FG006|Weeks 1 to 12|Adverse Event|0|||
19636160|NCT00797225|42085614|FG007|Weeks 1 to 12|Adverse Event|0|||
19636161|NCT00797225|42085607|FG000|Weeks 1 to 12|Non-compliance|0|||
19636162|NCT00797225|42085608|FG001|Weeks 1 to 12|Non-compliance|1|||
19636163|NCT00797225|42085609|FG002|Weeks 1 to 12|Non-compliance|0|||
19636164|NCT00797225|42085610|FG003|Weeks 1 to 12|Non-compliance|0|||
19636165|NCT00797225|42085611|FG004|Weeks 1 to 12|Non-compliance|0|||
19636166|NCT00797225|42085612|FG005|Weeks 1 to 12|Non-compliance|0|||
19636167|NCT00797225|42085613|FG006|Weeks 1 to 12|Non-compliance|0|||
19544002|NCT01149421|41993484|FG002|Overall Study|Protocol Violation|6|||
19544003|NCT01149343|41993502|FG000|Overall Study|Withdrawal by Subject|1|||
19544004|NCT01149343|41993503|FG001|Overall Study|Withdrawal by Subject|1|||
19544005|NCT01149343|41993504|FG002|Overall Study|Withdrawal by Subject|1|||
19544006|NCT01149343|41993505|FG003|Overall Study|Withdrawal by Subject|5|||
19544007|NCT01149343|41993502|FG000|Overall Study|Death|10|||
19544008|NCT01149343|41993503|FG001|Overall Study|Death|13|||
19544009|NCT01149343|41993504|FG002|Overall Study|Death|18|||
19544010|NCT01149343|41993505|FG003|Overall Study|Death|18|||
19544011|NCT01149343|41993502|FG000|Overall Study|Lost to Follow-up|1|||
19544012|NCT01149343|41993503|FG001|Overall Study|Lost to Follow-up|0|||
19544013|NCT01149343|41993504|FG002|Overall Study|Lost to Follow-up|0|||
19636168|NCT00797225|42085614|FG007|Weeks 1 to 12|Non-compliance|0|||
19636169|NCT00797225|42085607|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
19636170|NCT00797225|42085608|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
19636171|NCT00797225|42085609|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
19636172|NCT00797225|42085610|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
19636173|NCT00797225|42085611|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
19636174|NCT00797225|42085612|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
19636175|NCT00797225|42085613|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
19636176|NCT00797225|42085614|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
19636177|NCT00797225|42085607|FG000|Weeks 1 to 12|Sponsor Decision|1|||
19636178|NCT00797225|42085608|FG001|Weeks 1 to 12|Sponsor Decision|0|||
19636179|NCT00797225|42085609|FG002|Weeks 1 to 12|Sponsor Decision|0|||
19636180|NCT00797225|42085610|FG003|Weeks 1 to 12|Sponsor Decision|0|||
19636181|NCT00797225|42085611|FG004|Weeks 1 to 12|Sponsor Decision|0|||
19636182|NCT00797225|42085612|FG005|Weeks 1 to 12|Sponsor Decision|0|||
19636183|NCT00797225|42085613|FG006|Weeks 1 to 12|Sponsor Decision|0|||
19636184|NCT00797225|42085614|FG007|Weeks 1 to 12|Sponsor Decision|0|||
19636185|NCT00797225|42085607|FG000|Weeks 13 to 24|Non-compliance|0|||
19636186|NCT00797225|42085608|FG001|Weeks 13 to 24|Non-compliance|2|||
19636187|NCT00797225|42085609|FG002|Weeks 13 to 24|Non-compliance|0|||
19636188|NCT00797225|42085610|FG003|Weeks 13 to 24|Non-compliance|0|||
19636189|NCT00797225|42085611|FG004|Weeks 13 to 24|Non-compliance|0|||
19636190|NCT00797225|42085612|FG005|Weeks 13 to 24|Non-compliance|0|||
19636191|NCT00797225|42085613|FG006|Weeks 13 to 24|Non-compliance|0|||
19636192|NCT00797225|42085614|FG007|Weeks 13 to 24|Non-compliance|0|||
19636193|NCT00797225|42085607|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
19636194|NCT00797225|42085608|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
19636195|NCT00797225|42085609|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
19636196|NCT00797225|42085610|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
19636197|NCT00797225|42085611|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
19636198|NCT00797225|42085612|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
19636199|NCT00797225|42085613|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
19636200|NCT00797225|42085614|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
19636201|NCT00797225|42085607|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
19636202|NCT00797225|42085608|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
19636203|NCT00797225|42085609|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
19636204|NCT00797225|42085610|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
19636205|NCT00797225|42085611|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
19636206|NCT00797225|42085612|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
19636207|NCT00797225|42085613|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
19636208|NCT00797225|42085614|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
19636209|NCT00797225|42085607|FG000|Weeks 13 to 24|Adverse Event|0|||
19636210|NCT00797225|42085608|FG001|Weeks 13 to 24|Adverse Event|1|||
19636211|NCT00797225|42085609|FG002|Weeks 13 to 24|Adverse Event|0|||
19636212|NCT00797225|42085610|FG003|Weeks 13 to 24|Adverse Event|0|||
19636213|NCT00797225|42085611|FG004|Weeks 13 to 24|Adverse Event|0|||
19636214|NCT00797225|42085612|FG005|Weeks 13 to 24|Adverse Event|0|||
19636215|NCT00797225|42085613|FG006|Weeks 13 to 24|Adverse Event|1|||
19636216|NCT00797225|42085614|FG007|Weeks 13 to 24|Adverse Event|0|||
19636217|NCT00797225|42085607|FG000|Weeks 13 to 24|Sponsor Decision|0|||
19636218|NCT00797225|42085608|FG001|Weeks 13 to 24|Sponsor Decision|0|||
19636219|NCT00797225|42085609|FG002|Weeks 13 to 24|Sponsor Decision|0|||
19636220|NCT00797225|42085610|FG003|Weeks 13 to 24|Sponsor Decision|0|||
19636221|NCT00797225|42085611|FG004|Weeks 13 to 24|Sponsor Decision|0|||
19636222|NCT00797225|42085612|FG005|Weeks 13 to 24|Sponsor Decision|0|||
19636223|NCT00797225|42085613|FG006|Weeks 13 to 24|Sponsor Decision|1|||
19636224|NCT00797225|42085614|FG007|Weeks 13 to 24|Sponsor Decision|0|||
19636225|NCT00778700|42085634|FG000|Overall Study|Adverse Event|6|||
19636226|NCT00778700|42085635|FG001|Overall Study|Adverse Event|1|||
19636227|NCT00778700|42085636|FG002|Overall Study|Adverse Event|3|||
19636228|NCT00778700|42085637|FG003|Overall Study|Adverse Event|5|||
19636229|NCT00778700|42085634|FG000|Overall Study|Protocol Violation|1|||
19544014|NCT01149343|41993505|FG003|Overall Study|Lost to Follow-up|1|||
19544015|NCT01149343|41993502|FG000|Overall Study|Other|8|||
19544016|NCT01149343|41993503|FG001|Overall Study|Other|10|||
19544017|NCT01149343|41993504|FG002|Overall Study|Other|2|||
19636230|NCT00778700|42085635|FG001|Overall Study|Protocol Violation|1|||
19636231|NCT00778700|42085636|FG002|Overall Study|Protocol Violation|0|||
19636232|NCT00778700|42085637|FG003|Overall Study|Protocol Violation|0|||
19636233|NCT00778700|42085634|FG000|Overall Study|Subject Withdrew Consent|6|||
19636234|NCT00778700|42085635|FG001|Overall Study|Subject Withdrew Consent|4|||
19636235|NCT00778700|42085636|FG002|Overall Study|Subject Withdrew Consent|1|||
19636236|NCT00778700|42085637|FG003|Overall Study|Subject Withdrew Consent|4|||
19636237|NCT00778700|42085634|FG000|Overall Study|Lost to Follow-up|3|||
19636238|NCT00778700|42085635|FG001|Overall Study|Lost to Follow-up|1|||
19636239|NCT00778700|42085636|FG002|Overall Study|Lost to Follow-up|0|||
19636240|NCT00778700|42085637|FG003|Overall Study|Lost to Follow-up|1|||
19636241|NCT00778700|42085634|FG000|Overall Study|Reason not Specified|2|||
19636242|NCT00778700|42085635|FG001|Overall Study|Reason not Specified|0|||
19636243|NCT00778700|42085636|FG002|Overall Study|Reason not Specified|1|||
19636244|NCT00778700|42085637|FG003|Overall Study|Reason not Specified|3|||
19636245|NCT00778700|42085634|FG000|Overall Study|Other|0|||
19636246|NCT00778700|42085635|FG001|Overall Study|Other|0|||
19636247|NCT00778700|42085636|FG002|Overall Study|Other|1|||
19636248|NCT00778700|42085637|FG003|Overall Study|Other|0|||
19636249|NCT00793403|42085651|FG000|Overall Study|Other|73|||
19636250|NCT00793325|42085655|FG000|Overall Study|Protocol Violation|18|||
19636251|NCT00793325|42085655|FG000|Overall Study|Lost to Follow-up|1|||
19636252|NCT00778622|42085681|FG000|Overall Study|Adverse Event|5|||
19636253|NCT00778622|42085682|FG001|Overall Study|Adverse Event|4|||
19636254|NCT00778622|42085683|FG002|Overall Study|Adverse Event|7|||
19636255|NCT00778622|42085681|FG000|Overall Study|Withdrawal by Subject|4|||
19636256|NCT00778622|42085682|FG001|Overall Study|Withdrawal by Subject|5|||
19636257|NCT00778622|42085683|FG002|Overall Study|Withdrawal by Subject|5|||
19636258|NCT00778622|42085681|FG000|Overall Study|Lost to Follow-up|3|||
19636259|NCT00778622|42085682|FG001|Overall Study|Lost to Follow-up|3|||
19636260|NCT00778622|42085683|FG002|Overall Study|Lost to Follow-up|2|||
19636261|NCT00778622|42085681|FG000|Overall Study|Protocol Violation|0|||
19636262|NCT00778622|42085682|FG001|Overall Study|Protocol Violation|3|||
19636263|NCT00778622|42085683|FG002|Overall Study|Protocol Violation|0|||
19636264|NCT00778622|42085681|FG000|Overall Study|Lack of Efficacy|2|||
19636265|NCT00778622|42085682|FG001|Overall Study|Lack of Efficacy|0|||
19636266|NCT00778622|42085683|FG002|Overall Study|Lack of Efficacy|0|||
19636267|NCT00778622|42085681|FG000|Overall Study|immigration|1|||
19636268|NCT00778622|42085682|FG001|Overall Study|immigration|0|||
19636269|NCT00778622|42085683|FG002|Overall Study|immigration|0|||
19636270|NCT00778622|42085681|FG000|Overall Study|Other|1|||
19636271|NCT00778622|42085682|FG001|Overall Study|Other|0|||
19636272|NCT00778622|42085683|FG002|Overall Study|Other|1|||
19636273|NCT00777920|42085695|FG000|Overall Study|Adverse Event|39|||
19636274|NCT00777920|42085695|FG000|Overall Study|Withdrawal of Consent|4|||
19636275|NCT00777920|42085695|FG000|Overall Study|Lost to Follow-up|1|||
19636276|NCT00777920|42085695|FG000|Overall Study|Investigator's discretion|1|||
19636277|NCT00777920|42085695|FG000|Overall Study|Clinical status did not improve|1|||
19636278|NCT00777920|42085695|FG000|Overall Study|Other, not specified|4|||
19636279|NCT04236141|42085701|FG000|Overall Study|Death|18|||
19636280|NCT04236141|42085702|FG001|Overall Study|Death|10|||
19636281|NCT04236141|42085701|FG000|Overall Study|Withdrawal by Participant|1|||
19636282|NCT04236141|42085702|FG001|Overall Study|Withdrawal by Participant|0|||
19636283|NCT04236141|42085701|FG000|Overall Study|Reason not Specified|1|||
19636284|NCT04236141|42085702|FG001|Overall Study|Reason not Specified|0|||
19636285|NCT04236141|42085701|FG000|Overall Study|Study terminated by Sponsor|8|||
19636286|NCT04236141|42085702|FG001|Overall Study|Study terminated by Sponsor|4|||
19636287|NCT00796445|42085710|FG000|Overall Study|Protocol Violation|5|||
19636288|NCT00796445|42085711|FG001|Overall Study|Protocol Violation|3|||
19636289|NCT00796445|42085710|FG000|Overall Study|Adverse event, serious fatal|10|||
19636290|NCT00796445|42085711|FG001|Overall Study|Adverse event, serious fatal|5|||
19636291|NCT00796445|42085710|FG000|Overall Study|Adverse event, non-fatal|4|||
19636292|NCT00796445|42085711|FG001|Overall Study|Adverse event, non-fatal|0|||
19636293|NCT00796445|42085710|FG000|Overall Study|Disease progression/recurrence|537|||
19636294|NCT00796445|42085711|FG001|Overall Study|Disease progression/recurrence|268|||
19636295|NCT00796445|42085710|FG000|Overall Study|Other|10|||
19636296|NCT00796445|42085711|FG001|Overall Study|Other|7|||
19636297|NCT00796445|42085710|FG000|Overall Study|Withdrawal by Subject|18|||
19636298|NCT00796445|42085711|FG001|Overall Study|Withdrawal by Subject|9|||
19636299|NCT00796445|42085710|FG000|Overall Study|Invalid Informed Consent Form|1|||
19636300|NCT00796445|42085711|FG001|Overall Study|Invalid Informed Consent Form|0|||
19636301|NCT03939819|42085727|FG000|Overall Study|Death|2|||
19636302|NCT03939819|42085728|FG001|Overall Study|Death|0|||
19636303|NCT00756938|42085737|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
19636304|NCT00756938|42085738|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
19636305|NCT00756938|42085739|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
19636306|NCT00756938|42085740|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
19636307|NCT00756938|42085737|FG000|12-week Base Study|Protocol Violation|0|||
19636308|NCT00756938|42085738|FG001|12-week Base Study|Protocol Violation|0|||
19636309|NCT00756938|42085739|FG002|12-week Base Study|Protocol Violation|1|||
19636310|NCT00756938|42085740|FG003|12-week Base Study|Protocol Violation|0|||
19636311|NCT00756938|42085737|FG000|12-week Base Study|Lost to Follow-up|1|||
19636312|NCT00756938|42085738|FG001|12-week Base Study|Lost to Follow-up|0|||
19636313|NCT00756938|42085739|FG002|12-week Base Study|Lost to Follow-up|0|||
19636314|NCT00756938|42085740|FG003|12-week Base Study|Lost to Follow-up|0|||
19636315|NCT00756938|42085737|FG000|Optional Extension|Lack of Efficacy|0|||
19636316|NCT00756938|42085738|FG001|Optional Extension|Lack of Efficacy|0|||
19636317|NCT00756938|42085739|FG002|Optional Extension|Lack of Efficacy|0|||
19636318|NCT00756938|42085740|FG003|Optional Extension|Lack of Efficacy|1|||
19636319|NCT00756938|42085737|FG000|Optional Extension|End of Study|0|||
19636320|NCT00756938|42085738|FG001|Optional Extension|End of Study|0|||
19636321|NCT00756938|42085739|FG002|Optional Extension|End of Study|0|||
19636322|NCT00756938|42085740|FG003|Optional Extension|End of Study|11|||
19636323|NCT00756938|42085737|FG000|Optional Extension|Protocol-specific criteria met|0|||
19636324|NCT00756938|42085738|FG001|Optional Extension|Protocol-specific criteria met|0|||
19636325|NCT00756938|42085739|FG002|Optional Extension|Protocol-specific criteria met|0|||
19636326|NCT00756938|42085740|FG003|Optional Extension|Protocol-specific criteria met|9|||
19636327|NCT00756938|42085737|FG000|Optional Extension|Physician Decision|0|||
19636328|NCT00756938|42085738|FG001|Optional Extension|Physician Decision|0|||
19636329|NCT00756938|42085739|FG002|Optional Extension|Physician Decision|0|||
19636330|NCT00756938|42085740|FG003|Optional Extension|Physician Decision|3|||
19636331|NCT00756938|42085737|FG000|Optional Extension|Lost to Follow-up|0|||
19636332|NCT00756938|42085738|FG001|Optional Extension|Lost to Follow-up|0|||
19636333|NCT00756938|42085739|FG002|Optional Extension|Lost to Follow-up|0|||
19636334|NCT00756938|42085740|FG003|Optional Extension|Lost to Follow-up|1|||
19636335|NCT00756938|42085737|FG000|Optional Extension|Protocol Violation|0|||
19636336|NCT00756938|42085738|FG001|Optional Extension|Protocol Violation|0|||
19636337|NCT00756938|42085739|FG002|Optional Extension|Protocol Violation|0|||
19636338|NCT00756938|42085740|FG003|Optional Extension|Protocol Violation|1|||
19636339|NCT00756938|42085737|FG000|Optional Extension|Withdrawal by Subject|0|||
19636340|NCT00756938|42085738|FG001|Optional Extension|Withdrawal by Subject|0|||
19636341|NCT00756938|42085739|FG002|Optional Extension|Withdrawal by Subject|0|||
19636342|NCT00756938|42085740|FG003|Optional Extension|Withdrawal by Subject|10|||
19636343|NCT00756938|42085737|FG000|Optional Extension|Adverse Event|0|||
19636344|NCT00756938|42085738|FG001|Optional Extension|Adverse Event|0|||
19636345|NCT00756938|42085739|FG002|Optional Extension|Adverse Event|0|||
19636346|NCT00756938|42085740|FG003|Optional Extension|Adverse Event|1|||
19636347|NCT00796367|42085761|FG000|Overall Study|Adverse Event|6|||
19636348|NCT00796367|42085762|FG001|Overall Study|Adverse Event|4|||
19636349|NCT00796367|42085763|FG002|Overall Study|Adverse Event|7|||
19636350|NCT00796367|42085761|FG000|Overall Study|Lost to Follow-up|5|||
19636351|NCT00796367|42085762|FG001|Overall Study|Lost to Follow-up|4|||
19636352|NCT00796367|42085763|FG002|Overall Study|Lost to Follow-up|21|||
19636353|NCT00796367|42085761|FG000|Overall Study|Withdrawal by Subject|9|||
19636354|NCT00796367|42085762|FG001|Overall Study|Withdrawal by Subject|11|||
19636355|NCT00796367|42085763|FG002|Overall Study|Withdrawal by Subject|12|||
19636356|NCT00796367|42085761|FG000|Overall Study|Lack of Efficacy|2|||
19636357|NCT00796367|42085762|FG001|Overall Study|Lack of Efficacy|1|||
19636358|NCT00796367|42085763|FG002|Overall Study|Lack of Efficacy|0|||
19636359|NCT00796367|42085761|FG000|Overall Study|non compliance|3|||
19636360|NCT00796367|42085762|FG001|Overall Study|non compliance|1|||
19636361|NCT00796367|42085763|FG002|Overall Study|non compliance|1|||
19636362|NCT00796367|42085761|FG000|Overall Study|Pregnancy|1|||
19636363|NCT00796367|42085762|FG001|Overall Study|Pregnancy|0|||
19636364|NCT00796367|42085763|FG002|Overall Study|Pregnancy|1|||
19636365|NCT00796367|42085761|FG000|Overall Study|Requirement for restricted medication|2|||
19636366|NCT00796367|42085762|FG001|Overall Study|Requirement for restricted medication|0|||
19544018|NCT01149343|41993505|FG003|Overall Study|Other|14|||
19544019|NCT01149343|41993502|FG000|Overall Study|Sponsor study termination|0|||
19544020|NCT01149343|41993503|FG001|Overall Study|Sponsor study termination|0|||
19544021|NCT01149343|41993504|FG002|Overall Study|Sponsor study termination|0|||
19544022|NCT01149343|41993505|FG003|Overall Study|Sponsor study termination|2|||
19544023|NCT01149343|41993502|FG000|Overall Study|Recurrence / Progressive disease|0|||
19544024|NCT01149343|41993503|FG001|Overall Study|Recurrence / Progressive disease|0|||
19544025|NCT01149343|41993504|FG002|Overall Study|Recurrence / Progressive disease|1|||
19544026|NCT01149343|41993505|FG003|Overall Study|Recurrence / Progressive disease|0|||
19636367|NCT00796367|42085763|FG002|Overall Study|Requirement for restricted medication|2|||
19636368|NCT00796367|42085761|FG000|Overall Study|other|2|||
19636369|NCT00796367|42085762|FG001|Overall Study|other|4|||
19544027|NCT01149148|41993521|FG000|Overall Study|Lost to Follow-up|1|||
19636370|NCT00796367|42085763|FG002|Overall Study|other|3|||
19636371|NCT00770588|42085773|FG000|Overall Study|Adverse Event|9|||
19636372|NCT00770588|42085774|FG001|Overall Study|Adverse Event|2|||
19636373|NCT00770588|42085773|FG000|Overall Study|Death caused by progression of disease|70|||
19712074|NCT03560206|42155043|FG000|Overall Study|Busy schedule|14|||
19544028|NCT01149148|41993522|FG001|Overall Study|Lost to Follow-up|2|||
19636374|NCT00770588|42085774|FG001|Overall Study|Death caused by progression of disease|91|||
19636375|NCT00770588|42085773|FG000|Overall Study|Lost to Follow-up|1|||
19544029|NCT01149148|41993521|FG000|Overall Study|Death|1|||
19544030|NCT01149148|41993522|FG001|Overall Study|Death|0|||
19544031|NCT01148017|41993533|FG000|Overall Study|Withdrawal by Subject|31|||
19544032|NCT01148017|41993534|FG001|Overall Study|Withdrawal by Subject|14|||
19544033|NCT01148017|41993535|FG002|Overall Study|Withdrawal by Subject|0|||
19636376|NCT00770588|42085774|FG001|Overall Study|Lost to Follow-up|1|||
19636377|NCT00770588|42085773|FG000|Overall Study|Withdrawal by Subject|1|||
19636378|NCT00770588|42085774|FG001|Overall Study|Withdrawal by Subject|1|||
19636379|NCT00777608|42085783|FG000|Overall Study|Lost to Follow-up|1|||
19636380|NCT00777608|42085784|FG001|Overall Study|Lost to Follow-up|1|||
19636381|NCT00777608|42085783|FG000|Overall Study|Withdrawal by Subject|1|||
19636382|NCT00777608|42085784|FG001|Overall Study|Withdrawal by Subject|3|||
19636383|NCT00777608|42085783|FG000|Overall Study|Protocol Violation|1|||
19636384|NCT00777608|42085784|FG001|Overall Study|Protocol Violation|0|||
19636385|NCT00777608|42085783|FG000|Overall Study|Investigator Decision|1|||
19636386|NCT00777608|42085784|FG001|Overall Study|Investigator Decision|2|||
19636387|NCT00792935|42085792|FG000|Overall Study|Adverse Event|2|||
19636388|NCT00792935|42085793|FG001|Overall Study|Adverse Event|1|||
19636389|NCT00792935|42085792|FG000|Overall Study|Lost to Follow-up|0|||
19636390|NCT00792935|42085793|FG001|Overall Study|Lost to Follow-up|1|||
19636391|NCT00792935|42085792|FG000|Overall Study|Protocol Violation|2|||
19636392|NCT00792935|42085793|FG001|Overall Study|Protocol Violation|0|||
19636393|NCT00792935|42085792|FG000|Overall Study|Withdrawal by Subject|0|||
19636394|NCT00792935|42085793|FG001|Overall Study|Withdrawal by Subject|1|||
19636395|NCT00770510|42085799|FG000|Overall Study|Lost to Follow-up|2|||
19636396|NCT00770510|42085799|FG000|Overall Study|Pregnancy|1|||
19636397|NCT00770510|42085799|FG000|Overall Study|Withdrawal by Subject|2|||
19636398|NCT00770432|42085813|FG000|Overall Study|Other|4|||
19636399|NCT00770432|42085814|FG001|Overall Study|Other|6|||
19636400|NCT00770432|42085813|FG000|Overall Study|Non-compliance|0|||
19636401|NCT00770432|42085814|FG001|Overall Study|Non-compliance|1|||
19636402|NCT00792701|42085822|FG000|Overall Study|Adverse Event|0|||
19636403|NCT00792701|42085823|FG001|Overall Study|Adverse Event|22|||
19636404|NCT00792701|42085822|FG000|Overall Study|Ineligible|1|||
19712075|NCT03560206|42155044|FG001|Overall Study|Busy schedule|2|||
19712076|NCT03560206|42155043|FG000|Overall Study|patients' new health condition such as cancer|10|||
19712077|NCT03560206|42155044|FG001|Overall Study|patients' new health condition such as cancer|1|||
19712078|NCT02892760|42155050|FG000|Overall Study|Withdrawal by Subject|3|||
19636405|NCT00792701|42085823|FG001|Overall Study|Ineligible|3|||
19636406|NCT00792701|42085822|FG000|Overall Study|Withdrawal by Subject|1|||
19636407|NCT00792701|42085823|FG001|Overall Study|Withdrawal by Subject|19|||
19636408|NCT00792701|42085822|FG000|Overall Study|Not protocol specified|17|||
19636409|NCT00792701|42085823|FG001|Overall Study|Not protocol specified|0|||
19712079|NCT03635086|42155059|FG000|Overall Study|Withdrawal of consent|0|||
19712080|NCT03635086|42155060|FG001|Overall Study|Withdrawal of consent|0|||
19712081|NCT03635086|42155061|FG002|Overall Study|Withdrawal of consent|1|||
19712082|NCT03635086|42155062|FG003|Overall Study|Withdrawal of consent|0|||
19712083|NCT03635086|42155063|FG004|Overall Study|Withdrawal of consent|0|||
19636410|NCT00777296|42085835|FG000|Overall Study|Adverse Event|0|||
19636411|NCT00777296|42085836|FG001|Overall Study|Adverse Event|1|||
19636412|NCT00777296|42085837|FG002|Overall Study|Adverse Event|0|||
19636413|NCT00777296|42085838|FG003|Overall Study|Adverse Event|1|||
19636414|NCT00777296|42085835|FG000|Overall Study|Withdrawal by Subject|1|||
19636415|NCT00777296|42085836|FG001|Overall Study|Withdrawal by Subject|0|||
19636416|NCT00777296|42085837|FG002|Overall Study|Withdrawal by Subject|0|||
19636417|NCT00777296|42085838|FG003|Overall Study|Withdrawal by Subject|0|||
19636418|NCT00777296|42085835|FG000|Overall Study|CRF form not completed|0|||
19712084|NCT03635086|42155059|FG000|Overall Study|Adverse Event|0|||
19458298|NCT01425801|41712000|FG005|Period 4|Not able to maintain visit schedule|0|||
19458299|NCT01425723|41712025|FG000|Overall Study|Lack of Efficacy|0|||
19458300|NCT01425723|41712026|FG001|Overall Study|Lack of Efficacy|1|||
19458301|NCT01425723|41712025|FG000|Overall Study|Withdrawal by Subject|1|||
19458302|NCT01425723|41712026|FG001|Overall Study|Withdrawal by Subject|4|||
19458303|NCT01425723|41712025|FG000|Overall Study|Lost to Follow-up|0|||
19458304|NCT01425723|41712026|FG001|Overall Study|Lost to Follow-up|3|||
19458305|NCT01425723|41712025|FG000|Overall Study|Physician Decision|2|||
19458306|NCT01425723|41712026|FG001|Overall Study|Physician Decision|0|||
19458307|NCT01425723|41712025|FG000|Overall Study|Other|1|||
19458308|NCT01425723|41712026|FG001|Overall Study|Other|10|||
19458309|NCT01424397|41712057|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458310|NCT01424397|41712058|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458311|NCT01424397|41712059|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
19458312|NCT01424397|41712060|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458313|NCT01424397|41712061|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
19544034|NCT01148017|41993536|FG003|Overall Study|Withdrawal by Subject|0|||
19636419|NCT00777296|42085836|FG001|Overall Study|CRF form not completed|0|||
19544035|NCT01148017|41993533|FG000|Overall Study|Lost to Follow-up|23|||
19544036|NCT01148017|41993534|FG001|Overall Study|Lost to Follow-up|10|||
19636420|NCT00777296|42085837|FG002|Overall Study|CRF form not completed|2|||
19636421|NCT00777296|42085838|FG003|Overall Study|CRF form not completed|0|||
19636422|NCT00756470|42085860|FG000|Overall Study|Withdrawal by Subject|1|||
19636423|NCT00756470|42085860|FG000|Overall Study|Adverse Event|4|||
19636424|NCT00792623|42085864|FG000|Overall Study|Adverse Event|2|||
19544037|NCT01148017|41993535|FG002|Overall Study|Lost to Follow-up|0|||
19544038|NCT01148017|41993536|FG003|Overall Study|Lost to Follow-up|0|||
19544039|NCT01148017|41993533|FG000|Overall Study|Inappropriate enrollment|1|||
19544040|NCT01148017|41993534|FG001|Overall Study|Inappropriate enrollment|0|||
19544041|NCT01148017|41993535|FG002|Overall Study|Inappropriate enrollment|0|||
19544042|NCT01148017|41993536|FG003|Overall Study|Inappropriate enrollment|0|||
19544043|NCT01148017|41993533|FG000|Overall Study|Administrative reason|22|||
19544044|NCT01148017|41993534|FG001|Overall Study|Administrative reason|9|||
19544045|NCT01148017|41993535|FG002|Overall Study|Administrative reason|0|||
19544046|NCT01148017|41993536|FG003|Overall Study|Administrative reason|0|||
19544047|NCT01148017|41993533|FG000|Overall Study|Unable to classify|3|||
19544048|NCT01148017|41993534|FG001|Overall Study|Unable to classify|1|||
19544049|NCT01148017|41993535|FG002|Overall Study|Unable to classify|0|||
19544050|NCT01148017|41993536|FG003|Overall Study|Unable to classify|0|||
19544051|NCT01147900|41993550|FG000|At Year 10|Lost to Follow-up|0|||
19544052|NCT01147900|41993551|FG001|At Year 10|Lost to Follow-up|1|||
19544053|NCT01147900|41993552|FG002|At Year 10|Lost to Follow-up|0|||
19544054|NCT01147744|41993567|FG000|Overall Study|Protocol Violation|1|||
19544055|NCT01147744|41993568|FG001|Overall Study|Protocol Violation|0|||
19544056|NCT01147744|41993569|FG002|Overall Study|Protocol Violation|1|||
19544057|NCT01147744|41993570|FG003|Overall Study|Protocol Violation|0|||
19544058|NCT01147744|41993571|FG004|Overall Study|Protocol Violation|1|||
19544059|NCT01147744|41993572|FG005|Overall Study|Protocol Violation|3|||
19544060|NCT01147744|41993573|FG006|Overall Study|Protocol Violation|1|||
19544061|NCT01147744|41993567|FG000|Overall Study|Physician Decision|0|||
19544062|NCT01147744|41993568|FG001|Overall Study|Physician Decision|1|||
19544063|NCT01147744|41993569|FG002|Overall Study|Physician Decision|1|||
19544064|NCT01147744|41993570|FG003|Overall Study|Physician Decision|0|||
19544065|NCT01147744|41993571|FG004|Overall Study|Physician Decision|0|||
19544066|NCT01147744|41993572|FG005|Overall Study|Physician Decision|0|||
19544067|NCT01147744|41993573|FG006|Overall Study|Physician Decision|1|||
19544068|NCT01147744|41993567|FG000|Overall Study|Lack of Efficacy|11|||
19544069|NCT01147744|41993568|FG001|Overall Study|Lack of Efficacy|11|||
19544070|NCT01147744|41993569|FG002|Overall Study|Lack of Efficacy|9|||
19544071|NCT01147744|41993570|FG003|Overall Study|Lack of Efficacy|11|||
19544072|NCT01147744|41993571|FG004|Overall Study|Lack of Efficacy|13|||
19544073|NCT01147744|41993572|FG005|Overall Study|Lack of Efficacy|8|||
19544074|NCT01147744|41993573|FG006|Overall Study|Lack of Efficacy|7|||
19544075|NCT01147744|41993567|FG000|Overall Study|Adverse Event|1|||
19544076|NCT01147744|41993568|FG001|Overall Study|Adverse Event|2|||
19544077|NCT01147744|41993569|FG002|Overall Study|Adverse Event|3|||
19544078|NCT01147744|41993570|FG003|Overall Study|Adverse Event|0|||
19544079|NCT01147744|41993571|FG004|Overall Study|Adverse Event|2|||
19544080|NCT01147744|41993572|FG005|Overall Study|Adverse Event|1|||
19544081|NCT01147744|41993573|FG006|Overall Study|Adverse Event|2|||
19544082|NCT01147744|41993567|FG000|Overall Study|Withdrawal by Subject|8|||
19544083|NCT01147744|41993568|FG001|Overall Study|Withdrawal by Subject|4|||
19544084|NCT01147744|41993569|FG002|Overall Study|Withdrawal by Subject|2|||
19544085|NCT01147744|41993570|FG003|Overall Study|Withdrawal by Subject|2|||
19544086|NCT01147744|41993571|FG004|Overall Study|Withdrawal by Subject|2|||
19544087|NCT01147744|41993572|FG005|Overall Study|Withdrawal by Subject|5|||
19544088|NCT01147744|41993573|FG006|Overall Study|Withdrawal by Subject|2|||
19544089|NCT01147744|41993567|FG000|Overall Study|Lost to Follow-up|0|||
19544090|NCT01147744|41993568|FG001|Overall Study|Lost to Follow-up|1|||
19544091|NCT01147744|41993569|FG002|Overall Study|Lost to Follow-up|0|||
19544092|NCT01147744|41993570|FG003|Overall Study|Lost to Follow-up|0|||
19544093|NCT01147744|41993571|FG004|Overall Study|Lost to Follow-up|0|||
19544094|NCT01147744|41993572|FG005|Overall Study|Lost to Follow-up|0|||
19544095|NCT01147744|41993573|FG006|Overall Study|Lost to Follow-up|0|||
19544096|NCT01147744|41993567|FG000|Overall Study|Sponsor decision to amend protocol|7|||
19544097|NCT01147744|41993568|FG001|Overall Study|Sponsor decision to amend protocol|4|||
19544098|NCT01147744|41993569|FG002|Overall Study|Sponsor decision to amend protocol|2|||
19544099|NCT01147744|41993570|FG003|Overall Study|Sponsor decision to amend protocol|5|||
19544100|NCT01147744|41993571|FG004|Overall Study|Sponsor decision to amend protocol|7|||
19544101|NCT01147744|41993572|FG005|Overall Study|Sponsor decision to amend protocol|2|||
19544102|NCT01147744|41993573|FG006|Overall Study|Sponsor decision to amend protocol|6|||
19544103|NCT01147744|41993567|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19544104|NCT01147744|41993568|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19544105|NCT01147744|41993569|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19636425|NCT00792623|42085864|FG000|Overall Study|Withdrawal by Subject|5|||
19636426|NCT00756314|42085871|FG000|Overall Study|Lost to Follow-up|2|||
19544106|NCT01147744|41993570|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19544107|NCT01147744|41993571|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19544108|NCT01147744|41993572|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
19544109|NCT01147744|41993573|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
19544110|NCT01147471|41993597|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
19544111|NCT01147471|41993598|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
19544112|NCT01147471|41993597|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
19544113|NCT01147471|41993598|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
19544114|NCT01147471|41993597|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
19544115|NCT01147471|41993598|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
19544116|NCT01147471|41993597|FG000|3 Month Follow Up|Lost to Follow-up|1|||
19544117|NCT01147471|41993598|FG001|3 Month Follow Up|Lost to Follow-up|1|||
19544118|NCT01147471|41993597|FG000|3 Month Follow Up|Physician Decision|0|||
19544119|NCT01147471|41993598|FG001|3 Month Follow Up|Physician Decision|1|||
19544120|NCT01147471|41993597|FG000|6 Month Follow Up|Lost to Follow-up|4|||
19544121|NCT01147471|41993598|FG001|6 Month Follow Up|Lost to Follow-up|2|||
19544122|NCT01147393|41993604|FG000|Dose Level 1|Dose limiting Toxicity|2|||
19544123|NCT01147393|41993604|FG000|Dose Level -1|Dose Limited Toxicity|1|||
19544124|NCT01146652|41993611|FG000|Overall Study|Adverse Event|506|||
19544125|NCT01146652|41993612|FG001|Overall Study|Adverse Event|15|||
19544126|NCT01146652|41993611|FG000|Overall Study|Lack of Efficacy|91|||
19544127|NCT01146652|41993612|FG001|Overall Study|Lack of Efficacy|7|||
19544128|NCT01146652|41993611|FG000|Overall Study|Poor compliance to protocol|38|||
19636427|NCT00756314|42085872|FG001|Overall Study|Lost to Follow-up|59|||
19636428|NCT00727506|42085884|FG000|Overall Study|Adverse Event|0|||
19636429|NCT00727506|42085885|FG001|Overall Study|Adverse Event|0|||
19636430|NCT00727506|42085886|FG002|Overall Study|Adverse Event|4|||
19636431|NCT00727506|42085887|FG003|Overall Study|Adverse Event|4|||
19636432|NCT00727506|42085888|FG004|Overall Study|Adverse Event|1|||
19636433|NCT00727506|42085889|FG005|Overall Study|Adverse Event|8|||
19636434|NCT00727506|42085884|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19636435|NCT00727506|42085885|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19636436|NCT00727506|42085886|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
19636437|NCT00727506|42085887|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19636438|NCT00727506|42085888|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19636439|NCT00727506|42085889|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
19636440|NCT00727506|42085884|FG000|Overall Study|Progressive disease|4|||
19636441|NCT00727506|42085885|FG001|Overall Study|Progressive disease|7|||
19636442|NCT00727506|42085886|FG002|Overall Study|Progressive disease|9|||
19636443|NCT00727506|42085887|FG003|Overall Study|Progressive disease|28|||
19712085|NCT03635086|42155060|FG001|Overall Study|Adverse Event|1|||
19712086|NCT03635086|42155061|FG002|Overall Study|Adverse Event|0|||
19712087|NCT03635086|42155062|FG003|Overall Study|Adverse Event|0|||
19712088|NCT03635086|42155063|FG004|Overall Study|Adverse Event|0|||
19712089|NCT03635086|42155059|FG000|Overall Study|Lost to Follow-up|1|||
19712090|NCT03635086|42155060|FG001|Overall Study|Lost to Follow-up|0|||
19458314|NCT01424397|41712062|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458315|NCT01424397|41712063|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458316|NCT01424397|41712064|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458317|NCT01424397|41712065|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
19636444|NCT00727506|42085888|FG004|Overall Study|Progressive disease|38|||
19636445|NCT00727506|42085889|FG005|Overall Study|Progressive disease|28|||
19636446|NCT00727506|42085884|FG000|Overall Study|Refused to continue medication|0|||
19458318|NCT01424397|41712066|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458319|NCT01424397|41712067|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458320|NCT01424397|41712068|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
19458321|NCT01392963|41712084|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
19458322|NCT01392963|41712085|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
19458323|NCT01392963|41712084|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
19458324|NCT01392963|41712085|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
19458325|NCT01392963|41712084|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
19458326|NCT01392963|41712085|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
19458327|NCT01392573|41712095|FG000|Overall Study|Adverse Event|1|||
19458328|NCT01392573|41712096|FG001|Overall Study|Adverse Event|3|||
19544129|NCT01146652|41993612|FG001|Overall Study|Poor compliance to protocol|1|||
19544130|NCT01146652|41993611|FG000|Overall Study|Other unspecified reasons|314|||
19636447|NCT00727506|42085885|FG001|Overall Study|Refused to continue medication|1|||
19636448|NCT00727506|42085886|FG002|Overall Study|Refused to continue medication|2|||
19636449|NCT00727506|42085887|FG003|Overall Study|Refused to continue medication|3|||
19636450|NCT00727506|42085888|FG004|Overall Study|Refused to continue medication|1|||
19636451|NCT00727506|42085889|FG005|Overall Study|Refused to continue medication|2|||
19636452|NCT00727506|42085884|FG000|Overall Study|Other reason not described above|0|||
19636453|NCT00727506|42085885|FG001|Overall Study|Other reason not described above|0|||
19636454|NCT00727506|42085886|FG002|Overall Study|Other reason not described above|1|||
19636455|NCT00727506|42085887|FG003|Overall Study|Other reason not described above|4|||
19636456|NCT00727506|42085888|FG004|Overall Study|Other reason not described above|1|||
19636457|NCT00727506|42085889|FG005|Overall Study|Other reason not described above|1|||
19636458|NCT00789815|42085911|FG000|Overall Study|Protocol Violation|6|||
19636459|NCT00789815|42085912|FG001|Overall Study|Protocol Violation|1|||
19636460|NCT00789815|42085911|FG000|Overall Study|Intubation due to massive bleeding|1|||
19636461|NCT00789815|42085912|FG001|Overall Study|Intubation due to massive bleeding|0|||
19636462|NCT00721578|42085918|FG000|Overall Study|Death|1|||
19636463|NCT00721578|42085919|FG001|Overall Study|Death|1|||
19636464|NCT00721578|42085918|FG000|Overall Study|Withdrawal by Subject|1|||
19636465|NCT00721578|42085919|FG001|Overall Study|Withdrawal by Subject|1|||
19636466|NCT00789737|42085927|FG000|Overall Study|Withdrawal by Subject|13|||
19636467|NCT00789737|42085928|FG001|Overall Study|Withdrawal by Subject|22|||
19636468|NCT00789737|42085927|FG000|Overall Study|Lost to Follow-up|10|||
19636469|NCT00789737|42085928|FG001|Overall Study|Lost to Follow-up|14|||
19636470|NCT00789737|42085927|FG000|Overall Study|Adverse Event|8|||
19636471|NCT00789737|42085928|FG001|Overall Study|Adverse Event|8|||
19636472|NCT00789737|42085927|FG000|Overall Study|Protocol Violation|3|||
19636473|NCT00789737|42085928|FG001|Overall Study|Protocol Violation|0|||
19636474|NCT00789737|42085927|FG000|Overall Study|Lack of Efficacy|3|||
19636475|NCT00789737|42085928|FG001|Overall Study|Lack of Efficacy|0|||
19636476|NCT00789737|42085927|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
19636477|NCT00789737|42085928|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
19636478|NCT00789737|42085927|FG000|Overall Study|Other|11|||
19636479|NCT00789737|42085928|FG001|Overall Study|Other|7|||
19636480|NCT00792467|42085934|FG000|Overall Study|progression of disease|17|||
19636481|NCT00792467|42085934|FG000|Overall Study|Adverse Event|1|||
19636482|NCT00792467|42085934|FG000|Overall Study|patient request|1|||
19636483|NCT00792467|42085934|FG000|Overall Study|Lost to Follow-up|1|||
19636484|NCT00792467|42085934|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
19712091|NCT03635086|42155061|FG002|Overall Study|Lost to Follow-up|0|||
19712092|NCT03635086|42155062|FG003|Overall Study|Lost to Follow-up|0|||
19712093|NCT03635086|42155063|FG004|Overall Study|Lost to Follow-up|0|||
19636485|NCT00792467|42085934|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
19636486|NCT00585468|42085939|FG000|First Intervention|Withdrawal by Subject|1|||
19636487|NCT00585468|42085940|FG001|First Intervention|Withdrawal by Subject|1|||
19636488|NCT00724152|42085953|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
19636489|NCT00724152|42085954|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
19636490|NCT00724152|42085955|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
19636491|NCT00724152|42085953|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
19712094|NCT03588910|42155078|FG000|Overall Study|Withdrawal by Subject|1|||
19712095|NCT03588910|42155079|FG001|Overall Study|Withdrawal by Subject|0|||
19712096|NCT03588910|42155078|FG000|Overall Study|Allergy|2|||
19636492|NCT00724152|42085954|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
19636493|NCT00724152|42085955|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
19636494|NCT00721110|42085969|FG000|Overall Study|Ultram use|1|||
19636495|NCT00721110|42085970|FG001|Overall Study|Ultram use|0|||
19636496|NCT00721110|42085971|FG002|Overall Study|Ultram use|0|||
19636497|NCT00721110|42085972|FG003|Overall Study|Ultram use|0|||
19636498|NCT00721110|42085969|FG000|Overall Study|vertical incision|0|||
19636499|NCT00721110|42085970|FG001|Overall Study|vertical incision|0|||
19636500|NCT00721110|42085971|FG002|Overall Study|vertical incision|1|||
19636501|NCT00721110|42085972|FG003|Overall Study|vertical incision|0|||
19636502|NCT00791999|42085986|FG000|Overall Study|Protocol planed withdrawal|14|||
19636503|NCT00791999|42085987|FG001|Overall Study|Protocol planed withdrawal|11|||
19636504|NCT00791999|42085988|FG002|Overall Study|Protocol planed withdrawal|11|||
19636505|NCT00791999|42085989|FG003|Overall Study|Protocol planed withdrawal|45|||
19636506|NCT00791999|42085986|FG000|Overall Study|Withdrawal by Subject|0|||
19636507|NCT00791999|42085987|FG001|Overall Study|Withdrawal by Subject|1|||
19636508|NCT00791999|42085988|FG002|Overall Study|Withdrawal by Subject|0|||
19712097|NCT03588910|42155079|FG001|Overall Study|Allergy|0|||
19712098|NCT03588910|42155078|FG000|Overall Study|Protocol Violation|0|||
19712099|NCT03588910|42155079|FG001|Overall Study|Protocol Violation|3|||
19712100|NCT03588910|42155078|FG000|Overall Study|Did not complete Day 1 Survey|5|||
19712101|NCT03588910|42155079|FG001|Overall Study|Did not complete Day 1 Survey|10|||
19712102|NCT03588910|42155078|FG000|Overall Study|Did not complete Day 7 Survey|5|||
19712103|NCT03588910|42155079|FG001|Overall Study|Did not complete Day 7 Survey|2|||
19712104|NCT03587974|42155087|FG000|Overall Study|caregiver demented, care recipient died|3|||
19636509|NCT00791999|42085989|FG003|Overall Study|Withdrawal by Subject|2|||
19636510|NCT00791999|42085986|FG000|Overall Study|Protocol Violation|3|||
19636511|NCT00791999|42085987|FG001|Overall Study|Protocol Violation|0|||
19636512|NCT00791999|42085988|FG002|Overall Study|Protocol Violation|1|||
19636513|NCT00791999|42085989|FG003|Overall Study|Protocol Violation|0|||
19636514|NCT00791999|42085986|FG000|Overall Study|Adverse Event|3|||
19544131|NCT01146652|41993612|FG001|Overall Study|Other unspecified reasons|22|||
19544132|NCT01146652|41993611|FG000|Overall Study|Enrolled but not treated|2|||
19544133|NCT01146652|41993612|FG001|Overall Study|Enrolled but not treated|0|||
19544134|NCT01146613|41993627|FG000|Overall Study|Lost to Follow-up|3|||
19544135|NCT01146613|41993628|FG001|Overall Study|Lost to Follow-up|8|||
19544136|NCT01146613|41993627|FG000|Overall Study|Lack of Efficacy|0|||
19544137|NCT01146613|41993628|FG001|Overall Study|Lack of Efficacy|1|||
19544138|NCT01146613|41993627|FG000|Overall Study|Death|1|||
19544139|NCT01146613|41993628|FG001|Overall Study|Death|0|||
19544140|NCT01146613|41993627|FG000|Overall Study|Physician Decision|1|||
19544141|NCT01146613|41993628|FG001|Overall Study|Physician Decision|0|||
19544142|NCT01146613|41993627|FG000|Overall Study|Withdrawal by Subject|0|||
19544143|NCT01146613|41993628|FG001|Overall Study|Withdrawal by Subject|3|||
19544144|NCT01146613|41993627|FG000|Overall Study|schedule conflict|1|||
19544145|NCT01146613|41993628|FG001|Overall Study|schedule conflict|0|||
19544146|NCT01146613|41993627|FG000|Overall Study|Outpatient detox|1|||
19544147|NCT01146613|41993628|FG001|Overall Study|Outpatient detox|0|||
19544148|NCT01145755|41993637|FG000|Overall Study|Adverse Event|2|||
19544149|NCT01145755|41993638|FG001|Overall Study|Adverse Event|4|||
19544150|NCT01145755|41993639|FG002|Overall Study|Adverse Event|2|||
19544151|NCT01145755|41993637|FG000|Overall Study|Withdrawal by Subject|2|||
19544152|NCT01145755|41993638|FG001|Overall Study|Withdrawal by Subject|2|||
19544153|NCT01145755|41993639|FG002|Overall Study|Withdrawal by Subject|2|||
19544154|NCT01145755|41993637|FG000|Overall Study|Lost to Follow-up|2|||
19544155|NCT01145755|41993638|FG001|Overall Study|Lost to Follow-up|3|||
19544156|NCT01145755|41993639|FG002|Overall Study|Lost to Follow-up|1|||
19544157|NCT01145755|41993637|FG000|Overall Study|Protocol Violation|0|||
19544158|NCT01145755|41993638|FG001|Overall Study|Protocol Violation|3|||
19544159|NCT01145755|41993639|FG002|Overall Study|Protocol Violation|1|||
19544160|NCT01145755|41993637|FG000|Overall Study|Study Closure|14|||
19544161|NCT01145755|41993638|FG001|Overall Study|Study Closure|14|||
19544162|NCT01145755|41993639|FG002|Overall Study|Study Closure|17|||
19544163|NCT01145755|41993637|FG000|Overall Study|Lack of Efficacy|0|||
19544164|NCT01145755|41993638|FG001|Overall Study|Lack of Efficacy|1|||
19544165|NCT01145755|41993639|FG002|Overall Study|Lack of Efficacy|0|||
19544166|NCT01145755|41993637|FG000|Overall Study|Patient could not swollow medication|0|||
19544167|NCT01145755|41993638|FG001|Overall Study|Patient could not swollow medication|0|||
19544168|NCT01145755|41993639|FG002|Overall Study|Patient could not swollow medication|1|||
19544169|NCT01145755|41993637|FG000|Overall Study|Withdrawal by Subject|0|||
19544170|NCT01145755|41993638|FG001|Overall Study|Withdrawal by Subject|0|||
19544171|NCT01145755|41993639|FG002|Overall Study|Withdrawal by Subject|1|||
19544172|NCT01145755|41993637|FG000|Overall Study|Positive urine ethanol|0|||
19544173|NCT01145755|41993638|FG001|Overall Study|Positive urine ethanol|1|||
19544174|NCT01145755|41993639|FG002|Overall Study|Positive urine ethanol|0|||
19544175|NCT01145560|41993650|FG000|Overall Study|Withdrawal by Subject|2|||
19544176|NCT01145560|41993651|FG001|Overall Study|Withdrawal by Subject|1|||
19544177|NCT01145560|41993652|FG002|Overall Study|Withdrawal by Subject|0|||
19544178|NCT01145560|41993650|FG000|Overall Study|Lost to Follow-up|1|||
19544179|NCT01145560|41993651|FG001|Overall Study|Lost to Follow-up|1|||
19544180|NCT01145560|41993652|FG002|Overall Study|Lost to Follow-up|1|||
19544181|NCT01145560|41993650|FG000|Overall Study|No study drug by 24h after organ failure|1|||
19544182|NCT01145560|41993651|FG001|Overall Study|No study drug by 24h after organ failure|0|||
19544183|NCT01145560|41993652|FG002|Overall Study|No study drug by 24h after organ failure|0|||
19544184|NCT01145560|41993650|FG000|Overall Study|Accidental unblinding of study treatment|0|||
19544185|NCT01145560|41993651|FG001|Overall Study|Accidental unblinding of study treatment|1|||
19544186|NCT01145560|41993652|FG002|Overall Study|Accidental unblinding of study treatment|0|||
19544187|NCT01145560|41993650|FG000|Overall Study|False insurance information|0|||
19544188|NCT01145560|41993651|FG001|Overall Study|False insurance information|1|||
19544189|NCT01145560|41993652|FG002|Overall Study|False insurance information|0|||
19544190|NCT01145560|41993650|FG000|Overall Study|Withdrawal of therapy|0|||
19544191|NCT01145560|41993651|FG001|Overall Study|Withdrawal of therapy|0|||
19544192|NCT01145560|41993652|FG002|Overall Study|Withdrawal of therapy|1|||
19544193|NCT01145482|41993662|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
19544194|NCT01145482|41993663|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
19544195|NCT01145053|41993669|FG000|Overall Study|Adverse Event|22|||
19544196|NCT01145053|41993669|FG000|Overall Study|Lost to Follow-up|28|||
19544197|NCT01145053|41993669|FG000|Overall Study|Withdrawal by Subject|25|||
19544198|NCT01145053|41993669|FG000|Overall Study|Other|18|||
19544199|NCT01144663|41993677|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
19544200|NCT01144663|41993678|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
19544201|NCT01144663|41993679|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
19544202|NCT01144663|41993680|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
19544203|NCT01144663|41993677|FG000|Primary Vaccination Phase|Adverse Event|1|||
19544204|NCT01144663|41993678|FG001|Primary Vaccination Phase|Adverse Event|0|||
19544205|NCT01144663|41993679|FG002|Primary Vaccination Phase|Adverse Event|0|||
19544206|NCT01144663|41993680|FG003|Primary Vaccination Phase|Adverse Event|1|||
19544207|NCT01144663|41993677|FG000|Primary Vaccination Phase|Protocol Violation|2|||
19544208|NCT01144663|41993678|FG001|Primary Vaccination Phase|Protocol Violation|0|||
19544209|NCT01144663|41993679|FG002|Primary Vaccination Phase|Protocol Violation|1|||
19544210|NCT01144663|41993680|FG003|Primary Vaccination Phase|Protocol Violation|0|||
19544211|NCT01144663|41993677|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
19544212|NCT01144663|41993678|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
19544213|NCT01144663|41993679|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
19544214|NCT01144663|41993680|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
19544215|NCT01144663|41993677|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
19544216|NCT01144663|41993678|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
19544217|NCT01144663|41993679|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
19544218|NCT01144663|41993680|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
19544219|NCT01144663|41993677|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
19544220|NCT01144663|41993678|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
19544221|NCT01144663|41993679|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
19544222|NCT01144663|41993680|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
19544223|NCT01144663|41993677|FG000|Primary Vaccination Phase|Other|0|||
19544224|NCT01144663|41993678|FG001|Primary Vaccination Phase|Other|1|||
19544225|NCT01144663|41993679|FG002|Primary Vaccination Phase|Other|0|||
19544226|NCT01144663|41993680|FG003|Primary Vaccination Phase|Other|2|||
19544227|NCT01144663|41993677|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
19544228|NCT01144663|41993678|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
19544229|NCT01144663|41993679|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
19544230|NCT01144663|41993680|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
19544231|NCT01144663|41993677|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
19544232|NCT01144663|41993678|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
19544233|NCT01144663|41993679|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
19544234|NCT01144663|41993680|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
19544235|NCT01144663|41993677|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
19544236|NCT01144663|41993678|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
19544237|NCT01144663|41993679|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
19544238|NCT01144663|41993680|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
19544239|NCT01144663|41993677|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
19544240|NCT01144663|41993678|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
19544241|NCT01144663|41993679|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
19544242|NCT01144663|41993680|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
19544243|NCT01144663|41993677|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
19544244|NCT01144663|41993678|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
19544245|NCT01144663|41993679|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
19544246|NCT01144663|41993680|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
19544247|NCT01144663|41993677|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
19544248|NCT01144663|41993678|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
19544249|NCT01144663|41993679|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
19544250|NCT01144663|41993680|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
19544251|NCT01143337|41993692|FG000|Overall Study|Adverse Event|3|||
19544252|NCT01143337|41993693|FG001|Overall Study|Adverse Event|9|||
19544253|NCT01143337|41993694|FG002|Overall Study|Adverse Event|5|||
19544254|NCT01143337|41993692|FG000|Overall Study|Lack of Efficacy|6|||
19544255|NCT01143337|41993693|FG001|Overall Study|Lack of Efficacy|2|||
19544256|NCT01143337|41993694|FG002|Overall Study|Lack of Efficacy|1|||
19544257|NCT01143337|41993692|FG000|Overall Study|Protocol Violation|1|||
19544258|NCT01143337|41993693|FG001|Overall Study|Protocol Violation|0|||
19544259|NCT01143337|41993694|FG002|Overall Study|Protocol Violation|0|||
19544260|NCT01143337|41993692|FG000|Overall Study|Withdrawal by Subject|0|||
19544261|NCT01143337|41993693|FG001|Overall Study|Withdrawal by Subject|0|||
19544262|NCT01143337|41993694|FG002|Overall Study|Withdrawal by Subject|1|||
19544263|NCT01143337|41993692|FG000|Overall Study|Other reason|0|||
19544264|NCT01143337|41993693|FG001|Overall Study|Other reason|0|||
19544265|NCT01143337|41993694|FG002|Overall Study|Other reason|5|||
19544266|NCT01143259|41993702|FG000|Overall Study|Withdrawal by Subject|3|||
19544267|NCT01143259|41993703|FG001|Overall Study|Withdrawal by Subject|2|||
19544268|NCT01143259|41993702|FG000|Overall Study|Protocol Violation|13|||
19544269|NCT01143259|41993703|FG001|Overall Study|Protocol Violation|9|||
19544270|NCT01143259|41993702|FG000|Overall Study|Screen Failure|7|||
19544271|NCT01143259|41993703|FG001|Overall Study|Screen Failure|9|||
19544272|NCT01142908|41993711|FG000|Overall Study|Lost to Follow-up|19|||
19544273|NCT01142908|41993712|FG001|Overall Study|Lost to Follow-up|13|||
19544274|NCT01142908|41993711|FG000|Overall Study|Death|1|||
19544275|NCT01142908|41993712|FG001|Overall Study|Death|4|||
19544276|NCT01142908|41993711|FG000|Overall Study|Excluded - did not meet criteria|9|||
19544277|NCT01142908|41993712|FG001|Overall Study|Excluded - did not meet criteria|5|||
19544278|NCT01142908|41993711|FG000|Overall Study|Withdrawal by Subject|3|||
19544279|NCT01142908|41993712|FG001|Overall Study|Withdrawal by Subject|0|||
19544280|NCT01142791|41993718|FG000|Overall Study|Alternative Treatment|1|||
19544281|NCT01142791|41993719|FG001|Overall Study|Alternative Treatment|0|||
19544282|NCT01142791|41993718|FG000|Overall Study|Lost to Follow-up|1|||
19544283|NCT01142791|41993719|FG001|Overall Study|Lost to Follow-up|0|||
19544284|NCT01142791|41993718|FG000|Overall Study|Withdrawal by Subject|5|||
19544285|NCT01142791|41993719|FG001|Overall Study|Withdrawal by Subject|0|||
19544286|NCT01142791|41993718|FG000|Overall Study|Received only 1 sonication|0|||
19544287|NCT01142791|41993719|FG001|Overall Study|Received only 1 sonication|6|||
19544288|NCT01142596|41993725|FG000|Overall Study|Withdrawal by Subject|9|||
19544289|NCT01142596|41993726|FG001|Overall Study|Withdrawal by Subject|35|||
19544290|NCT01142596|41993725|FG000|Overall Study|Adverse Event|8|||
19544291|NCT01142596|41993726|FG001|Overall Study|Adverse Event|35|||
19544292|NCT01142596|41993725|FG000|Overall Study|Lack of Efficacy|5|||
19544293|NCT01142596|41993726|FG001|Overall Study|Lack of Efficacy|9|||
19544294|NCT01142596|41993725|FG000|Overall Study|Lost to Follow-up|2|||
19544295|NCT01142596|41993726|FG001|Overall Study|Lost to Follow-up|3|||
19544296|NCT01142596|41993725|FG000|Overall Study|Other reason (not specified)|5|||
19544297|NCT01142596|41993726|FG001|Overall Study|Other reason (not specified)|4|||
19544298|NCT01142128|41993736|FG000|Overall Study|Physician Decision|1|||
19544299|NCT01142128|41993736|FG000|Overall Study|Lost to Follow-up|1|||
19544300|NCT01142128|41993736|FG000|Overall Study|Withdrawal by Subject|2|||
19544301|NCT01142089|41993748|FG000|Overall Study|Physician Decision|1|||
19544302|NCT01142089|41993749|FG001|Overall Study|Physician Decision|0|||
19544303|NCT01142089|41993748|FG000|Overall Study|Withdrawal by Subject|1|||
19544304|NCT01142089|41993749|FG001|Overall Study|Withdrawal by Subject|2|||
19544305|NCT01142089|41993748|FG000|Overall Study|Use of prohibited medications|0|||
19544306|NCT01142089|41993749|FG001|Overall Study|Use of prohibited medications|1|||
19544307|NCT01142089|41993748|FG000|Overall Study|Noncompliance with study procedures|2|||
19544308|NCT01142089|41993749|FG001|Overall Study|Noncompliance with study procedures|1|||
19544309|NCT01142089|41993748|FG000|Overall Study|Patient required rescue medication|8|||
19544310|NCT01142089|41993749|FG001|Overall Study|Patient required rescue medication|17|||
19544311|NCT01141660|41993757|FG000|Overall Study|Physician Decision|0|||
19544312|NCT01141660|41993758|FG001|Overall Study|Physician Decision|12|||
19544313|NCT01140880|41993766|FG000|Overall Study|Death|0|||
19544314|NCT01140880|41993767|FG001|Overall Study|Death|1|||
19544315|NCT01140880|41993766|FG000|Overall Study|Withdrawal by Subject|6|||
19544316|NCT01140880|41993767|FG001|Overall Study|Withdrawal by Subject|3|||
19544317|NCT01140880|41993766|FG000|Overall Study|Lost to Follow-up|8|||
19544318|NCT01140880|41993767|FG001|Overall Study|Lost to Follow-up|10|||
19544319|NCT01140880|41993766|FG000|Overall Study|Protocol Violation|0|||
19544320|NCT01140880|41993767|FG001|Overall Study|Protocol Violation|30|||
19544321|NCT01140646|41993773|FG000|Overall Study|Adverse Event|4|||
19544322|NCT01140646|41993773|FG000|Overall Study|Refused Further Treatment|5|||
19544323|NCT01140568|41993777|FG000|Overall Study|disease progression|31|||
19544324|NCT01140568|41993777|FG000|Overall Study|Withdrawal by Subject|1|||
19544325|NCT01140568|41993777|FG000|Overall Study|Screen Fail|4|||
19544326|NCT01140451|41993783|FG000|Overall Study|Withdrawal by Subject|26|||
19544327|NCT01140451|41993784|FG001|Overall Study|Withdrawal by Subject|33|||
19544328|NCT01140451|41993783|FG000|Overall Study|Adverse Event|2|||
19544329|NCT01140451|41993784|FG001|Overall Study|Adverse Event|6|||
19544330|NCT01140451|41993783|FG000|Overall Study|Physician Decision|5|||
19544331|NCT01140451|41993784|FG001|Overall Study|Physician Decision|3|||
19544332|NCT01140451|41993783|FG000|Overall Study|Lost to Follow-up|2|||
19544333|NCT01140451|41993784|FG001|Overall Study|Lost to Follow-up|0|||
19544334|NCT01140451|41993783|FG000|Overall Study|Participants Planning Pregnancy|3|||
19544335|NCT01140451|41993784|FG001|Overall Study|Participants Planning Pregnancy|0|||
19544336|NCT01140061|41993801|FG000|Part I|Adverse Event|1|||
19544337|NCT01140061|41993802|FG001|Part I|Adverse Event|0|||
19544338|NCT01140061|41993803|FG002|Part I|Adverse Event|0|||
19544339|NCT01140061|41993804|FG003|Part I|Adverse Event|0|||
19544340|NCT01140061|41993805|FG004|Part I|Adverse Event|0|||
19544341|NCT01140061|41993806|FG005|Part I|Adverse Event|0|||
19544342|NCT01140061|41993807|FG006|Part I|Adverse Event|0|||
19544343|NCT01140061|41993808|FG007|Part I|Adverse Event|0|||
19544344|NCT01140061|41993809|FG008|Part I|Adverse Event|0|||
19544345|NCT01140061|41993810|FG009|Part I|Adverse Event|0|||
19544346|NCT01140061|41993801|FG000|Extension|Laboratory Adverse Event|0|||
19544347|NCT01140061|41993802|FG001|Extension|Laboratory Adverse Event|0|||
19544348|NCT01140061|41993803|FG002|Extension|Laboratory Adverse Event|0|||
19544349|NCT01140061|41993804|FG003|Extension|Laboratory Adverse Event|0|||
19544350|NCT01140061|41993805|FG004|Extension|Laboratory Adverse Event|0|||
19544351|NCT01140061|41993806|FG005|Extension|Laboratory Adverse Event|0|||
19544352|NCT01140061|41993807|FG006|Extension|Laboratory Adverse Event|0|||
19544353|NCT01140061|41993808|FG007|Extension|Laboratory Adverse Event|0|||
19544354|NCT01140061|41993809|FG008|Extension|Laboratory Adverse Event|0|||
19544355|NCT01140061|41993810|FG009|Extension|Laboratory Adverse Event|1|||
19544356|NCT01139164|41993828|FG000|Overall Study|Withdrawn prior to study start|0|||
19544357|NCT01139164|41993829|FG001|Overall Study|Withdrawn prior to study start|2|||
19544358|NCT01139164|41993830|FG002|Overall Study|Withdrawn prior to study start|0|||
19544359|NCT01139125|41993838|FG000|Overall Study|Withdrawal by Subject|1|||
19544360|NCT01139047|41993842|FG000|Overall Study|Withdrawal by Subject|1|||
19544361|NCT01139008|41993849|FG000|Overall Study|Withdrawal by Subject|5|||
19544362|NCT01139008|41993849|FG000|Overall Study|Non-compliant, lost product|1|||
19544363|NCT01138657|41993858|FG000|Overall Study|Adverse Event|3|||
19544364|NCT01138657|41993859|FG001|Overall Study|Adverse Event|10|||
19712105|NCT03587974|42155088|FG001|Overall Study|caregiver demented, care recipient died|3|||
19712106|NCT03587974|42155087|FG000|Overall Study|Withdrawal by Subject|2|||
19636515|NCT00791999|42085987|FG001|Overall Study|Adverse Event|3|||
19636516|NCT00791999|42085988|FG002|Overall Study|Adverse Event|7|||
19636517|NCT00791999|42085989|FG003|Overall Study|Adverse Event|3|||
19636518|NCT00791999|42085986|FG000|Overall Study|Lack of Efficacy|0|||
19636519|NCT00791999|42085987|FG001|Overall Study|Lack of Efficacy|1|||
19636520|NCT00791999|42085988|FG002|Overall Study|Lack of Efficacy|0|||
19636521|NCT00791999|42085989|FG003|Overall Study|Lack of Efficacy|2|||
19712107|NCT03587974|42155088|FG001|Overall Study|Withdrawal by Subject|1|||
19458329|NCT01392573|41712095|FG000|Overall Study|Lack of Efficacy|1|||
19636522|NCT00791999|42085986|FG000|Overall Study|Reason other than those above|1|||
19636523|NCT00791999|42085987|FG001|Overall Study|Reason other than those above|0|||
19636524|NCT00791999|42085988|FG002|Overall Study|Reason other than those above|1|||
19636525|NCT00791999|42085989|FG003|Overall Study|Reason other than those above|0|||
19636526|NCT00585078|42086003|FG000|Overall Study|Withdrawal by Subject|4|||
19636527|NCT00585078|42086003|FG000|Overall Study|Poor performance status|1|||
19636528|NCT00585078|42086003|FG000|Overall Study|Disease Progression|24|||
19458330|NCT01392573|41712096|FG001|Overall Study|Lack of Efficacy|2|||
19458331|NCT01392573|41712095|FG000|Overall Study|Protocol Violation|0|||
19458332|NCT01392573|41712096|FG001|Overall Study|Protocol Violation|2|||
19458333|NCT01392573|41712095|FG000|Overall Study|Withdrawal Criteria|13|||
19458334|NCT01392573|41712096|FG001|Overall Study|Withdrawal Criteria|15|||
19458335|NCT01392573|41712095|FG000|Overall Study|Site closure|8|||
19458336|NCT01392573|41712096|FG001|Overall Study|Site closure|7|||
19458337|NCT01392573|41712095|FG000|Overall Study|Unclassified|9|||
19458338|NCT01392573|41712096|FG001|Overall Study|Unclassified|6|||
19458339|NCT01392495|41712102|FG000|Overall Study|Death|3|||
19458340|NCT01392495|41712102|FG000|Overall Study|Administrative problems|8|||
19458341|NCT01392495|41712102|FG000|Overall Study|Withdrawal by Subject|2|||
19458342|NCT01392495|41712102|FG000|Overall Study|Adverse Event|3|||
19458343|NCT01405053|41712110|FG000|Overall Study|Adverse Event|3|||
19458344|NCT01405053|41712111|FG001|Overall Study|Adverse Event|0|||
19458345|NCT01405053|41712110|FG000|Overall Study|Lost to Follow-up|0|||
19458346|NCT01405053|41712111|FG001|Overall Study|Lost to Follow-up|1|||
19458347|NCT01405053|41712110|FG000|Overall Study|Participant choice|2|||
19458348|NCT01405053|41712111|FG001|Overall Study|Participant choice|1|||
19458349|NCT01405053|41712110|FG000|Overall Study|Inadequate therapeutic effect|2|||
19458350|NCT01405053|41712111|FG001|Overall Study|Inadequate therapeutic effect|1|||
19458351|NCT01405053|41712110|FG000|Overall Study|Withdrawal by Subject|3|||
19458352|NCT01405053|41712111|FG001|Overall Study|Withdrawal by Subject|4|||
19458353|NCT01405053|41712110|FG000|Overall Study|Other|0|||
19458354|NCT01405053|41712111|FG001|Overall Study|Other|1|||
19458355|NCT01403805|41712119|FG000|Overall Study|Withdrawal by Subject|0|||
19458356|NCT01403805|41712120|FG001|Overall Study|Withdrawal by Subject|4|||
19544365|NCT01138657|41993858|FG000|Overall Study|Lack of Efficacy|2|||
19544366|NCT01138657|41993859|FG001|Overall Study|Lack of Efficacy|1|||
19544367|NCT01138657|41993858|FG000|Overall Study|Lost to Follow-up|0|||
19544368|NCT01138657|41993859|FG001|Overall Study|Lost to Follow-up|3|||
19636529|NCT00585078|42086003|FG000|Overall Study|Adverse Event|10|||
19636530|NCT00585078|42086003|FG000|Overall Study|Death|1|||
19636531|NCT00720876|42086007|FG000|Overall Study|found to be ineligible after starting tx|2|||
19636532|NCT00723840|42086011|FG000|Overall Study|Lost to Follow-up|2|||
19636533|NCT00723840|42086011|FG000|Overall Study|Failure to return|18|||
19458357|NCT01403805|41712119|FG000|Overall Study|Lost to Follow-up|0|||
19458358|NCT01403805|41712120|FG001|Overall Study|Lost to Follow-up|2|||
19544369|NCT01138657|41993858|FG000|Overall Study|Miscellaneous Reasons|3|||
19544370|NCT01138657|41993859|FG001|Overall Study|Miscellaneous Reasons|4|||
19544371|NCT01138501|41993867|FG000|Overall Study|Protocol Violation|2|||
19636534|NCT00723840|42086011|FG000|Overall Study|Withdrawal by Subject|55|||
19636535|NCT00723840|42086011|FG000|Overall Study|Serious Adverse Events|3|||
19636536|NCT00723840|42086011|FG000|Overall Study|Other Medical Event|2|||
19636537|NCT00723840|42086011|FG000|Overall Study|Unspecified reason|2|||
19636538|NCT00789581|42086024|FG000|AC Therapy|Adverse Event|2|||
19458359|NCT01403805|41712119|FG000|Overall Study|Death|0|||
19458360|NCT01403805|41712120|FG001|Overall Study|Death|1|||
19544372|NCT01138501|41993867|FG000|Overall Study|Withdrawal by Subject|3|||
19544373|NCT01138150|41993873|FG000|Overall Study|blood unable to be processed|0|||
19544374|NCT01138150|41993874|FG001|Overall Study|blood unable to be processed|1|||
19544375|NCT01138150|41993873|FG000|Overall Study|Physician Decision|1|||
19544376|NCT01138150|41993874|FG001|Overall Study|Physician Decision|0|||
19544377|NCT01138111|41993890|FG000|Overall Study|Withdrawal by Subject|5|||
19544378|NCT01138111|41993890|FG000|Overall Study|Adverse Event|1|||
19544379|NCT01138111|41993890|FG000|Overall Study|Death|1|||
19544380|NCT01138111|41993890|FG000|Overall Study|Lost to Follow-up|2|||
19544381|NCT01137955|41993921|FG000|Overall Study|Withdrawal by Subject|5|||
19544382|NCT01137955|41993922|FG001|Overall Study|Withdrawal by Subject|4|||
19544383|NCT01137682|41993932|FG000|Overall Study|Adverse Event-CORE|2|||
19544384|NCT01137682|41993933|FG001|Overall Study|Adverse Event-CORE|4|||
19544385|NCT01137682|41993934|FG002|Overall Study|Adverse Event-CORE|0|||
19544386|NCT01137682|41993932|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
19544387|NCT01137682|41993933|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
19544388|NCT01137682|41993934|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
19544389|NCT01137682|41993932|FG000|Overall Study|Administrative problems-CORE|2|||
19544390|NCT01137682|41993933|FG001|Overall Study|Administrative problems-CORE|1|||
19544391|NCT01137682|41993934|FG002|Overall Study|Administrative problems-CORE|0|||
19544392|NCT01137682|41993932|FG000|Overall Study|Protocol Violation-CORE|0|||
19544393|NCT01137682|41993933|FG001|Overall Study|Protocol Violation-CORE|1|||
19544394|NCT01137682|41993934|FG002|Overall Study|Protocol Violation-CORE|1|||
19544395|NCT01137682|41993932|FG000|Overall Study|Adverse Event-Extension|4|||
19544396|NCT01137682|41993933|FG001|Overall Study|Adverse Event-Extension|8|||
19544397|NCT01137682|41993934|FG002|Overall Study|Adverse Event-Extension|7|||
19544398|NCT01137682|41993932|FG000|Overall Study|Lack of Efficacy-Extension|15|||
19544399|NCT01137682|41993933|FG001|Overall Study|Lack of Efficacy-Extension|9|||
19544400|NCT01137682|41993934|FG002|Overall Study|Lack of Efficacy-Extension|13|||
19544401|NCT01137682|41993932|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
19544402|NCT01137682|41993933|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
19544403|NCT01137682|41993934|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
19544404|NCT01137682|41993932|FG000|Overall Study|Lost to Follow Up-Extension|0|||
19544405|NCT01137682|41993933|FG001|Overall Study|Lost to Follow Up-Extension|1|||
19544406|NCT01137682|41993934|FG002|Overall Study|Lost to Follow Up-Extension|0|||
19544407|NCT01137682|41993932|FG000|Overall Study|Administrative problems-Extension|0|||
19544408|NCT01137682|41993933|FG001|Overall Study|Administrative problems-Extension|2|||
19544409|NCT01137682|41993934|FG002|Overall Study|Administrative problems-Extension|0|||
19544410|NCT01137682|41993932|FG000|Overall Study|Death-Extension|2|||
19544411|NCT01137682|41993933|FG001|Overall Study|Death-Extension|0|||
19544412|NCT01137682|41993934|FG002|Overall Study|Death-Extension|0|||
19544413|NCT01137682|41993932|FG000|Overall Study|Protocol Violation-Extension|2|||
19544414|NCT01137682|41993933|FG001|Overall Study|Protocol Violation-Extension|1|||
19544415|NCT01137682|41993934|FG002|Overall Study|Protocol Violation-Extension|0|||
19544416|NCT01137682|41993932|FG000|Overall Study|Did not enter extension|2|||
19544417|NCT01137682|41993933|FG001|Overall Study|Did not enter extension|3|||
19544418|NCT01137682|41993934|FG002|Overall Study|Did not enter extension|2|||
19544419|NCT01137682|41993932|FG000|Overall Study|Did not receive treatment in extension|0|||
19544420|NCT01137682|41993933|FG001|Overall Study|Did not receive treatment in extension|0|||
19544421|NCT01137682|41993934|FG002|Overall Study|Did not receive treatment in extension|1|||
19544422|NCT03452397|41993950|FG000|Overall Study|Adverse Event|1|||
19544423|NCT03452397|41993951|FG001|Overall Study|Adverse Event|0|||
19544424|NCT03452397|41993952|FG002|Overall Study|Adverse Event|0|||
19544425|NCT03452397|41993953|FG003|Overall Study|Adverse Event|0|||
19544426|NCT03452397|41993950|FG000|Overall Study|Administrative reason|0|||
19544427|NCT03452397|41993951|FG001|Overall Study|Administrative reason|0|||
19544428|NCT03452397|41993952|FG002|Overall Study|Administrative reason|1|||
19544429|NCT03452397|41993953|FG003|Overall Study|Administrative reason|1|||
19544430|NCT03452397|41993950|FG000|Overall Study|Withdrawal by Subject|0|||
19544431|NCT03452397|41993951|FG001|Overall Study|Withdrawal by Subject|0|||
19544432|NCT03452397|41993952|FG002|Overall Study|Withdrawal by Subject|1|||
19544433|NCT03452397|41993953|FG003|Overall Study|Withdrawal by Subject|0|||
19544434|NCT00199875|41993987|FG000|Overall Study|Withdrawal by Subject|0|||
19544435|NCT00199875|41993988|FG001|Overall Study|Withdrawal by Subject|0|||
19544436|NCT00199875|41993989|FG002|Overall Study|Withdrawal by Subject|0|||
19544437|NCT00199875|41993990|FG003|Overall Study|Withdrawal by Subject|0|||
19544438|NCT00199875|41993991|FG004|Overall Study|Withdrawal by Subject|1|||
19544439|NCT00199836|41994003|FG000|Overall Study|Progressive Disease|5|||
19636539|NCT00789581|42086025|FG001|AC Therapy|Adverse Event|3|||
19544440|NCT00199836|41994003|FG000|Overall Study|Death|1|||
19544441|NCT00199797|41994008|FG000|Overall Study|Progressive Disease|1|||
19544442|NCT00199797|41994008|FG000|Overall Study|Adverse Event|1|||
19544443|NCT00199797|41994008|FG000|Overall Study|Physician Decision|1|||
19544444|NCT01137604|41994017|FG000|Overall Study|Adverse Event|3|||
19544445|NCT01137604|41994018|FG001|Overall Study|Adverse Event|6|||
19636540|NCT00789581|42086024|FG000|AC Therapy|Withdrawal by Subject|4|||
19544446|NCT01137604|41994019|FG002|Overall Study|Adverse Event|9|||
19544447|NCT01137604|41994020|FG003|Overall Study|Adverse Event|9|||
19544448|NCT01137604|41994017|FG000|Overall Study|Participant Choice|0|||
19544449|NCT01137604|41994018|FG001|Overall Study|Participant Choice|2|||
19544450|NCT01137604|41994019|FG002|Overall Study|Participant Choice|2|||
19544451|NCT01137604|41994020|FG003|Overall Study|Participant Choice|0|||
19544452|NCT01137604|41994017|FG000|Overall Study|Withdrawal of consent|0|||
19544453|NCT01137604|41994018|FG001|Overall Study|Withdrawal of consent|0|||
19544454|NCT01137604|41994019|FG002|Overall Study|Withdrawal of consent|0|||
19544455|NCT01137604|41994020|FG003|Overall Study|Withdrawal of consent|2|||
19544456|NCT01137604|41994017|FG000|Overall Study|Clinical progression/deterioration|1|||
19544457|NCT01137604|41994018|FG001|Overall Study|Clinical progression/deterioration|2|||
19636541|NCT00789581|42086025|FG001|AC Therapy|Withdrawal by Subject|7|||
19636542|NCT00789581|42086024|FG000|AC Therapy|Disease recurrence|3|||
19636543|NCT00789581|42086025|FG001|AC Therapy|Disease recurrence|1|||
19636544|NCT00789581|42086024|FG000|AC Therapy|Intercurrent Illness|1|||
19636545|NCT00789581|42086025|FG001|AC Therapy|Intercurrent Illness|0|||
19636546|NCT00789581|42086024|FG000|AC Therapy|Never Treated|1|||
19636547|NCT00789581|42086025|FG001|AC Therapy|Never Treated|4|||
19636548|NCT00789581|42086024|FG000|AC Therapy|Other|0|||
19636549|NCT00789581|42086025|FG001|AC Therapy|Other|2|||
19636550|NCT00789581|42086024|FG000|Adjuvant Therapy|Never treated|2|||
19636551|NCT00789581|42086025|FG001|Adjuvant Therapy|Never treated|2|||
19636552|NCT00789581|42086024|FG000|Adjuvant Therapy|Adverse Event|20|||
19636553|NCT00789581|42086025|FG001|Adjuvant Therapy|Adverse Event|44|||
19636554|NCT00789581|42086024|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
19636555|NCT00789581|42086025|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
19636556|NCT00789581|42086024|FG000|Adjuvant Therapy|Disease recurrence|2|||
19636557|NCT00789581|42086025|FG001|Adjuvant Therapy|Disease recurrence|1|||
19636558|NCT00789581|42086024|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
19636559|NCT00789581|42086025|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
19636560|NCT00789581|42086024|FG000|Adjuvant Therapy|Protocol Violation|1|||
19636561|NCT00789581|42086025|FG001|Adjuvant Therapy|Protocol Violation|1|||
19636562|NCT00789581|42086024|FG000|Adjuvant Therapy|Other|0|||
19636563|NCT00789581|42086025|FG001|Adjuvant Therapy|Other|1|||
19636564|NCT00717756|42086032|FG000|Overall Study|Withdrawal by Subject|1|||
19636565|NCT00717522|42086036|FG000|Overall Study|Disease Progression|5|||
19636566|NCT00717522|42086036|FG000|Overall Study|Adverse Event|1|||
19636567|NCT00717522|42086036|FG000|Overall Study|Death|1|||
19636568|NCT00791921|42086042|FG000|Overall Study|Protocol planed|24|||
19636569|NCT00791921|42086043|FG001|Overall Study|Protocol planed|88|||
19712108|NCT00103857|42155101|FG000|54-Week Base Study|Adverse Event|12|||
19712109|NCT00103857|42155102|FG001|54-Week Base Study|Adverse Event|9|||
19712110|NCT00103857|42155103|FG002|54-Week Base Study|Adverse Event|11|||
19712111|NCT00103857|42155104|FG003|54-Week Base Study|Adverse Event|6|||
19712112|NCT00103857|42155105|FG004|54-Week Base Study|Adverse Event|5|||
19712113|NCT00103857|42155106|FG005|54-Week Base Study|Adverse Event|11|||
19712114|NCT00103857|42155107|FG006|54-Week Base Study|Adverse Event|3|||
19712115|NCT00103857|42155101|FG000|54-Week Base Study|Death|0|||
19636570|NCT00791921|42086042|FG000|Overall Study|Withdrawal by Subject|1|||
19636571|NCT00791921|42086043|FG001|Overall Study|Withdrawal by Subject|2|||
19636572|NCT00791921|42086042|FG000|Overall Study|Adverse Event|8|||
19636573|NCT00791921|42086043|FG001|Overall Study|Adverse Event|2|||
19636574|NCT00791921|42086042|FG000|Overall Study|Lack of Efficacy|0|||
19636575|NCT00791921|42086043|FG001|Overall Study|Lack of Efficacy|2|||
19636576|NCT00791921|42086042|FG000|Overall Study|Lack of study drug administration|1|||
19636577|NCT00791921|42086043|FG001|Overall Study|Lack of study drug administration|1|||
19636578|NCT00791921|42086042|FG000|Overall Study|Reason other than those above|0|||
19636579|NCT00791921|42086043|FG001|Overall Study|Reason other than those above|1|||
19636580|NCT00582933|42086049|FG000|Overall Study|Physician Decision|3|||
19636581|NCT00791765|42086055|FG000|Weeks 1 to 12|Adverse Event|0|||
19636582|NCT00791765|42086056|FG001|Weeks 1 to 12|Adverse Event|1|||
19636583|NCT00791765|42086055|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
19636584|NCT00791765|42086056|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
19636585|NCT00791765|42086055|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
19636586|NCT00791765|42086056|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
19636587|NCT00791765|42086055|FG000|Weeks 1 to 12|Physician Decision|1|||
19636588|NCT00791765|42086056|FG001|Weeks 1 to 12|Physician Decision|0|||
19636589|NCT00791765|42086055|FG000|Weeks 1 to 12|Disease progression|3|||
19636590|NCT00791765|42086056|FG001|Weeks 1 to 12|Disease progression|0|||
19636591|NCT00791765|42086055|FG000|Weeks 1 to 12|Ineligibility determined|0|||
19636592|NCT00791765|42086056|FG001|Weeks 1 to 12|Ineligibility determined|3|||
19712116|NCT00103857|42155102|FG001|54-Week Base Study|Death|0|||
19544458|NCT01137604|41994019|FG002|Overall Study|Clinical progression/deterioration|2|||
19636593|NCT00791765|42086055|FG000|Weeks 13 to 24|Protocol deviation|2|||
19636594|NCT00791765|42086056|FG001|Weeks 13 to 24|Protocol deviation|0|||
19636595|NCT00791765|42086055|FG000|Weeks 13 to 24|Adverse Event|0|||
19712117|NCT00103857|42155103|FG002|54-Week Base Study|Death|0|||
19712118|NCT00103857|42155104|FG003|54-Week Base Study|Death|0|||
19712119|NCT00103857|42155105|FG004|54-Week Base Study|Death|1|||
19636596|NCT00791765|42086056|FG001|Weeks 13 to 24|Adverse Event|3|||
19636597|NCT00791765|42086055|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
19636598|NCT00791765|42086056|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
19636599|NCT00791765|42086055|FG000|Weeks 13 to 24|Disease progression|0|||
19636600|NCT00791765|42086056|FG001|Weeks 13 to 24|Disease progression|1|||
19636601|NCT00791765|42086055|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
19636602|NCT00791765|42086056|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
19636603|NCT00791765|42086055|FG000|Weeks 13 to 24|Other|0|||
19636604|NCT00791765|42086056|FG001|Weeks 13 to 24|Other|1|||
19636605|NCT00789191|42086064|FG000|Overall Study|Adverse Event|2|||
19636606|NCT00789191|42086065|FG001|Overall Study|Adverse Event|4|||
19544459|NCT01137604|41994020|FG003|Overall Study|Clinical progression/deterioration|0|||
19636607|NCT00789191|42086064|FG000|Overall Study|Lack of Efficacy|0|||
19636608|NCT00789191|42086065|FG001|Overall Study|Lack of Efficacy|5|||
19636609|NCT00789191|42086064|FG000|Overall Study|Protocol Violation|5|||
19636610|NCT00789191|42086065|FG001|Overall Study|Protocol Violation|3|||
19636611|NCT00789191|42086064|FG000|Overall Study|Withdrawal Criteria|2|||
19544460|NCT00198822|41994033|FG000|Overall Study|Lost to Follow-up|14|||
19636612|NCT00789191|42086065|FG001|Overall Study|Withdrawal Criteria|4|||
19636613|NCT00789191|42086064|FG000|Overall Study|Unclassified|5|||
19636614|NCT00789191|42086065|FG001|Overall Study|Unclassified|3|||
19636615|NCT00789035|42086076|FG000|Overall Study|Adverse Event|0|||
19636616|NCT00789035|42086077|FG001|Overall Study|Adverse Event|2|||
19636617|NCT00789035|42086078|FG002|Overall Study|Adverse Event|0|||
19636618|NCT00789035|42086079|FG003|Overall Study|Adverse Event|1|||
19636619|NCT00789035|42086080|FG004|Overall Study|Adverse Event|3|||
19636620|NCT00789035|42086076|FG000|Overall Study|Lack of Efficacy|3|||
19636621|NCT00789035|42086077|FG001|Overall Study|Lack of Efficacy|0|||
19636622|NCT00789035|42086078|FG002|Overall Study|Lack of Efficacy|0|||
19636623|NCT00789035|42086079|FG003|Overall Study|Lack of Efficacy|0|||
19636624|NCT00789035|42086080|FG004|Overall Study|Lack of Efficacy|2|||
19636625|NCT00789035|42086076|FG000|Overall Study|Protocol Violation|1|||
19636626|NCT00789035|42086077|FG001|Overall Study|Protocol Violation|0|||
19636627|NCT00789035|42086078|FG002|Overall Study|Protocol Violation|0|||
19636628|NCT00789035|42086079|FG003|Overall Study|Protocol Violation|0|||
19636629|NCT00789035|42086080|FG004|Overall Study|Protocol Violation|0|||
19636630|NCT00789035|42086076|FG000|Overall Study|Withdrawal by Subject|0|||
19636631|NCT00789035|42086077|FG001|Overall Study|Withdrawal by Subject|2|||
19636632|NCT00789035|42086078|FG002|Overall Study|Withdrawal by Subject|0|||
19636633|NCT00789035|42086079|FG003|Overall Study|Withdrawal by Subject|0|||
19636634|NCT00789035|42086080|FG004|Overall Study|Withdrawal by Subject|0|||
19636635|NCT00789035|42086076|FG000|Overall Study|Other reason not defined above|2|||
19636636|NCT00789035|42086077|FG001|Overall Study|Other reason not defined above|3|||
19636637|NCT00789035|42086078|FG002|Overall Study|Other reason not defined above|1|||
19636638|NCT00789035|42086079|FG003|Overall Study|Other reason not defined above|0|||
19636639|NCT00789035|42086080|FG004|Overall Study|Other reason not defined above|1|||
19636640|NCT03326193|42086104|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
19636641|NCT03326193|42086104|FG000|Overall Study|Death|19|||
19636642|NCT03326193|42086104|FG000|Overall Study|Withdrawal by Subject|8|||
19636643|NCT00437203|42086127|FG000|Overall Study|Death|0|||
19636644|NCT00437203|42086128|FG001|Overall Study|Death|0|||
19636645|NCT00437203|42086129|FG002|Overall Study|Death|1|||
19636646|NCT00437203|42086130|FG003|Overall Study|Death|0|||
19636647|NCT00437203|42086131|FG004|Overall Study|Death|0|||
19636648|NCT00437203|42086132|FG005|Overall Study|Death|0|||
19636649|NCT00437203|42086133|FG006|Overall Study|Death|0|||
19636650|NCT00437203|42086134|FG007|Overall Study|Death|1|||
19636651|NCT00437203|42086135|FG008|Overall Study|Death|0|||
19636652|NCT00437203|42086136|FG009|Overall Study|Death|1|||
19636653|NCT00437203|42086127|FG000|Overall Study|Adverse Event|1|||
19636654|NCT00437203|42086128|FG001|Overall Study|Adverse Event|1|||
19636655|NCT00437203|42086129|FG002|Overall Study|Adverse Event|0|||
19636656|NCT00437203|42086130|FG003|Overall Study|Adverse Event|0|||
19636657|NCT00437203|42086131|FG004|Overall Study|Adverse Event|0|||
19636658|NCT00437203|42086132|FG005|Overall Study|Adverse Event|0|||
19636659|NCT00437203|42086133|FG006|Overall Study|Adverse Event|0|||
19636660|NCT00437203|42086134|FG007|Overall Study|Adverse Event|1|||
19636661|NCT00437203|42086135|FG008|Overall Study|Adverse Event|0|||
19636662|NCT00437203|42086136|FG009|Overall Study|Adverse Event|1|||
19458361|NCT01423617|41712132|FG000|Overall Study|Lost to Follow-up|0|||
19458362|NCT01423617|41712133|FG001|Overall Study|Lost to Follow-up|1|||
19458363|NCT01392183|41712141|FG000|First Drug Administration|Adverse Event|3|||
19458364|NCT01392183|41712142|FG001|First Drug Administration|Adverse Event|2|||
19458365|NCT01392183|41712141|FG000|First Drug Administration|Death|1|||
19458366|NCT01392183|41712142|FG001|First Drug Administration|Death|0|||
19458367|NCT01392183|41712141|FG000|First Drug Administration|Withdrawal by Subject|10|||
19458368|NCT01392183|41712142|FG001|First Drug Administration|Withdrawal by Subject|17|||
19458369|NCT01751906|41712152|FG000|Overall Study|Lost to Follow-up|151|||
19636663|NCT00437203|42086127|FG000|Overall Study|Study terminated by sponsor|0|||
19636664|NCT00437203|42086128|FG001|Overall Study|Study terminated by sponsor|0|||
19636665|NCT00437203|42086129|FG002|Overall Study|Study terminated by sponsor|0|||
19636666|NCT00437203|42086130|FG003|Overall Study|Study terminated by sponsor|0|||
19636667|NCT00437203|42086131|FG004|Overall Study|Study terminated by sponsor|0|||
19636668|NCT00437203|42086132|FG005|Overall Study|Study terminated by sponsor|0|||
19636669|NCT00437203|42086133|FG006|Overall Study|Study terminated by sponsor|0|||
19636670|NCT00437203|42086134|FG007|Overall Study|Study terminated by sponsor|0|||
19636671|NCT00437203|42086135|FG008|Overall Study|Study terminated by sponsor|1|||
19636672|NCT00437203|42086136|FG009|Overall Study|Study terminated by sponsor|0|||
19636673|NCT00437203|42086127|FG000|Overall Study|Objective progression or relapse|5|||
19636674|NCT00437203|42086128|FG001|Overall Study|Objective progression or relapse|6|||
19636675|NCT00437203|42086129|FG002|Overall Study|Objective progression or relapse|2|||
19636676|NCT00437203|42086130|FG003|Overall Study|Objective progression or relapse|3|||
19636677|NCT00437203|42086131|FG004|Overall Study|Objective progression or relapse|3|||
19636678|NCT00437203|42086132|FG005|Overall Study|Objective progression or relapse|3|||
19636679|NCT00437203|42086133|FG006|Overall Study|Objective progression or relapse|6|||
19636680|NCT00437203|42086134|FG007|Overall Study|Objective progression or relapse|1|||
19636681|NCT00437203|42086135|FG008|Overall Study|Objective progression or relapse|2|||
19636682|NCT00437203|42086136|FG009|Overall Study|Objective progression or relapse|2|||
19636683|NCT00437203|42086127|FG000|Overall Study|Other|0|||
19636684|NCT00437203|42086128|FG001|Overall Study|Other|1|||
19636685|NCT00437203|42086129|FG002|Overall Study|Other|0|||
19636686|NCT00437203|42086130|FG003|Overall Study|Other|0|||
19636687|NCT00437203|42086131|FG004|Overall Study|Other|0|||
19636688|NCT00437203|42086132|FG005|Overall Study|Other|0|||
19636689|NCT00437203|42086133|FG006|Overall Study|Other|1|||
19636690|NCT00437203|42086134|FG007|Overall Study|Other|0|||
19636691|NCT00437203|42086135|FG008|Overall Study|Other|0|||
19636692|NCT00437203|42086136|FG009|Overall Study|Other|0|||
19636693|NCT00753272|42086169|FG000|Overall Study|Adverse Event|878|||
19636694|NCT00753272|42086170|FG001|Overall Study|Adverse Event|869|||
19636695|NCT00753272|42086169|FG000|Overall Study|Protocol Violation|28|||
19636696|NCT00753272|42086170|FG001|Overall Study|Protocol Violation|46|||
19636697|NCT00753272|42086169|FG000|Overall Study|Withdrawal by Subject|2481|||
19636698|NCT00753272|42086170|FG001|Overall Study|Withdrawal by Subject|2407|||
19712120|NCT00103857|42155106|FG005|54-Week Base Study|Death|1|||
19712121|NCT00103857|42155107|FG006|54-Week Base Study|Death|0|||
19712122|NCT00103857|42155101|FG000|54-Week Base Study|Lack of Efficacy|11|||
19712123|NCT00103857|42155102|FG001|54-Week Base Study|Lack of Efficacy|14|||
19712124|NCT00103857|42155103|FG002|54-Week Base Study|Lack of Efficacy|8|||
19712125|NCT00103857|42155104|FG003|54-Week Base Study|Lack of Efficacy|4|||
19712126|NCT00103857|42155105|FG004|54-Week Base Study|Lack of Efficacy|3|||
19712127|NCT00103857|42155106|FG005|54-Week Base Study|Lack of Efficacy|14|||
19712128|NCT00103857|42155107|FG006|54-Week Base Study|Lack of Efficacy|19|||
19712129|NCT00103857|42155101|FG000|54-Week Base Study|Lost to Follow-up|5|||
19712130|NCT00103857|42155102|FG001|54-Week Base Study|Lost to Follow-up|4|||
19712131|NCT00103857|42155103|FG002|54-Week Base Study|Lost to Follow-up|7|||
19712132|NCT00103857|42155104|FG003|54-Week Base Study|Lost to Follow-up|5|||
19712133|NCT00103857|42155105|FG004|54-Week Base Study|Lost to Follow-up|10|||
19712134|NCT00103857|42155106|FG005|54-Week Base Study|Lost to Follow-up|9|||
19712135|NCT00103857|42155107|FG006|54-Week Base Study|Lost to Follow-up|3|||
19712136|NCT00103857|42155101|FG000|54-Week Base Study|Physician Decision|1|||
19712137|NCT00103857|42155102|FG001|54-Week Base Study|Physician Decision|1|||
19636699|NCT00753272|42086169|FG000|Overall Study|Lost to Follow-up|491|||
19636700|NCT00753272|42086170|FG001|Overall Study|Lost to Follow-up|497|||
19636701|NCT00753272|42086169|FG000|Overall Study|Other|1104|||
19636702|NCT00753272|42086170|FG001|Overall Study|Other|1088|||
19636703|NCT00437125|42086179|FG000|Overall Study|Adverse Event|12|||
19636704|NCT00437125|42086179|FG000|Overall Study|Death|1|||
19636705|NCT00437125|42086179|FG000|Overall Study|Clinical Relapse|1|||
19636706|NCT00437125|42086179|FG000|Overall Study|Lack of Efficacy|1|||
19636707|NCT00437125|42086179|FG000|Overall Study|Lost to Follow-up|1|||
19636708|NCT00437125|42086179|FG000|Overall Study|Withdrawal by Subject|13|||
19636709|NCT00437125|42086179|FG000|Overall Study|Withdrawal by Caregiver|2|||
19636710|NCT00437125|42086179|FG000|Overall Study|Physician Decision|1|||
19712138|NCT00103857|42155103|FG002|54-Week Base Study|Physician Decision|0|||
19712139|NCT00103857|42155104|FG003|54-Week Base Study|Physician Decision|0|||
19712140|NCT00103857|42155105|FG004|54-Week Base Study|Physician Decision|1|||
19712141|NCT00103857|42155106|FG005|54-Week Base Study|Physician Decision|0|||
19712142|NCT00103857|42155107|FG006|54-Week Base Study|Physician Decision|0|||
19458370|NCT01751906|41712153|FG001|Overall Study|Lost to Follow-up|68|||
19636711|NCT00582309|42086195|FG000|Overall Study|Protocol Violation|0|||
19636712|NCT00582309|42086196|FG001|Overall Study|Protocol Violation|0|||
19636713|NCT00582309|42086197|FG002|Overall Study|Protocol Violation|2|||
19636714|NCT00443053|42086207|FG000|Overall Study|Adverse Event|2|||
19636715|NCT00443053|42086208|FG001|Overall Study|Adverse Event|1|||
19712143|NCT00103857|42155101|FG000|54-Week Base Study|Pregnancy|1|||
19712144|NCT00103857|42155102|FG001|54-Week Base Study|Pregnancy|0|||
19712145|NCT00103857|42155103|FG002|54-Week Base Study|Pregnancy|0|||
19636716|NCT00443053|42086207|FG000|Overall Study|Withdrawal by Subject|9|||
19636717|NCT00443053|42086208|FG001|Overall Study|Withdrawal by Subject|18|||
19636718|NCT00443053|42086207|FG000|Overall Study|Lost to Follow-up|4|||
19636719|NCT00443053|42086208|FG001|Overall Study|Lost to Follow-up|5|||
19636720|NCT00443053|42086207|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
19636721|NCT00443053|42086208|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
19636722|NCT00443053|42086207|FG000|Overall Study|Noncompliance|2|||
19636723|NCT00443053|42086208|FG001|Overall Study|Noncompliance|1|||
19636724|NCT00443053|42086207|FG000|Overall Study|Other|3|||
19636725|NCT00443053|42086208|FG001|Overall Study|Other|4|||
19636726|NCT00443053|42086207|FG000|Overall Study|Physician Decision|0|||
19636727|NCT00443053|42086208|FG001|Overall Study|Physician Decision|4|||
19636728|NCT00720798|42086214|FG000|Overall Study|Adverse Event|304|||
19636729|NCT00720798|42086214|FG000|Overall Study|Death|39|||
19636730|NCT00720798|42086214|FG000|Overall Study|Insufficient Therapeutic Response|129|||
19636731|NCT00720798|42086214|FG000|Overall Study|Protocol Violation|4|||
19636732|NCT00720798|42086214|FG000|Overall Study|Refused Treatment|151|||
19636733|NCT00720798|42086214|FG000|Overall Study|Failure to Return|46|||
19636734|NCT00720798|42086214|FG000|Overall Study|Reason not Specified|83|||
19636735|NCT00756002|42086224|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
19636736|NCT00756002|42086225|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
19636737|NCT00756002|42086224|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
19636738|NCT00756002|42086225|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
19636739|NCT00756002|42086224|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
19636740|NCT00756002|42086225|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
19636741|NCT00756002|42086224|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
19636742|NCT00756002|42086225|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
19636743|NCT00756002|42086224|FG000|Double-Blind Treatment Period|Other|2|||
19636744|NCT00756002|42086225|FG001|Double-Blind Treatment Period|Other|2|||
19636745|NCT00717366|42086233|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
19636746|NCT00717366|42086234|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
19636747|NCT00717366|42086233|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
19636748|NCT00717366|42086234|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
19636749|NCT00717366|42086233|FG000|Core Study Period (20 Weeks)|Death|0|||
19636750|NCT00717366|42086234|FG001|Core Study Period (20 Weeks)|Death|1|||
19636751|NCT00717366|42086233|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
19636752|NCT00717366|42086234|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
19636753|NCT00717366|42086233|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
19636754|NCT00717366|42086234|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
19636755|NCT00717366|42086233|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
19636756|NCT00717366|42086234|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
19636757|NCT00717366|42086233|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
19636758|NCT00717366|42086234|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
19636759|NCT00723606|42086253|FG000|Overall Study|Adverse Event|2|||
19636760|NCT00723606|42086254|FG001|Overall Study|Adverse Event|5|||
19544461|NCT00198822|41994034|FG001|Overall Study|Lost to Follow-up|20|||
19544462|NCT00198822|41994035|FG002|Overall Study|Lost to Follow-up|21|||
19544463|NCT01137292|41994043|FG000|Overall Study|Death|30|||
19544464|NCT01137292|41994043|FG000|Overall Study|Adverse Event|3|||
19544465|NCT01137292|41994043|FG000|Overall Study|Lack of Efficacy|13|||
19544466|NCT01137292|41994043|FG000|Overall Study|Lost to Follow-up|1|||
19636761|NCT00723606|42086253|FG000|Overall Study|Other|2|||
19636762|NCT00723606|42086254|FG001|Overall Study|Other|0|||
19636763|NCT00723606|42086253|FG000|Overall Study|Withdrawal by Subject|0|||
19636764|NCT00723606|42086254|FG001|Overall Study|Withdrawal by Subject|2|||
19636765|NCT00442351|42086262|FG000|Overall Study|Administrative|6|||
19636766|NCT00442351|42086263|FG001|Overall Study|Administrative|5|||
19636767|NCT00442351|42086262|FG000|Overall Study|Did not meet protocol eligibility|1|||
19544467|NCT01137292|41994043|FG000|Overall Study|Other|7|||
19544468|NCT00197496|41994049|FG000|Baseline to Discharge|not interested|1|||
19544469|NCT00197496|41994050|FG001|Baseline to Discharge|not interested|0|||
19544470|NCT00197496|41994049|FG000|Baseline to Discharge|MRSA|1|||
19544471|NCT00197496|41994050|FG001|Baseline to Discharge|MRSA|0|||
19544472|NCT00197496|41994049|FG000|Baseline to Discharge|Physician Decision|0|||
19544473|NCT00197496|41994050|FG001|Baseline to Discharge|Physician Decision|1|||
19544474|NCT00197496|41994049|FG000|Baseline to Discharge|Protocol Violation|0|||
19544475|NCT00197496|41994050|FG001|Baseline to Discharge|Protocol Violation|1|||
19544476|NCT00197496|41994049|FG000|Follow-up|Lost to Follow-up|2|||
19544477|NCT00197496|41994050|FG001|Follow-up|Lost to Follow-up|1|||
19544478|NCT00197145|41994058|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
19636768|NCT00442351|42086263|FG001|Overall Study|Did not meet protocol eligibility|0|||
19636769|NCT00442351|42086262|FG000|Overall Study|Other|0|||
19636770|NCT00442351|42086263|FG001|Overall Study|Other|1|||
19636771|NCT00436501|42086271|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
19544479|NCT00197145|41994059|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
19544480|NCT00197145|41994058|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
19544481|NCT00197145|41994059|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
19636772|NCT00436501|42086272|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
19636773|NCT00436501|42086271|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
19636774|NCT00436501|42086272|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
19636775|NCT00755846|42086285|FG000|Overall Study|Adverse Event|0|||
19636776|NCT00755846|42086286|FG001|Overall Study|Adverse Event|0|||
19636777|NCT00755846|42086287|FG002|Overall Study|Adverse Event|0|||
19636778|NCT00755846|42086288|FG003|Overall Study|Adverse Event|1|||
19636779|NCT00755846|42086289|FG004|Overall Study|Adverse Event|3|||
19636780|NCT00755846|42086290|FG005|Overall Study|Adverse Event|2|||
19636781|NCT00755846|42086285|FG000|Overall Study|Protocol Violation|1|||
19636782|NCT00755846|42086286|FG001|Overall Study|Protocol Violation|1|||
19636783|NCT00755846|42086287|FG002|Overall Study|Protocol Violation|1|||
19636784|NCT00755846|42086288|FG003|Overall Study|Protocol Violation|1|||
19636785|NCT00755846|42086289|FG004|Overall Study|Protocol Violation|1|||
19636786|NCT00755846|42086290|FG005|Overall Study|Protocol Violation|1|||
19636787|NCT00755846|42086285|FG000|Overall Study|Lost to Follow-up|0|||
19636788|NCT00755846|42086286|FG001|Overall Study|Lost to Follow-up|2|||
19636789|NCT00755846|42086287|FG002|Overall Study|Lost to Follow-up|1|||
19636790|NCT00755846|42086288|FG003|Overall Study|Lost to Follow-up|0|||
19636791|NCT00755846|42086289|FG004|Overall Study|Lost to Follow-up|4|||
19636792|NCT00755846|42086290|FG005|Overall Study|Lost to Follow-up|2|||
19636793|NCT00755846|42086285|FG000|Overall Study|Withdrawal by Subject|2|||
19636794|NCT00755846|42086286|FG001|Overall Study|Withdrawal by Subject|3|||
19636795|NCT00755846|42086287|FG002|Overall Study|Withdrawal by Subject|5|||
19636796|NCT00755846|42086288|FG003|Overall Study|Withdrawal by Subject|2|||
19636797|NCT00755846|42086289|FG004|Overall Study|Withdrawal by Subject|0|||
19636798|NCT00755846|42086290|FG005|Overall Study|Withdrawal by Subject|1|||
19636799|NCT00755846|42086285|FG000|Overall Study|Hyperglycemic Rescue|21|||
19636800|NCT00755846|42086286|FG001|Overall Study|Hyperglycemic Rescue|7|||
19636801|NCT00755846|42086287|FG002|Overall Study|Hyperglycemic Rescue|5|||
19636802|NCT00755846|42086288|FG003|Overall Study|Hyperglycemic Rescue|8|||
19636803|NCT00755846|42086289|FG004|Overall Study|Hyperglycemic Rescue|8|||
19636804|NCT00755846|42086290|FG005|Overall Study|Hyperglycemic Rescue|7|||
19636805|NCT00755846|42086285|FG000|Overall Study|Physician Decision|1|||
19636806|NCT00755846|42086286|FG001|Overall Study|Physician Decision|3|||
19636807|NCT00755846|42086287|FG002|Overall Study|Physician Decision|0|||
19636808|NCT00755846|42086288|FG003|Overall Study|Physician Decision|1|||
19636809|NCT00755846|42086289|FG004|Overall Study|Physician Decision|0|||
19636810|NCT00755846|42086290|FG005|Overall Study|Physician Decision|1|||
19636811|NCT00755846|42086285|FG000|Overall Study|Administrative Error|0|||
19636812|NCT00755846|42086286|FG001|Overall Study|Administrative Error|1|||
19636813|NCT00755846|42086287|FG002|Overall Study|Administrative Error|0|||
19636814|NCT00755846|42086288|FG003|Overall Study|Administrative Error|0|||
19636815|NCT00755846|42086289|FG004|Overall Study|Administrative Error|0|||
19636816|NCT00755846|42086290|FG005|Overall Study|Administrative Error|0|||
19636817|NCT00755846|42086285|FG000|Overall Study|Participant Non-compliance|0|||
19636818|NCT00755846|42086286|FG001|Overall Study|Participant Non-compliance|0|||
19636819|NCT00755846|42086287|FG002|Overall Study|Participant Non-compliance|0|||
19636820|NCT00755846|42086288|FG003|Overall Study|Participant Non-compliance|0|||
19636821|NCT00755846|42086289|FG004|Overall Study|Participant Non-compliance|1|||
19636822|NCT00755846|42086290|FG005|Overall Study|Participant Non-compliance|0|||
19636823|NCT03850093|42086307|FG000|Overall Study|Withdrawal by Subject|1|||
19544482|NCT00197145|41994058|FG000|Period 1: Randomized Treatment Phase|Other|2|||
19544483|NCT00197145|41994059|FG001|Period 1: Randomized Treatment Phase|Other|2|||
19544484|NCT00197145|41994058|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
19544485|NCT00197145|41994059|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
19544486|NCT00197145|41994058|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
19544487|NCT00197145|41994059|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
19544488|NCT00197145|41994058|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
19544489|NCT00197145|41994059|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
19544490|NCT00197145|41994058|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
19544491|NCT00197145|41994059|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
19544492|NCT00197145|41994058|FG000|Period 2 : Open Label Phase|Other|1|||
19544493|NCT00197145|41994059|FG001|Period 2 : Open Label Phase|Other|0|||
19544494|NCT01136785|41994068|FG000|Overall Study|Protocol Violation|2|||
19636824|NCT03850093|42086308|FG001|Overall Study|Withdrawal by Subject|0|||
19636825|NCT03850093|42086309|FG002|Overall Study|Withdrawal by Subject|2|||
19636826|NCT00442117|42086319|FG000|Overall Study|Adverse Event|3|||
19636827|NCT00442117|42086320|FG001|Overall Study|Adverse Event|2|||
19636828|NCT00442117|42086319|FG000|Overall Study|Lack of Efficacy|2|||
19636829|NCT00442117|42086320|FG001|Overall Study|Lack of Efficacy|6|||
19636830|NCT00442117|42086319|FG000|Overall Study|Lost to Follow-up|1|||
19636831|NCT00442117|42086320|FG001|Overall Study|Lost to Follow-up|2|||
19544495|NCT01136785|41994069|FG001|Overall Study|Protocol Violation|1|||
19544496|NCT00197106|41994081|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
19544497|NCT00197106|41994082|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
19544498|NCT00197106|41994083|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
19544499|NCT00197106|41994081|FG000|Overall Treatment Period|Lack of Efficacy|0|||
19544500|NCT00197106|41994082|FG001|Overall Treatment Period|Lack of Efficacy|1|||
19544501|NCT00197106|41994083|FG002|Overall Treatment Period|Lack of Efficacy|0|||
19544502|NCT00197106|41994081|FG000|Overall Treatment Period|Lost to Follow-up|0|||
19544503|NCT00197106|41994082|FG001|Overall Treatment Period|Lost to Follow-up|0|||
19544504|NCT00197106|41994083|FG002|Overall Treatment Period|Lost to Follow-up|2|||
19544505|NCT00197106|41994081|FG000|Overall Treatment Period|Protocol Violation|0|||
19544506|NCT00197106|41994082|FG001|Overall Treatment Period|Protocol Violation|0|||
19636832|NCT00442117|42086319|FG000|Overall Study|Withdrawal by Subject|2|||
19636833|NCT00442117|42086320|FG001|Overall Study|Withdrawal by Subject|2|||
19636834|NCT00442117|42086319|FG000|Overall Study|Major Deviation|25|||
19636835|NCT00442117|42086320|FG001|Overall Study|Major Deviation|20|||
19636836|NCT00442117|42086319|FG000|Overall Study|Non compliance with protocol|3|||
19636837|NCT00442117|42086320|FG001|Overall Study|Non compliance with protocol|5|||
19636838|NCT00442117|42086319|FG000|Overall Study|Met Withdrawal Criteria|2|||
19636839|NCT00442117|42086320|FG001|Overall Study|Met Withdrawal Criteria|1|||
19636840|NCT00752726|42086328|FG000|Overall Study|Lost to Follow-up|2|||
19636841|NCT00752726|42086329|FG001|Overall Study|Lost to Follow-up|1|||
19636842|NCT00752726|42086328|FG000|Overall Study|Adverse Event|3|||
19636843|NCT00752726|42086329|FG001|Overall Study|Adverse Event|0|||
19636844|NCT00752726|42086328|FG000|Overall Study|Withdrawal by Subject|5|||
19636845|NCT00752726|42086329|FG001|Overall Study|Withdrawal by Subject|10|||
19636846|NCT00752726|42086328|FG000|Overall Study|Other Reason|1|||
19636847|NCT00752726|42086329|FG001|Overall Study|Other Reason|2|||
19636848|NCT00755222|42086337|FG000|Overall Study|Withdrawal by Subject|4|||
19636849|NCT00755222|42086338|FG001|Overall Study|Withdrawal by Subject|2|||
19636850|NCT00755222|42086337|FG000|Overall Study|Adverse Event|2|||
19636851|NCT00755222|42086338|FG001|Overall Study|Adverse Event|0|||
19636852|NCT00755222|42086337|FG000|Overall Study|Protocol Violation|2|||
19636853|NCT00755222|42086338|FG001|Overall Study|Protocol Violation|0|||
19636854|NCT00441727|42086347|FG000|Overall Study|Protocol Violation|19|||
19636855|NCT00441727|42086348|FG001|Overall Study|Protocol Violation|28|||
19636856|NCT00441727|42086349|FG002|Overall Study|Protocol Violation|32|||
19636857|NCT00441727|42086347|FG000|Overall Study|Adverse Event|26|||
19636858|NCT00441727|42086348|FG001|Overall Study|Adverse Event|33|||
19636859|NCT00441727|42086349|FG002|Overall Study|Adverse Event|28|||
19636860|NCT00441727|42086347|FG000|Overall Study|Lack of Efficacy|7|||
19636861|NCT00441727|42086348|FG001|Overall Study|Lack of Efficacy|8|||
19636862|NCT00441727|42086349|FG002|Overall Study|Lack of Efficacy|48|||
19636863|NCT00441727|42086347|FG000|Overall Study|Withdrawal by Subject|40|||
19636864|NCT00441727|42086348|FG001|Overall Study|Withdrawal by Subject|34|||
19636865|NCT00441727|42086349|FG002|Overall Study|Withdrawal by Subject|47|||
19636866|NCT00441727|42086347|FG000|Overall Study|Lost to Follow-up|5|||
19636867|NCT00441727|42086348|FG001|Overall Study|Lost to Follow-up|6|||
19636868|NCT00441727|42086349|FG002|Overall Study|Lost to Follow-up|5|||
19636869|NCT00441727|42086347|FG000|Overall Study|Safety Reasons|3|||
19636870|NCT00441727|42086348|FG001|Overall Study|Safety Reasons|1|||
19636871|NCT00441727|42086349|FG002|Overall Study|Safety Reasons|3|||
19636872|NCT00441727|42086347|FG000|Overall Study|Various reason specified|6|||
19636873|NCT00441727|42086348|FG001|Overall Study|Various reason specified|8|||
19636874|NCT00441727|42086349|FG002|Overall Study|Various reason specified|5|||
19636875|NCT00770120|42086371|FG000|Overall Study|Progression|31|||
19636876|NCT00770120|42086371|FG000|Overall Study|Adverse Event|11|||
19636877|NCT00770120|42086371|FG000|Overall Study|Not Protocol Specified|11|||
19636878|NCT00770120|42086371|FG000|Overall Study|Death|3|||
19636879|NCT00770120|42086371|FG000|Overall Study|Withdrawal by Subject|2|||
19636880|NCT00770120|42086371|FG000|Overall Study|Ineligible|1|||
19636881|NCT00770120|42086371|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
19636882|NCT00770120|42086371|FG000|Overall Study|Reason under Review|1|||
19636883|NCT00436345|42086378|FG000|Overall Study|ICU resident beyond follow-up period|3|||
19636884|NCT00436345|42086379|FG001|Overall Study|ICU resident beyond follow-up period|0|||
19636885|NCT00769184|42086386|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
19636886|NCT00769184|42086387|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
19636887|NCT00769184|42086386|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
19636888|NCT00769184|42086387|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
19544507|NCT00197106|41994083|FG002|Overall Treatment Period|Protocol Violation|2|||
19636889|NCT00769184|42086386|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
19636890|NCT00769184|42086387|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
19636891|NCT00768560|42086401|FG000|Intervention Set 1|Adverse Event|0|||
19636892|NCT00768560|42086402|FG001|Intervention Set 1|Adverse Event|1|||
19636893|NCT00768560|42086403|FG002|Intervention Set 1|Adverse Event|0|||
19636894|NCT00768560|42086404|FG003|Intervention Set 1|Adverse Event|0|||
19636895|NCT00768560|42086405|FG004|Intervention Set 1|Adverse Event|0|||
19636896|NCT00768560|42086406|FG005|Intervention Set 1|Adverse Event|0|||
19636897|NCT00468559|42086416|FG000|Open-label Treatment Phase|Adverse Event|5|||
19636898|NCT00468559|42086417|FG001|Open-label Treatment Phase|Adverse Event|0|||
19544508|NCT00197106|41994081|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
19544509|NCT00197106|41994082|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
19544510|NCT00197106|41994083|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
19544511|NCT01136746|41994091|FG000|Overall Study|Lost to Follow-up|0|||
19636899|NCT00468559|42086418|FG002|Open-label Treatment Phase|Adverse Event|0|||
19636900|NCT00468559|42086416|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
19636901|NCT00468559|42086417|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
19636902|NCT00468559|42086418|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
19636903|NCT00468559|42086416|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
19636904|NCT00468559|42086417|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
19636905|NCT00468559|42086418|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
19636906|NCT00468559|42086416|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
19636907|NCT00468559|42086417|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
19636908|NCT00468559|42086418|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
19636909|NCT00468559|42086416|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
19636910|NCT00468559|42086417|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
19636911|NCT00468559|42086418|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
19636912|NCT00754442|42086428|FG000|Overall Study|Withdrawal by Subject|5|||
19636913|NCT00754442|42086429|FG001|Overall Study|Withdrawal by Subject|3|||
19636914|NCT00754052|42086438|FG000|Overall Study|Study terminated by Sponsor|5|||
19636915|NCT00754052|42086439|FG001|Overall Study|Study terminated by Sponsor|3|||
19636916|NCT00753896|42086445|FG000|Overall Study|Adverse Event|4|||
19636917|NCT00753896|42086445|FG000|Overall Study|Death|1|||
19636918|NCT00753896|42086445|FG000|Overall Study|Lost to Follow-up|2|||
19636919|NCT00753896|42086445|FG000|Overall Study|Protocol Violation|1|||
19636920|NCT00753896|42086445|FG000|Overall Study|Withdrawal by Subject|4|||
19636921|NCT00753896|42086445|FG000|Overall Study|Entry Criteria Not Met|4|||
19544512|NCT01136746|41994092|FG001|Overall Study|Lost to Follow-up|2|||
19544513|NCT01136746|41994091|FG000|Overall Study|Protocol Violation|2|||
19544514|NCT01136746|41994092|FG001|Overall Study|Protocol Violation|1|||
19544515|NCT01136746|41994091|FG000|Overall Study|Death|1|||
19544516|NCT01136746|41994092|FG001|Overall Study|Death|0|||
19544517|NCT01136356|41994098|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
19544518|NCT01136356|41994099|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
19544519|NCT01136356|41994098|FG000|First 18-day Withdrawal|Physician Decision|1|||
19544520|NCT01136356|41994099|FG001|First 18-day Withdrawal|Physician Decision|0|||
19544521|NCT01136356|41994098|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
19544522|NCT01136356|41994099|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
19544523|NCT00196326|41994104|FG000|Overall Study|Did not meet protocol requirements|64|||
19544524|NCT00196326|41994104|FG000|Overall Study|Non-compliance with the protocol|81|||
19636922|NCT00747812|42086451|FG000|Overall Study|Research Site Staff Relocation|5|||
19636923|NCT00747812|42086452|FG001|Overall Study|Research Site Staff Relocation|3|||
19636924|NCT02927067|42086460|FG000|Overall Study|Withdrawn Consent|20|||
19636925|NCT02927067|42086461|FG001|Overall Study|Withdrawn Consent|12|||
19636926|NCT02927067|42086460|FG000|Overall Study|Death|18|||
19636927|NCT02927067|42086461|FG001|Overall Study|Death|31|||
19636928|NCT02927067|42086460|FG000|Overall Study|Adverse Event|13|||
19636929|NCT02927067|42086461|FG001|Overall Study|Adverse Event|10|||
19636930|NCT02927067|42086460|FG000|Overall Study|Noncompliance|5|||
19636931|NCT02927067|42086461|FG001|Overall Study|Noncompliance|2|||
19636932|NCT02927067|42086460|FG000|Overall Study|Reason not Specified|4|||
19636933|NCT02927067|42086461|FG001|Overall Study|Reason not Specified|6|||
19636934|NCT01771107|42086471|FG000|Overall Study|Adverse Event|1|||
19636935|NCT01771107|42086472|FG001|Overall Study|Adverse Event|3|||
19636936|NCT01771107|42086471|FG000|Overall Study|Withdrawal by Subject|0|||
19636937|NCT01771107|42086472|FG001|Overall Study|Withdrawal by Subject|2|||
19636938|NCT01771107|42086471|FG000|Overall Study|Lost to Follow-up|0|||
19636939|NCT01771107|42086472|FG001|Overall Study|Lost to Follow-up|1|||
19636940|NCT01771107|42086471|FG000|Overall Study|participant moved|0|||
19636941|NCT01771107|42086472|FG001|Overall Study|participant moved|1|||
19636942|NCT01771107|42086471|FG000|Overall Study|Other|0|||
19636943|NCT01771107|42086472|FG001|Overall Study|Other|1|||
19636944|NCT01751685|42086482|FG000|6-mo Followup|Missed study visit|1|||
19544525|NCT00196326|41994104|FG000|Overall Study|Physician Decision|3|||
19544526|NCT00196326|41994104|FG000|Overall Study|Withdrawal by Subject|225|||
19636945|NCT01751685|42086483|FG001|6-mo Followup|Missed study visit|0|||
19636946|NCT01751685|42086482|FG000|6-mo Followup|Withdrawal by Subject|2|||
19636947|NCT01751685|42086483|FG001|6-mo Followup|Withdrawal by Subject|2|||
19636948|NCT01751685|42086482|FG000|6-mo Followup|Lost to Follow-up|0|||
19636949|NCT01751685|42086483|FG001|6-mo Followup|Lost to Follow-up|1|||
19636950|NCT01751685|42086482|FG000|12-mo Followup|Lost to Follow-up|5|||
19636951|NCT01751685|42086483|FG001|12-mo Followup|Lost to Follow-up|0|||
19636952|NCT00586508|42086491|FG000|Overall Study|Progressive disease|52|||
19636953|NCT00586508|42086492|FG001|Overall Study|Progressive disease|8|||
19636954|NCT00586508|42086491|FG000|Overall Study|Death|0|||
19636955|NCT00586508|42086492|FG001|Overall Study|Death|1|||
19636956|NCT00586508|42086491|FG000|Overall Study|Adverse Event|12|||
19636957|NCT00586508|42086492|FG001|Overall Study|Adverse Event|4|||
19636958|NCT00586508|42086491|FG000|Overall Study|Withdrawal by Subject|4|||
19712146|NCT00103857|42155104|FG003|54-Week Base Study|Pregnancy|0|||
19712147|NCT00103857|42155105|FG004|54-Week Base Study|Pregnancy|1|||
19712148|NCT00103857|42155106|FG005|54-Week Base Study|Pregnancy|0|||
19458371|NCT01751906|41712152|FG000|Overall Study|Withdrawal by Subject|22|||
19458372|NCT01751906|41712153|FG001|Overall Study|Withdrawal by Subject|18|||
19458373|NCT01751906|41712152|FG000|Overall Study|Physician Decision|5|||
19458374|NCT01751906|41712153|FG001|Overall Study|Physician Decision|2|||
19458375|NCT01751906|41712152|FG000|Overall Study|Death|84|||
19458376|NCT01751906|41712153|FG001|Overall Study|Death|43|||
19458377|NCT01751906|41712152|FG000|Overall Study|Denied on premises for follow-up by law|1|||
19458378|NCT01751906|41712153|FG001|Overall Study|Denied on premises for follow-up by law|0|||
19458379|NCT01402947|41712161|FG000|First Intervention|Adverse Event|0|||
19458380|NCT01402947|41712162|FG001|First Intervention|Adverse Event|1|||
19458381|NCT01402869|41712171|FG000|Overall Study|Required Tooth Extraction|0|||
19458382|NCT01402869|41712172|FG001|Overall Study|Required Tooth Extraction|0|||
19458383|NCT01402869|41712173|FG002|Overall Study|Required Tooth Extraction|1|||
19458384|NCT01391793|41712183|FG000|Overall Study|Ineligible|3|||
19458385|NCT01391793|41712184|FG001|Overall Study|Ineligible|0|||
19458386|NCT01391793|41712183|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
19458387|NCT01391793|41712184|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
19458388|NCT01391793|41712183|FG000|Overall Study|No DMSA|73|||
19458389|NCT01391793|41712184|FG001|Overall Study|No DMSA|57|||
19458390|NCT01422915|41712190|FG000|Overall Study|Adverse Event|1|||
19458391|NCT01727024|41712195|FG000|Period 1|Lost to Follow-up|1|||
19458392|NCT01727024|41712196|FG001|Period 1|Lost to Follow-up|1|||
19458393|NCT01727024|41712195|FG000|Period 1|Withdrawal by Subject|2|||
19458394|NCT01727024|41712196|FG001|Period 1|Withdrawal by Subject|3|||
19458395|NCT01422213|41712205|FG000|Overall Study|Adverse Event|8|||
19458396|NCT01422213|41712206|FG001|Overall Study|Adverse Event|7|||
19458397|NCT01422213|41712207|FG002|Overall Study|Adverse Event|11|||
19458398|NCT01422213|41712205|FG000|Overall Study|Lack of Efficacy|10|||
19458399|NCT01422213|41712206|FG001|Overall Study|Lack of Efficacy|2|||
19458400|NCT01422213|41712207|FG002|Overall Study|Lack of Efficacy|2|||
19458401|NCT01422213|41712205|FG000|Overall Study|Non-compliance with study drug|0|||
19458402|NCT01422213|41712206|FG001|Overall Study|Non-compliance with study drug|1|||
19458403|NCT01422213|41712207|FG002|Overall Study|Non-compliance with study drug|0|||
19458404|NCT01422213|41712205|FG000|Overall Study|Protocol Violation|0|||
19712149|NCT00103857|42155107|FG006|54-Week Base Study|Pregnancy|1|||
19712150|NCT00103857|42155101|FG000|54-Week Base Study|Protocol Violation|6|||
19712151|NCT00103857|42155102|FG001|54-Week Base Study|Protocol Violation|4|||
19712152|NCT00103857|42155103|FG002|54-Week Base Study|Protocol Violation|2|||
19712153|NCT00103857|42155104|FG003|54-Week Base Study|Protocol Violation|4|||
19712154|NCT00103857|42155105|FG004|54-Week Base Study|Protocol Violation|0|||
19712155|NCT00103857|42155106|FG005|54-Week Base Study|Protocol Violation|3|||
19712156|NCT00103857|42155107|FG006|54-Week Base Study|Protocol Violation|3|||
19712157|NCT00103857|42155101|FG000|54-Week Base Study|Withdrawal by Subject|17|||
19712158|NCT00103857|42155102|FG001|54-Week Base Study|Withdrawal by Subject|16|||
19712159|NCT00103857|42155103|FG002|54-Week Base Study|Withdrawal by Subject|16|||
19712160|NCT00103857|42155104|FG003|54-Week Base Study|Withdrawal by Subject|15|||
19712161|NCT00103857|42155105|FG004|54-Week Base Study|Withdrawal by Subject|10|||
19712162|NCT00103857|42155106|FG005|54-Week Base Study|Withdrawal by Subject|15|||
19712163|NCT00103857|42155107|FG006|54-Week Base Study|Withdrawal by Subject|4|||
19712164|NCT00103857|42155101|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
19458405|NCT01422213|41712206|FG001|Overall Study|Protocol Violation|2|||
19458406|NCT01422213|41712207|FG002|Overall Study|Protocol Violation|4|||
19458407|NCT01422213|41712205|FG000|Overall Study|Withdrawal of Consent|7|||
19458408|NCT01422213|41712206|FG001|Overall Study|Withdrawal of Consent|3|||
19458409|NCT01422213|41712207|FG002|Overall Study|Withdrawal of Consent|5|||
19458410|NCT01422213|41712205|FG000|Overall Study|Lost to Follow-up|3|||
19458411|NCT01422213|41712206|FG001|Overall Study|Lost to Follow-up|3|||
19458412|NCT01422213|41712207|FG002|Overall Study|Lost to Follow-up|5|||
19458413|NCT01422213|41712205|FG000|Overall Study|Administrative or Other Reason(s)|5|||
19712165|NCT00103857|42155102|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
19458414|NCT01422213|41712206|FG001|Overall Study|Administrative or Other Reason(s)|4|||
19458415|NCT01422213|41712207|FG002|Overall Study|Administrative or Other Reason(s)|2|||
19636959|NCT00586508|42086492|FG001|Overall Study|Withdrawal by Subject|0|||
19636960|NCT00581919|42086498|FG000|Overall Study|Adverse Event|8|||
19636961|NCT00581919|42086498|FG000|Overall Study|Death|1|||
19712166|NCT00103857|42155103|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
19636962|NCT00581919|42086498|FG000|Overall Study|Disease Progression|10|||
19544527|NCT00196326|41994104|FG000|Overall Study|Adverse Event|253|||
19544528|NCT00196326|41994104|FG000|Overall Study|Pregnancy|34|||
19636963|NCT00581919|42086498|FG000|Overall Study|Physician Decision|1|||
19636964|NCT00581919|42086498|FG000|Overall Study|Other Complicating Disease|1|||
19636965|NCT00581919|42086498|FG000|Overall Study|Started Non-Protocol Therapy|2|||
19636966|NCT00581919|42086498|FG000|Overall Study|Withdrawal by Subject|1|||
19636967|NCT00723528|42086506|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636968|NCT00723528|42086507|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636969|NCT00723528|42086508|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
19636970|NCT00723528|42086509|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636971|NCT00723528|42086510|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636972|NCT00723528|42086511|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636973|NCT00723528|42086512|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
19636974|NCT00723528|42086506|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
19636975|NCT00723528|42086507|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636976|NCT00723528|42086508|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636977|NCT00723528|42086509|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636978|NCT00723528|42086510|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636979|NCT00723528|42086511|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636980|NCT00723528|42086512|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
19636981|NCT00723528|42086506|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636982|NCT00723528|42086507|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636983|NCT00723528|42086508|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
19636984|NCT00723528|42086509|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636985|NCT00723528|42086510|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636986|NCT00723528|42086511|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636987|NCT00723528|42086512|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
19636988|NCT00723528|42086506|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636989|NCT00723528|42086507|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636990|NCT00723528|42086508|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
19636991|NCT00723528|42086509|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636992|NCT00723528|42086510|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636993|NCT00723528|42086511|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636994|NCT00723528|42086512|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
19636995|NCT00723528|42086506|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
19636996|NCT00723528|42086507|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
19636997|NCT00723528|42086508|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
19636998|NCT00723528|42086509|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
19636999|NCT00723528|42086510|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
19637000|NCT00723528|42086511|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
19637001|NCT00723528|42086512|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
19637002|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
19637003|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
19637004|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
19637005|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
19637006|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
19637007|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
19637008|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
19637009|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19637010|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19637011|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19637012|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19637013|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19637014|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
19544529|NCT00196326|41994104|FG000|Overall Study|Lost to Follow-up|304|||
19544530|NCT00196326|41994104|FG000|Overall Study|Other|22|||
19544531|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
19544532|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
19544533|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
19544534|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Death|0|||
19544535|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Death|2|||
19544536|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Death|0|||
19544537|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
19544538|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
19637015|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
19544539|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
19544540|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
19544541|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
19637016|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Other|0|||
19637017|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Other|0|||
19637018|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Other|0|||
19637019|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Other|0|||
19637020|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Other|1|||
19637021|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Other|4|||
19637022|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Other|0|||
19637023|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Adverse Event|0|||
19637024|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Adverse Event|0|||
19637025|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Adverse Event|0|||
19637026|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Adverse Event|0|||
19637027|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Adverse Event|1|||
19637028|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Adverse Event|0|||
19637029|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Adverse Event|1|||
19637030|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637031|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637032|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637033|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637034|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637035|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
19637036|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
19637037|NCT00723528|42086506|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637038|NCT00723528|42086507|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637039|NCT00723528|42086508|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637040|NCT00723528|42086509|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637041|NCT00723528|42086510|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637042|NCT00723528|42086511|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
19637043|NCT00723528|42086512|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
19637044|NCT00751790|42086528|FG000|Overall Study|Lost to Follow-up|1|||
19637045|NCT00751790|42086528|FG000|Overall Study|Death|3|||
19637046|NCT00751790|42086528|FG000|Overall Study|Withdrawal by Subject|1|||
19637047|NCT00723450|42086534|FG000|Open-Label Phase|Adverse Event|26|||
19637048|NCT00723450|42086535|FG001|Open-Label Phase|Adverse Event|0|||
19637049|NCT00723450|42086536|FG002|Open-Label Phase|Adverse Event|0|||
19637050|NCT00723450|42086534|FG000|Open-Label Phase|Lack of Efficacy|18|||
19637051|NCT00723450|42086535|FG001|Open-Label Phase|Lack of Efficacy|0|||
19637052|NCT00723450|42086536|FG002|Open-Label Phase|Lack of Efficacy|0|||
19637053|NCT00723450|42086534|FG000|Open-Label Phase|Protocol Violation|35|||
19637054|NCT00723450|42086535|FG001|Open-Label Phase|Protocol Violation|0|||
19637055|NCT00723450|42086536|FG002|Open-Label Phase|Protocol Violation|0|||
19637056|NCT00723450|42086534|FG000|Open-Label Phase|Lost to Follow-up|7|||
19637057|NCT00723450|42086535|FG001|Open-Label Phase|Lost to Follow-up|0|||
19637058|NCT00723450|42086536|FG002|Open-Label Phase|Lost to Follow-up|0|||
19637059|NCT00723450|42086534|FG000|Open-Label Phase|Physician Decision|2|||
19637060|NCT00723450|42086535|FG001|Open-Label Phase|Physician Decision|0|||
19637061|NCT00723450|42086536|FG002|Open-Label Phase|Physician Decision|0|||
19637062|NCT00723450|42086534|FG000|Open-Label Phase|Withdrawal by Subject|37|||
19637063|NCT00723450|42086535|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19637064|NCT00723450|42086536|FG002|Open-Label Phase|Withdrawal by Subject|0|||
19637065|NCT00723450|42086534|FG000|Randomized Phase|Adverse Event|0|||
19637066|NCT00723450|42086535|FG001|Randomized Phase|Adverse Event|26|||
19637067|NCT00723450|42086536|FG002|Randomized Phase|Adverse Event|17|||
19637068|NCT00723450|42086534|FG000|Randomized Phase|Lack of Efficacy|0|||
19544542|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
19544543|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
19544544|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
19544545|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
19544546|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
19544547|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
19544548|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
19637069|NCT00723450|42086535|FG001|Randomized Phase|Lack of Efficacy|11|||
19637070|NCT00723450|42086536|FG002|Randomized Phase|Lack of Efficacy|11|||
19637071|NCT00723450|42086534|FG000|Randomized Phase|Protocol Violation|0|||
19637072|NCT00723450|42086535|FG001|Randomized Phase|Protocol Violation|9|||
19637073|NCT00723450|42086536|FG002|Randomized Phase|Protocol Violation|13|||
19637074|NCT00723450|42086534|FG000|Randomized Phase|Lost to Follow-up|0|||
19637075|NCT00723450|42086535|FG001|Randomized Phase|Lost to Follow-up|2|||
19637076|NCT00723450|42086536|FG002|Randomized Phase|Lost to Follow-up|3|||
19637077|NCT00723450|42086534|FG000|Randomized Phase|Physician Decision|0|||
19637078|NCT00723450|42086535|FG001|Randomized Phase|Physician Decision|3|||
19637079|NCT00723450|42086536|FG002|Randomized Phase|Physician Decision|1|||
19637080|NCT00723450|42086534|FG000|Randomized Phase|Withdrawal by Subject|0|||
19637081|NCT00723450|42086535|FG001|Randomized Phase|Withdrawal by Subject|14|||
19637082|NCT00723450|42086536|FG002|Randomized Phase|Withdrawal by Subject|22|||
19637083|NCT00751400|42086545|FG000|Overall Study|Lost to Follow-up|10|||
19544549|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
19544550|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
19544551|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
19544552|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Recovery|1|||
19544553|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Recovery|0|||
19544554|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Recovery|1|||
19637084|NCT00585312|42086551|FG000|Overall Study|Adverse Event|3|||
19637085|NCT00585312|42086552|FG001|Overall Study|Adverse Event|0|||
19637086|NCT00585312|42086551|FG000|Overall Study|Lack of Efficacy|6|||
19637087|NCT00585312|42086552|FG001|Overall Study|Lack of Efficacy|11|||
19637088|NCT00585312|42086551|FG000|Overall Study|Lost to Follow-up|1|||
19637089|NCT00585312|42086552|FG001|Overall Study|Lost to Follow-up|1|||
19637090|NCT00585312|42086551|FG000|Overall Study|Reason not specified|2|||
19637091|NCT00585312|42086552|FG001|Overall Study|Reason not specified|0|||
19637092|NCT00585312|42086551|FG000|Overall Study|Withdrawal by Subject|5|||
19637093|NCT00585312|42086552|FG001|Overall Study|Withdrawal by Subject|1|||
19637094|NCT00585312|42086551|FG000|Overall Study|Study terminated by the sponsor|34|||
19637095|NCT00585312|42086552|FG001|Overall Study|Study terminated by the sponsor|31|||
19637096|NCT00753506|42086560|FG000|Overall Study|Withdrawal by Subject|4|||
19637097|NCT00753506|42086561|FG001|Overall Study|Withdrawal by Subject|1|||
19637098|NCT00753506|42086560|FG000|Overall Study|Lost to Follow-up|2|||
19637099|NCT00753506|42086561|FG001|Overall Study|Lost to Follow-up|0|||
19637100|NCT00753506|42086560|FG000|Overall Study|Other reason|1|||
19637101|NCT00753506|42086561|FG001|Overall Study|Other reason|1|||
19637102|NCT00720096|42086569|FG000|Overall Study|Withdrawal by Subject|0|||
19637103|NCT00720096|42086570|FG001|Overall Study|Withdrawal by Subject|2|||
19637104|NCT00723294|42086576|FG000|Overall Study|Lobular histology|2|||
19637105|NCT00723294|42086576|FG000|Overall Study|>25% intraductal component|1|||
19544555|NCT00195663|41994111|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
19544556|NCT00195663|41994112|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
19544557|NCT00195663|41994113|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
19544558|NCT00195663|41994111|FG000|Open-Label Extension Period|Adverse Event|21|||
19544559|NCT00195663|41994112|FG001|Open-Label Extension Period|Adverse Event|32|||
19544560|NCT00195663|41994113|FG002|Open-Label Extension Period|Adverse Event|36|||
19544561|NCT00195663|41994111|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
19544562|NCT00195663|41994112|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
19544563|NCT00195663|41994113|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
19544564|NCT00195663|41994111|FG000|Open-Label Extension Period|Recovery|0|||
19544565|NCT00195663|41994112|FG001|Open-Label Extension Period|Recovery|2|||
19544566|NCT00195663|41994113|FG002|Open-Label Extension Period|Recovery|2|||
19544567|NCT00195663|41994111|FG000|Open-Label Extension Period|Protocol Violation|3|||
19544568|NCT00195663|41994112|FG001|Open-Label Extension Period|Protocol Violation|4|||
19544569|NCT00195663|41994113|FG002|Open-Label Extension Period|Protocol Violation|4|||
19637106|NCT00723294|42086576|FG000|Overall Study|No MRI tumor enhancement|1|||
19637107|NCT00723294|42086576|FG000|Overall Study|1.0-Tesla MRI|1|||
19637108|NCT00723294|42086576|FG000|Overall Study|No cryoabalation|2|||
19637109|NCT00723294|42086576|FG000|Overall Study|Did not undergo surgery|1|||
19712167|NCT00103857|42155104|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
19712168|NCT00103857|42155105|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
19712169|NCT00103857|42155106|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
19712170|NCT00103857|42155107|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
19712171|NCT00103857|42155101|FG000|54-Week Base Study|patient moved|0|||
19712172|NCT00103857|42155102|FG001|54-Week Base Study|patient moved|1|||
19712173|NCT00103857|42155103|FG002|54-Week Base Study|patient moved|1|||
19712174|NCT00103857|42155104|FG003|54-Week Base Study|patient moved|2|||
19712175|NCT00103857|42155105|FG004|54-Week Base Study|patient moved|3|||
19712176|NCT00103857|42155106|FG005|54-Week Base Study|patient moved|1|||
19544570|NCT00195663|41994111|FG000|Open-Label Extension Period|Death|2|||
19637110|NCT00723294|42086576|FG000|Overall Study|Treated prior to registration|1|||
19637111|NCT00723294|42086576|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
19637112|NCT00723294|42086576|FG000|Overall Study|Benign lesion|1|||
19637113|NCT00723294|42086576|FG000|Overall Study|Withdrawal by Subject|1|||
19637114|NCT00723294|42086576|FG000|Overall Study|No treatment due to probe failure|1|||
19637115|NCT00747344|42086582|FG000|Controlled Period|Adverse Event|3|||
19712177|NCT00103857|42155107|FG006|54-Week Base Study|patient moved|0|||
19637116|NCT00747344|42086583|FG001|Controlled Period|Adverse Event|0|||
19637117|NCT00747344|42086584|FG002|Controlled Period|Adverse Event|0|||
19637118|NCT00747344|42086585|FG003|Controlled Period|Adverse Event|0|||
19637119|NCT00747344|42086582|FG000|Controlled Period|Lack of Efficacy|2|||
19637120|NCT00747344|42086583|FG001|Controlled Period|Lack of Efficacy|1|||
19637121|NCT00747344|42086584|FG002|Controlled Period|Lack of Efficacy|0|||
19637122|NCT00747344|42086585|FG003|Controlled Period|Lack of Efficacy|0|||
19637123|NCT00747344|42086582|FG000|Controlled Period|Other|0|||
19637124|NCT00747344|42086583|FG001|Controlled Period|Other|3|||
19637125|NCT00747344|42086584|FG002|Controlled Period|Other|0|||
19637126|NCT00747344|42086585|FG003|Controlled Period|Other|0|||
19637127|NCT00747344|42086582|FG000|After Controlled Period|Adverse Event|0|||
19637128|NCT00747344|42086583|FG001|After Controlled Period|Adverse Event|0|||
19637129|NCT00747344|42086584|FG002|After Controlled Period|Adverse Event|0|||
19637130|NCT00747344|42086585|FG003|After Controlled Period|Adverse Event|1|||
19637131|NCT00580983|42086593|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
19637132|NCT00716976|42086599|FG000|Overall Study|Adverse Event|2|||
19544571|NCT00195663|41994112|FG001|Open-Label Extension Period|Death|2|||
19544572|NCT00195663|41994113|FG002|Open-Label Extension Period|Death|2|||
19544573|NCT00195663|41994111|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
19544574|NCT00195663|41994112|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
19544575|NCT00195663|41994113|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
19544576|NCT00195663|41994111|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
19544577|NCT00195663|41994112|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
19544578|NCT00195663|41994113|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
19544579|NCT00195663|41994111|FG000|Open-Label Extension Period|Administrative reasons|11|||
19544580|NCT00195663|41994112|FG001|Open-Label Extension Period|Administrative reasons|11|||
19544581|NCT00195663|41994113|FG002|Open-Label Extension Period|Administrative reasons|13|||
19544582|NCT01135498|41994131|FG000|Overall Study|Adverse Event|20|||
19544583|NCT01135498|41994131|FG000|Overall Study|Progressive disease|38|||
19544584|NCT01135498|41994131|FG000|Overall Study|Investigator judgement|25|||
19544585|NCT01135498|41994131|FG000|Overall Study|Withdrawal by Subject|4|||
19544586|NCT01135498|41994131|FG000|Overall Study|Death|1|||
19544587|NCT01135498|41994131|FG000|Overall Study|Ongoing at time of analysis|2|||
19544588|NCT00195507|41994138|FG000|Overall Study|Adverse Event|24|||
19544589|NCT00195507|41994139|FG001|Overall Study|Adverse Event|13|||
19544590|NCT00195507|41994138|FG000|Overall Study|Death|0|||
19544591|NCT00195507|41994139|FG001|Overall Study|Death|1|||
19544592|NCT00195507|41994138|FG000|Overall Study|Failed to Return|4|||
19544593|NCT00195507|41994139|FG001|Overall Study|Failed to Return|3|||
19544594|NCT00195507|41994138|FG000|Overall Study|Physician Decision|1|||
19544595|NCT00195507|41994139|FG001|Overall Study|Physician Decision|2|||
19544596|NCT00195507|41994138|FG000|Overall Study|Lost to Follow-up|3|||
19712178|NCT00103857|42155101|FG000|54-Week Base Study|non-compliance with study procedures|1|||
19712179|NCT00103857|42155102|FG001|54-Week Base Study|non-compliance with study procedures|2|||
19544597|NCT00195507|41994139|FG001|Overall Study|Lost to Follow-up|2|||
19544598|NCT00195507|41994138|FG000|Overall Study|Protocol Violation|5|||
19544599|NCT00195507|41994139|FG001|Overall Study|Protocol Violation|4|||
19544600|NCT00195507|41994138|FG000|Overall Study|Lack of Efficacy|40|||
19544601|NCT00195507|41994139|FG001|Overall Study|Lack of Efficacy|67|||
19544602|NCT00195507|41994138|FG000|Overall Study|Withdrawal by Subject|16|||
19544603|NCT00195507|41994139|FG001|Overall Study|Withdrawal by Subject|23|||
19544604|NCT00195507|41994138|FG000|Overall Study|Protocol Deviation|6|||
19544605|NCT00195507|41994139|FG001|Overall Study|Protocol Deviation|3|||
19544606|NCT01134562|41994150|FG000|Overall Study|Adverse Event|0|||
19544607|NCT01134562|41994151|FG001|Overall Study|Adverse Event|1|||
19544608|NCT01134562|41994152|FG002|Overall Study|Adverse Event|0|||
19544609|NCT01134562|41994153|FG003|Overall Study|Adverse Event|0|||
19544610|NCT01134562|41994154|FG004|Overall Study|Adverse Event|0|||
19544611|NCT00195429|41994181|FG000|Overall Study|Adverse Event|2|||
19544612|NCT00195429|41994182|FG001|Overall Study|Adverse Event|4|||
19544613|NCT00195429|41994181|FG000|Overall Study|Lack of Efficacy|2|||
19544614|NCT00195429|41994182|FG001|Overall Study|Lack of Efficacy|1|||
19637133|NCT00716976|42086600|FG001|Overall Study|Adverse Event|0|||
19637134|NCT00716976|42086599|FG000|Overall Study|Death|1|||
19637135|NCT00716976|42086600|FG001|Overall Study|Death|0|||
19637136|NCT00716976|42086599|FG000|Overall Study|Physician Decision|2|||
19712180|NCT00103857|42155103|FG002|54-Week Base Study|non-compliance with study procedures|0|||
19544615|NCT00195429|41994181|FG000|Overall Study|Lost to Follow-up|1|||
19544616|NCT00195429|41994182|FG001|Overall Study|Lost to Follow-up|0|||
19544617|NCT00195351|41994190|FG000|Overall Study|Lost to Follow-up|9|||
19544618|NCT00195351|41994191|FG001|Overall Study|Lost to Follow-up|9|||
19544619|NCT00195351|41994190|FG000|Overall Study|Withdrawal by Subject|6|||
19544620|NCT00195351|41994191|FG001|Overall Study|Withdrawal by Subject|3|||
19544621|NCT00195351|41994190|FG000|Overall Study|Protocol Deviation|3|||
19544622|NCT00195351|41994191|FG001|Overall Study|Protocol Deviation|2|||
19544623|NCT00195351|41994190|FG000|Overall Study|Death|3|||
19544624|NCT00195351|41994191|FG001|Overall Study|Death|1|||
19544625|NCT00195351|41994190|FG000|Overall Study|Lack of Efficacy|0|||
19544626|NCT00195351|41994191|FG001|Overall Study|Lack of Efficacy|1|||
19544627|NCT00195273|41994199|FG000|Overall Study|Adverse Event|9|||
19544628|NCT00195273|41994200|FG001|Overall Study|Adverse Event|9|||
19544629|NCT00195273|41994199|FG000|Overall Study|Protocol deviation|0|||
19544630|NCT00195273|41994200|FG001|Overall Study|Protocol deviation|1|||
19544631|NCT00195273|41994199|FG000|Overall Study|Lack of Efficacy|3|||
19544632|NCT00195273|41994200|FG001|Overall Study|Lack of Efficacy|1|||
19544633|NCT00195273|41994199|FG000|Overall Study|Procedural complications|9|||
19544634|NCT00195273|41994200|FG001|Overall Study|Procedural complications|3|||
19544635|NCT00193479|41994206|FG000|Induction Chemotherapy|Adverse Event|2|||
19544636|NCT00193479|41994206|FG000|Induction Chemotherapy|Disease Progression|1|||
19544637|NCT00193479|41994206|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
19544638|NCT00193479|41994206|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
19544639|NCT00193206|41994210|FG000|Preoperative Therapy|Lack of Efficacy|2|||
19544640|NCT00193206|41994210|FG000|Preoperative Therapy|Adverse Event|2|||
19544641|NCT00193206|41994210|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
19637137|NCT00716976|42086600|FG001|Overall Study|Physician Decision|2|||
19637138|NCT00716976|42086599|FG000|Overall Study|Withdrawal by Subject|5|||
19637139|NCT00716976|42086600|FG001|Overall Study|Withdrawal by Subject|1|||
19637140|NCT00716976|42086599|FG000|Overall Study|Premature discontinuation cisplatin|5|||
19637141|NCT00716976|42086600|FG001|Overall Study|Premature discontinuation cisplatin|4|||
19637142|NCT00716976|42086599|FG000|Overall Study|Radiation during protocol|1|||
19637143|NCT00716976|42086600|FG001|Overall Study|Radiation during protocol|0|||
19637144|NCT00716976|42086599|FG000|Overall Study|Ineligibles|4|||
19637145|NCT00716976|42086600|FG001|Overall Study|Ineligibles|2|||
19637146|NCT00743444|42086608|FG000|First Intervention|Catheter placement problems|0|||
19637147|NCT00743444|42086609|FG001|First Intervention|Catheter placement problems|1|||
19637148|NCT00743444|42086608|FG000|Washout Period|Adverse Event|0|||
19637149|NCT00743444|42086609|FG001|Washout Period|Adverse Event|1|||
19637150|NCT00743366|42086615|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
19637151|NCT00743366|42086616|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
19637152|NCT00721968|42086624|FG000|Overall Study|Lost to Follow-up|2|||
19637153|NCT00721968|42086625|FG001|Overall Study|Lost to Follow-up|0|||
19637154|NCT00743288|42086631|FG000|Overall Study|Adverse Event|1|||
19637155|NCT00743288|42086632|FG001|Overall Study|Adverse Event|1|||
19637156|NCT00743288|42086633|FG002|Overall Study|Adverse Event|2|||
19637157|NCT00743288|42086634|FG003|Overall Study|Adverse Event|2|||
19637158|NCT00743288|42086635|FG004|Overall Study|Adverse Event|1|||
19637159|NCT00743288|42086636|FG005|Overall Study|Adverse Event|1|||
19637160|NCT00743288|42086637|FG006|Overall Study|Adverse Event|2|||
19637161|NCT00743288|42086631|FG000|Overall Study|Withdrawal by Subject|0|||
19637162|NCT00743288|42086632|FG001|Overall Study|Withdrawal by Subject|0|||
19637163|NCT00743288|42086633|FG002|Overall Study|Withdrawal by Subject|1|||
19637164|NCT00743288|42086634|FG003|Overall Study|Withdrawal by Subject|0|||
19637165|NCT00743288|42086635|FG004|Overall Study|Withdrawal by Subject|0|||
19637166|NCT00743288|42086636|FG005|Overall Study|Withdrawal by Subject|1|||
19637167|NCT00743288|42086637|FG006|Overall Study|Withdrawal by Subject|1|||
19637168|NCT00743288|42086631|FG000|Overall Study|Progressive disease (PD)|2|||
19637169|NCT00743288|42086632|FG001|Overall Study|Progressive disease (PD)|0|||
19637170|NCT00743288|42086633|FG002|Overall Study|Progressive disease (PD)|1|||
19637171|NCT00743288|42086634|FG003|Overall Study|Progressive disease (PD)|4|||
19637172|NCT00743288|42086635|FG004|Overall Study|Progressive disease (PD)|5|||
19544642|NCT00193206|41994210|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
19544643|NCT00193206|41994210|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
19544644|NCT00193206|41994210|FG000|Postoperative Therapy|Physician Decision|3|||
19544645|NCT00193206|41994210|FG000|Postoperative Therapy|Intercurrent Illness|2|||
19544646|NCT00193206|41994210|FG000|Postoperative Therapy|Lack of Efficacy|1|||
19544647|NCT00193206|41994210|FG000|Postoperative Therapy|Protocol Violation|1|||
19544648|NCT00193050|41994214|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
19544649|NCT00193050|41994214|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
19544650|NCT00193050|41994214|FG000|Neoadjuvant Treatment|Physician Decision|2|||
19544651|NCT00193050|41994214|FG000|Neoadjuvant Treatment|Adverse Event|2|||
19544652|NCT00193050|41994214|FG000|Adjuvant|Physician Decision|5|||
19544653|NCT00193050|41994214|FG000|Adjuvant|Intercurrent Hospitalization|3|||
19544654|NCT00193050|41994214|FG000|Adjuvant|Lack of Efficacy|2|||
19544655|NCT00192504|41994223|FG000|Overall Study|Lost to Follow-up|1|||
19544656|NCT00192504|41994224|FG001|Overall Study|Lost to Follow-up|0|||
19637173|NCT00743288|42086636|FG005|Overall Study|Progressive disease (PD)|3|||
19544657|NCT00192504|41994225|FG002|Overall Study|Lost to Follow-up|0|||
19544658|NCT00192504|41994226|FG003|Overall Study|Lost to Follow-up|0|||
19544659|NCT00192504|41994223|FG000|Overall Study|Dosing window missed|0|||
19544660|NCT00192504|41994224|FG001|Overall Study|Dosing window missed|0|||
19637174|NCT00743288|42086637|FG006|Overall Study|Progressive disease (PD)|6|||
19637175|NCT00743288|42086631|FG000|Overall Study|Worsening of condition (Not PD)|0|||
19544661|NCT00192504|41994225|FG002|Overall Study|Dosing window missed|1|||
19637176|NCT00743288|42086632|FG001|Overall Study|Worsening of condition (Not PD)|2|||
19637177|NCT00743288|42086633|FG002|Overall Study|Worsening of condition (Not PD)|1|||
19637178|NCT00743288|42086634|FG003|Overall Study|Worsening of condition (Not PD)|1|||
19637179|NCT00743288|42086635|FG004|Overall Study|Worsening of condition (Not PD)|0|||
19637180|NCT00743288|42086636|FG005|Overall Study|Worsening of condition (Not PD)|0|||
19637181|NCT00743288|42086637|FG006|Overall Study|Worsening of condition (Not PD)|0|||
19637182|NCT00750308|42086648|FG000|First Treatment|Adverse Event|0|||
19712181|NCT00103857|42155104|FG003|54-Week Base Study|non-compliance with study procedures|0|||
19712182|NCT00103857|42155105|FG004|54-Week Base Study|non-compliance with study procedures|0|||
19712183|NCT00103857|42155106|FG005|54-Week Base Study|non-compliance with study procedures|2|||
19712184|NCT00103857|42155107|FG006|54-Week Base Study|non-compliance with study procedures|0|||
19712185|NCT00103857|42155101|FG000|54-Week Base Study|patient incarcerated|0|||
19712186|NCT00103857|42155102|FG001|54-Week Base Study|patient incarcerated|0|||
19712187|NCT00103857|42155103|FG002|54-Week Base Study|patient incarcerated|0|||
19712188|NCT00103857|42155104|FG003|54-Week Base Study|patient incarcerated|0|||
19712189|NCT00103857|42155105|FG004|54-Week Base Study|patient incarcerated|1|||
19712190|NCT00103857|42155106|FG005|54-Week Base Study|patient incarcerated|1|||
19712191|NCT00103857|42155107|FG006|54-Week Base Study|patient incarcerated|0|||
19712192|NCT00103857|42155101|FG000|54-Week Base Study|laboratory reporting error|0|||
19712193|NCT00103857|42155102|FG001|54-Week Base Study|laboratory reporting error|0|||
19712194|NCT00103857|42155103|FG002|54-Week Base Study|laboratory reporting error|0|||
19712195|NCT00103857|42155104|FG003|54-Week Base Study|laboratory reporting error|0|||
19712196|NCT00103857|42155105|FG004|54-Week Base Study|laboratory reporting error|1|||
19712197|NCT00103857|42155106|FG005|54-Week Base Study|laboratory reporting error|0|||
19712198|NCT00103857|42155107|FG006|54-Week Base Study|laboratory reporting error|0|||
19712199|NCT00103857|42155101|FG000|54-Week Base Study|site error|0|||
19712200|NCT00103857|42155102|FG001|54-Week Base Study|site error|0|||
19712201|NCT00103857|42155103|FG002|54-Week Base Study|site error|0|||
19712202|NCT00103857|42155104|FG003|54-Week Base Study|site error|0|||
19712203|NCT00103857|42155105|FG004|54-Week Base Study|site error|0|||
19712204|NCT00103857|42155106|FG005|54-Week Base Study|site error|1|||
19712205|NCT00103857|42155107|FG006|54-Week Base Study|site error|0|||
19712206|NCT00103857|42155101|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
19712207|NCT00103857|42155102|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712208|NCT00103857|42155103|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712209|NCT00103857|42155104|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712210|NCT00103857|42155105|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712211|NCT00103857|42155106|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712212|NCT00103857|42155107|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
19712213|NCT00103857|42155101|FG000|50-Week Extension Study|Adverse Event|2|||
19712214|NCT00103857|42155102|FG001|50-Week Extension Study|Adverse Event|3|||
19712215|NCT00103857|42155103|FG002|50-Week Extension Study|Adverse Event|2|||
19712216|NCT00103857|42155104|FG003|50-Week Extension Study|Adverse Event|0|||
19712217|NCT00103857|42155105|FG004|50-Week Extension Study|Adverse Event|1|||
19712218|NCT00103857|42155106|FG005|50-Week Extension Study|Adverse Event|1|||
19712219|NCT00103857|42155107|FG006|50-Week Extension Study|Adverse Event|0|||
19712220|NCT00103857|42155101|FG000|50-Week Extension Study|Death|0|||
19712221|NCT00103857|42155102|FG001|50-Week Extension Study|Death|0|||
19712222|NCT00103857|42155103|FG002|50-Week Extension Study|Death|0|||
19712223|NCT00103857|42155104|FG003|50-Week Extension Study|Death|1|||
19712224|NCT00103857|42155105|FG004|50-Week Extension Study|Death|0|||
19712225|NCT00103857|42155106|FG005|50-Week Extension Study|Death|1|||
19712226|NCT00103857|42155107|FG006|50-Week Extension Study|Death|0|||
19712227|NCT00103857|42155101|FG000|50-Week Extension Study|Lack of Efficacy|26|||
19712228|NCT00103857|42155102|FG001|50-Week Extension Study|Lack of Efficacy|15|||
19712229|NCT00103857|42155103|FG002|50-Week Extension Study|Lack of Efficacy|13|||
19712230|NCT00103857|42155104|FG003|50-Week Extension Study|Lack of Efficacy|16|||
19712231|NCT00103857|42155105|FG004|50-Week Extension Study|Lack of Efficacy|8|||
19712232|NCT00103857|42155106|FG005|50-Week Extension Study|Lack of Efficacy|8|||
19712233|NCT00103857|42155107|FG006|50-Week Extension Study|Lack of Efficacy|0|||
19712234|NCT00103857|42155101|FG000|50-Week Extension Study|Lost to Follow-up|4|||
19637183|NCT00750308|42086649|FG001|First Treatment|Adverse Event|1|||
19637184|NCT00750308|42086650|FG002|First Treatment|Adverse Event|0|||
19637185|NCT00750308|42086651|FG003|First Treatment|Adverse Event|0|||
19637186|NCT00750308|42086652|FG004|First Treatment|Adverse Event|0|||
19637187|NCT00750308|42086653|FG005|First Treatment|Adverse Event|0|||
19637188|NCT00750308|42086654|FG006|First Treatment|Adverse Event|0|||
19637189|NCT00750308|42086655|FG007|First Treatment|Adverse Event|0|||
19637190|NCT00750308|42086656|FG008|First Treatment|Adverse Event|0|||
19712235|NCT00103857|42155102|FG001|50-Week Extension Study|Lost to Follow-up|0|||
19712236|NCT00103857|42155103|FG002|50-Week Extension Study|Lost to Follow-up|1|||
19712237|NCT00103857|42155104|FG003|50-Week Extension Study|Lost to Follow-up|4|||
19637191|NCT00750308|42086657|FG009|First Treatment|Adverse Event|0|||
19637192|NCT00750308|42086658|FG010|First Treatment|Adverse Event|1|||
19637193|NCT00750308|42086659|FG011|First Treatment|Adverse Event|1|||
19637194|NCT00750308|42086648|FG000|First Treatment|Withdrawal by Subject|0|||
19637195|NCT00750308|42086649|FG001|First Treatment|Withdrawal by Subject|0|||
19637196|NCT00750308|42086650|FG002|First Treatment|Withdrawal by Subject|0|||
19637197|NCT00750308|42086651|FG003|First Treatment|Withdrawal by Subject|1|||
19637198|NCT00750308|42086652|FG004|First Treatment|Withdrawal by Subject|0|||
19637199|NCT00750308|42086653|FG005|First Treatment|Withdrawal by Subject|0|||
19637200|NCT00750308|42086654|FG006|First Treatment|Withdrawal by Subject|0|||
19637201|NCT00750308|42086655|FG007|First Treatment|Withdrawal by Subject|1|||
19637202|NCT00750308|42086656|FG008|First Treatment|Withdrawal by Subject|0|||
19637203|NCT00750308|42086657|FG009|First Treatment|Withdrawal by Subject|0|||
19637204|NCT00750308|42086658|FG010|First Treatment|Withdrawal by Subject|0|||
19637205|NCT00750308|42086659|FG011|First Treatment|Withdrawal by Subject|0|||
19637206|NCT00750308|42086648|FG000|Second Treatment|Adverse Event|0|||
19637207|NCT00750308|42086649|FG001|Second Treatment|Adverse Event|0|||
19637208|NCT00750308|42086650|FG002|Second Treatment|Adverse Event|0|||
19637209|NCT00750308|42086651|FG003|Second Treatment|Adverse Event|0|||
19637210|NCT00750308|42086652|FG004|Second Treatment|Adverse Event|0|||
19637211|NCT00750308|42086653|FG005|Second Treatment|Adverse Event|1|||
19637212|NCT00750308|42086654|FG006|Second Treatment|Adverse Event|0|||
19637213|NCT00750308|42086655|FG007|Second Treatment|Adverse Event|0|||
19637214|NCT00750308|42086656|FG008|Second Treatment|Adverse Event|1|||
19637215|NCT00750308|42086657|FG009|Second Treatment|Adverse Event|0|||
19637216|NCT00750308|42086658|FG010|Second Treatment|Adverse Event|0|||
19637217|NCT00750308|42086659|FG011|Second Treatment|Adverse Event|0|||
19637218|NCT00750308|42086648|FG000|Second Treatment|Withdrawal by Subject|0|||
19637219|NCT00750308|42086649|FG001|Second Treatment|Withdrawal by Subject|0|||
19637220|NCT00750308|42086650|FG002|Second Treatment|Withdrawal by Subject|0|||
19637221|NCT00750308|42086651|FG003|Second Treatment|Withdrawal by Subject|0|||
19637222|NCT00750308|42086652|FG004|Second Treatment|Withdrawal by Subject|1|||
19637223|NCT00750308|42086653|FG005|Second Treatment|Withdrawal by Subject|0|||
19637224|NCT00750308|42086654|FG006|Second Treatment|Withdrawal by Subject|0|||
19637225|NCT00750308|42086655|FG007|Second Treatment|Withdrawal by Subject|0|||
19637226|NCT00750308|42086656|FG008|Second Treatment|Withdrawal by Subject|0|||
19637227|NCT00750308|42086657|FG009|Second Treatment|Withdrawal by Subject|0|||
19637228|NCT00750308|42086658|FG010|Second Treatment|Withdrawal by Subject|0|||
19637229|NCT00750308|42086659|FG011|Second Treatment|Withdrawal by Subject|0|||
19637230|NCT00750308|42086648|FG000|Third Treatment|Withdrawal by Subject|0|||
19637231|NCT00750308|42086649|FG001|Third Treatment|Withdrawal by Subject|1|||
19637232|NCT00750308|42086650|FG002|Third Treatment|Withdrawal by Subject|0|||
19637233|NCT00750308|42086651|FG003|Third Treatment|Withdrawal by Subject|0|||
19637234|NCT00750308|42086652|FG004|Third Treatment|Withdrawal by Subject|0|||
19637235|NCT00750308|42086653|FG005|Third Treatment|Withdrawal by Subject|0|||
19637236|NCT00750308|42086654|FG006|Third Treatment|Withdrawal by Subject|0|||
19637237|NCT00750308|42086655|FG007|Third Treatment|Withdrawal by Subject|0|||
19637238|NCT00750308|42086656|FG008|Third Treatment|Withdrawal by Subject|0|||
19637239|NCT00750308|42086657|FG009|Third Treatment|Withdrawal by Subject|0|||
19637240|NCT00750308|42086658|FG010|Third Treatment|Withdrawal by Subject|0|||
19637241|NCT00750308|42086659|FG011|Third Treatment|Withdrawal by Subject|0|||
19637242|NCT00750152|42086675|FG000|Overall Study|Adverse Event|2|||
19637243|NCT00750152|42086676|FG001|Overall Study|Adverse Event|1|||
19637244|NCT00750152|42086675|FG000|Overall Study|Lost to Follow-up|8|||
19637245|NCT00750152|42086676|FG001|Overall Study|Lost to Follow-up|13|||
19637246|NCT00750152|42086675|FG000|Overall Study|Withdrawal by Subject|3|||
19637247|NCT00750152|42086676|FG001|Overall Study|Withdrawal by Subject|3|||
19637248|NCT00750152|42086675|FG000|Overall Study|Physician Decision|1|||
19637249|NCT00750152|42086676|FG001|Overall Study|Physician Decision|1|||
19637250|NCT00750152|42086675|FG000|Overall Study|Non-compliance|0|||
19637251|NCT00750152|42086676|FG001|Overall Study|Non-compliance|1|||
19637252|NCT00750152|42086675|FG000|Overall Study|Termination by sponsor|1|||
19637253|NCT00750152|42086676|FG001|Overall Study|Termination by sponsor|0|||
19544662|NCT00192504|41994226|FG003|Overall Study|Dosing window missed|0|||
19544663|NCT00192114|41994236|FG000|Overall Study|Objective Tumor Progression|19|||
19544664|NCT00192114|41994236|FG000|Overall Study|Adverse Event|2|||
19544665|NCT00192114|41994236|FG000|Overall Study|Clinical Progression|2|||
19544666|NCT00192114|41994236|FG000|Overall Study|Death|1|||
19544667|NCT00192075|41994242|FG000|Overall Study|Disease Progression|23|||
19544668|NCT00192075|41994243|FG001|Overall Study|Disease Progression|6|||
19544669|NCT00192075|41994242|FG000|Overall Study|Adverse Event|1|||
19544670|NCT00192075|41994243|FG001|Overall Study|Adverse Event|3|||
19544671|NCT00192075|41994242|FG000|Overall Study|Death|0|||
19544672|NCT00192075|41994243|FG001|Overall Study|Death|1|||
19544673|NCT00192075|41994242|FG000|Overall Study|Lack of Efficacy|0|||
19637254|NCT00750152|42086675|FG000|Overall Study|Other|7|||
19637255|NCT00750152|42086676|FG001|Overall Study|Other|8|||
19637256|NCT00749996|42086684|FG000|Overall Study|Lost to Follow-up|7|||
19637257|NCT00749996|42086685|FG001|Overall Study|Lost to Follow-up|4|||
19637258|NCT00749996|42086684|FG000|Overall Study|Withdrawal by Subject|5|||
19637259|NCT00749996|42086685|FG001|Overall Study|Withdrawal by Subject|4|||
19637260|NCT00749996|42086684|FG000|Overall Study|Protocol Violation|2|||
19637261|NCT00749996|42086685|FG001|Overall Study|Protocol Violation|3|||
19637262|NCT00749996|42086684|FG000|Overall Study|Physician Decision|2|||
19637263|NCT00749996|42086685|FG001|Overall Study|Physician Decision|0|||
19637264|NCT00749996|42086684|FG000|Overall Study|Pregnancy|0|||
19637265|NCT00749996|42086685|FG001|Overall Study|Pregnancy|2|||
19637266|NCT00749996|42086684|FG000|Overall Study|Adverse Event|1|||
19637267|NCT00749996|42086685|FG001|Overall Study|Adverse Event|0|||
19637268|NCT00749996|42086684|FG000|Overall Study|Death|1|||
19637269|NCT00749996|42086685|FG001|Overall Study|Death|0|||
19637270|NCT00749684|42086691|FG000|Overall Study|Death|1|||
19637271|NCT00749684|42086691|FG000|Overall Study|Adverse Event|27|||
19637272|NCT00749684|42086691|FG000|Overall Study|Participant's Wish|10|||
19637273|NCT00749684|42086691|FG000|Overall Study|Not Documented|1|||
19637274|NCT00749684|42086691|FG000|Overall Study|Progressive Desease|31|||
19637275|NCT00749684|42086691|FG000|Overall Study|Therapy according to protocol + AE|2|||
19637276|NCT00749684|42086691|FG000|Overall Study|AE+discontinuation on participants wish|1|||
19637277|NCT00749684|42086691|FG000|Overall Study|Missing|9|||
19637278|NCT00746798|42086699|FG000|Overall Study|Protocol Violation|0|||
19637279|NCT00746798|42086700|FG001|Overall Study|Protocol Violation|1|||
19637280|NCT00746798|42086701|FG002|Overall Study|Protocol Violation|0|||
19637281|NCT00746798|42086702|FG003|Overall Study|Protocol Violation|0|||
19637282|NCT00746798|42086699|FG000|Overall Study|Withdrawal by Subject|0|||
19637283|NCT00746798|42086700|FG001|Overall Study|Withdrawal by Subject|1|||
19637284|NCT00746798|42086701|FG002|Overall Study|Withdrawal by Subject|1|||
19637285|NCT00746798|42086702|FG003|Overall Study|Withdrawal by Subject|0|||
19544674|NCT00192075|41994243|FG001|Overall Study|Lack of Efficacy|0|||
19544675|NCT00192075|41994242|FG000|Overall Study|Physician Decision|3|||
19544676|NCT00192075|41994243|FG001|Overall Study|Physician Decision|0|||
19544677|NCT00192075|41994242|FG000|Overall Study|Withdrawal by Subject|5|||
19544678|NCT00192075|41994243|FG001|Overall Study|Withdrawal by Subject|5|||
19544679|NCT00192075|41994242|FG000|Overall Study|Patient Non-Compliance|0|||
19544680|NCT00192075|41994243|FG001|Overall Study|Patient Non-Compliance|1|||
19544681|NCT00192075|41994242|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
19544682|NCT00192075|41994243|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
19544683|NCT00192075|41994242|FG000|Overall Study|Other|5|||
19544684|NCT00192075|41994243|FG001|Overall Study|Other|2|||
19544685|NCT00192036|41994254|FG000|Overall Study|Protocol Violation|3|||
19544686|NCT00192036|41994254|FG000|Overall Study|Adverse Event|6|||
19544687|NCT00192036|41994254|FG000|Overall Study|Patient/Physician Perception|1|||
19544688|NCT00192036|41994254|FG000|Overall Study|Objective Tumor Progression|4|||
19544689|NCT00192036|41994254|FG000|Overall Study|Clinical Disease Progression|1|||
19544690|NCT00192036|41994254|FG000|Overall Study|Death|1|||
19544691|NCT00192036|41994254|FG000|Overall Study|Unknown or Not Specified|5|||
19544692|NCT00191724|41994263|FG000|Overall Study|Adverse Event|0|||
19544693|NCT00191724|41994264|FG001|Overall Study|Adverse Event|0|||
19544694|NCT00191724|41994265|FG002|Overall Study|Adverse Event|1|||
19544695|NCT00191724|41994266|FG003|Overall Study|Adverse Event|0|||
19544696|NCT00191724|41994267|FG004|Overall Study|Adverse Event|0|||
19544697|NCT00191724|41994263|FG000|Overall Study|Lost to Follow-up|1|||
19544698|NCT00191724|41994264|FG001|Overall Study|Lost to Follow-up|1|||
19544699|NCT00191724|41994265|FG002|Overall Study|Lost to Follow-up|0|||
19544700|NCT00191724|41994266|FG003|Overall Study|Lost to Follow-up|2|||
19544701|NCT00191724|41994267|FG004|Overall Study|Lost to Follow-up|3|||
19544702|NCT00191724|41994263|FG000|Overall Study|Withdrawal by Subject|0|||
19544703|NCT00191724|41994264|FG001|Overall Study|Withdrawal by Subject|0|||
19544704|NCT00191724|41994265|FG002|Overall Study|Withdrawal by Subject|0|||
19544705|NCT00191724|41994266|FG003|Overall Study|Withdrawal by Subject|1|||
19544706|NCT00191724|41994267|FG004|Overall Study|Withdrawal by Subject|0|||
19544707|NCT00191646|41994281|FG000|Overall Study|Toxicity|26|||
19544708|NCT00191646|41994282|FG001|Overall Study|Toxicity|37|||
19544709|NCT00191646|41994281|FG000|Overall Study|Disease Progression|5|||
19544710|NCT00191646|41994282|FG001|Overall Study|Disease Progression|6|||
19544711|NCT00191646|41994281|FG000|Overall Study|Physician Decision|20|||
19544712|NCT00191646|41994282|FG001|Overall Study|Physician Decision|11|||
19544713|NCT00191646|41994281|FG000|Overall Study|Withdrawal by Subject|58|||
19544714|NCT00191646|41994282|FG001|Overall Study|Withdrawal by Subject|39|||
19544715|NCT00191646|41994281|FG000|Overall Study|Protocol Violation|5|||
19544716|NCT00191646|41994282|FG001|Overall Study|Protocol Violation|7|||
19544717|NCT00191646|41994281|FG000|Overall Study|Death|6|||
19544718|NCT00191646|41994282|FG001|Overall Study|Death|8|||
19544719|NCT00191646|41994281|FG000|Overall Study|Other|33|||
19544720|NCT00191646|41994282|FG001|Overall Study|Other|34|||
19637286|NCT00746798|42086699|FG000|Overall Study|Death|0|||
19637287|NCT00746798|42086700|FG001|Overall Study|Death|0|||
19637288|NCT00746798|42086701|FG002|Overall Study|Death|2|||
19637289|NCT00746798|42086702|FG003|Overall Study|Death|0|||
19712238|NCT00103857|42155105|FG004|50-Week Extension Study|Lost to Follow-up|3|||
19544721|NCT00191646|41994281|FG000|Overall Study|Missing Data|18|||
19544722|NCT00191646|41994282|FG001|Overall Study|Missing Data|11|||
19544723|NCT00191451|41994299|FG000|Overall Study|Withdrawal by Subject|2|||
19544724|NCT00191451|41994300|FG001|Overall Study|Withdrawal by Subject|3|||
19544725|NCT00191451|41994301|FG002|Overall Study|Withdrawal by Subject|5|||
19544726|NCT00191451|41994299|FG000|Overall Study|Physician Decision|2|||
19544727|NCT00191451|41994300|FG001|Overall Study|Physician Decision|9|||
19544728|NCT00191451|41994301|FG002|Overall Study|Physician Decision|6|||
19544729|NCT00191451|41994299|FG000|Overall Study|Sponsor Decision|1|||
19544730|NCT00191451|41994300|FG001|Overall Study|Sponsor Decision|0|||
19544731|NCT00191451|41994301|FG002|Overall Study|Sponsor Decision|0|||
19544732|NCT00191451|41994299|FG000|Overall Study|Ineligible|0|||
19544733|NCT00191451|41994300|FG001|Overall Study|Ineligible|1|||
19544734|NCT00191451|41994301|FG002|Overall Study|Ineligible|0|||
19544735|NCT00191451|41994299|FG000|Overall Study|Reason Not Specified|2|||
19544736|NCT00191451|41994300|FG001|Overall Study|Reason Not Specified|1|||
19544737|NCT00191451|41994301|FG002|Overall Study|Reason Not Specified|3|||
19544738|NCT00191334|41994309|FG000|Overall Study|Adverse Event|4|||
19544739|NCT00191334|41994309|FG000|Overall Study|Disease Progression or Relapse|8|||
19544740|NCT00191334|41994309|FG000|Overall Study|Physician Decision|1|||
19544741|NCT00191334|41994309|FG000|Overall Study|Withdrawal by Subject|4|||
19544742|NCT00191139|41994315|FG000|Overall Study|Adverse Event|2|||
19544743|NCT00191139|41994316|FG001|Overall Study|Adverse Event|6|||
19544744|NCT00191139|41994315|FG000|Overall Study|Death|2|||
19544745|NCT00191139|41994316|FG001|Overall Study|Death|0|||
19544746|NCT00191139|41994315|FG000|Overall Study|Withdrawal by Subject|0|||
19544747|NCT00191139|41994316|FG001|Overall Study|Withdrawal by Subject|3|||
19544748|NCT00191139|41994315|FG000|Overall Study|Disease Progression|0|||
19544749|NCT00191139|41994316|FG001|Overall Study|Disease Progression|1|||
19544750|NCT00191139|41994315|FG000|Overall Study|Other|1|||
19544751|NCT00191139|41994316|FG001|Overall Study|Other|2|||
19544752|NCT00190983|41994322|FG000|Overall Study|Inevaluable (never treated)|2|||
19544753|NCT00190749|41994328|FG000|Overall Study|Lost to Follow-up|8|||
19544754|NCT00190749|41994329|FG001|Overall Study|Lost to Follow-up|11|||
19544755|NCT00190749|41994328|FG000|Overall Study|Withdrawal by Subject|10|||
19544756|NCT00190749|41994329|FG001|Overall Study|Withdrawal by Subject|6|||
19544757|NCT00190749|41994328|FG000|Overall Study|Protocol Violation|5|||
19544758|NCT00190749|41994329|FG001|Overall Study|Protocol Violation|4|||
19544759|NCT00190749|41994328|FG000|Overall Study|Adverse Event|0|||
19544760|NCT00190749|41994329|FG001|Overall Study|Adverse Event|5|||
19544761|NCT00190749|41994328|FG000|Overall Study|Lack of Efficacy|2|||
19544762|NCT00190749|41994329|FG001|Overall Study|Lack of Efficacy|3|||
19544763|NCT00190749|41994328|FG000|Overall Study|Reason Not Specified|0|||
19544764|NCT00190749|41994329|FG001|Overall Study|Reason Not Specified|2|||
19544765|NCT00190749|41994328|FG000|Overall Study|Sponsor Decision|1|||
19544766|NCT00190749|41994329|FG001|Overall Study|Sponsor Decision|0|||
19544767|NCT00190671|41994337|FG000|Overall Study|Satisfactory Response|4|||
19544768|NCT00190671|41994338|FG001|Overall Study|Satisfactory Response|7|||
19544769|NCT00190671|41994337|FG000|Overall Study|Lack of Efficacy|19|||
19544770|NCT00190671|41994338|FG001|Overall Study|Lack of Efficacy|24|||
19544771|NCT00190671|41994337|FG000|Overall Study|Death from Study Disease|1|||
19544772|NCT00190671|41994338|FG001|Overall Study|Death from Study Disease|1|||
19544773|NCT00190671|41994337|FG000|Overall Study|Adverse Event|3|||
19544774|NCT00190671|41994338|FG001|Overall Study|Adverse Event|2|||
19544775|NCT00190671|41994337|FG000|Overall Study|Clinical Relapse|0|||
19544776|NCT00190671|41994338|FG001|Overall Study|Clinical Relapse|1|||
19544777|NCT00190671|41994337|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
19544778|NCT00190671|41994338|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
19544779|NCT00190671|41994337|FG000|Overall Study|Death from Other Causes|0|||
19544780|NCT00190671|41994338|FG001|Overall Study|Death from Other Causes|2|||
19544781|NCT00190671|41994337|FG000|Overall Study|Protocol Violation|0|||
19544782|NCT00190671|41994338|FG001|Overall Study|Protocol Violation|1|||
19544783|NCT00190671|41994337|FG000|Overall Study|Withdrawal by Subject|0|||
19544784|NCT00190671|41994338|FG001|Overall Study|Withdrawal by Subject|2|||
19544785|NCT00477165|41994360|FG000|Overall Study|Adverse Event|7|||
19544786|NCT00477165|41994361|FG001|Overall Study|Adverse Event|2|||
19544787|NCT00476229|41994367|FG000|Overall Study|Progressive shortness of breath|1|||
19544788|NCT00476151|41994373|FG000|Overall Study|Adverse Event|0|||
19544789|NCT00476151|41994374|FG001|Overall Study|Adverse Event|2|||
19544790|NCT00476151|41994373|FG000|Overall Study|Protocol Violation|1|||
19544791|NCT00476151|41994374|FG001|Overall Study|Protocol Violation|3|||
19544792|NCT00476151|41994373|FG000|Overall Study|Withdrawal by Subject|2|||
19544793|NCT00476151|41994374|FG001|Overall Study|Withdrawal by Subject|0|||
19544794|NCT00476151|41994373|FG000|Overall Study|Physician Decision|0|||
19544795|NCT00476151|41994374|FG001|Overall Study|Physician Decision|2|||
19544796|NCT00475644|41994380|FG000|Overall Study|Protocol Violation|13|||
19544797|NCT00474903|41994387|FG000|Overall Study|Protocol Violation|1|||
19544798|NCT00474903|41994388|FG001|Overall Study|Protocol Violation|5|||
19544799|NCT00474903|41994389|FG002|Overall Study|Protocol Violation|2|||
19544800|NCT01134055|41994404|FG000|Overall Study|Adverse Event|5|||
19544801|NCT01134055|41994405|FG001|Overall Study|Adverse Event|2|||
19544802|NCT01134055|41994406|FG002|Overall Study|Adverse Event|2|||
19544803|NCT01134055|41994407|FG003|Overall Study|Adverse Event|2|||
19544804|NCT01134055|41994408|FG004|Overall Study|Adverse Event|5|||
19544805|NCT01134055|41994409|FG005|Overall Study|Adverse Event|7|||
19544806|NCT01134055|41994410|FG006|Overall Study|Adverse Event|2|||
19544807|NCT01134055|41994404|FG000|Overall Study|Lost to Follow-up|0|||
19544808|NCT01134055|41994405|FG001|Overall Study|Lost to Follow-up|1|||
19544809|NCT01134055|41994406|FG002|Overall Study|Lost to Follow-up|0|||
19544810|NCT01134055|41994407|FG003|Overall Study|Lost to Follow-up|1|||
19544811|NCT01134055|41994408|FG004|Overall Study|Lost to Follow-up|0|||
19544812|NCT01134055|41994409|FG005|Overall Study|Lost to Follow-up|0|||
19544813|NCT01134055|41994410|FG006|Overall Study|Lost to Follow-up|0|||
19544814|NCT01134055|41994404|FG000|Overall Study|Withdrawal by Subject|3|||
19544815|NCT01134055|41994405|FG001|Overall Study|Withdrawal by Subject|3|||
19637290|NCT00746798|42086699|FG000|Overall Study|Participant unable to return for visit|1|||
19637291|NCT00746798|42086700|FG001|Overall Study|Participant unable to return for visit|0|||
19637292|NCT00746798|42086701|FG002|Overall Study|Participant unable to return for visit|0|||
19637293|NCT00746798|42086702|FG003|Overall Study|Participant unable to return for visit|0|||
19637294|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
19637295|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
19637296|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
19637297|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
19637298|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
19637299|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
19637300|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
19637301|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
19637302|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
19637303|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
19637304|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
19637305|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
19637306|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
19637307|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
19637308|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
19637309|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
19637310|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
19637311|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
19637312|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
19637313|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
19712239|NCT00103857|42155106|FG005|50-Week Extension Study|Lost to Follow-up|3|||
19712240|NCT00103857|42155107|FG006|50-Week Extension Study|Lost to Follow-up|0|||
19712241|NCT00103857|42155101|FG000|50-Week Extension Study|Physician Decision|0|||
19712242|NCT00103857|42155102|FG001|50-Week Extension Study|Physician Decision|1|||
19712243|NCT00103857|42155103|FG002|50-Week Extension Study|Physician Decision|1|||
19458416|NCT01390857|41712215|FG000|Overall Study|Protocol Violation|2|||
19637314|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
19637315|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
19637316|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
19637317|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
19637318|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
19637319|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
19637320|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
19458417|NCT01390857|41712215|FG000|Overall Study|Lost to Follow-up|1|||
19458418|NCT01390857|41712215|FG000|Overall Study|No Visit after the First Visit|7|||
19458419|NCT01725386|41712221|FG000|Overall Study|Death|84|||
19458420|NCT01725386|41712222|FG001|Overall Study|Death|40|||
19458421|NCT01725386|41712221|FG000|Overall Study|Lost to Follow-up|81|||
19458422|NCT01725386|41712222|FG001|Overall Study|Lost to Follow-up|6|||
19458423|NCT01725386|41712221|FG000|Overall Study|Withdrawal by Subject|10|||
19458424|NCT01725386|41712222|FG001|Overall Study|Withdrawal by Subject|0|||
19458425|NCT01402011|41712231|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
19458426|NCT01402011|41712232|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
19544816|NCT01134055|41994406|FG002|Overall Study|Withdrawal by Subject|1|||
19458427|NCT01402011|41712233|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
19544817|NCT01134055|41994407|FG003|Overall Study|Withdrawal by Subject|2|||
19544818|NCT01134055|41994408|FG004|Overall Study|Withdrawal by Subject|0|||
19544819|NCT01134055|41994409|FG005|Overall Study|Withdrawal by Subject|0|||
19637321|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
19544820|NCT01134055|41994410|FG006|Overall Study|Withdrawal by Subject|8|||
19544821|NCT01134055|41994404|FG000|Overall Study|Protocol Violation|0|||
19544822|NCT01134055|41994405|FG001|Overall Study|Protocol Violation|0|||
19544823|NCT01134055|41994406|FG002|Overall Study|Protocol Violation|0|||
19544824|NCT01134055|41994407|FG003|Overall Study|Protocol Violation|1|||
19544825|NCT01134055|41994408|FG004|Overall Study|Protocol Violation|1|||
19544826|NCT01134055|41994409|FG005|Overall Study|Protocol Violation|0|||
19544827|NCT01134055|41994410|FG006|Overall Study|Protocol Violation|0|||
19637322|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
19637323|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
19637324|NCT00716274|42086715|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
19637325|NCT00716274|42086716|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
19637326|NCT00716274|42086717|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
19637327|NCT00716274|42086718|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
19637328|NCT00716274|42086719|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
19637329|NCT00716274|42086720|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
19637330|NCT00716274|42086715|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
19637331|NCT00716274|42086716|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
19637332|NCT00716274|42086717|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
19637333|NCT00716274|42086718|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
19637334|NCT00716274|42086719|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
19637335|NCT00716274|42086720|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
19637336|NCT00716274|42086715|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
19637337|NCT00716274|42086716|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
19637338|NCT00716274|42086717|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
19637339|NCT00716274|42086718|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
19637340|NCT00716274|42086719|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
19637341|NCT00716274|42086720|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
19458428|NCT01402011|41712231|FG000|Active Treatment Period|Withdrawal by Subject|1|||
19458429|NCT01402011|41712232|FG001|Active Treatment Period|Withdrawal by Subject|3|||
19458430|NCT01402011|41712233|FG002|Active Treatment Period|Withdrawal by Subject|0|||
19458431|NCT01402011|41712231|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
19458432|NCT01402011|41712232|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
19458433|NCT01402011|41712233|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
19458434|NCT01421667|41712248|FG000|Overall Study|Withdrawal by Subject|0|||
19458435|NCT01421667|41712249|FG001|Overall Study|Withdrawal by Subject|1|||
19458436|NCT01421667|41712250|FG002|Overall Study|Withdrawal by Subject|2|||
19458437|NCT01421667|41712251|FG003|Overall Study|Withdrawal by Subject|1|||
19458438|NCT01421667|41712248|FG000|Overall Study|Lost to Follow-up|0|||
19458439|NCT01421667|41712249|FG001|Overall Study|Lost to Follow-up|1|||
19458440|NCT01421667|41712250|FG002|Overall Study|Lost to Follow-up|0|||
19458441|NCT01421667|41712251|FG003|Overall Study|Lost to Follow-up|0|||
19458442|NCT01390779|41712269|FG000|Overall Study|Physician Decision|1|||
19458443|NCT01891669|41712283|FG000|Overall Study|Death|0|||
19458444|NCT01891669|41712284|FG001|Overall Study|Death|0|||
19458445|NCT01891669|41712285|FG002|Overall Study|Death|0|||
19458446|NCT01891669|41712286|FG003|Overall Study|Death|0|||
19458447|NCT01891669|41712287|FG004|Overall Study|Death|0|||
19458448|NCT01891669|41712288|FG005|Overall Study|Death|0|||
19458449|NCT01891669|41712289|FG006|Overall Study|Death|0|||
19458450|NCT01891669|41712290|FG007|Overall Study|Death|1|||
19458451|NCT01891669|41712291|FG008|Overall Study|Death|0|||
19458452|NCT01891669|41712292|FG009|Overall Study|Death|1|||
19458453|NCT01891669|41712283|FG000|Overall Study|Withdrawal by Subject|1|||
19458454|NCT01891669|41712284|FG001|Overall Study|Withdrawal by Subject|1|||
19458455|NCT01891669|41712285|FG002|Overall Study|Withdrawal by Subject|0|||
19458456|NCT01891669|41712286|FG003|Overall Study|Withdrawal by Subject|0|||
19458457|NCT01891669|41712287|FG004|Overall Study|Withdrawal by Subject|0|||
19458458|NCT01891669|41712288|FG005|Overall Study|Withdrawal by Subject|0|||
19458459|NCT01891669|41712289|FG006|Overall Study|Withdrawal by Subject|1|||
19458460|NCT01891669|41712290|FG007|Overall Study|Withdrawal by Subject|2|||
19458461|NCT01891669|41712291|FG008|Overall Study|Withdrawal by Subject|1|||
19458462|NCT01891669|41712292|FG009|Overall Study|Withdrawal by Subject|1|||
19544828|NCT01134055|41994404|FG000|Overall Study|Physician Decision|0|||
19544829|NCT01134055|41994405|FG001|Overall Study|Physician Decision|0|||
19544830|NCT01134055|41994406|FG002|Overall Study|Physician Decision|0|||
19544831|NCT01134055|41994407|FG003|Overall Study|Physician Decision|0|||
19544832|NCT01134055|41994408|FG004|Overall Study|Physician Decision|0|||
19544833|NCT01134055|41994409|FG005|Overall Study|Physician Decision|0|||
19544834|NCT01134055|41994410|FG006|Overall Study|Physician Decision|1|||
19544835|NCT00474708|41994434|FG000|Overall Study|Lack of Efficacy|11|||
19544836|NCT00474708|41994435|FG001|Overall Study|Lack of Efficacy|5|||
19458463|NCT01891669|41712283|FG000|Overall Study|Other|1|||
19458464|NCT01891669|41712284|FG001|Overall Study|Other|0|||
19458465|NCT01891669|41712285|FG002|Overall Study|Other|0|||
19458466|NCT01891669|41712286|FG003|Overall Study|Other|0|||
19544837|NCT00474708|41994434|FG000|Overall Study|Suicide ideation/behavior|0|||
19544838|NCT00474708|41994435|FG001|Overall Study|Suicide ideation/behavior|1|||
19544839|NCT00474708|41994434|FG000|Overall Study|Withdrawal by Subject|7|||
19544840|NCT00474708|41994435|FG001|Overall Study|Withdrawal by Subject|0|||
19544841|NCT00474708|41994434|FG000|Overall Study|Lack of compliance|12|||
19544842|NCT00474708|41994435|FG001|Overall Study|Lack of compliance|4|||
19544843|NCT00474708|41994434|FG000|Overall Study|Lost to Follow-up|18|||
19544844|NCT00474708|41994435|FG001|Overall Study|Lost to Follow-up|9|||
19544845|NCT00474708|41994434|FG000|Overall Study|Physician Decision|9|||
19544846|NCT00474708|41994435|FG001|Overall Study|Physician Decision|6|||
19544847|NCT00474240|41994447|FG000|Overall Study|Withdrawal by Subject|1|||
19544848|NCT00474240|41994448|FG001|Overall Study|Withdrawal by Subject|1|||
19544849|NCT00474240|41994449|FG002|Overall Study|Withdrawal by Subject|0|||
19544850|NCT00474240|41994450|FG003|Overall Study|Withdrawal by Subject|2|||
19544851|NCT00474240|41994451|FG004|Overall Study|Withdrawal by Subject|3|||
19544852|NCT00474240|41994452|FG005|Overall Study|Withdrawal by Subject|1|||
19544853|NCT00474240|41994447|FG000|Overall Study|Adverse Event|0|||
19544854|NCT00474240|41994448|FG001|Overall Study|Adverse Event|0|||
19544855|NCT00474240|41994449|FG002|Overall Study|Adverse Event|9|||
19544856|NCT00474240|41994450|FG003|Overall Study|Adverse Event|14|||
19544857|NCT00474240|41994451|FG004|Overall Study|Adverse Event|5|||
19544858|NCT00474240|41994452|FG005|Overall Study|Adverse Event|16|||
19544859|NCT00474240|41994447|FG000|Overall Study|Removed due to lab value|0|||
19544860|NCT00474240|41994448|FG001|Overall Study|Removed due to lab value|0|||
19544861|NCT00474240|41994449|FG002|Overall Study|Removed due to lab value|0|||
19544862|NCT00474240|41994450|FG003|Overall Study|Removed due to lab value|0|||
19544863|NCT00474240|41994451|FG004|Overall Study|Removed due to lab value|0|||
19544864|NCT00474240|41994452|FG005|Overall Study|Removed due to lab value|1|||
19544865|NCT00473889|41994468|FG000|Overall Study|Did not receive study medication|1|||
19544866|NCT00473889|41994469|FG001|Overall Study|Did not receive study medication|4|||
19544867|NCT00473889|41994468|FG000|Overall Study|Adverse Event|30|||
19544868|NCT00473889|41994469|FG001|Overall Study|Adverse Event|17|||
19544869|NCT00473889|41994468|FG000|Overall Study|Protocol Violation|4|||
19544870|NCT00473889|41994469|FG001|Overall Study|Protocol Violation|2|||
19544871|NCT00473889|41994468|FG000|Overall Study|Lack of Efficacy|28|||
19637342|NCT00716274|42086715|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
19637343|NCT00716274|42086716|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
19637344|NCT00716274|42086717|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
19637345|NCT00716274|42086718|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
19637346|NCT00716274|42086719|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
19637347|NCT00716274|42086720|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
19637348|NCT00716274|42086715|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
19637349|NCT00716274|42086716|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
19637350|NCT00716274|42086717|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
19637351|NCT00716274|42086718|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
19637352|NCT00716274|42086719|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
19637353|NCT00716274|42086720|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
19637354|NCT00746564|42086737|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
19637355|NCT01298193|42086743|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
19637356|NCT01298193|42086743|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
19637357|NCT01298193|42086743|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
19637358|NCT01298193|42086743|FG000|Efficacy Phase (Second Cycle)|Death|1|||
19637359|NCT00719862|42086752|FG000|Overall Study|Adverse Event|1|||
19637360|NCT00719862|42086753|FG001|Overall Study|Adverse Event|2|||
19637361|NCT00719862|42086752|FG000|Overall Study|Lack of Efficacy|3|||
19637362|NCT00719862|42086753|FG001|Overall Study|Lack of Efficacy|0|||
19637363|NCT00719862|42086752|FG000|Overall Study|Non-Compliance|1|||
19637364|NCT00719862|42086753|FG001|Overall Study|Non-Compliance|0|||
19637365|NCT00719862|42086752|FG000|Overall Study|Withdrawal by Subject|1|||
19637366|NCT00719862|42086753|FG001|Overall Study|Withdrawal by Subject|0|||
19637367|NCT00719862|42086752|FG000|Overall Study|Lost to Follow-up|0|||
19637368|NCT00719862|42086753|FG001|Overall Study|Lost to Follow-up|1|||
19637369|NCT00719862|42086752|FG000|Overall Study|Other|2|||
19637370|NCT00719862|42086753|FG001|Overall Study|Other|3|||
19637371|NCT00742508|42086761|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
19637372|NCT00742508|42086762|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
19637373|NCT00742508|42086761|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
19637374|NCT00742508|42086762|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
19637375|NCT00742508|42086761|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
19637376|NCT00742508|42086762|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
19637377|NCT00742508|42086761|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
19637378|NCT00742508|42086762|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
19637379|NCT00742508|42086761|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
19712244|NCT00103857|42155104|FG003|50-Week Extension Study|Physician Decision|0|||
19544872|NCT00473889|41994469|FG001|Overall Study|Lack of Efficacy|29|||
19544873|NCT00473889|41994468|FG000|Overall Study|Lost to Follow-up|2|||
19637380|NCT00742508|42086762|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
19637381|NCT00719706|42086770|FG000|Overall Study|Adverse Event|5|||
19637382|NCT00719706|42086771|FG001|Overall Study|Adverse Event|4|||
19637383|NCT00719706|42086770|FG000|Overall Study|Withdrawal by Subject|1|||
19637384|NCT00719706|42086771|FG001|Overall Study|Withdrawal by Subject|2|||
19637385|NCT00719706|42086770|FG000|Overall Study|Protocol Violation|3|||
19637386|NCT00719706|42086771|FG001|Overall Study|Protocol Violation|0|||
19637387|NCT00742274|42086779|FG000|Overall Study|Death|1|||
19637388|NCT00742274|42086780|FG001|Overall Study|Death|0|||
19637389|NCT00742274|42086779|FG000|Overall Study|Withdrawal by Subject|1|||
19637390|NCT00742274|42086780|FG001|Overall Study|Withdrawal by Subject|2|||
19637391|NCT00742274|42086779|FG000|Overall Study|Removed for medical reasons|1|||
19637392|NCT00742274|42086780|FG001|Overall Study|Removed for medical reasons|1|||
19637393|NCT00719472|42086786|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
19637394|NCT00719472|42086786|FG000|Enrolled in Study|Subject decision to withdraw|8|||
19637395|NCT00719472|42086786|FG000|Enrolled in Study|Various Reasons|17|||
19637396|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
19637397|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Death|5|||
19637398|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
19637399|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
19637400|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
19637401|NCT00719472|42086786|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
19637402|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
19637403|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Death|6|||
19637404|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Disease progression|3|||
19637405|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
19637406|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
19637407|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
19637408|NCT00719472|42086786|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
19637409|NCT00579501|42086790|FG000|Overall Study|Death|1|||
19637410|NCT00579501|42086790|FG000|Overall Study|End of neoadjuvant therapy|25|||
19637411|NCT00579501|42086790|FG000|Overall Study|toxicity|1|||
19637412|NCT00579501|42086790|FG000|Overall Study|Secondary lesion|1|||
19637413|NCT00579501|42086790|FG000|Overall Study|Radiation therapy before surgery|1|||
19637414|NCT00741338|42086796|FG000|Overall Study|Adverse Event|0|||
19637415|NCT00741338|42086797|FG001|Overall Study|Adverse Event|1|||
19637416|NCT00746330|42086807|FG000|Period 1|Abnormal test procedure result|0|||
19712245|NCT00103857|42155105|FG004|50-Week Extension Study|Physician Decision|0|||
19637417|NCT00746330|42086808|FG001|Period 1|Abnormal test procedure result|0|||
19637418|NCT00746330|42086809|FG002|Period 1|Abnormal test procedure result|1|||
19637419|NCT00746330|42086810|FG003|Period 1|Abnormal test procedure result|0|||
19637420|NCT00746252|42086823|FG000|Overall Study|weight gain >7.5 %|1|||
19637421|NCT00746252|42086824|FG001|Overall Study|weight gain >7.5 %|2|||
19712246|NCT00103857|42155106|FG005|50-Week Extension Study|Physician Decision|0|||
19712247|NCT00103857|42155107|FG006|50-Week Extension Study|Physician Decision|0|||
19712248|NCT00103857|42155101|FG000|50-Week Extension Study|Pregnancy|0|||
19712249|NCT00103857|42155102|FG001|50-Week Extension Study|Pregnancy|0|||
19712250|NCT00103857|42155103|FG002|50-Week Extension Study|Pregnancy|1|||
19712251|NCT00103857|42155104|FG003|50-Week Extension Study|Pregnancy|0|||
19712252|NCT00103857|42155105|FG004|50-Week Extension Study|Pregnancy|1|||
19712253|NCT00103857|42155106|FG005|50-Week Extension Study|Pregnancy|0|||
19712254|NCT00103857|42155107|FG006|50-Week Extension Study|Pregnancy|0|||
19712255|NCT00103857|42155101|FG000|50-Week Extension Study|Protocol Violation|1|||
19712256|NCT00103857|42155102|FG001|50-Week Extension Study|Protocol Violation|1|||
19712257|NCT00103857|42155103|FG002|50-Week Extension Study|Protocol Violation|1|||
19637422|NCT00718770|42086830|FG000|Overall Study|Adverse Event|1|||
19637423|NCT00718770|42086830|FG000|Overall Study|Lack of Efficacy|1|||
19637424|NCT00718770|42086830|FG000|Overall Study|Lack of Efficacy|1|||
19637425|NCT00718770|42086830|FG000|Overall Study|Adverse Event|1|||
19712258|NCT00103857|42155104|FG003|50-Week Extension Study|Protocol Violation|2|||
19712259|NCT00103857|42155105|FG004|50-Week Extension Study|Protocol Violation|0|||
19712260|NCT00103857|42155106|FG005|50-Week Extension Study|Protocol Violation|1|||
19712261|NCT00103857|42155107|FG006|50-Week Extension Study|Protocol Violation|0|||
19712262|NCT00103857|42155101|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
19712263|NCT00103857|42155102|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
19712264|NCT00103857|42155103|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
19712265|NCT00103857|42155104|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
19712266|NCT00103857|42155105|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
19712267|NCT00103857|42155106|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
19712268|NCT00103857|42155107|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
19637426|NCT00718770|42086830|FG000|Overall Study|Lack of Efficacy|1|||
19637427|NCT00718770|42086830|FG000|Overall Study|Adverse Event|1|||
19637428|NCT00718770|42086830|FG000|Overall Study|Lack of Efficacy|1|||
19637429|NCT00718770|42086830|FG000|Overall Study|Adverse Event|1|||
19637430|NCT00746096|42086836|FG000|Overall Study|Adverse Event|1|||
19637431|NCT00746096|42086837|FG001|Overall Study|Adverse Event|0|||
19637432|NCT00746096|42086836|FG000|Overall Study|Withdrawal by Subject|5|||
19637433|NCT00746096|42086837|FG001|Overall Study|Withdrawal by Subject|1|||
19637434|NCT00746096|42086836|FG000|Overall Study|Lost to Follow-up|2|||
19637435|NCT00746096|42086837|FG001|Overall Study|Lost to Follow-up|1|||
19637436|NCT00746096|42086836|FG000|Overall Study|Protocol Violation|1|||
19544874|NCT00473889|41994469|FG001|Overall Study|Lost to Follow-up|1|||
19544875|NCT00473889|41994468|FG000|Overall Study|Physician Decision|10|||
19637437|NCT00746096|42086837|FG001|Overall Study|Protocol Violation|0|||
19637438|NCT00746096|42086836|FG000|Overall Study|No study drug treatment|1|||
19544876|NCT00473889|41994469|FG001|Overall Study|Physician Decision|5|||
19544877|NCT00473889|41994468|FG000|Overall Study|Trial Terminated|3|||
19544878|NCT00473889|41994469|FG001|Overall Study|Trial Terminated|6|||
19544879|NCT00473889|41994468|FG000|Overall Study|Withdrawal by Subject|5|||
19544880|NCT00473889|41994469|FG001|Overall Study|Withdrawal by Subject|0|||
19544881|NCT00473694|41994479|FG000|Overall Study|Adverse Event|0|||
19544882|NCT00473694|41994480|FG001|Overall Study|Adverse Event|1|||
19544883|NCT00473694|41994481|FG002|Overall Study|Adverse Event|0|||
19544884|NCT00473694|41994482|FG003|Overall Study|Adverse Event|0|||
19637439|NCT00746096|42086837|FG001|Overall Study|No study drug treatment|1|||
19637440|NCT00715026|42086843|FG000|Overall Study|Withdrawal by Subject|5|||
19637441|NCT00715026|42086843|FG000|Overall Study|Lost to Follow-up|3|||
19637442|NCT00715026|42086843|FG000|Overall Study|Protocol Violation|1|||
19637443|NCT00715026|42086843|FG000|Overall Study|Surgery done on non-study consented hip|1|||
19637444|NCT00714948|42086847|FG000|Overall Study|Adverse Event|2|||
19637445|NCT00714870|42086853|FG000|Overall Study|Lost to Follow-up|22|||
19637446|NCT00714870|42086854|FG001|Overall Study|Lost to Follow-up|5|||
19637447|NCT00714870|42086853|FG000|Overall Study|patient unable to come b/c back pain|1|||
19637448|NCT00714870|42086854|FG001|Overall Study|patient unable to come b/c back pain|0|||
19637449|NCT00714870|42086853|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
19637450|NCT00714870|42086854|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
19637451|NCT00714714|42086860|FG000|Overall Study|Adverse Event|1|||
19637452|NCT00441337|42086870|FG000|Overall Study|Disease Progression|6|||
19637453|NCT00441337|42086871|FG001|Overall Study|Disease Progression|6|||
19637454|NCT00441337|42086872|FG002|Overall Study|Disease Progression|4|||
19637455|NCT00441337|42086873|FG003|Overall Study|Disease Progression|18|||
19637456|NCT00441337|42086870|FG000|Overall Study|Lost to Follow-up|0|||
19637457|NCT00441337|42086871|FG001|Overall Study|Lost to Follow-up|0|||
19637458|NCT00441337|42086872|FG002|Overall Study|Lost to Follow-up|0|||
19637459|NCT00441337|42086873|FG003|Overall Study|Lost to Follow-up|1|||
19637460|NCT00441337|42086870|FG000|Overall Study|Sponsor Decision|0|||
19637461|NCT00441337|42086871|FG001|Overall Study|Sponsor Decision|0|||
19637462|NCT00441337|42086872|FG002|Overall Study|Sponsor Decision|1|||
19637463|NCT00441337|42086873|FG003|Overall Study|Sponsor Decision|2|||
19637464|NCT00441337|42086870|FG000|Overall Study|Did not meet inclusion criteria|0|||
19637465|NCT00441337|42086871|FG001|Overall Study|Did not meet inclusion criteria|0|||
19637466|NCT00441337|42086872|FG002|Overall Study|Did not meet inclusion criteria|1|||
19637467|NCT00441337|42086873|FG003|Overall Study|Did not meet inclusion criteria|0|||
19637468|NCT00578877|42086893|FG000|Overall Study|Lost to Follow-up|8|||
19637469|NCT00578877|42086894|FG001|Overall Study|Lost to Follow-up|10|||
19637470|NCT00578877|42086893|FG000|Overall Study|early discontinue|61|||
19637471|NCT00578877|42086894|FG001|Overall Study|early discontinue|101|||
19637472|NCT00578877|42086893|FG000|Overall Study|did not provide follow-up data|12|||
19637473|NCT00578877|42086894|FG001|Overall Study|did not provide follow-up data|17|||
19637474|NCT00468481|42086902|FG000|Overall Study|Adverse Event|13|||
19637475|NCT00468481|42086903|FG001|Overall Study|Adverse Event|3|||
19637476|NCT00468481|42086902|FG000|Overall Study|Lost to Follow-up|25|||
19637477|NCT00468481|42086903|FG001|Overall Study|Lost to Follow-up|8|||
19637478|NCT00468481|42086902|FG000|Overall Study|Pregnancy|2|||
19637479|NCT00468481|42086903|FG001|Overall Study|Pregnancy|0|||
19637480|NCT00468481|42086902|FG000|Overall Study|Protocol Violation|18|||
19637481|NCT00468481|42086903|FG001|Overall Study|Protocol Violation|8|||
19637482|NCT00468481|42086902|FG000|Overall Study|Withdrawal by Subject|12|||
19637483|NCT00468481|42086903|FG001|Overall Study|Withdrawal by Subject|3|||
19637484|NCT00468481|42086902|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
19637485|NCT00468481|42086903|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
19637486|NCT00468481|42086902|FG000|Overall Study|Prohibited Medication|1|||
19637487|NCT00468481|42086903|FG001|Overall Study|Prohibited Medication|1|||
19637488|NCT00468481|42086902|FG000|Overall Study|Egg Donor|1|||
19637489|NCT00468481|42086903|FG001|Overall Study|Egg Donor|0|||
19637490|NCT00468481|42086902|FG000|Overall Study|Moved out of area|4|||
19544885|NCT00473694|41994479|FG000|Overall Study|Participants did not receive treatment|11|||
19637491|NCT00468481|42086903|FG001|Overall Study|Moved out of area|1|||
19637492|NCT00468481|42086902|FG000|Overall Study|Non-Compliance|5|||
19637493|NCT00468481|42086903|FG001|Overall Study|Non-Compliance|0|||
19544886|NCT00473694|41994480|FG001|Overall Study|Participants did not receive treatment|3|||
19637494|NCT00468481|42086902|FG000|Overall Study|Other|6|||
19544887|NCT00473694|41994481|FG002|Overall Study|Participants did not receive treatment|5|||
19544888|NCT00473694|41994482|FG003|Overall Study|Participants did not receive treatment|6|||
19544889|NCT00473694|41994479|FG000|Overall Study|Lost to Follow-up|0|||
19544890|NCT00473694|41994480|FG001|Overall Study|Lost to Follow-up|0|||
19544891|NCT00473694|41994481|FG002|Overall Study|Lost to Follow-up|0|||
19544892|NCT00473694|41994482|FG003|Overall Study|Lost to Follow-up|1|||
19544893|NCT00473655|41994498|FG000|Overall Study|Lost to Follow-up|9|||
19544894|NCT00473655|41994499|FG001|Overall Study|Lost to Follow-up|5|||
19544895|NCT00473655|41994500|FG002|Overall Study|Lost to Follow-up|8|||
19544896|NCT00473382|41994511|FG000|Core Study|Adverse Event|3|||
19544897|NCT00473382|41994512|FG001|Core Study|Adverse Event|1|||
19544898|NCT00473382|41994513|FG002|Core Study|Adverse Event|1|||
19544899|NCT00473382|41994511|FG000|Core Study|Death|3|||
19712269|NCT00103857|42155101|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
19712270|NCT00103857|42155102|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
19712271|NCT00103857|42155103|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
19712272|NCT00103857|42155104|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
19712273|NCT00103857|42155105|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
19712274|NCT00103857|42155106|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
19712275|NCT00103857|42155107|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
19544900|NCT00473382|41994512|FG001|Core Study|Death|5|||
19544901|NCT00473382|41994513|FG002|Core Study|Death|10|||
19544902|NCT00473382|41994511|FG000|Core Study|Lost to Follow-up|3|||
19637495|NCT00468481|42086903|FG001|Overall Study|Other|0|||
19637496|NCT00714168|42086911|FG000|Overall Study|Pregnancy|5|||
19637497|NCT00714168|42086912|FG001|Overall Study|Pregnancy|4|||
19637498|NCT00714168|42086911|FG000|Overall Study|Lost to Follow-up|32|||
19637499|NCT00714168|42086912|FG001|Overall Study|Lost to Follow-up|50|||
19637500|NCT00714168|42086911|FG000|Overall Study|Relocation|4|||
19637501|NCT00714168|42086912|FG001|Overall Study|Relocation|3|||
19637502|NCT00714168|42086911|FG000|Overall Study|Non-study medical condition|3|||
19637503|NCT00714168|42086912|FG001|Overall Study|Non-study medical condition|2|||
19637504|NCT00713700|42086918|FG000|Overall Study|Lost to Follow-up|3|||
19637505|NCT00713700|42086918|FG000|Overall Study|Withdrawal by Subject|1|||
19637506|NCT00468169|42086924|FG000|Overall Study|Withdrawal by Subject|1|||
19637507|NCT00468169|42086925|FG001|Overall Study|Withdrawal by Subject|0|||
19637508|NCT00435487|42086935|FG000|Overall Study|Death|3|||
19637509|NCT00435487|42086936|FG001|Overall Study|Death|4|||
19637510|NCT00435487|42086935|FG000|Overall Study|Adverse Event|0|||
19637511|NCT00435487|42086936|FG001|Overall Study|Adverse Event|3|||
19637512|NCT00435487|42086935|FG000|Overall Study|Lost to Follow-up|2|||
19637513|NCT00435487|42086936|FG001|Overall Study|Lost to Follow-up|2|||
19637514|NCT00435487|42086935|FG000|Overall Study|Other|5|||
19712276|NCT00103857|42155101|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
19712277|NCT00103857|42155102|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
19712278|NCT00103857|42155103|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
19712279|NCT00103857|42155104|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
19712280|NCT00103857|42155105|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
19712281|NCT00103857|42155106|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
19712282|NCT00103857|42155107|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
19712283|NCT00103857|42155101|FG000|50-Week Extension Study|patient moved|0|||
19712284|NCT00103857|42155102|FG001|50-Week Extension Study|patient moved|0|||
19712285|NCT00103857|42155103|FG002|50-Week Extension Study|patient moved|1|||
19712286|NCT00103857|42155104|FG003|50-Week Extension Study|patient moved|2|||
19712287|NCT00103857|42155105|FG004|50-Week Extension Study|patient moved|0|||
19712288|NCT00103857|42155106|FG005|50-Week Extension Study|patient moved|0|||
19712289|NCT00103857|42155107|FG006|50-Week Extension Study|patient moved|0|||
19712290|NCT00103857|42155101|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
19712291|NCT00103857|42155102|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
19712292|NCT00103857|42155103|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
19712293|NCT00103857|42155104|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
19544903|NCT00473382|41994512|FG001|Core Study|Lost to Follow-up|3|||
19637515|NCT00435487|42086936|FG001|Overall Study|Other|2|||
19637516|NCT00435487|42086935|FG000|Overall Study|Withdrawal by Subject|2|||
19637517|NCT00435487|42086936|FG001|Overall Study|Withdrawal by Subject|1|||
19637518|NCT00435487|42086935|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
19637519|NCT00435487|42086936|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
19637520|NCT00435487|42086935|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
19544904|NCT00473382|41994513|FG002|Core Study|Lost to Follow-up|3|||
19544905|NCT00473382|41994511|FG000|Core Study|Physician Decision|1|||
19544906|NCT00473382|41994512|FG001|Core Study|Physician Decision|2|||
19544907|NCT00473382|41994513|FG002|Core Study|Physician Decision|2|||
19637521|NCT00435487|42086936|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
19544908|NCT00473382|41994511|FG000|Core Study|Subject non-compliance|5|||
19637522|NCT00579345|42086950|FG000|Overall Study|Withdrawal by Subject|2|||
19637523|NCT00579345|42086951|FG001|Overall Study|Withdrawal by Subject|0|||
19637524|NCT00579345|42086952|FG002|Overall Study|Withdrawal by Subject|0|||
19637525|NCT00579345|42086953|FG003|Overall Study|Withdrawal by Subject|0|||
19637526|NCT00579345|42086954|FG004|Overall Study|Withdrawal by Subject|0|||
19637527|NCT00579345|42086955|FG005|Overall Study|Withdrawal by Subject|0|||
19637528|NCT00579345|42086956|FG006|Overall Study|Withdrawal by Subject|0|||
19637529|NCT00579345|42086957|FG007|Overall Study|Withdrawal by Subject|1|||
19637530|NCT00579345|42086950|FG000|Overall Study|Lost to Follow-up|1|||
19637531|NCT00579345|42086951|FG001|Overall Study|Lost to Follow-up|0|||
19637532|NCT00579345|42086952|FG002|Overall Study|Lost to Follow-up|0|||
19637533|NCT00579345|42086953|FG003|Overall Study|Lost to Follow-up|0|||
19637534|NCT00579345|42086954|FG004|Overall Study|Lost to Follow-up|0|||
19637535|NCT00579345|42086955|FG005|Overall Study|Lost to Follow-up|0|||
19637536|NCT00579345|42086956|FG006|Overall Study|Lost to Follow-up|0|||
19637537|NCT00579345|42086957|FG007|Overall Study|Lost to Follow-up|0|||
19637538|NCT00579345|42086950|FG000|Overall Study|Adverse Event|0|||
19637539|NCT00579345|42086951|FG001|Overall Study|Adverse Event|0|||
19375439|NCT00835211|41617402|FG000|First Intervention|Withdrawal by Subject|0|||
19375440|NCT00835211|41617403|FG001|First Intervention|Withdrawal by Subject|1|||
19375441|NCT00835211|41617402|FG000|Washout: 7 Days|Adverse Event|2|||
19375442|NCT00835211|41617403|FG001|Washout: 7 Days|Adverse Event|1|||
19458467|NCT01891669|41712287|FG004|Overall Study|Other|0|||
19458468|NCT01891669|41712288|FG005|Overall Study|Other|0|||
19637540|NCT00579345|42086952|FG002|Overall Study|Adverse Event|1|||
19637541|NCT00579345|42086953|FG003|Overall Study|Adverse Event|0|||
19637542|NCT00579345|42086954|FG004|Overall Study|Adverse Event|0|||
19637543|NCT00579345|42086955|FG005|Overall Study|Adverse Event|0|||
19637544|NCT00579345|42086956|FG006|Overall Study|Adverse Event|0|||
19637545|NCT00579345|42086957|FG007|Overall Study|Adverse Event|0|||
19637546|NCT00579345|42086950|FG000|Overall Study|Protocol Violation|1|||
19637547|NCT00579345|42086951|FG001|Overall Study|Protocol Violation|0|||
19637548|NCT00579345|42086952|FG002|Overall Study|Protocol Violation|0|||
19637549|NCT00579345|42086953|FG003|Overall Study|Protocol Violation|0|||
19637550|NCT00579345|42086954|FG004|Overall Study|Protocol Violation|0|||
19637551|NCT00579345|42086955|FG005|Overall Study|Protocol Violation|0|||
19637552|NCT00579345|42086956|FG006|Overall Study|Protocol Violation|0|||
19544909|NCT00473382|41994512|FG001|Core Study|Subject non-compliance|2|||
19544910|NCT00473382|41994513|FG002|Core Study|Subject non-compliance|1|||
19544911|NCT00473382|41994511|FG000|Core Study|Subject needed other treatment|1|||
19544912|NCT00473382|41994512|FG001|Core Study|Subject needed other treatment|3|||
19544913|NCT00473382|41994513|FG002|Core Study|Subject needed other treatment|2|||
19544914|NCT00473382|41994511|FG000|Core Study|Subject's decision|12|||
19544915|NCT00473382|41994512|FG001|Core Study|Subject's decision|11|||
19544916|NCT00473382|41994513|FG002|Core Study|Subject's decision|10|||
19637553|NCT00579345|42086957|FG007|Overall Study|Protocol Violation|1|||
19637554|NCT00579345|42086950|FG000|Overall Study|Death|1|||
19458469|NCT01891669|41712289|FG006|Overall Study|Other|0|||
19458470|NCT01891669|41712290|FG007|Overall Study|Other|1|||
19458471|NCT01891669|41712291|FG008|Overall Study|Other|0|||
19458472|NCT01891669|41712292|FG009|Overall Study|Other|0|||
19458473|NCT01421511|41712325|FG000|Overall Study|Lost to Follow-up|11|||
19458474|NCT01421511|41712326|FG001|Overall Study|Lost to Follow-up|14|||
19458475|NCT01421511|41712325|FG000|Overall Study|Randomized but didn't receive study drug|1|||
19458476|NCT01421511|41712326|FG001|Overall Study|Randomized but didn't receive study drug|7|||
19458477|NCT01421511|41712325|FG000|Overall Study|Physician Decision|0|||
19458478|NCT01421511|41712326|FG001|Overall Study|Physician Decision|1|||
19458479|NCT01421511|41712325|FG000|Overall Study|Withdrawal by Subject|6|||
19458480|NCT01421511|41712326|FG001|Overall Study|Withdrawal by Subject|5|||
19458481|NCT01421511|41712325|FG000|Overall Study|Death|1|||
19458482|NCT01421511|41712326|FG001|Overall Study|Death|1|||
19458483|NCT01864525|41712335|FG000|Overall Study|Adverse Event|1|||
19458484|NCT01864525|41712336|FG001|Overall Study|Adverse Event|0|||
19458485|NCT01421277|41712344|FG000|Overall Study|Lack of qualifying event|0|||
19458486|NCT01421277|41712345|FG001|Overall Study|Lack of qualifying event|61|||
19458487|NCT01421277|41712344|FG000|Overall Study|Incomplete baseline data|0|||
19458488|NCT01421277|41712345|FG001|Overall Study|Incomplete baseline data|31|||
19458489|NCT01891357|41712351|FG000|Overall Study|Protocol Violation|3|||
19458490|NCT01420965|41712358|FG000|Overall Study|Withdrawal by Subject|1|||
19458491|NCT01420965|41712359|FG001|Overall Study|Withdrawal by Subject|0|||
19458492|NCT01420965|41712360|FG002|Overall Study|Withdrawal by Subject|0|||
19458493|NCT01420965|41712358|FG000|Overall Study|Adverse Event|0|||
19458494|NCT01420965|41712359|FG001|Overall Study|Adverse Event|1|||
19458495|NCT01420965|41712360|FG002|Overall Study|Adverse Event|0|||
19544917|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
19637555|NCT00579345|42086951|FG001|Overall Study|Death|1|||
19637556|NCT00579345|42086952|FG002|Overall Study|Death|1|||
19458496|NCT01390389|41712370|FG000|Overall Study|Withdrawal by Subject|2|||
19544918|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
19544919|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
19544920|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Death|1|||
19544921|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Death|3|||
19544922|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Death|3|||
19544923|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
19544924|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
19544925|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
19544926|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
19544927|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
19544928|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
19544929|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
19544930|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
19544931|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
19544932|NCT00473382|41994511|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
19544933|NCT00473382|41994512|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
19544934|NCT00473382|41994513|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
19637557|NCT00579345|42086953|FG003|Overall Study|Death|1|||
19637558|NCT00579345|42086954|FG004|Overall Study|Death|0|||
19637559|NCT00579345|42086955|FG005|Overall Study|Death|0|||
19637560|NCT00579345|42086956|FG006|Overall Study|Death|0|||
19637561|NCT00579345|42086957|FG007|Overall Study|Death|0|||
19637562|NCT00795821|42087005|FG000|Acute Treatment Phase|Adverse Event|23|||
19637563|NCT00795821|42087006|FG001|Acute Treatment Phase|Adverse Event|4|||
19637564|NCT00795821|42087005|FG000|Acute Treatment Phase|Death|1|||
19637565|NCT00795821|42087006|FG001|Acute Treatment Phase|Death|0|||
19637566|NCT00795821|42087005|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
19637567|NCT00795821|42087006|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
19637568|NCT00795821|42087005|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
19637569|NCT00795821|42087006|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
19637570|NCT00795821|42087005|FG000|Acute Treatment Phase|Physician Decision|1|||
19637571|NCT00795821|42087006|FG001|Acute Treatment Phase|Physician Decision|1|||
19637572|NCT00795821|42087005|FG000|Acute Treatment Phase|Protocol Violation|1|||
19637573|NCT00795821|42087006|FG001|Acute Treatment Phase|Protocol Violation|2|||
19637574|NCT00795821|42087005|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
19637575|NCT00795821|42087006|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
19637576|NCT00795821|42087005|FG000|Long-term Extension Phase|Adverse Event|25|||
19637577|NCT00795821|42087006|FG001|Long-term Extension Phase|Adverse Event|32|||
19637578|NCT00795821|42087005|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
19637579|NCT00795821|42087006|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
19637580|NCT00795821|42087005|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
19637581|NCT00795821|42087006|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
19637582|NCT00795821|42087005|FG000|Long-term Extension Phase|Physician Decision|1|||
19637583|NCT00795821|42087006|FG001|Long-term Extension Phase|Physician Decision|2|||
19637584|NCT00795821|42087005|FG000|Long-term Extension Phase|Protocol Violation|3|||
19637585|NCT00795821|42087006|FG001|Long-term Extension Phase|Protocol Violation|5|||
19637586|NCT00795821|42087005|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
19637587|NCT00795821|42087006|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
19637588|NCT00795821|42087005|FG000|Taper Phase|Adverse Event|2|||
19637589|NCT00795821|42087006|FG001|Taper Phase|Adverse Event|0|||
19637590|NCT00795821|42087005|FG000|Taper Phase|Lost to Follow-up|1|||
19637591|NCT00795821|42087006|FG001|Taper Phase|Lost to Follow-up|0|||
19637592|NCT00795821|42087005|FG000|Taper Phase|Physician Decision|2|||
19637593|NCT00795821|42087006|FG001|Taper Phase|Physician Decision|0|||
19637594|NCT00795821|42087005|FG000|Taper Phase|Withdrawal by Subject|4|||
19637595|NCT00795821|42087006|FG001|Taper Phase|Withdrawal by Subject|0|||
19637596|NCT00578643|42087022|FG000|Overall Study|Death|1|||
19637597|NCT00578643|42087022|FG000|Overall Study|Lost to Follow-up|1|||
19637598|NCT00578565|42087026|FG000|Overall Study|Adverse Event|3|||
19637599|NCT00741260|42087038|FG000|Overall Study|Disease Progression|3|||
19637600|NCT00741260|42087039|FG001|Overall Study|Disease Progression|5|||
19637601|NCT00741260|42087040|FG002|Overall Study|Disease Progression|3|||
19637602|NCT00741260|42087041|FG003|Overall Study|Disease Progression|3|||
19637603|NCT00741260|42087042|FG004|Overall Study|Disease Progression|5|||
19637604|NCT00741260|42087043|FG005|Overall Study|Disease Progression|37|||
19637605|NCT00741260|42087044|FG006|Overall Study|Disease Progression|4|||
19637606|NCT00741260|42087038|FG000|Overall Study|Death|0|||
19637607|NCT00741260|42087039|FG001|Overall Study|Death|1|||
19637608|NCT00741260|42087040|FG002|Overall Study|Death|0|||
19637609|NCT00741260|42087041|FG003|Overall Study|Death|1|||
19637610|NCT00741260|42087042|FG004|Overall Study|Death|2|||
19637611|NCT00741260|42087043|FG005|Overall Study|Death|2|||
19637612|NCT00741260|42087044|FG006|Overall Study|Death|1|||
19637613|NCT00741260|42087038|FG000|Overall Study|Withdrawal by Subject|0|||
19637614|NCT00741260|42087039|FG001|Overall Study|Withdrawal by Subject|0|||
19637615|NCT00741260|42087040|FG002|Overall Study|Withdrawal by Subject|0|||
19637616|NCT00741260|42087041|FG003|Overall Study|Withdrawal by Subject|0|||
19637617|NCT00741260|42087042|FG004|Overall Study|Withdrawal by Subject|1|||
19637618|NCT00741260|42087043|FG005|Overall Study|Withdrawal by Subject|3|||
19637619|NCT00741260|42087044|FG006|Overall Study|Withdrawal by Subject|1|||
19637620|NCT00741260|42087038|FG000|Overall Study|Physician Decision|1|||
19637621|NCT00741260|42087039|FG001|Overall Study|Physician Decision|1|||
19637622|NCT00741260|42087040|FG002|Overall Study|Physician Decision|0|||
19637623|NCT00741260|42087041|FG003|Overall Study|Physician Decision|0|||
19637624|NCT00741260|42087042|FG004|Overall Study|Physician Decision|0|||
19637625|NCT00741260|42087043|FG005|Overall Study|Physician Decision|0|||
19637626|NCT00741260|42087044|FG006|Overall Study|Physician Decision|0|||
19637627|NCT00741260|42087038|FG000|Overall Study|Other|2|||
19637628|NCT00741260|42087039|FG001|Overall Study|Other|1|||
19637629|NCT00741260|42087040|FG002|Overall Study|Other|1|||
19637630|NCT00741260|42087041|FG003|Overall Study|Other|2|||
19637631|NCT00741260|42087042|FG004|Overall Study|Other|1|||
19637632|NCT00741260|42087043|FG005|Overall Study|Other|3|||
19637633|NCT00741260|42087044|FG006|Overall Study|Other|1|||
19637634|NCT00740870|42087065|FG000|Overall Study|Not Catheterized|4|||
19637635|NCT00740870|42087065|FG000|Overall Study|Further testing contraindicated implant|17|||
19637636|NCT00740792|42087076|FG000|Overall Study|Adverse Event|3|||
19637637|NCT00740792|42087077|FG001|Overall Study|Adverse Event|1|||
19637638|NCT00740792|42087078|FG002|Overall Study|Adverse Event|1|||
19637639|NCT00740792|42087079|FG003|Overall Study|Adverse Event|3|||
19637640|NCT00740792|42087076|FG000|Overall Study|Lack of Efficacy|1|||
19637641|NCT00740792|42087077|FG001|Overall Study|Lack of Efficacy|1|||
19637642|NCT00740792|42087078|FG002|Overall Study|Lack of Efficacy|0|||
19637643|NCT00740792|42087079|FG003|Overall Study|Lack of Efficacy|3|||
19637644|NCT00740792|42087076|FG000|Overall Study|Lost to Follow-up|2|||
19637645|NCT00740792|42087077|FG001|Overall Study|Lost to Follow-up|1|||
19637646|NCT00740792|42087078|FG002|Overall Study|Lost to Follow-up|0|||
19637647|NCT00740792|42087079|FG003|Overall Study|Lost to Follow-up|0|||
19637648|NCT00740792|42087076|FG000|Overall Study|Protocol Violation|0|||
19637649|NCT00740792|42087077|FG001|Overall Study|Protocol Violation|1|||
19637650|NCT00740792|42087078|FG002|Overall Study|Protocol Violation|0|||
19637651|NCT00740792|42087079|FG003|Overall Study|Protocol Violation|2|||
19637652|NCT00740792|42087076|FG000|Overall Study|Withdrawal by Subject|1|||
19637653|NCT00740792|42087077|FG001|Overall Study|Withdrawal by Subject|1|||
19637654|NCT00740792|42087078|FG002|Overall Study|Withdrawal by Subject|0|||
19637655|NCT00740792|42087079|FG003|Overall Study|Withdrawal by Subject|0|||
19637656|NCT00740792|42087076|FG000|Overall Study|administrative|3|||
19637657|NCT00740792|42087077|FG001|Overall Study|administrative|3|||
19712294|NCT00103857|42155105|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
19712295|NCT00103857|42155106|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
19712296|NCT00103857|42155107|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
19712297|NCT00103857|42155101|FG000|50-Week Extension Study|reason unspecified|0|||
19712298|NCT00103857|42155102|FG001|50-Week Extension Study|reason unspecified|0|||
19712299|NCT00103857|42155103|FG002|50-Week Extension Study|reason unspecified|0|||
19712300|NCT00103857|42155104|FG003|50-Week Extension Study|reason unspecified|0|||
19637658|NCT00740792|42087078|FG002|Overall Study|administrative|8|||
19637659|NCT00740792|42087079|FG003|Overall Study|administrative|2|||
19637660|NCT00740714|42087092|FG000|Overall Study|Withdrawal by Subject|17|||
19637661|NCT00740714|42087093|FG001|Overall Study|Withdrawal by Subject|19|||
19637662|NCT00740714|42087094|FG002|Overall Study|Withdrawal by Subject|29|||
19637663|NCT00788957|42087106|FG000|Part 1|Death|8|||
19637664|NCT00788957|42087107|FG001|Part 1|Death|0|||
19637665|NCT00788957|42087108|FG002|Part 1|Death|0|||
19637666|NCT00788957|42087109|FG003|Part 1|Death|0|||
19637667|NCT00788957|42087110|FG004|Part 1|Death|0|||
19637668|NCT00788957|42087111|FG005|Part 1|Death|0|||
19637669|NCT00788957|42087106|FG000|Part 1|Lost to Follow-up|1|||
19544935|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
19637670|NCT00788957|42087107|FG001|Part 1|Lost to Follow-up|0|||
19637671|NCT00788957|42087108|FG002|Part 1|Lost to Follow-up|0|||
19637672|NCT00788957|42087109|FG003|Part 1|Lost to Follow-up|0|||
19637673|NCT00788957|42087110|FG004|Part 1|Lost to Follow-up|0|||
19637674|NCT00788957|42087111|FG005|Part 1|Lost to Follow-up|0|||
19637675|NCT00788957|42087106|FG000|Part 2|Withdrawal by Subject|0|||
19637676|NCT00788957|42087107|FG001|Part 2|Withdrawal by Subject|9|||
19637677|NCT00788957|42087108|FG002|Part 2|Withdrawal by Subject|5|||
19637678|NCT00788957|42087109|FG003|Part 2|Withdrawal by Subject|3|||
19637679|NCT00788957|42087110|FG004|Part 2|Withdrawal by Subject|0|||
19544936|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
19637680|NCT00788957|42087111|FG005|Part 2|Withdrawal by Subject|0|||
19637681|NCT00788957|42087106|FG000|Part 2|Death|0|||
19637682|NCT00788957|42087107|FG001|Part 2|Death|32|||
19637683|NCT00788957|42087108|FG002|Part 2|Death|35|||
19637684|NCT00788957|42087109|FG003|Part 2|Death|37|||
19637685|NCT00788957|42087110|FG004|Part 2|Death|0|||
19637686|NCT00788957|42087111|FG005|Part 2|Death|0|||
19637687|NCT00788957|42087106|FG000|Part 2|Lost to Follow-up|0|||
19637688|NCT00788957|42087107|FG001|Part 2|Lost to Follow-up|0|||
19637689|NCT00788957|42087108|FG002|Part 2|Lost to Follow-up|3|||
19637690|NCT00788957|42087109|FG003|Part 2|Lost to Follow-up|0|||
19637691|NCT00788957|42087110|FG004|Part 2|Lost to Follow-up|0|||
19637692|NCT00788957|42087111|FG005|Part 2|Lost to Follow-up|0|||
19637693|NCT00788957|42087106|FG000|Part 2|On-study at time of data cut-off|0|||
19637694|NCT00788957|42087107|FG001|Part 2|On-study at time of data cut-off|1|||
19637695|NCT00788957|42087108|FG002|Part 2|On-study at time of data cut-off|1|||
19637696|NCT00788957|42087109|FG003|Part 2|On-study at time of data cut-off|1|||
19637697|NCT00788957|42087110|FG004|Part 2|On-study at time of data cut-off|0|||
19637698|NCT00788957|42087111|FG005|Part 2|On-study at time of data cut-off|0|||
19637699|NCT00788957|42087106|FG000|Part 3|Withdrawal by Subject|0|||
19637700|NCT00788957|42087107|FG001|Part 3|Withdrawal by Subject|0|||
19637701|NCT00788957|42087108|FG002|Part 3|Withdrawal by Subject|0|||
19637702|NCT00788957|42087109|FG003|Part 3|Withdrawal by Subject|0|||
19637703|NCT00788957|42087110|FG004|Part 3|Withdrawal by Subject|0|||
19637704|NCT00788957|42087111|FG005|Part 3|Withdrawal by Subject|2|||
19637705|NCT00788957|42087106|FG000|Part 3|Death|0|||
19637706|NCT00788957|42087107|FG001|Part 3|Death|0|||
19637707|NCT00788957|42087108|FG002|Part 3|Death|0|||
19637708|NCT00788957|42087109|FG003|Part 3|Death|0|||
19637709|NCT00788957|42087110|FG004|Part 3|Death|8|||
19544937|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
19544938|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Death|1|||
19544939|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Death|7|||
19544940|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Death|4|||
19544941|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
19544942|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
19544943|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
19544944|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
19544945|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
19544946|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
19544947|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
19544948|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
19544949|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
19637710|NCT00788957|42087111|FG005|Part 3|Death|9|||
19637711|NCT00788957|42087106|FG000|Part 3|On-study at time of data cut-off|0|||
19637712|NCT00788957|42087107|FG001|Part 3|On-study at time of data cut-off|0|||
19637713|NCT00788957|42087108|FG002|Part 3|On-study at time of data cut-off|0|||
19637714|NCT00788957|42087109|FG003|Part 3|On-study at time of data cut-off|0|||
19637715|NCT00788957|42087110|FG004|Part 3|On-study at time of data cut-off|1|||
19637716|NCT00788957|42087111|FG005|Part 3|On-study at time of data cut-off|0|||
19637717|NCT00740636|42087130|FG000|Overall Study|Adverse Event|0|||
19637718|NCT00740636|42087131|FG001|Overall Study|Adverse Event|2|||
19637719|NCT00740636|42087130|FG000|Overall Study|Patient Ineligible|0|||
19637720|NCT00740636|42087131|FG001|Overall Study|Patient Ineligible|1|||
19637721|NCT00740636|42087130|FG000|Overall Study|Patient Not Treated|0|||
19637722|NCT00740636|42087131|FG001|Overall Study|Patient Not Treated|1|||
19637723|NCT00740636|42087130|FG000|Overall Study|Progressive Disease|1|||
19637724|NCT00740636|42087131|FG001|Overall Study|Progressive Disease|0|||
19637725|NCT00740636|42087130|FG000|Overall Study|Death|1|||
19637726|NCT00740636|42087131|FG001|Overall Study|Death|0|||
19637727|NCT00735254|42087141|FG000|Overall Study|Protocol Violation|1|||
19712301|NCT00103857|42155105|FG004|50-Week Extension Study|reason unspecified|1|||
19637728|NCT00735254|42087142|FG001|Overall Study|Protocol Violation|1|||
19637729|NCT00735254|42087143|FG002|Overall Study|Protocol Violation|1|||
19637730|NCT00735254|42087144|FG003|Overall Study|Protocol Violation|0|||
19637731|NCT00795509|42087154|FG000|Overall Study|Protocol Violation|31|||
19637732|NCT00787787|42087158|FG000|Overall Study|Lack of Efficacy|4|||
19637733|NCT00787787|42087158|FG000|Overall Study|Adverse Event|3|||
19637734|NCT00787319|42087162|FG000|Overall Study|Lost to Follow-up|2|||
19637735|NCT00787319|42087162|FG000|Overall Study|Withdrawal by Subject|15|||
19637736|NCT00787319|42087162|FG000|Overall Study|Adverse Event|3|||
19637737|NCT00787319|42087162|FG000|Overall Study|Objective progression or relapse|30|||
19637738|NCT00787319|42087162|FG000|Overall Study|Lack of Efficacy|1|||
19637739|NCT00787319|42087162|FG000|Overall Study|Budget exhausted/exceeded|1|||
19637740|NCT00787319|42087162|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
19637741|NCT00787319|42087162|FG000|Overall Study|No health insurance reimbursement|2|||
19637742|NCT00787319|42087162|FG000|Overall Study|Stabilized disease findings|3|||
19637743|NCT00787319|42087162|FG000|Overall Study|Inactive disease|5|||
19637744|NCT00794963|42087179|FG000|Overall Study|Withdrawal by Subject|1|||
19637745|NCT00794963|42087180|FG001|Overall Study|Withdrawal by Subject|4|||
19637746|NCT00794573|42087188|FG000|Overall Study|Death|3|||
19637747|NCT00794573|42087189|FG001|Overall Study|Death|0|||
19637748|NCT00794573|42087188|FG000|Overall Study|Withdrawal by Subject|9|||
19637749|NCT00794573|42087189|FG001|Overall Study|Withdrawal by Subject|12|||
19637750|NCT00794573|42087188|FG000|Overall Study|Lost to Follow-up|26|||
19637751|NCT00794573|42087189|FG001|Overall Study|Lost to Follow-up|33|||
19637752|NCT00584844|42087195|FG000|Overall Study|Withdrawal by Subject|59|||
19637753|NCT00584844|42087195|FG000|Overall Study|Screen Failure|20|||
19637754|NCT00739934|42087203|FG000|Voriconazole IV|Adverse Event|6|||
19544950|NCT00473382|41994511|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
19637755|NCT00739934|42087203|FG000|Voriconazole Oral|Other|3|||
19637756|NCT00739310|42087212|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
19637757|NCT00739310|42087212|FG000|Overall Study|Withdrawal by Subject|1|||
19637758|NCT00739310|42087212|FG000|Overall Study|Lost to Follow-up|2|||
19637759|NCT00734630|42087219|FG000|Overall Study|Lack of Efficacy|4|||
19637760|NCT00734630|42087220|FG001|Overall Study|Lack of Efficacy|4|||
19637761|NCT00734630|42087219|FG000|Overall Study|Withdrawal by Subject|7|||
19637762|NCT00734630|42087220|FG001|Overall Study|Withdrawal by Subject|9|||
19637763|NCT00734630|42087219|FG000|Overall Study|Lost to Follow-up|13|||
19637764|NCT00734630|42087220|FG001|Overall Study|Lost to Follow-up|7|||
19637765|NCT00734630|42087219|FG000|Overall Study|Protocol Violation|0|||
19637766|NCT00734630|42087220|FG001|Overall Study|Protocol Violation|3|||
19637767|NCT00734630|42087219|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
19637768|NCT00734630|42087220|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
19637769|NCT00734630|42087219|FG000|Overall Study|Adverse Event|3|||
19637770|NCT00734630|42087220|FG001|Overall Study|Adverse Event|6|||
19637771|NCT00734630|42087219|FG000|Overall Study|Randomized in Error|0|||
19637772|NCT00734630|42087220|FG001|Overall Study|Randomized in Error|1|||
19637773|NCT00734630|42087219|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
19637774|NCT00734630|42087220|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
19637775|NCT00734630|42087219|FG000|Overall Study|Poor Compliance|1|||
19637776|NCT00734630|42087220|FG001|Overall Study|Poor Compliance|1|||
19637777|NCT00584454|42087226|FG000|Overall Study|Adverse Event|1|||
19544951|NCT00473382|41994512|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
19544952|NCT00473382|41994513|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
19544953|NCT00473265|41994539|FG000|Overall Study|Unrelated adverse event|5|||
19544954|NCT00473265|41994539|FG000|Overall Study|Off treatment early|15|||
19544955|NCT00472641|41994543|FG000|Overall Study|Lack of Efficacy|3|||
19544956|NCT00472641|41994543|FG000|Overall Study|Adverse Event|3|||
19544957|NCT00472641|41994543|FG000|Overall Study|Lost to Follow-up|1|||
19544958|NCT01133977|41994552|FG000|Overall Study|Adverse Event|0|||
19544959|NCT01133977|41994553|FG001|Overall Study|Adverse Event|0|||
19544960|NCT01133977|41994554|FG002|Overall Study|Adverse Event|1|||
19544961|NCT01133977|41994555|FG003|Overall Study|Adverse Event|0|||
19544962|NCT01133977|41994556|FG004|Overall Study|Adverse Event|0|||
19544963|NCT01133977|41994552|FG000|Overall Study|Death|1|||
19544964|NCT01133977|41994553|FG001|Overall Study|Death|1|||
19544965|NCT01133977|41994554|FG002|Overall Study|Death|1|||
19544966|NCT01133977|41994555|FG003|Overall Study|Death|7|||
19637778|NCT00584454|42087226|FG000|Overall Study|Relocation|1|||
19637779|NCT00584454|42087226|FG000|Overall Study|Clinical Hold|2|||
19637780|NCT00578175|42087233|FG000|Overall Study|Adverse Event|0|||
19637781|NCT00578175|42087234|FG001|Overall Study|Adverse Event|1|||
19637782|NCT00578175|42087235|FG002|Overall Study|Adverse Event|1|||
19637783|NCT00578175|42087233|FG000|Overall Study|Other reasons|70|||
19637784|NCT00578175|42087234|FG001|Overall Study|Other reasons|42|||
19637785|NCT00578175|42087235|FG002|Overall Study|Other reasons|23|||
19637786|NCT00435409|42087247|FG000|Overall Study|Protocol Violation|1|||
19637787|NCT00435409|42087248|FG001|Overall Study|Protocol Violation|2|||
19637788|NCT00435409|42087249|FG002|Overall Study|Protocol Violation|0|||
19637789|NCT00435409|42087247|FG000|Overall Study|Lost to Follow-up|1|||
19637790|NCT00435409|42087248|FG001|Overall Study|Lost to Follow-up|2|||
19637791|NCT00435409|42087249|FG002|Overall Study|Lost to Follow-up|0|||
19637792|NCT00435409|42087247|FG000|Overall Study|Death|8|||
19637793|NCT00435409|42087248|FG001|Overall Study|Death|6|||
19637794|NCT00435409|42087249|FG002|Overall Study|Death|6|||
19637795|NCT00435409|42087247|FG000|Overall Study|Objective progression or relapse|158|||
19637796|NCT00435409|42087248|FG001|Overall Study|Objective progression or relapse|93|||
19637797|NCT00435409|42087249|FG002|Overall Study|Objective progression or relapse|58|||
19637798|NCT00435409|42087247|FG000|Overall Study|Global deterioration of health status|0|||
19637799|NCT00435409|42087248|FG001|Overall Study|Global deterioration of health status|0|||
19637800|NCT00435409|42087249|FG002|Overall Study|Global deterioration of health status|4|||
19637801|NCT00435409|42087247|FG000|Overall Study|Withdrawal by Subject|8|||
19637802|NCT00435409|42087248|FG001|Overall Study|Withdrawal by Subject|7|||
19637803|NCT00435409|42087249|FG002|Overall Study|Withdrawal by Subject|1|||
19637804|NCT00435409|42087247|FG000|Overall Study|Other|45|||
19637805|NCT00435409|42087248|FG001|Overall Study|Other|30|||
19637806|NCT00435409|42087249|FG002|Overall Study|Other|1|||
19637807|NCT00435409|42087247|FG000|Overall Study|Adverse Event|0|||
19637808|NCT00435409|42087248|FG001|Overall Study|Adverse Event|0|||
19637809|NCT00435409|42087249|FG002|Overall Study|Adverse Event|8|||
19637810|NCT00435409|42087247|FG000|Overall Study|Sponsor decision|0|||
19637811|NCT00435409|42087248|FG001|Overall Study|Sponsor decision|3|||
19637812|NCT00435409|42087249|FG002|Overall Study|Sponsor decision|0|||
19637813|NCT00467857|42087266|FG000|Overall Study|Adverse Event|1|||
19637814|NCT00467857|42087267|FG001|Overall Study|Adverse Event|0|||
19637815|NCT00467857|42087266|FG000|Overall Study|Withdrew consent|2|||
19637816|NCT00467857|42087267|FG001|Overall Study|Withdrew consent|0|||
19637817|NCT00467857|42087266|FG000|Overall Study|Death|0|||
19637818|NCT00467857|42087267|FG001|Overall Study|Death|1|||
19637819|NCT00467857|42087266|FG000|Overall Study|Discharged from court service|0|||
19637820|NCT00467857|42087267|FG001|Overall Study|Discharged from court service|1|||
19637821|NCT00467857|42087266|FG000|Overall Study|Emergency care required|0|||
19637822|NCT00467857|42087267|FG001|Overall Study|Emergency care required|1|||
19637823|NCT00467857|42087266|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
19637824|NCT00467857|42087267|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
19712302|NCT00103857|42155106|FG005|50-Week Extension Study|reason unspecified|0|||
19458497|NCT01390389|41712371|FG001|Overall Study|Withdrawal by Subject|0|||
19458498|NCT01390389|41712370|FG000|Overall Study|Screen Fail|2|||
19458499|NCT01390389|41712371|FG001|Overall Study|Screen Fail|1|||
19458500|NCT01401465|41712383|FG000|Treatment Period 1|Adverse Event|4|||
19458501|NCT01401465|41712384|FG001|Treatment Period 1|Adverse Event|1|||
19458502|NCT01401465|41712383|FG000|Treatment Period 1|Pregnancy|0|||
19458503|NCT01401465|41712384|FG001|Treatment Period 1|Pregnancy|1|||
19458504|NCT01401465|41712383|FG000|Treatment Period 1|Protocol Violation|5|||
19458505|NCT01401465|41712384|FG001|Treatment Period 1|Protocol Violation|0|||
19458506|NCT01401465|41712383|FG000|Treatment Period 1|Withdrawal by Subject|1|||
19458507|NCT01401465|41712384|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19458508|NCT01401465|41712383|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
19458509|NCT01401465|41712384|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
19458510|NCT01401465|41712383|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
19458511|NCT01401465|41712384|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
19458512|NCT01401465|41712383|FG000|Treatment Period 1|Scheduling Difficulties|1|||
19458513|NCT01401465|41712384|FG001|Treatment Period 1|Scheduling Difficulties|1|||
19458514|NCT01401465|41712383|FG000|Treatment Period 2|Lost to Follow-up|0|||
19458515|NCT01401465|41712384|FG001|Treatment Period 2|Lost to Follow-up|1|||
19458516|NCT01401465|41712383|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19458517|NCT01401465|41712384|FG001|Treatment Period 2|Withdrawal by Subject|1|||
19458518|NCT01401153|41712395|FG000|First Test Day|Learning disabilities; illness|1|||
19458519|NCT01401153|41712396|FG001|First Test Day|Learning disabilities; illness|10|||
19458520|NCT01401153|41712395|FG000|Second Test Day|illness|0|||
19458521|NCT01401153|41712396|FG001|Second Test Day|illness|5|||
19458522|NCT01890967|41712409|FG000|Overall Study|Adverse Event|3|||
19458523|NCT01890967|41712410|FG001|Overall Study|Adverse Event|3|||
19458524|NCT01890967|41712411|FG002|Overall Study|Adverse Event|3|||
19458525|NCT01890967|41712412|FG003|Overall Study|Adverse Event|2|||
19458526|NCT01890967|41712413|FG004|Overall Study|Adverse Event|1|||
19458527|NCT01890967|41712414|FG005|Overall Study|Adverse Event|7|||
19458528|NCT01890967|41712409|FG000|Overall Study|Death|1|||
19458529|NCT01890967|41712410|FG001|Overall Study|Death|0|||
19637825|NCT00467857|42087266|FG000|Overall Study|Discontinuation reason missing|0|||
19637826|NCT00467857|42087267|FG001|Overall Study|Discontinuation reason missing|3|||
19637827|NCT00435019|42087275|FG000|Overall Study|Adverse Event|1|||
19637828|NCT00435019|42087276|FG001|Overall Study|Adverse Event|0|||
19637829|NCT00435019|42087275|FG000|Overall Study|Lack of Efficacy|1|||
19712303|NCT00103857|42155107|FG006|50-Week Extension Study|reason unspecified|0|||
19458530|NCT01890967|41712411|FG002|Overall Study|Death|0|||
19637830|NCT00435019|42087276|FG001|Overall Study|Lack of Efficacy|2|||
19637831|NCT00435019|42087275|FG000|Overall Study|Protocol Violation|3|||
19637832|NCT00435019|42087276|FG001|Overall Study|Protocol Violation|1|||
19637833|NCT00435019|42087275|FG000|Overall Study|Personal reasons for withdrawal|8|||
19637834|NCT00435019|42087276|FG001|Overall Study|Personal reasons for withdrawal|7|||
19637835|NCT00577863|42087284|FG000|Overall Study|Adverse Event|4|||
19637836|NCT00577863|42087285|FG001|Overall Study|Adverse Event|2|||
19637837|NCT00577863|42087284|FG000|Overall Study|Death|1|||
19637838|NCT00577863|42087285|FG001|Overall Study|Death|0|||
19637839|NCT00577863|42087284|FG000|Overall Study|Lost to Follow-up|2|||
19637840|NCT00577863|42087285|FG001|Overall Study|Lost to Follow-up|2|||
19637841|NCT00577863|42087284|FG000|Overall Study|Entry Criteria Exclusion|1|||
19637842|NCT00577863|42087285|FG001|Overall Study|Entry Criteria Exclusion|0|||
19637843|NCT00577863|42087284|FG000|Overall Study|Withdrawal by Subject|0|||
19637844|NCT00577863|42087285|FG001|Overall Study|Withdrawal by Subject|2|||
19637845|NCT00577863|42087284|FG000|Overall Study|Sponsor Decision|2|||
19637846|NCT00577863|42087285|FG001|Overall Study|Sponsor Decision|7|||
19637847|NCT00577863|42087284|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
19637848|NCT00577863|42087285|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
19637849|NCT00794417|42087295|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
19637850|NCT00794417|42087296|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
19637851|NCT00794417|42087297|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
19637852|NCT00794417|42087298|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
19637853|NCT00794417|42087295|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
19637854|NCT00794417|42087296|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
19637855|NCT00794417|42087297|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
19637856|NCT00794417|42087298|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
19637857|NCT00794417|42087295|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
19637858|NCT00794417|42087296|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
19637859|NCT00794417|42087297|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
19637860|NCT00794417|42087298|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
19637861|NCT00794417|42087295|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
19637862|NCT00794417|42087296|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
19637863|NCT00794417|42087297|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
19637864|NCT00794417|42087298|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
19637865|NCT00794417|42087295|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
19637866|NCT00794417|42087296|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
19637867|NCT00794417|42087297|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
19637868|NCT00794417|42087298|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
19637869|NCT00794417|42087295|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
19637870|NCT00794417|42087296|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
19637871|NCT00794417|42087297|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
19637872|NCT00794417|42087298|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
19637873|NCT00794339|42087310|FG000|Overall Study|Withdrawal by Subject|3|||
19637874|NCT00794339|42087310|FG000|Overall Study|Ineligible|4|||
19637875|NCT00794339|42087310|FG000|Overall Study|Tx prior to ATSM|3|||
19637876|NCT00794339|42087310|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
19637877|NCT00794339|42087310|FG000|Overall Study|Tx not per protocol|1|||
19637878|NCT00790907|42087334|FG000|Overall Study|Adverse Event|9|||
19637879|NCT00790907|42087335|FG001|Overall Study|Adverse Event|7|||
19637880|NCT00790907|42087336|FG002|Overall Study|Adverse Event|6|||
19637881|NCT00790907|42087334|FG000|Overall Study|Physician Decision|304|||
19637882|NCT00790907|42087335|FG001|Overall Study|Physician Decision|271|||
19712304|NCT03587584|42155124|FG000|Overall Study|SOC deviations|4|||
19712305|NCT03587584|42155125|FG001|Overall Study|SOC deviations|6|||
19712306|NCT03587584|42155124|FG000|Overall Study|Incomplete data|0|||
19712307|NCT03587584|42155125|FG001|Overall Study|Incomplete data|3|||
19712308|NCT03586726|42155131|FG000|Overall Study|Withdrawal by Subject|1|||
19712309|NCT03586648|42155135|FG000|Period 1|Withdrawal by Subject|0|||
19712310|NCT03586648|42155136|FG001|Period 1|Withdrawal by Subject|1|||
19712311|NCT03586648|42155135|FG000|Period 1|Lost to Follow-up|1|||
19712312|NCT03586648|42155136|FG001|Period 1|Lost to Follow-up|1|||
19712313|NCT03586648|42155135|FG000|Period 1|Adverse Event|1|||
19712314|NCT03586648|42155136|FG001|Period 1|Adverse Event|0|||
19712315|NCT03586648|42155135|FG000|Period 1|Study related symptoms or complaints|2|||
19712316|NCT03586648|42155136|FG001|Period 1|Study related symptoms or complaints|1|||
19712317|NCT03586648|42155135|FG000|Period 1|Physician Decision|0|||
19712318|NCT03586648|42155136|FG001|Period 1|Physician Decision|1|||
19637883|NCT00790907|42087336|FG002|Overall Study|Physician Decision|255|||
19637884|NCT00790907|42087334|FG000|Overall Study|Withdrawal by Subject|1|||
19637885|NCT00790907|42087335|FG001|Overall Study|Withdrawal by Subject|7|||
19637886|NCT00790907|42087336|FG002|Overall Study|Withdrawal by Subject|5|||
19637887|NCT00790907|42087334|FG000|Overall Study|Bleeding Event|11|||
19637888|NCT00790907|42087335|FG001|Overall Study|Bleeding Event|16|||
19712319|NCT03586648|42155135|FG000|Period 2|Adverse Event|1|||
19637889|NCT00790907|42087336|FG002|Overall Study|Bleeding Event|21|||
19637890|NCT00790907|42087334|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
19637891|NCT00790907|42087335|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
19637892|NCT00790907|42087336|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
19637893|NCT00790907|42087334|FG000|Overall Study|Qualifying Condition Not Present|29|||
19637894|NCT00790907|42087335|FG001|Overall Study|Qualifying Condition Not Present|14|||
19458531|NCT01890967|41712412|FG003|Overall Study|Death|0|||
19458532|NCT01890967|41712413|FG004|Overall Study|Death|0|||
19458533|NCT01890967|41712414|FG005|Overall Study|Death|0|||
19458534|NCT01890967|41712409|FG000|Overall Study|Lost to Follow-up|1|||
19458535|NCT01890967|41712410|FG001|Overall Study|Lost to Follow-up|1|||
19458536|NCT01890967|41712411|FG002|Overall Study|Lost to Follow-up|1|||
19544967|NCT01133977|41994556|FG004|Overall Study|Death|3|||
19712320|NCT03586648|42155136|FG001|Period 2|Adverse Event|0|||
19712321|NCT02892448|42155145|FG000|Overall Study|Screening failure|2|||
19712322|NCT02892448|42155146|FG001|Overall Study|Screening failure|2|||
19712323|NCT02892448|42155147|FG002|Overall Study|Screening failure|1|||
19712324|NCT03585712|42155155|FG000|Treatment Period 1|Protocol Violation|1|||
19712325|NCT03585712|42155156|FG001|Treatment Period 1|Protocol Violation|0|||
19712326|NCT03585712|42155157|FG002|Treatment Period 1|Protocol Violation|0|||
19712327|NCT03585712|42155155|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
19712328|NCT03585712|42155156|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
19712329|NCT03585712|42155157|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
19712330|NCT03585712|42155155|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
19712331|NCT03585712|42155156|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
19712332|NCT03585712|42155157|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
19712333|NCT03585712|42155155|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
19712334|NCT03585712|42155156|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
19712335|NCT03585712|42155157|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
19712336|NCT03585244|42155174|FG000|Overall Study|Withdrawal by Subject|15|||
19637895|NCT00790907|42087336|FG002|Overall Study|Qualifying Condition Not Present|16|||
19637896|NCT00790907|42087334|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
19637897|NCT00790907|42087335|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
19637898|NCT00790907|42087336|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
19712337|NCT00074984|42155180|FG000|Overall Study|Death|1|||
19712338|NCT00074984|42155181|FG001|Overall Study|Death|2|||
19712339|NCT00074984|42155180|FG000|Overall Study|Withdrawal by Subject|2|||
19712340|NCT00074984|42155181|FG001|Overall Study|Withdrawal by Subject|3|||
19712341|NCT00074984|42155180|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
19712342|NCT00074984|42155181|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
19712343|NCT03583606|42155191|FG000|Overall Study|Lost to Follow-up|0|||
19712344|NCT03583606|42155192|FG001|Overall Study|Lost to Follow-up|1|||
19712345|NCT03583606|42155193|FG002|Overall Study|Lost to Follow-up|0|||
19712346|NCT03583606|42155191|FG000|Overall Study|Ineligible at baseline|1|||
19712347|NCT03583606|42155192|FG001|Overall Study|Ineligible at baseline|0|||
19712348|NCT03583606|42155193|FG002|Overall Study|Ineligible at baseline|0|||
19712349|NCT03583450|42155204|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
19544968|NCT01133977|41994552|FG000|Overall Study|Started a New Line of Therapy|2|||
19544969|NCT01133977|41994553|FG001|Overall Study|Started a New Line of Therapy|6|||
19544970|NCT01133977|41994554|FG002|Overall Study|Started a New Line of Therapy|4|||
19544971|NCT01133977|41994555|FG003|Overall Study|Started a New Line of Therapy|25|||
19544972|NCT01133977|41994556|FG004|Overall Study|Started a New Line of Therapy|33|||
19637899|NCT00790907|42087334|FG000|Overall Study|Did Not Receive Study Drug|10|||
19637900|NCT00790907|42087335|FG001|Overall Study|Did Not Receive Study Drug|0|||
19637901|NCT00790907|42087336|FG002|Overall Study|Did Not Receive Study Drug|0|||
19712350|NCT03583450|42155205|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
19712351|NCT03583372|42155217|FG000|Overall Study|Withdrawal by Subject|6|||
19712352|NCT03583372|42155218|FG001|Overall Study|Withdrawal by Subject|11|||
19712353|NCT03583372|42155219|FG002|Overall Study|Withdrawal by Subject|7|||
19712354|NCT03583372|42155220|FG003|Overall Study|Withdrawal by Subject|8|||
19637902|NCT00793871|42087354|FG000|Overall Study|Death|50|||
19637903|NCT00793871|42087354|FG000|Overall Study|Lost to Follow-up|3|||
19458537|NCT01890967|41712412|FG003|Overall Study|Lost to Follow-up|1|||
19458538|NCT01890967|41712413|FG004|Overall Study|Lost to Follow-up|0|||
19458539|NCT01890967|41712414|FG005|Overall Study|Lost to Follow-up|1|||
19458540|NCT01890967|41712409|FG000|Overall Study|Protocol Violation|0|||
19458541|NCT01890967|41712410|FG001|Overall Study|Protocol Violation|3|||
19458542|NCT01890967|41712411|FG002|Overall Study|Protocol Violation|3|||
19458543|NCT01890967|41712412|FG003|Overall Study|Protocol Violation|2|||
19458544|NCT01890967|41712413|FG004|Overall Study|Protocol Violation|4|||
19544973|NCT01133977|41994552|FG000|Overall Study|Lost to Follow-up|0|||
19458545|NCT01890967|41712414|FG005|Overall Study|Protocol Violation|1|||
19637904|NCT00793871|42087354|FG000|Overall Study|Study terminated by the Sponsor|7|||
19637905|NCT00577707|42087362|FG000|Overall Study|Withdrawal by Subject|3|||
19637906|NCT00713349|42087366|FG000|Overall Study|Protocol Violation|1|||
19637907|NCT00712959|42087374|FG000|Overall Study|Protocol Violation|3|||
19637908|NCT00712959|42087375|FG001|Overall Study|Protocol Violation|1|||
19637909|NCT00712959|42087374|FG000|Overall Study|Lost to Follow-up|13|||
19637910|NCT00712959|42087375|FG001|Overall Study|Lost to Follow-up|2|||
19637911|NCT00712959|42087374|FG000|Overall Study|Withdrawal by Subject|3|||
19712355|NCT03583372|42155217|FG000|Overall Study|Lost to Follow-up|4|||
19712356|NCT03583372|42155218|FG001|Overall Study|Lost to Follow-up|6|||
19712357|NCT03583372|42155219|FG002|Overall Study|Lost to Follow-up|3|||
19712358|NCT03583372|42155220|FG003|Overall Study|Lost to Follow-up|2|||
19712359|NCT03583372|42155217|FG000|Overall Study|Adverse Event|1|||
19712360|NCT03583372|42155218|FG001|Overall Study|Adverse Event|3|||
19712361|NCT03583372|42155219|FG002|Overall Study|Adverse Event|4|||
19637912|NCT00712959|42087375|FG001|Overall Study|Withdrawal by Subject|0|||
19637913|NCT00712725|42087389|FG000|Overall Study|Adverse Event|1|||
19637914|NCT00712725|42087390|FG001|Overall Study|Adverse Event|0|||
19712362|NCT03583372|42155220|FG003|Overall Study|Adverse Event|4|||
19712363|NCT03583372|42155217|FG000|Overall Study|Physician Decision|0|||
19637915|NCT00712725|42087391|FG002|Overall Study|Adverse Event|0|||
19637916|NCT00712725|42087392|FG003|Overall Study|Adverse Event|1|||
19637917|NCT00712725|42087393|FG004|Overall Study|Adverse Event|0|||
19637918|NCT00712725|42087394|FG005|Overall Study|Adverse Event|0|||
19637919|NCT00712725|42087395|FG006|Overall Study|Adverse Event|0|||
19637920|NCT00712725|42087396|FG007|Overall Study|Adverse Event|0|||
19637921|NCT00712725|42087389|FG000|Overall Study|Lost to Follow-up|3|||
19637922|NCT00712725|42087390|FG001|Overall Study|Lost to Follow-up|2|||
19637923|NCT00712725|42087391|FG002|Overall Study|Lost to Follow-up|1|||
19637924|NCT00712725|42087392|FG003|Overall Study|Lost to Follow-up|1|||
19637925|NCT00712725|42087393|FG004|Overall Study|Lost to Follow-up|2|||
19637926|NCT00712725|42087394|FG005|Overall Study|Lost to Follow-up|2|||
19637927|NCT00712725|42087395|FG006|Overall Study|Lost to Follow-up|3|||
19637928|NCT00712725|42087396|FG007|Overall Study|Lost to Follow-up|1|||
19637929|NCT00712725|42087389|FG000|Overall Study|Physician Decision|2|||
19637930|NCT00712725|42087390|FG001|Overall Study|Physician Decision|0|||
19637931|NCT00712725|42087391|FG002|Overall Study|Physician Decision|0|||
19637932|NCT00712725|42087392|FG003|Overall Study|Physician Decision|0|||
19712364|NCT03583372|42155218|FG001|Overall Study|Physician Decision|1|||
19712365|NCT03583372|42155219|FG002|Overall Study|Physician Decision|1|||
19712366|NCT03583372|42155220|FG003|Overall Study|Physician Decision|1|||
19712367|NCT03583372|42155217|FG000|Overall Study|Lack of Efficacy|0|||
19712368|NCT03583372|42155218|FG001|Overall Study|Lack of Efficacy|1|||
19712369|NCT03583372|42155219|FG002|Overall Study|Lack of Efficacy|0|||
19637933|NCT00712725|42087393|FG004|Overall Study|Physician Decision|1|||
19637934|NCT00712725|42087394|FG005|Overall Study|Physician Decision|0|||
19712370|NCT03583372|42155220|FG003|Overall Study|Lack of Efficacy|1|||
19712371|NCT03583372|42155217|FG000|Overall Study|Death|1|||
19712372|NCT03583372|42155218|FG001|Overall Study|Death|0|||
19712373|NCT03583372|42155219|FG002|Overall Study|Death|0|||
19712374|NCT03583372|42155220|FG003|Overall Study|Death|0|||
19712375|NCT03583372|42155217|FG000|Overall Study|Protocol Violation|0|||
19712376|NCT03583372|42155218|FG001|Overall Study|Protocol Violation|1|||
19712377|NCT03583372|42155219|FG002|Overall Study|Protocol Violation|0|||
19637935|NCT00712725|42087395|FG006|Overall Study|Physician Decision|2|||
19637936|NCT00712725|42087396|FG007|Overall Study|Physician Decision|0|||
19637937|NCT00712725|42087389|FG000|Overall Study|Pregnancy|0|||
19637938|NCT00712725|42087390|FG001|Overall Study|Pregnancy|1|||
19637939|NCT00712725|42087391|FG002|Overall Study|Pregnancy|0|||
19637940|NCT00712725|42087392|FG003|Overall Study|Pregnancy|0|||
19637941|NCT00712725|42087393|FG004|Overall Study|Pregnancy|1|||
19637942|NCT00712725|42087394|FG005|Overall Study|Pregnancy|0|||
19637943|NCT00712725|42087395|FG006|Overall Study|Pregnancy|2|||
19637944|NCT00712725|42087396|FG007|Overall Study|Pregnancy|0|||
19637945|NCT00712725|42087389|FG000|Overall Study|Protocol Violation|2|||
19637946|NCT00712725|42087390|FG001|Overall Study|Protocol Violation|0|||
19637947|NCT00712725|42087391|FG002|Overall Study|Protocol Violation|1|||
19712378|NCT03583372|42155220|FG003|Overall Study|Protocol Violation|0|||
19712379|NCT03583372|42155217|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
19712380|NCT03583372|42155218|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
19712381|NCT03583372|42155219|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
19712382|NCT03583372|42155220|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
19712383|NCT03583372|42155217|FG000|Overall Study|Did Not Receive Study Drug|0|||
19637948|NCT00712725|42087392|FG003|Overall Study|Protocol Violation|3|||
19637949|NCT00712725|42087393|FG004|Overall Study|Protocol Violation|2|||
19637950|NCT00712725|42087394|FG005|Overall Study|Protocol Violation|0|||
19637951|NCT00712725|42087395|FG006|Overall Study|Protocol Violation|1|||
19637952|NCT00712725|42087396|FG007|Overall Study|Protocol Violation|1|||
19637953|NCT00712725|42087389|FG000|Overall Study|Withdrawal by Subject|2|||
19637954|NCT00712725|42087390|FG001|Overall Study|Withdrawal by Subject|1|||
19637955|NCT00712725|42087391|FG002|Overall Study|Withdrawal by Subject|1|||
19637956|NCT00712725|42087392|FG003|Overall Study|Withdrawal by Subject|2|||
19637957|NCT00712725|42087393|FG004|Overall Study|Withdrawal by Subject|1|||
19637958|NCT00712725|42087394|FG005|Overall Study|Withdrawal by Subject|1|||
19637959|NCT00712725|42087395|FG006|Overall Study|Withdrawal by Subject|1|||
19637960|NCT00712725|42087396|FG007|Overall Study|Withdrawal by Subject|2|||
19637961|NCT00712725|42087389|FG000|Overall Study|Lack of Qualifying Event|16|||
19637962|NCT00712725|42087390|FG001|Overall Study|Lack of Qualifying Event|2|||
19637963|NCT00712725|42087391|FG002|Overall Study|Lack of Qualifying Event|6|||
19637964|NCT00712725|42087392|FG003|Overall Study|Lack of Qualifying Event|8|||
19637965|NCT00712725|42087393|FG004|Overall Study|Lack of Qualifying Event|11|||
19637966|NCT00712725|42087394|FG005|Overall Study|Lack of Qualifying Event|13|||
19637967|NCT00712725|42087395|FG006|Overall Study|Lack of Qualifying Event|11|||
19637968|NCT00712725|42087396|FG007|Overall Study|Lack of Qualifying Event|6|||
19637969|NCT00712725|42087389|FG000|Overall Study|Protocol Specified Criteria|3|||
19637970|NCT00712725|42087390|FG001|Overall Study|Protocol Specified Criteria|0|||
19637971|NCT00712725|42087391|FG002|Overall Study|Protocol Specified Criteria|1|||
19637972|NCT00712725|42087392|FG003|Overall Study|Protocol Specified Criteria|2|||
19637973|NCT00712725|42087393|FG004|Overall Study|Protocol Specified Criteria|1|||
19637974|NCT00712725|42087394|FG005|Overall Study|Protocol Specified Criteria|0|||
19637975|NCT00712725|42087395|FG006|Overall Study|Protocol Specified Criteria|2|||
19637976|NCT00712725|42087396|FG007|Overall Study|Protocol Specified Criteria|1|||
19637977|NCT00712335|42087419|FG000|Overall Study|Withdrawal by Subject|0|||
19637978|NCT00712335|42087420|FG001|Overall Study|Withdrawal by Subject|7|||
19637979|NCT00712335|42087421|FG002|Overall Study|Withdrawal by Subject|2|||
19637980|NCT00712335|42087422|FG003|Overall Study|Withdrawal by Subject|3|||
19637981|NCT00712335|42087423|FG004|Overall Study|Withdrawal by Subject|0|||
19637982|NCT00712335|42087419|FG000|Overall Study|Lost to Follow-up|2|||
19637983|NCT00712335|42087420|FG001|Overall Study|Lost to Follow-up|5|||
19637984|NCT00712335|42087421|FG002|Overall Study|Lost to Follow-up|0|||
19637985|NCT00712335|42087422|FG003|Overall Study|Lost to Follow-up|1|||
19637986|NCT00712335|42087423|FG004|Overall Study|Lost to Follow-up|0|||
19637987|NCT00712335|42087419|FG000|Overall Study|Protocol Violation|1|||
19637988|NCT00712335|42087420|FG001|Overall Study|Protocol Violation|2|||
19637989|NCT00712335|42087421|FG002|Overall Study|Protocol Violation|1|||
19637990|NCT00712335|42087422|FG003|Overall Study|Protocol Violation|0|||
19637991|NCT00712335|42087423|FG004|Overall Study|Protocol Violation|0|||
19637992|NCT00712335|42087419|FG000|Overall Study|Lack of Efficacy|0|||
19637993|NCT00712335|42087420|FG001|Overall Study|Lack of Efficacy|0|||
19637994|NCT00712335|42087421|FG002|Overall Study|Lack of Efficacy|1|||
19637995|NCT00712335|42087422|FG003|Overall Study|Lack of Efficacy|1|||
19637996|NCT00712335|42087423|FG004|Overall Study|Lack of Efficacy|0|||
19637997|NCT00712335|42087419|FG000|Overall Study|Other Reason|0|||
19637998|NCT00712335|42087420|FG001|Overall Study|Other Reason|3|||
19637999|NCT00712335|42087421|FG002|Overall Study|Other Reason|1|||
19638000|NCT00712335|42087422|FG003|Overall Study|Other Reason|0|||
19638001|NCT00712335|42087423|FG004|Overall Study|Other Reason|0|||
19638002|NCT00577629|42087435|FG000|Treatment Period|Death|1|||
19638003|NCT00577629|42087435|FG000|Long Term Follow-Up|Death|15|||
19638004|NCT00577629|42087435|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
19638005|NCT00577629|42087435|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
19638006|NCT00577629|42087435|FG000|Long Term Follow-Up|Physician Decision|1|||
19638007|NCT00710385|42087441|FG000|Overall Study|Did not qualify|1|||
19638008|NCT00710385|42087441|FG000|Overall Study|Withdrawal by Subject|1|||
19638009|NCT00710385|42087441|FG000|Overall Study|Undisclosed back pain|1|||
19638010|NCT00710385|42087441|FG000|Overall Study|Physician Decision|1|||
19638011|NCT00710385|42087441|FG000|Overall Study|Undisclosed excessive methadone use|1|||
19638012|NCT00701415|42087453|FG000|Overall Study|Adverse Event|0|||
19638013|NCT00701415|42087454|FG001|Overall Study|Adverse Event|1|||
19638014|NCT00701415|42087453|FG000|Overall Study|Social/family issues and needle phobia|1|||
19638015|NCT00701415|42087454|FG001|Overall Study|Social/family issues and needle phobia|0|||
19638016|NCT00700011|42087462|FG000|Overall Study|Death|0|||
19638017|NCT00700011|42087463|FG001|Overall Study|Death|1|||
19638018|NCT00707031|42087471|FG000|Overall Study|Adverse Event|45|||
19638019|NCT00707031|42087472|FG001|Overall Study|Adverse Event|45|||
19638020|NCT00707031|42087471|FG000|Overall Study|Lack of Efficacy|19|||
19638021|NCT00707031|42087472|FG001|Overall Study|Lack of Efficacy|6|||
19638022|NCT00707031|42087471|FG000|Overall Study|Lost to Follow-up|2|||
19638023|NCT00707031|42087472|FG001|Overall Study|Lost to Follow-up|1|||
19638024|NCT00707031|42087471|FG000|Overall Study|Protocol Violation|1|||
19638025|NCT00707031|42087472|FG001|Overall Study|Protocol Violation|0|||
19638026|NCT00707031|42087471|FG000|Overall Study|Withdrawal by Subject|7|||
19638027|NCT00707031|42087472|FG001|Overall Study|Withdrawal by Subject|8|||
19638028|NCT00707031|42087471|FG000|Overall Study|Poor Compliance to Protocol|7|||
19638029|NCT00707031|42087472|FG001|Overall Study|Poor Compliance to Protocol|13|||
19638030|NCT00707031|42087471|FG000|Overall Study|Familial or Personal Reasons|12|||
19638031|NCT00707031|42087472|FG001|Overall Study|Familial or Personal Reasons|15|||
19638032|NCT00707031|42087471|FG000|Overall Study|Serious Noncompliance|2|||
19638033|NCT00707031|42087472|FG001|Overall Study|Serious Noncompliance|3|||
19638034|NCT00707031|42087471|FG000|Overall Study|Sponsor Decision|9|||
19638035|NCT00707031|42087472|FG001|Overall Study|Sponsor Decision|8|||
19638036|NCT00711477|42087481|FG000|Overall Study|Adverse Event|3|||
19638037|NCT00711477|42087482|FG001|Overall Study|Adverse Event|1|||
19638038|NCT00711477|42087481|FG000|Overall Study|Lost to Follow-up|0|||
19638039|NCT00711477|42087482|FG001|Overall Study|Lost to Follow-up|1|||
19638040|NCT00711477|42087481|FG000|Overall Study|Noncompliance|0|||
19638041|NCT00711477|42087482|FG001|Overall Study|Noncompliance|1|||
19638042|NCT00699699|42087490|FG000|Overall Study|Adverse Event|36|||
19638043|NCT00699699|42087490|FG000|Overall Study|Individual different reasons|21|||
19638044|NCT00734474|42087503|FG000|Overall Study|Entry Criteria Not Met|0|||
19638045|NCT00734474|42087504|FG001|Overall Study|Entry Criteria Not Met|0|||
19638046|NCT00734474|42087505|FG002|Overall Study|Entry Criteria Not Met|5|||
19638047|NCT00734474|42087506|FG003|Overall Study|Entry Criteria Not Met|0|||
19638048|NCT00734474|42087507|FG004|Overall Study|Entry Criteria Not Met|3|||
19638049|NCT00734474|42087508|FG005|Overall Study|Entry Criteria Not Met|1|||
19638050|NCT00734474|42087509|FG006|Overall Study|Entry Criteria Not Met|0|||
19638051|NCT00734474|42087510|FG007|Overall Study|Entry Criteria Not Met|1|||
19638052|NCT00734474|42087511|FG008|Overall Study|Entry Criteria Not Met|1|||
19638053|NCT00734474|42087503|FG000|Overall Study|Lost to Follow-up|1|||
19638054|NCT00734474|42087504|FG001|Overall Study|Lost to Follow-up|0|||
19638055|NCT00734474|42087505|FG002|Overall Study|Lost to Follow-up|13|||
19638056|NCT00734474|42087506|FG003|Overall Study|Lost to Follow-up|0|||
19638057|NCT00734474|42087507|FG004|Overall Study|Lost to Follow-up|11|||
19638058|NCT00734474|42087508|FG005|Overall Study|Lost to Follow-up|1|||
19638059|NCT00734474|42087509|FG006|Overall Study|Lost to Follow-up|0|||
19638060|NCT00734474|42087510|FG007|Overall Study|Lost to Follow-up|9|||
19638061|NCT00734474|42087511|FG008|Overall Study|Lost to Follow-up|4|||
19638062|NCT00734474|42087503|FG000|Overall Study|Withdrawal by Subject|2|||
19638063|NCT00734474|42087504|FG001|Overall Study|Withdrawal by Subject|1|||
19638064|NCT00734474|42087505|FG002|Overall Study|Withdrawal by Subject|18|||
19638065|NCT00734474|42087506|FG003|Overall Study|Withdrawal by Subject|0|||
19638066|NCT00734474|42087507|FG004|Overall Study|Withdrawal by Subject|24|||
19458546|NCT01890967|41712409|FG000|Overall Study|Sponsor Decision|2|||
19458547|NCT01890967|41712410|FG001|Overall Study|Sponsor Decision|0|||
19458548|NCT01890967|41712411|FG002|Overall Study|Sponsor Decision|1|||
19458549|NCT01890967|41712412|FG003|Overall Study|Sponsor Decision|3|||
19458550|NCT01890967|41712413|FG004|Overall Study|Sponsor Decision|2|||
19458551|NCT01890967|41712414|FG005|Overall Study|Sponsor Decision|3|||
19458552|NCT01890967|41712409|FG000|Overall Study|Withdrawal by Subject|3|||
19458553|NCT01890967|41712410|FG001|Overall Study|Withdrawal by Subject|4|||
19458554|NCT01890967|41712411|FG002|Overall Study|Withdrawal by Subject|2|||
19458555|NCT01890967|41712412|FG003|Overall Study|Withdrawal by Subject|3|||
19458556|NCT01890967|41712413|FG004|Overall Study|Withdrawal by Subject|3|||
19458557|NCT01890967|41712414|FG005|Overall Study|Withdrawal by Subject|1|||
19458558|NCT01400919|41712433|FG000|Overall Study|Withdrawal by Subject|4|||
19458559|NCT01400919|41712433|FG000|Overall Study|Lost to Follow-up|2|||
19458560|NCT01400919|41712433|FG000|Overall Study|Missed visit|2|||
19458561|NCT01864291|41712437|FG000|Overall Study|need for revision surgery|2|||
19458562|NCT01400841|41712441|FG000|Initial Study Phase (6 Months)|Death|1|||
19458563|NCT01400841|41712441|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
19458564|NCT01863667|41712447|FG000|Overall Study|Adverse Event|1|||
19458565|NCT01863667|41712448|FG001|Overall Study|Adverse Event|0|||
19458566|NCT01863667|41712447|FG000|Overall Study|Study terminated by Sponsor|30|||
19458567|NCT01863667|41712448|FG001|Overall Study|Study terminated by Sponsor|30|||
19458568|NCT01863667|41712447|FG000|Overall Study|Withdrawal by Subject|2|||
19458569|NCT01863667|41712448|FG001|Overall Study|Withdrawal by Subject|2|||
19458570|NCT01614769|41712454|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
19458571|NCT01614769|41712455|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
19458572|NCT01614769|41712456|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
19458573|NCT01614769|41712457|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
19458574|NCT01614769|41712458|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
19458575|NCT01614769|41712459|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
19458576|NCT01614769|41712454|FG000|Period 1|Protocol Violation|0|||
19458577|NCT01614769|41712455|FG001|Period 1|Protocol Violation|0|||
19458578|NCT01614769|41712456|FG002|Period 1|Protocol Violation|0|||
19458579|NCT01614769|41712457|FG003|Period 1|Protocol Violation|1|||
19458580|NCT01614769|41712458|FG004|Period 1|Protocol Violation|0|||
19458581|NCT01614769|41712459|FG005|Period 1|Protocol Violation|0|||
19458582|NCT01614769|41712454|FG000|Period 1|Withdrawal by Subject|1|||
19458583|NCT01614769|41712455|FG001|Period 1|Withdrawal by Subject|0|||
19458584|NCT01614769|41712456|FG002|Period 1|Withdrawal by Subject|0|||
19638067|NCT00734474|42087508|FG005|Overall Study|Withdrawal by Subject|2|||
19638068|NCT00734474|42087509|FG006|Overall Study|Withdrawal by Subject|0|||
19638069|NCT00734474|42087510|FG007|Overall Study|Withdrawal by Subject|36|||
19638070|NCT00734474|42087511|FG008|Overall Study|Withdrawal by Subject|21|||
19638071|NCT00734474|42087503|FG000|Overall Study|Physician Decision|0|||
19638072|NCT00734474|42087504|FG001|Overall Study|Physician Decision|0|||
19638073|NCT00734474|42087505|FG002|Overall Study|Physician Decision|4|||
19638074|NCT00734474|42087506|FG003|Overall Study|Physician Decision|1|||
19544974|NCT01133977|41994553|FG001|Overall Study|Lost to Follow-up|0|||
19544975|NCT01133977|41994554|FG002|Overall Study|Lost to Follow-up|0|||
19544976|NCT01133977|41994555|FG003|Overall Study|Lost to Follow-up|2|||
19544977|NCT01133977|41994556|FG004|Overall Study|Lost to Follow-up|1|||
19544978|NCT01133977|41994552|FG000|Overall Study|Withdrawal by Subject|0|||
19544979|NCT01133977|41994553|FG001|Overall Study|Withdrawal by Subject|0|||
19544980|NCT01133977|41994554|FG002|Overall Study|Withdrawal by Subject|0|||
19544981|NCT01133977|41994555|FG003|Overall Study|Withdrawal by Subject|5|||
19544982|NCT01133977|41994556|FG004|Overall Study|Withdrawal by Subject|1|||
19544983|NCT01133821|41994573|FG000|Overall Study|Lost to Follow-up|8|||
19638075|NCT00734474|42087507|FG004|Overall Study|Physician Decision|11|||
19638076|NCT00734474|42087508|FG005|Overall Study|Physician Decision|0|||
19638077|NCT00734474|42087509|FG006|Overall Study|Physician Decision|0|||
19638078|NCT00734474|42087510|FG007|Overall Study|Physician Decision|9|||
19638079|NCT00734474|42087511|FG008|Overall Study|Physician Decision|9|||
19638080|NCT00734474|42087503|FG000|Overall Study|Adverse Event|4|||
19638081|NCT00734474|42087504|FG001|Overall Study|Adverse Event|4|||
19638082|NCT00734474|42087505|FG002|Overall Study|Adverse Event|63|||
19638083|NCT00734474|42087506|FG003|Overall Study|Adverse Event|1|||
19638084|NCT00734474|42087507|FG004|Overall Study|Adverse Event|64|||
19638085|NCT00734474|42087508|FG005|Overall Study|Adverse Event|0|||
19638086|NCT00734474|42087509|FG006|Overall Study|Adverse Event|1|||
19638087|NCT00734474|42087510|FG007|Overall Study|Adverse Event|65|||
19638088|NCT00734474|42087511|FG008|Overall Study|Adverse Event|39|||
19638089|NCT00734474|42087503|FG000|Overall Study|Protocol Violation|0|||
19638090|NCT00734474|42087504|FG001|Overall Study|Protocol Violation|0|||
19638091|NCT00734474|42087505|FG002|Overall Study|Protocol Violation|4|||
19638092|NCT00734474|42087506|FG003|Overall Study|Protocol Violation|0|||
19638093|NCT00734474|42087507|FG004|Overall Study|Protocol Violation|3|||
19638094|NCT00734474|42087508|FG005|Overall Study|Protocol Violation|0|||
19638095|NCT00734474|42087509|FG006|Overall Study|Protocol Violation|0|||
19638096|NCT00734474|42087510|FG007|Overall Study|Protocol Violation|3|||
19638097|NCT00734474|42087511|FG008|Overall Study|Protocol Violation|1|||
19638098|NCT00734474|42087503|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
19638099|NCT00734474|42087504|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
19638100|NCT00734474|42087505|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
19638101|NCT00734474|42087506|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
19638102|NCT00734474|42087507|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
19638103|NCT00734474|42087508|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
19638104|NCT00734474|42087509|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
19638105|NCT00734474|42087510|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
19638106|NCT00734474|42087511|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
19638107|NCT00734474|42087503|FG000|Overall Study|Sponsor Decision|0|||
19638108|NCT00734474|42087504|FG001|Overall Study|Sponsor Decision|0|||
19638109|NCT00734474|42087505|FG002|Overall Study|Sponsor Decision|0|||
19638110|NCT00734474|42087506|FG003|Overall Study|Sponsor Decision|0|||
19638111|NCT00734474|42087507|FG004|Overall Study|Sponsor Decision|2|||
19638112|NCT00734474|42087508|FG005|Overall Study|Sponsor Decision|0|||
19638113|NCT00734474|42087509|FG006|Overall Study|Sponsor Decision|0|||
19638114|NCT00734474|42087510|FG007|Overall Study|Sponsor Decision|0|||
19638115|NCT00734474|42087511|FG008|Overall Study|Sponsor Decision|0|||
19638116|NCT00734474|42087503|FG000|Overall Study|Death|0|||
19638117|NCT00734474|42087504|FG001|Overall Study|Death|0|||
19638118|NCT00734474|42087505|FG002|Overall Study|Death|1|||
19638119|NCT00734474|42087506|FG003|Overall Study|Death|0|||
19638120|NCT00734474|42087507|FG004|Overall Study|Death|0|||
19638121|NCT00734474|42087508|FG005|Overall Study|Death|0|||
19638122|NCT00734474|42087509|FG006|Overall Study|Death|0|||
19638123|NCT00734474|42087510|FG007|Overall Study|Death|2|||
19638124|NCT00734474|42087511|FG008|Overall Study|Death|1|||
19638125|NCT00734474|42087503|FG000|Overall Study|Lack of Efficacy|0|||
19638126|NCT00734474|42087504|FG001|Overall Study|Lack of Efficacy|0|||
19638127|NCT00734474|42087505|FG002|Overall Study|Lack of Efficacy|4|||
19638128|NCT00734474|42087506|FG003|Overall Study|Lack of Efficacy|0|||
19544984|NCT01133821|41994574|FG001|Overall Study|Lost to Follow-up|11|||
19544985|NCT01133821|41994573|FG000|Overall Study|Withdrawal by Subject|8|||
19638129|NCT00734474|42087507|FG004|Overall Study|Lack of Efficacy|0|||
19638130|NCT00734474|42087508|FG005|Overall Study|Lack of Efficacy|0|||
19638131|NCT00734474|42087509|FG006|Overall Study|Lack of Efficacy|0|||
19638132|NCT00734474|42087510|FG007|Overall Study|Lack of Efficacy|4|||
19638133|NCT00734474|42087511|FG008|Overall Study|Lack of Efficacy|6|||
19638134|NCT00583362|42087537|FG000|Overall Study|Adverse Event|44|||
19638135|NCT00583362|42087537|FG000|Overall Study|Lack of Efficacy|22|||
19638136|NCT00583362|42087537|FG000|Overall Study|Lost to Follow-up|4|||
19638137|NCT00583362|42087537|FG000|Overall Study|Non-compliance with study drug|28|||
19638138|NCT00583362|42087537|FG000|Overall Study|Pregnancy|7|||
19638139|NCT00583362|42087537|FG000|Overall Study|Miscommunication of visit window|5|||
19638140|NCT00583362|42087537|FG000|Overall Study|Current site closed|7|||
19638141|NCT00583362|42087537|FG000|Overall Study|Subject not dosed in LBSL99|1|||
19638142|NCT00583362|42087537|FG000|Overall Study|Subject moved out of the country/state|2|||
19638143|NCT00583362|42087537|FG000|Overall Study|Missed visits due to staff changes|1|||
19638144|NCT00583362|42087537|FG000|Overall Study|Misunderstanding of protocol|1|||
19638145|NCT00583362|42087537|FG000|Overall Study|Behavioral problems and non-compliance|1|||
19638146|NCT00583362|42087537|FG000|Overall Study|Sponsor request due to missed doses|1|||
19638147|NCT00583362|42087537|FG000|Overall Study|Physician Decision|19|||
19712384|NCT03583372|42155218|FG001|Overall Study|Did Not Receive Study Drug|1|||
19458585|NCT01614769|41712457|FG003|Period 1|Withdrawal by Subject|0|||
19458586|NCT01614769|41712458|FG004|Period 1|Withdrawal by Subject|0|||
19458587|NCT01614769|41712459|FG005|Period 1|Withdrawal by Subject|0|||
19458588|NCT01614769|41712454|FG000|Period 3|Withdrawal by Subject|0|||
19458589|NCT01614769|41712455|FG001|Period 3|Withdrawal by Subject|0|||
19458590|NCT01614769|41712456|FG002|Period 3|Withdrawal by Subject|1|||
19458591|NCT01614769|41712457|FG003|Period 3|Withdrawal by Subject|0|||
19458592|NCT01614769|41712458|FG004|Period 3|Withdrawal by Subject|0|||
19458593|NCT01614769|41712459|FG005|Period 3|Withdrawal by Subject|0|||
19458594|NCT01614457|41712469|FG000|Overall Study|Non-Compliance|1|||
19458595|NCT01614457|41712470|FG001|Overall Study|Non-Compliance|0|||
19458596|NCT01614457|41712469|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
19458597|NCT01614457|41712470|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
19458598|NCT01863433|41712476|FG000|Overall Study|Protocol Violation|1|||
19458599|NCT01862029|41712480|FG000|Overall Study|Physician Decision|1|||
19458600|NCT01835431|41712487|FG000|Overall Study|Adverse Event|1|||
19458601|NCT01835431|41712488|FG001|Overall Study|Adverse Event|0|||
19458602|NCT01835431|41712487|FG000|Overall Study|other|0|||
19458603|NCT01835431|41712488|FG001|Overall Study|other|2|||
19458604|NCT01835431|41712487|FG000|Overall Study|Withdrawal by Subject|6|||
19458605|NCT01835431|41712488|FG001|Overall Study|Withdrawal by Subject|10|||
19458606|NCT01835431|41712487|FG000|Overall Study|Protocol Violation|1|||
19458607|NCT01835431|41712488|FG001|Overall Study|Protocol Violation|0|||
19458608|NCT01880593|41712496|FG000|Overall Study|Adverse Event|1|||
19458609|NCT01880593|41712497|FG001|Overall Study|Adverse Event|0|||
19458610|NCT01880593|41712496|FG000|Overall Study|Lack of Efficacy|1|||
19458611|NCT01880593|41712497|FG001|Overall Study|Lack of Efficacy|5|||
19458612|NCT01880593|41712496|FG000|Overall Study|Withdrawal by Subject|6|||
19458613|NCT01880593|41712497|FG001|Overall Study|Withdrawal by Subject|1|||
19458614|NCT01880515|41712505|FG000|Overall Study|Lost to Follow-up|3|||
19458615|NCT01880515|41712506|FG001|Overall Study|Lost to Follow-up|2|||
19458616|NCT01880515|41712505|FG000|Overall Study|Disease Progression|5|||
19458617|NCT01880515|41712506|FG001|Overall Study|Disease Progression|7|||
19458618|NCT01400451|41712516|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
19458619|NCT01400451|41712517|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
19458620|NCT01400451|41712518|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
19458621|NCT01400451|41712516|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
19458622|NCT01400451|41712517|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
19458623|NCT01400451|41712518|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
19458624|NCT01400451|41712516|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
19458625|NCT01400451|41712517|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
19458626|NCT01400451|41712518|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
19458627|NCT01400451|41712516|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
19458628|NCT01400451|41712517|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
19458629|NCT01400451|41712518|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
19458630|NCT01400451|41712516|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
19458631|NCT01400451|41712517|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
19458632|NCT01400451|41712518|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
19458633|NCT01400139|41712531|FG000|HYD Core Study|Adverse Event|210|||
19458634|NCT01400139|41712531|FG000|HYD Core Study|Lack of Efficacy|59|||
19458635|NCT01400139|41712531|FG000|HYD Core Study|Withdrawal by Subject|114|||
19458636|NCT01400139|41712531|FG000|HYD Core Study|Lost to Follow-up|39|||
19458637|NCT01400139|41712531|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
19458638|NCT01400139|41712531|FG000|HYD Core Study|Administrative|56|||
19458639|NCT01400139|41712531|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
19458640|NCT01400139|41712531|FG000|HYD Extension Period|Adverse Event|8|||
19458641|NCT01400139|41712531|FG000|HYD Extension Period|Withdrawal by Subject|5|||
19458642|NCT01400139|41712531|FG000|HYD Extension Period|Administrative|10|||
19458643|NCT01399905|41712539|FG000|Overall Study|Withdrawal by Subject|1|||
19458644|NCT01399905|41712540|FG001|Overall Study|Withdrawal by Subject|1|||
19458645|NCT01725308|41712554|FG000|Treatment Period I|Did Not Receive Drug|1|||
19458646|NCT01725308|41712555|FG001|Treatment Period I|Did Not Receive Drug|0|||
19458647|NCT01725308|41712556|FG002|Treatment Period I|Did Not Receive Drug|0|||
19712385|NCT03583372|42155219|FG002|Overall Study|Did Not Receive Study Drug|0|||
19458648|NCT01725308|41712554|FG000|Treatment Period I|Adverse Event|5|||
19458649|NCT01725308|41712555|FG001|Treatment Period I|Adverse Event|4|||
19458650|NCT01725308|41712556|FG002|Treatment Period I|Adverse Event|21|||
19458651|NCT01725308|41712554|FG000|Treatment Period I|Insufficient Response|7|||
19638148|NCT00583362|42087537|FG000|Overall Study|Protocol Violation|2|||
19638149|NCT00583362|42087537|FG000|Overall Study|Withdrawal by Subject|57|||
19638150|NCT00577473|42087543|FG000|Overall Study|Protocol Violation|1|||
19638151|NCT00577473|42087544|FG001|Overall Study|Protocol Violation|4|||
19638152|NCT00577473|42087543|FG000|Overall Study|Adverse Event|8|||
19638153|NCT00577473|42087544|FG001|Overall Study|Adverse Event|5|||
19638154|NCT00577473|42087543|FG000|Overall Study|Withdrawal by Subject|2|||
19638155|NCT00577473|42087544|FG001|Overall Study|Withdrawal by Subject|6|||
19638156|NCT00577473|42087543|FG000|Overall Study|Physician Decision|2|||
19638157|NCT00577473|42087544|FG001|Overall Study|Physician Decision|2|||
19638158|NCT00577473|42087543|FG000|Overall Study|Lack of Efficacy|8|||
19638159|NCT00577473|42087544|FG001|Overall Study|Lack of Efficacy|7|||
19638160|NCT00785291|42087553|FG000|Overall Study|Never began treatment|8|||
19638161|NCT00785291|42087554|FG001|Overall Study|Never began treatment|4|||
19638162|NCT00785291|42087555|FG002|Overall Study|Never began treatment|4|||
19638163|NCT00785291|42087553|FG000|Overall Study|Adverse Event|39|||
19638164|NCT00785291|42087554|FG001|Overall Study|Adverse Event|70|||
19638165|NCT00785291|42087555|FG002|Overall Study|Adverse Event|56|||
19638166|NCT00785291|42087553|FG000|Overall Study|Death|7|||
19638167|NCT00785291|42087554|FG001|Overall Study|Death|4|||
19638168|NCT00785291|42087555|FG002|Overall Study|Death|3|||
19638169|NCT00785291|42087553|FG000|Overall Study|Withdrawal by Subject|35|||
19638170|NCT00785291|42087554|FG001|Overall Study|Withdrawal by Subject|36|||
19638171|NCT00785291|42087555|FG002|Overall Study|Withdrawal by Subject|17|||
19638172|NCT00785291|42087553|FG000|Overall Study|Alternative Therapy|12|||
19638173|NCT00785291|42087554|FG001|Overall Study|Alternative Therapy|6|||
19638174|NCT00785291|42087555|FG002|Overall Study|Alternative Therapy|7|||
19638175|NCT00785291|42087553|FG000|Overall Study|Complicating illness|6|||
19638176|NCT00785291|42087554|FG001|Overall Study|Complicating illness|4|||
19638177|NCT00785291|42087555|FG002|Overall Study|Complicating illness|4|||
19638178|NCT00785291|42087553|FG000|Overall Study|Other Medical Reasons|29|||
19638179|NCT00785291|42087554|FG001|Overall Study|Other Medical Reasons|25|||
19638180|NCT00785291|42087555|FG002|Overall Study|Other Medical Reasons|15|||
19638181|NCT00705939|42087566|FG000|Overall Study|Protocol Violation|0|||
19638182|NCT00705939|42087567|FG001|Overall Study|Protocol Violation|0|||
19638183|NCT00705939|42087568|FG002|Overall Study|Protocol Violation|1|||
19638184|NCT00705939|42087566|FG000|Overall Study|Withdrawal by Subject|0|||
19638185|NCT00705939|42087567|FG001|Overall Study|Withdrawal by Subject|1|||
19638186|NCT00705939|42087568|FG002|Overall Study|Withdrawal by Subject|3|||
19638187|NCT00705939|42087566|FG000|Overall Study|Physician Decision|0|||
19638188|NCT00705939|42087567|FG001|Overall Study|Physician Decision|1|||
19638189|NCT00705939|42087568|FG002|Overall Study|Physician Decision|0|||
19544986|NCT01133821|41994574|FG001|Overall Study|Withdrawal by Subject|3|||
19544987|NCT01133821|41994573|FG000|Overall Study|preferred other treatment|1|||
19638190|NCT00583596|42087577|FG000|Overall Study|Lost to Follow-up|110|||
19544988|NCT01133821|41994574|FG001|Overall Study|preferred other treatment|1|||
19544989|NCT01133821|41994573|FG000|Overall Study|Protocol Violation|0|||
19544990|NCT01133821|41994574|FG001|Overall Study|Protocol Violation|1|||
19544991|NCT01133821|41994573|FG000|Overall Study|Refused participation|1|||
19544992|NCT01133821|41994574|FG001|Overall Study|Refused participation|3|||
19544993|NCT00472446|41994584|FG000|Overall Study|Protocol Violation|0|||
19544994|NCT00472446|41994585|FG001|Overall Study|Protocol Violation|0|||
19544995|NCT00472446|41994586|FG002|Overall Study|Protocol Violation|0|||
19544996|NCT00472446|41994587|FG003|Overall Study|Protocol Violation|1|||
19544997|NCT00472446|41994584|FG000|Overall Study|Reintervention|0|||
19544998|NCT00472446|41994585|FG001|Overall Study|Reintervention|0|||
19544999|NCT00472446|41994586|FG002|Overall Study|Reintervention|1|||
19545000|NCT00472446|41994587|FG003|Overall Study|Reintervention|1|||
19545001|NCT00472446|41994584|FG000|Overall Study|Questionnaires not returned|5|||
19545002|NCT00472446|41994585|FG001|Overall Study|Questionnaires not returned|6|||
19545003|NCT00472446|41994586|FG002|Overall Study|Questionnaires not returned|6|||
19545004|NCT00472446|41994587|FG003|Overall Study|Questionnaires not returned|4|||
19545005|NCT00472290|41994597|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
19545006|NCT00472290|41994597|FG000|Overall Study|Protocol Specified Criteria|7|||
19545007|NCT00472290|41994597|FG000|Overall Study|Administrative Decision|37|||
19545008|NCT00472290|41994597|FG000|Overall Study|Death|3|||
19545009|NCT00472290|41994597|FG000|Overall Study|Lost to Follow-up|1|||
19638191|NCT00583596|42087577|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
19545010|NCT00472290|41994597|FG000|Overall Study|Lack of Efficacy|1|||
19545011|NCT00472290|41994597|FG000|Overall Study|Disease Progression|4|||
19638192|NCT00583596|42087577|FG000|Overall Study|Death|2|||
19638193|NCT00583596|42087577|FG000|Overall Study|Withdrawal by Subject|6|||
19638194|NCT00583596|42087577|FG000|Overall Study|Lost to Follow-up|94|||
19638195|NCT00583596|42087577|FG000|Overall Study|Data not complete|1|||
19638196|NCT00583596|42087577|FG000|Overall Study|Not consented|15|||
19638197|NCT00583596|42087577|FG000|Overall Study|Outside f-up window|26|||
19638198|NCT00785213|42087582|FG000|Quinine Sulfate Alone|Adverse Event|4|||
19638199|NCT00785213|42087582|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
19638200|NCT00577317|42087591|FG000|Overall Study|Study Terminated|0|||
19638201|NCT00577317|42087592|FG001|Overall Study|Study Terminated|2|||
19638202|NCT00734162|42087602|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
19638203|NCT00734162|42087603|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
19638204|NCT00734162|42087604|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
19638205|NCT00734162|42087605|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
19638206|NCT00734162|42087602|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
19638207|NCT00734162|42087603|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
19638208|NCT00734162|42087604|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
19638209|NCT00734162|42087605|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
19638210|NCT00734162|42087602|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
19638211|NCT00734162|42087603|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
19638212|NCT00734162|42087604|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
19638213|NCT00734162|42087605|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
19638214|NCT00734162|42087602|FG000|Open-Label Phase|Withdrew Consent|1|||
19638215|NCT00734162|42087603|FG001|Open-Label Phase|Withdrew Consent|0|||
19638216|NCT00734162|42087604|FG002|Open-Label Phase|Withdrew Consent|1|||
19638217|NCT00734162|42087605|FG003|Open-Label Phase|Withdrew Consent|1|||
19638218|NCT00734162|42087602|FG000|Open-Label Phase|Lost to Follow-up|1|||
19638219|NCT00734162|42087603|FG001|Open-Label Phase|Lost to Follow-up|2|||
19638220|NCT00734162|42087604|FG002|Open-Label Phase|Lost to Follow-up|0|||
19638221|NCT00734162|42087605|FG003|Open-Label Phase|Lost to Follow-up|1|||
19638222|NCT00734162|42087602|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
19638223|NCT00734162|42087603|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
19638224|NCT00734162|42087604|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
19638225|NCT00734162|42087605|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
19712386|NCT03583372|42155220|FG003|Overall Study|Did Not Receive Study Drug|0|||
19712387|NCT03583372|42155217|FG000|Overall Study|Captured as Other in the Database|1|||
19712388|NCT03583372|42155218|FG001|Overall Study|Captured as Other in the Database|2|||
19712389|NCT03583372|42155219|FG002|Overall Study|Captured as Other in the Database|4|||
19712390|NCT03583372|42155220|FG003|Overall Study|Captured as Other in the Database|1|||
19712391|NCT00074282|42155230|FG000|Step 1|Adverse Event|32|||
19712392|NCT00074282|42155231|FG001|Step 1|Adverse Event|0|||
19712393|NCT00074282|42155232|FG002|Step 1|Adverse Event|0|||
19712394|NCT00074282|42155230|FG000|Step 1|Death|6|||
19712395|NCT00074282|42155231|FG001|Step 1|Death|0|||
19712396|NCT00074282|42155232|FG002|Step 1|Death|0|||
19712397|NCT00074282|42155230|FG000|Step 1|Withdrawal by Subject|7|||
19712398|NCT00074282|42155231|FG001|Step 1|Withdrawal by Subject|0|||
19712399|NCT00074282|42155232|FG002|Step 1|Withdrawal by Subject|0|||
19712400|NCT00074282|42155230|FG000|Step 1|Disease progression|2|||
19712401|NCT00074282|42155231|FG001|Step 1|Disease progression|0|||
19712402|NCT00074282|42155232|FG002|Step 1|Disease progression|0|||
19712403|NCT00074282|42155230|FG000|Step 1|Alternative therapy|2|||
19712404|NCT00074282|42155231|FG001|Step 1|Alternative therapy|0|||
19712405|NCT00074282|42155232|FG002|Step 1|Alternative therapy|0|||
19712406|NCT00074282|42155230|FG000|Step 1|Other complicating disease|2|||
19712407|NCT00074282|42155231|FG001|Step 1|Other complicating disease|0|||
19712408|NCT00074282|42155232|FG002|Step 1|Other complicating disease|0|||
19712409|NCT00074282|42155230|FG000|Step 1|Physician Decision|1|||
19712410|NCT00074282|42155231|FG001|Step 1|Physician Decision|0|||
19712411|NCT00074282|42155232|FG002|Step 1|Physician Decision|0|||
19712412|NCT00074282|42155230|FG000|Step 1|Ineligible|4|||
19712413|NCT00074282|42155231|FG001|Step 1|Ineligible|0|||
19712414|NCT00074282|42155232|FG002|Step 1|Ineligible|0|||
19712415|NCT00074282|42155230|FG000|Step 1|Never started treatment|2|||
19712416|NCT00074282|42155231|FG001|Step 1|Never started treatment|0|||
19712417|NCT00074282|42155232|FG002|Step 1|Never started treatment|0|||
19712418|NCT00074282|42155230|FG000|Step 2|Adverse Event|0|||
19712419|NCT00074282|42155231|FG001|Step 2|Adverse Event|2|||
19712420|NCT00074282|42155232|FG002|Step 2|Adverse Event|12|||
19458652|NCT01725308|41712555|FG001|Treatment Period I|Insufficient Response|0|||
19458653|NCT01725308|41712556|FG002|Treatment Period I|Insufficient Response|5|||
19458654|NCT01725308|41712554|FG000|Treatment Period I|Worsening of the Target Disease|8|||
19458655|NCT01725308|41712555|FG001|Treatment Period I|Worsening of the Target Disease|0|||
19458656|NCT01725308|41712556|FG002|Treatment Period I|Worsening of the Target Disease|2|||
19458657|NCT01725308|41712554|FG000|Treatment Period I|Changes in the Episodes|3|||
19712421|NCT00074282|42155230|FG000|Step 2|Disease progression|0|||
19712422|NCT00074282|42155231|FG001|Step 2|Disease progression|0|||
19712423|NCT00074282|42155232|FG002|Step 2|Disease progression|5|||
19712424|NCT00074282|42155230|FG000|Step 2|Death|0|||
19712425|NCT00074282|42155231|FG001|Step 2|Death|0|||
19712426|NCT00074282|42155232|FG002|Step 2|Death|3|||
19712427|NCT00074282|42155230|FG000|Step 2|Withdrawal by Subject|0|||
19712428|NCT00074282|42155231|FG001|Step 2|Withdrawal by Subject|0|||
19712429|NCT00074282|42155232|FG002|Step 2|Withdrawal by Subject|2|||
19712430|NCT00074282|42155230|FG000|Step 2|Physician Decision|0|||
19712431|NCT00074282|42155231|FG001|Step 2|Physician Decision|0|||
19712432|NCT00074282|42155232|FG002|Step 2|Physician Decision|1|||
19712433|NCT00074282|42155230|FG000|Step 2|Ineligible|0|||
19712434|NCT00074282|42155231|FG001|Step 2|Ineligible|0|||
19712435|NCT00074282|42155232|FG002|Step 2|Ineligible|1|||
19712436|NCT03582826|42155242|FG000|Overall Study|Lost to Follow-up|39|||
19712437|NCT03582826|42155243|FG001|Overall Study|Lost to Follow-up|0|||
19712438|NCT03582826|42155242|FG000|Overall Study|Withdrawal by Subject|2|||
19712439|NCT03582826|42155243|FG001|Overall Study|Withdrawal by Subject|0|||
19712440|NCT03518008|42155258|FG000|Period 2, Second Week of Wear|Family emergency|0|||
19712441|NCT03518008|42155259|FG001|Period 2, Second Week of Wear|Family emergency|1|||
19712442|NCT03810014|42155269|FG000|Overall Study|Pregnancy|2|||
19712443|NCT03810014|42155270|FG001|Overall Study|Pregnancy|2|||
19712444|NCT03810014|42155271|FG002|Overall Study|Pregnancy|0|||
19712445|NCT03810014|42155272|FG003|Overall Study|Pregnancy|2|||
19712446|NCT04881747|42155288|FG000|Period 2 Washout|Adverse Event|1|||
19712447|NCT04881747|42155289|FG001|Period 2 Washout|Adverse Event|0|||
19712448|NCT04881747|42155290|FG002|Period 2 Washout|Adverse Event|0|||
19712449|NCT04881747|42155291|FG003|Period 2 Washout|Adverse Event|0|||
19712450|NCT04881747|42155292|FG004|Period 2 Washout|Adverse Event|1|||
19712451|NCT04881747|42155293|FG005|Period 2 Washout|Adverse Event|0|||
19712452|NCT04881747|42155288|FG000|Period 2 Washout|Withdrawal by Subject|1|||
19712453|NCT04881747|42155289|FG001|Period 2 Washout|Withdrawal by Subject|0|||
19712454|NCT04881747|42155290|FG002|Period 2 Washout|Withdrawal by Subject|0|||
19712455|NCT04881747|42155291|FG003|Period 2 Washout|Withdrawal by Subject|1|||
19712456|NCT04881747|42155292|FG004|Period 2 Washout|Withdrawal by Subject|0|||
19712457|NCT04881747|42155293|FG005|Period 2 Washout|Withdrawal by Subject|0|||
19712458|NCT04795622|42155303|FG000|Overall Study|Adverse Event|1|||
19712459|NCT04795622|42155304|FG001|Overall Study|Adverse Event|0|||
19712460|NCT04795622|42155303|FG000|Overall Study|Withdrawal by Subject|3|||
19712461|NCT04795622|42155304|FG001|Overall Study|Withdrawal by Subject|3|||
19712462|NCT04795622|42155303|FG000|Overall Study|Protocol Violation|0|||
19712463|NCT04795622|42155304|FG001|Overall Study|Protocol Violation|2|||
19712464|NCT04795622|42155303|FG000|Overall Study|Lost to Follow-up|2|||
19712465|NCT04795622|42155304|FG001|Overall Study|Lost to Follow-up|3|||
19712466|NCT04795622|42155303|FG000|Overall Study|Other|7|||
19712467|NCT04795622|42155304|FG001|Overall Study|Other|8|||
19712468|NCT04652245|42155325|FG000|Wash-Out Period|Adverse Event|0|||
19712469|NCT04652245|42155326|FG001|Wash-Out Period|Adverse Event|2|||
19712470|NCT04652245|42155325|FG000|Wash-Out Period|Withdrawal by Subject|0|||
19712471|NCT04652245|42155326|FG001|Wash-Out Period|Withdrawal by Subject|2|||
19712472|NCT04405739|42155343|FG000|Overall Study|Adverse Event|0|||
19712473|NCT04405739|42155344|FG001|Overall Study|Adverse Event|1|||
19712474|NCT04405739|42155345|FG002|Overall Study|Adverse Event|0|||
19712475|NCT04405739|42155346|FG003|Overall Study|Adverse Event|0|||
19712476|NCT04405739|42155343|FG000|Overall Study|Lost to Follow-up|0|||
19712477|NCT04405739|42155344|FG001|Overall Study|Lost to Follow-up|2|||
19712478|NCT04405739|42155345|FG002|Overall Study|Lost to Follow-up|1|||
19712479|NCT04405739|42155346|FG003|Overall Study|Lost to Follow-up|3|||
19712480|NCT04405739|42155343|FG000|Overall Study|Withdrawal by Subject|0|||
19712481|NCT04405739|42155344|FG001|Overall Study|Withdrawal by Subject|2|||
19712482|NCT04405739|42155345|FG002|Overall Study|Withdrawal by Subject|1|||
19712483|NCT04405739|42155346|FG003|Overall Study|Withdrawal by Subject|1|||
19712484|NCT04405739|42155343|FG000|Overall Study|Death|0|||
19712485|NCT04405739|42155344|FG001|Overall Study|Death|0|||
19712486|NCT04405739|42155345|FG002|Overall Study|Death|1|||
19712487|NCT04405739|42155346|FG003|Overall Study|Death|0|||
19712488|NCT04405739|42155343|FG000|Overall Study|Transferred to rehab|0|||
19712489|NCT04405739|42155344|FG001|Overall Study|Transferred to rehab|0|||
19712490|NCT04405739|42155345|FG002|Overall Study|Transferred to rehab|0|||
19712491|NCT04405739|42155346|FG003|Overall Study|Transferred to rehab|1|||
19712492|NCT04405739|42155343|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
19712493|NCT04405739|42155344|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
19712494|NCT04405739|42155345|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
19712495|NCT04405739|42155346|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
19712496|NCT04241315|42155358|FG000|Overall Study|Withdrawal by Subject|0|||
19712497|NCT04241315|42155359|FG001|Overall Study|Withdrawal by Subject|1|||
19712498|NCT04225026|42155365|FG000|Overall Study|Withdrawal by Subject|4|||
19712499|NCT04225026|42155365|FG000|Overall Study|Adverse Event|1|||
19712500|NCT04225026|42155365|FG000|Overall Study|Other|1|||
19712501|NCT04225026|42155365|FG000|Overall Study|Death|11|||
19712502|NCT04225026|42155365|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
19712503|NCT04203823|42155372|FG000|Overall Study|Withdrawal by Subject|2|||
19712504|NCT04203823|42155373|FG001|Overall Study|Withdrawal by Subject|2|||
19712505|NCT04203823|42155372|FG000|Overall Study|Adverse Event|1|||
19712506|NCT04203823|42155373|FG001|Overall Study|Adverse Event|1|||
19712507|NCT04203823|42155372|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
19712508|NCT04203823|42155373|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
19712509|NCT03493958|42155780|FG000|Overall Study|Withdrawal by Subject|6|||
19712510|NCT03493958|42155780|FG000|Overall Study|Lost to Follow-up|7|||
19712511|NCT03493958|42155780|FG000|Overall Study|Did not complete all required study procedures|2|||
19712512|NCT03486223|42155786|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
19712513|NCT03486223|42155787|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
19712514|NCT03482024|42155798|FG000|Overall Study|Physician Decision|1|||
19712515|NCT03482024|42155799|FG001|Overall Study|Physician Decision|0|||
19712516|NCT03482024|42155800|FG002|Overall Study|Physician Decision|0|||
19712517|NCT03482024|42155801|FG003|Overall Study|Physician Decision|0|||
19712518|NCT03482024|42155802|FG004|Overall Study|Physician Decision|0|||
19712519|NCT03468309|42155814|FG000|Overall Study|Lost to Follow-up|4|||
19712520|NCT03468309|42155814|FG000|Overall Study|Withdrawal by Subject|2|||
19712521|NCT03423147|42155820|FG000|Overall Study|Lost to Follow-up|5|||
19712522|NCT03423147|42155821|FG001|Overall Study|Lost to Follow-up|8|||
19712523|NCT03423147|42155820|FG000|Overall Study|Withdrawal by Subject|1|||
19712524|NCT03423147|42155821|FG001|Overall Study|Withdrawal by Subject|0|||
19712525|NCT03423147|42155820|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
19712526|NCT03423147|42155821|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
19712527|NCT03423147|42155820|FG000|Overall Study|Age < 18|1|||
19712528|NCT03423147|42155821|FG001|Overall Study|Age < 18|0|||
19712529|NCT03423147|42155820|FG000|Overall Study|No Trial of Labor|0|||
19712530|NCT03423147|42155821|FG001|Overall Study|No Trial of Labor|1|||
19712531|NCT03322631|42155831|FG000|Overall Study|Withdrawal by Subject|0|||
19712532|NCT03322631|42155832|FG001|Overall Study|Withdrawal by Subject|1|||
19712533|NCT03322631|42155833|FG002|Overall Study|Withdrawal by Subject|0|||
19712534|NCT03322631|42155834|FG003|Overall Study|Withdrawal by Subject|0|||
19712535|NCT03322631|42155831|FG000|Overall Study|Adverse Event|0|||
19712536|NCT03322631|42155832|FG001|Overall Study|Adverse Event|0|||
19712537|NCT03322631|42155833|FG002|Overall Study|Adverse Event|1|||
19712538|NCT03322631|42155834|FG003|Overall Study|Adverse Event|0|||
19712539|NCT03018704|42155853|FG000|Overall Study|Lost to Follow-up|1|||
19712540|NCT03018704|42155854|FG001|Overall Study|Lost to Follow-up|1|||
19712541|NCT02663349|42155860|FG000|Overall Study|Withdrawal by Subject|6|||
19712542|NCT02558491|42155864|FG000|First Invention|Withdrawal by Subject|3|||
19712543|NCT02558491|42155865|FG001|First Invention|Withdrawal by Subject|1|||
19712544|NCT02558491|42155864|FG000|First Invention|Data collection issues|1|||
19712545|NCT02558491|42155865|FG001|First Invention|Data collection issues|0|||
19712546|NCT02558491|42155864|FG000|First Invention|Stopping criteria|0|||
19712547|NCT02558491|42155865|FG001|First Invention|Stopping criteria|1|||
19712548|NCT02558491|42155864|FG000|First Invention|Changed parameters during trial|1|||
19712549|NCT02558491|42155865|FG001|First Invention|Changed parameters during trial|0|||
19712550|NCT02558491|42155864|FG000|Second Intervention|Withdrawal by Subject|1|||
19712551|NCT02558491|42155865|FG001|Second Intervention|Withdrawal by Subject|0|||
19458658|NCT01725308|41712555|FG001|Treatment Period I|Changes in the Episodes|0|||
19458659|NCT01725308|41712556|FG002|Treatment Period I|Changes in the Episodes|2|||
19458660|NCT01725308|41712554|FG000|Treatment Period I|Withdrawal of Consent|12|||
19458661|NCT01725308|41712555|FG001|Treatment Period I|Withdrawal of Consent|7|||
19458662|NCT01725308|41712556|FG002|Treatment Period I|Withdrawal of Consent|5|||
19458663|NCT01725308|41712554|FG000|Treatment Period I|Lost to Follow-up|3|||
19458664|NCT01725308|41712555|FG001|Treatment Period I|Lost to Follow-up|2|||
19458665|NCT01725308|41712556|FG002|Treatment Period I|Lost to Follow-up|2|||
19458666|NCT01725308|41712554|FG000|Treatment Period I|Protocol Deviations|3|||
19458667|NCT01725308|41712555|FG001|Treatment Period I|Protocol Deviations|1|||
19458668|NCT01725308|41712556|FG002|Treatment Period I|Protocol Deviations|1|||
19458669|NCT01725308|41712554|FG000|Treatment Period I|Miscellaneous|2|||
19458670|NCT01725308|41712555|FG001|Treatment Period I|Miscellaneous|0|||
19458671|NCT01725308|41712556|FG002|Treatment Period I|Miscellaneous|3|||
19458672|NCT01725308|41712554|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
19458673|NCT01725308|41712555|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
19458674|NCT01725308|41712556|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
19458675|NCT01725308|41712554|FG000|Treatment Period II|Did Not Receive Drug|4|||
19458676|NCT01725308|41712555|FG001|Treatment Period II|Did Not Receive Drug|0|||
19458677|NCT01725308|41712556|FG002|Treatment Period II|Did Not Receive Drug|0|||
19458678|NCT01725308|41712554|FG000|Treatment Period II|Adverse Event|13|||
19458679|NCT01725308|41712555|FG001|Treatment Period II|Adverse Event|8|||
19458680|NCT01725308|41712556|FG002|Treatment Period II|Adverse Event|20|||
19458681|NCT01725308|41712554|FG000|Treatment Period II|Insufficient Response|2|||
19458682|NCT01725308|41712555|FG001|Treatment Period II|Insufficient Response|4|||
19458683|NCT01725308|41712556|FG002|Treatment Period II|Insufficient Response|6|||
19458684|NCT01725308|41712554|FG000|Treatment Period II|Worsening of the Target Disease|1|||
19458685|NCT01725308|41712555|FG001|Treatment Period II|Worsening of the Target Disease|4|||
19458686|NCT01725308|41712556|FG002|Treatment Period II|Worsening of the Target Disease|2|||
19458687|NCT01725308|41712554|FG000|Treatment Period II|Changes in the Episodes|1|||
19458688|NCT01725308|41712555|FG001|Treatment Period II|Changes in the Episodes|0|||
19458689|NCT01725308|41712556|FG002|Treatment Period II|Changes in the Episodes|5|||
19712552|NCT02558491|42155864|FG000|Second Intervention|Stopping Criteria|1|||
19712553|NCT02558491|42155865|FG001|Second Intervention|Stopping Criteria|0|||
19712554|NCT02490878|42155874|FG000|Overall Study|deemed ineligible|0|||
19712555|NCT02490878|42155875|FG001|Overall Study|deemed ineligible|1|||
19712556|NCT02490878|42155874|FG000|Overall Study|progression prior to treatment|0|||
19712557|NCT02490878|42155875|FG001|Overall Study|progression prior to treatment|1|||
19712558|NCT02490878|42155874|FG000|Overall Study|only submitted baseline QOL|0|||
19712559|NCT02490878|42155875|FG001|Overall Study|only submitted baseline QOL|1|||
19712560|NCT02421601|42155881|FG000|Overall Study|Adverse Event|4|||
19712561|NCT02421601|42155881|FG000|Overall Study|Lack of Efficacy|5|||
19712562|NCT02421601|42155881|FG000|Overall Study|Physician Decision|1|||
19712563|NCT02421601|42155881|FG000|Overall Study|Withdrawal by Subject|31|||
19712564|NCT02421601|42155881|FG000|Overall Study|Others|41|||
19712565|NCT01934218|42155887|FG000|Double-blind Phase|Adverse Event|8|||
19712566|NCT01934218|42155888|FG001|Double-blind Phase|Adverse Event|8|||
19712567|NCT01934218|42155887|FG000|Double-blind Phase|Lack of Efficacy|6|||
19545012|NCT00472290|41994597|FG000|Overall Study|Withdrawal by Subject|5|||
19545013|NCT00472290|41994597|FG000|Overall Study|Adverse Event|6|||
19712568|NCT01934218|42155888|FG001|Double-blind Phase|Lack of Efficacy|7|||
19712569|NCT01934218|42155887|FG000|Double-blind Phase|Lost to Follow-up|7|||
19712570|NCT01934218|42155888|FG001|Double-blind Phase|Lost to Follow-up|14|||
19712571|NCT01934218|42155887|FG000|Double-blind Phase|Physician Decision|1|||
19712572|NCT01934218|42155888|FG001|Double-blind Phase|Physician Decision|2|||
19712573|NCT01934218|42155887|FG000|Double-blind Phase|Protocol Violation|4|||
19712574|NCT01934218|42155888|FG001|Double-blind Phase|Protocol Violation|0|||
19712575|NCT01934218|42155887|FG000|Double-blind Phase|Withdrawal by Subject|16|||
19712576|NCT01934218|42155888|FG001|Double-blind Phase|Withdrawal by Subject|13|||
19712577|NCT01934218|42155887|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
19712578|NCT01934218|42155888|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
19712579|NCT01934218|42155887|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
19712580|NCT01934218|42155888|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
19712581|NCT01934218|42155887|FG000|Open-Label Phase|Adverse Event|2|||
19712582|NCT01934218|42155888|FG001|Open-Label Phase|Adverse Event|4|||
19712583|NCT01934218|42155887|FG000|Open-Label Phase|Lack of Efficacy|1|||
19712584|NCT01934218|42155888|FG001|Open-Label Phase|Lack of Efficacy|4|||
19712585|NCT01934218|42155887|FG000|Open-Label Phase|Lost to Follow-up|4|||
19712586|NCT01934218|42155888|FG001|Open-Label Phase|Lost to Follow-up|2|||
19712587|NCT01934218|42155887|FG000|Open-Label Phase|Physician Decision|1|||
19712588|NCT01934218|42155888|FG001|Open-Label Phase|Physician Decision|0|||
19712589|NCT01934218|42155887|FG000|Open-Label Phase|Protocol Violation|1|||
19712590|NCT01934218|42155888|FG001|Open-Label Phase|Protocol Violation|0|||
19712591|NCT01934218|42155887|FG000|Open-Label Phase|Withdrawal by Subject|13|||
19712592|NCT01934218|42155888|FG001|Open-Label Phase|Withdrawal by Subject|11|||
19712593|NCT01934218|42155887|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
19712594|NCT01934218|42155888|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
19712595|NCT01934218|42155887|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
19712596|NCT01934218|42155888|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
19712597|NCT01702805|42155896|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
19712598|NCT01702805|42155897|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
19712599|NCT01702805|42155896|FG000|Overall Study|Incomplete Follow-up|18|||
19712600|NCT01702805|42155897|FG001|Overall Study|Incomplete Follow-up|15|||
19712601|NCT01702805|42155896|FG000|Overall Study|Vital Status Assessment Only|40|||
19712602|NCT01702805|42155897|FG001|Overall Study|Vital Status Assessment Only|39|||
19712603|NCT01702805|42155896|FG000|Overall Study|Lost to Follow-up|5|||
19712604|NCT01702805|42155897|FG001|Overall Study|Lost to Follow-up|5|||
19712605|NCT01698905|42155903|FG000|Overall Study|Adverse Event|4|||
19712606|NCT01698905|42155903|FG000|Overall Study|Physician Decision|2|||
19712607|NCT01698905|42155903|FG000|Overall Study|Pregnancy|1|||
19545014|NCT00472290|41994597|FG000|Overall Study|Requirement for alternative therapy|7|||
19545015|NCT01133704|41994603|FG000|Overall Study|Death|44|||
19545016|NCT01133704|41994604|FG001|Overall Study|Death|26|||
19545017|NCT01133704|41994603|FG000|Overall Study|Patient refused to continue|4|||
19545018|NCT01133704|41994604|FG001|Overall Study|Patient refused to continue|0|||
19545019|NCT01133704|41994603|FG000|Overall Study|Study Closure|1|||
19545020|NCT01133704|41994604|FG001|Overall Study|Study Closure|0|||
19545021|NCT01133665|41994610|FG000|Overall Study|Physician Decision|2|||
19545022|NCT01133626|41994617|FG000|Overall Study|Adverse Event|0|||
19545023|NCT01133626|41994618|FG001|Overall Study|Adverse Event|1|||
19545024|NCT01133626|41994619|FG002|Overall Study|Adverse Event|0|||
19712608|NCT01698905|42155903|FG000|Overall Study|Protocol Violation|1|||
19712609|NCT01698905|42155903|FG000|Overall Study|Subject/guardian decision|2|||
19712610|NCT01698905|42155903|FG000|Overall Study|Death|1|||
19712611|NCT00097370|42155985|FG000|Stage 1|Adverse Event|3|||
19712612|NCT00097370|42155985|FG000|Stage 1|Withdrawal by Subject|1|||
19712613|NCT00097370|42155985|FG000|Stage 1|Lack of Efficacy|2|||
19712614|NCT00097370|42155985|FG000|Stage 2|Adverse Event|5|||
19545025|NCT01133626|41994617|FG000|Overall Study|Withdrawal by Subject|1|||
19712615|NCT00097370|42155985|FG000|Stage 2|Withdrawal by Subject|1|||
19712616|NCT00097370|42155985|FG000|Stage 2|Lack of Efficacy|3|||
19712617|NCT00097370|42155985|FG000|Stage 2|Pregnancy|1|||
19712618|NCT00097370|42155985|FG000|Stage 2|Sponsor Terminated Study|2|||
19712619|NCT00097370|42155985|FG000|Stage 2|Lost to Follow-up|1|||
19712620|NCT00097370|42155985|FG000|Stage 3|Adverse Event|2|||
19712621|NCT00097370|42155985|FG000|Stage 3|Withdrawal by Subject|3|||
19712622|NCT00097370|42155985|FG000|Stage 3|Lack of Efficacy|1|||
19712623|NCT00097370|42155985|FG000|Stage 3|Sponsor Terminated Study|52|||
19712624|NCT00097370|42155985|FG000|Stage 3|Lost to Follow-up|1|||
19712625|NCT03515824|42155992|FG000|Overall Study|Death|3|||
19712626|NCT03515824|42155993|FG001|Overall Study|Death|2|||
19712627|NCT03515824|42155994|FG002|Overall Study|Death|6|||
19712628|NCT03515824|42155995|FG003|Overall Study|Death|0|||
19712629|NCT03515824|42155992|FG000|Overall Study|Lost to Follow-up|0|||
19712630|NCT03515824|42155993|FG001|Overall Study|Lost to Follow-up|1|||
19712631|NCT03515824|42155994|FG002|Overall Study|Lost to Follow-up|1|||
19712632|NCT03515824|42155995|FG003|Overall Study|Lost to Follow-up|0|||
19712633|NCT03515824|42155992|FG000|Overall Study|Study terminated by sponsor|0|||
19712634|NCT03515824|42155993|FG001|Overall Study|Study terminated by sponsor|1|||
19712635|NCT03515824|42155994|FG002|Overall Study|Study terminated by sponsor|6|||
19712636|NCT03515824|42155995|FG003|Overall Study|Study terminated by sponsor|0|||
19712637|NCT03515824|42155992|FG000|Overall Study|Status not recorded|0|||
19712638|NCT03515824|42155993|FG001|Overall Study|Status not recorded|0|||
19712639|NCT03515824|42155994|FG002|Overall Study|Status not recorded|2|||
19712640|NCT03515824|42155995|FG003|Overall Study|Status not recorded|0|||
19712641|NCT03511378|42156005|FG000|Overall Study|Withdrawal by Subject|2|||
19712642|NCT03511378|42156006|FG001|Overall Study|Withdrawal by Subject|2|||
19712643|NCT03511378|42156005|FG000|Overall Study|Patient not coming or schedule visit|1|||
19712644|NCT03511378|42156006|FG001|Overall Study|Patient not coming or schedule visit|0|||
19712645|NCT03511066|42156015|FG000|Overall Study|Withdrawal by Subject|1|||
19712646|NCT03511066|42156016|FG001|Overall Study|Withdrawal by Subject|2|||
19712647|NCT03511066|42156017|FG002|Overall Study|Withdrawal by Subject|3|||
19712648|NCT03511066|42156015|FG000|Overall Study|Lost to Follow-up|2|||
19712649|NCT03511066|42156016|FG001|Overall Study|Lost to Follow-up|3|||
19712650|NCT03511066|42156017|FG002|Overall Study|Lost to Follow-up|0|||
19712651|NCT03510910|42156027|FG000|Overall Study|Incomplete Survey|2|||
19712652|NCT03510910|42156028|FG001|Overall Study|Incomplete Survey|3|||
19712653|NCT03509350|42156036|FG000|Overall Study|Withdrawal by Subject|0|||
19712654|NCT03509350|42156037|FG001|Overall Study|Withdrawal by Subject|2|||
19712655|NCT00072410|42156045|FG000|Overall Study|Progressive disease|0|||
19712656|NCT00072410|42156046|FG001|Overall Study|Progressive disease|3|||
19712657|NCT03478696|42156054|FG000|Overall Study|Adverse Event|1|||
19712658|NCT03478696|42156055|FG001|Overall Study|Adverse Event|5|||
19712659|NCT03478696|42156054|FG000|Overall Study|Lost to Follow-up|1|||
19712660|NCT03478696|42156055|FG001|Overall Study|Lost to Follow-up|0|||
19712661|NCT03478696|42156054|FG000|Overall Study|Physician Decision|6|||
19712662|NCT03478696|42156055|FG001|Overall Study|Physician Decision|3|||
19712663|NCT03478696|42156054|FG000|Overall Study|Withdrawal by Subject|9|||
19712664|NCT03478696|42156055|FG001|Overall Study|Withdrawal by Subject|4|||
19712665|NCT03477838|42156061|FG000|Overall Study|Lost to Follow-up|14|||
19712666|NCT00072176|42156067|FG000|Overall Study|Withdrawal by Subject|1|||
19712667|NCT00072176|42156068|FG001|Overall Study|Withdrawal by Subject|0|||
19712668|NCT00072176|42156067|FG000|Overall Study|Protocol Violation|0|||
19712669|NCT00072176|42156068|FG001|Overall Study|Protocol Violation|1|||
19712670|NCT00071396|42156074|FG000|Overall Study|Withdrawal by Subject|1|||
19712671|NCT00071396|42156074|FG000|Overall Study|Physician Decision|2|||
19712672|NCT03473236|42156088|FG000|Overall Study|Withdrawal by Subject|0|||
19712673|NCT03473236|42156089|FG001|Overall Study|Withdrawal by Subject|0|||
19712674|NCT03473236|42156090|FG002|Overall Study|Withdrawal by Subject|0|||
19712675|NCT03473236|42156091|FG003|Overall Study|Withdrawal by Subject|0|||
19712676|NCT03473236|42156092|FG004|Overall Study|Withdrawal by Subject|0|||
19712677|NCT03473236|42156093|FG005|Overall Study|Withdrawal by Subject|1|||
19712678|NCT03473236|42156094|FG006|Overall Study|Withdrawal by Subject|0|||
19712679|NCT03473236|42156095|FG007|Overall Study|Withdrawal by Subject|0|||
19712680|NCT03473236|42156096|FG008|Overall Study|Withdrawal by Subject|1|||
19712681|NCT03473236|42156097|FG009|Overall Study|Withdrawal by Subject|0|||
19712682|NCT03550378|42156129|FG000|Overall Study|Death|0|||
19712683|NCT03550378|42156130|FG001|Overall Study|Death|1|||
19712684|NCT03472534|42156137|FG000|Overall Study|Withdrawal by Subject|9|||
19712685|NCT03472534|42156137|FG000|Overall Study|Adverse Event|2|||
19712686|NCT03549130|42156143|FG000|Overall Study|Adverse Event|0|||
19712687|NCT03549130|42156144|FG001|Overall Study|Adverse Event|1|||
19712688|NCT03549130|42156143|FG000|Overall Study|Lost to Follow-up|0|||
19712689|NCT03549130|42156144|FG001|Overall Study|Lost to Follow-up|1|||
19712690|NCT03470194|42156154|FG000|Overall Study|Lost to Follow-up|11|||
19712691|NCT03470194|42156155|FG001|Overall Study|Lost to Follow-up|17|||
19712692|NCT03469336|42156161|FG000|Overall Study|Adverse Event|1|||
19712693|NCT03469258|42156171|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
19712694|NCT03503188|42156177|FG000|Overall Study|Non eligible in the sub study|0|||
19712695|NCT03503188|42156178|FG001|Overall Study|Non eligible in the sub study|1|||
19712696|NCT03502798|42156186|FG000|Overall Study|equipment failure|0|||
19712697|NCT03502798|42156187|FG001|Overall Study|equipment failure|7|||
19712698|NCT00066170|42156197|FG000|Overall Study|Adverse Event|2|||
19712699|NCT00066170|42156198|FG001|Overall Study|Adverse Event|4|||
19712700|NCT00066170|42156199|FG002|Overall Study|Adverse Event|1|||
19712701|NCT00066170|42156200|FG003|Overall Study|Adverse Event|7|||
19712702|NCT00066170|42156197|FG000|Overall Study|Serious Adverse Event|0|||
19712703|NCT00066170|42156198|FG001|Overall Study|Serious Adverse Event|0|||
19712704|NCT00066170|42156199|FG002|Overall Study|Serious Adverse Event|1|||
19712705|NCT00066170|42156200|FG003|Overall Study|Serious Adverse Event|1|||
19712706|NCT00066170|42156197|FG000|Overall Study|Lost to Follow-up|0|||
19712707|NCT00066170|42156198|FG001|Overall Study|Lost to Follow-up|1|||
19712708|NCT00066170|42156199|FG002|Overall Study|Lost to Follow-up|0|||
19712709|NCT00066170|42156200|FG003|Overall Study|Lost to Follow-up|0|||
19712710|NCT00066170|42156197|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
19712711|NCT00066170|42156198|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
19712712|NCT00066170|42156199|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
19712713|NCT00066170|42156200|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
19712714|NCT00066170|42156197|FG000|Overall Study|Protocol Violation|3|||
19712715|NCT00066170|42156198|FG001|Overall Study|Protocol Violation|0|||
19712716|NCT00066170|42156199|FG002|Overall Study|Protocol Violation|0|||
19712717|NCT00066170|42156200|FG003|Overall Study|Protocol Violation|0|||
19712718|NCT00066170|42156197|FG000|Overall Study|Other|1|||
19712719|NCT00066170|42156198|FG001|Overall Study|Other|5|||
19712720|NCT00066170|42156199|FG002|Overall Study|Other|2|||
19712721|NCT00066170|42156200|FG003|Overall Study|Other|0|||
19712722|NCT00065468|42156213|FG000|Overall Study|Death|172|||
19712723|NCT00065468|42156214|FG001|Overall Study|Death|169|||
19712724|NCT00065468|42156215|FG002|Overall Study|Death|171|||
19712725|NCT00065468|42156213|FG000|Overall Study|Withdrawal by Subject|3|||
19712726|NCT00065468|42156214|FG001|Overall Study|Withdrawal by Subject|4|||
19712727|NCT00065468|42156215|FG002|Overall Study|Withdrawal by Subject|5|||
19712728|NCT00065468|42156213|FG000|Overall Study|Lost to Follow-up|5|||
19712729|NCT00065468|42156214|FG001|Overall Study|Lost to Follow-up|3|||
19712730|NCT00065468|42156215|FG002|Overall Study|Lost to Follow-up|2|||
19712731|NCT00065468|42156213|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
19712732|NCT00065468|42156214|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
19712733|NCT00065468|42156215|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
19712734|NCT00065468|42156213|FG000|Overall Study|Disease progression|0|||
19712735|NCT00065468|42156214|FG001|Overall Study|Disease progression|0|||
19712736|NCT00065468|42156215|FG002|Overall Study|Disease progression|1|||
19712737|NCT00065468|42156213|FG000|Overall Study|Other|14|||
19712738|NCT00065468|42156214|FG001|Overall Study|Other|24|||
19712739|NCT00065468|42156215|FG002|Overall Study|Other|18|||
19712740|NCT00071006|42156223|FG000|Overall Study|Lack of Efficacy|7|||
19712741|NCT00071006|42156223|FG000|Overall Study|Adverse Event|1|||
19712742|NCT00071006|42156223|FG000|Overall Study|Withdrawal by Subject|1|||
19712743|NCT00071006|42156223|FG000|Overall Study|Other|3|||
19712744|NCT00094575|42156229|FG000|Overall Study|Death|146|||
19712745|NCT00094575|42156230|FG001|Overall Study|Death|146|||
19712746|NCT00057746|42156241|FG000|Overall Study|Withdrawal by Subject|0|||
19712747|NCT00057746|42156242|FG001|Overall Study|Withdrawal by Subject|0|||
19712748|NCT00057746|42156243|FG002|Overall Study|Withdrawal by Subject|1|||
19712749|NCT00094107|42156251|FG000|Overall Study|Lack of Efficacy|23|||
19712750|NCT00094107|42156251|FG000|Overall Study|Death|5|||
19712751|NCT00094107|42156251|FG000|Overall Study|Adverse Event|3|||
19712752|NCT00094107|42156251|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
19712753|NCT00102063|42156258|FG000|Overall Study|Lack of Efficacy|5|||
19712754|NCT00102063|42156259|FG001|Overall Study|Lack of Efficacy|1|||
19712755|NCT00102063|42156260|FG002|Overall Study|Lack of Efficacy|1|||
19712756|NCT00102063|42156258|FG000|Overall Study|Adverse Event|7|||
19712757|NCT00102063|42156259|FG001|Overall Study|Adverse Event|4|||
19712758|NCT00102063|42156260|FG002|Overall Study|Adverse Event|2|||
19712759|NCT00102063|42156258|FG000|Overall Study|Withdrawal by Subject|4|||
19712760|NCT00102063|42156259|FG001|Overall Study|Withdrawal by Subject|12|||
19712761|NCT00102063|42156260|FG002|Overall Study|Withdrawal by Subject|5|||
19712762|NCT00102063|42156258|FG000|Overall Study|Lost to Follow-up|0|||
19712763|NCT00102063|42156259|FG001|Overall Study|Lost to Follow-up|0|||
19712764|NCT00102063|42156260|FG002|Overall Study|Lost to Follow-up|1|||
19712765|NCT00102063|42156258|FG000|Overall Study|Protocol Violation|0|||
19712766|NCT00102063|42156259|FG001|Overall Study|Protocol Violation|1|||
19712767|NCT00102063|42156260|FG002|Overall Study|Protocol Violation|1|||
19712768|NCT00065156|42156268|FG000|Overall Study|Adverse Event|37|||
19712769|NCT00065156|42156268|FG000|Overall Study|Lack of Efficacy|52|||
19712770|NCT00065156|42156268|FG000|Overall Study|Withdrawal by Subject|8|||
19712771|NCT00065156|42156268|FG000|Overall Study|Lost to Follow-up|1|||
19712772|NCT00065156|42156268|FG000|Overall Study|Death|11|||
19712773|NCT00065156|42156268|FG000|Overall Study|Study Closed by Sponsor|2|||
19712774|NCT00065156|42156268|FG000|Overall Study|Disease Progression|7|||
19712775|NCT00065156|42156268|FG000|Overall Study|Investigator Decision|2|||
19712776|NCT00065156|42156268|FG000|Overall Study|Non-Compliance|2|||
19712777|NCT00065156|42156268|FG000|Overall Study|Loss of Response|1|||
19712778|NCT00065156|42156268|FG000|Overall Study|Secondary Malign Disease|1|||
19712779|NCT00064298|42156274|FG000|Overall Study|Withdrawal by Subject|2|||
19712780|NCT00064298|42156275|FG001|Overall Study|Withdrawal by Subject|1|||
19712781|NCT00064298|42156274|FG000|Overall Study|Lost to Follow-up|2|||
19712782|NCT00064298|42156275|FG001|Overall Study|Lost to Follow-up|2|||
19712783|NCT00064298|42156274|FG000|Overall Study|Death|0|||
19712784|NCT00064298|42156275|FG001|Overall Study|Death|1|||
19712785|NCT00064298|42156274|FG000|Overall Study|Disease Progression|2|||
19712786|NCT00064298|42156275|FG001|Overall Study|Disease Progression|1|||
19712787|NCT00078819|42156283|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
19712788|NCT00078819|42156284|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
19712789|NCT00078819|42156285|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
19712790|NCT00078819|42156286|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
19712791|NCT00078819|42156283|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
19712792|NCT00078819|42156284|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
19712793|NCT00078819|42156285|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
19712794|NCT00078819|42156286|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
19712795|NCT00078819|42156283|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
19712796|NCT00078819|42156284|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
19712797|NCT00078819|42156285|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
19712798|NCT00078819|42156286|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
19712799|NCT00078819|42156283|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
19712800|NCT00078819|42156284|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
19712801|NCT00078819|42156285|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
19712802|NCT00078819|42156286|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
19712803|NCT00078819|42156283|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
19712804|NCT00078819|42156284|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
19712805|NCT00078819|42156285|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
19712806|NCT00078819|42156286|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
19712807|NCT00078819|42156283|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
19712808|NCT00078819|42156284|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
19712809|NCT00078819|42156285|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
19712810|NCT00078819|42156286|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
19712811|NCT00078819|42156283|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
19712812|NCT00078819|42156284|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
19712813|NCT00078819|42156285|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
19712814|NCT00078819|42156286|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
19712815|NCT00078819|42156283|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
19712816|NCT00078819|42156284|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
19712817|NCT00078819|42156285|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
19712818|NCT00078819|42156286|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
19712819|NCT00063986|42156303|FG000|Overall Study|Withdrawal by Subject|1|||
19712820|NCT00063986|42156303|FG000|Overall Study|Ineligible|1|||
19712821|NCT00063986|42156303|FG000|Overall Study|Intra-operatively ineligible|4|||
19712822|NCT00098865|42156307|FG000|Overall Study|Progressive Disease|6|||
19712823|NCT00098865|42156307|FG000|Overall Study|Adverse Event|2|||
19712824|NCT00098865|42156307|FG000|Overall Study|Alternative Therapy|1|||
19712825|NCT00098787|42156314|FG000|Overall Study|Never started treatment|3|||
19712826|NCT00098787|42156315|FG001|Overall Study|Never started treatment|2|||
19712827|NCT00098787|42156316|FG002|Overall Study|Never started treatment|1|||
19712828|NCT00098787|42156314|FG000|Overall Study|Ineligible|9|||
19712829|NCT00098787|42156315|FG001|Overall Study|Ineligible|7|||
19712830|NCT00098787|42156316|FG002|Overall Study|Ineligible|3|||
19712831|NCT00098787|42156314|FG000|Overall Study|Disease progression|28|||
19712832|NCT00098787|42156315|FG001|Overall Study|Disease progression|17|||
19712833|NCT00098787|42156316|FG002|Overall Study|Disease progression|23|||
19712834|NCT00098787|42156314|FG000|Overall Study|Adverse Event|8|||
19545026|NCT01133626|41994618|FG001|Overall Study|Withdrawal by Subject|2|||
19545027|NCT01133626|41994619|FG002|Overall Study|Withdrawal by Subject|2|||
19545028|NCT01133626|41994617|FG000|Overall Study|Other|0|||
19545029|NCT01133626|41994618|FG001|Overall Study|Other|2|||
19545030|NCT01133626|41994619|FG002|Overall Study|Other|0|||
19545031|NCT01133392|41994629|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
19545032|NCT01133392|41994630|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
19545033|NCT01133392|41994629|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
19545034|NCT01133392|41994630|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
19545035|NCT00471354|41994636|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
19545036|NCT00471354|41994636|FG000|Overall Study|Adverse Event|13|||
19545037|NCT00471354|41994636|FG000|Overall Study|Protocol Violation|12|||
19545038|NCT00471354|41994636|FG000|Overall Study|Withdrawal by Subject|1|||
19712835|NCT00098787|42156315|FG001|Overall Study|Adverse Event|17|||
19712836|NCT00098787|42156316|FG002|Overall Study|Adverse Event|8|||
19712837|NCT00098787|42156314|FG000|Overall Study|Death|6|||
19712838|NCT00098787|42156315|FG001|Overall Study|Death|1|||
19712839|NCT00098787|42156316|FG002|Overall Study|Death|0|||
19712840|NCT00098787|42156314|FG000|Overall Study|Withdrawal by Subject|4|||
19712841|NCT00098787|42156315|FG001|Overall Study|Withdrawal by Subject|12|||
19712842|NCT00098787|42156316|FG002|Overall Study|Withdrawal by Subject|6|||
19712843|NCT00098787|42156314|FG000|Overall Study|Alternative therapy|8|||
19712844|NCT00098787|42156315|FG001|Overall Study|Alternative therapy|13|||
19712845|NCT00098787|42156316|FG002|Overall Study|Alternative therapy|13|||
19712846|NCT00098787|42156314|FG000|Overall Study|Other|7|||
19712847|NCT00098787|42156315|FG001|Overall Study|Other|6|||
19712848|NCT00098787|42156316|FG002|Overall Study|Other|9|||
19712849|NCT02954458|42156328|FG000|Overall Study|Adverse Event|0|||
19712850|NCT02954458|42156329|FG001|Overall Study|Adverse Event|0|||
19712851|NCT02954458|42156330|FG002|Overall Study|Adverse Event|0|||
19712852|NCT02954458|42156331|FG003|Overall Study|Adverse Event|1|||
19712853|NCT02954458|42156328|FG000|Overall Study|Withdrawal by Subject|0|||
19712854|NCT02954458|42156329|FG001|Overall Study|Withdrawal by Subject|0|||
19712855|NCT02954458|42156330|FG002|Overall Study|Withdrawal by Subject|0|||
19712856|NCT02954458|42156331|FG003|Overall Study|Withdrawal by Subject|1|||
19712857|NCT02954458|42156328|FG000|Overall Study|Physician Decision|0|||
19712858|NCT02954458|42156329|FG001|Overall Study|Physician Decision|0|||
19712859|NCT02954458|42156330|FG002|Overall Study|Physician Decision|1|||
19712860|NCT02954458|42156331|FG003|Overall Study|Physician Decision|1|||
19712861|NCT02954458|42156328|FG000|Overall Study|Lost to Follow-up|1|||
19712862|NCT02954458|42156329|FG001|Overall Study|Lost to Follow-up|0|||
19712863|NCT02954458|42156330|FG002|Overall Study|Lost to Follow-up|0|||
19712864|NCT02954458|42156331|FG003|Overall Study|Lost to Follow-up|1|||
19712865|NCT02954458|42156328|FG000|Overall Study|Death|0|||
19712866|NCT02954458|42156329|FG001|Overall Study|Death|0|||
19712867|NCT02954458|42156330|FG002|Overall Study|Death|0|||
19712868|NCT02954458|42156331|FG003|Overall Study|Death|1|||
19712869|NCT02954458|42156328|FG000|Overall Study|Other|0|||
19712870|NCT02954458|42156329|FG001|Overall Study|Other|0|||
19712871|NCT02954458|42156330|FG002|Overall Study|Other|0|||
19712872|NCT02954458|42156331|FG003|Overall Study|Other|7|||
19712873|NCT03500692|42156345|FG000|Overall Study|Death|76|||
19712874|NCT03500692|42156345|FG000|Overall Study|Missed visit|30|||
19712875|NCT03500692|42156345|FG000|Overall Study|Termination Reasons|3|||
19712876|NCT03500224|42156349|FG000|Overall Study|Withdrawal by Subject|2|||
19712877|NCT03495154|42156353|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
19545039|NCT00471354|41994636|FG000|Overall Study|Physician Decision|4|||
19545040|NCT00471354|41994636|FG000|Overall Study|Sponsor Decision|1|||
19545041|NCT00471354|41994636|FG000|Overall Study|Lost to Follow-up|3|||
19712878|NCT03495154|42156353|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
19712879|NCT03495154|42156353|FG000|Overall Study|Screen Failures During Surgery|6|||
19712880|NCT03495154|42156353|FG000|Overall Study|Death|2|||
19712881|NCT03495154|42156353|FG000|Overall Study|Lost to Follow-up|6|||
19712882|NCT03495154|42156353|FG000|Overall Study|Protocol Violation|1|||
19545042|NCT00471354|41994636|FG000|Overall Study|Lack of Efficacy|5|||
19712883|NCT03495154|42156353|FG000|Overall Study|Withdrawal by Subject|1|||
19712884|NCT00077649|42156361|FG000|Overall Study|Adverse Event|5|||
19712885|NCT00077649|42156362|FG001|Overall Study|Adverse Event|1|||
19712886|NCT00077649|42156363|FG002|Overall Study|Adverse Event|7|||
19712887|NCT00077649|42156364|FG003|Overall Study|Adverse Event|9|||
19712888|NCT00077649|42156361|FG000|Overall Study|Lack of Efficacy|5|||
19712889|NCT00077649|42156362|FG001|Overall Study|Lack of Efficacy|3|||
19712890|NCT00077649|42156363|FG002|Overall Study|Lack of Efficacy|3|||
19712891|NCT00077649|42156364|FG003|Overall Study|Lack of Efficacy|2|||
19712892|NCT00077649|42156361|FG000|Overall Study|Withdrawal by Subject|0|||
19712893|NCT00077649|42156362|FG001|Overall Study|Withdrawal by Subject|1|||
19712894|NCT00077649|42156363|FG002|Overall Study|Withdrawal by Subject|1|||
19545043|NCT00471354|41994636|FG000|Overall Study|Patient/Caregiver Decision|12|||
19545044|NCT01133275|41994640|FG000|Overall Study|Withdrawal by Subject|1|||
19545045|NCT01133275|41994640|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
19545046|NCT00471315|41994644|FG000|Overall Study|Adverse Event|7|||
19545047|NCT00471315|41994644|FG000|Overall Study|Withdrawal by Subject|1|||
19545048|NCT00471237|41994655|FG000|Overall Study|Adverse Event|6|||
19545049|NCT00471237|41994656|FG001|Overall Study|Adverse Event|5|||
19545050|NCT00471237|41994657|FG002|Overall Study|Adverse Event|4|||
19545051|NCT00471237|41994658|FG003|Overall Study|Adverse Event|8|||
19545052|NCT00471237|41994659|FG004|Overall Study|Adverse Event|7|||
19458690|NCT01725308|41712554|FG000|Treatment Period II|Withdrawal of Consent|28|||
19458691|NCT01725308|41712555|FG001|Treatment Period II|Withdrawal of Consent|2|||
19458692|NCT01725308|41712556|FG002|Treatment Period II|Withdrawal of Consent|16|||
19458693|NCT01725308|41712554|FG000|Treatment Period II|Lost to Follow-up|1|||
19458694|NCT01725308|41712555|FG001|Treatment Period II|Lost to Follow-up|5|||
19458695|NCT01725308|41712556|FG002|Treatment Period II|Lost to Follow-up|3|||
19458696|NCT01725308|41712554|FG000|Treatment Period II|Protocol Deviations|0|||
19458697|NCT01725308|41712555|FG001|Treatment Period II|Protocol Deviations|0|||
19458698|NCT01725308|41712556|FG002|Treatment Period II|Protocol Deviations|1|||
19458699|NCT01725308|41712554|FG000|Treatment Period II|Miscellaneous|5|||
19458700|NCT01725308|41712555|FG001|Treatment Period II|Miscellaneous|3|||
19458701|NCT01725308|41712556|FG002|Treatment Period II|Miscellaneous|7|||
19458702|NCT01724528|41712573|FG000|Overall Study|Death|3|||
19458703|NCT01724528|41712574|FG001|Overall Study|Death|0|||
19458704|NCT01724528|41712573|FG000|Overall Study|Withdrawal by Subject|0|||
19458705|NCT01724528|41712574|FG001|Overall Study|Withdrawal by Subject|2|||
19458706|NCT01724528|41712573|FG000|Overall Study|Protocol Violation|0|||
19458707|NCT01724528|41712574|FG001|Overall Study|Protocol Violation|1|||
19458708|NCT01724528|41712573|FG000|Overall Study|Patient refused to attend last visit|1|||
19458709|NCT01724528|41712574|FG001|Overall Study|Patient refused to attend last visit|0|||
19458710|NCT01779440|41712582|FG000|Overall Study|Withdrawal by Subject|3|||
19458711|NCT01779440|41712583|FG001|Overall Study|Withdrawal by Subject|5|||
19458712|NCT01750346|41712592|FG000|Overall Study|Adverse Event|1|||
19458713|NCT01750346|41712593|FG001|Overall Study|Adverse Event|0|||
19458714|NCT01750346|41712594|FG002|Overall Study|Adverse Event|0|||
19458715|NCT01750268|41712604|FG000|Overall Study|Lost to Follow-up|0|||
19458716|NCT01750268|41712605|FG001|Overall Study|Lost to Follow-up|2|||
19458717|NCT01750268|41712604|FG000|Overall Study|Physician Decision|0|||
19458718|NCT01750268|41712605|FG001|Overall Study|Physician Decision|3|||
19458719|NCT01750268|41712604|FG000|Overall Study|Withdrawal by Subject|2|||
19458720|NCT01750268|41712605|FG001|Overall Study|Withdrawal by Subject|0|||
19458721|NCT01880437|41712614|FG000|Overall Study|Death|12|||
19458722|NCT01880437|41712615|FG001|Overall Study|Death|4|||
19458723|NCT01880437|41712616|FG002|Overall Study|Death|17|||
19458724|NCT01880437|41712614|FG000|Overall Study|Study terminated by Sponsor|3|||
19458725|NCT01880437|41712615|FG001|Overall Study|Study terminated by Sponsor|0|||
19458726|NCT01880437|41712616|FG002|Overall Study|Study terminated by Sponsor|2|||
19458727|NCT01861717|41712626|FG000|Overall Study|Lost to Follow-up|1|||
19458728|NCT01861717|41712626|FG000|Overall Study|Withdrawal by Subject|1|||
19458729|NCT01834729|41712635|FG000|Overall Study|Did not return bowel diaries|0|||
19458730|NCT01834729|41712636|FG001|Overall Study|Did not return bowel diaries|0|||
19458731|NCT01834729|41712637|FG002|Overall Study|Did not return bowel diaries|3|||
19458732|NCT01834729|41712638|FG003|Overall Study|Did not return bowel diaries|0|||
19458733|NCT01834729|41712635|FG000|Overall Study|Withdrawal by Subject|1|||
19458734|NCT01834729|41712636|FG001|Overall Study|Withdrawal by Subject|1|||
19458735|NCT01834729|41712637|FG002|Overall Study|Withdrawal by Subject|0|||
19458736|NCT01834729|41712638|FG003|Overall Study|Withdrawal by Subject|0|||
19458737|NCT01834729|41712635|FG000|Overall Study|Adverse Event|0|||
19458738|NCT01834729|41712636|FG001|Overall Study|Adverse Event|0|||
19458739|NCT01834729|41712637|FG002|Overall Study|Adverse Event|0|||
19458740|NCT01834729|41712638|FG003|Overall Study|Adverse Event|2|||
19458741|NCT01860703|41712649|FG000|Overall Study|Adverse Event|1|||
19458742|NCT01860703|41712650|FG001|Overall Study|Adverse Event|4|||
19458743|NCT01860703|41712651|FG002|Overall Study|Adverse Event|0|||
19458744|NCT01860703|41712652|FG003|Overall Study|Adverse Event|2|||
19458745|NCT01860703|41712649|FG000|Overall Study|Withdrawal by Subject|0|||
19458746|NCT01860703|41712650|FG001|Overall Study|Withdrawal by Subject|1|||
19458747|NCT01860703|41712651|FG002|Overall Study|Withdrawal by Subject|0|||
19458748|NCT01860703|41712652|FG003|Overall Study|Withdrawal by Subject|0|||
19458749|NCT01860703|41712649|FG000|Overall Study|Personal reason|1|||
19458750|NCT01860703|41712650|FG001|Overall Study|Personal reason|0|||
19545053|NCT00471237|41994660|FG005|Overall Study|Adverse Event|5|||
19545054|NCT00471237|41994661|FG006|Overall Study|Adverse Event|0|||
19458751|NCT01860703|41712651|FG002|Overall Study|Personal reason|1|||
19458752|NCT01860703|41712652|FG003|Overall Study|Personal reason|0|||
19458753|NCT01399593|41712670|FG000|Overall Study|Physician Decision|1|||
19458754|NCT01399593|41712671|FG001|Overall Study|Physician Decision|0|||
19458755|NCT01399593|41712670|FG000|Overall Study|Adverse Event|1|||
19712895|NCT00077649|42156364|FG003|Overall Study|Withdrawal by Subject|2|||
19712896|NCT00077649|42156361|FG000|Overall Study|Lost to Follow-up|2|||
19712897|NCT00077649|42156362|FG001|Overall Study|Lost to Follow-up|2|||
19712898|NCT00077649|42156363|FG002|Overall Study|Lost to Follow-up|3|||
19712899|NCT00077649|42156364|FG003|Overall Study|Lost to Follow-up|2|||
19712900|NCT00077649|42156361|FG000|Overall Study|Abnormality of Laboratory Test|1|||
19712901|NCT00077649|42156362|FG001|Overall Study|Abnormality of Laboratory Test|2|||
19712902|NCT00077649|42156363|FG002|Overall Study|Abnormality of Laboratory Test|1|||
19712903|NCT00077649|42156364|FG003|Overall Study|Abnormality of Laboratory Test|2|||
19712904|NCT00077649|42156361|FG000|Overall Study|Randomized but never dosed|1|||
19712905|NCT00077649|42156362|FG001|Overall Study|Randomized but never dosed|0|||
19712906|NCT00077649|42156363|FG002|Overall Study|Randomized but never dosed|0|||
19712907|NCT00077649|42156364|FG003|Overall Study|Randomized but never dosed|0|||
19712908|NCT00038948|42156380|FG000|Overall Study|Adverse Event|131|||
19712909|NCT00038948|42156381|FG001|Overall Study|Adverse Event|43|||
19712910|NCT00038948|42156380|FG000|Overall Study|Lost to Follow-up|4|||
19712911|NCT00038948|42156381|FG001|Overall Study|Lost to Follow-up|4|||
19712912|NCT00038948|42156380|FG000|Overall Study|Nonmedical event|5|||
19712913|NCT00038948|42156381|FG001|Overall Study|Nonmedical event|7|||
19712914|NCT00038948|42156380|FG000|Overall Study|Withdrawal by Subject|23|||
19712915|NCT00038948|42156381|FG001|Overall Study|Withdrawal by Subject|10|||
19712916|NCT00038948|42156380|FG000|Overall Study|Protocol Violation|3|||
19712917|NCT00038948|42156381|FG001|Overall Study|Protocol Violation|7|||
19712918|NCT00038948|42156380|FG000|Overall Study|Lack of Efficacy|3|||
19712919|NCT00038948|42156381|FG001|Overall Study|Lack of Efficacy|6|||
19712920|NCT00054704|42156395|FG000|Overall Study|Lack of Efficacy|2|||
19712921|NCT00054704|42156396|FG001|Overall Study|Lack of Efficacy|3|||
19712922|NCT00054704|42156395|FG000|Overall Study|Adverse Event|3|||
19712923|NCT00054704|42156396|FG001|Overall Study|Adverse Event|1|||
19712924|NCT00054704|42156395|FG000|Overall Study|Lost to Follow-up|0|||
19712925|NCT00054704|42156396|FG001|Overall Study|Lost to Follow-up|1|||
19712926|NCT00031694|42156402|FG000|Overall Study|Adverse Event|12|||
19712927|NCT00031694|42156402|FG000|Overall Study|Death|2|||
19712928|NCT00031694|42156402|FG000|Overall Study|Withdrawal by Subject|5|||
19712929|NCT00093795|42156410|FG000|Overall Study|No follow up data|20|||
19712930|NCT00093795|42156411|FG001|Overall Study|No follow up data|16|||
19712931|NCT00093795|42156412|FG002|Overall Study|No follow up data|17|||
19712932|NCT03467152|42156422|FG000|Overall Study|Adverse Event|4|||
19712933|NCT03467152|42156423|FG001|Overall Study|Adverse Event|5|||
19712934|NCT03467152|42156424|FG002|Overall Study|Adverse Event|0|||
19712935|NCT03467152|42156422|FG000|Overall Study|Subject Choice|1|||
19712936|NCT03467152|42156423|FG001|Overall Study|Subject Choice|3|||
19712937|NCT03467152|42156424|FG002|Overall Study|Subject Choice|0|||
19712938|NCT03467152|42156422|FG000|Overall Study|Lost to Follow-up|1|||
19712939|NCT03467152|42156423|FG001|Overall Study|Lost to Follow-up|0|||
19712940|NCT03467152|42156424|FG002|Overall Study|Lost to Follow-up|0|||
19712941|NCT03467152|42156422|FG000|Overall Study|Withdrawal by Subject|4|||
19712942|NCT03467152|42156423|FG001|Overall Study|Withdrawal by Subject|2|||
19712943|NCT03467152|42156424|FG002|Overall Study|Withdrawal by Subject|0|||
19712944|NCT03467152|42156422|FG000|Overall Study|Others|3|||
19712945|NCT03467152|42156423|FG001|Overall Study|Others|0|||
19712946|NCT03467152|42156424|FG002|Overall Study|Others|0|||
19712947|NCT03467152|42156422|FG000|Overall Study|Not treated|3|||
19712948|NCT03467152|42156423|FG001|Overall Study|Not treated|1|||
19712949|NCT03467152|42156424|FG002|Overall Study|Not treated|6|||
19712950|NCT03466060|42156433|FG000|Period 1|Test Lens Damage|0|||
19712951|NCT03466060|42156434|FG001|Period 1|Test Lens Damage|2|||
19712952|NCT03466060|42156435|FG002|Period 1|Test Lens Damage|0|||
19712953|NCT03466060|42156436|FG003|Period 1|Test Lens Damage|0|||
19712954|NCT03466060|42156437|FG004|Period 1|Test Lens Damage|0|||
19712955|NCT03466060|42156438|FG005|Period 1|Test Lens Damage|0|||
19712956|NCT03466060|42156433|FG000|Period 1|Withdrawal by Subject|0|||
19712957|NCT03466060|42156434|FG001|Period 1|Withdrawal by Subject|0|||
19712958|NCT03466060|42156435|FG002|Period 1|Withdrawal by Subject|2|||
19712959|NCT03466060|42156436|FG003|Period 1|Withdrawal by Subject|0|||
19712960|NCT03466060|42156437|FG004|Period 1|Withdrawal by Subject|0|||
19712961|NCT03466060|42156438|FG005|Period 1|Withdrawal by Subject|0|||
19712962|NCT03466060|42156433|FG000|Period 1|Lost to Follow-up|0|||
19712963|NCT03466060|42156434|FG001|Period 1|Lost to Follow-up|0|||
19712964|NCT03466060|42156435|FG002|Period 1|Lost to Follow-up|0|||
19712965|NCT03466060|42156436|FG003|Period 1|Lost to Follow-up|1|||
19712966|NCT03466060|42156437|FG004|Period 1|Lost to Follow-up|0|||
19712967|NCT03466060|42156438|FG005|Period 1|Lost to Follow-up|0|||
19712968|NCT03466060|42156433|FG000|Period 1|Grade 2 Conjunctivitis|0|||
19712969|NCT03466060|42156434|FG001|Period 1|Grade 2 Conjunctivitis|0|||
19712970|NCT03466060|42156435|FG002|Period 1|Grade 2 Conjunctivitis|1|||
19712971|NCT03466060|42156436|FG003|Period 1|Grade 2 Conjunctivitis|0|||
19712972|NCT03466060|42156437|FG004|Period 1|Grade 2 Conjunctivitis|0|||
19712973|NCT03466060|42156438|FG005|Period 1|Grade 2 Conjunctivitis|0|||
19712974|NCT03466060|42156433|FG000|Period 2|Lens Handling Difficulties|0|||
19712975|NCT03466060|42156434|FG001|Period 2|Lens Handling Difficulties|0|||
19712976|NCT03466060|42156435|FG002|Period 2|Lens Handling Difficulties|1|||
19712977|NCT03466060|42156436|FG003|Period 2|Lens Handling Difficulties|0|||
19712978|NCT03466060|42156437|FG004|Period 2|Lens Handling Difficulties|0|||
19712979|NCT03466060|42156438|FG005|Period 2|Lens Handling Difficulties|0|||
19712980|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
19712981|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
19712982|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
19712983|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
19712984|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
19712985|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
19712986|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
19712987|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
19712988|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
19712989|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
19712990|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
19712991|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
19712992|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
19712993|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
19712994|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
19712995|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
19712996|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
19712997|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
19712998|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
19712999|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
19713000|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
19713001|NCT00092547|42156454|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
19713002|NCT00092547|42156455|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
19713003|NCT00092547|42156456|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
19713004|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
19713005|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
19713006|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
19713007|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
19713008|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
19713009|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
19713010|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
19713011|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
19713012|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
19713013|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
19713014|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
19713015|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
19713016|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
19713017|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
19713018|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
19713019|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
19713020|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
19713021|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
19713022|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
19713023|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
19713024|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
19713025|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
19713026|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
19713027|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
19713028|NCT00092547|42156454|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
19713029|NCT00092547|42156455|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
19713030|NCT00092547|42156456|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
19713031|NCT00092547|42156454|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
19713032|NCT00092547|42156455|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
19713033|NCT00092547|42156456|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
19713034|NCT00092547|42156454|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
19713035|NCT00092547|42156455|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
19713036|NCT00092547|42156456|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
19713037|NCT00092547|42156454|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
19713038|NCT00092547|42156455|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
19713039|NCT00092547|42156456|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
19713040|NCT00092547|42156454|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
19713041|NCT00092547|42156455|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
19713042|NCT00092547|42156456|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
19713043|NCT03802994|42156472|FG000|Overall Study|Lost to Follow-up|0|||
19713044|NCT03802994|42156473|FG001|Overall Study|Lost to Follow-up|2|||
19713045|NCT03802994|42156474|FG002|Overall Study|Lost to Follow-up|3|||
19713046|NCT03802994|42156475|FG003|Overall Study|Lost to Follow-up|2|||
19713047|NCT03802994|42156476|FG004|Overall Study|Lost to Follow-up|2|||
19713048|NCT03465904|42156501|FG000|Overall Study|Withdrawal by Subject|9|||
19713049|NCT03465904|42156502|FG001|Overall Study|Withdrawal by Subject|5|||
19713050|NCT03465904|42156501|FG000|Overall Study|Lost to Follow-up|10|||
19713051|NCT03465904|42156502|FG001|Overall Study|Lost to Follow-up|9|||
19713052|NCT03465904|42156501|FG000|Overall Study|Protocol Violation|8|||
19713053|NCT03465904|42156502|FG001|Overall Study|Protocol Violation|5|||
19713054|NCT03465904|42156501|FG000|Overall Study|Ineligible for mITT analysis|62|||
19713055|NCT03465904|42156502|FG001|Overall Study|Ineligible for mITT analysis|47|||
19713056|NCT03802916|42156510|FG000|Overall Study|Adverse Event|0|||
19713057|NCT03802916|42156511|FG001|Overall Study|Adverse Event|1|||
19713058|NCT03802916|42156510|FG000|Overall Study|Withdrawal by Subject|0|||
19713059|NCT03802916|42156511|FG001|Overall Study|Withdrawal by Subject|1|||
19713060|NCT00076011|42156519|FG000|Overall Study|Death|1|||
19713061|NCT00076011|42156519|FG000|Overall Study|Adverse Event|10|||
19713062|NCT00076011|42156519|FG000|Overall Study|Lack of Efficacy|25|||
19713063|NCT00076011|42156519|FG000|Overall Study|Withdrawal by Subject|1|||
19713064|NCT00076011|42156519|FG000|Overall Study|Study terminated by sponsor|3|||
19713065|NCT00076011|42156519|FG000|Overall Study|Other|11|||
19713066|NCT00076011|42156519|FG000|Overall Study|Ongoing|1|||
19713067|NCT03465436|42156527|FG000|Period 1|Protocol Violation|0|||
19713068|NCT03465436|42156528|FG001|Period 1|Protocol Violation|0|||
19713069|NCT03465436|42156529|FG002|Period 1|Protocol Violation|1|||
19713070|NCT03465436|42156530|FG003|Period 1|Protocol Violation|0|||
19713071|NCT03465436|42156527|FG000|Period 2|Protocol Violation|0|||
19713072|NCT03465436|42156528|FG001|Period 2|Protocol Violation|1|||
19713073|NCT03465436|42156529|FG002|Period 2|Protocol Violation|0|||
19713074|NCT03465436|42156530|FG003|Period 2|Protocol Violation|0|||
19713075|NCT03465436|42156527|FG000|Period 3|Protocol Violation|1|||
19713076|NCT03465436|42156528|FG001|Period 3|Protocol Violation|1|||
19713077|NCT03465436|42156529|FG002|Period 3|Protocol Violation|0|||
19713078|NCT03465436|42156530|FG003|Period 3|Protocol Violation|0|||
19713079|NCT03465436|42156527|FG000|Period 4|Protocol Violation|0|||
19713080|NCT03465436|42156528|FG001|Period 4|Protocol Violation|0|||
19713081|NCT03465436|42156529|FG002|Period 4|Protocol Violation|1|||
19713082|NCT03465436|42156530|FG003|Period 4|Protocol Violation|0|||
19713083|NCT00053846|42156544|FG000|Overall Study|Changed mind|8|||
19713084|NCT00053846|42156545|FG001|Overall Study|Changed mind|13|||
19713085|NCT00053846|42156544|FG000|Overall Study|Became too ill|8|||
19713086|NCT00053846|42156545|FG001|Overall Study|Became too ill|7|||
19713087|NCT00053846|42156544|FG000|Overall Study|Expired|5|||
19713088|NCT00053846|42156545|FG001|Overall Study|Expired|0|||
19713089|NCT00053846|42156544|FG000|Overall Study|Became ineligible|3|||
19713090|NCT00053846|42156545|FG001|Overall Study|Became ineligible|1|||
19713091|NCT00053846|42156544|FG000|Overall Study|Did not return data|1|||
19713092|NCT00053846|42156545|FG001|Overall Study|Did not return data|2|||
19713093|NCT00053846|42156544|FG000|Overall Study|Quit due to side effects|1|||
19713094|NCT00053846|42156545|FG001|Overall Study|Quit due to side effects|3|||
19713095|NCT00053846|42156544|FG000|Overall Study|Pills too large|0|||
19713096|NCT00053846|42156545|FG001|Overall Study|Pills too large|1|||
19713097|NCT00090987|42156551|FG000|Overall Study|Adverse Event|5|||
19713098|NCT00090987|42156551|FG000|Overall Study|Lack of Efficacy|7|||
19713099|NCT00090987|42156551|FG000|Overall Study|Withdrawal by Subject|3|||
19713100|NCT00090987|42156551|FG000|Overall Study|alternative therapy|1|||
19713101|NCT00090987|42156551|FG000|Overall Study|Non-compliance|4|||
19713102|NCT00090987|42156551|FG000|Overall Study|Incarcerated|1|||
19713103|NCT03464422|42156555|FG000|Overall Study|Lost to Follow-up|2|||
19713104|NCT03464422|42156555|FG000|Overall Study|Withdrawal by Subject|2|||
19713105|NCT03489304|42156561|FG000|Overall Study|Lost to Follow-up|4|||
19713106|NCT03543358|42156565|FG000|Overall Study|Death|1|||
19713107|NCT03543358|42156566|FG001|Overall Study|Death|0|||
19713108|NCT03543358|42156565|FG000|Overall Study|Disease Progression|1|||
19713109|NCT03543358|42156566|FG001|Overall Study|Disease Progression|0|||
19713110|NCT03543358|42156565|FG000|Overall Study|Parent Study Closure|1|||
19713111|NCT03543358|42156566|FG001|Overall Study|Parent Study Closure|0|||
19713112|NCT03485950|42156572|FG000|Overall Study|Adverse Event|1|||
19713113|NCT03485950|42156573|FG001|Overall Study|Adverse Event|0|||
19713114|NCT03485950|42156572|FG000|Overall Study|Death|3|||
19713115|NCT03485950|42156573|FG001|Overall Study|Death|2|||
19713116|NCT03485950|42156572|FG000|Overall Study|Withdrawal by Subject|3|||
19713117|NCT03485950|42156573|FG001|Overall Study|Withdrawal by Subject|0|||
19713118|NCT00060944|42156581|FG000|Overall Study|Adverse Event|12|||
19713119|NCT00060944|42156582|FG001|Overall Study|Adverse Event|10|||
19713120|NCT00060944|42156581|FG000|Overall Study|Death|2|||
19713121|NCT00060944|42156582|FG001|Overall Study|Death|3|||
19713122|NCT00060944|42156581|FG000|Overall Study|Withdrawal by Subject|18|||
19713123|NCT00060944|42156582|FG001|Overall Study|Withdrawal by Subject|5|||
19713124|NCT00060944|42156581|FG000|Overall Study|Disease Progression|93|||
19713125|NCT00060944|42156582|FG001|Overall Study|Disease Progression|94|||
19713126|NCT00060944|42156581|FG000|Overall Study|Lost to Follow-up|1|||
19713127|NCT00060944|42156582|FG001|Overall Study|Lost to Follow-up|0|||
19713128|NCT00060944|42156581|FG000|Overall Study|Subject Ineligible To Continue|2|||
19545055|NCT00471237|41994655|FG000|Overall Study|Lost to Follow-up|1|||
19545056|NCT00471237|41994656|FG001|Overall Study|Lost to Follow-up|1|||
19545057|NCT00471237|41994657|FG002|Overall Study|Lost to Follow-up|0|||
19545058|NCT00471237|41994658|FG003|Overall Study|Lost to Follow-up|2|||
19545059|NCT00471237|41994659|FG004|Overall Study|Lost to Follow-up|3|||
19545060|NCT00471237|41994660|FG005|Overall Study|Lost to Follow-up|0|||
19545061|NCT00471237|41994661|FG006|Overall Study|Lost to Follow-up|0|||
19545062|NCT00471237|41994655|FG000|Overall Study|Protocol Violation|3|||
19713129|NCT00060944|42156582|FG001|Overall Study|Subject Ineligible To Continue|1|||
19713130|NCT00060944|42156581|FG000|Overall Study|Treatment Switch|0|||
19713131|NCT00060944|42156582|FG001|Overall Study|Treatment Switch|13|||
19713132|NCT00060944|42156581|FG000|Overall Study|Other|2|||
19713133|NCT00060944|42156582|FG001|Overall Study|Other|4|||
19713134|NCT00060944|42156581|FG000|Overall Study|randomized but not treated|6|||
19713135|NCT00060944|42156582|FG001|Overall Study|randomized but not treated|4|||
19713136|NCT03462082|42156588|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713137|NCT03462082|42156589|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713138|NCT03462082|42156590|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713139|NCT03462082|42156591|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713140|NCT03462082|42156592|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713141|NCT03462082|42156593|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
19713142|NCT03462082|42156594|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
19713143|NCT03462082|42156595|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
19713144|NCT03461146|42156605|FG000|Overall Study|Adverse Event|2|||
19713145|NCT03461146|42156605|FG000|Overall Study|Physician Decision|1|||
19713146|NCT03541252|42156609|FG000|Overall Study|Withdrawal by Subject|1|||
19713147|NCT00031460|42156615|FG000|Overall Study|Lost to Follow-up|0|||
19713148|NCT00031460|42156616|FG001|Overall Study|Lost to Follow-up|1|||
19713149|NCT00031460|42156615|FG000|Overall Study|Withdrawal by Subject|1|||
19713150|NCT00031460|42156616|FG001|Overall Study|Withdrawal by Subject|1|||
19713151|NCT00031460|42156615|FG000|Overall Study|Non-Compliant|1|||
19713152|NCT00031460|42156616|FG001|Overall Study|Non-Compliant|1|||
19713153|NCT00031460|42156615|FG000|Overall Study|Death|0|||
19713154|NCT00031460|42156616|FG001|Overall Study|Death|1|||
19713155|NCT00031460|42156615|FG000|Overall Study|Reactivation of Disease|5|||
19713156|NCT00031460|42156616|FG001|Overall Study|Reactivation of Disease|9|||
19713157|NCT00031460|42156615|FG000|Overall Study|Disruption of blinded drug supply|2|||
19713158|NCT00031460|42156616|FG001|Overall Study|Disruption of blinded drug supply|0|||
19713159|NCT00031460|42156615|FG000|Overall Study|Confirmed unevaluable|0|||
19713160|NCT00031460|42156616|FG001|Overall Study|Confirmed unevaluable|1|||
19713161|NCT03540160|42156622|FG000|Overall Study|Protocol Violation|1|||
19713162|NCT03540160|42156622|FG000|Overall Study|Physician Decision|8|||
19713163|NCT03540160|42156622|FG000|Overall Study|Lack of Efficacy|60|||
19713164|NCT03540160|42156622|FG000|Overall Study|Pregnancy|1|||
19713165|NCT03540160|42156622|FG000|Overall Study|Adverse Event|20|||
19713166|NCT03540160|42156622|FG000|Overall Study|Withdrawal by Subject|68|||
19713167|NCT03540160|42156622|FG000|Overall Study|COVID-19|2|||
19713168|NCT03540160|42156622|FG000|Overall Study|Study Closure|10|||
19713169|NCT03540160|42156622|FG000|Overall Study|Lost to Follow-up|18|||
19713170|NCT03540160|42156622|FG000|Overall Study|Sponsor decision|191|||
19713171|NCT03459196|42156626|FG000|Overall Study|Subject didn't receive study catheter|2|||
19713172|NCT03459040|42156630|FG000|Overall Study|Death|8|||
19713173|NCT03459040|42156630|FG000|Overall Study|Withdrawal by Subject|1|||
19713174|NCT03457636|42156635|FG000|Overall Study|Lost to Follow-up|2|||
19713175|NCT03481816|42156641|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
19713176|NCT03481816|42156642|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
19713177|NCT03481816|42156641|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
19713178|NCT03481816|42156642|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
19713179|NCT03481816|42156641|FG000|Dose Expansion|Withdrawal by Subject|0|||
19713180|NCT03481816|42156642|FG001|Dose Expansion|Withdrawal by Subject|2|||
19713181|NCT03481816|42156641|FG000|Dose Expansion|Physician Decision|0|||
19713182|NCT03481816|42156642|FG001|Dose Expansion|Physician Decision|5|||
19713183|NCT03538054|42156650|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
19713184|NCT03538054|42156650|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
19713185|NCT03538054|42156650|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
19713186|NCT03480802|42156658|FG000|Overall Study|Lost to Follow-up|5|||
19545063|NCT00471237|41994656|FG001|Overall Study|Protocol Violation|6|||
19713187|NCT03480802|42156659|FG001|Overall Study|Lost to Follow-up|1|||
19713188|NCT03480802|42156658|FG000|Overall Study|Withdrawal by Subject|2|||
19713189|NCT03480802|42156659|FG001|Overall Study|Withdrawal by Subject|1|||
19713190|NCT03480802|42156658|FG000|Overall Study|Relocated|0|||
19713191|NCT03480802|42156659|FG001|Overall Study|Relocated|1|||
19713192|NCT00050960|42156669|FG000|Overall Study|Progressive Disease|137|||
19713193|NCT00050960|42156670|FG001|Overall Study|Progressive Disease|93|||
19713194|NCT00050960|42156669|FG000|Overall Study|Stable Disease|19|||
19713195|NCT00050960|42156670|FG001|Overall Study|Stable Disease|48|||
19713196|NCT00050960|42156669|FG000|Overall Study|Partial Response|14|||
19713197|NCT00050960|42156670|FG001|Overall Study|Partial Response|19|||
19713198|NCT00050960|42156669|FG000|Overall Study|Complete Response|0|||
19713199|NCT00050960|42156670|FG001|Overall Study|Complete Response|2|||
19713200|NCT00050960|42156669|FG000|Overall Study|Adverse Event|62|||
19713201|NCT00050960|42156670|FG001|Overall Study|Adverse Event|61|||
19713202|NCT00050960|42156669|FG000|Overall Study|Lost to Follow-up|0|||
19713203|NCT00050960|42156670|FG001|Overall Study|Lost to Follow-up|1|||
19713204|NCT00050960|42156669|FG000|Overall Study|Withdrawal by Subject|23|||
19713205|NCT00050960|42156670|FG001|Overall Study|Withdrawal by Subject|18|||
19713206|NCT00050960|42156669|FG000|Overall Study|Administrative|31|||
19713207|NCT00050960|42156670|FG001|Overall Study|Administrative|46|||
19713208|NCT00050960|42156669|FG000|Overall Study|Non-compliance|3|||
19713209|NCT00050960|42156670|FG001|Overall Study|Non-compliance|1|||
19713210|NCT00050960|42156669|FG000|Overall Study|Death|13|||
19713211|NCT00050960|42156670|FG001|Overall Study|Death|15|||
19713212|NCT03456856|42156676|FG000|Overall Study|Lost to Follow-up|2|||
19713213|NCT03456856|42156676|FG000|Overall Study|Withdrawal by Subject|1|||
19713214|NCT00058214|42156680|FG000|Overall Study|Adverse Event|1|||
19713215|NCT00097773|42156688|FG000|Overall Study|Lost to Follow-up|2|||
19713216|NCT00097773|42156689|FG001|Overall Study|Lost to Follow-up|2|||
19713217|NCT00097773|42156690|FG002|Overall Study|Lost to Follow-up|0|||
19713218|NCT00097773|42156691|FG003|Overall Study|Lost to Follow-up|1|||
19713219|NCT00097773|42156688|FG000|Overall Study|Physician Decision|2|||
19713220|NCT00097773|42156689|FG001|Overall Study|Physician Decision|2|||
19713221|NCT00097773|42156690|FG002|Overall Study|Physician Decision|3|||
19713222|NCT00097773|42156691|FG003|Overall Study|Physician Decision|1|||
19713223|NCT00097773|42156688|FG000|Overall Study|Withdrawal by Subject|3|||
19713224|NCT00097773|42156689|FG001|Overall Study|Withdrawal by Subject|3|||
19713225|NCT00097773|42156690|FG002|Overall Study|Withdrawal by Subject|3|||
19713226|NCT00097773|42156691|FG003|Overall Study|Withdrawal by Subject|1|||
19713227|NCT00097773|42156688|FG000|Overall Study|Adverse Event|0|||
19713228|NCT00097773|42156689|FG001|Overall Study|Adverse Event|1|||
19713229|NCT00097773|42156690|FG002|Overall Study|Adverse Event|0|||
19713230|NCT00097773|42156691|FG003|Overall Study|Adverse Event|0|||
19713231|NCT00097773|42156688|FG000|Overall Study|Other|1|||
19713232|NCT00097773|42156689|FG001|Overall Study|Other|0|||
19713233|NCT00097773|42156690|FG002|Overall Study|Other|2|||
19713234|NCT00097773|42156691|FG003|Overall Study|Other|0|||
19713235|NCT03480022|42156708|FG000|Overall Study|Pregnancy|2|||
19713236|NCT03480022|42156709|FG001|Overall Study|Pregnancy|0|||
19713237|NCT03480022|42156708|FG000|Overall Study|Adverse Event|6|||
19713238|NCT03480022|42156709|FG001|Overall Study|Adverse Event|0|||
19713239|NCT03480022|42156708|FG000|Overall Study|Lack of Efficacy|0|||
19713240|NCT03480022|42156709|FG001|Overall Study|Lack of Efficacy|2|||
19713241|NCT03480022|42156708|FG000|Overall Study|Physician Decision|0|||
19713242|NCT03480022|42156709|FG001|Overall Study|Physician Decision|1|||
19713243|NCT03480022|42156708|FG000|Overall Study|Withdrawal by Subject|2|||
19713244|NCT03480022|42156709|FG001|Overall Study|Withdrawal by Subject|0|||
19713245|NCT03480022|42156708|FG000|Overall Study|Medication concerns|1|||
19713246|NCT03480022|42156709|FG001|Overall Study|Medication concerns|0|||
19713247|NCT03480022|42156708|FG000|Overall Study|Family member COVID exposure|0|||
19713248|NCT03480022|42156709|FG001|Overall Study|Family member COVID exposure|1|||
19713249|NCT03533608|42156715|FG000|Overall Study|Withdrawal by Subject|3|||
19713250|NCT03533608|42156715|FG000|Overall Study|Physician Decision|2|||
19713251|NCT00049322|42156722|FG000|Overall Study|disease burden|0|||
19713252|NCT00049322|42156723|FG001|Overall Study|disease burden|3|||
19713253|NCT00049322|42156722|FG000|Overall Study|Adverse Event|1|||
19713254|NCT00049322|42156723|FG001|Overall Study|Adverse Event|0|||
19713255|NCT00049322|42156722|FG000|Overall Study|refused angio|0|||
19713256|NCT00049322|42156723|FG001|Overall Study|refused angio|3|||
19713257|NCT03437512|42156733|FG000|Randomized|Withdrawal by Subject|0|||
19713258|NCT03437512|42156734|FG001|Randomized|Withdrawal by Subject|2|||
19713259|NCT03437512|42156733|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
19713260|NCT03437512|42156734|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
19713261|NCT00058058|42156740|FG000|Overall Study|Withdrawal by Subject|4|||
19713262|NCT00058058|42156740|FG000|Overall Study|Ineligible|20|||
19713263|NCT00058058|42156740|FG000|Overall Study|Claustrophobic|5|||
19713264|NCT00058058|42156740|FG000|Overall Study|technical issues|6|||
19713265|NCT00058058|42156740|FG000|Overall Study|Poor positioning, illness,pain|3|||
19713266|NCT03532048|42156747|FG000|Overall Study|Lost to Follow-up|12|||
19713267|NCT03532048|42156748|FG001|Overall Study|Lost to Follow-up|17|||
19713268|NCT03532048|42156747|FG000|Overall Study|Withdrawal by Subject|7|||
19713269|NCT03532048|42156748|FG001|Overall Study|Withdrawal by Subject|0|||
19713270|NCT00008138|42156754|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
19713271|NCT00008138|42156754|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
19713272|NCT00008138|42156754|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
19713273|NCT00008138|42156754|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
19713274|NCT00008138|42156754|FG000|Interval Debulking|Withdrawal by Subject|2|||
19713275|NCT00008138|42156754|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
19713276|NCT00008138|42156754|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
19713277|NCT00008138|42156754|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
19713278|NCT03436732|42156761|FG000|Overall Study|Not treated-enrolled in different study|1|||
19713279|NCT03436732|42156762|FG001|Overall Study|Not treated-enrolled in different study|0|||
19713280|NCT03436732|42156761|FG000|Overall Study|Off study after cycle 1|1|||
19713281|NCT03436732|42156762|FG001|Overall Study|Off study after cycle 1|0|||
19713282|NCT03436732|42156761|FG000|Overall Study|Adverse Event|2|||
19713283|NCT03436732|42156762|FG001|Overall Study|Adverse Event|0|||
19713284|NCT03436732|42156761|FG000|Overall Study|Death|0|||
19713285|NCT03436732|42156762|FG001|Overall Study|Death|1|||
19713286|NCT03436420|42156769|FG000|Overall Study|Lack of Efficacy|3|||
19713287|NCT00027560|42156773|FG000|Overall Study|Withdrawal by Subject|1|||
19713288|NCT03451084|42156783|FG000|Overall Study|Withdrawal by Subject|2|||
19713289|NCT03451084|42156784|FG001|Overall Study|Withdrawal by Subject|1|||
19713290|NCT03451084|42156785|FG002|Overall Study|Withdrawal by Subject|2|||
19713291|NCT03451084|42156786|FG003|Overall Study|Withdrawal by Subject|1|||
19713292|NCT03451084|42156783|FG000|Overall Study|Disease recurrence|0|||
19713293|NCT03451084|42156784|FG001|Overall Study|Disease recurrence|2|||
19713294|NCT03451084|42156785|FG002|Overall Study|Disease recurrence|0|||
19713295|NCT03451084|42156786|FG003|Overall Study|Disease recurrence|0|||
19713296|NCT03451084|42156783|FG000|Overall Study|Lack of Efficacy|0|||
19713297|NCT03451084|42156784|FG001|Overall Study|Lack of Efficacy|3|||
19713298|NCT03451084|42156785|FG002|Overall Study|Lack of Efficacy|0|||
19713299|NCT03451084|42156786|FG003|Overall Study|Lack of Efficacy|1|||
19713300|NCT03451084|42156783|FG000|Overall Study|Death|1|||
19713301|NCT03451084|42156784|FG001|Overall Study|Death|0|||
19713302|NCT03451084|42156785|FG002|Overall Study|Death|2|||
19713303|NCT03451084|42156786|FG003|Overall Study|Death|0|||
19713304|NCT03451084|42156783|FG000|Overall Study|Physician Decision|0|||
19713305|NCT03451084|42156784|FG001|Overall Study|Physician Decision|0|||
19713306|NCT03451084|42156785|FG002|Overall Study|Physician Decision|2|||
19713307|NCT03451084|42156786|FG003|Overall Study|Physician Decision|2|||
19713308|NCT03451084|42156783|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
19713309|NCT03451084|42156784|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
19713310|NCT03451084|42156785|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
19713311|NCT03451084|42156786|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
19713312|NCT03451006|42156798|FG000|Overall Study|Withdrawal by Subject|2|||
19713313|NCT03451006|42156799|FG001|Overall Study|Withdrawal by Subject|2|||
19713314|NCT03450070|42156805|FG000|Overall Study|Withdrawal by Subject|8|||
19713315|NCT03449758|42156809|FG000|Overall Study|Major protocol deviation|1|||
19713316|NCT03449758|42156809|FG000|Overall Study|Treatment inefficacy|5|||
19713317|NCT03449758|42156809|FG000|Overall Study|Adverse Event|9|||
19713318|NCT03449758|42156809|FG000|Overall Study|Consent withdrawal|1|||
19713319|NCT03449758|42156809|FG000|Overall Study|Other unspecified reason|3|||
19713320|NCT03449446|42156821|FG000|Overall Study|Randomized but Never Treated|0|||
19713321|NCT03449446|42156822|FG001|Overall Study|Randomized but Never Treated|0|||
19713322|NCT03449446|42156823|FG002|Overall Study|Randomized but Never Treated|1|||
19713323|NCT03449446|42156824|FG003|Overall Study|Randomized but Never Treated|1|||
19713324|NCT03449446|42156825|FG004|Overall Study|Randomized but Never Treated|1|||
19713325|NCT03449446|42156826|FG005|Overall Study|Randomized but Never Treated|0|||
19713326|NCT03449446|42156827|FG006|Overall Study|Randomized but Never Treated|0|||
19713327|NCT03449446|42156821|FG000|Overall Study|Unknown Reason|33|||
19713328|NCT03449446|42156822|FG001|Overall Study|Unknown Reason|1|||
19713329|NCT03449446|42156823|FG002|Overall Study|Unknown Reason|1|||
19713330|NCT03449446|42156824|FG003|Overall Study|Unknown Reason|1|||
19713331|NCT03449446|42156825|FG004|Overall Study|Unknown Reason|2|||
19713332|NCT03449446|42156826|FG005|Overall Study|Unknown Reason|2|||
19713333|NCT03449446|42156827|FG006|Overall Study|Unknown Reason|0|||
19713334|NCT03449446|42156821|FG000|Overall Study|Withdrew Consent|1|||
19713335|NCT03449446|42156822|FG001|Overall Study|Withdrew Consent|3|||
19713336|NCT03449446|42156823|FG002|Overall Study|Withdrew Consent|1|||
19713337|NCT03449446|42156824|FG003|Overall Study|Withdrew Consent|4|||
19713338|NCT03449446|42156825|FG004|Overall Study|Withdrew Consent|4|||
19713339|NCT03449446|42156826|FG005|Overall Study|Withdrew Consent|4|||
19713340|NCT03449446|42156827|FG006|Overall Study|Withdrew Consent|1|||
19713341|NCT03449446|42156821|FG000|Overall Study|Adverse Event|1|||
19713342|NCT03449446|42156822|FG001|Overall Study|Adverse Event|2|||
19713343|NCT03449446|42156823|FG002|Overall Study|Adverse Event|1|||
19713344|NCT03449446|42156824|FG003|Overall Study|Adverse Event|0|||
19713345|NCT03449446|42156825|FG004|Overall Study|Adverse Event|0|||
19713346|NCT03449446|42156826|FG005|Overall Study|Adverse Event|2|||
19713347|NCT03449446|42156827|FG006|Overall Study|Adverse Event|0|||
19713348|NCT03449446|42156821|FG000|Overall Study|Lost to Follow-up|0|||
19713349|NCT03449446|42156822|FG001|Overall Study|Lost to Follow-up|0|||
19713350|NCT03449446|42156823|FG002|Overall Study|Lost to Follow-up|2|||
19713351|NCT03449446|42156824|FG003|Overall Study|Lost to Follow-up|1|||
19713352|NCT03449446|42156825|FG004|Overall Study|Lost to Follow-up|3|||
19713353|NCT03449446|42156826|FG005|Overall Study|Lost to Follow-up|0|||
19713354|NCT03449446|42156827|FG006|Overall Study|Lost to Follow-up|0|||
19713355|NCT03449446|42156821|FG000|Overall Study|Investigator's Discretion|0|||
19713356|NCT03449446|42156822|FG001|Overall Study|Investigator's Discretion|1|||
19713357|NCT03449446|42156823|FG002|Overall Study|Investigator's Discretion|1|||
19713358|NCT03449446|42156824|FG003|Overall Study|Investigator's Discretion|2|||
19713359|NCT03449446|42156825|FG004|Overall Study|Investigator's Discretion|0|||
19713360|NCT03449446|42156826|FG005|Overall Study|Investigator's Discretion|0|||
19713361|NCT03449446|42156827|FG006|Overall Study|Investigator's Discretion|0|||
19713362|NCT03449446|42156821|FG000|Overall Study|Non Compliance with Study Drug|1|||
19713363|NCT03449446|42156822|FG001|Overall Study|Non Compliance with Study Drug|0|||
19713364|NCT03449446|42156823|FG002|Overall Study|Non Compliance with Study Drug|0|||
19713365|NCT03449446|42156824|FG003|Overall Study|Non Compliance with Study Drug|0|||
19713366|NCT03449446|42156825|FG004|Overall Study|Non Compliance with Study Drug|0|||
19713367|NCT03449446|42156826|FG005|Overall Study|Non Compliance with Study Drug|0|||
19713368|NCT03449446|42156827|FG006|Overall Study|Non Compliance with Study Drug|0|||
19713369|NCT03449446|42156821|FG000|Overall Study|Protocol Violation|0|||
19713370|NCT03449446|42156822|FG001|Overall Study|Protocol Violation|0|||
19713371|NCT03449446|42156823|FG002|Overall Study|Protocol Violation|0|||
19713372|NCT03449446|42156824|FG003|Overall Study|Protocol Violation|0|||
19713373|NCT03449446|42156825|FG004|Overall Study|Protocol Violation|1|||
19713374|NCT03449446|42156826|FG005|Overall Study|Protocol Violation|1|||
19713375|NCT03449446|42156827|FG006|Overall Study|Protocol Violation|0|||
19713376|NCT03449446|42156821|FG000|Overall Study|Death|0|||
19713377|NCT03449446|42156822|FG001|Overall Study|Death|0|||
19713378|NCT03449446|42156823|FG002|Overall Study|Death|0|||
19713379|NCT03449446|42156824|FG003|Overall Study|Death|0|||
19713380|NCT03449446|42156825|FG004|Overall Study|Death|1|||
19713381|NCT03449446|42156826|FG005|Overall Study|Death|0|||
19713382|NCT03449446|42156827|FG006|Overall Study|Death|0|||
19713383|NCT03449134|42156846|FG000|52-Week Treatment Period|Death|2|||
19713384|NCT03449134|42156847|FG001|52-Week Treatment Period|Death|1|||
19713385|NCT03449134|42156848|FG002|52-Week Treatment Period|Death|0|||
19713386|NCT03449134|42156846|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
19713387|NCT03449134|42156847|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
19713388|NCT03449134|42156848|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
19713389|NCT03449134|42156846|FG000|52-Week Treatment Period|Physician Decision|2|||
19713390|NCT03449134|42156847|FG001|52-Week Treatment Period|Physician Decision|3|||
19713391|NCT03449134|42156848|FG002|52-Week Treatment Period|Physician Decision|3|||
19713392|NCT03449134|42156846|FG000|52-Week Treatment Period|Screen Failure|1|||
19713393|NCT03449134|42156847|FG001|52-Week Treatment Period|Screen Failure|0|||
19713394|NCT03449134|42156848|FG002|52-Week Treatment Period|Screen Failure|1|||
19713395|NCT03449134|42156846|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
19713396|NCT03449134|42156847|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
19713397|NCT03449134|42156848|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
19713398|NCT03449134|42156846|FG000|52-Week Treatment Period|Site Closure|1|||
19713399|NCT03449134|42156847|FG001|52-Week Treatment Period|Site Closure|0|||
19713400|NCT03449134|42156848|FG002|52-Week Treatment Period|Site Closure|0|||
19713401|NCT03529162|42156861|FG000|Overall Study|Lost to Follow-up|2|||
19713402|NCT03529162|42156862|FG001|Overall Study|Lost to Follow-up|2|||
19713403|NCT03447730|42156873|FG000|Overall Study|Adverse Event|0|||
19713404|NCT03447730|42156874|FG001|Overall Study|Adverse Event|2|||
19713405|NCT03447730|42156875|FG002|Overall Study|Adverse Event|0|||
19713406|NCT03429556|42156887|FG000|Overall Study|Lost to Follow-up|0|||
19713407|NCT03429556|42156888|FG001|Overall Study|Lost to Follow-up|1|||
19713408|NCT03429556|42156889|FG002|Overall Study|Lost to Follow-up|0|||
19713409|NCT03429556|42156890|FG003|Overall Study|Lost to Follow-up|0|||
19713410|NCT03428152|42156902|FG000|Overall Study|Physician Decision|4|||
19713411|NCT03428152|42156903|FG001|Overall Study|Physician Decision|2|||
19713412|NCT03428152|42156902|FG000|Overall Study|Protocol Violation|3|||
19713413|NCT03428152|42156903|FG001|Overall Study|Protocol Violation|5|||
19713414|NCT03428152|42156902|FG000|Overall Study|Lack of Efficacy|0|||
19458756|NCT01399593|41712671|FG001|Overall Study|Adverse Event|0|||
19713415|NCT03428152|42156903|FG001|Overall Study|Lack of Efficacy|4|||
19713416|NCT03444766|42156909|FG000|Overall Study|Other Reasons|2|||
19713417|NCT03444766|42156909|FG000|Overall Study|Participant Withdrew Consent|5|||
19713418|NCT03444766|42156909|FG000|Overall Study|Lost to Follow-up|2|||
19713419|NCT03444766|42156909|FG000|Overall Study|Death|2|||
19713420|NCT03444766|42156909|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
19713421|NCT03444766|42156909|FG000|Overall Study|Disease Progression|49|||
19713422|NCT03426436|42156913|FG000|Overall Study|Incorrect lead placement|12|||
19713423|NCT03426436|42156913|FG000|Overall Study|Withdrawal by Subject|2|||
19713424|NCT03426436|42156913|FG000|Overall Study|Consent issue|1|||
19713425|NCT03426436|42156913|FG000|Overall Study|ECGs not saved|4|||
19713426|NCT03425188|42156917|FG000|Overall Study|Withdrawal by Subject|1|||
19713427|NCT03423238|42156924|FG000|Overall Study|Lost to Follow-up|1|||
19713428|NCT03423238|42156925|FG001|Overall Study|Lost to Follow-up|0|||
19713429|NCT03423238|42156924|FG000|Overall Study|Withdrawal by Subject|1|||
19713430|NCT03423238|42156925|FG001|Overall Study|Withdrawal by Subject|0|||
19713431|NCT02953678|42156932|FG000|Overall Study|Adverse Event|20|||
19713432|NCT02953678|42156932|FG000|Overall Study|Death|7|||
19713433|NCT02953678|42156932|FG000|Overall Study|Physician Decision|23|||
19713434|NCT02953678|42156932|FG000|Overall Study|Progressive Disease of GVHD|7|||
19713435|NCT02953678|42156932|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
19713436|NCT02953678|42156932|FG000|Overall Study|Withdrawal by participant|3|||
19713437|NCT02953678|42156932|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
19713438|NCT02953678|42156932|FG000|Overall Study|Participants were transferred to commercial product.|3|||
19713439|NCT03412084|42156939|FG000|Overall Study|Withdrawal by Subject|2|||
19713440|NCT03412084|42156940|FG001|Overall Study|Withdrawal by Subject|0|||
19713441|NCT03412084|42156939|FG000|Overall Study|Participant moved|1|||
19713442|NCT03412084|42156940|FG001|Overall Study|Participant moved|0|||
19713443|NCT03412084|42156939|FG000|Overall Study|Lost to Follow-up|1|||
19713444|NCT03412084|42156940|FG001|Overall Study|Lost to Follow-up|1|||
19713445|NCT00090753|42156948|FG000|First Treatment Period|Adverse Event|20|||
19713446|NCT00090753|42156949|FG001|First Treatment Period|Adverse Event|8|||
19713447|NCT00090753|42156948|FG000|First Treatment Period|Death|88|||
19713448|NCT00090753|42156949|FG001|First Treatment Period|Death|62|||
19713449|NCT00090753|42156948|FG000|First Treatment Period|Lack of Efficacy|2|||
19713450|NCT00090753|42156949|FG001|First Treatment Period|Lack of Efficacy|1|||
19713451|NCT00090753|42156948|FG000|First Treatment Period|Refused Treatment|32|||
19713452|NCT00090753|42156949|FG001|First Treatment Period|Refused Treatment|25|||
19713453|NCT00090753|42156948|FG000|First Treatment Period|Lost to Follow-up|4|||
19713454|NCT00090753|42156949|FG001|First Treatment Period|Lost to Follow-up|4|||
19713455|NCT00090753|42156948|FG000|First Treatment Period|Renal Transplant|70|||
19713456|NCT00090753|42156949|FG001|First Treatment Period|Renal Transplant|50|||
19713457|NCT00090753|42156948|FG000|First Treatment Period|Mircera Commercialization|1|||
19713458|NCT00090753|42156949|FG001|First Treatment Period|Mircera Commercialization|0|||
19713459|NCT00090753|42156948|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
19713460|NCT00090753|42156949|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
19713461|NCT00090753|42156948|FG000|Extended Treatment Period|Adverse Event|11|||
19713462|NCT00090753|42156949|FG001|Extended Treatment Period|Adverse Event|0|||
19713463|NCT00090753|42156948|FG000|Extended Treatment Period|Death|58|||
19713464|NCT00090753|42156949|FG001|Extended Treatment Period|Death|30|||
19713465|NCT00090753|42156948|FG000|Extended Treatment Period|Lack of Efficacy|1|||
19713466|NCT00090753|42156949|FG001|Extended Treatment Period|Lack of Efficacy|0|||
19713467|NCT00090753|42156948|FG000|Extended Treatment Period|Refused Treatment|18|||
19713468|NCT00090753|42156949|FG001|Extended Treatment Period|Refused Treatment|12|||
19713469|NCT00090753|42156948|FG000|Extended Treatment Period|Lost to Follow-up|3|||
19713470|NCT00090753|42156949|FG001|Extended Treatment Period|Lost to Follow-up|1|||
19713471|NCT00090753|42156948|FG000|Extended Treatment Period|Renal Transplant|15|||
19713472|NCT00090753|42156949|FG001|Extended Treatment Period|Renal Transplant|12|||
19713473|NCT00090753|42156948|FG000|Extended Treatment Period|Mircera Commercialization|188|||
19713474|NCT00090753|42156949|FG001|Extended Treatment Period|Mircera Commercialization|93|||
19713475|NCT00090753|42156948|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
19713476|NCT00090753|42156949|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
19713477|NCT00048932|42156957|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
19713478|NCT00048932|42156958|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
19713479|NCT00048932|42156959|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
19713480|NCT00048932|42156957|FG000|Double Blind Period (DB)|Adverse Event|51|||
19713481|NCT00048932|42156958|FG001|Double Blind Period (DB)|Adverse Event|19|||
19713482|NCT00048932|42156959|FG002|Double Blind Period (DB)|Adverse Event|0|||
19713483|NCT00048932|42156957|FG000|Double Blind Period (DB)|Death|5|||
19713484|NCT00048932|42156958|FG001|Double Blind Period (DB)|Death|3|||
19713485|NCT00048932|42156959|FG002|Double Blind Period (DB)|Death|0|||
19713486|NCT00048932|42156957|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
19713487|NCT00048932|42156958|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
19713488|NCT00048932|42156959|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
19713489|NCT00048932|42156957|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
19713490|NCT00048932|42156958|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
19713491|NCT00048932|42156959|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
19713492|NCT00048932|42156957|FG000|Double Blind Period (DB)|Relocation|1|||
19713493|NCT00048932|42156958|FG001|Double Blind Period (DB)|Relocation|0|||
19713494|NCT00048932|42156959|FG002|Double Blind Period (DB)|Relocation|0|||
19713495|NCT00048932|42156957|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
19713496|NCT00048932|42156958|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
19713497|NCT00048932|42156959|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
19713498|NCT00048932|42156957|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
19713499|NCT00048932|42156958|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
19713500|NCT00048932|42156959|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
19713501|NCT00048932|42156957|FG000|Double Blind Period (DB)|Pregnancy|1|||
19713502|NCT00048932|42156958|FG001|Double Blind Period (DB)|Pregnancy|0|||
19713503|NCT00048932|42156959|FG002|Double Blind Period (DB)|Pregnancy|0|||
19713504|NCT00048932|42156957|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
19713505|NCT00048932|42156958|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
19713506|NCT00048932|42156959|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
19713507|NCT00048932|42156957|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
19713508|NCT00048932|42156958|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
19713509|NCT00048932|42156959|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
19713510|NCT00048932|42156957|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
19713511|NCT00048932|42156958|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
19713512|NCT00048932|42156959|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
19713513|NCT00048932|42156957|FG000|Open Label Period (OL)|Death|0|||
19713514|NCT00048932|42156958|FG001|Open Label Period (OL)|Death|0|||
19713515|NCT00048932|42156959|FG002|Open Label Period (OL)|Death|25|||
19713516|NCT00048932|42156957|FG000|Open Label Period (OL)|Adverse Event|0|||
19713517|NCT00048932|42156958|FG001|Open Label Period (OL)|Adverse Event|0|||
19713518|NCT00048932|42156959|FG002|Open Label Period (OL)|Adverse Event|103|||
19713519|NCT00048932|42156957|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
19713520|NCT00048932|42156958|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
19713521|NCT00048932|42156959|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
19713522|NCT00048932|42156957|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
19713523|NCT00048932|42156958|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
19713524|NCT00048932|42156959|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
19713525|NCT00048932|42156957|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
19713526|NCT00048932|42156958|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
19713527|NCT00048932|42156959|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
19713528|NCT00048932|42156957|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
19713529|NCT00048932|42156958|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
19713530|NCT00048932|42156959|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
19713531|NCT00048932|42156957|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
19713532|NCT00048932|42156958|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
19713533|NCT00048932|42156959|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
19713534|NCT00048932|42156957|FG000|Open Label Period (OL)|Pregnancy|0|||
19713535|NCT00048932|42156958|FG001|Open Label Period (OL)|Pregnancy|0|||
19713536|NCT00048932|42156959|FG002|Open Label Period (OL)|Pregnancy|6|||
19713537|NCT00048932|42156957|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
19713538|NCT00048932|42156958|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
19713539|NCT00048932|42156959|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
19713540|NCT00048932|42156957|FG000|Open Label Period (OL)|Investigator Retiring|0|||
19713541|NCT00048932|42156958|FG001|Open Label Period (OL)|Investigator Retiring|0|||
19713542|NCT00048932|42156959|FG002|Open Label Period (OL)|Investigator Retiring|2|||
19713543|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
19713544|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
19713545|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
19713546|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Relocated|0|||
19713547|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Relocated|0|||
19713548|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Relocated|6|||
19713549|NCT00048932|42156957|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
19713550|NCT00048932|42156958|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
19713551|NCT00048932|42156959|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
19713552|NCT00048932|42156957|FG000|Open Label Period (OL)|Site Closure|0|||
19713553|NCT00048932|42156958|FG001|Open Label Period (OL)|Site Closure|0|||
19713554|NCT00048932|42156959|FG002|Open Label Period (OL)|Site Closure|3|||
19713555|NCT00048932|42156957|FG000|Open Label Period (OL)|Trial Terminated|0|||
19713556|NCT00048932|42156958|FG001|Open Label Period (OL)|Trial Terminated|0|||
19713557|NCT00048932|42156959|FG002|Open Label Period (OL)|Trial Terminated|1|||
19713558|NCT00048932|42156957|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
19713559|NCT00048932|42156958|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
19713560|NCT00048932|42156959|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
19713561|NCT00048932|42156957|FG000|Open Label Period (OL)|Patient Decision|0|||
19713562|NCT00048932|42156958|FG001|Open Label Period (OL)|Patient Decision|0|||
19713563|NCT00048932|42156959|FG002|Open Label Period (OL)|Patient Decision|4|||
19713564|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
19713565|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
19713566|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
19713567|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
19713568|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
19713569|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
19458757|NCT01399593|41712670|FG000|Overall Study|Death|1|||
19458758|NCT01399593|41712671|FG001|Overall Study|Death|1|||
19458759|NCT01399593|41712670|FG000|Overall Study|Transplantectomy|0|||
19458760|NCT01399593|41712671|FG001|Overall Study|Transplantectomy|1|||
19458761|NCT01833169|41712677|FG000|Overall Study|Disease Progression|99|||
19458762|NCT01833169|41712677|FG000|Overall Study|Adverse Event|33|||
19458763|NCT01833169|41712677|FG000|Overall Study|Withdrawal by Subject|9|||
19458764|NCT01833169|41712677|FG000|Overall Study|Death|3|||
19458765|NCT01833169|41712677|FG000|Overall Study|Physician Decision|2|||
19458766|NCT01860079|41712683|FG000|Overall Study|Physician Decision|14|||
19458767|NCT01860079|41712684|FG001|Overall Study|Physician Decision|22|||
19458768|NCT01388985|41712692|FG000|Overall Study|Death|0|||
19458769|NCT01388985|41712693|FG001|Overall Study|Death|1|||
19458770|NCT01388985|41712692|FG000|Overall Study|Lost to Follow-up|30|||
19458771|NCT01388985|41712693|FG001|Overall Study|Lost to Follow-up|30|||
19458772|NCT01388985|41712692|FG000|Overall Study|Withdrawal by Subject|13|||
19458773|NCT01388985|41712693|FG001|Overall Study|Withdrawal by Subject|4|||
19458774|NCT01388985|41712692|FG000|Overall Study|Subject unavailable|1|||
19458775|NCT01388985|41712693|FG001|Overall Study|Subject unavailable|1|||
19458776|NCT01388985|41712692|FG000|Overall Study|Other (no reason)|0|||
19458777|NCT01388985|41712693|FG001|Overall Study|Other (no reason)|1|||
19458778|NCT01388985|41712692|FG000|Overall Study|Error of nurse|5|||
19458779|NCT01388985|41712693|FG001|Overall Study|Error of nurse|1|||
19458780|NCT01388907|41712701|FG000|Overall Study|Adverse Event|2|||
19458781|NCT01388907|41712702|FG001|Overall Study|Adverse Event|0|||
19458782|NCT01388361|41712713|FG000|Overall Study|Adverse Event|0|||
19458783|NCT01388361|41712714|FG001|Overall Study|Adverse Event|5|||
19458784|NCT01388361|41712715|FG002|Overall Study|Adverse Event|1|||
19458785|NCT01388361|41712713|FG000|Overall Study|Protocol Violation|0|||
19458786|NCT01388361|41712714|FG001|Overall Study|Protocol Violation|0|||
19458787|NCT01388361|41712715|FG002|Overall Study|Protocol Violation|2|||
19458788|NCT01388361|41712713|FG000|Overall Study|Withdrawal criteria|12|||
19458789|NCT01388361|41712714|FG001|Overall Study|Withdrawal criteria|7|||
19458790|NCT01388361|41712715|FG002|Overall Study|Withdrawal criteria|10|||
19458791|NCT01388361|41712713|FG000|Overall Study|Unclassified|0|||
19458792|NCT01388361|41712714|FG001|Overall Study|Unclassified|0|||
19458793|NCT01388361|41712715|FG002|Overall Study|Unclassified|1|||
19458794|NCT01399125|41712725|FG000|Overall Study|Adverse Event|32|||
19458795|NCT01399125|41712726|FG001|Overall Study|Adverse Event|30|||
19458796|NCT01399125|41712725|FG000|Overall Study|Abnormal Lab values|0|||
19458797|NCT01399125|41712726|FG001|Overall Study|Abnormal Lab values|1|||
19458798|NCT01399125|41712725|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
19458799|NCT01399125|41712726|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
19458800|NCT01399125|41712725|FG000|Overall Study|Withdrawal by Subject|5|||
19458801|NCT01399125|41712726|FG001|Overall Study|Withdrawal by Subject|8|||
19458802|NCT01399125|41712725|FG000|Overall Study|Lost to Follow-up|2|||
19458803|NCT01399125|41712726|FG001|Overall Study|Lost to Follow-up|3|||
19458804|NCT01399125|41712725|FG000|Overall Study|Administrative Problems|7|||
19458805|NCT01399125|41712726|FG001|Overall Study|Administrative Problems|11|||
19458806|NCT01399125|41712725|FG000|Overall Study|Death|0|||
19458807|NCT01399125|41712726|FG001|Overall Study|Death|1|||
19458808|NCT01399125|41712725|FG000|Overall Study|Protocol Deviation|5|||
19458809|NCT01399125|41712726|FG001|Overall Study|Protocol Deviation|2|||
19458810|NCT01399047|41712734|FG000|Overall Study|Withdrawal by Subject|0|||
19458811|NCT01399047|41712735|FG001|Overall Study|Withdrawal by Subject|1|||
19458812|NCT01387737|41712745|FG000|Overall Study|Adverse Event|20|||
19458813|NCT01387737|41712746|FG001|Overall Study|Adverse Event|30|||
19458814|NCT01387737|41712745|FG000|Overall Study|Lack of Efficacy|1|||
19458815|NCT01387737|41712746|FG001|Overall Study|Lack of Efficacy|0|||
19458816|NCT01387737|41712745|FG000|Overall Study|Physician Decision|3|||
19458817|NCT01387737|41712746|FG001|Overall Study|Physician Decision|10|||
19458818|NCT01387737|41712745|FG000|Overall Study|Withdrawal by Subject|27|||
19458819|NCT01387737|41712746|FG001|Overall Study|Withdrawal by Subject|31|||
19713570|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
19713571|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
19458820|NCT01387737|41712745|FG000|Overall Study|Clearly not eligible for the study|1|||
19458821|NCT01387737|41712746|FG001|Overall Study|Clearly not eligible for the study|3|||
19458822|NCT01387347|41712754|FG000|Overall Study|Lost to Follow-up|2|||
19458823|NCT01387347|41712755|FG001|Overall Study|Lost to Follow-up|1|||
19458824|NCT01859923|41712769|FG000|Overall Study|Adverse Event|0|||
19458825|NCT01859923|41712770|FG001|Overall Study|Adverse Event|0|||
19713572|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
19713573|NCT00048932|42156957|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
19713574|NCT00048932|42156958|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
19713575|NCT00048932|42156959|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
19713576|NCT00048932|42156957|FG000|Open Label Period (OL)|Investigator Decision|0|||
19713577|NCT00048932|42156958|FG001|Open Label Period (OL)|Investigator Decision|0|||
19713578|NCT00048932|42156959|FG002|Open Label Period (OL)|Investigator Decision|4|||
19713579|NCT00048932|42156957|FG000|Open Label Period (OL)|Site Staff Issues|0|||
19713580|NCT00048932|42156958|FG001|Open Label Period (OL)|Site Staff Issues|0|||
19713581|NCT00048932|42156959|FG002|Open Label Period (OL)|Site Staff Issues|2|||
19713582|NCT00048932|42156957|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
19713583|NCT00048932|42156958|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
19713584|NCT00048932|42156959|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
19713585|NCT00048932|42156957|FG000|Open Label Period (OL)|Participant Surgery|0|||
19713586|NCT00048932|42156958|FG001|Open Label Period (OL)|Participant Surgery|0|||
19713587|NCT00048932|42156959|FG002|Open Label Period (OL)|Participant Surgery|1|||
19713588|NCT00073983|42156968|FG000|Overall Study|not evaluable|1|||
19713589|NCT03812679|42156974|FG000|Overall Study|Adverse Event|2|||
19713590|NCT03812679|42156974|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
19713591|NCT03812679|42156974|FG000|Overall Study|Renal transplant|1|||
19713592|NCT03812679|42156974|FG000|Overall Study|Withdrawal by Subject|1|||
19713593|NCT03812679|42156974|FG000|Overall Study|Termination of study|2|||
19713594|NCT03812679|42156974|FG000|Overall Study|Water device replacement|1|||
19713595|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
19713596|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
19713597|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
19713598|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
19713599|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
19713600|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
19713601|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
19713602|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
19713603|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
19713604|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
19713605|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
19713606|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
19713607|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
19713608|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
19713609|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
19713610|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
19713611|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
19713612|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
19713613|NCT02952820|42156981|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
19713614|NCT02952820|42156982|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
19713615|NCT02952820|42156983|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
19713616|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
19713617|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
19713618|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
19713619|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
19713620|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
19713621|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
19713622|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
19713623|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
19713624|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
19713625|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
19713626|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
19713627|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
19713628|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
19713629|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
19713630|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
19713631|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
19713632|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
19713633|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
19713634|NCT02952820|42156981|FG000|Active Treatment Period (6 Months)|Not treated|0|||
19713635|NCT02952820|42156982|FG001|Active Treatment Period (6 Months)|Not treated|0|||
19713636|NCT02952820|42156983|FG002|Active Treatment Period (6 Months)|Not treated|1|||
19713637|NCT00006392|42156998|FG000|Overall Study|Ineligible|11|||
19713638|NCT00006392|42156999|FG001|Overall Study|Ineligible|3|||
19713639|NCT00006392|42157000|FG002|Overall Study|Ineligible|5|||
19713640|NCT00006392|42157001|FG003|Overall Study|Ineligible|5|||
19713641|NCT00006392|42156998|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
19713642|NCT00006392|42156999|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
19713643|NCT00006392|42157000|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
19713644|NCT00006392|42157001|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
19713645|NCT00379769|42157015|FG000|Main Study|Death|57|||
19713646|NCT00379769|42157016|FG001|Main Study|Death|67|||
19713647|NCT00379769|42157017|FG002|Main Study|Death|54|||
19713648|NCT00379769|42157018|FG003|Main Study|Death|72|||
19713649|NCT00379769|42157019|FG004|Main Study|Death|0|||
19713650|NCT00379769|42157020|FG005|Main Study|Death|0|||
19713651|NCT00379769|42157015|FG000|Main Study|Adverse Event|5|||
19713652|NCT00379769|42157016|FG001|Main Study|Adverse Event|8|||
19713653|NCT00379769|42157017|FG002|Main Study|Adverse Event|10|||
19713654|NCT00379769|42157018|FG003|Main Study|Adverse Event|11|||
19713655|NCT00379769|42157019|FG004|Main Study|Adverse Event|0|||
19713656|NCT00379769|42157020|FG005|Main Study|Adverse Event|0|||
19713657|NCT00379769|42157015|FG000|Main Study|Lost to Follow-up|29|||
19713658|NCT00379769|42157016|FG001|Main Study|Lost to Follow-up|29|||
19713659|NCT00379769|42157017|FG002|Main Study|Lost to Follow-up|25|||
19713660|NCT00379769|42157018|FG003|Main Study|Lost to Follow-up|26|||
19713661|NCT00379769|42157019|FG004|Main Study|Lost to Follow-up|0|||
19713662|NCT00379769|42157020|FG005|Main Study|Lost to Follow-up|0|||
19713663|NCT00379769|42157015|FG000|Main Study|Withdrawal by Subject|46|||
19713664|NCT00379769|42157016|FG001|Main Study|Withdrawal by Subject|56|||
19713665|NCT00379769|42157017|FG002|Main Study|Withdrawal by Subject|72|||
19713666|NCT00379769|42157018|FG003|Main Study|Withdrawal by Subject|70|||
19713667|NCT00379769|42157019|FG004|Main Study|Withdrawal by Subject|0|||
19713668|NCT00379769|42157020|FG005|Main Study|Withdrawal by Subject|0|||
19713669|NCT00379769|42157015|FG000|Main Study|Moved to survival status follow-up only|27|||
19713670|NCT00379769|42157016|FG001|Main Study|Moved to survival status follow-up only|25|||
19713671|NCT00379769|42157017|FG002|Main Study|Moved to survival status follow-up only|32|||
19713672|NCT00379769|42157018|FG003|Main Study|Moved to survival status follow-up only|36|||
19713673|NCT00379769|42157019|FG004|Main Study|Moved to survival status follow-up only|0|||
19713674|NCT00379769|42157020|FG005|Main Study|Moved to survival status follow-up only|0|||
19713675|NCT00379769|42157015|FG000|Main Study|Participant moved|3|||
19713676|NCT00379769|42157016|FG001|Main Study|Participant moved|2|||
19713677|NCT00379769|42157017|FG002|Main Study|Participant moved|3|||
19713678|NCT00379769|42157018|FG003|Main Study|Participant moved|3|||
19713679|NCT00379769|42157019|FG004|Main Study|Participant moved|0|||
19713680|NCT00379769|42157020|FG005|Main Study|Participant moved|0|||
19713681|NCT00379769|42157015|FG000|Main Study|Poor compliance|3|||
19713682|NCT00379769|42157016|FG001|Main Study|Poor compliance|2|||
19713683|NCT00379769|42157017|FG002|Main Study|Poor compliance|2|||
19713684|NCT00379769|42157018|FG003|Main Study|Poor compliance|1|||
19713685|NCT00379769|42157019|FG004|Main Study|Poor compliance|0|||
19713686|NCT00379769|42157020|FG005|Main Study|Poor compliance|0|||
19713687|NCT00379769|42157015|FG000|Main Study|Prohibited glucose lowering medication|0|||
19713688|NCT00379769|42157016|FG001|Main Study|Prohibited glucose lowering medication|3|||
19713689|NCT00379769|42157017|FG002|Main Study|Prohibited glucose lowering medication|0|||
19713690|NCT00379769|42157018|FG003|Main Study|Prohibited glucose lowering medication|1|||
19713691|NCT00379769|42157019|FG004|Main Study|Prohibited glucose lowering medication|0|||
19713692|NCT00379769|42157020|FG005|Main Study|Prohibited glucose lowering medication|0|||
19713693|NCT00379769|42157015|FG000|Main Study|Site closed|4|||
19713694|NCT00379769|42157016|FG001|Main Study|Site closed|4|||
19713695|NCT00379769|42157017|FG002|Main Study|Site closed|4|||
19713696|NCT00379769|42157018|FG003|Main Study|Site closed|8|||
19713697|NCT00379769|42157019|FG004|Main Study|Site closed|0|||
19713698|NCT00379769|42157020|FG005|Main Study|Site closed|0|||
19713699|NCT00379769|42157015|FG000|Main Study|Entry criteria violation|0|||
19713700|NCT00379769|42157016|FG001|Main Study|Entry criteria violation|0|||
19713701|NCT00379769|42157017|FG002|Main Study|Entry criteria violation|1|||
19713702|NCT00379769|42157018|FG003|Main Study|Entry criteria violation|1|||
19713703|NCT00379769|42157019|FG004|Main Study|Entry criteria violation|0|||
19713704|NCT00379769|42157020|FG005|Main Study|Entry criteria violation|0|||
19713705|NCT00379769|42157015|FG000|Main Study|Participant did not take study drug|0|||
19713706|NCT00379769|42157016|FG001|Main Study|Participant did not take study drug|0|||
19713707|NCT00379769|42157017|FG002|Main Study|Participant did not take study drug|1|||
19713708|NCT00379769|42157018|FG003|Main Study|Participant did not take study drug|0|||
19713709|NCT00379769|42157019|FG004|Main Study|Participant did not take study drug|0|||
19713710|NCT00379769|42157020|FG005|Main Study|Participant did not take study drug|0|||
19713711|NCT00379769|42157015|FG000|Main Study|Physician Decision|2|||
19713712|NCT00379769|42157016|FG001|Main Study|Physician Decision|2|||
19713713|NCT00379769|42157017|FG002|Main Study|Physician Decision|1|||
19713714|NCT00379769|42157018|FG003|Main Study|Physician Decision|1|||
19713715|NCT00379769|42157019|FG004|Main Study|Physician Decision|0|||
19713716|NCT00379769|42157020|FG005|Main Study|Physician Decision|0|||
19713717|NCT00379769|42157015|FG000|Main Study|Participant completed study at visit 27|1|||
19713718|NCT00379769|42157016|FG001|Main Study|Participant completed study at visit 27|0|||
19713719|NCT00379769|42157017|FG002|Main Study|Participant completed study at visit 27|0|||
19713720|NCT00379769|42157018|FG003|Main Study|Participant completed study at visit 27|0|||
19713721|NCT00379769|42157019|FG004|Main Study|Participant completed study at visit 27|0|||
19713722|NCT00379769|42157020|FG005|Main Study|Participant completed study at visit 27|0|||
19713723|NCT00379769|42157015|FG000|Main Study|Personal reasons|1|||
19713724|NCT00379769|42157016|FG001|Main Study|Personal reasons|0|||
19713725|NCT00379769|42157017|FG002|Main Study|Personal reasons|0|||
19713726|NCT00379769|42157018|FG003|Main Study|Personal reasons|0|||
19713727|NCT00379769|42157019|FG004|Main Study|Personal reasons|0|||
19713728|NCT00379769|42157020|FG005|Main Study|Personal reasons|0|||
19713729|NCT00379769|42157015|FG000|Main Study|Risk of heart failure|0|||
19713730|NCT00379769|42157016|FG001|Main Study|Risk of heart failure|1|||
19713731|NCT00379769|42157017|FG002|Main Study|Risk of heart failure|0|||
19713732|NCT00379769|42157018|FG003|Main Study|Risk of heart failure|0|||
19713733|NCT00379769|42157019|FG004|Main Study|Risk of heart failure|0|||
19713734|NCT00379769|42157020|FG005|Main Study|Risk of heart failure|0|||
19713735|NCT00379769|42157015|FG000|Main Study|Investigator refused to log temperature|0|||
19713736|NCT00379769|42157016|FG001|Main Study|Investigator refused to log temperature|0|||
19713737|NCT00379769|42157017|FG002|Main Study|Investigator refused to log temperature|1|||
19713738|NCT00379769|42157018|FG003|Main Study|Investigator refused to log temperature|0|||
19713739|NCT00379769|42157019|FG004|Main Study|Investigator refused to log temperature|0|||
19713740|NCT00379769|42157020|FG005|Main Study|Investigator refused to log temperature|0|||
19713741|NCT00379769|42157015|FG000|Main Study|Reason unspecified|0|||
19713742|NCT00379769|42157016|FG001|Main Study|Reason unspecified|0|||
19713743|NCT00379769|42157017|FG002|Main Study|Reason unspecified|1|||
19713744|NCT00379769|42157018|FG003|Main Study|Reason unspecified|0|||
19713745|NCT00379769|42157019|FG004|Main Study|Reason unspecified|0|||
19713746|NCT00379769|42157020|FG005|Main Study|Reason unspecified|0|||
19713747|NCT00379769|42157015|FG000|Observational Follow-up|Death|0|||
19713748|NCT00379769|42157016|FG001|Observational Follow-up|Death|0|||
19713749|NCT00379769|42157017|FG002|Observational Follow-up|Death|0|||
19713750|NCT00379769|42157018|FG003|Observational Follow-up|Death|0|||
19713751|NCT00379769|42157019|FG004|Observational Follow-up|Death|78|||
19713752|NCT00379769|42157020|FG005|Observational Follow-up|Death|70|||
19713753|NCT00379769|42157015|FG000|Observational Follow-up|Adverse Event|0|||
19713754|NCT00379769|42157016|FG001|Observational Follow-up|Adverse Event|0|||
19713755|NCT00379769|42157017|FG002|Observational Follow-up|Adverse Event|0|||
19713756|NCT00379769|42157018|FG003|Observational Follow-up|Adverse Event|0|||
19713757|NCT00379769|42157019|FG004|Observational Follow-up|Adverse Event|1|||
19713758|NCT00379769|42157020|FG005|Observational Follow-up|Adverse Event|0|||
19713759|NCT00379769|42157015|FG000|Observational Follow-up|Lost to Follow-up|0|||
19713760|NCT00379769|42157016|FG001|Observational Follow-up|Lost to Follow-up|0|||
19713761|NCT00379769|42157017|FG002|Observational Follow-up|Lost to Follow-up|0|||
19713762|NCT00379769|42157018|FG003|Observational Follow-up|Lost to Follow-up|0|||
19713763|NCT00379769|42157019|FG004|Observational Follow-up|Lost to Follow-up|25|||
19713764|NCT00379769|42157020|FG005|Observational Follow-up|Lost to Follow-up|27|||
19713765|NCT00379769|42157015|FG000|Observational Follow-up|Withdrawal by Subject|0|||
19713766|NCT00379769|42157016|FG001|Observational Follow-up|Withdrawal by Subject|0|||
19713767|NCT00379769|42157017|FG002|Observational Follow-up|Withdrawal by Subject|0|||
19713768|NCT00379769|42157018|FG003|Observational Follow-up|Withdrawal by Subject|0|||
19713769|NCT00379769|42157019|FG004|Observational Follow-up|Withdrawal by Subject|12|||
19713770|NCT00379769|42157020|FG005|Observational Follow-up|Withdrawal by Subject|12|||
19713771|NCT00379769|42157015|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
19713772|NCT00379769|42157016|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
19713773|NCT00379769|42157017|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
19713774|NCT00379769|42157018|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
19713775|NCT00379769|42157019|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
19713776|NCT00379769|42157020|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
19713777|NCT00379769|42157015|FG000|Observational Follow-up|Physician Decision|0|||
19713778|NCT00379769|42157016|FG001|Observational Follow-up|Physician Decision|0|||
19713779|NCT00379769|42157017|FG002|Observational Follow-up|Physician Decision|0|||
19713780|NCT00379769|42157018|FG003|Observational Follow-up|Physician Decision|0|||
19713781|NCT00379769|42157019|FG004|Observational Follow-up|Physician Decision|8|||
19713782|NCT00379769|42157020|FG005|Observational Follow-up|Physician Decision|8|||
19713783|NCT00379769|42157015|FG000|Observational Follow-up|Site Closed Early|0|||
19713784|NCT00379769|42157016|FG001|Observational Follow-up|Site Closed Early|0|||
19713785|NCT00379769|42157017|FG002|Observational Follow-up|Site Closed Early|0|||
19713786|NCT00379769|42157018|FG003|Observational Follow-up|Site Closed Early|0|||
19713787|NCT00379769|42157019|FG004|Observational Follow-up|Site Closed Early|6|||
19713788|NCT00379769|42157020|FG005|Observational Follow-up|Site Closed Early|7|||
19713789|NCT00379769|42157015|FG000|Observational Follow-up|Participant Moved|0|||
19713790|NCT00379769|42157016|FG001|Observational Follow-up|Participant Moved|0|||
19713791|NCT00379769|42157017|FG002|Observational Follow-up|Participant Moved|0|||
19713792|NCT00379769|42157018|FG003|Observational Follow-up|Participant Moved|0|||
19713793|NCT00379769|42157019|FG004|Observational Follow-up|Participant Moved|0|||
19713794|NCT00379769|42157020|FG005|Observational Follow-up|Participant Moved|1|||
19713795|NCT00379769|42157015|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
19713796|NCT00379769|42157016|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
19713797|NCT00379769|42157017|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
19713798|NCT00379769|42157018|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
19713799|NCT00379769|42157019|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
19713800|NCT00379769|42157020|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
19713801|NCT00006164|42157049|FG000|Overall Study|Withdrew or lost to follow-up|70|||
19713802|NCT00006164|42157050|FG001|Overall Study|Withdrew or lost to follow-up|81|||
19713803|NCT00378599|42157056|FG000|Overall Study|Adverse Event|38|||
19713804|NCT00378599|42157056|FG000|Overall Study|Protocol Violation|2|||
19713805|NCT00378599|42157056|FG000|Overall Study|Treatment failure|7|||
19713806|NCT00378599|42157056|FG000|Overall Study|Withdrawal by Subject|5|||
19713807|NCT00378209|42157060|FG000|Overall Study|Progressive disease|11|||
19713808|NCT00378209|42157060|FG000|Overall Study|Adverse Event|3|||
19713809|NCT00378209|42157060|FG000|Overall Study|Initiation of non-protocol therapy|3|||
19713810|NCT00378209|42157060|FG000|Overall Study|Physician Decision|3|||
19713811|NCT00378209|42157060|FG000|Overall Study|Death|1|||
19713812|NCT00378209|42157060|FG000|Overall Study|Treatment delay|1|||
19713813|NCT03410992|42157067|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713814|NCT03410992|42157068|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
19713815|NCT03410992|42157069|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713816|NCT03410992|42157070|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713817|NCT03410992|42157071|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713818|NCT03410992|42157072|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713819|NCT03410992|42157073|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713820|NCT03410992|42157074|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713821|NCT03410992|42157075|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713822|NCT03410992|42157076|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713823|NCT03410992|42157077|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
19713824|NCT03410992|42157067|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
19713825|NCT03410992|42157068|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
19713826|NCT03410992|42157069|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713827|NCT03410992|42157070|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713828|NCT03410992|42157071|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713829|NCT03410992|42157072|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713830|NCT03410992|42157073|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713831|NCT03410992|42157074|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713832|NCT03410992|42157075|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713833|NCT03410992|42157076|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713834|NCT03410992|42157077|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
19713835|NCT03410992|42157067|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
19713836|NCT03410992|42157068|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
19713837|NCT03410992|42157069|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713838|NCT03410992|42157070|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713839|NCT03410992|42157071|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713840|NCT03410992|42157072|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713841|NCT03410992|42157073|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713842|NCT03410992|42157074|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713843|NCT03410992|42157075|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713844|NCT03410992|42157076|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713845|NCT03410992|42157077|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
19713846|NCT03410992|42157067|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
19713847|NCT03410992|42157068|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713848|NCT03410992|42157069|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713849|NCT03410992|42157070|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713850|NCT03410992|42157071|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713851|NCT03410992|42157072|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713852|NCT03410992|42157073|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713853|NCT03410992|42157074|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713854|NCT03410992|42157075|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713855|NCT03410992|42157076|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713856|NCT03410992|42157077|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
19713857|NCT03410992|42157067|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
19713858|NCT03410992|42157068|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
19713859|NCT03410992|42157069|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713860|NCT03410992|42157070|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713861|NCT03410992|42157071|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713862|NCT03410992|42157072|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713863|NCT03410992|42157073|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713864|NCT03410992|42157074|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713865|NCT03410992|42157075|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713866|NCT03410992|42157076|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713867|NCT03410992|42157077|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
19713868|NCT03410992|42157067|FG000|Week 16 Assessment|Incorrect escapers|0|||
19713869|NCT03410992|42157068|FG001|Week 16 Assessment|Incorrect escapers|6|||
19713870|NCT03410992|42157069|FG002|Week 16 Assessment|Incorrect escapers|0|||
19713871|NCT03410992|42157070|FG003|Week 16 Assessment|Incorrect escapers|0|||
19713872|NCT03410992|42157071|FG004|Week 16 Assessment|Incorrect escapers|0|||
19713873|NCT03410992|42157072|FG005|Week 16 Assessment|Incorrect escapers|0|||
19713874|NCT03410992|42157073|FG006|Week 16 Assessment|Incorrect escapers|0|||
19713875|NCT03410992|42157074|FG007|Week 16 Assessment|Incorrect escapers|0|||
19713876|NCT03410992|42157075|FG008|Week 16 Assessment|Incorrect escapers|0|||
19713877|NCT03410992|42157076|FG009|Week 16 Assessment|Incorrect escapers|0|||
19713878|NCT03410992|42157077|FG010|Week 16 Assessment|Incorrect escapers|0|||
19713879|NCT03410992|42157067|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713880|NCT03410992|42157068|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713881|NCT03410992|42157069|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713882|NCT03410992|42157070|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
19713883|NCT03410992|42157071|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
19713884|NCT03410992|42157072|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713885|NCT03410992|42157073|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713886|NCT03410992|42157074|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713887|NCT03410992|42157075|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713888|NCT03410992|42157076|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713889|NCT03410992|42157077|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
19713890|NCT03410992|42157067|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713891|NCT03410992|42157068|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713892|NCT03410992|42157069|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713893|NCT03410992|42157070|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
19713894|NCT03410992|42157071|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
19713895|NCT03410992|42157072|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
19713896|NCT03410992|42157073|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713897|NCT03410992|42157074|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713898|NCT03410992|42157075|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713899|NCT03410992|42157076|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713900|NCT03410992|42157077|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
19713901|NCT03410992|42157067|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713902|NCT03410992|42157068|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19458826|NCT01859923|41712771|FG002|Overall Study|Adverse Event|1|||
19458827|NCT01859923|41712772|FG003|Overall Study|Adverse Event|1|||
19458828|NCT01832155|41712787|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
19713903|NCT03410992|42157069|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713904|NCT03410992|42157070|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713905|NCT03410992|42157071|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713906|NCT03410992|42157072|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
19713907|NCT03410992|42157073|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713908|NCT03410992|42157074|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713909|NCT03410992|42157075|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713910|NCT03410992|42157076|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713911|NCT03410992|42157077|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
19713912|NCT03410992|42157067|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713913|NCT03410992|42157068|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713914|NCT03410992|42157069|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713915|NCT03410992|42157070|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
19713916|NCT03410992|42157071|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
19713917|NCT03410992|42157072|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
19713918|NCT03410992|42157073|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713919|NCT03410992|42157074|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713920|NCT03410992|42157075|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713921|NCT03410992|42157076|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19713922|NCT03410992|42157077|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
19458829|NCT01832155|41712788|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
19458830|NCT01832155|41712787|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
19458831|NCT01832155|41712788|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
19458832|NCT01879579|41712802|FG000|Overall Study|Phone incompatible with texting platform|3|||
19458833|NCT01879579|41712803|FG001|Overall Study|Phone incompatible with texting platform|0|||
19458834|NCT01879579|41712802|FG000|Overall Study|Did not enroll in texting platform|1|||
19458835|NCT01879579|41712803|FG001|Overall Study|Did not enroll in texting platform|0|||
19458836|NCT01879579|41712802|FG000|Overall Study|Did not initiate insulin treatment|1|||
19458837|NCT01879579|41712803|FG001|Overall Study|Did not initiate insulin treatment|0|||
19458838|NCT01879579|41712802|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
19458839|NCT01879579|41712803|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
19458840|NCT01879579|41712802|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
19458841|NCT01879579|41712803|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
19458842|NCT01386645|41712815|FG000|Overall Study|Physician Decision|0|||
19458843|NCT01386645|41712816|FG001|Overall Study|Physician Decision|0|||
19458844|NCT01386645|41712817|FG002|Overall Study|Physician Decision|1|||
19458845|NCT01386645|41712815|FG000|Overall Study|Withdrawal by Subject|0|||
19458846|NCT01386645|41712816|FG001|Overall Study|Withdrawal by Subject|1|||
19458847|NCT01386645|41712817|FG002|Overall Study|Withdrawal by Subject|1|||
19458848|NCT01387269|41712827|FG000|Overall Study|Death|38|||
19458849|NCT01387269|41712828|FG001|Overall Study|Death|20|||
19458850|NCT01387269|41712827|FG000|Overall Study|Other|8|||
19458851|NCT01387269|41712828|FG001|Overall Study|Other|7|||
19458852|NCT01387269|41712827|FG000|Overall Study|Unrelated AE|12|||
19458853|NCT01387269|41712828|FG001|Overall Study|Unrelated AE|3|||
19458854|NCT01387269|41712827|FG000|Overall Study|Withdrawal by patient|32|||
19458855|NCT01387269|41712828|FG001|Overall Study|Withdrawal by patient|10|||
19458856|NCT01387269|41712827|FG000|Overall Study|Study drug-related AE|1|||
19458857|NCT01387269|41712828|FG001|Overall Study|Study drug-related AE|0|||
19458858|NCT01387269|41712827|FG000|Overall Study|Lost to Follow-up|1|||
19458859|NCT01387269|41712828|FG001|Overall Study|Lost to Follow-up|0|||
19458860|NCT01859143|41712836|FG000|Overall Study|Lost to Follow-up|2|||
19458861|NCT01859143|41712837|FG001|Overall Study|Lost to Follow-up|0|||
19458862|NCT01878253|41712844|FG000|Overall Study|Death|1|||
19458863|NCT01878253|41712844|FG000|Overall Study|SIdus System Removal|3|||
19458864|NCT01878253|41712844|FG000|Overall Study|Withdrawal by Subject|1|||
19458865|NCT01878253|41712844|FG000|Overall Study|Lost to Follow-up|2|||
19458866|NCT01878253|41712844|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
19458867|NCT01878175|41712853|FG000|Overall Study|Developed contraindicated health problem|2|||
19713923|NCT03410992|42157067|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713924|NCT03410992|42157068|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713925|NCT03410992|42157069|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713926|NCT03410992|42157070|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713927|NCT03410992|42157071|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713928|NCT03410992|42157072|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713929|NCT03410992|42157073|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713930|NCT03410992|42157074|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
19713931|NCT03410992|42157075|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713932|NCT03410992|42157076|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713933|NCT03410992|42157077|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
19713934|NCT03410992|42157067|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713935|NCT03410992|42157068|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713936|NCT03410992|42157069|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713937|NCT03410992|42157070|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713938|NCT03410992|42157071|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713939|NCT03410992|42157072|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713940|NCT03410992|42157073|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713941|NCT03410992|42157074|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713942|NCT03410992|42157075|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
19713943|NCT03410992|42157076|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713944|NCT03410992|42157077|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
19713945|NCT00377819|42157109|FG000|Overall Study|Adverse Event|2|||
19713946|NCT00377819|42157110|FG001|Overall Study|Adverse Event|3|||
19713947|NCT00377819|42157109|FG000|Overall Study|Withdrawal by Subject|10|||
19713948|NCT00377819|42157110|FG001|Overall Study|Withdrawal by Subject|4|||
19713949|NCT00377819|42157109|FG000|Overall Study|Death|0|||
19713950|NCT00377819|42157110|FG001|Overall Study|Death|1|||
19713951|NCT00377819|42157109|FG000|Overall Study|Lost to Follow-up|0|||
19713952|NCT00377819|42157110|FG001|Overall Study|Lost to Follow-up|1|||
19713953|NCT00377819|42157109|FG000|Overall Study|Protocol Violation|1|||
19713954|NCT00377819|42157110|FG001|Overall Study|Protocol Violation|1|||
19713955|NCT03419962|42157116|FG000|Overall Study|Change to other medication|1|||
19713956|NCT03419962|42157116|FG000|Overall Study|Refusal of continuing with trial drug|1|||
19713957|NCT03419962|42157116|FG000|Overall Study|Lost to Follow-up|3|||
19713958|NCT03419962|42157116|FG000|Overall Study|Difficulty in inhaling the doses|1|||
19713959|NCT03419962|42157116|FG000|Overall Study|Missing completion data|31|||
19713960|NCT00377429|42157120|FG000|Overall Study|Withdrawal by Subject|5|||
19713961|NCT00377429|42157120|FG000|Overall Study|Adverse Event|8|||
19713962|NCT00377429|42157120|FG000|Overall Study|Physician Decision|1|||
19713963|NCT00377429|42157120|FG000|Overall Study|Patient non-compliance|1|||
19713964|NCT00376961|42157124|FG000|Initial Registration|Adverse Event|1|||
19713965|NCT00376961|42157125|FG001|Initial Registration|Adverse Event|0|||
19713966|NCT00376961|42157124|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
19713967|NCT00376961|42157125|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
19713968|NCT00376961|42157124|FG000|Initial Registration|Progression/relapse|1|||
19713969|NCT00376961|42157125|FG001|Initial Registration|Progression/relapse|0|||
19713970|NCT00376961|42157124|FG000|Initial Registration|Ineligible|3|||
19713971|NCT00376961|42157125|FG001|Initial Registration|Ineligible|0|||
19713972|NCT00376961|42157124|FG000|Maintenance|Adverse Event|0|||
19713973|NCT00376961|42157125|FG001|Maintenance|Adverse Event|1|||
19713974|NCT00376961|42157124|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
19713975|NCT00376961|42157125|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
19713976|NCT00376961|42157124|FG000|Maintenance|Progression/relapse|0|||
19713977|NCT00376961|42157125|FG001|Maintenance|Progression/relapse|18|||
19713978|NCT00376961|42157124|FG000|Maintenance|Ineligible|0|||
19713979|NCT00376961|42157125|FG001|Maintenance|Ineligible|3|||
19713980|NCT03418324|42157135|FG000|Overall Study|Death|0|||
19713981|NCT03418324|42157136|FG001|Overall Study|Death|1|||
19713982|NCT03418324|42157135|FG000|Overall Study|Physician Decision|1|||
19713983|NCT03418324|42157136|FG001|Overall Study|Physician Decision|1|||
19713984|NCT00376259|42157144|FG000|Overall Study|Sponsor request - study termination|21|||
19713985|NCT00376259|42157145|FG001|Overall Study|Sponsor request - study termination|21|||
19713986|NCT00376259|42157144|FG000|Overall Study|Patient request|1|||
19713987|NCT00376259|42157145|FG001|Overall Study|Patient request|0|||
19713988|NCT03410056|42157155|FG000|Overall Study|Decision by Sponsor|0|||
19713989|NCT03410056|42157156|FG001|Overall Study|Decision by Sponsor|0|||
19713990|NCT03410056|42157157|FG002|Overall Study|Decision by Sponsor|3|||
19713991|NCT03410056|42157158|FG003|Overall Study|Decision by Sponsor|0|||
19713992|NCT03410056|42157159|FG004|Overall Study|Decision by Sponsor|0|||
19713993|NCT03410056|42157160|FG005|Overall Study|Decision by Sponsor|0|||
19713994|NCT03410056|42157161|FG006|Overall Study|Decision by Sponsor|0|||
19713995|NCT03410056|42157155|FG000|Overall Study|Withdrawal by Subject|0|||
19713996|NCT03410056|42157156|FG001|Overall Study|Withdrawal by Subject|2|||
19713997|NCT03410056|42157157|FG002|Overall Study|Withdrawal by Subject|5|||
19713998|NCT03410056|42157158|FG003|Overall Study|Withdrawal by Subject|5|||
19713999|NCT03410056|42157159|FG004|Overall Study|Withdrawal by Subject|0|||
19714000|NCT03410056|42157160|FG005|Overall Study|Withdrawal by Subject|0|||
19714001|NCT03410056|42157161|FG006|Overall Study|Withdrawal by Subject|0|||
19714002|NCT03409666|42157179|FG000|Overall Study|Physician Decision|0|||
19714003|NCT03409666|42157180|FG001|Overall Study|Physician Decision|1|||
19714004|NCT03409666|42157179|FG000|Overall Study|Protocol Violation|0|||
19714005|NCT03409666|42157180|FG001|Overall Study|Protocol Violation|3|||
19714006|NCT03440944|42157188|FG000|Overall Study|Physician Decision|1|||
19714007|NCT03440944|42157189|FG001|Overall Study|Physician Decision|0|||
19714008|NCT03440944|42157188|FG000|Overall Study|No Acceptable Vasculature|0|||
19714009|NCT03440944|42157189|FG001|Overall Study|No Acceptable Vasculature|1|||
19714010|NCT00365105|42157198|FG000|Overall Study|Protocol Violation|5|||
19714011|NCT00365105|42157199|FG001|Overall Study|Protocol Violation|8|||
19714012|NCT00399893|42157207|FG000|Overall Study|Withdrawal by Subject|1|||
19714013|NCT00399893|42157208|FG001|Overall Study|Withdrawal by Subject|0|||
19714014|NCT00048542|42157218|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
19714015|NCT00048542|42157219|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
19714016|NCT00048542|42157220|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
19714017|NCT00048542|42157221|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
19714018|NCT00048542|42157222|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
19714019|NCT00048542|42157223|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
19714020|NCT00048542|42157224|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
19714021|NCT00048542|42157225|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
19714022|NCT00048542|42157218|FG000|Double-Blind Phase|Protocol Violation|0|||
19714023|NCT00048542|42157219|FG001|Double-Blind Phase|Protocol Violation|0|||
19714024|NCT00048542|42157220|FG002|Double-Blind Phase|Protocol Violation|1|||
19714025|NCT00048542|42157221|FG003|Double-Blind Phase|Protocol Violation|0|||
19714026|NCT00048542|42157222|FG004|Double-Blind Phase|Protocol Violation|0|||
19714027|NCT00048542|42157223|FG005|Double-Blind Phase|Protocol Violation|0|||
19714028|NCT00048542|42157224|FG006|Double-Blind Phase|Protocol Violation|0|||
19714029|NCT00048542|42157225|FG007|Double-Blind Phase|Protocol Violation|0|||
19714030|NCT00048542|42157218|FG000|Double-Blind Phase|Sponsor request or decision|2|||
19714031|NCT00048542|42157219|FG001|Double-Blind Phase|Sponsor request or decision|0|||
19714032|NCT00048542|42157220|FG002|Double-Blind Phase|Sponsor request or decision|0|||
19714033|NCT00048542|42157221|FG003|Double-Blind Phase|Sponsor request or decision|0|||
19714034|NCT00048542|42157222|FG004|Double-Blind Phase|Sponsor request or decision|0|||
19714035|NCT00048542|42157223|FG005|Double-Blind Phase|Sponsor request or decision|0|||
19714036|NCT00048542|42157224|FG006|Double-Blind Phase|Sponsor request or decision|0|||
19714037|NCT00048542|42157225|FG007|Double-Blind Phase|Sponsor request or decision|0|||
19714038|NCT00048542|42157218|FG000|Double-Blind Phase|Randomized in error|1|||
19714039|NCT00048542|42157219|FG001|Double-Blind Phase|Randomized in error|0|||
19714040|NCT00048542|42157220|FG002|Double-Blind Phase|Randomized in error|0|||
19714041|NCT00048542|42157221|FG003|Double-Blind Phase|Randomized in error|0|||
19714042|NCT00048542|42157222|FG004|Double-Blind Phase|Randomized in error|0|||
19714043|NCT00048542|42157223|FG005|Double-Blind Phase|Randomized in error|0|||
19714044|NCT00048542|42157224|FG006|Double-Blind Phase|Randomized in error|0|||
19714045|NCT00048542|42157225|FG007|Double-Blind Phase|Randomized in error|0|||
19714046|NCT00048542|42157218|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714047|NCT00048542|42157219|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714048|NCT00048542|42157220|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714049|NCT00048542|42157221|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714050|NCT00048542|42157222|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
19714051|NCT00048542|42157223|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
19714052|NCT00048542|42157224|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714053|NCT00048542|42157225|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
19714054|NCT00048542|42157218|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714055|NCT00048542|42157219|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714056|NCT00048542|42157220|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714057|NCT00048542|42157221|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714058|NCT00048542|42157222|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714059|NCT00048542|42157223|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
19714060|NCT00048542|42157224|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714061|NCT00048542|42157225|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
19714062|NCT00048542|42157218|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714063|NCT00048542|42157219|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714064|NCT00048542|42157220|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714065|NCT00048542|42157221|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714066|NCT00048542|42157222|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
19714067|NCT00048542|42157223|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
19714068|NCT00048542|42157224|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714069|NCT00048542|42157225|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
19714070|NCT00048542|42157218|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
19714071|NCT00048542|42157219|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
19714072|NCT00048542|42157220|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
19714073|NCT00048542|42157221|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
19714074|NCT00048542|42157222|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
19714075|NCT00048542|42157223|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
19714076|NCT00048542|42157224|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
19714077|NCT00048542|42157225|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
19714078|NCT00048542|42157218|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714079|NCT00048542|42157219|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714080|NCT00048542|42157220|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714081|NCT00048542|42157221|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714082|NCT00048542|42157222|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
19714083|NCT00048542|42157223|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
19714084|NCT00048542|42157224|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714085|NCT00048542|42157225|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
19714086|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714087|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714088|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714089|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714090|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714091|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
19714092|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
19714093|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
19458868|NCT01878097|41712860|FG000|Baseline|Surveys not fully completed|2497|||
19458869|NCT01878097|41712861|FG001|Baseline|Surveys not fully completed|1800|||
19458870|NCT01878097|41712860|FG000|Implementation Year 1|Surveys not fully completed|3202|||
19458871|NCT01878097|41712861|FG001|Implementation Year 1|Surveys not fully completed|2549|||
19458872|NCT01878097|41712860|FG000|Implementation Year 2|Surveys not fully completed|3281|||
19458873|NCT01878097|41712861|FG001|Implementation Year 2|Surveys not fully completed|2841|||
19458874|NCT01878097|41712860|FG000|Implementation Year 3|Surveys not fully completed|3494|||
19458875|NCT01878097|41712861|FG001|Implementation Year 3|Surveys not fully completed|2980|||
19458876|NCT01878097|41712860|FG000|Implementation Year 4|Surveys not fully completed|3604|||
19458877|NCT01878097|41712861|FG001|Implementation Year 4|Surveys not fully completed|3007|||
19458878|NCT01750190|41712869|FG000|Overall Study|Adverse Event|47|||
19458879|NCT01750190|41712870|FG001|Overall Study|Adverse Event|19|||
19458880|NCT01750190|41712869|FG000|Overall Study|Death|38|||
19458881|NCT01750190|41712870|FG001|Overall Study|Death|11|||
19458882|NCT01750190|41712869|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
19458883|NCT01750190|41712870|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
19458884|NCT01750190|41712869|FG000|Overall Study|Lost to Follow-up|28|||
19458885|NCT01750190|41712870|FG001|Overall Study|Lost to Follow-up|7|||
19458886|NCT01750190|41712869|FG000|Overall Study|Physician Decision|16|||
19458887|NCT01750190|41712870|FG001|Overall Study|Physician Decision|17|||
19458888|NCT01750190|41712869|FG000|Overall Study|Protocol Violation|6|||
19458889|NCT01750190|41712870|FG001|Overall Study|Protocol Violation|5|||
19458890|NCT01750190|41712869|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
19458891|NCT01750190|41712870|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
19458892|NCT01750190|41712869|FG000|Overall Study|Withdrawal by Subject|83|||
19458893|NCT01750190|41712870|FG001|Overall Study|Withdrawal by Subject|89|||
19458894|NCT01750190|41712869|FG000|Overall Study|Kidney Transplant|8|||
19458895|NCT01750190|41712870|FG001|Overall Study|Kidney Transplant|4|||
19458896|NCT01750190|41712869|FG000|Overall Study|Dialysis|22|||
19458897|NCT01750190|41712870|FG001|Overall Study|Dialysis|8|||
19458898|NCT01750190|41712869|FG000|Overall Study|Other than Specified|13|||
19458899|NCT01750190|41712870|FG001|Overall Study|Other than Specified|4|||
19458900|NCT01831765|41712879|FG000|Overall Study|Lack of Efficacy|1|||
19458901|NCT01831765|41712880|FG001|Overall Study|Lack of Efficacy|0|||
19458902|NCT01831765|41712881|FG002|Overall Study|Lack of Efficacy|0|||
19458903|NCT01831765|41712879|FG000|Overall Study|Other, sponsor withdrew subject|0|||
19458904|NCT01831765|41712880|FG001|Overall Study|Other, sponsor withdrew subject|1|||
19458905|NCT01831765|41712881|FG002|Overall Study|Other, sponsor withdrew subject|0|||
19458906|NCT01831765|41712879|FG000|Overall Study|Pregnancy|1|||
19458907|NCT01831765|41712880|FG001|Overall Study|Pregnancy|1|||
19458908|NCT01831765|41712881|FG002|Overall Study|Pregnancy|2|||
19458909|NCT01831765|41712879|FG000|Overall Study|Death|0|||
19458910|NCT01831765|41712880|FG001|Overall Study|Death|1|||
19458911|NCT01831765|41712881|FG002|Overall Study|Death|1|||
19458912|NCT01831765|41712879|FG000|Overall Study|Other, site closed|1|||
19458913|NCT01831765|41712880|FG001|Overall Study|Other, site closed|1|||
19458914|NCT01831765|41712881|FG002|Overall Study|Other, site closed|0|||
19458915|NCT01831765|41712879|FG000|Overall Study|Adverse Event|5|||
19714094|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714095|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714096|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714097|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714098|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714099|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
19714100|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
19714101|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
19714102|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714103|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714104|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714105|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714106|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714107|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
19714108|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
19714109|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
19714110|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714111|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714112|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714113|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714114|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714115|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
19714116|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
19714117|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
19714118|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714119|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714120|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714121|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714122|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714123|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
19714124|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
19714125|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
19714126|NCT00048542|42157218|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714127|NCT00048542|42157219|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714128|NCT00048542|42157220|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714129|NCT00048542|42157221|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714130|NCT00048542|42157222|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714131|NCT00048542|42157223|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
19714132|NCT00048542|42157224|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
19714133|NCT00048542|42157225|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
19714134|NCT03814590|42157268|FG000|Overall Study|Adverse Event|0|||
19714135|NCT03814590|42157269|FG001|Overall Study|Adverse Event|0|||
19714136|NCT03814590|42157270|FG002|Overall Study|Adverse Event|0|||
19714137|NCT03814590|42157271|FG003|Overall Study|Adverse Event|0|||
19714138|NCT03814590|42157272|FG004|Overall Study|Adverse Event|0|||
19714139|NCT03814590|42157273|FG005|Overall Study|Adverse Event|1|||
19714140|NCT03814590|42157274|FG006|Overall Study|Adverse Event|1|||
19714141|NCT03814590|42157275|FG007|Overall Study|Adverse Event|1|||
19714142|NCT03814590|42157276|FG008|Overall Study|Adverse Event|0|||
19714143|NCT03814590|42157277|FG009|Overall Study|Adverse Event|0|||
19714144|NCT03814590|42157278|FG010|Overall Study|Adverse Event|1|||
19714145|NCT03814590|42157279|FG011|Overall Study|Adverse Event|0|||
19714146|NCT03814590|42157280|FG012|Overall Study|Adverse Event|3|||
19714147|NCT03814590|42157281|FG013|Overall Study|Adverse Event|0|||
19714148|NCT03814590|42157268|FG000|Overall Study|Lost to Follow-up|0|||
19714149|NCT03814590|42157269|FG001|Overall Study|Lost to Follow-up|2|||
19714150|NCT03814590|42157270|FG002|Overall Study|Lost to Follow-up|1|||
19714151|NCT03814590|42157271|FG003|Overall Study|Lost to Follow-up|0|||
19714152|NCT03814590|42157272|FG004|Overall Study|Lost to Follow-up|1|||
19714153|NCT03814590|42157273|FG005|Overall Study|Lost to Follow-up|1|||
19714154|NCT03814590|42157274|FG006|Overall Study|Lost to Follow-up|1|||
19714155|NCT03814590|42157275|FG007|Overall Study|Lost to Follow-up|1|||
19714156|NCT03814590|42157276|FG008|Overall Study|Lost to Follow-up|0|||
19714157|NCT03814590|42157277|FG009|Overall Study|Lost to Follow-up|0|||
19714158|NCT03814590|42157278|FG010|Overall Study|Lost to Follow-up|1|||
19714159|NCT03814590|42157279|FG011|Overall Study|Lost to Follow-up|0|||
19714160|NCT03814590|42157280|FG012|Overall Study|Lost to Follow-up|0|||
19714161|NCT03814590|42157281|FG013|Overall Study|Lost to Follow-up|1|||
19714162|NCT03814590|42157268|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714163|NCT03814590|42157269|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714164|NCT03814590|42157270|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714165|NCT03814590|42157271|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714166|NCT03814590|42157272|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714167|NCT03814590|42157273|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714168|NCT03814590|42157274|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714169|NCT03814590|42157275|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714170|NCT03814590|42157276|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714171|NCT03814590|42157277|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
19714172|NCT03814590|42157278|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714173|NCT03814590|42157279|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714174|NCT03814590|42157280|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714175|NCT03814590|42157281|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
19714176|NCT03814590|42157268|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714177|NCT03814590|42157269|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714178|NCT03814590|42157270|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714179|NCT03814590|42157271|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714180|NCT03814590|42157272|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714181|NCT03814590|42157273|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
19714182|NCT03814590|42157274|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
19714183|NCT03814590|42157275|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
19714184|NCT03814590|42157276|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714185|NCT03814590|42157277|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
19714186|NCT03814590|42157278|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
19714187|NCT03814590|42157279|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
19714188|NCT03814590|42157280|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
19714189|NCT03814590|42157281|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
19714190|NCT03814590|42157268|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714191|NCT03814590|42157269|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714192|NCT03814590|42157270|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714193|NCT03814590|42157271|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714194|NCT03814590|42157272|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714195|NCT03814590|42157273|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714196|NCT03814590|42157274|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714197|NCT03814590|42157275|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19714198|NCT03814590|42157276|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714199|NCT03814590|42157277|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
19714200|NCT03814590|42157278|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714201|NCT03814590|42157279|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714202|NCT03814590|42157280|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714203|NCT03814590|42157281|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
19714204|NCT03814590|42157268|FG000|Overall Study|UNKNOWN REASON|0|||
19714205|NCT03814590|42157269|FG001|Overall Study|UNKNOWN REASON|0|||
19714206|NCT03814590|42157270|FG002|Overall Study|UNKNOWN REASON|0|||
19714207|NCT03814590|42157271|FG003|Overall Study|UNKNOWN REASON|0|||
19714208|NCT03814590|42157272|FG004|Overall Study|UNKNOWN REASON|0|||
19714209|NCT03814590|42157273|FG005|Overall Study|UNKNOWN REASON|0|||
19714210|NCT03814590|42157274|FG006|Overall Study|UNKNOWN REASON|0|||
19714211|NCT03814590|42157275|FG007|Overall Study|UNKNOWN REASON|1|||
19714212|NCT03814590|42157276|FG008|Overall Study|UNKNOWN REASON|0|||
19714213|NCT03814590|42157277|FG009|Overall Study|UNKNOWN REASON|0|||
19714214|NCT03814590|42157278|FG010|Overall Study|UNKNOWN REASON|0|||
19714215|NCT03814590|42157279|FG011|Overall Study|UNKNOWN REASON|0|||
19714216|NCT03814590|42157280|FG012|Overall Study|UNKNOWN REASON|0|||
19714217|NCT03814590|42157281|FG013|Overall Study|UNKNOWN REASON|0|||
19714218|NCT00048074|42157324|FG000|Overall Study|Adverse Event|46|||
19714219|NCT00048074|42157325|FG001|Overall Study|Adverse Event|41|||
19714220|NCT00048074|42157326|FG002|Overall Study|Adverse Event|53|||
19714221|NCT00048074|42157324|FG000|Overall Study|Death|3|||
19714222|NCT00048074|42157325|FG001|Overall Study|Death|3|||
19714223|NCT00048074|42157326|FG002|Overall Study|Death|2|||
19714224|NCT00048074|42157324|FG000|Overall Study|Lost to Follow-up|2|||
19714225|NCT00048074|42157325|FG001|Overall Study|Lost to Follow-up|6|||
19714226|NCT00048074|42157326|FG002|Overall Study|Lost to Follow-up|6|||
19714227|NCT00048074|42157324|FG000|Overall Study|Withdrawal by Subject|28|||
19714228|NCT00048074|42157325|FG001|Overall Study|Withdrawal by Subject|30|||
19714229|NCT00048074|42157326|FG002|Overall Study|Withdrawal by Subject|35|||
19714230|NCT00048074|42157324|FG000|Overall Study|Protocol Violation|1|||
19714231|NCT00048074|42157325|FG001|Overall Study|Protocol Violation|3|||
19714232|NCT00048074|42157326|FG002|Overall Study|Protocol Violation|0|||
19714233|NCT00048074|42157324|FG000|Overall Study|Study participation was terminated|0|||
19714234|NCT00048074|42157325|FG001|Overall Study|Study participation was terminated|1|||
19714235|NCT00048074|42157326|FG002|Overall Study|Study participation was terminated|0|||
19714236|NCT00048074|42157324|FG000|Overall Study|Husband ill|0|||
19714237|NCT00048074|42157325|FG001|Overall Study|Husband ill|1|||
19714238|NCT00048074|42157326|FG002|Overall Study|Husband ill|0|||
19714239|NCT00048074|42157324|FG000|Overall Study|Poor compliance|0|||
19714240|NCT00048074|42157325|FG001|Overall Study|Poor compliance|1|||
19714241|NCT00048074|42157326|FG002|Overall Study|Poor compliance|0|||
19714242|NCT00048074|42157324|FG000|Overall Study|Out of station|0|||
19714243|NCT00048074|42157325|FG001|Overall Study|Out of station|1|||
19714244|NCT00048074|42157326|FG002|Overall Study|Out of station|1|||
19714245|NCT00048074|42157324|FG000|Overall Study|Social reasons|1|||
19714246|NCT00048074|42157325|FG001|Overall Study|Social reasons|0|||
19714247|NCT00048074|42157326|FG002|Overall Study|Social reasons|0|||
19714248|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
19714249|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
19714250|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
19714251|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
19714252|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
19714253|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
19714254|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
19714255|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
19714256|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
19714257|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
19714258|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
19714259|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
19714260|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
19714261|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
19714262|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
19714263|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
19714264|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
19714265|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714266|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714267|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714268|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714269|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714270|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714271|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714272|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714273|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714274|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714275|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714276|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714277|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
19714278|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
19714279|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
19714280|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
19714281|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
19714282|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
19714283|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
19714284|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
19714285|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
19714286|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
19714287|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
19714288|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
19714289|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
19714290|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
19714291|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
19714292|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
19714293|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
19714294|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
19714295|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
19714296|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
19714297|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
19714298|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
19714299|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
19714300|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
19714301|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
19714302|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
19714303|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
19714304|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
19714305|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
19714306|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
19714307|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
19714308|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
19714309|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
19714310|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
19714311|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
19714312|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714313|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714314|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714315|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714316|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714317|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714318|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714319|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714320|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714321|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714322|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
19714323|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
19714324|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
19714325|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
19714326|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
19714327|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714328|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714329|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714330|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714331|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714332|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714333|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19458916|NCT01831765|41712880|FG001|Overall Study|Adverse Event|3|||
19458917|NCT01831765|41712881|FG002|Overall Study|Adverse Event|3|||
19458918|NCT01831765|41712879|FG000|Overall Study|Withdrawal by Subject|22|||
19458919|NCT01831765|41712880|FG001|Overall Study|Withdrawal by Subject|7|||
19458920|NCT01831765|41712881|FG002|Overall Study|Withdrawal by Subject|17|||
19458921|NCT01831765|41712879|FG000|Overall Study|Withdrawal criteria|12|||
19458922|NCT01831765|41712880|FG001|Overall Study|Withdrawal criteria|10|||
19458923|NCT01831765|41712881|FG002|Overall Study|Withdrawal criteria|16|||
19458924|NCT01831765|41712879|FG000|Overall Study|Lost to Follow-up|2|||
19458925|NCT01831765|41712880|FG001|Overall Study|Lost to Follow-up|3|||
19458926|NCT01831765|41712881|FG002|Overall Study|Lost to Follow-up|3|||
19458927|NCT01749800|41712894|FG000|Overall Study|not meeting inclusion criteria|3|||
19458928|NCT01749800|41712895|FG001|Overall Study|not meeting inclusion criteria|0|||
19458929|NCT01749800|41712896|FG002|Overall Study|not meeting inclusion criteria|0|||
19458930|NCT01749800|41712894|FG000|Overall Study|Withdrawal by Subject|0|||
19458931|NCT01749800|41712895|FG001|Overall Study|Withdrawal by Subject|1|||
19458932|NCT01749800|41712896|FG002|Overall Study|Withdrawal by Subject|0|||
19458933|NCT01830595|41712904|FG000|First Period|Withdrawal by Subject|1|||
19458934|NCT01830595|41712905|FG001|First Period|Withdrawal by Subject|3|||
19458935|NCT01830595|41712904|FG000|Washout|Withdrawal by Subject|2|||
19458936|NCT01830595|41712905|FG001|Washout|Withdrawal by Subject|2|||
19458937|NCT01748552|41712923|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
19458938|NCT01748552|41712924|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
19458939|NCT01748552|41712925|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
19458940|NCT01748552|41712926|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
19458941|NCT01748552|41712927|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
19458942|NCT01748552|41712928|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
19458943|NCT01748552|41712929|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
19458944|NCT01748552|41712930|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
19458945|NCT01748552|41712931|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
19458946|NCT01748552|41712932|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
19458947|NCT01748552|41712933|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
19458948|NCT01748552|41712934|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
19458949|NCT01748552|41712923|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458950|NCT01748552|41712924|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458951|NCT01748552|41712925|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458952|NCT01748552|41712926|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19714334|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714335|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714336|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714337|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
19714338|NCT03831191|42157338|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714339|NCT03831191|42157339|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714340|NCT03831191|42157340|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714341|NCT03831191|42157341|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
19714342|NCT03831191|42157342|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714343|NCT03831191|42157343|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714344|NCT03831191|42157344|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714345|NCT03831191|42157345|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714346|NCT03831191|42157346|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714347|NCT03831191|42157347|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714348|NCT03831191|42157348|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714349|NCT03831191|42157349|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714350|NCT03831191|42157350|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714351|NCT03831191|42157351|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714352|NCT03831191|42157352|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
19714353|NCT03831191|42157338|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
19714354|NCT03831191|42157339|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
19714355|NCT03831191|42157340|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
19714356|NCT03831191|42157341|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
19714357|NCT03831191|42157342|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
19714358|NCT03831191|42157343|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
19714359|NCT03831191|42157344|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
19714360|NCT03831191|42157345|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
19714361|NCT03831191|42157346|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
19714362|NCT03831191|42157347|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
19714363|NCT03831191|42157348|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
19714364|NCT03831191|42157349|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
19714365|NCT03831191|42157350|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
19714366|NCT03831191|42157351|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
19714367|NCT03831191|42157352|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
19714368|NCT03831191|42157338|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714369|NCT03831191|42157339|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714370|NCT03831191|42157340|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714371|NCT03831191|42157341|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714372|NCT03831191|42157342|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714373|NCT03831191|42157343|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714374|NCT03831191|42157344|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714375|NCT03831191|42157345|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714376|NCT03831191|42157346|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714377|NCT03831191|42157347|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714378|NCT03831191|42157348|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714379|NCT03831191|42157349|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714380|NCT03831191|42157350|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714381|NCT03831191|42157351|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
19714382|NCT03831191|42157352|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
19714383|NCT03831191|42157338|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714384|NCT03831191|42157339|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714385|NCT03831191|42157340|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714386|NCT03831191|42157341|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714387|NCT03831191|42157342|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714388|NCT03831191|42157343|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714389|NCT03831191|42157344|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714390|NCT03831191|42157345|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714391|NCT03831191|42157346|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714392|NCT03831191|42157347|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714393|NCT03831191|42157348|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714394|NCT03831191|42157349|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714395|NCT03831191|42157350|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714396|NCT03831191|42157351|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
19714397|NCT03831191|42157352|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
19714398|NCT00005906|42157385|FG000|Overall Study|Lack of Efficacy|3|||
19714399|NCT00066690|42157392|FG000|Overall Study|Adverse Event|145|||
19714400|NCT00066690|42157393|FG001|Overall Study|Adverse Event|58|||
19714401|NCT00066690|42157394|FG002|Overall Study|Adverse Event|126|||
19714402|NCT00066690|42157392|FG000|Overall Study|Death|3|||
19714403|NCT00066690|42157393|FG001|Overall Study|Death|0|||
19714404|NCT00066690|42157394|FG002|Overall Study|Death|2|||
19714405|NCT00066690|42157392|FG000|Overall Study|Lack of Efficacy|114|||
19714406|NCT00066690|42157393|FG001|Overall Study|Lack of Efficacy|110|||
19714407|NCT00066690|42157394|FG002|Overall Study|Lack of Efficacy|76|||
19714408|NCT00066690|42157392|FG000|Overall Study|Lost to Follow-up|40|||
19714409|NCT00066690|42157393|FG001|Overall Study|Lost to Follow-up|21|||
19714410|NCT00066690|42157394|FG002|Overall Study|Lost to Follow-up|29|||
19714411|NCT00066690|42157392|FG000|Overall Study|Withdrawal by Subject|50|||
19714412|NCT00066690|42157393|FG001|Overall Study|Withdrawal by Subject|55|||
19714413|NCT00066690|42157394|FG002|Overall Study|Withdrawal by Subject|49|||
19458953|NCT01748552|41712927|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458954|NCT01748552|41712928|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458955|NCT01748552|41712929|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
19458956|NCT01748552|41712930|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
19458957|NCT01748552|41712931|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
19458958|NCT01748552|41712932|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458959|NCT01748552|41712933|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458960|NCT01748552|41712934|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
19458961|NCT01748162|41712976|FG000|Overall Study|no additional croup episodes to evaluate|2|||
19458962|NCT01748162|41712977|FG001|Overall Study|no additional croup episodes to evaluate|2|||
19458963|NCT01748162|41712976|FG000|Overall Study|participant consented but did not begin|0|||
19458964|NCT01748162|41712977|FG001|Overall Study|participant consented but did not begin|1|||
19458965|NCT01748162|41712976|FG000|Overall Study|reasons not available|3|||
19458966|NCT01748162|41712977|FG001|Overall Study|reasons not available|2|||
19458967|NCT01724216|41712983|FG000|Overall Study|Scan was not completed|1|||
19458968|NCT01723904|41712987|FG000|Overall Study|Noncompliant|3|||
19458969|NCT01723904|41712987|FG000|Overall Study|Adverse Event|5|||
19458970|NCT01723904|41712987|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
19458971|NCT01747772|41712991|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
19458972|NCT01830127|41713001|FG000|Overall Study|Adverse Event|1|||
19458973|NCT01830127|41713002|FG001|Overall Study|Adverse Event|6|||
19458974|NCT01830127|41713001|FG000|Overall Study|Lack of Efficacy|3|||
19458975|NCT01830127|41713002|FG001|Overall Study|Lack of Efficacy|0|||
19458976|NCT01830127|41713001|FG000|Overall Study|Withdrawal by Subject|1|||
19458977|NCT01830127|41713002|FG001|Overall Study|Withdrawal by Subject|1|||
19458978|NCT01830127|41713001|FG000|Overall Study|Other reason not defined above|0|||
19458979|NCT01830127|41713002|FG001|Overall Study|Other reason not defined above|2|||
19458980|NCT01614067|41713010|FG000|Overall Study|Pregnancy|1|||
19458981|NCT01614067|41713011|FG001|Overall Study|Pregnancy|0|||
19458982|NCT01614067|41713010|FG000|Overall Study|Physician Decision|6|||
19458983|NCT01614067|41713011|FG001|Overall Study|Physician Decision|5|||
19458984|NCT01614067|41713010|FG000|Overall Study|Withdrawal by Subject|0|||
19458985|NCT01614067|41713011|FG001|Overall Study|Withdrawal by Subject|1|||
19458986|NCT01614067|41713010|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
19458987|NCT01614067|41713011|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
19458988|NCT01777490|41713021|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
19458989|NCT01777490|41713022|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
19458990|NCT01777490|41713023|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
19458991|NCT01777490|41713024|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
19458992|NCT01397409|41713046|FG000|Stage 2|Adverse Event|0|||
19458993|NCT01397409|41713047|FG001|Stage 2|Adverse Event|0|||
19458994|NCT01397409|41713048|FG002|Stage 2|Adverse Event|0|||
19458995|NCT01397409|41713049|FG003|Stage 2|Adverse Event|0|||
19458996|NCT01397409|41713050|FG004|Stage 2|Adverse Event|6|||
19458997|NCT01397409|41713051|FG005|Stage 2|Adverse Event|3|||
19458998|NCT01397409|41713052|FG006|Stage 2|Adverse Event|0|||
19458999|NCT01397409|41713053|FG007|Stage 2|Adverse Event|0|||
19459000|NCT01397409|41713054|FG008|Stage 2|Adverse Event|0|||
19459001|NCT01397409|41713055|FG009|Stage 2|Adverse Event|0|||
19459002|NCT01397409|41713046|FG000|Stage 2|Personal Reasons|0|||
19459003|NCT01397409|41713047|FG001|Stage 2|Personal Reasons|0|||
19459004|NCT01397409|41713048|FG002|Stage 2|Personal Reasons|0|||
19459005|NCT01397409|41713049|FG003|Stage 2|Personal Reasons|0|||
19459006|NCT01397409|41713050|FG004|Stage 2|Personal Reasons|1|||
19459007|NCT01397409|41713051|FG005|Stage 2|Personal Reasons|0|||
19459008|NCT01397409|41713052|FG006|Stage 2|Personal Reasons|0|||
19459009|NCT01397409|41713053|FG007|Stage 2|Personal Reasons|0|||
19459010|NCT01397409|41713054|FG008|Stage 2|Personal Reasons|0|||
19459011|NCT01397409|41713055|FG009|Stage 2|Personal Reasons|0|||
19459012|NCT01397409|41713046|FG000|Stage 2|Other Miscellaneous Reasons|0|||
19459013|NCT01397409|41713047|FG001|Stage 2|Other Miscellaneous Reasons|0|||
19459014|NCT01397409|41713048|FG002|Stage 2|Other Miscellaneous Reasons|0|||
19459015|NCT01397409|41713049|FG003|Stage 2|Other Miscellaneous Reasons|0|||
19714414|NCT00066690|42157392|FG000|Overall Study|Treatment Ongoing|246|||
19459016|NCT01397409|41713050|FG004|Stage 2|Other Miscellaneous Reasons|1|||
19459017|NCT01397409|41713051|FG005|Stage 2|Other Miscellaneous Reasons|1|||
19459018|NCT01397409|41713052|FG006|Stage 2|Other Miscellaneous Reasons|0|||
19714415|NCT00066690|42157393|FG001|Overall Study|Treatment Ongoing|278|||
19714416|NCT00066690|42157394|FG002|Overall Study|Treatment Ongoing|282|||
19714417|NCT03409276|42157410|FG000|Overall Study|Withdrawal by Subject|0|||
19714418|NCT03409276|42157411|FG001|Overall Study|Withdrawal by Subject|0|||
19714419|NCT03409276|42157412|FG002|Overall Study|Withdrawal by Subject|0|||
19714420|NCT03409276|42157413|FG003|Overall Study|Withdrawal by Subject|0|||
19714421|NCT03409276|42157414|FG004|Overall Study|Withdrawal by Subject|1|||
19714422|NCT03409276|42157410|FG000|Overall Study|Lost to Follow-up|0|||
19714423|NCT03409276|42157411|FG001|Overall Study|Lost to Follow-up|0|||
19714424|NCT03409276|42157412|FG002|Overall Study|Lost to Follow-up|0|||
19714425|NCT03409276|42157413|FG003|Overall Study|Lost to Follow-up|2|||
19714426|NCT03409276|42157414|FG004|Overall Study|Lost to Follow-up|2|||
19714427|NCT00004562|42157432|FG000|Overall Study|Lost to Follow-up|102|||
19714428|NCT00004562|42157433|FG001|Overall Study|Lost to Follow-up|91|||
19714429|NCT00004412|42157442|FG000|Randomized Period|Moved to Crossover Period|3|||
19714430|NCT00004412|42157443|FG001|Randomized Period|Moved to Crossover Period|0|||
19714431|NCT00004412|42157444|FG002|Randomized Period|Moved to Crossover Period|0|||
19714432|NCT03440320|42157454|FG000|Overall Study|Withdrawal by Subject|0|||
19714433|NCT03440320|42157455|FG001|Overall Study|Withdrawal by Subject|1|||
19714434|NCT00004088|42157463|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
19714435|NCT00004088|42157463|FG000|Overall Study|Withdrawal by Subject|1|||
19714436|NCT00004088|42157463|FG000|Overall Study|Protocol Violation|3|||
19714437|NCT00004088|42157463|FG000|Overall Study|Physician Decision|1|||
19714438|NCT03439072|42157467|FG000|Overall Study|Withdrawal by Subject|2|||
19714439|NCT03439072|42157468|FG001|Overall Study|Withdrawal by Subject|3|||
19714440|NCT03439072|42157467|FG000|Overall Study|Physician Decision|0|||
19714441|NCT03439072|42157468|FG001|Overall Study|Physician Decision|1|||
19714442|NCT00078312|42157474|FG000|Overall Study|Adverse Event|43|||
19714443|NCT00078312|42157474|FG000|Overall Study|Lack of Efficacy|15|||
19714444|NCT00078312|42157474|FG000|Overall Study|Lost to Follow-up|41|||
19714445|NCT00078312|42157474|FG000|Overall Study|Physician Decision|9|||
19714446|NCT00078312|42157474|FG000|Overall Study|Protocol Violation|3|||
19714447|NCT00078312|42157474|FG000|Overall Study|Withdrawal by Subject|33|||
19714448|NCT00078312|42157474|FG000|Overall Study|Miscellaneous|33|||
19714449|NCT00003896|42157478|FG000|Overall Study|Adverse Event|16|||
19714450|NCT00003896|42157478|FG000|Overall Study|Withdrawal by Subject|1|||
19714451|NCT00003896|42157478|FG000|Overall Study|Lack of Efficacy|1|||
19714452|NCT00003896|42157478|FG000|Overall Study|Death|3|||
19714453|NCT00003896|42157478|FG000|Overall Study|not protocol specified|3|||
19714454|NCT00003896|42157478|FG000|Overall Study|ineligible|5|||
19714455|NCT00003830|42157485|FG000|Overall Study|No follow up data|3|||
19714456|NCT00003830|42157486|FG001|Overall Study|No follow up data|0|||
19714457|NCT00003830|42157485|FG000|Overall Study|Sentinel node positive patients|829|||
19714458|NCT00003830|42157486|FG001|Overall Study|Sentinel node positive patients|793|||
19714459|NCT03407482|42157494|FG000|Overall Study|Adverse Event|12|||
19714460|NCT03407482|42157494|FG000|Overall Study|Disease Relapse|1|||
19714461|NCT03407482|42157494|FG000|Overall Study|Lost to Follow-up|1|||
19714462|NCT03407482|42157494|FG000|Overall Study|Non-Compliance With Study Drug|1|||
19714463|NCT03407482|42157494|FG000|Overall Study|Pregnancy|2|||
19714464|NCT03407482|42157494|FG000|Overall Study|Protocol Violation|1|||
19714465|NCT03407482|42157494|FG000|Overall Study|Study Terminated By Sponsor|106|||
19714466|NCT03407482|42157494|FG000|Overall Study|Withdrawal by Subject|6|||
19714467|NCT03407482|42157494|FG000|Overall Study|Data Entry Error|1|||
19714468|NCT00003782|42157501|FG000|Overall Study|No follow up data|30|||
19714469|NCT00003782|42157502|FG001|Overall Study|No follow up data|31|||
19714470|NCT00003782|42157503|FG002|Overall Study|No follow up data|26|||
19714471|NCT03389308|42157511|FG000|Overall Study|Withdrawal by Subject|5|||
19714472|NCT03389308|42157511|FG000|Overall Study|Lost to Follow-up|3|||
19714473|NCT03389308|42157511|FG000|Overall Study|Adverse Event|2|||
19714474|NCT03389308|42157511|FG000|Overall Study|Sponsor Request|2|||
19714475|NCT03407170|42157515|FG000|Overall Study|Adverse Event|1|||
19714476|NCT03406858|42157519|FG000|Overall Study|Failure to receive treatment drug.|1|||
19714477|NCT03406858|42157519|FG000|Overall Study|ineligible|1|||
19714478|NCT03406702|42157523|FG000|Overall Study|Missed Day 27 Dosing|1|||
19714479|NCT00003656|42157541|FG000|Overall Study|Adverse Event|0|||
19714480|NCT00003656|42157542|FG001|Overall Study|Adverse Event|1|||
19714481|NCT00003590|42157549|FG000|Overall Study|Ineligible Patient|1|||
19714482|NCT00003590|42157549|FG000|Overall Study|Adverse Event|7|||
19714483|NCT00003590|42157549|FG000|Overall Study|Withdrawal by Subject|1|||
19714484|NCT00003590|42157549|FG000|Overall Study|Lack of Efficacy|11|||
19714485|NCT00003590|42157549|FG000|Overall Study|Death|1|||
19714486|NCT00003590|42157549|FG000|Overall Study|Physician Decision|1|||
19714487|NCT03416374|42157555|FG000|Between Treatment Period I and II|Other|0|||
19714488|NCT03416374|42157556|FG001|Between Treatment Period I and II|Other|9|||
19714489|NCT03416374|42157555|FG000|Treatment Period II|Lack of Efficacy|3|||
19714490|NCT03416374|42157556|FG001|Treatment Period II|Lack of Efficacy|11|||
19714491|NCT03416374|42157555|FG000|Treatment Period II|Adverse Event|1|||
19714492|NCT03416374|42157556|FG001|Treatment Period II|Adverse Event|4|||
19714493|NCT03416374|42157555|FG000|Treatment Period II|Death|0|||
19714494|NCT03416374|42157556|FG001|Treatment Period II|Death|1|||
19714495|NCT03416374|42157555|FG000|Treatment Period II|Other|0|||
19714496|NCT03416374|42157556|FG001|Treatment Period II|Other|2|||
19714497|NCT03799952|42157567|FG000|Overall Study|Program was too easy, discontinued|1|||
19714498|NCT03799952|42157568|FG001|Overall Study|Program was too easy, discontinued|0|||
19714499|NCT03799952|42157567|FG000|Overall Study|Lost to Follow-up|0|||
19714500|NCT03799952|42157568|FG001|Overall Study|Lost to Follow-up|2|||
19714501|NCT00077766|42157576|FG000|Overall Study|Adverse Event|1|||
19714502|NCT00077766|42157577|FG001|Overall Study|Adverse Event|1|||
19714503|NCT00077766|42157576|FG000|Overall Study|Withdrawal by Subject|4|||
19714504|NCT00077766|42157577|FG001|Overall Study|Withdrawal by Subject|3|||
19714505|NCT00077766|42157576|FG000|Overall Study|Death|12|||
19714506|NCT00077766|42157577|FG001|Overall Study|Death|10|||
19714507|NCT00077766|42157576|FG000|Overall Study|Lost to Follow-up|2|||
19714508|NCT00077766|42157577|FG001|Overall Study|Lost to Follow-up|0|||
19714509|NCT00077766|42157576|FG000|Overall Study|Protocol Violation|1|||
19714510|NCT00077766|42157577|FG001|Overall Study|Protocol Violation|0|||
19714511|NCT00077766|42157576|FG000|Overall Study|Kidney Transplantation|9|||
19714512|NCT00077766|42157577|FG001|Overall Study|Kidney Transplantation|5|||
19714513|NCT00077766|42157576|FG000|Overall Study|Transplantation|5|||
19714514|NCT00077766|42157577|FG001|Overall Study|Transplantation|1|||
19714515|NCT00077766|42157576|FG000|Overall Study|Investigators Discretion|1|||
19714516|NCT00077766|42157577|FG001|Overall Study|Investigators Discretion|0|||
19714517|NCT00077766|42157576|FG000|Overall Study|Participant's decision|1|||
19714518|NCT00077766|42157577|FG001|Overall Study|Participant's decision|0|||
19714519|NCT00077766|42157576|FG000|Overall Study|Dialysis Discontinued|1|||
19714520|NCT00077766|42157577|FG001|Overall Study|Dialysis Discontinued|0|||
19714521|NCT00077766|42157576|FG000|Overall Study|Dialysis|0|||
19714522|NCT00077766|42157577|FG001|Overall Study|Dialysis|1|||
19714523|NCT00077766|42157576|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
19714524|NCT00077766|42157577|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
19714525|NCT00077766|42157576|FG000|Overall Study|Started Nocturnal Dialysis|0|||
19714526|NCT00077766|42157577|FG001|Overall Study|Started Nocturnal Dialysis|1|||
19714527|NCT00077766|42157576|FG000|Overall Study|Stop Dialysis|0|||
19714528|NCT00077766|42157577|FG001|Overall Study|Stop Dialysis|1|||
19714529|NCT00077766|42157576|FG000|Overall Study|Participants Vacation|2|||
19714530|NCT00077766|42157577|FG001|Overall Study|Participants Vacation|1|||
19714531|NCT03799718|42157584|FG000|Overall Study|Adverse Event|2|||
19714532|NCT03388138|42157590|FG000|Overall Study|Protocol Violation|1|||
19714533|NCT03388138|42157591|FG001|Overall Study|Protocol Violation|0|||
19714534|NCT02952898|42157600|FG000|Overall Study|Withdrawal by Subject|10|||
19714535|NCT02952898|42157601|FG001|Overall Study|Withdrawal by Subject|8|||
19714536|NCT02952898|42157602|FG002|Overall Study|Withdrawal by Subject|8|||
19714537|NCT02952898|42157600|FG000|Overall Study|Adverse Event|8|||
19714538|NCT02952898|42157601|FG001|Overall Study|Adverse Event|8|||
19714539|NCT02952898|42157602|FG002|Overall Study|Adverse Event|3|||
19714540|NCT02952898|42157600|FG000|Overall Study|Lost to Follow-up|3|||
19714541|NCT02952898|42157601|FG001|Overall Study|Lost to Follow-up|2|||
19714542|NCT02952898|42157602|FG002|Overall Study|Lost to Follow-up|2|||
19714543|NCT02952898|42157600|FG000|Overall Study|Non-compliance with study drug|1|||
19714544|NCT02952898|42157601|FG001|Overall Study|Non-compliance with study drug|1|||
19714545|NCT02952898|42157602|FG002|Overall Study|Non-compliance with study drug|2|||
19714546|NCT00045734|42157610|FG000|Overall Study|Protocol Violation|1|||
19714547|NCT03387046|42157616|FG000|Overall Study|Adverse Event|1|||
19714548|NCT03387046|42157617|FG001|Overall Study|Adverse Event|1|||
19545064|NCT00471237|41994657|FG002|Overall Study|Protocol Violation|3|||
19545065|NCT00471237|41994658|FG003|Overall Study|Protocol Violation|2|||
19545066|NCT00471237|41994659|FG004|Overall Study|Protocol Violation|2|||
19545067|NCT00471237|41994660|FG005|Overall Study|Protocol Violation|4|||
19545068|NCT00471237|41994661|FG006|Overall Study|Protocol Violation|1|||
19545069|NCT00471237|41994655|FG000|Overall Study|Withdrawal by Subject|8|||
19545070|NCT00471237|41994656|FG001|Overall Study|Withdrawal by Subject|6|||
19545071|NCT00471237|41994657|FG002|Overall Study|Withdrawal by Subject|5|||
19545072|NCT00471237|41994658|FG003|Overall Study|Withdrawal by Subject|8|||
19545073|NCT00471237|41994659|FG004|Overall Study|Withdrawal by Subject|7|||
19545074|NCT00471237|41994660|FG005|Overall Study|Withdrawal by Subject|4|||
19545075|NCT00471237|41994661|FG006|Overall Study|Withdrawal by Subject|2|||
19545076|NCT00471237|41994655|FG000|Overall Study|Sponsor terminated study|20|||
19545077|NCT00471237|41994656|FG001|Overall Study|Sponsor terminated study|23|||
19714549|NCT00045110|42157626|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
19714550|NCT00045110|42157627|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
19714551|NCT00045110|42157628|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
19714552|NCT00045110|42157626|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
19714553|NCT00045110|42157627|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
19714554|NCT00045110|42157628|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
19545078|NCT00471237|41994657|FG002|Overall Study|Sponsor terminated study|19|||
19714555|NCT00045110|42157626|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
19714556|NCT00045110|42157627|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
19714557|NCT00045110|42157628|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
19714558|NCT03353740|42157645|FG000|Overall Study|Images for these participants not viable|52|||
19714559|NCT00003476|42157649|FG000|Overall Study|Not evaluable|1|||
19714560|NCT00003470|42157653|FG000|Overall Study|Not evaluable|6|||
19714561|NCT03386344|42157660|FG000|Overall Study|Adverse Event|6|||
19714562|NCT03386344|42157661|FG001|Overall Study|Adverse Event|3|||
19714563|NCT03386344|42157662|FG002|Overall Study|Adverse Event|1|||
19714564|NCT03386344|42157660|FG000|Overall Study|Poor Compliance to Protocol|0|||
19714565|NCT03386344|42157661|FG001|Overall Study|Poor Compliance to Protocol|1|||
19714566|NCT03386344|42157662|FG002|Overall Study|Poor Compliance to Protocol|0|||
19714567|NCT03386344|42157660|FG000|Overall Study|Study Terminated by Sponsor|101|||
19714568|NCT03386344|42157661|FG001|Overall Study|Study Terminated by Sponsor|102|||
19714569|NCT03386344|42157662|FG002|Overall Study|Study Terminated by Sponsor|106|||
19714570|NCT03386344|42157660|FG000|Overall Study|Lost to Follow-up|3|||
19459019|NCT01397409|41713053|FG007|Stage 2|Other Miscellaneous Reasons|0|||
19459020|NCT01397409|41713054|FG008|Stage 2|Other Miscellaneous Reasons|0|||
19459021|NCT01397409|41713055|FG009|Stage 2|Other Miscellaneous Reasons|0|||
19459022|NCT01397409|41713046|FG000|Stage 3|Adverse Event|0|||
19459023|NCT01397409|41713047|FG001|Stage 3|Adverse Event|0|||
19459024|NCT01397409|41713048|FG002|Stage 3|Adverse Event|0|||
19459025|NCT01397409|41713049|FG003|Stage 3|Adverse Event|0|||
19459026|NCT01397409|41713050|FG004|Stage 3|Adverse Event|0|||
19459027|NCT01397409|41713051|FG005|Stage 3|Adverse Event|0|||
19459028|NCT01397409|41713052|FG006|Stage 3|Adverse Event|0|||
19459029|NCT01397409|41713053|FG007|Stage 3|Adverse Event|1|||
19459030|NCT01397409|41713054|FG008|Stage 3|Adverse Event|0|||
19459031|NCT01397409|41713055|FG009|Stage 3|Adverse Event|0|||
19459032|NCT01397409|41713046|FG000|Stage 3|Other Miscellaneous Reasons|0|||
19459033|NCT01397409|41713047|FG001|Stage 3|Other Miscellaneous Reasons|0|||
19459034|NCT01397409|41713048|FG002|Stage 3|Other Miscellaneous Reasons|0|||
19459035|NCT01397409|41713049|FG003|Stage 3|Other Miscellaneous Reasons|0|||
19459036|NCT01397409|41713050|FG004|Stage 3|Other Miscellaneous Reasons|0|||
19459037|NCT01397409|41713051|FG005|Stage 3|Other Miscellaneous Reasons|0|||
19459038|NCT01397409|41713052|FG006|Stage 3|Other Miscellaneous Reasons|0|||
19459039|NCT01397409|41713053|FG007|Stage 3|Other Miscellaneous Reasons|1|||
19459040|NCT01397409|41713054|FG008|Stage 3|Other Miscellaneous Reasons|0|||
19459041|NCT01397409|41713055|FG009|Stage 3|Other Miscellaneous Reasons|0|||
19459042|NCT01397253|41713080|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
19459043|NCT01397253|41713081|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
19459044|NCT01777334|41713089|FG000|Overall Study|Adverse Event|18|||
19459045|NCT01777334|41713090|FG001|Overall Study|Adverse Event|14|||
19459046|NCT01777334|41713089|FG000|Overall Study|Lack of Efficacy|15|||
19459047|NCT01777334|41713090|FG001|Overall Study|Lack of Efficacy|29|||
19459048|NCT01777334|41713089|FG000|Overall Study|Protocol Violation|3|||
19459049|NCT01777334|41713090|FG001|Overall Study|Protocol Violation|7|||
19459050|NCT01777334|41713089|FG000|Overall Study|Lost to Follow-up|3|||
19459051|NCT01777334|41713090|FG001|Overall Study|Lost to Follow-up|2|||
19459052|NCT01777334|41713089|FG000|Overall Study|Withdrawal by Subject|14|||
19459053|NCT01777334|41713090|FG001|Overall Study|Withdrawal by Subject|11|||
19459054|NCT01383993|41713099|FG000|Overall Study|Adverse Event|1|||
19459055|NCT01383993|41713100|FG001|Overall Study|Adverse Event|1|||
19459056|NCT01383993|41713101|FG002|Overall Study|Adverse Event|0|||
19459057|NCT01383993|41713099|FG000|Overall Study|Withdrawal by Subject|0|||
19459058|NCT01383993|41713100|FG001|Overall Study|Withdrawal by Subject|0|||
19459059|NCT01383993|41713101|FG002|Overall Study|Withdrawal by Subject|1|||
19459060|NCT01383993|41713099|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
19459061|NCT01383993|41713100|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
19459062|NCT01383993|41713101|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
19459063|NCT01396395|41713112|FG000|Overall Study|Withdrawal by Subject|10|||
19459064|NCT01396395|41713113|FG001|Overall Study|Withdrawal by Subject|12|||
19459065|NCT01396395|41713112|FG000|Overall Study|Protocol Violation|3|||
19459066|NCT01396395|41713113|FG001|Overall Study|Protocol Violation|1|||
19459067|NCT01396395|41713112|FG000|Overall Study|Adverse Event|10|||
19459068|NCT01396395|41713113|FG001|Overall Study|Adverse Event|2|||
19459069|NCT01396395|41713112|FG000|Overall Study|Lost to Follow-up|17|||
19459070|NCT01396395|41713113|FG001|Overall Study|Lost to Follow-up|11|||
19459071|NCT01396395|41713112|FG000|Overall Study|Other|0|||
19459072|NCT01396395|41713113|FG001|Overall Study|Other|1|||
19459073|NCT01396317|41713123|FG000|Overall Study|Adverse Event|1|||
19459074|NCT01396317|41713124|FG001|Overall Study|Adverse Event|0|||
19459075|NCT01396161|41713139|FG000|Overall Study|Withdrawal by Subject|0|||
19459076|NCT01396161|41713140|FG001|Overall Study|Withdrawal by Subject|0|||
19459077|NCT01396161|41713141|FG002|Overall Study|Withdrawal by Subject|0|||
19459078|NCT01396161|41713142|FG003|Overall Study|Withdrawal by Subject|0|||
19714571|NCT03386344|42157661|FG001|Overall Study|Lost to Follow-up|2|||
19714572|NCT03386344|42157662|FG002|Overall Study|Lost to Follow-up|1|||
19459079|NCT01396161|41713143|FG004|Overall Study|Withdrawal by Subject|1|||
19459080|NCT01396161|41713144|FG005|Overall Study|Withdrawal by Subject|0|||
19714573|NCT03386344|42157660|FG000|Overall Study|At the Participant's own Request|7|||
19714574|NCT03386344|42157661|FG001|Overall Study|At the Participant's own Request|7|||
19714575|NCT03386344|42157662|FG002|Overall Study|At the Participant's own Request|8|||
19714576|NCT03386344|42157660|FG000|Overall Study|Reason not Specified|0|||
19714577|NCT03386344|42157661|FG001|Overall Study|Reason not Specified|1|||
19714578|NCT03386344|42157662|FG002|Overall Study|Reason not Specified|0|||
19714579|NCT00399035|42157673|FG000|Overall Study|Death|289|||
19714580|NCT00399035|42157674|FG001|Overall Study|Death|141|||
19714581|NCT00399035|42157675|FG002|Overall Study|Death|234|||
19714582|NCT00399035|42157673|FG000|Overall Study|Lost to Follow-up|2|||
19714583|NCT00399035|42157674|FG001|Overall Study|Lost to Follow-up|1|||
19714584|NCT00399035|42157675|FG002|Overall Study|Lost to Follow-up|5|||
19714585|NCT00399035|42157673|FG000|Overall Study|Withdrawal by Subject|19|||
19714586|NCT00399035|42157674|FG001|Overall Study|Withdrawal by Subject|15|||
19714587|NCT00399035|42157675|FG002|Overall Study|Withdrawal by Subject|12|||
19714588|NCT00399035|42157673|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
19714589|NCT00399035|42157674|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
19714590|NCT00399035|42157675|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
19714591|NCT00399035|42157673|FG000|Overall Study|Severe non-compliance with protocol|2|||
19714592|NCT00399035|42157674|FG001|Overall Study|Severe non-compliance with protocol|1|||
19714593|NCT00399035|42157675|FG002|Overall Study|Severe non-compliance with protocol|0|||
19459081|NCT01396161|41713145|FG006|Overall Study|Withdrawal by Subject|0|||
19714594|NCT00073749|42157689|FG000|Overall Study|Disease Progression|2|||
19714595|NCT00073749|42157690|FG001|Overall Study|Disease Progression|0|||
19714596|NCT00073749|42157691|FG002|Overall Study|Disease Progression|3|||
19714597|NCT00073749|42157692|FG003|Overall Study|Disease Progression|2|||
19714598|NCT00073749|42157693|FG004|Overall Study|Disease Progression|3|||
19714599|NCT00073749|42157694|FG005|Overall Study|Disease Progression|1|||
19714600|NCT00073749|42157695|FG006|Overall Study|Disease Progression|3|||
19714601|NCT00073749|42157689|FG000|Overall Study|Death|0|||
19714602|NCT00073749|42157690|FG001|Overall Study|Death|1|||
19714603|NCT00073749|42157691|FG002|Overall Study|Death|1|||
19714604|NCT00073749|42157692|FG003|Overall Study|Death|0|||
19714605|NCT00073749|42157693|FG004|Overall Study|Death|0|||
19714606|NCT00073749|42157694|FG005|Overall Study|Death|0|||
19714607|NCT00073749|42157695|FG006|Overall Study|Death|29|||
19714608|NCT00073749|42157689|FG000|Overall Study|Adverse Event|0|||
19714609|NCT00073749|42157690|FG001|Overall Study|Adverse Event|3|||
19714610|NCT00073749|42157691|FG002|Overall Study|Adverse Event|6|||
19714611|NCT00073749|42157692|FG003|Overall Study|Adverse Event|4|||
19714612|NCT00073749|42157693|FG004|Overall Study|Adverse Event|2|||
19714613|NCT00073749|42157694|FG005|Overall Study|Adverse Event|1|||
19714614|NCT00073749|42157695|FG006|Overall Study|Adverse Event|0|||
19714615|NCT00073749|42157689|FG000|Overall Study|Physician Decision|0|||
19714616|NCT00073749|42157690|FG001|Overall Study|Physician Decision|0|||
19714617|NCT00073749|42157691|FG002|Overall Study|Physician Decision|1|||
19714618|NCT00073749|42157692|FG003|Overall Study|Physician Decision|0|||
19714619|NCT00073749|42157693|FG004|Overall Study|Physician Decision|0|||
19714620|NCT00073749|42157694|FG005|Overall Study|Physician Decision|2|||
19714621|NCT00073749|42157695|FG006|Overall Study|Physician Decision|0|||
19714622|NCT00073749|42157689|FG000|Overall Study|Withdrawal by Subject|0|||
19714623|NCT00073749|42157690|FG001|Overall Study|Withdrawal by Subject|1|||
19714624|NCT00073749|42157691|FG002|Overall Study|Withdrawal by Subject|0|||
19714625|NCT00073749|42157692|FG003|Overall Study|Withdrawal by Subject|0|||
19714626|NCT00073749|42157693|FG004|Overall Study|Withdrawal by Subject|1|||
19714627|NCT00073749|42157694|FG005|Overall Study|Withdrawal by Subject|0|||
19714628|NCT00073749|42157695|FG006|Overall Study|Withdrawal by Subject|2|||
19714629|NCT00073749|42157689|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
19714630|NCT00073749|42157690|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
19714631|NCT00073749|42157691|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
19714632|NCT00073749|42157692|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
19714633|NCT00073749|42157693|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
19714634|NCT00073749|42157694|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
19714635|NCT00073749|42157695|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
19714636|NCT00073749|42157689|FG000|Overall Study|Lost to Follow-up|0|||
19714637|NCT00073749|42157690|FG001|Overall Study|Lost to Follow-up|0|||
19714638|NCT00073749|42157691|FG002|Overall Study|Lost to Follow-up|0|||
19714639|NCT00073749|42157692|FG003|Overall Study|Lost to Follow-up|0|||
19714640|NCT00073749|42157693|FG004|Overall Study|Lost to Follow-up|0|||
19714641|NCT00073749|42157694|FG005|Overall Study|Lost to Follow-up|0|||
19714642|NCT00073749|42157695|FG006|Overall Study|Lost to Follow-up|2|||
19714643|NCT00073749|42157689|FG000|Overall Study|Other|0|||
19714644|NCT00073749|42157690|FG001|Overall Study|Other|0|||
19714645|NCT00073749|42157691|FG002|Overall Study|Other|0|||
19714646|NCT00073749|42157692|FG003|Overall Study|Other|0|||
19714647|NCT00073749|42157693|FG004|Overall Study|Other|0|||
19714648|NCT00073749|42157694|FG005|Overall Study|Other|2|||
19714649|NCT00073749|42157695|FG006|Overall Study|Other|0|||
19714650|NCT00398567|42157717|FG000|Overall Study|Disease Progression|3|||
19714651|NCT00398567|42157718|FG001|Overall Study|Disease Progression|4|||
19714652|NCT00398567|42157719|FG002|Overall Study|Disease Progression|27|||
19714653|NCT00398567|42157717|FG000|Overall Study|Withdrawal by Subject|1|||
19714654|NCT00398567|42157718|FG001|Overall Study|Withdrawal by Subject|0|||
19714655|NCT00398567|42157719|FG002|Overall Study|Withdrawal by Subject|4|||
19714656|NCT00398567|42157717|FG000|Overall Study|Adverse Event|0|||
19714657|NCT00398567|42157718|FG001|Overall Study|Adverse Event|0|||
19714658|NCT00398567|42157719|FG002|Overall Study|Adverse Event|2|||
19714659|NCT00398567|42157717|FG000|Overall Study|Protocol Violation|0|||
19714660|NCT00398567|42157718|FG001|Overall Study|Protocol Violation|0|||
19714661|NCT00398567|42157719|FG002|Overall Study|Protocol Violation|1|||
19714662|NCT01347580|42157727|FG000|Overall Study|Withdrawal by Subject|13|||
19714663|NCT01347580|42157728|FG001|Overall Study|Withdrawal by Subject|23|||
19714664|NCT01347580|42157727|FG000|Overall Study|Death|30|||
19714665|NCT01347580|42157728|FG001|Overall Study|Death|19|||
19714666|NCT01347580|42157727|FG000|Overall Study|Protocol Violation|10|||
19714667|NCT01347580|42157728|FG001|Overall Study|Protocol Violation|7|||
19714668|NCT01347580|42157727|FG000|Overall Study|Lost to Follow-up|3|||
19714669|NCT01347580|42157728|FG001|Overall Study|Lost to Follow-up|1|||
19714670|NCT01347580|42157727|FG000|Overall Study|Had other reason|9|||
19714671|NCT01347580|42157728|FG001|Overall Study|Had other reason|6|||
19714672|NCT00398411|42157736|FG000|Overall Study|Death|0|||
19714673|NCT00398411|42157737|FG001|Overall Study|Death|1|||
19714674|NCT03352414|42157745|FG000|Overall Study|Ineligible by operative criteria|12|||
19714675|NCT03352414|42157746|FG001|Overall Study|Ineligible by operative criteria|10|||
19714676|NCT00364793|42157758|FG000|Overall Study|Adverse Event|2|||
19714677|NCT00364793|42157759|FG001|Overall Study|Adverse Event|0|||
19714678|NCT00364793|42157760|FG002|Overall Study|Adverse Event|0|||
19714679|NCT00364793|42157761|FG003|Overall Study|Adverse Event|0|||
19714680|NCT00364793|42157758|FG000|Overall Study|Death|1|||
19714681|NCT00364793|42157759|FG001|Overall Study|Death|0|||
19714682|NCT00364793|42157760|FG002|Overall Study|Death|1|||
19714683|NCT00364793|42157761|FG003|Overall Study|Death|0|||
19714684|NCT00364793|42157758|FG000|Overall Study|Lack of Efficacy|3|||
19714685|NCT00364793|42157759|FG001|Overall Study|Lack of Efficacy|3|||
19714686|NCT00364793|42157760|FG002|Overall Study|Lack of Efficacy|1|||
19714687|NCT00364793|42157761|FG003|Overall Study|Lack of Efficacy|1|||
19714688|NCT00364793|42157758|FG000|Overall Study|Lost to Follow-up|1|||
19714689|NCT00364793|42157759|FG001|Overall Study|Lost to Follow-up|0|||
19714690|NCT00364793|42157760|FG002|Overall Study|Lost to Follow-up|2|||
19714691|NCT00364793|42157761|FG003|Overall Study|Lost to Follow-up|0|||
19714692|NCT00364793|42157758|FG000|Overall Study|Poor or non-compliance|1|||
19714693|NCT00364793|42157759|FG001|Overall Study|Poor or non-compliance|1|||
19714694|NCT00364793|42157760|FG002|Overall Study|Poor or non-compliance|0|||
19714695|NCT00364793|42157761|FG003|Overall Study|Poor or non-compliance|1|||
19714696|NCT00364793|42157758|FG000|Overall Study|No longer meets criteria|0|||
19714697|NCT00364793|42157759|FG001|Overall Study|No longer meets criteria|0|||
19714698|NCT00364793|42157760|FG002|Overall Study|No longer meets criteria|0|||
19714699|NCT00364793|42157761|FG003|Overall Study|No longer meets criteria|1|||
19714700|NCT00364793|42157758|FG000|Overall Study|Withdrawal by Subject|0|||
19714701|NCT00364793|42157759|FG001|Overall Study|Withdrawal by Subject|1|||
19714702|NCT00364793|42157760|FG002|Overall Study|Withdrawal by Subject|0|||
19714703|NCT00364793|42157761|FG003|Overall Study|Withdrawal by Subject|0|||
19714704|NCT03351478|42157777|FG000|Overall Study|At the subject's own request|11|||
19714705|NCT03351478|42157778|FG001|Overall Study|At the subject's own request|12|||
19714706|NCT03351478|42157779|FG002|Overall Study|At the subject's own request|5|||
19714707|NCT03351478|42157777|FG000|Overall Study|Adverse Event|1|||
19714708|NCT03351478|42157778|FG001|Overall Study|Adverse Event|2|||
19714709|NCT03351478|42157779|FG002|Overall Study|Adverse Event|1|||
19714710|NCT03351478|42157777|FG000|Overall Study|Poor compliance to protocol|1|||
19714711|NCT03351478|42157778|FG001|Overall Study|Poor compliance to protocol|0|||
19714712|NCT03351478|42157779|FG002|Overall Study|Poor compliance to protocol|0|||
19714713|NCT03351478|42157777|FG000|Overall Study|Reason not Specified|1|||
19714714|NCT03351478|42157778|FG001|Overall Study|Reason not Specified|3|||
19714715|NCT03351478|42157779|FG002|Overall Study|Reason not Specified|0|||
19714716|NCT03351478|42157777|FG000|Overall Study|Lost to Follow-up|0|||
19714717|NCT03351478|42157778|FG001|Overall Study|Lost to Follow-up|0|||
19714718|NCT03351478|42157779|FG002|Overall Study|Lost to Follow-up|1|||
19714719|NCT00363545|42157789|FG000|Overall Study|Serious Adverse Event|0|||
19714720|NCT00363545|42157790|FG001|Overall Study|Serious Adverse Event|1|||
19714721|NCT00363545|42157789|FG000|Overall Study|Withdrawal by Subject|12|||
19714722|NCT00363545|42157790|FG001|Overall Study|Withdrawal by Subject|15|||
19714723|NCT00363545|42157789|FG000|Overall Study|Migrated/moved from study area|3|||
19714724|NCT00363545|42157790|FG001|Overall Study|Migrated/moved from study area|6|||
19714725|NCT00363545|42157789|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
19714726|NCT00363545|42157790|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
19714727|NCT00363545|42157789|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
19714728|NCT00363545|42157790|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
19714729|NCT00363545|42157789|FG000|Overall Study|Others|1|||
19714730|NCT00363545|42157790|FG001|Overall Study|Others|0|||
19714731|NCT03351244|42157799|FG000|Overall Study|Adverse Event|7|||
19714732|NCT03351244|42157800|FG001|Overall Study|Adverse Event|11|||
19714733|NCT03351244|42157801|FG002|Overall Study|Adverse Event|12|||
19714734|NCT03351244|42157799|FG000|Overall Study|Investigator's decision|0|||
19714735|NCT03351244|42157800|FG001|Overall Study|Investigator's decision|0|||
19714736|NCT03351244|42157801|FG002|Overall Study|Investigator's decision|2|||
19714737|NCT03351244|42157799|FG000|Overall Study|System error|0|||
19714738|NCT03351244|42157800|FG001|Overall Study|System error|0|||
19714739|NCT03351244|42157801|FG002|Overall Study|System error|2|||
19714740|NCT03351244|42157799|FG000|Overall Study|COVID-19 restrictions|3|||
19714741|NCT03351244|42157800|FG001|Overall Study|COVID-19 restrictions|0|||
19714742|NCT03351244|42157801|FG002|Overall Study|COVID-19 restrictions|1|||
19714743|NCT03351244|42157799|FG000|Overall Study|Non-compliance|2|||
19714744|NCT03351244|42157800|FG001|Overall Study|Non-compliance|5|||
19714745|NCT03351244|42157801|FG002|Overall Study|Non-compliance|0|||
19714746|NCT03351244|42157799|FG000|Overall Study|Withdrawal by Subject|11|||
19714747|NCT03351244|42157800|FG001|Overall Study|Withdrawal by Subject|16|||
19714748|NCT03351244|42157801|FG002|Overall Study|Withdrawal by Subject|13|||
19714749|NCT03351244|42157799|FG000|Overall Study|Lost to Follow-up|2|||
19714750|NCT03351244|42157800|FG001|Overall Study|Lost to Follow-up|6|||
19714751|NCT03351244|42157801|FG002|Overall Study|Lost to Follow-up|4|||
19714752|NCT03351244|42157799|FG000|Overall Study|Protocol Violation|2|||
19714753|NCT03351244|42157800|FG001|Overall Study|Protocol Violation|2|||
19714754|NCT03351244|42157801|FG002|Overall Study|Protocol Violation|0|||
19714755|NCT03386032|42157814|FG000|Overall Study|Lack of Efficacy|6|||
19714756|NCT03386032|42157815|FG001|Overall Study|Lack of Efficacy|2|||
19714757|NCT03386032|42157816|FG002|Overall Study|Lack of Efficacy|0|||
19714758|NCT03386032|42157814|FG000|Overall Study|Adverse Event|2|||
19714759|NCT03386032|42157815|FG001|Overall Study|Adverse Event|2|||
19714760|NCT03386032|42157816|FG002|Overall Study|Adverse Event|0|||
19714761|NCT03386032|42157814|FG000|Overall Study|Withdrawal by Subject|1|||
19714762|NCT03386032|42157815|FG001|Overall Study|Withdrawal by Subject|0|||
19714763|NCT03386032|42157816|FG002|Overall Study|Withdrawal by Subject|0|||
19714764|NCT03386032|42157814|FG000|Overall Study|Lost to Follow-up|9|||
19714765|NCT03386032|42157815|FG001|Overall Study|Lost to Follow-up|3|||
19714766|NCT03386032|42157816|FG002|Overall Study|Lost to Follow-up|0|||
19714767|NCT00077610|42157827|FG000|Overall Study|Adverse Event|9|||
19714768|NCT00077610|42157828|FG001|Overall Study|Adverse Event|7|||
19714769|NCT00077610|42157829|FG002|Overall Study|Adverse Event|1|||
19714770|NCT00077610|42157827|FG000|Overall Study|Lost to Follow-up|0|||
19714771|NCT00077610|42157828|FG001|Overall Study|Lost to Follow-up|1|||
19714772|NCT00077610|42157829|FG002|Overall Study|Lost to Follow-up|2|||
19714773|NCT00077610|42157827|FG000|Overall Study|Withdrawal by Subject|4|||
19714774|NCT00077610|42157828|FG001|Overall Study|Withdrawal by Subject|10|||
19714775|NCT00077610|42157829|FG002|Overall Study|Withdrawal by Subject|6|||
19714776|NCT00077610|42157827|FG000|Overall Study|Death|17|||
19714777|NCT00077610|42157828|FG001|Overall Study|Death|13|||
19714778|NCT00077610|42157829|FG002|Overall Study|Death|13|||
19714779|NCT00077610|42157827|FG000|Overall Study|Renal transplant|12|||
19714780|NCT00077610|42157828|FG001|Overall Study|Renal transplant|15|||
19714781|NCT00077610|42157829|FG002|Overall Study|Renal transplant|11|||
19714782|NCT00077610|42157827|FG000|Overall Study|Withdrew from dialysis care|5|||
19714783|NCT00077610|42157828|FG001|Overall Study|Withdrew from dialysis care|0|||
19714784|NCT00077610|42157829|FG002|Overall Study|Withdrew from dialysis care|3|||
19714785|NCT00077610|42157827|FG000|Overall Study|Insufficient Therapeutic Response|1|||
19714786|NCT00077610|42157828|FG001|Overall Study|Insufficient Therapeutic Response|0|||
19714787|NCT00077610|42157829|FG002|Overall Study|Insufficient Therapeutic Response|0|||
19714788|NCT00077610|42157827|FG000|Overall Study|Multiple blood transfusions|0|||
19714789|NCT00077610|42157828|FG001|Overall Study|Multiple blood transfusions|0|||
19714790|NCT00077610|42157829|FG002|Overall Study|Multiple blood transfusions|1|||
19714791|NCT00077610|42157827|FG000|Overall Study|Principal Investigator's decision|1|||
19714792|NCT00077610|42157828|FG001|Overall Study|Principal Investigator's decision|0|||
19714793|NCT00077610|42157829|FG002|Overall Study|Principal Investigator's decision|1|||
19714794|NCT00077610|42157827|FG000|Overall Study|Worsening of health condition|1|||
19714795|NCT00077610|42157828|FG001|Overall Study|Worsening of health condition|1|||
19714796|NCT00077610|42157829|FG002|Overall Study|Worsening of health condition|0|||
19714797|NCT00077610|42157827|FG000|Overall Study|Given Epogen in hospital|1|||
19714798|NCT00077610|42157828|FG001|Overall Study|Given Epogen in hospital|0|||
19714799|NCT00077610|42157829|FG002|Overall Study|Given Epogen in hospital|0|||
19714800|NCT00077610|42157827|FG000|Overall Study|Transferred to other unit|0|||
19714801|NCT00077610|42157828|FG001|Overall Study|Transferred to other unit|0|||
19714802|NCT00077610|42157829|FG002|Overall Study|Transferred to other unit|1|||
19714803|NCT00077610|42157827|FG000|Overall Study|Transferred to nursing home|0|||
19714804|NCT00077610|42157828|FG001|Overall Study|Transferred to nursing home|0|||
19714805|NCT00077610|42157829|FG002|Overall Study|Transferred to nursing home|1|||
19714806|NCT00077610|42157827|FG000|Overall Study|Transfer to satellite unit|1|||
19714807|NCT00077610|42157828|FG001|Overall Study|Transfer to satellite unit|0|||
19714808|NCT00077610|42157829|FG002|Overall Study|Transfer to satellite unit|0|||
19714809|NCT00077610|42157827|FG000|Overall Study|Transfer to other center for surgery|1|||
19714810|NCT00077610|42157828|FG001|Overall Study|Transfer to other center for surgery|0|||
19714811|NCT00077610|42157829|FG002|Overall Study|Transfer to other center for surgery|0|||
19714812|NCT00077610|42157827|FG000|Overall Study|Change in dialysis modality|1|||
19714813|NCT00077610|42157828|FG001|Overall Study|Change in dialysis modality|0|||
19714814|NCT00077610|42157829|FG002|Overall Study|Change in dialysis modality|0|||
19714815|NCT00077610|42157827|FG000|Overall Study|Relocation|0|||
19714816|NCT00077610|42157828|FG001|Overall Study|Relocation|8|||
19714817|NCT00077610|42157829|FG002|Overall Study|Relocation|5|||
19714818|NCT00077610|42157827|FG000|Overall Study|Financial issues|0|||
19714819|NCT00077610|42157828|FG001|Overall Study|Financial issues|1|||
19714820|NCT00077610|42157829|FG002|Overall Study|Financial issues|0|||
19714821|NCT00077610|42157827|FG000|Overall Study|Sponsors decision to withdraw|0|||
19714822|NCT00077610|42157828|FG001|Overall Study|Sponsors decision to withdraw|0|||
19714823|NCT00077610|42157829|FG002|Overall Study|Sponsors decision to withdraw|1|||
19714824|NCT03385564|42157846|FG000|Overall Study|Adverse Event|0|||
19714825|NCT03385564|42157847|FG001|Overall Study|Adverse Event|0|||
19714826|NCT03385564|42157848|FG002|Overall Study|Adverse Event|3|||
19714827|NCT03385564|42157849|FG003|Overall Study|Adverse Event|3|||
19714828|NCT03385564|42157846|FG000|Overall Study|Other than listed|0|||
19714829|NCT03385564|42157847|FG001|Overall Study|Other than listed|0|||
19714830|NCT03385564|42157848|FG002|Overall Study|Other than listed|0|||
19714831|NCT03385564|42157849|FG003|Overall Study|Other than listed|5|||
19714832|NCT03385564|42157846|FG000|Overall Study|Withdrawal by Subject|0|||
19714833|NCT03385564|42157847|FG001|Overall Study|Withdrawal by Subject|1|||
19714834|NCT03385564|42157848|FG002|Overall Study|Withdrawal by Subject|1|||
19714835|NCT03385564|42157849|FG003|Overall Study|Withdrawal by Subject|0|||
19714836|NCT03385564|42157846|FG000|Overall Study|Lack of Efficacy|0|||
19714837|NCT03385564|42157847|FG001|Overall Study|Lack of Efficacy|0|||
19714838|NCT03385564|42157848|FG002|Overall Study|Lack of Efficacy|0|||
19714839|NCT03385564|42157849|FG003|Overall Study|Lack of Efficacy|1|||
19714840|NCT03385564|42157846|FG000|Overall Study|Death|0|||
19714841|NCT03385564|42157847|FG001|Overall Study|Death|0|||
19714842|NCT03385564|42157848|FG002|Overall Study|Death|1|||
19714843|NCT03385564|42157849|FG003|Overall Study|Death|0|||
19714844|NCT00066222|42157859|FG000|Overall Study|No protocol treatment received|1|||
19714845|NCT00397943|42157868|FG000|Overall Study|Unspecified reasons|12|||
19714846|NCT00397943|42157869|FG001|Overall Study|Unspecified reasons|9|||
19714847|NCT00397943|42157870|FG002|Overall Study|Unspecified reasons|0|||
19714848|NCT00397943|42157871|FG003|Overall Study|Unspecified reasons|0|||
19714849|NCT00397943|42157872|FG004|Overall Study|Unspecified reasons|0|||
19714850|NCT00066066|42157887|FG000|Overall Study|Lost to Follow-up|6|||
19714851|NCT00066066|42157888|FG001|Overall Study|Lost to Follow-up|4|||
19714852|NCT00066066|42157889|FG002|Overall Study|Lost to Follow-up|7|||
19714853|NCT00066066|42157890|FG003|Overall Study|Lost to Follow-up|4|||
19714854|NCT00066066|42157891|FG004|Overall Study|Lost to Follow-up|3|||
19714855|NCT00066066|42157892|FG005|Overall Study|Lost to Follow-up|5|||
19714856|NCT00363467|42157906|FG000|Overall Study|Physician Decision|1|||
19714857|NCT00397631|42157912|FG000|Overall Study|Adverse Event|5|||
19714858|NCT00397631|42157913|FG001|Overall Study|Adverse Event|6|||
19714859|NCT00397631|42157912|FG000|Overall Study|Lack of Efficacy|7|||
19714860|NCT00397631|42157913|FG001|Overall Study|Lack of Efficacy|10|||
19714861|NCT00397631|42157912|FG000|Overall Study|Lost to Follow-up|8|||
19714862|NCT00397631|42157913|FG001|Overall Study|Lost to Follow-up|9|||
19714863|NCT00397631|42157912|FG000|Overall Study|Physician Decision|2|||
19714864|NCT00397631|42157913|FG001|Overall Study|Physician Decision|0|||
19714865|NCT00397631|42157912|FG000|Overall Study|Protocol Violation|0|||
19714866|NCT00397631|42157913|FG001|Overall Study|Protocol Violation|1|||
19714867|NCT00397631|42157912|FG000|Overall Study|Withdrawal by Subject|7|||
19714868|NCT00397631|42157913|FG001|Overall Study|Withdrawal by Subject|14|||
19714869|NCT00397631|42157912|FG000|Overall Study|protocol discontinuation criteria|1|||
19714870|NCT00397631|42157913|FG001|Overall Study|protocol discontinuation criteria|4|||
19714871|NCT00077376|42157919|FG000|Overall Study|Adverse Event|8|||
19714872|NCT00077376|42157919|FG000|Overall Study|Withdrawal by Subject|2|||
19714873|NCT00077376|42157919|FG000|Overall Study|Death|1|||
19714874|NCT00077376|42157919|FG000|Overall Study|Physician Decision|1|||
19714875|NCT00077376|42157919|FG000|Overall Study|Alternative therapy|5|||
19714876|NCT00077376|42157919|FG000|Overall Study|Complicating disease|1|||
19714877|NCT00077376|42157919|FG000|Overall Study|Still on treatment|1|||
19714878|NCT00077376|42157919|FG000|Overall Study|Symptomatic deterioration|1|||
19714879|NCT00077376|42157919|FG000|Overall Study|Surgery|1|||
19714880|NCT00077376|42157919|FG000|Overall Study|Insurance ran out|1|||
19714881|NCT03406156|42157925|FG000|Overall Study|Death|6|||
19714882|NCT03406156|42157926|FG001|Overall Study|Death|2|||
19714883|NCT03406156|42157925|FG000|Overall Study|Withdrawal by Subject|0|||
19714884|NCT03406156|42157926|FG001|Overall Study|Withdrawal by Subject|2|||
19714885|NCT03406156|42157925|FG000|Overall Study|COVID-19 infection|1|||
19714886|NCT03406156|42157926|FG001|Overall Study|COVID-19 infection|0|||
19714887|NCT03406156|42157925|FG000|Overall Study|Non-compliance with study procedures|0|||
19714888|NCT03406156|42157926|FG001|Overall Study|Non-compliance with study procedures|1|||
19714889|NCT03406156|42157925|FG000|Overall Study|Other, not specified|0|||
19714890|NCT03406156|42157926|FG001|Overall Study|Other, not specified|1|||
19714891|NCT00363311|42157936|FG000|Overall Study|Adverse Event|6|||
19714892|NCT00363311|42157937|FG001|Overall Study|Adverse Event|4|||
19714893|NCT00363311|42157936|FG000|Overall Study|Lost to Follow-up|3|||
19714894|NCT00363311|42157937|FG001|Overall Study|Lost to Follow-up|0|||
19714895|NCT00363311|42157936|FG000|Overall Study|Protocol Violation|1|||
19714896|NCT00363311|42157937|FG001|Overall Study|Protocol Violation|2|||
19714897|NCT00363311|42157936|FG000|Overall Study|Withdrawal by Subject|12|||
19714898|NCT00363311|42157937|FG001|Overall Study|Withdrawal by Subject|6|||
19714899|NCT00363311|42157936|FG000|Overall Study|Physician Decision|1|||
19714900|NCT00363311|42157937|FG001|Overall Study|Physician Decision|1|||
19714901|NCT00363311|42157936|FG000|Overall Study|Sponsor Terminated Study|2|||
19714902|NCT00363311|42157937|FG001|Overall Study|Sponsor Terminated Study|2|||
19714903|NCT00363311|42157936|FG000|Overall Study|Disease Progression|46|||
19714904|NCT00363311|42157937|FG001|Overall Study|Disease Progression|26|||
19714905|NCT00363311|42157936|FG000|Overall Study|Non-Compliance|1|||
19714906|NCT00363311|42157937|FG001|Overall Study|Non-Compliance|1|||
19714907|NCT00363311|42157936|FG000|Overall Study|Participant Refused Biopsy|1|||
19714908|NCT00363311|42157937|FG001|Overall Study|Participant Refused Biopsy|0|||
19714909|NCT00363311|42157936|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
19714910|NCT00363311|42157937|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
19714911|NCT00363311|42157936|FG000|Overall Study|Participant Opted for Treatment|1|||
19714912|NCT00363311|42157937|FG001|Overall Study|Participant Opted for Treatment|0|||
19714913|NCT00363311|42157936|FG000|Overall Study|Participant Moved to Another Country|1|||
19714914|NCT00363311|42157937|FG001|Overall Study|Participant Moved to Another Country|0|||
19714915|NCT00363311|42157936|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
19714916|NCT00363311|42157937|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
19714917|NCT00363311|42157936|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
19714918|NCT00363311|42157937|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
19714919|NCT00363311|42157936|FG000|Overall Study|Participant Moved to Louisiana|0|||
19714920|NCT00363311|42157937|FG001|Overall Study|Participant Moved to Louisiana|1|||
19714921|NCT00362609|42157945|FG000|Overall Study|Withdrawal by Subject|0|||
19714922|NCT00362609|42157946|FG001|Overall Study|Withdrawal by Subject|1|||
19714923|NCT00362609|42157945|FG000|Overall Study|Protocol Violation|0|||
19714924|NCT00362609|42157946|FG001|Overall Study|Protocol Violation|1|||
19714925|NCT00362375|42157954|FG000|Overall Study|Lost to Follow-up|40|||
19714926|NCT00362375|42157955|FG001|Overall Study|Lost to Follow-up|35|||
19714927|NCT00362297|42157963|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
19714928|NCT00362297|42157964|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
19714929|NCT00065442|42157972|FG000|Overall Study|Lost to Follow-up|1|||
19714930|NCT00065442|42157973|FG001|Overall Study|Lost to Follow-up|1|||
19714931|NCT00065442|42157972|FG000|Overall Study|Death|121|||
19714932|NCT00065442|42157973|FG001|Overall Study|Death|210|||
19714933|NCT00065442|42157972|FG000|Overall Study|Withdrawal by Subject|3|||
19714934|NCT00065442|42157973|FG001|Overall Study|Withdrawal by Subject|9|||
19714935|NCT00090402|42157982|FG000|Overall Study|Death|1|||
19714936|NCT00090402|42157983|FG001|Overall Study|Death|1|||
19714937|NCT00090402|42157984|FG002|Overall Study|Death|0|||
19714938|NCT00090402|42157982|FG000|Overall Study|subject moved|0|||
19714939|NCT00090402|42157983|FG001|Overall Study|subject moved|1|||
19714940|NCT00090402|42157984|FG002|Overall Study|subject moved|0|||
19714941|NCT00090402|42157982|FG000|Overall Study|stopped taking study medication|1|||
19714942|NCT00090402|42157983|FG001|Overall Study|stopped taking study medication|0|||
19714943|NCT00090402|42157984|FG002|Overall Study|stopped taking study medication|1|||
19714944|NCT00361283|42157995|FG000|Overall Study|Lost to Follow-up|27|||
19714945|NCT00077064|42158001|FG000|Overall Study|Adverse Event|0|||
19714946|NCT00077064|42158002|FG001|Overall Study|Adverse Event|4|||
19714947|NCT00077064|42158001|FG000|Overall Study|Patient refusal|0|||
19714948|NCT00077064|42158002|FG001|Overall Study|Patient refusal|2|||
19714949|NCT00396383|42158009|FG000|Overall Study|Death|2|||
19714950|NCT00396383|42158009|FG000|Overall Study|Lost to Follow-up|1|||
19714951|NCT00395447|42158015|FG000|Overall Study|Death|37|||
19714952|NCT00395447|42158016|FG001|Overall Study|Death|32|||
19714953|NCT00395447|42158015|FG000|Overall Study|Lost to Follow-up|52|||
19714954|NCT00395447|42158016|FG001|Overall Study|Lost to Follow-up|43|||
19714955|NCT00395447|42158015|FG000|Overall Study|Withdrawal by Subject|24|||
19714956|NCT00395447|42158016|FG001|Overall Study|Withdrawal by Subject|19|||
19714957|NCT00395447|42158015|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
19714958|NCT00395447|42158016|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
19714959|NCT03404674|42158028|FG000|Overall Study|Inability to Attend Future Visits|0|||
19714960|NCT03404674|42158029|FG001|Overall Study|Inability to Attend Future Visits|1|||
19714961|NCT03404674|42158030|FG002|Overall Study|Inability to Attend Future Visits|1|||
19714962|NCT03404674|42158031|FG003|Overall Study|Inability to Attend Future Visits|0|||
19714963|NCT03404674|42158032|FG004|Overall Study|Inability to Attend Future Visits|0|||
19714964|NCT03404674|42158033|FG005|Overall Study|Inability to Attend Future Visits|0|||
19714965|NCT03404674|42158028|FG000|Overall Study|Behavioral Problems|0|||
19714966|NCT03404674|42158029|FG001|Overall Study|Behavioral Problems|0|||
19714967|NCT03404674|42158030|FG002|Overall Study|Behavioral Problems|1|||
19714968|NCT03404674|42158031|FG003|Overall Study|Behavioral Problems|0|||
19714969|NCT03404674|42158032|FG004|Overall Study|Behavioral Problems|0|||
19714970|NCT03404674|42158033|FG005|Overall Study|Behavioral Problems|0|||
19714971|NCT03404674|42158028|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
19714972|NCT03404674|42158029|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
19714973|NCT03404674|42158030|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
19714974|NCT03404674|42158031|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
19714975|NCT03404674|42158032|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
19714976|NCT03404674|42158033|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
19714977|NCT00064662|42158050|FG000|Overall Study|Death|1|||
19714978|NCT00064662|42158051|FG001|Overall Study|Death|1|||
19714979|NCT00064662|42158050|FG000|Overall Study|Lost to Follow-up|57|||
19714980|NCT00064662|42158051|FG001|Overall Study|Lost to Follow-up|44|||
19714981|NCT00064662|42158050|FG000|Overall Study|Withdrawal by Subject|14|||
19714982|NCT00064662|42158051|FG001|Overall Study|Withdrawal by Subject|14|||
19714983|NCT00064662|42158050|FG000|Overall Study|Administratively withdrawn|2|||
19714984|NCT00064662|42158051|FG001|Overall Study|Administratively withdrawn|2|||
19714985|NCT03404518|42158059|FG000|Overall Study|Lost to Follow-up|28|||
19714986|NCT03404518|42158060|FG001|Overall Study|Lost to Follow-up|30|||
19714987|NCT03404518|42158059|FG000|Overall Study|Protocol Violation|13|||
19714988|NCT03404518|42158060|FG001|Overall Study|Protocol Violation|6|||
19714989|NCT03404206|42158069|FG000|Overall Study|Withdrawal by Subject|1|||
19714990|NCT03404206|42158070|FG001|Overall Study|Withdrawal by Subject|1|||
19714991|NCT03404206|42158071|FG002|Overall Study|Withdrawal by Subject|0|||
19714992|NCT03404206|42158069|FG000|Overall Study|Lost to Follow-up|3|||
19714993|NCT03404206|42158070|FG001|Overall Study|Lost to Follow-up|1|||
19714994|NCT03404206|42158071|FG002|Overall Study|Lost to Follow-up|0|||
19714995|NCT03403426|42158079|FG000|Overall Study|Death|1|||
19714996|NCT03403426|42158079|FG000|Overall Study|Lost to Follow-up|2|||
19714997|NCT00394901|42158087|FG000|Baseline Phase|Protocol Violation|0|||
19714998|NCT00394901|42158088|FG001|Baseline Phase|Protocol Violation|0|||
19714999|NCT00394901|42158089|FG002|Baseline Phase|Protocol Violation|1|||
19715000|NCT00394901|42158090|FG003|Baseline Phase|Protocol Violation|0|||
19715001|NCT00394901|42158087|FG000|Double-blind Phase|Adverse Event|5|||
19715002|NCT00394901|42158088|FG001|Double-blind Phase|Adverse Event|7|||
19715003|NCT00394901|42158089|FG002|Double-blind Phase|Adverse Event|16|||
19715004|NCT00394901|42158090|FG003|Double-blind Phase|Adverse Event|20|||
19715005|NCT00394901|42158087|FG000|Double-blind Phase|Lack of Efficacy|6|||
19715006|NCT00394901|42158088|FG001|Double-blind Phase|Lack of Efficacy|4|||
19715007|NCT00394901|42158089|FG002|Double-blind Phase|Lack of Efficacy|1|||
19715008|NCT00394901|42158090|FG003|Double-blind Phase|Lack of Efficacy|3|||
19715009|NCT00394901|42158087|FG000|Double-blind Phase|Withdrawal by Subject|2|||
19715010|NCT00394901|42158088|FG001|Double-blind Phase|Withdrawal by Subject|0|||
19715011|NCT00394901|42158089|FG002|Double-blind Phase|Withdrawal by Subject|0|||
19715012|NCT00394901|42158090|FG003|Double-blind Phase|Withdrawal by Subject|0|||
19715013|NCT00394901|42158087|FG000|Double-blind Phase|Lost to Follow-up|0|||
19715014|NCT00394901|42158088|FG001|Double-blind Phase|Lost to Follow-up|0|||
19715015|NCT00394901|42158089|FG002|Double-blind Phase|Lost to Follow-up|0|||
19715016|NCT00394901|42158090|FG003|Double-blind Phase|Lost to Follow-up|1|||
19715017|NCT00394901|42158087|FG000|Double-blind Phase|Protocol Violation|0|||
19715018|NCT00394901|42158088|FG001|Double-blind Phase|Protocol Violation|0|||
19715019|NCT00394901|42158089|FG002|Double-blind Phase|Protocol Violation|0|||
19715020|NCT00394901|42158090|FG003|Double-blind Phase|Protocol Violation|1|||
19715021|NCT00394901|42158087|FG000|Double-blind Phase|Death|1|||
19715022|NCT00394901|42158088|FG001|Double-blind Phase|Death|0|||
19715023|NCT00394901|42158089|FG002|Double-blind Phase|Death|0|||
19715024|NCT00394901|42158090|FG003|Double-blind Phase|Death|0|||
19715025|NCT00394901|42158087|FG000|Double-blind Phase|Subject's Personal Reason|1|||
19715026|NCT00394901|42158088|FG001|Double-blind Phase|Subject's Personal Reason|0|||
19715027|NCT00394901|42158089|FG002|Double-blind Phase|Subject's Personal Reason|0|||
19715028|NCT00394901|42158090|FG003|Double-blind Phase|Subject's Personal Reason|1|||
19715029|NCT00394901|42158087|FG000|Double-blind Phase|Lack of Compliance|0|||
19715030|NCT00394901|42158088|FG001|Double-blind Phase|Lack of Compliance|3|||
19715031|NCT00394901|42158089|FG002|Double-blind Phase|Lack of Compliance|0|||
19715032|NCT00394901|42158090|FG003|Double-blind Phase|Lack of Compliance|0|||
19715033|NCT00394901|42158087|FG000|Double-blind Phase|Entry into another study was found|0|||
19715034|NCT00394901|42158088|FG001|Double-blind Phase|Entry into another study was found|0|||
19715035|NCT00394901|42158089|FG002|Double-blind Phase|Entry into another study was found|1|||
19715036|NCT00394901|42158090|FG003|Double-blind Phase|Entry into another study was found|0|||
19715037|NCT00394901|42158087|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
19715038|NCT00394901|42158088|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
19715039|NCT00394901|42158089|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
19715040|NCT00394901|42158090|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
19715041|NCT03349060|42158106|FG000|Overall Study|Adverse Event|9|||
19715042|NCT03349060|42158107|FG001|Overall Study|Adverse Event|9|||
19715043|NCT03349060|42158108|FG002|Overall Study|Adverse Event|7|||
19715044|NCT03349060|42158106|FG000|Overall Study|Lack of Efficacy|1|||
19715045|NCT03349060|42158107|FG001|Overall Study|Lack of Efficacy|0|||
19715046|NCT03349060|42158108|FG002|Overall Study|Lack of Efficacy|2|||
19715047|NCT03349060|42158106|FG000|Overall Study|Lost to Follow-up|2|||
19715048|NCT03349060|42158107|FG001|Overall Study|Lost to Follow-up|1|||
19715049|NCT03349060|42158108|FG002|Overall Study|Lost to Follow-up|1|||
19715050|NCT03349060|42158106|FG000|Overall Study|Protocol Violation|2|||
19715051|NCT03349060|42158107|FG001|Overall Study|Protocol Violation|2|||
19715052|NCT03349060|42158108|FG002|Overall Study|Protocol Violation|1|||
19715053|NCT03349060|42158106|FG000|Overall Study|Withdrawal by Subject|5|||
19715054|NCT03349060|42158107|FG001|Overall Study|Withdrawal by Subject|3|||
19715055|NCT03349060|42158108|FG002|Overall Study|Withdrawal by Subject|4|||
19715056|NCT03349060|42158106|FG000|Overall Study|Medication error,no linked adverse event|0|||
19715057|NCT03349060|42158107|FG001|Overall Study|Medication error,no linked adverse event|0|||
19715058|NCT03349060|42158108|FG002|Overall Study|Medication error,no linked adverse event|1|||
19715059|NCT03349060|42158106|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
19715060|NCT03349060|42158107|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
19715061|NCT03349060|42158108|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
19715062|NCT03349060|42158106|FG000|Overall Study|Other|2|||
19715063|NCT03349060|42158107|FG001|Overall Study|Other|1|||
19715064|NCT03349060|42158108|FG002|Overall Study|Other|0|||
19715065|NCT03348904|42158119|FG000|Overall Study|Administrative reason by the sponsor|0|||
19715066|NCT03348904|42158120|FG001|Overall Study|Administrative reason by the sponsor|1|||
19715067|NCT03348904|42158121|FG002|Overall Study|Administrative reason by the sponsor|0|||
19715068|NCT00359021|42158131|FG000|Overall Study|Adverse Event|26|||
19715069|NCT00359021|42158132|FG001|Overall Study|Adverse Event|8|||
19715070|NCT00359021|42158131|FG000|Overall Study|Subject Non-Compliant|1|||
19715071|NCT00359021|42158132|FG001|Overall Study|Subject Non-Compliant|2|||
19715072|NCT00359021|42158131|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
19715073|NCT00359021|42158132|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
19715074|NCT00359021|42158131|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
19715075|NCT00359021|42158132|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
19715076|NCT00359021|42158131|FG000|Overall Study|Withdrawal by Subject|2|||
19715077|NCT00359021|42158132|FG001|Overall Study|Withdrawal by Subject|9|||
19715078|NCT00359021|42158131|FG000|Overall Study|Lost to Follow-up|1|||
19715079|NCT00359021|42158132|FG001|Overall Study|Lost to Follow-up|0|||
19715080|NCT00359021|42158131|FG000|Overall Study|Other|4|||
19715081|NCT00359021|42158132|FG001|Overall Study|Other|1|||
19715082|NCT00359021|42158131|FG000|Overall Study|Pregnancy|1|||
19715083|NCT00359021|42158132|FG001|Overall Study|Pregnancy|0|||
19715084|NCT00064350|42158143|FG000|Induction Treatment|Disease Progression|5|||
19715085|NCT00064350|42158144|FG001|Induction Treatment|Disease Progression|1|||
19715086|NCT00064350|42158145|FG002|Induction Treatment|Disease Progression|110|||
19715087|NCT00064350|42158143|FG000|Induction Treatment|Adverse Event|0|||
19715088|NCT00064350|42158144|FG001|Induction Treatment|Adverse Event|2|||
19715089|NCT00064350|42158145|FG002|Induction Treatment|Adverse Event|49|||
19715090|NCT00064350|42158143|FG000|Induction Treatment|Death|0|||
19715091|NCT00064350|42158144|FG001|Induction Treatment|Death|0|||
19715092|NCT00064350|42158145|FG002|Induction Treatment|Death|9|||
19715093|NCT00064350|42158143|FG000|Induction Treatment|Withdrawal by Subject|0|||
19715094|NCT00064350|42158144|FG001|Induction Treatment|Withdrawal by Subject|0|||
19715095|NCT00064350|42158145|FG002|Induction Treatment|Withdrawal by Subject|21|||
19715096|NCT00064350|42158143|FG000|Induction Treatment|Ineligible or never started treatment|3|||
19715097|NCT00064350|42158144|FG001|Induction Treatment|Ineligible or never started treatment|6|||
19715098|NCT00064350|42158145|FG002|Induction Treatment|Ineligible or never started treatment|34|||
19715099|NCT00064350|42158143|FG000|Induction Treatment|Other|0|||
19715100|NCT00064350|42158144|FG001|Induction Treatment|Other|0|||
19715101|NCT00064350|42158145|FG002|Induction Treatment|Other|13|||
19715102|NCT00064350|42158143|FG000|Randomization|Adverse Event|8|||
19715103|NCT00064350|42158144|FG001|Randomization|Adverse Event|3|||
19715104|NCT00064350|42158145|FG002|Randomization|Adverse Event|0|||
19715105|NCT00064350|42158143|FG000|Randomization|Death|3|||
19715106|NCT00064350|42158144|FG001|Randomization|Death|0|||
19715107|NCT00064350|42158145|FG002|Randomization|Death|0|||
19715108|NCT00064350|42158143|FG000|Randomization|Withdrawal by Subject|1|||
19715109|NCT00064350|42158144|FG001|Randomization|Withdrawal by Subject|0|||
19715110|NCT00064350|42158145|FG002|Randomization|Withdrawal by Subject|0|||
19715111|NCT00064350|42158143|FG000|Randomization|Ineligible or never started treatment|9|||
19715112|NCT00064350|42158144|FG001|Randomization|Ineligible or never started treatment|15|||
19715113|NCT00064350|42158145|FG002|Randomization|Ineligible or never started treatment|0|||
19715114|NCT00064350|42158143|FG000|Randomization|Other|5|||
19715115|NCT00064350|42158144|FG001|Randomization|Other|0|||
19715116|NCT00064350|42158145|FG002|Randomization|Other|0|||
19715117|NCT00064350|42158143|FG000|Cross-Over|Adverse Event|0|||
19715118|NCT00064350|42158144|FG001|Cross-Over|Adverse Event|1|||
19715119|NCT00064350|42158145|FG002|Cross-Over|Adverse Event|0|||
19715120|NCT00064350|42158143|FG000|Cross-Over|Death|1|||
19715121|NCT00064350|42158144|FG001|Cross-Over|Death|3|||
19715122|NCT00064350|42158145|FG002|Cross-Over|Death|0|||
19715123|NCT00064350|42158143|FG000|Cross-Over|Withdrawal by Subject|2|||
19715124|NCT00064350|42158144|FG001|Cross-Over|Withdrawal by Subject|2|||
19715125|NCT00064350|42158145|FG002|Cross-Over|Withdrawal by Subject|0|||
19715126|NCT00064350|42158143|FG000|Cross-Over|Ineligible or never started treatment|3|||
19715127|NCT00064350|42158144|FG001|Cross-Over|Ineligible or never started treatment|6|||
19715128|NCT00064350|42158145|FG002|Cross-Over|Ineligible or never started treatment|0|||
19715129|NCT00064350|42158143|FG000|Cross-Over|Other|0|||
19715130|NCT00064350|42158144|FG001|Cross-Over|Other|2|||
19715131|NCT00064350|42158145|FG002|Cross-Over|Other|0|||
19715132|NCT00360269|42158156|FG000|Overall Study|Lost to Follow-up|7|||
19715133|NCT00360269|42158157|FG001|Overall Study|Lost to Follow-up|9|||
19715134|NCT00360269|42158156|FG000|Overall Study|Physician Decision|1|||
19715135|NCT00360269|42158157|FG001|Overall Study|Physician Decision|2|||
19715136|NCT00360269|42158156|FG000|Overall Study|Adverse Event|1|||
19715137|NCT00360269|42158157|FG001|Overall Study|Adverse Event|0|||
19715138|NCT00360269|42158156|FG000|Overall Study|Withdrawal by Subject|1|||
19459082|NCT01396161|41713139|FG000|Overall Study|Other|0|||
19715139|NCT00360269|42158157|FG001|Overall Study|Withdrawal by Subject|1|||
19715140|NCT00076752|42158163|FG000|Overall Study|Death|2|||
19715141|NCT00076752|42158163|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
19715142|NCT03384940|42158171|FG000|Overall Study|Progressive disease|36|||
19715143|NCT03384940|42158172|FG001|Overall Study|Progressive disease|11|||
19715144|NCT03384940|42158173|FG002|Overall Study|Progressive disease|13|||
19715145|NCT03384940|42158171|FG000|Overall Study|Clinical progression|4|||
19715146|NCT03384940|42158172|FG001|Overall Study|Clinical progression|0|||
19715147|NCT03384940|42158173|FG002|Overall Study|Clinical progression|3|||
19715148|NCT03384940|42158171|FG000|Overall Study|Adverse Event|7|||
19715149|NCT03384940|42158172|FG001|Overall Study|Adverse Event|1|||
19715150|NCT03384940|42158173|FG002|Overall Study|Adverse Event|1|||
19715151|NCT03384940|42158171|FG000|Overall Study|Withdrawal by Subject|3|||
19715152|NCT03384940|42158172|FG001|Overall Study|Withdrawal by Subject|1|||
19715153|NCT03384940|42158173|FG002|Overall Study|Withdrawal by Subject|0|||
19715154|NCT03384940|42158171|FG000|Overall Study|Physician Decision|1|||
19715155|NCT03384940|42158172|FG001|Overall Study|Physician Decision|1|||
19715156|NCT03384940|42158173|FG002|Overall Study|Physician Decision|0|||
19715157|NCT03384940|42158171|FG000|Overall Study|Death|2|||
19715158|NCT03384940|42158172|FG001|Overall Study|Death|1|||
19715159|NCT03384940|42158173|FG002|Overall Study|Death|0|||
19715160|NCT03384940|42158171|FG000|Overall Study|Other|0|||
19715161|NCT03384940|42158172|FG001|Overall Study|Other|0|||
19715162|NCT03384940|42158173|FG002|Overall Study|Other|1|||
19715163|NCT00075582|42158183|FG000|Overall Study|Adverse Event|3|||
19715164|NCT00075582|42158184|FG001|Overall Study|Adverse Event|1|||
19715165|NCT00075582|42158183|FG000|Overall Study|Lack of Efficacy|4|||
19715166|NCT00075582|42158184|FG001|Overall Study|Lack of Efficacy|8|||
19715167|NCT00075582|42158183|FG000|Overall Study|Physician Decision|5|||
19715168|NCT00075582|42158184|FG001|Overall Study|Physician Decision|8|||
19715169|NCT00075582|42158183|FG000|Overall Study|Withdrawal by Subject|2|||
19715170|NCT00075582|42158184|FG001|Overall Study|Withdrawal by Subject|2|||
19715171|NCT00075582|42158183|FG000|Overall Study|Ineligible for study|36|||
19715172|NCT00075582|42158184|FG001|Overall Study|Ineligible for study|16|||
19715173|NCT00063258|42158196|FG000|Overall Study|Physician Decision|2|||
19715174|NCT00063258|42158197|FG001|Overall Study|Physician Decision|0|||
19715175|NCT00063258|42158196|FG000|Overall Study|Lack of Efficacy|2|||
19715176|NCT00063258|42158197|FG001|Overall Study|Lack of Efficacy|0|||
19715177|NCT00088530|42158205|FG000|Overall Study|Progressive/Relapsed Disease|28|||
19715178|NCT00088530|42158206|FG001|Overall Study|Progressive/Relapsed Disease|39|||
19715179|NCT00088530|42158205|FG000|Overall Study|Adverse Event|15|||
19715180|NCT00088530|42158206|FG001|Overall Study|Adverse Event|9|||
19715181|NCT00088530|42158205|FG000|Overall Study|Withdrawal by Subject|2|||
19715182|NCT00088530|42158206|FG001|Overall Study|Withdrawal by Subject|5|||
19715183|NCT00088530|42158205|FG000|Overall Study|Lost to Follow-up|2|||
19715184|NCT00088530|42158206|FG001|Overall Study|Lost to Follow-up|0|||
19715185|NCT00088530|42158205|FG000|Overall Study|Physician Decision|2|||
19715186|NCT00088530|42158206|FG001|Overall Study|Physician Decision|0|||
19715187|NCT00088530|42158205|FG000|Overall Study|Sponsor decision|0|||
19715188|NCT00088530|42158206|FG001|Overall Study|Sponsor decision|1|||
19715189|NCT00088530|42158205|FG000|Overall Study|Patient never treated|1|||
19715190|NCT00088530|42158206|FG001|Overall Study|Patient never treated|0|||
19715191|NCT00359801|42158214|FG000|Overall Study|Lost to Follow-up|72|||
19715192|NCT00359801|42158215|FG001|Overall Study|Lost to Follow-up|58|||
19715193|NCT00359801|42158214|FG000|Overall Study|Withdrawal by Subject|143|||
19715194|NCT00359801|42158215|FG001|Overall Study|Withdrawal by Subject|96|||
19715195|NCT00359801|42158214|FG000|Overall Study|Other|66|||
19715196|NCT00359801|42158215|FG001|Overall Study|Other|46|||
19715197|NCT00359801|42158214|FG000|Overall Study|Final Status Unknown: missing data|7|||
19715198|NCT00359801|42158215|FG001|Overall Study|Final Status Unknown: missing data|4|||
19715199|NCT00359801|42158214|FG000|Overall Study|Sponsor Decision|17|||
19715200|NCT00359801|42158215|FG001|Overall Study|Sponsor Decision|16|||
19715201|NCT00045032|42158224|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
19715202|NCT00045032|42158225|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
19715203|NCT00045032|42158226|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
19715204|NCT00045032|42158224|FG000|Overall Study|Death|22|||
19715205|NCT00045032|42158225|FG001|Overall Study|Death|24|||
19715206|NCT00045032|42158226|FG002|Overall Study|Death|17|||
19715207|NCT00045032|42158224|FG000|Overall Study|Insufficient Therapeutic Response|542|||
19715208|NCT00045032|42158225|FG001|Overall Study|Insufficient Therapeutic Response|437|||
19715209|NCT00045032|42158226|FG002|Overall Study|Insufficient Therapeutic Response|445|||
19715210|NCT00045032|42158224|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
19715211|NCT00045032|42158225|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
19715212|NCT00045032|42158226|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
19715213|NCT00045032|42158224|FG000|Overall Study|Other Protocol Violation|2|||
19715214|NCT00045032|42158225|FG001|Overall Study|Other Protocol Violation|0|||
19715215|NCT00045032|42158226|FG002|Overall Study|Other Protocol Violation|1|||
19715216|NCT00045032|42158224|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
19715217|NCT00045032|42158225|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
19715218|NCT00045032|42158226|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
19715219|NCT00045032|42158224|FG000|Overall Study|Failure to Return|57|||
19715220|NCT00045032|42158225|FG001|Overall Study|Failure to Return|62|||
19715221|NCT00045032|42158226|FG002|Overall Study|Failure to Return|61|||
19715222|NCT00045032|42158224|FG000|Overall Study|Other|93|||
19715223|NCT00045032|42158225|FG001|Overall Study|Other|84|||
19715224|NCT00045032|42158226|FG002|Overall Study|Other|105|||
19715225|NCT00356915|42158239|FG000|Overall Study|Non compliance|1|||
19715226|NCT00356915|42158240|FG001|Overall Study|Non compliance|2|||
19715227|NCT00356915|42158241|FG002|Overall Study|Non compliance|1|||
19715228|NCT00356915|42158239|FG000|Overall Study|Protocol Violation|2|||
19715229|NCT00356915|42158240|FG001|Overall Study|Protocol Violation|3|||
19715230|NCT00356915|42158241|FG002|Overall Study|Protocol Violation|2|||
19715231|NCT00356915|42158239|FG000|Overall Study|Withdrawal by Subject|14|||
19715232|NCT00356915|42158240|FG001|Overall Study|Withdrawal by Subject|14|||
19715233|NCT00356915|42158241|FG002|Overall Study|Withdrawal by Subject|10|||
19715234|NCT00356915|42158239|FG000|Overall Study|Lack of Efficacy|0|||
19715235|NCT00356915|42158240|FG001|Overall Study|Lack of Efficacy|0|||
19715236|NCT00356915|42158241|FG002|Overall Study|Lack of Efficacy|3|||
19715237|NCT00356915|42158239|FG000|Overall Study|Lost to Follow-up|27|||
19715238|NCT00356915|42158240|FG001|Overall Study|Lost to Follow-up|34|||
19715239|NCT00356915|42158241|FG002|Overall Study|Lost to Follow-up|14|||
19715240|NCT00356915|42158239|FG000|Overall Study|Administrative Decision|0|||
19715241|NCT00356915|42158240|FG001|Overall Study|Administrative Decision|0|||
19715242|NCT00356915|42158241|FG002|Overall Study|Administrative Decision|1|||
19715243|NCT00356915|42158239|FG000|Overall Study|Physician Decision|0|||
19715244|NCT00356915|42158240|FG001|Overall Study|Physician Decision|2|||
19715245|NCT00356915|42158241|FG002|Overall Study|Physician Decision|0|||
19715246|NCT00356915|42158239|FG000|Overall Study|Adverse Event|21|||
19715247|NCT00356915|42158240|FG001|Overall Study|Adverse Event|31|||
19715248|NCT00356915|42158241|FG002|Overall Study|Adverse Event|8|||
19715249|NCT00356915|42158239|FG000|Overall Study|Miscellaneous reasons|11|||
19715250|NCT00356915|42158240|FG001|Overall Study|Miscellaneous reasons|8|||
19715251|NCT00356915|42158241|FG002|Overall Study|Miscellaneous reasons|3|||
19715252|NCT00356759|42158257|FG000|Overall Study|Death|5|||
19715253|NCT00356759|42158258|FG001|Overall Study|Death|2|||
19715254|NCT00356759|42158257|FG000|Overall Study|Withdrawal by Subject|2|||
19715255|NCT00356759|42158258|FG001|Overall Study|Withdrawal by Subject|2|||
19715256|NCT00356759|42158257|FG000|Overall Study|Adverse Event|1|||
19715257|NCT00356759|42158258|FG001|Overall Study|Adverse Event|3|||
19715258|NCT00356759|42158257|FG000|Overall Study|Lost to Follow-up|1|||
19715259|NCT00356759|42158258|FG001|Overall Study|Lost to Follow-up|1|||
19715260|NCT00356759|42158257|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
19715261|NCT00356759|42158258|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
19715262|NCT03804710|42158266|FG000|Overall Study|Adverse Event|0|||
19715263|NCT03804710|42158267|FG001|Overall Study|Adverse Event|3|||
19715264|NCT03804710|42158266|FG000|Overall Study|Withdrawal by Subject|2|||
19715265|NCT03804710|42158267|FG001|Overall Study|Withdrawal by Subject|1|||
19715266|NCT03804710|42158266|FG000|Overall Study|Other|0|||
19715267|NCT03804710|42158267|FG001|Overall Study|Other|1|||
19715268|NCT00356603|42158279|FG000|Overall Study|Other|6|||
19715269|NCT00356603|42158280|FG001|Overall Study|Other|3|||
19715270|NCT00002558|42158290|FG000|Overall Study|Withdrawal by Subject|0|||
19715271|NCT00002558|42158291|FG001|Overall Study|Withdrawal by Subject|1|||
19715272|NCT00002540|42158299|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
19715273|NCT00002540|42158300|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
19715274|NCT00002540|42158299|FG000|Overall Study|Died Before Randomization|2|||
19715275|NCT00002540|42158300|FG001|Overall Study|Died Before Randomization|6|||
19715276|NCT00002540|42158299|FG000|Overall Study|Died Before ASU (Control)|202|||
19715277|NCT00002540|42158300|FG001|Overall Study|Died Before ASU (Control)|0|||
19715278|NCT00002540|42158299|FG000|Overall Study|Refused ASU (Control)|597|||
19715279|NCT00002540|42158300|FG001|Overall Study|Refused ASU (Control)|0|||
19715280|NCT00002540|42158299|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
19715281|NCT00002540|42158300|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
19715282|NCT00001880|42158306|FG000|Overall Study|Death|14|||
19715283|NCT00043550|42158313|FG000|Overall Study|Withdrawal by Subject|22|||
19715284|NCT00043550|42158314|FG001|Overall Study|Withdrawal by Subject|12|||
19715285|NCT00043550|42158315|FG002|Overall Study|Withdrawal by Subject|20|||
19715286|NCT00041756|42158328|FG000|Overall Study|Adverse Event|4|||
19715287|NCT00041756|42158329|FG001|Overall Study|Adverse Event|10|||
19715288|NCT00041756|42158330|FG002|Overall Study|Adverse Event|6|||
19715289|NCT00041756|42158331|FG003|Overall Study|Adverse Event|11|||
19715290|NCT00041756|42158332|FG004|Overall Study|Adverse Event|34|||
19715291|NCT00041756|42158328|FG000|Overall Study|Protocol Violation|1|||
19715292|NCT00041756|42158329|FG001|Overall Study|Protocol Violation|1|||
19715293|NCT00041756|42158330|FG002|Overall Study|Protocol Violation|2|||
19715294|NCT00041756|42158331|FG003|Overall Study|Protocol Violation|2|||
19715295|NCT00041756|42158332|FG004|Overall Study|Protocol Violation|1|||
19715296|NCT00041756|42158328|FG000|Overall Study|Withdrawal by Subject|3|||
19715297|NCT00041756|42158329|FG001|Overall Study|Withdrawal by Subject|3|||
19715298|NCT00041756|42158330|FG002|Overall Study|Withdrawal by Subject|4|||
19715299|NCT00041756|42158331|FG003|Overall Study|Withdrawal by Subject|2|||
19715300|NCT00041756|42158332|FG004|Overall Study|Withdrawal by Subject|3|||
19715301|NCT00041756|42158328|FG000|Overall Study|Lost to Follow-up|0|||
19715302|NCT00041756|42158329|FG001|Overall Study|Lost to Follow-up|1|||
19715303|NCT00041756|42158330|FG002|Overall Study|Lost to Follow-up|0|||
19715304|NCT00041756|42158331|FG003|Overall Study|Lost to Follow-up|1|||
19715305|NCT00041756|42158332|FG004|Overall Study|Lost to Follow-up|0|||
19715306|NCT00041756|42158328|FG000|Overall Study|Unable to meet protocol criteria|0|||
19715307|NCT00041756|42158329|FG001|Overall Study|Unable to meet protocol criteria|0|||
19715308|NCT00041756|42158330|FG002|Overall Study|Unable to meet protocol criteria|1|||
19715309|NCT00041756|42158331|FG003|Overall Study|Unable to meet protocol criteria|0|||
19715310|NCT00041756|42158332|FG004|Overall Study|Unable to meet protocol criteria|1|||
19715311|NCT00041756|42158328|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
19715312|NCT00041756|42158329|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
19715313|NCT00041756|42158330|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
19715314|NCT00041756|42158331|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
19715315|NCT00041756|42158332|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
19715316|NCT00041132|42158344|FG000|Overall Study|Adverse Event|19|||
19715317|NCT00041132|42158344|FG000|Overall Study|Death|1|||
19715318|NCT00041132|42158344|FG000|Overall Study|Not Eligible|7|||
19715319|NCT00041132|42158344|FG000|Overall Study|Withdrawal by Subject|1|||
19715320|NCT00041132|42158344|FG000|Overall Study|Physician Decision|2|||
19715321|NCT00040742|42158352|FG000|Overall Study|Death|0|||
19715322|NCT00040742|42158353|FG001|Overall Study|Death|0|||
19715323|NCT00040742|42158354|FG002|Overall Study|Death|1|||
19715324|NCT00040742|42158355|FG003|Overall Study|Death|0|||
19715325|NCT00040742|42158352|FG000|Overall Study|Adverse Event|15|||
19715326|NCT00040742|42158353|FG001|Overall Study|Adverse Event|16|||
19715327|NCT00040742|42158354|FG002|Overall Study|Adverse Event|21|||
19715328|NCT00040742|42158355|FG003|Overall Study|Adverse Event|9|||
19715329|NCT00040742|42158352|FG000|Overall Study|Withdrawal by Subject|7|||
19715330|NCT00040742|42158353|FG001|Overall Study|Withdrawal by Subject|15|||
19715331|NCT00040742|42158354|FG002|Overall Study|Withdrawal by Subject|10|||
19715332|NCT00040742|42158355|FG003|Overall Study|Withdrawal by Subject|13|||
19715333|NCT00040742|42158352|FG000|Overall Study|Chemotoxicity|4|||
19545079|NCT00471237|41994658|FG003|Overall Study|Sponsor terminated study|22|||
19545080|NCT00471237|41994659|FG004|Overall Study|Sponsor terminated study|18|||
19545081|NCT00471237|41994660|FG005|Overall Study|Sponsor terminated study|24|||
19545082|NCT00471237|41994661|FG006|Overall Study|Sponsor terminated study|0|||
19545083|NCT00471237|41994655|FG000|Overall Study|Non-compliance|0|||
19545084|NCT00471237|41994656|FG001|Overall Study|Non-compliance|1|||
19545085|NCT00471237|41994657|FG002|Overall Study|Non-compliance|0|||
19545086|NCT00471237|41994658|FG003|Overall Study|Non-compliance|1|||
19545087|NCT00471237|41994659|FG004|Overall Study|Non-compliance|0|||
19545088|NCT00471237|41994660|FG005|Overall Study|Non-compliance|0|||
19545089|NCT00471237|41994661|FG006|Overall Study|Non-compliance|0|||
19545090|NCT00471237|41994655|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
19545091|NCT00471237|41994656|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
19545092|NCT00471237|41994657|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
19545093|NCT00471237|41994658|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
19545094|NCT00471237|41994659|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
19715334|NCT00040742|42158353|FG001|Overall Study|Chemotoxicity|3|||
19715335|NCT00040742|42158354|FG002|Overall Study|Chemotoxicity|5|||
19715336|NCT00040742|42158355|FG003|Overall Study|Chemotoxicity|2|||
19715337|NCT00040742|42158352|FG000|Overall Study|Incomplete Forms|6|||
19715338|NCT00040742|42158353|FG001|Overall Study|Incomplete Forms|10|||
19715339|NCT00040742|42158354|FG002|Overall Study|Incomplete Forms|4|||
19715340|NCT00040742|42158355|FG003|Overall Study|Incomplete Forms|5|||
19715341|NCT00040742|42158352|FG000|Overall Study|Other medical|7|||
19715342|NCT00040742|42158353|FG001|Overall Study|Other medical|5|||
19715343|NCT00040742|42158354|FG002|Overall Study|Other medical|5|||
19715344|NCT00040742|42158355|FG003|Overall Study|Other medical|5|||
19715345|NCT00040664|42158365|FG000|Overall Study|Adverse Event|12|||
19715346|NCT00040664|42158366|FG001|Overall Study|Adverse Event|3|||
19715347|NCT00040664|42158367|FG002|Overall Study|Adverse Event|2|||
19715348|NCT00040664|42158368|FG003|Overall Study|Adverse Event|7|||
19715349|NCT00040664|42158365|FG000|Overall Study|Lack of Efficacy|9|||
19715350|NCT00040664|42158366|FG001|Overall Study|Lack of Efficacy|2|||
19715351|NCT00040664|42158367|FG002|Overall Study|Lack of Efficacy|3|||
19715352|NCT00040664|42158368|FG003|Overall Study|Lack of Efficacy|4|||
19715353|NCT00040664|42158365|FG000|Overall Study|Insufficient CD4 response|1|||
19715354|NCT00040664|42158366|FG001|Overall Study|Insufficient CD4 response|0|||
19715355|NCT00040664|42158367|FG002|Overall Study|Insufficient CD4 response|1|||
19715356|NCT00040664|42158368|FG003|Overall Study|Insufficient CD4 response|0|||
19715357|NCT00040664|42158365|FG000|Overall Study|Lost to Follow-up|4|||
19715358|NCT00040664|42158366|FG001|Overall Study|Lost to Follow-up|2|||
19715359|NCT00040664|42158367|FG002|Overall Study|Lost to Follow-up|0|||
19715360|NCT00040664|42158368|FG003|Overall Study|Lost to Follow-up|2|||
19715361|NCT00040664|42158365|FG000|Overall Study|Protocol Violation|2|||
19715362|NCT00040664|42158366|FG001|Overall Study|Protocol Violation|1|||
19715363|NCT00040664|42158367|FG002|Overall Study|Protocol Violation|0|||
19545095|NCT00471237|41994660|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
19715364|NCT00040664|42158368|FG003|Overall Study|Protocol Violation|1|||
19715365|NCT00040664|42158365|FG000|Overall Study|Withdrawal by Subject|7|||
19715366|NCT00040664|42158366|FG001|Overall Study|Withdrawal by Subject|0|||
19715367|NCT00040664|42158367|FG002|Overall Study|Withdrawal by Subject|3|||
19715368|NCT00040664|42158368|FG003|Overall Study|Withdrawal by Subject|4|||
19715369|NCT00040664|42158365|FG000|Overall Study|Pregnancy|3|||
19715370|NCT00040664|42158366|FG001|Overall Study|Pregnancy|0|||
19715371|NCT00040664|42158367|FG002|Overall Study|Pregnancy|0|||
19715372|NCT00040664|42158368|FG003|Overall Study|Pregnancy|3|||
19715373|NCT00040664|42158365|FG000|Overall Study|Medication adherence/compliance problems|8|||
19715374|NCT00040664|42158366|FG001|Overall Study|Medication adherence/compliance problems|2|||
19715375|NCT00040664|42158367|FG002|Overall Study|Medication adherence/compliance problems|1|||
19715376|NCT00040664|42158368|FG003|Overall Study|Medication adherence/compliance problems|5|||
19715377|NCT00040664|42158365|FG000|Overall Study|Poor taste|2|||
19715378|NCT00040664|42158366|FG001|Overall Study|Poor taste|0|||
19715379|NCT00040664|42158367|FG002|Overall Study|Poor taste|2|||
19715380|NCT00040664|42158368|FG003|Overall Study|Poor taste|0|||
19715381|NCT00040664|42158365|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
19715382|NCT00040664|42158366|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
19715383|NCT00040664|42158367|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
19715384|NCT00040664|42158368|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
19715385|NCT00040664|42158365|FG000|Overall Study|Change of formulation|2|||
19715386|NCT00040664|42158366|FG001|Overall Study|Change of formulation|2|||
19715387|NCT00040664|42158367|FG002|Overall Study|Change of formulation|0|||
19715388|NCT00040664|42158368|FG003|Overall Study|Change of formulation|0|||
19715389|NCT00040664|42158365|FG000|Overall Study|Non-viability of oral suspension|1|||
19715390|NCT00040664|42158366|FG001|Overall Study|Non-viability of oral suspension|0|||
19715391|NCT00040664|42158367|FG002|Overall Study|Non-viability of oral suspension|1|||
19715392|NCT00040664|42158368|FG003|Overall Study|Non-viability of oral suspension|0|||
19715393|NCT02952586|42158388|FG000|Lead-In Phase (7 Days)|Death|0|||
19715394|NCT02952586|42158389|FG001|Lead-In Phase (7 Days)|Death|1|||
19715395|NCT02952586|42158388|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
19715396|NCT02952586|42158389|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
19715397|NCT02952586|42158388|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
19715398|NCT02952586|42158389|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
19715399|NCT02952586|42158388|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
19715400|NCT02952586|42158389|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
19715401|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
19715402|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
19715403|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
19715404|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
19715405|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
19715406|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
19715407|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
19715408|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
19715409|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
19715410|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
19715411|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
19715412|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
19715413|NCT02952586|42158388|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
19715414|NCT02952586|42158389|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
19715415|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Death|3|||
19715416|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Death|8|||
19715417|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
19715418|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
19715419|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
19715420|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
19715421|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
19715422|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
19715423|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
19715424|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
19715425|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
19715426|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
19715427|NCT02952586|42158388|FG000|CRT for Cisplatin (63 Days)|Other|1|||
19715428|NCT02952586|42158389|FG001|CRT for Cisplatin (63 Days)|Other|1|||
19715429|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Death|5|||
19715430|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Death|8|||
19715431|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
19715432|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
19715433|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
19715434|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
19715435|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
19715436|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
19459083|NCT01396161|41713140|FG001|Overall Study|Other|0|||
19715437|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
19715438|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
19715439|NCT02952586|42158388|FG000|CRT for IMRT (63 Days)|Other|1|||
19715440|NCT02952586|42158389|FG001|CRT for IMRT (63 Days)|Other|0|||
19715441|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Death|17|||
19715442|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Death|11|||
19715443|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
19715444|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
19715445|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
19715446|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
19715447|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
19715448|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
19715449|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
19715450|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
19715451|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
19715452|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
19715453|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
19715454|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
19715455|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
19715456|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
19715457|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Other|2|||
19715458|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Other|1|||
19715459|NCT02952586|42158388|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
19715460|NCT02952586|42158389|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
19715461|NCT02952586|42158388|FG000|Follow-Up Phase (90 Days)|Death|12|||
19715462|NCT02952586|42158389|FG001|Follow-Up Phase (90 Days)|Death|10|||
19715463|NCT02952586|42158388|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
19715464|NCT02952586|42158389|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
19715465|NCT02952586|42158388|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
19715466|NCT02952586|42158389|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
19715467|NCT02952586|42158388|FG000|Follow-Up Phase (90 Days)|Other|7|||
19715468|NCT02952586|42158389|FG001|Follow-Up Phase (90 Days)|Other|5|||
19715469|NCT02952586|42158388|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
19715470|NCT02952586|42158389|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
19715471|NCT02952586|42158388|FG000|LT Follow-up (up to 45 Months)|Death|51|||
19715472|NCT02952586|42158389|FG001|LT Follow-up (up to 45 Months)|Death|31|||
19715473|NCT02952586|42158388|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
19715474|NCT02952586|42158389|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
19715475|NCT02952586|42158388|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
19715476|NCT02952586|42158389|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
19715477|NCT02952586|42158388|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
19715478|NCT02952586|42158389|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
19715479|NCT03384316|42158398|FG000|Overall Study|Screen failure|0|||
19715480|NCT03384316|42158399|FG001|Overall Study|Screen failure|1|||
19715481|NCT03403192|42158411|FG000|Overall Study|Lost to Follow-up|1|||
19715482|NCT03403192|42158412|FG001|Overall Study|Lost to Follow-up|2|||
19715483|NCT03403192|42158413|FG002|Overall Study|Lost to Follow-up|0|||
19715484|NCT03403192|42158414|FG003|Overall Study|Lost to Follow-up|0|||
19715485|NCT03403192|42158411|FG000|Overall Study|Unable to respond|0|||
19715486|NCT03403192|42158412|FG001|Overall Study|Unable to respond|1|||
19715487|NCT03403192|42158413|FG002|Overall Study|Unable to respond|0|||
19715488|NCT03403192|42158414|FG003|Overall Study|Unable to respond|0|||
19715489|NCT03403192|42158411|FG000|Overall Study|Incomplete|3|||
19715490|NCT03403192|42158412|FG001|Overall Study|Incomplete|1|||
19715491|NCT03403192|42158413|FG002|Overall Study|Incomplete|3|||
19715492|NCT03403192|42158414|FG003|Overall Study|Incomplete|6|||
19715493|NCT00356525|42158428|FG000|Overall Study|Progressive Disease|8|||
19715494|NCT00356525|42158429|FG001|Overall Study|Progressive Disease|5|||
19715495|NCT00356525|42158430|FG002|Overall Study|Progressive Disease|4|||
19715496|NCT00356525|42158431|FG003|Overall Study|Progressive Disease|2|||
19715497|NCT00356525|42158428|FG000|Overall Study|Adverse Event|1|||
19715498|NCT00356525|42158429|FG001|Overall Study|Adverse Event|3|||
19715499|NCT00356525|42158430|FG002|Overall Study|Adverse Event|1|||
19715500|NCT00356525|42158431|FG003|Overall Study|Adverse Event|1|||
19715501|NCT00356525|42158428|FG000|Overall Study|Lost to Follow-up|1|||
19715502|NCT00356525|42158429|FG001|Overall Study|Lost to Follow-up|0|||
19715503|NCT00356525|42158430|FG002|Overall Study|Lost to Follow-up|0|||
19715504|NCT00356525|42158431|FG003|Overall Study|Lost to Follow-up|0|||
19715505|NCT00356525|42158428|FG000|Overall Study|Physician Decision|2|||
19715506|NCT00356525|42158429|FG001|Overall Study|Physician Decision|2|||
19715507|NCT00356525|42158430|FG002|Overall Study|Physician Decision|2|||
19715508|NCT00356525|42158431|FG003|Overall Study|Physician Decision|1|||
19715509|NCT00356525|42158428|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
19715510|NCT00356525|42158429|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
19459084|NCT01396161|41713141|FG002|Overall Study|Other|0|||
19715511|NCT00356525|42158430|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
19715512|NCT00356525|42158431|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
19715513|NCT00356525|42158428|FG000|Overall Study|Withdrawal by Subject|1|||
19715514|NCT00356525|42158429|FG001|Overall Study|Withdrawal by Subject|1|||
19715515|NCT00356525|42158430|FG002|Overall Study|Withdrawal by Subject|0|||
19715516|NCT00356525|42158431|FG003|Overall Study|Withdrawal by Subject|3|||
19715517|NCT00356525|42158428|FG000|Overall Study|Death|0|||
19715518|NCT00356525|42158429|FG001|Overall Study|Death|0|||
19715519|NCT00356525|42158430|FG002|Overall Study|Death|0|||
19715520|NCT00356525|42158431|FG003|Overall Study|Death|1|||
19715521|NCT00356525|42158428|FG000|Overall Study|Sponsor Decision|0|||
19715522|NCT00356525|42158429|FG001|Overall Study|Sponsor Decision|0|||
19715523|NCT00356525|42158430|FG002|Overall Study|Sponsor Decision|0|||
19715524|NCT00356525|42158431|FG003|Overall Study|Sponsor Decision|1|||
19715525|NCT00356369|42158443|FG000|Active Phase|Withdrawal by Subject|2|||
19715526|NCT00356369|42158444|FG001|Active Phase|Withdrawal by Subject|1|||
19715527|NCT03383614|42158454|FG000|Overall Study|Withdrawal by Subject|0|||
19715528|NCT03383614|42158455|FG001|Overall Study|Withdrawal by Subject|1|||
19715529|NCT03383614|42158456|FG002|Overall Study|Withdrawal by Subject|0|||
19715530|NCT03383614|42158457|FG003|Overall Study|Withdrawal by Subject|0|||
19715531|NCT03403036|42158472|FG000|Overall Study|Lack of Efficacy|5|||
19715532|NCT00356135|42158479|FG000|Overall Study|Protocol Violation|1|||
19715533|NCT00356135|42158480|FG001|Overall Study|Protocol Violation|0|||
19715534|NCT00356135|42158481|FG002|Overall Study|Protocol Violation|0|||
19715535|NCT00356135|42158479|FG000|Overall Study|Adverse Event|1|||
19715536|NCT00356135|42158480|FG001|Overall Study|Adverse Event|0|||
19715537|NCT00356135|42158481|FG002|Overall Study|Adverse Event|0|||
19715538|NCT00356135|42158479|FG000|Overall Study|Lost to Follow-up|0|||
19715539|NCT00356135|42158480|FG001|Overall Study|Lost to Follow-up|0|||
19715540|NCT00356135|42158481|FG002|Overall Study|Lost to Follow-up|1|||
19715541|NCT00356135|42158479|FG000|Overall Study|Physician Decision|1|||
19715542|NCT00356135|42158480|FG001|Overall Study|Physician Decision|1|||
19715543|NCT00356135|42158481|FG002|Overall Study|Physician Decision|1|||
19715544|NCT00356135|42158479|FG000|Overall Study|Subject non-compliance|1|||
19715545|NCT00356135|42158480|FG001|Overall Study|Subject non-compliance|1|||
19715546|NCT00356135|42158481|FG002|Overall Study|Subject non-compliance|3|||
19715547|NCT03383146|42158493|FG000|Overall Study|Screen Failure|1|||
19715548|NCT03383146|42158494|FG001|Overall Study|Screen Failure|0|||
19715549|NCT03383146|42158493|FG000|Overall Study|Adverse Event|6|||
19715550|NCT03383146|42158494|FG001|Overall Study|Adverse Event|18|||
19715551|NCT03383146|42158493|FG000|Overall Study|Lack of Efficacy|0|||
19715552|NCT03383146|42158494|FG001|Overall Study|Lack of Efficacy|3|||
19715553|NCT03383146|42158493|FG000|Overall Study|Withdrawal by Subject|20|||
19715554|NCT03383146|42158494|FG001|Overall Study|Withdrawal by Subject|36|||
19715555|NCT03383146|42158493|FG000|Overall Study|Lost to Follow-up|5|||
19715556|NCT03383146|42158494|FG001|Overall Study|Lost to Follow-up|15|||
19715557|NCT03383146|42158493|FG000|Overall Study|Death|0|||
19715558|NCT03383146|42158494|FG001|Overall Study|Death|2|||
19715559|NCT03383146|42158493|FG000|Overall Study|Physician Decision|0|||
19715560|NCT03383146|42158494|FG001|Overall Study|Physician Decision|1|||
19715561|NCT03383146|42158493|FG000|Overall Study|Protocol Deviation|1|||
19715562|NCT03383146|42158494|FG001|Overall Study|Protocol Deviation|8|||
19715563|NCT03383146|42158493|FG000|Overall Study|Study Terminated by the Sponsor|48|||
19715564|NCT03383146|42158494|FG001|Overall Study|Study Terminated by the Sponsor|95|||
19715565|NCT03383146|42158493|FG000|Overall Study|Reason not Specified|4|||
19715566|NCT03383146|42158494|FG001|Overall Study|Reason not Specified|6|||
19715567|NCT03616964|42158504|FG000|Overall Study|Adverse Event|15|||
19715568|NCT03616964|42158505|FG001|Overall Study|Adverse Event|10|||
19715569|NCT03616964|42158506|FG002|Overall Study|Adverse Event|16|||
19715570|NCT03616964|42158504|FG000|Overall Study|Death|3|||
19459085|NCT01396161|41713142|FG003|Overall Study|Other|0|||
19459086|NCT01396161|41713143|FG004|Overall Study|Other|0|||
19459087|NCT01396161|41713144|FG005|Overall Study|Other|0|||
19459088|NCT01396161|41713145|FG006|Overall Study|Other|1|||
19459089|NCT01396083|41713168|FG000|Overall Study|Adverse Event|2|||
19459090|NCT01396083|41713169|FG001|Overall Study|Adverse Event|28|||
19459091|NCT01396083|41713168|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19459092|NCT01396083|41713169|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
19459093|NCT01396083|41713168|FG000|Overall Study|Consent withdrawn|4|||
19459094|NCT01396083|41713169|FG001|Overall Study|Consent withdrawn|5|||
19459095|NCT01396083|41713168|FG000|Overall Study|Protocol deviation(s)|0|||
19459096|NCT01396083|41713169|FG001|Overall Study|Protocol deviation(s)|1|||
19715571|NCT03616964|42158505|FG001|Overall Study|Death|0|||
19715572|NCT03616964|42158506|FG002|Overall Study|Death|4|||
19715573|NCT03616964|42158504|FG000|Overall Study|Lack of Efficacy|4|||
19715574|NCT03616964|42158505|FG001|Overall Study|Lack of Efficacy|8|||
19715575|NCT03616964|42158506|FG002|Overall Study|Lack of Efficacy|8|||
19715576|NCT03616964|42158504|FG000|Overall Study|Lost to Follow-up|2|||
19715577|NCT03616964|42158505|FG001|Overall Study|Lost to Follow-up|1|||
19715578|NCT03616964|42158506|FG002|Overall Study|Lost to Follow-up|3|||
19715579|NCT03616964|42158504|FG000|Overall Study|Withdrawal by Subject|18|||
19715580|NCT03616964|42158505|FG001|Overall Study|Withdrawal by Subject|14|||
19715581|NCT03616964|42158506|FG002|Overall Study|Withdrawal by Subject|21|||
19459097|NCT01396083|41713168|FG000|Overall Study|Abnormal laboratory value(s)|1|||
19459098|NCT01396083|41713169|FG001|Overall Study|Abnormal laboratory value(s)|0|||
19459099|NCT01396083|41713168|FG000|Overall Study|Administrative problems|1|||
19545096|NCT00471237|41994661|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
19545097|NCT00471237|41994655|FG000|Overall Study|Early stopping due to non-efficacy|1|||
19545098|NCT00471237|41994656|FG001|Overall Study|Early stopping due to non-efficacy|0|||
19545099|NCT00471237|41994657|FG002|Overall Study|Early stopping due to non-efficacy|0|||
19545100|NCT00471237|41994658|FG003|Overall Study|Early stopping due to non-efficacy|0|||
19545101|NCT00471237|41994659|FG004|Overall Study|Early stopping due to non-efficacy|1|||
19545102|NCT00471237|41994660|FG005|Overall Study|Early stopping due to non-efficacy|0|||
19545103|NCT00471237|41994661|FG006|Overall Study|Early stopping due to non-efficacy|0|||
19545104|NCT00471237|41994655|FG000|Overall Study|Participant planned to travel to abraod|1|||
19545105|NCT00471237|41994656|FG001|Overall Study|Participant planned to travel to abraod|0|||
19545106|NCT00471237|41994657|FG002|Overall Study|Participant planned to travel to abraod|0|||
19545107|NCT00471237|41994658|FG003|Overall Study|Participant planned to travel to abraod|0|||
19545108|NCT00471237|41994659|FG004|Overall Study|Participant planned to travel to abraod|0|||
19545109|NCT00471237|41994660|FG005|Overall Study|Participant planned to travel to abraod|1|||
19545110|NCT00471237|41994661|FG006|Overall Study|Participant planned to travel to abraod|0|||
19545111|NCT00471237|41994655|FG000|Overall Study|High parathyroid hormone|0|||
19545112|NCT00471237|41994656|FG001|Overall Study|High parathyroid hormone|0|||
19545113|NCT00471237|41994657|FG002|Overall Study|High parathyroid hormone|1|||
19459100|NCT01396083|41713169|FG001|Overall Study|Administrative problems|0|||
19459101|NCT01396083|41713168|FG000|Overall Study|Lost to Follow-up|1|||
19459102|NCT01396083|41713169|FG001|Overall Study|Lost to Follow-up|0|||
19459103|NCT01723826|41713179|FG000|Overall Study|Adverse Event|4|||
19459104|NCT01723826|41713180|FG001|Overall Study|Adverse Event|1|||
19459105|NCT01723826|41713181|FG002|Overall Study|Adverse Event|4|||
19459106|NCT01723826|41713182|FG003|Overall Study|Adverse Event|5|||
19459107|NCT01723826|41713179|FG000|Overall Study|Death according to AE eCRF|2|||
19459108|NCT01723826|41713180|FG001|Overall Study|Death according to AE eCRF|3|||
19459109|NCT01723826|41713181|FG002|Overall Study|Death according to AE eCRF|3|||
19459110|NCT01723826|41713182|FG003|Overall Study|Death according to AE eCRF|7|||
19459111|NCT01723826|41713179|FG000|Overall Study|Lost to Follow-up|1|||
19459112|NCT01723826|41713180|FG001|Overall Study|Lost to Follow-up|3|||
19459113|NCT01723826|41713181|FG002|Overall Study|Lost to Follow-up|1|||
19459114|NCT01723826|41713182|FG003|Overall Study|Lost to Follow-up|1|||
19459115|NCT01723826|41713179|FG000|Overall Study|Non-compliance|0|||
19459116|NCT01723826|41713180|FG001|Overall Study|Non-compliance|1|||
19459117|NCT01723826|41713181|FG002|Overall Study|Non-compliance|3|||
19715582|NCT03616964|42158504|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
19715583|NCT03616964|42158505|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
19715584|NCT03616964|42158506|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
19715585|NCT03616964|42158504|FG000|Overall Study|Sponsor's Decision|1|||
19715586|NCT03616964|42158505|FG001|Overall Study|Sponsor's Decision|0|||
19715587|NCT03616964|42158506|FG002|Overall Study|Sponsor's Decision|0|||
19715588|NCT03616964|42158504|FG000|Overall Study|Physician Decision|0|||
19715589|NCT03616964|42158505|FG001|Overall Study|Physician Decision|2|||
19715590|NCT03616964|42158506|FG002|Overall Study|Physician Decision|0|||
19715591|NCT03616964|42158504|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
19715592|NCT03616964|42158505|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
19715593|NCT03616964|42158506|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
19715594|NCT03616964|42158504|FG000|Overall Study|Protocol Violation|0|||
19715595|NCT03616964|42158505|FG001|Overall Study|Protocol Violation|1|||
19715596|NCT03616964|42158506|FG002|Overall Study|Protocol Violation|0|||
19715597|NCT03616964|42158504|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
19715598|NCT03616964|42158505|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
19545114|NCT00471237|41994658|FG003|Overall Study|High parathyroid hormone|0|||
19715599|NCT03616964|42158506|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
19715600|NCT03616964|42158504|FG000|Overall Study|Randomized but Never Treated|1|||
19715601|NCT03616964|42158505|FG001|Overall Study|Randomized but Never Treated|1|||
19715602|NCT03616964|42158506|FG002|Overall Study|Randomized but Never Treated|1|||
19715603|NCT00350519|42158518|FG000|Overall Study|Death|0|||
19715604|NCT00350519|42158519|FG001|Overall Study|Death|1|||
19715605|NCT00350519|42158518|FG000|Overall Study|Physician Decision|0|||
19715606|NCT00350519|42158519|FG001|Overall Study|Physician Decision|1|||
19715607|NCT00350519|42158518|FG000|Overall Study|Protocol Violation|1|||
19715608|NCT00350519|42158519|FG001|Overall Study|Protocol Violation|2|||
19715609|NCT00350519|42158518|FG000|Overall Study|Withdrawal by Subject|3|||
19715610|NCT00350519|42158519|FG001|Overall Study|Withdrawal by Subject|2|||
19715611|NCT03382912|42158527|FG000|Overall Study|Physician Decision|0|||
19715612|NCT03382912|42158528|FG001|Overall Study|Physician Decision|1|||
19715613|NCT03382912|42158527|FG000|Overall Study|Sponsor Decision|6|||
19715614|NCT03382912|42158528|FG001|Overall Study|Sponsor Decision|6|||
19715615|NCT03382912|42158527|FG000|Overall Study|Withdrawal by Subject|0|||
19715616|NCT03382912|42158528|FG001|Overall Study|Withdrawal by Subject|5|||
19715617|NCT00350207|42158537|FG000|Overall Study|Adverse Event|5|||
19715618|NCT00350207|42158538|FG001|Overall Study|Adverse Event|2|||
19715619|NCT00350207|42158539|FG002|Overall Study|Adverse Event|2|||
19715620|NCT00350207|42158537|FG000|Overall Study|Lack of Efficacy|1|||
19715621|NCT00350207|42158538|FG001|Overall Study|Lack of Efficacy|0|||
19715622|NCT00350207|42158539|FG002|Overall Study|Lack of Efficacy|2|||
19715623|NCT00350207|42158537|FG000|Overall Study|Lost to Follow-up|1|||
19715624|NCT00350207|42158538|FG001|Overall Study|Lost to Follow-up|0|||
19715625|NCT00350207|42158539|FG002|Overall Study|Lost to Follow-up|1|||
19715626|NCT00350207|42158537|FG000|Overall Study|Withdrawal by Subject|0|||
19715627|NCT00350207|42158538|FG001|Overall Study|Withdrawal by Subject|1|||
19715628|NCT00350207|42158539|FG002|Overall Study|Withdrawal by Subject|1|||
19715629|NCT00350207|42158537|FG000|Overall Study|Other|1|||
19715630|NCT00350207|42158538|FG001|Overall Study|Other|3|||
19715631|NCT00350207|42158539|FG002|Overall Study|Other|1|||
19715632|NCT00349973|42158549|FG000|Overall Study|Adverse Event|3|||
19715633|NCT00349973|42158550|FG001|Overall Study|Adverse Event|3|||
19715634|NCT00349973|42158549|FG000|Overall Study|Withdrawal by Subject|1|||
19715635|NCT00349973|42158550|FG001|Overall Study|Withdrawal by Subject|0|||
19715636|NCT03187262|42158556|FG000|Induction|Lack of Efficacy|2|||
19715637|NCT03187262|42158556|FG000|Induction|Progressive Disease|4|||
19715638|NCT03187262|42158556|FG000|Consolidation|Progressive Disease|5|||
19715639|NCT03381196|42158562|FG000|Overall Study|Withdrawal by Subject|7|||
19715640|NCT03381196|42158563|FG001|Overall Study|Withdrawal by Subject|7|||
19715641|NCT03381196|42158562|FG000|Overall Study|Other|0|||
19715642|NCT03381196|42158563|FG001|Overall Study|Other|1|||
19715643|NCT03381196|42158562|FG000|Overall Study|Lost to Follow-up|5|||
19715644|NCT03381196|42158563|FG001|Overall Study|Lost to Follow-up|4|||
19715645|NCT03381196|42158562|FG000|Overall Study|Death|0|||
19715646|NCT03381196|42158563|FG001|Overall Study|Death|1|||
19715647|NCT03381196|42158562|FG000|Overall Study|Adverse Event|1|||
19715648|NCT03381196|42158563|FG001|Overall Study|Adverse Event|0|||
19715649|NCT03381196|42158562|FG000|Overall Study|Randomized, not treated|3|||
19715650|NCT03381196|42158563|FG001|Overall Study|Randomized, not treated|6|||
19715651|NCT02950558|42158571|FG000|Overall Study|Lost to Follow-up|2|||
19715652|NCT02950558|42158572|FG001|Overall Study|Lost to Follow-up|0|||
19715653|NCT03345472|42158579|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
19715654|NCT03345472|42158579|FG000|Implant to 3 Months|Physician Decision|1|||
19715655|NCT03345472|42158579|FG000|Implant to 3 Months|Adverse Event|1|||
19715656|NCT03345472|42158579|FG000|3 Months to 12 Months|Physician Decision|3|||
19715657|NCT03345472|42158579|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
19715658|NCT03345472|42158579|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
19715659|NCT03345472|42158579|FG000|3 Months to 12 Months|Adverse Event|1|||
19715660|NCT03345472|42158579|FG000|3 Months to 12 Months|Death|1|||
19715661|NCT00349349|42158586|FG000|Overall Study|Adverse Event|5|||
19459118|NCT01723826|41713182|FG003|Overall Study|Non-compliance|3|||
19459119|NCT01723826|41713179|FG000|Overall Study|Non-compliance With Study Drug|0|||
19459120|NCT01723826|41713180|FG001|Overall Study|Non-compliance With Study Drug|1|||
19459121|NCT01723826|41713181|FG002|Overall Study|Non-compliance With Study Drug|0|||
19459122|NCT01723826|41713182|FG003|Overall Study|Non-compliance With Study Drug|0|||
19459123|NCT01723826|41713179|FG000|Overall Study|Other Reason|8|||
19459124|NCT01723826|41713180|FG001|Overall Study|Other Reason|6|||
19459125|NCT01723826|41713181|FG002|Overall Study|Other Reason|12|||
19459126|NCT01723826|41713182|FG003|Overall Study|Other Reason|14|||
19459127|NCT01723826|41713179|FG000|Overall Study|Physician Decision|1|||
19459128|NCT01723826|41713180|FG001|Overall Study|Physician Decision|3|||
19459129|NCT01723826|41713181|FG002|Overall Study|Physician Decision|4|||
19459130|NCT01723826|41713182|FG003|Overall Study|Physician Decision|11|||
19459131|NCT01723826|41713179|FG000|Overall Study|Protocol Violation|1|||
19459132|NCT01723826|41713180|FG001|Overall Study|Protocol Violation|1|||
19459133|NCT01723826|41713181|FG002|Overall Study|Protocol Violation|3|||
19459134|NCT01723826|41713182|FG003|Overall Study|Protocol Violation|1|||
19459135|NCT01723826|41713179|FG000|Overall Study|Withdrawal by Subject|10|||
19459136|NCT01723826|41713180|FG001|Overall Study|Withdrawal by Subject|17|||
19459137|NCT01723826|41713181|FG002|Overall Study|Withdrawal by Subject|27|||
19459138|NCT01723826|41713182|FG003|Overall Study|Withdrawal by Subject|48|||
19459139|NCT01721954|41713194|FG000|Overall Study|Death|58|||
19459140|NCT01721954|41713195|FG001|Overall Study|Death|64|||
19459141|NCT01721954|41713194|FG000|Overall Study|Withdrawal by Subject|8|||
19459142|NCT01721954|41713195|FG001|Overall Study|Withdrawal by Subject|4|||
19459143|NCT01721954|41713194|FG000|Overall Study|Adverse Event|2|||
19459144|NCT01721954|41713195|FG001|Overall Study|Adverse Event|0|||
19459145|NCT01721954|41713194|FG000|Overall Study|Lost to Follow-up|2|||
19459146|NCT01721954|41713195|FG001|Overall Study|Lost to Follow-up|1|||
19459147|NCT01776554|41713203|FG000|Overall Study|Adverse Event|1|||
19459148|NCT01776554|41713204|FG001|Overall Study|Adverse Event|0|||
19459149|NCT01776554|41713203|FG000|Overall Study|Withdrawal by Subject|3|||
19715662|NCT00349349|42158587|FG001|Overall Study|Adverse Event|6|||
19459150|NCT01776554|41713204|FG001|Overall Study|Withdrawal by Subject|8|||
19459151|NCT01776554|41713203|FG000|Overall Study|Lost to Follow-up|6|||
19459152|NCT01776554|41713204|FG001|Overall Study|Lost to Follow-up|9|||
19459153|NCT01776554|41713203|FG000|Overall Study|Administrative Reason|2|||
19459154|NCT01776554|41713204|FG001|Overall Study|Administrative Reason|5|||
19715663|NCT00349349|42158588|FG002|Overall Study|Adverse Event|2|||
19715664|NCT00349349|42158586|FG000|Overall Study|Withdrawal by Subject|5|||
19715665|NCT00349349|42158587|FG001|Overall Study|Withdrawal by Subject|2|||
19715666|NCT00349349|42158588|FG002|Overall Study|Withdrawal by Subject|1|||
19715667|NCT00349349|42158586|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
19715668|NCT00349349|42158587|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
19715669|NCT00349349|42158588|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
19715670|NCT00349349|42158586|FG000|Overall Study|Death|13|||
19715671|NCT00349349|42158587|FG001|Overall Study|Death|10|||
19459155|NCT01776554|41713203|FG000|Overall Study|Protocol Violation|1|||
19459156|NCT01776554|41713204|FG001|Overall Study|Protocol Violation|0|||
19715672|NCT00349349|42158588|FG002|Overall Study|Death|1|||
19715673|NCT00349349|42158586|FG000|Overall Study|Other Treatment Selected|2|||
19715674|NCT00349349|42158587|FG001|Overall Study|Other Treatment Selected|0|||
19715675|NCT00349349|42158588|FG002|Overall Study|Other Treatment Selected|0|||
19715676|NCT00349349|42158586|FG000|Overall Study|Participant Reduced General Condition|0|||
19715677|NCT00349349|42158587|FG001|Overall Study|Participant Reduced General Condition|1|||
19459157|NCT01776554|41713203|FG000|Overall Study|Unclassified|4|||
19459158|NCT01776554|41713204|FG001|Overall Study|Unclassified|1|||
19459159|NCT01776008|41713211|FG000|Overall Study|ineligible|2|||
19459160|NCT01746368|41713217|FG000|Overall Study|Lost to Follow-up|2|||
19459161|NCT01746368|41713218|FG001|Overall Study|Lost to Follow-up|0|||
19459162|NCT01746368|41713217|FG000|Overall Study|Withdrawal by Subject|0|||
19459163|NCT01746368|41713218|FG001|Overall Study|Withdrawal by Subject|1|||
19459164|NCT01381575|41713227|FG000|Overall Study|Serious Adverse Event|1|||
19459165|NCT01381575|41713228|FG001|Overall Study|Serious Adverse Event|0|||
19459166|NCT01381575|41713229|FG002|Overall Study|Serious Adverse Event|0|||
19459167|NCT01381575|41713227|FG000|Overall Study|Non-Serious Adverse Event|0|||
19459168|NCT01381575|41713228|FG001|Overall Study|Non-Serious Adverse Event|0|||
19459169|NCT01381575|41713229|FG002|Overall Study|Non-Serious Adverse Event|1|||
19459170|NCT01381575|41713227|FG000|Overall Study|Protocol Violation|0|||
19459171|NCT01381575|41713228|FG001|Overall Study|Protocol Violation|1|||
19459172|NCT01381575|41713229|FG002|Overall Study|Protocol Violation|1|||
19459173|NCT01381575|41713227|FG000|Overall Study|Withdrawal by Subject|15|||
19459174|NCT01381575|41713228|FG001|Overall Study|Withdrawal by Subject|9|||
19459175|NCT01381575|41713229|FG002|Overall Study|Withdrawal by Subject|7|||
19459176|NCT01381575|41713227|FG000|Overall Study|Migrated/moved from study area|2|||
19459177|NCT01381575|41713228|FG001|Overall Study|Migrated/moved from study area|12|||
19459178|NCT01381575|41713229|FG002|Overall Study|Migrated/moved from study area|2|||
19459179|NCT01381575|41713227|FG000|Overall Study|Lost to Follow-up|8|||
19459180|NCT01381575|41713228|FG001|Overall Study|Lost to Follow-up|17|||
19459181|NCT01381575|41713229|FG002|Overall Study|Lost to Follow-up|9|||
19459182|NCT01858363|41713240|FG000|Overall Study|Death|35|||
19459183|NCT01858363|41713241|FG001|Overall Study|Death|9|||
19459184|NCT01858363|41713240|FG000|Overall Study|Withdrawal by Subject|28|||
19459185|NCT01858363|41713241|FG001|Overall Study|Withdrawal by Subject|14|||
19459186|NCT01858363|41713240|FG000|Overall Study|Lost to Follow-up|13|||
19459187|NCT01858363|41713241|FG001|Overall Study|Lost to Follow-up|3|||
19459188|NCT01877551|41713249|FG000|Overall Study|Physician Decision|0|||
19459189|NCT01877551|41713250|FG001|Overall Study|Physician Decision|1|||
19459190|NCT01396005|41713258|FG000|Overall Study|Withdrawal by Subject|0|||
19459191|NCT01396005|41713259|FG001|Overall Study|Withdrawal by Subject|1|||
19459192|NCT01396005|41713258|FG000|Overall Study|Non-compliance with protocol|0|||
19459193|NCT01396005|41713259|FG001|Overall Study|Non-compliance with protocol|1|||
19459194|NCT01877239|41713267|FG000|Overall Study|Adverse Event|4|||
19459195|NCT01877239|41713267|FG000|Overall Study|Disease Remission|1|||
19459196|NCT01877239|41713267|FG000|Overall Study|Withdrawal by Subject|4|||
19459197|NCT01877239|41713267|FG000|Overall Study|Other|2|||
19459198|NCT01877239|41713267|FG000|Overall Study|Lack of Efficacy|4|||
19459199|NCT01877239|41713267|FG000|Overall Study|Data not available|35|||
19459200|NCT01877083|41713271|FG000|Treatment Phase|Disease Progression|10|||
19459201|NCT01877083|41713271|FG000|Treatment Phase|Clinical Progression|1|||
19459202|NCT01877083|41713271|FG000|Treatment Phase|Adverse Event|6|||
19459203|NCT01877083|41713271|FG000|Treatment Phase|Withdrawal by Subject|2|||
19459204|NCT01877083|41713271|FG000|Treatment Phase|Lost to Follow-up|1|||
19459205|NCT01877083|41713271|FG000|Extension Phase|Disease Progression|3|||
19459206|NCT01877083|41713271|FG000|Extension Phase|Adverse Event|2|||
19459207|NCT01380327|41713278|FG000|Overall Study|Lost to Follow-up|0|||
19459208|NCT01380327|41713279|FG001|Overall Study|Lost to Follow-up|1|||
19459209|NCT01380327|41713280|FG002|Overall Study|Lost to Follow-up|1|||
19459210|NCT01380327|41713278|FG000|Overall Study|Protocol Violation|3|||
19459211|NCT01380327|41713279|FG001|Overall Study|Protocol Violation|2|||
19459212|NCT01380327|41713280|FG002|Overall Study|Protocol Violation|3|||
19459213|NCT01380327|41713278|FG000|Overall Study|Withdrawal by Subject|0|||
19459214|NCT01380327|41713279|FG001|Overall Study|Withdrawal by Subject|0|||
19459215|NCT01380327|41713280|FG002|Overall Study|Withdrawal by Subject|1|||
19459216|NCT01380327|41713278|FG000|Overall Study|Housing situation precluded ability to k|0|||
19459217|NCT01380327|41713279|FG001|Overall Study|Housing situation precluded ability to k|0|||
19459218|NCT01380327|41713280|FG002|Overall Study|Housing situation precluded ability to k|1|||
19459219|NCT01380327|41713278|FG000|Overall Study|Questionable onset of epilepsy|0|||
19459220|NCT01380327|41713279|FG001|Overall Study|Questionable onset of epilepsy|0|||
19459221|NCT01380327|41713280|FG002|Overall Study|Questionable onset of epilepsy|1|||
19459222|NCT01829425|41713290|FG000|Overall Study|Withdrawal by Subject|4|||
19459223|NCT01829425|41713291|FG001|Overall Study|Withdrawal by Subject|3|||
19459224|NCT01829425|41713290|FG000|Overall Study|Lost to Follow-up|2|||
19459225|NCT01829425|41713291|FG001|Overall Study|Lost to Follow-up|1|||
19459226|NCT01394991|41713308|FG000|Overall Study|Adverse Event|0|||
19459227|NCT01394991|41713309|FG001|Overall Study|Adverse Event|4|||
19459228|NCT01394991|41713308|FG000|Overall Study|Lack of Efficacy|5|||
19459229|NCT01394991|41713309|FG001|Overall Study|Lack of Efficacy|7|||
19459230|NCT01394991|41713308|FG000|Overall Study|Lost to Follow-up|6|||
19459231|NCT01394991|41713309|FG001|Overall Study|Lost to Follow-up|8|||
19459232|NCT01394991|41713308|FG000|Overall Study|Physician Decision|1|||
19459233|NCT01394991|41713309|FG001|Overall Study|Physician Decision|3|||
19459234|NCT01394991|41713308|FG000|Overall Study|Protocol Violation|1|||
19459235|NCT01394991|41713309|FG001|Overall Study|Protocol Violation|1|||
19459236|NCT01394991|41713308|FG000|Overall Study|Withdrawal by Subject|20|||
19459237|NCT01394991|41713309|FG001|Overall Study|Withdrawal by Subject|17|||
19459238|NCT01394991|41713308|FG000|Overall Study|Chemotherapy Termination|10|||
19459239|NCT01394991|41713309|FG001|Overall Study|Chemotherapy Termination|15|||
19459240|NCT01394991|41713308|FG000|Overall Study|Disease Progression|7|||
19459241|NCT01394991|41713309|FG001|Overall Study|Disease Progression|7|||
19459242|NCT01394991|41713308|FG000|Overall Study|Prematurely Termination of Trial|9|||
19459243|NCT01394991|41713309|FG001|Overall Study|Prematurely Termination of Trial|10|||
19459244|NCT01829347|41713317|FG000|VTI-210|Death|5|||
19459245|NCT01829347|41713318|FG001|VTI-210|Death|3|||
19459246|NCT01829347|41713317|FG000|VTI-210|Withdrawal by Subject|1|||
19459247|NCT01829347|41713318|FG001|VTI-210|Withdrawal by Subject|0|||
19459248|NCT01829347|41713317|FG000|VTI-210E|Death|2|||
19459249|NCT01829347|41713318|FG001|VTI-210E|Death|1|||
19459250|NCT01829347|41713317|FG000|VTI-210E|Study terminated prematurely|1|||
19459251|NCT01829347|41713318|FG001|VTI-210E|Study terminated prematurely|5|||
19459252|NCT01394523|41713327|FG000|Overall Study|Unable to place block|1|||
19459253|NCT01394523|41713328|FG001|Overall Study|Unable to place block|0|||
19459254|NCT01394523|41713329|FG002|Overall Study|Unable to place block|0|||
19459255|NCT01857973|41713337|FG000|Overall Study|Subject did not meet required BG range|3|||
19459256|NCT01857973|41713337|FG000|Overall Study|drop out after 3 failed attempts|1|||
19459257|NCT01857973|41713337|FG000|Overall Study|Physician Decision|1|||
19459258|NCT01857583|41713345|FG000|Overall Study|Adverse Event|0|||
19459259|NCT01857583|41713346|FG001|Overall Study|Adverse Event|0|||
19459260|NCT01857583|41713347|FG002|Overall Study|Adverse Event|1|||
19459261|NCT01857583|41713348|FG003|Overall Study|Adverse Event|1|||
19459262|NCT01857583|41713345|FG000|Overall Study|Death|0|||
19459263|NCT01857583|41713346|FG001|Overall Study|Death|1|||
19459264|NCT01857583|41713347|FG002|Overall Study|Death|1|||
19459265|NCT01857583|41713348|FG003|Overall Study|Death|0|||
19459266|NCT01857583|41713345|FG000|Overall Study|Physician Decision|0|||
19459267|NCT01857583|41713346|FG001|Overall Study|Physician Decision|0|||
19459268|NCT01857583|41713347|FG002|Overall Study|Physician Decision|0|||
19459269|NCT01857583|41713348|FG003|Overall Study|Physician Decision|1|||
19459270|NCT01857583|41713345|FG000|Overall Study|Withdrawal by Subject|1|||
19459271|NCT01857583|41713346|FG001|Overall Study|Withdrawal by Subject|0|||
19459272|NCT01857583|41713347|FG002|Overall Study|Withdrawal by Subject|1|||
19459273|NCT01857583|41713348|FG003|Overall Study|Withdrawal by Subject|2|||
19459274|NCT01829191|41713360|FG000|Overall Study|Relocation|0|||
19459275|NCT01829191|41713361|FG001|Overall Study|Relocation|1|||
19715678|NCT00349349|42158588|FG002|Overall Study|Participant Reduced General Condition|0|||
19715679|NCT00349349|42158586|FG000|Overall Study|Physician Decision|1|||
19715680|NCT00349349|42158587|FG001|Overall Study|Physician Decision|2|||
19715681|NCT00349349|42158588|FG002|Overall Study|Physician Decision|1|||
19715682|NCT00349349|42158586|FG000|Overall Study|No Response|0|||
19715683|NCT00349349|42158587|FG001|Overall Study|No Response|3|||
19715684|NCT00349349|42158588|FG002|Overall Study|No Response|0|||
19715685|NCT00349349|42158586|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
19715686|NCT00349349|42158587|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
19715687|NCT00349349|42158588|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
19715688|NCT02950480|42158600|FG000|Overall Study|Withdrawal by Subject|1|||
19715689|NCT02950480|42158601|FG001|Overall Study|Withdrawal by Subject|0|||
19715690|NCT00348881|42158609|FG000|Overall Study|Lost to Follow-up|12|||
19715691|NCT00348881|42158610|FG001|Overall Study|Lost to Follow-up|6|||
19715692|NCT00348881|42158609|FG000|Overall Study|Withdrawal by Subject|3|||
19715693|NCT00348881|42158610|FG001|Overall Study|Withdrawal by Subject|4|||
19715694|NCT00348881|42158609|FG000|Overall Study|Adverse Event|2|||
19715695|NCT00348881|42158610|FG001|Overall Study|Adverse Event|0|||
19715696|NCT00348881|42158609|FG000|Overall Study|Serious Adverse Event|0|||
19715697|NCT00348881|42158610|FG001|Overall Study|Serious Adverse Event|2|||
19715698|NCT03376516|42158620|FG000|Overall Study|Not treated|1|||
19715699|NCT03376516|42158620|FG000|Overall Study|Consent withdrawn|1|||
19715700|NCT03797144|42158646|FG000|Enrollment|Protocol Violation|4|||
19715701|NCT03797144|42158647|FG001|Enrollment|Protocol Violation|1|||
19715702|NCT03797144|42158646|FG000|Surgery|Protocol Violation|1|||
19715703|NCT03797144|42158647|FG001|Surgery|Protocol Violation|0|||
19715704|NCT03797144|42158646|FG000|3 Month|Early termination cut-off date|2|||
19715705|NCT03797144|42158647|FG001|3 Month|Early termination cut-off date|0|||
19715706|NCT03797144|42158646|FG000|12 Month|Early termination cut-off date|8|||
19715707|NCT03797144|42158647|FG001|12 Month|Early termination cut-off date|9|||
19715708|NCT03797144|42158646|FG000|24 Month|Early termination cut-off date|1|||
19715709|NCT03797144|42158647|FG001|24 Month|Early termination cut-off date|1|||
19715710|NCT00347009|42158654|FG000|Overall Study|Death|1|||
19715711|NCT00347009|42158654|FG000|Overall Study|Adverse Event|6|||
19715712|NCT00347009|42158654|FG000|Overall Study|Withdrawal by Subject|3|||
19715713|NCT00347009|42158654|FG000|Overall Study|Physician Decision|5|||
19715714|NCT00347009|42158654|FG000|Overall Study|Lost to Follow-up|4|||
19715715|NCT00347009|42158654|FG000|Overall Study|Protocol Violation|2|||
19715716|NCT00347009|42158654|FG000|Overall Study|Adverse Laboratory Experience|1|||
19715717|NCT00347009|42158654|FG000|Overall Study|Insufficient Viral Suppression|3|||
19715718|NCT00347009|42158654|FG000|Overall Study|Increased ALT/HBV DNA|1|||
19715719|NCT00347009|42158654|FG000|Overall Study|Serious Adverse Event|1|||
19715720|NCT00346775|42158662|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
19715721|NCT00346775|42158663|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
19715722|NCT00346775|42158662|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
19715723|NCT00346775|42158663|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
19715724|NCT00346775|42158662|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
19715725|NCT00346775|42158663|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
19715726|NCT00346697|42158675|FG000|Overall Study|Lost to Follow-up|0|||
19715727|NCT00346697|42158676|FG001|Overall Study|Lost to Follow-up|1|||
19715728|NCT03400852|42158686|FG000|Blinded Treatment Period|Physician Decision|0|||
19715729|NCT03400852|42158687|FG001|Blinded Treatment Period|Physician Decision|1|||
19715730|NCT03400852|42158688|FG002|Blinded Treatment Period|Physician Decision|0|||
19715731|NCT03400852|42158686|FG000|Blinded Treatment Period|Adverse Event|1|||
19715732|NCT03400852|42158687|FG001|Blinded Treatment Period|Adverse Event|1|||
19715733|NCT03400852|42158688|FG002|Blinded Treatment Period|Adverse Event|0|||
19715734|NCT03400852|42158686|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
19715735|NCT03400852|42158687|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
19715736|NCT03400852|42158688|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
19715737|NCT03400852|42158686|FG000|Open Label Period|Physician Decision|0|||
19715738|NCT03400852|42158687|FG001|Open Label Period|Physician Decision|0|||
19715739|NCT03400852|42158688|FG002|Open Label Period|Physician Decision|1|||
19459276|NCT01829191|41713360|FG000|Overall Study|Lens discomfort|0|||
19459277|NCT01829191|41713361|FG001|Overall Study|Lens discomfort|3|||
19459278|NCT01829191|41713360|FG000|Overall Study|Lens handling difficulty|1|||
19715740|NCT03400852|42158686|FG000|Open Label Period|Study terminated by sponsor|0|||
19715741|NCT03400852|42158687|FG001|Open Label Period|Study terminated by sponsor|0|||
19715742|NCT03400852|42158688|FG002|Open Label Period|Study terminated by sponsor|21|||
19715743|NCT03398356|42158699|FG000|Before Treatment|Lost to Follow-up|1|||
19715744|NCT03398356|42158700|FG001|Before Treatment|Lost to Follow-up|2|||
19459279|NCT01829191|41713361|FG001|Overall Study|Lens handling difficulty|4|||
19459280|NCT01829191|41713360|FG000|Overall Study|Protocol Violation|4|||
19459281|NCT01829191|41713361|FG001|Overall Study|Protocol Violation|1|||
19459282|NCT01829191|41713360|FG000|Overall Study|Withdrawal by Subject|2|||
19459283|NCT01829191|41713361|FG001|Overall Study|Withdrawal by Subject|3|||
19459284|NCT01829191|41713360|FG000|Overall Study|Lost to Follow-up|0|||
19459285|NCT01829191|41713361|FG001|Overall Study|Lost to Follow-up|1|||
19459286|NCT01829191|41713360|FG000|Overall Study|Subject was fit for ortho - k|0|||
19459287|NCT01829191|41713361|FG001|Overall Study|Subject was fit for ortho - k|1|||
19459288|NCT00211185|41713366|FG000|Overall Study|Death|2|||
19459289|NCT00211185|41713366|FG000|Overall Study|Disease progression|7|||
19459290|NCT00211185|41713366|FG000|Overall Study|Withdrawal by Subject|6|||
19459291|NCT00211185|41713366|FG000|Overall Study|Physician Decision|5|||
19459292|NCT00210639|41713372|FG000|Overall Study|Lost to Follow-up|37|||
19459293|NCT00210639|41713373|FG001|Overall Study|Lost to Follow-up|29|||
19459294|NCT00210639|41713372|FG000|Overall Study|Withdrawal by Subject|8|||
19459295|NCT00210639|41713373|FG001|Overall Study|Withdrawal by Subject|1|||
19459296|NCT00210639|41713372|FG000|Overall Study|Other|18|||
19459297|NCT00210639|41713373|FG001|Overall Study|Other|12|||
19459298|NCT01829113|41713381|FG000|Overall Study|Disease Progression|37|||
19459299|NCT01829113|41713382|FG001|Overall Study|Disease Progression|48|||
19459300|NCT01829113|41713381|FG000|Overall Study|Adverse Event|14|||
19459301|NCT01829113|41713382|FG001|Overall Study|Adverse Event|10|||
19459302|NCT01829113|41713381|FG000|Overall Study|Withdrawal by Subject|17|||
19459303|NCT01829113|41713382|FG001|Overall Study|Withdrawal by Subject|10|||
19459304|NCT01829113|41713381|FG000|Overall Study|Death|4|||
19459305|NCT01829113|41713382|FG001|Overall Study|Death|6|||
19459306|NCT01829113|41713381|FG000|Overall Study|Sponsor Decision|1|||
19459307|NCT01829113|41713382|FG001|Overall Study|Sponsor Decision|1|||
19459308|NCT01829113|41713381|FG000|Overall Study|No Study Treatment Received|3|||
19459309|NCT01829113|41713382|FG001|Overall Study|No Study Treatment Received|2|||
19459310|NCT01829113|41713381|FG000|Overall Study|Physician Decision|1|||
19459311|NCT01829113|41713382|FG001|Overall Study|Physician Decision|1|||
19459312|NCT01857271|41713390|FG000|Overall Study|Lost to Follow-up|1|||
19459313|NCT01745120|41713396|FG000|Overall Study|Investigator decision|1|||
19459314|NCT01745120|41713397|FG001|Overall Study|Investigator decision|0|||
19545115|NCT00471237|41994659|FG004|Overall Study|High parathyroid hormone|0|||
19545116|NCT00471237|41994660|FG005|Overall Study|High parathyroid hormone|0|||
19545117|NCT00471237|41994661|FG006|Overall Study|High parathyroid hormone|0|||
19545118|NCT00471237|41994655|FG000|Overall Study|Participant lost medication|0|||
19545119|NCT00471237|41994656|FG001|Overall Study|Participant lost medication|0|||
19545120|NCT00471237|41994657|FG002|Overall Study|Participant lost medication|0|||
19545121|NCT00471237|41994658|FG003|Overall Study|Participant lost medication|0|||
19545122|NCT00471237|41994659|FG004|Overall Study|Participant lost medication|1|||
19545123|NCT00471237|41994660|FG005|Overall Study|Participant lost medication|0|||
19545124|NCT00471237|41994661|FG006|Overall Study|Participant lost medication|0|||
19545125|NCT00471237|41994655|FG000|Overall Study|Administration of prohibited medicine|0|||
19545126|NCT00471237|41994656|FG001|Overall Study|Administration of prohibited medicine|0|||
19545127|NCT00471237|41994657|FG002|Overall Study|Administration of prohibited medicine|0|||
19545128|NCT00471237|41994658|FG003|Overall Study|Administration of prohibited medicine|0|||
19545129|NCT00471237|41994659|FG004|Overall Study|Administration of prohibited medicine|1|||
19545130|NCT00471237|41994660|FG005|Overall Study|Administration of prohibited medicine|0|||
19545131|NCT00471237|41994661|FG006|Overall Study|Administration of prohibited medicine|0|||
19545132|NCT00471237|41994655|FG000|Overall Study|Participant shifted residence|0|||
19545133|NCT00471237|41994656|FG001|Overall Study|Participant shifted residence|0|||
19545134|NCT00471237|41994657|FG002|Overall Study|Participant shifted residence|0|||
19545135|NCT00471237|41994658|FG003|Overall Study|Participant shifted residence|0|||
19545136|NCT00471237|41994659|FG004|Overall Study|Participant shifted residence|1|||
19545137|NCT00471237|41994660|FG005|Overall Study|Participant shifted residence|0|||
19545138|NCT00471237|41994661|FG006|Overall Study|Participant shifted residence|0|||
19545139|NCT00471237|41994655|FG000|Overall Study|Participant's decision|0|||
19545140|NCT00471237|41994656|FG001|Overall Study|Participant's decision|0|||
19545141|NCT00471237|41994657|FG002|Overall Study|Participant's decision|0|||
19545142|NCT00471237|41994658|FG003|Overall Study|Participant's decision|0|||
19545143|NCT00471237|41994659|FG004|Overall Study|Participant's decision|0|||
19545144|NCT00471237|41994660|FG005|Overall Study|Participant's decision|1|||
19459315|NCT01828567|41713408|FG000|Overall Study|Lost to Follow-up|27|||
19545145|NCT00471237|41994661|FG006|Overall Study|Participant's decision|0|||
19545146|NCT00471081|41994683|FG000|Active Phase|Protocol Violation|1|||
19545147|NCT00471081|41994684|FG001|Active Phase|Protocol Violation|1|||
19545148|NCT00471081|41994683|FG000|Active Phase|Withdrawal by Subject|0|||
19459316|NCT01828567|41713409|FG001|Overall Study|Lost to Follow-up|9|||
19459317|NCT01828567|41713408|FG000|Overall Study|Excluded - did not meet criteria|4|||
19459318|NCT01828567|41713409|FG001|Overall Study|Excluded - did not meet criteria|1|||
19459319|NCT01721486|41713417|FG000|Overall Study|Protocol Violation|1|||
19459320|NCT01721486|41713418|FG001|Overall Study|Protocol Violation|0|||
19459321|NCT01721486|41713417|FG000|Overall Study|Physician Decision|0|||
19459322|NCT01721486|41713418|FG001|Overall Study|Physician Decision|1|||
19459323|NCT01775930|41713424|FG000|Overall Study|Futility stopping boundary met|1|||
19459324|NCT01856569|41713428|FG000|Overall Study|Other|1|||
19459325|NCT01856569|41713428|FG000|Overall Study|Changed Site/Structure|1|||
19459326|NCT01856569|41713428|FG000|Overall Study|Lost to Follow-up|3|||
19459327|NCT01856569|41713428|FG000|Overall Study|Did not met inclusion criteria|8|||
19459328|NCT01721408|41713434|FG000|Overall Study|Adverse Event|6|||
19459329|NCT01721408|41713435|FG001|Overall Study|Adverse Event|1|||
19459330|NCT01721408|41713434|FG000|Overall Study|Death|1|||
19459331|NCT01721408|41713435|FG001|Overall Study|Death|0|||
19459332|NCT01721408|41713434|FG000|Overall Study|Insufficient clinical response|15|||
19459333|NCT01721408|41713435|FG001|Overall Study|Insufficient clinical response|6|||
19459334|NCT01721408|41713434|FG000|Overall Study|No longer willing to participate study|9|||
19459335|NCT01721408|41713435|FG001|Overall Study|No longer willing to participate study|10|||
19459336|NCT01721408|41713434|FG000|Overall Study|Protocol Violation|0|||
19459337|NCT01721408|41713435|FG001|Overall Study|Protocol Violation|2|||
19459338|NCT01721408|41713434|FG000|Overall Study|Other|3|||
19459339|NCT01721408|41713435|FG001|Overall Study|Other|3|||
19459340|NCT01721408|41713434|FG000|Overall Study|Lost to Follow-up|1|||
19459341|NCT01721408|41713435|FG001|Overall Study|Lost to Follow-up|2|||
19459342|NCT01721408|41713434|FG000|Overall Study|Does not meet entrance criteria|1|||
19459343|NCT01721408|41713435|FG001|Overall Study|Does not meet entrance criteria|0|||
19459344|NCT01744496|41713443|FG000|Titration Period|Adverse Event|2|||
19459345|NCT01744496|41713444|FG001|Titration Period|Adverse Event|1|||
19459346|NCT01744496|41713443|FG000|Titration Period|Personal reasons|0|||
19459347|NCT01744496|41713444|FG001|Titration Period|Personal reasons|1|||
19459348|NCT01744496|41713443|FG000|Maintenance Period|Adverse Event|1|||
19459349|NCT01744496|41713444|FG001|Maintenance Period|Adverse Event|3|||
19459350|NCT01744496|41713443|FG000|Maintenance Period|Protocol Violation|1|||
19459351|NCT01744496|41713444|FG001|Maintenance Period|Protocol Violation|0|||
19459352|NCT01744496|41713443|FG000|Maintenance Period|Withdrawal by Subject|1|||
19459353|NCT01744496|41713444|FG001|Maintenance Period|Withdrawal by Subject|1|||
19459354|NCT01744496|41713443|FG000|Maintenance Period|Subject left town|1|||
19459355|NCT01744496|41713444|FG001|Maintenance Period|Subject left town|0|||
19459356|NCT01721330|41713452|FG000|Overall Study|Withdrawal by Subject|0|||
19459357|NCT01721330|41713453|FG001|Overall Study|Withdrawal by Subject|1|||
19459358|NCT01828099|41713471|FG000|Overall Study|Adverse Event|15|||
19459359|NCT01828099|41713472|FG001|Overall Study|Adverse Event|18|||
19459360|NCT01828099|41713471|FG000|Overall Study|Death|9|||
19459361|NCT01828099|41713472|FG001|Overall Study|Death|11|||
19459362|NCT01828099|41713471|FG000|Overall Study|Lost to Follow-up|2|||
19459363|NCT01828099|41713472|FG001|Overall Study|Lost to Follow-up|0|||
19459364|NCT01828099|41713471|FG000|Overall Study|Non-compliance with study treatment|2|||
19459365|NCT01828099|41713472|FG001|Overall Study|Non-compliance with study treatment|0|||
19459366|NCT01828099|41713471|FG000|Overall Study|Physician Decision|7|||
19459367|NCT01828099|41713472|FG001|Overall Study|Physician Decision|11|||
19459368|NCT01828099|41713471|FG000|Overall Study|Progressive disease|51|||
19459369|NCT01828099|41713472|FG001|Overall Study|Progressive disease|94|||
19459370|NCT01828099|41713471|FG000|Overall Study|Protocol Violation|1|||
19459371|NCT01828099|41713472|FG001|Overall Study|Protocol Violation|0|||
19459372|NCT01828099|41713471|FG000|Overall Study|Subject/guardian decision|7|||
19459373|NCT01828099|41713472|FG001|Overall Study|Subject/guardian decision|23|||
19459374|NCT01828021|41713478|FG000|Overall Study|Adverse Event|5|||
19459375|NCT01828021|41713478|FG000|Overall Study|Lack of Efficacy|17|||
19459376|NCT01828021|41713478|FG000|Overall Study|Withdrawal by Subject|2|||
19459377|NCT01828021|41713478|FG000|Overall Study|Ileal obstruction, unrelated|1|||
19459378|NCT01827943|41713482|FG000|Overall Study|Protocol Violation|8|||
19459379|NCT01827943|41713482|FG000|Overall Study|Never treated because of an rapid progression|1|||
19459380|NCT00217971|41713488|FG000|Overall Study|Adverse Event|1|||
19459381|NCT00217971|41713489|FG001|Overall Study|Adverse Event|1|||
19459382|NCT00217971|41713488|FG000|Overall Study|Lost to Follow-up|15|||
19459383|NCT00217971|41713489|FG001|Overall Study|Lost to Follow-up|19|||
19459384|NCT00217971|41713488|FG000|Overall Study|Physician Decision|0|||
19459385|NCT00217971|41713489|FG001|Overall Study|Physician Decision|1|||
19459386|NCT00217971|41713488|FG000|Overall Study|Withdrawal by Subject|7|||
19459387|NCT00217971|41713489|FG001|Overall Study|Withdrawal by Subject|12|||
19459388|NCT00217971|41713488|FG000|Overall Study|non compliant|1|||
19459389|NCT00217971|41713489|FG001|Overall Study|non compliant|0|||
19459390|NCT00217581|41713495|FG000|Overall Study|Withdrawal by Subject|1|||
19459391|NCT01856257|41713503|FG000|Overall Study|Death|2|||
19459392|NCT01856257|41713504|FG001|Overall Study|Death|0|||
19459393|NCT01856257|41713505|FG002|Overall Study|Death|0|||
19459394|NCT01856257|41713506|FG003|Overall Study|Death|0|||
19459395|NCT01856257|41713503|FG000|Overall Study|Physician Decision|0|||
19459396|NCT01856257|41713504|FG001|Overall Study|Physician Decision|0|||
19459397|NCT01856257|41713505|FG002|Overall Study|Physician Decision|0|||
19459398|NCT01856257|41713506|FG003|Overall Study|Physician Decision|1|||
19459399|NCT01856257|41713503|FG000|Overall Study|Withdrawal by Subject|1|||
19459400|NCT01856257|41713504|FG001|Overall Study|Withdrawal by Subject|1|||
19459401|NCT01856257|41713505|FG002|Overall Study|Withdrawal by Subject|0|||
19459402|NCT01856257|41713506|FG003|Overall Study|Withdrawal by Subject|0|||
19459403|NCT01856257|41713503|FG000|Overall Study|Donor complication|0|||
19459404|NCT01856257|41713504|FG001|Overall Study|Donor complication|0|||
19459405|NCT01856257|41713505|FG002|Overall Study|Donor complication|0|||
19459406|NCT01856257|41713506|FG003|Overall Study|Donor complication|1|||
19459407|NCT00215943|41713517|FG000|Overall Study|Disease Progression|3|||
19459408|NCT00215943|41713518|FG001|Overall Study|Disease Progression|5|||
19459409|NCT00215943|41713517|FG000|Overall Study|Alternate therapy|0|||
19459410|NCT00215943|41713518|FG001|Overall Study|Alternate therapy|1|||
19459411|NCT00215943|41713517|FG000|Overall Study|Adverse Event|3|||
19459412|NCT00215943|41713518|FG001|Overall Study|Adverse Event|6|||
19459413|NCT00215943|41713517|FG000|Overall Study|Other disease|0|||
19459414|NCT00215943|41713518|FG001|Overall Study|Other disease|1|||
19459415|NCT00215943|41713517|FG000|Overall Study|Other complications|3|||
19459416|NCT00215943|41713518|FG001|Overall Study|Other complications|1|||
19459417|NCT01827319|41713524|FG000|Overall Study|Lost to Follow-up|3|||
19459418|NCT01827163|41713528|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
19459419|NCT01827163|41713528|FG000|Overall Study|Adverse Event|9|||
19459420|NCT00215553|41713539|FG000|Overall Study|Adverse Event|0|||
19459421|NCT00215553|41713540|FG001|Overall Study|Adverse Event|1|||
19459422|NCT00215553|41713541|FG002|Overall Study|Adverse Event|2|||
19459423|NCT00215553|41713542|FG003|Overall Study|Adverse Event|1|||
19459424|NCT00215553|41713543|FG004|Overall Study|Adverse Event|2|||
19459425|NCT00215553|41713544|FG005|Overall Study|Adverse Event|6|||
19459426|NCT00215553|41713545|FG006|Overall Study|Adverse Event|0|||
19459427|NCT00214461|41713565|FG000|Overall Study|Adverse Event|0|||
19459428|NCT00214461|41713566|FG001|Overall Study|Adverse Event|0|||
19459429|NCT00214461|41713567|FG002|Overall Study|Adverse Event|1|||
19459430|NCT00214461|41713568|FG003|Overall Study|Adverse Event|1|||
19459431|NCT00214461|41713565|FG000|Overall Study|Withdrawal by Subject|0|||
19459432|NCT00214461|41713566|FG001|Overall Study|Withdrawal by Subject|0|||
19459433|NCT00214461|41713567|FG002|Overall Study|Withdrawal by Subject|1|||
19459434|NCT00214461|41713568|FG003|Overall Study|Withdrawal by Subject|0|||
19459435|NCT00214383|41713580|FG000|Overall Study|Lost to Follow-up|16|||
19459436|NCT00214383|41713581|FG001|Overall Study|Lost to Follow-up|26|||
19459437|NCT00212355|41713587|FG000|Overall Study|Adverse Event|1|||
19459438|NCT00212355|41713587|FG000|Overall Study|Withdrawal by Subject|1|||
19459439|NCT00212355|41713587|FG000|Overall Study|A change of address|1|||
19459440|NCT00211887|41713594|FG000|Overall Study|Adverse Event|8|||
19459441|NCT00211887|41713595|FG001|Overall Study|Adverse Event|4|||
19459442|NCT00211887|41713596|FG002|Overall Study|Adverse Event|6|||
19459443|NCT00211887|41713594|FG000|Overall Study|Death|1|||
19459444|NCT00211887|41713595|FG001|Overall Study|Death|1|||
19459445|NCT00211887|41713596|FG002|Overall Study|Death|1|||
19459446|NCT00211887|41713594|FG000|Overall Study|Lost to Follow-up|28|||
19459447|NCT00211887|41713595|FG001|Overall Study|Lost to Follow-up|13|||
19459448|NCT00211887|41713596|FG002|Overall Study|Lost to Follow-up|9|||
19459449|NCT00211887|41713594|FG000|Overall Study|Non-medical reason|31|||
19459450|NCT00211887|41713595|FG001|Overall Study|Non-medical reason|14|||
19459451|NCT00211887|41713596|FG002|Overall Study|Non-medical reason|8|||
19459452|NCT00211887|41713594|FG000|Overall Study|Other medical reason|15|||
19459453|NCT00211887|41713595|FG001|Overall Study|Other medical reason|11|||
19459454|NCT00211887|41713596|FG002|Overall Study|Other medical reason|7|||
19459455|NCT00211887|41713594|FG000|Overall Study|Side effects|19|||
19459456|NCT00211887|41713595|FG001|Overall Study|Side effects|13|||
19459457|NCT00211887|41713596|FG002|Overall Study|Side effects|5|||
19459458|NCT01855945|41713616|FG000|Overall Study|Adverse Event|0|||
19459459|NCT01855945|41713617|FG001|Overall Study|Adverse Event|0|||
19459460|NCT01855945|41713618|FG002|Overall Study|Adverse Event|0|||
19459461|NCT01855945|41713619|FG003|Overall Study|Adverse Event|0|||
19459462|NCT01855945|41713620|FG004|Overall Study|Adverse Event|0|||
19459463|NCT01855945|41713621|FG005|Overall Study|Adverse Event|0|||
19715745|NCT03398356|42158701|FG002|Before Treatment|Lost to Follow-up|0|||
19715746|NCT03398356|42158699|FG000|Before Treatment|drug intolerance|2|||
19459464|NCT01855945|41713622|FG006|Overall Study|Adverse Event|1|||
19459465|NCT01855945|41713623|FG007|Overall Study|Adverse Event|0|||
19459466|NCT01855945|41713624|FG008|Overall Study|Adverse Event|0|||
19459467|NCT01855945|41713625|FG009|Overall Study|Adverse Event|0|||
19459468|NCT01855945|41713626|FG010|Overall Study|Adverse Event|0|||
19459469|NCT01855945|41713627|FG011|Overall Study|Adverse Event|0|||
19459470|NCT01855945|41713616|FG000|Overall Study|Death|0|||
19459471|NCT01855945|41713617|FG001|Overall Study|Death|0|||
19459472|NCT01855945|41713618|FG002|Overall Study|Death|0|||
19459473|NCT01855945|41713619|FG003|Overall Study|Death|0|||
19459474|NCT01855945|41713620|FG004|Overall Study|Death|0|||
19459475|NCT01855945|41713621|FG005|Overall Study|Death|0|||
19459476|NCT01855945|41713622|FG006|Overall Study|Death|2|||
19459477|NCT01855945|41713623|FG007|Overall Study|Death|0|||
19459478|NCT01855945|41713624|FG008|Overall Study|Death|0|||
19459479|NCT01855945|41713625|FG009|Overall Study|Death|0|||
19459480|NCT01855945|41713626|FG010|Overall Study|Death|0|||
19459481|NCT01855945|41713627|FG011|Overall Study|Death|0|||
19459482|NCT01855945|41713616|FG000|Overall Study|Lost to Follow-up|11|||
19459483|NCT01855945|41713617|FG001|Overall Study|Lost to Follow-up|10|||
19459484|NCT01855945|41713618|FG002|Overall Study|Lost to Follow-up|7|||
19459485|NCT01855945|41713619|FG003|Overall Study|Lost to Follow-up|3|||
19459486|NCT01855945|41713620|FG004|Overall Study|Lost to Follow-up|0|||
19459487|NCT01855945|41713621|FG005|Overall Study|Lost to Follow-up|3|||
19459488|NCT01855945|41713622|FG006|Overall Study|Lost to Follow-up|4|||
19459489|NCT01855945|41713623|FG007|Overall Study|Lost to Follow-up|7|||
19459490|NCT01855945|41713624|FG008|Overall Study|Lost to Follow-up|2|||
19459491|NCT01855945|41713625|FG009|Overall Study|Lost to Follow-up|0|||
19459492|NCT01855945|41713626|FG010|Overall Study|Lost to Follow-up|0|||
19715747|NCT03398356|42158700|FG001|Before Treatment|drug intolerance|1|||
19715748|NCT03398356|42158701|FG002|Before Treatment|drug intolerance|0|||
19715749|NCT03398356|42158699|FG000|Before Treatment|Withdrawal by Subject|0|||
19715750|NCT03398356|42158700|FG001|Before Treatment|Withdrawal by Subject|5|||
19715751|NCT03398356|42158701|FG002|Before Treatment|Withdrawal by Subject|0|||
19715752|NCT03398356|42158699|FG000|Before Treatment|Physician Decision|0|||
19715753|NCT03398356|42158700|FG001|Before Treatment|Physician Decision|0|||
19715754|NCT03398356|42158701|FG002|Before Treatment|Physician Decision|11|||
19715755|NCT03398356|42158699|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
19715756|NCT03398356|42158700|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
19715757|NCT03398356|42158701|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
19715758|NCT00346151|42158709|FG000|Overall Study|Withdrawal by Subject|3|||
19715759|NCT00130286|42158717|FG000|Overall Study|Withdrawal by Subject|0|||
19715760|NCT00130286|42158718|FG001|Overall Study|Withdrawal by Subject|1|||
19715761|NCT00130286|42158719|FG002|Overall Study|Withdrawal by Subject|2|||
19715762|NCT00130286|42158720|FG003|Overall Study|Withdrawal by Subject|2|||
19715763|NCT00130286|42158717|FG000|Overall Study|Adverse Event|0|||
19715764|NCT00130286|42158718|FG001|Overall Study|Adverse Event|0|||
19715765|NCT00130286|42158719|FG002|Overall Study|Adverse Event|2|||
19715766|NCT00130286|42158720|FG003|Overall Study|Adverse Event|0|||
19715767|NCT00130286|42158717|FG000|Overall Study|Missing lab specimens|0|||
19715768|NCT00130286|42158718|FG001|Overall Study|Missing lab specimens|2|||
19715769|NCT00130286|42158719|FG002|Overall Study|Missing lab specimens|0|||
19715770|NCT00130286|42158720|FG003|Overall Study|Missing lab specimens|0|||
19715771|NCT00346073|42158732|FG000|Overall Study|Serious Adverse Event|2|||
19715772|NCT00346073|42158733|FG001|Overall Study|Serious Adverse Event|0|||
19715773|NCT00346073|42158732|FG000|Overall Study|Lost to Follow-up|39|||
19715774|NCT00346073|42158733|FG001|Overall Study|Lost to Follow-up|24|||
19715775|NCT03374488|42158741|FG000|Overall Study|Death|13|||
19715776|NCT03374488|42158742|FG001|Overall Study|Death|13|||
19715777|NCT03374488|42158741|FG000|Overall Study|Withdrawal by Subject|3|||
19715778|NCT03374488|42158742|FG001|Overall Study|Withdrawal by Subject|1|||
19715779|NCT03374488|42158741|FG000|Overall Study|Physician Decision|3|||
19715780|NCT03374488|42158742|FG001|Overall Study|Physician Decision|0|||
19715781|NCT00345683|42158751|FG000|Overall Study|Lost to Follow-up|19|||
19715782|NCT00345683|42158752|FG001|Overall Study|Lost to Follow-up|7|||
19715783|NCT00345683|42158751|FG000|Overall Study|Other|6|||
19715784|NCT00345683|42158752|FG001|Overall Study|Other|2|||
19715785|NCT03828383|42158760|FG000|Overall Study|Lost to Follow-up|3|||
19715786|NCT03828383|42158761|FG001|Overall Study|Lost to Follow-up|2|||
19715787|NCT03828383|42158760|FG000|Overall Study|Withdrawal by Subject|4|||
19459493|NCT01855945|41713627|FG011|Overall Study|Lost to Follow-up|2|||
19459494|NCT01855945|41713616|FG000|Overall Study|Other - Unclassified|1|||
19459495|NCT01855945|41713617|FG001|Overall Study|Other - Unclassified|1|||
19459496|NCT01855945|41713618|FG002|Overall Study|Other - Unclassified|1|||
19459497|NCT01855945|41713619|FG003|Overall Study|Other - Unclassified|0|||
19459498|NCT01855945|41713620|FG004|Overall Study|Other - Unclassified|0|||
19459499|NCT01855945|41713621|FG005|Overall Study|Other - Unclassified|0|||
19459500|NCT01855945|41713622|FG006|Overall Study|Other - Unclassified|2|||
19459501|NCT01855945|41713623|FG007|Overall Study|Other - Unclassified|1|||
19459502|NCT01855945|41713624|FG008|Overall Study|Other - Unclassified|0|||
19459503|NCT01855945|41713625|FG009|Overall Study|Other - Unclassified|0|||
19459504|NCT01855945|41713626|FG010|Overall Study|Other - Unclassified|1|||
19715788|NCT03828383|42158761|FG001|Overall Study|Withdrawal by Subject|5|||
19715789|NCT00345605|42158767|FG000|Arm 1|Adverse Event|0|||
19715790|NCT00345605|42158768|FG001|Arm 1|Adverse Event|1|||
19459505|NCT01855945|41713627|FG011|Overall Study|Other - Unclassified|0|||
19459506|NCT01855945|41713616|FG000|Overall Study|Withdrawal by Subject|4|||
19459507|NCT01855945|41713617|FG001|Overall Study|Withdrawal by Subject|0|||
19459508|NCT01855945|41713618|FG002|Overall Study|Withdrawal by Subject|4|||
19715791|NCT00345605|42158767|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
19715792|NCT00345605|42158768|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
19459509|NCT01855945|41713619|FG003|Overall Study|Withdrawal by Subject|1|||
19459510|NCT01855945|41713620|FG004|Overall Study|Withdrawal by Subject|1|||
19459511|NCT01855945|41713621|FG005|Overall Study|Withdrawal by Subject|0|||
19459512|NCT01855945|41713622|FG006|Overall Study|Withdrawal by Subject|1|||
19459513|NCT01855945|41713623|FG007|Overall Study|Withdrawal by Subject|0|||
19459514|NCT01855945|41713624|FG008|Overall Study|Withdrawal by Subject|0|||
19459515|NCT01855945|41713625|FG009|Overall Study|Withdrawal by Subject|2|||
19459516|NCT01855945|41713626|FG010|Overall Study|Withdrawal by Subject|4|||
19459517|NCT01855945|41713627|FG011|Overall Study|Withdrawal by Subject|1|||
19459518|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Adverse Event|37|||
19459519|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Adverse Event|0|||
19459520|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Adverse Event|0|||
19459521|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Adverse Event|0|||
19459522|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Death|2|||
19459523|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Death|0|||
19459524|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Death|0|||
19459525|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Death|0|||
19459526|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
19459527|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
19459528|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
19459529|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
19459530|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
19459531|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
19459532|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
19459533|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
19459534|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
19459535|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
19459536|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
19459537|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
19459538|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
19459539|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
19459540|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
19459541|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
19459542|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Physician Decision|4|||
19459543|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Physician Decision|0|||
19459544|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Physician Decision|0|||
19459545|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Physician Decision|0|||
19459546|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Pregnancy|1|||
19459547|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Pregnancy|0|||
19459548|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Pregnancy|0|||
19459549|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Pregnancy|0|||
19459550|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
19459551|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
19459552|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
19459553|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
19459554|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
19459555|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
19459556|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
19459557|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
19459558|NCT01855789|41713690|FG000|1) Baseline up to Week 24|Other|4|||
19459559|NCT01855789|41713691|FG001|1) Baseline up to Week 24|Other|0|||
19459560|NCT01855789|41713692|FG002|1) Baseline up to Week 24|Other|0|||
19459561|NCT01855789|41713693|FG003|1) Baseline up to Week 24|Other|0|||
19459562|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
19459563|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
19459564|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
19459565|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
19459566|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
19459567|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
19459568|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
19459569|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
19459570|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
19459571|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
19459572|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
19459573|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
19545149|NCT00471081|41994684|FG001|Active Phase|Withdrawal by Subject|3|||
19545150|NCT00471081|41994683|FG000|Active Phase|Lost to Follow-up|0|||
19459574|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
19459575|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
19459576|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
19459577|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
19459578|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
19545151|NCT00471081|41994684|FG001|Active Phase|Lost to Follow-up|1|||
19459579|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
19459580|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
19459581|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
19459582|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
19459583|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
19459584|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
19459585|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
19459586|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
19459587|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
19459588|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
19459589|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
19459590|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
19459591|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
19459592|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
19459593|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
19459594|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
19459595|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
19459596|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
19459597|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
19459598|NCT01855789|41713690|FG000|2) Week 24 up to End of Study|Other|0|||
19459599|NCT01855789|41713691|FG001|2) Week 24 up to End of Study|Other|0|||
19459600|NCT01855789|41713692|FG002|2) Week 24 up to End of Study|Other|0|||
19459601|NCT01855789|41713693|FG003|2) Week 24 up to End of Study|Other|1|||
19459602|NCT01610791|41713699|FG000|Overall Study|Lost to Follow-up|7|||
19459603|NCT01610791|41713699|FG000|Overall Study|Adverse Event|6|||
19459604|NCT01610791|41713699|FG000|Overall Study|Physician Decision|1|||
19459605|NCT01610791|41713699|FG000|Overall Study|Adverse event and Investigator decision|1|||
19459606|NCT01610791|41713699|FG000|Overall Study|Death|1|||
19459607|NCT01610791|41713699|FG000|Overall Study|Not determined|5|||
19459608|NCT01876381|41713703|FG000|Overall Study|Lack of Efficacy|5|||
19459609|NCT01876381|41713703|FG000|Overall Study|Physician Decision|1|||
19459610|NCT01876381|41713703|FG000|Overall Study|Withdrawal by Subject|1|||
19459611|NCT01855399|41713709|FG000|6 Month|Lost to Follow-up|12|||
19459612|NCT01855399|41713710|FG001|6 Month|Lost to Follow-up|9|||
19459613|NCT01855399|41713709|FG000|6 Month|Withdrawal by Subject|8|||
19459614|NCT01855399|41713710|FG001|6 Month|Withdrawal by Subject|6|||
19459615|NCT01855399|41713709|FG000|12 Month|Lost to Follow-up|7|||
19459616|NCT01855399|41713710|FG001|12 Month|Lost to Follow-up|11|||
19459617|NCT01875991|41713718|FG000|Overall Study|Withdrawal by Subject|6|||
19459618|NCT01875991|41713719|FG001|Overall Study|Withdrawal by Subject|6|||
19459619|NCT01875991|41713718|FG000|Overall Study|Sponsor Decision|1|||
19459620|NCT01875991|41713719|FG001|Overall Study|Sponsor Decision|0|||
19459621|NCT01855243|41713731|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
19459622|NCT01855243|41713732|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
19459623|NCT01855243|41713733|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
19459624|NCT01825837|41713745|FG000|PART I|Withdrawal by Subject|0|||
19459625|NCT01825837|41713746|FG001|PART I|Withdrawal by Subject|0|||
19459626|NCT01825837|41713747|FG002|PART I|Withdrawal by Subject|0|||
19459627|NCT01825837|41713748|FG003|PART I|Withdrawal by Subject|6|||
19459628|NCT01825837|41713745|FG000|PART I|Patient non-compliance|0|||
19459629|NCT01825837|41713746|FG001|PART I|Patient non-compliance|0|||
19459630|NCT01825837|41713747|FG002|PART I|Patient non-compliance|0|||
19459631|NCT01825837|41713748|FG003|PART I|Patient non-compliance|1|||
19459632|NCT01825837|41713745|FG000|PART I|Treatment failure|0|||
19459633|NCT01825837|41713746|FG001|PART I|Treatment failure|0|||
19545152|NCT00471081|41994683|FG000|Active Phase|Lost health plan/insurance|1|||
19545153|NCT00471081|41994684|FG001|Active Phase|Lost health plan/insurance|8|||
19545154|NCT00471081|41994683|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
19545155|NCT00471081|41994684|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
19545156|NCT00471081|41994683|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
19545157|NCT00471081|41994684|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
19545158|NCT00471081|41994683|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
19545159|NCT00471081|41994684|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
19545160|NCT00470847|41994691|FG000|Overall Study|Pt still receiving treatment|1|||
19545161|NCT00470535|41994697|FG000|Overall Study|Disease Progression|13|||
19545162|NCT00470535|41994697|FG000|Overall Study|Withdrawal by Subject|1|||
19545163|NCT00470535|41994697|FG000|Overall Study|Adverse Event|1|||
19459634|NCT01825837|41713747|FG002|PART I|Treatment failure|0|||
19459635|NCT01825837|41713748|FG003|PART I|Treatment failure|7|||
19545164|NCT00470535|41994697|FG000|Overall Study|Death|1|||
19459636|NCT01825837|41713745|FG000|PART I|reason unspecified|0|||
19459637|NCT01825837|41713746|FG001|PART I|reason unspecified|0|||
19459638|NCT01825837|41713747|FG002|PART I|reason unspecified|0|||
19459639|NCT01825837|41713748|FG003|PART I|reason unspecified|3|||
19459640|NCT01825837|41713745|FG000|PART II|Withdrawal by Subject|3|||
19459641|NCT01825837|41713746|FG001|PART II|Withdrawal by Subject|3|||
19459642|NCT01825837|41713747|FG002|PART II|Withdrawal by Subject|7|||
19459643|NCT01825837|41713748|FG003|PART II|Withdrawal by Subject|0|||
19459644|NCT01825837|41713745|FG000|PART II|Patient non-compliance|5|||
19459645|NCT01825837|41713746|FG001|PART II|Patient non-compliance|2|||
19459646|NCT01825837|41713747|FG002|PART II|Patient non-compliance|4|||
19459647|NCT01825837|41713748|FG003|PART II|Patient non-compliance|0|||
19459648|NCT01825837|41713745|FG000|PART II|Adverse Event|3|||
19459649|NCT01825837|41713746|FG001|PART II|Adverse Event|3|||
19459650|NCT01825837|41713747|FG002|PART II|Adverse Event|1|||
19459651|NCT01825837|41713748|FG003|PART II|Adverse Event|0|||
19459652|NCT01825837|41713745|FG000|PART II|Treatment failure|6|||
19715793|NCT03394924|42158779|FG000|Overall Study|Adverse Event|0|||
19715794|NCT03394924|42158780|FG001|Overall Study|Adverse Event|5|||
19715795|NCT03394924|42158781|FG002|Overall Study|Adverse Event|0|||
19459653|NCT01825837|41713746|FG001|PART II|Treatment failure|4|||
19459654|NCT01825837|41713747|FG002|PART II|Treatment failure|5|||
19459655|NCT01825837|41713748|FG003|PART II|Treatment failure|0|||
19459656|NCT01825837|41713745|FG000|PART II|reason unspecified|2|||
19459657|NCT01825837|41713746|FG001|PART II|reason unspecified|2|||
19459658|NCT01825837|41713747|FG002|PART II|reason unspecified|2|||
19459659|NCT01825837|41713748|FG003|PART II|reason unspecified|0|||
19459660|NCT01854697|41713761|FG000|Overall Study|Adverse Event|1|||
19459661|NCT01854697|41713762|FG001|Overall Study|Adverse Event|0|||
19459662|NCT01854697|41713763|FG002|Overall Study|Adverse Event|0|||
19459663|NCT01854697|41713764|FG003|Overall Study|Adverse Event|0|||
19459664|NCT01854697|41713765|FG004|Overall Study|Adverse Event|1|||
19459665|NCT01854697|41713761|FG000|Overall Study|Lost to Follow-up|4|||
19459666|NCT01854697|41713762|FG001|Overall Study|Lost to Follow-up|1|||
19459667|NCT01854697|41713763|FG002|Overall Study|Lost to Follow-up|1|||
19459668|NCT01854697|41713764|FG003|Overall Study|Lost to Follow-up|2|||
19459669|NCT01854697|41713765|FG004|Overall Study|Lost to Follow-up|0|||
19459670|NCT01854697|41713761|FG000|Overall Study|To enter another AbbVie study|1|||
19459671|NCT01854697|41713762|FG001|Overall Study|To enter another AbbVie study|0|||
19459672|NCT01854697|41713763|FG002|Overall Study|To enter another AbbVie study|0|||
19459673|NCT01854697|41713764|FG003|Overall Study|To enter another AbbVie study|0|||
19459674|NCT01854697|41713765|FG004|Overall Study|To enter another AbbVie study|1|||
19459675|NCT01854697|41713761|FG000|Overall Study|Withdrew Consent|0|||
19459676|NCT01854697|41713762|FG001|Overall Study|Withdrew Consent|1|||
19459677|NCT01854697|41713763|FG002|Overall Study|Withdrew Consent|0|||
19459678|NCT01854697|41713764|FG003|Overall Study|Withdrew Consent|1|||
19459679|NCT01854697|41713765|FG004|Overall Study|Withdrew Consent|0|||
19459680|NCT01854697|41713761|FG000|Overall Study|Other|0|||
19459681|NCT01854697|41713762|FG001|Overall Study|Other|1|||
19459682|NCT01854697|41713763|FG002|Overall Study|Other|1|||
19459683|NCT01854697|41713764|FG003|Overall Study|Other|0|||
19459684|NCT01854697|41713765|FG004|Overall Study|Other|0|||
19459685|NCT01824979|41713777|FG000|Overall Study|Withdrawal by Subject|5|||
19459686|NCT01824979|41713778|FG001|Overall Study|Withdrawal by Subject|0|||
19459687|NCT01824979|41713777|FG000|Overall Study|Physician Decision|2|||
19459688|NCT01824979|41713778|FG001|Overall Study|Physician Decision|0|||
19459689|NCT01824979|41713777|FG000|Overall Study|Protocol Violation|6|||
19459690|NCT01824979|41713778|FG001|Overall Study|Protocol Violation|13|||
19459691|NCT01824823|41713786|FG000|Overall Study|Lack of Efficacy|1|||
19459692|NCT01824823|41713787|FG001|Overall Study|Lack of Efficacy|1|||
19459693|NCT01824823|41713786|FG000|Overall Study|Off-treatment reason not submitted|1|||
19459694|NCT01824823|41713787|FG001|Overall Study|Off-treatment reason not submitted|0|||
19459695|NCT01875367|41713795|FG000|Overall Study|Not complete at least 2 questionaries|4|||
19459696|NCT01875367|41713796|FG001|Overall Study|Not complete at least 2 questionaries|2|||
19459697|NCT01875367|41713795|FG000|Overall Study|Not receive study treatment|1|||
19459698|NCT01875367|41713796|FG001|Overall Study|Not receive study treatment|0|||
19459699|NCT01853839|41713806|FG000|Overall Study|Violated inclusion criteria|2|||
19459700|NCT01853839|41713806|FG000|Overall Study|Not meet ITT population definition|58|||
19459701|NCT01853839|41713806|FG000|Overall Study|End of treatment visit too early|33|||
19459702|NCT01853839|41713806|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
19459703|NCT01874665|41713816|FG000|Overall Study|Adverse Event|6|||
19459704|NCT01874665|41713817|FG001|Overall Study|Adverse Event|2|||
19459705|NCT01874665|41713816|FG000|Overall Study|Withdrawal by Subject|4|||
19459706|NCT01874665|41713817|FG001|Overall Study|Withdrawal by Subject|1|||
19459707|NCT01874665|41713816|FG000|Overall Study|Physician Decision|3|||
19459708|NCT01874665|41713817|FG001|Overall Study|Physician Decision|0|||
19459709|NCT01874665|41713816|FG000|Overall Study|Clinical Progressive Disease|4|||
19459710|NCT01874665|41713817|FG001|Overall Study|Clinical Progressive Disease|3|||
19459711|NCT01874665|41713816|FG000|Overall Study|Study Terminated by Sponsor|0|||
19459712|NCT01874665|41713817|FG001|Overall Study|Study Terminated by Sponsor|2|||
19459713|NCT01874665|41713816|FG000|Overall Study|Documented Progressive Disease|11|||
19459714|NCT01874665|41713817|FG001|Overall Study|Documented Progressive Disease|7|||
19459715|NCT01874665|41713816|FG000|Overall Study|Other|2|||
19459716|NCT01874665|41713817|FG001|Overall Study|Other|0|||
19715796|NCT03394924|42158779|FG000|Overall Study|Withdrawal by Subject|2|||
19459717|NCT01874431|41713832|FG000|Overall Study|Physician Decision|0|||
19459718|NCT01874431|41713833|FG001|Overall Study|Physician Decision|0|||
19459719|NCT01874431|41713834|FG002|Overall Study|Physician Decision|1|||
19459720|NCT01874431|41713835|FG003|Overall Study|Physician Decision|0|||
19459721|NCT01874431|41713836|FG004|Overall Study|Physician Decision|0|||
19459722|NCT01874431|41713837|FG005|Overall Study|Physician Decision|0|||
19459723|NCT01874431|41713838|FG006|Overall Study|Physician Decision|0|||
19459724|NCT01874431|41713839|FG007|Overall Study|Physician Decision|0|||
19459725|NCT01874431|41713832|FG000|Overall Study|Adverse Event|5|||
19459726|NCT01874431|41713833|FG001|Overall Study|Adverse Event|4|||
19459727|NCT01874431|41713834|FG002|Overall Study|Adverse Event|6|||
19459728|NCT01874431|41713835|FG003|Overall Study|Adverse Event|5|||
19459729|NCT01874431|41713836|FG004|Overall Study|Adverse Event|2|||
19459730|NCT01874431|41713837|FG005|Overall Study|Adverse Event|8|||
19459731|NCT01874431|41713838|FG006|Overall Study|Adverse Event|2|||
19459732|NCT01874431|41713839|FG007|Overall Study|Adverse Event|3|||
19459733|NCT01874431|41713832|FG000|Overall Study|Protocol Violation|1|||
19459734|NCT01874431|41713833|FG001|Overall Study|Protocol Violation|1|||
19459735|NCT01874431|41713834|FG002|Overall Study|Protocol Violation|1|||
19459736|NCT01874431|41713835|FG003|Overall Study|Protocol Violation|0|||
19459737|NCT01874431|41713836|FG004|Overall Study|Protocol Violation|3|||
19459738|NCT01874431|41713837|FG005|Overall Study|Protocol Violation|2|||
19459739|NCT01874431|41713838|FG006|Overall Study|Protocol Violation|1|||
19459740|NCT01874431|41713839|FG007|Overall Study|Protocol Violation|1|||
19459741|NCT01874431|41713832|FG000|Overall Study|Non-compliance|0|||
19459742|NCT01874431|41713833|FG001|Overall Study|Non-compliance|0|||
19459743|NCT01874431|41713834|FG002|Overall Study|Non-compliance|0|||
19459744|NCT01874431|41713835|FG003|Overall Study|Non-compliance|0|||
19459745|NCT01874431|41713836|FG004|Overall Study|Non-compliance|1|||
19459746|NCT01874431|41713837|FG005|Overall Study|Non-compliance|0|||
19459747|NCT01874431|41713838|FG006|Overall Study|Non-compliance|1|||
19459748|NCT01874431|41713839|FG007|Overall Study|Non-compliance|0|||
19459749|NCT01874431|41713832|FG000|Overall Study|Logistical difficulties|0|||
19459750|NCT01874431|41713833|FG001|Overall Study|Logistical difficulties|0|||
19459751|NCT01874431|41713834|FG002|Overall Study|Logistical difficulties|0|||
19459752|NCT01874431|41713835|FG003|Overall Study|Logistical difficulties|0|||
19459753|NCT01874431|41713836|FG004|Overall Study|Logistical difficulties|0|||
19459754|NCT01874431|41713837|FG005|Overall Study|Logistical difficulties|0|||
19459755|NCT01874431|41713838|FG006|Overall Study|Logistical difficulties|1|||
19459756|NCT01874431|41713839|FG007|Overall Study|Logistical difficulties|0|||
19459757|NCT01874431|41713832|FG000|Overall Study|Withdrawal by Subject|0|||
19459758|NCT01874431|41713833|FG001|Overall Study|Withdrawal by Subject|0|||
19459759|NCT01874431|41713834|FG002|Overall Study|Withdrawal by Subject|1|||
19459760|NCT01874431|41713835|FG003|Overall Study|Withdrawal by Subject|2|||
19459761|NCT01874431|41713836|FG004|Overall Study|Withdrawal by Subject|1|||
19459762|NCT01874431|41713837|FG005|Overall Study|Withdrawal by Subject|1|||
19459763|NCT01874431|41713838|FG006|Overall Study|Withdrawal by Subject|3|||
19459764|NCT01874431|41713839|FG007|Overall Study|Withdrawal by Subject|0|||
19459765|NCT01874431|41713832|FG000|Overall Study|Sponsor decision|0|||
19459766|NCT01874431|41713833|FG001|Overall Study|Sponsor decision|0|||
19459767|NCT01874431|41713834|FG002|Overall Study|Sponsor decision|0|||
19459768|NCT01874431|41713835|FG003|Overall Study|Sponsor decision|0|||
19459769|NCT01874431|41713836|FG004|Overall Study|Sponsor decision|1|||
19459770|NCT01874431|41713837|FG005|Overall Study|Sponsor decision|0|||
19459771|NCT01874431|41713838|FG006|Overall Study|Sponsor decision|0|||
19459772|NCT01874431|41713839|FG007|Overall Study|Sponsor decision|0|||
19459773|NCT01874431|41713832|FG000|Overall Study|Lost to Follow-up|0|||
19459774|NCT01874431|41713833|FG001|Overall Study|Lost to Follow-up|0|||
19459775|NCT01874431|41713834|FG002|Overall Study|Lost to Follow-up|1|||
19459776|NCT01874431|41713835|FG003|Overall Study|Lost to Follow-up|0|||
19459777|NCT01874431|41713836|FG004|Overall Study|Lost to Follow-up|0|||
19459778|NCT01874431|41713837|FG005|Overall Study|Lost to Follow-up|0|||
19459779|NCT01874431|41713838|FG006|Overall Study|Lost to Follow-up|0|||
19459780|NCT01874431|41713839|FG007|Overall Study|Lost to Follow-up|0|||
19459781|NCT01824355|41713857|FG000|Overall Study|Adverse Event|2|||
19459782|NCT01824355|41713857|FG000|Overall Study|unevaluable reference method results per|1|||
19459783|NCT01823341|41713865|FG000|Overall Study|Failed run-in|7|||
19459784|NCT01823341|41713865|FG000|Overall Study|Withdrawal by Subject|7|||
19459785|NCT01823341|41713865|FG000|Overall Study|Adverse Event|1|||
19459786|NCT01853137|41713874|FG000|Overall Study|Lost to Follow-up|4|||
19459787|NCT01853137|41713875|FG001|Overall Study|Lost to Follow-up|1|||
19459788|NCT01823107|41713882|FG000|Overall Study|Withdrawal by Subject|1|||
19459789|NCT01874275|41713888|FG000|Overall Study|Lost to Follow-up|1|||
19459790|NCT01874275|41713889|FG001|Overall Study|Lost to Follow-up|0|||
19459791|NCT01873729|41713901|FG000|Overall Study|Withdrawal by Subject|1|||
19459792|NCT01873495|41713905|FG000|Overall Study|Withdrawal by Subject|1|||
19459793|NCT01873495|41713905|FG000|Overall Study|Physician Decision|3|||
19715797|NCT03394924|42158780|FG001|Overall Study|Withdrawal by Subject|0|||
19459794|NCT01873495|41713905|FG000|Overall Study|Adverse Event|1|||
19459795|NCT01873495|41713905|FG000|Overall Study|Removed for Transplantation|1|||
19459796|NCT01873495|41713905|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
19459797|NCT01852825|41713912|FG000|Overall Study|Withdrawal by Subject|2|||
19459798|NCT01852825|41713913|FG001|Overall Study|Withdrawal by Subject|0|||
19459799|NCT01852825|41713914|FG002|Overall Study|Withdrawal by Subject|0|||
19459800|NCT01822561|41713922|FG000|Overall Study|Withdrawal by Subject|2|||
19459801|NCT01852591|41713947|FG000|Overall Study|Withdrawal by Subject|2|||
19459802|NCT01852591|41713947|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
19459803|NCT01852045|41713954|FG000|Overall Study|Adverse Event|1|||
19459804|NCT01852045|41713955|FG001|Overall Study|Adverse Event|0|||
19459805|NCT01852045|41713956|FG002|Overall Study|Adverse Event|0|||
19459806|NCT01852045|41713954|FG000|Overall Study|Lack of Efficacy|3|||
19459807|NCT01852045|41713955|FG001|Overall Study|Lack of Efficacy|0|||
19459808|NCT01852045|41713956|FG002|Overall Study|Lack of Efficacy|0|||
19459809|NCT01852045|41713954|FG000|Overall Study|Lost to Follow-up|0|||
19459810|NCT01852045|41713955|FG001|Overall Study|Lost to Follow-up|1|||
19459811|NCT01852045|41713956|FG002|Overall Study|Lost to Follow-up|1|||
19459812|NCT01852045|41713954|FG000|Overall Study|Withdrawal by Subject|1|||
19459813|NCT01852045|41713955|FG001|Overall Study|Withdrawal by Subject|0|||
19459814|NCT01852045|41713956|FG002|Overall Study|Withdrawal by Subject|1|||
19459815|NCT01852045|41713954|FG000|Overall Study|Other Miscellaneous Reasons|1|||
19459816|NCT01852045|41713955|FG001|Overall Study|Other Miscellaneous Reasons|3|||
19459817|NCT01852045|41713956|FG002|Overall Study|Other Miscellaneous Reasons|2|||
19459818|NCT01821937|41713975|FG000|Overall Study|Adverse Event|0|||
19459819|NCT01821937|41713976|FG001|Overall Study|Adverse Event|3|||
19459820|NCT01821625|41713984|FG000|Overall Study|Withdrawal by Subject|2|||
19459821|NCT01821625|41713984|FG000|Overall Study|Lack of Efficacy|2|||
19459822|NCT01821625|41713984|FG000|Overall Study|Adverse Event|1|||
19459823|NCT01821625|41713984|FG000|Overall Study|Medical contraindication|1|||
19459824|NCT01821391|41713990|FG000|Overall Study|Adverse Event|1|||
19459825|NCT01821391|41713991|FG001|Overall Study|Adverse Event|0|||
19459826|NCT01873417|41713999|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
19459827|NCT01873417|41713999|FG000|Overall Study|Adverse Event|24|||
19459828|NCT01873417|41713999|FG000|Overall Study|Lost to Follow-up|2|||
19459829|NCT01873417|41713999|FG000|Overall Study|Withdrawal by Subject|2|||
19459830|NCT01873417|41713999|FG000|Overall Study|Physician Decision|3|||
19459831|NCT01872715|41714003|FG000|Overall Study|Adverse Event|1|||
19459832|NCT01872715|41714003|FG000|Overall Study|Protocol Violation|1|||
19459833|NCT01872715|41714003|FG000|Overall Study|Withdrawal by Subject|2|||
19459834|NCT01871545|41714019|FG000|Overall Study|Death|2|||
19459835|NCT01871545|41714020|FG001|Overall Study|Death|0|||
19459836|NCT01871545|41714019|FG000|Overall Study|Lack of Efficacy|11|||
19459837|NCT01871545|41714020|FG001|Overall Study|Lack of Efficacy|2|||
19459838|NCT01871545|41714019|FG000|Overall Study|Physician Decision|4|||
19459839|NCT01871545|41714020|FG001|Overall Study|Physician Decision|0|||
19459840|NCT01871545|41714019|FG000|Overall Study|Withdrawal by Subject|0|||
19459841|NCT01871545|41714020|FG001|Overall Study|Withdrawal by Subject|1|||
19459842|NCT01613599|41714029|FG000|Overall Study|Death|9|||
19459843|NCT01613599|41714029|FG000|Overall Study|Lost to Follow-up|5|||
19459844|NCT01613599|41714029|FG000|Overall Study|Withdrawal by Subject|8|||
19459845|NCT01613599|41714029|FG000|Overall Study|Reason not specified|3|||
19459846|NCT01850641|41714033|FG000|Overall Study|Physician Decision|1|||
19459847|NCT01850641|41714033|FG000|Overall Study|Decrease in serum phosphorus|1|||
19459848|NCT01850641|41714033|FG000|Overall Study|Decrease in serum calcium|2|||
19459849|NCT01850641|41714033|FG000|Overall Study|Increase in serum ferritin|1|||
19459850|NCT01850563|41714039|FG000|Overall Study|Not eligible|3|||
19459851|NCT01850563|41714040|FG001|Overall Study|Not eligible|0|||
19459852|NCT01819129|41714053|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
19459853|NCT01819129|41714054|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
19459854|NCT01819129|41714053|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
19459855|NCT01819129|41714054|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
19459856|NCT01819129|41714053|FG000|Overall Study|Other, Subject moved out of the country|0|||
19459857|NCT01819129|41714054|FG001|Overall Study|Other, Subject moved out of the country|1|||
19459858|NCT01819129|41714053|FG000|Overall Study|Withdrawal by Subject|15|||
19459859|NCT01819129|41714054|FG001|Overall Study|Withdrawal by Subject|15|||
19459860|NCT01819129|41714053|FG000|Overall Study|Lost to Follow-up|5|||
19459861|NCT01819129|41714054|FG001|Overall Study|Lost to Follow-up|2|||
19459862|NCT01819129|41714053|FG000|Overall Study|Lack of Efficacy|0|||
19459863|NCT01819129|41714054|FG001|Overall Study|Lack of Efficacy|1|||
19459864|NCT01819129|41714053|FG000|Overall Study|Adverse Event|1|||
19459865|NCT01819129|41714054|FG001|Overall Study|Adverse Event|4|||
19459866|NCT01819129|41714053|FG000|Overall Study|Death|1|||
19715798|NCT03394924|42158781|FG002|Overall Study|Withdrawal by Subject|0|||
19459867|NCT01819129|41714054|FG001|Overall Study|Death|1|||
19459868|NCT01819129|41714053|FG000|Overall Study|Withdrawal Criteria|20|||
19459869|NCT01819129|41714054|FG001|Overall Study|Withdrawal Criteria|15|||
19459870|NCT04022889|41714062|FG000|Stage 1: Period 1|Adverse Event|1|||
19459871|NCT04022889|41714063|FG001|Stage 1: Period 1|Adverse Event|0|||
19459872|NCT04022889|41714064|FG002|Stage 1: Period 1|Adverse Event|0|||
19459873|NCT04022889|41714062|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
19459874|NCT04022889|41714063|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
19459875|NCT04022889|41714064|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
19459876|NCT04022889|41714062|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
19459877|NCT04022889|41714063|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
19459878|NCT04022889|41714064|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
19459879|NCT04022889|41714062|FG000|Stage 2|Screen Failure|0|||
19459880|NCT04022889|41714063|FG001|Stage 2|Screen Failure|0|||
19459881|NCT04022889|41714064|FG002|Stage 2|Screen Failure|3|||
19459882|NCT04022889|41714062|FG000|Stage 2|Ineligible for apheresis donation|0|||
19459883|NCT04022889|41714063|FG001|Stage 2|Ineligible for apheresis donation|0|||
19459884|NCT04022889|41714064|FG002|Stage 2|Ineligible for apheresis donation|2|||
19459885|NCT04022889|41714062|FG000|Stage 2|Adverse Event|0|||
19459886|NCT04022889|41714063|FG001|Stage 2|Adverse Event|0|||
19459887|NCT04022889|41714064|FG002|Stage 2|Adverse Event|2|||
19459888|NCT04022889|41714062|FG000|Stage 2|Protocol Violation|0|||
19459889|NCT04022889|41714063|FG001|Stage 2|Protocol Violation|0|||
19459890|NCT04022889|41714064|FG002|Stage 2|Protocol Violation|1|||
19459891|NCT04022889|41714062|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
19459892|NCT04022889|41714063|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
19459893|NCT04022889|41714064|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
19459894|NCT01849783|41714096|FG000|Overall Study|Adverse Event|5|||
19459895|NCT01849783|41714096|FG000|Overall Study|Death|2|||
19459896|NCT01849783|41714096|FG000|Overall Study|Physician Decision|1|||
19459897|NCT01849783|41714096|FG000|Overall Study|Withdrawal by Subject|1|||
19459898|NCT01849783|41714096|FG000|Overall Study|Unable to comply|2|||
19459899|NCT01849783|41714096|FG000|Overall Study|Disease progression|11|||
19459900|NCT01611883|41714108|FG000|Overall Study|Adverse Event|1|||
19459901|NCT01611883|41714109|FG001|Overall Study|Adverse Event|1|||
19459902|NCT01848457|41714119|FG000|Overall Study|Death|1|||
19459903|NCT01848457|41714120|FG001|Overall Study|Death|0|||
19459904|NCT01848457|41714121|FG002|Overall Study|Death|0|||
19459905|NCT01848457|41714122|FG003|Overall Study|Death|0|||
19459906|NCT01817959|41714142|FG000|Overall Study|Graft loss|1|||
19459907|NCT01817959|41714143|FG001|Overall Study|Graft loss|1|||
19459908|NCT01817959|41714142|FG000|Overall Study|forbidden medication|1|||
19459909|NCT01817959|41714143|FG001|Overall Study|forbidden medication|1|||
19459910|NCT01817959|41714142|FG000|Overall Study|Adverse Event|1|||
19459911|NCT01817959|41714143|FG001|Overall Study|Adverse Event|0|||
19459912|NCT01817959|41714142|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
19459913|NCT01817959|41714143|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
19459914|NCT01817725|41714149|FG000|Overall Study|Withdrawal by Subject|1|||
19459915|NCT01870999|41714156|FG000|Overall Study|Adverse Event|0|||
19459916|NCT01870999|41714157|FG001|Overall Study|Adverse Event|4|||
19459917|NCT01870999|41714158|FG002|Overall Study|Adverse Event|1|||
19459918|NCT01870999|41714156|FG000|Overall Study|Subject met withdrawal criteria|3|||
19459919|NCT01870999|41714157|FG001|Overall Study|Subject met withdrawal criteria|2|||
19459920|NCT01870999|41714158|FG002|Overall Study|Subject met withdrawal criteria|0|||
19459921|NCT01870999|41714156|FG000|Overall Study|Subject withdrawn by Investigator|1|||
19459922|NCT01870999|41714157|FG001|Overall Study|Subject withdrawn by Investigator|0|||
19459923|NCT01870999|41714158|FG002|Overall Study|Subject withdrawn by Investigator|0|||
19459924|NCT01870999|41714156|FG000|Overall Study|Withdrawal by Subject|0|||
19459925|NCT01870999|41714157|FG001|Overall Study|Withdrawal by Subject|2|||
19459926|NCT01870999|41714158|FG002|Overall Study|Withdrawal by Subject|5|||
19459927|NCT01870999|41714156|FG000|Overall Study|Protocol Violation|0|||
19459928|NCT01870999|41714157|FG001|Overall Study|Protocol Violation|0|||
19459929|NCT01870999|41714158|FG002|Overall Study|Protocol Violation|1|||
19459930|NCT01870921|41714166|FG000|Overall Study|Subject decision|80|||
19459931|NCT01870921|41714166|FG000|Overall Study|Severe non-compliance to protocol|7|||
19459932|NCT01870921|41714166|FG000|Overall Study|Subject Lost to Follow up|2|||
19459933|NCT01870921|41714166|FG000|Overall Study|Other|1|||
19459934|NCT01848145|41714179|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
19459935|NCT01848145|41714179|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
19459936|NCT01848145|41714179|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
19459937|NCT01848145|41714179|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
19459938|NCT01848145|41714179|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
19459939|NCT01848145|41714179|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
19459940|NCT01848145|41714179|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
19459941|NCT01847755|41714183|FG000|Overall Study|Adverse Event|2|||
19459942|NCT01847755|41714183|FG000|Overall Study|Withdrawal by Subject|2|||
19459943|NCT01847755|41714183|FG000|Overall Study|Physician Decision|1|||
19459944|NCT01847443|41714214|FG000|Study Period 1|Withdrawal by Subject|0|||
19459945|NCT01847443|41714215|FG001|Study Period 1|Withdrawal by Subject|1|||
19459946|NCT01847443|41714216|FG002|Study Period 1|Withdrawal by Subject|0|||
19459947|NCT01847443|41714217|FG003|Study Period 1|Withdrawal by Subject|0|||
19459948|NCT01847443|41714214|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
19459949|NCT01847443|41714215|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
19459950|NCT01847443|41714216|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
19459951|NCT01847443|41714217|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
19459952|NCT01847443|41714214|FG000|Washout Period Before Study Period 2|Other reason|1|||
19459953|NCT01847443|41714215|FG001|Washout Period Before Study Period 2|Other reason|0|||
19459954|NCT01847443|41714216|FG002|Washout Period Before Study Period 2|Other reason|0|||
19459955|NCT01847443|41714217|FG003|Washout Period Before Study Period 2|Other reason|0|||
19459956|NCT01847443|41714214|FG000|Washout Period Before Study Period 3|Other reason|1|||
19459957|NCT01847443|41714215|FG001|Washout Period Before Study Period 3|Other reason|0|||
19459958|NCT01847443|41714216|FG002|Washout Period Before Study Period 3|Other reason|0|||
19459959|NCT01847443|41714217|FG003|Washout Period Before Study Period 3|Other reason|0|||
19459960|NCT01847443|41714214|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
19459961|NCT01847443|41714215|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
19459962|NCT01847443|41714216|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
19459963|NCT01847443|41714217|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
19459964|NCT01847443|41714214|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
19459965|NCT01847443|41714215|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
19459966|NCT01847443|41714216|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
19459967|NCT01847443|41714217|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
19459968|NCT01847209|41714236|FG000|Overall Study|Withdrawal by Subject|1|||
19459969|NCT01847209|41714236|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
19459970|NCT01846741|41714240|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
19459971|NCT01870843|41714279|FG000|Overall Study|Adverse Event|10|||
19459972|NCT01870843|41714279|FG000|Overall Study|Lost to Follow-up|24|||
19459973|NCT01870843|41714279|FG000|Overall Study|Death|1|||
19459974|NCT01870843|41714279|FG000|Overall Study|Withdrawal by Subject|18|||
19459975|NCT01816477|41714285|FG000|Overall Study|Withdrawal by Subject|13|||
19459976|NCT01816477|41714286|FG001|Overall Study|Withdrawal by Subject|1|||
19459977|NCT01816477|41714285|FG000|Overall Study|Unable to tolerate catheter placement|3|||
19459978|NCT01816477|41714286|FG001|Overall Study|Unable to tolerate catheter placement|0|||
19459979|NCT01846507|41714292|FG000|Overall Study|Lost to Follow-up|4|||
19459980|NCT01846507|41714292|FG000|Overall Study|Protocol Violation|1|||
19459981|NCT01846507|41714292|FG000|Overall Study|Missing data|2|||
19459982|NCT01846039|41714298|FG000|Overall Study|Protocol Violation|1|||
19459983|NCT01846039|41714298|FG000|Overall Study|Subject Withdrew Consent|1|||
19459984|NCT01610167|41714305|FG000|Overall Study|Scheduling conflict.|0|||
19459985|NCT01610167|41714306|FG001|Overall Study|Scheduling conflict.|0|||
19459986|NCT01610167|41714307|FG002|Overall Study|Scheduling conflict.|2|||
19459987|NCT01816243|41714315|FG000|Overall Study|Adverse Event|6|||
19459988|NCT01816243|41714315|FG000|Overall Study|Lost to Follow-up|1|||
19459989|NCT01816243|41714315|FG000|Overall Study|Lack of Efficacy|1|||
19459990|NCT01816243|41714315|FG000|Overall Study|Not eligible for the study|1|||
19459991|NCT01816243|41714315|FG000|Overall Study|Amputation|3|||
19459992|NCT01845805|41714321|FG000|Overall Study|Withdrawal by Subject|1|||
19459993|NCT01845805|41714322|FG001|Overall Study|Withdrawal by Subject|2|||
19459994|NCT01845805|41714321|FG000|Overall Study|Disease Progression|13|||
19459995|NCT01845805|41714322|FG001|Overall Study|Disease Progression|14|||
19459996|NCT01845805|41714321|FG000|Overall Study|Drug-related Toxicity|4|||
19459997|NCT01845805|41714322|FG001|Overall Study|Drug-related Toxicity|0|||
19459998|NCT01845025|41714330|FG000|Overall Study|Adverse Event|6|||
19459999|NCT01845025|41714331|FG001|Overall Study|Adverse Event|3|||
19460000|NCT01845025|41714330|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
19460001|NCT01845025|41714331|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19460002|NCT01845025|41714330|FG000|Overall Study|Withdrawal by Subject|48|||
19460003|NCT01845025|41714331|FG001|Overall Study|Withdrawal by Subject|44|||
19460004|NCT01845025|41714330|FG000|Overall Study|Lost to Follow-up|13|||
19460005|NCT01845025|41714331|FG001|Overall Study|Lost to Follow-up|13|||
19460006|NCT01845025|41714330|FG000|Overall Study|Administrative problems|8|||
19460007|NCT01845025|41714331|FG001|Overall Study|Administrative problems|8|||
19460008|NCT01845025|41714330|FG000|Overall Study|Death|2|||
19460009|NCT01845025|41714331|FG001|Overall Study|Death|0|||
19460010|NCT01845025|41714330|FG000|Overall Study|Protocol deviation|3|||
19460011|NCT01845025|41714331|FG001|Overall Study|Protocol deviation|6|||
19460012|NCT01845025|41714330|FG000|Overall Study|Missing|1|||
19460013|NCT01845025|41714331|FG001|Overall Study|Missing|1|||
19460014|NCT01870297|41714372|FG000|Overall Study|Adverse Event|0|||
19460015|NCT01870297|41714373|FG001|Overall Study|Adverse Event|0|||
19460016|NCT01870297|41714374|FG002|Overall Study|Adverse Event|0|||
19460017|NCT01870297|41714375|FG003|Overall Study|Adverse Event|0|||
19460018|NCT01870297|41714376|FG004|Overall Study|Adverse Event|2|||
19460019|NCT01870297|41714377|FG005|Overall Study|Adverse Event|0|||
19460020|NCT01870297|41714378|FG006|Overall Study|Adverse Event|0|||
19460021|NCT01870297|41714372|FG000|Overall Study|Lost to Follow-up|0|||
19460022|NCT01870297|41714373|FG001|Overall Study|Lost to Follow-up|1|||
19460023|NCT01870297|41714374|FG002|Overall Study|Lost to Follow-up|1|||
19460024|NCT01870297|41714375|FG003|Overall Study|Lost to Follow-up|0|||
19460025|NCT01870297|41714376|FG004|Overall Study|Lost to Follow-up|0|||
19460026|NCT01870297|41714377|FG005|Overall Study|Lost to Follow-up|0|||
19460027|NCT01870297|41714378|FG006|Overall Study|Lost to Follow-up|0|||
19460028|NCT01870297|41714372|FG000|Overall Study|Withdrawal by Subject|0|||
19460029|NCT01870297|41714373|FG001|Overall Study|Withdrawal by Subject|0|||
19460030|NCT01870297|41714374|FG002|Overall Study|Withdrawal by Subject|0|||
19460031|NCT01870297|41714375|FG003|Overall Study|Withdrawal by Subject|0|||
19460032|NCT01870297|41714376|FG004|Overall Study|Withdrawal by Subject|1|||
19460033|NCT01870297|41714377|FG005|Overall Study|Withdrawal by Subject|1|||
19460034|NCT01870297|41714378|FG006|Overall Study|Withdrawal by Subject|1|||
19460035|NCT01870297|41714372|FG000|Overall Study|Sponsor Decision|0|||
19460036|NCT01870297|41714373|FG001|Overall Study|Sponsor Decision|6|||
19460037|NCT01870297|41714374|FG002|Overall Study|Sponsor Decision|0|||
19460038|NCT01870297|41714375|FG003|Overall Study|Sponsor Decision|0|||
19460039|NCT01870297|41714376|FG004|Overall Study|Sponsor Decision|0|||
19460040|NCT01870297|41714377|FG005|Overall Study|Sponsor Decision|0|||
19460041|NCT01870297|41714378|FG006|Overall Study|Sponsor Decision|1|||
19460042|NCT01814761|41714405|FG000|Overall Study|Other Reasons|1|||
19460043|NCT01814761|41714406|FG001|Overall Study|Other Reasons|10|||
19460044|NCT01814761|41714405|FG000|Overall Study|Ocular Adverse Event|6|||
19460045|NCT01814761|41714406|FG001|Overall Study|Ocular Adverse Event|15|||
19460046|NCT01814761|41714405|FG000|Overall Study|Lost to Follow-up|1|||
19460047|NCT01814761|41714406|FG001|Overall Study|Lost to Follow-up|5|||
19460048|NCT01843933|41714414|FG000|Overall Study|Data lost|6|||
19460049|NCT01843933|41714415|FG001|Overall Study|Data lost|4|||
19460050|NCT01814371|41714423|FG000|Overall Study|Lost to Follow-up|30|||
19460051|NCT01814371|41714424|FG001|Overall Study|Lost to Follow-up|27|||
19715799|NCT03394924|42158779|FG000|Overall Study|Lost to Follow-up|0|||
19715800|NCT03394924|42158780|FG001|Overall Study|Lost to Follow-up|1|||
19715801|NCT03394924|42158781|FG002|Overall Study|Lost to Follow-up|0|||
19715802|NCT03394924|42158779|FG000|Overall Study|Did not meet all inclusion criteria|1|||
19715803|NCT03394924|42158780|FG001|Overall Study|Did not meet all inclusion criteria|0|||
19715804|NCT03394924|42158781|FG002|Overall Study|Did not meet all inclusion criteria|0|||
19715805|NCT00345293|42158791|FG000|Overall Study|Unable to access line for sample|1|||
19715806|NCT00345293|42158792|FG001|Overall Study|Unable to access line for sample|0|||
19715807|NCT00345293|42158791|FG000|Overall Study|Withdrawal by Subject|1|||
19715808|NCT00345293|42158792|FG001|Overall Study|Withdrawal by Subject|0|||
19715809|NCT00355121|42158801|FG000|Overall Study|Did not receive study vaccine|1|||
19715810|NCT00355121|42158802|FG001|Overall Study|Did not receive study vaccine|0|||
19715811|NCT00355121|42158803|FG002|Overall Study|Did not receive study vaccine|1|||
19715812|NCT00355121|42158801|FG000|Overall Study|Adverse Event|0|||
19715813|NCT00355121|42158802|FG001|Overall Study|Adverse Event|1|||
19715814|NCT00355121|42158803|FG002|Overall Study|Adverse Event|0|||
19715815|NCT00355121|42158801|FG000|Overall Study|Protocol Violation|7|||
19715816|NCT00355121|42158802|FG001|Overall Study|Protocol Violation|9|||
19715817|NCT00355121|42158803|FG002|Overall Study|Protocol Violation|1|||
19715818|NCT00355121|42158801|FG000|Overall Study|Lost to Follow-up|4|||
19715819|NCT00355121|42158802|FG001|Overall Study|Lost to Follow-up|7|||
19715820|NCT00355121|42158803|FG002|Overall Study|Lost to Follow-up|1|||
19715821|NCT00355121|42158801|FG000|Overall Study|Withdrawal by Subject|9|||
19715822|NCT00355121|42158802|FG001|Overall Study|Withdrawal by Subject|10|||
19715823|NCT00355121|42158803|FG002|Overall Study|Withdrawal by Subject|2|||
19715824|NCT00355121|42158801|FG000|Overall Study|Serious adverse events|0|||
19715825|NCT00355121|42158802|FG001|Overall Study|Serious adverse events|2|||
19715826|NCT00355121|42158803|FG002|Overall Study|Serious adverse events|0|||
19715827|NCT00343889|42158816|FG000|Overall Study|Lost to Follow-up|2|||
19715828|NCT00343889|42158817|FG001|Overall Study|Lost to Follow-up|0|||
19715829|NCT00343889|42158816|FG000|Overall Study|Withdrawal by Subject|0|||
19715830|NCT00343889|42158817|FG001|Overall Study|Withdrawal by Subject|1|||
19715831|NCT00343889|42158816|FG000|Overall Study|Protocol Violation|1|||
19715832|NCT00343889|42158817|FG001|Overall Study|Protocol Violation|0|||
19715833|NCT03343054|42158826|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
19715834|NCT03343054|42158827|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
19460052|NCT01814137|41714498|FG000|Overall Study|Adverse Event|0|||
19460053|NCT01814137|41714499|FG001|Overall Study|Adverse Event|1|||
19460054|NCT01814137|41714498|FG000|Overall Study|Withdrawal by Subject|2|||
19460055|NCT01814137|41714499|FG001|Overall Study|Withdrawal by Subject|2|||
19460056|NCT01814137|41714498|FG000|Overall Study|Physician Decision|1|||
19460057|NCT01814137|41714499|FG001|Overall Study|Physician Decision|1|||
19460058|NCT01814137|41714498|FG000|Overall Study|Unclassified|2|||
19460059|NCT01814137|41714499|FG001|Overall Study|Unclassified|1|||
19545165|NCT00470535|41994697|FG000|Overall Study|Other|2|||
19715835|NCT03343054|42158828|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
19460060|NCT01813435|41714516|FG000|Overall Study|did not finish experimental regimen|1902|||
19460061|NCT01813435|41714517|FG001|Overall Study|did not finish experimental regimen|770|||
19460062|NCT01813435|41714516|FG000|Overall Study|Lost to Follow-up|268|||
19460063|NCT01813435|41714517|FG001|Overall Study|Lost to Follow-up|237|||
19460064|NCT01813357|41714525|FG000|Overall Study|Lost to Follow-up|5|||
19460065|NCT01813357|41714526|FG001|Overall Study|Lost to Follow-up|6|||
19460066|NCT01812655|41714535|FG000|Overall Study|Protocol Violation|1|||
19460067|NCT01812655|41714536|FG001|Overall Study|Protocol Violation|1|||
19460068|NCT01812655|41714537|FG002|Overall Study|Protocol Violation|0|||
19460069|NCT01812109|41714558|FG000|Overall Study|research personnel delay|16|||
19460070|NCT01812109|41714558|FG000|Overall Study|NIRS Unattainable|17|||
19460071|NCT01811953|41714568|FG000|Overall Study|Adverse Event|0|||
19460072|NCT01811953|41714569|FG001|Overall Study|Adverse Event|0|||
19460073|NCT01811953|41714570|FG002|Overall Study|Adverse Event|0|||
19460074|NCT01811953|41714571|FG003|Overall Study|Adverse Event|1|||
19460075|NCT01811953|41714572|FG004|Overall Study|Adverse Event|0|||
19460076|NCT01811953|41714573|FG005|Overall Study|Adverse Event|1|||
19460077|NCT01811953|41714568|FG000|Overall Study|Protocol Violation|0|||
19460078|NCT01811953|41714569|FG001|Overall Study|Protocol Violation|0|||
19460079|NCT01811953|41714570|FG002|Overall Study|Protocol Violation|0|||
19460080|NCT01811953|41714571|FG003|Overall Study|Protocol Violation|0|||
19460081|NCT01811953|41714572|FG004|Overall Study|Protocol Violation|1|||
19460082|NCT01811953|41714573|FG005|Overall Study|Protocol Violation|0|||
19460083|NCT01811563|41714589|FG000|Overall Study|Lost to Follow-up|5|||
19460084|NCT01811563|41714590|FG001|Overall Study|Lost to Follow-up|2|||
19460085|NCT01811563|41714589|FG000|Overall Study|Incorrect Randomization procedure|0|||
19460086|NCT01811563|41714590|FG001|Overall Study|Incorrect Randomization procedure|1|||
19460087|NCT01811485|41714599|FG000|Overall Study|Adverse Event|1|||
19460088|NCT01811485|41714600|FG001|Overall Study|Adverse Event|3|||
19460089|NCT01811485|41714601|FG002|Overall Study|Adverse Event|2|||
19460090|NCT01811485|41714599|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19460091|NCT01811485|41714600|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19460092|NCT01811485|41714601|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
19460093|NCT01811485|41714599|FG000|Overall Study|Administrative problems|1|||
19460094|NCT01811485|41714600|FG001|Overall Study|Administrative problems|0|||
19460095|NCT01811485|41714601|FG002|Overall Study|Administrative problems|0|||
19460096|NCT01811485|41714599|FG000|Overall Study|Protocol Deviation|0|||
19460097|NCT01811485|41714600|FG001|Overall Study|Protocol Deviation|1|||
19460098|NCT01811485|41714601|FG002|Overall Study|Protocol Deviation|0|||
19460099|NCT01810939|41714612|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
19460100|NCT01810939|41714613|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
19460101|NCT01810939|41714614|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
19460102|NCT01810939|41714612|FG000|Part A Treatment Period|Protocol Violation|2|||
19460103|NCT01810939|41714613|FG001|Part A Treatment Period|Protocol Violation|0|||
19460104|NCT01810939|41714614|FG002|Part A Treatment Period|Protocol Violation|0|||
19460105|NCT01810939|41714612|FG000|Part A Treatment Period|Adverse Event|10|||
19460106|NCT01810939|41714613|FG001|Part A Treatment Period|Adverse Event|0|||
19460107|NCT01810939|41714614|FG002|Part A Treatment Period|Adverse Event|0|||
19460108|NCT01810939|41714612|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
19460109|NCT01810939|41714613|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
19460110|NCT01810939|41714614|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
19460111|NCT01810939|41714612|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
19460112|NCT01810939|41714613|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
19460113|NCT01810939|41714614|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
19460114|NCT01810939|41714612|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
19460115|NCT01810939|41714613|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
19460116|NCT01810939|41714614|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
19460117|NCT01810939|41714612|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
19460118|NCT01810939|41714613|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
19460119|NCT01810939|41714614|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
19460120|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
19460121|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
19460122|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
19460123|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
19460124|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
19460125|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
19460126|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
19460127|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
19460128|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
19460129|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
19460130|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
19460131|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
19460132|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
19460133|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
19460134|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
19460135|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
19460136|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
19460137|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
19460138|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
19460139|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
19460140|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
19460141|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
19460142|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
19460143|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
19460144|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
19460145|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
19460146|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
19460147|NCT01810939|41714612|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
19460148|NCT01810939|41714613|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
19460149|NCT01810939|41714614|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
19715836|NCT03343054|42158826|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
19715837|NCT03343054|42158827|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
19460150|NCT01810783|41714633|FG000|Overall Study|Adverse Event|32|||
19545166|NCT00470418|41994703|FG000|Overall Study|Withdrawal by Subject|1|||
19545167|NCT00470418|41994704|FG001|Overall Study|Withdrawal by Subject|0|||
19545168|NCT00470184|41994710|FG000|Overall Study|Not Treated(became ineligible)|4|||
19545169|NCT00470184|41994710|FG000|Overall Study|Not treated (other)|1|||
19545170|NCT00470184|41994710|FG000|Overall Study|disease Progression|4|||
19545171|NCT00470184|41994710|FG000|Overall Study|Adverse Event|3|||
19545172|NCT00470184|41994710|FG000|Overall Study|Withdrawal by Subject|4|||
19545173|NCT00470184|41994710|FG000|Overall Study|other|5|||
19545174|NCT00470184|41994710|FG000|Overall Study|recurrence|1|||
19545175|NCT00470067|41994715|FG000|Overall Study|Death|1|||
19545176|NCT00470067|41994715|FG000|Overall Study|Disease Progression|6|||
19545177|NCT00475020|41994719|FG000|Overall Study|Physician Decision|3|||
19545178|NCT00475020|41994719|FG000|Overall Study|Insurance Denial|1|||
19545179|NCT00475020|41994719|FG000|Overall Study|Donor not able to donate the last minute|1|||
19545180|NCT02484456|41994725|FG000|Washout Period|Withdrawal by Subject|0|||
19545181|NCT02484456|41994726|FG001|Washout Period|Withdrawal by Subject|1|||
19545182|NCT02484456|41994725|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
19545183|NCT02484456|41994726|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
19545184|NCT02484456|41994725|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
19545185|NCT02484456|41994726|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
19545186|NCT02484456|41994725|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
19545187|NCT02484456|41994726|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
19545188|NCT01132807|41994733|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
19545189|NCT01132807|41994734|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
19545190|NCT01132807|41994735|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
19545191|NCT01132807|41994733|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
19545192|NCT01132807|41994734|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
19545193|NCT01132807|41994735|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
19545194|NCT01132651|41994745|FG000|Overall Study|Lost to Follow-up|1|||
19545195|NCT01132651|41994746|FG001|Overall Study|Lost to Follow-up|1|||
19545196|NCT01089543|41994756|FG000|Overall Study|Withdrawal by Subject|2|||
19545197|NCT01089543|41994757|FG001|Overall Study|Withdrawal by Subject|3|||
19545198|NCT01089543|41994758|FG002|Overall Study|Withdrawal by Subject|3|||
19545199|NCT01089543|41994759|FG003|Overall Study|Withdrawal by Subject|1|||
19715838|NCT03343054|42158828|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
19715839|NCT03343054|42158826|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
19715840|NCT03343054|42158827|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
19715841|NCT03343054|42158828|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
19715842|NCT03343054|42158826|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
19715843|NCT03343054|42158827|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
19715844|NCT03343054|42158828|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
19715845|NCT00354341|42158839|FG000|Overall Study|Adverse Event|1|||
19715846|NCT00354341|42158840|FG001|Overall Study|Adverse Event|0|||
19715847|NCT00354341|42158839|FG000|Overall Study|Death|0|||
19715848|NCT00354341|42158840|FG001|Overall Study|Death|2|||
19715849|NCT00354341|42158839|FG000|Overall Study|Refused treatment|1|||
19715850|NCT00354341|42158840|FG001|Overall Study|Refused treatment|2|||
19715851|NCT00354341|42158839|FG000|Overall Study|Failure to return|0|||
19715852|NCT00354341|42158840|FG001|Overall Study|Failure to return|1|||
19545200|NCT01089543|41994756|FG000|Overall Study|Physician Decision|1|||
19545201|NCT01089543|41994757|FG001|Overall Study|Physician Decision|0|||
19545202|NCT01089543|41994758|FG002|Overall Study|Physician Decision|0|||
19545203|NCT01089543|41994759|FG003|Overall Study|Physician Decision|1|||
19545204|NCT01089543|41994756|FG000|Overall Study|Adverse Event|0|||
19545205|NCT01089543|41994757|FG001|Overall Study|Adverse Event|1|||
19545206|NCT01089543|41994758|FG002|Overall Study|Adverse Event|0|||
19545207|NCT01089543|41994759|FG003|Overall Study|Adverse Event|0|||
19545208|NCT01089504|41994771|FG000|Overall Study|Lost to Follow-up|1|||
19545209|NCT01089504|41994772|FG001|Overall Study|Lost to Follow-up|1|||
19545210|NCT01089504|41994771|FG000|Overall Study|Withdrawal by Subject|2|||
19545211|NCT01089504|41994772|FG001|Overall Study|Withdrawal by Subject|0|||
19545212|NCT01088997|41994780|FG000|Overall Study|Physician Decision|1|||
19545213|NCT01088997|41994781|FG001|Overall Study|Physician Decision|1|||
19545214|NCT01088997|41994780|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
19545215|NCT01088997|41994781|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
19545216|NCT01088997|41994780|FG000|Overall Study|Excluded prior to receiving drug|1|||
19545217|NCT01088997|41994781|FG001|Overall Study|Excluded prior to receiving drug|1|||
19545218|NCT01088529|41994792|FG000|Overall Study|Did not receive study treatment|0|||
19545219|NCT01088529|41994793|FG001|Overall Study|Did not receive study treatment|1|||
19545220|NCT01087944|41994799|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
19545221|NCT01087944|41994800|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
19545222|NCT01087944|41994799|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
19545223|NCT01087944|41994800|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
19545224|NCT01132612|41994809|FG000|Overall Study|Death|0|||
19715853|NCT00354341|42158839|FG000|Overall Study|Other|1|||
19715854|NCT00354341|42158840|FG001|Overall Study|Other|2|||
19715855|NCT00354107|42158846|FG000|Overall Study|Adverse Event|2|||
19715856|NCT00354107|42158846|FG000|Overall Study|Physician Decision|2|||
19715857|NCT00354107|42158846|FG000|Overall Study|Withdrawal by Subject|1|||
19715858|NCT00354029|42158852|FG000|Overall Study|Protocol Violation|4|||
19715859|NCT00354029|42158853|FG001|Overall Study|Protocol Violation|2|||
19715860|NCT00353873|42158861|FG000|Overall Study|Protocol Violation|1|||
19715861|NCT00353873|42158862|FG001|Overall Study|Protocol Violation|2|||
19715862|NCT00353873|42158861|FG000|Overall Study|Exacerbation|1|||
19715863|NCT00353873|42158862|FG001|Overall Study|Exacerbation|0|||
19715864|NCT00353873|42158861|FG000|Overall Study|Adverse Event|1|||
19715865|NCT00353873|42158862|FG001|Overall Study|Adverse Event|0|||
19715866|NCT00353873|42158861|FG000|Overall Study|Physician Decision|2|||
19715867|NCT00353873|42158862|FG001|Overall Study|Physician Decision|0|||
19715868|NCT00353873|42158861|FG000|Overall Study|Withdrawal by Subject|1|||
19715869|NCT00353873|42158862|FG001|Overall Study|Withdrawal by Subject|1|||
19545225|NCT01132612|41994810|FG001|Overall Study|Death|0|||
19545226|NCT01132612|41994811|FG002|Overall Study|Death|1|||
19715870|NCT03796676|42158871|FG000|Overall Study|Adverse Event|2|||
19715871|NCT03796676|42158872|FG001|Overall Study|Adverse Event|1|||
19715872|NCT03796676|42158873|FG002|Overall Study|Adverse Event|2|||
19715873|NCT03796676|42158871|FG000|Overall Study|Lost to Follow-up|2|||
19715874|NCT03796676|42158872|FG001|Overall Study|Lost to Follow-up|1|||
19715875|NCT03796676|42158873|FG002|Overall Study|Lost to Follow-up|0|||
19715876|NCT03796676|42158871|FG000|Overall Study|Protocol Violation|0|||
19715877|NCT03796676|42158872|FG001|Overall Study|Protocol Violation|0|||
19715878|NCT03796676|42158873|FG002|Overall Study|Protocol Violation|1|||
19715879|NCT03796676|42158871|FG000|Overall Study|Withdrawal by Subject|1|||
19715880|NCT03796676|42158872|FG001|Overall Study|Withdrawal by Subject|1|||
19715881|NCT03796676|42158873|FG002|Overall Study|Withdrawal by Subject|0|||
19715882|NCT03796676|42158871|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
19715883|NCT03796676|42158872|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
19715884|NCT03796676|42158873|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
19715885|NCT03342898|42158887|FG000|Overall Study|Adverse Event|3|||
19715886|NCT03342898|42158888|FG001|Overall Study|Adverse Event|1|||
19715887|NCT03342898|42158889|FG002|Overall Study|Adverse Event|0|||
19715888|NCT03342898|42158887|FG000|Overall Study|Lost to Follow-up|44|||
19715889|NCT03342898|42158888|FG001|Overall Study|Lost to Follow-up|40|||
19715890|NCT03342898|42158889|FG002|Overall Study|Lost to Follow-up|42|||
19545227|NCT01132612|41994809|FG000|Overall Study|Protocol deviation|0|||
19715891|NCT03342898|42158887|FG000|Overall Study|Withdrawal of Consent|5|||
19715892|NCT03342898|42158888|FG001|Overall Study|Withdrawal of Consent|9|||
19715893|NCT03342898|42158889|FG002|Overall Study|Withdrawal of Consent|11|||
19715894|NCT03342898|42158887|FG000|Overall Study|Death|0|||
19715895|NCT03342898|42158888|FG001|Overall Study|Death|1|||
19715896|NCT03342898|42158889|FG002|Overall Study|Death|1|||
19715897|NCT03342898|42158887|FG000|Overall Study|Reason not Specified|2|||
19545228|NCT01132612|41994810|FG001|Overall Study|Protocol deviation|0|||
19545229|NCT01132612|41994811|FG002|Overall Study|Protocol deviation|3|||
19545230|NCT01132612|41994809|FG000|Overall Study|Lost to Follow-up|2|||
19545231|NCT01132612|41994810|FG001|Overall Study|Lost to Follow-up|2|||
19545232|NCT01132612|41994811|FG002|Overall Study|Lost to Follow-up|7|||
19545233|NCT01132612|41994809|FG000|Overall Study|Adverse Event|5|||
19545234|NCT01132612|41994810|FG001|Overall Study|Adverse Event|2|||
19545235|NCT01132612|41994811|FG002|Overall Study|Adverse Event|15|||
19545236|NCT01132612|41994809|FG000|Overall Study|Withdrawal by Subject|5|||
19545237|NCT01132612|41994810|FG001|Overall Study|Withdrawal by Subject|8|||
19545238|NCT01132612|41994811|FG002|Overall Study|Withdrawal by Subject|19|||
19545239|NCT01132612|41994809|FG000|Overall Study|Administrative problems|5|||
19545240|NCT01132612|41994810|FG001|Overall Study|Administrative problems|1|||
19545241|NCT01132612|41994811|FG002|Overall Study|Administrative problems|52|||
19545242|NCT01132612|41994809|FG000|Overall Study|Lack of Efficacy|23|||
19545243|NCT01132612|41994810|FG001|Overall Study|Lack of Efficacy|22|||
19545244|NCT01132612|41994811|FG002|Overall Study|Lack of Efficacy|73|||
19545245|NCT01132495|41994823|FG000|Overall Study|Various reasons|40|||
19545246|NCT01132495|41994824|FG001|Overall Study|Various reasons|38|||
19545247|NCT01132495|41994825|FG002|Overall Study|Various reasons|20|||
19545248|NCT01132495|41994826|FG003|Overall Study|Various reasons|12|||
19545249|NCT01087905|41994845|FG000|Overall Study|Lost to Follow-up|24|||
19545250|NCT01087905|41994846|FG001|Overall Study|Lost to Follow-up|28|||
19545251|NCT01087905|41994847|FG002|Overall Study|Lost to Follow-up|18|||
19545252|NCT01087905|41994848|FG003|Overall Study|Lost to Follow-up|31|||
19545253|NCT01087905|41994849|FG004|Overall Study|Lost to Follow-up|27|||
19545254|NCT01087905|41994850|FG005|Overall Study|Lost to Follow-up|25|||
19545255|NCT01087905|41994851|FG006|Overall Study|Lost to Follow-up|20|||
19545256|NCT01087905|41994852|FG007|Overall Study|Lost to Follow-up|24|||
19545257|NCT01087905|41994845|FG000|Overall Study|Withdrawal by Subject|5|||
19545258|NCT01087905|41994846|FG001|Overall Study|Withdrawal by Subject|4|||
19545259|NCT01087905|41994847|FG002|Overall Study|Withdrawal by Subject|4|||
19545260|NCT01087905|41994848|FG003|Overall Study|Withdrawal by Subject|5|||
19545261|NCT01087905|41994849|FG004|Overall Study|Withdrawal by Subject|4|||
19545262|NCT01087905|41994850|FG005|Overall Study|Withdrawal by Subject|3|||
19545263|NCT01087905|41994851|FG006|Overall Study|Withdrawal by Subject|3|||
19545264|NCT01087905|41994852|FG007|Overall Study|Withdrawal by Subject|5|||
19545265|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
19545266|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
19545267|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
19545268|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
19545269|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
19545270|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
19545271|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
19545272|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
19545273|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
19545274|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
19545275|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
19545276|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
19545277|NCT01087788|41994871|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
19545278|NCT01087788|41994872|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
19545279|NCT01087788|41994873|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
19545280|NCT01087788|41994871|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
19545281|NCT01087788|41994872|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
19545282|NCT01087788|41994873|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
19545283|NCT01087788|41994871|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
19545284|NCT01087788|41994872|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
19545285|NCT01087788|41994873|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
19545286|NCT01087788|41994871|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
19545287|NCT01087788|41994872|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
19545288|NCT01087788|41994873|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
19545289|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
19545290|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
19545291|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
19545292|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
19545293|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
19545294|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
19545295|NCT01087788|41994871|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
19545296|NCT01087788|41994872|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
19545297|NCT01087788|41994873|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
19545298|NCT01087788|41994871|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
19545299|NCT01087788|41994872|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
19545300|NCT01087788|41994873|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
19545301|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
19545302|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
19545303|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
19545304|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
19545305|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
19545306|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
19545307|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
19545308|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
19545309|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
19545310|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
19545311|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
19545312|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
19545313|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
19545314|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
19545315|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
19545316|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
19545317|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
19545318|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
19545319|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
19545320|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
19545321|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
19545322|NCT01087788|41994871|FG000|24-weeks Dose-blind Period|Patient moved|0|||
19545323|NCT01087788|41994872|FG001|24-weeks Dose-blind Period|Patient moved|0|||
19545324|NCT01087788|41994873|FG002|24-weeks Dose-blind Period|Patient moved|1|||
19545325|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
19545326|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
19545327|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
19545328|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
19545329|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
19545330|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
19545331|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
19545332|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
19545333|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
19545334|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
19545335|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
19545336|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
19545337|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
19545338|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
19545339|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
19545340|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
19545341|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
19545342|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
19545343|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
19545344|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
19545345|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
19545346|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
19545347|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
19545348|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
19545349|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
19545350|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
19545351|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
19545352|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
19545353|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
19545354|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
19545355|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
19545356|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
19545357|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
19545358|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
19545359|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
19545360|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
19545361|NCT01087788|41994871|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
19545362|NCT01087788|41994872|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
19545363|NCT01087788|41994873|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
19545364|NCT01086969|41994885|FG000|Overall Study|Withdrawal by Subject|1|||
19545365|NCT01086969|41994886|FG001|Overall Study|Withdrawal by Subject|2|||
19545366|NCT01086969|41994887|FG002|Overall Study|Withdrawal by Subject|0|||
19545367|NCT01086423|41994898|FG000|Overall Study|Protocol Violation|0|||
19545368|NCT01086423|41994899|FG001|Overall Study|Protocol Violation|0|||
19545369|NCT01086423|41994900|FG002|Overall Study|Protocol Violation|1|||
19545370|NCT01086423|41994898|FG000|Overall Study|Migrated/moved from study area|2|||
19715898|NCT03342898|42158888|FG001|Overall Study|Reason not Specified|2|||
19545371|NCT01086423|41994899|FG001|Overall Study|Migrated/moved from study area|0|||
19545372|NCT01086423|41994900|FG002|Overall Study|Migrated/moved from study area|4|||
19545373|NCT01086423|41994898|FG000|Overall Study|Adverse event, fatal|1|||
19545374|NCT01086423|41994899|FG001|Overall Study|Adverse event, fatal|1|||
19545375|NCT01086423|41994900|FG002|Overall Study|Adverse event, fatal|0|||
19545376|NCT01086423|41994898|FG000|Overall Study|Adverse event, non-fatal|2|||
19545377|NCT01086423|41994899|FG001|Overall Study|Adverse event, non-fatal|1|||
19545378|NCT01086423|41994900|FG002|Overall Study|Adverse event, non-fatal|0|||
19545379|NCT01086423|41994898|FG000|Overall Study|Withdrawal by Subject|5|||
19545380|NCT01086423|41994899|FG001|Overall Study|Withdrawal by Subject|1|||
19545381|NCT01086423|41994900|FG002|Overall Study|Withdrawal by Subject|3|||
19545382|NCT01086423|41994898|FG000|Overall Study|Lost to Follow-up|0|||
19545383|NCT01086423|41994899|FG001|Overall Study|Lost to Follow-up|0|||
19545384|NCT01086423|41994900|FG002|Overall Study|Lost to Follow-up|1|||
19545385|NCT01086150|41994911|FG000|Overall Study|Withdrawal by Subject|0|||
19545386|NCT01086150|41994912|FG001|Overall Study|Withdrawal by Subject|4|||
19545387|NCT01086150|41994913|FG002|Overall Study|Withdrawal by Subject|1|||
19545388|NCT01086150|41994911|FG000|Overall Study|Lost to Follow-up|0|||
19545389|NCT01086150|41994912|FG001|Overall Study|Lost to Follow-up|1|||
19545390|NCT01086150|41994913|FG002|Overall Study|Lost to Follow-up|0|||
19545391|NCT01086150|41994911|FG000|Overall Study|Screen Failure|0|||
19545392|NCT01086150|41994912|FG001|Overall Study|Screen Failure|1|||
19545393|NCT01086150|41994913|FG002|Overall Study|Screen Failure|0|||
19545394|NCT01086033|41994921|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
19545395|NCT01086033|41994921|FG000|Overall Study|Lost to Follow-up|86|||
19545396|NCT01086033|41994921|FG000|Overall Study|Adverse Event|42|||
19545397|NCT01086033|41994921|FG000|Overall Study|Withdrawal by Subject|41|||
19545398|NCT01086033|41994921|FG000|Overall Study|Other|14|||
19545399|NCT01086033|41994921|FG000|Overall Study|Other|13|||
19545400|NCT01086033|41994921|FG000|Overall Study|AE and Withdrew Consent|5|||
19545401|NCT01086033|41994921|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
19545402|NCT01086033|41994921|FG000|Overall Study|Withdrew consent and Other Reason|4|||
19545403|NCT01086033|41994921|FG000|Overall Study|AE and Lack of Efficacy|4|||
19545404|NCT01086033|41994921|FG000|Overall Study|Death|1|||
19545405|NCT01086033|41994921|FG000|Overall Study|AE and Lost to Follow-up|1|||
19545406|NCT01086033|41994921|FG000|Overall Study|AE and Other Reason|1|||
19545407|NCT01086033|41994921|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
19545408|NCT01085682|41994930|FG000|Overall Study|Withdrawal by Subject|25|||
19545409|NCT01085682|41994931|FG001|Overall Study|Withdrawal by Subject|25|||
19545410|NCT01085214|41994937|FG000|Overall Study|Alternate treatment required|1|||
19545411|NCT01085136|41994941|FG000|Part A|Other Adverse event|223|||
19545412|NCT01085136|41994942|FG001|Part A|Other Adverse event|0|||
19545413|NCT01085136|41994943|FG002|Part A|Other Adverse event|0|||
19545414|NCT01085136|41994941|FG000|Part A|Protocol Violation|3|||
19545415|NCT01085136|41994942|FG001|Part A|Protocol Violation|0|||
19545416|NCT01085136|41994943|FG002|Part A|Protocol Violation|0|||
19545417|NCT01085136|41994941|FG000|Part A|Lost to Follow-up|3|||
19545418|NCT01085136|41994942|FG001|Part A|Lost to Follow-up|0|||
19545419|NCT01085136|41994943|FG002|Part A|Lost to Follow-up|0|||
19545420|NCT01085136|41994941|FG000|Part A|Refusal to continue trial medication|64|||
19545421|NCT01085136|41994942|FG001|Part A|Refusal to continue trial medication|0|||
19545422|NCT01085136|41994943|FG002|Part A|Refusal to continue trial medication|0|||
19545423|NCT01085136|41994941|FG000|Part A|Other reason not defined above|30|||
19545424|NCT01085136|41994942|FG001|Part A|Other reason not defined above|0|||
19545425|NCT01085136|41994943|FG002|Part A|Other reason not defined above|0|||
19545426|NCT01085136|41994941|FG000|Part B|Other AE|0|||
19545427|NCT01085136|41994942|FG001|Part B|Other AE|29|||
19545428|NCT01085136|41994943|FG002|Part B|Other AE|8|||
19545429|NCT01085136|41994941|FG000|Part B|Refusal to continue trial medication|0|||
19545430|NCT01085136|41994942|FG001|Part B|Refusal to continue trial medication|12|||
19545431|NCT01085136|41994943|FG002|Part B|Refusal to continue trial medication|7|||
19545432|NCT01085136|41994941|FG000|Part B|Not treated|0|||
19545433|NCT01085136|41994942|FG001|Part B|Not treated|4|||
19545434|NCT01085136|41994943|FG002|Part B|Not treated|8|||
19545435|NCT01085136|41994941|FG000|Part B|Other reason not defined above|0|||
19545436|NCT01085136|41994942|FG001|Part B|Other reason not defined above|6|||
19545437|NCT01085136|41994943|FG002|Part B|Other reason not defined above|3|||
19545438|NCT01084707|41994953|FG000|Overall Study|Withdrawal by Subject|6|||
19545439|NCT01084668|41994965|FG000|Overall Study|Lack of Efficacy|5|||
19545440|NCT01084668|41994965|FG000|Overall Study|Withdrawal by Subject|2|||
19545441|NCT01084668|41994965|FG000|Overall Study|Pregnancy|1|||
19545442|NCT01084668|41994965|FG000|Overall Study|Non-compliance|1|||
19715899|NCT03342898|42158889|FG002|Overall Study|Reason not Specified|0|||
19545443|NCT01084551|41994974|FG000|Overall Study|Adverse Event|2|||
19545444|NCT01084551|41994975|FG001|Overall Study|Adverse Event|9|||
19545445|NCT01084551|41994976|FG002|Overall Study|Adverse Event|4|||
19545446|NCT01084551|41994974|FG000|Overall Study|Lack of Efficacy|2|||
19545447|NCT01084551|41994975|FG001|Overall Study|Lack of Efficacy|0|||
19545448|NCT01084551|41994976|FG002|Overall Study|Lack of Efficacy|1|||
19545449|NCT01084551|41994974|FG000|Overall Study|Withdrawal by Subject|2|||
19545450|NCT01084551|41994975|FG001|Overall Study|Withdrawal by Subject|1|||
19545451|NCT01084551|41994976|FG002|Overall Study|Withdrawal by Subject|0|||
19545452|NCT01084551|41994974|FG000|Overall Study|Protocol Violation|2|||
19545453|NCT01084551|41994975|FG001|Overall Study|Protocol Violation|4|||
19715900|NCT00339833|42158899|FG000|Overall Study|Withdrawal by Subject|1|||
19715901|NCT00339833|42158900|FG001|Overall Study|Withdrawal by Subject|2|||
19715902|NCT00339833|42158899|FG000|Overall Study|toothache|0|||
19715903|NCT00339833|42158900|FG001|Overall Study|toothache|1|||
19545454|NCT01084551|41994976|FG002|Overall Study|Protocol Violation|0|||
19545455|NCT01084551|41994974|FG000|Overall Study|Lost to Follow-up|0|||
19545456|NCT01084551|41994975|FG001|Overall Study|Lost to Follow-up|0|||
19545457|NCT01084551|41994976|FG002|Overall Study|Lost to Follow-up|3|||
19545458|NCT01084551|41994974|FG000|Overall Study|Physician Decision|1|||
19545459|NCT01084551|41994975|FG001|Overall Study|Physician Decision|0|||
19545460|NCT01084551|41994976|FG002|Overall Study|Physician Decision|0|||
19545461|NCT01084083|41994984|FG000|Overall Study|Adverse Event|5|||
19545462|NCT01084083|41994984|FG000|Overall Study|Death|1|||
19545463|NCT01084083|41994984|FG000|Overall Study|Withdrawal by Subject|2|||
19545464|NCT01084083|41994984|FG000|Overall Study|Complicating disease|1|||
19545465|NCT01084083|41994984|FG000|Overall Study|Other|2|||
19545466|NCT01084083|41994984|FG000|Overall Study|Never started assigned therapy|1|||
19545467|NCT01084005|41994991|FG000|Overall Study|Adverse Event|1|||
19545468|NCT01084005|41994992|FG001|Overall Study|Adverse Event|8|||
19545469|NCT01084005|41994991|FG000|Overall Study|Protocol Violation|3|||
19545470|NCT01084005|41994992|FG001|Overall Study|Protocol Violation|7|||
19545471|NCT01084005|41994991|FG000|Overall Study|Withdrawal by Subject|1|||
19545472|NCT01084005|41994992|FG001|Overall Study|Withdrawal by Subject|1|||
19545473|NCT01083810|41995001|FG000|Overall Study|Lost to Follow-up|23|||
19545474|NCT01083810|41995002|FG001|Overall Study|Lost to Follow-up|11|||
19545475|NCT01083810|41995003|FG002|Overall Study|Lost to Follow-up|4|||
19545476|NCT01083810|41995001|FG000|Overall Study|Adverse Event|15|||
19545477|NCT01083810|41995002|FG001|Overall Study|Adverse Event|11|||
19545478|NCT01083810|41995003|FG002|Overall Study|Adverse Event|4|||
19545479|NCT01083810|41995001|FG000|Overall Study|Withdrawal by Subject|7|||
19545480|NCT01083810|41995002|FG001|Overall Study|Withdrawal by Subject|2|||
19545481|NCT01083810|41995003|FG002|Overall Study|Withdrawal by Subject|4|||
19545482|NCT01083810|41995001|FG000|Overall Study|Reason not reported|6|||
19715904|NCT00339833|42158899|FG000|Overall Study|indigestion|0|||
19715905|NCT00339833|42158900|FG001|Overall Study|indigestion|1|||
19715906|NCT00339833|42158899|FG000|Overall Study|Chest pain|0|||
19715907|NCT00339833|42158900|FG001|Overall Study|Chest pain|1|||
19715908|NCT00339833|42158899|FG000|Overall Study|minor infection|0|||
19715909|NCT00339833|42158900|FG001|Overall Study|minor infection|1|||
19715910|NCT00339833|42158899|FG000|Overall Study|Poor venous access|2|||
19715911|NCT00339833|42158900|FG001|Overall Study|Poor venous access|2|||
19715912|NCT00339833|42158899|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
19715913|NCT00339833|42158900|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
19715914|NCT00339833|42158899|FG000|Overall Study|Error in data records|1|||
19715915|NCT00339833|42158900|FG001|Overall Study|Error in data records|0|||
19715916|NCT03793556|42158908|FG000|Overall Study|Withdrawal by Subject|12|||
19715917|NCT03793556|42158909|FG001|Overall Study|Withdrawal by Subject|1|||
19715918|NCT03793556|42158908|FG000|Overall Study|Lost to Follow-up|1|||
19715919|NCT03793556|42158909|FG001|Overall Study|Lost to Follow-up|1|||
19715920|NCT03392194|42158920|FG000|Overall Study|Withdrawal by Subject|1|||
19715921|NCT03392194|42158921|FG001|Overall Study|Withdrawal by Subject|2|||
19715922|NCT03392194|42158920|FG000|Overall Study|Conflicts with personal schedule|1|||
19715923|NCT03392194|42158921|FG001|Overall Study|Conflicts with personal schedule|0|||
19715924|NCT03828617|42158931|FG000|Overall Study|Lost to Follow-up|22|||
19715925|NCT03828617|42158932|FG001|Overall Study|Lost to Follow-up|12|||
19715926|NCT03828617|42158933|FG002|Overall Study|Lost to Follow-up|23|||
19715927|NCT03828617|42158934|FG003|Overall Study|Lost to Follow-up|7|||
19715928|NCT03828617|42158931|FG000|Overall Study|No longer met eligibility criteria|0|||
19715929|NCT03828617|42158932|FG001|Overall Study|No longer met eligibility criteria|1|||
19715930|NCT03828617|42158933|FG002|Overall Study|No longer met eligibility criteria|1|||
19715931|NCT03828617|42158934|FG003|Overall Study|No longer met eligibility criteria|3|||
19715932|NCT03828617|42158931|FG000|Overall Study|Protocol Violation|0|||
19715933|NCT03828617|42158932|FG001|Overall Study|Protocol Violation|2|||
19715934|NCT03828617|42158933|FG002|Overall Study|Protocol Violation|0|||
19715935|NCT03828617|42158934|FG003|Overall Study|Protocol Violation|0|||
19715936|NCT03828617|42158931|FG000|Overall Study|Withdrawal by Subject|2|||
19715937|NCT03828617|42158932|FG001|Overall Study|Withdrawal by Subject|0|||
19545483|NCT01083810|41995002|FG001|Overall Study|Reason not reported|1|||
19545484|NCT01083810|41995003|FG002|Overall Study|Reason not reported|1|||
19545485|NCT01083810|41995001|FG000|Overall Study|Non-compliance|4|||
19545486|NCT01083810|41995002|FG001|Overall Study|Non-compliance|7|||
19715938|NCT03828617|42158933|FG002|Overall Study|Withdrawal by Subject|2|||
19545487|NCT01083810|41995003|FG002|Overall Study|Non-compliance|2|||
19715939|NCT03828617|42158934|FG003|Overall Study|Withdrawal by Subject|0|||
19545488|NCT01083810|41995001|FG000|Overall Study|Simplification|4|||
19545489|NCT01083810|41995002|FG001|Overall Study|Simplification|1|||
19545490|NCT01083810|41995003|FG002|Overall Study|Simplification|0|||
19545491|NCT01083810|41995001|FG000|Overall Study|Death|2|||
19545492|NCT01083810|41995002|FG001|Overall Study|Death|2|||
19545493|NCT01083810|41995003|FG002|Overall Study|Death|3|||
19545494|NCT01083810|41995001|FG000|Overall Study|Co-morbidities|1|||
19545495|NCT01083810|41995002|FG001|Overall Study|Co-morbidities|0|||
19545496|NCT01083810|41995003|FG002|Overall Study|Co-morbidities|0|||
19545497|NCT01083810|41995001|FG000|Overall Study|Participation in study|1|||
19545498|NCT01083810|41995002|FG001|Overall Study|Participation in study|0|||
19545499|NCT01083810|41995003|FG002|Overall Study|Participation in study|0|||
19545500|NCT01083810|41995001|FG000|Overall Study|Therapy break|1|||
19545501|NCT01083810|41995002|FG001|Overall Study|Therapy break|2|||
19545502|NCT01083810|41995003|FG002|Overall Study|Therapy break|2|||
19545503|NCT01083810|41995001|FG000|Overall Study|Virologic failure|1|||
19545504|NCT01083810|41995002|FG001|Overall Study|Virologic failure|8|||
19545505|NCT01083810|41995003|FG002|Overall Study|Virologic failure|0|||
19545506|NCT01083771|41995009|FG000|Overall Study|non-compliant|2|||
19545507|NCT01083771|41995009|FG000|Overall Study|Withdrawal by Subject|3|||
19545508|NCT01083693|41995016|FG000|Overall Study|Adverse Event|1|||
19545509|NCT01083693|41995017|FG001|Overall Study|Adverse Event|1|||
19545510|NCT01083693|41995018|FG002|Overall Study|Adverse Event|0|||
19545511|NCT01083693|41995016|FG000|Overall Study|Lost to Follow-up|2|||
19545512|NCT01083693|41995017|FG001|Overall Study|Lost to Follow-up|0|||
19545513|NCT01083693|41995018|FG002|Overall Study|Lost to Follow-up|2|||
19545514|NCT01083693|41995016|FG000|Overall Study|Lack of effectiveness|13|||
19545515|NCT01083693|41995017|FG001|Overall Study|Lack of effectiveness|2|||
19545516|NCT01083693|41995018|FG002|Overall Study|Lack of effectiveness|2|||
19545517|NCT01083693|41995016|FG000|Overall Study|Patient Moved|0|||
19545518|NCT01083693|41995017|FG001|Overall Study|Patient Moved|1|||
19545519|NCT01083693|41995018|FG002|Overall Study|Patient Moved|0|||
19545520|NCT01083693|41995016|FG000|Overall Study|Complete remission|0|||
19545521|NCT01083693|41995017|FG001|Overall Study|Complete remission|1|||
19545522|NCT01083693|41995018|FG002|Overall Study|Complete remission|0|||
19545523|NCT01083693|41995016|FG000|Overall Study|Other medical condition/surgery|1|||
19545524|NCT01083693|41995017|FG001|Overall Study|Other medical condition/surgery|1|||
19545525|NCT01083693|41995018|FG002|Overall Study|Other medical condition/surgery|0|||
19545526|NCT01083693|41995016|FG000|Overall Study|Withdrawal by Subject|3|||
19545527|NCT01083693|41995017|FG001|Overall Study|Withdrawal by Subject|0|||
19545528|NCT01083693|41995018|FG002|Overall Study|Withdrawal by Subject|2|||
19545529|NCT01083693|41995016|FG000|Overall Study|Reason unknown|0|||
19545530|NCT01083693|41995017|FG001|Overall Study|Reason unknown|0|||
19545531|NCT01083693|41995018|FG002|Overall Study|Reason unknown|1|||
19545532|NCT01083576|41995032|FG000|Overall Study|Treatment Failure|6|||
19545533|NCT01083576|41995033|FG001|Overall Study|Treatment Failure|1|||
19545534|NCT01083186|41995040|FG000|Overall Study|Lost to Follow-up|48|||
19545535|NCT01083186|41995040|FG000|Overall Study|Consent Withdrawal|7|||
19545536|NCT01083186|41995040|FG000|Overall Study|Death|3|||
19545537|NCT01083186|41995040|FG000|Overall Study|Adverse Event|3|||
19545538|NCT01083186|41995040|FG000|Overall Study|Lack of Efficacy|2|||
19545539|NCT01083186|41995040|FG000|Overall Study|Hemodialysis Initiation|28|||
19545540|NCT01083186|41995040|FG000|Overall Study|Administrative Reasons|2|||
19545541|NCT01083186|41995040|FG000|Overall Study|Non-compliance to Study Treatment|1|||
19545542|NCT01082640|41995067|FG000|Overall Study|Adverse Event|9|||
19545543|NCT01082640|41995068|FG001|Overall Study|Adverse Event|5|||
19545544|NCT01082640|41995069|FG002|Overall Study|Adverse Event|3|||
19545545|NCT01082640|41995067|FG000|Overall Study|Withdrawal by Subject|3|||
19545546|NCT01082640|41995068|FG001|Overall Study|Withdrawal by Subject|3|||
19545547|NCT01082640|41995069|FG002|Overall Study|Withdrawal by Subject|2|||
19545548|NCT01082640|41995067|FG000|Overall Study|Major protocol deviation|3|||
19545549|NCT01082640|41995068|FG001|Overall Study|Major protocol deviation|3|||
19545550|NCT01082640|41995069|FG002|Overall Study|Major protocol deviation|0|||
19545551|NCT01082640|41995067|FG000|Overall Study|Lost to Follow-up|0|||
19545552|NCT01082640|41995068|FG001|Overall Study|Lost to Follow-up|3|||
19545553|NCT01082640|41995069|FG002|Overall Study|Lost to Follow-up|0|||
19545554|NCT01082640|41995067|FG000|Overall Study|Other|2|||
19545555|NCT01082640|41995068|FG001|Overall Study|Other|1|||
19545556|NCT01082640|41995069|FG002|Overall Study|Other|3|||
19545557|NCT01082367|41995082|FG000|Double-blind Period|Administrative problems|0|||
19545558|NCT01082367|41995083|FG001|Double-blind Period|Administrative problems|1|||
19545559|NCT01082367|41995082|FG000|Double-blind Period|Lack of Efficacy|5|||
19545560|NCT01082367|41995083|FG001|Double-blind Period|Lack of Efficacy|11|||
19545561|NCT01082367|41995082|FG000|Double-blind Period|Adverse Event|0|||
19545562|NCT01082367|41995083|FG001|Double-blind Period|Adverse Event|1|||
19545563|NCT01082367|41995082|FG000|Follow-up (F-U) Period|Administrative problems|1|||
19545564|NCT01082367|41995083|FG001|Follow-up (F-U) Period|Administrative problems|0|||
19545565|NCT01082367|41995082|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
19545566|NCT01082367|41995083|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
19545567|NCT01082367|41995082|FG000|Follow-up (F-U) Period|Adverse Event|0|||
19545568|NCT01082367|41995083|FG001|Follow-up (F-U) Period|Adverse Event|1|||
19545569|NCT01082211|41995093|FG000|Overall Study|Protocol Violation|4|||
19545570|NCT01082211|41995093|FG000|Overall Study|No protocol treatment received|3|||
19545571|NCT01081665|41995100|FG000|Overall Study|Death|41|||
19545572|NCT01081665|41995100|FG000|Overall Study|Lost to Follow-up|18|||
19715940|NCT03391960|42158943|FG000|Overall Study|Protocol Violation|0|||
19715941|NCT03391960|42158944|FG001|Overall Study|Protocol Violation||||
19715942|NCT03390166|42158970|FG000|Overall Study|Death|0|||
19715943|NCT03390166|42158971|FG001|Overall Study|Death|1|||
19715944|NCT03390166|42158970|FG000|Overall Study|Lost to Follow-up|6|||
19715945|NCT03390166|42158971|FG001|Overall Study|Lost to Follow-up|4|||
19715946|NCT03390166|42158970|FG000|Overall Study|Physician Decision|2|||
19715947|NCT03390166|42158971|FG001|Overall Study|Physician Decision|1|||
19715948|NCT03390166|42158970|FG000|Overall Study|Move from study area|3|||
19715949|NCT03390166|42158971|FG001|Overall Study|Move from study area|2|||
19715950|NCT03390166|42158970|FG000|Overall Study|To militarycamp for conscript|1|||
19715951|NCT03390166|42158971|FG001|Overall Study|To militarycamp for conscript|0|||
19715952|NCT03390166|42158970|FG000|Overall Study|To drug therapy course|0|||
19715953|NCT03390166|42158971|FG001|Overall Study|To drug therapy course|1|||
19715954|NCT03390166|42158970|FG000|Overall Study|Move to work oversea|0|||
19715955|NCT03390166|42158971|FG001|Overall Study|Move to work oversea|1|||
19715956|NCT03828539|42158979|FG000|Overall Study|Adverse Event|3|||
19715957|NCT03828539|42158980|FG001|Overall Study|Adverse Event|12|||
19715958|NCT03828539|42158979|FG000|Overall Study|Patient's/guardian's decision|3|||
19715959|NCT03828539|42158980|FG001|Overall Study|Patient's/guardian's decision|5|||
19715960|NCT03828539|42158979|FG000|Overall Study|Lost to Follow-up|4|||
19715961|NCT03828539|42158980|FG001|Overall Study|Lost to Follow-up|2|||
19715962|NCT03828539|42158979|FG000|Overall Study|Protocol Violation|3|||
19715963|NCT03828539|42158980|FG001|Overall Study|Protocol Violation|2|||
19715964|NCT03828539|42158979|FG000|Overall Study|Withdrawal of informed consent|2|||
19715965|NCT03828539|42158980|FG001|Overall Study|Withdrawal of informed consent|1|||
19715966|NCT03828539|42158979|FG000|Overall Study|New therapy for study indication|1|||
19715967|NCT03828539|42158980|FG001|Overall Study|New therapy for study indication|0|||
19715968|NCT03336502|42158988|FG000|Overall Study|Physician Decision|0|||
19715969|NCT03336502|42158989|FG001|Overall Study|Physician Decision|1|||
19715970|NCT03336502|42158988|FG000|Overall Study|Prohibited Drugs|1|||
19715971|NCT03336502|42158989|FG001|Overall Study|Prohibited Drugs|1|||
19715972|NCT03336502|42158988|FG000|Overall Study|Death|1|||
19715973|NCT03336502|42158989|FG001|Overall Study|Death|2|||
19715974|NCT03336502|42158988|FG000|Overall Study|Adverse Event|2|||
19715975|NCT03336502|42158989|FG001|Overall Study|Adverse Event|5|||
19715976|NCT02949934|42159001|FG000|Natural Drinking Period|Adverse Event|1|||
19715977|NCT02949934|42159002|FG001|Natural Drinking Period|Adverse Event|0|||
19715978|NCT02949934|42159003|FG002|Natural Drinking Period|Adverse Event|0|||
19715979|NCT02949934|42159004|FG003|Natural Drinking Period|Adverse Event|1|||
19715980|NCT02949934|42159005|FG004|Natural Drinking Period|Adverse Event|0|||
19715981|NCT02949934|42159006|FG005|Natural Drinking Period|Adverse Event|0|||
19715982|NCT02949934|42159001|FG000|Natural Drinking Period|Lost to Follow-up|0|||
19715983|NCT02949934|42159002|FG001|Natural Drinking Period|Lost to Follow-up|0|||
19715984|NCT02949934|42159003|FG002|Natural Drinking Period|Lost to Follow-up|0|||
19715985|NCT02949934|42159004|FG003|Natural Drinking Period|Lost to Follow-up|0|||
19715986|NCT02949934|42159005|FG004|Natural Drinking Period|Lost to Follow-up|1|||
19715987|NCT02949934|42159006|FG005|Natural Drinking Period|Lost to Follow-up|0|||
19715988|NCT02949934|42159001|FG000|Neuroimaging|Protocol Violation|2|||
19715989|NCT02949934|42159002|FG001|Neuroimaging|Protocol Violation|0|||
19715990|NCT02949934|42159003|FG002|Neuroimaging|Protocol Violation|0|||
19715991|NCT02949934|42159004|FG003|Neuroimaging|Protocol Violation|0|||
19715992|NCT02949934|42159005|FG004|Neuroimaging|Protocol Violation|1|||
19715993|NCT02949934|42159006|FG005|Neuroimaging|Protocol Violation|0|||
19715994|NCT02949934|42159001|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
19715995|NCT02949934|42159002|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
19715996|NCT02949934|42159003|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
19715997|NCT02949934|42159004|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
19715998|NCT02949934|42159005|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
19715999|NCT02949934|42159006|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
19716000|NCT02949934|42159001|FG000|Neuroimaging|Not scanned|0|||
19716001|NCT02949934|42159002|FG001|Neuroimaging|Not scanned|0|||
19716002|NCT02949934|42159003|FG002|Neuroimaging|Not scanned|1|||
19716003|NCT02949934|42159004|FG003|Neuroimaging|Not scanned|0|||
19716004|NCT02949934|42159005|FG004|Neuroimaging|Not scanned|0|||
19716005|NCT02949934|42159006|FG005|Neuroimaging|Not scanned|2|||
19716006|NCT02949934|42159001|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
19716007|NCT02949934|42159002|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
19716008|NCT02949934|42159003|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
19545573|NCT01081665|41995100|FG000|Overall Study|Withdrawal by Subject|17|||
19545574|NCT01081665|41995100|FG000|Overall Study|Change of dialysis unit|10|||
19545575|NCT01081665|41995100|FG000|Overall Study|Regulation of iPTH|5|||
19545576|NCT01081665|41995100|FG000|Overall Study|Change in renal replacement therapy|2|||
19545577|NCT01081665|41995100|FG000|Overall Study|Adverse Event|1|||
19545578|NCT01081665|41995100|FG000|Overall Study|Lack of Efficacy|1|||
19545579|NCT01081626|41995106|FG000|Overall Study|Dosing error|1|||
19545580|NCT01081626|41995107|FG001|Overall Study|Dosing error|1|||
19545581|NCT01081626|41995106|FG000|Overall Study|Missing Estradiol|25|||
19545582|NCT01081626|41995107|FG001|Overall Study|Missing Estradiol|28|||
19545583|NCT01081626|41995106|FG000|Overall Study|Low antral follicle count|1|||
19545584|NCT01081626|41995107|FG001|Overall Study|Low antral follicle count|0|||
19545585|NCT01081626|41995106|FG000|Overall Study|Overstimulation|0|||
19545586|NCT01081626|41995107|FG001|Overall Study|Overstimulation|1|||
19545587|NCT01081626|41995106|FG000|Overall Study|Lost to Follow-up|0|||
19545588|NCT01081626|41995107|FG001|Overall Study|Lost to Follow-up|1|||
19545589|NCT01081626|41995106|FG000|Overall Study|Other|33|||
19545590|NCT01081626|41995107|FG001|Overall Study|Other|30|||
19545591|NCT01080768|41995115|FG000|Overall Study|Protocol Deviation|2|||
19545592|NCT01080768|41995116|FG001|Overall Study|Protocol Deviation|1|||
19545593|NCT01080300|41995124|FG000|Overall Study|Adverse Event|49|||
19545594|NCT01080300|41995125|FG001|Overall Study|Adverse Event|35|||
19545595|NCT01080300|41995124|FG000|Overall Study|Lack of Efficacy|12|||
19545596|NCT01080300|41995125|FG001|Overall Study|Lack of Efficacy|15|||
19545597|NCT01080300|41995124|FG000|Overall Study|Protocol Violation|7|||
19545598|NCT01080300|41995125|FG001|Overall Study|Protocol Violation|13|||
19545599|NCT01080300|41995124|FG000|Overall Study|Lost to Follow-up|10|||
19545600|NCT01080300|41995125|FG001|Overall Study|Lost to Follow-up|6|||
19545601|NCT01080300|41995124|FG000|Overall Study|Death|0|||
19545602|NCT01080300|41995125|FG001|Overall Study|Death|1|||
19545603|NCT01080300|41995124|FG000|Overall Study|Withdrawal by Subject|12|||
19545604|NCT01080300|41995125|FG001|Overall Study|Withdrawal by Subject|28|||
19545605|NCT01080300|41995124|FG000|Overall Study|Reasons not specified|4|||
19545606|NCT01080300|41995125|FG001|Overall Study|Reasons not specified|6|||
19545607|NCT01085097|41995136|FG000|Overall Study|Adverse Event|0|||
19545608|NCT01085097|41995137|FG001|Overall Study|Adverse Event|0|||
19545609|NCT01085097|41995138|FG002|Overall Study|Adverse Event|2|||
19545610|NCT01085097|41995136|FG000|Overall Study|Treatment failure|2|||
19545611|NCT01085097|41995137|FG001|Overall Study|Treatment failure|0|||
19545612|NCT01085097|41995138|FG002|Overall Study|Treatment failure|0|||
19545613|NCT03450629|41995152|FG000|Overall Study|Adverse Event|15|||
19545614|NCT03450629|41995153|FG001|Overall Study|Adverse Event|14|||
19545615|NCT03450629|41995152|FG000|Overall Study|Physician Decision|2|||
19545616|NCT03450629|41995153|FG001|Overall Study|Physician Decision|2|||
19545617|NCT03450629|41995152|FG000|Overall Study|Lack of Efficacy|2|||
19545618|NCT03450629|41995153|FG001|Overall Study|Lack of Efficacy|0|||
19545619|NCT03450629|41995152|FG000|Overall Study|Lost to Follow-up|4|||
19545620|NCT03450629|41995153|FG001|Overall Study|Lost to Follow-up|2|||
19545621|NCT03450629|41995152|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
19545622|NCT03450629|41995153|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
19545623|NCT03450629|41995152|FG000|Overall Study|Non-Compliance With Study Drug|2|||
19545624|NCT03450629|41995153|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19545625|NCT03450629|41995152|FG000|Overall Study|Protocol Violation|11|||
19545626|NCT03450629|41995153|FG001|Overall Study|Protocol Violation|8|||
19545627|NCT03450629|41995152|FG000|Overall Study|Withdrawal by Subject|12|||
19545628|NCT03450629|41995153|FG001|Overall Study|Withdrawal by Subject|6|||
19545629|NCT00198029|41995159|FG000|Overall Study|Withdrawal by Subject|4|||
19545630|NCT00197054|41995166|FG000|Overall Study|Withdrawal by Subject|9|||
19545631|NCT00197054|41995167|FG001|Overall Study|Withdrawal by Subject|3|||
19545632|NCT00197054|41995168|FG002|Overall Study|Withdrawal by Subject|3|||
19545633|NCT00197054|41995166|FG000|Overall Study|Moved from area|7|||
19545634|NCT00197054|41995167|FG001|Overall Study|Moved from area|14|||
19545635|NCT00197054|41995168|FG002|Overall Study|Moved from area|9|||
19545636|NCT00197054|41995166|FG000|Overall Study|Lost to Follow-up|1|||
19545637|NCT00197054|41995167|FG001|Overall Study|Lost to Follow-up|4|||
19545638|NCT00197054|41995168|FG002|Overall Study|Lost to Follow-up|0|||
19545639|NCT00197015|41995189|FG000|Overall Study|Adverse Event|3|||
19545640|NCT00197015|41995190|FG001|Overall Study|Adverse Event|0|||
19545641|NCT00197015|41995191|FG002|Overall Study|Adverse Event|1|||
19545642|NCT00197015|41995189|FG000|Overall Study|Protocol Violation|0|||
19545643|NCT00197015|41995190|FG001|Overall Study|Protocol Violation|3|||
19545644|NCT00197015|41995191|FG002|Overall Study|Protocol Violation|3|||
19545645|NCT00197015|41995189|FG000|Overall Study|Withdrawal by Subject|17|||
19545646|NCT00197015|41995190|FG001|Overall Study|Withdrawal by Subject|37|||
19545647|NCT00197015|41995191|FG002|Overall Study|Withdrawal by Subject|34|||
19545648|NCT00197015|41995189|FG000|Overall Study|Lost to Follow-up|28|||
19545649|NCT00197015|41995190|FG001|Overall Study|Lost to Follow-up|46|||
19545650|NCT00197015|41995191|FG002|Overall Study|Lost to Follow-up|37|||
19545651|NCT00197015|41995189|FG000|Overall Study|Other|2|||
19545652|NCT00197015|41995190|FG001|Overall Study|Other|3|||
19545653|NCT00197015|41995191|FG002|Overall Study|Other|2|||
19545654|NCT00196976|41995213|FG000|Primary Study|Migrated from study area|0|||
19545655|NCT00196976|41995214|FG001|Primary Study|Migrated from study area|0|||
19545656|NCT00196976|41995215|FG002|Primary Study|Migrated from study area|0|||
19545657|NCT00196976|41995216|FG003|Primary Study|Migrated from study area|0|||
19545658|NCT00196976|41995217|FG004|Primary Study|Migrated from study area|0|||
19545659|NCT00196976|41995218|FG005|Primary Study|Migrated from study area|0|||
19545660|NCT00196976|41995219|FG006|Primary Study|Migrated from study area|0|||
19545661|NCT00196976|41995220|FG007|Primary Study|Migrated from study area|1|||
19545662|NCT00196976|41995221|FG008|Primary Study|Migrated from study area|0|||
19545663|NCT00196976|41995222|FG009|Primary Study|Migrated from study area|0|||
19545664|NCT00196976|41995223|FG010|Primary Study|Migrated from study area|0|||
19545665|NCT00196976|41995224|FG011|Primary Study|Migrated from study area|0|||
19545666|NCT00196976|41995225|FG012|Primary Study|Migrated from study area|0|||
19545667|NCT00196976|41995226|FG013|Primary Study|Migrated from study area|0|||
19545668|NCT00196976|41995213|FG000|Primary Study|Protocol Violation|0|||
19545669|NCT00196976|41995214|FG001|Primary Study|Protocol Violation|1|||
19545670|NCT00196976|41995215|FG002|Primary Study|Protocol Violation|1|||
19545671|NCT00196976|41995216|FG003|Primary Study|Protocol Violation|0|||
19545672|NCT00196976|41995217|FG004|Primary Study|Protocol Violation|0|||
19545673|NCT00196976|41995218|FG005|Primary Study|Protocol Violation|0|||
19545674|NCT00196976|41995219|FG006|Primary Study|Protocol Violation|0|||
19545675|NCT00196976|41995220|FG007|Primary Study|Protocol Violation|0|||
19545676|NCT00196976|41995221|FG008|Primary Study|Protocol Violation|0|||
19545677|NCT00196976|41995222|FG009|Primary Study|Protocol Violation|0|||
19545678|NCT00196976|41995223|FG010|Primary Study|Protocol Violation|0|||
19545679|NCT00196976|41995224|FG011|Primary Study|Protocol Violation|0|||
19545680|NCT00196976|41995225|FG012|Primary Study|Protocol Violation|0|||
19545681|NCT00196976|41995226|FG013|Primary Study|Protocol Violation|0|||
19545682|NCT00196976|41995213|FG000|Primary Study|Withdrawal by Subject|1|||
19545683|NCT00196976|41995214|FG001|Primary Study|Withdrawal by Subject|0|||
19545684|NCT00196976|41995215|FG002|Primary Study|Withdrawal by Subject|1|||
19545685|NCT00196976|41995216|FG003|Primary Study|Withdrawal by Subject|1|||
19545686|NCT00196976|41995217|FG004|Primary Study|Withdrawal by Subject|2|||
19545687|NCT00196976|41995218|FG005|Primary Study|Withdrawal by Subject|1|||
19545688|NCT00196976|41995219|FG006|Primary Study|Withdrawal by Subject|0|||
19545689|NCT00196976|41995220|FG007|Primary Study|Withdrawal by Subject|0|||
19545690|NCT00196976|41995221|FG008|Primary Study|Withdrawal by Subject|0|||
19545691|NCT00196976|41995222|FG009|Primary Study|Withdrawal by Subject|1|||
19545692|NCT00196976|41995223|FG010|Primary Study|Withdrawal by Subject|0|||
19545693|NCT00196976|41995224|FG011|Primary Study|Withdrawal by Subject|0|||
19545694|NCT00196976|41995225|FG012|Primary Study|Withdrawal by Subject|0|||
19545695|NCT00196976|41995226|FG013|Primary Study|Withdrawal by Subject|0|||
19545696|NCT00196976|41995213|FG000|Primary Study|Lost to Follow-up|0|||
19545697|NCT00196976|41995214|FG001|Primary Study|Lost to Follow-up|0|||
19545698|NCT00196976|41995215|FG002|Primary Study|Lost to Follow-up|0|||
19545699|NCT00196976|41995216|FG003|Primary Study|Lost to Follow-up|0|||
19545700|NCT00196976|41995217|FG004|Primary Study|Lost to Follow-up|1|||
19545701|NCT00196976|41995218|FG005|Primary Study|Lost to Follow-up|1|||
19545702|NCT00196976|41995219|FG006|Primary Study|Lost to Follow-up|0|||
19545703|NCT00196976|41995220|FG007|Primary Study|Lost to Follow-up|2|||
19545704|NCT00196976|41995221|FG008|Primary Study|Lost to Follow-up|0|||
19545705|NCT00196976|41995222|FG009|Primary Study|Lost to Follow-up|0|||
19545706|NCT00196976|41995223|FG010|Primary Study|Lost to Follow-up|0|||
19545707|NCT00196976|41995224|FG011|Primary Study|Lost to Follow-up|0|||
19545708|NCT00196976|41995225|FG012|Primary Study|Lost to Follow-up|0|||
19545709|NCT00196976|41995226|FG013|Primary Study|Lost to Follow-up|0|||
19545710|NCT00196976|41995213|FG000|Primary Study|Other|0|||
19545711|NCT00196976|41995214|FG001|Primary Study|Other|0|||
19545712|NCT00196976|41995215|FG002|Primary Study|Other|2|||
19545713|NCT00196976|41995216|FG003|Primary Study|Other|0|||
19545714|NCT00196976|41995217|FG004|Primary Study|Other|0|||
19545715|NCT00196976|41995218|FG005|Primary Study|Other|0|||
19545716|NCT00196976|41995219|FG006|Primary Study|Other|0|||
19545717|NCT00196976|41995220|FG007|Primary Study|Other|0|||
19545718|NCT00196976|41995221|FG008|Primary Study|Other|0|||
19545719|NCT00196976|41995222|FG009|Primary Study|Other|0|||
19545720|NCT00196976|41995223|FG010|Primary Study|Other|0|||
19545721|NCT00196976|41995224|FG011|Primary Study|Other|0|||
19545722|NCT00196976|41995225|FG012|Primary Study|Other|0|||
19545723|NCT00196976|41995226|FG013|Primary Study|Other|0|||
19716009|NCT02949934|42159004|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
19545724|NCT00196976|41995213|FG000|Booster Study|Withdrawal by Subject|0|||
19545725|NCT00196976|41995214|FG001|Booster Study|Withdrawal by Subject|0|||
19545726|NCT00196976|41995215|FG002|Booster Study|Withdrawal by Subject|0|||
19545727|NCT00196976|41995216|FG003|Booster Study|Withdrawal by Subject|0|||
19545728|NCT00196976|41995217|FG004|Booster Study|Withdrawal by Subject|0|||
19545729|NCT00196976|41995218|FG005|Booster Study|Withdrawal by Subject|0|||
19545730|NCT00196976|41995219|FG006|Booster Study|Withdrawal by Subject|0|||
19545731|NCT00196976|41995220|FG007|Booster Study|Withdrawal by Subject|0|||
19545732|NCT00196976|41995221|FG008|Booster Study|Withdrawal by Subject|0|||
19545733|NCT00196976|41995222|FG009|Booster Study|Withdrawal by Subject|0|||
19545734|NCT00196976|41995223|FG010|Booster Study|Withdrawal by Subject|1|||
19545735|NCT00196976|41995224|FG011|Booster Study|Withdrawal by Subject|0|||
19545736|NCT00196976|41995225|FG012|Booster Study|Withdrawal by Subject|0|||
19545737|NCT00196976|41995226|FG013|Booster Study|Withdrawal by Subject|0|||
19545738|NCT00196976|41995213|FG000|Booster Study|Lost to Follow-up|0|||
19545739|NCT00196976|41995214|FG001|Booster Study|Lost to Follow-up|0|||
19545740|NCT00196976|41995215|FG002|Booster Study|Lost to Follow-up|0|||
19545741|NCT00196976|41995216|FG003|Booster Study|Lost to Follow-up|0|||
19545742|NCT00196976|41995217|FG004|Booster Study|Lost to Follow-up|0|||
19545743|NCT00196976|41995218|FG005|Booster Study|Lost to Follow-up|0|||
19545744|NCT00196976|41995219|FG006|Booster Study|Lost to Follow-up|0|||
19545745|NCT00196976|41995220|FG007|Booster Study|Lost to Follow-up|0|||
19545746|NCT00196976|41995221|FG008|Booster Study|Lost to Follow-up|0|||
19545747|NCT00196976|41995222|FG009|Booster Study|Lost to Follow-up|0|||
19545748|NCT00196976|41995223|FG010|Booster Study|Lost to Follow-up|1|||
19545749|NCT00196976|41995224|FG011|Booster Study|Lost to Follow-up|2|||
19545750|NCT00196976|41995225|FG012|Booster Study|Lost to Follow-up|0|||
19545751|NCT00196976|41995226|FG013|Booster Study|Lost to Follow-up|0|||
19545752|NCT00196313|41995268|FG000|Overall Study|Protocol Violation|2|||
19545753|NCT00196313|41995269|FG001|Overall Study|Protocol Violation|3|||
19545754|NCT00196313|41995268|FG000|Overall Study|Withdrawal by Subject|3|||
19545755|NCT00196313|41995269|FG001|Overall Study|Withdrawal by Subject|1|||
19545756|NCT00196313|41995268|FG000|Overall Study|Adverse Event|3|||
19545757|NCT00196313|41995269|FG001|Overall Study|Adverse Event|1|||
19545758|NCT00196313|41995268|FG000|Overall Study|Subject Pregnant|1|||
19545759|NCT00196313|41995269|FG001|Overall Study|Subject Pregnant|1|||
19545760|NCT00196313|41995268|FG000|Overall Study|Lost to Follow-up|2|||
19545761|NCT00196313|41995269|FG001|Overall Study|Lost to Follow-up|2|||
19545762|NCT00196196|41995276|FG000|Overall Study|Withdrawal by Subject|2|||
19545763|NCT00196196|41995276|FG000|Overall Study|Did not have required condition (hydroce|5|||
19545764|NCT00195650|41995280|FG000|Overall Study|Adverse Event|194|||
19545765|NCT00195650|41995280|FG000|Overall Study|Lack of Efficacy|99|||
19545766|NCT00195650|41995280|FG000|Overall Study|Withdrawal by Subject|67|||
19545767|NCT00195650|41995280|FG000|Overall Study|Lost to Follow-up|44|||
19545768|NCT00195650|41995280|FG000|Overall Study|Death|23|||
19545769|NCT00195650|41995280|FG000|Overall Study|Protocol Violation|15|||
19545770|NCT00195650|41995280|FG000|Overall Study|Administrative reasons|83|||
19545771|NCT00195494|41995286|FG000|Year 1|Adverse Event|0|||
19545772|NCT00195494|41995287|FG001|Year 1|Adverse Event|0|||
19545773|NCT00195494|41995288|FG002|Year 1|Adverse Event|0|||
19545774|NCT00195494|41995289|FG003|Year 1|Adverse Event|0|||
19545775|NCT00195494|41995290|FG004|Year 1|Adverse Event|34|||
19545776|NCT00195494|41995291|FG005|Year 1|Adverse Event|27|||
19545777|NCT00195494|41995286|FG000|Year 1|System Toxicity|0|||
19545778|NCT00195494|41995287|FG001|Year 1|System Toxicity|0|||
19545779|NCT00195494|41995288|FG002|Year 1|System Toxicity|0|||
19545780|NCT00195494|41995289|FG003|Year 1|System Toxicity|0|||
19545781|NCT00195494|41995290|FG004|Year 1|System Toxicity|0|||
19545782|NCT00195494|41995291|FG005|Year 1|System Toxicity|1|||
19545783|NCT00195494|41995286|FG000|Year 1|Lack of Efficacy|0|||
19545784|NCT00195494|41995287|FG001|Year 1|Lack of Efficacy|0|||
19545785|NCT00195494|41995288|FG002|Year 1|Lack of Efficacy|0|||
19545786|NCT00195494|41995289|FG003|Year 1|Lack of Efficacy|0|||
19545787|NCT00195494|41995290|FG004|Year 1|Lack of Efficacy|24|||
19545788|NCT00195494|41995291|FG005|Year 1|Lack of Efficacy|9|||
19545789|NCT00195494|41995286|FG000|Year 1|Compliance|0|||
19545790|NCT00195494|41995287|FG001|Year 1|Compliance|0|||
19545791|NCT00195494|41995288|FG002|Year 1|Compliance|0|||
19545792|NCT00195494|41995289|FG003|Year 1|Compliance|0|||
19545793|NCT00195494|41995290|FG004|Year 1|Compliance|5|||
19545794|NCT00195494|41995291|FG005|Year 1|Compliance|1|||
19545795|NCT00195494|41995286|FG000|Year 1|Lost to Follow-up|0|||
19545796|NCT00195494|41995287|FG001|Year 1|Lost to Follow-up|0|||
19716010|NCT02949934|42159005|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
19716011|NCT02949934|42159006|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
19545797|NCT00195494|41995288|FG002|Year 1|Lost to Follow-up|0|||
19545798|NCT00195494|41995289|FG003|Year 1|Lost to Follow-up|0|||
19545799|NCT00195494|41995290|FG004|Year 1|Lost to Follow-up|1|||
19545800|NCT00195494|41995291|FG005|Year 1|Lost to Follow-up|0|||
19545801|NCT00195494|41995286|FG000|Year 1|Missed >4 consecutive doses|0|||
19545802|NCT00195494|41995287|FG001|Year 1|Missed >4 consecutive doses|0|||
19545803|NCT00195494|41995288|FG002|Year 1|Missed >4 consecutive doses|0|||
19545804|NCT00195494|41995289|FG003|Year 1|Missed >4 consecutive doses|0|||
19545805|NCT00195494|41995290|FG004|Year 1|Missed >4 consecutive doses|3|||
19545806|NCT00195494|41995291|FG005|Year 1|Missed >4 consecutive doses|2|||
19545807|NCT00195494|41995286|FG000|Year 1|Protocol deviation|0|||
19545808|NCT00195494|41995287|FG001|Year 1|Protocol deviation|0|||
19545809|NCT00195494|41995288|FG002|Year 1|Protocol deviation|0|||
19545810|NCT00195494|41995289|FG003|Year 1|Protocol deviation|0|||
19545811|NCT00195494|41995290|FG004|Year 1|Protocol deviation|2|||
19545812|NCT00195494|41995291|FG005|Year 1|Protocol deviation|3|||
19545813|NCT00195494|41995286|FG000|Year 1|Physician Decision|0|||
19545814|NCT00195494|41995287|FG001|Year 1|Physician Decision|0|||
19545815|NCT00195494|41995288|FG002|Year 1|Physician Decision|0|||
19545816|NCT00195494|41995289|FG003|Year 1|Physician Decision|0|||
19545817|NCT00195494|41995290|FG004|Year 1|Physician Decision|1|||
19545818|NCT00195494|41995291|FG005|Year 1|Physician Decision|0|||
19545819|NCT00195494|41995286|FG000|Year 1|Withdrawal by Subject|0|||
19545820|NCT00195494|41995287|FG001|Year 1|Withdrawal by Subject|0|||
19545821|NCT00195494|41995288|FG002|Year 1|Withdrawal by Subject|0|||
19545822|NCT00195494|41995289|FG003|Year 1|Withdrawal by Subject|0|||
19545823|NCT00195494|41995290|FG004|Year 1|Withdrawal by Subject|8|||
19545824|NCT00195494|41995291|FG005|Year 1|Withdrawal by Subject|9|||
19545825|NCT00195494|41995286|FG000|Year 1|Protocol Violation|0|||
19545826|NCT00195494|41995287|FG001|Year 1|Protocol Violation|0|||
19545827|NCT00195494|41995288|FG002|Year 1|Protocol Violation|0|||
19545828|NCT00195494|41995289|FG003|Year 1|Protocol Violation|0|||
19545829|NCT00195494|41995290|FG004|Year 1|Protocol Violation|1|||
19545830|NCT00195494|41995291|FG005|Year 1|Protocol Violation|1|||
19545831|NCT00195494|41995286|FG000|Year 2|Adverse Event|3|||
19545832|NCT00195494|41995287|FG001|Year 2|Adverse Event|7|||
19545833|NCT00195494|41995288|FG002|Year 2|Adverse Event|5|||
19545834|NCT00195494|41995289|FG003|Year 2|Adverse Event|9|||
19545835|NCT00195494|41995290|FG004|Year 2|Adverse Event|0|||
19545836|NCT00195494|41995291|FG005|Year 2|Adverse Event|0|||
19545837|NCT00195494|41995286|FG000|Year 2|Lack of Efficacy|0|||
19545838|NCT00195494|41995287|FG001|Year 2|Lack of Efficacy|1|||
19545839|NCT00195494|41995288|FG002|Year 2|Lack of Efficacy|7|||
19545840|NCT00195494|41995289|FG003|Year 2|Lack of Efficacy|7|||
19545841|NCT00195494|41995290|FG004|Year 2|Lack of Efficacy|0|||
19545842|NCT00195494|41995291|FG005|Year 2|Lack of Efficacy|0|||
19545843|NCT00195494|41995286|FG000|Year 2|Compliance|1|||
19545844|NCT00195494|41995287|FG001|Year 2|Compliance|0|||
19545845|NCT00195494|41995288|FG002|Year 2|Compliance|0|||
19545846|NCT00195494|41995289|FG003|Year 2|Compliance|2|||
19545847|NCT00195494|41995290|FG004|Year 2|Compliance|0|||
19545848|NCT00195494|41995291|FG005|Year 2|Compliance|0|||
19545849|NCT00195494|41995286|FG000|Year 2|Lost to Follow-up|0|||
19545850|NCT00195494|41995287|FG001|Year 2|Lost to Follow-up|0|||
19545851|NCT00195494|41995288|FG002|Year 2|Lost to Follow-up|1|||
19545852|NCT00195494|41995289|FG003|Year 2|Lost to Follow-up|1|||
19545853|NCT00195494|41995290|FG004|Year 2|Lost to Follow-up|0|||
19545854|NCT00195494|41995291|FG005|Year 2|Lost to Follow-up|0|||
19545855|NCT00195494|41995286|FG000|Year 2|Missed >4 consecutive doses|1|||
19545856|NCT00195494|41995287|FG001|Year 2|Missed >4 consecutive doses|1|||
19545857|NCT00195494|41995288|FG002|Year 2|Missed >4 consecutive doses|1|||
19545858|NCT00195494|41995289|FG003|Year 2|Missed >4 consecutive doses|0|||
19545859|NCT00195494|41995290|FG004|Year 2|Missed >4 consecutive doses|0|||
19545860|NCT00195494|41995291|FG005|Year 2|Missed >4 consecutive doses|0|||
19545861|NCT00195494|41995286|FG000|Year 2|Protocol deviation|0|||
19545862|NCT00195494|41995287|FG001|Year 2|Protocol deviation|1|||
19545863|NCT00195494|41995288|FG002|Year 2|Protocol deviation|0|||
19545864|NCT00195494|41995289|FG003|Year 2|Protocol deviation|0|||
19545865|NCT00195494|41995290|FG004|Year 2|Protocol deviation|0|||
19545866|NCT00195494|41995291|FG005|Year 2|Protocol deviation|0|||
19545867|NCT00195494|41995286|FG000|Year 2|Physician Decision|1|||
19545868|NCT00195494|41995287|FG001|Year 2|Physician Decision|1|||
19545869|NCT00195494|41995288|FG002|Year 2|Physician Decision|0|||
19545870|NCT00195494|41995289|FG003|Year 2|Physician Decision|0|||
19545871|NCT00195494|41995290|FG004|Year 2|Physician Decision|0|||
19545872|NCT00195494|41995291|FG005|Year 2|Physician Decision|0|||
19545873|NCT00195494|41995286|FG000|Year 2|Withdrawal by Subject|1|||
19545874|NCT00195494|41995287|FG001|Year 2|Withdrawal by Subject|5|||
19545875|NCT00195494|41995288|FG002|Year 2|Withdrawal by Subject|4|||
19545876|NCT00195494|41995289|FG003|Year 2|Withdrawal by Subject|3|||
19545877|NCT00195494|41995290|FG004|Year 2|Withdrawal by Subject|0|||
19545878|NCT00195494|41995291|FG005|Year 2|Withdrawal by Subject|0|||
19545879|NCT00195494|41995286|FG000|Year 2|System toxicity|0|||
19545880|NCT00195494|41995287|FG001|Year 2|System toxicity|0|||
19545881|NCT00195494|41995288|FG002|Year 2|System toxicity|0|||
19545882|NCT00195494|41995289|FG003|Year 2|System toxicity|1|||
19545883|NCT00195494|41995290|FG004|Year 2|System toxicity|0|||
19545884|NCT00195494|41995291|FG005|Year 2|System toxicity|0|||
19545885|NCT00194987|41995309|FG000|Overall Study|Withdrawal by Subject|0|||
19545886|NCT00194987|41995310|FG001|Overall Study|Withdrawal by Subject|3|||
19545887|NCT00194792|41995318|FG000|Overall Study|Withdrawal by Subject|1|||
19545888|NCT00194675|41995333|FG000|Overall Study|Lost to Follow-up|1|||
19545889|NCT00194675|41995334|FG001|Overall Study|Lost to Follow-up|1|||
19545890|NCT00194675|41995333|FG000|Overall Study|lack of interest|1|||
19545891|NCT00194675|41995334|FG001|Overall Study|lack of interest|1|||
19545892|NCT00194675|41995333|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
19545893|NCT00194675|41995334|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
19545894|NCT00194675|41995333|FG000|Overall Study|Protocol Violation|1|||
19545895|NCT00194675|41995334|FG001|Overall Study|Protocol Violation|0|||
19545896|NCT00194675|41995333|FG000|Overall Study|Death|1|||
19545897|NCT00194675|41995334|FG001|Overall Study|Death|0|||
19545898|NCT00194012|41995344|FG000|Randomized Phase|Lack of Efficacy|8|||
19545899|NCT00194012|41995345|FG001|Randomized Phase|Lack of Efficacy|18|||
19545900|NCT00194012|41995344|FG000|Randomized Phase|Study nonadherence|2|||
19545901|NCT00194012|41995345|FG001|Randomized Phase|Study nonadherence|1|||
19545902|NCT00194012|41995344|FG000|Randomized Phase|Withdrawal by Subject|3|||
19545903|NCT00194012|41995345|FG001|Randomized Phase|Withdrawal by Subject|3|||
19545904|NCT00194012|41995344|FG000|Randomized Phase|Adverse Event|2|||
19545905|NCT00194012|41995345|FG001|Randomized Phase|Adverse Event|1|||
19545906|NCT00194012|41995344|FG000|Randomized Phase|Participant reported having a rash|1|||
19545907|NCT00194012|41995345|FG001|Randomized Phase|Participant reported having a rash|0|||
19545908|NCT00194012|41995344|FG000|Randomized Phase|Emesis and enuresis|0|||
19545909|NCT00194012|41995345|FG001|Randomized Phase|Emesis and enuresis|1|||
19545910|NCT00194012|41995344|FG000|Randomized Phase|Oral/nasal twitching|0|||
19545911|NCT00194012|41995345|FG001|Randomized Phase|Oral/nasal twitching|1|||
19545912|NCT00194012|41995344|FG000|Open Label Extension (OLE)|Weight Gain|1|||
19545913|NCT00194012|41995345|FG001|Open Label Extension (OLE)|Weight Gain|0|||
19545914|NCT00194012|41995344|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
19545915|NCT00194012|41995345|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
19545916|NCT00194012|41995344|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
19545917|NCT00194012|41995345|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
19545918|NCT00194012|41995344|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
19545919|NCT00194012|41995345|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
19545920|NCT00192647|41995359|FG000|Overall Study|Death|1|||
19545921|NCT00192647|41995360|FG001|Overall Study|Death|1|||
19545922|NCT00192647|41995359|FG000|Overall Study|Adverse Event|35|||
19545923|NCT00192647|41995360|FG001|Overall Study|Adverse Event|29|||
19545924|NCT00192647|41995359|FG000|Overall Study|Laboratory Test Abnormality|4|||
19545925|NCT00192647|41995360|FG001|Overall Study|Laboratory Test Abnormality|2|||
19545926|NCT00192647|41995359|FG000|Overall Study|Insufficient Therapeutic Response|53|||
19545927|NCT00192647|41995360|FG001|Overall Study|Insufficient Therapeutic Response|83|||
19545928|NCT00192647|41995359|FG000|Overall Study|Entry Criteria Violation|6|||
19545929|NCT00192647|41995360|FG001|Overall Study|Entry Criteria Violation|6|||
19545930|NCT00192647|41995359|FG000|Overall Study|Protocol Violation|3|||
19545931|NCT00192647|41995360|FG001|Overall Study|Protocol Violation|1|||
19545932|NCT00192647|41995359|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
19545933|NCT00192647|41995360|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
19545934|NCT00192647|41995359|FG000|Overall Study|Failure to Return|11|||
19545935|NCT00192647|41995360|FG001|Overall Study|Failure to Return|13|||
19545936|NCT00192647|41995359|FG000|Overall Study|Other/Administrative|5|||
19545937|NCT00192647|41995360|FG001|Overall Study|Other/Administrative|3|||
19545938|NCT00192296|41995370|FG000|Overall Study|Withdrawal by Subject|0|||
19545939|NCT00192296|41995371|FG001|Overall Study|Withdrawal by Subject|1|||
19545940|NCT00192296|41995372|FG002|Overall Study|Withdrawal by Subject|0|||
19545941|NCT00192296|41995373|FG003|Overall Study|Withdrawal by Subject|0|||
19545942|NCT00192023|41995385|FG000|Period III - Double-Blind|Adverse Event|3|||
19545943|NCT00192023|41995386|FG001|Period III - Double-Blind|Adverse Event|0|||
19545944|NCT00192023|41995385|FG000|Period III - Double-Blind|Physician Decision|2|||
19545945|NCT00192023|41995386|FG001|Period III - Double-Blind|Physician Decision|0|||
19545946|NCT00192023|41995385|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
19545947|NCT00192023|41995386|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
19545948|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
19545949|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
19545950|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
19545951|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
19545952|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
19545953|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
19545954|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
19545955|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
19545956|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
19545957|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
19545958|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
19545959|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
19545960|NCT00192023|41995385|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
19545961|NCT00192023|41995386|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
19545962|NCT00191984|41995392|FG000|Overall Study|Disease Progression|21|||
19545963|NCT00191984|41995392|FG000|Overall Study|Adverse Event|4|||
19545964|NCT00191984|41995392|FG000|Overall Study|Death|2|||
19545965|NCT00191984|41995392|FG000|Overall Study|Entry Criteria Exclusion|1|||
19545966|NCT00191984|41995392|FG000|Overall Study|Withdrawal by Subject|7|||
19545967|NCT00191984|41995392|FG000|Overall Study|Physician Decision|4|||
19545968|NCT00191906|41995400|FG000|Study Period II|Adverse Event|0|||
19545969|NCT00191906|41995401|FG001|Study Period II|Adverse Event|1|||
19545970|NCT00191906|41995402|FG002|Study Period II|Adverse Event|0|||
19545971|NCT00191906|41995403|FG003|Study Period II|Adverse Event|0|||
19545972|NCT00191906|41995400|FG000|Study Period II|Withdrawal by Subject|0|||
19545973|NCT00191906|41995401|FG001|Study Period II|Withdrawal by Subject|3|||
19545974|NCT00191906|41995402|FG002|Study Period II|Withdrawal by Subject|0|||
19545975|NCT00191906|41995403|FG003|Study Period II|Withdrawal by Subject|0|||
19545976|NCT00191906|41995400|FG000|Study Period II|Parent/Caregiver Decision|0|||
19545977|NCT00191906|41995401|FG001|Study Period II|Parent/Caregiver Decision|1|||
19545978|NCT00191906|41995402|FG002|Study Period II|Parent/Caregiver Decision|0|||
19545979|NCT00191906|41995403|FG003|Study Period II|Parent/Caregiver Decision|0|||
19545980|NCT00191906|41995400|FG000|Study Period II|Entry Criteria Exclusion|0|||
19545981|NCT00191906|41995401|FG001|Study Period II|Entry Criteria Exclusion|0|||
19545982|NCT00191906|41995402|FG002|Study Period II|Entry Criteria Exclusion|1|||
19545983|NCT00191906|41995403|FG003|Study Period II|Entry Criteria Exclusion|0|||
19545984|NCT00191906|41995400|FG000|Study Period III|Adverse Event|1|||
19545985|NCT00191906|41995401|FG001|Study Period III|Adverse Event|0|||
19545986|NCT00191906|41995402|FG002|Study Period III|Adverse Event|0|||
19545987|NCT00191906|41995403|FG003|Study Period III|Adverse Event|0|||
19545988|NCT00191906|41995400|FG000|Study Period III|Lost to Follow-up|0|||
19545989|NCT00191906|41995401|FG001|Study Period III|Lost to Follow-up|1|||
19545990|NCT00191906|41995402|FG002|Study Period III|Lost to Follow-up|0|||
19545991|NCT00191906|41995403|FG003|Study Period III|Lost to Follow-up|0|||
19545992|NCT00191906|41995400|FG000|Study Period III|Parent/Caregiver Decision|1|||
19545993|NCT00191906|41995401|FG001|Study Period III|Parent/Caregiver Decision|0|||
19545994|NCT00191906|41995402|FG002|Study Period III|Parent/Caregiver Decision|0|||
19545995|NCT00191906|41995403|FG003|Study Period III|Parent/Caregiver Decision|0|||
19545996|NCT00191906|41995400|FG000|Study Period III|Lack of Efficacy|3|||
19545997|NCT00191906|41995401|FG001|Study Period III|Lack of Efficacy|3|||
19545998|NCT00191906|41995402|FG002|Study Period III|Lack of Efficacy|0|||
19545999|NCT00191906|41995403|FG003|Study Period III|Lack of Efficacy|0|||
19546000|NCT00191789|41995419|FG000|Overall Study|Adverse Event|5|||
19546001|NCT00191789|41995419|FG000|Overall Study|Patient: Satisfactory Response|5|||
19546002|NCT00191789|41995419|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
19546003|NCT00191789|41995419|FG000|Overall Study|Withdrawal by Subject|4|||
19546004|NCT00191789|41995419|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
19546005|NCT00191789|41995419|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
19546006|NCT00191789|41995419|FG000|Overall Study|Death - Not Study-Drug Related|1|||
19546007|NCT00191282|41995425|FG000|Overall Study|Adverse Event|5|||
19546008|NCT00191282|41995426|FG001|Overall Study|Adverse Event|6|||
19546009|NCT00191282|41995425|FG000|Overall Study|Death|51|||
19546010|NCT00191282|41995426|FG001|Overall Study|Death|51|||
19546011|NCT00191282|41995425|FG000|Overall Study|Lack of Efficacy|11|||
19546012|NCT00191282|41995426|FG001|Overall Study|Lack of Efficacy|6|||
19546013|NCT00191282|41995425|FG000|Overall Study|Noncompliance|14|||
19546014|NCT00191282|41995426|FG001|Overall Study|Noncompliance|17|||
19546015|NCT00191282|41995425|FG000|Overall Study|Patient moved|11|||
19546016|NCT00191282|41995426|FG001|Overall Study|Patient moved|14|||
19546017|NCT00191282|41995425|FG000|Overall Study|Withdrawal by Subject|59|||
19546018|NCT00191282|41995426|FG001|Overall Study|Withdrawal by Subject|44|||
19546019|NCT00191282|41995425|FG000|Overall Study|Physician Decision|18|||
19546020|NCT00191282|41995426|FG001|Overall Study|Physician Decision|15|||
19546021|NCT00191282|41995425|FG000|Overall Study|Protocol entry criteria not met|14|||
19546022|NCT00191282|41995426|FG001|Overall Study|Protocol entry criteria not met|9|||
19546023|NCT00191282|41995425|FG000|Overall Study|Protocol Violation|9|||
19546024|NCT00191282|41995426|FG001|Overall Study|Protocol Violation|12|||
19546025|NCT00191282|41995425|FG000|Overall Study|Severity of outcome|2|||
19546026|NCT00191282|41995426|FG001|Overall Study|Severity of outcome|5|||
19546027|NCT00191282|41995425|FG000|Overall Study|Sponsor's decision|2|||
19546028|NCT00191282|41995426|FG001|Overall Study|Sponsor's decision|2|||
19546029|NCT00191282|41995425|FG000|Overall Study|Lost to Follow-up|24|||
19546030|NCT00191282|41995426|FG001|Overall Study|Lost to Follow-up|31|||
19546031|NCT00191165|41995434|FG000|Overall Study|Adverse Event|2|||
19546032|NCT00191165|41995435|FG001|Overall Study|Adverse Event|0|||
19546033|NCT00191165|41995434|FG000|Overall Study|Protocol Violation|0|||
19546034|NCT00191165|41995435|FG001|Overall Study|Protocol Violation|1|||
19546035|NCT00191165|41995434|FG000|Overall Study|Participant Moved Away|0|||
19546036|NCT00191165|41995435|FG001|Overall Study|Participant Moved Away|1|||
19546037|NCT00190775|41995443|FG000|Overall Study|Adverse Event|57|||
19546038|NCT00190775|41995444|FG001|Overall Study|Adverse Event|22|||
19546039|NCT00190775|41995443|FG000|Overall Study|Satisfactory Response|1|||
19546040|NCT00190775|41995444|FG001|Overall Study|Satisfactory Response|0|||
19546041|NCT00190775|41995443|FG000|Overall Study|Lack of Efficacy|28|||
19546042|NCT00190775|41995444|FG001|Overall Study|Lack of Efficacy|32|||
19546043|NCT00190775|41995443|FG000|Overall Study|Lost to Follow-up|31|||
19546044|NCT00190775|41995444|FG001|Overall Study|Lost to Follow-up|23|||
19546045|NCT00190775|41995443|FG000|Overall Study|Participant Moved|0|||
19546046|NCT00190775|41995444|FG001|Overall Study|Participant Moved|1|||
19546047|NCT00190775|41995443|FG000|Overall Study|Withdrawal by Subject|24|||
19546048|NCT00190775|41995444|FG001|Overall Study|Withdrawal by Subject|13|||
19546049|NCT00190775|41995443|FG000|Overall Study|Sponsor Decision|1|||
19546050|NCT00190775|41995444|FG001|Overall Study|Sponsor Decision|0|||
19546051|NCT00190775|41995443|FG000|Overall Study|Physician Decision|3|||
19546052|NCT00190775|41995444|FG001|Overall Study|Physician Decision|0|||
19546053|NCT00190775|41995443|FG000|Overall Study|Noncompliance|3|||
19546054|NCT00190775|41995444|FG001|Overall Study|Noncompliance|5|||
19546055|NCT00190775|41995443|FG000|Overall Study|Protocol Violation|0|||
19546056|NCT00190775|41995444|FG001|Overall Study|Protocol Violation|1|||
19546057|NCT00190775|41995443|FG000|Overall Study|Exclusion Criteria Met|1|||
19546058|NCT00190775|41995444|FG001|Overall Study|Exclusion Criteria Met|3|||
19546059|NCT00199901|41995459|FG000|Overall Study|Protocol Violation|2|||
19546060|NCT00199901|41995460|FG001|Overall Study|Protocol Violation|0|||
19546061|NCT00199901|41995459|FG000|Overall Study|Withdrawal by Subject|1|||
19546062|NCT00199901|41995460|FG001|Overall Study|Withdrawal by Subject|0|||
19546063|NCT00199901|41995459|FG000|Overall Study|Progressive Disease|24|||
19546064|NCT00199901|41995460|FG001|Overall Study|Progressive Disease|24|||
19546065|NCT00198107|41995470|FG000|Double-Blind Period|Adverse Event|1|||
19546066|NCT00198107|41995471|FG001|Double-Blind Period|Adverse Event|1|||
19546067|NCT00198107|41995472|FG002|Double-Blind Period|Adverse Event|0|||
19546068|NCT00198107|41995470|FG000|Double-Blind Period|Lack of Efficacy|2|||
19546069|NCT00198107|41995471|FG001|Double-Blind Period|Lack of Efficacy|0|||
19546070|NCT00198107|41995472|FG002|Double-Blind Period|Lack of Efficacy|0|||
19546071|NCT00198107|41995470|FG000|Double-Blind Period|Lost to Follow-up|2|||
19546072|NCT00198107|41995471|FG001|Double-Blind Period|Lost to Follow-up|1|||
19546073|NCT00198107|41995472|FG002|Double-Blind Period|Lost to Follow-up|0|||
19546074|NCT00198107|41995470|FG000|Double-Blind Period|Physician Decision|1|||
19546075|NCT00198107|41995471|FG001|Double-Blind Period|Physician Decision|0|||
19546076|NCT00198107|41995472|FG002|Double-Blind Period|Physician Decision|0|||
19546077|NCT00198107|41995470|FG000|Double-Blind Period|Withdrawal by Subject|0|||
19546078|NCT00198107|41995471|FG001|Double-Blind Period|Withdrawal by Subject|1|||
19546079|NCT00198107|41995472|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19546080|NCT00198107|41995470|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
19546081|NCT00198107|41995471|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
19546082|NCT00198107|41995472|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
19546083|NCT00179660|41995480|FG000|Overall Study|Adverse Event|7|||
19546084|NCT00179660|41995480|FG000|Overall Study|Lack of therapeutic effect|28|||
19546085|NCT00179660|41995480|FG000|Overall Study|Withdrawal by Subject|2|||
19546086|NCT00179660|41995480|FG000|Overall Study|Lost to Follow-up|1|||
19546087|NCT00179660|41995480|FG000|Overall Study|Death|3|||
19546088|NCT00179660|41995480|FG000|Overall Study|Other - Unspecified|9|||
19546089|NCT00178256|41995484|FG000|Overall Study|Adverse Event|2|||
19546090|NCT00178256|41995485|FG001|Overall Study|Adverse Event|0|||
19546091|NCT00178256|41995486|FG002|Overall Study|Adverse Event|0|||
19546092|NCT00178256|41995487|FG003|Overall Study|Adverse Event|0|||
19546093|NCT00178256|41995484|FG000|Overall Study|Death|0|||
19546094|NCT00178256|41995485|FG001|Overall Study|Death|1|||
19546095|NCT00178256|41995486|FG002|Overall Study|Death|0|||
19546096|NCT00178256|41995487|FG003|Overall Study|Death|1|||
19546097|NCT00178256|41995484|FG000|Overall Study|Cancer progression|2|||
19546098|NCT00178256|41995485|FG001|Overall Study|Cancer progression|0|||
19546099|NCT00178256|41995486|FG002|Overall Study|Cancer progression|0|||
19546100|NCT00178256|41995487|FG003|Overall Study|Cancer progression|1|||
19546101|NCT00177164|41995496|FG000|Overall Study|Protocol Violation|0|||
19546102|NCT00177164|41995497|FG001|Overall Study|Protocol Violation|7|||
19546103|NCT00177164|41995496|FG000|Overall Study|Lost to Follow-up|4|||
19546104|NCT00177164|41995497|FG001|Overall Study|Lost to Follow-up|5|||
19546105|NCT00177164|41995496|FG000|Overall Study|increase in alcohol and drug use|1|||
19546106|NCT00177164|41995497|FG001|Overall Study|increase in alcohol and drug use|2|||
19546107|NCT00177164|41995496|FG000|Overall Study|Adverse Event|1|||
19546108|NCT00177164|41995497|FG001|Overall Study|Adverse Event|0|||
19546109|NCT00177164|41995496|FG000|Overall Study|discharge from hospital|1|||
19546110|NCT00177164|41995497|FG001|Overall Study|discharge from hospital|0|||
19546111|NCT00177164|41995496|FG000|Overall Study|Lack of Efficacy|2|||
19546112|NCT00177164|41995497|FG001|Overall Study|Lack of Efficacy|1|||
19546113|NCT00177164|41995496|FG000|Overall Study|Pregnancy|0|||
19546114|NCT00177164|41995497|FG001|Overall Study|Pregnancy|1|||
19546115|NCT02489942|41995520|FG000|Overall Study|Request by patient|602|||
19546116|NCT02489942|41995520|FG000|Overall Study|Improvement/remission|157|||
19546117|NCT02489942|41995520|FG000|Overall Study|No change/Progressive disease|263|||
19546118|NCT02489942|41995520|FG000|Overall Study|Adverse Event|522|||
19546119|NCT02489942|41995520|FG000|Overall Study|Other personal reasons|1218|||
19546120|NCT02489942|41995520|FG000|Overall Study|Lost to Follow-up|456|||
19546121|NCT02489942|41995520|FG000|Overall Study|Not continuously investigated|7|||
19546122|NCT02489942|41995520|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
19546123|NCT02489942|41995520|FG000|Overall Study|Multiple registration|1|||
19546124|NCT02489942|41995520|FG000|Overall Study|No patient visit after entry|100|||
19546125|NCT02489942|41995520|FG000|Overall Study|No treatment with Jardiance|2|||
19716012|NCT02949934|42159001|FG000|Bar Laboratory|Adverse Event|1|||
19546126|NCT02489942|41995520|FG000|Overall Study|Patient received Jardiance before registration|1|||
19546127|NCT02489942|41995520|FG000|Overall Study|No CRF collected|86|||
19546128|NCT00176462|41995526|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
19546129|NCT00176462|41995527|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
19546130|NCT00176462|41995526|FG000|Induction (4 Weeks)|Death|1|||
19546131|NCT00176462|41995527|FG001|Induction (4 Weeks)|Death|2|||
19546132|NCT00176462|41995526|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
19546133|NCT00176462|41995527|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
19546134|NCT00176462|41995526|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
19546135|NCT00176462|41995527|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
19546136|NCT00176462|41995526|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
19546137|NCT00176462|41995527|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
19546138|NCT00176462|41995526|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
19546139|NCT00176462|41995527|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
19546140|NCT00176462|41995526|FG000|Consolidation (12 Weeks)|Not documented|0|||
19546141|NCT00176462|41995527|FG001|Consolidation (12 Weeks)|Not documented|1|||
19546142|NCT00176462|41995526|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
19546143|NCT00176462|41995527|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
19546144|NCT00176462|41995526|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
19546145|NCT00176462|41995527|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
19546146|NCT00175019|41995537|FG000|Overall Study|Adverse Event|54|||
19546147|NCT00175019|41995538|FG001|Overall Study|Adverse Event|22|||
19546148|NCT00175019|41995539|FG002|Overall Study|Adverse Event|2|||
19546149|NCT00175019|41995537|FG000|Overall Study|Protocol Violation|6|||
19546150|NCT00175019|41995538|FG001|Overall Study|Protocol Violation|3|||
19546151|NCT00175019|41995539|FG002|Overall Study|Protocol Violation|3|||
19546152|NCT00175019|41995537|FG000|Overall Study|Lost to Follow-up|42|||
19546153|NCT00175019|41995538|FG001|Overall Study|Lost to Follow-up|39|||
19546154|NCT00175019|41995539|FG002|Overall Study|Lost to Follow-up|9|||
19546155|NCT00175019|41995537|FG000|Overall Study|Did not continue under Amendment 4|1|||
19546156|NCT00175019|41995538|FG001|Overall Study|Did not continue under Amendment 4|1|||
19546157|NCT00175019|41995539|FG002|Overall Study|Did not continue under Amendment 4|2|||
19546158|NCT00175019|41995537|FG000|Overall Study|Personal Reason(s)|39|||
19546159|NCT00175019|41995538|FG001|Overall Study|Personal Reason(s)|31|||
19546160|NCT00175019|41995539|FG002|Overall Study|Personal Reason(s)|8|||
19546161|NCT00175019|41995537|FG000|Overall Study|Therapeutic Failure|10|||
19546162|NCT00175019|41995538|FG001|Overall Study|Therapeutic Failure|38|||
19546163|NCT00175019|41995539|FG002|Overall Study|Therapeutic Failure|22|||
19546164|NCT00175019|41995537|FG000|Overall Study|Gout Flare|2|||
19546165|NCT00175019|41995538|FG001|Overall Study|Gout Flare|3|||
19546166|NCT00175019|41995539|FG002|Overall Study|Gout Flare|0|||
19546167|NCT00175019|41995537|FG000|Overall Study|Reason Not Specified|40|||
19546168|NCT00175019|41995538|FG001|Overall Study|Reason Not Specified|34|||
19546169|NCT00175019|41995539|FG002|Overall Study|Reason Not Specified|11|||
19546170|NCT00174941|41995550|FG000|Overall Study|Adverse Event|1|||
19546171|NCT00174941|41995551|FG001|Overall Study|Adverse Event|10|||
19546172|NCT00174941|41995552|FG002|Overall Study|Adverse Event|2|||
19546173|NCT00174941|41995553|FG003|Overall Study|Adverse Event|13|||
19546174|NCT00174941|41995550|FG000|Overall Study|Protocol Violation|0|||
19546175|NCT00174941|41995551|FG001|Overall Study|Protocol Violation|1|||
19546176|NCT00174941|41995552|FG002|Overall Study|Protocol Violation|0|||
19546177|NCT00174941|41995553|FG003|Overall Study|Protocol Violation|1|||
19546178|NCT00174941|41995550|FG000|Overall Study|Lost to Follow-up|0|||
19546179|NCT00174941|41995551|FG001|Overall Study|Lost to Follow-up|3|||
19546180|NCT00174941|41995552|FG002|Overall Study|Lost to Follow-up|2|||
19546181|NCT00174941|41995553|FG003|Overall Study|Lost to Follow-up|5|||
19546182|NCT00174941|41995550|FG000|Overall Study|Personal Reason(s)|0|||
19546183|NCT00174941|41995551|FG001|Overall Study|Personal Reason(s)|14|||
19546184|NCT00174941|41995552|FG002|Overall Study|Personal Reason(s)|8|||
19546185|NCT00174941|41995553|FG003|Overall Study|Personal Reason(s)|22|||
19546186|NCT00174941|41995550|FG000|Overall Study|Gout Flare|0|||
19546187|NCT00174941|41995551|FG001|Overall Study|Gout Flare|4|||
19546188|NCT00174941|41995552|FG002|Overall Study|Gout Flare|4|||
19546189|NCT00174941|41995553|FG003|Overall Study|Gout Flare|8|||
19546190|NCT00174941|41995550|FG000|Overall Study|Reason Not Specified|1|||
19546191|NCT00174941|41995551|FG001|Overall Study|Reason Not Specified|6|||
19546192|NCT00174941|41995552|FG002|Overall Study|Reason Not Specified|2|||
19546193|NCT00174941|41995553|FG003|Overall Study|Reason Not Specified|9|||
19546194|NCT00171704|41995565|FG000|Overall Study|Adverse Event|24|||
19546195|NCT00171704|41995566|FG001|Overall Study|Adverse Event|33|||
19546196|NCT00171704|41995565|FG000|Overall Study|Disease Progression|14|||
19546197|NCT00171704|41995566|FG001|Overall Study|Disease Progression|9|||
19546198|NCT00171704|41995565|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
19546199|NCT00171704|41995566|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
19546200|NCT00171704|41995565|FG000|Overall Study|Administrative Problems|2|||
19546201|NCT00171704|41995566|FG001|Overall Study|Administrative Problems|1|||
19546202|NCT00171704|41995565|FG000|Overall Study|Death|2|||
19546203|NCT00171704|41995566|FG001|Overall Study|Death|2|||
19546204|NCT00171704|41995565|FG000|Overall Study|Withdrawal by Subject|1|||
19546205|NCT00171704|41995566|FG001|Overall Study|Withdrawal by Subject|3|||
19546206|NCT00171704|41995565|FG000|Overall Study|Protocol Violation|0|||
19546207|NCT00171704|41995566|FG001|Overall Study|Protocol Violation|1|||
19546208|NCT00171314|41995574|FG000|Overall Study|Adverse Event|44|||
19546209|NCT00171314|41995575|FG001|Overall Study|Adverse Event|41|||
19546210|NCT00171314|41995574|FG000|Overall Study|Lack of Efficacy|19|||
19546211|NCT00171314|41995575|FG001|Overall Study|Lack of Efficacy|14|||
19546212|NCT00171314|41995574|FG000|Overall Study|Withdrawal by Subject|9|||
19546213|NCT00171314|41995575|FG001|Overall Study|Withdrawal by Subject|6|||
19546214|NCT00171314|41995574|FG000|Overall Study|Abnormal Test Procedure Results|9|||
19546215|NCT00171314|41995575|FG001|Overall Study|Abnormal Test Procedure Results|3|||
19546216|NCT00171314|41995574|FG000|Overall Study|Protocol Violation|3|||
19546217|NCT00171314|41995575|FG001|Overall Study|Protocol Violation|7|||
19546218|NCT00171314|41995574|FG000|Overall Study|Administrative Problems|4|||
19546219|NCT00171314|41995575|FG001|Overall Study|Administrative Problems|3|||
19546220|NCT00171314|41995574|FG000|Overall Study|Lost to Follow-up|1|||
19546221|NCT00171314|41995575|FG001|Overall Study|Lost to Follow-up|3|||
19546222|NCT00171314|41995574|FG000|Overall Study|Death|2|||
19546223|NCT00171314|41995575|FG001|Overall Study|Death|1|||
19716013|NCT02949934|42159002|FG001|Bar Laboratory|Adverse Event|0|||
19716014|NCT02949934|42159003|FG002|Bar Laboratory|Adverse Event|2|||
19716015|NCT02949934|42159004|FG003|Bar Laboratory|Adverse Event|0|||
19546224|NCT00171158|41995581|FG000|Core Study|Death|27|||
19546225|NCT00171158|41995581|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
19546226|NCT00171158|41995581|FG000|Core Study|Protocol Violation|4|||
19546227|NCT00171158|41995581|FG000|Core Study|Administrative problems|1|||
19546228|NCT00171158|41995581|FG000|Core Study|Adverse event, non-fatal|21|||
19546229|NCT00171158|41995581|FG000|Core Study|Consent withdrawn by subject|6|||
19546230|NCT00171158|41995581|FG000|Core Study|No longer required drug (BMT)|14|||
19546231|NCT00171158|41995581|FG000|Core Study|Abnormal Laboratory Values|2|||
19546232|NCT00171158|41995581|FG000|Core Study|Lost to Follow-up|1|||
19546233|NCT00171158|41995581|FG000|E2 Extension|Other|7|||
19546234|NCT00170846|41995588|FG000|Overall Study|Subject withdrew Informed Consent|5|||
19546235|NCT00170846|41995589|FG001|Overall Study|Subject withdrew Informed Consent|12|||
19546236|NCT00170846|41995590|FG002|Overall Study|Subject withdrew Informed Consent|8|||
19546237|NCT00170846|41995588|FG000|Overall Study|Lost to Follow-up|6|||
19546238|NCT00170846|41995589|FG001|Overall Study|Lost to Follow-up|3|||
19546239|NCT00170846|41995590|FG002|Overall Study|Lost to Follow-up|2|||
19546240|NCT00170846|41995588|FG000|Overall Study|Death|0|||
19546241|NCT00170846|41995589|FG001|Overall Study|Death|3|||
19546242|NCT00170846|41995590|FG002|Overall Study|Death|3|||
19716016|NCT02949934|42159005|FG004|Bar Laboratory|Adverse Event|1|||
19716017|NCT02949934|42159006|FG005|Bar Laboratory|Adverse Event|0|||
19716018|NCT02949934|42159001|FG000|Bar Laboratory|Protocol Violation|0|||
19716019|NCT02949934|42159002|FG001|Bar Laboratory|Protocol Violation|0|||
19716020|NCT02949934|42159003|FG002|Bar Laboratory|Protocol Violation|0|||
19716021|NCT02949934|42159004|FG003|Bar Laboratory|Protocol Violation|1|||
19546243|NCT00170846|41995588|FG000|Overall Study|Reason Missing|0|||
19546244|NCT00170846|41995589|FG001|Overall Study|Reason Missing|1|||
19546245|NCT00170846|41995590|FG002|Overall Study|Reason Missing|0|||
19546246|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
19546247|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
19546248|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
19546249|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
19546250|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
19546251|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
19716022|NCT02949934|42159005|FG004|Bar Laboratory|Protocol Violation|0|||
19716023|NCT02949934|42159006|FG005|Bar Laboratory|Protocol Violation|0|||
19716024|NCT00338741|42159022|FG000|Overall Study|Lost to Follow-up|2|||
19716025|NCT00338741|42159023|FG001|Overall Study|Lost to Follow-up|0|||
19716026|NCT03370510|42159031|FG000|Overall Study|COVID-19|2|||
19716027|NCT03370510|42159032|FG001|Overall Study|COVID-19|0|||
19716028|NCT00351611|42159040|FG000|Overall Study|Adverse Event|11|||
19716029|NCT00351611|42159041|FG001|Overall Study|Adverse Event|3|||
19716030|NCT00351611|42159040|FG000|Overall Study|Death|1|||
19716031|NCT00351611|42159041|FG001|Overall Study|Death|0|||
19716032|NCT00351611|42159040|FG000|Overall Study|Lost to Follow-up|1|||
19716033|NCT00351611|42159041|FG001|Overall Study|Lost to Follow-up|0|||
19716034|NCT00351611|42159040|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
19716035|NCT00351611|42159041|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
19716036|NCT00351611|42159040|FG000|Overall Study|Other|1|||
19716037|NCT00351611|42159041|FG001|Overall Study|Other|0|||
19546252|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
19546253|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
19716038|NCT00351611|42159040|FG000|Overall Study|Protocol Violation|0|||
19716039|NCT00351611|42159041|FG001|Overall Study|Protocol Violation|2|||
19546254|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
19546255|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
19546256|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
19546257|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
19546258|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
19546259|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
19546260|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
19546261|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
19546262|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
19546263|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
19546264|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
19546265|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
19546266|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
19546267|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
19546268|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
19546269|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
19546270|NCT00479882|41995602|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
19546271|NCT00479882|41995603|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
19546272|NCT00479882|41995604|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
19546273|NCT00479882|41995605|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
19546274|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
19546275|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
19546276|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
19546277|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
19546278|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
19546279|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
19546280|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
19546281|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
19546282|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
19546283|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
19546284|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
19546285|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
19546286|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
19546287|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
19546288|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
19546289|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
19546290|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
19546291|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
19546292|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
19546293|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
19546294|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
19546295|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
19546296|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
19546297|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
19546298|NCT00479882|41995602|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
19546299|NCT00479882|41995603|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
19546300|NCT00479882|41995604|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
19546301|NCT00479882|41995605|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
19546302|NCT00479765|41995631|FG000|Overall Study|study terminated|4|||
19546303|NCT00479687|41995637|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
19546304|NCT00479687|41995638|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
19546305|NCT00479687|41995639|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
19546306|NCT00479687|41995637|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
19546307|NCT00479687|41995638|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
19546308|NCT00479687|41995639|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
19546309|NCT00479687|41995637|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
19546310|NCT00479687|41995638|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
19546311|NCT00479687|41995639|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
19546312|NCT00479687|41995637|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
19546313|NCT00479687|41995638|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
19546314|NCT00479687|41995639|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
19546315|NCT00479687|41995637|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
19546316|NCT00479687|41995638|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
19546317|NCT00479687|41995639|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
19546318|NCT00479687|41995637|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
19716040|NCT03789110|42159047|FG000|Overall Study|Adverse Event|2|||
19546319|NCT00479687|41995638|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
19546320|NCT00479687|41995639|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
19546321|NCT00479687|41995637|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
19546322|NCT00479687|41995638|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
19546323|NCT00479687|41995639|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
19546324|NCT00479687|41995637|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
19546325|NCT00479687|41995638|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
19546326|NCT00479687|41995639|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
19546327|NCT00479687|41995637|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
19546328|NCT00479687|41995638|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
19546329|NCT00479687|41995639|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
19546330|NCT00479336|41995650|FG000|Overall Study|Adverse Event|1|||
19546331|NCT00479336|41995651|FG001|Overall Study|Adverse Event|1|||
19546332|NCT00479336|41995652|FG002|Overall Study|Adverse Event|1|||
19546333|NCT00479336|41995653|FG003|Overall Study|Adverse Event|3|||
19546334|NCT00479336|41995650|FG000|Overall Study|Lack of Efficacy|1|||
19546335|NCT00479336|41995651|FG001|Overall Study|Lack of Efficacy|0|||
19546336|NCT00479336|41995652|FG002|Overall Study|Lack of Efficacy|0|||
19546337|NCT00479336|41995653|FG003|Overall Study|Lack of Efficacy|0|||
19546338|NCT00479336|41995650|FG000|Overall Study|Protocol Violation|0|||
19546339|NCT00479336|41995651|FG001|Overall Study|Protocol Violation|1|||
19546340|NCT00479336|41995652|FG002|Overall Study|Protocol Violation|0|||
19546341|NCT00479336|41995653|FG003|Overall Study|Protocol Violation|0|||
19546342|NCT00479336|41995650|FG000|Overall Study|Withdrawal by Subject|1|||
19546343|NCT00479336|41995651|FG001|Overall Study|Withdrawal by Subject|2|||
19546344|NCT00479336|41995652|FG002|Overall Study|Withdrawal by Subject|0|||
19546345|NCT00479336|41995653|FG003|Overall Study|Withdrawal by Subject|0|||
19546346|NCT00479336|41995650|FG000|Overall Study|Physician Decision|0|||
19546347|NCT00479336|41995651|FG001|Overall Study|Physician Decision|1|||
19546348|NCT00479336|41995652|FG002|Overall Study|Physician Decision|0|||
19546349|NCT00479336|41995653|FG003|Overall Study|Physician Decision|2|||
19546350|NCT00479336|41995650|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
19546351|NCT00479336|41995651|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
19546352|NCT00479336|41995652|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
19546353|NCT00479336|41995653|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
19546354|NCT00478244|41995663|FG000|Overall Study|Did not receive transplant|1|||
19546355|NCT00478205|41995669|FG000|Overall Study|Adverse Event|182|||
19546356|NCT00478205|41995670|FG001|Overall Study|Adverse Event|39|||
19546357|NCT00478205|41995669|FG000|Overall Study|Medication Non-compliance|9|||
19546358|NCT00478205|41995670|FG001|Overall Study|Medication Non-compliance|4|||
19546359|NCT00478205|41995669|FG000|Overall Study|Protocol Violation|15|||
19546360|NCT00478205|41995670|FG001|Overall Study|Protocol Violation|5|||
19546361|NCT00478205|41995669|FG000|Overall Study|Request of Investigator or Sponsor|4|||
19546362|NCT00478205|41995670|FG001|Overall Study|Request of Investigator or Sponsor|5|||
19546363|NCT00478205|41995669|FG000|Overall Study|Withdrawal by Subject|61|||
19546364|NCT00478205|41995670|FG001|Overall Study|Withdrawal by Subject|22|||
19546365|NCT00478205|41995669|FG000|Overall Study|Lack of Efficacy|1|||
19546366|NCT00478205|41995670|FG001|Overall Study|Lack of Efficacy|0|||
19546367|NCT00478205|41995669|FG000|Overall Study|Other|24|||
19546368|NCT00478205|41995670|FG001|Overall Study|Other|12|||
19546369|NCT00477971|41995678|FG000|Overall Study|Disease progression|6|||
19546370|NCT00477971|41995679|FG001|Overall Study|Disease progression|0|||
19546371|NCT00477971|41995678|FG000|Overall Study|Withdrawal by Subject|3|||
19546372|NCT00477971|41995679|FG001|Overall Study|Withdrawal by Subject|1|||
19546373|NCT00477971|41995678|FG000|Overall Study|Adverse Event|3|||
19546374|NCT00477971|41995679|FG001|Overall Study|Adverse Event|0|||
19546375|NCT00477971|41995678|FG000|Overall Study|Death|2|||
19546376|NCT00477971|41995679|FG001|Overall Study|Death|4|||
19546377|NCT00477971|41995678|FG000|Overall Study|Alternative treatment|3|||
19546378|NCT00477971|41995679|FG001|Overall Study|Alternative treatment|1|||
19546379|NCT00477464|41995685|FG000|Overall Study|Lost to Follow-up|1|||
19546380|NCT00477464|41995685|FG000|Overall Study|Death|36|||
19546381|NCT00477464|41995685|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
19546382|NCT00477386|41995693|FG000|Overall Study|Adverse Event|4|||
19546383|NCT00477386|41995694|FG001|Overall Study|Adverse Event|8|||
19546384|NCT00477386|41995693|FG000|Overall Study|Disease progression, relapse|3|||
19546385|NCT00477386|41995694|FG001|Overall Study|Disease progression, relapse|4|||
19546386|NCT00477386|41995693|FG000|Overall Study|Disease progression, refractory|1|||
19546387|NCT00477386|41995694|FG001|Overall Study|Disease progression, refractory|3|||
19546388|NCT00477386|41995693|FG000|Overall Study|Other|1|||
19546389|NCT00477386|41995694|FG001|Overall Study|Other|2|||
19546390|NCT00477386|41995693|FG000|Overall Study|Physician Decision|1|||
19546391|NCT00477386|41995694|FG001|Overall Study|Physician Decision|0|||
19546392|NCT00477386|41995693|FG000|Overall Study|Withdrawal by Subject|1|||
19546393|NCT00477386|41995694|FG001|Overall Study|Withdrawal by Subject|0|||
19546394|NCT00477269|41995702|FG000|Core Study|Adverse Event|6|||
19546395|NCT00477269|41995703|FG001|Core Study|Adverse Event|4|||
19546396|NCT00477269|41995704|FG002|Core Study|Adverse Event|0|||
19546397|NCT00477269|41995702|FG000|Core Study|Death|3|||
19546398|NCT00477269|41995703|FG001|Core Study|Death|3|||
19546399|NCT00477269|41995704|FG002|Core Study|Death|0|||
19546400|NCT00477269|41995702|FG000|Core Study|Withdrawn Consent|0|||
19546401|NCT00477269|41995703|FG001|Core Study|Withdrawn Consent|1|||
19546402|NCT00477269|41995704|FG002|Core Study|Withdrawn Consent|0|||
19546403|NCT00477269|41995702|FG000|Open Label Extension|Adverse Event|0|||
19546404|NCT00477269|41995703|FG001|Open Label Extension|Adverse Event|0|||
19546405|NCT00477269|41995704|FG002|Open Label Extension|Adverse Event|4|||
19546406|NCT00477269|41995702|FG000|Open Label Extension|Abnormal laboratory values|0|||
19546407|NCT00477269|41995703|FG001|Open Label Extension|Abnormal laboratory values|0|||
19546408|NCT00477269|41995704|FG002|Open Label Extension|Abnormal laboratory values|1|||
19546409|NCT00477269|41995702|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
19546410|NCT00477269|41995703|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
19546411|NCT00477269|41995704|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
19546412|NCT00477269|41995702|FG000|Open Label Extension|Adminiatrative problems|0|||
19546413|NCT00477269|41995703|FG001|Open Label Extension|Adminiatrative problems|0|||
19546414|NCT00477269|41995704|FG002|Open Label Extension|Adminiatrative problems|2|||
19546415|NCT00477269|41995702|FG000|Open Label Extension|Death|0|||
19546416|NCT00477269|41995703|FG001|Open Label Extension|Death|0|||
19546417|NCT00477269|41995704|FG002|Open Label Extension|Death|4|||
19546418|NCT00477152|41995712|FG000|Overall Study|Parent withdrew consent|2|||
19546419|NCT00477152|41995712|FG000|Overall Study|Adverse Event|1|||
19546420|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
19546421|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
19546422|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
19546423|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
19546424|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
19546425|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
19546426|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
19546427|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
19546428|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
19546429|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
19546430|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
19546431|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
19546432|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
19546433|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
19546434|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
19546435|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
19546436|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
19546437|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
19546438|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
19546439|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
19546440|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
19546441|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
19546442|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
19546443|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
19546444|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
19546445|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
19546446|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
19546447|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
19546448|NCT00476996|41995719|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
19546449|NCT00476996|41995720|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
19546450|NCT00476996|41995721|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
19546451|NCT00476996|41995722|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
19716041|NCT03789110|42159047|FG000|Overall Study|Physician Decision|1|||
19716042|NCT03789110|42159047|FG000|Overall Study|Withdrawal by Subject|2|||
19716043|NCT03789110|42159047|FG000|Overall Study|Lack of Efficacy|22|||
19716044|NCT03789110|42159047|FG000|Overall Study|still on treatment|3|||
19716045|NCT00351533|42159053|FG000|Overall Study|Extubated before first BAL|1|||
19716046|NCT00351533|42159054|FG001|Overall Study|Extubated before first BAL|0|||
19716047|NCT00351533|42159053|FG000|Overall Study|Lost to Follow-up|1|||
19716048|NCT00351533|42159054|FG001|Overall Study|Lost to Follow-up|3|||
19716049|NCT00351533|42159053|FG000|Overall Study|Physician Decision|0|||
19716050|NCT00351533|42159054|FG001|Overall Study|Physician Decision|1|||
19716051|NCT00351533|42159053|FG000|Overall Study|Withdrawal by Subject|0|||
19716052|NCT00351533|42159054|FG001|Overall Study|Withdrawal by Subject|1|||
19716053|NCT00351377|42159060|FG000|Overall Study|Adverse Event|5|||
19546452|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
19546453|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
19546454|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
19716054|NCT00351377|42159060|FG000|Overall Study|Death|1|||
19716055|NCT00351377|42159060|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
19716056|NCT00337727|42159066|FG000|Overall Study|Adverse Event|5|||
19716057|NCT00337727|42159067|FG001|Overall Study|Adverse Event|3|||
19716058|NCT00337727|42159066|FG000|Overall Study|Lost to Follow-up|5|||
19716059|NCT00337727|42159067|FG001|Overall Study|Lost to Follow-up|4|||
19716060|NCT00337727|42159066|FG000|Overall Study|Physician Decision|1|||
19716061|NCT00337727|42159067|FG001|Overall Study|Physician Decision|0|||
19716062|NCT00337727|42159066|FG000|Overall Study|Protocol Violation|4|||
19716063|NCT00337727|42159067|FG001|Overall Study|Protocol Violation|0|||
19716064|NCT00337727|42159066|FG000|Overall Study|Withdrawal by Subject|3|||
19716065|NCT00337727|42159067|FG001|Overall Study|Withdrawal by Subject|5|||
19716066|NCT00324233|42159075|FG000|First Period|unable to insert catheter|1|||
19716067|NCT00324233|42159076|FG001|First Period|unable to insert catheter|0|||
19716068|NCT00324233|42159075|FG000|Second Period|unable to insert catheter|1|||
19716069|NCT00324233|42159076|FG001|Second Period|unable to insert catheter|1|||
19716070|NCT00324233|42159075|FG000|Second Period|Protocol Violation|4|||
19716071|NCT00324233|42159076|FG001|Second Period|Protocol Violation|6|||
19716072|NCT02949700|42159086|FG000|Phase I|Withdrawal by Subject|1|||
19716073|NCT02949700|42159087|FG001|Phase I|Withdrawal by Subject|1|||
19716074|NCT02949700|42159088|FG002|Phase I|Withdrawal by Subject|0|||
19716075|NCT02949700|42159089|FG003|Phase I|Withdrawal by Subject|0|||
19716076|NCT02949700|42159086|FG000|Phase I|Protocol Violation|1|||
19716077|NCT02949700|42159087|FG001|Phase I|Protocol Violation|0|||
19716078|NCT02949700|42159088|FG002|Phase I|Protocol Violation|0|||
19716079|NCT02949700|42159089|FG003|Phase I|Protocol Violation|0|||
19716080|NCT02949700|42159086|FG000|Phase II|Withdrawal by Subject|0|||
19716081|NCT02949700|42159087|FG001|Phase II|Withdrawal by Subject|0|||
19716082|NCT02949700|42159088|FG002|Phase II|Withdrawal by Subject|0|||
19716083|NCT02949700|42159089|FG003|Phase II|Withdrawal by Subject|2|||
19716084|NCT02949700|42159086|FG000|Phase II|Protocol Violation|0|||
19716085|NCT02949700|42159087|FG001|Phase II|Protocol Violation|0|||
19716086|NCT02949700|42159088|FG002|Phase II|Protocol Violation|1|||
19546455|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
19546456|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
19546457|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
19546458|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
19546459|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
19546460|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Death|0|||
19546461|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Death|0|||
19546462|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Death|0|||
19546463|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Death|7|||
19546464|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
19546465|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
19546466|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
19546467|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
19546468|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
19546469|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
19546470|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
19546471|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
19546472|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
19546473|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
19546474|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
19546475|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
19546476|NCT00476996|41995719|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
19546477|NCT00476996|41995720|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
19546478|NCT00476996|41995721|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
19546479|NCT00476996|41995722|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
19546480|NCT00476957|41995733|FG000|Overall Study|Lost to Follow-up|176|||
19546481|NCT00476957|41995734|FG001|Overall Study|Lost to Follow-up|193|||
19546482|NCT00475865|41995743|FG000|Overall Study|Adverse Event|0|||
19546483|NCT00475865|41995744|FG001|Overall Study|Adverse Event|3|||
19546484|NCT00475865|41995745|FG002|Overall Study|Adverse Event|4|||
19546485|NCT00475865|41995743|FG000|Overall Study|Lack of Efficacy|1|||
19716087|NCT02949700|42159089|FG003|Phase II|Protocol Violation|3|||
19716088|NCT03335566|42159100|FG000|Overall Study|Adverse Event|0|||
19716089|NCT03335566|42159101|FG001|Overall Study|Adverse Event|1|||
19716090|NCT03335566|42159100|FG000|Overall Study|Lost to Follow-up|1|||
19716091|NCT03335566|42159101|FG001|Overall Study|Lost to Follow-up|0|||
19716092|NCT03335566|42159100|FG000|Overall Study|Technical Problems|1|||
19716093|NCT03335566|42159101|FG001|Overall Study|Technical Problems|0|||
19716094|NCT03335566|42159100|FG000|Overall Study|Protocol Violation|1|||
19716095|NCT03335566|42159101|FG001|Overall Study|Protocol Violation|0|||
19716096|NCT03335566|42159100|FG000|Overall Study|Other than specified above|1|||
19546486|NCT00475865|41995744|FG001|Overall Study|Lack of Efficacy|0|||
19546487|NCT00475865|41995745|FG002|Overall Study|Lack of Efficacy|0|||
19546488|NCT00475865|41995743|FG000|Overall Study|Progressive disease|0|||
19546489|NCT00475865|41995744|FG001|Overall Study|Progressive disease|1|||
19546490|NCT00475865|41995745|FG002|Overall Study|Progressive disease|2|||
19546491|NCT00475865|41995743|FG000|Overall Study|Participant did not wish to continue|1|||
19546492|NCT00475865|41995744|FG001|Overall Study|Participant did not wish to continue|0|||
19546493|NCT00475865|41995745|FG002|Overall Study|Participant did not wish to continue|0|||
19546494|NCT00475865|41995743|FG000|Overall Study|Other than above|0|||
19546495|NCT00475865|41995744|FG001|Overall Study|Other than above|1|||
19546496|NCT00475865|41995745|FG002|Overall Study|Other than above|0|||
19546497|NCT00475709|41995755|FG000|Overall Study|Did not meet eligibility criteria|8|||
19546498|NCT00475709|41995755|FG000|Overall Study|Death|41|||
19546499|NCT00475709|41995755|FG000|Overall Study|Device Explant|6|||
19546500|NCT00475709|41995755|FG000|Overall Study|Lost to Follow-up|21|||
19546501|NCT00475670|41995761|FG000|Overall Study|Death|0|||
19546502|NCT00475670|41995762|FG001|Overall Study|Death|1|||
19546503|NCT00475670|41995761|FG000|Overall Study|Lack of Efficacy|3|||
19546504|NCT00475670|41995762|FG001|Overall Study|Lack of Efficacy|34|||
19546505|NCT00475670|41995761|FG000|Overall Study|Refused treatment|0|||
19546506|NCT00475670|41995762|FG001|Overall Study|Refused treatment|2|||
19546507|NCT00475670|41995761|FG000|Overall Study|Failure to Return|0|||
19546508|NCT00475670|41995762|FG001|Overall Study|Failure to Return|1|||
19546509|NCT00475670|41995761|FG000|Overall Study|Other|0|||
19546510|NCT00475670|41995762|FG001|Overall Study|Other|3|||
19546511|NCT00474968|41995770|FG000|Overall Study|Withdrawal by Subject|8|||
19546512|NCT00474968|41995771|FG001|Overall Study|Withdrawal by Subject|7|||
19546513|NCT00474968|41995770|FG000|Overall Study|Protocol Violation|9|||
19546514|NCT00474968|41995771|FG001|Overall Study|Protocol Violation|8|||
19546515|NCT00474968|41995770|FG000|Overall Study|Sample not collected|1|||
19546516|NCT00474968|41995771|FG001|Overall Study|Sample not collected|1|||
19546517|NCT00474929|41995782|FG000|Overall Study|Withdrawal by Subject|0|||
19546518|NCT00474929|41995783|FG001|Overall Study|Withdrawal by Subject|1|||
19546519|NCT00474929|41995784|FG002|Overall Study|Withdrawal by Subject|0|||
19546520|NCT00474929|41995785|FG003|Overall Study|Withdrawal by Subject|0|||
19546521|NCT00474929|41995786|FG004|Overall Study|Withdrawal by Subject|0|||
19546522|NCT00474929|41995782|FG000|Overall Study|Unrelated medical condition|0|||
19546523|NCT00474929|41995783|FG001|Overall Study|Unrelated medical condition|0|||
19546524|NCT00474929|41995784|FG002|Overall Study|Unrelated medical condition|1|||
19546525|NCT00474929|41995785|FG003|Overall Study|Unrelated medical condition|0|||
19546526|NCT00474929|41995786|FG004|Overall Study|Unrelated medical condition|0|||
19546527|NCT00474929|41995782|FG000|Overall Study|Physician Decision|0|||
19546528|NCT00474929|41995783|FG001|Overall Study|Physician Decision|0|||
19546529|NCT00474929|41995784|FG002|Overall Study|Physician Decision|1|||
19546530|NCT00474929|41995785|FG003|Overall Study|Physician Decision|2|||
19546531|NCT00474929|41995786|FG004|Overall Study|Physician Decision|0|||
19546532|NCT00474812|41995799|FG000|Overall Study|Withdrawal by Subject|5|||
19546533|NCT00474812|41995799|FG000|Overall Study|No Initiation of treatment|2|||
19546534|NCT00474383|41995803|FG000|Main Study|Adverse Event|11|||
19546535|NCT00474383|41995804|FG001|Main Study|Adverse Event|0|||
19546536|NCT00474383|41995803|FG000|Main Study|Symptomatic Deterioration|1|||
19546537|NCT00474383|41995804|FG001|Main Study|Symptomatic Deterioration|0|||
19546538|NCT00474383|41995803|FG000|Main Study|Progressive Disease|23|||
19546539|NCT00474383|41995804|FG001|Main Study|Progressive Disease|0|||
19546540|NCT00474383|41995803|FG000|Main Study|Other|1|||
19546541|NCT00474383|41995804|FG001|Main Study|Other|0|||
19546542|NCT00474383|41995803|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
19546543|NCT00474383|41995804|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
19546544|NCT00474383|41995803|FG000|Extension|Progressive Disease|0|||
19546545|NCT00474383|41995804|FG001|Extension|Progressive Disease|5|||
19546546|NCT00474266|41995812|FG000|Overall Study|Withdrawal by Subject|7|||
19546547|NCT00474266|41995813|FG001|Overall Study|Withdrawal by Subject|20|||
19546548|NCT00474266|41995814|FG002|Overall Study|Withdrawal by Subject|4|||
19546549|NCT00474266|41995815|FG003|Overall Study|Withdrawal by Subject|7|||
19546550|NCT00473564|41995828|FG000|Overall Study|robot surgery aborted in OR|23|||
19546551|NCT00472199|41995834|FG000|Overall Study|Adverse Event|19|||
19546552|NCT00472199|41995835|FG001|Overall Study|Adverse Event|23|||
19546553|NCT00472199|41995834|FG000|Overall Study|Lack of Efficacy|4|||
19546554|NCT00472199|41995835|FG001|Overall Study|Lack of Efficacy|25|||
19546555|NCT00472199|41995834|FG000|Overall Study|Lost to Follow-up|2|||
19546556|NCT00472199|41995835|FG001|Overall Study|Lost to Follow-up|4|||
19546557|NCT00472199|41995834|FG000|Overall Study|Protocol Violation|3|||
19546558|NCT00472199|41995835|FG001|Overall Study|Protocol Violation|2|||
19546559|NCT00472199|41995834|FG000|Overall Study|Withdrawal by Subject|6|||
19546560|NCT00472199|41995835|FG001|Overall Study|Withdrawal by Subject|5|||
19546561|NCT00472199|41995834|FG000|Overall Study|personal reason|0|||
19546562|NCT00472199|41995835|FG001|Overall Study|personal reason|1|||
19546563|NCT00472199|41995834|FG000|Overall Study|patient was asymptomatic|1|||
19546564|NCT00472199|41995835|FG001|Overall Study|patient was asymptomatic|0|||
19546565|NCT00472082|41995841|FG000|Overall Study|Study prematurely terminated|5|||
19546566|NCT00471887|41995845|FG000|Overall Study|Adverse Event|9|||
19546567|NCT00471536|41995849|FG000|Overall Study|Withdrawal by Subject|1|||
19546568|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
19546569|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
19546570|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Adverse Event|7|||
19546571|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Adverse Event|6|||
19546572|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
19546573|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
19546574|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Physician Decision|4|||
19546575|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Physician Decision|4|||
19546576|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
19546577|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
19546578|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
19546579|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
19546580|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
19546581|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
19546582|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Non-compliance|1|||
19546583|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Non-compliance|0|||
19546584|NCT00470834|41995855|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
19546585|NCT00470834|41995856|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
19546586|NCT00470834|41995855|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
19546587|NCT00470834|41995856|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
19546588|NCT00470834|41995855|FG000|Extension Period (24 Months)|Adverse Event|3|||
19546589|NCT00470834|41995856|FG001|Extension Period (24 Months)|Adverse Event|4|||
19546590|NCT00470834|41995855|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
19546591|NCT00470834|41995856|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
19546592|NCT00470834|41995855|FG000|Extension Period (24 Months)|Physician Decision|4|||
19546593|NCT00470834|41995856|FG001|Extension Period (24 Months)|Physician Decision|3|||
19546594|NCT00470834|41995855|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
19546595|NCT00470834|41995856|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
19546596|NCT00470834|41995855|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
19546597|NCT00470834|41995856|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
19546598|NCT00470834|41995855|FG000|Extension Period (24 Months)|Non-compliance|0|||
19546599|NCT00470834|41995856|FG001|Extension Period (24 Months)|Non-compliance|1|||
19546600|NCT00470834|41995855|FG000|Extension Period (24 Months)|Disease Progression|0|||
19546601|NCT00470834|41995856|FG001|Extension Period (24 Months)|Disease Progression|1|||
19546602|NCT00470366|41995862|FG000|Overall Study|Adverse Event|3|||
19546603|NCT00470366|41995862|FG000|Overall Study|Poor compliance|1|||
19546604|NCT00470093|41995866|FG000|Overall Study|Adverse Event|2|||
19546605|NCT00470054|41995870|FG000|Overall Study|Ineligible|1|||
19546606|NCT00474188|41995874|FG000|Overall Study|Withdrawal by Subject|1|||
19546607|NCT00474188|41995874|FG000|Overall Study|Study discontinued by sponsor|5|||
19546608|NCT00475982|41995879|FG000|Overall Study|surgery rescheduled|7|||
19546609|NCT00475982|41995880|FG001|Overall Study|surgery rescheduled|3|||
19546610|NCT01089647|41995888|FG000|Overall Study|Lost to Follow-up|2|||
19546611|NCT01089647|41995889|FG001|Overall Study|Lost to Follow-up|2|||
19546612|NCT01089647|41995888|FG000|Overall Study|Withdrawal by Subject|2|||
19546613|NCT01089647|41995889|FG001|Overall Study|Withdrawal by Subject|1|||
19546614|NCT01089647|41995888|FG000|Overall Study|Adverse Event|0|||
19546615|NCT01089647|41995889|FG001|Overall Study|Adverse Event|1|||
19546616|NCT01089608|41995897|FG000|Overall Study|Adverse Event|0|||
19546617|NCT01089608|41995898|FG001|Overall Study|Adverse Event|4|||
19546618|NCT01089608|41995897|FG000|Overall Study|Lost to Follow-up|0|||
19546619|NCT01089608|41995898|FG001|Overall Study|Lost to Follow-up|2|||
19546620|NCT01089413|41995907|FG000|Overall Study|Lost to Follow-up|1|||
19546621|NCT01089413|41995907|FG000|Overall Study|Progressive Disease|93|||
19546622|NCT01089413|41995907|FG000|Overall Study|Participant Withdrew Consent|1|||
19546623|NCT01089413|41995907|FG000|Overall Study|Unacceptable Toxicity|12|||
19546624|NCT01089413|41995907|FG000|Overall Study|Death|10|||
19546625|NCT01089413|41995907|FG000|Overall Study|Metastasectomy|13|||
19546626|NCT01089413|41995907|FG000|Overall Study|Other|71|||
19546627|NCT01089023|41995917|FG000|Overall Study|Lost to Follow-up|3|||
19546628|NCT01089023|41995917|FG000|Overall Study|Adverse Event|1|||
19546629|NCT01089023|41995917|FG000|Overall Study|Withdrawal by Subject|1|||
19546630|NCT01089023|41995917|FG000|Overall Study|Protocol Violation|1|||
19546631|NCT01089023|41995917|FG000|Overall Study|Lack of Efficacy|1|||
19546632|NCT01088984|41995923|FG000|Phase 1|Death|2|||
19546633|NCT01088984|41995924|FG001|Phase 1|Death|1|||
19546634|NCT01088984|41995923|FG000|Phase 1|Disease Progression|2|||
19546635|NCT01088984|41995924|FG001|Phase 1|Disease Progression|4|||
19546636|NCT01088984|41995923|FG000|Phase 1|Other|1|||
19546637|NCT01088984|41995924|FG001|Phase 1|Other|1|||
19546638|NCT01088984|41995923|FG000|Phase 2|Death|0|||
19546639|NCT01088984|41995924|FG001|Phase 2|Death|5|||
19546640|NCT01088984|41995923|FG000|Phase 2|Withdrawal by Subject|0|||
19546641|NCT01088984|41995924|FG001|Phase 2|Withdrawal by Subject|1|||
19546642|NCT01088984|41995923|FG000|Phase 2|DIsease Progression|0|||
19546643|NCT01088984|41995924|FG001|Phase 2|DIsease Progression|25|||
19546644|NCT01088984|41995923|FG000|Phase 2|Other|0|||
19546645|NCT01088984|41995924|FG001|Phase 2|Other|1|||
19546646|NCT01088438|41995935|FG000|Overall Study|Withdrawal by Subject|11|||
19546647|NCT01088438|41995936|FG001|Overall Study|Withdrawal by Subject|6|||
19546648|NCT01088438|41995935|FG000|Overall Study|Lost to Follow-up|18|||
19546649|NCT01088438|41995936|FG001|Overall Study|Lost to Follow-up|30|||
19546650|NCT01088243|41995944|FG000|Overall Study|Adverse Event|1|||
19546651|NCT01088243|41995945|FG001|Overall Study|Adverse Event|0|||
19546652|NCT01088048|41995961|FG000|Overall Study|Adverse Event|7|||
19546653|NCT01088048|41995962|FG001|Overall Study|Adverse Event|9|||
19546654|NCT01088048|41995963|FG002|Overall Study|Adverse Event|7|||
19546655|NCT01088048|41995964|FG003|Overall Study|Adverse Event|5|||
19546656|NCT01088048|41995965|FG004|Overall Study|Adverse Event|6|||
19546657|NCT01088048|41995966|FG005|Overall Study|Adverse Event|3|||
19546658|NCT01088048|41995967|FG006|Overall Study|Adverse Event|3|||
19546659|NCT01088048|41995968|FG007|Overall Study|Adverse Event|0|||
19546660|NCT01088048|41995969|FG008|Overall Study|Adverse Event|2|||
19546661|NCT01088048|41995970|FG009|Overall Study|Adverse Event|2|||
19546662|NCT01088048|41995961|FG000|Overall Study|Withdrew Consent|1|||
19546663|NCT01088048|41995962|FG001|Overall Study|Withdrew Consent|1|||
19546664|NCT01088048|41995963|FG002|Overall Study|Withdrew Consent|1|||
19546665|NCT01088048|41995964|FG003|Overall Study|Withdrew Consent|1|||
19546666|NCT01088048|41995965|FG004|Overall Study|Withdrew Consent|2|||
19546667|NCT01088048|41995966|FG005|Overall Study|Withdrew Consent|1|||
19546668|NCT01088048|41995967|FG006|Overall Study|Withdrew Consent|0|||
19546669|NCT01088048|41995968|FG007|Overall Study|Withdrew Consent|2|||
19546670|NCT01088048|41995969|FG008|Overall Study|Withdrew Consent|2|||
19546671|NCT01088048|41995970|FG009|Overall Study|Withdrew Consent|1|||
19546672|NCT01088048|41995961|FG000|Overall Study|Concomitant Medication Prohibited|1|||
19546673|NCT01088048|41995962|FG001|Overall Study|Concomitant Medication Prohibited|0|||
19546674|NCT01088048|41995963|FG002|Overall Study|Concomitant Medication Prohibited|0|||
19546675|NCT01088048|41995964|FG003|Overall Study|Concomitant Medication Prohibited|0|||
19546676|NCT01088048|41995965|FG004|Overall Study|Concomitant Medication Prohibited|0|||
19546677|NCT01088048|41995966|FG005|Overall Study|Concomitant Medication Prohibited|0|||
19546678|NCT01088048|41995967|FG006|Overall Study|Concomitant Medication Prohibited|0|||
19546679|NCT01088048|41995968|FG007|Overall Study|Concomitant Medication Prohibited|0|||
19546680|NCT01088048|41995969|FG008|Overall Study|Concomitant Medication Prohibited|0|||
19546681|NCT01088048|41995970|FG009|Overall Study|Concomitant Medication Prohibited|0|||
19546682|NCT01088048|41995961|FG000|Overall Study|Investigator Request|2|||
19546683|NCT01088048|41995962|FG001|Overall Study|Investigator Request|2|||
19546684|NCT01088048|41995963|FG002|Overall Study|Investigator Request|0|||
19546685|NCT01088048|41995964|FG003|Overall Study|Investigator Request|0|||
19546686|NCT01088048|41995965|FG004|Overall Study|Investigator Request|3|||
19546687|NCT01088048|41995966|FG005|Overall Study|Investigator Request|1|||
19546688|NCT01088048|41995967|FG006|Overall Study|Investigator Request|1|||
19546689|NCT01088048|41995968|FG007|Overall Study|Investigator Request|0|||
19546690|NCT01088048|41995969|FG008|Overall Study|Investigator Request|0|||
19546691|NCT01088048|41995970|FG009|Overall Study|Investigator Request|0|||
19546692|NCT01088048|41995961|FG000|Overall Study|Patient Non-compliance|0|||
19546693|NCT01088048|41995962|FG001|Overall Study|Patient Non-compliance|1|||
19546694|NCT01088048|41995963|FG002|Overall Study|Patient Non-compliance|0|||
19546695|NCT01088048|41995964|FG003|Overall Study|Patient Non-compliance|0|||
19546696|NCT01088048|41995965|FG004|Overall Study|Patient Non-compliance|0|||
19546697|NCT01088048|41995966|FG005|Overall Study|Patient Non-compliance|0|||
19716097|NCT03335566|42159101|FG001|Overall Study|Other than specified above|2|||
19716098|NCT03369418|42159109|FG000|Overall Study|Withdrawal by Subject|3|||
19716099|NCT03369418|42159110|FG001|Overall Study|Withdrawal by Subject|3|||
19716100|NCT03334630|42159118|FG000|Overall Study|Withdrawal by Subject|7|||
19716101|NCT03334630|42159119|FG001|Overall Study|Withdrawal by Subject|7|||
19546698|NCT01088048|41995967|FG006|Overall Study|Patient Non-compliance|0|||
19546699|NCT01088048|41995968|FG007|Overall Study|Patient Non-compliance|0|||
19546700|NCT01088048|41995969|FG008|Overall Study|Patient Non-compliance|0|||
19546701|NCT01088048|41995970|FG009|Overall Study|Patient Non-compliance|0|||
19546702|NCT01088048|41995961|FG000|Overall Study|Disease Progression|7|||
19546703|NCT01088048|41995962|FG001|Overall Study|Disease Progression|4|||
19546704|NCT01088048|41995963|FG002|Overall Study|Disease Progression|3|||
19546705|NCT01088048|41995964|FG003|Overall Study|Disease Progression|5|||
19546706|NCT01088048|41995965|FG004|Overall Study|Disease Progression|3|||
19546707|NCT01088048|41995966|FG005|Overall Study|Disease Progression|3|||
19546708|NCT01088048|41995967|FG006|Overall Study|Disease Progression|2|||
19546709|NCT01088048|41995968|FG007|Overall Study|Disease Progression|1|||
19546710|NCT01088048|41995969|FG008|Overall Study|Disease Progression|0|||
19546711|NCT01088048|41995970|FG009|Overall Study|Disease Progression|0|||
19546712|NCT01088048|41995961|FG000|Overall Study|Death|1|||
19546713|NCT01088048|41995962|FG001|Overall Study|Death|5|||
19546714|NCT01088048|41995963|FG002|Overall Study|Death|3|||
19546715|NCT01088048|41995964|FG003|Overall Study|Death|3|||
19546716|NCT01088048|41995965|FG004|Overall Study|Death|1|||
19546717|NCT01088048|41995966|FG005|Overall Study|Death|3|||
19546718|NCT01088048|41995967|FG006|Overall Study|Death|0|||
19546719|NCT01088048|41995968|FG007|Overall Study|Death|0|||
19546720|NCT01088048|41995969|FG008|Overall Study|Death|3|||
19546721|NCT01088048|41995970|FG009|Overall Study|Death|1|||
19546722|NCT01088048|41995961|FG000|Overall Study|Other|3|||
19546723|NCT01088048|41995962|FG001|Overall Study|Other|5|||
19546724|NCT01088048|41995963|FG002|Overall Study|Other|0|||
19546725|NCT01088048|41995964|FG003|Overall Study|Other|0|||
19546726|NCT01088048|41995965|FG004|Overall Study|Other|2|||
19546727|NCT01088048|41995966|FG005|Overall Study|Other|0|||
19546728|NCT01088048|41995967|FG006|Overall Study|Other|0|||
19546729|NCT01088048|41995968|FG007|Overall Study|Other|2|||
19546730|NCT01088048|41995969|FG008|Overall Study|Other|0|||
19546731|NCT01088048|41995970|FG009|Overall Study|Other|0|||
19546732|NCT01087970|41996003|FG000|Overall Study|Protocol Violation|2|||
19546733|NCT01087814|41996010|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
19546734|NCT01087814|41996011|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
19546735|NCT01087814|41996010|FG000|Second Intervention (5 Days)|Physician Decision|1|||
19546736|NCT01087814|41996011|FG001|Second Intervention (5 Days)|Physician Decision|0|||
19546737|NCT01087775|41996017|FG000|Overall Study|failed inclusion criteria|2|||
19546738|NCT01087502|41996024|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
19546739|NCT01087502|41996025|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
19546740|NCT01087502|41996024|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
19546741|NCT01087502|41996025|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
19546742|NCT01087502|41996024|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
19546743|NCT01087502|41996025|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
19546744|NCT01087502|41996024|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
19546745|NCT01087502|41996025|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
19546746|NCT01087502|41996024|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
19546747|NCT01087502|41996025|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
19546748|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
19546749|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
19546750|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
19546751|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
19546752|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
19546753|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
19546754|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
19546755|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
19546756|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
19546757|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
19546758|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
19546759|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
19546760|NCT01087502|41996024|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
19546761|NCT01087502|41996025|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
19546762|NCT01086410|41996037|FG000|Overall Study|Adverse Event|1|||
19546763|NCT01086410|41996038|FG001|Overall Study|Adverse Event|0|||
19546764|NCT01086410|41996039|FG002|Overall Study|Adverse Event|0|||
19546765|NCT01086410|41996040|FG003|Overall Study|Adverse Event|2|||
19546766|NCT01086410|41996037|FG000|Overall Study|Lack of Efficacy|1|||
19546767|NCT01086410|41996038|FG001|Overall Study|Lack of Efficacy|1|||
19546768|NCT01086410|41996039|FG002|Overall Study|Lack of Efficacy|0|||
19546769|NCT01086410|41996040|FG003|Overall Study|Lack of Efficacy|0|||
19546770|NCT01086410|41996037|FG000|Overall Study|Protocol Violation|1|||
19546771|NCT01086410|41996038|FG001|Overall Study|Protocol Violation|1|||
19546772|NCT01086410|41996039|FG002|Overall Study|Protocol Violation|0|||
19546773|NCT01086410|41996040|FG003|Overall Study|Protocol Violation|0|||
19546774|NCT01086410|41996037|FG000|Overall Study|Lost to Follow-up|0|||
19546775|NCT01086410|41996038|FG001|Overall Study|Lost to Follow-up|0|||
19546776|NCT01086410|41996039|FG002|Overall Study|Lost to Follow-up|1|||
19546777|NCT01086410|41996040|FG003|Overall Study|Lost to Follow-up|0|||
19546778|NCT04553679|41996052|FG000|Overall Study|Withdrawal by Subject|2|||
19546779|NCT04553679|41996053|FG001|Overall Study|Withdrawal by Subject|0|||
19546780|NCT04553679|41996052|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
19546781|NCT04553679|41996053|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
19546782|NCT01086215|41996067|FG000|Overall Study|Death|14|||
19546783|NCT01086215|41996068|FG001|Overall Study|Death|8|||
19546784|NCT01086215|41996069|FG002|Overall Study|Death|8|||
19546785|NCT01086215|41996070|FG003|Overall Study|Death|1|||
19546786|NCT01086215|41996067|FG000|Overall Study|Lost to Follow-up|22|||
19546787|NCT01086215|41996068|FG001|Overall Study|Lost to Follow-up|39|||
19546788|NCT01086215|41996069|FG002|Overall Study|Lost to Follow-up|18|||
19546789|NCT01086215|41996070|FG003|Overall Study|Lost to Follow-up|2|||
19546790|NCT01085591|41996083|FG000|Overall Study|Adverse Event|0|||
19546791|NCT01085591|41996084|FG001|Overall Study|Adverse Event|1|||
19546792|NCT01085591|41996085|FG002|Overall Study|Adverse Event|3|||
19546793|NCT01085591|41996083|FG000|Overall Study|Physician Decision|1|||
19546794|NCT01085591|41996084|FG001|Overall Study|Physician Decision|0|||
19546795|NCT01085591|41996085|FG002|Overall Study|Physician Decision|1|||
19546796|NCT01085591|41996083|FG000|Overall Study|Withdrawal by Subject|0|||
19546797|NCT01085591|41996084|FG001|Overall Study|Withdrawal by Subject|2|||
19546798|NCT01085591|41996085|FG002|Overall Study|Withdrawal by Subject|1|||
19546799|NCT01085591|41996083|FG000|Overall Study|Lost to Follow-up|0|||
19546800|NCT01085591|41996084|FG001|Overall Study|Lost to Follow-up|1|||
19546801|NCT01085591|41996085|FG002|Overall Study|Lost to Follow-up|1|||
19546802|NCT01085591|41996083|FG000|Overall Study|Protocol Violation|1|||
19546803|NCT01085591|41996084|FG001|Overall Study|Protocol Violation|1|||
19546804|NCT01085591|41996085|FG002|Overall Study|Protocol Violation|1|||
19546805|NCT01085591|41996083|FG000|Overall Study|Other|0|||
19546806|NCT01085591|41996084|FG001|Overall Study|Other|1|||
19546807|NCT01085591|41996085|FG002|Overall Study|Other|0|||
19546808|NCT01085591|41996083|FG000|Overall Study|Not Properly Consented|1|||
19546809|NCT01085591|41996084|FG001|Overall Study|Not Properly Consented|0|||
19546810|NCT01085591|41996085|FG002|Overall Study|Not Properly Consented|0|||
19546811|NCT01085357|41996096|FG000|Overall Study|Adverse Event|1|||
19546812|NCT01085357|41996097|FG001|Overall Study|Adverse Event|1|||
19546813|NCT01085357|41996096|FG000|Overall Study|Subject Decision|4|||
19546814|NCT01085357|41996097|FG001|Overall Study|Subject Decision|3|||
19546815|NCT01085357|41996096|FG000|Overall Study|Investigator Decision|1|||
19546816|NCT01085357|41996097|FG001|Overall Study|Investigator Decision|1|||
19546817|NCT01085357|41996096|FG000|Overall Study|Death|11|||
19546818|NCT01085357|41996097|FG001|Overall Study|Death|1|||
19546819|NCT01085357|41996096|FG000|Overall Study|Lost to Follow-up|2|||
19546820|NCT01085357|41996097|FG001|Overall Study|Lost to Follow-up|0|||
19546821|NCT01085201|41996108|FG000|Overall Study|Scheduling conflict|1|||
19546822|NCT01085201|41996109|FG001|Overall Study|Scheduling conflict|0|||
19546823|NCT01085201|41996110|FG002|Overall Study|Scheduling conflict|1|||
19546824|NCT01085201|41996111|FG003|Overall Study|Scheduling conflict|0|||
19546825|NCT01085201|41996112|FG004|Overall Study|Scheduling conflict|0|||
19546826|NCT01085201|41996108|FG000|Overall Study|Unknown- no study drug|2|||
19546827|NCT01085201|41996109|FG001|Overall Study|Unknown- no study drug|0|||
19546828|NCT01085201|41996110|FG002|Overall Study|Unknown- no study drug|0|||
19546829|NCT01085201|41996111|FG003|Overall Study|Unknown- no study drug|0|||
19546830|NCT01085201|41996112|FG004|Overall Study|Unknown- no study drug|0|||
19546831|NCT01085201|41996108|FG000|Overall Study|Fond ineligible after consent|0|||
19546832|NCT01085201|41996109|FG001|Overall Study|Fond ineligible after consent|1|||
19546833|NCT01085201|41996110|FG002|Overall Study|Fond ineligible after consent|1|||
19546834|NCT01085201|41996111|FG003|Overall Study|Fond ineligible after consent|0|||
19546835|NCT01085201|41996112|FG004|Overall Study|Fond ineligible after consent|0|||
19546836|NCT01085084|41996132|FG000|Overall Study|Withdrawal by Subject|1|||
19546837|NCT01085084|41996133|FG001|Overall Study|Withdrawal by Subject|0|||
19546838|NCT01085084|41996134|FG002|Overall Study|Withdrawal by Subject|0|||
19546839|NCT01085084|41996132|FG000|Overall Study|Lost to Follow-up|2|||
19546840|NCT01085084|41996133|FG001|Overall Study|Lost to Follow-up|1|||
19546841|NCT01085084|41996134|FG002|Overall Study|Lost to Follow-up|1|||
19546842|NCT01085084|41996132|FG000|Overall Study|Adverse Event|4|||
19546843|NCT01085084|41996133|FG001|Overall Study|Adverse Event|3|||
19546844|NCT01085084|41996134|FG002|Overall Study|Adverse Event|6|||
19546845|NCT01085084|41996132|FG000|Overall Study|Treatment Failure|0|||
19546846|NCT01085084|41996133|FG001|Overall Study|Treatment Failure|1|||
19546847|NCT01085084|41996134|FG002|Overall Study|Treatment Failure|2|||
19546848|NCT01085045|41996142|FG000|Part A|Withdrawal by Subject|4|||
19546849|NCT01085045|41996142|FG000|Part A|Adverse Event|6|||
19546850|NCT01085045|41996142|FG000|Part A|Protocol Violation|1|||
19546851|NCT01085045|41996142|FG000|Part A|Protocol Specified Criteria|7|||
19546852|NCT01085045|41996142|FG000|Part B|Withdrawal by Subject|2|||
19546853|NCT01085045|41996142|FG000|Part B|Protocol Specified Criteria|6|||
19546854|NCT01085045|41996142|FG000|Part B|Lost to Follow-up|1|||
19716102|NCT03334630|42159118|FG000|Overall Study|Lost to Follow-up|3|||
19716103|NCT03334630|42159119|FG001|Overall Study|Lost to Follow-up|1|||
19546855|NCT01085045|41996142|FG000|Part B|Adverse Event|6|||
19546856|NCT01084772|41996164|FG000|Baseline|Withdrawal by Subject|7|||
19546857|NCT01084772|41996165|FG001|Baseline|Withdrawal by Subject|6|||
19546858|NCT01084772|41996164|FG000|3 Months|Death|1|||
19546859|NCT01084772|41996165|FG001|3 Months|Death|0|||
19546860|NCT01084772|41996164|FG000|3 Months|Study Termination|2|||
19546861|NCT01084772|41996165|FG001|3 Months|Study Termination|2|||
19546862|NCT01084772|41996164|FG000|1 Year|Withdrawal by Subject|0|||
19546863|NCT01084772|41996165|FG001|1 Year|Withdrawal by Subject|1|||
19546864|NCT01084772|41996164|FG000|1 Year|Lost to Follow-up|3|||
19546865|NCT01084772|41996165|FG001|1 Year|Lost to Follow-up|0|||
19546866|NCT01084772|41996164|FG000|1 Year|Study Termination|0|||
19546867|NCT01084772|41996165|FG001|1 Year|Study Termination|7|||
19546868|NCT01084772|41996164|FG000|2 Years|Withdrawal by Subject|1|||
19546869|NCT01084772|41996165|FG001|2 Years|Withdrawal by Subject|0|||
19546870|NCT01084772|41996164|FG000|2 Years|Lost to Follow-up|5|||
19546871|NCT01084772|41996165|FG001|2 Years|Lost to Follow-up|2|||
19546872|NCT01084772|41996164|FG000|2 Years|Study Termination|3|||
19546873|NCT01084772|41996165|FG001|2 Years|Study Termination|2|||
19546874|NCT00179673|41996171|FG000|Overall Study|Adverse Event|7|||
19546875|NCT00179673|41996171|FG000|Overall Study|Lack of Efficacy|15|||
19546876|NCT00179673|41996171|FG000|Overall Study|Withdrawal by Subject|3|||
19546877|NCT00179673|41996171|FG000|Overall Study|Death|4|||
19546878|NCT00179673|41996171|FG000|Overall Study|Other Observations and options|14|||
19546879|NCT01084655|41996178|FG000|Overall Study|Radiographic disease progression|3|||
19546880|NCT01084655|41996179|FG001|Overall Study|Radiographic disease progression|2|||
19546881|NCT01084655|41996180|FG002|Overall Study|Radiographic disease progression|8|||
19546882|NCT01084655|41996178|FG000|Overall Study|Withdrawal by Subject|1|||
19546883|NCT01084655|41996179|FG001|Overall Study|Withdrawal by Subject|0|||
19546884|NCT01084655|41996180|FG002|Overall Study|Withdrawal by Subject|4|||
19546885|NCT01084655|41996178|FG000|Overall Study|Adverse Event|2|||
19546886|NCT01084655|41996179|FG001|Overall Study|Adverse Event|1|||
19546887|NCT01084655|41996180|FG002|Overall Study|Adverse Event|2|||
19546888|NCT01084655|41996178|FG000|Overall Study|Other|0|||
19546889|NCT01084655|41996179|FG001|Overall Study|Other|3|||
19546890|NCT01084655|41996180|FG002|Overall Study|Other|2|||
19546891|NCT01084655|41996178|FG000|Overall Study|Symptomatic deterioration|0|||
19546892|NCT01084655|41996179|FG001|Overall Study|Symptomatic deterioration|0|||
19546893|NCT01084655|41996180|FG002|Overall Study|Symptomatic deterioration|2|||
19546894|NCT01084655|41996178|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
19546895|NCT01084655|41996179|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
19546896|NCT01084655|41996180|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
19546897|NCT01084538|41996192|FG000|Overall Study|Drug not available|30|||
19546898|NCT01084538|41996192|FG000|Overall Study|Adverse Event|9|||
19546899|NCT01084538|41996192|FG000|Overall Study|Kidney transplant|6|||
19546900|NCT01084538|41996192|FG000|Overall Study|Serious Adverse Event|3|||
19546901|NCT01084538|41996192|FG000|Overall Study|Lack of effectiveness|2|||
19546902|NCT01084538|41996192|FG000|Overall Study|Patient noncompliance|2|||
19546903|NCT01084538|41996192|FG000|Overall Study|Hyperphosphatemia|2|||
19546904|NCT01084538|41996192|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
19546905|NCT01084538|41996192|FG000|Overall Study|Change of residence|2|||
19546906|NCT01084538|41996192|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
19546907|NCT01084538|41996192|FG000|Overall Study|Reason unknown|8|||
19546908|NCT01083680|41996196|FG000|Overall Study|Lost to Follow-up|2758|||
19546909|NCT01083680|41996196|FG000|Overall Study|Withdrawal by Subject|1086|||
19546910|NCT00179517|41996202|FG000|Overall Study|Withdrawal by Subject|2|||
19546911|NCT00179517|41996203|FG001|Overall Study|Withdrawal by Subject|1|||
19546912|NCT01083641|41996209|FG000|Overall Study|Withdrawal by Subject|2|||
19546913|NCT00179010|41996215|FG000|Overall Study|Muscle probe defective|1|||
19546914|NCT00179010|41996216|FG001|Overall Study|Muscle probe defective|1|||
19546915|NCT00179010|41996215|FG000|Overall Study|Failure to place arterial line|0|||
19546916|NCT00179010|41996216|FG001|Overall Study|Failure to place arterial line|1|||
19546917|NCT01083602|41996223|FG000|Overall Study|Adverse Event|11|||
19546918|NCT01083602|41996223|FG000|Overall Study|New Cancer Therapy|2|||
19546919|NCT01083602|41996223|FG000|Overall Study|Death|1|||
19546920|NCT01083602|41996223|FG000|Overall Study|Withdrawal by Subject|5|||
19546921|NCT01083602|41996223|FG000|Overall Study|Lack of Efficacy|36|||
19546922|NCT00178464|41996227|FG000|Overall Study|Withdrawal by Subject|1|||
19546923|NCT00178464|41996227|FG000|Overall Study|Physician Decision|1|||
19546924|NCT01083485|41996233|FG000|Overall Study|Adverse Event|0|||
19546925|NCT01083485|41996234|FG001|Overall Study|Adverse Event|1|||
19546926|NCT01083485|41996233|FG000|Overall Study|Protocol Violation|1|||
19546927|NCT01083485|41996234|FG001|Overall Study|Protocol Violation|0|||
19546928|NCT01083485|41996233|FG000|Overall Study|Withdrawal by Subject|5|||
19546929|NCT01083485|41996234|FG001|Overall Study|Withdrawal by Subject|2|||
19546930|NCT01083485|41996233|FG000|Overall Study|Other|1|||
19546931|NCT01083485|41996234|FG001|Overall Study|Other|0|||
19546932|NCT01083173|41996242|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
19546933|NCT01083173|41996243|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
19546934|NCT01083173|41996242|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
19546935|NCT01083173|41996243|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
19546936|NCT01083173|41996242|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
19546937|NCT01083173|41996243|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
19546938|NCT01083173|41996242|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
19546939|NCT01083173|41996243|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
19716104|NCT03334630|42159118|FG000|Overall Study|Adverse Event|0|||
19546940|NCT01083173|41996242|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
19546941|NCT01083173|41996243|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
19546942|NCT01083173|41996242|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
19546943|NCT01083173|41996243|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
19546944|NCT01083173|41996242|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
19546945|NCT01083173|41996243|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
19546946|NCT01083173|41996242|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
19546947|NCT01083173|41996243|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
19546948|NCT01083173|41996242|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
19546949|NCT01083173|41996243|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
19546950|NCT01083173|41996242|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
19546951|NCT01083173|41996243|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
19546952|NCT01083173|41996242|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
19546953|NCT01083173|41996243|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
19546954|NCT00177294|41996254|FG000|Overall Study|Withdrawal by Subject|7|||
19546955|NCT00177294|41996255|FG001|Overall Study|Withdrawal by Subject|5|||
19546956|NCT01082081|41996264|FG000|Overall Study|Lost to Follow-up|0|||
19546957|NCT01082081|41996265|FG001|Overall Study|Lost to Follow-up|0|||
19546958|NCT01082081|41996266|FG002|Overall Study|Lost to Follow-up|1|||
19546959|NCT01082081|41996264|FG000|Overall Study|Withdrawal by Subject|0|||
19546960|NCT01082081|41996265|FG001|Overall Study|Withdrawal by Subject|0|||
19546961|NCT01082081|41996266|FG002|Overall Study|Withdrawal by Subject|1|||
19546962|NCT01082081|41996264|FG000|Overall Study|Other Reason|0|||
19546963|NCT01082081|41996265|FG001|Overall Study|Other Reason|1|||
19546964|NCT01082081|41996266|FG002|Overall Study|Other Reason|0|||
19546965|NCT00177216|41996277|FG000|Overall Study|Withdrawal by Subject|6|||
19546966|NCT00177216|41996278|FG001|Overall Study|Withdrawal by Subject|3|||
19546967|NCT00177216|41996279|FG002|Overall Study|Withdrawal by Subject|1|||
19546968|NCT01081886|41996293|FG000|Overall Study|Study termination|11|||
19546969|NCT01081886|41996294|FG001|Overall Study|Study termination|13|||
19546970|NCT01081769|41996302|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
19546971|NCT01081769|41996303|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
19546972|NCT01081769|41996302|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
19546973|NCT01081769|41996303|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
19546974|NCT01081769|41996302|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
19546975|NCT01081769|41996303|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
19546976|NCT01081769|41996302|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
19546977|NCT01081769|41996303|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
19546978|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Adverse Event|14|||
19546979|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Adverse Event|11|||
19546980|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Death|1|||
19546981|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Death|1|||
19546982|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
19546983|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
19546984|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
19546985|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
19546986|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Pregnancy|1|||
19546987|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Pregnancy|0|||
19546988|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
19546989|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
19546990|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
19546991|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
19546992|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Other|0|||
19546993|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Other|1|||
19546994|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Ineligibility|3|||
19546995|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Ineligibility|4|||
19546996|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
19546997|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
19546998|NCT01081769|41996302|FG000|CORE Intent-To-Treat|Patient Moved|2|||
19546999|NCT01081769|41996303|FG001|CORE Intent-To-Treat|Patient Moved|2|||
19547000|NCT01081301|41996309|FG000|Overall Study|Bereaved|3|||
19547001|NCT01081301|41996309|FG000|Overall Study|Too busy|5|||
19547002|NCT01081301|41996309|FG000|Overall Study|Patient too ill|2|||
19547003|NCT01081301|41996309|FG000|Overall Study|Lost to Follow-up|4|||
19547004|NCT00174954|41996330|FG000|Overall Study|Adverse Event|2|||
19547005|NCT00174954|41996330|FG000|Overall Study|No tophi found in MRI|1|||
19547006|NCT00174954|41996330|FG000|Overall Study|Physician Decision|1|||
19547007|NCT01081145|41996334|FG000|Open-Label Phase|Lack of Efficacy|56|||
19547008|NCT01081145|41996335|FG001|Open-Label Phase|Lack of Efficacy|0|||
19547009|NCT01081145|41996334|FG000|Open-Label Phase|Response criteria not met|46|||
19547010|NCT01081145|41996335|FG001|Open-Label Phase|Response criteria not met|0|||
19547011|NCT01081145|41996334|FG000|Open-Label Phase|Adverse Event|42|||
19547012|NCT01081145|41996335|FG001|Open-Label Phase|Adverse Event|0|||
19547013|NCT01081145|41996334|FG000|Open-Label Phase|Withdrawal by Subject|41|||
19547014|NCT01081145|41996335|FG001|Open-Label Phase|Withdrawal by Subject|0|||
19547015|NCT01081145|41996334|FG000|Open-Label Phase|Other|12|||
19547016|NCT01081145|41996335|FG001|Open-Label Phase|Other|0|||
19547017|NCT01081145|41996334|FG000|Open-Label Phase|Lost to Follow-up|11|||
19547018|NCT01081145|41996335|FG001|Open-Label Phase|Lost to Follow-up|0|||
19547019|NCT01081145|41996334|FG000|Open-Label Phase|Protocol Violation|4|||
19547020|NCT01081145|41996335|FG001|Open-Label Phase|Protocol Violation|0|||
19547021|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
19547022|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
19547023|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
19547024|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
19547025|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
19547026|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
19547027|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
19547028|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
19547029|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
19547030|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
19547031|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
19547032|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
19547033|NCT01081145|41996334|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
19547034|NCT01081145|41996335|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
19547035|NCT00174915|41996348|FG000|Overall Study|Lost to Follow-up|19|||
19547036|NCT00174915|41996349|FG001|Overall Study|Lost to Follow-up|17|||
19547037|NCT00174915|41996350|FG002|Overall Study|Lost to Follow-up|9|||
19547038|NCT00174915|41996351|FG003|Overall Study|Lost to Follow-up|17|||
19547039|NCT00174915|41996352|FG004|Overall Study|Lost to Follow-up|10|||
19547040|NCT00174915|41996348|FG000|Overall Study|Adverse Event|18|||
19547041|NCT00174915|41996349|FG001|Overall Study|Adverse Event|16|||
19547042|NCT00174915|41996350|FG002|Overall Study|Adverse Event|11|||
19547043|NCT00174915|41996351|FG003|Overall Study|Adverse Event|18|||
19547044|NCT00174915|41996352|FG004|Overall Study|Adverse Event|5|||
19547045|NCT00174915|41996348|FG000|Overall Study|Personal Reason(s)|16|||
19547046|NCT00174915|41996349|FG001|Overall Study|Personal Reason(s)|16|||
19547047|NCT00174915|41996350|FG002|Overall Study|Personal Reason(s)|9|||
19547048|NCT00174915|41996351|FG003|Overall Study|Personal Reason(s)|9|||
19547049|NCT00174915|41996352|FG004|Overall Study|Personal Reason(s)|9|||
19547050|NCT00174915|41996348|FG000|Overall Study|Other|15|||
19547051|NCT00174915|41996349|FG001|Overall Study|Other|8|||
19547052|NCT00174915|41996350|FG002|Overall Study|Other|6|||
19547053|NCT00174915|41996351|FG003|Overall Study|Other|5|||
19547054|NCT00174915|41996352|FG004|Overall Study|Other|3|||
19547055|NCT00174915|41996348|FG000|Overall Study|Gout Flare|13|||
19547056|NCT00174915|41996349|FG001|Overall Study|Gout Flare|6|||
19547057|NCT00174915|41996350|FG002|Overall Study|Gout Flare|8|||
19547058|NCT00174915|41996351|FG003|Overall Study|Gout Flare|1|||
19547059|NCT00174915|41996352|FG004|Overall Study|Gout Flare|0|||
19547060|NCT00174915|41996348|FG000|Overall Study|Protocol Violation|6|||
19547061|NCT00174915|41996349|FG001|Overall Study|Protocol Violation|3|||
19547062|NCT00174915|41996350|FG002|Overall Study|Protocol Violation|3|||
19547063|NCT00174915|41996351|FG003|Overall Study|Protocol Violation|6|||
19547064|NCT00174915|41996352|FG004|Overall Study|Protocol Violation|3|||
19547065|NCT00174915|41996348|FG000|Overall Study|Therapeutic Failure|6|||
19547066|NCT00174915|41996349|FG001|Overall Study|Therapeutic Failure|3|||
19547067|NCT00174915|41996350|FG002|Overall Study|Therapeutic Failure|2|||
19547068|NCT00174915|41996351|FG003|Overall Study|Therapeutic Failure|1|||
19547069|NCT00174915|41996352|FG004|Overall Study|Therapeutic Failure|3|||
19547070|NCT01080716|41996368|FG000|Part 1|Physician Decision|1|||
19547071|NCT01080716|41996369|FG001|Part 1|Physician Decision|0|||
19547072|NCT01080716|41996370|FG002|Part 1|Physician Decision|0|||
19547073|NCT01080716|41996371|FG003|Part 1|Physician Decision|0|||
19547074|NCT00172185|41996389|FG000|Overall Study|Adverse Event|0|||
19547075|NCT00172185|41996390|FG001|Overall Study|Adverse Event|1|||
19547076|NCT00172185|41996391|FG002|Overall Study|Adverse Event|3|||
19547077|NCT00172185|41996392|FG003|Overall Study|Adverse Event|4|||
19547078|NCT00172185|41996389|FG000|Overall Study|Physician Decision|0|||
19547079|NCT00172185|41996390|FG001|Overall Study|Physician Decision|0|||
19547080|NCT00172185|41996391|FG002|Overall Study|Physician Decision|1|||
19547081|NCT00172185|41996392|FG003|Overall Study|Physician Decision|0|||
19547082|NCT00172185|41996389|FG000|Overall Study|SPONSOR Decision|0|||
19547083|NCT00172185|41996390|FG001|Overall Study|SPONSOR Decision|1|||
19547084|NCT00172185|41996391|FG002|Overall Study|SPONSOR Decision|0|||
19547085|NCT00172185|41996392|FG003|Overall Study|SPONSOR Decision|0|||
19547086|NCT00172185|41996389|FG000|Overall Study|Withdrawal by Subject|0|||
19547087|NCT00172185|41996390|FG001|Overall Study|Withdrawal by Subject|0|||
19547088|NCT00172185|41996391|FG002|Overall Study|Withdrawal by Subject|1|||
19547089|NCT00172185|41996392|FG003|Overall Study|Withdrawal by Subject|0|||
19547090|NCT01080326|41996406|FG000|Overall Study|Patient deterioration prior to procedure|3|||
19547091|NCT01080326|41996406|FG000|Overall Study|Surgeon decision|1|||
19547092|NCT00171951|41996410|FG000|Overall Study|Adverse Event|1|||
19547093|NCT00171951|41996410|FG000|Overall Study|Abnormal Laboratory Values|2|||
19547094|NCT00171951|41996410|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19547095|NCT00171951|41996410|FG000|Overall Study|Participants Withdrew Consent|3|||
19547096|NCT00171951|41996410|FG000|Overall Study|New Cancer Therapy|5|||
19547097|NCT00171951|41996410|FG000|Overall Study|Reason not Specified|2|||
19547098|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
19547099|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
19547100|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
19547101|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
19547102|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
19547103|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
19547104|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
19547105|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
19547106|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Death|1|||
19547107|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Death|0|||
19547108|NCT01080131|41996419|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
19547109|NCT01080131|41996420|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
19547110|NCT01080131|41996419|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
19547111|NCT01080131|41996420|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
19547112|NCT01080131|41996419|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
19547113|NCT01080131|41996420|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
19547114|NCT01080131|41996419|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
19547115|NCT01080131|41996420|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
19547116|NCT01080131|41996419|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
19547117|NCT01080131|41996420|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
19547118|NCT01080131|41996419|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
19547119|NCT01080131|41996420|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
19547120|NCT01080131|41996419|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
19547121|NCT01080131|41996420|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
19547122|NCT01080131|41996419|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
19547123|NCT01080131|41996420|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
19547124|NCT00171873|41996446|FG000|Overall Study|Withdrawal by Subject|4|||
19547125|NCT00171873|41996447|FG001|Overall Study|Withdrawal by Subject|2|||
19547126|NCT00171873|41996446|FG000|Overall Study|Adverse Event|5|||
19547127|NCT00171873|41996447|FG001|Overall Study|Adverse Event|0|||
19547128|NCT00171873|41996446|FG000|Overall Study|Switched to Octreotide|0|||
19547129|NCT00171873|41996447|FG001|Overall Study|Switched to Octreotide|1|||
19547130|NCT00171834|41996460|FG000|Overall Study|Adverse Event|2|||
19547131|NCT00171834|41996461|FG001|Overall Study|Adverse Event|1|||
19547132|NCT00171834|41996462|FG002|Overall Study|Adverse Event|3|||
19547133|NCT00171834|41996463|FG003|Overall Study|Adverse Event|2|||
19547134|NCT00171834|41996464|FG004|Overall Study|Adverse Event|2|||
19547135|NCT00171834|41996465|FG005|Overall Study|Adverse Event|15|||
19547136|NCT00171834|41996466|FG006|Overall Study|Adverse Event|1|||
19547137|NCT00171834|41996460|FG000|Overall Study|Withdrawal by Subject|0|||
19547138|NCT00171834|41996461|FG001|Overall Study|Withdrawal by Subject|2|||
19547139|NCT00171834|41996462|FG002|Overall Study|Withdrawal by Subject|0|||
19547140|NCT00171834|41996463|FG003|Overall Study|Withdrawal by Subject|1|||
19547141|NCT00171834|41996464|FG004|Overall Study|Withdrawal by Subject|1|||
19547142|NCT00171834|41996465|FG005|Overall Study|Withdrawal by Subject|1|||
19547143|NCT00171834|41996466|FG006|Overall Study|Withdrawal by Subject|0|||
19547144|NCT00171834|41996460|FG000|Overall Study|Death from study indication|0|||
19547145|NCT00171834|41996461|FG001|Overall Study|Death from study indication|1|||
19547146|NCT00171834|41996462|FG002|Overall Study|Death from study indication|0|||
19547147|NCT00171834|41996463|FG003|Overall Study|Death from study indication|0|||
19547148|NCT00171834|41996464|FG004|Overall Study|Death from study indication|1|||
19547149|NCT00171834|41996465|FG005|Overall Study|Death from study indication|0|||
19547150|NCT00171834|41996466|FG006|Overall Study|Death from study indication|0|||
19547151|NCT00171834|41996460|FG000|Overall Study|Disease Progression|4|||
19547152|NCT00171834|41996461|FG001|Overall Study|Disease Progression|8|||
19547153|NCT00171834|41996462|FG002|Overall Study|Disease Progression|8|||
19547154|NCT00171834|41996463|FG003|Overall Study|Disease Progression|9|||
19547155|NCT00171834|41996464|FG004|Overall Study|Disease Progression|2|||
19547156|NCT00171834|41996465|FG005|Overall Study|Disease Progression|18|||
19547157|NCT00171834|41996466|FG006|Overall Study|Disease Progression|3|||
19547158|NCT00171834|41996460|FG000|Overall Study|Treatment Duration Completed|0|||
19547159|NCT00171834|41996461|FG001|Overall Study|Treatment Duration Completed|0|||
19547160|NCT00171834|41996462|FG002|Overall Study|Treatment Duration Completed|1|||
19547161|NCT00171834|41996463|FG003|Overall Study|Treatment Duration Completed|0|||
19547162|NCT00171834|41996464|FG004|Overall Study|Treatment Duration Completed|2|||
19547163|NCT00171834|41996465|FG005|Overall Study|Treatment Duration Completed|1|||
19547164|NCT00171834|41996466|FG006|Overall Study|Treatment Duration Completed|0|||
19547165|NCT00171249|41996496|FG000|Overall Study|Withdrawal by Subject|2|||
19547166|NCT00171249|41996497|FG001|Overall Study|Withdrawal by Subject|0|||
19547167|NCT00171249|41996498|FG002|Overall Study|Withdrawal by Subject|0|||
19547168|NCT00171249|41996499|FG003|Overall Study|Withdrawal by Subject|6|||
19547169|NCT00171249|41996500|FG004|Overall Study|Withdrawal by Subject|0|||
19547170|NCT00171249|41996501|FG005|Overall Study|Withdrawal by Subject|0|||
19547171|NCT00171249|41996502|FG006|Overall Study|Withdrawal by Subject|0|||
19547172|NCT00171249|41996496|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
19547173|NCT00171249|41996497|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19547174|NCT00171249|41996498|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
19547175|NCT00171249|41996499|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
19547176|NCT00171249|41996500|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19547177|NCT00171249|41996501|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
19547178|NCT00171249|41996502|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
19547179|NCT00171249|41996496|FG000|Overall Study|Death|7|||
19547180|NCT00171249|41996497|FG001|Overall Study|Death|1|||
19547181|NCT00171249|41996498|FG002|Overall Study|Death|0|||
19547182|NCT00171249|41996499|FG003|Overall Study|Death|4|||
19547183|NCT00171249|41996500|FG004|Overall Study|Death|0|||
19547184|NCT00171249|41996501|FG005|Overall Study|Death|3|||
19547185|NCT00171249|41996502|FG006|Overall Study|Death|1|||
19547186|NCT00171249|41996496|FG000|Overall Study|Other|10|||
19547187|NCT00171249|41996497|FG001|Overall Study|Other|0|||
19547188|NCT00171249|41996498|FG002|Overall Study|Other|0|||
19547189|NCT00171249|41996499|FG003|Overall Study|Other|43|||
19547190|NCT00171249|41996500|FG004|Overall Study|Other|0|||
19547191|NCT00171249|41996501|FG005|Overall Study|Other|2|||
19547192|NCT00171249|41996502|FG006|Overall Study|Other|0|||
19547193|NCT00171249|41996496|FG000|Overall Study|No Longer Requires Study Drug|4|||
19547194|NCT00171249|41996497|FG001|Overall Study|No Longer Requires Study Drug|0|||
19547195|NCT00171249|41996498|FG002|Overall Study|No Longer Requires Study Drug|0|||
19547196|NCT00171249|41996499|FG003|Overall Study|No Longer Requires Study Drug|3|||
19547197|NCT00171249|41996500|FG004|Overall Study|No Longer Requires Study Drug|0|||
19547198|NCT00171249|41996501|FG005|Overall Study|No Longer Requires Study Drug|5|||
19547199|NCT00171249|41996502|FG006|Overall Study|No Longer Requires Study Drug|0|||
19547200|NCT00171249|41996496|FG000|Overall Study|Administrative Problems|1|||
19547201|NCT00171249|41996497|FG001|Overall Study|Administrative Problems|0|||
19547202|NCT00171249|41996498|FG002|Overall Study|Administrative Problems|0|||
19547203|NCT00171249|41996499|FG003|Overall Study|Administrative Problems|2|||
19547204|NCT00171249|41996500|FG004|Overall Study|Administrative Problems|0|||
19547205|NCT00171249|41996501|FG005|Overall Study|Administrative Problems|0|||
19547206|NCT00171249|41996502|FG006|Overall Study|Administrative Problems|0|||
19547207|NCT00171249|41996496|FG000|Overall Study|Adverse Event|3|||
19547208|NCT00171249|41996497|FG001|Overall Study|Adverse Event|1|||
19547209|NCT00171249|41996498|FG002|Overall Study|Adverse Event|0|||
19716105|NCT03334630|42159119|FG001|Overall Study|Adverse Event|1|||
19716106|NCT03334630|42159118|FG000|Overall Study|Physician Decision|1|||
19716107|NCT03334630|42159119|FG001|Overall Study|Physician Decision|1|||
19716108|NCT03334630|42159118|FG000|Overall Study|Enrollment closed|2|||
19716109|NCT03334630|42159119|FG001|Overall Study|Enrollment closed|1|||
19716110|NCT03334630|42159118|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
19716111|NCT03334630|42159119|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
19716112|NCT03334630|42159118|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
19716113|NCT03334630|42159119|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
19716114|NCT03368170|42159127|FG000|Overall Study|Adverse Event|2|||
19716115|NCT03368170|42159128|FG001|Overall Study|Adverse Event|1|||
19716116|NCT00324155|42159136|FG000|Enrolled and Randomized|No longer met study criteria|3|||
19716117|NCT00324155|42159137|FG001|Enrolled and Randomized|No longer met study criteria|0|||
19716118|NCT00324155|42159136|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
19716119|NCT00324155|42159137|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
19716120|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
19716121|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
19716122|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
19716123|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
19716124|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Death|8|||
19547210|NCT00171249|41996499|FG003|Overall Study|Adverse Event|15|||
19547211|NCT00171249|41996500|FG004|Overall Study|Adverse Event|0|||
19547212|NCT00171249|41996501|FG005|Overall Study|Adverse Event|2|||
19547213|NCT00171249|41996502|FG006|Overall Study|Adverse Event|0|||
19547214|NCT00171249|41996496|FG000|Overall Study|Lost to Follow-up|5|||
19547215|NCT00171249|41996497|FG001|Overall Study|Lost to Follow-up|0|||
19547216|NCT00171249|41996498|FG002|Overall Study|Lost to Follow-up|0|||
19547217|NCT00171249|41996499|FG003|Overall Study|Lost to Follow-up|9|||
19547218|NCT00171249|41996500|FG004|Overall Study|Lost to Follow-up|0|||
19716125|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Death|15|||
19716126|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
19716127|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
19716128|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
19716129|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
19716130|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
19716131|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
19716132|NCT00324155|42159136|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
19716133|NCT00324155|42159137|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
19716134|NCT00324155|42159136|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
19716135|NCT00324155|42159137|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
19716136|NCT00324155|42159136|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
19716137|NCT00324155|42159137|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
19716138|NCT00324155|42159136|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
19716139|NCT00324155|42159137|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
19716140|NCT00324155|42159136|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
19716141|NCT00324155|42159137|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
19716142|NCT00324155|42159136|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
19716143|NCT00324155|42159137|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
19547219|NCT00171249|41996501|FG005|Overall Study|Lost to Follow-up|0|||
19547220|NCT00171249|41996502|FG006|Overall Study|Lost to Follow-up|0|||
19547221|NCT01085630|41996513|FG000|Overall Study|Insufficient data|1|||
19547222|NCT01085630|41996514|FG001|Overall Study|Insufficient data|0|||
19547223|NCT01085630|41996513|FG000|Overall Study|Ineligible|3|||
19547224|NCT01085630|41996514|FG001|Overall Study|Ineligible|0|||
19547225|NCT00171210|41996522|FG000|Overall Study|Adverse Event|16|||
19547226|NCT00171210|41996523|FG001|Overall Study|Adverse Event|27|||
19547227|NCT00171210|41996522|FG000|Overall Study|Abnormal laboratory value(s)|6|||
19547228|NCT00171210|41996523|FG001|Overall Study|Abnormal laboratory value(s)|3|||
19547229|NCT00171210|41996522|FG000|Overall Study|Abnormal test procedure result(s)|0|||
19547230|NCT00171210|41996523|FG001|Overall Study|Abnormal test procedure result(s)|1|||
19547231|NCT00171210|41996522|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
19547232|NCT00171210|41996523|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
19547233|NCT00171210|41996522|FG000|Overall Study|Protocol Violation|0|||
19547234|NCT00171210|41996523|FG001|Overall Study|Protocol Violation|2|||
19547235|NCT00171210|41996522|FG000|Overall Study|Withdrawal by Subject|32|||
19547236|NCT00171210|41996523|FG001|Overall Study|Withdrawal by Subject|30|||
19716144|NCT00324155|42159136|FG000|Follow-up Phase|On-going participants still on drug|11|||
19716145|NCT00324155|42159137|FG001|Follow-up Phase|On-going participants still on drug|6|||
19716146|NCT03334396|42159164|FG000|Overall Study|Adverse Event|1|||
19716147|NCT03334396|42159165|FG001|Overall Study|Adverse Event|0|||
19716148|NCT03334396|42159166|FG002|Overall Study|Adverse Event|1|||
19716149|NCT03334396|42159167|FG003|Overall Study|Adverse Event|0|||
19716150|NCT03334396|42159168|FG004|Overall Study|Adverse Event|0|||
19716151|NCT03334396|42159169|FG005|Overall Study|Adverse Event|0|||
19716152|NCT03334396|42159170|FG006|Overall Study|Adverse Event|0|||
19716153|NCT03334396|42159171|FG007|Overall Study|Adverse Event|0|||
19716154|NCT03334396|42159164|FG000|Overall Study|Lack of Efficacy|10|||
19716155|NCT03334396|42159165|FG001|Overall Study|Lack of Efficacy|4|||
19716156|NCT03334396|42159166|FG002|Overall Study|Lack of Efficacy|1|||
19716157|NCT03334396|42159167|FG003|Overall Study|Lack of Efficacy|3|||
19716158|NCT03334396|42159168|FG004|Overall Study|Lack of Efficacy|1|||
19716159|NCT03334396|42159169|FG005|Overall Study|Lack of Efficacy|0|||
19716160|NCT03334396|42159170|FG006|Overall Study|Lack of Efficacy|0|||
19716161|NCT03334396|42159171|FG007|Overall Study|Lack of Efficacy|1|||
19716162|NCT03334396|42159164|FG000|Overall Study|Lost to Follow-up|0|||
19716163|NCT03334396|42159165|FG001|Overall Study|Lost to Follow-up|0|||
19716164|NCT03334396|42159166|FG002|Overall Study|Lost to Follow-up|1|||
19716165|NCT03334396|42159167|FG003|Overall Study|Lost to Follow-up|0|||
19716166|NCT03334396|42159168|FG004|Overall Study|Lost to Follow-up|0|||
19716167|NCT03334396|42159169|FG005|Overall Study|Lost to Follow-up|0|||
19716168|NCT03334396|42159170|FG006|Overall Study|Lost to Follow-up|1|||
19716169|NCT03334396|42159171|FG007|Overall Study|Lost to Follow-up|0|||
19716170|NCT03334396|42159164|FG000|Overall Study|Physician Decision|1|||
19716171|NCT03334396|42159165|FG001|Overall Study|Physician Decision|0|||
19716172|NCT03334396|42159166|FG002|Overall Study|Physician Decision|0|||
19547237|NCT00171210|41996522|FG000|Overall Study|Lost to Follow-up|1|||
19547238|NCT00171210|41996523|FG001|Overall Study|Lost to Follow-up|0|||
19547239|NCT00171210|41996522|FG000|Overall Study|Administrative problems|1|||
19716173|NCT03334396|42159167|FG003|Overall Study|Physician Decision|0|||
19716174|NCT03334396|42159168|FG004|Overall Study|Physician Decision|0|||
19547240|NCT00171210|41996523|FG001|Overall Study|Administrative problems|1|||
19547241|NCT00171210|41996522|FG000|Overall Study|Death|2|||
19547242|NCT00171210|41996523|FG001|Overall Study|Death|3|||
19547243|NCT00171210|41996522|FG000|Overall Study|Stopped at end of core|0|||
19547244|NCT00171210|41996523|FG001|Overall Study|Stopped at end of core|32|||
19547245|NCT00171210|41996522|FG000|Overall Study|Stopped at end of extension 1|0|||
19547246|NCT00171210|41996523|FG001|Overall Study|Stopped at end of extension 1|1|||
19547247|NCT00171054|41996531|FG000|Overall Study|Protocol Violation|1|||
19547248|NCT00171054|41996532|FG001|Overall Study|Protocol Violation|2|||
19547249|NCT00171054|41996531|FG000|Overall Study|Patient withdrew consent|1|||
19547250|NCT00171054|41996532|FG001|Overall Study|Patient withdrew consent|0|||
19547251|NCT00171054|41996531|FG000|Overall Study|Lost to Follow-up|0|||
19547252|NCT00171054|41996532|FG001|Overall Study|Lost to Follow-up|1|||
19547253|NCT00171054|41996531|FG000|Overall Study|Adverse Event|8|||
19547254|NCT00171054|41996532|FG001|Overall Study|Adverse Event|8|||
19547255|NCT00171054|41996531|FG000|Overall Study|Condition no longer required study drug|0|||
19547256|NCT00171054|41996532|FG001|Overall Study|Condition no longer required study drug|1|||
19547257|NCT01084694|41996540|FG000|Overall Study|Withdrawal by Subject|2|||
19547258|NCT01084694|41996541|FG001|Overall Study|Withdrawal by Subject|1|||
19547259|NCT01084694|41996540|FG000|Overall Study|Death|2|||
19547260|NCT01084694|41996541|FG001|Overall Study|Death|12|||
19547261|NCT01084694|41996540|FG000|Overall Study|eligibility not maintained|2|||
19547262|NCT01084694|41996541|FG001|Overall Study|eligibility not maintained|7|||
19547263|NCT00479856|41996555|FG000|Overall Study|Adverse Event|1|||
19547264|NCT00479856|41996555|FG000|Overall Study|Withdrawal by Subject|1|||
19547265|NCT00479856|41996555|FG000|Overall Study|Physician Decision|1|||
19547266|NCT00479466|41996565|FG000|Overall Study|Adverse Event|5|||
19547267|NCT00479466|41996566|FG001|Overall Study|Adverse Event|1|||
19547268|NCT00479466|41996567|FG002|Overall Study|Adverse Event|0|||
19547269|NCT00479466|41996568|FG003|Overall Study|Adverse Event|1|||
19547270|NCT00479466|41996569|FG004|Overall Study|Adverse Event|2|||
19547271|NCT00479466|41996570|FG005|Overall Study|Adverse Event|0|||
19547272|NCT00479466|41996565|FG000|Overall Study|Hyperglycemia|0|||
19547273|NCT00479466|41996566|FG001|Overall Study|Hyperglycemia|0|||
19547274|NCT00479466|41996567|FG002|Overall Study|Hyperglycemia|0|||
19547275|NCT00479466|41996568|FG003|Overall Study|Hyperglycemia|0|||
19547276|NCT00479466|41996569|FG004|Overall Study|Hyperglycemia|0|||
19547277|NCT00479466|41996570|FG005|Overall Study|Hyperglycemia|1|||
19716175|NCT03334396|42159169|FG005|Overall Study|Physician Decision|0|||
19716176|NCT03334396|42159170|FG006|Overall Study|Physician Decision|0|||
19716177|NCT03334396|42159171|FG007|Overall Study|Physician Decision|0|||
19716178|NCT03334396|42159164|FG000|Overall Study|Withdrawal by Subject|10|||
19716179|NCT03334396|42159165|FG001|Overall Study|Withdrawal by Subject|5|||
19716180|NCT03334396|42159166|FG002|Overall Study|Withdrawal by Subject|7|||
19716181|NCT03334396|42159167|FG003|Overall Study|Withdrawal by Subject|2|||
19716182|NCT03334396|42159168|FG004|Overall Study|Withdrawal by Subject|2|||
19716183|NCT03334396|42159169|FG005|Overall Study|Withdrawal by Subject|1|||
19716184|NCT03334396|42159170|FG006|Overall Study|Withdrawal by Subject|2|||
19716185|NCT03334396|42159171|FG007|Overall Study|Withdrawal by Subject|0|||
19716186|NCT03334396|42159164|FG000|Overall Study|Pregnancy|0|||
19716187|NCT03334396|42159165|FG001|Overall Study|Pregnancy|1|||
19716188|NCT03334396|42159166|FG002|Overall Study|Pregnancy|0|||
19716189|NCT03334396|42159167|FG003|Overall Study|Pregnancy|0|||
19716190|NCT03334396|42159168|FG004|Overall Study|Pregnancy|0|||
19716191|NCT03334396|42159169|FG005|Overall Study|Pregnancy|0|||
19716192|NCT03334396|42159170|FG006|Overall Study|Pregnancy|0|||
19716193|NCT03334396|42159171|FG007|Overall Study|Pregnancy|0|||
19716194|NCT03334396|42159164|FG000|Overall Study|Ineligible|0|||
19716195|NCT03334396|42159165|FG001|Overall Study|Ineligible|1|||
19716196|NCT03334396|42159166|FG002|Overall Study|Ineligible|0|||
19716197|NCT03334396|42159167|FG003|Overall Study|Ineligible|0|||
19716198|NCT03334396|42159168|FG004|Overall Study|Ineligible|0|||
19716199|NCT03334396|42159169|FG005|Overall Study|Ineligible|0|||
19716200|NCT03334396|42159170|FG006|Overall Study|Ineligible|0|||
19716201|NCT03334396|42159171|FG007|Overall Study|Ineligible|0|||
19716202|NCT03334396|42159164|FG000|Overall Study|Started New Job|1|||
19547278|NCT00479466|41996565|FG000|Overall Study|Lack of Efficacy|2|||
19547279|NCT00479466|41996566|FG001|Overall Study|Lack of Efficacy|0|||
19547280|NCT00479466|41996567|FG002|Overall Study|Lack of Efficacy|1|||
19547281|NCT00479466|41996568|FG003|Overall Study|Lack of Efficacy|0|||
19547282|NCT00479466|41996569|FG004|Overall Study|Lack of Efficacy|0|||
19547283|NCT00479466|41996570|FG005|Overall Study|Lack of Efficacy|0|||
19547284|NCT00479466|41996565|FG000|Overall Study|Lost to Follow-up|0|||
19547285|NCT00479466|41996566|FG001|Overall Study|Lost to Follow-up|1|||
19716203|NCT03334396|42159165|FG001|Overall Study|Started New Job|0|||
19716204|NCT03334396|42159166|FG002|Overall Study|Started New Job|0|||
19716205|NCT03334396|42159167|FG003|Overall Study|Started New Job|0|||
19716206|NCT03334396|42159168|FG004|Overall Study|Started New Job|0|||
19716207|NCT03334396|42159169|FG005|Overall Study|Started New Job|0|||
19716208|NCT03334396|42159170|FG006|Overall Study|Started New Job|0|||
19716209|NCT03334396|42159171|FG007|Overall Study|Started New Job|0|||
19716210|NCT03338998|42159190|FG000|Treatment Period|Withdrawal by Subject|1|||
19716211|NCT03338998|42159191|FG001|Treatment Period|Withdrawal by Subject|1|||
19716212|NCT03338998|42159190|FG000|Treatment Period|Adverse Event|0|||
19716213|NCT03338998|42159191|FG001|Treatment Period|Adverse Event|2|||
19716214|NCT03338998|42159190|FG000|Treatment Period|Protocol deviation|1|||
19716215|NCT03338998|42159191|FG001|Treatment Period|Protocol deviation|0|||
19716216|NCT03338998|42159190|FG000|Treatment Period|Physician Decision|2|||
19716217|NCT03338998|42159191|FG001|Treatment Period|Physician Decision|0|||
19716218|NCT03338998|42159190|FG000|Treatment Period|Subject failed swallow test|4|||
19716219|NCT03338998|42159191|FG001|Treatment Period|Subject failed swallow test|0|||
19716220|NCT03338998|42159190|FG000|Safety Follow-Up Period|Adverse Event|0|||
19716221|NCT03338998|42159191|FG001|Safety Follow-Up Period|Adverse Event|1|||
19716222|NCT03338998|42159190|FG000|Safety Follow-Up Period|Protocol deviation|1|||
19716223|NCT03338998|42159191|FG001|Safety Follow-Up Period|Protocol deviation|0|||
19716224|NCT03338998|42159190|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
19716225|NCT03338998|42159191|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
19716226|NCT03338296|42159200|FG000|Overall Study|Adverse Event|0|||
19716227|NCT03338296|42159201|FG001|Overall Study|Adverse Event|1|||
19716228|NCT03338296|42159200|FG000|Overall Study|Withdrawal by Subject|14|||
19716229|NCT03338296|42159201|FG001|Overall Study|Withdrawal by Subject|13|||
19716230|NCT03338296|42159200|FG000|Overall Study|Lost to Follow-up|10|||
19716231|NCT03338296|42159201|FG001|Overall Study|Lost to Follow-up|10|||
19716232|NCT03338296|42159200|FG000|Overall Study|Study Terminated by Sponsor|77|||
19716233|NCT03338296|42159201|FG001|Overall Study|Study Terminated by Sponsor|76|||
19716234|NCT03338296|42159200|FG000|Overall Study|Other|2|||
19716235|NCT03338296|42159201|FG001|Overall Study|Other|7|||
19716236|NCT03338296|42159200|FG000|Overall Study|Missing|0|||
19716237|NCT03338296|42159201|FG001|Overall Study|Missing|1|||
19716238|NCT03338062|42159209|FG000|Overall Study|Alternative Therapy|1|||
19716239|NCT03338062|42159210|FG001|Overall Study|Alternative Therapy|0|||
19716240|NCT03364192|42159217|FG000|Overall Study|Ineligible|10|||
19716241|NCT03364192|42159217|FG000|Overall Study|Withdrawal by Subject|5|||
19716242|NCT03364192|42159217|FG000|Overall Study|Lost to Follow-up|1|||
19716243|NCT03783962|42159224|FG000|Overall Study|Lost to Follow-up|3|||
19716244|NCT03783962|42159225|FG001|Overall Study|Lost to Follow-up|6|||
19716245|NCT03783962|42159224|FG000|Overall Study|Protocol Violation|0|||
19716246|NCT03783962|42159225|FG001|Overall Study|Protocol Violation|1|||
19716247|NCT03361228|42159233|FG000|Overall Study|Other|1|||
19716248|NCT03361228|42159234|FG001|Overall Study|Other|1|||
19716249|NCT03361228|42159233|FG000|Overall Study|Death|3|||
19716250|NCT03361228|42159234|FG001|Overall Study|Death|0|||
19716251|NCT03359590|42159240|FG000|First Intervention|Withdrawal by Subject|1|||
19716252|NCT03359590|42159241|FG001|First Intervention|Withdrawal by Subject|1|||
19716253|NCT03359590|42159240|FG000|First Intervention|Protocol Violation|0|||
19716254|NCT03359590|42159241|FG001|First Intervention|Protocol Violation|1|||
19716255|NCT05085964|42159249|FG000|Overall Study|Premature termination of study|21|||
19716256|NCT05085964|42159250|FG001|Overall Study|Premature termination of study|0|||
19716257|NCT02891200|42159259|FG000|Overall Study|Lost to Follow-up|31|||
19716258|NCT02891200|42159260|FG001|Overall Study|Lost to Follow-up|36|||
19716259|NCT02891200|42159259|FG000|Overall Study|Death|10|||
19716260|NCT02891200|42159260|FG001|Overall Study|Death|9|||
19716261|NCT02891200|42159259|FG000|Overall Study|Withdrawal by Subject|1|||
19716262|NCT02891200|42159260|FG001|Overall Study|Withdrawal by Subject|4|||
19716263|NCT02946580|42159268|FG000|Overall Study|Withdrawal by Subject|1|||
19716264|NCT02946580|42159269|FG001|Overall Study|Withdrawal by Subject|2|||
19716265|NCT02946580|42159268|FG000|Overall Study|Adverse Event|0|||
19716266|NCT02946580|42159269|FG001|Overall Study|Adverse Event|2|||
19716267|NCT02946580|42159268|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
19716268|NCT02946580|42159269|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
19716269|NCT00323609|42159277|FG000|Overall Study|Death|16|||
19716270|NCT00323609|42159278|FG001|Overall Study|Death|21|||
19716271|NCT00323609|42159279|FG002|Overall Study|Death|0|||
19716272|NCT00323609|42159280|FG003|Overall Study|Death|0|||
19716273|NCT00323609|42159277|FG000|Overall Study|Lost to Follow-up|9|||
19716274|NCT00323609|42159278|FG001|Overall Study|Lost to Follow-up|10|||
19716275|NCT00323609|42159279|FG002|Overall Study|Lost to Follow-up|0|||
19716276|NCT00323609|42159280|FG003|Overall Study|Lost to Follow-up|0|||
19716277|NCT00323609|42159277|FG000|Overall Study|Physician Decision|2|||
19716278|NCT00323609|42159278|FG001|Overall Study|Physician Decision|0|||
19716279|NCT00323609|42159279|FG002|Overall Study|Physician Decision|0|||
19716280|NCT00323609|42159280|FG003|Overall Study|Physician Decision|1|||
19716281|NCT00323609|42159277|FG000|Overall Study|Withdrawal by Subject|11|||
19716282|NCT00323609|42159278|FG001|Overall Study|Withdrawal by Subject|23|||
19716283|NCT00323609|42159279|FG002|Overall Study|Withdrawal by Subject|4|||
19716284|NCT00323609|42159280|FG003|Overall Study|Withdrawal by Subject|4|||
19716285|NCT00323609|42159277|FG000|Overall Study|Other non-VCF-related medical condition|3|||
19716286|NCT00323609|42159278|FG001|Overall Study|Other non-VCF-related medical condition|2|||
19716287|NCT00323609|42159279|FG002|Overall Study|Other non-VCF-related medical condition|0|||
19547286|NCT00479466|41996567|FG002|Overall Study|Lost to Follow-up|1|||
19547287|NCT00479466|41996568|FG003|Overall Study|Lost to Follow-up|0|||
19547288|NCT00479466|41996569|FG004|Overall Study|Lost to Follow-up|2|||
19547289|NCT00479466|41996570|FG005|Overall Study|Lost to Follow-up|2|||
19547290|NCT00479466|41996565|FG000|Overall Study|Physician Decision|2|||
19547291|NCT00479466|41996566|FG001|Overall Study|Physician Decision|1|||
19547292|NCT00479466|41996567|FG002|Overall Study|Physician Decision|1|||
19547293|NCT00479466|41996568|FG003|Overall Study|Physician Decision|0|||
19547294|NCT00479466|41996569|FG004|Overall Study|Physician Decision|0|||
19547295|NCT00479466|41996570|FG005|Overall Study|Physician Decision|0|||
19547296|NCT00479466|41996565|FG000|Overall Study|Pregnancy|0|||
19547297|NCT00479466|41996566|FG001|Overall Study|Pregnancy|0|||
19547298|NCT00479466|41996567|FG002|Overall Study|Pregnancy|0|||
19547299|NCT00479466|41996568|FG003|Overall Study|Pregnancy|0|||
19547300|NCT00479466|41996569|FG004|Overall Study|Pregnancy|1|||
19547301|NCT00479466|41996570|FG005|Overall Study|Pregnancy|0|||
19547302|NCT00479466|41996565|FG000|Overall Study|Protocol Violation|1|||
19547303|NCT00479466|41996566|FG001|Overall Study|Protocol Violation|0|||
19547304|NCT00479466|41996567|FG002|Overall Study|Protocol Violation|0|||
19547305|NCT00479466|41996568|FG003|Overall Study|Protocol Violation|0|||
19547306|NCT00479466|41996569|FG004|Overall Study|Protocol Violation|0|||
19547307|NCT00479466|41996570|FG005|Overall Study|Protocol Violation|0|||
19547308|NCT00479466|41996565|FG000|Overall Study|Withdrawal by Subject|3|||
19547309|NCT00479466|41996566|FG001|Overall Study|Withdrawal by Subject|5|||
19547310|NCT00479466|41996567|FG002|Overall Study|Withdrawal by Subject|0|||
19547311|NCT00479466|41996568|FG003|Overall Study|Withdrawal by Subject|2|||
19547312|NCT00479466|41996569|FG004|Overall Study|Withdrawal by Subject|3|||
19547313|NCT00479466|41996570|FG005|Overall Study|Withdrawal by Subject|1|||
19547314|NCT00479388|41996586|FG000|Overall Study|Adverse Event|90|||
19547315|NCT00479388|41996587|FG001|Overall Study|Adverse Event|45|||
19547316|NCT00479388|41996586|FG000|Overall Study|Lost to Follow-up|0|||
19547317|NCT00479388|41996587|FG001|Overall Study|Lost to Follow-up|2|||
19547318|NCT00479388|41996586|FG000|Overall Study|Protocol Violation|10|||
19547319|NCT00479388|41996587|FG001|Overall Study|Protocol Violation|9|||
19547320|NCT00479388|41996586|FG000|Overall Study|Withdrawal by Subject|32|||
19547321|NCT00479388|41996587|FG001|Overall Study|Withdrawal by Subject|17|||
19547322|NCT00479232|41996595|FG000|Overall Study|Adverse Event|0|||
19547323|NCT00479232|41996596|FG001|Overall Study|Adverse Event|0|||
19547324|NCT00479232|41996597|FG002|Overall Study|Adverse Event|5|||
19547325|NCT00479232|41996598|FG003|Overall Study|Adverse Event|0|||
19547326|NCT00479232|41996599|FG004|Overall Study|Adverse Event|0|||
19547327|NCT00479232|41996600|FG005|Overall Study|Adverse Event|10|||
19547328|NCT00479232|41996595|FG000|Overall Study|Deviation from Protocol|0|||
19547329|NCT00479232|41996596|FG001|Overall Study|Deviation from Protocol|0|||
19547330|NCT00479232|41996597|FG002|Overall Study|Deviation from Protocol|1|||
19547331|NCT00479232|41996598|FG003|Overall Study|Deviation from Protocol|0|||
19547332|NCT00479232|41996599|FG004|Overall Study|Deviation from Protocol|0|||
19547333|NCT00479232|41996600|FG005|Overall Study|Deviation from Protocol|0|||
19547334|NCT00479232|41996595|FG000|Overall Study|Lack of Efficacy|0|||
19547335|NCT00479232|41996596|FG001|Overall Study|Lack of Efficacy|0|||
19547336|NCT00479232|41996597|FG002|Overall Study|Lack of Efficacy|2|||
19547337|NCT00479232|41996598|FG003|Overall Study|Lack of Efficacy|0|||
19547338|NCT00479232|41996599|FG004|Overall Study|Lack of Efficacy|0|||
19547339|NCT00479232|41996600|FG005|Overall Study|Lack of Efficacy|4|||
19547340|NCT00479232|41996595|FG000|Overall Study|Physician Decision|0|||
19547341|NCT00479232|41996596|FG001|Overall Study|Physician Decision|0|||
19547342|NCT00479232|41996597|FG002|Overall Study|Physician Decision|2|||
19547343|NCT00479232|41996598|FG003|Overall Study|Physician Decision|0|||
19547344|NCT00479232|41996599|FG004|Overall Study|Physician Decision|0|||
19547345|NCT00479232|41996600|FG005|Overall Study|Physician Decision|1|||
19547346|NCT00479232|41996595|FG000|Overall Study|Progressive Disease|3|||
19547347|NCT00479232|41996596|FG001|Overall Study|Progressive Disease|1|||
19547348|NCT00479232|41996597|FG002|Overall Study|Progressive Disease|12|||
19547349|NCT00479232|41996598|FG003|Overall Study|Progressive Disease|3|||
19547350|NCT00479232|41996599|FG004|Overall Study|Progressive Disease|3|||
19547351|NCT00479232|41996600|FG005|Overall Study|Progressive Disease|12|||
19547352|NCT00479232|41996595|FG000|Overall Study|Withdrew Consent|0|||
19547353|NCT00479232|41996596|FG001|Overall Study|Withdrew Consent|2|||
19547354|NCT00479232|41996597|FG002|Overall Study|Withdrew Consent|6|||
19547355|NCT00479232|41996598|FG003|Overall Study|Withdrew Consent|0|||
19547356|NCT00479232|41996599|FG004|Overall Study|Withdrew Consent|1|||
19547357|NCT00479232|41996600|FG005|Overall Study|Withdrew Consent|3|||
19547358|NCT00478881|41996620|FG000|Overall Study|Adverse Event|31|||
19547359|NCT00478881|41996621|FG001|Overall Study|Adverse Event|12|||
19547360|NCT00478881|41996620|FG000|Overall Study|Lack of Efficacy|0|||
19547361|NCT00478881|41996621|FG001|Overall Study|Lack of Efficacy|3|||
19547362|NCT00478881|41996620|FG000|Overall Study|Lost to Follow-up|0|||
19547363|NCT00478881|41996621|FG001|Overall Study|Lost to Follow-up|1|||
19547364|NCT00478881|41996620|FG000|Overall Study|Protocol Violation|2|||
19547365|NCT00478881|41996621|FG001|Overall Study|Protocol Violation|2|||
19547366|NCT00478881|41996620|FG000|Overall Study|Withdrawal by Subject|6|||
19547367|NCT00478881|41996621|FG001|Overall Study|Withdrawal by Subject|2|||
19547368|NCT00478881|41996620|FG000|Overall Study|Non-Compliance with Study Medication|0|||
19547369|NCT00478881|41996621|FG001|Overall Study|Non-Compliance with Study Medication|2|||
19547370|NCT00478647|41996627|FG000|Overall Study|Adverse Event|1|||
19547371|NCT00478647|41996627|FG000|Overall Study|Withdrawal by Subject|1|||
19547372|NCT00478608|41996631|FG000|Overall Study|Adverse Event|1|||
19547373|NCT00478608|41996631|FG000|Overall Study|Serious Adverse Event|14|||
19547374|NCT00478608|41996631|FG000|Overall Study|Withdrawal by Subject|2|||
19547375|NCT00478608|41996631|FG000|Overall Study|Protocol Violation|3|||
19547376|NCT00478257|41996637|FG000|Overall Study|Withdrawal by Subject|8|||
19547377|NCT00478257|41996638|FG001|Overall Study|Withdrawal by Subject|3|||
19547378|NCT00478140|41996644|FG000|Overall Study|Clinical Disease Progression|1|||
19547379|NCT00478023|41996653|FG000|Overall Study|Adverse Event|11|||
19547380|NCT00478023|41996654|FG001|Overall Study|Adverse Event|7|||
19547381|NCT00478023|41996655|FG002|Overall Study|Adverse Event|8|||
19547382|NCT00478023|41996656|FG003|Overall Study|Adverse Event|14|||
19547383|NCT00478023|41996657|FG004|Overall Study|Adverse Event|6|||
19547384|NCT00478023|41996653|FG000|Overall Study|Death|1|||
19547385|NCT00478023|41996654|FG001|Overall Study|Death|0|||
19547386|NCT00478023|41996655|FG002|Overall Study|Death|0|||
19547387|NCT00478023|41996656|FG003|Overall Study|Death|0|||
19547388|NCT00478023|41996657|FG004|Overall Study|Death|0|||
19547389|NCT00478023|41996653|FG000|Overall Study|Lack of Efficacy|11|||
19547390|NCT00478023|41996654|FG001|Overall Study|Lack of Efficacy|10|||
19547391|NCT00478023|41996655|FG002|Overall Study|Lack of Efficacy|4|||
19547392|NCT00478023|41996656|FG003|Overall Study|Lack of Efficacy|5|||
19547393|NCT00478023|41996657|FG004|Overall Study|Lack of Efficacy|41|||
19547394|NCT00478023|41996653|FG000|Overall Study|Lost to Follow-up|3|||
19547395|NCT00478023|41996654|FG001|Overall Study|Lost to Follow-up|1|||
19547396|NCT00478023|41996655|FG002|Overall Study|Lost to Follow-up|1|||
19547397|NCT00478023|41996656|FG003|Overall Study|Lost to Follow-up|1|||
19547398|NCT00478023|41996657|FG004|Overall Study|Lost to Follow-up|0|||
19547399|NCT00478023|41996653|FG000|Overall Study|Withdrawal by Subject|2|||
19547400|NCT00478023|41996654|FG001|Overall Study|Withdrawal by Subject|3|||
19547401|NCT00478023|41996655|FG002|Overall Study|Withdrawal by Subject|2|||
19547402|NCT00478023|41996656|FG003|Overall Study|Withdrawal by Subject|4|||
19547403|NCT00478023|41996657|FG004|Overall Study|Withdrawal by Subject|5|||
19547404|NCT00478023|41996653|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
19547405|NCT00478023|41996654|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
19547406|NCT00478023|41996655|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
19547407|NCT00478023|41996656|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
19547408|NCT00478023|41996657|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
19547409|NCT00477750|41996669|FG000|Overall Study|Currently Receiving Treatment|11|||
19547410|NCT00477672|41996678|FG000|Overall Study|Adverse Event|3|||
19547411|NCT00477672|41996679|FG001|Overall Study|Adverse Event|5|||
19547412|NCT00477672|41996680|FG002|Overall Study|Adverse Event|6|||
19547413|NCT00477672|41996678|FG000|Overall Study|Death|0|||
19547414|NCT00477672|41996679|FG001|Overall Study|Death|1|||
19547415|NCT00477672|41996680|FG002|Overall Study|Death|0|||
19547416|NCT00477672|41996678|FG000|Overall Study|Disease progression|0|||
19547417|NCT00477672|41996679|FG001|Overall Study|Disease progression|1|||
19547418|NCT00477672|41996680|FG002|Overall Study|Disease progression|0|||
19547419|NCT00477672|41996678|FG000|Overall Study|Physician Decision|1|||
19547420|NCT00477672|41996679|FG001|Overall Study|Physician Decision|0|||
19547421|NCT00477672|41996680|FG002|Overall Study|Physician Decision|0|||
19547422|NCT00477672|41996678|FG000|Overall Study|Protocol noncompliance|0|||
19547423|NCT00477672|41996679|FG001|Overall Study|Protocol noncompliance|2|||
19547424|NCT00477672|41996680|FG002|Overall Study|Protocol noncompliance|0|||
19547425|NCT00477672|41996678|FG000|Overall Study|Consent withdrawn|2|||
19547426|NCT00477672|41996679|FG001|Overall Study|Consent withdrawn|5|||
19547427|NCT00477672|41996680|FG002|Overall Study|Consent withdrawn|10|||
19547428|NCT00477672|41996678|FG000|Overall Study|Discretion of Sponsor|1|||
19547429|NCT00477672|41996679|FG001|Overall Study|Discretion of Sponsor|2|||
19547430|NCT00477672|41996680|FG002|Overall Study|Discretion of Sponsor|0|||
19547431|NCT00477633|41996688|FG000|Overall Study|Did not receive treatment|23|||
19547432|NCT00477633|41996688|FG000|Overall Study|Adverse Event|143|||
19547433|NCT00477633|41996688|FG000|Overall Study|Pregnancy|23|||
19547434|NCT00477633|41996688|FG000|Overall Study|Lost to Follow-up|271|||
19547435|NCT00477633|41996688|FG000|Overall Study|Withdrawal by Subject|149|||
19547436|NCT00477633|41996688|FG000|Overall Study|Protocol Violation|25|||
19547437|NCT00477633|41996688|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
19547438|NCT01131676|41996704|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
19547439|NCT01131676|41996705|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
19547440|NCT01131676|41996706|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
19547441|NCT01131676|41996704|FG000|Discontinuation From Treatment|Not treated|4|||
19547442|NCT01131676|41996705|FG001|Discontinuation From Treatment|Not treated|2|||
19547443|NCT01131676|41996706|FG002|Discontinuation From Treatment|Not treated|2|||
19547444|NCT01131676|41996704|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
19547445|NCT01131676|41996705|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
19547446|NCT01131676|41996706|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
19547447|NCT01131676|41996704|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
19547448|NCT01131676|41996705|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
19547449|NCT01131676|41996706|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
19547450|NCT01131676|41996704|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
19547451|NCT01131676|41996705|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
19547452|NCT01131676|41996706|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
19547453|NCT01131676|41996704|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
19547454|NCT01131676|41996705|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
19547455|NCT01131676|41996706|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
19547456|NCT01131676|41996704|FG000|Discontinuation From Treatment|Other than those specified|162|||
19547457|NCT01131676|41996705|FG001|Discontinuation From Treatment|Other than those specified|142|||
19547458|NCT01131676|41996706|FG002|Discontinuation From Treatment|Other than those specified|125|||
19547459|NCT01131676|41996704|FG000|Discontinuation From Treatment|Adverse Event|303|||
19547460|NCT01131676|41996705|FG001|Discontinuation From Treatment|Adverse Event|267|||
19547461|NCT01131676|41996706|FG002|Discontinuation From Treatment|Adverse Event|273|||
19547462|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
19547463|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
19547464|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
19716288|NCT00323609|42159280|FG003|Overall Study|Other non-VCF-related medical condition|0|||
19716289|NCT00323609|42159277|FG000|Overall Study|Sponsor discontinued trial|29|||
19716290|NCT00323609|42159278|FG001|Overall Study|Sponsor discontinued trial|29|||
19716291|NCT00323609|42159279|FG002|Overall Study|Sponsor discontinued trial|0|||
19716292|NCT00323609|42159280|FG003|Overall Study|Sponsor discontinued trial|0|||
19716293|NCT00323609|42159277|FG000|Overall Study|Unrelenting or severe back pain|1|||
19716294|NCT00323609|42159278|FG001|Overall Study|Unrelenting or severe back pain|1|||
19716295|NCT00323609|42159279|FG002|Overall Study|Unrelenting or severe back pain|0|||
19716296|NCT00323609|42159280|FG003|Overall Study|Unrelenting or severe back pain|0|||
19716297|NCT00323609|42159277|FG000|Overall Study|Logistical withdrawal|9|||
19716298|NCT00323609|42159278|FG001|Overall Study|Logistical withdrawal|5|||
19716299|NCT00323609|42159279|FG002|Overall Study|Logistical withdrawal|0|||
19716300|NCT00323609|42159280|FG003|Overall Study|Logistical withdrawal|1|||
19716301|NCT00323609|42159277|FG000|Overall Study|Other reason|11|||
19716302|NCT00323609|42159278|FG001|Overall Study|Other reason|8|||
19716303|NCT00323609|42159279|FG002|Overall Study|Other reason|4|||
19716304|NCT00323609|42159280|FG003|Overall Study|Other reason|9|||
19716305|NCT04598152|42159286|FG000|Overall Study|Lost to Follow-up|0|||
19716306|NCT04598152|42159287|FG001|Overall Study|Lost to Follow-up|1|||
19716307|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
19716308|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
19716309|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Death|0|||
19716310|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Death|1|||
19716311|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
19716312|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
19716313|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
19716314|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
19716315|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
19716316|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
19716317|NCT00323297|42159295|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
19716318|NCT00323297|42159296|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
19716319|NCT00323297|42159295|FG000|Part B (Open-label)|Death|0|||
19716320|NCT00323297|42159296|FG001|Part B (Open-label)|Death|1|||
19716321|NCT00323297|42159295|FG000|Part B (Open-label)|Reason unspecified|0|||
19716322|NCT00323297|42159296|FG001|Part B (Open-label)|Reason unspecified|1|||
19716323|NCT00323297|42159295|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
19716324|NCT00323297|42159296|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
19716325|NCT00323297|42159295|FG000|Part B (Open-label)|Lack of Efficacy|3|||
19716326|NCT00323297|42159296|FG001|Part B (Open-label)|Lack of Efficacy|1|||
19716327|NCT00323297|42159295|FG000|Part B (Open-label)|Adverse Event|5|||
19716328|NCT00323297|42159296|FG001|Part B (Open-label)|Adverse Event|5|||
19716329|NCT00323297|42159295|FG000|Part B (Open-label)|Protocol Violation|0|||
19716330|NCT00323297|42159296|FG001|Part B (Open-label)|Protocol Violation|1|||
19716331|NCT00323063|42159304|FG000|Overall Study|Adverse Event|1|||
19716332|NCT00323063|42159305|FG001|Overall Study|Adverse Event|0|||
19716333|NCT00323063|42159304|FG000|Overall Study|brain mets discovered prior to treatment|1|||
19716334|NCT00323063|42159305|FG001|Overall Study|brain mets discovered prior to treatment|0|||
19716335|NCT00322049|42159315|FG000|Overall Study|Moved out of area|0|||
19716336|NCT00322049|42159316|FG001|Overall Study|Moved out of area|0|||
19716337|NCT00322049|42159317|FG002|Overall Study|Moved out of area|0|||
19716338|NCT00322049|42159318|FG003|Overall Study|Moved out of area|1|||
19716339|NCT00322049|42159315|FG000|Overall Study|Infected with Dengue during study|0|||
19716340|NCT00322049|42159316|FG001|Overall Study|Infected with Dengue during study|1|||
19716341|NCT00322049|42159317|FG002|Overall Study|Infected with Dengue during study|0|||
19716342|NCT00322049|42159318|FG003|Overall Study|Infected with Dengue during study|0|||
19716343|NCT00321893|42159339|FG000|Overall Study|Non-Compliance/Refusal|16|||
19716344|NCT00321893|42159340|FG001|Overall Study|Non-Compliance/Refusal|10|||
19716345|NCT00321893|42159339|FG000|Overall Study|Lost to Follow-up|2|||
19716346|NCT00321893|42159340|FG001|Overall Study|Lost to Follow-up|1|||
19716347|NCT00321893|42159339|FG000|Overall Study|Adverse Event|6|||
19716348|NCT00321893|42159340|FG001|Overall Study|Adverse Event|3|||
19716349|NCT00371345|42159348|FG000|Overall Study|Disease Progression|21|||
19716350|NCT00371345|42159349|FG001|Overall Study|Disease Progression|35|||
19716351|NCT00371345|42159348|FG000|Overall Study|Study Drug Toxicity|1|||
19716352|NCT00371345|42159349|FG001|Overall Study|Study Drug Toxicity|7|||
19716353|NCT00371345|42159348|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
19716354|NCT00371345|42159349|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
19716355|NCT00371345|42159348|FG000|Overall Study|Participant Request|1|||
19716356|NCT00371345|42159349|FG001|Overall Study|Participant Request|1|||
19716357|NCT00371345|42159348|FG000|Overall Study|Participant Withdrew Consent|0|||
19716358|NCT00371345|42159349|FG001|Overall Study|Participant Withdrew Consent|1|||
19716359|NCT00321737|42159372|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
19716360|NCT00321737|42159373|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
19716361|NCT00321737|42159374|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
19716362|NCT00321737|42159372|FG000|Overall Study|Adverse Event|11|||
19716363|NCT00321737|42159373|FG001|Overall Study|Adverse Event|3|||
19716364|NCT00321737|42159374|FG002|Overall Study|Adverse Event|6|||
19716365|NCT00321737|42159372|FG000|Overall Study|Lost to Follow-up|5|||
19716366|NCT00321737|42159373|FG001|Overall Study|Lost to Follow-up|5|||
19716367|NCT00321737|42159374|FG002|Overall Study|Lost to Follow-up|6|||
19547465|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
19547466|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
19547467|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
19547468|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
19547469|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
19547470|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
19547471|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
19547472|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
19547473|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
19547474|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
19547475|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
19547476|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
19547477|NCT01131676|41996704|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
19547478|NCT01131676|41996705|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
19547479|NCT01131676|41996706|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
19547480|NCT01131520|41996728|FG000|Overall Study|Computer problem|1|||
19547481|NCT01131520|41996729|FG001|Overall Study|Computer problem|0|||
19547482|NCT01131520|41996728|FG000|Overall Study|Counselor not available|0|||
19547483|NCT01131520|41996729|FG001|Overall Study|Counselor not available|3|||
19547484|NCT01131520|41996728|FG000|Overall Study|Subject changed history after enrollment|0|||
19547485|NCT01131520|41996729|FG001|Overall Study|Subject changed history after enrollment|1|||
19547486|NCT01131325|41996735|FG000|Overall Study|Adverse Event|1|||
19547487|NCT01131325|41996735|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
19547488|NCT01131130|41996739|FG000|Period 1 - Baseline|Pregnancy|1|||
19547489|NCT01131130|41996739|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
19547490|NCT01130974|41996749|FG000|Overall Study|Protocol Violation|10|||
19547491|NCT01130974|41996750|FG001|Overall Study|Protocol Violation|10|||
19547492|NCT01130974|41996749|FG000|Overall Study|Withdrawal by Subject|0|||
19547493|NCT01130974|41996750|FG001|Overall Study|Withdrawal by Subject|1|||
19547494|NCT01130974|41996749|FG000|Overall Study|Ineligibility criteria|5|||
19547495|NCT01130974|41996750|FG001|Overall Study|Ineligibility criteria|2|||
19547496|NCT01130272|41996762|FG000|Overall Study|Adverse Event|2|||
19716368|NCT00321737|42159372|FG000|Overall Study|Withdrawal by Subject|19|||
19716369|NCT00321737|42159373|FG001|Overall Study|Withdrawal by Subject|12|||
19716370|NCT00321737|42159374|FG002|Overall Study|Withdrawal by Subject|17|||
19716371|NCT00321737|42159372|FG000|Overall Study|Protocol Violation|0|||
19716372|NCT00321737|42159373|FG001|Overall Study|Protocol Violation|0|||
19716373|NCT00321737|42159374|FG002|Overall Study|Protocol Violation|1|||
19547497|NCT01130272|41996763|FG001|Overall Study|Adverse Event|5|||
19547498|NCT01130272|41996764|FG002|Overall Study|Adverse Event|6|||
19547499|NCT01130272|41996765|FG003|Overall Study|Adverse Event|22|||
19547500|NCT01130272|41996766|FG004|Overall Study|Adverse Event|7|||
19547501|NCT01130272|41996762|FG000|Overall Study|IVRS-confirmed constipation|0|||
19547502|NCT01130272|41996763|FG001|Overall Study|IVRS-confirmed constipation|1|||
19547503|NCT01130272|41996764|FG002|Overall Study|IVRS-confirmed constipation|1|||
19547504|NCT01130272|41996765|FG003|Overall Study|IVRS-confirmed constipation|2|||
19547505|NCT01130272|41996766|FG004|Overall Study|IVRS-confirmed constipation|0|||
19547506|NCT01130272|41996762|FG000|Overall Study|Rescue medications due to diarrhea|3|||
19547507|NCT01130272|41996763|FG001|Overall Study|Rescue medications due to diarrhea|5|||
19547508|NCT01130272|41996764|FG002|Overall Study|Rescue medications due to diarrhea|8|||
19547509|NCT01130272|41996765|FG003|Overall Study|Rescue medications due to diarrhea|8|||
19547510|NCT01130272|41996766|FG004|Overall Study|Rescue medications due to diarrhea|6|||
19547511|NCT01130272|41996762|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
19547512|NCT01130272|41996763|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
19547513|NCT01130272|41996764|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
19547514|NCT01130272|41996765|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
19716374|NCT00321737|42159372|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
19716375|NCT00321737|42159373|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
19716376|NCT00321737|42159374|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
19716377|NCT00321737|42159372|FG000|Overall Study|Possible Barrett's Esophagus|2|||
19716378|NCT00321737|42159373|FG001|Overall Study|Possible Barrett's Esophagus|1|||
19716379|NCT00321737|42159374|FG002|Overall Study|Possible Barrett's Esophagus|1|||
19716380|NCT00321737|42159372|FG000|Overall Study|Therapeutic Failure|6|||
19716381|NCT00321737|42159373|FG001|Overall Study|Therapeutic Failure|0|||
19716382|NCT00321737|42159374|FG002|Overall Study|Therapeutic Failure|2|||
19716383|NCT00321737|42159372|FG000|Overall Study|Pregnancy|0|||
19716384|NCT00321737|42159373|FG001|Overall Study|Pregnancy|2|||
19716385|NCT00321737|42159374|FG002|Overall Study|Pregnancy|0|||
19716386|NCT00321737|42159372|FG000|Overall Study|Noncompliance|2|||
19716387|NCT00321737|42159373|FG001|Overall Study|Noncompliance|0|||
19716388|NCT00321737|42159374|FG002|Overall Study|Noncompliance|0|||
19716389|NCT00321737|42159372|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
19716390|NCT00321737|42159373|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
19716391|NCT00321737|42159374|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
19716392|NCT00320801|42159384|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
19716393|NCT00320801|42159385|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
19716394|NCT00320801|42159386|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
19716395|NCT00320801|42159387|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
19716396|NCT00320801|42159384|FG000|Open-label Run-in Period|Adverse Event|33|||
19716397|NCT00320801|42159385|FG001|Open-label Run-in Period|Adverse Event|0|||
19716398|NCT00320801|42159386|FG002|Open-label Run-in Period|Adverse Event|0|||
19716399|NCT00320801|42159387|FG003|Open-label Run-in Period|Adverse Event|0|||
19716400|NCT00320801|42159384|FG000|Open-label Run-in Period|Administrative|10|||
19716401|NCT00320801|42159385|FG001|Open-label Run-in Period|Administrative|0|||
19716402|NCT00320801|42159386|FG002|Open-label Run-in Period|Administrative|0|||
19716403|NCT00320801|42159387|FG003|Open-label Run-in Period|Administrative|0|||
19716404|NCT00320801|42159384|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
19716405|NCT00320801|42159385|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
19716406|NCT00320801|42159386|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
19716407|NCT00320801|42159387|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
19716408|NCT00320801|42159384|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
19716409|NCT00320801|42159385|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
19716410|NCT00320801|42159386|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
19716411|NCT00320801|42159387|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
19716412|NCT00320801|42159384|FG000|Open-label Run-in Period|Did not qualify|1|||
19716413|NCT00320801|42159385|FG001|Open-label Run-in Period|Did not qualify|0|||
19716414|NCT00320801|42159386|FG002|Open-label Run-in Period|Did not qualify|0|||
19716415|NCT00320801|42159387|FG003|Open-label Run-in Period|Did not qualify|0|||
19716416|NCT00320801|42159384|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19716417|NCT00320801|42159385|FG001|Double-blind Phase|Withdrawal by Subject|0|||
19716418|NCT00320801|42159386|FG002|Double-blind Phase|Withdrawal by Subject|1|||
19716419|NCT00320801|42159387|FG003|Double-blind Phase|Withdrawal by Subject|0|||
19716420|NCT00320801|42159384|FG000|Double-blind Phase|Adverse Event|0|||
19716421|NCT00320801|42159385|FG001|Double-blind Phase|Adverse Event|2|||
19716422|NCT00320801|42159386|FG002|Double-blind Phase|Adverse Event|8|||
19716423|NCT00320801|42159387|FG003|Double-blind Phase|Adverse Event|0|||
19716424|NCT00320801|42159384|FG000|Double-blind Phase|Administrative|0|||
19716425|NCT00320801|42159385|FG001|Double-blind Phase|Administrative|0|||
19716426|NCT00320801|42159386|FG002|Double-blind Phase|Administrative|4|||
19716427|NCT00320801|42159387|FG003|Double-blind Phase|Administrative|0|||
19716428|NCT00320801|42159384|FG000|Double-blind Phase|Lack of Efficacy|0|||
19547515|NCT01130272|41996766|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
19547516|NCT01130272|41996762|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
19547517|NCT01130272|41996763|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
19547518|NCT01130272|41996764|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
19547519|NCT01130272|41996765|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
19547520|NCT01130272|41996766|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
19547521|NCT01130272|41996762|FG000|Overall Study|Protocol Violation|0|||
19547522|NCT01130272|41996763|FG001|Overall Study|Protocol Violation|0|||
19547523|NCT01130272|41996764|FG002|Overall Study|Protocol Violation|3|||
19547524|NCT01130272|41996765|FG003|Overall Study|Protocol Violation|5|||
19547525|NCT01130272|41996766|FG004|Overall Study|Protocol Violation|5|||
19547526|NCT01130272|41996762|FG000|Overall Study|Lost to Follow-up|4|||
19547527|NCT01130272|41996763|FG001|Overall Study|Lost to Follow-up|3|||
19547528|NCT01130272|41996764|FG002|Overall Study|Lost to Follow-up|4|||
19547529|NCT01130272|41996765|FG003|Overall Study|Lost to Follow-up|7|||
19547530|NCT01130272|41996766|FG004|Overall Study|Lost to Follow-up|6|||
19547531|NCT01130272|41996762|FG000|Overall Study|Withdrawal by Subject|4|||
19547532|NCT01130272|41996763|FG001|Overall Study|Withdrawal by Subject|11|||
19547533|NCT01130272|41996764|FG002|Overall Study|Withdrawal by Subject|10|||
19547534|NCT01130272|41996765|FG003|Overall Study|Withdrawal by Subject|9|||
19547535|NCT01130272|41996766|FG004|Overall Study|Withdrawal by Subject|8|||
19547536|NCT01130272|41996762|FG000|Overall Study|Physician Decision|1|||
19547537|NCT01130272|41996763|FG001|Overall Study|Physician Decision|1|||
19547538|NCT01130272|41996764|FG002|Overall Study|Physician Decision|0|||
19547539|NCT01130272|41996765|FG003|Overall Study|Physician Decision|1|||
19547540|NCT01130272|41996766|FG004|Overall Study|Physician Decision|2|||
19716429|NCT00320801|42159385|FG001|Double-blind Phase|Lack of Efficacy|9|||
19716430|NCT00320801|42159386|FG002|Double-blind Phase|Lack of Efficacy|1|||
19716431|NCT00320801|42159387|FG003|Double-blind Phase|Lack of Efficacy|0|||
19716432|NCT00320801|42159384|FG000|Extension Phase|Withdrawal by Subject|0|||
19716433|NCT00320801|42159385|FG001|Extension Phase|Withdrawal by Subject|0|||
19716434|NCT00320801|42159386|FG002|Extension Phase|Withdrawal by Subject|0|||
19716435|NCT00320801|42159387|FG003|Extension Phase|Withdrawal by Subject|6|||
19716436|NCT00320801|42159384|FG000|Extension Phase|Adverse Event|0|||
19716437|NCT00320801|42159385|FG001|Extension Phase|Adverse Event|0|||
19716438|NCT00320801|42159386|FG002|Extension Phase|Adverse Event|0|||
19716439|NCT00320801|42159387|FG003|Extension Phase|Adverse Event|8|||
19716440|NCT00320801|42159384|FG000|Extension Phase|Administrative|0|||
19716441|NCT00320801|42159385|FG001|Extension Phase|Administrative|0|||
19716442|NCT00320801|42159386|FG002|Extension Phase|Administrative|0|||
19716443|NCT00320801|42159387|FG003|Extension Phase|Administrative|29|||
19716444|NCT00320801|42159384|FG000|Extension Phase|Lack of Efficacy|0|||
19716445|NCT00320801|42159385|FG001|Extension Phase|Lack of Efficacy|0|||
19716446|NCT00320801|42159386|FG002|Extension Phase|Lack of Efficacy|0|||
19716447|NCT00320801|42159387|FG003|Extension Phase|Lack of Efficacy|2|||
19716448|NCT00320801|42159384|FG000|Extension Phase|Lost to Follow-up|0|||
19716449|NCT00320801|42159385|FG001|Extension Phase|Lost to Follow-up|0|||
19716450|NCT00320801|42159386|FG002|Extension Phase|Lost to Follow-up|0|||
19716451|NCT00320801|42159387|FG003|Extension Phase|Lost to Follow-up|3|||
19716452|NCT00320489|42159399|FG000|Overall Study|Adverse Event|26|||
19716453|NCT00320489|42159400|FG001|Overall Study|Adverse Event|25|||
19716454|NCT00320489|42159399|FG000|Overall Study|Clinical Relapse|26|||
19716455|NCT00320489|42159400|FG001|Overall Study|Clinical Relapse|20|||
19716456|NCT00320489|42159399|FG000|Overall Study|Death|0|||
19716457|NCT00320489|42159400|FG001|Overall Study|Death|2|||
19716458|NCT00320489|42159399|FG000|Overall Study|Entry Criteria Exclusion|2|||
19716459|NCT00320489|42159400|FG001|Overall Study|Entry Criteria Exclusion|4|||
19716460|NCT00320489|42159399|FG000|Overall Study|Lack of Efficacy|16|||
19716461|NCT00320489|42159400|FG001|Overall Study|Lack of Efficacy|7|||
19716462|NCT00320489|42159399|FG000|Overall Study|Lost to Follow-up|21|||
19716463|NCT00320489|42159400|FG001|Overall Study|Lost to Follow-up|22|||
19716464|NCT00320489|42159399|FG000|Overall Study|Physician Decision|8|||
19716465|NCT00320489|42159400|FG001|Overall Study|Physician Decision|8|||
19547541|NCT01130272|41996762|FG000|Overall Study|Sponsor decision|6|||
19547542|NCT01130272|41996763|FG001|Overall Study|Sponsor decision|15|||
19547543|NCT01130272|41996764|FG002|Overall Study|Sponsor decision|16|||
19547544|NCT01130272|41996765|FG003|Overall Study|Sponsor decision|13|||
19547545|NCT01130272|41996766|FG004|Overall Study|Sponsor decision|16|||
19547546|NCT01130272|41996762|FG000|Overall Study|Study arm discontinued|38|||
19547547|NCT01130272|41996763|FG001|Overall Study|Study arm discontinued|0|||
19716466|NCT00320489|42159399|FG000|Overall Study|Protocol Violation|4|||
19716467|NCT00320489|42159400|FG001|Overall Study|Protocol Violation|4|||
19716468|NCT00320489|42159399|FG000|Overall Study|Sponsor Decision|3|||
19547548|NCT01130272|41996764|FG002|Overall Study|Study arm discontinued|0|||
19547549|NCT01130272|41996765|FG003|Overall Study|Study arm discontinued|0|||
19547550|NCT01130272|41996766|FG004|Overall Study|Study arm discontinued|0|||
19716469|NCT00320489|42159400|FG001|Overall Study|Sponsor Decision|3|||
19716470|NCT00320489|42159399|FG000|Overall Study|Withdrawal by Subject|39|||
19547551|NCT01129960|41996782|FG000|Overall Study|Withdrawal by Subject|3|||
19547552|NCT01129960|41996783|FG001|Overall Study|Withdrawal by Subject|0|||
19547553|NCT01129960|41996784|FG002|Overall Study|Withdrawal by Subject|3|||
19547554|NCT01129960|41996785|FG003|Overall Study|Withdrawal by Subject|2|||
19547555|NCT01129960|41996782|FG000|Overall Study|Lack of Efficacy|1|||
19547556|NCT01129960|41996783|FG001|Overall Study|Lack of Efficacy|1|||
19547557|NCT01129960|41996784|FG002|Overall Study|Lack of Efficacy|1|||
19547558|NCT01129960|41996785|FG003|Overall Study|Lack of Efficacy|1|||
19547559|NCT01129960|41996782|FG000|Overall Study|Adverse Event|23|||
19547560|NCT01129960|41996783|FG001|Overall Study|Adverse Event|16|||
19547561|NCT01129960|41996784|FG002|Overall Study|Adverse Event|16|||
19547562|NCT01129960|41996785|FG003|Overall Study|Adverse Event|7|||
19547563|NCT01129960|41996782|FG000|Overall Study|Protocol Violation|1|||
19547564|NCT01129960|41996783|FG001|Overall Study|Protocol Violation|2|||
19547565|NCT01129960|41996784|FG002|Overall Study|Protocol Violation|3|||
19547566|NCT01129960|41996785|FG003|Overall Study|Protocol Violation|0|||
19547567|NCT01129960|41996782|FG000|Overall Study|Lost to Follow-up|0|||
19547568|NCT01129960|41996783|FG001|Overall Study|Lost to Follow-up|2|||
19547569|NCT01129960|41996784|FG002|Overall Study|Lost to Follow-up|3|||
19547570|NCT01129960|41996785|FG003|Overall Study|Lost to Follow-up|3|||
19547571|NCT01129960|41996782|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
19547572|NCT01129960|41996783|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
19547573|NCT01129960|41996784|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
19547574|NCT01129960|41996785|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
19547575|NCT01129960|41996782|FG000|Overall Study|Physician Decision|1|||
19547576|NCT01129960|41996783|FG001|Overall Study|Physician Decision|0|||
19547577|NCT01129960|41996784|FG002|Overall Study|Physician Decision|0|||
19547578|NCT01129960|41996785|FG003|Overall Study|Physician Decision|0|||
19547579|NCT01129960|41996782|FG000|Overall Study|Pregnancy|1|||
19547580|NCT01129960|41996783|FG001|Overall Study|Pregnancy|0|||
19547581|NCT01129960|41996784|FG002|Overall Study|Pregnancy|0|||
19547582|NCT01129960|41996785|FG003|Overall Study|Pregnancy|0|||
19547583|NCT01129921|41996797|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
19547584|NCT01129921|41996798|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
19547585|NCT01129921|41996797|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
19547586|NCT01129921|41996798|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
19547587|NCT01129921|41996797|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
19547588|NCT01129921|41996798|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
19547589|NCT01129921|41996797|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
19547590|NCT01129921|41996798|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
19547591|NCT01129882|41996808|FG000|Overall Study|Adverse Event|39|||
19547592|NCT01129882|41996808|FG000|Overall Study|Death|6|||
19547593|NCT01129882|41996808|FG000|Overall Study|Lack of Efficacy|5|||
19547594|NCT01129882|41996808|FG000|Overall Study|Lost to Follow-up|13|||
19547595|NCT01129882|41996808|FG000|Overall Study|Physician Decision|27|||
19547596|NCT01129882|41996808|FG000|Overall Study|Protocol Deviation|3|||
19547597|NCT01129882|41996808|FG000|Overall Study|Withdrawal Criteria Met|19|||
19547598|NCT01129882|41996808|FG000|Overall Study|Trial Termination by Sponsor|6|||
19547599|NCT01129882|41996808|FG000|Overall Study|Withdrawal by Subject|160|||
19547600|NCT01129336|41996814|FG000|Overall Study|Protocol Violation|1|||
19547601|NCT01129336|41996815|FG001|Overall Study|Protocol Violation|0|||
19547602|NCT01129336|41996814|FG000|Overall Study|Disease Progression|1|||
19547603|NCT01129336|41996815|FG001|Overall Study|Disease Progression|4|||
19547604|NCT01129336|41996814|FG000|Overall Study|Lost to Follow-up|1|||
19547605|NCT01129336|41996815|FG001|Overall Study|Lost to Follow-up|0|||
19547606|NCT01129336|41996814|FG000|Overall Study|Withdrawal by Subject|7|||
19547607|NCT01129336|41996815|FG001|Overall Study|Withdrawal by Subject|4|||
19547608|NCT01129336|41996814|FG000|Overall Study|Adverse Event|0|||
19547609|NCT01129336|41996815|FG001|Overall Study|Adverse Event|1|||
19547610|NCT01129336|41996814|FG000|Overall Study|Missing Study Completion Status|2|||
19547611|NCT01129336|41996815|FG001|Overall Study|Missing Study Completion Status|3|||
19547612|NCT01129336|41996814|FG000|Overall Study|Death|0|||
19547613|NCT01129336|41996815|FG001|Overall Study|Death|4|||
19547614|NCT01129102|41996824|FG000|Overall Study|No study drug treatment|2|||
19547615|NCT01129102|41996825|FG001|Overall Study|No study drug treatment|3|||
19547616|NCT01129102|41996826|FG002|Overall Study|No study drug treatment|1|||
19547617|NCT01129102|41996824|FG000|Overall Study|Withdrawal by Subject|2|||
19547618|NCT01129102|41996825|FG001|Overall Study|Withdrawal by Subject|0|||
19547619|NCT01129102|41996826|FG002|Overall Study|Withdrawal by Subject|3|||
19547620|NCT01129102|41996824|FG000|Overall Study|Protocol Violation|0|||
19547621|NCT01129102|41996825|FG001|Overall Study|Protocol Violation|1|||
19547622|NCT01129102|41996826|FG002|Overall Study|Protocol Violation|1|||
19547623|NCT01129102|41996824|FG000|Overall Study|Pregnancy|0|||
19547624|NCT01129102|41996825|FG001|Overall Study|Pregnancy|0|||
19547625|NCT01129102|41996826|FG002|Overall Study|Pregnancy|1|||
19547626|NCT01129102|41996824|FG000|Overall Study|Adverse Event|2|||
19547627|NCT01129102|41996825|FG001|Overall Study|Adverse Event|2|||
19547628|NCT01129102|41996826|FG002|Overall Study|Adverse Event|1|||
19547629|NCT01129102|41996824|FG000|Overall Study|Lost to Follow-up|2|||
19547630|NCT01129102|41996825|FG001|Overall Study|Lost to Follow-up|0|||
19547631|NCT01129102|41996826|FG002|Overall Study|Lost to Follow-up|0|||
19547632|NCT01129024|41996833|FG000|Overall Study|Physician Decision|5|||
19547633|NCT01129024|41996833|FG000|Overall Study|Study Terminated by Sponsor|8|||
19547634|NCT01129024|41996833|FG000|Overall Study|Withdrawal by Subject|2|||
19547635|NCT01129024|41996833|FG000|Overall Study|Lack of Efficacy|3|||
19547636|NCT01129024|41996833|FG000|Overall Study|Needed a Platelet Transfusion|1|||
19547637|NCT01128946|41996837|FG000|Period I|Protocol Violation|0|||
19547638|NCT01128946|41996838|FG001|Period I|Protocol Violation|1|||
19547639|NCT01128946|41996839|FG002|Period I|Protocol Violation|0|||
19547640|NCT01128946|41996840|FG003|Period I|Protocol Violation|0|||
19547641|NCT01128946|41996837|FG000|Period I|Withdrawal by Subject|0|||
19547642|NCT01128946|41996838|FG001|Period I|Withdrawal by Subject|0|||
19547643|NCT01128946|41996839|FG002|Period I|Withdrawal by Subject|1|||
19547644|NCT01128946|41996840|FG003|Period I|Withdrawal by Subject|1|||
19547645|NCT01128946|41996837|FG000|Period II|Protocol Violation|0|||
19547646|NCT01128946|41996838|FG001|Period II|Protocol Violation|1|||
19547647|NCT01128946|41996839|FG002|Period II|Protocol Violation|0|||
19547648|NCT01128946|41996840|FG003|Period II|Protocol Violation|0|||
19547649|NCT01128946|41996837|FG000|Period II|Withdrawal by Subject|0|||
19547650|NCT01128946|41996838|FG001|Period II|Withdrawal by Subject|0|||
19547651|NCT01128946|41996839|FG002|Period II|Withdrawal by Subject|0|||
19547652|NCT01128946|41996840|FG003|Period II|Withdrawal by Subject|1|||
19547653|NCT01128946|41996837|FG000|Period III|Protocol Violation|1|||
19547654|NCT01128946|41996838|FG001|Period III|Protocol Violation|0|||
19547655|NCT01128946|41996839|FG002|Period III|Protocol Violation|0|||
19547656|NCT01128946|41996840|FG003|Period III|Protocol Violation|0|||
19547657|NCT01128595|41996851|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19547658|NCT01128595|41996852|FG001|Treatment Period 3|Withdrawal by Subject|1|||
19547659|NCT01128595|41996853|FG002|Treatment Period 3|Withdrawal by Subject|0|||
19547660|NCT01128595|41996854|FG003|Treatment Period 3|Withdrawal by Subject|0|||
19547661|NCT01128400|41996868|FG000|Overall Study|Lost to Follow-up|1|||
19547662|NCT01128400|41996869|FG001|Overall Study|Lost to Follow-up|0|||
19547663|NCT01128400|41996870|FG002|Overall Study|Lost to Follow-up|1|||
19547664|NCT01128400|41996868|FG000|Overall Study|Screening failure|1|||
19547665|NCT01128400|41996869|FG001|Overall Study|Screening failure|0|||
19547666|NCT01128400|41996870|FG002|Overall Study|Screening failure|0|||
19547667|NCT01128400|41996868|FG000|Overall Study|were not invited to participate on taste|0|||
19547668|NCT01128400|41996869|FG001|Overall Study|were not invited to participate on taste|0|||
19547669|NCT01128400|41996870|FG002|Overall Study|were not invited to participate on taste|15|||
19547670|NCT01128400|41996868|FG000|Overall Study|Excluded due to sinus problems|0|||
19547671|NCT01128400|41996869|FG001|Overall Study|Excluded due to sinus problems|1|||
19547672|NCT01128400|41996870|FG002|Overall Study|Excluded due to sinus problems|0|||
19547673|NCT01128361|41996880|FG000|Overall Study|Lost to Follow-up|0|||
19547674|NCT01128361|41996881|FG001|Overall Study|Lost to Follow-up|1|||
19547675|NCT01128361|41996880|FG000|Overall Study|Withdrawal by Subject|5|||
19547676|NCT01128361|41996881|FG001|Overall Study|Withdrawal by Subject|2|||
19547677|NCT01128244|41996887|FG000|Overall Study|Adverse Event|1|||
19547678|NCT01128244|41996887|FG000|Overall Study|Scheduling conflict|2|||
19547679|NCT01127893|41996895|FG000|Overall Study|Study Termination by the Sponsor|1|||
19547680|NCT01126879|41996901|FG000|Overall Study|Progressive Disease|3|||
19547681|NCT01126879|41996902|FG001|Overall Study|Progressive Disease|1|||
19547682|NCT01126879|41996901|FG000|Overall Study|Withdrawal by Subject|1|||
19547683|NCT01126879|41996902|FG001|Overall Study|Withdrawal by Subject|0|||
19547684|NCT01126879|41996901|FG000|Overall Study|Adverse Event|0|||
19547685|NCT01126879|41996902|FG001|Overall Study|Adverse Event|1|||
19547686|NCT01126879|41996901|FG000|Overall Study|Physician Decision|1|||
19547687|NCT01126879|41996902|FG001|Overall Study|Physician Decision|0|||
19547688|NCT01126060|41996910|FG000|Overall Study|Protocol Violation|0|||
19547689|NCT01126060|41996911|FG001|Overall Study|Protocol Violation|2|||
19547690|NCT01125748|41996919|FG000|Overall Study|Adverse Event|0|||
19547691|NCT01125748|41996920|FG001|Overall Study|Adverse Event|2|||
19547692|NCT01125748|41996919|FG000|Overall Study|Lost to Follow-up|0|||
19547693|NCT01125748|41996920|FG001|Overall Study|Lost to Follow-up|1|||
19547694|NCT01125748|41996919|FG000|Overall Study|Physician Decision|8|||
19547695|NCT01125748|41996920|FG001|Overall Study|Physician Decision|7|||
19547696|NCT01125748|41996919|FG000|Overall Study|Patient Decision to Withdraw|2|||
19547697|NCT01125748|41996920|FG001|Overall Study|Patient Decision to Withdraw|4|||
19547698|NCT01125514|41996926|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
19547699|NCT01125514|41996926|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
19547700|NCT01125514|41996926|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
19547701|NCT01125514|41996926|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
19547702|NCT01125514|41996926|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
19547703|NCT01125514|41996926|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
19547704|NCT01125358|41996944|FG000|Overall Study|Adverse Event|3|||
19547705|NCT01125358|41996945|FG001|Overall Study|Adverse Event|0|||
19547706|NCT01125358|41996946|FG002|Overall Study|Adverse Event|0|||
19547707|NCT01125358|41996947|FG003|Overall Study|Adverse Event|2|||
19547708|NCT01125358|41996944|FG000|Overall Study|Perceived Lack of Efficacy|6|||
19547709|NCT01125358|41996945|FG001|Overall Study|Perceived Lack of Efficacy|3|||
19547710|NCT01125358|41996946|FG002|Overall Study|Perceived Lack of Efficacy|7|||
19547711|NCT01125358|41996947|FG003|Overall Study|Perceived Lack of Efficacy|4|||
19547712|NCT01125358|41996944|FG000|Overall Study|Protocol Violation|1|||
19547713|NCT01125358|41996945|FG001|Overall Study|Protocol Violation|0|||
19547714|NCT01125358|41996946|FG002|Overall Study|Protocol Violation|0|||
19547715|NCT01125358|41996947|FG003|Overall Study|Protocol Violation|0|||
19547716|NCT01125358|41996944|FG000|Overall Study|Sponsor Decision|0|||
19547717|NCT01125358|41996945|FG001|Overall Study|Sponsor Decision|0|||
19547718|NCT01125358|41996946|FG002|Overall Study|Sponsor Decision|1|||
19547719|NCT01125358|41996947|FG003|Overall Study|Sponsor Decision|1|||
19547720|NCT01125358|41996944|FG000|Overall Study|Withdrawal by Subject|2|||
19547721|NCT01125358|41996945|FG001|Overall Study|Withdrawal by Subject|1|||
19547722|NCT01125358|41996946|FG002|Overall Study|Withdrawal by Subject|1|||
19547723|NCT01125358|41996947|FG003|Overall Study|Withdrawal by Subject|1|||
19547724|NCT01125046|41996957|FG000|First 6 Months of Treatment|Death|1|||
19547725|NCT01125046|41996957|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
19547726|NCT01125046|41996957|FG000|First 6 Months of Treatment|Non-compliance|1|||
19547727|NCT01125046|41996957|FG000|First 6 Months of Treatment|Surgery|1|||
19547728|NCT01125046|41996957|FG000|First 6 Months of Treatment|Progressive Disease|7|||
19547729|NCT01125046|41996957|FG000|First 6 Months of Treatment|Adverse Event|2|||
19547730|NCT01125046|41996957|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
19547731|NCT01125046|41996957|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
19547732|NCT01125046|41996957|FG000|Follow-up/Data Cut Off Point|Death|29|||
19547733|NCT01125046|41996957|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
19547734|NCT01124734|41996961|FG000|Overall Study|Disease progression|13|||
19547735|NCT01124734|41996961|FG000|Overall Study|Adverse Event|1|||
19547736|NCT01124734|41996961|FG000|Overall Study|Withdrawal by Subject|1|||
19547737|NCT01124734|41996961|FG000|Overall Study|Elected for alternative treatment|2|||
19547738|NCT01124617|41996972|FG000|Overall Study|Adverse Event|5|||
19547739|NCT01124617|41996973|FG001|Overall Study|Adverse Event|2|||
19547740|NCT01124617|41996972|FG000|Overall Study|Lack of Efficacy|2|||
19547741|NCT01124617|41996973|FG001|Overall Study|Lack of Efficacy|1|||
19547742|NCT01124617|41996972|FG000|Overall Study|Protocol Violation|1|||
19547743|NCT01124617|41996973|FG001|Overall Study|Protocol Violation|1|||
19547744|NCT01124617|41996972|FG000|Overall Study|Withdrawal by Subject|9|||
19547745|NCT01124617|41996973|FG001|Overall Study|Withdrawal by Subject|1|||
19547746|NCT01124617|41996972|FG000|Overall Study|Other|2|||
19547747|NCT01124617|41996973|FG001|Overall Study|Other|1|||
19547748|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
19547749|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
19547750|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
19547751|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
19547752|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
19547753|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
19547754|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
19547755|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
19547756|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
19547757|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
19547758|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
19547759|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
19547760|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
19547761|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
19547762|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
19547763|NCT01124422|41996981|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
19547764|NCT01124422|41996982|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
19547765|NCT01124422|41996983|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
19547766|NCT01124422|41996981|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
19547767|NCT01124422|41996982|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
19547768|NCT01124422|41996983|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
19547769|NCT01124422|41996981|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
19547770|NCT01124422|41996982|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
19547771|NCT01124422|41996983|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
19547772|NCT01124422|41996981|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
19547773|NCT01124422|41996982|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
19547774|NCT01124422|41996983|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
19547775|NCT01124422|41996981|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
19547776|NCT01124422|41996982|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
19547777|NCT01124422|41996983|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
19547778|NCT01124149|41996990|FG000|Acute Phase|Withdrawal by Subject|22|||
19547779|NCT01124149|41996990|FG000|Acute Phase|Adverse Event|21|||
19547780|NCT01124149|41996990|FG000|Acute Phase|Lack of Efficacy|17|||
19547781|NCT01124149|41996990|FG000|Acute Phase|Protocol Violation|14|||
19547782|NCT01124149|41996990|FG000|Acute Phase|Lost to Follow-up|2|||
19547783|NCT01124149|41996990|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
19547784|NCT01124149|41996990|FG000|Acute Phase|Sponsor request|1|||
19547785|NCT01124149|41996990|FG000|Acute Phase|UC symptoms not ameliorated|1|||
19547786|NCT01124149|41996990|FG000|Acute Phase|Non-compliance|1|||
19547787|NCT01124149|41996990|FG000|Acute Phase|Low hemoglobin|1|||
19547788|NCT01124149|41996990|FG000|Acute Phase|Travelling to another country|1|||
19547789|NCT01124149|41996990|FG000|Acute Phase|Sponsor decision|1|||
19547790|NCT01124149|41996990|FG000|Maintenance Phase|Lack of Efficacy|40|||
19547791|NCT01124149|41996990|FG000|Maintenance Phase|Adverse Event|24|||
19547792|NCT01124149|41996990|FG000|Maintenance Phase|Lost to Follow-up|15|||
19547793|NCT01124149|41996990|FG000|Maintenance Phase|Withdrawal by Subject|10|||
19547794|NCT01124149|41996990|FG000|Maintenance Phase|Protocol Violation|5|||
19547795|NCT01124149|41996990|FG000|Maintenance Phase|Coordinator error|1|||
19547796|NCT01124149|41996990|FG000|Maintenance Phase|Non-compliance|1|||
19547797|NCT01123642|41996997|FG000|Overall Study|Lost to Follow-up|23|||
19547798|NCT01123642|41996997|FG000|Overall Study|Withdrawal by Subject|9|||
19547799|NCT01123642|41996997|FG000|Overall Study|ineligible at baseline assessment|36|||
19547800|NCT01122862|41997002|FG000|Period 1|Protocol Violation|0|||
19547801|NCT01122862|41997003|FG001|Period 1|Protocol Violation|1|||
19547802|NCT01122862|41997004|FG002|Period 1|Protocol Violation|0|||
19547803|NCT01122862|41997002|FG000|Period 2|Adverse Event|0|||
19547804|NCT01122862|41997003|FG001|Period 2|Adverse Event|0|||
19547805|NCT01122862|41997004|FG002|Period 2|Adverse Event|1|||
19547806|NCT01122394|41997015|FG000|Overall Study|Withdrawal by Subject|1|||
19547807|NCT01122394|41997016|FG001|Overall Study|Withdrawal by Subject|1|||
19547808|NCT01122394|41997015|FG000|Overall Study|Lost to Follow-up|2|||
19547809|NCT01122394|41997016|FG001|Overall Study|Lost to Follow-up|2|||
19547810|NCT01122394|41997015|FG000|Overall Study|Adverse Event|0|||
19547811|NCT01122394|41997016|FG001|Overall Study|Adverse Event|1|||
19547812|NCT01121926|41997024|FG000|First Intervention Period|Adverse Event|1|||
19547813|NCT01121926|41997025|FG001|First Intervention Period|Adverse Event|0|||
19547814|NCT01121926|41997024|FG000|Washout Period|Adverse Event|0|||
19547815|NCT01121926|41997025|FG001|Washout Period|Adverse Event|1|||
19547816|NCT01121926|41997024|FG000|Washout Period|Positive pregnancy test|0|||
19547817|NCT01121926|41997025|FG001|Washout Period|Positive pregnancy test|1|||
19547818|NCT01121575|41997037|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
19547819|NCT01121575|41997038|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
19547820|NCT01121575|41997039|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
19547821|NCT01121575|41997040|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
19547822|NCT01121575|41997041|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
19547823|NCT01121575|41997042|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
19547824|NCT01121575|41997037|FG000|Overall Study|Unspecified Reasons|8|||
19547825|NCT01121575|41997038|FG001|Overall Study|Unspecified Reasons|6|||
19547826|NCT01121575|41997039|FG002|Overall Study|Unspecified Reasons|7|||
19547827|NCT01121575|41997040|FG003|Overall Study|Unspecified Reasons|5|||
19547828|NCT01121575|41997041|FG004|Overall Study|Unspecified Reasons|13|||
19547829|NCT01121575|41997042|FG005|Overall Study|Unspecified Reasons|10|||
19547830|NCT01121575|41997037|FG000|Overall Study|Death|6|||
19547831|NCT01121575|41997038|FG001|Overall Study|Death|0|||
19547832|NCT01121575|41997039|FG002|Overall Study|Death|0|||
19547833|NCT01121575|41997040|FG003|Overall Study|Death|1|||
19547834|NCT01121575|41997041|FG004|Overall Study|Death|7|||
19547835|NCT01121575|41997042|FG005|Overall Study|Death|1|||
19547836|NCT01121536|41997065|FG000|Overall Study|Adverse Event|63|||
19547837|NCT01121536|41997065|FG000|Overall Study|Lack of Efficacy|35|||
19547838|NCT01121536|41997065|FG000|Overall Study|Withdrawal by Subject|65|||
19547839|NCT01121536|41997065|FG000|Overall Study|Protocol Violation|20|||
19547840|NCT01121536|41997065|FG000|Overall Study|Noncompliance with study medication|12|||
19547841|NCT01121536|41997065|FG000|Overall Study|Noncompliance with study procedures|9|||
19547842|NCT01121536|41997065|FG000|Overall Study|Lost to Follow-up|39|||
19547843|NCT01121536|41997065|FG000|Overall Study|Other|118|||
19547844|NCT01121263|41997071|FG000|Overall Study|Death|3|||
19547845|NCT01121263|41997072|FG001|Overall Study|Death|2|||
19547846|NCT01121263|41997071|FG000|Overall Study|Lost to Follow-up|22|||
19547847|NCT01121263|41997072|FG001|Overall Study|Lost to Follow-up|12|||
19547848|NCT01121263|41997071|FG000|Overall Study|Withdrawal by Subject|0|||
19547849|NCT01121263|41997072|FG001|Overall Study|Withdrawal by Subject|1|||
19547850|NCT01121185|41997082|FG000|Overall Study|Not infused|0|||
19547851|NCT01121185|41997083|FG001|Overall Study|Not infused|1|||
19547852|NCT01121185|41997082|FG000|Overall Study|Not transplanted|1|||
19547853|NCT01121185|41997083|FG001|Overall Study|Not transplanted|0|||
19547854|NCT01121146|41997091|FG000|Overall Study|Death|17|||
19547855|NCT01121146|41997092|FG001|Overall Study|Death|15|||
19547856|NCT01121146|41997091|FG000|Overall Study|Adverse Event|2|||
19547857|NCT01121146|41997092|FG001|Overall Study|Adverse Event|11|||
19547858|NCT01121146|41997091|FG000|Overall Study|Lost to Follow-up|7|||
19547859|NCT01121146|41997092|FG001|Overall Study|Lost to Follow-up|16|||
19547860|NCT01120756|41997101|FG000|Overall Study|Withdrawal by Subject|1|||
19547861|NCT01120756|41997102|FG001|Overall Study|Withdrawal by Subject|1|||
19547862|NCT01120717|41997110|FG000|Overall Study|Withdrawal by Subject|11|||
19547863|NCT01120717|41997111|FG001|Overall Study|Withdrawal by Subject|6|||
19547864|NCT01120717|41997110|FG000|Overall Study|Adverse Event|10|||
19547865|NCT01120717|41997111|FG001|Overall Study|Adverse Event|6|||
19547866|NCT01120717|41997110|FG000|Overall Study|Protocol Deviation|2|||
19547867|NCT01120717|41997111|FG001|Overall Study|Protocol Deviation|5|||
19547868|NCT01120717|41997110|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19547869|NCT01120717|41997111|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
19547870|NCT01120717|41997110|FG000|Overall Study|Lost to Follow-up|2|||
19547871|NCT01120717|41997111|FG001|Overall Study|Lost to Follow-up|3|||
19547872|NCT01120717|41997110|FG000|Overall Study|Death|3|||
19547873|NCT01120717|41997111|FG001|Overall Study|Death|1|||
19547874|NCT01120717|41997110|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
19547875|NCT01120717|41997111|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
19547876|NCT01120600|41997119|FG000|Overall Study|Adverse Event|7|||
19547877|NCT01120600|41997120|FG001|Overall Study|Adverse Event|7|||
19547878|NCT01120600|41997119|FG000|Overall Study|Excessive Bone Loss|0|||
19547879|NCT01120600|41997120|FG001|Overall Study|Excessive Bone Loss|4|||
19547880|NCT01120600|41997119|FG000|Overall Study|Lost to Follow-up|1|||
19547881|NCT01120600|41997120|FG001|Overall Study|Lost to Follow-up|3|||
19547882|NCT01120600|41997119|FG000|Overall Study|Physician Decision|1|||
19547883|NCT01120600|41997120|FG001|Overall Study|Physician Decision|3|||
19547884|NCT01120600|41997119|FG000|Overall Study|Protocol Violation|0|||
19547885|NCT01120600|41997120|FG001|Overall Study|Protocol Violation|4|||
19547886|NCT01120600|41997119|FG000|Overall Study|Withdrawal by Subject|10|||
19547887|NCT01120600|41997120|FG001|Overall Study|Withdrawal by Subject|11|||
19547888|NCT01120210|41997128|FG000|MAIN INFUSION|Adverse Event|1|||
19547889|NCT01120210|41997129|FG001|MAIN INFUSION|Adverse Event|0|||
19547890|NCT01120210|41997128|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
19547891|NCT01120210|41997129|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
19547892|NCT01120093|41997135|FG000|Treatment Period 1|Adverse Event|0|||
19547893|NCT01120093|41997136|FG001|Treatment Period 1|Adverse Event|0|||
19547894|NCT01120093|41997137|FG002|Treatment Period 1|Adverse Event|1|||
19547895|NCT01120093|41997138|FG003|Treatment Period 1|Adverse Event|0|||
19547896|NCT01120093|41997139|FG004|Treatment Period 1|Adverse Event|1|||
19547897|NCT01120093|41997135|FG000|Treatment Period 1|Withdrawal by Subject|0|||
19547898|NCT01120093|41997136|FG001|Treatment Period 1|Withdrawal by Subject|1|||
19547899|NCT01120093|41997137|FG002|Treatment Period 1|Withdrawal by Subject|0|||
19547900|NCT01120093|41997138|FG003|Treatment Period 1|Withdrawal by Subject|0|||
19547901|NCT01120093|41997139|FG004|Treatment Period 1|Withdrawal by Subject|0|||
19547902|NCT01120093|41997135|FG000|Treatment Period 2|Adverse Event|0|||
19547903|NCT01120093|41997136|FG001|Treatment Period 2|Adverse Event|0|||
19547904|NCT01120093|41997137|FG002|Treatment Period 2|Adverse Event|0|||
19547905|NCT01120093|41997138|FG003|Treatment Period 2|Adverse Event|1|||
19547906|NCT01120093|41997139|FG004|Treatment Period 2|Adverse Event|0|||
19547907|NCT01120093|41997135|FG000|Treatment Period 2|Withdrawal by Subject|0|||
19547908|NCT01120093|41997136|FG001|Treatment Period 2|Withdrawal by Subject|0|||
19547909|NCT01120093|41997137|FG002|Treatment Period 2|Withdrawal by Subject|0|||
19547910|NCT01120093|41997138|FG003|Treatment Period 2|Withdrawal by Subject|0|||
19547911|NCT01120093|41997139|FG004|Treatment Period 2|Withdrawal by Subject|1|||
19547912|NCT01120093|41997135|FG000|Treatment Period 3|Lack of Efficacy|0|||
19547913|NCT01120093|41997136|FG001|Treatment Period 3|Lack of Efficacy|0|||
19547914|NCT01120093|41997137|FG002|Treatment Period 3|Lack of Efficacy|0|||
19547915|NCT01120093|41997138|FG003|Treatment Period 3|Lack of Efficacy|1|||
19547916|NCT01120093|41997139|FG004|Treatment Period 3|Lack of Efficacy|0|||
19547917|NCT01120093|41997135|FG000|Treatment Period 3|Adverse Event|0|||
19547918|NCT01120093|41997136|FG001|Treatment Period 3|Adverse Event|0|||
19547919|NCT01120093|41997137|FG002|Treatment Period 3|Adverse Event|0|||
19547920|NCT01120093|41997138|FG003|Treatment Period 3|Adverse Event|0|||
19547921|NCT01120093|41997139|FG004|Treatment Period 3|Adverse Event|1|||
19547922|NCT01120093|41997135|FG000|Treatment Period 3|Withdrawal by Subject|0|||
19547923|NCT01120093|41997136|FG001|Treatment Period 3|Withdrawal by Subject|0|||
19547924|NCT01120093|41997137|FG002|Treatment Period 3|Withdrawal by Subject|1|||
19547925|NCT01120093|41997138|FG003|Treatment Period 3|Withdrawal by Subject|0|||
19547926|NCT01120093|41997139|FG004|Treatment Period 3|Withdrawal by Subject|0|||
19547927|NCT01120093|41997135|FG000|Treatment Period 4|Adverse Event|1|||
19547928|NCT01120093|41997136|FG001|Treatment Period 4|Adverse Event|0|||
19547929|NCT01120093|41997137|FG002|Treatment Period 4|Adverse Event|0|||
19547930|NCT01120093|41997138|FG003|Treatment Period 4|Adverse Event|0|||
19547931|NCT01120093|41997139|FG004|Treatment Period 4|Adverse Event|0|||
19547932|NCT01120093|41997135|FG000|Treatment Period 5|Adverse Event|0|||
19547933|NCT01120093|41997136|FG001|Treatment Period 5|Adverse Event|1|||
19547934|NCT01120093|41997137|FG002|Treatment Period 5|Adverse Event|0|||
19547935|NCT01120093|41997138|FG003|Treatment Period 5|Adverse Event|1|||
19547936|NCT01120093|41997139|FG004|Treatment Period 5|Adverse Event|0|||
19547937|NCT01119937|41997153|FG000|Overall Study|Adverse Event|11|||
19547938|NCT01119937|41997154|FG001|Overall Study|Adverse Event|5|||
19547939|NCT01119937|41997153|FG000|Overall Study|Protocol deviation|3|||
19547940|NCT01119937|41997154|FG001|Overall Study|Protocol deviation|1|||
19547941|NCT01119937|41997153|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
19547942|NCT01119937|41997154|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
19547943|NCT01119937|41997153|FG000|Overall Study|Withdrawal by Subject|2|||
19547944|NCT01119937|41997154|FG001|Overall Study|Withdrawal by Subject|1|||
19547945|NCT01119898|41997162|FG000|Overall Study|Adverse Event|4|||
19547946|NCT01119898|41997163|FG001|Overall Study|Adverse Event|5|||
19547947|NCT01119898|41997162|FG000|Overall Study|Withdrawal by Subject|1|||
19547948|NCT01119898|41997163|FG001|Overall Study|Withdrawal by Subject|4|||
19547949|NCT01119898|41997162|FG000|Overall Study|Lack of Efficacy|0|||
19547950|NCT01119898|41997163|FG001|Overall Study|Lack of Efficacy|2|||
19547951|NCT01119898|41997162|FG000|Overall Study|Protocol Violation|1|||
19547952|NCT01119898|41997163|FG001|Overall Study|Protocol Violation|1|||
19547953|NCT01119898|41997162|FG000|Overall Study|Medical procedure|1|||
19547954|NCT01119898|41997163|FG001|Overall Study|Medical procedure|0|||
19547955|NCT01119898|41997162|FG000|Overall Study|Randomized in error did not participate|1|||
19547956|NCT01119898|41997163|FG001|Overall Study|Randomized in error did not participate|0|||
19547957|NCT01119859|41997171|FG000|Overall Study|Adverse Event|9|||
19547958|NCT01119859|41997172|FG001|Overall Study|Adverse Event|10|||
19547959|NCT01119859|41997171|FG000|Overall Study|Death|2|||
19547960|NCT01119859|41997172|FG001|Overall Study|Death|0|||
19547961|NCT01119859|41997171|FG000|Overall Study|Insufficient therapeutic response|7|||
19547962|NCT01119859|41997172|FG001|Overall Study|Insufficient therapeutic response|14|||
19547963|NCT01119859|41997171|FG000|Overall Study|Refused treatment|3|||
19547964|NCT01119859|41997172|FG001|Overall Study|Refused treatment|6|||
19547965|NCT01119859|41997171|FG000|Overall Study|Failure to return|3|||
19547966|NCT01119859|41997172|FG001|Overall Study|Failure to return|0|||
19547967|NCT01119703|41997180|FG000|Overall Study|Adverse Event|0|||
19547968|NCT01119703|41997181|FG001|Overall Study|Adverse Event|1|||
19547969|NCT01119625|41997188|FG000|Overall Study|Lost to Follow-up|1|||
19547970|NCT01119625|41997189|FG001|Overall Study|Lost to Follow-up|2|||
19547971|NCT01119625|41997188|FG000|Overall Study|Withdrawal by Subject|2|||
19547972|NCT01119625|41997189|FG001|Overall Study|Withdrawal by Subject|1|||
19547973|NCT01119625|41997188|FG000|Overall Study|Other|0|||
19547974|NCT01119625|41997189|FG001|Overall Study|Other|1|||
19547975|NCT01119118|41997195|FG000|Overall Study|Adverse Event|1|||
19547976|NCT01119001|41997199|FG000|Overall Study|Withdrawal by Subject|2|||
19547977|NCT01118962|41997205|FG000|Overall Study|Adverse Event|2|||
19547978|NCT01118962|41997205|FG000|Overall Study|Lack of Efficacy|1|||
19547979|NCT01118962|41997205|FG000|Overall Study|Protocol Violation|1|||
19547980|NCT01118962|41997205|FG000|Overall Study|Withdrawal by Subject|4|||
19547981|NCT01118962|41997205|FG000|Overall Study|Pregnancy|1|||
19547982|NCT01118962|41997205|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
19547983|NCT01118728|41997209|FG000|Overall Study|Adverse Event|17|||
19547984|NCT01118728|41997209|FG000|Overall Study|Lack of Efficacy|27|||
19547985|NCT01118728|41997209|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
19547986|NCT01118728|41997209|FG000|Overall Study|Withdrawal by Subject|3|||
19547987|NCT01118728|41997209|FG000|Overall Study|Lost to Follow-up|4|||
19547988|NCT01118455|41997215|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
19547989|NCT01118455|41997216|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
19547990|NCT01118377|41997230|FG000|Overall Study|Did Not Receive Study Medication|1|||
19547991|NCT01118377|41997230|FG000|Overall Study|Death|38|||
19547992|NCT01118377|41997230|FG000|Overall Study|Failure to Return|3|||
19547993|NCT01118299|41997236|FG000|Overall Study|Death|7|||
19547994|NCT01118299|41997237|FG001|Overall Study|Death|5|||
19547995|NCT01118299|41997236|FG000|Overall Study|Withdrawal by Subject|8|||
19547996|NCT01118299|41997237|FG001|Overall Study|Withdrawal by Subject|8|||
19547997|NCT01118299|41997236|FG000|Overall Study|Lost to Follow-up|2|||
19547998|NCT01118299|41997237|FG001|Overall Study|Lost to Follow-up|1|||
19547999|NCT01118299|41997236|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
19548000|NCT01118299|41997237|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
19548001|NCT01118143|41997244|FG000|Overall Study|Withdrawal by Subject|2|||
19548002|NCT01118143|41997245|FG001|Overall Study|Withdrawal by Subject|5|||
19548003|NCT01117987|41997255|FG000|Overall Study|Protocol deviation|0|||
19548004|NCT01117987|41997256|FG001|Overall Study|Protocol deviation|1|||
19548005|NCT01117987|41997255|FG000|Overall Study|Subject no longer requires study drug|1|||
19548006|NCT01117987|41997256|FG001|Overall Study|Subject no longer requires study drug|0|||
19548007|NCT01117987|41997255|FG000|Overall Study|Lost to Follow-up|1|||
19548008|NCT01117987|41997256|FG001|Overall Study|Lost to Follow-up|1|||
19548009|NCT01117987|41997255|FG000|Overall Study|Abnormal test procedure result|2|||
19548010|NCT01117987|41997256|FG001|Overall Study|Abnormal test procedure result|0|||
19548011|NCT01117987|41997255|FG000|Overall Study|Lack of Efficacy|3|||
19548012|NCT01117987|41997256|FG001|Overall Study|Lack of Efficacy|4|||
19548013|NCT01117987|41997255|FG000|Overall Study|Death|5|||
19548014|NCT01117987|41997256|FG001|Overall Study|Death|10|||
19548015|NCT01117987|41997255|FG000|Overall Study|Withdrawal by Subject|5|||
19548016|NCT01117987|41997256|FG001|Overall Study|Withdrawal by Subject|10|||
19548017|NCT01117987|41997255|FG000|Overall Study|Adverse Event|19|||
19548018|NCT01117987|41997256|FG001|Overall Study|Adverse Event|26|||
19548019|NCT01117987|41997255|FG000|Overall Study|Administrative problems|25|||
19548020|NCT01117987|41997256|FG001|Overall Study|Administrative problems|22|||
19548021|NCT01117870|41997264|FG000|Overall Study|Inability to place needle|1|||
19548022|NCT01117870|41997265|FG001|Overall Study|Inability to place needle|0|||
19548023|NCT01117792|41997275|FG000|Overall Study|Death|1|||
19548024|NCT01117792|41997275|FG000|Overall Study|Adverse Event|3|||
19548025|NCT02219490|41997279|FG000|Overall Study|Adverse Event|24|||
19548026|NCT02219490|41997279|FG000|Overall Study|Withdrew consent|96|||
19548027|NCT02219490|41997279|FG000|Overall Study|Lost to Follow-up|126|||
19548028|NCT02219490|41997279|FG000|Overall Study|COVID-19 infection|2|||
19548029|NCT02219490|41997279|FG000|Overall Study|COVID-19 logistical restrictions|33|||
19548030|NCT02219490|41997279|FG000|Overall Study|Other, not specified|57|||
19548031|NCT01117480|41997287|FG000|Overall Study|Protocol Violation|8|||
19548032|NCT01117480|41997287|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
19548033|NCT01117051|41997293|FG000|Overall Study|Withdrawal by Subject|5|||
19548034|NCT01117051|41997294|FG001|Overall Study|Withdrawal by Subject|3|||
19548035|NCT01117051|41997293|FG000|Overall Study|Adverse Event|4|||
19548036|NCT01117051|41997294|FG001|Overall Study|Adverse Event|3|||
19548037|NCT01117051|41997293|FG000|Overall Study|Lost to Follow-up|0|||
19548038|NCT01117051|41997294|FG001|Overall Study|Lost to Follow-up|1|||
19548039|NCT01117051|41997293|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
19548040|NCT01117051|41997294|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
19548041|NCT01117051|41997293|FG000|Overall Study|Sponsor's decision|3|||
19548042|NCT01117051|41997294|FG001|Overall Study|Sponsor's decision|1|||
19548043|NCT01117051|41997293|FG000|Overall Study|Surgical procedure|0|||
19548044|NCT01117051|41997294|FG001|Overall Study|Surgical procedure|1|||
19548045|NCT01117051|41997293|FG000|Overall Study|Randomized by mistake|0|||
19548046|NCT01117051|41997294|FG001|Overall Study|Randomized by mistake|1|||
19548047|NCT01117051|41997293|FG000|Overall Study|Convenience issue|1|||
19548048|NCT01117051|41997294|FG001|Overall Study|Convenience issue|0|||
19548049|NCT02211417|41997303|FG000|Overall Study|Withdrawal by Subject|11|||
19548050|NCT02211417|41997304|FG001|Overall Study|Withdrawal by Subject|8|||
19548051|NCT02211417|41997303|FG000|Overall Study|Protocol Violation|1|||
19548052|NCT02211417|41997304|FG001|Overall Study|Protocol Violation|0|||
19548053|NCT02211417|41997303|FG000|Overall Study|Pregnancy|0|||
19548054|NCT02211417|41997304|FG001|Overall Study|Pregnancy|1|||
19548055|NCT02211417|41997303|FG000|Overall Study|Lost to Follow-up|2|||
19548056|NCT02211417|41997304|FG001|Overall Study|Lost to Follow-up|3|||
19548057|NCT02211417|41997303|FG000|Overall Study|Adverse Event|1|||
19548058|NCT02211417|41997304|FG001|Overall Study|Adverse Event|4|||
19548059|NCT01117012|41997317|FG000|Overall Study|Adverse Event|0|||
19548060|NCT01117012|41997318|FG001|Overall Study|Adverse Event|1|||
19548061|NCT01117012|41997317|FG000|Overall Study|Death|1|||
19548062|NCT01117012|41997318|FG001|Overall Study|Death|1|||
19548063|NCT01117012|41997317|FG000|Overall Study|Withdrawal by Subject|3|||
19548064|NCT01117012|41997318|FG001|Overall Study|Withdrawal by Subject|0|||
19548065|NCT01117012|41997317|FG000|Overall Study|Undefined|4|||
19548066|NCT01117012|41997318|FG001|Overall Study|Undefined|3|||
19548067|NCT01116739|41997326|FG000|Overall Study|Child had 2 years of HS|110|||
19548068|NCT01116739|41997327|FG001|Overall Study|Child had 2 years of HS|128|||
19548069|NCT01116739|41997326|FG000|Overall Study|Withdrawal by Subject|6|||
19548070|NCT01116739|41997327|FG001|Overall Study|Withdrawal by Subject|0|||
19548071|NCT01116739|41997326|FG000|Overall Study|child too young|2|||
19548072|NCT01116739|41997327|FG001|Overall Study|child too young|6|||
19548073|NCT01116739|41997326|FG000|Overall Study|child not enrolled in head start|10|||
19548074|NCT01116739|41997327|FG001|Overall Study|child not enrolled in head start|2|||
19548075|NCT01116739|41997326|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
19548076|NCT01116739|41997327|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
19548077|NCT01116544|41997335|FG000|Overall Study|Protocol Violation|1|||
19548078|NCT01116544|41997336|FG001|Overall Study|Protocol Violation|0|||
19548079|NCT01116544|41997335|FG000|Overall Study|Withdrawal by Subject|1|||
19548080|NCT01116544|41997336|FG001|Overall Study|Withdrawal by Subject|1|||
19548081|NCT01116427|41997344|FG000|Core Phase|Adverse Event|0|||
19548082|NCT01116427|41997345|FG001|Core Phase|Adverse Event|1|||
19548083|NCT01116427|41997344|FG000|Core Phase|Lost to Follow-up|1|||
19548084|NCT01116427|41997345|FG001|Core Phase|Lost to Follow-up|0|||
19548085|NCT01116427|41997344|FG000|Core Phase|Withdrawal by Subject|3|||
19548086|NCT01116427|41997345|FG001|Core Phase|Withdrawal by Subject|0|||
19548087|NCT01116427|41997344|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
19548088|NCT01116427|41997345|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
19548089|NCT01116427|41997344|FG000|Extension Phase|Adverse Event|1|||
19548090|NCT01116427|41997345|FG001|Extension Phase|Adverse Event|1|||
19548091|NCT01116427|41997344|FG000|Extension Phase|Lost to Follow-up|2|||
19548092|NCT01116427|41997345|FG001|Extension Phase|Lost to Follow-up|0|||
19548093|NCT01116427|41997344|FG000|Extension Phase|Withdrawal by Subject|5|||
19716471|NCT00320489|42159400|FG001|Overall Study|Withdrawal by Subject|41|||
19716472|NCT03928028|42159409|FG000|Overall Study|Physician Decision|9|||
19716473|NCT03928028|42159410|FG001|Overall Study|Physician Decision|6|||
19716474|NCT03928028|42159411|FG002|Overall Study|Physician Decision|3|||
19716475|NCT03928028|42159409|FG000|Overall Study|Withdrawal by Subject|12|||
19716476|NCT03928028|42159410|FG001|Overall Study|Withdrawal by Subject|3|||
19716477|NCT03928028|42159411|FG002|Overall Study|Withdrawal by Subject|3|||
19716478|NCT00320411|42159419|FG000|Overall Study|No investigational product admin.|4|||
19716479|NCT00320255|42159429|FG000|Overall Study|Lack of Efficacy|1|||
19716480|NCT00320255|42159430|FG001|Overall Study|Lack of Efficacy|0|||
19716481|NCT00320255|42159431|FG002|Overall Study|Lack of Efficacy|0|||
19716482|NCT00320255|42159432|FG003|Overall Study|Lack of Efficacy|0|||
19716483|NCT00320255|42159433|FG004|Overall Study|Lack of Efficacy|0|||
19716484|NCT00320255|42159434|FG005|Overall Study|Lack of Efficacy|0|||
19716485|NCT00320255|42159429|FG000|Overall Study|Adverse Event|5|||
19716486|NCT00320255|42159430|FG001|Overall Study|Adverse Event|2|||
19716487|NCT00320255|42159431|FG002|Overall Study|Adverse Event|3|||
19716488|NCT00320255|42159432|FG003|Overall Study|Adverse Event|2|||
19716489|NCT00320255|42159433|FG004|Overall Study|Adverse Event|0|||
19716490|NCT00320255|42159434|FG005|Overall Study|Adverse Event|0|||
19716491|NCT00320255|42159429|FG000|Overall Study|Withdrawal by Subject|1|||
19716492|NCT00320255|42159430|FG001|Overall Study|Withdrawal by Subject|2|||
19716493|NCT00320255|42159431|FG002|Overall Study|Withdrawal by Subject|2|||
19716494|NCT00320255|42159432|FG003|Overall Study|Withdrawal by Subject|4|||
19716495|NCT00320255|42159433|FG004|Overall Study|Withdrawal by Subject|0|||
19716496|NCT00320255|42159434|FG005|Overall Study|Withdrawal by Subject|0|||
19716497|NCT00320255|42159429|FG000|Overall Study|Poor compliance/noncompliance|1|||
19716498|NCT00320255|42159430|FG001|Overall Study|Poor compliance/noncompliance|1|||
19716499|NCT00320255|42159431|FG002|Overall Study|Poor compliance/noncompliance|0|||
19716500|NCT00320255|42159432|FG003|Overall Study|Poor compliance/noncompliance|1|||
19716501|NCT00320255|42159433|FG004|Overall Study|Poor compliance/noncompliance|0|||
19716502|NCT00320255|42159434|FG005|Overall Study|Poor compliance/noncompliance|0|||
19716503|NCT00320255|42159429|FG000|Overall Study|No longer meets study criteria|0|||
19716504|NCT00320255|42159430|FG001|Overall Study|No longer meets study criteria|0|||
19716505|NCT00320255|42159431|FG002|Overall Study|No longer meets study criteria|0|||
19716506|NCT00320255|42159432|FG003|Overall Study|No longer meets study criteria|1|||
19716507|NCT00320255|42159433|FG004|Overall Study|No longer meets study criteria|0|||
19716508|NCT00320255|42159434|FG005|Overall Study|No longer meets study criteria|0|||
19716509|NCT00320255|42159429|FG000|Overall Study|Other|3|||
19716510|NCT00320255|42159430|FG001|Overall Study|Other|2|||
19716511|NCT00320255|42159431|FG002|Overall Study|Other|1|||
19716512|NCT00320255|42159432|FG003|Overall Study|Other|0|||
19716513|NCT00320255|42159433|FG004|Overall Study|Other|0|||
19716514|NCT00320255|42159434|FG005|Overall Study|Other|0|||
19716515|NCT00370331|42159451|FG000|Overall Study|Adverse Event|4|||
19716516|NCT00370331|42159452|FG001|Overall Study|Adverse Event|13|||
19716517|NCT00370331|42159451|FG000|Overall Study|Withdrawal by Subject|2|||
19716518|NCT00370331|42159452|FG001|Overall Study|Withdrawal by Subject|4|||
19716519|NCT00370331|42159451|FG000|Overall Study|Lost to Follow-up|0|||
19716520|NCT00370331|42159452|FG001|Overall Study|Lost to Follow-up|3|||
19716521|NCT00370331|42159451|FG000|Overall Study|Lack of Efficacy|0|||
19716522|NCT00370331|42159452|FG001|Overall Study|Lack of Efficacy|1|||
19716523|NCT00370331|42159451|FG000|Overall Study|Non-compliance|0|||
19716524|NCT00370331|42159452|FG001|Overall Study|Non-compliance|1|||
19716525|NCT00370331|42159451|FG000|Overall Study|Protocol Violation|1|||
19716526|NCT00370331|42159452|FG001|Overall Study|Protocol Violation|1|||
19716527|NCT03284710|42159462|FG000|Overall Study|Withdrawal by Subject|1|||
19716528|NCT03284710|42159463|FG001|Overall Study|Withdrawal by Subject|0|||
19716529|NCT03284710|42159464|FG002|Overall Study|Withdrawal by Subject|1|||
19716530|NCT03284710|42159465|FG003|Overall Study|Withdrawal by Subject|6|||
19716531|NCT03284710|42159462|FG000|Overall Study|Lost to Follow-up|3|||
19716532|NCT03284710|42159463|FG001|Overall Study|Lost to Follow-up|3|||
19716533|NCT03284710|42159464|FG002|Overall Study|Lost to Follow-up|1|||
19716534|NCT03284710|42159465|FG003|Overall Study|Lost to Follow-up|0|||
19548094|NCT01116427|41997345|FG001|Extension Phase|Withdrawal by Subject|1|||
19548095|NCT01116427|41997344|FG000|Extension Phase|Not using appropriate birth control|1|||
19548096|NCT01116427|41997345|FG001|Extension Phase|Not using appropriate birth control|0|||
19716535|NCT03284710|42159462|FG000|Overall Study|Physician Decision|1|||
19716536|NCT03284710|42159463|FG001|Overall Study|Physician Decision|0|||
19716537|NCT03284710|42159464|FG002|Overall Study|Physician Decision|0|||
19716538|NCT03284710|42159465|FG003|Overall Study|Physician Decision|0|||
19716539|NCT03284710|42159462|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
19548097|NCT01116232|41997355|FG000|Overall Study|Progressive diease|4|||
19716540|NCT03284710|42159463|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
19548098|NCT01115998|41997364|FG000|Overall Study|Lost to Follow-up|6|||
19548099|NCT01115998|41997365|FG001|Overall Study|Lost to Follow-up|6|||
19548100|NCT01205230|41997373|FG000|Overall Study|Adverse Event|4|||
19548101|NCT01205230|41997374|FG001|Overall Study|Adverse Event|0|||
19548102|NCT01205230|41997373|FG000|Overall Study|Physician Decision|1|||
19716541|NCT03284710|42159464|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
19716542|NCT03284710|42159465|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
19716543|NCT03284710|42159462|FG000|Overall Study|HIV Infection|0|||
19716544|NCT03284710|42159463|FG001|Overall Study|HIV Infection|2|||
19716545|NCT03284710|42159464|FG002|Overall Study|HIV Infection|2|||
19716546|NCT03284710|42159465|FG003|Overall Study|HIV Infection|1|||
19716547|NCT02962960|42159483|FG000|Overall Study|Withdrawal by Subject|1|||
19716548|NCT02962960|42159484|FG001|Overall Study|Withdrawal by Subject|1|||
19716549|NCT02962960|42159485|FG002|Overall Study|Withdrawal by Subject|0|||
19716550|NCT02962960|42159483|FG000|Overall Study|Adverse Event|1|||
19716551|NCT02962960|42159484|FG001|Overall Study|Adverse Event|1|||
19716552|NCT02962960|42159485|FG002|Overall Study|Adverse Event|0|||
19716553|NCT02962960|42159483|FG000|Overall Study|Protocol Violation|1|||
19716554|NCT02962960|42159484|FG001|Overall Study|Protocol Violation|0|||
19716555|NCT02962960|42159485|FG002|Overall Study|Protocol Violation|0|||
19716556|NCT00369941|42159497|FG000|Overall Study|Never Treated|1|||
19716557|NCT00369941|42159498|FG001|Overall Study|Never Treated|2|||
19716558|NCT00369941|42159497|FG000|Overall Study|Adverse Event|14|||
19716559|NCT00369941|42159498|FG001|Overall Study|Adverse Event|28|||
19716560|NCT00369941|42159497|FG000|Overall Study|Lack of Efficacy|6|||
19716561|NCT00369941|42159498|FG001|Overall Study|Lack of Efficacy|10|||
19716562|NCT00369941|42159497|FG000|Overall Study|Lost to Follow-up|12|||
19716563|NCT00369941|42159498|FG001|Overall Study|Lost to Follow-up|22|||
19716564|NCT00369941|42159497|FG000|Overall Study|Protocol Violation|5|||
19716565|NCT00369941|42159498|FG001|Overall Study|Protocol Violation|3|||
19716566|NCT00369941|42159497|FG000|Overall Study|Withdrawal by Subject|5|||
19716567|NCT00369941|42159498|FG001|Overall Study|Withdrawal by Subject|18|||
19716568|NCT00369941|42159497|FG000|Overall Study|Pregnancy|4|||
19716569|NCT00369941|42159498|FG001|Overall Study|Pregnancy|2|||
19716570|NCT00369941|42159497|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
19716571|NCT00369941|42159498|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
19716572|NCT00369941|42159497|FG000|Overall Study|Moved|11|||
19716573|NCT00369941|42159498|FG001|Overall Study|Moved|5|||
19716574|NCT00369941|42159497|FG000|Overall Study|Treatment with Prohibited Medication|3|||
19716575|NCT00369941|42159498|FG001|Overall Study|Treatment with Prohibited Medication|1|||
19716576|NCT00369941|42159497|FG000|Overall Study|Employment Interfered with Study Visits|1|||
19716577|NCT00369941|42159498|FG001|Overall Study|Employment Interfered with Study Visits|0|||
19548103|NCT01205230|41997374|FG001|Overall Study|Physician Decision|0|||
19548104|NCT01205152|41997385|FG000|Overall Study|Death|1|||
19548105|NCT01205035|41997393|FG000|Overall Study|Withdrawal by Subject|1|||
19716578|NCT00369941|42159497|FG000|Overall Study|Study Site Terminated|2|||
19716579|NCT00369941|42159498|FG001|Overall Study|Study Site Terminated|0|||
19716580|NCT00369941|42159497|FG000|Overall Study|Miscellaneous|3|||
19716581|NCT00369941|42159498|FG001|Overall Study|Miscellaneous|3|||
19716582|NCT00319553|42159507|FG000|Overall Study|Protocol Violation|1|||
19716583|NCT00319553|42159508|FG001|Overall Study|Protocol Violation|2|||
19716584|NCT00319553|42159507|FG000|Overall Study|Lost to Follow-up|2|||
19548106|NCT01205035|41997394|FG001|Overall Study|Withdrawal by Subject|0|||
19548107|NCT01205035|41997393|FG000|Overall Study|Physician Decision|1|||
19548108|NCT01205035|41997394|FG001|Overall Study|Physician Decision|0|||
19548109|NCT01204918|41997403|FG000|Overall Study|Withdrawal by Subject|4|||
19548110|NCT01204918|41997404|FG001|Overall Study|Withdrawal by Subject|10|||
19548111|NCT01204918|41997405|FG002|Overall Study|Withdrawal by Subject|5|||
19548112|NCT01204294|41997420|FG000|Overall Study|Adverse Event|2|||
19548113|NCT01204294|41997421|FG001|Overall Study|Adverse Event|6|||
19548114|NCT01204294|41997422|FG002|Overall Study|Adverse Event|0|||
19548115|NCT01204294|41997423|FG003|Overall Study|Adverse Event|7|||
19548116|NCT01204294|41997424|FG004|Overall Study|Adverse Event|1|||
19548117|NCT01204294|41997425|FG005|Overall Study|Adverse Event|4|||
19548118|NCT01204294|41997426|FG006|Overall Study|Adverse Event|0|||
19548119|NCT01204294|41997420|FG000|Overall Study|Protocol Violation|1|||
19548120|NCT01204294|41997421|FG001|Overall Study|Protocol Violation|0|||
19548121|NCT01204294|41997422|FG002|Overall Study|Protocol Violation|2|||
19548122|NCT01204294|41997423|FG003|Overall Study|Protocol Violation|1|||
19548123|NCT01204294|41997424|FG004|Overall Study|Protocol Violation|0|||
19716585|NCT00319553|42159508|FG001|Overall Study|Lost to Follow-up|1|||
19716586|NCT00319553|42159507|FG000|Overall Study|Withdrawal by Subject|1|||
19548124|NCT01204294|41997425|FG005|Overall Study|Protocol Violation|0|||
19548125|NCT01204294|41997426|FG006|Overall Study|Protocol Violation|0|||
19548126|NCT01204294|41997420|FG000|Overall Study|Withdrawal by Subject|0|||
19548127|NCT01204294|41997421|FG001|Overall Study|Withdrawal by Subject|2|||
19548128|NCT01204294|41997422|FG002|Overall Study|Withdrawal by Subject|2|||
19548129|NCT01204294|41997423|FG003|Overall Study|Withdrawal by Subject|1|||
19548130|NCT01204294|41997424|FG004|Overall Study|Withdrawal by Subject|1|||
19548131|NCT01204294|41997425|FG005|Overall Study|Withdrawal by Subject|1|||
19548132|NCT01204294|41997426|FG006|Overall Study|Withdrawal by Subject|2|||
19548133|NCT01204294|41997420|FG000|Overall Study|Lack of Efficacy|0|||
19548134|NCT01204294|41997421|FG001|Overall Study|Lack of Efficacy|0|||
19548135|NCT01204294|41997422|FG002|Overall Study|Lack of Efficacy|0|||
19548136|NCT01204294|41997423|FG003|Overall Study|Lack of Efficacy|2|||
19548137|NCT01204294|41997424|FG004|Overall Study|Lack of Efficacy|0|||
19716587|NCT00319553|42159508|FG001|Overall Study|Withdrawal by Subject|1|||
19716588|NCT00369785|42159516|FG000|Overall Study|Physician Decision|3|||
19716589|NCT00369785|42159517|FG001|Overall Study|Physician Decision|2|||
19716590|NCT00369785|42159516|FG000|Overall Study|Death|1|||
19716591|NCT00369785|42159517|FG001|Overall Study|Death|2|||
19716592|NCT00369785|42159516|FG000|Overall Study|Withdrawal by Subject|7|||
19716593|NCT00369785|42159517|FG001|Overall Study|Withdrawal by Subject|6|||
19716594|NCT00369785|42159516|FG000|Overall Study|Toxicity|6|||
19716595|NCT00369785|42159517|FG001|Overall Study|Toxicity|4|||
19716596|NCT00369785|42159516|FG000|Overall Study|Never started|0|||
19716597|NCT00369785|42159517|FG001|Overall Study|Never started|2|||
19716598|NCT00369785|42159516|FG000|Overall Study|Progression|4|||
19716599|NCT00369785|42159517|FG001|Overall Study|Progression|4|||
19716600|NCT00369785|42159516|FG000|Overall Study|Multiple reasons|6|||
19716601|NCT00369785|42159517|FG001|Overall Study|Multiple reasons|5|||
19716602|NCT00369707|42159523|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
19716603|NCT00369707|42159523|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
19716604|NCT00369707|42159523|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
19716605|NCT00369707|42159523|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
19716606|NCT00369707|42159523|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
19716607|NCT00369707|42159523|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
19716608|NCT00369707|42159523|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
19716609|NCT00369707|42159523|FG000|Follow up for 2 Years After Treatment|Death|1|||
19716610|NCT00369707|42159523|FG000|Follow up for 2 Years After Treatment|Other|2|||
19716611|NCT02943460|42159530|FG000|Blinded Study Phase|Adverse Event|3|||
19716612|NCT02943460|42159531|FG001|Blinded Study Phase|Adverse Event|0|||
19716613|NCT02943460|42159532|FG002|Blinded Study Phase|Adverse Event|0|||
19716614|NCT02943460|42159530|FG000|Blinded Study Phase|Withdrew Consent|0|||
19716615|NCT02943460|42159531|FG001|Blinded Study Phase|Withdrew Consent|1|||
19716616|NCT02943460|42159532|FG002|Blinded Study Phase|Withdrew Consent|0|||
19716617|NCT02943460|42159530|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
19716618|NCT02943460|42159531|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
19716619|NCT02943460|42159532|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
19716620|NCT02943460|42159530|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
19716621|NCT02943460|42159531|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
19716622|NCT02943460|42159532|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
19716623|NCT02943460|42159530|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
19716624|NCT02943460|42159531|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
19716625|NCT02943460|42159532|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
19716626|NCT03768206|42159543|FG000|Overall Study|Lost to Follow-up|2|||
19716627|NCT03768206|42159544|FG001|Overall Study|Lost to Follow-up|1|||
19716628|NCT03768206|42159543|FG000|Overall Study|Withdrawal by Subject|0|||
19716629|NCT03768206|42159544|FG001|Overall Study|Withdrawal by Subject|1|||
19716630|NCT03767894|42159551|FG000|Overall Study|Withdrawal by Subject|1|||
19716631|NCT03766646|42159557|FG000|Overall Study|Withdrawal by Subject|1|||
19716632|NCT03766646|42159558|FG001|Overall Study|Withdrawal by Subject|0|||
19716633|NCT03766646|42159557|FG000|Overall Study|Protocol Violation|0|||
19716634|NCT03766646|42159558|FG001|Overall Study|Protocol Violation|3|||
19716635|NCT03765164|42159566|FG000|Pre-intervention|Withdrawal by Subject|5|||
19716636|NCT03765164|42159567|FG001|Pre-intervention|Withdrawal by Subject|6|||
19716637|NCT00369629|42159573|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
19716638|NCT00369629|42159574|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
19716639|NCT00369629|42159575|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
19716640|NCT00369629|42159576|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
19716641|NCT00369629|42159573|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
19716642|NCT00369629|42159574|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
19716643|NCT00369629|42159575|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
19716644|NCT00369629|42159576|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
19716645|NCT00369629|42159573|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
19716646|NCT00369629|42159574|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
19716647|NCT00369629|42159575|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
19716648|NCT00369629|42159576|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
19716649|NCT00369629|42159573|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
19548138|NCT01204294|41997425|FG005|Overall Study|Lack of Efficacy|0|||
19548139|NCT01204294|41997426|FG006|Overall Study|Lack of Efficacy|0|||
19548140|NCT01204294|41997420|FG000|Overall Study|Other (house moving)|0|||
19548141|NCT01204294|41997421|FG001|Overall Study|Other (house moving)|0|||
19548142|NCT01204294|41997422|FG002|Overall Study|Other (house moving)|1|||
19548143|NCT01204294|41997423|FG003|Overall Study|Other (house moving)|0|||
19548144|NCT01204294|41997424|FG004|Overall Study|Other (house moving)|0|||
19548145|NCT01204294|41997425|FG005|Overall Study|Other (house moving)|0|||
19548146|NCT01204294|41997426|FG006|Overall Study|Other (house moving)|0|||
19548147|NCT01182181|41997444|FG000|First Intervention|Adverse Event|1|||
19548148|NCT01182181|41997445|FG001|First Intervention|Adverse Event|0|||
19548149|NCT01182181|41997444|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
19548150|NCT01182181|41997445|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
19548151|NCT01181986|41997453|FG000|Phase 1|Lost to Follow-up|0|||
19548152|NCT01181986|41997454|FG001|Phase 1|Lost to Follow-up|1|||
19548153|NCT01181986|41997455|FG002|Phase 1|Lost to Follow-up|1|||
19548154|NCT01181986|41997453|FG000|Phase 1|Adverse Event|0|||
19548155|NCT01181986|41997454|FG001|Phase 1|Adverse Event|0|||
19548156|NCT01181986|41997455|FG002|Phase 1|Adverse Event|1|||
19548157|NCT01181986|41997453|FG000|Phase 1|Protocol Violation|1|||
19548158|NCT01181986|41997454|FG001|Phase 1|Protocol Violation|0|||
19548159|NCT01181986|41997455|FG002|Phase 1|Protocol Violation|0|||
19548160|NCT01181986|41997453|FG000|Phase 2|Adverse Event|0|||
19548161|NCT01181986|41997454|FG001|Phase 2|Adverse Event|3|||
19548162|NCT01181986|41997455|FG002|Phase 2|Adverse Event|0|||
19548163|NCT01181986|41997453|FG000|Phase 2|Medical condition|0|||
19548164|NCT01181986|41997454|FG001|Phase 2|Medical condition|1|||
19548165|NCT01181986|41997455|FG002|Phase 2|Medical condition|0|||
19548166|NCT01181167|41997471|FG000|Overall Study|Adverse Event|11|||
19548167|NCT01181167|41997472|FG001|Overall Study|Adverse Event|21|||
19548168|NCT01181167|41997471|FG000|Overall Study|Lost to Follow-up|1|||
19548169|NCT01181167|41997472|FG001|Overall Study|Lost to Follow-up|0|||
19548170|NCT01181167|41997471|FG000|Overall Study|Physician Decision|2|||
19548171|NCT01181167|41997472|FG001|Overall Study|Physician Decision|3|||
19548172|NCT01181167|41997471|FG000|Overall Study|Protocol Violation|3|||
19548173|NCT01181167|41997472|FG001|Overall Study|Protocol Violation|0|||
19548174|NCT01181167|41997471|FG000|Overall Study|Withdrawal by Subject|6|||
19548175|NCT01181167|41997472|FG001|Overall Study|Withdrawal by Subject|8|||
19548176|NCT01181128|41997481|FG000|Overall Study|Withdrawal by Subject|2|||
19548177|NCT01181128|41997482|FG001|Overall Study|Withdrawal by Subject|2|||
19548178|NCT01181128|41997483|FG002|Overall Study|Withdrawal by Subject|0|||
19548179|NCT01181128|41997481|FG000|Overall Study|Death|1|||
19548180|NCT01181128|41997482|FG001|Overall Study|Death|0|||
19548181|NCT01181128|41997483|FG002|Overall Study|Death|0|||
19716650|NCT00369629|42159574|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
19716651|NCT00369629|42159575|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
19716652|NCT00369629|42159576|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
19716653|NCT00369629|42159573|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
19716654|NCT00369629|42159574|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
19716655|NCT00369629|42159575|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
19716656|NCT00369629|42159576|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
19716657|NCT00369629|42159573|FG000|Completed 4 More Cycles|Progressive disease|2|||
19716658|NCT00369629|42159574|FG001|Completed 4 More Cycles|Progressive disease|1|||
19716659|NCT00369629|42159575|FG002|Completed 4 More Cycles|Progressive disease|2|||
19716660|NCT00369629|42159576|FG003|Completed 4 More Cycles|Progressive disease|0|||
19716661|NCT00369629|42159573|FG000|Follow up for 1 Year|Death|2|||
19716662|NCT00369629|42159574|FG001|Follow up for 1 Year|Death|1|||
19716663|NCT00369629|42159575|FG002|Follow up for 1 Year|Death|1|||
19716664|NCT00369629|42159576|FG003|Follow up for 1 Year|Death|0|||
19716665|NCT00369629|42159573|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
19716666|NCT00369629|42159574|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
19548182|NCT01181128|41997481|FG000|Overall Study|Physician Decision|2|||
19548183|NCT01181128|41997482|FG001|Overall Study|Physician Decision|0|||
19548184|NCT01181128|41997483|FG002|Overall Study|Physician Decision|0|||
19548185|NCT01181128|41997481|FG000|Overall Study|Adverse Event|0|||
19548186|NCT01181128|41997482|FG001|Overall Study|Adverse Event|2|||
19548187|NCT01181128|41997483|FG002|Overall Study|Adverse Event|0|||
19716667|NCT00369629|42159575|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
19548188|NCT01181128|41997481|FG000|Overall Study|Other|1|||
19548189|NCT01181128|41997482|FG001|Overall Study|Other|1|||
19548190|NCT01181128|41997483|FG002|Overall Study|Other|1|||
19548191|NCT01203787|41997505|FG000|Overall Study|Death|12|||
19548192|NCT01203787|41997506|FG001|Overall Study|Death|10|||
19548193|NCT01203787|41997505|FG000|Overall Study|Withdrawal by Subject|6|||
19548194|NCT01203787|41997506|FG001|Overall Study|Withdrawal by Subject|2|||
19548195|NCT01203787|41997505|FG000|Overall Study|Lost to Follow-up|2|||
19548196|NCT01203787|41997506|FG001|Overall Study|Lost to Follow-up|0|||
19548197|NCT01203787|41997505|FG000|Overall Study|Adverse Event|11|||
19548198|NCT01203787|41997506|FG001|Overall Study|Adverse Event|15|||
19548199|NCT01181011|41997514|FG000|Overall Study|Adverse Event|2|||
19548200|NCT01181011|41997514|FG000|Overall Study|Lost to Follow-up|1|||
19548201|NCT01180777|41997523|FG000|Overall Study|Protocol Violation|6|||
19548202|NCT01180777|41997523|FG000|Overall Study|Poor lens fit|4|||
19548203|NCT01180777|41997523|FG000|Overall Study|Lost to Follow-up|1|||
19548204|NCT01180777|41997523|FG000|Overall Study|Adverse Event|1|||
19548205|NCT01648023|41997531|FG000|Overall Study|Screen Fail Post Randomization|1|||
19548206|NCT01648023|41997532|FG001|Overall Study|Screen Fail Post Randomization|2|||
19548207|NCT02756208|41997546|FG000|Overall Study|Withdrawal by Subject|1|||
19548208|NCT02756208|41997547|FG001|Overall Study|Withdrawal by Subject|0|||
19548209|NCT02756208|41997548|FG002|Overall Study|Withdrawal by Subject|1|||
19548210|NCT02756208|41997549|FG003|Overall Study|Withdrawal by Subject|3|||
19548211|NCT02756208|41997546|FG000|Overall Study|Lost to Follow-up|3|||
19548212|NCT02756208|41997547|FG001|Overall Study|Lost to Follow-up|1|||
19548213|NCT02756208|41997548|FG002|Overall Study|Lost to Follow-up|1|||
19548214|NCT02756208|41997549|FG003|Overall Study|Lost to Follow-up|1|||
19548215|NCT02756208|41997546|FG000|Overall Study|Physician Decision|1|||
19548216|NCT02756208|41997547|FG001|Overall Study|Physician Decision|0|||
19548217|NCT02756208|41997548|FG002|Overall Study|Physician Decision|0|||
19548218|NCT02756208|41997549|FG003|Overall Study|Physician Decision|0|||
19548219|NCT02756208|41997546|FG000|Overall Study|Protocol Violation|0|||
19548220|NCT02756208|41997547|FG001|Overall Study|Protocol Violation|1|||
19548221|NCT02756208|41997548|FG002|Overall Study|Protocol Violation|0|||
19548222|NCT02756208|41997549|FG003|Overall Study|Protocol Violation|0|||
19548223|NCT02756013|41997559|FG000|Overall Study|Adverse Event|1|||
19548224|NCT02756013|41997559|FG000|Overall Study|Hypersensitivity|1|||
19548225|NCT01202773|41997566|FG000|Overall Study|Adverse Event|4|||
19548226|NCT01202773|41997567|FG001|Overall Study|Adverse Event|5|||
19548227|NCT01202773|41997568|FG002|Overall Study|Adverse Event|5|||
19548228|NCT01202773|41997566|FG000|Overall Study|Lack of Efficacy|5|||
19548229|NCT01202773|41997567|FG001|Overall Study|Lack of Efficacy|4|||
19548230|NCT01202773|41997568|FG002|Overall Study|Lack of Efficacy|9|||
19548231|NCT01202773|41997566|FG000|Overall Study|Entry Criteria Not Met|2|||
19548232|NCT01202773|41997567|FG001|Overall Study|Entry Criteria Not Met|0|||
19548233|NCT01202773|41997568|FG002|Overall Study|Entry Criteria Not Met|1|||
19548234|NCT01202773|41997566|FG000|Overall Study|Lost to Follow-up|1|||
19548235|NCT01202773|41997567|FG001|Overall Study|Lost to Follow-up|2|||
19548236|NCT01202773|41997568|FG002|Overall Study|Lost to Follow-up|2|||
19548237|NCT01202773|41997566|FG000|Overall Study|Withdrawal by Subject|13|||
19548238|NCT01202773|41997567|FG001|Overall Study|Withdrawal by Subject|6|||
19548239|NCT01202773|41997568|FG002|Overall Study|Withdrawal by Subject|5|||
19548240|NCT01202773|41997566|FG000|Overall Study|Physician Decision|2|||
19548241|NCT01202773|41997567|FG001|Overall Study|Physician Decision|0|||
19548242|NCT01202773|41997568|FG002|Overall Study|Physician Decision|0|||
19548243|NCT01202773|41997566|FG000|Overall Study|Protocol Violation|11|||
19548244|NCT01202773|41997567|FG001|Overall Study|Protocol Violation|6|||
19548245|NCT01202773|41997568|FG002|Overall Study|Protocol Violation|10|||
19548246|NCT01202773|41997566|FG000|Overall Study|Sponsor Decision|19|||
19548247|NCT01202773|41997567|FG001|Overall Study|Sponsor Decision|20|||
19548248|NCT01202773|41997568|FG002|Overall Study|Sponsor Decision|23|||
19548249|NCT01180660|41997588|FG000|Overall Study|Changed to open surgery|1|||
19548250|NCT01180660|41997589|FG001|Overall Study|Changed to open surgery|0|||
19548251|NCT01202227|41997595|FG000|Overall Study|Adverse Event|16|||
19548252|NCT01202227|41997595|FG000|Overall Study|Withdrawal by Subject|2|||
19548253|NCT01202227|41997595|FG000|Overall Study|Lack of Efficacy|1|||
19548254|NCT01202188|41997604|FG000|Overall Study|Protocol deviation|14|||
19548255|NCT01202188|41997605|FG001|Overall Study|Protocol deviation|8|||
19548256|NCT01202188|41997606|FG002|Overall Study|Protocol deviation|12|||
19548257|NCT01202188|41997607|FG003|Overall Study|Protocol deviation|10|||
19548258|NCT01202188|41997608|FG004|Overall Study|Protocol deviation|11|||
19548259|NCT01202188|41997604|FG000|Overall Study|Subject withdrew consent|12|||
19548260|NCT01202188|41997605|FG001|Overall Study|Subject withdrew consent|13|||
19548261|NCT01202188|41997606|FG002|Overall Study|Subject withdrew consent|22|||
19548262|NCT01202188|41997607|FG003|Overall Study|Subject withdrew consent|11|||
19548263|NCT01202188|41997608|FG004|Overall Study|Subject withdrew consent|13|||
19548264|NCT01202188|41997604|FG000|Overall Study|Adverse Event|5|||
19548265|NCT01202188|41997605|FG001|Overall Study|Adverse Event|23|||
19548266|NCT01202188|41997606|FG002|Overall Study|Adverse Event|13|||
19548267|NCT01202188|41997607|FG003|Overall Study|Adverse Event|10|||
19716668|NCT00369629|42159576|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
19716669|NCT00369629|42159573|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
19716670|NCT00369629|42159574|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
19716671|NCT00369629|42159575|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
19548268|NCT01202188|41997608|FG004|Overall Study|Adverse Event|10|||
19548269|NCT01202188|41997604|FG000|Overall Study|Administrative problems|3|||
19548270|NCT01202188|41997605|FG001|Overall Study|Administrative problems|2|||
19548271|NCT01202188|41997606|FG002|Overall Study|Administrative problems|1|||
19548272|NCT01202188|41997607|FG003|Overall Study|Administrative problems|1|||
19548273|NCT01202188|41997608|FG004|Overall Study|Administrative problems|2|||
19548274|NCT01202188|41997604|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19548275|NCT01202188|41997605|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
19548276|NCT01202188|41997606|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19548277|NCT01202188|41997607|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
19548278|NCT01202188|41997608|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
19548279|NCT01202188|41997604|FG000|Overall Study|Lost to Follow-up|1|||
19548280|NCT01202188|41997605|FG001|Overall Study|Lost to Follow-up|1|||
19548281|NCT01202188|41997606|FG002|Overall Study|Lost to Follow-up|0|||
19548282|NCT01202188|41997607|FG003|Overall Study|Lost to Follow-up|4|||
19548283|NCT01202188|41997608|FG004|Overall Study|Lost to Follow-up|1|||
19716672|NCT00369629|42159576|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
19716673|NCT02469064|42159588|FG000|Overall Study|Request not to receive intervention.|1|||
19716674|NCT02469064|42159589|FG001|Overall Study|Request not to receive intervention.|3|||
19716675|NCT02446912|42159598|FG000|Overall Study|Adverse Event|3|||
19716676|NCT02446912|42159599|FG001|Overall Study|Adverse Event|13|||
19716677|NCT02446912|42159600|FG002|Overall Study|Adverse Event|5|||
19716678|NCT02446912|42159598|FG000|Overall Study|Condition under investigation worsened|0|||
19716679|NCT02446912|42159599|FG001|Overall Study|Condition under investigation worsened|1|||
19716680|NCT02446912|42159600|FG002|Overall Study|Condition under investigation worsened|1|||
19716681|NCT02446912|42159598|FG000|Overall Study|Study-specific withdrawal criteria|1|||
19716682|NCT02446912|42159599|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19716683|NCT02446912|42159600|FG002|Overall Study|Study-specific withdrawal criteria|0|||
19716684|NCT02446912|42159598|FG000|Overall Study|Lack of Efficacy|1|||
19716685|NCT02446912|42159599|FG001|Overall Study|Lack of Efficacy|4|||
19716686|NCT02446912|42159600|FG002|Overall Study|Lack of Efficacy|7|||
19716687|NCT02446912|42159598|FG000|Overall Study|Lost to Follow-up|0|||
19716688|NCT02446912|42159599|FG001|Overall Study|Lost to Follow-up|0|||
19716689|NCT02446912|42159600|FG002|Overall Study|Lost to Follow-up|2|||
19716690|NCT02446912|42159598|FG000|Overall Study|Severe non-compliance to protocol|1|||
19716691|NCT02446912|42159599|FG001|Overall Study|Severe non-compliance to protocol|0|||
19716692|NCT02446912|42159600|FG002|Overall Study|Severe non-compliance to protocol|1|||
19716693|NCT02446912|42159598|FG000|Overall Study|Withdrawal by Subject|10|||
19716694|NCT02446912|42159599|FG001|Overall Study|Withdrawal by Subject|15|||
19716695|NCT02446912|42159600|FG002|Overall Study|Withdrawal by Subject|15|||
19716696|NCT02446912|42159598|FG000|Overall Study|Miscellaneous|2|||
19716697|NCT02446912|42159599|FG001|Overall Study|Miscellaneous|2|||
19716698|NCT02446912|42159600|FG002|Overall Study|Miscellaneous|4|||
19716699|NCT00736840|42159608|FG000|Overall Study|Lost to Follow-up|13|||
19716700|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Adverse Event|11|||
19716701|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Adverse Event|23|||
19716702|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Adverse Event|29|||
19716703|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Adverse Event|2|||
19716704|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Adverse Event|8|||
19716705|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
19716706|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
19716707|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
19716708|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
19716709|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
19716710|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
19716711|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
19716712|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
19716713|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
19716714|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
19716715|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
19716716|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
19716717|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
19716718|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
19716719|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
19716720|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
19716721|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
19716722|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
19716723|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
19716724|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
19716725|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
19716726|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
19716727|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
19716728|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
19716729|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
19716730|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
19716731|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
19716732|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
19716733|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
19548284|NCT01202188|41997604|FG000|Overall Study|Death|1|||
19548285|NCT01202188|41997605|FG001|Overall Study|Death|1|||
19548286|NCT01202188|41997606|FG002|Overall Study|Death|1|||
19548287|NCT01202188|41997607|FG003|Overall Study|Death|1|||
19548288|NCT01202188|41997608|FG004|Overall Study|Death|0|||
19548289|NCT01202188|41997604|FG000|Overall Study|Abnormal test procedure result (s)|0|||
19548290|NCT01202188|41997605|FG001|Overall Study|Abnormal test procedure result (s)|0|||
19548291|NCT01202188|41997606|FG002|Overall Study|Abnormal test procedure result (s)|2|||
19548292|NCT01202188|41997607|FG003|Overall Study|Abnormal test procedure result (s)|0|||
19548293|NCT01202188|41997608|FG004|Overall Study|Abnormal test procedure result (s)|0|||
19548294|NCT01201915|41997629|FG000|Overall Study|Adverse Event|2|||
19548295|NCT01201915|41997630|FG001|Overall Study|Adverse Event|1|||
19548296|NCT01201915|41997631|FG002|Overall Study|Adverse Event|1|||
19548297|NCT01201915|41997629|FG000|Overall Study|Lost to Follow-up|0|||
19548298|NCT01201915|41997630|FG001|Overall Study|Lost to Follow-up|4|||
19548299|NCT01201915|41997631|FG002|Overall Study|Lost to Follow-up|0|||
19548300|NCT01201915|41997629|FG000|Overall Study|Physician Decision|3|||
19548301|NCT01201915|41997630|FG001|Overall Study|Physician Decision|0|||
19548302|NCT01201915|41997631|FG002|Overall Study|Physician Decision|0|||
19548303|NCT01201915|41997629|FG000|Overall Study|Subject Decision|3|||
19548304|NCT01201915|41997630|FG001|Overall Study|Subject Decision|3|||
19548305|NCT01201915|41997631|FG002|Overall Study|Subject Decision|5|||
19548306|NCT01201915|41997629|FG000|Overall Study|Target Lesion Progression|0|||
19548307|NCT01201915|41997630|FG001|Overall Study|Target Lesion Progression|3|||
19548308|NCT01201915|41997631|FG002|Overall Study|Target Lesion Progression|0|||
19548309|NCT01179919|41997639|FG000|Overall Study|Protocol Violation|1|||
19548310|NCT01179919|41997639|FG000|Overall Study|Adverse Event|1|||
19548311|NCT01201798|41997645|FG000|Overall Study|Adverse Event|2|||
19548312|NCT01201798|41997646|FG001|Overall Study|Adverse Event|0|||
19548313|NCT01201798|41997645|FG000|Overall Study|Lost to Follow-up|3|||
19548314|NCT01201798|41997646|FG001|Overall Study|Lost to Follow-up|5|||
19548315|NCT01201798|41997645|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
19548316|NCT01201798|41997646|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
19548317|NCT01201798|41997645|FG000|Overall Study|Noncompliance|1|||
19548318|NCT01201798|41997646|FG001|Overall Study|Noncompliance|0|||
19548319|NCT01201798|41997645|FG000|Overall Study|Protocol Violation|1|||
19548320|NCT01201798|41997646|FG001|Overall Study|Protocol Violation|1|||
19548321|NCT01201798|41997645|FG000|Overall Study|Treatment Failure|1|||
19548322|NCT01201798|41997646|FG001|Overall Study|Treatment Failure|8|||
19548323|NCT01201759|41997654|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
19548324|NCT01201759|41997655|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
19548325|NCT01201759|41997654|FG000|Visit 3 - Washout|Adverse Event|0|||
19548326|NCT01201759|41997655|FG001|Visit 3 - Washout|Adverse Event|3|||
19548327|NCT01201759|41997654|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
19548328|NCT01201759|41997655|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
19548329|NCT01201759|41997654|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
19548330|NCT01201759|41997655|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
19548331|NCT01200589|41997665|FG000|Overall Study|Withdrawal by Subject|13|||
19548332|NCT01200589|41997666|FG001|Overall Study|Withdrawal by Subject|11|||
19548333|NCT01200589|41997665|FG000|Overall Study|Physician Decision|2|||
19548334|NCT01200589|41997666|FG001|Overall Study|Physician Decision|2|||
19548335|NCT01200589|41997665|FG000|Overall Study|Lost to Follow-up|5|||
19548336|NCT01200589|41997666|FG001|Overall Study|Lost to Follow-up|4|||
19548337|NCT01200589|41997665|FG000|Overall Study|Study terminated|170|||
19548338|NCT01200589|41997666|FG001|Overall Study|Study terminated|172|||
19548339|NCT01200511|41997672|FG000|Overall Study|Lost to Follow-up|3|||
19548340|NCT01200511|41997672|FG000|Overall Study|Withdrawal by Subject|1|||
19548341|NCT01200511|41997672|FG000|Overall Study|Adverse Event|1|||
19548342|NCT01179334|41997680|FG000|Treatment Period|Adverse Event|1|||
19548343|NCT01179334|41997681|FG001|Treatment Period|Adverse Event|0|||
19548344|NCT01179334|41997680|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
19548345|NCT01179334|41997681|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
19548346|NCT01179334|41997680|FG000|Long-term Extension (LTE) Period|Death|3|||
19548347|NCT01179334|41997681|FG001|Long-term Extension (LTE) Period|Death|0|||
19548348|NCT01179334|41997680|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
19548349|NCT01179334|41997681|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
19548350|NCT01178671|41997689|FG000|Overall Study|Adverse Event|4|||
19548351|NCT01178671|41997690|FG001|Overall Study|Adverse Event|6|||
19548352|NCT01178671|41997689|FG000|Overall Study|Protocol Violation|1|||
19548353|NCT01178671|41997690|FG001|Overall Study|Protocol Violation|1|||
19548354|NCT01178671|41997689|FG000|Overall Study|Lack of Efficacy|0|||
19548355|NCT01178671|41997690|FG001|Overall Study|Lack of Efficacy|1|||
19548356|NCT01178671|41997689|FG000|Overall Study|Lost to Follow-up|3|||
19548357|NCT01178671|41997690|FG001|Overall Study|Lost to Follow-up|1|||
19548358|NCT01178671|41997689|FG000|Overall Study|Physician Decision|4|||
19548359|NCT01178671|41997690|FG001|Overall Study|Physician Decision|6|||
19716734|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
19548360|NCT01178125|41997696|FG000|Overall Study|Lost to Follow-up|397|||
19548361|NCT01178125|41997696|FG000|Overall Study|Adverse Event|244|||
19716735|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Move|0|||
19548362|NCT01178125|41997696|FG000|Overall Study|Withdrawal by Subject|209|||
19548363|NCT01178125|41997696|FG000|Overall Study|Noncompliance|184|||
19548364|NCT01178125|41997696|FG000|Overall Study|Pregnancy|55|||
19548365|NCT01178125|41997696|FG000|Overall Study|Other Reason|39|||
19548366|NCT01178125|41997696|FG000|Overall Study|Sponsor Decision|28|||
19548367|NCT01178125|41997696|FG000|Overall Study|Protocol Violation|17|||
19548368|NCT01178125|41997696|FG000|Overall Study|Investigator Decision|5|||
19548369|NCT01178086|41997718|FG000|Overall Study|Participant refusal|7|||
19548370|NCT01178086|41997718|FG000|Overall Study|Physician Decision|44|||
19548371|NCT01178086|41997718|FG000|Overall Study|Switch to other CLL therapy|113|||
19548372|NCT01178086|41997718|FG000|Overall Study|Death|59|||
19548373|NCT01178086|41997718|FG000|Overall Study|Other unspecified|89|||
19548374|NCT01178086|41997718|FG000|Overall Study|Excluded from EAS|20|||
19548375|NCT01177969|41997726|FG000|Overall Study|Protocol Violation|2|||
19548376|NCT01177969|41997727|FG001|Overall Study|Protocol Violation|1|||
19548377|NCT01177969|41997726|FG000|Overall Study|Withdrawal by Subject|1|||
19548378|NCT01177969|41997727|FG001|Overall Study|Withdrawal by Subject|2|||
19548379|NCT01177813|41997738|FG000|Overall Study|Adverse Event|8|||
19548380|NCT01177813|41997739|FG001|Overall Study|Adverse Event|2|||
19548381|NCT01177813|41997740|FG002|Overall Study|Adverse Event|4|||
19548382|NCT01177813|41997741|FG003|Overall Study|Adverse Event|6|||
19548383|NCT01177813|41997742|FG004|Overall Study|Adverse Event|3|||
19548384|NCT01177813|41997738|FG000|Overall Study|Lack of Efficacy|1|||
19548385|NCT01177813|41997739|FG001|Overall Study|Lack of Efficacy|0|||
19548386|NCT01177813|41997740|FG002|Overall Study|Lack of Efficacy|0|||
19548387|NCT01177813|41997741|FG003|Overall Study|Lack of Efficacy|0|||
19548388|NCT01177813|41997742|FG004|Overall Study|Lack of Efficacy|0|||
19548389|NCT01177813|41997738|FG000|Overall Study|Protocol Violation|3|||
19548390|NCT01177813|41997739|FG001|Overall Study|Protocol Violation|2|||
19548391|NCT01177813|41997740|FG002|Overall Study|Protocol Violation|2|||
19548392|NCT01177813|41997741|FG003|Overall Study|Protocol Violation|0|||
19548393|NCT01177813|41997742|FG004|Overall Study|Protocol Violation|1|||
19548394|NCT01177813|41997738|FG000|Overall Study|Lost to Follow-up|12|||
19548395|NCT01177813|41997739|FG001|Overall Study|Lost to Follow-up|5|||
19548396|NCT01177813|41997740|FG002|Overall Study|Lost to Follow-up|6|||
19548397|NCT01177813|41997741|FG003|Overall Study|Lost to Follow-up|3|||
19548398|NCT01177813|41997742|FG004|Overall Study|Lost to Follow-up|0|||
19548399|NCT01177813|41997738|FG000|Overall Study|Withdrawal by Subject|12|||
19548400|NCT01177813|41997739|FG001|Overall Study|Withdrawal by Subject|7|||
19548401|NCT01177813|41997740|FG002|Overall Study|Withdrawal by Subject|6|||
19548402|NCT01177813|41997741|FG003|Overall Study|Withdrawal by Subject|5|||
19548403|NCT01177813|41997742|FG004|Overall Study|Withdrawal by Subject|3|||
19548404|NCT01177813|41997738|FG000|Overall Study|Other reason not defined above|5|||
19548405|NCT01177813|41997739|FG001|Overall Study|Other reason not defined above|2|||
19548406|NCT01177813|41997740|FG002|Overall Study|Other reason not defined above|2|||
19548407|NCT01177813|41997741|FG003|Overall Study|Other reason not defined above|3|||
19548408|NCT01177813|41997742|FG004|Overall Study|Other reason not defined above|2|||
19548409|NCT01200394|41997756|FG000|Overall Study|Adverse Event|0|||
19548410|NCT01200394|41997757|FG001|Overall Study|Adverse Event|14|||
19548411|NCT01200394|41997756|FG000|Overall Study|Death|1|||
19548412|NCT01200394|41997757|FG001|Overall Study|Death|0|||
19548413|NCT01200394|41997756|FG000|Overall Study|Lost to Follow-up|0|||
19548414|NCT01200394|41997757|FG001|Overall Study|Lost to Follow-up|1|||
19548415|NCT01200394|41997756|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
19548416|NCT01200394|41997757|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
19548417|NCT01200394|41997756|FG000|Overall Study|Protocol Violation|0|||
19548418|NCT01200394|41997757|FG001|Overall Study|Protocol Violation|3|||
19548419|NCT01200394|41997756|FG000|Overall Study|Withdrawal by Subject|0|||
19548420|NCT01200394|41997757|FG001|Overall Study|Withdrawal by Subject|5|||
19548421|NCT01200394|41997756|FG000|Overall Study|Other|0|||
19548422|NCT01200394|41997757|FG001|Overall Study|Other|1|||
19548423|NCT01200355|41997766|FG000|Overall Study|Death|7|||
19548424|NCT01200355|41997767|FG001|Overall Study|Death|2|||
19548425|NCT01200238|41997775|FG000|Overall Study|Adverse Event|2|||
19548426|NCT01200238|41997776|FG001|Overall Study|Adverse Event|1|||
19548427|NCT01200238|41997775|FG000|Overall Study|Progressive Disease|5|||
19548428|NCT01200238|41997776|FG001|Overall Study|Progressive Disease|8|||
19548429|NCT01200238|41997775|FG000|Overall Study|Withdrawal by Subject|0|||
19548430|NCT01200238|41997776|FG001|Overall Study|Withdrawal by Subject|1|||
19548431|NCT01199731|41997785|FG000|Overall Study|Adverse Event|0|||
19548432|NCT01199731|41997786|FG001|Overall Study|Adverse Event|1|||
19548433|NCT01199731|41997787|FG002|Overall Study|Adverse Event|0|||
19548434|NCT01199731|41997785|FG000|Overall Study|Study closed/terminated|7|||
19548435|NCT01199731|41997786|FG001|Overall Study|Study closed/terminated|9|||
19548436|NCT01199731|41997787|FG002|Overall Study|Study closed/terminated|7|||
19548437|NCT01199731|41997785|FG000|Overall Study|Lost to Follow-up|0|||
19548438|NCT01199731|41997786|FG001|Overall Study|Lost to Follow-up|0|||
19548439|NCT01199731|41997787|FG002|Overall Study|Lost to Follow-up|2|||
19548440|NCT01199731|41997785|FG000|Overall Study|Physician Decision|0|||
19548441|NCT01199731|41997786|FG001|Overall Study|Physician Decision|1|||
19548442|NCT01199731|41997787|FG002|Overall Study|Physician Decision|1|||
19548443|NCT01199731|41997785|FG000|Overall Study|Withdrawal by Subject|2|||
19548444|NCT01199731|41997786|FG001|Overall Study|Withdrawal by Subject|0|||
19548445|NCT01199731|41997787|FG002|Overall Study|Withdrawal by Subject|0|||
19548446|NCT01199263|41997797|FG000|Overall Study|Ineligible|0|||
19548447|NCT01199263|41997798|FG001|Overall Study|Ineligible|2|||
19548448|NCT01199263|41997797|FG000|Overall Study|Never Treated|6|||
19548449|NCT01199263|41997798|FG001|Overall Study|Never Treated|0|||
19548450|NCT01199068|41997809|FG000|Overall Study|Unacceptable toxicity|0|||
19548451|NCT01199068|41997810|FG001|Overall Study|Unacceptable toxicity|0|||
19548452|NCT01199068|41997811|FG002|Overall Study|Unacceptable toxicity|2|||
19548453|NCT01199068|41997809|FG000|Overall Study|Progressive disease|3|||
19548454|NCT01199068|41997810|FG001|Overall Study|Progressive disease|3|||
19548455|NCT01199068|41997811|FG002|Overall Study|Progressive disease|6|||
19548456|NCT01199068|41997809|FG000|Overall Study|Withdrawal by Subject|0|||
19548457|NCT01199068|41997810|FG001|Overall Study|Withdrawal by Subject|0|||
19548458|NCT01199068|41997811|FG002|Overall Study|Withdrawal by Subject|1|||
19548459|NCT01198873|41997828|FG000|Overall Study|Adverse Event|4|||
19548460|NCT01198873|41997829|FG001|Overall Study|Adverse Event|7|||
19548461|NCT01198873|41997828|FG000|Overall Study|Study closure|29|||
19548462|NCT01198873|41997829|FG001|Overall Study|Study closure|23|||
19548463|NCT01198873|41997828|FG000|Overall Study|Other than above|4|||
19548464|NCT01198873|41997829|FG001|Overall Study|Other than above|2|||
19548465|NCT01198795|41997835|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
19548466|NCT01198795|41997835|FG000|Overall Study|Withdrawal by Subject|17|||
19548467|NCT01198795|41997835|FG000|Overall Study|Lost to Follow-up|15|||
19548468|NCT01198795|41997835|FG000|Overall Study|Adverse Event|9|||
19548469|NCT01198795|41997835|FG000|Overall Study|Lack of Efficacy|5|||
19548470|NCT01198795|41997835|FG000|Overall Study|Protocol Violation|2|||
19716736|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Move|1|||
19716737|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Move|0|||
19548471|NCT01198795|41997835|FG000|Overall Study|Other Reason|4|||
19548472|NCT01198756|41997843|FG000|Overall Study|Adverse Event|0|||
19548473|NCT01198756|41997844|FG001|Overall Study|Adverse Event|0|||
19548474|NCT01198756|41997845|FG002|Overall Study|Adverse Event|0|||
19548475|NCT01198756|41997846|FG003|Overall Study|Adverse Event|1|||
19548476|NCT01198756|41997843|FG000|Overall Study|Protocol Violation|0|||
19548477|NCT01198756|41997844|FG001|Overall Study|Protocol Violation|0|||
19548478|NCT01198756|41997845|FG002|Overall Study|Protocol Violation|0|||
19548479|NCT01198756|41997846|FG003|Overall Study|Protocol Violation|2|||
19716738|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Move|0|||
19716739|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Move|0|||
19716740|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
19716741|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
19548480|NCT01198756|41997843|FG000|Overall Study|Withdrawal by Subject|9|||
19548481|NCT01198756|41997844|FG001|Overall Study|Withdrawal by Subject|4|||
19548482|NCT01198756|41997845|FG002|Overall Study|Withdrawal by Subject|7|||
19548483|NCT01198756|41997846|FG003|Overall Study|Withdrawal by Subject|5|||
19548484|NCT01198756|41997843|FG000|Overall Study|Lost to Follow-up|29|||
19548485|NCT01198756|41997844|FG001|Overall Study|Lost to Follow-up|36|||
19548486|NCT01198756|41997845|FG002|Overall Study|Lost to Follow-up|23|||
19548487|NCT01198756|41997846|FG003|Overall Study|Lost to Follow-up|18|||
19548488|NCT01198600|41997863|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
19548489|NCT01198600|41997864|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
19716742|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
19716743|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
19716744|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
19716745|NCT00318461|42159617|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
19716746|NCT00318461|42159618|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
19716747|NCT00318461|42159619|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
19716748|NCT00318461|42159620|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
19716749|NCT00318461|42159621|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
19548490|NCT01198600|41997865|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
19548491|NCT01198600|41997866|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
19548492|NCT01198600|41997863|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
19548493|NCT01198600|41997864|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
19716750|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Work commitment|0|||
19716751|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Work commitment|0|||
19548494|NCT01198600|41997865|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
19548495|NCT01198600|41997866|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
19548496|NCT01198600|41997863|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
19548497|NCT01198600|41997864|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
19548498|NCT01198600|41997865|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
19548499|NCT01198600|41997866|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
19548500|NCT01198600|41997863|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
19548501|NCT01198600|41997864|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
19548502|NCT01198600|41997865|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
19548503|NCT01198600|41997866|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
19548504|NCT01198600|41997863|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
19548505|NCT01198600|41997864|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
19548506|NCT01198600|41997865|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
19548507|NCT01198600|41997866|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
19548508|NCT01198600|41997863|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
19548509|NCT01198600|41997864|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
19548510|NCT01198600|41997865|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
19548511|NCT01198600|41997866|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
19548512|NCT01198600|41997863|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
19548513|NCT01198600|41997864|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
19548514|NCT01198600|41997865|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
19548515|NCT01198600|41997866|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
19548516|NCT01198132|41997876|FG000|Overall Study|Withdrawal by Subject|4|||
19548517|NCT01198132|41997877|FG001|Overall Study|Withdrawal by Subject|5|||
19548518|NCT01198132|41997876|FG000|Overall Study|Physician Decision|5|||
19548519|NCT01198132|41997877|FG001|Overall Study|Physician Decision|4|||
19548520|NCT01198132|41997876|FG000|Overall Study|Other Unspecified|3|||
19548521|NCT01198132|41997877|FG001|Overall Study|Other Unspecified|6|||
19548522|NCT01198132|41997876|FG000|Overall Study|Lack of Efficacy|2|||
19548523|NCT01198132|41997877|FG001|Overall Study|Lack of Efficacy|3|||
19548524|NCT01198132|41997876|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
19548525|NCT01198132|41997877|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
19548526|NCT01198132|41997876|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
19548527|NCT01198132|41997877|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
19548528|NCT01198132|41997876|FG000|Overall Study|Adverse Event|0|||
19548529|NCT01198132|41997877|FG001|Overall Study|Adverse Event|1|||
19548530|NCT01198132|41997876|FG000|Overall Study|Protocol Violation|1|||
19548531|NCT01198132|41997877|FG001|Overall Study|Protocol Violation|0|||
19548532|NCT01197508|41997889|FG000|Overall Study|Withdrawal by Subject|8|||
19548533|NCT01197508|41997890|FG001|Overall Study|Withdrawal by Subject|7|||
19548534|NCT01197508|41997891|FG002|Overall Study|Withdrawal by Subject|15|||
19548535|NCT01197508|41997892|FG003|Overall Study|Withdrawal by Subject|4|||
19548536|NCT01197508|41997889|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
19548537|NCT01197508|41997890|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
19548538|NCT01197508|41997891|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
19548539|NCT01197508|41997892|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
19548540|NCT01197508|41997889|FG000|Overall Study|Adverse Event|10|||
19548541|NCT01197508|41997890|FG001|Overall Study|Adverse Event|13|||
19548542|NCT01197508|41997891|FG002|Overall Study|Adverse Event|23|||
19548543|NCT01197508|41997892|FG003|Overall Study|Adverse Event|3|||
19548544|NCT01197508|41997889|FG000|Overall Study|Severe non-compliance to protocol|0|||
19548545|NCT01197508|41997890|FG001|Overall Study|Severe non-compliance to protocol|3|||
19548546|NCT01197508|41997891|FG002|Overall Study|Severe non-compliance to protocol|1|||
19548547|NCT01197508|41997892|FG003|Overall Study|Severe non-compliance to protocol|3|||
19548548|NCT01197508|41997889|FG000|Overall Study|Condition under investigation worsened|1|||
19548549|NCT01197508|41997890|FG001|Overall Study|Condition under investigation worsened|1|||
19548550|NCT01197508|41997891|FG002|Overall Study|Condition under investigation worsened|1|||
19548551|NCT01197508|41997892|FG003|Overall Study|Condition under investigation worsened|1|||
19548552|NCT01197508|41997889|FG000|Overall Study|Lack of Efficacy|1|||
19548553|NCT01197508|41997890|FG001|Overall Study|Lack of Efficacy|2|||
19548554|NCT01197508|41997891|FG002|Overall Study|Lack of Efficacy|2|||
19716752|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Work commitment|0|||
19716753|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Work commitment|0|||
19716754|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Work commitment|1|||
19716755|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Investigator decision|0|||
19716756|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Investigator decision|0|||
19716757|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Investigator decision|0|||
19716758|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Investigator decision|0|||
19716759|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Investigator decision|1|||
19716760|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Lack of time|1|||
19716761|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Lack of time|0|||
19716762|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Lack of time|0|||
19716763|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Lack of time|0|||
19716764|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Lack of time|0|||
19716765|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
19716766|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
19716767|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
19548555|NCT01197508|41997892|FG003|Overall Study|Lack of Efficacy|1|||
19548556|NCT01197508|41997889|FG000|Overall Study|Study-specific withdrawal criteria|0|||
19548557|NCT01197508|41997890|FG001|Overall Study|Study-specific withdrawal criteria|0|||
19548558|NCT01197508|41997891|FG002|Overall Study|Study-specific withdrawal criteria|1|||
19548559|NCT01197508|41997892|FG003|Overall Study|Study-specific withdrawal criteria|2|||
19548560|NCT01197508|41997889|FG000|Overall Study|Lost to Follow-up|1|||
19548561|NCT01197508|41997890|FG001|Overall Study|Lost to Follow-up|1|||
19548562|NCT01197508|41997891|FG002|Overall Study|Lost to Follow-up|2|||
19548563|NCT01197508|41997892|FG003|Overall Study|Lost to Follow-up|0|||
19716768|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
19716769|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
19716770|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
19716771|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
19716772|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
19716773|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
19716774|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
19716775|NCT00318461|42159617|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
19716776|NCT00318461|42159618|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
19716777|NCT00318461|42159619|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
19716778|NCT00318461|42159620|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
19716779|NCT00318461|42159621|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
19716780|NCT00318461|42159617|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
19716781|NCT00318461|42159618|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
19716782|NCT00318461|42159619|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
19716783|NCT00318461|42159620|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
19716784|NCT00318461|42159621|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
19716785|NCT00318461|42159617|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
19716786|NCT00318461|42159618|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
19716787|NCT00318461|42159619|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
19716788|NCT00318461|42159620|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
19716789|NCT00318461|42159621|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
19716790|NCT00318461|42159617|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
19716791|NCT00318461|42159618|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
19716792|NCT00318461|42159619|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
19716793|NCT00318461|42159620|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
19548564|NCT01197508|41997889|FG000|Overall Study|Other|2|||
19548565|NCT01197508|41997890|FG001|Overall Study|Other|3|||
19716794|NCT00318461|42159621|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
19716795|NCT00318461|42159617|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
19716796|NCT00318461|42159618|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
19716797|NCT00318461|42159619|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
19716798|NCT00318461|42159620|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
19716799|NCT00318461|42159621|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
19716800|NCT00318461|42159617|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
19716801|NCT00318461|42159618|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
19716802|NCT00318461|42159619|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
19716803|NCT00318461|42159620|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
19716804|NCT00318461|42159621|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
19716805|NCT03764072|42159648|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
19716806|NCT03764072|42159649|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
19548566|NCT01197508|41997891|FG002|Overall Study|Other|2|||
19548567|NCT01197508|41997892|FG003|Overall Study|Other|2|||
19548568|NCT01196416|41997909|FG000|Overall Study|Withdrawal by Subject|2|||
19548569|NCT01196104|41997915|FG000|Overall Study|Lost to Follow-up|1|||
19548570|NCT01196104|41997916|FG001|Overall Study|Lost to Follow-up|0|||
19548571|NCT01196104|41997915|FG000|Overall Study|Physician Decision|0|||
19548572|NCT01196104|41997916|FG001|Overall Study|Physician Decision|1|||
19548573|NCT01196104|41997915|FG000|Overall Study|Withdrawal by Subject|3|||
19548574|NCT01196104|41997916|FG001|Overall Study|Withdrawal by Subject|3|||
19548575|NCT01196104|41997915|FG000|Overall Study|Various|0|||
19548576|NCT01196104|41997916|FG001|Overall Study|Various|1|||
19548577|NCT01196026|41997934|FG000|Overall Study|Withdrawal by Subject|1|||
19548578|NCT01196026|41997935|FG001|Overall Study|Withdrawal by Subject|4|||
19548579|NCT01196026|41997936|FG002|Overall Study|Withdrawal by Subject|0|||
19548580|NCT01196026|41997937|FG003|Overall Study|Withdrawal by Subject|0|||
19548581|NCT01196026|41997938|FG004|Overall Study|Withdrawal by Subject|0|||
19548582|NCT01196026|41997939|FG005|Overall Study|Withdrawal by Subject|0|||
19548583|NCT01196026|41997934|FG000|Overall Study|Lost to Follow-up|0|||
19548584|NCT01196026|41997935|FG001|Overall Study|Lost to Follow-up|3|||
19548585|NCT01196026|41997936|FG002|Overall Study|Lost to Follow-up|0|||
19548586|NCT01196026|41997937|FG003|Overall Study|Lost to Follow-up|0|||
19548587|NCT01196026|41997938|FG004|Overall Study|Lost to Follow-up|1|||
19548588|NCT01196026|41997939|FG005|Overall Study|Lost to Follow-up|0|||
19548589|NCT01196026|41997934|FG000|Overall Study|Other|0|||
19548590|NCT01196026|41997935|FG001|Overall Study|Other|1|||
19548591|NCT01196026|41997936|FG002|Overall Study|Other|0|||
19548592|NCT01196026|41997937|FG003|Overall Study|Other|0|||
19548593|NCT01196026|41997938|FG004|Overall Study|Other|0|||
19548594|NCT01196026|41997939|FG005|Overall Study|Other|0|||
19548595|NCT01195948|41997962|FG000|Overall Study|Lost to Follow-up|0|||
19548596|NCT01195948|41997963|FG001|Overall Study|Lost to Follow-up|1|||
19548597|NCT01195948|41997964|FG002|Overall Study|Lost to Follow-up|2|||
19548598|NCT01195831|41997977|FG000|Overall Study|Lost to Follow-up|2|||
19548599|NCT01195831|41997978|FG001|Overall Study|Lost to Follow-up|4|||
19548600|NCT01195831|41997977|FG000|Overall Study|Withdrawal by Subject|2|||
19548601|NCT01195831|41997978|FG001|Overall Study|Withdrawal by Subject|2|||
19548602|NCT01195831|41997977|FG000|Overall Study|Adverse Event|4|||
19548603|NCT01195831|41997978|FG001|Overall Study|Adverse Event|2|||
19548604|NCT01195831|41997977|FG000|Overall Study|Protocol Violation|0|||
19548605|NCT01195831|41997978|FG001|Overall Study|Protocol Violation|2|||
19548606|NCT01195675|41997984|FG000|Overall Study|Adverse Event|1|||
19548607|NCT01195675|41997984|FG000|Overall Study|Withdrawal by Subject|2|||
19548608|NCT01195636|41998001|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
19548609|NCT01195636|41998002|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
19548610|NCT01195636|41998001|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
19548611|NCT01195636|41998002|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
19548612|NCT01195636|41998001|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
19548613|NCT01195636|41998002|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
19548614|NCT01195636|41998001|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
19548615|NCT01195636|41998002|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
19548616|NCT01195636|41998001|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
19548617|NCT01195636|41998002|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
19548618|NCT01195636|41998001|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
19548619|NCT01195636|41998002|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
19548620|NCT01195636|41998001|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
19548621|NCT01195636|41998002|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
19548622|NCT01195636|41998001|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
19548623|NCT01195636|41998002|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
19548624|NCT01195363|41998010|FG000|Overall Study|Lost to Follow-up|7|||
19548625|NCT01195363|41998011|FG001|Overall Study|Lost to Follow-up|4|||
19548626|NCT01195363|41998010|FG000|Overall Study|Adverse Event|3|||
19548627|NCT01195363|41998011|FG001|Overall Study|Adverse Event|1|||
19548628|NCT01195363|41998010|FG000|Overall Study|Lack of Efficacy|0|||
19548629|NCT01195363|41998011|FG001|Overall Study|Lack of Efficacy|4|||
19548630|NCT01195363|41998010|FG000|Overall Study|incarceration|1|||
19548631|NCT01195363|41998011|FG001|Overall Study|incarceration|0|||
19548632|NCT01195090|41998019|FG000|Overall Study|Adverse Event|1|||
19548633|NCT01195090|41998020|FG001|Overall Study|Adverse Event|2|||
19548634|NCT01195090|41998019|FG000|Overall Study|Lost to Follow-up|2|||
19548635|NCT01195090|41998020|FG001|Overall Study|Lost to Follow-up|2|||
19548636|NCT01195090|41998019|FG000|Overall Study|Protocol Violation|3|||
19548637|NCT01195090|41998020|FG001|Overall Study|Protocol Violation|4|||
19548638|NCT01194973|41998026|FG000|Screening Period|Screen Failure|3|||
19548639|NCT01194973|41998026|FG000|26 Week Treatment Period|Adverse Event|1|||
19548640|NCT01194973|41998026|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
19548641|NCT01194973|41998026|FG000|26 Week Treatment Period|Pregnancy|1|||
19548642|NCT02218697|41998032|FG000|Overall Study|Adverse Event|0|||
19716807|NCT03764072|42159650|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
19716808|NCT03764072|42159651|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
19716809|NCT03764072|42159652|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
19716810|NCT03764072|42159653|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
19716811|NCT03764072|42159648|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
19716812|NCT03764072|42159649|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
19716813|NCT03764072|42159650|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
19716814|NCT03764072|42159651|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
19548643|NCT02218697|41998033|FG001|Overall Study|Adverse Event|2|||
19548644|NCT02218697|41998032|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
19548645|NCT02218697|41998033|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
19548646|NCT02218697|41998032|FG000|Overall Study|Withdrawal by Subject|2|||
19548647|NCT02218697|41998033|FG001|Overall Study|Withdrawal by Subject|3|||
19548648|NCT01177540|41998041|FG000|Overall Study|Adverse Event|1|||
19548649|NCT01177540|41998042|FG001|Overall Study|Adverse Event|0|||
19548650|NCT02211131|41998050|FG000|Overall Study|Death|20|||
19548651|NCT02211131|41998051|FG001|Overall Study|Death|11|||
19548652|NCT02211131|41998050|FG000|Overall Study|Lost to Follow-up|1|||
19548653|NCT02211131|41998051|FG001|Overall Study|Lost to Follow-up|0|||
19548654|NCT02211131|41998050|FG000|Overall Study|Decision by Sponsor|1|||
19548655|NCT02211131|41998051|FG001|Overall Study|Decision by Sponsor|1|||
19548656|NCT02211131|41998050|FG000|Overall Study|Withdrawal by Subject|3|||
19548657|NCT02211131|41998051|FG001|Overall Study|Withdrawal by Subject|4|||
19548658|NCT02211131|41998050|FG000|Overall Study|Continuing on Study|49|||
19548659|NCT02211131|41998051|FG001|Overall Study|Continuing on Study|60|||
19548660|NCT01177384|41998066|FG000|Overall Study|Adverse Event|6|||
19548661|NCT01177384|41998067|FG001|Overall Study|Adverse Event|4|||
19548662|NCT01177384|41998066|FG000|Overall Study|Lack of Efficacy|0|||
19548663|NCT01177384|41998067|FG001|Overall Study|Lack of Efficacy|1|||
19548664|NCT01177384|41998066|FG000|Overall Study|Lost to Follow-up|3|||
19548665|NCT01177384|41998067|FG001|Overall Study|Lost to Follow-up|4|||
19548666|NCT01177384|41998066|FG000|Overall Study|Physician Decision|0|||
19548667|NCT01177384|41998067|FG001|Overall Study|Physician Decision|3|||
19548668|NCT01177384|41998066|FG000|Overall Study|Protocol Violation|0|||
19548669|NCT01177384|41998067|FG001|Overall Study|Protocol Violation|2|||
19548670|NCT01177384|41998066|FG000|Overall Study|Withdrawal by Subject|5|||
19548671|NCT01177384|41998067|FG001|Overall Study|Withdrawal by Subject|12|||
19548672|NCT01194154|41998075|FG000|Overall Study|Adverse Event|12|||
19716815|NCT03764072|42159652|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
19716816|NCT03764072|42159653|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
19716817|NCT03764072|42159648|FG000|Overall Study|Lost to Follow-up|0|||
19716818|NCT03764072|42159649|FG001|Overall Study|Lost to Follow-up|0|||
19716819|NCT03764072|42159650|FG002|Overall Study|Lost to Follow-up|0|||
19716820|NCT03764072|42159651|FG003|Overall Study|Lost to Follow-up|0|||
19716821|NCT03764072|42159652|FG004|Overall Study|Lost to Follow-up|1|||
19716822|NCT03764072|42159653|FG005|Overall Study|Lost to Follow-up|0|||
19716823|NCT03333928|42159675|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
19716824|NCT03333928|42159676|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
19716825|NCT03333928|42159677|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
19716826|NCT03333928|42159675|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
19716827|NCT03333928|42159676|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
19716828|NCT03333928|42159677|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
19716829|NCT03333928|42159675|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
19716830|NCT03333928|42159676|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
19716831|NCT03333928|42159677|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
19716832|NCT03333928|42159675|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
19716833|NCT03333928|42159676|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
19716834|NCT03333928|42159677|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
19716835|NCT03333928|42159675|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
19548673|NCT01194154|41998076|FG001|Overall Study|Adverse Event|7|||
19548674|NCT01194154|41998075|FG000|Overall Study|Lost to Follow-up|2|||
19548675|NCT01194154|41998076|FG001|Overall Study|Lost to Follow-up|3|||
19548676|NCT01194154|41998075|FG000|Overall Study|Protocol Violation|0|||
19548677|NCT01194154|41998076|FG001|Overall Study|Protocol Violation|1|||
19548678|NCT01194154|41998075|FG000|Overall Study|Withdrawal by Subject|5|||
19548679|NCT01194154|41998076|FG001|Overall Study|Withdrawal by Subject|6|||
19548680|NCT01194154|41998075|FG000|Overall Study|Blood pressure increase|5|||
19548681|NCT01194154|41998076|FG001|Overall Study|Blood pressure increase|3|||
19548682|NCT01194154|41998075|FG000|Overall Study|Hemoglobin decrease|0|||
19548683|NCT01194154|41998076|FG001|Overall Study|Hemoglobin decrease|1|||
19716836|NCT03333928|42159676|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
19716837|NCT03333928|42159677|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
19716838|NCT03333928|42159675|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
19716839|NCT03333928|42159676|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
19716840|NCT03333928|42159677|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
19716841|NCT03333928|42159675|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
19716842|NCT03333928|42159676|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
19716843|NCT03333928|42159677|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
19716844|NCT03333928|42159675|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
19716845|NCT03333928|42159676|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
19716846|NCT03333928|42159677|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
19716847|NCT02945410|42159699|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19716848|NCT02945410|42159700|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
19716849|NCT02945410|42159701|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19548684|NCT01194154|41998075|FG000|Overall Study|Hemoglobin increase|12|||
19548685|NCT01194154|41998076|FG001|Overall Study|Hemoglobin increase|3|||
19548686|NCT01194154|41998075|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
19548687|NCT01194154|41998076|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
19548688|NCT01194154|41998075|FG000|Overall Study|Treatment with prohibited medication|4|||
19548689|NCT01194154|41998076|FG001|Overall Study|Treatment with prohibited medication|5|||
19548690|NCT01194154|41998075|FG000|Overall Study|Other|4|||
19548691|NCT01194154|41998076|FG001|Overall Study|Other|0|||
19548692|NCT01194154|41998075|FG000|Overall Study|Did not receive study medication|2|||
19548693|NCT01194154|41998076|FG001|Overall Study|Did not receive study medication|4|||
19548694|NCT01193920|41998103|FG000|Overall Study|Withdrawal by Subject|1|||
19548695|NCT01193920|41998104|FG001|Overall Study|Withdrawal by Subject|0|||
19548696|NCT01193920|41998105|FG002|Overall Study|Withdrawal by Subject|5|||
19548697|NCT01193920|41998106|FG003|Overall Study|Withdrawal by Subject|1|||
19548698|NCT01193920|41998107|FG004|Overall Study|Withdrawal by Subject|3|||
19548699|NCT01193920|41998108|FG005|Overall Study|Withdrawal by Subject|1|||
19548700|NCT01193920|41998109|FG006|Overall Study|Withdrawal by Subject|3|||
19548701|NCT01193920|41998110|FG007|Overall Study|Withdrawal by Subject|0|||
19548702|NCT01193920|41998111|FG008|Overall Study|Withdrawal by Subject|1|||
19548703|NCT01193920|41998112|FG009|Overall Study|Withdrawal by Subject|0|||
19548704|NCT01193920|41998103|FG000|Overall Study|Lost to Follow-up|1|||
19548705|NCT01193920|41998104|FG001|Overall Study|Lost to Follow-up|0|||
19548706|NCT01193920|41998105|FG002|Overall Study|Lost to Follow-up|1|||
19548707|NCT01193920|41998106|FG003|Overall Study|Lost to Follow-up|1|||
19548708|NCT01193920|41998107|FG004|Overall Study|Lost to Follow-up|3|||
19548709|NCT01193920|41998108|FG005|Overall Study|Lost to Follow-up|3|||
19548710|NCT01193920|41998109|FG006|Overall Study|Lost to Follow-up|1|||
19548711|NCT01193920|41998110|FG007|Overall Study|Lost to Follow-up|0|||
19548712|NCT01193920|41998111|FG008|Overall Study|Lost to Follow-up|2|||
19548713|NCT01193920|41998112|FG009|Overall Study|Lost to Follow-up|3|||
19548714|NCT01193920|41998103|FG000|Overall Study|Protocol Violation|1|||
19548715|NCT01193920|41998104|FG001|Overall Study|Protocol Violation|0|||
19548716|NCT01193920|41998105|FG002|Overall Study|Protocol Violation|0|||
19548717|NCT01193920|41998106|FG003|Overall Study|Protocol Violation|0|||
19548718|NCT01193920|41998107|FG004|Overall Study|Protocol Violation|0|||
19548719|NCT01193920|41998108|FG005|Overall Study|Protocol Violation|0|||
19548720|NCT01193920|41998109|FG006|Overall Study|Protocol Violation|0|||
19548721|NCT01193920|41998110|FG007|Overall Study|Protocol Violation|0|||
19548722|NCT01193920|41998111|FG008|Overall Study|Protocol Violation|0|||
19548723|NCT01193920|41998112|FG009|Overall Study|Protocol Violation|0|||
19548724|NCT01193920|41998103|FG000|Overall Study|Death|0|||
19548725|NCT01193920|41998104|FG001|Overall Study|Death|0|||
19548726|NCT01193920|41998105|FG002|Overall Study|Death|0|||
19548727|NCT01193920|41998106|FG003|Overall Study|Death|1|||
19548728|NCT01193920|41998107|FG004|Overall Study|Death|0|||
19548729|NCT01193920|41998108|FG005|Overall Study|Death|0|||
19548730|NCT01193920|41998109|FG006|Overall Study|Death|2|||
19548731|NCT01193920|41998110|FG007|Overall Study|Death|3|||
19548732|NCT01193920|41998111|FG008|Overall Study|Death|2|||
19548733|NCT01193920|41998112|FG009|Overall Study|Death|4|||
19548734|NCT01193920|41998103|FG000|Overall Study|Unable to classify|0|||
19548735|NCT01193920|41998104|FG001|Overall Study|Unable to classify|0|||
19548736|NCT01193920|41998105|FG002|Overall Study|Unable to classify|0|||
19548737|NCT01193920|41998106|FG003|Overall Study|Unable to classify|1|||
19548738|NCT01193920|41998107|FG004|Overall Study|Unable to classify|0|||
19548739|NCT01193920|41998108|FG005|Overall Study|Unable to classify|0|||
19548740|NCT01193920|41998109|FG006|Overall Study|Unable to classify|0|||
19548741|NCT01193920|41998110|FG007|Overall Study|Unable to classify|1|||
19548742|NCT01193920|41998111|FG008|Overall Study|Unable to classify|0|||
19548743|NCT01193920|41998112|FG009|Overall Study|Unable to classify|0|||
19548744|NCT01193686|41998137|FG000|Overall Study|Withdrawal by Subject|4|||
19548745|NCT01193686|41998138|FG001|Overall Study|Withdrawal by Subject|1|||
19548746|NCT01193686|41998137|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
19548747|NCT01193686|41998138|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
19548748|NCT01193608|41998151|FG000|Overall Study|Other|0|||
19548749|NCT01193608|41998152|FG001|Overall Study|Other|1|||
19548750|NCT01193608|41998153|FG002|Overall Study|Other|0|||
19548751|NCT01193608|41998154|FG003|Overall Study|Other|0|||
19548752|NCT01193608|41998155|FG004|Overall Study|Other|0|||
19548753|NCT01193608|41998156|FG005|Overall Study|Other|0|||
19548754|NCT01193608|41998151|FG000|Overall Study|Withdrawal by Subject|0|||
19548755|NCT01193608|41998152|FG001|Overall Study|Withdrawal by Subject|1|||
19548756|NCT01193608|41998153|FG002|Overall Study|Withdrawal by Subject|2|||
19548757|NCT01193608|41998154|FG003|Overall Study|Withdrawal by Subject|3|||
19548758|NCT01193608|41998155|FG004|Overall Study|Withdrawal by Subject|3|||
19716850|NCT02945410|42159702|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19548759|NCT01193608|41998156|FG005|Overall Study|Withdrawal by Subject|0|||
19548760|NCT01193608|41998151|FG000|Overall Study|Lost to Follow-up|0|||
19548761|NCT01193608|41998152|FG001|Overall Study|Lost to Follow-up|0|||
19548762|NCT01193608|41998153|FG002|Overall Study|Lost to Follow-up|0|||
19548763|NCT01193608|41998154|FG003|Overall Study|Lost to Follow-up|0|||
19548764|NCT01193608|41998155|FG004|Overall Study|Lost to Follow-up|1|||
19548765|NCT01193608|41998156|FG005|Overall Study|Lost to Follow-up|2|||
19548766|NCT01193608|41998151|FG000|Overall Study|Adverse Event|0|||
19548767|NCT01193608|41998152|FG001|Overall Study|Adverse Event|0|||
19548768|NCT01193608|41998153|FG002|Overall Study|Adverse Event|0|||
19548769|NCT01193608|41998154|FG003|Overall Study|Adverse Event|0|||
19548770|NCT01193608|41998155|FG004|Overall Study|Adverse Event|1|||
19548771|NCT01193608|41998156|FG005|Overall Study|Adverse Event|0|||
19548772|NCT01177228|41998179|FG000|Overall Study|Positive tuberculosis test|0|||
19548773|NCT01177228|41998180|FG001|Overall Study|Positive tuberculosis test|1|||
19548774|NCT01177228|41998181|FG002|Overall Study|Positive tuberculosis test|0|||
19548775|NCT01177228|41998182|FG003|Overall Study|Positive tuberculosis test|0|||
19548776|NCT01177228|41998179|FG000|Overall Study|Worsening disease activity|1|||
19548777|NCT01177228|41998180|FG001|Overall Study|Worsening disease activity|0|||
19548778|NCT01177228|41998181|FG002|Overall Study|Worsening disease activity|0|||
19548779|NCT01177228|41998182|FG003|Overall Study|Worsening disease activity|0|||
19548780|NCT01177228|41998179|FG000|Overall Study|Withdrawal by Subject|0|||
19548781|NCT01177228|41998180|FG001|Overall Study|Withdrawal by Subject|1|||
19548782|NCT01177228|41998181|FG002|Overall Study|Withdrawal by Subject|0|||
19548783|NCT01177228|41998182|FG003|Overall Study|Withdrawal by Subject|0|||
19548784|NCT01193530|41998199|FG000|Overall Study|Withdrawal by Subject|2|||
19548785|NCT01193530|41998200|FG001|Overall Study|Withdrawal by Subject|2|||
19548786|NCT01193530|41998199|FG000|Overall Study|Began Contraindicated Therapy|1|||
19548787|NCT01193530|41998200|FG001|Overall Study|Began Contraindicated Therapy|0|||
19548788|NCT01193530|41998199|FG000|Overall Study|Lost Light Box|0|||
19548789|NCT01193530|41998200|FG001|Overall Study|Lost Light Box|1|||
19548790|NCT01193530|41998199|FG000|Overall Study|Returned home - out of state|0|||
19548791|NCT01193530|41998200|FG001|Overall Study|Returned home - out of state|1|||
19548792|NCT01193530|41998199|FG000|Overall Study|Non-Compliance|0|||
19548793|NCT01193530|41998200|FG001|Overall Study|Non-Compliance|1|||
19548794|NCT00107172|41998208|FG000|Overall Study|Withdrawal by Subject|1|||
19548795|NCT00107172|41998209|FG001|Overall Study|Withdrawal by Subject|0|||
19548796|NCT00107172|41998208|FG000|Overall Study|Death|0|||
19548797|NCT00107172|41998209|FG001|Overall Study|Death|2|||
19548798|NCT00107172|41998208|FG000|Overall Study|Other Reason|4|||
19548799|NCT00107172|41998209|FG001|Overall Study|Other Reason|3|||
19548800|NCT01680965|41998223|FG000|Overall Study|Death|0|||
19548801|NCT01680965|41998224|FG001|Overall Study|Death|0|||
19548802|NCT01680965|41998225|FG002|Overall Study|Death|0|||
19548803|NCT01680965|41998226|FG003|Overall Study|Death|6|||
19548804|NCT01339923|41998241|FG000|Overall Study|Adverse Event|1|||
19548805|NCT01339923|41998242|FG001|Overall Study|Adverse Event|1|||
19548806|NCT01339923|41998243|FG002|Overall Study|Adverse Event|1|||
19548807|NCT01339923|41998244|FG003|Overall Study|Adverse Event|0|||
19548808|NCT01339923|41998245|FG004|Overall Study|Adverse Event|0|||
19548809|NCT01339923|41998246|FG005|Overall Study|Adverse Event|0|||
19548810|NCT01339923|41998247|FG006|Overall Study|Adverse Event|1|||
19548811|NCT01339923|41998241|FG000|Overall Study|Inappropriate Enrollment|1|||
19548812|NCT01339923|41998242|FG001|Overall Study|Inappropriate Enrollment|0|||
19548813|NCT01339923|41998243|FG002|Overall Study|Inappropriate Enrollment|0|||
19548814|NCT01339923|41998244|FG003|Overall Study|Inappropriate Enrollment|0|||
19548815|NCT01339923|41998245|FG004|Overall Study|Inappropriate Enrollment|0|||
19548816|NCT01339923|41998246|FG005|Overall Study|Inappropriate Enrollment|1|||
19548817|NCT01339923|41998247|FG006|Overall Study|Inappropriate Enrollment|0|||
19548818|NCT01339923|41998241|FG000|Overall Study|Lost to Follow-up|4|||
19548819|NCT01339923|41998242|FG001|Overall Study|Lost to Follow-up|4|||
19548820|NCT01339923|41998243|FG002|Overall Study|Lost to Follow-up|0|||
19548821|NCT01339923|41998244|FG003|Overall Study|Lost to Follow-up|3|||
19548822|NCT01339923|41998245|FG004|Overall Study|Lost to Follow-up|1|||
19548823|NCT01339923|41998246|FG005|Overall Study|Lost to Follow-up|1|||
19716851|NCT02945410|42159703|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19716852|NCT02945410|42159704|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
19716853|NCT02945410|42159699|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
19716854|NCT02945410|42159700|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
19716855|NCT02945410|42159701|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
19716856|NCT02945410|42159702|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
19716857|NCT02945410|42159703|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
19716858|NCT02945410|42159704|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
19716859|NCT02945410|42159699|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
19716860|NCT02945410|42159700|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
19716861|NCT02945410|42159701|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
19716862|NCT02945410|42159702|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
19716863|NCT02945410|42159703|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
19716864|NCT02945410|42159704|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
19716865|NCT02945254|42159714|FG000|Overall Study|Lost to Follow-up|1|||
19716866|NCT02945254|42159715|FG001|Overall Study|Lost to Follow-up|0|||
19548824|NCT01339923|41998247|FG006|Overall Study|Lost to Follow-up|5|||
19548825|NCT01339923|41998241|FG000|Overall Study|Protocol Violation|0|||
19548826|NCT01339923|41998242|FG001|Overall Study|Protocol Violation|0|||
19548827|NCT01339923|41998243|FG002|Overall Study|Protocol Violation|0|||
19716867|NCT02945254|42159714|FG000|Overall Study|Withdrawal by Subject|1|||
19716868|NCT02945254|42159715|FG001|Overall Study|Withdrawal by Subject|0|||
19716869|NCT02943070|42159737|FG000|Overall Study|Physician Decision|1|||
19548828|NCT01339923|41998244|FG003|Overall Study|Protocol Violation|0|||
19548829|NCT01339923|41998245|FG004|Overall Study|Protocol Violation|0|||
19548830|NCT01339923|41998246|FG005|Overall Study|Protocol Violation|3|||
19548831|NCT01339923|41998247|FG006|Overall Study|Protocol Violation|1|||
19548832|NCT01339923|41998241|FG000|Overall Study|Unable to Classify|1|||
19548833|NCT01339923|41998242|FG001|Overall Study|Unable to Classify|0|||
19548834|NCT01339923|41998243|FG002|Overall Study|Unable to Classify|1|||
19548835|NCT01339923|41998244|FG003|Overall Study|Unable to Classify|0|||
19548836|NCT01339923|41998245|FG004|Overall Study|Unable to Classify|0|||
19548837|NCT01339923|41998246|FG005|Overall Study|Unable to Classify|1|||
19548838|NCT01339923|41998247|FG006|Overall Study|Unable to Classify|5|||
19548839|NCT01339923|41998241|FG000|Overall Study|Withdrawal by Subject|7|||
19548840|NCT01339923|41998242|FG001|Overall Study|Withdrawal by Subject|11|||
19548841|NCT01339923|41998243|FG002|Overall Study|Withdrawal by Subject|6|||
19548842|NCT01339923|41998244|FG003|Overall Study|Withdrawal by Subject|1|||
19548843|NCT01339923|41998245|FG004|Overall Study|Withdrawal by Subject|4|||
19548844|NCT01339923|41998246|FG005|Overall Study|Withdrawal by Subject|3|||
19548845|NCT01339923|41998247|FG006|Overall Study|Withdrawal by Subject|2|||
19548846|NCT01380093|41998280|FG000|Naloxone Challenge Phase|Screen failures|21|||
19548847|NCT01380093|41998281|FG001|Naloxone Challenge Phase|Screen failures|0|||
19548848|NCT01380093|41998282|FG002|Naloxone Challenge Phase|Screen failures|0|||
19548849|NCT01380093|41998283|FG003|Naloxone Challenge Phase|Screen failures|0|||
19548850|NCT01380093|41998284|FG004|Naloxone Challenge Phase|Screen failures|0|||
19548851|NCT01380093|41998285|FG005|Naloxone Challenge Phase|Screen failures|0|||
19548852|NCT01380093|41998286|FG006|Naloxone Challenge Phase|Screen failures|0|||
19548853|NCT01380093|41998287|FG007|Naloxone Challenge Phase|Screen failures|0|||
19548854|NCT01380093|41998288|FG008|Naloxone Challenge Phase|Screen failures|0|||
19548855|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548856|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
19548857|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548858|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548859|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548860|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548861|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548862|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548863|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
19548864|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548865|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
19548866|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
19548867|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548868|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548869|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548870|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548871|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548872|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
19548873|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548874|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
19548875|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548876|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548877|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548878|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548879|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548880|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548881|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
19548882|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548883|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
19548884|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
19548885|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548886|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548887|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548888|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548889|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548890|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
19548891|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548892|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
19548893|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
19548894|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548895|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548896|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548897|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548898|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548899|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
19548900|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548901|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548902|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
19548903|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548904|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548905|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548906|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548907|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548908|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
19548909|NCT01380093|41998280|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548910|NCT01380093|41998281|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548911|NCT01380093|41998282|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
19548912|NCT01380093|41998283|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548913|NCT01380093|41998284|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548914|NCT01380093|41998285|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548915|NCT01380093|41998286|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548916|NCT01380093|41998287|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548917|NCT01380093|41998288|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
19548918|NCT01380093|41998280|FG000|Treatment Phase: Second Intervention|Other|0|||
19548919|NCT01380093|41998281|FG001|Treatment Phase: Second Intervention|Other|0|||
19548920|NCT01380093|41998282|FG002|Treatment Phase: Second Intervention|Other|0|||
19548921|NCT01380093|41998283|FG003|Treatment Phase: Second Intervention|Other|1|||
19548922|NCT01380093|41998284|FG004|Treatment Phase: Second Intervention|Other|0|||
19548923|NCT01380093|41998285|FG005|Treatment Phase: Second Intervention|Other|0|||
19548924|NCT01380093|41998286|FG006|Treatment Phase: Second Intervention|Other|0|||
19548925|NCT01380093|41998287|FG007|Treatment Phase: Second Intervention|Other|0|||
19548926|NCT01380093|41998288|FG008|Treatment Phase: Second Intervention|Other|0|||
19548927|NCT01380093|41998280|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
19548928|NCT01380093|41998281|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
19548929|NCT01380093|41998282|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
19548930|NCT01380093|41998283|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
19548931|NCT01380093|41998284|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
19548932|NCT01380093|41998285|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
19548933|NCT01380093|41998286|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
19548934|NCT01380093|41998287|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
19548935|NCT01380093|41998288|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
19548936|NCT01380093|41998280|FG000|Treatment Phase: Third Intervention|Other|0|||
19548937|NCT01380093|41998281|FG001|Treatment Phase: Third Intervention|Other|0|||
19548938|NCT01380093|41998282|FG002|Treatment Phase: Third Intervention|Other|0|||
19548939|NCT01380093|41998283|FG003|Treatment Phase: Third Intervention|Other|0|||
19548940|NCT01380093|41998284|FG004|Treatment Phase: Third Intervention|Other|0|||
19548941|NCT01380093|41998285|FG005|Treatment Phase: Third Intervention|Other|0|||
19548942|NCT01380093|41998286|FG006|Treatment Phase: Third Intervention|Other|0|||
19548943|NCT01380093|41998287|FG007|Treatment Phase: Third Intervention|Other|0|||
19548944|NCT01380093|41998288|FG008|Treatment Phase: Third Intervention|Other|1|||
19548945|NCT01379937|41998306|FG000|Overall Study|Protocol Violation|0|||
19548946|NCT01379937|41998307|FG001|Overall Study|Protocol Violation|0|||
19548947|NCT01379937|41998308|FG002|Overall Study|Protocol Violation|0|||
19548948|NCT01379937|41998309|FG003|Overall Study|Protocol Violation|1|||
19548949|NCT01379937|41998306|FG000|Overall Study|Consent withdrawal|0|||
19548950|NCT01379937|41998307|FG001|Overall Study|Consent withdrawal|1|||
19548951|NCT01379937|41998308|FG002|Overall Study|Consent withdrawal|0|||
19548952|NCT01379937|41998309|FG003|Overall Study|Consent withdrawal|0|||
19548953|NCT01379937|41998306|FG000|Overall Study|Lost to Follow-up|1|||
19548954|NCT01379937|41998307|FG001|Overall Study|Lost to Follow-up|2|||
19548955|NCT01379937|41998308|FG002|Overall Study|Lost to Follow-up|2|||
19548956|NCT01379937|41998309|FG003|Overall Study|Lost to Follow-up|0|||
19548957|NCT01379781|41998335|FG000|Overall Study|Lost to Follow-up|11|||
19548958|NCT01379781|41998336|FG001|Overall Study|Lost to Follow-up|8|||
19548959|NCT01379703|41998342|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
19548960|NCT01379703|41998343|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
19548961|NCT01379703|41998344|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
19548962|NCT01379703|41998342|FG000|Study Start Through 9 Months|Adverse Event|0|||
19548963|NCT01379703|41998343|FG001|Study Start Through 9 Months|Adverse Event|14|||
19548964|NCT01379703|41998344|FG002|Study Start Through 9 Months|Adverse Event|10|||
19548965|NCT01379703|41998342|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
19548966|NCT01379703|41998343|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
19548967|NCT01379703|41998344|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
19548968|NCT01379703|41998342|FG000|Study Start Through 9 Months|Treatment Failure|0|||
19548969|NCT01379703|41998343|FG001|Study Start Through 9 Months|Treatment Failure|2|||
19548970|NCT01379703|41998344|FG002|Study Start Through 9 Months|Treatment Failure|2|||
19548971|NCT01379703|41998342|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
19548972|NCT01379703|41998343|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
19548973|NCT01379703|41998344|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
19548974|NCT01379703|41998342|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
19548975|NCT01379703|41998343|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
19548976|NCT01379703|41998344|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
19548977|NCT01379703|41998342|FG000|Study Start Through 9 Months|Medication not available|0|||
19548978|NCT01379703|41998343|FG001|Study Start Through 9 Months|Medication not available|2|||
19548979|NCT01379703|41998344|FG002|Study Start Through 9 Months|Medication not available|1|||
19548980|NCT01379703|41998342|FG000|Study Start Through 9 Months|Poor general condition|0|||
19548981|NCT01379703|41998343|FG001|Study Start Through 9 Months|Poor general condition|1|||
19548982|NCT01379703|41998344|FG002|Study Start Through 9 Months|Poor general condition|0|||
19548983|NCT01379703|41998342|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
19548984|NCT01379703|41998343|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
19548985|NCT01379703|41998344|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
19548986|NCT01379703|41998342|FG000|Study Start Through 9 Months|Reason unknown|2|||
19548987|NCT01379703|41998343|FG001|Study Start Through 9 Months|Reason unknown|31|||
19548988|NCT01379703|41998344|FG002|Study Start Through 9 Months|Reason unknown|24|||
19548989|NCT01379703|41998342|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
19548990|NCT01379703|41998343|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
19548991|NCT01379703|41998344|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
19548992|NCT01379703|41998342|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
19716870|NCT02943070|42159737|FG000|Overall Study|Adverse Event|2|||
19716871|NCT02943070|42159737|FG000|Overall Study|Death|2|||
19716872|NCT02943070|42159737|FG000|Overall Study|Withdrawal by Subject|3|||
19716873|NCT02943070|42159737|FG000|Overall Study|Lost to Follow-up|4|||
19716874|NCT02943070|42159737|FG000|Overall Study|Retreatment or TURP|13|||
19716875|NCT02943070|42159737|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
19716876|NCT03332212|42159761|FG000|Overall Study|Not treated|0|||
19716877|NCT03332212|42159762|FG001|Overall Study|Not treated|1|||
19716878|NCT03332212|42159763|FG002|Overall Study|Not treated|0|||
19716879|NCT03332212|42159764|FG003|Overall Study|Not treated|0|||
19716880|NCT03332212|42159761|FG000|Overall Study|Adverse Event|0|||
19716881|NCT03332212|42159762|FG001|Overall Study|Adverse Event|0|||
19716882|NCT03332212|42159763|FG002|Overall Study|Adverse Event|0|||
19716883|NCT03332212|42159764|FG003|Overall Study|Adverse Event|1|||
19716884|NCT03332212|42159761|FG000|Overall Study|worsening of disease under study|1|||
19716885|NCT03332212|42159762|FG001|Overall Study|worsening of disease under study|1|||
19716886|NCT03332212|42159763|FG002|Overall Study|worsening of disease under study|0|||
19716887|NCT03332212|42159764|FG003|Overall Study|worsening of disease under study|0|||
19716888|NCT03331666|42159774|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
19716889|NCT03331666|42159775|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
19716890|NCT03331042|42159785|FG000|Overall Study|Protocol Violation|1|||
19716891|NCT03331042|42159786|FG001|Overall Study|Protocol Violation|0|||
19716892|NCT03331042|42159787|FG002|Overall Study|Protocol Violation|0|||
19716893|NCT03331042|42159788|FG003|Overall Study|Protocol Violation|0|||
19716894|NCT03331042|42159785|FG000|Overall Study|Physician Decision|0|||
19716895|NCT03331042|42159786|FG001|Overall Study|Physician Decision|0|||
19716896|NCT03331042|42159787|FG002|Overall Study|Physician Decision|1|||
19716897|NCT03331042|42159788|FG003|Overall Study|Physician Decision|0|||
19716898|NCT03331042|42159785|FG000|Overall Study|Lost to Follow-up|0|||
19716899|NCT03331042|42159786|FG001|Overall Study|Lost to Follow-up|0|||
19716900|NCT03331042|42159787|FG002|Overall Study|Lost to Follow-up|0|||
19716901|NCT03331042|42159788|FG003|Overall Study|Lost to Follow-up|1|||
19716902|NCT03762668|42159806|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
19716903|NCT03762668|42159807|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
19716904|NCT03762200|42159813|FG000|Overall Study|Death|2|||
19716905|NCT03329404|42159819|FG000|Overall Study|The study was suspended.|1|||
19716906|NCT03329404|42159820|FG001|Overall Study|The study was suspended.|4|||
19716907|NCT03478930|42159828|FG000|Overall Study|Adverse Event|0|||
19716908|NCT03478930|42159829|FG001|Overall Study|Adverse Event|1|||
19716909|NCT03478930|42159828|FG000|Overall Study|Lack of Efficacy|3|||
19716910|NCT03478930|42159829|FG001|Overall Study|Lack of Efficacy|3|||
19716911|NCT03478930|42159828|FG000|Overall Study|Withdrawal by Subject|6|||
19716912|NCT03478930|42159829|FG001|Overall Study|Withdrawal by Subject|5|||
19716913|NCT03038438|42159835|FG000|Overall Study|Death|3|||
19716914|NCT03038438|42159835|FG000|Overall Study|Lost to Follow-up|8|||
19716915|NCT03038438|42159835|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
19716916|NCT03038438|42159835|FG000|Overall Study|Withdrawal by Subject|5|||
19716917|NCT03038438|42159835|FG000|Overall Study|No 36-Month Follow-Up|18|||
19548993|NCT01379703|41998343|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
19548994|NCT01379703|41998344|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
19548995|NCT01379703|41998342|FG000|9 Months Through 18 Months|Adverse Event|0|||
19548996|NCT01379703|41998343|FG001|9 Months Through 18 Months|Adverse Event|6|||
19548997|NCT01379703|41998344|FG002|9 Months Through 18 Months|Adverse Event|0|||
19548998|NCT01379703|41998342|FG000|9 Months Through 18 Months|Treatment failure|0|||
19548999|NCT01379703|41998343|FG001|9 Months Through 18 Months|Treatment failure|5|||
19549000|NCT01379703|41998344|FG002|9 Months Through 18 Months|Treatment failure|0|||
19549001|NCT01379703|41998342|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
19549002|NCT01379703|41998343|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
19549003|NCT01379703|41998344|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
19549004|NCT01379703|41998342|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
19549005|NCT01379703|41998343|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
19549006|NCT01379703|41998344|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
19549007|NCT01379703|41998342|FG000|9 Months Through 18 Months|Fatigue|0|||
19549008|NCT01379703|41998343|FG001|9 Months Through 18 Months|Fatigue|1|||
19549009|NCT01379703|41998344|FG002|9 Months Through 18 Months|Fatigue|0|||
19549010|NCT01379703|41998342|FG000|9 Months Through 18 Months|Reason Unknown|0|||
19549011|NCT01379703|41998343|FG001|9 Months Through 18 Months|Reason Unknown|23|||
19549012|NCT01379703|41998344|FG002|9 Months Through 18 Months|Reason Unknown|0|||
19549013|NCT01335477|41998355|FG000|Overall Study|Adverse Event|30|||
19549014|NCT01335477|41998356|FG001|Overall Study|Adverse Event|42|||
19549015|NCT01335477|41998355|FG000|Overall Study|Non compliant with protocol|0|||
19549016|NCT01335477|41998356|FG001|Overall Study|Non compliant with protocol|2|||
19549017|NCT01335477|41998355|FG000|Overall Study|Lost to Follow-up|1|||
19549018|NCT01335477|41998356|FG001|Overall Study|Lost to Follow-up|2|||
19549019|NCT01335477|41998355|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
19549020|NCT01335477|41998356|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
19549021|NCT01335477|41998355|FG000|Overall Study|Not treated|1|||
19549022|NCT01335477|41998356|FG001|Overall Study|Not treated|2|||
19549023|NCT01335477|41998355|FG000|Overall Study|Reason other than those stated above|2|||
19549024|NCT01335477|41998356|FG001|Overall Study|Reason other than those stated above|2|||
19549025|NCT01371825|41998362|FG000|Overall Study|Death|4|||
19549026|NCT01371747|41998372|FG000|Overall Study|Adverse Event|4|||
19549027|NCT01371747|41998373|FG001|Overall Study|Adverse Event|2|||
19549028|NCT01371747|41998374|FG002|Overall Study|Adverse Event|7|||
19549029|NCT01371747|41998375|FG003|Overall Study|Adverse Event|2|||
19549030|NCT01371747|41998376|FG004|Overall Study|Adverse Event|2|||
19549031|NCT01371747|41998377|FG005|Overall Study|Adverse Event|2|||
19549032|NCT01371747|41998372|FG000|Overall Study|Death|1|||
19549033|NCT01371747|41998373|FG001|Overall Study|Death|0|||
19549034|NCT01371747|41998374|FG002|Overall Study|Death|4|||
19549035|NCT01371747|41998375|FG003|Overall Study|Death|1|||
19549036|NCT01371747|41998376|FG004|Overall Study|Death|2|||
19549037|NCT01371747|41998377|FG005|Overall Study|Death|0|||
19549038|NCT01371747|41998372|FG000|Overall Study|Abnormal Renal Function|0|||
19549039|NCT01371747|41998373|FG001|Overall Study|Abnormal Renal Function|2|||
19549040|NCT01371747|41998374|FG002|Overall Study|Abnormal Renal Function|0|||
19549041|NCT01371747|41998375|FG003|Overall Study|Abnormal Renal Function|1|||
19549042|NCT01371747|41998376|FG004|Overall Study|Abnormal Renal Function|0|||
19549043|NCT01371747|41998377|FG005|Overall Study|Abnormal Renal Function|1|||
19549044|NCT01371747|41998372|FG000|Overall Study|High Serum Potassium Results|1|||
19549045|NCT01371747|41998373|FG001|Overall Study|High Serum Potassium Results|1|||
19549046|NCT01371747|41998374|FG002|Overall Study|High Serum Potassium Results|1|||
19549047|NCT01371747|41998375|FG003|Overall Study|High Serum Potassium Results|2|||
19549048|NCT01371747|41998376|FG004|Overall Study|High Serum Potassium Results|0|||
19549049|NCT01371747|41998377|FG005|Overall Study|High Serum Potassium Results|2|||
19549050|NCT01371747|41998372|FG000|Overall Study|Low Serum Potassium Results|1|||
19549051|NCT01371747|41998373|FG001|Overall Study|Low Serum Potassium Results|1|||
19549052|NCT01371747|41998374|FG002|Overall Study|Low Serum Potassium Results|1|||
19549053|NCT01371747|41998375|FG003|Overall Study|Low Serum Potassium Results|1|||
19549054|NCT01371747|41998376|FG004|Overall Study|Low Serum Potassium Results|0|||
19549055|NCT01371747|41998377|FG005|Overall Study|Low Serum Potassium Results|3|||
19549056|NCT01371747|41998372|FG000|Overall Study|Protocol Violation|0|||
19549057|NCT01371747|41998373|FG001|Overall Study|Protocol Violation|0|||
19549058|NCT01371747|41998374|FG002|Overall Study|Protocol Violation|1|||
19549059|NCT01371747|41998375|FG003|Overall Study|Protocol Violation|0|||
19549060|NCT01371747|41998376|FG004|Overall Study|Protocol Violation|0|||
19549061|NCT01371747|41998377|FG005|Overall Study|Protocol Violation|0|||
19549062|NCT01371747|41998372|FG000|Overall Study|Non-Compliance|3|||
19549063|NCT01371747|41998373|FG001|Overall Study|Non-Compliance|4|||
19549064|NCT01371747|41998374|FG002|Overall Study|Non-Compliance|3|||
19549065|NCT01371747|41998375|FG003|Overall Study|Non-Compliance|0|||
19549066|NCT01371747|41998376|FG004|Overall Study|Non-Compliance|0|||
19549067|NCT01371747|41998377|FG005|Overall Study|Non-Compliance|1|||
19549068|NCT01371747|41998372|FG000|Overall Study|Physician Decision|0|||
19549069|NCT01371747|41998373|FG001|Overall Study|Physician Decision|0|||
19549070|NCT01371747|41998374|FG002|Overall Study|Physician Decision|0|||
19549071|NCT01371747|41998375|FG003|Overall Study|Physician Decision|0|||
19549072|NCT01371747|41998376|FG004|Overall Study|Physician Decision|1|||
19549073|NCT01371747|41998377|FG005|Overall Study|Physician Decision|0|||
19549074|NCT01371747|41998372|FG000|Overall Study|Withdrawal by Subject|6|||
19549075|NCT01371747|41998373|FG001|Overall Study|Withdrawal by Subject|12|||
19549076|NCT01371747|41998374|FG002|Overall Study|Withdrawal by Subject|5|||
19549077|NCT01371747|41998375|FG003|Overall Study|Withdrawal by Subject|2|||
19549078|NCT01371747|41998376|FG004|Overall Study|Withdrawal by Subject|2|||
19549079|NCT01371747|41998377|FG005|Overall Study|Withdrawal by Subject|4|||
19549080|NCT01371747|41998372|FG000|Overall Study|Other Reasons|2|||
19549081|NCT01371747|41998373|FG001|Overall Study|Other Reasons|1|||
19549082|NCT01371747|41998374|FG002|Overall Study|Other Reasons|2|||
19549083|NCT01371747|41998375|FG003|Overall Study|Other Reasons|0|||
19549084|NCT01371747|41998376|FG004|Overall Study|Other Reasons|0|||
19549085|NCT01371747|41998377|FG005|Overall Study|Other Reasons|1|||
19549086|NCT01371708|41998412|FG000|Overall Study|Insufficient clinical response|3|||
19549087|NCT01371708|41998413|FG001|Overall Study|Insufficient clinical response|2|||
19716918|NCT03523000|42159839|FG000|Overall Study|Withdrawal by Subject|3|||
19716919|NCT03523000|42159840|FG001|Overall Study|Withdrawal by Subject|0|||
19716920|NCT03523000|42159839|FG000|Overall Study|Unsuccessful trial|2|||
19716921|NCT03523000|42159840|FG001|Overall Study|Unsuccessful trial|0|||
19716922|NCT03327220|42159851|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
19716923|NCT03327220|42159852|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
19716924|NCT03327220|42159851|FG000|Overall Study|Investigator Decision|2|||
19716925|NCT03327220|42159852|FG001|Overall Study|Investigator Decision|0|||
19716926|NCT03327220|42159851|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
19716927|NCT03327220|42159852|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
19716928|NCT03327220|42159851|FG000|Overall Study|Fungal infection|1|||
19716929|NCT03327220|42159852|FG001|Overall Study|Fungal infection|0|||
19716930|NCT03327220|42159851|FG000|Overall Study|Discharged to Rehabilitation|0|||
19716931|NCT03327220|42159852|FG001|Overall Study|Discharged to Rehabilitation|1|||
19716932|NCT03327220|42159851|FG000|Overall Study|Missing|1|||
19716933|NCT03327220|42159852|FG001|Overall Study|Missing|0|||
19716934|NCT00318149|42159864|FG000|Overall Study|Adverse Event|0|||
19716935|NCT00318149|42159865|FG001|Overall Study|Adverse Event|0|||
19716936|NCT00318149|42159866|FG002|Overall Study|Adverse Event|0|||
19716937|NCT00318149|42159867|FG003|Overall Study|Adverse Event|0|||
19716938|NCT00318149|42159868|FG004|Overall Study|Adverse Event|0|||
19716939|NCT00318149|42159869|FG005|Overall Study|Adverse Event|2|||
19716940|NCT00317603|42159885|FG000|Overall Study|Progressive Disease|3|||
19716941|NCT03326518|42159892|FG000|Overall Study|Protocol Violation|1|||
19716942|NCT03326518|42159893|FG001|Overall Study|Protocol Violation|0|||
19716943|NCT03326518|42159894|FG002|Overall Study|Protocol Violation|0|||
19716944|NCT03326518|42159892|FG000|Overall Study|Withdrawal by Subject|1|||
19716945|NCT03326518|42159893|FG001|Overall Study|Withdrawal by Subject|0|||
19716946|NCT03326518|42159894|FG002|Overall Study|Withdrawal by Subject|0|||
19716947|NCT03326518|42159892|FG000|Overall Study|Lost to Follow-up|1|||
19716948|NCT03326518|42159893|FG001|Overall Study|Lost to Follow-up|0|||
19716949|NCT03326518|42159894|FG002|Overall Study|Lost to Follow-up|1|||
19716950|NCT00317369|42159905|FG000|Overall Study|Adverse Event|2|||
19716951|NCT00317369|42159906|FG001|Overall Study|Adverse Event|1|||
19716952|NCT00317369|42159907|FG002|Overall Study|Adverse Event|0|||
19716953|NCT00317369|42159905|FG000|Overall Study|Lack of Efficacy|0|||
19716954|NCT00317369|42159906|FG001|Overall Study|Lack of Efficacy|1|||
19716955|NCT00317369|42159907|FG002|Overall Study|Lack of Efficacy|1|||
19716956|NCT00317369|42159905|FG000|Overall Study|Withdrawal by Subject|0|||
19716957|NCT00317369|42159906|FG001|Overall Study|Withdrawal by Subject|0|||
19716958|NCT00317369|42159907|FG002|Overall Study|Withdrawal by Subject|1|||
19716959|NCT03325894|42159917|FG000|Overall Study|Adverse Event|2|||
19716960|NCT03325894|42159918|FG001|Overall Study|Adverse Event|3|||
19716961|NCT03325894|42159917|FG000|Overall Study|Protocol Violation|1|||
19716962|NCT03325894|42159918|FG001|Overall Study|Protocol Violation|2|||
19549088|NCT01371708|41998414|FG002|Overall Study|Insufficient clinical response|0|||
19716963|NCT03325894|42159917|FG000|Overall Study|Withdrawal by Subject|10|||
19716964|NCT03325894|42159918|FG001|Overall Study|Withdrawal by Subject|6|||
19716965|NCT03325894|42159917|FG000|Overall Study|Lost to Follow-up|4|||
19716966|NCT03325894|42159918|FG001|Overall Study|Lost to Follow-up|9|||
19716967|NCT03325894|42159917|FG000|Overall Study|Lack of Efficacy|8|||
19716968|NCT03325894|42159918|FG001|Overall Study|Lack of Efficacy|14|||
19549089|NCT01371708|41998412|FG000|Overall Study|Lost to Follow-up|5|||
19716969|NCT03325894|42159917|FG000|Overall Study|Study Terminated by Sponsor|38|||
19716970|NCT03325894|42159918|FG001|Overall Study|Study Terminated by Sponsor|43|||
19549090|NCT01371708|41998413|FG001|Overall Study|Lost to Follow-up|9|||
19549091|NCT01371708|41998414|FG002|Overall Study|Lost to Follow-up|7|||
19549092|NCT01371708|41998412|FG000|Overall Study|Protocol Violation|2|||
19549093|NCT01371708|41998413|FG001|Overall Study|Protocol Violation|1|||
19549094|NCT01371708|41998414|FG002|Overall Study|Protocol Violation|2|||
19549095|NCT01371708|41998412|FG000|Overall Study|No longer willing to participate|7|||
19549096|NCT01371708|41998413|FG001|Overall Study|No longer willing to participate|7|||
19549097|NCT01371708|41998414|FG002|Overall Study|No longer willing to participate|13|||
19549098|NCT01371708|41998412|FG000|Overall Study|Medication error/not related to AE|0|||
19549099|NCT01371708|41998413|FG001|Overall Study|Medication error/not related to AE|1|||
19549100|NCT01371708|41998414|FG002|Overall Study|Medication error/not related to AE|0|||
19549101|NCT01371708|41998412|FG000|Overall Study|Other|3|||
19549102|NCT01371708|41998413|FG001|Overall Study|Other|2|||
19549103|NCT01371708|41998414|FG002|Overall Study|Other|4|||
19549104|NCT01371708|41998412|FG000|Overall Study|Adverse Event|5|||
19549105|NCT01371708|41998413|FG001|Overall Study|Adverse Event|8|||
19549106|NCT01371708|41998414|FG002|Overall Study|Adverse Event|12|||
19549107|NCT01371708|41998412|FG000|Overall Study|Started but did not receive treatment|1|||
19549108|NCT01371708|41998413|FG001|Overall Study|Started but did not receive treatment|0|||
19549109|NCT01371708|41998414|FG002|Overall Study|Started but did not receive treatment|1|||
19549110|NCT01335399|41998426|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
19549111|NCT01335399|41998427|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
19549112|NCT01335399|41998426|FG000|Pre-treatment Period|Participant request to discontinue|0|||
19549113|NCT01335399|41998427|FG001|Pre-treatment Period|Participant request to discontinue|1|||
19549114|NCT01335399|41998426|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
19549115|NCT01335399|41998427|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
19549116|NCT01335399|41998426|FG000|Pre-treatment Period|Consent withdrawal|3|||
19549117|NCT01335399|41998427|FG001|Pre-treatment Period|Consent withdrawal|0|||
19549118|NCT01335399|41998426|FG000|Treatment Period|Disease progression|117|||
19549119|NCT01335399|41998427|FG001|Treatment Period|Disease progression|145|||
19549120|NCT01335399|41998426|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
19549121|NCT01335399|41998427|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
19549122|NCT01335399|41998426|FG000|Treatment Period|Study drug toxicity|52|||
19549123|NCT01335399|41998427|FG001|Treatment Period|Study drug toxicity|64|||
19549124|NCT01335399|41998426|FG000|Treatment Period|Participant request to discontinue|30|||
19549125|NCT01335399|41998427|FG001|Treatment Period|Participant request to discontinue|22|||
19549126|NCT01335399|41998426|FG000|Treatment Period|Other reasons|30|||
19549127|NCT01335399|41998427|FG001|Treatment Period|Other reasons|30|||
19549128|NCT01335399|41998426|FG000|Treatment Period|Consent withdrawal|10|||
19549129|NCT01335399|41998427|FG001|Treatment Period|Consent withdrawal|7|||
19549130|NCT01335399|41998426|FG000|Treatment Period|Death|7|||
19549131|NCT01335399|41998427|FG001|Treatment Period|Death|6|||
19549132|NCT01335399|41998426|FG000|Treatment Period|Poor/Non-compliance|3|||
19549133|NCT01335399|41998427|FG001|Treatment Period|Poor/Non-compliance|4|||
19549134|NCT01335399|41998426|FG000|Treatment Period|Lost to Follow-up|2|||
19549135|NCT01335399|41998427|FG001|Treatment Period|Lost to Follow-up|2|||
19549136|NCT01335399|41998426|FG000|Treatment Period|Maximum clinical benefit|1|||
19549137|NCT01335399|41998427|FG001|Treatment Period|Maximum clinical benefit|1|||
19549138|NCT01335399|41998426|FG000|Treatment Period|No longer meet study criteria|1|||
19549139|NCT01335399|41998427|FG001|Treatment Period|No longer meet study criteria|1|||
19549140|NCT01335399|41998426|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
19549141|NCT01335399|41998427|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
19549142|NCT01366521|41998437|FG000|Overall Study|Adverse Event|1|||
19549143|NCT01366521|41998438|FG001|Overall Study|Adverse Event|0|||
19549144|NCT01366521|41998439|FG002|Overall Study|Adverse Event|0|||
19549145|NCT01366521|41998440|FG003|Overall Study|Adverse Event|0|||
19549146|NCT01366521|41998437|FG000|Overall Study|Protocol Violation|0|||
19549147|NCT01366521|41998438|FG001|Overall Study|Protocol Violation|0|||
19549148|NCT01366521|41998439|FG002|Overall Study|Protocol Violation|1|||
19549149|NCT01366521|41998440|FG003|Overall Study|Protocol Violation|0|||
19549150|NCT01366521|41998437|FG000|Overall Study|Physician Decision|0|||
19549151|NCT01366521|41998438|FG001|Overall Study|Physician Decision|0|||
19549152|NCT01366521|41998439|FG002|Overall Study|Physician Decision|1|||
19549153|NCT01366521|41998440|FG003|Overall Study|Physician Decision|0|||
19716971|NCT03325894|42159917|FG000|Overall Study|Other (Not received Treatment)|1|||
19716972|NCT03325894|42159918|FG001|Overall Study|Other (Not received Treatment)|0|||
19716973|NCT01239368|42159937|FG000|Overall Study|Principal investigator discretion|1|||
19716974|NCT01239368|42159938|FG001|Overall Study|Principal investigator discretion|0|||
19716975|NCT01239368|42159939|FG002|Overall Study|Principal investigator discretion|0|||
19716976|NCT01239368|42159940|FG003|Overall Study|Principal investigator discretion|0|||
19716977|NCT01239368|42159941|FG004|Overall Study|Principal investigator discretion|1|||
19716978|NCT01239368|42159942|FG005|Overall Study|Principal investigator discretion|2|||
19716979|NCT01239368|42159943|FG006|Overall Study|Principal investigator discretion|0|||
19716980|NCT01239368|42159944|FG007|Overall Study|Principal investigator discretion|0|||
19716981|NCT01239368|42159945|FG008|Overall Study|Principal investigator discretion|0|||
19716982|NCT01239368|42159946|FG009|Overall Study|Principal investigator discretion|1|||
19716983|NCT01239368|42159937|FG000|Overall Study|Disease progression on study|1|||
19549154|NCT01366521|41998437|FG000|Overall Study|Withdrawal by Subject|0|||
19549155|NCT01366521|41998438|FG001|Overall Study|Withdrawal by Subject|1|||
19549156|NCT01366521|41998439|FG002|Overall Study|Withdrawal by Subject|0|||
19549157|NCT01366521|41998440|FG003|Overall Study|Withdrawal by Subject|0|||
19549158|NCT01335009|41998454|FG000|Overall Study|Too ill to travel to study sites|1|||
19549159|NCT01335009|41998455|FG001|Overall Study|Too ill to travel to study sites|0|||
19549160|NCT01335009|41998454|FG000|Overall Study|Death|28|||
19549161|NCT01335009|41998455|FG001|Overall Study|Death|32|||
19549162|NCT01335009|41998454|FG000|Overall Study|Withdrawal by Subject|1|||
19549163|NCT01335009|41998455|FG001|Overall Study|Withdrawal by Subject|1|||
19549164|NCT01335009|41998454|FG000|Overall Study|Lost to Follow-up|1|||
19549165|NCT01335009|41998455|FG001|Overall Study|Lost to Follow-up|0|||
19549166|NCT01366443|41998470|FG000|Overall Study|Lost to Follow-up|2|||
19549167|NCT01366443|41998470|FG000|Overall Study|Under 18 yo|1|||
19549168|NCT01332630|41998475|FG000|Overall Study|Withdrawal by Subject|3|||
19549169|NCT01366209|41998481|FG000|Overall Study|Adverse Event|6|||
19549170|NCT01366209|41998482|FG001|Overall Study|Adverse Event|7|||
19549171|NCT01366209|41998481|FG000|Overall Study|Withdrawal by Subject|4|||
19549172|NCT01366209|41998482|FG001|Overall Study|Withdrawal by Subject|4|||
19549173|NCT01366209|41998481|FG000|Overall Study|Death|12|||
19549174|NCT01366209|41998482|FG001|Overall Study|Death|19|||
19549175|NCT01366209|41998481|FG000|Overall Study|Lung transplantation|6|||
19549176|NCT01366209|41998482|FG001|Overall Study|Lung transplantation|1|||
19549177|NCT01366209|41998481|FG000|Overall Study|Lost to Follow-up|2|||
19549178|NCT01366209|41998482|FG001|Overall Study|Lost to Follow-up|1|||
19549179|NCT01366209|41998481|FG000|Overall Study|Physician Decision|1|||
19549180|NCT01366209|41998482|FG001|Overall Study|Physician Decision|0|||
19549181|NCT01366209|41998481|FG000|Overall Study|Sponsors decision|0|||
19549182|NCT01366209|41998482|FG001|Overall Study|Sponsors decision|1|||
19549183|NCT01366209|41998481|FG000|Overall Study|Withdrew consent|4|||
19549184|NCT01366209|41998482|FG001|Overall Study|Withdrew consent|3|||
19549185|NCT01365546|41998488|FG000|Overall Study|Withdrawal by Subject|1|||
19549186|NCT01365546|41998488|FG000|Overall Study|Screen failure|9|||
19549187|NCT01365546|41998488|FG000|Overall Study|Study termination|1|||
19549188|NCT01365507|41998498|FG000|Overall Study|Withdrawal Criteria|8|||
19549189|NCT01365507|41998499|FG001|Overall Study|Withdrawal Criteria|5|||
19549190|NCT01365507|41998498|FG000|Overall Study|Unclassified|1|||
19549191|NCT01365507|41998499|FG001|Overall Study|Unclassified|4|||
19549192|NCT01365468|41998523|FG000|Overall Study|Physician Decision|1|||
19549193|NCT01365468|41998524|FG001|Overall Study|Physician Decision|0|||
19549194|NCT01365468|41998523|FG000|Overall Study|Disease progression|1|||
19549195|NCT01365468|41998524|FG001|Overall Study|Disease progression|0|||
19549196|NCT01365468|41998523|FG000|Overall Study|Lost to Follow-up|2|||
19549197|NCT01365468|41998524|FG001|Overall Study|Lost to Follow-up|0|||
19549198|NCT01357980|41998535|FG000|Overall Study|Lack of Efficacy|0|||
19549199|NCT01357980|41998536|FG001|Overall Study|Lack of Efficacy|1|||
19549200|NCT01357980|41998537|FG002|Overall Study|Lack of Efficacy|0|||
19549201|NCT01357980|41998538|FG003|Overall Study|Lack of Efficacy|0|||
19549202|NCT01357980|41998535|FG000|Overall Study|Consent withdrawn|0|||
19549203|NCT01357980|41998536|FG001|Overall Study|Consent withdrawn|0|||
19549204|NCT01357980|41998537|FG002|Overall Study|Consent withdrawn|1|||
19549205|NCT01357980|41998538|FG003|Overall Study|Consent withdrawn|0|||
19549206|NCT01332318|41998552|FG000|Overall Study|Adverse Event|0|||
19549207|NCT01332318|41998553|FG001|Overall Study|Adverse Event|3|||
19549208|NCT01332318|41998554|FG002|Overall Study|Adverse Event|0|||
19549209|NCT01332318|41998555|FG003|Overall Study|Adverse Event|0|||
19549210|NCT01332318|41998552|FG000|Overall Study|Withdrawal by Subject|1|||
19549211|NCT01332318|41998553|FG001|Overall Study|Withdrawal by Subject|1|||
19549212|NCT01332318|41998554|FG002|Overall Study|Withdrawal by Subject|0|||
19549213|NCT01332318|41998555|FG003|Overall Study|Withdrawal by Subject|1|||
19549214|NCT01332318|41998552|FG000|Overall Study|Protocol Violation|1|||
19549215|NCT01332318|41998553|FG001|Overall Study|Protocol Violation|0|||
19549216|NCT01332318|41998554|FG002|Overall Study|Protocol Violation|1|||
19549217|NCT01332318|41998555|FG003|Overall Study|Protocol Violation|1|||
19549218|NCT01331109|41998570|FG000|Overall Study|Adverse Event|6|||
19716984|NCT01239368|42159938|FG001|Overall Study|Disease progression on study|1|||
19716985|NCT01239368|42159939|FG002|Overall Study|Disease progression on study|1|||
19716986|NCT01239368|42159940|FG003|Overall Study|Disease progression on study|1|||
19716987|NCT01239368|42159941|FG004|Overall Study|Disease progression on study|4|||
19716988|NCT01239368|42159942|FG005|Overall Study|Disease progression on study|2|||
19716989|NCT01239368|42159943|FG006|Overall Study|Disease progression on study|5|||
19716990|NCT01239368|42159944|FG007|Overall Study|Disease progression on study|0|||
19716991|NCT01239368|42159945|FG008|Overall Study|Disease progression on study|0|||
19716992|NCT01239368|42159946|FG009|Overall Study|Disease progression on study|2|||
19549219|NCT01331109|41998570|FG000|Overall Study|Lack of Efficacy|2|||
19549220|NCT01331109|41998570|FG000|Overall Study|Protocol Violation|3|||
19549221|NCT01331109|41998570|FG000|Overall Study|Withdrawal by Subject|7|||
19549222|NCT01331109|41998570|FG000|Overall Study|Lost to Follow-up|1|||
19549223|NCT01331109|41998570|FG000|Overall Study|Study Terminated by Sponsor|38|||
19549224|NCT01357551|41998576|FG000|Overall Study|Withdrawal by Subject|6|||
19549225|NCT01357551|41998577|FG001|Overall Study|Withdrawal by Subject|4|||
19549226|NCT01357551|41998576|FG000|Overall Study|Death|0|||
19549227|NCT01357551|41998577|FG001|Overall Study|Death|1|||
19549228|NCT01357551|41998576|FG000|Overall Study|Lost to Follow-up|16|||
19549229|NCT01357551|41998577|FG001|Overall Study|Lost to Follow-up|6|||
19549230|NCT01357239|41998590|FG000|Stratum: All Patients|Adverse Event|0|||
19549231|NCT01357239|41998591|FG001|Stratum: All Patients|Adverse Event|0|||
19549232|NCT01357239|41998592|FG002|Stratum: All Patients|Adverse Event|1|||
19549233|NCT01357239|41998593|FG003|Stratum: All Patients|Adverse Event|1|||
19549234|NCT01357239|41998590|FG000|Stratum: All Patients|Subject withdrew consent|0|||
19549235|NCT01357239|41998591|FG001|Stratum: All Patients|Subject withdrew consent|0|||
19549236|NCT01357239|41998592|FG002|Stratum: All Patients|Subject withdrew consent|1|||
19549237|NCT01357239|41998593|FG003|Stratum: All Patients|Subject withdrew consent|1|||
19549238|NCT01357239|41998590|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
19549239|NCT01357239|41998591|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
19549240|NCT01357239|41998592|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
19549241|NCT01357239|41998593|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
19549242|NCT01357239|41998590|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
19549243|NCT01357239|41998591|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
19549244|NCT01357239|41998592|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
19549245|NCT01357239|41998593|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
19549246|NCT01357239|41998590|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
19549247|NCT01357239|41998591|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
19549248|NCT01357239|41998592|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
19549249|NCT01357239|41998593|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
19549250|NCT01357161|41998609|FG000|Part 1 (Open Label Run-in)|Death|5|||
19549251|NCT01357161|41998610|FG001|Part 1 (Open Label Run-in)|Death|0|||
19549252|NCT01357161|41998611|FG002|Part 1 (Open Label Run-in)|Death|0|||
19549253|NCT01357161|41998609|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
19549254|NCT01357161|41998610|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
19549255|NCT01357161|41998611|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
19549256|NCT01357161|41998609|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
19549257|NCT01357161|41998610|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
19549258|NCT01357161|41998611|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
19549259|NCT01357161|41998609|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
19549260|NCT01357161|41998610|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
19549261|NCT01357161|41998611|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
19549262|NCT01357161|41998609|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
19549263|NCT01357161|41998610|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
19549264|NCT01357161|41998611|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
19549265|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
19549266|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
19549267|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
19549268|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
19549269|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
19549270|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
19549271|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
19549272|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
19549273|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
19549274|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
19549275|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
19549276|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
19549277|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
19549278|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
19549279|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
19549280|NCT01357161|41998609|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
19549281|NCT01357161|41998610|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
19549282|NCT01357161|41998611|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
19549283|NCT01351350|41998624|FG000|Overall Study|Disease Progression|5|||
19549284|NCT01351350|41998625|FG001|Overall Study|Disease Progression|13|||
19549285|NCT01351350|41998626|FG002|Overall Study|Disease Progression|6|||
19549286|NCT01351350|41998627|FG003|Overall Study|Disease Progression|8|||
19549287|NCT01351350|41998628|FG004|Overall Study|Disease Progression|5|||
19549288|NCT01351350|41998624|FG000|Overall Study|Adverse Event|1|||
19549289|NCT01351350|41998625|FG001|Overall Study|Adverse Event|10|||
19549290|NCT01351350|41998626|FG002|Overall Study|Adverse Event|1|||
19549291|NCT01351350|41998627|FG003|Overall Study|Adverse Event|2|||
19549292|NCT01351350|41998628|FG004|Overall Study|Adverse Event|0|||
19549293|NCT01351350|41998624|FG000|Overall Study|Participant Decision|2|||
19549294|NCT01351350|41998625|FG001|Overall Study|Participant Decision|6|||
19549295|NCT01351350|41998626|FG002|Overall Study|Participant Decision|3|||
19549296|NCT01351350|41998627|FG003|Overall Study|Participant Decision|3|||
19549297|NCT01351350|41998628|FG004|Overall Study|Participant Decision|2|||
19549298|NCT01351350|41998624|FG000|Overall Study|Enrolled but not Treated|0|||
19549299|NCT01351350|41998625|FG001|Overall Study|Enrolled but not Treated|0|||
19549300|NCT01351350|41998626|FG002|Overall Study|Enrolled but not Treated|1|||
19549301|NCT01351350|41998627|FG003|Overall Study|Enrolled but not Treated|0|||
19549302|NCT01351350|41998628|FG004|Overall Study|Enrolled but not Treated|0|||
19549303|NCT01350999|41998656|FG000|Overall Study|Adverse Event|4|||
19549304|NCT01350999|41998657|FG001|Overall Study|Adverse Event|9|||
19549305|NCT01350999|41998658|FG002|Overall Study|Adverse Event|10|||
19549306|NCT01350999|41998656|FG000|Overall Study|Voluntary withdrawal|3|||
19549307|NCT01350999|41998657|FG001|Overall Study|Voluntary withdrawal|4|||
19549308|NCT01350999|41998658|FG002|Overall Study|Voluntary withdrawal|6|||
19549309|NCT01350999|41998656|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
19549310|NCT01350999|41998657|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
19549311|NCT01350999|41998658|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
19549312|NCT01330914|41998677|FG000|Overall Study|Withdrawal by Subject|4|||
19549313|NCT01330914|41998677|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
19549314|NCT01350804|41998685|FG000|Core Study|Withdrawal by Subject|11|||
19549315|NCT01350804|41998686|FG001|Core Study|Withdrawal by Subject|17|||
19549316|NCT01350804|41998687|FG002|Core Study|Withdrawal by Subject|16|||
19549317|NCT01350804|41998688|FG003|Core Study|Withdrawal by Subject|7|||
19549318|NCT01350804|41998685|FG000|Core Study|Study terminated by Sponsor|0|||
19549319|NCT01350804|41998686|FG001|Core Study|Study terminated by Sponsor|0|||
19549320|NCT01350804|41998687|FG002|Core Study|Study terminated by Sponsor|0|||
19549321|NCT01350804|41998688|FG003|Core Study|Study terminated by Sponsor|2|||
19549322|NCT01350804|41998685|FG000|Core Study|Protocol deviation|1|||
19549323|NCT01350804|41998686|FG001|Core Study|Protocol deviation|0|||
19549324|NCT01350804|41998687|FG002|Core Study|Protocol deviation|1|||
19549325|NCT01350804|41998688|FG003|Core Study|Protocol deviation|0|||
19549326|NCT01350804|41998685|FG000|Core Study|Physician Decision|1|||
19549327|NCT01350804|41998686|FG001|Core Study|Physician Decision|0|||
19549328|NCT01350804|41998687|FG002|Core Study|Physician Decision|1|||
19549329|NCT01350804|41998688|FG003|Core Study|Physician Decision|3|||
19549330|NCT01350804|41998685|FG000|Core Study|Lost to Follow-up|3|||
19549331|NCT01350804|41998686|FG001|Core Study|Lost to Follow-up|0|||
19549332|NCT01350804|41998687|FG002|Core Study|Lost to Follow-up|2|||
19549333|NCT01350804|41998688|FG003|Core Study|Lost to Follow-up|1|||
19549334|NCT01350804|41998685|FG000|Core Study|Lack of Efficacy|16|||
19716993|NCT01239368|42159937|FG000|Overall Study|Refused further treatment|0|||
19716994|NCT01239368|42159938|FG001|Overall Study|Refused further treatment|0|||
19716995|NCT01239368|42159939|FG002|Overall Study|Refused further treatment|0|||
19716996|NCT01239368|42159940|FG003|Overall Study|Refused further treatment|0|||
19549335|NCT01350804|41998686|FG001|Core Study|Lack of Efficacy|19|||
19549336|NCT01350804|41998687|FG002|Core Study|Lack of Efficacy|18|||
19716997|NCT01239368|42159941|FG004|Overall Study|Refused further treatment|0|||
19716998|NCT01239368|42159942|FG005|Overall Study|Refused further treatment|0|||
19716999|NCT01239368|42159943|FG006|Overall Study|Refused further treatment|0|||
19717000|NCT01239368|42159944|FG007|Overall Study|Refused further treatment|0|||
19717001|NCT01239368|42159945|FG008|Overall Study|Refused further treatment|0|||
19717002|NCT01239368|42159946|FG009|Overall Study|Refused further treatment|1|||
19717003|NCT01239368|42159937|FG000|Overall Study|Death|0|||
19717004|NCT01239368|42159938|FG001|Overall Study|Death|0|||
19717005|NCT01239368|42159939|FG002|Overall Study|Death|0|||
19717006|NCT01239368|42159940|FG003|Overall Study|Death|0|||
19717007|NCT01239368|42159941|FG004|Overall Study|Death|0|||
19717008|NCT01239368|42159942|FG005|Overall Study|Death|0|||
19717009|NCT01239368|42159943|FG006|Overall Study|Death|1|||
19717010|NCT01239368|42159944|FG007|Overall Study|Death|0|||
19717011|NCT01239368|42159945|FG008|Overall Study|Death|0|||
19717012|NCT01239368|42159946|FG009|Overall Study|Death|0|||
19549337|NCT01350804|41998688|FG003|Core Study|Lack of Efficacy|5|||
19549338|NCT01350804|41998685|FG000|Core Study|Death|1|||
19549339|NCT01350804|41998686|FG001|Core Study|Death|1|||
19549340|NCT01350804|41998687|FG002|Core Study|Death|1|||
19549341|NCT01350804|41998688|FG003|Core Study|Death|0|||
19549342|NCT01350804|41998685|FG000|Core Study|Adverse Event|8|||
19549343|NCT01350804|41998686|FG001|Core Study|Adverse Event|10|||
19549344|NCT01350804|41998687|FG002|Core Study|Adverse Event|8|||
19549345|NCT01350804|41998688|FG003|Core Study|Adverse Event|8|||
19549346|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
19549347|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
19549348|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
19549349|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
19549350|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
19717013|NCT02903420|42159988|FG000|Overall Study|Death|3|||
19717014|NCT00369161|42159998|FG000|Overall Study|Adverse Event|15|||
19717015|NCT00369161|42159999|FG001|Overall Study|Adverse Event|13|||
19549351|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
19549352|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
19549353|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
19549354|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
19549355|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
19549356|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
19549357|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
19549358|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
19549359|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
19549360|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
19549361|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
19549362|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
19549363|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
19549364|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
19549365|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
19549366|NCT01350804|41998685|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
19549367|NCT01350804|41998686|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
19549368|NCT01350804|41998687|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
19549369|NCT01350804|41998688|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
19549370|NCT01350492|41998710|FG000|Intervention|Lost to Follow-up|2|||
19549371|NCT01350492|41998711|FG001|Intervention|Lost to Follow-up|5|||
19549372|NCT01350492|41998710|FG000|Intervention|Withdrawal by Subject|3|||
19549373|NCT01350492|41998711|FG001|Intervention|Withdrawal by Subject|1|||
19549374|NCT01350492|41998710|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
19549375|NCT01350492|41998711|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
19549376|NCT01350492|41998710|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
19549377|NCT01350492|41998711|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
19549378|NCT02270957|41998719|FG000|Overall Study|Lack of Efficacy|2|||
19549379|NCT02270957|41998720|FG001|Overall Study|Lack of Efficacy|4|||
19549380|NCT02270957|41998719|FG000|Overall Study|Adverse Event|2|||
19549381|NCT02270957|41998720|FG001|Overall Study|Adverse Event|0|||
19549382|NCT01350414|41998727|FG000|Overall Study|Lost to Follow-up|13|||
19549383|NCT01350414|41998727|FG000|Overall Study|Withdrawal by Subject|4|||
19549384|NCT01350414|41998727|FG000|Overall Study|Physician Decision|2|||
19549385|NCT01350336|41998737|FG000|Overall Study|Lost to Follow-up|31|||
19549386|NCT01350336|41998737|FG000|Overall Study|Withdrawal by Subject|14|||
19549387|NCT01350336|41998737|FG000|Overall Study|Physician Decision|8|||
19549388|NCT01350336|41998737|FG000|Overall Study|Death|4|||
19549389|NCT01349049|41998795|FG000|Overall Study|Disease progression|3|||
19549390|NCT01349049|41998796|FG001|Overall Study|Disease progression|5|||
19549391|NCT01349049|41998797|FG002|Overall Study|Disease progression|3|||
19549392|NCT01349049|41998798|FG003|Overall Study|Disease progression|2|||
19549393|NCT01349049|41998799|FG004|Overall Study|Disease progression|2|||
19549394|NCT01349049|41998800|FG005|Overall Study|Disease progression|2|||
19549395|NCT01349049|41998801|FG006|Overall Study|Disease progression|3|||
19549396|NCT01349049|41998802|FG007|Overall Study|Disease progression|2|||
19549397|NCT01349049|41998803|FG008|Overall Study|Disease progression|33|||
19549398|NCT01349049|41998795|FG000|Overall Study|Adverse Event|0|||
19549399|NCT01349049|41998796|FG001|Overall Study|Adverse Event|1|||
19549400|NCT01349049|41998797|FG002|Overall Study|Adverse Event|0|||
19549401|NCT01349049|41998798|FG003|Overall Study|Adverse Event|0|||
19549402|NCT01349049|41998799|FG004|Overall Study|Adverse Event|0|||
19549403|NCT01349049|41998800|FG005|Overall Study|Adverse Event|3|||
19549404|NCT01349049|41998801|FG006|Overall Study|Adverse Event|1|||
19549405|NCT01349049|41998802|FG007|Overall Study|Adverse Event|0|||
19549406|NCT01349049|41998803|FG008|Overall Study|Adverse Event|4|||
19549407|NCT01349049|41998795|FG000|Overall Study|Physician Decision|0|||
19549408|NCT01349049|41998796|FG001|Overall Study|Physician Decision|1|||
19549409|NCT01349049|41998797|FG002|Overall Study|Physician Decision|0|||
19549410|NCT01349049|41998798|FG003|Overall Study|Physician Decision|0|||
19549411|NCT01349049|41998799|FG004|Overall Study|Physician Decision|0|||
19549412|NCT01349049|41998800|FG005|Overall Study|Physician Decision|0|||
19549413|NCT01349049|41998801|FG006|Overall Study|Physician Decision|0|||
19549414|NCT01349049|41998802|FG007|Overall Study|Physician Decision|0|||
19549415|NCT01349049|41998803|FG008|Overall Study|Physician Decision|2|||
19549416|NCT01349049|41998795|FG000|Overall Study|Protocol Violation|0|||
19549417|NCT01349049|41998796|FG001|Overall Study|Protocol Violation|0|||
19549418|NCT01349049|41998797|FG002|Overall Study|Protocol Violation|0|||
19549419|NCT01349049|41998798|FG003|Overall Study|Protocol Violation|0|||
19549420|NCT01349049|41998799|FG004|Overall Study|Protocol Violation|0|||
19549421|NCT01349049|41998800|FG005|Overall Study|Protocol Violation|0|||
19549422|NCT01349049|41998801|FG006|Overall Study|Protocol Violation|0|||
19549423|NCT01349049|41998802|FG007|Overall Study|Protocol Violation|0|||
19549424|NCT01349049|41998803|FG008|Overall Study|Protocol Violation|1|||
19717016|NCT00369161|42159998|FG000|Overall Study|Abnormal laboratory value|0|||
19549425|NCT01349049|41998795|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
19549426|NCT01349049|41998796|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
19549427|NCT01349049|41998797|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
19549428|NCT01349049|41998798|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
19549429|NCT01349049|41998799|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
19549430|NCT01349049|41998800|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
19549431|NCT01349049|41998801|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
19549432|NCT01349049|41998802|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
19549433|NCT01349049|41998803|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
19549434|NCT01349049|41998795|FG000|Overall Study|Other|0|||
19549435|NCT01349049|41998796|FG001|Overall Study|Other|0|||
19549436|NCT01349049|41998797|FG002|Overall Study|Other|0|||
19549437|NCT01349049|41998798|FG003|Overall Study|Other|0|||
19549438|NCT01349049|41998799|FG004|Overall Study|Other|0|||
19549439|NCT01349049|41998800|FG005|Overall Study|Other|1|||
19549440|NCT01349049|41998801|FG006|Overall Study|Other|0|||
19549441|NCT01349049|41998802|FG007|Overall Study|Other|0|||
19549442|NCT01349049|41998803|FG008|Overall Study|Other|4|||
19549443|NCT01349049|41998795|FG000|Overall Study|Death|0|||
19549444|NCT01349049|41998796|FG001|Overall Study|Death|0|||
19549445|NCT01349049|41998797|FG002|Overall Study|Death|0|||
19549446|NCT01349049|41998798|FG003|Overall Study|Death|0|||
19549447|NCT01349049|41998799|FG004|Overall Study|Death|0|||
19549448|NCT01349049|41998800|FG005|Overall Study|Death|0|||
19549449|NCT01349049|41998801|FG006|Overall Study|Death|0|||
19549450|NCT01349049|41998802|FG007|Overall Study|Death|1|||
19549451|NCT01349049|41998803|FG008|Overall Study|Death|5|||
19549452|NCT01349049|41998795|FG000|Overall Study|Non-compliance|0|||
19549453|NCT01349049|41998796|FG001|Overall Study|Non-compliance|0|||
19549454|NCT01349049|41998797|FG002|Overall Study|Non-compliance|0|||
19549455|NCT01349049|41998798|FG003|Overall Study|Non-compliance|1|||
19549456|NCT01349049|41998799|FG004|Overall Study|Non-compliance|0|||
19549457|NCT01349049|41998800|FG005|Overall Study|Non-compliance|0|||
19549458|NCT01349049|41998801|FG006|Overall Study|Non-compliance|0|||
19549459|NCT01349049|41998802|FG007|Overall Study|Non-compliance|0|||
19549460|NCT01349049|41998803|FG008|Overall Study|Non-compliance|0|||
19549461|NCT01349049|41998795|FG000|Overall Study|Withdrawal by Subject|0|||
19549462|NCT01349049|41998796|FG001|Overall Study|Withdrawal by Subject|0|||
19549463|NCT01349049|41998797|FG002|Overall Study|Withdrawal by Subject|0|||
19549464|NCT01349049|41998798|FG003|Overall Study|Withdrawal by Subject|0|||
19549465|NCT01349049|41998799|FG004|Overall Study|Withdrawal by Subject|0|||
19549466|NCT01349049|41998800|FG005|Overall Study|Withdrawal by Subject|0|||
19549467|NCT01349049|41998801|FG006|Overall Study|Withdrawal by Subject|0|||
19549468|NCT01349049|41998802|FG007|Overall Study|Withdrawal by Subject|0|||
19549469|NCT01349049|41998803|FG008|Overall Study|Withdrawal by Subject|6|||
19549470|NCT01348854|41998837|FG000|Overall Study|Lost to Follow-up|2|||
19549471|NCT01348854|41998838|FG001|Overall Study|Lost to Follow-up|1|||
19549472|NCT01348854|41998837|FG000|Overall Study|Withdrawal by Subject|1|||
19549473|NCT01348854|41998838|FG001|Overall Study|Withdrawal by Subject|0|||
19549474|NCT01348776|41998844|FG000|Overall Study|Lost to Follow-up|3|||
19549475|NCT01348698|41998857|FG000|Overall Study|Does not meet lesion size criteria|1|||
19549476|NCT01348698|41998857|FG000|Overall Study|Death|3|||
19549477|NCT01348698|41998857|FG000|Overall Study|PI decision to close study|68|||
19549478|NCT01348542|41998863|FG000|Overall Study|Withdrawal by Subject|3|||
19549479|NCT01348542|41998864|FG001|Overall Study|Withdrawal by Subject|0|||
19549480|NCT01346709|41998870|FG000|Overall Study|Protocol Violation|35|||
19549481|NCT01346709|41998870|FG000|Overall Study|Lost to Follow-up|31|||
19549482|NCT01346709|41998870|FG000|Overall Study|Missing data in candidate risk factor|285|||
19549483|NCT01346592|41998877|FG000|Overall Study|Lost to Follow-up|62|||
19549484|NCT01346592|41998878|FG001|Overall Study|Lost to Follow-up|29|||
19549485|NCT01346592|41998879|FG002|Overall Study|Lost to Follow-up|29|||
19549486|NCT01346592|41998877|FG000|Overall Study|Protocol Violation|2|||
19549487|NCT01346592|41998878|FG001|Overall Study|Protocol Violation|1|||
19549488|NCT01346592|41998879|FG002|Overall Study|Protocol Violation|0|||
19549489|NCT01346592|41998877|FG000|Overall Study|Death|1|||
19549490|NCT01346592|41998878|FG001|Overall Study|Death|3|||
19549491|NCT01346592|41998879|FG002|Overall Study|Death|4|||
19549492|NCT01346592|41998877|FG000|Overall Study|Adverse Event|0|||
19549493|NCT01346592|41998878|FG001|Overall Study|Adverse Event|1|||
19549494|NCT01346592|41998879|FG002|Overall Study|Adverse Event|0|||
19549495|NCT01346592|41998877|FG000|Overall Study|Withdrawal by Subject|77|||
19549496|NCT01346592|41998878|FG001|Overall Study|Withdrawal by Subject|51|||
19549497|NCT01346592|41998879|FG002|Overall Study|Withdrawal by Subject|38|||
19549498|NCT01346592|41998877|FG000|Overall Study|Inappropriate enrollment|3|||
19549499|NCT01346592|41998878|FG001|Overall Study|Inappropriate enrollment|1|||
19549500|NCT01346592|41998879|FG002|Overall Study|Inappropriate enrollment|1|||
19549501|NCT01346592|41998877|FG000|Overall Study|Administrative reason|1|||
19549502|NCT01346592|41998878|FG001|Overall Study|Administrative reason|0|||
19549503|NCT01346592|41998879|FG002|Overall Study|Administrative reason|0|||
19549504|NCT01346592|41998877|FG000|Overall Study|Unable to Classify|7|||
19549505|NCT01346592|41998878|FG001|Overall Study|Unable to Classify|3|||
19549506|NCT01346592|41998879|FG002|Overall Study|Unable to Classify|6|||
19549507|NCT01346514|41998906|FG000|Overall Study|Lost to Follow-up|19|||
19549508|NCT01346514|41998907|FG001|Overall Study|Lost to Follow-up|30|||
19549509|NCT01346514|41998906|FG000|Overall Study|Withdrawal by Subject|7|||
19549510|NCT01346514|41998907|FG001|Overall Study|Withdrawal by Subject|3|||
19549511|NCT01346514|41998906|FG000|Overall Study|Death|3|||
19549512|NCT01346514|41998907|FG001|Overall Study|Death|4|||
19549513|NCT01193335|41998917|FG000|After Infant Series|Lost to Follow-up|1|||
19549514|NCT01193335|41998918|FG001|After Infant Series|Lost to Follow-up|2|||
19549515|NCT01193335|41998917|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
19549516|NCT01193335|41998918|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
19549517|NCT01193335|41998917|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
19549518|NCT01193335|41998918|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
19549519|NCT01193335|41998917|FG000|1-Year Follow-up|Lost to Follow-up|4|||
19549520|NCT01193335|41998918|FG001|1-Year Follow-up|Lost to Follow-up|0|||
19549521|NCT01193335|41998917|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
19549522|NCT01193335|41998918|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
19549523|NCT01193335|41998917|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
19549524|NCT01193335|41998918|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
19549525|NCT01342887|41998940|FG000|Overall Study|Death|2|||
19549526|NCT01342341|41998946|FG000|Overall Study|Lost to Follow-up|4|||
19549527|NCT01342341|41998947|FG001|Overall Study|Lost to Follow-up|4|||
19549528|NCT01340664|41998956|FG000|Overall Study|Adverse Event|0|||
19549529|NCT01340664|41998957|FG001|Overall Study|Adverse Event|1|||
19549530|NCT01340664|41998958|FG002|Overall Study|Adverse Event|7|||
19549531|NCT01340664|41998956|FG000|Overall Study|Lost to Follow-up|2|||
19549532|NCT01340664|41998957|FG001|Overall Study|Lost to Follow-up|0|||
19549533|NCT01340664|41998958|FG002|Overall Study|Lost to Follow-up|2|||
19549534|NCT01340664|41998956|FG000|Overall Study|Withdrawal by Subject|2|||
19549535|NCT01340664|41998957|FG001|Overall Study|Withdrawal by Subject|4|||
19549536|NCT01340664|41998958|FG002|Overall Study|Withdrawal by Subject|0|||
19549537|NCT01340664|41998956|FG000|Overall Study|Glycemic withdrawal criteria|2|||
19549538|NCT01340664|41998957|FG001|Overall Study|Glycemic withdrawal criteria|0|||
19549539|NCT01340664|41998958|FG002|Overall Study|Glycemic withdrawal criteria|0|||
19549540|NCT01340664|41998956|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
19549541|NCT01340664|41998957|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
19549542|NCT01340664|41998958|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
19549543|NCT01340664|41998956|FG000|Overall Study|Other|1|||
19549544|NCT01340664|41998957|FG001|Overall Study|Other|2|||
19549545|NCT01340664|41998958|FG002|Overall Study|Other|2|||
19549546|NCT01340625|41998968|FG000|First Intervention|Adverse Event|1|||
19549547|NCT01340625|41998969|FG001|First Intervention|Adverse Event|0|||
19549548|NCT01340625|41998968|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
19549549|NCT01340625|41998969|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
19549550|NCT01340196|41998975|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
19549551|NCT01327599|41998984|FG000|Overall Study|Adverse Event|1|||
19549552|NCT01327599|41998984|FG000|Overall Study|Could Not Attend Visit|1|||
19549553|NCT01327599|41998984|FG000|Overall Study|Withdrawal of Consent|1|||
19549554|NCT01193257|41998990|FG000|Overall Study|Death|202|||
19549555|NCT01193257|41998991|FG001|Overall Study|Death|391|||
19549556|NCT01193257|41998990|FG000|Overall Study|Study termination by sponsor|0|||
19549557|NCT01193257|41998991|FG001|Overall Study|Study termination by sponsor|3|||
19549558|NCT01193257|41998990|FG000|Overall Study|Withdrawal by Subject|26|||
19549559|NCT01193257|41998991|FG001|Overall Study|Withdrawal by Subject|86|||
19549560|NCT01193257|41998990|FG000|Overall Study|Lost to Follow-up|2|||
19549561|NCT01193257|41998991|FG001|Overall Study|Lost to Follow-up|3|||
19549562|NCT01193257|41998990|FG000|Overall Study|Unblinded due to futility|135|||
19549563|NCT01193257|41998991|FG001|Overall Study|Unblinded due to futility|251|||
19549564|NCT01193218|41999002|FG000|0-12 Weeks|Adverse Event|6|||
19549565|NCT01193218|41999003|FG001|0-12 Weeks|Adverse Event|0|||
19549566|NCT01193218|41999004|FG002|0-12 Weeks|Adverse Event|1|||
19549567|NCT01193218|41999005|FG003|0-12 Weeks|Adverse Event|0|||
19549568|NCT01193218|41999006|FG004|0-12 Weeks|Adverse Event|0|||
19549569|NCT01193218|41999007|FG005|0-12 Weeks|Adverse Event|2|||
19549570|NCT01193218|41999008|FG006|0-12 Weeks|Adverse Event|2|||
19717017|NCT00369161|42159999|FG001|Overall Study|Abnormal laboratory value|1|||
19717018|NCT00369161|42159998|FG000|Overall Study|Lack of Efficacy|3|||
19717019|NCT00369161|42159999|FG001|Overall Study|Lack of Efficacy|1|||
19717020|NCT00369161|42159998|FG000|Overall Study|Protocol Violation|0|||
19717021|NCT00369161|42159999|FG001|Overall Study|Protocol Violation|2|||
19549571|NCT01193218|41999009|FG007|0-12 Weeks|Adverse Event|0|||
19717022|NCT00369161|42159998|FG000|Overall Study|Withdrawal by Subject|2|||
19549572|NCT01193218|41999002|FG000|0-12 Weeks|Protocol Violation|0|||
19549573|NCT01193218|41999003|FG001|0-12 Weeks|Protocol Violation|0|||
19549574|NCT01193218|41999004|FG002|0-12 Weeks|Protocol Violation|0|||
19549575|NCT01193218|41999005|FG003|0-12 Weeks|Protocol Violation|0|||
19549576|NCT01193218|41999006|FG004|0-12 Weeks|Protocol Violation|1|||
19549577|NCT01193218|41999007|FG005|0-12 Weeks|Protocol Violation|1|||
19549578|NCT01193218|41999008|FG006|0-12 Weeks|Protocol Violation|0|||
19549579|NCT01193218|41999009|FG007|0-12 Weeks|Protocol Violation|0|||
19549580|NCT01193218|41999002|FG000|0-12 Weeks|Withdrawal by Subject|3|||
19549581|NCT01193218|41999003|FG001|0-12 Weeks|Withdrawal by Subject|0|||
19549582|NCT01193218|41999004|FG002|0-12 Weeks|Withdrawal by Subject|2|||
19549583|NCT01193218|41999005|FG003|0-12 Weeks|Withdrawal by Subject|0|||
19549584|NCT01193218|41999006|FG004|0-12 Weeks|Withdrawal by Subject|0|||
19549585|NCT01193218|41999007|FG005|0-12 Weeks|Withdrawal by Subject|0|||
19549586|NCT01193218|41999008|FG006|0-12 Weeks|Withdrawal by Subject|1|||
19549587|NCT01193218|41999009|FG007|0-12 Weeks|Withdrawal by Subject|0|||
19549588|NCT01193218|41999002|FG000|12-52 Weeks|Adverse Event|1|||
19549589|NCT01193218|41999003|FG001|12-52 Weeks|Adverse Event|0|||
19549590|NCT01193218|41999004|FG002|12-52 Weeks|Adverse Event|1|||
19549591|NCT01193218|41999005|FG003|12-52 Weeks|Adverse Event|2|||
19549592|NCT01193218|41999006|FG004|12-52 Weeks|Adverse Event|3|||
19549593|NCT01193218|41999007|FG005|12-52 Weeks|Adverse Event|3|||
19549594|NCT01193218|41999008|FG006|12-52 Weeks|Adverse Event|1|||
19549595|NCT01193218|41999009|FG007|12-52 Weeks|Adverse Event|2|||
19549596|NCT01193218|41999002|FG000|12-52 Weeks|Lack of Efficacy|0|||
19549597|NCT01193218|41999003|FG001|12-52 Weeks|Lack of Efficacy|0|||
19549598|NCT01193218|41999004|FG002|12-52 Weeks|Lack of Efficacy|0|||
19549599|NCT01193218|41999005|FG003|12-52 Weeks|Lack of Efficacy|0|||
19549600|NCT01193218|41999006|FG004|12-52 Weeks|Lack of Efficacy|0|||
19549601|NCT01193218|41999007|FG005|12-52 Weeks|Lack of Efficacy|0|||
19549602|NCT01193218|41999008|FG006|12-52 Weeks|Lack of Efficacy|1|||
19549603|NCT01193218|41999009|FG007|12-52 Weeks|Lack of Efficacy|0|||
19549604|NCT01193218|41999002|FG000|12-52 Weeks|Withdrawal by Subject|3|||
19549605|NCT01193218|41999003|FG001|12-52 Weeks|Withdrawal by Subject|0|||
19549606|NCT01193218|41999004|FG002|12-52 Weeks|Withdrawal by Subject|3|||
19549607|NCT01193218|41999005|FG003|12-52 Weeks|Withdrawal by Subject|0|||
19549608|NCT01193218|41999006|FG004|12-52 Weeks|Withdrawal by Subject|0|||
19549609|NCT01193218|41999007|FG005|12-52 Weeks|Withdrawal by Subject|2|||
19549610|NCT01193218|41999008|FG006|12-52 Weeks|Withdrawal by Subject|1|||
19549611|NCT01193218|41999009|FG007|12-52 Weeks|Withdrawal by Subject|2|||
19549612|NCT01193218|41999002|FG000|12-52 Weeks|Other reason than above|1|||
19549613|NCT01193218|41999003|FG001|12-52 Weeks|Other reason than above|0|||
19549614|NCT01193218|41999004|FG002|12-52 Weeks|Other reason than above|0|||
19549615|NCT01193218|41999005|FG003|12-52 Weeks|Other reason than above|1|||
19549616|NCT01193218|41999006|FG004|12-52 Weeks|Other reason than above|1|||
19549617|NCT01193218|41999007|FG005|12-52 Weeks|Other reason than above|0|||
19549618|NCT01193218|41999008|FG006|12-52 Weeks|Other reason than above|0|||
19549619|NCT01193218|41999009|FG007|12-52 Weeks|Other reason than above|0|||
19549620|NCT01193101|41999029|FG000|Overall Study|Adverse Event|0|||
19549621|NCT01193101|41999030|FG001|Overall Study|Adverse Event|1|||
19549622|NCT01193101|41999031|FG002|Overall Study|Adverse Event|1|||
19549623|NCT01193101|41999032|FG003|Overall Study|Adverse Event|3|||
19549624|NCT01193101|41999029|FG000|Overall Study|Lack of Efficacy|3|||
19549625|NCT01193101|41999030|FG001|Overall Study|Lack of Efficacy|1|||
19549626|NCT01193101|41999031|FG002|Overall Study|Lack of Efficacy|0|||
19549627|NCT01193101|41999032|FG003|Overall Study|Lack of Efficacy|8|||
19549628|NCT01193101|41999029|FG000|Overall Study|Withdrawal by Subject|2|||
19549629|NCT01193101|41999030|FG001|Overall Study|Withdrawal by Subject|4|||
19549630|NCT01193101|41999031|FG002|Overall Study|Withdrawal by Subject|1|||
19549631|NCT01193101|41999032|FG003|Overall Study|Withdrawal by Subject|1|||
19549632|NCT01193101|41999029|FG000|Overall Study|Administrative problems|0|||
19549633|NCT01193101|41999030|FG001|Overall Study|Administrative problems|0|||
19549634|NCT01193101|41999031|FG002|Overall Study|Administrative problems|1|||
19549635|NCT01193101|41999032|FG003|Overall Study|Administrative problems|0|||
19549636|NCT01193101|41999029|FG000|Overall Study|Abnormal test procedure results|0|||
19549637|NCT01193101|41999030|FG001|Overall Study|Abnormal test procedure results|1|||
19549638|NCT01193101|41999031|FG002|Overall Study|Abnormal test procedure results|0|||
19549639|NCT01193101|41999032|FG003|Overall Study|Abnormal test procedure results|0|||
19549640|NCT01192516|41999045|FG000|Overall Study|Lost to Follow-up|7|||
19549641|NCT01192516|41999046|FG001|Overall Study|Lost to Follow-up|10|||
19549642|NCT01192516|41999047|FG002|Overall Study|Lost to Follow-up|7|||
19549643|NCT01192516|41999045|FG000|Overall Study|Withdrawal by Subject|4|||
19549644|NCT01192516|41999046|FG001|Overall Study|Withdrawal by Subject|4|||
19549645|NCT01192516|41999047|FG002|Overall Study|Withdrawal by Subject|1|||
19549646|NCT01192516|41999045|FG000|Overall Study|started new treatment|5|||
19549647|NCT01192516|41999046|FG001|Overall Study|started new treatment|1|||
19549648|NCT01192516|41999047|FG002|Overall Study|started new treatment|0|||
19549649|NCT01192516|41999045|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
19549650|NCT01192516|41999046|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
19549651|NCT01192516|41999047|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
19549652|NCT01192399|41999059|FG000|Overall Study|Lack of Efficacy|2|||
19549653|NCT01176916|41999063|FG000|Overall Study|Adverse Event|61|||
19549654|NCT01176916|41999063|FG000|Overall Study|Death|1|||
19549655|NCT01176916|41999063|FG000|Overall Study|Lost to Follow-up|15|||
19549656|NCT01176916|41999063|FG000|Overall Study|Objective progression or relapse|17|||
19549657|NCT01176916|41999063|FG000|Overall Study|Protocol Violation|24|||
19549658|NCT01176916|41999063|FG000|Overall Study|Withdrawal by Subject|37|||
19549659|NCT01176916|41999063|FG000|Overall Study|Other|6|||
19549660|NCT01176916|41999063|FG000|Overall Study|Withdrawal prior to Treatment|6|||
19549661|NCT01192204|41999069|FG000|Overall Study|could not keep recall appointments|1|||
19549662|NCT01192204|41999070|FG001|Overall Study|could not keep recall appointments|0|||
19549663|NCT01192126|41999077|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
19549664|NCT01192126|41999078|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
19549665|NCT01192126|41999077|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
19549666|NCT01192126|41999078|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
19549667|NCT01327482|41999084|FG000|Overall Study|Adverse Event|1|||
19549668|NCT01176565|41999090|FG000|Overall Study|Lost to Follow-up|12|||
19549669|NCT01176565|41999091|FG001|Overall Study|Lost to Follow-up|16|||
19549670|NCT01176565|41999090|FG000|Overall Study|Withdrawal by Subject|7|||
19549671|NCT01176565|41999091|FG001|Overall Study|Withdrawal by Subject|1|||
19549672|NCT01176565|41999090|FG000|Overall Study|Not Analyzed (any other reason)|1|||
19549673|NCT01176565|41999091|FG001|Overall Study|Not Analyzed (any other reason)|2|||
19549674|NCT01176292|41999099|FG000|Overall Study|Lost to Follow-up|2|||
19549675|NCT01176292|41999100|FG001|Overall Study|Lost to Follow-up|4|||
19549676|NCT01176292|41999099|FG000|Overall Study|Adverse Event|1|||
19549677|NCT01176292|41999100|FG001|Overall Study|Adverse Event|1|||
19549678|NCT01176292|41999099|FG000|Overall Study|Physician Decision|0|||
19549679|NCT01176292|41999100|FG001|Overall Study|Physician Decision|2|||
19549680|NCT01176292|41999099|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
19549681|NCT01176292|41999100|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
19549682|NCT01113541|41999106|FG000|Overall Study|Withdrawal by Subject|1|||
19549683|NCT01113541|41999106|FG000|Overall Study|Protocol Violation|1|||
19549684|NCT01113541|41999106|FG000|Overall Study|Study Terminated by Sponsor|7|||
19549685|NCT01113541|41999106|FG000|Overall Study|Adverse Event|4|||
19549686|NCT01113502|41999119|FG000|Overall Study|Withdrawal by Subject|1|||
19549687|NCT01113502|41999120|FG001|Overall Study|Withdrawal by Subject|0|||
19549688|NCT01113502|41999121|FG002|Overall Study|Withdrawal by Subject|1|||
19549689|NCT01113502|41999122|FG003|Overall Study|Withdrawal by Subject|1|||
19549690|NCT01113502|41999123|FG004|Overall Study|Withdrawal by Subject|0|||
19549691|NCT01113502|41999119|FG000|Overall Study|Adverse Event|0|||
19549692|NCT01113502|41999120|FG001|Overall Study|Adverse Event|0|||
19549693|NCT01113502|41999121|FG002|Overall Study|Adverse Event|3|||
19549694|NCT01113502|41999122|FG003|Overall Study|Adverse Event|2|||
19549695|NCT01113502|41999123|FG004|Overall Study|Adverse Event|0|||
19549696|NCT01113463|41999136|FG000|Overall Study|Physician Decision|5|||
19549697|NCT01112917|41999140|FG000|Overall Study|Death|2|||
19549698|NCT01112917|41999141|FG001|Overall Study|Death|11|||
19549699|NCT01112917|41999140|FG000|Overall Study|Lost to Follow-up|1|||
19549700|NCT01112917|41999141|FG001|Overall Study|Lost to Follow-up|1|||
19549701|NCT01112917|41999140|FG000|Overall Study|Withdrawal by Subject|1|||
19549702|NCT01112917|41999141|FG001|Overall Study|Withdrawal by Subject|3|||
19549703|NCT01112917|41999140|FG000|Overall Study|Unable to Convert Filter|3|||
19549704|NCT01112917|41999141|FG001|Overall Study|Unable to Convert Filter|0|||
19549705|NCT01176058|41999147|FG000|Overall Study|Adverse Event|1|||
19549706|NCT01176058|41999148|FG001|Overall Study|Adverse Event|0|||
19549707|NCT01176058|41999147|FG000|Overall Study|Insufficient clinical response|2|||
19549708|NCT01176058|41999148|FG001|Overall Study|Insufficient clinical response|2|||
19549709|NCT01176058|41999147|FG000|Overall Study|Insufficient mycological response|0|||
19549710|NCT01176058|41999148|FG001|Overall Study|Insufficient mycological response|1|||
19549711|NCT01176058|41999147|FG000|Overall Study|Withdrawal by Subject|1|||
19549712|NCT01176058|41999148|FG001|Overall Study|Withdrawal by Subject|0|||
19549713|NCT01175824|41999156|FG000|Overall Study|Adverse Event|2|||
19549714|NCT01175824|41999157|FG001|Overall Study|Adverse Event|1|||
19549715|NCT01175824|41999156|FG000|Overall Study|Lack of Efficacy|2|||
19549716|NCT01175824|41999157|FG001|Overall Study|Lack of Efficacy|0|||
19549717|NCT01175824|41999156|FG000|Overall Study|Lost to Follow-up|0|||
19549718|NCT01175824|41999157|FG001|Overall Study|Lost to Follow-up|1|||
19549719|NCT01175824|41999156|FG000|Overall Study|Physician Decision|0|||
19549720|NCT01175824|41999157|FG001|Overall Study|Physician Decision|4|||
19549721|NCT01175824|41999156|FG000|Overall Study|Protocol Violation|2|||
19549722|NCT01175824|41999157|FG001|Overall Study|Protocol Violation|5|||
19549723|NCT01175824|41999156|FG000|Overall Study|Withdrawal by Subject|3|||
19549724|NCT01175824|41999157|FG001|Overall Study|Withdrawal by Subject|7|||
19549725|NCT01175824|41999156|FG000|Overall Study|Sponsor Decision|1|||
19549726|NCT01175824|41999157|FG001|Overall Study|Sponsor Decision|0|||
19549727|NCT01175824|41999156|FG000|Overall Study|Entry Criteria Not Met|6|||
19549728|NCT01175824|41999157|FG001|Overall Study|Entry Criteria Not Met|4|||
19549729|NCT01175707|41999165|FG000|Overall Study|Adverse Event|4|||
19549730|NCT01175707|41999166|FG001|Overall Study|Adverse Event|6|||
19549731|NCT01112059|41999175|FG000|Overall Study|Withdrawal by Subject|1|||
19717023|NCT00369161|42159999|FG001|Overall Study|Withdrawal by Subject|3|||
19549732|NCT01112059|41999176|FG001|Overall Study|Withdrawal by Subject|0|||
19549733|NCT01175668|41999187|FG000|Overall Study|Withdrawal by Subject|2|||
19549734|NCT01175668|41999188|FG001|Overall Study|Withdrawal by Subject|0|||
19549735|NCT01111825|41999198|FG000|Overall Study|Withdrawal by Subject|0|||
19549736|NCT01111825|41999199|FG001|Overall Study|Withdrawal by Subject|0|||
19549737|NCT01111825|41999200|FG002|Overall Study|Withdrawal by Subject|1|||
19549738|NCT01111825|41999201|FG003|Overall Study|Withdrawal by Subject|0|||
19549739|NCT01111825|41999198|FG000|Overall Study|Lost to Follow-up|0|||
19549740|NCT01111825|41999199|FG001|Overall Study|Lost to Follow-up|0|||
19549741|NCT01111825|41999200|FG002|Overall Study|Lost to Follow-up|3|||
19549742|NCT01111825|41999201|FG003|Overall Study|Lost to Follow-up|1|||
19549743|NCT01111825|41999198|FG000|Overall Study|Adverse Event|2|||
19549744|NCT01111825|41999199|FG001|Overall Study|Adverse Event|1|||
19549745|NCT01111825|41999200|FG002|Overall Study|Adverse Event|4|||
19549746|NCT01111825|41999201|FG003|Overall Study|Adverse Event|0|||
19549747|NCT01111825|41999198|FG000|Overall Study|Disease Progression|1|||
19549748|NCT01111825|41999199|FG001|Overall Study|Disease Progression|0|||
19549749|NCT01111825|41999200|FG002|Overall Study|Disease Progression|0|||
19549750|NCT01111825|41999201|FG003|Overall Study|Disease Progression|0|||
19549751|NCT01111825|41999198|FG000|Overall Study|Discontinuation by Sponsor|0|||
19549752|NCT01111825|41999199|FG001|Overall Study|Discontinuation by Sponsor|0|||
19549753|NCT01111825|41999200|FG002|Overall Study|Discontinuation by Sponsor|0|||
19549754|NCT01111825|41999201|FG003|Overall Study|Discontinuation by Sponsor|20|||
19549755|NCT01175590|41999213|FG000|Overall Study|Lost to Follow-up|1|||
19549756|NCT01175590|41999214|FG001|Overall Study|Lost to Follow-up|0|||
19549757|NCT01175590|41999213|FG000|Overall Study|Withdrawal by Subject|0|||
19549758|NCT01175590|41999214|FG001|Overall Study|Withdrawal by Subject|2|||
19549759|NCT01175590|41999213|FG000|Overall Study|Adverse Event|4|||
19549760|NCT01175590|41999214|FG001|Overall Study|Adverse Event|0|||
19549761|NCT01175590|41999213|FG000|Overall Study|Physician Decision|1|||
19549762|NCT01175590|41999214|FG001|Overall Study|Physician Decision|4|||
19549763|NCT01175590|41999213|FG000|Overall Study|Lack of Efficacy|1|||
19549764|NCT01175590|41999214|FG001|Overall Study|Lack of Efficacy|1|||
19549765|NCT01175590|41999213|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
19549766|NCT01175590|41999214|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
19549767|NCT01175590|41999213|FG000|Overall Study|Treated not as randomized|3|||
19549768|NCT01175590|41999214|FG001|Overall Study|Treated not as randomized|2|||
19549769|NCT01175590|41999213|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
19549770|NCT01175590|41999214|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
19549771|NCT01175590|41999213|FG000|Overall Study|Protocol Violation|0|||
19549772|NCT01175590|41999214|FG001|Overall Study|Protocol Violation|1|||
19549773|NCT01175473|41999223|FG000|Overall Study|Adverse Event|2|||
19549774|NCT01175473|41999224|FG001|Overall Study|Adverse Event|2|||
19549775|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
19549776|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19549777|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19549778|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19549779|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
19549780|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
19549781|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19717024|NCT00369161|42159998|FG000|Overall Study|Death|1|||
19717025|NCT00369161|42159999|FG001|Overall Study|Death|2|||
19717026|NCT00369161|42159998|FG000|Overall Study|Graft loss|4|||
19717027|NCT00369161|42159999|FG001|Overall Study|Graft loss|0|||
19717028|NCT00369161|42159998|FG000|Overall Study|Administrative Problem|2|||
19549782|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19549783|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19717029|NCT00369161|42159999|FG001|Overall Study|Administrative Problem|2|||
19717030|NCT00337571|42160009|FG000|Overall Study|Lack of Efficacy|3|||
19717031|NCT00337571|42160010|FG001|Overall Study|Lack of Efficacy|0|||
19717032|NCT00337571|42160011|FG002|Overall Study|Lack of Efficacy|0|||
19717033|NCT00337571|42160012|FG003|Overall Study|Lack of Efficacy|0|||
19717034|NCT00337571|42160009|FG000|Overall Study|Adverse Event|4|||
19717035|NCT00337571|42160010|FG001|Overall Study|Adverse Event|5|||
19549784|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
19717036|NCT00337571|42160011|FG002|Overall Study|Adverse Event|8|||
19549785|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
19549786|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19549787|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19549788|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19549789|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
19549790|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
19549791|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
19549792|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
19717037|NCT00337571|42160012|FG003|Overall Study|Adverse Event|4|||
19549793|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
19549794|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
19549795|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
19549796|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
19549797|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
19549798|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
19549799|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
19549800|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
19549801|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
19549802|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
19549803|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
19549804|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
19549805|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
19549806|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19549807|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19549808|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19549809|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
19549810|NCT01111552|41999230|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
19549811|NCT01111552|41999231|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
19549812|NCT01111552|41999232|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
19549813|NCT01111552|41999233|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
19549814|NCT01111552|41999234|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
19549815|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19549816|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19549817|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19549818|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
19549819|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
19549820|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
19549821|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
19549822|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
19549823|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
19549824|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
19549825|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
19549826|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
19549827|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
19549828|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
19549829|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
19549830|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
19549831|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
19549832|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
19549833|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
19549834|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
19549835|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
19549836|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
19549837|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
19549838|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
19549839|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
19549840|NCT01111552|41999230|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19549841|NCT01111552|41999231|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19549842|NCT01111552|41999232|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
19549843|NCT01111552|41999233|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19549844|NCT01111552|41999234|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
19549845|NCT01175083|41999250|FG000|Primary Epoch|Withdrawal by Subject|0|||
19549846|NCT01175083|41999251|FG001|Primary Epoch|Withdrawal by Subject|0|||
19549847|NCT01175083|41999252|FG002|Primary Epoch|Withdrawal by Subject|0|||
19549848|NCT01175083|41999253|FG003|Primary Epoch|Withdrawal by Subject|0|||
19549849|NCT01175083|41999254|FG004|Primary Epoch|Withdrawal by Subject|0|||
19549850|NCT01175083|41999255|FG005|Primary Epoch|Withdrawal by Subject|2|||
19549851|NCT01175083|41999250|FG000|Primary Epoch|Lost to Follow-up|0|||
19549852|NCT01175083|41999251|FG001|Primary Epoch|Lost to Follow-up|0|||
19549853|NCT01175083|41999252|FG002|Primary Epoch|Lost to Follow-up|0|||
19549854|NCT01175083|41999253|FG003|Primary Epoch|Lost to Follow-up|0|||
19549855|NCT01175083|41999254|FG004|Primary Epoch|Lost to Follow-up|0|||
19549856|NCT01175083|41999255|FG005|Primary Epoch|Lost to Follow-up|1|||
19717038|NCT00337571|42160009|FG000|Overall Study|Withdrawal by Subject|2|||
19549857|NCT01175083|41999250|FG000|Booster Epoch|Death|0|||
19549858|NCT01175083|41999251|FG001|Booster Epoch|Death|0|||
19549859|NCT01175083|41999252|FG002|Booster Epoch|Death|1|||
19549860|NCT01175083|41999253|FG003|Booster Epoch|Death|0|||
19549861|NCT01175083|41999254|FG004|Booster Epoch|Death|0|||
19549862|NCT01175083|41999255|FG005|Booster Epoch|Death|0|||
19549863|NCT01175083|41999250|FG000|Booster Epoch|Withdrawal by Subject|0|||
19549864|NCT01175083|41999251|FG001|Booster Epoch|Withdrawal by Subject|0|||
19549865|NCT01175083|41999252|FG002|Booster Epoch|Withdrawal by Subject|0|||
19549866|NCT01175083|41999253|FG003|Booster Epoch|Withdrawal by Subject|1|||
19549867|NCT01175083|41999254|FG004|Booster Epoch|Withdrawal by Subject|0|||
19549868|NCT01175083|41999255|FG005|Booster Epoch|Withdrawal by Subject|0|||
19549869|NCT01174459|41999273|FG000|Overall Study|case report form (CRF) not collected|5|||
19549870|NCT01174342|41999277|FG000|Overall Study|Conversion to cesarean section|4|||
19549871|NCT01111474|41999281|FG000|Overall Study|Lost to Follow-up|12|||
19549872|NCT01174264|41999290|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
19549873|NCT01174264|41999291|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
19549874|NCT01174264|41999292|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
19549875|NCT01174264|41999290|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
19549876|NCT01174264|41999291|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
19549877|NCT01174264|41999292|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
19549878|NCT01174264|41999290|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
19549879|NCT01174264|41999291|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
19549880|NCT01174264|41999292|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
19549881|NCT01174186|41999302|FG000|Overall Study|Lost to Follow-up|0|||
19549882|NCT01174186|41999303|FG001|Overall Study|Lost to Follow-up|1|||
19549883|NCT01174186|41999302|FG000|Overall Study|Withdrawal by Subject|0|||
19549884|NCT01174186|41999303|FG001|Overall Study|Withdrawal by Subject|2|||
19549885|NCT01173718|41999309|FG000|Overall Study|Death|17|||
19549886|NCT01173718|41999309|FG000|Overall Study|Abandonment of study graft|27|||
19549887|NCT01111240|41999313|FG000|Overall Study|Adverse Event|190|||
19549888|NCT01111240|41999313|FG000|Overall Study|Lack of Efficacy|545|||
19549889|NCT01111240|41999313|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
19549890|NCT01111240|41999313|FG000|Overall Study|Other|312|||
19549891|NCT01111123|41999319|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
19549892|NCT01111123|41999320|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
19549893|NCT01111123|41999319|FG000|Maintenance Phase|Lost to Follow-up|0|||
19549894|NCT01111123|41999320|FG001|Maintenance Phase|Lost to Follow-up|2|||
19549895|NCT01173679|41999328|FG000|Overall Study|Death|1|||
19549896|NCT01110382|41999335|FG000|Overall Study|Withdrawal by Subject|0|||
19549897|NCT01110382|41999336|FG001|Overall Study|Withdrawal by Subject|1|||
19549898|NCT01110382|41999335|FG000|Overall Study|Protocol Violation|0|||
19549899|NCT01110382|41999336|FG001|Overall Study|Protocol Violation|1|||
19549900|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
19549901|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19549902|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19549903|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19549904|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
19549905|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
19549906|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19549907|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19549908|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19549909|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
19549910|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
19549911|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19549912|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19549913|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19549914|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
19549915|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
19549916|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19549917|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19549918|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19549919|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
19549920|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
19549921|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19549922|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19549923|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19549924|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
19549925|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
19549926|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19549927|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19549928|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19549929|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
19549930|NCT01173601|41999346|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
19549931|NCT01173601|41999347|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19549932|NCT01173601|41999348|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19549933|NCT01173601|41999349|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19549934|NCT01173601|41999350|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
19549935|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
19549936|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
19549937|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
19549938|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
19549939|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
19549940|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
19549941|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
19549942|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
19549943|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
19549944|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
19549945|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
19549946|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
19549947|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
19549948|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
19549949|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
19549950|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19549951|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
19549952|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
19549953|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
19549954|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
19549955|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
19549956|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
19549957|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
19549958|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
19549959|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
19549960|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
19549961|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
19549962|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
19549963|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
19549964|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
19549965|NCT01173601|41999346|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19549966|NCT01173601|41999347|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19549967|NCT01173601|41999348|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
19549968|NCT01173601|41999349|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
19549969|NCT01173601|41999350|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
19549970|NCT01173523|41999370|FG000|Overall Study|Clinical Progression|1|||
19549971|NCT01173523|41999371|FG001|Overall Study|Clinical Progression|1|||
19549972|NCT01173523|41999370|FG000|Overall Study|Progressive Disease|10|||
19549973|NCT01173523|41999371|FG001|Overall Study|Progressive Disease|8|||
19549974|NCT01173523|41999370|FG000|Overall Study|Other|2|||
19549975|NCT01173523|41999371|FG001|Overall Study|Other|3|||
19549976|NCT01173055|41999379|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
19549977|NCT01173055|41999380|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
19549978|NCT01173055|41999379|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
19549979|NCT01173055|41999380|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
19549980|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
19549981|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
19549982|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
19549983|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549984|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549985|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549986|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549987|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549988|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
19549989|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
19549990|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
19549991|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
19549992|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549993|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549994|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549995|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549996|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549997|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
19549998|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19549999|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
19550000|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
19550001|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550002|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550003|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550004|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550005|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550006|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
19550007|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
19550008|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
19550009|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
19550010|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550011|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550012|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550013|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550014|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550015|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
19550016|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550017|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
19550018|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550019|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550020|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550021|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550022|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550023|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550024|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
19550025|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
19550026|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550027|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550028|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550029|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550030|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550031|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550032|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550033|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
19550034|NCT01172938|41999389|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550035|NCT01172938|41999390|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
19550036|NCT01172938|41999391|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
19550037|NCT01172938|41999392|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550038|NCT01172938|41999393|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550039|NCT01172938|41999394|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550040|NCT01172938|41999395|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
19717039|NCT00337571|42160010|FG001|Overall Study|Withdrawal by Subject|2|||
19717040|NCT00337571|42160011|FG002|Overall Study|Withdrawal by Subject|1|||
19717041|NCT00337571|42160012|FG003|Overall Study|Withdrawal by Subject|0|||
19717042|NCT00337571|42160009|FG000|Overall Study|Lost to Follow-up|3|||
19717043|NCT00337571|42160010|FG001|Overall Study|Lost to Follow-up|1|||
19717044|NCT00337571|42160011|FG002|Overall Study|Lost to Follow-up|0|||
19717045|NCT00337571|42160012|FG003|Overall Study|Lost to Follow-up|1|||
19717046|NCT00337571|42160009|FG000|Overall Study|Poor/noncompliance|1|||
19717047|NCT00337571|42160010|FG001|Overall Study|Poor/noncompliance|1|||
19717048|NCT00337571|42160011|FG002|Overall Study|Poor/noncompliance|1|||
19717049|NCT00337571|42160012|FG003|Overall Study|Poor/noncompliance|1|||
19717050|NCT00337571|42160009|FG000|Overall Study|No longer met study criteria|1|||
19717051|NCT00337571|42160010|FG001|Overall Study|No longer met study criteria|0|||
19717052|NCT00337571|42160011|FG002|Overall Study|No longer met study criteria|0|||
19717053|NCT00337571|42160012|FG003|Overall Study|No longer met study criteria|0|||
19717054|NCT00337571|42160009|FG000|Overall Study|High Potassium level|0|||
19717055|NCT00337571|42160010|FG001|Overall Study|High Potassium level|0|||
19717056|NCT00337571|42160011|FG002|Overall Study|High Potassium level|0|||
19717057|NCT00337571|42160012|FG003|Overall Study|High Potassium level|1|||
19717058|NCT00368927|42160024|FG000|Overall Study|Lost to Follow-up|2|||
19717059|NCT00368927|42160025|FG001|Overall Study|Lost to Follow-up|0|||
19717060|NCT00368927|42160024|FG000|Overall Study|Adverse Event|1|||
19550041|NCT01172938|41999396|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550042|NCT01172938|41999397|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
19550043|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
19550044|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
19550045|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
19550046|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
19550047|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
19550048|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
19550049|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
19550050|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
19550051|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
19550052|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
19550053|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
19550054|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
19550055|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
19550056|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
19550057|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
19550058|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
19550059|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
19550060|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
19550061|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550062|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550063|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
19550064|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550065|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550066|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550067|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550068|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550069|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
19550070|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
19550071|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
19550072|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
19550073|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
19550074|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
19550075|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
19550076|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
19550077|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
19550078|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
19550079|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550080|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
19550081|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
19550082|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
19550083|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550084|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550085|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550086|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550087|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
19550088|NCT01172938|41999389|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550089|NCT01172938|41999390|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550090|NCT01172938|41999391|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550091|NCT01172938|41999392|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550092|NCT01172938|41999393|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550093|NCT01172938|41999394|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
19550094|NCT01172938|41999395|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
19550095|NCT01172938|41999396|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550096|NCT01172938|41999397|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
19550097|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
19550098|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
19550099|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
19550100|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
19550101|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
19550102|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
19550103|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
19717061|NCT00368927|42160025|FG001|Overall Study|Adverse Event|1|||
19717062|NCT00368927|42160024|FG000|Overall Study|Withdrawal by Subject|1|||
19550104|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
19550105|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
19550106|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550107|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
19550108|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
19550109|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550110|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550111|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550112|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550113|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
19550114|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
19550115|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550116|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550117|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
19550118|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550119|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550120|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550121|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550122|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550123|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
19550124|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
19550125|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
19550126|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
19550127|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
19550128|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
19550129|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
19550130|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
19550131|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
19550132|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
19550133|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550134|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550135|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
19550136|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550137|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550138|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550139|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550140|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550141|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
19550142|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19717063|NCT00368927|42160025|FG001|Overall Study|Withdrawal by Subject|2|||
19717064|NCT00368927|42160024|FG000|Overall Study|Physician Decision|1|||
19717065|NCT00368927|42160025|FG001|Overall Study|Physician Decision|0|||
19717066|NCT00316589|42160048|FG000|Overall Study|Withdrawal by Subject|0|||
19717067|NCT00316589|42160049|FG001|Overall Study|Withdrawal by Subject|5|||
19717068|NCT00316589|42160050|FG002|Overall Study|Withdrawal by Subject|0|||
19717069|NCT00316589|42160051|FG003|Overall Study|Withdrawal by Subject|1|||
19717070|NCT00316589|42160048|FG000|Overall Study|Subject unwilling/unable to comply|0|||
19717071|NCT00316589|42160049|FG001|Overall Study|Subject unwilling/unable to comply|6|||
19717072|NCT00316589|42160050|FG002|Overall Study|Subject unwilling/unable to comply|0|||
19717073|NCT00316589|42160051|FG003|Overall Study|Subject unwilling/unable to comply|2|||
19717074|NCT00316589|42160048|FG000|Overall Study|Adverse Event|1|||
19717075|NCT00316589|42160049|FG001|Overall Study|Adverse Event|0|||
19717076|NCT00316589|42160050|FG002|Overall Study|Adverse Event|0|||
19550143|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
19550144|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
19550145|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19550146|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19550147|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19717077|NCT00316589|42160051|FG003|Overall Study|Adverse Event|1|||
19717078|NCT00316589|42160048|FG000|Overall Study|Physician Decision|0|||
19717079|NCT00316589|42160049|FG001|Overall Study|Physician Decision|1|||
19717080|NCT00316589|42160050|FG002|Overall Study|Physician Decision|0|||
19717081|NCT00316589|42160051|FG003|Overall Study|Physician Decision|0|||
19717082|NCT00316589|42160048|FG000|Overall Study|Other reason|0|||
19717083|NCT00316589|42160049|FG001|Overall Study|Other reason|12|||
19717084|NCT00316589|42160050|FG002|Overall Study|Other reason|1|||
19717085|NCT00316589|42160051|FG003|Overall Study|Other reason|1|||
19717086|NCT00316277|42160065|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
19550148|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19550149|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
19550150|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
19550151|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550152|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
19550153|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550154|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550155|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550156|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550157|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550158|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
19550159|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
19550160|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550161|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
19550162|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550163|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550164|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550165|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550166|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550167|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550168|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
19550169|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550170|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550171|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550172|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550173|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550174|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550175|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550176|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
19550177|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
19550178|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
19550179|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
19550180|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
19550181|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
19550182|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
19550183|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
19550184|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
19550185|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
19550186|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
19550187|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
19550188|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
19550189|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
19550190|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
19550191|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
19550192|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
19550193|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
19550194|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
19550195|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
19550196|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550197|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550198|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550199|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550200|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550201|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550202|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550203|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
19550204|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
19550205|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550206|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
19550207|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550208|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550209|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550210|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550211|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550212|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19717087|NCT00316277|42160066|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
19550213|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
19550214|NCT01172938|41999389|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550215|NCT01172938|41999390|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550216|NCT01172938|41999391|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
19550217|NCT01172938|41999392|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550218|NCT01172938|41999393|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550219|NCT01172938|41999394|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550220|NCT01172938|41999395|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550221|NCT01172938|41999396|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550222|NCT01172938|41999397|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
19550223|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550224|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
19550225|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
19550226|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550227|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550228|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550229|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550230|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
19550231|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
19550232|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
19550233|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
19550234|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
19550235|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
19550236|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
19550237|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
19550238|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
19550239|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
19550240|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
19550241|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
19550242|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
19550243|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
19550244|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
19550245|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
19550246|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
19550247|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
19550248|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
19550249|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
19550250|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550251|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550252|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
19550253|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550254|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550255|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550256|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550257|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
19550258|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
19550259|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550260|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550261|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550262|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550263|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550264|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19717088|NCT00316277|42160065|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
19717089|NCT00316277|42160066|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
19717090|NCT00316277|42160065|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
19717091|NCT00316277|42160066|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
19717092|NCT00316277|42160065|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
19717093|NCT00316277|42160066|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
19717094|NCT00316277|42160065|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
19717095|NCT00316277|42160066|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
19717096|NCT00368849|42160080|FG000|Overall Study|Withdrawal by Subject|0|||
19717097|NCT00368849|42160081|FG001|Overall Study|Withdrawal by Subject|1|||
19717098|NCT00368849|42160080|FG000|Overall Study|Physician Decision|0|||
19717099|NCT00368849|42160081|FG001|Overall Study|Physician Decision|1|||
19717100|NCT00316199|42160088|FG000|Overall Study|Adverse Event|2|||
19717101|NCT00316199|42160088|FG000|Overall Study|Death|8|||
19550265|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550266|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
19550267|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
19550268|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550269|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550270|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
19550271|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550272|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550273|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550274|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
19550275|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
19550276|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
19550277|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550278|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550279|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
19550280|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550281|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550282|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550283|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550284|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550285|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
19550286|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550287|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
19550288|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550289|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550290|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550291|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550292|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550293|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
19550294|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
19550295|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550296|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
19550297|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
19550298|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550299|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550300|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550301|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550302|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
19550303|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
19550304|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550305|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550306|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
19550307|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550308|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550309|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550310|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550311|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550312|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
19550313|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550314|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550315|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
19550316|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550317|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550318|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550319|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550320|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550321|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
19550322|NCT01172938|41999389|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550323|NCT01172938|41999390|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550324|NCT01172938|41999391|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550325|NCT01172938|41999392|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550326|NCT01172938|41999393|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550327|NCT01172938|41999394|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550328|NCT01172938|41999395|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550329|NCT01172938|41999396|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
19550330|NCT01172938|41999397|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
19550331|NCT01109992|41999417|FG000|Overall Study|Withdrawal by Subject|0|||
19550332|NCT01109992|41999418|FG001|Overall Study|Withdrawal by Subject|1|||
19550333|NCT01109992|41999417|FG000|Overall Study|Movement during rest scan.|0|||
19550334|NCT01109992|41999418|FG001|Overall Study|Movement during rest scan.|1|||
19550335|NCT01109524|41999427|FG000|Overall Study|Disease Progression|29|||
19550336|NCT01109524|41999427|FG000|Overall Study|Study Drug toxicity|6|||
19550337|NCT01109524|41999427|FG000|Overall Study|Adverse Event|4|||
19550338|NCT01109524|41999427|FG000|Overall Study|Withdrawal by Subject|2|||
19550339|NCT01109524|41999427|FG000|Overall Study|Maximum clinical benefit|3|||
19550340|NCT01109524|41999427|FG000|Overall Study|Death|2|||
19550341|NCT01109524|41999427|FG000|Overall Study|No longer meets criteria|2|||
19550342|NCT01109524|41999427|FG000|Overall Study|Participant requested to end treatment|4|||
19550343|NCT01109524|41999427|FG000|Overall Study|Other|5|||
19550344|NCT01109173|41999442|FG000|Overall Study|Adverse Event|15|||
19550345|NCT01109173|41999443|FG001|Overall Study|Adverse Event|17|||
19550346|NCT01109173|41999444|FG002|Overall Study|Adverse Event|9|||
19550347|NCT01109173|41999445|FG003|Overall Study|Adverse Event|6|||
19550348|NCT01109173|41999442|FG000|Overall Study|Lost to Follow-up|0|||
19550349|NCT01109173|41999443|FG001|Overall Study|Lost to Follow-up|1|||
19550350|NCT01109173|41999444|FG002|Overall Study|Lost to Follow-up|0|||
19550351|NCT01109173|41999445|FG003|Overall Study|Lost to Follow-up|0|||
19550352|NCT01109173|41999442|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
19550353|NCT01109173|41999443|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
19550354|NCT01109173|41999444|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
19550355|NCT01109173|41999445|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
19550356|NCT01109173|41999442|FG000|Overall Study|Noncompliance|0|||
19550357|NCT01109173|41999443|FG001|Overall Study|Noncompliance|1|||
19550358|NCT01109173|41999444|FG002|Overall Study|Noncompliance|0|||
19550359|NCT01109173|41999445|FG003|Overall Study|Noncompliance|0|||
19550360|NCT01109173|41999442|FG000|Overall Study|Treatment Failure|25|||
19550361|NCT01109173|41999443|FG001|Overall Study|Treatment Failure|32|||
19550362|NCT01109173|41999444|FG002|Overall Study|Treatment Failure|69|||
19550363|NCT01109173|41999445|FG003|Overall Study|Treatment Failure|64|||
19550364|NCT01109173|41999442|FG000|Overall Study|Protocol Violation|4|||
19550365|NCT01109173|41999443|FG001|Overall Study|Protocol Violation|5|||
19550366|NCT01109173|41999444|FG002|Overall Study|Protocol Violation|1|||
19550367|NCT01109173|41999445|FG003|Overall Study|Protocol Violation|2|||
19550368|NCT01109173|41999442|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
19550369|NCT01109173|41999443|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
19717102|NCT00316199|42160088|FG000|Overall Study|Lost to Follow-up|2|||
19717103|NCT00316121|42160094|FG000|Overall Study|Death|1|||
19717104|NCT00316121|42160095|FG001|Overall Study|Death|0|||
19717105|NCT00316121|42160094|FG000|Overall Study|Lost to Follow-up|14|||
19717106|NCT00316121|42160095|FG001|Overall Study|Lost to Follow-up|8|||
19717107|NCT00316121|42160094|FG000|Overall Study|Withdrawal by Subject|2|||
19717108|NCT00316121|42160095|FG001|Overall Study|Withdrawal by Subject|0|||
19717109|NCT00316121|42160094|FG000|Overall Study|Reason is missing|1|||
19717110|NCT00316121|42160095|FG001|Overall Study|Reason is missing|0|||
19717111|NCT00316121|42160094|FG000|Overall Study|Subject relocated|1|||
19717112|NCT00316121|42160095|FG001|Overall Study|Subject relocated|1|||
19717113|NCT00316121|42160094|FG000|Overall Study|Subject refused to return|1|||
19717114|NCT00316121|42160095|FG001|Overall Study|Subject refused to return|0|||
19717115|NCT00316121|42160094|FG000|Overall Study|Subject no show for visit x 3|1|||
19717116|NCT00316121|42160095|FG001|Overall Study|Subject no show for visit x 3|0|||
19717117|NCT00316121|42160094|FG000|Overall Study|Subject did not have 24 month visit|1|||
19717118|NCT00316121|42160095|FG001|Overall Study|Subject did not have 24 month visit|0|||
19717119|NCT00337103|42160114|FG000|Overall Study|Progressive Disease|414|||
19717120|NCT00337103|42160115|FG001|Overall Study|Progressive Disease|410|||
19717121|NCT00337103|42160114|FG000|Overall Study|Adverse Event|45|||
19717122|NCT00337103|42160115|FG001|Overall Study|Adverse Event|59|||
19717123|NCT00337103|42160114|FG000|Overall Study|Subject Choice|34|||
19717124|NCT00337103|42160115|FG001|Overall Study|Subject Choice|27|||
19717125|NCT00337103|42160114|FG000|Overall Study|Clinical Progression|27|||
19717126|NCT00337103|42160115|FG001|Overall Study|Clinical Progression|24|||
19717127|NCT00337103|42160114|FG000|Overall Study|Physician Decision|15|||
19717128|NCT00337103|42160115|FG001|Overall Study|Physician Decision|14|||
19717129|NCT00337103|42160114|FG000|Overall Study|Withdrawal by Subject|8|||
19550370|NCT01109173|41999444|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
19550371|NCT01109173|41999445|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
19550372|NCT01109173|41999442|FG000|Overall Study|Not Specifiied|5|||
19717130|NCT00337103|42160115|FG001|Overall Study|Withdrawal by Subject|5|||
19717131|NCT00337103|42160114|FG000|Overall Study|Other|5|||
19717132|NCT00337103|42160115|FG001|Overall Study|Other|6|||
19717133|NCT00337103|42160114|FG000|Overall Study|Entry Criteria Not Met|4|||
19717134|NCT00337103|42160115|FG001|Overall Study|Entry Criteria Not Met|1|||
19550373|NCT01109173|41999443|FG001|Overall Study|Not Specifiied|4|||
19550374|NCT01109173|41999444|FG002|Overall Study|Not Specifiied|9|||
19550375|NCT01109173|41999445|FG003|Overall Study|Not Specifiied|14|||
19550376|NCT01172821|41999459|FG000|Overall Study|Adverse Event|5|||
19550377|NCT01172821|41999460|FG001|Overall Study|Adverse Event|2|||
19550378|NCT01172821|41999461|FG002|Overall Study|Adverse Event|2|||
19550379|NCT01172821|41999462|FG003|Overall Study|Adverse Event|7|||
19550380|NCT01172821|41999459|FG000|Overall Study|Protocol Violation|0|||
19550381|NCT01172821|41999460|FG001|Overall Study|Protocol Violation|2|||
19550382|NCT01172821|41999461|FG002|Overall Study|Protocol Violation|1|||
19550383|NCT01172821|41999462|FG003|Overall Study|Protocol Violation|2|||
19550384|NCT01172821|41999459|FG000|Overall Study|Lost to Follow-up|4|||
19550385|NCT01172821|41999460|FG001|Overall Study|Lost to Follow-up|1|||
19550386|NCT01172821|41999461|FG002|Overall Study|Lost to Follow-up|2|||
19550387|NCT01172821|41999462|FG003|Overall Study|Lost to Follow-up|2|||
19550388|NCT01172821|41999459|FG000|Overall Study|Withdrawal by Subject|2|||
19550389|NCT01172821|41999460|FG001|Overall Study|Withdrawal by Subject|3|||
19550390|NCT01172821|41999461|FG002|Overall Study|Withdrawal by Subject|3|||
19550391|NCT01172821|41999462|FG003|Overall Study|Withdrawal by Subject|3|||
19550392|NCT01172821|41999459|FG000|Overall Study|Other|3|||
19550393|NCT01172821|41999460|FG001|Overall Study|Other|4|||
19550394|NCT01172821|41999461|FG002|Overall Study|Other|5|||
19550395|NCT01172821|41999462|FG003|Overall Study|Other|3|||
19550396|NCT01172275|41999474|FG000|Overall Study|Lost to Follow-up|1|||
19550397|NCT01172275|41999475|FG001|Overall Study|Lost to Follow-up|0|||
19550398|NCT01172275|41999474|FG000|Overall Study|Protocol Violation|1|||
19550399|NCT01172275|41999475|FG001|Overall Study|Protocol Violation|0|||
19550400|NCT01108510|41999483|FG000|Overall Study|Randomized but Not Treated|5|||
19550401|NCT01108510|41999484|FG001|Overall Study|Randomized but Not Treated|1|||
19550402|NCT01108510|41999483|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
19550403|NCT01108510|41999484|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
19550404|NCT01108510|41999483|FG000|Overall Study|Adverse Event|26|||
19550405|NCT01108510|41999484|FG001|Overall Study|Adverse Event|19|||
19550406|NCT01108510|41999483|FG000|Overall Study|Lost to Follow-up|20|||
19550407|NCT01108510|41999484|FG001|Overall Study|Lost to Follow-up|17|||
19550408|NCT01108510|41999483|FG000|Overall Study|Withdrew Consent|21|||
19550409|NCT01108510|41999484|FG001|Overall Study|Withdrew Consent|15|||
19550410|NCT01108510|41999483|FG000|Overall Study|Investigator's Discretion|12|||
19550411|NCT01108510|41999484|FG001|Overall Study|Investigator's Discretion|10|||
19550412|NCT01108510|41999483|FG000|Overall Study|Participant Noncompliance|5|||
19550413|NCT01108510|41999484|FG001|Overall Study|Participant Noncompliance|7|||
19717135|NCT00337103|42160114|FG000|Overall Study|Lost to Follow-up|1|||
19717136|NCT00337103|42160115|FG001|Overall Study|Lost to Follow-up|2|||
19717137|NCT00337103|42160114|FG000|Overall Study|Death|1|||
19717138|NCT00337103|42160115|FG001|Overall Study|Death|0|||
19717139|NCT00415532|42160124|FG000|Treatment Period|Adverse Event|2|||
19717140|NCT00415532|42160125|FG001|Treatment Period|Adverse Event|3|||
19717141|NCT00415532|42160124|FG000|Treatment Period|Death|2|||
19717142|NCT00415532|42160125|FG001|Treatment Period|Death|1|||
19717143|NCT00415532|42160124|FG000|Treatment Period|Lost to Follow-up|1|||
19717144|NCT00415532|42160125|FG001|Treatment Period|Lost to Follow-up|1|||
19717145|NCT00415532|42160124|FG000|Treatment Period|Protocol Violation|1|||
19717146|NCT00415532|42160125|FG001|Treatment Period|Protocol Violation|0|||
19550414|NCT01108510|41999483|FG000|Overall Study|Lack of Efficacy|3|||
19550415|NCT01108510|41999484|FG001|Overall Study|Lack of Efficacy|0|||
19550416|NCT01108510|41999483|FG000|Overall Study|Pregnancy|0|||
19550417|NCT01108510|41999484|FG001|Overall Study|Pregnancy|3|||
19550418|NCT01108510|41999483|FG000|Overall Study|Death|1|||
19550419|NCT01108510|41999484|FG001|Overall Study|Death|1|||
19550420|NCT01108237|41999492|FG000|Overall Study|No alignment data|2|||
19550421|NCT01108237|41999493|FG001|Overall Study|No alignment data|17|||
19550422|NCT01108237|41999492|FG000|Overall Study|Did not meet criteria for analysis|7|||
19550423|NCT01108237|41999493|FG001|Overall Study|Did not meet criteria for analysis|0|||
19550424|NCT01340027|41999511|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
19550425|NCT01340027|41999512|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
19550426|NCT01340027|41999513|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
19550427|NCT01340027|41999514|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
19550428|NCT01340027|41999515|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
19550429|NCT01340027|41999516|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
19550430|NCT01340027|41999517|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
19550431|NCT01340027|41999518|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
19550432|NCT01340027|41999519|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
19550433|NCT01340027|41999520|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
19550434|NCT01340027|41999521|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
19550435|NCT01340027|41999522|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
19717147|NCT00415532|42160124|FG000|Treatment Period|Withdrawal by Subject|6|||
19717148|NCT00415532|42160125|FG001|Treatment Period|Withdrawal by Subject|6|||
19550436|NCT01340027|41999511|FG000|Overall Study|Adverse Event|0|||
19550437|NCT01340027|41999512|FG001|Overall Study|Adverse Event|1|||
19550438|NCT01340027|41999513|FG002|Overall Study|Adverse Event|2|||
19550439|NCT01340027|41999514|FG003|Overall Study|Adverse Event|0|||
19550440|NCT01340027|41999515|FG004|Overall Study|Adverse Event|1|||
19550441|NCT01340027|41999516|FG005|Overall Study|Adverse Event|2|||
19550442|NCT01340027|41999517|FG006|Overall Study|Adverse Event|2|||
19550443|NCT01340027|41999518|FG007|Overall Study|Adverse Event|1|||
19550444|NCT01340027|41999519|FG008|Overall Study|Adverse Event|4|||
19550445|NCT01340027|41999520|FG009|Overall Study|Adverse Event|1|||
19550446|NCT01340027|41999521|FG010|Overall Study|Adverse Event|1|||
19550447|NCT01340027|41999522|FG011|Overall Study|Adverse Event|3|||
19550448|NCT01340027|41999511|FG000|Overall Study|Lack of Efficacy|0|||
19550449|NCT01340027|41999512|FG001|Overall Study|Lack of Efficacy|0|||
19550450|NCT01340027|41999513|FG002|Overall Study|Lack of Efficacy|0|||
19550451|NCT01340027|41999514|FG003|Overall Study|Lack of Efficacy|0|||
19550452|NCT01340027|41999515|FG004|Overall Study|Lack of Efficacy|0|||
19550453|NCT01340027|41999516|FG005|Overall Study|Lack of Efficacy|0|||
19550454|NCT01340027|41999517|FG006|Overall Study|Lack of Efficacy|1|||
19550455|NCT01340027|41999518|FG007|Overall Study|Lack of Efficacy|1|||
19550456|NCT01340027|41999519|FG008|Overall Study|Lack of Efficacy|1|||
19550457|NCT01340027|41999520|FG009|Overall Study|Lack of Efficacy|0|||
19550458|NCT01340027|41999521|FG010|Overall Study|Lack of Efficacy|0|||
19550459|NCT01340027|41999522|FG011|Overall Study|Lack of Efficacy|0|||
19550460|NCT01340027|41999511|FG000|Overall Study|Lost to Follow-up|0|||
19550461|NCT01340027|41999512|FG001|Overall Study|Lost to Follow-up|1|||
19550462|NCT01340027|41999513|FG002|Overall Study|Lost to Follow-up|0|||
19550463|NCT01340027|41999514|FG003|Overall Study|Lost to Follow-up|0|||
19550464|NCT01340027|41999515|FG004|Overall Study|Lost to Follow-up|0|||
19550465|NCT01340027|41999516|FG005|Overall Study|Lost to Follow-up|0|||
19550466|NCT01340027|41999517|FG006|Overall Study|Lost to Follow-up|1|||
19550467|NCT01340027|41999518|FG007|Overall Study|Lost to Follow-up|0|||
19550468|NCT01340027|41999519|FG008|Overall Study|Lost to Follow-up|0|||
19550469|NCT01340027|41999520|FG009|Overall Study|Lost to Follow-up|1|||
19550470|NCT01340027|41999521|FG010|Overall Study|Lost to Follow-up|0|||
19550471|NCT01340027|41999522|FG011|Overall Study|Lost to Follow-up|0|||
19550472|NCT01340027|41999511|FG000|Overall Study|Protocol Violation|1|||
19550473|NCT01340027|41999512|FG001|Overall Study|Protocol Violation|2|||
19550474|NCT01340027|41999513|FG002|Overall Study|Protocol Violation|0|||
19550475|NCT01340027|41999514|FG003|Overall Study|Protocol Violation|0|||
19550476|NCT01340027|41999515|FG004|Overall Study|Protocol Violation|6|||
19550477|NCT01340027|41999516|FG005|Overall Study|Protocol Violation|0|||
19550478|NCT01340027|41999517|FG006|Overall Study|Protocol Violation|0|||
19550479|NCT01340027|41999518|FG007|Overall Study|Protocol Violation|1|||
19550480|NCT01340027|41999519|FG008|Overall Study|Protocol Violation|2|||
19550481|NCT01340027|41999520|FG009|Overall Study|Protocol Violation|2|||
19550482|NCT01340027|41999521|FG010|Overall Study|Protocol Violation|0|||
19550483|NCT01340027|41999522|FG011|Overall Study|Protocol Violation|0|||
19550484|NCT01340027|41999511|FG000|Overall Study|Withdrawal by Subject|4|||
19550485|NCT01340027|41999512|FG001|Overall Study|Withdrawal by Subject|3|||
19550486|NCT01340027|41999513|FG002|Overall Study|Withdrawal by Subject|1|||
19550487|NCT01340027|41999514|FG003|Overall Study|Withdrawal by Subject|3|||
19550488|NCT01340027|41999515|FG004|Overall Study|Withdrawal by Subject|3|||
19550489|NCT01340027|41999516|FG005|Overall Study|Withdrawal by Subject|2|||
19550490|NCT01340027|41999517|FG006|Overall Study|Withdrawal by Subject|3|||
19550491|NCT01340027|41999518|FG007|Overall Study|Withdrawal by Subject|4|||
19550492|NCT01340027|41999519|FG008|Overall Study|Withdrawal by Subject|1|||
19550493|NCT01340027|41999520|FG009|Overall Study|Withdrawal by Subject|2|||
19550494|NCT01340027|41999521|FG010|Overall Study|Withdrawal by Subject|0|||
19550495|NCT01340027|41999522|FG011|Overall Study|Withdrawal by Subject|1|||
19550496|NCT01340027|41999511|FG000|Overall Study|Miscellaneous|0|||
19550497|NCT01340027|41999512|FG001|Overall Study|Miscellaneous|0|||
19550498|NCT01340027|41999513|FG002|Overall Study|Miscellaneous|0|||
19550499|NCT01340027|41999514|FG003|Overall Study|Miscellaneous|1|||
19550500|NCT01340027|41999515|FG004|Overall Study|Miscellaneous|0|||
19550501|NCT01340027|41999516|FG005|Overall Study|Miscellaneous|0|||
19550502|NCT01340027|41999517|FG006|Overall Study|Miscellaneous|0|||
19550503|NCT01340027|41999518|FG007|Overall Study|Miscellaneous|0|||
19550504|NCT01340027|41999519|FG008|Overall Study|Miscellaneous|0|||
19550505|NCT01340027|41999520|FG009|Overall Study|Miscellaneous|0|||
19550506|NCT01340027|41999521|FG010|Overall Study|Miscellaneous|1|||
19550507|NCT01340027|41999522|FG011|Overall Study|Miscellaneous|0|||
19550508|NCT01327053|41999550|FG000|Overall Study|Adverse Event|23|||
19550509|NCT01327053|41999551|FG001|Overall Study|Adverse Event|57|||
19550510|NCT01327053|41999550|FG000|Overall Study|Patient/guardian decision|11|||
19550511|NCT01327053|41999551|FG001|Overall Study|Patient/guardian decision|35|||
19550512|NCT01327053|41999550|FG000|Overall Study|Physician Decision|10|||
19550513|NCT01327053|41999551|FG001|Overall Study|Physician Decision|14|||
19550514|NCT01327053|41999550|FG000|Overall Study|Death|1|||
19550515|NCT01327053|41999551|FG001|Overall Study|Death|5|||
19550516|NCT01327053|41999550|FG000|Overall Study|Lost to Follow-up|2|||
19550517|NCT01327053|41999551|FG001|Overall Study|Lost to Follow-up|4|||
19550518|NCT01327053|41999550|FG000|Overall Study|Non-compliance with study treatment|0|||
19550519|NCT01327053|41999551|FG001|Overall Study|Non-compliance with study treatment|5|||
19550520|NCT01327053|41999550|FG000|Overall Study|Study terminated by Sponsor|1|||
19550521|NCT01327053|41999551|FG001|Overall Study|Study terminated by Sponsor|3|||
19550522|NCT01327053|41999550|FG000|Overall Study|Progressive disease|31|||
19550523|NCT01327053|41999551|FG001|Overall Study|Progressive disease|26|||
19550524|NCT01327053|41999550|FG000|Overall Study|Protocol Violation|0|||
19550525|NCT01327053|41999551|FG001|Overall Study|Protocol Violation|1|||
19550526|NCT01327053|41999550|FG000|Overall Study|Untreated|0|||
19550527|NCT01327053|41999551|FG001|Overall Study|Untreated|1|||
19717149|NCT00415532|42160124|FG000|Treatment Period|Other|2|||
19717150|NCT00415532|42160125|FG001|Treatment Period|Other|2|||
19717151|NCT00415532|42160124|FG000|Treatment Period|Ineligibility determined|1|||
19717152|NCT00415532|42160125|FG001|Treatment Period|Ineligibility determined|1|||
19717153|NCT00415532|42160124|FG000|Treatment Period|Noncompliance|1|||
19717154|NCT00415532|42160125|FG001|Treatment Period|Noncompliance|1|||
19717155|NCT00415532|42160124|FG000|Treatment Period|Requirement for alternative therapy|1|||
19717156|NCT00415532|42160125|FG001|Treatment Period|Requirement for alternative therapy|0|||
19717157|NCT00415532|42160124|FG000|Safety Follow Up Period|Adverse Event|1|||
19717158|NCT00415532|42160125|FG001|Safety Follow Up Period|Adverse Event|3|||
19717159|NCT00415532|42160124|FG000|Safety Follow Up Period|Death|3|||
19717160|NCT00415532|42160125|FG001|Safety Follow Up Period|Death|0|||
19717161|NCT00415532|42160124|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
19717162|NCT00415532|42160125|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
19717163|NCT00415532|42160124|FG000|Safety Follow Up Period|Other|1|||
19717164|NCT00415532|42160125|FG001|Safety Follow Up Period|Other|4|||
19717165|NCT00415532|42160124|FG000|Safety Follow Up Period|Ineligibility determined|1|||
19717166|NCT00415532|42160125|FG001|Safety Follow Up Period|Ineligibility determined|1|||
19717167|NCT00415532|42160124|FG000|Safety Follow Up Period|Noncompliance|1|||
19717168|NCT00415532|42160125|FG001|Safety Follow Up Period|Noncompliance|0|||
19717169|NCT00415532|42160124|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
19717170|NCT00415532|42160125|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
19717171|NCT00315731|42160131|FG000|Overall Study|Lost to Follow-up|1|||
19717172|NCT00315731|42160131|FG000|Overall Study|Death|5|||
19717173|NCT00062868|42160158|FG000|Dose Level 1|Death|2|||
19717174|NCT00062868|42160159|FG001|Dose Level 1|Death|0|||
19717175|NCT00062868|42160160|FG002|Dose Level 1|Death|0|||
19717176|NCT00062868|42160161|FG003|Dose Level 1|Death|2|||
19717177|NCT00062868|42160162|FG004|Dose Level 1|Death|0|||
19717178|NCT00062868|42160163|FG005|Dose Level 1|Death|0|||
19717179|NCT00062868|42160164|FG006|Dose Level 1|Death|3|||
19717180|NCT00062868|42160165|FG007|Dose Level 1|Death|0|||
19717181|NCT00062868|42160166|FG008|Dose Level 1|Death|0|||
19717182|NCT00062868|42160167|FG009|Dose Level 1|Death|0|||
19717183|NCT00062868|42160168|FG010|Dose Level 1|Death|0|||
19717184|NCT00062868|42160169|FG011|Dose Level 1|Death|0|||
19717185|NCT00062868|42160170|FG012|Dose Level 1|Death|0|||
19717186|NCT00062868|42160171|FG013|Dose Level 1|Death|0|||
19717187|NCT00062868|42160172|FG014|Dose Level 1|Death|0|||
19717188|NCT00062868|42160173|FG015|Dose Level 1|Death|0|||
19717189|NCT00062868|42160174|FG016|Dose Level 1|Death|0|||
19717190|NCT00062868|42160175|FG017|Dose Level 1|Death|0|||
19717191|NCT00062868|42160176|FG018|Dose Level 1|Death|7|||
19717192|NCT00062868|42160177|FG019|Dose Level 1|Death|0|||
19717193|NCT00062868|42160178|FG020|Dose Level 1|Death|1|||
19717194|NCT00062868|42160158|FG000|Dose Level 1|Lost to Follow-up|0|||
19717195|NCT00062868|42160159|FG001|Dose Level 1|Lost to Follow-up|0|||
19717196|NCT00062868|42160160|FG002|Dose Level 1|Lost to Follow-up|0|||
19717197|NCT00062868|42160161|FG003|Dose Level 1|Lost to Follow-up|0|||
19717198|NCT00062868|42160162|FG004|Dose Level 1|Lost to Follow-up|0|||
19717199|NCT00062868|42160163|FG005|Dose Level 1|Lost to Follow-up|0|||
19717200|NCT00062868|42160164|FG006|Dose Level 1|Lost to Follow-up|0|||
19717201|NCT00062868|42160165|FG007|Dose Level 1|Lost to Follow-up|0|||
19717202|NCT00062868|42160166|FG008|Dose Level 1|Lost to Follow-up|0|||
19717203|NCT00062868|42160167|FG009|Dose Level 1|Lost to Follow-up|0|||
19717204|NCT00062868|42160168|FG010|Dose Level 1|Lost to Follow-up|0|||
19717205|NCT00062868|42160169|FG011|Dose Level 1|Lost to Follow-up|0|||
19717206|NCT00062868|42160170|FG012|Dose Level 1|Lost to Follow-up|1|||
19717207|NCT00062868|42160171|FG013|Dose Level 1|Lost to Follow-up|0|||
19717208|NCT00062868|42160172|FG014|Dose Level 1|Lost to Follow-up|0|||
19717209|NCT00062868|42160173|FG015|Dose Level 1|Lost to Follow-up|0|||
19717210|NCT00062868|42160174|FG016|Dose Level 1|Lost to Follow-up|0|||
19550528|NCT01107925|41999565|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
19550529|NCT01107925|41999566|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
19717211|NCT00062868|42160175|FG017|Dose Level 1|Lost to Follow-up|0|||
19717212|NCT00062868|42160176|FG018|Dose Level 1|Lost to Follow-up|2|||
19717213|NCT00062868|42160177|FG019|Dose Level 1|Lost to Follow-up|0|||
19717214|NCT00062868|42160178|FG020|Dose Level 1|Lost to Follow-up|1|||
19717215|NCT00062868|42160158|FG000|Dose Level 2|Death|0|||
19717216|NCT00062868|42160159|FG001|Dose Level 2|Death|3|||
19717217|NCT00062868|42160160|FG002|Dose Level 2|Death|0|||
19717218|NCT00062868|42160161|FG003|Dose Level 2|Death|0|||
19717219|NCT00062868|42160162|FG004|Dose Level 2|Death|2|||
19717220|NCT00062868|42160163|FG005|Dose Level 2|Death|0|||
19717221|NCT00062868|42160164|FG006|Dose Level 2|Death|0|||
19717222|NCT00062868|42160165|FG007|Dose Level 2|Death|0|||
19717223|NCT00062868|42160166|FG008|Dose Level 2|Death|0|||
19717224|NCT00062868|42160167|FG009|Dose Level 2|Death|0|||
19717225|NCT00062868|42160168|FG010|Dose Level 2|Death|1|||
19717226|NCT00062868|42160169|FG011|Dose Level 2|Death|0|||
19717227|NCT00062868|42160170|FG012|Dose Level 2|Death|0|||
19717228|NCT00062868|42160171|FG013|Dose Level 2|Death|0|||
19717229|NCT00062868|42160172|FG014|Dose Level 2|Death|0|||
19717230|NCT00062868|42160173|FG015|Dose Level 2|Death|0|||
19717231|NCT00062868|42160174|FG016|Dose Level 2|Death|2|||
19717232|NCT00062868|42160175|FG017|Dose Level 2|Death|0|||
19717233|NCT00062868|42160176|FG018|Dose Level 2|Death|0|||
19717234|NCT00062868|42160177|FG019|Dose Level 2|Death|0|||
19717235|NCT00062868|42160178|FG020|Dose Level 2|Death|0|||
19717236|NCT00062868|42160158|FG000|Dose Level 2|Lost to Follow-up|0|||
19717237|NCT00062868|42160159|FG001|Dose Level 2|Lost to Follow-up|0|||
19717238|NCT00062868|42160160|FG002|Dose Level 2|Lost to Follow-up|0|||
19717239|NCT00062868|42160161|FG003|Dose Level 2|Lost to Follow-up|0|||
19717240|NCT00062868|42160162|FG004|Dose Level 2|Lost to Follow-up|0|||
19717241|NCT00062868|42160163|FG005|Dose Level 2|Lost to Follow-up|0|||
19717242|NCT00062868|42160164|FG006|Dose Level 2|Lost to Follow-up|0|||
19717243|NCT00062868|42160165|FG007|Dose Level 2|Lost to Follow-up|0|||
19717244|NCT00062868|42160166|FG008|Dose Level 2|Lost to Follow-up|0|||
19717245|NCT00062868|42160167|FG009|Dose Level 2|Lost to Follow-up|0|||
19717246|NCT00062868|42160168|FG010|Dose Level 2|Lost to Follow-up|0|||
19717247|NCT00062868|42160169|FG011|Dose Level 2|Lost to Follow-up|0|||
19717248|NCT00062868|42160170|FG012|Dose Level 2|Lost to Follow-up|0|||
19717249|NCT00062868|42160171|FG013|Dose Level 2|Lost to Follow-up|1|||
19717250|NCT00062868|42160172|FG014|Dose Level 2|Lost to Follow-up|0|||
19717251|NCT00062868|42160173|FG015|Dose Level 2|Lost to Follow-up|0|||
19717252|NCT00062868|42160174|FG016|Dose Level 2|Lost to Follow-up|1|||
19717253|NCT00062868|42160175|FG017|Dose Level 2|Lost to Follow-up|0|||
19717254|NCT00062868|42160176|FG018|Dose Level 2|Lost to Follow-up|0|||
19717255|NCT00062868|42160177|FG019|Dose Level 2|Lost to Follow-up|0|||
19717256|NCT00062868|42160178|FG020|Dose Level 2|Lost to Follow-up|0|||
19717257|NCT00062868|42160158|FG000|Dose Level 3|Death|0|||
19717258|NCT00062868|42160159|FG001|Dose Level 3|Death|0|||
19717259|NCT00062868|42160160|FG002|Dose Level 3|Death|0|||
19717260|NCT00062868|42160161|FG003|Dose Level 3|Death|0|||
19717261|NCT00062868|42160162|FG004|Dose Level 3|Death|0|||
19717262|NCT00062868|42160163|FG005|Dose Level 3|Death|0|||
19717263|NCT00062868|42160164|FG006|Dose Level 3|Death|0|||
19717264|NCT00062868|42160165|FG007|Dose Level 3|Death|0|||
19717265|NCT00062868|42160166|FG008|Dose Level 3|Death|0|||
19717266|NCT00062868|42160167|FG009|Dose Level 3|Death|0|||
19717267|NCT00062868|42160168|FG010|Dose Level 3|Death|0|||
19717268|NCT00062868|42160169|FG011|Dose Level 3|Death|1|||
19717269|NCT00062868|42160170|FG012|Dose Level 3|Death|0|||
19717270|NCT00062868|42160171|FG013|Dose Level 3|Death|0|||
19717271|NCT00062868|42160172|FG014|Dose Level 3|Death|0|||
19717272|NCT00062868|42160173|FG015|Dose Level 3|Death|0|||
19717273|NCT00062868|42160174|FG016|Dose Level 3|Death|0|||
19717274|NCT00062868|42160175|FG017|Dose Level 3|Death|1|||
19717275|NCT00062868|42160176|FG018|Dose Level 3|Death|0|||
19717276|NCT00062868|42160177|FG019|Dose Level 3|Death|0|||
19717277|NCT00062868|42160178|FG020|Dose Level 3|Death|0|||
19717278|NCT00062868|42160158|FG000|Dose Level 3|Lost to Follow-up|0|||
19717279|NCT00062868|42160159|FG001|Dose Level 3|Lost to Follow-up|0|||
19717280|NCT00062868|42160160|FG002|Dose Level 3|Lost to Follow-up|0|||
19717281|NCT00062868|42160161|FG003|Dose Level 3|Lost to Follow-up|0|||
19717282|NCT00062868|42160162|FG004|Dose Level 3|Lost to Follow-up|0|||
19717283|NCT00062868|42160163|FG005|Dose Level 3|Lost to Follow-up|0|||
19717284|NCT00062868|42160164|FG006|Dose Level 3|Lost to Follow-up|0|||
19717285|NCT00062868|42160165|FG007|Dose Level 3|Lost to Follow-up|0|||
19717286|NCT00062868|42160166|FG008|Dose Level 3|Lost to Follow-up|0|||
19717287|NCT00062868|42160167|FG009|Dose Level 3|Lost to Follow-up|0|||
19717288|NCT00062868|42160168|FG010|Dose Level 3|Lost to Follow-up|0|||
19717289|NCT00062868|42160169|FG011|Dose Level 3|Lost to Follow-up|0|||
19717290|NCT00062868|42160170|FG012|Dose Level 3|Lost to Follow-up|0|||
19717291|NCT00062868|42160171|FG013|Dose Level 3|Lost to Follow-up|0|||
19717292|NCT00062868|42160172|FG014|Dose Level 3|Lost to Follow-up|1|||
19717293|NCT00062868|42160173|FG015|Dose Level 3|Lost to Follow-up|0|||
19717294|NCT00062868|42160174|FG016|Dose Level 3|Lost to Follow-up|0|||
19717295|NCT00062868|42160175|FG017|Dose Level 3|Lost to Follow-up|0|||
19717296|NCT00062868|42160176|FG018|Dose Level 3|Lost to Follow-up|0|||
19717297|NCT00062868|42160177|FG019|Dose Level 3|Lost to Follow-up|0|||
19717298|NCT00062868|42160178|FG020|Dose Level 3|Lost to Follow-up|0|||
19717299|NCT00062868|42160158|FG000|Dose Level 3|Withdrew|0|||
19717300|NCT00062868|42160159|FG001|Dose Level 3|Withdrew|0|||
19717301|NCT00062868|42160160|FG002|Dose Level 3|Withdrew|2|||
19717302|NCT00062868|42160161|FG003|Dose Level 3|Withdrew|0|||
19717303|NCT00062868|42160162|FG004|Dose Level 3|Withdrew|0|||
19717304|NCT00062868|42160163|FG005|Dose Level 3|Withdrew|0|||
19717305|NCT00062868|42160164|FG006|Dose Level 3|Withdrew|0|||
19717306|NCT00062868|42160165|FG007|Dose Level 3|Withdrew|0|||
19717307|NCT00062868|42160166|FG008|Dose Level 3|Withdrew|0|||
19717308|NCT00062868|42160167|FG009|Dose Level 3|Withdrew|0|||
19717309|NCT00062868|42160168|FG010|Dose Level 3|Withdrew|0|||
19717310|NCT00062868|42160169|FG011|Dose Level 3|Withdrew|0|||
19717311|NCT00062868|42160170|FG012|Dose Level 3|Withdrew|0|||
19717312|NCT00062868|42160171|FG013|Dose Level 3|Withdrew|0|||
19717313|NCT00062868|42160172|FG014|Dose Level 3|Withdrew|0|||
19717314|NCT00062868|42160173|FG015|Dose Level 3|Withdrew|0|||
19717315|NCT00062868|42160174|FG016|Dose Level 3|Withdrew|0|||
19717316|NCT00062868|42160175|FG017|Dose Level 3|Withdrew|0|||
19717317|NCT00062868|42160176|FG018|Dose Level 3|Withdrew|0|||
19717318|NCT00062868|42160177|FG019|Dose Level 3|Withdrew|0|||
19717319|NCT00062868|42160178|FG020|Dose Level 3|Withdrew|0|||
19717320|NCT00075504|42160224|FG000|Overall Study|Withdrawal by Subject|9|||
19717321|NCT00075504|42160225|FG001|Overall Study|Withdrawal by Subject|7|||
19717322|NCT00062166|42160231|FG000|Overall Study|Withdrawal by Subject|6|||
19717323|NCT00087438|42160236|FG000|Overall Study|Ineligible / No protocol treatment|4|||
19717324|NCT00321464|42160244|FG000|Overall Study|Death|169|||
19717325|NCT00321464|42160245|FG001|Overall Study|Death|174|||
19717326|NCT00321464|42160244|FG000|Overall Study|Disease progression|124|||
19717327|NCT00321464|42160245|FG001|Overall Study|Disease progression|124|||
19717328|NCT00321464|42160244|FG000|Overall Study|Withdrawal by Subject|117|||
19717329|NCT00321464|42160245|FG001|Overall Study|Withdrawal by Subject|118|||
19717330|NCT00321464|42160244|FG000|Overall Study|Participant request|57|||
19717331|NCT00321464|42160245|FG001|Overall Study|Participant request|61|||
19717332|NCT00321464|42160244|FG000|Overall Study|Adverse Event|43|||
19717333|NCT00321464|42160245|FG001|Overall Study|Adverse Event|28|||
19717334|NCT00321464|42160244|FG000|Overall Study|Physician Decision|15|||
19717335|NCT00321464|42160245|FG001|Overall Study|Physician Decision|14|||
19717336|NCT00321464|42160244|FG000|Overall Study|Noncompliance|4|||
19717337|NCT00321464|42160245|FG001|Overall Study|Noncompliance|10|||
19717338|NCT00321464|42160244|FG000|Overall Study|Lost to Follow-up|7|||
19717339|NCT00321464|42160245|FG001|Overall Study|Lost to Follow-up|8|||
19717340|NCT00321464|42160244|FG000|Overall Study|Protocol deviation|0|||
19717341|NCT00321464|42160245|FG001|Overall Study|Protocol deviation|2|||
19717342|NCT00321464|42160244|FG000|Overall Study|Ineligibility determined|2|||
19717343|NCT00321464|42160245|FG001|Overall Study|Ineligibility determined|1|||
19717344|NCT00321464|42160244|FG000|Overall Study|Other|21|||
19717345|NCT00321464|42160245|FG001|Overall Study|Other|18|||
19717346|NCT02889796|42160255|FG000|Overall Study|Withdrew Consent|18|||
19717347|NCT02889796|42160256|FG001|Overall Study|Withdrew Consent|29|||
19717348|NCT02889796|42160257|FG002|Overall Study|Withdrew Consent|20|||
19717349|NCT02889796|42160258|FG003|Overall Study|Withdrew Consent|1|||
19717350|NCT02889796|42160259|FG004|Overall Study|Withdrew Consent|2|||
19717351|NCT02889796|42160260|FG005|Overall Study|Withdrew Consent|35|||
19717352|NCT02889796|42160255|FG000|Overall Study|Investigator's Discretion|10|||
19717353|NCT02889796|42160256|FG001|Overall Study|Investigator's Discretion|9|||
19717354|NCT02889796|42160257|FG002|Overall Study|Investigator's Discretion|10|||
19717355|NCT02889796|42160258|FG003|Overall Study|Investigator's Discretion|3|||
19717356|NCT02889796|42160259|FG004|Overall Study|Investigator's Discretion|0|||
19717357|NCT02889796|42160260|FG005|Overall Study|Investigator's Discretion|15|||
19717358|NCT02889796|42160255|FG000|Overall Study|Adverse Event|17|||
19717359|NCT02889796|42160256|FG001|Overall Study|Adverse Event|8|||
19717360|NCT02889796|42160257|FG002|Overall Study|Adverse Event|8|||
19717361|NCT02889796|42160258|FG003|Overall Study|Adverse Event|4|||
19717362|NCT02889796|42160259|FG004|Overall Study|Adverse Event|1|||
19717363|NCT02889796|42160260|FG005|Overall Study|Adverse Event|7|||
19717364|NCT02889796|42160255|FG000|Overall Study|Lost to Follow-up|5|||
19717365|NCT02889796|42160256|FG001|Overall Study|Lost to Follow-up|7|||
19717366|NCT02889796|42160257|FG002|Overall Study|Lost to Follow-up|2|||
19717367|NCT02889796|42160258|FG003|Overall Study|Lost to Follow-up|0|||
19717368|NCT02889796|42160259|FG004|Overall Study|Lost to Follow-up|2|||
19717369|NCT02889796|42160260|FG005|Overall Study|Lost to Follow-up|6|||
19717370|NCT02889796|42160255|FG000|Overall Study|Protocol Violation|0|||
19717371|NCT02889796|42160256|FG001|Overall Study|Protocol Violation|1|||
19717372|NCT02889796|42160257|FG002|Overall Study|Protocol Violation|3|||
19717373|NCT02889796|42160258|FG003|Overall Study|Protocol Violation|0|||
19717374|NCT02889796|42160259|FG004|Overall Study|Protocol Violation|0|||
19717375|NCT02889796|42160260|FG005|Overall Study|Protocol Violation|4|||
19717376|NCT02889796|42160255|FG000|Overall Study|Non-compliance With Study Drug|0|||
19717377|NCT02889796|42160256|FG001|Overall Study|Non-compliance With Study Drug|2|||
19717378|NCT02889796|42160257|FG002|Overall Study|Non-compliance With Study Drug|0|||
19717379|NCT02889796|42160258|FG003|Overall Study|Non-compliance With Study Drug|0|||
19717380|NCT02889796|42160259|FG004|Overall Study|Non-compliance With Study Drug|1|||
19717381|NCT02889796|42160260|FG005|Overall Study|Non-compliance With Study Drug|2|||
19717382|NCT02889796|42160255|FG000|Overall Study|Death|1|||
19717383|NCT02889796|42160256|FG001|Overall Study|Death|1|||
19717384|NCT02889796|42160257|FG002|Overall Study|Death|0|||
19717385|NCT02889796|42160258|FG003|Overall Study|Death|1|||
19717386|NCT02889796|42160259|FG004|Overall Study|Death|0|||
19717387|NCT02889796|42160260|FG005|Overall Study|Death|1|||
19717388|NCT02889796|42160255|FG000|Overall Study|Pregnancy|0|||
19717389|NCT02889796|42160256|FG001|Overall Study|Pregnancy|1|||
19717390|NCT02889796|42160257|FG002|Overall Study|Pregnancy|1|||
19717391|NCT02889796|42160258|FG003|Overall Study|Pregnancy|0|||
19717392|NCT02889796|42160259|FG004|Overall Study|Pregnancy|0|||
19717393|NCT02889796|42160260|FG005|Overall Study|Pregnancy|0|||
19717394|NCT02889796|42160255|FG000|Overall Study|Randomized but not Dosed|2|||
19717395|NCT02889796|42160256|FG001|Overall Study|Randomized but not Dosed|0|||
19717396|NCT02889796|42160257|FG002|Overall Study|Randomized but not Dosed|0|||
19717397|NCT02889796|42160258|FG003|Overall Study|Randomized but not Dosed|0|||
19717398|NCT02889796|42160259|FG004|Overall Study|Randomized but not Dosed|0|||
19717399|NCT02889796|42160260|FG005|Overall Study|Randomized but not Dosed|2|||
19717400|NCT02889562|42160285|FG000|Overall Study|Physician Decision|0|||
19717401|NCT02889562|42160286|FG001|Overall Study|Physician Decision|1|||
19717402|NCT02889562|42160285|FG000|Overall Study|Withdrawal by Subject|0|||
19717403|NCT02889562|42160286|FG001|Overall Study|Withdrawal by Subject|1|||
19717404|NCT03323164|42160294|FG000|Overall Study|Poor quality imaging/scans|2|||
19717405|NCT03323164|42160295|FG001|Overall Study|Poor quality imaging/scans|2|||
19717406|NCT03323086|42160307|FG000|Overall Study|Lost to Follow-up|3|||
19717407|NCT03323086|42160308|FG001|Overall Study|Lost to Follow-up|2|||
19717408|NCT02888080|42160316|FG000|Overall Study|Subject / Guardian decision|1|||
19717409|NCT02888080|42160317|FG001|Overall Study|Subject / Guardian decision|3|||
19717410|NCT02888080|42160316|FG000|Overall Study|New Therapy for study indication|1|||
19717411|NCT02888080|42160317|FG001|Overall Study|New Therapy for study indication|0|||
19717412|NCT02888080|42160316|FG000|Overall Study|Lack of Efficacy|0|||
19717413|NCT02888080|42160317|FG001|Overall Study|Lack of Efficacy|1|||
19717414|NCT02888080|42160316|FG000|Overall Study|Adverse Event|0|||
19717415|NCT02888080|42160317|FG001|Overall Study|Adverse Event|1|||
19717416|NCT03322462|42160323|FG000|Overall Study|Technical difficulties|2|||
19717417|NCT03322462|42160323|FG000|Overall Study|Other|1|||
19717418|NCT00086580|42160331|FG000|Treatment Period|Disease progression|9|||
19717419|NCT00086580|42160332|FG001|Treatment Period|Disease progression|8|||
19717420|NCT00086580|42160331|FG000|Treatment Period|Unable to comply with protocol|3|||
19717421|NCT00086580|42160332|FG001|Treatment Period|Unable to comply with protocol|1|||
19717422|NCT00086580|42160331|FG000|Treatment Period|Withdrawal by Subject|7|||
19717423|NCT00086580|42160332|FG001|Treatment Period|Withdrawal by Subject|8|||
19717424|NCT00086580|42160331|FG000|Treatment Period|Physician Decision|13|||
19717425|NCT00086580|42160332|FG001|Treatment Period|Physician Decision|7|||
19717426|NCT00086580|42160331|FG000|Treatment Period|AE - not treatment related|7|||
19717427|NCT00086580|42160332|FG001|Treatment Period|AE - not treatment related|7|||
19717428|NCT00086580|42160331|FG000|Treatment Period|Toxicity - treatment related|15|||
19717429|NCT00086580|42160332|FG001|Treatment Period|Toxicity - treatment related|15|||
19717430|NCT00086580|42160331|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
19717431|NCT00086580|42160332|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
19717432|NCT00086580|42160331|FG000|Treatment Period|Death|5|||
19717433|NCT00086580|42160332|FG001|Treatment Period|Death|7|||
19717434|NCT00086580|42160331|FG000|Treatment Period|Other|5|||
19717435|NCT00086580|42160332|FG001|Treatment Period|Other|3|||
19717436|NCT00086580|42160331|FG000|Follow-up Period|Disease progression|72|||
19717437|NCT00086580|42160332|FG001|Follow-up Period|Disease progression|99|||
19717438|NCT00086580|42160331|FG000|Follow-up Period|Unable to comply with protocol|5|||
19717439|NCT00086580|42160332|FG001|Follow-up Period|Unable to comply with protocol|0|||
19717440|NCT00086580|42160331|FG000|Follow-up Period|Withdrawal by Subject|6|||
19717441|NCT00086580|42160332|FG001|Follow-up Period|Withdrawal by Subject|6|||
19717442|NCT00086580|42160331|FG000|Follow-up Period|Physician Decision|0|||
19717443|NCT00086580|42160332|FG001|Follow-up Period|Physician Decision|1|||
19717444|NCT00086580|42160331|FG000|Follow-up Period|AE - not related|1|||
19717445|NCT00086580|42160332|FG001|Follow-up Period|AE - not related|0|||
19717446|NCT00086580|42160331|FG000|Follow-up Period|Death|13|||
19717447|NCT00086580|42160332|FG001|Follow-up Period|Death|7|||
19717448|NCT00086580|42160331|FG000|Follow-up Period|Other|7|||
19717449|NCT00086580|42160332|FG001|Follow-up Period|Other|6|||
19717450|NCT00086580|42160331|FG000|Observation Period|Unable to comply with protocol|1|||
19717451|NCT00086580|42160332|FG001|Observation Period|Unable to comply with protocol|1|||
19717452|NCT00086580|42160331|FG000|Observation Period|Withdrawal by Subject|4|||
19717453|NCT00086580|42160332|FG001|Observation Period|Withdrawal by Subject|2|||
19717454|NCT00086580|42160331|FG000|Observation Period|Death|33|||
19717455|NCT00086580|42160332|FG001|Observation Period|Death|55|||
19717456|NCT00086580|42160331|FG000|Observation Period|Other|8|||
19717457|NCT00086580|42160332|FG001|Observation Period|Other|7|||
19717458|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
19717459|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
19717460|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
19717461|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
19717462|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
19717463|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
19717464|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
19717465|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
19717466|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
19717467|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
19717468|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
19717469|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
19717470|NCT03321526|42160340|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
19717471|NCT03321526|42160341|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
19717472|NCT03321526|42160340|FG000|Follow-up Phase (2 Weeks)|Other|24|||
19717473|NCT03321526|42160341|FG001|Follow-up Phase (2 Weeks)|Other|24|||
19717474|NCT00086502|42160355|FG000|Overall Study|Adverse Event|11|||
19717475|NCT00086502|42160356|FG001|Overall Study|Adverse Event|2|||
19717476|NCT00086502|42160355|FG000|Overall Study|Lack of Efficacy|0|||
19717477|NCT00086502|42160356|FG001|Overall Study|Lack of Efficacy|2|||
19717478|NCT00086502|42160355|FG000|Overall Study|Lost to Follow-up|3|||
19717479|NCT00086502|42160356|FG001|Overall Study|Lost to Follow-up|1|||
19717480|NCT00086502|42160355|FG000|Overall Study|Physician Decision|1|||
19717481|NCT00086502|42160356|FG001|Overall Study|Physician Decision|1|||
19717482|NCT00086502|42160355|FG000|Overall Study|Pregnancy|0|||
19717483|NCT00086502|42160356|FG001|Overall Study|Pregnancy|1|||
19717484|NCT00086502|42160355|FG000|Overall Study|Protocol Violation|3|||
19717485|NCT00086502|42160356|FG001|Overall Study|Protocol Violation|3|||
19717486|NCT00086502|42160355|FG000|Overall Study|Withdrawal by Subject|5|||
19717487|NCT00086502|42160356|FG001|Overall Study|Withdrawal by Subject|6|||
19717488|NCT00086502|42160355|FG000|Overall Study|Patient Moved|1|||
19717489|NCT00086502|42160356|FG001|Overall Study|Patient Moved|1|||
19717490|NCT00086502|42160355|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
19717491|NCT00086502|42160356|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
19717492|NCT00086502|42160355|FG000|Overall Study|Patient Accidentally Unblinded|1|||
19717493|NCT00086502|42160356|FG001|Overall Study|Patient Accidentally Unblinded|0|||
19717494|NCT03826667|42160362|FG000|Overall Study|Protocol deviation|21|||
19717495|NCT03636542|42160374|FG000|Overall Study|Lost to Follow-up|1|||
19717496|NCT03636542|42160375|FG001|Overall Study|Lost to Follow-up|1|||
19717497|NCT03636542|42160374|FG000|Overall Study|Physician Decision|0|||
19717498|NCT03636542|42160375|FG001|Overall Study|Physician Decision|1|||
19717499|NCT03636542|42160374|FG000|Overall Study|Withdrawal by Subject|1|||
19717500|NCT03636542|42160375|FG001|Overall Study|Withdrawal by Subject|0|||
19717501|NCT03305770|42160383|FG000|Overall Study|Physician Decision - prior to dispense|0|||
19717502|NCT03305770|42160384|FG001|Overall Study|Physician Decision - prior to dispense|1|||
19717503|NCT03305770|42160383|FG000|Overall Study|Subject moved|1|||
19717504|NCT03305770|42160384|FG001|Overall Study|Subject moved|0|||
19717505|NCT00086190|42160395|FG000|Overall Study|Adverse Event|6|||
19717506|NCT00086190|42160396|FG001|Overall Study|Adverse Event|2|||
19717507|NCT00086190|42160397|FG002|Overall Study|Adverse Event|2|||
19717508|NCT00086190|42160395|FG000|Overall Study|Withdrawal by Subject|0|||
19717509|NCT00086190|42160396|FG001|Overall Study|Withdrawal by Subject|2|||
19717510|NCT00086190|42160397|FG002|Overall Study|Withdrawal by Subject|2|||
19717511|NCT00086190|42160395|FG000|Overall Study|Protocol Violation|1|||
19717512|NCT00086190|42160396|FG001|Overall Study|Protocol Violation|0|||
19717513|NCT00086190|42160397|FG002|Overall Study|Protocol Violation|0|||
19717514|NCT00086190|42160395|FG000|Overall Study|Moved|1|||
19717515|NCT00086190|42160396|FG001|Overall Study|Moved|0|||
19717516|NCT00086190|42160397|FG002|Overall Study|Moved|0|||
19717517|NCT00086190|42160395|FG000|Overall Study|Worsening depression|0|||
19717518|NCT00086190|42160396|FG001|Overall Study|Worsening depression|0|||
19717519|NCT00086190|42160397|FG002|Overall Study|Worsening depression|2|||
19717520|NCT03320824|42160407|FG000|Overall Study|Withdrawal by Subject|8|||
19717521|NCT03320824|42160408|FG001|Overall Study|Withdrawal by Subject|1|||
19717522|NCT03320824|42160407|FG000|Overall Study|Lost to Follow-up|10|||
19717523|NCT03320824|42160408|FG001|Overall Study|Lost to Follow-up|1|||
19717524|NCT03320824|42160407|FG000|Overall Study|moved out of state|0|||
19717525|NCT03320824|42160408|FG001|Overall Study|moved out of state|1|||
19717526|NCT03320824|42160407|FG000|Overall Study|could not complete final visit|0|||
19717527|NCT03320824|42160408|FG001|Overall Study|could not complete final visit|1|||
19717528|NCT03275350|42160420|FG000|Overall Study|Lost to Follow-up|4|||
19717529|NCT03275350|42160421|FG001|Overall Study|Lost to Follow-up|6|||
19717530|NCT03275350|42160420|FG000|Overall Study|Death|2|||
19717531|NCT03275350|42160421|FG001|Overall Study|Death|1|||
19717532|NCT03275350|42160420|FG000|Overall Study|Physician Decision|1|||
19717533|NCT03275350|42160421|FG001|Overall Study|Physician Decision|0|||
19717534|NCT03275350|42160420|FG000|Overall Study|Incarcerated|1|||
19717535|NCT03275350|42160421|FG001|Overall Study|Incarcerated|1|||
19717536|NCT03319732|42160428|FG000|Overall Study|Adverse Event|40|||
19717537|NCT03319732|42160428|FG000|Overall Study|Withdrawal by Subject|50|||
19717538|NCT03319732|42160428|FG000|Overall Study|MS relapse|10|||
19717539|NCT03319732|42160428|FG000|Overall Study|reason not specified|5|||
19717540|NCT03304522|42160435|FG000|Overall Study|Adverse Event|0|||
19717541|NCT03304522|42160436|FG001|Overall Study|Adverse Event|4|||
19717542|NCT03304522|42160435|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
19717543|NCT03304522|42160436|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
19717544|NCT03304522|42160435|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
19717545|NCT03304522|42160436|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
19717546|NCT03304522|42160435|FG000|Overall Study|Other|0|||
19717547|NCT03304522|42160436|FG001|Overall Study|Other|1|||
19717548|NCT03315286|42160444|FG000|Overall Study|Lost to Follow-up|0|||
19717549|NCT03315286|42160445|FG001|Overall Study|Lost to Follow-up|3|||
19717550|NCT03315286|42160444|FG000|Overall Study|Withdrawal by Subject|1|||
19717551|NCT03315286|42160445|FG001|Overall Study|Withdrawal by Subject|0|||
19717552|NCT03315286|42160444|FG000|Overall Study|Protocol Violation|0|||
19717553|NCT03315286|42160445|FG001|Overall Study|Protocol Violation|1|||
19717554|NCT03273946|42160451|FG000|Overall Study|Withdrawal by Subject|5|||
19717555|NCT03273946|42160451|FG000|Overall Study|Unwillingness of the guardian|1|||
19717556|NCT03273946|42160451|FG000|Overall Study|Participant refused to use the drug|2|||
19717557|NCT03273946|42160451|FG000|Overall Study|Participant relative refused to use drug|1|||
19717558|NCT00314951|42160457|FG000|Treatment|Didn't meet criteria for mITT population|16|||
19717559|NCT00314951|42160458|FG001|Treatment|Didn't meet criteria for mITT population|11|||
19717560|NCT00314951|42160457|FG000|Follow-up|mITT failure|44|||
19717561|NCT00314951|42160458|FG001|Follow-up|mITT failure|34|||
19717562|NCT00085644|42160466|FG000|Double-Blind Period|Adverse Event|5|||
19717563|NCT00085644|42160467|FG001|Double-Blind Period|Adverse Event|2|||
19717564|NCT00085644|42160468|FG002|Double-Blind Period|Adverse Event|0|||
19717565|NCT00085644|42160466|FG000|Double-Blind Period|Withdrawal by Subject|3|||
19717566|NCT00085644|42160467|FG001|Double-Blind Period|Withdrawal by Subject|0|||
19717567|NCT00085644|42160468|FG002|Double-Blind Period|Withdrawal by Subject|0|||
19717568|NCT00085644|42160466|FG000|Double-Blind Period|Lost to Follow-up|2|||
19717569|NCT00085644|42160467|FG001|Double-Blind Period|Lost to Follow-up|1|||
19717570|NCT00085644|42160468|FG002|Double-Blind Period|Lost to Follow-up|0|||
19717571|NCT00085644|42160466|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
19717572|NCT00085644|42160467|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
19717573|NCT00085644|42160468|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
19717574|NCT00085644|42160466|FG000|Double-Blind Period|Contemplating pregnancy|1|||
19717575|NCT00085644|42160467|FG001|Double-Blind Period|Contemplating pregnancy|0|||
19717576|NCT00085644|42160468|FG002|Double-Blind Period|Contemplating pregnancy|0|||
19717577|NCT00085644|42160466|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
19717578|NCT00085644|42160467|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
19717579|NCT00085644|42160468|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
19717580|NCT00085644|42160466|FG000|Open-Label Period|Adverse Event|0|||
19717581|NCT00085644|42160467|FG001|Open-Label Period|Adverse Event|0|||
19717582|NCT00085644|42160468|FG002|Open-Label Period|Adverse Event|38|||
19717583|NCT00085644|42160466|FG000|Open-Label Period|Withdrawal by Subject|0|||
19717584|NCT00085644|42160467|FG001|Open-Label Period|Withdrawal by Subject|0|||
19717585|NCT00085644|42160468|FG002|Open-Label Period|Withdrawal by Subject|29|||
19717586|NCT00085644|42160466|FG000|Open-Label Period|Lost to Follow-up|0|||
19717587|NCT00085644|42160467|FG001|Open-Label Period|Lost to Follow-up|0|||
19717588|NCT00085644|42160468|FG002|Open-Label Period|Lost to Follow-up|13|||
19717589|NCT00085644|42160466|FG000|Open-Label Period|Lack of Efficacy|0|||
19717590|NCT00085644|42160467|FG001|Open-Label Period|Lack of Efficacy|0|||
19717591|NCT00085644|42160468|FG002|Open-Label Period|Lack of Efficacy|15|||
19717592|NCT00085644|42160466|FG000|Open-Label Period|Pregnancy|0|||
19717593|NCT00085644|42160467|FG001|Open-Label Period|Pregnancy|0|||
19717594|NCT00085644|42160468|FG002|Open-Label Period|Pregnancy|3|||
19717595|NCT00085644|42160466|FG000|Open-Label Period|Contemplating pregnancy|0|||
19717596|NCT00085644|42160467|FG001|Open-Label Period|Contemplating pregnancy|0|||
19717597|NCT00085644|42160468|FG002|Open-Label Period|Contemplating pregnancy|3|||
19717598|NCT00085644|42160466|FG000|Open-Label Period|Protocol Violation|0|||
19717599|NCT00085644|42160467|FG001|Open-Label Period|Protocol Violation|0|||
19717600|NCT00085644|42160468|FG002|Open-Label Period|Protocol Violation|4|||
19717601|NCT00085644|42160466|FG000|Open-Label Period|Personal reason|0|||
19717602|NCT00085644|42160467|FG001|Open-Label Period|Personal reason|0|||
19717603|NCT00085644|42160468|FG002|Open-Label Period|Personal reason|4|||
19717604|NCT03315208|42160477|FG000|Overall Study|Lost to Follow-up|11|||
19717605|NCT03315208|42160478|FG001|Overall Study|Lost to Follow-up|6|||
19717606|NCT03315208|42160477|FG000|Overall Study|Withdrawal by Subject|2|||
19717607|NCT03315208|42160478|FG001|Overall Study|Withdrawal by Subject|0|||
19717608|NCT00314795|42160485|FG000|Overall Study|Adverse Event|8|||
19717609|NCT00314795|42160485|FG000|Overall Study|Death|4|||
19717610|NCT00314795|42160485|FG000|Overall Study|Reason not Specified|3|||
19717611|NCT00314795|42160485|FG000|Overall Study|Renal Transplant|3|||
19717612|NCT00314795|42160485|FG000|Overall Study|Participants Withdrew Consent|2|||
19717613|NCT00314327|42160489|FG000|Overall Study|Withdrawal by Subject|1|||
19717614|NCT00336479|42160497|FG000|Overall Study|Adverse Event|8|||
19717615|NCT00336479|42160498|FG001|Overall Study|Adverse Event|11|||
19717616|NCT00336479|42160499|FG002|Overall Study|Adverse Event|18|||
19717617|NCT00336479|42160500|FG003|Overall Study|Adverse Event|4|||
19717618|NCT00336479|42160497|FG000|Overall Study|Noncompliant|1|||
19717619|NCT00336479|42160498|FG001|Overall Study|Noncompliant|7|||
19717620|NCT00336479|42160499|FG002|Overall Study|Noncompliant|3|||
19717621|NCT00336479|42160500|FG003|Overall Study|Noncompliant|0|||
19717622|NCT00336479|42160497|FG000|Overall Study|Physician Decision|2|||
19717623|NCT00336479|42160498|FG001|Overall Study|Physician Decision|3|||
19717624|NCT00336479|42160499|FG002|Overall Study|Physician Decision|1|||
19717625|NCT00336479|42160500|FG003|Overall Study|Physician Decision|0|||
19717626|NCT00336479|42160497|FG000|Overall Study|Lost to Follow-up|3|||
19717627|NCT00336479|42160498|FG001|Overall Study|Lost to Follow-up|2|||
19717628|NCT00336479|42160499|FG002|Overall Study|Lost to Follow-up|0|||
19717629|NCT00336479|42160500|FG003|Overall Study|Lost to Follow-up|0|||
19717630|NCT00336479|42160497|FG000|Overall Study|Withdrawal by Subject|3|||
19717631|NCT00336479|42160498|FG001|Overall Study|Withdrawal by Subject|2|||
19717632|NCT00336479|42160499|FG002|Overall Study|Withdrawal by Subject|3|||
19717633|NCT00336479|42160500|FG003|Overall Study|Withdrawal by Subject|0|||
19717634|NCT00336479|42160497|FG000|Overall Study|Other|0|||
19717635|NCT00336479|42160498|FG001|Overall Study|Other|0|||
19717636|NCT00336479|42160499|FG002|Overall Study|Other|1|||
19717637|NCT00336479|42160500|FG003|Overall Study|Other|0|||
19717638|NCT00336479|42160497|FG000|Overall Study|Virologic Stopping Rule|20|||
19717639|NCT00336479|42160498|FG001|Overall Study|Virologic Stopping Rule|0|||
19717640|NCT00336479|42160499|FG002|Overall Study|Virologic Stopping Rule|0|||
19717641|NCT00336479|42160500|FG003|Overall Study|Virologic Stopping Rule|0|||
19717642|NCT00314249|42160513|FG000|Overall Study|Adverse Event|73|||
19717643|NCT00314249|42160514|FG001|Overall Study|Adverse Event|94|||
19717644|NCT00314249|42160513|FG000|Overall Study|Lack of Efficacy|33|||
19717645|NCT00314249|42160514|FG001|Overall Study|Lack of Efficacy|24|||
19717646|NCT00314249|42160513|FG000|Overall Study|Withdrawal by Subject|21|||
19717647|NCT00314249|42160514|FG001|Overall Study|Withdrawal by Subject|28|||
19717648|NCT00314249|42160513|FG000|Overall Study|Lost to Follow-up|15|||
19717649|NCT00314249|42160514|FG001|Overall Study|Lost to Follow-up|9|||
19717650|NCT00314249|42160513|FG000|Overall Study|Physician Decision|1|||
19717651|NCT00314249|42160514|FG001|Overall Study|Physician Decision|1|||
19717652|NCT00314249|42160513|FG000|Overall Study|Withdrawn for other reasons|4|||
19717653|NCT00314249|42160514|FG001|Overall Study|Withdrawn for other reasons|1|||
19717654|NCT00314249|42160513|FG000|Overall Study|Non-Compliant|5|||
19717655|NCT00314249|42160514|FG001|Overall Study|Non-Compliant|6|||
19717656|NCT03315130|42160523|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
19717657|NCT03315130|42160524|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
19717658|NCT03315130|42160525|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
19717659|NCT03315130|42160526|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
19717660|NCT03315130|42160523|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
19717661|NCT03315130|42160524|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
19717662|NCT03315130|42160525|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
19717663|NCT03315130|42160526|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
19717664|NCT03315130|42160523|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
19717665|NCT03315130|42160524|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
19717666|NCT03315130|42160525|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
19717667|NCT03315130|42160526|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
19717668|NCT03315130|42160523|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
19717669|NCT03315130|42160524|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
19717670|NCT03315130|42160525|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
19717671|NCT03315130|42160526|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
19717672|NCT03315130|42160523|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
19717673|NCT03315130|42160524|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
19717674|NCT03315130|42160525|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
19717675|NCT03315130|42160526|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
19717676|NCT03315130|42160523|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
19717677|NCT03315130|42160524|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
19717678|NCT03315130|42160525|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
19717679|NCT03315130|42160526|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
19717680|NCT03273166|42160546|FG000|Overall Study|Withdrawn prior to Completion|31|||
19717681|NCT03314662|42160554|FG000|Overall Study|Withdrawal by Subject|1|||
19717682|NCT03314662|42160555|FG001|Overall Study|Withdrawal by Subject|1|||
19717683|NCT03314662|42160556|FG002|Overall Study|Withdrawal by Subject|1|||
19717684|NCT03314662|42160554|FG000|Overall Study|Lost to Follow-up|5|||
19717685|NCT03314662|42160555|FG001|Overall Study|Lost to Follow-up|4|||
19717686|NCT03314662|42160556|FG002|Overall Study|Lost to Follow-up|4|||
19717687|NCT03314662|42160554|FG000|Overall Study|Death|2|||
19717688|NCT03314662|42160555|FG001|Overall Study|Death|0|||
19717689|NCT03314662|42160556|FG002|Overall Study|Death|0|||
19717690|NCT03271528|42160574|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
19717691|NCT03271528|42160575|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
19717692|NCT03271528|42160574|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
19717693|NCT03271528|42160575|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
19717694|NCT03271528|42160574|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
19717695|NCT03271528|42160575|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
19717696|NCT03271528|42160574|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
19717697|NCT03271528|42160575|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
19717698|NCT03271528|42160574|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
19717699|NCT03271528|42160575|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
19717700|NCT03271528|42160574|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
19717701|NCT03271528|42160575|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
19717702|NCT03271528|42160574|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
19717703|NCT03271528|42160575|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
19717704|NCT03301714|42160584|FG000|Overall Study|Lost to Follow-up|10|||
19717705|NCT03301714|42160585|FG001|Overall Study|Lost to Follow-up|4|||
19717706|NCT03301714|42160586|FG002|Overall Study|Lost to Follow-up|4|||
19717707|NCT03301714|42160584|FG000|Overall Study|Did not receive allocated intervention|0|||
19717708|NCT03301714|42160585|FG001|Overall Study|Did not receive allocated intervention|2|||
19717709|NCT03301714|42160586|FG002|Overall Study|Did not receive allocated intervention|3|||
19717710|NCT03299686|42160599|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
19717711|NCT03299686|42160600|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
19717712|NCT03299686|42160599|FG000|Treatment Epoch|Physician Decision|1|||
19717713|NCT03299686|42160600|FG001|Treatment Epoch|Physician Decision|0|||
19717714|NCT03299686|42160599|FG000|Treatment Epoch|Adverse Event|8|||
19717715|NCT03299686|42160600|FG001|Treatment Epoch|Adverse Event|4|||
19717716|NCT03299686|42160599|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
19717717|NCT03299686|42160600|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
19717718|NCT03462758|42160608|FG000|Overall Study|Chose no or other method of contraception|20|||
19717719|NCT03462758|42160609|FG001|Overall Study|Chose no or other method of contraception|23|||
19717720|NCT03462758|42160608|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
19717721|NCT03462758|42160609|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
19717722|NCT03462758|42160608|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
19717723|NCT03462758|42160609|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
19717724|NCT03462758|42160608|FG000|Overall Study|Medical contraindication|2|||
19717725|NCT03462758|42160609|FG001|Overall Study|Medical contraindication|2|||
19717726|NCT03462758|42160608|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
19717727|NCT03462758|42160609|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
19717728|NCT00075270|42160617|FG000|Overall Study|Withdrawal by Subject|28|||
19717729|NCT00075270|42160618|FG001|Overall Study|Withdrawal by Subject|21|||
19717730|NCT00075270|42160617|FG000|Overall Study|Lost to Follow-up|25|||
19717731|NCT00075270|42160618|FG001|Overall Study|Lost to Follow-up|28|||
19717732|NCT00075270|42160617|FG000|Overall Study|Protocol Violation|0|||
19717733|NCT00075270|42160618|FG001|Overall Study|Protocol Violation|2|||
19717734|NCT00075270|42160617|FG000|Overall Study|Death|198|||
19717735|NCT00075270|42160618|FG001|Overall Study|Death|215|||
19717736|NCT00075270|42160617|FG000|Overall Study|Other/Unknown|9|||
19717737|NCT00075270|42160618|FG001|Overall Study|Other/Unknown|5|||
19717738|NCT00075270|42160617|FG000|Overall Study|Missing|26|||
19717739|NCT00075270|42160618|FG001|Overall Study|Missing|13|||
19717740|NCT00074958|42160625|FG000|Overall Study|Adverse Event|1|||
19717741|NCT03298984|42160633|FG000|Overall Study|Physician Decision|1|||
19717742|NCT03298984|42160634|FG001|Overall Study|Physician Decision|0|||
19717743|NCT03298984|42160635|FG002|Overall Study|Physician Decision|0|||
19717744|NCT03298984|42160636|FG003|Overall Study|Physician Decision|6|||
19717745|NCT03298984|42160633|FG000|Overall Study|Lack of Efficacy|0|||
19717746|NCT03298984|42160634|FG001|Overall Study|Lack of Efficacy|1|||
19717747|NCT03298984|42160635|FG002|Overall Study|Lack of Efficacy|1|||
19717748|NCT03298984|42160636|FG003|Overall Study|Lack of Efficacy|4|||
19717749|NCT03298984|42160633|FG000|Overall Study|Relapsed disease (following remission)|0|||
19717750|NCT03298984|42160634|FG001|Overall Study|Relapsed disease (following remission)|0|||
19717751|NCT03298984|42160635|FG002|Overall Study|Relapsed disease (following remission)|1|||
19717752|NCT03298984|42160636|FG003|Overall Study|Relapsed disease (following remission)|1|||
19717753|NCT03298984|42160633|FG000|Overall Study|Adverse Event|0|||
19717754|NCT03298984|42160634|FG001|Overall Study|Adverse Event|0|||
19717755|NCT03298984|42160635|FG002|Overall Study|Adverse Event|0|||
19717756|NCT03298984|42160636|FG003|Overall Study|Adverse Event|1|||
19717757|NCT03298984|42160633|FG000|Overall Study|Death|0|||
19717758|NCT03298984|42160634|FG001|Overall Study|Death|0|||
19717759|NCT03298984|42160635|FG002|Overall Study|Death|0|||
19717760|NCT03298984|42160636|FG003|Overall Study|Death|2|||
19717761|NCT03298984|42160633|FG000|Overall Study|Insurance Company Decision|0|||
19717762|NCT03298984|42160634|FG001|Overall Study|Insurance Company Decision|0|||
19717763|NCT03298984|42160635|FG002|Overall Study|Insurance Company Decision|0|||
19717764|NCT03298984|42160636|FG003|Overall Study|Insurance Company Decision|1|||
19717765|NCT02940574|42160649|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
19717766|NCT02940574|42160650|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
19717767|NCT02940574|42160649|FG000|1-year Follow-up|Lost to Follow-up|3|||
19717768|NCT02940574|42160650|FG001|1-year Follow-up|Lost to Follow-up|4|||
19717769|NCT03606512|42160662|FG000|Overall Study|Lost to Follow-up|0|||
19717770|NCT03606512|42160663|FG001|Overall Study|Lost to Follow-up|1|||
19717771|NCT03606512|42160662|FG000|Overall Study|'moved from study area|0|||
19717772|NCT03606512|42160663|FG001|Overall Study|'moved from study area|1|||
19717773|NCT03760250|42160685|FG000|Overall Study|Withdrawal by Subject|1|||
19717774|NCT03760250|42160685|FG000|Overall Study|Physician Decision|1|||
19717775|NCT03757988|42160689|FG000|Overall Study|Withdrawal by Subject|1|||
19717776|NCT00313781|42160696|FG000|Before Crossover|Death|22|||
19717777|NCT00313781|42160697|FG001|Before Crossover|Death|8|||
19717778|NCT00313781|42160698|FG002|Before Crossover|Death|0|||
19717779|NCT00313781|42160696|FG000|Before Crossover|Lost to Follow-up|0|||
19717780|NCT00313781|42160697|FG001|Before Crossover|Lost to Follow-up|3|||
19717781|NCT00313781|42160698|FG002|Before Crossover|Lost to Follow-up|0|||
19717782|NCT00313781|42160696|FG000|Before Crossover|Withdrawal by Subject|3|||
19717783|NCT00313781|42160697|FG001|Before Crossover|Withdrawal by Subject|1|||
19717784|NCT00313781|42160698|FG002|Before Crossover|Withdrawal by Subject|0|||
19717785|NCT00313781|42160696|FG000|Before Crossover|Other|45|||
19717786|NCT00313781|42160697|FG001|Before Crossover|Other|30|||
19717787|NCT00313781|42160698|FG002|Before Crossover|Other|0|||
19717788|NCT00313781|42160696|FG000|Before Crossover|Crossover|0|||
19717789|NCT00313781|42160697|FG001|Before Crossover|Crossover|37|||
19717790|NCT00313781|42160698|FG002|Before Crossover|Crossover|0|||
19717791|NCT00313781|42160696|FG000|Before Crossover|Randomized, not treated|5|||
19717792|NCT00313781|42160697|FG001|Before Crossover|Randomized, not treated|0|||
19717793|NCT00313781|42160698|FG002|Before Crossover|Randomized, not treated|0|||
19717794|NCT00313781|42160696|FG000|After Crossover|Death|0|||
19717795|NCT00313781|42160697|FG001|After Crossover|Death|0|||
19717796|NCT00313781|42160698|FG002|After Crossover|Death|6|||
19717797|NCT00313781|42160696|FG000|After Crossover|Withdrawal by Subject|0|||
19717798|NCT00313781|42160697|FG001|After Crossover|Withdrawal by Subject|0|||
19717799|NCT00313781|42160698|FG002|After Crossover|Withdrawal by Subject|3|||
19717800|NCT00313781|42160696|FG000|After Crossover|Other|0|||
19717801|NCT00313781|42160697|FG001|After Crossover|Other|0|||
19717802|NCT00313781|42160698|FG002|After Crossover|Other|18|||
19717803|NCT00368537|42160709|FG000|Randomization|No study drug dosed|13|||
19717804|NCT00368537|42160710|FG001|Randomization|No study drug dosed|6|||
19717805|NCT00368537|42160709|FG000|Baseline Participants|Lost to Follow-up|16|||
19717806|NCT00368537|42160710|FG001|Baseline Participants|Lost to Follow-up|17|||
19717807|NCT00368537|42160709|FG000|Baseline Participants|Withdrawal by Subject|6|||
19717808|NCT00368537|42160710|FG001|Baseline Participants|Withdrawal by Subject|4|||
19717809|NCT00368537|42160709|FG000|Baseline Participants|Death|1|||
19717810|NCT00368537|42160710|FG001|Baseline Participants|Death|2|||
19717811|NCT00368537|42160709|FG000|Baseline Participants|No susceptibility|1|||
19717812|NCT00368537|42160710|FG001|Baseline Participants|No susceptibility|0|||
19717813|NCT00368537|42160709|FG000|Baseline Participants|Patient uncompliant|0|||
19717814|NCT00368537|42160710|FG001|Baseline Participants|Patient uncompliant|1|||
19717815|NCT00313703|42160720|FG000|Overall Study|Lost to Follow-up|11|||
19717816|NCT00313703|42160721|FG001|Overall Study|Lost to Follow-up|2|||
19717817|NCT00313703|42160722|FG002|Overall Study|Lost to Follow-up|5|||
19717818|NCT00313703|42160723|FG003|Overall Study|Lost to Follow-up|12|||
19717819|NCT00313313|42160736|FG000|Overall Study|Lack of Efficacy|14|||
19717820|NCT00313313|42160737|FG001|Overall Study|Lack of Efficacy|9|||
19717821|NCT00313313|42160738|FG002|Overall Study|Lack of Efficacy|20|||
19717822|NCT00313313|42160736|FG000|Overall Study|Withdrawal of consent by subject|18|||
19717823|NCT00313313|42160737|FG001|Overall Study|Withdrawal of consent by subject|17|||
19717824|NCT00313313|42160738|FG002|Overall Study|Withdrawal of consent by subject|31|||
19717825|NCT00313313|42160736|FG000|Overall Study|Lost to Follow-up|10|||
19717826|NCT00313313|42160737|FG001|Overall Study|Lost to Follow-up|7|||
19717827|NCT00313313|42160738|FG002|Overall Study|Lost to Follow-up|9|||
19717828|NCT00313313|42160736|FG000|Overall Study|Adverse Event|15|||
19717829|NCT00313313|42160737|FG001|Overall Study|Adverse Event|16|||
19717830|NCT00313313|42160738|FG002|Overall Study|Adverse Event|12|||
19717831|NCT00313313|42160736|FG000|Overall Study|Physician Decision|2|||
19717832|NCT00313313|42160737|FG001|Overall Study|Physician Decision|6|||
19717833|NCT00313313|42160738|FG002|Overall Study|Physician Decision|4|||
19717834|NCT00313313|42160736|FG000|Overall Study|Poor/Noncompliance|3|||
19717835|NCT00313313|42160737|FG001|Overall Study|Poor/Noncompliance|6|||
19717836|NCT00313313|42160738|FG002|Overall Study|Poor/Noncompliance|2|||
19717837|NCT00313313|42160736|FG000|Overall Study|Pregnancy|1|||
19717838|NCT00313313|42160737|FG001|Overall Study|Pregnancy|2|||
19717839|NCT00313313|42160738|FG002|Overall Study|Pregnancy|0|||
19717840|NCT00313313|42160736|FG000|Overall Study|Death|0|||
19717841|NCT00313313|42160737|FG001|Overall Study|Death|0|||
19717842|NCT00313313|42160738|FG002|Overall Study|Death|2|||
19717843|NCT00313313|42160736|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
19717844|NCT00313313|42160737|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
19717845|NCT00313313|42160738|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
19717846|NCT00312845|42160748|FG000|Overall Study|Adverse Event|19|||
19717847|NCT00312845|42160749|FG001|Overall Study|Adverse Event|5|||
19717848|NCT00312845|42160748|FG000|Overall Study|Death|2|||
19717849|NCT00312845|42160749|FG001|Overall Study|Death|2|||
19717850|NCT00312845|42160748|FG000|Overall Study|Withdrawal by Subject|14|||
19717851|NCT00312845|42160749|FG001|Overall Study|Withdrawal by Subject|6|||
19717852|NCT00312845|42160748|FG000|Overall Study|Disease Progression|56|||
19717853|NCT00312845|42160749|FG001|Overall Study|Disease Progression|77|||
19717854|NCT00312845|42160748|FG000|Overall Study|Lost to Follow-up|2|||
19717855|NCT00312845|42160749|FG001|Overall Study|Lost to Follow-up|0|||
19717856|NCT00312845|42160748|FG000|Overall Study|Other|6|||
19717857|NCT00312845|42160749|FG001|Overall Study|Other|5|||
19717858|NCT00368069|42160757|FG000|Overall Study|Adverse Event|5|||
19717859|NCT00368069|42160758|FG001|Overall Study|Adverse Event|2|||
19717860|NCT00368069|42160757|FG000|Overall Study|Lack of Efficacy|0|||
19717861|NCT00368069|42160758|FG001|Overall Study|Lack of Efficacy|1|||
19717862|NCT00368069|42160757|FG000|Overall Study|Lost to Follow-up|1|||
19717863|NCT00368069|42160758|FG001|Overall Study|Lost to Follow-up|0|||
19717864|NCT00368069|42160757|FG000|Overall Study|Protocol Violation|0|||
19717865|NCT00368069|42160758|FG001|Overall Study|Protocol Violation|2|||
19717866|NCT00368069|42160757|FG000|Overall Study|Withdrawal of Consent|2|||
19717867|NCT00368069|42160758|FG001|Overall Study|Withdrawal of Consent|1|||
19717868|NCT00368069|42160757|FG000|Overall Study|no blood sampling possible|0|||
19717869|NCT00368069|42160758|FG001|Overall Study|no blood sampling possible|1|||
19717870|NCT00367991|42160766|FG000|Overall Study|Withdrawal by Subject|1|||
19717871|NCT00367991|42160767|FG001|Overall Study|Withdrawal by Subject|1|||
19717872|NCT00367991|42160766|FG000|Overall Study|Adverse Event|1|||
19717873|NCT00367991|42160767|FG001|Overall Study|Adverse Event|1|||
19717874|NCT00367835|42160775|FG000|Overall Study|Adverse Event|14|||
19717875|NCT00367835|42160776|FG001|Overall Study|Adverse Event|1|||
19717876|NCT00367835|42160775|FG000|Overall Study|Protocol Violation|1|||
19717877|NCT00367835|42160776|FG001|Overall Study|Protocol Violation|7|||
19717878|NCT00367835|42160775|FG000|Overall Study|Withdrawal by Subject|7|||
19717879|NCT00367835|42160776|FG001|Overall Study|Withdrawal by Subject|6|||
19717880|NCT00367835|42160775|FG000|Overall Study|Lost to Follow-up|1|||
19717881|NCT00367835|42160776|FG001|Overall Study|Lost to Follow-up|4|||
19717882|NCT00367835|42160775|FG000|Overall Study|Lack of Efficacy|3|||
19717883|NCT00367835|42160776|FG001|Overall Study|Lack of Efficacy|12|||
19717884|NCT00367835|42160775|FG000|Overall Study|Subject in juvenile detention center|1|||
19717885|NCT00367835|42160776|FG001|Overall Study|Subject in juvenile detention center|0|||
19717886|NCT00367835|42160775|FG000|Overall Study|refused blood collection|1|||
19717887|NCT00367835|42160776|FG001|Overall Study|refused blood collection|0|||
19717888|NCT00367835|42160775|FG000|Overall Study|Did not respond to calls|1|||
19717889|NCT00367835|42160776|FG001|Overall Study|Did not respond to calls|0|||
19717890|NCT00367835|42160775|FG000|Overall Study|History of lead poisoning|0|||
19717891|NCT00367835|42160776|FG001|Overall Study|History of lead poisoning|1|||
19717892|NCT03267940|42160788|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
19717893|NCT03267940|42160789|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
19717894|NCT03267940|42160790|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
19717895|NCT03267940|42160791|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
19717896|NCT03267940|42160792|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
19717897|NCT03267940|42160793|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
19717898|NCT03267940|42160788|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
19717899|NCT03267940|42160789|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
19717900|NCT03267940|42160790|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
19717901|NCT03267940|42160791|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
19717902|NCT03267940|42160792|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
19717903|NCT03267940|42160793|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
19717904|NCT03267940|42160788|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
19717905|NCT03267940|42160789|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
19717906|NCT03267940|42160790|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
19717907|NCT03267940|42160791|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
19717908|NCT03267940|42160792|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
19717909|NCT03267940|42160793|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
19717910|NCT03267940|42160788|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
19717911|NCT03267940|42160789|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
19717912|NCT03267940|42160790|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
19717913|NCT03267940|42160791|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
19717914|NCT03267940|42160792|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
19717915|NCT03267940|42160793|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
19717916|NCT03267940|42160788|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
19717917|NCT03267940|42160789|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
19717918|NCT03267940|42160790|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
19717919|NCT03267940|42160791|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
19717920|NCT03267940|42160792|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
19717921|NCT03267940|42160793|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
19717922|NCT03267940|42160788|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
19717923|NCT03267940|42160789|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
19717924|NCT03267940|42160790|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
19717925|NCT03267940|42160791|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
19717926|NCT03267940|42160792|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
19717927|NCT03267940|42160793|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
19717928|NCT03267940|42160788|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
19717929|NCT03267940|42160789|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
19717930|NCT03267940|42160790|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
19717931|NCT03267940|42160791|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
19717932|NCT03267940|42160792|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
19717933|NCT03267940|42160793|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
19717934|NCT03267940|42160788|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
19717935|NCT03267940|42160789|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
19717936|NCT03267940|42160790|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
19717937|NCT03267940|42160791|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
19717938|NCT03267940|42160792|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
19717939|NCT03267940|42160793|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
19717940|NCT03267940|42160788|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
19717941|NCT03267940|42160789|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
19717942|NCT03267940|42160790|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
19717943|NCT03267940|42160791|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
19717944|NCT03267940|42160792|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
19717945|NCT03267940|42160793|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
19717946|NCT03296566|42160813|FG000|Overall Study|Lost to Follow-up|19|||
19717947|NCT03296566|42160814|FG001|Overall Study|Lost to Follow-up|46|||
19717948|NCT03296566|42160813|FG000|Overall Study|Withdrawal by Subject|0|||
19717949|NCT03296566|42160814|FG001|Overall Study|Withdrawal by Subject|3|||
19717950|NCT03755882|42160820|FG000|Period 1|Protocol Violation|1|||
19717951|NCT03755882|42160821|FG001|Period 1|Protocol Violation|0|||
19717952|NCT03755882|42160820|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
19717953|NCT03755882|42160821|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
19717954|NCT00312377|42160829|FG000|Overall Study|Death|403|||
19717955|NCT00312377|42160830|FG001|Overall Study|Death|418|||
19717956|NCT00312377|42160829|FG000|Overall Study|Withdrawal by Subject|23|||
19717957|NCT00312377|42160830|FG001|Overall Study|Withdrawal by Subject|30|||
19717958|NCT00312377|42160829|FG000|Overall Study|Lost to Follow-up|9|||
19717959|NCT00312377|42160830|FG001|Overall Study|Lost to Follow-up|12|||
19717960|NCT00312377|42160829|FG000|Overall Study|Non-compliance|0|||
19717961|NCT00312377|42160830|FG001|Overall Study|Non-compliance|2|||
19717962|NCT00312377|42160829|FG000|Overall Study|Randomised but never received treatment|6|||
19717963|NCT00312377|42160830|FG001|Overall Study|Randomised but never received treatment|6|||
19717964|NCT00312377|42160829|FG000|Overall Study|Discontinue treatment survival follow up|202|||
19717965|NCT00312377|42160830|FG001|Overall Study|Discontinue treatment survival follow up|200|||
19717966|NCT00312377|42160829|FG000|Overall Study|Site ended participation in study|1|||
19717967|NCT00312377|42160830|FG001|Overall Study|Site ended participation in study|0|||
19717968|NCT03295318|42160839|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
19717969|NCT03295318|42160840|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
19717970|NCT03295318|42160841|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
19717971|NCT03295318|42160839|FG000|Overall Study|Death|1|||
19717972|NCT03295318|42160840|FG001|Overall Study|Death|1|||
19717973|NCT03295318|42160841|FG002|Overall Study|Death|1|||
19717974|NCT03295318|42160839|FG000|Overall Study|Protocol Violation|4|||
19717975|NCT03295318|42160840|FG001|Overall Study|Protocol Violation|3|||
19717976|NCT03295318|42160841|FG002|Overall Study|Protocol Violation|3|||
19717977|NCT03295318|42160839|FG000|Overall Study|Withdrawal by Subject|0|||
19717978|NCT03295318|42160840|FG001|Overall Study|Withdrawal by Subject|0|||
19717979|NCT03295318|42160841|FG002|Overall Study|Withdrawal by Subject|1|||
19717980|NCT03295318|42160839|FG000|Overall Study|Subject discontinued due to travel|0|||
19717981|NCT03295318|42160840|FG001|Overall Study|Subject discontinued due to travel|1|||
19717982|NCT03295318|42160841|FG002|Overall Study|Subject discontinued due to travel|0|||
19717983|NCT03311230|42160871|FG000|Overall Study|Withdrawal by Subject|1|||
19717984|NCT03311230|42160872|FG001|Overall Study|Withdrawal by Subject|4|||
19717985|NCT03311230|42160873|FG002|Overall Study|Withdrawal by Subject|2|||
19717986|NCT03311230|42160874|FG003|Overall Study|Withdrawal by Subject|7|||
19717987|NCT03311230|42160871|FG000|Overall Study|Unrelated injury|0|||
19717988|NCT03311230|42160872|FG001|Overall Study|Unrelated injury|1|||
19717989|NCT03311230|42160873|FG002|Overall Study|Unrelated injury|0|||
19717990|NCT03311230|42160874|FG003|Overall Study|Unrelated injury|0|||
19717991|NCT00312221|42160887|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
19717992|NCT00312221|42160888|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
19717993|NCT00312221|42160889|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
19717994|NCT00312221|42160890|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
19717995|NCT00312221|42160887|FG000|Open-label Run-in Period|Adverse Event|74|||
19717996|NCT00312221|42160888|FG001|Open-label Run-in Period|Adverse Event|0|||
19717997|NCT00312221|42160889|FG002|Open-label Run-in Period|Adverse Event|0|||
19717998|NCT00312221|42160890|FG003|Open-label Run-in Period|Adverse Event|0|||
19717999|NCT00312221|42160887|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
19718000|NCT00312221|42160888|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
19718001|NCT00312221|42160889|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
19718002|NCT00312221|42160890|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
19718003|NCT00312221|42160887|FG000|Open-label Run-in Period|Administrative|42|||
19718004|NCT00312221|42160888|FG001|Open-label Run-in Period|Administrative|0|||
19718005|NCT00312221|42160889|FG002|Open-label Run-in Period|Administrative|0|||
19718006|NCT00312221|42160890|FG003|Open-label Run-in Period|Administrative|0|||
19718007|NCT00312221|42160887|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
19718008|NCT00312221|42160888|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
19718009|NCT00312221|42160889|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
19718010|NCT00312221|42160890|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
19718011|NCT00312221|42160887|FG000|Open-label Run-in Period|Did not qualify|5|||
19718012|NCT00312221|42160888|FG001|Open-label Run-in Period|Did not qualify|0|||
19718013|NCT00312221|42160889|FG002|Open-label Run-in Period|Did not qualify|0|||
19718014|NCT00312221|42160890|FG003|Open-label Run-in Period|Did not qualify|0|||
19718015|NCT00312221|42160887|FG000|Double-blind Phase|Withdrawal by Subject|0|||
19718016|NCT00312221|42160888|FG001|Double-blind Phase|Withdrawal by Subject|6|||
19718017|NCT00312221|42160889|FG002|Double-blind Phase|Withdrawal by Subject|8|||
19718018|NCT00312221|42160890|FG003|Double-blind Phase|Withdrawal by Subject|7|||
19718019|NCT00312221|42160887|FG000|Double-blind Phase|Adverse Event|0|||
19718020|NCT00312221|42160888|FG001|Double-blind Phase|Adverse Event|10|||
19718021|NCT00312221|42160889|FG002|Double-blind Phase|Adverse Event|19|||
19718022|NCT00312221|42160890|FG003|Double-blind Phase|Adverse Event|18|||
19718023|NCT00312221|42160887|FG000|Double-blind Phase|Lost to Follow-up|0|||
19718024|NCT00312221|42160888|FG001|Double-blind Phase|Lost to Follow-up|0|||
19718025|NCT00312221|42160889|FG002|Double-blind Phase|Lost to Follow-up|2|||
19718026|NCT00312221|42160890|FG003|Double-blind Phase|Lost to Follow-up|2|||
19718027|NCT00312221|42160887|FG000|Double-blind Phase|Administrative|0|||
19718028|NCT00312221|42160888|FG001|Double-blind Phase|Administrative|26|||
19718029|NCT00312221|42160889|FG002|Double-blind Phase|Administrative|37|||
19718030|NCT00312221|42160890|FG003|Double-blind Phase|Administrative|33|||
19718031|NCT00312221|42160887|FG000|Double-blind Phase|Lack of Efficacy|0|||
19718032|NCT00312221|42160888|FG001|Double-blind Phase|Lack of Efficacy|17|||
19718033|NCT00312221|42160889|FG002|Double-blind Phase|Lack of Efficacy|6|||
19718034|NCT00312221|42160890|FG003|Double-blind Phase|Lack of Efficacy|10|||
19718035|NCT03294538|42160914|FG000|Overall Study|Adverse Event|0|||
19718036|NCT03294538|42160915|FG001|Overall Study|Adverse Event|1|||
19718037|NCT03294538|42160916|FG002|Overall Study|Adverse Event|1|||
19718038|NCT03294538|42160914|FG000|Overall Study|Lost to Follow-up|1|||
19718039|NCT03294538|42160915|FG001|Overall Study|Lost to Follow-up|0|||
19718040|NCT03294538|42160916|FG002|Overall Study|Lost to Follow-up|0|||
19718041|NCT03294538|42160914|FG000|Overall Study|Outside of Visit Window|4|||
19718042|NCT03294538|42160915|FG001|Overall Study|Outside of Visit Window|4|||
19718043|NCT03294538|42160916|FG002|Overall Study|Outside of Visit Window|1|||
19718044|NCT03265600|42160926|FG000|Overall Study|Lost to Follow-up|17|||
19718045|NCT03265600|42160927|FG001|Overall Study|Lost to Follow-up|5|||
19718046|NCT03265600|42160926|FG000|Overall Study|Withdrawal by Subject|4|||
19718047|NCT03265600|42160927|FG001|Overall Study|Withdrawal by Subject|2|||
19718048|NCT03265600|42160926|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
19718049|NCT03265600|42160927|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
19718050|NCT00335153|42160933|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
19718051|NCT00335153|42160933|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
19718052|NCT00335153|42160933|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
19718053|NCT00335153|42160933|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
19718054|NCT00335153|42160933|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
19718055|NCT00335153|42160933|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
19718056|NCT00335153|42160933|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
19718057|NCT00335153|42160933|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
19718058|NCT00335153|42160933|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
19718059|NCT00335153|42160933|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
19718060|NCT03265132|42160939|FG000|Overall Study|Adverse Event|0|||
19718061|NCT03265132|42160940|FG001|Overall Study|Adverse Event|1|||
19718062|NCT03265132|42160939|FG000|Overall Study|Lack of Efficacy|0|||
19718063|NCT03265132|42160940|FG001|Overall Study|Lack of Efficacy|2|||
19718064|NCT03265132|42160939|FG000|Overall Study|Progressive disease|0|||
19718065|NCT03265132|42160940|FG001|Overall Study|Progressive disease|2|||
19718066|NCT03265132|42160939|FG000|Overall Study|Withdrawal by Subject|0|||
19718067|NCT03265132|42160940|FG001|Overall Study|Withdrawal by Subject|1|||
19718068|NCT02939950|42160950|FG000|Overall Study|Lost to Follow-up|13|||
19718069|NCT02939950|42160951|FG001|Overall Study|Lost to Follow-up|16|||
19718070|NCT02939950|42160950|FG000|Overall Study|Positive slit lamp findings|0|||
19718071|NCT02939950|42160951|FG001|Overall Study|Positive slit lamp findings|1|||
19718072|NCT02939950|42160950|FG000|Overall Study|Chalazion upper lid|0|||
19718073|NCT02939950|42160951|FG001|Overall Study|Chalazion upper lid|1|||
19718074|NCT02939950|42160950|FG000|Overall Study|Lack of motivation|0|||
19718075|NCT02939950|42160951|FG001|Overall Study|Lack of motivation|2|||
19718076|NCT02939950|42160950|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
19718077|NCT02939950|42160951|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
19718078|NCT02939950|42160950|FG000|Overall Study|Military orders|1|||
19718079|NCT02939950|42160951|FG001|Overall Study|Military orders|0|||
19718080|NCT02939950|42160950|FG000|Overall Study|Participant Relocated|5|||
19718081|NCT02939950|42160951|FG001|Overall Study|Participant Relocated|3|||
19718082|NCT02939950|42160950|FG000|Overall Study|Study related symptoms|8|||
19718083|NCT02939950|42160951|FG001|Overall Study|Study related symptoms|8|||
19718084|NCT02939950|42160950|FG000|Overall Study|Unacceptable lens movement|2|||
19718085|NCT02939950|42160951|FG001|Overall Study|Unacceptable lens movement|0|||
19718086|NCT02939950|42160950|FG000|Overall Study|Protocol Violation|6|||
19718087|NCT02939950|42160951|FG001|Overall Study|Protocol Violation|3|||
19718088|NCT02939950|42160950|FG000|Overall Study|Physician Decision|2|||
19718089|NCT02939950|42160951|FG001|Overall Study|Physician Decision|0|||
19718090|NCT02939950|42160950|FG000|Overall Study|Pregnancy|6|||
19718091|NCT02939950|42160951|FG001|Overall Study|Pregnancy|7|||
19718092|NCT02939950|42160950|FG000|Overall Study|Withdrawal by Subject|12|||
19718093|NCT02939950|42160951|FG001|Overall Study|Withdrawal by Subject|28|||
19718094|NCT02939950|42160950|FG000|Overall Study|Adverse Event|7|||
19718095|NCT02939950|42160951|FG001|Overall Study|Adverse Event|3|||
19718096|NCT02939950|42160950|FG000|Overall Study|Randomized, not dispensed|1|||
19718097|NCT02939950|42160951|FG001|Overall Study|Randomized, not dispensed|0|||
19718098|NCT02939950|42160950|FG000|Overall Study|Ineligible at Baseline|2|||
19718099|NCT02939950|42160951|FG001|Overall Study|Ineligible at Baseline|8|||
19718100|NCT03753542|42160959|FG000|Overall Study|Lost to Follow-up|9|||
19718101|NCT03753542|42160960|FG001|Overall Study|Lost to Follow-up|14|||
19718102|NCT03292588|42160968|FG000|Overall Study|Death|1|||
19718103|NCT03292588|42160969|FG001|Overall Study|Death|0|||
19718104|NCT03292588|42160968|FG000|Overall Study|Lost to Follow-up|12|||
19718105|NCT03292588|42160969|FG001|Overall Study|Lost to Follow-up|16|||
19718106|NCT03292588|42160968|FG000|Overall Study|Physician Decision|0|||
19718107|NCT03292588|42160969|FG001|Overall Study|Physician Decision|1|||
19718108|NCT03292588|42160968|FG000|Overall Study|Withdrawal by Subject|4|||
19718109|NCT03292588|42160969|FG001|Overall Study|Withdrawal by Subject|4|||
19718110|NCT03292588|42160968|FG000|Overall Study|Move out of town|1|||
19718111|NCT03292588|42160969|FG001|Overall Study|Move out of town|0|||
19718112|NCT03292588|42160968|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
19718113|NCT03292588|42160969|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
19718114|NCT03752528|42160977|FG000|Part A|Lost to Follow-up|1|||
19718115|NCT03752528|42160977|FG000|Part A|Protocol Violation|1|||
19718116|NCT03752528|42160977|FG000|Part B|Protocol Violation|1|||
19718117|NCT03752528|42160977|FG000|Part B|Study terminated by sponsor|3|||
19718118|NCT00334295|42160984|FG000|Overall Study|Patients received fewer than 3 injection|5|||
19718119|NCT03292432|42160990|FG000|Overall Study|Lost to Follow-up|11|||
19718120|NCT03292432|42160991|FG001|Overall Study|Lost to Follow-up|8|||
19718121|NCT03292432|42160990|FG000|Overall Study|Death|2|||
19718122|NCT03292432|42160991|FG001|Overall Study|Death|1|||
19718123|NCT03292432|42160990|FG000|Overall Study|Withdrawal by Subject|1|||
19718124|NCT03292432|42160991|FG001|Overall Study|Withdrawal by Subject|2|||
19718125|NCT03292432|42160990|FG000|Overall Study|Site closed before any data collected|1|||
19718126|NCT03292432|42160991|FG001|Overall Study|Site closed before any data collected|0|||
19718127|NCT03291808|42160997|FG000|Overall Study|Lost to Follow-up|6|||
19718128|NCT03291808|42160997|FG000|Overall Study|Research burden|4|||
19718129|NCT03263806|42161003|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
19718130|NCT03263806|42161004|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
19718131|NCT03263806|42161003|FG000|Overall Study|Withdrawal by Subject|0|||
19718132|NCT03263806|42161004|FG001|Overall Study|Withdrawal by Subject|1|||
19718133|NCT03263806|42161003|FG000|Overall Study|Study Termination|5|||
19718134|NCT03263806|42161004|FG001|Overall Study|Study Termination|6|||
19718135|NCT03751280|42161012|FG000|Overall Study|Adverse Event|0|||
19718136|NCT03751280|42161013|FG001|Overall Study|Adverse Event|1|||
19718137|NCT03751280|42161012|FG000|Overall Study|Lost to Follow-up|3|||
19718138|NCT03751280|42161013|FG001|Overall Study|Lost to Follow-up|5|||
19718139|NCT03751280|42161012|FG000|Overall Study|Physician Decision|0|||
19718140|NCT03751280|42161013|FG001|Overall Study|Physician Decision|2|||
19718141|NCT03751280|42161012|FG000|Overall Study|Protocol Violation|0|||
19718142|NCT03751280|42161013|FG001|Overall Study|Protocol Violation|2|||
19718143|NCT03751280|42161012|FG000|Overall Study|Withdrawal by Subject|5|||
19718144|NCT03751280|42161013|FG001|Overall Study|Withdrawal by Subject|2|||
19718145|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
19718146|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
19718147|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
19718148|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
19718149|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
19718150|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
19718151|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
19718152|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
19718153|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
19718154|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
19718155|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
19718156|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
19718157|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
19718158|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
19718159|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
19718160|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
19718161|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
19718162|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
19718163|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
19718164|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
19718165|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
19718166|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
19718167|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
19718168|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
19718169|NCT00311363|42161023|FG000|24-Week Single-Blind Treatment Period|Death|1|||
19718170|NCT00311363|42161024|FG001|24-Week Single-Blind Treatment Period|Death|0|||
19718171|NCT00311363|42161025|FG002|24-Week Single-Blind Treatment Period|Death|0|||
19718172|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
19718173|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
19718174|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
19718175|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
19718176|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
19718177|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
19718178|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
19718179|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
19718180|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
19718181|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
19718182|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
19718183|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
19718184|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
19718185|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
19718186|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
19718187|NCT00311363|42161023|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
19718188|NCT00311363|42161024|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
19718189|NCT00311363|42161025|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
19718190|NCT00333983|42161038|FG000|Overall Study|Lost to Follow-up|2|||
19718191|NCT00333983|42161039|FG001|Overall Study|Lost to Follow-up|1|||
19718192|NCT00333983|42161040|FG002|Overall Study|Lost to Follow-up|0|||
19718193|NCT00333983|42161038|FG000|Overall Study|Adverse Event|1|||
19718194|NCT00333983|42161039|FG001|Overall Study|Adverse Event|1|||
19718195|NCT00333983|42161040|FG002|Overall Study|Adverse Event|1|||
19718196|NCT00333983|42161038|FG000|Overall Study|Withdrawal by Subject|0|||
19718197|NCT00333983|42161039|FG001|Overall Study|Withdrawal by Subject|3|||
19718198|NCT00333983|42161040|FG002|Overall Study|Withdrawal by Subject|1|||
19718199|NCT03262012|42161052|FG000|Overall Study|Withdrawal by Subject|15|||
19718200|NCT03262012|42161053|FG001|Overall Study|Withdrawal by Subject|13|||
19718201|NCT03262012|42161054|FG002|Overall Study|Withdrawal by Subject|8|||
19718202|NCT03262012|42161055|FG003|Overall Study|Withdrawal by Subject|7|||
19718203|NCT03262012|42161052|FG000|Overall Study|Adverse Event|10|||
19718204|NCT03262012|42161053|FG001|Overall Study|Adverse Event|12|||
19718205|NCT03262012|42161054|FG002|Overall Study|Adverse Event|4|||
19718206|NCT03262012|42161055|FG003|Overall Study|Adverse Event|6|||
19718207|NCT03262012|42161052|FG000|Overall Study|Physician Decision|2|||
19718208|NCT03262012|42161053|FG001|Overall Study|Physician Decision|5|||
19718209|NCT03262012|42161054|FG002|Overall Study|Physician Decision|1|||
19718210|NCT03262012|42161055|FG003|Overall Study|Physician Decision|0|||
19718211|NCT03262012|42161052|FG000|Overall Study|Lack of Efficacy|0|||
19718212|NCT03262012|42161053|FG001|Overall Study|Lack of Efficacy|5|||
19718213|NCT03262012|42161054|FG002|Overall Study|Lack of Efficacy|1|||
19718214|NCT03262012|42161055|FG003|Overall Study|Lack of Efficacy|2|||
19718215|NCT03262012|42161052|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
19718216|NCT03262012|42161053|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
19718217|NCT03262012|42161054|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
19718218|NCT03262012|42161055|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
19718219|NCT03288142|42161067|FG000|Overall Study|Lost to Follow-up|22|||
19718220|NCT03288142|42161068|FG001|Overall Study|Lost to Follow-up|15|||
19718221|NCT00310817|42161080|FG000|Overall Study|AE or Death|3|||
19718222|NCT00310817|42161081|FG001|Overall Study|AE or Death|1|||
19718223|NCT00310817|42161082|FG002|Overall Study|AE or Death|0|||
19718224|NCT00310817|42161083|FG003|Overall Study|AE or Death|0|||
19718225|NCT00310817|42161080|FG000|Overall Study|Withdrawal by Subject|1|||
19718226|NCT00310817|42161081|FG001|Overall Study|Withdrawal by Subject|4|||
19718227|NCT00310817|42161082|FG002|Overall Study|Withdrawal by Subject|6|||
19718228|NCT00310817|42161083|FG003|Overall Study|Withdrawal by Subject|7|||
19718229|NCT00310817|42161080|FG000|Overall Study|Lost to Follow-up|2|||
19718230|NCT00310817|42161081|FG001|Overall Study|Lost to Follow-up|1|||
19718231|NCT00310817|42161082|FG002|Overall Study|Lost to Follow-up|0|||
19718232|NCT00310817|42161083|FG003|Overall Study|Lost to Follow-up|0|||
19718233|NCT00310817|42161080|FG000|Overall Study|Inappropriate Enrollment|1|||
19718234|NCT00310817|42161081|FG001|Overall Study|Inappropriate Enrollment|0|||
19718235|NCT00310817|42161082|FG002|Overall Study|Inappropriate Enrollment|1|||
19718236|NCT00310817|42161083|FG003|Overall Study|Inappropriate Enrollment|0|||
19718237|NCT00310817|42161080|FG000|Overall Study|Protocol Violation|1|||
19718238|NCT00310817|42161081|FG001|Overall Study|Protocol Violation|1|||
19718239|NCT00310817|42161082|FG002|Overall Study|Protocol Violation|1|||
19718240|NCT00310817|42161083|FG003|Overall Study|Protocol Violation|1|||
19718241|NCT00310817|42161080|FG000|Overall Study|Unable to classify|3|||
19718242|NCT00310817|42161081|FG001|Overall Study|Unable to classify|1|||
19718243|NCT00310817|42161082|FG002|Overall Study|Unable to classify|0|||
19718244|NCT00310817|42161083|FG003|Overall Study|Unable to classify|0|||
19718245|NCT02940886|42161128|FG000|Overall Study|Adverse Event|7|||
19718246|NCT02940886|42161129|FG001|Overall Study|Adverse Event|3|||
19718247|NCT02940886|42161128|FG000|Overall Study|Protocol Violation|0|||
19718248|NCT02940886|42161129|FG001|Overall Study|Protocol Violation|2|||
19718249|NCT02940886|42161128|FG000|Overall Study|Withdrawal by Subject|28|||
19718250|NCT02940886|42161129|FG001|Overall Study|Withdrawal by Subject|20|||
19718251|NCT02940886|42161128|FG000|Overall Study|Death|1|||
19718252|NCT02940886|42161129|FG001|Overall Study|Death|0|||
19718253|NCT02940886|42161128|FG000|Overall Study|Lack of Efficacy|1|||
19718254|NCT02940886|42161129|FG001|Overall Study|Lack of Efficacy|0|||
19718255|NCT02940886|42161128|FG000|Overall Study|Lost to Follow-up|49|||
19718256|NCT02940886|42161129|FG001|Overall Study|Lost to Follow-up|21|||
19718257|NCT02940886|42161128|FG000|Overall Study|Physician Decision|9|||
19718258|NCT02940886|42161129|FG001|Overall Study|Physician Decision|4|||
19718259|NCT02940886|42161128|FG000|Overall Study|Sponsor decision|0|||
19718260|NCT02940886|42161129|FG001|Overall Study|Sponsor decision|1|||
19718261|NCT02940886|42161128|FG000|Overall Study|No treatment|7|||
19718262|NCT02940886|42161129|FG001|Overall Study|No treatment|2|||
19718263|NCT02940886|42161128|FG000|Overall Study|Enrolment error|0|||
19718264|NCT02940886|42161129|FG001|Overall Study|Enrolment error|1|||
19718265|NCT03285958|42161139|FG000|Overall Study|Lost to Follow-up|1|||
19718266|NCT03285958|42161140|FG001|Overall Study|Lost to Follow-up|1|||
19718267|NCT03285958|42161139|FG000|Overall Study|Withdrawal by Subject|1|||
19718268|NCT03285958|42161140|FG001|Overall Study|Withdrawal by Subject|0|||
19718269|NCT03285958|42161139|FG000|Overall Study|Not able to attend required orientation|3|||
19718270|NCT03285958|42161140|FG001|Overall Study|Not able to attend required orientation|0|||
19718271|NCT03285646|42161149|FG000|Overall Study|Adverse Event|1|||
19718272|NCT03285646|42161150|FG001|Overall Study|Adverse Event|0|||
19718273|NCT03285646|42161149|FG000|Overall Study|Withdrawal by Subject|10|||
19718274|NCT03285646|42161150|FG001|Overall Study|Withdrawal by Subject|2|||
19718275|NCT03285646|42161149|FG000|Overall Study|Lost to Follow-up|2|||
19718276|NCT03285646|42161150|FG001|Overall Study|Lost to Follow-up|1|||
19718277|NCT03285646|42161149|FG000|Overall Study|Investigator/Sponsor Decision|0|||
19718278|NCT03285646|42161150|FG001|Overall Study|Investigator/Sponsor Decision|1|||
19718279|NCT03309202|42161161|FG000|Overall Study|Lost to Follow-up|1|||
19718280|NCT03309202|42161162|FG001|Overall Study|Lost to Follow-up|0|||
19718281|NCT03309202|42161163|FG002|Overall Study|Lost to Follow-up|0|||
19718282|NCT03309202|42161164|FG003|Overall Study|Lost to Follow-up|0|||
19718283|NCT00074490|42161179|FG000|Overall Study|Progressive malignancy|0|||
19718284|NCT00074490|42161180|FG001|Overall Study|Progressive malignancy|7|||
19718285|NCT00074490|42161181|FG002|Overall Study|Progressive malignancy|0|||
19718286|NCT00074490|42161182|FG003|Overall Study|Progressive malignancy|0|||
19718287|NCT00074490|42161183|FG004|Overall Study|Progressive malignancy|3|||
19718288|NCT00074490|42161184|FG005|Overall Study|Progressive malignancy|0|||
19718289|NCT03285490|42161199|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
19718290|NCT03285490|42161200|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
19718291|NCT03285490|42161199|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
19718292|NCT03285490|42161200|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
19718293|NCT02939716|42161207|FG000|Overall Study|scanner failure|0|||
19718294|NCT02939716|42161208|FG001|Overall Study|scanner failure|0|||
19718295|NCT02939716|42161209|FG002|Overall Study|scanner failure|0|||
19718296|NCT02939716|42161210|FG003|Overall Study|scanner failure|1|||
19718297|NCT02939716|42161211|FG004|Overall Study|scanner failure|1|||
19718298|NCT02939716|42161212|FG005|Overall Study|scanner failure|1|||
19718299|NCT00367133|42161241|FG000|2 Years|Death|20|||
19718300|NCT00367133|42161242|FG001|2 Years|Death|12|||
19718301|NCT00367133|42161243|FG002|2 Years|Death|12|||
19718302|NCT00367133|42161241|FG000|2 Years|Dropped|34|||
19718303|NCT00367133|42161242|FG001|2 Years|Dropped|19|||
19718304|NCT00367133|42161243|FG002|2 Years|Dropped|33|||
19718305|NCT00367133|42161241|FG000|2 Years|Missed visit|4|||
19718306|NCT00367133|42161242|FG001|2 Years|Missed visit|5|||
19718307|NCT00367133|42161243|FG002|2 Years|Missed visit|4|||
19718308|NCT00367055|42161253|FG000|Overall Study|Adverse Event|6|||
19718309|NCT00367055|42161254|FG001|Overall Study|Adverse Event|3|||
19718310|NCT00367055|42161253|FG000|Overall Study|Patient's Willing|3|||
19718311|NCT00367055|42161254|FG001|Overall Study|Patient's Willing|2|||
19718312|NCT00367055|42161253|FG000|Overall Study|Lack of Efficacy|1|||
19718313|NCT00367055|42161254|FG001|Overall Study|Lack of Efficacy|2|||
19718314|NCT00367055|42161253|FG000|Overall Study|Lost to Follow-up|1|||
19718315|NCT00367055|42161254|FG001|Overall Study|Lost to Follow-up|1|||
19718316|NCT00367055|42161253|FG000|Overall Study|Protocol Violation|0|||
19718317|NCT00367055|42161254|FG001|Overall Study|Protocol Violation|1|||
19718318|NCT00367055|42161253|FG000|Overall Study|Stopping Criterion Met|0|||
19718319|NCT00367055|42161254|FG001|Overall Study|Stopping Criterion Met|1|||
19718320|NCT00367055|42161253|FG000|Overall Study|Participant Living too Far from Hospital|0|||
19718321|NCT00367055|42161254|FG001|Overall Study|Participant Living too Far from Hospital|1|||
19718322|NCT00057330|42161262|FG000|Overall Study|Adverse Event|9|||
19718323|NCT00057330|42161263|FG001|Overall Study|Adverse Event|12|||
19718324|NCT00057330|42161262|FG000|Overall Study|Death|1|||
19718325|NCT00057330|42161263|FG001|Overall Study|Death|0|||
19718326|NCT00057330|42161262|FG000|Overall Study|Protocol Violation|1|||
19718327|NCT00057330|42161263|FG001|Overall Study|Protocol Violation|1|||
19718328|NCT00057330|42161262|FG000|Overall Study|Withdrawal by Subject|115|||
19718329|NCT00057330|42161263|FG001|Overall Study|Withdrawal by Subject|84|||
19718330|NCT00057330|42161262|FG000|Overall Study|Lost to Follow-up|745|||
19718331|NCT00057330|42161263|FG001|Overall Study|Lost to Follow-up|617|||
19718332|NCT00057330|42161262|FG000|Overall Study|Physician Decision|1|||
19718333|NCT00057330|42161263|FG001|Overall Study|Physician Decision|0|||
19718334|NCT00057330|42161262|FG000|Overall Study|Other|260|||
19718335|NCT00057330|42161263|FG001|Overall Study|Other|206|||
19718336|NCT03283696|42161271|FG000|Overall Study|Physician Decision|5|||
19718337|NCT03283696|42161272|FG001|Overall Study|Physician Decision|6|||
19718338|NCT03283696|42161271|FG000|Overall Study|Withdrawal by Subject|2|||
19718339|NCT03283696|42161272|FG001|Overall Study|Withdrawal by Subject|0|||
19718340|NCT02939560|42161278|FG000|Overall Study|Withdrawal by Subject|2|||
19718341|NCT02939560|42161278|FG000|Overall Study|Protocol Violation|1|||
19718342|NCT03748706|42161282|FG000|Overall Study|Lost to Follow-up|1|||
19718343|NCT00062010|42161286|FG000|Overall Study|Ineligible|3|||
19718344|NCT03747302|42161292|FG000|Overall Study|Withdrawal by Subject|1|||
19718345|NCT03747302|42161293|FG001|Overall Study|Withdrawal by Subject|2|||
19718346|NCT00056862|42161303|FG000|Overall Study|Protocol Violation|1|||
19718347|NCT00056862|42161304|FG001|Overall Study|Protocol Violation|0|||
19718348|NCT00056316|42161312|FG000|Overall Study|Withdrawal by Subject|2|||
19718349|NCT00056316|42161313|FG001|Overall Study|Withdrawal by Subject|2|||
19718350|NCT00056316|42161312|FG000|Overall Study|Death/NH placement of pt|1|||
19718351|NCT00056316|42161313|FG001|Overall Study|Death/NH placement of pt|1|||
19718352|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
19718353|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
19718354|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
19718355|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
19718356|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
19718357|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
19718358|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
19718359|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
19718360|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
19718361|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
19718362|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
19718363|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
19718364|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
19718365|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
19718366|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
19718367|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
19718368|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
19718369|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
19718370|NCT03308968|42161322|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
19718371|NCT03308968|42161323|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
19718372|NCT03308968|42161324|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
19718373|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
19718374|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
19718375|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
19718376|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
19718377|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
19718378|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
19718379|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
19718380|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
19718381|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
19718382|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
19718383|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
19718384|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
19718385|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
19718386|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
19718387|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
19718388|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
19718389|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
19718390|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
19718391|NCT03308968|42161322|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
19718392|NCT03308968|42161323|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
19718393|NCT03308968|42161324|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
19718394|NCT02940730|42161337|FG000|Intervention 2|Physician Decision|7|||
19718395|NCT02940730|42161338|FG001|Intervention 2|Physician Decision|0|||
19718396|NCT03741062|42161346|FG000|Overall Study|Protocol Violation|1|||
19718397|NCT03741062|42161347|FG001|Overall Study|Protocol Violation|0|||
19718398|NCT03281668|42161353|FG000|Overall Study|Physician Decision|1|||
19718399|NCT03281668|42161353|FG000|Overall Study|scheduling conflict, family circumstance|2|||
19718400|NCT03281668|42161353|FG000|Overall Study|Withdrawal by Subject|4|||
19718401|NCT03281668|42161353|FG000|Overall Study|Lost to Follow-up|1|||
19718402|NCT03307252|42161368|FG000|Part 2, Period 1|Treatment not received|0|||
19718403|NCT03307252|42161369|FG001|Part 2, Period 1|Treatment not received|0|||
19718404|NCT03307252|42161370|FG002|Part 2, Period 1|Treatment not received|0|||
19718405|NCT03307252|42161371|FG003|Part 2, Period 1|Treatment not received|0|||
19718406|NCT03307252|42161372|FG004|Part 2, Period 1|Treatment not received|0|||
19718407|NCT03307252|42161373|FG005|Part 2, Period 1|Treatment not received|1|||
19718408|NCT03307252|42161374|FG006|Part 2, Period 1|Treatment not received|0|||
19718409|NCT03307252|42161375|FG007|Part 2, Period 1|Treatment not received|0|||
19718410|NCT03307252|42161376|FG008|Part 2, Period 1|Treatment not received|0|||
19718411|NCT03307252|42161377|FG009|Part 2, Period 1|Treatment not received|0|||
19718412|NCT03307252|42161378|FG010|Part 2, Period 1|Treatment not received|0|||
19718413|NCT03307252|42161368|FG000|Part 2, Period 3|Other than listed|0|||
19718414|NCT03307252|42161369|FG001|Part 2, Period 3|Other than listed|0|||
19718415|NCT03307252|42161370|FG002|Part 2, Period 3|Other than listed|0|||
19718416|NCT03307252|42161371|FG003|Part 2, Period 3|Other than listed|0|||
19718417|NCT03307252|42161372|FG004|Part 2, Period 3|Other than listed|1|||
19718418|NCT03307252|42161373|FG005|Part 2, Period 3|Other than listed|0|||
19718419|NCT03307252|42161374|FG006|Part 2, Period 3|Other than listed|0|||
19718420|NCT03307252|42161375|FG007|Part 2, Period 3|Other than listed|0|||
19718421|NCT03307252|42161376|FG008|Part 2, Period 3|Other than listed|0|||
19718422|NCT03307252|42161377|FG009|Part 2, Period 3|Other than listed|0|||
19718423|NCT03307252|42161378|FG010|Part 2, Period 3|Other than listed|0|||
19718424|NCT03307252|42161368|FG000|Part 2, Period 4|Other than listed|0|||
19718425|NCT03307252|42161369|FG001|Part 2, Period 4|Other than listed|0|||
19718426|NCT03307252|42161370|FG002|Part 2, Period 4|Other than listed|0|||
19718427|NCT03307252|42161371|FG003|Part 2, Period 4|Other than listed|0|||
19718428|NCT03307252|42161372|FG004|Part 2, Period 4|Other than listed|0|||
19718429|NCT03307252|42161373|FG005|Part 2, Period 4|Other than listed|0|||
19718430|NCT03307252|42161374|FG006|Part 2, Period 4|Other than listed|1|||
19718431|NCT03307252|42161375|FG007|Part 2, Period 4|Other than listed|0|||
19718432|NCT03307252|42161376|FG008|Part 2, Period 4|Other than listed|0|||
19718433|NCT03307252|42161377|FG009|Part 2, Period 4|Other than listed|0|||
19718434|NCT03307252|42161378|FG010|Part 2, Period 4|Other than listed|0|||
19718435|NCT03307252|42161368|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718436|NCT03307252|42161369|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718437|NCT03307252|42161370|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718438|NCT03307252|42161371|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718439|NCT03307252|42161372|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718440|NCT03307252|42161373|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718441|NCT03307252|42161374|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718442|NCT03307252|42161375|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718443|NCT03307252|42161376|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718444|NCT03307252|42161377|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
19718445|NCT03307252|42161378|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
19718446|NCT03307174|42161396|FG000|Overall Study|Unplanned ICU Administrion|5|||
19718447|NCT03307174|42161397|FG001|Overall Study|Unplanned ICU Administrion|3|||
19718448|NCT03307174|42161396|FG000|Overall Study|Aborted Surgery|1|||
19718449|NCT03307174|42161397|FG001|Overall Study|Aborted Surgery|2|||
19718450|NCT03307174|42161396|FG000|Overall Study|Hypotension|6|||
19718451|NCT03307174|42161397|FG001|Overall Study|Hypotension|0|||
19718452|NCT03307174|42161396|FG000|Overall Study|Nonfunctional epidural|1|||
19718453|NCT03307174|42161397|FG001|Overall Study|Nonfunctional epidural|1|||
19718454|NCT03307174|42161396|FG000|Overall Study|Planned epidural removal|1|||
19718455|NCT03307174|42161397|FG001|Overall Study|Planned epidural removal|0|||
19718456|NCT03307174|42161396|FG000|Overall Study|Intrathecal catheter placement|0|||
19718457|NCT03307174|42161397|FG001|Overall Study|Intrathecal catheter placement|1|||
19718458|NCT03258814|42161405|FG000|Overall Study|Early Termination|4|||
19718459|NCT03258814|42161406|FG001|Overall Study|Early Termination|3|||
19718460|NCT03258814|42161407|FG002|Overall Study|Early Termination|10|||
19718461|NCT03257410|42161416|FG000|Overall Study|Adverse Event|2|||
19718462|NCT03257410|42161417|FG001|Overall Study|Adverse Event|3|||
19718463|NCT03257410|42161416|FG000|Overall Study|Protocol Violation|1|||
19718464|NCT03257410|42161417|FG001|Overall Study|Protocol Violation|2|||
19718465|NCT03257410|42161416|FG000|Overall Study|Lost to Follow-up|1|||
19718466|NCT03257410|42161417|FG001|Overall Study|Lost to Follow-up|0|||
19718467|NCT03257410|42161416|FG000|Overall Study|Withdrawal by Subject|1|||
19718468|NCT03257410|42161417|FG001|Overall Study|Withdrawal by Subject|2|||
19718469|NCT03257410|42161416|FG000|Overall Study|Physician Decision|1|||
19718470|NCT03257410|42161417|FG001|Overall Study|Physician Decision|1|||
19718471|NCT03257410|42161416|FG000|Overall Study|Renal transplantation|2|||
19718472|NCT03257410|42161417|FG001|Overall Study|Renal transplantation|0|||
19718473|NCT03257410|42161416|FG000|Overall Study|Switch to peritoneal dialysis|1|||
19718474|NCT03257410|42161417|FG001|Overall Study|Switch to peritoneal dialysis|0|||
19718475|NCT03257410|42161416|FG000|Overall Study|Death|3|||
19718476|NCT03257410|42161417|FG001|Overall Study|Death|2|||
19718477|NCT03257410|42161416|FG000|Overall Study|Change to another dialysis center|2|||
19718478|NCT03257410|42161417|FG001|Overall Study|Change to another dialysis center|2|||
19718479|NCT03257410|42161416|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
19718480|NCT03257410|42161417|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
19718481|NCT03257410|42161416|FG000|Overall Study|Miscellaneous|2|||
19718482|NCT03257410|42161417|FG001|Overall Study|Miscellaneous|2|||
19718483|NCT03257410|42161416|FG000|Overall Study|Other|0|||
19718484|NCT03257410|42161417|FG001|Overall Study|Other|1|||
19718485|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
19718486|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
19718487|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
19718488|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
19718489|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
19718490|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
19718491|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
19718492|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
19718493|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
19718494|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
19718495|NCT00056160|42161425|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
19718496|NCT00056160|42161426|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
19718497|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
19718498|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
19718499|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
19718500|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
19718501|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
19718502|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
19718503|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
19718504|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
19718505|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
19718506|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
19718507|NCT00056160|42161425|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
19718508|NCT00056160|42161426|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
19718509|NCT00056160|42161425|FG000|Final Follow-up|Transferred into expanded access study.|3|||
19718510|NCT00056160|42161426|FG001|Final Follow-up|Transferred into expanded access study.|0|||
19718511|NCT00056160|42161425|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
19718512|NCT00056160|42161426|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
19718513|NCT00056160|42161425|FG000|Final Follow-up|Adverse Event|1|||
19718514|NCT00056160|42161426|FG001|Final Follow-up|Adverse Event|0|||
19718515|NCT00061932|42161434|FG000|Overall Study|Withdrawal by Subject|13|||
19718516|NCT00061932|42161435|FG001|Overall Study|Withdrawal by Subject|4|||
19718517|NCT03280264|42161442|FG000|Overall Study|Adverse Event|1|||
19718518|NCT03280264|42161442|FG000|Overall Study|Physician Decision|1|||
19718519|NCT03280264|42161442|FG000|Overall Study|Withdrawal by Subject|1|||
19718520|NCT00060840|42161449|FG000|Overall Study|Change in surgical plan|2|||
19718521|NCT00060840|42161450|FG001|Overall Study|Change in surgical plan|6|||
19718522|NCT00060840|42161449|FG000|Overall Study|Death|0|||
19718523|NCT00060840|42161450|FG001|Overall Study|Death|1|||
19718524|NCT00060840|42161449|FG000|Overall Study|Withdrawal by Subject|0|||
19718525|NCT00060840|42161450|FG001|Overall Study|Withdrawal by Subject|1|||
19718526|NCT00060840|42161449|FG000|Overall Study|Subinvestigator unavailable|0|||
19718527|NCT00060840|42161450|FG001|Overall Study|Subinvestigator unavailable|1|||
19718528|NCT00060840|42161449|FG000|Overall Study|Physician Decision|1|||
19718529|NCT00060840|42161450|FG001|Overall Study|Physician Decision|0|||
19718530|NCT00060840|42161449|FG000|Overall Study|Other|1|||
19718531|NCT00060840|42161450|FG001|Overall Study|Other|0|||
19718532|NCT03280108|42161458|FG000|Overall Study|Lost to Follow-up|2|||
19718533|NCT03280108|42161459|FG001|Overall Study|Lost to Follow-up|0|||
19718534|NCT00059202|42161472|FG000|Overall Study|Withdrawal by Subject|5|||
19718535|NCT00059202|42161473|FG001|Overall Study|Withdrawal by Subject|9|||
19718536|NCT00059202|42161472|FG000|Overall Study|Protocol Violation|1|||
19718537|NCT00059202|42161473|FG001|Overall Study|Protocol Violation|3|||
19718538|NCT00059202|42161472|FG000|Overall Study|drug toxicity|0|||
19718539|NCT00059202|42161473|FG001|Overall Study|drug toxicity|3|||
19718540|NCT03278626|42161482|FG000|Overall Study|Death|2|||
19718541|NCT03278626|42161482|FG000|Overall Study|Toxicity|1|||
19718542|NCT03278626|42161482|FG000|Overall Study|Disease Progression|2|||
19718543|NCT03277846|42161488|FG000|Overall Study|Inpatient stay too brief|12|||
19718544|NCT03277846|42161489|FG001|Overall Study|Inpatient stay too brief|11|||
19718545|NCT00073008|42161497|FG000|Overall Study|Missing|6|||
19718546|NCT00073008|42161498|FG001|Overall Study|Missing|6|||
19718547|NCT00073008|42161497|FG000|Overall Study|Withdrawal by Subject|2|||
19718548|NCT00073008|42161498|FG001|Overall Study|Withdrawal by Subject|2|||
19718549|NCT00073008|42161497|FG000|Overall Study|Lost to Follow-up|1|||
19718550|NCT00073008|42161498|FG001|Overall Study|Lost to Follow-up|3|||
19718551|NCT00073008|42161497|FG000|Overall Study|Death|46|||
19718552|NCT00073008|42161498|FG001|Overall Study|Death|47|||
19718553|NCT00073008|42161497|FG000|Overall Study|"Other selected on Case Report Form"|7|||
19718554|NCT00073008|42161498|FG001|Overall Study|"Other selected on Case Report Form"|5|||
19718555|NCT00058422|42161504|FG000|Overall Study|Not treated|2|||
19718556|NCT00072384|42161508|FG000|Overall Study|Physician Decision|1|||
19718557|NCT00072384|42161508|FG000|Overall Study|Ineligible|8|||
19718558|NCT00054132|42161514|FG000|Overall Study|Not Treated|1|||
19718559|NCT00071760|42161519|FG000|Overall Study|Adverse Event|3|||
19718560|NCT00071760|42161519|FG000|Overall Study|Lost to Follow-up|4|||
19718561|NCT00071760|42161519|FG000|Overall Study|Protocol Violation|1|||
19718562|NCT00071760|42161519|FG000|Overall Study|Withdrawal by Subject|3|||
19718563|NCT00071760|42161519|FG000|Overall Study|Insufficient Viral Load Response|3|||
19718564|NCT00071760|42161519|FG000|Overall Study|Pulmonary Tuberculosis|1|||
19718565|NCT00071760|42161519|FG000|Overall Study|Unavailability of RTV|8|||
19718566|NCT00071760|42161519|FG000|Overall Study|Relocation|1|||
19718567|NCT00071760|42161519|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
19718568|NCT00071760|42161519|FG000|Overall Study|Study Team Rec./Resistance|1|||
19718569|NCT00071760|42161519|FG000|Overall Study|Ongoing|25|||
19718570|NCT00057954|42161529|FG000|Overall Study|Death|1|||
19718571|NCT00057954|42161529|FG000|Overall Study|Disease progression|1|||
19718572|NCT00057876|42161535|FG000|Overall Study|Adverse Event|8|||
19718573|NCT00057876|42161536|FG001|Overall Study|Adverse Event|8|||
19718574|NCT00057876|42161535|FG000|Overall Study|Death|2|||
19718575|NCT00057876|42161536|FG001|Overall Study|Death|1|||
19718576|NCT00057876|42161535|FG000|Overall Study|Withdrawal by Subject|5|||
19718577|NCT00057876|42161536|FG001|Overall Study|Withdrawal by Subject|6|||
19718578|NCT00057876|42161535|FG000|Overall Study|Lack of Efficacy|10|||
19718579|NCT00057876|42161536|FG001|Overall Study|Lack of Efficacy|8|||
19718580|NCT00057876|42161535|FG000|Overall Study|Ineligible|1|||
19718581|NCT00057876|42161536|FG001|Overall Study|Ineligible|2|||
19718582|NCT00057876|42161535|FG000|Overall Study|other reason|2|||
19718583|NCT00057876|42161536|FG001|Overall Study|other reason|2|||
19718584|NCT00057876|42161535|FG000|Overall Study|other complicating disease|1|||
19718585|NCT00057876|42161536|FG001|Overall Study|other complicating disease|0|||
19718586|NCT00053898|42161544|FG000|Overall Study|No follow-up data from any source|9|||
19718587|NCT00053898|42161545|FG001|Overall Study|No follow-up data from any source|12|||
19718588|NCT00053898|42161544|FG000|Overall Study|Follow-up from telephone contact only|5|||
19718589|NCT00053898|42161545|FG001|Overall Study|Follow-up from telephone contact only|1|||
19718590|NCT03256552|42161581|FG000|Overall Study|Protocol Violation|1|||
19718591|NCT03256552|42161581|FG000|Overall Study|Physician Decision|1|||
19718592|NCT03256552|42161581|FG000|Overall Study|Adverse Event|1|||
19718593|NCT03256552|42161581|FG000|Overall Study|Withdrawal by Subject|2|||
19718594|NCT00071058|42161591|FG000|Overall Study|brain tumor-removed from study|1|||
19718595|NCT00053352|42161598|FG000|Overall Study|Lost to Follow-up|0|||
19718596|NCT00053352|42161599|FG001|Overall Study|Lost to Follow-up|1|||
19718597|NCT00053352|42161598|FG000|Overall Study|Physician Decision|11|||
19718598|NCT00053352|42161599|FG001|Overall Study|Physician Decision|1|||
19718599|NCT00053352|42161598|FG000|Overall Study|Withdrawal by Subject|1|||
19718600|NCT00053352|42161599|FG001|Overall Study|Withdrawal by Subject|0|||
19718601|NCT00053352|42161598|FG000|Overall Study|Ineligible|8|||
19718602|NCT00053352|42161599|FG001|Overall Study|Ineligible|8|||
19718603|NCT00053352|42161598|FG000|Overall Study|Disease at new site|1|||
19718604|NCT00053352|42161599|FG001|Overall Study|Disease at new site|0|||
19718605|NCT03245398|42161608|FG000|Overall Study|Travelled to another island|1|||
19718606|NCT03245398|42161609|FG001|Overall Study|Travelled to another island|0|||
19718607|NCT03244618|42161619|FG000|Overall Study|Lost to Follow-up|3|||
19718608|NCT03244618|42161620|FG001|Overall Study|Lost to Follow-up|4|||
19718609|NCT03244618|42161619|FG000|Overall Study|Protocol Violation|4|||
19718610|NCT03244618|42161620|FG001|Overall Study|Protocol Violation|3|||
19718611|NCT03244618|42161619|FG000|Overall Study|Withdrawal by Subject|0|||
19718612|NCT03244618|42161620|FG001|Overall Study|Withdrawal by Subject|2|||
19718613|NCT00052962|42161628|FG000|Overall Study|Not evaluable|0|||
19718614|NCT00052962|42161629|FG001|Overall Study|Not evaluable|2|||
19718615|NCT00052962|42161628|FG000|Overall Study|Not randomized/not evaluable|1|||
19718616|NCT00052962|42161629|FG001|Overall Study|Not randomized/not evaluable|0|||
19718617|NCT00051636|42161637|FG000|Period 1 - Core|Adverse Event|2|||
19718618|NCT00051636|42161638|FG001|Period 1 - Core|Adverse Event|2|||
19718619|NCT00051636|42161637|FG000|Period 1 - Core|Protocol Violation|1|||
19718620|NCT00051636|42161638|FG001|Period 1 - Core|Protocol Violation|0|||
19718621|NCT00051636|42161637|FG000|Period 1 - Core|Withdrawal by Subject|1|||
19718622|NCT00051636|42161638|FG001|Period 1 - Core|Withdrawal by Subject|2|||
19718623|NCT00051636|42161637|FG000|Period 1 - Core|Lost to Follow-up|0|||
19718624|NCT00051636|42161638|FG001|Period 1 - Core|Lost to Follow-up|2|||
19718625|NCT00051636|42161637|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
19718626|NCT00051636|42161638|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
19718627|NCT00051636|42161637|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
19718628|NCT00051636|42161638|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
19718629|NCT00051636|42161637|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
19718630|NCT00051636|42161638|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
19718631|NCT00051636|42161637|FG000|Period 2- Extended Observation Period|Death|4|||
19718632|NCT00051636|42161638|FG001|Period 2- Extended Observation Period|Death|5|||
19718633|NCT00051636|42161637|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
19718634|NCT00051636|42161638|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
19718635|NCT03255382|42161646|FG000|Overall Study|Adverse Event|3|||
19718636|NCT03255382|42161647|FG001|Overall Study|Adverse Event|0|||
19718637|NCT03255382|42161646|FG000|Overall Study|Lost to Follow-up|2|||
19718638|NCT03255382|42161647|FG001|Overall Study|Lost to Follow-up|0|||
19718639|NCT03255382|42161646|FG000|Overall Study|Withdrawal by Subject|2|||
19718640|NCT03255382|42161647|FG001|Overall Study|Withdrawal by Subject|0|||
19718641|NCT03255382|42161646|FG000|Overall Study|Other|6|||
19718642|NCT03255382|42161647|FG001|Overall Study|Other|0|||
19718643|NCT03254602|42161654|FG000|Overall Study|Lost to Follow-up|4|||
19718644|NCT00038142|42161660|FG000|Overall Study|Ineligible|1|||
19718645|NCT00038142|42161661|FG001|Overall Study|Ineligible|0|||
19718646|NCT00038142|42161660|FG000|Overall Study|Progressive Disease|11|||
19718647|NCT00038142|42161661|FG001|Overall Study|Progressive Disease|7|||
19718648|NCT00038142|42161660|FG000|Overall Study|Death|1|||
19718649|NCT00038142|42161661|FG001|Overall Study|Death|0|||
19718650|NCT00038142|42161660|FG000|Overall Study|Adverse Event|1|||
19718651|NCT00038142|42161661|FG001|Overall Study|Adverse Event|0|||
19718652|NCT00038142|42161660|FG000|Overall Study|Unknown Reason|8|||
19718653|NCT00038142|42161661|FG001|Overall Study|Unknown Reason|0|||
19718654|NCT00366899|42161669|FG000|Infant Series|Withdrawal by Subject|4|||
19718655|NCT00366899|42161670|FG001|Infant Series|Withdrawal by Subject|7|||
19718656|NCT00366899|42161669|FG000|Infant Series|Protocol Violation|2|||
19718657|NCT00366899|42161670|FG001|Infant Series|Protocol Violation|1|||
19718658|NCT00366899|42161669|FG000|Infant Series|Failed to return|1|||
19718659|NCT00366899|42161670|FG001|Infant Series|Failed to return|1|||
19718660|NCT00366899|42161669|FG000|Infant Series|Lost to Follow-up|0|||
19718661|NCT00366899|42161670|FG001|Infant Series|Lost to Follow-up|2|||
19718662|NCT00366899|42161669|FG000|Infant Series|Adverse Event|0|||
19718663|NCT00366899|42161670|FG001|Infant Series|Adverse Event|1|||
19718664|NCT00366899|42161669|FG000|Infant Series|Physician Decision|1|||
19718665|NCT00366899|42161670|FG001|Infant Series|Physician Decision|0|||
19718666|NCT00366899|42161669|FG000|Infant Series|Randomized but not consented|1|||
19718667|NCT00366899|42161670|FG001|Infant Series|Randomized but not consented|0|||
19718668|NCT00366899|42161669|FG000|After Infant Series|Lost to Follow-up|4|||
19718669|NCT00366899|42161670|FG001|After Infant Series|Lost to Follow-up|3|||
19718670|NCT00366899|42161669|FG000|After Infant Series|Withdrawal by Subject|1|||
19718671|NCT00366899|42161670|FG001|After Infant Series|Withdrawal by Subject|4|||
19718672|NCT00366899|42161669|FG000|After Infant Series|Adverse Event|1|||
19718673|NCT00366899|42161670|FG001|After Infant Series|Adverse Event|2|||
19718674|NCT00366899|42161669|FG000|After Infant Series|Protocol Violation|1|||
19718675|NCT00366899|42161670|FG001|After Infant Series|Protocol Violation|0|||
19718676|NCT00366899|42161669|FG000|Toddler Dose|Withdrawal by Subject|1|||
19718677|NCT00366899|42161670|FG001|Toddler Dose|Withdrawal by Subject|1|||
19718678|NCT00366899|42161669|FG000|Toddler Dose|Protocol Violation|1|||
19718679|NCT00366899|42161670|FG001|Toddler Dose|Protocol Violation|0|||
19718680|NCT03254134|42161704|FG000|Overall Study|Not eligible patients|599|||
19718681|NCT03254134|42161705|FG001|Overall Study|Not eligible patients|3630|||
19718682|NCT00037830|42161714|FG000|Overall Study|Adverse Event|2|||
19718683|NCT00037830|42161715|FG001|Overall Study|Adverse Event|0|||
19718684|NCT00037830|42161716|FG002|Overall Study|Adverse Event|0|||
19718685|NCT00037830|42161714|FG000|Overall Study|Withdrawal by Subject|4|||
19718686|NCT00037830|42161715|FG001|Overall Study|Withdrawal by Subject|5|||
19718687|NCT00037830|42161716|FG002|Overall Study|Withdrawal by Subject|1|||
19718688|NCT00037830|42161714|FG000|Overall Study|Protocol Violation|2|||
19718689|NCT00037830|42161715|FG001|Overall Study|Protocol Violation|2|||
19718690|NCT00037830|42161716|FG002|Overall Study|Protocol Violation|0|||
19718691|NCT00037830|42161714|FG000|Overall Study|Unrelated Medical Problem|2|||
19718692|NCT00037830|42161715|FG001|Overall Study|Unrelated Medical Problem|0|||
19718693|NCT00037830|42161716|FG002|Overall Study|Unrelated Medical Problem|0|||
19718694|NCT03242434|42161726|FG000|Overall Study|Death|0|||
19718695|NCT03242434|42161727|FG001|Overall Study|Death|2|||
19718696|NCT02939014|42161736|FG000|Overall Study|Lost to Follow-up|1|||
19718697|NCT02939014|42161737|FG001|Overall Study|Lost to Follow-up|0|||
19718698|NCT02939014|42161736|FG000|Overall Study|Death|4|||
19718699|NCT02939014|42161737|FG001|Overall Study|Death|3|||
19718700|NCT00051558|42161746|FG000|Overall Study|Adverse Event|30|||
19718701|NCT00051558|42161747|FG001|Overall Study|Adverse Event|18|||
19718702|NCT00051558|42161746|FG000|Overall Study|Withdrawal by Subject|29|||
19718703|NCT00051558|42161747|FG001|Overall Study|Withdrawal by Subject|42|||
19718704|NCT00051558|42161746|FG000|Overall Study|Death|9|||
19718705|NCT00051558|42161747|FG001|Overall Study|Death|15|||
19718706|NCT00051558|42161746|FG000|Overall Study|Lost to Follow-up|4|||
19718707|NCT00051558|42161747|FG001|Overall Study|Lost to Follow-up|13|||
19718708|NCT00051558|42161746|FG000|Overall Study|Protocol Violation|3|||
19718709|NCT00051558|42161747|FG001|Overall Study|Protocol Violation|4|||
19718710|NCT00051558|42161746|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
19718711|NCT00051558|42161747|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
19718712|NCT00051558|42161746|FG000|Overall Study|Sponsor Decision|6|||
19718713|NCT00051558|42161747|FG001|Overall Study|Sponsor Decision|1|||
19718714|NCT00051558|42161746|FG000|Overall Study|Other|2|||
19718715|NCT00051558|42161747|FG001|Overall Study|Other|1|||
19718716|NCT00051558|42161746|FG000|Overall Study|Significant Lab Value|2|||
19718717|NCT00051558|42161747|FG001|Overall Study|Significant Lab Value|0|||
19718718|NCT00051558|42161746|FG000|Overall Study|Physician Decision|5|||
19718719|NCT00051558|42161747|FG001|Overall Study|Physician Decision|0|||
19718720|NCT03251482|42161758|FG000|Overall Study|Withdrawal by Subject|0|||
19718721|NCT03251482|42161759|FG001|Overall Study|Withdrawal by Subject|1|||
19718722|NCT03251482|42161760|FG002|Overall Study|Withdrawal by Subject|0|||
19718723|NCT03251482|42161761|FG003|Overall Study|Withdrawal by Subject|0|||
19718724|NCT03251482|42161762|FG004|Overall Study|Withdrawal by Subject|0|||
19718725|NCT03249454|42161774|FG000|Overall Study|Withdrawal by Subject|0|||
19718726|NCT03249454|42161775|FG001|Overall Study|Withdrawal by Subject|0|||
19718727|NCT03249454|42161776|FG002|Overall Study|Withdrawal by Subject|0|||
19718728|NCT03249454|42161777|FG003|Overall Study|Withdrawal by Subject|0|||
19718729|NCT03249454|42161778|FG004|Overall Study|Withdrawal by Subject|0|||
19718730|NCT03249454|42161779|FG005|Overall Study|Withdrawal by Subject|0|||
19718731|NCT03249454|42161780|FG006|Overall Study|Withdrawal by Subject|0|||
19718732|NCT03249454|42161781|FG007|Overall Study|Withdrawal by Subject|0|||
19718733|NCT03249454|42161782|FG008|Overall Study|Withdrawal by Subject|0|||
19718734|NCT03249454|42161783|FG009|Overall Study|Withdrawal by Subject|1|||
19718735|NCT03249454|42161784|FG010|Overall Study|Withdrawal by Subject|1|||
19718736|NCT03732248|42161797|FG000|Overall Study|Withdrawal by Subject|1|||
19718737|NCT03732248|42161798|FG001|Overall Study|Withdrawal by Subject|0|||
19718738|NCT00310037|42161806|FG000|Overall Study|Adverse Event|7|||
19718739|NCT00310037|42161807|FG001|Overall Study|Adverse Event|14|||
19718740|NCT00310037|42161806|FG000|Overall Study|Withdrawal by Subject|4|||
19718741|NCT00310037|42161807|FG001|Overall Study|Withdrawal by Subject|3|||
19718742|NCT00310037|42161806|FG000|Overall Study|Progression|6|||
19718743|NCT00310037|42161807|FG001|Overall Study|Progression|0|||
19718744|NCT00310037|42161806|FG000|Overall Study|Non-protocol treatment|1|||
19718745|NCT00310037|42161807|FG001|Overall Study|Non-protocol treatment|0|||
19718746|NCT00309959|42161813|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
19718747|NCT03238924|42161824|FG000|Overall Study|Withdrawal by Subject|2|||
19718748|NCT03238924|42161825|FG001|Overall Study|Withdrawal by Subject|2|||
19718749|NCT03247816|42161831|FG000|Overall Study|Adverse Event|12|||
19718750|NCT03247816|42161831|FG000|Overall Study|Physician Decision|3|||
19718751|NCT03247816|42161831|FG000|Overall Study|Lack of Efficacy|1|||
19718752|NCT03247816|42161831|FG000|Overall Study|Lost to Follow-up|10|||
19718753|NCT03247816|42161831|FG000|Overall Study|Missing Feraccru stop date|3|||
19718754|NCT00333359|42161849|FG000|Overall Study|Adverse Event|29|||
19718755|NCT00333359|42161850|FG001|Overall Study|Adverse Event|35|||
19718756|NCT00333359|42161849|FG000|Overall Study|Withdrawal by Subject|19|||
19718757|NCT00333359|42161850|FG001|Overall Study|Withdrawal by Subject|37|||
19718758|NCT00333359|42161849|FG000|Overall Study|Physician Decision|2|||
19718759|NCT00333359|42161850|FG001|Overall Study|Physician Decision|2|||
19718760|NCT00333359|42161849|FG000|Overall Study|Protocol Non-compliance|2|||
19718761|NCT00333359|42161850|FG001|Overall Study|Protocol Non-compliance|8|||
19718762|NCT00333359|42161849|FG000|Overall Study|Lost to Follow-up|15|||
19718763|NCT00333359|42161850|FG001|Overall Study|Lost to Follow-up|25|||
19718764|NCT00333359|42161849|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
19718765|NCT00333359|42161850|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
19718766|NCT00333359|42161849|FG000|Overall Study|Treatment Failure|3|||
19718767|NCT00333359|42161850|FG001|Overall Study|Treatment Failure|8|||
19718768|NCT00333359|42161849|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
19718769|NCT00333359|42161850|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
19718770|NCT03246724|42161862|FG000|Overall Study|Withdrawal by Subject|5|||
19718771|NCT03246724|42161863|FG001|Overall Study|Withdrawal by Subject|2|||
19718772|NCT03246724|42161864|FG002|Overall Study|Withdrawal by Subject|4|||
19718773|NCT03246724|42161865|FG003|Overall Study|Withdrawal by Subject|2|||
19718774|NCT03246724|42161862|FG000|Overall Study|Ineligible on day of surgery|7|||
19718775|NCT03246724|42161863|FG001|Overall Study|Ineligible on day of surgery|2|||
19718776|NCT03246724|42161864|FG002|Overall Study|Ineligible on day of surgery|0|||
19718777|NCT03246724|42161865|FG003|Overall Study|Ineligible on day of surgery|3|||
19718778|NCT03246724|42161862|FG000|Overall Study|Study completed before surgical date|2|||
19718779|NCT03246724|42161863|FG001|Overall Study|Study completed before surgical date|1|||
19718780|NCT03246724|42161864|FG002|Overall Study|Study completed before surgical date|8|||
19718781|NCT03246724|42161865|FG003|Overall Study|Study completed before surgical date|1|||
19718782|NCT03246724|42161862|FG000|Overall Study|Transferred to other arm|0|||
19718783|NCT03246724|42161863|FG001|Overall Study|Transferred to other arm|0|||
19718784|NCT03246724|42161864|FG002|Overall Study|Transferred to other arm|1|||
19718785|NCT03246724|42161865|FG003|Overall Study|Transferred to other arm|0|||
19718786|NCT03246724|42161862|FG000|Overall Study|Unable to obtain medication timely|0|||
19718787|NCT03246724|42161863|FG001|Overall Study|Unable to obtain medication timely|2|||
19718788|NCT03246724|42161864|FG002|Overall Study|Unable to obtain medication timely|2|||
19718789|NCT03246724|42161865|FG003|Overall Study|Unable to obtain medication timely|1|||
19718790|NCT03246724|42161862|FG000|Overall Study|Re-consented to participate|0|||
19718791|NCT03246724|42161863|FG001|Overall Study|Re-consented to participate|0|||
19718792|NCT03246724|42161864|FG002|Overall Study|Re-consented to participate|0|||
19718793|NCT03246724|42161865|FG003|Overall Study|Re-consented to participate|1|||
19718794|NCT03246646|42161877|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
19718795|NCT03246646|42161878|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
19718796|NCT03246646|42161877|FG000|Overall Study|Withdrawal by Subject|3|||
19718797|NCT03246646|42161878|FG001|Overall Study|Withdrawal by Subject|0|||
19718798|NCT03246646|42161877|FG000|Overall Study|Lost to Follow-up|7|||
19718799|NCT03246646|42161878|FG001|Overall Study|Lost to Follow-up|0|||
19718800|NCT01347112|42161886|FG000|Overall Study|Withdrawal by Subject|1|||
19718801|NCT01347112|42161887|FG001|Overall Study|Withdrawal by Subject|7|||
19718802|NCT01347112|42161886|FG000|Overall Study|Lost to Follow-up|3|||
19718803|NCT01347112|42161887|FG001|Overall Study|Lost to Follow-up|5|||
19718804|NCT00308711|42161897|FG000|Overall Study|Withdrawal by Subject|1|||
19718805|NCT00308711|42161898|FG001|Overall Study|Withdrawal by Subject|0|||
19718806|NCT00308711|42161899|FG002|Overall Study|Withdrawal by Subject|1|||
19718807|NCT00308711|42161897|FG000|Overall Study|Protocol Violation|0|||
19718808|NCT00308711|42161898|FG001|Overall Study|Protocol Violation|1|||
19718809|NCT00308711|42161899|FG002|Overall Study|Protocol Violation|1|||
19718810|NCT00308711|42161897|FG000|Overall Study|Lost to Follow-up|0|||
19718811|NCT00308711|42161898|FG001|Overall Study|Lost to Follow-up|1|||
19718812|NCT00308711|42161899|FG002|Overall Study|Lost to Follow-up|0|||
19718813|NCT00308711|42161897|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
19718814|NCT00308711|42161898|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
19718815|NCT00308711|42161899|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
19718816|NCT00308711|42161897|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
19718817|NCT00308711|42161898|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
19718818|NCT00308711|42161899|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
19718819|NCT00308555|42161909|FG000|Overall Study|Withdrawal by Subject|1|||
19718820|NCT00308555|42161910|FG001|Overall Study|Withdrawal by Subject|0|||
19718821|NCT00308555|42161909|FG000|Overall Study|Physician Decision|2|||
19718822|NCT00308555|42161910|FG001|Overall Study|Physician Decision|0|||
19718823|NCT00050778|42161919|FG000|Overall Study|Adverse Event|13|||
19718824|NCT00050778|42161920|FG001|Overall Study|Adverse Event|3|||
19718825|NCT00050778|42161921|FG002|Overall Study|Adverse Event|2|||
19718826|NCT00050778|42161919|FG000|Overall Study|Death|0|||
19718827|NCT00050778|42161920|FG001|Overall Study|Death|1|||
19718828|NCT00050778|42161921|FG002|Overall Study|Death|1|||
19718829|NCT00050778|42161919|FG000|Overall Study|Lack of Efficacy|16|||
19718830|NCT00050778|42161920|FG001|Overall Study|Lack of Efficacy|2|||
19718831|NCT00050778|42161921|FG002|Overall Study|Lack of Efficacy|2|||
19718832|NCT00050778|42161919|FG000|Overall Study|Lost to Follow-up|0|||
19718833|NCT00050778|42161920|FG001|Overall Study|Lost to Follow-up|2|||
19718834|NCT00050778|42161921|FG002|Overall Study|Lost to Follow-up|4|||
19718835|NCT00050778|42161919|FG000|Overall Study|Physician Decision|3|||
19718836|NCT00050778|42161920|FG001|Overall Study|Physician Decision|0|||
19718837|NCT00050778|42161921|FG002|Overall Study|Physician Decision|2|||
19718838|NCT00050778|42161919|FG000|Overall Study|Protocol Violation|2|||
19718839|NCT00050778|42161920|FG001|Overall Study|Protocol Violation|0|||
19718840|NCT00050778|42161921|FG002|Overall Study|Protocol Violation|1|||
19718841|NCT00050778|42161919|FG000|Overall Study|Withdrawal by Subject|6|||
19718842|NCT00050778|42161920|FG001|Overall Study|Withdrawal by Subject|8|||
19718843|NCT00050778|42161921|FG002|Overall Study|Withdrawal by Subject|4|||
19718844|NCT00050778|42161919|FG000|Overall Study|Randomized but not treated|4|||
19718845|NCT00050778|42161920|FG001|Overall Study|Randomized but not treated|5|||
19718846|NCT00050778|42161921|FG002|Overall Study|Randomized but not treated|2|||
19718847|NCT00050778|42161919|FG000|Overall Study|Familial and personal reasons|1|||
19718848|NCT00050778|42161920|FG001|Overall Study|Familial and personal reasons|0|||
19718849|NCT00050778|42161921|FG002|Overall Study|Familial and personal reasons|0|||
19718850|NCT00050622|42161931|FG000|Overall Study|Adverse Event|1|||
19718851|NCT00308087|42161957|FG000|Overall Study|Progressive Disease|19|||
19718852|NCT00308087|42161958|FG001|Overall Study|Progressive Disease|21|||
19718853|NCT00308087|42161957|FG000|Overall Study|Study Closure|11|||
19718854|NCT00308087|42161958|FG001|Overall Study|Study Closure|12|||
19718855|NCT00308087|42161957|FG000|Overall Study|Withdrawal by Subject|2|||
19718856|NCT00308087|42161958|FG001|Overall Study|Withdrawal by Subject|1|||
19718857|NCT00308087|42161957|FG000|Overall Study|Other|4|||
19718858|NCT00308087|42161958|FG001|Overall Study|Other|3|||
19718859|NCT00307931|42161964|FG000|Overall Study|Adverse Event|1|||
19718860|NCT02796170|42161970|FG000|Overall Study|Lost to Follow-up|3|||
19718861|NCT02796170|42161971|FG001|Overall Study|Lost to Follow-up|0|||
19718862|NCT00049842|42161979|FG000|Treatment Phase|Adverse Event|47|||
19718863|NCT00049842|42161980|FG001|Treatment Phase|Adverse Event|12|||
19718864|NCT00049842|42161979|FG000|Treatment Phase|Withdrawal by Subject|35|||
19718865|NCT00049842|42161980|FG001|Treatment Phase|Withdrawal by Subject|46|||
19718866|NCT00049842|42161979|FG000|Treatment Phase|Non-compliance with protocol|7|||
19718867|NCT00049842|42161980|FG001|Treatment Phase|Non-compliance with protocol|8|||
19718868|NCT00049842|42161979|FG000|Treatment Phase|Lost to Follow-up|4|||
19718869|NCT00049842|42161980|FG001|Treatment Phase|Lost to Follow-up|8|||
19718870|NCT00049842|42161979|FG000|Treatment Phase|Administrative|0|||
19718871|NCT00049842|42161980|FG001|Treatment Phase|Administrative|3|||
19718872|NCT00049842|42161979|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
19718873|NCT00049842|42161980|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
19718874|NCT00049842|42161979|FG000|Follow-up Phase|Adverse Event|6|||
19718875|NCT00049842|42161980|FG001|Follow-up Phase|Adverse Event|1|||
19718876|NCT00049842|42161979|FG000|Follow-up Phase|Other|1|||
19718877|NCT00049842|42161980|FG001|Follow-up Phase|Other|4|||
19718878|NCT00307151|42161990|FG000|Overall Study|Death|4|||
19718879|NCT00307151|42161991|FG001|Overall Study|Death|3|||
19718880|NCT00307151|42161992|FG002|Overall Study|Death|10|||
19718881|NCT00307151|42161993|FG003|Overall Study|Death|3|||
19718882|NCT00307151|42161990|FG000|Overall Study|Severe debilitation, unable to continue|1|||
19718883|NCT00307151|42161991|FG001|Overall Study|Severe debilitation, unable to continue|0|||
19718884|NCT00307151|42161992|FG002|Overall Study|Severe debilitation, unable to continue|0|||
19718885|NCT00307151|42161993|FG003|Overall Study|Severe debilitation, unable to continue|0|||
19718886|NCT00307151|42161990|FG000|Overall Study|Subject unable to get to clinic|1|||
19718887|NCT00307151|42161991|FG001|Overall Study|Subject unable to get to clinic|0|||
19718888|NCT00307151|42161992|FG002|Overall Study|Subject unable to get to clinic|6|||
19718889|NCT00307151|42161993|FG003|Overall Study|Subject unable to get to clinic|2|||
19718890|NCT00307151|42161990|FG000|Overall Study|Withdrew consent|0|||
19718891|NCT00307151|42161991|FG001|Overall Study|Withdrew consent|1|||
19718892|NCT00307151|42161992|FG002|Overall Study|Withdrew consent|1|||
19718893|NCT00307151|42161993|FG003|Overall Study|Withdrew consent|3|||
19718894|NCT00307151|42161990|FG000|Overall Study|Not willing to adhere to study reqs|2|||
19718895|NCT00307151|42161991|FG001|Overall Study|Not willing to adhere to study reqs|0|||
19718896|NCT00307151|42161992|FG002|Overall Study|Not willing to adhere to study reqs|2|||
19718897|NCT00307151|42161993|FG003|Overall Study|Not willing to adhere to study reqs|2|||
19718898|NCT00307151|42161990|FG000|Overall Study|Clinic unable to contact subject|3|||
19718899|NCT00307151|42161991|FG001|Overall Study|Clinic unable to contact subject|3|||
19718900|NCT00307151|42161992|FG002|Overall Study|Clinic unable to contact subject|1|||
19718901|NCT00307151|42161993|FG003|Overall Study|Clinic unable to contact subject|1|||
19718902|NCT02654132|42162005|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
19718903|NCT02654132|42162006|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
19718904|NCT02654132|42162005|FG000|Treatment Period|Disease progression|43|||
19718905|NCT02654132|42162006|FG001|Treatment Period|Disease progression|38|||
19718906|NCT02654132|42162005|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
19718907|NCT02654132|42162006|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
19718908|NCT02654132|42162005|FG000|Treatment Period|Other reasons|4|||
19718909|NCT02654132|42162006|FG001|Treatment Period|Other reasons|2|||
19718910|NCT02654132|42162005|FG000|Treatment Period|Study drug toxicity|2|||
19718911|NCT02654132|42162006|FG001|Treatment Period|Study drug toxicity|2|||
19718912|NCT02654132|42162005|FG000|Treatment Period|Withdrawal by Subject|2|||
19718913|NCT02654132|42162006|FG001|Treatment Period|Withdrawal by Subject|1|||
19718914|NCT02654132|42162005|FG000|Treatment Period|Maximum Clinical Benefit|0|||
19718915|NCT02654132|42162006|FG001|Treatment Period|Maximum Clinical Benefit|2|||
19718916|NCT02654132|42162005|FG000|Treatment Period|Participant request to discontinue|2|||
19718917|NCT02654132|42162006|FG001|Treatment Period|Participant request to discontinue|0|||
19718918|NCT02654132|42162005|FG000|Treatment Period|Administrative reasons by sponsor|0|||
19718919|NCT02654132|42162006|FG001|Treatment Period|Administrative reasons by sponsor|1|||
19718920|NCT02654132|42162005|FG000|Treatment Period|Death|1|||
19718921|NCT02654132|42162006|FG001|Treatment Period|Death|0|||
19718922|NCT03241342|42162015|FG000|Overall Study|Adverse Event|5|||
19718923|NCT03241342|42162016|FG001|Overall Study|Adverse Event|8|||
19718924|NCT03241342|42162017|FG002|Overall Study|Adverse Event|4|||
19718925|NCT03241342|42162015|FG000|Overall Study|Lack of Efficacy|0|||
19718926|NCT03241342|42162016|FG001|Overall Study|Lack of Efficacy|0|||
19718927|NCT03241342|42162017|FG002|Overall Study|Lack of Efficacy|1|||
19718928|NCT03241342|42162015|FG000|Overall Study|noncompliance with study drug|2|||
19718929|NCT03241342|42162016|FG001|Overall Study|noncompliance with study drug|1|||
19718930|NCT03241342|42162017|FG002|Overall Study|noncompliance with study drug|1|||
19718931|NCT03241342|42162015|FG000|Overall Study|sponsor decision|0|||
19718932|NCT03241342|42162016|FG001|Overall Study|sponsor decision|1|||
19718933|NCT03241342|42162017|FG002|Overall Study|sponsor decision|2|||
19718934|NCT03241342|42162015|FG000|Overall Study|not reported|15|||
19718935|NCT03241342|42162016|FG001|Overall Study|not reported|21|||
19718936|NCT03241342|42162017|FG002|Overall Study|not reported|19|||
19718937|NCT02618408|42162028|FG000|Overall Study|Withdrawal by Subject|1|||
19718938|NCT02618408|42162029|FG001|Overall Study|Withdrawal by Subject|0|||
19718939|NCT02618408|42162030|FG002|Overall Study|Withdrawal by Subject|4|||
19718940|NCT02618408|42162028|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
19718941|NCT02618408|42162029|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
19718942|NCT02618408|42162030|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
19718943|NCT02618408|42162028|FG000|Overall Study|Lost to Follow-up|4|||
19718944|NCT02618408|42162029|FG001|Overall Study|Lost to Follow-up|2|||
19718945|NCT02618408|42162030|FG002|Overall Study|Lost to Follow-up|6|||
19718946|NCT02618408|42162028|FG000|Overall Study|Adverse Event|4|||
19718947|NCT02618408|42162029|FG001|Overall Study|Adverse Event|0|||
19718948|NCT02618408|42162030|FG002|Overall Study|Adverse Event|10|||
19718949|NCT02618408|42162028|FG000|Overall Study|Physician Decision|1|||
19718950|NCT02618408|42162029|FG001|Overall Study|Physician Decision|1|||
19718951|NCT02618408|42162030|FG002|Overall Study|Physician Decision|2|||
19718952|NCT02618408|42162028|FG000|Overall Study|Protocol Violation|1|||
19718953|NCT02618408|42162029|FG001|Overall Study|Protocol Violation|1|||
19718954|NCT02618408|42162030|FG002|Overall Study|Protocol Violation|2|||
19718955|NCT02618408|42162028|FG000|Overall Study|Other, Multiple Categories|0|||
19718956|NCT02618408|42162029|FG001|Overall Study|Other, Multiple Categories|0|||
19718957|NCT02618408|42162030|FG002|Overall Study|Other, Multiple Categories|4|||
19718958|NCT00306995|42162048|FG000|Study Part I|Withdrawal by Subject|0|||
19718959|NCT00306995|42162049|FG001|Study Part I|Withdrawal by Subject|0|||
19718960|NCT00306995|42162050|FG002|Study Part I|Withdrawal by Subject|0|||
19718961|NCT00306995|42162051|FG003|Study Part I|Withdrawal by Subject|0|||
19718962|NCT00306995|42162052|FG004|Study Part I|Withdrawal by Subject|0|||
19718963|NCT00306995|42162053|FG005|Study Part I|Withdrawal by Subject|0|||
19718964|NCT00306995|42162054|FG006|Study Part I|Withdrawal by Subject|1|||
19718965|NCT00306995|42162048|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
19718966|NCT00306995|42162049|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
19718967|NCT00306995|42162050|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
19718968|NCT00306995|42162051|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
19718969|NCT00306995|42162052|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
19718970|NCT00306995|42162053|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
19718971|NCT00306995|42162054|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
19718972|NCT00121108|42162101|FG000|Overall Study|Lost to Follow-up|10|||
19718973|NCT00121108|42162102|FG001|Overall Study|Lost to Follow-up|22|||
19718974|NCT00121108|42162101|FG000|Overall Study|Withdrawal by Subject|106|||
19718975|NCT00121108|42162102|FG001|Overall Study|Withdrawal by Subject|195|||
19718976|NCT00121108|42162101|FG000|Overall Study|Death|5|||
19718977|NCT00121108|42162102|FG001|Overall Study|Death|8|||
19718978|NCT02387996|42162109|FG000|Overall Study|Disease Progression|167|||
19718979|NCT02387996|42162109|FG000|Overall Study|Study Drug Toxicity|31|||
19718980|NCT02387996|42162109|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
19718981|NCT02387996|42162109|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
19718982|NCT02387996|42162109|FG000|Overall Study|Subject Withdrew Consent|5|||
19718983|NCT02387996|42162109|FG000|Overall Study|Lost to Follow-up|1|||
19718984|NCT02387996|42162109|FG000|Overall Study|Poor/Non-Compliance|1|||
19718985|NCT02387996|42162109|FG000|Overall Study|Other Reasons|5|||
19718986|NCT02387996|42162109|FG000|Overall Study|Death|1|||
19718987|NCT03214198|42162113|FG000|Overall Study|Case Report Forms Uncollected|18|||
19718988|NCT03214198|42162113|FG000|Overall Study|Protocol Deviation|18|||
19718989|NCT03212326|42162117|FG000|Overall Study|Physician Decision|4|||
19718990|NCT03229486|42162123|FG000|Overall Study|Protocol Violation|0|||
19718991|NCT03229486|42162124|FG001|Overall Study|Protocol Violation|1|||
19718992|NCT01779050|42162132|FG000|Overall Study|Withdrawal by Subject|1|||
19718993|NCT01779050|42162133|FG001|Overall Study|Withdrawal by Subject|0|||
19718994|NCT00306527|42162143|FG000|Overall Study|Lost to Follow-up|3|||
19718995|NCT00306527|42162144|FG001|Overall Study|Lost to Follow-up|4|||
19718996|NCT00306527|42162145|FG002|Overall Study|Lost to Follow-up|3|||
19718997|NCT00306527|42162146|FG003|Overall Study|Lost to Follow-up|0|||
19718998|NCT00306527|42162143|FG000|Overall Study|Withdrawal by Subject|2|||
19718999|NCT00306527|42162144|FG001|Overall Study|Withdrawal by Subject|3|||
19719000|NCT00306527|42162145|FG002|Overall Study|Withdrawal by Subject|0|||
19719001|NCT00306527|42162146|FG003|Overall Study|Withdrawal by Subject|3|||
19719002|NCT00306527|42162143|FG000|Overall Study|Adverse Event|0|||
19719003|NCT00306527|42162144|FG001|Overall Study|Adverse Event|0|||
19719004|NCT00306527|42162145|FG002|Overall Study|Adverse Event|1|||
19719005|NCT00306527|42162146|FG003|Overall Study|Adverse Event|1|||
19719006|NCT00306527|42162143|FG000|Overall Study|Death|1|||
19719007|NCT00306527|42162144|FG001|Overall Study|Death|0|||
19719008|NCT00306527|42162145|FG002|Overall Study|Death|1|||
19719009|NCT00306527|42162146|FG003|Overall Study|Death|2|||
19719010|NCT00306293|42162160|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
19719011|NCT00306293|42162161|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
19719012|NCT00306293|42162160|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
19719013|NCT00306293|42162161|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
19719014|NCT00306293|42162160|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
19719015|NCT00306293|42162161|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
19719016|NCT00306293|42162160|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
19719017|NCT00306293|42162161|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
19719018|NCT00306293|42162160|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
19719019|NCT00306293|42162161|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
19719020|NCT00306293|42162160|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
19719021|NCT00306293|42162161|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
19719022|NCT00306293|42162160|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
19719023|NCT00306293|42162161|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
19719024|NCT00306293|42162160|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
19719025|NCT00306293|42162161|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
19719026|NCT00294671|42162171|FG000|Overall Study|Lack of Efficacy|11|||
19719027|NCT00294671|42162172|FG001|Overall Study|Lack of Efficacy|23|||
19719028|NCT00294671|42162171|FG000|Overall Study|Liver transplant|7|||
19719029|NCT00294671|42162172|FG001|Overall Study|Liver transplant|9|||
19719030|NCT00294671|42162171|FG000|Overall Study|Drug related adverse event (AE)|4|||
19719031|NCT00294671|42162172|FG001|Overall Study|Drug related adverse event (AE)|2|||
19719032|NCT00294671|42162171|FG000|Overall Study|Non-drug related AE|3|||
19719033|NCT00294671|42162172|FG001|Overall Study|Non-drug related AE|2|||
19719034|NCT00294671|42162171|FG000|Overall Study|Lost to Follow-up|1|||
19719035|NCT00294671|42162172|FG001|Overall Study|Lost to Follow-up|3|||
19719036|NCT00294671|42162171|FG000|Overall Study|Non-compliance|1|||
19719037|NCT00294671|42162172|FG001|Overall Study|Non-compliance|0|||
19719038|NCT00294671|42162171|FG000|Overall Study|Death|0|||
19719039|NCT00294671|42162172|FG001|Overall Study|Death|1|||
19719040|NCT01495598|42162178|FG000|Overall Study|Death during follow up period|2|||
19719041|NCT01495598|42162178|FG000|Overall Study|Death on study|1|||
19719042|NCT01495598|42162178|FG000|Overall Study|Lost to Follow-up|3|||
19719043|NCT01495598|42162178|FG000|Overall Study|Physician Decision|8|||
19719044|NCT02937454|42162209|FG000|Overall Study|Adverse Event|0|||
19719045|NCT02937454|42162210|FG001|Overall Study|Adverse Event|1|||
19719046|NCT02937454|42162209|FG000|Overall Study|Death|98|||
19719047|NCT02937454|42162210|FG001|Overall Study|Death|95|||
19719048|NCT02937454|42162209|FG000|Overall Study|Lost to Follow-up|1|||
19719049|NCT02937454|42162210|FG001|Overall Study|Lost to Follow-up|1|||
19719050|NCT02937454|42162209|FG000|Overall Study|Physician Decision|0|||
19719051|NCT02937454|42162210|FG001|Overall Study|Physician Decision|1|||
19719052|NCT02937454|42162209|FG000|Overall Study|Protocol Violation|6|||
19719053|NCT02937454|42162210|FG001|Overall Study|Protocol Violation|10|||
19719054|NCT02937454|42162209|FG000|Overall Study|Withdrawal by Subject|27|||
19719055|NCT02937454|42162210|FG001|Overall Study|Withdrawal by Subject|15|||
19719056|NCT02937454|42162209|FG000|Overall Study|Other|8|||
19719057|NCT02937454|42162210|FG001|Overall Study|Other|5|||
19719058|NCT03211858|42162229|FG000|Overall Study|Adverse Event|8|||
19719059|NCT03211858|42162230|FG001|Overall Study|Adverse Event|6|||
19719060|NCT03211858|42162229|FG000|Overall Study|Lack of Efficacy|0|||
19719061|NCT03211858|42162230|FG001|Overall Study|Lack of Efficacy|4|||
19719062|NCT03211858|42162229|FG000|Overall Study|Poor compliance to protocol|6|||
19719063|NCT03211858|42162230|FG001|Overall Study|Poor compliance to protocol|2|||
19719064|NCT03211858|42162229|FG000|Overall Study|Non-serious Hypoglycemia|1|||
19719065|NCT03211858|42162230|FG001|Overall Study|Non-serious Hypoglycemia|0|||
19719066|NCT03211858|42162229|FG000|Overall Study|Other than specified above|22|||
19719067|NCT03211858|42162230|FG001|Overall Study|Other than specified above|21|||
19719068|NCT03211156|42162242|FG000|Overall Study|Withdrawal by Subject|0|||
19719069|NCT03211156|42162243|FG001|Overall Study|Withdrawal by Subject|2|||
19719070|NCT03211156|42162242|FG000|Overall Study|Lost to Follow-up|1|||
19719071|NCT03211156|42162243|FG001|Overall Study|Lost to Follow-up|1|||
19719072|NCT03211156|42162242|FG000|Overall Study|Adverse Event|1|||
19719073|NCT03211156|42162243|FG001|Overall Study|Adverse Event|0|||
19719074|NCT04472494|42162251|FG000|Pre-treatment|Other reasons|2|||
19719075|NCT04472494|42162252|FG001|Pre-treatment|Other reasons|0|||
19719076|NCT04472494|42162251|FG000|Treatment|Death|5|||
19719077|NCT04472494|42162252|FG001|Treatment|Death|2|||
19719078|NCT04472494|42162251|FG000|Treatment|Hospital discharge|1|||
19719079|NCT04472494|42162252|FG001|Treatment|Hospital discharge|1|||
19719080|NCT04419506|42162262|FG000|Overall Study|Adverse Event|0|||
19719081|NCT04419506|42162263|FG001|Overall Study|Adverse Event|10|||
19719082|NCT04419506|42162264|FG002|Overall Study|Adverse Event|0|||
19719083|NCT04419506|42162265|FG003|Overall Study|Adverse Event|3|||
19719084|NCT04419506|42162262|FG000|Overall Study|Withdrawal by Subject|0|||
19719085|NCT04419506|42162263|FG001|Overall Study|Withdrawal by Subject|0|||
19719086|NCT04419506|42162264|FG002|Overall Study|Withdrawal by Subject|0|||
19719087|NCT04419506|42162265|FG003|Overall Study|Withdrawal by Subject|1|||
19719088|NCT04419506|42162262|FG000|Overall Study|poor-compliance|0|||
19719089|NCT04419506|42162263|FG001|Overall Study|poor-compliance|0|||
19719090|NCT04419506|42162264|FG002|Overall Study|poor-compliance|0|||
19719091|NCT04419506|42162265|FG003|Overall Study|poor-compliance|1|||
19719092|NCT03236506|42162278|FG000|Overall Study|Death|1|||
19719093|NCT03236506|42162279|FG001|Overall Study|Death|1|||
19719094|NCT03236506|42162280|FG002|Overall Study|Death|1|||
19719095|NCT03236506|42162278|FG000|Overall Study|Withdrawal by Subject|3|||
19719096|NCT03236506|42162279|FG001|Overall Study|Withdrawal by Subject|3|||
19719097|NCT03236506|42162280|FG002|Overall Study|Withdrawal by Subject|4|||
19719098|NCT03236506|42162278|FG000|Overall Study|Did not initiate treatment|2|||
19719099|NCT03236506|42162279|FG001|Overall Study|Did not initiate treatment|1|||
19719100|NCT03236506|42162280|FG002|Overall Study|Did not initiate treatment|2|||
19719101|NCT03227692|42162299|FG000|Overall Study|Protocol Violation|1|||
19719102|NCT03227692|42162300|FG001|Overall Study|Protocol Violation|1|||
19719103|NCT03227692|42162299|FG000|Overall Study|Lost to Follow-up|4|||
19719104|NCT03227692|42162300|FG001|Overall Study|Lost to Follow-up|2|||
19719105|NCT03227692|42162299|FG000|Overall Study|Adverse Event|0|||
19719106|NCT03227692|42162300|FG001|Overall Study|Adverse Event|2|||
19719107|NCT03210220|42162308|FG000|Overall Study|Physician Decision|1|||
19719108|NCT03210220|42162309|FG001|Overall Study|Physician Decision|0|||
19719109|NCT03209518|42162315|FG000|Overall Study|Case Report Forms Uncollected|1|||
19719110|NCT03209518|42162315|FG000|Overall Study|Protocol Deviation|1|||
19719111|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
19719112|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
19719113|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
19719114|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
19719115|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
19719116|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
19719117|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
19719118|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
19719119|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
19719120|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
19719121|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
19719122|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
19719123|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
19719124|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19719125|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19719126|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
19719127|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
19719128|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
19719129|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
19719130|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
19719131|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
19719132|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
19719133|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
19719134|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
19719135|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
19719136|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
19719137|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
19719138|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
19719139|NCT03227224|42162323|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
19719140|NCT03227224|42162324|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
19719141|NCT03227224|42162325|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
19719142|NCT03227224|42162326|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
19719143|NCT03227224|42162323|FG000|Follow-up Phase (2 Weeks)|Other|4|||
19719144|NCT03227224|42162324|FG001|Follow-up Phase (2 Weeks)|Other|4|||
19719145|NCT03227224|42162325|FG002|Follow-up Phase (2 Weeks)|Other|6|||
19719146|NCT03227224|42162326|FG003|Follow-up Phase (2 Weeks)|Other|3|||
19719147|NCT03725852|42162345|FG000|Overall Study|Death|1|||
19719148|NCT03725852|42162346|FG001|Overall Study|Death|0|||
19719149|NCT03725852|42162345|FG000|Overall Study|Withdrawal by Subject|1|||
19719150|NCT03725852|42162346|FG001|Overall Study|Withdrawal by Subject|0|||
19719151|NCT03725852|42162345|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
19719152|NCT03725852|42162346|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
19719153|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
19719154|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
19719155|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
19719156|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
19719157|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
19719158|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
19719159|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
19719160|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
19719161|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
19719162|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
19719163|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
19719164|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
19719165|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
19719166|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
19719167|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
19719168|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
19719169|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
19719170|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
19719171|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
19719172|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
19719173|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
19719174|NCT00304031|42162355|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
19719175|NCT00304031|42162356|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
19719176|NCT00304031|42162357|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
19719177|NCT00304031|42162355|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
19719178|NCT00304031|42162356|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
19719179|NCT00304031|42162357|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
19719180|NCT00332189|42162372|FG000|Overall Study|Adverse Event|3|||
19719181|NCT00332189|42162372|FG000|Overall Study|Uncooperative/Noncompliant|3|||
19719182|NCT00332189|42162372|FG000|Overall Study|Withdrawal by Subject|9|||
19719183|NCT00332189|42162372|FG000|Overall Study|Lack of Efficacy|4|||
19719184|NCT00332189|42162372|FG000|Overall Study|Moved out of country|2|||
19719185|NCT00331799|42162377|FG000|Overall Study|Withdrawal by Subject|2|||
19719186|NCT00331799|42162377|FG000|Overall Study|Sedation|1|||
19719187|NCT00303953|42162381|FG000|Overall Study|Ineligible|1|||
19719188|NCT00303953|42162381|FG000|Overall Study|Death|1|||
19719189|NCT00303953|42162381|FG000|Overall Study|Adverse Event|4|||
19719190|NCT00303953|42162381|FG000|Overall Study|Lack of Efficacy|12|||
19719191|NCT00303953|42162381|FG000|Overall Study|Physician Decision|1|||
19719192|NCT00303719|42162387|FG000|Overall Study|Not evaluable, prior therapies|0|||
19719193|NCT00303719|42162388|FG001|Overall Study|Not evaluable, prior therapies|30|||
19719194|NCT00303719|42162387|FG000|Overall Study|Lost to Follow-up|0|||
19719195|NCT00303719|42162388|FG001|Overall Study|Lost to Follow-up|7|||
19719196|NCT00331409|42162395|FG000|Overall Study|Lack of Efficacy|4|||
19719197|NCT00303485|42162401|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
19719198|NCT00303485|42162402|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
19719199|NCT00303485|42162401|FG000|Overall Study|Failure to return|0|||
19719200|NCT00303485|42162402|FG001|Overall Study|Failure to return|1|||
19719201|NCT00303485|42162401|FG000|Overall Study|Withdrawal by Subject|1|||
19719202|NCT00303485|42162402|FG001|Overall Study|Withdrawal by Subject|0|||
19719203|NCT03235726|42162416|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719204|NCT03235726|42162417|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719205|NCT03235726|42162418|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719206|NCT03235726|42162419|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719207|NCT03235726|42162420|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
19719208|NCT03235726|42162421|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719209|NCT03235726|42162422|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719210|NCT03235726|42162423|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719211|NCT03235726|42162424|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719212|NCT03235726|42162425|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
19719213|NCT03235726|42162416|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719214|NCT03235726|42162417|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719215|NCT03235726|42162418|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719216|NCT03235726|42162419|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719217|NCT03235726|42162420|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
19719218|NCT03235726|42162421|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719219|NCT03235726|42162422|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719220|NCT03235726|42162423|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719221|NCT03235726|42162424|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719222|NCT03235726|42162425|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
19719223|NCT03723590|42162460|FG000|Overall Study|Withdrawal by Subject|3|||
19719224|NCT02935894|42162464|FG000|Overall Study|Subject dismissed|1|||
19719225|NCT03224182|42162470|FG000|Overall Study|Study Drug Not Instilled|6|||
19719226|NCT03224182|42162471|FG001|Overall Study|Study Drug Not Instilled|1|||
19719227|NCT03224182|42162470|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
19719228|NCT03224182|42162471|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
19719229|NCT03224182|42162470|FG000|Overall Study|Withdrew of Consent|4|||
19719230|NCT03224182|42162471|FG001|Overall Study|Withdrew of Consent|2|||
19719231|NCT03224182|42162470|FG000|Overall Study|Investigator Decision|3|||
19719232|NCT03224182|42162471|FG001|Overall Study|Investigator Decision|1|||
19719233|NCT03224182|42162470|FG000|Overall Study|Sponsor Decision|26|||
19719234|NCT03224182|42162471|FG001|Overall Study|Sponsor Decision|12|||
19719235|NCT03224182|42162470|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
19719236|NCT03224182|42162471|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
19719237|NCT03224182|42162470|FG000|Overall Study|Lost to Follow-up|1|||
19719238|NCT03224182|42162471|FG001|Overall Study|Lost to Follow-up|0|||
19719239|NCT03224182|42162470|FG000|Overall Study|Participant Had Recurrence|11|||
19719240|NCT03224182|42162471|FG001|Overall Study|Participant Had Recurrence|5|||
19719241|NCT03224182|42162470|FG000|Overall Study|Death|0|||
19719242|NCT03224182|42162471|FG001|Overall Study|Death|1|||
19719243|NCT03224182|42162470|FG000|Overall Study|Reason not Specified|3|||
19719244|NCT03224182|42162471|FG001|Overall Study|Reason not Specified|3|||
19719245|NCT03224182|42162470|FG000|Overall Study|Other|1|||
19719246|NCT03224182|42162471|FG001|Overall Study|Other|0|||
19719247|NCT02935192|42162479|FG000|Overall Study|Withdrawal by Subject|8|||
19719248|NCT02935192|42162480|FG001|Overall Study|Withdrawal by Subject|4|||
19719249|NCT03722264|42162486|FG000|Overall Study|Physician Decision|3|||
19719250|NCT03722030|42162494|FG000|Overall Study|Withdrawal by Subject|1|||
19719251|NCT03722030|42162495|FG001|Overall Study|Withdrawal by Subject|0|||
19719252|NCT03221842|42162502|FG000|Period 1 (Open-label)|Adverse Event|4|||
19719253|NCT03221842|42162503|FG001|Period 1 (Open-label)|Adverse Event|0|||
19719254|NCT03221842|42162502|FG000|Period 1 (Open-label)|Physician Decision|2|||
19719255|NCT03221842|42162503|FG001|Period 1 (Open-label)|Physician Decision|0|||
19719256|NCT03221842|42162502|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
19719257|NCT03221842|42162503|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
19719258|NCT03221842|42162502|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
19719259|NCT03221842|42162503|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
19719260|NCT03221842|42162502|FG000|Period 1 (Open-label)|Other|2|||
19719261|NCT03221842|42162503|FG001|Period 1 (Open-label)|Other|0|||
19719262|NCT03221842|42162502|FG000|Period 2 (Randomized, Blinded)|Death|0|||
19719263|NCT03221842|42162503|FG001|Period 2 (Randomized, Blinded)|Death|1|||
19719264|NCT03221842|42162502|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
19719265|NCT03221842|42162503|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
19719266|NCT03364738|42162513|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
19719267|NCT03364738|42162513|FG000|Overall Study|Withdrawal by Subject|1|||
19719268|NCT03364738|42162513|FG000|Overall Study|Adverse Event|1|||
19719269|NCT00303329|42162520|FG000|Overall Study|Adverse Event|7|||
19719270|NCT00303329|42162521|FG001|Overall Study|Adverse Event|14|||
19719271|NCT00303329|42162520|FG000|Overall Study|Abnormal Laboratory Values|0|||
19719272|NCT00303329|42162521|FG001|Overall Study|Abnormal Laboratory Values|1|||
19719273|NCT00303329|42162520|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
19719274|NCT00303329|42162521|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19719275|NCT00303329|42162520|FG000|Overall Study|Condition no longer requires study drug|0|||
19719276|NCT00303329|42162521|FG001|Overall Study|Condition no longer requires study drug|8|||
19719277|NCT00303329|42162520|FG000|Overall Study|Protocol Violation|3|||
19719278|NCT00303329|42162521|FG001|Overall Study|Protocol Violation|0|||
19719279|NCT00303329|42162520|FG000|Overall Study|Withdrawal by Subject|9|||
19719280|NCT00303329|42162521|FG001|Overall Study|Withdrawal by Subject|15|||
19719281|NCT00303329|42162520|FG000|Overall Study|Lost to Follow-up|0|||
19719282|NCT00303329|42162521|FG001|Overall Study|Lost to Follow-up|1|||
19719283|NCT00303329|42162520|FG000|Overall Study|Administrative problems|1|||
19719284|NCT00303329|42162521|FG001|Overall Study|Administrative problems|0|||
19719285|NCT00303329|42162520|FG000|Overall Study|Death|2|||
19719286|NCT00303329|42162521|FG001|Overall Study|Death|12|||
19719287|NCT00303329|42162520|FG000|Overall Study|Stopped at end of core|3|||
19719288|NCT00303329|42162521|FG001|Overall Study|Stopped at end of core|9|||
19719289|NCT00303329|42162520|FG000|Overall Study|Stopped at end of extension 1|1|||
19719290|NCT00303329|42162521|FG001|Overall Study|Stopped at end of extension 1|0|||
19719291|NCT00329849|42162529|FG000|Overall Study|Withdrawal by Subject|6|||
19719292|NCT00329849|42162530|FG001|Overall Study|Withdrawal by Subject|4|||
19719293|NCT02934178|42162542|FG000|Received Vaccination 2|Death|0|||
19719294|NCT02934178|42162543|FG001|Received Vaccination 2|Death|1|||
19719295|NCT02934178|42162542|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
19719296|NCT02934178|42162543|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
19719297|NCT00329303|42162552|FG000|Overall Study|Lack of Efficacy|1|||
19719298|NCT00329303|42162553|FG001|Overall Study|Lack of Efficacy|0|||
19719299|NCT00329303|42162552|FG000|Overall Study|Decision of the sponsor|0|||
19719300|NCT00329303|42162553|FG001|Overall Study|Decision of the sponsor|1|||
19719301|NCT00329303|42162552|FG000|Overall Study|Patient no longer available|1|||
19719302|NCT00329303|42162553|FG001|Overall Study|Patient no longer available|0|||
19719303|NCT00329303|42162552|FG000|Overall Study|Patient relocated|0|||
19719304|NCT00329303|42162553|FG001|Overall Study|Patient relocated|1|||
19719305|NCT03216850|42162560|FG000|Overall Study|Pre-analytical error|6|||
19719306|NCT00302159|42162564|FG000|Overall Study|pt declined before treatment started|1|||
19719307|NCT00302159|42162564|FG000|Overall Study|pt started Avastin|1|||
19719308|NCT00302081|42162572|FG000|Overall Study|Adverse Event|6|||
19719309|NCT00302081|42162573|FG001|Overall Study|Adverse Event|5|||
19719310|NCT00302081|42162574|FG002|Overall Study|Adverse Event|4|||
19719311|NCT00302081|42162572|FG000|Overall Study|Lost to Follow-up|21|||
19719312|NCT00302081|42162573|FG001|Overall Study|Lost to Follow-up|18|||
19719313|NCT00302081|42162574|FG002|Overall Study|Lost to Follow-up|28|||
19719314|NCT00302081|42162572|FG000|Overall Study|Withdrawal by Subject|8|||
19719315|NCT00302081|42162573|FG001|Overall Study|Withdrawal by Subject|12|||
19719316|NCT00302081|42162574|FG002|Overall Study|Withdrawal by Subject|8|||
19719317|NCT00302081|42162572|FG000|Overall Study|Protocol Violation|5|||
19719318|NCT00302081|42162573|FG001|Overall Study|Protocol Violation|1|||
19719319|NCT00302081|42162574|FG002|Overall Study|Protocol Violation|2|||
19719320|NCT00302081|42162572|FG000|Overall Study|Lack of Efficacy|1|||
19719321|NCT00302081|42162573|FG001|Overall Study|Lack of Efficacy|0|||
19719322|NCT00302081|42162574|FG002|Overall Study|Lack of Efficacy|5|||
19719323|NCT00302081|42162572|FG000|Overall Study|Death|2|||
19719324|NCT00302081|42162573|FG001|Overall Study|Death|1|||
19719325|NCT00302081|42162574|FG002|Overall Study|Death|0|||
19719326|NCT00302081|42162572|FG000|Overall Study|Other|13|||
19719327|NCT00302081|42162573|FG001|Overall Study|Other|6|||
19719328|NCT00302081|42162574|FG002|Overall Study|Other|5|||
19719329|NCT00302003|42162582|FG000|Overall Study|Lack of Efficacy|62|||
19719330|NCT00302003|42162582|FG000|Overall Study|Lost to Follow-up|1|||
19719331|NCT00302003|42162582|FG000|Overall Study|Physician Decision|2|||
19719332|NCT00302003|42162582|FG000|Overall Study|Withdrawal by Subject|5|||
19719333|NCT00302003|42162582|FG000|Overall Study|Ineligible|9|||
19719334|NCT00302003|42162582|FG000|Overall Study|Protocol Violation|1|||
19719335|NCT00036270|42162588|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
19719336|NCT00036270|42162589|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
19719337|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
19719338|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
19719339|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
19719340|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
19719341|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
19719342|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
19719343|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Other|277|||
19719344|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Other|288|||
19719345|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
19719346|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
19719347|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
19719348|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
19719349|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
19719350|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
19719351|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
19719352|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
19719353|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
19719354|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
19719355|NCT00036270|42162588|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
19719356|NCT00036270|42162589|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
19719357|NCT00049530|42162595|FG000|Overall Study|Lack of Efficacy|25|||
19719358|NCT00049530|42162595|FG000|Overall Study|Adverse Event|2|||
19719359|NCT00049530|42162595|FG000|Overall Study|Death|1|||
19719360|NCT00049530|42162595|FG000|Overall Study|symptomatic deterioration|1|||
19719361|NCT00049530|42162595|FG000|Overall Study|ineligible|3|||
19719362|NCT00301067|42162599|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
19719363|NCT00301067|42162600|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
19719364|NCT00301067|42162601|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
19719365|NCT00301067|42162602|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
19719366|NCT00301067|42162599|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
19719367|NCT00301067|42162600|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
19719368|NCT00301067|42162601|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
19719369|NCT00301067|42162602|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
19719370|NCT00301067|42162599|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
19719371|NCT00301067|42162600|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
19719372|NCT00301067|42162601|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
19719373|NCT00301067|42162602|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
19719374|NCT00301067|42162599|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
19719375|NCT00301067|42162600|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
19719376|NCT00301067|42162601|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
19719377|NCT00301067|42162602|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
19719378|NCT00301067|42162599|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
19719379|NCT00301067|42162600|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
19719380|NCT00301067|42162601|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
19719381|NCT00301067|42162602|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
19719382|NCT00301067|42162599|FG000|Follow up Until Death|Alive at last data cut point|1|||
19719383|NCT00301067|42162600|FG001|Follow up Until Death|Alive at last data cut point|0|||
19719384|NCT00301067|42162601|FG002|Follow up Until Death|Alive at last data cut point|0|||
19719385|NCT00301067|42162602|FG003|Follow up Until Death|Alive at last data cut point|1|||
19719386|NCT00007020|42162613|FG000|Overall Study|Death|16|||
19719387|NCT00007020|42162613|FG000|Overall Study|Lost to Follow-up|13|||
19719388|NCT00007020|42162613|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
19719389|NCT00007020|42162613|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
19719390|NCT00007020|42162613|FG000|Overall Study|Pt cared for by outside physician|4|||
19719391|NCT00007020|42162613|FG000|Overall Study|No evidence of treatment|6|||
19719392|NCT00300755|42162622|FG000|Overall Study|Adverse Event|1|||
19719393|NCT00300755|42162623|FG001|Overall Study|Adverse Event|2|||
19719394|NCT00300755|42162624|FG002|Overall Study|Adverse Event|1|||
19719395|NCT00300755|42162622|FG000|Overall Study|Withdrawal by Subject|0|||
19719396|NCT00300755|42162623|FG001|Overall Study|Withdrawal by Subject|2|||
19719397|NCT00300755|42162624|FG002|Overall Study|Withdrawal by Subject|0|||
19719398|NCT00300755|42162622|FG000|Overall Study|Protocol Violation|0|||
19719399|NCT00300755|42162623|FG001|Overall Study|Protocol Violation|0|||
19719400|NCT00300755|42162624|FG002|Overall Study|Protocol Violation|1|||
19719401|NCT00033540|42162632|FG000|Overall Study|Adverse Event|14|||
19719402|NCT00033540|42162632|FG000|Overall Study|Death|1|||
19719403|NCT00033540|42162632|FG000|Overall Study|Progression|26|||
19719404|NCT00033540|42162632|FG000|Overall Study|Withdrawal by Subject|6|||
19719405|NCT00033540|42162632|FG000|Overall Study|Other|5|||
19719406|NCT00033540|42162632|FG000|Overall Study|Ineligible|3|||
19719407|NCT00033540|42162632|FG000|Overall Study|Never received treatment|2|||
19719408|NCT00300365|42162639|FG000|Overall Study|Lost to Follow-up|1|||
19719409|NCT00300365|42162640|FG001|Overall Study|Lost to Follow-up|0|||
19719410|NCT00300365|42162639|FG000|Overall Study|Physician Decision|2|||
19719411|NCT00300365|42162640|FG001|Overall Study|Physician Decision|0|||
19719412|NCT00300365|42162639|FG000|Overall Study|Withdrawal by Subject|1|||
19719413|NCT00300365|42162640|FG001|Overall Study|Withdrawal by Subject|0|||
19719414|NCT00300365|42162639|FG000|Overall Study|Adverse Event|0|||
19719415|NCT00300365|42162640|FG001|Overall Study|Adverse Event|2|||
19719416|NCT00048048|42162655|FG000|Core Treatment|Withdrawal by Subject|0|||
19719417|NCT00048048|42162656|FG001|Core Treatment|Withdrawal by Subject|0|||
19719418|NCT00048048|42162657|FG002|Core Treatment|Withdrawal by Subject|1|||
19719419|NCT00048048|42162658|FG003|Core Treatment|Withdrawal by Subject|0|||
19719420|NCT00048048|42162659|FG004|Core Treatment|Withdrawal by Subject|0|||
19719421|NCT00048048|42162660|FG005|Core Treatment|Withdrawal by Subject|0|||
19719422|NCT00048048|42162661|FG006|Core Treatment|Withdrawal by Subject|0|||
19719423|NCT00048048|42162662|FG007|Core Treatment|Withdrawal by Subject|0|||
19719424|NCT00048048|42162663|FG008|Core Treatment|Withdrawal by Subject|0|||
19719425|NCT00048048|42162664|FG009|Core Treatment|Withdrawal by Subject|0|||
19719426|NCT00048048|42162665|FG010|Core Treatment|Withdrawal by Subject|0|||
19719427|NCT00048048|42162666|FG011|Core Treatment|Withdrawal by Subject|0|||
19719428|NCT00048048|42162655|FG000|Core Treatment|Adverse Event|0|||
19719429|NCT00048048|42162656|FG001|Core Treatment|Adverse Event|0|||
19719430|NCT00048048|42162657|FG002|Core Treatment|Adverse Event|0|||
19719431|NCT00048048|42162658|FG003|Core Treatment|Adverse Event|0|||
19719432|NCT00048048|42162659|FG004|Core Treatment|Adverse Event|0|||
19719433|NCT00048048|42162660|FG005|Core Treatment|Adverse Event|0|||
19719434|NCT00048048|42162661|FG006|Core Treatment|Adverse Event|0|||
19719435|NCT00048048|42162662|FG007|Core Treatment|Adverse Event|1|||
19719436|NCT00048048|42162663|FG008|Core Treatment|Adverse Event|0|||
19719437|NCT00048048|42162664|FG009|Core Treatment|Adverse Event|0|||
19719438|NCT00048048|42162665|FG010|Core Treatment|Adverse Event|0|||
19719439|NCT00048048|42162666|FG011|Core Treatment|Adverse Event|0|||
19719440|NCT00048048|42162655|FG000|Extension Year 1|Early withdrawals|0|||
19719441|NCT00048048|42162656|FG001|Extension Year 1|Early withdrawals|0|||
19719442|NCT00048048|42162657|FG002|Extension Year 1|Early withdrawals|0|||
19719443|NCT00048048|42162658|FG003|Extension Year 1|Early withdrawals|0|||
19719444|NCT00048048|42162659|FG004|Extension Year 1|Early withdrawals|0|||
19719445|NCT00048048|42162660|FG005|Extension Year 1|Early withdrawals|0|||
19719446|NCT00048048|42162661|FG006|Extension Year 1|Early withdrawals|0|||
19719447|NCT00048048|42162662|FG007|Extension Year 1|Early withdrawals|0|||
19719448|NCT00048048|42162663|FG008|Extension Year 1|Early withdrawals|0|||
19719449|NCT00048048|42162664|FG009|Extension Year 1|Early withdrawals|2|||
19719450|NCT00048048|42162665|FG010|Extension Year 1|Early withdrawals|2|||
19719451|NCT00048048|42162666|FG011|Extension Year 1|Early withdrawals|4|||
19719452|NCT00048048|42162655|FG000|Extension Year 2|Early withdrawals|0|||
19719453|NCT00048048|42162656|FG001|Extension Year 2|Early withdrawals|0|||
19719454|NCT00048048|42162657|FG002|Extension Year 2|Early withdrawals|0|||
19719455|NCT00048048|42162658|FG003|Extension Year 2|Early withdrawals|0|||
19719456|NCT00048048|42162659|FG004|Extension Year 2|Early withdrawals|0|||
19719457|NCT00048048|42162660|FG005|Extension Year 2|Early withdrawals|0|||
19719458|NCT00048048|42162661|FG006|Extension Year 2|Early withdrawals|0|||
19719459|NCT00048048|42162662|FG007|Extension Year 2|Early withdrawals|0|||
19719460|NCT00048048|42162663|FG008|Extension Year 2|Early withdrawals|0|||
19719461|NCT00048048|42162664|FG009|Extension Year 2|Early withdrawals|0|||
19719462|NCT00048048|42162665|FG010|Extension Year 2|Early withdrawals|4|||
19719463|NCT00048048|42162666|FG011|Extension Year 2|Early withdrawals|2|||
19719464|NCT00300053|42162696|FG000|Overall Study|Patient/Caregiver Preference|2|||
19719465|NCT00300053|42162697|FG001|Overall Study|Patient/Caregiver Preference|2|||
19719466|NCT00300053|42162698|FG002|Overall Study|Patient/Caregiver Preference|3|||
19719467|NCT00300053|42162696|FG000|Overall Study|Death|0|||
19719468|NCT00300053|42162697|FG001|Overall Study|Death|0|||
19719469|NCT00300053|42162698|FG002|Overall Study|Death|3|||
19719470|NCT00300053|42162696|FG000|Overall Study|Lost to Follow-up|0|||
19719471|NCT00300053|42162697|FG001|Overall Study|Lost to Follow-up|1|||
19719472|NCT00300053|42162698|FG002|Overall Study|Lost to Follow-up|0|||
19719473|NCT00299975|42162710|FG000|Overall Study|Adverse Event|1|||
19719474|NCT00299975|42162711|FG001|Overall Study|Adverse Event|0|||
19719475|NCT00299975|42162712|FG002|Overall Study|Adverse Event|2|||
19719476|NCT00299975|42162710|FG000|Overall Study|Pregnancy|0|||
19719477|NCT00299975|42162711|FG001|Overall Study|Pregnancy|0|||
19719478|NCT00299975|42162712|FG002|Overall Study|Pregnancy|1|||
19719479|NCT00299975|42162710|FG000|Overall Study|Lack of Efficacy|1|||
19719480|NCT00299975|42162711|FG001|Overall Study|Lack of Efficacy|0|||
19719481|NCT00299975|42162712|FG002|Overall Study|Lack of Efficacy|1|||
19719482|NCT00299975|42162710|FG000|Overall Study|Lost to Follow-up|1|||
19719483|NCT00299975|42162711|FG001|Overall Study|Lost to Follow-up|0|||
19719484|NCT00299975|42162712|FG002|Overall Study|Lost to Follow-up|0|||
19719485|NCT00299975|42162710|FG000|Overall Study|Withdrawal by Subject|0|||
19719486|NCT00299975|42162711|FG001|Overall Study|Withdrawal by Subject|1|||
19719487|NCT00299975|42162712|FG002|Overall Study|Withdrawal by Subject|3|||
19719488|NCT00299975|42162710|FG000|Overall Study|Physician Decision|0|||
19719489|NCT00299975|42162711|FG001|Overall Study|Physician Decision|0|||
19719490|NCT00299975|42162712|FG002|Overall Study|Physician Decision|1|||
19719491|NCT00004980|42162722|FG000|Overall Study|Withdrawal by Subject|1|||
19719492|NCT00004980|42162723|FG001|Overall Study|Withdrawal by Subject|0|||
19719493|NCT00004980|42162722|FG000|Overall Study|memory difficulties|1|||
19719494|NCT00004980|42162723|FG001|Overall Study|memory difficulties|1|||
19719495|NCT00004980|42162722|FG000|Overall Study|Physician Decision|0|||
19719496|NCT00004980|42162723|FG001|Overall Study|Physician Decision|1|||
19719497|NCT00326963|42162729|FG000|Overall Study|Adverse Event|2|||
19719498|NCT00326963|42162729|FG000|Overall Study|Injection site reaction|1|||
19719499|NCT00326963|42162729|FG000|Overall Study|Death|1|||
19719500|NCT00326963|42162729|FG000|Overall Study|Failure to return|10|||
19719501|NCT00326963|42162729|FG000|Overall Study|Withdrawal by Subject|10|||
19719502|NCT00326963|42162729|FG000|Overall Study|Refused treatment / did not cooperate|5|||
19719503|NCT00326963|42162729|FG000|Overall Study|Violation of selection criteria at entry|2|||
19719504|NCT00326963|42162729|FG000|Overall Study|Other protocol violation|1|||
19719505|NCT00326963|42162729|FG000|Overall Study|Administrative / other|1|||
19719506|NCT00326885|42162734|FG000|Overall Study|Adverse Event|1|||
19719507|NCT00326885|42162734|FG000|Overall Study|Withdrawal by Subject|3|||
19719508|NCT00326885|42162734|FG000|Overall Study|Physician Decision|1|||
19719509|NCT00326885|42162734|FG000|Overall Study|Hospice withdrew consent|2|||
19719510|NCT00326495|42162739|FG000|Overall Study|Switched to alternative treatment|1|||
19719511|NCT00326495|42162739|FG000|Overall Study|Disease progression before treatment|1|||
19719512|NCT00326495|42162739|FG000|Overall Study|Refused further treatment|2|||
19719513|NCT00326495|42162739|FG000|Overall Study|Subject off study before assessment|1|||
19719514|NCT00326417|42162745|FG000|Overall Study|Withdrawal by Subject|0|||
19719515|NCT00326417|42162746|FG001|Overall Study|Withdrawal by Subject|0|||
19719516|NCT00326417|42162747|FG002|Overall Study|Withdrawal by Subject|1|||
19719517|NCT00326417|42162748|FG003|Overall Study|Withdrawal by Subject|0|||
19719518|NCT00326417|42162745|FG000|Overall Study|Arm Closed|7|||
19719519|NCT00326417|42162746|FG001|Overall Study|Arm Closed|0|||
19719520|NCT00326417|42162747|FG002|Overall Study|Arm Closed|0|||
19719521|NCT00326417|42162748|FG003|Overall Study|Arm Closed|3|||
19719522|NCT00326417|42162745|FG000|Overall Study|Death|7|||
19719523|NCT00326417|42162746|FG001|Overall Study|Death|0|||
19719524|NCT00326417|42162747|FG002|Overall Study|Death|0|||
19719525|NCT00326417|42162748|FG003|Overall Study|Death|0|||
19719526|NCT03825341|42162758|FG000|Overall Study|Withdrawal by Subject|0|||
19719527|NCT03825341|42162759|FG001|Overall Study|Withdrawal by Subject|1|||
19719528|NCT00297479|42162770|FG000|Overall Study|Lost to Follow-up|37|||
19719529|NCT00297479|42162771|FG001|Overall Study|Lost to Follow-up|54|||
19719530|NCT00297479|42162772|FG002|Overall Study|Lost to Follow-up|51|||
19719531|NCT00688870|42162782|FG000|Infant Series|Parent or legal guardian request|4|||
19719532|NCT00688870|42162783|FG001|Infant Series|Parent or legal guardian request|0|||
19719533|NCT00297167|42162793|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
19719534|NCT00297167|42162794|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
19719535|NCT00297167|42162795|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
19719536|NCT00297167|42162793|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
19719537|NCT00297167|42162794|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
19719538|NCT00297167|42162795|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
19719539|NCT03216226|42162804|FG000|Overall Study|Adverse Event|3|||
19719540|NCT03216226|42162805|FG001|Overall Study|Adverse Event|0|||
19719541|NCT03216226|42162804|FG000|Overall Study|Protocol Violation|1|||
19719542|NCT03216226|42162805|FG001|Overall Study|Protocol Violation|3|||
19719543|NCT03216226|42162804|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
19719544|NCT03216226|42162805|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
19719545|NCT03216226|42162804|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
19719546|NCT03216226|42162805|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
19719547|NCT03216226|42162804|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
19719548|NCT03216226|42162805|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
19719549|NCT03215758|42162813|FG000|Overall Study|Technical Problems|1|||
19719550|NCT03215758|42162814|FG001|Overall Study|Technical Problems|0|||
19719551|NCT03215758|42162813|FG000|Overall Study|Protocol deviation|0|||
19719552|NCT03215758|42162814|FG001|Overall Study|Protocol deviation|1|||
19719553|NCT03215758|42162813|FG000|Overall Study|Physician Decision|0|||
19719554|NCT03215758|42162814|FG001|Overall Study|Physician Decision|1|||
19719555|NCT03215758|42162813|FG000|Overall Study|Death|0|||
19719556|NCT03215758|42162814|FG001|Overall Study|Death|1|||
19719557|NCT03215758|42162813|FG000|Overall Study|Adverse Event|1|||
19719558|NCT03215758|42162814|FG001|Overall Study|Adverse Event|2|||
19719559|NCT03215758|42162813|FG000|Overall Study|Subject/Guardian Decision|3|||
19719560|NCT03215758|42162814|FG001|Overall Study|Subject/Guardian Decision|3|||
19719561|NCT00290771|42162822|FG000|Overall Study|Disease progression|95|||
19719562|NCT00290771|42162823|FG001|Overall Study|Disease progression|73|||
19719563|NCT00290771|42162822|FG000|Overall Study|Death|11|||
19719564|NCT00290771|42162823|FG001|Overall Study|Death|10|||
19719565|NCT00290771|42162822|FG000|Overall Study|Adverse Event|12|||
19719566|NCT00290771|42162823|FG001|Overall Study|Adverse Event|6|||
19719567|NCT00290771|42162822|FG000|Overall Study|Withdrawal by Subject|5|||
19719568|NCT00290771|42162823|FG001|Overall Study|Withdrawal by Subject|6|||
19719569|NCT00290771|42162822|FG000|Overall Study|Administrative problems|2|||
19719570|NCT00290771|42162823|FG001|Overall Study|Administrative problems|1|||
19719571|NCT00290771|42162822|FG000|Overall Study|Protocol Violation|2|||
19719572|NCT00290771|42162823|FG001|Overall Study|Protocol Violation|0|||
19719573|NCT00290771|42162822|FG000|Overall Study|Lost to Follow-up|0|||
19719574|NCT00290771|42162823|FG001|Overall Study|Lost to Follow-up|1|||
19719575|NCT00274625|42162832|FG000|Overall Study|Lost to Follow-up|46|||
19719576|NCT00274625|42162833|FG001|Overall Study|Lost to Follow-up|54|||
19719577|NCT00274625|42162832|FG000|Overall Study|Excluded from analysis|14|||
19719578|NCT00274625|42162833|FG001|Overall Study|Excluded from analysis|8|||
19719579|NCT00290693|42162839|FG000|Overall Study|Withdrawal by Subject|2|||
19719580|NCT03214666|42162850|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
19719581|NCT03214666|42162851|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
19719582|NCT03214666|42162852|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
19719583|NCT03214666|42162853|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
19719584|NCT03214666|42162854|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
19719585|NCT03214666|42162855|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
19719586|NCT00274469|42162872|FG000|Overall Study|Death|63|||
19719587|NCT00274469|42162873|FG001|Overall Study|Death|74|||
19719588|NCT00274469|42162872|FG000|Overall Study|Did not consent to OS follow-up|16|||
19719589|NCT00274469|42162873|FG001|Overall Study|Did not consent to OS follow-up|19|||
19719590|NCT03214588|42162882|FG000|Overall Study|Adverse Event|1|||
19719591|NCT03214588|42162883|FG001|Overall Study|Adverse Event|0|||
19719592|NCT03214588|42162884|FG002|Overall Study|Adverse Event|2|||
19719593|NCT03214588|42162882|FG000|Overall Study|Reason Not Specified|0|||
19719594|NCT03214588|42162883|FG001|Overall Study|Reason Not Specified|1|||
19719595|NCT03214588|42162884|FG002|Overall Study|Reason Not Specified|0|||
19719596|NCT03166618|42162894|FG000|Overall Study|Study was Terminated|0|||
19719597|NCT03166618|42162895|FG001|Overall Study|Study was Terminated|1|||
19719598|NCT03164356|42162914|FG000|Overall Study|Lost to Follow-up|1|||
19719599|NCT03164356|42162915|FG001|Overall Study|Lost to Follow-up|1|||
19719600|NCT03164356|42162916|FG002|Overall Study|Lost to Follow-up|2|||
19719601|NCT03164356|42162917|FG003|Overall Study|Lost to Follow-up|1|||
19719602|NCT03164356|42162914|FG000|Overall Study|Physician Decision|0|||
19719603|NCT03164356|42162915|FG001|Overall Study|Physician Decision|0|||
19719604|NCT03164356|42162916|FG002|Overall Study|Physician Decision|3|||
19719605|NCT03164356|42162917|FG003|Overall Study|Physician Decision|0|||
19719606|NCT03164356|42162914|FG000|Overall Study|Protocol Violation|2|||
19550530|NCT01107925|41999567|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
19719607|NCT03164356|42162915|FG001|Overall Study|Protocol Violation|1|||
19719608|NCT03164356|42162916|FG002|Overall Study|Protocol Violation|0|||
19719609|NCT03164356|42162917|FG003|Overall Study|Protocol Violation|0|||
19719610|NCT03164356|42162914|FG000|Overall Study|Withdrawal by Subject|1|||
19719611|NCT03164356|42162915|FG001|Overall Study|Withdrawal by Subject|0|||
19719612|NCT03164356|42162916|FG002|Overall Study|Withdrawal by Subject|0|||
19719613|NCT03164356|42162917|FG003|Overall Study|Withdrawal by Subject|0|||
19719614|NCT03164356|42162914|FG000|Overall Study|Study timeframe interrupted by COVID-19|1|||
19719615|NCT03164356|42162915|FG001|Overall Study|Study timeframe interrupted by COVID-19|0|||
19719616|NCT03164356|42162916|FG002|Overall Study|Study timeframe interrupted by COVID-19|0|||
19719617|NCT03164356|42162917|FG003|Overall Study|Study timeframe interrupted by COVID-19|1|||
19719618|NCT03164356|42162914|FG000|Overall Study|Subject Incarcerated|0|||
19719619|NCT03164356|42162915|FG001|Overall Study|Subject Incarcerated|1|||
19719620|NCT03164356|42162916|FG002|Overall Study|Subject Incarcerated|0|||
19719621|NCT03164356|42162917|FG003|Overall Study|Subject Incarcerated|0|||
19719622|NCT03164356|42162914|FG000|Overall Study|Prosthetist unable to participate|0|||
19719623|NCT03164356|42162915|FG001|Overall Study|Prosthetist unable to participate|2|||
19719624|NCT03164356|42162916|FG002|Overall Study|Prosthetist unable to participate|1|||
19719625|NCT03164356|42162917|FG003|Overall Study|Prosthetist unable to participate|0|||
19719626|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
19719627|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
19719628|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
19719629|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
19719630|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
19719631|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
19719632|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
19719633|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
19719634|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
19719635|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
19719636|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
19719637|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
19719638|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
19719639|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
19719640|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
19719641|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
19719642|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
19719643|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
19719644|NCT03162796|42162940|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
19719645|NCT03162796|42162941|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
19719646|NCT03162796|42162942|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
19719647|NCT03162796|42162940|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
19719648|NCT03162796|42162941|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
19719649|NCT03162796|42162942|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
19719650|NCT03162796|42162940|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
19719651|NCT03162796|42162941|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
19719652|NCT03162796|42162942|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
19719653|NCT03162796|42162940|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
19719654|NCT03162796|42162941|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
19719655|NCT03162796|42162942|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
19719656|NCT03162796|42162940|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
19719657|NCT03162796|42162941|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
19719658|NCT03162796|42162942|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
19719659|NCT03162328|42162955|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
19719660|NCT03162328|42162956|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
19719661|NCT03162328|42162957|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
19719662|NCT03162328|42162955|FG000|Screening Period|Withdrawal by Subject|1|||
19719663|NCT03162328|42162956|FG001|Screening Period|Withdrawal by Subject|0|||
19719664|NCT03162328|42162957|FG002|Screening Period|Withdrawal by Subject|0|||
19719665|NCT03162328|42162955|FG000|Study Period|Withdrawal by Subject|0|||
19719666|NCT03162328|42162956|FG001|Study Period|Withdrawal by Subject|0|||
19719667|NCT03162328|42162957|FG002|Study Period|Withdrawal by Subject|1|||
19719668|NCT00272987|42162971|FG000|Overall Study|Adverse Event|1|||
19719669|NCT00272987|42162972|FG001|Overall Study|Adverse Event|0|||
19719670|NCT00272987|42162973|FG002|Overall Study|Adverse Event|0|||
19719671|NCT00272987|42162971|FG000|Overall Study|Lost to Follow-up|3|||
19719672|NCT00272987|42162972|FG001|Overall Study|Lost to Follow-up|1|||
19719673|NCT00272987|42162973|FG002|Overall Study|Lost to Follow-up|1|||
19719674|NCT00272987|42162971|FG000|Overall Study|Withdrawal by Subject|1|||
19719675|NCT00272987|42162972|FG001|Overall Study|Withdrawal by Subject|0|||
19719676|NCT00272987|42162973|FG002|Overall Study|Withdrawal by Subject|3|||
19719677|NCT00272987|42162971|FG000|Overall Study|Sponsor Terminated study|0|||
19719678|NCT00272987|42162972|FG001|Overall Study|Sponsor Terminated study|1|||
19719679|NCT00272987|42162973|FG002|Overall Study|Sponsor Terminated study|1|||
19719680|NCT00272987|42162971|FG000|Overall Study|Disease progression|1|||
19719681|NCT00272987|42162972|FG001|Overall Study|Disease progression|1|||
19719682|NCT00272987|42162973|FG002|Overall Study|Disease progression|2|||
19719683|NCT00272987|42162971|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
19719684|NCT00272987|42162972|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
19719685|NCT00272987|42162973|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
19719686|NCT00272987|42162971|FG000|Overall Study|Death|1|||
19719687|NCT00272987|42162972|FG001|Overall Study|Death|0|||
19719688|NCT00272987|42162973|FG002|Overall Study|Death|0|||
19719689|NCT01730950|42162983|FG000|Overall Study|Protocol Violation|6|||
19719690|NCT01730950|42162984|FG001|Overall Study|Protocol Violation|6|||
19719691|NCT00271505|42162991|FG000|Overall Study|Screen Failure|3|||
19719692|NCT00271505|42162991|FG000|Overall Study|Adverse Event|1|||
19719693|NCT00271505|42162991|FG000|Overall Study|Death|1|||
19719694|NCT01642186|42162999|FG000|Overall Study|Death|0|||
19719695|NCT01642186|42163000|FG001|Overall Study|Death|2|||
19719696|NCT01642186|42163001|FG002|Overall Study|Death|2|||
19719697|NCT01642186|42162999|FG000|Overall Study|Lost to Follow-up|0|||
19719698|NCT01642186|42163000|FG001|Overall Study|Lost to Follow-up|0|||
19719699|NCT01642186|42163001|FG002|Overall Study|Lost to Follow-up|1|||
19719700|NCT00423514|42163011|FG000|Overall Study|Ineligible|1|||
19719701|NCT00423514|42163012|FG001|Overall Study|Ineligible|0|||
19719702|NCT00289991|42163020|FG000|Overall Study|Death|35|||
19719703|NCT00289991|42163021|FG001|Overall Study|Death|38|||
19719704|NCT00289991|42163020|FG000|Overall Study|Adverse Event|15|||
19719705|NCT00289991|42163021|FG001|Overall Study|Adverse Event|13|||
19719706|NCT00289991|42163020|FG000|Overall Study|Failure of prophylaxis|1|||
19719707|NCT00289991|42163021|FG001|Overall Study|Failure of prophylaxis|1|||
19719708|NCT00289991|42163020|FG000|Overall Study|Fungal breakthrough infection|0|||
19719709|NCT00289991|42163021|FG001|Overall Study|Fungal breakthrough infection|1|||
19719710|NCT00289991|42163020|FG000|Overall Study|Lost to Follow-up|0|||
19719711|NCT00289991|42163021|FG001|Overall Study|Lost to Follow-up|1|||
19719712|NCT00289991|42163020|FG000|Overall Study|Withdrawal by Subject|2|||
19719713|NCT00289991|42163021|FG001|Overall Study|Withdrawal by Subject|12|||
19719714|NCT00289991|42163020|FG000|Overall Study|Other|5|||
19719715|NCT00289991|42163021|FG001|Overall Study|Other|14|||
19719716|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719717|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
19719718|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719719|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719720|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719721|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
19719722|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
19719723|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
19719724|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
19719725|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
19719726|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
19719727|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
19719728|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719729|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
19719730|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
19719731|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
19719732|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
19719733|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
19719734|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
19719735|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
19719736|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719737|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719738|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719739|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
19719740|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719741|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
19719742|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
19719743|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
19719744|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
19719745|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
19719746|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
19719747|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
19719748|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
19719749|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
19719750|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
19719751|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
19719752|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
19719753|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
19719754|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
19719755|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
19719756|NCT00289913|42163032|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
19719757|NCT00289913|42163033|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719758|NCT00289913|42163034|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
19719759|NCT00289913|42163035|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719760|NCT00289913|42163036|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719761|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719762|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719763|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
19719764|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719765|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719766|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
19719767|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
19719768|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
19719769|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
19719770|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
19719771|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
19719772|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
19719773|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
19719774|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
19719775|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
19719776|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
19719777|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
19719778|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
19719779|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719780|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719781|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
19719782|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719783|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
19719784|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719785|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719786|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
19719787|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
19719788|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
19719789|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
19719790|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
19719791|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
19719792|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
19719793|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
19719794|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
19719795|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
19719796|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
19719797|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
19719798|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
19719799|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
19719800|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
19719801|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
19719802|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
19719803|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
19719804|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
19719805|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
19719806|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
19719807|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
19719808|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
19719809|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
19719810|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
19719811|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
19719812|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
19719813|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
19719814|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
19719815|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
19719816|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
19719817|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
19719818|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
19719819|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
19719820|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
19719821|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
19719822|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
19719823|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
19719824|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
19719825|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
19719826|NCT00289913|42163032|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
19719827|NCT00289913|42163033|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
19719828|NCT00289913|42163034|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
19719829|NCT00289913|42163035|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
19719830|NCT00289913|42163036|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
19719831|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719832|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
19719833|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719834|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719835|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
19719836|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
19719837|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
19719838|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
19719839|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
19719840|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
19719841|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719842|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719843|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719844|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
19719845|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
19719846|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719847|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719848|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719849|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
19719850|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
19719851|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
19719852|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
19719853|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
19719854|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
19719855|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
19719856|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
19719857|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
19719858|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
19719859|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
19719860|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
19719861|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
19719862|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
19719863|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
19719864|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
19719865|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
19719866|NCT00289913|42163032|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719867|NCT00289913|42163033|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
19719868|NCT00289913|42163034|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719869|NCT00289913|42163035|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719870|NCT00289913|42163036|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
19719871|NCT00289289|42163054|FG000|Overall Study|Withdrawal by Subject|5|||
19719872|NCT00289289|42163055|FG001|Overall Study|Withdrawal by Subject|3|||
19719873|NCT00289289|42163056|FG002|Overall Study|Withdrawal by Subject|15|||
19719874|NCT00289289|42163054|FG000|Overall Study|Lost to Follow-up|1|||
19719875|NCT00289289|42163055|FG001|Overall Study|Lost to Follow-up|0|||
19719876|NCT00289289|42163056|FG002|Overall Study|Lost to Follow-up|1|||
19719877|NCT00289289|42163054|FG000|Overall Study|Death|4|||
19719878|NCT00289289|42163055|FG001|Overall Study|Death|2|||
19719879|NCT00289289|42163056|FG002|Overall Study|Death|5|||
19719880|NCT00289289|42163054|FG000|Overall Study|No implant attempted|0|||
19719881|NCT00289289|42163055|FG001|Overall Study|No implant attempted|0|||
19719882|NCT00289289|42163056|FG002|Overall Study|No implant attempted|1|||
19719883|NCT00289289|42163054|FG000|Overall Study|Physician Decision|1|||
19719884|NCT00289289|42163055|FG001|Overall Study|Physician Decision|0|||
19719885|NCT00289289|42163056|FG002|Overall Study|Physician Decision|6|||
19719886|NCT00289289|42163054|FG000|Overall Study|Non-study device implanted|2|||
19719887|NCT00289289|42163055|FG001|Overall Study|Non-study device implanted|1|||
19719888|NCT00289289|42163056|FG002|Overall Study|Non-study device implanted|3|||
19719889|NCT00289289|42163054|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
19719890|NCT00289289|42163055|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
19719891|NCT00289289|42163056|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
19719892|NCT00289289|42163054|FG000|Overall Study|Other Exit Reason|6|||
19719893|NCT00289289|42163055|FG001|Overall Study|Other Exit Reason|4|||
19719894|NCT00289289|42163056|FG002|Overall Study|Other Exit Reason|12|||
19719895|NCT00270257|42163065|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
19719896|NCT00270257|42163066|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
19719897|NCT00269633|42163076|FG000|Overall Study|Withdrawal by Subject|1|||
19719898|NCT00269633|42163077|FG001|Overall Study|Withdrawal by Subject|0|||
19719899|NCT00269477|42163087|FG000|Overall Study|Protocol Violation|5|||
19719900|NCT00269477|42163088|FG001|Overall Study|Protocol Violation|5|||
19719901|NCT00269477|42163089|FG002|Overall Study|Protocol Violation|1|||
19719902|NCT00269477|42163090|FG003|Overall Study|Protocol Violation|0|||
19719903|NCT00269477|42163087|FG000|Overall Study|Missed post-vaccination blood draw|0|||
19719904|NCT00269477|42163088|FG001|Overall Study|Missed post-vaccination blood draw|1|||
19719905|NCT00269477|42163089|FG002|Overall Study|Missed post-vaccination blood draw|0|||
19719906|NCT00269477|42163090|FG003|Overall Study|Missed post-vaccination blood draw|0|||
19719907|NCT00269399|42163102|FG000|Overall Study|Lack of Efficacy|27|||
19719908|NCT00269399|42163103|FG001|Overall Study|Lack of Efficacy|10|||
19719909|NCT00269399|42163102|FG000|Overall Study|Adverse Event|10|||
19719910|NCT00269399|42163103|FG001|Overall Study|Adverse Event|4|||
19719911|NCT00269399|42163102|FG000|Overall Study|Withdrawal by Subject|2|||
19719912|NCT00269399|42163103|FG001|Overall Study|Withdrawal by Subject|5|||
19719913|NCT00269399|42163102|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
19719914|NCT00269399|42163103|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
19719915|NCT00269399|42163102|FG000|Overall Study|Other|0|||
19719916|NCT00269399|42163103|FG001|Overall Study|Other|4|||
19719917|NCT00269399|42163102|FG000|Overall Study|Development of exclusion criteria|0|||
19719918|NCT00269399|42163103|FG001|Overall Study|Development of exclusion criteria|1|||
19719919|NCT00269087|42163109|FG000|Overall Study|Adverse Event|20|||
19719920|NCT00269087|42163109|FG000|Overall Study|Withdrawal by Subject|1|||
19719921|NCT00269087|42163109|FG000|Overall Study|Exacerbation of COPD|13|||
19719922|NCT00289133|42163115|FG000|Overall Study|Non-study device implanted|12|||
19719923|NCT00289133|42163116|FG001|Overall Study|Non-study device implanted|0|||
19719924|NCT00289133|42163115|FG000|Overall Study|Protocol Violation|32|||
19719925|NCT00289133|42163116|FG001|Overall Study|Protocol Violation|38|||
19719926|NCT00289133|42163115|FG000|Overall Study|Withdrawal by Subject|9|||
19719927|NCT00289133|42163116|FG001|Overall Study|Withdrawal by Subject|10|||
19719928|NCT00289133|42163115|FG000|Overall Study|Death|5|||
19719929|NCT00289133|42163116|FG001|Overall Study|Death|10|||
19719930|NCT00289133|42163115|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
19719931|NCT00289133|42163116|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
19719932|NCT00289133|42163115|FG000|Overall Study|Physician Decision|41|||
19719933|NCT00289133|42163116|FG001|Overall Study|Physician Decision|45|||
19719934|NCT00289133|42163115|FG000|Overall Study|Revision|8|||
19719935|NCT00289133|42163116|FG001|Overall Study|Revision|6|||
19719936|NCT00289133|42163115|FG000|Overall Study|Lost to Follow-up|92|||
19719937|NCT00289133|42163116|FG001|Overall Study|Lost to Follow-up|115|||
19719938|NCT00288587|42163128|FG000|Overall Study|Death|4|||
19719939|NCT00288587|42163129|FG001|Overall Study|Death|4|||
19719940|NCT00288587|42163128|FG000|Overall Study|Transplant|0|||
19719941|NCT00288587|42163129|FG001|Overall Study|Transplant|3|||
19719942|NCT00288587|42163128|FG000|Overall Study|Adverse Event|0|||
19719943|NCT00288587|42163129|FG001|Overall Study|Adverse Event|1|||
19719944|NCT00288587|42163128|FG000|Overall Study|Physician Decision|0|||
19719945|NCT00288587|42163129|FG001|Overall Study|Physician Decision|2|||
19719946|NCT00288587|42163128|FG000|Overall Study|Severe Aortic Stenosis|1|||
19719947|NCT00288587|42163129|FG001|Overall Study|Severe Aortic Stenosis|0|||
19719948|NCT00268463|42163137|FG000|Overall Study|study terminated due to low accrual|10|||
19719949|NCT00268463|42163138|FG001|Overall Study|study terminated due to low accrual|12|||
19719950|NCT00288509|42163144|FG000|Treatment Cycle 1|Adverse Event|1|||
19719951|NCT00288509|42163144|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
19719952|NCT00288509|42163144|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
19719953|NCT00288509|42163144|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
19719954|NCT00288509|42163144|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
19719955|NCT00288509|42163144|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
19719956|NCT00288509|42163144|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
19719957|NCT00288509|42163144|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
19719958|NCT00288509|42163144|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
19719959|NCT00288509|42163144|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
19719960|NCT00288509|42163144|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
19719961|NCT00288509|42163144|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
19719962|NCT00288509|42163144|FG000|Treatment Cycle 4|Physician Decision|4|||
19719963|NCT00288509|42163144|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
19719964|NCT00266825|42163150|FG000|Completed Follow-Up|Lost to Follow-up|14|||
19719965|NCT00266825|42163151|FG001|Completed Follow-Up|Lost to Follow-up|19|||
19719966|NCT00266825|42163150|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
19719967|NCT00266825|42163151|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
19719968|NCT00265889|42163159|FG000|Overall Study|Physician Decision|1|||
19719969|NCT00265889|42163159|FG000|Overall Study|Protocol Violation|1|||
19719970|NCT00265889|42163159|FG000|Overall Study|Insurance denied the request|3|||
19719971|NCT02795182|42163167|FG000|Overall Study|Death|5|||
19719972|NCT02795182|42163168|FG001|Overall Study|Death|4|||
19719973|NCT02795182|42163169|FG002|Overall Study|Death|4|||
19719974|NCT02795182|42163170|FG003|Overall Study|Death|18|||
19719975|NCT02795182|42163167|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
19719976|NCT02795182|42163168|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
19719977|NCT02795182|42163169|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
19719978|NCT02795182|42163170|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
19719979|NCT02795182|42163167|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
19719980|NCT02795182|42163168|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
19719981|NCT02795182|42163169|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
19719982|NCT02795182|42163170|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
19719983|NCT02795182|42163167|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
19719984|NCT02795182|42163168|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
19719985|NCT02795182|42163169|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
19719986|NCT02795182|42163170|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
19719987|NCT02795182|42163167|FG000|Overall Study|Withdrawal by Subject|4|||
19719988|NCT02795182|42163168|FG001|Overall Study|Withdrawal by Subject|0|||
19719989|NCT02795182|42163169|FG002|Overall Study|Withdrawal by Subject|0|||
19719990|NCT02795182|42163170|FG003|Overall Study|Withdrawal by Subject|3|||
19719991|NCT02795182|42163167|FG000|Overall Study|Lost to Follow-up|0|||
19719992|NCT02795182|42163168|FG001|Overall Study|Lost to Follow-up|0|||
19719993|NCT02795182|42163169|FG002|Overall Study|Lost to Follow-up|1|||
19719994|NCT02795182|42163170|FG003|Overall Study|Lost to Follow-up|1|||
19719995|NCT02795182|42163167|FG000|Overall Study|Roll Over to Long Term Extension|3|||
19719996|NCT02795182|42163168|FG001|Overall Study|Roll Over to Long Term Extension|3|||
19719997|NCT02795182|42163169|FG002|Overall Study|Roll Over to Long Term Extension|2|||
19719998|NCT02795182|42163170|FG003|Overall Study|Roll Over to Long Term Extension|5|||
19719999|NCT02795182|42163167|FG000|Overall Study|Progressive Disease|0|||
19720000|NCT02795182|42163168|FG001|Overall Study|Progressive Disease|1|||
19720001|NCT02795182|42163169|FG002|Overall Study|Progressive Disease|0|||
19720002|NCT02795182|42163170|FG003|Overall Study|Progressive Disease|4|||
19720003|NCT02795182|42163167|FG000|Overall Study|Physician Decision|0|||
19720004|NCT02795182|42163168|FG001|Overall Study|Physician Decision|0|||
19720005|NCT02795182|42163169|FG002|Overall Study|Physician Decision|0|||
19720006|NCT02795182|42163170|FG003|Overall Study|Physician Decision|1|||
19720007|NCT03209362|42163189|FG000|Overall Study|Adverse Event|0|||
19720008|NCT03209362|42163190|FG001|Overall Study|Adverse Event|1|||
19720009|NCT03209362|42163189|FG000|Overall Study|Lost to Follow-up|0|||
19720010|NCT03209362|42163190|FG001|Overall Study|Lost to Follow-up|1|||
19720011|NCT03209362|42163189|FG000|Overall Study|Withdrawal by Subject|2|||
19720012|NCT03209362|42163190|FG001|Overall Study|Withdrawal by Subject|0|||
19720013|NCT03209362|42163189|FG000|Overall Study|Other|0|||
19720014|NCT03209362|42163190|FG001|Overall Study|Other|1|||
19720015|NCT02932462|42163198|FG000|Overall Study|Adverse Event|1|||
19720016|NCT02932462|42163199|FG001|Overall Study|Adverse Event|2|||
19720017|NCT02932462|42163198|FG000|Overall Study|Lost to Follow-up|4|||
19720018|NCT02932462|42163199|FG001|Overall Study|Lost to Follow-up|1|||
19720019|NCT02932462|42163198|FG000|Overall Study|Protocol Violation|0|||
19720020|NCT02932462|42163199|FG001|Overall Study|Protocol Violation|5|||
19720021|NCT02932462|42163198|FG000|Overall Study|Withdrawal by Subject|1|||
19720022|NCT02932462|42163199|FG001|Overall Study|Withdrawal by Subject|4|||
19720023|NCT02932462|42163198|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19720024|NCT02932462|42163199|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19720025|NCT02932462|42163198|FG000|Overall Study|Progressive Disease|1|||
19720026|NCT02932462|42163199|FG001|Overall Study|Progressive Disease|0|||
19720027|NCT03206788|42163207|FG000|Overall Study|Withdrawal by Subject|0|||
19720028|NCT03206788|42163208|FG001|Overall Study|Withdrawal by Subject|1|||
19720029|NCT03206788|42163207|FG000|Overall Study|Adverse Event|0|||
19720030|NCT03206788|42163208|FG001|Overall Study|Adverse Event|1|||
19720031|NCT03206788|42163207|FG000|Overall Study|Physician Decision|0|||
19720032|NCT03206788|42163208|FG001|Overall Study|Physician Decision|1|||
19720033|NCT03205150|42163217|FG000|Overall Study|Protocol deviation|1|||
19720034|NCT03205150|42163218|FG001|Overall Study|Protocol deviation|3|||
19720035|NCT03205150|42163219|FG002|Overall Study|Protocol deviation|0|||
19720036|NCT03205150|42163217|FG000|Overall Study|Patient/guardian decision|0|||
19720037|NCT03205150|42163218|FG001|Overall Study|Patient/guardian decision|3|||
19720038|NCT03205150|42163219|FG002|Overall Study|Patient/guardian decision|0|||
19720039|NCT03205150|42163217|FG000|Overall Study|Adverse Event|1|||
19720040|NCT03205150|42163218|FG001|Overall Study|Adverse Event|1|||
19720041|NCT03205150|42163219|FG002|Overall Study|Adverse Event|1|||
19720042|NCT03205150|42163217|FG000|Overall Study|Lost to Follow-up|0|||
19720043|NCT03205150|42163218|FG001|Overall Study|Lost to Follow-up|0|||
19720044|NCT03205150|42163219|FG002|Overall Study|Lost to Follow-up|1|||
19720045|NCT02932306|42163230|FG000|Overall Study|Withdrawal by Subject|16|||
19720046|NCT02932306|42163231|FG001|Overall Study|Withdrawal by Subject|25|||
19720047|NCT02932306|42163230|FG000|Overall Study|Adverse Event|3|||
19720048|NCT02932306|42163231|FG001|Overall Study|Adverse Event|0|||
19720049|NCT02932306|42163230|FG000|Overall Study|Pregnancy|2|||
19720050|NCT02932306|42163231|FG001|Overall Study|Pregnancy|0|||
19720051|NCT02932306|42163230|FG000|Overall Study|Protocol Violation|1|||
19720052|NCT02932306|42163231|FG001|Overall Study|Protocol Violation|1|||
19720053|NCT02932306|42163230|FG000|Overall Study|Noncompliance with Study Drug|1|||
19720054|NCT02932306|42163231|FG001|Overall Study|Noncompliance with Study Drug|1|||
19720055|NCT02932306|42163230|FG000|Overall Study|Lost to Follow-up|36|||
19720056|NCT02932306|42163231|FG001|Overall Study|Lost to Follow-up|40|||
19720057|NCT02932306|42163230|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
19720058|NCT02932306|42163231|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
19720059|NCT02932306|42163230|FG000|Overall Study|Lack of Efficacy|0|||
19720060|NCT02932306|42163231|FG001|Overall Study|Lack of Efficacy|2|||
19720061|NCT02932306|42163230|FG000|Overall Study|Worsening condition|2|||
19720062|NCT02932306|42163231|FG001|Overall Study|Worsening condition|0|||
19720063|NCT02932306|42163230|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
19720064|NCT02932306|42163231|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
19720065|NCT02932228|42163239|FG000|Overall Study|Death|8|||
19720066|NCT02932228|42163240|FG001|Overall Study|Death|23|||
19720067|NCT02932228|42163239|FG000|Overall Study|not eligible upon chart review|2|||
19720068|NCT02932228|42163240|FG001|Overall Study|not eligible upon chart review|5|||
19720069|NCT02931838|42163254|FG000|Overall Study|Reason not provided by investigator|1|||
19720070|NCT02931838|42163255|FG001|Overall Study|Reason not provided by investigator|0|||
19720071|NCT02931838|42163256|FG002|Overall Study|Reason not provided by investigator|1|||
19720072|NCT02931838|42163257|FG003|Overall Study|Reason not provided by investigator|0|||
19720073|NCT02931838|42163258|FG004|Overall Study|Reason not provided by investigator|0|||
19720074|NCT02931838|42163259|FG005|Overall Study|Reason not provided by investigator|0|||
19720075|NCT02931838|42163254|FG000|Overall Study|Poor/non-compliance|0|||
19720076|NCT02931838|42163255|FG001|Overall Study|Poor/non-compliance|0|||
19720077|NCT02931838|42163256|FG002|Overall Study|Poor/non-compliance|1|||
19720078|NCT02931838|42163257|FG003|Overall Study|Poor/non-compliance|0|||
19720079|NCT02931838|42163258|FG004|Overall Study|Poor/non-compliance|0|||
19720080|NCT02931838|42163259|FG005|Overall Study|Poor/non-compliance|0|||
19720081|NCT02931838|42163254|FG000|Overall Study|Lack of Efficacy|5|||
19720082|NCT02931838|42163255|FG001|Overall Study|Lack of Efficacy|4|||
19720083|NCT02931838|42163256|FG002|Overall Study|Lack of Efficacy|0|||
19720084|NCT02931838|42163257|FG003|Overall Study|Lack of Efficacy|0|||
19720085|NCT02931838|42163258|FG004|Overall Study|Lack of Efficacy|0|||
19720086|NCT02931838|42163259|FG005|Overall Study|Lack of Efficacy|1|||
19720087|NCT02931838|42163254|FG000|Overall Study|Lost to Follow-up|1|||
19720088|NCT02931838|42163255|FG001|Overall Study|Lost to Follow-up|0|||
19720089|NCT02931838|42163256|FG002|Overall Study|Lost to Follow-up|1|||
19720090|NCT02931838|42163257|FG003|Overall Study|Lost to Follow-up|1|||
19720091|NCT02931838|42163258|FG004|Overall Study|Lost to Follow-up|2|||
19720092|NCT02931838|42163259|FG005|Overall Study|Lost to Follow-up|0|||
19720093|NCT02931838|42163254|FG000|Overall Study|Subject request to discontinue treatment|4|||
19720094|NCT02931838|42163255|FG001|Overall Study|Subject request to discontinue treatment|3|||
19720095|NCT02931838|42163256|FG002|Overall Study|Subject request to discontinue treatment|3|||
19720096|NCT02931838|42163257|FG003|Overall Study|Subject request to discontinue treatment|0|||
19720097|NCT02931838|42163258|FG004|Overall Study|Subject request to discontinue treatment|1|||
19720098|NCT02931838|42163259|FG005|Overall Study|Subject request to discontinue treatment|0|||
19720099|NCT02931838|42163254|FG000|Overall Study|Withdrawal by Subject|1|||
19720100|NCT02931838|42163255|FG001|Overall Study|Withdrawal by Subject|2|||
19720101|NCT02931838|42163256|FG002|Overall Study|Withdrawal by Subject|0|||
19720102|NCT02931838|42163257|FG003|Overall Study|Withdrawal by Subject|1|||
19720103|NCT02931838|42163258|FG004|Overall Study|Withdrawal by Subject|0|||
19720104|NCT02931838|42163259|FG005|Overall Study|Withdrawal by Subject|0|||
19720105|NCT02931838|42163254|FG000|Overall Study|Adverse Event|2|||
19720106|NCT02931838|42163255|FG001|Overall Study|Adverse Event|1|||
19720107|NCT02931838|42163256|FG002|Overall Study|Adverse Event|2|||
19720108|NCT02931838|42163257|FG003|Overall Study|Adverse Event|1|||
19720109|NCT02931838|42163258|FG004|Overall Study|Adverse Event|3|||
19720110|NCT02931838|42163259|FG005|Overall Study|Adverse Event|1|||
19720111|NCT03201562|42163281|FG000|Overall Study|Physician Decision|0|||
19720112|NCT03201562|42163282|FG001|Overall Study|Physician Decision|0|||
19720113|NCT03201562|42163283|FG002|Overall Study|Physician Decision|1|||
19720114|NCT03201562|42163281|FG000|Overall Study|Adverse Event|0|||
19720115|NCT03201562|42163282|FG001|Overall Study|Adverse Event|0|||
19720116|NCT03201562|42163283|FG002|Overall Study|Adverse Event|1|||
19720117|NCT03201562|42163281|FG000|Overall Study|Lost to Follow-up|0|||
19720118|NCT03201562|42163282|FG001|Overall Study|Lost to Follow-up|1|||
19720119|NCT03201562|42163283|FG002|Overall Study|Lost to Follow-up|2|||
19720120|NCT03200860|42163293|FG000|Overall Study|Withdrawal by Subject|1|||
19720121|NCT03200860|42163294|FG001|Overall Study|Withdrawal by Subject|0|||
19720122|NCT03198754|42163302|FG000|Overall Study|Withdrawal by Subject|5|||
19720123|NCT03198754|42163303|FG001|Overall Study|Withdrawal by Subject|4|||
19720124|NCT03198754|42163302|FG000|Overall Study|Lost to Follow-up|4|||
19720125|NCT03198754|42163303|FG001|Overall Study|Lost to Follow-up|3|||
19720126|NCT03198754|42163302|FG000|Overall Study|Ineligible|2|||
19720127|NCT03198754|42163303|FG001|Overall Study|Ineligible|1|||
19720128|NCT03198520|42163309|FG000|Overall Study|Physician Decision|2|||
19720129|NCT03198520|42163309|FG000|Overall Study|Protocol Violation|2|||
19720130|NCT03198520|42163309|FG000|Overall Study|Withdrawal by Subject|1|||
19720131|NCT03198520|42163309|FG000|Overall Study|Study Ended|1|||
19720132|NCT03194464|42163321|FG000|Overall Study|data not usable|2|||
19720133|NCT03192904|42163329|FG000|Overall Study|Physician Decision|3|||
19720134|NCT03192904|42163330|FG001|Overall Study|Physician Decision|1|||
19720135|NCT03192904|42163329|FG000|Overall Study|Lost to Follow-up|0|||
19720136|NCT03192904|42163330|FG001|Overall Study|Lost to Follow-up|1|||
19720137|NCT03268954|42163338|FG000|Overall Study|Ongoing|23|||
19720138|NCT03268954|42163339|FG001|Overall Study|Ongoing|31|||
19720139|NCT03268954|42163338|FG000|Overall Study|Adverse Event|53|||
19720140|NCT03268954|42163339|FG001|Overall Study|Adverse Event|62|||
19720141|NCT03268954|42163338|FG000|Overall Study|Withdrawal by Subject|25|||
19720142|NCT03268954|42163339|FG001|Overall Study|Withdrawal by Subject|16|||
19720143|NCT03268954|42163338|FG000|Overall Study|Progressive Disease|61|||
19720144|NCT03268954|42163339|FG001|Overall Study|Progressive Disease|48|||
19720145|NCT03268954|42163338|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
19720146|NCT03268954|42163339|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
19720147|NCT03268954|42163338|FG000|Overall Study|Reason not Specified|40|||
19720148|NCT03268954|42163339|FG001|Overall Study|Reason not Specified|40|||
19720149|NCT03188536|42163345|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
19720150|NCT03188536|42163345|FG000|Overall Study|Not participated/met inclusion criteria|1|||
19720151|NCT03187756|42163349|FG000|Overall Study|Termination of study|4|||
19720152|NCT03187132|42163355|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
19720153|NCT03187132|42163356|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
19720154|NCT03187132|42163355|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
19720155|NCT03187132|42163356|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
19720156|NCT03187132|42163355|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
19720157|NCT03187132|42163356|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
19720158|NCT03187132|42163355|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
19720159|NCT03187132|42163356|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
19720160|NCT03187132|42163355|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
19720161|NCT03187132|42163356|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
19720162|NCT03187132|42163355|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
19720163|NCT03187132|42163356|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
19720164|NCT03187132|42163355|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
19720165|NCT03187132|42163356|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
19720166|NCT03187132|42163355|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
19720167|NCT03187132|42163356|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
19720168|NCT03187132|42163355|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
19720169|NCT03187132|42163356|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
19720170|NCT03187132|42163355|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
19720171|NCT03187132|42163356|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
19720172|NCT03187132|42163355|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
19720173|NCT03187132|42163356|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
19720174|NCT03184558|42163362|FG000|Overall Study|Withdrawal by Subject|2|||
19720175|NCT03184558|42163362|FG000|Overall Study|Death|16|||
19720176|NCT03184558|42163362|FG000|Overall Study|Lost to Follow-up|2|||
19720177|NCT03184558|42163362|FG000|Overall Study|Other|9|||
19720178|NCT03183778|42163366|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
19720179|NCT03182686|42163372|FG000|Overall Study|Lost to Follow-up|2|||
19720180|NCT03182686|42163373|FG001|Overall Study|Lost to Follow-up|0|||
19720181|NCT03182686|42163372|FG000|Overall Study|Adverse Event|2|||
19720182|NCT03182686|42163373|FG001|Overall Study|Adverse Event|0|||
19720183|NCT03182686|42163372|FG000|Overall Study|Withdrawal by Subject|3|||
19720184|NCT03182686|42163373|FG001|Overall Study|Withdrawal by Subject|0|||
19720185|NCT03181594|42163379|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
19720186|NCT03181594|42163379|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
19720187|NCT03181594|42163379|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
19720188|NCT03181594|42163379|FG000|Initial Study Protocol (12-month FU)|Death|1|||
19720189|NCT03181594|42163379|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
19720190|NCT03181594|42163379|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
19720191|NCT03180736|42163385|FG000|Overall Study|Adverse Event|3|||
19720192|NCT03180736|42163386|FG001|Overall Study|Adverse Event|4|||
19720193|NCT03180736|42163385|FG000|Overall Study|Death|10|||
19720194|NCT03180736|42163386|FG001|Overall Study|Death|7|||
19720195|NCT03180736|42163385|FG000|Overall Study|Withdrawal by Subject|5|||
19720196|NCT03180736|42163386|FG001|Overall Study|Withdrawal by Subject|12|||
19720197|NCT03180736|42163385|FG000|Overall Study|Lost to Follow-up|1|||
19720198|NCT03180736|42163386|FG001|Overall Study|Lost to Follow-up|0|||
19720199|NCT03180736|42163385|FG000|Overall Study|Lack of Efficacy|66|||
19720200|NCT03180736|42163386|FG001|Overall Study|Lack of Efficacy|87|||
19720201|NCT03180736|42163385|FG000|Overall Study|Physician Decision|4|||
19720202|NCT03180736|42163386|FG001|Overall Study|Physician Decision|7|||
19720203|NCT03180736|42163385|FG000|Overall Study|randomized but not treated|2|||
19720204|NCT03180736|42163386|FG001|Overall Study|randomized but not treated|3|||
19720205|NCT03178942|42163399|FG000|Overall Study|Withdrawal by Subject|2|||
19720206|NCT03178942|42163400|FG001|Overall Study|Withdrawal by Subject|0|||
19720207|NCT03178942|42163399|FG000|Overall Study|Lost to Follow-up|1|||
19720208|NCT03178942|42163400|FG001|Overall Study|Lost to Follow-up|2|||
19720209|NCT03175198|42163406|FG000|Overall Study|Adverse Event|480|||
19720210|NCT03175198|42163406|FG000|Overall Study|No actual visit|120|||
19720211|NCT03175198|42163406|FG000|Overall Study|Registration rule not followed|4|||
19720212|NCT03175198|42163406|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
19720213|NCT03175198|42163406|FG000|Overall Study|Other personal reason|509|||
19720214|NCT03175198|42163406|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
19720215|NCT03175198|42163406|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
19720216|NCT03175198|42163406|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
19720217|NCT03175198|42163406|FG000|Overall Study|To conduct invasive treatment of operation|53|||
19720218|NCT03175198|42163406|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
19720219|NCT03175120|42163412|FG000|Overall Study|Adverse Event|2|||
19720220|NCT03175120|42163413|FG001|Overall Study|Adverse Event|2|||
19720221|NCT03175120|42163412|FG000|Overall Study|Protocol Violation|5|||
19720222|NCT03175120|42163413|FG001|Overall Study|Protocol Violation|2|||
19720223|NCT03175120|42163412|FG000|Overall Study|Lost to Follow-up|1|||
19720224|NCT03175120|42163413|FG001|Overall Study|Lost to Follow-up|0|||
19720225|NCT03175120|42163412|FG000|Overall Study|Withdrawal by Subject|2|||
19720226|NCT03175120|42163413|FG001|Overall Study|Withdrawal by Subject|5|||
19720227|NCT03175120|42163412|FG000|Overall Study|Other|2|||
19720228|NCT03175120|42163413|FG001|Overall Study|Other|3|||
19720229|NCT03172702|42163419|FG000|Overall Study|Adverse Event|9|||
19720230|NCT03172702|42163419|FG000|Overall Study|Death|2|||
19720231|NCT03172702|42163419|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
19720232|NCT03172702|42163419|FG000|Overall Study|Withdrawal by Subject|5|||
19720233|NCT03172702|42163419|FG000|Overall Study|Other|2|||
19720234|NCT03167242|42163436|FG000|Overall Study|Patient/Guardian Decision|0|||
19720235|NCT03167242|42163437|FG001|Overall Study|Patient/Guardian Decision|1|||
19720236|NCT03167242|42163438|FG002|Overall Study|Patient/Guardian Decision|2|||
19720237|NCT03167242|42163439|FG003|Overall Study|Patient/Guardian Decision|1|||
19720238|NCT03167242|42163440|FG004|Overall Study|Patient/Guardian Decision|1|||
19720239|NCT03167242|42163441|FG005|Overall Study|Patient/Guardian Decision|1|||
19720240|NCT03167242|42163442|FG006|Overall Study|Patient/Guardian Decision|0|||
19720241|NCT03167242|42163443|FG007|Overall Study|Patient/Guardian Decision|0|||
19720242|NCT03167242|42163444|FG008|Overall Study|Patient/Guardian Decision|0|||
19720243|NCT03167242|42163445|FG009|Overall Study|Patient/Guardian Decision|0|||
19720244|NCT03167242|42163446|FG010|Overall Study|Patient/Guardian Decision|1|||
19550531|NCT01107925|41999568|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
19550532|NCT01107925|41999569|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
19720245|NCT03167242|42163447|FG011|Overall Study|Patient/Guardian Decision|0|||
19720246|NCT03167242|42163436|FG000|Overall Study|Lost to Follow-up|0|||
19720247|NCT03167242|42163437|FG001|Overall Study|Lost to Follow-up|0|||
19720248|NCT03167242|42163438|FG002|Overall Study|Lost to Follow-up|1|||
19720249|NCT03167242|42163439|FG003|Overall Study|Lost to Follow-up|0|||
19720250|NCT03167242|42163440|FG004|Overall Study|Lost to Follow-up|0|||
19720251|NCT03167242|42163441|FG005|Overall Study|Lost to Follow-up|1|||
19720252|NCT03167242|42163442|FG006|Overall Study|Lost to Follow-up|2|||
19720253|NCT03167242|42163443|FG007|Overall Study|Lost to Follow-up|1|||
19720254|NCT03167242|42163444|FG008|Overall Study|Lost to Follow-up|0|||
19720255|NCT03167242|42163445|FG009|Overall Study|Lost to Follow-up|0|||
19720256|NCT03167242|42163446|FG010|Overall Study|Lost to Follow-up|1|||
19720257|NCT03167242|42163447|FG011|Overall Study|Lost to Follow-up|1|||
19720258|NCT03167242|42163436|FG000|Overall Study|Reason not provided|0|||
19720259|NCT03167242|42163437|FG001|Overall Study|Reason not provided|0|||
19720260|NCT03167242|42163438|FG002|Overall Study|Reason not provided|0|||
19720261|NCT03167242|42163439|FG003|Overall Study|Reason not provided|0|||
19720262|NCT03167242|42163440|FG004|Overall Study|Reason not provided|0|||
19720263|NCT03167242|42163441|FG005|Overall Study|Reason not provided|0|||
19720264|NCT03167242|42163442|FG006|Overall Study|Reason not provided|0|||
19720265|NCT03167242|42163443|FG007|Overall Study|Reason not provided|0|||
19720266|NCT03167242|42163444|FG008|Overall Study|Reason not provided|1|||
19720267|NCT03167242|42163445|FG009|Overall Study|Reason not provided|0|||
19720268|NCT03167242|42163446|FG010|Overall Study|Reason not provided|0|||
19720269|NCT03167242|42163447|FG011|Overall Study|Reason not provided|0|||
19720270|NCT03286426|42163499|FG000|Overall Study|Physician Decision|3|||
19720271|NCT02882152|42163518|FG000|Overall Study|Lost to Follow-up|1|||
19720272|NCT02882152|42163519|FG001|Overall Study|Lost to Follow-up|0|||
19720273|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
19720274|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
19720275|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
19720276|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
19720277|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Death|58|||
19720278|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Death|65|||
19720279|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Adverse Event|28|||
19720280|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Adverse Event|40|||
19720281|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Disease Progression|22|||
19720282|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Disease Progression|35|||
19720283|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Other|25|||
19720284|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Other|33|||
19720285|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
19720286|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
19720287|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Noncompliance|8|||
19720288|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Noncompliance|8|||
19720289|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
19720290|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
19720291|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
19720292|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
19720293|NCT00286091|42163527|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
19720294|NCT00286091|42163528|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
19720295|NCT00286091|42163527|FG000|Open-label Treatment Phase|Physician Decision|24|||
19720296|NCT00286091|42163528|FG001|Open-label Treatment Phase|Physician Decision|21|||
19720297|NCT00286091|42163527|FG000|Open-label Treatment Phase|Adverse Event|5|||
19720298|NCT00286091|42163528|FG001|Open-label Treatment Phase|Adverse Event|16|||
19720299|NCT00286091|42163527|FG000|Open-label Treatment Phase|Other|11|||
19720300|NCT00286091|42163528|FG001|Open-label Treatment Phase|Other|11|||
19720301|NCT00286091|42163527|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
19720302|NCT00286091|42163528|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
19720303|NCT00286091|42163527|FG000|Open-label Treatment Phase|Death|10|||
19720304|NCT00286091|42163528|FG001|Open-label Treatment Phase|Death|7|||
19720305|NCT00286091|42163527|FG000|Open-label Treatment Phase|Disease Progression|9|||
19720306|NCT00286091|42163528|FG001|Open-label Treatment Phase|Disease Progression|3|||
19720307|NCT00286091|42163527|FG000|Open-label Treatment Phase|Noncompliance|3|||
19720308|NCT00286091|42163528|FG001|Open-label Treatment Phase|Noncompliance|1|||
19720309|NCT00286091|42163527|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
19720310|NCT00286091|42163528|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
19720311|NCT00286091|42163527|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
19720312|NCT00286091|42163528|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
19720313|NCT00286091|42163527|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
19720314|NCT00286091|42163528|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
19720315|NCT00285857|42163536|FG000|Overall Study|Withdrawal by Subject|2|||
19720316|NCT00285857|42163536|FG000|Overall Study|Inadequate initial breast cytology|1|||
19720317|NCT00285857|42163536|FG000|Overall Study|Adverse Event|1|||
19720318|NCT00284141|42163545|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
19720319|NCT00284141|42163545|FG000|Overall Study|Adverse Event|19|||
19720320|NCT00284141|42163545|FG000|Overall Study|Participant's request|9|||
19720321|NCT00284141|42163545|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
19720322|NCT00284141|42163545|FG000|Overall Study|Clinical deterioration / death|2|||
19720323|NCT00284141|42163545|FG000|Overall Study|General decline|1|||
19720324|NCT00284141|42163545|FG000|Overall Study|Pneumonia|1|||
19720325|NCT00284141|42163545|FG000|Overall Study|Did not take study medication|2|||
19720326|NCT00284141|42163545|FG000|Overall Study|Ongoing treatment|2|||
19720327|NCT00265343|42163553|FG000|Overall Study|Adverse Event|10|||
19720328|NCT00265343|42163554|FG001|Overall Study|Adverse Event|7|||
19720329|NCT00265343|42163553|FG000|Overall Study|Withdrawal by Subject|3|||
19720330|NCT00265343|42163554|FG001|Overall Study|Withdrawal by Subject|9|||
19720331|NCT00265343|42163553|FG000|Overall Study|Other|8|||
19720332|NCT00265343|42163554|FG001|Overall Study|Other|3|||
19720333|NCT00283595|42163562|FG000|Overall Study|Withdrawal by Subject|1|||
19720334|NCT00283595|42163563|FG001|Overall Study|Withdrawal by Subject|2|||
19720335|NCT00265109|42163569|FG000|Overall Study|Withdrawal by Subject|5|||
19720336|NCT00265109|42163569|FG000|Overall Study|Adverse Event|1|||
19720337|NCT03235024|42163576|FG000|Overall Study|Adverse Event|2|||
19720338|NCT03235024|42163577|FG001|Overall Study|Adverse Event|2|||
19720339|NCT03235024|42163576|FG000|Overall Study|Death|1|||
19720340|NCT03235024|42163577|FG001|Overall Study|Death|0|||
19720341|NCT03235024|42163576|FG000|Overall Study|Lost to Follow-up|2|||
19720342|NCT03235024|42163577|FG001|Overall Study|Lost to Follow-up|5|||
19720343|NCT03235024|42163576|FG000|Overall Study|Protocol Violation|1|||
19720344|NCT03235024|42163577|FG001|Overall Study|Protocol Violation|0|||
19720345|NCT03235024|42163576|FG000|Overall Study|Withdrawal by Subject|0|||
19720346|NCT03235024|42163577|FG001|Overall Study|Withdrawal by Subject|3|||
19720347|NCT03233308|42163583|FG000|Overall Study|Adverse Event|1|||
19720348|NCT03233308|42163583|FG000|Overall Study|Protocol Violation|1|||
19720349|NCT00283439|42163598|FG000|Overall Study|Adverse Event|0|||
19720350|NCT00283439|42163599|FG001|Overall Study|Adverse Event|0|||
19720351|NCT00283439|42163600|FG002|Overall Study|Adverse Event|0|||
19720352|NCT00283439|42163601|FG003|Overall Study|Adverse Event|1|||
19720353|NCT00283439|42163598|FG000|Overall Study|Death|0|||
19720354|NCT00283439|42163599|FG001|Overall Study|Death|0|||
19720355|NCT00283439|42163600|FG002|Overall Study|Death|1|||
19720356|NCT00283439|42163601|FG003|Overall Study|Death|0|||
19720357|NCT00283439|42163598|FG000|Overall Study|Disease progression|0|||
19720358|NCT00283439|42163599|FG001|Overall Study|Disease progression|1|||
19720359|NCT00283439|42163600|FG002|Overall Study|Disease progression|0|||
19720360|NCT00283439|42163601|FG003|Overall Study|Disease progression|0|||
19720361|NCT00283439|42163598|FG000|Overall Study|Requirement for alternative therapy|1|||
19720362|NCT00283439|42163599|FG001|Overall Study|Requirement for alternative therapy|2|||
19720363|NCT00283439|42163600|FG002|Overall Study|Requirement for alternative therapy|5|||
19720364|NCT00283439|42163601|FG003|Overall Study|Requirement for alternative therapy|2|||
19720365|NCT00283439|42163598|FG000|Overall Study|Stem cell transplant|6|||
19720366|NCT00283439|42163599|FG001|Overall Study|Stem cell transplant|6|||
19720367|NCT00283439|42163600|FG002|Overall Study|Stem cell transplant|4|||
19720368|NCT00283439|42163601|FG003|Overall Study|Stem cell transplant|3|||
19720369|NCT00283439|42163598|FG000|Overall Study|Treatment discontinued|0|||
19720370|NCT00283439|42163599|FG001|Overall Study|Treatment discontinued|2|||
19720371|NCT00283439|42163600|FG002|Overall Study|Treatment discontinued|1|||
19720372|NCT00283439|42163601|FG003|Overall Study|Treatment discontinued|3|||
19720373|NCT00283439|42163598|FG000|Overall Study|Other|1|||
19720374|NCT00283439|42163599|FG001|Overall Study|Other|0|||
19720375|NCT00283439|42163600|FG002|Overall Study|Other|0|||
19720376|NCT00283439|42163601|FG003|Overall Study|Other|0|||
19720377|NCT03233230|42163615|FG000|Overall Study|Adverse Event|6|||
19720378|NCT03233230|42163616|FG001|Overall Study|Adverse Event|3|||
19720379|NCT03233230|42163617|FG002|Overall Study|Adverse Event|6|||
19720380|NCT03233230|42163618|FG003|Overall Study|Adverse Event|3|||
19720381|NCT03233230|42163615|FG000|Overall Study|Protocol Violation|1|||
19720382|NCT03233230|42163616|FG001|Overall Study|Protocol Violation|2|||
19720383|NCT03233230|42163617|FG002|Overall Study|Protocol Violation|1|||
19720384|NCT03233230|42163618|FG003|Overall Study|Protocol Violation|1|||
19720385|NCT03233230|42163615|FG000|Overall Study|Lack of Efficacy|1|||
19720386|NCT03233230|42163616|FG001|Overall Study|Lack of Efficacy|0|||
19720387|NCT03233230|42163617|FG002|Overall Study|Lack of Efficacy|0|||
19720388|NCT03233230|42163618|FG003|Overall Study|Lack of Efficacy|0|||
19720389|NCT03233230|42163615|FG000|Overall Study|Other|5|||
19720390|NCT03233230|42163616|FG001|Overall Study|Other|5|||
19720391|NCT03233230|42163617|FG002|Overall Study|Other|5|||
19720392|NCT03233230|42163618|FG003|Overall Study|Other|3|||
19720393|NCT03233230|42163615|FG000|Overall Study|Withdrawal by Subject|2|||
19720394|NCT03233230|42163616|FG001|Overall Study|Withdrawal by Subject|2|||
19720395|NCT03233230|42163617|FG002|Overall Study|Withdrawal by Subject|0|||
19720396|NCT03233230|42163618|FG003|Overall Study|Withdrawal by Subject|1|||
19720397|NCT03233230|42163615|FG000|Overall Study|Lost to Follow-up|0|||
19720398|NCT03233230|42163616|FG001|Overall Study|Lost to Follow-up|3|||
19720399|NCT03233230|42163617|FG002|Overall Study|Lost to Follow-up|0|||
19720400|NCT03233230|42163618|FG003|Overall Study|Lost to Follow-up|0|||
19720401|NCT00283049|42163631|FG000|Overall Study|Adverse Event|6|||
19720402|NCT00283049|42163632|FG001|Overall Study|Adverse Event|1|||
19720403|NCT00283049|42163633|FG002|Overall Study|Adverse Event|4|||
19720404|NCT00283049|42163631|FG000|Overall Study|Protocol Violation|3|||
19720405|NCT00283049|42163632|FG001|Overall Study|Protocol Violation|0|||
19720406|NCT00283049|42163633|FG002|Overall Study|Protocol Violation|3|||
19720407|NCT00283049|42163631|FG000|Overall Study|Death|1|||
19720408|NCT00283049|42163632|FG001|Overall Study|Death|1|||
19720409|NCT00283049|42163633|FG002|Overall Study|Death|1|||
19720410|NCT00283049|42163631|FG000|Overall Study|Lack of Efficacy|0|||
19720411|NCT00283049|42163632|FG001|Overall Study|Lack of Efficacy|1|||
19720412|NCT00283049|42163633|FG002|Overall Study|Lack of Efficacy|1|||
19720413|NCT00283049|42163631|FG000|Overall Study|Lost to Follow-up|4|||
19720414|NCT00283049|42163632|FG001|Overall Study|Lost to Follow-up|2|||
19720415|NCT00283049|42163633|FG002|Overall Study|Lost to Follow-up|5|||
19720416|NCT00283049|42163631|FG000|Overall Study|Withdrawal by Subject|26|||
19720417|NCT00283049|42163632|FG001|Overall Study|Withdrawal by Subject|24|||
19720418|NCT00283049|42163633|FG002|Overall Study|Withdrawal by Subject|19|||
19720419|NCT00283049|42163631|FG000|Overall Study|Discontinuation of Study|18|||
19720420|NCT00283049|42163632|FG001|Overall Study|Discontinuation of Study|16|||
19720421|NCT00283049|42163633|FG002|Overall Study|Discontinuation of Study|20|||
19720422|NCT00283049|42163631|FG000|Overall Study|No longer requires study treatment|0|||
19720423|NCT00283049|42163632|FG001|Overall Study|No longer requires study treatment|0|||
19720424|NCT00283049|42163633|FG002|Overall Study|No longer requires study treatment|1|||
19720425|NCT00264875|42163641|FG000|Overall Study|Adverse Event|6|||
19720426|NCT00264875|42163641|FG000|Overall Study|Lost to Follow-up|6|||
19720427|NCT00264875|42163641|FG000|Overall Study|Protocol Violation|11|||
19720428|NCT00264875|42163641|FG000|Overall Study|Withdrawal by Subject|7|||
19720429|NCT03152110|42163645|FG000|Overall Study|Withdrawal by Subject|3|||
19720430|NCT03151408|42163652|FG000|Overall Study|Adverse Event|24|||
19720431|NCT03151408|42163653|FG001|Overall Study|Adverse Event|23|||
19720432|NCT03151408|42163652|FG000|Overall Study|Death|46|||
19720433|NCT03151408|42163653|FG001|Overall Study|Death|26|||
19720434|NCT03151408|42163652|FG000|Overall Study|Physician Decision|13|||
19720435|NCT03151408|42163653|FG001|Overall Study|Physician Decision|19|||
19720436|NCT03151408|42163652|FG000|Overall Study|Withdrawal by Subject|16|||
19720437|NCT03151408|42163653|FG001|Overall Study|Withdrawal by Subject|20|||
19720438|NCT03151408|42163652|FG000|Overall Study|Progressive disease|45|||
19720439|NCT03151408|42163653|FG001|Overall Study|Progressive disease|61|||
19720440|NCT03151408|42163652|FG000|Overall Study|non-compliance by patient|1|||
19720441|NCT03151408|42163653|FG001|Overall Study|non-compliance by patient|0|||
19720442|NCT03151408|42163652|FG000|Overall Study|other reasons|56|||
19720443|NCT03151408|42163653|FG001|Overall Study|other reasons|52|||
19720444|NCT03151408|42163652|FG000|Overall Study|randomized and not treated|2|||
19720445|NCT03151408|42163653|FG001|Overall Study|randomized and not treated|2|||
19720446|NCT00546754|42163661|FG000|Overall Study|Serious Adverse Event|1|||
19720447|NCT00546754|42163662|FG001|Overall Study|Serious Adverse Event|1|||
19720448|NCT00546754|42163661|FG000|Overall Study|Adverse Event|11|||
19720449|NCT00546754|42163662|FG001|Overall Study|Adverse Event|16|||
19720450|NCT00546754|42163661|FG000|Overall Study|Lack of Efficacy|1|||
19720451|NCT00546754|42163662|FG001|Overall Study|Lack of Efficacy|1|||
19720452|NCT00546754|42163661|FG000|Overall Study|Lost to Follow-up|9|||
19720453|NCT00546754|42163662|FG001|Overall Study|Lost to Follow-up|15|||
19720454|NCT00546754|42163661|FG000|Overall Study|Protocol Violation|3|||
19720455|NCT00546754|42163662|FG001|Overall Study|Protocol Violation|0|||
19720456|NCT00546754|42163661|FG000|Overall Study|Withdrawal by Subject|6|||
19720457|NCT00546754|42163662|FG001|Overall Study|Withdrawal by Subject|7|||
19720458|NCT00546754|42163661|FG000|Overall Study|Dyspnea|1|||
19720459|NCT00546754|42163662|FG001|Overall Study|Dyspnea|0|||
19720460|NCT00546754|42163661|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
19720461|NCT00546754|42163662|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
19720462|NCT00546754|42163661|FG000|Overall Study|Hip Replacement|1|||
19720463|NCT00546754|42163662|FG001|Overall Study|Hip Replacement|0|||
19720464|NCT00546754|42163661|FG000|Overall Study|Suicide|1|||
19720465|NCT00546754|42163662|FG001|Overall Study|Suicide|0|||
19720466|NCT00546754|42163661|FG000|Overall Study|Missing Cooperation|1|||
19720467|NCT00546754|42163662|FG001|Overall Study|Missing Cooperation|0|||
19720468|NCT00546754|42163661|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
19720469|NCT00546754|42163662|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
19720470|NCT00546754|42163661|FG000|Overall Study|Patient's Decision|0|||
19720471|NCT00546754|42163662|FG001|Overall Study|Patient's Decision|1|||
19720472|NCT00546754|42163661|FG000|Overall Study|Missing|14|||
19720473|NCT00546754|42163662|FG001|Overall Study|Missing|7|||
19720474|NCT00282347|42163670|FG000|Treatment Period|Death|2|||
19720475|NCT00282347|42163671|FG001|Treatment Period|Death|0|||
19720476|NCT00282347|42163670|FG000|Treatment Period|Lost to Follow-up|2|||
19720477|NCT00282347|42163671|FG001|Treatment Period|Lost to Follow-up|5|||
19720478|NCT00282347|42163670|FG000|Treatment Period|Withdrawal by Subject|1|||
19720479|NCT00282347|42163671|FG001|Treatment Period|Withdrawal by Subject|3|||
19720480|NCT00282347|42163670|FG000|Treatment Period|Physician Decision|0|||
19720481|NCT00282347|42163671|FG001|Treatment Period|Physician Decision|1|||
19720482|NCT00282347|42163670|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
19720483|NCT00282347|42163671|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
19720484|NCT00282347|42163670|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
19720485|NCT00282347|42163671|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
19720486|NCT00282347|42163670|FG000|Safety Follow-up Period|Physician Decision|1|||
19720487|NCT00282347|42163671|FG001|Safety Follow-up Period|Physician Decision|1|||
19720488|NCT00282347|42163670|FG000|Safety Follow-up Period|Protocol Deviation|0|||
19720489|NCT00282347|42163671|FG001|Safety Follow-up Period|Protocol Deviation|2|||
19720490|NCT00282347|42163670|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
19720491|NCT00282347|42163671|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
19720492|NCT00282347|42163670|FG000|B Cell Follow-up Period|Physician Decision|1|||
19720493|NCT00282347|42163671|FG001|B Cell Follow-up Period|Physician Decision|0|||
19720494|NCT00282347|42163670|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
19720495|NCT00282347|42163671|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
19720496|NCT00405964|42163681|FG000|Overall Study|Treatment Failure|17|||
19720497|NCT00405964|42163682|FG001|Overall Study|Treatment Failure|45|||
19720498|NCT00405964|42163681|FG000|Overall Study|Adverse Event|7|||
19720499|NCT00405964|42163682|FG001|Overall Study|Adverse Event|16|||
19720500|NCT00405964|42163681|FG000|Overall Study|Lost to Follow-up|5|||
19720501|NCT00405964|42163682|FG001|Overall Study|Lost to Follow-up|5|||
19720502|NCT00405964|42163681|FG000|Overall Study|Withdrawal by Subject|19|||
19720503|NCT00405964|42163682|FG001|Overall Study|Withdrawal by Subject|23|||
19720504|NCT00405964|42163681|FG000|Overall Study|Protocol Violation|11|||
19720505|NCT00405964|42163682|FG001|Overall Study|Protocol Violation|6|||
19720506|NCT00264797|42163690|FG000|Overall Study|Withdrawal by Subject|11|||
19720507|NCT00264797|42163691|FG001|Overall Study|Withdrawal by Subject|11|||
19720508|NCT00264797|42163690|FG000|Overall Study|Lost to Follow-up|9|||
19720509|NCT00264797|42163691|FG001|Overall Study|Lost to Follow-up|17|||
19720510|NCT00264797|42163690|FG000|Overall Study|Moved from area|3|||
19720511|NCT00264797|42163691|FG001|Overall Study|Moved from area|1|||
19720512|NCT00264797|42163690|FG000|Overall Study|Practical Problems|2|||
19720513|NCT00264797|42163691|FG001|Overall Study|Practical Problems|3|||
19720514|NCT00264797|42163690|FG000|Overall Study|Incarceration|4|||
19720515|NCT00264797|42163691|FG001|Overall Study|Incarceration|5|||
19720516|NCT00264797|42163690|FG000|Overall Study|Pressure/advice from Outsiders|1|||
19720517|NCT00264797|42163691|FG001|Overall Study|Pressure/advice from Outsiders|1|||
19720518|NCT00264797|42163690|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
19720519|NCT00264797|42163691|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
19720520|NCT00264797|42163690|FG000|Overall Study|Other|3|||
19720521|NCT00264797|42163691|FG001|Overall Study|Other|4|||
19720522|NCT03148756|42163699|FG000|Overall Study|Study Terminated|0|||
19720523|NCT03148756|42163700|FG001|Overall Study|Study Terminated|1|||
19720524|NCT00282113|42163709|FG000|Overall Study|Removed at parents request|1|||
19720525|NCT00282113|42163710|FG001|Overall Study|Removed at parents request|0|||
19720526|NCT00282113|42163711|FG002|Overall Study|Removed at parents request|0|||
19720527|NCT00281957|42163721|FG000|Overall Study|Adverse Event|7|||
19720528|NCT00281957|42163722|FG001|Overall Study|Adverse Event|2|||
19720529|NCT00281957|42163721|FG000|Overall Study|Death|1|||
19720530|NCT00281957|42163722|FG001|Overall Study|Death|0|||
19720531|NCT00281957|42163721|FG000|Overall Study|Progression/relapse|47|||
19720532|NCT00281957|42163722|FG001|Overall Study|Progression/relapse|35|||
19720533|NCT00281957|42163721|FG000|Overall Study|Not protocol specified|8|||
19720534|NCT00281957|42163722|FG001|Overall Study|Not protocol specified|1|||
19720535|NCT00281957|42163721|FG000|Overall Study|Not eligible|1|||
19720536|NCT00281957|42163722|FG001|Overall Study|Not eligible|2|||
19720537|NCT00281957|42163721|FG000|Overall Study|Did not start treatment|3|||
19720538|NCT00281957|42163722|FG001|Overall Study|Did not start treatment|1|||
19720539|NCT00281957|42163721|FG000|Overall Study|Refusal unrelated to adverse events|0|||
19720540|NCT00281957|42163722|FG001|Overall Study|Refusal unrelated to adverse events|1|||
19720541|NCT00281099|42163732|FG000|Overall Study|Death|46|||
19720542|NCT00281099|42163733|FG001|Overall Study|Death|57|||
19720543|NCT00281099|42163732|FG000|Overall Study|Lost to Follow-up|10|||
19720544|NCT00281099|42163733|FG001|Overall Study|Lost to Follow-up|19|||
19720545|NCT00281099|42163732|FG000|Overall Study|Withdrawal by Subject|65|||
19720546|NCT00281099|42163733|FG001|Overall Study|Withdrawal by Subject|70|||
19720547|NCT00281099|42163732|FG000|Overall Study|Physician Decision|79|||
19720548|NCT00281099|42163733|FG001|Overall Study|Physician Decision|72|||
19720549|NCT00281099|42163732|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
19720550|NCT00281099|42163733|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
19720551|NCT00262925|42163740|FG000|Overall Study|Lack of Efficacy|3|||
19720552|NCT00262925|42163740|FG000|Overall Study|Adverse Event|4|||
19720553|NCT00262925|42163740|FG000|Overall Study|Death|2|||
19720554|NCT00262925|42163740|FG000|Overall Study|alternative therapy|1|||
19720555|NCT00262925|42163740|FG000|Overall Study|Other|1|||
19720556|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
19720557|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
19720558|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
19720559|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
19720560|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
19720561|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
19720562|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
19720563|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
19720564|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
19720565|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
19720566|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
19720567|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
19720568|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
19720569|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
19720570|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
19720571|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
19720572|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
19720573|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
19720574|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
19720575|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
19720576|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
19720577|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
19720578|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
19720579|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
19720580|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
19720581|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
19720582|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
19720583|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
19720584|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
19720585|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
19720586|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
19720587|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
19720588|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
19720589|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
19720590|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
19720591|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
19720592|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
19720593|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
19720594|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
19720595|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
19720596|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
19720597|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
19720598|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
19720599|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
19720600|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
19720601|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
19720602|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
19720603|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
19720604|NCT03720470|42163750|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
19720605|NCT03720470|42163751|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
19720606|NCT03720470|42163752|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
19720607|NCT03720470|42163753|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
19720608|NCT03720470|42163754|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
19720609|NCT03720470|42163755|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
19720610|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
19720611|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
19720612|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
19720613|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
19720614|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
19720615|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
19720616|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
19720617|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
19720618|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
19720619|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
19720620|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
19720621|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
19720622|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
19720623|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
19720624|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
19720625|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
19720626|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
19720627|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
19720628|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
19720629|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
19720630|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
19720631|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
19720632|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
19720633|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
19720634|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
19720635|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
19720636|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
19720637|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
19720638|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
19720639|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
19720640|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
19720641|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
19720642|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
19720643|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
19720644|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
19720645|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
19720646|NCT03720470|42163750|FG000|Treatment Period: Final 4 Weeks|Other|0|||
19720647|NCT03720470|42163751|FG001|Treatment Period: Final 4 Weeks|Other|1|||
19720648|NCT03720470|42163752|FG002|Treatment Period: Final 4 Weeks|Other|0|||
19720649|NCT03720470|42163753|FG003|Treatment Period: Final 4 Weeks|Other|2|||
19720650|NCT03720470|42163754|FG004|Treatment Period: Final 4 Weeks|Other|1|||
19720651|NCT03720470|42163755|FG005|Treatment Period: Final 4 Weeks|Other|0|||
19720652|NCT00262847|42163778|FG000|Overall Study|Disease Progression|309|||
19720653|NCT00262847|42163779|FG001|Overall Study|Disease Progression|274|||
19720654|NCT00262847|42163780|FG002|Overall Study|Disease Progression|195|||
19720655|NCT00262847|42163778|FG000|Overall Study|Patient Refusal|41|||
19720656|NCT00262847|42163779|FG001|Overall Study|Patient Refusal|52|||
19720657|NCT00262847|42163780|FG002|Overall Study|Patient Refusal|47|||
19720658|NCT00262847|42163778|FG000|Overall Study|Adverse Event|74|||
19720659|NCT00262847|42163779|FG001|Overall Study|Adverse Event|88|||
19720660|NCT00262847|42163780|FG002|Overall Study|Adverse Event|108|||
19720661|NCT00262847|42163778|FG000|Overall Study|Death|8|||
19720662|NCT00262847|42163779|FG001|Overall Study|Death|8|||
19720663|NCT00262847|42163780|FG002|Overall Study|Death|11|||
19720664|NCT00262847|42163778|FG000|Overall Study|Concomitant disease|3|||
19720665|NCT00262847|42163779|FG001|Overall Study|Concomitant disease|2|||
19720666|NCT00262847|42163780|FG002|Overall Study|Concomitant disease|4|||
19720667|NCT00262847|42163778|FG000|Overall Study|Other Reasons|79|||
19720668|NCT00262847|42163779|FG001|Overall Study|Other Reasons|88|||
19720669|NCT00262847|42163780|FG002|Overall Study|Other Reasons|27|||
19720670|NCT00262847|42163778|FG000|Overall Study|Did not receive study treatment|4|||
19720671|NCT00262847|42163779|FG001|Overall Study|Did not receive study treatment|1|||
19720672|NCT00262847|42163780|FG002|Overall Study|Did not receive study treatment|4|||
19720673|NCT00280397|42163791|FG000|Overall Study|Adverse Event|1|||
19720674|NCT00262301|42163800|FG000|Double-blind Phase|Lost to Follow-up|1|||
19720675|NCT00262301|42163801|FG001|Double-blind Phase|Lost to Follow-up|0|||
19720676|NCT00262301|42163802|FG002|Double-blind Phase|Lost to Follow-up|0|||
19720677|NCT00262301|42163800|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
19720678|NCT00262301|42163801|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
19720679|NCT00262301|42163802|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
19720680|NCT00279305|42163812|FG000|Overall Study|Pregnancy|1|||
19720681|NCT00279305|42163813|FG001|Overall Study|Pregnancy|0|||
19720682|NCT00279305|42163812|FG000|Overall Study|Withdrawal by Subject|2|||
19720683|NCT00279305|42163813|FG001|Overall Study|Withdrawal by Subject|0|||
19720684|NCT00279305|42163812|FG000|Overall Study|Dificulting establishing IV|1|||
19720685|NCT00279305|42163813|FG001|Overall Study|Dificulting establishing IV|0|||
19720686|NCT00279305|42163812|FG000|Overall Study|FDA Safety Alert|4|||
19720687|NCT00279305|42163813|FG001|Overall Study|FDA Safety Alert|1|||
19720688|NCT00278993|42163819|FG000|Overall Study|Adverse Event|24|||
19720689|NCT00278993|42163819|FG000|Overall Study|Withdrawal by Subject|5|||
19720690|NCT00278993|42163819|FG000|Overall Study|Progressive Disease|65|||
19720691|NCT00278993|42163819|FG000|Overall Study|Physician Decision|9|||
19720692|NCT00278993|42163819|FG000|Overall Study|Not Otherwise Specified|4|||
19720693|NCT00277355|42163825|FG000|Overall Study|Withdrawal by Subject|3|||
19720694|NCT00277355|42163826|FG001|Overall Study|Withdrawal by Subject|3|||
19720695|NCT00277355|42163825|FG000|Overall Study|Lost to Follow-up|2|||
19720696|NCT00277355|42163826|FG001|Overall Study|Lost to Follow-up|2|||
19720697|NCT00277355|42163825|FG000|Overall Study|Adverse Event|5|||
19720698|NCT00277355|42163826|FG001|Overall Study|Adverse Event|0|||
19720699|NCT00277355|42163825|FG000|Overall Study|Death|3|||
19720700|NCT00277355|42163826|FG001|Overall Study|Death|0|||
19720701|NCT00277355|42163825|FG000|Overall Study|Physician Decision|1|||
19720702|NCT00277355|42163826|FG001|Overall Study|Physician Decision|0|||
19720703|NCT00262223|42163835|FG000|Treatment Phase|Withdrawal by Subject|3|||
19720704|NCT00262223|42163836|FG001|Treatment Phase|Withdrawal by Subject|6|||
19720705|NCT00262223|42163835|FG000|Treatment Phase|Adverse Event|1|||
19720706|NCT00262223|42163836|FG001|Treatment Phase|Adverse Event|2|||
19720707|NCT00262223|42163835|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
19720708|NCT00262223|42163836|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
19720709|NCT00262223|42163835|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
19720710|NCT00262223|42163836|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
19720711|NCT00262223|42163835|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
19720712|NCT00262223|42163836|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
19720713|NCT00276419|42163845|FG000|First Intervention|Adverse Event|1|||
19720714|NCT00276419|42163846|FG001|First Intervention|Adverse Event|0|||
19720715|NCT00276419|42163845|FG000|First Intervention|Withdrawal by Subject|0|||
19720716|NCT00276419|42163846|FG001|First Intervention|Withdrawal by Subject|2|||
19720717|NCT00262067|42163867|FG000|Overall Study|Death|190|||
19720718|NCT00262067|42163868|FG001|Overall Study|Death|89|||
19720719|NCT00262067|42163869|FG002|Overall Study|Death|186|||
19720720|NCT00262067|42163870|FG003|Overall Study|Death|99|||
19720721|NCT00262067|42163867|FG000|Overall Study|Lost to Follow-up|5|||
19720722|NCT00262067|42163868|FG001|Overall Study|Lost to Follow-up|4|||
19720723|NCT00262067|42163869|FG002|Overall Study|Lost to Follow-up|7|||
19720724|NCT00262067|42163870|FG003|Overall Study|Lost to Follow-up|5|||
19720725|NCT00262067|42163867|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
19720726|NCT00262067|42163868|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
19720727|NCT00262067|42163869|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
19720728|NCT00262067|42163870|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
19720729|NCT00262067|42163867|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
19720730|NCT00262067|42163868|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
19720731|NCT00262067|42163869|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
19720732|NCT00262067|42163870|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
19720733|NCT00275561|42163882|FG000|Overall Study|Withdrawal by Subject|0|||
19720734|NCT00275561|42163883|FG001|Overall Study|Withdrawal by Subject|1|||
19720735|NCT00275561|42163882|FG000|Overall Study|Travel|1|||
19720736|NCT00275561|42163883|FG001|Overall Study|Travel|1|||
19720737|NCT00275561|42163882|FG000|Overall Study|Scheduling|1|||
19720738|NCT00275561|42163883|FG001|Overall Study|Scheduling|2|||
19720739|NCT00275561|42163882|FG000|Overall Study|Family Issues|0|||
19720740|NCT00275561|42163883|FG001|Overall Study|Family Issues|2|||
19720741|NCT00274937|42163893|FG000|Overall Study|Physician Decision|10|||
19720742|NCT00274937|42163893|FG000|Overall Study|Withdrawal by Subject|6|||
19720743|NCT00274937|42163893|FG000|Overall Study|Progressive Disease|4|||
19720744|NCT00251693|42163900|FG000|Overall Study|Adverse Event|17|||
19720745|NCT00251693|42163901|FG001|Overall Study|Adverse Event|9|||
19720746|NCT00251693|42163902|FG002|Overall Study|Adverse Event|9|||
19720747|NCT00251693|42163900|FG000|Overall Study|Protocol Violation|2|||
19720748|NCT00251693|42163901|FG001|Overall Study|Protocol Violation|0|||
19720749|NCT00251693|42163902|FG002|Overall Study|Protocol Violation|2|||
19720750|NCT00251693|42163900|FG000|Overall Study|Lost to Follow-up|12|||
19720751|NCT00251693|42163901|FG001|Overall Study|Lost to Follow-up|7|||
19720752|NCT00251693|42163902|FG002|Overall Study|Lost to Follow-up|8|||
19720753|NCT00251693|42163900|FG000|Overall Study|Withdrawal by Subject|11|||
19720754|NCT00251693|42163901|FG001|Overall Study|Withdrawal by Subject|17|||
19720755|NCT00251693|42163902|FG002|Overall Study|Withdrawal by Subject|14|||
19720756|NCT00251693|42163900|FG000|Overall Study|Lack of Efficacy|0|||
19720757|NCT00251693|42163901|FG001|Overall Study|Lack of Efficacy|1|||
19720758|NCT00251693|42163902|FG002|Overall Study|Lack of Efficacy|0|||
19720759|NCT00251693|42163900|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
19720760|NCT00251693|42163901|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
19720761|NCT00251693|42163902|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
19720762|NCT00251693|42163900|FG000|Overall Study|Noncompliant|0|||
19720763|NCT00251693|42163901|FG001|Overall Study|Noncompliant|0|||
19720764|NCT00251693|42163902|FG002|Overall Study|Noncompliant|2|||
19720765|NCT00251693|42163900|FG000|Overall Study|Possible Barrett's esophagus|3|||
19720766|NCT00251693|42163901|FG001|Overall Study|Possible Barrett's esophagus|5|||
19720767|NCT00251693|42163902|FG002|Overall Study|Possible Barrett's esophagus|2|||
19720768|NCT00251693|42163900|FG000|Overall Study|Subject request/subject unavailable|1|||
19720769|NCT00251693|42163901|FG001|Overall Study|Subject request/subject unavailable|2|||
19720770|NCT00251693|42163902|FG002|Overall Study|Subject request/subject unavailable|0|||
19720771|NCT00251693|42163900|FG000|Overall Study|Abnormal laboratory findings|0|||
19720772|NCT00251693|42163901|FG001|Overall Study|Abnormal laboratory findings|0|||
19720773|NCT00251693|42163902|FG002|Overall Study|Abnormal laboratory findings|1|||
19720774|NCT00250835|42163910|FG000|Overall Study|Withdrawal by Subject|1|||
19720775|NCT03716024|42163920|FG000|Overall Study|Randomized, not Treated|7|||
19720776|NCT03716024|42163921|FG001|Overall Study|Randomized, not Treated|8|||
19720777|NCT03716024|42163920|FG000|Overall Study|Adverse Event|1|||
19720778|NCT03716024|42163921|FG001|Overall Study|Adverse Event|2|||
19720779|NCT03716024|42163920|FG000|Overall Study|Treatment Failure|1|||
19720780|NCT03716024|42163921|FG001|Overall Study|Treatment Failure|0|||
19720781|NCT03716024|42163920|FG000|Overall Study|Lost to Follow-up|2|||
19720782|NCT03716024|42163921|FG001|Overall Study|Lost to Follow-up|6|||
19720783|NCT03716024|42163920|FG000|Overall Study|Withdrawal by Subject|0|||
19720784|NCT03716024|42163921|FG001|Overall Study|Withdrawal by Subject|1|||
19720785|NCT03716024|42163920|FG000|Overall Study|Missing Reason|0|||
19720786|NCT03716024|42163921|FG001|Overall Study|Missing Reason|1|||
19720787|NCT00250679|42163930|FG000|Overall Study|Adverse Event|12|||
19720788|NCT00250679|42163931|FG001|Overall Study|Adverse Event|15|||
19720789|NCT00250679|42163932|FG002|Overall Study|Adverse Event|16|||
19720790|NCT00250679|42163930|FG000|Overall Study|Protocol Violation|2|||
19720791|NCT00250679|42163931|FG001|Overall Study|Protocol Violation|4|||
19720792|NCT00250679|42163932|FG002|Overall Study|Protocol Violation|3|||
19720793|NCT00250679|42163930|FG000|Overall Study|Withdrawal by Subject|15|||
19720794|NCT00250679|42163931|FG001|Overall Study|Withdrawal by Subject|18|||
19720795|NCT00250679|42163932|FG002|Overall Study|Withdrawal by Subject|15|||
19720796|NCT00250679|42163930|FG000|Overall Study|Lost to Follow-up|3|||
19720797|NCT00250679|42163931|FG001|Overall Study|Lost to Follow-up|4|||
19720798|NCT00250679|42163932|FG002|Overall Study|Lost to Follow-up|2|||
19720799|NCT00250679|42163930|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
19720800|NCT00250679|42163931|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
19720801|NCT00250679|42163932|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
19720802|NCT00250679|42163930|FG000|Overall Study|Lack of Efficacy|0|||
19720803|NCT00250679|42163931|FG001|Overall Study|Lack of Efficacy|1|||
19720804|NCT00250679|42163932|FG002|Overall Study|Lack of Efficacy|3|||
19720805|NCT00250679|42163930|FG000|Overall Study|Technical Holter issues|1|||
19720806|NCT00250679|42163931|FG001|Overall Study|Technical Holter issues|0|||
19720807|NCT00250679|42163932|FG002|Overall Study|Technical Holter issues|2|||
19720808|NCT00250679|42163930|FG000|Overall Study|Moved|1|||
19720809|NCT00250679|42163931|FG001|Overall Study|Moved|1|||
19720810|NCT00250679|42163932|FG002|Overall Study|Moved|0|||
19720811|NCT00250679|42163930|FG000|Overall Study|Non-compliance|1|||
19720812|NCT00250679|42163931|FG001|Overall Study|Non-compliance|1|||
19720813|NCT00250679|42163932|FG002|Overall Study|Non-compliance|0|||
19720814|NCT00250679|42163930|FG000|Overall Study|various single events: hip surgery,diary|3|||
19720815|NCT00250679|42163931|FG001|Overall Study|various single events: hip surgery,diary|1|||
19720816|NCT00250679|42163932|FG002|Overall Study|various single events: hip surgery,diary|1|||
19720817|NCT00261833|42163942|FG000|Overall Study|Death|1|||
19720818|NCT00261833|42163943|FG001|Overall Study|Death|3|||
19720819|NCT00261833|42163942|FG000|Overall Study|Adverse Event|1|||
19720820|NCT00261833|42163943|FG001|Overall Study|Adverse Event|4|||
19720821|NCT00261833|42163942|FG000|Overall Study|Withdrawal by Subject|5|||
19720822|NCT00261833|42163943|FG001|Overall Study|Withdrawal by Subject|7|||
19720823|NCT00261833|42163942|FG000|Overall Study|Protocol Violation|0|||
19720824|NCT00261833|42163943|FG001|Overall Study|Protocol Violation|1|||
19720825|NCT00261833|42163942|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
19720826|NCT00261833|42163943|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
19720827|NCT00261833|42163942|FG000|Overall Study|Lung transplantation|1|||
19720828|NCT00261833|42163943|FG001|Overall Study|Lung transplantation|1|||
19720829|NCT00261833|42163942|FG000|Overall Study|Missing reason|1|||
19720830|NCT00261833|42163943|FG001|Overall Study|Missing reason|0|||
19720831|NCT00261833|42163942|FG000|Overall Study|Not interested in being participant|0|||
19720832|NCT00261833|42163943|FG001|Overall Study|Not interested in being participant|1|||
19720833|NCT03713684|42163954|FG000|Overall Study|Adverse Event|1|||
19720834|NCT03713684|42163955|FG001|Overall Study|Adverse Event|3|||
19720835|NCT03713684|42163956|FG002|Overall Study|Adverse Event|1|||
19720836|NCT03713684|42163957|FG003|Overall Study|Adverse Event|0|||
19720837|NCT03713684|42163954|FG000|Overall Study|Poor compliance to protocol|2|||
19720838|NCT03713684|42163955|FG001|Overall Study|Poor compliance to protocol|1|||
19720839|NCT03713684|42163956|FG002|Overall Study|Poor compliance to protocol|0|||
19720840|NCT03713684|42163957|FG003|Overall Study|Poor compliance to protocol|1|||
19720841|NCT03713684|42163954|FG000|Overall Study|Withdrawal by Subject|14|||
19720842|NCT03713684|42163955|FG001|Overall Study|Withdrawal by Subject|6|||
19720843|NCT03713684|42163956|FG002|Overall Study|Withdrawal by Subject|14|||
19720844|NCT03713684|42163957|FG003|Overall Study|Withdrawal by Subject|16|||
19720845|NCT03713684|42163954|FG000|Overall Study|Other than specified|69|||
19720846|NCT03713684|42163955|FG001|Overall Study|Other than specified|77|||
19720847|NCT03713684|42163956|FG002|Overall Study|Other than specified|73|||
19720848|NCT03713684|42163957|FG003|Overall Study|Other than specified|70|||
19720849|NCT03711266|42163967|FG000|Overall Study|Lost to Follow-up|10|||
19720850|NCT03150862|42163979|FG000|Overall Study|Death|2|||
19720851|NCT03150862|42163980|FG001|Overall Study|Death|7|||
19720852|NCT03150862|42163981|FG002|Overall Study|Death|8|||
19720853|NCT03150862|42163982|FG003|Overall Study|Death|27|||
19720854|NCT03150862|42163983|FG004|Overall Study|Death|4|||
19720855|NCT03150862|42163984|FG005|Overall Study|Death|8|||
19720856|NCT03150862|42163985|FG006|Overall Study|Death|6|||
19720857|NCT03150862|42163986|FG007|Overall Study|Death|21|||
19720858|NCT03150862|42163979|FG000|Overall Study|Withdrawal by Subject|1|||
19720859|NCT03150862|42163980|FG001|Overall Study|Withdrawal by Subject|1|||
19720860|NCT03150862|42163981|FG002|Overall Study|Withdrawal by Subject|0|||
19720861|NCT03150862|42163982|FG003|Overall Study|Withdrawal by Subject|3|||
19720862|NCT03150862|42163983|FG004|Overall Study|Withdrawal by Subject|1|||
19720863|NCT03150862|42163984|FG005|Overall Study|Withdrawal by Subject|1|||
19720864|NCT03150862|42163985|FG006|Overall Study|Withdrawal by Subject|1|||
19720865|NCT03150862|42163986|FG007|Overall Study|Withdrawal by Subject|3|||
19720866|NCT03150862|42163979|FG000|Overall Study|Lost to Follow-up|0|||
19720867|NCT03150862|42163980|FG001|Overall Study|Lost to Follow-up|0|||
19720868|NCT03150862|42163981|FG002|Overall Study|Lost to Follow-up|1|||
19720869|NCT03150862|42163982|FG003|Overall Study|Lost to Follow-up|0|||
19720870|NCT03150862|42163983|FG004|Overall Study|Lost to Follow-up|0|||
19720871|NCT03150862|42163984|FG005|Overall Study|Lost to Follow-up|0|||
19720872|NCT03150862|42163985|FG006|Overall Study|Lost to Follow-up|0|||
19720873|NCT03150862|42163986|FG007|Overall Study|Lost to Follow-up|2|||
19720874|NCT03150862|42163979|FG000|Overall Study|Sponsor's decision|0|||
19720875|NCT03150862|42163980|FG001|Overall Study|Sponsor's decision|0|||
19720876|NCT03150862|42163981|FG002|Overall Study|Sponsor's decision|0|||
19720877|NCT03150862|42163982|FG003|Overall Study|Sponsor's decision|10|||
19720878|NCT03150862|42163983|FG004|Overall Study|Sponsor's decision|3|||
19720879|NCT03150862|42163984|FG005|Overall Study|Sponsor's decision|0|||
19720880|NCT03150862|42163985|FG006|Overall Study|Sponsor's decision|1|||
19720881|NCT03150862|42163986|FG007|Overall Study|Sponsor's decision|1|||
19720882|NCT03150862|42163979|FG000|Overall Study|Change in Methylation status|0|||
19720883|NCT03150862|42163980|FG001|Overall Study|Change in Methylation status|0|||
19720884|NCT03150862|42163981|FG002|Overall Study|Change in Methylation status|0|||
19720885|NCT03150862|42163982|FG003|Overall Study|Change in Methylation status|0|||
19720886|NCT03150862|42163983|FG004|Overall Study|Change in Methylation status|1|||
19720887|NCT03150862|42163984|FG005|Overall Study|Change in Methylation status|0|||
19720888|NCT03150862|42163985|FG006|Overall Study|Change in Methylation status|0|||
19720889|NCT03150862|42163986|FG007|Overall Study|Change in Methylation status|0|||
19720890|NCT03150862|42163979|FG000|Overall Study|Roll over in to Long Term Extension|0|||
19720891|NCT03150862|42163980|FG001|Overall Study|Roll over in to Long Term Extension|0|||
19720892|NCT03150862|42163981|FG002|Overall Study|Roll over in to Long Term Extension|0|||
19720893|NCT03150862|42163982|FG003|Overall Study|Roll over in to Long Term Extension|0|||
19720894|NCT03150862|42163983|FG004|Overall Study|Roll over in to Long Term Extension|0|||
19720895|NCT03150862|42163984|FG005|Overall Study|Roll over in to Long Term Extension|0|||
19720896|NCT03150862|42163985|FG006|Overall Study|Roll over in to Long Term Extension|0|||
19720897|NCT03150862|42163986|FG007|Overall Study|Roll over in to Long Term Extension|1|||
19720898|NCT03150862|42163979|FG000|Overall Study|Progressive Disease|0|||
19720899|NCT03150862|42163980|FG001|Overall Study|Progressive Disease|0|||
19720900|NCT03150862|42163981|FG002|Overall Study|Progressive Disease|0|||
19720901|NCT03150862|42163982|FG003|Overall Study|Progressive Disease|0|||
19720902|NCT03150862|42163983|FG004|Overall Study|Progressive Disease|0|||
19720903|NCT03150862|42163984|FG005|Overall Study|Progressive Disease|0|||
19720904|NCT03150862|42163985|FG006|Overall Study|Progressive Disease|0|||
19720905|NCT03150862|42163986|FG007|Overall Study|Progressive Disease|2|||
19720906|NCT00260429|42164015|FG000|Overall Study|failure to follow appointments|1|||
19720907|NCT00260429|42164016|FG001|Overall Study|failure to follow appointments|0|||
19720908|NCT00260429|42164015|FG000|Overall Study|scheduled hand surgery|1|||
19720909|NCT00260429|42164016|FG001|Overall Study|scheduled hand surgery|0|||
19720910|NCT00379288|42164026|FG000|Overall Study|Adverse Event|5|||
19720911|NCT00379288|42164027|FG001|Overall Study|Adverse Event|6|||
19720912|NCT00379288|42164028|FG002|Overall Study|Adverse Event|2|||
19720913|NCT00379288|42164029|FG003|Overall Study|Adverse Event|0|||
19720914|NCT00379288|42164026|FG000|Overall Study|Treatment Failure|0|||
19720915|NCT00379288|42164027|FG001|Overall Study|Treatment Failure|1|||
19720916|NCT00379288|42164028|FG002|Overall Study|Treatment Failure|0|||
19720917|NCT00379288|42164029|FG003|Overall Study|Treatment Failure|1|||
19720918|NCT00379288|42164026|FG000|Overall Study|Lost to Follow-up|3|||
19720919|NCT00379288|42164027|FG001|Overall Study|Lost to Follow-up|3|||
19720920|NCT00379288|42164028|FG002|Overall Study|Lost to Follow-up|2|||
19720921|NCT00379288|42164029|FG003|Overall Study|Lost to Follow-up|0|||
19720922|NCT00379288|42164026|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
19720923|NCT00379288|42164027|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
19720924|NCT00379288|42164028|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
19720925|NCT00379288|42164029|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
19720926|NCT00379288|42164026|FG000|Overall Study|Subject withdrew-related to study drug|1|||
19720927|NCT00379288|42164027|FG001|Overall Study|Subject withdrew-related to study drug|0|||
19720928|NCT00379288|42164028|FG002|Overall Study|Subject withdrew-related to study drug|0|||
19720929|NCT00379288|42164029|FG003|Overall Study|Subject withdrew-related to study drug|1|||
19720930|NCT00379288|42164026|FG000|Overall Study|Noncompliance with protocol|8|||
19720931|NCT00379288|42164027|FG001|Overall Study|Noncompliance with protocol|6|||
19720932|NCT00379288|42164028|FG002|Overall Study|Noncompliance with protocol|2|||
19720933|NCT00379288|42164029|FG003|Overall Study|Noncompliance with protocol|1|||
19720934|NCT00379288|42164026|FG000|Overall Study|Did not meet protocol eligibility|0|||
19720935|NCT00379288|42164027|FG001|Overall Study|Did not meet protocol eligibility|1|||
19720936|NCT00379288|42164028|FG002|Overall Study|Did not meet protocol eligibility|0|||
19720937|NCT00379288|42164029|FG003|Overall Study|Did not meet protocol eligibility|2|||
19720938|NCT00379288|42164026|FG000|Overall Study|Administrative|2|||
19720939|NCT00379288|42164027|FG001|Overall Study|Administrative|2|||
19720940|NCT00379288|42164028|FG002|Overall Study|Administrative|0|||
19720941|NCT00379288|42164029|FG003|Overall Study|Administrative|1|||
19720942|NCT00243503|42164039|FG000|Overall Study|Adverse Event|11|||
19720943|NCT00243503|42164039|FG000|Overall Study|Withdrawal by Subject|1|||
19720944|NCT00243503|42164039|FG000|Overall Study|Lack of Efficacy|44|||
19720945|NCT00243503|42164039|FG000|Overall Study|Death|1|||
19720946|NCT00243503|42164039|FG000|Overall Study|Other|1|||
19720947|NCT00239837|42164046|FG000|Overall Study|Lost to Follow-up|3|||
19720948|NCT00239837|42164047|FG001|Overall Study|Lost to Follow-up|7|||
19720949|NCT00259649|42164055|FG000|Overall Study|Lost to Follow-up|7|||
19720950|NCT00259649|42164055|FG000|Overall Study|irregular menses|3|||
19720951|NCT03712280|42164063|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
19720952|NCT03712280|42164064|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
19720953|NCT03712280|42164065|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
19720954|NCT03712280|42164066|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
19720955|NCT03712280|42164063|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
19720956|NCT03712280|42164064|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
19720957|NCT03712280|42164065|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
19720958|NCT03712280|42164066|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
19720959|NCT03712280|42164063|FG000|Overall Study|Adverse Event|0|||
19720960|NCT03712280|42164064|FG001|Overall Study|Adverse Event|0|||
19720961|NCT03712280|42164065|FG002|Overall Study|Adverse Event|1|||
19720962|NCT03712280|42164066|FG003|Overall Study|Adverse Event|0|||
19720963|NCT01345240|42164081|FG000|Overall Study|Adverse Event|3|||
19720964|NCT01345240|42164082|FG001|Overall Study|Adverse Event|5|||
19720965|NCT01345240|42164083|FG002|Overall Study|Adverse Event|4|||
19720966|NCT01345240|42164084|FG003|Overall Study|Adverse Event|2|||
19720967|NCT01345240|42164085|FG004|Overall Study|Adverse Event|1|||
19720968|NCT01345240|42164081|FG000|Overall Study|Lost to Follow-up|8|||
19720969|NCT01345240|42164082|FG001|Overall Study|Lost to Follow-up|9|||
19720970|NCT01345240|42164083|FG002|Overall Study|Lost to Follow-up|14|||
19720971|NCT01345240|42164084|FG003|Overall Study|Lost to Follow-up|7|||
19720972|NCT01345240|42164085|FG004|Overall Study|Lost to Follow-up|9|||
19720973|NCT03707912|42164117|FG000|Overall Study|Violation of inclusion criteria|1|||
19720974|NCT03707912|42164118|FG001|Overall Study|Violation of inclusion criteria|0|||
19720975|NCT02883244|42164126|FG000|Overall Study|Lost to Follow-up|0|||
19720976|NCT02883244|42164127|FG001|Overall Study|Lost to Follow-up|1|||
19720977|NCT02882854|42164135|FG000|Overall Study|Lost to Follow-up|1|||
19720978|NCT02882854|42164136|FG001|Overall Study|Lost to Follow-up|2|||
19720979|NCT02882854|42164135|FG000|Overall Study|Physician Decision|0|||
19720980|NCT02882854|42164136|FG001|Overall Study|Physician Decision|1|||
19720981|NCT03707522|42164146|FG000|Overall Study|Lost to Follow-up|24|||
19720982|NCT03707522|42164147|FG001|Overall Study|Lost to Follow-up|27|||
19720983|NCT03707522|42164148|FG002|Overall Study|Lost to Follow-up|41|||
19720984|NCT03707522|42164149|FG003|Overall Study|Lost to Follow-up|36|||
19720985|NCT03150082|42164159|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
19720986|NCT03150082|42164160|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
19720987|NCT03142750|42164188|FG000|Overall Study|Lost to Follow-up|4|||
19720988|NCT03142750|42164189|FG001|Overall Study|Lost to Follow-up|1|||
19720989|NCT03149848|42164199|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
19720990|NCT03149848|42164199|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
19720991|NCT03706040|42164209|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
19720992|NCT03706040|42164210|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
19720993|NCT03706040|42164211|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
19720994|NCT03706040|42164212|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
19720995|NCT03706040|42164213|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
19720996|NCT03706040|42164214|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
19720997|NCT03706040|42164215|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
19720998|NCT03706040|42164209|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
19720999|NCT03706040|42164210|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
19721000|NCT03706040|42164211|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
19721001|NCT03706040|42164212|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
19721002|NCT03706040|42164213|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
19721003|NCT03706040|42164214|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
19721004|NCT03706040|42164215|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
19721005|NCT03706040|42164209|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
19721006|NCT03706040|42164210|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
19721007|NCT03706040|42164211|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
19721008|NCT03706040|42164212|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
19721009|NCT03706040|42164213|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
19721010|NCT03706040|42164214|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
19721011|NCT03706040|42164215|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
19721012|NCT03706040|42164209|FG000|Period A (Week 0 to Week 16)|Other|2|||
19721013|NCT03706040|42164210|FG001|Period A (Week 0 to Week 16)|Other|0|||
19721014|NCT03706040|42164211|FG002|Period A (Week 0 to Week 16)|Other|2|||
19721015|NCT03706040|42164212|FG003|Period A (Week 0 to Week 16)|Other|0|||
19721016|NCT03706040|42164213|FG004|Period A (Week 0 to Week 16)|Other|0|||
19721017|NCT03706040|42164214|FG005|Period A (Week 0 to Week 16)|Other|0|||
19721018|NCT03706040|42164215|FG006|Period A (Week 0 to Week 16)|Other|0|||
19721019|NCT03706040|42164209|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
19721020|NCT03706040|42164210|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
19721021|NCT03706040|42164211|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
19721022|NCT03706040|42164212|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
19721023|NCT03706040|42164213|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
19721024|NCT03706040|42164214|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
19721025|NCT03706040|42164215|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
19721026|NCT03706040|42164209|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
19721027|NCT03706040|42164210|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
19721028|NCT03706040|42164211|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
19721029|NCT03706040|42164212|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
19721030|NCT03706040|42164213|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
19721031|NCT03706040|42164214|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
19721032|NCT03706040|42164215|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
19721033|NCT03706040|42164209|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
19721034|NCT03706040|42164210|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
19721035|NCT03706040|42164211|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
19721036|NCT03706040|42164212|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
19721037|NCT03706040|42164213|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
19721038|NCT03706040|42164214|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
19721039|NCT03706040|42164215|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
19721040|NCT03706040|42164209|FG000|Period B (Week 16 to Week 52)|Other|0|||
19721041|NCT03706040|42164210|FG001|Period B (Week 16 to Week 52)|Other|0|||
19721042|NCT03706040|42164211|FG002|Period B (Week 16 to Week 52)|Other|0|||
19721043|NCT03706040|42164212|FG003|Period B (Week 16 to Week 52)|Other|4|||
19721044|NCT03706040|42164213|FG004|Period B (Week 16 to Week 52)|Other|5|||
19721045|NCT03706040|42164214|FG005|Period B (Week 16 to Week 52)|Other|23|||
19721046|NCT03706040|42164215|FG006|Period B (Week 16 to Week 52)|Other|17|||
19721047|NCT03770000|42164236|FG000|Overall Study|Premature discontinuation due to PD|0|||
19721048|NCT03770000|42164237|FG001|Overall Study|Premature discontinuation due to PD|0|||
19721049|NCT03770000|42164238|FG002|Overall Study|Premature discontinuation due to PD|1|||
19721050|NCT03770000|42164239|FG003|Overall Study|Premature discontinuation due to PD|3|||
19721051|NCT03770000|42164240|FG004|Overall Study|Premature discontinuation due to PD|2|||
19721052|NCT03158272|42164259|FG000|Overall Study|Disease progression|3|||
19721053|NCT03158272|42164260|FG001|Overall Study|Disease progression|3|||
19721054|NCT03158272|42164261|FG002|Overall Study|Disease progression|4|||
19721055|NCT03158272|42164262|FG003|Overall Study|Disease progression|6|||
19721056|NCT03158272|42164259|FG000|Overall Study|Death|0|||
19721057|NCT03158272|42164260|FG001|Overall Study|Death|0|||
19721058|NCT03158272|42164261|FG002|Overall Study|Death|1|||
19721059|NCT03158272|42164262|FG003|Overall Study|Death|0|||
19721060|NCT03158272|42164259|FG000|Overall Study|Other reasons|0|||
19721061|NCT03158272|42164260|FG001|Overall Study|Other reasons|0|||
19721062|NCT03158272|42164261|FG002|Overall Study|Other reasons|1|||
19721063|NCT03158272|42164262|FG003|Overall Study|Other reasons|0|||
19721064|NCT03158272|42164259|FG000|Overall Study|Adverse event unrelated to the drug|0|||
19721065|NCT03158272|42164260|FG001|Overall Study|Adverse event unrelated to the drug|1|||
19721066|NCT03158272|42164261|FG002|Overall Study|Adverse event unrelated to the drug|0|||
19721067|NCT03158272|42164262|FG003|Overall Study|Adverse event unrelated to the drug|0|||
19550533|NCT01107925|41999570|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
19721068|NCT03705494|42164276|FG000|Overall Study|Lost to Follow-up|2|||
19721069|NCT03705494|42164277|FG001|Overall Study|Lost to Follow-up|1|||
19721070|NCT03705494|42164276|FG000|Overall Study|Withdrawal by Subject|5|||
19721071|NCT03705494|42164277|FG001|Overall Study|Withdrawal by Subject|2|||
19721072|NCT01431508|42164283|FG000|Overall Study|Lack of Efficacy|1|||
19721073|NCT01431508|42164283|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
19721074|NCT00654628|42164287|FG000|6-week Active Treatment Period|Adverse Event|9|||
19721075|NCT00654628|42164287|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
19721076|NCT00654628|42164287|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
19721077|NCT00654628|42164287|FG000|6-week Active Treatment Period|Out of window period|1|||
19721078|NCT00654628|42164287|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
19721079|NCT00654628|42164287|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
19721080|NCT00536380|42164294|FG000|Overall Study|Adverse Event|0|||
19721081|NCT00536380|42164295|FG001|Overall Study|Adverse Event|2|||
19721082|NCT00536380|42164296|FG002|Overall Study|Adverse Event|2|||
19721083|NCT00536380|42164294|FG000|Overall Study|Lost to Follow-up|0|||
19721084|NCT00536380|42164295|FG001|Overall Study|Lost to Follow-up|0|||
19721085|NCT00536380|42164296|FG002|Overall Study|Lost to Follow-up|1|||
19721086|NCT00536380|42164294|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
19721087|NCT00536380|42164295|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
19721088|NCT00536380|42164296|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
19721089|NCT00536380|42164294|FG000|Overall Study|Withdrawal related to study drug|7|||
19721090|NCT00536380|42164295|FG001|Overall Study|Withdrawal related to study drug|5|||
19721091|NCT00536380|42164296|FG002|Overall Study|Withdrawal related to study drug|2|||
19721092|NCT00536380|42164294|FG000|Overall Study|Noncompliance with protocol|3|||
19721093|NCT00536380|42164295|FG001|Overall Study|Noncompliance with protocol|2|||
19721094|NCT00536380|42164296|FG002|Overall Study|Noncompliance with protocol|2|||
19721095|NCT00536380|42164294|FG000|Overall Study|Did not meet protocol eligibility|0|||
19721096|NCT00536380|42164295|FG001|Overall Study|Did not meet protocol eligibility|0|||
19721097|NCT00536380|42164296|FG002|Overall Study|Did not meet protocol eligibility|1|||
19721098|NCT00536380|42164294|FG000|Overall Study|Administrative|0|||
19721099|NCT00536380|42164295|FG001|Overall Study|Administrative|0|||
19721100|NCT00536380|42164296|FG002|Overall Study|Administrative|1|||
19721101|NCT00496834|42164306|FG000|Overall Study|Withdrawal by Subject|4|||
19721102|NCT00496834|42164307|FG001|Overall Study|Withdrawal by Subject|6|||
19721103|NCT00496834|42164306|FG000|Overall Study|Contraindicated medication administered|0|||
19721104|NCT00496834|42164307|FG001|Overall Study|Contraindicated medication administered|1|||
19721105|NCT00496834|42164306|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
19721106|NCT00496834|42164307|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
19721107|NCT00496834|42164306|FG000|Overall Study|Adverse Event|5|||
19721108|NCT00496834|42164307|FG001|Overall Study|Adverse Event|3|||
19721109|NCT00496834|42164306|FG000|Overall Study|IP administration violation|2|||
19721110|NCT00496834|42164307|FG001|Overall Study|IP administration violation|0|||
19721111|NCT00496834|42164306|FG000|Overall Study|Lost to Follow-up|2|||
19721112|NCT00496834|42164307|FG001|Overall Study|Lost to Follow-up|0|||
19721113|NCT00496834|42164306|FG000|Overall Study|Blood Pressure control failure|2|||
19721114|NCT00496834|42164307|FG001|Overall Study|Blood Pressure control failure|1|||
19721115|NCT05244122|42164315|FG000|Overall Study|Withdrawal by Subject|318|||
19721116|NCT00166504|42164336|FG000|Overall Study|Adverse Event|3|||
19721117|NCT00166504|42164337|FG001|Overall Study|Adverse Event|3|||
19721118|NCT00166504|42164336|FG000|Overall Study|Lost to Follow-up|1|||
19721119|NCT00166504|42164337|FG001|Overall Study|Lost to Follow-up|1|||
19721120|NCT00166504|42164336|FG000|Overall Study|Withdrawal by Subject|1|||
19721121|NCT00166504|42164337|FG001|Overall Study|Withdrawal by Subject|0|||
19721122|NCT03137992|42164343|FG000|Washout Period 1|Adverse Event|1|||
19721123|NCT03137992|42164344|FG001|Washout Period 1|Adverse Event|1|||
19721124|NCT03137992|42164345|FG002|Washout Period 1|Adverse Event|0|||
19721125|NCT03137992|42164346|FG003|Washout Period 1|Adverse Event|0|||
19721126|NCT03137992|42164347|FG004|Washout Period 1|Adverse Event|0|||
19721127|NCT03137992|42164348|FG005|Washout Period 1|Adverse Event|1|||
19721128|NCT03137992|42164343|FG000|Washout Period 1|Withdrawal by Subject|0|||
19721129|NCT03137992|42164344|FG001|Washout Period 1|Withdrawal by Subject|1|||
19721130|NCT03137992|42164345|FG002|Washout Period 1|Withdrawal by Subject|1|||
19721131|NCT03137992|42164346|FG003|Washout Period 1|Withdrawal by Subject|0|||
19721132|NCT03137992|42164347|FG004|Washout Period 1|Withdrawal by Subject|0|||
19721133|NCT03137992|42164348|FG005|Washout Period 1|Withdrawal by Subject|0|||
19721134|NCT03137992|42164343|FG000|Washout Period 1|Principal Investigator Discretion|0|||
19721135|NCT03137992|42164344|FG001|Washout Period 1|Principal Investigator Discretion|1|||
19721136|NCT03137992|42164345|FG002|Washout Period 1|Principal Investigator Discretion|0|||
19721137|NCT03137992|42164346|FG003|Washout Period 1|Principal Investigator Discretion|0|||
19721138|NCT03137992|42164347|FG004|Washout Period 1|Principal Investigator Discretion|0|||
19721139|NCT03137992|42164348|FG005|Washout Period 1|Principal Investigator Discretion|0|||
19721140|NCT03137992|42164343|FG000|Washout Period 1|COPD Exacerbation|1|||
19721141|NCT03137992|42164344|FG001|Washout Period 1|COPD Exacerbation|1|||
19721142|NCT03137992|42164345|FG002|Washout Period 1|COPD Exacerbation|1|||
19721143|NCT03137992|42164346|FG003|Washout Period 1|COPD Exacerbation|0|||
19721144|NCT03137992|42164347|FG004|Washout Period 1|COPD Exacerbation|1|||
19721145|NCT03137992|42164348|FG005|Washout Period 1|COPD Exacerbation|1|||
19721146|NCT03137992|42164343|FG000|Washout Period 1|Subject Noncompliance|1|||
19721147|NCT03137992|42164344|FG001|Washout Period 1|Subject Noncompliance|0|||
19721148|NCT03137992|42164345|FG002|Washout Period 1|Subject Noncompliance|0|||
19721149|NCT03137992|42164346|FG003|Washout Period 1|Subject Noncompliance|0|||
19721150|NCT03137992|42164347|FG004|Washout Period 1|Subject Noncompliance|1|||
19721151|NCT03137992|42164348|FG005|Washout Period 1|Subject Noncompliance|0|||
19721152|NCT03137992|42164343|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
19721153|NCT03137992|42164344|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
19721154|NCT03137992|42164345|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
19721155|NCT03137992|42164346|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
19721156|NCT03137992|42164347|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
19721157|NCT03137992|42164348|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
19721158|NCT03137992|42164343|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
19721159|NCT03137992|42164344|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
19721160|NCT03137992|42164345|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
19721161|NCT03137992|42164346|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
19721162|NCT03137992|42164347|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
19721163|NCT03137992|42164348|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
19721164|NCT03137992|42164343|FG000|Period 2 (Visit 3)|Adverse Event|0|||
19721165|NCT03137992|42164344|FG001|Period 2 (Visit 3)|Adverse Event|1|||
19721166|NCT03137992|42164345|FG002|Period 2 (Visit 3)|Adverse Event|0|||
19721167|NCT03137992|42164346|FG003|Period 2 (Visit 3)|Adverse Event|0|||
19721168|NCT03137992|42164347|FG004|Period 2 (Visit 3)|Adverse Event|0|||
19721169|NCT03137992|42164348|FG005|Period 2 (Visit 3)|Adverse Event|0|||
19721170|NCT03137992|42164343|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
19721171|NCT03137992|42164344|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
19721172|NCT03137992|42164345|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
19721173|NCT03137992|42164346|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
19721174|NCT03137992|42164347|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
19721175|NCT03137992|42164348|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
19721176|NCT03137992|42164343|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
19721177|NCT03137992|42164344|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
19721178|NCT03137992|42164345|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
19721179|NCT03137992|42164346|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
19721180|NCT03137992|42164347|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
19721181|NCT03137992|42164348|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
19721182|NCT03137992|42164343|FG000|Washout Period 2|COPD Exacerbation|1|||
19721183|NCT03137992|42164344|FG001|Washout Period 2|COPD Exacerbation|1|||
19721184|NCT03137992|42164345|FG002|Washout Period 2|COPD Exacerbation|0|||
19721185|NCT03137992|42164346|FG003|Washout Period 2|COPD Exacerbation|0|||
19721186|NCT03137992|42164347|FG004|Washout Period 2|COPD Exacerbation|1|||
19721187|NCT03137992|42164348|FG005|Washout Period 2|COPD Exacerbation|0|||
19721188|NCT03137992|42164343|FG000|Washout Period 2|Subject Non-compliance|0|||
19721189|NCT03137992|42164344|FG001|Washout Period 2|Subject Non-compliance|1|||
19721190|NCT03137992|42164345|FG002|Washout Period 2|Subject Non-compliance|0|||
19721191|NCT03137992|42164346|FG003|Washout Period 2|Subject Non-compliance|0|||
19721192|NCT03137992|42164347|FG004|Washout Period 2|Subject Non-compliance|0|||
19721193|NCT03137992|42164348|FG005|Washout Period 2|Subject Non-compliance|0|||
19721194|NCT03137992|42164343|FG000|Washout Period 2|Adverse Event|0|||
19721195|NCT03137992|42164344|FG001|Washout Period 2|Adverse Event|0|||
19721196|NCT03137992|42164345|FG002|Washout Period 2|Adverse Event|0|||
19721197|NCT03137992|42164346|FG003|Washout Period 2|Adverse Event|1|||
19721198|NCT03137992|42164347|FG004|Washout Period 2|Adverse Event|1|||
19721199|NCT03137992|42164348|FG005|Washout Period 2|Adverse Event|0|||
19721200|NCT03137992|42164343|FG000|Washout Period 2|Withdrawal by Subject|1|||
19721201|NCT03137992|42164344|FG001|Washout Period 2|Withdrawal by Subject|0|||
19721202|NCT03137992|42164345|FG002|Washout Period 2|Withdrawal by Subject|0|||
19721203|NCT03137992|42164346|FG003|Washout Period 2|Withdrawal by Subject|0|||
19721204|NCT03137992|42164347|FG004|Washout Period 2|Withdrawal by Subject|1|||
19721205|NCT03137992|42164348|FG005|Washout Period 2|Withdrawal by Subject|0|||
19721206|NCT03137992|42164343|FG000|Washout Period 2|Sponsor Decision|0|||
19721207|NCT03137992|42164344|FG001|Washout Period 2|Sponsor Decision|0|||
19721208|NCT03137992|42164345|FG002|Washout Period 2|Sponsor Decision|0|||
19721209|NCT03137992|42164346|FG003|Washout Period 2|Sponsor Decision|0|||
19721210|NCT03137992|42164347|FG004|Washout Period 2|Sponsor Decision|0|||
19721211|NCT03137992|42164348|FG005|Washout Period 2|Sponsor Decision|1|||
19721212|NCT03137992|42164343|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
19721213|NCT03137992|42164344|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
19721214|NCT03137992|42164345|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
19721215|NCT03137992|42164346|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
19721216|NCT03137992|42164347|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
19721217|NCT03137992|42164348|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
19721218|NCT03137992|42164343|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
19721219|NCT03137992|42164344|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
19721220|NCT03137992|42164345|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
19721221|NCT03137992|42164346|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
19721222|NCT03137992|42164347|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
19721223|NCT03137992|42164348|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
19721224|NCT03137992|42164343|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
19721225|NCT03137992|42164344|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
19721226|NCT03137992|42164345|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
19721227|NCT03137992|42164346|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
19721228|NCT03137992|42164347|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
19721229|NCT03137992|42164348|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
19721230|NCT03137992|42164343|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
19721231|NCT03137992|42164344|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
19721232|NCT03137992|42164345|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
19721233|NCT03137992|42164346|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
19721234|NCT03137992|42164347|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
19721235|NCT03137992|42164348|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
19721236|NCT03137992|42164343|FG000|Part 2 (Open-label Extension)|Per study team|1|||
19721237|NCT03137992|42164344|FG001|Part 2 (Open-label Extension)|Per study team|0|||
19721238|NCT03137992|42164345|FG002|Part 2 (Open-label Extension)|Per study team|0|||
19721239|NCT03137992|42164346|FG003|Part 2 (Open-label Extension)|Per study team|0|||
19721240|NCT03137992|42164347|FG004|Part 2 (Open-label Extension)|Per study team|0|||
19721241|NCT03137992|42164348|FG005|Part 2 (Open-label Extension)|Per study team|0|||
19721242|NCT03137992|42164343|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
19721243|NCT03137992|42164344|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
19721244|NCT03137992|42164345|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
19721245|NCT03137992|42164346|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
19721246|NCT03137992|42164347|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
19721247|NCT03137992|42164348|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
19721248|NCT03703466|42164359|FG000|Overall Study|Death|2|||
19721249|NCT03703466|42164360|FG001|Overall Study|Death|1|||
19721250|NCT03703466|42164361|FG002|Overall Study|Death|0|||
19721251|NCT03703466|42164359|FG000|Overall Study|Protocol Violation|1|||
19721252|NCT03703466|42164360|FG001|Overall Study|Protocol Violation|0|||
19721253|NCT03703466|42164361|FG002|Overall Study|Protocol Violation|0|||
19721254|NCT03703466|42164359|FG000|Overall Study|Withdrawal by Subject|0|||
19721255|NCT03703466|42164360|FG001|Overall Study|Withdrawal by Subject|3|||
19721256|NCT03703466|42164361|FG002|Overall Study|Withdrawal by Subject|0|||
19721257|NCT03703466|42164359|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
19721258|NCT03703466|42164360|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
19721259|NCT03703466|42164361|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
19721260|NCT03704636|42164370|FG000|Overall Study|Inadequate Venous Flow|3|||
19721261|NCT05096312|42164385|FG000|Overall Study|Lost to Follow-up|2|||
19721262|NCT05096312|42164386|FG001|Overall Study|Lost to Follow-up|4|||
19721263|NCT05096312|42164385|FG000|Overall Study|Adverse Event|1|||
19721264|NCT05096312|42164386|FG001|Overall Study|Adverse Event|0|||
19721265|NCT04908488|42164394|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
19721266|NCT04908488|42164395|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
19721267|NCT04908488|42164394|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
19721268|NCT04908488|42164395|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
19721269|NCT04876274|42164406|FG000|Overall Study|Lost to Follow-up|9|||
19721270|NCT04876274|42164407|FG001|Overall Study|Lost to Follow-up|12|||
19721271|NCT04865354|42164415|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
19721272|NCT04865354|42164416|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
19721273|NCT04865354|42164415|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
19721274|NCT04865354|42164416|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
19721275|NCT04865354|42164415|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
19721276|NCT04865354|42164416|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
19721277|NCT04860518|42164427|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
19721278|NCT04860518|42164428|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
19721279|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
19721280|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
19721281|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
19721282|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
19721283|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
19721284|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
19721285|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19721286|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
19721287|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
19721288|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
19721289|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
19721290|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
19721291|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
19550534|NCT01107925|41999565|FG000|Period 2|Withdrawal by Subject|0|||
19550535|NCT01107925|41999566|FG001|Period 2|Withdrawal by Subject|1|||
19721292|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
19721293|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
19721294|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
19721295|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Death|2|||
19721296|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Death|1|||
19721297|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Death|0|||
19721298|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Death|0|||
19721299|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
19721300|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
19721301|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
19721302|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
19721303|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
19721304|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
19721305|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
19721306|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
19721307|NCT03110380|42164436|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
19721308|NCT03110380|42164437|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
19721309|NCT03110380|42164438|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
19721310|NCT03110380|42164439|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
19721311|NCT03110380|42164436|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
19721312|NCT03110380|42164437|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
19721313|NCT03110380|42164438|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
19721314|NCT03110380|42164439|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
19721315|NCT03110380|42164436|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
19721316|NCT03110380|42164437|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
19721317|NCT03110380|42164438|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
19721318|NCT03110380|42164439|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
19721319|NCT03110380|42164436|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
19721320|NCT03110380|42164437|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
19721321|NCT03110380|42164438|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
19721322|NCT03110380|42164439|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
19721323|NCT04851314|42164449|FG000|Overall Study|Unable to complete research set-up procedures|0|||
19721324|NCT04851314|42164450|FG001|Overall Study|Unable to complete research set-up procedures|2|||
19721325|NCT04851314|42164449|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
19721326|NCT04851314|42164450|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
19721327|NCT04848662|42164458|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
19721328|NCT04848662|42164459|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
19721329|NCT03701516|42164465|FG000|Period 1|Lost to Follow-up|0|||
19721330|NCT03701516|42164466|FG001|Period 1|Lost to Follow-up|1|||
19721331|NCT03701516|42164465|FG000|Period 1|Adverse Event|0|||
19721332|NCT03701516|42164466|FG001|Period 1|Adverse Event|2|||
19721333|NCT03701516|42164465|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
19721334|NCT03701516|42164466|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
19721335|NCT03701516|42164465|FG000|Period 1|Non Compliance to Protocol|2|||
19721336|NCT03701516|42164466|FG001|Period 1|Non Compliance to Protocol|1|||
19721337|NCT03701516|42164465|FG000|Period 1|Withdrawal by Subject|0|||
19721338|NCT03701516|42164466|FG001|Period 1|Withdrawal by Subject|1|||
19721339|NCT03701516|42164465|FG000|Period 2|failed to meet all eligibility creiteria|1|||
19721340|NCT03701516|42164466|FG001|Period 2|failed to meet all eligibility creiteria|0|||
19721341|NCT03701516|42164465|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
19721342|NCT03701516|42164466|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
19721343|NCT03700892|42164474|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
19721344|NCT03700892|42164475|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
19721345|NCT03700892|42164476|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
19721346|NCT03700736|42164487|FG000|Overall Study|Pregnancy|1|||
19721347|NCT03700736|42164488|FG001|Overall Study|Pregnancy|1|||
19721348|NCT03700736|42164487|FG000|Overall Study|Withdrawal by Subject|2|||
19721349|NCT03700736|42164488|FG001|Overall Study|Withdrawal by Subject|6|||
19721350|NCT04737278|42164499|FG000|Overall Study|Lost to Follow-up|1|||
19721351|NCT04737278|42164500|FG001|Overall Study|Lost to Follow-up|1|||
19721352|NCT04737278|42164499|FG000|Overall Study|Withdrawal by Subject|1|||
19721353|NCT04737278|42164500|FG001|Overall Study|Withdrawal by Subject|0|||
19721354|NCT04737278|42164499|FG000|Overall Study|Protocol Violation|1|||
19721355|NCT04737278|42164500|FG001|Overall Study|Protocol Violation|1|||
19721356|NCT04737278|42164499|FG000|Overall Study|failure to complete questionnaire|1|||
19721357|NCT04737278|42164500|FG001|Overall Study|failure to complete questionnaire|1|||
19721358|NCT04725500|42164506|FG000|Screening|Screen Failure|26|||
19721359|NCT04725500|42164506|FG000|Screening|Withdrawal by Subject|1|||
19550536|NCT01107925|41999567|FG002|Period 2|Withdrawal by Subject|0|||
19721360|NCT04725500|42164506|FG000|2 Week Take Home|Screen Fail|5|||
19721361|NCT04684394|42164512|FG000|Overall Study|Death|1|||
19721362|NCT04684394|42164513|FG001|Overall Study|Death|2|||
19721363|NCT04684394|42164512|FG000|Overall Study|Lost to Follow-up|1|||
19721364|NCT04684394|42164513|FG001|Overall Study|Lost to Follow-up|0|||
19721365|NCT04684394|42164512|FG000|Overall Study|Withdrawal by Subject|2|||
19721366|NCT04684394|42164513|FG001|Overall Study|Withdrawal by Subject|0|||
19721367|NCT04684394|42164512|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
19721368|NCT04684394|42164513|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
19721369|NCT04674644|42164519|FG000|Overall Study|with missing data|37|||
19721370|NCT04668950|42164526|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
19721371|NCT04668950|42164527|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
19721372|NCT04668950|42164526|FG000|Overall Study|Could not confirm started study medication|15|||
19721373|NCT04668950|42164527|FG001|Overall Study|Could not confirm started study medication|15|||
19721374|NCT04668950|42164526|FG000|Overall Study|Could not confirm baseline status|6|||
19721375|NCT04668950|42164527|FG001|Overall Study|Could not confirm baseline status|2|||
19721376|NCT04668950|42164526|FG000|Overall Study|Drop out and did not start medication|15|||
19721377|NCT04668950|42164527|FG001|Overall Study|Drop out and did not start medication|17|||
19721378|NCT04668950|42164526|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
19721379|NCT04668950|42164527|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
19721380|NCT04668950|42164526|FG000|Overall Study|Other|2|||
19721381|NCT04668950|42164527|FG001|Overall Study|Other|4|||
19721382|NCT03078478|42164535|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
19721383|NCT03078478|42164536|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
19721384|NCT03078478|42164535|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
19721385|NCT03078478|42164536|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
19721386|NCT03078478|42164535|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
19721387|NCT03078478|42164536|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
19721388|NCT03078478|42164535|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
19721389|NCT03078478|42164536|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
19721390|NCT03078478|42164535|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
19721391|NCT03078478|42164536|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
19721392|NCT03078478|42164535|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
19721393|NCT03078478|42164536|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
19721394|NCT03078478|42164535|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
19721395|NCT03078478|42164536|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
19721396|NCT03078478|42164535|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
19721397|NCT03078478|42164536|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
19721398|NCT03539458|42164542|FG000|Overall Study|Death|1|||
19721399|NCT02879578|42164549|FG000|Overall Study|Adverse Event|1|||
19721400|NCT02879578|42164550|FG001|Overall Study|Adverse Event|2|||
19721401|NCT02879578|42164551|FG002|Overall Study|Adverse Event|14|||
19721402|NCT02879578|42164549|FG000|Overall Study|Protocol Violation|0|||
19721403|NCT02879578|42164550|FG001|Overall Study|Protocol Violation|1|||
19721404|NCT02879578|42164551|FG002|Overall Study|Protocol Violation|1|||
19721405|NCT02879578|42164549|FG000|Overall Study|Withdrawal by Subject|8|||
19721406|NCT02879578|42164550|FG001|Overall Study|Withdrawal by Subject|6|||
19721407|NCT02879578|42164551|FG002|Overall Study|Withdrawal by Subject|9|||
19721408|NCT02879578|42164549|FG000|Overall Study|Lost to Follow-up|1|||
19721409|NCT02879578|42164550|FG001|Overall Study|Lost to Follow-up|0|||
19721410|NCT02879578|42164551|FG002|Overall Study|Lost to Follow-up|4|||
19721411|NCT02879578|42164549|FG000|Overall Study|Physician Decision|0|||
19721412|NCT02879578|42164550|FG001|Overall Study|Physician Decision|0|||
19721413|NCT02879578|42164551|FG002|Overall Study|Physician Decision|4|||
19721414|NCT00045942|42164568|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
19721415|NCT00045942|42164569|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721416|NCT00045942|42164570|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721417|NCT00045942|42164571|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721418|NCT00045942|42164572|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721419|NCT00045942|42164573|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721420|NCT00045942|42164574|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721421|NCT00045942|42164575|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721422|NCT00045942|42164576|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
19721423|NCT00045942|42164568|FG000|PKC412A2104 (Core)|Adverse Event|5|||
19721424|NCT00045942|42164569|FG001|PKC412A2104 (Core)|Adverse Event|0|||
19721425|NCT00045942|42164570|FG002|PKC412A2104 (Core)|Adverse Event|0|||
19721426|NCT00045942|42164571|FG003|PKC412A2104 (Core)|Adverse Event|0|||
19721427|NCT00045942|42164572|FG004|PKC412A2104 (Core)|Adverse Event|0|||
19721428|NCT00045942|42164573|FG005|PKC412A2104 (Core)|Adverse Event|0|||
19721429|NCT00045942|42164574|FG006|PKC412A2104 (Core)|Adverse Event|0|||
19721430|NCT00045942|42164575|FG007|PKC412A2104 (Core)|Adverse Event|0|||
19721431|NCT00045942|42164576|FG008|PKC412A2104 (Core)|Adverse Event|0|||
19721432|NCT00045942|42164568|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
19721433|NCT00045942|42164569|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721434|NCT00045942|42164570|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721435|NCT00045942|42164571|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721436|NCT00045942|42164572|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721437|NCT00045942|42164573|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721438|NCT00045942|42164574|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721439|NCT00045942|42164575|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721440|NCT00045942|42164576|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
19721441|NCT00045942|42164568|FG000|PKC412A2104 (Core)|Death|1|||
19721442|NCT00045942|42164569|FG001|PKC412A2104 (Core)|Death|0|||
19721443|NCT00045942|42164570|FG002|PKC412A2104 (Core)|Death|0|||
19721444|NCT00045942|42164571|FG003|PKC412A2104 (Core)|Death|0|||
19721445|NCT00045942|42164572|FG004|PKC412A2104 (Core)|Death|0|||
19721446|NCT00045942|42164573|FG005|PKC412A2104 (Core)|Death|0|||
19721447|NCT00045942|42164574|FG006|PKC412A2104 (Core)|Death|0|||
19721448|NCT00045942|42164575|FG007|PKC412A2104 (Core)|Death|0|||
19721449|NCT00045942|42164576|FG008|PKC412A2104 (Core)|Death|0|||
19721450|NCT00045942|42164568|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
19721451|NCT00045942|42164569|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
19721452|NCT00045942|42164570|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
19721453|NCT00045942|42164571|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
19721454|NCT00045942|42164572|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
19721455|NCT00045942|42164573|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
19721456|NCT00045942|42164574|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
19721457|NCT00045942|42164575|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
19721458|NCT00045942|42164576|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
19721459|NCT00045942|42164568|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
19721460|NCT00045942|42164569|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
19721461|NCT00045942|42164570|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
19721462|NCT00045942|42164571|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
19721463|NCT00045942|42164572|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
19721464|NCT00045942|42164573|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
19721465|NCT00045942|42164574|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
19721466|NCT00045942|42164575|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
19721467|NCT00045942|42164576|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
19721468|NCT00045942|42164568|FG000|PKC412A2104E1|Lack of Efficacy|0|||
19721469|NCT00045942|42164569|FG001|PKC412A2104E1|Lack of Efficacy|11|||
19721470|NCT00045942|42164570|FG002|PKC412A2104E1|Lack of Efficacy|11|||
19721471|NCT00045942|42164571|FG003|PKC412A2104E1|Lack of Efficacy|23|||
19721472|NCT00045942|42164572|FG004|PKC412A2104E1|Lack of Efficacy|17|||
19721473|NCT00045942|42164573|FG005|PKC412A2104E1|Lack of Efficacy|0|||
19721474|NCT00045942|42164574|FG006|PKC412A2104E1|Lack of Efficacy|0|||
19721475|NCT00045942|42164575|FG007|PKC412A2104E1|Lack of Efficacy|0|||
19721476|NCT00045942|42164576|FG008|PKC412A2104E1|Lack of Efficacy|0|||
19721477|NCT00045942|42164568|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
19721478|NCT00045942|42164569|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
19721479|NCT00045942|42164570|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
19721480|NCT00045942|42164571|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
19721481|NCT00045942|42164572|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
19721482|NCT00045942|42164573|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
19721483|NCT00045942|42164574|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
19721484|NCT00045942|42164575|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
19721485|NCT00045942|42164576|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
19721486|NCT00045942|42164568|FG000|PKC412A2104E1|Adverse Event|0|||
19721487|NCT00045942|42164569|FG001|PKC412A2104E1|Adverse Event|1|||
19721488|NCT00045942|42164570|FG002|PKC412A2104E1|Adverse Event|1|||
19721489|NCT00045942|42164571|FG003|PKC412A2104E1|Adverse Event|3|||
19721490|NCT00045942|42164572|FG004|PKC412A2104E1|Adverse Event|6|||
19721491|NCT00045942|42164573|FG005|PKC412A2104E1|Adverse Event|0|||
19721492|NCT00045942|42164574|FG006|PKC412A2104E1|Adverse Event|0|||
19721493|NCT00045942|42164575|FG007|PKC412A2104E1|Adverse Event|0|||
19721494|NCT00045942|42164576|FG008|PKC412A2104E1|Adverse Event|0|||
19721495|NCT00045942|42164568|FG000|PKC412A2104E1|Death|0|||
19721496|NCT00045942|42164569|FG001|PKC412A2104E1|Death|4|||
19721497|NCT00045942|42164570|FG002|PKC412A2104E1|Death|1|||
19721498|NCT00045942|42164571|FG003|PKC412A2104E1|Death|1|||
19721499|NCT00045942|42164572|FG004|PKC412A2104E1|Death|1|||
19721500|NCT00045942|42164573|FG005|PKC412A2104E1|Death|0|||
19721501|NCT00045942|42164574|FG006|PKC412A2104E1|Death|0|||
19721502|NCT00045942|42164575|FG007|PKC412A2104E1|Death|0|||
19721503|NCT00045942|42164576|FG008|PKC412A2104E1|Death|0|||
19721504|NCT00045942|42164568|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721505|NCT00045942|42164569|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721506|NCT00045942|42164570|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
19721507|NCT00045942|42164571|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
19721508|NCT00045942|42164572|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721509|NCT00045942|42164573|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721510|NCT00045942|42164574|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19550537|NCT01107925|41999568|FG003|Period 2|Withdrawal by Subject|0|||
19721511|NCT00045942|42164575|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721512|NCT00045942|42164576|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
19721513|NCT00045942|42164568|FG000|PKC412A2104E2|Lost to Follow-up|0|||
19721514|NCT00045942|42164569|FG001|PKC412A2104E2|Lost to Follow-up|0|||
19721515|NCT00045942|42164570|FG002|PKC412A2104E2|Lost to Follow-up|0|||
19721516|NCT00045942|42164571|FG003|PKC412A2104E2|Lost to Follow-up|0|||
19721517|NCT00045942|42164572|FG004|PKC412A2104E2|Lost to Follow-up|0|||
19721518|NCT00045942|42164573|FG005|PKC412A2104E2|Lost to Follow-up|0|||
19721519|NCT00045942|42164574|FG006|PKC412A2104E2|Lost to Follow-up|0|||
19721520|NCT00045942|42164575|FG007|PKC412A2104E2|Lost to Follow-up|3|||
19721521|NCT00045942|42164576|FG008|PKC412A2104E2|Lost to Follow-up|0|||
19721522|NCT00045942|42164568|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
19721523|NCT00045942|42164569|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
19721524|NCT00045942|42164570|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
19721525|NCT00045942|42164571|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
19721526|NCT00045942|42164572|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
19721527|NCT00045942|42164573|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
19721528|NCT00045942|42164574|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
19721529|NCT00045942|42164575|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
19721530|NCT00045942|42164576|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
19721531|NCT00045942|42164568|FG000|PKC412A2104E2|Lack of Efficacy|0|||
19721532|NCT00045942|42164569|FG001|PKC412A2104E2|Lack of Efficacy|0|||
19721533|NCT00045942|42164570|FG002|PKC412A2104E2|Lack of Efficacy|0|||
19721534|NCT00045942|42164571|FG003|PKC412A2104E2|Lack of Efficacy|0|||
19721535|NCT00045942|42164572|FG004|PKC412A2104E2|Lack of Efficacy|0|||
19721536|NCT00045942|42164573|FG005|PKC412A2104E2|Lack of Efficacy|3|||
19721537|NCT00045942|42164574|FG006|PKC412A2104E2|Lack of Efficacy|2|||
19721538|NCT00045942|42164575|FG007|PKC412A2104E2|Lack of Efficacy|2|||
19721539|NCT00045942|42164576|FG008|PKC412A2104E2|Lack of Efficacy|6|||
19721540|NCT00045942|42164568|FG000|PKC412A2104E2|Adverse Event|0|||
19721541|NCT00045942|42164569|FG001|PKC412A2104E2|Adverse Event|0|||
19721542|NCT00045942|42164570|FG002|PKC412A2104E2|Adverse Event|0|||
19721543|NCT00045942|42164571|FG003|PKC412A2104E2|Adverse Event|0|||
19721544|NCT00045942|42164572|FG004|PKC412A2104E2|Adverse Event|0|||
19721545|NCT00045942|42164573|FG005|PKC412A2104E2|Adverse Event|4|||
19721546|NCT00045942|42164574|FG006|PKC412A2104E2|Adverse Event|3|||
19721547|NCT00045942|42164575|FG007|PKC412A2104E2|Adverse Event|1|||
19721548|NCT00045942|42164576|FG008|PKC412A2104E2|Adverse Event|0|||
19721549|NCT00045942|42164568|FG000|PKC412A2104E2|Death|0|||
19721550|NCT00045942|42164569|FG001|PKC412A2104E2|Death|0|||
19721551|NCT00045942|42164570|FG002|PKC412A2104E2|Death|0|||
19721552|NCT00045942|42164571|FG003|PKC412A2104E2|Death|0|||
19721553|NCT00045942|42164572|FG004|PKC412A2104E2|Death|0|||
19721554|NCT00045942|42164573|FG005|PKC412A2104E2|Death|1|||
19721555|NCT00045942|42164574|FG006|PKC412A2104E2|Death|2|||
19721556|NCT00045942|42164575|FG007|PKC412A2104E2|Death|0|||
19721557|NCT00045942|42164576|FG008|PKC412A2104E2|Death|0|||
19721558|NCT04386616|42164603|FG000|Overall Study|Death|22|||
19721559|NCT04386616|42164604|FG001|Overall Study|Death|22|||
19721560|NCT04386616|42164605|FG002|Overall Study|Death|21|||
19721561|NCT04386616|42164603|FG000|Overall Study|Lost to Follow-up|5|||
19721562|NCT04386616|42164604|FG001|Overall Study|Lost to Follow-up|8|||
19721563|NCT04386616|42164605|FG002|Overall Study|Lost to Follow-up|6|||
19721564|NCT04386616|42164603|FG000|Overall Study|Withdrawal by Subject|2|||
19721565|NCT04386616|42164604|FG001|Overall Study|Withdrawal by Subject|4|||
19721566|NCT04386616|42164605|FG002|Overall Study|Withdrawal by Subject|1|||
19721567|NCT04386616|42164603|FG000|Overall Study|Adverse Event|1|||
19721568|NCT04386616|42164604|FG001|Overall Study|Adverse Event|1|||
19721569|NCT04386616|42164605|FG002|Overall Study|Adverse Event|0|||
19721570|NCT00045708|42164625|FG000|Phase 1|early progressive disease|0|||
19721571|NCT00045708|42164626|FG001|Phase 1|early progressive disease|1|||
19721572|NCT00045708|42164627|FG002|Phase 1|early progressive disease|0|||
19721573|NCT00045630|42164644|FG000|Overall Study|Adverse Event|1|||
19721574|NCT00045630|42164644|FG000|Overall Study|Refusal unrelated to adverse event|1|||
19721575|NCT00045630|42164644|FG000|Overall Study|Progression/relapse|1|||
19721576|NCT00045630|42164644|FG000|Overall Study|Death|1|||
19721577|NCT00045630|42164644|FG000|Overall Study|Ineligible|2|||
19721578|NCT00003702|42164650|FG000|Overall Study|Ineligible cell types|2|||
19721579|NCT00003702|42164651|FG001|Overall Study|Ineligible cell types|2|||
19721580|NCT00003702|42164650|FG000|Overall Study|Did not meet criteria for persistence|8|||
19721581|NCT00003702|42164651|FG001|Overall Study|Did not meet criteria for persistence|5|||
19721582|NCT00003702|42164650|FG000|Overall Study|WHO score > 6|2|||
19550538|NCT01107925|41999569|FG004|Period 2|Withdrawal by Subject|0|||
19721583|NCT00003702|42164651|FG001|Overall Study|WHO score > 6|1|||
19721584|NCT00003702|42164650|FG000|Overall Study|Inadequate documentation of disease|1|||
19721585|NCT00003702|42164651|FG001|Overall Study|Inadequate documentation of disease|3|||
19721586|NCT00031590|42164658|FG000|Overall Study|Adverse Event|1|||
19721587|NCT00031590|42164658|FG000|Overall Study|Withdrawal by parents|2|||
19721588|NCT00239681|42164665|FG000|Overall Study|Adverse Event|100|||
19721589|NCT00239681|42164666|FG001|Overall Study|Adverse Event|99|||
19721590|NCT00239681|42164665|FG000|Overall Study|Withdrawal by Subject|458|||
19721591|NCT00239681|42164666|FG001|Overall Study|Withdrawal by Subject|489|||
19721592|NCT00239681|42164665|FG000|Overall Study|Lost to Follow-up|28|||
19721593|NCT00239681|42164666|FG001|Overall Study|Lost to Follow-up|22|||
19721594|NCT00239681|42164665|FG000|Overall Study|Protocol Violation|4|||
19721595|NCT00239681|42164666|FG001|Overall Study|Protocol Violation|4|||
19721596|NCT00239681|42164665|FG000|Overall Study|Physician Decision|13|||
19721597|NCT00239681|42164666|FG001|Overall Study|Physician Decision|17|||
19721598|NCT00239681|42164665|FG000|Overall Study|No information chacked on CaseReportForm|90|||
19721599|NCT00239681|42164666|FG001|Overall Study|No information chacked on CaseReportForm|84|||
19721600|NCT02878330|42164674|FG000|Overall Study|Death|3|||
19721601|NCT02878330|42164675|FG001|Overall Study|Death|2|||
19721602|NCT02878330|42164674|FG000|Overall Study|Lost to Follow-up|11|||
19721603|NCT02878330|42164675|FG001|Overall Study|Lost to Follow-up|26|||
19721604|NCT02878330|42164674|FG000|Overall Study|Withdrawal by Subject|11|||
19721605|NCT02878330|42164675|FG001|Overall Study|Withdrawal by Subject|21|||
19721606|NCT02878330|42164674|FG000|Overall Study|Other|4|||
19721607|NCT02878330|42164675|FG001|Overall Study|Other|7|||
19721608|NCT00238433|42164682|FG000|Overall Study|Screen failure|1|||
19721609|NCT00238433|42164682|FG000|Overall Study|Lost to Follow-up|1|||
19721610|NCT00238433|42164682|FG000|Overall Study|Death|1|||
19721611|NCT00045162|42164689|FG000|Overall Study|Ineligible|12|||
19721612|NCT00045162|42164690|FG001|Overall Study|Ineligible|8|||
19721613|NCT00045162|42164689|FG000|Overall Study|Not treated|7|||
19721614|NCT00045162|42164690|FG001|Overall Study|Not treated|2|||
19721615|NCT00045162|42164689|FG000|Overall Study|Adverse Event|55|||
19721616|NCT00045162|42164690|FG001|Overall Study|Adverse Event|50|||
19721617|NCT00045162|42164689|FG000|Overall Study|Lack of Efficacy|32|||
19721618|NCT00045162|42164690|FG001|Overall Study|Lack of Efficacy|29|||
19721619|NCT00045162|42164689|FG000|Overall Study|Death|10|||
19721620|NCT00045162|42164690|FG001|Overall Study|Death|10|||
19721621|NCT00045162|42164689|FG000|Overall Study|Withdrawal by Subject|5|||
19721622|NCT00045162|42164690|FG001|Overall Study|Withdrawal by Subject|3|||
19721623|NCT00045162|42164689|FG000|Overall Study|Other|21|||
19721624|NCT00045162|42164690|FG001|Overall Study|Other|16|||
19721625|NCT02748616|42164696|FG000|Overall Study|Lost to Follow-up|1|||
19721626|NCT02748616|42164696|FG000|Overall Study|Withdrawal by Subject|2|||
19721627|NCT02748616|42164696|FG000|Overall Study|Physician Decision|2|||
19721628|NCT02748616|42164696|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
19721629|NCT00238121|42164702|FG000|Overall Study|Withdrawal by Subject|1|||
19721630|NCT00238121|42164703|FG001|Overall Study|Withdrawal by Subject|1|||
19721631|NCT00238121|42164702|FG000|Overall Study|Adverse Event|2|||
19721632|NCT00238121|42164703|FG001|Overall Study|Adverse Event|1|||
19721633|NCT03139552|42164708|FG000|Overall Study|unable to attend tasting due to schedule|3|||
19721634|NCT03804918|42164719|FG000|Overall Study|Participant did not use the app|1|||
19721635|NCT03139240|42164727|FG000|Overall Study|Lost to Follow-up|0|||
19721636|NCT03139240|42164728|FG001|Overall Study|Lost to Follow-up|1|||
19721637|NCT03139240|42164729|FG002|Overall Study|Lost to Follow-up|1|||
19721638|NCT03139240|42164730|FG003|Overall Study|Lost to Follow-up|0|||
19721639|NCT00237809|42164742|FG000|Overall Study|Lost to Follow-up|11|||
19721640|NCT00237809|42164743|FG001|Overall Study|Lost to Follow-up|10|||
19721641|NCT00237809|42164744|FG002|Overall Study|Lost to Follow-up|9|||
19721642|NCT00237809|42164745|FG003|Overall Study|Lost to Follow-up|9|||
19721643|NCT00003498|42164755|FG000|Overall Study|Not evaluable.|4|||
19721644|NCT00003492|42164759|FG000|Overall Study|Not evaluable|6|||
19721645|NCT03136198|42164765|FG000|Overall Study|Withdrawal by Subject|0|||
19721646|NCT03136198|42164766|FG001|Overall Study|Withdrawal by Subject|1|||
19721647|NCT00042666|42164772|FG000|Overall Study|Adverse Event|2|||
19721648|NCT00042666|42164772|FG000|Overall Study|Death|4|||
19721649|NCT00042666|42164772|FG000|Overall Study|Protocol Violation|1|||
19721650|NCT00042666|42164772|FG000|Overall Study|Participant/Physician Perception|1|||
19721651|NCT00042666|42164772|FG000|Overall Study|Progressive Disease|41|||
19721652|NCT00042666|42164772|FG000|Overall Study|Other|1|||
19721653|NCT00042666|42164772|FG000|Overall Study|Other|4|||
19721654|NCT00042432|42164779|FG000|Overall Study|Adverse Event|4|||
19721655|NCT00042432|42164780|FG001|Overall Study|Adverse Event|1|||
19721656|NCT00042432|42164779|FG000|Overall Study|Withdrawal by Subject|1|||
19721657|NCT00042432|42164780|FG001|Overall Study|Withdrawal by Subject|3|||
19721658|NCT00042432|42164779|FG000|Overall Study|Death|0|||
19721659|NCT00042432|42164780|FG001|Overall Study|Death|2|||
19721660|NCT00042432|42164779|FG000|Overall Study|Ineligibility determined|1|||
19721661|NCT00042432|42164780|FG001|Overall Study|Ineligibility determined|0|||
19721662|NCT00042432|42164779|FG000|Overall Study|Initiation of maintenance dialysis|1|||
19721663|NCT00042432|42164780|FG001|Overall Study|Initiation of maintenance dialysis|1|||
19721664|NCT00042432|42164779|FG000|Overall Study|Other|2|||
19721665|NCT00042432|42164780|FG001|Overall Study|Other|0|||
19721666|NCT00003474|42164786|FG000|Overall Study|Not Evaluable|14|||
19721667|NCT01542736|42164790|FG000|Overall Study|Death|1|||
19721668|NCT01346410|42164794|FG000|Overall Study|Death|1|||
19721669|NCT00003456|42164798|FG000|Overall Study|Not evaluable|8|||
19721670|NCT02719522|42164802|FG000|Overall Study|Implant Failure|4|||
19721671|NCT02719522|42164802|FG000|Overall Study|Death|2|||
19721672|NCT02719522|42164802|FG000|Overall Study|Lost to Follow-up|5|||
19721673|NCT00237185|42164808|FG000|Core|Adverse Event|3|||
19721674|NCT00237185|42164809|FG001|Core|Adverse Event|4|||
19721675|NCT00237185|42164808|FG000|Core|Abnormal laboratory value|0|||
19721676|NCT00237185|42164809|FG001|Core|Abnormal laboratory value|4|||
19721677|NCT00237185|42164808|FG000|Core|Abnormal test procedure results|1|||
19721678|NCT00237185|42164809|FG001|Core|Abnormal test procedure results|0|||
19721679|NCT00237185|42164808|FG000|Core|Lack of Efficacy|30|||
19721680|NCT00237185|42164809|FG001|Core|Lack of Efficacy|23|||
19721681|NCT00237185|42164808|FG000|Core|Protocol Violation|1|||
19721682|NCT00237185|42164809|FG001|Core|Protocol Violation|1|||
19721683|NCT00237185|42164808|FG000|Core|Withdrawal by Subject|4|||
19721684|NCT00237185|42164809|FG001|Core|Withdrawal by Subject|4|||
19721685|NCT00237185|42164808|FG000|Core|Administrative problems|0|||
19721686|NCT00237185|42164809|FG001|Core|Administrative problems|1|||
19721687|NCT00237185|42164808|FG000|Core|Death|4|||
19721688|NCT00237185|42164809|FG001|Core|Death|0|||
19721689|NCT00237185|42164808|FG000|Core|Determined ineligible post randomization|1|||
19721690|NCT00237185|42164809|FG001|Core|Determined ineligible post randomization|0|||
19721691|NCT00237185|42164808|FG000|Extension|Adverse Event|1|||
19721692|NCT00237185|42164809|FG001|Extension|Adverse Event|0|||
19721693|NCT00237185|42164808|FG000|Extension|Abnormal laboratory value|0|||
19721694|NCT00237185|42164809|FG001|Extension|Abnormal laboratory value|1|||
19721695|NCT00237185|42164808|FG000|Extension|Lack of Efficacy|9|||
19721696|NCT00237185|42164809|FG001|Extension|Lack of Efficacy|14|||
19721697|NCT00237185|42164808|FG000|Extension|Condition no longer required study drug|0|||
19721698|NCT00237185|42164809|FG001|Extension|Condition no longer required study drug|1|||
19721699|NCT00237185|42164808|FG000|Extension|Withdrawal by Subject|3|||
19721700|NCT00237185|42164809|FG001|Extension|Withdrawal by Subject|2|||
19721701|NCT00237185|42164808|FG000|Extension|Lost to Follow-up|1|||
19721702|NCT00237185|42164809|FG001|Extension|Lost to Follow-up|0|||
19721703|NCT00237185|42164808|FG000|Extension|Administrative problems|1|||
19721704|NCT00237185|42164809|FG001|Extension|Administrative problems|0|||
19721705|NCT00237185|42164808|FG000|Extension|Death|1|||
19721706|NCT00237185|42164809|FG001|Extension|Death|1|||
19721707|NCT00003222|42164817|FG000|Overall Study|Physician Decision|0|||
19721708|NCT00003222|42164818|FG001|Overall Study|Physician Decision|1|||
19721709|NCT02877082|42164824|FG000|Overall Study|Trial was closed early|5|||
19721710|NCT00003138|42164830|FG000|Step 1|Reasons off treatment not documented|60|||
19721711|NCT00003138|42164831|FG001|Step 1|Reasons off treatment not documented|57|||
19721712|NCT00003138|42164830|FG000|Step 1|Never started treatment|1|||
19721713|NCT00003138|42164831|FG001|Step 1|Never started treatment|0|||
19721714|NCT00003138|42164830|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
19721715|NCT00003138|42164831|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
19721716|NCT00003138|42164830|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
19721717|NCT00003138|42164831|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
19721718|NCT00003138|42164830|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
19721719|NCT00003138|42164831|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
19721720|NCT00003138|42164830|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
19721721|NCT00003138|42164831|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
19721722|NCT02875834|42164844|FG000|Open-label Phase|Withdrawal by Subject|3|||
19721723|NCT02875834|42164845|FG001|Open-label Phase|Withdrawal by Subject|0|||
19721724|NCT02875834|42164846|FG002|Open-label Phase|Withdrawal by Subject|0|||
19721725|NCT02875834|42164847|FG003|Open-label Phase|Withdrawal by Subject|0|||
19721726|NCT02875834|42164844|FG000|Open-label Phase|(Not collected)|4|||
19721727|NCT02875834|42164845|FG001|Open-label Phase|(Not collected)|0|||
19721728|NCT02875834|42164846|FG002|Open-label Phase|(Not collected)|0|||
19721729|NCT02875834|42164847|FG003|Open-label Phase|(Not collected)|0|||
19721730|NCT02875834|42164844|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
19721731|NCT02875834|42164845|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
19721732|NCT02875834|42164846|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
19721733|NCT02875834|42164847|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
19721734|NCT02875834|42164844|FG000|Randomized Treatment Phase|Protocol Violation|0|||
19721735|NCT02875834|42164845|FG001|Randomized Treatment Phase|Protocol Violation|2|||
19721736|NCT02875834|42164846|FG002|Randomized Treatment Phase|Protocol Violation|0|||
19721737|NCT02875834|42164847|FG003|Randomized Treatment Phase|Protocol Violation|0|||
19721738|NCT02875834|42164844|FG000|Randomized Treatment Phase|(Not collected)|0|||
19721739|NCT02875834|42164845|FG001|Randomized Treatment Phase|(Not collected)|9|||
19721740|NCT02875834|42164846|FG002|Randomized Treatment Phase|(Not collected)|10|||
19721741|NCT02875834|42164847|FG003|Randomized Treatment Phase|(Not collected)|9|||
19721742|NCT02875366|42164859|FG000|Overall Study|Adverse Event|0|||
19721743|NCT02875366|42164860|FG001|Overall Study|Adverse Event|2|||
19721744|NCT02875366|42164859|FG000|Overall Study|Noncompliance|0|||
19721745|NCT02875366|42164860|FG001|Overall Study|Noncompliance|1|||
19721746|NCT00003102|42164869|FG000|Overall Study|Physician Decision|1|||
19721747|NCT00003102|42164870|FG001|Overall Study|Physician Decision|1|||
19721748|NCT00003102|42164871|FG002|Overall Study|Physician Decision|0|||
19721749|NCT00003102|42164869|FG000|Overall Study|Progressive Disease|0|||
19721750|NCT00003102|42164870|FG001|Overall Study|Progressive Disease|1|||
19721751|NCT00003102|42164871|FG002|Overall Study|Progressive Disease|0|||
19721752|NCT00003102|42164869|FG000|Overall Study|Adverse Event|0|||
19721753|NCT00003102|42164870|FG001|Overall Study|Adverse Event|1|||
19721754|NCT00003102|42164871|FG002|Overall Study|Adverse Event|1|||
19721755|NCT00003102|42164869|FG000|Overall Study|Death|0|||
19721756|NCT00003102|42164870|FG001|Overall Study|Death|0|||
19721757|NCT00003102|42164871|FG002|Overall Study|Death|1|||
19721758|NCT00002850|42164882|FG000|Overall Study|Death|4|||
19721759|NCT00002850|42164883|FG001|Overall Study|Death|1|||
19721760|NCT00002850|42164884|FG002|Overall Study|Death|3|||
19721761|NCT00002850|42164882|FG000|Overall Study|Protocol Violation|1|||
19721762|NCT00002850|42164883|FG001|Overall Study|Protocol Violation|0|||
19721763|NCT00002850|42164884|FG002|Overall Study|Protocol Violation|1|||
19721764|NCT00002850|42164882|FG000|Overall Study|Withdrawal by Subject|0|||
19721765|NCT00002850|42164883|FG001|Overall Study|Withdrawal by Subject|1|||
19721766|NCT00002850|42164884|FG002|Overall Study|Withdrawal by Subject|0|||
19721767|NCT00002766|42164894|FG000|Overall Study|Withdrawal by Subject|0|||
19721768|NCT00002766|42164895|FG001|Overall Study|Withdrawal by Subject|1|||
19721769|NCT00002766|42164894|FG000|Overall Study|Patient Not Treated|1|||
19721770|NCT00002766|42164895|FG001|Overall Study|Patient Not Treated|2|||
19721771|NCT00002766|42164894|FG000|Overall Study|Adverse Event|1|||
19721772|NCT00002766|42164895|FG001|Overall Study|Adverse Event|1|||
19721773|NCT00002766|42164894|FG000|Overall Study|Protocol Violation|1|||
19721774|NCT00002766|42164895|FG001|Overall Study|Protocol Violation|0|||
19721775|NCT02306122|42164908|FG000|Initial Physician Randomization|Physician Decision|0|||
19721776|NCT02306122|42164909|FG001|Initial Physician Randomization|Physician Decision|0|||
19721777|NCT02306122|42164910|FG002|Initial Physician Randomization|Physician Decision|0|||
19721778|NCT02306122|42164911|FG003|Initial Physician Randomization|Physician Decision|0|||
19721779|NCT02306122|42164912|FG004|Initial Physician Randomization|Physician Decision|0|||
19721780|NCT02306122|42164913|FG005|Initial Physician Randomization|Physician Decision|0|||
19721781|NCT02306122|42164914|FG006|Initial Physician Randomization|Physician Decision|0|||
19721782|NCT02306122|42164915|FG007|Initial Physician Randomization|Physician Decision|0|||
19721783|NCT02306122|42164916|FG008|Initial Physician Randomization|Physician Decision|1|||
19721784|NCT02306122|42164917|FG009|Initial Physician Randomization|Physician Decision|0|||
19721785|NCT02306122|42164918|FG010|Initial Physician Randomization|Physician Decision|0|||
19721786|NCT00001962|42164936|FG000|Overall Study|Lack of Efficacy|18|||
19721787|NCT00001962|42164936|FG000|Overall Study|Lack of Accrual|6|||
19721788|NCT00001962|42164936|FG000|Overall Study|Death|1|||
19721789|NCT00001962|42164936|FG000|Overall Study|Lost to Follow-up|2|||
19721790|NCT00001962|42164936|FG000|Overall Study|Adverse Event|1|||
19721791|NCT00028002|42164940|FG000|Overall Study|Withdrawal by Subject|3|||
19721792|NCT00028002|42164940|FG000|Overall Study|Ineligible|8|||
19721793|NCT00256997|42164947|FG000|Overall Study|Protocol Violation|1|||
19721794|NCT00256997|42164948|FG001|Overall Study|Protocol Violation|4|||
19721795|NCT00256997|42164947|FG000|Overall Study|Lack of Efficacy|1|||
19721796|NCT00256997|42164948|FG001|Overall Study|Lack of Efficacy|4|||
19721797|NCT00256997|42164947|FG000|Overall Study|Death|2|||
19721798|NCT00256997|42164948|FG001|Overall Study|Death|0|||
19721799|NCT00256997|42164947|FG000|Overall Study|Adverse Event|4|||
19721800|NCT00256997|42164948|FG001|Overall Study|Adverse Event|0|||
19721801|NCT00256997|42164947|FG000|Overall Study|Lost to Follow-up|3|||
19721802|NCT00256997|42164948|FG001|Overall Study|Lost to Follow-up|5|||
19721803|NCT00256997|42164947|FG000|Overall Study|Withdrawal by Subject|13|||
19721804|NCT00256997|42164948|FG001|Overall Study|Withdrawal by Subject|3|||
19721805|NCT00256997|42164947|FG000|Overall Study|Started but not treated|2|||
19721806|NCT00256997|42164948|FG001|Overall Study|Started but not treated|0|||
19721807|NCT00256997|42164947|FG000|Overall Study|Other|5|||
19721808|NCT00256997|42164948|FG001|Overall Study|Other|8|||
19721809|NCT00256997|42164947|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
19721810|NCT00256997|42164948|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
19721811|NCT00256997|42164947|FG000|Overall Study|Participant Non-compliant|3|||
19721812|NCT00256997|42164948|FG001|Overall Study|Participant Non-compliant|6|||
19721813|NCT00256997|42164947|FG000|Overall Study|Investigator Withdrew Participant|2|||
19721814|NCT00256997|42164948|FG001|Overall Study|Investigator Withdrew Participant|1|||
19721815|NCT00027846|42164958|FG000|Overall Study|Lost to Follow-up|0|||
19721816|NCT00027846|42164959|FG001|Overall Study|Lost to Follow-up|41|||
19721817|NCT00027846|42164960|FG002|Overall Study|Lost to Follow-up|9|||
19721818|NCT00027846|42164958|FG000|Overall Study|Withdrawal by Subject|0|||
19721819|NCT00027846|42164959|FG001|Overall Study|Withdrawal by Subject|14|||
19721820|NCT00027846|42164960|FG002|Overall Study|Withdrawal by Subject|7|||
19721821|NCT00027846|42164958|FG000|Overall Study|Ineligible for study|2|||
19721822|NCT00027846|42164959|FG001|Overall Study|Ineligible for study|6|||
19721823|NCT00027846|42164960|FG002|Overall Study|Ineligible for study|14|||
19721824|NCT00027846|42164958|FG000|Overall Study|Entry into another COG therapeutic study|0|||
19721825|NCT00027846|42164959|FG001|Overall Study|Entry into another COG therapeutic study|5|||
19721826|NCT00027846|42164960|FG002|Overall Study|Entry into another COG therapeutic study|2|||
19721827|NCT00027846|42164958|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
19721828|NCT00027846|42164959|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
19721829|NCT00027846|42164960|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
19721830|NCT00027378|42164972|FG000|Overall Study|Physician Decision|0|||
19721831|NCT00027378|42164973|FG001|Overall Study|Physician Decision|3|||
19721832|NCT00235391|42164985|FG000|Overall Study|Adverse Event|4|||
19721833|NCT00235391|42164986|FG001|Overall Study|Adverse Event|5|||
19721834|NCT00235391|42164987|FG002|Overall Study|Adverse Event|10|||
19721835|NCT00235391|42164988|FG003|Overall Study|Adverse Event|72|||
19721836|NCT00235391|42164989|FG004|Overall Study|Adverse Event|5|||
19721837|NCT00235391|42164990|FG005|Overall Study|Adverse Event|2|||
19721838|NCT00235391|42164985|FG000|Overall Study|Abnormal laboratory value(s)|3|||
19721839|NCT00235391|42164986|FG001|Overall Study|Abnormal laboratory value(s)|5|||
19721840|NCT00235391|42164987|FG002|Overall Study|Abnormal laboratory value(s)|4|||
19721841|NCT00235391|42164988|FG003|Overall Study|Abnormal laboratory value(s)|27|||
19721842|NCT00235391|42164989|FG004|Overall Study|Abnormal laboratory value(s)|1|||
19721843|NCT00235391|42164990|FG005|Overall Study|Abnormal laboratory value(s)|2|||
19721844|NCT00235391|42164985|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
19721845|NCT00235391|42164986|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
19721846|NCT00235391|42164987|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
19721847|NCT00235391|42164988|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
19721848|NCT00235391|42164989|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
19721849|NCT00235391|42164990|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
19721850|NCT00235391|42164985|FG000|Overall Study|Condition no longer requires treatment|3|||
19721851|NCT00235391|42164986|FG001|Overall Study|Condition no longer requires treatment|0|||
19721852|NCT00235391|42164987|FG002|Overall Study|Condition no longer requires treatment|0|||
19721853|NCT00235391|42164988|FG003|Overall Study|Condition no longer requires treatment|11|||
19721854|NCT00235391|42164989|FG004|Overall Study|Condition no longer requires treatment|1|||
19721855|NCT00235391|42164990|FG005|Overall Study|Condition no longer requires treatment|0|||
19721856|NCT00235391|42164985|FG000|Overall Study|Protocol deviation|0|||
19721857|NCT00235391|42164986|FG001|Overall Study|Protocol deviation|0|||
19721858|NCT00235391|42164987|FG002|Overall Study|Protocol deviation|1|||
19721859|NCT00235391|42164988|FG003|Overall Study|Protocol deviation|11|||
19721860|NCT00235391|42164989|FG004|Overall Study|Protocol deviation|0|||
19721861|NCT00235391|42164990|FG005|Overall Study|Protocol deviation|0|||
19721862|NCT00235391|42164985|FG000|Overall Study|Withdrawal by Subject|2|||
19721863|NCT00235391|42164986|FG001|Overall Study|Withdrawal by Subject|3|||
19721864|NCT00235391|42164987|FG002|Overall Study|Withdrawal by Subject|3|||
19721865|NCT00235391|42164988|FG003|Overall Study|Withdrawal by Subject|61|||
19721866|NCT00235391|42164989|FG004|Overall Study|Withdrawal by Subject|5|||
19721867|NCT00235391|42164990|FG005|Overall Study|Withdrawal by Subject|0|||
19721868|NCT00235391|42164985|FG000|Overall Study|Lost to Follow-up|0|||
19721869|NCT00235391|42164986|FG001|Overall Study|Lost to Follow-up|3|||
19721870|NCT00235391|42164987|FG002|Overall Study|Lost to Follow-up|3|||
19721871|NCT00235391|42164988|FG003|Overall Study|Lost to Follow-up|16|||
19721872|NCT00235391|42164989|FG004|Overall Study|Lost to Follow-up|0|||
19721873|NCT00235391|42164990|FG005|Overall Study|Lost to Follow-up|0|||
19721874|NCT00235391|42164985|FG000|Overall Study|Administrative problems|0|||
19721875|NCT00235391|42164986|FG001|Overall Study|Administrative problems|0|||
19721876|NCT00235391|42164987|FG002|Overall Study|Administrative problems|0|||
19721877|NCT00235391|42164988|FG003|Overall Study|Administrative problems|1|||
19721878|NCT00235391|42164989|FG004|Overall Study|Administrative problems|0|||
19721879|NCT00235391|42164990|FG005|Overall Study|Administrative problems|0|||
19721880|NCT00235391|42164985|FG000|Overall Study|Death|0|||
19721881|NCT00235391|42164986|FG001|Overall Study|Death|0|||
19721882|NCT00235391|42164987|FG002|Overall Study|Death|1|||
19721883|NCT00235391|42164988|FG003|Overall Study|Death|4|||
19721884|NCT00235391|42164989|FG004|Overall Study|Death|0|||
19721885|NCT00235391|42164990|FG005|Overall Study|Death|0|||
19721886|NCT00234533|42165034|FG000|Overall Study|Withdrawal by Subject|6|||
19721887|NCT00234533|42165034|FG000|Overall Study|Adverse Event|2|||
19721888|NCT00234533|42165034|FG000|Overall Study|Enrolled but not treated|3|||
19721889|NCT00026208|42165041|FG000|Overall Study|Complications of auto accident|1|||
19721890|NCT00026208|42165042|FG001|Overall Study|Complications of auto accident|0|||
19721891|NCT00025662|42165048|FG000|Overall Study|Withdrawal by Subject|2|||
19721892|NCT00025662|42165048|FG000|Overall Study|Technical failure of manipulation|1|||
19721893|NCT00025506|42165052|FG000|Overall Study|Ineligible: clerical error|1|||
19721894|NCT00025506|42165052|FG000|Overall Study|Ineligible: wrong cell type|5|||
19721895|NCT00025506|42165052|FG000|Overall Study|Ineligible: inadequate pathology|2|||
19721896|NCT00025506|42165052|FG000|Overall Study|Never Treated|2|||
19550539|NCT01107925|41999570|FG005|Period 2|Withdrawal by Subject|1|||
19721897|NCT00024258|42165061|FG000|Overall Study|Withdrawal by Subject|1|||
19721898|NCT00024258|42165061|FG000|Overall Study|Disease Progression|8|||
19721899|NCT00023712|42165067|FG000|Overall Study|Not platinum sensitive|1|||
19721900|NCT00023712|42165068|FG001|Overall Study|Not platinum sensitive|0|||
19721901|NCT00023712|42165067|FG000|Overall Study|Never treated|1|||
19721902|NCT00023712|42165068|FG001|Overall Study|Never treated|1|||
19721903|NCT00023322|42165084|FG000|Overall Study|Lost to Follow-up|1|||
19721904|NCT04640168|42165090|FG000|Overall Study|Withdrawal by Subject|8|||
19721905|NCT04640168|42165091|FG001|Overall Study|Withdrawal by Subject|7|||
19721906|NCT04640168|42165090|FG000|Overall Study|Lost to Follow-up|1|||
19721907|NCT04640168|42165091|FG001|Overall Study|Lost to Follow-up|0|||
19721908|NCT04640168|42165090|FG000|Overall Study|Enrolled but not treated|12|||
19721909|NCT04640168|42165091|FG001|Overall Study|Enrolled but not treated|12|||
19721910|NCT00022698|42165099|FG000|Overall Study|Adverse Event|5|||
19721911|NCT00022698|42165100|FG001|Overall Study|Adverse Event|9|||
19721912|NCT00022698|42165099|FG000|Overall Study|Death|0|||
19721913|NCT00022698|42165100|FG001|Overall Study|Death|2|||
19721914|NCT00022698|42165099|FG000|Overall Study|Failure to return|0|||
19721915|NCT00022698|42165100|FG001|Overall Study|Failure to return|1|||
19721916|NCT00022698|42165099|FG000|Overall Study|Refused treatment|0|||
19721917|NCT00022698|42165100|FG001|Overall Study|Refused treatment|2|||
19721918|NCT00022698|42165099|FG000|Overall Study|Insufficient therapeutic response|2|||
19721919|NCT00022698|42165100|FG001|Overall Study|Insufficient therapeutic response|14|||
19721920|NCT00022698|42165099|FG000|Overall Study|Administrative /other|1|||
19721921|NCT00022698|42165100|FG001|Overall Study|Administrative /other|7|||
19721922|NCT04625972|42165110|FG000|Overall Study|Physician Decision|1|||
19721923|NCT04625972|42165111|FG001|Overall Study|Physician Decision|0|||
19721924|NCT04625972|42165110|FG000|Overall Study|Protocol Violation|0|||
19721925|NCT04625972|42165111|FG001|Overall Study|Protocol Violation|1|||
19721926|NCT04625972|42165110|FG000|Overall Study|Ongoing in Study|741|||
19721927|NCT04625972|42165111|FG001|Overall Study|Ongoing in Study|369|||
19721928|NCT04625972|42165110|FG000|Overall Study|Lost to Follow-up|2|||
19721929|NCT04625972|42165111|FG001|Overall Study|Lost to Follow-up|0|||
19721930|NCT04625972|42165110|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
19721931|NCT04625972|42165111|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
19721932|NCT04625972|42165110|FG000|Overall Study|Withdrawal by Subject|7|||
19721933|NCT04625972|42165111|FG001|Overall Study|Withdrawal by Subject|3|||
19721934|NCT00234065|42165119|FG000|Overall Study|Adverse Event|268|||
19721935|NCT00234065|42165120|FG001|Overall Study|Adverse Event|166|||
19721936|NCT00234065|42165119|FG000|Overall Study|Withdrawal by Subject|73|||
19721937|NCT00234065|42165120|FG001|Overall Study|Withdrawal by Subject|56|||
19721938|NCT00234065|42165119|FG000|Overall Study|Physician Decision|23|||
19721939|NCT00234065|42165120|FG001|Overall Study|Physician Decision|22|||
19721940|NCT00234065|42165119|FG000|Overall Study|Not Classified|111|||
19721941|NCT00234065|42165120|FG001|Overall Study|Not Classified|112|||
19721942|NCT00233987|42165126|FG000|Overall Study|Withdrawal by Subject|1|||
19721943|NCT00233987|42165126|FG000|Overall Study|Lack of Efficacy|2|||
19721944|NCT00233987|42165126|FG000|Overall Study|Reason Under Review|1|||
19721945|NCT00233987|42165126|FG000|Overall Study|Other - Not Protocol Specified|5|||
19721946|NCT00233987|42165126|FG000|Overall Study|Eligible but No Treatment Received|2|||
19721947|NCT00233987|42165126|FG000|Overall Study|Ineligible|4|||
19721948|NCT04623242|42165135|FG000|Overall Study|Withdrawal by Subject|7|||
19721949|NCT04623242|42165136|FG001|Overall Study|Withdrawal by Subject|12|||
19721950|NCT04623242|42165137|FG002|Overall Study|Withdrawal by Subject|5|||
19721951|NCT04623242|42165138|FG003|Overall Study|Withdrawal by Subject|7|||
19721952|NCT04623242|42165139|FG004|Overall Study|Withdrawal by Subject|0|||
19721953|NCT04623242|42165135|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
19721954|NCT04623242|42165136|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
19721955|NCT04623242|42165137|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
19721956|NCT04623242|42165138|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
19721957|NCT04623242|42165139|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
19721958|NCT04623242|42165135|FG000|Overall Study|Subject unblinded to mutation status|0|||
19721959|NCT04623242|42165136|FG001|Overall Study|Subject unblinded to mutation status|0|||
19721960|NCT04623242|42165137|FG002|Overall Study|Subject unblinded to mutation status|0|||
19721961|NCT04623242|42165138|FG003|Overall Study|Subject unblinded to mutation status|13|||
19721962|NCT04623242|42165139|FG004|Overall Study|Subject unblinded to mutation status|0|||
19721963|NCT00233363|42165156|FG000|Overall Study|Adverse Event|1|||
19721964|NCT00233363|42165157|FG001|Overall Study|Adverse Event|2|||
19721965|NCT00233363|42165156|FG000|Overall Study|Lack of Efficacy|0|||
19721966|NCT00233363|42165157|FG001|Overall Study|Lack of Efficacy|2|||
19721967|NCT00233363|42165156|FG000|Overall Study|Withdrawal by Subject|1|||
19721968|NCT00233363|42165157|FG001|Overall Study|Withdrawal by Subject|1|||
19721969|NCT00233363|42165156|FG000|Overall Study|Aggravation of complication|1|||
19550540|NCT01339832|41999598|FG000|Overall Study|Lost to Follow-up|3|||
19721970|NCT00233363|42165157|FG001|Overall Study|Aggravation of complication|0|||
19721971|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
19721972|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
19721973|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
19721974|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721975|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721976|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721977|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721978|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721979|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721980|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721981|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721982|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721983|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
19721984|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721985|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
19721986|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721987|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
19721988|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721989|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721990|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
19721991|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
19721992|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
19721993|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
19721994|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721995|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
19721996|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721997|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19721998|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
19721999|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
19722000|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
19722001|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
19722002|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
19722003|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
19722004|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
19722005|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
19722006|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
19722007|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
19722008|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
19722009|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
19722010|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
19722011|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
19722012|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
19722013|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
19722014|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
19722015|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
19722016|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
19722017|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722018|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722019|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
19722020|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722021|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722022|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722023|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722024|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722025|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722026|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
19722027|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722028|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722029|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722030|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
19722031|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722032|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722033|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722034|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722035|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722036|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722037|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722038|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722039|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722040|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722041|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722042|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722043|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722044|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
19722045|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
19722046|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722047|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722048|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722049|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
19722050|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722051|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722052|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722053|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722054|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722055|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722056|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
19722057|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722058|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722059|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722060|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
19722061|NCT01147666|42165178|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722062|NCT01147666|42165179|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722063|NCT01147666|42165180|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722064|NCT01147666|42165181|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722065|NCT01147666|42165182|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722066|NCT01147666|42165183|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722067|NCT01147666|42165184|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722068|NCT01147666|42165185|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722069|NCT01147666|42165186|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722070|NCT01147666|42165187|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722071|NCT01147666|42165188|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722072|NCT01147666|42165189|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
19722073|NCT01147666|42165190|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
19722074|NCT01147666|42165191|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
19722075|NCT01147666|42165192|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
19722076|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
19722077|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
19722078|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
19722079|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
19722080|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
19722081|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
19722082|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
19722083|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
19722084|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
19722085|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
19722086|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
19722087|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
19722088|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
19722089|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
19722090|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
19722091|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722092|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722093|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722094|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722095|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
19722096|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
19722097|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
19722098|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
19722099|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722100|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
19722101|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722102|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722103|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
19722104|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
19722105|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
19722106|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722107|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722108|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722109|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
19722110|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722111|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722112|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722113|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722114|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722115|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722116|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722117|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722118|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722119|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722120|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
19722121|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722122|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722123|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722124|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722125|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
19722126|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
19722127|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722128|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
19722129|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722130|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
19722131|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722132|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722133|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722134|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
19722135|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
19722136|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722137|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722138|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722139|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
19722140|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722141|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722142|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722143|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722144|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722145|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722146|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
19722147|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722148|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722149|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722150|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
19722151|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722152|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722153|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722154|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722155|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722156|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722157|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722158|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722159|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722160|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722161|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722162|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722163|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
19722164|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722165|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
19722166|NCT01147666|42165178|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722167|NCT01147666|42165179|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722168|NCT01147666|42165180|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722169|NCT01147666|42165181|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722170|NCT01147666|42165182|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722171|NCT01147666|42165183|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722172|NCT01147666|42165184|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722173|NCT01147666|42165185|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722174|NCT01147666|42165186|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722175|NCT01147666|42165187|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722176|NCT01147666|42165188|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722177|NCT01147666|42165189|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722178|NCT01147666|42165190|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
19722179|NCT01147666|42165191|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
19722180|NCT01147666|42165192|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
19722181|NCT00256295|42165254|FG000|Overall Study|Withdrawal by Subject|3|||
19722182|NCT00256295|42165254|FG000|Overall Study|Death|1|||
19722183|NCT02877004|42165261|FG000|Overall Study|Pregnancy|0|||
19722184|NCT02877004|42165262|FG001|Overall Study|Pregnancy|0|||
19722185|NCT02877004|42165263|FG002|Overall Study|Pregnancy|1|||
19722186|NCT04617860|42165293|FG000|Overall Study|Adverse Event|0|||
19722187|NCT04617860|42165294|FG001|Overall Study|Adverse Event|2|||
19722188|NCT04617860|42165295|FG002|Overall Study|Adverse Event|2|||
19722189|NCT04617860|42165293|FG000|Overall Study|Withdrawal by Subject|0|||
19722190|NCT04617860|42165294|FG001|Overall Study|Withdrawal by Subject|0|||
19722191|NCT04617860|42165295|FG002|Overall Study|Withdrawal by Subject|2|||
19722192|NCT04617860|42165293|FG000|Overall Study|Physician Decision|0|||
19722193|NCT04617860|42165294|FG001|Overall Study|Physician Decision|1|||
19722194|NCT04617860|42165295|FG002|Overall Study|Physician Decision|0|||
19722195|NCT04617860|42165293|FG000|Overall Study|Sponsor Decision|0|||
19722196|NCT04617860|42165294|FG001|Overall Study|Sponsor Decision|3|||
19722197|NCT04617860|42165295|FG002|Overall Study|Sponsor Decision|1|||
19722198|NCT04617860|42165293|FG000|Overall Study|Termination of Study by Sponsor|8|||
19722199|NCT04617860|42165294|FG001|Overall Study|Termination of Study by Sponsor|4|||
19722200|NCT04617860|42165295|FG002|Overall Study|Termination of Study by Sponsor|13|||
19722201|NCT04608500|42165307|FG000|Overall Study|Adverse Event|2|||
19722202|NCT04608500|42165308|FG001|Overall Study|Adverse Event|0|||
19722203|NCT04608500|42165307|FG000|Overall Study|Lost to Follow-up|15|||
19722204|NCT04608500|42165308|FG001|Overall Study|Lost to Follow-up|9|||
19722205|NCT04608500|42165307|FG000|Overall Study|Participant request|11|||
19722206|NCT04608500|42165308|FG001|Overall Study|Participant request|7|||
19722207|NCT04608500|42165307|FG000|Overall Study|Protocol Violation|1|||
19722208|NCT04608500|42165308|FG001|Overall Study|Protocol Violation|0|||
19722209|NCT04608500|42165307|FG000|Overall Study|Other|6|||
19722210|NCT04608500|42165308|FG001|Overall Study|Other|2|||
19722211|NCT04585646|42165314|FG000|First Intervention|Physician Decision|1|||
19722212|NCT04585646|42165315|FG001|First Intervention|Physician Decision|0|||
19722213|NCT04585646|42165314|FG000|First Intervention|Lost to Follow-up|0|||
19722214|NCT04585646|42165315|FG001|First Intervention|Lost to Follow-up|3|||
19722215|NCT04585646|42165314|FG000|First Intervention|Withdrawal by Subject|0|||
19722216|NCT04585646|42165315|FG001|First Intervention|Withdrawal by Subject|1|||
19722217|NCT04584788|42165331|FG000|Overall Study|Physician Decision|8|||
19722218|NCT04584788|42165331|FG000|Overall Study|Withdrawal by Subject|1|||
19722219|NCT04584788|42165331|FG000|Overall Study|Adverse Event|3|||
19722220|NCT04575038|42165337|FG000|Overall Study|Withdrawal by Subject|1|||
19722221|NCT04575038|42165338|FG001|Overall Study|Withdrawal by Subject|1|||
19722222|NCT03066622|42165346|FG000|Overall Study|Lost to Follow-up|24|||
19722223|NCT03066622|42165347|FG001|Overall Study|Lost to Follow-up|25|||
19722224|NCT03066622|42165346|FG000|Overall Study|Withdrawal by Subject|2|||
19722225|NCT03066622|42165347|FG001|Overall Study|Withdrawal by Subject|1|||
19722226|NCT04501952|42165379|FG000|Overall Study|Adverse Event|0|||
19722227|NCT04501952|42165380|FG001|Overall Study|Adverse Event|3|||
19722228|NCT04501952|42165379|FG000|Overall Study|Investigator's Discretion|0|||
19722229|NCT04501952|42165380|FG001|Overall Study|Investigator's Discretion|1|||
19722230|NCT04501952|42165379|FG000|Overall Study|Protocol Violation|1|||
19722231|NCT04501952|42165380|FG001|Overall Study|Protocol Violation|1|||
19722232|NCT04501952|42165379|FG000|Overall Study|Withdrew Consent|5|||
19722233|NCT04501952|42165380|FG001|Overall Study|Withdrew Consent|4|||
19722234|NCT04501952|42165379|FG000|Overall Study|Lost to Follow-up|7|||
19722235|NCT04501952|42165380|FG001|Overall Study|Lost to Follow-up|2|||
19722236|NCT04501952|42165379|FG000|Overall Study|Randomized and Never Treated|13|||
19722237|NCT04501952|42165380|FG001|Overall Study|Randomized and Never Treated|9|||
19722238|NCT02930122|42165398|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
19722239|NCT02930122|42165399|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
19722240|NCT04546724|42165408|FG000|Overall Study|Withdrawal by Subject|37|||
19722241|NCT04546724|42165409|FG001|Overall Study|Withdrawal by Subject|10|||
19722242|NCT04546724|42165408|FG000|Overall Study|Adverse Event|1|||
19722243|NCT04546724|42165409|FG001|Overall Study|Adverse Event|1|||
19722244|NCT04546724|42165408|FG000|Overall Study|Lost to Follow-up|30|||
19722245|NCT04546724|42165409|FG001|Overall Study|Lost to Follow-up|10|||
19722246|NCT04546724|42165408|FG000|Overall Study|Physician Decision|4|||
19722247|NCT04546724|42165409|FG001|Overall Study|Physician Decision|1|||
19722248|NCT04546724|42165408|FG000|Overall Study|Subject Moved|2|||
19722249|NCT04546724|42165409|FG001|Overall Study|Subject Moved|0|||
19722250|NCT04546724|42165408|FG000|Overall Study|Subject Praticipating in another trial|0|||
19722251|NCT04546724|42165409|FG001|Overall Study|Subject Praticipating in another trial|1|||
19722252|NCT04546724|42165408|FG000|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|49|||
19722253|NCT04546724|42165409|FG001|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|12|||
19722254|NCT03697460|42165419|FG000|Overall Study|Withdrawal by Subject|3|||
19722255|NCT00070018|42165423|FG000|Overall Study|Adverse Event|2|||
19722256|NCT00070018|42165423|FG000|Overall Study|Lack of Efficacy|1|||
19722257|NCT00070018|42165423|FG000|Overall Study|Withdrawal by Subject|1|||
19722258|NCT00231413|42165434|FG000|Overall Study|Non-serious AE|0|||
19722259|NCT00231413|42165435|FG001|Overall Study|Non-serious AE|0|||
19722260|NCT00231413|42165436|FG002|Overall Study|Non-serious AE|1|||
19722261|NCT00231413|42165437|FG003|Overall Study|Non-serious AE|0|||
19722262|NCT00231413|42165438|FG004|Overall Study|Non-serious AE|0|||
19722263|NCT00231413|42165439|FG005|Overall Study|Non-serious AE|0|||
19722264|NCT00231413|42165440|FG006|Overall Study|Non-serious AE|1|||
19722265|NCT00231413|42165434|FG000|Overall Study|Withdrawal by Subject|3|||
19722266|NCT00231413|42165435|FG001|Overall Study|Withdrawal by Subject|1|||
19722267|NCT00231413|42165436|FG002|Overall Study|Withdrawal by Subject|4|||
19722268|NCT00231413|42165437|FG003|Overall Study|Withdrawal by Subject|2|||
19722269|NCT00231413|42165438|FG004|Overall Study|Withdrawal by Subject|2|||
19722270|NCT00231413|42165439|FG005|Overall Study|Withdrawal by Subject|0|||
19722271|NCT00231413|42165440|FG006|Overall Study|Withdrawal by Subject|3|||
19722272|NCT00231413|42165434|FG000|Overall Study|Migrated/moved from study area|0|||
19722273|NCT00231413|42165435|FG001|Overall Study|Migrated/moved from study area|0|||
19722274|NCT00231413|42165436|FG002|Overall Study|Migrated/moved from study area|1|||
19722275|NCT00231413|42165437|FG003|Overall Study|Migrated/moved from study area|0|||
19722276|NCT00231413|42165438|FG004|Overall Study|Migrated/moved from study area|0|||
19722277|NCT00231413|42165439|FG005|Overall Study|Migrated/moved from study area|1|||
19722278|NCT00231413|42165440|FG006|Overall Study|Migrated/moved from study area|0|||
19722279|NCT00231413|42165434|FG000|Overall Study|Lost to Follow-up|4|||
19722280|NCT00231413|42165435|FG001|Overall Study|Lost to Follow-up|4|||
19722281|NCT00231413|42165436|FG002|Overall Study|Lost to Follow-up|1|||
19722282|NCT00231413|42165437|FG003|Overall Study|Lost to Follow-up|1|||
19722283|NCT00231413|42165438|FG004|Overall Study|Lost to Follow-up|1|||
19722284|NCT00231413|42165439|FG005|Overall Study|Lost to Follow-up|4|||
19722285|NCT00231413|42165440|FG006|Overall Study|Lost to Follow-up|0|||
19722286|NCT00231413|42165434|FG000|Overall Study|Pregnancy|1|||
19722287|NCT00231413|42165435|FG001|Overall Study|Pregnancy|0|||
19722288|NCT00231413|42165436|FG002|Overall Study|Pregnancy|0|||
19722289|NCT00231413|42165437|FG003|Overall Study|Pregnancy|0|||
19722290|NCT00231413|42165438|FG004|Overall Study|Pregnancy|0|||
19722291|NCT00231413|42165439|FG005|Overall Study|Pregnancy|0|||
19722292|NCT00231413|42165440|FG006|Overall Study|Pregnancy|0|||
19722293|NCT04494646|42165458|FG000|Overall Study|Adverse Event|0|||
19722294|NCT04494646|42165459|FG001|Overall Study|Adverse Event|1|||
19722295|NCT04494646|42165458|FG000|Overall Study|Withdrawal by Subject|0|||
19722296|NCT04494646|42165459|FG001|Overall Study|Withdrawal by Subject|1|||
19722297|NCT04529096|42165467|FG000|Overall Study|Adverse Event|6|||
19722298|NCT04529096|42165468|FG001|Overall Study|Adverse Event|1|||
19722299|NCT04529096|42165467|FG000|Overall Study|Lack of Efficacy|1|||
19722300|NCT04529096|42165468|FG001|Overall Study|Lack of Efficacy|0|||
19722301|NCT04529096|42165467|FG000|Overall Study|Lost to Follow-up|1|||
19722302|NCT04529096|42165468|FG001|Overall Study|Lost to Follow-up|1|||
19722303|NCT04529096|42165467|FG000|Overall Study|Non-Compliance With Study Drug|0|||
19722304|NCT04529096|42165468|FG001|Overall Study|Non-Compliance With Study Drug|1|||
19722305|NCT04529096|42165467|FG000|Overall Study|Physician Decision|1|||
19722306|NCT04529096|42165468|FG001|Overall Study|Physician Decision|3|||
19722307|NCT04529096|42165467|FG000|Overall Study|Withdrawal by Subject|5|||
19722308|NCT04529096|42165468|FG001|Overall Study|Withdrawal by Subject|0|||
19722309|NCT00231179|42165476|FG000|Overall Study|Lost to Follow-up|21|||
19722310|NCT00231179|42165477|FG001|Overall Study|Lost to Follow-up|21|||
19722311|NCT00231179|42165476|FG000|Overall Study|Withdrawal by Subject|3|||
19722312|NCT00231179|42165477|FG001|Overall Study|Withdrawal by Subject|3|||
19722313|NCT00229931|42165485|FG000|Overall Study|Death|1|||
19722314|NCT00229931|42165486|FG001|Overall Study|Death|0|||
19722315|NCT00229931|42165485|FG000|Overall Study|Lost to Follow-up|3|||
19550541|NCT01339832|41999598|FG000|Overall Study|Death|11|||
19722316|NCT00229931|42165486|FG001|Overall Study|Lost to Follow-up|2|||
19722317|NCT03135028|42165492|FG000|Overall Study|Death|6|||
19722318|NCT03135028|42165492|FG000|Overall Study|Study Terminated by Sponsor|2|||
19722319|NCT03135028|42165492|FG000|Overall Study|Withdrew Consent|1|||
19722320|NCT00228917|42165504|FG000|Overall Study|Migrated/moved from study area|0|||
19722321|NCT00228917|42165505|FG001|Overall Study|Migrated/moved from study area|0|||
19722322|NCT00228917|42165506|FG002|Overall Study|Migrated/moved from study area|0|||
19722323|NCT00228917|42165507|FG003|Overall Study|Migrated/moved from study area|0|||
19722324|NCT00228917|42165508|FG004|Overall Study|Migrated/moved from study area|0|||
19722325|NCT00228917|42165509|FG005|Overall Study|Migrated/moved from study area|2|||
19722326|NCT00228917|42165510|FG006|Overall Study|Migrated/moved from study area|0|||
19722327|NCT00228917|42165511|FG007|Overall Study|Migrated/moved from study area|0|||
19722328|NCT00227903|42165527|FG000|Overall Study|Withdrawal by Subject|2|||
19722329|NCT00227903|42165528|FG001|Overall Study|Withdrawal by Subject|5|||
19722330|NCT00227903|42165527|FG000|Overall Study|Subject moved out of area|1|||
19722331|NCT00227903|42165528|FG001|Overall Study|Subject moved out of area|2|||
19722332|NCT00227903|42165527|FG000|Overall Study|Lost to Follow-up|1|||
19722333|NCT00227903|42165528|FG001|Overall Study|Lost to Follow-up|3|||
19722334|NCT00227903|42165527|FG000|Overall Study|Miscarriage|1|||
19722335|NCT00227903|42165528|FG001|Overall Study|Miscarriage|0|||
19722336|NCT04411628|42165538|FG000|Overall Study|Withdrawal by Subject|1|||
19722337|NCT04411628|42165539|FG001|Overall Study|Withdrawal by Subject|1|||
19722338|NCT04411628|42165540|FG002|Overall Study|Withdrawal by Subject|2|||
19722339|NCT04411628|42165541|FG003|Overall Study|Withdrawal by Subject|0|||
19722340|NCT04411628|42165538|FG000|Overall Study|Lost to Follow-up|0|||
19722341|NCT04411628|42165539|FG001|Overall Study|Lost to Follow-up|1|||
19722342|NCT04411628|42165540|FG002|Overall Study|Lost to Follow-up|0|||
19722343|NCT04411628|42165541|FG003|Overall Study|Lost to Follow-up|0|||
19722344|NCT00227591|42165554|FG000|Overall Study|Withdrawal by Subject|1|||
19722345|NCT04512482|42165560|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
19722346|NCT04512482|42165561|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
19722347|NCT00226811|42165567|FG000|Overall Study|Death|8|||
19722348|NCT00226811|42165567|FG000|Overall Study|Adverse Event|11|||
19722349|NCT00226811|42165567|FG000|Overall Study|Lack of Efficacy|55|||
19722350|NCT00226811|42165567|FG000|Overall Study|Withdrawal by Subject|2|||
19722351|NCT02951052|42165573|FG000|Overall Study|Adverse Event|13|||
19722352|NCT02951052|42165574|FG001|Overall Study|Adverse Event|5|||
19722353|NCT02951052|42165573|FG000|Overall Study|Withdrawal by Subject|1|||
19722354|NCT02951052|42165574|FG001|Overall Study|Withdrawal by Subject|5|||
19722355|NCT02951052|42165573|FG000|Overall Study|Physician Decision|2|||
19722356|NCT02951052|42165574|FG001|Overall Study|Physician Decision|0|||
19722357|NCT02951052|42165573|FG000|Overall Study|Lost to Follow-up|1|||
19722358|NCT02951052|42165574|FG001|Overall Study|Lost to Follow-up|1|||
19722359|NCT02951052|42165573|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
19722360|NCT02951052|42165574|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
19722361|NCT02951052|42165573|FG000|Overall Study|Protocol Violation|5|||
19722362|NCT02951052|42165574|FG001|Overall Study|Protocol Violation|3|||
19722363|NCT02951052|42165573|FG000|Overall Study|Lack of Efficacy|3|||
19722364|NCT02951052|42165574|FG001|Overall Study|Lack of Efficacy|4|||
19722365|NCT02951052|42165573|FG000|Overall Study|Ongoing|1|||
19722366|NCT02951052|42165574|FG001|Overall Study|Ongoing|0|||
19722367|NCT00226655|42165584|FG000|Overall Study|Death|13|||
19722368|NCT00226655|42165584|FG000|Overall Study|Withdrawal by Subject|15|||
19722369|NCT00226655|42165584|FG000|Overall Study|Adverse Event|35|||
19722370|NCT00226655|42165584|FG000|Overall Study|Physician Decision|6|||
19722371|NCT00226655|42165584|FG000|Overall Study|Clinical deterioration|10|||
19722372|NCT03124108|42165600|FG000|Overall Study|Adverse Event|0|||
19722373|NCT03124108|42165601|FG001|Overall Study|Adverse Event|1|||
19722374|NCT03124108|42165602|FG002|Overall Study|Adverse Event|0|||
19722375|NCT04475588|42165614|FG000|Overall Study|Adverse Event|2|||
19722376|NCT04475588|42165615|FG001|Overall Study|Adverse Event|0|||
19722377|NCT04353596|42165624|FG000|Overall Study|Protocol Violation|4|||
19722378|NCT04353596|42165625|FG001|Overall Study|Protocol Violation|4|||
19722379|NCT04353596|42165624|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
19722380|NCT04353596|42165625|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
19722381|NCT04350788|42165633|FG000|Overall Study|Lost to Follow-up|6|||
19722382|NCT04350788|42165634|FG001|Overall Study|Lost to Follow-up|2|||
19722383|NCT04350788|42165633|FG000|Overall Study|Withdrawal by Subject|2|||
19722384|NCT04350788|42165634|FG001|Overall Study|Withdrawal by Subject|4|||
19722385|NCT04350788|42165633|FG000|Overall Study|Protocol Violation|4|||
19722386|NCT04350788|42165634|FG001|Overall Study|Protocol Violation|0|||
19722387|NCT03852316|42165645|FG000|Overall Study|Protocol Violation|1|||
19722388|NCT03852316|42165645|FG000|Overall Study|Withdrawal by Subject|2|||
19722389|NCT03852316|42165645|FG000|Overall Study|Enrolled but Device not Utilized|1|||
19722390|NCT04335812|42165651|FG000|Overall Study|Withdrawal by Subject|1|||
19722391|NCT04335812|42165652|FG001|Overall Study|Withdrawal by Subject|3|||
19722392|NCT04335812|42165651|FG000|Overall Study|Lost to Follow-up|12|||
19722393|NCT04335812|42165652|FG001|Overall Study|Lost to Follow-up|12|||
19722394|NCT04335812|42165651|FG000|Overall Study|Did not engage in the intervention|22|||
19722395|NCT04335812|42165652|FG001|Overall Study|Did not engage in the intervention|18|||
19722396|NCT03127384|42165658|FG000|Overall Study|Lost to Follow-up|4|||
19722397|NCT03127384|42165658|FG000|Overall Study|Subject request|2|||
19722398|NCT04398134|42165685|FG000|Overall Study|Adverse Event|0|||
19722399|NCT04398134|42165686|FG001|Overall Study|Adverse Event|0|||
19722400|NCT04398134|42165687|FG002|Overall Study|Adverse Event|1|||
19722401|NCT04398134|42165688|FG003|Overall Study|Adverse Event|0|||
19722402|NCT04398134|42165685|FG000|Overall Study|Withdrawal by Subject|2|||
19722403|NCT04398134|42165686|FG001|Overall Study|Withdrawal by Subject|0|||
19722404|NCT04398134|42165687|FG002|Overall Study|Withdrawal by Subject|0|||
19722405|NCT04398134|42165688|FG003|Overall Study|Withdrawal by Subject|1|||
19722406|NCT04398134|42165685|FG000|Overall Study|Study Terminated by Sponsor|30|||
19722407|NCT04398134|42165686|FG001|Overall Study|Study Terminated by Sponsor|11|||
19722408|NCT04398134|42165687|FG002|Overall Study|Study Terminated by Sponsor|32|||
19722409|NCT04398134|42165688|FG003|Overall Study|Study Terminated by Sponsor|11|||
19722410|NCT03122860|42165704|FG000|Overall Study|Discontinued Before Treatment|1|||
19722411|NCT03122860|42165705|FG001|Overall Study|Discontinued Before Treatment|1|||
19722412|NCT03122860|42165706|FG002|Overall Study|Discontinued Before Treatment|2|||
19722413|NCT03122860|42165707|FG003|Overall Study|Discontinued Before Treatment|0|||
19722414|NCT03122860|42165708|FG004|Overall Study|Discontinued Before Treatment|1|||
19722415|NCT03122860|42165709|FG005|Overall Study|Discontinued Before Treatment|0|||
19722416|NCT03122860|42165704|FG000|Overall Study|Adverse Event|1|||
19722417|NCT03122860|42165705|FG001|Overall Study|Adverse Event|0|||
19722418|NCT03122860|42165706|FG002|Overall Study|Adverse Event|1|||
19722419|NCT03122860|42165707|FG003|Overall Study|Adverse Event|1|||
19722420|NCT03122860|42165708|FG004|Overall Study|Adverse Event|0|||
19722421|NCT03122860|42165709|FG005|Overall Study|Adverse Event|0|||
19722422|NCT03122860|42165704|FG000|Overall Study|Lost to Follow-up|5|||
19722423|NCT03122860|42165705|FG001|Overall Study|Lost to Follow-up|2|||
19722424|NCT03122860|42165706|FG002|Overall Study|Lost to Follow-up|3|||
19722425|NCT03122860|42165707|FG003|Overall Study|Lost to Follow-up|3|||
19722426|NCT03122860|42165708|FG004|Overall Study|Lost to Follow-up|5|||
19722427|NCT03122860|42165709|FG005|Overall Study|Lost to Follow-up|4|||
19722428|NCT03122860|42165704|FG000|Overall Study|Subject Non-Compliance|0|||
19722429|NCT03122860|42165705|FG001|Overall Study|Subject Non-Compliance|0|||
19722430|NCT03122860|42165706|FG002|Overall Study|Subject Non-Compliance|1|||
19722431|NCT03122860|42165707|FG003|Overall Study|Subject Non-Compliance|0|||
19722432|NCT03122860|42165708|FG004|Overall Study|Subject Non-Compliance|0|||
19722433|NCT03122860|42165709|FG005|Overall Study|Subject Non-Compliance|0|||
19722434|NCT03122860|42165704|FG000|Overall Study|Withdrawal by Subject|3|||
19722435|NCT03122860|42165705|FG001|Overall Study|Withdrawal by Subject|2|||
19722436|NCT03122860|42165706|FG002|Overall Study|Withdrawal by Subject|5|||
19722437|NCT03122860|42165707|FG003|Overall Study|Withdrawal by Subject|7|||
19722438|NCT03122860|42165708|FG004|Overall Study|Withdrawal by Subject|9|||
19722439|NCT03122860|42165709|FG005|Overall Study|Withdrawal by Subject|8|||
19722440|NCT03798366|42165726|FG000|Overall Study|Lost to Follow-up|0|||
19722441|NCT03798366|42165727|FG001|Overall Study|Lost to Follow-up|1|||
19722442|NCT04327388|42165736|FG000|Overall Study|Adverse Event|17|||
19722443|NCT04327388|42165737|FG001|Overall Study|Adverse Event|18|||
19722444|NCT04327388|42165738|FG002|Overall Study|Adverse Event|9|||
19722445|NCT04327388|42165736|FG000|Overall Study|Other|1|||
19722446|NCT04327388|42165737|FG001|Overall Study|Other|2|||
19722447|NCT04327388|42165738|FG002|Overall Study|Other|0|||
19722448|NCT04327388|42165736|FG000|Overall Study|Randomized and not treated|2|||
19722449|NCT04327388|42165737|FG001|Overall Study|Randomized and not treated|0|||
19722450|NCT04327388|42165738|FG002|Overall Study|Randomized and not treated|2|||
19722451|NCT03796728|42165746|FG000|Overall Study|Lost to Follow-up|8|||
19722452|NCT03796728|42165746|FG000|Overall Study|Reason not Specified|16|||
19722453|NCT00352534|42165752|FG000|Initial Staging|Ineligible|8|||
19722454|NCT00352534|42165753|FG001|Initial Staging|Ineligible|9|||
19722455|NCT00352534|42165754|FG002|Initial Staging|Ineligible|0|||
19722456|NCT00352534|42165755|FG003|Initial Staging|Ineligible|0|||
19722457|NCT00352534|42165756|FG004|Initial Staging|Ineligible|0|||
19722458|NCT00352534|42165757|FG005|Initial Staging|Ineligible|0|||
19722459|NCT00352534|42165758|FG006|Initial Staging|Ineligible|0|||
19722460|NCT00352534|42165752|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
19722461|NCT00352534|42165753|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
19722462|NCT00352534|42165754|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
19722463|NCT00352534|42165755|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
19722464|NCT00352534|42165756|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
19722465|NCT00352534|42165757|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
19722466|NCT00352534|42165758|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
19722467|NCT00352534|42165752|FG000|Final Risk Group Assignment|Physician Decision|0|||
19722468|NCT00352534|42165753|FG001|Final Risk Group Assignment|Physician Decision|0|||
19722469|NCT00352534|42165754|FG002|Final Risk Group Assignment|Physician Decision|0|||
19722470|NCT00352534|42165755|FG003|Final Risk Group Assignment|Physician Decision|0|||
19722471|NCT00352534|42165756|FG004|Final Risk Group Assignment|Physician Decision|0|||
19722472|NCT00352534|42165757|FG005|Final Risk Group Assignment|Physician Decision|8|||
19722473|NCT00352534|42165758|FG006|Final Risk Group Assignment|Physician Decision|0|||
19722474|NCT00352534|42165752|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722475|NCT00352534|42165753|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722476|NCT00352534|42165754|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722477|NCT00352534|42165755|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722478|NCT00352534|42165756|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722479|NCT00352534|42165757|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
19722480|NCT00352534|42165758|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
19722481|NCT00352534|42165752|FG000|Final Risk Group Assignment|Ineligible|0|||
19722482|NCT00352534|42165753|FG001|Final Risk Group Assignment|Ineligible|0|||
19722483|NCT00352534|42165754|FG002|Final Risk Group Assignment|Ineligible|3|||
19722484|NCT00352534|42165755|FG003|Final Risk Group Assignment|Ineligible|1|||
19722485|NCT00352534|42165756|FG004|Final Risk Group Assignment|Ineligible|0|||
19722486|NCT00352534|42165757|FG005|Final Risk Group Assignment|Ineligible|13|||
19722487|NCT00352534|42165758|FG006|Final Risk Group Assignment|Ineligible|0|||
19722488|NCT00352534|42165752|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722489|NCT00352534|42165753|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722490|NCT00352534|42165754|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722491|NCT00352534|42165755|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722492|NCT00352534|42165756|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722493|NCT00352534|42165757|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
19722494|NCT00352534|42165758|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
19722495|NCT00352534|42165752|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722496|NCT00352534|42165753|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722497|NCT00352534|42165754|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722498|NCT00352534|42165755|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722499|NCT00352534|42165756|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722500|NCT00352534|42165757|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
19722501|NCT00352534|42165758|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
19722502|NCT00352534|42165752|FG000|Final Risk Group Assignment|Death|0|||
19722503|NCT00352534|42165753|FG001|Final Risk Group Assignment|Death|0|||
19722504|NCT00352534|42165754|FG002|Final Risk Group Assignment|Death|0|||
19722505|NCT00352534|42165755|FG003|Final Risk Group Assignment|Death|0|||
19722506|NCT00352534|42165756|FG004|Final Risk Group Assignment|Death|0|||
19722507|NCT00352534|42165757|FG005|Final Risk Group Assignment|Death|2|||
19722508|NCT00352534|42165758|FG006|Final Risk Group Assignment|Death|0|||
19722509|NCT04323800|42165770|FG000|Overall Study|Withdrawal by Subject|4|||
19722510|NCT04323800|42165771|FG001|Overall Study|Withdrawal by Subject|4|||
19722511|NCT04323800|42165770|FG000|Overall Study|Incomplete transfusion|1|||
19722512|NCT04323800|42165771|FG001|Overall Study|Incomplete transfusion|0|||
19722513|NCT04323800|42165770|FG000|Overall Study|Other|0|||
19722514|NCT04323800|42165771|FG001|Overall Study|Other|1|||
19722515|NCT04323800|42165770|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
19722516|NCT04323800|42165771|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
19722517|NCT04321460|42165779|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
19722518|NCT04321460|42165780|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
19722519|NCT03122548|42165786|FG000|Overall Study|Death|2|||
19722520|NCT03122548|42165786|FG000|Overall Study|Progression - subject went into hospice|1|||
19722521|NCT03122548|42165786|FG000|Overall Study|Study Terminated by Sponsor|2|||
19722522|NCT04459598|42165792|FG000|Overall Study|Adverse Event|1|||
19722523|NCT04459598|42165793|FG001|Overall Study|Adverse Event|1|||
19722524|NCT02929498|42165802|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
19722525|NCT02929498|42165803|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
19722526|NCT02929498|42165804|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
19722527|NCT02929498|42165802|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
19722528|NCT02929498|42165803|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
19722529|NCT02929498|42165804|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
19722530|NCT03792672|42165810|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
19722531|NCT03792672|42165811|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
19722532|NCT03792672|42165812|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
19722533|NCT03792672|42165813|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
19722534|NCT03792672|42165814|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
19722535|NCT03792672|42165815|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
19722536|NCT03792672|42165810|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
19722537|NCT03792672|42165811|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
19722538|NCT03792672|42165812|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
19722539|NCT03792672|42165813|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
19722540|NCT03792672|42165814|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
19722541|NCT03792672|42165815|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
19722542|NCT03792672|42165810|FG000|Treatment Period 4 (2 Days)|Other|1|||
19722543|NCT03792672|42165811|FG001|Treatment Period 4 (2 Days)|Other|0|||
19722544|NCT03792672|42165812|FG002|Treatment Period 4 (2 Days)|Other|0|||
19722545|NCT03792672|42165813|FG003|Treatment Period 4 (2 Days)|Other|0|||
19722546|NCT03792672|42165814|FG004|Treatment Period 4 (2 Days)|Other|0|||
19722547|NCT03792672|42165815|FG005|Treatment Period 4 (2 Days)|Other|0|||
19722548|NCT03120676|42165830|FG000|Overall Study|Not treated|1|||
19722549|NCT03120520|42165838|FG000|Overall Study|Lost to Follow-up|1|||
19722550|NCT03120520|42165839|FG001|Overall Study|Lost to Follow-up|1|||
19722551|NCT03120520|42165840|FG002|Overall Study|Lost to Follow-up|1|||
19722552|NCT03120520|42165841|FG003|Overall Study|Lost to Follow-up|1|||
19722553|NCT03120520|42165838|FG000|Overall Study|Withdrawal by Subject|3|||
19722554|NCT03120520|42165839|FG001|Overall Study|Withdrawal by Subject|2|||
19722555|NCT03120520|42165840|FG002|Overall Study|Withdrawal by Subject|3|||
19722556|NCT03120520|42165841|FG003|Overall Study|Withdrawal by Subject|2|||
19722557|NCT03120520|42165838|FG000|Overall Study|Other|0|||
19722558|NCT03120520|42165839|FG001|Overall Study|Other|1|||
19722559|NCT03120520|42165840|FG002|Overall Study|Other|0|||
19722560|NCT03120520|42165841|FG003|Overall Study|Other|0|||
19722561|NCT03787212|42165851|FG000|Period 1|Study Termination|2|||
19722562|NCT03787212|42165852|FG001|Period 1|Study Termination|2|||
19722563|NCT03125200|42165865|FG000|Overall Study|Study Termination|0|||
19722564|NCT03125200|42165866|FG001|Overall Study|Study Termination|0|||
19722565|NCT03125200|42165867|FG002|Overall Study|Study Termination|0|||
19722566|NCT03125200|42165868|FG003|Overall Study|Study Termination|1|||
19722567|NCT03125200|42165869|FG004|Overall Study|Study Termination|1|||
19722568|NCT03125200|42165870|FG005|Overall Study|Study Termination|2|||
19722569|NCT03125200|42165871|FG006|Overall Study|Study Termination|1|||
19722570|NCT03125200|42165865|FG000|Overall Study|Clinical Progression|0|||
19722571|NCT03125200|42165866|FG001|Overall Study|Clinical Progression|0|||
19722572|NCT03125200|42165867|FG002|Overall Study|Clinical Progression|0|||
19722573|NCT03125200|42165868|FG003|Overall Study|Clinical Progression|1|||
19722574|NCT03125200|42165869|FG004|Overall Study|Clinical Progression|0|||
19722575|NCT03125200|42165870|FG005|Overall Study|Clinical Progression|1|||
19722576|NCT03125200|42165871|FG006|Overall Study|Clinical Progression|0|||
19722577|NCT03125200|42165865|FG000|Overall Study|Progressive Disease|2|||
19722578|NCT03125200|42165866|FG001|Overall Study|Progressive Disease|1|||
19722579|NCT03125200|42165867|FG002|Overall Study|Progressive Disease|2|||
19722580|NCT03125200|42165868|FG003|Overall Study|Progressive Disease|1|||
19722581|NCT03125200|42165869|FG004|Overall Study|Progressive Disease|2|||
19722582|NCT03125200|42165870|FG005|Overall Study|Progressive Disease|0|||
19722583|NCT03125200|42165871|FG006|Overall Study|Progressive Disease|1|||
19722584|NCT03125200|42165865|FG000|Overall Study|Lack of Efficacy|0|||
19722585|NCT03125200|42165866|FG001|Overall Study|Lack of Efficacy|0|||
19722586|NCT03125200|42165867|FG002|Overall Study|Lack of Efficacy|0|||
19722587|NCT03125200|42165868|FG003|Overall Study|Lack of Efficacy|1|||
19722588|NCT03125200|42165869|FG004|Overall Study|Lack of Efficacy|0|||
19722589|NCT03125200|42165870|FG005|Overall Study|Lack of Efficacy|0|||
19722590|NCT03125200|42165871|FG006|Overall Study|Lack of Efficacy|0|||
19722591|NCT03125200|42165865|FG000|Overall Study|Toxicity|0|||
19722592|NCT03125200|42165866|FG001|Overall Study|Toxicity|0|||
19722593|NCT03125200|42165867|FG002|Overall Study|Toxicity|0|||
19722594|NCT03125200|42165868|FG003|Overall Study|Toxicity|1|||
19722595|NCT03125200|42165869|FG004|Overall Study|Toxicity|0|||
19722596|NCT03125200|42165870|FG005|Overall Study|Toxicity|0|||
19722597|NCT03125200|42165871|FG006|Overall Study|Toxicity|0|||
19722598|NCT03125200|42165865|FG000|Overall Study|Consent Withdrawn by Subject|0|||
19722599|NCT03125200|42165866|FG001|Overall Study|Consent Withdrawn by Subject|1|||
19722600|NCT03125200|42165867|FG002|Overall Study|Consent Withdrawn by Subject|0|||
19722601|NCT03125200|42165868|FG003|Overall Study|Consent Withdrawn by Subject|0|||
19722602|NCT03125200|42165869|FG004|Overall Study|Consent Withdrawn by Subject|1|||
19722603|NCT03125200|42165870|FG005|Overall Study|Consent Withdrawn by Subject|0|||
19722604|NCT03125200|42165871|FG006|Overall Study|Consent Withdrawn by Subject|1|||
19722605|NCT03132220|42165892|FG000|Overall Study|Lost to Follow-up|17|||
19722606|NCT03132220|42165893|FG001|Overall Study|Lost to Follow-up|8|||
19722607|NCT03132220|42165892|FG000|Overall Study|Withdrawal by Subject|1|||
19722608|NCT03132220|42165893|FG001|Overall Study|Withdrawal by Subject|4|||
19722609|NCT03119662|42165901|FG000|Overall Study|Withdrawal by Subject|0|||
19722610|NCT03119662|42165902|FG001|Overall Study|Withdrawal by Subject|1|||
19722611|NCT02728804|42165908|FG000|Overall Study|Ineligible|3|||
19722612|NCT02728804|42165908|FG000|Overall Study|Did not complete baseline questionnaire|9|||
19722613|NCT02728804|42165908|FG000|Overall Study|Death|99|||
19722614|NCT02699554|42165924|FG000|Overall Study|Lost to Follow-up|9|||
19722615|NCT03783780|42165949|FG000|Overall Study|Withdrawn prior to completion|1|||
19722616|NCT03783702|42165956|FG000|Overall Study|Lost to Follow-up|6|||
19722617|NCT03783702|42165957|FG001|Overall Study|Lost to Follow-up|8|||
19722618|NCT03783702|42165956|FG000|Overall Study|Protocol Violation|1|||
19722619|NCT03783702|42165957|FG001|Overall Study|Protocol Violation|3|||
19722620|NCT03575572|42165965|FG000|Overall Study|Withdrawal by Subject|2|||
19722621|NCT03575572|42165965|FG000|Overall Study|Physician Decision|2|||
19722622|NCT03116698|42165991|FG000|Overall Study|Adverse Event|1|||
19722623|NCT03116698|42165992|FG001|Overall Study|Adverse Event|1|||
19722624|NCT03116698|42165993|FG002|Overall Study|Adverse Event|1|||
19722625|NCT03116698|42165994|FG003|Overall Study|Adverse Event|0|||
19722626|NCT03116698|42165991|FG000|Overall Study|Withdrawal by Subject|1|||
19722627|NCT03116698|42165992|FG001|Overall Study|Withdrawal by Subject|4|||
19722628|NCT03116698|42165993|FG002|Overall Study|Withdrawal by Subject|5|||
19722629|NCT03116698|42165994|FG003|Overall Study|Withdrawal by Subject|2|||
19722630|NCT03116698|42165991|FG000|Overall Study|Lost to Follow-up|2|||
19722631|NCT03116698|42165992|FG001|Overall Study|Lost to Follow-up|0|||
19722632|NCT03116698|42165993|FG002|Overall Study|Lost to Follow-up|0|||
19722633|NCT03116698|42165994|FG003|Overall Study|Lost to Follow-up|0|||
19722634|NCT03116698|42165991|FG000|Overall Study|Physician Decision|1|||
19722635|NCT03116698|42165992|FG001|Overall Study|Physician Decision|1|||
19722636|NCT03116698|42165993|FG002|Overall Study|Physician Decision|0|||
19722637|NCT03116698|42165994|FG003|Overall Study|Physician Decision|0|||
19722638|NCT03116698|42165991|FG000|Overall Study|Protocol Violation|1|||
19722639|NCT03116698|42165992|FG001|Overall Study|Protocol Violation|0|||
19722640|NCT03116698|42165993|FG002|Overall Study|Protocol Violation|0|||
19722641|NCT03116698|42165994|FG003|Overall Study|Protocol Violation|0|||
19722642|NCT03116698|42165991|FG000|Overall Study|Death|0|||
19722643|NCT03116698|42165992|FG001|Overall Study|Death|0|||
19722644|NCT03116698|42165993|FG002|Overall Study|Death|2|||
19722645|NCT03116698|42165994|FG003|Overall Study|Death|0|||
19722646|NCT03116152|42166006|FG000|Overall Study|Disease Progression|49|||
19722647|NCT03116152|42166007|FG001|Overall Study|Disease Progression|47|||
19722648|NCT03116152|42166006|FG000|Overall Study|Death|5|||
19722649|NCT03116152|42166007|FG001|Overall Study|Death|2|||
19722650|NCT03116152|42166006|FG000|Overall Study|Adverse Event|21|||
19722651|NCT03116152|42166007|FG001|Overall Study|Adverse Event|7|||
19722652|NCT03116152|42166006|FG000|Overall Study|Protocol Violation|2|||
19722653|NCT03116152|42166007|FG001|Overall Study|Protocol Violation|2|||
19722654|NCT03116152|42166006|FG000|Overall Study|Withdrawal by Subject|0|||
19722655|NCT03116152|42166007|FG001|Overall Study|Withdrawal by Subject|1|||
19722656|NCT03116152|42166006|FG000|Overall Study|Physician Decision|3|||
19722657|NCT03116152|42166007|FG001|Overall Study|Physician Decision|2|||
19722658|NCT03116152|42166006|FG000|Overall Study|other|11|||
19722659|NCT03116152|42166007|FG001|Overall Study|other|34|||
19722660|NCT00226499|42166018|FG000|Overall Study|Adverse Event|10|||
19722661|NCT00226499|42166019|FG001|Overall Study|Adverse Event|6|||
19722662|NCT00226499|42166020|FG002|Overall Study|Adverse Event|3|||
19722663|NCT00226499|42166018|FG000|Overall Study|Others|1064|||
19722664|NCT00226499|42166019|FG001|Overall Study|Others|1066|||
19722665|NCT00226499|42166020|FG002|Overall Study|Others|356|||
19722666|NCT01400776|42166034|FG000|Overall Study|Adverse Event|7|||
19722667|NCT01400776|42166035|FG001|Overall Study|Adverse Event|2|||
19722668|NCT01400776|42166036|FG002|Overall Study|Adverse Event|9|||
19722669|NCT01400776|42166037|FG003|Overall Study|Adverse Event|2|||
19722670|NCT01400776|42166034|FG000|Overall Study|Lost to Follow-up|1|||
19722671|NCT01400776|42166035|FG001|Overall Study|Lost to Follow-up|0|||
19722672|NCT01400776|42166036|FG002|Overall Study|Lost to Follow-up|4|||
19722673|NCT01400776|42166037|FG003|Overall Study|Lost to Follow-up|1|||
19722674|NCT01400776|42166034|FG000|Overall Study|Withdrew Consent|4|||
19722675|NCT01400776|42166035|FG001|Overall Study|Withdrew Consent|2|||
19722676|NCT01400776|42166036|FG002|Overall Study|Withdrew Consent|6|||
19722677|NCT01400776|42166037|FG003|Overall Study|Withdrew Consent|1|||
19722678|NCT01400776|42166034|FG000|Overall Study|Protocol Deviation|6|||
19722679|NCT01400776|42166035|FG001|Overall Study|Protocol Deviation|1|||
19722680|NCT01400776|42166036|FG002|Overall Study|Protocol Deviation|5|||
19722681|NCT01400776|42166037|FG003|Overall Study|Protocol Deviation|2|||
19722682|NCT01400776|42166034|FG000|Overall Study|Reason not Specified|3|||
19722683|NCT01400776|42166035|FG001|Overall Study|Reason not Specified|0|||
19722684|NCT01400776|42166036|FG002|Overall Study|Reason not Specified|4|||
19722685|NCT01400776|42166037|FG003|Overall Study|Reason not Specified|3|||
19722686|NCT03131596|42166049|FG000|Overall Study|Protocol Violation|3|||
19722687|NCT03131596|42166050|FG001|Overall Study|Protocol Violation|3|||
19722688|NCT03131596|42166049|FG000|Overall Study|Lost to Follow-up|3|||
19722689|NCT03131596|42166050|FG001|Overall Study|Lost to Follow-up|0|||
19722690|NCT00255047|42166064|FG000|Overall Study|Serious Adverse Events|2|||
19722691|NCT00255047|42166065|FG001|Overall Study|Serious Adverse Events|1|||
19722692|NCT00255047|42166066|FG002|Overall Study|Serious Adverse Events|2|||
19722693|NCT00255047|42166067|FG003|Overall Study|Serious Adverse Events|1|||
19722694|NCT00255047|42166064|FG000|Overall Study|Adverse Event|0|||
19722695|NCT00255047|42166065|FG001|Overall Study|Adverse Event|3|||
19722696|NCT00255047|42166066|FG002|Overall Study|Adverse Event|2|||
19722697|NCT00255047|42166067|FG003|Overall Study|Adverse Event|1|||
19722698|NCT00255047|42166064|FG000|Overall Study|Protocol Violation|13|||
19722699|NCT00255047|42166065|FG001|Overall Study|Protocol Violation|13|||
19722700|NCT00255047|42166066|FG002|Overall Study|Protocol Violation|16|||
19722701|NCT00255047|42166067|FG003|Overall Study|Protocol Violation|20|||
19722702|NCT00255047|42166064|FG000|Overall Study|Lost to Follow-up|9|||
19722703|NCT00255047|42166065|FG001|Overall Study|Lost to Follow-up|8|||
19722704|NCT00255047|42166066|FG002|Overall Study|Lost to Follow-up|5|||
19722705|NCT00255047|42166067|FG003|Overall Study|Lost to Follow-up|6|||
19722706|NCT00255047|42166064|FG000|Overall Study|Withdrawal by Subject|24|||
19722707|NCT00255047|42166065|FG001|Overall Study|Withdrawal by Subject|23|||
19722708|NCT00255047|42166066|FG002|Overall Study|Withdrawal by Subject|25|||
19722709|NCT00255047|42166067|FG003|Overall Study|Withdrawal by Subject|18|||
19722710|NCT00225251|42166079|FG000|Overall Study|Withdrawal by Subject|1|||
19722711|NCT00225251|42166080|FG001|Overall Study|Withdrawal by Subject|1|||
19722712|NCT00254501|42166088|FG000|Overall Study|Lost to Follow-up|1|||
19722713|NCT00254501|42166089|FG001|Overall Study|Lost to Follow-up|1|||
19722714|NCT00253643|42166101|FG000|Overall Study|Withdrawal by Subject|0|||
19722715|NCT00253643|42166102|FG001|Overall Study|Withdrawal by Subject|0|||
19722716|NCT00253643|42166103|FG002|Overall Study|Withdrawal by Subject|1|||
19722717|NCT00253643|42166104|FG003|Overall Study|Withdrawal by Subject|1|||
19722718|NCT00253643|42166101|FG000|Overall Study|Non-Compliance|0|||
19722719|NCT00253643|42166102|FG001|Overall Study|Non-Compliance|0|||
19722720|NCT00253643|42166103|FG002|Overall Study|Non-Compliance|0|||
19722721|NCT00253643|42166104|FG003|Overall Study|Non-Compliance|2|||
19722722|NCT00221195|42166116|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
19722723|NCT00221195|42166117|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
19722724|NCT00221195|42166116|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
19722725|NCT00221195|42166117|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
19722726|NCT00221195|42166116|FG000|Washout Period (Months 7-9)|Death|0|||
19722727|NCT00221195|42166117|FG001|Washout Period (Months 7-9)|Death|1|||
19722728|NCT00221195|42166116|FG000|Therapy 2 (Months 10-15)|Death|1|||
19722729|NCT00221195|42166117|FG001|Therapy 2 (Months 10-15)|Death|0|||
19722730|NCT00221195|42166116|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
19722731|NCT00221195|42166117|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
19722732|NCT00220805|42166126|FG000|Overall Study|Adverse Event|1|||
19722733|NCT00220805|42166127|FG001|Overall Study|Adverse Event|3|||
19722734|NCT00220805|42166126|FG000|Overall Study|Withdrawal by Subject|3|||
19722735|NCT00220805|42166127|FG001|Overall Study|Withdrawal by Subject|0|||
19722736|NCT00220805|42166126|FG000|Overall Study|Lack of Efficacy|1|||
19722737|NCT00220805|42166127|FG001|Overall Study|Lack of Efficacy|0|||
19722738|NCT00220805|42166126|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
19722739|NCT00220805|42166127|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
19722740|NCT00220727|42166135|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
19722741|NCT00220727|42166136|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
19722742|NCT04495816|42166146|FG000|Overall Study|Lost to Follow-up|10|||
19722743|NCT04495816|42166147|FG001|Overall Study|Lost to Follow-up|4|||
19722744|NCT04495816|42166146|FG000|Overall Study|Withdrawal by Subject|3|||
19722745|NCT04495816|42166147|FG001|Overall Study|Withdrawal by Subject|5|||
19722746|NCT03971357|42166155|FG000|Overall Study|Lack of Efficacy|0|||
19722747|NCT03971357|42166156|FG001|Overall Study|Lack of Efficacy|1|||
19722748|NCT04310566|42166162|FG000|Period 1|Study Termination due to COVID-19|15|||
19722749|NCT04310566|42166163|FG001|Period 1|Study Termination due to COVID-19|17|||
19722750|NCT04310566|42166162|FG000|Period 1|Protocol Violation|0|||
19722751|NCT04310566|42166163|FG001|Period 1|Protocol Violation|1|||
19722752|NCT04310566|42166162|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
19722753|NCT04310566|42166163|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
19722754|NCT04310566|42166162|FG000|Period 1|Lost to Follow-up|1|||
19722755|NCT04310566|42166163|FG001|Period 1|Lost to Follow-up|0|||
19722756|NCT04310566|42166162|FG000|Period 1|Withdrawal by Subject|0|||
19722757|NCT04310566|42166163|FG001|Period 1|Withdrawal by Subject|1|||
19722758|NCT04310566|42166162|FG000|Period 2|Study Termination|7|||
19722759|NCT04310566|42166163|FG001|Period 2|Study Termination|5|||
19722760|NCT00252239|42166173|FG000|Overall Study|Withdrawal by Subject|1|||
19722761|NCT00252239|42166174|FG001|Overall Study|Withdrawal by Subject|0|||
19722762|NCT00252239|42166175|FG002|Overall Study|Withdrawal by Subject|0|||
19722763|NCT00252239|42166176|FG003|Overall Study|Withdrawal by Subject|1|||
19722764|NCT00252239|42166173|FG000|Overall Study|Lost to Follow-up|0|||
19722765|NCT00252239|42166174|FG001|Overall Study|Lost to Follow-up|0|||
19722766|NCT00252239|42166175|FG002|Overall Study|Lost to Follow-up|2|||
19722767|NCT00252239|42166176|FG003|Overall Study|Lost to Follow-up|0|||
19722768|NCT03103906|42166188|FG000|Overall Study|Adverse Event|2|||
19722769|NCT03103906|42166189|FG001|Overall Study|Adverse Event|3|||
19722770|NCT03103906|42166188|FG000|Overall Study|Other|2|||
19722771|NCT03103906|42166189|FG001|Overall Study|Other|0|||
19722772|NCT04799158|42166199|FG000|Run-In Period|Adverse Event|6|||
19722773|NCT04799158|42166200|FG001|Run-In Period|Adverse Event|0|||
19722774|NCT04799158|42166201|FG002|Run-In Period|Adverse Event|0|||
19722775|NCT04799158|42166202|FG003|Run-In Period|Adverse Event|0|||
19722776|NCT04799158|42166203|FG004|Run-In Period|Adverse Event|0|||
19722777|NCT04799158|42166199|FG000|Run-In Period|Lost to Follow-up|4|||
19722778|NCT04799158|42166200|FG001|Run-In Period|Lost to Follow-up|0|||
19722779|NCT04799158|42166201|FG002|Run-In Period|Lost to Follow-up|0|||
19722780|NCT04799158|42166202|FG003|Run-In Period|Lost to Follow-up|0|||
19722781|NCT04799158|42166203|FG004|Run-In Period|Lost to Follow-up|0|||
19722782|NCT04799158|42166199|FG000|Run-In Period|Significant Protocol Deviation|1|||
19722783|NCT04799158|42166200|FG001|Run-In Period|Significant Protocol Deviation|0|||
19722784|NCT04799158|42166201|FG002|Run-In Period|Significant Protocol Deviation|0|||
19722785|NCT04799158|42166202|FG003|Run-In Period|Significant Protocol Deviation|0|||
19722786|NCT04799158|42166203|FG004|Run-In Period|Significant Protocol Deviation|0|||
19722787|NCT04799158|42166199|FG000|Run-In Period|Withdrawal by Subject|11|||
19722788|NCT04799158|42166200|FG001|Run-In Period|Withdrawal by Subject|0|||
19722789|NCT04799158|42166201|FG002|Run-In Period|Withdrawal by Subject|0|||
19722790|NCT04799158|42166202|FG003|Run-In Period|Withdrawal by Subject|0|||
19722791|NCT04799158|42166203|FG004|Run-In Period|Withdrawal by Subject|0|||
19722792|NCT04799158|42166199|FG000|Run-In Period|Miscellaneous|3|||
19722793|NCT04799158|42166200|FG001|Run-In Period|Miscellaneous|0|||
19722794|NCT04799158|42166201|FG002|Run-In Period|Miscellaneous|0|||
19722795|NCT04799158|42166202|FG003|Run-In Period|Miscellaneous|0|||
19722796|NCT04799158|42166203|FG004|Run-In Period|Miscellaneous|0|||
19722797|NCT04799158|42166199|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
19722798|NCT04799158|42166200|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
19722799|NCT04799158|42166201|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
19722800|NCT04799158|42166202|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
19722801|NCT04799158|42166203|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
19722802|NCT04799158|42166199|FG000|On-Demand Treatment Period|Adverse Event|0|||
19722803|NCT04799158|42166200|FG001|On-Demand Treatment Period|Adverse Event|1|||
19722804|NCT04799158|42166201|FG002|On-Demand Treatment Period|Adverse Event|0|||
19722805|NCT04799158|42166202|FG003|On-Demand Treatment Period|Adverse Event|0|||
19722806|NCT04799158|42166203|FG004|On-Demand Treatment Period|Adverse Event|1|||
19722807|NCT04799158|42166199|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
19722808|NCT04799158|42166200|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
19722809|NCT04799158|42166201|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
19722810|NCT04799158|42166202|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
19722811|NCT04799158|42166203|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
19722812|NCT04799158|42166199|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
19722813|NCT04799158|42166200|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
19722814|NCT04799158|42166201|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
19722815|NCT04799158|42166202|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
19722816|NCT04799158|42166203|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
19722817|NCT04799158|42166199|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
19722818|NCT04799158|42166200|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
19722819|NCT04799158|42166201|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
19722820|NCT04799158|42166202|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
19722821|NCT04799158|42166203|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
19722822|NCT04799158|42166199|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
19722823|NCT04799158|42166200|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
19722824|NCT04799158|42166201|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
19722825|NCT04799158|42166202|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
19722826|NCT04799158|42166203|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
19722827|NCT04799158|42166199|FG000|On-Demand Treatment Period|Miscellaneous|0|||
19722828|NCT04799158|42166200|FG001|On-Demand Treatment Period|Miscellaneous|0|||
19722829|NCT04799158|42166201|FG002|On-Demand Treatment Period|Miscellaneous|0|||
19722830|NCT04799158|42166202|FG003|On-Demand Treatment Period|Miscellaneous|0|||
19722831|NCT04799158|42166203|FG004|On-Demand Treatment Period|Miscellaneous|1|||
19722832|NCT01319422|42166216|FG000|Overall Study|Withdrawal by Subject|1|||
19722833|NCT01319422|42166217|FG001|Overall Study|Withdrawal by Subject|0|||
19722834|NCT03102034|42166225|FG000|Overall Study|Withdrawal by Subject|1|||
19722835|NCT03102034|42166226|FG001|Overall Study|Withdrawal by Subject|0|||
19722836|NCT03774576|42166232|FG000|Period 2|Adverse Event|1|||
19722837|NCT02928952|42166243|FG000|Overall Study|Lost to Follow-up|5|||
19722838|NCT02928952|42166244|FG001|Overall Study|Lost to Follow-up|5|||
19722839|NCT02928952|42166243|FG000|Overall Study|Withdrawal by Subject|5|||
19722840|NCT02928952|42166244|FG001|Overall Study|Withdrawal by Subject|1|||
19722841|NCT02928952|42166243|FG000|Overall Study|Physician Decision|0|||
19722842|NCT02928952|42166244|FG001|Overall Study|Physician Decision|1|||
19722843|NCT03773796|42166250|FG000|Overall Study|Adverse Event|1|||
19722844|NCT03773796|42166250|FG000|Overall Study|Withdrawal by Subject|1|||
19722845|NCT03773796|42166250|FG000|Overall Study|Lack of Efficacy|1|||
19722846|NCT02927938|42166258|FG000|Overall Study|Death|0|||
19722847|NCT02927938|42166259|FG001|Overall Study|Death|1|||
19722848|NCT02927938|42166260|FG002|Overall Study|Death|0|||
19722849|NCT02927938|42166261|FG003|Overall Study|Death|4|||
19722850|NCT02927938|42166258|FG000|Overall Study|Early Study Termination|1|||
19722851|NCT02927938|42166259|FG001|Overall Study|Early Study Termination|5|||
19722852|NCT02927938|42166260|FG002|Overall Study|Early Study Termination|4|||
19722853|NCT02927938|42166261|FG003|Overall Study|Early Study Termination|3|||
19722854|NCT03765138|42166269|FG000|Overall Study|Lost to Follow-up|1|||
19722855|NCT03768726|42166276|FG000|Treatment Phase|Adverse Event|2|||
19722856|NCT03768726|42166277|FG001|Treatment Phase|Adverse Event|2|||
19722857|NCT03768726|42166276|FG000|Treatment Phase|Lost to Follow-up|1|||
19722858|NCT03768726|42166277|FG001|Treatment Phase|Lost to Follow-up|0|||
19722859|NCT03768726|42166276|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
19722860|NCT03768726|42166277|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
19722861|NCT03768726|42166276|FG000|Treatment Phase|Withdrawal by Subject|3|||
19722862|NCT03768726|42166277|FG001|Treatment Phase|Withdrawal by Subject|1|||
19722863|NCT03768726|42166276|FG000|Follow-Up|Adverse Event|2|||
19722864|NCT03768726|42166277|FG001|Follow-Up|Adverse Event|2|||
19722865|NCT03768726|42166276|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
19722866|NCT03768726|42166277|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
19722867|NCT03768726|42166276|FG000|Follow-Up|Withdrawal by Subject|2|||
19722868|NCT03768726|42166277|FG001|Follow-Up|Withdrawal by Subject|0|||
19722869|NCT03768726|42166276|FG000|Follow-Up|Other|1|||
19722870|NCT03768726|42166277|FG001|Follow-Up|Other|0|||
19722871|NCT03769896|42166285|FG000|Open-label Phase|Lack of Efficacy|5|||
19722872|NCT03769896|42166286|FG001|Open-label Phase|Lack of Efficacy|0|||
19722873|NCT03769896|42166285|FG000|Open-label Phase|Adverse Event|3|||
19722874|NCT03769896|42166286|FG001|Open-label Phase|Adverse Event|0|||
19722875|NCT03769896|42166285|FG000|Open-label Phase|Withdrawal by Subject|1|||
19722876|NCT03769896|42166286|FG001|Open-label Phase|Withdrawal by Subject|0|||
19722877|NCT04979858|42166317|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
19722878|NCT04979858|42166318|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
19722879|NCT04030598|42166366|FG000|Overall Study|Voluntary Withdrawal|0|||
19722880|NCT04030598|42166367|FG001|Overall Study|Voluntary Withdrawal|1|||
19722881|NCT04030598|42166368|FG002|Overall Study|Voluntary Withdrawal|0|||
19722882|NCT03830164|42166388|FG000|Overall Study|Adverse Event|0|||
19722883|NCT03830164|42166389|FG001|Overall Study|Adverse Event|2|||
19722884|NCT03830164|42166390|FG002|Overall Study|Adverse Event|0|||
19722885|NCT03830164|42166388|FG000|Overall Study|Lack of Efficacy|1|||
19722886|NCT03830164|42166389|FG001|Overall Study|Lack of Efficacy|5|||
19722887|NCT03830164|42166390|FG002|Overall Study|Lack of Efficacy|0|||
19722888|NCT03830164|42166388|FG000|Overall Study|Lost to Follow-up|0|||
19722889|NCT03830164|42166389|FG001|Overall Study|Lost to Follow-up|1|||
19722890|NCT03830164|42166390|FG002|Overall Study|Lost to Follow-up|0|||
19722891|NCT03830164|42166388|FG000|Overall Study|Withdrawal by Subject|1|||
19722892|NCT03830164|42166389|FG001|Overall Study|Withdrawal by Subject|0|||
19722893|NCT03830164|42166390|FG002|Overall Study|Withdrawal by Subject|0|||
19722894|NCT03777436|42166400|FG000|Placebo-controlled Phase|Adverse Event|8|||
19722895|NCT03777436|42166401|FG001|Placebo-controlled Phase|Adverse Event|10|||
19722896|NCT03777436|42166402|FG002|Placebo-controlled Phase|Adverse Event|0|||
19722897|NCT03777436|42166400|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
19722898|NCT03777436|42166401|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
19722899|NCT03777436|42166402|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
19722900|NCT03777436|42166400|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
19722901|NCT03777436|42166401|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
19722902|NCT03777436|42166402|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
19722903|NCT03777436|42166400|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
19722904|NCT03777436|42166401|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
19722905|NCT03777436|42166402|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
19722906|NCT03777436|42166400|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
19722907|NCT03777436|42166401|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
19722908|NCT03777436|42166402|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
19722909|NCT03777436|42166400|FG000|Placebo-controlled Phase|Physician Decision|0|||
19722910|NCT03777436|42166401|FG001|Placebo-controlled Phase|Physician Decision|1|||
19722911|NCT03777436|42166402|FG002|Placebo-controlled Phase|Physician Decision|0|||
19722912|NCT03777436|42166400|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
19722913|NCT03777436|42166401|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
19722914|NCT03777436|42166402|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
19722915|NCT03777436|42166400|FG000|Apremilast Extension Phase|Adverse Event|0|||
19722916|NCT03777436|42166401|FG001|Apremilast Extension Phase|Adverse Event|0|||
19722917|NCT03777436|42166402|FG002|Apremilast Extension Phase|Adverse Event|6|||
19722918|NCT03777436|42166400|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
19722919|NCT03777436|42166401|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
19722920|NCT03777436|42166402|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
19722921|NCT03777436|42166400|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
19722922|NCT03777436|42166401|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
19722923|NCT03777436|42166402|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
19722924|NCT03777436|42166400|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
19722925|NCT03777436|42166401|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
19722926|NCT03777436|42166402|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
19550542|NCT01339559|41999602|FG000|Overall Study|Adverse Event|92|||
19722927|NCT03777436|42166400|FG000|Apremilast Extension Phase|Miscellaneous|0|||
19722928|NCT03777436|42166401|FG001|Apremilast Extension Phase|Miscellaneous|0|||
19722929|NCT03777436|42166402|FG002|Apremilast Extension Phase|Miscellaneous|1|||
19722930|NCT03156023|42166418|FG000|Overall Study|Withdrawal by Subject|1|||
19722931|NCT03156023|42166419|FG001|Overall Study|Withdrawal by Subject|0|||
19722932|NCT03156023|42166420|FG002|Overall Study|Withdrawal by Subject|2|||
19722933|NCT03156023|42166421|FG003|Overall Study|Withdrawal by Subject|1|||
19722934|NCT03156023|42166422|FG004|Overall Study|Withdrawal by Subject|1|||
19722935|NCT03156023|42166418|FG000|Overall Study|Lost to Follow-up|0|||
19722936|NCT03156023|42166419|FG001|Overall Study|Lost to Follow-up|0|||
19722937|NCT03156023|42166420|FG002|Overall Study|Lost to Follow-up|0|||
19722938|NCT03156023|42166421|FG003|Overall Study|Lost to Follow-up|0|||
19722939|NCT03156023|42166422|FG004|Overall Study|Lost to Follow-up|1|||
19722940|NCT03025880|42166440|FG000|Overall Study|Adverse Event|1|||
19722941|NCT03025880|42166441|FG001|Overall Study|Adverse Event|0|||
19722942|NCT03025880|42166440|FG000|Overall Study|Death|1|||
19722943|NCT03025880|42166441|FG001|Overall Study|Death|1|||
19722944|NCT03025880|42166440|FG000|Overall Study|Withdrawal by Subject|0|||
19722945|NCT03025880|42166441|FG001|Overall Study|Withdrawal by Subject|1|||
19722946|NCT03025880|42166440|FG000|Overall Study|Physician Decision|0|||
19722947|NCT03025880|42166441|FG001|Overall Study|Physician Decision|1|||
19722948|NCT03025880|42166440|FG000|Overall Study|Progressive Disease|12|||
19722949|NCT03025880|42166441|FG001|Overall Study|Progressive Disease|19|||
19722950|NCT02027376|42166458|FG000|Overall Study|Death|1|||
19722951|NCT02027376|42166459|FG001|Overall Study|Death|0|||
19722952|NCT02027376|42166460|FG002|Overall Study|Death|0|||
19722953|NCT01924533|42166472|FG000|Overall Study|Death|181|||
19722954|NCT01924533|42166473|FG001|Overall Study|Death|200|||
19722955|NCT01924533|42166472|FG000|Overall Study|Lost to Follow-up|0|||
19722956|NCT01924533|42166473|FG001|Overall Study|Lost to Follow-up|1|||
19722957|NCT01924533|42166472|FG000|Overall Study|Withdrawal by Subject|7|||
19722958|NCT01924533|42166473|FG001|Overall Study|Withdrawal by Subject|3|||
19722959|NCT01924533|42166472|FG000|Overall Study|Other Eligibility criteria|1|||
19722960|NCT01924533|42166473|FG001|Overall Study|Other Eligibility criteria|1|||
19722961|NCT01606436|42166479|FG000|Overall Study|Withdrawal by Subject|0|||
19722962|NCT01606436|42166480|FG001|Overall Study|Withdrawal by Subject|0|||
19722963|NCT01606436|42166481|FG002|Overall Study|Withdrawal by Subject|1|||
19722964|NCT01606436|42166482|FG003|Overall Study|Withdrawal by Subject|1|||
19722965|NCT01606436|42166483|FG004|Overall Study|Withdrawal by Subject|1|||
19722966|NCT01606436|42166484|FG005|Overall Study|Withdrawal by Subject|0|||
19722967|NCT01606436|42166479|FG000|Overall Study|Adverse Event|0|||
19722968|NCT01606436|42166480|FG001|Overall Study|Adverse Event|0|||
19722969|NCT01606436|42166481|FG002|Overall Study|Adverse Event|1|||
19722970|NCT01606436|42166482|FG003|Overall Study|Adverse Event|0|||
19722971|NCT01606436|42166483|FG004|Overall Study|Adverse Event|0|||
19722972|NCT01606436|42166484|FG005|Overall Study|Adverse Event|0|||
19722973|NCT01606436|42166479|FG000|Overall Study|Sponsor Decision|0|||
19722974|NCT01606436|42166480|FG001|Overall Study|Sponsor Decision|0|||
19722975|NCT01606436|42166481|FG002|Overall Study|Sponsor Decision|0|||
19722976|NCT01606436|42166482|FG003|Overall Study|Sponsor Decision|1|||
19722977|NCT01606436|42166483|FG004|Overall Study|Sponsor Decision|0|||
19722978|NCT01606436|42166484|FG005|Overall Study|Sponsor Decision|0|||
19722979|NCT00219557|42166495|FG000|Phase 1|Lack of Efficacy|3|||
19722980|NCT00219557|42166496|FG001|Phase 1|Lack of Efficacy|0|||
19722981|NCT00219557|42166497|FG002|Phase 1|Lack of Efficacy|0|||
19722982|NCT00219557|42166495|FG000|Phase 1|Adverse Event|2|||
19722983|NCT00219557|42166496|FG001|Phase 1|Adverse Event|0|||
19722984|NCT00219557|42166497|FG002|Phase 1|Adverse Event|0|||
19722985|NCT00219557|42166495|FG000|Phase 1|Withdrawal by Subject|1|||
19722986|NCT00219557|42166496|FG001|Phase 1|Withdrawal by Subject|0|||
19722987|NCT00219557|42166497|FG002|Phase 1|Withdrawal by Subject|0|||
19722988|NCT00219557|42166495|FG000|Phase 1|Started chemotherapy at other institute|1|||
19722989|NCT00219557|42166496|FG001|Phase 1|Started chemotherapy at other institute|0|||
19722990|NCT00219557|42166497|FG002|Phase 1|Started chemotherapy at other institute|0|||
19722991|NCT00219557|42166495|FG000|Phase 2|Lack of Efficacy|0|||
19722992|NCT00219557|42166496|FG001|Phase 2|Lack of Efficacy|21|||
19722993|NCT00219557|42166497|FG002|Phase 2|Lack of Efficacy|15|||
19722994|NCT00219557|42166495|FG000|Phase 2|Adverse Event|0|||
19722995|NCT00219557|42166496|FG001|Phase 2|Adverse Event|22|||
19722996|NCT00219557|42166497|FG002|Phase 2|Adverse Event|2|||
19722997|NCT00219557|42166495|FG000|Phase 2|Death|0|||
19722998|NCT00219557|42166496|FG001|Phase 2|Death|8|||
19722999|NCT00219557|42166497|FG002|Phase 2|Death|2|||
19723000|NCT00219557|42166495|FG000|Phase 2|Other|0|||
19723001|NCT00219557|42166496|FG001|Phase 2|Other|8|||
19723002|NCT00219557|42166497|FG002|Phase 2|Other|6|||
19723003|NCT00219557|42166495|FG000|Phase 2|Withdrawal by Subject|0|||
19723004|NCT00219557|42166496|FG001|Phase 2|Withdrawal by Subject|9|||
19723005|NCT00219557|42166497|FG002|Phase 2|Withdrawal by Subject|5|||
19723006|NCT00219557|42166495|FG000|Phase 2|Treatment not received|0|||
19723007|NCT00219557|42166496|FG001|Phase 2|Treatment not received|1|||
19723008|NCT00219557|42166497|FG002|Phase 2|Treatment not received|3|||
19723009|NCT00251927|42166512|FG000|Overall Study|Adverse Event|3|||
19723010|NCT00251927|42166513|FG001|Overall Study|Adverse Event|15|||
19723011|NCT00251927|42166512|FG000|Overall Study|Lack of Efficacy|22|||
19723012|NCT00251927|42166513|FG001|Overall Study|Lack of Efficacy|16|||
19723013|NCT00251927|42166512|FG000|Overall Study|Lost to Follow-up|22|||
19723014|NCT00251927|42166513|FG001|Overall Study|Lost to Follow-up|8|||
19723015|NCT00251927|42166512|FG000|Overall Study|Protocol Violation|1|||
19723016|NCT00251927|42166513|FG001|Overall Study|Protocol Violation|2|||
19723017|NCT00251927|42166512|FG000|Overall Study|Pregnancy|2|||
19723018|NCT00251927|42166513|FG001|Overall Study|Pregnancy|0|||
19723019|NCT00251927|42166512|FG000|Overall Study|Withdrawal by Subject|40|||
19723020|NCT00251927|42166513|FG001|Overall Study|Withdrawal by Subject|25|||
19723021|NCT00251927|42166512|FG000|Overall Study|Study-specific discont. achieved|13|||
19723022|NCT00251927|42166513|FG001|Overall Study|Study-specific discont. achieved|2|||
19723023|NCT00251927|42166512|FG000|Overall Study|Study procedure non-compliance|5|||
19723024|NCT00251927|42166513|FG001|Overall Study|Study procedure non-compliance|6|||
19723025|NCT00165503|42166520|FG000|Overall Study|Death|1|||
19723026|NCT00165503|42166520|FG000|Overall Study|Lost to Follow-up|12|||
19723027|NCT00165503|42166520|FG000|Overall Study|Unresectable|3|||
19723028|NCT00162773|42166524|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
19723029|NCT00209339|42166528|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
19723030|NCT00209339|42166528|FG000|At 12 Months Follow-up|Death|1|||
19723031|NCT00209339|42166528|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
19723032|NCT00209339|42166528|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
19723033|NCT00209339|42166528|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
19723034|NCT00209339|42166528|FG000|At 24 Months Follow-up|Death|1|||
19723035|NCT00209339|42166528|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
19723036|NCT00209339|42166528|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
19723037|NCT00209339|42166528|FG000|At 4 Years Follow-up|Death|1|||
19723038|NCT00209339|42166528|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
19723039|NCT00209339|42166528|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
19723040|NCT00209339|42166528|FG000|At 5 Years Follow-up|Death|1|||
19723041|NCT03823391|42166534|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
19723042|NCT03823391|42166535|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
19723043|NCT03823391|42166534|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
19723044|NCT03823391|42166535|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
19723045|NCT00161213|42166543|FG000|Overall Study|Withdrawal by Subject|1|||
19723046|NCT00161213|42166543|FG000|Overall Study|Evaluable for toxicity but not response|1|||
19723047|NCT00209027|42166549|FG000|Overall Study|study terminated|10|||
19723048|NCT00209027|42166550|FG001|Overall Study|study terminated|0|||
19723049|NCT00208325|42166560|FG000|Overall Study|Death|18|||
19723050|NCT00208325|42166561|FG001|Overall Study|Death|19|||
19723051|NCT00208325|42166562|FG002|Overall Study|Death|7|||
19723052|NCT00208325|42166563|FG003|Overall Study|Death|5|||
19723053|NCT00208325|42166560|FG000|Overall Study|Withdrawal by Subject|0|||
19723054|NCT00208325|42166561|FG001|Overall Study|Withdrawal by Subject|1|||
19723055|NCT00208325|42166562|FG002|Overall Study|Withdrawal by Subject|0|||
19723056|NCT00208325|42166563|FG003|Overall Study|Withdrawal by Subject|0|||
19723057|NCT00208325|42166560|FG000|Overall Study|Revision|4|||
19723058|NCT00208325|42166561|FG001|Overall Study|Revision|1|||
19723059|NCT00208325|42166562|FG002|Overall Study|Revision|0|||
19723060|NCT00208325|42166563|FG003|Overall Study|Revision|4|||
19723061|NCT00208325|42166560|FG000|Overall Study|Lost to Follow-up|1|||
19723062|NCT00208325|42166561|FG001|Overall Study|Lost to Follow-up|0|||
19723063|NCT00208325|42166562|FG002|Overall Study|Lost to Follow-up|2|||
19723064|NCT00208325|42166563|FG003|Overall Study|Lost to Follow-up|0|||
19723065|NCT00208325|42166560|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
19723066|NCT00208325|42166561|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
19723067|NCT00208325|42166562|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
19723068|NCT00208325|42166563|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
19723069|NCT00208325|42166560|FG000|Overall Study|Does not wish to Continue in Study|5|||
19723070|NCT00208325|42166561|FG001|Overall Study|Does not wish to Continue in Study|8|||
19723071|NCT00208325|42166562|FG002|Overall Study|Does not wish to Continue in Study|3|||
19723072|NCT00208325|42166563|FG003|Overall Study|Does not wish to Continue in Study|2|||
19723073|NCT00208325|42166560|FG000|Overall Study|Other|2|||
19723074|NCT00208325|42166561|FG001|Overall Study|Other|1|||
19723075|NCT00208325|42166562|FG002|Overall Study|Other|1|||
19723076|NCT00208325|42166563|FG003|Overall Study|Other|0|||
19723077|NCT00208325|42166560|FG000|Overall Study|Mis-Randomized|17|||
19723078|NCT00208325|42166561|FG001|Overall Study|Mis-Randomized|20|||
19723079|NCT00208325|42166562|FG002|Overall Study|Mis-Randomized|0|||
19723080|NCT00208325|42166563|FG003|Overall Study|Mis-Randomized|0|||
19723081|NCT00160667|42166576|FG000|Overall Study|Adverse Event|3|||
19723082|NCT00160667|42166577|FG001|Overall Study|Adverse Event|1|||
19723083|NCT00160667|42166578|FG002|Overall Study|Adverse Event|4|||
19723084|NCT00160667|42166576|FG000|Overall Study|Withdrawal by Subject|2|||
19723085|NCT00160667|42166577|FG001|Overall Study|Withdrawal by Subject|0|||
19723086|NCT00160667|42166578|FG002|Overall Study|Withdrawal by Subject|1|||
19723087|NCT00160667|42166576|FG000|Overall Study|Lack of Efficacy|0|||
19723088|NCT00160667|42166577|FG001|Overall Study|Lack of Efficacy|1|||
19723089|NCT00160667|42166578|FG002|Overall Study|Lack of Efficacy|0|||
19723090|NCT00160667|42166576|FG000|Overall Study|Protocol Violation|0|||
19723091|NCT00160667|42166577|FG001|Overall Study|Protocol Violation|1|||
19723092|NCT00160667|42166578|FG002|Overall Study|Protocol Violation|0|||
19723093|NCT00160667|42166576|FG000|Overall Study|Patient decision|0|||
19723094|NCT00160667|42166577|FG001|Overall Study|Patient decision|0|||
19723095|NCT00160667|42166578|FG002|Overall Study|Patient decision|1|||
19723096|NCT00206375|42166590|FG000|Overall Study|Lost to Follow-up|1|||
19723097|NCT00206375|42166591|FG001|Overall Study|Lost to Follow-up|0|||
19723098|NCT00206375|42166592|FG002|Overall Study|Lost to Follow-up|0|||
19723099|NCT00206375|42166590|FG000|Overall Study|Withdrawal by Subject|2|||
19723100|NCT00206375|42166591|FG001|Overall Study|Withdrawal by Subject|1|||
19723101|NCT00206375|42166592|FG002|Overall Study|Withdrawal by Subject|3|||
19723102|NCT00206375|42166590|FG000|Overall Study|Study terminated due to lack of funds|0|||
19723103|NCT00206375|42166591|FG001|Overall Study|Study terminated due to lack of funds|1|||
19723104|NCT00206375|42166592|FG002|Overall Study|Study terminated due to lack of funds|1|||
19723105|NCT00160199|42166602|FG000|Overall Study|Adverse Event|5|||
19723106|NCT00160199|42166603|FG001|Overall Study|Adverse Event|14|||
19723107|NCT00160199|42166602|FG000|Overall Study|Lack of Efficacy|0|||
19723108|NCT00160199|42166603|FG001|Overall Study|Lack of Efficacy|1|||
19723109|NCT00160199|42166602|FG000|Overall Study|Lost to Follow-up|7|||
19723110|NCT00160199|42166603|FG001|Overall Study|Lost to Follow-up|7|||
19723111|NCT00160199|42166602|FG000|Overall Study|Withdrawal by Subject|4|||
19723112|NCT00160199|42166603|FG001|Overall Study|Withdrawal by Subject|6|||
19723113|NCT00160199|42166602|FG000|Overall Study|Administrative|0|||
19723114|NCT00160199|42166603|FG001|Overall Study|Administrative|1|||
19723115|NCT00160199|42166602|FG000|Overall Study|Protocol Violation|8|||
19723116|NCT00160199|42166603|FG001|Overall Study|Protocol Violation|8|||
19723117|NCT00157157|42166609|FG000|Overall Study|Withdrawal by Subject|6|||
19723118|NCT00157157|42166609|FG000|Overall Study|Physician Decision|1|||
19723119|NCT00157157|42166609|FG000|Overall Study|Lost to Follow-up|1|||
19723120|NCT00157157|42166609|FG000|Overall Study|Enrolled in another study|1|||
19723121|NCT00157157|42166609|FG000|Overall Study|Met exclusion criteria|1|||
19723122|NCT00157157|42166609|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
19723123|NCT00203411|42166620|FG000|Follow-up|Progressive Disease|4|||
19723124|NCT00203021|42166627|FG000|Overall Study|Death|4|||
19723125|NCT00203021|42166628|FG001|Overall Study|Death|1|||
19723126|NCT00203021|42166627|FG000|Overall Study|Adverse Event|10|||
19723127|NCT00203021|42166628|FG001|Overall Study|Adverse Event|5|||
19723128|NCT00203021|42166627|FG000|Overall Study|Withdrawal by Subject|45|||
19723129|NCT00203021|42166628|FG001|Overall Study|Withdrawal by Subject|48|||
19723130|NCT00203021|42166627|FG000|Overall Study|Lost to Follow-up|9|||
19723131|NCT00203021|42166628|FG001|Overall Study|Lost to Follow-up|7|||
19723132|NCT00203021|42166627|FG000|Overall Study|Other than specified|11|||
19723133|NCT00203021|42166628|FG001|Overall Study|Other than specified|16|||
19723134|NCT00201851|42166637|FG000|Overall Study|Lost to Follow-up|2|||
19723135|NCT00201851|42166638|FG001|Overall Study|Lost to Follow-up|1|||
19723136|NCT00201851|42166639|FG002|Overall Study|Lost to Follow-up|0|||
19723137|NCT00201851|42166637|FG000|Overall Study|Ineligible post enrollment|6|||
19723138|NCT00201851|42166638|FG001|Overall Study|Ineligible post enrollment|1|||
19723139|NCT00201851|42166639|FG002|Overall Study|Ineligible post enrollment|1|||
19723140|NCT00200057|42166647|FG000|Overall Study|Lack of Efficacy|3|||
19723141|NCT00200057|42166647|FG000|Overall Study|Exited due to terminal illness of PI|2|||
19723142|NCT00200057|42166647|FG000|Overall Study|Withdrawal by Subject|1|||
19723143|NCT00200057|42166647|FG000|Overall Study|Change in medical condition|1|||
19723144|NCT00200057|42166647|FG000|Overall Study|Infection|1|||
19723145|NCT00200057|42166647|FG000|Overall Study|Death|1|||
19723146|NCT03129100|42166656|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
19723147|NCT03129100|42166657|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
19723148|NCT03129100|42166658|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
19723149|NCT03129100|42166659|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
19723150|NCT03129100|42166660|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
19723151|NCT03129100|42166661|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
19723152|NCT03129100|42166662|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
19723153|NCT03129100|42166663|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
19723154|NCT03129100|42166664|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
19723155|NCT03129100|42166665|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
19723156|NCT03129100|42166666|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
19723157|NCT03129100|42166667|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
19723158|NCT03129100|42166668|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
19723159|NCT03129100|42166669|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
19723160|NCT03129100|42166670|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
19723161|NCT03129100|42166671|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
19723162|NCT03129100|42166672|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
19723163|NCT03129100|42166673|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
19723164|NCT03129100|42166674|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
19723165|NCT03129100|42166675|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
19723166|NCT03129100|42166676|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
19723167|NCT03129100|42166677|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
19723168|NCT03129100|42166678|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
19723169|NCT03129100|42166679|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
19723170|NCT03129100|42166680|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
19723171|NCT03129100|42166681|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
19723172|NCT03129100|42166656|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
19723173|NCT03129100|42166657|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723174|NCT03129100|42166658|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723175|NCT03129100|42166659|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723176|NCT03129100|42166660|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723177|NCT03129100|42166661|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723178|NCT03129100|42166662|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723179|NCT03129100|42166663|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723180|NCT03129100|42166664|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723181|NCT03129100|42166665|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723182|NCT03129100|42166666|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723183|NCT03129100|42166667|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723184|NCT03129100|42166668|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723185|NCT03129100|42166669|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723186|NCT03129100|42166670|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723187|NCT03129100|42166671|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723188|NCT03129100|42166672|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723189|NCT03129100|42166673|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723190|NCT03129100|42166674|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723191|NCT03129100|42166675|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723192|NCT03129100|42166676|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723193|NCT03129100|42166677|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723194|NCT03129100|42166678|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723195|NCT03129100|42166679|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723196|NCT03129100|42166680|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723197|NCT03129100|42166681|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
19723198|NCT03129100|42166656|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
19723199|NCT03129100|42166657|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
19723200|NCT03129100|42166658|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723201|NCT03129100|42166659|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723202|NCT03129100|42166660|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723203|NCT03129100|42166661|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723204|NCT03129100|42166662|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723205|NCT03129100|42166663|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723206|NCT03129100|42166664|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723207|NCT03129100|42166665|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723208|NCT03129100|42166666|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723209|NCT03129100|42166667|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723210|NCT03129100|42166668|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723211|NCT03129100|42166669|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723212|NCT03129100|42166670|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723213|NCT03129100|42166671|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723214|NCT03129100|42166672|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723215|NCT03129100|42166673|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723216|NCT03129100|42166674|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723217|NCT03129100|42166675|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723218|NCT03129100|42166676|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723219|NCT03129100|42166677|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723220|NCT03129100|42166678|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723221|NCT03129100|42166679|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723222|NCT03129100|42166680|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723223|NCT03129100|42166681|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
19723224|NCT03129100|42166656|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
19723225|NCT03129100|42166657|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
19723226|NCT03129100|42166658|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723227|NCT03129100|42166659|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723228|NCT03129100|42166660|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723229|NCT03129100|42166661|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723230|NCT03129100|42166662|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723231|NCT03129100|42166663|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723232|NCT03129100|42166664|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723233|NCT03129100|42166665|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723234|NCT03129100|42166666|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723235|NCT03129100|42166667|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723236|NCT03129100|42166668|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723237|NCT03129100|42166669|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723238|NCT03129100|42166670|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723239|NCT03129100|42166671|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723240|NCT03129100|42166672|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723241|NCT03129100|42166673|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723242|NCT03129100|42166674|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723243|NCT03129100|42166675|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723244|NCT03129100|42166676|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723245|NCT03129100|42166677|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723246|NCT03129100|42166678|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723247|NCT03129100|42166679|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723248|NCT03129100|42166680|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723249|NCT03129100|42166681|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
19723250|NCT03129100|42166656|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723251|NCT03129100|42166657|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
19723252|NCT03129100|42166658|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723253|NCT03129100|42166659|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723254|NCT03129100|42166660|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723255|NCT03129100|42166661|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723256|NCT03129100|42166662|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723257|NCT03129100|42166663|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723258|NCT03129100|42166664|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723259|NCT03129100|42166665|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723260|NCT03129100|42166666|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723261|NCT03129100|42166667|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723262|NCT03129100|42166668|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723263|NCT03129100|42166669|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723264|NCT03129100|42166670|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723265|NCT03129100|42166671|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723266|NCT03129100|42166672|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723267|NCT03129100|42166673|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723268|NCT03129100|42166674|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723269|NCT03129100|42166675|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723270|NCT03129100|42166676|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723271|NCT03129100|42166677|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723272|NCT03129100|42166678|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723273|NCT03129100|42166679|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723274|NCT03129100|42166680|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723275|NCT03129100|42166681|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
19723276|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723277|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723278|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
19723279|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
19723280|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723281|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
19723282|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723283|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723284|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723285|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723286|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723287|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723288|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723289|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723290|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723291|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723292|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723293|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723294|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723295|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723296|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723297|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723298|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723299|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723300|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723301|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
19723302|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Death|0|||
19723303|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Death|0|||
19723304|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Death|1|||
19723305|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Death|0|||
19723306|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Death|0|||
19723307|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Death|0|||
19723308|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Death|0|||
19723309|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Death|0|||
19723310|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Death|0|||
19723311|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Death|0|||
19723312|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Death|0|||
19723313|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Death|0|||
19723314|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Death|0|||
19723315|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Death|0|||
19723316|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Death|0|||
19723317|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Death|0|||
19723318|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Death|0|||
19723319|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Death|0|||
19723320|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Death|0|||
19723321|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Death|0|||
19723322|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Death|0|||
19723323|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Death|0|||
19723324|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Death|0|||
19723325|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Death|0|||
19723326|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Death|0|||
19723327|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Death|0|||
19723328|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723329|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723330|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
19723331|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
19723332|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
19723333|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
19723334|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
19723335|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723336|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723337|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723338|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723339|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723340|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723341|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723342|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723343|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723344|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723345|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723346|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723347|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723348|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723349|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723350|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723351|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723352|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723353|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
19723354|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723355|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723356|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
19723357|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723358|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723359|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723360|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723361|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723362|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723363|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723364|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723365|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723366|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723367|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723368|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723369|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723370|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723371|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723372|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723373|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723374|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723375|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723376|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723377|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723378|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723379|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
19723380|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723381|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723382|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
19723383|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723384|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723385|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723386|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723387|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723388|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723389|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723390|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723391|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723392|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723393|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723394|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723395|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723396|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723397|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723398|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723399|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723400|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723401|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723402|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723403|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723404|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723405|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
19723406|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723407|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723408|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
19723409|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723410|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723411|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723412|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723413|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723414|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723415|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723416|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723417|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723418|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723419|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723420|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723421|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723422|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723423|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723424|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723425|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723426|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723427|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723428|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723429|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723430|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723431|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
19723432|NCT03129100|42166656|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723433|NCT03129100|42166657|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723434|NCT03129100|42166658|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723435|NCT03129100|42166659|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723436|NCT03129100|42166660|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
19723437|NCT03129100|42166661|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
19723438|NCT03129100|42166662|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
19723439|NCT03129100|42166663|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723440|NCT03129100|42166664|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723441|NCT03129100|42166665|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723442|NCT03129100|42166666|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723443|NCT03129100|42166667|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723444|NCT03129100|42166668|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723445|NCT03129100|42166669|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723446|NCT03129100|42166670|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723447|NCT03129100|42166671|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723448|NCT03129100|42166672|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723449|NCT03129100|42166673|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723450|NCT03129100|42166674|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723451|NCT03129100|42166675|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723452|NCT03129100|42166676|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723453|NCT03129100|42166677|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723454|NCT03129100|42166678|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723455|NCT03129100|42166679|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723456|NCT03129100|42166680|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723457|NCT03129100|42166681|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
19723458|NCT03129100|42166656|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723459|NCT03129100|42166657|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723460|NCT03129100|42166658|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723461|NCT03129100|42166659|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723462|NCT03129100|42166660|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723463|NCT03129100|42166661|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723464|NCT03129100|42166662|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723465|NCT03129100|42166663|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723466|NCT03129100|42166664|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723467|NCT03129100|42166665|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
19723468|NCT03129100|42166666|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723469|NCT03129100|42166667|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723470|NCT03129100|42166668|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723471|NCT03129100|42166669|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723472|NCT03129100|42166670|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723473|NCT03129100|42166671|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723474|NCT03129100|42166672|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723475|NCT03129100|42166673|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723476|NCT03129100|42166674|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723477|NCT03129100|42166675|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723478|NCT03129100|42166676|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723479|NCT03129100|42166677|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723480|NCT03129100|42166678|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723481|NCT03129100|42166679|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723482|NCT03129100|42166680|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723483|NCT03129100|42166681|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
19723484|NCT03129100|42166656|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723485|NCT03129100|42166657|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723486|NCT03129100|42166658|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723487|NCT03129100|42166659|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723488|NCT03129100|42166660|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723489|NCT03129100|42166661|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723490|NCT03129100|42166662|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723491|NCT03129100|42166663|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723492|NCT03129100|42166664|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723493|NCT03129100|42166665|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723494|NCT03129100|42166666|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723495|NCT03129100|42166667|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
19723496|NCT03129100|42166668|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723497|NCT03129100|42166669|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723498|NCT03129100|42166670|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723499|NCT03129100|42166671|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723500|NCT03129100|42166672|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723501|NCT03129100|42166673|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723502|NCT03129100|42166674|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723503|NCT03129100|42166675|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723504|NCT03129100|42166676|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723505|NCT03129100|42166677|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723506|NCT03129100|42166678|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723507|NCT03129100|42166679|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723508|NCT03129100|42166680|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723509|NCT03129100|42166681|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
19723510|NCT03129100|42166656|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723511|NCT03129100|42166657|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723512|NCT03129100|42166658|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723513|NCT03129100|42166659|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723514|NCT03129100|42166660|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723515|NCT03129100|42166661|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723516|NCT03129100|42166662|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723517|NCT03129100|42166663|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723518|NCT03129100|42166664|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723519|NCT03129100|42166665|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723520|NCT03129100|42166666|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723521|NCT03129100|42166667|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
19723522|NCT03129100|42166668|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
19723523|NCT03129100|42166669|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
19723524|NCT03129100|42166670|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
19723525|NCT03129100|42166671|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723526|NCT03129100|42166672|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723527|NCT03129100|42166673|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723528|NCT03129100|42166674|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723529|NCT03129100|42166675|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723530|NCT03129100|42166676|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723531|NCT03129100|42166677|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723532|NCT03129100|42166678|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723533|NCT03129100|42166679|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723534|NCT03129100|42166680|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723535|NCT03129100|42166681|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
19723536|NCT03129100|42166656|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723537|NCT03129100|42166657|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723538|NCT03129100|42166658|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723539|NCT03129100|42166659|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723540|NCT03129100|42166660|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723541|NCT03129100|42166661|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723542|NCT03129100|42166662|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723543|NCT03129100|42166663|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723544|NCT03129100|42166664|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723545|NCT03129100|42166665|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723546|NCT03129100|42166666|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723547|NCT03129100|42166667|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
19723548|NCT03129100|42166668|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723549|NCT03129100|42166669|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
19723550|NCT03129100|42166670|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
19723551|NCT03129100|42166671|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723552|NCT03129100|42166672|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723553|NCT03129100|42166673|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723554|NCT03129100|42166674|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723555|NCT03129100|42166675|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723556|NCT03129100|42166676|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723557|NCT03129100|42166677|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723558|NCT03129100|42166678|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723559|NCT03129100|42166679|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723560|NCT03129100|42166680|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723561|NCT03129100|42166681|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
19723562|NCT03129100|42166656|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723563|NCT03129100|42166657|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723564|NCT03129100|42166658|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723565|NCT03129100|42166659|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723566|NCT03129100|42166660|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723567|NCT03129100|42166661|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723568|NCT03129100|42166662|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723569|NCT03129100|42166663|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723570|NCT03129100|42166664|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723571|NCT03129100|42166665|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723572|NCT03129100|42166666|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723573|NCT03129100|42166667|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723574|NCT03129100|42166668|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723575|NCT03129100|42166669|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723576|NCT03129100|42166670|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723577|NCT03129100|42166671|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
19723578|NCT03129100|42166672|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723579|NCT03129100|42166673|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723580|NCT03129100|42166674|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723581|NCT03129100|42166675|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723582|NCT03129100|42166676|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723583|NCT03129100|42166677|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723584|NCT03129100|42166678|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723585|NCT03129100|42166679|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723586|NCT03129100|42166680|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723587|NCT03129100|42166681|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
19723588|NCT03129100|42166656|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723589|NCT03129100|42166657|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723590|NCT03129100|42166658|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723591|NCT03129100|42166659|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723592|NCT03129100|42166660|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723593|NCT03129100|42166661|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723594|NCT03129100|42166662|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723595|NCT03129100|42166663|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723596|NCT03129100|42166664|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723597|NCT03129100|42166665|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723598|NCT03129100|42166666|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723599|NCT03129100|42166667|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723600|NCT03129100|42166668|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
19723601|NCT03129100|42166669|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723602|NCT03129100|42166670|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
19723603|NCT03129100|42166671|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
19723604|NCT03129100|42166672|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723605|NCT03129100|42166673|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723606|NCT03129100|42166674|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723607|NCT03129100|42166675|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723608|NCT03129100|42166676|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723609|NCT03129100|42166677|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723610|NCT03129100|42166678|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723611|NCT03129100|42166679|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723612|NCT03129100|42166680|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723613|NCT03129100|42166681|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
19723614|NCT03129100|42166656|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19550543|NCT01339559|41999602|FG000|Overall Study|Death|5|||
19550544|NCT01339559|41999602|FG000|Overall Study|Lack of Efficacy|164|||
19723615|NCT03129100|42166657|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723616|NCT03129100|42166658|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723617|NCT03129100|42166659|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723618|NCT03129100|42166660|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723619|NCT03129100|42166661|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723620|NCT03129100|42166662|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723621|NCT03129100|42166663|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723622|NCT03129100|42166664|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723623|NCT03129100|42166665|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723624|NCT03129100|42166666|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723625|NCT03129100|42166667|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723626|NCT03129100|42166668|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723627|NCT03129100|42166669|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723628|NCT03129100|42166670|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723629|NCT03129100|42166671|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723630|NCT03129100|42166672|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723631|NCT03129100|42166673|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
19723632|NCT03129100|42166674|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723633|NCT03129100|42166675|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
19723634|NCT03129100|42166676|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723635|NCT03129100|42166677|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723636|NCT03129100|42166678|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723637|NCT03129100|42166679|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723638|NCT03129100|42166680|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723639|NCT03129100|42166681|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
19723640|NCT03129100|42166656|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723641|NCT03129100|42166657|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723642|NCT03129100|42166658|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723643|NCT03129100|42166659|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723644|NCT03129100|42166660|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723645|NCT03129100|42166661|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723646|NCT03129100|42166662|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723647|NCT03129100|42166663|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723648|NCT03129100|42166664|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723649|NCT03129100|42166665|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723650|NCT03129100|42166666|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723651|NCT03129100|42166667|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723652|NCT03129100|42166668|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723653|NCT03129100|42166669|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723654|NCT03129100|42166670|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723655|NCT03129100|42166671|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723656|NCT03129100|42166672|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723657|NCT03129100|42166673|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723658|NCT03129100|42166674|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723659|NCT03129100|42166675|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723660|NCT03129100|42166676|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
19723661|NCT03129100|42166677|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723662|NCT03129100|42166678|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723663|NCT03129100|42166679|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723664|NCT03129100|42166680|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723665|NCT03129100|42166681|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
19723666|NCT03129100|42166656|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
19723667|NCT03129100|42166657|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
19723668|NCT03129100|42166658|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
19723669|NCT03129100|42166659|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
19723670|NCT03129100|42166660|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
19723671|NCT03129100|42166661|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
19723672|NCT03129100|42166662|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
19723673|NCT03129100|42166663|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
19723674|NCT03129100|42166664|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
19723675|NCT03129100|42166665|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
19723676|NCT03129100|42166666|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
19723677|NCT03129100|42166667|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
19723678|NCT03129100|42166668|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
19723679|NCT03129100|42166669|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
19723680|NCT03129100|42166670|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
19723681|NCT03129100|42166671|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
19723682|NCT03129100|42166672|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
19723683|NCT03129100|42166673|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
19723684|NCT03129100|42166674|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
19723685|NCT03129100|42166675|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
19723686|NCT03129100|42166676|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
19723687|NCT03129100|42166677|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
19723688|NCT03129100|42166678|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
19723689|NCT03129100|42166679|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
19723690|NCT03129100|42166680|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
19723691|NCT03129100|42166681|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
19723692|NCT03129100|42166656|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723693|NCT03129100|42166657|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723694|NCT03129100|42166658|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723695|NCT03129100|42166659|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723696|NCT03129100|42166660|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723697|NCT03129100|42166661|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723698|NCT03129100|42166662|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723699|NCT03129100|42166663|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723700|NCT03129100|42166664|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723701|NCT03129100|42166665|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723702|NCT03129100|42166666|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723703|NCT03129100|42166667|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723704|NCT03129100|42166668|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723705|NCT03129100|42166669|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723706|NCT03129100|42166670|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723707|NCT03129100|42166671|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723708|NCT03129100|42166672|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723709|NCT03129100|42166673|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723710|NCT03129100|42166674|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723711|NCT03129100|42166675|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723712|NCT03129100|42166676|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
19723713|NCT03129100|42166677|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723714|NCT03129100|42166678|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723715|NCT03129100|42166679|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723716|NCT03129100|42166680|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723717|NCT03129100|42166681|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
19723718|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
19723719|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
19723720|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
19723721|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
19723722|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
19723723|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
19723724|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
19723725|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
19723726|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
19723727|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
19723728|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
19723729|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
19723730|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
19723731|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
19723732|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
19723733|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
19723734|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
19723735|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
19723736|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
19723737|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
19723738|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
19723739|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
19723740|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
19723741|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
19723742|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
19723743|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
19723744|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723745|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723746|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723747|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723748|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723749|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723750|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723751|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723752|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723753|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723754|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723755|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723756|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723757|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723758|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723759|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723760|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723761|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723762|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723763|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723764|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723765|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723766|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723767|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
19723768|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
19723769|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
19723770|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723771|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723772|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723773|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723774|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723775|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723776|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723777|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723778|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723779|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723780|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723781|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723782|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723783|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723784|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723785|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723786|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723787|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723788|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723789|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723790|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723791|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723792|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
19723793|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
19723794|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
19723795|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
19723796|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723797|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723798|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723799|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723800|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723801|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723802|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723803|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723804|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723805|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723806|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723807|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723808|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723809|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723810|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723811|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723812|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723813|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723814|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723815|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723816|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723817|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723818|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723819|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723820|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
19723821|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
19723822|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723823|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723824|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723825|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723826|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723827|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723828|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723829|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723830|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723831|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723832|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723833|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723834|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723835|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723836|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723837|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723838|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723839|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723840|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723841|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723842|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723843|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723844|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723845|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723846|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
19723847|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
19723848|NCT03129100|42166656|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
19723849|NCT03129100|42166657|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
19723850|NCT03129100|42166658|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
19723851|NCT03129100|42166659|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
19723852|NCT03129100|42166660|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
19723853|NCT03129100|42166661|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
19723854|NCT03129100|42166662|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
19723855|NCT03129100|42166663|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
19723856|NCT03129100|42166664|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
19723857|NCT03129100|42166665|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
19723858|NCT03129100|42166666|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
19723859|NCT03129100|42166667|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
19723860|NCT03129100|42166668|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
19723861|NCT03129100|42166669|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
19723862|NCT03129100|42166670|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
19723863|NCT03129100|42166671|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
19723864|NCT03129100|42166672|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
19723865|NCT03129100|42166673|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
19723866|NCT03129100|42166674|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
19723867|NCT03129100|42166675|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
19723868|NCT03129100|42166676|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
19723869|NCT03129100|42166677|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
19723870|NCT03129100|42166678|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
19723871|NCT03129100|42166679|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
19723872|NCT03129100|42166680|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
19723873|NCT03129100|42166681|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
19723874|NCT03101020|42166720|FG000|Overall Study|Lack of time to participate|1|||
19723875|NCT03101020|42166721|FG001|Overall Study|Lack of time to participate|0|||
19723876|NCT03101020|42166720|FG000|Overall Study|Ran over by a car|0|||
19723877|NCT03101020|42166721|FG001|Overall Study|Ran over by a car|1|||
19723878|NCT03101020|42166720|FG000|Overall Study|Withdrawal by Subject|0|||
19723879|NCT03101020|42166721|FG001|Overall Study|Withdrawal by Subject|2|||
19723880|NCT03100942|42166731|FG000|Randomized Treatment Period|Withdrew Consent|4|||
19723881|NCT03100942|42166732|FG001|Randomized Treatment Period|Withdrew Consent|5|||
19723882|NCT03100942|42166733|FG002|Randomized Treatment Period|Withdrew Consent|3|||
19723883|NCT03100942|42166734|FG003|Randomized Treatment Period|Withdrew Consent|3|||
19723884|NCT03100942|42166735|FG004|Randomized Treatment Period|Withdrew Consent|0|||
19723885|NCT03100942|42166736|FG005|Randomized Treatment Period|Withdrew Consent|0|||
19723886|NCT03100942|42166737|FG006|Randomized Treatment Period|Withdrew Consent|0|||
19723887|NCT03100942|42166731|FG000|Randomized Treatment Period|Adverse Event|5|||
19723888|NCT03100942|42166732|FG001|Randomized Treatment Period|Adverse Event|2|||
19723889|NCT03100942|42166733|FG002|Randomized Treatment Period|Adverse Event|1|||
19723890|NCT03100942|42166734|FG003|Randomized Treatment Period|Adverse Event|0|||
19723891|NCT03100942|42166735|FG004|Randomized Treatment Period|Adverse Event|0|||
19723892|NCT03100942|42166736|FG005|Randomized Treatment Period|Adverse Event|0|||
19723893|NCT03100942|42166737|FG006|Randomized Treatment Period|Adverse Event|0|||
19723894|NCT03100942|42166731|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
19723895|NCT03100942|42166732|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
19723896|NCT03100942|42166733|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
19723897|NCT03100942|42166734|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
19723898|NCT03100942|42166735|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
19723899|NCT03100942|42166736|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
19723900|NCT03100942|42166737|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
19723901|NCT03100942|42166731|FG000|Randomized Treatment Period|Protocol Violation|0|||
19723902|NCT03100942|42166732|FG001|Randomized Treatment Period|Protocol Violation|1|||
19723903|NCT03100942|42166733|FG002|Randomized Treatment Period|Protocol Violation|1|||
19723904|NCT03100942|42166734|FG003|Randomized Treatment Period|Protocol Violation|1|||
19723905|NCT03100942|42166735|FG004|Randomized Treatment Period|Protocol Violation|0|||
19723906|NCT03100942|42166736|FG005|Randomized Treatment Period|Protocol Violation|0|||
19723907|NCT03100942|42166737|FG006|Randomized Treatment Period|Protocol Violation|0|||
19723908|NCT03100942|42166731|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
19723909|NCT03100942|42166732|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
19723910|NCT03100942|42166733|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
19723911|NCT03100942|42166734|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
19723912|NCT03100942|42166735|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
19723913|NCT03100942|42166736|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
19723914|NCT03100942|42166737|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
19723915|NCT03100942|42166731|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
19723916|NCT03100942|42166732|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
19723917|NCT03100942|42166733|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
19723918|NCT03100942|42166734|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
19723919|NCT03100942|42166735|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
19723920|NCT03100942|42166736|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
19723921|NCT03100942|42166737|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
19723922|NCT03100942|42166731|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723923|NCT03100942|42166732|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723924|NCT03100942|42166733|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723925|NCT03100942|42166734|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723926|NCT03100942|42166735|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723927|NCT03100942|42166736|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
19723928|NCT03100942|42166737|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
19723929|NCT03099694|42166752|FG000|Overall Study|Withdrawal by Subject|11|||
19723930|NCT03099694|42166753|FG001|Overall Study|Withdrawal by Subject|13|||
19723931|NCT03099694|42166752|FG000|Overall Study|Lost to Follow-up|9|||
19723932|NCT03099694|42166753|FG001|Overall Study|Lost to Follow-up|5|||
19723933|NCT03099538|42166760|FG000|Overall Study|Lack of Efficacy|3|||
19723934|NCT03099304|42166769|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
19723935|NCT03099304|42166770|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
19723936|NCT03099304|42166771|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
19723937|NCT03099304|42166772|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
19723938|NCT03099304|42166773|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
19723939|NCT03099304|42166774|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
19723940|NCT03099304|42166769|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
19723941|NCT03099304|42166770|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
19723942|NCT03099304|42166771|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
19723943|NCT03099304|42166772|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
19723944|NCT03099304|42166773|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
19723945|NCT03099304|42166774|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
19723946|NCT03099304|42166769|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
19723947|NCT03099304|42166770|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
19723948|NCT03099304|42166771|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
19723949|NCT03099304|42166772|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
19723950|NCT03099304|42166773|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
19723951|NCT03099304|42166774|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
19723952|NCT03099304|42166769|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
19723953|NCT03099304|42166770|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
19723954|NCT03099304|42166771|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
19723955|NCT03099304|42166772|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
19723956|NCT03099304|42166773|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
19723957|NCT03099304|42166774|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
19723958|NCT03099304|42166769|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
19723959|NCT03099304|42166770|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
19723960|NCT03099304|42166771|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
19723961|NCT03099304|42166772|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
19723962|NCT03099304|42166773|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
19723963|NCT03099304|42166774|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
19723964|NCT03099304|42166769|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
19723965|NCT03099304|42166770|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
19723966|NCT03099304|42166771|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
19723967|NCT03099304|42166772|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
19723968|NCT03099304|42166773|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
19723969|NCT03099304|42166774|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
19723970|NCT03099304|42166769|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
19723971|NCT03099304|42166770|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
19723972|NCT03099304|42166771|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
19723973|NCT03099304|42166772|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
19723974|NCT03099304|42166773|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
19723975|NCT03099304|42166774|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
19723976|NCT03099304|42166769|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
19723977|NCT03099304|42166770|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
19723978|NCT03099304|42166771|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
19723979|NCT03099304|42166772|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
19723980|NCT03099304|42166773|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
19723981|NCT03099304|42166774|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
19723982|NCT03099304|42166769|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
19723983|NCT03099304|42166770|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
19723984|NCT03099304|42166771|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
19723985|NCT03099304|42166772|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
19723986|NCT03099304|42166773|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
19723987|NCT03099304|42166774|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
19723988|NCT03099304|42166769|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
19723989|NCT03099304|42166770|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
19723990|NCT03099304|42166771|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
19723991|NCT03099304|42166772|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
19723992|NCT03099304|42166773|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
19723993|NCT03099304|42166774|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
19723994|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
19723995|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
19723996|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
19723997|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
19723998|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
19723999|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
19724000|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
19724001|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
19724002|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
19724003|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
19724004|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
19724005|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
19724006|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
19724007|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
19724008|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
19724009|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
19724010|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
19724011|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
19724012|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
19724013|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
19724014|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
19724015|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
19724016|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
19724017|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
19724018|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
19724019|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
19724020|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
19724021|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
19724022|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
19724023|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
19724024|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
19724025|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
19724026|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
19724027|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
19550545|NCT01339559|41999602|FG000|Overall Study|Lost to Follow-up|22|||
19724028|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
19724029|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
19724030|NCT03099304|42166769|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
19724031|NCT03099304|42166770|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
19724032|NCT03099304|42166771|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
19724033|NCT03099304|42166772|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
19724034|NCT03099304|42166773|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
19724035|NCT03099304|42166774|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
19724036|NCT03097588|42166801|FG000|Overall Study|Adverse Event|1|||
19724037|NCT01631214|42166807|FG000|Overall Study|Withdrawal by Subject|276|||
19724038|NCT01631214|42166808|FG001|Overall Study|Withdrawal by Subject|290|||
19724039|NCT01631214|42166807|FG000|Overall Study|Death|113|||
19724040|NCT01631214|42166808|FG001|Overall Study|Death|106|||
19724041|NCT01631214|42166807|FG000|Overall Study|Lost to Follow-up|54|||
19724042|NCT01631214|42166808|FG001|Overall Study|Lost to Follow-up|40|||
19724043|NCT01631214|42166807|FG000|Overall Study|Adverse Event|45|||
19724044|NCT01631214|42166808|FG001|Overall Study|Adverse Event|45|||
19724045|NCT01631214|42166807|FG000|Overall Study|Other|22|||
19724046|NCT01631214|42166808|FG001|Overall Study|Other|19|||
19724047|NCT01631214|42166807|FG000|Overall Study|Noncompliance|16|||
19724048|NCT01631214|42166808|FG001|Overall Study|Noncompliance|15|||
19724049|NCT01631214|42166807|FG000|Overall Study|Requirement for Alternative Therapy|8|||
19724050|NCT01631214|42166808|FG001|Overall Study|Requirement for Alternative Therapy|3|||
19724051|NCT01631214|42166807|FG000|Overall Study|Protocol Deviation|4|||
19724052|NCT01631214|42166808|FG001|Overall Study|Protocol Deviation|3|||
19724053|NCT01631214|42166807|FG000|Overall Study|Ineligibility determined|5|||
19724054|NCT01631214|42166808|FG001|Overall Study|Ineligibility determined|2|||
19724055|NCT01631214|42166807|FG000|Overall Study|Administrative Decision|1|||
19724056|NCT01631214|42166808|FG001|Overall Study|Administrative Decision|0|||
19724057|NCT03093454|42166818|FG000|Overall Study|Withdrawal by Subject|1|||
19724058|NCT03093454|42166819|FG001|Overall Study|Withdrawal by Subject|1|||
19724059|NCT03093454|42166818|FG000|Overall Study|Scheduling conflict|3|||
19724060|NCT03093454|42166819|FG001|Overall Study|Scheduling conflict|1|||
19724061|NCT03093454|42166818|FG000|Overall Study|Physician Decision|2|||
19724062|NCT03093454|42166819|FG001|Overall Study|Physician Decision|1|||
19724063|NCT00468130|42166840|FG000|Overall Study|Adverse Event|2|||
19724064|NCT00468130|42166841|FG001|Overall Study|Adverse Event|1|||
19724065|NCT00468130|42166840|FG000|Overall Study|Withdrawal by Subject|0|||
19724066|NCT00468130|42166841|FG001|Overall Study|Withdrawal by Subject|1|||
19724067|NCT00911820|42166851|FG000|Overall Study|RECIST progression|12|||
19724068|NCT00911820|42166852|FG001|Overall Study|RECIST progression|8|||
19724069|NCT00911820|42166851|FG000|Overall Study|Adverse Event|8|||
19724070|NCT00911820|42166852|FG001|Overall Study|Adverse Event|8|||
19724071|NCT00911820|42166851|FG000|Overall Study|Clinical Progression|7|||
19724072|NCT00911820|42166852|FG001|Overall Study|Clinical Progression|5|||
19724073|NCT00911820|42166851|FG000|Overall Study|Physician Decision|5|||
19724074|NCT00911820|42166852|FG001|Overall Study|Physician Decision|9|||
19724075|NCT00911820|42166851|FG000|Overall Study|Decline in Performance Status|4|||
19724076|NCT00911820|42166852|FG001|Overall Study|Decline in Performance Status|2|||
19724077|NCT00911820|42166851|FG000|Overall Study|Withdrawal by Subject|3|||
19724078|NCT00911820|42166852|FG001|Overall Study|Withdrawal by Subject|4|||
19724079|NCT00911820|42166851|FG000|Overall Study|Death|1|||
19724080|NCT00911820|42166852|FG001|Overall Study|Death|2|||
19724081|NCT00911820|42166851|FG000|Overall Study|Pursue surgery|1|||
19724082|NCT00911820|42166852|FG001|Overall Study|Pursue surgery|1|||
19724083|NCT00911820|42166851|FG000|Overall Study|Pursue Radiation|1|||
19724084|NCT00911820|42166852|FG001|Overall Study|Pursue Radiation|0|||
19724085|NCT00911820|42166851|FG000|Overall Study|Still on Therapy|2|||
19724086|NCT00911820|42166852|FG001|Overall Study|Still on Therapy|2|||
19724087|NCT00911820|42166851|FG000|Overall Study|Pathology Not Confirmed|1|||
19724088|NCT00911820|42166852|FG001|Overall Study|Pathology Not Confirmed|0|||
19724089|NCT00911820|42166851|FG000|Overall Study|Withdraw before Receive Treatment|0|||
19724090|NCT00911820|42166852|FG001|Overall Study|Withdraw before Receive Treatment|2|||
19724091|NCT00246324|42166867|FG000|Overall Study|Withdrawal by Subject|1|||
19724092|NCT00999804|42166873|FG000|Overall Study|Lack of Efficacy|9|||
19724093|NCT00999804|42166874|FG001|Overall Study|Lack of Efficacy|2|||
19724094|NCT00999804|42166873|FG000|Overall Study|Adverse Event|4|||
19724095|NCT00999804|42166874|FG001|Overall Study|Adverse Event|3|||
19724096|NCT00999804|42166873|FG000|Overall Study|Withdrawal by Subject|4|||
19724097|NCT00999804|42166874|FG001|Overall Study|Withdrawal by Subject|0|||
19724098|NCT00999804|42166873|FG000|Overall Study|Death|1|||
19724099|NCT00999804|42166874|FG001|Overall Study|Death|0|||
19724100|NCT00999804|42166873|FG000|Overall Study|Ineligible|3|||
19724101|NCT00999804|42166874|FG001|Overall Study|Ineligible|0|||
19724102|NCT02874742|42166883|FG000|Overall Study|Death|3|||
19724103|NCT02874742|42166884|FG001|Overall Study|Death|1|||
19724104|NCT02874742|42166885|FG002|Overall Study|Death|1|||
19724105|NCT02874742|42166883|FG000|Overall Study|Lost to Follow-up|2|||
19724106|NCT02874742|42166884|FG001|Overall Study|Lost to Follow-up|0|||
19724107|NCT02874742|42166885|FG002|Overall Study|Lost to Follow-up|0|||
19724108|NCT02874742|42166883|FG000|Overall Study|Withdrawal by Subject|8|||
19724109|NCT02874742|42166884|FG001|Overall Study|Withdrawal by Subject|4|||
19724110|NCT02874742|42166885|FG002|Overall Study|Withdrawal by Subject|0|||
19724111|NCT02874742|42166883|FG000|Overall Study|Other|3|||
19724112|NCT02874742|42166884|FG001|Overall Study|Other|1|||
19724113|NCT02874742|42166885|FG002|Overall Study|Other|0|||
19724114|NCT02874742|42166883|FG000|Overall Study|Ongoing|87|||
19724115|NCT02874742|42166884|FG001|Overall Study|Ongoing|98|||
19724116|NCT02874742|42166885|FG002|Overall Study|Ongoing|15|||
19724117|NCT04234984|42166895|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
19724118|NCT04234984|42166895|FG000|Follow-up at the Second Time Point|Death|1|||
19724119|NCT04234984|42166895|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
19724120|NCT03922750|42166909|FG000|Overall Study|Unclassified|0|||
19724121|NCT03922750|42166910|FG001|Overall Study|Unclassified|0|||
19724122|NCT03922750|42166911|FG002|Overall Study|Unclassified|1|||
19724123|NCT03922750|42166909|FG000|Overall Study|Adverse Event|0|||
19724124|NCT03922750|42166910|FG001|Overall Study|Adverse Event|1|||
19724125|NCT03922750|42166911|FG002|Overall Study|Adverse Event|0|||
19724126|NCT03617172|42166921|FG000|Overall Study|Lost to Follow-up|1|||
19724127|NCT03617172|42166922|FG001|Overall Study|Lost to Follow-up|0|||
19724128|NCT03760146|42166934|FG000|Overall Study|Adverse Event|11|||
19724129|NCT03760146|42166935|FG001|Overall Study|Adverse Event|8|||
19724130|NCT03760146|42166936|FG002|Overall Study|Adverse Event|0|||
19724131|NCT03760146|42166937|FG003|Overall Study|Adverse Event|0|||
19724132|NCT03760146|42166938|FG004|Overall Study|Adverse Event|0|||
19724133|NCT03760146|42166939|FG005|Overall Study|Adverse Event|0|||
19724134|NCT03760146|42166934|FG000|Overall Study|Death|1|||
19724135|NCT03760146|42166935|FG001|Overall Study|Death|0|||
19724136|NCT03760146|42166936|FG002|Overall Study|Death|0|||
19724137|NCT03760146|42166937|FG003|Overall Study|Death|0|||
19724138|NCT03760146|42166938|FG004|Overall Study|Death|0|||
19724139|NCT03760146|42166939|FG005|Overall Study|Death|0|||
19724140|NCT03760146|42166934|FG000|Overall Study|Lost to Follow-up|41|||
19724141|NCT03760146|42166935|FG001|Overall Study|Lost to Follow-up|28|||
19724142|NCT03760146|42166936|FG002|Overall Study|Lost to Follow-up|9|||
19724143|NCT03760146|42166937|FG003|Overall Study|Lost to Follow-up|2|||
19724144|NCT03760146|42166938|FG004|Overall Study|Lost to Follow-up|14|||
19724145|NCT03760146|42166939|FG005|Overall Study|Lost to Follow-up|8|||
19724146|NCT03760146|42166934|FG000|Overall Study|No longer met eligibility criteria|3|||
19724147|NCT03760146|42166935|FG001|Overall Study|No longer met eligibility criteria|9|||
19724148|NCT03760146|42166936|FG002|Overall Study|No longer met eligibility criteria|0|||
19724149|NCT03760146|42166937|FG003|Overall Study|No longer met eligibility criteria|0|||
19724150|NCT03760146|42166938|FG004|Overall Study|No longer met eligibility criteria|1|||
19724151|NCT03760146|42166939|FG005|Overall Study|No longer met eligibility criteria|0|||
19724152|NCT03760146|42166934|FG000|Overall Study|Protocol Violation|21|||
19724153|NCT03760146|42166935|FG001|Overall Study|Protocol Violation|13|||
19724154|NCT03760146|42166936|FG002|Overall Study|Protocol Violation|1|||
19724155|NCT03760146|42166937|FG003|Overall Study|Protocol Violation|0|||
19724156|NCT03760146|42166938|FG004|Overall Study|Protocol Violation|1|||
19724157|NCT03760146|42166939|FG005|Overall Study|Protocol Violation|0|||
19724158|NCT03760146|42166934|FG000|Overall Study|Withdrawal by Subject|19|||
19724159|NCT03760146|42166935|FG001|Overall Study|Withdrawal by Subject|20|||
19724160|NCT03760146|42166936|FG002|Overall Study|Withdrawal by Subject|1|||
19724161|NCT03760146|42166937|FG003|Overall Study|Withdrawal by Subject|0|||
19724162|NCT03760146|42166938|FG004|Overall Study|Withdrawal by Subject|1|||
19724163|NCT03760146|42166939|FG005|Overall Study|Withdrawal by Subject|0|||
19724164|NCT03759366|42166957|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
19724165|NCT03759366|42166957|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
19724166|NCT03760068|42166963|FG000|Overall Study|Withdrawal by Subject|7|||
19724167|NCT03760068|42166964|FG001|Overall Study|Withdrawal by Subject|8|||
19724168|NCT03760068|42166963|FG000|Overall Study|Adverse Event|1|||
19724169|NCT03760068|42166964|FG001|Overall Study|Adverse Event|2|||
19724170|NCT03760068|42166963|FG000|Overall Study|Administrative Decision by Sponsor|0|||
19724171|NCT03760068|42166964|FG001|Overall Study|Administrative Decision by Sponsor|2|||
19724172|NCT03760068|42166963|FG000|Overall Study|Physician Decision|1|||
19724173|NCT03760068|42166964|FG001|Overall Study|Physician Decision|2|||
19724174|NCT03760068|42166963|FG000|Overall Study|Lost to Follow-up|4|||
19724175|NCT03760068|42166964|FG001|Overall Study|Lost to Follow-up|9|||
19724176|NCT03760068|42166963|FG000|Overall Study|Subject Moved Out of State|1|||
19724177|NCT03760068|42166964|FG001|Overall Study|Subject Moved Out of State|0|||
19724178|NCT03759600|42166971|FG000|Overall Study|Ongoing at Data Cut-off|16|||
19724179|NCT03759600|42166971|FG000|Overall Study|Adverse Event|1|||
19724180|NCT03759600|42166971|FG000|Overall Study|Progressive Disease|3|||
19724181|NCT04724733|42166978|FG000|Overall Study|Lost to Follow-up|1|||
19724182|NCT04724733|42166979|FG001|Overall Study|Lost to Follow-up|1|||
19724183|NCT04724733|42166980|FG002|Overall Study|Lost to Follow-up|1|||
19724184|NCT04635839|42166990|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
19724185|NCT04635839|42166991|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
19724186|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
19724187|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
19724188|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
19724189|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
19724190|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
19724191|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
19724192|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
19724193|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
19724194|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
19724195|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
19724196|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
19724197|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
19724198|NCT04493502|42166999|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
19724199|NCT04493502|42167000|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
19724200|NCT04493502|42166999|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
19724201|NCT04493502|42167000|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
19724202|NCT04493502|42166999|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
19724203|NCT04493502|42167000|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
19724204|NCT04493502|42166999|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
19724205|NCT04493502|42167000|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
19724206|NCT04493502|42166999|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
19724207|NCT04493502|42167000|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
19724208|NCT04493502|42166999|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
19724209|NCT04493502|42167000|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
19724210|NCT04493502|42166999|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
19724211|NCT04493502|42167000|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
19724212|NCT04325828|42167008|FG000|Overall Study|Ongoing|26|||
19724213|NCT04147858|42167015|FG000|Overall Study|Adverse Event|6|||
19724214|NCT04147858|42167016|FG001|Overall Study|Adverse Event|6|||
19724215|NCT04147858|42167017|FG002|Overall Study|Adverse Event|6|||
19724216|NCT04147858|42167015|FG000|Overall Study|Lack of Efficacy|3|||
19724217|NCT04147858|42167016|FG001|Overall Study|Lack of Efficacy|3|||
19724218|NCT04147858|42167017|FG002|Overall Study|Lack of Efficacy|1|||
19724219|NCT04147858|42167015|FG000|Overall Study|Lost to Follow-up|1|||
19724220|NCT04147858|42167016|FG001|Overall Study|Lost to Follow-up|6|||
19724221|NCT04147858|42167017|FG002|Overall Study|Lost to Follow-up|2|||
19724222|NCT04147858|42167015|FG000|Overall Study|Withdrawal by Subject|3|||
19724223|NCT04147858|42167016|FG001|Overall Study|Withdrawal by Subject|4|||
19724224|NCT04147858|42167017|FG002|Overall Study|Withdrawal by Subject|10|||
19724225|NCT04147858|42167015|FG000|Overall Study|Subject Noncompliance, Other|4|||
19724226|NCT04147858|42167016|FG001|Overall Study|Subject Noncompliance, Other|3|||
19724227|NCT04147858|42167017|FG002|Overall Study|Subject Noncompliance, Other|1|||
19724228|NCT04146896|42167027|FG000|Overall Study|Adverse Event|5|||
19724229|NCT04146896|42167028|FG001|Overall Study|Adverse Event|8|||
19724230|NCT04146896|42167027|FG000|Overall Study|Lack of Efficacy|3|||
19724231|NCT04146896|42167028|FG001|Overall Study|Lack of Efficacy|2|||
19724232|NCT04146896|42167027|FG000|Overall Study|Lost to Follow-up|0|||
19724233|NCT04146896|42167028|FG001|Overall Study|Lost to Follow-up|1|||
19724234|NCT04146896|42167027|FG000|Overall Study|Non-compliance|5|||
19724235|NCT04146896|42167028|FG001|Overall Study|Non-compliance|4|||
19724236|NCT04146896|42167027|FG000|Overall Study|Withdrawal by Subject|3|||
19724237|NCT04146896|42167028|FG001|Overall Study|Withdrawal by Subject|5|||
19724238|NCT04146896|42167027|FG000|Overall Study|Randomized in error|1|||
19724239|NCT04146896|42167028|FG001|Overall Study|Randomized in error|2|||
19724240|NCT04072887|42167040|FG000|Overall Study|Withdrawal by Subject|3|||
19724241|NCT04072887|42167041|FG001|Overall Study|Withdrawal by Subject|8|||
19724242|NCT04072887|42167042|FG002|Overall Study|Withdrawal by Subject|1|||
19724243|NCT04072887|42167043|FG003|Overall Study|Withdrawal by Subject|3|||
19724244|NCT04072887|42167044|FG004|Overall Study|Withdrawal by Subject|3|||
19724245|NCT04072887|42167045|FG005|Overall Study|Withdrawal by Subject|13|||
19724246|NCT04072887|42167040|FG000|Overall Study|Adverse Event|2|||
19724247|NCT04072887|42167041|FG001|Overall Study|Adverse Event|4|||
19724248|NCT04072887|42167042|FG002|Overall Study|Adverse Event|1|||
19724249|NCT04072887|42167043|FG003|Overall Study|Adverse Event|4|||
19724250|NCT04072887|42167044|FG004|Overall Study|Adverse Event|0|||
19724251|NCT04072887|42167045|FG005|Overall Study|Adverse Event|1|||
19724252|NCT04072887|42167040|FG000|Overall Study|Physician Decision|2|||
19724253|NCT04072887|42167041|FG001|Overall Study|Physician Decision|0|||
19724254|NCT04072887|42167042|FG002|Overall Study|Physician Decision|0|||
19724255|NCT04072887|42167043|FG003|Overall Study|Physician Decision|0|||
19724256|NCT04072887|42167044|FG004|Overall Study|Physician Decision|0|||
19724257|NCT04072887|42167045|FG005|Overall Study|Physician Decision|1|||
19724258|NCT04072887|42167040|FG000|Overall Study|Lost to Follow-up|1|||
19724259|NCT04072887|42167041|FG001|Overall Study|Lost to Follow-up|3|||
19724260|NCT04072887|42167042|FG002|Overall Study|Lost to Follow-up|0|||
19724261|NCT04072887|42167043|FG003|Overall Study|Lost to Follow-up|0|||
19724262|NCT04072887|42167044|FG004|Overall Study|Lost to Follow-up|0|||
19724263|NCT04072887|42167045|FG005|Overall Study|Lost to Follow-up|0|||
19724264|NCT04072887|42167040|FG000|Overall Study|Death|0|||
19724265|NCT04072887|42167041|FG001|Overall Study|Death|2|||
19724266|NCT04072887|42167042|FG002|Overall Study|Death|0|||
19724267|NCT04072887|42167043|FG003|Overall Study|Death|2|||
19724268|NCT04072887|42167044|FG004|Overall Study|Death|3|||
19724269|NCT04072887|42167045|FG005|Overall Study|Death|0|||
19724270|NCT03516812|42167138|FG000|Overall Study|Adverse Event|4|||
19724271|NCT03516812|42167138|FG000|Overall Study|Lack of Efficacy|2|||
19724272|NCT03366844|42167173|FG000|Overall Study|Physician Decision|1|||
19724273|NCT03366844|42167173|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
19724274|NCT03282123|42167188|FG000|Overall Study|Withdrawal by Subject|5|||
19724275|NCT03213665|42167193|FG000|Overall Study|Adverse Event|1|||
19724276|NCT03213665|42167193|FG000|Overall Study|Physician Decision|2|||
19724277|NCT03213665|42167193|FG000|Overall Study|Withdrawal by Subject|3|||
19724278|NCT03213665|42167193|FG000|Overall Study|Progressive Disease|13|||
19724279|NCT03122119|42167197|FG000|Overall Study|Did not meet eligibility critria|1|||
19724280|NCT02613169|42167217|FG000|Overall Study|Withdrawal by Subject|4|||
19724281|NCT02613169|42167218|FG001|Overall Study|Withdrawal by Subject|1|||
19724282|NCT02613169|42167217|FG000|Overall Study|Lost to Follow-up|0|||
19724283|NCT02613169|42167218|FG001|Overall Study|Lost to Follow-up|5|||
19724284|NCT02613169|42167217|FG000|Overall Study|HIV|0|||
19724285|NCT02613169|42167218|FG001|Overall Study|HIV|2|||
19724286|NCT02613169|42167217|FG000|Overall Study|No TB infection endpoint|14|||
19724287|NCT02613169|42167218|FG001|Overall Study|No TB infection endpoint|9|||
19724288|NCT02362464|42167237|FG000|Overall Study|Switched to alternative therapy|1|||
19724289|NCT02362464|42167237|FG000|Overall Study|Refused further treatment|1|||
19724290|NCT02362464|42167237|FG000|Overall Study|Physician Decision|4|||
19724291|NCT02352948|42167247|FG000|Overall Study|Death|47|||
19724292|NCT02352948|42167248|FG001|Overall Study|Death|48|||
19724293|NCT02352948|42167249|FG002|Overall Study|Death|114|||
19724294|NCT02352948|42167250|FG003|Overall Study|Death|74|||
19724295|NCT02352948|42167251|FG004|Overall Study|Death|77|||
19724296|NCT02352948|42167252|FG005|Overall Study|Death|44|||
19724297|NCT02352948|42167247|FG000|Overall Study|Lost to Follow-up|1|||
19724298|NCT02352948|42167248|FG001|Overall Study|Lost to Follow-up|0|||
19724299|NCT02352948|42167249|FG002|Overall Study|Lost to Follow-up|2|||
19724300|NCT02352948|42167250|FG003|Overall Study|Lost to Follow-up|1|||
19724301|NCT02352948|42167251|FG004|Overall Study|Lost to Follow-up|2|||
19724302|NCT02352948|42167252|FG005|Overall Study|Lost to Follow-up|1|||
19724303|NCT02352948|42167247|FG000|Overall Study|Withdrawal by Subject|1|||
19724304|NCT02352948|42167248|FG001|Overall Study|Withdrawal by Subject|10|||
19724305|NCT02352948|42167249|FG002|Overall Study|Withdrawal by Subject|11|||
19724306|NCT02352948|42167250|FG003|Overall Study|Withdrawal by Subject|23|||
19724307|NCT02352948|42167251|FG004|Overall Study|Withdrawal by Subject|9|||
19724308|NCT02352948|42167252|FG005|Overall Study|Withdrawal by Subject|4|||
19724309|NCT02352948|42167247|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
19724310|NCT02352948|42167248|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
19724311|NCT02352948|42167249|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
19724312|NCT02352948|42167250|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
19724313|NCT02352948|42167251|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
19724314|NCT02352948|42167252|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
19724315|NCT02352948|42167247|FG000|Overall Study|Other|0|||
19724316|NCT02352948|42167248|FG001|Overall Study|Other|0|||
19724317|NCT02352948|42167249|FG002|Overall Study|Other|2|||
19724318|NCT02352948|42167250|FG003|Overall Study|Other|0|||
19724319|NCT02352948|42167251|FG004|Overall Study|Other|0|||
19724320|NCT02352948|42167252|FG005|Overall Study|Other|0|||
19724321|NCT02008396|42167274|FG000|Overall Study|Protocol Violation|0|||
19724322|NCT02008396|42167275|FG001|Overall Study|Protocol Violation|1|||
19724323|NCT01974765|42167282|FG000|Overall Study|Withdrawal by Subject|1|||
19724324|NCT01974765|42167282|FG000|Overall Study|Death|1|||
19724325|NCT01974765|42167282|FG000|Overall Study|Adverse Event|2|||
19724326|NCT01802281|42167298|FG000|Overall Study|Death|1|||
19724327|NCT01802281|42167299|FG001|Overall Study|Death|2|||
19724328|NCT01802281|42167298|FG000|Overall Study|Withdrawal by Subject|2|||
19724329|NCT01802281|42167299|FG001|Overall Study|Withdrawal by Subject|1|||
19724330|NCT01802281|42167298|FG000|Overall Study|Ineligible|5|||
19724331|NCT01802281|42167299|FG001|Overall Study|Ineligible|3|||
19724332|NCT01793610|42167308|FG000|Overall Study|Withdrawal by Subject|1|||
19724333|NCT01793610|42167309|FG001|Overall Study|Withdrawal by Subject|0|||
19724334|NCT01793610|42167310|FG002|Overall Study|Withdrawal by Subject|1|||
19724335|NCT01725217|42167325|FG000|Overall Study|Withdrawal by Subject|1|||
19724336|NCT01725217|42167326|FG001|Overall Study|Withdrawal by Subject|0|||
19724337|NCT01725217|42167327|FG002|Overall Study|Withdrawal by Subject|0|||
19724338|NCT01592370|42167351|FG000|Overall Study|Disease Progression|62|||
19724339|NCT01592370|42167352|FG001|Overall Study|Disease Progression|16|||
19724340|NCT01592370|42167353|FG002|Overall Study|Disease Progression|52|||
19724341|NCT01592370|42167354|FG003|Overall Study|Disease Progression|3|||
19724342|NCT01592370|42167355|FG004|Overall Study|Disease Progression|3|||
19724343|NCT01592370|42167356|FG005|Overall Study|Disease Progression|31|||
19724344|NCT01592370|42167357|FG006|Overall Study|Disease Progression|14|||
19724345|NCT01592370|42167351|FG000|Overall Study|Study Drug Toxicity|14|||
19724346|NCT01592370|42167352|FG001|Overall Study|Study Drug Toxicity|3|||
19724347|NCT01592370|42167353|FG002|Overall Study|Study Drug Toxicity|0|||
19724348|NCT01592370|42167354|FG003|Overall Study|Study Drug Toxicity|0|||
19724349|NCT01592370|42167355|FG004|Overall Study|Study Drug Toxicity|0|||
19724350|NCT01592370|42167356|FG005|Overall Study|Study Drug Toxicity|0|||
19724351|NCT01592370|42167357|FG006|Overall Study|Study Drug Toxicity|1|||
19724352|NCT01592370|42167351|FG000|Overall Study|AE unrelated to study drug|4|||
19724353|NCT01592370|42167352|FG001|Overall Study|AE unrelated to study drug|3|||
19724354|NCT01592370|42167353|FG002|Overall Study|AE unrelated to study drug|0|||
19724355|NCT01592370|42167354|FG003|Overall Study|AE unrelated to study drug|0|||
19724356|NCT01592370|42167355|FG004|Overall Study|AE unrelated to study drug|0|||
19724357|NCT01592370|42167356|FG005|Overall Study|AE unrelated to study drug|0|||
19724358|NCT01592370|42167357|FG006|Overall Study|AE unrelated to study drug|1|||
19724359|NCT01592370|42167351|FG000|Overall Study|Request to discontinue study treatment|5|||
19724360|NCT01592370|42167352|FG001|Overall Study|Request to discontinue study treatment|0|||
19724361|NCT01592370|42167353|FG002|Overall Study|Request to discontinue study treatment|2|||
19724362|NCT01592370|42167354|FG003|Overall Study|Request to discontinue study treatment|0|||
19724363|NCT01592370|42167355|FG004|Overall Study|Request to discontinue study treatment|1|||
19724364|NCT01592370|42167356|FG005|Overall Study|Request to discontinue study treatment|2|||
19724365|NCT01592370|42167357|FG006|Overall Study|Request to discontinue study treatment|0|||
19724366|NCT01592370|42167351|FG000|Overall Study|Withdrew consent|1|||
19724367|NCT01592370|42167352|FG001|Overall Study|Withdrew consent|2|||
19724368|NCT01592370|42167353|FG002|Overall Study|Withdrew consent|1|||
19724369|NCT01592370|42167354|FG003|Overall Study|Withdrew consent|1|||
19724370|NCT01592370|42167355|FG004|Overall Study|Withdrew consent|0|||
19724371|NCT01592370|42167356|FG005|Overall Study|Withdrew consent|0|||
19724372|NCT01592370|42167357|FG006|Overall Study|Withdrew consent|0|||
19724373|NCT01592370|42167351|FG000|Overall Study|Maximum clinical benefit|11|||
19724374|NCT01592370|42167352|FG001|Overall Study|Maximum clinical benefit|1|||
19724375|NCT01592370|42167353|FG002|Overall Study|Maximum clinical benefit|7|||
19724376|NCT01592370|42167354|FG003|Overall Study|Maximum clinical benefit|1|||
19724377|NCT01592370|42167355|FG004|Overall Study|Maximum clinical benefit|0|||
19724378|NCT01592370|42167356|FG005|Overall Study|Maximum clinical benefit|0|||
19724379|NCT01592370|42167357|FG006|Overall Study|Maximum clinical benefit|0|||
19724380|NCT01592370|42167351|FG000|Overall Study|No longer meets study criteria|1|||
19724381|NCT01592370|42167352|FG001|Overall Study|No longer meets study criteria|0|||
19724382|NCT01592370|42167353|FG002|Overall Study|No longer meets study criteria|0|||
19724383|NCT01592370|42167354|FG003|Overall Study|No longer meets study criteria|0|||
19724384|NCT01592370|42167355|FG004|Overall Study|No longer meets study criteria|0|||
19724385|NCT01592370|42167356|FG005|Overall Study|No longer meets study criteria|0|||
19724386|NCT01592370|42167357|FG006|Overall Study|No longer meets study criteria|0|||
19724387|NCT01592370|42167351|FG000|Overall Study|Other Reasons|6|||
19724388|NCT01592370|42167352|FG001|Overall Study|Other Reasons|0|||
19724389|NCT01592370|42167353|FG002|Overall Study|Other Reasons|10|||
19724390|NCT01592370|42167354|FG003|Overall Study|Other Reasons|0|||
19724391|NCT01592370|42167355|FG004|Overall Study|Other Reasons|0|||
19724392|NCT01592370|42167356|FG005|Overall Study|Other Reasons|1|||
19724393|NCT01592370|42167357|FG006|Overall Study|Other Reasons|0|||
19724394|NCT01344057|42167386|FG000|Overall Study|Premature Withdrawal|1|||
19724395|NCT00886782|42167393|FG000|Overall Study|Disease progression|3|||
19724396|NCT00886782|42167394|FG001|Overall Study|Disease progression|3|||
19724397|NCT00886782|42167395|FG002|Overall Study|Disease progression|3|||
19724398|NCT00886782|42167393|FG000|Overall Study|Study drug toxicity|0|||
19724399|NCT00886782|42167394|FG001|Overall Study|Study drug toxicity|0|||
19724400|NCT00886782|42167395|FG002|Overall Study|Study drug toxicity|1|||
19724401|NCT00886782|42167393|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
19724402|NCT00886782|42167394|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
19724403|NCT00886782|42167395|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
19724404|NCT00583024|42167403|FG000|Overall Study|Lost to Follow-up|4|||
19724405|NCT03435640|42167431|FG000|Overall Study|Withdrawal by Subject|0|||
19724406|NCT03435640|42167432|FG001|Overall Study|Withdrawal by Subject|1|||
19724407|NCT03435640|42167433|FG002|Overall Study|Withdrawal by Subject|0|||
19724408|NCT03435640|42167434|FG003|Overall Study|Withdrawal by Subject|2|||
19724409|NCT03435640|42167435|FG004|Overall Study|Withdrawal by Subject|0|||
19724410|NCT03435640|42167436|FG005|Overall Study|Withdrawal by Subject|0|||
19724411|NCT03435640|42167437|FG006|Overall Study|Withdrawal by Subject|3|||
19724412|NCT03435640|42167438|FG007|Overall Study|Withdrawal by Subject|0|||
19724413|NCT03435640|42167439|FG008|Overall Study|Withdrawal by Subject|0|||
19724414|NCT03435640|42167440|FG009|Overall Study|Withdrawal by Subject|2|||
19724415|NCT03435640|42167441|FG010|Overall Study|Withdrawal by Subject|3|||
19724416|NCT03435640|42167431|FG000|Overall Study|Lost to Follow-up|0|||
19724417|NCT03435640|42167432|FG001|Overall Study|Lost to Follow-up|0|||
19724418|NCT03435640|42167433|FG002|Overall Study|Lost to Follow-up|1|||
19724419|NCT03435640|42167434|FG003|Overall Study|Lost to Follow-up|0|||
19724420|NCT03435640|42167435|FG004|Overall Study|Lost to Follow-up|0|||
19724421|NCT03435640|42167436|FG005|Overall Study|Lost to Follow-up|0|||
19724422|NCT03435640|42167437|FG006|Overall Study|Lost to Follow-up|0|||
19724423|NCT03435640|42167438|FG007|Overall Study|Lost to Follow-up|0|||
19724424|NCT03435640|42167439|FG008|Overall Study|Lost to Follow-up|0|||
19724425|NCT03435640|42167440|FG009|Overall Study|Lost to Follow-up|0|||
19724426|NCT03435640|42167441|FG010|Overall Study|Lost to Follow-up|0|||
19724427|NCT00655876|42167469|FG000|Overall Study|Protocol Violation|9|||
19724428|NCT00655876|42167470|FG001|Overall Study|Protocol Violation|7|||
19724429|NCT03092752|42167476|FG000|Overall Study|Aged <40 years|14209|||
19724430|NCT03092752|42167476|FG000|Overall Study|At least one claim with T2DM|61299|||
19724431|NCT03092752|42167476|FG000|Overall Study|Having no claim of study drugs|29282|||
19724432|NCT03092752|42167476|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
19724433|NCT03092752|42167476|FG000|Overall Study|<6 month history|245900|||
19724434|NCT03750552|42167499|FG000|Overall Study|Adverse Event|5|||
19724435|NCT03750552|42167500|FG001|Overall Study|Adverse Event|1|||
19724436|NCT03750552|42167499|FG000|Overall Study|Withdrawal by Subject|1|||
19724437|NCT03750552|42167500|FG001|Overall Study|Withdrawal by Subject|1|||
19724438|NCT03750552|42167499|FG000|Overall Study|Other|2|||
19724439|NCT03750552|42167500|FG001|Overall Study|Other|0|||
19724440|NCT03750240|42167507|FG000|Overall Study|Technical Difficulties|2|||
19724441|NCT00047008|42167513|FG000|Overall Study|Withdrawn consent|2|||
19724442|NCT00047008|42167514|FG001|Overall Study|Withdrawn consent|3|||
19724443|NCT00047008|42167513|FG000|Overall Study|Ineligible|9|||
19724444|NCT00047008|42167514|FG001|Overall Study|Ineligible|8|||
19724445|NCT03091738|42167520|FG000|Overall Study|Adverse Event|1|||
19724446|NCT03091738|42167520|FG000|Overall Study|Lost to Follow-up|1|||
19724447|NCT03193216|42167526|FG000|Overall Study|Lost to Follow-up|1|||
19724448|NCT03193216|42167527|FG001|Overall Study|Lost to Follow-up|0|||
19724449|NCT03193216|42167526|FG000|Overall Study|Withdrawal by Subject|5|||
19724450|NCT03193216|42167527|FG001|Overall Study|Withdrawal by Subject|0|||
19724451|NCT03193216|42167526|FG000|Overall Study|Physician Decision|4|||
19724452|NCT03193216|42167527|FG001|Overall Study|Physician Decision|0|||
19724453|NCT03091348|42167535|FG000|Overall Study|Lost to Follow-up|2|||
19724454|NCT03091348|42167536|FG001|Overall Study|Lost to Follow-up|1|||
19724455|NCT03751098|42167543|FG000|Overall Study|Withdrawal by Subject|0|||
19724456|NCT03751098|42167544|FG001|Overall Study|Withdrawal by Subject|1|||
19460151|NCT01810783|41714633|FG000|Overall Study|Withdrawal by Subject|22|||
19460152|NCT01810783|41714633|FG000|Overall Study|Lack of Efficacy|12|||
19460153|NCT01810783|41714633|FG000|Overall Study|Lost to Follow-up|10|||
19460154|NCT01810783|41714633|FG000|Overall Study|Protocol Violation|5|||
19460155|NCT01810783|41714633|FG000|Overall Study|Non-compliance with IMP|4|||
19460156|NCT01810783|41714633|FG000|Overall Study|Adminstrative or other reason(s)|23|||
19460157|NCT01810783|41714633|FG000|Overall Study|Enrolled, not treated|1|||
19460158|NCT01808209|41714654|FG000|Overall Study|Lost to Follow-up|0|||
19460159|NCT01808209|41714655|FG001|Overall Study|Lost to Follow-up|1|||
19460160|NCT01807117|41714665|FG000|Overall Study|Physician Decision|2|||
19460161|NCT01807117|41714665|FG000|Overall Study|Disease diagnosis not a study disease|1|||
19460162|NCT01806961|41714671|FG000|Overall Study|sponsor decision|16|||
19460163|NCT01613131|41714677|FG000|Overall Study|Withdrawal by Subject|3|||
19724457|NCT03751020|42167555|FG000|Overall Study|Withdrawal by Subject|2|||
19724458|NCT03751020|42167556|FG001|Overall Study|Withdrawal by Subject|0|||
19724459|NCT03751020|42167557|FG002|Overall Study|Withdrawal by Subject|0|||
19724460|NCT03751020|42167555|FG000|Overall Study|Lost to Follow-up|7|||
19724461|NCT03751020|42167556|FG001|Overall Study|Lost to Follow-up|4|||
19724462|NCT03751020|42167557|FG002|Overall Study|Lost to Follow-up|10|||
19724463|NCT03090100|42167567|FG000|Overall Study|Adverse Event|9|||
19724464|NCT03090100|42167568|FG001|Overall Study|Adverse Event|11|||
19724465|NCT03090100|42167567|FG000|Overall Study|Pregnancy|1|||
19724466|NCT03090100|42167568|FG001|Overall Study|Pregnancy|1|||
19460164|NCT01613131|41714678|FG001|Overall Study|Withdrawal by Subject|5|||
19460165|NCT01868893|41714684|FG000|Overall Study|Adverse Event|2|||
19724467|NCT03090100|42167567|FG000|Overall Study|Lack of Efficacy|2|||
19724468|NCT03090100|42167568|FG001|Overall Study|Lack of Efficacy|7|||
19724469|NCT03090100|42167567|FG000|Overall Study|Lost to Follow-up|2|||
19724470|NCT03090100|42167568|FG001|Overall Study|Lost to Follow-up|2|||
19724471|NCT03090100|42167567|FG000|Overall Study|Withdrawal by Subject|7|||
19724472|NCT03090100|42167568|FG001|Overall Study|Withdrawal by Subject|19|||
19724473|NCT03090100|42167567|FG000|Overall Study|Protocol Violation|2|||
19724474|NCT03090100|42167568|FG001|Overall Study|Protocol Violation|6|||
19724475|NCT03090100|42167567|FG000|Overall Study|Non-compliance|2|||
19724476|NCT03090100|42167568|FG001|Overall Study|Non-compliance|0|||
19724477|NCT03090100|42167567|FG000|Overall Study|Other|2|||
19724478|NCT03090100|42167568|FG001|Overall Study|Other|2|||
19724479|NCT03089944|42167574|FG000|Overall Study|Lost to Follow-up|8|||
19724480|NCT03089944|42167574|FG000|Overall Study|Withdrew Consent|2|||
19724481|NCT03089944|42167574|FG000|Overall Study|Adverse Event|1|||
19724482|NCT03089944|42167574|FG000|Overall Study|Other|1|||
19724483|NCT03739866|42167597|FG000|Overall Study|Lost to Follow-up|0|||
19724484|NCT03739866|42167598|FG001|Overall Study|Lost to Follow-up|0|||
19724485|NCT03739866|42167599|FG002|Overall Study|Lost to Follow-up|0|||
19724486|NCT03739866|42167600|FG003|Overall Study|Lost to Follow-up|1|||
19724487|NCT03739866|42167601|FG004|Overall Study|Lost to Follow-up|0|||
19724488|NCT03739866|42167602|FG005|Overall Study|Lost to Follow-up|0|||
19724489|NCT03739866|42167603|FG006|Overall Study|Lost to Follow-up|0|||
19724490|NCT03739866|42167604|FG007|Overall Study|Lost to Follow-up|0|||
19724491|NCT03739866|42167597|FG000|Overall Study|Enrolled but not treated|0|||
19724492|NCT03739866|42167598|FG001|Overall Study|Enrolled but not treated|0|||
19724493|NCT03739866|42167599|FG002|Overall Study|Enrolled but not treated|1|||
19724494|NCT03739866|42167600|FG003|Overall Study|Enrolled but not treated|0|||
19724495|NCT03739866|42167601|FG004|Overall Study|Enrolled but not treated|1|||
19724496|NCT03739866|42167602|FG005|Overall Study|Enrolled but not treated|0|||
19724497|NCT03739866|42167603|FG006|Overall Study|Enrolled but not treated|0|||
19724498|NCT03739866|42167604|FG007|Overall Study|Enrolled but not treated|0|||
19724499|NCT03739242|42167628|FG000|Overall Study|Withdrawal by Subject|1|||
19724500|NCT03739242|42167629|FG001|Overall Study|Withdrawal by Subject|1|||
19724501|NCT03739242|42167628|FG000|Overall Study|Protocol Violation|0|||
19724502|NCT03739242|42167629|FG001|Overall Study|Protocol Violation|1|||
19724503|NCT02849626|42167686|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
19724504|NCT02849626|42167687|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
19724505|NCT02849626|42167688|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
19724506|NCT02849626|42167689|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
19724507|NCT02849626|42167686|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
19724508|NCT02849626|42167687|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
19724509|NCT02849626|42167688|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
19724510|NCT02849626|42167689|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
19724511|NCT02849626|42167686|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
19724512|NCT02849626|42167687|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
19724513|NCT02849626|42167688|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
19724514|NCT02849626|42167689|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
19724515|NCT02849626|42167686|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
19724516|NCT02849626|42167687|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
19724517|NCT02849626|42167688|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
19724518|NCT02849626|42167689|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
19724519|NCT02849626|42167686|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
19724520|NCT02849626|42167687|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
19724521|NCT02849626|42167688|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
19724522|NCT02849626|42167689|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
19724523|NCT02849626|42167686|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
19724524|NCT02849626|42167687|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
19724525|NCT02849626|42167688|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
19724526|NCT02849626|42167689|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
19724527|NCT02849626|42167686|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
19724528|NCT02849626|42167687|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
19724529|NCT02849626|42167688|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
19724530|NCT02849626|42167689|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
19724531|NCT02849626|42167686|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
19724532|NCT02849626|42167687|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
19724533|NCT02849626|42167688|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
19724534|NCT02849626|42167689|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
19724535|NCT02849626|42167686|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
19724536|NCT02849626|42167687|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
19724537|NCT02849626|42167688|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
19724538|NCT02849626|42167689|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
19724539|NCT02849626|42167686|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
19724540|NCT02849626|42167687|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
19724541|NCT02849626|42167688|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
19724542|NCT02849626|42167689|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
19724543|NCT02849626|42167686|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
19724544|NCT02849626|42167687|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
19724545|NCT02849626|42167688|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
19724546|NCT02849626|42167689|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
19724547|NCT03735498|42167707|FG000|Overall Study|Withdrawal by Subject|5|||
19724548|NCT03735498|42167707|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
19724549|NCT02659540|42167713|FG000|Overall Study|Adverse Event|3|||
19724550|NCT02659540|42167714|FG001|Overall Study|Adverse Event|2|||
19724551|NCT02659540|42167713|FG000|Overall Study|Death|1|||
19724552|NCT02659540|42167714|FG001|Overall Study|Death|0|||
19724553|NCT02659540|42167713|FG000|Overall Study|Progressive disease|2|||
19724554|NCT02659540|42167714|FG001|Overall Study|Progressive disease|6|||
19724555|NCT01097746|42167720|FG000|Overall Study|Adverse Event|4|||
19724556|NCT01097746|42167720|FG000|Overall Study|taken off study before any treatment given|1|||
19724557|NCT03733470|42167750|FG000|Overall Study|PI Decision|1|||
19724558|NCT03733470|42167751|FG001|Overall Study|PI Decision|1|||
19724559|NCT03732534|42167757|FG000|Overall Study|Study terminated by Sponsor|6|||
19724560|NCT03087058|42167763|FG000|Overall Study|Withdrawal by Subject|2|||
19724561|NCT03087058|42167764|FG001|Overall Study|Withdrawal by Subject|0|||
19724562|NCT03087058|42167765|FG002|Overall Study|Withdrawal by Subject|0|||
19724563|NCT03726996|42167772|FG000|Overall Study|Parent's decision|2|||
19724564|NCT03726996|42167772|FG000|Overall Study|Study early termination|2|||
19724565|NCT03882970|42167780|FG000|Overall Study|Adverse Event|5|||
19724566|NCT03882970|42167781|FG001|Overall Study|Adverse Event|7|||
19724567|NCT03882970|42167782|FG002|Overall Study|Adverse Event|3|||
19724568|NCT03882970|42167783|FG003|Overall Study|Adverse Event|1|||
19724569|NCT03882970|42167780|FG000|Overall Study|Death|1|||
19724570|NCT03882970|42167781|FG001|Overall Study|Death|2|||
19724571|NCT03882970|42167782|FG002|Overall Study|Death|1|||
19724572|NCT03882970|42167783|FG003|Overall Study|Death|1|||
19724573|NCT03882970|42167780|FG000|Overall Study|Lost to Follow-up|8|||
19724574|NCT03882970|42167781|FG001|Overall Study|Lost to Follow-up|9|||
19724575|NCT03882970|42167782|FG002|Overall Study|Lost to Follow-up|5|||
19724576|NCT03882970|42167783|FG003|Overall Study|Lost to Follow-up|5|||
19724577|NCT03882970|42167780|FG000|Overall Study|Physician Decision|0|||
19724578|NCT03882970|42167781|FG001|Overall Study|Physician Decision|2|||
19724579|NCT03882970|42167782|FG002|Overall Study|Physician Decision|2|||
19724580|NCT03882970|42167783|FG003|Overall Study|Physician Decision|2|||
19724581|NCT03882970|42167780|FG000|Overall Study|Protocol Violation|2|||
19724582|NCT03882970|42167781|FG001|Overall Study|Protocol Violation|0|||
19724583|NCT03882970|42167782|FG002|Overall Study|Protocol Violation|0|||
19724584|NCT03882970|42167783|FG003|Overall Study|Protocol Violation|0|||
19724585|NCT03882970|42167780|FG000|Overall Study|Withdrawal by Subject|8|||
19724586|NCT03882970|42167781|FG001|Overall Study|Withdrawal by Subject|17|||
19724587|NCT03882970|42167782|FG002|Overall Study|Withdrawal by Subject|7|||
19724588|NCT03882970|42167783|FG003|Overall Study|Withdrawal by Subject|22|||
19724589|NCT03882970|42167780|FG000|Overall Study|Personal Reason|2|||
19724590|NCT03882970|42167781|FG001|Overall Study|Personal Reason|3|||
19724591|NCT03882970|42167782|FG002|Overall Study|Personal Reason|1|||
19724592|NCT03882970|42167783|FG003|Overall Study|Personal Reason|3|||
19724593|NCT03730480|42167797|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
19724594|NCT03674112|42167804|FG000|Overall Study|Adverse Event|1|||
19724595|NCT03674112|42167805|FG001|Overall Study|Adverse Event|0|||
19724596|NCT03674112|42167804|FG000|Overall Study|Ongoing in the Study|79|||
19724597|NCT03674112|42167805|FG001|Overall Study|Ongoing in the Study|80|||
19724598|NCT03668808|42167831|FG000|First Intervention|Withdrawal by Subject|2|||
19724599|NCT03668808|42167832|FG001|First Intervention|Withdrawal by Subject|2|||
19724600|NCT03725982|42167842|FG000|First Intervention|Withdrawal by Subject|0|||
19724601|NCT03725982|42167843|FG001|First Intervention|Withdrawal by Subject|1|||
19724602|NCT03725982|42167842|FG000|First Intervention|Physician Decision|1|||
19724603|NCT03725982|42167843|FG001|First Intervention|Physician Decision|1|||
19724604|NCT02982954|42167859|FG000|Overall Study|Death|55|||
19724605|NCT02982954|42167860|FG001|Overall Study|Death|29|||
19724606|NCT02982954|42167861|FG002|Overall Study|Death|15|||
19724607|NCT02982954|42167862|FG003|Overall Study|Death|20|||
19724608|NCT02982954|42167859|FG000|Overall Study|Lost to Follow-up|2|||
19724609|NCT02982954|42167860|FG001|Overall Study|Lost to Follow-up|1|||
19724610|NCT02982954|42167861|FG002|Overall Study|Lost to Follow-up|0|||
19724611|NCT02982954|42167862|FG003|Overall Study|Lost to Follow-up|0|||
19724612|NCT02982954|42167859|FG000|Overall Study|Participant withdrew consent|7|||
19724613|NCT02982954|42167860|FG001|Overall Study|Participant withdrew consent|5|||
19724614|NCT02982954|42167861|FG002|Overall Study|Participant withdrew consent|1|||
19724615|NCT02982954|42167862|FG003|Overall Study|Participant withdrew consent|1|||
19724616|NCT02982954|42167859|FG000|Overall Study|Other reasons|42|||
19724617|NCT02982954|42167860|FG001|Overall Study|Other reasons|17|||
19724618|NCT02982954|42167861|FG002|Overall Study|Other reasons|12|||
19724619|NCT02982954|42167862|FG003|Overall Study|Other reasons|3|||
19724620|NCT02982954|42167859|FG000|Overall Study|Premature site closure|0|||
19724621|NCT02982954|42167860|FG001|Overall Study|Premature site closure|0|||
19724622|NCT02982954|42167861|FG002|Overall Study|Premature site closure|0|||
19724623|NCT02982954|42167862|FG003|Overall Study|Premature site closure|1|||
19724624|NCT03724968|42167874|FG000|Overall Study|Insurance issues|0|||
19724625|NCT03724968|42167875|FG001|Overall Study|Insurance issues|1|||
19724626|NCT03724968|42167874|FG000|Overall Study|Study closed|0|||
19724627|NCT03724968|42167875|FG001|Overall Study|Study closed|1|||
19724628|NCT03724812|42167881|FG000|Overall Study|Missed Visit|1|||
19724629|NCT03724812|42167881|FG000|Overall Study|Death|2|||
19724630|NCT03724812|42167881|FG000|Overall Study|Withdrawal by Subject|1|||
19724631|NCT03722784|42167888|FG000|Overall Study|Withdrawal by Subject|1|||
19724632|NCT03722784|42167889|FG001|Overall Study|Withdrawal by Subject|0|||
19724633|NCT03722784|42167888|FG000|Overall Study|Physician Decision|1|||
19724634|NCT03722784|42167889|FG001|Overall Study|Physician Decision|1|||
19724635|NCT03722784|42167888|FG000|Overall Study|Protocol Violation|0|||
19724636|NCT03722784|42167889|FG001|Overall Study|Protocol Violation|1|||
19724637|NCT03722238|42167898|FG000|Overall Study|Protocol Violation|1|||
19724638|NCT03722238|42167899|FG001|Overall Study|Protocol Violation|0|||
19724639|NCT03722238|42167898|FG000|Overall Study|Physician Decision|1|||
19724640|NCT03722238|42167899|FG001|Overall Study|Physician Decision|0|||
19724641|NCT03722238|42167898|FG000|Overall Study|Death|1|||
19724642|NCT03722238|42167899|FG001|Overall Study|Death|0|||
19724643|NCT03722238|42167898|FG000|Overall Study|Lost to Follow-up|6|||
19724644|NCT03722238|42167899|FG001|Overall Study|Lost to Follow-up|0|||
19724645|NCT03722238|42167898|FG000|Overall Study|Partial missing data|44|||
19724646|NCT03722238|42167899|FG001|Overall Study|Partial missing data|1|||
19724647|NCT03722238|42167898|FG000|Overall Study|Withdrawal by Subject|2|||
19724648|NCT03722238|42167899|FG001|Overall Study|Withdrawal by Subject|0|||
19724649|NCT03722238|42167898|FG000|Overall Study|Other|4|||
19724650|NCT03722238|42167899|FG001|Overall Study|Other|0|||
19724651|NCT03722238|42167898|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
19724652|NCT03722238|42167899|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
19724653|NCT03722238|42167898|FG000|Overall Study|Did not meet risk classification group criteria|90|||
19724654|NCT03722238|42167899|FG001|Overall Study|Did not meet risk classification group criteria|0|||
19724655|NCT03722238|42167898|FG000|Overall Study|Did not sign consent|17|||
19724656|NCT03722238|42167899|FG001|Overall Study|Did not sign consent|0|||
19724657|NCT03722238|42167898|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
19724658|NCT03722238|42167899|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
19724659|NCT03722238|42167898|FG000|Overall Study|Not willing to purchase study medication|142|||
19724660|NCT03722238|42167899|FG001|Overall Study|Not willing to purchase study medication|0|||
19724661|NCT03722238|42167898|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
19724662|NCT03722238|42167899|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
19724663|NCT02927080|42167915|FG000|Overall Study|Withdrawal by Subject|0|||
19724664|NCT02927080|42167916|FG001|Overall Study|Withdrawal by Subject|0|||
19724665|NCT02927080|42167917|FG002|Overall Study|Withdrawal by Subject|0|||
19724666|NCT02927080|42167918|FG003|Overall Study|Withdrawal by Subject|0|||
19724667|NCT02927080|42167919|FG004|Overall Study|Withdrawal by Subject|1|||
19724668|NCT02927080|42167920|FG005|Overall Study|Withdrawal by Subject|0|||
19724669|NCT02927080|42167921|FG006|Overall Study|Withdrawal by Subject|1|||
19724670|NCT02927080|42167922|FG007|Overall Study|Withdrawal by Subject|1|||
19724671|NCT02927080|42167923|FG008|Overall Study|Withdrawal by Subject|0|||
19724672|NCT02927080|42167924|FG009|Overall Study|Withdrawal by Subject|2|||
19724673|NCT02927080|42167915|FG000|Overall Study|Willingness to comply with protocol|0|||
19724674|NCT02927080|42167916|FG001|Overall Study|Willingness to comply with protocol|0|||
19724675|NCT02927080|42167917|FG002|Overall Study|Willingness to comply with protocol|0|||
19724676|NCT02927080|42167918|FG003|Overall Study|Willingness to comply with protocol|0|||
19724677|NCT02927080|42167919|FG004|Overall Study|Willingness to comply with protocol|0|||
19724678|NCT02927080|42167920|FG005|Overall Study|Willingness to comply with protocol|0|||
19724679|NCT02927080|42167921|FG006|Overall Study|Willingness to comply with protocol|0|||
19724680|NCT02927080|42167922|FG007|Overall Study|Willingness to comply with protocol|0|||
19724681|NCT02927080|42167923|FG008|Overall Study|Willingness to comply with protocol|0|||
19724682|NCT02927080|42167924|FG009|Overall Study|Willingness to comply with protocol|1|||
19724683|NCT02927080|42167915|FG000|Overall Study|Study terminated by Sponsor|0|||
19724684|NCT02927080|42167916|FG001|Overall Study|Study terminated by Sponsor|0|||
19724685|NCT02927080|42167917|FG002|Overall Study|Study terminated by Sponsor|0|||
19724686|NCT02927080|42167918|FG003|Overall Study|Study terminated by Sponsor|0|||
19724687|NCT02927080|42167919|FG004|Overall Study|Study terminated by Sponsor|0|||
19724688|NCT02927080|42167920|FG005|Overall Study|Study terminated by Sponsor|0|||
19724689|NCT02927080|42167921|FG006|Overall Study|Study terminated by Sponsor|6|||
19724690|NCT02927080|42167922|FG007|Overall Study|Study terminated by Sponsor|7|||
19724691|NCT02927080|42167923|FG008|Overall Study|Study terminated by Sponsor|2|||
19724692|NCT02927080|42167924|FG009|Overall Study|Study terminated by Sponsor|3|||
19724693|NCT02927080|42167915|FG000|Overall Study|Adverse Event|0|||
19724694|NCT02927080|42167916|FG001|Overall Study|Adverse Event|1|||
19724695|NCT02927080|42167917|FG002|Overall Study|Adverse Event|0|||
19724696|NCT02927080|42167918|FG003|Overall Study|Adverse Event|0|||
19724697|NCT02927080|42167919|FG004|Overall Study|Adverse Event|0|||
19724698|NCT02927080|42167920|FG005|Overall Study|Adverse Event|0|||
19724699|NCT02927080|42167921|FG006|Overall Study|Adverse Event|0|||
19724700|NCT02927080|42167922|FG007|Overall Study|Adverse Event|1|||
19724701|NCT02927080|42167923|FG008|Overall Study|Adverse Event|0|||
19724702|NCT02927080|42167924|FG009|Overall Study|Adverse Event|1|||
19724703|NCT02927080|42167915|FG000|Overall Study|Other|0|||
19724704|NCT02927080|42167916|FG001|Overall Study|Other|0|||
19724705|NCT02927080|42167917|FG002|Overall Study|Other|0|||
19724706|NCT02927080|42167918|FG003|Overall Study|Other|0|||
19724707|NCT02927080|42167919|FG004|Overall Study|Other|0|||
19724708|NCT02927080|42167920|FG005|Overall Study|Other|0|||
19724709|NCT02927080|42167921|FG006|Overall Study|Other|1|||
19724710|NCT02927080|42167922|FG007|Overall Study|Other|0|||
19724711|NCT02927080|42167923|FG008|Overall Study|Other|1|||
19724712|NCT02927080|42167924|FG009|Overall Study|Other|0|||
19724713|NCT02563002|42167971|FG000|Overall Study|Death|62|||
19724714|NCT02563002|42167972|FG001|Overall Study|Death|75|||
19724715|NCT02563002|42167971|FG000|Overall Study|Lost to Follow-up|1|||
19724716|NCT02563002|42167972|FG001|Overall Study|Lost to Follow-up|0|||
19724717|NCT02563002|42167971|FG000|Overall Study|Withdrawal by Subject|0|||
19724718|NCT02563002|42167972|FG001|Overall Study|Withdrawal by Subject|9|||
19724719|NCT02563002|42167971|FG000|Overall Study|Ongoing|90|||
19724720|NCT02563002|42167972|FG001|Overall Study|Ongoing|70|||
19724721|NCT02374476|42167983|FG000|VT Induced Ablation|Screening Failures|36|||
19724722|NCT02374476|42167984|FG001|VT Induced Ablation|Screening Failures|0|||
19724723|NCT02374476|42167985|FG002|VT Induced Ablation|Screening Failures|0|||
19724724|NCT02374476|42167983|FG000|Arm Assignment|Withdrawal by Subject|0|||
19724725|NCT02374476|42167984|FG001|Arm Assignment|Withdrawal by Subject|0|||
19724726|NCT02374476|42167985|FG002|Arm Assignment|Withdrawal by Subject|1|||
19724727|NCT02918292|42167992|FG000|Study Enrollment Prior to Transplant|Death|1|||
19724728|NCT02918292|42167992|FG000|Study Follow up After Transplant|Death|6|||
19724729|NCT03720210|42167996|FG000|Overall Study|Lost to Follow-up|1|||
19724730|NCT03719586|42168004|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
19724731|NCT03719586|42168005|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
19724732|NCT03719586|42168006|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
19724733|NCT03719586|42168007|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
19724734|NCT00843882|42168020|FG000|Step 1|Lack of Efficacy|14|||
19724735|NCT00843882|42168021|FG001|Step 1|Lack of Efficacy|10|||
19724736|NCT00843882|42168022|FG002|Step 1|Lack of Efficacy|21|||
19724737|NCT00843882|42168020|FG000|Step 1|Adverse Event|8|||
19724738|NCT00843882|42168021|FG001|Step 1|Adverse Event|17|||
19724739|NCT00843882|42168022|FG002|Step 1|Adverse Event|20|||
19724740|NCT00843882|42168020|FG000|Step 1|Death|1|||
19724741|NCT00843882|42168021|FG001|Step 1|Death|2|||
19724742|NCT00843882|42168022|FG002|Step 1|Death|4|||
19724743|NCT00843882|42168020|FG000|Step 1|Withdrawal by Subject|6|||
19724744|NCT00843882|42168021|FG001|Step 1|Withdrawal by Subject|12|||
19724745|NCT00843882|42168022|FG002|Step 1|Withdrawal by Subject|9|||
19724746|NCT00843882|42168020|FG000|Step 1|Physician Decision|0|||
19724747|NCT00843882|42168021|FG001|Step 1|Physician Decision|5|||
19724748|NCT00843882|42168022|FG002|Step 1|Physician Decision|1|||
19724749|NCT00843882|42168020|FG000|Step 1|Patient and physician's decision|0|||
19724750|NCT00843882|42168021|FG001|Step 1|Patient and physician's decision|0|||
19724751|NCT00843882|42168022|FG002|Step 1|Patient and physician's decision|1|||
19724752|NCT00843882|42168020|FG000|Step 1|Other complicating disease|1|||
19724753|NCT00843882|42168021|FG001|Step 1|Other complicating disease|3|||
19724754|NCT00843882|42168022|FG002|Step 1|Other complicating disease|4|||
19724755|NCT00843882|42168020|FG000|Step 1|Alternative therapy|0|||
19724756|NCT00843882|42168021|FG001|Step 1|Alternative therapy|1|||
19724757|NCT00843882|42168022|FG002|Step 1|Alternative therapy|1|||
19724758|NCT00843882|42168020|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
19724759|NCT00843882|42168021|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
19724760|NCT00843882|42168022|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
19724761|NCT00843882|42168020|FG000|Step 1|Off treatment reason unknown|0|||
19724762|NCT00843882|42168021|FG001|Step 1|Off treatment reason unknown|1|||
19724763|NCT00843882|42168022|FG002|Step 1|Off treatment reason unknown|4|||
19724764|NCT00843882|42168020|FG000|Step 1|Never started treatment|2|||
19724765|NCT00843882|42168021|FG001|Step 1|Never started treatment|0|||
19724766|NCT00843882|42168022|FG002|Step 1|Never started treatment|0|||
19724767|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
19724768|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
19724769|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
19724770|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
19724771|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
19724772|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
19724773|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
19724774|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
19724775|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
19724776|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
19724777|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
19724778|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
19724779|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
19724780|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
19724781|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
19724782|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
19724783|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
19724784|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
19724785|NCT00843882|42168020|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
19724786|NCT00843882|42168021|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
19724787|NCT00843882|42168022|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
19724788|NCT03353350|42168051|FG000|30-week Core Treatment Period|Protocol Violation|1|||
19724789|NCT03353350|42168052|FG001|30-week Core Treatment Period|Protocol Violation|1|||
19724790|NCT03353350|42168053|FG002|30-week Core Treatment Period|Protocol Violation|1|||
19724791|NCT03353350|42168054|FG003|30-week Core Treatment Period|Protocol Violation|0|||
19724792|NCT03353350|42168051|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
19724793|NCT03353350|42168052|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
19724794|NCT03353350|42168053|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
19724795|NCT03353350|42168054|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
19724796|NCT03353350|42168051|FG000|30-week Core Treatment Period|Adverse Event|0|||
19724797|NCT03353350|42168052|FG001|30-week Core Treatment Period|Adverse Event|4|||
19724798|NCT03353350|42168053|FG002|30-week Core Treatment Period|Adverse Event|2|||
19724799|NCT03353350|42168054|FG003|30-week Core Treatment Period|Adverse Event|3|||
19724800|NCT03353350|42168051|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
19724801|NCT03353350|42168052|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
19724802|NCT03353350|42168053|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
19724803|NCT03353350|42168054|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
19724804|NCT03353350|42168051|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
19724805|NCT03353350|42168052|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
19724806|NCT03353350|42168053|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
19724807|NCT03353350|42168054|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
19724808|NCT03353350|42168051|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
19724809|NCT03353350|42168052|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
19724810|NCT03353350|42168053|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
19724811|NCT03353350|42168054|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
19724812|NCT03353350|42168051|FG000|26-week Treatment Extension Period|Adverse Event|1|||
19724813|NCT03353350|42168052|FG001|26-week Treatment Extension Period|Adverse Event|0|||
19724814|NCT03353350|42168053|FG002|26-week Treatment Extension Period|Adverse Event|0|||
19724815|NCT03353350|42168054|FG003|26-week Treatment Extension Period|Adverse Event|1|||
19724816|NCT03353350|42168051|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
19724817|NCT03353350|42168052|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
19724818|NCT03353350|42168053|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
19724819|NCT03353350|42168054|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
19724820|NCT03032068|42168068|FG000|Overall Study|Adverse Event|1|||
19724821|NCT02674516|42168088|FG000|Overall Study|Lost to Follow-up|3|||
19724822|NCT02674516|42168089|FG001|Overall Study|Lost to Follow-up|0|||
19724823|NCT02674516|42168088|FG000|Overall Study|Protocol Violation|0|||
19724824|NCT02674516|42168089|FG001|Overall Study|Protocol Violation|4|||
19724825|NCT02674516|42168088|FG000|Overall Study|Knowledge of study hypothesis|1|||
19724826|NCT02674516|42168089|FG001|Overall Study|Knowledge of study hypothesis|0|||
19724827|NCT02463448|42168095|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
19724828|NCT02463448|42168095|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
19724829|NCT02463448|42168095|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
19724830|NCT02463448|42168095|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
19724831|NCT03794544|42168103|FG000|Overall Study|Withdrawal by Subject|1|||
19724832|NCT03794544|42168104|FG001|Overall Study|Withdrawal by Subject|1|||
19724833|NCT03794544|42168105|FG002|Overall Study|Withdrawal by Subject|0|||
19724834|NCT03794544|42168106|FG003|Overall Study|Withdrawal by Subject|0|||
19724835|NCT03794544|42168103|FG000|Overall Study|Death|0|||
19724836|NCT03794544|42168104|FG001|Overall Study|Death|0|||
19724837|NCT03794544|42168105|FG002|Overall Study|Death|0|||
19724838|NCT03794544|42168106|FG003|Overall Study|Death|1|||
19724839|NCT03794544|42168103|FG000|Overall Study|Lost to Follow-up|0|||
19724840|NCT03794544|42168104|FG001|Overall Study|Lost to Follow-up|1|||
19724841|NCT03794544|42168105|FG002|Overall Study|Lost to Follow-up|1|||
19724842|NCT03794544|42168106|FG003|Overall Study|Lost to Follow-up|0|||
19724843|NCT03794544|42168103|FG000|Overall Study|Other|0|||
19724844|NCT03794544|42168104|FG001|Overall Study|Other|1|||
19724845|NCT03794544|42168105|FG002|Overall Study|Other|0|||
19724846|NCT03794544|42168106|FG003|Overall Study|Other|0|||
19724847|NCT01804270|42168118|FG000|Overall Study|Withdrawal by Subject|1|||
19724848|NCT01804270|42168119|FG001|Overall Study|Withdrawal by Subject|1|||
19724849|NCT03107026|42168128|FG000|Overall Study|Adverse Event|2|||
19724850|NCT03107026|42168129|FG001|Overall Study|Adverse Event|14|||
19724851|NCT03107026|42168130|FG002|Overall Study|Adverse Event|23|||
19724852|NCT03107026|42168128|FG000|Overall Study|Lost to Follow-up|12|||
19724853|NCT03107026|42168129|FG001|Overall Study|Lost to Follow-up|12|||
19724854|NCT03107026|42168130|FG002|Overall Study|Lost to Follow-up|13|||
19724855|NCT03107026|42168128|FG000|Overall Study|Protocol Violation|1|||
19724856|NCT03107026|42168129|FG001|Overall Study|Protocol Violation|2|||
19724857|NCT03107026|42168130|FG002|Overall Study|Protocol Violation|0|||
19724858|NCT03107026|42168128|FG000|Overall Study|Pregnancy|1|||
19724859|NCT03107026|42168129|FG001|Overall Study|Pregnancy|0|||
19724860|NCT03107026|42168130|FG002|Overall Study|Pregnancy|0|||
19724861|NCT03107026|42168128|FG000|Overall Study|Withdrawal by Subject|13|||
19724862|NCT03107026|42168129|FG001|Overall Study|Withdrawal by Subject|5|||
19724863|NCT03107026|42168130|FG002|Overall Study|Withdrawal by Subject|17|||
19724864|NCT03107026|42168128|FG000|Overall Study|non compliance with study visits|1|||
19724865|NCT03107026|42168129|FG001|Overall Study|non compliance with study visits|2|||
19724866|NCT03107026|42168130|FG002|Overall Study|non compliance with study visits|0|||
19724867|NCT03107026|42168128|FG000|Overall Study|non-compliance with study drug|2|||
19724868|NCT03107026|42168129|FG001|Overall Study|non-compliance with study drug|2|||
19724869|NCT03107026|42168130|FG002|Overall Study|non-compliance with study drug|3|||
19724870|NCT03107026|42168128|FG000|Overall Study|Physician Decision|0|||
19724871|NCT03107026|42168129|FG001|Overall Study|Physician Decision|1|||
19724872|NCT03107026|42168130|FG002|Overall Study|Physician Decision|0|||
19724873|NCT03717480|42168138|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
19724874|NCT00005044|42168144|FG000|Overall Study|Protocol Violation|37|||
19724875|NCT00005044|42168145|FG001|Overall Study|Protocol Violation|46|||
19724876|NCT00005044|42168144|FG000|Overall Study|Withdrawal by Subject|1|||
19724877|NCT00005044|42168145|FG001|Overall Study|Withdrawal by Subject|5|||
19724878|NCT00005044|42168144|FG000|Overall Study|No protocol treatment|0|||
19724879|NCT00005044|42168145|FG001|Overall Study|No protocol treatment|1|||
19724880|NCT03084796|42168157|FG000|Overall Study|Adverse Event|4|||
19724881|NCT03084796|42168158|FG001|Overall Study|Adverse Event|5|||
19724882|NCT03084796|42168159|FG002|Overall Study|Adverse Event|6|||
19724883|NCT03084796|42168160|FG003|Overall Study|Adverse Event|2|||
19724884|NCT03084796|42168161|FG004|Overall Study|Adverse Event|3|||
19724885|NCT03084796|42168162|FG005|Overall Study|Adverse Event|5|||
19724886|NCT03084796|42168157|FG000|Overall Study|Withdrawal by Subject|3|||
19724887|NCT03084796|42168158|FG001|Overall Study|Withdrawal by Subject|5|||
19724888|NCT03084796|42168159|FG002|Overall Study|Withdrawal by Subject|2|||
19724889|NCT03084796|42168160|FG003|Overall Study|Withdrawal by Subject|1|||
19724890|NCT03084796|42168161|FG004|Overall Study|Withdrawal by Subject|3|||
19724891|NCT03084796|42168162|FG005|Overall Study|Withdrawal by Subject|0|||
19724892|NCT03084796|42168157|FG000|Overall Study|Protocol Violation|0|||
19724893|NCT03084796|42168158|FG001|Overall Study|Protocol Violation|0|||
19724894|NCT03084796|42168159|FG002|Overall Study|Protocol Violation|1|||
19724895|NCT03084796|42168160|FG003|Overall Study|Protocol Violation|0|||
19724896|NCT03084796|42168161|FG004|Overall Study|Protocol Violation|1|||
19724897|NCT03084796|42168162|FG005|Overall Study|Protocol Violation|1|||
19724898|NCT03084796|42168157|FG000|Overall Study|Lack of Efficacy|0|||
19724899|NCT03084796|42168158|FG001|Overall Study|Lack of Efficacy|0|||
19724900|NCT03084796|42168159|FG002|Overall Study|Lack of Efficacy|1|||
19724901|NCT03084796|42168160|FG003|Overall Study|Lack of Efficacy|0|||
19724902|NCT03084796|42168161|FG004|Overall Study|Lack of Efficacy|1|||
19724903|NCT03084796|42168162|FG005|Overall Study|Lack of Efficacy|0|||
19724904|NCT03084796|42168157|FG000|Overall Study|Lost to Follow-up|0|||
19724905|NCT03084796|42168158|FG001|Overall Study|Lost to Follow-up|0|||
19724906|NCT03084796|42168159|FG002|Overall Study|Lost to Follow-up|1|||
19724907|NCT03084796|42168160|FG003|Overall Study|Lost to Follow-up|1|||
19724908|NCT03084796|42168161|FG004|Overall Study|Lost to Follow-up|3|||
19724909|NCT03084796|42168162|FG005|Overall Study|Lost to Follow-up|1|||
19724910|NCT03084796|42168157|FG000|Overall Study|Randomization error|0|||
19724911|NCT03084796|42168158|FG001|Overall Study|Randomization error|0|||
19724912|NCT03084796|42168159|FG002|Overall Study|Randomization error|1|||
19724913|NCT03084796|42168160|FG003|Overall Study|Randomization error|0|||
19724914|NCT03084796|42168161|FG004|Overall Study|Randomization error|0|||
19724915|NCT03084796|42168162|FG005|Overall Study|Randomization error|0|||
19724916|NCT03717012|42168178|FG000|Overall Study|Due to trial termination|1|||
19724917|NCT03717012|42168179|FG001|Overall Study|Due to trial termination|2|||
19724918|NCT03717012|42168178|FG000|Overall Study|Protocol Violation|0|||
19724919|NCT03717012|42168179|FG001|Overall Study|Protocol Violation|2|||
19724920|NCT03717012|42168178|FG000|Overall Study|Adverse Event|0|||
19724921|NCT03717012|42168179|FG001|Overall Study|Adverse Event|1|||
19724922|NCT03717012|42168178|FG000|Overall Study|Lung transplant|0|||
19724923|NCT03717012|42168179|FG001|Overall Study|Lung transplant|1|||
19724924|NCT00579826|42168192|FG000|Overall Study|Withdrawal by Subject|5|||
19724925|NCT00579826|42168193|FG001|Overall Study|Withdrawal by Subject|3|||
19724926|NCT03078556|42168201|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
19724927|NCT03078556|42168202|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
19724928|NCT03078556|42168203|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
19724929|NCT03078556|42168204|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
19724930|NCT03078556|42168201|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
19724931|NCT03078556|42168202|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
19724932|NCT03078556|42168203|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
19724933|NCT03078556|42168204|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
19724934|NCT03078556|42168201|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
19724935|NCT03078556|42168202|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
19724936|NCT03078556|42168203|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
19724937|NCT03078556|42168204|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
19724938|NCT03078556|42168201|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
19724939|NCT03078556|42168202|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
19724940|NCT03078556|42168203|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
19724941|NCT03078556|42168204|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
19724942|NCT03714672|42168233|FG000|Overall Study|Adverse Event|0|||
19724943|NCT03714672|42168234|FG001|Overall Study|Adverse Event|0|||
19724944|NCT03714672|42168235|FG002|Overall Study|Adverse Event|3|||
19724945|NCT03714672|42168236|FG003|Overall Study|Adverse Event|0|||
19724946|NCT03714672|42168233|FG000|Overall Study|Physician Decision|0|||
19724947|NCT03714672|42168234|FG001|Overall Study|Physician Decision|1|||
19724948|NCT03714672|42168235|FG002|Overall Study|Physician Decision|0|||
19724949|NCT03714672|42168236|FG003|Overall Study|Physician Decision|0|||
19724950|NCT03714672|42168233|FG000|Overall Study|Other Reason|1|||
19724951|NCT03714672|42168234|FG001|Overall Study|Other Reason|2|||
19724952|NCT03714672|42168235|FG002|Overall Study|Other Reason|1|||
19724953|NCT03714672|42168236|FG003|Overall Study|Other Reason|1|||
19724954|NCT03714672|42168233|FG000|Overall Study|Lost to Follow-up|1|||
19724955|NCT03714672|42168234|FG001|Overall Study|Lost to Follow-up|1|||
19724956|NCT03714672|42168235|FG002|Overall Study|Lost to Follow-up|0|||
19724957|NCT03714672|42168236|FG003|Overall Study|Lost to Follow-up|0|||
19724958|NCT03083470|42168252|FG000|Overall Study|Lost to Follow-up|0|||
19724959|NCT03083470|42168253|FG001|Overall Study|Lost to Follow-up|0|||
19724960|NCT03083470|42168254|FG002|Overall Study|Lost to Follow-up|0|||
19724961|NCT03083470|42168255|FG003|Overall Study|Lost to Follow-up|0|||
19724962|NCT03083470|42168256|FG004|Overall Study|Lost to Follow-up|1|||
19724963|NCT03083470|42168252|FG000|Overall Study|Withdrawal by Subject|0|||
19724964|NCT03083470|42168253|FG001|Overall Study|Withdrawal by Subject|0|||
19724965|NCT03083470|42168254|FG002|Overall Study|Withdrawal by Subject|0|||
19724966|NCT03083470|42168255|FG003|Overall Study|Withdrawal by Subject|0|||
19724967|NCT03083470|42168256|FG004|Overall Study|Withdrawal by Subject|1|||
19724968|NCT05405244|42168268|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
19724969|NCT05405244|42168269|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
19724970|NCT05405244|42168268|FG000|Washout (2 Weeks)|Adverse Event|2|||
19724971|NCT05405244|42168269|FG001|Washout (2 Weeks)|Adverse Event|0|||
19724972|NCT05405244|42168268|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
19724973|NCT05405244|42168269|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
19724974|NCT03074500|42168282|FG000|Overall Study|Lost to Follow-up|1|||
19724975|NCT03074500|42168283|FG001|Overall Study|Lost to Follow-up|0|||
19724976|NCT03074500|42168284|FG002|Overall Study|Lost to Follow-up|0|||
19724977|NCT03074500|42168282|FG000|Overall Study|Lack of Efficacy|0|||
19724978|NCT03074500|42168283|FG001|Overall Study|Lack of Efficacy|1|||
19724979|NCT03074500|42168284|FG002|Overall Study|Lack of Efficacy|0|||
19724980|NCT03074500|42168282|FG000|Overall Study|Adverse Event|0|||
19724981|NCT03074500|42168283|FG001|Overall Study|Adverse Event|0|||
19724982|NCT03074500|42168284|FG002|Overall Study|Adverse Event|1|||
19724983|NCT03715530|42168297|FG000|Overall Study|Lost to Follow-up|3|||
19724984|NCT03715530|42168298|FG001|Overall Study|Lost to Follow-up|1|||
19724985|NCT03715530|42168299|FG002|Overall Study|Lost to Follow-up|2|||
19724986|NCT03077698|42168309|FG000|Progestin Monotherapy|Stable Disease|8|||
19724987|NCT03077698|42168310|FG001|Progestin Monotherapy|Stable Disease|0|||
19724988|NCT03077698|42168309|FG000|Progestin Monotherapy|Adverse Event|1|||
19724989|NCT03077698|42168310|FG001|Progestin Monotherapy|Adverse Event|0|||
19550546|NCT01339559|41999602|FG000|Overall Study|Subject choice|89|||
19724990|NCT03077698|42168309|FG000|Progestin Monotherapy|Death|1|||
19724991|NCT03077698|42168310|FG001|Progestin Monotherapy|Death|0|||
19724992|NCT03077698|42168309|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
19724993|NCT03077698|42168310|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
19724994|NCT03077698|42168309|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
19724995|NCT03077698|42168310|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
19724996|NCT03077698|42168309|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
19724997|NCT03077698|42168310|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
19724998|NCT03077698|42168309|FG000|Safety Follow Up|Withdrawal by Subject|2|||
19724999|NCT03077698|42168310|FG001|Safety Follow Up|Withdrawal by Subject|1|||
19725000|NCT03077698|42168309|FG000|Safety Follow Up|Transfer of care to hospice|1|||
19725001|NCT03077698|42168310|FG001|Safety Follow Up|Transfer of care to hospice|0|||
19725002|NCT03079102|42168328|FG000|Overall Study|Physician Decision|0|||
19725003|NCT03079102|42168329|FG001|Overall Study|Physician Decision|1|||
19725004|NCT02434354|42168335|FG000|Overall Study|screen fail|3|||
19725005|NCT03076996|42168339|FG000|Overall Study|Withdrawal by Subject|2|||
19725006|NCT03076996|42168339|FG000|Overall Study|Lost to Follow-up|3|||
19725007|NCT03076996|42168339|FG000|Overall Study|Literacy precluded participation|1|||
19725008|NCT03078868|42168343|FG000|Overall Study|Physician Decision|3|||
19725009|NCT04524598|42168351|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
19725010|NCT04524598|42168352|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
19725011|NCT04524598|42168353|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
19725012|NCT04524598|42168354|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
19725013|NCT04524598|42168355|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
19725014|NCT04524598|42168351|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
19725015|NCT04524598|42168352|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
19725016|NCT04524598|42168353|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725017|NCT04524598|42168354|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725018|NCT04524598|42168355|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725019|NCT04524598|42168351|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
19725020|NCT04524598|42168352|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
19725021|NCT04524598|42168353|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
19725022|NCT04524598|42168354|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
19725023|NCT04524598|42168355|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
19725024|NCT04524598|42168351|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
19725025|NCT04524598|42168352|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
19725026|NCT04524598|42168353|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
19725027|NCT04524598|42168354|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
19725028|NCT04524598|42168355|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
19725029|NCT04524598|42168351|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725030|NCT04524598|42168352|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725031|NCT04524598|42168353|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
19725032|NCT04524598|42168354|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
19725033|NCT04524598|42168355|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725034|NCT04524598|42168351|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
19725035|NCT04524598|42168352|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
19725036|NCT04524598|42168353|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
19725037|NCT04524598|42168354|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
19725038|NCT04524598|42168355|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
19725039|NCT04524598|42168351|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725040|NCT04524598|42168352|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725041|NCT04524598|42168353|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725042|NCT04524598|42168354|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
19725043|NCT04524598|42168355|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
19725044|NCT03075904|42168369|FG000|Overall Study|Physician Decision|3|||
19725045|NCT03075904|42168369|FG000|Overall Study|Need for Medication not Permitted|1|||
19725046|NCT03073798|42168373|FG000|Overall Study|Adverse Event|1|||
19725047|NCT03073798|42168373|FG000|Overall Study|Withdrawal by Subject|1|||
19725048|NCT03075826|42168378|FG000|Overall Study|Withdrawal by Subject|1|||
19725049|NCT03075826|42168378|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
19725050|NCT02865850|42168393|FG000|Overall Study|Death|15|||
19725051|NCT02865850|42168394|FG001|Overall Study|Death|19|||
19725052|NCT02865850|42168393|FG000|Overall Study|Withdrawal by Subject|3|||
19725053|NCT02865850|42168394|FG001|Overall Study|Withdrawal by Subject|2|||
19725054|NCT02865850|42168393|FG000|Overall Study|Lost to Follow-up|3|||
19725055|NCT02865850|42168394|FG001|Overall Study|Lost to Follow-up|2|||
19725056|NCT03711162|42168403|FG000|Overall Study|Adverse Event|5|||
19550547|NCT01339559|41999602|FG000|Overall Study|Protocol Violation|15|||
19725057|NCT03711162|42168404|FG001|Overall Study|Adverse Event|2|||
19725058|NCT03711162|42168405|FG002|Overall Study|Adverse Event|4|||
19725059|NCT03711162|42168403|FG000|Overall Study|Death|11|||
19725060|NCT03711162|42168404|FG001|Overall Study|Death|7|||
19725061|NCT03711162|42168405|FG002|Overall Study|Death|8|||
19725062|NCT03711162|42168403|FG000|Overall Study|Lost to Follow-up|1|||
19725063|NCT03711162|42168404|FG001|Overall Study|Lost to Follow-up|0|||
19725064|NCT03711162|42168405|FG002|Overall Study|Lost to Follow-up|1|||
19725065|NCT03711162|42168403|FG000|Overall Study|Study Terminated by Sponsor|139|||
19725066|NCT03711162|42168404|FG001|Overall Study|Study Terminated by Sponsor|152|||
19725067|NCT03711162|42168405|FG002|Overall Study|Study Terminated by Sponsor|146|||
19725068|NCT03711162|42168403|FG000|Overall Study|Withdrawal by Subject|17|||
19725069|NCT03711162|42168404|FG001|Overall Study|Withdrawal by Subject|10|||
19725070|NCT03711162|42168405|FG002|Overall Study|Withdrawal by Subject|10|||
19725071|NCT03711162|42168403|FG000|Overall Study|Miscellaneous|1|||
19725072|NCT03711162|42168404|FG001|Overall Study|Miscellaneous|2|||
19725073|NCT03711162|42168405|FG002|Overall Study|Miscellaneous|2|||
19725074|NCT03711162|42168403|FG000|Overall Study|Not Treated|1|||
19725075|NCT03711162|42168404|FG001|Overall Study|Not Treated|0|||
19725076|NCT03711162|42168405|FG002|Overall Study|Not Treated|1|||
19725077|NCT03711162|42168403|FG000|Overall Study|Physician Decision|0|||
19725078|NCT03711162|42168404|FG001|Overall Study|Physician Decision|2|||
19725079|NCT03711162|42168405|FG002|Overall Study|Physician Decision|0|||
19725080|NCT03711162|42168403|FG000|Overall Study|Lack of Efficacy|0|||
19725081|NCT03711162|42168404|FG001|Overall Study|Lack of Efficacy|0|||
19725082|NCT03711162|42168405|FG002|Overall Study|Lack of Efficacy|2|||
19725083|NCT03711162|42168403|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
19725084|NCT03711162|42168404|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
19725085|NCT03711162|42168405|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
19725086|NCT03072160|42168421|FG000|Overall Study|Adverse Event|3|||
19725087|NCT03072160|42168422|FG001|Overall Study|Adverse Event|1|||
19725088|NCT03072160|42168421|FG000|Overall Study|Refused further treatment|6|||
19725089|NCT03072160|42168422|FG001|Overall Study|Refused further treatment|1|||
19725090|NCT03072160|42168421|FG000|Overall Study|Physician Decision|1|||
19725091|NCT03072160|42168422|FG001|Overall Study|Physician Decision|0|||
19725092|NCT03072160|42168421|FG000|Overall Study|Disease progression on study|1|||
19725093|NCT03072160|42168422|FG001|Overall Study|Disease progression on study|1|||
19725094|NCT03072160|42168421|FG000|Overall Study|No contact|0|||
19725095|NCT03072160|42168422|FG001|Overall Study|No contact|1|||
19725096|NCT00407602|42168460|FG000|Overall Study|Death - unrelated to device|1|||
19725097|NCT00407602|42168460|FG000|Overall Study|Device explanted|5|||
19725098|NCT00407602|42168460|FG000|Overall Study|Withdrawal by Subject|1|||
19725099|NCT03057496|42168467|FG000|Overall Study|Withdrawal by Subject|8|||
19725100|NCT03057496|42168467|FG000|Overall Study|Lost to Follow-up|5|||
19725101|NCT03057496|42168467|FG000|Overall Study|Did not use device during home trial|3|||
19725102|NCT03057496|42168467|FG000|Overall Study|Device failure|2|||
19725103|NCT03708744|42168477|FG000|Overall Study|Withdrawal by Subject|0|||
19725104|NCT03708744|42168478|FG001|Overall Study|Withdrawal by Subject|0|||
19725105|NCT03708744|42168479|FG002|Overall Study|Withdrawal by Subject|1|||
19725106|NCT03708744|42168480|FG003|Overall Study|Withdrawal by Subject|0|||
19725107|NCT02574286|42168494|FG000|Overall Study|Adverse Event|3|||
19725108|NCT02574286|42168494|FG000|Overall Study|Withdrawal by Subject|2|||
19725109|NCT02366728|42168501|FG000|Overall Study|Death|0|||
19725110|NCT02366728|42168502|FG001|Overall Study|Death|0|||
19725111|NCT02366728|42168503|FG002|Overall Study|Death|1|||
19725112|NCT02366728|42168501|FG000|Overall Study|Adverse Event|1|||
19725113|NCT02366728|42168502|FG001|Overall Study|Adverse Event|0|||
19725114|NCT02366728|42168503|FG002|Overall Study|Adverse Event|0|||
19725115|NCT02366728|42168501|FG000|Overall Study|Screen Failure|2|||
19725116|NCT02366728|42168502|FG001|Overall Study|Screen Failure|1|||
19725117|NCT02366728|42168503|FG002|Overall Study|Screen Failure|0|||
19725118|NCT02366728|42168501|FG000|Overall Study|Only yielded 2 vaccines|1|||
19725119|NCT02366728|42168502|FG001|Overall Study|Only yielded 2 vaccines|0|||
19725120|NCT02366728|42168503|FG002|Overall Study|Only yielded 2 vaccines|0|||
19725121|NCT02083354|42168515|FG000|Overall Study|Withdrawal by Subject|9|||
19725122|NCT02083354|42168515|FG000|Overall Study|Lost to Follow-up|1|||
19725123|NCT02083354|42168515|FG000|Overall Study|Adverse Event|3|||
19725124|NCT02083354|42168515|FG000|Overall Study|Disease progression|46|||
19725125|NCT02083354|42168515|FG000|Overall Study|Study closed/terminated|5|||
19725126|NCT04230486|42168519|FG000|Overall Study|Screen Failure|1|||
19725127|NCT01399918|42168525|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
19725128|NCT00112840|42168532|FG000|Overall Study|Physician Decision|1|||
19725129|NCT00112840|42168533|FG001|Overall Study|Physician Decision|0|||
19725130|NCT00112840|42168534|FG002|Overall Study|Physician Decision|0|||
19725131|NCT00112840|42168532|FG000|Overall Study|Withdrawal by Subject|1|||
19725132|NCT00112840|42168533|FG001|Overall Study|Withdrawal by Subject|0|||
19725133|NCT00112840|42168534|FG002|Overall Study|Withdrawal by Subject|1|||
19725134|NCT00112840|42168532|FG000|Overall Study|Protocol Violation|0|||
19725135|NCT00112840|42168533|FG001|Overall Study|Protocol Violation|0|||
19725136|NCT00112840|42168534|FG002|Overall Study|Protocol Violation|5|||
19725137|NCT02197572|42168547|FG000|Overall Study|Progressive Disease|28|||
19725138|NCT02197572|42168547|FG000|Overall Study|Withdrawal by Subject|9|||
19725139|NCT02197572|42168547|FG000|Overall Study|Adverse Event|3|||
19725140|NCT02197572|42168547|FG000|Overall Study|Reason Not Specified|4|||
19725141|NCT03176784|42168555|FG000|Overall Study|Lost to Follow-up|77|||
19725142|NCT03176784|42168556|FG001|Overall Study|Lost to Follow-up|79|||
19725143|NCT03176784|42168557|FG002|Overall Study|Lost to Follow-up|79|||
19725144|NCT03176784|42168558|FG003|Overall Study|Lost to Follow-up|49|||
19725145|NCT03176784|42168555|FG000|Overall Study|Withdrawal by Subject|28|||
19725146|NCT03176784|42168556|FG001|Overall Study|Withdrawal by Subject|34|||
19725147|NCT03176784|42168557|FG002|Overall Study|Withdrawal by Subject|34|||
19725148|NCT03176784|42168558|FG003|Overall Study|Withdrawal by Subject|21|||
19725149|NCT03049852|42168571|FG000|Overall Study|Lost to Follow-up|0|||
19725150|NCT03049852|42168572|FG001|Overall Study|Lost to Follow-up|1|||
19725151|NCT03049852|42168573|FG002|Overall Study|Lost to Follow-up|0|||
19725152|NCT05091528|42168585|FG000|Overall Study|Study Termination by Sponsor|0|||
19725153|NCT05091528|42168586|FG001|Overall Study|Study Termination by Sponsor|1|||
19725154|NCT05091528|42168587|FG002|Overall Study|Study Termination by Sponsor|0|||
19725155|NCT05091528|42168588|FG003|Overall Study|Study Termination by Sponsor|1|||
19725156|NCT01317160|42168598|FG000|Overall Study|Incorrect inclusion|1|||
19725157|NCT01317160|42168599|FG001|Overall Study|Incorrect inclusion|1|||
19725158|NCT01317160|42168598|FG000|Overall Study|Lost to Follow-up|3|||
19725159|NCT01317160|42168599|FG001|Overall Study|Lost to Follow-up|3|||
19725160|NCT01317160|42168598|FG000|Overall Study|Withdrawal by Subject|0|||
19725161|NCT01317160|42168599|FG001|Overall Study|Withdrawal by Subject|2|||
19725162|NCT01317004|42168620|FG000|Overall Study|Withdrawal by Subject|1|||
19725163|NCT01317004|42168621|FG001|Overall Study|Withdrawal by Subject|4|||
19725164|NCT01317004|42168620|FG000|Overall Study|Protocol Violation|0|||
19725165|NCT01317004|42168621|FG001|Overall Study|Protocol Violation|2|||
19725166|NCT01317004|42168620|FG000|Overall Study|Adverse Event|3|||
19725167|NCT01317004|42168621|FG001|Overall Study|Adverse Event|3|||
19725168|NCT01343056|42168631|FG000|Overall Study|Lost to Follow-up|7|||
19725169|NCT01343056|42168632|FG001|Overall Study|Lost to Follow-up|5|||
19725170|NCT01343056|42168633|FG002|Overall Study|Lost to Follow-up|3|||
19725171|NCT01343056|42168634|FG003|Overall Study|Lost to Follow-up|9|||
19725172|NCT01316692|42168648|FG000|Overall Study|Adverse Event|5|||
19725173|NCT01316692|42168648|FG000|Overall Study|Disease Progression|7|||
19725174|NCT01316380|42168655|FG000|Overall Study|Adverse Event|0|||
19725175|NCT01316380|42168656|FG001|Overall Study|Adverse Event|2|||
19725176|NCT01316380|42168657|FG002|Overall Study|Adverse Event|1|||
19725177|NCT01316380|42168655|FG000|Overall Study|Protocol Violation|0|||
19725178|NCT01316380|42168656|FG001|Overall Study|Protocol Violation|0|||
19725179|NCT01316380|42168657|FG002|Overall Study|Protocol Violation|1|||
19725180|NCT01316380|42168655|FG000|Overall Study|Withdrawal by Subject|1|||
19725181|NCT01316380|42168656|FG001|Overall Study|Withdrawal by Subject|2|||
19725182|NCT01316380|42168657|FG002|Overall Study|Withdrawal by Subject|0|||
19725183|NCT01316380|42168655|FG000|Overall Study|Other|0|||
19725184|NCT01316380|42168656|FG001|Overall Study|Other|1|||
19725185|NCT01316380|42168657|FG002|Overall Study|Other|1|||
19725186|NCT01316380|42168655|FG000|Overall Study|Not treated|1|||
19725187|NCT01316380|42168656|FG001|Overall Study|Not treated|0|||
19725188|NCT01316380|42168657|FG002|Overall Study|Not treated|0|||
19725189|NCT01316224|42168665|FG000|Overall Study|Protocol Violation|3|||
19725190|NCT01316224|42168665|FG000|Overall Study|Adverse Event|3|||
19725191|NCT01316224|42168665|FG000|Overall Study|Lack of Efficacy|1|||
19725192|NCT01316224|42168665|FG000|Overall Study|Withdrawal by Subject|1|||
19725193|NCT01316224|42168665|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
19725194|NCT01316224|42168665|FG000|Overall Study|Other|1|||
19725195|NCT04315298|42168688|FG000|Overall Study|Withdrawal by Subject|0|||
19725196|NCT04315298|42168689|FG001|Overall Study|Withdrawal by Subject|0|||
19725197|NCT04315298|42168690|FG002|Overall Study|Withdrawal by Subject|0|||
19725198|NCT04315298|42168691|FG003|Overall Study|Withdrawal by Subject|2|||
19725199|NCT04315298|42168692|FG004|Overall Study|Withdrawal by Subject|2|||
19725200|NCT04315298|42168693|FG005|Overall Study|Withdrawal by Subject|2|||
19725201|NCT04315298|42168694|FG006|Overall Study|Withdrawal by Subject|0|||
19725202|NCT04315298|42168695|FG007|Overall Study|Withdrawal by Subject|1|||
19725203|NCT04315298|42168696|FG008|Overall Study|Withdrawal by Subject|1|||
19725204|NCT04315298|42168697|FG009|Overall Study|Withdrawal by Subject|1|||
19725205|NCT04315298|42168698|FG010|Overall Study|Withdrawal by Subject|0|||
19725206|NCT04315298|42168699|FG011|Overall Study|Withdrawal by Subject|0|||
19725207|NCT04315298|42168700|FG012|Overall Study|Withdrawal by Subject|0|||
19725208|NCT04315298|42168701|FG013|Overall Study|Withdrawal by Subject|0|||
19725209|NCT04315298|42168702|FG014|Overall Study|Withdrawal by Subject|0|||
19725210|NCT04315298|42168703|FG015|Overall Study|Withdrawal by Subject|0|||
19725211|NCT04315298|42168704|FG016|Overall Study|Withdrawal by Subject|0|||
19725212|NCT04315298|42168705|FG017|Overall Study|Withdrawal by Subject|0|||
19725213|NCT04315298|42168706|FG018|Overall Study|Withdrawal by Subject|0|||
19725214|NCT04315298|42168688|FG000|Overall Study|Physician Decision|0|||
19725215|NCT04315298|42168689|FG001|Overall Study|Physician Decision|0|||
19725216|NCT04315298|42168690|FG002|Overall Study|Physician Decision|0|||
19725217|NCT04315298|42168691|FG003|Overall Study|Physician Decision|0|||
19725218|NCT04315298|42168692|FG004|Overall Study|Physician Decision|1|||
19725219|NCT04315298|42168693|FG005|Overall Study|Physician Decision|0|||
19725220|NCT04315298|42168694|FG006|Overall Study|Physician Decision|0|||
19725221|NCT04315298|42168695|FG007|Overall Study|Physician Decision|0|||
19725222|NCT04315298|42168696|FG008|Overall Study|Physician Decision|0|||
19725223|NCT04315298|42168697|FG009|Overall Study|Physician Decision|0|||
19725224|NCT04315298|42168698|FG010|Overall Study|Physician Decision|0|||
19725225|NCT04315298|42168699|FG011|Overall Study|Physician Decision|0|||
19725226|NCT04315298|42168700|FG012|Overall Study|Physician Decision|0|||
19725227|NCT04315298|42168701|FG013|Overall Study|Physician Decision|0|||
19725228|NCT04315298|42168702|FG014|Overall Study|Physician Decision|0|||
19725229|NCT04315298|42168703|FG015|Overall Study|Physician Decision|0|||
19725230|NCT04315298|42168704|FG016|Overall Study|Physician Decision|0|||
19725231|NCT04315298|42168705|FG017|Overall Study|Physician Decision|0|||
19725232|NCT04315298|42168706|FG018|Overall Study|Physician Decision|0|||
19725233|NCT04315298|42168688|FG000|Overall Study|Lost to Follow-up|5|||
19725234|NCT04315298|42168689|FG001|Overall Study|Lost to Follow-up|10|||
19725235|NCT04315298|42168690|FG002|Overall Study|Lost to Follow-up|6|||
19725236|NCT04315298|42168691|FG003|Overall Study|Lost to Follow-up|8|||
19725237|NCT04315298|42168692|FG004|Overall Study|Lost to Follow-up|12|||
19725238|NCT04315298|42168693|FG005|Overall Study|Lost to Follow-up|13|||
19725239|NCT04315298|42168694|FG006|Overall Study|Lost to Follow-up|9|||
19725240|NCT04315298|42168695|FG007|Overall Study|Lost to Follow-up|16|||
19725241|NCT04315298|42168696|FG008|Overall Study|Lost to Follow-up|14|||
19725242|NCT04315298|42168697|FG009|Overall Study|Lost to Follow-up|0|||
19725243|NCT04315298|42168698|FG010|Overall Study|Lost to Follow-up|2|||
19725244|NCT04315298|42168699|FG011|Overall Study|Lost to Follow-up|1|||
19725245|NCT04315298|42168700|FG012|Overall Study|Lost to Follow-up|0|||
19725246|NCT04315298|42168701|FG013|Overall Study|Lost to Follow-up|0|||
19725247|NCT04315298|42168702|FG014|Overall Study|Lost to Follow-up|0|||
19725248|NCT04315298|42168703|FG015|Overall Study|Lost to Follow-up|2|||
19725249|NCT04315298|42168704|FG016|Overall Study|Lost to Follow-up|0|||
19725250|NCT04315298|42168705|FG017|Overall Study|Lost to Follow-up|0|||
19725251|NCT04315298|42168706|FG018|Overall Study|Lost to Follow-up|0|||
19725252|NCT04315298|42168688|FG000|Overall Study|Death|24|||
19725253|NCT04315298|42168689|FG001|Overall Study|Death|60|||
19725254|NCT04315298|42168690|FG002|Overall Study|Death|49|||
19725255|NCT04315298|42168691|FG003|Overall Study|Death|59|||
19725256|NCT04315298|42168692|FG004|Overall Study|Death|70|||
19725257|NCT04315298|42168693|FG005|Overall Study|Death|114|||
19725258|NCT04315298|42168694|FG006|Overall Study|Death|9|||
19725259|NCT04315298|42168695|FG007|Overall Study|Death|12|||
19725260|NCT04315298|42168696|FG008|Overall Study|Death|21|||
19725261|NCT04315298|42168697|FG009|Overall Study|Death|16|||
19725262|NCT04315298|42168698|FG010|Overall Study|Death|40|||
19725263|NCT04315298|42168699|FG011|Overall Study|Death|40|||
19725264|NCT04315298|42168700|FG012|Overall Study|Death|3|||
19725265|NCT04315298|42168701|FG013|Overall Study|Death|4|||
19725266|NCT04315298|42168702|FG014|Overall Study|Death|6|||
19725267|NCT04315298|42168703|FG015|Overall Study|Death|4|||
19725268|NCT04315298|42168704|FG016|Overall Study|Death|3|||
19725269|NCT04315298|42168705|FG017|Overall Study|Death|1|||
19725270|NCT04315298|42168706|FG018|Overall Study|Death|0|||
19725271|NCT04314284|42168775|FG000|Overall Study|Withdrawal by Subject|4|||
19725272|NCT04314284|42168776|FG001|Overall Study|Withdrawal by Subject|7|||
19725273|NCT04314284|42168775|FG000|Overall Study|Consented but did not complete survey|0|||
19725274|NCT04314284|42168776|FG001|Overall Study|Consented but did not complete survey|6|||
19725275|NCT04308668|42168784|FG000|Overall Study|Lost to Follow-up|32|||
19725276|NCT04308668|42168785|FG001|Overall Study|Lost to Follow-up|38|||
19725277|NCT04308668|42168784|FG000|Overall Study|Withdrawal by Subject|4|||
19725278|NCT04308668|42168785|FG001|Overall Study|Withdrawal by Subject|4|||
19725279|NCT04451330|42168793|FG000|Overall Study|Adverse Event|1|||
19725280|NCT04451330|42168794|FG001|Overall Study|Adverse Event|2|||
19725281|NCT04451330|42168793|FG000|Overall Study|Lost to Follow-up|5|||
19725282|NCT04451330|42168794|FG001|Overall Study|Lost to Follow-up|0|||
19725283|NCT04451330|42168793|FG000|Overall Study|Withdrawal by Subject|3|||
19725284|NCT04451330|42168794|FG001|Overall Study|Withdrawal by Subject|1|||
19725285|NCT04451330|42168793|FG000|Overall Study|Withdrawal by parent/guardian|1|||
19725286|NCT04451330|42168794|FG001|Overall Study|Withdrawal by parent/guardian|0|||
19725287|NCT04451330|42168793|FG000|Overall Study|Other than specified|0|||
19725288|NCT04451330|42168794|FG001|Overall Study|Other than specified|1|||
19725289|NCT02493426|42168800|FG000|Overall Study|Withdrawal by Subject|0|||
19725290|NCT02493426|42168801|FG001|Overall Study|Withdrawal by Subject|1|||
19725291|NCT04448756|42168810|FG000|Overall Study|Adverse Event|0|||
19725292|NCT04448756|42168811|FG001|Overall Study|Adverse Event|1|||
19725293|NCT04448756|42168812|FG002|Overall Study|Adverse Event|0|||
19725294|NCT04448756|42168810|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
19725295|NCT04448756|42168811|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
19725296|NCT04448756|42168812|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
19725297|NCT04448756|42168810|FG000|Overall Study|Withdrawal by Subject|0|||
19725298|NCT04448756|42168811|FG001|Overall Study|Withdrawal by Subject|3|||
19725299|NCT04448756|42168812|FG002|Overall Study|Withdrawal by Subject|1|||
19725300|NCT04448756|42168810|FG000|Overall Study|Death|2|||
19725301|NCT04448756|42168811|FG001|Overall Study|Death|1|||
19725302|NCT04448756|42168812|FG002|Overall Study|Death|0|||
19725303|NCT04274192|42168822|FG000|Overall Study|Protocol Violation|1|||
19725304|NCT04274192|42168823|FG001|Overall Study|Protocol Violation|0|||
19725305|NCT04387136|42168833|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
19725306|NCT04387136|42168834|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
19725307|NCT04658784|42168842|FG000|6-month Follow-up|Lost to Follow-up|2|||
19725308|NCT04658784|42168843|FG001|6-month Follow-up|Lost to Follow-up|5|||
19725309|NCT04252586|42168849|FG000|Overall Study|Withdrawal by parent/guardian|3|||
19725310|NCT04252586|42168849|FG000|Overall Study|Adverse Event|1|||
19725311|NCT04252586|42168849|FG000|Overall Study|Death|2|||
19725312|NCT04252586|42168849|FG000|Overall Study|Study terminated by sponsor|4|||
19725313|NCT04252586|42168849|FG000|Overall Study|Sponsor request|10|||
19725314|NCT04252586|42168849|FG000|Overall Study|Did not complete treatment period|1|||
19725315|NCT04247828|42168854|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
19725316|NCT04507776|42168858|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
19725317|NCT04386902|42168867|FG000|Overall Study|Withdrawal by Subject|5|||
19725318|NCT04386902|42168867|FG000|Overall Study|Technical problems in the recording|5|||
19725319|NCT04232540|42168873|FG000|Overall Study|Lost to Follow-up|1|||
19725320|NCT04232540|42168874|FG001|Overall Study|Lost to Follow-up|0|||
19725321|NCT04504032|42168882|FG000|Overall Study|Adverse Event|1|||
19725322|NCT04504032|42168883|FG001|Overall Study|Adverse Event|2|||
19725323|NCT04504032|42168882|FG000|Overall Study|Lost to Follow-up|6|||
19725324|NCT04504032|42168883|FG001|Overall Study|Lost to Follow-up|9|||
19725325|NCT04504032|42168882|FG000|Overall Study|Protocol Violation|2|||
19725326|NCT04504032|42168883|FG001|Overall Study|Protocol Violation|0|||
19725327|NCT04504032|42168882|FG000|Overall Study|Study terminated by sponsor|1|||
19725328|NCT04504032|42168883|FG001|Overall Study|Study terminated by sponsor|2|||
19725329|NCT04504032|42168882|FG000|Overall Study|Withdrawal by Subject|9|||
19725330|NCT04504032|42168883|FG001|Overall Study|Withdrawal by Subject|11|||
19725331|NCT04504032|42168882|FG000|Overall Study|Disease progression prior to dosing|15|||
19725332|NCT04504032|42168883|FG001|Overall Study|Disease progression prior to dosing|3|||
19725333|NCT04504032|42168882|FG000|Overall Study|Drug supply issues|1|||
19725334|NCT04504032|42168883|FG001|Overall Study|Drug supply issues|1|||
19725335|NCT04504032|42168882|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
19725336|NCT04504032|42168883|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
19725337|NCT04439240|42168889|FG000|Overall Study|Ineligible|2|||
19725338|NCT04439240|42168889|FG000|Overall Study|Never started treatment|2|||
19725339|NCT04439240|42168889|FG000|Overall Study|Adverse Event|12|||
19725340|NCT04439240|42168889|FG000|Overall Study|Death|2|||
19725341|NCT04439240|42168889|FG000|Overall Study|Disease progression|25|||
19725342|NCT04439240|42168889|FG000|Overall Study|Other diseases|2|||
19725343|NCT04439240|42168889|FG000|Overall Study|Withdrawal by Subject|3|||
19725344|NCT04439240|42168889|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
19725345|NCT04439240|42168889|FG000|Overall Study|Symptomatic decline|1|||
19725346|NCT04439240|42168889|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
19725347|NCT04439240|42168889|FG000|Overall Study|Clinical progression|1|||
19725348|NCT04605588|42168895|FG000|Overall Study|Withdrawal by Subject|1|||
19725349|NCT04605588|42168896|FG001|Overall Study|Withdrawal by Subject|0|||
19725350|NCT04885296|42168902|FG000|Period 1|Covid-19 Related|1|||
19725351|NCT04885296|42168903|FG001|Period 1|Covid-19 Related|0|||
19725352|NCT04885296|42168902|FG000|Period 1|Adverse Event|0|||
19725353|NCT04885296|42168903|FG001|Period 1|Adverse Event|1|||
19725354|NCT04885296|42168902|FG000|Period 1|Withdrawal by Subject|1|||
19725355|NCT04885296|42168903|FG001|Period 1|Withdrawal by Subject|1|||
19725356|NCT04885296|42168902|FG000|Period 1|Test Article No Longer Available|1|||
19725357|NCT04885296|42168903|FG001|Period 1|Test Article No Longer Available|0|||
19725358|NCT04885296|42168902|FG000|Period 1|Dispensed Study lens in Error|1|||
19725359|NCT04885296|42168903|FG001|Period 1|Dispensed Study lens in Error|0|||
19725360|NCT04885296|42168902|FG000|Period 1|Lost to Follow-up|1|||
19725361|NCT04885296|42168903|FG001|Period 1|Lost to Follow-up|0|||
19725362|NCT04885296|42168902|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
19725363|NCT04885296|42168903|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
19725364|NCT04602000|42168914|FG000|Overall Study|Withdrawal by Subject|3|||
19725365|NCT04602000|42168915|FG001|Overall Study|Withdrawal by Subject|6|||
19725366|NCT04602000|42168916|FG002|Overall Study|Withdrawal by Subject|3|||
19725367|NCT04602000|42168917|FG003|Overall Study|Withdrawal by Subject|27|||
19725368|NCT04602000|42168918|FG004|Overall Study|Withdrawal by Subject|39|||
19725369|NCT04602000|42168914|FG000|Overall Study|Physician Decision|1|||
19725370|NCT04602000|42168915|FG001|Overall Study|Physician Decision|0|||
19725371|NCT04602000|42168916|FG002|Overall Study|Physician Decision|0|||
19725372|NCT04602000|42168917|FG003|Overall Study|Physician Decision|2|||
19725373|NCT04602000|42168918|FG004|Overall Study|Physician Decision|2|||
19725374|NCT04602000|42168914|FG000|Overall Study|Death|0|||
19725375|NCT04602000|42168915|FG001|Overall Study|Death|1|||
19725376|NCT04602000|42168916|FG002|Overall Study|Death|0|||
19725377|NCT04602000|42168917|FG003|Overall Study|Death|1|||
19725378|NCT04602000|42168918|FG004|Overall Study|Death|2|||
19725379|NCT04602000|42168914|FG000|Overall Study|Lost to Follow-up|0|||
19725380|NCT04602000|42168915|FG001|Overall Study|Lost to Follow-up|0|||
19725381|NCT04602000|42168916|FG002|Overall Study|Lost to Follow-up|0|||
19725382|NCT04602000|42168917|FG003|Overall Study|Lost to Follow-up|3|||
19725383|NCT04602000|42168918|FG004|Overall Study|Lost to Follow-up|4|||
19725384|NCT04602000|42168914|FG000|Overall Study|Other|4|||
19725385|NCT04602000|42168915|FG001|Overall Study|Other|1|||
19725386|NCT04602000|42168916|FG002|Overall Study|Other|2|||
19725387|NCT04602000|42168917|FG003|Overall Study|Other|5|||
19725388|NCT04602000|42168918|FG004|Overall Study|Other|4|||
19725389|NCT04602000|42168914|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
19725390|NCT04602000|42168915|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
19725391|NCT04602000|42168916|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
19725392|NCT04602000|42168917|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
19725393|NCT04602000|42168918|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
19725394|NCT03041116|42168934|FG000|Double-blind|Death|0|||
19725395|NCT03041116|42168935|FG001|Double-blind|Death|2|||
19725396|NCT03041116|42168934|FG000|Double-blind|Withdrawal by Subject|0|||
19725397|NCT03041116|42168935|FG001|Double-blind|Withdrawal by Subject|4|||
19725398|NCT03041116|42168934|FG000|Open-label|Death|1|||
19725399|NCT03041116|42168935|FG001|Open-label|Death|0|||
19725400|NCT03041116|42168934|FG000|Open-label|Termination of the study by Sponsor|39|||
19725401|NCT03041116|42168935|FG001|Open-label|Termination of the study by Sponsor|37|||
19725402|NCT03041116|42168934|FG000|Open-label|Withdrawal by Subject|1|||
19725403|NCT03041116|42168935|FG001|Open-label|Withdrawal by Subject|0|||
19725404|NCT04860258|42168952|FG000|Overall Study|Withdrawal by Subject|0|||
19725405|NCT04860258|42168953|FG001|Overall Study|Withdrawal by Subject|0|||
19725406|NCT04860258|42168954|FG002|Overall Study|Withdrawal by Subject|4|||
19725407|NCT04860258|42168955|FG003|Overall Study|Withdrawal by Subject|1|||
19725408|NCT04860258|42168956|FG004|Overall Study|Withdrawal by Subject|4|||
19725409|NCT04860258|42168957|FG005|Overall Study|Withdrawal by Subject|1|||
19725410|NCT04860258|42168958|FG006|Overall Study|Withdrawal by Subject|0|||
19725411|NCT03041038|42168976|FG000|Overall Study|Withdrawal by Subject|4|||
19725412|NCT03041038|42168977|FG001|Overall Study|Withdrawal by Subject|0|||
19725413|NCT03041038|42168976|FG000|Overall Study|Lost to Follow-up|1|||
19725414|NCT03041038|42168977|FG001|Overall Study|Lost to Follow-up|1|||
19725415|NCT03041038|42168976|FG000|Overall Study|Protocol Violation|1|||
19725416|NCT03041038|42168977|FG001|Overall Study|Protocol Violation|1|||
19725417|NCT04382066|42168988|FG000|Overall Study|Adverse Event|1|||
19725418|NCT04382066|42168989|FG001|Overall Study|Adverse Event|0|||
19725419|NCT04382066|42168990|FG002|Overall Study|Adverse Event|0|||
19725420|NCT04382066|42168988|FG000|Overall Study|Death|1|||
19725421|NCT04382066|42168989|FG001|Overall Study|Death|0|||
19725422|NCT04382066|42168990|FG002|Overall Study|Death|1|||
19725423|NCT04435184|42169006|FG000|Overall Study|follow-up blood draws missing|3|||
19725424|NCT04435184|42169007|FG001|Overall Study|follow-up blood draws missing|5|||
19725425|NCT04432376|42169016|FG000|Double-blind Treatment Period|Adverse Event|2|||
19725426|NCT04432376|42169017|FG001|Double-blind Treatment Period|Adverse Event|6|||
19725427|NCT04432376|42169018|FG002|Double-blind Treatment Period|Adverse Event|0|||
19725428|NCT04432376|42169016|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
19725429|NCT04432376|42169017|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
19725430|NCT04432376|42169018|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
19725431|NCT04432376|42169016|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
19725432|NCT04432376|42169017|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
19725433|NCT04432376|42169018|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
19725434|NCT04432376|42169016|FG000|Double-blind Treatment Period|Protocol Violation|0|||
19725435|NCT04432376|42169017|FG001|Double-blind Treatment Period|Protocol Violation|1|||
19725436|NCT04432376|42169018|FG002|Double-blind Treatment Period|Protocol Violation|0|||
19725437|NCT04432376|42169016|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
19725438|NCT04432376|42169017|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
19725439|NCT04432376|42169018|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
19725440|NCT03693404|42169027|FG000|Overall Study|Withdrawal by Subject|1|||
19725441|NCT03693404|42169028|FG001|Overall Study|Withdrawal by Subject|0|||
19725442|NCT03693404|42169027|FG000|Overall Study|Lost to Follow-up|0|||
19725443|NCT03693404|42169028|FG001|Overall Study|Lost to Follow-up|5|||
19725444|NCT03693404|42169027|FG000|Overall Study|Excluded from Analysis|0|||
19725445|NCT03693404|42169028|FG001|Overall Study|Excluded from Analysis|1|||
19725446|NCT03696108|42169036|FG000|Overall Study|Physician Decision|1|||
19725447|NCT03696108|42169037|FG001|Overall Study|Physician Decision|0|||
19725448|NCT03696108|42169036|FG000|Overall Study|Withdrawal by Subject|3|||
19725449|NCT03696108|42169037|FG001|Overall Study|Withdrawal by Subject|6|||
19725450|NCT04218110|42169047|FG000|Overall Study|Withdrawal by Subject|0|||
19725451|NCT04218110|42169048|FG001|Overall Study|Withdrawal by Subject|0|||
19725452|NCT04218110|42169049|FG002|Overall Study|Withdrawal by Subject|0|||
19725453|NCT04218110|42169050|FG003|Overall Study|Withdrawal by Subject|1|||
19725454|NCT04214600|42169062|FG000|Overall Study|Lost to Follow-up|9|||
19725455|NCT04214600|42169063|FG001|Overall Study|Lost to Follow-up|14|||
19725456|NCT04210310|42169072|FG000|Overall Study|Lost to Follow-up|32|||
19725457|NCT04210310|42169073|FG001|Overall Study|Lost to Follow-up|1|||
19725458|NCT04209530|42169081|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
19725459|NCT04209530|42169082|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
19725460|NCT04209530|42169081|FG000|Overall Study|Withdrawal by Subject|0|||
19725461|NCT04209530|42169082|FG001|Overall Study|Withdrawal by Subject|1|||
19725462|NCT04349098|42169090|FG000|Overall Study|Death|16|||
19725463|NCT04349098|42169091|FG001|Overall Study|Death|8|||
19725464|NCT04349098|42169090|FG000|Overall Study|Lost to Follow-up|11|||
19725465|NCT04349098|42169091|FG001|Overall Study|Lost to Follow-up|8|||
19725466|NCT04349098|42169090|FG000|Overall Study|Withdrawal by Subject|8|||
19725467|NCT04349098|42169091|FG001|Overall Study|Withdrawal by Subject|5|||
19725468|NCT04349098|42169090|FG000|Overall Study|Other|3|||
19725469|NCT04349098|42169091|FG001|Overall Study|Other|5|||
19725470|NCT04208750|42169099|FG000|Overall Study|Lost to Follow-up|16|||
19725471|NCT04208750|42169100|FG001|Overall Study|Lost to Follow-up|15|||
19725472|NCT04381988|42169108|FG000|Overall Study|The study was terminated|4|||
19725473|NCT04381988|42169109|FG001|Overall Study|The study was terminated|0|||
19725474|NCT04333498|42169117|FG000|Overall Study|Lost to Follow-up|1|||
19725475|NCT04333498|42169118|FG001|Overall Study|Lost to Follow-up|0|||
19725476|NCT04333498|42169117|FG000|Overall Study|Lost to Follow-up|0|||
19725477|NCT04333498|42169118|FG001|Overall Study|Lost to Follow-up|1|||
19725478|NCT03355664|42169126|FG000|Overall Study|Adverse Event|1|||
19725479|NCT03355664|42169127|FG001|Overall Study|Adverse Event|2|||
19725480|NCT03355664|42169126|FG000|Overall Study|Lost to Follow-up|11|||
19725481|NCT03355664|42169127|FG001|Overall Study|Lost to Follow-up|7|||
19725482|NCT03355664|42169126|FG000|Overall Study|Protocol Violation|1|||
19725483|NCT03355664|42169127|FG001|Overall Study|Protocol Violation|2|||
19725484|NCT03355664|42169126|FG000|Overall Study|Withdrawal by Subject|2|||
19725485|NCT03355664|42169127|FG001|Overall Study|Withdrawal by Subject|1|||
19725486|NCT04170686|42169135|FG000|Screening|Physician Decision|12|||
19725487|NCT04170686|42169136|FG001|Screening|Physician Decision|13|||
19725488|NCT04170686|42169135|FG000|Randomization and Treatment|Lost to Follow-up|26|||
19725489|NCT04170686|42169136|FG001|Randomization and Treatment|Lost to Follow-up|15|||
19725490|NCT03695094|42169144|FG000|Overall Study|Adverse Event|1|||
19725491|NCT03695094|42169145|FG001|Overall Study|Adverse Event|1|||
19725492|NCT03695094|42169144|FG000|Overall Study|Withdrawal by Subject|1|||
19725493|NCT03695094|42169145|FG001|Overall Study|Withdrawal by Subject|0|||
19725494|NCT04497948|42169153|FG000|Overall Study|Death|2|||
19725495|NCT04495374|42169163|FG000|Overall Study|Protocol Violation|2|||
19725496|NCT04495374|42169164|FG001|Overall Study|Protocol Violation|1|||
19725497|NCT04794270|42169170|FG000|Period 1|Non Compliance|1|||
19725498|NCT04794270|42169171|FG001|Period 1|Non Compliance|0|||
19725499|NCT04794270|42169170|FG000|Period 1|Adverse Event|1|||
19725500|NCT04794270|42169171|FG001|Period 1|Adverse Event|0|||
19725501|NCT04794270|42169170|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
19725502|NCT04794270|42169171|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
19725503|NCT04567186|42169177|FG000|Period 1|COVID-19 related|1|||
19725504|NCT04567186|42169178|FG001|Period 1|COVID-19 related|0|||
19725505|NCT04567186|42169177|FG000|Period 1|Protocol Violation|0|||
19725506|NCT04567186|42169178|FG001|Period 1|Protocol Violation|1|||
19725507|NCT04567186|42169177|FG000|Period 1|Adverse Event|0|||
19725508|NCT04567186|42169178|FG001|Period 1|Adverse Event|2|||
19725509|NCT04567186|42169177|FG000|Period 2|COVID-19 Related|0|||
19725510|NCT04567186|42169178|FG001|Period 2|COVID-19 Related|1|||
19725511|NCT04567186|42169177|FG000|Period 2|Protocol Violation|0|||
19725512|NCT04567186|42169178|FG001|Period 2|Protocol Violation|1|||
19725513|NCT04567186|42169177|FG000|Period 2|Lost to Follow-up|0|||
19725514|NCT04567186|42169178|FG001|Period 2|Lost to Follow-up|1|||
19725515|NCT04567186|42169177|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
19725516|NCT04567186|42169178|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
19375443|NCT00835211|41617402|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19375444|NCT00835211|41617403|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
19375445|NCT00834743|41617416|FG000|Second Intervention|Withdrawal by Subject|1|||
19375446|NCT00834743|41617417|FG001|Second Intervention|Withdrawal by Subject|0|||
19375447|NCT00834587|41617423|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
19375448|NCT00834587|41617424|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
19375449|NCT00834431|41617430|FG000|First Intervention|Adverse Event|0|||
19375450|NCT00834431|41617431|FG001|First Intervention|Adverse Event|1|||
19375451|NCT00834431|41617430|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
19375452|NCT00834431|41617431|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
19375453|NCT00830219|41617451|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19375454|NCT00830219|41617452|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
19375455|NCT02274766|41617458|FG000|Overall Study|Withdrawal by Subject|3|||
19375456|NCT02274766|41617459|FG001|Overall Study|Withdrawal by Subject|6|||
19375457|NCT02274766|41617458|FG000|Overall Study|Did Not Receive Study Drug|1|||
19375458|NCT02274766|41617459|FG001|Overall Study|Did Not Receive Study Drug|1|||
19375459|NCT02274766|41617458|FG000|Overall Study|Subject Unwilling to Proceed|0|||
19375460|NCT02274766|41617459|FG001|Overall Study|Subject Unwilling to Proceed|1|||
19375461|NCT02274766|41617458|FG000|Overall Study|Adverse Event|0|||
19375462|NCT02274766|41617459|FG001|Overall Study|Adverse Event|1|||
19375463|NCT00829673|41617467|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
19375464|NCT00829673|41617468|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
19375465|NCT02370238|41617474|FG000|Overall Study|Death|42|||
19375466|NCT02370238|41617475|FG001|Overall Study|Death|35|||
19375467|NCT02370238|41617474|FG000|Overall Study|Lost to Follow-up|1|||
19375468|NCT02370238|41617475|FG001|Overall Study|Lost to Follow-up|3|||
19375469|NCT02370238|41617474|FG000|Overall Study|Withdrawal by Subject|2|||
19375470|NCT02370238|41617475|FG001|Overall Study|Withdrawal by Subject|6|||
19375471|NCT02370238|41617474|FG000|Overall Study|Other|2|||
19375472|NCT02370238|41617475|FG001|Overall Study|Other|1|||
19375473|NCT02370160|41617485|FG000|Overall Study|Death|3|||
19375474|NCT02370160|41617486|FG001|Overall Study|Death|4|||
19375475|NCT02370160|41617487|FG002|Overall Study|Death|1|||
19375476|NCT02273908|41617502|FG000|Overall Study|Adverse Event|16|||
19375477|NCT02273908|41617503|FG001|Overall Study|Adverse Event|0|||
19375478|NCT02273908|41617502|FG000|Overall Study|Lost to Follow-up|10|||
19375479|NCT02273908|41617503|FG001|Overall Study|Lost to Follow-up|1|||
19375480|NCT02273908|41617502|FG000|Overall Study|Did not meet entrance criteria|3|||
19375481|NCT02273908|41617503|FG001|Overall Study|Did not meet entrance criteria|2|||
19375482|NCT02273908|41617502|FG000|Overall Study|Withdrawal by Subject|4|||
19375483|NCT02273908|41617503|FG001|Overall Study|Withdrawal by Subject|2|||
19375484|NCT02273752|41617513|FG000|Overall Study|Trial was terminated early|2|||
19375485|NCT02273596|41617517|FG000|24-Week Treatment Period|Adverse Event|3|||
19375486|NCT02273596|41617517|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
19375487|NCT02273596|41617517|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
19375488|NCT02273596|41617517|FG000|24-Week Treatment Period|Physician Decision|1|||
19375489|NCT02273596|41617517|FG000|24-Week Treatment Period|Protocol Deviation|1|||
19375490|NCT02273596|41617517|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
19375491|NCT02273596|41617517|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
19375492|NCT02273596|41617517|FG000|Extension Period|Lost to Follow-up|1|||
19375493|NCT02273596|41617517|FG000|Extension Period|Protocol Deviation|1|||
19375494|NCT01656200|41617527|FG000|Overall Study|Withdrawal by Subject|1|||
19375495|NCT02369848|41617531|FG000|Overall Study|Death|1|||
19375496|NCT02369848|41617531|FG000|Overall Study|Withdrawal by Subject|2|||
19375497|NCT02369848|41617531|FG000|Overall Study|Lost to Follow-up|1|||
19375498|NCT02368210|41617537|FG000|Overall Study|Withdrawal by Subject|1|||
19375499|NCT02368210|41617538|FG001|Overall Study|Withdrawal by Subject|0|||
19375500|NCT02368210|41617537|FG000|Overall Study|Adverse Event|0|||
19375501|NCT02368210|41617538|FG001|Overall Study|Adverse Event|1|||
19375502|NCT02273050|41617547|FG000|Overall Study|Adverse Event|4|||
19375503|NCT02273050|41617548|FG001|Overall Study|Adverse Event|3|||
19375504|NCT02273050|41617549|FG002|Overall Study|Adverse Event|3|||
19375505|NCT02273050|41617547|FG000|Overall Study|Death|0|||
19375506|NCT02273050|41617548|FG001|Overall Study|Death|0|||
19375507|NCT02273050|41617549|FG002|Overall Study|Death|1|||
19375508|NCT02273050|41617547|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
19375509|NCT02273050|41617548|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
19375510|NCT02273050|41617549|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
19375511|NCT02273050|41617547|FG000|Overall Study|Lack of Efficacy|0|||
19375512|NCT02273050|41617548|FG001|Overall Study|Lack of Efficacy|1|||
19375513|NCT02273050|41617549|FG002|Overall Study|Lack of Efficacy|1|||
19375514|NCT02273050|41617547|FG000|Overall Study|Withdrawal by Subject|17|||
19375515|NCT02273050|41617548|FG001|Overall Study|Withdrawal by Subject|14|||
19375516|NCT02273050|41617549|FG002|Overall Study|Withdrawal by Subject|16|||
19375517|NCT02273050|41617547|FG000|Overall Study|Lost to Follow-up|0|||
19375518|NCT02273050|41617548|FG001|Overall Study|Lost to Follow-up|2|||
19375519|NCT02273050|41617549|FG002|Overall Study|Lost to Follow-up|3|||
19375520|NCT02273050|41617547|FG000|Overall Study|Protocol Violation|3|||
19375521|NCT02273050|41617548|FG001|Overall Study|Protocol Violation|1|||
19375522|NCT02273050|41617549|FG002|Overall Study|Protocol Violation|4|||
19375523|NCT02272816|41617557|FG000|Overall Study|Adverse Event|1|||
19375524|NCT02271880|41617563|FG000|Overall Study|Premature discontinuation of study|3|||
19375525|NCT02271880|41617564|FG001|Overall Study|Premature discontinuation of study|4|||
19375526|NCT02367352|41617572|FG000|Overall Study|Progressive disease|7|||
19375527|NCT02367352|41617573|FG001|Overall Study|Progressive disease|0|||
19375528|NCT02367352|41617574|FG002|Overall Study|Progressive disease|0|||
19375529|NCT02367352|41617572|FG000|Overall Study|Participant Received Alternative Therapy|1|||
19375530|NCT02367352|41617573|FG001|Overall Study|Participant Received Alternative Therapy|0|||
19375531|NCT02367352|41617574|FG002|Overall Study|Participant Received Alternative Therapy|0|||
19375532|NCT02367352|41617572|FG000|Overall Study|Adverse Event|1|||
19375533|NCT02367352|41617573|FG001|Overall Study|Adverse Event|0|||
19375534|NCT02367352|41617574|FG002|Overall Study|Adverse Event|0|||
19375535|NCT02365636|41617583|FG000|Overall Study|Adverse Event|3|||
19375536|NCT02365636|41617584|FG001|Overall Study|Adverse Event|3|||
19375537|NCT02365636|41617585|FG002|Overall Study|Adverse Event|2|||
19375538|NCT02365636|41617583|FG000|Overall Study|Protocol Violation|1|||
19375539|NCT02365636|41617584|FG001|Overall Study|Protocol Violation|4|||
19375540|NCT02365636|41617585|FG002|Overall Study|Protocol Violation|0|||
19375541|NCT02365636|41617583|FG000|Overall Study|Lost to Follow-up|0|||
19375542|NCT02365636|41617584|FG001|Overall Study|Lost to Follow-up|0|||
19375543|NCT02365636|41617585|FG002|Overall Study|Lost to Follow-up|1|||
19375544|NCT02365636|41617583|FG000|Overall Study|Other|2|||
19375545|NCT02365636|41617584|FG001|Overall Study|Other|0|||
19375546|NCT02365636|41617585|FG002|Overall Study|Other|0|||
19375547|NCT01655498|41617593|FG000|Overall Study|Unrelated health issue|2|||
19375548|NCT01655498|41617593|FG000|Overall Study|Protocol Violation|2|||
19375549|NCT01655498|41617593|FG000|Overall Study|Withdrawal by Subject|1|||
19375550|NCT02270944|41617602|FG000|Overall Study|Lost to Follow-up|9|||
19375551|NCT02270944|41617603|FG001|Overall Study|Lost to Follow-up|4|||
19375552|NCT02270944|41617602|FG000|Overall Study|Withdrawal by Subject|2|||
19375553|NCT02270944|41617603|FG001|Overall Study|Withdrawal by Subject|1|||
19375554|NCT02365558|41617610|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
19375555|NCT02365558|41617611|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
19375556|NCT02365558|41617610|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
19375557|NCT02365558|41617611|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
19375558|NCT02365480|41617622|FG000|Overall Study|Withdrawal by Subject|2|||
19375559|NCT02365480|41617623|FG001|Overall Study|Withdrawal by Subject|0|||
19375560|NCT02270242|41617631|FG000|Overall Study|Withdrawal by Subject|18|||
19375561|NCT02270242|41617632|FG001|Overall Study|Withdrawal by Subject|25|||
19375562|NCT02270242|41617631|FG000|Overall Study|Lost to Follow-up|41|||
19375563|NCT02270242|41617632|FG001|Overall Study|Lost to Follow-up|27|||
19375564|NCT02270242|41617631|FG000|Overall Study|Physician Decision|0|||
19375565|NCT02270242|41617632|FG001|Overall Study|Physician Decision|1|||
19375566|NCT02364388|41617638|FG000|Overall Study|Protocol Violation|1|||
19375567|NCT02364388|41617638|FG000|Overall Study|Technical Failure|3|||
19375568|NCT02364388|41617638|FG000|Overall Study|No OA/US data|2|||
19375569|NCT02364388|41617638|FG000|Overall Study|No Biopsy|2|||
19375570|NCT02363686|41617642|FG000|Overall Study|Withdrawal by Subject|22|||
19375571|NCT02363686|41617642|FG000|Overall Study|incomplete FEES examinations|13|||
19375572|NCT02268916|41617648|FG000|Overall Study|Lost to Follow-up|1|||
19375573|NCT02268916|41617649|FG001|Overall Study|Lost to Follow-up|1|||
19375574|NCT02268916|41617648|FG000|Overall Study|Withdrawal by Subject|6|||
19375575|NCT02268916|41617649|FG001|Overall Study|Withdrawal by Subject|5|||
19375576|NCT02268916|41617648|FG000|Overall Study|Participant did not have diabetes|1|||
19375577|NCT02268916|41617649|FG001|Overall Study|Participant did not have diabetes|0|||
19375578|NCT02268916|41617648|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
19375579|NCT02268916|41617649|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
19375580|NCT02518490|41617656|FG000|Overall Study|Withdrawal by Subject|1|||
19375581|NCT02518490|41617657|FG001|Overall Study|Withdrawal by Subject|1|||
19375582|NCT01364870|41617667|FG000|Overall Study|Withdrawal by Subject|13|||
19375583|NCT01364870|41617668|FG001|Overall Study|Withdrawal by Subject|24|||
19375584|NCT01364870|41617669|FG002|Overall Study|Withdrawal by Subject|10|||
19375585|NCT01364870|41617667|FG000|Overall Study|Adverse Event|8|||
19375586|NCT01364870|41617668|FG001|Overall Study|Adverse Event|6|||
19375587|NCT01364870|41617669|FG002|Overall Study|Adverse Event|4|||
19375588|NCT01364870|41617667|FG000|Overall Study|Protocol Violation|1|||
19375589|NCT01364870|41617668|FG001|Overall Study|Protocol Violation|0|||
19375590|NCT01364870|41617669|FG002|Overall Study|Protocol Violation|0|||
19375591|NCT02268526|41617680|FG000|Overall Study|Adverse Event|0|||
19375592|NCT02268526|41617681|FG001|Overall Study|Adverse Event|2|||
19375593|NCT02268526|41617682|FG002|Overall Study|Adverse Event|1|||
19375594|NCT02268526|41617680|FG000|Overall Study|Death|1|||
19375595|NCT02268526|41617681|FG001|Overall Study|Death|11|||
19375596|NCT02268526|41617682|FG002|Overall Study|Death|0|||
19375597|NCT02268526|41617680|FG000|Overall Study|protocol deviation|0|||
19375598|NCT02268526|41617681|FG001|Overall Study|protocol deviation|1|||
19375599|NCT02268526|41617682|FG002|Overall Study|protocol deviation|0|||
19375600|NCT02268526|41617680|FG000|Overall Study|Physician Decision|0|||
19375601|NCT02268526|41617681|FG001|Overall Study|Physician Decision|0|||
19375602|NCT02268526|41617682|FG002|Overall Study|Physician Decision|1|||
19375603|NCT02268526|41617680|FG000|Overall Study|Subject/guardian decision|0|||
19375604|NCT02268526|41617681|FG001|Overall Study|Subject/guardian decision|7|||
19375605|NCT02268526|41617682|FG002|Overall Study|Subject/guardian decision|3|||
19375606|NCT02268214|41617695|FG000|Overall Study|Subject no longer meets study criteria|0|||
19375607|NCT02268214|41617696|FG001|Overall Study|Subject no longer meets study criteria|2|||
19375608|NCT02268214|41617697|FG002|Overall Study|Subject no longer meets study criteria|0|||
19375609|NCT02268214|41617695|FG000|Overall Study|Pregnancy|2|||
19375610|NCT02268214|41617696|FG001|Overall Study|Pregnancy|2|||
19375611|NCT02268214|41617697|FG002|Overall Study|Pregnancy|1|||
19375612|NCT02268214|41617695|FG000|Overall Study|Lost to Follow-up|3|||
19375613|NCT02268214|41617696|FG001|Overall Study|Lost to Follow-up|3|||
19375614|NCT02268214|41617697|FG002|Overall Study|Lost to Follow-up|4|||
19375615|NCT02268214|41617695|FG000|Overall Study|Lack of Efficacy|1|||
19375616|NCT02268214|41617696|FG001|Overall Study|Lack of Efficacy|0|||
19375617|NCT02268214|41617697|FG002|Overall Study|Lack of Efficacy|2|||
19375618|NCT02268214|41617695|FG000|Overall Study|Adverse Event|11|||
19375619|NCT02268214|41617696|FG001|Overall Study|Adverse Event|14|||
19375620|NCT02268214|41617697|FG002|Overall Study|Adverse Event|9|||
19375621|NCT02268214|41617695|FG000|Overall Study|Withdrawal by Subject|4|||
19375622|NCT02268214|41617696|FG001|Overall Study|Withdrawal by Subject|5|||
19375623|NCT02268214|41617697|FG002|Overall Study|Withdrawal by Subject|10|||
19375624|NCT02268214|41617695|FG000|Overall Study|Subject request to discontinue treatment|10|||
19375625|NCT02268214|41617696|FG001|Overall Study|Subject request to discontinue treatment|8|||
19375626|NCT02268214|41617697|FG002|Overall Study|Subject request to discontinue treatment|6|||
19375627|NCT02268214|41617695|FG000|Overall Study|Poor/non-compliance|2|||
19375628|NCT02268214|41617696|FG001|Overall Study|Poor/non-compliance|1|||
19375629|NCT02268214|41617697|FG002|Overall Study|Poor/non-compliance|2|||
19375630|NCT02268214|41617695|FG000|Overall Study|Other reasons|7|||
19375631|NCT02268214|41617696|FG001|Overall Study|Other reasons|3|||
19375632|NCT02268214|41617697|FG002|Overall Study|Other reasons|3|||
19375633|NCT02268214|41617695|FG000|Overall Study|Not entering long-term period|2|||
19375634|NCT02268214|41617696|FG001|Overall Study|Not entering long-term period|3|||
19375635|NCT02268214|41617697|FG002|Overall Study|Not entering long-term period|5|||
19375636|NCT02521376|41617709|FG000|Overall Study|Enrolled, But Not Treated|1|||
19375637|NCT02521376|41617710|FG001|Overall Study|Enrolled, But Not Treated|0|||
19375638|NCT02521376|41617711|FG002|Overall Study|Enrolled, But Not Treated|0|||
19375639|NCT02521376|41617712|FG003|Overall Study|Enrolled, But Not Treated|0|||
19375640|NCT02268058|41617734|FG000|Overall Study|Protocol Violation|1|||
19375641|NCT02268058|41617735|FG001|Overall Study|Protocol Violation|0|||
19375642|NCT02268058|41617736|FG002|Overall Study|Protocol Violation|0|||
19375643|NCT02268058|41617737|FG003|Overall Study|Protocol Violation|0|||
19375644|NCT02267824|41617749|FG000|Overall Study|Pregnancy|1|||
19375645|NCT02267824|41617750|FG001|Overall Study|Pregnancy|1|||
19375646|NCT02267824|41617749|FG000|Overall Study|Lost to Follow-up|4|||
19375647|NCT02267824|41617750|FG001|Overall Study|Lost to Follow-up|0|||
19375648|NCT02267824|41617749|FG000|Overall Study|Protocol Violation|3|||
19375649|NCT02267824|41617750|FG001|Overall Study|Protocol Violation|0|||
19375650|NCT02267824|41617749|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
19375651|NCT02267824|41617750|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
19375652|NCT02267746|41617759|FG000|Overall Study|Adverse Event|0|||
19375653|NCT02267746|41617760|FG001|Overall Study|Adverse Event|2|||
19375654|NCT02267746|41617761|FG002|Overall Study|Adverse Event|1|||
19375655|NCT02267746|41617759|FG000|Overall Study|Protocol Violation|8|||
19375656|NCT02267746|41617760|FG001|Overall Study|Protocol Violation|7|||
19375657|NCT02267746|41617761|FG002|Overall Study|Protocol Violation|3|||
19375658|NCT02267746|41617759|FG000|Overall Study|Lack of Efficacy|11|||
19375659|NCT02267746|41617760|FG001|Overall Study|Lack of Efficacy|11|||
19375660|NCT02267746|41617761|FG002|Overall Study|Lack of Efficacy|15|||
19375661|NCT02267746|41617759|FG000|Overall Study|Protocol Violation|1|||
19375662|NCT02267746|41617760|FG001|Overall Study|Protocol Violation|2|||
19375663|NCT02267746|41617761|FG002|Overall Study|Protocol Violation|1|||
19375664|NCT02267746|41617759|FG000|Overall Study|Miscellaneous|1|||
19375665|NCT02267746|41617760|FG001|Overall Study|Miscellaneous|0|||
19375666|NCT02267746|41617761|FG002|Overall Study|Miscellaneous|1|||
19375667|NCT02362360|41617771|FG000|Period 1|Lack of Efficacy|1|||
19375668|NCT02362360|41617772|FG001|Period 1|Lack of Efficacy|0|||
19375669|NCT02362360|41617771|FG000|Period 1|Withdrawal by Subject|2|||
19375670|NCT02362360|41617772|FG001|Period 1|Withdrawal by Subject|1|||
19375671|NCT02362282|41617780|FG000|Overall Study|Withdrawal by Subject|1|||
19375672|NCT02362282|41617781|FG001|Overall Study|Withdrawal by Subject|0|||
19375673|NCT02361580|41617789|FG000|Overall Study|Lost to Follow-up|6|||
19375674|NCT02361580|41617790|FG001|Overall Study|Lost to Follow-up|3|||
19375675|NCT02520284|41617799|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
19375676|NCT02520284|41617800|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
19375677|NCT02520284|41617801|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
19375678|NCT02520284|41617799|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
19375679|NCT02520284|41617800|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
19375680|NCT02520284|41617801|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
19375681|NCT02520284|41617799|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
19375682|NCT02520284|41617800|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
19375683|NCT02520284|41617801|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
19375684|NCT02520284|41617799|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
19375685|NCT02520284|41617800|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
19375686|NCT02520284|41617801|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
19375687|NCT02520284|41617799|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
19375688|NCT02520284|41617800|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
19375689|NCT02520284|41617801|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
19375690|NCT02520284|41617799|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
19375691|NCT02520284|41617800|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
19375692|NCT02520284|41617801|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
19375693|NCT02520284|41617799|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
19375694|NCT02520284|41617800|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
19375695|NCT02520284|41617801|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
19375696|NCT02520284|41617799|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
19375697|NCT02520284|41617800|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
19375698|NCT02520284|41617801|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
19375699|NCT02520284|41617799|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
19375700|NCT02520284|41617800|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
19375701|NCT02520284|41617801|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
19375702|NCT02520284|41617799|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
19375703|NCT02520284|41617800|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
19375704|NCT02520284|41617801|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
19375705|NCT02520284|41617799|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
19375706|NCT02520284|41617800|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
19375707|NCT02520284|41617801|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
19375708|NCT02517866|41617815|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
19375709|NCT02517866|41617816|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
19375710|NCT02517866|41617817|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
19375711|NCT02517866|41617815|FG000|Overall Study|Significant Protocol Deviation|4|||
19375712|NCT02517866|41617816|FG001|Overall Study|Significant Protocol Deviation|1|||
19375713|NCT02517866|41617817|FG002|Overall Study|Significant Protocol Deviation|0|||
19375714|NCT02517866|41617815|FG000|Overall Study|Lost to Follow-up|1|||
19375715|NCT02517866|41617816|FG001|Overall Study|Lost to Follow-up|0|||
19375716|NCT02517866|41617817|FG002|Overall Study|Lost to Follow-up|0|||
19375717|NCT02517866|41617815|FG000|Overall Study|Voluntary Withdrawal|2|||
19375718|NCT02517866|41617816|FG001|Overall Study|Voluntary Withdrawal|2|||
19375719|NCT02517866|41617817|FG002|Overall Study|Voluntary Withdrawal|0|||
19375720|NCT02517866|41617815|FG000|Overall Study|Investigator Decision|2|||
19375721|NCT02517866|41617816|FG001|Overall Study|Investigator Decision|1|||
19375722|NCT02517866|41617817|FG002|Overall Study|Investigator Decision|0|||
19375723|NCT02517866|41617815|FG000|Overall Study|Reason not specified|2|||
19375724|NCT02517866|41617816|FG001|Overall Study|Reason not specified|0|||
19375725|NCT02517866|41617817|FG002|Overall Study|Reason not specified|0|||
19375726|NCT02515994|41617829|FG000|Overall Study|Protocol Violation|3|||
19375727|NCT02515994|41617830|FG001|Overall Study|Protocol Violation|5|||
19375728|NCT02515994|41617829|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
19375729|NCT02515994|41617830|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
19375730|NCT02515994|41617829|FG000|Overall Study|Adverse Event|3|||
19375731|NCT02515994|41617830|FG001|Overall Study|Adverse Event|1|||
19375732|NCT02515994|41617829|FG000|Overall Study|Withdrawal by Subject|2|||
19375733|NCT02515994|41617830|FG001|Overall Study|Withdrawal by Subject|0|||
19375734|NCT02516306|41617838|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
19375735|NCT02516306|41617839|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
19375736|NCT02516228|41617845|FG000|Overall Study|Lost to Follow-up|1|||
19375737|NCT02516228|41617845|FG000|Overall Study|Withdrawal by Subject|1|||
19375738|NCT02516228|41617845|FG000|Overall Study|Physician Decision|1|||
19375739|NCT02519504|41617851|FG000|Overall Study|Protocol Violation|6|||
19375740|NCT02519504|41617852|FG001|Overall Study|Protocol Violation|5|||
19375741|NCT02519504|41617851|FG000|Overall Study|Ineligible for direct testing|12|||
19375742|NCT02519504|41617852|FG001|Overall Study|Ineligible for direct testing|12|||
19375743|NCT02519504|41617851|FG000|Overall Study|Did not participate in direct testing|95|||
19375744|NCT02519504|41617852|FG001|Overall Study|Did not participate in direct testing|86|||
19375745|NCT02514824|41617860|FG000|Overall Study|Withdrawal by Subject|1|||
19375746|NCT02514824|41617861|FG001|Overall Study|Withdrawal by Subject|0|||
19375747|NCT02514824|41617862|FG002|Overall Study|Withdrawal by Subject|0|||
19375748|NCT02514824|41617863|FG003|Overall Study|Withdrawal by Subject|0|||
19375749|NCT02514824|41617860|FG000|Overall Study|Dose-Limiting Toxicity|0|||
19375750|NCT02514824|41617861|FG001|Overall Study|Dose-Limiting Toxicity|1|||
19375751|NCT02514824|41617862|FG002|Overall Study|Dose-Limiting Toxicity|0|||
19375752|NCT02514824|41617863|FG003|Overall Study|Dose-Limiting Toxicity|0|||
19375753|NCT02514746|41617872|FG000|Overall Study|Chronically Ill|1|||
19375754|NCT02514746|41617873|FG001|Overall Study|Chronically Ill|2|||
19375755|NCT02514746|41617872|FG000|Overall Study|Physician Decision|4|||
19375756|NCT02514746|41617873|FG001|Overall Study|Physician Decision|2|||
19375757|NCT02514746|41617872|FG000|Overall Study|Withdrawal by Subject|12|||
19375758|NCT02514746|41617873|FG001|Overall Study|Withdrawal by Subject|10|||
19375759|NCT02514746|41617872|FG000|Overall Study|Other|5|||
19375760|NCT02514746|41617873|FG001|Overall Study|Other|1|||
19375761|NCT02483078|41617883|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
19375762|NCT02483078|41617884|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
19375763|NCT02483078|41617883|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
19375764|NCT02483078|41617884|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
19375765|NCT02483078|41617883|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
19375766|NCT02483078|41617884|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
19375767|NCT02483078|41617883|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
19375768|NCT02483078|41617884|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
19375769|NCT02483078|41617883|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
19375770|NCT02483078|41617884|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
19375771|NCT02483078|41617883|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
19375772|NCT02483078|41617884|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
19375773|NCT02452190|41617898|FG000|Overall Study|Withdrawal by Sponsor|1|||
19375774|NCT02452190|41617899|FG001|Overall Study|Withdrawal by Sponsor|3|||
19375775|NCT02452190|41617898|FG000|Overall Study|Pregnancy|1|||
19375776|NCT02452190|41617899|FG001|Overall Study|Pregnancy|0|||
19375777|NCT02452190|41617898|FG000|Overall Study|Investigator's Decision|2|||
19375778|NCT02452190|41617899|FG001|Overall Study|Investigator's Decision|0|||
19375779|NCT02452190|41617898|FG000|Overall Study|Lack of Efficacy|3|||
19375780|NCT02452190|41617899|FG001|Overall Study|Lack of Efficacy|1|||
19375781|NCT02452190|41617898|FG000|Overall Study|Lost to Follow-up|4|||
19375782|NCT02452190|41617899|FG001|Overall Study|Lost to Follow-up|3|||
19375783|NCT02452190|41617898|FG000|Overall Study|Adverse Event|2|||
19375784|NCT02452190|41617899|FG001|Overall Study|Adverse Event|5|||
19375785|NCT02452190|41617898|FG000|Overall Study|Withdrawal by Subject|20|||
19375786|NCT02452190|41617899|FG001|Overall Study|Withdrawal by Subject|11|||
19375787|NCT02452190|41617898|FG000|Overall Study|Noncompliance with study drug|1|||
19375788|NCT02452190|41617899|FG001|Overall Study|Noncompliance with study drug|0|||
19375789|NCT02452190|41617898|FG000|Overall Study|Participant traveled abroad|1|||
19375790|NCT02452190|41617899|FG001|Overall Study|Participant traveled abroad|0|||
19375791|NCT02452190|41617898|FG000|Overall Study|Death|0|||
19375792|NCT02452190|41617899|FG001|Overall Study|Death|1|||
19375793|NCT02514122|41617907|FG000|Overall Study|Withdrawal by Subject|2|||
19375794|NCT02514122|41617908|FG001|Overall Study|Withdrawal by Subject|0|||
19375795|NCT00730639|41617919|FG000|Overall Study|Adverse Event|3|||
19375796|NCT00730639|41617920|FG001|Overall Study|Adverse Event|0|||
19375797|NCT00730639|41617921|FG002|Overall Study|Adverse Event|9|||
19375798|NCT00730639|41617922|FG003|Overall Study|Adverse Event|8|||
19375799|NCT00730639|41617923|FG004|Overall Study|Adverse Event|23|||
19375800|NCT00730639|41617919|FG000|Overall Study|Complete Response|0|||
19375801|NCT00730639|41617920|FG001|Overall Study|Complete Response|0|||
19375802|NCT00730639|41617921|FG002|Overall Study|Complete Response|2|||
19375803|NCT00730639|41617922|FG003|Overall Study|Complete Response|2|||
19375804|NCT00730639|41617923|FG004|Overall Study|Complete Response|1|||
19375805|NCT00730639|41617919|FG000|Overall Study|Completed Maximum Cycles|0|||
19460166|NCT01868893|41714684|FG000|Overall Study|Commercial availability of study drug|17|||
19460167|NCT01868893|41714684|FG000|Overall Study|Neutropenia|1|||
19460168|NCT01868503|41714690|FG000|Overall Study|Withdrawal by Subject|1|||
19460169|NCT01868503|41714690|FG000|Overall Study|Protocol Violation|1|||
19460170|NCT01868035|41714700|FG000|Overall Study|Lost to Follow-up|3|||
19460171|NCT01868035|41714700|FG000|Overall Study|Withdrawal by Subject|1|||
19460172|NCT01868035|41714700|FG000|Overall Study|Progressive Disease|2|||
19550548|NCT01339559|41999602|FG000|Overall Study|Study closure at site|1|||
19550549|NCT01339559|41999602|FG000|Overall Study|Incarcerated|2|||
19550550|NCT01339559|41999602|FG000|Overall Study|Epilepsy surgery|1|||
19550551|NCT01339559|41999602|FG000|Overall Study|Pregnancy planned|2|||
19550552|NCT01339559|41999602|FG000|Overall Study|Left the country|1|||
19550553|NCT01339559|41999602|FG000|Overall Study|Investigator decision|2|||
19550554|NCT01339559|41999602|FG000|Overall Study|Patient didn't wish to continue|1|||
19550555|NCT01339559|41999602|FG000|Overall Study|PI decision|1|||
19550556|NCT00107900|41999613|FG000|Overall Study|Adverse Event|3|||
19550557|NCT00107900|41999614|FG001|Overall Study|Adverse Event|2|||
19550558|NCT00107900|41999615|FG002|Overall Study|Adverse Event|10|||
19550559|NCT00107900|41999616|FG003|Overall Study|Adverse Event|3|||
19550560|NCT00107900|41999617|FG004|Overall Study|Adverse Event|5|||
19550561|NCT00107900|41999618|FG005|Overall Study|Adverse Event|3|||
19550562|NCT00107900|41999613|FG000|Overall Study|Death|0|||
19375806|NCT00730639|41617920|FG001|Overall Study|Completed Maximum Cycles|0|||
19375807|NCT00730639|41617921|FG002|Overall Study|Completed Maximum Cycles|11|||
19375808|NCT00730639|41617922|FG003|Overall Study|Completed Maximum Cycles|3|||
19375809|NCT00730639|41617923|FG004|Overall Study|Completed Maximum Cycles|6|||
19375810|NCT00730639|41617919|FG000|Overall Study|Death|0|||
19375811|NCT00730639|41617920|FG001|Overall Study|Death|0|||
19460173|NCT01868035|41714700|FG000|Overall Study|Non-compliance|1|||
19550563|NCT00107900|41999614|FG001|Overall Study|Death|0|||
19550564|NCT00107900|41999615|FG002|Overall Study|Death|0|||
19550565|NCT00107900|41999616|FG003|Overall Study|Death|0|||
19375812|NCT00730639|41617921|FG002|Overall Study|Death|0|||
19375813|NCT00730639|41617922|FG003|Overall Study|Death|0|||
19375814|NCT00730639|41617923|FG004|Overall Study|Death|2|||
19375815|NCT00730639|41617919|FG000|Overall Study|Disease Progression|12|||
19375816|NCT00730639|41617920|FG001|Overall Study|Disease Progression|13|||
19375817|NCT00730639|41617921|FG002|Overall Study|Disease Progression|48|||
19375818|NCT00730639|41617922|FG003|Overall Study|Disease Progression|32|||
19375819|NCT00730639|41617923|FG004|Overall Study|Disease Progression|88|||
19375820|NCT00730639|41617919|FG000|Overall Study|non-specified|0|||
19375821|NCT00730639|41617920|FG001|Overall Study|non-specified|0|||
19375822|NCT00730639|41617921|FG002|Overall Study|non-specified|4|||
19375823|NCT00730639|41617922|FG003|Overall Study|non-specified|2|||
19375824|NCT00730639|41617923|FG004|Overall Study|non-specified|3|||
19375825|NCT00730639|41617919|FG000|Overall Study|Protocol Violation|0|||
19375826|NCT00730639|41617920|FG001|Overall Study|Protocol Violation|0|||
19375827|NCT00730639|41617921|FG002|Overall Study|Protocol Violation|1|||
19375828|NCT00730639|41617922|FG003|Overall Study|Protocol Violation|0|||
19375829|NCT00730639|41617923|FG004|Overall Study|Protocol Violation|0|||
19375830|NCT00730639|41617919|FG000|Overall Study|Withdrawal by Subject|0|||
19375831|NCT00730639|41617920|FG001|Overall Study|Withdrawal by Subject|0|||
19375832|NCT00730639|41617921|FG002|Overall Study|Withdrawal by Subject|6|||
19375833|NCT00730639|41617922|FG003|Overall Study|Withdrawal by Subject|3|||
19375834|NCT00730639|41617923|FG004|Overall Study|Withdrawal by Subject|4|||
19375835|NCT00730639|41617919|FG000|Overall Study|Treatment on-going|2|||
19375836|NCT00730639|41617920|FG001|Overall Study|Treatment on-going|5|||
19375837|NCT00730639|41617921|FG002|Overall Study|Treatment on-going|5|||
19375838|NCT00730639|41617922|FG003|Overall Study|Treatment on-going|4|||
19375839|NCT00730639|41617923|FG004|Overall Study|Treatment on-going|4|||
19375840|NCT02536339|41617946|FG000|Overall Study|Death|20|||
19375841|NCT02536339|41617946|FG000|Overall Study|Withdrawal by Subject|3|||
19375842|NCT02536339|41617946|FG000|Overall Study|Lost to Follow-up|2|||
19375843|NCT02536339|41617946|FG000|Overall Study|Treatment discontinued|2|||
19375844|NCT02536339|41617946|FG000|Overall Study|Physician Decision|1|||
19375845|NCT02743871|41617980|FG000|Overall Study|Lost to Follow-up|0|||
19375846|NCT02743871|41617981|FG001|Overall Study|Lost to Follow-up|0|||
19375847|NCT02743871|41617982|FG002|Overall Study|Lost to Follow-up|0|||
19375848|NCT02743871|41617983|FG003|Overall Study|Lost to Follow-up|1|||
19375849|NCT02743871|41617984|FG004|Overall Study|Lost to Follow-up|0|||
19375850|NCT02743871|41617985|FG005|Overall Study|Lost to Follow-up|0|||
19375851|NCT02743871|41617986|FG006|Overall Study|Lost to Follow-up|1|||
19375852|NCT02743871|41617987|FG007|Overall Study|Lost to Follow-up|0|||
19375853|NCT02743871|41617988|FG008|Overall Study|Lost to Follow-up|0|||
19375854|NCT02743871|41617989|FG009|Overall Study|Lost to Follow-up|0|||
19375855|NCT02743871|41617990|FG010|Overall Study|Lost to Follow-up|0|||
19375856|NCT02743871|41617991|FG011|Overall Study|Lost to Follow-up|2|||
19375857|NCT02743871|41617992|FG012|Overall Study|Lost to Follow-up|0|||
19375858|NCT02743871|41617993|FG013|Overall Study|Lost to Follow-up|0|||
19375859|NCT02743871|41617980|FG000|Overall Study|Withdrawal by Subject|0|||
19375860|NCT02743871|41617981|FG001|Overall Study|Withdrawal by Subject|0|||
19375861|NCT02743871|41617982|FG002|Overall Study|Withdrawal by Subject|0|||
19375862|NCT02743871|41617983|FG003|Overall Study|Withdrawal by Subject|0|||
19375863|NCT02743871|41617984|FG004|Overall Study|Withdrawal by Subject|0|||
19375864|NCT02743871|41617985|FG005|Overall Study|Withdrawal by Subject|0|||
19375865|NCT02743871|41617986|FG006|Overall Study|Withdrawal by Subject|0|||
19375866|NCT02743871|41617987|FG007|Overall Study|Withdrawal by Subject|0|||
19375867|NCT02743871|41617988|FG008|Overall Study|Withdrawal by Subject|0|||
19375868|NCT02743871|41617989|FG009|Overall Study|Withdrawal by Subject|0|||
19375869|NCT02743871|41617990|FG010|Overall Study|Withdrawal by Subject|1|||
19375870|NCT02743871|41617991|FG011|Overall Study|Withdrawal by Subject|0|||
19375871|NCT02743871|41617992|FG012|Overall Study|Withdrawal by Subject|12|||
19375872|NCT02743871|41617993|FG013|Overall Study|Withdrawal by Subject|6|||
19375873|NCT02743871|41617980|FG000|Overall Study|Adverse Event|1|||
19375874|NCT02743871|41617981|FG001|Overall Study|Adverse Event|0|||
19375875|NCT02743871|41617982|FG002|Overall Study|Adverse Event|0|||
19375876|NCT02743871|41617983|FG003|Overall Study|Adverse Event|0|||
19375877|NCT02743871|41617984|FG004|Overall Study|Adverse Event|0|||
19375878|NCT02743871|41617985|FG005|Overall Study|Adverse Event|0|||
19375879|NCT02743871|41617986|FG006|Overall Study|Adverse Event|0|||
19375880|NCT02743871|41617987|FG007|Overall Study|Adverse Event|0|||
19375881|NCT02743871|41617988|FG008|Overall Study|Adverse Event|0|||
19375882|NCT02743871|41617989|FG009|Overall Study|Adverse Event|0|||
19375883|NCT02743871|41617990|FG010|Overall Study|Adverse Event|0|||
19375884|NCT02743871|41617991|FG011|Overall Study|Adverse Event|0|||
19375885|NCT02743871|41617992|FG012|Overall Study|Adverse Event|0|||
19375886|NCT02743871|41617993|FG013|Overall Study|Adverse Event|0|||
19375887|NCT02743871|41617980|FG000|Overall Study|Other|0|||
19375888|NCT02743871|41617981|FG001|Overall Study|Other|0|||
19375889|NCT02743871|41617982|FG002|Overall Study|Other|0|||
19375890|NCT02743871|41617983|FG003|Overall Study|Other|0|||
19375891|NCT02743871|41617984|FG004|Overall Study|Other|0|||
19375892|NCT02743871|41617985|FG005|Overall Study|Other|0|||
19375893|NCT02743871|41617986|FG006|Overall Study|Other|0|||
19375894|NCT02743871|41617987|FG007|Overall Study|Other|0|||
19375895|NCT02743871|41617988|FG008|Overall Study|Other|0|||
19375896|NCT02743871|41617989|FG009|Overall Study|Other|0|||
19375897|NCT02743871|41617990|FG010|Overall Study|Other|0|||
19375898|NCT02743871|41617991|FG011|Overall Study|Other|1|||
19375899|NCT02743871|41617992|FG012|Overall Study|Other|1|||
19375900|NCT02743871|41617993|FG013|Overall Study|Other|1|||
19375901|NCT02743871|41617980|FG000|Overall Study|Protocol Violation|0|||
19375902|NCT02743871|41617981|FG001|Overall Study|Protocol Violation|0|||
19375903|NCT02743871|41617982|FG002|Overall Study|Protocol Violation|0|||
19375904|NCT02743871|41617983|FG003|Overall Study|Protocol Violation|0|||
19375905|NCT02743871|41617984|FG004|Overall Study|Protocol Violation|0|||
19375906|NCT02743871|41617985|FG005|Overall Study|Protocol Violation|0|||
19375907|NCT02743871|41617986|FG006|Overall Study|Protocol Violation|0|||
19375908|NCT02743871|41617987|FG007|Overall Study|Protocol Violation|0|||
19375909|NCT02743871|41617988|FG008|Overall Study|Protocol Violation|0|||
19375910|NCT02743871|41617989|FG009|Overall Study|Protocol Violation|0|||
19375911|NCT02743871|41617990|FG010|Overall Study|Protocol Violation|0|||
19375912|NCT02743871|41617991|FG011|Overall Study|Protocol Violation|0|||
19375913|NCT02743871|41617992|FG012|Overall Study|Protocol Violation|2|||
19375914|NCT02743871|41617993|FG013|Overall Study|Protocol Violation|0|||
19375915|NCT01704547|41618035|FG000|Overall Study|Physician Decision|4|||
19375916|NCT01704547|41618035|FG000|Overall Study|Withdrawal by Subject|1|||
19375917|NCT00796523|41618055|FG000|Overall Study|Lost to Follow-up|9|||
19375918|NCT00796523|41618056|FG001|Overall Study|Lost to Follow-up|7|||
19375919|NCT01352585|41618071|FG000|Overall Study|Adverse Event|2|||
19375920|NCT01352585|41618072|FG001|Overall Study|Adverse Event|1|||
19375921|NCT01352585|41618071|FG000|Overall Study|Lost to Follow-up|1|||
19375922|NCT01352585|41618072|FG001|Overall Study|Lost to Follow-up|0|||
19375923|NCT01352585|41618071|FG000|Overall Study|Other|5|||
19375924|NCT01352585|41618072|FG001|Overall Study|Other|2|||
19375935|NCT01352507|41618090|FG000|Treatment Period 1|Adverse Event|3|||
19375936|NCT01352507|41618091|FG001|Treatment Period 1|Adverse Event|0|||
19375937|NCT01352507|41618090|FG000|Treatment Period 1|Lost to Follow-up|3|||
19375938|NCT01352507|41618091|FG001|Treatment Period 1|Lost to Follow-up|4|||
19375939|NCT01352507|41618090|FG000|Treatment Period 1|Withdrawal by Subject|7|||
19375940|NCT01352507|41618091|FG001|Treatment Period 1|Withdrawal by Subject|5|||
19375941|NCT01352507|41618090|FG000|Treatment Period 1|Physician Decision|1|||
19375942|NCT01352507|41618091|FG001|Treatment Period 1|Physician Decision|0|||
19375943|NCT01352507|41618090|FG000|Washout Period|Withdrawal by Subject|0|||
19375944|NCT01352507|41618091|FG001|Washout Period|Withdrawal by Subject|1|||
19375945|NCT01352507|41618090|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
19375946|NCT01352507|41618091|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
19375947|NCT01352507|41618090|FG000|Treatment Period 2|Withdrawal by Subject|4|||
19375948|NCT01352507|41618091|FG001|Treatment Period 2|Withdrawal by Subject|3|||
19375949|NCT01352507|41618090|FG000|Treatment Period 2|Lack of Efficacy|1|||
19375950|NCT01352507|41618091|FG001|Treatment Period 2|Lack of Efficacy|0|||
19375951|NCT02361346|41618112|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375952|NCT02361346|41618113|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375953|NCT02361346|41618114|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375954|NCT02361346|41618115|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
19375955|NCT02361346|41618116|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375956|NCT02361346|41618117|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375957|NCT02361346|41618118|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
19460174|NCT01609933|41714704|FG000|Overall Study|Adverse Event|1|||
19460175|NCT01609933|41714704|FG000|Overall Study|Withdrawal by Subject|3|||
19460176|NCT01843777|41714712|FG000|Overall Study|Withdrawal by Subject|1|||
19460177|NCT01843777|41714713|FG001|Overall Study|Withdrawal by Subject|0|||
19460178|NCT01842607|41714719|FG000|Overall Study|Adverse Event|11|||
19460179|NCT01842607|41714719|FG000|Overall Study|Lack of Efficacy|19|||
19460180|NCT01842607|41714719|FG000|Overall Study|Protocol Violation|8|||
19460181|NCT01842607|41714719|FG000|Overall Study|Protocol defined stopping criteria|2|||
19460182|NCT01842607|41714719|FG000|Overall Study|Lost to Follow-up|3|||
19460183|NCT01842607|41714719|FG000|Overall Study|Physician Decision|9|||
19460184|NCT01842607|41714719|FG000|Overall Study|Withdrawal by Subject|14|||
19460185|NCT01803607|41714725|FG000|Overall Study|Adverse Event|5|||
19460186|NCT01803607|41714726|FG001|Overall Study|Adverse Event|3|||
19460187|NCT01803607|41714725|FG000|Overall Study|Lack of Efficacy|0|||
19460188|NCT01803607|41714726|FG001|Overall Study|Lack of Efficacy|1|||
19460189|NCT01803607|41714725|FG000|Overall Study|Protocol Violation|3|||
19460190|NCT01803607|41714726|FG001|Overall Study|Protocol Violation|2|||
19460191|NCT01803607|41714725|FG000|Overall Study|Study terminated by sponsor|54|||
19375958|NCT02361346|41618119|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375959|NCT02361346|41618120|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
19375960|NCT02361346|41618112|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375961|NCT02361346|41618113|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375962|NCT02361346|41618114|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375963|NCT02361346|41618115|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375964|NCT02361346|41618116|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
19375965|NCT02361346|41618117|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375966|NCT02361346|41618118|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375967|NCT02361346|41618119|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375968|NCT02361346|41618120|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
19375969|NCT02361346|41618112|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
19375970|NCT02361346|41618113|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
19375971|NCT02361346|41618114|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
19375972|NCT02361346|41618115|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
19375973|NCT02361346|41618116|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
19375974|NCT02361346|41618117|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
19460192|NCT01803607|41714726|FG001|Overall Study|Study terminated by sponsor|56|||
19460193|NCT01803607|41714725|FG000|Overall Study|Withdrawal by Subject|6|||
19460194|NCT01803607|41714726|FG001|Overall Study|Withdrawal by Subject|5|||
19460195|NCT01867021|41714734|FG000|Overall Study|Adverse Event|0|||
19460196|NCT01867021|41714735|FG001|Overall Study|Adverse Event|1|||
19460197|NCT01867021|41714734|FG000|Overall Study|Not Eligible|0|||
19460198|NCT01867021|41714735|FG001|Overall Study|Not Eligible|1|||
19460199|NCT01867021|41714734|FG000|Overall Study|Death|1|||
19460200|NCT01867021|41714735|FG001|Overall Study|Death|0|||
19460201|NCT01867021|41714734|FG000|Overall Study|Lost to Follow-up|0|||
19460202|NCT01867021|41714735|FG001|Overall Study|Lost to Follow-up|2|||
19460203|NCT01867021|41714734|FG000|Overall Study|Withdrawal by Subject|1|||
19460204|NCT01867021|41714735|FG001|Overall Study|Withdrawal by Subject|6|||
19460205|NCT01866709|41714748|FG000|Overall Study|Adverse Event|1|||
19460206|NCT01866709|41714749|FG001|Overall Study|Adverse Event|0|||
19460207|NCT01841593|41714757|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
19460208|NCT01841593|41714758|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
19460209|NCT01841593|41714757|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
19460210|NCT01841593|41714758|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
19460211|NCT01866319|41715026|FG000|Overall Study|Adverse Event|12|||
19460212|NCT01866319|41715027|FG001|Overall Study|Adverse Event|5|||
19460213|NCT01866319|41715028|FG002|Overall Study|Adverse Event|9|||
19460214|NCT01866319|41715026|FG000|Overall Study|Clinical progression|3|||
19460215|NCT01866319|41715027|FG001|Overall Study|Clinical progression|2|||
19460216|NCT01866319|41715028|FG002|Overall Study|Clinical progression|2|||
19460217|NCT01866319|41715026|FG000|Overall Study|Death|153|||
19460218|NCT01866319|41715027|FG001|Overall Study|Death|154|||
19460219|NCT01866319|41715028|FG002|Overall Study|Death|147|||
19460220|NCT01866319|41715026|FG000|Overall Study|Lost to Follow-up|6|||
19460221|NCT01866319|41715027|FG001|Overall Study|Lost to Follow-up|3|||
19460222|NCT01866319|41715028|FG002|Overall Study|Lost to Follow-up|8|||
19460223|NCT01866319|41715026|FG000|Overall Study|Physician Decision|1|||
19460224|NCT01866319|41715027|FG001|Overall Study|Physician Decision|0|||
19460225|NCT01866319|41715028|FG002|Overall Study|Physician Decision|1|||
19460226|NCT01866319|41715026|FG000|Overall Study|Protocol Violation|0|||
19460227|NCT01866319|41715027|FG001|Overall Study|Protocol Violation|0|||
19460228|NCT01866319|41715028|FG002|Overall Study|Protocol Violation|1|||
19460229|NCT01866319|41715026|FG000|Overall Study|Withdrawal by Subject|32|||
19460230|NCT01866319|41715027|FG001|Overall Study|Withdrawal by Subject|14|||
19460231|NCT01866319|41715028|FG002|Overall Study|Withdrawal by Subject|12|||
19460232|NCT01802515|41715055|FG000|Overall Study|Withdrawal by Subject|3|||
19460233|NCT01802515|41715056|FG001|Overall Study|Withdrawal by Subject|0|||
19460234|NCT01802515|41715057|FG002|Overall Study|Withdrawal by Subject|0|||
19460235|NCT01802437|41715067|FG000|Overall Study|Lost to Follow-up|1|||
19460236|NCT01802437|41715068|FG001|Overall Study|Lost to Follow-up|0|||
19460237|NCT01802437|41715067|FG000|Overall Study|Withdrawal by Subject|3|||
19460238|NCT01802437|41715068|FG001|Overall Study|Withdrawal by Subject|4|||
19460245|NCT01801735|41715184|FG000|Overall Study|Adverse Event|79|||
19460246|NCT01801735|41715184|FG000|Overall Study|Lack of Efficacy|28|||
19460247|NCT01801735|41715184|FG000|Overall Study|Withdrawal by Subject|27|||
19460248|NCT01801735|41715184|FG000|Overall Study|Protocol Violation|25|||
19460249|NCT01801735|41715184|FG000|Overall Study|Lost to Follow-up|15|||
19460250|NCT01801735|41715184|FG000|Overall Study|Non-compliance with Trial Drug|13|||
19460251|NCT01801735|41715184|FG000|Overall Study|Physician Decision|3|||
19460252|NCT01801735|41715184|FG000|Overall Study|Death|1|||
19460253|NCT01801735|41715184|FG000|Overall Study|Other, including site closure|19|||
19460254|NCT01841359|41715188|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
19460255|NCT01841359|41715188|FG000|Overall Study|Concommitant medical issues|2|||
19460256|NCT01841359|41715188|FG000|Overall Study|Adverse Event|3|||
19460257|NCT01841359|41715188|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
19460258|NCT01840579|41715971|FG000|Overall Study|Status not recorded|0|||
19460259|NCT01840579|41715972|FG001|Overall Study|Status not recorded|0|||
19460260|NCT01840579|41715973|FG002|Overall Study|Status not recorded|2|||
19460261|NCT01840579|41715974|FG003|Overall Study|Status not recorded|3|||
19460262|NCT01840579|41715975|FG004|Overall Study|Status not recorded|4|||
19460263|NCT01840579|41715976|FG005|Overall Study|Status not recorded|3|||
19460264|NCT01840579|41715977|FG006|Overall Study|Status not recorded|0|||
19460265|NCT01840579|41715978|FG007|Overall Study|Status not recorded|3|||
19460266|NCT01840579|41715979|FG008|Overall Study|Status not recorded|3|||
19460267|NCT01840579|41715980|FG009|Overall Study|Status not recorded|3|||
19460268|NCT01840579|41715971|FG000|Overall Study|Progressive disease|3|||
19460269|NCT01840579|41715972|FG001|Overall Study|Progressive disease|5|||
19460270|NCT01840579|41715973|FG002|Overall Study|Progressive disease|0|||
19460271|NCT01840579|41715974|FG003|Overall Study|Progressive disease|0|||
19460272|NCT01840579|41715975|FG004|Overall Study|Progressive disease|0|||
19460273|NCT01840579|41715976|FG005|Overall Study|Progressive disease|0|||
19460274|NCT01840579|41715977|FG006|Overall Study|Progressive disease|0|||
19460275|NCT01840579|41715978|FG007|Overall Study|Progressive disease|0|||
19460276|NCT01840579|41715979|FG008|Overall Study|Progressive disease|0|||
19460277|NCT01840579|41715980|FG009|Overall Study|Progressive disease|0|||
19460278|NCT01840579|41715971|FG000|Overall Study|Ongoing in study|0|||
19460279|NCT01840579|41715972|FG001|Overall Study|Ongoing in study|1|||
19460280|NCT01840579|41715973|FG002|Overall Study|Ongoing in study|0|||
19460281|NCT01840579|41715974|FG003|Overall Study|Ongoing in study|0|||
19460282|NCT01840579|41715975|FG004|Overall Study|Ongoing in study|0|||
19460283|NCT01840579|41715976|FG005|Overall Study|Ongoing in study|0|||
19460284|NCT01840579|41715977|FG006|Overall Study|Ongoing in study|0|||
19460285|NCT01840579|41715978|FG007|Overall Study|Ongoing in study|0|||
19460286|NCT01840579|41715979|FG008|Overall Study|Ongoing in study|0|||
19460287|NCT01840579|41715980|FG009|Overall Study|Ongoing in study|0|||
19460288|NCT01840579|41715971|FG000|Overall Study|Death|0|||
19460289|NCT01840579|41715972|FG001|Overall Study|Death|0|||
19460290|NCT01840579|41715973|FG002|Overall Study|Death|0|||
19460291|NCT01840579|41715974|FG003|Overall Study|Death|0|||
19460292|NCT01840579|41715975|FG004|Overall Study|Death|0|||
19460293|NCT01840579|41715976|FG005|Overall Study|Death|1|||
19460294|NCT01840579|41715977|FG006|Overall Study|Death|0|||
19460295|NCT01840579|41715978|FG007|Overall Study|Death|0|||
19460296|NCT01840579|41715979|FG008|Overall Study|Death|0|||
19460297|NCT01840579|41715980|FG009|Overall Study|Death|0|||
19460298|NCT01840579|41715971|FG000|Overall Study|Adverse Event|0|||
19460299|NCT01840579|41715972|FG001|Overall Study|Adverse Event|1|||
19460300|NCT01840579|41715973|FG002|Overall Study|Adverse Event|0|||
19460301|NCT01840579|41715974|FG003|Overall Study|Adverse Event|0|||
19460302|NCT01840579|41715975|FG004|Overall Study|Adverse Event|0|||
19460303|NCT01840579|41715976|FG005|Overall Study|Adverse Event|0|||
19460304|NCT01840579|41715977|FG006|Overall Study|Adverse Event|0|||
19460305|NCT01840579|41715978|FG007|Overall Study|Adverse Event|0|||
19460306|NCT01840579|41715979|FG008|Overall Study|Adverse Event|0|||
19460307|NCT01840579|41715980|FG009|Overall Study|Adverse Event|0|||
19460308|NCT01840579|41715971|FG000|Overall Study|Follow-up ended by Sponsor|0|||
19460309|NCT01840579|41715972|FG001|Overall Study|Follow-up ended by Sponsor|0|||
19460310|NCT01840579|41715973|FG002|Overall Study|Follow-up ended by Sponsor|0|||
19460311|NCT01840579|41715974|FG003|Overall Study|Follow-up ended by Sponsor|0|||
19460312|NCT01840579|41715975|FG004|Overall Study|Follow-up ended by Sponsor|0|||
19460313|NCT01840579|41715976|FG005|Overall Study|Follow-up ended by Sponsor|0|||
19460314|NCT01840579|41715977|FG006|Overall Study|Follow-up ended by Sponsor|2|||
19460315|NCT01840579|41715978|FG007|Overall Study|Follow-up ended by Sponsor|0|||
19460316|NCT01840579|41715979|FG008|Overall Study|Follow-up ended by Sponsor|0|||
19460317|NCT01840579|41715980|FG009|Overall Study|Follow-up ended by Sponsor|0|||
19460318|NCT01801111|41716059|FG000|Overall Study|Adverse Event|12|||
19460319|NCT01801111|41716059|FG000|Overall Study|Death|8|||
19460320|NCT01801111|41716059|FG000|Overall Study|Physician Decision|5|||
19460321|NCT01801111|41716059|FG000|Overall Study|Other|1|||
19460322|NCT01801111|41716059|FG000|Overall Study|Withdrawal by Subject|4|||
19460323|NCT01801111|41716059|FG000|Overall Study|Study Terminated by Sponsor|27|||
19460324|NCT01801111|41716059|FG000|Overall Study|Progressive Disease|81|||
19460325|NCT01773967|41716091|FG000|Overall Study|Lost to Follow-up|15|||
19460326|NCT01773967|41716092|FG001|Overall Study|Lost to Follow-up|13|||
19460327|NCT01773889|41716102|FG000|Overall Study|lack of funding|2|||
19460328|NCT01839487|41716280|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
19460329|NCT01839487|41716281|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
19460330|NCT01839487|41716282|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
19460331|NCT01839487|41716283|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
19460332|NCT01839487|41716284|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
19460333|NCT01839487|41716285|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
19460334|NCT01839487|41716280|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
19460335|NCT01839487|41716281|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
19460336|NCT01839487|41716282|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
19460337|NCT01839487|41716283|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
19460338|NCT01839487|41716284|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
19460339|NCT01839487|41716285|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
19460340|NCT01839487|41716280|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
19460341|NCT01839487|41716281|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
19460342|NCT01839487|41716282|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
19460343|NCT01839487|41716283|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
19460344|NCT01839487|41716284|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
19460345|NCT01839487|41716285|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
19460346|NCT01839487|41716280|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
19460347|NCT01839487|41716281|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
19460348|NCT01839487|41716282|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
19460349|NCT01839487|41716283|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
19460350|NCT01839487|41716284|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
19460351|NCT01839487|41716285|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
19460352|NCT01839487|41716280|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
19460353|NCT01839487|41716281|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
19460354|NCT01839487|41716282|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
19460355|NCT01839487|41716283|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
19460356|NCT01839487|41716284|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
19460357|NCT01839487|41716285|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
19460358|NCT01839487|41716280|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
19460359|NCT01839487|41716281|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
19460360|NCT01839487|41716282|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
19460361|NCT01839487|41716283|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
19460362|NCT01839487|41716284|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
19460363|NCT01839487|41716285|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
19460364|NCT01839487|41716280|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
19460365|NCT01839487|41716281|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
19460366|NCT01839487|41716282|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
19460367|NCT01839487|41716283|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
19460368|NCT01839487|41716284|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
19460369|NCT01839487|41716285|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
19460370|NCT01839487|41716280|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
19460371|NCT01839487|41716281|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
19460372|NCT01839487|41716282|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
19460373|NCT01839487|41716283|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
19460374|NCT01839487|41716284|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
19460375|NCT01839487|41716285|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
19460376|NCT01839487|41716280|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
19460377|NCT01839487|41716281|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
19460378|NCT01839487|41716282|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
19460379|NCT01839487|41716283|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
19460380|NCT01839487|41716284|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
19460381|NCT01839487|41716285|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
19460382|NCT01799941|41716312|FG000|Overall Study|Adverse Event|34|||
19460383|NCT01799941|41716312|FG000|Overall Study|Withdrawal by Subject|21|||
19460384|NCT01799941|41716312|FG000|Overall Study|Death|2|||
19460385|NCT01799941|41716312|FG000|Overall Study|Investigator Decision|4|||
19460386|NCT01799941|41716312|FG000|Overall Study|Lack of Efficacy|3|||
19460387|NCT01799941|41716312|FG000|Overall Study|Lost to Follow-up|17|||
19460388|NCT01799941|41716312|FG000|Overall Study|Other|15|||
19460389|NCT01799239|41716340|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
19460390|NCT01799239|41716341|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
19460391|NCT01799239|41716340|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
19460392|NCT01799239|41716341|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
19460393|NCT01799239|41716340|FG000|Period 1 (7 Days)|Protocol Violation|0|||
19460394|NCT01799239|41716341|FG001|Period 1 (7 Days)|Protocol Violation|1|||
19460395|NCT01799239|41716340|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
19460396|NCT01799239|41716341|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
19460397|NCT01799239|41716340|FG000|Period 2 (7 Days)|Protocol Violation|1|||
19460398|NCT01799239|41716341|FG001|Period 2 (7 Days)|Protocol Violation|0|||
19460399|NCT02999854|41716357|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
19460400|NCT02999854|41716358|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
19460401|NCT02999854|41716357|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
19460402|NCT02999854|41716358|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
19460403|NCT02999854|41716357|FG000|Active Study Phase (up to 18 Months)|Death|7|||
19460404|NCT02999854|41716358|FG001|Active Study Phase (up to 18 Months)|Death|5|||
19460405|NCT02999854|41716357|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
19460406|NCT02999854|41716358|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
19460407|NCT02999854|41716357|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
19460408|NCT02999854|41716358|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
19460409|NCT02999854|41716357|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
19460410|NCT02999854|41716358|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
19460411|NCT02999854|41716357|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
19460412|NCT02999854|41716358|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
19460413|NCT02999854|41716357|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
19460414|NCT02999854|41716358|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
19460415|NCT04146363|41716491|FG000|Induction Period|Adverse Event|1|||
19460416|NCT04146363|41716492|FG001|Induction Period|Adverse Event|2|||
19460417|NCT04146363|41716493|FG002|Induction Period|Adverse Event|0|||
19460418|NCT04146363|41716494|FG003|Induction Period|Adverse Event|0|||
19460419|NCT04146363|41716495|FG004|Induction Period|Adverse Event|0|||
19460420|NCT04146363|41716496|FG005|Induction Period|Adverse Event|0|||
19460421|NCT04146363|41716497|FG006|Induction Period|Adverse Event|0|||
19460422|NCT04146363|41716498|FG007|Induction Period|Adverse Event|0|||
19460423|NCT04146363|41716499|FG008|Induction Period|Adverse Event|0|||
19460424|NCT04146363|41716500|FG009|Induction Period|Adverse Event|0|||
19460425|NCT04146363|41716501|FG010|Induction Period|Adverse Event|0|||
19460426|NCT04146363|41716491|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
19460427|NCT04146363|41716492|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
19460428|NCT04146363|41716493|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
19460429|NCT04146363|41716494|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
19460430|NCT04146363|41716495|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
19460431|NCT04146363|41716496|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
19460432|NCT04146363|41716497|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
19460433|NCT04146363|41716498|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
19460434|NCT04146363|41716499|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
19460435|NCT04146363|41716500|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
19460436|NCT04146363|41716501|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
19460437|NCT04146363|41716491|FG000|Induction Period|Lack of Efficacy|7|||
19460438|NCT04146363|41716492|FG001|Induction Period|Lack of Efficacy|2|||
19460439|NCT04146363|41716493|FG002|Induction Period|Lack of Efficacy|0|||
19460440|NCT04146363|41716494|FG003|Induction Period|Lack of Efficacy|0|||
19460441|NCT04146363|41716495|FG004|Induction Period|Lack of Efficacy|0|||
19460442|NCT04146363|41716496|FG005|Induction Period|Lack of Efficacy|0|||
19460443|NCT04146363|41716497|FG006|Induction Period|Lack of Efficacy|0|||
19460444|NCT04146363|41716498|FG007|Induction Period|Lack of Efficacy|0|||
19460445|NCT04146363|41716499|FG008|Induction Period|Lack of Efficacy|0|||
19460446|NCT04146363|41716500|FG009|Induction Period|Lack of Efficacy|0|||
19460447|NCT04146363|41716501|FG010|Induction Period|Lack of Efficacy|0|||
19460448|NCT04146363|41716491|FG000|Induction Period|Lost to Follow-up|1|||
19460449|NCT04146363|41716492|FG001|Induction Period|Lost to Follow-up|4|||
19460450|NCT04146363|41716493|FG002|Induction Period|Lost to Follow-up|0|||
19460451|NCT04146363|41716494|FG003|Induction Period|Lost to Follow-up|0|||
19460452|NCT04146363|41716495|FG004|Induction Period|Lost to Follow-up|0|||
19460453|NCT04146363|41716496|FG005|Induction Period|Lost to Follow-up|0|||
19460454|NCT04146363|41716497|FG006|Induction Period|Lost to Follow-up|0|||
19460455|NCT04146363|41716498|FG007|Induction Period|Lost to Follow-up|0|||
19460456|NCT04146363|41716499|FG008|Induction Period|Lost to Follow-up|0|||
19460457|NCT04146363|41716500|FG009|Induction Period|Lost to Follow-up|0|||
19460458|NCT04146363|41716501|FG010|Induction Period|Lost to Follow-up|0|||
19460459|NCT04146363|41716491|FG000|Induction Period|Positive quantiferon test|0|||
19460460|NCT04146363|41716492|FG001|Induction Period|Positive quantiferon test|1|||
19460461|NCT04146363|41716493|FG002|Induction Period|Positive quantiferon test|0|||
19460462|NCT04146363|41716494|FG003|Induction Period|Positive quantiferon test|0|||
19460463|NCT04146363|41716495|FG004|Induction Period|Positive quantiferon test|0|||
19460464|NCT04146363|41716496|FG005|Induction Period|Positive quantiferon test|0|||
19460465|NCT04146363|41716497|FG006|Induction Period|Positive quantiferon test|0|||
19460466|NCT04146363|41716498|FG007|Induction Period|Positive quantiferon test|0|||
19460467|NCT04146363|41716499|FG008|Induction Period|Positive quantiferon test|0|||
19460468|NCT04146363|41716500|FG009|Induction Period|Positive quantiferon test|0|||
19460469|NCT04146363|41716501|FG010|Induction Period|Positive quantiferon test|0|||
19460470|NCT04146363|41716491|FG000|Induction Period|Protocol Deviation|5|||
19460471|NCT04146363|41716492|FG001|Induction Period|Protocol Deviation|6|||
19460472|NCT04146363|41716493|FG002|Induction Period|Protocol Deviation|0|||
19460473|NCT04146363|41716494|FG003|Induction Period|Protocol Deviation|0|||
19460474|NCT04146363|41716495|FG004|Induction Period|Protocol Deviation|0|||
19460475|NCT04146363|41716496|FG005|Induction Period|Protocol Deviation|0|||
19460476|NCT04146363|41716497|FG006|Induction Period|Protocol Deviation|0|||
19460477|NCT04146363|41716498|FG007|Induction Period|Protocol Deviation|0|||
19460478|NCT04146363|41716499|FG008|Induction Period|Protocol Deviation|0|||
19460479|NCT04146363|41716500|FG009|Induction Period|Protocol Deviation|0|||
19460480|NCT04146363|41716501|FG010|Induction Period|Protocol Deviation|0|||
19460481|NCT04146363|41716491|FG000|Induction Period|Withdrawal by Subject|6|||
19460482|NCT04146363|41716492|FG001|Induction Period|Withdrawal by Subject|3|||
19460483|NCT04146363|41716493|FG002|Induction Period|Withdrawal by Subject|0|||
19460484|NCT04146363|41716494|FG003|Induction Period|Withdrawal by Subject|0|||
19460485|NCT04146363|41716495|FG004|Induction Period|Withdrawal by Subject|0|||
19460486|NCT04146363|41716496|FG005|Induction Period|Withdrawal by Subject|0|||
19460487|NCT04146363|41716497|FG006|Induction Period|Withdrawal by Subject|0|||
19460488|NCT04146363|41716498|FG007|Induction Period|Withdrawal by Subject|0|||
19460489|NCT04146363|41716499|FG008|Induction Period|Withdrawal by Subject|0|||
19460490|NCT04146363|41716500|FG009|Induction Period|Withdrawal by Subject|0|||
19460491|NCT04146363|41716501|FG010|Induction Period|Withdrawal by Subject|0|||
19460492|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460493|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460494|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460495|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460496|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460497|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460498|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
19460499|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
19460500|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460501|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460502|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
19460503|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460504|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460505|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460506|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460507|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460508|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460509|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460510|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
19460511|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460512|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460513|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
19460514|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460515|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460516|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460517|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460518|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460519|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460520|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
19460521|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
19460522|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460523|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460524|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
19460525|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460526|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460527|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
19460528|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460529|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460530|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
19460531|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460532|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460533|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460534|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460535|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
19460536|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460537|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460538|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460539|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460540|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
19460541|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
19460542|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
19460543|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
19460544|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460545|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460546|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
19460547|NCT04146363|41716491|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460548|NCT04146363|41716492|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460549|NCT04146363|41716493|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
19460550|NCT04146363|41716494|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460551|NCT04146363|41716495|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460552|NCT04146363|41716496|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
19460553|NCT04146363|41716497|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
19460554|NCT04146363|41716498|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
19460555|NCT04146363|41716499|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460556|NCT04146363|41716500|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460557|NCT04146363|41716501|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
19460558|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460559|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460560|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460561|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460562|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460563|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460564|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460565|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460566|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
19460567|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
19460568|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
19460569|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460570|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460571|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460572|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460573|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460574|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460575|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460576|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
19460577|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
19460578|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
19460579|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
19460580|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460581|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460582|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460583|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460584|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460585|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460586|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460587|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460588|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
19460589|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
19460590|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
19460591|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460592|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460593|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460594|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460595|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460596|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460597|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460598|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460599|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
19460600|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
19460601|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
19460602|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460603|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460604|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460605|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460606|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460607|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460608|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460609|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
19460610|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
19460611|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
19460612|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
19460613|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460614|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460615|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460616|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460617|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460618|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460619|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460620|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460621|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460622|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
19460623|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
19460624|NCT04146363|41716491|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460625|NCT04146363|41716492|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460626|NCT04146363|41716493|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460627|NCT04146363|41716494|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460628|NCT04146363|41716495|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460629|NCT04146363|41716496|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460630|NCT04146363|41716497|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460631|NCT04146363|41716498|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460632|NCT04146363|41716499|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460633|NCT04146363|41716500|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
19460634|NCT04146363|41716501|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
19460635|NCT01773421|41716526|FG000|Treatment Phase|Other|0|||
19460636|NCT01773421|41716527|FG001|Treatment Phase|Other|0|||
19460637|NCT01773421|41716528|FG002|Treatment Phase|Other|2|||
19460638|NCT01773421|41716529|FG003|Treatment Phase|Other|0|||
19460639|NCT01773421|41716530|FG004|Treatment Phase|Other|0|||
19460640|NCT01773421|41716531|FG005|Treatment Phase|Other|0|||
19460641|NCT01773421|41716532|FG006|Treatment Phase|Other|0|||
19460642|NCT01773421|41716526|FG000|Treatment Phase|Adverse Event|0|||
19460643|NCT01773421|41716527|FG001|Treatment Phase|Adverse Event|0|||
19460644|NCT01773421|41716528|FG002|Treatment Phase|Adverse Event|3|||
19460645|NCT01773421|41716529|FG003|Treatment Phase|Adverse Event|1|||
19460646|NCT01773421|41716530|FG004|Treatment Phase|Adverse Event|0|||
19460647|NCT01773421|41716531|FG005|Treatment Phase|Adverse Event|0|||
19460648|NCT01773421|41716532|FG006|Treatment Phase|Adverse Event|0|||
19460649|NCT01773421|41716526|FG000|Treatment Phase|Withdrawal by Subject|0|||
19460650|NCT01773421|41716527|FG001|Treatment Phase|Withdrawal by Subject|0|||
19460651|NCT01773421|41716528|FG002|Treatment Phase|Withdrawal by Subject|1|||
19460652|NCT01773421|41716529|FG003|Treatment Phase|Withdrawal by Subject|1|||
19460653|NCT01773421|41716530|FG004|Treatment Phase|Withdrawal by Subject|0|||
19460654|NCT01773421|41716531|FG005|Treatment Phase|Withdrawal by Subject|0|||
19460655|NCT01773421|41716532|FG006|Treatment Phase|Withdrawal by Subject|0|||
19460656|NCT01773421|41716526|FG000|Extension Phase|Other|0|||
19460657|NCT01773421|41716527|FG001|Extension Phase|Other|0|||
19460658|NCT01773421|41716528|FG002|Extension Phase|Other|0|||
19460659|NCT01773421|41716529|FG003|Extension Phase|Other|0|||
19460660|NCT01773421|41716530|FG004|Extension Phase|Other|1|||
19460661|NCT01773421|41716531|FG005|Extension Phase|Other|2|||
19460662|NCT01773421|41716532|FG006|Extension Phase|Other|0|||
19460663|NCT01773421|41716526|FG000|Extension Phase|Adverse Event|0|||
19460664|NCT01773421|41716527|FG001|Extension Phase|Adverse Event|0|||
19460665|NCT01773421|41716528|FG002|Extension Phase|Adverse Event|0|||
19460666|NCT01773421|41716529|FG003|Extension Phase|Adverse Event|0|||
19460667|NCT01773421|41716530|FG004|Extension Phase|Adverse Event|2|||
19460668|NCT01773421|41716531|FG005|Extension Phase|Adverse Event|0|||
19460669|NCT01773421|41716532|FG006|Extension Phase|Adverse Event|0|||
19460670|NCT01838941|41716552|FG000|Overall Study|Adverse Event|1|||
19460671|NCT01838941|41716552|FG000|Overall Study|Withdrawal by Subject|1|||
19460672|NCT01773109|41716557|FG000|Overall Study|Symptomatic Progression|2|||
19460673|NCT01773109|41716557|FG000|Overall Study|Death|1|||
19460674|NCT01772719|41716561|FG000|Overall Study|Withdrawal by Subject|3|||
19460675|NCT01772719|41716561|FG000|Overall Study|Adverse Event|2|||
19460676|NCT01772719|41716561|FG000|Overall Study|Protocol Violation|1|||
19460677|NCT01772719|41716561|FG000|Overall Study|Lost to Follow-up|1|||
19460678|NCT01798927|41716568|FG000|Overall Study|Withdrawal by Subject|1|||
19460679|NCT01276288|41716637|FG000|Overall Study|Adverse Event|1|||
19460680|NCT01276288|41716638|FG001|Overall Study|Adverse Event|1|||
19460681|NCT01276288|41716639|FG002|Overall Study|Adverse Event|0|||
19460682|NCT01276288|41716640|FG003|Overall Study|Adverse Event|0|||
19460683|NCT01276288|41716637|FG000|Overall Study|not treated|1|||
19460684|NCT01276288|41716638|FG001|Overall Study|not treated|0|||
19460685|NCT01276288|41716639|FG002|Overall Study|not treated|0|||
19460686|NCT01276288|41716640|FG003|Overall Study|not treated|0|||
19460687|NCT02702271|41716664|FG000|Overall Study|Death|36|||
19460688|NCT02702271|41716665|FG001|Overall Study|Death|7|||
19460689|NCT02702271|41716664|FG000|Overall Study|Lost to Follow-up|12|||
19460690|NCT02702271|41716665|FG001|Overall Study|Lost to Follow-up|0|||
19460691|NCT02702271|41716664|FG000|Overall Study|Withdrawal by Subject|8|||
19460692|NCT02702271|41716665|FG001|Overall Study|Withdrawal by Subject|1|||
19460693|NCT02702271|41716664|FG000|Overall Study|Physician Decision|2|||
19460694|NCT02702271|41716665|FG001|Overall Study|Physician Decision|0|||
19460695|NCT02702271|41716664|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
19460696|NCT02702271|41716665|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
19460697|NCT01276054|41716750|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
19460698|NCT01276054|41716751|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
19460699|NCT01798849|41716760|FG000|Overall Study|Physician Decision|0|||
19460700|NCT01798849|41716761|FG001|Overall Study|Physician Decision|0|||
19460701|NCT01798849|41716762|FG002|Overall Study|Physician Decision|1|||
19460702|NCT01797835|41716842|FG000|Overall Study|Lost to Follow-up|31|||
19460703|NCT01797835|41716843|FG001|Overall Study|Lost to Follow-up|27|||
19460704|NCT01275430|41716849|FG000|Overall Study|Adverse Event|1|||
19460705|NCT01275430|41716849|FG000|Overall Study|No Contrast Injection|6|||
19460706|NCT01275430|41716849|FG000|Overall Study|Device Malfunction|1|||
19460707|NCT01275430|41716849|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
19460708|NCT01838551|41716854|FG000|Overall Study|Adverse Event|16|||
19460709|NCT01838551|41716854|FG000|Overall Study|Death|1|||
19460710|NCT01838551|41716854|FG000|Overall Study|Lack of Efficacy|10|||
19460711|NCT01838551|41716854|FG000|Overall Study|Physician Decision|4|||
19460712|NCT01838551|41716854|FG000|Overall Study|Withdrawal by Subject|10|||
19460713|NCT01838551|41716854|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
19460714|NCT01797445|41716860|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
19460715|NCT01797445|41716861|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
19460716|NCT01797445|41716860|FG000|Double-Blind Phase|Adverse Event|3|||
19460717|NCT01797445|41716861|FG001|Double-Blind Phase|Adverse Event|0|||
19460718|NCT01797445|41716860|FG000|Double-Blind Phase|Death|5|||
19460719|NCT01797445|41716861|FG001|Double-Blind Phase|Death|4|||
19460720|NCT01797445|41716860|FG000|Double-Blind Phase|Pregnancy|0|||
19460721|NCT01797445|41716861|FG001|Double-Blind Phase|Pregnancy|1|||
19460722|NCT01797445|41716860|FG000|Double-Blind Phase|Lack of Efficacy|1|||
19460723|NCT01797445|41716861|FG001|Double-Blind Phase|Lack of Efficacy|2|||
19460724|NCT01797445|41716860|FG000|Double-Blind Phase|Investigator's Discretion|15|||
19460725|NCT01797445|41716861|FG001|Double-Blind Phase|Investigator's Discretion|17|||
19460726|NCT01797445|41716860|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
19460727|NCT01797445|41716861|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
19460728|NCT01797445|41716860|FG000|Double-Blind Phase|Protocol Violation|0|||
19460729|NCT01797445|41716861|FG001|Double-Blind Phase|Protocol Violation|1|||
19460730|NCT01797445|41716860|FG000|Double-Blind Phase|Withdrew Consent|20|||
19460731|NCT01797445|41716861|FG001|Double-Blind Phase|Withdrew Consent|35|||
19460732|NCT01797445|41716860|FG000|Double-Blind Phase|Lost to Follow-up|34|||
19460733|NCT01797445|41716861|FG001|Double-Blind Phase|Lost to Follow-up|26|||
19460734|NCT01797445|41716860|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
19460735|NCT01797445|41716861|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
19460736|NCT01611259|41716869|FG000|Overall Study|Physician Decision|1|||
19460737|NCT01611259|41716869|FG000|Overall Study|Lack of Efficacy|2|||
19460738|NCT01611259|41716869|FG000|Overall Study|Adverse Event|4|||
19460739|NCT01611259|41716869|FG000|Overall Study|Withdrawal by Subject|7|||
19460740|NCT01796197|41716873|FG000|Overall Study|Lost to Follow-up|1|||
19460741|NCT01796197|41716873|FG000|Overall Study|Lack of Efficacy|1|||
19460742|NCT01795495|41716880|FG000|Overall Study|Protocol Violation|1|||
19460743|NCT01795495|41716881|FG001|Overall Study|Protocol Violation|0|||
19460744|NCT01795495|41716882|FG002|Overall Study|Protocol Violation|1|||
19460745|NCT01795495|41716880|FG000|Overall Study|Physician Decision|0|||
19460746|NCT01795495|41716881|FG001|Overall Study|Physician Decision|0|||
19460747|NCT01795495|41716882|FG002|Overall Study|Physician Decision|1|||
19460748|NCT01794949|41716892|FG000|Overall Study|Lost to Follow-up|1|||
19460749|NCT01794949|41716893|FG001|Overall Study|Lost to Follow-up|0|||
19460750|NCT01770379|41716902|FG000|Overall Study|Technical issues|1|||
19460751|NCT01770379|41716903|FG001|Overall Study|Technical issues|0|||
19460752|NCT01770379|41716904|FG002|Overall Study|Technical issues|0|||
19460753|NCT01770379|41716902|FG000|Overall Study|Withdrawal by Subject|7|||
19460754|NCT01770379|41716903|FG001|Overall Study|Withdrawal by Subject|10|||
19460755|NCT01770379|41716904|FG002|Overall Study|Withdrawal by Subject|7|||
19460756|NCT01770379|41716902|FG000|Overall Study|study terminated by sponsor|22|||
19460757|NCT01770379|41716903|FG001|Overall Study|study terminated by sponsor|23|||
19460758|NCT01770379|41716904|FG002|Overall Study|study terminated by sponsor|22|||
19460759|NCT01770379|41716902|FG000|Overall Study|Protocol Violation|0|||
19460760|NCT01770379|41716903|FG001|Overall Study|Protocol Violation|1|||
19460761|NCT01770379|41716904|FG002|Overall Study|Protocol Violation|1|||
19460762|NCT01770379|41716902|FG000|Overall Study|Physician Decision|0|||
19460763|NCT01770379|41716903|FG001|Overall Study|Physician Decision|1|||
19460764|NCT01770379|41716904|FG002|Overall Study|Physician Decision|2|||
19460765|NCT01770379|41716902|FG000|Overall Study|Lost to Follow-up|0|||
19460766|NCT01770379|41716903|FG001|Overall Study|Lost to Follow-up|0|||
19460767|NCT01770379|41716904|FG002|Overall Study|Lost to Follow-up|2|||
19460768|NCT01770379|41716902|FG000|Overall Study|Lack of Efficacy|8|||
19460769|NCT01770379|41716903|FG001|Overall Study|Lack of Efficacy|6|||
19460770|NCT01770379|41716904|FG002|Overall Study|Lack of Efficacy|6|||
19460771|NCT01770379|41716902|FG000|Overall Study|Adverse Event|1|||
19460772|NCT01770379|41716903|FG001|Overall Study|Adverse Event|3|||
19460773|NCT01770379|41716904|FG002|Overall Study|Adverse Event|2|||
19460774|NCT01986881|41716917|FG000|Overall Study|Death|228|||
19460775|NCT01986881|41716918|FG001|Overall Study|Death|233|||
19460776|NCT01986881|41716919|FG002|Overall Study|Death|247|||
19460777|NCT01986881|41716917|FG000|Overall Study|Lost to Follow-up|51|||
19460778|NCT01986881|41716918|FG001|Overall Study|Lost to Follow-up|44|||
19460779|NCT01986881|41716919|FG002|Overall Study|Lost to Follow-up|55|||
19460780|NCT01986881|41716917|FG000|Overall Study|Physician Decision|7|||
19460781|NCT01986881|41716918|FG001|Overall Study|Physician Decision|4|||
19460782|NCT01986881|41716919|FG002|Overall Study|Physician Decision|6|||
19460783|NCT01986881|41716917|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
19460784|NCT01986881|41716918|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
19460785|NCT01986881|41716919|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
19460786|NCT01986881|41716917|FG000|Overall Study|Withdrawal by Subject|41|||
19460787|NCT01986881|41716918|FG001|Overall Study|Withdrawal by Subject|60|||
19460788|NCT01986881|41716919|FG002|Overall Study|Withdrawal by Subject|45|||
19460789|NCT01986881|41716917|FG000|Overall Study|Subject Moved|0|||
19460790|NCT01986881|41716918|FG001|Overall Study|Subject Moved|1|||
19460791|NCT01986881|41716919|FG002|Overall Study|Subject Moved|0|||
19460792|NCT01986881|41716917|FG000|Overall Study|Other|1|||
19460793|NCT01986881|41716918|FG001|Overall Study|Other|2|||
19460794|NCT01986881|41716919|FG002|Overall Study|Other|2|||
19460795|NCT01770145|41716950|FG000|Baseline|Adverse Event|20|||
19460796|NCT01770145|41716950|FG000|Baseline|Withdrawal by Subject|1|||
19460797|NCT01770145|41716950|FG000|Baseline|Lost to Follow-up|1|||
19460798|NCT01770145|41716950|FG000|Baseline|Unable to define optimal dose|4|||
19460799|NCT01770145|41716950|FG000|Treatment|Adverse Event|3|||
19460800|NCT01770145|41716950|FG000|Treatment|Withdrawal by Subject|1|||
19460801|NCT01609543|41716954|FG000|Overall Study|Disease Progression|28|||
19460802|NCT01609543|41716954|FG000|Overall Study|Adverse Event|5|||
19460803|NCT01609543|41716954|FG000|Overall Study|Withdrawal by Subject|1|||
19460804|NCT01609543|41716954|FG000|Overall Study|Protocol Violation|1|||
19460805|NCT01609543|41716954|FG000|Overall Study|Death|7|||
19460806|NCT02003183|41716961|FG000|Overall Study|Lost to Follow-up|0|||
19460807|NCT02003183|41716962|FG001|Overall Study|Lost to Follow-up|2|||
19460808|NCT01986647|41716972|FG000|Overall Study|Lost to Follow-up|4|||
19460809|NCT01986647|41716973|FG001|Overall Study|Lost to Follow-up|1|||
19460810|NCT01986647|41716974|FG002|Overall Study|Lost to Follow-up|4|||
19460811|NCT01986647|41716975|FG003|Overall Study|Lost to Follow-up|4|||
19460812|NCT01986647|41716972|FG000|Overall Study|Withdrawal by Subject|1|||
19460813|NCT01986647|41716973|FG001|Overall Study|Withdrawal by Subject|3|||
19460814|NCT01986647|41716974|FG002|Overall Study|Withdrawal by Subject|2|||
19460815|NCT01986647|41716975|FG003|Overall Study|Withdrawal by Subject|3|||
19460816|NCT01986647|41716972|FG000|Overall Study|Health|5|||
19460817|NCT01986647|41716973|FG001|Overall Study|Health|3|||
19460818|NCT01986647|41716974|FG002|Overall Study|Health|6|||
19460819|NCT01986647|41716975|FG003|Overall Study|Health|4|||
19460820|NCT02002091|41716991|FG000|Screening|Lost to Follow-up|10|||
19460821|NCT02002091|41716992|FG001|Screening|Lost to Follow-up|12|||
19460822|NCT02002091|41716991|FG000|Screening|Death|3|||
19460823|NCT02002091|41716992|FG001|Screening|Death|2|||
19460824|NCT01985321|41717029|FG000|Overall Study|Protocol Violation|4|||
19460825|NCT01985321|41717030|FG001|Overall Study|Protocol Violation|3|||
19460826|NCT01985321|41717029|FG000|Overall Study|Withdrawal by Subject|1|||
19460827|NCT01985321|41717030|FG001|Overall Study|Withdrawal by Subject|0|||
19460828|NCT01985321|41717029|FG000|Overall Study|Lost to Follow-up|5|||
19460829|NCT01985321|41717030|FG001|Overall Study|Lost to Follow-up|2|||
19460830|NCT01985321|41717029|FG000|Overall Study|Subject treated wrong type of sore|1|||
19460831|NCT01985321|41717030|FG001|Overall Study|Subject treated wrong type of sore|0|||
19460832|NCT02000921|41717039|FG000|Overall Study|Withdrawal by Subject|3|||
19460833|NCT02000921|41717040|FG001|Overall Study|Withdrawal by Subject|10|||
19460834|NCT02000921|41717041|FG002|Overall Study|Withdrawal by Subject|5|||
19460835|NCT02000921|41717039|FG000|Overall Study|Lost to Follow-up|2|||
19460836|NCT02000921|41717040|FG001|Overall Study|Lost to Follow-up|4|||
19460837|NCT02000921|41717041|FG002|Overall Study|Lost to Follow-up|5|||
19460838|NCT02000921|41717039|FG000|Overall Study|Physician Decision|0|||
19460839|NCT02000921|41717040|FG001|Overall Study|Physician Decision|2|||
19460840|NCT02000921|41717041|FG002|Overall Study|Physician Decision|0|||
19460841|NCT01836523|41717087|FG000|Overall Study|Adverse Event|15|||
19460842|NCT01836523|41717088|FG001|Overall Study|Adverse Event|41|||
19460843|NCT01836523|41717089|FG002|Overall Study|Adverse Event|49|||
19460844|NCT01836523|41717090|FG003|Overall Study|Adverse Event|14|||
19460845|NCT01836523|41717087|FG000|Overall Study|Protocol Violation|6|||
19460846|NCT01836523|41717088|FG001|Overall Study|Protocol Violation|3|||
19460847|NCT01836523|41717089|FG002|Overall Study|Protocol Violation|2|||
19460848|NCT01836523|41717090|FG003|Overall Study|Protocol Violation|4|||
19460849|NCT01836523|41717087|FG000|Overall Study|Met Withdrawal Criteria|13|||
19460850|NCT01836523|41717088|FG001|Overall Study|Met Withdrawal Criteria|13|||
19460851|NCT01836523|41717089|FG002|Overall Study|Met Withdrawal Criteria|21|||
19460852|NCT01836523|41717090|FG003|Overall Study|Met Withdrawal Criteria|27|||
19460853|NCT01836523|41717087|FG000|Overall Study|Unclassified|17|||
19460854|NCT01836523|41717088|FG001|Overall Study|Unclassified|28|||
19460855|NCT01836523|41717089|FG002|Overall Study|Unclassified|19|||
19460856|NCT01836523|41717090|FG003|Overall Study|Unclassified|29|||
19460857|NCT01275196|41717102|FG000|Overall Study|Adverse Event|3|||
19460858|NCT01275196|41717103|FG001|Overall Study|Adverse Event|5|||
19460859|NCT01275196|41717102|FG000|Overall Study|Withdrawal by Subject|4|||
19460860|NCT01275196|41717103|FG001|Overall Study|Withdrawal by Subject|5|||
19460861|NCT01275196|41717102|FG000|Overall Study|Lost to Follow-up|1|||
19460862|NCT01275196|41717103|FG001|Overall Study|Lost to Follow-up|0|||
19460863|NCT01275196|41717102|FG000|Overall Study|Disease Progression|6|||
19460864|NCT01275196|41717103|FG001|Overall Study|Disease Progression|5|||
19460865|NCT01275196|41717102|FG000|Overall Study|Protocol Violation|1|||
19460866|NCT01275196|41717103|FG001|Overall Study|Protocol Violation|0|||
19460867|NCT01275196|41717102|FG000|Overall Study|Suboptimal response/treatment failure|5|||
19460868|NCT01275196|41717103|FG001|Overall Study|Suboptimal response/treatment failure|6|||
19460869|NCT01984697|41717116|FG000|Overall Study|Adverse Event|0|||
19460870|NCT01984697|41717117|FG001|Overall Study|Adverse Event|0|||
19460871|NCT01984697|41717118|FG002|Overall Study|Adverse Event|2|||
19460872|NCT01984697|41717119|FG003|Overall Study|Adverse Event|0|||
19460873|NCT01984697|41717120|FG004|Overall Study|Adverse Event|0|||
19460874|NCT01984697|41717116|FG000|Overall Study|Lost to Follow-up|14|||
19460875|NCT01984697|41717117|FG001|Overall Study|Lost to Follow-up|5|||
19460876|NCT01984697|41717118|FG002|Overall Study|Lost to Follow-up|10|||
19460877|NCT01984697|41717119|FG003|Overall Study|Lost to Follow-up|6|||
19460878|NCT01984697|41717120|FG004|Overall Study|Lost to Follow-up|21|||
19460879|NCT01984697|41717116|FG000|Overall Study|Physician Decision|3|||
19460880|NCT01984697|41717117|FG001|Overall Study|Physician Decision|0|||
19460881|NCT01984697|41717118|FG002|Overall Study|Physician Decision|0|||
19460882|NCT01984697|41717119|FG003|Overall Study|Physician Decision|1|||
19460883|NCT01984697|41717120|FG004|Overall Study|Physician Decision|0|||
19460884|NCT01984697|41717116|FG000|Overall Study|Protocol Violation|8|||
19375975|NCT02361346|41618118|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
19375976|NCT02361346|41618119|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
19375977|NCT02361346|41618120|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
19375978|NCT02361346|41618112|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375979|NCT02361346|41618113|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375980|NCT02361346|41618114|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375981|NCT02361346|41618115|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375982|NCT02361346|41618116|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375983|NCT02361346|41618117|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375984|NCT02361346|41618118|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375985|NCT02361346|41618119|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
19375986|NCT02361346|41618120|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
19375987|NCT02361346|41618112|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375988|NCT02361346|41618113|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375989|NCT02361346|41618114|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375990|NCT02361346|41618115|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375991|NCT02361346|41618116|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375992|NCT02361346|41618117|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375993|NCT02361346|41618118|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375994|NCT02361346|41618119|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
19375995|NCT02361346|41618120|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
19375996|NCT02361346|41618112|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19375997|NCT02361346|41618113|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19375998|NCT02361346|41618114|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19375999|NCT02361346|41618115|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19376000|NCT02361346|41618116|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19376001|NCT02361346|41618117|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19376002|NCT02361346|41618118|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19376003|NCT02361346|41618119|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
19376004|NCT02361346|41618120|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
19376005|NCT02267278|41618162|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
19376006|NCT02267278|41618162|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
19376007|NCT02267278|41618162|FG000|Overall Study|Developed new cancer diagnoses|2|||
19376008|NCT02267278|41618162|FG000|Overall Study|prescribed prohibited medication|1|||
19376009|NCT02360098|41618168|FG000|Overall Study|Physician Decision|7|||
19376010|NCT02266888|41618179|FG000|Overall Study|Death|2|||
19376011|NCT02266888|41618180|FG001|Overall Study|Death|2|||
19460885|NCT01984697|41717117|FG001|Overall Study|Protocol Violation|5|||
19460886|NCT01984697|41717118|FG002|Overall Study|Protocol Violation|3|||
19460887|NCT01984697|41717119|FG003|Overall Study|Protocol Violation|2|||
19460888|NCT01984697|41717120|FG004|Overall Study|Protocol Violation|0|||
19376012|NCT02266888|41618181|FG002|Overall Study|Death|4|||
19376013|NCT02266888|41618182|FG003|Overall Study|Death|2|||
19376014|NCT02266888|41618179|FG000|Overall Study|Physician Decision|0|||
19376015|NCT02266888|41618180|FG001|Overall Study|Physician Decision|1|||
19460889|NCT01984697|41717116|FG000|Overall Study|Withdrawal by Subject|15|||
19376016|NCT02266888|41618181|FG002|Overall Study|Physician Decision|2|||
19376017|NCT02266888|41618182|FG003|Overall Study|Physician Decision|2|||
19376018|NCT02266888|41618179|FG000|Overall Study|Study Terminated|5|||
19376019|NCT02266888|41618180|FG001|Overall Study|Study Terminated|1|||
19376020|NCT02266888|41618181|FG002|Overall Study|Study Terminated|0|||
19376021|NCT02266888|41618182|FG003|Overall Study|Study Terminated|0|||
19376022|NCT02266888|41618179|FG000|Overall Study|No Longer Eligible|0|||
19376023|NCT02266888|41618180|FG001|Overall Study|No Longer Eligible|0|||
19376024|NCT02266888|41618181|FG002|Overall Study|No Longer Eligible|0|||
19376025|NCT02266888|41618182|FG003|Overall Study|No Longer Eligible|2|||
19376026|NCT02266888|41618179|FG000|Overall Study|Randomization Closed|0|||
19376027|NCT02266888|41618180|FG001|Overall Study|Randomization Closed|0|||
19376028|NCT02266888|41618181|FG002|Overall Study|Randomization Closed|4|||
19376029|NCT02266888|41618182|FG003|Overall Study|Randomization Closed|0|||
19376030|NCT02266888|41618179|FG000|Overall Study|Personnel unavailable at transplant|0|||
19376031|NCT02266888|41618180|FG001|Overall Study|Personnel unavailable at transplant|0|||
19376032|NCT02266888|41618181|FG002|Overall Study|Personnel unavailable at transplant|0|||
19376033|NCT02266888|41618182|FG003|Overall Study|Personnel unavailable at transplant|1|||
19376034|NCT02266888|41618179|FG000|Overall Study|Transfer of care|0|||
19376035|NCT02266888|41618180|FG001|Overall Study|Transfer of care|0|||
19376036|NCT02266888|41618181|FG002|Overall Study|Transfer of care|1|||
19376037|NCT02266888|41618182|FG003|Overall Study|Transfer of care|0|||
19376038|NCT01641952|41618190|FG000|Overall Study|Lost to Follow-up|28|||
19376039|NCT01641952|41618190|FG000|Overall Study|Adverse Event|6|||
19376040|NCT02359552|41618196|FG000|Overall Study|Lost to Follow-up|3|||
19376041|NCT02359552|41618197|FG001|Overall Study|Lost to Follow-up|4|||
19376042|NCT02743793|41618205|FG000|Overall Study|Death|1|||
19376043|NCT02743793|41618206|FG001|Overall Study|Death|1|||
19376044|NCT02743793|41618205|FG000|Overall Study|Withdrawal by Subject|0|||
19376045|NCT02743793|41618206|FG001|Overall Study|Withdrawal by Subject|1|||
19376046|NCT02743793|41618205|FG000|Overall Study|Screen Failure|4|||
19376047|NCT02743793|41618206|FG001|Overall Study|Screen Failure|0|||
19376048|NCT02743793|41618205|FG000|Overall Study|No Primary Care Physician|0|||
19376049|NCT02743793|41618206|FG001|Overall Study|No Primary Care Physician|1|||
19376050|NCT02743793|41618205|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
19376051|NCT02743793|41618206|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
19376052|NCT02743793|41618205|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
19376053|NCT02743793|41618206|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
19376054|NCT00152009|41618215|FG000|Overall Study|Adverse Event|9|||
19376055|NCT00152009|41618216|FG001|Overall Study|Adverse Event|13|||
19376056|NCT00152009|41618217|FG002|Overall Study|Adverse Event|20|||
19376057|NCT00152009|41618218|FG003|Overall Study|Adverse Event|1|||
19376058|NCT00152009|41618215|FG000|Overall Study|Protocol Violation|3|||
19376059|NCT00152009|41618216|FG001|Overall Study|Protocol Violation|0|||
19376060|NCT00152009|41618217|FG002|Overall Study|Protocol Violation|0|||
19376061|NCT00152009|41618218|FG003|Overall Study|Protocol Violation|1|||
19376062|NCT00152009|41618215|FG000|Overall Study|Withdrawal by Subject|2|||
19376063|NCT00152009|41618216|FG001|Overall Study|Withdrawal by Subject|3|||
19376064|NCT00152009|41618217|FG002|Overall Study|Withdrawal by Subject|4|||
19376065|NCT00152009|41618218|FG003|Overall Study|Withdrawal by Subject|9|||
19376066|NCT00152009|41618215|FG000|Overall Study|Lost to Follow-up|2|||
19376067|NCT00152009|41618216|FG001|Overall Study|Lost to Follow-up|4|||
19376068|NCT00152009|41618217|FG002|Overall Study|Lost to Follow-up|3|||
19376069|NCT00152009|41618218|FG003|Overall Study|Lost to Follow-up|3|||
19376070|NCT00152009|41618215|FG000|Overall Study|Lack of Efficacy|8|||
19376071|NCT00152009|41618216|FG001|Overall Study|Lack of Efficacy|6|||
19376072|NCT00152009|41618217|FG002|Overall Study|Lack of Efficacy|7|||
19376073|NCT00152009|41618218|FG003|Overall Study|Lack of Efficacy|15|||
19376074|NCT00152009|41618215|FG000|Overall Study|ECG abnormalities|2|||
19376075|NCT00152009|41618216|FG001|Overall Study|ECG abnormalities|2|||
19376076|NCT00152009|41618217|FG002|Overall Study|ECG abnormalities|2|||
19376077|NCT00152009|41618218|FG003|Overall Study|ECG abnormalities|1|||
19376078|NCT00152009|41618215|FG000|Overall Study|Sponsor's decision|3|||
19376079|NCT00152009|41618216|FG001|Overall Study|Sponsor's decision|3|||
19376080|NCT00152009|41618217|FG002|Overall Study|Sponsor's decision|1|||
19376081|NCT00152009|41618218|FG003|Overall Study|Sponsor's decision|3|||
19376082|NCT02265952|41618228|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
19376083|NCT02265952|41618229|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
19376084|NCT02265952|41618228|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
19376085|NCT02265952|41618229|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
19376086|NCT02265796|41618237|FG000|Overall Study|Death|1|||
19376087|NCT02265796|41618238|FG001|Overall Study|Death|0|||
19376088|NCT02265796|41618237|FG000|Overall Study|started on excluded medication|1|||
19376089|NCT02265796|41618238|FG001|Overall Study|started on excluded medication|0|||
19376090|NCT02265796|41618237|FG000|Overall Study|Withdrawal by Subject|1|||
19376091|NCT02265796|41618238|FG001|Overall Study|Withdrawal by Subject|1|||
19376092|NCT02357368|41618248|FG000|Overall Study|Lost to Follow-up|0|||
19376093|NCT02357368|41618249|FG001|Overall Study|Lost to Follow-up|0|||
19376094|NCT02357368|41618250|FG002|Overall Study|Lost to Follow-up|0|||
19376095|NCT02357368|41618251|FG003|Overall Study|Lost to Follow-up|1|||
19376096|NCT02357368|41618248|FG000|Overall Study|Pregnancy|3|||
19376097|NCT02357368|41618249|FG001|Overall Study|Pregnancy|2|||
19376098|NCT02357368|41618250|FG002|Overall Study|Pregnancy|0|||
19376099|NCT02357368|41618251|FG003|Overall Study|Pregnancy|0|||
19376100|NCT02357368|41618248|FG000|Overall Study|Withdrawal by Subject|3|||
19376101|NCT02357368|41618249|FG001|Overall Study|Withdrawal by Subject|1|||
19376102|NCT02357368|41618250|FG002|Overall Study|Withdrawal by Subject|1|||
19376103|NCT02357368|41618251|FG003|Overall Study|Withdrawal by Subject|2|||
19376104|NCT03287245|41618265|FG000|Overall Study|Study terminated by sponsor|3|||
19376105|NCT03287245|41618266|FG001|Overall Study|Study terminated by sponsor|0|||
19376106|NCT03287245|41618267|FG002|Overall Study|Study terminated by sponsor|3|||
19460890|NCT01984697|41717117|FG001|Overall Study|Withdrawal by Subject|21|||
19460891|NCT01984697|41717118|FG002|Overall Study|Withdrawal by Subject|13|||
19460892|NCT01984697|41717119|FG003|Overall Study|Withdrawal by Subject|11|||
19460893|NCT01984697|41717120|FG004|Overall Study|Withdrawal by Subject|13|||
19460894|NCT01984697|41717116|FG000|Overall Study|Missed last follow-up visit|1|||
19460895|NCT01984697|41717117|FG001|Overall Study|Missed last follow-up visit|0|||
19460896|NCT01984697|41717118|FG002|Overall Study|Missed last follow-up visit|0|||
19460897|NCT01984697|41717119|FG003|Overall Study|Missed last follow-up visit|0|||
19460898|NCT01984697|41717120|FG004|Overall Study|Missed last follow-up visit|0|||
19460899|NCT01984697|41717116|FG000|Overall Study|Death|0|||
19460900|NCT01984697|41717117|FG001|Overall Study|Death|0|||
19460901|NCT01984697|41717118|FG002|Overall Study|Death|0|||
19460902|NCT01984697|41717119|FG003|Overall Study|Death|1|||
19460903|NCT01984697|41717120|FG004|Overall Study|Death|0|||
19460904|NCT01984697|41717116|FG000|Overall Study|Pregnancy|2|||
19460905|NCT01984697|41717117|FG001|Overall Study|Pregnancy|0|||
19460906|NCT01984697|41717118|FG002|Overall Study|Pregnancy|1|||
19460907|NCT01984697|41717119|FG003|Overall Study|Pregnancy|0|||
19460908|NCT01984697|41717120|FG004|Overall Study|Pregnancy|1|||
19460909|NCT02000531|41717143|FG000|Overall Study|Lost to Follow-up|1|||
19460910|NCT02000531|41717144|FG001|Overall Study|Lost to Follow-up|0|||
19460911|NCT02000531|41717143|FG000|Overall Study|Discontinued due to data cut-off|3|||
19460912|NCT02000531|41717144|FG001|Overall Study|Discontinued due to data cut-off|8|||
19460913|NCT01609231|41717152|FG000|Overall Study|Adverse Event|1|||
19460914|NCT01609231|41717153|FG001|Overall Study|Adverse Event|3|||
19460915|NCT01609231|41717152|FG000|Overall Study|Physician Decision|1|||
19460916|NCT01609231|41717153|FG001|Overall Study|Physician Decision|0|||
19460917|NCT01609231|41717152|FG000|Overall Study|Withdrawal by Subject|1|||
19460918|NCT01609231|41717153|FG001|Overall Study|Withdrawal by Subject|0|||
19460919|NCT01793935|41717161|FG000|Overall Study|Pregnancy|1|||
19460920|NCT01793935|41717162|FG001|Overall Study|Pregnancy|0|||
19460921|NCT01793935|41717161|FG000|Overall Study|Protocol Violation|2|||
19460922|NCT01793935|41717162|FG001|Overall Study|Protocol Violation|1|||
19460923|NCT01793935|41717161|FG000|Overall Study|Adverse Event|2|||
19460924|NCT01793935|41717162|FG001|Overall Study|Adverse Event|0|||
19460925|NCT01793935|41717161|FG000|Overall Study|Patient did not take study medication|1|||
19460926|NCT01793935|41717162|FG001|Overall Study|Patient did not take study medication|1|||
19460927|NCT01793935|41717161|FG000|Overall Study|Lost to Follow-up|0|||
19460928|NCT01793935|41717162|FG001|Overall Study|Lost to Follow-up|1|||
19460929|NCT02092025|41717168|FG000|Overall Study|Case Report Forms Uncollected|44|||
19460930|NCT02092025|41717168|FG000|Overall Study|Protocol Deviation|24|||
19460931|NCT01769443|41717174|FG000|Overall Study|Study closure|1|||
19460932|NCT01769443|41717175|FG001|Overall Study|Study closure|0|||
19460933|NCT01768117|41717182|FG000|Overall Study|Lost to Follow-up|1|||
19460934|NCT01768117|41717182|FG000|Overall Study|Withdrawal by Subject|2|||
19460935|NCT01768117|41717182|FG000|Overall Study|Protocol Violation|3|||
19460936|NCT01767493|41717186|FG000|Overall Study|screen failures|3|||
19460937|NCT01274182|41717193|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
19460938|NCT01274182|41717194|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
19460939|NCT01274182|41717195|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
19460940|NCT01274182|41717193|FG000|Overall Study|Adverse Event|4|||
19460941|NCT01274182|41717194|FG001|Overall Study|Adverse Event|5|||
19460942|NCT01274182|41717195|FG002|Overall Study|Adverse Event|3|||
19460943|NCT01274182|41717193|FG000|Overall Study|Withdrawal by Subject|5|||
19460944|NCT01274182|41717194|FG001|Overall Study|Withdrawal by Subject|5|||
19460945|NCT01274182|41717195|FG002|Overall Study|Withdrawal by Subject|3|||
19460946|NCT01274182|41717193|FG000|Overall Study|Lost to Follow-up|2|||
19460947|NCT01274182|41717194|FG001|Overall Study|Lost to Follow-up|3|||
19460948|NCT01274182|41717195|FG002|Overall Study|Lost to Follow-up|1|||
19460949|NCT01274182|41717193|FG000|Overall Study|Protocol Violation|3|||
19460950|NCT01274182|41717194|FG001|Overall Study|Protocol Violation|2|||
19460951|NCT01274182|41717195|FG002|Overall Study|Protocol Violation|0|||
19460952|NCT01274182|41717193|FG000|Overall Study|Death|1|||
19460953|NCT01274182|41717194|FG001|Overall Study|Death|0|||
19460954|NCT01274182|41717195|FG002|Overall Study|Death|1|||
19550566|NCT00107900|41999617|FG004|Overall Study|Death|1|||
19460955|NCT01984229|41717209|FG000|Safety Follow-up Period|Adverse Event|1|||
19460956|NCT01984229|41717210|FG001|Safety Follow-up Period|Adverse Event|1|||
19460957|NCT01984229|41717209|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
19460958|NCT01984229|41717210|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
19460959|NCT01835899|41717225|FG000|Overall Study|Adverse Event|0|||
19460960|NCT01835899|41717226|FG001|Overall Study|Adverse Event|0|||
19460961|NCT01835899|41717227|FG002|Overall Study|Adverse Event|1|||
19460962|NCT01835899|41717225|FG000|Overall Study|Other than stated above|0|||
19460963|NCT01835899|41717226|FG001|Overall Study|Other than stated above|1|||
19460964|NCT01835899|41717227|FG002|Overall Study|Other than stated above|0|||
19460965|NCT01766401|41717239|FG000|Overall Study|Adverse Event|7|||
19460966|NCT01766401|41717240|FG001|Overall Study|Adverse Event|22|||
19460967|NCT01766401|41717239|FG000|Overall Study|Lack of Efficacy|1|||
19460968|NCT01766401|41717240|FG001|Overall Study|Lack of Efficacy|2|||
19460969|NCT01766401|41717239|FG000|Overall Study|Protocol Violation|3|||
19460970|NCT01766401|41717240|FG001|Overall Study|Protocol Violation|8|||
19460971|NCT01766401|41717239|FG000|Overall Study|Withdrawal by Subject|15|||
19460972|NCT01766401|41717240|FG001|Overall Study|Withdrawal by Subject|12|||
19460973|NCT01766401|41717239|FG000|Overall Study|Lost to Follow-up|10|||
19460974|NCT01766401|41717240|FG001|Overall Study|Lost to Follow-up|11|||
19460975|NCT01766401|41717239|FG000|Overall Study|Pregnancy|1|||
19460976|NCT01766401|41717240|FG001|Overall Study|Pregnancy|1|||
19460977|NCT01272934|41717248|FG000|Overall Study|Adverse Event|0|||
19460978|NCT01272934|41717249|FG001|Overall Study|Adverse Event|1|||
19460979|NCT01272934|41717248|FG000|Overall Study|Abnormal Laboratory Value|0|||
19460980|NCT01272934|41717249|FG001|Overall Study|Abnormal Laboratory Value|1|||
19460981|NCT01983683|41717267|FG000|Overall Study|Withdrawal by Subject|14|||
19460982|NCT01983683|41717268|FG001|Overall Study|Withdrawal by Subject|18|||
19460983|NCT01983683|41717267|FG000|Overall Study|Death|11|||
19460984|NCT01983683|41717268|FG001|Overall Study|Death|15|||
19460985|NCT01983683|41717267|FG000|Overall Study|Physician Decision|8|||
19460986|NCT01983683|41717268|FG001|Overall Study|Physician Decision|9|||
19460987|NCT01983683|41717267|FG000|Overall Study|Lost to Follow-up|4|||
19460988|NCT01983683|41717268|FG001|Overall Study|Lost to Follow-up|8|||
19460989|NCT01983683|41717267|FG000|Overall Study|Sponsor Decision|1|||
19460990|NCT01983683|41717268|FG001|Overall Study|Sponsor Decision|1|||
19460991|NCT01998893|41717274|FG000|Overall Study|Adverse Event|2|||
19460992|NCT01998893|41717274|FG000|Overall Study|Death|1|||
19460993|NCT01998893|41717274|FG000|Overall Study|Lost to Follow-up|8|||
19460994|NCT01998893|41717274|FG000|Overall Study|Physician Decision|2|||
19460995|NCT01998893|41717274|FG000|Overall Study|Protocol Violation|2|||
19460996|NCT01998893|41717274|FG000|Overall Study|Withdrawal by Subject|1|||
19460997|NCT01998893|41717274|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
19460998|NCT01791985|41717278|FG000|Overall Study|Adverse Event|7|||
19460999|NCT01791985|41717278|FG000|Overall Study|Withdrawal by Subject|1|||
19461000|NCT01998737|41717285|FG000|Overall Study|Corrupted database|23|||
19461001|NCT01998737|41717286|FG001|Overall Study|Corrupted database|0|||
19461002|NCT01791517|41717295|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
19461003|NCT01791517|41717296|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
19461004|NCT01791517|41717297|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
19461005|NCT01791517|41717298|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
19461006|NCT01791517|41717299|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
19461007|NCT01791517|41717300|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
19461008|NCT01791517|41717301|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
19461009|NCT01791517|41717302|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
19461010|NCT01791517|41717303|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
19461011|NCT01791517|41717304|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
19461012|NCT01791517|41717305|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
19461013|NCT01791517|41717306|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
19461014|NCT01791517|41717295|FG000|Phase I: Period 1|Adverse Event|0|||
19461015|NCT01791517|41717296|FG001|Phase I: Period 1|Adverse Event|0|||
19461016|NCT01791517|41717297|FG002|Phase I: Period 1|Adverse Event|1|||
19461017|NCT01791517|41717298|FG003|Phase I: Period 1|Adverse Event|1|||
19461018|NCT01791517|41717299|FG004|Phase I: Period 1|Adverse Event|0|||
19461019|NCT01791517|41717300|FG005|Phase I: Period 1|Adverse Event|0|||
19461020|NCT01791517|41717301|FG006|Phase I: Period 1|Adverse Event|0|||
19461021|NCT01791517|41717302|FG007|Phase I: Period 1|Adverse Event|0|||
19461022|NCT01791517|41717303|FG008|Phase I: Period 1|Adverse Event|0|||
19461023|NCT01791517|41717304|FG009|Phase I: Period 1|Adverse Event|0|||
19461024|NCT01791517|41717305|FG010|Phase I: Period 1|Adverse Event|0|||
19461025|NCT01791517|41717306|FG011|Phase I: Period 1|Adverse Event|0|||
19461026|NCT01791517|41717295|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
19461027|NCT01791517|41717296|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461028|NCT01791517|41717297|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461029|NCT01791517|41717298|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461030|NCT01791517|41717299|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461031|NCT01791517|41717300|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461032|NCT01791517|41717301|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461033|NCT01791517|41717302|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461034|NCT01791517|41717303|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461035|NCT01791517|41717304|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461036|NCT01791517|41717305|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461037|NCT01791517|41717306|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
19461038|NCT01791517|41717295|FG000|Phase I: Period 1|Protocol Violation|0|||
19461039|NCT01791517|41717296|FG001|Phase I: Period 1|Protocol Violation|1|||
19461040|NCT01791517|41717297|FG002|Phase I: Period 1|Protocol Violation|0|||
19461041|NCT01791517|41717298|FG003|Phase I: Period 1|Protocol Violation|0|||
19461042|NCT01791517|41717299|FG004|Phase I: Period 1|Protocol Violation|0|||
19461043|NCT01791517|41717300|FG005|Phase I: Period 1|Protocol Violation|0|||
19461044|NCT01791517|41717301|FG006|Phase I: Period 1|Protocol Violation|0|||
19461045|NCT01791517|41717302|FG007|Phase I: Period 1|Protocol Violation|0|||
19461046|NCT01791517|41717303|FG008|Phase I: Period 1|Protocol Violation|0|||
19461047|NCT01791517|41717304|FG009|Phase I: Period 1|Protocol Violation|0|||
19461048|NCT01791517|41717305|FG010|Phase I: Period 1|Protocol Violation|0|||
19461049|NCT01791517|41717306|FG011|Phase I: Period 1|Protocol Violation|0|||
19461050|NCT01791517|41717295|FG000|Phase I: Period 1|Lost to Follow-up|0|||
19461051|NCT01791517|41717296|FG001|Phase I: Period 1|Lost to Follow-up|0|||
19461052|NCT01791517|41717297|FG002|Phase I: Period 1|Lost to Follow-up|0|||
19461053|NCT01791517|41717298|FG003|Phase I: Period 1|Lost to Follow-up|1|||
19461054|NCT01791517|41717299|FG004|Phase I: Period 1|Lost to Follow-up|0|||
19461055|NCT01791517|41717300|FG005|Phase I: Period 1|Lost to Follow-up|0|||
19461056|NCT01791517|41717301|FG006|Phase I: Period 1|Lost to Follow-up|1|||
19461057|NCT01791517|41717302|FG007|Phase I: Period 1|Lost to Follow-up|0|||
19461058|NCT01791517|41717303|FG008|Phase I: Period 1|Lost to Follow-up|1|||
19461059|NCT01791517|41717304|FG009|Phase I: Period 1|Lost to Follow-up|1|||
19461060|NCT01791517|41717305|FG010|Phase I: Period 1|Lost to Follow-up|0|||
19461061|NCT01791517|41717306|FG011|Phase I: Period 1|Lost to Follow-up|0|||
19461062|NCT01791517|41717295|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461063|NCT01791517|41717296|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461064|NCT01791517|41717297|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461065|NCT01791517|41717298|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461066|NCT01791517|41717299|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461067|NCT01791517|41717300|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461068|NCT01791517|41717301|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461069|NCT01791517|41717302|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461070|NCT01791517|41717303|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461071|NCT01791517|41717304|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461072|NCT01791517|41717305|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
19461073|NCT01791517|41717306|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
19461074|NCT01791517|41717295|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
19461075|NCT01791517|41717296|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461076|NCT01791517|41717297|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461077|NCT01791517|41717298|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461078|NCT01791517|41717299|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461079|NCT01791517|41717300|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461080|NCT01791517|41717301|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461081|NCT01791517|41717302|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461082|NCT01791517|41717303|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461083|NCT01791517|41717304|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461084|NCT01791517|41717305|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461085|NCT01791517|41717306|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
19461086|NCT01791517|41717295|FG000|Phase I: Period 2|Protocol Violation|0|||
19461087|NCT01791517|41717296|FG001|Phase I: Period 2|Protocol Violation|0|||
19461088|NCT01791517|41717297|FG002|Phase I: Period 2|Protocol Violation|0|||
19461089|NCT01791517|41717298|FG003|Phase I: Period 2|Protocol Violation|1|||
19461090|NCT01791517|41717299|FG004|Phase I: Period 2|Protocol Violation|0|||
19461091|NCT01791517|41717300|FG005|Phase I: Period 2|Protocol Violation|0|||
19461092|NCT01791517|41717301|FG006|Phase I: Period 2|Protocol Violation|0|||
19461093|NCT01791517|41717302|FG007|Phase I: Period 2|Protocol Violation|0|||
19461094|NCT01791517|41717303|FG008|Phase I: Period 2|Protocol Violation|0|||
19461095|NCT01791517|41717304|FG009|Phase I: Period 2|Protocol Violation|0|||
19461096|NCT01791517|41717305|FG010|Phase I: Period 2|Protocol Violation|0|||
19461097|NCT01791517|41717306|FG011|Phase I: Period 2|Protocol Violation|0|||
19461098|NCT01791517|41717295|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
19461099|NCT01791517|41717296|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
19461100|NCT01791517|41717297|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
19461101|NCT01791517|41717298|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
19461102|NCT01791517|41717299|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
19461103|NCT01791517|41717300|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
19461104|NCT01791517|41717301|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
19461105|NCT01791517|41717302|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
19461106|NCT01791517|41717303|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
19461107|NCT01791517|41717304|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
19461108|NCT01791517|41717305|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
19461109|NCT01791517|41717306|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
19461110|NCT01791517|41717295|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461111|NCT01791517|41717296|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461112|NCT01791517|41717297|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461113|NCT01791517|41717298|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461114|NCT01791517|41717299|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461115|NCT01791517|41717300|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461116|NCT01791517|41717301|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461117|NCT01791517|41717302|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461118|NCT01791517|41717303|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461119|NCT01791517|41717304|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461120|NCT01791517|41717305|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
19461121|NCT01791517|41717306|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
19461122|NCT01791517|41717295|FG000|Phase I: Period 2|Lens Discomfort|0|||
19461123|NCT01791517|41717296|FG001|Phase I: Period 2|Lens Discomfort|0|||
19461124|NCT01791517|41717297|FG002|Phase I: Period 2|Lens Discomfort|0|||
19461125|NCT01791517|41717298|FG003|Phase I: Period 2|Lens Discomfort|0|||
19461126|NCT01791517|41717299|FG004|Phase I: Period 2|Lens Discomfort|0|||
19461127|NCT01791517|41717300|FG005|Phase I: Period 2|Lens Discomfort|1|||
19461128|NCT01791517|41717301|FG006|Phase I: Period 2|Lens Discomfort|0|||
19461129|NCT01791517|41717302|FG007|Phase I: Period 2|Lens Discomfort|0|||
19461130|NCT01791517|41717303|FG008|Phase I: Period 2|Lens Discomfort|0|||
19461131|NCT01791517|41717304|FG009|Phase I: Period 2|Lens Discomfort|0|||
19461132|NCT01791517|41717305|FG010|Phase I: Period 2|Lens Discomfort|0|||
19461133|NCT01791517|41717306|FG011|Phase I: Period 2|Lens Discomfort|0|||
19461134|NCT01791517|41717295|FG000|Phase I: Period 2|Lost to Follow-up|0|||
19461135|NCT01791517|41717296|FG001|Phase I: Period 2|Lost to Follow-up|3|||
19461136|NCT01791517|41717297|FG002|Phase I: Period 2|Lost to Follow-up|2|||
19461137|NCT01791517|41717298|FG003|Phase I: Period 2|Lost to Follow-up|0|||
19461138|NCT01791517|41717299|FG004|Phase I: Period 2|Lost to Follow-up|0|||
19461139|NCT01791517|41717300|FG005|Phase I: Period 2|Lost to Follow-up|0|||
19461140|NCT01791517|41717301|FG006|Phase I: Period 2|Lost to Follow-up|0|||
19461141|NCT01791517|41717302|FG007|Phase I: Period 2|Lost to Follow-up|0|||
19461142|NCT01791517|41717303|FG008|Phase I: Period 2|Lost to Follow-up|0|||
19461143|NCT01791517|41717304|FG009|Phase I: Period 2|Lost to Follow-up|0|||
19461144|NCT01791517|41717305|FG010|Phase I: Period 2|Lost to Follow-up|0|||
19461145|NCT01791517|41717306|FG011|Phase I: Period 2|Lost to Follow-up|0|||
19461146|NCT01791517|41717295|FG000|Phase I: Period 3|Lens Discomfort|0|||
19461147|NCT01791517|41717296|FG001|Phase I: Period 3|Lens Discomfort|0|||
19461148|NCT01791517|41717297|FG002|Phase I: Period 3|Lens Discomfort|0|||
19461149|NCT01791517|41717298|FG003|Phase I: Period 3|Lens Discomfort|0|||
19461150|NCT01791517|41717299|FG004|Phase I: Period 3|Lens Discomfort|0|||
19461151|NCT01791517|41717300|FG005|Phase I: Period 3|Lens Discomfort|0|||
19461152|NCT01791517|41717301|FG006|Phase I: Period 3|Lens Discomfort|0|||
19461153|NCT01791517|41717302|FG007|Phase I: Period 3|Lens Discomfort|0|||
19461154|NCT01791517|41717303|FG008|Phase I: Period 3|Lens Discomfort|0|||
19461155|NCT01791517|41717304|FG009|Phase I: Period 3|Lens Discomfort|0|||
19461156|NCT01791517|41717305|FG010|Phase I: Period 3|Lens Discomfort|0|||
19461157|NCT01791517|41717306|FG011|Phase I: Period 3|Lens Discomfort|1|||
19461158|NCT01791517|41717295|FG000|Phase I: Period 3|Lost to Follow-up|0|||
19461159|NCT01791517|41717296|FG001|Phase I: Period 3|Lost to Follow-up|1|||
19461160|NCT01791517|41717297|FG002|Phase I: Period 3|Lost to Follow-up|0|||
19461161|NCT01791517|41717298|FG003|Phase I: Period 3|Lost to Follow-up|0|||
19461162|NCT01791517|41717299|FG004|Phase I: Period 3|Lost to Follow-up|1|||
19461163|NCT01791517|41717300|FG005|Phase I: Period 3|Lost to Follow-up|0|||
19461164|NCT01791517|41717301|FG006|Phase I: Period 3|Lost to Follow-up|0|||
19461165|NCT01791517|41717302|FG007|Phase I: Period 3|Lost to Follow-up|0|||
19461166|NCT01791517|41717303|FG008|Phase I: Period 3|Lost to Follow-up|0|||
19461167|NCT01791517|41717304|FG009|Phase I: Period 3|Lost to Follow-up|0|||
19461168|NCT01791517|41717305|FG010|Phase I: Period 3|Lost to Follow-up|0|||
19461169|NCT01791517|41717306|FG011|Phase I: Period 3|Lost to Follow-up|0|||
19461170|NCT01791517|41717295|FG000|Phase I: Period 3|Adverse Event|0|||
19461171|NCT01791517|41717296|FG001|Phase I: Period 3|Adverse Event|0|||
19461172|NCT01791517|41717297|FG002|Phase I: Period 3|Adverse Event|0|||
19461173|NCT01791517|41717298|FG003|Phase I: Period 3|Adverse Event|1|||
19461174|NCT01791517|41717299|FG004|Phase I: Period 3|Adverse Event|0|||
19461175|NCT01791517|41717300|FG005|Phase I: Period 3|Adverse Event|0|||
19461176|NCT01791517|41717301|FG006|Phase I: Period 3|Adverse Event|0|||
19461177|NCT01791517|41717302|FG007|Phase I: Period 3|Adverse Event|0|||
19461178|NCT01791517|41717303|FG008|Phase I: Period 3|Adverse Event|0|||
19461179|NCT01791517|41717304|FG009|Phase I: Period 3|Adverse Event|0|||
19461180|NCT01791517|41717305|FG010|Phase I: Period 3|Adverse Event|0|||
19461181|NCT01791517|41717306|FG011|Phase I: Period 3|Adverse Event|0|||
19461182|NCT01791517|41717295|FG000|Phase II|Lost to Follow-up|1|||
19461183|NCT01791517|41717296|FG001|Phase II|Lost to Follow-up|0|||
19461184|NCT01791517|41717297|FG002|Phase II|Lost to Follow-up|1|||
19461185|NCT01791517|41717298|FG003|Phase II|Lost to Follow-up|0|||
19461186|NCT01791517|41717299|FG004|Phase II|Lost to Follow-up|1|||
19461187|NCT01791517|41717300|FG005|Phase II|Lost to Follow-up|2|||
19461188|NCT01791517|41717301|FG006|Phase II|Lost to Follow-up|0|||
19461189|NCT01791517|41717302|FG007|Phase II|Lost to Follow-up|1|||
19461190|NCT01791517|41717303|FG008|Phase II|Lost to Follow-up|1|||
19461191|NCT01791517|41717304|FG009|Phase II|Lost to Follow-up|1|||
19461192|NCT01791517|41717305|FG010|Phase II|Lost to Follow-up|0|||
19461193|NCT01791517|41717306|FG011|Phase II|Lost to Follow-up|0|||
19461194|NCT01791517|41717295|FG000|Phase II|Withdrawal by Subject|1|||
19461195|NCT01791517|41717296|FG001|Phase II|Withdrawal by Subject|0|||
19461196|NCT01791517|41717297|FG002|Phase II|Withdrawal by Subject|0|||
19461197|NCT01791517|41717298|FG003|Phase II|Withdrawal by Subject|0|||
19461198|NCT01791517|41717299|FG004|Phase II|Withdrawal by Subject|0|||
19461199|NCT01791517|41717300|FG005|Phase II|Withdrawal by Subject|2|||
19461200|NCT01791517|41717301|FG006|Phase II|Withdrawal by Subject|0|||
19461201|NCT01791517|41717302|FG007|Phase II|Withdrawal by Subject|1|||
19461202|NCT01791517|41717303|FG008|Phase II|Withdrawal by Subject|0|||
19461203|NCT01791517|41717304|FG009|Phase II|Withdrawal by Subject|0|||
19461204|NCT01791517|41717305|FG010|Phase II|Withdrawal by Subject|1|||
19461205|NCT01791517|41717306|FG011|Phase II|Withdrawal by Subject|0|||
19461206|NCT01791517|41717295|FG000|Phase II|Lack of Efficacy|0|||
19461207|NCT01791517|41717296|FG001|Phase II|Lack of Efficacy|0|||
19461208|NCT01791517|41717297|FG002|Phase II|Lack of Efficacy|0|||
19461209|NCT01791517|41717298|FG003|Phase II|Lack of Efficacy|0|||
19461210|NCT01791517|41717299|FG004|Phase II|Lack of Efficacy|1|||
19461211|NCT01791517|41717300|FG005|Phase II|Lack of Efficacy|0|||
19461212|NCT01791517|41717301|FG006|Phase II|Lack of Efficacy|0|||
19461213|NCT01791517|41717302|FG007|Phase II|Lack of Efficacy|0|||
19461214|NCT01791517|41717303|FG008|Phase II|Lack of Efficacy|0|||
19461215|NCT01791517|41717304|FG009|Phase II|Lack of Efficacy|0|||
19461216|NCT01791517|41717305|FG010|Phase II|Lack of Efficacy|0|||
19461217|NCT01791517|41717306|FG011|Phase II|Lack of Efficacy|0|||
19461218|NCT01791517|41717295|FG000|Phase II|Adverse Event|0|||
19461219|NCT01791517|41717296|FG001|Phase II|Adverse Event|0|||
19461220|NCT01791517|41717297|FG002|Phase II|Adverse Event|0|||
19461221|NCT01791517|41717298|FG003|Phase II|Adverse Event|0|||
19461222|NCT01791517|41717299|FG004|Phase II|Adverse Event|0|||
19461223|NCT01791517|41717300|FG005|Phase II|Adverse Event|0|||
19461224|NCT01791517|41717301|FG006|Phase II|Adverse Event|2|||
19461225|NCT01791517|41717302|FG007|Phase II|Adverse Event|1|||
19461226|NCT01791517|41717303|FG008|Phase II|Adverse Event|0|||
19461227|NCT01791517|41717304|FG009|Phase II|Adverse Event|1|||
19461228|NCT01791517|41717305|FG010|Phase II|Adverse Event|0|||
19461229|NCT01791517|41717306|FG011|Phase II|Adverse Event|0|||
19461230|NCT01791517|41717295|FG000|Phase II|Lens Handling Difficulties|0|||
19461231|NCT01791517|41717296|FG001|Phase II|Lens Handling Difficulties|0|||
19461232|NCT01791517|41717297|FG002|Phase II|Lens Handling Difficulties|0|||
19461233|NCT01791517|41717298|FG003|Phase II|Lens Handling Difficulties|0|||
19461234|NCT01791517|41717299|FG004|Phase II|Lens Handling Difficulties|0|||
19461235|NCT01791517|41717300|FG005|Phase II|Lens Handling Difficulties|0|||
19461236|NCT01791517|41717301|FG006|Phase II|Lens Handling Difficulties|0|||
19461237|NCT01791517|41717302|FG007|Phase II|Lens Handling Difficulties|0|||
19461238|NCT01791517|41717303|FG008|Phase II|Lens Handling Difficulties|1|||
19461239|NCT01791517|41717304|FG009|Phase II|Lens Handling Difficulties|0|||
19461240|NCT01791517|41717305|FG010|Phase II|Lens Handling Difficulties|0|||
19461241|NCT01791517|41717306|FG011|Phase II|Lens Handling Difficulties|0|||
19461242|NCT01791517|41717295|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
19461243|NCT01791517|41717296|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
19461244|NCT01791517|41717297|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
19461245|NCT01791517|41717298|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
19461246|NCT01791517|41717299|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
19461247|NCT01791517|41717300|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
19461248|NCT01791517|41717301|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
19461249|NCT01791517|41717302|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
19461250|NCT01791517|41717303|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
19461251|NCT01791517|41717304|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
19461252|NCT01791517|41717305|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
19461253|NCT01791517|41717306|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
19461254|NCT01791517|41717295|FG000|Phase II|Pre-Existing Ocular Issue|0|||
19461255|NCT01791517|41717296|FG001|Phase II|Pre-Existing Ocular Issue|0|||
19461256|NCT01791517|41717297|FG002|Phase II|Pre-Existing Ocular Issue|0|||
19461257|NCT01791517|41717298|FG003|Phase II|Pre-Existing Ocular Issue|0|||
19461258|NCT01791517|41717299|FG004|Phase II|Pre-Existing Ocular Issue|0|||
19461259|NCT01791517|41717300|FG005|Phase II|Pre-Existing Ocular Issue|0|||
19461260|NCT01791517|41717301|FG006|Phase II|Pre-Existing Ocular Issue|0|||
19461261|NCT01791517|41717302|FG007|Phase II|Pre-Existing Ocular Issue|0|||
19461262|NCT01791517|41717303|FG008|Phase II|Pre-Existing Ocular Issue|0|||
19461263|NCT01791517|41717304|FG009|Phase II|Pre-Existing Ocular Issue|0|||
19461264|NCT01791517|41717305|FG010|Phase II|Pre-Existing Ocular Issue|0|||
19461265|NCT01791517|41717306|FG011|Phase II|Pre-Existing Ocular Issue|1|||
19461266|NCT01998581|41717326|FG000|Overall Study|Refused repeat treatment|20|||
19461267|NCT01998581|41717327|FG001|Overall Study|Refused repeat treatment|4|||
19461268|NCT01998581|41717326|FG000|Overall Study|Protocol Violation|1|||
19461269|NCT01998581|41717327|FG001|Overall Study|Protocol Violation|0|||
19461270|NCT01998581|41717326|FG000|Overall Study|Withdrawal by Subject|8|||
19461271|NCT01998581|41717327|FG001|Overall Study|Withdrawal by Subject|1|||
19461272|NCT01998581|41717326|FG000|Overall Study|Lost to Follow-up|12|||
19461273|NCT01998581|41717327|FG001|Overall Study|Lost to Follow-up|4|||
19461274|NCT01998581|41717326|FG000|Overall Study|Adverse Event|1|||
19461275|NCT01998581|41717327|FG001|Overall Study|Adverse Event|1|||
19461276|NCT01998581|41717326|FG000|Overall Study|Other reasons|3|||
19461277|NCT01998581|41717327|FG001|Overall Study|Other reasons|2|||
19461278|NCT01998581|41717326|FG000|Overall Study|Randomized but withdrew before treatment|1|||
19461279|NCT01998581|41717327|FG001|Overall Study|Randomized but withdrew before treatment|0|||
19461280|NCT01983293|41717336|FG000|Overall Study|Withdrawal by Subject|29|||
19461281|NCT01983293|41717337|FG001|Overall Study|Withdrawal by Subject|15|||
19461282|NCT01983293|41717336|FG000|Overall Study|Missing 12-month visit|3|||
19461283|NCT01983293|41717337|FG001|Overall Study|Missing 12-month visit|3|||
19461284|NCT01983293|41717336|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
19461285|NCT01983293|41717337|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
19461286|NCT01791205|41717345|FG000|Phase II|Lack of Efficacy|6|||
19461287|NCT01791205|41717346|FG001|Phase II|Lack of Efficacy|0|||
19461288|NCT01791205|41717345|FG000|Phase II|Adverse Event|2|||
19461289|NCT01791205|41717346|FG001|Phase II|Adverse Event|0|||
19461290|NCT01791205|41717345|FG000|Phase II|Safety|1|||
19461291|NCT01791205|41717346|FG001|Phase II|Safety|0|||
19461292|NCT01791205|41717345|FG000|Phase II|Lost to Follow-up|1|||
19461293|NCT01791205|41717346|FG001|Phase II|Lost to Follow-up|0|||
19461294|NCT01791205|41717345|FG000|Phase II|Remission of disease|1|||
19461295|NCT01791205|41717346|FG001|Phase II|Remission of disease|0|||
19461296|NCT01791205|41717345|FG000|Phase II|Physician's decision|1|||
19461297|NCT01791205|41717346|FG001|Phase II|Physician's decision|0|||
19461298|NCT01272232|41717355|FG000|Weeks 0-56|Adverse Event|39|||
19461299|NCT01272232|41717356|FG001|Weeks 0-56|Adverse Event|18|||
19461300|NCT01272232|41717357|FG002|Weeks 0-56|Adverse Event|7|||
19461301|NCT01272232|41717355|FG000|Weeks 0-56|Lack of Efficacy|0|||
19461302|NCT01272232|41717356|FG001|Weeks 0-56|Lack of Efficacy|0|||
19461303|NCT01272232|41717357|FG002|Weeks 0-56|Lack of Efficacy|3|||
19461304|NCT01272232|41717355|FG000|Weeks 0-56|Protocol Violation|12|||
19461305|NCT01272232|41717356|FG001|Weeks 0-56|Protocol Violation|8|||
19461306|NCT01272232|41717357|FG002|Weeks 0-56|Protocol Violation|13|||
19461307|NCT01272232|41717355|FG000|Weeks 0-56|Withdrawal criteria|32|||
19461308|NCT01272232|41717356|FG001|Weeks 0-56|Withdrawal criteria|14|||
19461309|NCT01272232|41717357|FG002|Weeks 0-56|Withdrawal criteria|37|||
19461310|NCT01272232|41717355|FG000|Weeks 0-56|Unclassified|16|||
19461311|NCT01272232|41717356|FG001|Weeks 0-56|Unclassified|7|||
19461312|NCT01272232|41717357|FG002|Weeks 0-56|Unclassified|12|||
19461313|NCT01272232|41717355|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
19461314|NCT01272232|41717356|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
19461315|NCT01272232|41717357|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
19461316|NCT01272232|41717355|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
19461317|NCT01272232|41717356|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
19461318|NCT01272232|41717357|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
19461319|NCT01272232|41717355|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
19461320|NCT01272232|41717356|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
19461321|NCT01272232|41717357|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
19461322|NCT01272232|41717355|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
19461323|NCT01272232|41717356|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
19461324|NCT01272232|41717357|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
19461325|NCT01272232|41717355|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
19461326|NCT01272232|41717356|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
19461327|NCT01272232|41717357|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
19461328|NCT01791127|41717365|FG000|Overall Study|Death|356|||
19461329|NCT01791127|41717365|FG000|Overall Study|Patient has withdrawn from study|293|||
19461330|NCT01791127|41717365|FG000|Overall Study|Lost to Follow-up|42|||
19461331|NCT01791127|41717365|FG000|Overall Study|All Siello leads are explanted|31|||
19461332|NCT01791127|41717365|FG000|Overall Study|Completion of 30 day safety registry|1|||
19461333|NCT01791127|41717365|FG000|Overall Study|Study terminated for EP Passion|749|||
19461334|NCT01997333|41717396|FG000|Randomization and Treatment|Disease Progression|70|||
19461335|NCT01997333|41717397|FG001|Randomization and Treatment|Disease Progression|159|||
19461336|NCT01997333|41717396|FG000|Randomization and Treatment|Adverse Event|10|||
19461337|NCT01997333|41717397|FG001|Randomization and Treatment|Adverse Event|32|||
19461338|NCT01997333|41717396|FG000|Randomization and Treatment|Physician Decision|0|||
19461339|NCT01997333|41717397|FG001|Randomization and Treatment|Physician Decision|4|||
19461340|NCT01997333|41717396|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
19461341|NCT01997333|41717397|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
19461342|NCT01997333|41717396|FG000|Randomization and Treatment|Did not receive treatment|17|||
19461343|NCT01997333|41717397|FG001|Randomization and Treatment|Did not receive treatment|5|||
19461344|NCT01997333|41717396|FG000|Survival Follow up|Withdrawal by Subject|15|||
19461345|NCT01997333|41717397|FG001|Survival Follow up|Withdrawal by Subject|6|||
19461346|NCT01997333|41717396|FG000|Survival Follow up|Lost to Follow-up|0|||
19461347|NCT01997333|41717397|FG001|Survival Follow up|Lost to Follow-up|6|||
19461348|NCT01997333|41717396|FG000|Survival Follow up|Various|1|||
19461349|NCT01997333|41717397|FG001|Survival Follow up|Various|2|||
19461350|NCT01982435|41717461|FG000|Overall Study|Adverse Event|1|||
19461351|NCT01982435|41717462|FG001|Overall Study|Adverse Event|0|||
19461352|NCT01620983|41717502|FG000|Overall Study|Lost to Follow-up|8|||
19461353|NCT01620983|41717503|FG001|Overall Study|Lost to Follow-up|4|||
19461354|NCT01620983|41717504|FG002|Overall Study|Lost to Follow-up|9|||
19461355|NCT01620983|41717502|FG000|Overall Study|Withdrawal by Subject|6|||
19461356|NCT01620983|41717503|FG001|Overall Study|Withdrawal by Subject|8|||
19461357|NCT01620983|41717504|FG002|Overall Study|Withdrawal by Subject|1|||
19461358|NCT01620983|41717502|FG000|Overall Study|Death|2|||
19461359|NCT01620983|41717503|FG001|Overall Study|Death|0|||
19461360|NCT01620983|41717504|FG002|Overall Study|Death|0|||
19461361|NCT01620983|41717502|FG000|Overall Study|Physician Decision|3|||
19461362|NCT01620983|41717503|FG001|Overall Study|Physician Decision|10|||
19461363|NCT01620983|41717504|FG002|Overall Study|Physician Decision|5|||
19461364|NCT01996709|41717514|FG000|Overall Study|Withdrawal by Subject|1|||
19461365|NCT01996709|41717515|FG001|Overall Study|Withdrawal by Subject|0|||
19461366|NCT01996709|41717514|FG000|Overall Study|Lost to Follow-up|3|||
19461367|NCT01996709|41717515|FG001|Overall Study|Lost to Follow-up|0|||
19461368|NCT01996709|41717514|FG000|Overall Study|Subject Non-Compliant|1|||
19461369|NCT01996709|41717515|FG001|Overall Study|Subject Non-Compliant|0|||
19461370|NCT01996709|41717514|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
19461371|NCT01996709|41717515|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
19461372|NCT01996319|41717540|FG000|Overall Study|Protocol Violation|1|||
19461373|NCT01996319|41717541|FG001|Overall Study|Protocol Violation|0|||
19461374|NCT01996319|41717540|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
19461375|NCT01996319|41717541|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
19461376|NCT01996319|41717540|FG000|Overall Study|Adverse Event|2|||
19461377|NCT01996319|41717541|FG001|Overall Study|Adverse Event|2|||
19461378|NCT01279486|41717547|FG000|Overall Study|Lost to Follow-up|1|||
19461379|NCT01279954|41717553|FG000|Overall Study|Lack of Efficacy|3|||
19461380|NCT01279954|41717554|FG001|Overall Study|Lack of Efficacy|4|||
19461381|NCT01278862|41717565|FG000|Overall Study|Lost to Follow-up|1|||
19461382|NCT01278862|41717566|FG001|Overall Study|Lost to Follow-up|1|||
19461383|NCT01278394|41717581|FG000|Overall Study|Lost to Follow-up|1|||
19461384|NCT01981187|41717585|FG000|Overall Study|Participant/guardian decision|2|||
19461385|NCT01981187|41717585|FG000|Overall Study|Physician Decision|1|||
19461386|NCT01981187|41717585|FG000|Overall Study|Disease progression|2|||
19461387|NCT01981187|41717585|FG000|Overall Study|Adverse Event|7|||
19461388|NCT01278160|41717591|FG000|Overall Study|Adverse Event|1|||
19461389|NCT01278160|41717592|FG001|Overall Study|Adverse Event|1|||
19461390|NCT01278160|41717591|FG000|Overall Study|Lost to Follow-up|0|||
19461391|NCT01278160|41717592|FG001|Overall Study|Lost to Follow-up|1|||
19461392|NCT01278160|41717591|FG000|Overall Study|Withdrawal by Subject|3|||
19461393|NCT01278160|41717592|FG001|Overall Study|Withdrawal by Subject|2|||
19461394|NCT01278160|41717591|FG000|Overall Study|Unclassified|1|||
19461395|NCT01278160|41717592|FG001|Overall Study|Unclassified|2|||
19461396|NCT01996241|41717600|FG000|Overall Study|Lost to Follow-up|252|||
19461397|NCT01996241|41717601|FG001|Overall Study|Lost to Follow-up|235|||
19461398|NCT02091869|41717611|FG000|Overall Study|Withdrawal by Subject|0|||
19461399|NCT02091869|41717612|FG001|Overall Study|Withdrawal by Subject|3|||
19461400|NCT01981109|41717627|FG000|Overall Study|Death|36|||
19461401|NCT01981109|41717627|FG000|Overall Study|Withdrawal by Subject|40|||
19461402|NCT01981109|41717627|FG000|Overall Study|Lost to Follow-up|9|||
19461403|NCT01981109|41717627|FG000|Overall Study|No Discontinuation Documentation|37|||
19461404|NCT01981109|41717627|FG000|Overall Study|Study Termination|100|||
19461405|NCT01981109|41717627|FG000|Overall Study|No data available|2|||
19461406|NCT00248794|41717635|FG000|Overall Study|Lost to Follow-up|6|||
19461407|NCT00248794|41717636|FG001|Overall Study|Lost to Follow-up|8|||
19461408|NCT00248794|41717637|FG002|Overall Study|Lost to Follow-up|3|||
19461409|NCT01995539|41717651|FG000|Overall Study|Screening Failure|1|||
19461410|NCT01995539|41717651|FG000|Overall Study|Withdrawal by Investigator|15|||
19461411|NCT01995539|41717651|FG000|Overall Study|Withdrawal by Subject|11|||
19461412|NCT01995539|41717651|FG000|Overall Study|Lost to Follow-up|5|||
19461413|NCT01995539|41717651|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
19461414|NCT01835587|41717659|FG000|Overall Study|Disease Recurrence or Relapse|0|||
19461415|NCT01835587|41717660|FG001|Overall Study|Disease Recurrence or Relapse|3|||
19461416|NCT01835587|41717661|FG002|Overall Study|Disease Recurrence or Relapse|0|||
19461417|NCT01835587|41717662|FG003|Overall Study|Disease Recurrence or Relapse|3|||
19461418|NCT01835587|41717659|FG000|Overall Study|Withdrawal by Subject|2|||
19461419|NCT01835587|41717660|FG001|Overall Study|Withdrawal by Subject|0|||
19461420|NCT01835587|41717661|FG002|Overall Study|Withdrawal by Subject|0|||
19461421|NCT01835587|41717662|FG003|Overall Study|Withdrawal by Subject|3|||
19461422|NCT01835587|41717659|FG000|Overall Study|Adverse Event|0|||
19461423|NCT01835587|41717660|FG001|Overall Study|Adverse Event|0|||
19461424|NCT01835587|41717661|FG002|Overall Study|Adverse Event|2|||
19461425|NCT01835587|41717662|FG003|Overall Study|Adverse Event|2|||
19461426|NCT01835587|41717659|FG000|Overall Study|Death|0|||
19461427|NCT01835587|41717660|FG001|Overall Study|Death|0|||
19461428|NCT01835587|41717661|FG002|Overall Study|Death|0|||
19461429|NCT01835587|41717662|FG003|Overall Study|Death|1|||
19461430|NCT01835587|41717659|FG000|Overall Study|Miscellaneous|0|||
19461431|NCT01835587|41717660|FG001|Overall Study|Miscellaneous|1|||
19461432|NCT01835587|41717661|FG002|Overall Study|Miscellaneous|0|||
19461433|NCT01835587|41717662|FG003|Overall Study|Miscellaneous|0|||
19461434|NCT01736917|41717679|FG000|Overall Study|Adverse Event|1|||
19461435|NCT01736917|41717679|FG000|Overall Study|Protocol Violation|10|||
19461436|NCT01277302|41717688|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
19461437|NCT01277302|41717689|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
19461438|NCT01277302|41717690|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
19461439|NCT01277302|41717688|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
19461440|NCT01277302|41717689|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
19461441|NCT01277302|41717690|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
19461442|NCT01277302|41717688|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
19461443|NCT01277302|41717689|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
19461444|NCT01277302|41717690|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
19461445|NCT01277302|41717688|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
19461446|NCT01277302|41717689|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
19461447|NCT01277302|41717690|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
19461448|NCT01277302|41717688|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
19461449|NCT01277302|41717689|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
19461450|NCT01277302|41717690|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
19461451|NCT01277302|41717688|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
19461452|NCT01277302|41717689|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
19461453|NCT01277302|41717690|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
19461454|NCT01277302|41717688|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
19461455|NCT01277302|41717689|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
19461456|NCT01277302|41717690|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
19461457|NCT01277302|41717688|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
19461458|NCT01277302|41717689|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
19461459|NCT01277302|41717690|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
19461460|NCT01277302|41717688|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
19461461|NCT01277302|41717689|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
19461462|NCT01277302|41717690|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
19461463|NCT01980875|41717701|FG000|Overall Study|Withdrew Consent|1|||
19461464|NCT01980875|41717702|FG001|Overall Study|Withdrew Consent|1|||
19461465|NCT01980875|41717703|FG002|Overall Study|Withdrew Consent|1|||
19461466|NCT01980875|41717701|FG000|Overall Study|Study Terminated by Sponsor|7|||
19461467|NCT01980875|41717702|FG001|Overall Study|Study Terminated by Sponsor|24|||
19461468|NCT01980875|41717703|FG002|Overall Study|Study Terminated by Sponsor|22|||
19461469|NCT01980875|41717701|FG000|Overall Study|Lost to Follow-up|0|||
19461470|NCT01980875|41717702|FG001|Overall Study|Lost to Follow-up|0|||
19461471|NCT01980875|41717703|FG002|Overall Study|Lost to Follow-up|1|||
19461472|NCT01995461|41717711|FG000|Overall Study|Death|1|||
19461473|NCT01995461|41717711|FG000|Overall Study|Lost to Follow-up|2|||
19461474|NCT01995461|41717711|FG000|Overall Study|Withdrawal by Subject|2|||
19461475|NCT01980095|41717717|FG000|Overall Study|Lost to Follow-up|6|||
19461476|NCT01980095|41717718|FG001|Overall Study|Lost to Follow-up|7|||
19461477|NCT01980095|41717717|FG000|Overall Study|Withdrawal by Subject|2|||
19461478|NCT01980095|41717718|FG001|Overall Study|Withdrawal by Subject|3|||
19461479|NCT01980095|41717717|FG000|Overall Study|Poor compliance|5|||
19461480|NCT01980095|41717718|FG001|Overall Study|Poor compliance|0|||
19461481|NCT01980095|41717717|FG000|Overall Study|Safety issue|0|||
19461482|NCT01980095|41717718|FG001|Overall Study|Safety issue|1|||
19461483|NCT01980095|41717717|FG000|Overall Study|Study drug discontinued|1|||
19461484|NCT01980095|41717718|FG001|Overall Study|Study drug discontinued|0|||
19461485|NCT01980095|41717717|FG000|Overall Study|Randomized by mistake|1|||
19461486|NCT01980095|41717718|FG001|Overall Study|Randomized by mistake|0|||
19461487|NCT01980017|41717728|FG000|Overall Study|Lost to Follow-up|30|||
19461488|NCT01980017|41717729|FG001|Overall Study|Lost to Follow-up|21|||
19461489|NCT01980017|41717728|FG000|Overall Study|Death|0|||
19461490|NCT01980017|41717729|FG001|Overall Study|Death|1|||
19461491|NCT01978145|41717738|FG000|Treatment Period 1|Adverse Event|1|||
19461492|NCT01978145|41717739|FG001|Treatment Period 1|Adverse Event|9|||
19461493|NCT01978145|41717738|FG000|Treatment Period 1|Physician Decision|1|||
19461494|NCT01978145|41717739|FG001|Treatment Period 1|Physician Decision|0|||
19461495|NCT01978145|41717738|FG000|Treatment Period 1|Withdrawal by Subject|5|||
19461496|NCT01978145|41717739|FG001|Treatment Period 1|Withdrawal by Subject|4|||
19461497|NCT01978145|41717738|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
19461498|NCT01978145|41717739|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
19461499|NCT01978145|41717738|FG000|Washout Period 1|Adverse Event|0|||
19461500|NCT01978145|41717739|FG001|Washout Period 1|Adverse Event|1|||
19461501|NCT01978145|41717738|FG000|Washout Period 1|Withdrawal by Subject|1|||
19461502|NCT01978145|41717739|FG001|Washout Period 1|Withdrawal by Subject|1|||
19461503|NCT01978145|41717738|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
19461504|NCT01978145|41717739|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
19461505|NCT01978145|41717738|FG000|Treatment Period 2|Adverse Event|3|||
19461506|NCT01978145|41717739|FG001|Treatment Period 2|Adverse Event|3|||
19461507|NCT01978145|41717738|FG000|Treatment Period 2|Protocol Violation|0|||
19461508|NCT01978145|41717739|FG001|Treatment Period 2|Protocol Violation|1|||
19461509|NCT01978145|41717738|FG000|Treatment Period 2|Lost to Follow-up|1|||
19461510|NCT01978145|41717739|FG001|Treatment Period 2|Lost to Follow-up|1|||
19461511|NCT01978145|41717738|FG000|Treatment Period 2|Withdrawal by Subject|7|||
19461512|NCT01978145|41717739|FG001|Treatment Period 2|Withdrawal by Subject|4|||
19461513|NCT01978145|41717738|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
19461514|NCT01978145|41717739|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
19461515|NCT01967537|41717745|FG000|Overall Study|Withdrawal by Subject|52|||
19461516|NCT01967537|41717745|FG000|Overall Study|Refuse treatment|2|||
19461517|NCT01967537|41717745|FG000|Overall Study|Lost to Follow-up|6|||
19461518|NCT01967225|41717753|FG000|Overall Study|Adverse Event|3|||
19461519|NCT01967225|41717754|FG001|Overall Study|Adverse Event|1|||
19461520|NCT01967225|41717753|FG000|Overall Study|Withdrawal by Subject|2|||
19461521|NCT01967225|41717754|FG001|Overall Study|Withdrawal by Subject|1|||
19461522|NCT01967225|41717753|FG000|Overall Study|Lack of Efficacy|1|||
19461523|NCT01967225|41717754|FG001|Overall Study|Lack of Efficacy|1|||
19461524|NCT01967225|41717753|FG000|Overall Study|Switching to other therapy|2|||
19461525|NCT01967225|41717754|FG001|Overall Study|Switching to other therapy|0|||
19461526|NCT01967225|41717753|FG000|Overall Study|Protocol driven decision point|1|||
19461527|NCT01967225|41717754|FG001|Overall Study|Protocol driven decision point|0|||
19461528|NCT01967225|41717753|FG000|Overall Study|Logistical difficulties|1|||
19461529|NCT01967225|41717754|FG001|Overall Study|Logistical difficulties|0|||
19461530|NCT01967225|41717753|FG000|Overall Study|Protocol Violation|2|||
19461531|NCT01967225|41717754|FG001|Overall Study|Protocol Violation|0|||
19461532|NCT01967147|41717764|FG000|Overall Study|Adverse Event|5|||
19461533|NCT01967147|41717765|FG001|Overall Study|Adverse Event|2|||
19461534|NCT01967147|41717764|FG000|Overall Study|Lack of Efficacy|1|||
19461535|NCT01967147|41717765|FG001|Overall Study|Lack of Efficacy|4|||
19461536|NCT01967147|41717764|FG000|Overall Study|Lost to Follow-up|1|||
19461537|NCT01967147|41717765|FG001|Overall Study|Lost to Follow-up|2|||
19461538|NCT01967147|41717764|FG000|Overall Study|Withdrawal by Subject|2|||
19461539|NCT01967147|41717765|FG001|Overall Study|Withdrawal by Subject|4|||
19461540|NCT01967147|41717764|FG000|Overall Study|Non-compliance with Study Drug|0|||
19461541|NCT01967147|41717765|FG001|Overall Study|Non-compliance with Study Drug|3|||
19461542|NCT01967147|41717764|FG000|Overall Study|Other|4|||
19461543|NCT01967147|41717765|FG001|Overall Study|Other|5|||
19461544|NCT01967069|41717774|FG000|Overall Study|Adverse Event|2|||
19461545|NCT01967069|41717775|FG001|Overall Study|Adverse Event|2|||
19461546|NCT01967069|41717774|FG000|Overall Study|Lost to Follow-up|5|||
19461547|NCT01967069|41717775|FG001|Overall Study|Lost to Follow-up|2|||
19461548|NCT01967069|41717774|FG000|Overall Study|Withdrawal by Subject|1|||
19461549|NCT01967069|41717775|FG001|Overall Study|Withdrawal by Subject|3|||
19461550|NCT01967069|41717774|FG000|Overall Study|Lack of Efficacy|0|||
19461551|NCT01967069|41717775|FG001|Overall Study|Lack of Efficacy|1|||
19461552|NCT01790503|41717792|FG000|Overall Study|Adverse Event|1|||
19461553|NCT01790503|41717793|FG001|Overall Study|Adverse Event|0|||
19461554|NCT01790503|41717794|FG002|Overall Study|Adverse Event|0|||
19461555|NCT01790503|41717795|FG003|Overall Study|Adverse Event|0|||
19461556|NCT01790503|41717796|FG004|Overall Study|Adverse Event|0|||
19461557|NCT01790503|41717797|FG005|Overall Study|Adverse Event|2|||
19461558|NCT01790503|41717798|FG006|Overall Study|Adverse Event|0|||
19461559|NCT01790503|41717799|FG007|Overall Study|Adverse Event|0|||
19461560|NCT01790503|41717800|FG008|Overall Study|Adverse Event|2|||
19461561|NCT01790503|41717801|FG009|Overall Study|Adverse Event|4|||
19461562|NCT01790503|41717802|FG010|Overall Study|Adverse Event|7|||
19461563|NCT01790503|41717792|FG000|Overall Study|Withdrawal by Subject|0|||
19461564|NCT01790503|41717793|FG001|Overall Study|Withdrawal by Subject|0|||
19461565|NCT01790503|41717794|FG002|Overall Study|Withdrawal by Subject|1|||
19461566|NCT01790503|41717795|FG003|Overall Study|Withdrawal by Subject|1|||
19461567|NCT01790503|41717796|FG004|Overall Study|Withdrawal by Subject|1|||
19461568|NCT01790503|41717797|FG005|Overall Study|Withdrawal by Subject|2|||
19461569|NCT01790503|41717798|FG006|Overall Study|Withdrawal by Subject|1|||
19461570|NCT01790503|41717799|FG007|Overall Study|Withdrawal by Subject|0|||
19461571|NCT01790503|41717800|FG008|Overall Study|Withdrawal by Subject|0|||
19461572|NCT01790503|41717801|FG009|Overall Study|Withdrawal by Subject|0|||
19461573|NCT01790503|41717802|FG010|Overall Study|Withdrawal by Subject|1|||
19461574|NCT01790503|41717792|FG000|Overall Study|Disease progression|2|||
19461575|NCT01790503|41717793|FG001|Overall Study|Disease progression|1|||
19461576|NCT01790503|41717794|FG002|Overall Study|Disease progression|0|||
19461577|NCT01790503|41717795|FG003|Overall Study|Disease progression|1|||
19461578|NCT01790503|41717796|FG004|Overall Study|Disease progression|2|||
19461579|NCT01790503|41717797|FG005|Overall Study|Disease progression|1|||
19461580|NCT01790503|41717798|FG006|Overall Study|Disease progression|0|||
19461581|NCT01790503|41717799|FG007|Overall Study|Disease progression|1|||
19461582|NCT01790503|41717800|FG008|Overall Study|Disease progression|0|||
19461583|NCT01790503|41717801|FG009|Overall Study|Disease progression|17|||
19461584|NCT01790503|41717802|FG010|Overall Study|Disease progression|7|||
19461585|NCT01790503|41717792|FG000|Overall Study|Protocol Violation|0|||
19461586|NCT01790503|41717793|FG001|Overall Study|Protocol Violation|0|||
19461587|NCT01790503|41717794|FG002|Overall Study|Protocol Violation|0|||
19461588|NCT01790503|41717795|FG003|Overall Study|Protocol Violation|0|||
19461589|NCT01790503|41717796|FG004|Overall Study|Protocol Violation|0|||
19461590|NCT01790503|41717797|FG005|Overall Study|Protocol Violation|0|||
19461591|NCT01790503|41717798|FG006|Overall Study|Protocol Violation|0|||
19461592|NCT01790503|41717799|FG007|Overall Study|Protocol Violation|0|||
19461593|NCT01790503|41717800|FG008|Overall Study|Protocol Violation|0|||
19461594|NCT01790503|41717801|FG009|Overall Study|Protocol Violation|1|||
19461595|NCT01790503|41717802|FG010|Overall Study|Protocol Violation|0|||
19461596|NCT01790503|41717792|FG000|Overall Study|Physician Decision|0|||
19461597|NCT01790503|41717793|FG001|Overall Study|Physician Decision|0|||
19461598|NCT01790503|41717794|FG002|Overall Study|Physician Decision|0|||
19461599|NCT01790503|41717795|FG003|Overall Study|Physician Decision|0|||
19461600|NCT01790503|41717796|FG004|Overall Study|Physician Decision|0|||
19461601|NCT01790503|41717797|FG005|Overall Study|Physician Decision|0|||
19461602|NCT01790503|41717798|FG006|Overall Study|Physician Decision|0|||
19461603|NCT01790503|41717799|FG007|Overall Study|Physician Decision|0|||
19461604|NCT01790503|41717800|FG008|Overall Study|Physician Decision|0|||
19461605|NCT01790503|41717801|FG009|Overall Study|Physician Decision|1|||
19461606|NCT01790503|41717802|FG010|Overall Study|Physician Decision|1|||
19461607|NCT01790503|41717792|FG000|Overall Study|Death|0|||
19461608|NCT01790503|41717793|FG001|Overall Study|Death|0|||
19461609|NCT01790503|41717794|FG002|Overall Study|Death|0|||
19461610|NCT01790503|41717795|FG003|Overall Study|Death|0|||
19461611|NCT01790503|41717796|FG004|Overall Study|Death|0|||
19461612|NCT01790503|41717797|FG005|Overall Study|Death|0|||
19461613|NCT01790503|41717798|FG006|Overall Study|Death|0|||
19461614|NCT01790503|41717799|FG007|Overall Study|Death|0|||
19461615|NCT01790503|41717800|FG008|Overall Study|Death|0|||
19461616|NCT01790503|41717801|FG009|Overall Study|Death|1|||
19461617|NCT01790503|41717802|FG010|Overall Study|Death|0|||
19461618|NCT01790503|41717792|FG000|Overall Study|Non Compliance|0|||
19461619|NCT01790503|41717793|FG001|Overall Study|Non Compliance|0|||
19461620|NCT01790503|41717794|FG002|Overall Study|Non Compliance|0|||
19461621|NCT01790503|41717795|FG003|Overall Study|Non Compliance|0|||
19461622|NCT01790503|41717796|FG004|Overall Study|Non Compliance|1|||
19461623|NCT01790503|41717797|FG005|Overall Study|Non Compliance|0|||
19461624|NCT01790503|41717798|FG006|Overall Study|Non Compliance|0|||
19461625|NCT01790503|41717799|FG007|Overall Study|Non Compliance|0|||
19461626|NCT01790503|41717800|FG008|Overall Study|Non Compliance|0|||
19461627|NCT01790503|41717801|FG009|Overall Study|Non Compliance|0|||
19461628|NCT01790503|41717802|FG010|Overall Study|Non Compliance|0|||
19461629|NCT01790503|41717792|FG000|Overall Study|Other|0|||
19461630|NCT01790503|41717793|FG001|Overall Study|Other|0|||
19461631|NCT01790503|41717794|FG002|Overall Study|Other|0|||
19461632|NCT01790503|41717795|FG003|Overall Study|Other|0|||
19461633|NCT01790503|41717796|FG004|Overall Study|Other|1|||
19461634|NCT01790503|41717797|FG005|Overall Study|Other|0|||
19461635|NCT01790503|41717798|FG006|Overall Study|Other|0|||
19461636|NCT01790503|41717799|FG007|Overall Study|Other|0|||
19461637|NCT01790503|41717800|FG008|Overall Study|Other|1|||
19461638|NCT01790503|41717801|FG009|Overall Study|Other|2|||
19461639|NCT01790503|41717802|FG010|Overall Study|Other|0|||
19461640|NCT01790113|41717841|FG000|Overall Study|Adverse Event|2|||
19461641|NCT01790113|41717842|FG001|Overall Study|Adverse Event|7|||
19461642|NCT01790113|41717841|FG000|Overall Study|Study ended due to FDA clearance|1|||
19461643|NCT01790113|41717842|FG001|Overall Study|Study ended due to FDA clearance|68|||
19461644|NCT01789567|41717848|FG000|Overall Study|Death|6|||
19461645|NCT01765543|41717852|FG000|Overall Study|Death|1|||
19461646|NCT01765543|41717852|FG000|Overall Study|Withdrawal by Subject|2|||
19461647|NCT01765153|41717862|FG000|Training Phase 1|Format of intervention differed|1|||
19461648|NCT01765153|41717863|FG001|Training Phase 1|Format of intervention differed|0|||
19461649|NCT01765153|41717862|FG000|Training Phase 1|Poor participation in intervention|0|||
19461650|NCT01765153|41717863|FG001|Training Phase 1|Poor participation in intervention|1|||
19461651|NCT01765153|41717862|FG000|Rest Phase 1|Withdrawal by Subject|0|||
19461652|NCT01765153|41717863|FG001|Rest Phase 1|Withdrawal by Subject|1|||
19461653|NCT01765153|41717862|FG000|Training Phase 2|Withdrawal by Subject|0|||
19461654|NCT01765153|41717863|FG001|Training Phase 2|Withdrawal by Subject|1|||
19461655|NCT01765153|41717862|FG000|Rest Phase 2|Lost to Follow-up|2|||
19461656|NCT01765153|41717863|FG001|Rest Phase 2|Lost to Follow-up|1|||
19461657|NCT00248170|41717875|FG000|Overall Study|Withdrawal by Subject|71|||
19461658|NCT00248170|41717876|FG001|Overall Study|Withdrawal by Subject|79|||
19461659|NCT00248170|41717875|FG000|Overall Study|Protocol Violation|35|||
19461660|NCT00248170|41717876|FG001|Overall Study|Protocol Violation|30|||
19461661|NCT00248170|41717875|FG000|Overall Study|Lost to Follow-up|28|||
19461662|NCT00248170|41717876|FG001|Overall Study|Lost to Follow-up|35|||
19461663|NCT00248170|41717875|FG000|Overall Study|Disease progression|196|||
19461664|NCT00248170|41717876|FG001|Overall Study|Disease progression|216|||
19461665|NCT00248170|41717875|FG000|Overall Study|Death|28|||
19461666|NCT00248170|41717876|FG001|Overall Study|Death|47|||
19461667|NCT00248170|41717875|FG000|Overall Study|Adverse Event|311|||
19461668|NCT00248170|41717876|FG001|Overall Study|Adverse Event|296|||
19461669|NCT00248170|41717875|FG000|Overall Study|Administrative problems|22|||
19461670|NCT00248170|41717876|FG001|Overall Study|Administrative problems|25|||
19461671|NCT00248170|41717875|FG000|Overall Study|Abnormal test procedure(s) result|49|||
19461672|NCT00248170|41717876|FG001|Overall Study|Abnormal test procedure(s) result|61|||
19461673|NCT00248170|41717875|FG000|Overall Study|Abnormal laboratory values|4|||
19461674|NCT00248170|41717876|FG001|Overall Study|Abnormal laboratory values|0|||
19461675|NCT00248170|41717875|FG000|Overall Study|Protocol deviation|17|||
19461676|NCT00248170|41717876|FG001|Overall Study|Protocol deviation|19|||
19461677|NCT01764997|41717887|FG000|Run-in Period|Adverse Event|15|||
19461678|NCT01764997|41717888|FG001|Run-in Period|Adverse Event|0|||
19461679|NCT01764997|41717889|FG002|Run-in Period|Adverse Event|0|||
19461680|NCT01764997|41717890|FG003|Run-in Period|Adverse Event|0|||
19461681|NCT01764997|41717891|FG004|Run-in Period|Adverse Event|0|||
19461682|NCT01764997|41717887|FG000|Run-in Period|Lack of Efficacy|5|||
19461683|NCT01764997|41717888|FG001|Run-in Period|Lack of Efficacy|0|||
19461684|NCT01764997|41717889|FG002|Run-in Period|Lack of Efficacy|0|||
19461685|NCT01764997|41717890|FG003|Run-in Period|Lack of Efficacy|0|||
19461686|NCT01764997|41717891|FG004|Run-in Period|Lack of Efficacy|0|||
19461687|NCT01764997|41717887|FG000|Run-in Period|Poor compliance to protocol|1|||
19461688|NCT01764997|41717888|FG001|Run-in Period|Poor compliance to protocol|0|||
19461689|NCT01764997|41717889|FG002|Run-in Period|Poor compliance to protocol|0|||
19461690|NCT01764997|41717890|FG003|Run-in Period|Poor compliance to protocol|0|||
19461691|NCT01764997|41717891|FG004|Run-in Period|Poor compliance to protocol|0|||
19461692|NCT01764997|41717887|FG000|Run-in Period|Other than specified above|17|||
19461693|NCT01764997|41717888|FG001|Run-in Period|Other than specified above|0|||
19461694|NCT01764997|41717889|FG002|Run-in Period|Other than specified above|0|||
19461695|NCT01764997|41717890|FG003|Run-in Period|Other than specified above|0|||
19461696|NCT01764997|41717891|FG004|Run-in Period|Other than specified above|0|||
19461697|NCT01764997|41717887|FG000|Study Drug Treatment Period|Adverse Event|0|||
19461698|NCT01764997|41717888|FG001|Study Drug Treatment Period|Adverse Event|1|||
19461699|NCT01764997|41717889|FG002|Study Drug Treatment Period|Adverse Event|0|||
19461700|NCT01764997|41717890|FG003|Study Drug Treatment Period|Adverse Event|0|||
19461701|NCT01764997|41717891|FG004|Study Drug Treatment Period|Adverse Event|24|||
19461702|NCT01764997|41717887|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
19461703|NCT01764997|41717888|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
19461704|NCT01764997|41717889|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
19461705|NCT01764997|41717890|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
19461706|NCT01764997|41717891|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
19461707|NCT01764997|41717887|FG000|Study Drug Treatment Period|Other than specified above|0|||
19461708|NCT01764997|41717888|FG001|Study Drug Treatment Period|Other than specified above|0|||
19461709|NCT01764997|41717889|FG002|Study Drug Treatment Period|Other than specified above|0|||
19461710|NCT01764997|41717890|FG003|Study Drug Treatment Period|Other than specified above|0|||
19461711|NCT01764997|41717891|FG004|Study Drug Treatment Period|Other than specified above|10|||
19461712|NCT01276756|41717903|FG000|Overall Study|Lost to Follow-up|2|||
19461713|NCT01276756|41717904|FG001|Overall Study|Lost to Follow-up|0|||
19461714|NCT01276756|41717903|FG000|Overall Study|Adverse Event|3|||
19461715|NCT01276756|41717904|FG001|Overall Study|Adverse Event|2|||
19461716|NCT00246376|41717915|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
19461717|NCT00246376|41717916|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
19461718|NCT00246376|41717917|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
19461719|NCT00246376|41717918|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
19461720|NCT00246376|41717919|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
19461721|NCT00246376|41717915|FG000|Overall Study|Adverse Event|2|||
19461722|NCT00246376|41717916|FG001|Overall Study|Adverse Event|3|||
19461723|NCT00246376|41717917|FG002|Overall Study|Adverse Event|1|||
19461724|NCT00246376|41717918|FG003|Overall Study|Adverse Event|3|||
19461725|NCT00246376|41717919|FG004|Overall Study|Adverse Event|1|||
19461726|NCT00246376|41717915|FG000|Overall Study|Lost to Follow-up|2|||
19461727|NCT00246376|41717916|FG001|Overall Study|Lost to Follow-up|11|||
19461728|NCT00246376|41717917|FG002|Overall Study|Lost to Follow-up|11|||
19461729|NCT00246376|41717918|FG003|Overall Study|Lost to Follow-up|16|||
19461730|NCT00246376|41717919|FG004|Overall Study|Lost to Follow-up|13|||
19461731|NCT01764841|41717977|FG000|Overall Study|Logistical Difficulties|0|||
19461732|NCT01764841|41717978|FG001|Overall Study|Logistical Difficulties|1|||
19461733|NCT01764841|41717979|FG002|Overall Study|Logistical Difficulties|0|||
19461734|NCT01764841|41717980|FG003|Overall Study|Logistical Difficulties|0|||
19461735|NCT01764841|41717977|FG000|Overall Study|Death|3|||
19461736|NCT01764841|41717978|FG001|Overall Study|Death|0|||
19461737|NCT01764841|41717979|FG002|Overall Study|Death|1|||
19461738|NCT01764841|41717980|FG003|Overall Study|Death|4|||
19461739|NCT01764841|41717977|FG000|Overall Study|No Follow Up|1|||
19461740|NCT01764841|41717978|FG001|Overall Study|No Follow Up|0|||
19461741|NCT01764841|41717979|FG002|Overall Study|No Follow Up|1|||
19461742|NCT01764841|41717980|FG003|Overall Study|No Follow Up|0|||
19461743|NCT01764841|41717977|FG000|Overall Study|Protocol Violation|0|||
19461744|NCT01764841|41717978|FG001|Overall Study|Protocol Violation|1|||
19461745|NCT01764841|41717979|FG002|Overall Study|Protocol Violation|0|||
19461746|NCT01764841|41717980|FG003|Overall Study|Protocol Violation|0|||
19461747|NCT01764841|41717977|FG000|Overall Study|Withdrawal by Subject|16|||
19461748|NCT01764841|41717978|FG001|Overall Study|Withdrawal by Subject|24|||
19461749|NCT01764841|41717979|FG002|Overall Study|Withdrawal by Subject|11|||
19461750|NCT01764841|41717980|FG003|Overall Study|Withdrawal by Subject|15|||
19461751|NCT01764841|41717977|FG000|Overall Study|Lost to Follow-up|3|||
19461752|NCT01764841|41717978|FG001|Overall Study|Lost to Follow-up|0|||
19461753|NCT01764841|41717979|FG002|Overall Study|Lost to Follow-up|1|||
19461754|NCT01764841|41717980|FG003|Overall Study|Lost to Follow-up|0|||
19461755|NCT00245050|41717992|FG000|Overall Study|Adverse Event|3|||
19461756|NCT00245050|41717993|FG001|Overall Study|Adverse Event|2|||
19461757|NCT00243412|41718031|FG000|Overall Study|Death|0|||
19461758|NCT00243412|41718032|FG001|Overall Study|Death|1|||
19461759|NCT00243412|41718031|FG000|Overall Study|Adverse Event|4|||
19461760|NCT00243412|41718032|FG001|Overall Study|Adverse Event|2|||
19461761|NCT00243412|41718031|FG000|Overall Study|Lost to Follow-up|0|||
19461762|NCT00243412|41718032|FG001|Overall Study|Lost to Follow-up|1|||
19461763|NCT00243412|41718031|FG000|Overall Study|Physician Decision|1|||
19461764|NCT00243412|41718032|FG001|Overall Study|Physician Decision|1|||
19461765|NCT00243412|41718031|FG000|Overall Study|Withdrawal by Subject|4|||
19461766|NCT00243412|41718032|FG001|Overall Study|Withdrawal by Subject|5|||
19461767|NCT00243412|41718031|FG000|Overall Study|Other|1|||
19461768|NCT00243412|41718032|FG001|Overall Study|Other|1|||
19461769|NCT03805750|41718047|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
19461770|NCT03805750|41718048|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
19461771|NCT03804268|41718056|FG000|Overall Study|Adverse Event|2|||
19461772|NCT03804268|41718057|FG001|Overall Study|Adverse Event|2|||
19461773|NCT03804268|41718056|FG000|Overall Study|Withdrawal by Subject|2|||
19461774|NCT03804268|41718057|FG001|Overall Study|Withdrawal by Subject|0|||
19461775|NCT03804268|41718056|FG000|Overall Study|Lost to Follow-up|1|||
19461776|NCT03804268|41718057|FG001|Overall Study|Lost to Follow-up|0|||
19461777|NCT03804268|41718056|FG000|Overall Study|Physician Decision|2|||
19461778|NCT03804268|41718057|FG001|Overall Study|Physician Decision|0|||
19461779|NCT00243022|41718082|FG000|Overall Study|Withdrawal by Subject|1|||
19461780|NCT00243022|41718083|FG001|Overall Study|Withdrawal by Subject|0|||
19461781|NCT00243022|41718082|FG000|Overall Study|Death|1|||
19461782|NCT00243022|41718083|FG001|Overall Study|Death|0|||
19461783|NCT00243022|41718082|FG000|Overall Study|Difficult Travel Distance|0|||
19461784|NCT00243022|41718083|FG001|Overall Study|Difficult Travel Distance|1|||
19461785|NCT01736683|41718168|FG000|Overall Study|Disease Relapse|0|||
19461786|NCT01736683|41718169|FG001|Overall Study|Disease Relapse|0|||
19461787|NCT01736683|41718170|FG002|Overall Study|Disease Relapse|2|||
19461788|NCT01736683|41718171|FG003|Overall Study|Disease Relapse|1|||
19461789|NCT01736683|41718172|FG004|Overall Study|Disease Relapse|0|||
19461790|NCT01736683|41718168|FG000|Overall Study|Adverse Event|0|||
19461791|NCT01736683|41718169|FG001|Overall Study|Adverse Event|2|||
19461792|NCT01736683|41718170|FG002|Overall Study|Adverse Event|2|||
19461793|NCT01736683|41718171|FG003|Overall Study|Adverse Event|3|||
19461794|NCT01736683|41718172|FG004|Overall Study|Adverse Event|2|||
19461795|NCT01736683|41718168|FG000|Overall Study|Withdrawal by Subject|0|||
19461796|NCT01736683|41718169|FG001|Overall Study|Withdrawal by Subject|0|||
19461797|NCT01736683|41718170|FG002|Overall Study|Withdrawal by Subject|3|||
19461798|NCT01736683|41718171|FG003|Overall Study|Withdrawal by Subject|1|||
19461799|NCT01736683|41718172|FG004|Overall Study|Withdrawal by Subject|1|||
19461800|NCT01736683|41718168|FG000|Overall Study|Lack of Therapeutic Effect|7|||
19461801|NCT01736683|41718169|FG001|Overall Study|Lack of Therapeutic Effect|4|||
19461802|NCT01736683|41718170|FG002|Overall Study|Lack of Therapeutic Effect|13|||
19461803|NCT01736683|41718171|FG003|Overall Study|Lack of Therapeutic Effect|20|||
19461804|NCT01736683|41718172|FG004|Overall Study|Lack of Therapeutic Effect|1|||
19461805|NCT01736683|41718168|FG000|Overall Study|Progressive Disease|0|||
19461806|NCT01736683|41718169|FG001|Overall Study|Progressive Disease|0|||
19461807|NCT01736683|41718170|FG002|Overall Study|Progressive Disease|0|||
19461808|NCT01736683|41718171|FG003|Overall Study|Progressive Disease|1|||
19461809|NCT01736683|41718172|FG004|Overall Study|Progressive Disease|0|||
19461810|NCT01736683|41718168|FG000|Overall Study|Other|0|||
19461811|NCT01736683|41718169|FG001|Overall Study|Other|0|||
19461812|NCT01736683|41718170|FG002|Overall Study|Other|1|||
19461813|NCT01736683|41718171|FG003|Overall Study|Other|9|||
19461814|NCT01736683|41718172|FG004|Overall Study|Other|1|||
19461815|NCT01788943|41718188|FG000|Overall Study|Withdrawal by Subject|1|||
19461816|NCT01788943|41718189|FG001|Overall Study|Withdrawal by Subject|0|||
19461817|NCT01788163|41718216|FG000|Overall Study|Other|53|||
19461818|NCT01788163|41718217|FG001|Overall Study|Other|0|||
19461819|NCT01788163|41718218|FG002|Overall Study|Other|0|||
19461820|NCT01788163|41718219|FG003|Overall Study|Other|0|||
19461821|NCT01788163|41718220|FG004|Overall Study|Other|0|||
19461822|NCT01788163|41718221|FG005|Overall Study|Other|7|||
19461823|NCT01788163|41718222|FG006|Overall Study|Other|1|||
19461824|NCT01788163|41718223|FG007|Overall Study|Other|48|||
19461825|NCT01788163|41718224|FG008|Overall Study|Other|15|||
19461826|NCT01788163|41718216|FG000|Overall Study|Withdrawal by Subject|2|||
19461827|NCT01788163|41718217|FG001|Overall Study|Withdrawal by Subject|0|||
19461828|NCT01788163|41718218|FG002|Overall Study|Withdrawal by Subject|0|||
19461829|NCT01788163|41718219|FG003|Overall Study|Withdrawal by Subject|0|||
19461830|NCT01788163|41718220|FG004|Overall Study|Withdrawal by Subject|0|||
19461831|NCT01788163|41718221|FG005|Overall Study|Withdrawal by Subject|0|||
19461832|NCT01788163|41718222|FG006|Overall Study|Withdrawal by Subject|0|||
19461833|NCT01788163|41718223|FG007|Overall Study|Withdrawal by Subject|0|||
19461834|NCT01788163|41718224|FG008|Overall Study|Withdrawal by Subject|1|||
19461835|NCT01787461|41718360|FG000|Overall Study|Adverse Event|4|||
19461836|NCT01787461|41718361|FG001|Overall Study|Adverse Event|3|||
19461837|NCT01787461|41718360|FG000|Overall Study|Lost to Follow-up|3|||
19461838|NCT01787461|41718361|FG001|Overall Study|Lost to Follow-up|2|||
19461839|NCT01787461|41718360|FG000|Overall Study|No longer met eligibility criteria|1|||
19461840|NCT01787461|41718361|FG001|Overall Study|No longer met eligibility criteria|0|||
19461841|NCT01787461|41718360|FG000|Overall Study|Withdrawal by Subject|3|||
19461842|NCT01787461|41718361|FG001|Overall Study|Withdrawal by Subject|4|||
19461843|NCT01787461|41718360|FG000|Overall Study|Protocol Violation|3|||
19461844|NCT01787461|41718361|FG001|Overall Study|Protocol Violation|0|||
19461845|NCT01786993|41718386|FG000|Overall Study|Death|6|||
19461846|NCT01786993|41718387|FG001|Overall Study|Death|7|||
19461847|NCT01786993|41718386|FG000|Overall Study|Withdrawal by Subject|3|||
19461848|NCT01786993|41718387|FG001|Overall Study|Withdrawal by Subject|2|||
19461849|NCT01786993|41718386|FG000|Overall Study|Lost to Follow-up|0|||
19461850|NCT01786993|41718387|FG001|Overall Study|Lost to Follow-up|1|||
19461851|NCT01786993|41718386|FG000|Overall Study|Subject Non-Compliance|1|||
19461852|NCT01786993|41718387|FG001|Overall Study|Subject Non-Compliance|0|||
19461853|NCT01786993|41718386|FG000|Overall Study|System Explant|1|||
19461854|NCT01786993|41718387|FG001|Overall Study|System Explant|0|||
19461855|NCT01786993|41718386|FG000|Overall Study|Hospice Admission|1|||
19461856|NCT01786993|41718387|FG001|Overall Study|Hospice Admission|0|||
19461857|NCT01966445|41718412|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
19461858|NCT01966445|41718413|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
19461859|NCT01966445|41718414|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
19461860|NCT01966445|41718415|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
19461861|NCT01966445|41718416|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
19461862|NCT01966445|41718417|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
19461863|NCT01966445|41718418|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
19461864|NCT01966445|41718412|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
19461865|NCT01966445|41718413|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
19461866|NCT01966445|41718414|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
19461867|NCT01966445|41718415|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
19461868|NCT01966445|41718416|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
19461869|NCT01966445|41718417|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
19461870|NCT01966445|41718418|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
19461871|NCT01966445|41718412|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
19461872|NCT01966445|41718413|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
19461873|NCT01966445|41718414|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
19461874|NCT01966445|41718415|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
19461875|NCT01966445|41718416|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
19461876|NCT01966445|41718417|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
19461877|NCT01966445|41718418|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
19461878|NCT01966445|41718412|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461879|NCT01966445|41718413|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461880|NCT01966445|41718414|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461881|NCT01966445|41718415|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461882|NCT01966445|41718416|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461883|NCT01966445|41718417|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
19461884|NCT01966445|41718418|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
19461885|NCT01966445|41718412|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461886|NCT01966445|41718413|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461887|NCT01966445|41718414|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461888|NCT01966445|41718415|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461889|NCT01966445|41718416|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461890|NCT01966445|41718417|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
19461891|NCT01966445|41718418|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
19461892|NCT01763905|41718438|FG000|Overall Study|Withdrawal by Subject|1|||
19461893|NCT01763905|41718439|FG001|Overall Study|Withdrawal by Subject|1|||
19461894|NCT01763905|41718440|FG002|Overall Study|Withdrawal by Subject|0|||
19461895|NCT01763905|41718441|FG003|Overall Study|Withdrawal by Subject|1|||
19461896|NCT01763905|41718438|FG000|Overall Study|Decision by sponsor|5|||
19461897|NCT01763905|41718439|FG001|Overall Study|Decision by sponsor|0|||
19461898|NCT01763905|41718440|FG002|Overall Study|Decision by sponsor|8|||
19461899|NCT01763905|41718441|FG003|Overall Study|Decision by sponsor|0|||
19461900|NCT01763905|41718438|FG000|Overall Study|Lost to Follow-up|0|||
19461901|NCT01763905|41718439|FG001|Overall Study|Lost to Follow-up|0|||
19461902|NCT01763905|41718440|FG002|Overall Study|Lost to Follow-up|1|||
19461903|NCT01763905|41718441|FG003|Overall Study|Lost to Follow-up|0|||
19461904|NCT02091167|41718453|FG000|Overall Study|Lost to Follow-up|0|||
19461905|NCT02091167|41718454|FG001|Overall Study|Lost to Follow-up|2|||
19461906|NCT02091089|41718460|FG000|Overall Study|Lost to Follow-up|2|||
19461907|NCT01763203|41718475|FG000|Overall Study|Death|4|||
19461908|NCT01763203|41718476|FG001|Overall Study|Death|7|||
19461909|NCT01763203|41718475|FG000|Overall Study|Lost to Follow-up|12|||
19461910|NCT01763203|41718476|FG001|Overall Study|Lost to Follow-up|12|||
19461911|NCT01763203|41718475|FG000|Overall Study|Withdrawal by Subject|8|||
19461912|NCT01763203|41718476|FG001|Overall Study|Withdrawal by Subject|12|||
19461913|NCT01763203|41718475|FG000|Overall Study|Moved out of study region|7|||
19461914|NCT01763203|41718476|FG001|Overall Study|Moved out of study region|10|||
19461915|NCT01763203|41718475|FG000|Overall Study|Physician Decision|2|||
19461916|NCT01763203|41718476|FG001|Overall Study|Physician Decision|1|||
19461917|NCT01763047|41718493|FG000|Period 1|Test Article Not Available|4|||
19461918|NCT01763047|41718494|FG001|Period 1|Test Article Not Available|1|||
19461919|NCT01763047|41718493|FG000|Period 1|Protocol Violation|4|||
19461920|NCT01763047|41718494|FG001|Period 1|Protocol Violation|4|||
19461921|NCT01763047|41718493|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
19461922|NCT01763047|41718494|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
19461923|NCT01763047|41718493|FG000|Period 1|Adverse Event|0|||
19461924|NCT01763047|41718494|FG001|Period 1|Adverse Event|1|||
19461925|NCT01763047|41718493|FG000|Period 1|Unsatisfactory Visual Response|0|||
19461926|NCT01763047|41718494|FG001|Period 1|Unsatisfactory Visual Response|3|||
19461927|NCT01763047|41718493|FG000|Period 1|Lens Power Not Available|0|||
19461928|NCT01763047|41718494|FG001|Period 1|Lens Power Not Available|1|||
19461929|NCT01763047|41718493|FG000|Period 1|Study Site office Closed|0|||
19461930|NCT01763047|41718494|FG001|Period 1|Study Site office Closed|1|||
19461931|NCT01763047|41718493|FG000|Period 2|Lens Discomfort|1|||
19461932|NCT01763047|41718494|FG001|Period 2|Lens Discomfort|0|||
19461933|NCT01763047|41718493|FG000|Period 2|No longer meets Eligibility Criteria|1|||
19461934|NCT01763047|41718494|FG001|Period 2|No longer meets Eligibility Criteria|0|||
19461935|NCT01763047|41718493|FG000|Period 2|Study Site office Closed|1|||
19461936|NCT01763047|41718494|FG001|Period 2|Study Site office Closed|1|||
19461937|NCT01763047|41718493|FG000|Period 2|Unsatisfactory Visual Response|1|||
19461938|NCT01763047|41718494|FG001|Period 2|Unsatisfactory Visual Response|1|||
19461939|NCT01763047|41718493|FG000|Period 2|Protocol Violation|0|||
19461940|NCT01763047|41718494|FG001|Period 2|Protocol Violation|2|||
19461941|NCT01763047|41718493|FG000|Period 2|Unsatisfactory lens Fitting|0|||
19461942|NCT01763047|41718494|FG001|Period 2|Unsatisfactory lens Fitting|1|||
19461943|NCT01977677|41718506|FG000|Overall Study|Unrelated Adverse Event|0|||
19461944|NCT01977677|41718507|FG001|Overall Study|Unrelated Adverse Event|0|||
19461945|NCT01977677|41718508|FG002|Overall Study|Unrelated Adverse Event|1|||
19461946|NCT01762345|41718516|FG000|Overall Study|Adverse Event|5|||
19461947|NCT01762345|41718516|FG000|Overall Study|Protocol Violation|2|||
19461948|NCT02090855|41718521|FG000|Overall Study|no evaluable Standard of Truth results|2|||
19461949|NCT01761565|41718528|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
19461950|NCT01619579|41718538|FG000|Overall Study|Withdrawal by Subject|0|||
19461951|NCT01619579|41718539|FG001|Overall Study|Withdrawal by Subject|3|||
19461952|NCT01736215|41718545|FG000|Overall Study|Early termination of erythropoietin use|1|||
19461953|NCT01736215|41718545|FG000|Overall Study|Adverse Event|4|||
19461954|NCT01736215|41718545|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
19461955|NCT01736215|41718545|FG000|Overall Study|Insufficient data to perform analysis|8|||
19461956|NCT01786603|41718551|FG000|Overall Study|Death|5|||
19461957|NCT01786603|41718552|FG001|Overall Study|Death|1|||
19461958|NCT01786603|41718551|FG000|Overall Study|Adverse Event|6|||
19461959|NCT01786603|41718552|FG001|Overall Study|Adverse Event|2|||
19461960|NCT01786603|41718551|FG000|Overall Study|Physician decision to withdraw|6|||
19461961|NCT01786603|41718552|FG001|Overall Study|Physician decision to withdraw|7|||
19461962|NCT01786603|41718551|FG000|Overall Study|Lost to Follow-up|1|||
19461963|NCT01786603|41718552|FG001|Overall Study|Lost to Follow-up|2|||
19461964|NCT01619423|41718575|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
19461965|NCT01619423|41718576|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
19461966|NCT01619423|41718577|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
19461967|NCT01619423|41718578|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
19461968|NCT01735279|41718591|FG000|Overall Study|Lost to Follow-up|11|||
19461969|NCT01735279|41718592|FG001|Overall Study|Lost to Follow-up|8|||
19461970|NCT01759381|41718600|FG000|Overall Study|Death|1|||
19461971|NCT01759381|41718601|FG001|Overall Study|Death|0|||
19461972|NCT01758523|41718620|FG000|Overall Study|Adverse Event|2|||
19461973|NCT01758523|41718621|FG001|Overall Study|Adverse Event|1|||
19461974|NCT01758523|41718620|FG000|Overall Study|Lack of Efficacy|4|||
19461975|NCT01758523|41718621|FG001|Overall Study|Lack of Efficacy|2|||
19461976|NCT01758523|41718620|FG000|Overall Study|Lost to Follow-up|3|||
19461977|NCT01758523|41718621|FG001|Overall Study|Lost to Follow-up|4|||
19461978|NCT01758523|41718620|FG000|Overall Study|Withdrawal by Subject|12|||
19461979|NCT01758523|41718621|FG001|Overall Study|Withdrawal by Subject|7|||
19461980|NCT01758289|41718644|FG000|Overall Study|Premature Study Termination|44|||
19461981|NCT01758289|41718644|FG000|Overall Study|Adverse Event|9|||
19461982|NCT01757821|41718668|FG000|Overall Study|Adverse Event|1|||
19461983|NCT01735201|41718697|FG000|Overall Study|Adverse Event|1|||
19461984|NCT01735201|41718698|FG001|Overall Study|Adverse Event|1|||
19461985|NCT01735201|41718699|FG002|Overall Study|Adverse Event|0|||
19461986|NCT01735201|41718700|FG003|Overall Study|Adverse Event|1|||
19461987|NCT01735201|41718701|FG004|Overall Study|Adverse Event|1|||
19461988|NCT01735201|41718702|FG005|Overall Study|Adverse Event|3|||
19461989|NCT01735201|41718703|FG006|Overall Study|Adverse Event|2|||
19461990|NCT01735201|41718704|FG007|Overall Study|Adverse Event|1|||
19461991|NCT01735201|41718697|FG000|Overall Study|Personal Reasons|1|||
19461992|NCT01735201|41718698|FG001|Overall Study|Personal Reasons|0|||
19461993|NCT01735201|41718699|FG002|Overall Study|Personal Reasons|0|||
19461994|NCT01735201|41718700|FG003|Overall Study|Personal Reasons|0|||
19461995|NCT01735201|41718701|FG004|Overall Study|Personal Reasons|0|||
19461996|NCT01735201|41718702|FG005|Overall Study|Personal Reasons|0|||
19461997|NCT01735201|41718703|FG006|Overall Study|Personal Reasons|0|||
19461998|NCT01735201|41718704|FG007|Overall Study|Personal Reasons|0|||
19461999|NCT01735201|41718697|FG000|Overall Study|Protocol Violation|1|||
19462000|NCT01735201|41718698|FG001|Overall Study|Protocol Violation|0|||
19462001|NCT01735201|41718699|FG002|Overall Study|Protocol Violation|0|||
19462002|NCT01735201|41718700|FG003|Overall Study|Protocol Violation|0|||
19462003|NCT01735201|41718701|FG004|Overall Study|Protocol Violation|0|||
19462004|NCT01735201|41718702|FG005|Overall Study|Protocol Violation|0|||
19462005|NCT01735201|41718703|FG006|Overall Study|Protocol Violation|0|||
19462006|NCT01735201|41718704|FG007|Overall Study|Protocol Violation|0|||
19462007|NCT01735201|41718697|FG000|Overall Study|Other Miscellaneous Reasons|0|||
19462008|NCT01735201|41718698|FG001|Overall Study|Other Miscellaneous Reasons|0|||
19462009|NCT01735201|41718699|FG002|Overall Study|Other Miscellaneous Reasons|0|||
19462010|NCT01735201|41718700|FG003|Overall Study|Other Miscellaneous Reasons|1|||
19462011|NCT01735201|41718701|FG004|Overall Study|Other Miscellaneous Reasons|0|||
19462012|NCT01735201|41718702|FG005|Overall Study|Other Miscellaneous Reasons|2|||
19462013|NCT01735201|41718703|FG006|Overall Study|Other Miscellaneous Reasons|1|||
19462014|NCT01735201|41718704|FG007|Overall Study|Other Miscellaneous Reasons|1|||
19462015|NCT01734811|41718724|FG000|Overall Study|Lost to Follow-up|2|||
19462016|NCT01734811|41718725|FG001|Overall Study|Lost to Follow-up|3|||
19462017|NCT01734811|41718724|FG000|Overall Study|Withdrawal by Subject|2|||
19462018|NCT01734811|41718725|FG001|Overall Study|Withdrawal by Subject|0|||
19462019|NCT01757275|41718733|FG000|Overall Study|Lost to Follow-up|1|||
19462020|NCT01757275|41718734|FG001|Overall Study|Lost to Follow-up|2|||
19462021|NCT01757275|41718733|FG000|Overall Study|Adverse Event|3|||
19462022|NCT01757275|41718734|FG001|Overall Study|Adverse Event|3|||
19462023|NCT01757275|41718733|FG000|Overall Study|Withdrawal by Subject|2|||
19462024|NCT01757275|41718734|FG001|Overall Study|Withdrawal by Subject|4|||
19462025|NCT01757275|41718733|FG000|Overall Study|Not treated|3|||
19462026|NCT01757275|41718734|FG001|Overall Study|Not treated|4|||
19462027|NCT01757197|41718749|FG000|Overall Study|Death|2|||
19462028|NCT01784965|41718773|FG000|Overall Study|Withdrawal by Subject|6|||
19462029|NCT01784965|41718774|FG001|Overall Study|Withdrawal by Subject|3|||
19462030|NCT01784965|41718773|FG000|Overall Study|Adverse Event|0|||
19462031|NCT01784965|41718774|FG001|Overall Study|Adverse Event|8|||
19462032|NCT01784419|41718782|FG000|Overall Study|Adverse Event|3|||
19462033|NCT01784029|41718789|FG000|Overall Study|Lost to Follow-up|19|||
19462034|NCT01784029|41718790|FG001|Overall Study|Lost to Follow-up|20|||
19462035|NCT01784029|41718791|FG002|Overall Study|Lost to Follow-up|22|||
19462036|NCT01733329|41718813|FG000|Overall Study|Protocol Violation|1|||
19462037|NCT01733329|41718814|FG001|Overall Study|Protocol Violation|1|||
19462038|NCT01733329|41718813|FG000|Overall Study|Uterine artery injury|1|||
19462039|NCT01733329|41718814|FG001|Overall Study|Uterine artery injury|0|||
19462040|NCT01783483|41718822|FG000|Overall Study|Death|3|||
19462041|NCT01783483|41718823|FG001|Overall Study|Death|3|||
19462042|NCT01783483|41718822|FG000|Overall Study|Lost to Follow-up|14|||
19462043|NCT01783483|41718823|FG001|Overall Study|Lost to Follow-up|10|||
19462044|NCT01783483|41718822|FG000|Overall Study|Withdrawal by Subject|2|||
19462045|NCT01783483|41718823|FG001|Overall Study|Withdrawal by Subject|1|||
19462046|NCT01783483|41718822|FG000|Overall Study|Physician Decision|1|||
19462047|NCT01783483|41718823|FG001|Overall Study|Physician Decision|1|||
19462048|NCT01607593|41718842|FG000|Overall Study|Adverse Event|15|||
19462049|NCT01607593|41718842|FG000|Overall Study|Lack of Efficacy|16|||
19462050|NCT01607593|41718842|FG000|Overall Study|Lost to Follow-up|25|||
19462051|NCT01607593|41718842|FG000|Overall Study|Continuation|33|||
19462052|NCT01607593|41718842|FG000|Overall Study|Other|4|||
19462053|NCT01755637|41718855|FG000|Period 1|Adverse Event|0|||
19462054|NCT01755637|41718856|FG001|Period 1|Adverse Event|1|||
19462055|NCT01732549|41718874|FG000|Overall Study|Adverse Event|13|||
19462056|NCT01732549|41718875|FG001|Overall Study|Adverse Event|3|||
19462057|NCT01732549|41718874|FG000|Overall Study|Consent withdrawn|13|||
19462058|NCT01732549|41718875|FG001|Overall Study|Consent withdrawn|6|||
19462059|NCT01732549|41718874|FG000|Overall Study|Disease progression|37|||
19462060|NCT01732549|41718875|FG001|Overall Study|Disease progression|50|||
19462061|NCT01732549|41718874|FG000|Overall Study|Other|8|||
19462062|NCT01732549|41718875|FG001|Overall Study|Other|14|||
19462063|NCT01755091|41718894|FG000|Overall Study|Withdrawal by Subject|6|||
19462064|NCT01755091|41718895|FG001|Overall Study|Withdrawal by Subject|1|||
19462065|NCT01755091|41718896|FG002|Overall Study|Withdrawal by Subject|3|||
19462066|NCT01755091|41718894|FG000|Overall Study|Adverse Event|1|||
19462067|NCT01755091|41718895|FG001|Overall Study|Adverse Event|1|||
19462068|NCT01755091|41718896|FG002|Overall Study|Adverse Event|1|||
19462069|NCT01755091|41718894|FG000|Overall Study|Lost to Follow-up|1|||
19462070|NCT01755091|41718895|FG001|Overall Study|Lost to Follow-up|0|||
19462071|NCT01755091|41718896|FG002|Overall Study|Lost to Follow-up|1|||
19462072|NCT01755091|41718894|FG000|Overall Study|Physician Decision|1|||
19462073|NCT01755091|41718895|FG001|Overall Study|Physician Decision|1|||
19462074|NCT01755091|41718896|FG002|Overall Study|Physician Decision|2|||
19462075|NCT01754467|41718929|FG000|Overall Study|Lost to Follow-up|1|||
19462076|NCT01753999|41718933|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
19462077|NCT01753999|41718934|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
19462078|NCT01753999|41718933|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
19462079|NCT01753999|41718934|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
19462080|NCT01753999|41718933|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
19462081|NCT01753999|41718934|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
19462082|NCT01753999|41718933|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
19462083|NCT01753999|41718934|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
19462084|NCT01753999|41718933|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
19462085|NCT01753999|41718934|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
19462086|NCT01753999|41718933|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
19462087|NCT01753999|41718934|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
19462088|NCT01783015|41718954|FG000|Blinded Treatment|Adverse Event|0|||
19462089|NCT01783015|41718955|FG001|Blinded Treatment|Adverse Event|1|||
19462090|NCT01783015|41718956|FG002|Blinded Treatment|Adverse Event|0|||
19462091|NCT01783015|41718954|FG000|Blinded Treatment|Protocol Violation|0|||
19462092|NCT01783015|41718955|FG001|Blinded Treatment|Protocol Violation|1|||
19462093|NCT01783015|41718956|FG002|Blinded Treatment|Protocol Violation|0|||
19462094|NCT01783015|41718954|FG000|Blinded Treatment|Withdrawal by Subject|0|||
19462095|NCT01783015|41718955|FG001|Blinded Treatment|Withdrawal by Subject|1|||
19462096|NCT01783015|41718956|FG002|Blinded Treatment|Withdrawal by Subject|0|||
19462097|NCT01783015|41718954|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
19462098|NCT01783015|41718955|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
19462099|NCT01783015|41718956|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
19462100|NCT01783015|41718954|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
19462101|NCT01783015|41718955|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
19462102|NCT01783015|41718956|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
19462103|NCT01782859|41718966|FG000|Overall Study|Protocol Violation|6|||
19462104|NCT01782859|41718967|FG001|Overall Study|Protocol Violation|6|||
19462105|NCT01782859|41718966|FG000|Overall Study|Withdrawal by Subject|0|||
19462106|NCT01782859|41718967|FG001|Overall Study|Withdrawal by Subject|1|||
19462107|NCT01782469|41718974|FG000|Overall Study|Lost to Follow-up|1|||
19462108|NCT01782313|41718978|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
19462109|NCT01782313|41718978|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
19462110|NCT01782313|41718978|FG000|Treated Cycle 3|Progressive Disease|21|||
19462111|NCT01782313|41718978|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
19462112|NCT01782313|41718978|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
19462113|NCT01782313|41718978|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
19462114|NCT01782313|41718978|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
19462115|NCT01782313|41718978|FG000|Survival Follow up|Lost to Follow-up|1|||
19462116|NCT01781611|41719001|FG000|Overall Study|Adverse Event|4|||
19462117|NCT01781611|41719002|FG001|Overall Study|Adverse Event|0|||
19462118|NCT01781299|41719019|FG000|Overall Study|Withdrawal by Subject|0|||
19462119|NCT01781299|41719020|FG001|Overall Study|Withdrawal by Subject|1|||
19462120|NCT01732471|41719026|FG000|Overall Study|Withdrawal by Subject|1|||
19462121|NCT01780987|41719045|FG000|Overall Study|Adverse Event|0|||
19462122|NCT01780987|41719046|FG001|Overall Study|Adverse Event|4|||
19462123|NCT01780987|41719045|FG000|Overall Study|Withdrawal by Subject|2|||
19462124|NCT01780987|41719046|FG001|Overall Study|Withdrawal by Subject|0|||
19462125|NCT01780987|41719045|FG000|Overall Study|Request of Changing Hospital|0|||
19462126|NCT01780987|41719046|FG001|Overall Study|Request of Changing Hospital|1|||
19462127|NCT01780987|41719045|FG000|Overall Study|Changing Residence|1|||
19462128|NCT01780987|41719046|FG001|Overall Study|Changing Residence|0|||
19462129|NCT01780987|41719045|FG000|Overall Study|Not Receiving any Study Medication|0|||
19462130|NCT01780987|41719046|FG001|Overall Study|Not Receiving any Study Medication|1|||
19462131|NCT01753297|41719109|FG000|Overall Study|Lost to Follow-up|7|||
19462132|NCT01753297|41719110|FG001|Overall Study|Lost to Follow-up|2|||
19462133|NCT01753297|41719109|FG000|Overall Study|Withdrawal by Subject|26|||
19462134|NCT01753297|41719110|FG001|Overall Study|Withdrawal by Subject|23|||
19462135|NCT01753297|41719109|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
19462136|NCT01753297|41719110|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
19462137|NCT01753297|41719109|FG000|Overall Study|Death|0|||
19462138|NCT01753297|41719110|FG001|Overall Study|Death|2|||
19462139|NCT01753297|41719109|FG000|Overall Study|Did not attend end of study visit|7|||
19462140|NCT01753297|41719110|FG001|Overall Study|Did not attend end of study visit|8|||
19462141|NCT01730053|41719146|FG000|Overall Study|Participant moved|0|||
19462142|NCT01730053|41719147|FG001|Overall Study|Participant moved|0|||
19462143|NCT01730053|41719148|FG002|Overall Study|Participant moved|1|||
19462144|NCT01730053|41719149|FG003|Overall Study|Participant moved|0|||
19462145|NCT01730053|41719150|FG004|Overall Study|Participant moved|0|||
19462146|NCT01730053|41719151|FG005|Overall Study|Participant moved|0|||
19462147|NCT01730053|41719146|FG000|Overall Study|Physician Decision|0|||
19462148|NCT01730053|41719147|FG001|Overall Study|Physician Decision|0|||
19462149|NCT01730053|41719148|FG002|Overall Study|Physician Decision|0|||
19462150|NCT01730053|41719149|FG003|Overall Study|Physician Decision|1|||
19462151|NCT01730053|41719150|FG004|Overall Study|Physician Decision|0|||
19462152|NCT01730053|41719151|FG005|Overall Study|Physician Decision|0|||
19462153|NCT01730053|41719146|FG000|Overall Study|Adverse Event|2|||
19462154|NCT01730053|41719147|FG001|Overall Study|Adverse Event|6|||
19462155|NCT01730053|41719148|FG002|Overall Study|Adverse Event|3|||
19462156|NCT01730053|41719149|FG003|Overall Study|Adverse Event|3|||
19462157|NCT01730053|41719150|FG004|Overall Study|Adverse Event|2|||
19462158|NCT01730053|41719151|FG005|Overall Study|Adverse Event|2|||
19462159|NCT01730053|41719146|FG000|Overall Study|Poor compliance to protocol|1|||
19462160|NCT01730053|41719147|FG001|Overall Study|Poor compliance to protocol|2|||
19462161|NCT01730053|41719148|FG002|Overall Study|Poor compliance to protocol|2|||
19462162|NCT01730053|41719149|FG003|Overall Study|Poor compliance to protocol|0|||
19462163|NCT01730053|41719150|FG004|Overall Study|Poor compliance to protocol|0|||
19462164|NCT01730053|41719151|FG005|Overall Study|Poor compliance to protocol|2|||
19462165|NCT01730053|41719146|FG000|Overall Study|Other than specified|2|||
19462166|NCT01730053|41719147|FG001|Overall Study|Other than specified|6|||
19462167|NCT01730053|41719148|FG002|Overall Study|Other than specified|5|||
19462168|NCT01730053|41719149|FG003|Overall Study|Other than specified|4|||
19462169|NCT01730053|41719150|FG004|Overall Study|Other than specified|7|||
19462170|NCT01730053|41719151|FG005|Overall Study|Other than specified|9|||
19462171|NCT01752985|41719186|FG000|Treatment Period|Subject request to discontinue treatment|1|||
19462172|NCT01752985|41719187|FG001|Treatment Period|Subject request to discontinue treatment|0|||
19462173|NCT01752985|41719188|FG002|Treatment Period|Subject request to discontinue treatment|1|||
19462174|NCT01752985|41719186|FG000|Treatment Period|Subject no longer meets study criteria|0|||
19462175|NCT01752985|41719187|FG001|Treatment Period|Subject no longer meets study criteria|1|||
19462176|NCT01752985|41719188|FG002|Treatment Period|Subject no longer meets study criteria|1|||
19462177|NCT01752985|41719186|FG000|Treatment Period|Adverse Event|2|||
19462178|NCT01752985|41719187|FG001|Treatment Period|Adverse Event|1|||
19462179|NCT01752985|41719188|FG002|Treatment Period|Adverse Event|2|||
19462180|NCT01752985|41719186|FG000|Treatment Period|Withdrawal by Subject|1|||
19462181|NCT01752985|41719187|FG001|Treatment Period|Withdrawal by Subject|1|||
19462182|NCT01752985|41719188|FG002|Treatment Period|Withdrawal by Subject|0|||
19462183|NCT01752985|41719186|FG000|Treatment Period|Lost to Follow-up|0|||
19462184|NCT01752985|41719187|FG001|Treatment Period|Lost to Follow-up|0|||
19462185|NCT01752985|41719188|FG002|Treatment Period|Lost to Follow-up|1|||
19462186|NCT01751113|41719196|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19462187|NCT01751113|41719197|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19462188|NCT01751113|41719198|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19462189|NCT01751113|41719199|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
19462190|NCT01751113|41719200|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
19462191|NCT01751113|41719201|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
19462192|NCT01751113|41719196|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
19462193|NCT01751113|41719197|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
19462194|NCT01751113|41719198|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
19462195|NCT01751113|41719199|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
19462196|NCT01751113|41719200|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
19462197|NCT01751113|41719201|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
19462198|NCT01750879|41719221|FG000|Overall Study|Adverse Event|8|||
19462199|NCT01750879|41719222|FG001|Overall Study|Adverse Event|0|||
19462200|NCT01750879|41719221|FG000|Overall Study|Lack of Efficacy|1|||
19462201|NCT01750879|41719222|FG001|Overall Study|Lack of Efficacy|0|||
19462202|NCT01750879|41719221|FG000|Overall Study|Withdrawal by Subject|1|||
19462203|NCT01750879|41719222|FG001|Overall Study|Withdrawal by Subject|0|||
19462204|NCT01750879|41719221|FG000|Overall Study|Did not complete per protocol|0|||
19462205|NCT01750879|41719222|FG001|Overall Study|Did not complete per protocol|3|||
19462206|NCT01719380|41719248|FG000|Overall Study|Adverse Event|0|||
19462207|NCT01719380|41719249|FG001|Overall Study|Adverse Event|0|||
19462208|NCT01719380|41719250|FG002|Overall Study|Adverse Event|1|||
19462209|NCT01719380|41719251|FG003|Overall Study|Adverse Event|2|||
19462210|NCT01719380|41719252|FG004|Overall Study|Adverse Event|0|||
19462211|NCT01719380|41719253|FG005|Overall Study|Adverse Event|1|||
19462212|NCT01719380|41719254|FG006|Overall Study|Adverse Event|0|||
19462213|NCT01719380|41719255|FG007|Overall Study|Adverse Event|1|||
19462214|NCT01719380|41719256|FG008|Overall Study|Adverse Event|4|||
19462215|NCT01719380|41719257|FG009|Overall Study|Adverse Event|3|||
19462216|NCT01719380|41719248|FG000|Overall Study|Death|0|||
19462217|NCT01719380|41719249|FG001|Overall Study|Death|1|||
19462218|NCT01719380|41719250|FG002|Overall Study|Death|0|||
19462219|NCT01719380|41719251|FG003|Overall Study|Death|0|||
19462220|NCT01719380|41719252|FG004|Overall Study|Death|0|||
19462221|NCT01719380|41719253|FG005|Overall Study|Death|0|||
19462222|NCT01719380|41719254|FG006|Overall Study|Death|0|||
19462223|NCT01719380|41719255|FG007|Overall Study|Death|0|||
19462224|NCT01719380|41719256|FG008|Overall Study|Death|3|||
19462225|NCT01719380|41719257|FG009|Overall Study|Death|3|||
19462226|NCT01719380|41719248|FG000|Overall Study|Participant/Guardian Decision|0|||
19462227|NCT01719380|41719249|FG001|Overall Study|Participant/Guardian Decision|0|||
19462228|NCT01719380|41719250|FG002|Overall Study|Participant/Guardian Decision|1|||
19462229|NCT01719380|41719251|FG003|Overall Study|Participant/Guardian Decision|0|||
19462230|NCT01719380|41719252|FG004|Overall Study|Participant/Guardian Decision|0|||
19462231|NCT01719380|41719253|FG005|Overall Study|Participant/Guardian Decision|0|||
19462232|NCT01719380|41719254|FG006|Overall Study|Participant/Guardian Decision|0|||
19462233|NCT01719380|41719255|FG007|Overall Study|Participant/Guardian Decision|0|||
19462234|NCT01719380|41719256|FG008|Overall Study|Participant/Guardian Decision|2|||
19462235|NCT01719380|41719257|FG009|Overall Study|Participant/Guardian Decision|2|||
19462236|NCT01719380|41719248|FG000|Overall Study|Physician Decision|0|||
19462237|NCT01719380|41719249|FG001|Overall Study|Physician Decision|0|||
19462238|NCT01719380|41719250|FG002|Overall Study|Physician Decision|2|||
19462239|NCT01719380|41719251|FG003|Overall Study|Physician Decision|0|||
19462240|NCT01719380|41719252|FG004|Overall Study|Physician Decision|0|||
19462241|NCT01719380|41719253|FG005|Overall Study|Physician Decision|0|||
19462242|NCT01719380|41719254|FG006|Overall Study|Physician Decision|0|||
19462243|NCT01719380|41719255|FG007|Overall Study|Physician Decision|0|||
19462244|NCT01719380|41719256|FG008|Overall Study|Physician Decision|1|||
19462245|NCT01719380|41719257|FG009|Overall Study|Physician Decision|1|||
19462246|NCT01719380|41719248|FG000|Overall Study|Lack of Efficacy|2|||
19462247|NCT01719380|41719249|FG001|Overall Study|Lack of Efficacy|6|||
19462248|NCT01719380|41719250|FG002|Overall Study|Lack of Efficacy|5|||
19462249|NCT01719380|41719251|FG003|Overall Study|Lack of Efficacy|6|||
19462250|NCT01719380|41719252|FG004|Overall Study|Lack of Efficacy|3|||
19462251|NCT01719380|41719253|FG005|Overall Study|Lack of Efficacy|7|||
19462252|NCT01719380|41719254|FG006|Overall Study|Lack of Efficacy|10|||
19462253|NCT01719380|41719255|FG007|Overall Study|Lack of Efficacy|6|||
19462254|NCT01719380|41719256|FG008|Overall Study|Lack of Efficacy|39|||
19462255|NCT01719380|41719257|FG009|Overall Study|Lack of Efficacy|42|||
19462256|NCT01719380|41719248|FG000|Overall Study|Progressive Disease|0|||
19462257|NCT01719380|41719249|FG001|Overall Study|Progressive Disease|0|||
19462258|NCT01719380|41719250|FG002|Overall Study|Progressive Disease|0|||
19462259|NCT01719380|41719251|FG003|Overall Study|Progressive Disease|0|||
19462260|NCT01719380|41719252|FG004|Overall Study|Progressive Disease|0|||
19462261|NCT01719380|41719253|FG005|Overall Study|Progressive Disease|0|||
19462262|NCT01719380|41719254|FG006|Overall Study|Progressive Disease|0|||
19462263|NCT01719380|41719255|FG007|Overall Study|Progressive Disease|0|||
19462264|NCT01719380|41719256|FG008|Overall Study|Progressive Disease|1|||
19462265|NCT01719380|41719257|FG009|Overall Study|Progressive Disease|0|||
19462266|NCT01743560|41719307|FG000|Overall Study|Disease progression|26|||
19462267|NCT01743560|41719307|FG000|Overall Study|Adverse Event|8|||
19462268|NCT01743560|41719307|FG000|Overall Study|Death|3|||
19462269|NCT01743560|41719307|FG000|Overall Study|Withdrawal by Subject|2|||
19462270|NCT01743560|41719307|FG000|Overall Study|Protocol Violation|1|||
19462271|NCT01743560|41719307|FG000|Overall Study|>1 dose of study drug|3|||
19462272|NCT01743092|41719337|FG000|Overall Study|Lost to Follow-up|14|||
19462273|NCT01743092|41719338|FG001|Overall Study|Lost to Follow-up|15|||
19462274|NCT01780831|41719371|FG000|Overall Study|Withdrawal by Subject|0|||
19462275|NCT01780831|41719372|FG001|Overall Study|Withdrawal by Subject|0|||
19462276|NCT01780831|41719373|FG002|Overall Study|Withdrawal by Subject|4|||
19462277|NCT01780831|41719374|FG003|Overall Study|Withdrawal by Subject|0|||
19462278|NCT01780831|41719371|FG000|Overall Study|Lost to Follow-up|0|||
19462279|NCT01780831|41719372|FG001|Overall Study|Lost to Follow-up|0|||
19462280|NCT01780831|41719373|FG002|Overall Study|Lost to Follow-up|0|||
19462281|NCT01780831|41719374|FG003|Overall Study|Lost to Follow-up|1|||
19462282|NCT01778023|41719433|FG000|Overall Study|Withdrawal by Subject|0|||
19462283|NCT01778023|41719434|FG001|Overall Study|Withdrawal by Subject|3|||
19462284|NCT01777321|41719442|FG000|Overall Study|Withdrawal by Subject|0|||
19462285|NCT01777321|41719443|FG001|Overall Study|Withdrawal by Subject|1|||
19462286|NCT01729819|41719451|FG000|Overall Study|Adverse Event|2|||
19462287|NCT01729819|41719452|FG001|Overall Study|Adverse Event|4|||
19462288|NCT01729819|41719451|FG000|Overall Study|Lack of Efficacy|1|||
19462289|NCT01729819|41719452|FG001|Overall Study|Lack of Efficacy|0|||
19462290|NCT01729819|41719451|FG000|Overall Study|Lost to Follow-up|2|||
19462291|NCT01729819|41719452|FG001|Overall Study|Lost to Follow-up|0|||
19462292|NCT01729819|41719451|FG000|Overall Study|Other reason|1|||
19462293|NCT01729819|41719452|FG001|Overall Study|Other reason|0|||
19462294|NCT01729819|41719451|FG000|Overall Study|Protocol Violation|0|||
19462295|NCT01729819|41719452|FG001|Overall Study|Protocol Violation|1|||
19462296|NCT01729819|41719451|FG000|Overall Study|Withdrawal by Subject|0|||
19462297|NCT01729819|41719452|FG001|Overall Study|Withdrawal by Subject|2|||
19462298|NCT01776541|41719463|FG000|Overall Study|Administrative Reason|6|||
19462299|NCT01776541|41719464|FG001|Overall Study|Administrative Reason|2|||
19462300|NCT01776541|41719463|FG000|Overall Study|Death|4|||
19462301|NCT01776541|41719464|FG001|Overall Study|Death|0|||
19462302|NCT01776541|41719463|FG000|Overall Study|Lost to Follow-up|27|||
19462303|NCT01776541|41719464|FG001|Overall Study|Lost to Follow-up|48|||
19462304|NCT01776541|41719463|FG000|Overall Study|Unclassified|5|||
19462305|NCT01776541|41719464|FG001|Overall Study|Unclassified|4|||
19462306|NCT01776541|41719463|FG000|Overall Study|Protocol Violation|2|||
19462307|NCT01776541|41719464|FG001|Overall Study|Protocol Violation|1|||
19462308|NCT01776541|41719463|FG000|Overall Study|Withdrawal by Subject|12|||
19462309|NCT01776541|41719464|FG001|Overall Study|Withdrawal by Subject|20|||
19462310|NCT01742078|41719493|FG000|Overall Study|Withdrawal by Subject|0|||
19462311|NCT01742078|41719494|FG001|Overall Study|Withdrawal by Subject|0|||
19462312|NCT01742078|41719495|FG002|Overall Study|Withdrawal by Subject|0|||
19462313|NCT01742078|41719496|FG003|Overall Study|Withdrawal by Subject|1|||
19462314|NCT01742078|41719497|FG004|Overall Study|Withdrawal by Subject|0|||
19462315|NCT01742078|41719498|FG005|Overall Study|Withdrawal by Subject|0|||
19462316|NCT01742078|41719499|FG006|Overall Study|Withdrawal by Subject|0|||
19462317|NCT01742078|41719500|FG007|Overall Study|Withdrawal by Subject|0|||
19462318|NCT01742078|41719501|FG008|Overall Study|Withdrawal by Subject|0|||
19462319|NCT01741688|41719523|FG000|Overall Study|Lack of insurance coverage|2|||
19462320|NCT01741688|41719523|FG000|Overall Study|Withdrawal by Subject|1|||
19462321|NCT01709084|41719530|FG000|Overall Study|Lost to Follow-up|4|||
19462322|NCT01709084|41719531|FG001|Overall Study|Lost to Follow-up|7|||
19462323|NCT01709084|41719530|FG000|Overall Study|Withdrawal by Subject|2|||
19462324|NCT01709084|41719531|FG001|Overall Study|Withdrawal by Subject|2|||
19462325|NCT01709084|41719530|FG000|Overall Study|Adverse Event|5|||
19462326|NCT01709084|41719531|FG001|Overall Study|Adverse Event|0|||
19462327|NCT01709084|41719530|FG000|Overall Study|Other|5|||
19462328|NCT01709084|41719531|FG001|Overall Study|Other|3|||
19462329|NCT01709084|41719530|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
19462330|NCT01709084|41719531|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
19462331|NCT01709084|41719530|FG000|Overall Study|Not Treated|0|||
19462332|NCT01709084|41719531|FG001|Overall Study|Not Treated|2|||
19462333|NCT01776307|41719540|FG000|Overall Study|Not dosed|0|||
19462334|NCT01776307|41719541|FG001|Overall Study|Not dosed|0|||
19462335|NCT01776307|41719542|FG002|Overall Study|Not dosed|1|||
19462336|NCT01729039|41719573|FG000|Overall Study|disqualified|2|||
19462337|NCT01729039|41719574|FG001|Overall Study|disqualified|5|||
19462338|NCT01729039|41719573|FG000|Overall Study|Withdrawal by Subject|8|||
19462339|NCT01729039|41719574|FG001|Overall Study|Withdrawal by Subject|7|||
19462340|NCT01775995|41719585|FG000|Overall Study|Lost to Follow-up|1|||
19462341|NCT01775995|41719586|FG001|Overall Study|Lost to Follow-up|1|||
19462342|NCT01741532|41719594|FG000|Overall Study|Adverse Event|4|||
19462343|NCT01741532|41719595|FG001|Overall Study|Adverse Event|0|||
19462344|NCT01741532|41719594|FG000|Overall Study|Withdrawal by Subject|1|||
19462345|NCT01741532|41719595|FG001|Overall Study|Withdrawal by Subject|1|||
19462346|NCT01741532|41719594|FG000|Overall Study|Protocol Violation|0|||
19462347|NCT01741532|41719595|FG001|Overall Study|Protocol Violation|1|||
19462348|NCT01741532|41719594|FG000|Overall Study|Worsening of the disease|3|||
19462349|NCT01741532|41719595|FG001|Overall Study|Worsening of the disease|1|||
19462350|NCT01741532|41719594|FG000|Overall Study|Sponsor decision|1|||
19462351|NCT01741532|41719595|FG001|Overall Study|Sponsor decision|0|||
19462352|NCT01741532|41719594|FG000|Overall Study|Medical event|1|||
19462353|NCT01741532|41719595|FG001|Overall Study|Medical event|0|||
19462354|NCT01719224|41719605|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
19462355|NCT01719224|41719606|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
19462356|NCT01717976|41719617|FG000|Overall Study|Protocol Violation|0|||
19462357|NCT01717976|41719618|FG001|Overall Study|Protocol Violation|1|||
19462358|NCT01740440|41719624|FG000|Overall Study|Lost to Follow-up|3|||
19462359|NCT01740128|41719631|FG000|Overall Study|Pregnancy|0|||
19462360|NCT01740128|41719632|FG001|Overall Study|Pregnancy|1|||
19462361|NCT01740128|41719631|FG000|Overall Study|Protocol Violation|1|||
19462362|NCT01740128|41719632|FG001|Overall Study|Protocol Violation|2|||
19462363|NCT01740128|41719631|FG000|Overall Study|Lost to Follow-up|2|||
19462364|NCT01740128|41719632|FG001|Overall Study|Lost to Follow-up|2|||
19462365|NCT01740128|41719631|FG000|Overall Study|Withdrawal by Subject|1|||
19462366|NCT01740128|41719632|FG001|Overall Study|Withdrawal by Subject|0|||
19462367|NCT01740128|41719631|FG000|Overall Study|Insufficient protocol compliance|2|||
19462368|NCT01740128|41719632|FG001|Overall Study|Insufficient protocol compliance|2|||
19462369|NCT01976741|41719648|FG000|Overall Study|Withdrawal by Subject|1|||
19462370|NCT01976741|41719649|FG001|Overall Study|Withdrawal by Subject|0|||
19462371|NCT01976741|41719650|FG002|Overall Study|Withdrawal by Subject|1|||
19462372|NCT01976741|41719651|FG003|Overall Study|Withdrawal by Subject|1|||
19462373|NCT01976741|41719652|FG004|Overall Study|Withdrawal by Subject|0|||
19462374|NCT01976741|41719653|FG005|Overall Study|Withdrawal by Subject|0|||
19462375|NCT01976741|41719654|FG006|Overall Study|Withdrawal by Subject|1|||
19462376|NCT01976741|41719655|FG007|Overall Study|Withdrawal by Subject|4|||
19462377|NCT01976741|41719656|FG008|Overall Study|Withdrawal by Subject|0|||
19462378|NCT01976741|41719657|FG009|Overall Study|Withdrawal by Subject|0|||
19462379|NCT01976741|41719648|FG000|Overall Study|Adverse Event|0|||
19462380|NCT01976741|41719649|FG001|Overall Study|Adverse Event|0|||
19462381|NCT01976741|41719650|FG002|Overall Study|Adverse Event|2|||
19462382|NCT01976741|41719651|FG003|Overall Study|Adverse Event|0|||
19462383|NCT01976741|41719652|FG004|Overall Study|Adverse Event|0|||
19462384|NCT01976741|41719653|FG005|Overall Study|Adverse Event|0|||
19462385|NCT01976741|41719654|FG006|Overall Study|Adverse Event|3|||
19462386|NCT01976741|41719655|FG007|Overall Study|Adverse Event|8|||
19462387|NCT01976741|41719656|FG008|Overall Study|Adverse Event|1|||
19462388|NCT01976741|41719657|FG009|Overall Study|Adverse Event|4|||
19462389|NCT01727713|41719691|FG000|Overall Study|Lost to Follow-up|5|||
19462390|NCT01727713|41719691|FG000|Overall Study|Adverse Event|10|||
19462391|NCT01727713|41719691|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
19462392|NCT01727713|41719691|FG000|Overall Study|Withdrawal by Subject|13|||
19462393|NCT01727713|41719691|FG000|Overall Study|Protocol Deviation|2|||
19462394|NCT01965431|41719695|FG000|Overall Study|Adverse Event|0|||
19462395|NCT01965431|41719696|FG001|Overall Study|Adverse Event|1|||
19462396|NCT01965431|41719697|FG002|Overall Study|Adverse Event|0|||
19462397|NCT01965431|41719698|FG003|Overall Study|Adverse Event|0|||
19462398|NCT01965431|41719699|FG004|Overall Study|Adverse Event|0|||
19462399|NCT01965431|41719700|FG005|Overall Study|Adverse Event|0|||
19462400|NCT01965431|41719695|FG000|Overall Study|Other than stated above|6|||
19462401|NCT01965431|41719696|FG001|Overall Study|Other than stated above|5|||
19462402|NCT01965431|41719697|FG002|Overall Study|Other than stated above|6|||
19462403|NCT01965431|41719698|FG003|Overall Study|Other than stated above|6|||
19462404|NCT01965431|41719699|FG004|Overall Study|Other than stated above|6|||
19462405|NCT01965431|41719700|FG005|Overall Study|Other than stated above|6|||
19462406|NCT01976663|41719710|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
19462407|NCT01976663|41719710|FG000|Overall Study|Personal Reasons|6|||
19462408|NCT01976663|41719710|FG000|Overall Study|Withdrawal by Subject|4|||
19462409|NCT01976663|41719710|FG000|Overall Study|Screen Failure|3|||
19462410|NCT01976663|41719710|FG000|Overall Study|Adverse Event|2|||
19462411|NCT01976663|41719710|FG000|Overall Study|Lost to Follow-up|3|||
19462412|NCT01775137|41719718|FG000|Overall Study|Death|1|||
19462413|NCT01775137|41719718|FG000|Overall Study|Protocol deviation|2|||
19462414|NCT01775137|41719718|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
19462415|NCT01775137|41719718|FG000|Overall Study|Adverse Event|1|||
19462416|NCT01775137|41719718|FG000|Overall Study|Withdrawal by participants|5|||
19462417|NCT01976507|41719725|FG000|Overall Study|Adverse Event|6|||
19462418|NCT01976507|41719725|FG000|Overall Study|ablation not done, drug not given|1|||
19462419|NCT01964963|41719729|FG000|Overall Study|Case Report Forms Uncollected|888|||
19462420|NCT01964963|41719729|FG000|Overall Study|Protocol Deviation|50|||
19462421|NCT01964963|41719729|FG000|Overall Study|Data Reliability was not Assured|5|||
19462422|NCT01964105|41719736|FG000|Overall Study|Lost to Follow-up|2|||
19462423|NCT01964105|41719737|FG001|Overall Study|Lost to Follow-up|13|||
19462424|NCT01964105|41719738|FG002|Overall Study|Lost to Follow-up|0|||
19462425|NCT01974323|41719748|FG000|Overall Study|Other Reasons|25|||
19462426|NCT01974323|41719749|FG001|Overall Study|Other Reasons|28|||
19462427|NCT01974323|41719748|FG000|Overall Study|Protocol Violation|2|||
19462428|NCT01974323|41719749|FG001|Overall Study|Protocol Violation|2|||
19462429|NCT01974323|41719748|FG000|Overall Study|Personal Reasons|15|||
19462430|NCT01974323|41719749|FG001|Overall Study|Personal Reasons|19|||
19462431|NCT01974323|41719748|FG000|Overall Study|Lost to Follow-up|45|||
19462432|NCT01974323|41719749|FG001|Overall Study|Lost to Follow-up|40|||
19462433|NCT01974323|41719748|FG000|Overall Study|Pregnancy|2|||
19462434|NCT01974323|41719749|FG001|Overall Study|Pregnancy|1|||
19462435|NCT01974323|41719748|FG000|Overall Study|Lack of Efficacy|1|||
19462436|NCT01974323|41719749|FG001|Overall Study|Lack of Efficacy|1|||
19462437|NCT01974323|41719748|FG000|Overall Study|Adverse Event|2|||
19462438|NCT01974323|41719749|FG001|Overall Study|Adverse Event|2|||
19462439|NCT01963403|41719757|FG000|Overall Study|Lost to Follow-up|2|||
19462440|NCT01963403|41719758|FG001|Overall Study|Lost to Follow-up|3|||
19462441|NCT01963403|41719757|FG000|Overall Study|Implant removal|0|||
19462442|NCT01963403|41719758|FG001|Overall Study|Implant removal|1|||
19462443|NCT01973387|41719768|FG000|Overall Study|Adverse Event|14|||
19462444|NCT01973387|41719769|FG001|Overall Study|Adverse Event|4|||
19462445|NCT01973387|41719768|FG000|Overall Study|Withdrawal by Subject|7|||
19462446|NCT01973387|41719769|FG001|Overall Study|Withdrawal by Subject|4|||
19462447|NCT01973387|41719768|FG000|Overall Study|Study terminated by sponsor|63|||
19462448|NCT01973387|41719769|FG001|Overall Study|Study terminated by sponsor|0|||
19462449|NCT01973387|41719768|FG000|Overall Study|Progressive disease or relapse|16|||
19462450|NCT01973387|41719769|FG001|Overall Study|Progressive disease or relapse|5|||
19462451|NCT01973387|41719768|FG000|Overall Study|Death|4|||
19462452|NCT01973387|41719769|FG001|Overall Study|Death|3|||
19462453|NCT01973387|41719768|FG000|Overall Study|Randomized, not treated|2|||
19462454|NCT01973387|41719769|FG001|Overall Study|Randomized, not treated|2|||
19462455|NCT01973231|41719777|FG000|Overall Study|Protocol Violation|1|||
19462456|NCT01973231|41719778|FG001|Overall Study|Protocol Violation|1|||
19462457|NCT01973231|41719777|FG000|Overall Study|Lost to Follow-up|1|||
19462458|NCT01973231|41719778|FG001|Overall Study|Lost to Follow-up|1|||
19462459|NCT01973231|41719777|FG000|Overall Study|unclassified|2|||
19462460|NCT01973231|41719778|FG001|Overall Study|unclassified|1|||
19462461|NCT01973231|41719777|FG000|Overall Study|Withdrawal by Subject|7|||
19462462|NCT01973231|41719778|FG001|Overall Study|Withdrawal by Subject|9|||
19462463|NCT01961687|41719784|FG000|Overall Study|Lost to Follow-up|19|||
19462464|NCT01961687|41719784|FG000|Overall Study|Re-operation|17|||
19462465|NCT01961687|41719784|FG000|Overall Study|Death|7|||
19462466|NCT01961687|41719784|FG000|Overall Study|Withdrawal by Subject|6|||
19462467|NCT01961687|41719784|FG000|Overall Study|Adverse Event|6|||
19462468|NCT01961687|41719784|FG000|Overall Study|Moved to area without study site|2|||
19462469|NCT01961687|41719784|FG000|Overall Study|Sponsor decision|2|||
19462470|NCT01961687|41719784|FG000|Overall Study|Physician Decision|1|||
19462471|NCT01961687|41719784|FG000|Overall Study|Unable to meet follow-up requirements|1|||
19462472|NCT01961609|41719846|FG000|Initiation|Missing|3|||
19462473|NCT01961609|41719847|FG001|Initiation|Missing|2|||
19462474|NCT01961609|41719848|FG002|Initiation|Missing|0|||
19462475|NCT01961609|41719849|FG003|Initiation|Missing|0|||
19462476|NCT01961609|41719846|FG000|Initiation|Protocol deviation|1|||
19462477|NCT01961609|41719847|FG001|Initiation|Protocol deviation|0|||
19462478|NCT01961609|41719848|FG002|Initiation|Protocol deviation|0|||
19462479|NCT01961609|41719849|FG003|Initiation|Protocol deviation|0|||
19462480|NCT01961609|41719846|FG000|Initiation|Death|0|||
19462481|NCT01961609|41719847|FG001|Initiation|Death|1|||
19462482|NCT01961609|41719848|FG002|Initiation|Death|0|||
19462483|NCT01961609|41719849|FG003|Initiation|Death|0|||
19462484|NCT01961609|41719846|FG000|Initiation|Administrative problems|1|||
19462485|NCT01961609|41719847|FG001|Initiation|Administrative problems|0|||
19462486|NCT01961609|41719848|FG002|Initiation|Administrative problems|0|||
19462487|NCT01961609|41719849|FG003|Initiation|Administrative problems|0|||
19462488|NCT01961609|41719846|FG000|Initiation|Withdrawal by Subject|1|||
19462489|NCT01961609|41719847|FG001|Initiation|Withdrawal by Subject|2|||
19462490|NCT01961609|41719848|FG002|Initiation|Withdrawal by Subject|0|||
19462491|NCT01961609|41719849|FG003|Initiation|Withdrawal by Subject|0|||
19462492|NCT01961609|41719846|FG000|Initiation|Lack of Efficacy|2|||
19462493|NCT01961609|41719847|FG001|Initiation|Lack of Efficacy|1|||
19462494|NCT01961609|41719848|FG002|Initiation|Lack of Efficacy|0|||
19462495|NCT01961609|41719849|FG003|Initiation|Lack of Efficacy|0|||
19462496|NCT01961609|41719846|FG000|Initiation|Abnormal lab values|0|||
19462497|NCT01961609|41719847|FG001|Initiation|Abnormal lab values|1|||
19462498|NCT01961609|41719848|FG002|Initiation|Abnormal lab values|0|||
19462499|NCT01961609|41719849|FG003|Initiation|Abnormal lab values|0|||
19462500|NCT01961609|41719846|FG000|Initiation|Adverse Event|3|||
19462501|NCT01961609|41719847|FG001|Initiation|Adverse Event|5|||
19462502|NCT01961609|41719848|FG002|Initiation|Adverse Event|0|||
19462503|NCT01961609|41719849|FG003|Initiation|Adverse Event|0|||
19462504|NCT01961609|41719846|FG000|Initiation|Randomized but not treated|1|||
19462505|NCT01961609|41719847|FG001|Initiation|Randomized but not treated|1|||
19462506|NCT01961609|41719848|FG002|Initiation|Randomized but not treated|0|||
19462507|NCT01961609|41719849|FG003|Initiation|Randomized but not treated|0|||
19462508|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
19462509|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
19462510|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
19462511|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
19462512|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
19376107|NCT03287245|41618268|FG003|Overall Study|Study terminated by sponsor|1|||
19376108|NCT03287245|41618265|FG000|Overall Study|Adverse Event|1|||
19376109|NCT03287245|41618266|FG001|Overall Study|Adverse Event|0|||
19376110|NCT03287245|41618267|FG002|Overall Study|Adverse Event|0|||
19376111|NCT03287245|41618268|FG003|Overall Study|Adverse Event|0|||
19376112|NCT03287245|41618265|FG000|Overall Study|Withdrawal by Subject|8|||
19376113|NCT03287245|41618266|FG001|Overall Study|Withdrawal by Subject|3|||
19376114|NCT03287245|41618267|FG002|Overall Study|Withdrawal by Subject|3|||
19376115|NCT03287245|41618268|FG003|Overall Study|Withdrawal by Subject|0|||
19376116|NCT03287245|41618265|FG000|Overall Study|Physician Decision|3|||
19376117|NCT03287245|41618266|FG001|Overall Study|Physician Decision|2|||
19376118|NCT03287245|41618267|FG002|Overall Study|Physician Decision|0|||
19376119|NCT03287245|41618268|FG003|Overall Study|Physician Decision|0|||
19376120|NCT02262754|41618301|FG000|Overall Study|Adverse Event|3|||
19376121|NCT02262754|41618302|FG001|Overall Study|Adverse Event|4|||
19376122|NCT02262754|41618303|FG002|Overall Study|Adverse Event|0|||
19376123|NCT02262754|41618301|FG000|Overall Study|Lack of Efficacy|2|||
19376124|NCT02262754|41618302|FG001|Overall Study|Lack of Efficacy|0|||
19376125|NCT02262754|41618303|FG002|Overall Study|Lack of Efficacy|1|||
19376126|NCT02262754|41618301|FG000|Overall Study|Lost to Follow-up|0|||
19376127|NCT02262754|41618302|FG001|Overall Study|Lost to Follow-up|0|||
19376128|NCT02262754|41618303|FG002|Overall Study|Lost to Follow-up|1|||
19376129|NCT02262754|41618301|FG000|Overall Study|No longer meets eligibility criteria|0|||
19376130|NCT02262754|41618302|FG001|Overall Study|No longer meets eligibility criteria|1|||
19376131|NCT02262754|41618303|FG002|Overall Study|No longer meets eligibility criteria|0|||
19376132|NCT02262754|41618301|FG000|Overall Study|Study terminated by sponsor|5|||
19376133|NCT02262754|41618302|FG001|Overall Study|Study terminated by sponsor|4|||
19376134|NCT02262754|41618303|FG002|Overall Study|Study terminated by sponsor|4|||
19376135|NCT02262754|41618301|FG000|Overall Study|Protocol Violation|1|||
19376136|NCT02262754|41618302|FG001|Overall Study|Protocol Violation|0|||
19376137|NCT02262754|41618303|FG002|Overall Study|Protocol Violation|0|||
19376138|NCT02262754|41618301|FG000|Overall Study|Withdrawal by Subject|1|||
19376139|NCT02262754|41618302|FG001|Overall Study|Withdrawal by Subject|0|||
19376140|NCT02262754|41618303|FG002|Overall Study|Withdrawal by Subject|1|||
19376141|NCT02262754|41618301|FG000|Overall Study|Other|4|||
19376142|NCT02262754|41618302|FG001|Overall Study|Other|0|||
19376143|NCT02262754|41618303|FG002|Overall Study|Other|2|||
19462513|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
19462514|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
19462515|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
19462516|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
19462517|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
19462518|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
19462519|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
19462520|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
19462521|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
19462522|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
19462523|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
19462524|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
19462525|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
19462526|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
19462527|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
19462528|NCT01961609|41719846|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
19462529|NCT01961609|41719847|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
19462530|NCT01961609|41719848|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
19462531|NCT01961609|41719849|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
19462532|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
19462533|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
19462534|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
19462535|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
19462536|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
19462537|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
19462538|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
19462539|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
19462540|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
19462541|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
19462542|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
19462543|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
19462544|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
19462545|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
19462546|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
19462547|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
19462548|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
19462549|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
19462550|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
19462551|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
19462552|NCT01961609|41719846|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
19462553|NCT01961609|41719847|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
19462554|NCT01961609|41719848|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
19462555|NCT01961609|41719849|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
19462556|NCT01774981|41719958|FG000|Overall Study|Adverse Event|0|||
19462557|NCT01774981|41719959|FG001|Overall Study|Adverse Event|0|||
19462558|NCT01774981|41719960|FG002|Overall Study|Adverse Event|0|||
19462559|NCT01774981|41719961|FG003|Overall Study|Adverse Event|0|||
19462560|NCT01774981|41719962|FG004|Overall Study|Adverse Event|0|||
19462561|NCT01774981|41719963|FG005|Overall Study|Adverse Event|1|||
19462562|NCT01774981|41719964|FG006|Overall Study|Adverse Event|0|||
19462563|NCT01774981|41719965|FG007|Overall Study|Adverse Event|0|||
19462564|NCT01774981|41719958|FG000|Overall Study|Withdrawal by Subject|0|||
19462565|NCT01774981|41719959|FG001|Overall Study|Withdrawal by Subject|0|||
19462566|NCT01774981|41719960|FG002|Overall Study|Withdrawal by Subject|0|||
19462567|NCT01774981|41719961|FG003|Overall Study|Withdrawal by Subject|0|||
19462568|NCT01774981|41719962|FG004|Overall Study|Withdrawal by Subject|0|||
19462569|NCT01774981|41719963|FG005|Overall Study|Withdrawal by Subject|0|||
19462570|NCT01774981|41719964|FG006|Overall Study|Withdrawal by Subject|0|||
19462571|NCT01774981|41719965|FG007|Overall Study|Withdrawal by Subject|1|||
19462572|NCT01774981|41719958|FG000|Overall Study|Death|0|||
19462573|NCT01774981|41719959|FG001|Overall Study|Death|0|||
19462574|NCT01774981|41719960|FG002|Overall Study|Death|0|||
19462575|NCT01774981|41719961|FG003|Overall Study|Death|0|||
19462576|NCT01774981|41719962|FG004|Overall Study|Death|1|||
19462577|NCT01774981|41719963|FG005|Overall Study|Death|0|||
19462578|NCT01774981|41719964|FG006|Overall Study|Death|0|||
19462579|NCT01774981|41719965|FG007|Overall Study|Death|0|||
19462580|NCT01972841|41719994|FG000|Overall Study|Randomized but Never Received Treatment|2|||
19462581|NCT01972841|41719995|FG001|Overall Study|Randomized but Never Received Treatment|5|||
19462582|NCT01972841|41719996|FG002|Overall Study|Randomized but Never Received Treatment|4|||
19462583|NCT01972841|41719997|FG003|Overall Study|Randomized but Never Received Treatment|2|||
19462584|NCT01972841|41719998|FG004|Overall Study|Randomized but Never Received Treatment|6|||
19462585|NCT01972841|41719999|FG005|Overall Study|Randomized but Never Received Treatment|13|||
19462586|NCT01972841|41719994|FG000|Overall Study|Adverse Event|13|||
19462587|NCT01972841|41719995|FG001|Overall Study|Adverse Event|8|||
19462588|NCT01972841|41719996|FG002|Overall Study|Adverse Event|12|||
19462589|NCT01972841|41719997|FG003|Overall Study|Adverse Event|9|||
19462590|NCT01972841|41719998|FG004|Overall Study|Adverse Event|21|||
19462591|NCT01972841|41719999|FG005|Overall Study|Adverse Event|26|||
19462592|NCT01972841|41719994|FG000|Overall Study|Lack of Efficacy|1|||
19462593|NCT01972841|41719995|FG001|Overall Study|Lack of Efficacy|0|||
19462594|NCT01972841|41719996|FG002|Overall Study|Lack of Efficacy|0|||
19462595|NCT01972841|41719997|FG003|Overall Study|Lack of Efficacy|2|||
19462596|NCT01972841|41719998|FG004|Overall Study|Lack of Efficacy|4|||
19462597|NCT01972841|41719999|FG005|Overall Study|Lack of Efficacy|1|||
19462598|NCT01972841|41719994|FG000|Overall Study|Lost to Follow-up|4|||
19462599|NCT01972841|41719995|FG001|Overall Study|Lost to Follow-up|2|||
19462600|NCT01972841|41719996|FG002|Overall Study|Lost to Follow-up|4|||
19462601|NCT01972841|41719997|FG003|Overall Study|Lost to Follow-up|2|||
19462602|NCT01972841|41719998|FG004|Overall Study|Lost to Follow-up|9|||
19462603|NCT01972841|41719999|FG005|Overall Study|Lost to Follow-up|3|||
19462604|NCT01972841|41719994|FG000|Overall Study|Protocol Violation|2|||
19462605|NCT01972841|41719995|FG001|Overall Study|Protocol Violation|2|||
19462606|NCT01972841|41719996|FG002|Overall Study|Protocol Violation|3|||
19462607|NCT01972841|41719997|FG003|Overall Study|Protocol Violation|5|||
19462608|NCT01972841|41719998|FG004|Overall Study|Protocol Violation|9|||
19462609|NCT01972841|41719999|FG005|Overall Study|Protocol Violation|4|||
19462610|NCT01972841|41719994|FG000|Overall Study|Withdrawal by participants|21|||
19462611|NCT01972841|41719995|FG001|Overall Study|Withdrawal by participants|27|||
19462612|NCT01972841|41719996|FG002|Overall Study|Withdrawal by participants|23|||
19462613|NCT01972841|41719997|FG003|Overall Study|Withdrawal by participants|16|||
19462614|NCT01972841|41719998|FG004|Overall Study|Withdrawal by participants|33|||
19462615|NCT01972841|41719999|FG005|Overall Study|Withdrawal by participants|34|||
19462616|NCT01972841|41719994|FG000|Overall Study|Miscellaneous|0|||
19462617|NCT01972841|41719995|FG001|Overall Study|Miscellaneous|0|||
19462618|NCT01972841|41719996|FG002|Overall Study|Miscellaneous|4|||
19462619|NCT01972841|41719997|FG003|Overall Study|Miscellaneous|1|||
19462620|NCT01972841|41719998|FG004|Overall Study|Miscellaneous|0|||
19462621|NCT01972841|41719999|FG005|Overall Study|Miscellaneous|4|||
19462622|NCT01972841|41719994|FG000|Overall Study|Did not have end of treatment page|0|||
19462623|NCT01972841|41719995|FG001|Overall Study|Did not have end of treatment page|0|||
19462624|NCT01972841|41719996|FG002|Overall Study|Did not have end of treatment page|0|||
19462625|NCT01972841|41719997|FG003|Overall Study|Did not have end of treatment page|0|||
19462626|NCT01972841|41719998|FG004|Overall Study|Did not have end of treatment page|1|||
19462627|NCT01972841|41719999|FG005|Overall Study|Did not have end of treatment page|0|||
19462628|NCT01774903|41720013|FG000|Overall Study|Adverse Event|7|||
19462629|NCT01774903|41720013|FG000|Overall Study|Withdrawal by Subject|2|||
19462630|NCT01774903|41720013|FG000|Overall Study|Lack of Efficacy|1|||
19462631|NCT01774903|41720013|FG000|Overall Study|Ineligible to continue the trial|1|||
19462632|NCT01774591|41720020|FG000|Overall Study|Physician Decision|1|||
19462633|NCT01774591|41720021|FG001|Overall Study|Physician Decision|1|||
19462634|NCT01774591|41720020|FG000|Overall Study|Withdrawal by Subject|0|||
19462635|NCT01774591|41720021|FG001|Overall Study|Withdrawal by Subject|1|||
19462636|NCT01774591|41720020|FG000|Overall Study|Adverse Event|0|||
19462637|NCT01774591|41720021|FG001|Overall Study|Adverse Event|2|||
19462638|NCT01708915|41720031|FG000|Overall Study|Adverse Event|1|||
19462639|NCT01708915|41720032|FG001|Overall Study|Adverse Event|0|||
19462640|NCT01708915|41720033|FG002|Overall Study|Adverse Event|9|||
19462641|NCT01708915|41720034|FG003|Overall Study|Adverse Event|13|||
19462642|NCT01708915|41720031|FG000|Overall Study|Lack of Efficacy|84|||
19462643|NCT01708915|41720032|FG001|Overall Study|Lack of Efficacy|60|||
19462644|NCT01708915|41720033|FG002|Overall Study|Lack of Efficacy|35|||
19462645|NCT01708915|41720034|FG003|Overall Study|Lack of Efficacy|15|||
19462646|NCT01708915|41720031|FG000|Overall Study|Protocol Violation|0|||
19462647|NCT01708915|41720032|FG001|Overall Study|Protocol Violation|0|||
19462648|NCT01708915|41720033|FG002|Overall Study|Protocol Violation|0|||
19462649|NCT01708915|41720034|FG003|Overall Study|Protocol Violation|1|||
19462650|NCT01708915|41720031|FG000|Overall Study|Withdrawal by Subject|0|||
19462651|NCT01708915|41720032|FG001|Overall Study|Withdrawal by Subject|1|||
19462652|NCT01708915|41720033|FG002|Overall Study|Withdrawal by Subject|2|||
19462653|NCT01708915|41720034|FG003|Overall Study|Withdrawal by Subject|2|||
19462654|NCT01708915|41720031|FG000|Overall Study|Other reasons than stated above|1|||
19462655|NCT01708915|41720032|FG001|Overall Study|Other reasons than stated above|1|||
19462656|NCT01708915|41720033|FG002|Overall Study|Other reasons than stated above|0|||
19462657|NCT01708915|41720034|FG003|Overall Study|Other reasons than stated above|2|||
19462658|NCT01708291|41720046|FG000|Overall Study|fighting|2|||
19462659|NCT01708291|41720047|FG001|Overall Study|fighting|1|||
19462660|NCT01708057|41720053|FG000|Overall Study|Withdrawal due to study termination.|1|||
19462661|NCT01708057|41720054|FG001|Overall Study|Withdrawal due to study termination.|1|||
19462662|NCT01708057|41720055|FG002|Overall Study|Withdrawal due to study termination.|1|||
19462663|NCT01748071|41720072|FG000|Overall Study|Adverse Event|2|||
19462664|NCT01748071|41720073|FG001|Overall Study|Adverse Event|2|||
19462665|NCT01748071|41720074|FG002|Overall Study|Adverse Event|0|||
19462666|NCT01972529|41720086|FG000|Overall Study|Adverse Event|0|||
19462667|NCT01972529|41720087|FG001|Overall Study|Adverse Event|1|||
19462668|NCT01972529|41720088|FG002|Overall Study|Adverse Event|0|||
19462669|NCT01972529|41720089|FG003|Overall Study|Adverse Event|0|||
19462670|NCT01972529|41720086|FG000|Overall Study|Lost to Follow-up|1|||
19462671|NCT01972529|41720087|FG001|Overall Study|Lost to Follow-up|0|||
19462672|NCT01972529|41720088|FG002|Overall Study|Lost to Follow-up|0|||
19462673|NCT01972529|41720089|FG003|Overall Study|Lost to Follow-up|0|||
19462674|NCT01972529|41720086|FG000|Overall Study|Participant Choice|0|||
19462675|NCT01972529|41720087|FG001|Overall Study|Participant Choice|1|||
19462676|NCT01972529|41720088|FG002|Overall Study|Participant Choice|0|||
19462677|NCT01972529|41720089|FG003|Overall Study|Participant Choice|0|||
19462678|NCT01972529|41720086|FG000|Overall Study|Withdrawl of Consent|1|||
19462679|NCT01972529|41720087|FG001|Overall Study|Withdrawl of Consent|2|||
19462680|NCT01972529|41720088|FG002|Overall Study|Withdrawl of Consent|0|||
19462681|NCT01972529|41720089|FG003|Overall Study|Withdrawl of Consent|1|||
19462682|NCT01972529|41720086|FG000|Overall Study|Other|0|||
19462683|NCT01972529|41720087|FG001|Overall Study|Other|0|||
19462684|NCT01972529|41720088|FG002|Overall Study|Other|0|||
19462685|NCT01972529|41720089|FG003|Overall Study|Other|2|||
19462686|NCT01972529|41720086|FG000|Overall Study|Not treated|0|||
19462687|NCT01972529|41720087|FG001|Overall Study|Not treated|1|||
19462688|NCT01972529|41720088|FG002|Overall Study|Not treated|2|||
19462689|NCT01972529|41720089|FG003|Overall Study|Not treated|1|||
19462690|NCT01747915|41720103|FG000|Overall Study|Other|1|||
19462691|NCT01747915|41720104|FG001|Overall Study|Other|1|||
19462692|NCT01747915|41720105|FG002|Overall Study|Other|1|||
19462693|NCT01747915|41720103|FG000|Overall Study|Adverse Event|8|||
19462694|NCT01747915|41720104|FG001|Overall Study|Adverse Event|5|||
19462695|NCT01747915|41720105|FG002|Overall Study|Adverse Event|2|||
19462696|NCT01747915|41720103|FG000|Overall Study|Death|0|||
19462697|NCT01747915|41720104|FG001|Overall Study|Death|0|||
19462698|NCT01747915|41720105|FG002|Overall Study|Death|1|||
19462699|NCT01747915|41720103|FG000|Overall Study|Lack of Efficacy|0|||
19462700|NCT01747915|41720104|FG001|Overall Study|Lack of Efficacy|1|||
19462701|NCT01747915|41720105|FG002|Overall Study|Lack of Efficacy|0|||
19462702|NCT01747915|41720103|FG000|Overall Study|Lost to Follow-up|1|||
19462703|NCT01747915|41720104|FG001|Overall Study|Lost to Follow-up|0|||
19462704|NCT01747915|41720105|FG002|Overall Study|Lost to Follow-up|0|||
19462705|NCT01747915|41720103|FG000|Overall Study|Withdrawal by Subject|4|||
19462706|NCT01747915|41720104|FG001|Overall Study|Withdrawal by Subject|4|||
19462707|NCT01747915|41720105|FG002|Overall Study|Withdrawal by Subject|1|||
19462708|NCT01747915|41720103|FG000|Overall Study|Protocol Violation|1|||
19462709|NCT01747915|41720104|FG001|Overall Study|Protocol Violation|0|||
19462710|NCT01747915|41720105|FG002|Overall Study|Protocol Violation|0|||
19462711|NCT01747915|41720103|FG000|Overall Study|Pregnancy|0|||
19462712|NCT01747915|41720104|FG001|Overall Study|Pregnancy|0|||
19462713|NCT01747915|41720105|FG002|Overall Study|Pregnancy|1|||
19462714|NCT01961297|41720115|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
19462715|NCT01961297|41720116|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
19462716|NCT01960907|41720124|FG000|Overall Study|Death|4|||
19462717|NCT01960907|41720125|FG001|Overall Study|Death|3|||
19462718|NCT01960907|41720124|FG000|Overall Study|Withdrawal by Subject|32|||
19462719|NCT01960907|41720125|FG001|Overall Study|Withdrawal by Subject|42|||
19462720|NCT01747837|41720136|FG000|Overall Study|Lost to Follow-up|5|||
19462721|NCT01747837|41720137|FG001|Overall Study|Lost to Follow-up|2|||
19462722|NCT01747837|41720136|FG000|Overall Study|Death|4|||
19462723|NCT01747837|41720137|FG001|Overall Study|Death|4|||
19462724|NCT01971203|41720145|FG000|Overall Study|Protocol Violation|3|||
19462725|NCT01971203|41720146|FG001|Overall Study|Protocol Violation|2|||
19462726|NCT01971203|41720145|FG000|Overall Study|Withdrawal by Subject|5|||
19462727|NCT01971203|41720146|FG001|Overall Study|Withdrawal by Subject|6|||
19462728|NCT01971203|41720145|FG000|Overall Study|Adverse Event|1|||
19462729|NCT01971203|41720146|FG001|Overall Study|Adverse Event|0|||
19462730|NCT01605877|41720152|FG000|Overall Study|Withdrawal by Subject|1|||
19462731|NCT01970501|41720176|FG000|Overall Study|Discontinuation of study by sponsor|16|||
19462732|NCT01970501|41720177|FG001|Overall Study|Discontinuation of study by sponsor|14|||
19462733|NCT01970501|41720176|FG000|Overall Study|Withdrawal by Subject|6|||
19462734|NCT01970501|41720177|FG001|Overall Study|Withdrawal by Subject|7|||
19462735|NCT01970501|41720176|FG000|Overall Study|Adverse Event|2|||
19462736|NCT01970501|41720177|FG001|Overall Study|Adverse Event|4|||
19462737|NCT01970501|41720176|FG000|Overall Study|Death|1|||
19462738|NCT01970501|41720177|FG001|Overall Study|Death|3|||
19462739|NCT01970501|41720176|FG000|Overall Study|Physician Decision|2|||
19462740|NCT01970501|41720177|FG001|Overall Study|Physician Decision|0|||
19462741|NCT01969799|41720185|FG000|Overall Study|Adverse Event|0|||
19462742|NCT01969799|41720186|FG001|Overall Study|Adverse Event|1|||
19462743|NCT01969799|41720185|FG000|Overall Study|Death|16|||
19462744|NCT01969799|41720186|FG001|Overall Study|Death|11|||
19462745|NCT01969799|41720185|FG000|Overall Study|Lost to Follow-up|0|||
19462746|NCT01969799|41720186|FG001|Overall Study|Lost to Follow-up|2|||
19462747|NCT01969799|41720185|FG000|Overall Study|Physician Decision|1|||
19462748|NCT01969799|41720186|FG001|Overall Study|Physician Decision|0|||
19462749|NCT01969721|41720192|FG000|Overall Study|Adverse Event|3|||
19462750|NCT01969721|41720193|FG001|Overall Study|Adverse Event|8|||
19462751|NCT01969721|41720194|FG002|Overall Study|Adverse Event|3|||
19462752|NCT01969721|41720195|FG003|Overall Study|Adverse Event|2|||
19462753|NCT01969721|41720192|FG000|Overall Study|Lack of Efficacy|0|||
19462754|NCT01969721|41720193|FG001|Overall Study|Lack of Efficacy|0|||
19462755|NCT01969721|41720194|FG002|Overall Study|Lack of Efficacy|1|||
19462756|NCT01969721|41720195|FG003|Overall Study|Lack of Efficacy|0|||
19462757|NCT01969721|41720192|FG000|Overall Study|Non compliant with protocol|1|||
19462758|NCT01969721|41720193|FG001|Overall Study|Non compliant with protocol|1|||
19462759|NCT01969721|41720194|FG002|Overall Study|Non compliant with protocol|0|||
19462760|NCT01969721|41720195|FG003|Overall Study|Non compliant with protocol|2|||
19462761|NCT01969721|41720192|FG000|Overall Study|Other not defined above|0|||
19462762|NCT01969721|41720193|FG001|Overall Study|Other not defined above|2|||
19462763|NCT01969721|41720194|FG002|Overall Study|Other not defined above|0|||
19462764|NCT01969721|41720195|FG003|Overall Study|Other not defined above|0|||
19462765|NCT01969721|41720192|FG000|Overall Study|Discontinued during washout periods.|0|||
19462766|NCT01969721|41720193|FG001|Overall Study|Discontinued during washout periods.|1|||
19462767|NCT01969721|41720194|FG002|Overall Study|Discontinued during washout periods.|1|||
19462768|NCT01969721|41720195|FG003|Overall Study|Discontinued during washout periods.|2|||
19462769|NCT01969565|41720205|FG000|Overall Study|Withdrawal by Subject|1|||
19462770|NCT01968707|41720218|FG000|Overall Study|Did not meet treatment day baseline|49|||
19462771|NCT01968707|41720219|FG001|Overall Study|Did not meet treatment day baseline|12|||
19462772|NCT01968707|41720220|FG002|Overall Study|Did not meet treatment day baseline|41|||
19462773|NCT01968707|41720221|FG003|Overall Study|Did not meet treatment day baseline|44|||
19462774|NCT01968707|41720222|FG004|Overall Study|Did not meet treatment day baseline|36|||
19462775|NCT01968707|41720223|FG005|Overall Study|Did not meet treatment day baseline|11|||
19462776|NCT01968707|41720224|FG006|Overall Study|Did not meet treatment day baseline|34|||
19462777|NCT01968707|41720225|FG007|Overall Study|Did not meet treatment day baseline|35|||
19462778|NCT01959581|41720258|FG000|Overall Study|Lost to Follow-up|5|||
19462779|NCT01746901|41720262|FG000|Naloxone Challenge Phase|Adverse Event|2|||
19462780|NCT01746901|41720263|FG001|Naloxone Challenge Phase|Adverse Event|0|||
19462781|NCT01746901|41720264|FG002|Naloxone Challenge Phase|Adverse Event|0|||
19462782|NCT01746901|41720265|FG003|Naloxone Challenge Phase|Adverse Event|0|||
19462783|NCT01746901|41720266|FG004|Naloxone Challenge Phase|Adverse Event|0|||
19462784|NCT01746901|41720267|FG005|Naloxone Challenge Phase|Adverse Event|0|||
19462785|NCT01746901|41720268|FG006|Naloxone Challenge Phase|Adverse Event|0|||
19462786|NCT01746901|41720269|FG007|Naloxone Challenge Phase|Adverse Event|0|||
19462787|NCT01746901|41720270|FG008|Naloxone Challenge Phase|Adverse Event|0|||
19462788|NCT01746901|41720262|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
19462789|NCT01746901|41720263|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462790|NCT01746901|41720264|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462791|NCT01746901|41720265|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462792|NCT01746901|41720266|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462793|NCT01746901|41720267|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462794|NCT01746901|41720268|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462795|NCT01746901|41720269|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462796|NCT01746901|41720270|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
19462797|NCT01746901|41720262|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462798|NCT01746901|41720263|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
19462799|NCT01746901|41720264|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462800|NCT01746901|41720265|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462801|NCT01746901|41720266|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462802|NCT01746901|41720267|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462803|NCT01746901|41720268|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462804|NCT01746901|41720269|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462805|NCT01746901|41720270|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
19462806|NCT01746901|41720262|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462807|NCT01746901|41720263|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
19462808|NCT01746901|41720264|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
19462809|NCT01746901|41720265|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462810|NCT01746901|41720266|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462811|NCT01746901|41720267|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462812|NCT01746901|41720268|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462813|NCT01746901|41720269|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462814|NCT01746901|41720270|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
19462815|NCT01746901|41720262|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462816|NCT01746901|41720263|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
19462817|NCT01746901|41720264|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
19462818|NCT01746901|41720265|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462819|NCT01746901|41720266|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462820|NCT01746901|41720267|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462821|NCT01746901|41720268|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462822|NCT01746901|41720269|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462823|NCT01746901|41720270|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
19462824|NCT01746901|41720262|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462825|NCT01746901|41720263|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
19462826|NCT01746901|41720264|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
19462827|NCT01746901|41720265|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462828|NCT01746901|41720266|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462829|NCT01746901|41720267|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462830|NCT01746901|41720268|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462831|NCT01746901|41720269|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462832|NCT01746901|41720270|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
19462833|NCT01746901|41720262|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
19462834|NCT01746901|41720263|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
19462835|NCT01746901|41720264|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
19462836|NCT01746901|41720265|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
19462837|NCT01746901|41720266|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
19462838|NCT01746901|41720267|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
19462839|NCT01746901|41720268|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
19462840|NCT01746901|41720269|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
19462841|NCT01746901|41720270|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
19462842|NCT01746901|41720262|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462843|NCT01746901|41720263|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462844|NCT01746901|41720264|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462845|NCT01746901|41720265|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462846|NCT01746901|41720266|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462847|NCT01746901|41720267|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462848|NCT01746901|41720268|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462849|NCT01746901|41720269|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
19462850|NCT01746901|41720270|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
19462851|NCT01746901|41720262|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462852|NCT01746901|41720263|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462853|NCT01746901|41720264|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462854|NCT01746901|41720265|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462855|NCT01746901|41720266|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462856|NCT01746901|41720267|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
19462857|NCT01746901|41720268|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
19462858|NCT01746901|41720269|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462859|NCT01746901|41720270|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
19462860|NCT01746901|41720262|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462861|NCT01746901|41720263|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462862|NCT01746901|41720264|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462863|NCT01746901|41720265|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
19462864|NCT01746901|41720266|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462865|NCT01746901|41720267|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462866|NCT01746901|41720268|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462867|NCT01746901|41720269|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462868|NCT01746901|41720270|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
19462869|NCT01746901|41720262|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462870|NCT01746901|41720263|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462871|NCT01746901|41720264|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462872|NCT01746901|41720265|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462873|NCT01746901|41720266|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462874|NCT01746901|41720267|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
19462875|NCT01746901|41720268|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462876|NCT01746901|41720269|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
19462877|NCT01746901|41720270|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
19462878|NCT01746901|41720262|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462879|NCT01746901|41720263|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462880|NCT01746901|41720264|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462881|NCT01746901|41720265|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462882|NCT01746901|41720266|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462883|NCT01746901|41720267|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462884|NCT01746901|41720268|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
19462885|NCT01746901|41720269|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
19462886|NCT01746901|41720270|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
19462887|NCT01968551|41720309|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
19462888|NCT01968551|41720310|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
19462889|NCT01968551|41720311|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
19462890|NCT01968551|41720309|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
19462891|NCT01968551|41720310|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
19462892|NCT01968551|41720311|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
19462893|NCT01968551|41720309|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
19462894|NCT01968551|41720310|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
19462895|NCT01968551|41720311|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
19462896|NCT01968551|41720309|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
19462897|NCT01968551|41720310|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
19462898|NCT01968551|41720311|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
19462899|NCT01968551|41720309|FG000|Extension Phase|Adverse Event|0|||
19462900|NCT01968551|41720310|FG001|Extension Phase|Adverse Event|0|||
19462901|NCT01968551|41720311|FG002|Extension Phase|Adverse Event|2|||
19462902|NCT01968551|41720309|FG000|Extension Phase|Death|0|||
19462903|NCT01968551|41720310|FG001|Extension Phase|Death|1|||
19462904|NCT01968551|41720311|FG002|Extension Phase|Death|0|||
19462905|NCT01968551|41720309|FG000|Extension Phase|Withdrew Consent|0|||
19462906|NCT01968551|41720310|FG001|Extension Phase|Withdrew Consent|0|||
19462907|NCT01968551|41720311|FG002|Extension Phase|Withdrew Consent|1|||
19462908|NCT01968551|41720309|FG000|Extension Phase|Lost to Follow-up|1|||
19462909|NCT01968551|41720310|FG001|Extension Phase|Lost to Follow-up|0|||
19462910|NCT01968551|41720311|FG002|Extension Phase|Lost to Follow-up|1|||
19462911|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
19462912|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
19462913|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
19462914|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
19462915|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
19462916|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
19462917|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
19462918|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
19462919|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
19462920|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
19462921|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
19462922|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
19462923|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
19462924|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
19462925|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
19462926|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
19462927|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
19462928|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
19462929|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
19462930|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
19462931|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
19462932|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
19462933|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
19462934|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
19462935|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
19462936|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
19462937|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
19462938|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
19462939|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
19462940|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
19462941|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
19462942|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
19462943|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
19462944|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
19462945|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
19462946|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
19462947|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
19462948|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
19462949|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
19462950|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
19462951|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
19462952|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
19462953|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
19462954|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
19462955|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
19462956|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
19462957|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
19462958|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
19462959|NCT01707992|41720326|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
19462960|NCT01707992|41720327|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
19462961|NCT01707992|41720328|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
19462962|NCT01707992|41720329|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
19462963|NCT01707992|41720330|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
19462964|NCT01707992|41720331|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
19462965|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
19462966|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
19462967|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
19462968|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
19462969|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
19462970|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
19462971|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
19462972|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
19462973|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
19462974|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
19462975|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
19462976|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
19462977|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
19462978|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
19462979|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
19462980|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
19462981|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
19462982|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
19462983|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
19462984|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
19462985|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
19462986|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
19462987|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
19462988|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
19462989|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
19462990|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
19462991|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
19462992|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
19462993|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
19462994|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
19462995|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Death|0|||
19462996|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Death|0|||
19462997|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Death|0|||
19462998|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Death|2|||
19462999|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Death|0|||
19463000|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Death|0|||
19463001|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
19463002|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
19463003|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
19463004|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
19463005|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
19463006|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
19463007|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
19463008|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
19463009|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
19463010|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
19463011|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
19463012|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
19463013|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
19463014|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
19463015|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
19463016|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
19463017|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
19463018|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
19463019|NCT01707992|41720326|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
19463020|NCT01707992|41720327|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
19463021|NCT01707992|41720328|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
19463022|NCT01707992|41720329|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
19463023|NCT01707992|41720330|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
19463024|NCT01707992|41720331|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
19463025|NCT01946165|41720348|FG000|Overall Study|Physician Decision|2|||
19463026|NCT01946165|41720349|FG001|Overall Study|Physician Decision|0|||
19463027|NCT01946165|41720348|FG000|Overall Study|Withdrawal by Subject|0|||
19463028|NCT01946165|41720349|FG001|Overall Study|Withdrawal by Subject|2|||
19463029|NCT01707667|41720358|FG000|Period 1|expulsion of colonic sensor catheter|1|||
19463030|NCT01707667|41720359|FG001|Period 1|expulsion of colonic sensor catheter|0|||
19463031|NCT01959503|41720367|FG000|Overall Study|Death|2|||
19463032|NCT01959503|41720368|FG001|Overall Study|Death|1|||
19463033|NCT01959503|41720367|FG000|Overall Study|Randomized but not treated|1|||
19463034|NCT01959503|41720368|FG001|Overall Study|Randomized but not treated|1|||
19463035|NCT01605799|41720376|FG000|Overall Study|Withdrawal by Subject|2|||
19463036|NCT01605799|41720377|FG001|Overall Study|Withdrawal by Subject|1|||
19463037|NCT01706575|41720383|FG000|Overall Study|Participant Withdrew Consent|4|||
19463038|NCT01706575|41720383|FG000|Overall Study|Lost to Follow-up|2|||
19463039|NCT01706575|41720383|FG000|Overall Study|Started but not Treated|6|||
19463040|NCT01959425|41720389|FG000|Overall Study|Withdrawal by Subject|5|||
19463041|NCT01959425|41720390|FG001|Overall Study|Withdrawal by Subject|4|||
19463042|NCT01959425|41720389|FG000|Overall Study|Lost to Follow-up|1|||
19463043|NCT01959425|41720390|FG001|Overall Study|Lost to Follow-up|0|||
19463044|NCT01959425|41720389|FG000|Overall Study|Discontinued Subjects|6|||
19463045|NCT01959425|41720390|FG001|Overall Study|Discontinued Subjects|4|||
19463046|NCT01725529|41720399|FG000|Overall Study|Adverse Event|1|||
19463047|NCT01725529|41720400|FG001|Overall Study|Adverse Event|0|||
19463048|NCT01725529|41720401|FG002|Overall Study|Adverse Event|0|||
19463049|NCT01725529|41720399|FG000|Overall Study|Lost to Follow-up|2|||
19463050|NCT01725529|41720400|FG001|Overall Study|Lost to Follow-up|1|||
19463051|NCT01725529|41720401|FG002|Overall Study|Lost to Follow-up|1|||
19463052|NCT01725529|41720399|FG000|Overall Study|Protocol Violation|0|||
19463053|NCT01725529|41720400|FG001|Overall Study|Protocol Violation|1|||
19463054|NCT01725529|41720401|FG002|Overall Study|Protocol Violation|1|||
19463055|NCT01725529|41720399|FG000|Overall Study|Withdrawal by Subject|12|||
19463056|NCT01725529|41720400|FG001|Overall Study|Withdrawal by Subject|14|||
19463057|NCT01725529|41720401|FG002|Overall Study|Withdrawal by Subject|8|||
19463058|NCT01605097|41720409|FG000|Overall Study|Protocol Violation|1|||
19463059|NCT01605019|41720416|FG000|Overall Study|pt did not meet transplant endpoint|3|||
19463060|NCT01605019|41720417|FG001|Overall Study|pt did not meet transplant endpoint|0|||
19463061|NCT01705717|41720425|FG000|Overall Study|Adverse Event|2|||
19463062|NCT01705717|41720426|FG001|Overall Study|Adverse Event|2|||
19463063|NCT01705717|41720425|FG000|Overall Study|Lack of Efficacy|0|||
19463064|NCT01705717|41720426|FG001|Overall Study|Lack of Efficacy|1|||
19463065|NCT01705717|41720425|FG000|Overall Study|Other|0|||
19463066|NCT01705717|41720426|FG001|Overall Study|Other|2|||
19463067|NCT01744483|41720434|FG000|Overall Study|Death|9|||
19463068|NCT01744483|41720435|FG001|Overall Study|Death|4|||
19463069|NCT01744483|41720436|FG002|Overall Study|Death|11|||
19463070|NCT01744483|41720434|FG000|Overall Study|Lost to Follow-up|8|||
19463071|NCT01744483|41720435|FG001|Overall Study|Lost to Follow-up|9|||
19463072|NCT01744483|41720436|FG002|Overall Study|Lost to Follow-up|11|||
19463073|NCT01744483|41720434|FG000|Overall Study|Protocol Violation|1|||
19463074|NCT01744483|41720435|FG001|Overall Study|Protocol Violation|2|||
19463075|NCT01744483|41720436|FG002|Overall Study|Protocol Violation|1|||
19463076|NCT01744483|41720434|FG000|Overall Study|Withdrawal by Subject|4|||
19463077|NCT01744483|41720435|FG001|Overall Study|Withdrawal by Subject|6|||
19463078|NCT01744483|41720436|FG002|Overall Study|Withdrawal by Subject|2|||
19463079|NCT01744483|41720434|FG000|Overall Study|No ICU Admit|5|||
19463080|NCT01744483|41720435|FG001|Overall Study|No ICU Admit|1|||
19463081|NCT01744483|41720436|FG002|Overall Study|No ICU Admit|2|||
19463082|NCT01744483|41720434|FG000|Overall Study|Routed to OSH|2|||
19463083|NCT01744483|41720435|FG001|Overall Study|Routed to OSH|0|||
19463084|NCT01744483|41720436|FG002|Overall Study|Routed to OSH|1|||
19463085|NCT01744093|41720446|FG000|Overall Study|Withdrawal by Subject|6|||
19463086|NCT01744093|41720447|FG001|Overall Study|Withdrawal by Subject|1|||
19463087|NCT01725451|41720461|FG000|Period 1|Withdrawal by Subject|1|||
19463088|NCT01725451|41720462|FG001|Period 1|Withdrawal by Subject|0|||
19463089|NCT01725451|41720463|FG002|Period 1|Withdrawal by Subject|0|||
19463090|NCT01725451|41720464|FG003|Period 1|Withdrawal by Subject|0|||
19463091|NCT01725451|41720461|FG000|Washout From Period 3|Protocol Violation|0|||
19463092|NCT01725451|41720462|FG001|Washout From Period 3|Protocol Violation|0|||
19463093|NCT01725451|41720463|FG002|Washout From Period 3|Protocol Violation|1|||
19463094|NCT01725451|41720464|FG003|Washout From Period 3|Protocol Violation|0|||
19463095|NCT01725451|41720461|FG000|Washout From Period 3|Adverse Event|0|||
19463096|NCT01725451|41720462|FG001|Washout From Period 3|Adverse Event|1|||
19463097|NCT01725451|41720463|FG002|Washout From Period 3|Adverse Event|0|||
19463098|NCT01725451|41720464|FG003|Washout From Period 3|Adverse Event|0|||
19463099|NCT01725451|41720461|FG000|Period 4|Adverse Event|0|||
19463100|NCT01725451|41720462|FG001|Period 4|Adverse Event|0|||
19463101|NCT01725451|41720463|FG002|Period 4|Adverse Event|1|||
19463102|NCT01725451|41720464|FG003|Period 4|Adverse Event|0|||
19463106|NCT01707290|41720503|FG000|Overall Study|Adverse event (AE)|1|||
19463107|NCT01707290|41720504|FG001|Overall Study|Adverse event (AE)|0|||
19463108|NCT01707290|41720503|FG000|Overall Study|Physician Decision|1|||
19463109|NCT01707290|41720504|FG001|Overall Study|Physician Decision|0|||
19463110|NCT01707290|41720503|FG000|Overall Study|Lost to Follow-up|3|||
19463111|NCT01707290|41720504|FG001|Overall Study|Lost to Follow-up|0|||
19463112|NCT01707290|41720503|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
19463113|NCT01707290|41720504|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
19463114|NCT01707290|41720503|FG000|Overall Study|Commercial drug available|60|||
19463115|NCT01707290|41720504|FG001|Overall Study|Commercial drug available|1|||
19463116|NCT01707290|41720503|FG000|Overall Study|Other unspecified|17|||
19463117|NCT01707290|41720504|FG001|Overall Study|Other unspecified|0|||
19463118|NCT01717040|41720515|FG000|Overall Study|Lost to Follow-up|2|||
19463119|NCT01717040|41720516|FG001|Overall Study|Lost to Follow-up|3|||
19463120|NCT01717040|41720515|FG000|Overall Study|Lack of Efficacy|1|||
19463121|NCT01717040|41720516|FG001|Overall Study|Lack of Efficacy|1|||
19463122|NCT01717040|41720515|FG000|Overall Study|Adverse Event|1|||
19463123|NCT01717040|41720516|FG001|Overall Study|Adverse Event|0|||
19463124|NCT01717040|41720515|FG000|Overall Study|Required Medication Change|0|||
19463125|NCT01717040|41720516|FG001|Overall Study|Required Medication Change|1|||
19463126|NCT01717040|41720515|FG000|Overall Study|New Substance Use Disorder|1|||
19463127|NCT01717040|41720516|FG001|Overall Study|New Substance Use Disorder|0|||
19463128|NCT01743469|41720543|FG000|Active Treatment Phase|Adverse Event|10|||
19463129|NCT01743469|41720544|FG001|Active Treatment Phase|Adverse Event|5|||
19463130|NCT01743469|41720545|FG002|Active Treatment Phase|Adverse Event|8|||
19463131|NCT01743469|41720546|FG003|Active Treatment Phase|Adverse Event|1|||
19463132|NCT01743469|41720543|FG000|Active Treatment Phase|Disease Progression|40|||
19463133|NCT01743469|41720544|FG001|Active Treatment Phase|Disease Progression|47|||
19463134|NCT01743469|41720545|FG002|Active Treatment Phase|Disease Progression|30|||
19463135|NCT01743469|41720546|FG003|Active Treatment Phase|Disease Progression|20|||
19463136|NCT01743469|41720543|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
19463137|NCT01743469|41720544|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
19463138|NCT01743469|41720545|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
19463139|NCT01743469|41720546|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
19463140|NCT01743469|41720543|FG000|Active Treatment Phase|Missing|1|||
19463141|NCT01743469|41720544|FG001|Active Treatment Phase|Missing|0|||
19463142|NCT01743469|41720545|FG002|Active Treatment Phase|Missing|0|||
19463143|NCT01743469|41720546|FG003|Active Treatment Phase|Missing|0|||
19463144|NCT01743469|41720543|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
19463145|NCT01743469|41720544|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
19463146|NCT01743469|41720545|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
19463147|NCT01743469|41720546|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
19463148|NCT01743469|41720543|FG000|Follow-up Period - Post-Treatment|Death|43|||
19463149|NCT01743469|41720544|FG001|Follow-up Period - Post-Treatment|Death|47|||
19463150|NCT01743469|41720545|FG002|Follow-up Period - Post-Treatment|Death|22|||
19463151|NCT01743469|41720546|FG003|Follow-up Period - Post-Treatment|Death|16|||
19463152|NCT01743469|41720543|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
19463153|NCT01743469|41720544|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
19463154|NCT01743469|41720545|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
19463155|NCT01743469|41720546|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
19463156|NCT01743001|41720558|FG000|Overall Study|Physician Decision|1|||
19463157|NCT01743001|41720559|FG001|Overall Study|Physician Decision|0|||
19463158|NCT01743001|41720558|FG000|Overall Study|Pregnancy|1|||
19463159|NCT01743001|41720559|FG001|Overall Study|Pregnancy|0|||
19463160|NCT01743001|41720558|FG000|Overall Study|Death|1|||
19463161|NCT01743001|41720559|FG001|Overall Study|Death|0|||
19463162|NCT01704079|41720578|FG000|Overall Study|Withdrawal by Subject|5|||
19463163|NCT01704079|41720579|FG001|Overall Study|Withdrawal by Subject|7|||
19463164|NCT01704079|41720578|FG000|Overall Study|Lost to Follow-up|2|||
19463165|NCT01704079|41720579|FG001|Overall Study|Lost to Follow-up|5|||
19463166|NCT01704079|41720578|FG000|Overall Study|Adverse Event|4|||
19463167|NCT01704079|41720579|FG001|Overall Study|Adverse Event|7|||
19463168|NCT01704079|41720578|FG000|Overall Study|Protocol Violation|1|||
19463169|NCT01704079|41720579|FG001|Overall Study|Protocol Violation|0|||
19463170|NCT01704079|41720578|FG000|Overall Study|Subject noncompliance|2|||
19463171|NCT01704079|41720579|FG001|Overall Study|Subject noncompliance|3|||
19463172|NCT01704079|41720578|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
19463173|NCT01704079|41720579|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
19463174|NCT01703845|41720587|FG000|Overall Study|Adverse Event|1|||
19463175|NCT01703845|41720588|FG001|Overall Study|Adverse Event|0|||
19463176|NCT01703845|41720587|FG000|Overall Study|Protocol Violation|1|||
19463177|NCT01703845|41720588|FG001|Overall Study|Protocol Violation|0|||
19463178|NCT01703845|41720587|FG000|Overall Study|other than stated above|1|||
19463179|NCT01703845|41720588|FG001|Overall Study|other than stated above|0|||
19463180|NCT01724359|41720596|FG000|Overall Study|Adverse Event|10|||
19463181|NCT01724359|41720596|FG000|Overall Study|Death|1|||
19463182|NCT01724359|41720596|FG000|Overall Study|Other|20|||
19463183|NCT01703221|41720605|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
19463184|NCT01703221|41720606|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
19463185|NCT01703221|41720607|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
19463186|NCT01703221|41720605|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
19463187|NCT01703221|41720606|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
19463188|NCT01703221|41720607|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
19463189|NCT01703221|41720605|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
19463190|NCT01703221|41720606|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19463191|NCT01703221|41720607|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
19463192|NCT01703221|41720605|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
19463193|NCT01703221|41720606|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
19463194|NCT01703221|41720607|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
19463195|NCT01703221|41720605|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19463196|NCT01703221|41720606|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
19463197|NCT01703221|41720607|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
19463198|NCT01703221|41720605|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
19463199|NCT01703221|41720606|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
19463200|NCT01703221|41720607|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
19463201|NCT01703221|41720605|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
19463202|NCT01703221|41720606|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
19463203|NCT01703221|41720607|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
19463204|NCT01703221|41720605|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
19463205|NCT01703221|41720606|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
19463206|NCT01703221|41720607|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
19463207|NCT01722877|41720621|FG000|Overall Study|Death|1|||
19463208|NCT01722877|41720621|FG000|Overall Study|Lost to Follow-up|1|||
19550567|NCT00107900|41999618|FG005|Overall Study|Death|0|||
19550568|NCT00107900|41999613|FG000|Overall Study|Lost to Follow-up|4|||
19550569|NCT00107900|41999614|FG001|Overall Study|Lost to Follow-up|1|||
19550570|NCT00107900|41999615|FG002|Overall Study|Lost to Follow-up|3|||
19550571|NCT00107900|41999616|FG003|Overall Study|Lost to Follow-up|2|||
19550572|NCT00107900|41999617|FG004|Overall Study|Lost to Follow-up|5|||
19550573|NCT00107900|41999618|FG005|Overall Study|Lost to Follow-up|5|||
19550574|NCT00107900|41999613|FG000|Overall Study|Protocol Violation|1|||
19550575|NCT00107900|41999614|FG001|Overall Study|Protocol Violation|0|||
19550576|NCT00107900|41999615|FG002|Overall Study|Protocol Violation|5|||
19550577|NCT00107900|41999616|FG003|Overall Study|Protocol Violation|5|||
19550578|NCT00107900|41999617|FG004|Overall Study|Protocol Violation|7|||
19550579|NCT00107900|41999618|FG005|Overall Study|Protocol Violation|0|||
19550580|NCT00107900|41999613|FG000|Overall Study|Withdrawal by Subject|1|||
19550581|NCT00107900|41999614|FG001|Overall Study|Withdrawal by Subject|0|||
19550582|NCT00107900|41999615|FG002|Overall Study|Withdrawal by Subject|5|||
19550583|NCT00107900|41999616|FG003|Overall Study|Withdrawal by Subject|0|||
19550584|NCT00107900|41999617|FG004|Overall Study|Withdrawal by Subject|1|||
19550585|NCT00107900|41999618|FG005|Overall Study|Withdrawal by Subject|1|||
19550586|NCT00107900|41999613|FG000|Overall Study|Administrative Reasons|1|||
19550587|NCT00107900|41999614|FG001|Overall Study|Administrative Reasons|0|||
19550588|NCT00107900|41999615|FG002|Overall Study|Administrative Reasons|2|||
19550589|NCT00107900|41999616|FG003|Overall Study|Administrative Reasons|2|||
19550590|NCT00107900|41999617|FG004|Overall Study|Administrative Reasons|2|||
19550591|NCT00107900|41999618|FG005|Overall Study|Administrative Reasons|0|||
19550592|NCT01339052|41999634|FG000|Overall Study|Disease progression|13|||
19550593|NCT01339052|41999635|FG001|Overall Study|Disease progression|46|||
19550594|NCT01339052|41999634|FG000|Overall Study|Adverse Event|1|||
19550595|NCT01339052|41999635|FG001|Overall Study|Adverse Event|1|||
19550596|NCT01339052|41999634|FG000|Overall Study|Withdrawal by Subject|0|||
19550597|NCT01339052|41999635|FG001|Overall Study|Withdrawal by Subject|3|||
19550598|NCT01339052|41999634|FG000|Overall Study|Physician Decision|1|||
19550599|NCT01339052|41999635|FG001|Overall Study|Physician Decision|0|||
19550600|NCT00107315|41999644|FG000|Overall Study|Disease Progression|9|||
19550601|NCT00107315|41999644|FG000|Overall Study|Adverse Event|4|||
19550602|NCT00107315|41999644|FG000|Overall Study|Withdrawal by Subject|2|||
19550603|NCT01335971|41999651|FG000|Overall Study|Withdrawal by Subject|1|||
19550604|NCT01335971|41999652|FG001|Overall Study|Withdrawal by Subject|0|||
19550605|NCT01335971|41999653|FG002|Overall Study|Withdrawal by Subject|0|||
19550606|NCT01335971|41999651|FG000|Overall Study|Did not complete bronchoscopy|1|||
19550607|NCT01335971|41999652|FG001|Overall Study|Did not complete bronchoscopy|1|||
19550608|NCT01335971|41999653|FG002|Overall Study|Did not complete bronchoscopy|1|||
19550609|NCT00107276|41999661|FG000|Overall Study|Progression|46|||
19550610|NCT00107276|41999661|FG000|Overall Study|Adverse Event|6|||
19550611|NCT00107276|41999661|FG000|Overall Study|M.D. decision|2|||
19550612|NCT00107276|41999661|FG000|Overall Study|Patient refusal|1|||
19550613|NCT00107276|41999661|FG000|Overall Study|Death|1|||
19550614|NCT00107276|41999661|FG000|Overall Study|Ineligible|16|||
19550615|NCT01335698|41999671|FG000|Treatment Stage 1|Lack of Efficacy|3|||
19550616|NCT01335698|41999672|FG001|Treatment Stage 1|Lack of Efficacy|1|||
19550617|NCT01335698|41999673|FG002|Treatment Stage 1|Lack of Efficacy|3|||
19550618|NCT01335698|41999674|FG003|Treatment Stage 1|Lack of Efficacy|3|||
19550619|NCT01335698|41999675|FG004|Treatment Stage 1|Lack of Efficacy|1|||
19550620|NCT01335698|41999671|FG000|Treatment Stage 1|Adverse Event|1|||
19550621|NCT01335698|41999672|FG001|Treatment Stage 1|Adverse Event|2|||
19550622|NCT01335698|41999673|FG002|Treatment Stage 1|Adverse Event|2|||
19550623|NCT01335698|41999674|FG003|Treatment Stage 1|Adverse Event|1|||
19550624|NCT01335698|41999675|FG004|Treatment Stage 1|Adverse Event|1|||
19550625|NCT01335698|41999671|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
19550626|NCT01335698|41999672|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
19550627|NCT01335698|41999673|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
19550628|NCT01335698|41999674|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
19550629|NCT01335698|41999675|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
19550630|NCT01335698|41999671|FG000|Treatment Stage 1|Lost to Follow-up|1|||
19550631|NCT01335698|41999672|FG001|Treatment Stage 1|Lost to Follow-up|1|||
19550632|NCT01335698|41999673|FG002|Treatment Stage 1|Lost to Follow-up|0|||
19550633|NCT01335698|41999674|FG003|Treatment Stage 1|Lost to Follow-up|0|||
19550634|NCT01335698|41999675|FG004|Treatment Stage 1|Lost to Follow-up|0|||
19550635|NCT01335698|41999671|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
19550636|NCT01335698|41999672|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
19550637|NCT01335698|41999673|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
19550638|NCT01335698|41999674|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
19550639|NCT01335698|41999675|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
19550640|NCT01335698|41999671|FG000|Treatment Stage 1|No longer meets study criteria|1|||
19550641|NCT01335698|41999672|FG001|Treatment Stage 1|No longer meets study criteria|1|||
19550642|NCT01335698|41999673|FG002|Treatment Stage 1|No longer meets study criteria|0|||
19550643|NCT01335698|41999674|FG003|Treatment Stage 1|No longer meets study criteria|1|||
19550644|NCT01335698|41999675|FG004|Treatment Stage 1|No longer meets study criteria|0|||
19550645|NCT01335698|41999671|FG000|Treatment Stage 1|Other|1|||
19550646|NCT01335698|41999672|FG001|Treatment Stage 1|Other|0|||
19550647|NCT01335698|41999673|FG002|Treatment Stage 1|Other|0|||
19550648|NCT01335698|41999674|FG003|Treatment Stage 1|Other|1|||
19550649|NCT01335698|41999675|FG004|Treatment Stage 1|Other|0|||
19550650|NCT01335698|41999671|FG000|Treatment Stage 2|Lack of Efficacy|2|||
19550651|NCT01335698|41999672|FG001|Treatment Stage 2|Lack of Efficacy|1|||
19550652|NCT01335698|41999673|FG002|Treatment Stage 2|Lack of Efficacy|3|||
19550653|NCT01335698|41999674|FG003|Treatment Stage 2|Lack of Efficacy|1|||
19550654|NCT01335698|41999675|FG004|Treatment Stage 2|Lack of Efficacy|0|||
19550655|NCT01335698|41999671|FG000|Treatment Stage 2|Adverse Event|2|||
19550656|NCT01335698|41999672|FG001|Treatment Stage 2|Adverse Event|0|||
19550657|NCT01335698|41999673|FG002|Treatment Stage 2|Adverse Event|0|||
19550658|NCT01335698|41999674|FG003|Treatment Stage 2|Adverse Event|3|||
19550659|NCT01335698|41999675|FG004|Treatment Stage 2|Adverse Event|0|||
19550660|NCT01335698|41999671|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
19550661|NCT01335698|41999672|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
19550662|NCT01335698|41999673|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
19550663|NCT01335698|41999674|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
19550664|NCT01335698|41999675|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
19550665|NCT01335698|41999671|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
19550666|NCT01335698|41999672|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
19550667|NCT01335698|41999673|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
19550668|NCT01335698|41999674|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
19550669|NCT01335698|41999675|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
19550670|NCT01335698|41999671|FG000|Treatment Stage 2|Lost to Follow-up|1|||
19550671|NCT01335698|41999672|FG001|Treatment Stage 2|Lost to Follow-up|0|||
19550672|NCT01335698|41999673|FG002|Treatment Stage 2|Lost to Follow-up|0|||
19550673|NCT01335698|41999674|FG003|Treatment Stage 2|Lost to Follow-up|0|||
19550674|NCT01335698|41999675|FG004|Treatment Stage 2|Lost to Follow-up|0|||
19550675|NCT01335698|41999671|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
19550676|NCT01335698|41999672|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
19550677|NCT01335698|41999673|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
19550678|NCT01335698|41999674|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
19550679|NCT01335698|41999675|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
19550680|NCT01335698|41999671|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
19550681|NCT01335698|41999672|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
19550682|NCT01335698|41999673|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
19550683|NCT01335698|41999674|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
19550684|NCT01335698|41999675|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
19550685|NCT01335698|41999671|FG000|Treatment Stage 2|Switched to another formulation|1|||
19550686|NCT01335698|41999672|FG001|Treatment Stage 2|Switched to another formulation|1|||
19550687|NCT01335698|41999673|FG002|Treatment Stage 2|Switched to another formulation|0|||
19550688|NCT01335698|41999674|FG003|Treatment Stage 2|Switched to another formulation|0|||
19550689|NCT01335698|41999675|FG004|Treatment Stage 2|Switched to another formulation|0|||
19550690|NCT00107198|41999689|FG000|Overall Study|Lack of Efficacy|28|||
19550691|NCT00107198|41999689|FG000|Overall Study|Lost to Follow-up|12|||
19550692|NCT00107198|41999689|FG000|Overall Study|Protocol Violation|1|||
19550693|NCT00107198|41999689|FG000|Overall Study|Withdrawal by Subject|6|||
19550694|NCT00107198|41999689|FG000|Overall Study|Ineligible|5|||
19550695|NCT00107120|41999695|FG000|Overall Study|Adverse Event|4|||
19550696|NCT00107120|41999696|FG001|Overall Study|Adverse Event|1|||
19550697|NCT00107120|41999695|FG000|Overall Study|Lack of Efficacy|5|||
19550698|NCT00107120|41999696|FG001|Overall Study|Lack of Efficacy|5|||
19550699|NCT00107120|41999695|FG000|Overall Study|Protocol Violation|3|||
19550700|NCT00107120|41999696|FG001|Overall Study|Protocol Violation|0|||
19550701|NCT00107120|41999695|FG000|Overall Study|Withdrawal by Subject|8|||
19550702|NCT00107120|41999696|FG001|Overall Study|Withdrawal by Subject|9|||
19550703|NCT00107120|41999695|FG000|Overall Study|Lost to Follow-up|8|||
19550704|NCT00107120|41999696|FG001|Overall Study|Lost to Follow-up|6|||
19550705|NCT00107120|41999695|FG000|Overall Study|Pregnancy|0|||
19550706|NCT00107120|41999696|FG001|Overall Study|Pregnancy|1|||
19550707|NCT00107120|41999695|FG000|Overall Study|moving away from site|1|||
19550708|NCT00107120|41999696|FG001|Overall Study|moving away from site|1|||
19550709|NCT00107120|41999695|FG000|Overall Study|death of parent|0|||
19550710|NCT00107120|41999696|FG001|Overall Study|death of parent|1|||
19550711|NCT01335464|41999704|FG000|Overall Study|Adverse Event|15|||
19550712|NCT01335464|41999705|FG001|Overall Study|Adverse Event|25|||
19550713|NCT01335464|41999704|FG000|Overall Study|Non compliant with protocol|2|||
19550714|NCT01335464|41999705|FG001|Overall Study|Non compliant with protocol|0|||
19550715|NCT01335464|41999704|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
19550716|NCT01335464|41999705|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
19550717|NCT01335464|41999704|FG000|Overall Study|Not treated|2|||
19550718|NCT01335464|41999705|FG001|Overall Study|Not treated|0|||
19550719|NCT01335464|41999704|FG000|Overall Study|Reason other than those stated above|1|||
19550720|NCT01335464|41999705|FG001|Overall Study|Reason other than those stated above|1|||
19550721|NCT00107042|41999713|FG000|Overall Study|Lost to Follow-up|9|||
19550722|NCT00107042|41999714|FG001|Overall Study|Lost to Follow-up|7|||
19550723|NCT00107042|41999713|FG000|Overall Study|Withdrawal by Subject|6|||
19550724|NCT00107042|41999714|FG001|Overall Study|Withdrawal by Subject|1|||
19550725|NCT00107042|41999713|FG000|Overall Study|Moved out of area|5|||
19550726|NCT00107042|41999714|FG001|Overall Study|Moved out of area|3|||
19550727|NCT00107042|41999713|FG000|Overall Study|Pregnancy|1|||
19550728|NCT00107042|41999714|FG001|Overall Study|Pregnancy|1|||
19550729|NCT00107042|41999713|FG000|Overall Study|Inadvertent enrollment|0|||
19550730|NCT00107042|41999714|FG001|Overall Study|Inadvertent enrollment|1|||
19550731|NCT00107042|41999713|FG000|Overall Study|vaccinated outside window|1|||
19550732|NCT00107042|41999714|FG001|Overall Study|vaccinated outside window|1|||
19550733|NCT00107042|41999713|FG000|Overall Study|Disallowed medications|0|||
19550734|NCT00107042|41999714|FG001|Overall Study|Disallowed medications|2|||
19550735|NCT00106964|41999765|FG000|Overall Study|Lost to Follow-up|8|||
19550736|NCT00106964|41999766|FG001|Overall Study|Lost to Follow-up|6|||
19550737|NCT00106964|41999767|FG002|Overall Study|Lost to Follow-up|2|||
19550738|NCT00106964|41999765|FG000|Overall Study|Pregnancy|2|||
19550739|NCT00106964|41999766|FG001|Overall Study|Pregnancy|3|||
19550740|NCT00106964|41999767|FG002|Overall Study|Pregnancy|2|||
19550741|NCT00106964|41999765|FG000|Overall Study|Death|1|||
19550742|NCT00106964|41999766|FG001|Overall Study|Death|1|||
19550743|NCT00106964|41999767|FG002|Overall Study|Death|0|||
19550744|NCT00106964|41999765|FG000|Overall Study|Incarceration|0|||
19550745|NCT00106964|41999766|FG001|Overall Study|Incarceration|1|||
19550746|NCT00106964|41999767|FG002|Overall Study|Incarceration|0|||
19550747|NCT00106964|41999765|FG000|Overall Study|Site Funding Terminated|0|||
19550748|NCT00106964|41999766|FG001|Overall Study|Site Funding Terminated|1|||
19550749|NCT00106964|41999767|FG002|Overall Study|Site Funding Terminated|1|||
19550750|NCT00106964|41999765|FG000|Overall Study|Failure to adhere|2|||
19550751|NCT00106964|41999766|FG001|Overall Study|Failure to adhere|0|||
19550752|NCT00106964|41999767|FG002|Overall Study|Failure to adhere|0|||
19550753|NCT00106964|41999765|FG000|Overall Study|Did not meet eligibility criteria|0|||
19550754|NCT00106964|41999766|FG001|Overall Study|Did not meet eligibility criteria|2|||
19550755|NCT00106964|41999767|FG002|Overall Study|Did not meet eligibility criteria|2|||
19550756|NCT00106964|41999765|FG000|Overall Study|Required disallowed medication|0|||
19550757|NCT00106964|41999766|FG001|Overall Study|Required disallowed medication|1|||
19550758|NCT00106964|41999767|FG002|Overall Study|Required disallowed medication|0|||
19550759|NCT00106184|41999786|FG000|Overall Study|Withdrawal by Subject|3|||
19550760|NCT00106184|41999787|FG001|Overall Study|Withdrawal by Subject|2|||
19550761|NCT01334918|41999797|FG000|Overall Study|Did not receive study drug|6|||
19550762|NCT01334918|41999798|FG001|Overall Study|Did not receive study drug|0|||
19550763|NCT01334918|41999797|FG000|Overall Study|Adverse Event|2|||
19550764|NCT01334918|41999798|FG001|Overall Study|Adverse Event|0|||
19550765|NCT01334918|41999797|FG000|Overall Study|Withdrawal by Subject|0|||
19550766|NCT01334918|41999798|FG001|Overall Study|Withdrawal by Subject|1|||
19550767|NCT01332968|41999817|FG000|Induction Period|Adverse Event|23|||
19550768|NCT01332968|41999818|FG001|Induction Period|Adverse Event|26|||
19550769|NCT01332968|41999819|FG002|Induction Period|Adverse Event|0|||
19550770|NCT01332968|41999820|FG003|Induction Period|Adverse Event|0|||
19550771|NCT01332968|41999821|FG004|Induction Period|Adverse Event|0|||
19550772|NCT01332968|41999822|FG005|Induction Period|Adverse Event|0|||
19550773|NCT01332968|41999823|FG006|Induction Period|Adverse Event|0|||
19550774|NCT01332968|41999824|FG007|Induction Period|Adverse Event|0|||
19550775|NCT01332968|41999817|FG000|Induction Period|Death|1|||
19550776|NCT01332968|41999818|FG001|Induction Period|Death|4|||
19550777|NCT01332968|41999819|FG002|Induction Period|Death|0|||
19550778|NCT01332968|41999820|FG003|Induction Period|Death|0|||
19550779|NCT01332968|41999821|FG004|Induction Period|Death|0|||
19550780|NCT01332968|41999822|FG005|Induction Period|Death|0|||
19550781|NCT01332968|41999823|FG006|Induction Period|Death|0|||
19550782|NCT01332968|41999824|FG007|Induction Period|Death|0|||
19550783|NCT01332968|41999817|FG000|Induction Period|Non-compliance|1|||
19550784|NCT01332968|41999818|FG001|Induction Period|Non-compliance|0|||
19550785|NCT01332968|41999819|FG002|Induction Period|Non-compliance|0|||
19550786|NCT01332968|41999820|FG003|Induction Period|Non-compliance|0|||
19550787|NCT01332968|41999821|FG004|Induction Period|Non-compliance|0|||
19550788|NCT01332968|41999822|FG005|Induction Period|Non-compliance|0|||
19550789|NCT01332968|41999823|FG006|Induction Period|Non-compliance|0|||
19550790|NCT01332968|41999824|FG007|Induction Period|Non-compliance|0|||
19550791|NCT01332968|41999817|FG000|Induction Period|Other|2|||
19550792|NCT01332968|41999818|FG001|Induction Period|Other|2|||
19550793|NCT01332968|41999819|FG002|Induction Period|Other|0|||
19550794|NCT01332968|41999820|FG003|Induction Period|Other|0|||
19550795|NCT01332968|41999821|FG004|Induction Period|Other|0|||
19550796|NCT01332968|41999822|FG005|Induction Period|Other|0|||
19550797|NCT01332968|41999823|FG006|Induction Period|Other|0|||
19550798|NCT01332968|41999824|FG007|Induction Period|Other|0|||
19550799|NCT01332968|41999817|FG000|Induction Period|Physician Decision|6|||
19550800|NCT01332968|41999818|FG001|Induction Period|Physician Decision|1|||
19550801|NCT01332968|41999819|FG002|Induction Period|Physician Decision|0|||
19550802|NCT01332968|41999820|FG003|Induction Period|Physician Decision|0|||
19550803|NCT01332968|41999821|FG004|Induction Period|Physician Decision|0|||
19550804|NCT01332968|41999822|FG005|Induction Period|Physician Decision|0|||
19550805|NCT01332968|41999823|FG006|Induction Period|Physician Decision|0|||
19550806|NCT01332968|41999824|FG007|Induction Period|Physician Decision|0|||
19550807|NCT01332968|41999817|FG000|Induction Period|Progressive Disease|15|||
19550808|NCT01332968|41999818|FG001|Induction Period|Progressive Disease|7|||
19550809|NCT01332968|41999819|FG002|Induction Period|Progressive Disease|0|||
19550810|NCT01332968|41999820|FG003|Induction Period|Progressive Disease|0|||
19550811|NCT01332968|41999821|FG004|Induction Period|Progressive Disease|0|||
19550812|NCT01332968|41999822|FG005|Induction Period|Progressive Disease|0|||
19550813|NCT01332968|41999823|FG006|Induction Period|Progressive Disease|0|||
19550814|NCT01332968|41999824|FG007|Induction Period|Progressive Disease|0|||
19550815|NCT01332968|41999817|FG000|Induction Period|Protocol Violation|3|||
19550816|NCT01332968|41999818|FG001|Induction Period|Protocol Violation|4|||
19550817|NCT01332968|41999819|FG002|Induction Period|Protocol Violation|0|||
19550818|NCT01332968|41999820|FG003|Induction Period|Protocol Violation|0|||
19550819|NCT01332968|41999821|FG004|Induction Period|Protocol Violation|0|||
19550820|NCT01332968|41999822|FG005|Induction Period|Protocol Violation|0|||
19550821|NCT01332968|41999823|FG006|Induction Period|Protocol Violation|0|||
19550822|NCT01332968|41999824|FG007|Induction Period|Protocol Violation|0|||
19550823|NCT01332968|41999817|FG000|Induction Period|Withdrawal by Subject|3|||
19550824|NCT01332968|41999818|FG001|Induction Period|Withdrawal by Subject|5|||
19550825|NCT01332968|41999819|FG002|Induction Period|Withdrawal by Subject|0|||
19550826|NCT01332968|41999820|FG003|Induction Period|Withdrawal by Subject|0|||
19550827|NCT01332968|41999821|FG004|Induction Period|Withdrawal by Subject|0|||
19550828|NCT01332968|41999822|FG005|Induction Period|Withdrawal by Subject|0|||
19550829|NCT01332968|41999823|FG006|Induction Period|Withdrawal by Subject|0|||
19550830|NCT01332968|41999824|FG007|Induction Period|Withdrawal by Subject|0|||
19550831|NCT01332968|41999817|FG000|Induction Period|Randomised but not treated|4|||
19550832|NCT01332968|41999818|FG001|Induction Period|Randomised but not treated|7|||
19550833|NCT01332968|41999819|FG002|Induction Period|Randomised but not treated|0|||
19550834|NCT01332968|41999820|FG003|Induction Period|Randomised but not treated|0|||
19550835|NCT01332968|41999821|FG004|Induction Period|Randomised but not treated|0|||
19550836|NCT01332968|41999822|FG005|Induction Period|Randomised but not treated|0|||
19550837|NCT01332968|41999823|FG006|Induction Period|Randomised but not treated|0|||
19550838|NCT01332968|41999824|FG007|Induction Period|Randomised but not treated|0|||
19550839|NCT01332968|41999817|FG000|Maintenance/Observation Period|Adverse Event|0|||
19550840|NCT01332968|41999818|FG001|Maintenance/Observation Period|Adverse Event|0|||
19550841|NCT01332968|41999819|FG002|Maintenance/Observation Period|Adverse Event|53|||
19550842|NCT01332968|41999820|FG003|Maintenance/Observation Period|Adverse Event|66|||
19550843|NCT01332968|41999821|FG004|Maintenance/Observation Period|Adverse Event|0|||
19550844|NCT01332968|41999822|FG005|Maintenance/Observation Period|Adverse Event|0|||
19550845|NCT01332968|41999823|FG006|Maintenance/Observation Period|Adverse Event|0|||
19550846|NCT01332968|41999824|FG007|Maintenance/Observation Period|Adverse Event|0|||
19550847|NCT01332968|41999817|FG000|Maintenance/Observation Period|Death|0|||
19550848|NCT01332968|41999818|FG001|Maintenance/Observation Period|Death|0|||
19550849|NCT01332968|41999819|FG002|Maintenance/Observation Period|Death|5|||
19550850|NCT01332968|41999820|FG003|Maintenance/Observation Period|Death|6|||
19550851|NCT01332968|41999821|FG004|Maintenance/Observation Period|Death|0|||
19550852|NCT01332968|41999822|FG005|Maintenance/Observation Period|Death|0|||
19550853|NCT01332968|41999823|FG006|Maintenance/Observation Period|Death|0|||
19550854|NCT01332968|41999824|FG007|Maintenance/Observation Period|Death|0|||
19550855|NCT01332968|41999817|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
19550856|NCT01332968|41999818|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
19550857|NCT01332968|41999819|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
19550858|NCT01332968|41999820|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
19550859|NCT01332968|41999821|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
19550860|NCT01332968|41999822|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
19550861|NCT01332968|41999823|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
19550862|NCT01332968|41999824|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
19550863|NCT01332968|41999817|FG000|Maintenance/Observation Period|Non-compliance|0|||
19550864|NCT01332968|41999818|FG001|Maintenance/Observation Period|Non-compliance|0|||
19550865|NCT01332968|41999819|FG002|Maintenance/Observation Period|Non-compliance|4|||
19550866|NCT01332968|41999820|FG003|Maintenance/Observation Period|Non-compliance|3|||
19550867|NCT01332968|41999821|FG004|Maintenance/Observation Period|Non-compliance|0|||
19550868|NCT01332968|41999822|FG005|Maintenance/Observation Period|Non-compliance|0|||
19550869|NCT01332968|41999823|FG006|Maintenance/Observation Period|Non-compliance|0|||
19550870|NCT01332968|41999824|FG007|Maintenance/Observation Period|Non-compliance|0|||
19550871|NCT01332968|41999817|FG000|Maintenance/Observation Period|Other|0|||
19550872|NCT01332968|41999818|FG001|Maintenance/Observation Period|Other|0|||
19550873|NCT01332968|41999819|FG002|Maintenance/Observation Period|Other|4|||
19550874|NCT01332968|41999820|FG003|Maintenance/Observation Period|Other|7|||
19550875|NCT01332968|41999821|FG004|Maintenance/Observation Period|Other|0|||
19550876|NCT01332968|41999822|FG005|Maintenance/Observation Period|Other|0|||
19550877|NCT01332968|41999823|FG006|Maintenance/Observation Period|Other|0|||
19550878|NCT01332968|41999824|FG007|Maintenance/Observation Period|Other|0|||
19550879|NCT01332968|41999817|FG000|Maintenance/Observation Period|Physician Decision|0|||
19550880|NCT01332968|41999818|FG001|Maintenance/Observation Period|Physician Decision|0|||
19550881|NCT01332968|41999819|FG002|Maintenance/Observation Period|Physician Decision|14|||
19550882|NCT01332968|41999820|FG003|Maintenance/Observation Period|Physician Decision|19|||
19550883|NCT01332968|41999821|FG004|Maintenance/Observation Period|Physician Decision|0|||
19550884|NCT01332968|41999822|FG005|Maintenance/Observation Period|Physician Decision|1|||
19550885|NCT01332968|41999823|FG006|Maintenance/Observation Period|Physician Decision|0|||
19550886|NCT01332968|41999824|FG007|Maintenance/Observation Period|Physician Decision|0|||
19550887|NCT01332968|41999817|FG000|Maintenance/Observation Period|Progressive Disease|0|||
19550888|NCT01332968|41999818|FG001|Maintenance/Observation Period|Progressive Disease|0|||
19550889|NCT01332968|41999819|FG002|Maintenance/Observation Period|Progressive Disease|72|||
19550890|NCT01332968|41999820|FG003|Maintenance/Observation Period|Progressive Disease|40|||
19550891|NCT01332968|41999821|FG004|Maintenance/Observation Period|Progressive Disease|0|||
19550892|NCT01332968|41999822|FG005|Maintenance/Observation Period|Progressive Disease|0|||
19550893|NCT01332968|41999823|FG006|Maintenance/Observation Period|Progressive Disease|0|||
19550894|NCT01332968|41999824|FG007|Maintenance/Observation Period|Progressive Disease|0|||
19550895|NCT01332968|41999817|FG000|Maintenance/Observation Period|Protocol Violation|0|||
19550896|NCT01332968|41999818|FG001|Maintenance/Observation Period|Protocol Violation|0|||
19550897|NCT01332968|41999819|FG002|Maintenance/Observation Period|Protocol Violation|1|||
19550898|NCT01332968|41999820|FG003|Maintenance/Observation Period|Protocol Violation|1|||
19550899|NCT01332968|41999821|FG004|Maintenance/Observation Period|Protocol Violation|0|||
19550900|NCT01332968|41999822|FG005|Maintenance/Observation Period|Protocol Violation|0|||
19550901|NCT01332968|41999823|FG006|Maintenance/Observation Period|Protocol Violation|0|||
19550902|NCT01332968|41999824|FG007|Maintenance/Observation Period|Protocol Violation|0|||
19550903|NCT01332968|41999817|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550904|NCT01332968|41999818|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550905|NCT01332968|41999819|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
19550906|NCT01332968|41999820|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
19550907|NCT01332968|41999821|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550908|NCT01332968|41999822|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550909|NCT01332968|41999823|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550910|NCT01332968|41999824|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
19550911|NCT01332968|41999817|FG000|Follow-Up Period|Adverse Event|0|||
19550912|NCT01332968|41999818|FG001|Follow-Up Period|Adverse Event|0|||
19550913|NCT01332968|41999819|FG002|Follow-Up Period|Adverse Event|0|||
19550914|NCT01332968|41999820|FG003|Follow-Up Period|Adverse Event|0|||
19550915|NCT01332968|41999821|FG004|Follow-Up Period|Adverse Event|0|||
19550916|NCT01332968|41999822|FG005|Follow-Up Period|Adverse Event|0|||
19550917|NCT01332968|41999823|FG006|Follow-Up Period|Adverse Event|0|||
19550918|NCT01332968|41999824|FG007|Follow-Up Period|Adverse Event|4|||
19550919|NCT01332968|41999817|FG000|Follow-Up Period|Death|0|||
19550920|NCT01332968|41999818|FG001|Follow-Up Period|Death|0|||
19550921|NCT01332968|41999819|FG002|Follow-Up Period|Death|0|||
19550922|NCT01332968|41999820|FG003|Follow-Up Period|Death|0|||
19550923|NCT01332968|41999821|FG004|Follow-Up Period|Death|0|||
19550924|NCT01332968|41999822|FG005|Follow-Up Period|Death|0|||
19550925|NCT01332968|41999823|FG006|Follow-Up Period|Death|27|||
19550926|NCT01332968|41999824|FG007|Follow-Up Period|Death|30|||
19550927|NCT01332968|41999817|FG000|Follow-Up Period|Lost to Follow-up|0|||
19550928|NCT01332968|41999818|FG001|Follow-Up Period|Lost to Follow-up|0|||
19550929|NCT01332968|41999819|FG002|Follow-Up Period|Lost to Follow-up|0|||
19550930|NCT01332968|41999820|FG003|Follow-Up Period|Lost to Follow-up|0|||
19550931|NCT01332968|41999821|FG004|Follow-Up Period|Lost to Follow-up|0|||
19550932|NCT01332968|41999822|FG005|Follow-Up Period|Lost to Follow-up|0|||
19550933|NCT01332968|41999823|FG006|Follow-Up Period|Lost to Follow-up|11|||
19550934|NCT01332968|41999824|FG007|Follow-Up Period|Lost to Follow-up|15|||
19550935|NCT01332968|41999817|FG000|Follow-Up Period|Non-compliance|0|||
19550936|NCT01332968|41999818|FG001|Follow-Up Period|Non-compliance|0|||
19550937|NCT01332968|41999819|FG002|Follow-Up Period|Non-compliance|0|||
19550938|NCT01332968|41999820|FG003|Follow-Up Period|Non-compliance|0|||
19550939|NCT01332968|41999821|FG004|Follow-Up Period|Non-compliance|0|||
19550940|NCT01332968|41999822|FG005|Follow-Up Period|Non-compliance|0|||
19550941|NCT01332968|41999823|FG006|Follow-Up Period|Non-compliance|4|||
19550942|NCT01332968|41999824|FG007|Follow-Up Period|Non-compliance|9|||
19550943|NCT01332968|41999817|FG000|Follow-Up Period|Other|0|||
19550944|NCT01332968|41999818|FG001|Follow-Up Period|Other|0|||
19550945|NCT01332968|41999819|FG002|Follow-Up Period|Other|0|||
19550946|NCT01332968|41999820|FG003|Follow-Up Period|Other|0|||
19550947|NCT01332968|41999821|FG004|Follow-Up Period|Other|0|||
19550948|NCT01332968|41999822|FG005|Follow-Up Period|Other|0|||
19550949|NCT01332968|41999823|FG006|Follow-Up Period|Other|18|||
19550950|NCT01332968|41999824|FG007|Follow-Up Period|Other|21|||
19550951|NCT01332968|41999817|FG000|Follow-Up Period|Physician Decision|0|||
19550952|NCT01332968|41999818|FG001|Follow-Up Period|Physician Decision|0|||
19550953|NCT01332968|41999819|FG002|Follow-Up Period|Physician Decision|0|||
19550954|NCT01332968|41999820|FG003|Follow-Up Period|Physician Decision|0|||
19550955|NCT01332968|41999821|FG004|Follow-Up Period|Physician Decision|0|||
19550956|NCT01332968|41999822|FG005|Follow-Up Period|Physician Decision|0|||
19550957|NCT01332968|41999823|FG006|Follow-Up Period|Physician Decision|12|||
19550958|NCT01332968|41999824|FG007|Follow-Up Period|Physician Decision|15|||
19550959|NCT01332968|41999817|FG000|Follow-Up Period|Progressive Disease|0|||
19550960|NCT01332968|41999818|FG001|Follow-Up Period|Progressive Disease|0|||
19550961|NCT01332968|41999819|FG002|Follow-Up Period|Progressive Disease|0|||
19550962|NCT01332968|41999820|FG003|Follow-Up Period|Progressive Disease|0|||
19550963|NCT01332968|41999821|FG004|Follow-Up Period|Progressive Disease|0|||
19550964|NCT01332968|41999822|FG005|Follow-Up Period|Progressive Disease|0|||
19550965|NCT01332968|41999823|FG006|Follow-Up Period|Progressive Disease|126|||
19550966|NCT01332968|41999824|FG007|Follow-Up Period|Progressive Disease|106|||
19550967|NCT01332968|41999817|FG000|Follow-Up Period|Protocol Violation|0|||
19550968|NCT01332968|41999818|FG001|Follow-Up Period|Protocol Violation|0|||
19550969|NCT01332968|41999819|FG002|Follow-Up Period|Protocol Violation|0|||
19550970|NCT01332968|41999820|FG003|Follow-Up Period|Protocol Violation|0|||
19550971|NCT01332968|41999821|FG004|Follow-Up Period|Protocol Violation|0|||
19550972|NCT01332968|41999822|FG005|Follow-Up Period|Protocol Violation|0|||
19550973|NCT01332968|41999823|FG006|Follow-Up Period|Protocol Violation|1|||
19550974|NCT01332968|41999824|FG007|Follow-Up Period|Protocol Violation|0|||
19550975|NCT01332968|41999817|FG000|Follow-Up Period|Withdrawal by Subject|0|||
19550976|NCT01332968|41999818|FG001|Follow-Up Period|Withdrawal by Subject|0|||
19550977|NCT01332968|41999819|FG002|Follow-Up Period|Withdrawal by Subject|0|||
19550978|NCT01332968|41999820|FG003|Follow-Up Period|Withdrawal by Subject|0|||
19550979|NCT01332968|41999821|FG004|Follow-Up Period|Withdrawal by Subject|0|||
19550980|NCT01332968|41999822|FG005|Follow-Up Period|Withdrawal by Subject|0|||
19550981|NCT01332968|41999823|FG006|Follow-Up Period|Withdrawal by Subject|29|||
19550982|NCT01332968|41999824|FG007|Follow-Up Period|Withdrawal by Subject|32|||
19550983|NCT01332968|41999817|FG000|Follow-Up Period|No reason provided|0|||
19550984|NCT01332968|41999818|FG001|Follow-Up Period|No reason provided|0|||
19550985|NCT01332968|41999819|FG002|Follow-Up Period|No reason provided|0|||
19550986|NCT01332968|41999820|FG003|Follow-Up Period|No reason provided|0|||
19550987|NCT01332968|41999821|FG004|Follow-Up Period|No reason provided|0|||
19550988|NCT01332968|41999822|FG005|Follow-Up Period|No reason provided|0|||
19550989|NCT01332968|41999823|FG006|Follow-Up Period|No reason provided|2|||
19550990|NCT01332968|41999824|FG007|Follow-Up Period|No reason provided|3|||
19550991|NCT01332851|41999834|FG000|Overall Study|Withdrawal by Subject|4|||
19550992|NCT01332851|41999835|FG001|Overall Study|Withdrawal by Subject|2|||
19550993|NCT01332851|41999834|FG000|Overall Study|Lost to Follow-up|7|||
19550994|NCT01332851|41999835|FG001|Overall Study|Lost to Follow-up|11|||
19550995|NCT01332305|41999850|FG000|Overall Study|Adverse Event|1|||
19550996|NCT01332305|41999851|FG001|Overall Study|Adverse Event|4|||
19550997|NCT01332305|41999852|FG002|Overall Study|Adverse Event|6|||
19550998|NCT01332305|41999853|FG003|Overall Study|Adverse Event|3|||
19550999|NCT01332305|41999854|FG004|Overall Study|Adverse Event|5|||
19551000|NCT01332305|41999850|FG000|Overall Study|Withdrawal by Subject|6|||
19551001|NCT01332305|41999851|FG001|Overall Study|Withdrawal by Subject|5|||
19551002|NCT01332305|41999852|FG002|Overall Study|Withdrawal by Subject|4|||
19551003|NCT01332305|41999853|FG003|Overall Study|Withdrawal by Subject|1|||
19551004|NCT01332305|41999854|FG004|Overall Study|Withdrawal by Subject|0|||
19551005|NCT01332305|41999850|FG000|Overall Study|Lost to Follow-up|0|||
19551006|NCT01332305|41999851|FG001|Overall Study|Lost to Follow-up|2|||
19551007|NCT01332305|41999852|FG002|Overall Study|Lost to Follow-up|3|||
19551008|NCT01332305|41999853|FG003|Overall Study|Lost to Follow-up|2|||
19551009|NCT01332305|41999854|FG004|Overall Study|Lost to Follow-up|3|||
19551010|NCT01332305|41999850|FG000|Overall Study|Protocol Violation|1|||
19551011|NCT01332305|41999851|FG001|Overall Study|Protocol Violation|2|||
19551012|NCT01332305|41999852|FG002|Overall Study|Protocol Violation|1|||
19551013|NCT01332305|41999853|FG003|Overall Study|Protocol Violation|0|||
19551014|NCT01332305|41999854|FG004|Overall Study|Protocol Violation|3|||
19551015|NCT01332305|41999850|FG000|Overall Study|Withdrawal by Sponsor|1|||
19551016|NCT01332305|41999851|FG001|Overall Study|Withdrawal by Sponsor|0|||
19551017|NCT01332305|41999852|FG002|Overall Study|Withdrawal by Sponsor|0|||
19551018|NCT01332305|41999853|FG003|Overall Study|Withdrawal by Sponsor|1|||
19551019|NCT01332305|41999854|FG004|Overall Study|Withdrawal by Sponsor|1|||
19551020|NCT01332305|41999850|FG000|Overall Study|Treatment Failure|1|||
19551021|NCT01332305|41999851|FG001|Overall Study|Treatment Failure|1|||
19551022|NCT01332305|41999852|FG002|Overall Study|Treatment Failure|0|||
19551023|NCT01332305|41999853|FG003|Overall Study|Treatment Failure|0|||
19551024|NCT01332305|41999854|FG004|Overall Study|Treatment Failure|0|||
19551025|NCT01332305|41999850|FG000|Overall Study|Physician Decision|0|||
19551026|NCT01332305|41999851|FG001|Overall Study|Physician Decision|0|||
19551027|NCT01332305|41999852|FG002|Overall Study|Physician Decision|0|||
19551028|NCT01332305|41999853|FG003|Overall Study|Physician Decision|1|||
19551029|NCT01332305|41999854|FG004|Overall Study|Physician Decision|0|||
